case_submitter_id,case_id,diagnosis_id,days_to_treatment_end,treatment_intent_type,days_to_treatment_start,updated_datetime,submitter_id,treatment_id,treatment_outcome,state,therapeutic_agents,treatment_or_therapy,created_datetime,treatment_type,initial_disease_status,regimen_or_line_of_therapy
HCM-BROD-0924-C34,00432ef4-23b6-49ff-8393-b030cfa9a65d,b3209234-7b59-47c2-a899-539e38c41dba,97.0,Maintenance Therapy,55.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0924-C34_treatment7,4a6a0973-10a7-49b6-9382-c882df01b286,Stable Disease,released,Etoposide,1,2021-12-21T13:56:55.642419-06:00,,,
HCM-BROD-0924-C34,00432ef4-23b6-49ff-8393-b030cfa9a65d,b3209234-7b59-47c2-a899-539e38c41dba,97.0,Maintenance Therapy,55.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0924-C34_treatment8,7297b9e9-2253-4de7-a5f2-cd21ee7f4e65,Stable Disease,released,Cisplatin,1,2021-12-21T13:56:55.642419-06:00,,,
HCM-BROD-0924-C34,00432ef4-23b6-49ff-8393-b030cfa9a65d,cf208fb3-ffa0-429b-8a93-2ef9d916bd9b,,,8.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0924-C34_treatment4,62382ff9-f35f-4a3b-af52-25446b9457b9,,released,,1,2021-12-21T13:56:55.642419-06:00,"Surgery, NOS",Initial Diagnosis,
HCM-BROD-0924-C34,00432ef4-23b6-49ff-8393-b030cfa9a65d,cf208fb3-ffa0-429b-8a93-2ef9d916bd9b,713.0,Adjuvant,708.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0924-C34_treatment6,739fd036-1680-40fa-85e3-f72cb18cc0d5,,released,,1,2021-12-21T13:56:55.642419-06:00,"Radiation Therapy, NOS",Residual Disease,
HCM-BROD-0924-C34,00432ef4-23b6-49ff-8393-b030cfa9a65d,cf208fb3-ffa0-429b-8a93-2ef9d916bd9b,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0924-C34_treatment5,76035c39-3a84-4a88-a15b-524381c07463,,released,,0,2021-12-21T13:56:55.642419-06:00,Targeted Molecular Therapy,Residual Disease,
HCM-BROD-0924-C34,00432ef4-23b6-49ff-8393-b030cfa9a65d,cf208fb3-ffa0-429b-8a93-2ef9d916bd9b,896.0,Adjuvant,882.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0924-C34_treatment3,91b0a02d-8ecc-477f-bc3b-e7d4fe7754c7,Treatment Ongoing,released,Nivolumab,1,2021-12-21T13:56:55.642419-06:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-BROD-0924-C34,00432ef4-23b6-49ff-8393-b030cfa9a65d,cf208fb3-ffa0-429b-8a93-2ef9d916bd9b,795.0,Adjuvant,788.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0924-C34_treatment2,d4dde050-7082-4d7d-8d36-27905f87585d,,released,Irinotecan,1,2021-12-21T13:56:55.642419-06:00,Chemotherapy,Residual Disease,
HCM-BROD-0924-C34,00432ef4-23b6-49ff-8393-b030cfa9a65d,cf208fb3-ffa0-429b-8a93-2ef9d916bd9b,,Neoadjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0924-C34_treatment,f097088b-9b45-46d3-bade-862cf6166f8b,,released,,0,2021-12-21T13:56:55.642419-06:00,,,
HCM-SANG-0522-C18,00d751af-4f77-488b-aa56-b67d38091c86,d668655f-d979-402f-9baf-375831055e74,,Neoadjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-SANG-0522-C18_treatment,dc09ffc6-0618-456e-a827-45d008a840bf,,released,,0,2021-12-21T15:13:14.297353-06:00,,,
HCM-CSHL-0161-C18,00dc3ba8-5a10-4120-bdad-c1c17b4b1ae7,c9c9c9ae-8c87-44c0-b23b-b36fc07f7953,,Adjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0161-C18_treatment5,0d2665a5-2243-4bde-a9be-415e3a75908c,,released,,0,2020-09-27T13:02:25.775217-05:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-CSHL-0161-C18,00dc3ba8-5a10-4120-bdad-c1c17b4b1ae7,c9c9c9ae-8c87-44c0-b23b-b36fc07f7953,143.0,Adjuvant,51.0,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0161-C18_treatment4,15f0ebda-ced4-48fc-9eda-f0650ea38386,,released,,1,2020-09-27T13:02:25.775217-05:00,Chemotherapy,Residual Disease,XELOX
HCM-CSHL-0161-C18,00dc3ba8-5a10-4120-bdad-c1c17b4b1ae7,c9c9c9ae-8c87-44c0-b23b-b36fc07f7953,,,41.0,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0161-C18_treatment6,1718e6ab-f514-4a50-996c-d743e7159baa,,released,,1,2020-09-27T13:02:25.775217-05:00,"Surgery, NOS",Initial Diagnosis,
HCM-CSHL-0161-C18,00dc3ba8-5a10-4120-bdad-c1c17b4b1ae7,c9c9c9ae-8c87-44c0-b23b-b36fc07f7953,143.0,Adjuvant,51.0,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0161-C18_treatment2,6c67545a-41e7-41d5-be24-e58b1060fdd0,,released,Oxaliplatin,1,2020-09-27T13:02:25.775217-05:00,Chemotherapy,Residual Disease,
HCM-CSHL-0161-C18,00dc3ba8-5a10-4120-bdad-c1c17b4b1ae7,c9c9c9ae-8c87-44c0-b23b-b36fc07f7953,,Neoadjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0161-C18_treatment,7883b0cc-85a7-4309-b43b-5214c76704b5,,released,,0,2020-09-27T13:02:25.775217-05:00,,,
HCM-CSHL-0161-C18,00dc3ba8-5a10-4120-bdad-c1c17b4b1ae7,c9c9c9ae-8c87-44c0-b23b-b36fc07f7953,,Adjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0161-C18_treatment8,873ad34b-4628-41be-ae27-f39c76498eff,,released,,0,2020-09-27T13:02:25.775217-05:00,"Radiation Therapy, NOS",Residual Disease,
HCM-CSHL-0161-C18,00dc3ba8-5a10-4120-bdad-c1c17b4b1ae7,c9c9c9ae-8c87-44c0-b23b-b36fc07f7953,,Adjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0161-C18_treatment7,c003a417-5637-4f01-8ef2-0da9ef9a0663,,released,,0,2020-09-27T13:02:25.775217-05:00,Targeted Molecular Therapy,Residual Disease,
HCM-CSHL-0161-C18,00dc3ba8-5a10-4120-bdad-c1c17b4b1ae7,c9c9c9ae-8c87-44c0-b23b-b36fc07f7953,143.0,Adjuvant,51.0,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0161-C18_treatment3,ec6f46e7-4346-40f8-98f4-0f161d52899b,,released,Capecitabine,1,2020-09-27T13:02:25.775217-05:00,Chemotherapy,Residual Disease,
HCM-CSHL-0867-C18,00ee2954-76fb-4157-bcb8-9ff3b7d94707,66e9ec80-d89d-41ec-b4d4-6a18f116ef9b,,Maintenance Therapy,,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0867-C18_treatment17,4cae4a20-acfc-4264-8e50-30999f03fc7e,Complete Response,released,Xeloda,1,2021-12-21T14:36:31.294022-06:00,,,
HCM-CSHL-0867-C18,00ee2954-76fb-4157-bcb8-9ff3b7d94707,66e9ec80-d89d-41ec-b4d4-6a18f116ef9b,,Maintenance Therapy,,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0867-C18_treatment20,9c413165-de8c-4615-85a4-981d79bdb355,Complete Response,released,,1,2021-12-21T14:36:31.294022-06:00,,,FOLFOX
HCM-CSHL-0867-C18,00ee2954-76fb-4157-bcb8-9ff3b7d94707,66e9ec80-d89d-41ec-b4d4-6a18f116ef9b,,Maintenance Therapy,,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0867-C18_treatment18,a0710a75-eff3-44cb-8889-7a457eaab6b5,Complete Response,released,Leucovorin Calcium,1,2021-12-21T14:36:31.294022-06:00,,,
HCM-CSHL-0867-C18,00ee2954-76fb-4157-bcb8-9ff3b7d94707,66e9ec80-d89d-41ec-b4d4-6a18f116ef9b,,Maintenance Therapy,,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0867-C18_treatment19,ae2dbab3-5b49-49e8-961a-c64733d17db7,Complete Response,released,Fluorouracil,1,2021-12-21T14:36:31.294022-06:00,,,
HCM-CSHL-0867-C18,00ee2954-76fb-4157-bcb8-9ff3b7d94707,66e9ec80-d89d-41ec-b4d4-6a18f116ef9b,,Maintenance Therapy,,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0867-C18_treatment15,d61308c8-3e92-4647-bf4a-a303c38c339a,Complete Response,released,Oxaliplatin,1,2021-12-21T14:36:31.294022-06:00,,,
HCM-CSHL-0867-C18,00ee2954-76fb-4157-bcb8-9ff3b7d94707,66e9ec80-d89d-41ec-b4d4-6a18f116ef9b,,Maintenance Therapy,,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0867-C18_treatment16,ed99b26c-9be8-4818-a3f6-930ebc29797c,Complete Response,released,Leucovorin,1,2021-12-21T14:36:31.294022-06:00,,,
HCM-CSHL-0867-C18,00ee2954-76fb-4157-bcb8-9ff3b7d94707,fa34dd60-be05-4298-984e-6a54d969fecc,174.0,Adjuvant,146.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0867-C18_treatment7,1ac52c5f-8354-4c45-8fe6-a41303f4d243,,released,Fluorouracil,1,2021-12-21T14:36:31.294022-06:00,Chemotherapy,Residual Disease,
HCM-CSHL-0867-C18,00ee2954-76fb-4157-bcb8-9ff3b7d94707,fa34dd60-be05-4298-984e-6a54d969fecc,300.0,Adjuvant,272.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0867-C18_treatment10,22369af6-f3b5-4825-beb2-ee61df249abe,,released,Leucovorin,1,2021-12-21T14:36:31.294022-06:00,Chemotherapy,Residual Disease,
HCM-CSHL-0867-C18,00ee2954-76fb-4157-bcb8-9ff3b7d94707,fa34dd60-be05-4298-984e-6a54d969fecc,132.0,Adjuvant,62.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0867-C18_treatment5,2e57d688-e6cf-42b6-b217-08e1a5315036,,released,Oxaliplatin,1,2021-12-21T14:36:31.294022-06:00,Chemotherapy,Residual Disease,
HCM-CSHL-0867-C18,00ee2954-76fb-4157-bcb8-9ff3b7d94707,fa34dd60-be05-4298-984e-6a54d969fecc,,,196.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0867-C18_treatment12,407ac759-9e03-4e0f-b653-bc2a08490533,,released,,1,2021-12-21T14:36:31.294022-06:00,"Surgery, NOS",Initial Diagnosis,
HCM-CSHL-0867-C18,00ee2954-76fb-4157-bcb8-9ff3b7d94707,fa34dd60-be05-4298-984e-6a54d969fecc,,Neoadjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0867-C18_treatment,4a2d8003-a027-47b9-92b5-d11ed8828579,,released,,0,2021-12-21T14:36:31.294022-06:00,,,
HCM-CSHL-0867-C18,00ee2954-76fb-4157-bcb8-9ff3b7d94707,fa34dd60-be05-4298-984e-6a54d969fecc,174.0,Adjuvant,146.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0867-C18_treatment8,4e23f2a9-6a73-4d11-9baa-1289f339329b,,released,Leucovorin,1,2021-12-21T14:36:31.294022-06:00,Chemotherapy,Residual Disease,
HCM-CSHL-0867-C18,00ee2954-76fb-4157-bcb8-9ff3b7d94707,fa34dd60-be05-4298-984e-6a54d969fecc,300.0,Adjuvant,272.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0867-C18_treatment9,58bd596f-8b41-4308-816e-3c04f046504c,,released,Fluorouracil,1,2021-12-21T14:36:31.294022-06:00,Chemotherapy,Residual Disease,
HCM-CSHL-0867-C18,00ee2954-76fb-4157-bcb8-9ff3b7d94707,fa34dd60-be05-4298-984e-6a54d969fecc,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0867-C18_treatment14,61ac0558-83a1-4eef-ba1d-13dd7eccf704,,released,,0,2021-12-21T14:36:31.294022-06:00,"Radiation Therapy, NOS",Residual Disease,
HCM-CSHL-0867-C18,00ee2954-76fb-4157-bcb8-9ff3b7d94707,fa34dd60-be05-4298-984e-6a54d969fecc,33.0,Adjuvant,12.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0867-C18_treatment2,8223ea59-f79e-4367-9c34-ef9300acb95e,,released,Capecitabine,1,2021-12-21T14:36:31.294022-06:00,Chemotherapy,Residual Disease,
HCM-CSHL-0867-C18,00ee2954-76fb-4157-bcb8-9ff3b7d94707,fa34dd60-be05-4298-984e-6a54d969fecc,132.0,Adjuvant,62.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0867-C18_treatment4,8808f85e-8559-46ba-bb7e-6022cfcbd1a7,,released,Fluorouracil,1,2021-12-21T14:36:31.294022-06:00,Chemotherapy,Residual Disease,
HCM-CSHL-0867-C18,00ee2954-76fb-4157-bcb8-9ff3b7d94707,fa34dd60-be05-4298-984e-6a54d969fecc,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0867-C18_treatment11,8e806829-d29c-4b26-86d0-33de05d58a0d,,released,,0,2021-12-21T14:36:31.294022-06:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-CSHL-0867-C18,00ee2954-76fb-4157-bcb8-9ff3b7d94707,fa34dd60-be05-4298-984e-6a54d969fecc,132.0,Adjuvant,62.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0867-C18_treatment6,dc47d01b-1ded-47b6-a7e2-839576362fea,,released,,1,2021-12-21T14:36:31.294022-06:00,Chemotherapy,Residual Disease,FOLFOX
HCM-CSHL-0867-C18,00ee2954-76fb-4157-bcb8-9ff3b7d94707,fa34dd60-be05-4298-984e-6a54d969fecc,132.0,Adjuvant,62.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0867-C18_treatment3,f3f0eb27-1776-40bc-a736-39211f2907ba,,released,Leucovorin Calcium,1,2021-12-21T14:36:31.294022-06:00,Chemotherapy,Residual Disease,
HCM-CSHL-0867-C18,00ee2954-76fb-4157-bcb8-9ff3b7d94707,fa34dd60-be05-4298-984e-6a54d969fecc,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0867-C18_treatment13,fe98ef74-63b1-4319-a958-51317a85c05e,,released,,0,2021-12-21T14:36:31.294022-06:00,Targeted Molecular Therapy,Residual Disease,
HCM-SANG-0537-C18,01c25a0f-5335-4fbd-870c-e533c4f7c7e1,93fdfe50-2461-4815-b00d-897ff8aa8684,,Neoadjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-SANG-0537-C18_treatment,d3ebc026-6f0b-4a89-913f-b7f822f2c15d,,released,,0,2021-12-21T15:15:21.378045-06:00,,,
HCM-SANG-0293-C15,01c29556-6af2-4ff8-b03b-911dfb5195fd,13c5624d-49ea-4230-b8b4-acce972ce035,,Neoadjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-SANG-0293-C15_treatment,89bae452-506c-4da7-af20-5ff6ec5ea0c7,,released,,0,2021-12-21T15:09:07.683949-06:00,,,
HCM-BROD-0759-C15,02187bfb-54f4-4bed-a056-06c9f10e3335,0efa4a6c-b389-4500-8e37-ad77a0883bbb,,Neoadjuvant,250.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0759-C15_treatment5,014ad81f-65a9-4741-be87-5dcad3fe9f28,,released,Nivolumab,1,2021-12-21T13:50:42.579115-06:00,Immunotherapy (Including Vaccines),,
HCM-BROD-0759-C15,02187bfb-54f4-4bed-a056-06c9f10e3335,0efa4a6c-b389-4500-8e37-ad77a0883bbb,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0759-C15_treatment15,0c9eabe8-13d7-4253-be17-711b9738d26c,,released,,0,2021-12-21T13:50:42.579115-06:00,"Radiation Therapy, NOS",Residual Disease,
HCM-BROD-0759-C15,02187bfb-54f4-4bed-a056-06c9f10e3335,0efa4a6c-b389-4500-8e37-ad77a0883bbb,775.0,Adjuvant,733.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0759-C15_treatment10,26e2a6f5-3061-4f94-867d-eade33e313c0,,released,Oxaliplatin,1,2021-12-21T13:50:42.579115-06:00,Chemotherapy,Residual Disease,
HCM-BROD-0759-C15,02187bfb-54f4-4bed-a056-06c9f10e3335,0efa4a6c-b389-4500-8e37-ad77a0883bbb,775.0,Adjuvant,733.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0759-C15_treatment9,3bc249a4-f02c-402a-bcac-03a3a0d3a8a5,,released,Fluorouracil,1,2021-12-21T13:50:42.579115-06:00,Chemotherapy,Residual Disease,
HCM-BROD-0759-C15,02187bfb-54f4-4bed-a056-06c9f10e3335,0efa4a6c-b389-4500-8e37-ad77a0883bbb,,Neoadjuvant,222.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0759-C15_treatment,4f67fa6b-dd40-4694-9462-6f095187f751,,released,Leucovorin Calcium,1,2021-12-21T13:50:42.579115-06:00,Chemotherapy,,
HCM-BROD-0759-C15,02187bfb-54f4-4bed-a056-06c9f10e3335,0efa4a6c-b389-4500-8e37-ad77a0883bbb,706.0,Adjuvant,544.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0759-C15_treatment7,6f881e64-f6f5-431f-aa50-f73423a92a58,,released,Paclitaxel,1,2021-12-21T13:50:42.579115-06:00,Chemotherapy,Residual Disease,
HCM-BROD-0759-C15,02187bfb-54f4-4bed-a056-06c9f10e3335,0efa4a6c-b389-4500-8e37-ad77a0883bbb,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0759-C15_treatment12,77275c64-90f4-42ec-aab5-699750281327,,released,,0,2021-12-21T13:50:42.579115-06:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-BROD-0759-C15,02187bfb-54f4-4bed-a056-06c9f10e3335,0efa4a6c-b389-4500-8e37-ad77a0883bbb,,Neoadjuvant,222.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0759-C15_treatment2,790d6095-fbfb-4e01-aa64-c7d6c1748747,,released,Fluorouracil,1,2021-12-21T13:50:42.579115-06:00,Chemotherapy,,
HCM-BROD-0759-C15,02187bfb-54f4-4bed-a056-06c9f10e3335,0efa4a6c-b389-4500-8e37-ad77a0883bbb,,Neoadjuvant,222.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0759-C15_treatment4,7db41817-2060-432e-b60f-96cb938c00fb,,released,,1,2021-12-21T13:50:42.579115-06:00,Chemotherapy,,FOLFOX
HCM-BROD-0759-C15,02187bfb-54f4-4bed-a056-06c9f10e3335,0efa4a6c-b389-4500-8e37-ad77a0883bbb,775.0,Adjuvant,733.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0759-C15_treatment11,94c63fe0-5b54-4c16-be36-cc01531fd0fd,,released,,1,2021-12-21T13:50:42.579115-06:00,Chemotherapy,Residual Disease,FOLFOX
HCM-BROD-0759-C15,02187bfb-54f4-4bed-a056-06c9f10e3335,0efa4a6c-b389-4500-8e37-ad77a0883bbb,706.0,Adjuvant,544.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0759-C15_treatment14,a3ecf646-f62e-4a06-a72e-ebc1bec9c0de,,released,Ramucirumab,1,2021-12-21T13:50:42.579115-06:00,Targeted Molecular Therapy,Residual Disease,
HCM-BROD-0759-C15,02187bfb-54f4-4bed-a056-06c9f10e3335,0efa4a6c-b389-4500-8e37-ad77a0883bbb,,Neoadjuvant,222.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0759-C15_treatment3,d0d2f922-5f22-4d4a-9dbb-0e2f122ceec7,,released,Oxaliplatin,1,2021-12-21T13:50:42.579115-06:00,Chemotherapy,,
HCM-BROD-0759-C15,02187bfb-54f4-4bed-a056-06c9f10e3335,0efa4a6c-b389-4500-8e37-ad77a0883bbb,,,,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0759-C15_treatment13,dad3b4d0-6e0c-4126-b6ba-28f9eb72351e,,released,,0,2021-12-21T13:50:42.579115-06:00,"Surgery, NOS",Initial Diagnosis,
HCM-BROD-0759-C15,02187bfb-54f4-4bed-a056-06c9f10e3335,0efa4a6c-b389-4500-8e37-ad77a0883bbb,,Neoadjuvant,165.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0759-C15_treatment6,e7340744-0b00-4c83-b47d-5b32b126e4a1,,released,Ramucirumab,1,2021-12-21T13:50:42.579115-06:00,Targeted Molecular Therapy,,
HCM-BROD-0759-C15,02187bfb-54f4-4bed-a056-06c9f10e3335,0efa4a6c-b389-4500-8e37-ad77a0883bbb,775.0,Adjuvant,733.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0759-C15_treatment8,edfa4512-f5ea-4811-99d3-adb1a6f56455,,released,Leucovorin Calcium,1,2021-12-21T13:50:42.579115-06:00,Chemotherapy,Residual Disease,
HCM-WCMC-0946-C34,0249b26e-7928-4d28-a0e7-68a31d49ca33,e9f9d800-b47c-442b-968d-c041adb5d13f,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-WCMC-0946-C34_treatment4,047c2a15-d508-4aeb-b3ca-155b22052d8b,,released,,0,2023-02-27T11:49:45.455791-06:00,"Radiation Therapy, NOS",Residual Disease,
HCM-WCMC-0946-C34,0249b26e-7928-4d28-a0e7-68a31d49ca33,e9f9d800-b47c-442b-968d-c041adb5d13f,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-WCMC-0946-C34_treatment3,274f664e-631e-44b6-99a6-d319b85f5998,,released,,0,2023-02-27T11:49:45.455791-06:00,"Pharmaceutical Therapy, NOS",Residual Disease,
HCM-WCMC-0946-C34,0249b26e-7928-4d28-a0e7-68a31d49ca33,e9f9d800-b47c-442b-968d-c041adb5d13f,,Neoadjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-WCMC-0946-C34_treatment,67f0e8ca-6884-4df2-a084-76bd3029b231,,released,,0,2023-02-27T11:49:45.455791-06:00,,,
HCM-WCMC-0946-C34,0249b26e-7928-4d28-a0e7-68a31d49ca33,e9f9d800-b47c-442b-968d-c041adb5d13f,,,42.0,2025-04-07T17:13:09.336794-05:00,HCM-WCMC-0946-C34_treatment2,c236c884-8bd1-435c-9a12-5bf652cb646c,,released,,1,2023-02-27T11:49:45.455791-06:00,"Surgery, NOS",Initial Diagnosis,
HCM-BROD-0204-C25,0251b915-6bf6-43a3-b3a3-aadbac0be13f,9c113ef5-eccd-4480-a651-4af9f44b398d,,Adjuvant,,2023-11-07T14:28:29.403873-06:00,HCM-BROD-0204-C25_treatment5,524e4a7f-3692-4e8b-9c9c-d991a562008d,,released,,0,2020-09-17T16:01:21.506049-05:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-BROD-0204-C25,0251b915-6bf6-43a3-b3a3-aadbac0be13f,9c113ef5-eccd-4480-a651-4af9f44b398d,,Adjuvant,,2023-11-07T14:28:29.403873-06:00,HCM-BROD-0204-C25_treatment8,54a9e842-c989-43b5-b69d-9bd75d6944b3,,released,,0,2020-09-17T16:01:21.506049-05:00,"Radiation Therapy, NOS",Residual Disease,
HCM-BROD-0204-C25,0251b915-6bf6-43a3-b3a3-aadbac0be13f,9c113ef5-eccd-4480-a651-4af9f44b398d,,Adjuvant,,2023-11-07T14:28:29.403873-06:00,HCM-BROD-0204-C25_treatment7,581662ee-7818-4bbb-a81a-2ef515de00ec,,released,,0,2020-09-17T16:01:21.506049-05:00,Targeted Molecular Therapy,Residual Disease,
HCM-BROD-0204-C25,0251b915-6bf6-43a3-b3a3-aadbac0be13f,9c113ef5-eccd-4480-a651-4af9f44b398d,,Neoadjuvant,,2023-11-07T14:28:29.403873-06:00,HCM-BROD-0204-C25_treatment2,88b9efab-316b-4b8c-9881-d37899ba3738,,released,Nab-paclitaxel,1,2020-09-17T16:01:21.506049-05:00,Chemotherapy,,
HCM-BROD-0204-C25,0251b915-6bf6-43a3-b3a3-aadbac0be13f,9c113ef5-eccd-4480-a651-4af9f44b398d,,Adjuvant,,2023-11-07T14:28:29.403873-06:00,HCM-BROD-0204-C25_treatment4,e9a80b16-583c-42a7-ac0c-171beb51c883,,released,,0,2020-09-17T16:01:21.506049-05:00,Chemotherapy,Residual Disease,
HCM-BROD-0204-C25,0251b915-6bf6-43a3-b3a3-aadbac0be13f,9c113ef5-eccd-4480-a651-4af9f44b398d,,Neoadjuvant,,2023-11-07T14:28:29.403873-06:00,HCM-BROD-0204-C25_treatment3,ea4b9b3c-15ff-4b30-b24d-bc2e8eeaccbb,,released,,1,2020-09-17T16:01:21.506049-05:00,"Radiation Therapy, NOS",,
HCM-BROD-0204-C25,0251b915-6bf6-43a3-b3a3-aadbac0be13f,9c113ef5-eccd-4480-a651-4af9f44b398d,,,301.0,2023-11-07T14:28:29.403873-06:00,HCM-BROD-0204-C25_treatment6,f65075e9-d232-49e4-a440-f06937a8b78d,,released,,1,2020-09-17T16:01:21.506049-05:00,"Surgery, NOS",Initial Diagnosis,
HCM-BROD-0204-C25,0251b915-6bf6-43a3-b3a3-aadbac0be13f,9c113ef5-eccd-4480-a651-4af9f44b398d,,Neoadjuvant,,2023-11-07T14:28:29.403873-06:00,HCM-BROD-0204-C25_treatment,fd641332-1d58-4c26-9aa8-7045fe4c897d,,released,Gemcitabine,1,2020-09-17T16:01:21.506049-05:00,Chemotherapy,,
HCM-CSHL-0084-C25,0286c31b-a704-4d7d-99e3-0bc4e8975b8b,70da7d37-590b-41a5-97c7-17238c0c8652,,Adjuvant,,2023-03-13T12:42:42.837350-05:00,HCM-CSHL-0084-C25_treatment3,32259a9c-1376-43c9-8b59-203a611038b9,,released,,unknown,2020-10-09T15:00:09.016502-05:00,"Pharmaceutical Therapy, NOS",Residual Disease,
HCM-CSHL-0084-C25,0286c31b-a704-4d7d-99e3-0bc4e8975b8b,70da7d37-590b-41a5-97c7-17238c0c8652,,Neoadjuvant,,2023-02-22T07:39:25.979291-06:00,HCM-CSHL-0084-C25_treatment,41534693-7349-4d49-b0a3-67c30d6331d1,,released,,0,2020-10-09T15:00:09.016502-05:00,,,
HCM-CSHL-0084-C25,0286c31b-a704-4d7d-99e3-0bc4e8975b8b,70da7d37-590b-41a5-97c7-17238c0c8652,,,-6.0,2023-03-13T12:42:42.837350-05:00,HCM-CSHL-0084-C25_treatment2,7c5955c6-7546-4e88-8df7-5c91a2e42685,,released,,1,2020-10-09T15:00:09.016502-05:00,"Surgery, NOS",Initial Diagnosis,
HCM-CSHL-0084-C25,0286c31b-a704-4d7d-99e3-0bc4e8975b8b,70da7d37-590b-41a5-97c7-17238c0c8652,,Adjuvant,,2023-03-13T12:42:42.837350-05:00,HCM-CSHL-0084-C25_treatment4,de04dbb3-a7e0-439c-8f36-0aebe38399dc,,released,,unknown,2020-10-09T15:00:09.016502-05:00,"Radiation Therapy, NOS",Residual Disease,
HCM-CSHL-0670-C18,028fb179-0872-4477-ab89-cf39f1ed9420,4bfe1ee5-ce9c-4f2d-b0bb-883580084f7d,,Adjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0670-C18_treatment12,218b8f1a-b26c-4bb9-90a8-cec2392252f1,,released,,0,2021-12-21T14:18:20.524321-06:00,"Radiation Therapy, NOS",Residual Disease,
HCM-CSHL-0670-C18,028fb179-0872-4477-ab89-cf39f1ed9420,4bfe1ee5-ce9c-4f2d-b0bb-883580084f7d,,Neoadjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0670-C18_treatment,36f8d1b2-1fb6-482b-b9de-f2f2875ab77d,,released,,0,2021-12-21T14:18:20.524321-06:00,,,
HCM-CSHL-0670-C18,028fb179-0872-4477-ab89-cf39f1ed9420,4bfe1ee5-ce9c-4f2d-b0bb-883580084f7d,456.0,Adjuvant,412.0,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0670-C18_treatment7,432670c8-794c-4887-99ad-43f4e50754b7,,released,Leucovorin,1,2021-12-21T14:18:20.524321-06:00,Chemotherapy,Residual Disease,
HCM-CSHL-0670-C18,028fb179-0872-4477-ab89-cf39f1ed9420,4bfe1ee5-ce9c-4f2d-b0bb-883580084f7d,412.0,Adjuvant,55.0,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0670-C18_treatment2,4ab2725e-fd7a-4847-a6e7-27d63d80dbd5,,released,Leucovorin Calcium,1,2021-12-21T14:18:20.524321-06:00,Chemotherapy,Residual Disease,
HCM-CSHL-0670-C18,028fb179-0872-4477-ab89-cf39f1ed9420,4bfe1ee5-ce9c-4f2d-b0bb-883580084f7d,456.0,Adjuvant,412.0,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0670-C18_treatment6,528d4707-eeb3-4754-b97e-7b24e943b403,,released,Fluorouracil,1,2021-12-21T14:18:20.524321-06:00,Chemotherapy,Residual Disease,
HCM-CSHL-0670-C18,028fb179-0872-4477-ab89-cf39f1ed9420,4bfe1ee5-ce9c-4f2d-b0bb-883580084f7d,,,122.0,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0670-C18_treatment10,577b4f98-3d6d-4ea6-a39e-47a921a133e9,,released,,1,2021-12-21T14:18:20.524321-06:00,"Surgery, NOS",Initial Diagnosis,
HCM-CSHL-0670-C18,028fb179-0872-4477-ab89-cf39f1ed9420,4bfe1ee5-ce9c-4f2d-b0bb-883580084f7d,,Adjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0670-C18_treatment11,62953503-78b4-43e5-8e66-201bf746b9cc,,released,,0,2021-12-21T14:18:20.524321-06:00,Targeted Molecular Therapy,Residual Disease,
HCM-CSHL-0670-C18,028fb179-0872-4477-ab89-cf39f1ed9420,4bfe1ee5-ce9c-4f2d-b0bb-883580084f7d,1199.0,Adjuvant,476.0,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0670-C18_treatment8,650af823-bbbf-445c-9979-ef4e2592eb87,,released,Capecitabine,1,2021-12-21T14:18:20.524321-06:00,Chemotherapy,Residual Disease,
HCM-CSHL-0670-C18,028fb179-0872-4477-ab89-cf39f1ed9420,4bfe1ee5-ce9c-4f2d-b0bb-883580084f7d,412.0,Adjuvant,55.0,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0670-C18_treatment3,835c46f8-c198-4143-bfb9-4060114eb1b2,,released,Fluorouracil,1,2021-12-21T14:18:20.524321-06:00,Chemotherapy,Residual Disease,
HCM-CSHL-0670-C18,028fb179-0872-4477-ab89-cf39f1ed9420,4bfe1ee5-ce9c-4f2d-b0bb-883580084f7d,,Adjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0670-C18_treatment9,b6f9196a-d0b5-4d66-809a-e46e3c6a090d,,released,,0,2021-12-21T14:18:20.524321-06:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-CSHL-0670-C18,028fb179-0872-4477-ab89-cf39f1ed9420,4bfe1ee5-ce9c-4f2d-b0bb-883580084f7d,412.0,Adjuvant,55.0,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0670-C18_treatment4,e34f745c-6677-4d62-98ec-c62f5e5b4760,,released,Oxaliplatin,1,2021-12-21T14:18:20.524321-06:00,Chemotherapy,Residual Disease,
HCM-CSHL-0670-C18,028fb179-0872-4477-ab89-cf39f1ed9420,4bfe1ee5-ce9c-4f2d-b0bb-883580084f7d,412.0,Adjuvant,55.0,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0670-C18_treatment5,ef0a0ad5-a737-464c-8134-077b93c20e73,,released,,1,2021-12-21T14:18:20.524321-06:00,Chemotherapy,Residual Disease,FOLFOX
HCM-CSHL-0670-C18,028fb179-0872-4477-ab89-cf39f1ed9420,59a8a0c3-680d-4875-9756-e38306ceceb7,554.0,Maintenance Therapy,43.0,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0670-C18_treatment13,71c64a46-fbe6-4b16-b3c5-56f24fb88d43,Not Reported,released,Xeloda,1,2021-12-21T14:18:20.524321-06:00,,,
HCM-SANG-1337-C18,029399ba-21fa-4e49-8ddf-f73e4704858a,ef67a718-56f8-42c7-8705-4b8b63b7e01f,,Neoadjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-SANG-1337-C18_treatment,9f2c888a-ed1e-42d9-9861-ba0208ab77c2,,released,,0,2023-02-27T12:46:56.622960-06:00,,,
HCM-BROD-0408-C71,02f6d684-b6b5-419a-b0e1-b74d0a384a30,9fc0fac7-b813-4c0f-995d-4045f0db272c,,Neoadjuvant,,2023-02-22T07:39:25.979291-06:00,HCM-BROD-0408-C71_treatment,0ad0ffdc-2f6f-40f4-b70f-bac3fbbfab86,,released,,0,2020-06-15T13:40:11.094740-05:00,,,
HCM-BROD-0408-C71,02f6d684-b6b5-419a-b0e1-b74d0a384a30,9fc0fac7-b813-4c0f-995d-4045f0db272c,,Adjuvant,,2023-02-22T07:39:25.979291-06:00,HCM-BROD-0408-C71_treatment6,4f7d83e8-839a-4270-bb96-faf9c2980f36,,released,,0,2020-06-15T13:40:11.094740-05:00,"Radiation Therapy, NOS",Residual Disease,
HCM-BROD-0408-C71,02f6d684-b6b5-419a-b0e1-b74d0a384a30,9fc0fac7-b813-4c0f-995d-4045f0db272c,,Adjuvant,,2023-02-22T07:39:25.979291-06:00,HCM-BROD-0408-C71_treatment2,5e5ff864-7631-46df-9aad-2a408bb29c0f,,released,,1,2020-06-15T13:40:11.094740-05:00,Chemotherapy,Residual Disease,
HCM-BROD-0408-C71,02f6d684-b6b5-419a-b0e1-b74d0a384a30,9fc0fac7-b813-4c0f-995d-4045f0db272c,,Adjuvant,,2023-02-22T07:39:25.979291-06:00,HCM-BROD-0408-C71_treatment5,6b7adf0c-dc46-4947-9091-b9589fd437c7,,released,,0,2020-06-15T13:40:11.094740-05:00,Targeted Molecular Therapy,Residual Disease,
HCM-BROD-0408-C71,02f6d684-b6b5-419a-b0e1-b74d0a384a30,9fc0fac7-b813-4c0f-995d-4045f0db272c,,Adjuvant,,2023-02-22T07:39:25.979291-06:00,HCM-BROD-0408-C71_treatment3,8c8f8717-64df-4556-8cc3-810ab7d9f142,,released,,0,2020-06-15T13:40:11.094740-05:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-BROD-0408-C71,02f6d684-b6b5-419a-b0e1-b74d0a384a30,9fc0fac7-b813-4c0f-995d-4045f0db272c,,,-529.0,2023-03-13T12:52:25.361274-05:00,HCM-BROD-0408-C71_treatment4,b1c41c69-15bc-46c9-ab53-ab0518b5e553,,released,,1,2020-06-15T13:40:11.094740-05:00,"Surgery, NOS",Initial Diagnosis,
HCM-WCMC-0504-C18,031b40e7-2e1d-43e9-83a1-a4fae1e1e6a4,c0c2a085-de17-4b07-b396-0d500271433b,89.0,Maintenance Therapy,42.0,2023-07-13T10:35:44.371881-05:00,HCM-WCMC-0504-C18_treatment13,0f44332c-1e03-4c89-8cca-2ab659828ad0,Complete Response,released,Oxaliplatin,1,2023-02-27T12:20:43.084621-06:00,,,
HCM-WCMC-0504-C18,031b40e7-2e1d-43e9-83a1-a4fae1e1e6a4,c0c2a085-de17-4b07-b396-0d500271433b,89.0,Maintenance Therapy,42.0,2023-07-13T10:35:44.371881-05:00,HCM-WCMC-0504-C18_treatment11,3352d00b-3c47-46e1-b55d-e60691e18dc3,Complete Response,released,Leucovorin Calcium,1,2023-02-27T12:20:43.084621-06:00,,,
HCM-WCMC-0504-C18,031b40e7-2e1d-43e9-83a1-a4fae1e1e6a4,c0c2a085-de17-4b07-b396-0d500271433b,89.0,Maintenance Therapy,42.0,2023-07-13T10:35:44.371881-05:00,HCM-WCMC-0504-C18_treatment12,906a3f93-4f5b-417d-92fd-261802c956fb,Complete Response,released,Fluorouracil,1,2023-02-27T12:20:43.084621-06:00,,,
HCM-WCMC-0504-C18,031b40e7-2e1d-43e9-83a1-a4fae1e1e6a4,c0c2a085-de17-4b07-b396-0d500271433b,89.0,Maintenance Therapy,42.0,2023-07-13T10:35:44.371881-05:00,HCM-WCMC-0504-C18_treatment14,937691d1-b8e2-4c27-adcd-91d068abafbe,Complete Response,released,,1,2023-02-27T12:20:43.084621-06:00,,,FOLFOX
HCM-WCMC-0504-C18,031b40e7-2e1d-43e9-83a1-a4fae1e1e6a4,da906777-f594-4a26-8d09-192c8a3c10b9,89.0,Adjuvant,42.0,2023-07-13T10:35:44.371881-05:00,HCM-WCMC-0504-C18_treatment4,223bf9f1-fc69-42e2-b8d1-9504d14d98de,,released,Fluorouracil,1,2023-02-27T12:20:43.084621-06:00,Chemotherapy,Residual Disease,
HCM-WCMC-0504-C18,031b40e7-2e1d-43e9-83a1-a4fae1e1e6a4,da906777-f594-4a26-8d09-192c8a3c10b9,89.0,Adjuvant,42.0,2023-07-13T10:35:44.371881-05:00,HCM-WCMC-0504-C18_treatment5,3de5204a-cd3d-4e22-bfb0-56b8e3228582,,released,,1,2023-02-27T12:20:43.084621-06:00,Chemotherapy,Residual Disease,FOLFOX-6 (modified)
HCM-WCMC-0504-C18,031b40e7-2e1d-43e9-83a1-a4fae1e1e6a4,da906777-f594-4a26-8d09-192c8a3c10b9,,,1.0,2023-07-13T10:35:44.371881-05:00,HCM-WCMC-0504-C18_treatment8,4d5575d1-61e5-49a0-b381-3499627ce16a,,released,,1,2023-02-27T12:20:43.084621-06:00,"Surgery, NOS",Initial Diagnosis,
HCM-WCMC-0504-C18,031b40e7-2e1d-43e9-83a1-a4fae1e1e6a4,da906777-f594-4a26-8d09-192c8a3c10b9,271.0,Adjuvant,152.0,2023-07-13T10:35:44.371881-05:00,HCM-WCMC-0504-C18_treatment7,762fc9ff-5d28-481f-b5e3-f9271f71cc93,,released,Nivolumab,1,2023-02-27T12:20:43.084621-06:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-WCMC-0504-C18,031b40e7-2e1d-43e9-83a1-a4fae1e1e6a4,da906777-f594-4a26-8d09-192c8a3c10b9,89.0,Adjuvant,42.0,2023-07-13T10:35:44.371881-05:00,HCM-WCMC-0504-C18_treatment3,7a209bb4-c6bb-4334-9d89-5ce74307945d,,released,Oxaliplatin,1,2023-02-27T12:20:43.084621-06:00,Chemotherapy,Residual Disease,
HCM-WCMC-0504-C18,031b40e7-2e1d-43e9-83a1-a4fae1e1e6a4,da906777-f594-4a26-8d09-192c8a3c10b9,,Adjuvant,,2023-07-13T10:35:44.371881-05:00,HCM-WCMC-0504-C18_treatment9,8fc0c866-84cf-47e7-a5b7-9849bdf982b0,,released,,0,2023-02-27T12:20:43.084621-06:00,Targeted Molecular Therapy,Residual Disease,
HCM-WCMC-0504-C18,031b40e7-2e1d-43e9-83a1-a4fae1e1e6a4,da906777-f594-4a26-8d09-192c8a3c10b9,615.0,Adjuvant,293.0,2023-07-13T10:35:44.371881-05:00,HCM-WCMC-0504-C18_treatment6,9a83578f-9472-4815-8c90-7e4bb9e348d0,,released,Pembrolizumab,1,2023-02-27T12:20:43.084621-06:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-WCMC-0504-C18,031b40e7-2e1d-43e9-83a1-a4fae1e1e6a4,da906777-f594-4a26-8d09-192c8a3c10b9,89.0,Adjuvant,42.0,2023-07-13T10:35:44.371881-05:00,HCM-WCMC-0504-C18_treatment2,cb699459-0046-493f-9cc3-7564ec934a99,,released,Leucovorin Calcium,1,2023-02-27T12:20:43.084621-06:00,Chemotherapy,Residual Disease,
HCM-WCMC-0504-C18,031b40e7-2e1d-43e9-83a1-a4fae1e1e6a4,da906777-f594-4a26-8d09-192c8a3c10b9,,Adjuvant,,2023-07-13T10:35:44.371881-05:00,HCM-WCMC-0504-C18_treatment10,cc6a2475-3161-4f3d-aaae-279a05f6ce5d,,released,,0,2023-02-27T12:20:43.084621-06:00,"Radiation Therapy, NOS",Residual Disease,
HCM-WCMC-0504-C18,031b40e7-2e1d-43e9-83a1-a4fae1e1e6a4,da906777-f594-4a26-8d09-192c8a3c10b9,,Neoadjuvant,,2023-07-13T10:35:44.371881-05:00,HCM-WCMC-0504-C18_treatment,dd30d7b8-cc0e-46c6-a095-070ab7c55027,,released,,0,2023-02-27T12:20:43.084621-06:00,,,
HCM-BROD-0108-C25,035fa980-159e-4c0d-87da-d13d3dd7c17c,dad608bb-2695-4823-83c6-6f7b1af6ce22,171.0,Adjuvant,129.0,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0108-C25_treatment5,06e4edb1-4da2-49ba-9f3f-c77c5c6ea312,,released,Irinotecan,1,2020-09-17T15:59:54.285311-05:00,Chemotherapy,Residual Disease,
HCM-BROD-0108-C25,035fa980-159e-4c0d-87da-d13d3dd7c17c,dad608bb-2695-4823-83c6-6f7b1af6ce22,192.0,Adjuvant,192.0,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0108-C25_treatment9,0d7bd7df-4dfb-41eb-a5e1-4a26745f382d,,released,Oxaliplatin,1,2020-09-17T15:59:54.285311-05:00,Chemotherapy,Residual Disease,
HCM-BROD-0108-C25,035fa980-159e-4c0d-87da-d13d3dd7c17c,dad608bb-2695-4823-83c6-6f7b1af6ce22,,Adjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0108-C25_treatment11,31c0de1f-74bb-48ac-99e6-98131d199ee5,,released,,0,2020-09-17T15:59:54.285311-05:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-BROD-0108-C25,035fa980-159e-4c0d-87da-d13d3dd7c17c,dad608bb-2695-4823-83c6-6f7b1af6ce22,,Neoadjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0108-C25_treatment,3cc05da7-df69-48bd-aea5-b673990ec1e8,,released,,unknown,2020-09-17T15:59:54.285311-05:00,"Pharmaceutical Therapy, NOS",,
HCM-BROD-0108-C25,035fa980-159e-4c0d-87da-d13d3dd7c17c,dad608bb-2695-4823-83c6-6f7b1af6ce22,,Adjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0108-C25_treatment13,405e693d-f0b9-4bbe-a678-9e4d09d9ce6c,,released,,0,2020-09-17T15:59:54.285311-05:00,Targeted Molecular Therapy,Residual Disease,
HCM-BROD-0108-C25,035fa980-159e-4c0d-87da-d13d3dd7c17c,dad608bb-2695-4823-83c6-6f7b1af6ce22,192.0,Adjuvant,192.0,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0108-C25_treatment10,65f0eac2-efe7-4747-8563-d76192924226,,released,,1,2020-09-17T15:59:54.285311-05:00,Chemotherapy,Residual Disease,FOLFIRINOX
HCM-BROD-0108-C25,035fa980-159e-4c0d-87da-d13d3dd7c17c,dad608bb-2695-4823-83c6-6f7b1af6ce22,,,20.0,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0108-C25_treatment12,665348b2-09f2-43cf-a828-7f11876f4a83,,released,,1,2020-09-17T15:59:54.285311-05:00,"Surgery, NOS",Initial Diagnosis,
HCM-BROD-0108-C25,035fa980-159e-4c0d-87da-d13d3dd7c17c,dad608bb-2695-4823-83c6-6f7b1af6ce22,115.0,Adjuvant,94.0,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0108-C25_treatment4,673e1ab0-2afa-4e8b-8a7c-96fb12511fc4,,released,Nab-paclitaxel,1,2020-09-17T15:59:54.285311-05:00,Chemotherapy,Residual Disease,
HCM-BROD-0108-C25,035fa980-159e-4c0d-87da-d13d3dd7c17c,dad608bb-2695-4823-83c6-6f7b1af6ce22,80.0,Adjuvant,59.0,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0108-C25_treatment2,80f3554d-fa5b-4735-8228-ad95a4e87352,,released,Gemcitabine,1,2020-09-17T15:59:54.285311-05:00,Chemotherapy,Residual Disease,
HCM-BROD-0108-C25,035fa980-159e-4c0d-87da-d13d3dd7c17c,dad608bb-2695-4823-83c6-6f7b1af6ce22,192.0,Adjuvant,192.0,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0108-C25_treatment8,87c13323-3672-45c5-86cf-3c3622136d2d,,released,Fluorouracil,1,2020-09-17T15:59:54.285311-05:00,Chemotherapy,Residual Disease,
HCM-BROD-0108-C25,035fa980-159e-4c0d-87da-d13d3dd7c17c,dad608bb-2695-4823-83c6-6f7b1af6ce22,,Adjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0108-C25_treatment14,ad1a5bd9-6cf8-4f6a-aeb8-141f14ec60a6,,released,,0,2020-09-17T15:59:54.285311-05:00,"Radiation Therapy, NOS",Residual Disease,
HCM-BROD-0108-C25,035fa980-159e-4c0d-87da-d13d3dd7c17c,dad608bb-2695-4823-83c6-6f7b1af6ce22,115.0,Adjuvant,94.0,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0108-C25_treatment3,b27e35fe-d06a-4832-9fb4-74a43b86a3ff,,released,Gemcitabine,1,2020-09-17T15:59:54.285311-05:00,Chemotherapy,Residual Disease,
HCM-BROD-0108-C25,035fa980-159e-4c0d-87da-d13d3dd7c17c,dad608bb-2695-4823-83c6-6f7b1af6ce22,192.0,Adjuvant,192.0,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0108-C25_treatment6,eff6d94c-89ae-4c4f-bbce-6968dccd36f9,,released,Irinotecan Hydrochloride,1,2020-09-17T15:59:54.285311-05:00,Chemotherapy,Residual Disease,
HCM-BROD-0108-C25,035fa980-159e-4c0d-87da-d13d3dd7c17c,dad608bb-2695-4823-83c6-6f7b1af6ce22,192.0,Adjuvant,192.0,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0108-C25_treatment7,f09d144f-f39a-4ce6-ac4e-8aecebbe6450,,released,Leucovorin Calcium,1,2020-09-17T15:59:54.285311-05:00,Chemotherapy,Residual Disease,
HCM-BROD-0334-C43,03974dc9-0162-4de8-9897-09f88693681a,3d666f1b-58c2-451f-8ebf-87b5caa02aaf,,Neoadjuvant,,2021-03-03T15:15:08.075155-06:00,HCM-BROD-0334-C43_treatment,0c6a4143-1879-4c11-81d0-ceddf33f8f14,,released,,0,2020-07-31T09:27:46.473911-05:00,,,
HCM-BROD-0334-C43,03974dc9-0162-4de8-9897-09f88693681a,3d666f1b-58c2-451f-8ebf-87b5caa02aaf,,Adjuvant,,2021-03-03T15:15:08.075155-06:00,HCM-BROD-0334-C43_treatment6,39ef398d-b0c4-4a41-a8fd-134435e7ba96,,released,,0,2020-07-31T09:27:46.473911-05:00,Targeted Molecular Therapy,Residual Disease,
HCM-BROD-0334-C43,03974dc9-0162-4de8-9897-09f88693681a,3d666f1b-58c2-451f-8ebf-87b5caa02aaf,,,,2023-02-27T12:17:49.052980-06:00,HCM-BROD-0334-C43_treatment5,4c1c747f-94a4-4ffb-8b19-178d83e9a175,,released,,0,2020-07-31T09:27:46.473911-05:00,"Surgery, NOS",Initial Diagnosis,
HCM-BROD-0334-C43,03974dc9-0162-4de8-9897-09f88693681a,3d666f1b-58c2-451f-8ebf-87b5caa02aaf,,Adjuvant,,2021-03-03T15:15:08.075155-06:00,HCM-BROD-0334-C43_treatment7,7ef4348b-c662-43d1-9d75-f3b6e1356164,,released,,0,2020-10-08T12:09:21.914666-05:00,"Radiation Therapy, NOS",Residual Disease,
HCM-BROD-0334-C43,03974dc9-0162-4de8-9897-09f88693681a,3d666f1b-58c2-451f-8ebf-87b5caa02aaf,750.0,Adjuvant,645.0,2021-03-03T15:15:08.075155-06:00,HCM-BROD-0334-C43_treatment4,949e0998-a12d-4d96-b975-3de67b747de5,,released,Pembrolizumab,1,2020-07-31T09:27:46.473911-05:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-BROD-0334-C43,03974dc9-0162-4de8-9897-09f88693681a,3d666f1b-58c2-451f-8ebf-87b5caa02aaf,,Adjuvant,,2021-03-03T15:15:08.075155-06:00,HCM-BROD-0334-C43_treatment3,dc298414-f6a0-4545-9425-b07486390aa3,,released,,0,2020-07-31T09:27:46.473911-05:00,Hormone Therapy,Residual Disease,
HCM-BROD-0334-C43,03974dc9-0162-4de8-9897-09f88693681a,3d666f1b-58c2-451f-8ebf-87b5caa02aaf,,Adjuvant,,2021-03-03T15:15:08.075155-06:00,HCM-BROD-0334-C43_treatment2,f5dd53cd-5dc6-4fb5-bf05-e3bda8024308,,released,,0,2020-07-31T09:27:46.473911-05:00,Chemotherapy,Residual Disease,
HCM-BROD-0334-C43,03974dc9-0162-4de8-9897-09f88693681a,fedc3533-85f7-4fc6-b996-a1f596e021df,750.0,Maintenance Therapy,414.0,2021-03-03T15:15:08.075155-06:00,HCM-BROD-0334-C43_treatment8,253633e8-0988-44aa-b2bd-b9e90c1c896f,Stable Disease,released,Pembrolizumab,1,2020-10-08T12:09:21.914666-05:00,,,
HCM-BROD-0124-C25,03bfeb7c-cecf-4691-8263-33cdfe391ea9,00184ed8-780a-4acf-b5f1-b1fcd6b08dcf,,Adjuvant,,2021-07-12T12:25:55.528644-05:00,HCM-BROD-0124-C25_treatment8,22c54d45-1f98-435a-b598-4a4361551014,,released,,0,2020-09-27T10:37:49.634434-05:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-BROD-0124-C25,03bfeb7c-cecf-4691-8263-33cdfe391ea9,00184ed8-780a-4acf-b5f1-b1fcd6b08dcf,420.0,Adjuvant,359.0,2021-07-12T12:25:55.528644-05:00,HCM-BROD-0124-C25_treatment5,411153f6-4ae6-4f1b-a911-b8d65c5972d2,,released,Fluorouracil,1,2019-04-16T11:21:56.471158-05:00,Chemotherapy,Residual Disease,
HCM-BROD-0124-C25,03bfeb7c-cecf-4691-8263-33cdfe391ea9,00184ed8-780a-4acf-b5f1-b1fcd6b08dcf,420.0,Adjuvant,359.0,2021-07-12T12:25:55.528644-05:00,HCM-BROD-0124-C25_treatment4,69a6a8a2-5dc9-4d93-afa4-d39499e0f8ea,,released,Leucovorin Calcium,1,2019-04-16T11:21:56.471158-05:00,Chemotherapy,Residual Disease,
HCM-BROD-0124-C25,03bfeb7c-cecf-4691-8263-33cdfe391ea9,00184ed8-780a-4acf-b5f1-b1fcd6b08dcf,,Neoadjuvant,,2021-07-12T12:25:55.528644-05:00,HCM-BROD-0124-C25_treatment,8b90777b-2b37-4c7f-a4f1-cd6fb6f3508e,,released,,0,2019-04-16T11:21:56.471158-05:00,,,
HCM-BROD-0124-C25,03bfeb7c-cecf-4691-8263-33cdfe391ea9,00184ed8-780a-4acf-b5f1-b1fcd6b08dcf,290.0,Adjuvant,252.0,2021-07-12T12:25:55.528644-05:00,HCM-BROD-0124-C25_treatment11,8c6e6cdc-0e86-48a9-9a21-31612eaa6b07,,released,,1,2020-09-27T10:37:49.634434-05:00,"Radiation, Intensity-Modulated Radiotherapy",Residual Disease,
HCM-BROD-0124-C25,03bfeb7c-cecf-4691-8263-33cdfe391ea9,00184ed8-780a-4acf-b5f1-b1fcd6b08dcf,420.0,Adjuvant,359.0,2021-07-12T12:25:55.528644-05:00,HCM-BROD-0124-C25_treatment7,97178adc-4981-49cc-9f6a-46fd4c3f6446,,released,,1,2019-04-16T11:21:56.471158-05:00,Chemotherapy,Residual Disease,FOLFIRINOX
HCM-BROD-0124-C25,03bfeb7c-cecf-4691-8263-33cdfe391ea9,00184ed8-780a-4acf-b5f1-b1fcd6b08dcf,420.0,Adjuvant,359.0,2021-07-12T12:25:55.528644-05:00,HCM-BROD-0124-C25_treatment6,bc07a93c-580d-462b-843f-71f8afd612b7,,released,Oxaliplatin,1,2019-04-16T11:21:56.471158-05:00,Chemotherapy,Residual Disease,
HCM-BROD-0124-C25,03bfeb7c-cecf-4691-8263-33cdfe391ea9,00184ed8-780a-4acf-b5f1-b1fcd6b08dcf,420.0,Adjuvant,359.0,2021-07-12T12:25:55.528644-05:00,HCM-BROD-0124-C25_treatment3,c23c32ff-e21e-4284-8e06-7b389aafbfe5,,released,Irinotecan Hydrochloride,1,2019-04-16T11:21:56.471158-05:00,Chemotherapy,Residual Disease,
HCM-BROD-0124-C25,03bfeb7c-cecf-4691-8263-33cdfe391ea9,00184ed8-780a-4acf-b5f1-b1fcd6b08dcf,,Adjuvant,,2021-07-12T12:25:55.528644-05:00,HCM-BROD-0124-C25_treatment10,c4c4b6c7-7d73-475a-9488-79baab61c7cf,,released,,0,2020-09-27T10:37:49.634434-05:00,Targeted Molecular Therapy,Residual Disease,
HCM-BROD-0124-C25,03bfeb7c-cecf-4691-8263-33cdfe391ea9,00184ed8-780a-4acf-b5f1-b1fcd6b08dcf,286.0,Adjuvant,252.0,2021-07-12T12:25:55.528644-05:00,HCM-BROD-0124-C25_treatment2,e19f49d5-f266-4c69-85af-7965f6a7fce5,,released,Fluorouracil,1,2019-04-16T11:21:56.471158-05:00,Chemotherapy,Residual Disease,
HCM-BROD-0124-C25,03bfeb7c-cecf-4691-8263-33cdfe391ea9,00184ed8-780a-4acf-b5f1-b1fcd6b08dcf,,,0.0,2023-02-27T13:20:39.786851-06:00,HCM-BROD-0124-C25_treatment9,f31e96e1-80fc-45a2-807a-b6e9b48fbbc2,,released,,1,2020-09-27T10:37:49.634434-05:00,"Surgery, NOS",Initial Diagnosis,
HCM-SANG-0272-C20,043a7275-04cd-414d-bd57-05e3e5926129,64cdd445-b4ee-432b-918d-6f54cc200551,,Neoadjuvant,,2023-07-13T10:35:44.371881-05:00,HCM-SANG-0272-C20_treatment,0e7f4416-9d9d-407d-bb84-6d29df073b81,,released,,0,2021-12-21T15:06:44.982024-06:00,,,
HCM-BROD-0219-C15,04ab7e95-8c7f-466b-9209-11e36c95dbfe,d8323b2d-3963-4622-b7e5-db7446715642,,Adjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0219-C15_treatment2,0ac7040c-af8a-4015-aad7-fe51dd48b5ed,,released,,unknown,2020-09-17T16:02:22.848569-05:00,Chemotherapy,Residual Disease,
HCM-BROD-0219-C15,04ab7e95-8c7f-466b-9209-11e36c95dbfe,d8323b2d-3963-4622-b7e5-db7446715642,,Adjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0219-C15_treatment3,0dcd60e9-5f1f-421c-80ad-8de52e73c3d3,,released,,unknown,2020-09-17T16:02:22.848569-05:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-BROD-0219-C15,04ab7e95-8c7f-466b-9209-11e36c95dbfe,d8323b2d-3963-4622-b7e5-db7446715642,,Adjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0219-C15_treatment5,21106fbc-3115-4d9a-9de6-f726b3cb58b6,,released,,unknown,2020-09-17T16:02:22.848569-05:00,Targeted Molecular Therapy,Residual Disease,
HCM-BROD-0219-C15,04ab7e95-8c7f-466b-9209-11e36c95dbfe,d8323b2d-3963-4622-b7e5-db7446715642,,Neoadjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0219-C15_treatment,27dd29a1-3d45-48da-aede-66ba15e45673,,released,Unknown,1,2020-09-17T16:02:22.848569-05:00,Chemotherapy,,
HCM-BROD-0219-C15,04ab7e95-8c7f-466b-9209-11e36c95dbfe,d8323b2d-3963-4622-b7e5-db7446715642,,,,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0219-C15_treatment4,ad16d389-29f1-4c31-9e5e-0141cccdfd4f,,released,,0,2020-09-17T16:02:22.848569-05:00,"Surgery, NOS",Initial Diagnosis,
HCM-BROD-0219-C15,04ab7e95-8c7f-466b-9209-11e36c95dbfe,d8323b2d-3963-4622-b7e5-db7446715642,1156.0,Adjuvant,1150.0,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0219-C15_treatment6,de17d931-4e16-4386-a433-44c82dbc9452,,released,,1,2020-09-17T16:02:22.848569-05:00,"Radiation, Stereotactic/Gamma Knife/SRS",Residual Disease,
HCM-STAN-0841-C18,04b88744-7738-4bc2-ab67-14545f5b761f,70dc7d1b-95be-48e5-99e0-2dbbb522fe64,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-STAN-0841-C18_treatment6,06ff494e-91e1-4c86-986b-d3ff748a6cca,,released,,0,2022-09-22T07:05:13.869683-05:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-STAN-0841-C18,04b88744-7738-4bc2-ab67-14545f5b761f,70dc7d1b-95be-48e5-99e0-2dbbb522fe64,,Neoadjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-STAN-0841-C18_treatment,171bf083-6150-4490-96b2-f8464ad2436a,,released,,0,2022-09-22T07:05:13.869683-05:00,,,
HCM-STAN-0841-C18,04b88744-7738-4bc2-ab67-14545f5b761f,70dc7d1b-95be-48e5-99e0-2dbbb522fe64,,,193.0,2025-04-07T17:13:09.336794-05:00,HCM-STAN-0841-C18_treatment7,6ed7eecf-3b42-4fa2-af43-48ca875710bb,,released,,1,2022-09-22T07:05:13.869683-05:00,"Surgery, NOS",Initial Diagnosis,
HCM-STAN-0841-C18,04b88744-7738-4bc2-ab67-14545f5b761f,70dc7d1b-95be-48e5-99e0-2dbbb522fe64,972.0,Adjuvant,228.0,2025-04-07T17:13:09.336794-05:00,HCM-STAN-0841-C18_treatment2,79bae04b-36c1-441a-ab98-896d5a20f49e,Treatment Ongoing,released,Leucovorin Calcium,1,2022-09-22T07:05:13.869683-05:00,Chemotherapy,Residual Disease,
HCM-STAN-0841-C18,04b88744-7738-4bc2-ab67-14545f5b761f,70dc7d1b-95be-48e5-99e0-2dbbb522fe64,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-STAN-0841-C18_treatment9,7d17c83f-a9be-40fa-9473-27df49af92c5,,released,,0,2022-09-22T07:05:13.869683-05:00,"Radiation Therapy, NOS",Residual Disease,
HCM-STAN-0841-C18,04b88744-7738-4bc2-ab67-14545f5b761f,70dc7d1b-95be-48e5-99e0-2dbbb522fe64,972.0,Adjuvant,228.0,2025-04-07T17:13:09.336794-05:00,HCM-STAN-0841-C18_treatment3,9340d28e-aa42-4764-a8d2-b0a0aaa5ffa7,Treatment Ongoing,released,Fluorouracil,1,2022-09-22T07:05:13.869683-05:00,Chemotherapy,Residual Disease,
HCM-STAN-0841-C18,04b88744-7738-4bc2-ab67-14545f5b761f,70dc7d1b-95be-48e5-99e0-2dbbb522fe64,972.0,Adjuvant,228.0,2025-04-07T17:13:09.336794-05:00,HCM-STAN-0841-C18_treatment5,a571be1e-0331-4421-8e92-a1c4bfcd233b,Treatment Ongoing,released,,1,2022-09-22T07:05:13.869683-05:00,Chemotherapy,Residual Disease,FOLFIRI
HCM-STAN-0841-C18,04b88744-7738-4bc2-ab67-14545f5b761f,70dc7d1b-95be-48e5-99e0-2dbbb522fe64,972.0,Adjuvant,228.0,2025-04-07T17:13:09.336794-05:00,HCM-STAN-0841-C18_treatment4,b5d69abc-cfdd-4e29-9bc0-43754633f81e,Treatment Ongoing,released,Irinotecan,1,2022-09-22T07:05:13.869683-05:00,Chemotherapy,Residual Disease,
HCM-STAN-0841-C18,04b88744-7738-4bc2-ab67-14545f5b761f,70dc7d1b-95be-48e5-99e0-2dbbb522fe64,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-STAN-0841-C18_treatment8,cf4cd56d-08ed-4369-a4bd-3faf5648bb0a,,released,,0,2022-09-22T07:05:13.869683-05:00,Targeted Molecular Therapy,Residual Disease,
HCM-BROD-0761-C71,04ba3395-30c3-4e6e-964a-fe9f82dd8a97,447911c1-3c4a-4608-9c7b-e022cdd69c71,624.0,Adjuvant,509.0,2023-11-07T14:20:00.017270-06:00,HCM-BROD-0761-C71_treatment7,10be068c-5335-4ef4-bc0a-23f385a1d3fc,,released,Bevacizumab,1,2021-12-21T13:50:46.631914-06:00,Targeted Molecular Therapy,Residual Disease,
HCM-BROD-0761-C71,04ba3395-30c3-4e6e-964a-fe9f82dd8a97,447911c1-3c4a-4608-9c7b-e022cdd69c71,68.0,Adjuvant,19.0,2023-11-07T14:20:00.017270-06:00,HCM-BROD-0761-C71_treatment8,14c44f30-f5c6-4631-bcd2-c8df7122e07c,,released,,1,2021-12-21T13:50:46.631914-06:00,"Radiation, 2D Conventional",Residual Disease,
HCM-BROD-0761-C71,04ba3395-30c3-4e6e-964a-fe9f82dd8a97,447911c1-3c4a-4608-9c7b-e022cdd69c71,266.0,Adjuvant,19.0,2023-11-07T14:20:00.017270-06:00,HCM-BROD-0761-C71_treatment2,683152ba-7eaf-47ed-9a78-c149bb6f3b7f,,released,Temozolomide,1,2021-12-21T13:50:46.631914-06:00,Chemotherapy,Residual Disease,
HCM-BROD-0761-C71,04ba3395-30c3-4e6e-964a-fe9f82dd8a97,447911c1-3c4a-4608-9c7b-e022cdd69c71,,,2.0,2023-11-07T14:20:00.017270-06:00,HCM-BROD-0761-C71_treatment5,6a5e7f09-416b-4397-8ee2-0fa834ed69fa,,released,,1,2021-12-21T13:50:46.631914-06:00,"Surgery, NOS",Initial Diagnosis,
HCM-BROD-0761-C71,04ba3395-30c3-4e6e-964a-fe9f82dd8a97,447911c1-3c4a-4608-9c7b-e022cdd69c71,445.0,Adjuvant,404.0,2023-11-07T14:20:00.017270-06:00,HCM-BROD-0761-C71_treatment3,73e9d2f3-a9d4-4c33-935d-ad873124320b,,released,Lomustine,1,2021-12-21T13:50:46.631914-06:00,Chemotherapy,Residual Disease,
HCM-BROD-0761-C71,04ba3395-30c3-4e6e-964a-fe9f82dd8a97,447911c1-3c4a-4608-9c7b-e022cdd69c71,,Neoadjuvant,,2023-11-07T14:20:00.017270-06:00,HCM-BROD-0761-C71_treatment,9981dd39-f9b6-442d-8eb1-28b2f16b3567,,released,,0,2021-12-21T13:50:46.631914-06:00,,,
HCM-BROD-0761-C71,04ba3395-30c3-4e6e-964a-fe9f82dd8a97,447911c1-3c4a-4608-9c7b-e022cdd69c71,,Adjuvant,,2023-11-07T14:20:00.017270-06:00,HCM-BROD-0761-C71_treatment4,aa354819-2f85-4296-abe0-bcfc6f27c414,,released,,0,2021-12-21T13:50:46.631914-06:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-BROD-0761-C71,04ba3395-30c3-4e6e-964a-fe9f82dd8a97,447911c1-3c4a-4608-9c7b-e022cdd69c71,500.0,Adjuvant,455.0,2023-11-07T14:20:00.017270-06:00,HCM-BROD-0761-C71_treatment6,b33b9b8e-ce39-48ec-b3de-88f41bbd6878,,released,Regorafenib,1,2021-12-21T13:50:46.631914-06:00,Targeted Molecular Therapy,Residual Disease,
HCM-BROD-0719-C43,04c73a4a-8dec-4727-979a-6bc041e5a2f6,005284ee-d67e-47bb-a33d-ac53d11c72f7,504.0,Maintenance Therapy,262.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0719-C43_treatment10,0e074979-bda9-442f-96bf-bd56ba119901,Treatment Ongoing,released,Trametinib,1,2021-12-21T13:48:10.469697-06:00,,,
HCM-BROD-0719-C43,04c73a4a-8dec-4727-979a-6bc041e5a2f6,005284ee-d67e-47bb-a33d-ac53d11c72f7,504.0,Maintenance Therapy,262.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0719-C43_treatment9,f6bae2d7-32fd-4cae-84ec-4a1d93d1c52b,Treatment Ongoing,released,Dabrafenib,1,2021-12-21T13:48:10.469697-06:00,,,
HCM-BROD-0719-C43,04c73a4a-8dec-4727-979a-6bc041e5a2f6,e812b591-3758-4c5f-a3d8-633c631e0302,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0719-C43_treatment2,02646e9f-1a88-4cb7-a703-a587dfd7a37e,,released,,0,2021-12-21T13:48:10.469697-06:00,Chemotherapy,Residual Disease,
HCM-BROD-0719-C43,04c73a4a-8dec-4727-979a-6bc041e5a2f6,e812b591-3758-4c5f-a3d8-633c631e0302,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0719-C43_treatment3,47818ed5-947f-4d72-8d2d-e15ca09f8cad,,released,,0,2021-12-21T13:48:10.469697-06:00,Hormone Therapy,Residual Disease,
HCM-BROD-0719-C43,04c73a4a-8dec-4727-979a-6bc041e5a2f6,e812b591-3758-4c5f-a3d8-633c631e0302,,,0.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0719-C43_treatment5,519bae46-944e-4d20-a430-c229f60a2305,,released,,1,2021-12-21T13:48:10.469697-06:00,"Surgery, NOS",Initial Diagnosis,
HCM-BROD-0719-C43,04c73a4a-8dec-4727-979a-6bc041e5a2f6,e812b591-3758-4c5f-a3d8-633c631e0302,771.0,Adjuvant,250.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0719-C43_treatment6,99d31e97-5ad3-4169-ba73-4a097eea09bd,Treatment Ongoing,released,Dabrafenib,1,2021-12-21T13:48:10.469697-06:00,Targeted Molecular Therapy,Residual Disease,
HCM-BROD-0719-C43,04c73a4a-8dec-4727-979a-6bc041e5a2f6,e812b591-3758-4c5f-a3d8-633c631e0302,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0719-C43_treatment8,a540ffe0-ba24-4a21-9c5b-0801a8dd7e6e,,released,,0,2021-12-21T13:48:10.469697-06:00,"Radiation Therapy, NOS",Residual Disease,
HCM-BROD-0719-C43,04c73a4a-8dec-4727-979a-6bc041e5a2f6,e812b591-3758-4c5f-a3d8-633c631e0302,,Neoadjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0719-C43_treatment,d623f4fd-62eb-41a9-9920-c296ecf63218,,released,,0,2021-12-21T13:48:10.469697-06:00,,,
HCM-BROD-0719-C43,04c73a4a-8dec-4727-979a-6bc041e5a2f6,e812b591-3758-4c5f-a3d8-633c631e0302,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0719-C43_treatment4,dc9a0f04-f747-4bfd-b7bc-f52d26e62558,,released,,0,2021-12-21T13:48:10.469697-06:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-BROD-0719-C43,04c73a4a-8dec-4727-979a-6bc041e5a2f6,e812b591-3758-4c5f-a3d8-633c631e0302,771.0,Adjuvant,250.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0719-C43_treatment7,df1a31c1-f9c3-43e8-bc86-668b37fe0f83,Treatment Ongoing,released,Trametinib,1,2021-12-21T13:48:10.469697-06:00,Targeted Molecular Therapy,Residual Disease,
HCM-BROD-0421-C71,04cbceab-f945-482b-956b-840756a17a4a,252e0d9f-6cdb-4849-b981-e5a5ef0bb151,1619.0,Adjuvant,1470.0,2023-02-22T07:39:25.979291-06:00,HCM-BROD-0421-C71_treatment5,035608cf-fbbd-4e4c-9c7c-f1c821c4d93a,,released,Pembrolizumab,1,2020-09-27T11:34:31.711167-05:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-BROD-0421-C71,04cbceab-f945-482b-956b-840756a17a4a,252e0d9f-6cdb-4849-b981-e5a5ef0bb151,195.0,Adjuvant,92.0,2023-02-22T07:39:25.979291-06:00,HCM-BROD-0421-C71_treatment3,4548d38e-b8d7-470c-9b81-ef54f172b83b,,released,Temozolomide,1,2020-09-27T11:34:31.711167-05:00,Chemotherapy,Residual Disease,
HCM-BROD-0421-C71,04cbceab-f945-482b-956b-840756a17a4a,252e0d9f-6cdb-4849-b981-e5a5ef0bb151,,Neoadjuvant,,2023-02-22T07:39:25.979291-06:00,HCM-BROD-0421-C71_treatment,9a9eb40a-f7bc-4d4e-bf80-7ee7e74e6106,,released,,0,2020-09-27T11:34:31.711167-05:00,,,
HCM-BROD-0421-C71,04cbceab-f945-482b-956b-840756a17a4a,252e0d9f-6cdb-4849-b981-e5a5ef0bb151,1619.0,Adjuvant,1415.0,2023-02-22T07:39:25.979291-06:00,HCM-BROD-0421-C71_treatment7,9c4fb67e-5673-4832-99ac-af32d6ddbe44,,released,Bevacizumab,1,2020-09-27T11:34:31.711167-05:00,Targeted Molecular Therapy,Residual Disease,
HCM-BROD-0421-C71,04cbceab-f945-482b-956b-840756a17a4a,252e0d9f-6cdb-4849-b981-e5a5ef0bb151,59.0,Adjuvant,16.0,2023-02-22T07:39:25.979291-06:00,HCM-BROD-0421-C71_treatment2,a6b3741c-d57a-4074-b050-af7902456d1d,,released,Temozolomide,1,2020-09-27T11:34:31.711167-05:00,Chemotherapy,Residual Disease,
HCM-BROD-0421-C71,04cbceab-f945-482b-956b-840756a17a4a,252e0d9f-6cdb-4849-b981-e5a5ef0bb151,1363.0,Adjuvant,1114.0,2023-02-22T07:39:25.979291-06:00,HCM-BROD-0421-C71_treatment4,ab7dbf9c-d24b-4504-bb37-5a48c7360bcc,,released,Temozolomide,1,2020-09-27T11:34:31.711167-05:00,Chemotherapy,Residual Disease,
HCM-BROD-0421-C71,04cbceab-f945-482b-956b-840756a17a4a,252e0d9f-6cdb-4849-b981-e5a5ef0bb151,59.0,Adjuvant,16.0,2023-02-22T07:39:25.979291-06:00,HCM-BROD-0421-C71_treatment8,ac79ca2f-8daa-4e76-8e85-d3db6485e147,,released,,1,2020-09-27T11:34:31.711167-05:00,"Radiation Therapy, NOS",Residual Disease,
HCM-BROD-0421-C71,04cbceab-f945-482b-956b-840756a17a4a,252e0d9f-6cdb-4849-b981-e5a5ef0bb151,,,-6.0,2023-02-27T13:02:41.519762-06:00,HCM-BROD-0421-C71_treatment6,b5746ecb-94c1-4970-990b-a0b169000e1f,,released,,1,2020-09-27T11:34:31.711167-05:00,"Surgery, NOS",Initial Diagnosis,
HCM-BROD-0650-C56,05cbd57f-0c12-486e-8ced-edb9ed3cbbb0,1dbca213-579a-4de6-8e8e-54fbad934601,85.0,Maintenance Therapy,7.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0650-C56_treatment11,6135afc7-a4ee-42cf-b84c-aa0db094da8d,Progressive Disease,released,Carboplatin,1,2021-12-21T13:42:44.014507-06:00,,,
HCM-BROD-0650-C56,05cbd57f-0c12-486e-8ced-edb9ed3cbbb0,1dbca213-579a-4de6-8e8e-54fbad934601,85.0,Maintenance Therapy,7.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0650-C56_treatment12,73ec3513-a654-42dd-89a0-428d5a59f664,Progressive Disease,released,Paclitaxel,1,2021-12-21T13:42:44.014507-06:00,,,
HCM-BROD-0650-C56,05cbd57f-0c12-486e-8ced-edb9ed3cbbb0,84104925-47b8-4e5e-95c9-183074ec8172,,Neoadjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0650-C56_treatment,031d6235-ca4e-4b24-a0d3-b8d4bab82c0e,,released,,unknown,2021-12-21T13:42:44.014507-06:00,"Pharmaceutical Therapy, NOS",,
HCM-BROD-0650-C56,05cbd57f-0c12-486e-8ced-edb9ed3cbbb0,84104925-47b8-4e5e-95c9-183074ec8172,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0650-C56_treatment7,0c1e99fb-41ed-439e-a0c0-37e8444542b0,,released,,0,2021-12-21T13:42:44.014507-06:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-BROD-0650-C56,05cbd57f-0c12-486e-8ced-edb9ed3cbbb0,84104925-47b8-4e5e-95c9-183074ec8172,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0650-C56_treatment10,3a6b6aa9-a798-4c1f-8264-1ac1efc090bb,,released,,0,2021-12-21T13:42:44.014507-06:00,"Radiation Therapy, NOS",Residual Disease,
HCM-BROD-0650-C56,05cbd57f-0c12-486e-8ced-edb9ed3cbbb0,84104925-47b8-4e5e-95c9-183074ec8172,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0650-C56_treatment9,4abbf9e2-086b-47db-a212-6e98d82a072a,,released,,0,2021-12-21T13:42:44.014507-06:00,Targeted Molecular Therapy,Residual Disease,
HCM-BROD-0650-C56,05cbd57f-0c12-486e-8ced-edb9ed3cbbb0,84104925-47b8-4e5e-95c9-183074ec8172,85.0,Adjuvant,7.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0650-C56_treatment3,61497cca-2497-4550-8cb1-9eb7d235fbec,,released,Carboplatin,1,2021-12-21T13:42:44.014507-06:00,Chemotherapy,Residual Disease,
HCM-BROD-0650-C56,05cbd57f-0c12-486e-8ced-edb9ed3cbbb0,84104925-47b8-4e5e-95c9-183074ec8172,,,,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0650-C56_treatment8,77bf3a90-4543-403e-9dec-782652a14d00,,released,,unknown,2021-12-21T13:42:44.014507-06:00,"Surgery, NOS",Initial Diagnosis,
HCM-BROD-0650-C56,05cbd57f-0c12-486e-8ced-edb9ed3cbbb0,84104925-47b8-4e5e-95c9-183074ec8172,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0650-C56_treatment6,b4464f71-c2f6-4161-bba8-dd097989d3a5,,released,,0,2021-12-21T13:42:44.014507-06:00,Hormone Therapy,Residual Disease,
HCM-BROD-0650-C56,05cbd57f-0c12-486e-8ced-edb9ed3cbbb0,84104925-47b8-4e5e-95c9-183074ec8172,964.0,Adjuvant,670.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0650-C56_treatment5,daf12ba7-4056-4e80-8168-aa6353e38d80,,released,Pegylated Liposomal Doxorubicin Hydrochloride,1,2021-12-21T13:42:44.014507-06:00,Chemotherapy,Residual Disease,
HCM-BROD-0650-C56,05cbd57f-0c12-486e-8ced-edb9ed3cbbb0,84104925-47b8-4e5e-95c9-183074ec8172,964.0,Adjuvant,542.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0650-C56_treatment4,f5ce32de-9ac6-4f7f-ae36-d8fa9efd811c,,released,Paclitaxel,1,2021-12-21T13:42:44.014507-06:00,Chemotherapy,Residual Disease,
HCM-BROD-0650-C56,05cbd57f-0c12-486e-8ced-edb9ed3cbbb0,84104925-47b8-4e5e-95c9-183074ec8172,,Neoadjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0650-C56_treatment2,f632d2af-a16e-4448-94ef-74084f4fea7d,,released,,unknown,2021-12-21T13:42:44.014507-06:00,"Radiation Therapy, NOS",,
HCM-BROD-0095-C15,05f41641-ee22-4d41-bb87-2bfa47cd983f,cd0da3ad-189b-4be0-a8c6-55e0294e7c73,188.0,Adjuvant,146.0,2021-01-06T22:55:10.531130-06:00,HCM-BROD-0095-C15_treatment9,06d60b33-b792-47d4-8979-a246b928eb3d,,released,,1,2020-09-27T10:21:12.325852-05:00,Chemotherapy,Residual Disease,FOLFIRI
HCM-BROD-0095-C15,05f41641-ee22-4d41-bb87-2bfa47cd983f,cd0da3ad-189b-4be0-a8c6-55e0294e7c73,,Adjuvant,,2021-01-06T22:55:10.531130-06:00,HCM-BROD-0095-C15_treatment10,0b4b92e1-8bff-4867-9f37-8677002d28dd,,released,,0,2020-09-27T10:21:12.325852-05:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-BROD-0095-C15,05f41641-ee22-4d41-bb87-2bfa47cd983f,cd0da3ad-189b-4be0-a8c6-55e0294e7c73,,Neoadjuvant,,2021-01-06T22:55:10.531130-06:00,HCM-BROD-0095-C15_treatment,13786225-ac07-401c-aaea-187e26ac4811,,released,,0,2019-04-04T14:07:27.780827-05:00,,,
HCM-BROD-0095-C15,05f41641-ee22-4d41-bb87-2bfa47cd983f,cd0da3ad-189b-4be0-a8c6-55e0294e7c73,67.0,Adjuvant,13.0,2021-01-06T22:55:10.531130-06:00,HCM-BROD-0095-C15_treatment2,25a818a9-bb32-4047-a9ba-d811122cc6a1,,released,Oxaliplatin,1,2019-04-04T14:07:27.780827-05:00,Chemotherapy,Residual Disease,
HCM-BROD-0095-C15,05f41641-ee22-4d41-bb87-2bfa47cd983f,cd0da3ad-189b-4be0-a8c6-55e0294e7c73,215.0,Adjuvant,202.0,2021-01-06T22:55:10.531130-06:00,HCM-BROD-0095-C15_treatment13,62e39ce4-89f3-4c11-8661-82fee15c9e63,,released,,1,2020-09-27T10:21:12.325852-05:00,"Radiation, 3D Conformal",Residual Disease,
HCM-BROD-0095-C15,05f41641-ee22-4d41-bb87-2bfa47cd983f,cd0da3ad-189b-4be0-a8c6-55e0294e7c73,67.0,Adjuvant,13.0,2021-01-06T22:55:10.531130-06:00,HCM-BROD-0095-C15_treatment3,87ca94eb-c580-47cb-9f74-5fe4ae0f0af6,,released,Fluorouracil,1,2019-04-04T14:07:27.780827-05:00,Chemotherapy,Residual Disease,
HCM-BROD-0095-C15,05f41641-ee22-4d41-bb87-2bfa47cd983f,cd0da3ad-189b-4be0-a8c6-55e0294e7c73,188.0,Adjuvant,146.0,2021-01-06T22:55:10.531130-06:00,HCM-BROD-0095-C15_treatment7,87da9764-9695-4823-8aa7-2a810343eb08,,released,Fluorouracil,1,2019-04-04T14:07:27.780827-05:00,Chemotherapy,Residual Disease,
HCM-BROD-0095-C15,05f41641-ee22-4d41-bb87-2bfa47cd983f,cd0da3ad-189b-4be0-a8c6-55e0294e7c73,188.0,Adjuvant,146.0,2021-01-06T22:55:10.531130-06:00,HCM-BROD-0095-C15_treatment6,a7e26bed-3986-4384-bb34-a9134b06a26f,,released,Leucovorin Calcium,1,2019-04-04T14:07:27.780827-05:00,Chemotherapy,Residual Disease,
HCM-BROD-0095-C15,05f41641-ee22-4d41-bb87-2bfa47cd983f,cd0da3ad-189b-4be0-a8c6-55e0294e7c73,104.0,Adjuvant,76.0,2021-01-06T22:55:10.531130-06:00,HCM-BROD-0095-C15_treatment5,bb6c3d4f-c692-4cfd-b59c-1827f011aa6e,,released,Paclitaxel,1,2019-04-04T14:07:27.780827-05:00,Chemotherapy,Residual Disease,
HCM-BROD-0095-C15,05f41641-ee22-4d41-bb87-2bfa47cd983f,cd0da3ad-189b-4be0-a8c6-55e0294e7c73,67.0,Adjuvant,13.0,2021-01-06T22:55:10.531130-06:00,HCM-BROD-0095-C15_treatment4,cf7632b1-4c8c-4ff8-b200-d1c47fbe537f,,released,Leucovorin,1,2019-04-04T14:07:27.780827-05:00,Chemotherapy,Residual Disease,
HCM-BROD-0095-C15,05f41641-ee22-4d41-bb87-2bfa47cd983f,cd0da3ad-189b-4be0-a8c6-55e0294e7c73,,,,2023-02-27T11:24:51.849894-06:00,HCM-BROD-0095-C15_treatment11,d8d1fd47-6099-450c-ae9c-bac16725a0ef,,released,,0,2020-09-27T10:21:12.325852-05:00,"Surgery, NOS",Initial Diagnosis,
HCM-BROD-0095-C15,05f41641-ee22-4d41-bb87-2bfa47cd983f,cd0da3ad-189b-4be0-a8c6-55e0294e7c73,104.0,Adjuvant,76.0,2021-01-06T22:55:10.531130-06:00,HCM-BROD-0095-C15_treatment12,e83c75d4-9a25-4af4-a8fa-106365e15e36,,released,Ramucirumab,1,2020-09-27T10:21:12.325852-05:00,Targeted Molecular Therapy,Residual Disease,
HCM-BROD-0095-C15,05f41641-ee22-4d41-bb87-2bfa47cd983f,cd0da3ad-189b-4be0-a8c6-55e0294e7c73,188.0,Adjuvant,146.0,2021-01-06T22:55:10.531130-06:00,HCM-BROD-0095-C15_treatment8,f48b3c47-f60c-4118-9fe3-b6438dcd60bc,,released,Irinotecan,1,2020-09-27T10:21:12.325852-05:00,Chemotherapy,Residual Disease,
HCM-SANG-1332-C18,0608526c-70d5-4740-a9eb-1cce282ddd15,036320cc-29c9-4a04-8944-e0b525c73305,,Neoadjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-SANG-1332-C18_treatment,45894e36-cb42-4105-974e-d503b5b011ef,,released,,0,2023-02-27T13:17:38.903011-06:00,,,
HCM-CSHL-0511-C24,0693e8b4-9a8d-4356-9f3f-7da3bf1d202d,febc5b31-1966-455a-9110-5784e5ac89f7,,Adjuvant,,2023-02-22T07:39:25.979291-06:00,HCM-CSHL-0511-C24_treatment3,5346cb40-3501-438c-ad6c-54ca4d022172,,released,,0,2021-11-23T08:37:44.393081-06:00,Hormone Therapy,Residual Disease,
HCM-CSHL-0511-C24,0693e8b4-9a8d-4356-9f3f-7da3bf1d202d,febc5b31-1966-455a-9110-5784e5ac89f7,700.0,Adjuvant,514.0,2023-02-22T07:39:25.979291-06:00,HCM-CSHL-0511-C24_treatment2,6e70ffbc-a9bc-473b-9d45-00f28019b84b,,released,Gemcitabine,1,2021-11-23T08:37:44.393081-06:00,Chemotherapy,Residual Disease,
HCM-CSHL-0511-C24,0693e8b4-9a8d-4356-9f3f-7da3bf1d202d,febc5b31-1966-455a-9110-5784e5ac89f7,,Adjuvant,,2023-02-22T07:39:25.979291-06:00,HCM-CSHL-0511-C24_treatment4,d44836fc-36ba-4f69-9f0a-7b3ec730d888,,released,,0,2021-11-23T08:37:44.393081-06:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-CSHL-0511-C24,0693e8b4-9a8d-4356-9f3f-7da3bf1d202d,febc5b31-1966-455a-9110-5784e5ac89f7,,Neoadjuvant,,2023-02-22T07:39:25.979291-06:00,HCM-CSHL-0511-C24_treatment,dfdf6b34-692c-4015-9d5d-82812db0c822,,released,,0,2021-11-23T08:37:44.393081-06:00,,,
HCM-CSHL-0511-C24,0693e8b4-9a8d-4356-9f3f-7da3bf1d202d,febc5b31-1966-455a-9110-5784e5ac89f7,,,-10.0,2023-02-24T14:21:15.453689-06:00,HCM-CSHL-0511-C24_treatment5,e6ebfc35-3bfb-4ef3-bf68-bf7352c7e675,,released,,1,2021-11-23T08:37:44.393081-06:00,"Surgery, NOS",Initial Diagnosis,
HCM-CSHL-0511-C24,0693e8b4-9a8d-4356-9f3f-7da3bf1d202d,febc5b31-1966-455a-9110-5784e5ac89f7,,Adjuvant,,2023-02-22T07:39:25.979291-06:00,HCM-CSHL-0511-C24_treatment6,f9cfb989-d964-4809-aee7-95594f8056e8,,released,,0,2021-11-23T08:37:44.393081-06:00,Targeted Molecular Therapy,Residual Disease,
HCM-CSHL-0511-C24,0693e8b4-9a8d-4356-9f3f-7da3bf1d202d,febc5b31-1966-455a-9110-5784e5ac89f7,,Adjuvant,,2023-02-22T07:39:25.979291-06:00,HCM-CSHL-0511-C24_treatment7,fe25c9dd-c02d-44de-9641-d6301483b0ca,,released,,0,2021-11-23T08:37:44.393081-06:00,"Radiation Therapy, NOS",Residual Disease,
HCM-CSHL-0811-C55,06a0e127-713b-484d-8617-83f4be109792,4d8f3953-eaeb-48b8-b9f2-b34a64968375,,Neoadjuvant,,2023-07-13T10:27:19.665852-05:00,HCM-CSHL-0811-C55_treatment,465ab6ea-eb39-4dd3-8aa0-c261221b7652,,released,,0,2021-12-21T14:27:22.571706-06:00,,,
HCM-CSHL-0811-C55,06a0e127-713b-484d-8617-83f4be109792,4d8f3953-eaeb-48b8-b9f2-b34a64968375,155.0,Adjuvant,43.0,2023-07-13T10:27:19.665852-05:00,HCM-CSHL-0811-C55_treatment3,5a6071ae-f0bf-4803-add9-06505f211639,,released,Paclitaxel,1,2021-12-21T14:27:22.571706-06:00,Chemotherapy,Residual Disease,
HCM-CSHL-0811-C55,06a0e127-713b-484d-8617-83f4be109792,4d8f3953-eaeb-48b8-b9f2-b34a64968375,,Adjuvant,,2023-07-13T10:27:19.665852-05:00,HCM-CSHL-0811-C55_treatment4,6170a906-5e78-486f-a68f-b7d3bf564f7f,,released,,0,2021-12-21T14:27:22.571706-06:00,Hormone Therapy,Residual Disease,
HCM-CSHL-0811-C55,06a0e127-713b-484d-8617-83f4be109792,4d8f3953-eaeb-48b8-b9f2-b34a64968375,155.0,Adjuvant,43.0,2023-07-13T10:27:19.665852-05:00,HCM-CSHL-0811-C55_treatment2,6b5147d8-b6e1-4c35-8b40-982efdd9ee8b,,released,Carboplatin,1,2021-12-21T14:27:22.571706-06:00,Chemotherapy,Residual Disease,
HCM-CSHL-0811-C55,06a0e127-713b-484d-8617-83f4be109792,4d8f3953-eaeb-48b8-b9f2-b34a64968375,,Adjuvant,,2023-07-13T10:27:19.665852-05:00,HCM-CSHL-0811-C55_treatment7,9b4e570a-ae6e-4c8c-bb0f-38886d15ad40,,released,,0,2021-12-21T14:27:22.571706-06:00,Targeted Molecular Therapy,Residual Disease,
HCM-CSHL-0811-C55,06a0e127-713b-484d-8617-83f4be109792,4d8f3953-eaeb-48b8-b9f2-b34a64968375,,,0.0,2023-07-13T10:27:19.665852-05:00,HCM-CSHL-0811-C55_treatment6,e9cf7190-da98-4475-90e3-e405e8641da2,,released,,1,2021-12-21T14:27:22.571706-06:00,"Surgery, NOS",Initial Diagnosis,
HCM-CSHL-0811-C55,06a0e127-713b-484d-8617-83f4be109792,4d8f3953-eaeb-48b8-b9f2-b34a64968375,218.0,Adjuvant,203.0,2023-07-13T10:27:19.665852-05:00,HCM-CSHL-0811-C55_treatment8,f080e7dd-a31b-4575-825c-feadb8ce3db8,,released,,1,2021-12-21T14:27:22.571706-06:00,"Brachytherapy, High Dose",Residual Disease,
HCM-CSHL-0811-C55,06a0e127-713b-484d-8617-83f4be109792,4d8f3953-eaeb-48b8-b9f2-b34a64968375,,Adjuvant,,2023-07-13T10:27:19.665852-05:00,HCM-CSHL-0811-C55_treatment5,f7fb4320-2959-4801-a2c2-15c63b973e49,,released,,0,2021-12-21T14:27:22.571706-06:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-CSHL-0160-C18,06d42c21-4c97-4171-ac00-3979a51a59d9,c48f812c-f619-4846-830d-0ed2c343372d,,Adjuvant,,2023-03-13T13:21:16.151296-05:00,HCM-CSHL-0160-C18_treatment4,6c150e5c-1650-4df7-9228-0e641839fa16,,released,,0,2020-09-27T13:01:16.032710-05:00,"Radiation Therapy, NOS",Residual Disease,
HCM-CSHL-0160-C18,06d42c21-4c97-4171-ac00-3979a51a59d9,c48f812c-f619-4846-830d-0ed2c343372d,,Adjuvant,,2023-03-13T13:21:16.151296-05:00,HCM-CSHL-0160-C18_treatment3,817438a6-61a4-4323-bad0-0a7d520f2c9e,,released,,0,2020-09-27T13:01:16.032710-05:00,"Pharmaceutical Therapy, NOS",Residual Disease,
HCM-CSHL-0160-C18,06d42c21-4c97-4171-ac00-3979a51a59d9,c48f812c-f619-4846-830d-0ed2c343372d,,Neoadjuvant,,2023-02-22T07:39:25.979291-06:00,HCM-CSHL-0160-C18_treatment,bc9c62c1-d78a-4639-bbf2-af767e512eb2,,released,,0,2020-09-27T13:01:16.032710-05:00,,,
HCM-CSHL-0160-C18,06d42c21-4c97-4171-ac00-3979a51a59d9,c48f812c-f619-4846-830d-0ed2c343372d,,,21.0,2023-03-13T13:21:16.151296-05:00,HCM-CSHL-0160-C18_treatment2,f1b96223-f43e-44e3-90c2-d40909db619d,,released,,1,2020-09-27T13:01:16.032710-05:00,"Surgery, NOS",Initial Diagnosis,
HCM-SANG-0523-C15,0766560b-53a8-4cc9-8f84-4cbe651a86b9,fec6c448-3817-44ff-8cea-773313801d01,,Neoadjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-SANG-0523-C15_treatment,1c1641b0-3b0b-497e-b816-9e4b90da7a0c,,released,,0,2021-12-21T15:13:23.978010-06:00,,,
HCM-BROD-0417-C71,0798bf7a-53f3-4d88-a863-b4fc186bb5b6,2ed95ded-e81e-403f-ad19-d8c5e132b6f5,287.0,Adjuvant,207.0,2023-02-22T07:39:25.979291-06:00,HCM-BROD-0417-C71_treatment6,075b232d-7e73-49b2-b5c8-2b3afd4ba565,,released,Not Reported,1,2021-04-20T10:32:50.415650-05:00,Targeted Molecular Therapy,Residual Disease,
HCM-BROD-0417-C71,0798bf7a-53f3-4d88-a863-b4fc186bb5b6,2ed95ded-e81e-403f-ad19-d8c5e132b6f5,,,2.0,2023-03-13T12:42:05.390156-05:00,HCM-BROD-0417-C71_treatment4,0e6b4fe5-2c98-4533-af18-ce551b0f33d3,,released,,1,2021-04-20T10:32:50.415650-05:00,"Surgery, NOS",Initial Diagnosis,
HCM-BROD-0417-C71,0798bf7a-53f3-4d88-a863-b4fc186bb5b6,2ed95ded-e81e-403f-ad19-d8c5e132b6f5,501.0,Adjuvant,417.0,2023-02-22T07:39:25.979291-06:00,HCM-BROD-0417-C71_treatment7,2036c0f3-a8b2-4da0-97f8-76838c26a9f1,,released,Bevacizumab,1,2021-04-20T10:32:50.415650-05:00,Targeted Molecular Therapy,Residual Disease,
HCM-BROD-0417-C71,0798bf7a-53f3-4d88-a863-b4fc186bb5b6,2ed95ded-e81e-403f-ad19-d8c5e132b6f5,473.0,Adjuvant,417.0,2023-02-22T07:39:25.979291-06:00,HCM-BROD-0417-C71_treatment3,808803c7-1875-4d43-8d3a-54dc38e3193b,,released,Not Reported,1,2021-04-20T10:32:50.415650-05:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-BROD-0417-C71,0798bf7a-53f3-4d88-a863-b4fc186bb5b6,2ed95ded-e81e-403f-ad19-d8c5e132b6f5,,Neoadjuvant,,2023-02-22T07:39:25.979291-06:00,HCM-BROD-0417-C71_treatment,a785fc8f-fbb8-42be-986e-7a0e26ca7c6d,,released,,0,2021-04-20T10:32:50.415650-05:00,,,
HCM-BROD-0417-C71,0798bf7a-53f3-4d88-a863-b4fc186bb5b6,2ed95ded-e81e-403f-ad19-d8c5e132b6f5,170.0,Adjuvant,31.0,2023-02-22T07:39:25.979291-06:00,HCM-BROD-0417-C71_treatment8,d8bebdca-d458-411a-ae29-a93e90627c0e,,released,,1,2021-04-20T10:32:50.415650-05:00,"Radiation Therapy, NOS",Residual Disease,
HCM-BROD-0417-C71,0798bf7a-53f3-4d88-a863-b4fc186bb5b6,2ed95ded-e81e-403f-ad19-d8c5e132b6f5,403.0,Adjuvant,292.0,2023-02-22T07:39:25.979291-06:00,HCM-BROD-0417-C71_treatment2,fa50446c-61d3-47f7-9f22-b12eb182df44,,released,Lomustine,1,2021-04-20T10:32:50.415650-05:00,Chemotherapy,Residual Disease,
HCM-BROD-0417-C71,0798bf7a-53f3-4d88-a863-b4fc186bb5b6,2ed95ded-e81e-403f-ad19-d8c5e132b6f5,170.0,Adjuvant,31.0,2023-02-22T07:39:25.979291-06:00,HCM-BROD-0417-C71_treatment5,fcbe617c-1a97-47af-ab55-d76a363389bc,,released,Not Reported,1,2021-04-20T10:32:50.415650-05:00,Targeted Molecular Therapy,Residual Disease,
HCM-SANG-0268-C18,07a067d0-7dfc-4817-b4c5-9200da20a59f,78f3dc9e-9b51-42b2-b809-405e438f7f68,,Neoadjuvant,,2023-03-13T13:04:20.351769-05:00,HCM-SANG-0268-C18_treatment,b5337798-181a-4b32-ad3a-2edf84643490,,released,,0,2020-06-15T13:43:49.196827-05:00,,,
HCM-BROD-0351-C49,082faf22-1925-4478-94da-f124da62cd7e,2887b881-43cb-4aa2-b199-82512f517d6d,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0351-C49_treatment2,1bbf40a5-926a-44cc-b240-7de7cfac34bc,,released,,unknown,2021-12-21T13:36:57.884394-06:00,Chemotherapy,Residual Disease,
HCM-BROD-0351-C49,082faf22-1925-4478-94da-f124da62cd7e,2887b881-43cb-4aa2-b199-82512f517d6d,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0351-C49_treatment7,2768c35d-4965-4a52-8f79-9d5deafb3b3a,,released,,unknown,2021-12-21T13:36:57.884394-06:00,"Radiation Therapy, NOS",Residual Disease,
HCM-BROD-0351-C49,082faf22-1925-4478-94da-f124da62cd7e,2887b881-43cb-4aa2-b199-82512f517d6d,,,,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0351-C49_treatment5,466c3cd6-75ff-4a97-aa00-86df7cf907f1,,released,,unknown,2021-12-21T13:36:57.884394-06:00,"Surgery, NOS",Initial Diagnosis,
HCM-BROD-0351-C49,082faf22-1925-4478-94da-f124da62cd7e,2887b881-43cb-4aa2-b199-82512f517d6d,,Neoadjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0351-C49_treatment,46d578ea-d385-4c61-9a76-c764b9f20d73,,released,,0,2021-12-21T13:36:57.884394-06:00,,,
HCM-BROD-0351-C49,082faf22-1925-4478-94da-f124da62cd7e,2887b881-43cb-4aa2-b199-82512f517d6d,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0351-C49_treatment4,c592d6f1-cbf7-4969-87d9-0e71a5d9b460,,released,,unknown,2021-12-21T13:36:57.884394-06:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-BROD-0351-C49,082faf22-1925-4478-94da-f124da62cd7e,2887b881-43cb-4aa2-b199-82512f517d6d,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0351-C49_treatment3,e146d3c1-df9b-44a3-9fa0-30cc5bfcb7b3,,released,,unknown,2021-12-21T13:36:57.884394-06:00,Hormone Therapy,Residual Disease,
HCM-BROD-0351-C49,082faf22-1925-4478-94da-f124da62cd7e,2887b881-43cb-4aa2-b199-82512f517d6d,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0351-C49_treatment6,fd6f2725-1a87-4877-9031-d89af88a15bd,,released,,unknown,2021-12-21T13:36:57.884394-06:00,Targeted Molecular Therapy,Residual Disease,
HCM-BROD-0213-C71,08b22310-e8dd-4638-8c5b-dea48328450e,d45af56c-a54d-4c45-a783-3f1422fad837,226.0,Adjuvant,196.0,2021-01-06T22:55:10.531130-06:00,HCM-BROD-0213-C71_treatment3,3b34f429-0eae-4fda-927a-1a9464ff3a15,,released,Temozolomide,1,2020-02-27T12:36:30.343704-06:00,Chemotherapy,Residual Disease,
HCM-BROD-0213-C71,08b22310-e8dd-4638-8c5b-dea48328450e,d45af56c-a54d-4c45-a783-3f1422fad837,,,-9.0,2023-02-27T11:20:52.729333-06:00,HCM-BROD-0213-C71_treatment6,79198132-fa79-4e67-a4a2-27a9a64a9c4a,,released,,1,2020-02-27T12:36:30.343704-06:00,"Surgery, NOS",Initial Diagnosis,
HCM-BROD-0213-C71,08b22310-e8dd-4638-8c5b-dea48328450e,d45af56c-a54d-4c45-a783-3f1422fad837,,Neoadjuvant,,2021-01-06T22:55:10.531130-06:00,HCM-BROD-0213-C71_treatment,8afa85c0-fd37-4ba7-bae8-55bf7732b89d,,released,,0,2019-04-04T15:04:35.955336-05:00,,,
HCM-BROD-0213-C71,08b22310-e8dd-4638-8c5b-dea48328450e,d45af56c-a54d-4c45-a783-3f1422fad837,,Adjuvant,,2021-01-06T22:55:10.531130-06:00,HCM-BROD-0213-C71_treatment7,8c0bc31c-329f-4bd4-9a93-15e3e83e9ea8,,released,,0,2020-02-27T12:36:30.343704-06:00,Targeted Molecular Therapy,Residual Disease,
HCM-BROD-0213-C71,08b22310-e8dd-4638-8c5b-dea48328450e,d45af56c-a54d-4c45-a783-3f1422fad837,291.0,Adjuvant,287.0,2021-01-06T22:55:10.531130-06:00,HCM-BROD-0213-C71_treatment4,b4902fde-a6cd-4676-9e17-421b6e097d33,,released,Temozolomide,1,2020-02-27T12:36:30.343704-06:00,Chemotherapy,Residual Disease,
HCM-BROD-0213-C71,08b22310-e8dd-4638-8c5b-dea48328450e,d45af56c-a54d-4c45-a783-3f1422fad837,,Adjuvant,,2021-01-06T22:55:10.531130-06:00,HCM-BROD-0213-C71_treatment5,c0638bfa-09d7-4a76-908d-5ce1f3b2fb8e,,released,,0,2020-02-27T12:36:30.343704-06:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-BROD-0213-C71,08b22310-e8dd-4638-8c5b-dea48328450e,d45af56c-a54d-4c45-a783-3f1422fad837,159.0,Adjuvant,133.0,2021-01-06T22:55:10.531130-06:00,HCM-BROD-0213-C71_treatment2,ddc23375-0ed3-47cf-bbd5-aa09bd3bbae4,,released,Temozolomide,1,2020-02-27T12:36:30.343704-06:00,Chemotherapy,Residual Disease,
HCM-BROD-0213-C71,08b22310-e8dd-4638-8c5b-dea48328450e,d45af56c-a54d-4c45-a783-3f1422fad837,92.0,Adjuvant,55.0,2021-01-06T22:55:10.531130-06:00,HCM-BROD-0213-C71_treatment8,fc89a4ca-8655-4273-9adb-b628e8aee9aa,,released,,1,2020-02-27T12:36:30.343704-06:00,"Radiation Therapy, NOS",Residual Disease,
HCM-BROD-1124-C16,08fcc52a-8c11-45bd-bff4-9a3fa5ed7d82,d63c784a-9195-4615-bb26-8eb14dbf9892,21.0,Maintenance Therapy,2.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-1124-C16_treatment7,30c4a3dc-70f3-4f49-87ed-d3d15374ebe1,Progressive Disease,released,Oxaliplatin,1,2023-02-28T13:09:27.190728-06:00,,,
HCM-BROD-1124-C16,08fcc52a-8c11-45bd-bff4-9a3fa5ed7d82,d63c784a-9195-4615-bb26-8eb14dbf9892,21.0,Maintenance Therapy,2.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-1124-C16_treatment6,3d2f7f1e-afa0-4cb1-a06f-1c571fa610bb,Progressive Disease,released,Fluorouracil,1,2023-02-28T13:09:27.190728-06:00,,,
HCM-BROD-1124-C16,08fcc52a-8c11-45bd-bff4-9a3fa5ed7d82,d63c784a-9195-4615-bb26-8eb14dbf9892,21.0,Maintenance Therapy,2.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-1124-C16_treatment5,a542f22a-c621-4783-a7a8-6ca988382d8f,Progressive Disease,released,Leucovorin Calcium,1,2023-02-28T13:09:27.190728-06:00,,,
HCM-BROD-1124-C16,08fcc52a-8c11-45bd-bff4-9a3fa5ed7d82,d63c784a-9195-4615-bb26-8eb14dbf9892,21.0,Maintenance Therapy,2.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-1124-C16_treatment8,a9313852-1564-44f0-9b9c-0907350a50be,Progressive Disease,released,,1,2021-12-21T15:25:03.077169-06:00,,,FOLFOX
HCM-BROD-1124-C16,08fcc52a-8c11-45bd-bff4-9a3fa5ed7d82,d84d887b-8233-44cf-8f8a-d13002d2db4f,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-BROD-1124-C16_treatment4,582d829e-f47f-4bb2-a866-9f8b8aedcccf,,released,,0,2021-12-21T15:25:03.077169-06:00,"Radiation Therapy, NOS",Residual Disease,
HCM-BROD-1124-C16,08fcc52a-8c11-45bd-bff4-9a3fa5ed7d82,d84d887b-8233-44cf-8f8a-d13002d2db4f,,Neoadjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-BROD-1124-C16_treatment,a07a8348-2238-47ae-94ef-cb06f770fdf9,,released,,0,2021-12-21T15:25:03.077169-06:00,,,
HCM-BROD-1124-C16,08fcc52a-8c11-45bd-bff4-9a3fa5ed7d82,d84d887b-8233-44cf-8f8a-d13002d2db4f,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-BROD-1124-C16_treatment3,bdff01c2-1c66-43ba-8272-f7cdf6d66cec,,released,,0,2021-12-21T15:25:03.077169-06:00,"Pharmaceutical Therapy, NOS",Residual Disease,
HCM-BROD-1124-C16,08fcc52a-8c11-45bd-bff4-9a3fa5ed7d82,d84d887b-8233-44cf-8f8a-d13002d2db4f,,,,2025-04-07T17:13:09.336794-05:00,HCM-BROD-1124-C16_treatment2,c4be2787-6ec7-4ec4-b927-a3742715fda8,,released,,0,2021-12-21T15:25:03.077169-06:00,"Surgery, NOS",Initial Diagnosis,
HCM-WCMC-0789-C34,098d387f-beb5-48e2-ad69-537db301dff4,bc0375cc-5ebd-4a56-becb-25387517f575,,Neoadjuvant,,2023-11-07T14:20:00.017270-06:00,HCM-WCMC-0789-C34_treatment,08c1e1aa-3f85-44f1-934a-68c2075ebb93,,released,,0,2023-02-27T11:23:49.787909-06:00,,,
HCM-WCMC-0789-C34,098d387f-beb5-48e2-ad69-537db301dff4,bc0375cc-5ebd-4a56-becb-25387517f575,,Adjuvant,,2023-11-07T14:20:00.017270-06:00,HCM-WCMC-0789-C34_treatment3,256d192d-dfa1-4c1e-bf6f-7291691512ea,,released,,0,2023-02-27T11:23:49.787909-06:00,"Pharmaceutical Therapy, NOS",Residual Disease,
HCM-WCMC-0789-C34,098d387f-beb5-48e2-ad69-537db301dff4,bc0375cc-5ebd-4a56-becb-25387517f575,,Adjuvant,,2023-11-07T14:20:00.017270-06:00,HCM-WCMC-0789-C34_treatment4,7a2c5fab-d297-4140-ae79-c7a3297b1e8c,,released,,0,2023-02-27T11:23:49.787909-06:00,"Radiation Therapy, NOS",Residual Disease,
HCM-WCMC-0789-C34,098d387f-beb5-48e2-ad69-537db301dff4,bc0375cc-5ebd-4a56-becb-25387517f575,,,25.0,2023-11-07T14:20:00.017270-06:00,HCM-WCMC-0789-C34_treatment2,cf57c034-ed6e-4582-a6eb-d08e54b23906,,released,,1,2023-02-27T11:23:49.787909-06:00,"Surgery, NOS",Initial Diagnosis,
HCM-WCMC-0786-C34,0992e3ff-b15d-4985-988d-8f0a05e717a7,6e68afd7-ab31-4c6e-aa87-9c81d00c4fe7,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-WCMC-0786-C34_treatment7,06314ab6-b94c-41fd-884f-7acb631c37b1,,released,,0,2023-02-27T12:28:39.745293-06:00,"Radiation Therapy, NOS",Residual Disease,
HCM-WCMC-0786-C34,0992e3ff-b15d-4985-988d-8f0a05e717a7,6e68afd7-ab31-4c6e-aa87-9c81d00c4fe7,305.0,Adjuvant,291.0,2025-04-07T17:13:09.336794-05:00,HCM-WCMC-0786-C34_treatment2,15303a97-ce1f-4f89-9755-9db725ba1a95,,released,Paclitaxel,1,2023-02-27T12:28:39.745293-06:00,Chemotherapy,Residual Disease,
HCM-WCMC-0786-C34,0992e3ff-b15d-4985-988d-8f0a05e717a7,6e68afd7-ab31-4c6e-aa87-9c81d00c4fe7,,Neoadjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-WCMC-0786-C34_treatment,24a0555e-0039-4947-9860-557956304e15,,released,,0,2023-02-27T12:28:39.745293-06:00,,,
HCM-WCMC-0786-C34,0992e3ff-b15d-4985-988d-8f0a05e717a7,6e68afd7-ab31-4c6e-aa87-9c81d00c4fe7,291.0,Adjuvant,291.0,2025-04-07T17:13:09.336794-05:00,HCM-WCMC-0786-C34_treatment3,61df2902-329d-437a-b6e5-c01522f3466d,,released,Carboplatin,1,2023-02-27T12:28:39.745293-06:00,Chemotherapy,Residual Disease,
HCM-WCMC-0786-C34,0992e3ff-b15d-4985-988d-8f0a05e717a7,6e68afd7-ab31-4c6e-aa87-9c81d00c4fe7,291.0,Adjuvant,291.0,2025-04-07T17:13:09.336794-05:00,HCM-WCMC-0786-C34_treatment4,7ba197e5-df62-4665-9b6d-f3d55278f988,,released,Pembrolizumab,1,2023-02-27T12:28:39.745293-06:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-WCMC-0786-C34,0992e3ff-b15d-4985-988d-8f0a05e717a7,6e68afd7-ab31-4c6e-aa87-9c81d00c4fe7,,,0.0,2025-04-07T17:13:09.336794-05:00,HCM-WCMC-0786-C34_treatment5,c15dc135-c8da-41d2-8b92-cf3fa8d4f33c,,released,,1,2023-02-27T12:28:39.745293-06:00,"Surgery, NOS",Initial Diagnosis,
HCM-WCMC-0786-C34,0992e3ff-b15d-4985-988d-8f0a05e717a7,6e68afd7-ab31-4c6e-aa87-9c81d00c4fe7,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-WCMC-0786-C34_treatment6,cb0944be-1735-4c00-84fb-093df78b4982,,released,,0,2023-02-27T12:28:39.745293-06:00,Targeted Molecular Therapy,Residual Disease,
HCM-WCMC-0505-C16,0a66800c-c5e6-4fc9-ba09-a147107b721c,90f8d3f9-cc69-4560-92e2-59c7446ba14b,,Adjuvant,,2023-07-13T10:35:44.371881-05:00,HCM-WCMC-0505-C16_treatment4,6378084b-75f3-4e61-81a0-6bc1f7c7cb2a,,released,,0,2023-02-27T13:00:43.499335-06:00,"Radiation Therapy, NOS",Residual Disease,
HCM-WCMC-0505-C16,0a66800c-c5e6-4fc9-ba09-a147107b721c,90f8d3f9-cc69-4560-92e2-59c7446ba14b,,Neoadjuvant,,2023-07-13T10:35:44.371881-05:00,HCM-WCMC-0505-C16_treatment,6c1a7f3d-47ed-4c37-9f9b-9402fde67b13,,released,,0,2023-02-27T13:00:43.499335-06:00,,,
HCM-WCMC-0505-C16,0a66800c-c5e6-4fc9-ba09-a147107b721c,90f8d3f9-cc69-4560-92e2-59c7446ba14b,,Adjuvant,,2023-07-13T10:35:44.371881-05:00,HCM-WCMC-0505-C16_treatment3,d5c837b6-442e-47c6-925e-95c713e1fbdd,,released,,0,2023-02-27T13:00:43.499335-06:00,"Pharmaceutical Therapy, NOS",Residual Disease,
HCM-WCMC-0505-C16,0a66800c-c5e6-4fc9-ba09-a147107b721c,90f8d3f9-cc69-4560-92e2-59c7446ba14b,,,76.0,2023-07-13T10:35:44.371881-05:00,HCM-WCMC-0505-C16_treatment2,de785988-f6db-442a-ad23-f3c0bf955cf1,,released,,1,2023-02-27T13:00:43.499335-06:00,"Surgery, NOS",Initial Diagnosis,
HCM-SANG-0271-D12,0a6a14db-ca5c-4bf9-9125-611d672bc67b,17a41ef7-aafc-4b70-8d8f-484dc5cd27bd,,Neoadjuvant,,2023-02-22T07:39:25.979291-06:00,HCM-SANG-0271-D12_treatment,dea7bc4e-95ec-4d75-9c97-c041a3438f90,,released,,0,2021-12-21T15:06:43.990965-06:00,,,
HCM-CSHL-1266-C20,0ae6526b-17fa-4a08-b79c-916942feb7a1,12b7cade-4170-400c-8e08-0805ad91cc02,,Neoadjuvant,62.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-1266-C20_treatment3,007b33dc-7e90-4874-a417-40ea1982b8f7,,released,Oxaliplatin,1,2021-12-23T08:40:01.625113-06:00,Chemotherapy,,
HCM-CSHL-1266-C20,0ae6526b-17fa-4a08-b79c-916942feb7a1,12b7cade-4170-400c-8e08-0805ad91cc02,353.0,Adjuvant,276.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-1266-C20_treatment11,013e6560-da72-4750-abba-57e221029790,,released,Irinotecan,1,2021-12-23T08:40:01.625113-06:00,Chemotherapy,Residual Disease,
HCM-CSHL-1266-C20,0ae6526b-17fa-4a08-b79c-916942feb7a1,12b7cade-4170-400c-8e08-0805ad91cc02,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-1266-C20_treatment16,0ec74170-2ddb-46e0-9741-fda2b198fd89,,released,,0,2021-12-23T08:40:01.625113-06:00,Targeted Molecular Therapy,Residual Disease,
HCM-CSHL-1266-C20,0ae6526b-17fa-4a08-b79c-916942feb7a1,12b7cade-4170-400c-8e08-0805ad91cc02,234.0,Adjuvant,72.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-1266-C20_treatment7,1740b04a-5781-46c3-be4f-a6ed27d68ccd,,released,Irinotecan,1,2021-12-23T08:40:01.625113-06:00,Chemotherapy,Residual Disease,
HCM-CSHL-1266-C20,0ae6526b-17fa-4a08-b79c-916942feb7a1,12b7cade-4170-400c-8e08-0805ad91cc02,353.0,Adjuvant,276.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-1266-C20_treatment9,3ee4a5b6-39f1-44e1-9ac5-350b9dfe4efd,,released,Ziv-Aflibercept,1,2021-12-23T08:40:01.625113-06:00,Chemotherapy,Residual Disease,
HCM-CSHL-1266-C20,0ae6526b-17fa-4a08-b79c-916942feb7a1,12b7cade-4170-400c-8e08-0805ad91cc02,353.0,Adjuvant,276.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-1266-C20_treatment12,5cd8f706-b54e-42fa-87b9-3a293905482c,,released,Fluorouracil,1,2021-12-23T08:40:01.625113-06:00,Chemotherapy,Residual Disease,
HCM-CSHL-1266-C20,0ae6526b-17fa-4a08-b79c-916942feb7a1,12b7cade-4170-400c-8e08-0805ad91cc02,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-1266-C20_treatment17,85c0bc08-1cef-434e-a161-97d0168e6269,,released,,0,2021-12-23T08:40:01.625113-06:00,"Radiation Therapy, NOS",Residual Disease,
HCM-CSHL-1266-C20,0ae6526b-17fa-4a08-b79c-916942feb7a1,12b7cade-4170-400c-8e08-0805ad91cc02,234.0,Adjuvant,72.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-1266-C20_treatment5,86a8d90a-ba3d-4898-9ce3-94b678c769a2,,released,Leucovorin Calcium,1,2021-12-23T08:40:01.625113-06:00,Chemotherapy,Residual Disease,
HCM-CSHL-1266-C20,0ae6526b-17fa-4a08-b79c-916942feb7a1,12b7cade-4170-400c-8e08-0805ad91cc02,234.0,Adjuvant,72.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-1266-C20_treatment6,88823610-f2f2-4990-87e5-64bbcbeebaa6,,released,Fluorouracil,1,2021-12-23T08:40:01.625113-06:00,Chemotherapy,Residual Disease,
HCM-CSHL-1266-C20,0ae6526b-17fa-4a08-b79c-916942feb7a1,12b7cade-4170-400c-8e08-0805ad91cc02,,Neoadjuvant,62.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-1266-C20_treatment4,b03f49f6-e1c6-4200-8b79-70ad0e7a057e,,released,,1,2021-12-23T08:40:01.625113-06:00,Chemotherapy,,FOLFOX
HCM-CSHL-1266-C20,0ae6526b-17fa-4a08-b79c-916942feb7a1,12b7cade-4170-400c-8e08-0805ad91cc02,234.0,Adjuvant,72.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-1266-C20_treatment8,b7b13645-bfb3-41c7-872e-5663cae00c5f,,released,,1,2021-12-23T08:40:01.625113-06:00,Chemotherapy,Residual Disease,FOLFIRI
HCM-CSHL-1266-C20,0ae6526b-17fa-4a08-b79c-916942feb7a1,12b7cade-4170-400c-8e08-0805ad91cc02,,Neoadjuvant,62.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-1266-C20_treatment2,bec9c582-75f2-49d8-8c53-79801b79ee47,,released,Fluorouracil,1,2021-12-23T08:40:01.625113-06:00,Chemotherapy,,
HCM-CSHL-1266-C20,0ae6526b-17fa-4a08-b79c-916942feb7a1,12b7cade-4170-400c-8e08-0805ad91cc02,353.0,Adjuvant,276.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-1266-C20_treatment13,cb7bfcbf-6108-4709-b676-88082c3d5124,,released,,1,2021-12-23T08:40:01.625113-06:00,Chemotherapy,Residual Disease,FOLFIRI
HCM-CSHL-1266-C20,0ae6526b-17fa-4a08-b79c-916942feb7a1,12b7cade-4170-400c-8e08-0805ad91cc02,,,395.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-1266-C20_treatment15,ce106a72-be9f-4198-a859-13368b80c414,,released,,1,2021-12-23T08:40:01.625113-06:00,"Surgery, NOS",Initial Diagnosis,
HCM-CSHL-1266-C20,0ae6526b-17fa-4a08-b79c-916942feb7a1,12b7cade-4170-400c-8e08-0805ad91cc02,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-1266-C20_treatment14,e8f57f9a-d340-40b8-8c08-1a30910e42d9,,released,,0,2021-12-23T08:40:01.625113-06:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-CSHL-1266-C20,0ae6526b-17fa-4a08-b79c-916942feb7a1,12b7cade-4170-400c-8e08-0805ad91cc02,,Neoadjuvant,62.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-1266-C20_treatment,ebffdbea-f148-49af-963d-276ab0972bb6,,released,Leucovorin Calcium,1,2021-12-23T08:40:01.625113-06:00,Chemotherapy,,
HCM-CSHL-1266-C20,0ae6526b-17fa-4a08-b79c-916942feb7a1,12b7cade-4170-400c-8e08-0805ad91cc02,353.0,Adjuvant,276.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-1266-C20_treatment10,efa7daa1-787c-4b11-83e3-881cd51fef8e,,released,Leucovorin Calcium,1,2021-12-23T08:40:01.625113-06:00,Chemotherapy,Residual Disease,
HCM-CSHL-1266-C20,0ae6526b-17fa-4a08-b79c-916942feb7a1,56369e46-5db3-4c47-8f10-f032090e2e39,234.0,Maintenance Therapy,62.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-1266-C20_treatment23,46a2aeda-d541-4d42-ac1b-95da9c0bd162,Stable Disease,released,Fluorouracil,1,2021-12-23T08:40:01.625113-06:00,,,
HCM-CSHL-1266-C20,0ae6526b-17fa-4a08-b79c-916942feb7a1,56369e46-5db3-4c47-8f10-f032090e2e39,234.0,Maintenance Therapy,62.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-1266-C20_treatment24,6886add6-7359-4e82-9750-56755b1ab817,Stable Disease,released,Oxaliplatin,1,2021-12-23T08:40:01.625113-06:00,,,
HCM-CSHL-1266-C20,0ae6526b-17fa-4a08-b79c-916942feb7a1,56369e46-5db3-4c47-8f10-f032090e2e39,234.0,Maintenance Therapy,62.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-1266-C20_treatment22,afaf75c4-ff0c-4d24-8b3a-d09da719a58e,Stable Disease,released,Leucovorin Calcium,1,2021-12-23T08:40:01.625113-06:00,,,
HCM-CSHL-1266-C20,0ae6526b-17fa-4a08-b79c-916942feb7a1,56369e46-5db3-4c47-8f10-f032090e2e39,234.0,Maintenance Therapy,62.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-1266-C20_treatment25,f4a9dc35-1043-444b-a915-43900f39ae67,Stable Disease,released,,1,2021-12-23T08:40:01.625113-06:00,,,FOLFOX
HCM-CSHL-1266-C20,0ae6526b-17fa-4a08-b79c-916942feb7a1,9f9a8e10-e68a-4f57-8fce-6593c12d30a1,234.0,Maintenance Therapy,62.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-1266-C20_treatment21,23c22f5c-8e6f-414b-942b-eade2e04a3f7,Stable Disease,released,,1,2021-12-23T08:40:01.625113-06:00,,,FOLFOX
HCM-CSHL-1266-C20,0ae6526b-17fa-4a08-b79c-916942feb7a1,9f9a8e10-e68a-4f57-8fce-6593c12d30a1,234.0,Maintenance Therapy,62.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-1266-C20_treatment20,40b023fa-79d2-435d-bdc6-fa368e0ac036,Stable Disease,released,Oxaliplatin,1,2021-12-23T08:40:01.625113-06:00,,,
HCM-CSHL-1266-C20,0ae6526b-17fa-4a08-b79c-916942feb7a1,9f9a8e10-e68a-4f57-8fce-6593c12d30a1,234.0,Maintenance Therapy,62.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-1266-C20_treatment19,56785918-1afa-4afc-804c-06b19a104328,Stable Disease,released,Fluorouracil,1,2021-12-23T08:40:01.625113-06:00,,,
HCM-CSHL-1266-C20,0ae6526b-17fa-4a08-b79c-916942feb7a1,9f9a8e10-e68a-4f57-8fce-6593c12d30a1,234.0,Maintenance Therapy,62.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-1266-C20_treatment18,60c28853-47d9-4867-9316-0f21897ea661,Stable Disease,released,Leucovorin Calcium,1,2021-12-23T08:40:01.625113-06:00,,,
HCM-CSHL-0366-C50,0bbe1b04-f582-453c-9070-7aafc07912fe,56367e18-176b-432a-8389-889547888a87,,Adjuvant,316.0,2020-10-20T19:20:06.800740-05:00,HCM-CSHL-0366-C50_treatment6,03bfd8c1-3387-47b9-8b85-c37d3bc76a21,,released,Exemestane,1,2020-02-27T12:51:45.340980-06:00,Hormone Therapy,Residual Disease,
HCM-CSHL-0366-C50,0bbe1b04-f582-453c-9070-7aafc07912fe,56367e18-176b-432a-8389-889547888a87,,,125.0,2023-02-24T14:44:14.295292-06:00,HCM-CSHL-0366-C50_treatment9,1525b875-71bd-4043-b4c2-8954ab613afd,,released,,1,2020-02-27T12:51:45.340980-06:00,"Surgery, NOS",Initial Diagnosis,
HCM-CSHL-0366-C50,0bbe1b04-f582-453c-9070-7aafc07912fe,56367e18-176b-432a-8389-889547888a87,,Neoadjuvant,40.0,2020-10-20T19:20:06.800740-05:00,HCM-CSHL-0366-C50_treatment4,26d47359-aaa2-42b8-863d-ae40fc41a300,,released,,1,2020-02-27T12:51:45.340980-06:00,Chemotherapy,,dose-dense AC
HCM-CSHL-0366-C50,0bbe1b04-f582-453c-9070-7aafc07912fe,56367e18-176b-432a-8389-889547888a87,,Adjuvant,,2020-10-20T19:20:06.800740-05:00,HCM-CSHL-0366-C50_treatment5,3b2ab66c-ea4d-4bd9-9c85-ee8a9db4eec6,,released,,0,2020-02-27T12:51:45.340980-06:00,Chemotherapy,Residual Disease,
HCM-CSHL-0366-C50,0bbe1b04-f582-453c-9070-7aafc07912fe,56367e18-176b-432a-8389-889547888a87,,Neoadjuvant,40.0,2020-10-20T19:20:06.800740-05:00,HCM-CSHL-0366-C50_treatment,60899f92-ae3b-46e6-a9fb-6cf711448feb,,released,Paclitaxel,1,2020-02-27T12:51:45.340980-06:00,Chemotherapy,,
HCM-CSHL-0366-C50,0bbe1b04-f582-453c-9070-7aafc07912fe,56367e18-176b-432a-8389-889547888a87,,Neoadjuvant,40.0,2020-10-20T19:20:06.800740-05:00,HCM-CSHL-0366-C50_treatment3,72209bf4-d388-438d-ba03-6495c83c7582,,released,Cyclophosphamide,1,2020-02-27T12:51:45.340980-06:00,Chemotherapy,,
HCM-CSHL-0366-C50,0bbe1b04-f582-453c-9070-7aafc07912fe,56367e18-176b-432a-8389-889547888a87,,Adjuvant,,2020-10-20T19:20:06.800740-05:00,HCM-CSHL-0366-C50_treatment8,7f87ead4-5a6e-4cb2-9115-1cae7ca93a0a,,released,,0,2020-02-27T12:51:45.340980-06:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-CSHL-0366-C50,0bbe1b04-f582-453c-9070-7aafc07912fe,56367e18-176b-432a-8389-889547888a87,,Adjuvant,,2020-10-20T19:20:06.800740-05:00,HCM-CSHL-0366-C50_treatment7,9127e258-c5a2-4678-948c-ba056bea7b42,,released,Not Reported,1,2020-02-27T12:51:45.340980-06:00,Hormone Therapy,Residual Disease,
HCM-CSHL-0366-C50,0bbe1b04-f582-453c-9070-7aafc07912fe,56367e18-176b-432a-8389-889547888a87,,Adjuvant,316.0,2020-10-20T19:20:06.800740-05:00,HCM-CSHL-0366-C50_treatment10,931e6d88-84c9-446d-a617-c2e737f08052,,released,Everolimus,1,2020-09-28T09:49:02.526747-05:00,Targeted Molecular Therapy,Residual Disease,
HCM-CSHL-0366-C50,0bbe1b04-f582-453c-9070-7aafc07912fe,56367e18-176b-432a-8389-889547888a87,236.0,Adjuvant,212.0,2020-10-20T19:20:06.800740-05:00,HCM-CSHL-0366-C50_treatment11,c3e20a17-7eb4-4aa0-a9ab-f66cc6f7a8ff,,released,,1,2020-09-28T09:49:02.526747-05:00,"Radiation, Intensity-Modulated Radiotherapy",Residual Disease,
HCM-CSHL-0366-C50,0bbe1b04-f582-453c-9070-7aafc07912fe,56367e18-176b-432a-8389-889547888a87,,Neoadjuvant,40.0,2020-10-20T19:20:06.800740-05:00,HCM-CSHL-0366-C50_treatment2,eb3819db-1236-4659-bf31-dcd5d84fe964,,released,Doxorubicin Hydrochloride,1,2020-02-27T12:51:45.340980-06:00,Chemotherapy,,
HCM-CSHL-0835-C20,0bc32bb1-1770-41cc-8b98-71498a3d7c21,bd14ed25-55ef-4309-b57e-8a47b40e7dfc,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0835-C20_treatment3,7274a069-23ff-4515-a3d4-ba4b09901830,,released,Capecitabine,1,2021-12-21T14:31:56.060828-06:00,Chemotherapy,Residual Disease,
HCM-CSHL-0835-C20,0bc32bb1-1770-41cc-8b98-71498a3d7c21,bd14ed25-55ef-4309-b57e-8a47b40e7dfc,,,1260.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0835-C20_treatment6,741be78a-842c-4a29-9253-60310d863d14,,released,,1,2021-12-21T14:31:56.060828-06:00,"Surgery, NOS",Initial Diagnosis,
HCM-CSHL-0835-C20,0bc32bb1-1770-41cc-8b98-71498a3d7c21,bd14ed25-55ef-4309-b57e-8a47b40e7dfc,,Neoadjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0835-C20_treatment,74474521-6a7c-4137-90e8-c6db8415d8cb,,released,,unknown,2021-12-21T14:31:56.060828-06:00,"Pharmaceutical Therapy, NOS",,
HCM-CSHL-0835-C20,0bc32bb1-1770-41cc-8b98-71498a3d7c21,bd14ed25-55ef-4309-b57e-8a47b40e7dfc,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0835-C20_treatment4,77c91739-6a04-4b40-9d6b-99f9ddc8965f,,released,,0,2021-12-21T14:31:56.060828-06:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-CSHL-0835-C20,0bc32bb1-1770-41cc-8b98-71498a3d7c21,bd14ed25-55ef-4309-b57e-8a47b40e7dfc,,,865.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0835-C20_treatment5,8e53f865-eae1-44ce-9fc1-2af1437079ef,,released,,1,2021-12-21T14:31:56.060828-06:00,"Surgery, NOS",Initial Diagnosis,
HCM-CSHL-0835-C20,0bc32bb1-1770-41cc-8b98-71498a3d7c21,bd14ed25-55ef-4309-b57e-8a47b40e7dfc,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0835-C20_treatment8,9d479444-2bc4-4fbe-a589-5e7493223204,,released,,unknown,2021-12-21T14:31:56.060828-06:00,"Radiation Therapy, NOS",Residual Disease,
HCM-CSHL-0835-C20,0bc32bb1-1770-41cc-8b98-71498a3d7c21,bd14ed25-55ef-4309-b57e-8a47b40e7dfc,,Neoadjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0835-C20_treatment2,9dbc9dfd-dad1-44a1-bf0a-217bf23de62e,,released,,unknown,2021-12-21T14:31:56.060828-06:00,"Radiation Therapy, NOS",,
HCM-CSHL-0835-C20,0bc32bb1-1770-41cc-8b98-71498a3d7c21,bd14ed25-55ef-4309-b57e-8a47b40e7dfc,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0835-C20_treatment7,ba7d9c62-018d-46d0-8767-4915790df1e9,,released,,0,2021-12-21T14:31:56.060828-06:00,Targeted Molecular Therapy,Residual Disease,
HCM-CSHL-0835-C20,0bc32bb1-1770-41cc-8b98-71498a3d7c21,eed15fc5-faf6-482a-8e93-d1e1ecc2ecf2,1212.0,Maintenance Therapy,932.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0835-C20_treatment9,242ab1d8-d67c-4375-95c1-4108f2589ae1,Stable Disease,released,Xeloda,1,2021-12-21T14:31:56.060828-06:00,,,
HCM-SANG-0552-C25,0bcbe03e-51c9-45d8-bc88-34ebada85d3e,a71b3306-27d3-4311-951b-dd43ce73f84b,,Neoadjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-SANG-0552-C25_treatment,07a3a087-d621-49b1-9029-23338bbdc85c,,released,,0,2023-02-27T12:13:08.606836-06:00,,,
HCM-WCMC-0673-C56,0bcca666-3c62-4eb9-a47c-93bb7c020ad6,896de6c7-0272-40b4-a48f-736627753c90,,Neoadjuvant,,2023-02-22T07:39:25.979291-06:00,HCM-WCMC-0673-C56_treatment10,efa821b2-fd8e-4da6-abbf-30dcede71e59,No Response,released,,1,2022-07-13T17:51:20.407651-05:00,Chemotherapy,,
HCM-WCMC-0673-C56,0bcca666-3c62-4eb9-a47c-93bb7c020ad6,b7b4bdb9-dece-403c-a46d-bfe8344b0c27,,,,2023-02-27T11:32:53.810890-06:00,HCM-WCMC-0673-C56_treatment6,0b09216f-c993-4460-9a6b-1e9f05830b80,,released,,0,2022-07-13T17:51:20.407651-05:00,"Surgery, NOS",Initial Diagnosis,
HCM-WCMC-0673-C56,0bcca666-3c62-4eb9-a47c-93bb7c020ad6,b7b4bdb9-dece-403c-a46d-bfe8344b0c27,,Adjuvant,,2023-02-22T07:39:25.979291-06:00,HCM-WCMC-0673-C56_treatment5,3bbbcc77-0ce5-4122-bde0-d31e349e373c,,released,,unknown,2022-07-13T17:51:20.407651-05:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-WCMC-0673-C56,0bcca666-3c62-4eb9-a47c-93bb7c020ad6,b7b4bdb9-dece-403c-a46d-bfe8344b0c27,,Neoadjuvant,37.0,2023-02-22T07:39:25.979291-06:00,HCM-WCMC-0673-C56_treatment,3e9a49d4-4513-4d9d-a7e3-dc11a4d677cd,,released,,1,2022-07-13T17:51:20.407651-05:00,Chemotherapy,,
HCM-WCMC-0673-C56,0bcca666-3c62-4eb9-a47c-93bb7c020ad6,b7b4bdb9-dece-403c-a46d-bfe8344b0c27,,Neoadjuvant,,2023-02-22T07:39:25.979291-06:00,HCM-WCMC-0673-C56_treatment9,65aef658-ca92-4dc8-8857-5c9dc6df72c8,No Response,released,,1,2022-07-13T17:51:20.407651-05:00,Chemotherapy,,
HCM-WCMC-0673-C56,0bcca666-3c62-4eb9-a47c-93bb7c020ad6,b7b4bdb9-dece-403c-a46d-bfe8344b0c27,,Adjuvant,,2023-02-22T07:39:25.979291-06:00,HCM-WCMC-0673-C56_treatment4,8b8f66ba-4b3b-47f5-9792-126ec678319a,,released,,unknown,2022-07-13T17:51:20.407651-05:00,Hormone Therapy,Residual Disease,
HCM-WCMC-0673-C56,0bcca666-3c62-4eb9-a47c-93bb7c020ad6,b7b4bdb9-dece-403c-a46d-bfe8344b0c27,,Adjuvant,,2023-02-22T07:39:25.979291-06:00,HCM-WCMC-0673-C56_treatment7,b9810192-27ce-443a-b084-ca655c45eab6,,released,,unknown,2022-07-13T17:51:20.407651-05:00,Targeted Molecular Therapy,Residual Disease,
HCM-WCMC-0673-C56,0bcca666-3c62-4eb9-a47c-93bb7c020ad6,b7b4bdb9-dece-403c-a46d-bfe8344b0c27,142.0,Adjuvant,142.0,2023-02-22T07:39:25.979291-06:00,HCM-WCMC-0673-C56_treatment3,dc417814-fac5-48d6-91a2-dbea6e90ee4c,,released,Carboplatin,1,2022-07-13T17:51:20.407651-05:00,Chemotherapy,Residual Disease,
HCM-WCMC-0673-C56,0bcca666-3c62-4eb9-a47c-93bb7c020ad6,b7b4bdb9-dece-403c-a46d-bfe8344b0c27,142.0,Adjuvant,142.0,2023-02-22T07:39:25.979291-06:00,HCM-WCMC-0673-C56_treatment2,e6afde08-19d3-4892-8838-92dfd157952f,,released,Paclitaxel,1,2022-07-13T17:51:20.407651-05:00,Chemotherapy,Residual Disease,
HCM-WCMC-0673-C56,0bcca666-3c62-4eb9-a47c-93bb7c020ad6,b7b4bdb9-dece-403c-a46d-bfe8344b0c27,,Adjuvant,,2023-02-22T07:39:25.979291-06:00,HCM-WCMC-0673-C56_treatment8,eed46cec-1f99-4626-bf66-d30ac92743bf,,released,,unknown,2022-07-13T17:51:20.407651-05:00,"Radiation Therapy, NOS",Residual Disease,
HCM-CSHL-0512-C24,0cafd069-029f-449d-97ce-b69009a80d80,c4f9e2d2-d399-4baa-b172-e024f9ed01fc,,Adjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0512-C24_treatment3,138339a0-6bb8-42ac-a55d-2b39c1473b1f,,released,,unknown,2021-12-21T14:06:23.747147-06:00,"Pharmaceutical Therapy, NOS",Residual Disease,
HCM-CSHL-0512-C24,0cafd069-029f-449d-97ce-b69009a80d80,c4f9e2d2-d399-4baa-b172-e024f9ed01fc,,Neoadjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0512-C24_treatment,15f1fc6b-f074-41b1-81d0-06d8253514c3,,released,,0,2021-12-21T14:06:23.747147-06:00,,,
HCM-CSHL-0512-C24,0cafd069-029f-449d-97ce-b69009a80d80,c4f9e2d2-d399-4baa-b172-e024f9ed01fc,,Adjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0512-C24_treatment4,591751c6-3331-4598-8d06-0e2612a6eb50,,released,,unknown,2021-12-21T14:06:23.747147-06:00,"Radiation Therapy, NOS",Residual Disease,
HCM-CSHL-0512-C24,0cafd069-029f-449d-97ce-b69009a80d80,c4f9e2d2-d399-4baa-b172-e024f9ed01fc,,,-11.0,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0512-C24_treatment2,a4211d3b-abaa-4ba7-a08e-2d05926c5d62,,released,,1,2021-12-21T14:06:23.747147-06:00,"Surgery, NOS",Initial Diagnosis,
HCM-BROD-0555-C15,0cd60ea0-92de-44fa-86be-c75842b4123e,3b045dfa-c32b-4998-99db-1a2dced80314,,Neoadjuvant,39.0,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0555-C15_treatment3,0078ab58-2cba-4291-b981-a48fb728d67c,,released,Oxaliplatin,1,2020-09-27T11:57:35.545995-05:00,Chemotherapy,,
HCM-BROD-0555-C15,0cd60ea0-92de-44fa-86be-c75842b4123e,3b045dfa-c32b-4998-99db-1a2dced80314,14.0,Adjuvant,4.0,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0555-C15_treatment8,169d1f10-9c9d-44b6-b1d7-8a879e406b0d,,released,,1,2020-09-27T11:57:35.545995-05:00,Chemotherapy,Residual Disease,FOLFOX
HCM-BROD-0555-C15,0cd60ea0-92de-44fa-86be-c75842b4123e,3b045dfa-c32b-4998-99db-1a2dced80314,14.0,Adjuvant,4.0,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0555-C15_treatment7,27d6f45f-8030-41ff-b3fc-1cc714ee8b24,,released,Oxaliplatin,1,2020-09-27T11:57:35.545995-05:00,Chemotherapy,Residual Disease,
HCM-BROD-0555-C15,0cd60ea0-92de-44fa-86be-c75842b4123e,3b045dfa-c32b-4998-99db-1a2dced80314,,Neoadjuvant,39.0,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0555-C15_treatment4,2cc4389d-b8bb-44e1-b23f-a358518fbadd,,released,,1,2020-09-27T11:57:35.545995-05:00,Chemotherapy,,FOLFOX
HCM-BROD-0555-C15,0cd60ea0-92de-44fa-86be-c75842b4123e,3b045dfa-c32b-4998-99db-1a2dced80314,14.0,Adjuvant,4.0,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0555-C15_treatment5,964f08ef-221b-4c3e-8954-84610702e1e5,,released,Leucovorin Calcium,1,2020-09-27T11:57:35.545995-05:00,Chemotherapy,Residual Disease,
HCM-BROD-0555-C15,0cd60ea0-92de-44fa-86be-c75842b4123e,3b045dfa-c32b-4998-99db-1a2dced80314,,Adjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0555-C15_treatment12,9921979f-f96c-4071-ae9e-5ee12a90849a,,released,,0,2020-09-27T11:57:35.545995-05:00,"Radiation Therapy, NOS",Residual Disease,
HCM-BROD-0555-C15,0cd60ea0-92de-44fa-86be-c75842b4123e,3b045dfa-c32b-4998-99db-1a2dced80314,14.0,Adjuvant,4.0,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0555-C15_treatment6,ba811f38-d575-4b62-aab0-02777586512e,,released,Fluorouracil,1,2020-09-27T11:57:35.545995-05:00,Chemotherapy,Residual Disease,
HCM-BROD-0555-C15,0cd60ea0-92de-44fa-86be-c75842b4123e,3b045dfa-c32b-4998-99db-1a2dced80314,,,,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0555-C15_treatment10,bfef1336-7088-4a65-a8fd-6ccd41d62d0f,,released,,0,2020-09-27T11:57:35.545995-05:00,"Surgery, NOS",Initial Diagnosis,
HCM-BROD-0555-C15,0cd60ea0-92de-44fa-86be-c75842b4123e,3b045dfa-c32b-4998-99db-1a2dced80314,,Neoadjuvant,39.0,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0555-C15_treatment2,d189ef64-46a8-4b87-845f-7f5b0d2dd880,,released,Fluorouracil,1,2020-09-27T11:57:35.545995-05:00,Chemotherapy,,
HCM-BROD-0555-C15,0cd60ea0-92de-44fa-86be-c75842b4123e,3b045dfa-c32b-4998-99db-1a2dced80314,,Neoadjuvant,39.0,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0555-C15_treatment,dd2d266d-cbf2-4a74-b45e-a1ff514d2c5b,,released,Leucovorin Calcium,1,2020-09-27T11:57:35.545995-05:00,Chemotherapy,,
HCM-BROD-0555-C15,0cd60ea0-92de-44fa-86be-c75842b4123e,3b045dfa-c32b-4998-99db-1a2dced80314,,Adjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0555-C15_treatment9,dfe6eb3e-7163-4ad0-8165-3e2b461ca49c,,released,,0,2020-09-27T11:57:35.545995-05:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-BROD-0555-C15,0cd60ea0-92de-44fa-86be-c75842b4123e,3b045dfa-c32b-4998-99db-1a2dced80314,,Adjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0555-C15_treatment11,f7d8a149-600d-4fc4-a47b-05e0da0aa16f,,released,,0,2020-09-27T11:57:35.545995-05:00,Targeted Molecular Therapy,Residual Disease,
HCM-SANG-0287-C20,0cf7d1fe-e9c7-4e84-9497-df13ca2ed2c9,c91c84dc-0e49-412f-9c97-8c69b195cf02,,Neoadjuvant,105.0,2023-03-13T12:47:34.029089-05:00,HCM-SANG-0287-C20_treatment2,06e08cd0-c4e5-460c-8ce4-c55aae27cba2,,released,,1,2021-12-21T15:08:41.557351-06:00,"Radiation Therapy, NOS",,
HCM-SANG-0287-C20,0cf7d1fe-e9c7-4e84-9497-df13ca2ed2c9,c91c84dc-0e49-412f-9c97-8c69b195cf02,,Neoadjuvant,105.0,2023-03-13T12:47:34.029089-05:00,HCM-SANG-0287-C20_treatment,5f3ee649-6672-437d-b085-8188c797d658,,released,Fluorouracil,1,2021-12-21T15:08:41.557351-06:00,Chemotherapy,,
HCM-WCMC-1285-C54,0dc9723e-f5ff-4fe3-98a4-325a23e61b5f,662bfc86-845b-4e30-bb25-3df027046e4e,111.0,Adjuvant,66.0,2025-04-07T17:13:09.336794-05:00,HCM-WCMC-1285-C54_treatment10,0a49eea2-b7ba-431c-870e-fbd1d39db372,,released,,1,2023-02-27T11:52:24.969293-06:00,"Brachytherapy, NOS",Residual Disease,
HCM-WCMC-1285-C54,0dc9723e-f5ff-4fe3-98a4-325a23e61b5f,662bfc86-845b-4e30-bb25-3df027046e4e,229.0,Adjuvant,166.0,2025-04-07T17:13:09.336794-05:00,HCM-WCMC-1285-C54_treatment4,4069c217-9991-49b8-a453-215632eb1fef,,released,Bortezomib,1,2023-02-27T11:52:24.969293-06:00,Chemotherapy,Residual Disease,
HCM-WCMC-1285-C54,0dc9723e-f5ff-4fe3-98a4-325a23e61b5f,662bfc86-845b-4e30-bb25-3df027046e4e,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-WCMC-1285-C54_treatment9,4c4b939b-c6b6-4d27-a8f2-170476f5799c,,released,,0,2023-02-27T11:52:24.969293-06:00,Targeted Molecular Therapy,Residual Disease,
HCM-WCMC-1285-C54,0dc9723e-f5ff-4fe3-98a4-325a23e61b5f,662bfc86-845b-4e30-bb25-3df027046e4e,229.0,Adjuvant,166.0,2025-04-07T17:13:09.336794-05:00,HCM-WCMC-1285-C54_treatment3,964bc6d9-fd48-43a5-bc1d-63a9eef7ffee,,released,Paclitaxel,1,2023-02-27T11:52:24.969293-06:00,Chemotherapy,Residual Disease,
HCM-WCMC-1285-C54,0dc9723e-f5ff-4fe3-98a4-325a23e61b5f,662bfc86-845b-4e30-bb25-3df027046e4e,229.0,Adjuvant,166.0,2025-04-07T17:13:09.336794-05:00,HCM-WCMC-1285-C54_treatment5,9e377009-2b41-4197-9174-a27712fc359f,,released,Carboplatin,1,2023-02-27T11:52:24.969293-06:00,Chemotherapy,Residual Disease,
HCM-WCMC-1285-C54,0dc9723e-f5ff-4fe3-98a4-325a23e61b5f,662bfc86-845b-4e30-bb25-3df027046e4e,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-WCMC-1285-C54_treatment6,9fd90e1c-313b-4d5e-a761-8b0c7722a4f4,,released,,0,2023-02-27T11:52:24.969293-06:00,Hormone Therapy,Residual Disease,
HCM-WCMC-1285-C54,0dc9723e-f5ff-4fe3-98a4-325a23e61b5f,662bfc86-845b-4e30-bb25-3df027046e4e,94.0,Adjuvant,66.0,2025-04-07T17:13:09.336794-05:00,HCM-WCMC-1285-C54_treatment2,a3198f5c-72a3-419d-bee7-12f3e1fb7135,,released,Cisplatin,1,2023-02-27T11:52:24.969293-06:00,Chemotherapy,Residual Disease,
HCM-WCMC-1285-C54,0dc9723e-f5ff-4fe3-98a4-325a23e61b5f,662bfc86-845b-4e30-bb25-3df027046e4e,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-WCMC-1285-C54_treatment7,b56b9146-c561-499e-a01b-d8792b89bd2d,,released,,0,2023-02-27T11:52:24.969293-06:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-WCMC-1285-C54,0dc9723e-f5ff-4fe3-98a4-325a23e61b5f,662bfc86-845b-4e30-bb25-3df027046e4e,,,35.0,2025-04-07T17:13:09.336794-05:00,HCM-WCMC-1285-C54_treatment8,fcb03765-bc39-4239-a4a4-443a21ec38b3,,released,,1,2023-02-27T11:52:24.969293-06:00,"Surgery, NOS",Initial Diagnosis,
HCM-WCMC-1285-C54,0dc9723e-f5ff-4fe3-98a4-325a23e61b5f,662bfc86-845b-4e30-bb25-3df027046e4e,,Neoadjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-WCMC-1285-C54_treatment,fd62f224-c19c-46b1-89a8-5e42eb033f24,,released,,0,2023-02-27T11:52:24.969293-06:00,,,
HCM-CSHL-0248-C19,0df0db7a-b473-4643-9caf-a7c272c54c29,c9aee97d-8ba9-4f4f-9879-9326ad0c91b8,296.0,Adjuvant,88.0,2020-10-20T19:20:06.800740-05:00,HCM-CSHL-0248-C19_treatment2,023f4c99-d9a8-457b-859a-8acf7df207cf,,released,Oxaliplatin,1,2020-02-27T12:51:08.303017-06:00,Chemotherapy,Residual Disease,
HCM-CSHL-0248-C19,0df0db7a-b473-4643-9caf-a7c272c54c29,c9aee97d-8ba9-4f4f-9879-9326ad0c91b8,,Neoadjuvant,,2020-10-20T19:20:06.800740-05:00,HCM-CSHL-0248-C19_treatment,31f0ffe2-774c-4ed9-a8a5-da1f97eb7b54,,released,,0,2020-02-27T12:51:08.303017-06:00,,,
HCM-CSHL-0248-C19,0df0db7a-b473-4643-9caf-a7c272c54c29,c9aee97d-8ba9-4f4f-9879-9326ad0c91b8,,Adjuvant,,2020-10-20T19:20:06.800740-05:00,HCM-CSHL-0248-C19_treatment5,38fdc3f0-5984-4dae-9259-bd06d07817c8,,released,,0,2020-02-27T12:51:08.303017-06:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-CSHL-0248-C19,0df0db7a-b473-4643-9caf-a7c272c54c29,c9aee97d-8ba9-4f4f-9879-9326ad0c91b8,296.0,Adjuvant,88.0,2020-10-20T19:20:06.800740-05:00,HCM-CSHL-0248-C19_treatment3,5839a653-a7be-4bc3-9edf-5840007607a5,,released,Capecitabine,1,2020-02-27T12:51:08.303017-06:00,Chemotherapy,Residual Disease,
HCM-CSHL-0248-C19,0df0db7a-b473-4643-9caf-a7c272c54c29,c9aee97d-8ba9-4f4f-9879-9326ad0c91b8,,,43.0,2023-03-13T13:00:10.926207-05:00,HCM-CSHL-0248-C19_treatment6,84f90c32-a8b4-431c-b6c0-686053c4b517,,released,,1,2020-02-27T12:51:08.303017-06:00,"Surgery, NOS",Initial Diagnosis,
HCM-CSHL-0248-C19,0df0db7a-b473-4643-9caf-a7c272c54c29,c9aee97d-8ba9-4f4f-9879-9326ad0c91b8,,Adjuvant,,2020-10-20T19:20:06.800740-05:00,HCM-CSHL-0248-C19_treatment7,a711fef6-6cf4-4b82-b581-b97c2a8b1ab7,,released,,0,2020-09-28T09:32:55.440268-05:00,Targeted Molecular Therapy,Residual Disease,
HCM-CSHL-0248-C19,0df0db7a-b473-4643-9caf-a7c272c54c29,c9aee97d-8ba9-4f4f-9879-9326ad0c91b8,296.0,Adjuvant,88.0,2020-10-20T19:20:06.800740-05:00,HCM-CSHL-0248-C19_treatment4,d2291678-f5ec-4095-be20-b45c3fdebad1,,released,,1,2020-02-27T12:51:08.303017-06:00,Chemotherapy,Residual Disease,XELOX
HCM-CSHL-0248-C19,0df0db7a-b473-4643-9caf-a7c272c54c29,c9aee97d-8ba9-4f4f-9879-9326ad0c91b8,,Adjuvant,,2020-10-20T19:20:06.800740-05:00,HCM-CSHL-0248-C19_treatment8,e0ecbbe6-c927-4799-bd26-2e84fb47a19f,,released,,0,2020-09-28T09:32:55.440268-05:00,"Radiation Therapy, NOS",Residual Disease,
HCM-CSHL-0507-C20,0e791e67-655b-4d32-93fe-caccae0fd673,b9bc04fb-331b-4825-976a-4c16c7af7f2b,,Adjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0507-C20_treatment4,10a128fa-e0b4-4e89-b294-8360a0ec6e6d,,released,,0,2021-12-21T14:06:12.192771-06:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-CSHL-0507-C20,0e791e67-655b-4d32-93fe-caccae0fd673,b9bc04fb-331b-4825-976a-4c16c7af7f2b,,Neoadjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0507-C20_treatment,5d8006dc-c6ee-45db-84e3-1e96342514be,,released,,0,2021-12-21T14:06:12.192771-06:00,,,
HCM-CSHL-0507-C20,0e791e67-655b-4d32-93fe-caccae0fd673,b9bc04fb-331b-4825-976a-4c16c7af7f2b,,,386.0,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0507-C20_treatment5,5fcd9c50-040d-446a-881b-5682ce8d59df,,released,,1,2021-12-21T14:06:12.192771-06:00,"Surgery, NOS",Initial Diagnosis,
HCM-CSHL-0507-C20,0e791e67-655b-4d32-93fe-caccae0fd673,b9bc04fb-331b-4825-976a-4c16c7af7f2b,592.0,Adjuvant,450.0,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0507-C20_treatment2,68ca966a-320f-4f6a-b6ac-732cc993056c,,released,Oxaliplatin,1,2021-12-21T14:06:12.192771-06:00,Chemotherapy,Residual Disease,
HCM-CSHL-0507-C20,0e791e67-655b-4d32-93fe-caccae0fd673,b9bc04fb-331b-4825-976a-4c16c7af7f2b,,Adjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0507-C20_treatment6,7918da44-b8a7-4882-93bc-c78c4b6457ea,,released,,0,2021-12-21T14:06:12.192771-06:00,Targeted Molecular Therapy,Residual Disease,
HCM-CSHL-0507-C20,0e791e67-655b-4d32-93fe-caccae0fd673,b9bc04fb-331b-4825-976a-4c16c7af7f2b,1021.0,Adjuvant,1016.0,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0507-C20_treatment7,e8ae7e17-0575-4779-b413-2bad402dd3a9,,released,,1,2021-12-21T14:06:12.192771-06:00,"Radiation, Stereotactic/Gamma Knife/SRS",Residual Disease,
HCM-CSHL-0507-C20,0e791e67-655b-4d32-93fe-caccae0fd673,b9bc04fb-331b-4825-976a-4c16c7af7f2b,592.0,Adjuvant,450.0,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0507-C20_treatment3,f9f6d8fa-b6ae-4021-8a1b-3b5dd05440e4,,released,Capecitabine,1,2021-12-21T14:06:12.192771-06:00,Chemotherapy,Residual Disease,
HCM-WCMC-0950-C67,0e9262d1-5aa8-4528-9aee-2815afcd23cd,82806bbe-6770-4697-93aa-c8b87aa73044,,Neoadjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-WCMC-0950-C67_treatment,562ddb00-fd43-4ffb-968d-fb225eb11668,,released,,0,2023-02-27T13:22:20.918362-06:00,,,
HCM-WCMC-0950-C67,0e9262d1-5aa8-4528-9aee-2815afcd23cd,82806bbe-6770-4697-93aa-c8b87aa73044,379.0,Adjuvant,344.0,2025-04-07T17:13:09.336794-05:00,HCM-WCMC-0950-C67_treatment5,56ff1595-a410-4d11-94ec-d76f446b3c62,,released,BCG Vaccine,1,2023-02-27T13:22:20.918362-06:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-WCMC-0950-C67,0e9262d1-5aa8-4528-9aee-2815afcd23cd,82806bbe-6770-4697-93aa-c8b87aa73044,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-WCMC-0950-C67_treatment8,6a058241-7f9c-41ad-9c60-1c5d5fea16de,,released,,0,2023-02-27T13:22:20.918362-06:00,"Radiation Therapy, NOS",Residual Disease,
HCM-WCMC-0950-C67,0e9262d1-5aa8-4528-9aee-2815afcd23cd,82806bbe-6770-4697-93aa-c8b87aa73044,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-WCMC-0950-C67_treatment3,6a0b145e-3b22-482f-9371-fb78bc62a2ad,,released,,0,2023-02-27T13:22:20.918362-06:00,Hormone Therapy,Residual Disease,
HCM-WCMC-0950-C67,0e9262d1-5aa8-4528-9aee-2815afcd23cd,82806bbe-6770-4697-93aa-c8b87aa73044,127.0,Adjuvant,91.0,2025-04-07T17:13:09.336794-05:00,HCM-WCMC-0950-C67_treatment4,aef2b972-cc60-40ab-9d81-9b185b9b1187,,released,BCG Vaccine,1,2023-02-27T13:22:20.918362-06:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-WCMC-0950-C67,0e9262d1-5aa8-4528-9aee-2815afcd23cd,82806bbe-6770-4697-93aa-c8b87aa73044,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-WCMC-0950-C67_treatment2,b994f1bf-6c78-43d4-8a1c-1ff232e9bf88,,released,,0,2023-02-27T13:22:20.918362-06:00,Chemotherapy,Residual Disease,
HCM-WCMC-0950-C67,0e9262d1-5aa8-4528-9aee-2815afcd23cd,82806bbe-6770-4697-93aa-c8b87aa73044,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-WCMC-0950-C67_treatment7,b9b6250c-b29e-42ad-a7eb-65e34afdd420,,released,,0,2023-02-27T13:22:20.918362-06:00,Targeted Molecular Therapy,Residual Disease,
HCM-WCMC-0950-C67,0e9262d1-5aa8-4528-9aee-2815afcd23cd,82806bbe-6770-4697-93aa-c8b87aa73044,,,0.0,2025-04-07T17:13:09.336794-05:00,HCM-WCMC-0950-C67_treatment6,cc247aad-99d4-443b-918f-c20f41b334ed,,released,,1,2023-02-27T13:22:20.918362-06:00,"Surgery, NOS",Initial Diagnosis,
HCM-CSHL-0376-D37,0e9a9e97-f0bf-4f4a-84cc-73eccfc627b1,9ce37f22-bbde-4447-bbf0-28e85f4f2837,,Adjuvant,,2023-03-13T12:49:00.711770-05:00,HCM-CSHL-0376-D37_treatment3,1d53cda2-38a1-48ac-9457-5b16f471f6cc,,released,,0,2020-09-28T09:57:03.740068-05:00,"Pharmaceutical Therapy, NOS",Residual Disease,
HCM-CSHL-0376-D37,0e9a9e97-f0bf-4f4a-84cc-73eccfc627b1,9ce37f22-bbde-4447-bbf0-28e85f4f2837,,,78.0,2023-03-13T12:49:00.711770-05:00,HCM-CSHL-0376-D37_treatment2,4fdd878b-e879-4e4c-914f-69d5ba2b0c4c,,released,,1,2020-09-28T09:57:03.740068-05:00,"Surgery, NOS",Initial Diagnosis,
HCM-CSHL-0376-D37,0e9a9e97-f0bf-4f4a-84cc-73eccfc627b1,9ce37f22-bbde-4447-bbf0-28e85f4f2837,,Adjuvant,,2023-03-13T12:49:00.711770-05:00,HCM-CSHL-0376-D37_treatment4,b554b536-8816-4378-a3c9-efad1a51b0af,,released,,0,2020-09-28T09:57:03.740068-05:00,"Radiation Therapy, NOS",Residual Disease,
HCM-CSHL-0376-D37,0e9a9e97-f0bf-4f4a-84cc-73eccfc627b1,9ce37f22-bbde-4447-bbf0-28e85f4f2837,,Neoadjuvant,,2023-02-22T07:39:25.979291-06:00,HCM-CSHL-0376-D37_treatment,fd770e14-5f77-4e4a-b01b-e26ed5acc8cd,,released,,0,2020-09-28T09:57:03.740068-05:00,,,
HCM-BROD-0682-C64,0ee53efd-b992-4aeb-a091-8dd1bd32da6e,3c95e3a3-c388-452c-88e8-13704668f55a,632.0,Adjuvant,612.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0682-C64_treatment5,07302338-3d57-4994-8b18-664df8c333de,,released,Ipilimumab,1,2021-12-21T13:42:59.028809-06:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-BROD-0682-C64,0ee53efd-b992-4aeb-a091-8dd1bd32da6e,3c95e3a3-c388-452c-88e8-13704668f55a,1435.0,Adjuvant,672.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0682-C64_treatment7,08435b27-dc90-4bbb-a3a7-0d7d8762c593,Treatment Ongoing,released,Cabozantinib,1,2021-12-21T13:42:59.028809-06:00,Targeted Molecular Therapy,Residual Disease,
HCM-BROD-0682-C64,0ee53efd-b992-4aeb-a091-8dd1bd32da6e,3c95e3a3-c388-452c-88e8-13704668f55a,,Neoadjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0682-C64_treatment,571a1c4d-feef-493a-8657-047594523649,,released,,0,2021-12-21T13:42:59.028809-06:00,,,
HCM-BROD-0682-C64,0ee53efd-b992-4aeb-a091-8dd1bd32da6e,3c95e3a3-c388-452c-88e8-13704668f55a,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0682-C64_treatment3,6d286cb0-5e5b-401b-b32d-e11850f4e874,,released,,0,2021-12-21T13:42:59.028809-06:00,Hormone Therapy,Residual Disease,
HCM-BROD-0682-C64,0ee53efd-b992-4aeb-a091-8dd1bd32da6e,3c95e3a3-c388-452c-88e8-13704668f55a,,,0.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0682-C64_treatment6,701b6ae2-68b5-47f0-888e-30cb2eacbd02,,released,,1,2021-12-21T13:42:59.028809-06:00,"Surgery, NOS",Initial Diagnosis,
HCM-BROD-0682-C64,0ee53efd-b992-4aeb-a091-8dd1bd32da6e,3c95e3a3-c388-452c-88e8-13704668f55a,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0682-C64_treatment2,71302855-5e8b-499b-af73-64c0a7a38eef,,released,,0,2021-12-21T13:42:59.028809-06:00,Chemotherapy,Residual Disease,
HCM-BROD-0682-C64,0ee53efd-b992-4aeb-a091-8dd1bd32da6e,3c95e3a3-c388-452c-88e8-13704668f55a,632.0,Adjuvant,612.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0682-C64_treatment4,be0e2c19-e8be-4a10-9c01-621165989978,,released,Nivolumab,1,2021-12-21T13:42:59.028809-06:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-BROD-0960-C16,0f1a10df-5962-40d1-b15c-bb998d0934c9,8f5aea83-441c-4115-99ea-271c483e71b8,149.0,Adjuvant,113.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0960-C16_treatment8,09eb66f0-b8e2-4d40-baf3-8cd08751aac8,,released,,1,2021-12-21T13:59:06.485421-06:00,Chemotherapy,Residual Disease,FOLFIRI
HCM-BROD-0960-C16,0f1a10df-5962-40d1-b15c-bb998d0934c9,8f5aea83-441c-4115-99ea-271c483e71b8,212.0,Adjuvant,149.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0960-C16_treatment12,20bc020f-0efe-47d1-b0b2-de4f128acaf1,,released,Ramucirumab,1,2021-12-21T13:59:06.485421-06:00,Targeted Molecular Therapy,Residual Disease,
HCM-BROD-0960-C16,0f1a10df-5962-40d1-b15c-bb998d0934c9,8f5aea83-441c-4115-99ea-271c483e71b8,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0960-C16_treatment10,2427a98b-fc62-464a-b66d-77818dd35218,,released,,0,2021-12-21T13:59:06.485421-06:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-BROD-0960-C16,0f1a10df-5962-40d1-b15c-bb998d0934c9,8f5aea83-441c-4115-99ea-271c483e71b8,92.0,Adjuvant,15.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0960-C16_treatment3,31bcad67-5495-4b43-b299-c0e64f169f31,,released,Fluorouracil,1,2021-12-21T13:59:06.485421-06:00,Chemotherapy,Residual Disease,
HCM-BROD-0960-C16,0f1a10df-5962-40d1-b15c-bb998d0934c9,8f5aea83-441c-4115-99ea-271c483e71b8,149.0,Adjuvant,113.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0960-C16_treatment5,5bf1afda-b480-4242-9da4-c880e0d3e201,,released,Fluorouracil,1,2021-12-21T13:59:06.485421-06:00,Chemotherapy,Residual Disease,
HCM-BROD-0960-C16,0f1a10df-5962-40d1-b15c-bb998d0934c9,8f5aea83-441c-4115-99ea-271c483e71b8,,,,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0960-C16_treatment11,758e57bf-c0e5-44fc-803f-14e05c841685,,released,,0,2021-12-21T13:59:06.485421-06:00,"Surgery, NOS",Initial Diagnosis,
HCM-BROD-0960-C16,0f1a10df-5962-40d1-b15c-bb998d0934c9,8f5aea83-441c-4115-99ea-271c483e71b8,149.0,Adjuvant,113.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0960-C16_treatment6,86eeb8a6-7ba2-4f3d-9ad7-02fe74baf7dc,,released,Leucovorin Calcium,1,2021-12-21T13:59:06.485421-06:00,Chemotherapy,Residual Disease,
HCM-BROD-0960-C16,0f1a10df-5962-40d1-b15c-bb998d0934c9,8f5aea83-441c-4115-99ea-271c483e71b8,149.0,Adjuvant,113.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0960-C16_treatment7,872a98c8-3e55-4e2b-b01f-271a7ece4e0a,,released,Irinotecan,1,2021-12-21T13:59:06.485421-06:00,Chemotherapy,Residual Disease,
HCM-BROD-0960-C16,0f1a10df-5962-40d1-b15c-bb998d0934c9,8f5aea83-441c-4115-99ea-271c483e71b8,92.0,Adjuvant,15.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0960-C16_treatment2,89520dcb-e1bc-4233-88df-c4f2e4bcc31b,,released,Docetaxel,1,2021-12-21T13:59:06.485421-06:00,Chemotherapy,Residual Disease,
HCM-BROD-0960-C16,0f1a10df-5962-40d1-b15c-bb998d0934c9,8f5aea83-441c-4115-99ea-271c483e71b8,212.0,Adjuvant,176.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0960-C16_treatment9,aa98dc53-90b2-4e3c-bb4e-24415a53982c,,released,Paclitaxel,1,2021-12-21T13:59:06.485421-06:00,Chemotherapy,Residual Disease,
HCM-BROD-0960-C16,0f1a10df-5962-40d1-b15c-bb998d0934c9,8f5aea83-441c-4115-99ea-271c483e71b8,,Neoadjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0960-C16_treatment,c4bf215b-f13c-4e57-8787-e2df8b3c44ad,,released,,0,2021-12-21T13:59:06.485421-06:00,,,
HCM-BROD-0960-C16,0f1a10df-5962-40d1-b15c-bb998d0934c9,8f5aea83-441c-4115-99ea-271c483e71b8,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0960-C16_treatment13,d82bc353-f9d3-4822-b18e-40c9dca5482f,,released,,0,2021-12-21T13:59:06.485421-06:00,"Radiation Therapy, NOS",Residual Disease,
HCM-BROD-0960-C16,0f1a10df-5962-40d1-b15c-bb998d0934c9,8f5aea83-441c-4115-99ea-271c483e71b8,92.0,Adjuvant,15.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0960-C16_treatment4,de844f56-b16b-4846-87ec-d16b100cc22f,,released,Oxaliplatin,1,2021-12-21T13:59:06.485421-06:00,Chemotherapy,Residual Disease,
HCM-BROD-0960-C16,0f1a10df-5962-40d1-b15c-bb998d0934c9,f715238a-5ed1-4072-9385-495c9306dedd,176.0,Maintenance Therapy,113.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0960-C16_treatment16,522b803e-f584-4aac-99b9-29e820f56df9,Progressive Disease,released,Irinotecan,1,2021-12-21T13:59:06.485421-06:00,,,
HCM-BROD-0960-C16,0f1a10df-5962-40d1-b15c-bb998d0934c9,f715238a-5ed1-4072-9385-495c9306dedd,176.0,Maintenance Therapy,113.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0960-C16_treatment15,7e5909ea-7ab6-4606-8b9e-2bc21a9b0920,Progressive Disease,released,Fluorouracil,1,2021-12-21T13:59:06.485421-06:00,,,
HCM-BROD-0960-C16,0f1a10df-5962-40d1-b15c-bb998d0934c9,f715238a-5ed1-4072-9385-495c9306dedd,176.0,Maintenance Therapy,113.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0960-C16_treatment14,ebc77254-216b-40d8-a33c-f33b568e3d14,Progressive Disease,released,Leucovorin Calcium,1,2021-12-21T13:59:06.485421-06:00,,,
HCM-BROD-0960-C16,0f1a10df-5962-40d1-b15c-bb998d0934c9,f715238a-5ed1-4072-9385-495c9306dedd,176.0,Maintenance Therapy,113.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0960-C16_treatment17,fdb981ac-3639-4ee1-a206-e6cc6da493f8,Progressive Disease,released,,1,2021-12-21T13:59:06.485421-06:00,,,FOLFIRI
HCM-BROD-0012-C71,0f89e089-4a1d-4e66-8537-502a788cfe75,26192cfd-1129-40b7-a99c-7ae133fcb595,,Adjuvant,,2019-04-29T14:45:04.583966-05:00,HCM-BROD-0012-C71_treatment3,2976e2d5-ec09-4cf9-bf71-a0f7816b1300,,released,,0,2019-04-04T14:16:25.317982-05:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-BROD-0012-C71,0f89e089-4a1d-4e66-8537-502a788cfe75,26192cfd-1129-40b7-a99c-7ae133fcb595,,,25.0,2023-03-13T13:31:26.371099-05:00,HCM-BROD-0012-C71_treatment4,55f82d82-95ab-497b-bd6d-ddaa550248db,,released,,1,2019-04-04T14:16:25.317982-05:00,"Surgery, NOS",Initial Diagnosis,
HCM-BROD-0012-C71,0f89e089-4a1d-4e66-8537-502a788cfe75,26192cfd-1129-40b7-a99c-7ae133fcb595,,Neoadjuvant,,2019-04-29T14:45:04.583966-05:00,HCM-BROD-0012-C71_treatment,8c275d6e-bd3a-481b-b381-5b6fb496d263,,released,,0,2019-03-12T10:15:03.937781-05:00,,,
HCM-BROD-0012-C71,0f89e089-4a1d-4e66-8537-502a788cfe75,26192cfd-1129-40b7-a99c-7ae133fcb595,148.0,Adjuvant,110.0,2019-04-29T14:45:04.583966-05:00,HCM-BROD-0012-C71_treatment2,d674d04c-4df4-41b2-adbb-88b8da1a9285,,released,Temozolomide,1,2019-04-04T14:16:25.317982-05:00,Chemotherapy,Residual Disease,
HCM-BROD-0012-C71,0f89e089-4a1d-4e66-8537-502a788cfe75,26192cfd-1129-40b7-a99c-7ae133fcb595,,Adjuvant,,2019-04-29T14:45:04.583966-05:00,HCM-BROD-0012-C71_treatment5,e9d9bb09-e916-4e88-be9d-3605e1435a7d,,released,,0,2019-04-04T14:16:25.317982-05:00,Targeted Molecular Therapy,Residual Disease,
HCM-BROD-0012-C71,0f89e089-4a1d-4e66-8537-502a788cfe75,26192cfd-1129-40b7-a99c-7ae133fcb595,148.0,Adjuvant,110.0,2019-04-29T14:45:04.583966-05:00,HCM-BROD-0012-C71_treatment6,f5d5457f-66df-42b1-afee-f03a04080044,,released,,1,2019-04-04T14:16:25.317982-05:00,"Radiation Therapy, NOS",Residual Disease,
HCM-BROD-0568-C15,10bd5d19-7a67-41c2-bb24-898e9078fd04,a5186653-9f3a-4648-bab6-4c50d1d1edcf,,Neoadjuvant,26.0,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0568-C15_treatment3,2b920a3f-1af0-4605-8697-2211e6de6bea,,released,Oxaliplatin,1,2020-09-27T12:00:38.167753-05:00,Chemotherapy,,
HCM-BROD-0568-C15,10bd5d19-7a67-41c2-bb24-898e9078fd04,a5186653-9f3a-4648-bab6-4c50d1d1edcf,,Neoadjuvant,26.0,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0568-C15_treatment2,4a2fa9ff-9356-4999-9669-6750e79d1dfa,,released,Fluorouracil,1,2020-09-27T12:00:38.167753-05:00,Chemotherapy,,
HCM-BROD-0568-C15,10bd5d19-7a67-41c2-bb24-898e9078fd04,a5186653-9f3a-4648-bab6-4c50d1d1edcf,83.0,Adjuvant,26.0,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0568-C15_treatment6,52bf01c0-aa06-4634-b2e4-8af4a47d000a,,released,Leucovorin Calcium,1,2020-09-27T12:00:38.167753-05:00,Chemotherapy,Residual Disease,
HCM-BROD-0568-C15,10bd5d19-7a67-41c2-bb24-898e9078fd04,a5186653-9f3a-4648-bab6-4c50d1d1edcf,,Neoadjuvant,26.0,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0568-C15_treatment4,6404cd70-55af-44d0-9472-1211a91430b9,,released,Leucovorin,1,2020-09-27T12:00:38.167753-05:00,Chemotherapy,,
HCM-BROD-0568-C15,10bd5d19-7a67-41c2-bb24-898e9078fd04,a5186653-9f3a-4648-bab6-4c50d1d1edcf,83.0,Adjuvant,26.0,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0568-C15_treatment8,6584b537-10f2-4a31-9bad-dcd1e802577d,,released,Oxaliplatin,1,2020-09-27T12:00:38.167753-05:00,Chemotherapy,Residual Disease,
HCM-BROD-0568-C15,10bd5d19-7a67-41c2-bb24-898e9078fd04,a5186653-9f3a-4648-bab6-4c50d1d1edcf,,Adjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0568-C15_treatment14,6b9de8ce-146c-47eb-b619-aae5d1feeae9,,released,,0,2020-09-27T12:00:38.167753-05:00,"Radiation Therapy, NOS",Residual Disease,
HCM-BROD-0568-C15,10bd5d19-7a67-41c2-bb24-898e9078fd04,a5186653-9f3a-4648-bab6-4c50d1d1edcf,83.0,Adjuvant,26.0,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0568-C15_treatment9,8dbd74c8-130a-41fd-b868-00086d6eaf65,,released,,1,2020-09-27T12:00:38.167753-05:00,Chemotherapy,Residual Disease,FOLFOX
HCM-BROD-0568-C15,10bd5d19-7a67-41c2-bb24-898e9078fd04,a5186653-9f3a-4648-bab6-4c50d1d1edcf,,Adjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0568-C15_treatment13,93787d9e-cd7b-492a-acc4-93289fb1ffd4,,released,,0,2020-09-27T12:00:38.167753-05:00,Targeted Molecular Therapy,Residual Disease,
HCM-BROD-0568-C15,10bd5d19-7a67-41c2-bb24-898e9078fd04,a5186653-9f3a-4648-bab6-4c50d1d1edcf,83.0,Adjuvant,26.0,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0568-C15_treatment7,bd37254c-c6da-4320-93cb-0edca7a1358b,,released,Fluorouracil,1,2020-09-27T12:00:38.167753-05:00,Chemotherapy,Residual Disease,
HCM-BROD-0568-C15,10bd5d19-7a67-41c2-bb24-898e9078fd04,a5186653-9f3a-4648-bab6-4c50d1d1edcf,,Neoadjuvant,26.0,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0568-C15_treatment,bfdb0b9e-aee0-410a-98ee-4da87ab8d1c2,,released,Paclitaxel,1,2020-09-27T12:00:38.167753-05:00,Chemotherapy,,
HCM-BROD-0568-C15,10bd5d19-7a67-41c2-bb24-898e9078fd04,a5186653-9f3a-4648-bab6-4c50d1d1edcf,265.0,Adjuvant,139.0,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0568-C15_treatment10,dbe9e08b-59c6-4696-a71b-456193b11d65,,released,Paclitaxel,1,2020-09-27T12:00:38.167753-05:00,Chemotherapy,Residual Disease,
HCM-BROD-0568-C15,10bd5d19-7a67-41c2-bb24-898e9078fd04,a5186653-9f3a-4648-bab6-4c50d1d1edcf,,Adjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0568-C15_treatment11,ddec443b-a80d-40c1-9517-3b4bb5212cf9,,released,,0,2020-09-27T12:00:38.167753-05:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-BROD-0568-C15,10bd5d19-7a67-41c2-bb24-898e9078fd04,a5186653-9f3a-4648-bab6-4c50d1d1edcf,,,300.0,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0568-C15_treatment12,e407b4a2-2cd5-4301-ba30-072c5a553b2f,,released,,1,2020-09-27T12:00:38.167753-05:00,"Surgery, NOS",Initial Diagnosis,
HCM-BROD-0568-C15,10bd5d19-7a67-41c2-bb24-898e9078fd04,a5186653-9f3a-4648-bab6-4c50d1d1edcf,,Neoadjuvant,26.0,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0568-C15_treatment5,fa78d5ed-8e95-4203-982b-951ebb87c95e,,released,,1,2020-09-27T12:00:38.167753-05:00,Chemotherapy,,FU-LV regimen
HCM-SANG-0312-C15,10e69494-3ce2-4c13-ab1b-6fc0e6b14853,0afc2770-d043-487a-bd81-035e40310397,,Neoadjuvant,110.0,2023-07-13T10:35:44.371881-05:00,HCM-SANG-0312-C15_treatment,1027f917-2a26-4058-a376-49e990ecc50f,,released,Paclitaxel,1,2021-12-21T15:11:24.973771-06:00,Chemotherapy,,
HCM-SANG-0312-C15,10e69494-3ce2-4c13-ab1b-6fc0e6b14853,0afc2770-d043-487a-bd81-035e40310397,,Neoadjuvant,110.0,2023-07-13T10:35:44.371881-05:00,HCM-SANG-0312-C15_treatment3,74d73996-d98f-45cb-96fd-32a133bd6156,,released,,1,2021-12-21T15:11:24.973771-06:00,"Radiation, 2D Conventional",,
HCM-SANG-0312-C15,10e69494-3ce2-4c13-ab1b-6fc0e6b14853,0afc2770-d043-487a-bd81-035e40310397,,Neoadjuvant,110.0,2023-07-13T10:35:44.371881-05:00,HCM-SANG-0312-C15_treatment2,f68797dd-145a-4a2a-b5b8-ed3451559e2f,,released,Carboplatin,1,2021-12-21T15:11:24.973771-06:00,Chemotherapy,,
HCM-CSHL-0061-C18,118bf677-caed-4f7f-a837-dd966dce5ca7,e4625cb5-071d-4de7-af73-29b2e44af6cb,,Neoadjuvant,,2019-05-24T12:11:41.511797-05:00,HCM-CSHL-0061-C18_treatment,0559ee63-b76e-4a34-b426-da10cbb36ea5,,released,,0,2019-05-15T15:00:21.508948-05:00,,,
HCM-CSHL-0061-C18,118bf677-caed-4f7f-a837-dd966dce5ca7,e4625cb5-071d-4de7-af73-29b2e44af6cb,,,8.0,2023-02-27T12:48:38.152597-06:00,HCM-CSHL-0061-C18_treatment7,11865103-44e9-4d9c-a19c-ac8945a8e3b6,,released,,1,2020-10-08T19:00:15.562772-05:00,"Surgery, NOS",Initial Diagnosis,
HCM-CSHL-0061-C18,118bf677-caed-4f7f-a837-dd966dce5ca7,e4625cb5-071d-4de7-af73-29b2e44af6cb,,Adjuvant,,2020-10-08T19:00:15.562772-05:00,HCM-CSHL-0061-C18_treatment6,124aa9f8-fbcc-47f6-8863-aa53cb6e911a,,released,,0,2019-05-15T15:00:21.508948-05:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-CSHL-0061-C18,118bf677-caed-4f7f-a837-dd966dce5ca7,e4625cb5-071d-4de7-af73-29b2e44af6cb,144.0,Adjuvant,40.0,2020-10-08T19:00:15.562772-05:00,HCM-CSHL-0061-C18_treatment2,12543e2f-55c6-4f64-b5a1-e9f9b28f0cb4,,released,Leucovorin Calcium,1,2019-05-15T15:00:21.508948-05:00,Chemotherapy,Residual Disease,
HCM-CSHL-0061-C18,118bf677-caed-4f7f-a837-dd966dce5ca7,e4625cb5-071d-4de7-af73-29b2e44af6cb,144.0,Adjuvant,40.0,2020-10-08T19:00:15.562772-05:00,HCM-CSHL-0061-C18_treatment3,1c94fab9-66bd-4eaf-ada6-fa83584fcea5,,released,Fluorouracil,1,2019-05-15T15:00:21.508948-05:00,Chemotherapy,Residual Disease,
HCM-CSHL-0061-C18,118bf677-caed-4f7f-a837-dd966dce5ca7,e4625cb5-071d-4de7-af73-29b2e44af6cb,144.0,Adjuvant,40.0,2020-10-08T19:00:15.562772-05:00,HCM-CSHL-0061-C18_treatment4,9d80590b-05b0-4023-9acc-121b093de6dd,,released,Oxaliplatin,1,2019-05-15T15:00:21.508948-05:00,Chemotherapy,Residual Disease,
HCM-CSHL-0061-C18,118bf677-caed-4f7f-a837-dd966dce5ca7,e4625cb5-071d-4de7-af73-29b2e44af6cb,,Adjuvant,,2020-10-20T19:20:06.800740-05:00,HCM-CSHL-0061-C18_treatment9,9dad17d6-348f-4666-8cd1-49b1cc568081,,released,,0,2020-10-08T19:00:15.562772-05:00,"Radiation Therapy, NOS",Residual Disease,
HCM-CSHL-0061-C18,118bf677-caed-4f7f-a837-dd966dce5ca7,e4625cb5-071d-4de7-af73-29b2e44af6cb,,Adjuvant,,2020-10-20T19:20:06.800740-05:00,HCM-CSHL-0061-C18_treatment8,a927e28a-9d63-4600-8dc5-d483bcc0d624,,released,,0,2020-10-08T19:00:15.562772-05:00,Targeted Molecular Therapy,Residual Disease,
HCM-CSHL-0061-C18,118bf677-caed-4f7f-a837-dd966dce5ca7,e4625cb5-071d-4de7-af73-29b2e44af6cb,144.0,Adjuvant,40.0,2020-10-08T19:00:15.562772-05:00,HCM-CSHL-0061-C18_treatment5,e8f7a402-4433-4545-8d47-4c0f2cd146c1,,released,,1,2019-05-15T15:00:21.508948-05:00,Chemotherapy,Residual Disease,FOLFOX
HCM-SANG-1335-C18,12603388-e5f0-45ac-ab7b-3a839de7a9e8,05c6c397-b06f-4fc3-806d-584e01bb976b,,Neoadjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-SANG-1335-C18_treatment,fb507039-1610-4163-bbe0-ef0a04fca83c,,released,,0,2023-02-27T12:14:36.021883-06:00,,,
HCM-SANG-1322-C15,1312ba61-8d33-4b61-89cf-0c6e5c6d06a7,1b0aa02b-19d9-4e30-98d7-86d641180351,,Neoadjuvant,119.0,2025-04-07T17:13:09.336794-05:00,HCM-SANG-1322-C15_treatment2,a29ee214-cb81-4f1a-9a61-8b94fcc752fb,,released,Capecitabine,1,2023-02-27T11:42:39.683110-06:00,Chemotherapy,,
HCM-SANG-1322-C15,1312ba61-8d33-4b61-89cf-0c6e5c6d06a7,1b0aa02b-19d9-4e30-98d7-86d641180351,,Neoadjuvant,119.0,2025-04-07T17:13:09.336794-05:00,HCM-SANG-1322-C15_treatment3,a2a62e7e-2314-43d6-bc76-02912eb56dde,,released,Cisplatin,1,2023-02-27T11:42:39.683110-06:00,Chemotherapy,,
HCM-SANG-1322-C15,1312ba61-8d33-4b61-89cf-0c6e5c6d06a7,1b0aa02b-19d9-4e30-98d7-86d641180351,,Neoadjuvant,119.0,2025-04-07T17:13:09.336794-05:00,HCM-SANG-1322-C15_treatment,cd34a4b4-02e3-47f0-9e76-e272f425d6cd,,released,Epirubicin,1,2023-02-27T11:42:39.683110-06:00,Chemotherapy,,
HCM-SANG-1322-C15,1312ba61-8d33-4b61-89cf-0c6e5c6d06a7,1b0aa02b-19d9-4e30-98d7-86d641180351,,Neoadjuvant,119.0,2025-04-07T17:13:09.336794-05:00,HCM-SANG-1322-C15_treatment4,df02076c-ebad-42c3-9a88-a89fe69bd6e5,,released,,1,2023-02-27T11:42:39.683110-06:00,Chemotherapy,,ECX
HCM-SANG-1317-C20,13cacc39-4a3d-440e-87da-75772dc0a3fe,167f8ec0-65f1-4925-9a6a-4b100149ce13,,Neoadjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-SANG-1317-C20_treatment,aa8de378-e941-4a94-85db-b88e247a085b,,released,,0,2023-02-27T12:45:14.910829-06:00,,,
HCM-CSHL-0621-C18,13f33795-7d8b-411d-8b33-998e66e484ea,82c4c99b-3b7f-4774-8aac-cec3bc3a5f67,,,1996.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0621-C18_treatment2,1b6b253b-da0b-4a34-9e62-a1c43ebb88bb,,released,,1,2021-12-21T14:12:18.020478-06:00,"Surgery, NOS",Initial Diagnosis,
HCM-CSHL-0621-C18,13f33795-7d8b-411d-8b33-998e66e484ea,82c4c99b-3b7f-4774-8aac-cec3bc3a5f67,,Neoadjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0621-C18_treatment,3073ac3b-c756-474e-8958-006f4a532cee,,released,,0,2021-12-21T14:12:18.020478-06:00,,,
HCM-CSHL-0621-C18,13f33795-7d8b-411d-8b33-998e66e484ea,82c4c99b-3b7f-4774-8aac-cec3bc3a5f67,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0621-C18_treatment4,3e687e75-1d6e-4b9e-993a-77554874d748,,released,,0,2021-12-21T14:12:18.020478-06:00,"Radiation Therapy, NOS",Residual Disease,
HCM-CSHL-0621-C18,13f33795-7d8b-411d-8b33-998e66e484ea,82c4c99b-3b7f-4774-8aac-cec3bc3a5f67,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0621-C18_treatment3,792bc6c0-23ce-4d72-ac54-2a579ea1699d,,released,,0,2021-12-21T14:12:18.020478-06:00,"Pharmaceutical Therapy, NOS",Residual Disease,
HCM-CSHL-0621-C18,13f33795-7d8b-411d-8b33-998e66e484ea,cc522711-b772-4e78-9c6a-079a2b6650aa,,Maintenance Therapy,,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0621-C18_treatment5,7245468e-ecff-4b5e-86de-4cbb4b6a2cc6,Not Reported,released,Capecitabine,1,2023-02-28T12:14:10.005746-06:00,,,
HCM-BROD-0232-C25,13f667da-a66b-4622-9e6a-b3e861e96961,9db2a11b-291d-4ea8-b226-9b52ef1b045d,,,,2023-02-27T12:00:51.566501-06:00,HCM-BROD-0232-C25_treatment5,15d29f24-b42f-4b8d-a33b-808da5b1266d,,released,,0,2020-06-15T13:29:02.624490-05:00,"Surgery, NOS",Initial Diagnosis,
HCM-BROD-0232-C25,13f667da-a66b-4622-9e6a-b3e861e96961,9db2a11b-291d-4ea8-b226-9b52ef1b045d,,Adjuvant,,2023-02-22T07:39:25.979291-06:00,HCM-BROD-0232-C25_treatment4,5f0b24f2-447c-455c-b94f-0b7977ca4970,,released,,0,2020-06-15T13:29:02.624490-05:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-BROD-0232-C25,13f667da-a66b-4622-9e6a-b3e861e96961,9db2a11b-291d-4ea8-b226-9b52ef1b045d,,Neoadjuvant,,2023-02-22T07:39:25.979291-06:00,HCM-BROD-0232-C25_treatment,84eed376-47c5-4043-aaeb-aecb7c202c11,,released,,0,2020-06-15T13:29:02.624490-05:00,,,
HCM-BROD-0232-C25,13f667da-a66b-4622-9e6a-b3e861e96961,9db2a11b-291d-4ea8-b226-9b52ef1b045d,314.0,Adjuvant,6.0,2023-02-22T07:39:25.979291-06:00,HCM-BROD-0232-C25_treatment3,8f8a84b9-53f1-47d3-8d21-4d5bbb1bb1d0,,released,Nab-paclitaxel,1,2020-06-15T13:29:02.624490-05:00,Chemotherapy,Residual Disease,
HCM-BROD-0232-C25,13f667da-a66b-4622-9e6a-b3e861e96961,9db2a11b-291d-4ea8-b226-9b52ef1b045d,,Adjuvant,,2023-02-22T07:39:25.979291-06:00,HCM-BROD-0232-C25_treatment7,917d5777-fd89-430f-b29e-11981b271338,,released,,0,2020-06-15T13:29:02.624490-05:00,"Radiation Therapy, NOS",Residual Disease,
HCM-BROD-0232-C25,13f667da-a66b-4622-9e6a-b3e861e96961,9db2a11b-291d-4ea8-b226-9b52ef1b045d,314.0,Adjuvant,6.0,2023-02-22T07:39:25.979291-06:00,HCM-BROD-0232-C25_treatment2,b1282ce5-d5e9-4b48-a124-bcd49d68a8d2,,released,Gemcitabine,1,2020-06-15T13:29:02.624490-05:00,Chemotherapy,Residual Disease,
HCM-BROD-0232-C25,13f667da-a66b-4622-9e6a-b3e861e96961,9db2a11b-291d-4ea8-b226-9b52ef1b045d,,Adjuvant,,2023-02-22T07:39:25.979291-06:00,HCM-BROD-0232-C25_treatment6,e957a200-b186-4f8a-930f-2886a012ae76,,released,,0,2020-06-15T13:29:02.624490-05:00,Targeted Molecular Therapy,Residual Disease,
HCM-SANG-1304-C20,147d66fc-1d48-47a9-b9c8-4b96be0bf152,2ff5ead4-0e8d-4f8e-8893-68d8e770a88e,,Neoadjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-SANG-1304-C20_treatment,79bf9fb4-7c29-4bea-9da1-29a63538d330,,released,,1,2023-02-27T11:42:10.971743-06:00,Chemotherapy,,
HCM-SANG-1304-C20,147d66fc-1d48-47a9-b9c8-4b96be0bf152,2ff5ead4-0e8d-4f8e-8893-68d8e770a88e,,Neoadjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-SANG-1304-C20_treatment2,b1722aa5-ad00-4e24-8231-ccfce658079b,,released,,1,2023-02-27T11:42:10.971743-06:00,"Radiation Therapy, NOS",,
HCM-BROD-0199-C71,149a8565-e0c5-4474-a693-d44f1b445c0c,2d72ecab-4038-4ef7-b921-79b88ad62722,,Adjuvant,,2021-01-06T22:55:10.531130-06:00,HCM-BROD-0199-C71_treatment5,3628d901-a2d8-4648-af85-557da09fb0be,,released,,0,2020-06-15T13:02:56.008585-05:00,Targeted Molecular Therapy,Residual Disease,
HCM-BROD-0199-C71,149a8565-e0c5-4474-a693-d44f1b445c0c,2d72ecab-4038-4ef7-b921-79b88ad62722,,,-6.0,2023-02-27T13:23:57.287898-06:00,HCM-BROD-0199-C71_treatment4,39acc0fc-8776-497e-bd99-48634f0f7a08,,released,,1,2020-06-15T13:02:56.008585-05:00,"Surgery, NOS",Initial Diagnosis,
HCM-BROD-0199-C71,149a8565-e0c5-4474-a693-d44f1b445c0c,2d72ecab-4038-4ef7-b921-79b88ad62722,,Adjuvant,,2021-01-06T22:55:10.531130-06:00,HCM-BROD-0199-C71_treatment3,5d137e7f-f788-4801-b014-f02014038b1c,,released,,0,2020-06-15T13:02:56.008585-05:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-BROD-0199-C71,149a8565-e0c5-4474-a693-d44f1b445c0c,2d72ecab-4038-4ef7-b921-79b88ad62722,77.0,Adjuvant,28.0,2021-01-06T22:55:10.531130-06:00,HCM-BROD-0199-C71_treatment2,6406e648-e6b5-4dcf-99ee-f81940ae5d28,,released,Temozolomide,1,2020-06-15T13:02:56.008585-05:00,Chemotherapy,Residual Disease,
HCM-BROD-0199-C71,149a8565-e0c5-4474-a693-d44f1b445c0c,2d72ecab-4038-4ef7-b921-79b88ad62722,,Neoadjuvant,,2021-01-06T22:55:10.531130-06:00,HCM-BROD-0199-C71_treatment,a0f0d4e4-7007-4c34-892b-e585846b6552,,released,,0,2019-04-04T15:00:32.807421-05:00,,,
HCM-BROD-0199-C71,149a8565-e0c5-4474-a693-d44f1b445c0c,2d72ecab-4038-4ef7-b921-79b88ad62722,77.0,Adjuvant,28.0,2021-01-06T22:55:10.531130-06:00,HCM-BROD-0199-C71_treatment6,d419c6e1-de7f-4b4d-8b6c-0a4fc9a2b318,,released,,1,2020-06-15T13:02:56.008585-05:00,"Radiation Therapy, NOS",Residual Disease,
HCM-BROD-0199-C71,149a8565-e0c5-4474-a693-d44f1b445c0c,df0230e6-d07c-4814-9aee-5be560d1ce58,87.0,Maintenance Therapy,28.0,2021-01-06T22:55:10.531130-06:00,HCM-BROD-0199-C71_treatment7,f80c17b7-e725-45e6-bf8b-b6ac85bc6fd0,Stable Disease,released,Temozolomide,1,2020-06-15T13:02:56.008585-05:00,,,
HCM-BROD-1105-C73,149eef24-418a-4f5e-b32e-060a8baa8322,7480722d-21ee-4b63-9d8c-69cfedc9a107,7288.0,Maintenance Therapy,7151.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-1105-C73_treatment9,4afa9bef-4a12-43e9-a7b4-32cd258c8a21,Progressive Disease,released,Lenvatinib,1,2021-12-21T14:00:57.747810-06:00,,,
HCM-BROD-1105-C73,149eef24-418a-4f5e-b32e-060a8baa8322,7480722d-21ee-4b63-9d8c-69cfedc9a107,7288.0,Maintenance Therapy,7151.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-1105-C73_treatment8,c2bb7f79-ddc8-4825-b6b0-2d936ccd616d,Progressive Disease,released,Sorafenib,1,2021-12-21T14:00:57.747810-06:00,,,
HCM-BROD-1105-C73,149eef24-418a-4f5e-b32e-060a8baa8322,9c9efbbe-9e37-4c2c-ae4a-84a05781e95b,7627.0,Adjuvant,7546.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-1105-C73_treatment6,0883e2d4-3d1c-445b-a88e-f07acc1ed4b7,,released,Not Reported,1,2021-12-21T14:00:57.747810-06:00,Targeted Molecular Therapy,Residual Disease,
HCM-BROD-1105-C73,149eef24-418a-4f5e-b32e-060a8baa8322,9c9efbbe-9e37-4c2c-ae4a-84a05781e95b,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-BROD-1105-C73_treatment7,511b43f1-8476-4f84-ae25-4af8ff91fccd,,released,,0,2021-12-21T14:00:57.747810-06:00,"Radiation Therapy, NOS",Residual Disease,
HCM-BROD-1105-C73,149eef24-418a-4f5e-b32e-060a8baa8322,9c9efbbe-9e37-4c2c-ae4a-84a05781e95b,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-BROD-1105-C73_treatment3,96e447a7-551e-4d2d-a8c7-4812bfaa4eee,,released,,0,2021-12-21T14:00:57.747810-06:00,Hormone Therapy,Residual Disease,
HCM-BROD-1105-C73,149eef24-418a-4f5e-b32e-060a8baa8322,9c9efbbe-9e37-4c2c-ae4a-84a05781e95b,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-BROD-1105-C73_treatment2,b593d062-8130-47af-b721-67bfb125e6a2,,released,,0,2021-12-21T14:00:57.747810-06:00,Chemotherapy,Residual Disease,
HCM-BROD-1105-C73,149eef24-418a-4f5e-b32e-060a8baa8322,9c9efbbe-9e37-4c2c-ae4a-84a05781e95b,,,0.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-1105-C73_treatment5,e5e96843-891b-49e9-8940-23709395694e,,released,,1,2021-12-21T14:00:57.747810-06:00,"Surgery, NOS",Initial Diagnosis,
HCM-BROD-1105-C73,149eef24-418a-4f5e-b32e-060a8baa8322,9c9efbbe-9e37-4c2c-ae4a-84a05781e95b,,Neoadjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-BROD-1105-C73_treatment,e9d9a6a3-8634-497c-adbc-72b0129878d9,,released,,0,2021-12-21T14:00:57.747810-06:00,,,
HCM-BROD-1105-C73,149eef24-418a-4f5e-b32e-060a8baa8322,9c9efbbe-9e37-4c2c-ae4a-84a05781e95b,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-BROD-1105-C73_treatment4,ea0e8676-bc2a-4409-92e1-018968540318,,released,,0,2021-12-21T14:00:57.747810-06:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-CSHL-0625-C18,14d24b35-141b-4743-b4a9-321e2393bb54,dceb4b03-d5e1-4097-a188-e1fa3199f844,,,373.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0625-C18_treatment16,091da4fe-8696-4ba8-b6f6-c430fa0caaa9,,released,,1,2021-12-21T14:13:40.809190-06:00,"Surgery, NOS",Initial Diagnosis,
HCM-CSHL-0625-C18,14d24b35-141b-4743-b4a9-321e2393bb54,dceb4b03-d5e1-4097-a188-e1fa3199f844,,Neoadjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0625-C18_treatment,12414e25-77c8-4a56-8acc-f6981cee9c84,,released,,0,2021-12-21T14:13:40.809190-06:00,,,
HCM-CSHL-0625-C18,14d24b35-141b-4743-b4a9-321e2393bb54,dceb4b03-d5e1-4097-a188-e1fa3199f844,70.0,Adjuvant,47.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0625-C18_treatment4,371af0b4-58c8-4aeb-9717-7bb1075235ad,,released,,1,2021-12-21T14:13:40.809190-06:00,Chemotherapy,Residual Disease,XELOX
HCM-CSHL-0625-C18,14d24b35-141b-4743-b4a9-321e2393bb54,dceb4b03-d5e1-4097-a188-e1fa3199f844,877.0,Adjuvant,684.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0625-C18_treatment11,3d09cde7-f62e-47f2-96a4-1f755e0f05e5,,released,Bevacizumab,1,2021-12-21T14:13:40.809190-06:00,Chemotherapy,Residual Disease,
HCM-CSHL-0625-C18,14d24b35-141b-4743-b4a9-321e2393bb54,dceb4b03-d5e1-4097-a188-e1fa3199f844,246.0,Adjuvant,135.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0625-C18_treatment8,416481f5-17a3-4d40-b217-fbfc5bdd4776,,released,Cetuximab,1,2021-12-21T14:13:40.809190-06:00,Chemotherapy,Residual Disease,
HCM-CSHL-0625-C18,14d24b35-141b-4743-b4a9-321e2393bb54,dceb4b03-d5e1-4097-a188-e1fa3199f844,877.0,Adjuvant,684.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0625-C18_treatment12,47573e09-f174-41b0-8440-59957e6912b9,,released,Leucovorin Calcium,1,2021-12-21T14:13:40.809190-06:00,Chemotherapy,Residual Disease,
HCM-CSHL-0625-C18,14d24b35-141b-4743-b4a9-321e2393bb54,dceb4b03-d5e1-4097-a188-e1fa3199f844,70.0,Adjuvant,47.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0625-C18_treatment3,648e5dc4-ba04-46c7-8670-08bc38181e70,,released,Capecitabine,1,2021-12-21T14:13:40.809190-06:00,Chemotherapy,Residual Disease,
HCM-CSHL-0625-C18,14d24b35-141b-4743-b4a9-321e2393bb54,dceb4b03-d5e1-4097-a188-e1fa3199f844,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0625-C18_treatment17,6acf4d00-e315-40df-9485-fa7990e29138,,released,,0,2021-12-21T14:13:40.809190-06:00,Targeted Molecular Therapy,Residual Disease,
HCM-CSHL-0625-C18,14d24b35-141b-4743-b4a9-321e2393bb54,dceb4b03-d5e1-4097-a188-e1fa3199f844,246.0,Adjuvant,135.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0625-C18_treatment9,7e86f2de-df6a-4be2-b399-f6d4975e7879,,released,,1,2021-12-21T14:13:40.809190-06:00,Chemotherapy,Residual Disease,FOLFIRI-cetuximab
HCM-CSHL-0625-C18,14d24b35-141b-4743-b4a9-321e2393bb54,dceb4b03-d5e1-4097-a188-e1fa3199f844,877.0,Adjuvant,684.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0625-C18_treatment13,8c21240a-2799-439a-98b1-0c5df4483502,,released,Fluorouracil,1,2021-12-21T14:13:40.809190-06:00,Chemotherapy,Residual Disease,
HCM-CSHL-0625-C18,14d24b35-141b-4743-b4a9-321e2393bb54,dceb4b03-d5e1-4097-a188-e1fa3199f844,246.0,Adjuvant,135.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0625-C18_treatment5,8d25ccd1-14bc-4b4c-8dc3-ca33fd406ab7,,released,Irinotecan,1,2021-12-21T14:13:40.809190-06:00,Chemotherapy,Residual Disease,
HCM-CSHL-0625-C18,14d24b35-141b-4743-b4a9-321e2393bb54,dceb4b03-d5e1-4097-a188-e1fa3199f844,590.0,Adjuvant,524.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0625-C18_treatment18,8e77b886-dcd2-4bdc-a396-91a5d1b3cc43,,released,,1,2021-12-21T14:13:40.809190-06:00,"Radiation, Stereotactic/Gamma Knife/SRS",Residual Disease,
HCM-CSHL-0625-C18,14d24b35-141b-4743-b4a9-321e2393bb54,dceb4b03-d5e1-4097-a188-e1fa3199f844,246.0,Adjuvant,135.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0625-C18_treatment7,b113ea8f-151f-41c9-967f-1c4f12e50d74,,released,Fluorouracil,1,2021-12-21T14:13:40.809190-06:00,Chemotherapy,Residual Disease,
HCM-CSHL-0625-C18,14d24b35-141b-4743-b4a9-321e2393bb54,dceb4b03-d5e1-4097-a188-e1fa3199f844,877.0,Adjuvant,684.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0625-C18_treatment14,b5c66d29-8c80-4d15-b19b-f6a0cc2285f0,,released,,1,2021-12-21T14:13:40.809190-06:00,Chemotherapy,Residual Disease,FOLFOX
HCM-CSHL-0625-C18,14d24b35-141b-4743-b4a9-321e2393bb54,dceb4b03-d5e1-4097-a188-e1fa3199f844,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0625-C18_treatment15,bfcdf9f2-c248-44fa-87e4-5b41913f1d27,,released,,0,2021-12-21T14:13:40.809190-06:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-CSHL-0625-C18,14d24b35-141b-4743-b4a9-321e2393bb54,dceb4b03-d5e1-4097-a188-e1fa3199f844,70.0,Adjuvant,47.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0625-C18_treatment2,e5072cc4-c887-41ee-af7a-7733b7856a58,,released,Oxaliplatin,1,2021-12-21T14:13:40.809190-06:00,Chemotherapy,Residual Disease,
HCM-CSHL-0625-C18,14d24b35-141b-4743-b4a9-321e2393bb54,dceb4b03-d5e1-4097-a188-e1fa3199f844,246.0,Adjuvant,135.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0625-C18_treatment6,f11a1598-6310-4083-8ab4-4022e7914c68,,released,Leucovorin Calcium,1,2021-12-21T14:13:40.809190-06:00,Chemotherapy,Residual Disease,
HCM-CSHL-0625-C18,14d24b35-141b-4743-b4a9-321e2393bb54,dceb4b03-d5e1-4097-a188-e1fa3199f844,877.0,Adjuvant,684.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0625-C18_treatment10,ff62f0ec-9857-4759-a6e3-fb871eb5db73,,released,Oxaliplatin,1,2021-12-21T14:13:40.809190-06:00,Chemotherapy,Residual Disease,
HCM-CSHL-0625-C18,14d24b35-141b-4743-b4a9-321e2393bb54,ddc2cd05-9276-45b7-a629-974b02869272,246.0,Maintenance Therapy,47.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0625-C18_treatment22,0b5e1b6e-6c6e-4699-8b96-63b02106eb19,Stable Disease,released,Oxaliplatin,1,2021-12-21T14:13:40.809190-06:00,,,
HCM-CSHL-0625-C18,14d24b35-141b-4743-b4a9-321e2393bb54,ddc2cd05-9276-45b7-a629-974b02869272,246.0,Maintenance Therapy,47.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0625-C18_treatment23,41fd2d64-56f2-4290-8df8-d6200dda4445,Stable Disease,released,Irinotecan,1,2021-12-21T14:13:40.809190-06:00,,,
HCM-CSHL-0625-C18,14d24b35-141b-4743-b4a9-321e2393bb54,ddc2cd05-9276-45b7-a629-974b02869272,246.0,Maintenance Therapy,47.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0625-C18_treatment24,90850d40-77cc-45ee-98a9-c6849b4d0d4e,Stable Disease,released,Capecitabine,1,2021-12-21T14:13:40.809190-06:00,,,
HCM-CSHL-0625-C18,14d24b35-141b-4743-b4a9-321e2393bb54,ddc2cd05-9276-45b7-a629-974b02869272,246.0,Maintenance Therapy,47.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0625-C18_treatment19,a94926c5-fdd2-4434-8361-2f3c33e83da1,Stable Disease,released,Fluorouracil,1,2021-12-21T14:13:40.809190-06:00,,,
HCM-CSHL-0625-C18,14d24b35-141b-4743-b4a9-321e2393bb54,ddc2cd05-9276-45b7-a629-974b02869272,246.0,Maintenance Therapy,47.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0625-C18_treatment20,bc63490c-a58b-4a5a-aba7-685ba0fc3c21,Stable Disease,released,Leucovorin Calcium,1,2021-12-21T14:13:40.809190-06:00,,,
HCM-CSHL-0625-C18,14d24b35-141b-4743-b4a9-321e2393bb54,ddc2cd05-9276-45b7-a629-974b02869272,246.0,Maintenance Therapy,47.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0625-C18_treatment26,e1f41894-187f-4f8a-b182-c9dcb0133ef8,Stable Disease,released,,1,2021-12-21T14:13:40.809190-06:00,,,XELOX
HCM-CSHL-0625-C18,14d24b35-141b-4743-b4a9-321e2393bb54,ddc2cd05-9276-45b7-a629-974b02869272,246.0,Maintenance Therapy,47.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0625-C18_treatment25,eacbe05b-8204-464c-b03e-b242ff17563e,Stable Disease,released,,1,2021-12-21T14:13:40.809190-06:00,,,FOLFIRI
HCM-CSHL-0625-C18,14d24b35-141b-4743-b4a9-321e2393bb54,ddc2cd05-9276-45b7-a629-974b02869272,246.0,Maintenance Therapy,47.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0625-C18_treatment21,eb6009a9-6e0e-4fa7-82d9-709057b00759,Stable Disease,released,Cetuximab,1,2021-12-21T14:13:40.809190-06:00,,,
HCM-WCMC-1287-C67,150dfaa3-1eb3-427a-a82f-560d706cabc2,3fddd527-5d17-413b-b165-0f0343565004,442.0,Adjuvant,435.0,2025-04-07T17:13:09.336794-05:00,HCM-WCMC-1287-C67_treatment7,254f5555-4049-492f-b065-ffe69fbfbc0a,,released,Enfortumab Vedotin,1,2023-02-27T13:14:48.334547-06:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-WCMC-1287-C67,150dfaa3-1eb3-427a-a82f-560d706cabc2,3fddd527-5d17-413b-b165-0f0343565004,260.0,Adjuvant,190.0,2025-04-07T17:13:09.336794-05:00,HCM-WCMC-1287-C67_treatment6,3bd62b83-c242-4454-993a-e0efbbdb8171,,released,Avelumab,1,2023-02-27T13:14:48.334547-06:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-WCMC-1287-C67,150dfaa3-1eb3-427a-a82f-560d706cabc2,3fddd527-5d17-413b-b165-0f0343565004,155.0,Adjuvant,43.0,2025-04-07T17:13:09.336794-05:00,HCM-WCMC-1287-C67_treatment2,803e7a86-5ac9-4c8e-b4ce-6a22f2dd36fb,,released,Etoposide,1,2023-02-27T13:14:48.334547-06:00,Chemotherapy,Residual Disease,
HCM-WCMC-1287-C67,150dfaa3-1eb3-427a-a82f-560d706cabc2,3fddd527-5d17-413b-b165-0f0343565004,,,0.0,2025-04-07T17:13:09.336794-05:00,HCM-WCMC-1287-C67_treatment8,94ca05d8-c73b-4f5f-b355-4d4275006e17,,released,,1,2023-02-27T13:14:48.334547-06:00,"Surgery, NOS",Initial Diagnosis,
HCM-WCMC-1287-C67,150dfaa3-1eb3-427a-a82f-560d706cabc2,3fddd527-5d17-413b-b165-0f0343565004,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-WCMC-1287-C67_treatment5,9fd62d5a-11c5-4629-9533-c988a934b2b3,,released,,0,2023-02-27T13:14:48.334547-06:00,Hormone Therapy,Residual Disease,
HCM-WCMC-1287-C67,150dfaa3-1eb3-427a-a82f-560d706cabc2,3fddd527-5d17-413b-b165-0f0343565004,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-WCMC-1287-C67_treatment9,a1f3e25c-ab1d-483b-9897-f0e6ddbcf490,,released,,0,2023-02-27T13:14:48.334547-06:00,Targeted Molecular Therapy,Residual Disease,
HCM-WCMC-1287-C67,150dfaa3-1eb3-427a-a82f-560d706cabc2,3fddd527-5d17-413b-b165-0f0343565004,155.0,Adjuvant,43.0,2025-04-07T17:13:09.336794-05:00,HCM-WCMC-1287-C67_treatment3,e3f00d2d-b96f-4786-b311-6f6879f75426,,released,Cisplatin,1,2023-02-27T13:14:48.334547-06:00,Chemotherapy,Residual Disease,
HCM-WCMC-1287-C67,150dfaa3-1eb3-427a-a82f-560d706cabc2,3fddd527-5d17-413b-b165-0f0343565004,407.0,Adjuvant,365.0,2025-04-07T17:13:09.336794-05:00,HCM-WCMC-1287-C67_treatment4,eb030069-112c-436b-a134-6c97364659e8,,released,Lurbinectedin,1,2023-02-27T13:14:48.334547-06:00,Chemotherapy,Residual Disease,
HCM-WCMC-1287-C67,150dfaa3-1eb3-427a-a82f-560d706cabc2,3fddd527-5d17-413b-b165-0f0343565004,,Neoadjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-WCMC-1287-C67_treatment,f98f49cc-1c6a-493c-b772-5764c46d59e0,,released,,0,2023-02-27T13:14:48.334547-06:00,,,
HCM-WCMC-1287-C67,150dfaa3-1eb3-427a-a82f-560d706cabc2,3fddd527-5d17-413b-b165-0f0343565004,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-WCMC-1287-C67_treatment10,fdd52ac1-88b1-4e0c-85d4-ee6660ac8283,,released,,0,2023-02-27T13:14:48.334547-06:00,"Radiation Therapy, NOS",Residual Disease,
HCM-CSHL-0860-C18,157d4813-8461-4593-8232-863c7ace4b35,43034527-795f-4d93-8ce0-777dd3947050,,Neoadjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0860-C18_treatment,04773181-1ac6-4659-9be6-a23e6e17f844,,released,,0,2021-12-21T14:36:00.645302-06:00,,,
HCM-CSHL-0860-C18,157d4813-8461-4593-8232-863c7ace4b35,43034527-795f-4d93-8ce0-777dd3947050,122.0,Adjuvant,62.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0860-C18_treatment2,0d32b1a0-d7c1-4a19-9fbb-64edc685d508,,released,Oxaliplatin,1,2021-12-21T14:36:00.645302-06:00,Chemotherapy,Residual Disease,
HCM-CSHL-0860-C18,157d4813-8461-4593-8232-863c7ace4b35,43034527-795f-4d93-8ce0-777dd3947050,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0860-C18_treatment12,2ba801ff-06e6-4437-9d22-4ad49e0f0d0c,,released,,0,2021-12-21T14:36:00.645302-06:00,"Radiation Therapy, NOS",Residual Disease,
HCM-CSHL-0860-C18,157d4813-8461-4593-8232-863c7ace4b35,43034527-795f-4d93-8ce0-777dd3947050,428.0,Adjuvant,397.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0860-C18_treatment7,4365571a-a77f-4b0d-9e04-a8869259a38f,,released,Fluorouracil,1,2021-12-21T14:36:00.645302-06:00,Chemotherapy,Residual Disease,
HCM-CSHL-0860-C18,157d4813-8461-4593-8232-863c7ace4b35,43034527-795f-4d93-8ce0-777dd3947050,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0860-C18_treatment11,55f84249-afa9-4279-9236-e3b72b33e7ba,,released,,0,2021-12-21T14:36:00.645302-06:00,Targeted Molecular Therapy,Residual Disease,
HCM-CSHL-0860-C18,157d4813-8461-4593-8232-863c7ace4b35,43034527-795f-4d93-8ce0-777dd3947050,428.0,Adjuvant,397.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0860-C18_treatment5,6d8fb0cd-e78a-42fe-8a5e-b48a74e194e8,,released,Bevacizumab,1,2021-12-21T14:36:00.645302-06:00,Chemotherapy,Residual Disease,
HCM-CSHL-0860-C18,157d4813-8461-4593-8232-863c7ace4b35,43034527-795f-4d93-8ce0-777dd3947050,122.0,Adjuvant,62.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0860-C18_treatment3,77f5501c-b709-4827-848d-4fe82a1e2945,,released,Capecitabine,1,2021-12-21T14:36:00.645302-06:00,Chemotherapy,Residual Disease,
HCM-CSHL-0860-C18,157d4813-8461-4593-8232-863c7ace4b35,43034527-795f-4d93-8ce0-777dd3947050,428.0,Adjuvant,397.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0860-C18_treatment6,8d3040b3-ad37-4b5c-82aa-33077af50f60,,released,Leucovorin Calcium,1,2021-12-21T14:36:00.645302-06:00,Chemotherapy,Residual Disease,
HCM-CSHL-0860-C18,157d4813-8461-4593-8232-863c7ace4b35,43034527-795f-4d93-8ce0-777dd3947050,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0860-C18_treatment9,aed041ed-dd12-47eb-a311-75282c1a3311,,released,,0,2021-12-21T14:36:00.645302-06:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-CSHL-0860-C18,157d4813-8461-4593-8232-863c7ace4b35,43034527-795f-4d93-8ce0-777dd3947050,428.0,Adjuvant,397.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0860-C18_treatment8,c0ba084e-df46-4b44-a7b0-84a2b271a64d,,released,,1,2021-12-21T14:36:00.645302-06:00,Chemotherapy,Residual Disease,FOLFOX
HCM-CSHL-0860-C18,157d4813-8461-4593-8232-863c7ace4b35,43034527-795f-4d93-8ce0-777dd3947050,428.0,Adjuvant,397.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0860-C18_treatment4,dd73d23a-d260-4e12-96e2-554544f3dcdd,,released,Oxaliplatin,1,2021-12-21T14:36:00.645302-06:00,Chemotherapy,Residual Disease,
HCM-CSHL-0860-C18,157d4813-8461-4593-8232-863c7ace4b35,43034527-795f-4d93-8ce0-777dd3947050,,,200.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0860-C18_treatment10,fdb66eb5-09b9-4e43-bf6d-7a6093fa5fbe,,released,,1,2021-12-21T14:36:00.645302-06:00,"Surgery, NOS",Initial Diagnosis,
HCM-CSHL-0860-C18,157d4813-8461-4593-8232-863c7ace4b35,de5b2d58-3b24-4e7a-bc6f-8558fc7ec068,149.0,Maintenance Therapy,72.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0860-C18_treatment13,241cea9c-f039-480c-9468-ce681a20786f,Progressive Disease,released,Oxaliplatin,1,2021-12-21T14:36:00.645302-06:00,,,
HCM-CSHL-0860-C18,157d4813-8461-4593-8232-863c7ace4b35,de5b2d58-3b24-4e7a-bc6f-8558fc7ec068,149.0,Maintenance Therapy,72.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0860-C18_treatment14,75020a20-a1aa-4226-b40c-9797e4457afc,Progressive Disease,released,Capecitabine,1,2021-12-21T14:36:00.645302-06:00,,,
HCM-CSHL-0860-C18,157d4813-8461-4593-8232-863c7ace4b35,de5b2d58-3b24-4e7a-bc6f-8558fc7ec068,149.0,Maintenance Therapy,72.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0860-C18_treatment15,acc29839-6207-4714-ac3b-7d63a05d78f8,Progressive Disease,released,,1,2021-12-21T14:36:00.645302-06:00,,,XELOX
HCM-BROD-0489-C15,15fda26e-ea06-4ead-be90-9af1d94473aa,ba6fc32c-3904-4580-8522-cf1c155cee90,,Neoadjuvant,15.0,2023-07-13T10:35:44.371881-05:00,HCM-BROD-0489-C15_treatment3,07b607ae-ccd0-4c56-88b9-b5970c011e25,,released,Irinotecan,1,2021-12-21T13:38:35.778498-06:00,Chemotherapy,,
HCM-BROD-0489-C15,15fda26e-ea06-4ead-be90-9af1d94473aa,ba6fc32c-3904-4580-8522-cf1c155cee90,435.0,Adjuvant,15.0,2023-07-13T10:35:44.371881-05:00,HCM-BROD-0489-C15_treatment9,197785f8-0a2f-4aff-a8a9-69e722bd4512,,released,,1,2021-12-21T13:38:35.778498-06:00,Chemotherapy,Residual Disease,FOLFOX
HCM-BROD-0489-C15,15fda26e-ea06-4ead-be90-9af1d94473aa,ba6fc32c-3904-4580-8522-cf1c155cee90,435.0,Adjuvant,15.0,2023-07-13T10:35:44.371881-05:00,HCM-BROD-0489-C15_treatment8,2d4a0139-b0b0-4bea-8406-11fdd2b34c27,,released,Oxaliplatin,1,2021-12-21T13:38:35.778498-06:00,Chemotherapy,Residual Disease,
HCM-BROD-0489-C15,15fda26e-ea06-4ead-be90-9af1d94473aa,ba6fc32c-3904-4580-8522-cf1c155cee90,,Neoadjuvant,15.0,2023-07-13T10:35:44.371881-05:00,HCM-BROD-0489-C15_treatment4,364ecc9f-d2df-4c3a-9912-2772d8a0bb66,,released,,1,2021-12-21T13:38:35.778498-06:00,Chemotherapy,,FOLFIRI
HCM-BROD-0489-C15,15fda26e-ea06-4ead-be90-9af1d94473aa,ba6fc32c-3904-4580-8522-cf1c155cee90,,Neoadjuvant,15.0,2023-07-13T10:35:44.371881-05:00,HCM-BROD-0489-C15_treatment2,48bc8e06-76d8-4e71-b2d3-5a18ab42151f,,released,Fluorouracil,1,2021-12-21T13:38:35.778498-06:00,Chemotherapy,,
HCM-BROD-0489-C15,15fda26e-ea06-4ead-be90-9af1d94473aa,ba6fc32c-3904-4580-8522-cf1c155cee90,,Neoadjuvant,15.0,2023-07-13T10:35:44.371881-05:00,HCM-BROD-0489-C15_treatment5,5d728fbb-d988-4237-9e0e-189ebf236949,,released,Ramucirumab,1,2021-12-21T13:38:35.778498-06:00,Targeted Molecular Therapy,,
HCM-BROD-0489-C15,15fda26e-ea06-4ead-be90-9af1d94473aa,ba6fc32c-3904-4580-8522-cf1c155cee90,,Adjuvant,,2023-07-13T10:35:44.371881-05:00,HCM-BROD-0489-C15_treatment12,676274c7-7c0e-48ab-89e5-88d06bdc5460,,released,,0,2021-12-21T13:38:35.778498-06:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-BROD-0489-C15,15fda26e-ea06-4ead-be90-9af1d94473aa,ba6fc32c-3904-4580-8522-cf1c155cee90,,Adjuvant,,2023-07-13T10:35:44.371881-05:00,HCM-BROD-0489-C15_treatment14,87d0e9b2-43fb-426e-97fe-a6d68aae1bb5,,released,,0,2021-12-21T13:38:35.778498-06:00,Targeted Molecular Therapy,Residual Disease,
HCM-BROD-0489-C15,15fda26e-ea06-4ead-be90-9af1d94473aa,ba6fc32c-3904-4580-8522-cf1c155cee90,,Neoadjuvant,15.0,2023-07-13T10:35:44.371881-05:00,HCM-BROD-0489-C15_treatment,8eef039a-4f1a-40a0-b8d8-9b157daa48c5,,released,Leucovorin Calcium,1,2021-12-21T13:38:35.778498-06:00,Chemotherapy,,
HCM-BROD-0489-C15,15fda26e-ea06-4ead-be90-9af1d94473aa,ba6fc32c-3904-4580-8522-cf1c155cee90,435.0,Adjuvant,15.0,2023-07-13T10:35:44.371881-05:00,HCM-BROD-0489-C15_treatment6,9c1d598f-36e0-4d8b-9f94-076e3a653beb,,released,Leucovorin Calcium,1,2021-12-21T13:38:35.778498-06:00,Chemotherapy,Residual Disease,
HCM-BROD-0489-C15,15fda26e-ea06-4ead-be90-9af1d94473aa,ba6fc32c-3904-4580-8522-cf1c155cee90,435.0,Adjuvant,15.0,2023-07-13T10:35:44.371881-05:00,HCM-BROD-0489-C15_treatment7,ceb066ec-791e-4980-a3af-9ae14b364d81,,released,Fluorouracil,1,2021-12-21T13:38:35.778498-06:00,Chemotherapy,Residual Disease,
HCM-BROD-0489-C15,15fda26e-ea06-4ead-be90-9af1d94473aa,ba6fc32c-3904-4580-8522-cf1c155cee90,,,0.0,2023-07-13T10:35:44.371881-05:00,HCM-BROD-0489-C15_treatment13,d9c256c3-0af3-4b71-b2c8-511edc0fe988,,released,,1,2021-12-21T13:38:35.778498-06:00,"Surgery, NOS",Initial Diagnosis,
HCM-BROD-0489-C15,15fda26e-ea06-4ead-be90-9af1d94473aa,ba6fc32c-3904-4580-8522-cf1c155cee90,435.0,Adjuvant,15.0,2023-07-13T10:35:44.371881-05:00,HCM-BROD-0489-C15_treatment10,e8703381-b984-4572-840c-3f541979d624,,released,Irinotecan,1,2021-12-21T13:38:35.778498-06:00,Chemotherapy,Residual Disease,
HCM-BROD-0489-C15,15fda26e-ea06-4ead-be90-9af1d94473aa,ba6fc32c-3904-4580-8522-cf1c155cee90,435.0,Adjuvant,15.0,2023-07-13T10:35:44.371881-05:00,HCM-BROD-0489-C15_treatment11,ee79cba8-6d93-4b07-9a4f-5d67a25ec895,,released,,1,2021-12-21T13:38:35.778498-06:00,Chemotherapy,Residual Disease,FOLFIRI
HCM-BROD-0489-C15,15fda26e-ea06-4ead-be90-9af1d94473aa,ba6fc32c-3904-4580-8522-cf1c155cee90,,Adjuvant,,2023-07-13T10:35:44.371881-05:00,HCM-BROD-0489-C15_treatment15,f9e35320-f6f9-4c80-b9e9-9d86fdaf13f2,,released,,0,2021-12-21T13:38:35.778498-06:00,"Radiation Therapy, NOS",Residual Disease,
HCM-BROD-0111-C25,164eeaa7-4229-493f-ae77-0843f36af6b8,2c65803b-ecf3-4990-afd6-f9fab6c17ea9,,Neoadjuvant,3.0,2023-11-07T14:28:29.403873-06:00,HCM-BROD-0111-C25_treatment8,03ac042a-5f5c-4f0e-b832-5703d615087d,,released,Nab-paclitaxel,1,2020-09-17T15:45:42.548915-05:00,Chemotherapy,,
HCM-BROD-0111-C25,164eeaa7-4229-493f-ae77-0843f36af6b8,2c65803b-ecf3-4990-afd6-f9fab6c17ea9,,Adjuvant,,2023-11-07T14:28:29.403873-06:00,HCM-BROD-0111-C25_treatment11,043d646a-8446-42bc-be3a-b2a0327ad855,,released,,0,2020-09-17T15:45:42.548915-05:00,Chemotherapy,Residual Disease,
HCM-BROD-0111-C25,164eeaa7-4229-493f-ae77-0843f36af6b8,2c65803b-ecf3-4990-afd6-f9fab6c17ea9,,Adjuvant,,2023-11-07T14:28:29.403873-06:00,HCM-BROD-0111-C25_treatment14,26083536-0686-459a-a23e-7a0f1947e152,,released,,0,2020-09-17T15:45:42.548915-05:00,Targeted Molecular Therapy,Residual Disease,
HCM-BROD-0111-C25,164eeaa7-4229-493f-ae77-0843f36af6b8,2c65803b-ecf3-4990-afd6-f9fab6c17ea9,,Adjuvant,,2023-11-07T14:28:29.403873-06:00,HCM-BROD-0111-C25_treatment12,311ab237-d60b-4060-a494-f80906a8515e,,released,,0,2020-09-17T15:45:42.548915-05:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-BROD-0111-C25,164eeaa7-4229-493f-ae77-0843f36af6b8,2c65803b-ecf3-4990-afd6-f9fab6c17ea9,,Neoadjuvant,3.0,2023-11-07T14:28:29.403873-06:00,HCM-BROD-0111-C25_treatment4,319a31ea-79d6-4015-8060-3e1d018d3831,,released,Oxaliplatin,1,2020-09-17T15:45:42.548915-05:00,Chemotherapy,,
HCM-BROD-0111-C25,164eeaa7-4229-493f-ae77-0843f36af6b8,2c65803b-ecf3-4990-afd6-f9fab6c17ea9,,Neoadjuvant,3.0,2023-11-07T14:28:29.403873-06:00,HCM-BROD-0111-C25_treatment,82258f1e-1fe5-471a-92b6-01efdde6725c,,released,Irinotecan Hydrochloride,1,2020-09-17T15:45:42.548915-05:00,Chemotherapy,,
HCM-BROD-0111-C25,164eeaa7-4229-493f-ae77-0843f36af6b8,2c65803b-ecf3-4990-afd6-f9fab6c17ea9,,Neoadjuvant,3.0,2023-11-07T14:28:29.403873-06:00,HCM-BROD-0111-C25_treatment2,869423df-4f9f-432a-a43c-85422eb7a13e,,released,Leucovorin Calcium,1,2020-09-17T15:45:42.548915-05:00,Chemotherapy,,
HCM-BROD-0111-C25,164eeaa7-4229-493f-ae77-0843f36af6b8,2c65803b-ecf3-4990-afd6-f9fab6c17ea9,,Neoadjuvant,3.0,2023-11-07T14:28:29.403873-06:00,HCM-BROD-0111-C25_treatment3,ba2a6d13-03af-40f3-b27e-62105aa5bea1,,released,Fluorouracil,1,2020-09-17T15:45:42.548915-05:00,Chemotherapy,,
HCM-BROD-0111-C25,164eeaa7-4229-493f-ae77-0843f36af6b8,2c65803b-ecf3-4990-afd6-f9fab6c17ea9,,,,2023-11-07T14:28:29.403873-06:00,HCM-BROD-0111-C25_treatment13,c4893d31-5e02-42ac-b1e6-74cd9da35779,,released,,0,2020-09-17T15:45:42.548915-05:00,"Surgery, NOS",Initial Diagnosis,
HCM-BROD-0111-C25,164eeaa7-4229-493f-ae77-0843f36af6b8,2c65803b-ecf3-4990-afd6-f9fab6c17ea9,,Neoadjuvant,3.0,2023-11-07T14:28:29.403873-06:00,HCM-BROD-0111-C25_treatment10,c851b0fc-11ab-4d18-a97d-b856826f4eae,,released,,1,2020-09-17T15:45:42.548915-05:00,Chemotherapy,,FU-LV regimen
HCM-BROD-0111-C25,164eeaa7-4229-493f-ae77-0843f36af6b8,2c65803b-ecf3-4990-afd6-f9fab6c17ea9,,Neoadjuvant,3.0,2023-11-07T14:28:29.403873-06:00,HCM-BROD-0111-C25_treatment5,c8e613bb-5722-4162-94fe-58d1a75db02b,,released,,1,2020-09-17T15:45:42.548915-05:00,Chemotherapy,,FOLFIRINOX
HCM-BROD-0111-C25,164eeaa7-4229-493f-ae77-0843f36af6b8,2c65803b-ecf3-4990-afd6-f9fab6c17ea9,,Neoadjuvant,3.0,2023-11-07T14:28:29.403873-06:00,HCM-BROD-0111-C25_treatment9,d645b039-e227-4418-96f4-88d990cff467,,released,Leucovorin,1,2020-09-17T15:45:42.548915-05:00,Chemotherapy,,
HCM-BROD-0111-C25,164eeaa7-4229-493f-ae77-0843f36af6b8,2c65803b-ecf3-4990-afd6-f9fab6c17ea9,,Neoadjuvant,3.0,2023-11-07T14:28:29.403873-06:00,HCM-BROD-0111-C25_treatment7,d6a6f4ef-591a-403f-a789-7fb5dfc14fb3,,released,Gemcitabine,1,2020-09-17T15:45:42.548915-05:00,Chemotherapy,,
HCM-BROD-0111-C25,164eeaa7-4229-493f-ae77-0843f36af6b8,2c65803b-ecf3-4990-afd6-f9fab6c17ea9,,Adjuvant,,2023-11-07T14:28:29.403873-06:00,HCM-BROD-0111-C25_treatment15,e07cf33a-30ae-49bf-93a8-d21f574138d8,,released,,0,2020-09-17T15:45:42.548915-05:00,"Radiation Therapy, NOS",Residual Disease,
HCM-BROD-0111-C25,164eeaa7-4229-493f-ae77-0843f36af6b8,2c65803b-ecf3-4990-afd6-f9fab6c17ea9,,Neoadjuvant,3.0,2023-11-07T14:28:29.403873-06:00,HCM-BROD-0111-C25_treatment6,e5a97aed-2c6a-4d2c-96eb-4e7d5b9a3c82,,released,Irinotecan,1,2020-09-17T15:45:42.548915-05:00,Chemotherapy,,
HCM-WCMC-0951-C67,165c2263-819e-46f2-9ccf-4f7ea4d83300,97e0e5f2-bbd1-4381-adbc-7a916aa24f5d,,,0.0,2025-04-07T17:13:09.336794-05:00,HCM-WCMC-0951-C67_treatment5,2b6c4943-e18a-4e18-948b-df13e43558b2,,released,,1,2023-02-27T12:12:04.050227-06:00,"Surgery, NOS",Initial Diagnosis,
HCM-WCMC-0951-C67,165c2263-819e-46f2-9ccf-4f7ea4d83300,97e0e5f2-bbd1-4381-adbc-7a916aa24f5d,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-WCMC-0951-C67_treatment2,43e731d6-fa3d-4124-887f-f8ed0f4f6807,,released,,0,2023-02-27T12:12:04.050227-06:00,Chemotherapy,Residual Disease,
HCM-WCMC-0951-C67,165c2263-819e-46f2-9ccf-4f7ea4d83300,97e0e5f2-bbd1-4381-adbc-7a916aa24f5d,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-WCMC-0951-C67_treatment7,5e060a10-435b-4e06-8be8-05b9660c9216,,released,,0,2023-02-27T12:12:04.050227-06:00,"Radiation Therapy, NOS",Residual Disease,
HCM-WCMC-0951-C67,165c2263-819e-46f2-9ccf-4f7ea4d83300,97e0e5f2-bbd1-4381-adbc-7a916aa24f5d,,Neoadjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-WCMC-0951-C67_treatment,7cbadabd-8e7a-464e-bfbd-58f6afd4fb6f,,released,,0,2023-02-27T12:12:04.050227-06:00,,,
HCM-WCMC-0951-C67,165c2263-819e-46f2-9ccf-4f7ea4d83300,97e0e5f2-bbd1-4381-adbc-7a916aa24f5d,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-WCMC-0951-C67_treatment3,80f498e9-ae2c-4843-bfe8-ceec07ce256b,,released,,0,2023-02-27T12:12:04.050227-06:00,Hormone Therapy,Residual Disease,
HCM-WCMC-0951-C67,165c2263-819e-46f2-9ccf-4f7ea4d83300,97e0e5f2-bbd1-4381-adbc-7a916aa24f5d,0.0,Adjuvant,0.0,2025-04-07T17:13:09.336794-05:00,HCM-WCMC-0951-C67_treatment4,afd5cd16-c16f-43aa-b97c-db19646879d6,,released,BCG Solution,1,2023-02-27T12:12:04.050227-06:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-WCMC-0951-C67,165c2263-819e-46f2-9ccf-4f7ea4d83300,97e0e5f2-bbd1-4381-adbc-7a916aa24f5d,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-WCMC-0951-C67_treatment6,ce06452a-8918-44f1-8fa2-ca6847783dae,,released,,0,2023-02-27T12:12:04.050227-06:00,Targeted Molecular Therapy,Residual Disease,
HCM-CSHL-0176-C25,17f4b889-d7b9-42d1-adb8-cbad65a56547,d27c890b-2652-4ac8-9302-d1595c8ce831,,Adjuvant,,2023-03-13T13:22:30.424061-05:00,HCM-CSHL-0176-C25_treatment3,188a21ad-2762-4c53-833f-3883ed1b86f8,,released,,unknown,2020-09-28T09:13:08.711050-05:00,"Pharmaceutical Therapy, NOS",Residual Disease,
HCM-CSHL-0176-C25,17f4b889-d7b9-42d1-adb8-cbad65a56547,d27c890b-2652-4ac8-9302-d1595c8ce831,,Adjuvant,,2023-03-13T13:22:30.424061-05:00,HCM-CSHL-0176-C25_treatment4,7cd9f36f-c00e-40a5-8ca4-b3fa6daae1ba,,released,,unknown,2020-09-28T09:13:08.711050-05:00,"Radiation Therapy, NOS",Residual Disease,
HCM-CSHL-0176-C25,17f4b889-d7b9-42d1-adb8-cbad65a56547,d27c890b-2652-4ac8-9302-d1595c8ce831,,,-6.0,2023-03-13T13:22:30.424061-05:00,HCM-CSHL-0176-C25_treatment2,a413dfb1-54d4-4a52-bd9c-16cfc2d5cbbe,,released,,1,2020-09-28T09:13:08.711050-05:00,"Surgery, NOS",Initial Diagnosis,
HCM-CSHL-0176-C25,17f4b889-d7b9-42d1-adb8-cbad65a56547,d27c890b-2652-4ac8-9302-d1595c8ce831,,Neoadjuvant,,2023-02-22T07:39:25.979291-06:00,HCM-CSHL-0176-C25_treatment,dd3ec9f7-ee98-4dff-8b3f-54533a24368e,,released,,0,2020-09-28T09:13:08.711050-05:00,,,
HCM-BROD-0009-C25,18909e2d-a178-49b3-9a70-998f944af8a3,e50d0efe-b604-41d8-ae6e-9a8adaf43e3e,,Adjuvant,,2021-07-12T12:25:55.528644-05:00,HCM-BROD-0009-C25_treatment10,2ac1902c-445f-4b1c-9109-7854dff19d0a,,released,,0,2020-09-27T09:59:38.839530-05:00,"Radiation Therapy, NOS",Residual Disease,
HCM-BROD-0009-C25,18909e2d-a178-49b3-9a70-998f944af8a3,e50d0efe-b604-41d8-ae6e-9a8adaf43e3e,,Adjuvant,,2021-07-12T12:25:55.528644-05:00,HCM-BROD-0009-C25_treatment7,2d6f422d-7597-43f0-9960-cb7ef6429749,,released,,0,2020-09-27T09:59:38.839530-05:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-BROD-0009-C25,18909e2d-a178-49b3-9a70-998f944af8a3,e50d0efe-b604-41d8-ae6e-9a8adaf43e3e,,Adjuvant,,2021-07-12T12:25:55.528644-05:00,HCM-BROD-0009-C25_treatment9,3562d800-8470-4042-a3a1-f5b9cba48757,,released,,0,2020-09-27T09:59:38.839530-05:00,Targeted Molecular Therapy,Residual Disease,
HCM-BROD-0009-C25,18909e2d-a178-49b3-9a70-998f944af8a3,e50d0efe-b604-41d8-ae6e-9a8adaf43e3e,221.0,Adjuvant,67.0,2021-07-12T12:25:55.528644-05:00,HCM-BROD-0009-C25_treatment3,39c41b1b-3d27-4dbb-9446-8e319970385e,,released,Leucovorin Calcium,1,2019-04-16T11:17:51.825330-05:00,Chemotherapy,Residual Disease,
HCM-BROD-0009-C25,18909e2d-a178-49b3-9a70-998f944af8a3,e50d0efe-b604-41d8-ae6e-9a8adaf43e3e,221.0,Adjuvant,67.0,2021-07-12T12:25:55.528644-05:00,HCM-BROD-0009-C25_treatment4,4a038cdb-8716-48c6-9eb1-a7bcb6100cdb,,released,Fluorouracil,1,2019-04-16T11:17:51.825330-05:00,Chemotherapy,Residual Disease,
HCM-BROD-0009-C25,18909e2d-a178-49b3-9a70-998f944af8a3,e50d0efe-b604-41d8-ae6e-9a8adaf43e3e,221.0,Adjuvant,67.0,2021-07-12T12:25:55.528644-05:00,HCM-BROD-0009-C25_treatment6,540f1ace-df95-443e-b1c0-aeb5acbaa176,,released,,1,2019-04-16T11:17:51.825330-05:00,Chemotherapy,Residual Disease,FOLFIRINOX
HCM-BROD-0009-C25,18909e2d-a178-49b3-9a70-998f944af8a3,e50d0efe-b604-41d8-ae6e-9a8adaf43e3e,221.0,Adjuvant,67.0,2021-07-12T12:25:55.528644-05:00,HCM-BROD-0009-C25_treatment5,941187fe-6ac4-4716-b55b-6f57e35cf7c9,,released,Oxaliplatin,1,2019-04-16T11:17:51.825330-05:00,Chemotherapy,Residual Disease,
HCM-BROD-0009-C25,18909e2d-a178-49b3-9a70-998f944af8a3,e50d0efe-b604-41d8-ae6e-9a8adaf43e3e,,,17.0,2023-02-27T11:52:53.196293-06:00,HCM-BROD-0009-C25_treatment8,a710514d-305f-4d9c-afcf-ec0ff359613e,,released,,1,2020-09-27T09:59:38.839530-05:00,"Surgery, NOS",Initial Diagnosis,
HCM-BROD-0009-C25,18909e2d-a178-49b3-9a70-998f944af8a3,e50d0efe-b604-41d8-ae6e-9a8adaf43e3e,221.0,Adjuvant,67.0,2021-07-12T12:25:55.528644-05:00,HCM-BROD-0009-C25_treatment2,bad47bbb-1f23-407d-8679-a07ec12c9cdd,,released,Irinotecan Hydrochloride,1,2019-04-16T11:17:51.825330-05:00,Chemotherapy,Residual Disease,
HCM-BROD-0009-C25,18909e2d-a178-49b3-9a70-998f944af8a3,e50d0efe-b604-41d8-ae6e-9a8adaf43e3e,,Neoadjuvant,,2021-07-12T12:25:55.528644-05:00,HCM-BROD-0009-C25_treatment,cc4bbe6b-2231-47f6-8e50-fbd9b624a096,,released,,0,2019-04-16T11:17:51.825330-05:00,,,
HCM-WCMC-0502-C15,18d012fb-77b9-4a9f-b3c7-986f9a0592d1,71ab8cea-7131-49cb-a85b-d6de056592ab,,Neoadjuvant,34.0,2023-07-13T10:35:44.371881-05:00,HCM-WCMC-0502-C15_treatment2,05b2aae6-5a99-4470-b98e-0a3998a7343c,,released,Fluorouracil,1,2023-02-27T12:15:10.249107-06:00,Chemotherapy,,
HCM-WCMC-0502-C15,18d012fb-77b9-4a9f-b3c7-986f9a0592d1,71ab8cea-7131-49cb-a85b-d6de056592ab,253.0,Adjuvant,34.0,2023-07-13T10:35:44.371881-05:00,HCM-WCMC-0502-C15_treatment13,1bc4726e-356a-4aa7-9da4-a8216e00693b,,released,Andecaliximab,1,2023-02-27T12:15:10.249107-06:00,Targeted Molecular Therapy,Residual Disease,
HCM-WCMC-0502-C15,18d012fb-77b9-4a9f-b3c7-986f9a0592d1,71ab8cea-7131-49cb-a85b-d6de056592ab,,Adjuvant,,2023-07-13T10:35:44.371881-05:00,HCM-WCMC-0502-C15_treatment15,42b286c5-7f36-45d5-abc2-3e94555a345f,,released,,0,2023-02-27T12:15:10.249107-06:00,"Radiation Therapy, NOS",Residual Disease,
HCM-WCMC-0502-C15,18d012fb-77b9-4a9f-b3c7-986f9a0592d1,71ab8cea-7131-49cb-a85b-d6de056592ab,253.0,Adjuvant,34.0,2023-07-13T10:35:44.371881-05:00,HCM-WCMC-0502-C15_treatment6,5684a20a-a1dc-4575-b7c6-e37295d9241b,,released,Leucovorin Calcium,1,2023-02-27T12:15:10.249107-06:00,Chemotherapy,Residual Disease,
HCM-WCMC-0502-C15,18d012fb-77b9-4a9f-b3c7-986f9a0592d1,71ab8cea-7131-49cb-a85b-d6de056592ab,,,349.0,2023-07-13T10:35:44.371881-05:00,HCM-WCMC-0502-C15_treatment12,60b22fca-b419-4800-b799-1002360d8320,,released,,1,2023-02-27T12:15:10.249107-06:00,"Surgery, NOS",Initial Diagnosis,
HCM-WCMC-0502-C15,18d012fb-77b9-4a9f-b3c7-986f9a0592d1,71ab8cea-7131-49cb-a85b-d6de056592ab,,Neoadjuvant,34.0,2023-07-13T10:35:44.371881-05:00,HCM-WCMC-0502-C15_treatment4,71b9f582-14e6-4d82-b1eb-cd1a5c92fdee,,released,,1,2023-02-27T12:15:10.249107-06:00,Chemotherapy,,FOLFOX
HCM-WCMC-0502-C15,18d012fb-77b9-4a9f-b3c7-986f9a0592d1,71ab8cea-7131-49cb-a85b-d6de056592ab,,Neoadjuvant,34.0,2023-07-13T10:35:44.371881-05:00,HCM-WCMC-0502-C15_treatment3,9315627e-06d4-4631-bec9-b1ad03d9f521,,released,Oxaliplatin,1,2023-02-27T12:15:10.249107-06:00,Chemotherapy,,
HCM-WCMC-0502-C15,18d012fb-77b9-4a9f-b3c7-986f9a0592d1,71ab8cea-7131-49cb-a85b-d6de056592ab,315.0,Adjuvant,273.0,2023-07-13T10:35:44.371881-05:00,HCM-WCMC-0502-C15_treatment10,9366b705-71f6-4ab0-b3ef-54c8fd33bd03,,released,Paclitaxel,1,2023-02-27T12:15:10.249107-06:00,Chemotherapy,Residual Disease,
HCM-WCMC-0502-C15,18d012fb-77b9-4a9f-b3c7-986f9a0592d1,71ab8cea-7131-49cb-a85b-d6de056592ab,253.0,Adjuvant,34.0,2023-07-13T10:35:44.371881-05:00,HCM-WCMC-0502-C15_treatment7,9cb797d8-97aa-480b-a932-1fb226ea5cf7,,released,Fluorouracil,1,2023-02-27T12:15:10.249107-06:00,Chemotherapy,Residual Disease,
HCM-WCMC-0502-C15,18d012fb-77b9-4a9f-b3c7-986f9a0592d1,71ab8cea-7131-49cb-a85b-d6de056592ab,,Neoadjuvant,34.0,2023-07-13T10:35:44.371881-05:00,HCM-WCMC-0502-C15_treatment5,9d28bfe7-1b8f-4eab-9e93-0ba06a0044ee,,released,,1,2023-02-27T12:15:10.249107-06:00,Targeted Molecular Therapy,,
HCM-WCMC-0502-C15,18d012fb-77b9-4a9f-b3c7-986f9a0592d1,71ab8cea-7131-49cb-a85b-d6de056592ab,,Adjuvant,,2023-07-13T10:35:44.371881-05:00,HCM-WCMC-0502-C15_treatment11,acb51489-97a8-4197-9121-3788dea0faad,,released,,0,2023-02-27T12:15:10.249107-06:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-WCMC-0502-C15,18d012fb-77b9-4a9f-b3c7-986f9a0592d1,71ab8cea-7131-49cb-a85b-d6de056592ab,,Neoadjuvant,34.0,2023-07-13T10:35:44.371881-05:00,HCM-WCMC-0502-C15_treatment,c488d0d6-be9d-4dad-9a8d-484fe691dedb,,released,Leucovorin Calcium,1,2023-02-27T12:15:10.249107-06:00,Chemotherapy,,
HCM-WCMC-0502-C15,18d012fb-77b9-4a9f-b3c7-986f9a0592d1,71ab8cea-7131-49cb-a85b-d6de056592ab,253.0,Adjuvant,34.0,2023-07-13T10:35:44.371881-05:00,HCM-WCMC-0502-C15_treatment9,e0cbfed6-7cbb-4340-858f-9dae489b604a,,released,,1,2023-02-27T12:15:10.249107-06:00,Chemotherapy,Residual Disease,FOLFOX
HCM-WCMC-0502-C15,18d012fb-77b9-4a9f-b3c7-986f9a0592d1,71ab8cea-7131-49cb-a85b-d6de056592ab,253.0,Adjuvant,34.0,2023-07-13T10:35:44.371881-05:00,HCM-WCMC-0502-C15_treatment8,f5e6c796-b340-4dfd-b32a-cfcde0bd9666,,released,Oxaliplatin,1,2023-02-27T12:15:10.249107-06:00,Chemotherapy,Residual Disease,
HCM-WCMC-0502-C15,18d012fb-77b9-4a9f-b3c7-986f9a0592d1,71ab8cea-7131-49cb-a85b-d6de056592ab,315.0,Adjuvant,273.0,2023-07-13T10:35:44.371881-05:00,HCM-WCMC-0502-C15_treatment14,fea92f89-4342-44ce-9c6e-d8fe5393bce7,,released,Ramucirumab,1,2023-02-27T12:15:10.249107-06:00,Targeted Molecular Therapy,Residual Disease,
HCM-BROD-0829-C71,18eab58c-ac14-4f6a-a30a-2c05134a2a46,ae09717d-8154-4e6e-85d0-2548d1d624be,409.0,Adjuvant,307.0,2023-11-07T14:20:00.017270-06:00,HCM-BROD-0829-C71_treatment6,192cdcd7-cde2-4798-84b8-2ea72cc5fff5,,released,Bevacizumab,1,2021-12-21T13:54:13.466196-06:00,Targeted Molecular Therapy,Residual Disease,
HCM-BROD-0829-C71,18eab58c-ac14-4f6a-a30a-2c05134a2a46,ae09717d-8154-4e6e-85d0-2548d1d624be,,Adjuvant,,2023-11-07T14:20:00.017270-06:00,HCM-BROD-0829-C71_treatment4,2170c9ca-a235-45a4-8e22-4fb09743e72d,,released,,0,2021-12-21T13:54:13.466196-06:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-BROD-0829-C71,18eab58c-ac14-4f6a-a30a-2c05134a2a46,ae09717d-8154-4e6e-85d0-2548d1d624be,297.0,Adjuvant,10.0,2023-11-07T14:20:00.017270-06:00,HCM-BROD-0829-C71_treatment3,23bef5c0-e9c8-4afc-aeba-5de5a8b5ab76,,released,Temozolomide,1,2021-12-21T13:54:13.466196-06:00,Chemotherapy,Residual Disease,
HCM-BROD-0829-C71,18eab58c-ac14-4f6a-a30a-2c05134a2a46,ae09717d-8154-4e6e-85d0-2548d1d624be,,,0.0,2023-11-07T14:20:00.017270-06:00,HCM-BROD-0829-C71_treatment5,2dbbf65c-06b1-4120-acd2-b107da433c4c,,released,,1,2021-12-21T13:54:13.466196-06:00,"Surgery, NOS",Initial Diagnosis,
HCM-BROD-0829-C71,18eab58c-ac14-4f6a-a30a-2c05134a2a46,ae09717d-8154-4e6e-85d0-2548d1d624be,307.0,Adjuvant,307.0,2023-11-07T14:20:00.017270-06:00,HCM-BROD-0829-C71_treatment2,622072e3-7d62-45fb-b87b-c710987f8894,,released,Lomustine,1,2021-12-21T13:54:13.466196-06:00,Chemotherapy,Residual Disease,
HCM-BROD-0829-C71,18eab58c-ac14-4f6a-a30a-2c05134a2a46,ae09717d-8154-4e6e-85d0-2548d1d624be,,Neoadjuvant,,2023-11-07T14:20:00.017270-06:00,HCM-BROD-0829-C71_treatment,f79da244-0202-4d63-b10d-d99aa0805dc8,,released,,0,2021-12-21T13:54:13.466196-06:00,,,
HCM-BROD-0829-C71,18eab58c-ac14-4f6a-a30a-2c05134a2a46,ae09717d-8154-4e6e-85d0-2548d1d624be,61.0,Adjuvant,10.0,2023-11-07T14:20:00.017270-06:00,HCM-BROD-0829-C71_treatment7,f7e4e301-8bdb-4af2-b2b3-66f97e10b0f9,,released,,1,2021-12-21T13:54:13.466196-06:00,"Radiation, 2D Conventional",Residual Disease,
HCM-BROD-0564-C71,19252fcc-76e8-4072-aebe-ce8845771090,7a3821f8-ed7c-4bba-b47b-a5b3b5380b39,,Adjuvant,,2023-02-22T07:39:25.979291-06:00,HCM-BROD-0564-C71_treatment7,2c0a220d-e3c7-4738-955c-82c3c9d8aa48,,released,,1,2020-07-31T09:31:26.101160-05:00,"Radiation Therapy, NOS",Residual Disease,
HCM-BROD-0564-C71,19252fcc-76e8-4072-aebe-ce8845771090,7a3821f8-ed7c-4bba-b47b-a5b3b5380b39,,Neoadjuvant,90.0,2023-02-22T07:39:25.979291-06:00,HCM-BROD-0564-C71_treatment2,48b0f6a9-30a7-46e5-9d37-886b80cb5d37,,released,,1,2020-07-31T09:31:26.101160-05:00,"Radiation Therapy, NOS",,
HCM-BROD-0564-C71,19252fcc-76e8-4072-aebe-ce8845771090,7a3821f8-ed7c-4bba-b47b-a5b3b5380b39,,Adjuvant,,2023-02-22T07:39:25.979291-06:00,HCM-BROD-0564-C71_treatment6,b2adb415-6459-4b2c-b126-c1345697244a,,released,,unknown,2020-07-31T09:31:26.101160-05:00,Targeted Molecular Therapy,Residual Disease,
HCM-BROD-0564-C71,19252fcc-76e8-4072-aebe-ce8845771090,7a3821f8-ed7c-4bba-b47b-a5b3b5380b39,,,0.0,2023-02-27T12:58:27.903823-06:00,HCM-BROD-0564-C71_treatment5,c9ab2e5b-857f-4a90-ac59-4c018202cf21,,released,,1,2020-07-31T09:31:26.101160-05:00,"Surgery, NOS",Initial Diagnosis,
HCM-BROD-0564-C71,19252fcc-76e8-4072-aebe-ce8845771090,7a3821f8-ed7c-4bba-b47b-a5b3b5380b39,,Adjuvant,,2023-02-22T07:39:25.979291-06:00,HCM-BROD-0564-C71_treatment4,ca48a5af-eb2d-4090-b275-4a31884e98ce,,released,,unknown,2020-07-31T09:31:26.101160-05:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-BROD-0564-C71,19252fcc-76e8-4072-aebe-ce8845771090,7a3821f8-ed7c-4bba-b47b-a5b3b5380b39,,Adjuvant,,2023-02-22T07:39:25.979291-06:00,HCM-BROD-0564-C71_treatment3,f1eca7df-33cf-42d3-ba76-4034abe405e0,,released,,unknown,2020-07-31T09:31:26.101160-05:00,Chemotherapy,Residual Disease,
HCM-BROD-0564-C71,19252fcc-76e8-4072-aebe-ce8845771090,7a3821f8-ed7c-4bba-b47b-a5b3b5380b39,,Neoadjuvant,82.0,2023-02-22T07:39:25.979291-06:00,HCM-BROD-0564-C71_treatment,f9386dba-5fc4-42df-87b7-a5e279f3cc89,,released,Temozolomide,1,2020-07-31T09:31:26.101160-05:00,Chemotherapy,,
HCM-SANG-0299-C15,19b1e69a-355a-4dd7-9c56-d701f6c2c5a0,c1a6f70f-b871-4b4e-a292-aef67c2d4776,,Neoadjuvant,,2023-03-13T13:20:58.494686-05:00,HCM-SANG-0299-C15_treatment,de0c16ce-c9bb-4304-b1fe-dfa68060c598,,released,,0,2021-12-21T15:09:13.654991-06:00,,,
HCM-CSHL-0081-C25,19f1d344-4c14-4733-abbd-c2db6737e210,c1cca3a7-e0ac-40a1-9db7-6902b48d3c62,,Adjuvant,43.0,2023-02-22T07:39:25.979291-06:00,HCM-CSHL-0081-C25_treatment3,2812a954-8977-4cb1-b38d-1320c9321643,,released,Nab-paclitaxel,1,2020-09-27T12:48:03.448906-05:00,Chemotherapy,Residual Disease,
HCM-CSHL-0081-C25,19f1d344-4c14-4733-abbd-c2db6737e210,c1cca3a7-e0ac-40a1-9db7-6902b48d3c62,,Adjuvant,,2023-02-22T07:39:25.979291-06:00,HCM-CSHL-0081-C25_treatment9,2de06f30-7300-417b-9e54-b3dbe81f8b02,,released,,0,2020-09-27T12:48:03.448906-05:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-CSHL-0081-C25,19f1d344-4c14-4733-abbd-c2db6737e210,c1cca3a7-e0ac-40a1-9db7-6902b48d3c62,188.0,Adjuvant,,2023-02-22T07:39:25.979291-06:00,HCM-CSHL-0081-C25_treatment6,4c5349b0-3d48-48d8-8e3a-84dda4456bdd,,released,Fluorouracil,1,2020-09-27T12:48:03.448906-05:00,Chemotherapy,Residual Disease,
HCM-CSHL-0081-C25,19f1d344-4c14-4733-abbd-c2db6737e210,c1cca3a7-e0ac-40a1-9db7-6902b48d3c62,,,-5.0,2023-02-27T11:47:19.767665-06:00,HCM-CSHL-0081-C25_treatment10,6a959097-6e20-4b0c-a353-2b7f60403779,,released,,1,2020-09-27T12:48:03.448906-05:00,"Surgery, NOS",Initial Diagnosis,
HCM-CSHL-0081-C25,19f1d344-4c14-4733-abbd-c2db6737e210,c1cca3a7-e0ac-40a1-9db7-6902b48d3c62,,Adjuvant,43.0,2023-02-22T07:39:25.979291-06:00,HCM-CSHL-0081-C25_treatment2,72f0330b-d588-490f-b0d7-a17eff69dfe3,,released,Gemcitabine,1,2020-09-27T12:48:03.448906-05:00,Chemotherapy,Residual Disease,
HCM-CSHL-0081-C25,19f1d344-4c14-4733-abbd-c2db6737e210,c1cca3a7-e0ac-40a1-9db7-6902b48d3c62,,Adjuvant,,2023-02-22T07:39:25.979291-06:00,HCM-CSHL-0081-C25_treatment12,7fe73c39-4d46-4ad6-b9f0-dee5cb0fbdac,,released,,0,2020-09-27T12:48:03.448906-05:00,"Radiation Therapy, NOS",Residual Disease,
HCM-CSHL-0081-C25,19f1d344-4c14-4733-abbd-c2db6737e210,c1cca3a7-e0ac-40a1-9db7-6902b48d3c62,,Neoadjuvant,,2023-02-22T07:39:25.979291-06:00,HCM-CSHL-0081-C25_treatment,b972799b-7423-4953-a4a3-e9216cc91c74,,released,,0,2020-09-27T12:48:03.448906-05:00,,,
HCM-CSHL-0081-C25,19f1d344-4c14-4733-abbd-c2db6737e210,c1cca3a7-e0ac-40a1-9db7-6902b48d3c62,188.0,Adjuvant,,2023-02-22T07:39:25.979291-06:00,HCM-CSHL-0081-C25_treatment5,bd7970bb-f093-4ffd-a3d3-5e4e5e803e13,,released,Leucovorin Calcium,1,2020-09-27T12:48:03.448906-05:00,Chemotherapy,Residual Disease,
HCM-CSHL-0081-C25,19f1d344-4c14-4733-abbd-c2db6737e210,c1cca3a7-e0ac-40a1-9db7-6902b48d3c62,188.0,Adjuvant,,2023-02-22T07:39:25.979291-06:00,HCM-CSHL-0081-C25_treatment4,cea2bd57-fa6e-4994-8bed-846dc8337040,,released,Irinotecan Hydrochloride,1,2020-09-27T12:48:03.448906-05:00,Chemotherapy,Residual Disease,
HCM-CSHL-0081-C25,19f1d344-4c14-4733-abbd-c2db6737e210,c1cca3a7-e0ac-40a1-9db7-6902b48d3c62,188.0,Adjuvant,,2023-02-22T07:39:25.979291-06:00,HCM-CSHL-0081-C25_treatment8,d0ee8dc8-8278-4136-914f-d9c6770f6965,,released,,1,2020-09-27T12:48:03.448906-05:00,Chemotherapy,Residual Disease,FOLFIRINOX
HCM-CSHL-0081-C25,19f1d344-4c14-4733-abbd-c2db6737e210,c1cca3a7-e0ac-40a1-9db7-6902b48d3c62,188.0,Adjuvant,,2023-02-22T07:39:25.979291-06:00,HCM-CSHL-0081-C25_treatment7,d7693755-5f57-4ccf-a8c1-be332e885f43,,released,Oxaliplatin,1,2020-09-27T12:48:03.448906-05:00,Chemotherapy,Residual Disease,
HCM-CSHL-0081-C25,19f1d344-4c14-4733-abbd-c2db6737e210,c1cca3a7-e0ac-40a1-9db7-6902b48d3c62,,Adjuvant,,2023-02-22T07:39:25.979291-06:00,HCM-CSHL-0081-C25_treatment11,fe99547d-8570-4d84-8baa-dfc6867acd8f,,released,,0,2020-09-27T12:48:03.448906-05:00,Targeted Molecular Therapy,Residual Disease,
HCM-BROD-0103-C71,1aad065b-567d-4f08-9cf0-bcc57e8ef496,f9689239-d224-4a99-a094-c81db1714640,,,0.0,2023-02-27T13:07:49.929552-06:00,HCM-BROD-0103-C71_treatment4,486decc8-8839-46f8-a7ff-812b7a26d32d,,released,,1,2020-04-21T14:48:23.815762-05:00,"Surgery, NOS",Initial Diagnosis,
HCM-BROD-0103-C71,1aad065b-567d-4f08-9cf0-bcc57e8ef496,f9689239-d224-4a99-a094-c81db1714640,,Neoadjuvant,,2021-01-06T22:55:10.531130-06:00,HCM-BROD-0103-C71_treatment,5fe08f9b-124d-494f-82aa-89e94ff8efe7,,released,,0,2019-04-04T14:46:12.859480-05:00,,,
HCM-BROD-0103-C71,1aad065b-567d-4f08-9cf0-bcc57e8ef496,f9689239-d224-4a99-a094-c81db1714640,226.0,Adjuvant,134.0,2021-01-06T22:55:10.531130-06:00,HCM-BROD-0103-C71_treatment5,61a2ac5f-263d-44b2-842e-2db462e75d28,,released,Bevacizumab,1,2020-04-21T14:48:23.815762-05:00,Targeted Molecular Therapy,Residual Disease,
HCM-BROD-0103-C71,1aad065b-567d-4f08-9cf0-bcc57e8ef496,f9689239-d224-4a99-a094-c81db1714640,92.0,Adjuvant,50.0,2021-01-06T22:55:10.531130-06:00,HCM-BROD-0103-C71_treatment6,ca4f5702-39eb-4b7c-8ef4-f90f54e2f394,,released,,1,2020-04-21T14:48:23.815762-05:00,"Radiation, Proton Beam",Residual Disease,
HCM-BROD-0103-C71,1aad065b-567d-4f08-9cf0-bcc57e8ef496,f9689239-d224-4a99-a094-c81db1714640,,Adjuvant,,2021-01-06T22:55:10.531130-06:00,HCM-BROD-0103-C71_treatment2,e570fed4-624e-411e-84fd-901cb002ab92,,released,,0,2020-04-21T14:48:23.815762-05:00,Chemotherapy,Residual Disease,
HCM-BROD-0103-C71,1aad065b-567d-4f08-9cf0-bcc57e8ef496,f9689239-d224-4a99-a094-c81db1714640,226.0,Adjuvant,134.0,2021-01-06T22:55:10.531130-06:00,HCM-BROD-0103-C71_treatment3,e7429dd5-5250-488d-8bda-6e23992c3c9c,,released,Pembrolizumab,1,2020-04-21T14:48:23.815762-05:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-BROD-0231-C25,1ae8657f-477f-4e1a-aef2-dd1c1ab5f26a,6c563424-6cf6-4a5f-9615-46f87b430169,,Adjuvant,,2023-02-22T07:39:25.979291-06:00,HCM-BROD-0231-C25_treatment10,1bccc7bd-9805-4de0-9aed-c1030a5f6297,,released,,0,2020-09-17T16:08:31.238891-05:00,"Radiation Therapy, NOS",Residual Disease,
HCM-BROD-0231-C25,1ae8657f-477f-4e1a-aef2-dd1c1ab5f26a,6c563424-6cf6-4a5f-9615-46f87b430169,54.0,Adjuvant,12.0,2023-02-22T07:39:25.979291-06:00,HCM-BROD-0231-C25_treatment2,281e85da-1443-4505-bf83-40d9c707acfb,,released,Irinotecan Hydrochloride,1,2020-09-17T16:08:31.238891-05:00,Chemotherapy,Residual Disease,
HCM-BROD-0231-C25,1ae8657f-477f-4e1a-aef2-dd1c1ab5f26a,6c563424-6cf6-4a5f-9615-46f87b430169,,Neoadjuvant,,2023-02-22T07:39:25.979291-06:00,HCM-BROD-0231-C25_treatment,28c0471f-1e19-43e9-a377-addeaf079304,,released,,0,2020-09-17T16:08:31.238891-05:00,,,
HCM-BROD-0231-C25,1ae8657f-477f-4e1a-aef2-dd1c1ab5f26a,6c563424-6cf6-4a5f-9615-46f87b430169,,Adjuvant,,2023-02-22T07:39:25.979291-06:00,HCM-BROD-0231-C25_treatment9,46b18ed9-81e4-48c7-a668-aa8f4d2f18ba,,released,,0,2020-09-17T16:08:31.238891-05:00,Targeted Molecular Therapy,Residual Disease,
HCM-BROD-0231-C25,1ae8657f-477f-4e1a-aef2-dd1c1ab5f26a,6c563424-6cf6-4a5f-9615-46f87b430169,54.0,Adjuvant,12.0,2023-02-22T07:39:25.979291-06:00,HCM-BROD-0231-C25_treatment5,4a8710fa-143f-4656-a589-370a4842f60f,,released,Oxaliplatin,1,2020-09-17T16:08:31.238891-05:00,Chemotherapy,Residual Disease,
HCM-BROD-0231-C25,1ae8657f-477f-4e1a-aef2-dd1c1ab5f26a,6c563424-6cf6-4a5f-9615-46f87b430169,,,,2023-02-27T11:44:29.151934-06:00,HCM-BROD-0231-C25_treatment8,61ceddf6-7e0d-481a-bc75-d1b365b17c2f,,released,,0,2020-09-17T16:08:31.238891-05:00,"Surgery, NOS",Initial Diagnosis,
HCM-BROD-0231-C25,1ae8657f-477f-4e1a-aef2-dd1c1ab5f26a,6c563424-6cf6-4a5f-9615-46f87b430169,180.0,Adjuvant,137.0,2023-02-22T07:39:25.979291-06:00,HCM-BROD-0231-C25_treatment7,8a9662a9-bc72-4006-b2af-6580f49b00dc,,released,Trametinib,1,2020-09-17T16:08:31.238891-05:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-BROD-0231-C25,1ae8657f-477f-4e1a-aef2-dd1c1ab5f26a,6c563424-6cf6-4a5f-9615-46f87b430169,54.0,Adjuvant,12.0,2023-02-22T07:39:25.979291-06:00,HCM-BROD-0231-C25_treatment6,dbdb1a46-0e86-4d43-b3bd-242811b29a48,,released,,1,2020-09-17T16:08:31.238891-05:00,Chemotherapy,Residual Disease,FOLFIRINOX
HCM-BROD-0231-C25,1ae8657f-477f-4e1a-aef2-dd1c1ab5f26a,6c563424-6cf6-4a5f-9615-46f87b430169,54.0,Adjuvant,12.0,2023-02-22T07:39:25.979291-06:00,HCM-BROD-0231-C25_treatment4,e31a80d3-0152-4ed0-be86-c45790a9b284,,released,Fluorouracil,1,2020-09-17T16:08:31.238891-05:00,Chemotherapy,Residual Disease,
HCM-BROD-0231-C25,1ae8657f-477f-4e1a-aef2-dd1c1ab5f26a,6c563424-6cf6-4a5f-9615-46f87b430169,54.0,Adjuvant,12.0,2023-02-22T07:39:25.979291-06:00,HCM-BROD-0231-C25_treatment3,fb3c6e6b-a426-4fe3-b8fe-5aefc7832bb5,,released,Leucovorin Calcium,1,2020-09-17T16:08:31.238891-05:00,Chemotherapy,Residual Disease,
HCM-BROD-0745-C43,1afc9344-bb0c-4074-a7d8-dc941a47266d,60a1174e-2822-47cf-afec-6be5a3fcdb4a,,Adjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0745-C43_treatment3,20907ca2-47fa-4d8c-830d-923d40e5bcf7,,released,,0,2021-12-21T13:48:54.827002-06:00,Hormone Therapy,Residual Disease,
HCM-BROD-0745-C43,1afc9344-bb0c-4074-a7d8-dc941a47266d,60a1174e-2822-47cf-afec-6be5a3fcdb4a,141.0,Adjuvant,78.0,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0745-C43_treatment4,6622fb34-c93a-422e-aba5-21d15ac9db1e,,released,Pembrolizumab,1,2021-12-21T13:48:54.827002-06:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-BROD-0745-C43,1afc9344-bb0c-4074-a7d8-dc941a47266d,60a1174e-2822-47cf-afec-6be5a3fcdb4a,148.0,Adjuvant,148.0,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0745-C43_treatment5,6ada17ed-85ad-4045-b6c8-9d8a9331247c,,released,Nivolumab,1,2021-12-21T13:48:54.827002-06:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-BROD-0745-C43,1afc9344-bb0c-4074-a7d8-dc941a47266d,60a1174e-2822-47cf-afec-6be5a3fcdb4a,526.0,Adjuvant,186.0,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0745-C43_treatment9,7093bfbf-3957-4437-b29e-0659be6efc5b,,released,Binimetinib,1,2021-12-21T13:48:54.827002-06:00,Targeted Molecular Therapy,Residual Disease,
HCM-BROD-0745-C43,1afc9344-bb0c-4074-a7d8-dc941a47266d,60a1174e-2822-47cf-afec-6be5a3fcdb4a,526.0,Adjuvant,186.0,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0745-C43_treatment8,7bff4ed3-4818-4b59-abb4-546b0b8098d0,,released,Encorafenib,1,2021-12-21T13:48:54.827002-06:00,Targeted Molecular Therapy,Residual Disease,
HCM-BROD-0745-C43,1afc9344-bb0c-4074-a7d8-dc941a47266d,60a1174e-2822-47cf-afec-6be5a3fcdb4a,,,4.0,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0745-C43_treatment7,a1c83b7b-df1e-472b-a5bd-eecc3e0c1b52,,released,,1,2021-12-21T13:48:54.827002-06:00,"Surgery, NOS",Initial Diagnosis,
HCM-BROD-0745-C43,1afc9344-bb0c-4074-a7d8-dc941a47266d,60a1174e-2822-47cf-afec-6be5a3fcdb4a,,Adjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0745-C43_treatment2,b01c8647-95c0-47eb-ad24-8799c38dea21,,released,,0,2021-12-21T13:48:54.827002-06:00,Chemotherapy,Residual Disease,
HCM-BROD-0745-C43,1afc9344-bb0c-4074-a7d8-dc941a47266d,60a1174e-2822-47cf-afec-6be5a3fcdb4a,148.0,Adjuvant,148.0,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0745-C43_treatment6,c929ff44-f5a9-4416-9f9c-429f47bb88f3,,released,Ipilimumab,1,2021-12-21T13:48:54.827002-06:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-BROD-0745-C43,1afc9344-bb0c-4074-a7d8-dc941a47266d,60a1174e-2822-47cf-afec-6be5a3fcdb4a,,Adjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0745-C43_treatment10,d16cd1d9-30e5-49d3-9462-196114ba5f30,,released,,0,2021-12-21T13:48:54.827002-06:00,"Radiation Therapy, NOS",Residual Disease,
HCM-BROD-0745-C43,1afc9344-bb0c-4074-a7d8-dc941a47266d,60a1174e-2822-47cf-afec-6be5a3fcdb4a,,Neoadjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0745-C43_treatment,ed88cb11-9abc-41a1-9eb4-59e091669586,,released,,0,2021-12-21T13:48:54.827002-06:00,,,
HCM-CSHL-0584-C19,1b6aad54-f571-4cb0-bce2-a79447b9bb64,8b9619da-f859-4d40-bf50-98f24c681106,,Adjuvant,290.0,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0584-C19_treatment14,020b9336-dfe0-4cca-ab52-7c3101ee4273,,released,Bevacizumab,1,2024-06-12T17:45:48.543879-05:00,Targeted Molecular Therapy,Residual Disease,
HCM-CSHL-0584-C19,1b6aad54-f571-4cb0-bce2-a79447b9bb64,8b9619da-f859-4d40-bf50-98f24c681106,136.0,Adjuvant,71.0,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0584-C19_treatment4,06259d2d-20f7-4f18-b279-d5d4b63f9ab3,,released,Fluorouracil,1,2021-12-21T14:08:49.042087-06:00,Chemotherapy,Residual Disease,
HCM-CSHL-0584-C19,1b6aad54-f571-4cb0-bce2-a79447b9bb64,8b9619da-f859-4d40-bf50-98f24c681106,,Adjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0584-C19_treatment11,07c0fcac-618c-456a-a90b-bf11f5f5126d,,released,,0,2024-06-12T17:45:48.543879-05:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-CSHL-0584-C19,1b6aad54-f571-4cb0-bce2-a79447b9bb64,8b9619da-f859-4d40-bf50-98f24c681106,,,178.0,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0584-C19_treatment13,0ed63cec-8cfd-4d0c-9edf-151039d7f921,,released,,1,2024-06-12T17:45:48.543879-05:00,"Surgery, NOS",Initial Diagnosis,
HCM-CSHL-0584-C19,1b6aad54-f571-4cb0-bce2-a79447b9bb64,8b9619da-f859-4d40-bf50-98f24c681106,,Adjuvant,290.0,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0584-C19_treatment10,1d98cd07-72c6-4f77-b56b-6540b892679d,,released,,1,2021-12-21T14:08:49.042087-06:00,Chemotherapy,Residual Disease,FOLFOX
HCM-CSHL-0584-C19,1b6aad54-f571-4cb0-bce2-a79447b9bb64,8b9619da-f859-4d40-bf50-98f24c681106,,Adjuvant,290.0,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0584-C19_treatment8,358e4a8a-1358-4c52-a632-b4b6b99e1bcd,,released,Fluorouracil,1,2021-12-21T14:08:49.042087-06:00,Chemotherapy,Residual Disease,
HCM-CSHL-0584-C19,1b6aad54-f571-4cb0-bce2-a79447b9bb64,8b9619da-f859-4d40-bf50-98f24c681106,136.0,Adjuvant,71.0,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0584-C19_treatment5,409840e7-5dfd-4980-9e24-57d281e6efab,,released,Oxaliplatin,1,2021-12-21T14:08:49.042087-06:00,Chemotherapy,Residual Disease,
HCM-CSHL-0584-C19,1b6aad54-f571-4cb0-bce2-a79447b9bb64,8b9619da-f859-4d40-bf50-98f24c681106,,Neoadjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0584-C19_treatment,496a3552-6b53-46d0-b580-efcd583b2bd9,,released,,unknown,2021-12-21T14:08:49.042087-06:00,"Pharmaceutical Therapy, NOS",,
HCM-CSHL-0584-C19,1b6aad54-f571-4cb0-bce2-a79447b9bb64,8b9619da-f859-4d40-bf50-98f24c681106,,,6.0,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0584-C19_treatment12,6a969c01-0389-4320-bc29-6c0e440c4944,,released,,1,2024-06-12T17:45:48.543879-05:00,"Surgery, NOS",Initial Diagnosis,
HCM-CSHL-0584-C19,1b6aad54-f571-4cb0-bce2-a79447b9bb64,8b9619da-f859-4d40-bf50-98f24c681106,,Neoadjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0584-C19_treatment2,70d3a789-2a49-4f5f-8122-bffd9b50d7b4,,released,,unknown,2021-12-21T14:08:49.042087-06:00,"Radiation Therapy, NOS",,
HCM-CSHL-0584-C19,1b6aad54-f571-4cb0-bce2-a79447b9bb64,8b9619da-f859-4d40-bf50-98f24c681106,,Adjuvant,290.0,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0584-C19_treatment7,790ade68-52e1-454b-8e55-b482fb0e55fe,,released,Leucovorin Calcium,1,2021-12-21T14:08:49.042087-06:00,Chemotherapy,Residual Disease,
HCM-CSHL-0584-C19,1b6aad54-f571-4cb0-bce2-a79447b9bb64,8b9619da-f859-4d40-bf50-98f24c681106,136.0,Adjuvant,71.0,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0584-C19_treatment6,86c3938f-e644-48f3-9909-2842ebf0464d,,released,,1,2021-12-21T14:08:49.042087-06:00,Chemotherapy,Residual Disease,FOLFOX
HCM-CSHL-0584-C19,1b6aad54-f571-4cb0-bce2-a79447b9bb64,8b9619da-f859-4d40-bf50-98f24c681106,,Adjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0584-C19_treatment15,8a38a04b-0c36-4f6a-8195-e02356ca7172,,released,,0,2024-06-12T17:45:48.543879-05:00,"Radiation Therapy, NOS",Residual Disease,
HCM-CSHL-0584-C19,1b6aad54-f571-4cb0-bce2-a79447b9bb64,8b9619da-f859-4d40-bf50-98f24c681106,136.0,Adjuvant,71.0,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0584-C19_treatment3,ea23e7dc-bbce-446e-8132-7a9635281f69,,released,Leucovorin Calcium,1,2021-12-21T14:08:49.042087-06:00,Chemotherapy,Residual Disease,
HCM-CSHL-0584-C19,1b6aad54-f571-4cb0-bce2-a79447b9bb64,8b9619da-f859-4d40-bf50-98f24c681106,,Adjuvant,290.0,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0584-C19_treatment9,fefd5119-901e-44f9-9c3a-f298e6b56480,,released,Oxaliplatin,1,2021-12-21T14:08:49.042087-06:00,Chemotherapy,Residual Disease,
HCM-CSHL-0584-C19,1b6aad54-f571-4cb0-bce2-a79447b9bb64,91caed88-500c-44dc-bed3-352fdf8771db,,Maintenance Therapy,,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0584-C19_treatment18,2021d392-f299-4aaa-b607-0e1b3e25568b,Progressive Disease,released,Oxaliplatin,1,2024-06-12T17:45:48.543879-05:00,,,
HCM-CSHL-0584-C19,1b6aad54-f571-4cb0-bce2-a79447b9bb64,91caed88-500c-44dc-bed3-352fdf8771db,,Maintenance Therapy,,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0584-C19_treatment19,6a0a994f-ece8-4767-be2a-80daa7dd60a4,Progressive Disease,released,,1,2024-06-12T17:45:48.543879-05:00,,,FOLFOX
HCM-CSHL-0584-C19,1b6aad54-f571-4cb0-bce2-a79447b9bb64,91caed88-500c-44dc-bed3-352fdf8771db,,Maintenance Therapy,,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0584-C19_treatment17,9a8a6efb-4b05-4aed-8347-b0d00a7fcf7f,Progressive Disease,released,Fluorouracil,1,2024-06-12T17:45:48.543879-05:00,,,
HCM-CSHL-0584-C19,1b6aad54-f571-4cb0-bce2-a79447b9bb64,91caed88-500c-44dc-bed3-352fdf8771db,,Maintenance Therapy,,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0584-C19_treatment16,f83d37bc-cdab-44de-859f-c05a0b43ac14,Progressive Disease,released,Leucovorin Calcium,1,2024-06-12T17:45:48.543879-05:00,,,
HCM-CSHL-0818-C56,1bfa0189-6e43-4d76-928c-026673ec775e,f411b58c-7dc2-40af-ac55-5e21a2391029,,,12.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0818-C56_treatment6,135ce18d-4312-466a-89da-93eb4500cb38,,released,,1,2021-12-21T14:29:33.343810-06:00,"Surgery, NOS",Initial Diagnosis,
HCM-CSHL-0818-C56,1bfa0189-6e43-4d76-928c-026673ec775e,f411b58c-7dc2-40af-ac55-5e21a2391029,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0818-C56_treatment5,18d3d786-ce47-4ddb-ab49-b1ec7bee583f,,released,,0,2021-12-21T14:29:33.343810-06:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-CSHL-0818-C56,1bfa0189-6e43-4d76-928c-026673ec775e,f411b58c-7dc2-40af-ac55-5e21a2391029,,Neoadjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0818-C56_treatment,360343d8-a35d-4803-8754-085d80585acf,,released,,0,2021-12-21T14:29:33.343810-06:00,,,
HCM-CSHL-0818-C56,1bfa0189-6e43-4d76-928c-026673ec775e,f411b58c-7dc2-40af-ac55-5e21a2391029,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0818-C56_treatment8,65a39ccc-ede8-4996-bbc6-739129e18dd1,,released,,0,2021-12-21T14:29:33.343810-06:00,"Radiation Therapy, NOS",Residual Disease,
HCM-CSHL-0818-C56,1bfa0189-6e43-4d76-928c-026673ec775e,f411b58c-7dc2-40af-ac55-5e21a2391029,145.0,Adjuvant,33.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0818-C56_treatment2,7be2aecd-e640-4c91-b6c6-86bb54b4d8d6,,released,Cisplatin,1,2021-12-21T14:29:33.343810-06:00,Chemotherapy,Residual Disease,
HCM-CSHL-0818-C56,1bfa0189-6e43-4d76-928c-026673ec775e,f411b58c-7dc2-40af-ac55-5e21a2391029,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0818-C56_treatment4,97696191-d2e9-4d79-9fb9-c08c8682f3f6,,released,,0,2021-12-21T14:29:33.343810-06:00,Hormone Therapy,Residual Disease,
HCM-CSHL-0818-C56,1bfa0189-6e43-4d76-928c-026673ec775e,f411b58c-7dc2-40af-ac55-5e21a2391029,145.0,Adjuvant,33.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0818-C56_treatment3,c66519c8-b03f-477d-922c-730ca9698ce6,,released,Paclitaxel,1,2021-12-21T14:29:33.343810-06:00,Chemotherapy,Residual Disease,
HCM-CSHL-0818-C56,1bfa0189-6e43-4d76-928c-026673ec775e,f411b58c-7dc2-40af-ac55-5e21a2391029,,Adjuvant,181.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0818-C56_treatment7,d10d3c22-43af-41f8-b8e6-d5f81946118c,Treatment Ongoing,released,Niraparib,1,2021-12-21T14:29:33.343810-06:00,Targeted Molecular Therapy,Residual Disease,
HCM-BROD-0643-C43,1c54d889-a752-4025-90ce-af896cdb95d4,379deec7-50a8-4219-9bd2-1737e7908d50,,,0.0,2023-02-27T11:45:06.247824-06:00,HCM-BROD-0643-C43_treatment5,4eb8991d-f7ea-4b0f-9595-ba648630889b,,released,,1,2021-09-07T12:03:47.327892-05:00,"Surgery, NOS",Initial Diagnosis,
HCM-BROD-0643-C43,1c54d889-a752-4025-90ce-af896cdb95d4,379deec7-50a8-4219-9bd2-1737e7908d50,,Adjuvant,,2021-09-10T10:36:37.981324-05:00,HCM-BROD-0643-C43_treatment7,5e2133f5-e611-4218-b7fd-aaa15694905f,,released,,0,2021-09-07T12:03:47.327892-05:00,"Radiation Therapy, NOS",Residual Disease,
HCM-BROD-0643-C43,1c54d889-a752-4025-90ce-af896cdb95d4,379deec7-50a8-4219-9bd2-1737e7908d50,,Adjuvant,,2021-09-10T10:36:37.981324-05:00,HCM-BROD-0643-C43_treatment2,603f7ab7-d1aa-47fa-a7a0-47bc71177a9b,,released,,0,2021-09-07T12:03:47.327892-05:00,Chemotherapy,Residual Disease,
HCM-BROD-0643-C43,1c54d889-a752-4025-90ce-af896cdb95d4,379deec7-50a8-4219-9bd2-1737e7908d50,,Neoadjuvant,,2021-03-11T14:53:13.958052-06:00,HCM-BROD-0643-C43_treatment,83598b19-b0eb-4f35-9be8-91bdb9674e85,,released,,0,2021-03-11T14:33:32.013919-06:00,,,
HCM-BROD-0643-C43,1c54d889-a752-4025-90ce-af896cdb95d4,379deec7-50a8-4219-9bd2-1737e7908d50,,Adjuvant,,2021-09-10T10:36:37.981324-05:00,HCM-BROD-0643-C43_treatment3,be663c30-1b65-42fd-8744-977b665739a7,,released,,0,2021-09-07T12:03:47.327892-05:00,Hormone Therapy,Residual Disease,
HCM-BROD-0643-C43,1c54d889-a752-4025-90ce-af896cdb95d4,379deec7-50a8-4219-9bd2-1737e7908d50,,Adjuvant,,2021-09-10T10:36:37.981324-05:00,HCM-BROD-0643-C43_treatment6,e41f0ee1-e030-4fa1-93d2-b2d14983b513,,released,,0,2021-09-07T12:03:47.327892-05:00,Targeted Molecular Therapy,Residual Disease,
HCM-BROD-0643-C43,1c54d889-a752-4025-90ce-af896cdb95d4,379deec7-50a8-4219-9bd2-1737e7908d50,,Adjuvant,1104.0,2021-09-10T10:36:37.981324-05:00,HCM-BROD-0643-C43_treatment4,ecb520bb-f21d-4f12-8e12-308a3fec97e0,Treatment Ongoing,released,Nivolumab,1,2021-09-07T12:03:47.327892-05:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-BROD-0643-C43,1c54d889-a752-4025-90ce-af896cdb95d4,3ea0fe35-fd02-4e73-b294-965afe66a719,,Maintenance Therapy,,2021-09-10T10:36:37.981324-05:00,HCM-BROD-0643-C43_treatment8,d57337b6-13d2-4c2f-8425-fb229f0caa65,Treatment Ongoing,released,Nivolumab,1,2021-09-07T12:03:47.327892-05:00,,,
HCM-BROD-0758-C43,1c906cee-df63-4348-9354-0a523ab88dfa,640cca22-1494-46df-82e5-8f9bffd253ce,,Neoadjuvant,,2023-02-22T07:39:25.979291-06:00,HCM-BROD-0758-C43_treatment,2fb9ae99-2b2f-4280-bc4f-01cc1e2f2f81,,released,,0,2021-12-21T13:49:35.680126-06:00,,,
HCM-BROD-0758-C43,1c906cee-df63-4348-9354-0a523ab88dfa,640cca22-1494-46df-82e5-8f9bffd253ce,1446.0,Adjuvant,1350.0,2023-02-22T07:39:25.979291-06:00,HCM-BROD-0758-C43_treatment7,344ac719-ca2d-42d1-a332-5146e9db2e49,,released,Trametinib,1,2021-12-21T13:49:35.680126-06:00,Targeted Molecular Therapy,Residual Disease,
HCM-BROD-0758-C43,1c906cee-df63-4348-9354-0a523ab88dfa,640cca22-1494-46df-82e5-8f9bffd253ce,,,-21.0,2023-03-13T12:57:25.671139-05:00,HCM-BROD-0758-C43_treatment6,444eb6a3-7c26-4803-8867-88c2de01bcc2,,released,,1,2021-12-21T13:49:35.680126-06:00,"Surgery, NOS",Initial Diagnosis,
HCM-BROD-0758-C43,1c906cee-df63-4348-9354-0a523ab88dfa,640cca22-1494-46df-82e5-8f9bffd253ce,1330.0,Adjuvant,1309.0,2023-02-22T07:39:25.979291-06:00,HCM-BROD-0758-C43_treatment5,5603df9e-948d-4091-b352-e7428a50df84,,released,Ipilimumab,1,2021-12-21T13:49:35.680126-06:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-BROD-0758-C43,1c906cee-df63-4348-9354-0a523ab88dfa,640cca22-1494-46df-82e5-8f9bffd253ce,1446.0,Adjuvant,1350.0,2023-02-22T07:39:25.979291-06:00,HCM-BROD-0758-C43_treatment8,6ce7a0c3-f759-425a-9c80-5c708ab85998,,released,Dabrafenib,1,2021-12-21T13:49:35.680126-06:00,Targeted Molecular Therapy,Residual Disease,
HCM-BROD-0758-C43,1c906cee-df63-4348-9354-0a523ab88dfa,640cca22-1494-46df-82e5-8f9bffd253ce,1329.0,Adjuvant,1313.0,2023-02-22T07:39:25.979291-06:00,HCM-BROD-0758-C43_treatment9,76ea7217-ca28-482c-b914-2ebece15e2d5,,released,,1,2021-12-21T13:49:35.680126-06:00,"Radiation Therapy, NOS",Residual Disease,
HCM-BROD-0758-C43,1c906cee-df63-4348-9354-0a523ab88dfa,640cca22-1494-46df-82e5-8f9bffd253ce,,Adjuvant,,2023-02-22T07:39:25.979291-06:00,HCM-BROD-0758-C43_treatment3,9b173226-53cf-482e-b21c-9651370d83d7,,released,,0,2021-12-21T13:49:35.680126-06:00,Hormone Therapy,Residual Disease,
HCM-BROD-0758-C43,1c906cee-df63-4348-9354-0a523ab88dfa,640cca22-1494-46df-82e5-8f9bffd253ce,1329.0,Adjuvant,1309.0,2023-02-22T07:39:25.979291-06:00,HCM-BROD-0758-C43_treatment4,9fedce83-d033-42a9-87aa-9466d3bb14b0,,released,Nivolumab,1,2021-12-21T13:49:35.680126-06:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-BROD-0758-C43,1c906cee-df63-4348-9354-0a523ab88dfa,640cca22-1494-46df-82e5-8f9bffd253ce,,Adjuvant,,2023-02-22T07:39:25.979291-06:00,HCM-BROD-0758-C43_treatment2,b9b42ed2-0e29-400b-ba07-05dbd61ad1fd,,released,,0,2021-12-21T13:49:35.680126-06:00,Chemotherapy,Residual Disease,
HCM-SANG-0300-C15,1cddb064-84ff-4ca1-b980-fb3ec30053eb,f571e3ff-e4b8-492e-955d-f72c2af83ffa,,Neoadjuvant,,2023-02-22T07:39:25.979291-06:00,HCM-SANG-0300-C15_treatment,a35cf4c2-79c5-4ffa-87d9-486c1cee392e,,released,,0,2021-12-21T15:09:30.575820-06:00,,,
HCM-CSHL-0368-D37,1d8a21f2-0671-45ce-ba44-94d3d0d29dd4,f10edebf-938a-420e-b4eb-6a35b1064a7c,,Adjuvant,,2023-03-13T13:15:06.728296-05:00,HCM-CSHL-0368-D37_treatment3,307b188c-7033-4e99-a278-750802818ee5,,released,,0,2020-09-28T10:43:11.850886-05:00,"Pharmaceutical Therapy, NOS",Residual Disease,
HCM-CSHL-0368-D37,1d8a21f2-0671-45ce-ba44-94d3d0d29dd4,f10edebf-938a-420e-b4eb-6a35b1064a7c,,Adjuvant,,2023-03-13T13:15:06.728296-05:00,HCM-CSHL-0368-D37_treatment4,38e71cc8-07c6-4347-b97e-b1da5cb4a141,,released,,0,2020-09-28T10:43:11.850886-05:00,"Radiation Therapy, NOS",Residual Disease,
HCM-CSHL-0368-D37,1d8a21f2-0671-45ce-ba44-94d3d0d29dd4,f10edebf-938a-420e-b4eb-6a35b1064a7c,,,11.0,2023-03-13T13:15:06.728296-05:00,HCM-CSHL-0368-D37_treatment2,b31cae76-2462-4b51-9a72-2a1798260348,,released,,1,2020-09-28T10:43:11.850886-05:00,"Surgery, NOS",Initial Diagnosis,
HCM-CSHL-0368-D37,1d8a21f2-0671-45ce-ba44-94d3d0d29dd4,f10edebf-938a-420e-b4eb-6a35b1064a7c,,Neoadjuvant,,2023-02-22T07:39:25.979291-06:00,HCM-CSHL-0368-D37_treatment,fb7ac6da-09be-40d8-bbb2-7182f019a2e9,,released,,0,2020-09-28T10:43:11.850886-05:00,,,
HCM-BROD-0121-C41,1da2dae2-d5ed-49c9-9f9e-c12e6e262dc4,f07d5d79-a50a-4893-a7ec-dec09cc52da4,,Neoadjuvant,334.0,2021-07-12T12:25:55.528644-05:00,HCM-BROD-0121-C41_treatment5,14ff269f-e6b1-4f08-8cbe-8d55382cfac3,,released,,1,2019-04-03T18:03:55.442588-05:00,Chemotherapy,,VIT
HCM-BROD-0121-C41,1da2dae2-d5ed-49c9-9f9e-c12e6e262dc4,f07d5d79-a50a-4893-a7ec-dec09cc52da4,,Neoadjuvant,,2021-07-12T12:25:55.528644-05:00,HCM-BROD-0121-C41_treatment13,226334ee-5320-4bf3-ad04-ca7e28a37a35,,released,,1,2020-09-27T10:36:45.842746-05:00,"Radiation Therapy, NOS",,
HCM-BROD-0121-C41,1da2dae2-d5ed-49c9-9f9e-c12e6e262dc4,f07d5d79-a50a-4893-a7ec-dec09cc52da4,,Neoadjuvant,334.0,2021-07-12T12:25:55.528644-05:00,HCM-BROD-0121-C41_treatment2,273aaada-de3c-4c50-bda6-73378ca08d32,,released,Vincristine,1,2019-04-03T18:03:55.442588-05:00,Chemotherapy,,
HCM-BROD-0121-C41,1da2dae2-d5ed-49c9-9f9e-c12e6e262dc4,f07d5d79-a50a-4893-a7ec-dec09cc52da4,,Maintenance Therapy,0.0,2021-07-12T12:25:55.528644-05:00,HCM-BROD-0121-C41_treatment7,28dba380-efe7-436d-bf44-96d09bcacb97,Progressive Disease,released,Vincristine,1,2019-04-03T18:03:55.442588-05:00,,Progressive Disease,
HCM-BROD-0121-C41,1da2dae2-d5ed-49c9-9f9e-c12e6e262dc4,f07d5d79-a50a-4893-a7ec-dec09cc52da4,,Neoadjuvant,334.0,2021-07-12T12:25:55.528644-05:00,HCM-BROD-0121-C41_treatment6,3a3be4d9-4bae-47c7-8dae-94acab37d4c2,,released,Pembrolizumab,1,2019-04-03T18:03:55.442588-05:00,Immunotherapy (Including Vaccines),,
HCM-BROD-0121-C41,1da2dae2-d5ed-49c9-9f9e-c12e6e262dc4,f07d5d79-a50a-4893-a7ec-dec09cc52da4,365.0,Adjuvant,334.0,2021-07-12T12:25:55.528644-05:00,HCM-BROD-0121-C41_treatment15,5e8dfefa-7c3e-449b-9a51-8a22c1a5768f,,released,Pembrolizumab,1,2020-09-27T10:36:45.842746-05:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-BROD-0121-C41,1da2dae2-d5ed-49c9-9f9e-c12e6e262dc4,f07d5d79-a50a-4893-a7ec-dec09cc52da4,,Neoadjuvant,334.0,2021-07-12T12:25:55.528644-05:00,HCM-BROD-0121-C41_treatment3,7b377513-3542-458b-b14f-ec64cc80a0b7,,released,Temozolomide,1,2019-04-03T18:03:55.442588-05:00,Chemotherapy,,
HCM-BROD-0121-C41,1da2dae2-d5ed-49c9-9f9e-c12e6e262dc4,f07d5d79-a50a-4893-a7ec-dec09cc52da4,,Adjuvant,,2021-07-12T12:25:55.528644-05:00,HCM-BROD-0121-C41_treatment18,7fabbc82-a456-40d1-843e-36a5cf61c55a,,released,,0,2020-09-27T10:36:45.842746-05:00,"Radiation Therapy, NOS",Residual Disease,
HCM-BROD-0121-C41,1da2dae2-d5ed-49c9-9f9e-c12e6e262dc4,f07d5d79-a50a-4893-a7ec-dec09cc52da4,,,,2023-02-24T14:51:43.543206-06:00,HCM-BROD-0121-C41_treatment16,8c404d97-83fb-4539-89b6-2c5cee24f5db,,released,,unknown,2020-09-27T10:36:45.842746-05:00,"Surgery, NOS",Initial Diagnosis,
HCM-BROD-0121-C41,1da2dae2-d5ed-49c9-9f9e-c12e6e262dc4,f07d5d79-a50a-4893-a7ec-dec09cc52da4,,Adjuvant,,2021-07-12T12:25:55.528644-05:00,HCM-BROD-0121-C41_treatment14,a053b193-e95e-40a3-a218-4476fb4d9bc5,,released,,0,2020-09-27T10:36:45.842746-05:00,Chemotherapy,Residual Disease,
HCM-BROD-0121-C41,1da2dae2-d5ed-49c9-9f9e-c12e6e262dc4,f07d5d79-a50a-4893-a7ec-dec09cc52da4,,Adjuvant,,2021-07-12T12:25:55.528644-05:00,HCM-BROD-0121-C41_treatment17,a23185be-9cc2-4cfe-a297-51c5e1431960,,released,,0,2020-09-27T10:36:45.842746-05:00,Targeted Molecular Therapy,Residual Disease,
HCM-BROD-0121-C41,1da2dae2-d5ed-49c9-9f9e-c12e6e262dc4,f07d5d79-a50a-4893-a7ec-dec09cc52da4,,Maintenance Therapy,0.0,2021-07-12T12:25:55.528644-05:00,HCM-BROD-0121-C41_treatment11,aaf8a389-edb0-49bd-a268-939c4e616b31,Progressive Disease,released,Etoposide,1,2020-09-27T10:36:45.842746-05:00,,Progressive Disease,
HCM-BROD-0121-C41,1da2dae2-d5ed-49c9-9f9e-c12e6e262dc4,f07d5d79-a50a-4893-a7ec-dec09cc52da4,,Neoadjuvant,334.0,2021-07-12T12:25:55.528644-05:00,HCM-BROD-0121-C41_treatment,b0d84256-085c-4c20-819d-53da757482b1,,released,Cyclophosphamide,1,2019-04-03T18:03:55.442588-05:00,Chemotherapy,,
HCM-BROD-0121-C41,1da2dae2-d5ed-49c9-9f9e-c12e6e262dc4,f07d5d79-a50a-4893-a7ec-dec09cc52da4,,Maintenance Therapy,0.0,2021-07-12T12:25:55.528644-05:00,HCM-BROD-0121-C41_treatment8,b27824dd-5691-4ccc-9231-d0524418736b,Progressive Disease,released,Ifosfamide,1,2019-04-03T18:03:55.442588-05:00,,Progressive Disease,
HCM-BROD-0121-C41,1da2dae2-d5ed-49c9-9f9e-c12e6e262dc4,f07d5d79-a50a-4893-a7ec-dec09cc52da4,,Maintenance Therapy,0.0,2021-07-12T12:25:55.528644-05:00,HCM-BROD-0121-C41_treatment10,baa34262-f5f1-45a3-8ed0-4d972d561ed9,Progressive Disease,released,Doxorubicin,1,2020-09-27T10:36:45.842746-05:00,,Progressive Disease,
HCM-BROD-0121-C41,1da2dae2-d5ed-49c9-9f9e-c12e6e262dc4,f07d5d79-a50a-4893-a7ec-dec09cc52da4,,Maintenance Therapy,0.0,2021-07-12T12:25:55.528644-05:00,HCM-BROD-0121-C41_treatment9,d2788b87-1ec5-45da-810f-36c146b0602f,Progressive Disease,released,Cyclophosphamide,1,2019-04-03T18:03:55.442588-05:00,,Progressive Disease,
HCM-BROD-0121-C41,1da2dae2-d5ed-49c9-9f9e-c12e6e262dc4,f07d5d79-a50a-4893-a7ec-dec09cc52da4,,Maintenance Therapy,0.0,2021-07-12T12:25:55.528644-05:00,HCM-BROD-0121-C41_treatment12,f03302c3-afd3-4f0b-aa9f-f97e70875569,Progressive Disease,released,,1,2020-09-27T10:36:45.842746-05:00,,Progressive Disease,VDC/IE
HCM-BROD-0121-C41,1da2dae2-d5ed-49c9-9f9e-c12e6e262dc4,f07d5d79-a50a-4893-a7ec-dec09cc52da4,,Neoadjuvant,334.0,2021-07-12T12:25:55.528644-05:00,HCM-BROD-0121-C41_treatment4,f3104541-8af0-4313-9dc2-4e5e8525caee,,released,Irinotecan,1,2019-04-03T18:03:55.442588-05:00,Chemotherapy,,
HCM-SANG-0544-C15,1deecd23-2a3a-4de3-9b79-26ad4492787f,11f19aca-4e57-4d6f-8b7f-02976e5695bc,,Neoadjuvant,105.0,2025-03-31T16:34:59.906497-05:00,HCM-SANG-0544-C15_treatment4,2bac9fa8-2984-458f-b238-f5d22dc569f7,,released,,1,2021-12-21T15:15:32.809805-06:00,Chemotherapy,,ECX
HCM-SANG-0544-C15,1deecd23-2a3a-4de3-9b79-26ad4492787f,11f19aca-4e57-4d6f-8b7f-02976e5695bc,,Neoadjuvant,105.0,2025-03-31T16:34:59.906497-05:00,HCM-SANG-0544-C15_treatment,34b47072-aac4-4a11-8ff0-e4ff63797a0e,,released,Epirubicin,1,2021-12-21T15:15:32.809805-06:00,Chemotherapy,,
HCM-SANG-0544-C15,1deecd23-2a3a-4de3-9b79-26ad4492787f,11f19aca-4e57-4d6f-8b7f-02976e5695bc,,Neoadjuvant,105.0,2025-03-31T16:34:59.906497-05:00,HCM-SANG-0544-C15_treatment2,bf2dc235-fd22-4c6f-8995-e30deffdde2e,,released,Capecitabine,1,2021-12-21T15:15:32.809805-06:00,Chemotherapy,,
HCM-SANG-0544-C15,1deecd23-2a3a-4de3-9b79-26ad4492787f,11f19aca-4e57-4d6f-8b7f-02976e5695bc,,Neoadjuvant,105.0,2025-03-31T16:34:59.906497-05:00,HCM-SANG-0544-C15_treatment3,d2259c81-0677-4c90-b26d-12f9e0ccb79c,,released,Cisplatin,1,2021-12-21T15:15:32.809805-06:00,Chemotherapy,,
HCM-BROD-0794-C16,1e76d41a-9cf7-4114-b48a-84571c929f22,302030b4-7c58-4eef-be7e-419d85657d3c,1286.0,Maintenance Therapy,7.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0794-C16_treatment21,09f8d999-62c4-465f-80b5-80a58b3e165d,Progressive Disease,released,,1,2021-12-21T13:53:40.883770-06:00,,,FOLFOX
HCM-BROD-0794-C16,1e76d41a-9cf7-4114-b48a-84571c929f22,302030b4-7c58-4eef-be7e-419d85657d3c,1286.0,Maintenance Therapy,7.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0794-C16_treatment20,49e2b4b4-3a5c-4569-b0dd-a3226d396363,Progressive Disease,released,,1,2021-12-21T13:53:40.883770-06:00,,,FOLFIRINOX
HCM-BROD-0794-C16,1e76d41a-9cf7-4114-b48a-84571c929f22,302030b4-7c58-4eef-be7e-419d85657d3c,1286.0,Maintenance Therapy,7.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0794-C16_treatment13,5efcd8c9-85e8-43c2-a9f3-6c6745fa4538,Progressive Disease,released,Irinotecan Hydrochloride,1,2021-12-21T13:53:40.883770-06:00,,,
HCM-BROD-0794-C16,1e76d41a-9cf7-4114-b48a-84571c929f22,302030b4-7c58-4eef-be7e-419d85657d3c,1286.0,Maintenance Therapy,7.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0794-C16_treatment16,5fbb8e40-5660-4fe4-b626-46d61f4793a8,Progressive Disease,released,Epirubicin,1,2021-12-21T13:53:40.883770-06:00,,,
HCM-BROD-0794-C16,1e76d41a-9cf7-4114-b48a-84571c929f22,302030b4-7c58-4eef-be7e-419d85657d3c,1286.0,Maintenance Therapy,7.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0794-C16_treatment12,7746c702-0768-42ab-9838-cd1176d8cb7c,Progressive Disease,released,Capecitabine,1,2021-12-21T13:53:40.883770-06:00,,,
HCM-BROD-0794-C16,1e76d41a-9cf7-4114-b48a-84571c929f22,302030b4-7c58-4eef-be7e-419d85657d3c,1286.0,Maintenance Therapy,7.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0794-C16_treatment15,86964b74-381b-4613-be84-28bfae9670b5,Progressive Disease,released,Oxaliplatin,1,2021-12-21T13:53:40.883770-06:00,,,
HCM-BROD-0794-C16,1e76d41a-9cf7-4114-b48a-84571c929f22,302030b4-7c58-4eef-be7e-419d85657d3c,1286.0,Maintenance Therapy,7.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0794-C16_treatment18,b0d293b9-d61b-4f93-834d-a4032330c0fc,Progressive Disease,released,,1,2021-12-21T13:53:40.883770-06:00,,,FOLFIRI
HCM-BROD-0794-C16,1e76d41a-9cf7-4114-b48a-84571c929f22,302030b4-7c58-4eef-be7e-419d85657d3c,1286.0,Maintenance Therapy,7.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0794-C16_treatment10,c19db555-f700-4e1d-8440-c2faa83aca69,Progressive Disease,released,Paclitaxel,1,2021-12-21T13:53:40.883770-06:00,,,
HCM-BROD-0794-C16,1e76d41a-9cf7-4114-b48a-84571c929f22,302030b4-7c58-4eef-be7e-419d85657d3c,1286.0,Maintenance Therapy,7.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0794-C16_treatment14,d879e330-c7f7-4ff1-ac13-d7274fbad8c5,Progressive Disease,released,Leucovorin Calcium,1,2021-12-21T13:53:40.883770-06:00,,,
HCM-BROD-0794-C16,1e76d41a-9cf7-4114-b48a-84571c929f22,302030b4-7c58-4eef-be7e-419d85657d3c,1286.0,Maintenance Therapy,7.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0794-C16_treatment19,d88f720d-2a49-4c6c-8583-4576fbaea4d3,Progressive Disease,released,,1,2021-12-21T13:53:40.883770-06:00,,,EOX
HCM-BROD-0794-C16,1e76d41a-9cf7-4114-b48a-84571c929f22,302030b4-7c58-4eef-be7e-419d85657d3c,1286.0,Maintenance Therapy,7.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0794-C16_treatment17,dc7cf3a1-00e3-407d-a1de-cac4720e0ed4,Progressive Disease,released,Fluorouracil,1,2021-12-21T13:53:40.883770-06:00,,,
HCM-BROD-0794-C16,1e76d41a-9cf7-4114-b48a-84571c929f22,302030b4-7c58-4eef-be7e-419d85657d3c,1286.0,Maintenance Therapy,7.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0794-C16_treatment11,f35308ce-343e-460d-9b10-2817b2537cb1,Progressive Disease,released,Ramucirumab,1,2021-12-21T13:53:40.883770-06:00,,,
HCM-BROD-0794-C16,1e76d41a-9cf7-4114-b48a-84571c929f22,cc1abd43-a9cf-4834-a954-0e9b59045b17,,Neoadjuvant,7.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0794-C16_treatment3,0f2e6b21-9cb7-473a-89ed-237847f80e71,,released,Capecitabine,1,2021-12-21T13:53:40.883770-06:00,Chemotherapy,,
HCM-BROD-0794-C16,1e76d41a-9cf7-4114-b48a-84571c929f22,cc1abd43-a9cf-4834-a954-0e9b59045b17,,Neoadjuvant,7.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0794-C16_treatment4,2832fc63-95ef-40bc-8112-559c4ee3bddf,,released,,1,2021-12-21T13:53:40.883770-06:00,Chemotherapy,,EOX
HCM-BROD-0794-C16,1e76d41a-9cf7-4114-b48a-84571c929f22,cc1abd43-a9cf-4834-a954-0e9b59045b17,,Neoadjuvant,7.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0794-C16_treatment,4f990a91-1f34-4e72-9187-e6b828478273,,released,Epirubicin,1,2021-12-21T13:53:40.883770-06:00,Chemotherapy,,
HCM-BROD-0794-C16,1e76d41a-9cf7-4114-b48a-84571c929f22,cc1abd43-a9cf-4834-a954-0e9b59045b17,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0794-C16_treatment6,5ac2f9b9-9f57-4630-8376-ea282965d022,,released,,0,2021-12-21T13:53:40.883770-06:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-BROD-0794-C16,1e76d41a-9cf7-4114-b48a-84571c929f22,cc1abd43-a9cf-4834-a954-0e9b59045b17,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0794-C16_treatment8,6ce570d0-f546-498b-aebb-92710292ed9a,,released,,0,2021-12-21T13:53:40.883770-06:00,Targeted Molecular Therapy,Residual Disease,
HCM-BROD-0794-C16,1e76d41a-9cf7-4114-b48a-84571c929f22,cc1abd43-a9cf-4834-a954-0e9b59045b17,,Neoadjuvant,7.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0794-C16_treatment2,707a254f-2891-43ca-817e-f38c54f3c61d,,released,Oxaliplatin,1,2021-12-21T13:53:40.883770-06:00,Chemotherapy,,
HCM-BROD-0794-C16,1e76d41a-9cf7-4114-b48a-84571c929f22,cc1abd43-a9cf-4834-a954-0e9b59045b17,,,,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0794-C16_treatment7,96172379-2c3e-4575-9b10-fac78ace5343,,released,,0,2021-12-21T13:53:40.883770-06:00,"Surgery, NOS",Initial Diagnosis,
HCM-BROD-0794-C16,1e76d41a-9cf7-4114-b48a-84571c929f22,cc1abd43-a9cf-4834-a954-0e9b59045b17,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0794-C16_treatment5,cb42267c-e17e-4d0e-bc12-ac2343323078,,released,,0,2021-12-21T13:53:40.883770-06:00,Chemotherapy,Residual Disease,
HCM-BROD-0794-C16,1e76d41a-9cf7-4114-b48a-84571c929f22,cc1abd43-a9cf-4834-a954-0e9b59045b17,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0794-C16_treatment9,e5a03da3-5966-4ea9-bc9f-295446d746c6,,released,,0,2021-12-21T13:53:40.883770-06:00,"Radiation Therapy, NOS",Residual Disease,
HCM-BROD-0597-C64,1e93db0d-0b15-4682-80d9-0a29ae04ce68,8a04affb-eb75-404d-9570-53f598547cc9,214.0,Adjuvant,30.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0597-C64_treatment4,0ad22d66-d52d-4881-b43e-3fb737627a1a,,released,Doxorubicin Hydrochloride,1,2021-12-21T13:40:44.901195-06:00,Chemotherapy,Residual Disease,
HCM-BROD-0597-C64,1e93db0d-0b15-4682-80d9-0a29ae04ce68,8a04affb-eb75-404d-9570-53f598547cc9,214.0,Adjuvant,0.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0597-C64_treatment2,261298a9-d1a0-429c-aae0-fba4a76a85cb,,released,Vincristine,1,2021-12-21T13:40:44.901195-06:00,Chemotherapy,Residual Disease,
HCM-BROD-0597-C64,1e93db0d-0b15-4682-80d9-0a29ae04ce68,8a04affb-eb75-404d-9570-53f598547cc9,214.0,Adjuvant,0.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0597-C64_treatment3,50adcc28-c08c-40d3-a125-f70d80174bfd,,released,Dactinomycin,1,2021-12-21T13:40:44.901195-06:00,Chemotherapy,Residual Disease,
HCM-BROD-0597-C64,1e93db0d-0b15-4682-80d9-0a29ae04ce68,8a04affb-eb75-404d-9570-53f598547cc9,122.0,Adjuvant,92.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0597-C64_treatment10,639de7f2-5a3b-4013-a064-f6f0f3b1b5af,,released,,1,2021-12-21T13:40:44.901195-06:00,"Radiation, Intensity-Modulated Radiotherapy",Residual Disease,
HCM-BROD-0597-C64,1e93db0d-0b15-4682-80d9-0a29ae04ce68,8a04affb-eb75-404d-9570-53f598547cc9,,Neoadjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0597-C64_treatment,6606741f-9dcf-4964-8892-081ff8011c77,,released,,0,2021-12-21T13:40:44.901195-06:00,,,
HCM-BROD-0597-C64,1e93db0d-0b15-4682-80d9-0a29ae04ce68,8a04affb-eb75-404d-9570-53f598547cc9,183.0,Adjuvant,30.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0597-C64_treatment6,8d56616a-ecb9-48cb-883d-6a1c2d1724b0,,released,Etoposide,1,2021-12-21T13:40:44.901195-06:00,Chemotherapy,Residual Disease,
HCM-BROD-0597-C64,1e93db0d-0b15-4682-80d9-0a29ae04ce68,8a04affb-eb75-404d-9570-53f598547cc9,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0597-C64_treatment7,a1cca6d1-cd36-420e-b2ae-daeae4bbb87e,,released,,0,2021-12-21T13:40:44.901195-06:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-BROD-0597-C64,1e93db0d-0b15-4682-80d9-0a29ae04ce68,8a04affb-eb75-404d-9570-53f598547cc9,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0597-C64_treatment9,af66fdec-b016-4155-9b91-8ba6ef936a10,,released,,0,2021-12-21T13:40:44.901195-06:00,Targeted Molecular Therapy,Residual Disease,
HCM-BROD-0597-C64,1e93db0d-0b15-4682-80d9-0a29ae04ce68,8a04affb-eb75-404d-9570-53f598547cc9,183.0,Adjuvant,30.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0597-C64_treatment5,cac33e70-6362-42aa-af9c-e9be6c3e0a29,,released,Cyclophosphamide,1,2021-12-21T13:40:44.901195-06:00,Chemotherapy,Residual Disease,
HCM-BROD-0597-C64,1e93db0d-0b15-4682-80d9-0a29ae04ce68,8a04affb-eb75-404d-9570-53f598547cc9,,,92.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0597-C64_treatment8,dda20cd0-b420-4e5e-9acf-9b0a2368ac4f,,released,,1,2021-12-21T13:40:44.901195-06:00,"Surgery, NOS",Initial Diagnosis,
HCM-BROD-0954-C34,1ee582bc-c8f2-4c31-836a-e9e3fd8ecd72,58cc191c-8e69-47c9-b77f-63263b4d217c,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0954-C34_treatment3,ac086c6d-80ec-472d-9518-93376f8630da,,released,,0,2021-12-21T13:58:17.376016-06:00,"Pharmaceutical Therapy, NOS",Residual Disease,
HCM-BROD-0954-C34,1ee582bc-c8f2-4c31-836a-e9e3fd8ecd72,58cc191c-8e69-47c9-b77f-63263b4d217c,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0954-C34_treatment4,c0f11261-1672-4328-91cc-d926fa34fa4d,,released,,0,2021-12-21T13:58:17.376016-06:00,"Radiation Therapy, NOS",Residual Disease,
HCM-BROD-0954-C34,1ee582bc-c8f2-4c31-836a-e9e3fd8ecd72,58cc191c-8e69-47c9-b77f-63263b4d217c,,Neoadjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0954-C34_treatment,c65de1a0-4e3a-40da-825a-6f7f7725e55c,,released,,0,2021-12-21T13:58:17.376016-06:00,,,
HCM-BROD-0954-C34,1ee582bc-c8f2-4c31-836a-e9e3fd8ecd72,58cc191c-8e69-47c9-b77f-63263b4d217c,,,8.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0954-C34_treatment2,da46b897-2a62-4034-83e7-763c080babab,,released,,1,2021-12-21T13:58:17.376016-06:00,"Surgery, NOS",Initial Diagnosis,
HCM-BROD-0783-C71,1ef1165f-72e5-43eb-ba3a-9886aa1f2fc4,118616a5-f55b-4914-91e6-b1785957647f,,Adjuvant,,2023-11-07T14:20:00.017270-06:00,HCM-BROD-0783-C71_treatment6,0e6beacb-d147-40d2-8d49-1fdc00bd1ed0,,released,,0,2021-12-21T13:53:25.043083-06:00,"Radiation Therapy, NOS",Residual Disease,
HCM-BROD-0783-C71,1ef1165f-72e5-43eb-ba3a-9886aa1f2fc4,118616a5-f55b-4914-91e6-b1785957647f,,Adjuvant,,2023-11-07T14:20:00.017270-06:00,HCM-BROD-0783-C71_treatment5,54d7788b-de20-4f5a-97a7-8132fca88505,,released,,0,2021-12-21T13:53:25.043083-06:00,Targeted Molecular Therapy,Residual Disease,
HCM-BROD-0783-C71,1ef1165f-72e5-43eb-ba3a-9886aa1f2fc4,118616a5-f55b-4914-91e6-b1785957647f,197.0,Adjuvant,166.0,2023-11-07T14:20:00.017270-06:00,HCM-BROD-0783-C71_treatment2,54fa310b-f098-40e4-8ff0-a50990dc2b5c,,released,Irinotecan,1,2021-12-21T13:53:25.043083-06:00,Chemotherapy,Residual Disease,
HCM-BROD-0783-C71,1ef1165f-72e5-43eb-ba3a-9886aa1f2fc4,118616a5-f55b-4914-91e6-b1785957647f,,,-4.0,2023-11-07T14:20:00.017270-06:00,HCM-BROD-0783-C71_treatment4,6f5834f1-dd50-4df1-94fa-19be37569cd5,,released,,1,2021-12-21T13:53:25.043083-06:00,"Surgery, NOS",Initial Diagnosis,
HCM-BROD-0783-C71,1ef1165f-72e5-43eb-ba3a-9886aa1f2fc4,118616a5-f55b-4914-91e6-b1785957647f,,Neoadjuvant,,2023-11-07T14:20:00.017270-06:00,HCM-BROD-0783-C71_treatment,bc0e8bb9-b978-4148-8bd8-0e71d6adab8b,,released,,0,2021-12-21T13:53:25.043083-06:00,,,
HCM-BROD-0783-C71,1ef1165f-72e5-43eb-ba3a-9886aa1f2fc4,118616a5-f55b-4914-91e6-b1785957647f,,Adjuvant,,2023-11-07T14:20:00.017270-06:00,HCM-BROD-0783-C71_treatment3,ea091c8a-4e56-42cb-aa67-2bb0f4531bc2,,released,,0,2021-12-21T13:53:25.043083-06:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-BROD-0783-C71,1ef1165f-72e5-43eb-ba3a-9886aa1f2fc4,4af50a79-9d81-4ecf-b669-58b062e3d04e,82.0,Maintenance Therapy,8.0,2023-11-07T14:20:00.017270-06:00,HCM-BROD-0783-C71_treatment7,7eb5705a-7ff6-4345-889d-755faa95deb8,Progressive Disease,released,Temozolomide,1,2021-12-21T13:53:25.043083-06:00,,,
HCM-BROD-0116-C16,1f080fcb-15c8-452a-a083-05ed83098a52,6ea02426-0463-4156-be3c-87878458bea9,,,101.0,2023-03-13T13:18:01.324308-05:00,HCM-BROD-0116-C16_treatment2,15c422d5-203f-453f-9aa1-17c975968a3c,,released,,1,2019-04-04T15:42:26.851849-05:00,"Surgery, NOS",Initial Diagnosis,
HCM-BROD-0116-C16,1f080fcb-15c8-452a-a083-05ed83098a52,6ea02426-0463-4156-be3c-87878458bea9,,Adjuvant,,2023-03-13T13:18:01.324308-05:00,HCM-BROD-0116-C16_treatment3,20181765-8731-4682-9c34-abc079a0d649,,released,,unknown,2019-04-04T15:42:26.851849-05:00,"Pharmaceutical Therapy, NOS",Residual Disease,
HCM-BROD-0116-C16,1f080fcb-15c8-452a-a083-05ed83098a52,6ea02426-0463-4156-be3c-87878458bea9,,Neoadjuvant,,2021-07-12T12:25:55.528644-05:00,HCM-BROD-0116-C16_treatment,4cc64f5a-33f0-4dcb-bdc0-a2a2d16e5c32,,released,,1,2019-04-04T15:42:26.851849-05:00,Chemotherapy,,
HCM-BROD-0116-C16,1f080fcb-15c8-452a-a083-05ed83098a52,6ea02426-0463-4156-be3c-87878458bea9,,Adjuvant,,2023-03-13T13:18:01.324308-05:00,HCM-BROD-0116-C16_treatment4,7c711ad4-6d12-40d3-ba59-663da89dd27c,,released,,unknown,2019-04-04T15:42:26.851849-05:00,"Radiation Therapy, NOS",Residual Disease,
HCM-BROD-0577-C15,20b6fd08-f99a-47f0-9f41-ff2163490057,ac6b2224-eb4e-4b5d-a6a4-afdd75c77e9b,,,,2023-07-13T10:35:44.371881-05:00,HCM-BROD-0577-C15_treatment7,030a8855-2548-4049-a82a-2dd57d941a1b,,released,,0,2020-10-08T14:46:59.857659-05:00,"Surgery, NOS",Initial Diagnosis,
HCM-BROD-0577-C15,20b6fd08-f99a-47f0-9f41-ff2163490057,ac6b2224-eb4e-4b5d-a6a4-afdd75c77e9b,,Neoadjuvant,50.0,2023-07-13T10:35:44.371881-05:00,HCM-BROD-0577-C15_treatment4,241639e5-87f0-4f17-a08c-5ef9aff79ae7,,released,,1,2020-10-08T14:46:59.857659-05:00,Chemotherapy,,FOLFOX
HCM-BROD-0577-C15,20b6fd08-f99a-47f0-9f41-ff2163490057,ac6b2224-eb4e-4b5d-a6a4-afdd75c77e9b,,Adjuvant,,2023-07-13T10:35:44.371881-05:00,HCM-BROD-0577-C15_treatment6,60cefbc7-807a-40db-ac47-520e0947a47d,,released,,0,2020-10-08T14:46:59.857659-05:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-BROD-0577-C15,20b6fd08-f99a-47f0-9f41-ff2163490057,ac6b2224-eb4e-4b5d-a6a4-afdd75c77e9b,,Neoadjuvant,50.0,2023-07-13T10:35:44.371881-05:00,HCM-BROD-0577-C15_treatment2,67a3451a-c69e-4b1b-bfb8-e2e9a6285a93,,released,Fluorouracil,1,2020-10-08T14:46:59.857659-05:00,Chemotherapy,,
HCM-BROD-0577-C15,20b6fd08-f99a-47f0-9f41-ff2163490057,ac6b2224-eb4e-4b5d-a6a4-afdd75c77e9b,,Neoadjuvant,50.0,2023-07-13T10:35:44.371881-05:00,HCM-BROD-0577-C15_treatment3,740325bb-08d1-4f4d-b83b-eb2431b0f175,,released,Oxaliplatin,1,2020-10-08T14:46:59.857659-05:00,Chemotherapy,,
HCM-BROD-0577-C15,20b6fd08-f99a-47f0-9f41-ff2163490057,ac6b2224-eb4e-4b5d-a6a4-afdd75c77e9b,,Adjuvant,,2023-07-13T10:35:44.371881-05:00,HCM-BROD-0577-C15_treatment9,93e6845e-641e-42d9-9c93-7e88c0e9c712,,released,,0,2020-10-08T14:46:59.857659-05:00,"Radiation Therapy, NOS",Residual Disease,
HCM-BROD-0577-C15,20b6fd08-f99a-47f0-9f41-ff2163490057,ac6b2224-eb4e-4b5d-a6a4-afdd75c77e9b,,Neoadjuvant,50.0,2023-07-13T10:35:44.371881-05:00,HCM-BROD-0577-C15_treatment,b39b2ce8-c7ab-4b9b-b914-42e9812b2277,,released,Leucovorin Calcium,1,2020-10-08T14:46:59.857659-05:00,Chemotherapy,,
HCM-BROD-0577-C15,20b6fd08-f99a-47f0-9f41-ff2163490057,ac6b2224-eb4e-4b5d-a6a4-afdd75c77e9b,465.0,Adjuvant,295.0,2023-07-13T10:35:44.371881-05:00,HCM-BROD-0577-C15_treatment5,cb91beab-179a-4df6-ab83-5d1a12b0f196,,released,Paclitaxel,1,2020-10-08T14:46:59.857659-05:00,Chemotherapy,Residual Disease,
HCM-BROD-0577-C15,20b6fd08-f99a-47f0-9f41-ff2163490057,ac6b2224-eb4e-4b5d-a6a4-afdd75c77e9b,,Adjuvant,,2023-07-13T10:35:44.371881-05:00,HCM-BROD-0577-C15_treatment8,ec9b3fde-999d-49e0-98c7-956f810a1943,,released,,0,2020-10-08T14:46:59.857659-05:00,Targeted Molecular Therapy,Residual Disease,
HCM-SANG-0315-C25,2127626f-247f-4c47-b096-a876f08db1a0,cb47433e-612c-4d5a-9e2a-03d8c712234a,,Neoadjuvant,208.0,2023-03-13T12:51:12.978797-05:00,HCM-SANG-0315-C25_treatment3,0e08adac-88eb-42c2-a70d-fd9d28f2df0a,,released,,1,2021-08-26T15:04:30.424290-05:00,"Radiation Therapy, NOS",,
HCM-SANG-0315-C25,2127626f-247f-4c47-b096-a876f08db1a0,cb47433e-612c-4d5a-9e2a-03d8c712234a,,Neoadjuvant,208.0,2023-03-13T12:51:12.978797-05:00,HCM-SANG-0315-C25_treatment,4cac4490-6353-4067-a942-2116416e5eb1,,released,Capecitabine,1,2020-02-27T12:54:33.401352-06:00,Chemotherapy,,
HCM-SANG-0315-C25,2127626f-247f-4c47-b096-a876f08db1a0,cb47433e-612c-4d5a-9e2a-03d8c712234a,,Neoadjuvant,208.0,2023-03-13T12:51:12.978797-05:00,HCM-SANG-0315-C25_treatment2,f1ea8b82-f8c8-4d62-9df1-d50ef089864d,,released,Gemcitabine,1,2020-02-27T12:54:33.401352-06:00,Chemotherapy,,
HCM-BROD-0348-C25,219cfe52-363e-424b-b833-717637eab99a,af0b06a9-eaa1-4da9-b780-5e819eac899c,423.0,Adjuvant,17.0,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0348-C25_treatment2,13b1ee66-5d7a-4931-83c0-757ed76120db,,released,Gemcitabine,1,2020-09-17T16:10:55.318135-05:00,Chemotherapy,Residual Disease,
HCM-BROD-0348-C25,219cfe52-363e-424b-b833-717637eab99a,af0b06a9-eaa1-4da9-b780-5e819eac899c,,,,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0348-C25_treatment5,26b56316-afaf-4a26-8dd4-6ed7daa8d162,,released,,0,2020-09-17T16:10:55.318135-05:00,"Surgery, NOS",Initial Diagnosis,
HCM-BROD-0348-C25,219cfe52-363e-424b-b833-717637eab99a,af0b06a9-eaa1-4da9-b780-5e819eac899c,,Adjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0348-C25_treatment4,47447822-0ed8-4ff3-957e-7c332db4097a,,released,,0,2020-09-17T16:10:55.318135-05:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-BROD-0348-C25,219cfe52-363e-424b-b833-717637eab99a,af0b06a9-eaa1-4da9-b780-5e819eac899c,,Adjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0348-C25_treatment6,492cf357-867d-4a9e-9e71-4eae4fd05894,,released,,0,2020-09-17T16:10:55.318135-05:00,Targeted Molecular Therapy,Residual Disease,
HCM-BROD-0348-C25,219cfe52-363e-424b-b833-717637eab99a,af0b06a9-eaa1-4da9-b780-5e819eac899c,423.0,Adjuvant,17.0,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0348-C25_treatment3,79e5a2a0-09e1-421a-a80c-03fd65c2d7f0,,released,Nab-paclitaxel,1,2020-09-17T16:10:55.318135-05:00,Chemotherapy,Residual Disease,
HCM-BROD-0348-C25,219cfe52-363e-424b-b833-717637eab99a,af0b06a9-eaa1-4da9-b780-5e819eac899c,,Adjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0348-C25_treatment7,b9b0c1aa-2cd8-4440-8cc7-4bb305c30e8d,,released,,0,2020-09-17T16:10:55.318135-05:00,"Radiation Therapy, NOS",Residual Disease,
HCM-BROD-0348-C25,219cfe52-363e-424b-b833-717637eab99a,af0b06a9-eaa1-4da9-b780-5e819eac899c,,Neoadjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0348-C25_treatment,bb7aeb24-b91d-4021-a82a-bc4ee9abec74,,released,,0,2020-09-17T16:10:55.318135-05:00,,,
HCM-SANG-1326-C15,220be274-e7e5-4148-9bd2-60c36ae5d688,ab1e2849-9fbb-4906-9369-588c902f3ebf,,Neoadjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-SANG-1326-C15_treatment,325fae4e-6875-4fe7-bc53-1d55c39c9939,,released,,0,2023-02-27T13:14:41.300709-06:00,,,
HCM-BROD-0229-C25,22f26b5c-41b7-4142-9d87-6cf8b7fee3af,1541cf35-c584-422f-91b2-cb98bd9b46e4,,Neoadjuvant,30.0,2021-01-06T22:55:10.531130-06:00,HCM-BROD-0229-C25_treatment7,02ee9c06-5e6d-4000-98a7-c4fa1a6cd01c,,released,Nab-paclitaxel,1,2020-06-15T13:28:13.853772-05:00,Chemotherapy,,
HCM-BROD-0229-C25,22f26b5c-41b7-4142-9d87-6cf8b7fee3af,1541cf35-c584-422f-91b2-cb98bd9b46e4,,Adjuvant,,2021-01-06T22:55:10.531130-06:00,HCM-BROD-0229-C25_treatment17,0cf64084-8ead-4833-bd6e-f011089be555,,released,,0,2020-09-27T11:11:28.468142-05:00,Targeted Molecular Therapy,Residual Disease,
HCM-BROD-0229-C25,22f26b5c-41b7-4142-9d87-6cf8b7fee3af,1541cf35-c584-422f-91b2-cb98bd9b46e4,,Neoadjuvant,30.0,2021-01-06T22:55:10.531130-06:00,HCM-BROD-0229-C25_treatment3,12488dc6-479b-433f-bdb2-b13302697c42,,released,Fluorouracil,1,2020-06-15T13:28:13.853772-05:00,Chemotherapy,,
HCM-BROD-0229-C25,22f26b5c-41b7-4142-9d87-6cf8b7fee3af,1541cf35-c584-422f-91b2-cb98bd9b46e4,57.0,Adjuvant,17.0,2021-01-06T22:55:10.531130-06:00,HCM-BROD-0229-C25_treatment10,1500f8f1-433a-4932-9c40-4f89b8e17a21,,released,Fluorouracil,1,2020-06-15T13:28:13.853772-05:00,Chemotherapy,Residual Disease,
HCM-BROD-0229-C25,22f26b5c-41b7-4142-9d87-6cf8b7fee3af,1541cf35-c584-422f-91b2-cb98bd9b46e4,,Adjuvant,,2021-01-06T22:55:10.531130-06:00,HCM-BROD-0229-C25_treatment15,16042fa2-59f5-443c-a5a9-7929554d61d0,,released,,0,2020-09-27T11:11:28.468142-05:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-BROD-0229-C25,22f26b5c-41b7-4142-9d87-6cf8b7fee3af,1541cf35-c584-422f-91b2-cb98bd9b46e4,57.0,Adjuvant,17.0,2021-01-06T22:55:10.531130-06:00,HCM-BROD-0229-C25_treatment11,49daccfc-e58c-456a-a77f-86dca0e14dbc,,released,Oxaliplatin,1,2020-09-27T11:11:28.468142-05:00,Chemotherapy,Residual Disease,
HCM-BROD-0229-C25,22f26b5c-41b7-4142-9d87-6cf8b7fee3af,1541cf35-c584-422f-91b2-cb98bd9b46e4,57.0,Adjuvant,17.0,2021-01-06T22:55:10.531130-06:00,HCM-BROD-0229-C25_treatment8,605ad9f6-8a98-4fa7-acec-55da435afbe1,,released,Irinotecan Hydrochloride,1,2020-06-15T13:28:13.853772-05:00,Chemotherapy,Residual Disease,
HCM-BROD-0229-C25,22f26b5c-41b7-4142-9d87-6cf8b7fee3af,1541cf35-c584-422f-91b2-cb98bd9b46e4,57.0,Adjuvant,17.0,2021-01-06T22:55:10.531130-06:00,HCM-BROD-0229-C25_treatment9,6e4344fd-a8f9-4342-9a02-3ee982a10250,,released,Leucovorin Calcium,1,2020-06-15T13:28:13.853772-05:00,Chemotherapy,Residual Disease,
HCM-BROD-0229-C25,22f26b5c-41b7-4142-9d87-6cf8b7fee3af,1541cf35-c584-422f-91b2-cb98bd9b46e4,,Neoadjuvant,30.0,2021-01-06T22:55:10.531130-06:00,HCM-BROD-0229-C25_treatment,703af59c-dd7d-40e1-b6d6-65e5d83f33a3,,released,Irinotecan Hydrochloride,1,2020-06-15T13:28:13.853772-05:00,Chemotherapy,,
HCM-BROD-0229-C25,22f26b5c-41b7-4142-9d87-6cf8b7fee3af,1541cf35-c584-422f-91b2-cb98bd9b46e4,190.0,Adjuvant,78.0,2021-01-06T22:55:10.531130-06:00,HCM-BROD-0229-C25_treatment14,7dd12456-4fc0-4299-8887-5cd2f76cba84,,released,Nab-paclitaxel,1,2020-09-27T11:11:28.468142-05:00,Chemotherapy,Residual Disease,
HCM-BROD-0229-C25,22f26b5c-41b7-4142-9d87-6cf8b7fee3af,1541cf35-c584-422f-91b2-cb98bd9b46e4,,,,2023-02-27T12:16:48.434053-06:00,HCM-BROD-0229-C25_treatment16,80beeb46-6014-404b-b68d-9d3e45d94548,,released,,0,2020-09-27T11:11:28.468142-05:00,"Surgery, NOS",Initial Diagnosis,
HCM-BROD-0229-C25,22f26b5c-41b7-4142-9d87-6cf8b7fee3af,1541cf35-c584-422f-91b2-cb98bd9b46e4,,Neoadjuvant,30.0,2021-01-06T22:55:10.531130-06:00,HCM-BROD-0229-C25_treatment5,863c4aa4-9aa3-42e1-b25b-10a1b0786c3d,,released,,1,2020-06-15T13:28:13.853772-05:00,Chemotherapy,,FOLFIRINOX
HCM-BROD-0229-C25,22f26b5c-41b7-4142-9d87-6cf8b7fee3af,1541cf35-c584-422f-91b2-cb98bd9b46e4,190.0,Adjuvant,78.0,2021-01-06T22:55:10.531130-06:00,HCM-BROD-0229-C25_treatment13,987e3c0c-dc81-4f9c-8c73-7e109f699f8c,,released,Gemcitabine,1,2020-09-27T11:11:28.468142-05:00,Chemotherapy,Residual Disease,
HCM-BROD-0229-C25,22f26b5c-41b7-4142-9d87-6cf8b7fee3af,1541cf35-c584-422f-91b2-cb98bd9b46e4,,Neoadjuvant,30.0,2021-01-06T22:55:10.531130-06:00,HCM-BROD-0229-C25_treatment6,b52a6ce7-ea39-4cba-a828-6dc235206278,,released,Gemcitabine,1,2020-06-15T13:28:13.853772-05:00,Chemotherapy,,
HCM-BROD-0229-C25,22f26b5c-41b7-4142-9d87-6cf8b7fee3af,1541cf35-c584-422f-91b2-cb98bd9b46e4,57.0,Adjuvant,17.0,2021-01-06T22:55:10.531130-06:00,HCM-BROD-0229-C25_treatment12,b776bfbc-92dc-4eac-8d40-241a17303065,,released,,1,2020-09-27T11:11:28.468142-05:00,Chemotherapy,Residual Disease,FOLFIRINOX
HCM-BROD-0229-C25,22f26b5c-41b7-4142-9d87-6cf8b7fee3af,1541cf35-c584-422f-91b2-cb98bd9b46e4,,Neoadjuvant,30.0,2021-01-06T22:55:10.531130-06:00,HCM-BROD-0229-C25_treatment4,bca48180-94ce-40e3-8af3-8668508868fd,,released,Oxaliplatin,1,2020-06-15T13:28:13.853772-05:00,Chemotherapy,,
HCM-BROD-0229-C25,22f26b5c-41b7-4142-9d87-6cf8b7fee3af,1541cf35-c584-422f-91b2-cb98bd9b46e4,,Adjuvant,,2021-01-06T22:55:10.531130-06:00,HCM-BROD-0229-C25_treatment18,c53eec3f-708e-45e2-9c99-fece015665b0,,released,,0,2020-09-27T11:11:28.468142-05:00,"Radiation Therapy, NOS",Residual Disease,
HCM-BROD-0229-C25,22f26b5c-41b7-4142-9d87-6cf8b7fee3af,1541cf35-c584-422f-91b2-cb98bd9b46e4,,Neoadjuvant,30.0,2021-01-06T22:55:10.531130-06:00,HCM-BROD-0229-C25_treatment2,cf351140-42d2-405d-8951-c261666a9157,,released,Leucovorin Calcium,1,2020-06-15T13:28:13.853772-05:00,Chemotherapy,,
HCM-CSHL-0141-C18,23443700-fe39-4fd5-862f-ffb02cda3947,4985cf41-de70-458f-b1c6-efdf4e3eb663,,Adjuvant,,2021-07-12T12:25:55.528644-05:00,HCM-CSHL-0141-C18_treatment9,572b2fd6-c961-4347-82e1-2b8f1fb02b89,,released,,0,2020-09-27T12:53:37.241394-05:00,"Radiation Therapy, NOS",Residual Disease,
HCM-CSHL-0141-C18,23443700-fe39-4fd5-862f-ffb02cda3947,4985cf41-de70-458f-b1c6-efdf4e3eb663,189.0,Adjuvant,30.0,2021-07-12T12:25:55.528644-05:00,HCM-CSHL-0141-C18_treatment3,66865703-185d-4795-b4d2-89e17a11eaac,,released,Fluorouracil,1,2020-09-27T12:53:37.241394-05:00,Chemotherapy,Residual Disease,
HCM-CSHL-0141-C18,23443700-fe39-4fd5-862f-ffb02cda3947,4985cf41-de70-458f-b1c6-efdf4e3eb663,,,10.0,2023-03-13T12:54:06.590212-05:00,HCM-CSHL-0141-C18_treatment7,a478561a-4c22-4292-8e77-588de69851a8,,released,,1,2020-09-27T12:53:37.241394-05:00,"Surgery, NOS",Initial Diagnosis,
HCM-CSHL-0141-C18,23443700-fe39-4fd5-862f-ffb02cda3947,4985cf41-de70-458f-b1c6-efdf4e3eb663,189.0,Adjuvant,30.0,2021-07-12T12:25:55.528644-05:00,HCM-CSHL-0141-C18_treatment4,adc444f8-7bf2-471b-8bda-99251ae27a80,,released,Oxaliplatin,1,2020-09-27T12:53:37.241394-05:00,Chemotherapy,Residual Disease,
HCM-CSHL-0141-C18,23443700-fe39-4fd5-862f-ffb02cda3947,4985cf41-de70-458f-b1c6-efdf4e3eb663,,Neoadjuvant,,2021-07-12T12:25:55.528644-05:00,HCM-CSHL-0141-C18_treatment,ae0ac17e-ce60-4358-980c-af0cea6e1e60,,released,,0,2020-09-27T12:53:37.241394-05:00,,,
HCM-CSHL-0141-C18,23443700-fe39-4fd5-862f-ffb02cda3947,4985cf41-de70-458f-b1c6-efdf4e3eb663,,Adjuvant,,2021-07-12T12:25:55.528644-05:00,HCM-CSHL-0141-C18_treatment6,d0077754-efed-412b-9c30-d16159a81388,,released,,0,2020-09-27T12:53:37.241394-05:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-CSHL-0141-C18,23443700-fe39-4fd5-862f-ffb02cda3947,4985cf41-de70-458f-b1c6-efdf4e3eb663,,Adjuvant,,2021-07-12T12:25:55.528644-05:00,HCM-CSHL-0141-C18_treatment8,d7d8c9e0-cf69-4145-927f-f022eb84a26e,,released,,0,2020-09-27T12:53:37.241394-05:00,Targeted Molecular Therapy,Residual Disease,
HCM-CSHL-0141-C18,23443700-fe39-4fd5-862f-ffb02cda3947,4985cf41-de70-458f-b1c6-efdf4e3eb663,189.0,Adjuvant,30.0,2021-07-12T12:25:55.528644-05:00,HCM-CSHL-0141-C18_treatment2,e1fb390c-ddc5-4e94-9344-8ffffc36e55f,,released,Leucovorin Calcium,1,2020-09-27T12:53:37.241394-05:00,Chemotherapy,Residual Disease,
HCM-CSHL-0141-C18,23443700-fe39-4fd5-862f-ffb02cda3947,4985cf41-de70-458f-b1c6-efdf4e3eb663,189.0,Adjuvant,30.0,2021-07-12T12:25:55.528644-05:00,HCM-CSHL-0141-C18_treatment5,e6c2a4c3-e6bf-4dc0-9f01-97184c694ab5,,released,,1,2020-09-27T12:53:37.241394-05:00,Chemotherapy,Residual Disease,FOLFOX
HCM-CSHL-0158-C20,24d58043-7070-4791-ac86-fdd4af8f2431,05ea5e59-b1e1-4852-afd0-fa83a479b5f3,300.0,Adjuvant,40.0,2020-10-20T19:20:06.800740-05:00,HCM-CSHL-0158-C20_treatment3,048dd01e-19e4-42ac-9992-48c2b2f6c852,,released,Fluorouracil,1,2020-02-27T12:48:29.327947-06:00,Chemotherapy,Residual Disease,
HCM-CSHL-0158-C20,24d58043-7070-4791-ac86-fdd4af8f2431,05ea5e59-b1e1-4852-afd0-fa83a479b5f3,,Adjuvant,657.0,2020-10-20T19:20:06.800740-05:00,HCM-CSHL-0158-C20_treatment11,13cc6804-a792-4b47-9d00-cd5d19ad7c39,Treatment Ongoing,released,Panitumumab,1,2020-09-27T13:01:16.920342-05:00,Targeted Molecular Therapy,Residual Disease,
HCM-CSHL-0158-C20,24d58043-7070-4791-ac86-fdd4af8f2431,05ea5e59-b1e1-4852-afd0-fa83a479b5f3,,,12.0,2023-03-13T12:41:23.183781-05:00,HCM-CSHL-0158-C20_treatment9,188a229c-e875-488a-ae7e-261d5c6d72ad,,released,,1,2020-09-27T13:01:16.920342-05:00,"Surgery, NOS",Initial Diagnosis,
HCM-CSHL-0158-C20,24d58043-7070-4791-ac86-fdd4af8f2431,05ea5e59-b1e1-4852-afd0-fa83a479b5f3,,Neoadjuvant,,2020-10-20T19:20:06.800740-05:00,HCM-CSHL-0158-C20_treatment,30ae3e82-0a06-420a-aeb1-472d5c303ab4,,released,,0,2020-02-27T12:48:29.327947-06:00,,,
HCM-CSHL-0158-C20,24d58043-7070-4791-ac86-fdd4af8f2431,05ea5e59-b1e1-4852-afd0-fa83a479b5f3,538.0,Adjuvant,462.0,2020-10-20T19:20:06.800740-05:00,HCM-CSHL-0158-C20_treatment10,337e25f1-3f07-4c62-9edf-31852b4fbb0e,,released,Panitumumab,1,2020-09-27T13:01:16.920342-05:00,Targeted Molecular Therapy,Residual Disease,
HCM-CSHL-0158-C20,24d58043-7070-4791-ac86-fdd4af8f2431,05ea5e59-b1e1-4852-afd0-fa83a479b5f3,,Adjuvant,657.0,2020-10-20T19:20:06.800740-05:00,HCM-CSHL-0158-C20_treatment7,5515fb26-c722-4ec7-a8c4-9b8ba7a02363,Treatment Ongoing,released,Irinotecan,1,2020-02-27T12:48:29.327947-06:00,Chemotherapy,Residual Disease,
HCM-CSHL-0158-C20,24d58043-7070-4791-ac86-fdd4af8f2431,05ea5e59-b1e1-4852-afd0-fa83a479b5f3,300.0,Adjuvant,40.0,2020-10-20T19:20:06.800740-05:00,HCM-CSHL-0158-C20_treatment4,987dbaf7-e147-4887-af61-678345156eb4,,released,Oxaliplatin,1,2020-02-27T12:48:29.327947-06:00,Chemotherapy,Residual Disease,
HCM-CSHL-0158-C20,24d58043-7070-4791-ac86-fdd4af8f2431,05ea5e59-b1e1-4852-afd0-fa83a479b5f3,538.0,Adjuvant,462.0,2020-10-20T19:20:06.800740-05:00,HCM-CSHL-0158-C20_treatment6,9ac79ea0-15e4-4fd1-a8ac-3fa7f876b13f,,released,Irinotecan,1,2020-02-27T12:48:29.327947-06:00,Chemotherapy,Residual Disease,
HCM-CSHL-0158-C20,24d58043-7070-4791-ac86-fdd4af8f2431,05ea5e59-b1e1-4852-afd0-fa83a479b5f3,300.0,Adjuvant,40.0,2020-10-20T19:20:06.800740-05:00,HCM-CSHL-0158-C20_treatment2,a86f861d-3797-4678-9fde-77cf0520ea20,,released,Leucovorin Calcium,1,2020-02-27T12:48:29.327947-06:00,Chemotherapy,Residual Disease,
HCM-CSHL-0158-C20,24d58043-7070-4791-ac86-fdd4af8f2431,05ea5e59-b1e1-4852-afd0-fa83a479b5f3,,Adjuvant,,2020-10-20T19:20:06.800740-05:00,HCM-CSHL-0158-C20_treatment12,c2cbd0dd-908c-40c7-94d6-7b3e4c65e45c,,released,,0,2020-09-27T13:01:16.920342-05:00,"Radiation Therapy, NOS",Residual Disease,
HCM-CSHL-0158-C20,24d58043-7070-4791-ac86-fdd4af8f2431,05ea5e59-b1e1-4852-afd0-fa83a479b5f3,300.0,Adjuvant,40.0,2020-10-20T19:20:06.800740-05:00,HCM-CSHL-0158-C20_treatment5,c307bc3f-18e5-4898-85a0-a2944dbe4be9,,released,,1,2020-02-27T12:48:29.327947-06:00,Chemotherapy,Residual Disease,FOLFOX
HCM-CSHL-0158-C20,24d58043-7070-4791-ac86-fdd4af8f2431,05ea5e59-b1e1-4852-afd0-fa83a479b5f3,,Adjuvant,,2020-10-20T19:20:06.800740-05:00,HCM-CSHL-0158-C20_treatment8,c6329b5d-2cc8-4d17-b6f3-8679604063b7,,released,,0,2020-02-27T12:48:29.327947-06:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-BROD-1186-C64,2539dadb-533b-4aa3-b9b1-475052a93551,c3657f42-faaf-4dac-994f-0fa66a716917,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-BROD-1186-C64_treatment3,50456ce6-697e-4231-8dc4-37d18783b453,,released,,0,2021-12-21T14:03:03.340777-06:00,Hormone Therapy,Residual Disease,
HCM-BROD-1186-C64,2539dadb-533b-4aa3-b9b1-475052a93551,c3657f42-faaf-4dac-994f-0fa66a716917,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-BROD-1186-C64_treatment7,87abe780-9452-46e3-9182-eaedc99070c9,,released,,0,2021-12-21T14:03:03.340777-06:00,"Radiation Therapy, NOS",Residual Disease,
HCM-BROD-1186-C64,2539dadb-533b-4aa3-b9b1-475052a93551,c3657f42-faaf-4dac-994f-0fa66a716917,,,13.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-1186-C64_treatment5,9d3da606-a2cd-4247-8ca0-92be7915f146,,released,,1,2021-12-21T14:03:03.340777-06:00,"Surgery, NOS",Initial Diagnosis,
HCM-BROD-1186-C64,2539dadb-533b-4aa3-b9b1-475052a93551,c3657f42-faaf-4dac-994f-0fa66a716917,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-BROD-1186-C64_treatment6,aef9caa1-01f4-4991-9a8c-335624b179df,,released,,0,2021-12-21T14:03:03.340777-06:00,Targeted Molecular Therapy,Residual Disease,
HCM-BROD-1186-C64,2539dadb-533b-4aa3-b9b1-475052a93551,c3657f42-faaf-4dac-994f-0fa66a716917,143.0,Adjuvant,55.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-1186-C64_treatment2,d98828df-fb2d-4373-91f1-af6af35ba7df,Treatment Ongoing,released,Carboplatin,1,2021-12-21T14:03:03.340777-06:00,Chemotherapy,Residual Disease,
HCM-BROD-1186-C64,2539dadb-533b-4aa3-b9b1-475052a93551,c3657f42-faaf-4dac-994f-0fa66a716917,,Neoadjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-BROD-1186-C64_treatment,ee2a5b56-d828-4027-987b-058eaa10dce7,,released,,0,2021-12-21T14:03:03.340777-06:00,,,
HCM-BROD-1186-C64,2539dadb-533b-4aa3-b9b1-475052a93551,c3657f42-faaf-4dac-994f-0fa66a716917,143.0,Adjuvant,55.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-1186-C64_treatment4,ff2e6a5a-b39a-440d-bde2-91004bb30868,Treatment Ongoing,released,Nivolumab,1,2021-12-21T14:03:03.340777-06:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-SANG-1089-C18,267f7bca-ae79-4066-9657-a42407f570a4,11faa574-0363-446c-9ac4-b1204d5d1184,,Neoadjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-SANG-1089-C18_treatment,93a4eb3a-6f97-45ae-b288-a9243937181e,,released,,0,2023-02-27T11:55:52.445394-06:00,,,
HCM-CSHL-0806-C54,27d256aa-9f73-47e0-8eec-7814c019bb45,b850de55-0c34-46b1-a1f1-2a3f4f61e29b,,Adjuvant,,2023-11-07T14:20:00.017270-06:00,HCM-CSHL-0806-C54_treatment7,5a3173f2-4ade-4e80-9b96-0fe29d7cab03,,released,,0,2021-12-21T14:26:36.514249-06:00,Targeted Molecular Therapy,Residual Disease,
HCM-CSHL-0806-C54,27d256aa-9f73-47e0-8eec-7814c019bb45,b850de55-0c34-46b1-a1f1-2a3f4f61e29b,164.0,Adjuvant,60.0,2023-11-07T14:20:00.017270-06:00,HCM-CSHL-0806-C54_treatment3,89b1ccd1-2d03-4b7d-add7-b71208ab2161,,released,Paclitaxel,1,2021-12-21T14:26:36.514249-06:00,Chemotherapy,Residual Disease,
HCM-CSHL-0806-C54,27d256aa-9f73-47e0-8eec-7814c019bb45,b850de55-0c34-46b1-a1f1-2a3f4f61e29b,164.0,Adjuvant,60.0,2023-11-07T14:20:00.017270-06:00,HCM-CSHL-0806-C54_treatment2,8dca11d6-e1ec-42ba-acf7-cf3fab0da6e9,,released,Carboplatin,1,2021-12-21T14:26:36.514249-06:00,Chemotherapy,Residual Disease,
HCM-CSHL-0806-C54,27d256aa-9f73-47e0-8eec-7814c019bb45,b850de55-0c34-46b1-a1f1-2a3f4f61e29b,,,0.0,2023-11-07T14:20:00.017270-06:00,HCM-CSHL-0806-C54_treatment6,ab02fe21-6751-47e2-833c-39d02cf9615f,,released,,1,2021-12-21T14:26:36.514249-06:00,"Surgery, NOS",Initial Diagnosis,
HCM-CSHL-0806-C54,27d256aa-9f73-47e0-8eec-7814c019bb45,b850de55-0c34-46b1-a1f1-2a3f4f61e29b,254.0,Adjuvant,192.0,2023-11-07T14:20:00.017270-06:00,HCM-CSHL-0806-C54_treatment8,b5db5213-0959-4b5b-8c6c-6404b352c0c2,,released,,1,2021-12-21T14:26:36.514249-06:00,"Radiation, Intensity-Modulated Radiotherapy",Residual Disease,
HCM-CSHL-0806-C54,27d256aa-9f73-47e0-8eec-7814c019bb45,b850de55-0c34-46b1-a1f1-2a3f4f61e29b,,Neoadjuvant,,2023-11-07T14:20:00.017270-06:00,HCM-CSHL-0806-C54_treatment,c36648e8-f122-4065-b77c-3a083c1baaac,,released,,0,2021-12-21T14:26:36.514249-06:00,,,
HCM-CSHL-0806-C54,27d256aa-9f73-47e0-8eec-7814c019bb45,b850de55-0c34-46b1-a1f1-2a3f4f61e29b,,Adjuvant,,2023-11-07T14:20:00.017270-06:00,HCM-CSHL-0806-C54_treatment5,ef50868e-4fdd-4510-9956-a06edecadb70,,released,,0,2021-12-21T14:26:36.514249-06:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-CSHL-0806-C54,27d256aa-9f73-47e0-8eec-7814c019bb45,b850de55-0c34-46b1-a1f1-2a3f4f61e29b,,Adjuvant,,2023-11-07T14:20:00.017270-06:00,HCM-CSHL-0806-C54_treatment4,fbb58f94-0398-49c9-a1e7-c1e9496f60b4,,released,,0,2021-12-21T14:26:36.514249-06:00,Hormone Therapy,Residual Disease,
HCM-CSHL-0079-C25,27e13777-6ed1-4411-a935-245ba6953cf5,6e120ed7-9f57-4ecf-ba20-d56eefeaa97e,,Neoadjuvant,,2020-10-20T19:20:06.800740-05:00,HCM-CSHL-0079-C25_treatment,0a871992-1572-49f4-bdb2-9add21ddbc2b,,released,,0,2020-02-27T13:23:43.301369-06:00,,,
HCM-CSHL-0079-C25,27e13777-6ed1-4411-a935-245ba6953cf5,6e120ed7-9f57-4ecf-ba20-d56eefeaa97e,,Adjuvant,,2020-10-20T19:20:06.800740-05:00,HCM-CSHL-0079-C25_treatment2,0f20fc49-7ed2-46e0-8c83-5e8ed814963f,,released,Gemcitabine,1,2020-02-27T13:23:43.301369-06:00,Chemotherapy,Residual Disease,
HCM-CSHL-0079-C25,27e13777-6ed1-4411-a935-245ba6953cf5,6e120ed7-9f57-4ecf-ba20-d56eefeaa97e,,Adjuvant,,2020-10-20T19:20:06.800740-05:00,HCM-CSHL-0079-C25_treatment6,52e03ea4-d5cc-45be-bafc-324438259984,,released,,0,2020-02-27T13:23:43.301369-06:00,Targeted Molecular Therapy,Residual Disease,
HCM-CSHL-0079-C25,27e13777-6ed1-4411-a935-245ba6953cf5,6e120ed7-9f57-4ecf-ba20-d56eefeaa97e,,Adjuvant,,2020-10-20T19:20:06.800740-05:00,HCM-CSHL-0079-C25_treatment7,b4161c12-e42b-417d-a11c-a903159779e3,,released,,0,2020-06-15T12:50:05.758097-05:00,"Radiation Therapy, NOS",Residual Disease,
HCM-CSHL-0079-C25,27e13777-6ed1-4411-a935-245ba6953cf5,6e120ed7-9f57-4ecf-ba20-d56eefeaa97e,,,-19.0,2023-02-27T11:48:29.690584-06:00,HCM-CSHL-0079-C25_treatment5,d74e078f-0b70-4078-8c9e-cc666e2f37f2,,released,,1,2020-02-27T13:23:43.301369-06:00,"Surgery, NOS",Initial Diagnosis,
HCM-CSHL-0079-C25,27e13777-6ed1-4411-a935-245ba6953cf5,6e120ed7-9f57-4ecf-ba20-d56eefeaa97e,,Adjuvant,,2020-10-20T19:20:06.800740-05:00,HCM-CSHL-0079-C25_treatment3,da65efd5-12aa-4db4-964c-16a8459a60b1,,released,Nab-paclitaxel,1,2020-02-27T13:23:43.301369-06:00,Chemotherapy,Residual Disease,
HCM-CSHL-0079-C25,27e13777-6ed1-4411-a935-245ba6953cf5,6e120ed7-9f57-4ecf-ba20-d56eefeaa97e,,Adjuvant,,2020-10-20T19:20:06.800740-05:00,HCM-CSHL-0079-C25_treatment4,dcd92441-a7e1-4bce-961e-ba72b9a5d4fc,,released,,0,2020-02-27T13:23:43.301369-06:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-BROD-0873-C43,284c98af-cf5d-4f6a-9994-4d99a2ad8aeb,84a23d91-a55f-46da-9f79-50b2fcd41e0f,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0873-C43_treatment2,00bbca24-27b5-446e-a97a-42f174e2bb5d,,released,,0,2021-12-21T13:56:23.281428-06:00,Chemotherapy,Residual Disease,
HCM-BROD-0873-C43,284c98af-cf5d-4f6a-9994-4d99a2ad8aeb,84a23d91-a55f-46da-9f79-50b2fcd41e0f,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0873-C43_treatment3,10ff938a-e8b4-445f-a6eb-d0eb7637f66d,,released,,0,2021-12-21T13:56:23.281428-06:00,Hormone Therapy,Residual Disease,
HCM-BROD-0873-C43,284c98af-cf5d-4f6a-9994-4d99a2ad8aeb,84a23d91-a55f-46da-9f79-50b2fcd41e0f,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0873-C43_treatment7,49882cd9-8a08-4926-ae67-dcc7933061af,,released,,0,2021-12-21T13:56:23.281428-06:00,"Radiation Therapy, NOS",Residual Disease,
HCM-BROD-0873-C43,284c98af-cf5d-4f6a-9994-4d99a2ad8aeb,84a23d91-a55f-46da-9f79-50b2fcd41e0f,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0873-C43_treatment6,7f0b3564-522c-4afb-9c0b-ae1506d9d2ad,,released,,0,2021-12-21T13:56:23.281428-06:00,Targeted Molecular Therapy,Residual Disease,
HCM-BROD-0873-C43,284c98af-cf5d-4f6a-9994-4d99a2ad8aeb,84a23d91-a55f-46da-9f79-50b2fcd41e0f,,,2.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0873-C43_treatment5,9ee8b828-d86c-4c7e-a8cf-6ca283f2b904,,released,,1,2021-12-21T13:56:23.281428-06:00,"Surgery, NOS",Initial Diagnosis,
HCM-BROD-0873-C43,284c98af-cf5d-4f6a-9994-4d99a2ad8aeb,84a23d91-a55f-46da-9f79-50b2fcd41e0f,192.0,Adjuvant,94.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0873-C43_treatment4,da7e8e46-c1f2-49fc-b148-6514dc265c5a,,released,Nivolumab,1,2021-12-21T13:56:23.281428-06:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-BROD-0873-C43,284c98af-cf5d-4f6a-9994-4d99a2ad8aeb,84a23d91-a55f-46da-9f79-50b2fcd41e0f,,Neoadjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0873-C43_treatment,e8195205-8647-4e93-beb1-473ea001e7b6,,released,,0,2021-12-21T13:56:23.281428-06:00,,,
HCM-BROD-0208-C16,288f90bf-43fc-40ef-b3fa-40f35ce0007e,20d7f1bf-2fa9-4984-9a25-dfedc8a76bc5,,Adjuvant,,2021-07-12T12:25:55.528644-05:00,HCM-BROD-0208-C16_treatment9,0757e60f-5bdd-478e-8224-6f7c4453505b,,released,,0,2020-09-27T10:59:04.648230-05:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-BROD-0208-C16,288f90bf-43fc-40ef-b3fa-40f35ce0007e,20d7f1bf-2fa9-4984-9a25-dfedc8a76bc5,192.0,Adjuvant,165.0,2021-07-12T12:25:55.528644-05:00,HCM-BROD-0208-C16_treatment3,5e31ae72-1f75-4b5e-a74f-b17e601b07cf,,released,Oxaliplatin,1,2020-02-11T15:46:21.987672-06:00,Chemotherapy,Residual Disease,
HCM-BROD-0208-C16,288f90bf-43fc-40ef-b3fa-40f35ce0007e,20d7f1bf-2fa9-4984-9a25-dfedc8a76bc5,,Adjuvant,,2021-07-12T12:25:55.528644-05:00,HCM-BROD-0208-C16_treatment12,69f95a9c-e24b-4104-bdf0-7886fccb85f7,,released,,0,2020-09-27T10:59:04.648230-05:00,"Radiation Therapy, NOS",Residual Disease,
HCM-BROD-0208-C16,288f90bf-43fc-40ef-b3fa-40f35ce0007e,20d7f1bf-2fa9-4984-9a25-dfedc8a76bc5,658.0,Adjuvant,461.0,2021-07-12T12:25:55.528644-05:00,HCM-BROD-0208-C16_treatment8,78f5b2f1-9f10-4d89-95fd-310b74ce466f,Treatment Ongoing,released,,1,2020-09-27T10:59:04.648230-05:00,Chemotherapy,Residual Disease,FOLFIRI
HCM-BROD-0208-C16,288f90bf-43fc-40ef-b3fa-40f35ce0007e,20d7f1bf-2fa9-4984-9a25-dfedc8a76bc5,,Neoadjuvant,,2021-07-12T12:25:55.528644-05:00,HCM-BROD-0208-C16_treatment,8989be34-c8d4-414d-b926-98f1565a3fcd,,released,Unknown,1,2020-02-11T15:46:21.987672-06:00,Chemotherapy,,
HCM-BROD-0208-C16,288f90bf-43fc-40ef-b3fa-40f35ce0007e,20d7f1bf-2fa9-4984-9a25-dfedc8a76bc5,,Adjuvant,,2021-07-12T12:25:55.528644-05:00,HCM-BROD-0208-C16_treatment11,8caa9180-ee74-4a0e-91e4-130a9ec4277c,,released,,0,2020-09-27T10:59:04.648230-05:00,Targeted Molecular Therapy,Residual Disease,
HCM-BROD-0208-C16,288f90bf-43fc-40ef-b3fa-40f35ce0007e,20d7f1bf-2fa9-4984-9a25-dfedc8a76bc5,192.0,Adjuvant,165.0,2021-07-12T12:25:55.528644-05:00,HCM-BROD-0208-C16_treatment4,9baec952-ca96-4d1a-ac24-f65960f1a5f2,,released,Docetaxel,1,2020-02-11T15:46:21.987672-06:00,Chemotherapy,Residual Disease,
HCM-BROD-0208-C16,288f90bf-43fc-40ef-b3fa-40f35ce0007e,20d7f1bf-2fa9-4984-9a25-dfedc8a76bc5,658.0,Adjuvant,461.0,2021-07-12T12:25:55.528644-05:00,HCM-BROD-0208-C16_treatment6,a36a87cb-93d3-4a6b-9884-3f4630fab3c5,Treatment Ongoing,released,Fluorouracil,1,2020-02-11T15:46:21.987672-06:00,Chemotherapy,Residual Disease,
HCM-BROD-0208-C16,288f90bf-43fc-40ef-b3fa-40f35ce0007e,20d7f1bf-2fa9-4984-9a25-dfedc8a76bc5,192.0,Adjuvant,165.0,2021-07-12T12:25:55.528644-05:00,HCM-BROD-0208-C16_treatment2,a65f5b08-6d18-4253-904c-326a66983569,,released,Fluorouracil,1,2020-02-11T15:46:21.987672-06:00,Chemotherapy,Residual Disease,
HCM-BROD-0208-C16,288f90bf-43fc-40ef-b3fa-40f35ce0007e,20d7f1bf-2fa9-4984-9a25-dfedc8a76bc5,,,122.0,2023-02-27T11:38:12.773337-06:00,HCM-BROD-0208-C16_treatment10,c27713be-a8fa-43cb-a8b1-e28694ac6f81,,released,,1,2020-09-27T10:59:04.648230-05:00,"Surgery, NOS",Initial Diagnosis,
HCM-BROD-0208-C16,288f90bf-43fc-40ef-b3fa-40f35ce0007e,20d7f1bf-2fa9-4984-9a25-dfedc8a76bc5,658.0,Adjuvant,461.0,2021-07-12T12:25:55.528644-05:00,HCM-BROD-0208-C16_treatment7,f28f99e7-b33c-4054-b876-7b016ef726ab,Treatment Ongoing,released,Irinotecan,1,2020-02-11T15:46:21.987672-06:00,Chemotherapy,Residual Disease,
HCM-BROD-0208-C16,288f90bf-43fc-40ef-b3fa-40f35ce0007e,20d7f1bf-2fa9-4984-9a25-dfedc8a76bc5,658.0,Adjuvant,461.0,2021-07-12T12:25:55.528644-05:00,HCM-BROD-0208-C16_treatment5,f5263429-cc67-4e27-9bf5-332eba50a092,Treatment Ongoing,released,Leucovorin Calcium,1,2020-02-11T15:46:21.987672-06:00,Chemotherapy,Residual Disease,
HCM-CSHL-0255-C18,28dbcedb-a919-4fee-86a3-a3de2f0ce254,2044d8c2-dd27-44ee-800f-5c8fcca45466,,Neoadjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0255-C18_treatment,6a2ed170-ebba-4949-bc0a-05838603d0e5,,released,,0,2020-09-28T09:36:26.618730-05:00,,,
HCM-CSHL-0255-C18,28dbcedb-a919-4fee-86a3-a3de2f0ce254,2044d8c2-dd27-44ee-800f-5c8fcca45466,,Adjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0255-C18_treatment4,79be2a8c-d085-48db-8903-abf98c945885,,released,,0,2020-09-28T09:36:26.618730-05:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-CSHL-0255-C18,28dbcedb-a919-4fee-86a3-a3de2f0ce254,2044d8c2-dd27-44ee-800f-5c8fcca45466,,Adjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0255-C18_treatment6,91bc13c2-3fcb-4ec9-9fe2-d186e1d88bb4,,released,,0,2020-09-28T09:36:26.618730-05:00,Targeted Molecular Therapy,Residual Disease,
HCM-CSHL-0255-C18,28dbcedb-a919-4fee-86a3-a3de2f0ce254,2044d8c2-dd27-44ee-800f-5c8fcca45466,,,16.0,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0255-C18_treatment5,b551f4b7-1871-478f-8fbe-bc0168523698,,released,,1,2020-09-28T09:36:26.618730-05:00,"Surgery, NOS",Initial Diagnosis,
HCM-CSHL-0255-C18,28dbcedb-a919-4fee-86a3-a3de2f0ce254,2044d8c2-dd27-44ee-800f-5c8fcca45466,,Adjuvant,64.0,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0255-C18_treatment2,ec462ecc-996b-40e0-9c8d-9f41e37f8f4e,,released,Capecitabine,1,2020-09-28T09:36:26.618730-05:00,Chemotherapy,Residual Disease,
HCM-CSHL-0255-C18,28dbcedb-a919-4fee-86a3-a3de2f0ce254,2044d8c2-dd27-44ee-800f-5c8fcca45466,,Adjuvant,64.0,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0255-C18_treatment3,fd634d6c-27df-46d2-9922-694903decb4d,,released,Oxaliplatin,1,2020-09-28T09:36:26.618730-05:00,Chemotherapy,Residual Disease,
HCM-CSHL-0255-C18,28dbcedb-a919-4fee-86a3-a3de2f0ce254,2044d8c2-dd27-44ee-800f-5c8fcca45466,,Adjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0255-C18_treatment7,fd9a23c3-27d7-407a-8df4-6fdc28f9c03f,,released,,0,2020-09-28T09:36:26.618730-05:00,"Radiation Therapy, NOS",Residual Disease,
HCM-CSHL-0727-C18,28f77d34-e59d-4b80-8885-88d11c2ced74,2833b1ba-f46b-4fbc-8ed1-ae4c1f342654,,Adjuvant,,2023-02-22T07:39:25.979291-06:00,HCM-CSHL-0727-C18_treatment5,350eec24-26f6-4d58-9576-d0ce96f1910c,,released,,0,2021-12-21T14:18:56.750090-06:00,Targeted Molecular Therapy,Residual Disease,
HCM-CSHL-0727-C18,28f77d34-e59d-4b80-8885-88d11c2ced74,2833b1ba-f46b-4fbc-8ed1-ae4c1f342654,,Adjuvant,,2023-02-22T07:39:25.979291-06:00,HCM-CSHL-0727-C18_treatment3,47968968-7dd7-4f52-aebd-bf8af1a8f7ad,,released,,0,2021-12-21T14:18:56.750090-06:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-CSHL-0727-C18,28f77d34-e59d-4b80-8885-88d11c2ced74,2833b1ba-f46b-4fbc-8ed1-ae4c1f342654,,Neoadjuvant,,2023-02-22T07:39:25.979291-06:00,HCM-CSHL-0727-C18_treatment,509304b9-5270-45ce-9737-f119c2b1d886,,released,,0,2021-12-21T14:18:56.750090-06:00,,,
HCM-CSHL-0727-C18,28f77d34-e59d-4b80-8885-88d11c2ced74,2833b1ba-f46b-4fbc-8ed1-ae4c1f342654,,,91.0,2023-03-13T13:01:05.369786-05:00,HCM-CSHL-0727-C18_treatment4,65c83a2d-a56c-4c1a-9400-04456d2090dc,,released,,1,2021-12-21T14:18:56.750090-06:00,"Surgery, NOS",Initial Diagnosis,
HCM-CSHL-0727-C18,28f77d34-e59d-4b80-8885-88d11c2ced74,2833b1ba-f46b-4fbc-8ed1-ae4c1f342654,,Adjuvant,,2023-02-22T07:39:25.979291-06:00,HCM-CSHL-0727-C18_treatment6,6b788707-ebd3-4c7b-b4ba-33e3e52990fb,,released,,0,2021-12-21T14:18:56.750090-06:00,"Radiation Therapy, NOS",Residual Disease,
HCM-CSHL-0727-C18,28f77d34-e59d-4b80-8885-88d11c2ced74,2833b1ba-f46b-4fbc-8ed1-ae4c1f342654,307.0,Adjuvant,139.0,2023-02-22T07:39:25.979291-06:00,HCM-CSHL-0727-C18_treatment2,c000c2ed-2c27-4d1c-9913-eeecfaaa4bf5,,released,Capecitabine,1,2021-12-21T14:18:56.750090-06:00,Chemotherapy,Residual Disease,
HCM-SANG-0286-C20,291bc57c-0163-4dae-8eab-afb756a565e6,5d161d86-206d-4157-9a99-366aa6027caa,,Neoadjuvant,713.0,2023-03-13T13:09:06.826915-05:00,HCM-SANG-0286-C20_treatment,1ec2339d-ca78-4d46-9122-735ff0d3ce22,,released,Oxaliplatin,1,2021-12-21T15:08:36.662144-06:00,Chemotherapy,,
HCM-SANG-0286-C20,291bc57c-0163-4dae-8eab-afb756a565e6,5d161d86-206d-4157-9a99-366aa6027caa,,Neoadjuvant,713.0,2023-03-13T13:09:06.826915-05:00,HCM-SANG-0286-C20_treatment2,2c4d1ee0-fda5-4399-8725-61d437f2712d,,released,Dexamethasone,1,2021-12-21T15:08:36.662144-06:00,Chemotherapy,,
HCM-SANG-0286-C20,291bc57c-0163-4dae-8eab-afb756a565e6,5d161d86-206d-4157-9a99-366aa6027caa,,Neoadjuvant,713.0,2023-03-13T13:09:06.826915-05:00,HCM-SANG-0286-C20_treatment3,8757ee5f-2279-413b-872f-e9674ef497d0,,released,Bevacizumab,1,2021-12-21T15:08:36.662144-06:00,Targeted Molecular Therapy,,
HCM-CSHL-0250-C50,291dcbe0-c3cb-48ae-a988-b217fc840a5c,be5d793b-c1a1-46c2-aef3-d41a949ff8ae,,Adjuvant,,2023-02-22T07:39:25.979291-06:00,HCM-CSHL-0250-C50_treatment7,2d7a9867-8214-48ce-a7b7-854a2b7f6319,,released,,0,2020-09-28T09:34:37.567256-05:00,Targeted Molecular Therapy,Residual Disease,
HCM-CSHL-0250-C50,291dcbe0-c3cb-48ae-a988-b217fc840a5c,be5d793b-c1a1-46c2-aef3-d41a949ff8ae,,Adjuvant,,2023-02-22T07:39:25.979291-06:00,HCM-CSHL-0250-C50_treatment8,4e0a0c1d-4f8d-472f-947d-66199af4f77d,,released,,0,2020-09-28T09:34:37.567256-05:00,"Radiation Therapy, NOS",Residual Disease,
HCM-CSHL-0250-C50,291dcbe0-c3cb-48ae-a988-b217fc840a5c,be5d793b-c1a1-46c2-aef3-d41a949ff8ae,,Neoadjuvant,,2023-02-22T07:39:25.979291-06:00,HCM-CSHL-0250-C50_treatment,4ec82461-578d-4eea-ba74-0713d46aed60,,released,,0,2020-09-28T09:34:37.567256-05:00,,,
HCM-CSHL-0250-C50,291dcbe0-c3cb-48ae-a988-b217fc840a5c,be5d793b-c1a1-46c2-aef3-d41a949ff8ae,,,39.0,2023-02-24T14:43:30.006889-06:00,HCM-CSHL-0250-C50_treatment6,4ecd23e8-c6a0-461c-9890-f23df0bed657,,released,,1,2020-09-28T09:34:37.567256-05:00,"Surgery, NOS",Initial Diagnosis,
HCM-CSHL-0250-C50,291dcbe0-c3cb-48ae-a988-b217fc840a5c,be5d793b-c1a1-46c2-aef3-d41a949ff8ae,,Adjuvant,,2023-02-22T07:39:25.979291-06:00,HCM-CSHL-0250-C50_treatment3,5bd29428-4a0d-40c3-8cfb-0e405f728351,,released,Cyclophosphamide,1,2020-09-28T09:34:37.567256-05:00,Chemotherapy,Residual Disease,
HCM-CSHL-0250-C50,291dcbe0-c3cb-48ae-a988-b217fc840a5c,be5d793b-c1a1-46c2-aef3-d41a949ff8ae,,Adjuvant,,2023-02-22T07:39:25.979291-06:00,HCM-CSHL-0250-C50_treatment2,6420ce44-5b0f-44e0-9c59-50dddb5ebdef,,released,Docetaxel,1,2020-09-28T09:34:37.567256-05:00,Chemotherapy,Residual Disease,
HCM-CSHL-0250-C50,291dcbe0-c3cb-48ae-a988-b217fc840a5c,be5d793b-c1a1-46c2-aef3-d41a949ff8ae,,Adjuvant,,2023-02-22T07:39:25.979291-06:00,HCM-CSHL-0250-C50_treatment5,83b78695-e287-4942-8668-5eb69b824b44,,released,,0,2020-09-28T09:34:37.567256-05:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-CSHL-0250-C50,291dcbe0-c3cb-48ae-a988-b217fc840a5c,be5d793b-c1a1-46c2-aef3-d41a949ff8ae,203.0,Adjuvant,152.0,2023-02-22T07:39:25.979291-06:00,HCM-CSHL-0250-C50_treatment4,a3f5fabb-c67b-46db-b79c-e004826dc78b,,released,Not Reported,1,2020-09-28T09:34:37.567256-05:00,Hormone Therapy,Residual Disease,
HCM-SANG-0551-C18,29730787-a20b-4957-8b5c-afc8a3e4a7db,0bf5c29a-33bf-46ce-81f6-2c9f3c89da70,,Neoadjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-SANG-0551-C18_treatment,d26a2a78-4f39-4e41-9089-782cee55fa50,,released,,0,2021-12-21T15:17:21.484672-06:00,,,
HCM-SANG-0275-C18,29df97f4-6e7e-48a0-a320-09df82fc0b81,c5277378-c3f8-4bfb-920e-111824621c28,,Neoadjuvant,,2023-11-07T14:28:29.403873-06:00,HCM-SANG-0275-C18_treatment,c817ad0f-503e-4ba4-99ac-9b1a11e99c7c,,released,,0,2021-12-21T15:06:49.907685-06:00,,,
HCM-SANG-0543-C15,2a12f40c-d79a-4e24-a0f1-bf80a65c62d4,05d118ee-a09f-40b7-aa68-81700a5a0958,,Neoadjuvant,103.0,2025-03-31T16:34:59.906497-05:00,HCM-SANG-0543-C15_treatment,472e7ef4-2086-4555-9173-f73ded1d7fbf,,released,Oxaliplatin,1,2023-02-27T12:13:45.942880-06:00,Chemotherapy,,
HCM-SANG-0543-C15,2a12f40c-d79a-4e24-a0f1-bf80a65c62d4,05d118ee-a09f-40b7-aa68-81700a5a0958,,Neoadjuvant,103.0,2025-03-31T16:34:59.906497-05:00,HCM-SANG-0543-C15_treatment2,cf794855-3c92-4660-9cb9-9c75674138cd,,released,Capecitabine,1,2023-02-27T12:13:45.942880-06:00,Chemotherapy,,
HCM-BROD-0008-C25,2a40e945-95d5-4f4d-9865-b3dc2a27782c,1d096cb3-570b-4cc6-983f-fe142192cf4c,,Neoadjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0008-C25_treatment,3a138ef8-98ab-443c-9458-129f44e95082,,released,,0,2019-04-16T11:16:53.684381-05:00,,,
HCM-BROD-0008-C25,2a40e945-95d5-4f4d-9865-b3dc2a27782c,1d096cb3-570b-4cc6-983f-fe142192cf4c,,,,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0008-C25_treatment2,42f66a00-58d4-459d-a623-a8ba3670660f,,released,,unknown,2019-04-16T11:16:53.684381-05:00,"Surgery, NOS",Initial Diagnosis,
HCM-BROD-0008-C25,2a40e945-95d5-4f4d-9865-b3dc2a27782c,1d096cb3-570b-4cc6-983f-fe142192cf4c,,Adjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0008-C25_treatment4,ad7137d0-c0f0-434d-8c6e-c3338756e90e,,released,,0,2019-04-16T11:16:53.684381-05:00,"Radiation Therapy, NOS",Residual Disease,
HCM-BROD-0008-C25,2a40e945-95d5-4f4d-9865-b3dc2a27782c,1d096cb3-570b-4cc6-983f-fe142192cf4c,,Adjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0008-C25_treatment3,e7f14641-cc0b-4b32-a5ca-ee99ea2cbe78,,released,,0,2019-04-16T11:16:53.684381-05:00,"Pharmaceutical Therapy, NOS",Residual Disease,
HCM-BROD-0475-C16,2ae5f389-df9b-46d8-8234-193bc40fe742,feab693d-b0cb-4bda-8956-eb4d28ee4e54,,Neoadjuvant,17.0,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0475-C16_treatment,0e429a19-e2b5-4219-b0ab-0f6787b999a7,,released,Oxaliplatin,1,2020-10-08T14:45:50.496219-05:00,Chemotherapy,,
HCM-BROD-0475-C16,2ae5f389-df9b-46d8-8234-193bc40fe742,feab693d-b0cb-4bda-8956-eb4d28ee4e54,441.0,Adjuvant,402.0,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0475-C16_treatment4,13c87f48-d97b-46c6-a2b2-7bc95a032234,,released,Paclitaxel,1,2020-10-08T14:45:50.496219-05:00,Chemotherapy,Residual Disease,
HCM-BROD-0475-C16,2ae5f389-df9b-46d8-8234-193bc40fe742,feab693d-b0cb-4bda-8956-eb4d28ee4e54,,,,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0475-C16_treatment6,7302f5f5-4102-41c3-ab26-5f5c5ee9163f,,released,,unknown,2020-10-08T14:45:50.496219-05:00,"Surgery, NOS",Initial Diagnosis,
HCM-BROD-0475-C16,2ae5f389-df9b-46d8-8234-193bc40fe742,feab693d-b0cb-4bda-8956-eb4d28ee4e54,,Adjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0475-C16_treatment7,76658278-5520-4c93-96de-8bbcfd8eb9fe,,released,,0,2020-10-08T14:45:50.496219-05:00,Targeted Molecular Therapy,Residual Disease,
HCM-BROD-0475-C16,2ae5f389-df9b-46d8-8234-193bc40fe742,feab693d-b0cb-4bda-8956-eb4d28ee4e54,,Neoadjuvant,17.0,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0475-C16_treatment3,7e2b3636-eee6-4d75-a5d0-846508e86013,,released,Fluorouracil,1,2020-10-08T14:45:50.496219-05:00,Chemotherapy,,
HCM-BROD-0475-C16,2ae5f389-df9b-46d8-8234-193bc40fe742,feab693d-b0cb-4bda-8956-eb4d28ee4e54,,Adjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0475-C16_treatment8,9ab03115-f3cd-4b42-ac84-5a480c1fe3c3,,released,,0,2020-10-08T14:45:50.496219-05:00,"Radiation Therapy, NOS",Residual Disease,
HCM-BROD-0475-C16,2ae5f389-df9b-46d8-8234-193bc40fe742,feab693d-b0cb-4bda-8956-eb4d28ee4e54,,Neoadjuvant,17.0,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0475-C16_treatment2,b9699a54-a5c3-477e-b41a-219e200b9b85,,released,Docetaxel,1,2020-10-08T14:45:50.496219-05:00,Chemotherapy,,
HCM-BROD-0475-C16,2ae5f389-df9b-46d8-8234-193bc40fe742,feab693d-b0cb-4bda-8956-eb4d28ee4e54,,Adjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0475-C16_treatment5,f5a5c4e8-3341-4f91-b66e-14bf8cc85242,,released,,0,2020-10-08T14:45:50.496219-05:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-BROD-0411-C25,2b1c768d-fbc5-4956-b834-dff3b3559e75,d02eb1ee-62f2-49af-bade-15e75745bf3b,,Adjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0411-C25_treatment2,1d0b2679-7616-4ec5-b00d-35770ffa2e22,,released,,0,2020-09-27T11:30:21.442104-05:00,Chemotherapy,Residual Disease,
HCM-BROD-0411-C25,2b1c768d-fbc5-4956-b834-dff3b3559e75,d02eb1ee-62f2-49af-bade-15e75745bf3b,,Adjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0411-C25_treatment3,20f5a531-09f6-4c56-a540-3706f74ed835,,released,,0,2020-09-27T11:30:21.442104-05:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-BROD-0411-C25,2b1c768d-fbc5-4956-b834-dff3b3559e75,d02eb1ee-62f2-49af-bade-15e75745bf3b,,Adjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0411-C25_treatment6,3859eec1-6efa-4022-b7d6-d715ae08c2c2,,released,,0,2020-09-27T11:30:21.442104-05:00,"Radiation Therapy, NOS",Residual Disease,
HCM-BROD-0411-C25,2b1c768d-fbc5-4956-b834-dff3b3559e75,d02eb1ee-62f2-49af-bade-15e75745bf3b,,Neoadjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0411-C25_treatment,8b7c35fa-bcf7-4404-a7f4-dbafacaa92b5,,released,,0,2020-09-27T11:30:21.442104-05:00,,,
HCM-BROD-0411-C25,2b1c768d-fbc5-4956-b834-dff3b3559e75,d02eb1ee-62f2-49af-bade-15e75745bf3b,,,,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0411-C25_treatment4,b0cc1a82-d08a-4fa4-b5bb-7bb672708079,,released,,0,2020-09-27T11:30:21.442104-05:00,"Surgery, NOS",Initial Diagnosis,
HCM-BROD-0411-C25,2b1c768d-fbc5-4956-b834-dff3b3559e75,d02eb1ee-62f2-49af-bade-15e75745bf3b,,Adjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0411-C25_treatment5,bda36d22-9ffe-43c9-8974-b035763d074e,,released,,0,2020-09-27T11:30:21.442104-05:00,Targeted Molecular Therapy,Residual Disease,
HCM-BROD-0458-C15,2b746913-bcba-4374-a6a0-0350ff814041,684fc7e4-8839-4b68-a812-6d2524947940,,Adjuvant,,2021-07-12T12:25:55.528644-05:00,HCM-BROD-0458-C15_treatment6,6a064d60-7213-44e5-85aa-4ed9762de823,,released,,0,2020-09-27T11:40:20.063316-05:00,"Radiation Therapy, NOS",Residual Disease,
HCM-BROD-0458-C15,2b746913-bcba-4374-a6a0-0350ff814041,684fc7e4-8839-4b68-a812-6d2524947940,,,249.0,2023-02-27T12:28:48.906509-06:00,HCM-BROD-0458-C15_treatment4,6e043851-1f67-44c0-b9c1-d2b9a49ef055,,released,,1,2020-09-27T11:40:20.063316-05:00,"Surgery, NOS",Initial Diagnosis,
HCM-BROD-0458-C15,2b746913-bcba-4374-a6a0-0350ff814041,684fc7e4-8839-4b68-a812-6d2524947940,,Adjuvant,,2021-07-12T12:25:55.528644-05:00,HCM-BROD-0458-C15_treatment3,8a5ddc62-a77e-4857-918e-b074e1996a0d,,released,,0,2020-09-27T11:40:20.063316-05:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-BROD-0458-C15,2b746913-bcba-4374-a6a0-0350ff814041,684fc7e4-8839-4b68-a812-6d2524947940,,Neoadjuvant,,2021-07-12T12:25:55.528644-05:00,HCM-BROD-0458-C15_treatment,cf4e8b35-b8e6-4611-aefe-ccea7cd817b4,,released,,0,2020-09-27T11:40:20.063316-05:00,,,
HCM-BROD-0458-C15,2b746913-bcba-4374-a6a0-0350ff814041,684fc7e4-8839-4b68-a812-6d2524947940,,Adjuvant,,2021-07-12T12:25:55.528644-05:00,HCM-BROD-0458-C15_treatment5,d5695b84-7ff9-4a79-b435-727af5d6f462,,released,,0,2020-09-27T11:40:20.063316-05:00,Targeted Molecular Therapy,Residual Disease,
HCM-BROD-0458-C15,2b746913-bcba-4374-a6a0-0350ff814041,684fc7e4-8839-4b68-a812-6d2524947940,,Adjuvant,,2021-07-12T12:25:55.528644-05:00,HCM-BROD-0458-C15_treatment2,d710ef67-a5b6-4b81-b1ab-97cc03ca37ba,,released,,0,2020-09-27T11:40:20.063316-05:00,Chemotherapy,Residual Disease,
HCM-CSHL-1269-C18,2b7832fe-682f-4bca-97ec-5f7bf6070e5f,7fadc2dd-2f87-4f96-ab6c-ea3062fabe0d,,Adjuvant,1711.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-1269-C18_treatment20,02295665-51cc-433f-aad2-0c7db0237d01,Treatment Ongoing,released,Leucovorin Calcium,1,2021-12-23T08:44:59.608138-06:00,Chemotherapy,Residual Disease,
HCM-CSHL-1269-C18,2b7832fe-682f-4bca-97ec-5f7bf6070e5f,7fadc2dd-2f87-4f96-ab6c-ea3062fabe0d,,Adjuvant,1711.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-1269-C18_treatment22,04be71c2-9021-40e3-8314-8f4da693b73e,Treatment Ongoing,released,Oxaliplatin,1,2021-12-23T08:44:59.608138-06:00,Chemotherapy,Residual Disease,
HCM-CSHL-1269-C18,2b7832fe-682f-4bca-97ec-5f7bf6070e5f,7fadc2dd-2f87-4f96-ab6c-ea3062fabe0d,939.0,Adjuvant,817.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-1269-C18_treatment10,0a6a7fb9-4199-41fa-949e-3cb585d0d8aa,,released,Bevacizumab,1,2021-12-23T08:44:59.608138-06:00,Chemotherapy,Residual Disease,
HCM-CSHL-1269-C18,2b7832fe-682f-4bca-97ec-5f7bf6070e5f,7fadc2dd-2f87-4f96-ab6c-ea3062fabe0d,,Adjuvant,1711.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-1269-C18_treatment21,10722166-de7e-4a16-94c2-e5a093197586,Treatment Ongoing,released,Fluorouracil,1,2021-12-23T08:44:59.608138-06:00,Chemotherapy,Residual Disease,
HCM-CSHL-1269-C18,2b7832fe-682f-4bca-97ec-5f7bf6070e5f,7fadc2dd-2f87-4f96-ab6c-ea3062fabe0d,209.0,Adjuvant,26.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-1269-C18_treatment3,25021b27-39a5-4fd8-8c44-3f8962f2adeb,,released,Bevacizumab,1,2021-12-23T08:44:59.608138-06:00,Chemotherapy,Residual Disease,
HCM-CSHL-1269-C18,2b7832fe-682f-4bca-97ec-5f7bf6070e5f,7fadc2dd-2f87-4f96-ab6c-ea3062fabe0d,209.0,Adjuvant,26.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-1269-C18_treatment6,25841336-e7c4-4a31-bded-64b6b54895b2,,released,,1,2021-12-23T08:44:59.608138-06:00,Chemotherapy,Residual Disease,FOLFIRI
HCM-CSHL-1269-C18,2b7832fe-682f-4bca-97ec-5f7bf6070e5f,7fadc2dd-2f87-4f96-ab6c-ea3062fabe0d,209.0,Adjuvant,26.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-1269-C18_treatment2,2a120c80-77be-432d-8d9d-e1f3252e41ef,,released,Irinotecan,1,2021-12-23T08:44:59.608138-06:00,Chemotherapy,Residual Disease,
HCM-CSHL-1269-C18,2b7832fe-682f-4bca-97ec-5f7bf6070e5f,7fadc2dd-2f87-4f96-ab6c-ea3062fabe0d,,Adjuvant,939.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-1269-C18_treatment14,2df86da6-255d-4dcf-9339-cd934958a77e,,released,Capecitabine,1,2021-12-23T08:44:59.608138-06:00,Chemotherapy,Residual Disease,
HCM-CSHL-1269-C18,2b7832fe-682f-4bca-97ec-5f7bf6070e5f,7fadc2dd-2f87-4f96-ab6c-ea3062fabe0d,209.0,Adjuvant,26.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-1269-C18_treatment5,360adeaf-cc7e-4cda-8c90-58512903b760,,released,Fluorouracil,1,2021-12-23T08:44:59.608138-06:00,Chemotherapy,Residual Disease,
HCM-CSHL-1269-C18,2b7832fe-682f-4bca-97ec-5f7bf6070e5f,7fadc2dd-2f87-4f96-ab6c-ea3062fabe0d,786.0,Adjuvant,209.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-1269-C18_treatment7,383e51fd-85e2-43a2-a835-99b17b4d0646,,released,Capecitabine,1,2021-12-23T08:44:59.608138-06:00,Chemotherapy,Residual Disease,
HCM-CSHL-1269-C18,2b7832fe-682f-4bca-97ec-5f7bf6070e5f,7fadc2dd-2f87-4f96-ab6c-ea3062fabe0d,,Adjuvant,1442.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-1269-C18_treatment19,3b756879-1d75-450e-bcf2-ad2f01ccfe61,,released,,1,2021-12-23T08:44:59.608138-06:00,Chemotherapy,Residual Disease,FOLFIRI
HCM-CSHL-1269-C18,2b7832fe-682f-4bca-97ec-5f7bf6070e5f,7fadc2dd-2f87-4f96-ab6c-ea3062fabe0d,,Adjuvant,421.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-1269-C18_treatment27,3ee8ed70-4a5a-4d68-9210-b7e9186d452c,,released,,1,2021-12-23T08:44:59.608138-06:00,"Radiation, Stereotactic/Gamma Knife/SRS",Residual Disease,
HCM-CSHL-1269-C18,2b7832fe-682f-4bca-97ec-5f7bf6070e5f,7fadc2dd-2f87-4f96-ab6c-ea3062fabe0d,,Adjuvant,1442.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-1269-C18_treatment18,50d64641-d8bf-47e2-8374-e1ae5717b8ee,,released,Bevacizumab,1,2021-12-23T08:44:59.608138-06:00,Chemotherapy,Residual Disease,
HCM-CSHL-1269-C18,2b7832fe-682f-4bca-97ec-5f7bf6070e5f,7fadc2dd-2f87-4f96-ab6c-ea3062fabe0d,939.0,Adjuvant,817.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-1269-C18_treatment12,7156489c-c770-428b-a3ab-5fa4507bfc78,,released,Fluorouracil,1,2021-12-23T08:44:59.608138-06:00,Chemotherapy,Residual Disease,
HCM-CSHL-1269-C18,2b7832fe-682f-4bca-97ec-5f7bf6070e5f,7fadc2dd-2f87-4f96-ab6c-ea3062fabe0d,,,1250.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-1269-C18_treatment25,763d69b1-1b8f-48ca-9e08-a1a55b661d56,,released,,1,2021-12-23T08:44:59.608138-06:00,"Surgery, NOS",Initial Diagnosis,
HCM-CSHL-1269-C18,2b7832fe-682f-4bca-97ec-5f7bf6070e5f,7fadc2dd-2f87-4f96-ab6c-ea3062fabe0d,,Neoadjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-1269-C18_treatment,7b2822b0-cc36-4c1a-a481-c8b2036259c2,,released,,0,2021-12-23T08:44:59.608138-06:00,,,
HCM-CSHL-1269-C18,2b7832fe-682f-4bca-97ec-5f7bf6070e5f,7fadc2dd-2f87-4f96-ab6c-ea3062fabe0d,939.0,Adjuvant,817.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-1269-C18_treatment13,80f611eb-ebcf-4468-8c2b-cfc932c704cb,,released,,1,2021-12-23T08:44:59.608138-06:00,Chemotherapy,Residual Disease,FOLFIRI
HCM-CSHL-1269-C18,2b7832fe-682f-4bca-97ec-5f7bf6070e5f,7fadc2dd-2f87-4f96-ab6c-ea3062fabe0d,939.0,Adjuvant,817.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-1269-C18_treatment11,91bd7777-91ff-4f9d-92b2-b4c4a3b23963,,released,Leucovorin Calcium,1,2021-12-23T08:44:59.608138-06:00,Chemotherapy,Residual Disease,
HCM-CSHL-1269-C18,2b7832fe-682f-4bca-97ec-5f7bf6070e5f,7fadc2dd-2f87-4f96-ab6c-ea3062fabe0d,,Adjuvant,1711.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-1269-C18_treatment23,9402d615-3030-428d-9e1e-996109f086e9,Treatment Ongoing,released,,1,2021-12-23T08:44:59.608138-06:00,Chemotherapy,Residual Disease,FOLFOX
HCM-CSHL-1269-C18,2b7832fe-682f-4bca-97ec-5f7bf6070e5f,7fadc2dd-2f87-4f96-ab6c-ea3062fabe0d,939.0,Adjuvant,817.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-1269-C18_treatment9,9f3847f9-5ca0-428d-9c3b-95d122095b7a,,released,Irinotecan,1,2021-12-23T08:44:59.608138-06:00,Chemotherapy,Residual Disease,
HCM-CSHL-1269-C18,2b7832fe-682f-4bca-97ec-5f7bf6070e5f,7fadc2dd-2f87-4f96-ab6c-ea3062fabe0d,1442.0,Adjuvant,1275.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-1269-C18_treatment24,a6bd5217-d98c-47cc-b1e2-f3ede8419081,,released,Bevacizumab,1,2021-12-23T08:44:59.608138-06:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-CSHL-1269-C18,2b7832fe-682f-4bca-97ec-5f7bf6070e5f,7fadc2dd-2f87-4f96-ab6c-ea3062fabe0d,,Adjuvant,1442.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-1269-C18_treatment16,b16c116a-a2e1-43ac-9044-d9740a161f49,,released,Fluorouracil,1,2021-12-23T08:44:59.608138-06:00,Chemotherapy,Residual Disease,
HCM-CSHL-1269-C18,2b7832fe-682f-4bca-97ec-5f7bf6070e5f,7fadc2dd-2f87-4f96-ab6c-ea3062fabe0d,,Adjuvant,1442.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-1269-C18_treatment17,b8119dda-43ba-41c8-b899-04e70b73fb73,,released,Irinotecan,1,2021-12-23T08:44:59.608138-06:00,Chemotherapy,Residual Disease,
HCM-CSHL-1269-C18,2b7832fe-682f-4bca-97ec-5f7bf6070e5f,7fadc2dd-2f87-4f96-ab6c-ea3062fabe0d,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-1269-C18_treatment26,d02e463e-579e-4337-aca9-d439a01a38d8,,released,,0,2021-12-23T08:44:59.608138-06:00,Targeted Molecular Therapy,Residual Disease,
HCM-CSHL-1269-C18,2b7832fe-682f-4bca-97ec-5f7bf6070e5f,7fadc2dd-2f87-4f96-ab6c-ea3062fabe0d,,Adjuvant,1442.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-1269-C18_treatment15,eb1e6bb0-9787-4186-8570-c246d8550180,,released,Leucovorin Calcium,1,2021-12-23T08:44:59.608138-06:00,Chemotherapy,Residual Disease,
HCM-CSHL-1269-C18,2b7832fe-682f-4bca-97ec-5f7bf6070e5f,7fadc2dd-2f87-4f96-ab6c-ea3062fabe0d,209.0,Adjuvant,26.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-1269-C18_treatment4,f6f818c7-9d18-42e6-ae79-df1a234ced18,,released,Leucovorin Calcium,1,2021-12-23T08:44:59.608138-06:00,Chemotherapy,Residual Disease,
HCM-CSHL-1269-C18,2b7832fe-682f-4bca-97ec-5f7bf6070e5f,7fadc2dd-2f87-4f96-ab6c-ea3062fabe0d,786.0,Adjuvant,209.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-1269-C18_treatment8,f759af9c-1a77-43c4-902b-19c80c89725c,,released,Bevacizumab,1,2021-12-23T08:44:59.608138-06:00,Chemotherapy,Residual Disease,
HCM-CSHL-1269-C18,2b7832fe-682f-4bca-97ec-5f7bf6070e5f,d673ee45-40ff-4fec-b1b6-df1e0ead878d,1548.0,Maintenance Therapy,121.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-1269-C18_treatment28,0e9c9600-e41b-4669-9845-1b7bbec14395,Stable Disease,released,Irinotecan,1,2021-12-23T08:44:59.608138-06:00,,,
HCM-CSHL-1269-C18,2b7832fe-682f-4bca-97ec-5f7bf6070e5f,d673ee45-40ff-4fec-b1b6-df1e0ead878d,1548.0,Maintenance Therapy,121.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-1269-C18_treatment29,5a6e69e2-6066-4920-b397-ef5410bc049b,Stable Disease,released,Bevacizumab,1,2021-12-23T08:44:59.608138-06:00,,,
HCM-CSHL-1269-C18,2b7832fe-682f-4bca-97ec-5f7bf6070e5f,d673ee45-40ff-4fec-b1b6-df1e0ead878d,1548.0,Maintenance Therapy,121.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-1269-C18_treatment30,8afdcc5d-0079-456a-8303-52d0fc020d39,Stable Disease,released,Leucovorin Calcium,1,2021-12-23T08:44:59.608138-06:00,,,
HCM-CSHL-1269-C18,2b7832fe-682f-4bca-97ec-5f7bf6070e5f,d673ee45-40ff-4fec-b1b6-df1e0ead878d,1548.0,Maintenance Therapy,121.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-1269-C18_treatment31,d3cc08c7-e35f-44ba-bfbd-b8ee240b9ac9,Stable Disease,released,Fluorouracil,1,2021-12-23T08:44:59.608138-06:00,,,
HCM-CSHL-1269-C18,2b7832fe-682f-4bca-97ec-5f7bf6070e5f,d673ee45-40ff-4fec-b1b6-df1e0ead878d,1548.0,Maintenance Therapy,121.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-1269-C18_treatment32,e92ba4c3-b526-4283-b658-03822825090d,Stable Disease,released,,1,2021-12-23T08:44:59.608138-06:00,,,FOLFIRI
HCM-BROD-0649-C49,2c0409da-a354-4e40-bb7c-442f454aca8b,4a43f458-e49e-4290-adfa-2f91f029b8b8,1170.0,Maintenance Therapy,214.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0649-C49_treatment8,94653a66-9e75-4d8c-a341-f56caa63be0c,Progressive Disease,released,Rivaroxaban,1,2021-12-21T13:42:24.455337-06:00,,,
HCM-BROD-0649-C49,2c0409da-a354-4e40-bb7c-442f454aca8b,e1d7e626-f499-4022-afbd-33dcf7bf6e12,,,,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0649-C49_treatment5,2d4f9bfa-1e0b-47bc-9681-6db59cd7ceb4,,released,,unknown,2021-12-21T13:42:24.455337-06:00,"Surgery, NOS",Initial Diagnosis,
HCM-BROD-0649-C49,2c0409da-a354-4e40-bb7c-442f454aca8b,e1d7e626-f499-4022-afbd-33dcf7bf6e12,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0649-C49_treatment6,3232bba4-6d69-419b-b508-11ad53886362,,released,,0,2021-12-21T13:42:24.455337-06:00,Targeted Molecular Therapy,Residual Disease,
HCM-BROD-0649-C49,2c0409da-a354-4e40-bb7c-442f454aca8b,e1d7e626-f499-4022-afbd-33dcf7bf6e12,1294.0,Adjuvant,1247.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0649-C49_treatment2,439f75f6-7973-4883-b635-02599f6ff80b,,released,Doxorubicin Hydrochloride,1,2021-12-21T13:42:24.455337-06:00,Chemotherapy,Residual Disease,
HCM-BROD-0649-C49,2c0409da-a354-4e40-bb7c-442f454aca8b,e1d7e626-f499-4022-afbd-33dcf7bf6e12,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0649-C49_treatment7,5b10fe59-066d-471b-84fe-af81a2181345,,released,,0,2021-12-21T13:42:24.455337-06:00,"Radiation Therapy, NOS",Residual Disease,
HCM-BROD-0649-C49,2c0409da-a354-4e40-bb7c-442f454aca8b,e1d7e626-f499-4022-afbd-33dcf7bf6e12,,Neoadjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0649-C49_treatment,ab1a9049-beaa-4422-aaa7-2bfc05e40ef3,,released,,0,2021-12-21T13:42:24.455337-06:00,,,
HCM-BROD-0649-C49,2c0409da-a354-4e40-bb7c-442f454aca8b,e1d7e626-f499-4022-afbd-33dcf7bf6e12,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0649-C49_treatment3,b8a502ef-bf79-4f3d-bd85-ed91d207b772,,released,,0,2021-12-21T13:42:24.455337-06:00,Hormone Therapy,Residual Disease,
HCM-BROD-0649-C49,2c0409da-a354-4e40-bb7c-442f454aca8b,e1d7e626-f499-4022-afbd-33dcf7bf6e12,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0649-C49_treatment4,fc120df0-139a-4b4c-a839-5178ae6a63ff,,released,,0,2021-12-21T13:42:24.455337-06:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-BROD-0209-C71,2c636721-d11e-463e-8f77-a23501dd3d60,9e6f18f6-e306-4366-8fb8-a6d2b346b0dd,,Adjuvant,,2021-03-03T15:15:08.075155-06:00,HCM-BROD-0209-C71_treatment6,042c502e-f162-48f2-9d71-99b8e1644bd1,,released,,0,2020-02-27T12:35:20.972329-06:00,"Radiation Therapy, NOS",Residual Disease,
HCM-BROD-0209-C71,2c636721-d11e-463e-8f77-a23501dd3d60,9e6f18f6-e306-4366-8fb8-a6d2b346b0dd,693.0,Adjuvant,648.0,2021-03-03T15:15:08.075155-06:00,HCM-BROD-0209-C71_treatment5,5cccb008-6054-4c38-8218-ff99f8a7c232,,released,Bevacizumab,1,2020-02-27T12:35:20.972329-06:00,Targeted Molecular Therapy,Residual Disease,
HCM-BROD-0209-C71,2c636721-d11e-463e-8f77-a23501dd3d60,9e6f18f6-e306-4366-8fb8-a6d2b346b0dd,,Adjuvant,,2021-03-03T15:15:08.075155-06:00,HCM-BROD-0209-C71_treatment3,785c5d69-0d88-4cd3-954d-fb3b1692009e,,released,,0,2020-02-27T12:35:20.972329-06:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-BROD-0209-C71,2c636721-d11e-463e-8f77-a23501dd3d60,9e6f18f6-e306-4366-8fb8-a6d2b346b0dd,,,-28.0,2023-03-13T13:32:34.313354-05:00,HCM-BROD-0209-C71_treatment4,9158a3ed-ee74-4ae1-9960-524a6e7ef513,,released,,1,2020-02-27T12:35:20.972329-06:00,"Surgery, NOS",Initial Diagnosis,
HCM-BROD-0209-C71,2c636721-d11e-463e-8f77-a23501dd3d60,9e6f18f6-e306-4366-8fb8-a6d2b346b0dd,,Adjuvant,,2021-03-03T15:15:08.075155-06:00,HCM-BROD-0209-C71_treatment2,993b55bf-5067-4ff3-8ea8-3f1bf2914993,,released,,0,2020-02-27T12:35:20.972329-06:00,Chemotherapy,Residual Disease,
HCM-BROD-0209-C71,2c636721-d11e-463e-8f77-a23501dd3d60,9e6f18f6-e306-4366-8fb8-a6d2b346b0dd,,Neoadjuvant,,2021-03-03T15:15:08.075155-06:00,HCM-BROD-0209-C71_treatment,cc8a5a8d-7f1d-47cc-a89d-65c8527bc496,,released,,0,2019-04-04T15:02:40.743808-05:00,,,
HCM-CSHL-0900-C54,2cd10d26-8dc7-4e0c-a7f8-9cc0dee9543f,9174a136-2577-46d6-a623-d62ae82f4b32,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0900-C54_treatment7,07c420f9-929f-4158-a64c-2efe0f32a785,,released,,0,2021-12-21T14:38:22.483956-06:00,Targeted Molecular Therapy,Residual Disease,
HCM-CSHL-0900-C54,2cd10d26-8dc7-4e0c-a7f8-9cc0dee9543f,9174a136-2577-46d6-a623-d62ae82f4b32,,,0.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0900-C54_treatment6,0ebb2811-3322-4461-8f90-efc1948bca27,,released,,1,2021-12-21T14:38:22.483956-06:00,"Surgery, NOS",Initial Diagnosis,
HCM-CSHL-0900-C54,2cd10d26-8dc7-4e0c-a7f8-9cc0dee9543f,9174a136-2577-46d6-a623-d62ae82f4b32,,Neoadjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0900-C54_treatment,1eee8081-c483-470f-a1ee-3aad63a1061a,,released,,0,2021-12-21T14:38:22.483956-06:00,,,
HCM-CSHL-0900-C54,2cd10d26-8dc7-4e0c-a7f8-9cc0dee9543f,9174a136-2577-46d6-a623-d62ae82f4b32,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0900-C54_treatment4,3ff3ef17-42b5-4787-abaa-ddf21ef27eb8,,released,,0,2021-12-21T14:38:22.483956-06:00,Hormone Therapy,Residual Disease,
HCM-CSHL-0900-C54,2cd10d26-8dc7-4e0c-a7f8-9cc0dee9543f,9174a136-2577-46d6-a623-d62ae82f4b32,152.0,Adjuvant,47.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0900-C54_treatment2,8c5a570b-d413-467a-beaf-e905ba12e1f3,,released,Carboplatin,1,2021-12-21T14:38:22.483956-06:00,Chemotherapy,Residual Disease,
HCM-CSHL-0900-C54,2cd10d26-8dc7-4e0c-a7f8-9cc0dee9543f,9174a136-2577-46d6-a623-d62ae82f4b32,152.0,Adjuvant,47.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0900-C54_treatment3,931a14bf-53ef-4cc1-a376-9ecd160e2c68,,released,Paclitaxel,1,2021-12-21T14:38:22.483956-06:00,Chemotherapy,Residual Disease,
HCM-CSHL-0900-C54,2cd10d26-8dc7-4e0c-a7f8-9cc0dee9543f,9174a136-2577-46d6-a623-d62ae82f4b32,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0900-C54_treatment5,e492891a-494e-44f3-abb4-36247842c892,,released,,0,2021-12-21T14:38:22.483956-06:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-CSHL-0900-C54,2cd10d26-8dc7-4e0c-a7f8-9cc0dee9543f,9174a136-2577-46d6-a623-d62ae82f4b32,227.0,Adjuvant,186.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0900-C54_treatment8,f0d98d24-c357-426d-a047-761eedb4ce44,,released,,1,2021-12-21T14:38:22.483956-06:00,"Radiation, Intensity-Modulated Radiotherapy",Residual Disease,
HCM-SANG-1307-C25,2d0b1976-6a09-4623-a32c-eed22e944dbf,cb33e4d8-6aad-4545-92e1-8769c4a81bb5,,Neoadjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-SANG-1307-C25_treatment,8344103a-7f50-4a62-acdc-7e0b248e55ea,,released,,0,2023-02-27T11:19:20.846732-06:00,,,
HCM-CSHL-0516-C56,2df05263-7905-463f-9a78-3ece600174e5,11571bf0-82f3-4b02-b096-4572b9609eb0,,Adjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0516-C56_treatment4,0832b944-87be-4088-b70e-5ee9eec77aa2,,released,,0,2020-10-08T13:36:23.961006-05:00,"Radiation Therapy, NOS",Residual Disease,
HCM-CSHL-0516-C56,2df05263-7905-463f-9a78-3ece600174e5,11571bf0-82f3-4b02-b096-4572b9609eb0,,Neoadjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0516-C56_treatment,a6ac5cfd-8572-4e43-82df-14544d2f5cba,,released,,0,2020-10-08T13:36:23.961006-05:00,,,
HCM-CSHL-0516-C56,2df05263-7905-463f-9a78-3ece600174e5,11571bf0-82f3-4b02-b096-4572b9609eb0,,,70.0,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0516-C56_treatment2,bff41cd3-309e-4e50-aae1-2942a79d40c4,,released,,1,2020-10-08T13:36:23.961006-05:00,"Surgery, NOS",Initial Diagnosis,
HCM-CSHL-0516-C56,2df05263-7905-463f-9a78-3ece600174e5,11571bf0-82f3-4b02-b096-4572b9609eb0,,Adjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0516-C56_treatment3,c530a43f-492b-4016-ae2a-febba15133c4,,released,,unknown,2020-10-08T13:36:23.961006-05:00,"Pharmaceutical Therapy, NOS",Residual Disease,
HCM-SANG-1081-C20,2e54fb22-3161-4495-acf7-2a60ceda8fa5,1fc7dfba-b825-45a2-8cae-2aaf79d5e31a,,Neoadjuvant,446.0,2025-03-31T16:34:59.906497-05:00,HCM-SANG-1081-C20_treatment3,3d07bf29-ba5e-49ee-bd43-e62ec3dbb160,,released,,1,2023-02-27T12:08:42.282291-06:00,"Radiation, 2D Conventional",,
HCM-SANG-1081-C20,2e54fb22-3161-4495-acf7-2a60ceda8fa5,1fc7dfba-b825-45a2-8cae-2aaf79d5e31a,,Neoadjuvant,446.0,2025-03-31T16:34:59.906497-05:00,HCM-SANG-1081-C20_treatment2,66142017-0d2f-469f-a429-68239b924d2f,,released,Oxaliplatin,1,2023-02-27T12:08:42.282291-06:00,Chemotherapy,,
HCM-SANG-1081-C20,2e54fb22-3161-4495-acf7-2a60ceda8fa5,1fc7dfba-b825-45a2-8cae-2aaf79d5e31a,,Neoadjuvant,446.0,2025-03-31T16:34:59.906497-05:00,HCM-SANG-1081-C20_treatment,d5047d17-7643-4da0-ad64-72892283a7a2,,released,Capecitabine,1,2023-02-27T12:08:42.282291-06:00,Chemotherapy,,
HCM-SANG-0529-C18,2ecaa554-37da-43ee-96be-66f274789929,3ee43486-d593-4df5-b31d-aecae51b207d,,Neoadjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-SANG-0529-C18_treatment,324c6b96-51dc-4ba0-b6fe-e3ce7b4bfad9,,released,,0,2021-12-21T15:13:45.953350-06:00,,,
HCM-BROD-0444-C43,2f644ec3-923d-41b0-8ab2-de0f74fe2bd8,89182e66-f1ad-43dc-811c-8a9aef97ff55,,,-20.0,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0444-C43_treatment5,1cf18dd9-6262-4788-b990-7c8891f1dcc2,,released,,1,2020-09-27T11:35:50.827695-05:00,"Surgery, NOS",Initial Diagnosis,
HCM-BROD-0444-C43,2f644ec3-923d-41b0-8ab2-de0f74fe2bd8,89182e66-f1ad-43dc-811c-8a9aef97ff55,,Adjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0444-C43_treatment6,52aad011-a5db-4872-be0c-07118e47dc8d,,released,,0,2020-09-27T11:35:50.827695-05:00,Targeted Molecular Therapy,Residual Disease,
HCM-BROD-0444-C43,2f644ec3-923d-41b0-8ab2-de0f74fe2bd8,89182e66-f1ad-43dc-811c-8a9aef97ff55,,Neoadjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0444-C43_treatment,6a296e7c-3224-451c-95af-d6304e9f6750,,released,,0,2020-09-27T11:35:50.827695-05:00,,,
HCM-BROD-0444-C43,2f644ec3-923d-41b0-8ab2-de0f74fe2bd8,89182e66-f1ad-43dc-811c-8a9aef97ff55,2446.0,Adjuvant,2442.0,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0444-C43_treatment7,b7ce3958-0f13-4243-bef3-f9270443c0e1,,released,,1,2020-09-27T11:35:50.827695-05:00,"Radiation, Stereotactic/Gamma Knife/SRS",Residual Disease,
HCM-BROD-0444-C43,2f644ec3-923d-41b0-8ab2-de0f74fe2bd8,89182e66-f1ad-43dc-811c-8a9aef97ff55,,Adjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0444-C43_treatment2,c13ae508-5cfd-4d7d-ab1f-3ab2abc75d06,,released,,0,2020-09-27T11:35:50.827695-05:00,Chemotherapy,Residual Disease,
HCM-BROD-0444-C43,2f644ec3-923d-41b0-8ab2-de0f74fe2bd8,89182e66-f1ad-43dc-811c-8a9aef97ff55,,Adjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0444-C43_treatment3,e0871738-729b-4713-a7b3-bab6da3590cc,,released,,0,2020-09-27T11:35:50.827695-05:00,Hormone Therapy,Residual Disease,
HCM-BROD-0444-C43,2f644ec3-923d-41b0-8ab2-de0f74fe2bd8,89182e66-f1ad-43dc-811c-8a9aef97ff55,2555.0,Adjuvant,2444.0,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0444-C43_treatment4,e15d7484-7b75-47ac-a370-1f7d3c696861,,released,Nivolumab,1,2020-09-27T11:35:50.827695-05:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-BROD-0444-C43,2f644ec3-923d-41b0-8ab2-de0f74fe2bd8,b2141d2c-847a-4dbb-abe2-cbfa5de6d08c,1245.0,Maintenance Therapy,1198.0,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0444-C43_treatment8,3aab6a47-2a1d-428a-bdaf-174652366397,Progressive Disease,released,Nivolumab,1,2020-09-27T11:35:50.827695-05:00,,,
HCM-BROD-0444-C43,2f644ec3-923d-41b0-8ab2-de0f74fe2bd8,b2141d2c-847a-4dbb-abe2-cbfa5de6d08c,1245.0,Maintenance Therapy,1198.0,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0444-C43_treatment9,e3dceea1-4da7-4b4f-a754-4588b3fd3c47,Progressive Disease,released,Ipilimumab,1,2020-09-27T11:35:50.827695-05:00,,,
HCM-BROD-0834-C43,2fe77db2-e5c5-49e8-87c0-ba82521c17c5,9992b928-ab2d-438f-80ad-9bdf33aee4eb,,Adjuvant,,2023-07-13T10:27:19.665852-05:00,HCM-BROD-0834-C43_treatment6,0ece948d-515e-4881-ba8c-4189819624e0,,released,,0,2021-12-21T13:54:43.690373-06:00,Targeted Molecular Therapy,Residual Disease,
HCM-BROD-0834-C43,2fe77db2-e5c5-49e8-87c0-ba82521c17c5,9992b928-ab2d-438f-80ad-9bdf33aee4eb,497.0,Adjuvant,119.0,2023-07-13T10:27:19.665852-05:00,HCM-BROD-0834-C43_treatment4,5f9590c8-6c0c-4ac3-92fe-9bd2f37401a5,Treatment Ongoing,released,Nivolumab,1,2021-12-21T13:54:43.690373-06:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-BROD-0834-C43,2fe77db2-e5c5-49e8-87c0-ba82521c17c5,9992b928-ab2d-438f-80ad-9bdf33aee4eb,,Adjuvant,,2023-07-13T10:27:19.665852-05:00,HCM-BROD-0834-C43_treatment2,6e658866-36e8-4469-998b-c7c22a8bbd2d,,released,,0,2021-12-21T13:54:43.690373-06:00,Chemotherapy,Residual Disease,
HCM-BROD-0834-C43,2fe77db2-e5c5-49e8-87c0-ba82521c17c5,9992b928-ab2d-438f-80ad-9bdf33aee4eb,,,0.0,2023-07-13T10:27:19.665852-05:00,HCM-BROD-0834-C43_treatment5,77d427e9-7761-43e9-a042-71264ee705d7,,released,,1,2021-12-21T13:54:43.690373-06:00,"Surgery, NOS",Initial Diagnosis,
HCM-BROD-0834-C43,2fe77db2-e5c5-49e8-87c0-ba82521c17c5,9992b928-ab2d-438f-80ad-9bdf33aee4eb,,Neoadjuvant,,2023-07-13T10:27:19.665852-05:00,HCM-BROD-0834-C43_treatment,88e5ebff-ccfe-4034-9a1b-97f39f75bb9f,,released,,0,2021-12-21T13:54:43.690373-06:00,,,
HCM-BROD-0834-C43,2fe77db2-e5c5-49e8-87c0-ba82521c17c5,9992b928-ab2d-438f-80ad-9bdf33aee4eb,,Adjuvant,,2023-07-13T10:27:19.665852-05:00,HCM-BROD-0834-C43_treatment7,d5380384-42c5-447d-b595-8b2acc8725b4,,released,,0,2021-12-21T13:54:43.690373-06:00,"Radiation Therapy, NOS",Residual Disease,
HCM-BROD-0834-C43,2fe77db2-e5c5-49e8-87c0-ba82521c17c5,9992b928-ab2d-438f-80ad-9bdf33aee4eb,,Adjuvant,,2023-07-13T10:27:19.665852-05:00,HCM-BROD-0834-C43_treatment3,fb1e81b7-274a-40c4-8e8e-4d606f5e7482,,released,,0,2021-12-21T13:54:43.690373-06:00,Hormone Therapy,Residual Disease,
HCM-BROD-0254-C49,300223b2-7479-4849-8de5-14b30c586c3a,2cc13d6e-5c91-4a3b-8753-0fe1ce141fdb,,Neoadjuvant,275.0,2021-07-12T12:25:55.528644-05:00,HCM-BROD-0254-C49_treatment,02291c51-5918-44e9-a7e9-4b46ab064d29,,released,Vinorelbine Tartrate,1,2020-06-15T13:32:11.417090-05:00,Chemotherapy,,
HCM-BROD-0254-C49,300223b2-7479-4849-8de5-14b30c586c3a,2cc13d6e-5c91-4a3b-8753-0fe1ce141fdb,487.0,Adjuvant,440.0,2021-07-12T12:25:55.528644-05:00,HCM-BROD-0254-C49_treatment12,05953126-8531-4df4-909a-a86afb9aef67,,released,Docetaxel,1,2020-06-15T13:32:11.417090-05:00,Chemotherapy,Residual Disease,
HCM-BROD-0254-C49,300223b2-7479-4849-8de5-14b30c586c3a,2cc13d6e-5c91-4a3b-8753-0fe1ce141fdb,,Neoadjuvant,275.0,2021-07-12T12:25:55.528644-05:00,HCM-BROD-0254-C49_treatment8,19726d31-00ae-463a-aad9-6f571eeed918,,released,Docetaxel,1,2020-06-15T13:32:11.417090-05:00,Chemotherapy,,
HCM-BROD-0254-C49,300223b2-7479-4849-8de5-14b30c586c3a,2cc13d6e-5c91-4a3b-8753-0fe1ce141fdb,,Neoadjuvant,275.0,2021-07-12T12:25:55.528644-05:00,HCM-BROD-0254-C49_treatment4,22535d9e-a865-49f9-80e7-ab0358349cff,,released,Irinotecan,1,2020-06-15T13:32:11.417090-05:00,Chemotherapy,,
HCM-BROD-0254-C49,300223b2-7479-4849-8de5-14b30c586c3a,2cc13d6e-5c91-4a3b-8753-0fe1ce141fdb,,Neoadjuvant,275.0,2021-07-12T12:25:55.528644-05:00,HCM-BROD-0254-C49_treatment6,369aedc4-54eb-4933-9046-6026a8d4f9d4,,released,,1,2020-06-15T13:32:11.417090-05:00,Chemotherapy,,VAC/VI
HCM-BROD-0254-C49,300223b2-7479-4849-8de5-14b30c586c3a,2cc13d6e-5c91-4a3b-8753-0fe1ce141fdb,441.0,Adjuvant,440.0,2021-07-12T12:25:55.528644-05:00,HCM-BROD-0254-C49_treatment16,5d57463b-8a7b-4cc9-9045-46c24a5fe2e5,,released,,1,2020-10-09T15:11:23.023062-05:00,"Radiation Therapy, NOS",Residual Disease,
HCM-BROD-0254-C49,300223b2-7479-4849-8de5-14b30c586c3a,2cc13d6e-5c91-4a3b-8753-0fe1ce141fdb,487.0,Adjuvant,440.0,2021-07-12T12:25:55.528644-05:00,HCM-BROD-0254-C49_treatment11,6df29d9b-1179-4995-9490-88c83e606cb2,,released,Gemcitabine,1,2020-06-15T13:32:11.417090-05:00,Chemotherapy,Residual Disease,
HCM-BROD-0254-C49,300223b2-7479-4849-8de5-14b30c586c3a,2cc13d6e-5c91-4a3b-8753-0fe1ce141fdb,,,,2023-03-13T13:06:31.625767-05:00,HCM-BROD-0254-C49_treatment14,70751465-8a10-48c3-bbf8-f03a2eedac65,,released,,unknown,2020-10-09T15:11:23.023062-05:00,"Surgery, NOS",Initial Diagnosis,
HCM-BROD-0254-C49,300223b2-7479-4849-8de5-14b30c586c3a,2cc13d6e-5c91-4a3b-8753-0fe1ce141fdb,,Adjuvant,,2021-07-12T12:25:55.528644-05:00,HCM-BROD-0254-C49_treatment15,94a98847-d4c2-42d8-96df-378bb4e8acde,,released,,0,2020-10-09T15:11:23.023062-05:00,Targeted Molecular Therapy,Residual Disease,
HCM-BROD-0254-C49,300223b2-7479-4849-8de5-14b30c586c3a,2cc13d6e-5c91-4a3b-8753-0fe1ce141fdb,,Neoadjuvant,334.0,2021-07-12T12:25:55.528644-05:00,HCM-BROD-0254-C49_treatment10,991e6e19-661f-46b3-897e-950762d094bb,,released,Temsirolimus,1,2020-06-15T13:32:11.417090-05:00,Targeted Molecular Therapy,,
HCM-BROD-0254-C49,300223b2-7479-4849-8de5-14b30c586c3a,2cc13d6e-5c91-4a3b-8753-0fe1ce141fdb,,Adjuvant,,2021-07-12T12:25:55.528644-05:00,HCM-BROD-0254-C49_treatment13,bc02baaf-ccfc-4df1-a446-c398c3bbbb9e,,released,,0,2020-10-09T15:11:23.023062-05:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-BROD-0254-C49,300223b2-7479-4849-8de5-14b30c586c3a,2cc13d6e-5c91-4a3b-8753-0fe1ce141fdb,,Neoadjuvant,275.0,2021-07-12T12:25:55.528644-05:00,HCM-BROD-0254-C49_treatment5,ca52ad48-d2f1-4361-b188-0978ed2603fb,,released,Cyclophosphamide,1,2020-06-15T13:32:11.417090-05:00,Chemotherapy,,
HCM-BROD-0254-C49,300223b2-7479-4849-8de5-14b30c586c3a,2cc13d6e-5c91-4a3b-8753-0fe1ce141fdb,,Neoadjuvant,275.0,2021-07-12T12:25:55.528644-05:00,HCM-BROD-0254-C49_treatment2,cb6e94df-8183-476a-8955-1ef0748de8a1,,released,Vincristine,1,2020-06-15T13:32:11.417090-05:00,Chemotherapy,,
HCM-BROD-0254-C49,300223b2-7479-4849-8de5-14b30c586c3a,2cc13d6e-5c91-4a3b-8753-0fe1ce141fdb,,Neoadjuvant,275.0,2021-07-12T12:25:55.528644-05:00,HCM-BROD-0254-C49_treatment3,d0a11c25-a115-4bdd-bc90-eae7652397cb,,released,Dactinomycin,1,2020-06-15T13:32:11.417090-05:00,Chemotherapy,,
HCM-BROD-0254-C49,300223b2-7479-4849-8de5-14b30c586c3a,2cc13d6e-5c91-4a3b-8753-0fe1ce141fdb,,Neoadjuvant,275.0,2021-07-12T12:25:55.528644-05:00,HCM-BROD-0254-C49_treatment7,eb172a44-1b7a-4e77-a0cb-1095b3b3ea0c,,released,Gemcitabine Hydrochloride,1,2020-06-15T13:32:11.417090-05:00,Chemotherapy,,
HCM-BROD-0254-C49,300223b2-7479-4849-8de5-14b30c586c3a,2cc13d6e-5c91-4a3b-8753-0fe1ce141fdb,,Neoadjuvant,,2021-07-12T12:25:55.528644-05:00,HCM-BROD-0254-C49_treatment9,edc4b18e-209d-4554-846b-628338e8fa0a,,released,,1,2020-06-15T13:32:11.417090-05:00,"Radiation Therapy, NOS",,
HCM-BROD-0036-C41,307c905f-c276-4501-988a-b083f9462a98,c45b5acf-9aad-4308-9fd4-acaa0a536bc1,,Adjuvant,,2020-10-20T19:20:06.800740-05:00,HCM-BROD-0036-C41_treatment16,0373bea4-3a88-4fbe-b12f-b82c5f6cd669,,released,,0,2020-10-08T15:37:15.255262-05:00,Targeted Molecular Therapy,Residual Disease,
HCM-BROD-0036-C41,307c905f-c276-4501-988a-b083f9462a98,c45b5acf-9aad-4308-9fd4-acaa0a536bc1,,Maintenance Therapy,1157.0,2020-10-08T15:37:15.255262-05:00,HCM-BROD-0036-C41_treatment10,0aa0e95a-44ba-4858-8b5b-2c725aa0caab,Progressive Disease,released,,1,2020-03-26T12:37:41.457145-05:00,,Progressive Disease,VAC
HCM-BROD-0036-C41,307c905f-c276-4501-988a-b083f9462a98,c45b5acf-9aad-4308-9fd4-acaa0a536bc1,,Maintenance Therapy,1157.0,2020-10-08T15:37:15.255262-05:00,HCM-BROD-0036-C41_treatment8,0c39aec9-513b-4138-83a6-5cfd220d31fd,Progressive Disease,released,Etoposide,1,2019-04-03T17:59:55.017435-05:00,,Progressive Disease,
HCM-BROD-0036-C41,307c905f-c276-4501-988a-b083f9462a98,c45b5acf-9aad-4308-9fd4-acaa0a536bc1,,Maintenance Therapy,1157.0,2020-10-08T15:37:15.255262-05:00,HCM-BROD-0036-C41_treatment2,187dbc66-47bf-4002-82ee-8cbdb58d06c9,Progressive Disease,released,Temozolomide,1,2019-04-03T17:59:55.017435-05:00,,Progressive Disease,
HCM-BROD-0036-C41,307c905f-c276-4501-988a-b083f9462a98,c45b5acf-9aad-4308-9fd4-acaa0a536bc1,,Neoadjuvant,,2020-10-08T15:37:15.255262-05:00,HCM-BROD-0036-C41_treatment11,1d7d1b91-15b0-4850-a1e8-d6a5af7dfb5a,,released,,1,2020-03-26T12:37:41.457145-05:00,"Radiation Therapy, NOS",,
HCM-BROD-0036-C41,307c905f-c276-4501-988a-b083f9462a98,c45b5acf-9aad-4308-9fd4-acaa0a536bc1,,,,2023-03-13T13:09:49.086596-05:00,HCM-BROD-0036-C41_treatment15,31f483a8-771f-4c7b-95a1-954217d8889f,,released,,unknown,2020-10-08T15:37:15.255262-05:00,"Surgery, NOS",Initial Diagnosis,
HCM-BROD-0036-C41,307c905f-c276-4501-988a-b083f9462a98,c45b5acf-9aad-4308-9fd4-acaa0a536bc1,,Adjuvant,,2020-10-20T19:20:06.800740-05:00,HCM-BROD-0036-C41_treatment17,32719bd1-5be1-4829-b77f-dd76315e6a3d,,released,,0,2020-10-08T15:37:15.255262-05:00,"Radiation Therapy, NOS",Residual Disease,
HCM-BROD-0036-C41,307c905f-c276-4501-988a-b083f9462a98,c45b5acf-9aad-4308-9fd4-acaa0a536bc1,,Adjuvant,,2020-10-20T19:20:06.800740-05:00,HCM-BROD-0036-C41_treatment13,54c98415-38fa-4859-bb7c-d70b0874b8a0,,released,,0,2020-10-08T15:37:15.255262-05:00,Chemotherapy,Residual Disease,
HCM-BROD-0036-C41,307c905f-c276-4501-988a-b083f9462a98,c45b5acf-9aad-4308-9fd4-acaa0a536bc1,,Maintenance Therapy,1157.0,2020-10-08T15:37:15.255262-05:00,HCM-BROD-0036-C41_treatment7,74082899-07b2-44e3-a929-981c307040dc,Progressive Disease,released,Irinotecan,1,2019-04-03T17:59:55.017435-05:00,,Progressive Disease,
HCM-BROD-0036-C41,307c905f-c276-4501-988a-b083f9462a98,c45b5acf-9aad-4308-9fd4-acaa0a536bc1,,Neoadjuvant,,2020-10-08T15:37:15.255262-05:00,HCM-BROD-0036-C41_treatment,8351edcf-f56c-4cc2-a052-45f1650a0c1a,,released,Unknown,1,2019-04-03T17:59:55.017435-05:00,Chemotherapy,,
HCM-BROD-0036-C41,307c905f-c276-4501-988a-b083f9462a98,c45b5acf-9aad-4308-9fd4-acaa0a536bc1,,Maintenance Therapy,1157.0,2020-10-08T15:37:15.255262-05:00,HCM-BROD-0036-C41_treatment4,ae2ae478-3ebf-481b-a64c-b6109b33ceaa,Progressive Disease,released,Vincristine,1,2019-04-03T17:59:55.017435-05:00,,Progressive Disease,
HCM-BROD-0036-C41,307c905f-c276-4501-988a-b083f9462a98,c45b5acf-9aad-4308-9fd4-acaa0a536bc1,,Maintenance Therapy,1157.0,2020-10-08T15:37:15.255262-05:00,HCM-BROD-0036-C41_treatment6,c67539e2-8790-40c4-99ca-ad62f4c0dc0e,Progressive Disease,released,Cyclophosphamide,1,2019-04-03T17:59:55.017435-05:00,,Progressive Disease,
HCM-BROD-0036-C41,307c905f-c276-4501-988a-b083f9462a98,c45b5acf-9aad-4308-9fd4-acaa0a536bc1,,Maintenance Therapy,1157.0,2020-10-08T15:37:15.255262-05:00,HCM-BROD-0036-C41_treatment3,d22e0dd8-81d2-47ee-95e4-67d778142f42,Progressive Disease,released,Dactinomycin,1,2019-04-03T17:59:55.017435-05:00,,Progressive Disease,
HCM-BROD-0036-C41,307c905f-c276-4501-988a-b083f9462a98,c45b5acf-9aad-4308-9fd4-acaa0a536bc1,,Adjuvant,4656.0,2020-10-20T19:20:06.800740-05:00,HCM-BROD-0036-C41_treatment14,dcb805dd-8417-45cd-986e-7478c2cdf5a9,,released,Pembrolizumab,1,2020-10-08T15:37:15.255262-05:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-BROD-0036-C41,307c905f-c276-4501-988a-b083f9462a98,c45b5acf-9aad-4308-9fd4-acaa0a536bc1,,Maintenance Therapy,1157.0,2020-10-08T15:37:15.255262-05:00,HCM-BROD-0036-C41_treatment5,f2c4c403-cacb-4759-8c41-5dda2ad1f84d,Progressive Disease,released,Ifosfamide,1,2019-04-03T17:59:55.017435-05:00,,Progressive Disease,
HCM-BROD-0036-C41,307c905f-c276-4501-988a-b083f9462a98,c45b5acf-9aad-4308-9fd4-acaa0a536bc1,,Maintenance Therapy,1157.0,2020-10-08T15:37:15.255262-05:00,HCM-BROD-0036-C41_treatment9,f859a9ce-5041-4f69-82e4-ad0ca70d7c77,Progressive Disease,released,,1,2019-04-03T17:59:55.017435-05:00,,Progressive Disease,VIT
HCM-BROD-0036-C41,307c905f-c276-4501-988a-b083f9462a98,c45b5acf-9aad-4308-9fd4-acaa0a536bc1,,Neoadjuvant,4506.0,2020-10-20T19:20:06.800740-05:00,HCM-BROD-0036-C41_treatment12,fffd90bc-bd36-4f4b-8059-57ed94254371,,released,Regorafenib,1,2020-10-08T15:37:15.255262-05:00,Targeted Molecular Therapy,,
HCM-BROD-0002-C71,3092d72b-75b1-4ae2-ac38-d4c1cd377e4c,f68b1f17-da54-4595-b017-37fd6d6d1e3e,,Neoadjuvant,,2020-01-13T20:10:25.832065-06:00,HCM-BROD-0002-C71_treatment,07c5c0b5-735e-44f0-9124-897ff844ea9e,,released,,0,2019-03-12T10:12:01.634698-05:00,,,
HCM-BROD-0002-C71,3092d72b-75b1-4ae2-ac38-d4c1cd377e4c,f68b1f17-da54-4595-b017-37fd6d6d1e3e,,Adjuvant,,2020-01-13T20:10:25.832065-06:00,HCM-BROD-0002-C71_treatment3,2642c297-b1b5-43ca-8a2c-ca43fcfc5925,,released,,0,2019-04-04T14:12:17.703236-05:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-BROD-0002-C71,3092d72b-75b1-4ae2-ac38-d4c1cd377e4c,f68b1f17-da54-4595-b017-37fd6d6d1e3e,,,-12.0,2023-02-27T12:26:09.116772-06:00,HCM-BROD-0002-C71_treatment4,2f6fac8c-16ad-44ea-9537-bbe0d47f49a0,,released,,1,2019-04-04T14:12:17.703236-05:00,"Surgery, NOS",Initial Diagnosis,
HCM-BROD-0002-C71,3092d72b-75b1-4ae2-ac38-d4c1cd377e4c,f68b1f17-da54-4595-b017-37fd6d6d1e3e,69.0,Adjuvant,49.0,2020-01-13T20:10:25.832065-06:00,HCM-BROD-0002-C71_treatment6,5b30641f-53dd-429b-af46-cb4d220a5eea,,released,,1,2019-04-04T14:12:17.703236-05:00,"Radiation Therapy, NOS",Residual Disease,
HCM-BROD-0002-C71,3092d72b-75b1-4ae2-ac38-d4c1cd377e4c,f68b1f17-da54-4595-b017-37fd6d6d1e3e,210.0,Adjuvant,18.0,2020-01-13T20:10:25.832065-06:00,HCM-BROD-0002-C71_treatment2,6e712acb-bd35-4f67-9b9a-6a2e4bf147ca,,released,Temozolomide,1,2019-04-04T14:12:17.703236-05:00,Chemotherapy,Residual Disease,
HCM-BROD-0002-C71,3092d72b-75b1-4ae2-ac38-d4c1cd377e4c,f68b1f17-da54-4595-b017-37fd6d6d1e3e,525.0,Adjuvant,322.0,2020-06-25T08:43:53.820342-05:00,HCM-BROD-0002-C71_treatment5,9da2bb50-6b21-47db-a544-552c2c76b88c,,released,Bevacizumab,1,2019-04-04T14:12:17.703236-05:00,Targeted Molecular Therapy,Residual Disease,
HCM-CSHL-0459-C17,30ad857e-34d5-4ae1-8ca1-e962d10d6440,2b6add79-1643-48f6-9d7e-0b10afd504ce,,Adjuvant,,2023-03-13T13:21:58.189766-05:00,HCM-CSHL-0459-C17_treatment3,17cf08da-9304-47fc-8e2a-d5230d23abed,,released,,0,2020-06-15T13:08:11.882136-05:00,"Pharmaceutical Therapy, NOS",Residual Disease,
HCM-CSHL-0459-C17,30ad857e-34d5-4ae1-8ca1-e962d10d6440,2b6add79-1643-48f6-9d7e-0b10afd504ce,,,30.0,2023-03-13T13:21:58.189766-05:00,HCM-CSHL-0459-C17_treatment2,43aa98eb-81a6-4ede-bd99-936297207db8,,released,,1,2020-06-15T13:08:11.882136-05:00,"Surgery, NOS",Initial Diagnosis,
HCM-CSHL-0459-C17,30ad857e-34d5-4ae1-8ca1-e962d10d6440,2b6add79-1643-48f6-9d7e-0b10afd504ce,,Adjuvant,,2023-03-13T13:21:58.189766-05:00,HCM-CSHL-0459-C17_treatment4,91849286-8952-40d0-86dd-c77007b14438,,released,,0,2020-06-15T13:08:11.882136-05:00,"Radiation Therapy, NOS",Residual Disease,
HCM-CSHL-0459-C17,30ad857e-34d5-4ae1-8ca1-e962d10d6440,2b6add79-1643-48f6-9d7e-0b10afd504ce,,Neoadjuvant,,2020-10-20T20:46:30.021349-05:00,HCM-CSHL-0459-C17_treatment,f8e49bd5-2547-453e-a7a6-f50511d42a36,,released,,0,2020-06-15T13:08:11.882136-05:00,,,
HCM-SANG-1338-C20,30c7489c-dd72-4d6a-9371-6df76a072282,cff80cce-389e-436f-9d0e-6d4d18711bb0,,Neoadjuvant,98.0,2025-04-07T17:13:09.336794-05:00,HCM-SANG-1338-C20_treatment2,4b1ef1c3-161f-4997-83e9-072d2d70d6ec,,released,,1,2023-02-27T11:30:04.999985-06:00,"Radiation Therapy, NOS",,
HCM-SANG-1338-C20,30c7489c-dd72-4d6a-9371-6df76a072282,cff80cce-389e-436f-9d0e-6d4d18711bb0,,Neoadjuvant,98.0,2025-04-07T17:13:09.336794-05:00,HCM-SANG-1338-C20_treatment,d6b35b05-0056-4d80-a347-88c7ac6cb0c7,,released,Capecitabine,1,2023-02-27T11:30:04.999985-06:00,Chemotherapy,,
HCM-BROD-0476-C56,30eb4b39-20c9-4d1c-8d87-ec84971943fc,981bc3f4-25ac-4fe1-9d8b-6d344dcf3455,,Neoadjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0476-C56_treatment,07dbe3f5-6b24-4279-b07e-e66ffd6e70a4,,released,,unknown,2021-12-21T13:38:00.857158-06:00,"Pharmaceutical Therapy, NOS",,
HCM-BROD-0476-C56,30eb4b39-20c9-4d1c-8d87-ec84971943fc,981bc3f4-25ac-4fe1-9d8b-6d344dcf3455,,Adjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0476-C56_treatment10,36793f96-56fd-436f-8275-4f4d5ad0cf73,,released,,0,2021-12-21T13:38:00.857158-06:00,"Radiation Therapy, NOS",Residual Disease,
HCM-BROD-0476-C56,30eb4b39-20c9-4d1c-8d87-ec84971943fc,981bc3f4-25ac-4fe1-9d8b-6d344dcf3455,,Neoadjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0476-C56_treatment2,45775b70-f8ba-4a16-ad4c-f0f59983e0bd,,released,,unknown,2021-12-21T13:38:00.857158-06:00,"Radiation Therapy, NOS",,
HCM-BROD-0476-C56,30eb4b39-20c9-4d1c-8d87-ec84971943fc,981bc3f4-25ac-4fe1-9d8b-6d344dcf3455,,Adjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0476-C56_treatment7,4cac7c94-5dcc-4f1d-a698-56cfcabb0be0,,released,,0,2021-12-21T13:38:00.857158-06:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-BROD-0476-C56,30eb4b39-20c9-4d1c-8d87-ec84971943fc,981bc3f4-25ac-4fe1-9d8b-6d344dcf3455,,Adjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0476-C56_treatment6,524c8aa1-4bcb-47b3-895d-0d4b753a096f,,released,,0,2021-12-21T13:38:00.857158-06:00,Hormone Therapy,Residual Disease,
HCM-BROD-0476-C56,30eb4b39-20c9-4d1c-8d87-ec84971943fc,981bc3f4-25ac-4fe1-9d8b-6d344dcf3455,,Adjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0476-C56_treatment9,5563ba70-b64a-4356-9d02-0d8c118437be,,released,,0,2021-12-21T13:38:00.857158-06:00,Targeted Molecular Therapy,Residual Disease,
HCM-BROD-0476-C56,30eb4b39-20c9-4d1c-8d87-ec84971943fc,981bc3f4-25ac-4fe1-9d8b-6d344dcf3455,2265.0,Adjuvant,2265.0,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0476-C56_treatment5,703fb4e3-95a8-42d1-9b74-2728a11900d7,,released,Pegylated Liposomal Doxorubicin Hydrochloride,1,2021-12-21T13:38:00.857158-06:00,Chemotherapy,Residual Disease,
HCM-BROD-0476-C56,30eb4b39-20c9-4d1c-8d87-ec84971943fc,981bc3f4-25ac-4fe1-9d8b-6d344dcf3455,,,,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0476-C56_treatment8,722c9b0c-74f0-41e2-bc14-6b483575c9d6,,released,,unknown,2021-12-21T13:38:00.857158-06:00,"Surgery, NOS",Initial Diagnosis,
HCM-BROD-0476-C56,30eb4b39-20c9-4d1c-8d87-ec84971943fc,981bc3f4-25ac-4fe1-9d8b-6d344dcf3455,2149.0,Adjuvant,1990.0,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0476-C56_treatment3,9d59b807-a060-4d90-86e6-f22aeafc3178,,released,Paclitaxel,1,2021-12-21T13:38:00.857158-06:00,Chemotherapy,Residual Disease,
HCM-BROD-0476-C56,30eb4b39-20c9-4d1c-8d87-ec84971943fc,981bc3f4-25ac-4fe1-9d8b-6d344dcf3455,2265.0,Adjuvant,2265.0,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0476-C56_treatment4,bbe4e9c9-5ce9-460d-8cc3-2a29d181dd15,,released,Carboplatin,1,2021-12-21T13:38:00.857158-06:00,Chemotherapy,Residual Disease,
HCM-BROD-0476-C56,30eb4b39-20c9-4d1c-8d87-ec84971943fc,bbd98e7e-5b22-4274-bcc5-630e24149607,3102.0,Maintenance Therapy,1990.0,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0476-C56_treatment11,10936666-7bb5-4770-b038-78051634a2d9,Not Reported,released,Anastrozole,1,2021-12-21T13:38:00.857158-06:00,,,
HCM-BROD-0476-C56,30eb4b39-20c9-4d1c-8d87-ec84971943fc,bbd98e7e-5b22-4274-bcc5-630e24149607,3102.0,Maintenance Therapy,1990.0,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0476-C56_treatment14,92f55b58-8e6f-44bc-b248-ba4d91a98d7a,Not Reported,released,Pegylated Liposomal Doxorubicin Hydrochloride,1,2021-12-21T13:38:00.857158-06:00,,,
HCM-BROD-0476-C56,30eb4b39-20c9-4d1c-8d87-ec84971943fc,bbd98e7e-5b22-4274-bcc5-630e24149607,3102.0,Maintenance Therapy,1990.0,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0476-C56_treatment12,b3999be2-b165-4481-af2b-71171d29aea3,Not Reported,released,Carboplatin,1,2021-12-21T13:38:00.857158-06:00,,,
HCM-BROD-0476-C56,30eb4b39-20c9-4d1c-8d87-ec84971943fc,bbd98e7e-5b22-4274-bcc5-630e24149607,3102.0,Maintenance Therapy,1990.0,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0476-C56_treatment15,bc0704a3-a710-46b0-9c44-e72cd64c58db,Not Reported,released,Encorafenib,1,2021-12-21T13:38:00.857158-06:00,,,
HCM-BROD-0476-C56,30eb4b39-20c9-4d1c-8d87-ec84971943fc,bbd98e7e-5b22-4274-bcc5-630e24149607,3102.0,Maintenance Therapy,1990.0,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0476-C56_treatment13,d832961f-54fa-4fc2-a7f7-aa57d90d907a,Not Reported,released,Paclitaxel,1,2021-12-21T13:38:00.857158-06:00,,,
HCM-BROD-1121-C71,31e8c099-f4f0-4736-b8a1-2baf7f8777c8,46049f22-1278-4334-9234-c760fbc2db09,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-BROD-1121-C71_treatment5,26abd488-a8c1-4e04-a935-c0481322cd5b,,released,,0,2021-12-21T14:01:22.321497-06:00,Targeted Molecular Therapy,Residual Disease,
HCM-BROD-1121-C71,31e8c099-f4f0-4736-b8a1-2baf7f8777c8,46049f22-1278-4334-9234-c760fbc2db09,,,0.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-1121-C71_treatment4,33397f21-9bd5-4c8e-b10f-49e6eee175b0,,released,,1,2021-12-21T14:01:22.321497-06:00,"Surgery, NOS",Initial Diagnosis,
HCM-BROD-1121-C71,31e8c099-f4f0-4736-b8a1-2baf7f8777c8,46049f22-1278-4334-9234-c760fbc2db09,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-BROD-1121-C71_treatment3,768a1790-c469-42df-825f-ec3d13ea001b,,released,,0,2021-12-21T14:01:22.321497-06:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-BROD-1121-C71,31e8c099-f4f0-4736-b8a1-2baf7f8777c8,46049f22-1278-4334-9234-c760fbc2db09,,Neoadjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-BROD-1121-C71_treatment,7741be8f-b22e-430c-a4d5-45c5b0f28aa9,,released,,0,2021-12-21T14:01:22.321497-06:00,,,
HCM-BROD-1121-C71,31e8c099-f4f0-4736-b8a1-2baf7f8777c8,46049f22-1278-4334-9234-c760fbc2db09,81.0,Adjuvant,38.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-1121-C71_treatment2,e73bcb86-6229-47da-be8e-0f7b451ed522,,released,Temozolomide,1,2021-12-21T14:01:22.321497-06:00,Chemotherapy,Residual Disease,
HCM-BROD-1121-C71,31e8c099-f4f0-4736-b8a1-2baf7f8777c8,46049f22-1278-4334-9234-c760fbc2db09,81.0,Adjuvant,38.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-1121-C71_treatment6,ffc3a8f5-7832-43da-a51e-557f489f78ca,,released,,1,2021-12-21T14:01:22.321497-06:00,"Radiation Therapy, NOS",Residual Disease,
HCM-BROD-0870-C43,325efd72-eaf4-4e85-80d0-911d360434d1,2b8e661e-a1c9-4b0a-8d89-bd3ba3d80bb0,,Adjuvant,,2023-11-07T14:20:00.017270-06:00,HCM-BROD-0870-C43_treatment2,2c5b8caf-1bee-4807-884e-638fcea57a55,,released,,0,2021-12-21T13:56:11.124122-06:00,Chemotherapy,Residual Disease,
HCM-BROD-0870-C43,325efd72-eaf4-4e85-80d0-911d360434d1,2b8e661e-a1c9-4b0a-8d89-bd3ba3d80bb0,3752.0,Adjuvant,3669.0,2023-11-07T14:20:00.017270-06:00,HCM-BROD-0870-C43_treatment6,51038656-10f9-468c-9616-95a0d1186a7c,Treatment Ongoing,released,Not Reported,1,2021-12-21T13:56:11.124122-06:00,Targeted Molecular Therapy,Residual Disease,
HCM-BROD-0870-C43,325efd72-eaf4-4e85-80d0-911d360434d1,2b8e661e-a1c9-4b0a-8d89-bd3ba3d80bb0,,Adjuvant,,2023-11-07T14:20:00.017270-06:00,HCM-BROD-0870-C43_treatment7,65f652ef-2daa-46d1-b3b1-7e8b3188170b,,released,,0,2021-12-21T13:56:11.124122-06:00,"Radiation Therapy, NOS",Residual Disease,
HCM-BROD-0870-C43,325efd72-eaf4-4e85-80d0-911d360434d1,2b8e661e-a1c9-4b0a-8d89-bd3ba3d80bb0,,Adjuvant,,2023-11-07T14:20:00.017270-06:00,HCM-BROD-0870-C43_treatment3,85f539ee-5212-420a-affb-755b007e052f,,released,,0,2021-12-21T13:56:11.124122-06:00,Hormone Therapy,Residual Disease,
HCM-BROD-0870-C43,325efd72-eaf4-4e85-80d0-911d360434d1,2b8e661e-a1c9-4b0a-8d89-bd3ba3d80bb0,,,0.0,2023-11-07T14:20:00.017270-06:00,HCM-BROD-0870-C43_treatment5,a838b38e-a52b-49ae-9471-4d95e5f253c6,,released,,1,2021-12-21T13:56:11.124122-06:00,"Surgery, NOS",Initial Diagnosis,
HCM-BROD-0870-C43,325efd72-eaf4-4e85-80d0-911d360434d1,2b8e661e-a1c9-4b0a-8d89-bd3ba3d80bb0,,Neoadjuvant,818.0,2023-11-07T14:20:00.017270-06:00,HCM-BROD-0870-C43_treatment,c005aab4-18ea-4010-b4c1-97daf4a384ff,,released,Unknown,1,2021-12-21T13:56:11.124122-06:00,Immunotherapy (Including Vaccines),,
HCM-BROD-0870-C43,325efd72-eaf4-4e85-80d0-911d360434d1,2b8e661e-a1c9-4b0a-8d89-bd3ba3d80bb0,3752.0,Adjuvant,3669.0,2023-11-07T14:20:00.017270-06:00,HCM-BROD-0870-C43_treatment4,fc07eb4f-c28b-4e5d-b43c-3c37fcfe63f6,Treatment Ongoing,released,Not Reported,1,2021-12-21T13:56:11.124122-06:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-BROD-0870-C43,325efd72-eaf4-4e85-80d0-911d360434d1,40385f8e-ba4b-40eb-a2c3-851f7f67964b,3374.0,Maintenance Therapy,3254.0,2023-11-07T14:20:00.017270-06:00,HCM-BROD-0870-C43_treatment8,3fc88889-f6c8-4c75-a4ee-a1a0999d986c,Stable Disease,released,,1,2021-12-21T13:56:11.124122-06:00,,,
HCM-BROD-0871-C49,33165ed4-5f38-4566-8d0d-82e2a6d2743f,d245f226-ed78-44d4-a452-9f219612c88c,2948.0,Maintenance Therapy,58.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0871-C49_treatment8,76109255-7f20-48d8-8482-b72f23d1508a,Progressive Disease,released,Docetaxel,1,2023-02-28T13:08:35.301254-06:00,,,
HCM-BROD-0871-C49,33165ed4-5f38-4566-8d0d-82e2a6d2743f,d245f226-ed78-44d4-a452-9f219612c88c,2948.0,Maintenance Therapy,58.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0871-C49_treatment6,cfcd2fb2-2f4d-4d59-a6b9-16ca315e054b,Progressive Disease,released,Anastrozole,1,2023-02-28T13:08:35.301254-06:00,,,
HCM-BROD-0871-C49,33165ed4-5f38-4566-8d0d-82e2a6d2743f,d245f226-ed78-44d4-a452-9f219612c88c,2948.0,Maintenance Therapy,58.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0871-C49_treatment5,f02cf39c-ced5-48c0-b96b-4fa14208e29a,Progressive Disease,released,Trabectedin,1,2023-02-28T13:08:35.301254-06:00,,,
HCM-BROD-0871-C49,33165ed4-5f38-4566-8d0d-82e2a6d2743f,d245f226-ed78-44d4-a452-9f219612c88c,2948.0,Maintenance Therapy,58.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0871-C49_treatment7,faf96ff4-3186-45b9-b4dc-a43c31f4eec9,Progressive Disease,released,Dacarbazine,1,2023-02-28T13:08:35.301254-06:00,,,
HCM-BROD-0871-C49,33165ed4-5f38-4566-8d0d-82e2a6d2743f,f297b2b5-29a7-4f2d-a094-e2666fb04bf5,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0871-C49_treatment4,c9127c5d-aeaf-4190-a9e1-1bda3f94d73b,,released,,0,2021-12-21T13:56:21.205280-06:00,"Radiation Therapy, NOS",Residual Disease,
HCM-BROD-0871-C49,33165ed4-5f38-4566-8d0d-82e2a6d2743f,f297b2b5-29a7-4f2d-a094-e2666fb04bf5,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0871-C49_treatment3,ed001e27-67ce-49ab-a745-28c645b6fe2b,,released,,0,2021-12-21T13:56:21.205280-06:00,"Pharmaceutical Therapy, NOS",Residual Disease,
HCM-BROD-0871-C49,33165ed4-5f38-4566-8d0d-82e2a6d2743f,f297b2b5-29a7-4f2d-a094-e2666fb04bf5,,Neoadjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0871-C49_treatment,f4e07579-b9c3-41dc-9abc-e7667d7603cb,,released,,0,2021-12-21T13:56:21.205280-06:00,,,
HCM-BROD-0871-C49,33165ed4-5f38-4566-8d0d-82e2a6d2743f,f297b2b5-29a7-4f2d-a094-e2666fb04bf5,,,0.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0871-C49_treatment2,fb5d36b8-781f-407c-ba81-3d307320b82a,,released,,1,2021-12-21T13:56:21.205280-06:00,"Surgery, NOS",Initial Diagnosis,
HCM-CSHL-1264-C25,331b37c2-0a17-4078-8364-0df9ae026900,8e175cb2-5c53-4478-b19f-5b8a5708f8ee,218.0,Adjuvant,65.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-1264-C25_treatment3,1b6bde4c-c5e7-4b6a-952c-3cbb4e09b901,,released,Nab-paclitaxel,1,2021-12-23T08:33:45.148749-06:00,Chemotherapy,Residual Disease,
HCM-CSHL-1264-C25,331b37c2-0a17-4078-8364-0df9ae026900,8e175cb2-5c53-4478-b19f-5b8a5708f8ee,218.0,Adjuvant,65.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-1264-C25_treatment2,5d75d993-a01e-4a37-89b4-de01fa314f13,,released,Gemcitabine,1,2021-12-23T08:33:45.148749-06:00,Chemotherapy,Residual Disease,
HCM-CSHL-1264-C25,331b37c2-0a17-4078-8364-0df9ae026900,8e175cb2-5c53-4478-b19f-5b8a5708f8ee,,,-10.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-1264-C25_treatment5,69ec511b-ae9d-4dd0-949c-ab60fc63cf09,,released,,1,2021-12-23T08:33:45.148749-06:00,"Surgery, NOS",Initial Diagnosis,
HCM-CSHL-1264-C25,331b37c2-0a17-4078-8364-0df9ae026900,8e175cb2-5c53-4478-b19f-5b8a5708f8ee,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-1264-C25_treatment7,7544a64c-8d0b-440d-84cb-fde1b9c17cdb,,released,,0,2021-12-23T08:33:45.148749-06:00,"Radiation Therapy, NOS",Residual Disease,
HCM-CSHL-1264-C25,331b37c2-0a17-4078-8364-0df9ae026900,8e175cb2-5c53-4478-b19f-5b8a5708f8ee,,Neoadjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-1264-C25_treatment,77d9e558-a51e-4b79-977e-c9958572cbbb,,released,,0,2021-12-23T08:33:45.148749-06:00,,,
HCM-CSHL-1264-C25,331b37c2-0a17-4078-8364-0df9ae026900,8e175cb2-5c53-4478-b19f-5b8a5708f8ee,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-1264-C25_treatment4,8b24ce5e-9dbf-4625-b4f8-8cd17725bb4b,,released,,0,2021-12-23T08:33:45.148749-06:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-CSHL-1264-C25,331b37c2-0a17-4078-8364-0df9ae026900,8e175cb2-5c53-4478-b19f-5b8a5708f8ee,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-1264-C25_treatment6,d00ab4c8-cc7a-466b-98f6-086e9b07134a,,released,,0,2021-12-23T08:33:45.148749-06:00,Targeted Molecular Therapy,Residual Disease,
HCM-STAN-1111-C19,337c0400-baff-494d-a790-03169ed1e547,0ed72b53-465b-417f-8f70-e8206e523b29,,Neoadjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-STAN-1111-C19_treatment,2336a478-06d3-426f-9bfc-f6c86e34959f,,released,,0,2022-09-22T07:11:20.934917-05:00,,,
HCM-STAN-1111-C19,337c0400-baff-494d-a790-03169ed1e547,0ed72b53-465b-417f-8f70-e8206e523b29,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-STAN-1111-C19_treatment4,65c11847-b7f4-499b-b366-2568329e3baf,,released,,0,2022-09-22T07:11:20.934917-05:00,"Radiation Therapy, NOS",Residual Disease,
HCM-STAN-1111-C19,337c0400-baff-494d-a790-03169ed1e547,0ed72b53-465b-417f-8f70-e8206e523b29,,,0.0,2025-04-07T17:13:09.336794-05:00,HCM-STAN-1111-C19_treatment2,f3a25481-1337-4323-8917-8508876ff5df,,released,,1,2022-09-22T07:11:20.934917-05:00,"Surgery, NOS",Initial Diagnosis,
HCM-STAN-1111-C19,337c0400-baff-494d-a790-03169ed1e547,0ed72b53-465b-417f-8f70-e8206e523b29,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-STAN-1111-C19_treatment3,f4e083c7-51e7-4834-9765-abc38a5c31fc,,released,,0,2022-09-22T07:11:20.934917-05:00,"Pharmaceutical Therapy, NOS",Residual Disease,
HCM-CSHL-0429-C06,345d11d3-7376-4a47-bcc2-cd6cf5c2ed0f,6d5c80c6-0d27-4934-92cb-f6a82ffea58f,,Neoadjuvant,,2023-11-07T14:28:29.403873-06:00,HCM-CSHL-0429-C06_treatment,447ec792-1f90-4b07-b7ea-60b9b0145869,,released,,0,2020-09-28T10:05:25.577038-05:00,,,
HCM-CSHL-0429-C06,345d11d3-7376-4a47-bcc2-cd6cf5c2ed0f,6d5c80c6-0d27-4934-92cb-f6a82ffea58f,,,41.0,2023-11-07T14:28:29.403873-06:00,HCM-CSHL-0429-C06_treatment2,5d9a4a0b-2738-41c6-8198-27fe9f8124c7,,released,,1,2020-09-28T10:05:25.577038-05:00,"Surgery, NOS",Initial Diagnosis,
HCM-CSHL-0429-C06,345d11d3-7376-4a47-bcc2-cd6cf5c2ed0f,6d5c80c6-0d27-4934-92cb-f6a82ffea58f,,Adjuvant,,2023-11-07T14:28:29.403873-06:00,HCM-CSHL-0429-C06_treatment3,6e6fa051-e302-4a4f-831e-aeeda9153b04,,released,,0,2020-09-28T10:05:25.577038-05:00,"Pharmaceutical Therapy, NOS",Residual Disease,
HCM-CSHL-0429-C06,345d11d3-7376-4a47-bcc2-cd6cf5c2ed0f,6d5c80c6-0d27-4934-92cb-f6a82ffea58f,,Adjuvant,,2023-11-07T14:28:29.403873-06:00,HCM-CSHL-0429-C06_treatment4,7bad2e20-2499-4762-9c91-16ba5ea3c6b4,,released,,0,2020-09-28T10:05:25.577038-05:00,"Radiation Therapy, NOS",Residual Disease,
HCM-BROD-0016-C25,359ca5c2-0d00-4b88-be2d-476e6b4c02ef,c6875de1-a360-40c3-8c74-c28de273a1bc,80.0,Adjuvant,40.0,2023-02-22T07:39:25.979291-06:00,HCM-BROD-0016-C25_treatment3,1090dd67-497f-49b9-85a8-a48db458fb0d,,released,Fluorouracil,1,2020-09-17T15:42:55.614463-05:00,Chemotherapy,Residual Disease,
HCM-BROD-0016-C25,359ca5c2-0d00-4b88-be2d-476e6b4c02ef,c6875de1-a360-40c3-8c74-c28de273a1bc,208.0,Adjuvant,122.0,2023-02-22T07:39:25.979291-06:00,HCM-BROD-0016-C25_treatment6,2207cd92-039e-4f28-8c4e-81c8b9416d41,,released,Gemcitabine,1,2020-09-17T15:42:55.614463-05:00,Chemotherapy,Residual Disease,
HCM-BROD-0016-C25,359ca5c2-0d00-4b88-be2d-476e6b4c02ef,c6875de1-a360-40c3-8c74-c28de273a1bc,,Adjuvant,,2023-02-22T07:39:25.979291-06:00,HCM-BROD-0016-C25_treatment8,296a9661-d8ff-4b42-b158-5d118ff87aa7,,released,,0,2020-09-17T15:42:55.614463-05:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-BROD-0016-C25,359ca5c2-0d00-4b88-be2d-476e6b4c02ef,c6875de1-a360-40c3-8c74-c28de273a1bc,80.0,Adjuvant,40.0,2023-02-22T07:39:25.979291-06:00,HCM-BROD-0016-C25_treatment4,3d832512-2fe6-439d-937b-0b323023607e,,released,Leucovorin,1,2020-09-17T15:42:55.614463-05:00,Chemotherapy,Residual Disease,
HCM-BROD-0016-C25,359ca5c2-0d00-4b88-be2d-476e6b4c02ef,c6875de1-a360-40c3-8c74-c28de273a1bc,,Adjuvant,,2023-02-22T07:39:25.979291-06:00,HCM-BROD-0016-C25_treatment10,53c656ca-dc60-4d5a-af12-a6088df902e2,,released,,0,2020-09-17T15:42:55.614463-05:00,Targeted Molecular Therapy,Residual Disease,
HCM-BROD-0016-C25,359ca5c2-0d00-4b88-be2d-476e6b4c02ef,c6875de1-a360-40c3-8c74-c28de273a1bc,,Neoadjuvant,40.0,2023-02-22T07:39:25.979291-06:00,HCM-BROD-0016-C25_treatment2,8dbcec3c-5ed7-43ee-b522-729680341a15,,released,Oxaliplatin,1,2020-09-17T15:42:55.614463-05:00,Chemotherapy,,
HCM-BROD-0016-C25,359ca5c2-0d00-4b88-be2d-476e6b4c02ef,c6875de1-a360-40c3-8c74-c28de273a1bc,,,,2023-02-27T11:33:53.107589-06:00,HCM-BROD-0016-C25_treatment9,a5ec6e55-fa1d-46a1-a7e8-abf6dbf08fe9,,released,,0,2020-09-17T15:42:55.614463-05:00,"Surgery, NOS",Initial Diagnosis,
HCM-BROD-0016-C25,359ca5c2-0d00-4b88-be2d-476e6b4c02ef,c6875de1-a360-40c3-8c74-c28de273a1bc,,Adjuvant,,2023-02-22T07:39:25.979291-06:00,HCM-BROD-0016-C25_treatment11,ab2c5872-4ee0-4780-8b93-9b6d985d2c6d,,released,,0,2020-09-17T15:42:55.614463-05:00,"Radiation Therapy, NOS",Residual Disease,
HCM-BROD-0016-C25,359ca5c2-0d00-4b88-be2d-476e6b4c02ef,c6875de1-a360-40c3-8c74-c28de273a1bc,208.0,Adjuvant,122.0,2023-02-22T07:39:25.979291-06:00,HCM-BROD-0016-C25_treatment7,ade23f87-d17f-4360-a063-aba36f86751d,,released,Nab-paclitaxel,1,2020-09-17T15:42:55.614463-05:00,Chemotherapy,Residual Disease,
HCM-BROD-0016-C25,359ca5c2-0d00-4b88-be2d-476e6b4c02ef,c6875de1-a360-40c3-8c74-c28de273a1bc,80.0,Adjuvant,40.0,2023-02-22T07:39:25.979291-06:00,HCM-BROD-0016-C25_treatment5,c37da40d-10ac-4753-a140-5ee25dd9ce3c,,released,Oxaliplatin,1,2020-09-17T15:42:55.614463-05:00,Chemotherapy,Residual Disease,
HCM-BROD-0016-C25,359ca5c2-0d00-4b88-be2d-476e6b4c02ef,c6875de1-a360-40c3-8c74-c28de273a1bc,,Neoadjuvant,40.0,2023-02-22T07:39:25.979291-06:00,HCM-BROD-0016-C25_treatment,db8cbac7-a59b-48f4-9b7c-1deca73cb992,,released,Fluorouracil,1,2020-09-17T15:42:55.614463-05:00,Chemotherapy,,
HCM-BROD-0046-C71,35a8dada-9a8b-4dd7-8565-e5e2c1e69958,bbe94910-fbe5-49bf-b984-2d2021bc1b30,,Neoadjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0046-C71_treatment,80960eef-a273-477f-a526-f0d65e6dd8e3,,released,,0,2019-04-04T14:43:01.620260-05:00,,,
HCM-BROD-0046-C71,35a8dada-9a8b-4dd7-8565-e5e2c1e69958,bbe94910-fbe5-49bf-b984-2d2021bc1b30,,Adjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0046-C71_treatment3,995c1320-c2d9-4e92-8af8-9d7108ab1f61,,released,,0,2020-02-27T12:15:20.030640-06:00,"Pharmaceutical Therapy, NOS",Residual Disease,
HCM-BROD-0046-C71,35a8dada-9a8b-4dd7-8565-e5e2c1e69958,bbe94910-fbe5-49bf-b984-2d2021bc1b30,,,-2.0,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0046-C71_treatment2,bc77ace7-046f-4130-8ebf-7101a045f95a,,released,,1,2020-02-27T12:15:20.030640-06:00,"Surgery, NOS",Initial Diagnosis,
HCM-BROD-0046-C71,35a8dada-9a8b-4dd7-8565-e5e2c1e69958,bbe94910-fbe5-49bf-b984-2d2021bc1b30,,Adjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0046-C71_treatment4,d36bdd6b-d332-46f0-9ebc-248a536c4b5b,,released,,0,2020-02-27T12:15:20.030640-06:00,"Radiation Therapy, NOS",Residual Disease,
HCM-SANG-1339-C18,35e5f3ec-89ea-4859-914c-5995b7162a0d,9a5f738b-e7fd-4f43-b198-6abee3075f35,,Neoadjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-SANG-1339-C18_treatment,9bcf12eb-b0a0-4dc2-90fd-9921e7a7732e,,released,,0,2023-02-27T11:54:51.687953-06:00,,,
HCM-CSHL-0622-C18,36a9ed92-cc75-4e39-ba21-afe93f3af7c2,0a0d94d1-57b5-47f4-9f21-6e0867da18d5,,Adjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0622-C18_treatment7,0e19d0fe-582c-411a-a789-bc86afd3020b,,released,,0,2021-12-21T14:12:44.771571-06:00,"Radiation Therapy, NOS",Residual Disease,
HCM-CSHL-0622-C18,36a9ed92-cc75-4e39-ba21-afe93f3af7c2,0a0d94d1-57b5-47f4-9f21-6e0867da18d5,,Adjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0622-C18_treatment6,6f9661af-bbcd-4876-8f88-371ae8573d5c,,released,,0,2021-12-21T14:12:44.771571-06:00,"Pharmaceutical Therapy, NOS",Residual Disease,
HCM-CSHL-0622-C18,36a9ed92-cc75-4e39-ba21-afe93f3af7c2,0a0d94d1-57b5-47f4-9f21-6e0867da18d5,,Neoadjuvant,28.0,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0622-C18_treatment3,8bbe646d-09fc-4baa-8255-45471ea13100,,released,Irinotecan,1,2021-12-21T14:12:44.771571-06:00,Chemotherapy,,
HCM-CSHL-0622-C18,36a9ed92-cc75-4e39-ba21-afe93f3af7c2,0a0d94d1-57b5-47f4-9f21-6e0867da18d5,,Neoadjuvant,28.0,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0622-C18_treatment,99074269-0f46-4d6c-bb77-ee5eb17072f4,,released,Leucovorin Calcium,1,2021-12-21T14:12:44.771571-06:00,Chemotherapy,,
HCM-CSHL-0622-C18,36a9ed92-cc75-4e39-ba21-afe93f3af7c2,0a0d94d1-57b5-47f4-9f21-6e0867da18d5,,Neoadjuvant,28.0,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0622-C18_treatment4,9a2cbee0-4302-4f16-9bef-db0f2580beef,,released,,1,2021-12-21T14:12:44.771571-06:00,Chemotherapy,,FOLFIRI
HCM-CSHL-0622-C18,36a9ed92-cc75-4e39-ba21-afe93f3af7c2,0a0d94d1-57b5-47f4-9f21-6e0867da18d5,,Neoadjuvant,28.0,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0622-C18_treatment2,be37bdc0-8bbf-46a3-a387-fa9fa645a884,,released,Fluorouracil,1,2021-12-21T14:12:44.771571-06:00,Chemotherapy,,
HCM-CSHL-0622-C18,36a9ed92-cc75-4e39-ba21-afe93f3af7c2,0a0d94d1-57b5-47f4-9f21-6e0867da18d5,,,203.0,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0622-C18_treatment5,c393090b-2966-4e7f-865a-0fa568da38fb,,released,,1,2021-12-21T14:12:44.771571-06:00,"Surgery, NOS",Initial Diagnosis,
HCM-CSHL-0622-C18,36a9ed92-cc75-4e39-ba21-afe93f3af7c2,5f417ec2-b0e6-465a-aaa7-175848f3f94c,152.0,Maintenance Therapy,28.0,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0622-C18_treatment9,41682223-24f6-47e3-8246-eab4ff3c60e9,Stable Disease,released,Fluorouracil,1,2023-02-28T12:14:53.271670-06:00,,,
HCM-CSHL-0622-C18,36a9ed92-cc75-4e39-ba21-afe93f3af7c2,5f417ec2-b0e6-465a-aaa7-175848f3f94c,152.0,Maintenance Therapy,28.0,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0622-C18_treatment8,b1e2fa89-fa7e-41af-ad5f-dda938e58606,Stable Disease,released,Leucovorin Calcium,1,2023-02-28T12:14:53.271670-06:00,,,
HCM-CSHL-0622-C18,36a9ed92-cc75-4e39-ba21-afe93f3af7c2,5f417ec2-b0e6-465a-aaa7-175848f3f94c,152.0,Maintenance Therapy,28.0,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0622-C18_treatment10,c694212a-ca6e-4bed-8f3a-eca061c36ac8,Stable Disease,released,Irinotecan,1,2023-02-28T12:14:53.271670-06:00,,,
HCM-CSHL-0622-C18,36a9ed92-cc75-4e39-ba21-afe93f3af7c2,5f417ec2-b0e6-465a-aaa7-175848f3f94c,152.0,Maintenance Therapy,28.0,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0622-C18_treatment11,cf0ee83a-20fd-4378-a790-dbcc0f19a151,Stable Disease,released,,1,2021-12-21T14:12:44.771571-06:00,,,FOLFIRI
HCM-CSHL-0085-C24,373c15fd-f995-419d-beef-951db2706411,eafbdc4a-d4f4-4be7-80b4-cc2e220d6bf1,,,,2023-03-13T13:09:59.050581-05:00,HCM-CSHL-0085-C24_treatment2,076500bb-dc15-4e75-a0b4-aa300a8986ad,,released,,unknown,2020-07-31T09:32:26.046185-05:00,"Surgery, NOS",Initial Diagnosis,
HCM-CSHL-0085-C24,373c15fd-f995-419d-beef-951db2706411,eafbdc4a-d4f4-4be7-80b4-cc2e220d6bf1,,Adjuvant,,2023-03-13T13:09:59.050581-05:00,HCM-CSHL-0085-C24_treatment4,0f77ffdc-21b0-467b-a3e3-c4dd08aac723,,released,,unknown,2020-07-31T09:32:26.046185-05:00,"Radiation Therapy, NOS",Residual Disease,
HCM-CSHL-0085-C24,373c15fd-f995-419d-beef-951db2706411,eafbdc4a-d4f4-4be7-80b4-cc2e220d6bf1,,Adjuvant,,2023-03-13T13:09:59.050581-05:00,HCM-CSHL-0085-C24_treatment3,3c91c244-6198-4f3b-96b2-df2cbbeb483f,,released,,unknown,2020-07-31T09:32:26.046185-05:00,"Pharmaceutical Therapy, NOS",Residual Disease,
HCM-CSHL-0085-C24,373c15fd-f995-419d-beef-951db2706411,eafbdc4a-d4f4-4be7-80b4-cc2e220d6bf1,,Neoadjuvant,,2020-10-20T19:20:06.800740-05:00,HCM-CSHL-0085-C24_treatment,bfd3adad-fd17-429e-9edf-472e71f1031c,,released,,0,2019-04-03T17:46:39.008727-05:00,,,
HCM-SANG-1327-C18,37e1311a-a125-4ea8-9db1-1f1b14f87856,926a4720-6364-46bc-8004-bc1b5372d599,,Neoadjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-SANG-1327-C18_treatment,f563d462-b915-4f69-8db7-19af2658c53b,,released,,0,2023-02-27T11:54:58.655785-06:00,,,
HCM-CSHL-0151-C50,38349235-a34c-4ced-a4a0-051090e47332,69839ce1-c66e-4f00-8509-a9f26bf06fe3,,Adjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0151-C50_treatment6,03dbe73e-548c-4070-9a67-4fb3ccd42b32,,released,,0,2020-09-27T12:58:24.162952-05:00,Targeted Molecular Therapy,Residual Disease,
HCM-CSHL-0151-C50,38349235-a34c-4ced-a4a0-051090e47332,69839ce1-c66e-4f00-8509-a9f26bf06fe3,,Adjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0151-C50_treatment4,05a22f85-d9b4-428c-93be-607db558909d,,released,,0,2020-09-27T12:58:24.162952-05:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-CSHL-0151-C50,38349235-a34c-4ced-a4a0-051090e47332,69839ce1-c66e-4f00-8509-a9f26bf06fe3,,,96.0,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0151-C50_treatment5,2503cec1-4474-4cab-bdda-3ee3d35d929e,,released,,1,2020-09-27T12:58:24.162952-05:00,"Surgery, NOS",Initial Diagnosis,
HCM-CSHL-0151-C50,38349235-a34c-4ced-a4a0-051090e47332,69839ce1-c66e-4f00-8509-a9f26bf06fe3,,Adjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0151-C50_treatment2,3034f150-0f22-42b3-8dd9-73e33e4807dd,,released,,0,2020-09-27T12:58:24.162952-05:00,Chemotherapy,Residual Disease,
HCM-CSHL-0151-C50,38349235-a34c-4ced-a4a0-051090e47332,69839ce1-c66e-4f00-8509-a9f26bf06fe3,,Adjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0151-C50_treatment7,635391cc-3d3f-4ee5-91cd-1e25f07836e3,,released,,0,2020-09-27T12:58:24.162952-05:00,"Radiation Therapy, NOS",Residual Disease,
HCM-CSHL-0151-C50,38349235-a34c-4ced-a4a0-051090e47332,69839ce1-c66e-4f00-8509-a9f26bf06fe3,,Neoadjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0151-C50_treatment,b7f8e9bc-d4cf-49d6-b1e8-821f58f2cfda,,released,,0,2020-09-27T12:58:24.162952-05:00,,,
HCM-CSHL-0151-C50,38349235-a34c-4ced-a4a0-051090e47332,69839ce1-c66e-4f00-8509-a9f26bf06fe3,,Adjuvant,166.0,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0151-C50_treatment3,e05cf28b-89b1-458e-be23-89109dcc5995,Treatment Ongoing,released,Tamoxifen,1,2020-09-27T12:58:24.162952-05:00,Hormone Therapy,Residual Disease,
HCM-CSHL-0186-C25,387a6f37-fe35-4ffc-a4b3-dda1af08f6c3,ec57a3df-7c69-4379-a9da-bcf784b3a52b,,,,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0186-C25_treatment2,568d2fda-c1ae-4853-9f5b-7d9cd20317e5,,released,,unknown,2020-09-28T09:15:30.201930-05:00,"Surgery, NOS",Initial Diagnosis,
HCM-CSHL-0186-C25,387a6f37-fe35-4ffc-a4b3-dda1af08f6c3,ec57a3df-7c69-4379-a9da-bcf784b3a52b,,Adjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0186-C25_treatment4,71b87aad-a268-485e-b11e-1e51f5d71c4d,,released,,unknown,2020-09-28T09:15:30.201930-05:00,"Radiation Therapy, NOS",Residual Disease,
HCM-CSHL-0186-C25,387a6f37-fe35-4ffc-a4b3-dda1af08f6c3,ec57a3df-7c69-4379-a9da-bcf784b3a52b,,Adjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0186-C25_treatment3,be70d5cd-a23a-4b90-9d33-a375cb0227c4,,released,,unknown,2020-09-28T09:15:30.201930-05:00,"Pharmaceutical Therapy, NOS",Residual Disease,
HCM-CSHL-0186-C25,387a6f37-fe35-4ffc-a4b3-dda1af08f6c3,ec57a3df-7c69-4379-a9da-bcf784b3a52b,,Neoadjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0186-C25_treatment,d9b88631-97e5-4f95-838d-debb7239b4b7,,released,,0,2020-09-28T09:15:30.201930-05:00,,,
HCM-SANG-0288-C18,388c484f-639a-448c-882e-2897f29e55b2,3ea77bd2-af57-4bb1-89f9-6901b98910d6,,Neoadjuvant,,2023-02-22T07:39:25.979291-06:00,HCM-SANG-0288-C18_treatment,caf1d54a-373a-4570-b016-15173e70ed1a,,released,,0,2021-12-21T15:08:43.427372-06:00,,,
HCM-BROD-0614-C71,39aa41b3-af16-4ac0-aaab-49baf567e77c,6aaf0e48-a34e-46a3-8e4c-58a03e4c5ec0,99.0,Adjuvant,57.0,2023-02-22T07:39:25.979291-06:00,HCM-BROD-0614-C71_treatment6,65ee600b-4b48-4f3f-96d0-e157b2487b68,,released,,1,2021-11-23T08:36:18.243684-06:00,"Radiation, 2D Conventional",Residual Disease,
HCM-BROD-0614-C71,39aa41b3-af16-4ac0-aaab-49baf567e77c,6aaf0e48-a34e-46a3-8e4c-58a03e4c5ec0,,Neoadjuvant,,2023-02-22T07:39:25.979291-06:00,HCM-BROD-0614-C71_treatment,697fecd7-4356-43e5-806e-2f830c30705d,,released,,0,2021-11-23T08:36:18.243684-06:00,,,
HCM-BROD-0614-C71,39aa41b3-af16-4ac0-aaab-49baf567e77c,6aaf0e48-a34e-46a3-8e4c-58a03e4c5ec0,,Adjuvant,,2023-02-22T07:39:25.979291-06:00,HCM-BROD-0614-C71_treatment3,90dfd3cf-0356-46b2-9b2e-4e5f7defd3a9,,released,,0,2021-11-23T08:36:18.243684-06:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-BROD-0614-C71,39aa41b3-af16-4ac0-aaab-49baf567e77c,6aaf0e48-a34e-46a3-8e4c-58a03e4c5ec0,,,0.0,2023-02-27T11:50:37.841811-06:00,HCM-BROD-0614-C71_treatment4,9691dbd8-7238-4a84-8883-36996dd3a27b,,released,,1,2021-11-23T08:36:18.243684-06:00,"Surgery, NOS",Initial Diagnosis,
HCM-BROD-0614-C71,39aa41b3-af16-4ac0-aaab-49baf567e77c,6aaf0e48-a34e-46a3-8e4c-58a03e4c5ec0,272.0,Adjuvant,128.0,2023-02-22T07:39:25.979291-06:00,HCM-BROD-0614-C71_treatment5,c19b07a1-834f-41e5-a828-91a342d39f21,,released,Bevacizumab,1,2021-11-23T08:36:18.243684-06:00,Targeted Molecular Therapy,Residual Disease,
HCM-BROD-0614-C71,39aa41b3-af16-4ac0-aaab-49baf567e77c,6aaf0e48-a34e-46a3-8e4c-58a03e4c5ec0,272.0,Adjuvant,128.0,2023-02-22T07:39:25.979291-06:00,HCM-BROD-0614-C71_treatment2,d9e2a070-117d-4551-9eac-23cc4b1de327,,released,Temozolomide,1,2021-11-23T08:36:18.243684-06:00,Chemotherapy,Residual Disease,
HCM-SANG-0545-C15,39ad1462-013d-460c-af44-c0b36ebb07a7,a21e8f93-5bdf-4a91-baca-5146119157a5,,Neoadjuvant,160.0,2025-03-31T16:34:59.906497-05:00,HCM-SANG-0545-C15_treatment3,46f2c558-222c-4119-96e2-d2b2c540c2ff,,released,Cisplatin,1,2021-12-21T15:15:36.750890-06:00,Chemotherapy,,
HCM-SANG-0545-C15,39ad1462-013d-460c-af44-c0b36ebb07a7,a21e8f93-5bdf-4a91-baca-5146119157a5,,Neoadjuvant,160.0,2025-03-31T16:34:59.906497-05:00,HCM-SANG-0545-C15_treatment4,a1c178db-2612-42c6-87f0-05fcc9d97137,,released,,1,2021-12-21T15:15:36.750890-06:00,Chemotherapy,,ECX
HCM-SANG-0545-C15,39ad1462-013d-460c-af44-c0b36ebb07a7,a21e8f93-5bdf-4a91-baca-5146119157a5,,Neoadjuvant,160.0,2025-03-31T16:34:59.906497-05:00,HCM-SANG-0545-C15_treatment,b5962f17-b976-4596-aff7-16a572b9e9cc,,released,Epirubicin,1,2021-12-21T15:15:36.750890-06:00,Chemotherapy,,
HCM-SANG-0545-C15,39ad1462-013d-460c-af44-c0b36ebb07a7,a21e8f93-5bdf-4a91-baca-5146119157a5,,Neoadjuvant,160.0,2025-03-31T16:34:59.906497-05:00,HCM-SANG-0545-C15_treatment2,e6e279bf-f3bc-4850-8410-2d361314ca2b,,released,Capecitabine,1,2021-12-21T15:15:36.750890-06:00,Chemotherapy,,
HCM-BROD-0131-C25,3a37b417-9f45-4bd4-a545-f4084e7e68c2,a60cb174-cbb2-44e1-903c-b4ae99a81c91,,Neoadjuvant,7.0,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0131-C25_treatment5,02ee2ad6-0560-476b-a5a5-9791b8b3f530,,released,,1,2020-09-17T15:59:41.557221-05:00,Chemotherapy,,FOLFIRINOX
HCM-BROD-0131-C25,3a37b417-9f45-4bd4-a545-f4084e7e68c2,a60cb174-cbb2-44e1-903c-b4ae99a81c91,,Neoadjuvant,7.0,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0131-C25_treatment4,1940b1e5-6835-4e50-80fc-909773277708,,released,Oxaliplatin,1,2020-09-17T15:59:41.557221-05:00,Chemotherapy,,
HCM-BROD-0131-C25,3a37b417-9f45-4bd4-a545-f4084e7e68c2,a60cb174-cbb2-44e1-903c-b4ae99a81c91,,Adjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0131-C25_treatment11,204ddb68-acfe-4759-beed-944216f069db,,released,,0,2020-09-17T15:59:41.557221-05:00,"Radiation Therapy, NOS",Residual Disease,
HCM-BROD-0131-C25,3a37b417-9f45-4bd4-a545-f4084e7e68c2,a60cb174-cbb2-44e1-903c-b4ae99a81c91,146.0,Adjuvant,139.0,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0131-C25_treatment6,45fdd3e1-a4b5-4d82-b5f6-dab1f2002e8b,,released,Gemcitabine,1,2020-09-17T15:59:41.557221-05:00,Chemotherapy,Residual Disease,
HCM-BROD-0131-C25,3a37b417-9f45-4bd4-a545-f4084e7e68c2,a60cb174-cbb2-44e1-903c-b4ae99a81c91,,Neoadjuvant,7.0,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0131-C25_treatment2,52f6b81f-abb1-4178-a2ef-fe14ad6afcac,,released,Leucovorin Calcium,1,2020-09-17T15:59:41.557221-05:00,Chemotherapy,,
HCM-BROD-0131-C25,3a37b417-9f45-4bd4-a545-f4084e7e68c2,a60cb174-cbb2-44e1-903c-b4ae99a81c91,,Neoadjuvant,7.0,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0131-C25_treatment,6e1411de-7570-4e10-b10e-f72091dfe792,,released,Irinotecan Hydrochloride,1,2020-09-17T15:59:41.557221-05:00,Chemotherapy,,
HCM-BROD-0131-C25,3a37b417-9f45-4bd4-a545-f4084e7e68c2,a60cb174-cbb2-44e1-903c-b4ae99a81c91,,Adjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0131-C25_treatment10,78078809-b163-4999-a06e-d00f5365c3bf,,released,,0,2020-09-17T15:59:41.557221-05:00,Targeted Molecular Therapy,Residual Disease,
HCM-BROD-0131-C25,3a37b417-9f45-4bd4-a545-f4084e7e68c2,a60cb174-cbb2-44e1-903c-b4ae99a81c91,,Neoadjuvant,7.0,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0131-C25_treatment3,93ab00b9-31c4-475a-8e07-714b2d76a556,,released,Fluorouracil,1,2020-09-17T15:59:41.557221-05:00,Chemotherapy,,
HCM-BROD-0131-C25,3a37b417-9f45-4bd4-a545-f4084e7e68c2,a60cb174-cbb2-44e1-903c-b4ae99a81c91,146.0,Adjuvant,139.0,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0131-C25_treatment7,bc0c3dbd-4bd8-4175-884a-b03826b2d952,,released,Nab-paclitaxel,1,2020-09-17T15:59:41.557221-05:00,Chemotherapy,Residual Disease,
HCM-BROD-0131-C25,3a37b417-9f45-4bd4-a545-f4084e7e68c2,a60cb174-cbb2-44e1-903c-b4ae99a81c91,,,,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0131-C25_treatment9,de595f09-a881-4d4c-be63-cab159b2739d,,released,,0,2020-09-17T15:59:41.557221-05:00,"Surgery, NOS",Initial Diagnosis,
HCM-BROD-0131-C25,3a37b417-9f45-4bd4-a545-f4084e7e68c2,a60cb174-cbb2-44e1-903c-b4ae99a81c91,,Adjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0131-C25_treatment8,ed03c412-76ba-449a-8f95-d6f844a27a45,,released,,0,2020-09-17T15:59:41.557221-05:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-CSHL-0058-C34,3b013c00-dfc1-451e-aacc-be734f4b1c00,77a6c840-5cfc-40c3-8264-8d3b4b62692b,,,8.0,2023-03-13T12:53:36.302130-05:00,HCM-CSHL-0058-C34_treatment2,1e9f5100-fb0a-4cb5-919a-11fa88863ff3,,released,,1,2019-04-04T15:12:48.367373-05:00,"Surgery, NOS",Initial Diagnosis,
HCM-CSHL-0058-C34,3b013c00-dfc1-451e-aacc-be734f4b1c00,77a6c840-5cfc-40c3-8264-8d3b4b62692b,,Neoadjuvant,,2020-10-20T19:20:06.800740-05:00,HCM-CSHL-0058-C34_treatment,2d2e3f41-ae69-4cf3-a3b9-a69aa4e80bc9,,released,,0,2019-04-04T15:12:48.367373-05:00,,,
HCM-CSHL-0058-C34,3b013c00-dfc1-451e-aacc-be734f4b1c00,77a6c840-5cfc-40c3-8264-8d3b4b62692b,,Adjuvant,,2023-03-13T12:53:36.302130-05:00,HCM-CSHL-0058-C34_treatment4,65018b06-046a-4724-8390-a92f678a49ae,,released,,0,2019-04-04T15:12:48.367373-05:00,"Radiation Therapy, NOS",Residual Disease,
HCM-CSHL-0058-C34,3b013c00-dfc1-451e-aacc-be734f4b1c00,77a6c840-5cfc-40c3-8264-8d3b4b62692b,,Adjuvant,,2023-03-13T12:53:36.302130-05:00,HCM-CSHL-0058-C34_treatment3,9d51023d-32f0-45a8-9e62-735d3c43df5d,,released,,0,2019-04-04T15:12:48.367373-05:00,"Pharmaceutical Therapy, NOS",Residual Disease,
HCM-CSHL-0080-C25,3b348a82-127f-42ac-bc41-c55fdf8cac7a,dee72a2c-cc97-4cbb-a1e3-a0bcae4214f4,272.0,Adjuvant,233.0,2023-02-22T07:39:25.979291-06:00,HCM-CSHL-0080-C25_treatment7,07806536-7cc2-42bc-9f86-6f0b63583e1d,,released,,1,2020-10-09T14:58:16.760417-05:00,"Radiation, 2D Conventional",Residual Disease,
HCM-CSHL-0080-C25,3b348a82-127f-42ac-bc41-c55fdf8cac7a,dee72a2c-cc97-4cbb-a1e3-a0bcae4214f4,200.0,Adjuvant,43.0,2023-02-22T07:39:25.979291-06:00,HCM-CSHL-0080-C25_treatment3,24a0b1ef-2485-4f4e-932d-1e08b537afeb,,released,Nab-paclitaxel,1,2020-10-09T14:58:16.760417-05:00,Chemotherapy,Residual Disease,
HCM-CSHL-0080-C25,3b348a82-127f-42ac-bc41-c55fdf8cac7a,dee72a2c-cc97-4cbb-a1e3-a0bcae4214f4,200.0,Adjuvant,43.0,2023-02-22T07:39:25.979291-06:00,HCM-CSHL-0080-C25_treatment2,56ded739-75c1-41ea-afd5-961f1c9047a7,,released,Gemcitabine,1,2020-10-09T14:58:16.760417-05:00,Chemotherapy,Residual Disease,
HCM-CSHL-0080-C25,3b348a82-127f-42ac-bc41-c55fdf8cac7a,dee72a2c-cc97-4cbb-a1e3-a0bcae4214f4,,,-22.0,2023-02-27T11:35:24.204429-06:00,HCM-CSHL-0080-C25_treatment5,63db03c8-acfe-4030-966f-72a9a82bd794,,released,,1,2020-10-09T14:58:16.760417-05:00,"Surgery, NOS",Initial Diagnosis,
HCM-CSHL-0080-C25,3b348a82-127f-42ac-bc41-c55fdf8cac7a,dee72a2c-cc97-4cbb-a1e3-a0bcae4214f4,,Neoadjuvant,,2023-02-22T07:39:25.979291-06:00,HCM-CSHL-0080-C25_treatment,c27ed7e3-6e7e-46ea-a7ca-9409426ae3f0,,released,,0,2020-10-09T14:58:16.760417-05:00,,,
HCM-CSHL-0080-C25,3b348a82-127f-42ac-bc41-c55fdf8cac7a,dee72a2c-cc97-4cbb-a1e3-a0bcae4214f4,,Adjuvant,,2023-02-22T07:39:25.979291-06:00,HCM-CSHL-0080-C25_treatment6,ce6708c4-5e8b-4d77-9cbf-3a28746bd88b,,released,,0,2020-10-09T14:58:16.760417-05:00,Targeted Molecular Therapy,Residual Disease,
HCM-CSHL-0080-C25,3b348a82-127f-42ac-bc41-c55fdf8cac7a,dee72a2c-cc97-4cbb-a1e3-a0bcae4214f4,,Adjuvant,,2023-02-22T07:39:25.979291-06:00,HCM-CSHL-0080-C25_treatment4,cfa6af83-93bb-4f58-add4-d71242999839,,released,,0,2020-10-09T14:58:16.760417-05:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-CSHL-0060-C18,3b797720-33ef-45e0-9830-5f6007f1d5a7,bb2a4816-93d8-49d1-acc9-e6aefc5095f7,150.0,Adjuvant,80.0,2020-10-08T18:59:08.767031-05:00,HCM-CSHL-0060-C18_treatment3,133ab461-7799-4e44-810a-ad69c64b59c5,,released,Fluorouracil,1,2020-02-11T14:36:35.999470-06:00,Chemotherapy,Residual Disease,
HCM-CSHL-0060-C18,3b797720-33ef-45e0-9830-5f6007f1d5a7,bb2a4816-93d8-49d1-acc9-e6aefc5095f7,150.0,Adjuvant,80.0,2020-10-08T18:59:08.767031-05:00,HCM-CSHL-0060-C18_treatment5,46f62c14-2cdb-4221-b628-206c2ad109fc,,released,,1,2020-02-11T14:36:35.999470-06:00,Chemotherapy,Residual Disease,FOLFOX
HCM-CSHL-0060-C18,3b797720-33ef-45e0-9830-5f6007f1d5a7,bb2a4816-93d8-49d1-acc9-e6aefc5095f7,,Adjuvant,,2020-10-08T18:59:08.767031-05:00,HCM-CSHL-0060-C18_treatment6,5e7cdcea-b09d-484a-b41b-bf28c9ae98a4,,released,,0,2020-02-11T14:36:35.999470-06:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-CSHL-0060-C18,3b797720-33ef-45e0-9830-5f6007f1d5a7,bb2a4816-93d8-49d1-acc9-e6aefc5095f7,,,25.0,2023-03-13T12:58:03.899566-05:00,HCM-CSHL-0060-C18_treatment7,6b76a315-4dd5-421c-a650-37499d85e834,,released,,1,2020-10-08T18:59:08.767031-05:00,"Surgery, NOS",Initial Diagnosis,
HCM-CSHL-0060-C18,3b797720-33ef-45e0-9830-5f6007f1d5a7,bb2a4816-93d8-49d1-acc9-e6aefc5095f7,,Adjuvant,,2020-10-20T19:20:06.800740-05:00,HCM-CSHL-0060-C18_treatment9,906586eb-b94f-457c-a008-6c711e47ddd4,,released,,0,2020-10-08T18:59:08.767031-05:00,"Radiation Therapy, NOS",Residual Disease,
HCM-CSHL-0060-C18,3b797720-33ef-45e0-9830-5f6007f1d5a7,bb2a4816-93d8-49d1-acc9-e6aefc5095f7,,Neoadjuvant,,2020-03-26T16:04:47.706904-05:00,HCM-CSHL-0060-C18_treatment,98f5860a-83ff-4670-b0a0-c8027b5e348c,,released,,0,2020-02-11T14:36:35.999470-06:00,,,
HCM-CSHL-0060-C18,3b797720-33ef-45e0-9830-5f6007f1d5a7,bb2a4816-93d8-49d1-acc9-e6aefc5095f7,150.0,Adjuvant,80.0,2020-10-08T18:59:08.767031-05:00,HCM-CSHL-0060-C18_treatment2,b13eb825-5cb4-4b16-bea4-5337d9320d72,,released,Leucovorin Calcium,1,2020-02-11T14:36:35.999470-06:00,Chemotherapy,Residual Disease,
HCM-CSHL-0060-C18,3b797720-33ef-45e0-9830-5f6007f1d5a7,bb2a4816-93d8-49d1-acc9-e6aefc5095f7,,Adjuvant,,2020-10-20T19:20:06.800740-05:00,HCM-CSHL-0060-C18_treatment8,d6a0d466-5081-4cb8-84a3-69475b9462b0,,released,,0,2020-10-08T18:59:08.767031-05:00,Targeted Molecular Therapy,Residual Disease,
HCM-CSHL-0060-C18,3b797720-33ef-45e0-9830-5f6007f1d5a7,bb2a4816-93d8-49d1-acc9-e6aefc5095f7,150.0,Adjuvant,80.0,2020-10-08T18:59:08.767031-05:00,HCM-CSHL-0060-C18_treatment4,f84f00ac-f051-4404-8170-e41c2f1a9dc6,,released,Oxaliplatin,1,2020-02-11T14:36:35.999470-06:00,Chemotherapy,Residual Disease,
HCM-BROD-0339-C43,3b84c894-91d7-4c3e-8f17-4d6adc8bb468,1c9f6d6d-12e9-4e4d-b301-8e9ec59c12d8,,Adjuvant,,2021-01-06T22:55:10.531130-06:00,HCM-BROD-0339-C43_treatment3,175ac743-669b-468d-af64-276628f10c09,,released,,0,2020-06-15T13:34:01.593117-05:00,Hormone Therapy,Residual Disease,
HCM-BROD-0339-C43,3b84c894-91d7-4c3e-8f17-4d6adc8bb468,1c9f6d6d-12e9-4e4d-b301-8e9ec59c12d8,,Adjuvant,,2021-01-06T22:55:10.531130-06:00,HCM-BROD-0339-C43_treatment4,5c3c08ce-1179-46b9-8f27-7f6ebe141185,,released,,0,2020-06-15T13:34:01.593117-05:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-BROD-0339-C43,3b84c894-91d7-4c3e-8f17-4d6adc8bb468,1c9f6d6d-12e9-4e4d-b301-8e9ec59c12d8,,Neoadjuvant,,2021-01-06T22:55:10.531130-06:00,HCM-BROD-0339-C43_treatment,9f0dc4e3-f4e1-4650-899f-86c729d32094,,released,,0,2020-06-15T13:34:01.593117-05:00,,,
HCM-BROD-0339-C43,3b84c894-91d7-4c3e-8f17-4d6adc8bb468,1c9f6d6d-12e9-4e4d-b301-8e9ec59c12d8,11977.0,Adjuvant,11627.0,2021-01-06T22:55:10.531130-06:00,HCM-BROD-0339-C43_treatment6,c6657cd3-4186-4855-b32a-823307736141,,released,Nivolumab,1,2020-06-15T13:34:01.593117-05:00,Targeted Molecular Therapy,Residual Disease,
HCM-BROD-0339-C43,3b84c894-91d7-4c3e-8f17-4d6adc8bb468,1c9f6d6d-12e9-4e4d-b301-8e9ec59c12d8,11601.0,Adjuvant,11576.0,2021-01-06T22:55:10.531130-06:00,HCM-BROD-0339-C43_treatment7,d82f418f-804e-4cf6-999a-cf59cbf16073,,released,,1,2020-09-27T11:25:50.357917-05:00,"Radiation Therapy, NOS",Residual Disease,
HCM-BROD-0339-C43,3b84c894-91d7-4c3e-8f17-4d6adc8bb468,1c9f6d6d-12e9-4e4d-b301-8e9ec59c12d8,,,,2023-02-27T13:34:11.069159-06:00,HCM-BROD-0339-C43_treatment5,e9d97697-866c-4b5c-9684-0c5994ab56da,,released,,unknown,2020-06-15T13:34:01.593117-05:00,"Surgery, NOS",Initial Diagnosis,
HCM-BROD-0339-C43,3b84c894-91d7-4c3e-8f17-4d6adc8bb468,1c9f6d6d-12e9-4e4d-b301-8e9ec59c12d8,,Adjuvant,,2021-01-06T22:55:10.531130-06:00,HCM-BROD-0339-C43_treatment2,ecba704e-76cb-4d4c-a885-070202292386,,released,,0,2020-06-15T13:34:01.593117-05:00,Chemotherapy,Residual Disease,
HCM-BROD-1100-C84,3bf3c1c9-413a-4013-8577-b7338a15c4f4,84c06531-78fb-4109-947c-746fbaed1892,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-BROD-1100-C84_treatment7,0322ffb6-9bec-4d37-9811-416e8121519b,,released,,0,2021-12-21T15:23:24.032739-06:00,"Radiation Therapy, NOS",Residual Disease,
HCM-BROD-1100-C84,3bf3c1c9-413a-4013-8577-b7338a15c4f4,84c06531-78fb-4109-947c-746fbaed1892,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-BROD-1100-C84_treatment3,07a1f5cc-1b1b-4289-9df2-f3a1284fce10,,released,,0,2021-12-21T15:23:24.032739-06:00,Hormone Therapy,Residual Disease,
HCM-BROD-1100-C84,3bf3c1c9-413a-4013-8577-b7338a15c4f4,84c06531-78fb-4109-947c-746fbaed1892,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-BROD-1100-C84_treatment6,2141c443-a2a9-4365-b3e3-f060dcb497e1,,released,,0,2021-12-21T15:23:24.032739-06:00,Targeted Molecular Therapy,Residual Disease,
HCM-BROD-1100-C84,3bf3c1c9-413a-4013-8577-b7338a15c4f4,84c06531-78fb-4109-947c-746fbaed1892,477.0,Adjuvant,388.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-1100-C84_treatment4,7ea11644-bcf6-4949-8635-39e20341a07c,,released,Brentuximab,1,2021-12-21T15:23:24.032739-06:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-BROD-1100-C84,3bf3c1c9-413a-4013-8577-b7338a15c4f4,84c06531-78fb-4109-947c-746fbaed1892,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-BROD-1100-C84_treatment2,9e520ff4-c94c-4f34-8c8a-3948841ea663,,released,,0,2021-12-21T15:23:24.032739-06:00,Chemotherapy,Residual Disease,
HCM-BROD-1100-C84,3bf3c1c9-413a-4013-8577-b7338a15c4f4,84c06531-78fb-4109-947c-746fbaed1892,,,,2025-04-07T17:13:09.336794-05:00,HCM-BROD-1100-C84_treatment5,e880f7c2-d6c7-40f3-a34b-79dee6e1dfc4,,released,,0,2021-12-21T15:23:24.032739-06:00,"Surgery, NOS",Initial Diagnosis,
HCM-BROD-1100-C84,3bf3c1c9-413a-4013-8577-b7338a15c4f4,84c06531-78fb-4109-947c-746fbaed1892,,Neoadjuvant,117.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-1100-C84_treatment,f4698ef1-92b7-49e0-a665-4bf0bd101bc2,,released,Alemtuzumab,1,2021-12-21T15:23:24.032739-06:00,Immunotherapy (Including Vaccines),,
HCM-BROD-0052-C49,3d06ca77-a9a1-4e52-9b3d-a6f4f98167d6,cc58e97e-7ddb-4ff9-a617-8669c49e1021,,Neoadjuvant,,2023-02-22T07:39:25.979291-06:00,HCM-BROD-0052-C49_treatment,1156256f-d033-4073-aaa2-cdc7c8b6d639,,released,,0,2020-06-15T13:10:23.732353-05:00,,,
HCM-BROD-0052-C49,3d06ca77-a9a1-4e52-9b3d-a6f4f98167d6,cc58e97e-7ddb-4ff9-a617-8669c49e1021,150.0,Adjuvant,150.0,2023-02-22T07:39:25.979291-06:00,HCM-BROD-0052-C49_treatment4,66e5bb9c-ba38-4603-b351-769b73e4401a,,released,Gemcitabine Hydrochloride,1,2020-06-15T13:10:23.732353-05:00,Chemotherapy,Residual Disease,
HCM-BROD-0052-C49,3d06ca77-a9a1-4e52-9b3d-a6f4f98167d6,cc58e97e-7ddb-4ff9-a617-8669c49e1021,,Adjuvant,,2023-02-22T07:39:25.979291-06:00,HCM-BROD-0052-C49_treatment10,925d855b-4c10-4352-afc7-60f99f1c2667,,released,,0,2020-09-27T10:18:11.209035-05:00,"Radiation Therapy, NOS",Residual Disease,
HCM-BROD-0052-C49,3d06ca77-a9a1-4e52-9b3d-a6f4f98167d6,cc58e97e-7ddb-4ff9-a617-8669c49e1021,150.0,Adjuvant,150.0,2023-02-22T07:39:25.979291-06:00,HCM-BROD-0052-C49_treatment5,977c8324-f236-49c0-aecb-2c3ab22e6e63,,released,Docetaxel,1,2020-06-15T13:10:23.732353-05:00,Chemotherapy,Residual Disease,
HCM-BROD-0052-C49,3d06ca77-a9a1-4e52-9b3d-a6f4f98167d6,cc58e97e-7ddb-4ff9-a617-8669c49e1021,150.0,Adjuvant,89.0,2023-02-22T07:39:25.979291-06:00,HCM-BROD-0052-C49_treatment2,b282d154-5208-4f87-9ebb-5ed5ec527ce0,,released,Irinotecan,1,2020-06-15T13:10:23.732353-05:00,Chemotherapy,Residual Disease,
HCM-BROD-0052-C49,3d06ca77-a9a1-4e52-9b3d-a6f4f98167d6,cc58e97e-7ddb-4ff9-a617-8669c49e1021,,,,2023-03-13T13:17:05.734743-05:00,HCM-BROD-0052-C49_treatment8,b729bf2e-08b8-4f07-a140-3238ff0545eb,,released,,unknown,2020-09-27T10:18:11.209035-05:00,"Surgery, NOS",Initial Diagnosis,
HCM-BROD-0052-C49,3d06ca77-a9a1-4e52-9b3d-a6f4f98167d6,cc58e97e-7ddb-4ff9-a617-8669c49e1021,,Adjuvant,,2023-02-22T07:39:25.979291-06:00,HCM-BROD-0052-C49_treatment9,b883e9f7-81d0-4336-a0b9-7f646eb0c3a8,,released,,0,2020-09-27T10:18:11.209035-05:00,Targeted Molecular Therapy,Residual Disease,
HCM-BROD-0052-C49,3d06ca77-a9a1-4e52-9b3d-a6f4f98167d6,cc58e97e-7ddb-4ff9-a617-8669c49e1021,,Adjuvant,,2023-02-22T07:39:25.979291-06:00,HCM-BROD-0052-C49_treatment6,cb5f4bd1-6c38-4e64-8382-ecf18b86ba6b,,released,,0,2020-06-15T13:10:23.732353-05:00,Hormone Therapy,Residual Disease,
HCM-BROD-0052-C49,3d06ca77-a9a1-4e52-9b3d-a6f4f98167d6,cc58e97e-7ddb-4ff9-a617-8669c49e1021,,Adjuvant,,2023-02-22T07:39:25.979291-06:00,HCM-BROD-0052-C49_treatment7,cf8eb82a-f25f-4722-b401-cb097635e885,,released,,0,2020-06-15T13:10:23.732353-05:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-BROD-0052-C49,3d06ca77-a9a1-4e52-9b3d-a6f4f98167d6,cc58e97e-7ddb-4ff9-a617-8669c49e1021,150.0,Adjuvant,89.0,2023-02-22T07:39:25.979291-06:00,HCM-BROD-0052-C49_treatment3,dc83a5af-9eb4-4f91-a082-23bb92e7e475,,released,Temozolomide,1,2020-06-15T13:10:23.732353-05:00,Chemotherapy,Residual Disease,
HCM-SANG-0280-C18,3dab73f4-1fd2-440d-a194-4368818ee701,d82fe2d4-ba50-4289-ab5e-ed2757f042c8,,Neoadjuvant,,2023-11-07T14:28:29.403873-06:00,HCM-SANG-0280-C18_treatment,ff874aa1-e4af-4b36-9aee-cc3bd20ecb97,,released,,0,2021-12-21T15:07:11.731422-06:00,,,
HCM-CSHL-0803-C54,3e296517-6c60-4f65-ab54-98b1753ed39c,9d93b4d8-995a-477c-9d46-95409711b43f,,Adjuvant,,2023-11-07T14:20:00.017270-06:00,HCM-CSHL-0803-C54_treatment5,02efa19a-fd72-42f5-b583-27a1fabd20e6,,released,,0,2021-12-21T14:24:17.054829-06:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-CSHL-0803-C54,3e296517-6c60-4f65-ab54-98b1753ed39c,9d93b4d8-995a-477c-9d46-95409711b43f,,Adjuvant,,2023-11-07T14:20:00.017270-06:00,HCM-CSHL-0803-C54_treatment7,6461eeda-aabe-45b0-bd14-e986ecffe5f1,,released,,0,2021-12-21T14:24:17.054829-06:00,Targeted Molecular Therapy,Residual Disease,
HCM-CSHL-0803-C54,3e296517-6c60-4f65-ab54-98b1753ed39c,9d93b4d8-995a-477c-9d46-95409711b43f,,Adjuvant,,2023-11-07T14:20:00.017270-06:00,HCM-CSHL-0803-C54_treatment4,7376ef51-1951-4bcf-b504-2153fae10305,,released,,0,2021-12-21T14:24:17.054829-06:00,Hormone Therapy,Residual Disease,
HCM-CSHL-0803-C54,3e296517-6c60-4f65-ab54-98b1753ed39c,9d93b4d8-995a-477c-9d46-95409711b43f,,,0.0,2023-11-07T14:20:00.017270-06:00,HCM-CSHL-0803-C54_treatment6,9562f79a-d90b-47b1-a708-5ce4703fb172,,released,,1,2021-12-21T14:24:17.054829-06:00,"Surgery, NOS",Initial Diagnosis,
HCM-CSHL-0803-C54,3e296517-6c60-4f65-ab54-98b1753ed39c,9d93b4d8-995a-477c-9d46-95409711b43f,156.0,Adjuvant,53.0,2023-11-07T14:20:00.017270-06:00,HCM-CSHL-0803-C54_treatment2,afb1fa3b-b3c5-46c9-aaf5-46b6b7c5ec17,,released,Carboplatin,1,2021-12-21T14:24:17.054829-06:00,Chemotherapy,Residual Disease,
HCM-CSHL-0803-C54,3e296517-6c60-4f65-ab54-98b1753ed39c,9d93b4d8-995a-477c-9d46-95409711b43f,156.0,Adjuvant,53.0,2023-11-07T14:20:00.017270-06:00,HCM-CSHL-0803-C54_treatment3,ccd65059-8f79-40e8-9421-0ed873c9b775,,released,Paclitaxel,1,2021-12-21T14:24:17.054829-06:00,Chemotherapy,Residual Disease,
HCM-CSHL-0803-C54,3e296517-6c60-4f65-ab54-98b1753ed39c,9d93b4d8-995a-477c-9d46-95409711b43f,,Neoadjuvant,,2023-11-07T14:20:00.017270-06:00,HCM-CSHL-0803-C54_treatment,cf9de150-16f2-427f-9f63-39312eadbf1d,,released,,0,2021-12-21T14:24:17.054829-06:00,,,
HCM-CSHL-0803-C54,3e296517-6c60-4f65-ab54-98b1753ed39c,9d93b4d8-995a-477c-9d46-95409711b43f,206.0,Adjuvant,197.0,2023-11-07T14:20:00.017270-06:00,HCM-CSHL-0803-C54_treatment8,f71f80a1-04b2-41dc-874a-176ba025bb80,,released,,1,2021-12-21T14:24:17.054829-06:00,"Brachytherapy, High Dose",Residual Disease,
HCM-SANG-0313-C15,3faa062f-758e-4c76-91ec-a8566dded5c2,04b8ec69-2d9f-44f7-ae8e-13ac9c2e36cd,,Neoadjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-SANG-0313-C15_treatment,ac7a0b16-0709-4b40-9cf6-161f4eef9b5c,,released,,0,2021-12-21T15:11:29.925173-06:00,,,
HCM-SANG-0306-C15,40520215-88c6-4cab-8f58-af3936a8faba,cf7f6f4d-cba6-4ca4-bd3b-ecd6e483a946,,Neoadjuvant,140.0,2023-03-13T13:32:18.365304-05:00,HCM-SANG-0306-C15_treatment4,6d3a610b-f07d-49b4-bfde-8985776113b7,,released,,1,2021-12-21T15:10:53.904524-06:00,Chemotherapy,,ECX
HCM-SANG-0306-C15,40520215-88c6-4cab-8f58-af3936a8faba,cf7f6f4d-cba6-4ca4-bd3b-ecd6e483a946,,Neoadjuvant,140.0,2023-03-13T13:32:18.365304-05:00,HCM-SANG-0306-C15_treatment2,719bc294-05d6-4be7-89c1-888d14ad3804,,released,Capecitabine,1,2021-12-21T15:10:53.904524-06:00,Chemotherapy,,
HCM-SANG-0306-C15,40520215-88c6-4cab-8f58-af3936a8faba,cf7f6f4d-cba6-4ca4-bd3b-ecd6e483a946,,Neoadjuvant,140.0,2023-03-13T13:32:18.365304-05:00,HCM-SANG-0306-C15_treatment3,8552fe99-f54b-4eaf-8970-1a86408e3f49,,released,Cisplatin,1,2021-12-21T15:10:53.904524-06:00,Chemotherapy,,
HCM-SANG-0306-C15,40520215-88c6-4cab-8f58-af3936a8faba,cf7f6f4d-cba6-4ca4-bd3b-ecd6e483a946,,Neoadjuvant,140.0,2023-03-13T13:32:18.365304-05:00,HCM-SANG-0306-C15_treatment,c52b5fed-94a8-47f3-86a4-a3344df93c47,,released,Epirubicin,1,2021-12-21T15:10:53.904524-06:00,Chemotherapy,,
HCM-BROD-0112-C25,41537847-e29c-446a-b83b-ef0bb5085c75,778b73fd-b284-4c2f-8c1d-bdb75d23f15d,,Adjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0112-C25_treatment10,128d88ed-fa0d-44a7-b940-bd4af7da99df,,released,,0,2020-09-17T15:48:24.843145-05:00,"Radiation Therapy, NOS",Residual Disease,
HCM-BROD-0112-C25,41537847-e29c-446a-b83b-ef0bb5085c75,778b73fd-b284-4c2f-8c1d-bdb75d23f15d,,Adjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0112-C25_treatment6,2511db6c-59b0-4fd0-aa91-3c18933dc85f,,released,,0,2020-09-17T15:48:24.843145-05:00,Chemotherapy,Residual Disease,
HCM-BROD-0112-C25,41537847-e29c-446a-b83b-ef0bb5085c75,778b73fd-b284-4c2f-8c1d-bdb75d23f15d,,Neoadjuvant,10.0,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0112-C25_treatment4,52f2b11f-1109-4476-8880-1f0251d7d6c5,,released,Oxaliplatin,1,2020-09-17T15:48:24.843145-05:00,Chemotherapy,,
HCM-BROD-0112-C25,41537847-e29c-446a-b83b-ef0bb5085c75,778b73fd-b284-4c2f-8c1d-bdb75d23f15d,,Adjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0112-C25_treatment7,61232390-5d9b-452f-95cf-5cc91833bae7,,released,,0,2020-09-17T15:48:24.843145-05:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-BROD-0112-C25,41537847-e29c-446a-b83b-ef0bb5085c75,778b73fd-b284-4c2f-8c1d-bdb75d23f15d,,Neoadjuvant,10.0,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0112-C25_treatment,9152c739-223d-4add-99ca-6f91c1c860d7,,released,Irinotecan Hydrochloride,1,2020-09-17T15:48:24.843145-05:00,Chemotherapy,,
HCM-BROD-0112-C25,41537847-e29c-446a-b83b-ef0bb5085c75,778b73fd-b284-4c2f-8c1d-bdb75d23f15d,,Neoadjuvant,10.0,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0112-C25_treatment3,ad5f8972-07cf-4ec8-a661-d149d380d6c2,,released,Fluorouracil,1,2020-09-17T15:48:24.843145-05:00,Chemotherapy,,
HCM-BROD-0112-C25,41537847-e29c-446a-b83b-ef0bb5085c75,778b73fd-b284-4c2f-8c1d-bdb75d23f15d,,,,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0112-C25_treatment8,bac62e6c-f523-4fb2-ad65-e54aa47249a3,,released,,0,2020-09-17T15:48:24.843145-05:00,"Surgery, NOS",Initial Diagnosis,
HCM-BROD-0112-C25,41537847-e29c-446a-b83b-ef0bb5085c75,778b73fd-b284-4c2f-8c1d-bdb75d23f15d,,Neoadjuvant,10.0,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0112-C25_treatment5,db2187c3-b8ca-4d8d-97bd-49db0f71a871,,released,,1,2020-09-17T15:48:24.843145-05:00,Chemotherapy,,FOLFIRINOX
HCM-BROD-0112-C25,41537847-e29c-446a-b83b-ef0bb5085c75,778b73fd-b284-4c2f-8c1d-bdb75d23f15d,,Neoadjuvant,10.0,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0112-C25_treatment2,dc339feb-ef89-4177-a210-f1e4103db8c4,,released,Leucovorin Calcium,1,2020-09-17T15:48:24.843145-05:00,Chemotherapy,,
HCM-BROD-0112-C25,41537847-e29c-446a-b83b-ef0bb5085c75,778b73fd-b284-4c2f-8c1d-bdb75d23f15d,,Adjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0112-C25_treatment9,f79e2c34-9bf3-47b5-977a-c10ef4d88011,,released,,0,2020-09-17T15:48:24.843145-05:00,Targeted Molecular Therapy,Residual Disease,
HCM-BROD-0690-C43,427b401b-b73a-450d-ad99-028033c6aa54,04f68b24-0175-4ded-867e-d6a11c534996,,Neoadjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0690-C43_treatment,6254a9dd-1b7d-4376-8402-52bd1f200369,,released,,0,2021-12-21T13:45:27.089477-06:00,,,
HCM-BROD-0690-C43,427b401b-b73a-450d-ad99-028033c6aa54,04f68b24-0175-4ded-867e-d6a11c534996,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0690-C43_treatment6,7893e1f9-493c-4dae-83bf-cdb7497798ac,,released,,0,2021-12-21T13:45:27.089477-06:00,Targeted Molecular Therapy,Residual Disease,
HCM-BROD-0690-C43,427b401b-b73a-450d-ad99-028033c6aa54,04f68b24-0175-4ded-867e-d6a11c534996,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0690-C43_treatment3,a0c7af63-e1fd-4d06-8670-de3a0e0bc563,,released,,0,2021-12-21T13:45:27.089477-06:00,Hormone Therapy,Residual Disease,
HCM-BROD-0690-C43,427b401b-b73a-450d-ad99-028033c6aa54,04f68b24-0175-4ded-867e-d6a11c534996,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0690-C43_treatment2,b5693e5e-75c6-41da-8e7c-2d0b27cd2dc3,,released,,0,2021-12-21T13:45:27.089477-06:00,Chemotherapy,Residual Disease,
HCM-BROD-0690-C43,427b401b-b73a-450d-ad99-028033c6aa54,04f68b24-0175-4ded-867e-d6a11c534996,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0690-C43_treatment7,e9652c2e-f98e-4a05-bafa-fc5a715503e1,,released,,0,2021-12-21T13:45:27.089477-06:00,"Radiation Therapy, NOS",Residual Disease,
HCM-BROD-0690-C43,427b401b-b73a-450d-ad99-028033c6aa54,04f68b24-0175-4ded-867e-d6a11c534996,2397.0,Adjuvant,2331.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0690-C43_treatment4,f1453efd-d21e-47d0-90b8-d35103c6259a,,released,Ipilimumab,1,2021-12-21T13:45:27.089477-06:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-BROD-0690-C43,427b401b-b73a-450d-ad99-028033c6aa54,04f68b24-0175-4ded-867e-d6a11c534996,,,0.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0690-C43_treatment5,f28e7a14-6e30-46f0-b337-dbceeb4b70ca,,released,,1,2021-12-21T13:45:27.089477-06:00,"Surgery, NOS",Initial Diagnosis,
HCM-BROD-0690-C43,427b401b-b73a-450d-ad99-028033c6aa54,5e3015c5-bedb-48f8-900d-aaeef0204c38,2219.0,Maintenance Therapy,1973.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0690-C43_treatment8,c7a32724-90de-4f44-9a32-946956d42b7a,Not Reported,released,Temozolomide,1,2021-12-21T13:45:27.089477-06:00,,,
HCM-BROD-0025-C16,42d1a293-4c3b-496b-92b5-7482c8020751,d27c6e9b-79d8-43ac-80bc-fca9e7ca8242,,Neoadjuvant,,2021-03-03T15:15:08.075155-06:00,HCM-BROD-0025-C16_treatment,236d8b19-0c6c-43bd-93e6-dd5d39913e67,,released,Unknown,1,2019-04-04T14:02:39.021089-05:00,Chemotherapy,,
HCM-BROD-0025-C16,42d1a293-4c3b-496b-92b5-7482c8020751,d27c6e9b-79d8-43ac-80bc-fca9e7ca8242,206.0,Adjuvant,165.0,2021-03-03T15:15:08.075155-06:00,HCM-BROD-0025-C16_treatment2,5a1c30a2-5587-4bed-946e-9c5d767be5ae,,released,Docetaxel,1,2019-04-04T14:02:39.021089-05:00,Chemotherapy,Residual Disease,
HCM-BROD-0025-C16,42d1a293-4c3b-496b-92b5-7482c8020751,d27c6e9b-79d8-43ac-80bc-fca9e7ca8242,206.0,Adjuvant,165.0,2021-03-03T15:15:08.075155-06:00,HCM-BROD-0025-C16_treatment4,6ff85af0-faa6-4ec9-8658-ba6a54ff06e5,,released,Fluorouracil,1,2019-04-04T14:02:39.021089-05:00,Chemotherapy,Residual Disease,
HCM-BROD-0025-C16,42d1a293-4c3b-496b-92b5-7482c8020751,d27c6e9b-79d8-43ac-80bc-fca9e7ca8242,206.0,Adjuvant,165.0,2021-03-03T15:15:08.075155-06:00,HCM-BROD-0025-C16_treatment3,76125707-39fc-4e5f-87cd-154308eca7af,,released,Cisplatin,1,2019-04-04T14:02:39.021089-05:00,Chemotherapy,Residual Disease,
HCM-BROD-0025-C16,42d1a293-4c3b-496b-92b5-7482c8020751,d27c6e9b-79d8-43ac-80bc-fca9e7ca8242,,Adjuvant,,2021-03-03T15:15:08.075155-06:00,HCM-BROD-0025-C16_treatment8,80ca8767-36ed-4c26-9f23-4d2c79945ad8,,released,,0,2020-09-27T10:06:56.872923-05:00,"Radiation Therapy, NOS",Residual Disease,
HCM-BROD-0025-C16,42d1a293-4c3b-496b-92b5-7482c8020751,d27c6e9b-79d8-43ac-80bc-fca9e7ca8242,,,104.0,2023-03-13T13:31:42.178829-05:00,HCM-BROD-0025-C16_treatment6,821a0f60-f405-451e-a36e-b46769a6a016,,released,,1,2019-04-04T14:02:39.021089-05:00,"Surgery, NOS",Initial Diagnosis,
HCM-BROD-0025-C16,42d1a293-4c3b-496b-92b5-7482c8020751,d27c6e9b-79d8-43ac-80bc-fca9e7ca8242,,Adjuvant,,2021-03-03T15:15:08.075155-06:00,HCM-BROD-0025-C16_treatment5,a2452e3c-3cb4-4a9f-a262-ed056eb1ceb7,,released,,0,2019-04-04T14:02:39.021089-05:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-BROD-0025-C16,42d1a293-4c3b-496b-92b5-7482c8020751,d27c6e9b-79d8-43ac-80bc-fca9e7ca8242,,Adjuvant,,2021-03-03T15:15:08.075155-06:00,HCM-BROD-0025-C16_treatment7,a89e29a0-feab-46dc-88e3-17873842f321,,released,,0,2020-09-27T10:06:56.872923-05:00,Targeted Molecular Therapy,Residual Disease,
HCM-BROD-1104-C85,42f8ece8-70dc-48b8-a9ec-28dc218a735a,84583c76-531a-402b-aa22-28ec99bda9e6,,,,2025-04-07T17:13:09.336794-05:00,HCM-BROD-1104-C85_treatment2,1bc57c0a-d348-46f2-a410-dc0dea8e72cc,,released,,0,2021-12-21T15:24:48.933387-06:00,"Surgery, NOS",Initial Diagnosis,
HCM-BROD-1104-C85,42f8ece8-70dc-48b8-a9ec-28dc218a735a,84583c76-531a-402b-aa22-28ec99bda9e6,,Neoadjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-BROD-1104-C85_treatment,1c303fca-0d83-4922-8cf5-69ea559de8c8,,released,,0,2021-12-21T15:24:48.933387-06:00,,,
HCM-BROD-1104-C85,42f8ece8-70dc-48b8-a9ec-28dc218a735a,84583c76-531a-402b-aa22-28ec99bda9e6,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-BROD-1104-C85_treatment3,52be26af-7edd-4217-bbef-472395249dcb,,released,,unknown,2021-12-21T15:24:48.933387-06:00,"Pharmaceutical Therapy, NOS",Residual Disease,
HCM-BROD-1104-C85,42f8ece8-70dc-48b8-a9ec-28dc218a735a,84583c76-531a-402b-aa22-28ec99bda9e6,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-BROD-1104-C85_treatment4,8efcd11f-f7a3-4cbc-8ac3-7f0b192398eb,,released,,unknown,2021-12-21T15:24:48.933387-06:00,"Radiation Therapy, NOS",Residual Disease,
HCM-SANG-0528-C25,4362ae25-19a3-4d5c-b608-af73414f1aa3,ed70022f-2cd2-4394-8140-6b038c27f6cf,,Neoadjuvant,684.0,2025-03-31T16:34:59.906497-05:00,HCM-SANG-0528-C25_treatment3,41aa943d-0787-4eca-9805-a42acc41abea,,released,Dexamethasone,1,2021-12-21T15:13:36.893598-06:00,Chemotherapy,,
HCM-SANG-0528-C25,4362ae25-19a3-4d5c-b608-af73414f1aa3,ed70022f-2cd2-4394-8140-6b038c27f6cf,,Neoadjuvant,684.0,2025-03-31T16:34:59.906497-05:00,HCM-SANG-0528-C25_treatment2,63b245dc-0d13-4f81-8963-e6e4b1ffd7ab,,released,Oxaliplatin,1,2021-12-21T15:13:36.893598-06:00,Chemotherapy,,
HCM-SANG-0528-C25,4362ae25-19a3-4d5c-b608-af73414f1aa3,ed70022f-2cd2-4394-8140-6b038c27f6cf,,Neoadjuvant,684.0,2025-03-31T16:34:59.906497-05:00,HCM-SANG-0528-C25_treatment,e88747b6-3443-43b2-a130-a9b9da8d6a5e,,released,Fluorouracil,1,2021-12-21T15:13:36.893598-06:00,Chemotherapy,,
HCM-SANG-0298-C15,43cf7159-9c43-4a01-91ef-ca5df26acfca,65068696-aca2-40eb-af2e-8a07e86397e8,,Neoadjuvant,92.0,2023-03-13T13:04:40.693103-05:00,HCM-SANG-0298-C15_treatment3,55a41344-9ed1-42d5-87b1-78a6e605fd88,,released,Cisplatin,1,2021-12-21T15:09:06.137162-06:00,Chemotherapy,,
HCM-SANG-0298-C15,43cf7159-9c43-4a01-91ef-ca5df26acfca,65068696-aca2-40eb-af2e-8a07e86397e8,,Neoadjuvant,92.0,2023-03-13T13:04:40.693103-05:00,HCM-SANG-0298-C15_treatment,a946aaa8-c5af-467f-a66d-2fc99ef34152,,released,Epirubicin,1,2021-12-21T15:09:06.137162-06:00,Chemotherapy,,
HCM-SANG-0298-C15,43cf7159-9c43-4a01-91ef-ca5df26acfca,65068696-aca2-40eb-af2e-8a07e86397e8,,Neoadjuvant,92.0,2023-03-13T13:04:40.693103-05:00,HCM-SANG-0298-C15_treatment2,d1a796ca-9c03-4b40-a9ca-d0e44c51e88c,,released,Capecitabine,1,2021-12-21T15:09:06.137162-06:00,Chemotherapy,,
HCM-SANG-0298-C15,43cf7159-9c43-4a01-91ef-ca5df26acfca,65068696-aca2-40eb-af2e-8a07e86397e8,,Neoadjuvant,92.0,2023-03-13T13:04:40.693103-05:00,HCM-SANG-0298-C15_treatment4,e2ef89c1-73a0-4bbc-ab3e-7d202e119ae7,,released,,1,2021-12-21T15:09:06.137162-06:00,Chemotherapy,,ECX
HCM-BROD-0703-C16,45ae5a7e-95c8-453c-bd9d-446cd0f3734e,8720807f-d6d0-404d-b312-5e812ef4f0e9,363.0,Maintenance Therapy,307.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0703-C16_treatment17,3d670f4c-2415-4421-a5de-566a1b855684,Progressive Disease,released,Ramucirumab,1,2021-12-21T13:46:04.444314-06:00,,,
HCM-BROD-0703-C16,45ae5a7e-95c8-453c-bd9d-446cd0f3734e,8720807f-d6d0-404d-b312-5e812ef4f0e9,363.0,Maintenance Therapy,307.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0703-C16_treatment18,8c1927f1-e9e1-42c7-84a0-d3d425b63207,Progressive Disease,released,Paclitaxel,1,2021-12-21T13:46:04.444314-06:00,,,
HCM-BROD-0703-C16,45ae5a7e-95c8-453c-bd9d-446cd0f3734e,ad1eb6a6-dc4a-40b9-8d85-3d99e529124b,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0703-C16_treatment12,05e46ac1-4940-42e3-bde5-1132bfa11c52,,released,,0,2021-12-21T13:46:04.444314-06:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-BROD-0703-C16,45ae5a7e-95c8-453c-bd9d-446cd0f3734e,ad1eb6a6-dc4a-40b9-8d85-3d99e529124b,,Neoadjuvant,307.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0703-C16_treatment6,0abd9b56-6c29-4d2c-a976-be2dce6f5c80,,released,Ramucirumab,1,2021-12-21T13:46:04.444314-06:00,Targeted Molecular Therapy,,
HCM-BROD-0703-C16,45ae5a7e-95c8-453c-bd9d-446cd0f3734e,ad1eb6a6-dc4a-40b9-8d85-3d99e529124b,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0703-C16_treatment16,0b39bd18-405e-4d0e-ab06-a438df65a7c4,,released,,0,2021-12-21T13:46:04.444314-06:00,"Radiation Therapy, NOS",Residual Disease,
HCM-BROD-0703-C16,45ae5a7e-95c8-453c-bd9d-446cd0f3734e,ad1eb6a6-dc4a-40b9-8d85-3d99e529124b,,Neoadjuvant,11.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0703-C16_treatment3,2194c2a1-dd57-40e8-9398-844cffa264d9,,released,Oxaliplatin,1,2021-12-21T13:46:04.444314-06:00,Chemotherapy,,
HCM-BROD-0703-C16,45ae5a7e-95c8-453c-bd9d-446cd0f3734e,ad1eb6a6-dc4a-40b9-8d85-3d99e529124b,,Neoadjuvant,11.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0703-C16_treatment2,21b971c1-619f-4743-87dd-a4090d1d20ae,,released,Leucovorin Calcium,1,2021-12-21T13:46:04.444314-06:00,Chemotherapy,,
HCM-BROD-0703-C16,45ae5a7e-95c8-453c-bd9d-446cd0f3734e,ad1eb6a6-dc4a-40b9-8d85-3d99e529124b,,Neoadjuvant,11.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0703-C16_treatment4,5a7b6f15-a0f5-476d-9dc5-d01010b75c61,,released,Paclitaxel,1,2021-12-21T13:46:04.444314-06:00,Chemotherapy,,
HCM-BROD-0703-C16,45ae5a7e-95c8-453c-bd9d-446cd0f3734e,ad1eb6a6-dc4a-40b9-8d85-3d99e529124b,477.0,Adjuvant,381.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0703-C16_treatment15,5ab72e28-8f5d-4134-9076-1723a953eefc,,released,Erdafitinib,1,2021-12-21T13:46:04.444314-06:00,Targeted Molecular Therapy,Residual Disease,
HCM-BROD-0703-C16,45ae5a7e-95c8-453c-bd9d-446cd0f3734e,ad1eb6a6-dc4a-40b9-8d85-3d99e529124b,306.0,Adjuvant,11.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0703-C16_treatment10,6eaee507-448a-495e-ab23-0c080d4daae1,,released,,1,2021-12-21T13:46:04.444314-06:00,Chemotherapy,Residual Disease,FOLFOX
HCM-BROD-0703-C16,45ae5a7e-95c8-453c-bd9d-446cd0f3734e,ad1eb6a6-dc4a-40b9-8d85-3d99e529124b,,Neoadjuvant,11.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0703-C16_treatment,7369b421-f7bb-4d18-965d-6349dde25155,,released,Fluorouracil,1,2021-12-21T13:46:04.444314-06:00,Chemotherapy,,
HCM-BROD-0703-C16,45ae5a7e-95c8-453c-bd9d-446cd0f3734e,ad1eb6a6-dc4a-40b9-8d85-3d99e529124b,306.0,Adjuvant,11.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0703-C16_treatment9,7b356d44-ef99-4f92-b801-794ff0a1af2f,,released,Oxaliplatin,1,2021-12-21T13:46:04.444314-06:00,Chemotherapy,Residual Disease,
HCM-BROD-0703-C16,45ae5a7e-95c8-453c-bd9d-446cd0f3734e,ad1eb6a6-dc4a-40b9-8d85-3d99e529124b,,,,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0703-C16_treatment13,ae424bce-3722-4c13-a592-b867a5ed5ea3,,released,,0,2021-12-21T13:46:04.444314-06:00,"Surgery, NOS",Initial Diagnosis,
HCM-BROD-0703-C16,45ae5a7e-95c8-453c-bd9d-446cd0f3734e,ad1eb6a6-dc4a-40b9-8d85-3d99e529124b,477.0,Adjuvant,381.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0703-C16_treatment11,ae7ee945-c48a-4c04-b60d-1407e2dc72ac,,released,Paclitaxel,1,2021-12-21T13:46:04.444314-06:00,Chemotherapy,Residual Disease,
HCM-BROD-0703-C16,45ae5a7e-95c8-453c-bd9d-446cd0f3734e,ad1eb6a6-dc4a-40b9-8d85-3d99e529124b,306.0,Adjuvant,11.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0703-C16_treatment8,c0ef904e-cacf-45d9-81de-67e1140d278c,,released,Fluorouracil,1,2021-12-21T13:46:04.444314-06:00,Chemotherapy,Residual Disease,
HCM-BROD-0703-C16,45ae5a7e-95c8-453c-bd9d-446cd0f3734e,ad1eb6a6-dc4a-40b9-8d85-3d99e529124b,363.0,Adjuvant,307.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0703-C16_treatment14,c772185d-a486-4255-9c28-8790d4652d81,,released,Ramucirumab,1,2021-12-21T13:46:04.444314-06:00,Targeted Molecular Therapy,Residual Disease,
HCM-BROD-0703-C16,45ae5a7e-95c8-453c-bd9d-446cd0f3734e,ad1eb6a6-dc4a-40b9-8d85-3d99e529124b,,Neoadjuvant,11.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0703-C16_treatment5,d5b382fa-acb4-43c0-bf16-0d131360c073,,released,,1,2021-12-21T13:46:04.444314-06:00,Chemotherapy,,FOLFOX
HCM-BROD-0703-C16,45ae5a7e-95c8-453c-bd9d-446cd0f3734e,ad1eb6a6-dc4a-40b9-8d85-3d99e529124b,306.0,Adjuvant,11.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0703-C16_treatment7,ff29495a-585d-4c85-893a-9d8c96e8e5df,,released,Leucovorin Calcium,1,2021-12-21T13:46:04.444314-06:00,Chemotherapy,Residual Disease,
HCM-BROD-0138-C25,45f60f6f-3ee8-4da5-b3de-bd5e29b25198,dca73664-3063-4032-b33b-140bb6bda50a,,Adjuvant,,2023-03-13T12:58:53.847307-05:00,HCM-BROD-0138-C25_treatment3,74dbf001-8d27-47ce-9420-b6222f6ec47f,,released,,0,2020-03-26T12:54:12.737375-05:00,"Pharmaceutical Therapy, NOS",Residual Disease,
HCM-BROD-0138-C25,45f60f6f-3ee8-4da5-b3de-bd5e29b25198,dca73664-3063-4032-b33b-140bb6bda50a,,,,2023-03-13T12:58:53.847307-05:00,HCM-BROD-0138-C25_treatment2,801afd8d-6712-4f88-ab42-2fca29b0bbcc,,released,,0,2019-04-16T11:22:52.061182-05:00,"Surgery, NOS",Initial Diagnosis,
HCM-BROD-0138-C25,45f60f6f-3ee8-4da5-b3de-bd5e29b25198,dca73664-3063-4032-b33b-140bb6bda50a,,Neoadjuvant,,2023-02-22T07:39:25.979291-06:00,HCM-BROD-0138-C25_treatment,d39e249c-0d10-4c0f-9ecd-641706212596,,released,,0,2019-04-16T11:22:52.061182-05:00,,,
HCM-BROD-0138-C25,45f60f6f-3ee8-4da5-b3de-bd5e29b25198,dca73664-3063-4032-b33b-140bb6bda50a,,Adjuvant,,2023-03-13T12:58:53.847307-05:00,HCM-BROD-0138-C25_treatment4,d7495088-c248-4233-8806-eb0a0aba1d7d,,released,,0,2020-03-26T12:54:12.737375-05:00,"Radiation Therapy, NOS",Residual Disease,
HCM-BROD-0051-C64,46b1210c-4042-4c67-9e68-06e960f201f2,31003449-79c0-4c54-a2bd-4604737894e1,,Maintenance Therapy,,2021-08-05T13:55:08.207361-05:00,HCM-BROD-0051-C64_treatment11,09b8e78f-b8e8-4047-8d25-31b1d21160a2,Not Reported,released,Etoposide,1,2020-09-27T10:18:35.076340-05:00,,Progressive Disease,
HCM-BROD-0051-C64,46b1210c-4042-4c67-9e68-06e960f201f2,31003449-79c0-4c54-a2bd-4604737894e1,,Neoadjuvant,61.0,2021-07-12T12:25:55.528644-05:00,HCM-BROD-0051-C64_treatment3,3b596e47-6f1a-4ffe-b5ff-84a92b20a855,,released,Vincristine,1,2019-04-04T13:42:46.632048-05:00,Chemotherapy,,
HCM-BROD-0051-C64,46b1210c-4042-4c67-9e68-06e960f201f2,31003449-79c0-4c54-a2bd-4604737894e1,,,,2023-03-13T13:06:14.110017-05:00,HCM-BROD-0051-C64_treatment14,3c216c4f-88d0-4abe-9b1e-289bfd2b36e9,,released,,unknown,2020-09-27T10:18:35.076340-05:00,"Surgery, NOS",Initial Diagnosis,
HCM-BROD-0051-C64,46b1210c-4042-4c67-9e68-06e960f201f2,31003449-79c0-4c54-a2bd-4604737894e1,,Adjuvant,,2023-03-13T13:06:14.110017-05:00,HCM-BROD-0051-C64_treatment15,44d1ef95-969b-4876-beba-cec1cd4acc3e,,released,,unknown,2020-09-27T10:18:35.076340-05:00,"Pharmaceutical Therapy, NOS",Residual Disease,
HCM-BROD-0051-C64,46b1210c-4042-4c67-9e68-06e960f201f2,31003449-79c0-4c54-a2bd-4604737894e1,,Maintenance Therapy,,2021-08-05T13:55:08.207361-05:00,HCM-BROD-0051-C64_treatment7,622bd277-a796-430f-a866-70944295fdd4,Not Reported,released,Dactinomycin,1,2020-02-27T12:17:46.865711-06:00,,Progressive Disease,
HCM-BROD-0051-C64,46b1210c-4042-4c67-9e68-06e960f201f2,31003449-79c0-4c54-a2bd-4604737894e1,,Maintenance Therapy,,2021-08-05T13:55:08.207361-05:00,HCM-BROD-0051-C64_treatment10,6a531eb9-d50d-4e34-842a-38e62de4d159,Not Reported,released,Doxorubicin,1,2020-09-27T10:18:35.076340-05:00,,Progressive Disease,
HCM-BROD-0051-C64,46b1210c-4042-4c67-9e68-06e960f201f2,31003449-79c0-4c54-a2bd-4604737894e1,,Maintenance Therapy,,2021-08-05T13:55:08.207361-05:00,HCM-BROD-0051-C64_treatment12,6e1a74b9-749d-49c9-a6b8-b7ca25b38a36,Not Reported,released,,1,2020-09-27T10:18:35.076340-05:00,,Progressive Disease,DD4A
HCM-BROD-0051-C64,46b1210c-4042-4c67-9e68-06e960f201f2,31003449-79c0-4c54-a2bd-4604737894e1,,Neoadjuvant,61.0,2021-07-12T12:25:55.528644-05:00,HCM-BROD-0051-C64_treatment2,9432d678-4537-4bc9-a341-89b2477580fa,,released,Etoposide,1,2019-04-04T13:42:46.632048-05:00,Chemotherapy,,
HCM-BROD-0051-C64,46b1210c-4042-4c67-9e68-06e960f201f2,31003449-79c0-4c54-a2bd-4604737894e1,,Neoadjuvant,61.0,2021-07-12T12:25:55.528644-05:00,HCM-BROD-0051-C64_treatment,a3f6e8e1-b05a-461c-aabf-c4cd73fd9982,,released,Doxorubicin Hydrochloride,1,2019-04-04T13:42:46.632048-05:00,Chemotherapy,,
HCM-BROD-0051-C64,46b1210c-4042-4c67-9e68-06e960f201f2,31003449-79c0-4c54-a2bd-4604737894e1,,Neoadjuvant,61.0,2021-08-05T13:55:08.207361-05:00,HCM-BROD-0051-C64_treatment5,a6fbc0ec-0453-46d0-a839-532d660a1f25,,released,Cyclophosphamide,1,2019-04-04T13:42:46.632048-05:00,Chemotherapy,,
HCM-BROD-0051-C64,46b1210c-4042-4c67-9e68-06e960f201f2,31003449-79c0-4c54-a2bd-4604737894e1,,Maintenance Therapy,,2021-08-05T13:55:08.207361-05:00,HCM-BROD-0051-C64_treatment8,b2f466bb-355d-41c1-88f8-43ef98388590,Not Reported,released,Vincristine,1,2020-02-27T12:17:46.865711-06:00,,Progressive Disease,
HCM-BROD-0051-C64,46b1210c-4042-4c67-9e68-06e960f201f2,31003449-79c0-4c54-a2bd-4604737894e1,,Neoadjuvant,122.0,2021-08-05T13:55:08.207361-05:00,HCM-BROD-0051-C64_treatment13,cda66db0-5e1c-4771-96e8-54494030e0a6,,released,,1,2020-09-27T10:18:35.076340-05:00,"Radiation Therapy, NOS",,
HCM-BROD-0051-C64,46b1210c-4042-4c67-9e68-06e960f201f2,31003449-79c0-4c54-a2bd-4604737894e1,,Neoadjuvant,61.0,2021-08-05T13:55:08.207361-05:00,HCM-BROD-0051-C64_treatment4,dc2f616d-900f-4546-87fc-dbe484d679dc,,released,Dactinomycin,1,2019-04-04T13:42:46.632048-05:00,Chemotherapy,,
HCM-BROD-0051-C64,46b1210c-4042-4c67-9e68-06e960f201f2,31003449-79c0-4c54-a2bd-4604737894e1,,Neoadjuvant,61.0,2021-08-05T13:55:08.207361-05:00,HCM-BROD-0051-C64_treatment6,dec955e4-9ab5-4c86-8722-9138565a61be,,released,,1,2019-04-04T13:42:46.632048-05:00,Chemotherapy,,VAC
HCM-BROD-0051-C64,46b1210c-4042-4c67-9e68-06e960f201f2,31003449-79c0-4c54-a2bd-4604737894e1,,Adjuvant,,2023-03-13T13:06:14.110017-05:00,HCM-BROD-0051-C64_treatment16,e49fdbc3-6377-477a-9937-d13e84e1f38b,,released,,unknown,2020-09-27T10:18:35.076340-05:00,"Radiation Therapy, NOS",Residual Disease,
HCM-BROD-0051-C64,46b1210c-4042-4c67-9e68-06e960f201f2,31003449-79c0-4c54-a2bd-4604737894e1,,Maintenance Therapy,,2021-08-05T13:55:08.207361-05:00,HCM-BROD-0051-C64_treatment9,ea55d05b-9a98-428b-9c51-a4fbcd962a6c,Not Reported,released,Cyclophosphamide,1,2020-02-27T12:17:46.865711-06:00,,Progressive Disease,
HCM-BROD-0335-C43,47322ea3-6bbe-442b-a656-c48469cc99c1,207053c5-a053-449c-94c4-a3e36f19b161,,Adjuvant,,2021-07-12T12:25:55.528644-05:00,HCM-BROD-0335-C43_treatment7,50431878-a88e-451c-89ae-9e0c9362157a,,released,,0,2020-09-17T16:10:31.527022-05:00,"Radiation Therapy, NOS",Residual Disease,
HCM-BROD-0335-C43,47322ea3-6bbe-442b-a656-c48469cc99c1,207053c5-a053-449c-94c4-a3e36f19b161,278.0,Adjuvant,171.0,2021-07-12T12:25:55.528644-05:00,HCM-BROD-0335-C43_treatment4,754099ca-0b2d-4f17-a2c8-7114322eaddd,,released,Not Reported,1,2020-09-17T16:10:31.527022-05:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-BROD-0335-C43,47322ea3-6bbe-442b-a656-c48469cc99c1,207053c5-a053-449c-94c4-a3e36f19b161,,Adjuvant,,2021-07-12T12:25:55.528644-05:00,HCM-BROD-0335-C43_treatment3,765105fd-a45f-4486-be8a-7b1174ca5063,,released,,0,2020-09-17T16:10:31.527022-05:00,Hormone Therapy,Residual Disease,
HCM-BROD-0335-C43,47322ea3-6bbe-442b-a656-c48469cc99c1,207053c5-a053-449c-94c4-a3e36f19b161,,Neoadjuvant,,2021-07-12T12:25:55.528644-05:00,HCM-BROD-0335-C43_treatment,9308453c-950a-45eb-a57c-cdafc5ec5daa,,released,,0,2020-09-17T16:10:31.527022-05:00,,,
HCM-BROD-0335-C43,47322ea3-6bbe-442b-a656-c48469cc99c1,207053c5-a053-449c-94c4-a3e36f19b161,,Adjuvant,,2021-07-12T12:25:55.528644-05:00,HCM-BROD-0335-C43_treatment6,af689515-a8d3-4e2d-97e9-4fee3e17fddc,,released,,0,2020-09-17T16:10:31.527022-05:00,Targeted Molecular Therapy,Residual Disease,
HCM-BROD-0335-C43,47322ea3-6bbe-442b-a656-c48469cc99c1,207053c5-a053-449c-94c4-a3e36f19b161,,Adjuvant,,2021-07-12T12:25:55.528644-05:00,HCM-BROD-0335-C43_treatment2,bfcc4117-4aff-4d46-852d-05665938a2ad,,released,,0,2020-09-17T16:10:31.527022-05:00,Chemotherapy,Residual Disease,
HCM-BROD-0335-C43,47322ea3-6bbe-442b-a656-c48469cc99c1,207053c5-a053-449c-94c4-a3e36f19b161,,,0.0,2023-02-27T12:14:45.179018-06:00,HCM-BROD-0335-C43_treatment5,dcb06f47-c5a4-458f-ae7a-9479ffa35c90,,released,,1,2020-09-17T16:10:31.527022-05:00,"Surgery, NOS",Initial Diagnosis,
HCM-CSHL-0318-C18,4770c370-5846-49af-bafb-e49229ca2319,ecf8cf14-fb2a-4218-ae3d-63f5d474579d,,Adjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0318-C18_treatment4,1ad9c065-9aeb-47fa-bebd-bf8dcf8f1944,,released,,0,2020-09-28T09:39:00.295202-05:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-CSHL-0318-C18,4770c370-5846-49af-bafb-e49229ca2319,ecf8cf14-fb2a-4218-ae3d-63f5d474579d,,,27.0,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0318-C18_treatment5,1ed785ea-942b-4cd7-908a-96e5cabe9c4a,,released,,1,2020-09-28T09:39:00.295202-05:00,"Surgery, NOS",Initial Diagnosis,
HCM-CSHL-0318-C18,4770c370-5846-49af-bafb-e49229ca2319,ecf8cf14-fb2a-4218-ae3d-63f5d474579d,,Adjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0318-C18_treatment7,2ac235a9-ad87-4808-ae30-f833c63f47de,,released,,unknown,2020-09-28T09:39:00.295202-05:00,"Radiation Therapy, NOS",Residual Disease,
HCM-CSHL-0318-C18,4770c370-5846-49af-bafb-e49229ca2319,ecf8cf14-fb2a-4218-ae3d-63f5d474579d,,Adjuvant,64.0,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0318-C18_treatment3,2b6a8389-dc40-4a89-b867-d14b8a79b9ad,,released,Oxaliplatin,1,2020-09-28T09:39:00.295202-05:00,Chemotherapy,Residual Disease,
HCM-CSHL-0318-C18,4770c370-5846-49af-bafb-e49229ca2319,ecf8cf14-fb2a-4218-ae3d-63f5d474579d,,Adjuvant,64.0,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0318-C18_treatment2,37332d6b-66fc-48b3-8129-3cbffb43bd4c,,released,Capecitabine,1,2020-09-28T09:39:00.295202-05:00,Chemotherapy,Residual Disease,
HCM-CSHL-0318-C18,4770c370-5846-49af-bafb-e49229ca2319,ecf8cf14-fb2a-4218-ae3d-63f5d474579d,,Neoadjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0318-C18_treatment,aefd3586-9cc6-4d70-a44d-8ccb15cd83ce,,released,,0,2020-09-28T09:39:00.295202-05:00,,,
HCM-CSHL-0318-C18,4770c370-5846-49af-bafb-e49229ca2319,ecf8cf14-fb2a-4218-ae3d-63f5d474579d,,Adjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0318-C18_treatment6,caf444eb-61b2-430a-a530-a1b99869df5c,,released,,0,2020-09-28T09:39:00.295202-05:00,Targeted Molecular Therapy,Residual Disease,
HCM-BROD-0683-C43,4776d0d4-489f-4fb4-9ab3-03d6790baa66,af74743a-f72a-47e3-9be6-69a4c31a5536,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0683-C43_treatment7,23df4bb2-550b-485e-bf9f-840f91101bf8,,released,,0,2021-12-21T13:45:18.119299-06:00,"Radiation Therapy, NOS",Residual Disease,
HCM-BROD-0683-C43,4776d0d4-489f-4fb4-9ab3-03d6790baa66,af74743a-f72a-47e3-9be6-69a4c31a5536,,,0.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0683-C43_treatment5,3f1f4034-b7f8-420a-aff6-c106b3235d32,,released,,1,2021-12-21T13:45:18.119299-06:00,"Surgery, NOS",Initial Diagnosis,
HCM-BROD-0683-C43,4776d0d4-489f-4fb4-9ab3-03d6790baa66,af74743a-f72a-47e3-9be6-69a4c31a5536,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0683-C43_treatment2,84518389-05a8-4939-a7c6-aae4a1b8ce35,,released,,0,2021-12-21T13:45:18.119299-06:00,Chemotherapy,Residual Disease,
HCM-BROD-0683-C43,4776d0d4-489f-4fb4-9ab3-03d6790baa66,af74743a-f72a-47e3-9be6-69a4c31a5536,436.0,Adjuvant,410.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0683-C43_treatment4,c59c7ef1-df3d-40bd-a8ac-37386cba4f00,,released,Ipilimumab,1,2021-12-21T13:45:18.119299-06:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-BROD-0683-C43,4776d0d4-489f-4fb4-9ab3-03d6790baa66,af74743a-f72a-47e3-9be6-69a4c31a5536,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0683-C43_treatment6,cc0467cc-b634-4373-8a86-92d943155a22,,released,,0,2021-12-21T13:45:18.119299-06:00,Targeted Molecular Therapy,Residual Disease,
HCM-BROD-0683-C43,4776d0d4-489f-4fb4-9ab3-03d6790baa66,af74743a-f72a-47e3-9be6-69a4c31a5536,,Neoadjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0683-C43_treatment,d126e889-c8fc-4ce4-91bd-525eca41ba84,,released,,0,2021-12-21T13:45:18.119299-06:00,,,
HCM-BROD-0683-C43,4776d0d4-489f-4fb4-9ab3-03d6790baa66,af74743a-f72a-47e3-9be6-69a4c31a5536,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0683-C43_treatment3,f7088571-d446-48f6-ac67-e5efa6e7b5a6,,released,,0,2021-12-21T13:45:18.119299-06:00,Hormone Therapy,Residual Disease,
HCM-BROD-0001-C18,4829dd8c-5445-41b3-ae37-bbcc333e8c9e,a7f019db-c623-4d56-94e9-102cc4574f88,,Maintenance Therapy,53.0,2021-07-12T12:25:55.528644-05:00,HCM-BROD-0001-C18_treatment4,0619e104-8110-441b-97ef-a6a13d6823bb,Progressive Disease,released,Oxaliplatin,1,2020-07-31T09:25:24.402855-05:00,,Progressive Disease,
HCM-BROD-0001-C18,4829dd8c-5445-41b3-ae37-bbcc333e8c9e,a7f019db-c623-4d56-94e9-102cc4574f88,,,,2023-03-13T13:02:40.283252-05:00,HCM-BROD-0001-C18_treatment7,08fe38df-97af-42b3-a5a7-d5a0c9fe1ac9,,released,,unknown,2020-07-31T09:25:24.402855-05:00,"Surgery, NOS",Initial Diagnosis,
HCM-BROD-0001-C18,4829dd8c-5445-41b3-ae37-bbcc333e8c9e,a7f019db-c623-4d56-94e9-102cc4574f88,,Neoadjuvant,,2021-07-12T12:25:55.528644-05:00,HCM-BROD-0001-C18_treatment6,1c552e4c-343e-4f8b-8f97-20b8991f5bd4,,released,,0,2020-07-31T09:25:24.402855-05:00,,,
HCM-BROD-0001-C18,4829dd8c-5445-41b3-ae37-bbcc333e8c9e,a7f019db-c623-4d56-94e9-102cc4574f88,,Maintenance Therapy,53.0,2021-07-12T12:25:55.528644-05:00,HCM-BROD-0001-C18_treatment5,2a07cf82-209e-44d1-8547-3e9c38e50b9d,Progressive Disease,released,,1,2020-07-31T09:25:24.402855-05:00,,Progressive Disease,FOLFIRINOX
HCM-BROD-0001-C18,4829dd8c-5445-41b3-ae37-bbcc333e8c9e,a7f019db-c623-4d56-94e9-102cc4574f88,916.0,Adjuvant,902.0,2023-07-07T13:02:23.902070-05:00,HCM-BROD-0001-C18_treatment9,3059b954-3336-4da3-9c6c-0c0e6e3e4373,,released,,1,2020-09-25T16:42:46.477800-05:00,"Radiation Therapy, NOS",Residual Disease,
HCM-BROD-0001-C18,4829dd8c-5445-41b3-ae37-bbcc333e8c9e,a7f019db-c623-4d56-94e9-102cc4574f88,,Maintenance Therapy,53.0,2021-07-12T12:25:55.528644-05:00,HCM-BROD-0001-C18_treatment2,43fa9dd4-6205-44f7-9aa4-0edb84d456fe,Progressive Disease,released,Leucovorin Calcium,1,2020-07-31T09:25:24.402855-05:00,,Progressive Disease,
HCM-BROD-0001-C18,4829dd8c-5445-41b3-ae37-bbcc333e8c9e,a7f019db-c623-4d56-94e9-102cc4574f88,,Maintenance Therapy,53.0,2021-07-12T12:25:55.528644-05:00,HCM-BROD-0001-C18_treatment,5943365f-0bd4-4736-b0ac-c283bd58c821,Progressive Disease,released,Irinotecan Hydrochloride,1,2020-07-31T09:25:24.402855-05:00,,Progressive Disease,
HCM-BROD-0001-C18,4829dd8c-5445-41b3-ae37-bbcc333e8c9e,a7f019db-c623-4d56-94e9-102cc4574f88,,Maintenance Therapy,53.0,2021-07-12T12:25:55.528644-05:00,HCM-BROD-0001-C18_treatment3,b46f832c-4b86-4395-94bf-500af2bdcd35,Progressive Disease,released,Fluorouracil,1,2020-07-31T09:25:24.402855-05:00,,Progressive Disease,
HCM-BROD-0001-C18,4829dd8c-5445-41b3-ae37-bbcc333e8c9e,a7f019db-c623-4d56-94e9-102cc4574f88,,Adjuvant,,2023-03-13T13:02:40.283252-05:00,HCM-BROD-0001-C18_treatment8,cf1cce8f-b3ab-4ff3-a848-b2e9ded1a95b,,released,,0,2020-09-25T16:42:46.477800-05:00,"Pharmaceutical Therapy, NOS",Residual Disease,
HCM-WCMC-0751-C54,482c0ee1-5046-4fc7-b284-57923228ca23,0e0ca5a2-a776-4916-b80d-050f9c79d57b,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-WCMC-0751-C54_treatment3,4867eb6a-1ecd-4ccd-a06b-1cadb9ed66b5,,released,,0,2023-02-27T13:29:26.421692-06:00,"Pharmaceutical Therapy, NOS",Residual Disease,
HCM-WCMC-0751-C54,482c0ee1-5046-4fc7-b284-57923228ca23,0e0ca5a2-a776-4916-b80d-050f9c79d57b,96.0,Adjuvant,47.0,2025-04-07T17:13:09.336794-05:00,HCM-WCMC-0751-C54_treatment4,7af18639-9788-4a86-bb5c-5da211466abd,,released,,1,2023-02-27T13:29:26.421692-06:00,"Radiation, External Beam",Residual Disease,
HCM-WCMC-0751-C54,482c0ee1-5046-4fc7-b284-57923228ca23,0e0ca5a2-a776-4916-b80d-050f9c79d57b,,Neoadjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-WCMC-0751-C54_treatment,7c30da6c-cb7c-4db4-b01e-6c139f47348f,,released,,0,2023-02-27T13:29:26.421692-06:00,,,
HCM-WCMC-0751-C54,482c0ee1-5046-4fc7-b284-57923228ca23,0e0ca5a2-a776-4916-b80d-050f9c79d57b,,,0.0,2025-04-07T17:13:09.336794-05:00,HCM-WCMC-0751-C54_treatment2,a360ebd5-6ac3-41ef-b4cf-6c0ba5ee8bef,,released,,1,2023-02-27T13:29:26.421692-06:00,"Surgery, NOS",Initial Diagnosis,
HCM-CSHL-0180-C25,489ae53c-0c19-433b-b22d-8dc09f2161be,eeefcad2-9a62-45d1-8d27-4c9554922a23,,Adjuvant,,2023-02-22T07:39:25.979291-06:00,HCM-CSHL-0180-C25_treatment10,33968ee3-8b3e-4887-ab05-2026caf19e3e,,released,,0,2020-09-28T09:13:36.939899-05:00,Targeted Molecular Therapy,Residual Disease,
HCM-CSHL-0180-C25,489ae53c-0c19-433b-b22d-8dc09f2161be,eeefcad2-9a62-45d1-8d27-4c9554922a23,,Adjuvant,360.0,2023-02-22T07:39:25.979291-06:00,HCM-CSHL-0180-C25_treatment4,3de81377-f1b6-4457-a537-993b19af2c37,,released,Leucovorin Calcium,1,2020-09-28T09:13:36.939899-05:00,Chemotherapy,Residual Disease,
HCM-CSHL-0180-C25,489ae53c-0c19-433b-b22d-8dc09f2161be,eeefcad2-9a62-45d1-8d27-4c9554922a23,,Neoadjuvant,,2023-02-22T07:39:25.979291-06:00,HCM-CSHL-0180-C25_treatment,3f1439b9-6efe-40cb-be52-4b2d01235a84,,released,,0,2020-09-28T09:13:36.939899-05:00,,,
HCM-CSHL-0180-C25,489ae53c-0c19-433b-b22d-8dc09f2161be,eeefcad2-9a62-45d1-8d27-4c9554922a23,,Adjuvant,360.0,2023-02-22T07:39:25.979291-06:00,HCM-CSHL-0180-C25_treatment5,411a94c7-b8c4-4cdb-9aa4-c85b2952cf44,,released,Fluorouracil,1,2020-09-28T09:13:36.939899-05:00,Chemotherapy,Residual Disease,
HCM-CSHL-0180-C25,489ae53c-0c19-433b-b22d-8dc09f2161be,eeefcad2-9a62-45d1-8d27-4c9554922a23,,,-20.0,2023-02-27T12:30:24.075160-06:00,HCM-CSHL-0180-C25_treatment9,4758d852-6e89-49b1-a8c2-71793d4f37b0,,released,,1,2020-09-28T09:13:36.939899-05:00,"Surgery, NOS",Initial Diagnosis,
HCM-CSHL-0180-C25,489ae53c-0c19-433b-b22d-8dc09f2161be,eeefcad2-9a62-45d1-8d27-4c9554922a23,317.0,Adjuvant,164.0,2023-02-22T07:39:25.979291-06:00,HCM-CSHL-0180-C25_treatment2,5fc24220-9f93-40f5-a14e-1c1d5e4e840b,,released,Gemcitabine,1,2020-09-28T09:13:36.939899-05:00,Chemotherapy,Residual Disease,
HCM-CSHL-0180-C25,489ae53c-0c19-433b-b22d-8dc09f2161be,eeefcad2-9a62-45d1-8d27-4c9554922a23,,Adjuvant,,2023-02-22T07:39:25.979291-06:00,HCM-CSHL-0180-C25_treatment11,6a3dc737-fa04-4097-9484-ce08bb9854c7,,released,,0,2020-09-28T09:13:36.939899-05:00,"Radiation Therapy, NOS",Residual Disease,
HCM-CSHL-0180-C25,489ae53c-0c19-433b-b22d-8dc09f2161be,eeefcad2-9a62-45d1-8d27-4c9554922a23,,Adjuvant,360.0,2023-02-22T07:39:25.979291-06:00,HCM-CSHL-0180-C25_treatment6,858b5832-030f-4b25-8c7d-a0fbbe02550c,,released,Irinotecan,1,2020-09-28T09:13:36.939899-05:00,Chemotherapy,Residual Disease,
HCM-CSHL-0180-C25,489ae53c-0c19-433b-b22d-8dc09f2161be,eeefcad2-9a62-45d1-8d27-4c9554922a23,,Adjuvant,360.0,2023-02-22T07:39:25.979291-06:00,HCM-CSHL-0180-C25_treatment7,affaba00-2b6f-497d-ab6f-2762341f21ce,,released,,1,2020-09-28T09:13:36.939899-05:00,Chemotherapy,Residual Disease,FOLFIRI
HCM-CSHL-0180-C25,489ae53c-0c19-433b-b22d-8dc09f2161be,eeefcad2-9a62-45d1-8d27-4c9554922a23,317.0,Adjuvant,164.0,2023-02-22T07:39:25.979291-06:00,HCM-CSHL-0180-C25_treatment3,b92f1953-0283-4d4f-8d6e-f706949d17ef,,released,Nab-paclitaxel,1,2020-09-28T09:13:36.939899-05:00,Chemotherapy,Residual Disease,
HCM-CSHL-0180-C25,489ae53c-0c19-433b-b22d-8dc09f2161be,eeefcad2-9a62-45d1-8d27-4c9554922a23,,Adjuvant,,2023-02-22T07:39:25.979291-06:00,HCM-CSHL-0180-C25_treatment8,f571ba36-8ad1-4844-954b-c1a9c45df94d,,released,,0,2020-09-28T09:13:36.939899-05:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-CSHL-0601-C25,491159e8-4599-4dec-a05c-1d35dc6f3d05,e22d19c9-a416-491f-a8dc-e0ffaa846312,,Adjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0601-C25_treatment6,2dbbdb96-23ac-4d74-a7cc-57d206dbaab3,,released,,0,2021-12-21T14:09:26.597980-06:00,"Pharmaceutical Therapy, NOS",Residual Disease,
HCM-CSHL-0601-C25,491159e8-4599-4dec-a05c-1d35dc6f3d05,e22d19c9-a416-491f-a8dc-e0ffaa846312,,,-21.0,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0601-C25_treatment5,2e75259c-71cf-4983-9713-8da0646e1399,,released,,1,2021-12-21T14:09:26.597980-06:00,"Surgery, NOS",Initial Diagnosis,
HCM-CSHL-0601-C25,491159e8-4599-4dec-a05c-1d35dc6f3d05,e22d19c9-a416-491f-a8dc-e0ffaa846312,,Neoadjuvant,92.0,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0601-C25_treatment2,68b58f75-b03b-4360-b818-7e5c50cbbf77,,released,Fluorouracil,1,2021-12-21T14:09:26.597980-06:00,Chemotherapy,,
HCM-CSHL-0601-C25,491159e8-4599-4dec-a05c-1d35dc6f3d05,e22d19c9-a416-491f-a8dc-e0ffaa846312,,Neoadjuvant,92.0,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0601-C25_treatment3,96151e93-d652-495d-a60f-19eb0d66315f,,released,Oxaliplatin,1,2021-12-21T14:09:26.597980-06:00,Chemotherapy,,
HCM-CSHL-0601-C25,491159e8-4599-4dec-a05c-1d35dc6f3d05,e22d19c9-a416-491f-a8dc-e0ffaa846312,,Neoadjuvant,92.0,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0601-C25_treatment4,c1861590-6f3b-4ad4-a233-961e29ef1eb8,,released,,1,2021-12-21T14:09:26.597980-06:00,Chemotherapy,,FOLFOX
HCM-CSHL-0601-C25,491159e8-4599-4dec-a05c-1d35dc6f3d05,e22d19c9-a416-491f-a8dc-e0ffaa846312,,Neoadjuvant,92.0,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0601-C25_treatment,dec73750-71b6-42ff-bb66-4ad7370771e7,,released,Leucovorin Calcium,1,2021-12-21T14:09:26.597980-06:00,Chemotherapy,,
HCM-CSHL-0601-C25,491159e8-4599-4dec-a05c-1d35dc6f3d05,e22d19c9-a416-491f-a8dc-e0ffaa846312,,Adjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0601-C25_treatment7,fc98776e-3567-4d82-9bfc-9ad256eaa05d,,released,,0,2021-12-21T14:09:26.597980-06:00,"Radiation Therapy, NOS",Residual Disease,
HCM-CSHL-0155-C50,496a0dcf-431a-467a-a150-5c7486d72bee,f16bec06-481e-410b-8874-0a5b7ce52289,,Adjuvant,,2023-03-13T13:02:10.450107-05:00,HCM-CSHL-0155-C50_treatment3,3d14f232-97e6-408c-afeb-c436ef1f2857,,released,,unknown,2020-09-27T12:59:52.462518-05:00,"Pharmaceutical Therapy, NOS",Residual Disease,
HCM-CSHL-0155-C50,496a0dcf-431a-467a-a150-5c7486d72bee,f16bec06-481e-410b-8874-0a5b7ce52289,,,34.0,2023-03-13T13:02:10.450107-05:00,HCM-CSHL-0155-C50_treatment2,78c1d1fa-aa3c-4634-b4b3-47bb62f691d6,,released,,1,2020-09-27T12:59:52.462518-05:00,"Surgery, NOS",Initial Diagnosis,
HCM-CSHL-0155-C50,496a0dcf-431a-467a-a150-5c7486d72bee,f16bec06-481e-410b-8874-0a5b7ce52289,,Adjuvant,,2023-03-13T13:02:10.450107-05:00,HCM-CSHL-0155-C50_treatment4,a881f3ab-dfc9-47b3-b085-6ad9515bdd46,,released,,unknown,2020-09-27T12:59:52.462518-05:00,"Radiation Therapy, NOS",Residual Disease,
HCM-CSHL-0155-C50,496a0dcf-431a-467a-a150-5c7486d72bee,f16bec06-481e-410b-8874-0a5b7ce52289,,Neoadjuvant,,2023-02-22T07:39:25.979291-06:00,HCM-CSHL-0155-C50_treatment,e28e339d-46d6-4278-94e9-01cc7358255a,,released,,0,2020-09-27T12:59:52.462518-05:00,,,
HCM-CSHL-0810-C54,49ad0220-8d59-4277-a174-011677a80f69,7a5daba7-5c1c-4834-9f67-eabcd11d54ad,,,0.0,2023-07-13T10:27:19.665852-05:00,HCM-CSHL-0810-C54_treatment6,72344c10-d3e6-4ba8-a643-ad5d775d5af6,,released,,1,2021-12-21T14:27:10.723212-06:00,"Surgery, NOS",Initial Diagnosis,
HCM-CSHL-0810-C54,49ad0220-8d59-4277-a174-011677a80f69,7a5daba7-5c1c-4834-9f67-eabcd11d54ad,,Adjuvant,,2023-07-13T10:27:19.665852-05:00,HCM-CSHL-0810-C54_treatment4,7db14c65-5a14-44d0-b0d6-3c0eb0e907c6,,released,,0,2021-12-21T14:27:10.723212-06:00,Hormone Therapy,Residual Disease,
HCM-CSHL-0810-C54,49ad0220-8d59-4277-a174-011677a80f69,7a5daba7-5c1c-4834-9f67-eabcd11d54ad,,Adjuvant,,2023-07-13T10:27:19.665852-05:00,HCM-CSHL-0810-C54_treatment5,b1f57664-cf00-4145-859b-602468842bb3,,released,,0,2021-12-21T14:27:10.723212-06:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-CSHL-0810-C54,49ad0220-8d59-4277-a174-011677a80f69,7a5daba7-5c1c-4834-9f67-eabcd11d54ad,,Neoadjuvant,,2023-07-13T10:27:19.665852-05:00,HCM-CSHL-0810-C54_treatment,c28c5eed-55c2-415a-bbe8-eebe9192ff82,,released,,0,2021-12-21T14:27:10.723212-06:00,,,
HCM-CSHL-0810-C54,49ad0220-8d59-4277-a174-011677a80f69,7a5daba7-5c1c-4834-9f67-eabcd11d54ad,,Adjuvant,,2023-07-13T10:27:19.665852-05:00,HCM-CSHL-0810-C54_treatment7,c296d5bf-879a-4a96-b9a5-11dab45dbfda,,released,,0,2021-12-21T14:27:10.723212-06:00,Targeted Molecular Therapy,Residual Disease,
HCM-CSHL-0810-C54,49ad0220-8d59-4277-a174-011677a80f69,7a5daba7-5c1c-4834-9f67-eabcd11d54ad,158.0,Adjuvant,48.0,2023-07-13T10:27:19.665852-05:00,HCM-CSHL-0810-C54_treatment3,e44f19dd-d2e9-4ea7-b987-cf2ffccdf5e3,,released,Paclitaxel,1,2021-12-21T14:27:10.723212-06:00,Chemotherapy,Residual Disease,
HCM-CSHL-0810-C54,49ad0220-8d59-4277-a174-011677a80f69,7a5daba7-5c1c-4834-9f67-eabcd11d54ad,158.0,Adjuvant,48.0,2023-07-13T10:27:19.665852-05:00,HCM-CSHL-0810-C54_treatment2,ed16dc9b-d248-4101-b8e4-d14bbf76c260,,released,Carboplatin,1,2021-12-21T14:27:10.723212-06:00,Chemotherapy,Residual Disease,
HCM-CSHL-0810-C54,49ad0220-8d59-4277-a174-011677a80f69,7a5daba7-5c1c-4834-9f67-eabcd11d54ad,235.0,Adjuvant,208.0,2023-07-13T10:27:19.665852-05:00,HCM-CSHL-0810-C54_treatment8,f76850f7-3993-49e7-bec4-31b91fdd6c99,,released,,1,2021-12-21T14:27:10.723212-06:00,External Beam Radiation,Residual Disease,
HCM-SANG-1084-C15,49c761f2-8804-41ac-ad2f-93ba8a2a6ef5,0db47c45-4a58-4d6c-bae1-8daee3f8c92b,,Neoadjuvant,109.0,2025-03-31T16:34:59.906497-05:00,HCM-SANG-1084-C15_treatment3,3d288258-0fb8-4237-acb8-4d606ca6ab57,,released,,1,2023-02-27T12:24:26.861822-06:00,"Radiation, 2D Conventional",,
HCM-SANG-1084-C15,49c761f2-8804-41ac-ad2f-93ba8a2a6ef5,0db47c45-4a58-4d6c-bae1-8daee3f8c92b,,Neoadjuvant,109.0,2025-03-31T16:34:59.906497-05:00,HCM-SANG-1084-C15_treatment,956ac140-0177-46ee-96ca-581ce5b81220,,released,Paclitaxel,1,2023-02-27T12:24:26.861822-06:00,Chemotherapy,,
HCM-SANG-1084-C15,49c761f2-8804-41ac-ad2f-93ba8a2a6ef5,0db47c45-4a58-4d6c-bae1-8daee3f8c92b,,Neoadjuvant,109.0,2025-03-31T16:34:59.906497-05:00,HCM-SANG-1084-C15_treatment2,ee212578-3a6a-4c1f-bf0a-f0b7926eba94,,released,Carboplatin,1,2023-02-27T12:24:26.861822-06:00,Chemotherapy,,
HCM-BROD-0953-C34,49c7df8f-26db-4e9c-9f9b-8f1a515df3b5,2946de7c-a5db-4fcc-bbcb-aca0ca5c8334,96.0,Adjuvant,56.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0953-C34_treatment4,1e598eb8-c550-4425-8bc5-69aead465277,,released,Leucovorin,1,2022-03-09T20:55:52.463525-06:00,Chemotherapy,Residual Disease,
HCM-BROD-0953-C34,49c7df8f-26db-4e9c-9f9b-8f1a515df3b5,2946de7c-a5db-4fcc-bbcb-aca0ca5c8334,,Neoadjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0953-C34_treatment,27dec9b0-67d1-4904-bc1d-62d56d2d20fd,,released,,0,2022-03-09T20:55:52.463525-06:00,,,
HCM-BROD-0953-C34,49c7df8f-26db-4e9c-9f9b-8f1a515df3b5,2946de7c-a5db-4fcc-bbcb-aca0ca5c8334,,,,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0953-C34_treatment6,2e1793cc-0268-42c6-bc63-5a40c3122b6c,,released,,0,2022-03-09T20:55:52.463525-06:00,"Surgery, NOS",Initial Diagnosis,
HCM-BROD-0953-C34,49c7df8f-26db-4e9c-9f9b-8f1a515df3b5,2946de7c-a5db-4fcc-bbcb-aca0ca5c8334,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0953-C34_treatment5,7bbdcf28-00f6-457b-a986-d4194475f404,,released,,0,2022-03-09T20:55:52.463525-06:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-BROD-0953-C34,49c7df8f-26db-4e9c-9f9b-8f1a515df3b5,2946de7c-a5db-4fcc-bbcb-aca0ca5c8334,96.0,Adjuvant,56.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0953-C34_treatment3,a7366228-7b2b-4cb7-b0cf-80db53e7e096,,released,Fluorouracil,1,2022-03-09T20:55:52.463525-06:00,Chemotherapy,Residual Disease,
HCM-BROD-0953-C34,49c7df8f-26db-4e9c-9f9b-8f1a515df3b5,2946de7c-a5db-4fcc-bbcb-aca0ca5c8334,26.0,Adjuvant,20.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0953-C34_treatment8,bc0fef7f-3b0c-445d-8f3a-b80a994a3106,,released,,1,2022-03-09T20:55:52.463525-06:00,Stereotactic Radiosurgery,Residual Disease,
HCM-BROD-0953-C34,49c7df8f-26db-4e9c-9f9b-8f1a515df3b5,2946de7c-a5db-4fcc-bbcb-aca0ca5c8334,96.0,Adjuvant,56.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0953-C34_treatment2,e999804d-42b3-49df-a2fb-d974c508e948,,released,Oxaliplatin,1,2022-03-09T20:55:52.463525-06:00,Chemotherapy,Residual Disease,
HCM-BROD-0953-C34,49c7df8f-26db-4e9c-9f9b-8f1a515df3b5,2946de7c-a5db-4fcc-bbcb-aca0ca5c8334,96.0,Adjuvant,56.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0953-C34_treatment7,e9eaf96e-b8da-4854-8f26-21e131750c97,,released,Bevacizumab,1,2022-03-09T20:55:52.463525-06:00,Targeted Molecular Therapy,Residual Disease,
HCM-SANG-1090-C18,4a10a586-64ab-4136-8dba-0545589772cd,68770c77-4915-4aec-95b4-345d2c1ac1fe,,Neoadjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-SANG-1090-C18_treatment,55fe0bfb-fda7-402d-aadb-c4be5b5f1462,,released,,0,2023-02-27T12:29:44.231473-06:00,,,
HCM-CSHL-0639-C56,4a10c499-7f11-49dc-b865-b6cbaf5b1df7,8022dec2-f6e8-4fe9-9c7d-6a892bf65166,,Neoadjuvant,-107.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0639-C56_treatment3,2f808f87-9f86-4102-a67c-5ea9198002c5,,released,Acetylcysteine,1,2021-12-21T14:13:43.925636-06:00,Chemotherapy,,
HCM-CSHL-0639-C56,4a10c499-7f11-49dc-b865-b6cbaf5b1df7,8022dec2-f6e8-4fe9-9c7d-6a892bf65166,,,0.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0639-C56_treatment4,7b6445ed-2d60-4328-9ac3-0bf9ed1eecc9,,released,,1,2021-12-21T14:13:43.925636-06:00,"Surgery, NOS",Initial Diagnosis,
HCM-CSHL-0639-C56,4a10c499-7f11-49dc-b865-b6cbaf5b1df7,8022dec2-f6e8-4fe9-9c7d-6a892bf65166,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0639-C56_treatment6,8d83fca8-453a-48b1-9379-b06a26770559,,released,,0,2021-12-21T14:13:43.925636-06:00,"Radiation Therapy, NOS",Residual Disease,
HCM-CSHL-0639-C56,4a10c499-7f11-49dc-b865-b6cbaf5b1df7,8022dec2-f6e8-4fe9-9c7d-6a892bf65166,,Neoadjuvant,-107.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0639-C56_treatment2,a9e0b77f-fe63-4f58-84fb-546002af64e8,,released,Paclitaxel,1,2021-12-21T14:13:43.925636-06:00,Chemotherapy,,
HCM-CSHL-0639-C56,4a10c499-7f11-49dc-b865-b6cbaf5b1df7,8022dec2-f6e8-4fe9-9c7d-6a892bf65166,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0639-C56_treatment5,b68c0acb-7c3f-42cd-8d98-0d2080a1740c,,released,,0,2021-12-21T14:13:43.925636-06:00,"Pharmaceutical Therapy, NOS",Residual Disease,
HCM-CSHL-0639-C56,4a10c499-7f11-49dc-b865-b6cbaf5b1df7,8022dec2-f6e8-4fe9-9c7d-6a892bf65166,,Neoadjuvant,-107.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0639-C56_treatment,dc3e9fa6-3206-4d88-9205-2b46f3d205aa,,released,Carboplatin,1,2021-12-21T14:13:43.925636-06:00,Chemotherapy,,
HCM-BROD-0048-C71,4b9b3130-2483-4e5d-8c4d-e225590a5cd2,7f7968f0-e608-441d-b7a6-61c30361d16d,,Adjuvant,,2021-03-03T15:15:08.075155-06:00,HCM-BROD-0048-C71_treatment6,08474a1e-f8b2-4c18-b605-c3e00149d0ed,,released,,0,2020-02-27T12:16:53.481408-06:00,Targeted Molecular Therapy,Residual Disease,
HCM-BROD-0048-C71,4b9b3130-2483-4e5d-8c4d-e225590a5cd2,7f7968f0-e608-441d-b7a6-61c30361d16d,60.0,Adjuvant,29.0,2021-03-03T15:15:08.075155-06:00,HCM-BROD-0048-C71_treatment2,3e2b3782-eec3-49b1-88fa-04f34571fda5,,released,Temozolomide,1,2020-02-27T12:16:53.481408-06:00,Chemotherapy,Residual Disease,
HCM-BROD-0048-C71,4b9b3130-2483-4e5d-8c4d-e225590a5cd2,7f7968f0-e608-441d-b7a6-61c30361d16d,508.0,Adjuvant,109.0,2021-03-03T15:15:08.075155-06:00,HCM-BROD-0048-C71_treatment3,5caf0316-e104-4ae6-ae37-8420c1407a10,,released,Temozolomide,1,2020-02-27T12:16:53.481408-06:00,Chemotherapy,Residual Disease,
HCM-BROD-0048-C71,4b9b3130-2483-4e5d-8c4d-e225590a5cd2,7f7968f0-e608-441d-b7a6-61c30361d16d,,Adjuvant,,2021-03-03T15:15:08.075155-06:00,HCM-BROD-0048-C71_treatment4,5e5e3b5d-c231-430f-8956-33fbb4a2970b,,released,,0,2020-02-27T12:16:53.481408-06:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-BROD-0048-C71,4b9b3130-2483-4e5d-8c4d-e225590a5cd2,7f7968f0-e608-441d-b7a6-61c30361d16d,,,-5.0,2023-02-27T13:23:09.240312-06:00,HCM-BROD-0048-C71_treatment5,b71bff6e-95e8-43d3-8e61-d08c15f7f2dc,,released,,1,2020-02-27T12:16:53.481408-06:00,"Surgery, NOS",Initial Diagnosis,
HCM-BROD-0048-C71,4b9b3130-2483-4e5d-8c4d-e225590a5cd2,7f7968f0-e608-441d-b7a6-61c30361d16d,60.0,Adjuvant,29.0,2021-03-03T15:15:08.075155-06:00,HCM-BROD-0048-C71_treatment7,cf707c68-0352-46cc-b5b4-7f7e48380d7b,,released,,1,2020-02-27T12:16:53.481408-06:00,"Radiation Therapy, NOS",Residual Disease,
HCM-BROD-0048-C71,4b9b3130-2483-4e5d-8c4d-e225590a5cd2,7f7968f0-e608-441d-b7a6-61c30361d16d,,Neoadjuvant,,2021-03-03T15:15:08.075155-06:00,HCM-BROD-0048-C71_treatment,ededa8f1-37df-429d-8f7b-7e2ec83aa7c9,,released,,0,2019-04-04T14:43:48.822667-05:00,,,
HCM-BROD-0488-C16,4ba45a91-c521-42cc-b2c5-8c4d04444d22,314fb703-c8aa-4cc7-918a-21578e21a779,,Neoadjuvant,17.0,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0488-C16_treatment3,10654e22-f014-453a-a581-3796f9bf093e,,released,Leucovorin,1,2020-10-08T14:46:17.696741-05:00,Chemotherapy,,
HCM-BROD-0488-C16,4ba45a91-c521-42cc-b2c5-8c4d04444d22,314fb703-c8aa-4cc7-918a-21578e21a779,,Neoadjuvant,17.0,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0488-C16_treatment5,237673b0-19f0-441d-b1ac-4d340ad86765,,released,Capecitabine,1,2020-10-08T14:46:17.696741-05:00,Chemotherapy,,
HCM-BROD-0488-C16,4ba45a91-c521-42cc-b2c5-8c4d04444d22,314fb703-c8aa-4cc7-918a-21578e21a779,,Neoadjuvant,17.0,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0488-C16_treatment4,54cf82ae-c0f5-4b16-a8ce-677e1ea4cf0c,,released,Fluorouracil,1,2020-10-08T14:46:17.696741-05:00,Chemotherapy,,
HCM-BROD-0488-C16,4ba45a91-c521-42cc-b2c5-8c4d04444d22,314fb703-c8aa-4cc7-918a-21578e21a779,,Adjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0488-C16_treatment14,565090de-2cec-4748-8c84-cdc565d7f32f,,released,,0,2020-10-08T14:46:17.696741-05:00,"Radiation Therapy, NOS",Residual Disease,
HCM-BROD-0488-C16,4ba45a91-c521-42cc-b2c5-8c4d04444d22,314fb703-c8aa-4cc7-918a-21578e21a779,,Neoadjuvant,17.0,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0488-C16_treatment,689fa079-d875-460a-88e5-9166ab4b5836,,released,Oxaliplatin,1,2020-10-08T14:46:17.696741-05:00,Chemotherapy,,
HCM-BROD-0488-C16,4ba45a91-c521-42cc-b2c5-8c4d04444d22,314fb703-c8aa-4cc7-918a-21578e21a779,,Neoadjuvant,2507.0,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0488-C16_treatment9,7f19405e-44c9-45ce-b2c7-e3a99ccb24d9,,released,Trastuzumab,1,2020-10-08T14:46:17.696741-05:00,Targeted Molecular Therapy,,
HCM-BROD-0488-C16,4ba45a91-c521-42cc-b2c5-8c4d04444d22,314fb703-c8aa-4cc7-918a-21578e21a779,,Neoadjuvant,17.0,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0488-C16_treatment6,8a75f6e1-3e86-4d1e-8d58-dc3a3d895258,,released,,1,2020-10-08T14:46:17.696741-05:00,Chemotherapy,,FU-LV regimen
HCM-BROD-0488-C16,4ba45a91-c521-42cc-b2c5-8c4d04444d22,314fb703-c8aa-4cc7-918a-21578e21a779,,,0.0,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0488-C16_treatment12,914edf2d-cb85-4b2a-83dd-be06f592b187,,released,,1,2020-10-08T14:46:17.696741-05:00,"Surgery, NOS",Initial Diagnosis,
HCM-BROD-0488-C16,4ba45a91-c521-42cc-b2c5-8c4d04444d22,314fb703-c8aa-4cc7-918a-21578e21a779,,Neoadjuvant,17.0,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0488-C16_treatment7,af607608-19f6-4f52-ad33-ea998c100536,,released,,1,2020-10-08T14:46:17.696741-05:00,"Radiation Therapy, NOS",,
HCM-BROD-0488-C16,4ba45a91-c521-42cc-b2c5-8c4d04444d22,314fb703-c8aa-4cc7-918a-21578e21a779,,Neoadjuvant,17.0,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0488-C16_treatment2,c852d390-b009-4108-9357-c1e65ef43dc4,,released,Irinotecan,1,2020-10-08T14:46:17.696741-05:00,Chemotherapy,,
HCM-BROD-0488-C16,4ba45a91-c521-42cc-b2c5-8c4d04444d22,314fb703-c8aa-4cc7-918a-21578e21a779,,Adjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0488-C16_treatment10,cf1f6579-9636-4cd8-9650-64379bc977ed,,released,,unknown,2020-10-08T14:46:17.696741-05:00,Chemotherapy,Residual Disease,
HCM-BROD-0488-C16,4ba45a91-c521-42cc-b2c5-8c4d04444d22,314fb703-c8aa-4cc7-918a-21578e21a779,,Adjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0488-C16_treatment11,d4cb714f-6f4b-4899-9b6d-1180a14df48a,,released,,unknown,2020-10-08T14:46:17.696741-05:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-BROD-0488-C16,4ba45a91-c521-42cc-b2c5-8c4d04444d22,314fb703-c8aa-4cc7-918a-21578e21a779,,Adjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0488-C16_treatment13,de75fef6-10cb-4174-93c2-707e4769f6f0,,released,,unknown,2020-10-08T14:46:17.696741-05:00,Targeted Molecular Therapy,Residual Disease,
HCM-BROD-0488-C16,4ba45a91-c521-42cc-b2c5-8c4d04444d22,314fb703-c8aa-4cc7-918a-21578e21a779,,Neoadjuvant,2507.0,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0488-C16_treatment8,e98f1140-f477-4807-a867-1adfaffc78c8,,released,Cetuximab,1,2020-10-08T14:46:17.696741-05:00,Targeted Molecular Therapy,,
HCM-CSHL-0179-C25,4c48e9c9-5f8f-43e2-a972-367b260b40eb,9e52827a-5b12-45f1-b701-259bf2c45f63,,,-12.0,2023-02-27T12:43:35.769603-06:00,HCM-CSHL-0179-C25_treatment4,6478502f-cd05-4867-9775-b5b5b0ad3209,,released,,1,2020-09-28T09:13:27.999637-05:00,"Surgery, NOS",Initial Diagnosis,
HCM-CSHL-0179-C25,4c48e9c9-5f8f-43e2-a972-367b260b40eb,9e52827a-5b12-45f1-b701-259bf2c45f63,258.0,Adjuvant,13.0,2023-02-22T07:39:25.979291-06:00,HCM-CSHL-0179-C25_treatment2,7b97103c-0f8d-4afc-8e55-c1a69c2e1592,,released,Gemcitabine,1,2020-09-28T09:13:27.999637-05:00,Chemotherapy,Residual Disease,
HCM-CSHL-0179-C25,4c48e9c9-5f8f-43e2-a972-367b260b40eb,9e52827a-5b12-45f1-b701-259bf2c45f63,,Adjuvant,,2023-02-22T07:39:25.979291-06:00,HCM-CSHL-0179-C25_treatment5,b5a59d32-8e62-420b-bfbf-062d9d64d80b,,released,,0,2020-09-28T09:13:27.999637-05:00,Targeted Molecular Therapy,Residual Disease,
HCM-CSHL-0179-C25,4c48e9c9-5f8f-43e2-a972-367b260b40eb,9e52827a-5b12-45f1-b701-259bf2c45f63,313.0,Adjuvant,289.0,2023-02-22T07:39:25.979291-06:00,HCM-CSHL-0179-C25_treatment6,deadab53-2029-47ba-a249-b97b91091c62,,released,,1,2020-09-28T09:13:27.999637-05:00,"Radiation, 2D Conventional",Residual Disease,
HCM-CSHL-0179-C25,4c48e9c9-5f8f-43e2-a972-367b260b40eb,9e52827a-5b12-45f1-b701-259bf2c45f63,,Neoadjuvant,,2023-02-22T07:39:25.979291-06:00,HCM-CSHL-0179-C25_treatment,e3d0963d-6e97-424d-a5f0-e608df51b614,,released,,0,2020-09-28T09:13:27.999637-05:00,,,
HCM-CSHL-0179-C25,4c48e9c9-5f8f-43e2-a972-367b260b40eb,9e52827a-5b12-45f1-b701-259bf2c45f63,,Adjuvant,,2023-02-22T07:39:25.979291-06:00,HCM-CSHL-0179-C25_treatment3,fb3fc2b3-c02d-4393-9f0b-4e69eaa320ad,,released,,0,2020-09-28T09:13:27.999637-05:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-SANG-0541-C20,4d4cc629-2f04-4688-a396-a3c30ca27886,5723233c-8350-4cf9-950e-510b6046394f,,Neoadjuvant,20.0,2025-03-31T16:34:59.906497-05:00,HCM-SANG-0541-C20_treatment,be4dad67-b5c6-468b-bc7c-0fe58bff3ca0,,released,,1,2023-02-27T12:39:27.253834-06:00,"Radiation, 2D Conventional",,
HCM-BROD-0715-C43,4e3d5c85-6a93-4421-8ae6-de4826abdcb5,8c0fc9bf-de6c-4077-80cb-f6937658e453,6414.0,Adjuvant,5148.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0715-C43_treatment4,2b29ab12-b6c7-4695-bd67-0c8f5716ce8b,,released,Nivolumab,1,2021-12-21T13:47:47.449535-06:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-BROD-0715-C43,4e3d5c85-6a93-4421-8ae6-de4826abdcb5,8c0fc9bf-de6c-4077-80cb-f6937658e453,,Neoadjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0715-C43_treatment,3ea4b1bc-9a63-4e68-8982-bd596554d59f,,released,,0,2021-12-21T13:47:47.449535-06:00,,,
HCM-BROD-0715-C43,4e3d5c85-6a93-4421-8ae6-de4826abdcb5,8c0fc9bf-de6c-4077-80cb-f6937658e453,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0715-C43_treatment3,4d085213-1547-4f24-9998-3b50234d2b96,,released,,0,2021-12-21T13:47:47.449535-06:00,Hormone Therapy,Residual Disease,
HCM-BROD-0715-C43,4e3d5c85-6a93-4421-8ae6-de4826abdcb5,8c0fc9bf-de6c-4077-80cb-f6937658e453,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0715-C43_treatment7,79ed5ca5-9e52-4c17-b99b-226cf4b30d2e,,released,,0,2021-12-21T13:47:47.449535-06:00,"Radiation Therapy, NOS",Residual Disease,
HCM-BROD-0715-C43,4e3d5c85-6a93-4421-8ae6-de4826abdcb5,8c0fc9bf-de6c-4077-80cb-f6937658e453,,,0.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0715-C43_treatment5,85ffebf6-57f9-4b42-9916-ae789ab86ab9,,released,,1,2021-12-21T13:47:47.449535-06:00,"Surgery, NOS",Initial Diagnosis,
HCM-BROD-0715-C43,4e3d5c85-6a93-4421-8ae6-de4826abdcb5,8c0fc9bf-de6c-4077-80cb-f6937658e453,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0715-C43_treatment6,92c49395-58fd-4bf2-a2d6-6c0f8665609a,,released,,0,2021-12-21T13:47:47.449535-06:00,Targeted Molecular Therapy,Residual Disease,
HCM-BROD-0715-C43,4e3d5c85-6a93-4421-8ae6-de4826abdcb5,8c0fc9bf-de6c-4077-80cb-f6937658e453,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0715-C43_treatment2,a07a7c46-d2e2-4f42-8688-828a295b84b4,,released,,0,2021-12-21T13:47:47.449535-06:00,Chemotherapy,Residual Disease,
HCM-BROD-0715-C43,4e3d5c85-6a93-4421-8ae6-de4826abdcb5,9d5facf3-b617-47dd-a609-d34c46d0629e,5105.0,Maintenance Therapy,4192.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0715-C43_treatment8,d3ea573d-689d-48af-9768-a0222d26af00,Stable Disease,released,Nivolumab,1,2021-12-21T13:47:47.449535-06:00,,,
HCM-CSHL-0383-C18,4e727a6a-72b0-447c-9fa4-0f81f0736562,ddbd32c0-b282-4408-8db0-61941c5181cf,,,27.0,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0383-C18_treatment4,02541a26-1564-4a4d-9826-38ee8c5a4148,,released,,1,2020-09-28T09:58:42.545234-05:00,"Surgery, NOS",Initial Diagnosis,
HCM-CSHL-0383-C18,4e727a6a-72b0-447c-9fa4-0f81f0736562,ddbd32c0-b282-4408-8db0-61941c5181cf,63.0,Adjuvant,63.0,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0383-C18_treatment2,0563f7e4-d463-45c2-8eb3-ec54de93121f,,released,Capecitabine,1,2020-09-28T09:58:42.545234-05:00,Chemotherapy,Residual Disease,
HCM-CSHL-0383-C18,4e727a6a-72b0-447c-9fa4-0f81f0736562,ddbd32c0-b282-4408-8db0-61941c5181cf,,Adjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0383-C18_treatment5,35e693f5-b061-4ac2-b54c-155cae694fa8,,released,,0,2020-09-28T09:58:42.545234-05:00,Targeted Molecular Therapy,Residual Disease,
HCM-CSHL-0383-C18,4e727a6a-72b0-447c-9fa4-0f81f0736562,ddbd32c0-b282-4408-8db0-61941c5181cf,,Adjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0383-C18_treatment6,6640d8f1-01dd-4a77-960b-4de6556eba24,,released,,0,2020-09-28T09:58:42.545234-05:00,"Radiation Therapy, NOS",Residual Disease,
HCM-CSHL-0383-C18,4e727a6a-72b0-447c-9fa4-0f81f0736562,ddbd32c0-b282-4408-8db0-61941c5181cf,,Neoadjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0383-C18_treatment,6e484735-2c17-4f92-b222-f53409538731,,released,,0,2020-09-28T09:58:42.545234-05:00,,,
HCM-CSHL-0383-C18,4e727a6a-72b0-447c-9fa4-0f81f0736562,ddbd32c0-b282-4408-8db0-61941c5181cf,,Adjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0383-C18_treatment3,84c1a2e4-7a50-4697-98a6-c5453465a300,,released,,0,2020-09-28T09:58:42.545234-05:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-BROD-0569-C43,4e828c35-5fc3-40af-a2ee-10b4281c77b8,5191a8e6-4ec6-4a84-af18-70d24c53d97d,733.0,Maintenance Therapy,518.0,2021-09-10T10:36:37.981324-05:00,HCM-BROD-0569-C43_treatment8,c8a24f2b-2fa7-4b8a-ada2-1ed29530e625,Treatment Ongoing,released,Nivolumab,1,2021-09-07T12:02:33.564120-05:00,,,
HCM-BROD-0569-C43,4e828c35-5fc3-40af-a2ee-10b4281c77b8,e795772c-a156-49cc-8578-4ba5901f374e,,Neoadjuvant,,2021-03-11T14:53:13.958052-06:00,HCM-BROD-0569-C43_treatment,0f83528e-48e3-4547-9337-2436adce2efd,,released,,0,2021-03-11T14:31:21.933263-06:00,,,
HCM-BROD-0569-C43,4e828c35-5fc3-40af-a2ee-10b4281c77b8,e795772c-a156-49cc-8578-4ba5901f374e,,Adjuvant,,2021-09-10T10:36:37.981324-05:00,HCM-BROD-0569-C43_treatment3,298bbd94-371e-44ba-b06b-e37dc161406b,,released,,0,2021-09-07T12:02:33.564120-05:00,Hormone Therapy,Residual Disease,
HCM-BROD-0569-C43,4e828c35-5fc3-40af-a2ee-10b4281c77b8,e795772c-a156-49cc-8578-4ba5901f374e,892.0,Adjuvant,518.0,2021-09-10T10:36:37.981324-05:00,HCM-BROD-0569-C43_treatment4,5f34e6ed-ca77-46c9-bd65-c94a9e14cb5b,,released,Nivolumab,1,2021-09-07T12:02:33.564120-05:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-BROD-0569-C43,4e828c35-5fc3-40af-a2ee-10b4281c77b8,e795772c-a156-49cc-8578-4ba5901f374e,,,0.0,2023-02-27T12:40:11.295181-06:00,HCM-BROD-0569-C43_treatment5,77640169-c586-476a-82b3-67f055d7d86b,,released,,1,2021-09-07T12:02:33.564120-05:00,"Surgery, NOS",Initial Diagnosis,
HCM-BROD-0569-C43,4e828c35-5fc3-40af-a2ee-10b4281c77b8,e795772c-a156-49cc-8578-4ba5901f374e,,Adjuvant,,2021-09-10T10:36:37.981324-05:00,HCM-BROD-0569-C43_treatment2,da0deb5d-fc8e-4022-9887-f5fea7902309,,released,,0,2021-09-07T12:02:33.564120-05:00,Chemotherapy,Residual Disease,
HCM-BROD-0569-C43,4e828c35-5fc3-40af-a2ee-10b4281c77b8,e795772c-a156-49cc-8578-4ba5901f374e,,Adjuvant,,2021-09-10T10:36:37.981324-05:00,HCM-BROD-0569-C43_treatment7,e12b8693-5e83-48a6-8bb3-4142bb56c7d9,,released,,0,2021-09-07T12:02:33.564120-05:00,"Radiation Therapy, NOS",Residual Disease,
HCM-BROD-0569-C43,4e828c35-5fc3-40af-a2ee-10b4281c77b8,e795772c-a156-49cc-8578-4ba5901f374e,,Adjuvant,,2021-09-10T10:36:37.981324-05:00,HCM-BROD-0569-C43_treatment6,e14dfea8-6f8f-49a5-ae75-36b213545ed5,,released,,0,2021-09-07T12:02:33.564120-05:00,Targeted Molecular Therapy,Residual Disease,
HCM-CSHL-0462-D05,4eea6e7d-a49d-49c5-b849-48665b79548b,c59eada7-59f3-49d5-9b0f-263cd36c621e,,Adjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0462-D05_treatment3,5edd7795-c7dd-4be8-bad8-76812df6cbed,,released,,0,2020-08-31T19:17:26.755105-05:00,"Pharmaceutical Therapy, NOS",Residual Disease,
HCM-CSHL-0462-D05,4eea6e7d-a49d-49c5-b849-48665b79548b,c59eada7-59f3-49d5-9b0f-263cd36c621e,,Adjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0462-D05_treatment4,6600fb28-f9b4-4a3f-8f7e-94d4480ff0f1,,released,,0,2020-08-31T19:17:26.755105-05:00,"Radiation Therapy, NOS",Residual Disease,
HCM-CSHL-0462-D05,4eea6e7d-a49d-49c5-b849-48665b79548b,c59eada7-59f3-49d5-9b0f-263cd36c621e,,,76.0,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0462-D05_treatment2,9b031a7a-a43e-4590-94a8-46e35f01e6a5,,released,,1,2020-08-31T19:17:26.755105-05:00,"Surgery, NOS",Initial Diagnosis,
HCM-CSHL-0462-D05,4eea6e7d-a49d-49c5-b849-48665b79548b,c59eada7-59f3-49d5-9b0f-263cd36c621e,,Neoadjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0462-D05_treatment,ceb15621-a552-48bc-98bd-f8548a6b0447,,released,,0,2020-08-31T19:17:26.755105-05:00,,,
HCM-BROD-0140-C16,4f86f0ad-83af-45fb-8579-16cf09f4de2f,cff61451-d48e-4ef8-ac7a-f376937c8fbf,,Adjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0140-C16_treatment2,0db1273b-572f-4d2f-a7c8-367dad0fe432,,released,,0,2020-04-21T15:04:13.043029-05:00,Chemotherapy,Residual Disease,
HCM-BROD-0140-C16,4f86f0ad-83af-45fb-8579-16cf09f4de2f,cff61451-d48e-4ef8-ac7a-f376937c8fbf,,,,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0140-C16_treatment4,19387388-9c93-42b2-8e68-bfbd7b45824f,,released,,0,2020-04-21T15:04:13.043029-05:00,"Surgery, NOS",Initial Diagnosis,
HCM-BROD-0140-C16,4f86f0ad-83af-45fb-8579-16cf09f4de2f,cff61451-d48e-4ef8-ac7a-f376937c8fbf,,Neoadjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0140-C16_treatment,92479cc9-dad2-42b7-8206-14a2fd3db8e2,,released,,0,2019-04-04T15:43:03.494155-05:00,,,
HCM-BROD-0140-C16,4f86f0ad-83af-45fb-8579-16cf09f4de2f,cff61451-d48e-4ef8-ac7a-f376937c8fbf,,Adjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0140-C16_treatment6,9c976371-7290-48bf-9075-52efd55e56ad,,released,,0,2020-04-21T15:04:13.043029-05:00,"Radiation Therapy, NOS",Residual Disease,
HCM-BROD-0140-C16,4f86f0ad-83af-45fb-8579-16cf09f4de2f,cff61451-d48e-4ef8-ac7a-f376937c8fbf,,Adjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0140-C16_treatment5,a4ea2447-7233-4755-9ed1-4beddefbe1f4,,released,,0,2020-04-21T15:04:13.043029-05:00,Targeted Molecular Therapy,Residual Disease,
HCM-BROD-0140-C16,4f86f0ad-83af-45fb-8579-16cf09f4de2f,cff61451-d48e-4ef8-ac7a-f376937c8fbf,,Adjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0140-C16_treatment3,c4846b89-4298-4f4e-97bb-6d02a2b5076e,,released,,0,2020-04-21T15:04:13.043029-05:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-CSHL-0189-C25,4fc3862d-16a0-459b-a0b4-7f9edd6dd087,a4c314cb-2f3e-4fd2-b551-27c8c5d97d1a,,Adjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0189-C25_treatment4,79c75275-cedf-4b8b-94d5-5cd5631adf75,,released,,0,2020-09-28T12:59:20.372901-05:00,"Radiation Therapy, NOS",Residual Disease,
HCM-CSHL-0189-C25,4fc3862d-16a0-459b-a0b4-7f9edd6dd087,a4c314cb-2f3e-4fd2-b551-27c8c5d97d1a,,Neoadjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0189-C25_treatment,7e554bf4-12d8-4062-bf2e-ee4bb4b99b66,,released,,0,2020-09-28T12:59:20.372901-05:00,,,
HCM-CSHL-0189-C25,4fc3862d-16a0-459b-a0b4-7f9edd6dd087,a4c314cb-2f3e-4fd2-b551-27c8c5d97d1a,,,-4.0,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0189-C25_treatment2,cf95a17d-faa0-4e22-9c1f-4ede112c98bc,,released,,1,2020-09-28T12:59:20.372901-05:00,"Surgery, NOS",Initial Diagnosis,
HCM-CSHL-0189-C25,4fc3862d-16a0-459b-a0b4-7f9edd6dd087,a4c314cb-2f3e-4fd2-b551-27c8c5d97d1a,,Adjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0189-C25_treatment3,feae9685-85a4-419f-8372-78255292d046,,released,,0,2020-09-28T12:59:20.372901-05:00,"Pharmaceutical Therapy, NOS",Residual Disease,
HCM-SANG-1085-C20,50854c28-2457-4b22-98a9-50d4b7c66701,a0657433-5e14-442d-b0f6-ed42542a13de,,Neoadjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-SANG-1085-C20_treatment2,0e7fde1f-d0ca-450b-8de5-b3df4609522f,,released,Oxaliplatin,1,2023-02-27T12:09:53.209916-06:00,Chemotherapy,,
HCM-SANG-1085-C20,50854c28-2457-4b22-98a9-50d4b7c66701,a0657433-5e14-442d-b0f6-ed42542a13de,,Neoadjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-SANG-1085-C20_treatment3,85521275-b4fa-45f7-9850-44551027212d,,released,,1,2023-02-27T12:09:53.209916-06:00,"Radiation, 2D Conventional",,
HCM-SANG-1085-C20,50854c28-2457-4b22-98a9-50d4b7c66701,a0657433-5e14-442d-b0f6-ed42542a13de,,Neoadjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-SANG-1085-C20_treatment,f62f7029-1b92-4b13-a5c1-849791213561,,released,Capecitabine,1,2023-02-27T12:09:53.209916-06:00,Chemotherapy,,
HCM-BROD-0762-C49,509a9942-11da-479b-b38a-2ca2a30b5134,0421d309-7e63-446d-b8a8-5f4f4d9cff58,313.0,Adjuvant,1.0,2023-07-13T10:27:19.665852-05:00,HCM-BROD-0762-C49_treatment4,08acad03-1917-4ce3-af05-d530bd312e41,,released,Vinblastine,1,2021-12-21T13:50:53.446920-06:00,Chemotherapy,Residual Disease,
HCM-BROD-0762-C49,509a9942-11da-479b-b38a-2ca2a30b5134,0421d309-7e63-446d-b8a8-5f4f4d9cff58,313.0,Adjuvant,1.0,2023-07-13T10:27:19.665852-05:00,HCM-BROD-0762-C49_treatment3,1c5dfe0f-f80e-412f-a75d-027bdd8e0c1d,,released,Methotrexate,1,2021-12-21T13:50:53.446920-06:00,Chemotherapy,Residual Disease,
HCM-BROD-0762-C49,509a9942-11da-479b-b38a-2ca2a30b5134,0421d309-7e63-446d-b8a8-5f4f4d9cff58,,Neoadjuvant,183.0,2023-07-13T10:27:19.665852-05:00,HCM-BROD-0762-C49_treatment2,324888f3-4129-4ae8-9f2c-0adda184e648,,released,Vinblastine,1,2021-12-21T13:50:53.446920-06:00,Chemotherapy,,
HCM-BROD-0762-C49,509a9942-11da-479b-b38a-2ca2a30b5134,0421d309-7e63-446d-b8a8-5f4f4d9cff58,,Adjuvant,,2023-07-13T10:27:19.665852-05:00,HCM-BROD-0762-C49_treatment9,4bca5a08-a55c-4ef5-97d1-4b3d30c31033,,released,,0,2021-12-21T13:50:53.446920-06:00,"Radiation Therapy, NOS",Residual Disease,
HCM-BROD-0762-C49,509a9942-11da-479b-b38a-2ca2a30b5134,0421d309-7e63-446d-b8a8-5f4f4d9cff58,,,5.0,2023-07-13T10:27:19.665852-05:00,HCM-BROD-0762-C49_treatment7,a23b5c70-b924-4fbc-af8f-5c401ad02f4a,,released,,1,2021-12-21T13:50:53.446920-06:00,"Surgery, NOS",Initial Diagnosis,
HCM-BROD-0762-C49,509a9942-11da-479b-b38a-2ca2a30b5134,0421d309-7e63-446d-b8a8-5f4f4d9cff58,,Adjuvant,,2023-07-13T10:27:19.665852-05:00,HCM-BROD-0762-C49_treatment8,b6a92e7f-f7a8-469c-8781-1a786cbad73b,,released,,0,2021-12-21T13:50:53.446920-06:00,Targeted Molecular Therapy,Residual Disease,
HCM-BROD-0762-C49,509a9942-11da-479b-b38a-2ca2a30b5134,0421d309-7e63-446d-b8a8-5f4f4d9cff58,,Neoadjuvant,183.0,2023-07-13T10:27:19.665852-05:00,HCM-BROD-0762-C49_treatment,c09826f3-a5ea-45c6-989d-090e8dcde3be,,released,Methotrexate,1,2021-12-21T13:50:53.446920-06:00,Chemotherapy,,
HCM-BROD-0762-C49,509a9942-11da-479b-b38a-2ca2a30b5134,0421d309-7e63-446d-b8a8-5f4f4d9cff58,,Adjuvant,,2023-07-13T10:27:19.665852-05:00,HCM-BROD-0762-C49_treatment5,cd9d5350-b622-41e7-aa3f-c3b7fcd95313,,released,,0,2021-12-21T13:50:53.446920-06:00,Hormone Therapy,Residual Disease,
HCM-BROD-0762-C49,509a9942-11da-479b-b38a-2ca2a30b5134,0421d309-7e63-446d-b8a8-5f4f4d9cff58,,Adjuvant,,2023-07-13T10:27:19.665852-05:00,HCM-BROD-0762-C49_treatment6,fad621b7-2b63-467f-bfa1-6bb3c0ea74aa,,released,,0,2021-12-21T13:50:53.446920-06:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-CSHL-0800-C67,50d40aee-8e5d-4094-81e3-46c1bcb85abf,dcfdb561-ac74-4793-95fc-e73dee5b0061,76.0,Adjuvant,27.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0800-C67_treatment2,068d43b7-bf20-4794-8652-ac4936ea04c7,,released,Carboplatin,1,2021-12-21T14:23:50.850864-06:00,Chemotherapy,Residual Disease,
HCM-CSHL-0800-C67,50d40aee-8e5d-4094-81e3-46c1bcb85abf,dcfdb561-ac74-4793-95fc-e73dee5b0061,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0800-C67_treatment4,0bfb2660-adbc-4064-81e5-0f1ddf2ea89b,,released,,0,2021-12-21T14:23:50.850864-06:00,Hormone Therapy,Residual Disease,
HCM-CSHL-0800-C67,50d40aee-8e5d-4094-81e3-46c1bcb85abf,dcfdb561-ac74-4793-95fc-e73dee5b0061,,,0.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0800-C67_treatment6,0d1af18c-f3ad-4340-8292-bad014eba81a,,released,,1,2021-12-21T14:23:50.850864-06:00,"Surgery, NOS",Initial Diagnosis,
HCM-CSHL-0800-C67,50d40aee-8e5d-4094-81e3-46c1bcb85abf,dcfdb561-ac74-4793-95fc-e73dee5b0061,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0800-C67_treatment5,84a8c019-d8b8-463b-9447-0eb19252e9db,,released,,0,2021-12-21T14:23:50.850864-06:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-CSHL-0800-C67,50d40aee-8e5d-4094-81e3-46c1bcb85abf,dcfdb561-ac74-4793-95fc-e73dee5b0061,,Neoadjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0800-C67_treatment,d3f0c13e-e143-4a86-b7d4-a221227240b7,,released,,0,2021-12-21T14:23:50.850864-06:00,,,
HCM-CSHL-0800-C67,50d40aee-8e5d-4094-81e3-46c1bcb85abf,dcfdb561-ac74-4793-95fc-e73dee5b0061,76.0,Adjuvant,27.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0800-C67_treatment3,e29737d4-6321-4fde-877b-1693173f53be,,released,Gemcitabine,1,2021-12-21T14:23:50.850864-06:00,Chemotherapy,Residual Disease,
HCM-CSHL-0800-C67,50d40aee-8e5d-4094-81e3-46c1bcb85abf,dcfdb561-ac74-4793-95fc-e73dee5b0061,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0800-C67_treatment7,f04bf1e2-724c-4dc5-a43f-da8a1f9f4721,,released,,0,2021-12-21T14:23:50.850864-06:00,Targeted Molecular Therapy,Residual Disease,
HCM-CSHL-0800-C67,50d40aee-8e5d-4094-81e3-46c1bcb85abf,dcfdb561-ac74-4793-95fc-e73dee5b0061,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0800-C67_treatment8,f0636ca8-eb72-4438-87c3-e4c02523eca2,,released,,0,2021-12-21T14:23:50.850864-06:00,"Radiation Therapy, NOS",Residual Disease,
HCM-BROD-0685-C71,50d99ee7-b965-4211-9a4e-b857f4775208,9008c037-11a2-45db-bf92-099853808c23,480.0,Adjuvant,453.0,2023-02-22T07:39:25.979291-06:00,HCM-BROD-0685-C71_treatment3,59e8b741-af79-460a-a4ba-2438276f8528,,released,Temozolomide,1,2021-12-21T13:45:22.009055-06:00,Chemotherapy,Residual Disease,
HCM-BROD-0685-C71,50d99ee7-b965-4211-9a4e-b857f4775208,9008c037-11a2-45db-bf92-099853808c23,,Neoadjuvant,,2023-02-22T07:39:25.979291-06:00,HCM-BROD-0685-C71_treatment,60f9ee7a-35fa-4463-9891-031388c379bf,,released,,0,2021-12-21T13:45:22.009055-06:00,,,
HCM-BROD-0685-C71,50d99ee7-b965-4211-9a4e-b857f4775208,9008c037-11a2-45db-bf92-099853808c23,,Adjuvant,,2023-02-22T07:39:25.979291-06:00,HCM-BROD-0685-C71_treatment4,6ef815c4-3b30-4875-9c94-d6f03a011d54,,released,,0,2021-12-21T13:45:22.009055-06:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-BROD-0685-C71,50d99ee7-b965-4211-9a4e-b857f4775208,9008c037-11a2-45db-bf92-099853808c23,62.0,Adjuvant,20.0,2023-02-22T07:39:25.979291-06:00,HCM-BROD-0685-C71_treatment7,804142c1-a5a1-46a7-89da-5bbf348890ba,,released,,1,2021-12-21T13:45:22.009055-06:00,"Radiation Therapy, NOS",Residual Disease,
HCM-BROD-0685-C71,50d99ee7-b965-4211-9a4e-b857f4775208,9008c037-11a2-45db-bf92-099853808c23,,,0.0,2023-02-27T13:11:15.714825-06:00,HCM-BROD-0685-C71_treatment5,923cf6d2-4a07-431c-a5ba-3651a00d9d25,,released,,1,2021-12-21T13:45:22.009055-06:00,"Surgery, NOS",Initial Diagnosis,
HCM-BROD-0685-C71,50d99ee7-b965-4211-9a4e-b857f4775208,9008c037-11a2-45db-bf92-099853808c23,600.0,Adjuvant,579.0,2023-02-22T07:39:25.979291-06:00,HCM-BROD-0685-C71_treatment6,9f117353-5aff-41d6-81cb-05344b00f4cf,,released,Bevacizumab,1,2021-12-21T13:45:22.009055-06:00,Targeted Molecular Therapy,Residual Disease,
HCM-BROD-0685-C71,50d99ee7-b965-4211-9a4e-b857f4775208,9008c037-11a2-45db-bf92-099853808c23,260.0,Adjuvant,20.0,2023-02-22T07:39:25.979291-06:00,HCM-BROD-0685-C71_treatment2,a1648d86-d045-46ac-a425-2a95f242129a,,released,Temozolomide,1,2021-12-21T13:45:22.009055-06:00,Chemotherapy,Residual Disease,
HCM-BROD-1119-C43,511b885f-5e6d-4d7c-a08a-8dda5d042b4e,c9d7280a-54b6-4bba-890c-dcf954f3d572,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-BROD-1119-C43_treatment4,1691c872-e1c4-4742-8904-6f9c86b90a8d,,released,,0,2021-12-21T14:01:05.755510-06:00,"Radiation Therapy, NOS",Residual Disease,
HCM-BROD-1119-C43,511b885f-5e6d-4d7c-a08a-8dda5d042b4e,c9d7280a-54b6-4bba-890c-dcf954f3d572,,,0.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-1119-C43_treatment2,333b8c0a-eea9-49fc-9a7c-bb5e8a9d55b8,,released,,1,2021-12-21T14:01:05.755510-06:00,"Surgery, NOS",Initial Diagnosis,
HCM-BROD-1119-C43,511b885f-5e6d-4d7c-a08a-8dda5d042b4e,c9d7280a-54b6-4bba-890c-dcf954f3d572,,Neoadjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-BROD-1119-C43_treatment,8b8898ec-ba99-4552-9149-474a54b95213,,released,,0,2021-12-21T14:01:05.755510-06:00,,,
HCM-BROD-1119-C43,511b885f-5e6d-4d7c-a08a-8dda5d042b4e,c9d7280a-54b6-4bba-890c-dcf954f3d572,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-BROD-1119-C43_treatment3,ad4f5b3e-25cb-443d-886b-d999b654d5ae,,released,,0,2021-12-21T14:01:05.755510-06:00,"Pharmaceutical Therapy, NOS",Residual Disease,
HCM-BROD-1119-C43,511b885f-5e6d-4d7c-a08a-8dda5d042b4e,e2ef59e0-3a6e-4dfb-8b05-334038b17625,1633.0,Maintenance Therapy,1403.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-1119-C43_treatment5,ac7d71b5-ecdb-4178-8868-0e54b4ff7442,Complete Response,released,Unknown,1,2023-02-28T13:43:31.801497-06:00,,,
HCM-BROD-0196-C71,51b83c83-b639-424b-a023-fd5fe7c2f4b5,dbd3dfca-2deb-4ae0-abd7-1a49c5d92d2d,78.0,Adjuvant,36.0,2021-01-06T22:55:10.531130-06:00,HCM-BROD-0196-C71_treatment2,1d521697-fef3-491e-be88-a0a7c9a25cf9,,released,Temozolomide,1,2020-02-27T12:33:21.669786-06:00,Chemotherapy,Residual Disease,
HCM-BROD-0196-C71,51b83c83-b639-424b-a023-fd5fe7c2f4b5,dbd3dfca-2deb-4ae0-abd7-1a49c5d92d2d,,Adjuvant,,2021-01-06T22:55:10.531130-06:00,HCM-BROD-0196-C71_treatment6,24d77377-3f7f-440f-8de4-1581a00cca57,,released,,0,2020-02-27T12:33:21.669786-06:00,Targeted Molecular Therapy,Residual Disease,
HCM-BROD-0196-C71,51b83c83-b639-424b-a023-fd5fe7c2f4b5,dbd3dfca-2deb-4ae0-abd7-1a49c5d92d2d,,Adjuvant,,2021-01-06T22:55:10.531130-06:00,HCM-BROD-0196-C71_treatment4,2e19f73d-2fa2-4980-9b83-54a5fac6eae0,,released,,0,2020-02-27T12:33:21.669786-06:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-BROD-0196-C71,51b83c83-b639-424b-a023-fd5fe7c2f4b5,dbd3dfca-2deb-4ae0-abd7-1a49c5d92d2d,,Neoadjuvant,,2021-01-06T22:55:10.531130-06:00,HCM-BROD-0196-C71_treatment,4f2aef9b-b10e-4aaf-b587-3e3eb2ade75a,,released,,0,2019-04-04T14:54:33.197276-05:00,,,
HCM-BROD-0196-C71,51b83c83-b639-424b-a023-fd5fe7c2f4b5,dbd3dfca-2deb-4ae0-abd7-1a49c5d92d2d,246.0,Adjuvant,93.0,2021-01-06T22:55:10.531130-06:00,HCM-BROD-0196-C71_treatment3,618800b5-25ea-4eac-9e57-5aab47f64c6d,,released,Temozolomide,1,2020-02-27T12:33:21.669786-06:00,Chemotherapy,Residual Disease,
HCM-BROD-0196-C71,51b83c83-b639-424b-a023-fd5fe7c2f4b5,dbd3dfca-2deb-4ae0-abd7-1a49c5d92d2d,,,-6.0,2023-02-27T12:55:17.047225-06:00,HCM-BROD-0196-C71_treatment5,7ac9291d-27f6-43a6-8921-934d1132781e,,released,,1,2020-02-27T12:33:21.669786-06:00,"Surgery, NOS",Initial Diagnosis,
HCM-BROD-0196-C71,51b83c83-b639-424b-a023-fd5fe7c2f4b5,dbd3dfca-2deb-4ae0-abd7-1a49c5d92d2d,78.0,Adjuvant,36.0,2021-01-06T22:55:10.531130-06:00,HCM-BROD-0196-C71_treatment7,e644ee0b-5202-46ae-b22f-6481ffef6508,,released,,1,2020-02-27T12:33:21.669786-06:00,"Radiation Therapy, NOS",Residual Disease,
HCM-BROD-0230-C25,53159c56-0604-455c-8efc-db9cdaa7642c,f4801c96-ff19-45d2-9e9d-b43a05702c6a,708.0,Adjuvant,673.0,2023-07-13T10:35:44.371881-05:00,HCM-BROD-0230-C25_treatment7,185882c5-740b-4c9b-9d5c-223fc6cf759e,,released,Unknown,1,2020-09-17T16:07:29.990615-05:00,Targeted Molecular Therapy,Residual Disease,
HCM-BROD-0230-C25,53159c56-0604-455c-8efc-db9cdaa7642c,f4801c96-ff19-45d2-9e9d-b43a05702c6a,,,,2023-07-13T10:35:44.371881-05:00,HCM-BROD-0230-C25_treatment6,1b0c1c64-26d3-47d1-960d-6665f40c12eb,,released,,0,2020-09-17T16:07:29.990615-05:00,"Surgery, NOS",Initial Diagnosis,
HCM-BROD-0230-C25,53159c56-0604-455c-8efc-db9cdaa7642c,f4801c96-ff19-45d2-9e9d-b43a05702c6a,,Neoadjuvant,586.0,2023-07-13T10:35:44.371881-05:00,HCM-BROD-0230-C25_treatment2,34dc5b27-c66e-403e-9263-3be5fc30d612,,released,Nab-paclitaxel,1,2020-09-17T16:07:29.990615-05:00,Chemotherapy,,
HCM-BROD-0230-C25,53159c56-0604-455c-8efc-db9cdaa7642c,f4801c96-ff19-45d2-9e9d-b43a05702c6a,,Neoadjuvant,,2023-07-13T10:35:44.371881-05:00,HCM-BROD-0230-C25_treatment3,478ae97e-f322-4455-b028-192ac280ad27,,released,,1,2020-09-17T16:07:29.990615-05:00,Targeted Molecular Therapy,,
HCM-BROD-0230-C25,53159c56-0604-455c-8efc-db9cdaa7642c,f4801c96-ff19-45d2-9e9d-b43a05702c6a,,Adjuvant,,2023-07-13T10:35:44.371881-05:00,HCM-BROD-0230-C25_treatment5,50005c75-2f5c-4876-8ff8-23a741ec4c98,,released,,0,2020-09-17T16:07:29.990615-05:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-BROD-0230-C25,53159c56-0604-455c-8efc-db9cdaa7642c,f4801c96-ff19-45d2-9e9d-b43a05702c6a,,Neoadjuvant,586.0,2023-07-13T10:35:44.371881-05:00,HCM-BROD-0230-C25_treatment,823c8e55-eef4-4a6b-93b1-15f052af17d8,,released,Gemcitabine,1,2020-09-17T16:07:29.990615-05:00,Chemotherapy,,
HCM-BROD-0230-C25,53159c56-0604-455c-8efc-db9cdaa7642c,f4801c96-ff19-45d2-9e9d-b43a05702c6a,,Adjuvant,,2023-07-13T10:35:44.371881-05:00,HCM-BROD-0230-C25_treatment4,b00766be-b9c2-42a5-a3da-42b6fdfbb473,,released,,0,2020-09-17T16:07:29.990615-05:00,Chemotherapy,Residual Disease,
HCM-BROD-0230-C25,53159c56-0604-455c-8efc-db9cdaa7642c,f4801c96-ff19-45d2-9e9d-b43a05702c6a,,Adjuvant,,2023-07-13T10:35:44.371881-05:00,HCM-BROD-0230-C25_treatment8,d849e4d7-32be-40af-9107-c4aee0a4c8ce,,released,,0,2020-09-17T16:07:29.990615-05:00,"Radiation Therapy, NOS",Residual Disease,
HCM-CSHL-0181-C25,5426912c-da56-46dd-b00c-dedb7d5c89cc,131ddc91-4d80-47a0-9bc4-993c8632c635,,Adjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0181-C25_treatment4,03ef0680-850e-40fc-a3e5-2157efae53a5,,released,,0,2020-09-28T09:14:25.343113-05:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-CSHL-0181-C25,5426912c-da56-46dd-b00c-dedb7d5c89cc,131ddc91-4d80-47a0-9bc4-993c8632c635,112.0,Adjuvant,69.0,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0181-C25_treatment2,341c3d34-fe62-4b6b-b5cf-b7f354b36a5e,,released,Gemcitabine,1,2020-09-28T09:14:25.343113-05:00,Chemotherapy,Residual Disease,
HCM-CSHL-0181-C25,5426912c-da56-46dd-b00c-dedb7d5c89cc,131ddc91-4d80-47a0-9bc4-993c8632c635,174.0,Adjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0181-C25_treatment7,4915e13f-045d-44bb-a180-43622f8f4147,,released,,1,2020-09-28T09:14:25.343113-05:00,"Radiation, 2D Conventional",Residual Disease,
HCM-CSHL-0181-C25,5426912c-da56-46dd-b00c-dedb7d5c89cc,131ddc91-4d80-47a0-9bc4-993c8632c635,,Adjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0181-C25_treatment6,4a3fa713-b8a5-4632-bf3a-ad4e3e74c670,,released,,0,2020-09-28T09:14:25.343113-05:00,Targeted Molecular Therapy,Residual Disease,
HCM-CSHL-0181-C25,5426912c-da56-46dd-b00c-dedb7d5c89cc,131ddc91-4d80-47a0-9bc4-993c8632c635,,Neoadjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0181-C25_treatment,73e60edd-5a0b-4108-9d28-06e0fa8da8a5,,released,,0,2020-09-28T09:14:25.343113-05:00,,,
HCM-CSHL-0181-C25,5426912c-da56-46dd-b00c-dedb7d5c89cc,131ddc91-4d80-47a0-9bc4-993c8632c635,112.0,Adjuvant,69.0,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0181-C25_treatment3,7a9ab0a5-6f6e-4d26-b213-a7f2698e1b67,,released,Nab-paclitaxel,1,2020-09-28T09:14:25.343113-05:00,Chemotherapy,Residual Disease,
HCM-CSHL-0181-C25,5426912c-da56-46dd-b00c-dedb7d5c89cc,131ddc91-4d80-47a0-9bc4-993c8632c635,,,-11.0,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0181-C25_treatment5,8a8d4b38-30d5-4d98-8440-63ce08e215fb,,released,,1,2020-09-28T09:14:25.343113-05:00,"Surgery, NOS",Initial Diagnosis,
HCM-SANG-0267-D12,54722e41-2feb-4c8a-b29f-3780da916e49,10303cf9-f830-48d5-8f92-d77467d461fe,,Neoadjuvant,,2023-02-22T07:39:25.979291-06:00,HCM-SANG-0267-D12_treatment,5943b9ec-46b6-4919-b834-3258b30dcd92,,released,,0,2020-02-27T12:19:29.618761-06:00,,,
HCM-WCMC-1074-C56,5538445e-03c2-4466-a09a-83d5a527b26e,b2ee880b-b20c-443b-9e73-1300c21840cf,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-WCMC-1074-C56_treatment4,24312c9f-cd1b-49fc-ba65-11eb9b3c3854,,released,,0,2022-07-14T11:05:36.215897-05:00,"Radiation Therapy, NOS",Residual Disease,
HCM-WCMC-1074-C56,5538445e-03c2-4466-a09a-83d5a527b26e,b2ee880b-b20c-443b-9e73-1300c21840cf,,Neoadjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-WCMC-1074-C56_treatment,29c7170c-64fe-43bc-8119-b5ee6b53d806,,released,,0,2022-07-14T11:05:36.215897-05:00,,,
HCM-WCMC-1074-C56,5538445e-03c2-4466-a09a-83d5a527b26e,b2ee880b-b20c-443b-9e73-1300c21840cf,,,0.0,2025-04-07T17:13:09.336794-05:00,HCM-WCMC-1074-C56_treatment2,2dfa0f29-36fa-443c-9394-6f5a7db2ec23,,released,,1,2022-07-14T11:05:36.215897-05:00,"Surgery, NOS",Initial Diagnosis,
HCM-WCMC-1074-C56,5538445e-03c2-4466-a09a-83d5a527b26e,b2ee880b-b20c-443b-9e73-1300c21840cf,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-WCMC-1074-C56_treatment3,8e0f40a5-3c80-4806-8381-267d8dfaaa48,,released,,0,2022-07-14T11:05:36.215897-05:00,"Pharmaceutical Therapy, NOS",Residual Disease,
HCM-CSHL-0861-C25,561a4c46-ca78-444f-8346-c30daa041d27,3a277df3-fcf7-4b58-a1b6-a814dbb19f32,,Adjuvant,45.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0861-C25_treatment2,0c206897-bcf5-45f4-934a-c8ce5ba36ff0,,released,Gemcitabine,1,2021-12-21T14:36:01.031311-06:00,Chemotherapy,Residual Disease,
HCM-CSHL-0861-C25,561a4c46-ca78-444f-8346-c30daa041d27,3a277df3-fcf7-4b58-a1b6-a814dbb19f32,,Neoadjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0861-C25_treatment,15e9ec58-caee-4cde-95c5-bef565074f06,,released,,0,2021-12-21T14:36:01.031311-06:00,,,
HCM-CSHL-0861-C25,561a4c46-ca78-444f-8346-c30daa041d27,3a277df3-fcf7-4b58-a1b6-a814dbb19f32,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0861-C25_treatment3,18f97627-7375-4f74-816e-2d28682e37e5,,released,,0,2021-12-21T14:36:01.031311-06:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-CSHL-0861-C25,561a4c46-ca78-444f-8346-c30daa041d27,3a277df3-fcf7-4b58-a1b6-a814dbb19f32,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0861-C25_treatment6,481bb7b7-bb2b-436f-a8a4-f85dd4630a4d,,released,,0,2021-12-21T14:36:01.031311-06:00,"Radiation Therapy, NOS",Residual Disease,
HCM-CSHL-0861-C25,561a4c46-ca78-444f-8346-c30daa041d27,3a277df3-fcf7-4b58-a1b6-a814dbb19f32,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0861-C25_treatment5,d2a7fff3-feb9-4695-b18c-153a85e0168a,,released,,0,2021-12-21T14:36:01.031311-06:00,Targeted Molecular Therapy,Residual Disease,
HCM-CSHL-0861-C25,561a4c46-ca78-444f-8346-c30daa041d27,3a277df3-fcf7-4b58-a1b6-a814dbb19f32,,,-6.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0861-C25_treatment4,d60372a6-19af-4e51-a45e-b799dd8fdb52,,released,,1,2021-12-21T14:36:01.031311-06:00,"Surgery, NOS",Initial Diagnosis,
HCM-BROD-0027-C34,56c07b06-c6d3-4c03-9e57-7be636e7cc5c,b8698977-9702-4a4c-96b7-55db868e6c71,252.0,Adjuvant,246.0,2020-01-13T20:10:25.832065-06:00,HCM-BROD-0027-C34_treatment6,26b53016-2c58-4e39-8885-6a24c240feda,,released,,1,2019-04-04T15:11:28.695214-05:00,Stereotactic Radiosurgery,Residual Disease,
HCM-BROD-0027-C34,56c07b06-c6d3-4c03-9e57-7be636e7cc5c,b8698977-9702-4a4c-96b7-55db868e6c71,,Neoadjuvant,,2020-01-13T20:10:25.832065-06:00,HCM-BROD-0027-C34_treatment,4b918f22-a15a-4f24-b962-418839960e93,,released,,0,2019-04-04T15:11:28.695214-05:00,,,
HCM-BROD-0027-C34,56c07b06-c6d3-4c03-9e57-7be636e7cc5c,b8698977-9702-4a4c-96b7-55db868e6c71,,,,2023-02-27T12:43:03.593510-06:00,HCM-BROD-0027-C34_treatment4,97bd8233-822b-448f-89c5-30a6d9c9e1da,,released,,0,2019-04-04T15:11:28.695214-05:00,"Surgery, NOS",Initial Diagnosis,
HCM-BROD-0027-C34,56c07b06-c6d3-4c03-9e57-7be636e7cc5c,b8698977-9702-4a4c-96b7-55db868e6c71,,Adjuvant,,2020-01-13T20:10:25.832065-06:00,HCM-BROD-0027-C34_treatment2,9b8dca2c-0e17-4476-9ef3-fd1a13db4025,,released,,0,2019-04-04T15:11:28.695214-05:00,Chemotherapy,Residual Disease,
HCM-BROD-0027-C34,56c07b06-c6d3-4c03-9e57-7be636e7cc5c,b8698977-9702-4a4c-96b7-55db868e6c71,1065.0,Adjuvant,1022.0,2020-01-13T20:10:25.832065-06:00,HCM-BROD-0027-C34_treatment3,a5cd0216-04ef-4131-b328-0393170b70b2,Treatment Ongoing,released,Pembrolizumab,1,2019-04-04T15:11:28.695214-05:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-BROD-0027-C34,56c07b06-c6d3-4c03-9e57-7be636e7cc5c,b8698977-9702-4a4c-96b7-55db868e6c71,,Adjuvant,,2020-01-13T20:10:25.832065-06:00,HCM-BROD-0027-C34_treatment5,fd1432df-aa0a-49d6-87c5-a334fe668eab,,released,,0,2019-04-04T15:11:28.695214-05:00,Targeted Molecular Therapy,Residual Disease,
HCM-CSHL-0174-C22,5739bcf8-92f0-406a-b4ee-45b6b989bdb5,26f98bcf-809b-43cd-bd77-3cfa80cdb4de,,Adjuvant,,2020-10-20T19:20:06.800740-05:00,HCM-CSHL-0174-C22_treatment5,0cbdb89a-7f47-4803-b7e8-337da02832bb,,released,,0,2020-09-28T09:12:25.398710-05:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-CSHL-0174-C22,5739bcf8-92f0-406a-b4ee-45b6b989bdb5,26f98bcf-809b-43cd-bd77-3cfa80cdb4de,,Neoadjuvant,,2020-10-20T19:20:06.800740-05:00,HCM-CSHL-0174-C22_treatment,31210c89-11db-4f98-b707-ef96abae4228,,released,,0,2020-09-28T09:12:25.398710-05:00,,,
HCM-CSHL-0174-C22,5739bcf8-92f0-406a-b4ee-45b6b989bdb5,26f98bcf-809b-43cd-bd77-3cfa80cdb4de,169.0,Adjuvant,41.0,2020-10-20T19:20:06.800740-05:00,HCM-CSHL-0174-C22_treatment2,5281a679-4d72-41ad-ab8f-46884dc6b50e,,released,Gemcitabine,1,2020-09-28T09:12:25.398710-05:00,Chemotherapy,Residual Disease,
HCM-CSHL-0174-C22,5739bcf8-92f0-406a-b4ee-45b6b989bdb5,26f98bcf-809b-43cd-bd77-3cfa80cdb4de,,Adjuvant,,2020-10-20T19:20:06.800740-05:00,HCM-CSHL-0174-C22_treatment4,8ba63422-208e-4692-93b2-ca54cdf64e9a,,released,,0,2020-09-28T09:12:25.398710-05:00,Hormone Therapy,Residual Disease,
HCM-CSHL-0174-C22,5739bcf8-92f0-406a-b4ee-45b6b989bdb5,26f98bcf-809b-43cd-bd77-3cfa80cdb4de,,,-34.0,2023-02-24T15:07:45.741368-06:00,HCM-CSHL-0174-C22_treatment6,90724f64-01c4-4b3b-b439-7a8992693a2e,,released,,1,2020-09-28T09:12:25.398710-05:00,"Surgery, NOS",Initial Diagnosis,
HCM-CSHL-0174-C22,5739bcf8-92f0-406a-b4ee-45b6b989bdb5,26f98bcf-809b-43cd-bd77-3cfa80cdb4de,,Adjuvant,,2020-10-20T19:20:06.800740-05:00,HCM-CSHL-0174-C22_treatment7,aa4dd8fd-f27c-4292-8d19-b48d9463314d,,released,,0,2020-09-28T09:12:25.398710-05:00,Targeted Molecular Therapy,Residual Disease,
HCM-CSHL-0174-C22,5739bcf8-92f0-406a-b4ee-45b6b989bdb5,26f98bcf-809b-43cd-bd77-3cfa80cdb4de,,Adjuvant,,2020-10-20T19:20:06.800740-05:00,HCM-CSHL-0174-C22_treatment8,da2d7b0b-2992-472e-8cdf-43d1aa6efa46,,released,,0,2020-09-28T09:12:25.398710-05:00,"Radiation Therapy, NOS",Residual Disease,
HCM-CSHL-0174-C22,5739bcf8-92f0-406a-b4ee-45b6b989bdb5,26f98bcf-809b-43cd-bd77-3cfa80cdb4de,274.0,Adjuvant,190.0,2020-10-20T19:20:06.800740-05:00,HCM-CSHL-0174-C22_treatment3,e00ccf54-93eb-4c0f-9a8e-541e923211ef,,released,Oxaliplatin,1,2020-09-28T09:12:25.398710-05:00,Chemotherapy,Residual Disease,
HCM-BROD-0791-C43,575844b7-cfa1-406a-b0dd-d55cf9fff978,1b8eabc7-922b-469e-a712-99965d780ea1,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0791-C43_treatment3,0565f23f-8ca5-4fe5-851a-286ff87d1746,,released,,0,2021-12-21T13:53:28.705789-06:00,Hormone Therapy,Residual Disease,
HCM-BROD-0791-C43,575844b7-cfa1-406a-b0dd-d55cf9fff978,1b8eabc7-922b-469e-a712-99965d780ea1,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0791-C43_treatment2,25a33a38-07c5-4a68-923f-4a25b6575d7c,,released,,0,2021-12-21T13:53:28.705789-06:00,Chemotherapy,Residual Disease,
HCM-BROD-0791-C43,575844b7-cfa1-406a-b0dd-d55cf9fff978,1b8eabc7-922b-469e-a712-99965d780ea1,,Neoadjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0791-C43_treatment,39ece580-fe35-44a2-881e-722d39dd355c,,released,,0,2021-12-21T13:53:28.705789-06:00,,,
HCM-BROD-0791-C43,575844b7-cfa1-406a-b0dd-d55cf9fff978,1b8eabc7-922b-469e-a712-99965d780ea1,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0791-C43_treatment7,783a821c-5d37-47fa-97f4-f8229c4582fc,,released,,0,2021-12-21T13:53:28.705789-06:00,"Radiation Therapy, NOS",Residual Disease,
HCM-BROD-0791-C43,575844b7-cfa1-406a-b0dd-d55cf9fff978,1b8eabc7-922b-469e-a712-99965d780ea1,,,196.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0791-C43_treatment5,c719261e-c01e-4941-87fb-6018d14503aa,,released,,1,2021-12-21T13:53:28.705789-06:00,"Surgery, NOS",Initial Diagnosis,
HCM-BROD-0791-C43,575844b7-cfa1-406a-b0dd-d55cf9fff978,1b8eabc7-922b-469e-a712-99965d780ea1,2062.0,Adjuvant,1999.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0791-C43_treatment4,debcbd8c-6cf8-4cf9-919b-c33a2515d2e4,,released,Ipilimumab,1,2021-12-21T13:53:28.705789-06:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-BROD-0791-C43,575844b7-cfa1-406a-b0dd-d55cf9fff978,1b8eabc7-922b-469e-a712-99965d780ea1,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0791-C43_treatment6,f39925eb-f768-4a3a-a782-08621d1e913a,,released,,0,2021-12-21T13:53:28.705789-06:00,Targeted Molecular Therapy,Residual Disease,
HCM-BROD-0791-C43,575844b7-cfa1-406a-b0dd-d55cf9fff978,ce0a590f-3bc7-4e28-84ad-0b8a94d250c9,2038.0,Maintenance Therapy,33.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0791-C43_treatment10,5f260d9c-220c-42ed-98c7-aeb23afe18df,Progressive Disease,released,Binimetinib,1,2021-12-21T13:53:28.705789-06:00,,,
HCM-BROD-0791-C43,575844b7-cfa1-406a-b0dd-d55cf9fff978,ce0a590f-3bc7-4e28-84ad-0b8a94d250c9,2038.0,Maintenance Therapy,33.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0791-C43_treatment9,5fa3a044-6dbc-40c5-9ba7-87a5fa38dab9,Progressive Disease,released,Ipilimumab,1,2021-12-21T13:53:28.705789-06:00,,,
HCM-BROD-0791-C43,575844b7-cfa1-406a-b0dd-d55cf9fff978,ce0a590f-3bc7-4e28-84ad-0b8a94d250c9,2038.0,Maintenance Therapy,33.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0791-C43_treatment12,af823ae0-493f-4834-bb03-e89631ffe34e,Progressive Disease,released,Entinostat,1,2021-12-21T13:53:28.705789-06:00,,,
HCM-BROD-0791-C43,575844b7-cfa1-406a-b0dd-d55cf9fff978,ce0a590f-3bc7-4e28-84ad-0b8a94d250c9,2038.0,Maintenance Therapy,33.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0791-C43_treatment8,b2bd01bb-3c4a-461b-a0f5-71ad646b2770,Progressive Disease,released,BRAFV600/PI3K Inhibitor ASN003,1,2021-12-21T13:53:28.705789-06:00,,,
HCM-BROD-0791-C43,575844b7-cfa1-406a-b0dd-d55cf9fff978,ce0a590f-3bc7-4e28-84ad-0b8a94d250c9,2038.0,Maintenance Therapy,33.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0791-C43_treatment11,b3830cc3-ba9b-4c71-96d3-33d2bc13fc06,Progressive Disease,released,Pembrolizumab,1,2021-12-21T13:53:28.705789-06:00,,,
HCM-BROD-0791-C43,575844b7-cfa1-406a-b0dd-d55cf9fff978,ce0a590f-3bc7-4e28-84ad-0b8a94d250c9,2038.0,Maintenance Therapy,33.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0791-C43_treatment13,b5159583-5a00-49b3-a954-d344eec44c3e,Progressive Disease,released,PI3K-gamma Inhibitor IPI-549,1,2021-12-21T13:53:28.705789-06:00,,,
HCM-BROD-0791-C43,575844b7-cfa1-406a-b0dd-d55cf9fff978,ce0a590f-3bc7-4e28-84ad-0b8a94d250c9,2038.0,Maintenance Therapy,33.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0791-C43_treatment14,de9b7d71-11a4-4296-9051-63cef59a2011,Progressive Disease,released,Nivolumab,1,2021-12-21T13:53:28.705789-06:00,,,
HCM-BROD-0791-C43,575844b7-cfa1-406a-b0dd-d55cf9fff978,ef3bb758-7e47-4d02-8a15-3b81293e2c51,2089.0,Maintenance Therapy,33.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0791-C43_treatment15,167dd094-0e7c-48de-a7a8-29a8e8f6fff9,Progressive Disease,released,BRAFV600/PI3K Inhibitor ASN003,1,2021-12-21T13:53:28.705789-06:00,,,
HCM-BROD-0791-C43,575844b7-cfa1-406a-b0dd-d55cf9fff978,ef3bb758-7e47-4d02-8a15-3b81293e2c51,2089.0,Maintenance Therapy,33.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0791-C43_treatment17,4e04f56d-c2d5-4466-8427-246f9a1254b1,Progressive Disease,released,Binimetinib,1,2021-12-21T13:53:28.705789-06:00,,,
HCM-BROD-0791-C43,575844b7-cfa1-406a-b0dd-d55cf9fff978,ef3bb758-7e47-4d02-8a15-3b81293e2c51,2089.0,Maintenance Therapy,33.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0791-C43_treatment18,69574b2c-8355-4bdc-9d81-5df2965e3a7c,Progressive Disease,released,Pembrolizumab,1,2021-12-21T13:53:28.705789-06:00,,,
HCM-BROD-0791-C43,575844b7-cfa1-406a-b0dd-d55cf9fff978,ef3bb758-7e47-4d02-8a15-3b81293e2c51,2089.0,Maintenance Therapy,33.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0791-C43_treatment21,834759bc-6749-4628-a39f-4fac18e6211e,Progressive Disease,released,Nivolumab,1,2021-12-21T13:53:28.705789-06:00,,,
HCM-BROD-0791-C43,575844b7-cfa1-406a-b0dd-d55cf9fff978,ef3bb758-7e47-4d02-8a15-3b81293e2c51,2089.0,Maintenance Therapy,33.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0791-C43_treatment20,ad757f6f-927a-4bd0-b34d-ffe578c8ecae,Progressive Disease,released,PI3K-gamma Inhibitor IPI-549,1,2021-12-21T13:53:28.705789-06:00,,,
HCM-BROD-0791-C43,575844b7-cfa1-406a-b0dd-d55cf9fff978,ef3bb758-7e47-4d02-8a15-3b81293e2c51,2089.0,Maintenance Therapy,33.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0791-C43_treatment16,af39dab9-4b88-4a01-92de-d3c4b3c42687,Progressive Disease,released,Ipilimumab,1,2021-12-21T13:53:28.705789-06:00,,,
HCM-BROD-0791-C43,575844b7-cfa1-406a-b0dd-d55cf9fff978,ef3bb758-7e47-4d02-8a15-3b81293e2c51,2089.0,Maintenance Therapy,33.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0791-C43_treatment19,fe426c8b-7207-4e7a-a8e2-12817136cc44,Progressive Disease,released,Entinostat,1,2021-12-21T13:53:28.705789-06:00,,,
HCM-WCMC-0753-C54,57c28338-4fbb-47ab-94a0-c9988a650cda,3b29eb33-6982-4662-a466-8cf003d41b32,71.0,Adjuvant,36.0,2025-04-07T17:13:09.336794-05:00,HCM-WCMC-0753-C54_treatment4,28961364-b4b4-4997-95b1-75b4101aaadb,,released,,1,2023-02-27T12:57:22.683342-06:00,"Radiation Therapy, NOS",Residual Disease,
HCM-WCMC-0753-C54,57c28338-4fbb-47ab-94a0-c9988a650cda,3b29eb33-6982-4662-a466-8cf003d41b32,,,0.0,2025-04-07T17:13:09.336794-05:00,HCM-WCMC-0753-C54_treatment2,359c184e-d1d6-419e-97c0-48985db5947d,,released,,1,2023-02-27T12:57:22.683342-06:00,"Surgery, NOS",Initial Diagnosis,
HCM-WCMC-0753-C54,57c28338-4fbb-47ab-94a0-c9988a650cda,3b29eb33-6982-4662-a466-8cf003d41b32,,Neoadjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-WCMC-0753-C54_treatment,79ed67af-f2f7-4340-98e6-7fac244a86f2,,released,,0,2023-02-27T12:57:22.683342-06:00,,,
HCM-WCMC-0753-C54,57c28338-4fbb-47ab-94a0-c9988a650cda,3b29eb33-6982-4662-a466-8cf003d41b32,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-WCMC-0753-C54_treatment3,f8a600fb-7a25-44ce-a936-31a88bbd20dd,,released,,0,2023-02-27T12:57:22.683342-06:00,"Pharmaceutical Therapy, NOS",Residual Disease,
HCM-SANG-0548-C25,585787a1-db13-4dbf-bfaa-8268381afa62,39e0dece-56e5-4cc2-88f9-21869d8fa82b,,Neoadjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-SANG-0548-C25_treatment,5bb4848b-e91c-4c3f-a4be-d3c4b6cf312c,,released,,0,2021-12-21T15:15:58.502986-06:00,,,
HCM-CSHL-0582-C18,5868f125-ca3b-4b98-85ea-64f0ea5b45da,21126e95-4518-417c-bd7c-e7c00c88a0e7,484.0,Maintenance Therapy,344.0,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0582-C18_treatment19,0bc73bbd-b2fa-4cc8-b2fe-a142d2a227f0,Progressive Disease,released,Fluorouracil,1,2021-12-21T14:08:47.221959-06:00,,,
HCM-CSHL-0582-C18,5868f125-ca3b-4b98-85ea-64f0ea5b45da,21126e95-4518-417c-bd7c-e7c00c88a0e7,484.0,Maintenance Therapy,344.0,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0582-C18_treatment20,9120bef4-3328-4612-9ebb-db5727ce5899,Progressive Disease,released,Irinotecan,1,2021-12-21T14:08:47.221959-06:00,,,
HCM-CSHL-0582-C18,5868f125-ca3b-4b98-85ea-64f0ea5b45da,21126e95-4518-417c-bd7c-e7c00c88a0e7,484.0,Maintenance Therapy,344.0,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0582-C18_treatment18,a6d3ebca-094e-4108-9811-4345c314d035,Progressive Disease,released,Leucovorin Calcium,1,2021-12-21T14:08:47.221959-06:00,,,
HCM-CSHL-0582-C18,5868f125-ca3b-4b98-85ea-64f0ea5b45da,21126e95-4518-417c-bd7c-e7c00c88a0e7,484.0,Maintenance Therapy,344.0,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0582-C18_treatment21,d8ad4106-df60-47ba-bcbd-1f83658d145a,Progressive Disease,released,,1,2021-12-21T14:08:47.221959-06:00,,,FOLFIRI
HCM-CSHL-0582-C18,5868f125-ca3b-4b98-85ea-64f0ea5b45da,a3a2c172-34bc-4879-98ce-b520afe288d9,,,520.0,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0582-C18_treatment15,1238ee4f-0a49-4899-b26f-fd68ed8b4734,,released,,1,2021-12-21T14:08:47.221959-06:00,"Surgery, NOS",Initial Diagnosis,
HCM-CSHL-0582-C18,5868f125-ca3b-4b98-85ea-64f0ea5b45da,a3a2c172-34bc-4879-98ce-b520afe288d9,624.0,Adjuvant,568.0,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0582-C18_treatment11,179df153-4450-49fd-9015-667ebb46986c,,released,Irinotecan,1,2021-12-21T14:08:47.221959-06:00,Chemotherapy,Residual Disease,
HCM-CSHL-0582-C18,5868f125-ca3b-4b98-85ea-64f0ea5b45da,a3a2c172-34bc-4879-98ce-b520afe288d9,484.0,Adjuvant,344.0,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0582-C18_treatment8,1d188634-11dd-4b0a-a5af-a74fd08af130,,released,,1,2021-12-21T14:08:47.221959-06:00,Chemotherapy,Residual Disease,FOLFIRI
HCM-CSHL-0582-C18,5868f125-ca3b-4b98-85ea-64f0ea5b45da,a3a2c172-34bc-4879-98ce-b520afe288d9,,Adjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0582-C18_treatment16,28a90ccb-ad7b-4a57-98ca-b763afbbc7b8,,released,,0,2021-12-21T14:08:47.221959-06:00,Targeted Molecular Therapy,Residual Disease,
HCM-CSHL-0582-C18,5868f125-ca3b-4b98-85ea-64f0ea5b45da,a3a2c172-34bc-4879-98ce-b520afe288d9,484.0,Adjuvant,344.0,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0582-C18_treatment5,3525302c-c9b9-4024-b645-d721453a7a1e,,released,Leucovorin Calcium,1,2021-12-21T14:08:47.221959-06:00,Chemotherapy,Residual Disease,
HCM-CSHL-0582-C18,5868f125-ca3b-4b98-85ea-64f0ea5b45da,a3a2c172-34bc-4879-98ce-b520afe288d9,624.0,Adjuvant,568.0,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0582-C18_treatment9,36b9b4ce-0022-4a37-8fa8-101498a0c1fa,,released,Leucovorin Calcium,1,2021-12-21T14:08:47.221959-06:00,Chemotherapy,Residual Disease,
HCM-CSHL-0582-C18,5868f125-ca3b-4b98-85ea-64f0ea5b45da,a3a2c172-34bc-4879-98ce-b520afe288d9,,Adjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0582-C18_treatment17,72ee6bb3-56c3-4443-a888-f993abcbd487,,released,,0,2021-12-21T14:08:47.221959-06:00,"Radiation Therapy, NOS",Residual Disease,
HCM-CSHL-0582-C18,5868f125-ca3b-4b98-85ea-64f0ea5b45da,a3a2c172-34bc-4879-98ce-b520afe288d9,,,34.0,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0582-C18_treatment14,78d4af15-f036-4c1d-a675-24efd68b9441,,released,,1,2021-12-21T14:08:47.221959-06:00,"Surgery, NOS",Initial Diagnosis,
HCM-CSHL-0582-C18,5868f125-ca3b-4b98-85ea-64f0ea5b45da,a3a2c172-34bc-4879-98ce-b520afe288d9,191.0,Adjuvant,64.0,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0582-C18_treatment2,886bb414-6766-4aaa-89ed-be5b0b0d5547,,released,Oxaliplatin,1,2021-12-21T14:08:47.221959-06:00,Chemotherapy,Residual Disease,
HCM-CSHL-0582-C18,5868f125-ca3b-4b98-85ea-64f0ea5b45da,a3a2c172-34bc-4879-98ce-b520afe288d9,624.0,Adjuvant,568.0,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0582-C18_treatment10,8e5e6048-a8b0-401f-b761-395c5125093f,,released,Fluorouracil,1,2021-12-21T14:08:47.221959-06:00,Chemotherapy,Residual Disease,
HCM-CSHL-0582-C18,5868f125-ca3b-4b98-85ea-64f0ea5b45da,a3a2c172-34bc-4879-98ce-b520afe288d9,,Adjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0582-C18_treatment13,b034ddc1-986b-478c-97f0-a49b101b18fe,,released,,0,2021-12-21T14:08:47.221959-06:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-CSHL-0582-C18,5868f125-ca3b-4b98-85ea-64f0ea5b45da,a3a2c172-34bc-4879-98ce-b520afe288d9,191.0,Adjuvant,64.0,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0582-C18_treatment3,bb7b965c-390b-4c0f-a612-795aa619ee52,,released,Capecitabine,1,2021-12-21T14:08:47.221959-06:00,Chemotherapy,Residual Disease,
HCM-CSHL-0582-C18,5868f125-ca3b-4b98-85ea-64f0ea5b45da,a3a2c172-34bc-4879-98ce-b520afe288d9,624.0,Adjuvant,568.0,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0582-C18_treatment12,bcca64e7-5e05-4cd9-8340-8c64d8973a0c,,released,,1,2021-12-21T14:08:47.221959-06:00,Chemotherapy,Residual Disease,FOLFIRI
HCM-CSHL-0582-C18,5868f125-ca3b-4b98-85ea-64f0ea5b45da,a3a2c172-34bc-4879-98ce-b520afe288d9,484.0,Adjuvant,344.0,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0582-C18_treatment6,c9be243d-6012-46d9-bbf7-f262a66ee29c,,released,Fluorouracil,1,2021-12-21T14:08:47.221959-06:00,Chemotherapy,Residual Disease,
HCM-CSHL-0582-C18,5868f125-ca3b-4b98-85ea-64f0ea5b45da,a3a2c172-34bc-4879-98ce-b520afe288d9,,Neoadjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0582-C18_treatment,d6e9e53f-51ee-488a-8941-2f956eb4eebf,,released,,0,2021-12-21T14:08:47.221959-06:00,,,
HCM-CSHL-0582-C18,5868f125-ca3b-4b98-85ea-64f0ea5b45da,a3a2c172-34bc-4879-98ce-b520afe288d9,484.0,Adjuvant,344.0,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0582-C18_treatment7,eb7d5877-a6af-4dfe-aafd-67a98b2e6620,,released,Irinotecan,1,2021-12-21T14:08:47.221959-06:00,Chemotherapy,Residual Disease,
HCM-CSHL-0582-C18,5868f125-ca3b-4b98-85ea-64f0ea5b45da,a3a2c172-34bc-4879-98ce-b520afe288d9,191.0,Adjuvant,64.0,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0582-C18_treatment4,ebf688bd-ed53-4723-bf74-20e1125ba67c,,released,,1,2021-12-21T14:08:47.221959-06:00,Chemotherapy,Residual Disease,XELOX
HCM-CSHL-0808-C55,58c8d6cf-e866-4991-b2c0-04f7bf5f71bd,0f74e2f7-ce3a-4940-b97a-b1b190b43ba8,,Neoadjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0808-C55_treatment,01acc186-5d0f-4d1d-a4c7-9efbfae1d2ee,,released,,0,2021-12-21T14:26:47.235159-06:00,,,
HCM-CSHL-0808-C55,58c8d6cf-e866-4991-b2c0-04f7bf5f71bd,0f74e2f7-ce3a-4940-b97a-b1b190b43ba8,230.0,Adjuvant,189.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0808-C55_treatment8,4740b7ba-1202-4207-a07d-ec5b793f424b,,released,,1,2021-12-21T14:26:47.235159-06:00,"Radiation, Intensity-Modulated Radiotherapy",Residual Disease,
HCM-CSHL-0808-C55,58c8d6cf-e866-4991-b2c0-04f7bf5f71bd,0f74e2f7-ce3a-4940-b97a-b1b190b43ba8,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0808-C55_treatment7,480e71cd-f39f-4dab-aa7c-dbb12a2d8523,,released,,0,2021-12-21T14:26:47.235159-06:00,Targeted Molecular Therapy,Residual Disease,
HCM-CSHL-0808-C55,58c8d6cf-e866-4991-b2c0-04f7bf5f71bd,0f74e2f7-ce3a-4940-b97a-b1b190b43ba8,146.0,Adjuvant,41.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0808-C55_treatment2,5a523cce-b89d-45f4-8f13-a09d9b8cab0e,,released,Carboplatin,1,2021-12-21T14:26:47.235159-06:00,Chemotherapy,Residual Disease,
HCM-CSHL-0808-C55,58c8d6cf-e866-4991-b2c0-04f7bf5f71bd,0f74e2f7-ce3a-4940-b97a-b1b190b43ba8,,,0.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0808-C55_treatment6,a9293b16-73be-4a95-8282-efeed39a5644,,released,,1,2021-12-21T14:26:47.235159-06:00,"Surgery, NOS",Initial Diagnosis,
HCM-CSHL-0808-C55,58c8d6cf-e866-4991-b2c0-04f7bf5f71bd,0f74e2f7-ce3a-4940-b97a-b1b190b43ba8,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0808-C55_treatment4,b55041c4-8ae3-4b98-a070-70a185260f33,,released,,0,2021-12-21T14:26:47.235159-06:00,Hormone Therapy,Residual Disease,
HCM-CSHL-0808-C55,58c8d6cf-e866-4991-b2c0-04f7bf5f71bd,0f74e2f7-ce3a-4940-b97a-b1b190b43ba8,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0808-C55_treatment5,d4645f90-af4a-47c7-a6a3-57596eaabf39,,released,,0,2021-12-21T14:26:47.235159-06:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-CSHL-0808-C55,58c8d6cf-e866-4991-b2c0-04f7bf5f71bd,0f74e2f7-ce3a-4940-b97a-b1b190b43ba8,146.0,Adjuvant,41.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0808-C55_treatment3,e31fdaa4-ae65-4834-b629-e4d835c97eb2,,released,Paclitaxel,1,2021-12-21T14:26:47.235159-06:00,Chemotherapy,Residual Disease,
HCM-SANG-1333-C20,58f3fa31-4c91-4fce-9807-afdd200cc194,032d2fb6-a74d-4b6f-b4f9-7b396dcda7ec,,Neoadjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-SANG-1333-C20_treatment,64679e56-e0ed-4805-be99-6fd71ed3c534,,released,,0,2023-02-27T13:05:35.901748-06:00,,,
HCM-CSHL-0823-C34,5c09c5da-e995-49df-be9e-16ca3388771e,38ab0e18-e405-4ea2-858b-3849af81c51d,,Neoadjuvant,13.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0823-C34_treatment6,06ee8f05-4197-474c-9da9-0fb039216862,,released,,1,2021-12-21T14:31:22.244867-06:00,"Radiation Therapy, NOS",,
HCM-CSHL-0823-C34,5c09c5da-e995-49df-be9e-16ca3388771e,38ab0e18-e405-4ea2-858b-3849af81c51d,,,482.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0823-C34_treatment10,0b75e00a-e04f-4127-98d2-2c170b47bd07,,released,,1,2021-12-21T14:31:22.244867-06:00,"Surgery, NOS",Initial Diagnosis,
HCM-CSHL-0823-C34,5c09c5da-e995-49df-be9e-16ca3388771e,38ab0e18-e405-4ea2-858b-3849af81c51d,,Neoadjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0823-C34_treatment3,15bb6b5e-e418-40bc-b5f9-53d3b212c87d,,released,Gemcitabine,1,2021-12-21T14:31:22.244867-06:00,Chemotherapy,,
HCM-CSHL-0823-C34,5c09c5da-e995-49df-be9e-16ca3388771e,38ab0e18-e405-4ea2-858b-3849af81c51d,,,777.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0823-C34_treatment11,1c01bb44-a92e-442c-9d88-b73eba0bcecc,,released,,1,2021-12-21T14:31:22.244867-06:00,"Surgery, NOS",Initial Diagnosis,
HCM-CSHL-0823-C34,5c09c5da-e995-49df-be9e-16ca3388771e,38ab0e18-e405-4ea2-858b-3849af81c51d,939.0,Adjuvant,827.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0823-C34_treatment9,2f8eb7a7-8a4e-4cef-8568-ded081ae1957,,released,Pembrolizumab,1,2021-12-21T14:31:22.244867-06:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-CSHL-0823-C34,5c09c5da-e995-49df-be9e-16ca3388771e,38ab0e18-e405-4ea2-858b-3849af81c51d,939.0,Adjuvant,827.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0823-C34_treatment8,4b129911-0862-4577-8e24-987d9e196ada,,released,Paclitaxel,1,2021-12-21T14:31:22.244867-06:00,Chemotherapy,Residual Disease,
HCM-CSHL-0823-C34,5c09c5da-e995-49df-be9e-16ca3388771e,38ab0e18-e405-4ea2-858b-3849af81c51d,,Neoadjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0823-C34_treatment,a91c6204-3e25-4699-8726-2f358dbb6513,,released,Cisplatin,1,2021-12-21T14:31:22.244867-06:00,Chemotherapy,,
HCM-CSHL-0823-C34,5c09c5da-e995-49df-be9e-16ca3388771e,38ab0e18-e405-4ea2-858b-3849af81c51d,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0823-C34_treatment13,b8e9043b-0c41-499e-9ef5-a19aa56851f9,,released,,0,2021-12-21T14:31:22.244867-06:00,"Radiation Therapy, NOS",Residual Disease,
HCM-CSHL-0823-C34,5c09c5da-e995-49df-be9e-16ca3388771e,38ab0e18-e405-4ea2-858b-3849af81c51d,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0823-C34_treatment12,bf236769-4202-4cc2-ab66-b1ac73da7373,,released,,0,2021-12-21T14:31:22.244867-06:00,Targeted Molecular Therapy,Residual Disease,
HCM-CSHL-0823-C34,5c09c5da-e995-49df-be9e-16ca3388771e,38ab0e18-e405-4ea2-858b-3849af81c51d,,Neoadjuvant,223.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0823-C34_treatment5,bfca953e-37cc-45dc-9a8d-1ca7699ef59c,,released,Durvalumab,1,2021-12-21T14:31:22.244867-06:00,Immunotherapy (Including Vaccines),,
HCM-CSHL-0823-C34,5c09c5da-e995-49df-be9e-16ca3388771e,38ab0e18-e405-4ea2-858b-3849af81c51d,,Neoadjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0823-C34_treatment2,ca4ebb20-e0f5-4940-9c6e-4e0aa3397c04,,released,Carboplatin,1,2021-12-21T14:31:22.244867-06:00,Chemotherapy,,
HCM-CSHL-0823-C34,5c09c5da-e995-49df-be9e-16ca3388771e,38ab0e18-e405-4ea2-858b-3849af81c51d,939.0,Adjuvant,827.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0823-C34_treatment7,d0a8663d-8dd7-4d2d-a795-5bc5c4acc540,,released,Carboplatin,1,2021-12-21T14:31:22.244867-06:00,Chemotherapy,Residual Disease,
HCM-CSHL-0823-C34,5c09c5da-e995-49df-be9e-16ca3388771e,38ab0e18-e405-4ea2-858b-3849af81c51d,,Neoadjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0823-C34_treatment4,f2919538-0e88-42fa-93a3-64fd5ec2a725,,released,Paclitaxel,1,2021-12-21T14:31:22.244867-06:00,Chemotherapy,,
HCM-BROD-0019-C25,5c2bff0f-0e8e-4d98-83c5-0d9ab866241a,5366d9e1-4958-4337-839c-5ba4179f38db,212.0,Adjuvant,58.0,2023-07-13T10:35:44.371881-05:00,HCM-BROD-0019-C25_treatment2,3c4f4e6b-b013-4289-88ed-c159c0d70486,,released,Gemcitabine,1,2020-09-17T15:44:14.005206-05:00,Chemotherapy,Residual Disease,
HCM-BROD-0019-C25,5c2bff0f-0e8e-4d98-83c5-0d9ab866241a,5366d9e1-4958-4337-839c-5ba4179f38db,,Adjuvant,,2023-07-13T10:35:44.371881-05:00,HCM-BROD-0019-C25_treatment4,3e78ff32-60a3-4258-ac9a-6a1e85870a74,,released,,0,2020-09-17T15:44:14.005206-05:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-BROD-0019-C25,5c2bff0f-0e8e-4d98-83c5-0d9ab866241a,5366d9e1-4958-4337-839c-5ba4179f38db,,Adjuvant,,2023-07-13T10:35:44.371881-05:00,HCM-BROD-0019-C25_treatment6,757f0ffa-14d1-4fb8-84ea-c14980faca5b,,released,,0,2020-09-17T15:44:14.005206-05:00,Targeted Molecular Therapy,Residual Disease,
HCM-BROD-0019-C25,5c2bff0f-0e8e-4d98-83c5-0d9ab866241a,5366d9e1-4958-4337-839c-5ba4179f38db,212.0,Adjuvant,58.0,2023-07-13T10:35:44.371881-05:00,HCM-BROD-0019-C25_treatment3,9bc09eac-d8ed-49a5-8637-3926e0625c2b,,released,Capecitabine,1,2020-09-17T15:44:14.005206-05:00,Chemotherapy,Residual Disease,
HCM-BROD-0019-C25,5c2bff0f-0e8e-4d98-83c5-0d9ab866241a,5366d9e1-4958-4337-839c-5ba4179f38db,,Adjuvant,,2023-07-13T10:35:44.371881-05:00,HCM-BROD-0019-C25_treatment7,a1f96d37-2316-488e-a6f3-b96dbd484f29,,released,,0,2020-09-17T15:44:14.005206-05:00,"Radiation Therapy, NOS",Residual Disease,
HCM-BROD-0019-C25,5c2bff0f-0e8e-4d98-83c5-0d9ab866241a,5366d9e1-4958-4337-839c-5ba4179f38db,,,,2023-07-13T10:35:44.371881-05:00,HCM-BROD-0019-C25_treatment5,a222e70f-c57e-476a-af9c-18ea329c0d75,,released,,unknown,2020-09-17T15:44:14.005206-05:00,"Surgery, NOS",Initial Diagnosis,
HCM-BROD-0019-C25,5c2bff0f-0e8e-4d98-83c5-0d9ab866241a,5366d9e1-4958-4337-839c-5ba4179f38db,,Neoadjuvant,,2023-07-13T10:35:44.371881-05:00,HCM-BROD-0019-C25_treatment,c3abb904-a7dc-4124-ae3e-0d0002eddc13,,released,,0,2020-09-17T15:44:14.005206-05:00,,,
HCM-BROD-0214-C71,5c5ef9c4-5896-4553-bbbd-afe4e4b52a6a,fd765487-c517-44d5-92dc-2dcd6424d975,,Neoadjuvant,,2023-02-22T07:39:25.979291-06:00,HCM-BROD-0214-C71_treatment,282c72ac-0fd6-409b-980a-8b9f9a196d75,,released,,0,2019-04-04T15:07:48.286883-05:00,,,
HCM-BROD-0214-C71,5c5ef9c4-5896-4553-bbbd-afe4e4b52a6a,fd765487-c517-44d5-92dc-2dcd6424d975,604.0,Adjuvant,596.0,2023-02-22T07:39:25.979291-06:00,HCM-BROD-0214-C71_treatment8,664c6092-a45a-483a-a4a8-6591d195aead,,released,,1,2020-09-27T11:01:01.785781-05:00,"Radiation Therapy, NOS",Residual Disease,
HCM-BROD-0214-C71,5c5ef9c4-5896-4553-bbbd-afe4e4b52a6a,fd765487-c517-44d5-92dc-2dcd6424d975,783.0,Adjuvant,699.0,2023-02-22T07:39:25.979291-06:00,HCM-BROD-0214-C71_treatment7,756f6f6b-0f38-4ec8-b957-f9143220b1e6,,released,Bevacizumab,1,2019-04-04T15:07:48.286883-05:00,Targeted Molecular Therapy,Residual Disease,
HCM-BROD-0214-C71,5c5ef9c4-5896-4553-bbbd-afe4e4b52a6a,fd765487-c517-44d5-92dc-2dcd6424d975,699.0,Adjuvant,617.0,2023-02-22T07:39:25.979291-06:00,HCM-BROD-0214-C71_treatment3,8b6ad854-0439-4b59-be10-20347565e34e,,released,Irinotecan,1,2019-04-04T15:07:48.286883-05:00,Chemotherapy,Residual Disease,
HCM-BROD-0214-C71,5c5ef9c4-5896-4553-bbbd-afe4e4b52a6a,fd765487-c517-44d5-92dc-2dcd6424d975,699.0,Adjuvant,596.0,2023-02-22T07:39:25.979291-06:00,HCM-BROD-0214-C71_treatment2,c42ca838-fec7-4655-b9f1-71dffbed1e4a,,released,Temozolomide,1,2019-04-04T15:07:48.286883-05:00,Chemotherapy,Residual Disease,
HCM-BROD-0214-C71,5c5ef9c4-5896-4553-bbbd-afe4e4b52a6a,fd765487-c517-44d5-92dc-2dcd6424d975,783.0,Adjuvant,699.0,2023-02-22T07:39:25.979291-06:00,HCM-BROD-0214-C71_treatment4,c54cf29c-7ad3-446b-b91e-a44192acd44e,,released,Carboplatin,1,2019-04-04T15:07:48.286883-05:00,Chemotherapy,Residual Disease,
HCM-BROD-0214-C71,5c5ef9c4-5896-4553-bbbd-afe4e4b52a6a,fd765487-c517-44d5-92dc-2dcd6424d975,,Adjuvant,,2023-02-22T07:39:25.979291-06:00,HCM-BROD-0214-C71_treatment5,d40dc4d1-64c7-4f8c-843a-2b68155304d9,,released,,0,2019-04-04T15:07:48.286883-05:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-BROD-0214-C71,5c5ef9c4-5896-4553-bbbd-afe4e4b52a6a,fd765487-c517-44d5-92dc-2dcd6424d975,,,0.0,2023-02-27T11:58:16.269229-06:00,HCM-BROD-0214-C71_treatment6,f8d8f003-ef65-4a28-975a-1d24737bf577,,released,,1,2019-04-04T15:07:48.286883-05:00,"Surgery, NOS",Initial Diagnosis,
HCM-CSHL-0603-C18,5d27f395-e77f-46af-baf1-4ac783449f52,704b721b-850f-4489-8355-82ba7606cd36,983.0,Adjuvant,799.0,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0603-C18_treatment6,087cc5fa-9c74-42d5-8874-5192c775cee1,,released,,1,2021-12-21T14:09:27.521398-06:00,Chemotherapy,Residual Disease,FOLFIRI-cetuximab
HCM-CSHL-0603-C18,5d27f395-e77f-46af-baf1-4ac783449f52,704b721b-850f-4489-8355-82ba7606cd36,,Neoadjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0603-C18_treatment,0e7b3f23-6417-4d57-9496-a1e14a7da134,,released,,0,2021-12-21T14:09:27.521398-06:00,,,
HCM-CSHL-0603-C18,5d27f395-e77f-46af-baf1-4ac783449f52,704b721b-850f-4489-8355-82ba7606cd36,983.0,Adjuvant,799.0,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0603-C18_treatment2,3419702c-58ad-48e9-ade5-b892543ffb99,,released,Irinotecan,1,2021-12-21T14:09:27.521398-06:00,Chemotherapy,Residual Disease,
HCM-CSHL-0603-C18,5d27f395-e77f-46af-baf1-4ac783449f52,704b721b-850f-4489-8355-82ba7606cd36,,Adjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0603-C18_treatment9,b402761f-1ede-484d-ac8c-a2c6254f1596,,released,,0,2021-12-21T14:09:27.521398-06:00,Targeted Molecular Therapy,Residual Disease,
HCM-CSHL-0603-C18,5d27f395-e77f-46af-baf1-4ac783449f52,704b721b-850f-4489-8355-82ba7606cd36,,,1143.0,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0603-C18_treatment8,c7d7dd61-b336-4726-a19c-ebc35cba8035,,released,,1,2021-12-21T14:09:27.521398-06:00,"Surgery, NOS",Initial Diagnosis,
HCM-CSHL-0603-C18,5d27f395-e77f-46af-baf1-4ac783449f52,704b721b-850f-4489-8355-82ba7606cd36,983.0,Adjuvant,799.0,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0603-C18_treatment5,cdcf75d3-1919-4b83-aeb0-47c839adf280,,released,Cetuximab,1,2021-12-21T14:09:27.521398-06:00,Chemotherapy,Residual Disease,
HCM-CSHL-0603-C18,5d27f395-e77f-46af-baf1-4ac783449f52,704b721b-850f-4489-8355-82ba7606cd36,983.0,Adjuvant,799.0,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0603-C18_treatment4,d9d3f5a4-21dd-4d32-8402-812d41f9cb8d,,released,Fluorouracil,1,2021-12-21T14:09:27.521398-06:00,Chemotherapy,Residual Disease,
HCM-CSHL-0603-C18,5d27f395-e77f-46af-baf1-4ac783449f52,704b721b-850f-4489-8355-82ba7606cd36,,Adjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0603-C18_treatment10,e480635b-fc28-4dfc-ae70-fb4f7e1a957e,,released,,0,2021-12-21T14:09:27.521398-06:00,"Radiation Therapy, NOS",Residual Disease,
HCM-CSHL-0603-C18,5d27f395-e77f-46af-baf1-4ac783449f52,704b721b-850f-4489-8355-82ba7606cd36,983.0,Adjuvant,799.0,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0603-C18_treatment3,f8ed8832-2aa3-4b16-a4b3-f35308b54b68,,released,Leucovorin Calcium,1,2021-12-21T14:09:27.521398-06:00,Chemotherapy,Residual Disease,
HCM-CSHL-0603-C18,5d27f395-e77f-46af-baf1-4ac783449f52,704b721b-850f-4489-8355-82ba7606cd36,,Adjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0603-C18_treatment7,fcb52132-7587-4938-9d42-4c1b768c072e,,released,,0,2021-12-21T14:09:27.521398-06:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-CSHL-0603-C18,5d27f395-e77f-46af-baf1-4ac783449f52,c928728d-159c-4f0f-8f17-23a1dfbfb163,1113.0,Maintenance Therapy,800.0,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0603-C18_treatment14,2bead3d5-d517-4e22-a97a-79285dea336f,Treatment Ongoing,released,Irinotecan,1,2021-12-21T14:09:27.521398-06:00,,,
HCM-CSHL-0603-C18,5d27f395-e77f-46af-baf1-4ac783449f52,c928728d-159c-4f0f-8f17-23a1dfbfb163,1113.0,Maintenance Therapy,800.0,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0603-C18_treatment12,3b852a2c-a276-4031-9c9c-45d40fb63a46,Treatment Ongoing,released,Leucovorin Calcium,1,2021-12-21T14:09:27.521398-06:00,,,
HCM-CSHL-0603-C18,5d27f395-e77f-46af-baf1-4ac783449f52,c928728d-159c-4f0f-8f17-23a1dfbfb163,1113.0,Maintenance Therapy,800.0,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0603-C18_treatment11,b62a766f-c516-44b0-a8e9-323f83618d4b,Treatment Ongoing,released,Cetuximab,1,2021-12-21T14:09:27.521398-06:00,,,
HCM-CSHL-0603-C18,5d27f395-e77f-46af-baf1-4ac783449f52,c928728d-159c-4f0f-8f17-23a1dfbfb163,1113.0,Maintenance Therapy,800.0,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0603-C18_treatment15,d3d7763f-bb60-4590-b896-56482b7b4f87,Treatment Ongoing,released,,1,2021-12-21T14:09:27.521398-06:00,,,FOLFIRI-cetuximab
HCM-CSHL-0603-C18,5d27f395-e77f-46af-baf1-4ac783449f52,c928728d-159c-4f0f-8f17-23a1dfbfb163,1113.0,Maintenance Therapy,800.0,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0603-C18_treatment13,da08766d-57a7-4e81-b418-d80094cdebff,Treatment Ongoing,released,Fluorouracil,1,2021-12-21T14:09:27.521398-06:00,,,
HCM-BROD-0010-C25,5d47d75b-1c71-4864-a2d9-b7f55967c6f4,c1bb31b0-74d5-49b1-8a94-0b9e961f6b65,286.0,Adjuvant,216.0,2023-02-22T07:39:25.979291-06:00,HCM-BROD-0010-C25_treatment8,007af535-ec4e-4443-ab7f-123cd0803b68,,released,Nab-paclitaxel,1,2020-06-15T13:38:29.761225-05:00,Chemotherapy,Residual Disease,
HCM-BROD-0010-C25,5d47d75b-1c71-4864-a2d9-b7f55967c6f4,c1bb31b0-74d5-49b1-8a94-0b9e961f6b65,182.0,Adjuvant,18.0,2023-02-22T07:39:25.979291-06:00,HCM-BROD-0010-C25_treatment4,07746601-a9ee-4f05-a7f9-1b84ee5c2242,,released,Fluorouracil,1,2019-04-16T11:19:01.055673-05:00,Chemotherapy,Residual Disease,
HCM-BROD-0010-C25,5d47d75b-1c71-4864-a2d9-b7f55967c6f4,c1bb31b0-74d5-49b1-8a94-0b9e961f6b65,182.0,Adjuvant,18.0,2023-02-22T07:39:25.979291-06:00,HCM-BROD-0010-C25_treatment3,126fa08a-b493-4d96-9bb5-f84eb336640d,,released,Leucovorin Calcium,1,2019-04-16T11:19:01.055673-05:00,Chemotherapy,Residual Disease,
HCM-BROD-0010-C25,5d47d75b-1c71-4864-a2d9-b7f55967c6f4,c1bb31b0-74d5-49b1-8a94-0b9e961f6b65,182.0,Adjuvant,18.0,2023-02-22T07:39:25.979291-06:00,HCM-BROD-0010-C25_treatment6,1a220bac-ee46-45eb-8172-f7d39173b32a,,released,,1,2019-04-16T11:19:01.055673-05:00,Chemotherapy,Residual Disease,FOLFIRINOX
HCM-BROD-0010-C25,5d47d75b-1c71-4864-a2d9-b7f55967c6f4,c1bb31b0-74d5-49b1-8a94-0b9e961f6b65,,,,2023-02-27T12:07:30.067556-06:00,HCM-BROD-0010-C25_treatment10,27d1b8dc-9c6f-40dd-9de1-83885c2ee0ab,,released,,0,2020-09-27T10:01:16.656962-05:00,"Surgery, NOS",Initial Diagnosis,
HCM-BROD-0010-C25,5d47d75b-1c71-4864-a2d9-b7f55967c6f4,c1bb31b0-74d5-49b1-8a94-0b9e961f6b65,,Adjuvant,,2023-02-22T07:39:25.979291-06:00,HCM-BROD-0010-C25_treatment11,42d3fc90-0ea5-4018-b77f-5d7ba5c8f02c,,released,,0,2020-09-27T10:01:16.656962-05:00,Targeted Molecular Therapy,Residual Disease,
HCM-BROD-0010-C25,5d47d75b-1c71-4864-a2d9-b7f55967c6f4,c1bb31b0-74d5-49b1-8a94-0b9e961f6b65,,Adjuvant,,2023-02-22T07:39:25.979291-06:00,HCM-BROD-0010-C25_treatment12,522a8540-d7db-41c9-9301-1ef9927fb224,,released,,0,2020-09-27T10:01:16.656962-05:00,"Radiation Therapy, NOS",Residual Disease,
HCM-BROD-0010-C25,5d47d75b-1c71-4864-a2d9-b7f55967c6f4,c1bb31b0-74d5-49b1-8a94-0b9e961f6b65,286.0,Adjuvant,216.0,2023-02-22T07:39:25.979291-06:00,HCM-BROD-0010-C25_treatment7,589f0a75-89f6-449a-a8b2-ac7e22596564,,released,Gemcitabine,1,2019-04-16T11:19:01.055673-05:00,Chemotherapy,Residual Disease,
HCM-BROD-0010-C25,5d47d75b-1c71-4864-a2d9-b7f55967c6f4,c1bb31b0-74d5-49b1-8a94-0b9e961f6b65,,Neoadjuvant,,2023-02-22T07:39:25.979291-06:00,HCM-BROD-0010-C25_treatment,81db8a7d-afe8-4edc-b4dd-cd9efebf0007,,released,,0,2019-04-16T11:19:01.055673-05:00,,,
HCM-BROD-0010-C25,5d47d75b-1c71-4864-a2d9-b7f55967c6f4,c1bb31b0-74d5-49b1-8a94-0b9e961f6b65,182.0,Adjuvant,18.0,2023-02-22T07:39:25.979291-06:00,HCM-BROD-0010-C25_treatment2,9db92a5c-aa95-4e71-b9e1-bc41e79c5a85,,released,Irinotecan Hydrochloride,1,2019-04-16T11:19:01.055673-05:00,Chemotherapy,Residual Disease,
HCM-BROD-0010-C25,5d47d75b-1c71-4864-a2d9-b7f55967c6f4,c1bb31b0-74d5-49b1-8a94-0b9e961f6b65,,Adjuvant,,2023-02-22T07:39:25.979291-06:00,HCM-BROD-0010-C25_treatment9,f0420514-3157-438c-a6e6-efd0a88cb6a6,,released,,0,2020-09-27T10:01:16.656962-05:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-BROD-0010-C25,5d47d75b-1c71-4864-a2d9-b7f55967c6f4,c1bb31b0-74d5-49b1-8a94-0b9e961f6b65,182.0,Adjuvant,18.0,2023-02-22T07:39:25.979291-06:00,HCM-BROD-0010-C25_treatment5,f7aa7985-4c9d-468e-8d1e-95cc4c20b8f8,,released,Oxaliplatin,1,2019-04-16T11:19:01.055673-05:00,Chemotherapy,Residual Disease,
HCM-BROD-0053-C49,5d62edfc-03c7-4545-91b1-9ad3abfcfeb8,994211f5-ade5-4659-977e-e650136d56a9,,Adjuvant,,2023-02-22T07:39:25.979291-06:00,HCM-BROD-0053-C49_treatment11,12f3d718-b74d-46ca-b0a2-b2820941e91f,,released,,0,2020-10-08T12:07:19.366528-05:00,"Radiation Therapy, NOS",Residual Disease,
HCM-BROD-0053-C49,5d62edfc-03c7-4545-91b1-9ad3abfcfeb8,994211f5-ade5-4659-977e-e650136d56a9,,Neoadjuvant,0.0,2023-02-22T07:39:25.979291-06:00,HCM-BROD-0053-C49_treatment,257528e1-a2a8-4de7-b92a-31fe44641448,,released,Docetaxel,1,2020-06-15T13:00:20.616704-05:00,Chemotherapy,,
HCM-BROD-0053-C49,5d62edfc-03c7-4545-91b1-9ad3abfcfeb8,994211f5-ade5-4659-977e-e650136d56a9,,Adjuvant,,2023-02-22T07:39:25.979291-06:00,HCM-BROD-0053-C49_treatment6,63738d8c-d391-4409-a162-3e07fe63f87a,,released,,0,2020-06-15T13:00:20.616704-05:00,Chemotherapy,Residual Disease,
HCM-BROD-0053-C49,5d62edfc-03c7-4545-91b1-9ad3abfcfeb8,994211f5-ade5-4659-977e-e650136d56a9,,Neoadjuvant,0.0,2023-02-22T07:39:25.979291-06:00,HCM-BROD-0053-C49_treatment4,69c4c4c3-6288-4f4c-bf9a-a4d8590d85ff,,released,Doxorubicin,1,2020-06-15T13:00:20.616704-05:00,Chemotherapy,,
HCM-BROD-0053-C49,5d62edfc-03c7-4545-91b1-9ad3abfcfeb8,994211f5-ade5-4659-977e-e650136d56a9,,,,2023-03-13T13:20:23.289665-05:00,HCM-BROD-0053-C49_treatment9,6c60d1d4-91e6-4aed-8fa8-f123729ae261,,released,,0,2020-10-08T12:07:19.366528-05:00,"Surgery, NOS",Initial Diagnosis,
HCM-BROD-0053-C49,5d62edfc-03c7-4545-91b1-9ad3abfcfeb8,994211f5-ade5-4659-977e-e650136d56a9,,Adjuvant,,2023-02-22T07:39:25.979291-06:00,HCM-BROD-0053-C49_treatment7,713d1ed3-f8ea-4c6a-8f74-be08dfe3a98c,,released,,0,2020-06-15T13:00:20.616704-05:00,Hormone Therapy,Residual Disease,
HCM-BROD-0053-C49,5d62edfc-03c7-4545-91b1-9ad3abfcfeb8,994211f5-ade5-4659-977e-e650136d56a9,,Neoadjuvant,0.0,2023-02-22T07:39:25.979291-06:00,HCM-BROD-0053-C49_treatment2,726752b4-0180-4d00-b64e-175b2f50d6dc,,released,Gemcitabine,1,2020-06-15T13:00:20.616704-05:00,Chemotherapy,,
HCM-BROD-0053-C49,5d62edfc-03c7-4545-91b1-9ad3abfcfeb8,994211f5-ade5-4659-977e-e650136d56a9,,Neoadjuvant,62.0,2023-02-22T07:39:25.979291-06:00,HCM-BROD-0053-C49_treatment5,c3cee61b-f466-49e4-87e7-575330b4c132,,released,,1,2020-06-15T13:00:20.616704-05:00,"Radiation Therapy, NOS",,
HCM-BROD-0053-C49,5d62edfc-03c7-4545-91b1-9ad3abfcfeb8,994211f5-ade5-4659-977e-e650136d56a9,212.0,Adjuvant,182.0,2023-02-22T07:39:25.979291-06:00,HCM-BROD-0053-C49_treatment8,cf10fec2-c3ea-48ea-a217-761484d75c7a,,released,Pembrolizumab,1,2020-06-15T15:23:52.477289-05:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-BROD-0053-C49,5d62edfc-03c7-4545-91b1-9ad3abfcfeb8,994211f5-ade5-4659-977e-e650136d56a9,,Neoadjuvant,0.0,2023-02-22T07:39:25.979291-06:00,HCM-BROD-0053-C49_treatment3,f846a145-1afa-47ac-89ea-2ff4b3fac63c,,released,Ifosfamide,1,2020-06-15T13:00:20.616704-05:00,Chemotherapy,,
HCM-BROD-0053-C49,5d62edfc-03c7-4545-91b1-9ad3abfcfeb8,994211f5-ade5-4659-977e-e650136d56a9,182.0,Adjuvant,151.0,2023-02-22T07:39:25.979291-06:00,HCM-BROD-0053-C49_treatment10,f87ae6d5-75fd-4596-b700-3e67b2e35b74,,released,Not Reported,1,2020-10-08T12:07:19.366528-05:00,Targeted Molecular Therapy,Residual Disease,
HCM-SANG-1328-C15,5dc3e355-af0d-414e-a612-caa7e75d7614,8c50b4dc-d6bd-479c-a485-5da38dac8c42,,Neoadjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-SANG-1328-C15_treatment,a5aae5dd-e2f5-4f0c-b332-a5002317afe7,,released,,0,2023-02-27T12:04:03.165739-06:00,,,
HCM-BROD-1099-C84,5e2f613c-4a63-44da-b367-329c9245a762,416a3d59-4951-46a1-9b4b-c21b627149a2,,Neoadjuvant,19.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-1099-C84_treatment3,16e436fb-a6b5-4533-a6fb-04fde448dae5,,released,Vincristine,1,2021-12-21T15:23:12.145029-06:00,Chemotherapy,,
HCM-BROD-1099-C84,5e2f613c-4a63-44da-b367-329c9245a762,416a3d59-4951-46a1-9b4b-c21b627149a2,,Neoadjuvant,19.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-1099-C84_treatment7,46e7c61c-a751-46a2-b3d6-d612c0e6d67a,,released,Ifosfamide,1,2021-12-21T15:23:12.145029-06:00,Chemotherapy,,
HCM-BROD-1099-C84,5e2f613c-4a63-44da-b367-329c9245a762,416a3d59-4951-46a1-9b4b-c21b627149a2,,Neoadjuvant,19.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-1099-C84_treatment5,6043d8df-7cf5-40b1-b0af-96b306ec2012,,released,Doxorubicin,1,2021-12-21T15:23:12.145029-06:00,Chemotherapy,,
HCM-BROD-1099-C84,5e2f613c-4a63-44da-b367-329c9245a762,416a3d59-4951-46a1-9b4b-c21b627149a2,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-BROD-1099-C84_treatment12,6b091207-f75d-4062-b186-22471d47151e,,released,,0,2021-12-21T15:23:12.145029-06:00,"Radiation Therapy, NOS",Residual Disease,
HCM-BROD-1099-C84,5e2f613c-4a63-44da-b367-329c9245a762,416a3d59-4951-46a1-9b4b-c21b627149a2,,Neoadjuvant,19.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-1099-C84_treatment,6b20bfba-6229-4015-96fa-da351c8f0934,,released,Carboplatin,1,2021-12-21T15:23:12.145029-06:00,Chemotherapy,,
HCM-BROD-1099-C84,5e2f613c-4a63-44da-b367-329c9245a762,416a3d59-4951-46a1-9b4b-c21b627149a2,,Neoadjuvant,19.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-1099-C84_treatment4,6ce01d4f-9300-461a-b59f-840470ec26f0,,released,Romidepsin,1,2021-12-21T15:23:12.145029-06:00,Chemotherapy,,
HCM-BROD-1099-C84,5e2f613c-4a63-44da-b367-329c9245a762,416a3d59-4951-46a1-9b4b-c21b627149a2,,,,2025-04-07T17:13:09.336794-05:00,HCM-BROD-1099-C84_treatment10,804b33fc-35a4-445a-95fa-e7fab1b390b8,,released,,0,2021-12-21T15:23:12.145029-06:00,"Surgery, NOS",Initial Diagnosis,
HCM-BROD-1099-C84,5e2f613c-4a63-44da-b367-329c9245a762,416a3d59-4951-46a1-9b4b-c21b627149a2,,Neoadjuvant,19.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-1099-C84_treatment6,8c280a3c-7e76-4ce3-abdb-9fbdef7c8958,,released,Etoposide,1,2021-12-21T15:23:12.145029-06:00,Chemotherapy,,
HCM-BROD-1099-C84,5e2f613c-4a63-44da-b367-329c9245a762,416a3d59-4951-46a1-9b4b-c21b627149a2,,Neoadjuvant,274.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-1099-C84_treatment9,8f55f129-39ca-4335-b900-5d09fde465c2,,released,,1,2021-12-21T15:23:12.145029-06:00,Immunotherapy (Including Vaccines),,
HCM-BROD-1099-C84,5e2f613c-4a63-44da-b367-329c9245a762,416a3d59-4951-46a1-9b4b-c21b627149a2,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-BROD-1099-C84_treatment11,adeda203-c7d2-4ddb-932c-20267041f9d1,,released,,0,2021-12-21T15:23:12.145029-06:00,"Pharmaceutical Therapy, NOS",Residual Disease,
HCM-BROD-1099-C84,5e2f613c-4a63-44da-b367-329c9245a762,416a3d59-4951-46a1-9b4b-c21b627149a2,,Neoadjuvant,19.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-1099-C84_treatment2,cde37d1d-0fd4-4c6b-b5eb-dd184baf1634,,released,Cyclophosphamide,1,2021-12-21T15:23:12.145029-06:00,Chemotherapy,,
HCM-BROD-1099-C84,5e2f613c-4a63-44da-b367-329c9245a762,416a3d59-4951-46a1-9b4b-c21b627149a2,,Neoadjuvant,19.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-1099-C84_treatment8,df2ae7ce-d89e-4307-9fe9-0ed6f2a6797a,,released,Prednisone,1,2021-12-21T15:23:12.145029-06:00,Chemotherapy,,
HCM-WCMC-0675-C67,5e44aad4-b3e9-4007-9983-e41188b749c9,a8b4d8fd-6f7a-4cfb-8bc1-dde88d2ef5d7,5021.0,Adjuvant,4400.0,2025-03-31T16:34:59.906497-05:00,HCM-WCMC-0675-C67_treatment4,18262690-e942-4d14-bcb6-5dd0ba8a326e,,released,Pembrolizumab,1,2023-02-27T13:24:36.630783-06:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-WCMC-0675-C67,5e44aad4-b3e9-4007-9983-e41188b749c9,a8b4d8fd-6f7a-4cfb-8bc1-dde88d2ef5d7,,Adjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-WCMC-0675-C67_treatment6,4136dc83-640b-49b9-8a1e-2d1b16690ded,,released,,0,2023-02-27T13:24:36.630783-06:00,Targeted Molecular Therapy,Residual Disease,
HCM-WCMC-0675-C67,5e44aad4-b3e9-4007-9983-e41188b749c9,a8b4d8fd-6f7a-4cfb-8bc1-dde88d2ef5d7,5021.0,Adjuvant,5021.0,2025-03-31T16:34:59.906497-05:00,HCM-WCMC-0675-C67_treatment7,77603ae9-9f7d-4241-9664-41c385fd36cb,,released,,1,2023-02-27T13:24:36.630783-06:00,"Radiation, Stereotactic/Gamma Knife/SRS",Residual Disease,
HCM-WCMC-0675-C67,5e44aad4-b3e9-4007-9983-e41188b749c9,a8b4d8fd-6f7a-4cfb-8bc1-dde88d2ef5d7,,,693.0,2025-03-31T16:34:59.906497-05:00,HCM-WCMC-0675-C67_treatment5,b82050fd-ea4b-41c2-a35e-bcf0365cd4a7,,released,,1,2023-02-27T13:24:36.630783-06:00,"Surgery, NOS",Initial Diagnosis,
HCM-WCMC-0675-C67,5e44aad4-b3e9-4007-9983-e41188b749c9,a8b4d8fd-6f7a-4cfb-8bc1-dde88d2ef5d7,,Adjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-WCMC-0675-C67_treatment2,b86c84b0-f144-4732-8b61-2a90d45be1ad,,released,,0,2023-02-27T13:24:36.630783-06:00,Chemotherapy,Residual Disease,
HCM-WCMC-0675-C67,5e44aad4-b3e9-4007-9983-e41188b749c9,a8b4d8fd-6f7a-4cfb-8bc1-dde88d2ef5d7,,Adjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-WCMC-0675-C67_treatment3,c0cb4a2a-ca62-4886-b71f-34e4f0bf648d,,released,,0,2023-02-27T13:24:36.630783-06:00,Hormone Therapy,Residual Disease,
HCM-WCMC-0675-C67,5e44aad4-b3e9-4007-9983-e41188b749c9,a8b4d8fd-6f7a-4cfb-8bc1-dde88d2ef5d7,,Neoadjuvant,693.0,2025-03-31T16:34:59.906497-05:00,HCM-WCMC-0675-C67_treatment,ca91235a-a9e6-4398-90c5-e55ac10ac63d,,released,,1,2023-02-27T13:24:36.630783-06:00,Immunotherapy (Including Vaccines),,
HCM-BROD-0014-C71,5e5684d2-14b0-4823-9956-d69aea6d6beb,ba1d7f88-da33-4a82-84d1-5c8192c6842d,,Adjuvant,,2020-01-13T20:10:25.832065-06:00,HCM-BROD-0014-C71_treatment5,0d898e5a-bfc7-44e3-9c41-fd282eac38d0,,released,,unknown,2019-04-04T14:17:46.995307-05:00,Targeted Molecular Therapy,Residual Disease,
HCM-BROD-0014-C71,5e5684d2-14b0-4823-9956-d69aea6d6beb,ba1d7f88-da33-4a82-84d1-5c8192c6842d,,Adjuvant,,2020-01-13T20:10:25.832065-06:00,HCM-BROD-0014-C71_treatment2,2586bd24-2518-454f-9f38-588980faa357,,released,,unknown,2019-04-04T14:17:46.995307-05:00,Chemotherapy,Residual Disease,
HCM-BROD-0014-C71,5e5684d2-14b0-4823-9956-d69aea6d6beb,ba1d7f88-da33-4a82-84d1-5c8192c6842d,,,-6.0,2023-03-13T13:00:33.467907-05:00,HCM-BROD-0014-C71_treatment4,4247142f-0652-4531-b772-7bc8b50b273e,,released,,1,2019-04-04T14:17:46.995307-05:00,"Surgery, NOS",Initial Diagnosis,
HCM-BROD-0014-C71,5e5684d2-14b0-4823-9956-d69aea6d6beb,ba1d7f88-da33-4a82-84d1-5c8192c6842d,,Adjuvant,,2020-01-13T20:10:25.832065-06:00,HCM-BROD-0014-C71_treatment6,4a9ef5db-4bce-4564-83f9-8814fa3d398a,,released,,unknown,2019-04-04T14:17:46.995307-05:00,"Radiation Therapy, NOS",Residual Disease,
HCM-BROD-0014-C71,5e5684d2-14b0-4823-9956-d69aea6d6beb,ba1d7f88-da33-4a82-84d1-5c8192c6842d,,Adjuvant,,2020-01-13T20:10:25.832065-06:00,HCM-BROD-0014-C71_treatment3,62b7f38e-9dcc-4f78-9312-18f376376db2,,released,,unknown,2019-04-04T14:17:46.995307-05:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-BROD-0014-C71,5e5684d2-14b0-4823-9956-d69aea6d6beb,ba1d7f88-da33-4a82-84d1-5c8192c6842d,,Neoadjuvant,,2020-01-13T20:10:25.832065-06:00,HCM-BROD-0014-C71_treatment,6ff2363a-d7cd-48f0-965a-1fd83da2664b,,released,,0,2019-03-12T10:15:41.981178-05:00,,,
HCM-BROD-0129-C25,5ea6bd70-feef-407b-8b88-55fcb2695e7d,908a5955-92eb-4c27-807c-ca861bd080fe,241.0,Adjuvant,85.0,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0129-C25_treatment2,43c7c303-67dc-4146-927a-6e5e0f0061bb,,released,Gemcitabine,1,2020-09-17T15:58:23.646791-05:00,Chemotherapy,Residual Disease,
HCM-BROD-0129-C25,5ea6bd70-feef-407b-8b88-55fcb2695e7d,908a5955-92eb-4c27-807c-ca861bd080fe,,Adjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0129-C25_treatment3,78b6f764-a9ec-4ab0-9556-7e037e3ee24a,,released,,0,2020-09-17T15:58:23.646791-05:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-BROD-0129-C25,5ea6bd70-feef-407b-8b88-55fcb2695e7d,908a5955-92eb-4c27-807c-ca861bd080fe,,,42.0,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0129-C25_treatment4,7dd4e0b4-3e0e-440f-aa8d-c472ab3b407b,,released,,1,2020-09-17T15:58:23.646791-05:00,"Surgery, NOS",Initial Diagnosis,
HCM-BROD-0129-C25,5ea6bd70-feef-407b-8b88-55fcb2695e7d,908a5955-92eb-4c27-807c-ca861bd080fe,,Adjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0129-C25_treatment5,873fb173-b4bf-4ca1-ab12-7aa2cd0851b8,,released,,0,2020-09-17T15:58:23.646791-05:00,Targeted Molecular Therapy,Residual Disease,
HCM-BROD-0129-C25,5ea6bd70-feef-407b-8b88-55fcb2695e7d,908a5955-92eb-4c27-807c-ca861bd080fe,,Adjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0129-C25_treatment6,b9f5abec-ab64-4b28-9c34-13e24830de72,,released,,0,2020-09-17T15:58:23.646791-05:00,"Radiation Therapy, NOS",Residual Disease,
HCM-BROD-0129-C25,5ea6bd70-feef-407b-8b88-55fcb2695e7d,908a5955-92eb-4c27-807c-ca861bd080fe,,Neoadjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0129-C25_treatment,f8997161-8bd4-48a7-8b5b-b121fe5d2607,,released,,unknown,2020-09-17T15:58:23.646791-05:00,"Pharmaceutical Therapy, NOS",,
HCM-BROD-0611-C71,5ec86383-f228-4987-a10a-214a603932f8,c0e4677a-9a45-4510-a565-e7567702bd2f,552.0,Adjuvant,377.0,2023-07-13T10:35:44.371881-05:00,HCM-BROD-0611-C71_treatment3,13696381-6184-4fa0-89bc-2d3f9122e29b,,released,Pembrolizumab,1,2021-12-21T13:40:51.118675-06:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-BROD-0611-C71,5ec86383-f228-4987-a10a-214a603932f8,c0e4677a-9a45-4510-a565-e7567702bd2f,781.0,Adjuvant,46.0,2023-07-13T10:35:44.371881-05:00,HCM-BROD-0611-C71_treatment5,46fb6360-3b8c-4999-8e48-b820b0a34d22,,released,Bevacizumab,1,2021-12-21T13:40:51.118675-06:00,Targeted Molecular Therapy,Residual Disease,
HCM-BROD-0611-C71,5ec86383-f228-4987-a10a-214a603932f8,c0e4677a-9a45-4510-a565-e7567702bd2f,,,-3.0,2023-07-13T10:35:44.371881-05:00,HCM-BROD-0611-C71_treatment4,6d88984a-0296-48a7-8d7c-b118f979bd7b,,released,,1,2021-12-21T13:40:51.118675-06:00,"Surgery, NOS",Initial Diagnosis,
HCM-BROD-0611-C71,5ec86383-f228-4987-a10a-214a603932f8,c0e4677a-9a45-4510-a565-e7567702bd2f,,Neoadjuvant,,2023-07-13T10:35:44.371881-05:00,HCM-BROD-0611-C71_treatment,b80ffd22-44bf-4616-a28a-c227ac1c2c8a,,released,,0,2021-12-21T13:40:51.118675-06:00,,,
HCM-BROD-0611-C71,5ec86383-f228-4987-a10a-214a603932f8,c0e4677a-9a45-4510-a565-e7567702bd2f,107.0,Adjuvant,46.0,2023-07-13T10:35:44.371881-05:00,HCM-BROD-0611-C71_treatment2,d4c1ab21-b37f-409c-b5d4-a32d156ee4ba,,released,Temozolomide,1,2021-12-21T13:40:51.118675-06:00,Chemotherapy,Residual Disease,
HCM-BROD-0611-C71,5ec86383-f228-4987-a10a-214a603932f8,c0e4677a-9a45-4510-a565-e7567702bd2f,77.0,Adjuvant,46.0,2023-07-13T10:35:44.371881-05:00,HCM-BROD-0611-C71_treatment6,dbc2d070-c6f7-4167-8547-c1c9176c8a0b,,released,,1,2021-12-21T13:40:51.118675-06:00,"Radiation, 3D Conformal",Residual Disease,
HCM-BROD-0611-C71,5ec86383-f228-4987-a10a-214a603932f8,d64d123d-9098-4515-af9b-ec51c59d6829,552.0,Maintenance Therapy,40.0,2023-07-13T10:35:44.371881-05:00,HCM-BROD-0611-C71_treatment9,133215c9-315a-49a3-88b9-fadb25aa2936,Treatment Ongoing,released,Pembrolizumab,1,2021-12-21T13:40:51.118675-06:00,,,
HCM-BROD-0611-C71,5ec86383-f228-4987-a10a-214a603932f8,d64d123d-9098-4515-af9b-ec51c59d6829,552.0,Maintenance Therapy,40.0,2023-07-13T10:35:44.371881-05:00,HCM-BROD-0611-C71_treatment8,36064817-a6c9-472a-b0bc-aca34fbfe473,Treatment Ongoing,released,Temozolomide,1,2021-12-21T13:40:51.118675-06:00,,,
HCM-BROD-0611-C71,5ec86383-f228-4987-a10a-214a603932f8,d64d123d-9098-4515-af9b-ec51c59d6829,552.0,Maintenance Therapy,40.0,2023-07-13T10:35:44.371881-05:00,HCM-BROD-0611-C71_treatment7,72053212-de3e-4efe-bf32-49e260de7d66,Treatment Ongoing,released,Bavituximab,1,2021-12-21T13:40:51.118675-06:00,,,
HCM-SANG-1315-C18,5f93dc35-0917-4206-bc5f-8903db299abc,cf874eaf-b593-45f2-b99c-b3bcbefe5ad2,,Neoadjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-SANG-1315-C18_treatment,5f09d207-3eaf-423b-b63d-9a25d35da56f,,released,,0,2023-02-27T11:50:03.066599-06:00,,,
HCM-BROD-0958-C56,5fd76dd8-87e1-422d-bac2-63e447ca3ba4,6ab071c3-07c7-4e65-a3d5-cab43509e113,,Neoadjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0958-C56_treatment,336da3a9-e685-4457-b6e4-895a1bc29712,,released,,0,2021-12-21T13:58:45.389627-06:00,,,
HCM-BROD-0958-C56,5fd76dd8-87e1-422d-bac2-63e447ca3ba4,6ab071c3-07c7-4e65-a3d5-cab43509e113,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0958-C56_treatment7,4a8be664-a55f-4692-b960-b405428c9646,,released,,0,2021-12-21T13:58:45.389627-06:00,"Radiation Therapy, NOS",Residual Disease,
HCM-BROD-0958-C56,5fd76dd8-87e1-422d-bac2-63e447ca3ba4,6ab071c3-07c7-4e65-a3d5-cab43509e113,,,0.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0958-C56_treatment5,6104921c-be7c-4ef5-8a4a-6b6a86986627,,released,,1,2021-12-21T13:58:45.389627-06:00,"Surgery, NOS",Initial Diagnosis,
HCM-BROD-0958-C56,5fd76dd8-87e1-422d-bac2-63e447ca3ba4,6ab071c3-07c7-4e65-a3d5-cab43509e113,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0958-C56_treatment6,74f5d5ab-b99a-44b7-930b-2c44aeb35415,,released,,0,2021-12-21T13:58:45.389627-06:00,Targeted Molecular Therapy,Residual Disease,
HCM-BROD-0958-C56,5fd76dd8-87e1-422d-bac2-63e447ca3ba4,6ab071c3-07c7-4e65-a3d5-cab43509e113,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0958-C56_treatment4,7eee1a7c-3070-4782-8e3e-85b650403d2e,,released,,0,2021-12-21T13:58:45.389627-06:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-BROD-0958-C56,5fd76dd8-87e1-422d-bac2-63e447ca3ba4,6ab071c3-07c7-4e65-a3d5-cab43509e113,1429.0,Adjuvant,1346.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0958-C56_treatment2,d249c685-c6e5-4c73-8b9f-de1c2329cdba,,released,Carboplatin,1,2021-12-21T13:58:45.389627-06:00,Chemotherapy,Residual Disease,
HCM-BROD-0958-C56,5fd76dd8-87e1-422d-bac2-63e447ca3ba4,6ab071c3-07c7-4e65-a3d5-cab43509e113,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0958-C56_treatment3,fd8c563d-1f2f-4e25-a172-101d75717fc4,,released,,0,2021-12-21T13:58:45.389627-06:00,Hormone Therapy,Residual Disease,
HCM-BROD-0958-C56,5fd76dd8-87e1-422d-bac2-63e447ca3ba4,89dcf4e4-5c6d-417d-9e77-1e65564dc365,1291.0,Maintenance Therapy,31.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0958-C56_treatment11,0ea05712-0136-4e60-a8a4-aefbcea0facc,Progressive Disease,released,Doxorubicin,1,2021-12-21T13:58:45.389627-06:00,,,
HCM-BROD-0958-C56,5fd76dd8-87e1-422d-bac2-63e447ca3ba4,89dcf4e4-5c6d-417d-9e77-1e65564dc365,1291.0,Maintenance Therapy,31.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0958-C56_treatment14,48d56289-2882-4c85-876b-14cbb4f73521,Progressive Disease,released,Vinorelbine,1,2021-12-21T13:58:45.389627-06:00,,,
HCM-BROD-0958-C56,5fd76dd8-87e1-422d-bac2-63e447ca3ba4,89dcf4e4-5c6d-417d-9e77-1e65564dc365,1291.0,Maintenance Therapy,31.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0958-C56_treatment13,5aa1019d-7c93-446e-bccf-ba7e4f80617b,Progressive Disease,released,Olaparib,1,2021-12-21T13:58:45.389627-06:00,,,
HCM-BROD-0958-C56,5fd76dd8-87e1-422d-bac2-63e447ca3ba4,89dcf4e4-5c6d-417d-9e77-1e65564dc365,1291.0,Maintenance Therapy,31.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0958-C56_treatment8,6abb2ebe-0db6-4d69-b324-25878531c942,Progressive Disease,released,Gemcitabine,1,2021-12-21T13:58:45.389627-06:00,,,
HCM-BROD-0958-C56,5fd76dd8-87e1-422d-bac2-63e447ca3ba4,89dcf4e4-5c6d-417d-9e77-1e65564dc365,1291.0,Maintenance Therapy,31.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0958-C56_treatment9,6cb63472-946e-4cb9-bac1-6abf2492774a,Progressive Disease,released,Carboplatin,1,2021-12-21T13:58:45.389627-06:00,,,
HCM-BROD-0958-C56,5fd76dd8-87e1-422d-bac2-63e447ca3ba4,89dcf4e4-5c6d-417d-9e77-1e65564dc365,1291.0,Maintenance Therapy,31.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0958-C56_treatment10,7f3e7139-c3d6-452b-a5a5-7564090e6b87,Progressive Disease,released,Paclitaxel,1,2021-12-21T13:58:45.389627-06:00,,,
HCM-BROD-0958-C56,5fd76dd8-87e1-422d-bac2-63e447ca3ba4,89dcf4e4-5c6d-417d-9e77-1e65564dc365,1291.0,Maintenance Therapy,31.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0958-C56_treatment12,9c7572df-ea99-435d-87dd-c8dad56a5882,Progressive Disease,released,Bevacizumab,1,2021-12-21T13:58:45.389627-06:00,,,
HCM-WCMC-0671-C18,603035e9-eef7-490a-a102-af4eb005fb73,eb926bf9-6d68-4bda-948b-e1266312e800,88.0,Adjuvant,46.0,2023-02-22T07:39:25.979291-06:00,HCM-WCMC-0671-C18_treatment2,1813455c-617c-4c36-8c05-489e67669efa,,released,Oxaliplatin,1,2022-07-06T10:24:47.413062-05:00,Chemotherapy,Residual Disease,
HCM-WCMC-0671-C18,603035e9-eef7-490a-a102-af4eb005fb73,eb926bf9-6d68-4bda-948b-e1266312e800,,Adjuvant,,2023-02-22T07:39:25.979291-06:00,HCM-WCMC-0671-C18_treatment5,28c194af-f9cf-4bd9-9774-102f74581184,,released,,unknown,2022-07-06T10:24:47.413062-05:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-WCMC-0671-C18,603035e9-eef7-490a-a102-af4eb005fb73,eb926bf9-6d68-4bda-948b-e1266312e800,,Neoadjuvant,,2023-02-22T07:39:25.979291-06:00,HCM-WCMC-0671-C18_treatment,49b57a26-5fa9-4c9c-afe0-ba7b5afc5958,,released,,0,2022-07-06T10:24:47.413062-05:00,,,
HCM-WCMC-0671-C18,603035e9-eef7-490a-a102-af4eb005fb73,eb926bf9-6d68-4bda-948b-e1266312e800,,Adjuvant,,2023-02-22T07:39:25.979291-06:00,HCM-WCMC-0671-C18_treatment7,5a3f91ba-bc33-4dae-9464-b26684e6d5a2,,released,,unknown,2022-07-06T10:24:47.413062-05:00,Targeted Molecular Therapy,Residual Disease,
HCM-WCMC-0671-C18,603035e9-eef7-490a-a102-af4eb005fb73,eb926bf9-6d68-4bda-948b-e1266312e800,88.0,Adjuvant,46.0,2023-02-22T07:39:25.979291-06:00,HCM-WCMC-0671-C18_treatment3,7491645b-aae0-4ca2-bca6-64934ccfe8ce,,released,Capecitabine,1,2022-07-06T10:24:47.413062-05:00,Chemotherapy,Residual Disease,
HCM-WCMC-0671-C18,603035e9-eef7-490a-a102-af4eb005fb73,eb926bf9-6d68-4bda-948b-e1266312e800,88.0,Adjuvant,46.0,2023-02-22T07:39:25.979291-06:00,HCM-WCMC-0671-C18_treatment4,d902368b-f5d3-4578-8e24-496be3be1da8,,released,,1,2022-07-06T10:24:47.413062-05:00,Chemotherapy,Residual Disease,XELOX
HCM-WCMC-0671-C18,603035e9-eef7-490a-a102-af4eb005fb73,eb926bf9-6d68-4bda-948b-e1266312e800,,,0.0,2023-03-13T13:03:37.092948-05:00,HCM-WCMC-0671-C18_treatment6,ee0e3194-8b0a-4227-acd3-b1456445ab1a,,released,,1,2022-07-06T10:24:47.413062-05:00,"Surgery, NOS",Initial Diagnosis,
HCM-WCMC-0671-C18,603035e9-eef7-490a-a102-af4eb005fb73,eb926bf9-6d68-4bda-948b-e1266312e800,,Adjuvant,,2023-02-22T07:39:25.979291-06:00,HCM-WCMC-0671-C18_treatment8,efe7ac60-ef2c-4bf0-b2a6-07c2cebb4691,,released,,unknown,2022-07-06T10:24:47.413062-05:00,"Radiation Therapy, NOS",Residual Disease,
HCM-CSHL-0164-C20,6058fb8d-eb5d-4dbc-b939-7e92c7cd2776,1f1bf129-fcfa-43f9-8726-4e50323d183e,,Adjuvant,,2023-03-13T12:43:48.711224-05:00,HCM-CSHL-0164-C20_treatment15,09fe91b9-ca3e-4126-9045-60c63e9c222f,,released,,unknown,2020-09-27T13:03:40.864508-05:00,"Radiation Therapy, NOS",Residual Disease,
HCM-CSHL-0164-C20,6058fb8d-eb5d-4dbc-b939-7e92c7cd2776,1f1bf129-fcfa-43f9-8726-4e50323d183e,163.0,Maintenance Therapy,37.0,2021-08-26T08:54:54.023984-05:00,HCM-CSHL-0164-C20_treatment8,41cdcb80-427f-4225-9ccb-5b6dfcb22993,Treatment Ongoing,released,Fluorouracil,1,2020-09-27T13:03:40.864508-05:00,,Progressive Disease,
HCM-CSHL-0164-C20,6058fb8d-eb5d-4dbc-b939-7e92c7cd2776,1f1bf129-fcfa-43f9-8726-4e50323d183e,,Adjuvant,,2023-03-13T12:43:48.711224-05:00,HCM-CSHL-0164-C20_treatment14,46348995-bc0c-4dc5-ae32-33c9f1ab470c,,released,,unknown,2020-09-27T13:03:40.864508-05:00,"Pharmaceutical Therapy, NOS",Residual Disease,
HCM-CSHL-0164-C20,6058fb8d-eb5d-4dbc-b939-7e92c7cd2776,1f1bf129-fcfa-43f9-8726-4e50323d183e,,Neoadjuvant,37.0,2021-01-06T22:55:10.531130-06:00,HCM-CSHL-0164-C20_treatment3,5fc998c2-4741-4d6c-bc18-d3a410b2b142,,released,Oxaliplatin,1,2020-02-27T12:49:04.421900-06:00,Chemotherapy,,
HCM-CSHL-0164-C20,6058fb8d-eb5d-4dbc-b939-7e92c7cd2776,1f1bf129-fcfa-43f9-8726-4e50323d183e,,Neoadjuvant,37.0,2021-01-06T22:55:10.531130-06:00,HCM-CSHL-0164-C20_treatment4,617105e9-3995-4548-a44f-3dc827bc2dc6,,released,,1,2020-02-27T12:49:04.421900-06:00,Chemotherapy,,FOLFOX
HCM-CSHL-0164-C20,6058fb8d-eb5d-4dbc-b939-7e92c7cd2776,1f1bf129-fcfa-43f9-8726-4e50323d183e,,Neoadjuvant,37.0,2021-08-26T08:54:54.023984-05:00,HCM-CSHL-0164-C20_treatment6,705d2394-f5c2-41a7-a017-f438f132cf25,,released,,1,2020-02-27T12:49:04.421900-06:00,Chemotherapy,,FOLFOXIRI
HCM-CSHL-0164-C20,6058fb8d-eb5d-4dbc-b939-7e92c7cd2776,1f1bf129-fcfa-43f9-8726-4e50323d183e,,,272.0,2023-03-13T12:43:48.711224-05:00,HCM-CSHL-0164-C20_treatment13,7d9f1c66-7bd5-4fa3-8ac5-ba8b343ab8eb,,released,,1,2020-09-27T13:03:40.864508-05:00,"Surgery, NOS",Initial Diagnosis,
HCM-CSHL-0164-C20,6058fb8d-eb5d-4dbc-b939-7e92c7cd2776,1f1bf129-fcfa-43f9-8726-4e50323d183e,,Neoadjuvant,37.0,2021-01-06T22:55:10.531130-06:00,HCM-CSHL-0164-C20_treatment2,a06e6755-372c-4727-9533-b2a3eb750fa6,,released,Fluorouracil,1,2020-02-27T12:49:04.421900-06:00,Chemotherapy,,
HCM-CSHL-0164-C20,6058fb8d-eb5d-4dbc-b939-7e92c7cd2776,1f1bf129-fcfa-43f9-8726-4e50323d183e,163.0,Maintenance Therapy,37.0,2021-08-26T08:54:54.023984-05:00,HCM-CSHL-0164-C20_treatment7,b072a765-6839-4db4-b09c-d8cca341736e,Treatment Ongoing,released,Leucovorin Calcium,1,2020-09-27T13:03:40.864508-05:00,,Progressive Disease,
HCM-CSHL-0164-C20,6058fb8d-eb5d-4dbc-b939-7e92c7cd2776,1f1bf129-fcfa-43f9-8726-4e50323d183e,163.0,Maintenance Therapy,37.0,2021-08-26T08:54:54.023984-05:00,HCM-CSHL-0164-C20_treatment12,cd29e5a3-1ce4-4d78-9836-9758a466b034,Treatment Ongoing,released,,1,2020-09-27T13:03:40.864508-05:00,,Progressive Disease,FOLFOXIRI
HCM-CSHL-0164-C20,6058fb8d-eb5d-4dbc-b939-7e92c7cd2776,1f1bf129-fcfa-43f9-8726-4e50323d183e,163.0,Maintenance Therapy,37.0,2021-08-26T08:54:54.023984-05:00,HCM-CSHL-0164-C20_treatment9,d00addc6-183d-43d8-8ad5-fbf1d13f529d,Treatment Ongoing,released,Oxaliplatin,1,2020-09-27T13:03:40.864508-05:00,,Progressive Disease,
HCM-CSHL-0164-C20,6058fb8d-eb5d-4dbc-b939-7e92c7cd2776,1f1bf129-fcfa-43f9-8726-4e50323d183e,163.0,Maintenance Therapy,37.0,2021-08-26T08:54:54.023984-05:00,HCM-CSHL-0164-C20_treatment10,d7a92524-4ba1-499e-801d-0b70c3df822a,Treatment Ongoing,released,Irinotecan,1,2020-09-27T13:03:40.864508-05:00,,Progressive Disease,
HCM-CSHL-0164-C20,6058fb8d-eb5d-4dbc-b939-7e92c7cd2776,1f1bf129-fcfa-43f9-8726-4e50323d183e,,Neoadjuvant,37.0,2021-01-06T22:55:10.531130-06:00,HCM-CSHL-0164-C20_treatment,d934ff0e-fa10-4955-83f6-912aa088753d,,released,Leucovorin Calcium,1,2020-02-27T12:49:04.421900-06:00,Chemotherapy,,
HCM-CSHL-0164-C20,6058fb8d-eb5d-4dbc-b939-7e92c7cd2776,1f1bf129-fcfa-43f9-8726-4e50323d183e,163.0,Maintenance Therapy,37.0,2021-08-26T08:54:54.023984-05:00,HCM-CSHL-0164-C20_treatment11,edc647aa-28aa-4c30-90e2-66f1c9596be7,Treatment Ongoing,released,,1,2020-09-27T13:03:40.864508-05:00,,Progressive Disease,FOLFOX
HCM-CSHL-0164-C20,6058fb8d-eb5d-4dbc-b939-7e92c7cd2776,1f1bf129-fcfa-43f9-8726-4e50323d183e,,Neoadjuvant,37.0,2021-08-26T08:54:54.023984-05:00,HCM-CSHL-0164-C20_treatment5,ee2f1674-4acd-4391-ab10-c08bc1f0d328,,released,Irinotecan,1,2020-02-27T12:49:04.421900-06:00,Chemotherapy,,
HCM-SANG-1329-C15,612e9381-a24f-49cb-8d48-1f4e1b90f64c,ee33764d-232f-4a30-9e56-7eec310eea1b,,Neoadjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-SANG-1329-C15_treatment,94647a0c-f9da-48ef-a10a-46479f0ab3c8,,released,,0,2023-02-27T12:04:31.149300-06:00,,,
HCM-CSHL-0773-C50,6135448b-e32a-4836-8355-b00036503577,6ac827aa-3756-4a9e-b3df-2e922f821073,,Maintenance Therapy,,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0773-C50_treatment15,281a96e0-49fc-4d00-8288-2e1d90349df2,Treatment Ongoing,released,Nab-paclitaxel,1,2021-12-21T14:23:45.161475-06:00,,,
HCM-CSHL-0773-C50,6135448b-e32a-4836-8355-b00036503577,6ac827aa-3756-4a9e-b3df-2e922f821073,,Maintenance Therapy,,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0773-C50_treatment16,28a75c90-0fc3-4e8f-98bd-5c86f1e8da5c,Treatment Ongoing,released,Xeloda,1,2021-12-21T14:23:45.161475-06:00,,,
HCM-CSHL-0773-C50,6135448b-e32a-4836-8355-b00036503577,6ac827aa-3756-4a9e-b3df-2e922f821073,,Maintenance Therapy,,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0773-C50_treatment18,3b960c1b-a8b0-46ae-8d87-aee889ff7f72,Treatment Ongoing,released,Anastrozole,1,2021-12-21T14:23:45.161475-06:00,,,
HCM-CSHL-0773-C50,6135448b-e32a-4836-8355-b00036503577,6ac827aa-3756-4a9e-b3df-2e922f821073,,Maintenance Therapy,,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0773-C50_treatment17,93d09e16-05b9-4c94-b5d7-7b549b850e25,Treatment Ongoing,released,Letrozole,1,2021-12-21T14:23:45.161475-06:00,,,
HCM-CSHL-0773-C50,6135448b-e32a-4836-8355-b00036503577,6ac827aa-3756-4a9e-b3df-2e922f821073,,Prevention,,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0773-C50_treatment20,c39c29ff-0b03-4530-ace2-a142f4bc523d,,released,,0,2021-12-21T14:23:45.161475-06:00,Hormone Therapy,,
HCM-CSHL-0773-C50,6135448b-e32a-4836-8355-b00036503577,ceeaa9ad-43f6-4466-80c8-ad2eaa0e42de,3808.0,Adjuvant,3794.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0773-C50_treatment14,1b59c13d-a1fe-4ecd-8299-5093d4221b31,,released,,1,2021-12-21T14:23:45.161475-06:00,"Radiation Therapy, NOS",Residual Disease,
HCM-CSHL-0773-C50,6135448b-e32a-4836-8355-b00036503577,ceeaa9ad-43f6-4466-80c8-ad2eaa0e42de,,Prevention,,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0773-C50_treatment19,3e57c94e-ddf1-426d-9754-d2b43d4ef03c,,released,,0,2021-12-21T14:23:45.161475-06:00,Hormone Therapy,,
HCM-CSHL-0773-C50,6135448b-e32a-4836-8355-b00036503577,ceeaa9ad-43f6-4466-80c8-ad2eaa0e42de,3979.0,Adjuvant,3817.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0773-C50_treatment3,43de2a69-aeeb-4588-8ed0-dd29c2aa689c,,released,Capecitabine,1,2021-12-21T14:23:45.161475-06:00,Chemotherapy,Residual Disease,
HCM-CSHL-0773-C50,6135448b-e32a-4836-8355-b00036503577,ceeaa9ad-43f6-4466-80c8-ad2eaa0e42de,,,3.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0773-C50_treatment12,5a396c7b-e17f-473a-a23e-33d2f9764a0f,,released,,1,2021-12-21T14:23:45.161475-06:00,"Surgery, NOS",Initial Diagnosis,
HCM-CSHL-0773-C50,6135448b-e32a-4836-8355-b00036503577,ceeaa9ad-43f6-4466-80c8-ad2eaa0e42de,1526.0,Adjuvant,54.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0773-C50_treatment8,738a242b-4da7-4f73-9fd3-e1f58b6ebfcf,,released,Not Reported,1,2021-12-21T14:23:45.161475-06:00,Hormone Therapy,Residual Disease,
HCM-CSHL-0773-C50,6135448b-e32a-4836-8355-b00036503577,ceeaa9ad-43f6-4466-80c8-ad2eaa0e42de,,Adjuvant,4507.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0773-C50_treatment7,74d40bad-2e9c-48b0-8523-bf11fea99d57,,released,Carboplatin,1,2021-12-21T14:23:45.161475-06:00,Chemotherapy,Residual Disease,
HCM-CSHL-0773-C50,6135448b-e32a-4836-8355-b00036503577,ceeaa9ad-43f6-4466-80c8-ad2eaa0e42de,,Adjuvant,4638.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0773-C50_treatment6,85ba0fc8-ed19-4d29-9e6a-d2085b87d91f,Treatment Ongoing,released,Docetaxel,1,2021-12-21T14:23:45.161475-06:00,Chemotherapy,Residual Disease,
HCM-CSHL-0773-C50,6135448b-e32a-4836-8355-b00036503577,ceeaa9ad-43f6-4466-80c8-ad2eaa0e42de,4467.0,Adjuvant,4420.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0773-C50_treatment13,860cbff5-f53e-4eec-a597-d862774ff98a,,released,Everolimus,1,2021-12-21T14:23:45.161475-06:00,Targeted Molecular Therapy,Residual Disease,
HCM-CSHL-0773-C50,6135448b-e32a-4836-8355-b00036503577,ceeaa9ad-43f6-4466-80c8-ad2eaa0e42de,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0773-C50_treatment11,aa5641da-7e70-43ed-b66b-186bd141f459,,released,Not Reported,1,2021-12-21T14:23:45.161475-06:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-CSHL-0773-C50,6135448b-e32a-4836-8355-b00036503577,ceeaa9ad-43f6-4466-80c8-ad2eaa0e42de,4194.0,Adjuvant,4141.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0773-C50_treatment4,b22e7d3f-201b-45d0-9ccc-5dbb70c0e305,,released,Pegylated Liposomal Doxorubicin Hydrochloride,1,2021-12-21T14:23:45.161475-06:00,Chemotherapy,Residual Disease,
HCM-CSHL-0773-C50,6135448b-e32a-4836-8355-b00036503577,ceeaa9ad-43f6-4466-80c8-ad2eaa0e42de,,Adjuvant,4305.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0773-C50_treatment10,c6a06d40-405e-404e-9302-11e496b46e68,,released,Sacituzumab Govitecan,1,2021-12-21T14:23:45.161475-06:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-CSHL-0773-C50,6135448b-e32a-4836-8355-b00036503577,ceeaa9ad-43f6-4466-80c8-ad2eaa0e42de,,Neoadjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0773-C50_treatment,d6838390-57bd-40c7-8ad1-d1ad490268d1,,released,,0,2021-12-21T14:23:45.161475-06:00,,,
HCM-CSHL-0773-C50,6135448b-e32a-4836-8355-b00036503577,ceeaa9ad-43f6-4466-80c8-ad2eaa0e42de,4132.0,Adjuvant,3979.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0773-C50_treatment2,e67c6ef6-643a-47ad-aa93-1fbed5f67d87,,released,Paclitaxel,1,2021-12-21T14:23:45.161475-06:00,Chemotherapy,Residual Disease,
HCM-CSHL-0773-C50,6135448b-e32a-4836-8355-b00036503577,ceeaa9ad-43f6-4466-80c8-ad2eaa0e42de,4254.0,Adjuvant,4227.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0773-C50_treatment5,f15eaa71-3143-4129-b18d-c57561952979,,released,Eribulin Mesylate,1,2021-12-21T14:23:45.161475-06:00,Chemotherapy,Residual Disease,
HCM-CSHL-0773-C50,6135448b-e32a-4836-8355-b00036503577,ceeaa9ad-43f6-4466-80c8-ad2eaa0e42de,1880.0,Adjuvant,1545.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0773-C50_treatment9,f2fa0011-4ccb-4b52-b6eb-d8874eb22f59,,released,Letrozole,1,2021-12-21T14:23:45.161475-06:00,Hormone Therapy,Residual Disease,
HCM-WCMC-1359-C34,6199d20e-91c3-4ebb-9f87-16777ab803d6,76710a04-3b6c-4499-b0dc-8c5318292bfd,119.0,Adjuvant,56.0,2025-04-07T17:13:09.336794-05:00,HCM-WCMC-1359-C34_treatment4,2b1eee57-86a7-496e-b42c-d31e62b8381e,,released,,1,2023-02-27T11:31:25.359113-06:00,Chemotherapy,Residual Disease,Cisplatin-Pemetrexed regimen
HCM-WCMC-1359-C34,6199d20e-91c3-4ebb-9f87-16777ab803d6,76710a04-3b6c-4499-b0dc-8c5318292bfd,119.0,Adjuvant,56.0,2025-04-07T17:13:09.336794-05:00,HCM-WCMC-1359-C34_treatment2,520de0e3-1afc-4704-8931-936744016035,,released,Pemetrexed,1,2023-02-27T11:31:25.359113-06:00,Chemotherapy,Residual Disease,
HCM-WCMC-1359-C34,6199d20e-91c3-4ebb-9f87-16777ab803d6,76710a04-3b6c-4499-b0dc-8c5318292bfd,119.0,Adjuvant,56.0,2025-04-07T17:13:09.336794-05:00,HCM-WCMC-1359-C34_treatment3,7e538d60-1f37-4e7c-9f6a-14af83e769f7,,released,Cisplatin,1,2023-02-27T11:31:25.359113-06:00,Chemotherapy,Residual Disease,
HCM-WCMC-1359-C34,6199d20e-91c3-4ebb-9f87-16777ab803d6,76710a04-3b6c-4499-b0dc-8c5318292bfd,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-WCMC-1359-C34_treatment7,81a14a51-8d42-40a8-bc21-054681a85e7d,,released,,0,2023-02-27T11:31:25.359113-06:00,Targeted Molecular Therapy,Residual Disease,
HCM-WCMC-1359-C34,6199d20e-91c3-4ebb-9f87-16777ab803d6,76710a04-3b6c-4499-b0dc-8c5318292bfd,,Neoadjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-WCMC-1359-C34_treatment,a4876b5a-255c-4818-b722-2ca023f2b84b,,released,,0,2023-02-27T11:31:25.359113-06:00,,,
HCM-WCMC-1359-C34,6199d20e-91c3-4ebb-9f87-16777ab803d6,76710a04-3b6c-4499-b0dc-8c5318292bfd,180.0,Adjuvant,173.0,2025-04-07T17:13:09.336794-05:00,HCM-WCMC-1359-C34_treatment8,c87a73a7-7de0-4ee0-8e22-a71f2147c310,,released,,1,2023-02-27T11:31:25.359113-06:00,"Radiation Therapy, NOS",Residual Disease,
HCM-WCMC-1359-C34,6199d20e-91c3-4ebb-9f87-16777ab803d6,76710a04-3b6c-4499-b0dc-8c5318292bfd,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-WCMC-1359-C34_treatment5,d2693e5c-d330-40cc-8b67-48e9c03d1468,,released,,0,2023-02-27T11:31:25.359113-06:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-WCMC-1359-C34,6199d20e-91c3-4ebb-9f87-16777ab803d6,76710a04-3b6c-4499-b0dc-8c5318292bfd,,,14.0,2025-04-07T17:13:09.336794-05:00,HCM-WCMC-1359-C34_treatment6,f696a50d-788d-4226-925b-cfaaa2dd9da2,,released,,1,2023-02-27T11:31:25.359113-06:00,"Surgery, NOS",Initial Diagnosis,
HCM-BROD-0478-C16,623abf17-efbf-4433-86e9-0089601de5c0,e2e5f402-db94-4d99-a51d-8a2b85b0dd3b,118.0,Adjuvant,20.0,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0478-C16_treatment6,53cbdfc0-1ce5-4e73-827f-9c4d140c995b,,released,Pembrolizumab,1,2020-09-27T11:43:19.684874-05:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-BROD-0478-C16,623abf17-efbf-4433-86e9-0089601de5c0,e2e5f402-db94-4d99-a51d-8a2b85b0dd3b,,Neoadjuvant,13.0,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0478-C16_treatment2,54737f8c-067c-436d-9a0e-04ccea2181e2,,released,Fluorouracil,1,2020-09-27T11:43:19.684874-05:00,Chemotherapy,,
HCM-BROD-0478-C16,623abf17-efbf-4433-86e9-0089601de5c0,e2e5f402-db94-4d99-a51d-8a2b85b0dd3b,,Adjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0478-C16_treatment8,655f5ee2-09a1-46c6-9414-0993a84fb38e,,released,,0,2020-09-27T11:43:19.684874-05:00,Targeted Molecular Therapy,Residual Disease,
HCM-BROD-0478-C16,623abf17-efbf-4433-86e9-0089601de5c0,e2e5f402-db94-4d99-a51d-8a2b85b0dd3b,,Neoadjuvant,13.0,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0478-C16_treatment3,8927e72b-9ed5-46d0-b67f-40720e87738f,,released,Leucovorin,1,2020-09-27T11:43:19.684874-05:00,Chemotherapy,,
HCM-BROD-0478-C16,623abf17-efbf-4433-86e9-0089601de5c0,e2e5f402-db94-4d99-a51d-8a2b85b0dd3b,,Neoadjuvant,13.0,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0478-C16_treatment,8a18fd31-0aa8-4962-ab7e-6c8ec40cba94,,released,Irinotecan,1,2020-09-27T11:43:19.684874-05:00,Chemotherapy,,
HCM-BROD-0478-C16,623abf17-efbf-4433-86e9-0089601de5c0,e2e5f402-db94-4d99-a51d-8a2b85b0dd3b,161.0,Adjuvant,125.0,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0478-C16_treatment5,9fd4f73f-e10e-4c28-9c28-227ee1c27455,,released,Paclitaxel,1,2020-09-27T11:43:19.684874-05:00,Chemotherapy,Residual Disease,
HCM-BROD-0478-C16,623abf17-efbf-4433-86e9-0089601de5c0,e2e5f402-db94-4d99-a51d-8a2b85b0dd3b,,,,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0478-C16_treatment7,a6f9760c-76cc-4c0c-88e7-50abb967e702,,released,,unknown,2020-09-27T11:43:19.684874-05:00,"Surgery, NOS",Initial Diagnosis,
HCM-BROD-0478-C16,623abf17-efbf-4433-86e9-0089601de5c0,e2e5f402-db94-4d99-a51d-8a2b85b0dd3b,,Neoadjuvant,13.0,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0478-C16_treatment4,cab58eb8-62e0-42b6-9496-7d3aedc17a5e,,released,,1,2020-09-27T11:43:19.684874-05:00,Chemotherapy,,FU-LV regimen
HCM-BROD-0478-C16,623abf17-efbf-4433-86e9-0089601de5c0,e2e5f402-db94-4d99-a51d-8a2b85b0dd3b,,Adjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0478-C16_treatment9,ef9098fd-4424-4e23-875e-e62b8e684819,,released,,0,2020-09-27T11:43:19.684874-05:00,"Radiation Therapy, NOS",Residual Disease,
HCM-BROD-0004-C64,63653137-c694-4ad6-83a3-eaaff1df2ca7,1f0360f7-90da-4d15-b0f4-894719a6c971,,Neoadjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0004-C64_treatment,14f3b343-c629-460e-bb59-608f54e89538,,released,,0,2019-04-04T13:36:52.336425-05:00,,,
HCM-BROD-0004-C64,63653137-c694-4ad6-83a3-eaaff1df2ca7,1f0360f7-90da-4d15-b0f4-894719a6c971,,Adjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0004-C64_treatment10,31978212-a435-4e32-9380-e2915dc5add4,,released,,0,2020-09-16T19:51:33.759052-05:00,Targeted Molecular Therapy,Residual Disease,
HCM-BROD-0004-C64,63653137-c694-4ad6-83a3-eaaff1df2ca7,1f0360f7-90da-4d15-b0f4-894719a6c971,,,,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0004-C64_treatment9,56c53c34-7804-4788-9349-5af3671d3a1c,,released,,unknown,2020-09-16T19:51:33.759052-05:00,"Surgery, NOS",Initial Diagnosis,
HCM-BROD-0004-C64,63653137-c694-4ad6-83a3-eaaff1df2ca7,1f0360f7-90da-4d15-b0f4-894719a6c971,625.0,Adjuvant,610.0,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0004-C64_treatment6,7d5c331d-ffb4-4752-b693-85b18d2492f2,,released,Etoposide,1,2020-09-16T19:51:33.759052-05:00,Chemotherapy,Residual Disease,
HCM-BROD-0004-C64,63653137-c694-4ad6-83a3-eaaff1df2ca7,1f0360f7-90da-4d15-b0f4-894719a6c971,625.0,Adjuvant,610.0,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0004-C64_treatment2,8a3128ea-5bc5-48ff-8e95-01368d3f1294,,released,Vincristine,1,2020-09-16T19:51:33.759052-05:00,Chemotherapy,Residual Disease,
HCM-BROD-0004-C64,63653137-c694-4ad6-83a3-eaaff1df2ca7,1f0360f7-90da-4d15-b0f4-894719a6c971,625.0,Adjuvant,610.0,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0004-C64_treatment3,8d379317-f310-4cc3-803c-514987db162f,,released,Ifosfamide,1,2020-09-16T19:51:33.759052-05:00,Chemotherapy,Residual Disease,
HCM-BROD-0004-C64,63653137-c694-4ad6-83a3-eaaff1df2ca7,1f0360f7-90da-4d15-b0f4-894719a6c971,625.0,Adjuvant,610.0,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0004-C64_treatment11,8e0c11cc-e0ec-49ce-960f-2d8cdbdcc42a,,released,,1,2020-09-16T19:51:33.759052-05:00,"Radiation Therapy, NOS",Residual Disease,
HCM-BROD-0004-C64,63653137-c694-4ad6-83a3-eaaff1df2ca7,1f0360f7-90da-4d15-b0f4-894719a6c971,625.0,Adjuvant,610.0,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0004-C64_treatment5,98163382-4651-4ff2-a4eb-de556b1919b3,,released,Doxorubicin,1,2020-09-16T19:51:33.759052-05:00,Chemotherapy,Residual Disease,
HCM-BROD-0004-C64,63653137-c694-4ad6-83a3-eaaff1df2ca7,1f0360f7-90da-4d15-b0f4-894719a6c971,,Adjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0004-C64_treatment8,aaef3944-2aef-41eb-a958-38caab76d509,,released,,0,2020-09-16T19:51:33.759052-05:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-BROD-0004-C64,63653137-c694-4ad6-83a3-eaaff1df2ca7,1f0360f7-90da-4d15-b0f4-894719a6c971,625.0,Adjuvant,610.0,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0004-C64_treatment7,af17a5a9-7ea2-4016-995e-5b363efaed10,,released,,1,2020-09-16T19:51:33.759052-05:00,Chemotherapy,Residual Disease,VDC/IE
HCM-BROD-0004-C64,63653137-c694-4ad6-83a3-eaaff1df2ca7,1f0360f7-90da-4d15-b0f4-894719a6c971,625.0,Adjuvant,610.0,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0004-C64_treatment4,b54b5e91-7fe6-48ce-a2bc-01cb7d838031,,released,Cyclophosphamide,1,2020-09-16T19:51:33.759052-05:00,Chemotherapy,Residual Disease,
HCM-BROD-0028-C71,6375cc59-6cd1-4b1e-8de1-510841c3bebd,2c497764-9031-4c03-b7f7-45615b605416,876.0,Adjuvant,771.0,2020-01-13T20:10:25.832065-06:00,HCM-BROD-0028-C71_treatment2,0e5301ca-a25f-4a53-9655-f6f7904ff795,,released,Temozolomide,1,2019-04-04T14:18:18.835652-05:00,Chemotherapy,Residual Disease,
HCM-BROD-0028-C71,6375cc59-6cd1-4b1e-8de1-510841c3bebd,2c497764-9031-4c03-b7f7-45615b605416,,Adjuvant,,2020-01-13T20:10:25.832065-06:00,HCM-BROD-0028-C71_treatment6,210c09d6-56eb-494c-a32b-8e43929b93bf,,released,,0,2019-04-04T14:18:18.835652-05:00,"Radiation Therapy, NOS",Residual Disease,
HCM-BROD-0028-C71,6375cc59-6cd1-4b1e-8de1-510841c3bebd,2c497764-9031-4c03-b7f7-45615b605416,,Neoadjuvant,,2020-01-13T20:10:25.832065-06:00,HCM-BROD-0028-C71_treatment,529b058e-3906-448d-8a4c-c31c3fce063a,,released,,0,2019-03-12T10:13:49.767516-05:00,,,
HCM-BROD-0028-C71,6375cc59-6cd1-4b1e-8de1-510841c3bebd,2c497764-9031-4c03-b7f7-45615b605416,,,-1.0,2023-03-13T13:05:58.768371-05:00,HCM-BROD-0028-C71_treatment4,70e0bb57-5dce-4685-afcd-aee597892ede,,released,,1,2019-04-04T14:18:18.835652-05:00,"Surgery, NOS",Initial Diagnosis,
HCM-BROD-0028-C71,6375cc59-6cd1-4b1e-8de1-510841c3bebd,2c497764-9031-4c03-b7f7-45615b605416,876.0,Adjuvant,771.0,2020-06-15T09:41:27.974207-05:00,HCM-BROD-0028-C71_treatment5,9acc224a-9744-4f4f-ba3f-597e3196b4cb,,released,Bevacizumab,1,2019-04-04T14:18:18.835652-05:00,Targeted Molecular Therapy,Residual Disease,
HCM-BROD-0028-C71,6375cc59-6cd1-4b1e-8de1-510841c3bebd,2c497764-9031-4c03-b7f7-45615b605416,,Adjuvant,,2020-01-13T20:10:25.832065-06:00,HCM-BROD-0028-C71_treatment3,b6104ef6-30e3-4f22-bea6-ff9e0c285870,,released,,0,2019-04-04T14:18:18.835652-05:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-CSHL-0510-D13,6380f4ca-f7ca-41ee-90ed-54403bed84f6,7ca3765b-c0dd-495d-be3e-9333fe62a2a7,,,-10.0,2023-03-13T12:56:18.548626-05:00,HCM-CSHL-0510-D13_treatment2,212d727b-e848-44b2-bf48-335127c78c74,,released,,1,2021-08-26T09:37:18.881696-05:00,"Surgery, NOS",Initial Diagnosis,
HCM-CSHL-0510-D13,6380f4ca-f7ca-41ee-90ed-54403bed84f6,7ca3765b-c0dd-495d-be3e-9333fe62a2a7,,Neoadjuvant,,2021-09-10T10:36:37.981324-05:00,HCM-CSHL-0510-D13_treatment,610f5acb-bda6-4b10-89a2-6347d2413371,,released,,0,2021-07-19T20:13:23.885391-05:00,,,
HCM-CSHL-0510-D13,6380f4ca-f7ca-41ee-90ed-54403bed84f6,7ca3765b-c0dd-495d-be3e-9333fe62a2a7,,Adjuvant,,2023-03-13T12:56:18.548626-05:00,HCM-CSHL-0510-D13_treatment4,c1adba06-be30-49e3-b250-d12f87f949dc,,released,,0,2021-08-26T09:37:18.881696-05:00,"Radiation Therapy, NOS",Residual Disease,
HCM-CSHL-0510-D13,6380f4ca-f7ca-41ee-90ed-54403bed84f6,7ca3765b-c0dd-495d-be3e-9333fe62a2a7,,Adjuvant,,2023-03-13T12:56:18.548626-05:00,HCM-CSHL-0510-D13_treatment3,c3fb197d-e27e-47f6-a2c7-b1239cc66369,,released,,0,2021-08-26T09:37:18.881696-05:00,"Pharmaceutical Therapy, NOS",Residual Disease,
HCM-CSHL-0623-C18,6382c82d-dffb-4f43-8fb2-1d0ec187363e,31da82c5-2a39-4901-a980-a007294b6118,283.0,Maintenance Therapy,214.0,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0623-C18_treatment20,10b86ee1-1a95-460b-b2c1-77b55e107f6c,Progressive Disease,released,,1,2021-12-21T14:12:50.204791-06:00,,,XELOX
HCM-CSHL-0623-C18,6382c82d-dffb-4f43-8fb2-1d0ec187363e,31da82c5-2a39-4901-a980-a007294b6118,283.0,Maintenance Therapy,214.0,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0623-C18_treatment13,1237ef20-d6bb-48c2-a07b-c398cc9b352b,Progressive Disease,released,Oxaliplatin,1,2021-12-21T14:12:50.204791-06:00,,,
HCM-CSHL-0623-C18,6382c82d-dffb-4f43-8fb2-1d0ec187363e,31da82c5-2a39-4901-a980-a007294b6118,283.0,Maintenance Therapy,214.0,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0623-C18_treatment18,13e43020-7efe-4da1-98cf-dc377b6023a7,Progressive Disease,released,Irinotecan,1,2021-12-21T14:12:50.204791-06:00,,,
HCM-CSHL-0623-C18,6382c82d-dffb-4f43-8fb2-1d0ec187363e,31da82c5-2a39-4901-a980-a007294b6118,283.0,Maintenance Therapy,214.0,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0623-C18_treatment16,2db95c85-3505-4826-8644-f096408e005e,Progressive Disease,released,Capecitabine,1,2021-12-21T14:12:50.204791-06:00,,,
HCM-CSHL-0623-C18,6382c82d-dffb-4f43-8fb2-1d0ec187363e,31da82c5-2a39-4901-a980-a007294b6118,283.0,Maintenance Therapy,214.0,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0623-C18_treatment17,378079cd-643d-48e4-bce6-0fa225fcc72f,Progressive Disease,released,Leucovorin Calcium,1,2021-12-21T14:12:50.204791-06:00,,,
HCM-CSHL-0623-C18,6382c82d-dffb-4f43-8fb2-1d0ec187363e,31da82c5-2a39-4901-a980-a007294b6118,283.0,Maintenance Therapy,214.0,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0623-C18_treatment15,5ed91c19-f67c-4f87-9251-90a2738d25b3,Progressive Disease,released,Cetuximab,1,2021-12-21T14:12:50.204791-06:00,,,
HCM-CSHL-0623-C18,6382c82d-dffb-4f43-8fb2-1d0ec187363e,31da82c5-2a39-4901-a980-a007294b6118,283.0,Maintenance Therapy,214.0,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0623-C18_treatment19,93de4434-b003-455b-85a7-137c523662bf,Progressive Disease,released,,1,2021-12-21T14:12:50.204791-06:00,,,FOLFIRI
HCM-CSHL-0623-C18,6382c82d-dffb-4f43-8fb2-1d0ec187363e,31da82c5-2a39-4901-a980-a007294b6118,283.0,Maintenance Therapy,214.0,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0623-C18_treatment14,fcf49555-0299-463f-abcf-8a9105828c66,Progressive Disease,released,Fluorouracil,1,2021-12-21T14:12:50.204791-06:00,,,
HCM-CSHL-0623-C18,6382c82d-dffb-4f43-8fb2-1d0ec187363e,efb55859-77f5-47ba-bced-ebb193b5847c,285.0,Adjuvant,237.0,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0623-C18_treatment6,219b1fa7-6608-4315-9b54-3e620df1364a,,released,Fluorouracil,1,2021-12-21T14:12:50.204791-06:00,Chemotherapy,Residual Disease,
HCM-CSHL-0623-C18,6382c82d-dffb-4f43-8fb2-1d0ec187363e,efb55859-77f5-47ba-bced-ebb193b5847c,,,404.0,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0623-C18_treatment10,364b9887-ad7d-4c7b-a6e0-30aba88e1a9b,,released,,1,2021-12-21T14:12:50.204791-06:00,"Surgery, NOS",Initial Diagnosis,
HCM-CSHL-0623-C18,6382c82d-dffb-4f43-8fb2-1d0ec187363e,efb55859-77f5-47ba-bced-ebb193b5847c,,Adjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0623-C18_treatment9,3fe07eec-d246-40be-9dee-d204135b5196,,released,,0,2021-12-21T14:12:50.204791-06:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-CSHL-0623-C18,6382c82d-dffb-4f43-8fb2-1d0ec187363e,efb55859-77f5-47ba-bced-ebb193b5847c,285.0,Adjuvant,237.0,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0623-C18_treatment7,43aaadda-00cc-4164-ba73-f5c258d58466,,released,Cetuximab,1,2021-12-21T14:12:50.204791-06:00,Chemotherapy,Residual Disease,
HCM-CSHL-0623-C18,6382c82d-dffb-4f43-8fb2-1d0ec187363e,efb55859-77f5-47ba-bced-ebb193b5847c,,Neoadjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0623-C18_treatment,4784ea7c-c57e-40cb-89e7-368eac6ad851,,released,,0,2021-12-21T14:12:50.204791-06:00,,,
HCM-CSHL-0623-C18,6382c82d-dffb-4f43-8fb2-1d0ec187363e,efb55859-77f5-47ba-bced-ebb193b5847c,285.0,Adjuvant,237.0,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0623-C18_treatment5,6b3b0ca3-b780-4884-8546-67d6408d5a63,,released,Leucovorin Calcium,1,2021-12-21T14:12:50.204791-06:00,Chemotherapy,Residual Disease,
HCM-CSHL-0623-C18,6382c82d-dffb-4f43-8fb2-1d0ec187363e,efb55859-77f5-47ba-bced-ebb193b5847c,285.0,Adjuvant,237.0,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0623-C18_treatment4,760135f0-c616-4615-9788-a843be4ac204,,released,Irinotecan,1,2021-12-21T14:12:50.204791-06:00,Chemotherapy,Residual Disease,
HCM-CSHL-0623-C18,6382c82d-dffb-4f43-8fb2-1d0ec187363e,efb55859-77f5-47ba-bced-ebb193b5847c,196.0,Adjuvant,32.0,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0623-C18_treatment2,84121acc-b3c1-4317-bd1c-9737d49cbb33,,released,Oxaliplatin,1,2021-12-21T14:12:50.204791-06:00,Chemotherapy,Residual Disease,
HCM-CSHL-0623-C18,6382c82d-dffb-4f43-8fb2-1d0ec187363e,efb55859-77f5-47ba-bced-ebb193b5847c,,Adjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0623-C18_treatment11,98815661-6b61-4e0d-9d68-193119f99200,,released,,0,2021-12-21T14:12:50.204791-06:00,Targeted Molecular Therapy,Residual Disease,
HCM-CSHL-0623-C18,6382c82d-dffb-4f43-8fb2-1d0ec187363e,efb55859-77f5-47ba-bced-ebb193b5847c,561.0,Adjuvant,438.0,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0623-C18_treatment12,b8ac6fbd-763c-413f-bbeb-e02c10762505,,released,,1,2021-12-21T14:12:50.204791-06:00,"Radiation, Stereotactic/Gamma Knife/SRS",Residual Disease,
HCM-CSHL-0623-C18,6382c82d-dffb-4f43-8fb2-1d0ec187363e,efb55859-77f5-47ba-bced-ebb193b5847c,285.0,Adjuvant,237.0,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0623-C18_treatment8,dd12d6a2-5897-4365-8ad1-628bf21ae290,,released,,1,2021-12-21T14:12:50.204791-06:00,Chemotherapy,Residual Disease,FOLFIRI-cetuximab
HCM-CSHL-0623-C18,6382c82d-dffb-4f43-8fb2-1d0ec187363e,efb55859-77f5-47ba-bced-ebb193b5847c,196.0,Adjuvant,32.0,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0623-C18_treatment3,ebb24790-6b92-4a09-8c69-215df488ef89,,released,Capecitabine,1,2021-12-21T14:12:50.204791-06:00,Chemotherapy,Residual Disease,
HCM-SANG-0270-C20,6397deca-2bff-4c0a-a8c1-1b8c14bddabe,92f088d8-d7d2-4948-9658-3ef12baaebd2,,Neoadjuvant,,2023-03-13T13:25:53.708410-05:00,HCM-SANG-0270-C20_treatment2,34ebeedc-a923-44b4-8ff8-7e06b83e324f,,released,,1,2020-02-11T15:51:58.477251-06:00,"Radiation, 2D Conventional",,
HCM-SANG-0270-C20,6397deca-2bff-4c0a-a8c1-1b8c14bddabe,92f088d8-d7d2-4948-9658-3ef12baaebd2,,Neoadjuvant,,2023-03-13T13:25:53.708410-05:00,HCM-SANG-0270-C20_treatment,d5a4183d-5f9a-4161-9579-6d75ad7384bf,,released,Capecitabine,1,2020-02-11T15:51:58.477251-06:00,Chemotherapy,,
HCM-CSHL-0088-C25,64a54aa5-ce7c-4002-87f8-3b61f912104a,3dd66d45-e706-44ab-8400-7aa22e5fb81a,,Neoadjuvant,,2023-02-22T07:39:25.979291-06:00,HCM-CSHL-0088-C25_treatment,1d6c2b64-c78f-4f25-a5d4-e72f688a324c,,released,,0,2020-09-27T12:49:21.089408-05:00,,,
HCM-CSHL-0088-C25,64a54aa5-ce7c-4002-87f8-3b61f912104a,3dd66d45-e706-44ab-8400-7aa22e5fb81a,,Adjuvant,,2023-02-22T07:39:25.979291-06:00,HCM-CSHL-0088-C25_treatment7,36014c09-011f-47f6-ba08-96216ab579a1,,released,,0,2020-09-27T12:49:21.089408-05:00,Targeted Molecular Therapy,Residual Disease,
HCM-CSHL-0088-C25,64a54aa5-ce7c-4002-87f8-3b61f912104a,3dd66d45-e706-44ab-8400-7aa22e5fb81a,695.0,Adjuvant,603.0,2023-02-22T07:39:25.979291-06:00,HCM-CSHL-0088-C25_treatment4,3c8b5824-83ea-44c5-a60d-08b58510e8d4,,released,Oxaliplatin,1,2020-09-27T12:49:21.089408-05:00,Chemotherapy,Residual Disease,
HCM-CSHL-0088-C25,64a54aa5-ce7c-4002-87f8-3b61f912104a,3dd66d45-e706-44ab-8400-7aa22e5fb81a,,Adjuvant,289.0,2023-02-22T07:39:25.979291-06:00,HCM-CSHL-0088-C25_treatment2,442deeb7-c693-49c7-800b-2763a498b4ee,,released,Gemcitabine,1,2020-09-27T12:49:21.089408-05:00,Chemotherapy,Residual Disease,
HCM-CSHL-0088-C25,64a54aa5-ce7c-4002-87f8-3b61f912104a,3dd66d45-e706-44ab-8400-7aa22e5fb81a,,Adjuvant,,2023-02-22T07:39:25.979291-06:00,HCM-CSHL-0088-C25_treatment5,5446423d-9126-4c0c-8924-53e13e69cca7,,released,,0,2020-09-27T12:49:21.089408-05:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-CSHL-0088-C25,64a54aa5-ce7c-4002-87f8-3b61f912104a,3dd66d45-e706-44ab-8400-7aa22e5fb81a,,Adjuvant,289.0,2023-02-22T07:39:25.979291-06:00,HCM-CSHL-0088-C25_treatment3,5924669e-476d-4c62-8681-2a361ad88bdb,,released,Nab-paclitaxel,1,2020-09-27T12:49:21.089408-05:00,Chemotherapy,Residual Disease,
HCM-CSHL-0088-C25,64a54aa5-ce7c-4002-87f8-3b61f912104a,3dd66d45-e706-44ab-8400-7aa22e5fb81a,,,-5.0,2023-02-27T11:51:56.052926-06:00,HCM-CSHL-0088-C25_treatment6,dce6c3ea-94a9-4671-84a4-95a489073a0d,,released,,1,2020-09-27T12:49:21.089408-05:00,"Surgery, NOS",Initial Diagnosis,
HCM-CSHL-0088-C25,64a54aa5-ce7c-4002-87f8-3b61f912104a,3dd66d45-e706-44ab-8400-7aa22e5fb81a,,Adjuvant,,2023-02-22T07:39:25.979291-06:00,HCM-CSHL-0088-C25_treatment8,dcf21381-f59c-4319-91a3-b53c442cb1b2,,released,,0,2020-09-27T12:49:21.089408-05:00,"Radiation Therapy, NOS",Residual Disease,
HCM-BROD-0710-C43,64fbbfbe-8749-4b31-8ee6-ef711518fa66,02e8ff45-41ef-4450-82f3-dd889d18408e,,Adjuvant,,2023-11-07T14:20:00.017270-06:00,HCM-BROD-0710-C43_treatment7,131a7d41-a500-4c7c-8325-81d1759b9708,,released,,0,2021-12-21T13:47:39.506854-06:00,Targeted Molecular Therapy,Residual Disease,
HCM-BROD-0710-C43,64fbbfbe-8749-4b31-8ee6-ef711518fa66,02e8ff45-41ef-4450-82f3-dd889d18408e,,Adjuvant,,2023-11-07T14:20:00.017270-06:00,HCM-BROD-0710-C43_treatment2,13435b97-1938-4ea1-a9b1-bcb6e9052df8,,released,,0,2021-12-21T13:47:39.506854-06:00,Chemotherapy,Residual Disease,
HCM-BROD-0710-C43,64fbbfbe-8749-4b31-8ee6-ef711518fa66,02e8ff45-41ef-4450-82f3-dd889d18408e,,Adjuvant,,2023-11-07T14:20:00.017270-06:00,HCM-BROD-0710-C43_treatment3,21a6fa68-3e92-4948-bb0b-4929e710dc60,,released,,0,2021-12-21T13:47:39.506854-06:00,Hormone Therapy,Residual Disease,
HCM-BROD-0710-C43,64fbbfbe-8749-4b31-8ee6-ef711518fa66,02e8ff45-41ef-4450-82f3-dd889d18408e,,Adjuvant,,2023-11-07T14:20:00.017270-06:00,HCM-BROD-0710-C43_treatment8,45fc71fd-2aee-4f73-8ca3-a6bbc678ca81,,released,,0,2021-12-21T13:47:39.506854-06:00,"Radiation Therapy, NOS",Residual Disease,
HCM-BROD-0710-C43,64fbbfbe-8749-4b31-8ee6-ef711518fa66,02e8ff45-41ef-4450-82f3-dd889d18408e,,Neoadjuvant,965.0,2023-11-07T14:20:00.017270-06:00,HCM-BROD-0710-C43_treatment,5aedadd3-acb3-4654-b57c-b5c6181bb96f,,released,Nivolumab,1,2021-12-21T13:47:39.506854-06:00,Immunotherapy (Including Vaccines),,
HCM-BROD-0710-C43,64fbbfbe-8749-4b31-8ee6-ef711518fa66,02e8ff45-41ef-4450-82f3-dd889d18408e,2024.0,Adjuvant,1879.0,2023-11-07T14:20:00.017270-06:00,HCM-BROD-0710-C43_treatment4,6173d598-0bbc-4fcc-bc92-5042384c1ed9,,released,Nivolumab,1,2021-12-21T13:47:39.506854-06:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-BROD-0710-C43,64fbbfbe-8749-4b31-8ee6-ef711518fa66,02e8ff45-41ef-4450-82f3-dd889d18408e,,,0.0,2023-11-07T14:20:00.017270-06:00,HCM-BROD-0710-C43_treatment6,a3b373ca-b413-439a-90c6-2bfa8b3cb698,,released,,1,2021-12-21T13:47:39.506854-06:00,"Surgery, NOS",Initial Diagnosis,
HCM-BROD-0710-C43,64fbbfbe-8749-4b31-8ee6-ef711518fa66,02e8ff45-41ef-4450-82f3-dd889d18408e,2024.0,Adjuvant,1879.0,2023-11-07T14:20:00.017270-06:00,HCM-BROD-0710-C43_treatment5,d5114cca-2f5b-4fd1-aba5-5fb706f3c407,,released,Ipilimumab,1,2021-12-21T13:47:39.506854-06:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-BROD-0710-C43,64fbbfbe-8749-4b31-8ee6-ef711518fa66,ed425758-d374-4f95-9747-3f51dea7337e,1441.0,Maintenance Therapy,965.0,2023-11-07T14:20:00.017270-06:00,HCM-BROD-0710-C43_treatment9,638009a5-7f9a-4358-85c3-cbb399fe382e,Progressive Disease,released,Nivolumab,1,2021-12-21T13:47:39.506854-06:00,,,
HCM-CSHL-0078-C25,653a556f-c127-421d-8118-4bf98929fe53,87e438c1-5af0-435b-8cc3-d68f11e49d9c,,,-12.0,2023-03-13T13:05:18.703281-05:00,HCM-CSHL-0078-C25_treatment4,13b5f1cd-8013-44e4-a244-4869ef224d74,,released,,1,2020-09-27T12:46:52.359288-05:00,"Surgery, NOS",Initial Diagnosis,
HCM-CSHL-0078-C25,653a556f-c127-421d-8118-4bf98929fe53,87e438c1-5af0-435b-8cc3-d68f11e49d9c,,Adjuvant,,2023-02-22T07:39:25.979291-06:00,HCM-CSHL-0078-C25_treatment3,1892e8b9-d4e8-4a17-b15f-35096d24c6fa,,released,,0,2020-09-27T12:46:52.359288-05:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-CSHL-0078-C25,653a556f-c127-421d-8118-4bf98929fe53,87e438c1-5af0-435b-8cc3-d68f11e49d9c,,Adjuvant,,2023-02-22T07:39:25.979291-06:00,HCM-CSHL-0078-C25_treatment5,6643ff5d-67be-4360-88b0-a05e54b9849e,,released,,0,2020-09-27T12:46:52.359288-05:00,Targeted Molecular Therapy,Residual Disease,
HCM-CSHL-0078-C25,653a556f-c127-421d-8118-4bf98929fe53,87e438c1-5af0-435b-8cc3-d68f11e49d9c,89.0,Adjuvant,89.0,2023-02-22T07:39:25.979291-06:00,HCM-CSHL-0078-C25_treatment2,a5ca5e42-fafa-4746-a2be-397de974c0bb,,released,Gemcitabine,1,2020-09-27T12:46:52.359288-05:00,Chemotherapy,Residual Disease,
HCM-CSHL-0078-C25,653a556f-c127-421d-8118-4bf98929fe53,87e438c1-5af0-435b-8cc3-d68f11e49d9c,,Neoadjuvant,,2023-02-22T07:39:25.979291-06:00,HCM-CSHL-0078-C25_treatment,bd2c0269-3b95-4266-aff7-e3b34f00e9f5,,released,,0,2020-09-27T12:46:52.359288-05:00,,,
HCM-CSHL-0078-C25,653a556f-c127-421d-8118-4bf98929fe53,87e438c1-5af0-435b-8cc3-d68f11e49d9c,,Adjuvant,,2023-02-22T07:39:25.979291-06:00,HCM-CSHL-0078-C25_treatment6,e03beb89-0c43-4de0-bfd9-1955b701e882,,released,,0,2020-09-27T12:46:52.359288-05:00,"Radiation Therapy, NOS",Residual Disease,
HCM-CSHL-0076-C25,6548cb23-ee55-47c2-811a-156a090fbaee,9a4a502b-1c0e-4f9f-aeff-13732c7e6b04,197.0,Adjuvant,34.0,2023-02-22T07:39:25.979291-06:00,HCM-CSHL-0076-C25_treatment2,4bb933a9-014e-4543-b9b7-0f48b9bb6f33,,released,Gemcitabine,1,2020-09-27T12:46:28.410824-05:00,Chemotherapy,Residual Disease,
HCM-CSHL-0076-C25,6548cb23-ee55-47c2-811a-156a090fbaee,9a4a502b-1c0e-4f9f-aeff-13732c7e6b04,,Adjuvant,,2023-02-22T07:39:25.979291-06:00,HCM-CSHL-0076-C25_treatment6,558c0851-9ad1-4154-ba82-051142be4684,,released,,0,2020-09-27T12:46:28.410824-05:00,"Radiation Therapy, NOS",Residual Disease,
HCM-CSHL-0076-C25,6548cb23-ee55-47c2-811a-156a090fbaee,9a4a502b-1c0e-4f9f-aeff-13732c7e6b04,,,-6.0,2023-02-27T12:31:40.264091-06:00,HCM-CSHL-0076-C25_treatment4,5fdfa321-683f-4cb4-b0b7-2a79c65148ee,,released,,1,2020-09-27T12:46:28.410824-05:00,"Surgery, NOS",Initial Diagnosis,
HCM-CSHL-0076-C25,6548cb23-ee55-47c2-811a-156a090fbaee,9a4a502b-1c0e-4f9f-aeff-13732c7e6b04,,Neoadjuvant,,2023-02-22T07:39:25.979291-06:00,HCM-CSHL-0076-C25_treatment,600d3948-a77d-4677-a537-e5a6b241b2f7,,released,,0,2020-09-27T12:46:28.410824-05:00,,,
HCM-CSHL-0076-C25,6548cb23-ee55-47c2-811a-156a090fbaee,9a4a502b-1c0e-4f9f-aeff-13732c7e6b04,,Adjuvant,,2023-02-22T07:39:25.979291-06:00,HCM-CSHL-0076-C25_treatment3,d595b8ff-3bc3-4f5c-a09c-0e8c0e581759,,released,,0,2020-09-27T12:46:28.410824-05:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-CSHL-0076-C25,6548cb23-ee55-47c2-811a-156a090fbaee,9a4a502b-1c0e-4f9f-aeff-13732c7e6b04,,Adjuvant,,2023-02-22T07:39:25.979291-06:00,HCM-CSHL-0076-C25_treatment5,e8c0d52b-5f26-4651-bf0f-40e9562ecc3f,,released,,0,2020-09-27T12:46:28.410824-05:00,Targeted Molecular Therapy,Residual Disease,
HCM-BROD-0101-C15,662665d0-31b6-4a71-ab27-1190365cf856,ea9a5891-f381-4035-bdad-983f00261507,,Adjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0101-C15_treatment7,15300641-335d-422a-9500-62cf3a3b12c4,,released,,0,2020-09-27T10:25:54.901290-05:00,Targeted Molecular Therapy,Residual Disease,
HCM-BROD-0101-C15,662665d0-31b6-4a71-ab27-1190365cf856,ea9a5891-f381-4035-bdad-983f00261507,,Neoadjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0101-C15_treatment2,1714024d-9a64-4fc4-8533-79d5bc8989f2,,released,,1,2019-04-04T15:53:25.081649-05:00,Immunotherapy (Including Vaccines),,
HCM-BROD-0101-C15,662665d0-31b6-4a71-ab27-1190365cf856,ea9a5891-f381-4035-bdad-983f00261507,,,,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0101-C15_treatment6,22952015-a9aa-43e1-8a2d-8ec67588cead,,released,,0,2020-09-27T10:25:54.901290-05:00,"Surgery, NOS",Initial Diagnosis,
HCM-BROD-0101-C15,662665d0-31b6-4a71-ab27-1190365cf856,ea9a5891-f381-4035-bdad-983f00261507,,Neoadjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0101-C15_treatment,9282aeea-5666-46fa-b037-1e1a39ef9adb,,released,,1,2019-04-04T15:53:25.081649-05:00,Chemotherapy,,
HCM-BROD-0101-C15,662665d0-31b6-4a71-ab27-1190365cf856,ea9a5891-f381-4035-bdad-983f00261507,436.0,Adjuvant,333.0,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0101-C15_treatment3,94c84547-2d35-4eed-8946-7e622ec952e8,,released,Fluorouracil,1,2020-09-27T10:25:54.901290-05:00,Chemotherapy,Residual Disease,
HCM-BROD-0101-C15,662665d0-31b6-4a71-ab27-1190365cf856,ea9a5891-f381-4035-bdad-983f00261507,436.0,Adjuvant,333.0,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0101-C15_treatment4,a8c7dfb1-30fb-41ee-8ddf-f85e07b55553,,released,Leucovorin,1,2020-09-27T10:25:54.901290-05:00,Chemotherapy,Residual Disease,
HCM-BROD-0101-C15,662665d0-31b6-4a71-ab27-1190365cf856,ea9a5891-f381-4035-bdad-983f00261507,,Adjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0101-C15_treatment8,d79f562c-9bd1-4265-8920-8836da292046,,released,,0,2020-09-27T10:25:54.901290-05:00,"Radiation Therapy, NOS",Residual Disease,
HCM-BROD-0101-C15,662665d0-31b6-4a71-ab27-1190365cf856,ea9a5891-f381-4035-bdad-983f00261507,,Adjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0101-C15_treatment5,e1a7da75-50fb-4497-ae6e-308a5af2798a,,released,,0,2020-09-27T10:25:54.901290-05:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-CSHL-0655-C50,66f2f8d4-f8e2-4bb6-93e1-3edd7c5a3b48,2935a4d9-979a-4507-841b-afc4ba3458ee,,Neoadjuvant,,2023-11-07T14:28:29.403873-06:00,HCM-CSHL-0655-C50_treatment,25f04c4d-edee-4ba8-a350-129e1fa0b2f3,,released,,0,2021-12-21T14:14:23.961730-06:00,,,
HCM-CSHL-0655-C50,66f2f8d4-f8e2-4bb6-93e1-3edd7c5a3b48,2935a4d9-979a-4507-841b-afc4ba3458ee,,Prevention,,2023-11-07T14:28:29.403873-06:00,HCM-CSHL-0655-C50_treatment10,2f0be315-6bcf-4ce2-8a58-3dc49f0c60f9,,released,,0,2021-12-21T14:14:23.961730-06:00,Hormone Therapy,,
HCM-CSHL-0655-C50,66f2f8d4-f8e2-4bb6-93e1-3edd7c5a3b48,2935a4d9-979a-4507-841b-afc4ba3458ee,99.0,Adjuvant,62.0,2023-11-07T14:28:29.403873-06:00,HCM-CSHL-0655-C50_treatment2,52fe517e-3f9c-4871-93c5-83c0230c61c0,,released,Cyclophosphamide,1,2021-12-21T14:14:23.961730-06:00,Chemotherapy,Residual Disease,
HCM-CSHL-0655-C50,66f2f8d4-f8e2-4bb6-93e1-3edd7c5a3b48,2935a4d9-979a-4507-841b-afc4ba3458ee,319.0,Adjuvant,285.0,2023-11-07T14:28:29.403873-06:00,HCM-CSHL-0655-C50_treatment9,6dd32b96-a85c-465c-9c9b-bc29bc9bd8bc,,released,,1,2021-12-21T14:14:23.961730-06:00,"Radiation, Intensity-Modulated Radiotherapy",Residual Disease,
HCM-CSHL-0655-C50,66f2f8d4-f8e2-4bb6-93e1-3edd7c5a3b48,2935a4d9-979a-4507-841b-afc4ba3458ee,,Adjuvant,,2023-11-07T14:28:29.403873-06:00,HCM-CSHL-0655-C50_treatment5,7a11bbb4-3a00-4dac-b699-a9575041fc34,,released,,0,2021-12-21T14:14:23.961730-06:00,Hormone Therapy,Residual Disease,
HCM-CSHL-0655-C50,66f2f8d4-f8e2-4bb6-93e1-3edd7c5a3b48,2935a4d9-979a-4507-841b-afc4ba3458ee,,,12.0,2023-11-07T14:28:29.403873-06:00,HCM-CSHL-0655-C50_treatment7,7cb78892-8feb-42b8-9b93-30961fe302d0,,released,,1,2021-12-21T14:14:23.961730-06:00,"Surgery, NOS",Initial Diagnosis,
HCM-CSHL-0655-C50,66f2f8d4-f8e2-4bb6-93e1-3edd7c5a3b48,2935a4d9-979a-4507-841b-afc4ba3458ee,99.0,Adjuvant,62.0,2023-11-07T14:28:29.403873-06:00,HCM-CSHL-0655-C50_treatment3,9d67b042-d1ba-4319-ba58-bc1ce0394462,,released,Doxorubicin,1,2021-12-21T14:14:23.961730-06:00,Chemotherapy,Residual Disease,
HCM-CSHL-0655-C50,66f2f8d4-f8e2-4bb6-93e1-3edd7c5a3b48,2935a4d9-979a-4507-841b-afc4ba3458ee,,Adjuvant,,2023-11-07T14:28:29.403873-06:00,HCM-CSHL-0655-C50_treatment6,deee9815-fc54-4cc2-a0ff-396890069c64,,released,,0,2021-12-21T14:14:23.961730-06:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-CSHL-0655-C50,66f2f8d4-f8e2-4bb6-93e1-3edd7c5a3b48,2935a4d9-979a-4507-841b-afc4ba3458ee,,Adjuvant,,2023-11-07T14:28:29.403873-06:00,HCM-CSHL-0655-C50_treatment8,e808a7cf-01db-410d-89f6-b7ca3a4dd9ea,,released,,0,2021-12-21T14:14:23.961730-06:00,Targeted Molecular Therapy,Residual Disease,
HCM-CSHL-0655-C50,66f2f8d4-f8e2-4bb6-93e1-3edd7c5a3b48,2935a4d9-979a-4507-841b-afc4ba3458ee,169.0,Adjuvant,113.0,2023-11-07T14:28:29.403873-06:00,HCM-CSHL-0655-C50_treatment4,f860252a-d032-495a-a221-34920fe88f3c,,released,Paclitaxel,1,2021-12-21T14:14:23.961730-06:00,Chemotherapy,Residual Disease,
HCM-CSHL-0655-C50,66f2f8d4-f8e2-4bb6-93e1-3edd7c5a3b48,f67a4a87-2095-4972-bb29-797c331de34d,,Prevention,,2023-11-07T14:28:29.403873-06:00,HCM-CSHL-0655-C50_treatment11,34bd3b16-425f-42d0-8148-7b7b1a19f86d,,released,,0,2021-12-21T14:14:23.961730-06:00,Hormone Therapy,,
HCM-CSHL-0243-C18,6767fba3-9c1f-4df7-9f2b-2461d8f99d51,db11e998-792e-49ad-9105-97996ca3a7a6,,Adjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0243-C18_treatment3,022c0fd2-f688-4dc7-9db4-68739d12b41e,,released,,0,2020-09-28T09:25:38.761011-05:00,"Pharmaceutical Therapy, NOS",Residual Disease,
HCM-CSHL-0243-C18,6767fba3-9c1f-4df7-9f2b-2461d8f99d51,db11e998-792e-49ad-9105-97996ca3a7a6,,Neoadjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0243-C18_treatment,4159a650-c8c1-4169-a648-c8c8ce955bcf,,released,,0,2020-09-28T09:25:38.761011-05:00,,,
HCM-CSHL-0243-C18,6767fba3-9c1f-4df7-9f2b-2461d8f99d51,db11e998-792e-49ad-9105-97996ca3a7a6,,Adjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0243-C18_treatment4,4a99591b-3106-477b-843c-5a58a61c4089,,released,,0,2020-09-28T09:25:38.761011-05:00,"Radiation Therapy, NOS",Residual Disease,
HCM-CSHL-0243-C18,6767fba3-9c1f-4df7-9f2b-2461d8f99d51,db11e998-792e-49ad-9105-97996ca3a7a6,,,42.0,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0243-C18_treatment2,b5fdd9f8-812b-40d3-96a4-c793c58b87c3,,released,,1,2020-09-28T09:25:38.761011-05:00,"Surgery, NOS",Initial Diagnosis,
HCM-STAN-1277-C55,6784de63-5d64-4203-9e17-336202359820,7624ba62-bbfc-433f-9ee5-3c13b60a6f9d,252.0,Adjuvant,39.0,2025-04-07T17:13:09.336794-05:00,HCM-STAN-1277-C55_treatment2,06e19576-f43a-4352-803b-d66cde5084f0,,released,Paclitaxel,1,2023-01-03T13:01:07.483192-06:00,Chemotherapy,Residual Disease,
HCM-STAN-1277-C55,6784de63-5d64-4203-9e17-336202359820,7624ba62-bbfc-433f-9ee5-3c13b60a6f9d,,,0.0,2025-04-07T17:13:09.336794-05:00,HCM-STAN-1277-C55_treatment6,2b6766e5-8afc-4546-9694-971b90322c99,,released,,1,2023-01-03T13:01:07.483192-06:00,"Surgery, NOS",Initial Diagnosis,
HCM-STAN-1277-C55,6784de63-5d64-4203-9e17-336202359820,7624ba62-bbfc-433f-9ee5-3c13b60a6f9d,252.0,Adjuvant,39.0,2025-04-07T17:13:09.336794-05:00,HCM-STAN-1277-C55_treatment3,57362a2b-220d-4637-8d11-06f66625cf70,,released,Carboplatin,1,2023-01-03T13:01:07.483192-06:00,Chemotherapy,Residual Disease,
HCM-STAN-1277-C55,6784de63-5d64-4203-9e17-336202359820,7624ba62-bbfc-433f-9ee5-3c13b60a6f9d,,Neoadjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-STAN-1277-C55_treatment,5fd00747-3498-470f-b0e8-5f8e4a649927,,released,,0,2023-01-03T13:01:07.483192-06:00,,,
HCM-STAN-1277-C55,6784de63-5d64-4203-9e17-336202359820,7624ba62-bbfc-433f-9ee5-3c13b60a6f9d,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-STAN-1277-C55_treatment5,7d0e5e9f-6122-4d35-b257-bd44ac569086,,released,,0,2023-01-03T13:01:07.483192-06:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-STAN-1277-C55,6784de63-5d64-4203-9e17-336202359820,7624ba62-bbfc-433f-9ee5-3c13b60a6f9d,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-STAN-1277-C55_treatment7,7ed871c6-1e47-4ef9-9b0b-47568681c2c2,,released,,0,2023-01-03T13:01:07.483192-06:00,Targeted Molecular Therapy,Residual Disease,
HCM-STAN-1277-C55,6784de63-5d64-4203-9e17-336202359820,7624ba62-bbfc-433f-9ee5-3c13b60a6f9d,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-STAN-1277-C55_treatment4,a10361b6-2f59-4da3-9946-216c2ac5cff6,,released,,0,2023-01-03T13:01:07.483192-06:00,Hormone Therapy,Residual Disease,
HCM-STAN-1277-C55,6784de63-5d64-4203-9e17-336202359820,7624ba62-bbfc-433f-9ee5-3c13b60a6f9d,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-STAN-1277-C55_treatment8,f056b8d4-f2c6-4474-8198-c891be29f470,,released,,0,2023-01-03T13:01:07.483192-06:00,"Radiation Therapy, NOS",Residual Disease,
HCM-CSHL-0091-C25,6796ddd8-0295-4965-911c-d4ad67232d13,9f1ffa4a-0aa8-4bc7-8226-79b2896a04b9,,Adjuvant,600.0,2020-10-08T19:08:57.989157-05:00,HCM-CSHL-0091-C25_treatment7,24318916-859c-4a73-8c66-ea172b8b2eda,Treatment Ongoing,released,Leucovorin Calcium,1,2020-03-26T12:47:31.001478-05:00,Chemotherapy,Residual Disease,
HCM-CSHL-0091-C25,6796ddd8-0295-4965-911c-d4ad67232d13,9f1ffa4a-0aa8-4bc7-8226-79b2896a04b9,,Adjuvant,600.0,2020-10-08T19:08:57.989157-05:00,HCM-CSHL-0091-C25_treatment8,32385bd7-3859-4127-9173-ece06cb75368,Treatment Ongoing,released,Fluorouracil,1,2020-03-26T12:47:31.001478-05:00,Chemotherapy,Residual Disease,
HCM-CSHL-0091-C25,6796ddd8-0295-4965-911c-d4ad67232d13,9f1ffa4a-0aa8-4bc7-8226-79b2896a04b9,,Adjuvant,,2020-10-20T19:20:06.800740-05:00,HCM-CSHL-0091-C25_treatment11,4a3232e6-c4cb-4a5e-8e71-7510b099880b,,released,,0,2020-10-08T19:08:57.989157-05:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-CSHL-0091-C25,6796ddd8-0295-4965-911c-d4ad67232d13,9f1ffa4a-0aa8-4bc7-8226-79b2896a04b9,392.0,Adjuvant,300.0,2020-06-15T12:08:36.760818-05:00,HCM-CSHL-0091-C25_treatment4,4b302d47-db01-44d7-857d-126f35cfeaef,,released,Gemcitabine,1,2020-02-11T14:42:16.450679-06:00,Chemotherapy,Residual Disease,
HCM-CSHL-0091-C25,6796ddd8-0295-4965-911c-d4ad67232d13,9f1ffa4a-0aa8-4bc7-8226-79b2896a04b9,,Adjuvant,,2020-10-20T19:20:06.800740-05:00,HCM-CSHL-0091-C25_treatment14,86085982-d4de-4cc2-bdd5-47b687f9fa0b,,released,,1,2020-10-08T19:08:57.989157-05:00,"Radiation Therapy, NOS",Residual Disease,
HCM-CSHL-0091-C25,6796ddd8-0295-4965-911c-d4ad67232d13,9f1ffa4a-0aa8-4bc7-8226-79b2896a04b9,,Neoadjuvant,,2020-03-26T16:04:47.706904-05:00,HCM-CSHL-0091-C25_treatment,877b5843-564b-4525-8643-b7fb1380a18b,,released,,0,2020-02-11T14:42:16.450679-06:00,,,
HCM-CSHL-0091-C25,6796ddd8-0295-4965-911c-d4ad67232d13,9f1ffa4a-0aa8-4bc7-8226-79b2896a04b9,139.0,Adjuvant,27.0,2020-03-26T16:04:47.706904-05:00,HCM-CSHL-0091-C25_treatment3,89d614b1-252a-43bf-88a2-a7a5158ac317,,released,Capecitabine,1,2020-02-11T14:42:16.450679-06:00,Chemotherapy,Residual Disease,
HCM-CSHL-0091-C25,6796ddd8-0295-4965-911c-d4ad67232d13,9f1ffa4a-0aa8-4bc7-8226-79b2896a04b9,,,-7.0,2023-02-27T12:37:26.482115-06:00,HCM-CSHL-0091-C25_treatment12,8a6ec1ed-0f2a-4545-aad4-f10263ce3946,,released,,1,2020-10-08T19:08:57.989157-05:00,"Surgery, NOS",Initial Diagnosis,
HCM-CSHL-0091-C25,6796ddd8-0295-4965-911c-d4ad67232d13,9f1ffa4a-0aa8-4bc7-8226-79b2896a04b9,,Adjuvant,600.0,2020-10-20T19:20:06.800740-05:00,HCM-CSHL-0091-C25_treatment10,94cd4188-dc4b-46e3-80df-f513f1b946b1,Treatment Ongoing,released,,1,2020-10-08T19:08:57.989157-05:00,Chemotherapy,Residual Disease,FOLFIRINOX
HCM-CSHL-0091-C25,6796ddd8-0295-4965-911c-d4ad67232d13,9f1ffa4a-0aa8-4bc7-8226-79b2896a04b9,392.0,Adjuvant,300.0,2020-06-15T12:08:36.760818-05:00,HCM-CSHL-0091-C25_treatment5,9ed48989-68bf-4a0d-a63e-e5997c57860f,,released,Nab-paclitaxel,1,2020-02-11T14:42:16.450679-06:00,Chemotherapy,Residual Disease,
HCM-CSHL-0091-C25,6796ddd8-0295-4965-911c-d4ad67232d13,9f1ffa4a-0aa8-4bc7-8226-79b2896a04b9,,Adjuvant,600.0,2020-10-08T19:08:57.989157-05:00,HCM-CSHL-0091-C25_treatment6,a166afc8-a92a-4095-a1c0-26adb0da49e7,Treatment Ongoing,released,Irinotecan Hydrochloride,1,2020-02-11T14:42:16.450679-06:00,Chemotherapy,Residual Disease,
HCM-CSHL-0091-C25,6796ddd8-0295-4965-911c-d4ad67232d13,9f1ffa4a-0aa8-4bc7-8226-79b2896a04b9,,Adjuvant,,2020-10-20T19:20:06.800740-05:00,HCM-CSHL-0091-C25_treatment13,a349fbef-69c6-4c70-9b16-bb106ce7f2c3,,released,,0,2020-10-08T19:08:57.989157-05:00,Targeted Molecular Therapy,Residual Disease,
HCM-CSHL-0091-C25,6796ddd8-0295-4965-911c-d4ad67232d13,9f1ffa4a-0aa8-4bc7-8226-79b2896a04b9,,Adjuvant,600.0,2020-10-20T19:20:06.800740-05:00,HCM-CSHL-0091-C25_treatment9,a3746a99-c151-4565-b29e-b3d0fe3e4140,Treatment Ongoing,released,Oxaliplatin,1,2020-10-08T19:08:57.989157-05:00,Chemotherapy,Residual Disease,
HCM-CSHL-0091-C25,6796ddd8-0295-4965-911c-d4ad67232d13,9f1ffa4a-0aa8-4bc7-8226-79b2896a04b9,139.0,Adjuvant,27.0,2020-03-26T16:04:47.706904-05:00,HCM-CSHL-0091-C25_treatment2,baec325b-3d17-49ee-830a-40f6afeac77d,,released,Gemcitabine,1,2020-02-11T14:42:16.450679-06:00,Chemotherapy,Residual Disease,
HCM-CSHL-0238-C18,67e3c17e-e524-4681-8162-99742c802256,0d48a2dd-33e1-47f1-a05d-6d2611a9b0a1,,Adjuvant,,2023-03-13T12:56:55.371895-05:00,HCM-CSHL-0238-C18_treatment3,7e5a5495-8078-462e-9939-3252c68e7f93,,released,,unknown,2020-02-27T12:49:49.846763-06:00,"Pharmaceutical Therapy, NOS",Residual Disease,
HCM-CSHL-0238-C18,67e3c17e-e524-4681-8162-99742c802256,0d48a2dd-33e1-47f1-a05d-6d2611a9b0a1,,,4.0,2023-03-13T12:56:55.371895-05:00,HCM-CSHL-0238-C18_treatment2,ae259239-30d4-4da4-8994-94784569829c,,released,,1,2020-02-27T12:49:49.846763-06:00,"Surgery, NOS",Initial Diagnosis,
HCM-CSHL-0238-C18,67e3c17e-e524-4681-8162-99742c802256,0d48a2dd-33e1-47f1-a05d-6d2611a9b0a1,,Neoadjuvant,,2020-10-20T19:20:06.800740-05:00,HCM-CSHL-0238-C18_treatment,c25d5bea-8e07-4fb3-84af-25261c2be3d0,,released,,0,2020-02-27T12:49:49.846763-06:00,,,
HCM-CSHL-0238-C18,67e3c17e-e524-4681-8162-99742c802256,0d48a2dd-33e1-47f1-a05d-6d2611a9b0a1,,Adjuvant,,2023-03-13T12:56:55.371895-05:00,HCM-CSHL-0238-C18_treatment4,ec835451-0f06-498f-9087-5b6efaef5633,,released,,unknown,2020-02-27T12:49:49.846763-06:00,"Radiation Therapy, NOS",Residual Disease,
HCM-CSHL-0372-C25,68fda2a7-baf4-4bba-90ff-9ebd35b71a4b,39867bea-5718-45ef-a23f-0c2517e8b4be,,,-12.0,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0372-C25_treatment2,2c270401-ea77-4916-87fe-ad0cd20724c9,,released,,1,2020-09-28T09:54:13.372132-05:00,"Surgery, NOS",Initial Diagnosis,
HCM-CSHL-0372-C25,68fda2a7-baf4-4bba-90ff-9ebd35b71a4b,39867bea-5718-45ef-a23f-0c2517e8b4be,,Neoadjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0372-C25_treatment,4f2475d7-8c51-4c30-a200-940848919786,,released,,0,2020-09-28T09:54:13.372132-05:00,,,
HCM-CSHL-0372-C25,68fda2a7-baf4-4bba-90ff-9ebd35b71a4b,39867bea-5718-45ef-a23f-0c2517e8b4be,,Adjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0372-C25_treatment4,6c15ed23-bffd-4fcd-8413-ddcd7aee1355,,released,,0,2020-09-28T09:54:13.372132-05:00,"Radiation Therapy, NOS",Residual Disease,
HCM-CSHL-0372-C25,68fda2a7-baf4-4bba-90ff-9ebd35b71a4b,39867bea-5718-45ef-a23f-0c2517e8b4be,,Adjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0372-C25_treatment3,6cbd74b5-aa9f-4a5b-8d2b-20b6d5292b10,,released,,0,2020-09-28T09:54:13.372132-05:00,"Pharmaceutical Therapy, NOS",Residual Disease,
HCM-CSHL-0371-C25,69b4a2cd-dc6f-4413-bdb4-b6f44ff8677f,439a8ccc-7812-4292-98b5-38b78f1e448f,,Adjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0371-C25_treatment4,164987b1-6d08-4fc6-9c74-c38b782fc5b5,,released,,unknown,2020-09-28T09:54:23.248510-05:00,"Radiation Therapy, NOS",Residual Disease,
HCM-CSHL-0371-C25,69b4a2cd-dc6f-4413-bdb4-b6f44ff8677f,439a8ccc-7812-4292-98b5-38b78f1e448f,,,-6.0,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0371-C25_treatment2,76d8dbf3-d831-441e-b20d-143b149a7382,,released,,1,2020-09-28T09:54:23.248510-05:00,"Surgery, NOS",Initial Diagnosis,
HCM-CSHL-0371-C25,69b4a2cd-dc6f-4413-bdb4-b6f44ff8677f,439a8ccc-7812-4292-98b5-38b78f1e448f,,Neoadjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0371-C25_treatment,861ce86e-6d7a-4717-aefa-cf31b93654fb,,released,,0,2020-09-28T09:54:23.248510-05:00,,,
HCM-CSHL-0371-C25,69b4a2cd-dc6f-4413-bdb4-b6f44ff8677f,439a8ccc-7812-4292-98b5-38b78f1e448f,,Adjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0371-C25_treatment3,ee58c159-84fb-4f28-9b22-bb29b85f1dde,,released,,unknown,2020-09-28T09:54:23.248510-05:00,"Pharmaceutical Therapy, NOS",Residual Disease,
HCM-BROD-0011-C71,69eced5b-1e76-45c9-bc9c-2aa71a921c57,7b142a98-5022-43e9-bcbb-647d3b28b308,69.0,Adjuvant,27.0,2022-09-09T16:33:51.233314-05:00,HCM-BROD-0011-C71_treatment10,012d6d85-7bf7-4ff6-9947-11b95e13c21a,,released,,1,2019-04-04T14:14:00.900831-05:00,"Radiation Therapy, NOS",Residual Disease,
HCM-BROD-0011-C71,69eced5b-1e76-45c9-bc9c-2aa71a921c57,7b142a98-5022-43e9-bcbb-647d3b28b308,,Neoadjuvant,,2022-09-09T16:33:51.233314-05:00,HCM-BROD-0011-C71_treatment,3714a756-2832-4a31-83ca-bc9da41361a9,,released,,0,2019-03-12T10:13:02.718709-05:00,,,
HCM-BROD-0011-C71,69eced5b-1e76-45c9-bc9c-2aa71a921c57,7b142a98-5022-43e9-bcbb-647d3b28b308,109.0,Adjuvant,109.0,2022-09-09T16:33:51.233314-05:00,HCM-BROD-0011-C71_treatment3,5c0296c6-e15a-4b7c-9a8a-451acef6a59b,,released,Temozolomide,1,2019-04-04T14:14:00.900831-05:00,Chemotherapy,Residual Disease,
HCM-BROD-0011-C71,69eced5b-1e76-45c9-bc9c-2aa71a921c57,7b142a98-5022-43e9-bcbb-647d3b28b308,144.0,Adjuvant,144.0,2022-09-09T16:33:51.233314-05:00,HCM-BROD-0011-C71_treatment5,74e7a791-4e10-4ba6-87e9-9f77b3dc5626,,released,Temozolomide,1,2019-04-04T14:14:00.900831-05:00,Chemotherapy,Residual Disease,
HCM-BROD-0011-C71,69eced5b-1e76-45c9-bc9c-2aa71a921c57,7b142a98-5022-43e9-bcbb-647d3b28b308,295.0,Adjuvant,239.0,2022-09-09T16:33:51.233314-05:00,HCM-BROD-0011-C71_treatment6,7c146a16-0ca3-4e22-8e9d-bdbe56ee4b73,,released,Irinotecan,1,2019-04-04T14:14:00.900831-05:00,Chemotherapy,Residual Disease,
HCM-BROD-0011-C71,69eced5b-1e76-45c9-bc9c-2aa71a921c57,7b142a98-5022-43e9-bcbb-647d3b28b308,,Adjuvant,,2022-09-09T16:33:51.233314-05:00,HCM-BROD-0011-C71_treatment7,7f0626d7-30f0-4f27-b1f9-a67e4df3a1e2,,released,,0,2019-04-04T14:14:00.900831-05:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-BROD-0011-C71,69eced5b-1e76-45c9-bc9c-2aa71a921c57,7b142a98-5022-43e9-bcbb-647d3b28b308,295.0,Adjuvant,216.0,2022-09-09T16:33:51.233314-05:00,HCM-BROD-0011-C71_treatment9,8eebccaf-7619-427a-97aa-6edb7c9ad1f2,,released,Bevacizumab,1,2019-04-04T14:14:00.900831-05:00,Targeted Molecular Therapy,Residual Disease,
HCM-BROD-0011-C71,69eced5b-1e76-45c9-bc9c-2aa71a921c57,7b142a98-5022-43e9-bcbb-647d3b28b308,69.0,Adjuvant,50.0,2022-09-09T16:33:51.233314-05:00,HCM-BROD-0011-C71_treatment2,ba69b647-695d-474a-b721-b7b30d759bd0,,released,Temozolomide,1,2019-04-04T14:14:00.900831-05:00,Chemotherapy,Residual Disease,
HCM-BROD-0011-C71,69eced5b-1e76-45c9-bc9c-2aa71a921c57,7b142a98-5022-43e9-bcbb-647d3b28b308,137.0,Adjuvant,137.0,2022-09-09T16:33:51.233314-05:00,HCM-BROD-0011-C71_treatment4,f6c77d78-52af-4de1-ae5c-b977faecd05c,,released,Temozolomide,1,2019-04-04T14:14:00.900831-05:00,Chemotherapy,Residual Disease,
HCM-BROD-0011-C71,69eced5b-1e76-45c9-bc9c-2aa71a921c57,7b142a98-5022-43e9-bcbb-647d3b28b308,,,-7.0,2023-03-15T10:53:43.774863-05:00,HCM-BROD-0011-C71_treatment8,ff608e4f-1813-4adc-b589-b8a4105f46d4,,released,,1,2019-04-04T14:14:00.900831-05:00,"Surgery, NOS",Initial Diagnosis,
HCM-SANG-0539-C18,6a5157d6-cdb8-42e1-ab48-6d354be62b44,6d476ae2-253b-4bbd-92f6-3cdea9071f8c,,Neoadjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-SANG-0539-C18_treatment,ff38c272-560f-4049-81e4-7667906fe742,,released,,0,2023-02-27T13:31:22.819448-06:00,,,
HCM-CSHL-0093-C25,6a8427ec-14cc-4168-a536-12c8ad27ba89,07bfbd03-b5de-4615-90be-d1c8c90e7a7f,193.0,Adjuvant,37.0,2020-10-20T19:20:06.800740-05:00,HCM-CSHL-0093-C25_treatment2,0b8ea714-d930-4b03-9990-8d13fbb5fcda,,released,Gemcitabine,1,2020-02-27T12:45:56.146309-06:00,Chemotherapy,Residual Disease,
HCM-CSHL-0093-C25,6a8427ec-14cc-4168-a536-12c8ad27ba89,07bfbd03-b5de-4615-90be-d1c8c90e7a7f,193.0,Adjuvant,37.0,2020-10-20T19:20:06.800740-05:00,HCM-CSHL-0093-C25_treatment3,3588a38f-8d9e-451d-a3ac-9f3ed758494a,,released,Nab-paclitaxel,1,2020-02-27T12:45:56.146309-06:00,Chemotherapy,Residual Disease,
HCM-CSHL-0093-C25,6a8427ec-14cc-4168-a536-12c8ad27ba89,07bfbd03-b5de-4615-90be-d1c8c90e7a7f,,Adjuvant,,2020-10-20T19:20:06.800740-05:00,HCM-CSHL-0093-C25_treatment7,3b67243e-dc30-4b79-b835-a42964ce9a8e,,released,,0,2020-06-15T09:54:41.762402-05:00,"Radiation Therapy, NOS",Residual Disease,
HCM-CSHL-0093-C25,6a8427ec-14cc-4168-a536-12c8ad27ba89,07bfbd03-b5de-4615-90be-d1c8c90e7a7f,,Adjuvant,,2020-10-20T19:20:06.800740-05:00,HCM-CSHL-0093-C25_treatment4,3b78473b-f1ba-4c47-9760-e9d6f589c89c,,released,,0,2020-02-27T12:45:56.146309-06:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-CSHL-0093-C25,6a8427ec-14cc-4168-a536-12c8ad27ba89,07bfbd03-b5de-4615-90be-d1c8c90e7a7f,,Neoadjuvant,,2020-10-20T19:20:06.800740-05:00,HCM-CSHL-0093-C25_treatment,5da20016-933e-40b0-905a-158750049f65,,released,,0,2020-02-27T12:45:56.146309-06:00,,,
HCM-CSHL-0093-C25,6a8427ec-14cc-4168-a536-12c8ad27ba89,07bfbd03-b5de-4615-90be-d1c8c90e7a7f,,,-15.0,2023-02-27T12:14:17.015540-06:00,HCM-CSHL-0093-C25_treatment5,a718ca0b-9286-4911-8586-4d8b7c903a98,,released,,1,2020-02-27T12:45:56.146309-06:00,"Surgery, NOS",Initial Diagnosis,
HCM-CSHL-0093-C25,6a8427ec-14cc-4168-a536-12c8ad27ba89,07bfbd03-b5de-4615-90be-d1c8c90e7a7f,,Adjuvant,,2020-10-20T19:20:06.800740-05:00,HCM-CSHL-0093-C25_treatment6,cd0e06ae-4434-4b71-8a92-d60c869375af,,released,,0,2020-02-27T12:45:56.146309-06:00,Targeted Molecular Therapy,Residual Disease,
HCM-BROD-0013-C71,6a9d7152-bc4b-4137-ada9-5b8a50121482,bdc93ab2-6a09-4315-805a-aded5a7c4e03,,,-15.0,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0013-C71_treatment2,230565da-fe83-42cc-9f52-6d99bc1a557e,,released,,1,2020-02-27T12:08:23.501334-06:00,"Surgery, NOS",Initial Diagnosis,
HCM-BROD-0013-C71,6a9d7152-bc4b-4137-ada9-5b8a50121482,bdc93ab2-6a09-4315-805a-aded5a7c4e03,,Neoadjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0013-C71_treatment,477cfa5a-a312-4aa1-b56a-56c7edad4751,,released,,0,2019-04-04T14:41:36.734325-05:00,,,
HCM-BROD-0013-C71,6a9d7152-bc4b-4137-ada9-5b8a50121482,bdc93ab2-6a09-4315-805a-aded5a7c4e03,,Adjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0013-C71_treatment4,73bd116f-fd1c-4ba4-8008-e61135f031fd,,released,,0,2020-02-27T12:08:23.501334-06:00,"Radiation Therapy, NOS",Residual Disease,
HCM-BROD-0013-C71,6a9d7152-bc4b-4137-ada9-5b8a50121482,bdc93ab2-6a09-4315-805a-aded5a7c4e03,,Adjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0013-C71_treatment3,c715cf05-0c7b-4a09-b9bc-479540935f61,,released,,0,2020-02-27T12:08:23.501334-06:00,"Pharmaceutical Therapy, NOS",Residual Disease,
HCM-BROD-0236-C34,6ae8e01b-bcff-44c1-ad03-b354aae0d7d5,797b5b6d-f990-4608-baf2-fee902249f7f,363.0,Adjuvant,340.0,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0236-C34_treatment4,059f0393-65c2-48e2-83ea-e951be215dd9,,released,,1,2019-04-04T15:17:12.952975-05:00,Stereotactic Radiosurgery,Residual Disease,
HCM-BROD-0236-C34,6ae8e01b-bcff-44c1-ad03-b354aae0d7d5,797b5b6d-f990-4608-baf2-fee902249f7f,,,25.0,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0236-C34_treatment2,61e5d1d8-be5f-46f7-b467-a573cb37d12d,,released,,1,2019-04-04T15:17:12.952975-05:00,"Surgery, NOS",Initial Diagnosis,
HCM-BROD-0236-C34,6ae8e01b-bcff-44c1-ad03-b354aae0d7d5,797b5b6d-f990-4608-baf2-fee902249f7f,,Adjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0236-C34_treatment3,a3d506aa-ec0c-419d-acde-c01e5a224b37,,released,,0,2019-04-04T15:17:12.952975-05:00,"Pharmaceutical Therapy, NOS",Residual Disease,
HCM-BROD-0236-C34,6ae8e01b-bcff-44c1-ad03-b354aae0d7d5,797b5b6d-f990-4608-baf2-fee902249f7f,,Neoadjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0236-C34_treatment,aae923d2-4b41-4e99-8935-c6be2a2c91fa,,released,,0,2019-04-04T15:17:12.952975-05:00,,,
HCM-CSHL-0857-C19,6b69e46e-41af-4709-a04a-74474f32ba34,38216e73-0e92-4afe-8f0d-e4c071336298,,Neoadjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0857-C19_treatment4,1927c919-efc4-42e6-91f0-e34468c1d514,,released,,1,2021-12-21T14:34:47.554758-06:00,Chemotherapy,,FOLFOX
HCM-CSHL-0857-C19,6b69e46e-41af-4709-a04a-74474f32ba34,38216e73-0e92-4afe-8f0d-e4c071336298,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0857-C19_treatment8,20d43085-f8ed-4e56-9fbd-c156ab7a3a46,,released,,unknown,2021-12-21T14:34:47.554758-06:00,"Radiation Therapy, NOS",Residual Disease,
HCM-CSHL-0857-C19,6b69e46e-41af-4709-a04a-74474f32ba34,38216e73-0e92-4afe-8f0d-e4c071336298,,Neoadjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0857-C19_treatment3,41fbd431-60cb-48d5-94fa-244e012ee563,,released,Oxaliplatin,1,2021-12-21T14:34:47.554758-06:00,Chemotherapy,,
HCM-CSHL-0857-C19,6b69e46e-41af-4709-a04a-74474f32ba34,38216e73-0e92-4afe-8f0d-e4c071336298,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0857-C19_treatment7,4825d4d3-450e-47bf-96d4-24c66961f394,,released,,unknown,2021-12-21T14:34:47.554758-06:00,"Pharmaceutical Therapy, NOS",Residual Disease,
HCM-CSHL-0857-C19,6b69e46e-41af-4709-a04a-74474f32ba34,38216e73-0e92-4afe-8f0d-e4c071336298,,Neoadjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0857-C19_treatment,7ae1409e-da89-4d9b-b44c-a9a54df3c04b,,released,Leucovorin Calcium,1,2021-12-21T14:34:47.554758-06:00,Chemotherapy,,
HCM-CSHL-0857-C19,6b69e46e-41af-4709-a04a-74474f32ba34,38216e73-0e92-4afe-8f0d-e4c071336298,,Neoadjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0857-C19_treatment5,9242ff3f-469f-4d73-b5e8-bfb03a7438b0,,released,Cetuximab,1,2021-12-21T14:34:47.554758-06:00,Chemotherapy,,
HCM-CSHL-0857-C19,6b69e46e-41af-4709-a04a-74474f32ba34,38216e73-0e92-4afe-8f0d-e4c071336298,,,97.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0857-C19_treatment6,bbf0bc54-fb74-4a9f-847b-eff5ffc91ac6,,released,,1,2021-12-21T14:34:47.554758-06:00,"Surgery, NOS",Initial Diagnosis,
HCM-CSHL-0857-C19,6b69e46e-41af-4709-a04a-74474f32ba34,38216e73-0e92-4afe-8f0d-e4c071336298,,Neoadjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0857-C19_treatment2,c8743404-4e54-4b31-9c36-e2bb51e51897,,released,Fluorouracil,1,2021-12-21T14:34:47.554758-06:00,Chemotherapy,,
HCM-CSHL-1097-C18,6bbc3ea9-7cd3-4526-9d1e-bacab5b50d42,b45467bc-065f-424e-8b6d-795bf7016885,,Neoadjuvant,26.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-1097-C18_treatment6,07485a38-31f3-441d-b699-2b26d0057663,,released,,1,2021-12-21T14:38:58.240418-06:00,Chemotherapy,,FOLFOX
HCM-CSHL-1097-C18,6bbc3ea9-7cd3-4526-9d1e-bacab5b50d42,b45467bc-065f-424e-8b6d-795bf7016885,,,,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-1097-C18_treatment7,1c46413b-33de-4e27-9c99-a5183e87cde8,,released,,0,2021-12-21T14:38:58.240418-06:00,"Surgery, NOS",Initial Diagnosis,
HCM-CSHL-1097-C18,6bbc3ea9-7cd3-4526-9d1e-bacab5b50d42,b45467bc-065f-424e-8b6d-795bf7016885,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-1097-C18_treatment9,35c971b7-3858-4d7a-9763-c776340a07c7,,released,,0,2021-12-21T14:38:58.240418-06:00,"Radiation Therapy, NOS",Residual Disease,
HCM-CSHL-1097-C18,6bbc3ea9-7cd3-4526-9d1e-bacab5b50d42,b45467bc-065f-424e-8b6d-795bf7016885,,Neoadjuvant,26.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-1097-C18_treatment4,41edf2ca-ed4f-416a-940c-b1288099c970,,released,,1,2021-12-21T14:38:58.240418-06:00,Chemotherapy,,FOLFIRI
HCM-CSHL-1097-C18,6bbc3ea9-7cd3-4526-9d1e-bacab5b50d42,b45467bc-065f-424e-8b6d-795bf7016885,,Neoadjuvant,26.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-1097-C18_treatment3,76ba8cf4-4fb4-4a6d-9d08-7a5a0c5a10c7,,released,Irinotecan,1,2021-12-21T14:38:58.240418-06:00,Chemotherapy,,
HCM-CSHL-1097-C18,6bbc3ea9-7cd3-4526-9d1e-bacab5b50d42,b45467bc-065f-424e-8b6d-795bf7016885,,Neoadjuvant,26.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-1097-C18_treatment5,8905917b-516d-435c-b567-d29964f74379,,released,Oxaliplatin,1,2021-12-21T14:38:58.240418-06:00,Chemotherapy,,
HCM-CSHL-1097-C18,6bbc3ea9-7cd3-4526-9d1e-bacab5b50d42,b45467bc-065f-424e-8b6d-795bf7016885,,Neoadjuvant,26.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-1097-C18_treatment,8d9066aa-171b-42ec-a8fd-624af552ce53,,released,Leucovorin Calcium,1,2021-12-21T14:38:58.240418-06:00,Chemotherapy,,
HCM-CSHL-1097-C18,6bbc3ea9-7cd3-4526-9d1e-bacab5b50d42,b45467bc-065f-424e-8b6d-795bf7016885,,Neoadjuvant,26.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-1097-C18_treatment2,f7b5e905-6547-4d46-a1d8-44e7a649f4f4,,released,Fluorouracil,1,2021-12-21T14:38:58.240418-06:00,Chemotherapy,,
HCM-CSHL-1097-C18,6bbc3ea9-7cd3-4526-9d1e-bacab5b50d42,b45467bc-065f-424e-8b6d-795bf7016885,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-1097-C18_treatment8,fd4aeeb6-aac8-438a-8af5-018ff3e8a087,,released,,0,2021-12-21T14:38:58.240418-06:00,"Pharmaceutical Therapy, NOS",Residual Disease,
HCM-CSHL-0736-C18,6bcd339d-a1fb-469e-aab7-9621ede29188,821657aa-415b-44eb-b0d4-c9f9849cc53f,728.0,Adjuvant,605.0,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0736-C18_treatment4,012821f6-4dff-489b-8055-dcc13e9dd9f8,,released,Oxaliplatin,1,2021-12-21T14:21:07.435329-06:00,Chemotherapy,Residual Disease,
HCM-CSHL-0736-C18,6bcd339d-a1fb-469e-aab7-9621ede29188,821657aa-415b-44eb-b0d4-c9f9849cc53f,,,7.0,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0736-C18_treatment7,189d7860-1c01-4a72-a9a9-6e3324288a19,,released,,1,2021-12-21T14:21:07.435329-06:00,"Surgery, NOS",Initial Diagnosis,
HCM-CSHL-0736-C18,6bcd339d-a1fb-469e-aab7-9621ede29188,821657aa-415b-44eb-b0d4-c9f9849cc53f,728.0,Adjuvant,605.0,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0736-C18_treatment5,1adb6de7-5795-44cb-b398-8dabe4405ef5,,released,,1,2021-12-21T14:21:07.435329-06:00,Chemotherapy,Residual Disease,FOLFOX
HCM-CSHL-0736-C18,6bcd339d-a1fb-469e-aab7-9621ede29188,821657aa-415b-44eb-b0d4-c9f9849cc53f,848.0,Adjuvant,788.0,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0736-C18_treatment10,1dc4d260-1816-41d8-9e2b-c971b75895b7,,released,,1,2021-12-21T14:21:07.435329-06:00,"Radiation Therapy, NOS",Residual Disease,
HCM-CSHL-0736-C18,6bcd339d-a1fb-469e-aab7-9621ede29188,821657aa-415b-44eb-b0d4-c9f9849cc53f,728.0,Adjuvant,605.0,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0736-C18_treatment2,8ce466c6-74cb-4b9c-a6ce-03493ee6051a,,released,Leucovorin Calcium,1,2021-12-21T14:21:07.435329-06:00,Chemotherapy,Residual Disease,
HCM-CSHL-0736-C18,6bcd339d-a1fb-469e-aab7-9621ede29188,821657aa-415b-44eb-b0d4-c9f9849cc53f,,,1559.0,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0736-C18_treatment8,abe69758-e85e-4143-bc0b-6b60178588a8,,released,,1,2021-12-21T14:21:07.435329-06:00,"Surgery, NOS",Initial Diagnosis,
HCM-CSHL-0736-C18,6bcd339d-a1fb-469e-aab7-9621ede29188,821657aa-415b-44eb-b0d4-c9f9849cc53f,,Adjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0736-C18_treatment6,bda8848e-b2fb-470a-ad91-dc428e90e315,,released,,0,2021-12-21T14:21:07.435329-06:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-CSHL-0736-C18,6bcd339d-a1fb-469e-aab7-9621ede29188,821657aa-415b-44eb-b0d4-c9f9849cc53f,,Neoadjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0736-C18_treatment,d18f7a35-c9b2-41a4-ba26-c819dac88bfd,,released,,0,2021-12-21T14:21:07.435329-06:00,,,
HCM-CSHL-0736-C18,6bcd339d-a1fb-469e-aab7-9621ede29188,821657aa-415b-44eb-b0d4-c9f9849cc53f,728.0,Adjuvant,605.0,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0736-C18_treatment9,f53cd436-8864-4c65-8b09-f5b859ddfb08,,released,Bevacizumab,1,2021-12-21T14:21:07.435329-06:00,Targeted Molecular Therapy,Residual Disease,
HCM-CSHL-0736-C18,6bcd339d-a1fb-469e-aab7-9621ede29188,821657aa-415b-44eb-b0d4-c9f9849cc53f,728.0,Adjuvant,605.0,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0736-C18_treatment3,f875be68-6158-4620-b47b-f8742ca0d36c,,released,Fluorouracil,1,2021-12-21T14:21:07.435329-06:00,Chemotherapy,Residual Disease,
HCM-CSHL-0736-C18,6bcd339d-a1fb-469e-aab7-9621ede29188,adace733-853a-4b41-9423-01fdd760f5a9,,Maintenance Therapy,,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0736-C18_treatment13,1fbcdaba-96a2-42f7-acd4-beabae835e1f,Stable Disease,released,Leucovorin Calcium,1,2021-12-21T14:21:07.435329-06:00,,,
HCM-CSHL-0736-C18,6bcd339d-a1fb-469e-aab7-9621ede29188,adace733-853a-4b41-9423-01fdd760f5a9,,Maintenance Therapy,,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0736-C18_treatment11,5dcab3c3-ae2b-4c84-9d80-d1817e680376,Stable Disease,released,Bevacizumab,1,2021-12-21T14:21:07.435329-06:00,,,
HCM-CSHL-0736-C18,6bcd339d-a1fb-469e-aab7-9621ede29188,adace733-853a-4b41-9423-01fdd760f5a9,,Maintenance Therapy,,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0736-C18_treatment15,5fd1610b-9029-4c2f-b1eb-afb491e2fd07,Stable Disease,released,,1,2021-12-21T14:21:07.435329-06:00,,,FOLFOX
HCM-CSHL-0736-C18,6bcd339d-a1fb-469e-aab7-9621ede29188,adace733-853a-4b41-9423-01fdd760f5a9,,Maintenance Therapy,,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0736-C18_treatment14,744a8f0e-dedf-4c15-8e94-b235fd4d7458,Stable Disease,released,Fluorouracil,1,2021-12-21T14:21:07.435329-06:00,,,
HCM-CSHL-0736-C18,6bcd339d-a1fb-469e-aab7-9621ede29188,adace733-853a-4b41-9423-01fdd760f5a9,,Maintenance Therapy,,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0736-C18_treatment12,da0898c2-28bc-4345-b172-23e3cbb1d7bb,Stable Disease,released,Oxaliplatin,1,2021-12-21T14:21:07.435329-06:00,,,
HCM-CSHL-0657-C25,6cb73e78-c352-4fed-b206-5eabc02a5045,f4b747b4-fa26-4c13-a56b-b5a96b961f93,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0657-C25_treatment2,0e7ae9dd-99c3-470d-a9fd-db2709c4fef0,,released,,0,2021-12-21T14:15:11.353788-06:00,Chemotherapy,Residual Disease,
HCM-CSHL-0657-C25,6cb73e78-c352-4fed-b206-5eabc02a5045,f4b747b4-fa26-4c13-a56b-b5a96b961f93,,,,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0657-C25_treatment4,140682fe-d3d9-499e-ab6f-4db30864afbb,,released,,0,2021-12-21T14:15:11.353788-06:00,"Surgery, NOS",Initial Diagnosis,
HCM-CSHL-0657-C25,6cb73e78-c352-4fed-b206-5eabc02a5045,f4b747b4-fa26-4c13-a56b-b5a96b961f93,,Neoadjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0657-C25_treatment,61365c0f-4145-4543-8e95-3b717145cdc9,,released,,0,2021-12-21T14:15:11.353788-06:00,,,
HCM-CSHL-0657-C25,6cb73e78-c352-4fed-b206-5eabc02a5045,f4b747b4-fa26-4c13-a56b-b5a96b961f93,132.0,Adjuvant,37.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0657-C25_treatment3,a34409e8-b3c6-4df7-99d5-ceb5e7920227,,released,Lanreotide Acetate,1,2021-12-21T14:15:11.353788-06:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-CSHL-0657-C25,6cb73e78-c352-4fed-b206-5eabc02a5045,f4b747b4-fa26-4c13-a56b-b5a96b961f93,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0657-C25_treatment5,a619c0a7-6463-437b-8118-6981896c2c42,,released,,0,2021-12-21T14:15:11.353788-06:00,Targeted Molecular Therapy,Residual Disease,
HCM-CSHL-0657-C25,6cb73e78-c352-4fed-b206-5eabc02a5045,f4b747b4-fa26-4c13-a56b-b5a96b961f93,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0657-C25_treatment6,b3ec5309-596c-4eef-ac66-dbed0dd2b356,,released,,0,2021-12-21T14:15:11.353788-06:00,"Radiation Therapy, NOS",Residual Disease,
HCM-SANG-0295-C15,6d0825eb-bac2-45be-9f2a-58f6bacba2ef,64a26b2d-d713-4353-847a-dde195cb5c6b,,Neoadjuvant,,2023-02-22T07:39:25.979291-06:00,HCM-SANG-0295-C15_treatment,5aacfa37-ded6-4b00-bfdb-e31d2a232b60,,released,,0,2020-02-27T12:53:09.114302-06:00,,,
HCM-BROD-0557-C43,6ded7d89-1235-4b52-90aa-52c57c669301,4e02019a-674d-49a1-9d7c-af3daeaec684,,Adjuvant,,2021-09-10T10:36:37.981324-05:00,HCM-BROD-0557-C43_treatment4,09866f72-9c1f-4f96-90f6-5974a0039125,,released,,0,2021-09-07T08:30:04.904922-05:00,Hormone Therapy,Residual Disease,
HCM-BROD-0557-C43,6ded7d89-1235-4b52-90aa-52c57c669301,4e02019a-674d-49a1-9d7c-af3daeaec684,,Adjuvant,,2021-09-10T10:36:37.981324-05:00,HCM-BROD-0557-C43_treatment8,52187edc-e125-43e9-9857-fb3baa7f2578,,released,,0,2021-09-07T08:30:04.904922-05:00,Targeted Molecular Therapy,Residual Disease,
HCM-BROD-0557-C43,6ded7d89-1235-4b52-90aa-52c57c669301,4e02019a-674d-49a1-9d7c-af3daeaec684,738.0,Adjuvant,299.0,2021-09-10T10:36:37.981324-05:00,HCM-BROD-0557-C43_treatment6,82496790-d5c0-4c4e-a763-38e6d83ebb25,Treatment Ongoing,released,Ipilimumab,1,2021-09-07T08:30:04.904922-05:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-BROD-0557-C43,6ded7d89-1235-4b52-90aa-52c57c669301,4e02019a-674d-49a1-9d7c-af3daeaec684,,Neoadjuvant,354.0,2021-09-07T08:30:04.904922-05:00,HCM-BROD-0557-C43_treatment2,9bf1b7df-bfd9-4821-83bc-2d0602b38c34,,released,Nivolumab,1,2021-03-11T14:30:11.765496-06:00,Immunotherapy (Including Vaccines),,
HCM-BROD-0557-C43,6ded7d89-1235-4b52-90aa-52c57c669301,4e02019a-674d-49a1-9d7c-af3daeaec684,13.0,Adjuvant,6.0,2021-09-10T10:36:37.981324-05:00,HCM-BROD-0557-C43_treatment9,ac9605d8-a15b-4458-9172-7c0e8e14511b,,released,,1,2021-09-07T08:30:04.904922-05:00,"Radiation, Stereotactic/Gamma Knife/SRS",Residual Disease,
HCM-BROD-0557-C43,6ded7d89-1235-4b52-90aa-52c57c669301,4e02019a-674d-49a1-9d7c-af3daeaec684,,,,2023-02-27T12:16:25.549257-06:00,HCM-BROD-0557-C43_treatment7,b0932d36-54b4-4526-b6ab-2d03004eaf87,,released,,unknown,2021-09-07T08:30:04.904922-05:00,"Surgery, NOS",Initial Diagnosis,
HCM-BROD-0557-C43,6ded7d89-1235-4b52-90aa-52c57c669301,4e02019a-674d-49a1-9d7c-af3daeaec684,,Neoadjuvant,354.0,2021-09-07T08:30:04.904922-05:00,HCM-BROD-0557-C43_treatment,b37af2a6-fd8e-4bb3-bf7d-bd768b3c98a9,,released,Ipilimumab,1,2021-03-11T14:30:11.765496-06:00,Immunotherapy (Including Vaccines),,
HCM-BROD-0557-C43,6ded7d89-1235-4b52-90aa-52c57c669301,4e02019a-674d-49a1-9d7c-af3daeaec684,,Adjuvant,,2021-09-10T10:36:37.981324-05:00,HCM-BROD-0557-C43_treatment3,de43e6b4-0568-4f05-8676-dbf25b346f4a,,released,,0,2021-09-07T08:30:04.904922-05:00,Chemotherapy,Residual Disease,
HCM-BROD-0557-C43,6ded7d89-1235-4b52-90aa-52c57c669301,4e02019a-674d-49a1-9d7c-af3daeaec684,149.0,Adjuvant,54.0,2021-09-10T10:36:37.981324-05:00,HCM-BROD-0557-C43_treatment5,f975a98c-a9b6-461d-9b4b-6bedef640c81,Treatment Ongoing,released,Nivolumab,1,2021-09-07T08:30:04.904922-05:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-CSHL-0405-C25,6e3a1f73-d16b-4dc8-acc2-ae452eec1bbd,f665edcb-a441-4485-babe-ddd368efed1a,,Neoadjuvant,23.0,2023-07-13T10:35:44.371881-05:00,HCM-CSHL-0405-C25_treatment5,06ff7940-960b-49d9-bb23-9ce794c126b7,,released,,1,2020-09-28T10:02:28.555012-05:00,Chemotherapy,,FOLFIRINOX
HCM-CSHL-0405-C25,6e3a1f73-d16b-4dc8-acc2-ae452eec1bbd,f665edcb-a441-4485-babe-ddd368efed1a,,Neoadjuvant,23.0,2023-07-13T10:35:44.371881-05:00,HCM-CSHL-0405-C25_treatment3,727f2cec-631e-4244-919e-55df5bf0477d,,released,Fluorouracil,1,2020-09-28T10:02:28.555012-05:00,Chemotherapy,,
HCM-CSHL-0405-C25,6e3a1f73-d16b-4dc8-acc2-ae452eec1bbd,f665edcb-a441-4485-babe-ddd368efed1a,,Neoadjuvant,23.0,2023-07-13T10:35:44.371881-05:00,HCM-CSHL-0405-C25_treatment2,816532d7-02d0-47d6-ad1c-adeb0952619f,,released,Leucovorin Calcium,1,2020-09-28T10:02:28.555012-05:00,Chemotherapy,,
HCM-CSHL-0405-C25,6e3a1f73-d16b-4dc8-acc2-ae452eec1bbd,f665edcb-a441-4485-babe-ddd368efed1a,,Neoadjuvant,23.0,2023-07-13T10:35:44.371881-05:00,HCM-CSHL-0405-C25_treatment4,cb78324d-5752-478f-9734-00bc7280b68d,,released,Oxaliplatin,1,2020-09-28T10:02:28.555012-05:00,Chemotherapy,,
HCM-CSHL-0405-C25,6e3a1f73-d16b-4dc8-acc2-ae452eec1bbd,f665edcb-a441-4485-babe-ddd368efed1a,,Adjuvant,,2023-07-13T10:35:44.371881-05:00,HCM-CSHL-0405-C25_treatment8,cd6907e7-e91f-455d-8a9f-e166d5e9952f,,released,,0,2020-09-28T10:02:28.555012-05:00,"Radiation Therapy, NOS",Residual Disease,
HCM-CSHL-0405-C25,6e3a1f73-d16b-4dc8-acc2-ae452eec1bbd,f665edcb-a441-4485-babe-ddd368efed1a,,Adjuvant,,2023-07-13T10:35:44.371881-05:00,HCM-CSHL-0405-C25_treatment7,dea6492b-16a6-4d98-89b6-5a40ed39d3d1,,released,,0,2020-09-28T10:02:28.555012-05:00,"Pharmaceutical Therapy, NOS",Residual Disease,
HCM-CSHL-0405-C25,6e3a1f73-d16b-4dc8-acc2-ae452eec1bbd,f665edcb-a441-4485-babe-ddd368efed1a,,,162.0,2023-07-13T10:35:44.371881-05:00,HCM-CSHL-0405-C25_treatment6,e4148282-ebda-4d3e-8f90-943bb2da3be1,,released,,1,2020-09-28T10:02:28.555012-05:00,"Surgery, NOS",Initial Diagnosis,
HCM-CSHL-0405-C25,6e3a1f73-d16b-4dc8-acc2-ae452eec1bbd,f665edcb-a441-4485-babe-ddd368efed1a,,Neoadjuvant,23.0,2023-07-13T10:35:44.371881-05:00,HCM-CSHL-0405-C25_treatment,f52bedd2-70ec-4126-a4aa-9c5eb875ecb2,,released,Irinotecan Hydrochloride,1,2020-09-28T10:02:28.555012-05:00,Chemotherapy,,
HCM-WCMC-0491-C16,6e757d59-1eb2-4f38-b662-f3f543ba5844,a1e3f4b9-1a5e-4d3c-b470-d276d1c27b4b,1128.0,Adjuvant,962.0,2023-07-13T10:35:44.371881-05:00,HCM-WCMC-0491-C16_treatment19,0015cff5-3037-4c9e-b470-000ae3833457,,released,Trastuzumab,1,2023-02-27T11:45:33.310572-06:00,Targeted Molecular Therapy,Residual Disease,
HCM-WCMC-0491-C16,6e757d59-1eb2-4f38-b662-f3f543ba5844,a1e3f4b9-1a5e-4d3c-b470-d276d1c27b4b,619.0,Adjuvant,374.0,2023-07-13T10:35:44.371881-05:00,HCM-WCMC-0491-C16_treatment13,15cdd3d5-4a4e-424f-8fa5-094cff8de316,,released,Capecitabine,1,2023-02-27T11:45:33.310572-06:00,Chemotherapy,Residual Disease,
HCM-WCMC-0491-C16,6e757d59-1eb2-4f38-b662-f3f543ba5844,a1e3f4b9-1a5e-4d3c-b470-d276d1c27b4b,360.0,Adjuvant,234.0,2023-07-13T10:35:44.371881-05:00,HCM-WCMC-0491-C16_treatment12,1fd50b18-b5fa-4554-a9be-a59e6e6d2c10,,released,,1,2023-02-27T11:45:33.310572-06:00,Chemotherapy,Residual Disease,FU-LV regimen
HCM-WCMC-0491-C16,6e757d59-1eb2-4f38-b662-f3f543ba5844,a1e3f4b9-1a5e-4d3c-b470-d276d1c27b4b,1182.0,Adjuvant,1177.0,2023-07-13T10:35:44.371881-05:00,HCM-WCMC-0491-C16_treatment8,31fe0d35-4cb6-4104-9ffd-3977a73ee914,,released,Oxaliplatin,1,2023-02-27T11:45:33.310572-06:00,Chemotherapy,Residual Disease,
HCM-WCMC-0491-C16,6e757d59-1eb2-4f38-b662-f3f543ba5844,a1e3f4b9-1a5e-4d3c-b470-d276d1c27b4b,1182.0,Adjuvant,1177.0,2023-07-13T10:35:44.371881-05:00,HCM-WCMC-0491-C16_treatment6,36e8166f-276d-4fe3-b13e-a1d0705fdc16,,released,Leucovorin Calcium,1,2023-02-27T11:45:33.310572-06:00,Chemotherapy,Residual Disease,
HCM-WCMC-0491-C16,6e757d59-1eb2-4f38-b662-f3f543ba5844,a1e3f4b9-1a5e-4d3c-b470-d276d1c27b4b,1046.0,Adjuvant,962.0,2023-07-13T10:35:44.371881-05:00,HCM-WCMC-0491-C16_treatment14,40daa11e-f6ac-4193-971b-24e0ea6245a9,,released,Fluorouracil,1,2023-02-27T11:45:33.310572-06:00,Chemotherapy,Residual Disease,
HCM-WCMC-0491-C16,6e757d59-1eb2-4f38-b662-f3f543ba5844,a1e3f4b9-1a5e-4d3c-b470-d276d1c27b4b,,Neoadjuvant,15.0,2023-07-13T10:35:44.371881-05:00,HCM-WCMC-0491-C16_treatment3,694cac2a-412c-45d7-a26e-b01c3ffc731d,,released,Oxaliplatin,1,2023-02-27T11:45:33.310572-06:00,Chemotherapy,,
HCM-WCMC-0491-C16,6e757d59-1eb2-4f38-b662-f3f543ba5844,a1e3f4b9-1a5e-4d3c-b470-d276d1c27b4b,1182.0,Adjuvant,1177.0,2023-07-13T10:35:44.371881-05:00,HCM-WCMC-0491-C16_treatment17,8556264f-dd96-428a-9fe0-83cfa619bd52,,released,Trastuzumab,1,2023-02-27T11:45:33.310572-06:00,Targeted Molecular Therapy,Residual Disease,
HCM-WCMC-0491-C16,6e757d59-1eb2-4f38-b662-f3f543ba5844,a1e3f4b9-1a5e-4d3c-b470-d276d1c27b4b,,Adjuvant,,2023-07-13T10:35:44.371881-05:00,HCM-WCMC-0491-C16_treatment15,9547fa50-4da2-43db-9638-c8c8ec0e0de1,,released,,0,2023-02-27T11:45:33.310572-06:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-WCMC-0491-C16,6e757d59-1eb2-4f38-b662-f3f543ba5844,a1e3f4b9-1a5e-4d3c-b470-d276d1c27b4b,360.0,Adjuvant,234.0,2023-07-13T10:35:44.371881-05:00,HCM-WCMC-0491-C16_treatment10,9955ac39-ebe3-4379-a7a7-2749a3338ed9,,released,Leucovorin,1,2023-02-27T11:45:33.310572-06:00,Chemotherapy,Residual Disease,
HCM-WCMC-0491-C16,6e757d59-1eb2-4f38-b662-f3f543ba5844,a1e3f4b9-1a5e-4d3c-b470-d276d1c27b4b,619.0,Adjuvant,374.0,2023-07-13T10:35:44.371881-05:00,HCM-WCMC-0491-C16_treatment18,aa6e413a-a152-484e-a8e7-b192c4dbcd10,,released,Trastuzumab,1,2023-02-27T11:45:33.310572-06:00,Targeted Molecular Therapy,Residual Disease,
HCM-WCMC-0491-C16,6e757d59-1eb2-4f38-b662-f3f543ba5844,a1e3f4b9-1a5e-4d3c-b470-d276d1c27b4b,,,730.0,2023-07-13T10:35:44.371881-05:00,HCM-WCMC-0491-C16_treatment16,af60960b-b3c7-466c-aec0-7719100ebeab,,released,,1,2023-02-27T11:45:33.310572-06:00,"Surgery, NOS",Initial Diagnosis,
HCM-WCMC-0491-C16,6e757d59-1eb2-4f38-b662-f3f543ba5844,a1e3f4b9-1a5e-4d3c-b470-d276d1c27b4b,1182.0,Adjuvant,1177.0,2023-07-13T10:35:44.371881-05:00,HCM-WCMC-0491-C16_treatment7,bbf0c34e-9c41-487f-a6ce-b00c37545c0f,,released,Fluorouracil,1,2023-02-27T11:45:33.310572-06:00,Chemotherapy,Residual Disease,
HCM-WCMC-0491-C16,6e757d59-1eb2-4f38-b662-f3f543ba5844,a1e3f4b9-1a5e-4d3c-b470-d276d1c27b4b,,Neoadjuvant,15.0,2023-07-13T10:35:44.371881-05:00,HCM-WCMC-0491-C16_treatment5,d4859560-7973-46a7-83f7-ab0cfab9b1da,,released,,1,2023-02-27T11:45:33.310572-06:00,Chemotherapy,,FOLFOX
HCM-WCMC-0491-C16,6e757d59-1eb2-4f38-b662-f3f543ba5844,a1e3f4b9-1a5e-4d3c-b470-d276d1c27b4b,1182.0,Adjuvant,1177.0,2023-07-13T10:35:44.371881-05:00,HCM-WCMC-0491-C16_treatment9,d5b3f6a9-1c86-4866-b6f6-f352bab4931f,,released,,1,2023-02-27T11:45:33.310572-06:00,Chemotherapy,Residual Disease,FOLFOX
HCM-WCMC-0491-C16,6e757d59-1eb2-4f38-b662-f3f543ba5844,a1e3f4b9-1a5e-4d3c-b470-d276d1c27b4b,,Neoadjuvant,15.0,2023-07-13T10:35:44.371881-05:00,HCM-WCMC-0491-C16_treatment2,d8cf418a-98cb-4e5d-bdcc-d36a0aceed4e,,released,Fluorouracil,1,2023-02-27T11:45:33.310572-06:00,Chemotherapy,,
HCM-WCMC-0491-C16,6e757d59-1eb2-4f38-b662-f3f543ba5844,a1e3f4b9-1a5e-4d3c-b470-d276d1c27b4b,,Neoadjuvant,15.0,2023-07-13T10:35:44.371881-05:00,HCM-WCMC-0491-C16_treatment4,e63a508c-59e0-4c31-8a30-b25adc6b1653,,released,Trastuzumab,1,2023-02-27T11:45:33.310572-06:00,Chemotherapy,,
HCM-WCMC-0491-C16,6e757d59-1eb2-4f38-b662-f3f543ba5844,a1e3f4b9-1a5e-4d3c-b470-d276d1c27b4b,1182.0,Adjuvant,1177.0,2023-07-13T10:35:44.371881-05:00,HCM-WCMC-0491-C16_treatment20,ed2df4c8-ef2c-4575-b472-10a64432ae60,,released,,1,2023-02-27T11:45:33.310572-06:00,"Radiation Therapy, NOS",Residual Disease,
HCM-WCMC-0491-C16,6e757d59-1eb2-4f38-b662-f3f543ba5844,a1e3f4b9-1a5e-4d3c-b470-d276d1c27b4b,,Neoadjuvant,15.0,2023-07-13T10:35:44.371881-05:00,HCM-WCMC-0491-C16_treatment,f5553dbf-9e2a-4621-b8d3-8ca9f3996d2d,,released,Leucovorin Calcium,1,2023-02-27T11:45:33.310572-06:00,Chemotherapy,,
HCM-WCMC-0491-C16,6e757d59-1eb2-4f38-b662-f3f543ba5844,a1e3f4b9-1a5e-4d3c-b470-d276d1c27b4b,360.0,Adjuvant,234.0,2023-07-13T10:35:44.371881-05:00,HCM-WCMC-0491-C16_treatment11,fab5f0b0-35ae-4fc6-89e7-b061ea4a8076,,released,Fluorouracil,1,2023-02-27T11:45:33.310572-06:00,Chemotherapy,Residual Disease,
HCM-CSHL-0585-C06,6ea6550b-389d-416f-ab43-f532c5afcc94,7b6353a5-d434-45b0-b842-5dd542028862,,,29.0,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0585-C06_treatment5,1a37e1e9-747d-43a5-818a-515de0411a37,,released,,1,2020-10-08T13:35:18.675146-05:00,"Surgery, NOS",Initial Diagnosis,
HCM-CSHL-0585-C06,6ea6550b-389d-416f-ab43-f532c5afcc94,7b6353a5-d434-45b0-b842-5dd542028862,,Neoadjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0585-C06_treatment,1a462939-a9bb-4e5f-9480-3248b091f34d,,released,,0,2020-10-08T13:35:18.675146-05:00,,,
HCM-CSHL-0585-C06,6ea6550b-389d-416f-ab43-f532c5afcc94,7b6353a5-d434-45b0-b842-5dd542028862,,Adjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0585-C06_treatment4,2e4a3f74-a294-40f5-9628-1b6aa8ee493f,,released,,0,2020-10-08T13:35:18.675146-05:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-CSHL-0585-C06,6ea6550b-389d-416f-ab43-f532c5afcc94,7b6353a5-d434-45b0-b842-5dd542028862,,Adjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0585-C06_treatment6,51f21d0d-d50f-410c-aeb6-d54816e7bf8e,,released,,0,2020-10-08T13:35:18.675146-05:00,Targeted Molecular Therapy,Residual Disease,
HCM-CSHL-0585-C06,6ea6550b-389d-416f-ab43-f532c5afcc94,7b6353a5-d434-45b0-b842-5dd542028862,,Adjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0585-C06_treatment7,97b35105-d817-4ee7-97cc-623397ffb378,,released,,0,2020-10-08T13:35:18.675146-05:00,"Radiation Therapy, NOS",Residual Disease,
HCM-CSHL-0585-C06,6ea6550b-389d-416f-ab43-f532c5afcc94,7b6353a5-d434-45b0-b842-5dd542028862,96.0,Adjuvant,72.0,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0585-C06_treatment2,c3e1fea2-7a15-44f9-995a-80ea9526b275,,released,Cisplatin,1,2020-10-08T13:35:18.675146-05:00,Chemotherapy,Residual Disease,
HCM-CSHL-0585-C06,6ea6550b-389d-416f-ab43-f532c5afcc94,7b6353a5-d434-45b0-b842-5dd542028862,,Adjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0585-C06_treatment3,e6dcbda6-59be-44e6-ba16-b22aa94f29e8,,released,,0,2020-10-08T13:35:18.675146-05:00,Hormone Therapy,Residual Disease,
HCM-CSHL-0509-C24,6ecd59ce-a391-4187-87a3-a69a71919585,78385db4-82a6-4b0a-95dc-9e2365b19a69,,Adjuvant,,2023-03-13T12:40:26.862946-05:00,HCM-CSHL-0509-C24_treatment4,570976af-6989-4e6d-9617-d35d36c6185d,,released,,0,2021-12-21T14:06:19.428202-06:00,"Radiation Therapy, NOS",Residual Disease,
HCM-CSHL-0509-C24,6ecd59ce-a391-4187-87a3-a69a71919585,78385db4-82a6-4b0a-95dc-9e2365b19a69,,Neoadjuvant,,2023-02-22T07:39:25.979291-06:00,HCM-CSHL-0509-C24_treatment,a76be820-9071-43ad-8e35-eccbaa132c75,,released,,0,2021-12-21T14:06:19.428202-06:00,,,
HCM-CSHL-0509-C24,6ecd59ce-a391-4187-87a3-a69a71919585,78385db4-82a6-4b0a-95dc-9e2365b19a69,,Adjuvant,,2023-03-13T12:40:26.862946-05:00,HCM-CSHL-0509-C24_treatment3,c391dea6-1ce2-44e4-9f1a-5e42b42ebc62,,released,,0,2021-12-21T14:06:19.428202-06:00,"Pharmaceutical Therapy, NOS",Residual Disease,
HCM-CSHL-0509-C24,6ecd59ce-a391-4187-87a3-a69a71919585,78385db4-82a6-4b0a-95dc-9e2365b19a69,,,-13.0,2023-03-13T12:40:26.862946-05:00,HCM-CSHL-0509-C24_treatment2,fa945718-2cff-4767-9a1a-96b736fac40f,,released,,1,2021-12-21T14:06:19.428202-06:00,"Surgery, NOS",Initial Diagnosis,
HCM-BROD-1122-C49,6f991912-1110-4ba2-9c63-078ee2bd6b59,458fd285-796b-4c0b-b38c-9ba26cb110fa,,Neoadjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-BROD-1122-C49_treatment,9c6f01cb-580b-4beb-bcaa-2de43b909c6f,,released,,0,2021-12-21T14:01:27.654348-06:00,,,
HCM-BROD-1122-C49,6f991912-1110-4ba2-9c63-078ee2bd6b59,458fd285-796b-4c0b-b38c-9ba26cb110fa,,,40.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-1122-C49_treatment2,adc25186-056d-4a0f-9c03-3d8fcee3a832,,released,,1,2021-12-21T14:01:27.654348-06:00,"Surgery, NOS",Initial Diagnosis,
HCM-BROD-1122-C49,6f991912-1110-4ba2-9c63-078ee2bd6b59,458fd285-796b-4c0b-b38c-9ba26cb110fa,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-BROD-1122-C49_treatment4,dfeb9c70-d4b8-4191-81f9-2dd4564416fb,,released,,0,2021-12-21T14:01:27.654348-06:00,"Radiation Therapy, NOS",Residual Disease,
HCM-BROD-1122-C49,6f991912-1110-4ba2-9c63-078ee2bd6b59,458fd285-796b-4c0b-b38c-9ba26cb110fa,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-BROD-1122-C49_treatment3,f9ea92de-73cd-48cb-8363-60ea01b5dbd5,,released,,0,2021-12-21T14:01:27.654348-06:00,"Pharmaceutical Therapy, NOS",Residual Disease,
HCM-BROD-0220-C15,6fd2c09d-e1d8-4cb8-bd86-39fa5d1c0cd5,bfbf99d5-d984-4c5b-aa22-8a8f007c4f56,,Neoadjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0220-C15_treatment,37a92ed1-fbc2-4cd9-9231-59e5b55c5957,,released,,0,2019-04-04T16:03:09.368016-05:00,,,
HCM-BROD-0220-C15,6fd2c09d-e1d8-4cb8-bd86-39fa5d1c0cd5,bfbf99d5-d984-4c5b-aa22-8a8f007c4f56,226.0,Adjuvant,14.0,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0220-C15_treatment6,74a75c47-86c6-45fb-99f1-f3235851176e,,released,Trastuzumab,1,2019-04-04T16:03:09.368016-05:00,Targeted Molecular Therapy,Residual Disease,
HCM-BROD-0220-C15,6fd2c09d-e1d8-4cb8-bd86-39fa5d1c0cd5,bfbf99d5-d984-4c5b-aa22-8a8f007c4f56,226.0,Adjuvant,14.0,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0220-C15_treatment3,8f79909b-48cf-48aa-9fbf-2f72c69b1c9c,,released,Oxaliplatin,1,2019-04-04T16:03:09.368016-05:00,Chemotherapy,Residual Disease,
HCM-BROD-0220-C15,6fd2c09d-e1d8-4cb8-bd86-39fa5d1c0cd5,bfbf99d5-d984-4c5b-aa22-8a8f007c4f56,226.0,Adjuvant,14.0,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0220-C15_treatment2,b593d98c-1c0e-428f-9c1b-6428c9a7e111,,released,Fluorouracil,1,2019-04-04T16:03:09.368016-05:00,Chemotherapy,Residual Disease,
HCM-BROD-0220-C15,6fd2c09d-e1d8-4cb8-bd86-39fa5d1c0cd5,bfbf99d5-d984-4c5b-aa22-8a8f007c4f56,,,-3.0,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0220-C15_treatment5,c192b6f5-5a4d-4422-84f5-876dbd22c2a3,,released,,1,2019-04-04T16:03:09.368016-05:00,"Surgery, NOS",Initial Diagnosis,
HCM-BROD-0220-C15,6fd2c09d-e1d8-4cb8-bd86-39fa5d1c0cd5,bfbf99d5-d984-4c5b-aa22-8a8f007c4f56,,Adjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0220-C15_treatment7,da70fec4-38dd-477a-bbc7-10f7b931be8f,,released,,0,2020-09-27T11:02:16.043743-05:00,"Radiation Therapy, NOS",Residual Disease,
HCM-BROD-0220-C15,6fd2c09d-e1d8-4cb8-bd86-39fa5d1c0cd5,bfbf99d5-d984-4c5b-aa22-8a8f007c4f56,,Adjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0220-C15_treatment4,eb42a841-3365-455b-a0b6-540cb601fda0,,released,,0,2019-04-04T16:03:09.368016-05:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-CSHL-0177-C25,6fd57448-daf9-4d8c-9cbc-88e53b246932,419f63d2-a093-43eb-a1c0-a3ec42f1577a,,,-12.0,2023-02-27T13:35:25.883698-06:00,HCM-CSHL-0177-C25_treatment4,118a7f2e-1530-4a1a-9dee-35b7c42a6eb9,,released,,1,2020-09-28T09:13:10.234692-05:00,"Surgery, NOS",Initial Diagnosis,
HCM-CSHL-0177-C25,6fd57448-daf9-4d8c-9cbc-88e53b246932,419f63d2-a093-43eb-a1c0-a3ec42f1577a,,Adjuvant,,2023-02-22T07:39:25.979291-06:00,HCM-CSHL-0177-C25_treatment3,3c60877d-ac74-47d0-8e51-cccc472431c8,,released,,0,2020-09-28T09:13:10.234692-05:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-CSHL-0177-C25,6fd57448-daf9-4d8c-9cbc-88e53b246932,419f63d2-a093-43eb-a1c0-a3ec42f1577a,285.0,Adjuvant,223.0,2023-02-22T07:39:25.979291-06:00,HCM-CSHL-0177-C25_treatment6,9d5a0644-bc74-4298-ad72-1a858af0cc9d,,released,,1,2020-09-28T09:13:10.234692-05:00,"Radiation Therapy, NOS",Residual Disease,
HCM-CSHL-0177-C25,6fd57448-daf9-4d8c-9cbc-88e53b246932,419f63d2-a093-43eb-a1c0-a3ec42f1577a,,Adjuvant,40.0,2023-02-22T07:39:25.979291-06:00,HCM-CSHL-0177-C25_treatment2,c2c4b472-0499-4b5a-afa7-4844f5f639ba,,released,Gemcitabine,1,2020-09-28T09:13:10.234692-05:00,Chemotherapy,Residual Disease,
HCM-CSHL-0177-C25,6fd57448-daf9-4d8c-9cbc-88e53b246932,419f63d2-a093-43eb-a1c0-a3ec42f1577a,,Adjuvant,,2023-02-22T07:39:25.979291-06:00,HCM-CSHL-0177-C25_treatment5,cafd8ac8-a376-4738-9059-d42d71f6ef3d,,released,,0,2020-09-28T09:13:10.234692-05:00,Targeted Molecular Therapy,Residual Disease,
HCM-CSHL-0177-C25,6fd57448-daf9-4d8c-9cbc-88e53b246932,419f63d2-a093-43eb-a1c0-a3ec42f1577a,,Neoadjuvant,,2023-02-22T07:39:25.979291-06:00,HCM-CSHL-0177-C25_treatment,e2861960-f18a-4270-af8f-8ffa67032cc7,,released,,0,2020-09-28T09:13:10.234692-05:00,,,
HCM-SANG-0525-C18,6fe93402-3532-42bf-9df9-981213da81f8,6f510377-afa0-4475-ba8a-2e35d35c25fe,,Neoadjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-SANG-0525-C18_treatment,c60b3e12-e3de-4022-b1f0-7297e526b26c,,released,,0,2023-02-27T12:00:18.574983-06:00,,,
HCM-SANG-0534-C18,708cf1d9-3214-469b-9530-715fa4d41352,420058fd-c4a1-4d8c-81fd-effbd912cc55,,Neoadjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-SANG-0534-C18_treatment,085af3b2-36a1-435e-9081-e936cb1d86a6,,released,,0,2021-12-21T15:15:03.850895-06:00,,,
HCM-BROD-0096-C15,70e98240-6f6d-4d45-bb10-566ea820e5de,b5087abb-360a-4c0c-8a19-76c4d4178ca2,,Adjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0096-C15_treatment7,1b1a93bc-ee56-42f6-8e07-992e8dfa28ee,,released,,0,2020-09-27T10:21:35.786095-05:00,"Radiation Therapy, NOS",Residual Disease,
HCM-BROD-0096-C15,70e98240-6f6d-4d45-bb10-566ea820e5de,b5087abb-360a-4c0c-8a19-76c4d4178ca2,,Neoadjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0096-C15_treatment2,484c47c3-0bfa-40dc-aede-e87eda485831,,released,,unknown,2019-04-04T15:48:14.895630-05:00,"Radiation Therapy, NOS",,
HCM-BROD-0096-C15,70e98240-6f6d-4d45-bb10-566ea820e5de,b5087abb-360a-4c0c-8a19-76c4d4178ca2,,Adjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0096-C15_treatment6,498539a4-859f-4e49-836f-7eaf78718e62,,released,,0,2020-09-27T10:21:35.786095-05:00,Targeted Molecular Therapy,Residual Disease,
HCM-BROD-0096-C15,70e98240-6f6d-4d45-bb10-566ea820e5de,b5087abb-360a-4c0c-8a19-76c4d4178ca2,,,126.0,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0096-C15_treatment5,b8a301c3-b38a-4a7c-9404-0b216d311b8d,,released,,1,2020-09-27T10:21:35.786095-05:00,"Surgery, NOS",Initial Diagnosis,
HCM-BROD-0096-C15,70e98240-6f6d-4d45-bb10-566ea820e5de,b5087abb-360a-4c0c-8a19-76c4d4178ca2,,Adjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0096-C15_treatment3,c24611aa-d301-4204-be31-683215346ccd,,released,,0,2020-09-27T10:21:35.786095-05:00,Chemotherapy,Residual Disease,
HCM-BROD-0096-C15,70e98240-6f6d-4d45-bb10-566ea820e5de,b5087abb-360a-4c0c-8a19-76c4d4178ca2,,Adjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0096-C15_treatment4,c8bfb08b-6f77-4bf4-a6bb-c8b37465af3a,,released,,0,2020-09-27T10:21:35.786095-05:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-BROD-0096-C15,70e98240-6f6d-4d45-bb10-566ea820e5de,b5087abb-360a-4c0c-8a19-76c4d4178ca2,,Neoadjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0096-C15_treatment,f4b9b39f-ab53-477c-83b0-d6797bf9a330,,released,,unknown,2019-04-04T15:48:14.895630-05:00,"Pharmaceutical Therapy, NOS",,
HCM-BROD-0781-C71,711f0482-0800-4f18-962f-1d35f9d30727,719c55ae-9cce-4c25-ae68-58b355c4fbea,,Adjuvant,,2023-11-07T14:20:00.017270-06:00,HCM-BROD-0781-C71_treatment3,011aab10-8f00-4985-9dbb-efd91c1f8db0,,released,,0,2021-12-21T13:50:58.029147-06:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-BROD-0781-C71,711f0482-0800-4f18-962f-1d35f9d30727,719c55ae-9cce-4c25-ae68-58b355c4fbea,,,-14.0,2023-11-07T14:20:00.017270-06:00,HCM-BROD-0781-C71_treatment4,1570b448-977f-4906-b702-bfd1861b723d,,released,,1,2021-12-21T13:50:58.029147-06:00,"Surgery, NOS",Initial Diagnosis,
HCM-BROD-0781-C71,711f0482-0800-4f18-962f-1d35f9d30727,719c55ae-9cce-4c25-ae68-58b355c4fbea,194.0,Adjuvant,105.0,2024-04-08T09:01:30.151723-05:00,HCM-BROD-0781-C71_treatment5,547b9afc-2a14-4a57-b77a-d4ce946e4173,,released,Bevacizumab,1,2021-12-21T13:50:58.029147-06:00,Targeted Molecular Therapy,Residual Disease,
HCM-BROD-0781-C71,711f0482-0800-4f18-962f-1d35f9d30727,719c55ae-9cce-4c25-ae68-58b355c4fbea,68.0,Adjuvant,32.0,2023-11-07T14:20:00.017270-06:00,HCM-BROD-0781-C71_treatment2,836900c9-bf37-4d95-bdf6-0522fb2a6169,,released,Temozolomide,1,2021-12-21T13:50:58.029147-06:00,Chemotherapy,Residual Disease,
HCM-BROD-0781-C71,711f0482-0800-4f18-962f-1d35f9d30727,719c55ae-9cce-4c25-ae68-58b355c4fbea,68.0,Adjuvant,32.0,2023-11-07T14:20:00.017270-06:00,HCM-BROD-0781-C71_treatment6,bab9a380-1151-4fad-bf87-f33eaf922607,,released,,1,2021-12-21T13:50:58.029147-06:00,"Radiation, 2D Conventional",Residual Disease,
HCM-BROD-0781-C71,711f0482-0800-4f18-962f-1d35f9d30727,719c55ae-9cce-4c25-ae68-58b355c4fbea,,Neoadjuvant,,2023-11-07T14:20:00.017270-06:00,HCM-BROD-0781-C71_treatment,e1329f40-a9e6-4ccf-85c6-dcb71d8a4b80,,released,,0,2021-12-21T13:50:58.029147-06:00,,,
HCM-BROD-0702-C43,71dd56c3-0048-4ec9-89cb-53b5e966255a,228d20c0-aa60-46f5-938b-3b10fcdea7dd,,Adjuvant,,2023-02-22T07:39:25.979291-06:00,HCM-BROD-0702-C43_treatment8,0c3e4793-a9d4-4e70-8d70-cce252fbd097,,released,,unknown,2021-11-23T08:37:02.024883-06:00,"Radiation Therapy, NOS",Residual Disease,
HCM-BROD-0702-C43,71dd56c3-0048-4ec9-89cb-53b5e966255a,228d20c0-aa60-46f5-938b-3b10fcdea7dd,,Neoadjuvant,,2023-02-22T07:39:25.979291-06:00,HCM-BROD-0702-C43_treatment,22f21a14-5b1b-40dd-8cae-c6a89cbd2797,,released,,unknown,2021-11-23T08:37:02.024883-06:00,"Pharmaceutical Therapy, NOS",,
HCM-BROD-0702-C43,71dd56c3-0048-4ec9-89cb-53b5e966255a,228d20c0-aa60-46f5-938b-3b10fcdea7dd,,Adjuvant,,2023-02-22T07:39:25.979291-06:00,HCM-BROD-0702-C43_treatment3,72ec37b6-0b04-4e26-80b3-d723f2f38917,,released,,unknown,2021-11-23T08:37:02.024883-06:00,Chemotherapy,Residual Disease,
HCM-BROD-0702-C43,71dd56c3-0048-4ec9-89cb-53b5e966255a,228d20c0-aa60-46f5-938b-3b10fcdea7dd,,Neoadjuvant,,2023-02-22T07:39:25.979291-06:00,HCM-BROD-0702-C43_treatment2,7744df38-a494-4cce-90f1-2dfe8588fee2,,released,,unknown,2021-11-23T08:37:02.024883-06:00,"Radiation Therapy, NOS",,
HCM-BROD-0702-C43,71dd56c3-0048-4ec9-89cb-53b5e966255a,228d20c0-aa60-46f5-938b-3b10fcdea7dd,,Adjuvant,,2023-02-22T07:39:25.979291-06:00,HCM-BROD-0702-C43_treatment4,7bbb0432-cbef-4073-91ba-3550bd552995,,released,,unknown,2021-11-23T08:37:02.024883-06:00,Hormone Therapy,Residual Disease,
HCM-BROD-0702-C43,71dd56c3-0048-4ec9-89cb-53b5e966255a,228d20c0-aa60-46f5-938b-3b10fcdea7dd,,Adjuvant,,2023-02-22T07:39:25.979291-06:00,HCM-BROD-0702-C43_treatment7,a3663bba-7c87-49d0-b25e-7e668cf214cd,,released,,unknown,2021-11-23T08:37:02.024883-06:00,Targeted Molecular Therapy,Residual Disease,
HCM-BROD-0702-C43,71dd56c3-0048-4ec9-89cb-53b5e966255a,228d20c0-aa60-46f5-938b-3b10fcdea7dd,,,,2023-03-13T13:12:45.133816-05:00,HCM-BROD-0702-C43_treatment6,c391309f-ae54-44c9-8da0-f8ee074943dd,,released,,unknown,2021-11-23T08:37:02.024883-06:00,"Surgery, NOS",Initial Diagnosis,
HCM-BROD-0702-C43,71dd56c3-0048-4ec9-89cb-53b5e966255a,228d20c0-aa60-46f5-938b-3b10fcdea7dd,,Adjuvant,,2023-02-22T07:39:25.979291-06:00,HCM-BROD-0702-C43_treatment5,f5e9b550-e99c-4fba-8411-7594915a254d,,released,,unknown,2021-11-23T08:37:02.024883-06:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-BROD-0702-C43,71dd56c3-0048-4ec9-89cb-53b5e966255a,9ce4d590-fc03-4b3f-9cb3-012ae0639d37,612.0,Maintenance Therapy,304.0,2023-02-22T07:39:25.979291-06:00,HCM-BROD-0702-C43_treatment10,0a509779-e240-4dfa-9bf8-164f72595c9e,Progressive Disease,released,Ipilimumab,1,2021-11-23T08:37:02.024883-06:00,,,
HCM-BROD-0702-C43,71dd56c3-0048-4ec9-89cb-53b5e966255a,9ce4d590-fc03-4b3f-9cb3-012ae0639d37,612.0,Maintenance Therapy,304.0,2023-02-22T07:39:25.979291-06:00,HCM-BROD-0702-C43_treatment9,808b751b-6e3b-4ce1-b7e3-5c1c742a603b,Progressive Disease,released,Pembrolizumab,1,2021-11-23T08:37:02.024883-06:00,,,
HCM-CSHL-0381-C20,723fd0ed-5223-41ef-8f09-677a1b3ca9d4,0b8dc911-8727-455a-8050-1658e81b463d,,,234.0,2023-03-13T12:45:41.823572-05:00,HCM-CSHL-0381-C20_treatment5,0a8cb547-50c6-48db-afad-52567ea99158,,released,,1,2020-06-15T13:36:29.216615-05:00,"Surgery, NOS",Initial Diagnosis,
HCM-CSHL-0381-C20,723fd0ed-5223-41ef-8f09-677a1b3ca9d4,0b8dc911-8727-455a-8050-1658e81b463d,,Adjuvant,,2021-01-06T22:55:10.531130-06:00,HCM-CSHL-0381-C20_treatment6,55ebadd6-50bb-4b80-b6cd-d91d96e1c4c7,,released,,0,2020-06-15T13:36:29.216615-05:00,Targeted Molecular Therapy,Residual Disease,
HCM-CSHL-0381-C20,723fd0ed-5223-41ef-8f09-677a1b3ca9d4,0b8dc911-8727-455a-8050-1658e81b463d,,Neoadjuvant,315.0,2021-01-06T22:55:10.531130-06:00,HCM-CSHL-0381-C20_treatment,820c5cd6-2db9-435a-ad85-1e2727f6ff3b,,released,Capecitabine,1,2020-06-15T13:36:29.216615-05:00,Chemotherapy,,
HCM-CSHL-0381-C20,723fd0ed-5223-41ef-8f09-677a1b3ca9d4,0b8dc911-8727-455a-8050-1658e81b463d,,Adjuvant,,2021-01-06T22:55:10.531130-06:00,HCM-CSHL-0381-C20_treatment7,8ae3ee18-882f-4ed7-9b30-a6475d6fa00e,,released,,0,2020-06-15T13:36:29.216615-05:00,"Radiation Therapy, NOS",Residual Disease,
HCM-CSHL-0381-C20,723fd0ed-5223-41ef-8f09-677a1b3ca9d4,0b8dc911-8727-455a-8050-1658e81b463d,,Neoadjuvant,88.0,2021-01-06T22:55:10.531130-06:00,HCM-CSHL-0381-C20_treatment2,c4eba771-728e-45ed-bdf9-042760baf2d2,,released,,1,2020-06-15T13:36:29.216615-05:00,"Radiation, Intensity-Modulated Radiotherapy",,
HCM-CSHL-0381-C20,723fd0ed-5223-41ef-8f09-677a1b3ca9d4,0b8dc911-8727-455a-8050-1658e81b463d,,Adjuvant,,2021-01-06T22:55:10.531130-06:00,HCM-CSHL-0381-C20_treatment4,f0117a64-dcea-4081-8144-2361a8374b8a,,released,,0,2020-06-15T13:36:29.216615-05:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-CSHL-0381-C20,723fd0ed-5223-41ef-8f09-677a1b3ca9d4,0b8dc911-8727-455a-8050-1658e81b463d,464.0,Adjuvant,299.0,2021-01-06T22:55:10.531130-06:00,HCM-CSHL-0381-C20_treatment3,fe89cfb5-a459-4b01-be61-390a8e004a32,,released,Capecitabine,1,2020-06-15T13:36:29.216615-05:00,Chemotherapy,Residual Disease,
HCM-SANG-1321-C18,72b32ae9-d75d-43d4-a094-04b457ed99a6,7cc9d591-6653-43c3-8919-cdc4bcbdf636,,Neoadjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-SANG-1321-C18_treatment,a1afee1d-7d10-4714-9e22-96945d704505,,released,,0,2023-02-27T12:29:05.643617-06:00,,,
HCM-WCMC-0747-C50,74016d27-4ade-46de-85d9-504e6e840042,13725bda-eaad-4888-be9c-14ddaaa0cf20,928.0,Maintenance Therapy,106.0,2025-04-07T17:13:09.336794-05:00,HCM-WCMC-0747-C50_treatment13,1a5bc4b6-279d-4999-a315-863bd37b5462,Treatment Ongoing,released,Leuprolide Acetate,1,2023-02-24T14:47:25.740338-06:00,,,
HCM-WCMC-0747-C50,74016d27-4ade-46de-85d9-504e6e840042,13725bda-eaad-4888-be9c-14ddaaa0cf20,928.0,Maintenance Therapy,106.0,2025-04-07T17:13:09.336794-05:00,HCM-WCMC-0747-C50_treatment14,92f4919b-6d70-43f5-acd5-8ed787fc1c8a,Treatment Ongoing,released,Tamoxifen,1,2023-02-24T14:47:25.740338-06:00,,,
HCM-WCMC-0747-C50,74016d27-4ade-46de-85d9-504e6e840042,13725bda-eaad-4888-be9c-14ddaaa0cf20,,Prevention,,2025-04-07T17:13:09.336794-05:00,HCM-WCMC-0747-C50_treatment16,a6f0dd1e-c9cb-46f8-a6f2-5fa30bd63931,,released,,1,2023-02-24T14:47:25.740338-06:00,Hormone Therapy,,
HCM-WCMC-0747-C50,74016d27-4ade-46de-85d9-504e6e840042,3e2aed94-79e2-42d5-a63e-aeffaf920b81,411.0,Adjuvant,106.0,2025-04-07T17:13:09.336794-05:00,HCM-WCMC-0747-C50_treatment8,07c65af6-bdcf-45f6-bcee-e173bd6ca5bd,,released,Tamoxifen,1,2023-02-24T14:47:25.740338-06:00,Hormone Therapy,Residual Disease,
HCM-WCMC-0747-C50,74016d27-4ade-46de-85d9-504e6e840042,3e2aed94-79e2-42d5-a63e-aeffaf920b81,1175.0,Adjuvant,745.0,2025-04-07T17:13:09.336794-05:00,HCM-WCMC-0747-C50_treatment5,1ff08f18-f686-4663-8685-d5312d96ea42,Treatment Ongoing,released,Anastrozole,1,2023-02-24T14:47:25.740338-06:00,Hormone Therapy,Residual Disease,
HCM-WCMC-0747-C50,74016d27-4ade-46de-85d9-504e6e840042,3e2aed94-79e2-42d5-a63e-aeffaf920b81,,Prevention,,2025-04-07T17:13:09.336794-05:00,HCM-WCMC-0747-C50_treatment15,4d286d88-c75e-4ae8-a773-04d71e1a1d4a,,released,,0,2023-02-24T14:47:25.740338-06:00,Hormone Therapy,,
HCM-WCMC-0747-C50,74016d27-4ade-46de-85d9-504e6e840042,3e2aed94-79e2-42d5-a63e-aeffaf920b81,,,43.0,2025-04-07T17:13:09.336794-05:00,HCM-WCMC-0747-C50_treatment10,8efa1358-99d1-4112-85b4-09d6492e0c90,,released,,1,2023-02-24T14:47:25.740338-06:00,"Surgery, NOS",Initial Diagnosis,
HCM-WCMC-0747-C50,74016d27-4ade-46de-85d9-504e6e840042,3e2aed94-79e2-42d5-a63e-aeffaf920b81,,Neoadjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-WCMC-0747-C50_treatment,959df3dd-ed50-451f-835d-b0b9a8a3b88a,,released,,0,2023-02-24T14:47:25.740338-06:00,,,
HCM-WCMC-0747-C50,74016d27-4ade-46de-85d9-504e6e840042,3e2aed94-79e2-42d5-a63e-aeffaf920b81,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-WCMC-0747-C50_treatment11,9e8507a6-7c02-44c2-8fa1-80019ae14a6a,,released,,0,2023-02-24T14:47:25.740338-06:00,Targeted Molecular Therapy,Residual Disease,
HCM-WCMC-0747-C50,74016d27-4ade-46de-85d9-504e6e840042,3e2aed94-79e2-42d5-a63e-aeffaf920b81,435.0,Adjuvant,435.0,2025-04-07T17:13:09.336794-05:00,HCM-WCMC-0747-C50_treatment7,bd7dbbf0-658a-4e51-a140-1b93cbf885ad,,released,Leuprolide,1,2023-02-24T14:47:25.740338-06:00,Hormone Therapy,Residual Disease,
HCM-WCMC-0747-C50,74016d27-4ade-46de-85d9-504e6e840042,3e2aed94-79e2-42d5-a63e-aeffaf920b81,613.0,Adjuvant,580.0,2025-04-07T17:13:09.336794-05:00,HCM-WCMC-0747-C50_treatment12,c0ea8953-65a0-4023-9e52-9d89b6c6be3f,,released,,1,2023-02-24T14:47:25.740338-06:00,"Radiation Therapy, NOS",Residual Disease,
HCM-WCMC-0747-C50,74016d27-4ade-46de-85d9-504e6e840042,3e2aed94-79e2-42d5-a63e-aeffaf920b81,1175.0,Adjuvant,745.0,2025-04-07T17:13:09.336794-05:00,HCM-WCMC-0747-C50_treatment6,ccf9b793-ec1f-45af-8f5f-80c53219cb9a,Treatment Ongoing,released,Leuprolide,1,2023-02-24T14:47:25.740338-06:00,Hormone Therapy,Residual Disease,
HCM-WCMC-0747-C50,74016d27-4ade-46de-85d9-504e6e840042,3e2aed94-79e2-42d5-a63e-aeffaf920b81,764.0,Adjuvant,594.0,2025-04-07T17:13:09.336794-05:00,HCM-WCMC-0747-C50_treatment3,d504a013-d555-4d3e-b71a-a9fd58604e16,,released,Leuprolide,1,2023-02-24T14:47:25.740338-06:00,Hormone Therapy,Residual Disease,
HCM-WCMC-0747-C50,74016d27-4ade-46de-85d9-504e6e840042,3e2aed94-79e2-42d5-a63e-aeffaf920b81,552.0,Adjuvant,510.0,2025-04-07T17:13:09.336794-05:00,HCM-WCMC-0747-C50_treatment2,d982d5a5-a716-4468-a829-0dfcea0a6e7f,,released,Paclitaxel,1,2023-02-24T14:47:25.740338-06:00,Chemotherapy,Residual Disease,
HCM-WCMC-0747-C50,74016d27-4ade-46de-85d9-504e6e840042,3e2aed94-79e2-42d5-a63e-aeffaf920b81,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-WCMC-0747-C50_treatment9,da57e4ea-a300-40be-b198-dce252546667,,released,,0,2023-02-24T14:47:25.740338-06:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-WCMC-0747-C50,74016d27-4ade-46de-85d9-504e6e840042,3e2aed94-79e2-42d5-a63e-aeffaf920b81,764.0,Adjuvant,594.0,2025-04-07T17:13:09.336794-05:00,HCM-WCMC-0747-C50_treatment4,fe3de1bc-66a7-443b-b8c3-c562b6229d10,,released,Letrozole,1,2023-02-24T14:47:25.740338-06:00,Hormone Therapy,Residual Disease,
HCM-BROD-0344-C25,74250d5d-e275-4315-8775-589aa79c7fac,1d076ae2-cee6-4f0f-82a1-43aa92e84fc0,,Adjuvant,,2021-07-12T12:25:55.528644-05:00,HCM-BROD-0344-C25_treatment3,1741db55-938f-4819-887b-8d48a2118641,,released,,0,2020-07-31T09:28:27.709218-05:00,Chemotherapy,Residual Disease,
HCM-BROD-0344-C25,74250d5d-e275-4315-8775-589aa79c7fac,1d076ae2-cee6-4f0f-82a1-43aa92e84fc0,,Neoadjuvant,,2021-07-12T12:25:55.528644-05:00,HCM-BROD-0344-C25_treatment,70965b52-296e-4388-8324-5ac7aa4126ec,,released,,1,2020-07-31T09:28:27.709218-05:00,Chemotherapy,,
HCM-BROD-0344-C25,74250d5d-e275-4315-8775-589aa79c7fac,1d076ae2-cee6-4f0f-82a1-43aa92e84fc0,,Adjuvant,,2021-07-12T12:25:55.528644-05:00,HCM-BROD-0344-C25_treatment7,adc15e98-f13b-4d0b-97fc-4dda0293ef9b,,released,,0,2020-07-31T09:28:27.709218-05:00,"Radiation Therapy, NOS",Residual Disease,
HCM-BROD-0344-C25,74250d5d-e275-4315-8775-589aa79c7fac,1d076ae2-cee6-4f0f-82a1-43aa92e84fc0,,Adjuvant,,2021-07-12T12:25:55.528644-05:00,HCM-BROD-0344-C25_treatment4,c44ecf29-df9b-4e8b-971c-692264bed2de,,released,,0,2020-07-31T09:28:27.709218-05:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-BROD-0344-C25,74250d5d-e275-4315-8775-589aa79c7fac,1d076ae2-cee6-4f0f-82a1-43aa92e84fc0,,Adjuvant,,2021-07-12T12:25:55.528644-05:00,HCM-BROD-0344-C25_treatment6,d131c5ed-6d8d-4446-aec2-e48d9cca4390,,released,,0,2020-07-31T09:28:27.709218-05:00,Targeted Molecular Therapy,Residual Disease,
HCM-BROD-0344-C25,74250d5d-e275-4315-8775-589aa79c7fac,1d076ae2-cee6-4f0f-82a1-43aa92e84fc0,,,,2023-03-13T13:10:52.878565-05:00,HCM-BROD-0344-C25_treatment5,d1356326-d66c-4457-b32d-486093d39142,,released,,0,2020-07-31T09:28:27.709218-05:00,"Surgery, NOS",Initial Diagnosis,
HCM-BROD-0344-C25,74250d5d-e275-4315-8775-589aa79c7fac,1d076ae2-cee6-4f0f-82a1-43aa92e84fc0,,Neoadjuvant,,2021-07-12T12:25:55.528644-05:00,HCM-BROD-0344-C25_treatment2,f02675f2-aa3d-4099-82c9-4041ee25e024,,released,,1,2020-07-31T09:28:27.709218-05:00,"Radiation Therapy, NOS",,
HCM-SANG-0779-C25,74512b64-70e7-4d12-b9b8-8810d7a3bf34,df599677-dde3-4ff0-8cae-11a6463cf274,,Neoadjuvant,133.0,2025-03-31T16:34:59.906497-05:00,HCM-SANG-0779-C25_treatment2,1b69880f-3f86-41f9-aaa6-f3ff16ee3fba,,released,Irinotecan,1,2023-02-27T11:24:02.783341-06:00,Chemotherapy,,
HCM-SANG-0779-C25,74512b64-70e7-4d12-b9b8-8810d7a3bf34,df599677-dde3-4ff0-8cae-11a6463cf274,,Neoadjuvant,133.0,2025-03-31T16:34:59.906497-05:00,HCM-SANG-0779-C25_treatment,31c93f89-2f51-4365-b141-4b131e5bb3d9,,released,Fluorouracil,1,2023-02-27T11:24:02.783341-06:00,Chemotherapy,,
HCM-SANG-0779-C25,74512b64-70e7-4d12-b9b8-8810d7a3bf34,df599677-dde3-4ff0-8cae-11a6463cf274,,Neoadjuvant,133.0,2025-03-31T16:34:59.906497-05:00,HCM-SANG-0779-C25_treatment4,42bffe27-e681-4384-b347-d39e6acfd0fb,,released,Leucovorin,1,2023-02-27T11:24:02.783341-06:00,Chemotherapy,,
HCM-SANG-0779-C25,74512b64-70e7-4d12-b9b8-8810d7a3bf34,df599677-dde3-4ff0-8cae-11a6463cf274,,Neoadjuvant,133.0,2025-03-31T16:34:59.906497-05:00,HCM-SANG-0779-C25_treatment3,90ada73f-93aa-4008-b129-23206cd8c039,,released,Oxaliplatin,1,2023-02-27T11:24:02.783341-06:00,Chemotherapy,,
HCM-BROD-0644-C25,745d26a1-1072-4ac0-b168-03f4287c32b0,87084624-73bb-47ea-9ae3-380158c67ac0,,Adjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0644-C25_treatment5,05e5a80b-26bb-42f4-89e2-55a1d57d7c62,,released,,0,2020-10-08T14:49:03.103433-05:00,"Pharmaceutical Therapy, NOS",Residual Disease,
HCM-BROD-0644-C25,745d26a1-1072-4ac0-b168-03f4287c32b0,87084624-73bb-47ea-9ae3-380158c67ac0,,,,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0644-C25_treatment4,3b8d598b-3595-473d-9db8-cb5b3ab54ea4,,released,,0,2020-10-08T14:49:03.103433-05:00,"Surgery, NOS",Initial Diagnosis,
HCM-BROD-0644-C25,745d26a1-1072-4ac0-b168-03f4287c32b0,87084624-73bb-47ea-9ae3-380158c67ac0,,Neoadjuvant,742.0,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0644-C25_treatment2,47b625d4-b113-43f0-8d3c-c9ad70b5cf3b,,released,Gemcitabine,1,2020-10-08T14:49:03.103433-05:00,Chemotherapy,,
HCM-BROD-0644-C25,745d26a1-1072-4ac0-b168-03f4287c32b0,87084624-73bb-47ea-9ae3-380158c67ac0,,Neoadjuvant,907.0,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0644-C25_treatment3,aaf26bf2-0d02-478b-840a-64fb4c7bf992,,released,,1,2020-10-08T14:49:03.103433-05:00,Stereotactic Radiosurgery,,
HCM-BROD-0644-C25,745d26a1-1072-4ac0-b168-03f4287c32b0,87084624-73bb-47ea-9ae3-380158c67ac0,,Adjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0644-C25_treatment6,acfa3580-e2b4-4531-a852-b428374a88e9,,released,,0,2020-10-08T14:49:03.103433-05:00,"Radiation Therapy, NOS",Residual Disease,
HCM-BROD-0644-C25,745d26a1-1072-4ac0-b168-03f4287c32b0,87084624-73bb-47ea-9ae3-380158c67ac0,,Neoadjuvant,742.0,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0644-C25_treatment,e1f8c11d-0409-4784-8007-394a8ffd15b9,,released,Cisplatin,1,2020-10-08T14:49:03.103433-05:00,Chemotherapy,,
HCM-BROD-0644-C25,745d26a1-1072-4ac0-b168-03f4287c32b0,c4383dd9-ba1a-480d-8fd1-6cda99501eb1,944.0,Maintenance Therapy,742.0,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0644-C25_treatment9,14fcbc77-3706-4ad1-bde6-1dc2db826fcf,Progressive Disease,released,Gemcitabine,1,2023-02-28T13:21:18.868545-06:00,,,
HCM-BROD-0644-C25,745d26a1-1072-4ac0-b168-03f4287c32b0,c4383dd9-ba1a-480d-8fd1-6cda99501eb1,944.0,Maintenance Therapy,742.0,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0644-C25_treatment8,681739d8-2beb-4d22-8418-15c2e3330162,Progressive Disease,released,Nab-paclitaxel,1,2023-02-28T13:21:18.868545-06:00,,,
HCM-BROD-0644-C25,745d26a1-1072-4ac0-b168-03f4287c32b0,c4383dd9-ba1a-480d-8fd1-6cda99501eb1,944.0,Maintenance Therapy,742.0,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0644-C25_treatment7,7add3454-3645-4f8f-9f8d-3bb48812f32c,Progressive Disease,released,Capecitabine,1,2023-02-28T13:21:18.868545-06:00,,,
HCM-BROD-0594-C43,74862d9d-4f3d-4ba9-a345-2f2fd38e2490,6d96f62a-af25-4ff0-ab1a-83c0ce25b6bb,945.0,Maintenance Therapy,924.0,2023-11-07T14:20:00.017270-06:00,HCM-BROD-0594-C43_treatment5,31736403-c7b2-439d-96ae-1a84fded72ac,Progressive Disease,released,Pembrolizumab,1,2023-02-28T12:25:07.226372-06:00,,,
HCM-BROD-0594-C43,74862d9d-4f3d-4ba9-a345-2f2fd38e2490,c5a5bc34-308b-479d-9185-355cf1281ae9,,,0.0,2023-11-07T14:20:00.017270-06:00,HCM-BROD-0594-C43_treatment2,3e02cbce-d354-4c45-957d-e1e88e1fc24b,,released,,1,2021-12-21T13:40:23.585768-06:00,"Surgery, NOS",Initial Diagnosis,
HCM-BROD-0594-C43,74862d9d-4f3d-4ba9-a345-2f2fd38e2490,c5a5bc34-308b-479d-9185-355cf1281ae9,,Neoadjuvant,,2023-11-07T14:20:00.017270-06:00,HCM-BROD-0594-C43_treatment,591ca0cf-2252-42ec-a917-c6e3834c4e42,,released,,0,2021-12-21T13:40:23.585768-06:00,,,
HCM-BROD-0594-C43,74862d9d-4f3d-4ba9-a345-2f2fd38e2490,c5a5bc34-308b-479d-9185-355cf1281ae9,,Adjuvant,,2023-11-07T14:20:00.017270-06:00,HCM-BROD-0594-C43_treatment3,c64a186b-c2ed-4cfd-bd16-9a2b47f58fcd,,released,,0,2021-12-21T13:40:23.585768-06:00,"Pharmaceutical Therapy, NOS",Residual Disease,
HCM-BROD-0594-C43,74862d9d-4f3d-4ba9-a345-2f2fd38e2490,c5a5bc34-308b-479d-9185-355cf1281ae9,,Adjuvant,,2023-11-07T14:20:00.017270-06:00,HCM-BROD-0594-C43_treatment4,ecd702d1-848d-454f-a1bd-44e344c87362,,released,,0,2021-12-21T13:40:23.585768-06:00,"Radiation Therapy, NOS",Residual Disease,
HCM-SANG-1330-C19,74dcf5eb-e06f-46bc-88b2-9702ac41b2f2,7cb692f8-5b94-40e6-b693-765aa8410319,,Neoadjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-SANG-1330-C19_treatment,4fb83f7e-ae7c-4e07-9c69-0d790d6a3a4c,,released,,0,2023-02-27T11:56:30.932101-06:00,,,
HCM-STAN-0848-C20,7588a6b5-7c21-4a45-90ba-42a8220e11ac,64d78e96-8683-4479-aad6-c6b25dec813f,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-STAN-0848-C20_treatment9,52f75b72-60a9-41a9-a557-f186fe991605,,released,,0,2022-09-22T07:07:22.929533-05:00,Targeted Molecular Therapy,Residual Disease,
HCM-STAN-0848-C20,7588a6b5-7c21-4a45-90ba-42a8220e11ac,64d78e96-8683-4479-aad6-c6b25dec813f,567.0,Adjuvant,497.0,2025-04-07T17:13:09.336794-05:00,HCM-STAN-0848-C20_treatment5,8de0abc0-38fe-4f2c-86ed-3b4d11eec66d,,released,Oxaliplatin,1,2022-09-22T07:07:22.929533-05:00,Chemotherapy,Residual Disease,
HCM-STAN-0848-C20,7588a6b5-7c21-4a45-90ba-42a8220e11ac,64d78e96-8683-4479-aad6-c6b25dec813f,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-STAN-0848-C20_treatment7,ba56c94a-d82a-4fce-82e4-bd0f764f022d,,released,,0,2022-09-22T07:07:22.929533-05:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-STAN-0848-C20,7588a6b5-7c21-4a45-90ba-42a8220e11ac,64d78e96-8683-4479-aad6-c6b25dec813f,,Neoadjuvant,42.0,2025-04-07T17:13:09.336794-05:00,HCM-STAN-0848-C20_treatment2,bc27735b-fffd-4ba1-8731-11067f8655e2,,released,,1,2022-09-22T07:07:22.929533-05:00,"Radiation, 2D Conventional",,
HCM-STAN-0848-C20,7588a6b5-7c21-4a45-90ba-42a8220e11ac,64d78e96-8683-4479-aad6-c6b25dec813f,567.0,Adjuvant,497.0,2025-04-07T17:13:09.336794-05:00,HCM-STAN-0848-C20_treatment6,cc993889-d263-4329-b34b-bad462befc47,,released,,1,2022-09-22T07:07:22.929533-05:00,Chemotherapy,Residual Disease,FOLFOX
HCM-STAN-0848-C20,7588a6b5-7c21-4a45-90ba-42a8220e11ac,64d78e96-8683-4479-aad6-c6b25dec813f,,,0.0,2025-04-07T17:13:09.336794-05:00,HCM-STAN-0848-C20_treatment8,ccf85517-bb54-4359-a094-8e9cb71fee77,,released,,1,2022-09-22T07:07:22.929533-05:00,"Surgery, NOS",Initial Diagnosis,
HCM-STAN-0848-C20,7588a6b5-7c21-4a45-90ba-42a8220e11ac,64d78e96-8683-4479-aad6-c6b25dec813f,567.0,Adjuvant,497.0,2025-04-07T17:13:09.336794-05:00,HCM-STAN-0848-C20_treatment4,d8af83b5-12fc-4d0d-8248-10476f666ed2,,released,Fluorouracil,1,2022-09-22T07:07:22.929533-05:00,Chemotherapy,Residual Disease,
HCM-STAN-0848-C20,7588a6b5-7c21-4a45-90ba-42a8220e11ac,64d78e96-8683-4479-aad6-c6b25dec813f,,Neoadjuvant,291.0,2025-04-07T17:13:09.336794-05:00,HCM-STAN-0848-C20_treatment,d8c7aa9a-f4a4-44b0-89e4-a835308d5b45,,released,Capecitabine,1,2022-09-22T07:07:22.929533-05:00,Chemotherapy,,
HCM-STAN-0848-C20,7588a6b5-7c21-4a45-90ba-42a8220e11ac,64d78e96-8683-4479-aad6-c6b25dec813f,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-STAN-0848-C20_treatment10,f6abbbe4-9819-4fea-afec-596ccef2dfc0,,released,,0,2022-09-22T07:07:22.929533-05:00,"Radiation Therapy, NOS",Residual Disease,
HCM-STAN-0848-C20,7588a6b5-7c21-4a45-90ba-42a8220e11ac,64d78e96-8683-4479-aad6-c6b25dec813f,567.0,Adjuvant,497.0,2025-04-07T17:13:09.336794-05:00,HCM-STAN-0848-C20_treatment3,ff867d05-009b-4f24-99b5-8e4215ba2697,,released,Leucovorin Calcium,1,2022-09-22T07:07:22.929533-05:00,Chemotherapy,Residual Disease,
HCM-CSHL-0244-C20,75a0e6f3-8ae3-4fd3-ac81-17eaffacd796,57b05d2e-4c61-4439-a608-49dbd4fd7fde,,,462.0,2023-02-27T12:00:06.680645-06:00,HCM-CSHL-0244-C20_treatment5,03fe61d4-0b64-4137-a84a-72999fc58d1f,,released,,1,2020-09-28T09:25:47.675598-05:00,"Surgery, NOS",Initial Diagnosis,
HCM-CSHL-0244-C20,75a0e6f3-8ae3-4fd3-ac81-17eaffacd796,57b05d2e-4c61-4439-a608-49dbd4fd7fde,,Adjuvant,,2021-01-06T22:55:10.531130-06:00,HCM-CSHL-0244-C20_treatment6,24113873-4fba-4d13-9d7b-ddfdecbf704a,,released,,0,2020-09-28T09:25:47.675598-05:00,Targeted Molecular Therapy,Residual Disease,
HCM-CSHL-0244-C20,75a0e6f3-8ae3-4fd3-ac81-17eaffacd796,57b05d2e-4c61-4439-a608-49dbd4fd7fde,,Adjuvant,,2021-01-06T22:55:10.531130-06:00,HCM-CSHL-0244-C20_treatment7,3f422f49-a26b-4155-ba30-4124c88595f6,,released,,unknown,2020-09-28T09:25:47.675598-05:00,"Radiation Therapy, NOS",Residual Disease,
HCM-CSHL-0244-C20,75a0e6f3-8ae3-4fd3-ac81-17eaffacd796,57b05d2e-4c61-4439-a608-49dbd4fd7fde,,Adjuvant,,2021-01-06T22:55:10.531130-06:00,HCM-CSHL-0244-C20_treatment4,60b53d43-59c9-4578-b17a-5dfae79ec46f,,released,,0,2020-09-28T09:25:47.675598-05:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-CSHL-0244-C20,75a0e6f3-8ae3-4fd3-ac81-17eaffacd796,57b05d2e-4c61-4439-a608-49dbd4fd7fde,,Neoadjuvant,0.0,2021-01-06T22:55:10.531130-06:00,HCM-CSHL-0244-C20_treatment,7fd155b8-c83c-45c2-b9fb-bf9ef557d303,,released,,1,2020-09-28T09:25:47.675598-05:00,Chemotherapy,,
HCM-CSHL-0244-C20,75a0e6f3-8ae3-4fd3-ac81-17eaffacd796,57b05d2e-4c61-4439-a608-49dbd4fd7fde,615.0,Adjuvant,498.0,2021-01-06T22:55:10.531130-06:00,HCM-CSHL-0244-C20_treatment3,d799a489-97a0-42f3-b933-e06b62ceef2b,,released,Unknown,1,2020-09-28T09:25:47.675598-05:00,Chemotherapy,Residual Disease,
HCM-CSHL-0244-C20,75a0e6f3-8ae3-4fd3-ac81-17eaffacd796,57b05d2e-4c61-4439-a608-49dbd4fd7fde,,Neoadjuvant,0.0,2021-01-06T22:55:10.531130-06:00,HCM-CSHL-0244-C20_treatment2,ddbb0d51-527c-4326-9c79-850a5c4cea74,,released,,1,2020-09-28T09:25:47.675598-05:00,"Radiation Therapy, NOS",,
HCM-BROD-0701-C43,76190b91-c744-4fc5-8e4d-eba10785d98b,e6349d25-3851-4ff5-9b67-b0b55abda9ca,,Adjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0701-C43_treatment2,0adcb103-00b0-4dcd-aeb9-2e4c936a58b5,,released,,0,2021-12-21T13:46:02.975813-06:00,Chemotherapy,Residual Disease,
HCM-BROD-0701-C43,76190b91-c744-4fc5-8e4d-eba10785d98b,e6349d25-3851-4ff5-9b67-b0b55abda9ca,,Adjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0701-C43_treatment6,51be59ba-713e-420f-b72e-d18729ad875a,,released,,0,2021-12-21T13:46:02.975813-06:00,Targeted Molecular Therapy,Residual Disease,
HCM-BROD-0701-C43,76190b91-c744-4fc5-8e4d-eba10785d98b,e6349d25-3851-4ff5-9b67-b0b55abda9ca,,Adjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0701-C43_treatment7,570766b4-3e08-49ca-8578-e5210ca37713,,released,,0,2021-12-21T13:46:02.975813-06:00,"Radiation Therapy, NOS",Residual Disease,
HCM-BROD-0701-C43,76190b91-c744-4fc5-8e4d-eba10785d98b,e6349d25-3851-4ff5-9b67-b0b55abda9ca,,Neoadjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0701-C43_treatment,a2b170a2-b629-40d9-9f4f-ae84c993393d,,released,,0,2021-12-21T13:46:02.975813-06:00,,,
HCM-BROD-0701-C43,76190b91-c744-4fc5-8e4d-eba10785d98b,e6349d25-3851-4ff5-9b67-b0b55abda9ca,449.0,Adjuvant,323.0,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0701-C43_treatment4,af80214f-cfcb-4143-8cc3-03a97c580568,,released,Pembrolizumab,1,2021-12-21T13:46:02.975813-06:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-BROD-0701-C43,76190b91-c744-4fc5-8e4d-eba10785d98b,e6349d25-3851-4ff5-9b67-b0b55abda9ca,,Adjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0701-C43_treatment3,b6514a9b-b9bf-4096-90de-b108ae138ce0,,released,,0,2021-12-21T13:46:02.975813-06:00,Hormone Therapy,Residual Disease,
HCM-BROD-0701-C43,76190b91-c744-4fc5-8e4d-eba10785d98b,e6349d25-3851-4ff5-9b67-b0b55abda9ca,,,0.0,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0701-C43_treatment5,f700c757-3e4e-4ccc-8730-75051963561c,,released,,1,2021-12-21T13:46:02.975813-06:00,"Surgery, NOS",Initial Diagnosis,
HCM-CSHL-0073-C25,77163cf2-4651-475f-9d60-4306c1712ed7,72d109a1-4d2a-4b98-8ece-e0dd7baf598f,,,-6.0,2023-03-13T13:03:52.297539-05:00,HCM-CSHL-0073-C25_treatment2,370fd0e0-1675-4bcf-8bbe-dbdff303201b,,released,,1,2020-02-27T13:22:59.636834-06:00,"Surgery, NOS",Initial Diagnosis,
HCM-CSHL-0073-C25,77163cf2-4651-475f-9d60-4306c1712ed7,72d109a1-4d2a-4b98-8ece-e0dd7baf598f,,Neoadjuvant,,2020-10-20T19:20:06.800740-05:00,HCM-CSHL-0073-C25_treatment,4ba4e78d-7a47-4482-a755-20c20d2f2b3e,,released,,0,2020-02-27T13:22:59.636834-06:00,,,
HCM-CSHL-0073-C25,77163cf2-4651-475f-9d60-4306c1712ed7,72d109a1-4d2a-4b98-8ece-e0dd7baf598f,,Adjuvant,,2023-03-13T13:03:52.297539-05:00,HCM-CSHL-0073-C25_treatment3,b8e6192a-55bb-430d-8188-024b9138e129,,released,,unknown,2020-02-27T13:22:59.636834-06:00,"Pharmaceutical Therapy, NOS",Residual Disease,
HCM-CSHL-0073-C25,77163cf2-4651-475f-9d60-4306c1712ed7,72d109a1-4d2a-4b98-8ece-e0dd7baf598f,,Adjuvant,,2023-03-13T13:03:52.297539-05:00,HCM-CSHL-0073-C25_treatment4,bfc0b38b-a723-469d-bbc3-3225bd26ea15,,released,,unknown,2020-02-27T13:22:59.636834-06:00,"Radiation Therapy, NOS",Residual Disease,
HCM-SANG-0266-C20,7717ccee-02fc-42aa-9951-e28ecb689ed5,64b215db-2341-44bf-8aaf-aad136a81150,,Neoadjuvant,461.0,2023-03-13T13:04:39.154718-05:00,HCM-SANG-0266-C20_treatment,13ce11c2-91a2-4311-bc00-790e975bae68,,released,Leucovorin Calcium,1,2020-02-11T15:49:08.229652-06:00,Chemotherapy,,
HCM-SANG-0266-C20,7717ccee-02fc-42aa-9951-e28ecb689ed5,64b215db-2341-44bf-8aaf-aad136a81150,,Neoadjuvant,461.0,2023-03-13T13:04:39.154718-05:00,HCM-SANG-0266-C20_treatment2,1e107747-ff6d-4d4b-91e4-3acfb83d7c72,,released,Fluorouracil,1,2020-02-11T15:49:08.229652-06:00,Chemotherapy,,
HCM-SANG-0266-C20,7717ccee-02fc-42aa-9951-e28ecb689ed5,64b215db-2341-44bf-8aaf-aad136a81150,,Neoadjuvant,461.0,2023-03-13T13:04:39.154718-05:00,HCM-SANG-0266-C20_treatment4,3cdee5e5-b670-4534-a1a4-5eaf045a0980,,released,,1,2021-08-26T15:00:47.360883-05:00,Chemotherapy,,FOLFOX
HCM-SANG-0266-C20,7717ccee-02fc-42aa-9951-e28ecb689ed5,64b215db-2341-44bf-8aaf-aad136a81150,,Neoadjuvant,461.0,2023-03-13T13:04:39.154718-05:00,HCM-SANG-0266-C20_treatment3,686107e1-9ad5-4922-9396-e6025a28360a,,released,Oxaliplatin,1,2021-08-26T15:00:47.360883-05:00,Chemotherapy,,
HCM-SANG-0266-C20,7717ccee-02fc-42aa-9951-e28ecb689ed5,64b215db-2341-44bf-8aaf-aad136a81150,,Neoadjuvant,461.0,2023-03-13T13:04:39.154718-05:00,HCM-SANG-0266-C20_treatment5,c11dd977-4ed1-4d23-a9d4-1ae5e946e626,,released,,1,2021-08-26T15:00:47.360883-05:00,"Radiation, 2D Conventional",,
HCM-SANG-0266-C20,7717ccee-02fc-42aa-9951-e28ecb689ed5,64b215db-2341-44bf-8aaf-aad136a81150,,Neoadjuvant,461.0,2023-03-13T13:04:39.154718-05:00,HCM-SANG-0266-C20_treatment6,ce11d367-7d42-4eb6-a735-8ee3336388ea,,released,Bevacizumab,1,2021-08-26T15:00:47.360883-05:00,Targeted Molecular Therapy,,
HCM-CSHL-0143-C20,77c0c6b9-2d22-404f-91da-3f588a9174ab,d3cb666f-62a3-4a8d-8a33-e69e1cadebaf,,Adjuvant,,2023-03-13T13:08:11.599529-05:00,HCM-CSHL-0143-C20_treatment4,01a6a1b3-542d-4983-a023-97ac4cea06a5,,released,,0,2020-02-27T12:47:09.609777-06:00,"Radiation Therapy, NOS",Residual Disease,
HCM-CSHL-0143-C20,77c0c6b9-2d22-404f-91da-3f588a9174ab,d3cb666f-62a3-4a8d-8a33-e69e1cadebaf,,Neoadjuvant,,2020-10-20T19:20:06.800740-05:00,HCM-CSHL-0143-C20_treatment,9ba7fc13-d3d1-4853-966b-72d494e3af68,,released,,0,2020-02-27T12:47:09.609777-06:00,,,
HCM-CSHL-0143-C20,77c0c6b9-2d22-404f-91da-3f588a9174ab,d3cb666f-62a3-4a8d-8a33-e69e1cadebaf,,Adjuvant,,2023-03-13T13:08:11.599529-05:00,HCM-CSHL-0143-C20_treatment3,a1309ca5-b8c5-45d8-a1b7-fc117580f434,,released,,0,2020-02-27T12:47:09.609777-06:00,"Pharmaceutical Therapy, NOS",Residual Disease,
HCM-CSHL-0143-C20,77c0c6b9-2d22-404f-91da-3f588a9174ab,d3cb666f-62a3-4a8d-8a33-e69e1cadebaf,,,60.0,2023-03-13T13:08:11.599529-05:00,HCM-CSHL-0143-C20_treatment2,d786a97b-d31d-4bf0-b553-4ef6d30ad542,,released,,1,2020-02-27T12:47:09.609777-06:00,"Surgery, NOS",Initial Diagnosis,
HCM-CSHL-0807-C54,77e36a58-fc44-4b8a-a81c-173362967082,ca464a66-eb1f-4030-a065-cf9dc130955c,199.0,Adjuvant,185.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0807-C54_treatment8,45b93fd2-9929-4bba-899b-a3df29e67871,,released,,1,2021-12-21T14:26:39.957485-06:00,"Brachytherapy, High Dose",Residual Disease,
HCM-CSHL-0807-C54,77e36a58-fc44-4b8a-a81c-173362967082,ca464a66-eb1f-4030-a065-cf9dc130955c,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0807-C54_treatment5,70a76e22-0ddd-4918-a8ff-7d34a93c21ad,,released,,0,2021-12-21T14:26:39.957485-06:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-CSHL-0807-C54,77e36a58-fc44-4b8a-a81c-173362967082,ca464a66-eb1f-4030-a065-cf9dc130955c,,,0.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0807-C54_treatment6,74cfe856-81f7-4635-8959-050cd75aab29,,released,,1,2021-12-21T14:26:39.957485-06:00,"Surgery, NOS",Initial Diagnosis,
HCM-CSHL-0807-C54,77e36a58-fc44-4b8a-a81c-173362967082,ca464a66-eb1f-4030-a065-cf9dc130955c,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0807-C54_treatment7,8127fda0-ef4a-431d-bb23-cf2e0c0cac30,,released,,0,2021-12-21T14:26:39.957485-06:00,Targeted Molecular Therapy,Residual Disease,
HCM-CSHL-0807-C54,77e36a58-fc44-4b8a-a81c-173362967082,ca464a66-eb1f-4030-a065-cf9dc130955c,145.0,Adjuvant,39.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0807-C54_treatment2,aaa27398-96db-4281-8df9-b4019b8ab6a3,,released,Carboplatin,1,2021-12-21T14:26:39.957485-06:00,Chemotherapy,Residual Disease,
HCM-CSHL-0807-C54,77e36a58-fc44-4b8a-a81c-173362967082,ca464a66-eb1f-4030-a065-cf9dc130955c,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0807-C54_treatment4,b4b38a5b-7df9-451b-8900-be289ea7aaab,,released,,0,2021-12-21T14:26:39.957485-06:00,Hormone Therapy,Residual Disease,
HCM-CSHL-0807-C54,77e36a58-fc44-4b8a-a81c-173362967082,ca464a66-eb1f-4030-a065-cf9dc130955c,145.0,Adjuvant,39.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0807-C54_treatment3,d7a25673-b6e6-42a6-98a8-6804c308baf3,,released,Paclitaxel,1,2021-12-21T14:26:39.957485-06:00,Chemotherapy,Residual Disease,
HCM-CSHL-0807-C54,77e36a58-fc44-4b8a-a81c-173362967082,ca464a66-eb1f-4030-a065-cf9dc130955c,,Neoadjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0807-C54_treatment,dd4fa0a2-1ab8-403a-acb4-25105b7c4a2e,,released,,0,2021-12-21T14:26:39.957485-06:00,,,
HCM-BROD-0716-C43,78b05ced-6b5e-44e0-b8e2-07ab9b69e440,3c60679c-040d-4809-aa03-24d976c7d4c2,,Adjuvant,,2023-02-22T07:39:25.979291-06:00,HCM-BROD-0716-C43_treatment7,5a70a381-ea95-4660-bae7-5955dab158b2,,released,,0,2021-12-21T13:47:52.557823-06:00,"Radiation Therapy, NOS",Residual Disease,
HCM-BROD-0716-C43,78b05ced-6b5e-44e0-b8e2-07ab9b69e440,3c60679c-040d-4809-aa03-24d976c7d4c2,,Adjuvant,,2023-02-22T07:39:25.979291-06:00,HCM-BROD-0716-C43_treatment2,a0610632-8556-4c58-9ef5-0b4c7c360230,,released,,0,2021-12-21T13:47:52.557823-06:00,Chemotherapy,Residual Disease,
HCM-BROD-0716-C43,78b05ced-6b5e-44e0-b8e2-07ab9b69e440,3c60679c-040d-4809-aa03-24d976c7d4c2,,Adjuvant,3160.0,2023-02-22T07:39:25.979291-06:00,HCM-BROD-0716-C43_treatment4,b47661ac-8ce7-46c8-8e12-8e28560632fd,Treatment Ongoing,released,Nivolumab,1,2021-12-21T13:47:52.557823-06:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-BROD-0716-C43,78b05ced-6b5e-44e0-b8e2-07ab9b69e440,3c60679c-040d-4809-aa03-24d976c7d4c2,,,0.0,2023-02-27T12:06:19.992797-06:00,HCM-BROD-0716-C43_treatment5,d9af5cfa-7769-48c1-ab54-bb6232232125,,released,,1,2021-12-21T13:47:52.557823-06:00,"Surgery, NOS",Initial Diagnosis,
HCM-BROD-0716-C43,78b05ced-6b5e-44e0-b8e2-07ab9b69e440,3c60679c-040d-4809-aa03-24d976c7d4c2,,Adjuvant,,2023-02-22T07:39:25.979291-06:00,HCM-BROD-0716-C43_treatment6,e93e29e0-fc8b-4835-8144-e2b8304e916c,,released,,0,2021-12-21T13:47:52.557823-06:00,Targeted Molecular Therapy,Residual Disease,
HCM-BROD-0716-C43,78b05ced-6b5e-44e0-b8e2-07ab9b69e440,3c60679c-040d-4809-aa03-24d976c7d4c2,,Neoadjuvant,,2023-02-22T07:39:25.979291-06:00,HCM-BROD-0716-C43_treatment,ed534ad1-e4d6-4630-a480-7c7cc7274e6b,,released,,0,2021-12-21T13:47:52.557823-06:00,,,
HCM-BROD-0716-C43,78b05ced-6b5e-44e0-b8e2-07ab9b69e440,3c60679c-040d-4809-aa03-24d976c7d4c2,,Adjuvant,,2023-02-22T07:39:25.979291-06:00,HCM-BROD-0716-C43_treatment3,fed82810-2c0d-4b9f-8ee0-24876fc3ad99,,released,,0,2021-12-21T13:47:52.557823-06:00,Hormone Therapy,Residual Disease,
HCM-CSHL-0859-C22,78b640aa-5327-496a-87bc-8e264cd772f2,99e9d21c-9a5b-44f2-8022-562a376a3875,483.0,Adjuvant,352.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0859-C22_treatment6,14f6451d-849c-4bc9-9cfa-d3724cbdda58,,released,Oxaliplatin,1,2021-12-21T14:34:52.141751-06:00,Chemotherapy,Residual Disease,
HCM-CSHL-0859-C22,78b640aa-5327-496a-87bc-8e264cd772f2,99e9d21c-9a5b-44f2-8022-562a376a3875,483.0,Adjuvant,352.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0859-C22_treatment7,4c572f90-1571-4ed1-9466-3e8c887fb685,,released,,1,2021-12-21T14:34:52.141751-06:00,Chemotherapy,Residual Disease,FOLFOX
HCM-CSHL-0859-C22,78b640aa-5327-496a-87bc-8e264cd772f2,99e9d21c-9a5b-44f2-8022-562a376a3875,483.0,Adjuvant,352.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0859-C22_treatment4,50078654-ef64-4fa4-946c-53e2504445cb,,released,Leucovorin Calcium,1,2021-12-21T14:34:52.141751-06:00,Chemotherapy,Residual Disease,
HCM-CSHL-0859-C22,78b640aa-5327-496a-87bc-8e264cd772f2,99e9d21c-9a5b-44f2-8022-562a376a3875,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0859-C22_treatment12,71cb8cd3-0c0b-4fd0-bb42-3b6307c82215,,released,,0,2021-12-21T14:34:52.141751-06:00,"Radiation Therapy, NOS",Residual Disease,
HCM-CSHL-0859-C22,78b640aa-5327-496a-87bc-8e264cd772f2,99e9d21c-9a5b-44f2-8022-562a376a3875,483.0,Adjuvant,352.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0859-C22_treatment5,8abc4f92-af15-4ca7-83d2-a48de6176251,,released,Fluorouracil,1,2021-12-21T14:34:52.141751-06:00,Chemotherapy,Residual Disease,
HCM-CSHL-0859-C22,78b640aa-5327-496a-87bc-8e264cd772f2,99e9d21c-9a5b-44f2-8022-562a376a3875,295.0,Adjuvant,223.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0859-C22_treatment3,8b66ec97-77cf-4d23-b154-9d02c9cf8542,,released,Gemcitabine,1,2021-12-21T14:34:52.141751-06:00,Chemotherapy,Residual Disease,
HCM-CSHL-0859-C22,78b640aa-5327-496a-87bc-8e264cd772f2,99e9d21c-9a5b-44f2-8022-562a376a3875,,Neoadjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0859-C22_treatment,af8a8bb0-64a2-4b41-a566-c2f3419c093a,,released,,0,2021-12-21T14:34:52.141751-06:00,,,
HCM-CSHL-0859-C22,78b640aa-5327-496a-87bc-8e264cd772f2,99e9d21c-9a5b-44f2-8022-562a376a3875,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0859-C22_treatment8,b57cea08-dfc8-4552-9285-023dc52fe72f,,released,,0,2021-12-21T14:34:52.141751-06:00,Hormone Therapy,Residual Disease,
HCM-CSHL-0859-C22,78b640aa-5327-496a-87bc-8e264cd772f2,99e9d21c-9a5b-44f2-8022-562a376a3875,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0859-C22_treatment9,c76bb420-4753-4b79-b5e7-56a748c6f074,,released,,0,2021-12-21T14:34:52.141751-06:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-CSHL-0859-C22,78b640aa-5327-496a-87bc-8e264cd772f2,99e9d21c-9a5b-44f2-8022-562a376a3875,295.0,Adjuvant,223.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0859-C22_treatment2,d07f5779-a711-4da0-bc84-9d5d615f6ba8,,released,Cisplatin,1,2021-12-21T14:34:52.141751-06:00,Chemotherapy,Residual Disease,
HCM-CSHL-0859-C22,78b640aa-5327-496a-87bc-8e264cd772f2,99e9d21c-9a5b-44f2-8022-562a376a3875,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0859-C22_treatment11,f1aaa607-f586-42d5-b037-73f97e4c5d49,,released,,0,2021-12-21T14:34:52.141751-06:00,Targeted Molecular Therapy,Residual Disease,
HCM-CSHL-0859-C22,78b640aa-5327-496a-87bc-8e264cd772f2,99e9d21c-9a5b-44f2-8022-562a376a3875,,,-36.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0859-C22_treatment10,fb8368b5-eaf4-4bdd-a31e-8f52159cd960,,released,,1,2021-12-21T14:34:52.141751-06:00,"Surgery, NOS",Initial Diagnosis,
HCM-SANG-0303-C15,78c3e337-c084-4033-9d30-2505060192a3,f744cfe9-aa79-432c-bf46-ac1566ac1e8f,,Neoadjuvant,,2023-03-13T12:50:00.399644-05:00,HCM-SANG-0303-C15_treatment,8304093f-01a6-470c-a9c3-f91388bef633,,released,,0,2021-12-21T15:10:44.302303-06:00,,,
HCM-CSHL-1265-C25,78f0db28-1e72-4fad-9515-5ff0e0d9ddf7,92438f0f-0732-4ea0-9a75-9b8c23d47885,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-1265-C25_treatment4,24dac94c-eb8f-44ba-80c3-af8f9b6681e8,,released,,0,2022-03-13T19:48:02.989676-05:00,"Radiation Therapy, NOS",Residual Disease,
HCM-CSHL-1265-C25,78f0db28-1e72-4fad-9515-5ff0e0d9ddf7,92438f0f-0732-4ea0-9a75-9b8c23d47885,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-1265-C25_treatment3,52d7ffdf-6561-4dc0-8567-d32e71573270,,released,,0,2022-03-13T19:48:02.989676-05:00,"Pharmaceutical Therapy, NOS",Residual Disease,
HCM-CSHL-1265-C25,78f0db28-1e72-4fad-9515-5ff0e0d9ddf7,92438f0f-0732-4ea0-9a75-9b8c23d47885,,,-25.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-1265-C25_treatment2,7a32a250-6d3d-41e7-9425-ce8535b5a054,,released,,1,2022-03-13T19:48:02.989676-05:00,"Surgery, NOS",Initial Diagnosis,
HCM-CSHL-1265-C25,78f0db28-1e72-4fad-9515-5ff0e0d9ddf7,92438f0f-0732-4ea0-9a75-9b8c23d47885,,Neoadjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-1265-C25_treatment,ce5d5898-1d41-46b4-b28c-613afc117e50,,released,,0,2022-03-13T19:48:02.989676-05:00,,,
HCM-BROD-0110-C25,792ea820-f289-49b9-80f7-e746eddc2922,5280569e-17d8-4554-9303-69b2dadc47f6,,,69.0,2023-02-27T12:52:14.793536-06:00,HCM-BROD-0110-C25_treatment5,28fa7eb7-1095-4349-9bf5-704c5b508fa2,,released,,1,2020-09-17T15:46:02.505191-05:00,"Surgery, NOS",Initial Diagnosis,
HCM-BROD-0110-C25,792ea820-f289-49b9-80f7-e746eddc2922,5280569e-17d8-4554-9303-69b2dadc47f6,216.0,Adjuvant,125.0,2023-02-22T07:39:25.979291-06:00,HCM-BROD-0110-C25_treatment3,3b2cf470-7a42-4d4e-93bb-aec8cee93fec,,released,Nab-paclitaxel,1,2020-09-17T15:46:02.505191-05:00,Chemotherapy,Residual Disease,
HCM-BROD-0110-C25,792ea820-f289-49b9-80f7-e746eddc2922,5280569e-17d8-4554-9303-69b2dadc47f6,216.0,Adjuvant,125.0,2023-02-22T07:39:25.979291-06:00,HCM-BROD-0110-C25_treatment2,3cee24e2-4028-45be-914b-e5fb017f752d,,released,Gemcitabine,1,2020-09-17T15:46:02.505191-05:00,Chemotherapy,Residual Disease,
HCM-BROD-0110-C25,792ea820-f289-49b9-80f7-e746eddc2922,5280569e-17d8-4554-9303-69b2dadc47f6,,Adjuvant,,2023-02-22T07:39:25.979291-06:00,HCM-BROD-0110-C25_treatment4,9a5411cb-e618-4d49-841a-3a5096271c32,,released,,0,2020-09-17T15:46:02.505191-05:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-BROD-0110-C25,792ea820-f289-49b9-80f7-e746eddc2922,5280569e-17d8-4554-9303-69b2dadc47f6,,Adjuvant,,2023-02-22T07:39:25.979291-06:00,HCM-BROD-0110-C25_treatment6,ae2f7f10-09a5-4fda-a2a9-e9aaf54a892a,,released,,0,2020-09-17T15:46:02.505191-05:00,Targeted Molecular Therapy,Residual Disease,
HCM-BROD-0110-C25,792ea820-f289-49b9-80f7-e746eddc2922,5280569e-17d8-4554-9303-69b2dadc47f6,,Adjuvant,,2023-02-22T07:39:25.979291-06:00,HCM-BROD-0110-C25_treatment7,c5e30d07-c113-41bf-9cc5-f561ffe97490,,released,,unknown,2020-09-17T15:46:02.505191-05:00,"Radiation Therapy, NOS",Residual Disease,
HCM-BROD-0110-C25,792ea820-f289-49b9-80f7-e746eddc2922,5280569e-17d8-4554-9303-69b2dadc47f6,,Neoadjuvant,,2023-02-22T07:39:25.979291-06:00,HCM-BROD-0110-C25_treatment,e39879e0-ece1-4c54-accf-d46ee8ddfef0,,released,,unknown,2020-09-17T15:46:02.505191-05:00,"Pharmaceutical Therapy, NOS",,
HCM-BROD-0678-C71,79858538-bc27-4abd-9b42-16659ad5da56,d96f0dad-49dc-4977-ab8a-6d65d1c6783e,,Adjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0678-C71_treatment3,3e3c34ca-5a95-441f-9f7a-8cb90cff99a2,,released,,0,2020-10-08T14:47:08.707719-05:00,"Pharmaceutical Therapy, NOS",Residual Disease,
HCM-BROD-0678-C71,79858538-bc27-4abd-9b42-16659ad5da56,d96f0dad-49dc-4977-ab8a-6d65d1c6783e,,Neoadjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0678-C71_treatment,47b759b9-b12e-4f45-8843-8fdab86be245,,released,,0,2020-10-08T14:47:08.707719-05:00,,,
HCM-BROD-0678-C71,79858538-bc27-4abd-9b42-16659ad5da56,d96f0dad-49dc-4977-ab8a-6d65d1c6783e,,,13.0,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0678-C71_treatment2,9616b102-0a59-44af-812a-c6eaa26ee93c,,released,,1,2020-10-08T14:47:08.707719-05:00,"Surgery, NOS",Initial Diagnosis,
HCM-BROD-0678-C71,79858538-bc27-4abd-9b42-16659ad5da56,d96f0dad-49dc-4977-ab8a-6d65d1c6783e,,Adjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0678-C71_treatment4,e1584f99-20ab-4cd1-9f1f-0e9d5ee9a01c,,released,,0,2020-10-08T14:47:08.707719-05:00,"Radiation Therapy, NOS",Residual Disease,
HCM-SANG-0302-C15,799c9373-815b-4031-a495-47858e06908e,5d6a9815-8342-4a70-a154-bcc0fce20f37,,Neoadjuvant,12.0,2023-03-13T13:00:48.763169-05:00,HCM-SANG-0302-C15_treatment4,3995288a-e7c2-471e-9309-aed6863c2cd6,,released,,1,2021-12-21T15:09:34.237412-06:00,Chemotherapy,,ECX
HCM-SANG-0302-C15,799c9373-815b-4031-a495-47858e06908e,5d6a9815-8342-4a70-a154-bcc0fce20f37,,Neoadjuvant,12.0,2023-03-13T13:00:48.763169-05:00,HCM-SANG-0302-C15_treatment,5691cf24-8f91-4485-b89b-9f5854fed02e,,released,Epirubicin,1,2021-12-21T15:09:34.237412-06:00,Chemotherapy,,
HCM-SANG-0302-C15,799c9373-815b-4031-a495-47858e06908e,5d6a9815-8342-4a70-a154-bcc0fce20f37,,Neoadjuvant,12.0,2023-03-13T13:00:48.763169-05:00,HCM-SANG-0302-C15_treatment2,930fa744-3428-407d-bed0-99981e4b57e7,,released,Capecitabine,1,2021-12-21T15:09:34.237412-06:00,Chemotherapy,,
HCM-SANG-0302-C15,799c9373-815b-4031-a495-47858e06908e,5d6a9815-8342-4a70-a154-bcc0fce20f37,,Neoadjuvant,12.0,2023-03-13T13:00:48.763169-05:00,HCM-SANG-0302-C15_treatment3,a2b36a40-1e46-40bb-90bd-39035d2b236f,,released,Cisplatin,1,2021-12-21T15:09:34.237412-06:00,Chemotherapy,,
HCM-SANG-0518-C18,79bb4e5b-5dc9-4103-9f61-5a43b15c56fa,a4235ce1-4426-4bb2-b0e6-bac541b359ce,,Neoadjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-SANG-0518-C18_treatment,c4cb0fbe-76ea-4c37-97b8-1d398f1ecfdc,,released,,0,2021-12-21T15:12:59.124373-06:00,,,
HCM-BROD-0453-C16,7a4676bb-3b9f-4e1c-b58f-30f80660df44,d77b94e3-d684-4197-a5d2-c67ac610964d,,Neoadjuvant,26.0,2023-02-22T07:39:25.979291-06:00,HCM-BROD-0453-C16_treatment,187c828c-8ce9-4776-aa31-bc40effeeb42,,released,Oxaliplatin,1,2020-09-27T11:38:45.277683-05:00,Chemotherapy,,
HCM-BROD-0453-C16,7a4676bb-3b9f-4e1c-b58f-30f80660df44,d77b94e3-d684-4197-a5d2-c67ac610964d,,Neoadjuvant,26.0,2023-02-22T07:39:25.979291-06:00,HCM-BROD-0453-C16_treatment2,2da20b25-fd65-4855-9bb3-569d7d5209fb,,released,Docetaxel,1,2020-09-27T11:38:45.277683-05:00,Chemotherapy,,
HCM-BROD-0453-C16,7a4676bb-3b9f-4e1c-b58f-30f80660df44,d77b94e3-d684-4197-a5d2-c67ac610964d,278.0,Adjuvant,179.0,2023-02-22T07:39:25.979291-06:00,HCM-BROD-0453-C16_treatment6,31e49f92-1f47-4028-bcdc-e8558e7709cb,,released,Fluorouracil,1,2020-09-27T11:38:45.277683-05:00,Chemotherapy,Residual Disease,
HCM-BROD-0453-C16,7a4676bb-3b9f-4e1c-b58f-30f80660df44,d77b94e3-d684-4197-a5d2-c67ac610964d,,Neoadjuvant,26.0,2023-02-22T07:39:25.979291-06:00,HCM-BROD-0453-C16_treatment5,3a80de79-e876-493e-8722-52cfe17ebd8c,,released,,1,2020-09-27T11:38:45.277683-05:00,Chemotherapy,,FU-LV regimen
HCM-BROD-0453-C16,7a4676bb-3b9f-4e1c-b58f-30f80660df44,d77b94e3-d684-4197-a5d2-c67ac610964d,395.0,Adjuvant,336.0,2023-02-22T07:39:25.979291-06:00,HCM-BROD-0453-C16_treatment7,3afbdd40-c786-4053-a460-fd726d5616d2,Treatment Ongoing,released,Docetaxel,1,2020-09-27T11:38:45.277683-05:00,Chemotherapy,Residual Disease,
HCM-BROD-0453-C16,7a4676bb-3b9f-4e1c-b58f-30f80660df44,d77b94e3-d684-4197-a5d2-c67ac610964d,,Adjuvant,,2023-02-22T07:39:25.979291-06:00,HCM-BROD-0453-C16_treatment12,81ad83b2-f3d7-458f-ba76-8b00030a4a1a,,released,,0,2020-09-27T11:38:45.277683-05:00,Targeted Molecular Therapy,Residual Disease,
HCM-BROD-0453-C16,7a4676bb-3b9f-4e1c-b58f-30f80660df44,d77b94e3-d684-4197-a5d2-c67ac610964d,395.0,Adjuvant,334.0,2023-02-22T07:39:25.979291-06:00,HCM-BROD-0453-C16_treatment8,839ae1c6-dcdc-4fea-bb9c-259a3f26d7cf,Treatment Ongoing,released,Oxaliplatin,1,2020-09-27T11:38:45.277683-05:00,Chemotherapy,Residual Disease,
HCM-BROD-0453-C16,7a4676bb-3b9f-4e1c-b58f-30f80660df44,d77b94e3-d684-4197-a5d2-c67ac610964d,,Neoadjuvant,26.0,2023-02-22T07:39:25.979291-06:00,HCM-BROD-0453-C16_treatment4,9a57dbfd-fac6-42a2-9253-22cbd9eed35f,,released,Leucovorin,1,2020-09-27T11:38:45.277683-05:00,Chemotherapy,,
HCM-BROD-0453-C16,7a4676bb-3b9f-4e1c-b58f-30f80660df44,d77b94e3-d684-4197-a5d2-c67ac610964d,,Adjuvant,,2023-02-22T07:39:25.979291-06:00,HCM-BROD-0453-C16_treatment10,9e382c0c-1a3a-4831-bdee-3d0cac38dd6a,,released,,0,2020-09-27T11:38:45.277683-05:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-BROD-0453-C16,7a4676bb-3b9f-4e1c-b58f-30f80660df44,d77b94e3-d684-4197-a5d2-c67ac610964d,,,,2023-02-27T12:31:07.083481-06:00,HCM-BROD-0453-C16_treatment11,a6ca61e8-c370-4c3f-a32b-c52e6270d516,,released,,unknown,2020-09-27T11:38:45.277683-05:00,"Surgery, NOS",Initial Diagnosis,
HCM-BROD-0453-C16,7a4676bb-3b9f-4e1c-b58f-30f80660df44,d77b94e3-d684-4197-a5d2-c67ac610964d,395.0,Adjuvant,336.0,2023-02-22T07:39:25.979291-06:00,HCM-BROD-0453-C16_treatment9,c9fc2916-066e-4f1b-9bec-1a4f23dff42c,Treatment Ongoing,released,Fluorouracil,1,2020-09-27T11:38:45.277683-05:00,Chemotherapy,Residual Disease,
HCM-BROD-0453-C16,7a4676bb-3b9f-4e1c-b58f-30f80660df44,d77b94e3-d684-4197-a5d2-c67ac610964d,216.0,Adjuvant,179.0,2023-02-22T07:39:25.979291-06:00,HCM-BROD-0453-C16_treatment13,f3c0c992-29a1-4de3-a882-8aebb7d6a11f,,released,,1,2020-09-27T11:38:45.277683-05:00,"Radiation Therapy, NOS",Residual Disease,
HCM-BROD-0453-C16,7a4676bb-3b9f-4e1c-b58f-30f80660df44,d77b94e3-d684-4197-a5d2-c67ac610964d,,Neoadjuvant,26.0,2023-02-22T07:39:25.979291-06:00,HCM-BROD-0453-C16_treatment3,ff238100-5704-4948-8234-095c4deb50a5,,released,Fluorouracil,1,2020-09-27T11:38:45.277683-05:00,Chemotherapy,,
HCM-SANG-0296-C15,7ad830fb-890c-4a3e-b1ac-aa59f23a9333,b872062b-6b79-417e-a717-5226c2a0aa2d,,Neoadjuvant,95.0,2023-03-13T13:03:30.293145-05:00,HCM-SANG-0296-C15_treatment,11bfa38e-91cd-4968-817d-8bba342ee3f3,,released,Epirubicin,1,2020-02-27T12:53:26.911590-06:00,Chemotherapy,,
HCM-SANG-0296-C15,7ad830fb-890c-4a3e-b1ac-aa59f23a9333,b872062b-6b79-417e-a717-5226c2a0aa2d,,Neoadjuvant,95.0,2023-03-13T13:03:30.293145-05:00,HCM-SANG-0296-C15_treatment3,531fd1d0-82cf-425d-88eb-688e8c391416,,released,Cisplatin,1,2020-11-11T09:36:43.716814-06:00,Chemotherapy,,
HCM-SANG-0296-C15,7ad830fb-890c-4a3e-b1ac-aa59f23a9333,b872062b-6b79-417e-a717-5226c2a0aa2d,,Neoadjuvant,95.0,2023-03-13T13:03:30.293145-05:00,HCM-SANG-0296-C15_treatment2,9fe4a627-d255-4ae2-964a-909a62a75555,,released,Capecitabine,1,2020-11-11T09:36:43.716814-06:00,Chemotherapy,,
HCM-SANG-0296-C15,7ad830fb-890c-4a3e-b1ac-aa59f23a9333,b872062b-6b79-417e-a717-5226c2a0aa2d,,Neoadjuvant,95.0,2023-03-13T13:03:30.293145-05:00,HCM-SANG-0296-C15_treatment4,aa5e806c-4061-4e2b-b372-88e01a662574,,released,,1,2020-11-11T09:36:43.716814-06:00,Chemotherapy,,ECX
HCM-SANG-1091-C18,7ae084ae-e644-46e1-97f5-52be2ed93538,9ed6b482-2fca-45ab-9e42-f3df0d4a0f4b,,Neoadjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-SANG-1091-C18_treatment,bdb759eb-ba77-4d0a-af89-c9421add0dda,,released,,0,2023-02-27T11:44:06.995961-06:00,,,
HCM-CSHL-0658-C20,7b9b67c9-28f3-47f3-beb0-1b2e8c0b05d7,b3bdf29a-4ab4-4a48-9eca-7dc5f314b0fe,,Neoadjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0658-C20_treatment,294868dd-4bee-46f0-af91-77a2c28084fc,,released,,0,2021-12-21T14:15:16.458472-06:00,,,
HCM-CSHL-0658-C20,7b9b67c9-28f3-47f3-beb0-1b2e8c0b05d7,b3bdf29a-4ab4-4a48-9eca-7dc5f314b0fe,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0658-C20_treatment3,3d6eb31f-64e1-483f-80ff-7f24135164fa,,released,,unknown,2021-12-21T14:15:16.458472-06:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-CSHL-0658-C20,7b9b67c9-28f3-47f3-beb0-1b2e8c0b05d7,b3bdf29a-4ab4-4a48-9eca-7dc5f314b0fe,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0658-C20_treatment2,572444ea-f34f-461c-b90f-18e6f046db95,,released,,unknown,2021-12-21T14:15:16.458472-06:00,Chemotherapy,Residual Disease,
HCM-CSHL-0658-C20,7b9b67c9-28f3-47f3-beb0-1b2e8c0b05d7,b3bdf29a-4ab4-4a48-9eca-7dc5f314b0fe,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0658-C20_treatment7,94d103d4-5245-422f-852c-ed162ff4c3e9,,released,,0,2021-12-21T14:15:16.458472-06:00,"Radiation Therapy, NOS",Residual Disease,
HCM-CSHL-0658-C20,7b9b67c9-28f3-47f3-beb0-1b2e8c0b05d7,b3bdf29a-4ab4-4a48-9eca-7dc5f314b0fe,,,932.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0658-C20_treatment4,aeadbb69-c8c6-4f33-9969-5909144d5a6c,,released,,1,2021-12-21T14:15:16.458472-06:00,"Surgery, NOS",Initial Diagnosis,
HCM-CSHL-0658-C20,7b9b67c9-28f3-47f3-beb0-1b2e8c0b05d7,b3bdf29a-4ab4-4a48-9eca-7dc5f314b0fe,,,1093.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0658-C20_treatment5,b95fc487-1cc3-4b25-9a89-fb52d5201b37,,released,,1,2021-12-21T14:15:16.458472-06:00,"Surgery, NOS",Initial Diagnosis,
HCM-CSHL-0658-C20,7b9b67c9-28f3-47f3-beb0-1b2e8c0b05d7,b3bdf29a-4ab4-4a48-9eca-7dc5f314b0fe,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0658-C20_treatment6,ed004a25-d519-41fe-b7ca-d83702600b85,,released,,unknown,2021-12-21T14:15:16.458472-06:00,Targeted Molecular Therapy,Residual Disease,
HCM-CSHL-0373-C25,7b9b6956-d4b6-46cd-8ad9-41e9c21a0316,f2f7992c-7f09-4f62-9548-732ed9859f0d,,,-14.0,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0373-C25_treatment5,0e34316a-c30c-4efb-b5e2-84515b668ac4,,released,,1,2020-09-28T09:54:05.598221-05:00,"Surgery, NOS",Initial Diagnosis,
HCM-CSHL-0373-C25,7b9b6956-d4b6-46cd-8ad9-41e9c21a0316,f2f7992c-7f09-4f62-9548-732ed9859f0d,,Adjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0373-C25_treatment2,12f38442-c1f2-459b-a5f6-c4e75f88285e,,released,Gemcitabine,1,2020-09-28T09:54:05.598221-05:00,Chemotherapy,Residual Disease,
HCM-CSHL-0373-C25,7b9b6956-d4b6-46cd-8ad9-41e9c21a0316,f2f7992c-7f09-4f62-9548-732ed9859f0d,,Adjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0373-C25_treatment4,2493062a-24df-4dd3-9416-365b1a86abcc,,released,,0,2020-09-28T09:54:05.598221-05:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-CSHL-0373-C25,7b9b6956-d4b6-46cd-8ad9-41e9c21a0316,f2f7992c-7f09-4f62-9548-732ed9859f0d,,Adjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0373-C25_treatment3,93b82051-1415-48c9-80d2-65204c12706d,,released,Carboplatin,1,2020-09-28T09:54:05.598221-05:00,Chemotherapy,Residual Disease,
HCM-CSHL-0373-C25,7b9b6956-d4b6-46cd-8ad9-41e9c21a0316,f2f7992c-7f09-4f62-9548-732ed9859f0d,,Neoadjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0373-C25_treatment,93d287eb-a0de-436e-8352-86dfd670951d,,released,,0,2020-09-28T09:54:05.598221-05:00,,,
HCM-CSHL-0373-C25,7b9b6956-d4b6-46cd-8ad9-41e9c21a0316,f2f7992c-7f09-4f62-9548-732ed9859f0d,,Adjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0373-C25_treatment6,9c1d07ba-697a-48d9-a6a9-e49a09100779,,released,,0,2020-09-28T09:54:05.598221-05:00,Targeted Molecular Therapy,Residual Disease,
HCM-CSHL-0373-C25,7b9b6956-d4b6-46cd-8ad9-41e9c21a0316,f2f7992c-7f09-4f62-9548-732ed9859f0d,,Adjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0373-C25_treatment7,bf3aa0e4-1a5b-4181-becf-d7fcb3d82945,,released,,0,2020-09-28T09:54:05.598221-05:00,"Radiation Therapy, NOS",Residual Disease,
HCM-BROD-0122-C25,7cdc52da-546a-4318-adb8-00ade0a941db,6ff09240-b994-4c1c-ba3b-3392cd45b632,,Neoadjuvant,,2023-07-13T10:35:44.371881-05:00,HCM-BROD-0122-C25_treatment,3fbf0c1b-e316-4d8c-9738-d4993068a79a,,released,,0,2020-07-23T14:36:17.120169-05:00,,,
HCM-BROD-0122-C25,7cdc52da-546a-4318-adb8-00ade0a941db,6ff09240-b994-4c1c-ba3b-3392cd45b632,,,,2023-07-13T10:35:44.371881-05:00,HCM-BROD-0122-C25_treatment4,62068cca-4040-4259-9573-bbd2e53aa327,,released,,0,2020-07-23T14:36:17.120169-05:00,"Surgery, NOS",Initial Diagnosis,
HCM-BROD-0122-C25,7cdc52da-546a-4318-adb8-00ade0a941db,6ff09240-b994-4c1c-ba3b-3392cd45b632,,Adjuvant,,2023-07-13T10:35:44.371881-05:00,HCM-BROD-0122-C25_treatment2,7da0cc72-27a5-49e1-ab6c-8a7f724b99fe,,released,,unknown,2020-07-23T14:36:17.120169-05:00,Chemotherapy,Residual Disease,
HCM-BROD-0122-C25,7cdc52da-546a-4318-adb8-00ade0a941db,6ff09240-b994-4c1c-ba3b-3392cd45b632,,Adjuvant,,2023-07-13T10:35:44.371881-05:00,HCM-BROD-0122-C25_treatment5,8ae4b0fb-0376-4594-aee8-7fc185286611,,released,,unknown,2020-07-23T14:36:17.120169-05:00,Targeted Molecular Therapy,Residual Disease,
HCM-BROD-0122-C25,7cdc52da-546a-4318-adb8-00ade0a941db,6ff09240-b994-4c1c-ba3b-3392cd45b632,,Adjuvant,,2023-07-13T10:35:44.371881-05:00,HCM-BROD-0122-C25_treatment6,a344a62c-051d-466e-8767-1c06e9bc82d1,,released,,0,2020-07-23T14:36:17.120169-05:00,"Radiation Therapy, NOS",Residual Disease,
HCM-BROD-0122-C25,7cdc52da-546a-4318-adb8-00ade0a941db,6ff09240-b994-4c1c-ba3b-3392cd45b632,,Adjuvant,,2023-07-13T10:35:44.371881-05:00,HCM-BROD-0122-C25_treatment3,a56d5a02-c198-4185-aaaf-1304807cdce2,,released,,unknown,2020-07-23T14:36:17.120169-05:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-BROD-1098-C91,7d03e209-ad89-461e-b5f9-f7dc88a2684c,0fc79262-4c6e-434e-98ed-c2c2202bc47a,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-BROD-1098-C91_treatment4,34408269-a359-4d69-8f9b-d3d9b4f76809,,released,,0,2021-12-21T15:22:16.674428-06:00,Hormone Therapy,Residual Disease,
HCM-BROD-1098-C91,7d03e209-ad89-461e-b5f9-f7dc88a2684c,0fc79262-4c6e-434e-98ed-c2c2202bc47a,,,,2025-04-07T17:13:09.336794-05:00,HCM-BROD-1098-C91_treatment6,39b2cc02-ecf1-4aab-964f-ec3a168276e6,,released,,0,2021-12-21T15:22:16.674428-06:00,"Surgery, NOS",Initial Diagnosis,
HCM-BROD-1098-C91,7d03e209-ad89-461e-b5f9-f7dc88a2684c,0fc79262-4c6e-434e-98ed-c2c2202bc47a,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-BROD-1098-C91_treatment8,4262e2c4-b433-419f-b07f-3b4fd6180ce6,,released,,0,2021-12-21T15:22:16.674428-06:00,"Radiation Therapy, NOS",Residual Disease,
HCM-BROD-1098-C91,7d03e209-ad89-461e-b5f9-f7dc88a2684c,0fc79262-4c6e-434e-98ed-c2c2202bc47a,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-BROD-1098-C91_treatment5,614eed52-24cc-4fdc-9f77-51369387f755,,released,,0,2021-12-21T15:22:16.674428-06:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-BROD-1098-C91,7d03e209-ad89-461e-b5f9-f7dc88a2684c,0fc79262-4c6e-434e-98ed-c2c2202bc47a,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-BROD-1098-C91_treatment7,6c936689-08ce-49da-8411-4027d7fcbc86,,released,,0,2021-12-21T15:22:16.674428-06:00,Targeted Molecular Therapy,Residual Disease,
HCM-BROD-1098-C91,7d03e209-ad89-461e-b5f9-f7dc88a2684c,0fc79262-4c6e-434e-98ed-c2c2202bc47a,1310.0,Adjuvant,1307.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-1098-C91_treatment2,79058ae4-b9e2-421b-9cfb-7bcf95b54cfc,,released,Fludarabine,1,2021-12-21T15:22:16.674428-06:00,Chemotherapy,Residual Disease,
HCM-BROD-1098-C91,7d03e209-ad89-461e-b5f9-f7dc88a2684c,0fc79262-4c6e-434e-98ed-c2c2202bc47a,1310.0,Adjuvant,1307.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-1098-C91_treatment3,8568ed81-bbc3-4a69-b634-079192801de1,,released,Busulfan,1,2021-12-21T15:22:16.674428-06:00,Chemotherapy,Residual Disease,
HCM-BROD-1098-C91,7d03e209-ad89-461e-b5f9-f7dc88a2684c,0fc79262-4c6e-434e-98ed-c2c2202bc47a,,Neoadjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-BROD-1098-C91_treatment,d117ecdc-5e39-4041-8305-2abd0cb28941,,released,,0,2021-12-21T15:22:16.674428-06:00,,,
HCM-BROD-1098-C91,7d03e209-ad89-461e-b5f9-f7dc88a2684c,0fc79262-4c6e-434e-98ed-c2c2202bc47a,,,1306.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-1098-C91_treatment9,e46a5eb3-bf7a-446b-9f7a-0b47c94f5ad7,,released,,1,2021-12-21T15:22:16.674428-06:00,"Stem Cell Transplantation, Allogeneic",,
HCM-WCMC-0790-C67,7d2af728-4620-4ed4-946c-70956f6e6f57,402e910d-bfbc-4433-b8e9-a3260e56608a,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-WCMC-0790-C67_treatment10,06bddd32-e22d-4856-b8ca-e048f77ff921,,released,,0,2023-02-27T11:29:02.317289-06:00,Targeted Molecular Therapy,Residual Disease,
HCM-WCMC-0790-C67,7d2af728-4620-4ed4-946c-70956f6e6f57,402e910d-bfbc-4433-b8e9-a3260e56608a,,Neoadjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-WCMC-0790-C67_treatment,1048b2d0-9c7a-457e-b1cb-ac3c7dd781c3,,released,,0,2023-02-27T11:29:02.317289-06:00,,,
HCM-WCMC-0790-C67,7d2af728-4620-4ed4-946c-70956f6e6f57,402e910d-bfbc-4433-b8e9-a3260e56608a,211.0,Adjuvant,167.0,2025-04-07T17:13:09.336794-05:00,HCM-WCMC-0790-C67_treatment3,206d2902-550d-4fdb-ac58-ac46eeb17104,,released,Cisplatin,1,2023-02-27T11:29:02.317289-06:00,Chemotherapy,Residual Disease,
HCM-WCMC-0790-C67,7d2af728-4620-4ed4-946c-70956f6e6f57,402e910d-bfbc-4433-b8e9-a3260e56608a,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-WCMC-0790-C67_treatment8,64d95ee8-5da8-4fb0-a830-490970b73c0d,,released,,0,2023-02-27T11:29:02.317289-06:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-WCMC-0790-C67,7d2af728-4620-4ed4-946c-70956f6e6f57,402e910d-bfbc-4433-b8e9-a3260e56608a,211.0,Adjuvant,167.0,2025-04-07T17:13:09.336794-05:00,HCM-WCMC-0790-C67_treatment2,8f4eda46-5994-4db8-9a43-aac0a89e6d37,,released,Vinblastine,1,2023-02-27T11:29:02.317289-06:00,Chemotherapy,Residual Disease,
HCM-WCMC-0790-C67,7d2af728-4620-4ed4-946c-70956f6e6f57,402e910d-bfbc-4433-b8e9-a3260e56608a,,,94.0,2025-04-07T17:13:09.336794-05:00,HCM-WCMC-0790-C67_treatment9,972ba69f-1157-4431-906f-50419773b19c,,released,,1,2023-02-27T11:29:02.317289-06:00,"Surgery, NOS",Initial Diagnosis,
HCM-WCMC-0790-C67,7d2af728-4620-4ed4-946c-70956f6e6f57,402e910d-bfbc-4433-b8e9-a3260e56608a,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-WCMC-0790-C67_treatment11,bb6b18e5-d172-4ac0-8096-dc3ce94fc5e8,,released,,0,2023-02-27T11:29:02.317289-06:00,"Radiation Therapy, NOS",Residual Disease,
HCM-WCMC-0790-C67,7d2af728-4620-4ed4-946c-70956f6e6f57,402e910d-bfbc-4433-b8e9-a3260e56608a,211.0,Adjuvant,167.0,2025-04-07T17:13:09.336794-05:00,HCM-WCMC-0790-C67_treatment4,d14b3a76-f5a7-46d2-bbed-f8de7f36a22c,,released,Doxorubicin,1,2023-02-27T11:29:02.317289-06:00,Chemotherapy,Residual Disease,
HCM-WCMC-0790-C67,7d2af728-4620-4ed4-946c-70956f6e6f57,402e910d-bfbc-4433-b8e9-a3260e56608a,211.0,Adjuvant,167.0,2025-04-07T17:13:09.336794-05:00,HCM-WCMC-0790-C67_treatment5,d3cb29b6-aa68-4857-8f6a-8eea13f53dba,,released,Methotrexate,1,2023-02-27T11:29:02.317289-06:00,Chemotherapy,Residual Disease,
HCM-WCMC-0790-C67,7d2af728-4620-4ed4-946c-70956f6e6f57,402e910d-bfbc-4433-b8e9-a3260e56608a,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-WCMC-0790-C67_treatment7,d4fd661d-295b-4346-940d-c143a8c80207,,released,,0,2023-02-27T11:29:02.317289-06:00,Hormone Therapy,Residual Disease,
HCM-WCMC-0790-C67,7d2af728-4620-4ed4-946c-70956f6e6f57,402e910d-bfbc-4433-b8e9-a3260e56608a,211.0,Adjuvant,167.0,2025-04-07T17:13:09.336794-05:00,HCM-WCMC-0790-C67_treatment6,e5b37129-3287-4eb5-b51e-5356ba1b439d,,released,,1,2023-02-27T11:29:02.317289-06:00,Chemotherapy,Residual Disease,MVAC-Growth Factor Regimen
HCM-BROD-0676-C71,7da47919-73f4-4e05-a5f5-16aa5cd243bf,1641b1b9-f479-4234-86cf-52f6df837d8d,86.0,Maintenance Therapy,45.0,2023-02-22T07:39:25.979291-06:00,HCM-BROD-0676-C71_treatment7,1a15c094-7b0e-4219-980c-4a18fd24ab0c,Progressive Disease,released,Temozolomide,1,2021-12-21T13:42:52.738810-06:00,,,
HCM-BROD-0676-C71,7da47919-73f4-4e05-a5f5-16aa5cd243bf,29252521-279f-4244-b996-7de71a21b46c,,,0.0,2023-02-27T13:33:37.524548-06:00,HCM-BROD-0676-C71_treatment4,3843a35e-171f-4bce-900e-56e619096017,,released,,1,2021-12-21T13:42:52.738810-06:00,"Surgery, NOS",Initial Diagnosis,
HCM-BROD-0676-C71,7da47919-73f4-4e05-a5f5-16aa5cd243bf,29252521-279f-4244-b996-7de71a21b46c,,Adjuvant,,2023-02-22T07:39:25.979291-06:00,HCM-BROD-0676-C71_treatment3,3f4ac288-e2bb-4a1c-84fa-ead0544500db,,released,,0,2021-12-21T13:42:52.738810-06:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-BROD-0676-C71,7da47919-73f4-4e05-a5f5-16aa5cd243bf,29252521-279f-4244-b996-7de71a21b46c,355.0,Adjuvant,283.0,2023-02-22T07:39:25.979291-06:00,HCM-BROD-0676-C71_treatment5,7dd73152-a211-4867-b3c6-e954d04084ac,,released,Not Reported,1,2021-12-21T13:42:52.738810-06:00,Targeted Molecular Therapy,Residual Disease,
HCM-BROD-0676-C71,7da47919-73f4-4e05-a5f5-16aa5cd243bf,29252521-279f-4244-b996-7de71a21b46c,,Adjuvant,,2023-02-22T07:39:25.979291-06:00,HCM-BROD-0676-C71_treatment2,8c31df20-55dc-4ae3-b8ea-681b4c390c3d,,released,,0,2021-12-21T13:42:52.738810-06:00,Chemotherapy,Residual Disease,
HCM-BROD-0676-C71,7da47919-73f4-4e05-a5f5-16aa5cd243bf,29252521-279f-4244-b996-7de71a21b46c,,Neoadjuvant,,2023-02-22T07:39:25.979291-06:00,HCM-BROD-0676-C71_treatment,9222fb62-1d70-461b-88cf-67a37bdb2228,,released,,0,2021-12-21T13:42:52.738810-06:00,,,
HCM-BROD-0676-C71,7da47919-73f4-4e05-a5f5-16aa5cd243bf,29252521-279f-4244-b996-7de71a21b46c,,Adjuvant,,2023-02-22T07:39:25.979291-06:00,HCM-BROD-0676-C71_treatment6,f7402b61-6ed7-44fc-84ec-02f008c62c82,,released,,0,2021-12-21T13:42:52.738810-06:00,"Radiation Therapy, NOS",Residual Disease,
HCM-BROD-0869-C43,7e4f2097-9694-48de-aa29-2130dd39416b,1ba37c32-da52-457c-9968-26e4a1704b34,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0869-C43_treatment8,0ceabfe7-2981-41dc-a837-317055bd6135,,released,,0,2021-12-21T13:56:14.406589-06:00,Targeted Molecular Therapy,Residual Disease,
HCM-BROD-0869-C43,7e4f2097-9694-48de-aa29-2130dd39416b,1ba37c32-da52-457c-9968-26e4a1704b34,579.0,Adjuvant,497.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0869-C43_treatment6,1ac7302b-ff0d-4479-bc4e-f12d732c065b,,released,Nivolumab,1,2021-12-21T13:56:14.406589-06:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-BROD-0869-C43,7e4f2097-9694-48de-aa29-2130dd39416b,1ba37c32-da52-457c-9968-26e4a1704b34,,,0.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0869-C43_treatment7,2fe0de05-52d4-4d0c-9ca2-25a57fe1150d,,released,,1,2021-12-21T13:56:14.406589-06:00,"Surgery, NOS",Initial Diagnosis,
HCM-BROD-0869-C43,7e4f2097-9694-48de-aa29-2130dd39416b,1ba37c32-da52-457c-9968-26e4a1704b34,579.0,Adjuvant,497.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0869-C43_treatment5,3afcfc45-3ace-41ae-b7e7-ef1b6115b2c5,,released,Ipilimumab,1,2021-12-21T13:56:14.406589-06:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-BROD-0869-C43,7e4f2097-9694-48de-aa29-2130dd39416b,1ba37c32-da52-457c-9968-26e4a1704b34,,Neoadjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0869-C43_treatment,49f9818f-6760-4a78-9fb9-7cc60e78df64,,released,,0,2021-12-21T13:56:14.406589-06:00,,,
HCM-BROD-0869-C43,7e4f2097-9694-48de-aa29-2130dd39416b,1ba37c32-da52-457c-9968-26e4a1704b34,490.0,Adjuvant,122.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0869-C43_treatment4,82980f80-ab75-40be-ba19-c55b9356da8a,,released,Pembrolizumab,1,2021-12-21T13:56:14.406589-06:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-BROD-0869-C43,7e4f2097-9694-48de-aa29-2130dd39416b,1ba37c32-da52-457c-9968-26e4a1704b34,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0869-C43_treatment9,b3c58f20-d0c1-4cf7-89ba-5614539f8599,,released,,0,2021-12-21T13:56:14.406589-06:00,"Radiation Therapy, NOS",Residual Disease,
HCM-BROD-0869-C43,7e4f2097-9694-48de-aa29-2130dd39416b,1ba37c32-da52-457c-9968-26e4a1704b34,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0869-C43_treatment3,d1c82d94-6b2a-41e4-b442-e43f351165fb,,released,,0,2021-12-21T13:56:14.406589-06:00,Hormone Therapy,Residual Disease,
HCM-BROD-0869-C43,7e4f2097-9694-48de-aa29-2130dd39416b,1ba37c32-da52-457c-9968-26e4a1704b34,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0869-C43_treatment2,f9fcd8d5-9330-4494-9058-749e46a33131,,released,,0,2021-12-21T13:56:14.406589-06:00,Chemotherapy,Residual Disease,
HCM-CSHL-0460-C50,7eb28d9c-d25e-4112-9666-145bf7cee7c5,0212cd72-ea8c-44d2-98e5-47eaa67722c6,,Adjuvant,68.0,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0460-C50_treatment3,094ec7cf-07fb-4fb8-b6b7-c177623e72e3,Treatment Ongoing,released,Not Reported,1,2020-09-28T10:19:40.728772-05:00,Hormone Therapy,Residual Disease,
HCM-CSHL-0460-C50,7eb28d9c-d25e-4112-9666-145bf7cee7c5,0212cd72-ea8c-44d2-98e5-47eaa67722c6,,Adjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0460-C50_treatment2,0b6a824b-042d-4fea-9ffe-af76a8d11d96,,released,,0,2020-09-28T10:19:40.728772-05:00,Chemotherapy,Residual Disease,
HCM-CSHL-0460-C50,7eb28d9c-d25e-4112-9666-145bf7cee7c5,0212cd72-ea8c-44d2-98e5-47eaa67722c6,,Neoadjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0460-C50_treatment,72c6d113-2b98-47a4-85e2-a9fafe1a4dcc,,released,,0,2020-09-28T10:19:40.728772-05:00,,,
HCM-CSHL-0460-C50,7eb28d9c-d25e-4112-9666-145bf7cee7c5,0212cd72-ea8c-44d2-98e5-47eaa67722c6,,Adjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0460-C50_treatment7,bdc27cfa-12af-4848-8af5-79b3c2fde4ce,,released,,0,2020-09-28T10:19:40.728772-05:00,"Radiation Therapy, NOS",Residual Disease,
HCM-CSHL-0460-C50,7eb28d9c-d25e-4112-9666-145bf7cee7c5,0212cd72-ea8c-44d2-98e5-47eaa67722c6,,,30.0,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0460-C50_treatment5,cc690333-f732-4248-ba28-768dc4a34762,,released,,1,2020-09-28T10:19:40.728772-05:00,"Surgery, NOS",Initial Diagnosis,
HCM-CSHL-0460-C50,7eb28d9c-d25e-4112-9666-145bf7cee7c5,0212cd72-ea8c-44d2-98e5-47eaa67722c6,,Adjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0460-C50_treatment6,cfdd8585-58a4-47c1-8377-f2d3ba90df64,,released,,0,2020-09-28T10:19:40.728772-05:00,Targeted Molecular Therapy,Residual Disease,
HCM-CSHL-0460-C50,7eb28d9c-d25e-4112-9666-145bf7cee7c5,0212cd72-ea8c-44d2-98e5-47eaa67722c6,,Adjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0460-C50_treatment4,ed86a962-1470-4722-b9e2-58e703498ad7,,released,,0,2020-09-28T10:19:40.728772-05:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-BROD-0227-C43,7ec96446-8a5e-400a-966b-986452c972e4,538d631d-9d1b-4fac-b5df-36547334d590,,,0.0,2023-02-27T11:20:10.957339-06:00,HCM-BROD-0227-C43_treatment5,12cffa0a-328c-4ed8-a06b-7347b788e7a4,,released,,1,2020-07-31T09:26:18.684105-05:00,"Surgery, NOS",Initial Diagnosis,
HCM-BROD-0227-C43,7ec96446-8a5e-400a-966b-986452c972e4,538d631d-9d1b-4fac-b5df-36547334d590,,Adjuvant,,2021-01-06T22:55:10.531130-06:00,HCM-BROD-0227-C43_treatment2,1de9a2ab-158e-4b95-b166-3154a85108af,,released,,0,2020-07-31T09:26:18.684105-05:00,Chemotherapy,Residual Disease,
HCM-BROD-0227-C43,7ec96446-8a5e-400a-966b-986452c972e4,538d631d-9d1b-4fac-b5df-36547334d590,90.0,Adjuvant,62.0,2021-01-06T22:55:10.531130-06:00,HCM-BROD-0227-C43_treatment7,2047a6d4-5c8c-4dd5-95f4-2d9f9b00c3c4,,released,,1,2020-09-27T11:09:01.249053-05:00,"Radiation Therapy, NOS",Residual Disease,
HCM-BROD-0227-C43,7ec96446-8a5e-400a-966b-986452c972e4,538d631d-9d1b-4fac-b5df-36547334d590,,Adjuvant,,2021-01-06T22:55:10.531130-06:00,HCM-BROD-0227-C43_treatment3,af822ff8-1078-46d8-8c5a-73a5bb9172a1,,released,,0,2020-07-31T09:26:18.684105-05:00,Hormone Therapy,Residual Disease,
HCM-BROD-0227-C43,7ec96446-8a5e-400a-966b-986452c972e4,538d631d-9d1b-4fac-b5df-36547334d590,420.0,Adjuvant,98.0,2021-01-06T22:55:10.531130-06:00,HCM-BROD-0227-C43_treatment6,b139591c-bb34-4f08-acde-af2661d60763,Treatment Ongoing,released,Nivolumab,1,2020-07-31T09:26:18.684105-05:00,Targeted Molecular Therapy,Residual Disease,
HCM-BROD-0227-C43,7ec96446-8a5e-400a-966b-986452c972e4,538d631d-9d1b-4fac-b5df-36547334d590,,Neoadjuvant,,2021-01-06T22:55:10.531130-06:00,HCM-BROD-0227-C43_treatment,e6010cb2-7f38-459c-ae4d-089199b5b37a,,released,,0,2020-07-31T09:26:18.684105-05:00,,,
HCM-BROD-0227-C43,7ec96446-8a5e-400a-966b-986452c972e4,538d631d-9d1b-4fac-b5df-36547334d590,,Adjuvant,,2021-01-06T22:55:10.531130-06:00,HCM-BROD-0227-C43_treatment4,ecec33fc-195a-47c2-83f8-045ce4ea8830,,released,Not Reported,1,2020-07-31T09:26:18.684105-05:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-SANG-1318-C20,7edcd40e-5a42-42ab-85d7-61a950cf0d2d,6ec2c98d-c607-4f56-87f5-e70619ba78fd,,Neoadjuvant,132.0,2025-04-07T17:13:09.336794-05:00,HCM-SANG-1318-C20_treatment,00613eb9-4d68-45c7-b5e6-039fbb5dd804,,released,Capecitabine,1,2023-02-27T13:27:49.470335-06:00,Chemotherapy,,
HCM-SANG-1318-C20,7edcd40e-5a42-42ab-85d7-61a950cf0d2d,6ec2c98d-c607-4f56-87f5-e70619ba78fd,,Neoadjuvant,132.0,2025-04-07T17:13:09.336794-05:00,HCM-SANG-1318-C20_treatment2,80d7ca3f-cec6-4cf4-bbf5-0ba321507710,,released,Oxaliplatin,1,2023-02-27T13:27:49.470335-06:00,Chemotherapy,,
HCM-CSHL-0382-C19,7ee0c283-701b-47ac-bc3a-30f45e5c4eb2,2cb76b91-c491-471a-bb1d-1f6e8153b329,,Adjuvant,,2022-03-15T20:08:16.194346-05:00,HCM-CSHL-0382-C19_treatment4,18bae5ea-f93d-47fd-89ae-b94c9633461c,,released,,0,2020-06-15T13:24:58.329176-05:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-CSHL-0382-C19,7ee0c283-701b-47ac-bc3a-30f45e5c4eb2,2cb76b91-c491-471a-bb1d-1f6e8153b329,,Adjuvant,,2022-03-15T20:08:16.194346-05:00,HCM-CSHL-0382-C19_treatment7,5f7b8831-970b-4d61-a646-4ddf159974d0,,released,,0,2020-06-15T13:24:58.329176-05:00,Targeted Molecular Therapy,Residual Disease,
HCM-CSHL-0382-C19,7ee0c283-701b-47ac-bc3a-30f45e5c4eb2,2cb76b91-c491-471a-bb1d-1f6e8153b329,219.0,Adjuvant,38.0,2022-03-15T20:08:16.194346-05:00,HCM-CSHL-0382-C19_treatment3,6a5cc475-f86f-45fd-890f-f0250f25d8fc,,released,Leucovorin,1,2020-06-15T13:24:58.329176-05:00,Chemotherapy,Residual Disease,
HCM-CSHL-0382-C19,7ee0c283-701b-47ac-bc3a-30f45e5c4eb2,2cb76b91-c491-471a-bb1d-1f6e8153b329,,,765.0,2023-03-13T12:54:05.176421-05:00,HCM-CSHL-0382-C19_treatment6,6dc44141-27dc-481f-9bd6-b4f27597e95c,,released,,1,2020-06-15T13:24:58.329176-05:00,"Surgery, NOS",Initial Diagnosis,
HCM-CSHL-0382-C19,7ee0c283-701b-47ac-bc3a-30f45e5c4eb2,2cb76b91-c491-471a-bb1d-1f6e8153b329,219.0,Adjuvant,38.0,2022-03-15T20:08:16.194346-05:00,HCM-CSHL-0382-C19_treatment2,92d4af99-7d10-4ce6-bc49-2dd75bea700b,,released,Fluorouracil,1,2020-06-15T13:24:58.329176-05:00,Chemotherapy,Residual Disease,
HCM-CSHL-0382-C19,7ee0c283-701b-47ac-bc3a-30f45e5c4eb2,2cb76b91-c491-471a-bb1d-1f6e8153b329,,,6.0,2023-03-13T12:54:05.176421-05:00,HCM-CSHL-0382-C19_treatment5,a6574bda-a61c-4153-a455-ceb35305237e,,released,,1,2020-06-15T13:24:58.329176-05:00,"Surgery, NOS",Initial Diagnosis,
HCM-CSHL-0382-C19,7ee0c283-701b-47ac-bc3a-30f45e5c4eb2,2cb76b91-c491-471a-bb1d-1f6e8153b329,,Neoadjuvant,,2021-03-03T15:15:08.075155-06:00,HCM-CSHL-0382-C19_treatment,f2209d2f-9939-4649-aad2-a1b36e6f809f,,released,,0,2020-06-15T13:24:58.329176-05:00,,,
HCM-CSHL-0382-C19,7ee0c283-701b-47ac-bc3a-30f45e5c4eb2,2cb76b91-c491-471a-bb1d-1f6e8153b329,914.0,Adjuvant,905.0,2022-03-15T20:08:16.194346-05:00,HCM-CSHL-0382-C19_treatment8,f23d76ec-22b3-491c-8cd5-a96daebf3edf,,released,,1,2020-09-28T09:59:11.818404-05:00,"Radiation, Stereotactic/Gamma Knife/SRS",Residual Disease,
HCM-CSHL-0382-C19,7ee0c283-701b-47ac-bc3a-30f45e5c4eb2,5b2a6f0f-db0a-4266-9c24-b25a3ab9c466,,Maintenance Therapy,,2023-03-14T11:40:17.645275-05:00,HCM-CSHL-0382-C19_treatment9,bdd2e837-36c1-4ce3-bf08-28a1a11a28f9,Treatment Ongoing,released,Fluorouracil,1,2022-03-15T20:08:16.194346-05:00,,,
HCM-CSHL-0382-C19,7ee0c283-701b-47ac-bc3a-30f45e5c4eb2,5b2a6f0f-db0a-4266-9c24-b25a3ab9c466,,Maintenance Therapy,,2023-03-14T11:40:17.645275-05:00,HCM-CSHL-0382-C19_treatment10,e8531664-d6de-4b01-a5ef-e71ce8b856b0,Treatment Ongoing,released,Leucovorin,1,2022-03-15T20:08:16.194346-05:00,,,
HCM-SANG-0546-C15,7f1867a9-37cc-4604-8c15-56467c12e193,fad3e16f-fcf0-4177-9c67-a421f4c172d8,,Neoadjuvant,100.0,2025-03-31T16:34:59.906497-05:00,HCM-SANG-0546-C15_treatment,6c708dc2-9271-4643-ab45-62bb3a500625,,released,Leucovorin,1,2021-12-21T15:15:48.932931-06:00,Chemotherapy,,
HCM-SANG-0546-C15,7f1867a9-37cc-4604-8c15-56467c12e193,fad3e16f-fcf0-4177-9c67-a421f4c172d8,,Neoadjuvant,100.0,2025-03-31T16:34:59.906497-05:00,HCM-SANG-0546-C15_treatment2,71d83e46-dbae-4cf8-94d9-36ab161f7d2c,,released,Fluorouracil,1,2021-12-21T15:15:48.932931-06:00,Chemotherapy,,
HCM-SANG-0546-C15,7f1867a9-37cc-4604-8c15-56467c12e193,fad3e16f-fcf0-4177-9c67-a421f4c172d8,,Neoadjuvant,100.0,2025-03-31T16:34:59.906497-05:00,HCM-SANG-0546-C15_treatment3,768245ab-e99f-4e56-a852-af21d66a4388,,released,Docetaxel,1,2021-12-21T15:15:48.932931-06:00,Chemotherapy,,
HCM-SANG-0546-C15,7f1867a9-37cc-4604-8c15-56467c12e193,fad3e16f-fcf0-4177-9c67-a421f4c172d8,,Neoadjuvant,100.0,2025-03-31T16:34:59.906497-05:00,HCM-SANG-0546-C15_treatment4,e28a2eac-b665-4517-bb33-86aa338887dd,,released,Oxaliplatin,1,2021-12-21T15:15:48.932931-06:00,Chemotherapy,,
HCM-BROD-0874-C43,7fa35302-efb7-4ca9-a23a-a5dcb54197c7,fc20dc18-b842-4dd4-bf9c-3404a5017219,,Neoadjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0874-C43_treatment,1965e0c3-0d60-4c70-9ccc-dcec07ff07ab,,released,,0,2021-12-21T13:56:41.209883-06:00,,,
HCM-BROD-0874-C43,7fa35302-efb7-4ca9-a23a-a5dcb54197c7,fc20dc18-b842-4dd4-bf9c-3404a5017219,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0874-C43_treatment4,2a267b10-592f-4d25-8836-c2d2e773ba12,,released,,0,2021-12-21T13:56:41.209883-06:00,"Radiation Therapy, NOS",Residual Disease,
HCM-BROD-0874-C43,7fa35302-efb7-4ca9-a23a-a5dcb54197c7,fc20dc18-b842-4dd4-bf9c-3404a5017219,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0874-C43_treatment3,3c542f53-bae6-4ec2-9f28-4b6c5745f437,,released,,0,2021-12-21T13:56:41.209883-06:00,"Pharmaceutical Therapy, NOS",Residual Disease,
HCM-BROD-0874-C43,7fa35302-efb7-4ca9-a23a-a5dcb54197c7,fc20dc18-b842-4dd4-bf9c-3404a5017219,,,,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0874-C43_treatment2,cfd19ba1-6576-4736-b3bb-9b05842ef495,,released,,0,2021-12-21T13:56:41.209883-06:00,"Surgery, NOS",Initial Diagnosis,
HCM-CSHL-0247-C18,7fa8bc57-4bc7-48a5-99fe-98ed02fa17e8,cde4e8e5-19c5-4576-9647-80d190ca2bf5,,Adjuvant,155.0,2021-07-12T12:25:55.528644-05:00,HCM-CSHL-0247-C18_treatment5,12b4c665-9161-43e7-8c8a-f9f02cad532e,,released,,1,2020-04-21T14:57:30.109195-05:00,Chemotherapy,Residual Disease,FOLFOX
HCM-CSHL-0247-C18,7fa8bc57-4bc7-48a5-99fe-98ed02fa17e8,cde4e8e5-19c5-4576-9647-80d190ca2bf5,,Adjuvant,,2021-07-12T12:25:55.528644-05:00,HCM-CSHL-0247-C18_treatment12,3ceb476d-da26-4049-9e85-01383486cfae,,released,,0,2020-10-08T12:09:47.671632-05:00,"Radiation Therapy, NOS",Residual Disease,
HCM-CSHL-0247-C18,7fa8bc57-4bc7-48a5-99fe-98ed02fa17e8,cde4e8e5-19c5-4576-9647-80d190ca2bf5,,,56.0,2023-03-13T13:15:01.199579-05:00,HCM-CSHL-0247-C18_treatment10,507740ed-af9c-42cb-a53e-50514dc1c882,,released,,1,2020-10-08T12:09:47.671632-05:00,"Surgery, NOS",Initial Diagnosis,
HCM-CSHL-0247-C18,7fa8bc57-4bc7-48a5-99fe-98ed02fa17e8,cde4e8e5-19c5-4576-9647-80d190ca2bf5,,Adjuvant,392.0,2021-07-12T12:25:55.528644-05:00,HCM-CSHL-0247-C18_treatment8,621b555f-451f-4d6c-81cf-5afda9709a28,Treatment Ongoing,released,Oxaliplatin,1,2020-10-08T12:09:47.671632-05:00,Chemotherapy,Residual Disease,
HCM-CSHL-0247-C18,7fa8bc57-4bc7-48a5-99fe-98ed02fa17e8,cde4e8e5-19c5-4576-9647-80d190ca2bf5,,Adjuvant,155.0,2021-07-12T12:25:55.528644-05:00,HCM-CSHL-0247-C18_treatment11,79f83b59-bf84-43e8-be08-6efaa5ab6e5c,Treatment Ongoing,released,Bevacizumab,1,2020-10-08T12:09:47.671632-05:00,Targeted Molecular Therapy,Residual Disease,
HCM-CSHL-0247-C18,7fa8bc57-4bc7-48a5-99fe-98ed02fa17e8,cde4e8e5-19c5-4576-9647-80d190ca2bf5,,Adjuvant,,2021-07-12T12:25:55.528644-05:00,HCM-CSHL-0247-C18_treatment9,8faa0b0f-541e-4673-94fb-ad1e45b036cd,,released,,0,2020-10-08T12:09:47.671632-05:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-CSHL-0247-C18,7fa8bc57-4bc7-48a5-99fe-98ed02fa17e8,cde4e8e5-19c5-4576-9647-80d190ca2bf5,,Neoadjuvant,,2021-07-12T12:25:55.528644-05:00,HCM-CSHL-0247-C18_treatment,9ae03485-c2d9-4e15-a171-38d05aaa5e74,,released,,0,2020-04-21T14:57:30.109195-05:00,,,
HCM-CSHL-0247-C18,7fa8bc57-4bc7-48a5-99fe-98ed02fa17e8,cde4e8e5-19c5-4576-9647-80d190ca2bf5,,Adjuvant,155.0,2021-07-12T12:25:55.528644-05:00,HCM-CSHL-0247-C18_treatment4,b4e00b9e-2ded-4bce-8ab6-56190e790f04,,released,Oxaliplatin,1,2020-04-21T14:57:30.109195-05:00,Chemotherapy,Residual Disease,
HCM-CSHL-0247-C18,7fa8bc57-4bc7-48a5-99fe-98ed02fa17e8,cde4e8e5-19c5-4576-9647-80d190ca2bf5,,Adjuvant,392.0,2021-07-12T12:25:55.528644-05:00,HCM-CSHL-0247-C18_treatment7,cafdb21c-4fc4-40b5-80dc-a1acd5caddb2,Treatment Ongoing,released,Leucovorin,1,2020-04-21T14:57:30.109195-05:00,Chemotherapy,Residual Disease,
HCM-CSHL-0247-C18,7fa8bc57-4bc7-48a5-99fe-98ed02fa17e8,cde4e8e5-19c5-4576-9647-80d190ca2bf5,,Adjuvant,155.0,2021-07-12T12:25:55.528644-05:00,HCM-CSHL-0247-C18_treatment2,df082093-a2b9-48a4-8814-486a8d36aec8,,released,Leucovorin Calcium,1,2020-04-21T14:57:30.109195-05:00,Chemotherapy,Residual Disease,
HCM-CSHL-0247-C18,7fa8bc57-4bc7-48a5-99fe-98ed02fa17e8,cde4e8e5-19c5-4576-9647-80d190ca2bf5,,Adjuvant,155.0,2021-07-12T12:25:55.528644-05:00,HCM-CSHL-0247-C18_treatment3,f2f83b32-19a8-4529-b36c-3c32662f1391,,released,Fluorouracil,1,2020-04-21T14:57:30.109195-05:00,Chemotherapy,Residual Disease,
HCM-CSHL-0247-C18,7fa8bc57-4bc7-48a5-99fe-98ed02fa17e8,cde4e8e5-19c5-4576-9647-80d190ca2bf5,,Adjuvant,392.0,2021-07-12T12:25:55.528644-05:00,HCM-CSHL-0247-C18_treatment6,fa3c33a2-da1e-4b17-b2d0-3191f946936a,Treatment Ongoing,released,Fluorouracil,1,2020-04-21T14:57:30.109195-05:00,Chemotherapy,Residual Disease,
HCM-CSHL-0863-C18,80662c9b-a131-4e8e-8622-07eca4e1127b,4458e439-d28d-4a08-9da5-a1758b6b9de5,45.0,Maintenance Therapy,,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0863-C18_treatment8,602ad20f-1007-4fcb-bd02-a3dd08a07991,Not Reported,released,Bevacizumab,1,2021-12-21T14:36:07.036845-06:00,,,
HCM-CSHL-0863-C18,80662c9b-a131-4e8e-8622-07eca4e1127b,91c3aa2b-c76c-44ee-b9fd-821c914ca487,,Neoadjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0863-C18_treatment,0889018f-3056-4b29-83f1-03e075cb2a72,,released,,unknown,2021-12-21T14:36:07.036845-06:00,"Pharmaceutical Therapy, NOS",,
HCM-CSHL-0863-C18,80662c9b-a131-4e8e-8622-07eca4e1127b,91c3aa2b-c76c-44ee-b9fd-821c914ca487,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0863-C18_treatment7,1a02d652-2ace-4271-84db-e6174d7f18ac,,released,,0,2021-12-21T14:36:07.036845-06:00,"Radiation Therapy, NOS",Residual Disease,
HCM-CSHL-0863-C18,80662c9b-a131-4e8e-8622-07eca4e1127b,91c3aa2b-c76c-44ee-b9fd-821c914ca487,,Neoadjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0863-C18_treatment2,25819df9-6c79-4da2-9ac7-5f7035e9ba31,,released,,unknown,2021-12-21T14:36:07.036845-06:00,"Radiation Therapy, NOS",,
HCM-CSHL-0863-C18,80662c9b-a131-4e8e-8622-07eca4e1127b,91c3aa2b-c76c-44ee-b9fd-821c914ca487,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0863-C18_treatment3,29f005aa-6daf-47d3-9b11-c42e1add7810,,released,,0,2021-12-21T14:36:07.036845-06:00,Chemotherapy,Residual Disease,
HCM-CSHL-0863-C18,80662c9b-a131-4e8e-8622-07eca4e1127b,91c3aa2b-c76c-44ee-b9fd-821c914ca487,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0863-C18_treatment4,5338a67d-c7f3-484e-903c-d3f9b4d4fdd0,,released,,0,2021-12-21T14:36:07.036845-06:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-CSHL-0863-C18,80662c9b-a131-4e8e-8622-07eca4e1127b,91c3aa2b-c76c-44ee-b9fd-821c914ca487,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0863-C18_treatment6,ccc9cfa7-eecd-4f4b-b348-1a35437e2e1d,,released,Bevacizumab,1,2021-12-21T14:36:07.036845-06:00,Targeted Molecular Therapy,Residual Disease,
HCM-CSHL-0863-C18,80662c9b-a131-4e8e-8622-07eca4e1127b,91c3aa2b-c76c-44ee-b9fd-821c914ca487,,,29.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0863-C18_treatment5,e1c46ce6-8eca-4b7b-ade4-596595f4c1ce,,released,,1,2021-12-21T14:36:07.036845-06:00,"Surgery, NOS",Initial Diagnosis,
HCM-CSHL-0385-C18,80a596d1-04f0-447b-8151-fc74ca6f7c5e,3b71bc66-8111-4b16-8fef-504a5db6bf98,,Neoadjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0385-C18_treatment,7481e096-2107-42d8-93c9-cc253b88e3a0,,released,,0,2020-09-28T09:58:12.339518-05:00,,,
HCM-CSHL-0385-C18,80a596d1-04f0-447b-8151-fc74ca6f7c5e,3b71bc66-8111-4b16-8fef-504a5db6bf98,,Adjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0385-C18_treatment3,7f8548d6-4b2b-4bc0-9148-6dafb6aa7747,,released,,0,2020-09-28T09:58:12.339518-05:00,"Pharmaceutical Therapy, NOS",Residual Disease,
HCM-CSHL-0385-C18,80a596d1-04f0-447b-8151-fc74ca6f7c5e,3b71bc66-8111-4b16-8fef-504a5db6bf98,,,6.0,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0385-C18_treatment2,9842befe-701b-4cfe-ba22-af56cad9bf7e,,released,,1,2020-09-28T09:58:12.339518-05:00,"Surgery, NOS",Initial Diagnosis,
HCM-CSHL-0385-C18,80a596d1-04f0-447b-8151-fc74ca6f7c5e,3b71bc66-8111-4b16-8fef-504a5db6bf98,,Adjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0385-C18_treatment4,cda5b12d-31cb-46a0-b1c1-6e114610a2b5,,released,,0,2020-09-28T09:58:12.339518-05:00,"Radiation Therapy, NOS",Residual Disease,
HCM-SANG-0289-C15,80bbff05-a62d-49c3-adee-08d992f0ba67,e75ceab9-5ad2-4638-8031-6db63ec00fb7,,Neoadjuvant,91.0,2023-03-13T13:25:37.212375-05:00,HCM-SANG-0289-C15_treatment4,0451ea6e-1fe4-4f1e-836e-d8e48c3eba03,,released,,1,2020-11-11T09:35:23.035588-06:00,Chemotherapy,,ECX
HCM-SANG-0289-C15,80bbff05-a62d-49c3-adee-08d992f0ba67,e75ceab9-5ad2-4638-8031-6db63ec00fb7,,Neoadjuvant,91.0,2023-03-13T13:25:37.212375-05:00,HCM-SANG-0289-C15_treatment,5e51cc84-bc17-4733-bb3b-cc9ae9ccdeb0,,released,Epirubicin,1,2020-02-11T15:32:50.052516-06:00,Chemotherapy,,
HCM-SANG-0289-C15,80bbff05-a62d-49c3-adee-08d992f0ba67,e75ceab9-5ad2-4638-8031-6db63ec00fb7,,Neoadjuvant,91.0,2023-03-13T13:25:37.212375-05:00,HCM-SANG-0289-C15_treatment2,c17524c2-6ec1-4610-9c4d-0455c25ef51e,,released,Capecitabine,1,2020-11-11T09:35:23.035588-06:00,Chemotherapy,,
HCM-SANG-0289-C15,80bbff05-a62d-49c3-adee-08d992f0ba67,e75ceab9-5ad2-4638-8031-6db63ec00fb7,,Neoadjuvant,91.0,2023-03-13T13:25:37.212375-05:00,HCM-SANG-0289-C15_treatment3,fb5a10b8-07fa-458b-bdc0-144b8522492e,,released,Cisplatin,1,2020-11-11T09:35:23.035588-06:00,Chemotherapy,,
HCM-SANG-1314-C18,80e571e3-8edf-40ff-883d-bce4e31acac2,7c31d333-3de3-4f6e-b60f-c68f84ac76a3,,Neoadjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-SANG-1314-C18_treatment,47cff4fd-c62c-443d-871f-16645dbc0f05,,released,,0,2023-02-27T12:11:41.179818-06:00,,,
HCM-BROD-0681-C71,816e3eb6-1d9c-4f79-b672-c76b3af02d1c,176c7d32-9b90-4693-b9cc-553171a6aedc,862.0,Adjuvant,629.0,2023-02-22T07:39:25.979291-06:00,HCM-BROD-0681-C71_treatment3,09bf7f72-51d8-46c0-a71d-c64c15b84ad4,,released,Nivolumab,1,2021-12-21T13:42:59.125837-06:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-BROD-0681-C71,816e3eb6-1d9c-4f79-b672-c76b3af02d1c,176c7d32-9b90-4693-b9cc-553171a6aedc,,,-1.0,2023-02-27T12:46:16.349750-06:00,HCM-BROD-0681-C71_treatment4,0d8b1957-2bcd-491c-8bbf-aa1acba48fba,,released,,1,2021-12-21T13:42:59.125837-06:00,"Surgery, NOS",Initial Diagnosis,
HCM-BROD-0681-C71,816e3eb6-1d9c-4f79-b672-c76b3af02d1c,176c7d32-9b90-4693-b9cc-553171a6aedc,289.0,Adjuvant,41.0,2023-02-22T07:39:25.979291-06:00,HCM-BROD-0681-C71_treatment2,0fcc908c-9392-42f1-8553-3135135f8ffd,,released,Temozolomide,1,2021-12-21T13:42:59.125837-06:00,Chemotherapy,Residual Disease,
HCM-BROD-0681-C71,816e3eb6-1d9c-4f79-b672-c76b3af02d1c,176c7d32-9b90-4693-b9cc-553171a6aedc,,Neoadjuvant,,2023-02-22T07:39:25.979291-06:00,HCM-BROD-0681-C71_treatment,7946e2c8-4e63-4605-96bd-32e755a0c759,,released,,0,2021-12-21T13:42:59.125837-06:00,,,
HCM-BROD-0681-C71,816e3eb6-1d9c-4f79-b672-c76b3af02d1c,176c7d32-9b90-4693-b9cc-553171a6aedc,,Adjuvant,,2023-02-22T07:39:25.979291-06:00,HCM-BROD-0681-C71_treatment5,98be0462-9119-4885-8f55-d277739e315f,,released,,0,2021-12-21T13:42:59.125837-06:00,Targeted Molecular Therapy,Residual Disease,
HCM-BROD-0681-C71,816e3eb6-1d9c-4f79-b672-c76b3af02d1c,176c7d32-9b90-4693-b9cc-553171a6aedc,956.0,Adjuvant,41.0,2023-02-22T07:39:25.979291-06:00,HCM-BROD-0681-C71_treatment6,ba807133-02cc-4a26-a394-bd591fb58e5c,,released,,1,2021-12-21T13:42:59.125837-06:00,"Radiation, 3D Conformal",Residual Disease,
HCM-BROD-0681-C71,816e3eb6-1d9c-4f79-b672-c76b3af02d1c,d732d362-9c5b-47a3-8a10-29e1d91508a2,862.0,Maintenance Therapy,41.0,2023-02-22T07:39:25.979291-06:00,HCM-BROD-0681-C71_treatment8,1004b761-6220-43b5-b532-b091d46986d7,Treatment Ongoing,released,Temozolomide,1,2021-12-21T13:42:59.125837-06:00,,,
HCM-BROD-0681-C71,816e3eb6-1d9c-4f79-b672-c76b3af02d1c,d732d362-9c5b-47a3-8a10-29e1d91508a2,862.0,Maintenance Therapy,41.0,2023-02-22T07:39:25.979291-06:00,HCM-BROD-0681-C71_treatment7,d40f682e-9cfd-4e24-bef3-c1a626763a43,Treatment Ongoing,released,Nivolumab,1,2021-12-21T13:42:59.125837-06:00,,,
HCM-SANG-0304-C15,818627f6-9dda-446c-8ea7-d8f6fa707c27,8e4ed005-24a6-4ded-89bc-86a5b4829d5d,,Neoadjuvant,,2023-02-22T07:39:25.979291-06:00,HCM-SANG-0304-C15_treatment,c0798f78-7de9-4575-b9ca-12c3d159c477,,released,,0,2020-02-27T12:54:00.713566-06:00,,,
HCM-BROD-0041-C64,819b41c2-1aa4-4a98-959f-096fd3df1446,f3df3538-722b-4d28-b8cd-f7265b250f2a,273.0,Adjuvant,0.0,2023-02-22T07:39:25.979291-06:00,HCM-BROD-0041-C64_treatment2,096a3721-50d5-4d23-adf4-c7ac2c400937,,released,Ifosfamide,1,2020-09-27T10:13:30.616701-05:00,Chemotherapy,Residual Disease,
HCM-BROD-0041-C64,819b41c2-1aa4-4a98-959f-096fd3df1446,f3df3538-722b-4d28-b8cd-f7265b250f2a,273.0,Adjuvant,0.0,2023-02-22T07:39:25.979291-06:00,HCM-BROD-0041-C64_treatment5,46ed5f36-27e2-4de4-b854-9a75475d5f89,,released,,1,2020-09-27T10:13:30.616701-05:00,Chemotherapy,Residual Disease,ICE
HCM-BROD-0041-C64,819b41c2-1aa4-4a98-959f-096fd3df1446,f3df3538-722b-4d28-b8cd-f7265b250f2a,273.0,Adjuvant,0.0,2023-02-22T07:39:25.979291-06:00,HCM-BROD-0041-C64_treatment6,71c0e88a-906d-45a6-bca7-ab499108adb7,,released,Doxorubicin Hydrochloride,1,2020-09-27T10:13:30.616701-05:00,Chemotherapy,Residual Disease,
HCM-BROD-0041-C64,819b41c2-1aa4-4a98-959f-096fd3df1446,f3df3538-722b-4d28-b8cd-f7265b250f2a,,,0.0,2023-02-24T14:52:49.856107-06:00,HCM-BROD-0041-C64_treatment10,9490d1c1-96a3-4205-9c6a-d4962137ef68,,released,,1,2020-09-27T10:13:30.616701-05:00,"Surgery, NOS",Initial Diagnosis,
HCM-BROD-0041-C64,819b41c2-1aa4-4a98-959f-096fd3df1446,f3df3538-722b-4d28-b8cd-f7265b250f2a,,Adjuvant,,2023-02-22T07:39:25.979291-06:00,HCM-BROD-0041-C64_treatment11,aefd9448-e05d-4705-ae45-4eb15e75cf8d,,released,,0,2020-09-27T10:13:30.616701-05:00,Targeted Molecular Therapy,Residual Disease,
HCM-BROD-0041-C64,819b41c2-1aa4-4a98-959f-096fd3df1446,f3df3538-722b-4d28-b8cd-f7265b250f2a,,Neoadjuvant,,2023-02-22T07:39:25.979291-06:00,HCM-BROD-0041-C64_treatment,b8d56ee2-56c6-4e2b-8936-d8afbde956c6,,released,,0,2019-04-04T13:38:32.954522-05:00,,,
HCM-BROD-0041-C64,819b41c2-1aa4-4a98-959f-096fd3df1446,f3df3538-722b-4d28-b8cd-f7265b250f2a,,Adjuvant,,2023-02-22T07:39:25.979291-06:00,HCM-BROD-0041-C64_treatment9,c908a5d4-0766-43ee-834e-3d1fb34a19d5,,released,,0,2020-09-27T10:13:30.616701-05:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-BROD-0041-C64,819b41c2-1aa4-4a98-959f-096fd3df1446,f3df3538-722b-4d28-b8cd-f7265b250f2a,273.0,Adjuvant,0.0,2023-02-22T07:39:25.979291-06:00,HCM-BROD-0041-C64_treatment8,cd147d5b-7bb3-48a6-b299-7230374b603e,,released,Vincristine,1,2020-09-27T10:13:30.616701-05:00,Chemotherapy,Residual Disease,
HCM-BROD-0041-C64,819b41c2-1aa4-4a98-959f-096fd3df1446,f3df3538-722b-4d28-b8cd-f7265b250f2a,273.0,Adjuvant,0.0,2023-02-22T07:39:25.979291-06:00,HCM-BROD-0041-C64_treatment4,ce1aad05-322d-41b9-86fb-f7a0a070efc2,,released,Etoposide,1,2020-09-27T10:13:30.616701-05:00,Chemotherapy,Residual Disease,
HCM-BROD-0041-C64,819b41c2-1aa4-4a98-959f-096fd3df1446,f3df3538-722b-4d28-b8cd-f7265b250f2a,273.0,Adjuvant,0.0,2023-02-22T07:39:25.979291-06:00,HCM-BROD-0041-C64_treatment3,cfca2c4d-b6bd-4e50-a189-86df11803c08,,released,Carboplatin,1,2020-09-27T10:13:30.616701-05:00,Chemotherapy,Residual Disease,
HCM-BROD-0041-C64,819b41c2-1aa4-4a98-959f-096fd3df1446,f3df3538-722b-4d28-b8cd-f7265b250f2a,273.0,Adjuvant,0.0,2023-02-22T07:39:25.979291-06:00,HCM-BROD-0041-C64_treatment7,d66cddab-2246-4339-9efe-54b09706bf3f,,released,Cyclophosphamide,1,2020-09-27T10:13:30.616701-05:00,Chemotherapy,Residual Disease,
HCM-BROD-0041-C64,819b41c2-1aa4-4a98-959f-096fd3df1446,f3df3538-722b-4d28-b8cd-f7265b250f2a,1.0,Adjuvant,0.0,2023-02-22T07:39:25.979291-06:00,HCM-BROD-0041-C64_treatment12,e7846f99-99fb-46b6-a5d5-5aee27402e1c,,released,,1,2020-09-27T10:13:30.616701-05:00,"Radiation Therapy, NOS",Residual Disease,
HCM-CSHL-0878-C18,81d695dd-8c6d-42fc-b169-52996a7d93ad,6287add5-e096-42f6-ae9c-930f75add617,,Adjuvant,212.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0878-C18_treatment9,1faf96b5-95fa-441d-b029-1cef50206574,Treatment Ongoing,released,,1,2021-12-21T14:37:00.592878-06:00,Chemotherapy,Residual Disease,FOLFOX
HCM-CSHL-0878-C18,81d695dd-8c6d-42fc-b169-52996a7d93ad,6287add5-e096-42f6-ae9c-930f75add617,,Neoadjuvant,34.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0878-C18_treatment4,2ce26241-a677-4504-ad5d-9bd935c762f2,,released,,1,2021-12-21T14:37:00.592878-06:00,Chemotherapy,,FOLFIRI
HCM-CSHL-0878-C18,81d695dd-8c6d-42fc-b169-52996a7d93ad,6287add5-e096-42f6-ae9c-930f75add617,,Neoadjuvant,34.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0878-C18_treatment2,348df54a-02fb-4dac-bdc6-3426855d74e8,,released,Fluorouracil,1,2021-12-21T14:37:00.592878-06:00,Chemotherapy,,
HCM-CSHL-0878-C18,81d695dd-8c6d-42fc-b169-52996a7d93ad,6287add5-e096-42f6-ae9c-930f75add617,,Adjuvant,212.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0878-C18_treatment8,5e2dc983-b04d-48f9-a4a0-c393f6556908,Treatment Ongoing,released,Oxaliplatin,1,2021-12-21T14:37:00.592878-06:00,Chemotherapy,Residual Disease,
HCM-CSHL-0878-C18,81d695dd-8c6d-42fc-b169-52996a7d93ad,6287add5-e096-42f6-ae9c-930f75add617,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0878-C18_treatment12,63ef015e-69ad-40f2-83f1-6a80359ce4a2,,released,,0,2021-12-21T14:37:00.592878-06:00,Targeted Molecular Therapy,Residual Disease,
HCM-CSHL-0878-C18,81d695dd-8c6d-42fc-b169-52996a7d93ad,6287add5-e096-42f6-ae9c-930f75add617,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0878-C18_treatment10,69249e46-bc58-498f-be27-41b8b36a5fb5,,released,,0,2021-12-21T14:37:00.592878-06:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-CSHL-0878-C18,81d695dd-8c6d-42fc-b169-52996a7d93ad,6287add5-e096-42f6-ae9c-930f75add617,188.0,Adjuvant,188.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0878-C18_treatment5,796ee72e-19bd-4bb6-b8e7-9c16c9f0e8dd,,released,Fluorouracil,1,2021-12-21T14:37:00.592878-06:00,Chemotherapy,Residual Disease,
HCM-CSHL-0878-C18,81d695dd-8c6d-42fc-b169-52996a7d93ad,6287add5-e096-42f6-ae9c-930f75add617,,Adjuvant,212.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0878-C18_treatment7,7c7af29e-b2cd-4793-9322-4acc886cad18,Treatment Ongoing,released,Fluorouracil,1,2021-12-21T14:37:00.592878-06:00,Chemotherapy,Residual Disease,
HCM-CSHL-0878-C18,81d695dd-8c6d-42fc-b169-52996a7d93ad,6287add5-e096-42f6-ae9c-930f75add617,,Neoadjuvant,34.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0878-C18_treatment,87dba89b-423f-499f-bd7b-94b290dd61e8,,released,Leucovorin Calcium,1,2021-12-21T14:37:00.592878-06:00,Chemotherapy,,
HCM-CSHL-0878-C18,81d695dd-8c6d-42fc-b169-52996a7d93ad,6287add5-e096-42f6-ae9c-930f75add617,,Neoadjuvant,34.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0878-C18_treatment3,8f0cc086-0e4b-4852-9e93-49cd9228540a,,released,Irinotecan,1,2021-12-21T14:37:00.592878-06:00,Chemotherapy,,
HCM-CSHL-0878-C18,81d695dd-8c6d-42fc-b169-52996a7d93ad,6287add5-e096-42f6-ae9c-930f75add617,,,129.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0878-C18_treatment11,92e710c4-3d83-4163-8187-57f4ae1870b6,,released,,1,2021-12-21T14:37:00.592878-06:00,"Surgery, NOS",Initial Diagnosis,
HCM-CSHL-0878-C18,81d695dd-8c6d-42fc-b169-52996a7d93ad,6287add5-e096-42f6-ae9c-930f75add617,,Adjuvant,212.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0878-C18_treatment6,9c0ea79b-f1d8-4fb3-9dec-5f03f2afc593,Treatment Ongoing,released,Leucovorin Calcium,1,2021-12-21T14:37:00.592878-06:00,Chemotherapy,Residual Disease,
HCM-CSHL-0878-C18,81d695dd-8c6d-42fc-b169-52996a7d93ad,6287add5-e096-42f6-ae9c-930f75add617,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0878-C18_treatment13,d7093751-4c44-427c-9502-d7a89d3ebb09,,released,,0,2021-12-21T14:37:00.592878-06:00,"Radiation Therapy, NOS",Residual Disease,
HCM-BROD-0689-C71,81f2ed11-f83b-489a-b9a9-d0c7f99a2022,14a08303-ac60-4816-bccb-6d9423ade109,266.0,Maintenance Therapy,106.0,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0689-C71_treatment5,527f03f0-f3bb-4280-9e1a-eacdb9ed0507,Progressive Disease,released,Temozolomide,1,2023-02-28T11:50:33.536090-06:00,,,
HCM-BROD-0689-C71,81f2ed11-f83b-489a-b9a9-d0c7f99a2022,991c40a4-3ca7-4263-b423-745404230d4c,,Neoadjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0689-C71_treatment,2abb7de5-091d-4c92-840b-48f18f05d8d7,,released,,0,2020-10-08T14:47:13.024720-05:00,,,
HCM-BROD-0689-C71,81f2ed11-f83b-489a-b9a9-d0c7f99a2022,991c40a4-3ca7-4263-b423-745404230d4c,,Adjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0689-C71_treatment3,6753af2a-98f9-43f8-b44a-3368f648c777,,released,,0,2020-10-08T14:47:13.024720-05:00,"Pharmaceutical Therapy, NOS",Residual Disease,
HCM-BROD-0689-C71,81f2ed11-f83b-489a-b9a9-d0c7f99a2022,991c40a4-3ca7-4263-b423-745404230d4c,,,0.0,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0689-C71_treatment2,e1229cba-e510-4e9b-b44e-275b4da41541,,released,,1,2020-10-08T14:47:13.024720-05:00,"Surgery, NOS",Initial Diagnosis,
HCM-BROD-0689-C71,81f2ed11-f83b-489a-b9a9-d0c7f99a2022,991c40a4-3ca7-4263-b423-745404230d4c,,Adjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0689-C71_treatment4,e6dc63e7-901e-4440-9bb1-1944b9e374e3,,released,,0,2020-10-08T14:47:13.024720-05:00,"Radiation Therapy, NOS",Residual Disease,
HCM-CSHL-0731-C19,82caa0cd-b0ec-4d24-95bb-144b9fcc293e,803d9e30-c9b8-4715-a766-96764e53147a,,Neoadjuvant,31.0,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0731-C19_treatment2,02770ba6-1585-494d-a7c0-e53d9cf42ed8,,released,,1,2021-12-21T14:21:04.684129-06:00,"Radiation, Intensity-Modulated Radiotherapy",,
HCM-CSHL-0731-C19,82caa0cd-b0ec-4d24-95bb-144b9fcc293e,803d9e30-c9b8-4715-a766-96764e53147a,,Adjuvant,518.0,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0731-C19_treatment10,05068255-f7fa-4535-97e5-9259eaa57985,Treatment Ongoing,released,,1,2021-12-21T14:21:04.684129-06:00,Chemotherapy,Residual Disease,FOLFIRI
HCM-CSHL-0731-C19,82caa0cd-b0ec-4d24-95bb-144b9fcc293e,803d9e30-c9b8-4715-a766-96764e53147a,,Adjuvant,518.0,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0731-C19_treatment9,05a8eed8-f442-48e1-a7af-de5e7c0a02a0,Treatment Ongoing,released,Irinotecan,1,2021-12-21T14:21:04.684129-06:00,Chemotherapy,Residual Disease,
HCM-CSHL-0731-C19,82caa0cd-b0ec-4d24-95bb-144b9fcc293e,803d9e30-c9b8-4715-a766-96764e53147a,680.0,Adjuvant,644.0,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0731-C19_treatment15,3ada79fa-8adc-4b13-87b3-8e9e992dc8e2,,released,,1,2021-12-21T14:21:04.684129-06:00,"Radiation, Stereotactic/Gamma Knife/SRS",Residual Disease,
HCM-CSHL-0731-C19,82caa0cd-b0ec-4d24-95bb-144b9fcc293e,803d9e30-c9b8-4715-a766-96764e53147a,,,307.0,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0731-C19_treatment13,49f9b1e0-8040-45e4-8364-261ec8526788,,released,,1,2021-12-21T14:21:04.684129-06:00,"Surgery, NOS",Initial Diagnosis,
HCM-CSHL-0731-C19,82caa0cd-b0ec-4d24-95bb-144b9fcc293e,803d9e30-c9b8-4715-a766-96764e53147a,258.0,Adjuvant,149.0,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0731-C19_treatment3,4a77e2eb-b298-4c7c-8039-2cabd55c46d8,,released,Leucovorin Calcium,1,2021-12-21T14:21:04.684129-06:00,Chemotherapy,Residual Disease,
HCM-CSHL-0731-C19,82caa0cd-b0ec-4d24-95bb-144b9fcc293e,803d9e30-c9b8-4715-a766-96764e53147a,,Adjuvant,518.0,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0731-C19_treatment8,5a205899-2165-488b-9c33-5a43e347c20c,Treatment Ongoing,released,Fluorouracil,1,2021-12-21T14:21:04.684129-06:00,Chemotherapy,Residual Disease,
HCM-CSHL-0731-C19,82caa0cd-b0ec-4d24-95bb-144b9fcc293e,803d9e30-c9b8-4715-a766-96764e53147a,,Neoadjuvant,31.0,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0731-C19_treatment,605bb853-bd58-4277-bae0-fa323725a456,,released,Capecitabine,1,2021-12-21T14:21:04.684129-06:00,Chemotherapy,,
HCM-CSHL-0731-C19,82caa0cd-b0ec-4d24-95bb-144b9fcc293e,803d9e30-c9b8-4715-a766-96764e53147a,,Adjuvant,518.0,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0731-C19_treatment14,74d7b340-5378-4c94-87ac-49c4f9e34ce2,Treatment Ongoing,released,Panitumumab,1,2021-12-21T14:21:04.684129-06:00,Targeted Molecular Therapy,Residual Disease,
HCM-CSHL-0731-C19,82caa0cd-b0ec-4d24-95bb-144b9fcc293e,803d9e30-c9b8-4715-a766-96764e53147a,,Adjuvant,518.0,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0731-C19_treatment7,9d435ca3-c083-400c-8f17-c3c73f418ffa,Treatment Ongoing,released,Leucovorin Calcium,1,2021-12-21T14:21:04.684129-06:00,Chemotherapy,Residual Disease,
HCM-CSHL-0731-C19,82caa0cd-b0ec-4d24-95bb-144b9fcc293e,803d9e30-c9b8-4715-a766-96764e53147a,,,107.0,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0731-C19_treatment12,b1e51d3a-4145-4d28-bc6d-b869f997bb16,,released,,1,2021-12-21T14:21:04.684129-06:00,"Surgery, NOS",Initial Diagnosis,
HCM-CSHL-0731-C19,82caa0cd-b0ec-4d24-95bb-144b9fcc293e,803d9e30-c9b8-4715-a766-96764e53147a,,Adjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0731-C19_treatment11,c1d06716-ee78-48c4-b086-c1bff1488be8,,released,,0,2021-12-21T14:21:04.684129-06:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-CSHL-0731-C19,82caa0cd-b0ec-4d24-95bb-144b9fcc293e,803d9e30-c9b8-4715-a766-96764e53147a,258.0,Adjuvant,149.0,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0731-C19_treatment6,d380f405-2dfb-497b-a492-9873dbbf7b4c,,released,,1,2021-12-21T14:21:04.684129-06:00,Chemotherapy,Residual Disease,FOLFOX
HCM-CSHL-0731-C19,82caa0cd-b0ec-4d24-95bb-144b9fcc293e,803d9e30-c9b8-4715-a766-96764e53147a,258.0,Adjuvant,149.0,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0731-C19_treatment5,d51accc8-3200-41b9-b18c-a28d999334a8,,released,Oxaliplatin,1,2021-12-21T14:21:04.684129-06:00,Chemotherapy,Residual Disease,
HCM-CSHL-0731-C19,82caa0cd-b0ec-4d24-95bb-144b9fcc293e,803d9e30-c9b8-4715-a766-96764e53147a,258.0,Adjuvant,149.0,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0731-C19_treatment4,eef062a8-8f5e-43f4-bf4b-48cb875f2984,,released,Fluorouracil,1,2021-12-21T14:21:04.684129-06:00,Chemotherapy,Residual Disease,
HCM-CSHL-0731-C19,82caa0cd-b0ec-4d24-95bb-144b9fcc293e,9783a7d6-2be4-44d5-a49d-68695f41a1c3,276.0,Maintenance Therapy,149.0,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0731-C19_treatment17,38bd4a39-fd2b-4732-8662-9c5aa34a87c8,Stable Disease,released,Fluorouracil,1,2021-12-21T14:21:04.684129-06:00,,,
HCM-CSHL-0731-C19,82caa0cd-b0ec-4d24-95bb-144b9fcc293e,9783a7d6-2be4-44d5-a49d-68695f41a1c3,276.0,Maintenance Therapy,149.0,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0731-C19_treatment18,5100a120-27f0-4c3f-90c3-87c7e1de5f44,Stable Disease,released,Oxaliplatin,1,2021-12-21T14:21:04.684129-06:00,,,
HCM-CSHL-0731-C19,82caa0cd-b0ec-4d24-95bb-144b9fcc293e,9783a7d6-2be4-44d5-a49d-68695f41a1c3,276.0,Maintenance Therapy,149.0,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0731-C19_treatment16,6da3467c-d1fb-435c-8c56-c94cd6abc3bf,Stable Disease,released,Leucovorin Calcium,1,2021-12-21T14:21:04.684129-06:00,,,
HCM-CSHL-0731-C19,82caa0cd-b0ec-4d24-95bb-144b9fcc293e,9783a7d6-2be4-44d5-a49d-68695f41a1c3,276.0,Maintenance Therapy,149.0,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0731-C19_treatment19,f61cfd08-5797-487d-8cf4-69b64da373ec,Stable Disease,released,,1,2021-12-21T14:21:04.684129-06:00,,,FOLFOX
HCM-SANG-1316-C18,82ce9f95-f322-4867-8abb-266b5b8289d0,76319dd7-8d88-4cb5-a6e3-0cc3fa0a62b1,,Neoadjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-SANG-1316-C18_treatment,7f0364c0-0557-4a08-a28b-63a886529fcc,,released,,0,2023-02-27T12:18:18.690363-06:00,,,
HCM-CSHL-0659-C18,8376d8ee-20ce-41bc-b36d-3fbadd194084,0bc6de7c-9af2-473e-acd8-22dc25502808,,Maintenance Therapy,,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0659-C18_treatment19,09d84ec0-060b-4a5a-bc0c-68b1d475302a,Treatment Ongoing,released,Fluorouracil,1,2021-12-21T14:15:22.541820-06:00,,,
HCM-CSHL-0659-C18,8376d8ee-20ce-41bc-b36d-3fbadd194084,0bc6de7c-9af2-473e-acd8-22dc25502808,,Maintenance Therapy,,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0659-C18_treatment23,1966a941-f7e6-49bf-ba6b-8ba14a66e80a,Treatment Ongoing,released,,1,2021-12-21T14:15:22.541820-06:00,,,FOLFIRI
HCM-CSHL-0659-C18,8376d8ee-20ce-41bc-b36d-3fbadd194084,0bc6de7c-9af2-473e-acd8-22dc25502808,,Maintenance Therapy,,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0659-C18_treatment22,6e3a448d-b566-4cb0-8901-1a3a83bd06f1,Treatment Ongoing,released,Leucovorin Calcium,1,2021-12-21T14:15:22.541820-06:00,,,
HCM-CSHL-0659-C18,8376d8ee-20ce-41bc-b36d-3fbadd194084,0bc6de7c-9af2-473e-acd8-22dc25502808,,Maintenance Therapy,,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0659-C18_treatment21,83389510-6e37-4075-beb0-1de1fd4f78ae,Treatment Ongoing,released,Irinotecan,1,2021-12-21T14:15:22.541820-06:00,,,
HCM-CSHL-0659-C18,8376d8ee-20ce-41bc-b36d-3fbadd194084,0bc6de7c-9af2-473e-acd8-22dc25502808,,Maintenance Therapy,,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0659-C18_treatment20,fae59eb0-6b6c-40a2-850f-65c76430e54a,Treatment Ongoing,released,Bevacizumab,1,2021-12-21T14:15:22.541820-06:00,,,
HCM-CSHL-0659-C18,8376d8ee-20ce-41bc-b36d-3fbadd194084,d0594736-0baa-41d8-811b-ce376f6d0d4a,,Neoadjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0659-C18_treatment,00135817-1f47-4ca1-bf94-c740b40f18bf,,released,,0,2021-12-21T14:15:22.541820-06:00,,,
HCM-CSHL-0659-C18,8376d8ee-20ce-41bc-b36d-3fbadd194084,d0594736-0baa-41d8-811b-ce376f6d0d4a,674.0,Adjuvant,656.0,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0659-C18_treatment15,22e0db74-4233-4892-b8e6-ce0dac862b0e,,released,Regorafenib,1,2021-12-21T14:15:22.541820-06:00,Targeted Molecular Therapy,Residual Disease,
HCM-CSHL-0659-C18,8376d8ee-20ce-41bc-b36d-3fbadd194084,d0594736-0baa-41d8-811b-ce376f6d0d4a,271.0,Adjuvant,40.0,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0659-C18_treatment4,23a2a8e1-e0ab-4eef-ae6d-0e6071441352,,released,Oxaliplatin,1,2021-12-21T14:15:22.541820-06:00,Chemotherapy,Residual Disease,
HCM-CSHL-0659-C18,8376d8ee-20ce-41bc-b36d-3fbadd194084,d0594736-0baa-41d8-811b-ce376f6d0d4a,,,509.0,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0659-C18_treatment13,2685e23e-e59f-422c-b655-492a682c7bd2,,released,,1,2021-12-21T14:15:22.541820-06:00,"Surgery, NOS",Initial Diagnosis,
HCM-CSHL-0659-C18,8376d8ee-20ce-41bc-b36d-3fbadd194084,d0594736-0baa-41d8-811b-ce376f6d0d4a,271.0,Adjuvant,40.0,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0659-C18_treatment5,2918ebea-2bbf-43b1-a58a-f0934c315f73,,released,,1,2021-12-21T14:15:22.541820-06:00,Chemotherapy,Residual Disease,FOLFOX
HCM-CSHL-0659-C18,8376d8ee-20ce-41bc-b36d-3fbadd194084,d0594736-0baa-41d8-811b-ce376f6d0d4a,,,9.0,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0659-C18_treatment12,3ef0daa0-d9cc-4a74-a41e-a1e44e69f473,,released,,1,2021-12-21T14:15:22.541820-06:00,"Surgery, NOS",Initial Diagnosis,
HCM-CSHL-0659-C18,8376d8ee-20ce-41bc-b36d-3fbadd194084,d0594736-0baa-41d8-811b-ce376f6d0d4a,674.0,Adjuvant,592.0,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0659-C18_treatment10,46680579-a7a2-49f6-bd37-a45f787250c4,,released,Capecitabine,1,2021-12-21T14:15:22.541820-06:00,Chemotherapy,Residual Disease,
HCM-CSHL-0659-C18,8376d8ee-20ce-41bc-b36d-3fbadd194084,d0594736-0baa-41d8-811b-ce376f6d0d4a,488.0,Adjuvant,390.0,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0659-C18_treatment9,716e57e0-7974-4c1b-96c8-f4586d682bfc,,released,,1,2021-12-21T14:15:22.541820-06:00,Chemotherapy,Residual Disease,FOLFIRI
HCM-CSHL-0659-C18,8376d8ee-20ce-41bc-b36d-3fbadd194084,d0594736-0baa-41d8-811b-ce376f6d0d4a,460.0,Adjuvant,390.0,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0659-C18_treatment14,7c785a38-64e5-483b-8cf4-1dd4ed81b20b,,released,Bevacizumab,1,2021-12-21T14:15:22.541820-06:00,Targeted Molecular Therapy,Residual Disease,
HCM-CSHL-0659-C18,8376d8ee-20ce-41bc-b36d-3fbadd194084,d0594736-0baa-41d8-811b-ce376f6d0d4a,271.0,Adjuvant,40.0,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0659-C18_treatment2,84aab4fe-7588-4337-9884-97d5f0b96cbf,,released,Leucovorin Calcium,1,2021-12-21T14:15:22.541820-06:00,Chemotherapy,Residual Disease,
HCM-CSHL-0659-C18,8376d8ee-20ce-41bc-b36d-3fbadd194084,d0594736-0baa-41d8-811b-ce376f6d0d4a,,Adjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0659-C18_treatment18,85fd00b0-3e77-4761-8dd1-b3430fd7c2f5,,released,,0,2021-12-21T14:15:22.541820-06:00,"Radiation Therapy, NOS",Residual Disease,
HCM-CSHL-0659-C18,8376d8ee-20ce-41bc-b36d-3fbadd194084,d0594736-0baa-41d8-811b-ce376f6d0d4a,,Adjuvant,807.0,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0659-C18_treatment16,97d7a1ef-422d-4358-8815-f78d5d675341,Treatment Ongoing,released,Ipilimumab,1,2021-12-21T14:15:22.541820-06:00,Targeted Molecular Therapy,Residual Disease,
HCM-CSHL-0659-C18,8376d8ee-20ce-41bc-b36d-3fbadd194084,d0594736-0baa-41d8-811b-ce376f6d0d4a,,Adjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0659-C18_treatment11,9a8358ac-3638-4d0e-8da5-4125fd4edc02,,released,,0,2021-12-21T14:15:22.541820-06:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-CSHL-0659-C18,8376d8ee-20ce-41bc-b36d-3fbadd194084,d0594736-0baa-41d8-811b-ce376f6d0d4a,488.0,Adjuvant,390.0,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0659-C18_treatment8,ae50247b-0e31-46d9-a7b5-4fcfa2e867e9,,released,Irinotecan,1,2021-12-21T14:15:22.541820-06:00,Chemotherapy,Residual Disease,
HCM-CSHL-0659-C18,8376d8ee-20ce-41bc-b36d-3fbadd194084,d0594736-0baa-41d8-811b-ce376f6d0d4a,271.0,Adjuvant,40.0,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0659-C18_treatment3,ccc80ef8-f9cf-444b-ba52-bb9ce9e526ad,,released,Fluorouracil,1,2021-12-21T14:15:22.541820-06:00,Chemotherapy,Residual Disease,
HCM-CSHL-0659-C18,8376d8ee-20ce-41bc-b36d-3fbadd194084,d0594736-0baa-41d8-811b-ce376f6d0d4a,488.0,Adjuvant,390.0,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0659-C18_treatment7,db231961-19f5-4ccd-b13b-a5735cac3991,,released,Fluorouracil,1,2021-12-21T14:15:22.541820-06:00,Chemotherapy,Residual Disease,
HCM-CSHL-0659-C18,8376d8ee-20ce-41bc-b36d-3fbadd194084,d0594736-0baa-41d8-811b-ce376f6d0d4a,488.0,Adjuvant,390.0,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0659-C18_treatment6,eeb73428-19ee-4afe-bb84-523b485cca9e,,released,Leucovorin Calcium,1,2021-12-21T14:15:22.541820-06:00,Chemotherapy,Residual Disease,
HCM-CSHL-0659-C18,8376d8ee-20ce-41bc-b36d-3fbadd194084,d0594736-0baa-41d8-811b-ce376f6d0d4a,,Adjuvant,807.0,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0659-C18_treatment17,fc1040a8-43b5-4ba3-9387-f93ba55e9be7,Treatment Ongoing,released,Nivolumab,1,2021-12-21T14:15:22.541820-06:00,Targeted Molecular Therapy,Residual Disease,
HCM-BROD-0045-C16,844a5119-2fc7-43c5-be14-6285e6c79474,b8fded20-edf7-46d2-8ac1-120e1c0c16c1,,Adjuvant,,2023-03-13T12:49:04.196418-05:00,HCM-BROD-0045-C16_treatment4,2a742f86-3cfb-4487-a465-9ba186d6cfbe,,released,,0,2019-04-04T15:22:17.422971-05:00,"Radiation Therapy, NOS",Residual Disease,
HCM-BROD-0045-C16,844a5119-2fc7-43c5-be14-6285e6c79474,b8fded20-edf7-46d2-8ac1-120e1c0c16c1,,Adjuvant,,2023-03-13T12:49:04.196418-05:00,HCM-BROD-0045-C16_treatment3,419fb921-3a10-4df0-933e-75bdb62c80fa,,released,,0,2019-04-04T15:22:17.422971-05:00,"Pharmaceutical Therapy, NOS",Residual Disease,
HCM-BROD-0045-C16,844a5119-2fc7-43c5-be14-6285e6c79474,b8fded20-edf7-46d2-8ac1-120e1c0c16c1,,,,2023-03-13T12:49:04.196418-05:00,HCM-BROD-0045-C16_treatment2,563d0d52-847c-44ba-bfc7-8da28264b452,,released,,0,2019-04-04T15:22:17.422971-05:00,"Surgery, NOS",Initial Diagnosis,
HCM-BROD-0045-C16,844a5119-2fc7-43c5-be14-6285e6c79474,b8fded20-edf7-46d2-8ac1-120e1c0c16c1,,Neoadjuvant,,2021-07-12T12:25:55.528644-05:00,HCM-BROD-0045-C16_treatment,e862dae4-be1c-475b-be04-1ddcbbcbeea7,,released,,0,2019-04-04T15:22:17.422971-05:00,,,
HCM-SANG-1320-C25,848d6440-7980-449d-9698-52de610ea561,b6a71928-c42a-478c-ac4f-25b45b3cc997,,Neoadjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-SANG-1320-C25_treatment,cfaffbea-65c6-480e-99f1-4d4d6f2fc159,,released,,0,2023-02-27T11:50:22.760459-06:00,,,
HCM-SANG-0547-C25,854e555d-16d1-4817-a63b-e45cfad8161b,231c5b38-f68e-48e0-95a7-05f0162a0dce,,Neoadjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-SANG-0547-C25_treatment,1df5312a-3708-48a2-947f-fb0d2bf4954b,,released,,0,2021-12-21T15:15:52.686861-06:00,,,
HCM-BROD-1127-C15,856282a3-fcad-4002-9190-64825ae6d77f,30428dd0-e6e4-406e-810f-17f1f71ce9f5,266.0,Maintenance Therapy,28.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-1127-C15_treatment12,4d93aa81-d3f4-4ee1-9687-f1768a29fb12,Progressive Disease,released,Trastuzumab,1,2021-12-21T14:02:07.696604-06:00,,,
HCM-BROD-1127-C15,856282a3-fcad-4002-9190-64825ae6d77f,30428dd0-e6e4-406e-810f-17f1f71ce9f5,266.0,Maintenance Therapy,28.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-1127-C15_treatment11,862e473a-c452-4bd0-a588-e68326801706,Progressive Disease,released,Paclitaxel,1,2021-12-21T14:02:07.696604-06:00,,,
HCM-BROD-1127-C15,856282a3-fcad-4002-9190-64825ae6d77f,30428dd0-e6e4-406e-810f-17f1f71ce9f5,266.0,Maintenance Therapy,28.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-1127-C15_treatment16,9cae3138-c538-4c57-acb4-71812a786bd3,Progressive Disease,released,,1,2021-12-21T14:02:07.696604-06:00,,,FOLFOX
HCM-BROD-1127-C15,856282a3-fcad-4002-9190-64825ae6d77f,30428dd0-e6e4-406e-810f-17f1f71ce9f5,266.0,Maintenance Therapy,28.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-1127-C15_treatment10,a85a59fa-e6d6-4c00-b4a0-ecc258ed3d08,Progressive Disease,released,Oxaliplatin,1,2021-12-21T14:02:07.696604-06:00,,,
HCM-BROD-1127-C15,856282a3-fcad-4002-9190-64825ae6d77f,30428dd0-e6e4-406e-810f-17f1f71ce9f5,266.0,Maintenance Therapy,28.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-1127-C15_treatment13,a8f7f391-3de8-4107-976a-69a28138d9bc,Progressive Disease,released,Leucovorin Calcium,1,2021-12-21T14:02:07.696604-06:00,,,
HCM-BROD-1127-C15,856282a3-fcad-4002-9190-64825ae6d77f,30428dd0-e6e4-406e-810f-17f1f71ce9f5,266.0,Maintenance Therapy,28.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-1127-C15_treatment15,bd7a3cba-fa18-4ec8-bb3c-9097d4d33ba4,Progressive Disease,released,Ramucirumab,1,2021-12-21T14:02:07.696604-06:00,,,
HCM-BROD-1127-C15,856282a3-fcad-4002-9190-64825ae6d77f,30428dd0-e6e4-406e-810f-17f1f71ce9f5,266.0,Maintenance Therapy,28.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-1127-C15_treatment14,f231148e-066e-46e1-995e-610cdf66cb6b,Progressive Disease,released,Fluorouracil,1,2021-12-21T14:02:07.696604-06:00,,,
HCM-BROD-1127-C15,856282a3-fcad-4002-9190-64825ae6d77f,c30b4e81-962c-49b5-926b-2008f5a36642,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-BROD-1127-C15_treatment8,051e35c6-b7fe-420f-9937-56f643911591,,released,,0,2021-12-21T14:02:07.696604-06:00,Targeted Molecular Therapy,Residual Disease,
HCM-BROD-1127-C15,856282a3-fcad-4002-9190-64825ae6d77f,c30b4e81-962c-49b5-926b-2008f5a36642,287.0,Adjuvant,287.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-1127-C15_treatment5,0a3a9908-059f-41f0-8a5b-5fb6ed908677,Treatment Ongoing,released,,1,2021-12-21T14:02:07.696604-06:00,Chemotherapy,Residual Disease,FU-LV regimen
HCM-BROD-1127-C15,856282a3-fcad-4002-9190-64825ae6d77f,c30b4e81-962c-49b5-926b-2008f5a36642,,Neoadjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-BROD-1127-C15_treatment,0fb7820a-cbb0-4657-91aa-6fded41a8856,,released,,0,2021-12-21T14:02:07.696604-06:00,,,
HCM-BROD-1127-C15,856282a3-fcad-4002-9190-64825ae6d77f,c30b4e81-962c-49b5-926b-2008f5a36642,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-BROD-1127-C15_treatment9,57ae85c0-442d-4e6c-af1e-381007dce269,,released,,0,2021-12-21T14:02:07.696604-06:00,"Radiation Therapy, NOS",Residual Disease,
HCM-BROD-1127-C15,856282a3-fcad-4002-9190-64825ae6d77f,c30b4e81-962c-49b5-926b-2008f5a36642,287.0,Adjuvant,287.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-1127-C15_treatment4,8e9c4260-864d-45c7-8e19-87c40f59a541,Treatment Ongoing,released,Leucovorin,1,2021-12-21T14:02:07.696604-06:00,Chemotherapy,Residual Disease,
HCM-BROD-1127-C15,856282a3-fcad-4002-9190-64825ae6d77f,c30b4e81-962c-49b5-926b-2008f5a36642,,,0.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-1127-C15_treatment7,b9c01f96-0ad3-401a-95ac-419770dc6dd5,,released,,1,2021-12-21T14:02:07.696604-06:00,"Surgery, NOS",Initial Diagnosis,
HCM-BROD-1127-C15,856282a3-fcad-4002-9190-64825ae6d77f,c30b4e81-962c-49b5-926b-2008f5a36642,287.0,Adjuvant,287.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-1127-C15_treatment3,c3a86878-6685-43e7-85c0-b2c2fc1cfb8e,Treatment Ongoing,released,Fluorouracil,1,2021-12-21T14:02:07.696604-06:00,Chemotherapy,Residual Disease,
HCM-BROD-1127-C15,856282a3-fcad-4002-9190-64825ae6d77f,c30b4e81-962c-49b5-926b-2008f5a36642,287.0,Adjuvant,287.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-1127-C15_treatment2,e99c0a0f-bf4e-497b-95ca-f7a8c60f2caf,Treatment Ongoing,released,Irinotecan,1,2021-12-21T14:02:07.696604-06:00,Chemotherapy,Residual Disease,
HCM-BROD-1127-C15,856282a3-fcad-4002-9190-64825ae6d77f,c30b4e81-962c-49b5-926b-2008f5a36642,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-BROD-1127-C15_treatment6,f1b5875c-61f9-479e-a990-2f3bacbb450e,,released,,0,2021-12-21T14:02:07.696604-06:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-WCMC-0494-C16,858a84e1-002b-451c-a2dc-cf5673f08992,af559a9c-9422-4239-a671-eeb7c357bc10,,Neoadjuvant,,2023-07-13T10:35:44.371881-05:00,HCM-WCMC-0494-C16_treatment,0963e3b7-821f-403d-a72d-574d8346c0d0,,released,,0,2023-02-27T12:05:25.583371-06:00,,,
HCM-WCMC-0494-C16,858a84e1-002b-451c-a2dc-cf5673f08992,af559a9c-9422-4239-a671-eeb7c357bc10,,Adjuvant,,2023-07-13T10:35:44.371881-05:00,HCM-WCMC-0494-C16_treatment8,3a853791-bd9f-4ec6-aa55-4f908b2dd9cf,,released,,0,2023-02-27T12:05:25.583371-06:00,Targeted Molecular Therapy,Residual Disease,
HCM-WCMC-0494-C16,858a84e1-002b-451c-a2dc-cf5673f08992,af559a9c-9422-4239-a671-eeb7c357bc10,190.0,Adjuvant,95.0,2023-07-13T10:35:44.371881-05:00,HCM-WCMC-0494-C16_treatment2,4ca9adc6-8b14-41eb-a46a-f0396ea9956e,,released,Leucovorin,1,2023-02-27T12:05:25.583371-06:00,Chemotherapy,Residual Disease,
HCM-WCMC-0494-C16,858a84e1-002b-451c-a2dc-cf5673f08992,af559a9c-9422-4239-a671-eeb7c357bc10,149.0,Adjuvant,121.0,2023-07-13T10:35:44.371881-05:00,HCM-WCMC-0494-C16_treatment5,5b3b1632-2ab5-48e0-a86f-45178b45c3d3,,released,Capecitabine,1,2023-02-27T12:05:25.583371-06:00,Chemotherapy,Residual Disease,
HCM-WCMC-0494-C16,858a84e1-002b-451c-a2dc-cf5673f08992,af559a9c-9422-4239-a671-eeb7c357bc10,,Adjuvant,,2023-07-13T10:35:44.371881-05:00,HCM-WCMC-0494-C16_treatment6,732c56b7-233d-44c2-8f46-f6a28f6241b7,,released,,0,2023-02-27T12:05:25.583371-06:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-WCMC-0494-C16,858a84e1-002b-451c-a2dc-cf5673f08992,af559a9c-9422-4239-a671-eeb7c357bc10,190.0,Adjuvant,95.0,2023-07-13T10:35:44.371881-05:00,HCM-WCMC-0494-C16_treatment3,8302ce9e-7b3f-45b4-989e-ea709e158ec1,,released,Fluorouracil,1,2023-02-27T12:05:25.583371-06:00,Chemotherapy,Residual Disease,
HCM-WCMC-0494-C16,858a84e1-002b-451c-a2dc-cf5673f08992,af559a9c-9422-4239-a671-eeb7c357bc10,155.0,Adjuvant,121.0,2023-07-13T10:35:44.371881-05:00,HCM-WCMC-0494-C16_treatment9,8d3b317d-d5d7-4130-aaed-dd4209f880e3,,released,,1,2023-02-27T12:05:25.583371-06:00,"Radiation Therapy, NOS",Residual Disease,
HCM-WCMC-0494-C16,858a84e1-002b-451c-a2dc-cf5673f08992,af559a9c-9422-4239-a671-eeb7c357bc10,190.0,Adjuvant,95.0,2023-07-13T10:35:44.371881-05:00,HCM-WCMC-0494-C16_treatment4,d9c953e9-29ab-4398-85da-c422ad5fefbc,,released,,1,2023-02-27T12:05:25.583371-06:00,Chemotherapy,Residual Disease,FU-LV regimen
HCM-WCMC-0494-C16,858a84e1-002b-451c-a2dc-cf5673f08992,af559a9c-9422-4239-a671-eeb7c357bc10,,,44.0,2023-07-13T10:35:44.371881-05:00,HCM-WCMC-0494-C16_treatment7,feeaeb44-a452-42ea-952a-59289c048358,,released,,1,2023-02-27T12:05:25.583371-06:00,"Surgery, NOS",Initial Diagnosis,
HCM-CSHL-0665-C24,85defb91-94b6-4f5e-b4b4-3d857a429ab3,d8615033-b394-4242-bfaa-e8f422fe9e47,214.0,Adjuvant,103.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0665-C24_treatment2,099d0756-82ff-44d6-9e11-76ff2e1e7d5b,,released,Capecitabine,1,2021-12-21T14:16:43.785688-06:00,Chemotherapy,Residual Disease,
HCM-CSHL-0665-C24,85defb91-94b6-4f5e-b4b4-3d857a429ab3,d8615033-b394-4242-bfaa-e8f422fe9e47,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0665-C24_treatment6,4a52f505-0db4-463f-8b9a-5ec6e9991ec5,,released,,0,2021-12-21T14:16:43.785688-06:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-CSHL-0665-C24,85defb91-94b6-4f5e-b4b4-3d857a429ab3,d8615033-b394-4242-bfaa-e8f422fe9e47,,Neoadjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0665-C24_treatment,62bf0f84-9c01-4696-91e4-7c4159287ecd,,released,,0,2021-12-21T14:16:43.785688-06:00,,,
HCM-CSHL-0665-C24,85defb91-94b6-4f5e-b4b4-3d857a429ab3,d8615033-b394-4242-bfaa-e8f422fe9e47,,,-8.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0665-C24_treatment7,652a8b11-ac5e-4653-8f58-48be13550edc,,released,,1,2021-12-21T14:16:43.785688-06:00,"Surgery, NOS",Initial Diagnosis,
HCM-CSHL-0665-C24,85defb91-94b6-4f5e-b4b4-3d857a429ab3,d8615033-b394-4242-bfaa-e8f422fe9e47,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0665-C24_treatment5,6551c8fa-0780-40ea-8783-7bf75f3018c9,,released,,0,2021-12-21T14:16:43.785688-06:00,Hormone Therapy,Residual Disease,
HCM-CSHL-0665-C24,85defb91-94b6-4f5e-b4b4-3d857a429ab3,d8615033-b394-4242-bfaa-e8f422fe9e47,,Adjuvant,367.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0665-C24_treatment3,81740285-d8ba-4ed1-b124-d03b8b8e2534,Treatment Ongoing,released,Oxaliplatin,1,2021-12-21T14:16:43.785688-06:00,Chemotherapy,Residual Disease,
HCM-CSHL-0665-C24,85defb91-94b6-4f5e-b4b4-3d857a429ab3,d8615033-b394-4242-bfaa-e8f422fe9e47,,Adjuvant,367.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0665-C24_treatment4,81e750ba-73c1-4d73-aa73-b5cecbf0423c,Treatment Ongoing,released,Capecitabine,1,2021-12-21T14:16:43.785688-06:00,Chemotherapy,Residual Disease,
HCM-CSHL-0665-C24,85defb91-94b6-4f5e-b4b4-3d857a429ab3,d8615033-b394-4242-bfaa-e8f422fe9e47,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0665-C24_treatment8,e38f62d8-c01f-421d-9676-04de4f3d4cff,,released,,0,2021-12-21T14:16:43.785688-06:00,Targeted Molecular Therapy,Residual Disease,
HCM-CSHL-0665-C24,85defb91-94b6-4f5e-b4b4-3d857a429ab3,d8615033-b394-4242-bfaa-e8f422fe9e47,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0665-C24_treatment9,f4c765bd-b852-4d0f-8458-fcf035626c80,,released,,0,2021-12-21T14:16:43.785688-06:00,"Radiation Therapy, NOS",Residual Disease,
HCM-BROD-0830-C71,85f48da8-16cc-4e6f-9f1b-2eaed60f93d8,3beedeef-9cc3-44f9-8618-52f7c423d223,,Adjuvant,,2023-03-13T12:51:50.849462-05:00,HCM-BROD-0830-C71_treatment3,91c125c4-d26c-4cb7-9bc2-0965bbde7bbf,,released,,0,2021-12-21T13:54:14.357230-06:00,"Pharmaceutical Therapy, NOS",Residual Disease,
HCM-BROD-0830-C71,85f48da8-16cc-4e6f-9f1b-2eaed60f93d8,3beedeef-9cc3-44f9-8618-52f7c423d223,,Neoadjuvant,,2023-02-22T07:39:25.979291-06:00,HCM-BROD-0830-C71_treatment,96042a14-4ae8-4717-84b1-bb9f6220e4ea,,released,,0,2021-12-21T13:54:14.357230-06:00,,,
HCM-BROD-0830-C71,85f48da8-16cc-4e6f-9f1b-2eaed60f93d8,3beedeef-9cc3-44f9-8618-52f7c423d223,,Adjuvant,,2023-03-13T12:51:50.849462-05:00,HCM-BROD-0830-C71_treatment4,bdda715c-bf8d-483e-9644-584ae15fbdca,,released,,0,2021-12-21T13:54:14.357230-06:00,"Radiation Therapy, NOS",Residual Disease,
HCM-BROD-0830-C71,85f48da8-16cc-4e6f-9f1b-2eaed60f93d8,3beedeef-9cc3-44f9-8618-52f7c423d223,,,0.0,2023-03-13T12:51:50.849462-05:00,HCM-BROD-0830-C71_treatment2,de874f16-d631-42a2-997b-53e988a289f8,,released,,1,2021-12-21T13:54:14.357230-06:00,"Surgery, NOS",Initial Diagnosis,
HCM-BROD-0830-C71,85f48da8-16cc-4e6f-9f1b-2eaed60f93d8,e150df26-fa11-463e-86da-c45f24a66a89,328.0,Maintenance Therapy,202.0,2023-03-14T11:40:17.645275-05:00,HCM-BROD-0830-C71_treatment5,7921d43c-51fb-4089-95ec-efa450ffc330,Progressive Disease,released,Temozolomide,1,2023-03-13T12:51:50.849462-05:00,,,
HCM-BROD-0420-C71,864de84d-7936-4bfd-89ff-b552a9d470aa,ea678a7c-2a3a-4e03-8eed-f8ca208ed0b6,,,0.0,2023-02-27T11:36:21.099672-06:00,HCM-BROD-0420-C71_treatment5,1e194a40-965b-429b-ab1e-98110cd051e5,,released,,1,2020-08-31T19:03:03.372481-05:00,"Surgery, NOS",Initial Diagnosis,
HCM-BROD-0420-C71,864de84d-7936-4bfd-89ff-b552a9d470aa,ea678a7c-2a3a-4e03-8eed-f8ca208ed0b6,,Adjuvant,,2021-07-12T12:25:55.528644-05:00,HCM-BROD-0420-C71_treatment4,323bd2dc-740c-4a0e-b56c-1497ea81ab2e,,released,,0,2020-08-31T19:03:03.372481-05:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-BROD-0420-C71,864de84d-7936-4bfd-89ff-b552a9d470aa,ea678a7c-2a3a-4e03-8eed-f8ca208ed0b6,,Neoadjuvant,36.0,2021-07-12T12:25:55.528644-05:00,HCM-BROD-0420-C71_treatment2,5017fc3b-3b92-4971-8501-09b9165b6f37,,released,,1,2020-08-31T19:03:03.372481-05:00,"Radiation Therapy, NOS",,
HCM-BROD-0420-C71,864de84d-7936-4bfd-89ff-b552a9d470aa,ea678a7c-2a3a-4e03-8eed-f8ca208ed0b6,283.0,Adjuvant,222.0,2021-07-12T12:25:55.528644-05:00,HCM-BROD-0420-C71_treatment3,508a9153-9660-4c33-a6d6-b0ac00a63295,,released,Temozolomide,1,2020-08-31T19:03:03.372481-05:00,Chemotherapy,Residual Disease,
HCM-BROD-0420-C71,864de84d-7936-4bfd-89ff-b552a9d470aa,ea678a7c-2a3a-4e03-8eed-f8ca208ed0b6,,Neoadjuvant,36.0,2021-07-12T12:25:55.528644-05:00,HCM-BROD-0420-C71_treatment,664d7d0c-bca9-48dc-9cba-e0985b7a4acf,,released,Temozolomide,1,2020-08-31T19:03:03.372481-05:00,Chemotherapy,,
HCM-BROD-0420-C71,864de84d-7936-4bfd-89ff-b552a9d470aa,ea678a7c-2a3a-4e03-8eed-f8ca208ed0b6,,Adjuvant,,2021-07-12T12:25:55.528644-05:00,HCM-BROD-0420-C71_treatment6,98ce7ca9-9e86-415f-8142-a37c44520878,,released,,0,2020-08-31T19:03:03.372481-05:00,Targeted Molecular Therapy,Residual Disease,
HCM-BROD-0420-C71,864de84d-7936-4bfd-89ff-b552a9d470aa,ea678a7c-2a3a-4e03-8eed-f8ca208ed0b6,88.0,Adjuvant,36.0,2021-07-12T12:25:55.528644-05:00,HCM-BROD-0420-C71_treatment7,dd56bc11-3225-4fe1-82c4-b97a49ebcc58,,released,,1,2020-08-31T19:03:03.372481-05:00,"Radiation Therapy, NOS",Residual Disease,
HCM-SANG-0532-C20,8747f56e-c1bf-4c1e-bb1c-02d46ae597db,bc0a5c9b-2d16-4942-9743-0564d4fb12f1,,Neoadjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-SANG-0532-C20_treatment3,0f148d63-fff6-4694-b584-bbcb4d73b712,,released,,1,2023-02-27T11:27:03.619777-06:00,"Radiation, 2D Conventional",,
HCM-SANG-0532-C20,8747f56e-c1bf-4c1e-bb1c-02d46ae597db,bc0a5c9b-2d16-4942-9743-0564d4fb12f1,,Neoadjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-SANG-0532-C20_treatment2,374b5aee-0a01-4df6-9851-b22f08783415,,released,Oxaliplatin,1,2023-02-27T11:27:03.619777-06:00,Chemotherapy,,
HCM-SANG-0532-C20,8747f56e-c1bf-4c1e-bb1c-02d46ae597db,bc0a5c9b-2d16-4942-9743-0564d4fb12f1,,Neoadjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-SANG-0532-C20_treatment,752b8040-6189-448a-a34c-7b232b893d34,,released,Capecitabine,1,2023-02-27T11:27:03.619777-06:00,Chemotherapy,,
HCM-CSHL-0821-C19,87653787-214f-4c79-af6d-087cb0240521,5ed84145-ca40-4e4f-8361-9d0ba4d37b81,250.0,Maintenance Therapy,55.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0821-C19_treatment13,0eb89dd6-7261-4233-ba71-c08f9dae3de8,Stable Disease,released,Oxaliplatin,1,2021-12-21T14:31:19.659505-06:00,,,
HCM-CSHL-0821-C19,87653787-214f-4c79-af6d-087cb0240521,5ed84145-ca40-4e4f-8361-9d0ba4d37b81,250.0,Maintenance Therapy,55.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0821-C19_treatment14,21d478df-1cd8-4782-b52b-f1015936d455,Stable Disease,released,,1,2021-12-21T14:31:19.659505-06:00,,,FOLFOX
HCM-CSHL-0821-C19,87653787-214f-4c79-af6d-087cb0240521,5ed84145-ca40-4e4f-8361-9d0ba4d37b81,250.0,Maintenance Therapy,55.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0821-C19_treatment12,71e844e1-8cd9-40de-b2dc-a4b2cd6b04e5,Stable Disease,released,Fluorouracil,1,2021-12-21T14:31:19.659505-06:00,,,
HCM-CSHL-0821-C19,87653787-214f-4c79-af6d-087cb0240521,5ed84145-ca40-4e4f-8361-9d0ba4d37b81,250.0,Maintenance Therapy,55.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0821-C19_treatment11,7b8e8ac4-ecb3-4b4f-b473-5e5aae4c6792,Stable Disease,released,Leucovorin Calcium,1,2021-12-21T14:31:19.659505-06:00,,,
HCM-CSHL-0821-C19,87653787-214f-4c79-af6d-087cb0240521,c319566f-35d5-4ee3-8bad-54003b198d44,250.0,Adjuvant,55.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0821-C19_treatment5,10a38db7-60e7-4ead-85a4-b6963b1d476e,,released,,1,2021-12-21T14:31:19.659505-06:00,Chemotherapy,Residual Disease,FOLFOX
HCM-CSHL-0821-C19,87653787-214f-4c79-af6d-087cb0240521,c319566f-35d5-4ee3-8bad-54003b198d44,250.0,Adjuvant,55.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0821-C19_treatment3,1a06a35a-2eec-426e-b111-0c8647371d28,,released,Fluorouracil,1,2021-12-21T14:31:19.659505-06:00,Chemotherapy,Residual Disease,
HCM-CSHL-0821-C19,87653787-214f-4c79-af6d-087cb0240521,c319566f-35d5-4ee3-8bad-54003b198d44,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0821-C19_treatment10,1d93f571-83d5-4675-a54c-e99dfa3574fb,,released,,0,2021-12-21T14:31:19.659505-06:00,"Radiation Therapy, NOS",Residual Disease,
HCM-CSHL-0821-C19,87653787-214f-4c79-af6d-087cb0240521,c319566f-35d5-4ee3-8bad-54003b198d44,,,1533.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0821-C19_treatment8,3883739e-0c74-4132-961c-2d1a95cce6cd,,released,,1,2021-12-21T14:31:19.659505-06:00,"Surgery, NOS",Initial Diagnosis,
HCM-CSHL-0821-C19,87653787-214f-4c79-af6d-087cb0240521,c319566f-35d5-4ee3-8bad-54003b198d44,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0821-C19_treatment6,58046ae6-3fe5-4aae-ba93-4dd4d3abc5ed,,released,,0,2021-12-21T14:31:19.659505-06:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-CSHL-0821-C19,87653787-214f-4c79-af6d-087cb0240521,c319566f-35d5-4ee3-8bad-54003b198d44,,Neoadjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0821-C19_treatment,5a9c91e3-57b2-402b-83e7-19b19ab87a11,,released,,0,2021-12-21T14:31:19.659505-06:00,,,
HCM-CSHL-0821-C19,87653787-214f-4c79-af6d-087cb0240521,c319566f-35d5-4ee3-8bad-54003b198d44,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0821-C19_treatment9,79c9c247-1ae0-42c2-b7fd-30de5314b1bb,,released,,0,2021-12-21T14:31:19.659505-06:00,Targeted Molecular Therapy,Residual Disease,
HCM-CSHL-0821-C19,87653787-214f-4c79-af6d-087cb0240521,c319566f-35d5-4ee3-8bad-54003b198d44,,,15.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0821-C19_treatment7,b90f204e-9e3b-40ad-9247-0bcbf4d29cd9,,released,,1,2021-12-21T14:31:19.659505-06:00,"Surgery, NOS",Initial Diagnosis,
HCM-CSHL-0821-C19,87653787-214f-4c79-af6d-087cb0240521,c319566f-35d5-4ee3-8bad-54003b198d44,250.0,Adjuvant,55.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0821-C19_treatment4,c7a3c698-ea3a-47ec-9382-c44bd7ac7eab,,released,Oxaliplatin,1,2021-12-21T14:31:19.659505-06:00,Chemotherapy,Residual Disease,
HCM-CSHL-0821-C19,87653787-214f-4c79-af6d-087cb0240521,c319566f-35d5-4ee3-8bad-54003b198d44,250.0,Adjuvant,55.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0821-C19_treatment2,e8d3d475-1a82-4bd0-a69f-b99622253dfa,,released,Leucovorin Calcium,1,2021-12-21T14:31:19.659505-06:00,Chemotherapy,Residual Disease,
HCM-BROD-0223-C43,87804fe2-1c07-4bcc-80c6-d225e4089ba6,6b3960fc-a3d1-47a2-bc7a-8a565ea8623b,545.0,Maintenance Therapy,545.0,2021-01-06T22:55:10.531130-06:00,HCM-BROD-0223-C43_treatment8,0d75ec22-3ab2-4121-bd90-21eb3701cd58,Stable Disease,released,,1,2020-10-08T12:07:53.915718-05:00,,,
HCM-BROD-0223-C43,87804fe2-1c07-4bcc-80c6-d225e4089ba6,b31cc85f-f637-4b9b-889f-78d472b98255,,Adjuvant,,2021-01-06T22:55:10.531130-06:00,HCM-BROD-0223-C43_treatment7,127e196e-72a1-42ab-ac3a-7740fdc5b70c,,released,,0,2020-10-08T12:07:53.915718-05:00,"Radiation Therapy, NOS",Residual Disease,
HCM-BROD-0223-C43,87804fe2-1c07-4bcc-80c6-d225e4089ba6,b31cc85f-f637-4b9b-889f-78d472b98255,,Adjuvant,,2021-01-06T22:55:10.531130-06:00,HCM-BROD-0223-C43_treatment3,1342ab49-f196-406f-98ba-d3c9a7fb90de,,released,,0,2020-06-15T13:39:37.499745-05:00,Hormone Therapy,Residual Disease,
HCM-BROD-0223-C43,87804fe2-1c07-4bcc-80c6-d225e4089ba6,b31cc85f-f637-4b9b-889f-78d472b98255,,Adjuvant,,2021-01-06T22:55:10.531130-06:00,HCM-BROD-0223-C43_treatment2,1832bc62-8aed-44ef-a55c-12bee451ad72,,released,,0,2020-06-15T13:39:37.499745-05:00,Chemotherapy,Residual Disease,
HCM-BROD-0223-C43,87804fe2-1c07-4bcc-80c6-d225e4089ba6,b31cc85f-f637-4b9b-889f-78d472b98255,,Adjuvant,,2021-01-06T22:55:10.531130-06:00,HCM-BROD-0223-C43_treatment6,1a34aa5f-7536-47ef-84d3-ed7830cab78c,,released,,0,2020-06-15T13:39:37.499745-05:00,Targeted Molecular Therapy,Residual Disease,
HCM-BROD-0223-C43,87804fe2-1c07-4bcc-80c6-d225e4089ba6,b31cc85f-f637-4b9b-889f-78d472b98255,,Neoadjuvant,545.0,2021-01-06T22:55:10.531130-06:00,HCM-BROD-0223-C43_treatment,8674057b-75f6-40a8-8765-e6f4ca837038,,released,,1,2020-06-15T13:39:37.499745-05:00,Stereotactic Radiosurgery,,
HCM-BROD-0223-C43,87804fe2-1c07-4bcc-80c6-d225e4089ba6,b31cc85f-f637-4b9b-889f-78d472b98255,,,-18.0,2023-02-27T12:21:31.406431-06:00,HCM-BROD-0223-C43_treatment5,d681d715-58b6-488e-9c4e-b3cf88754d3c,,released,,1,2020-06-15T13:39:37.499745-05:00,"Surgery, NOS",Initial Diagnosis,
HCM-BROD-0223-C43,87804fe2-1c07-4bcc-80c6-d225e4089ba6,b31cc85f-f637-4b9b-889f-78d472b98255,954.0,Adjuvant,647.0,2021-01-06T22:55:10.531130-06:00,HCM-BROD-0223-C43_treatment4,e0d4ba8b-944e-410a-ac14-57ff1d85db59,,released,Pembrolizumab,1,2020-06-15T13:39:37.499745-05:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-BROD-0595-C43,87cd2ae0-d743-4c63-bbb7-694c8d12a21a,42061609-7b24-460a-b6da-6e1355e18e0e,2111.0,Maintenance Therapy,15.0,2021-07-12T12:25:55.528644-05:00,HCM-BROD-0595-C43_treatment12,1a27a89f-2c35-4ed0-aa61-85d2c94bd521,Treatment Ongoing,released,Vemurafenib,1,2021-04-20T10:33:00.663172-05:00,,,
HCM-BROD-0595-C43,87cd2ae0-d743-4c63-bbb7-694c8d12a21a,42061609-7b24-460a-b6da-6e1355e18e0e,2111.0,Maintenance Therapy,15.0,2021-07-12T12:25:55.528644-05:00,HCM-BROD-0595-C43_treatment11,fe54c5fd-d9ea-4bc3-b9f4-a0b26d8362c0,Treatment Ongoing,released,Pembrolizumab,1,2021-04-20T10:33:00.663172-05:00,,,
HCM-BROD-0595-C43,87cd2ae0-d743-4c63-bbb7-694c8d12a21a,ca612bad-38fb-49fc-a6b0-912657f58a6c,,Adjuvant,,2021-07-12T12:25:55.528644-05:00,HCM-BROD-0595-C43_treatment3,3f166e0b-a787-4208-84a6-57164943ee43,,released,,0,2021-04-20T10:33:00.663172-05:00,Chemotherapy,Residual Disease,
HCM-BROD-0595-C43,87cd2ae0-d743-4c63-bbb7-694c8d12a21a,ca612bad-38fb-49fc-a6b0-912657f58a6c,2133.0,Adjuvant,237.0,2021-07-12T12:25:55.528644-05:00,HCM-BROD-0595-C43_treatment5,491e7d3a-5a7e-47e0-b6c8-6464e6f39152,,released,Pembrolizumab,1,2021-04-20T10:33:00.663172-05:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-BROD-0595-C43,87cd2ae0-d743-4c63-bbb7-694c8d12a21a,ca612bad-38fb-49fc-a6b0-912657f58a6c,2482.0,Adjuvant,2425.0,2021-07-12T12:25:55.528644-05:00,HCM-BROD-0595-C43_treatment6,842cb0df-358a-4c34-929c-fe5226d3dec2,,released,Nivolumab,1,2021-04-20T10:33:00.663172-05:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-BROD-0595-C43,87cd2ae0-d743-4c63-bbb7-694c8d12a21a,ca612bad-38fb-49fc-a6b0-912657f58a6c,,Neoadjuvant,,2021-07-12T12:25:55.528644-05:00,HCM-BROD-0595-C43_treatment,852c994e-90bb-46dc-a293-0e4eb58420c0,,released,,unknown,2021-04-20T10:33:00.663172-05:00,"Pharmaceutical Therapy, NOS",,
HCM-BROD-0595-C43,87cd2ae0-d743-4c63-bbb7-694c8d12a21a,ca612bad-38fb-49fc-a6b0-912657f58a6c,,,,2023-02-27T11:18:13.660494-06:00,HCM-BROD-0595-C43_treatment7,96d9ead7-09ff-49ae-b13d-f74c23caa35c,,released,,0,2021-04-20T10:33:00.663172-05:00,"Surgery, NOS",Initial Diagnosis,
HCM-BROD-0595-C43,87cd2ae0-d743-4c63-bbb7-694c8d12a21a,ca612bad-38fb-49fc-a6b0-912657f58a6c,,Neoadjuvant,,2021-07-12T12:25:55.528644-05:00,HCM-BROD-0595-C43_treatment2,c2e64815-516d-4c80-802f-1514291ccf08,,released,,unknown,2021-04-20T10:33:00.663172-05:00,"Radiation Therapy, NOS",,
HCM-BROD-0595-C43,87cd2ae0-d743-4c63-bbb7-694c8d12a21a,ca612bad-38fb-49fc-a6b0-912657f58a6c,,Adjuvant,,2021-07-12T12:25:55.528644-05:00,HCM-BROD-0595-C43_treatment4,d3a1b9fb-dbc8-4c9b-80b2-4973023b4fab,,released,,0,2021-04-20T10:33:00.663172-05:00,Hormone Therapy,Residual Disease,
HCM-BROD-0595-C43,87cd2ae0-d743-4c63-bbb7-694c8d12a21a,ca612bad-38fb-49fc-a6b0-912657f58a6c,2291.0,Adjuvant,2278.0,2021-07-12T12:25:55.528644-05:00,HCM-BROD-0595-C43_treatment10,d7231eef-d5b7-4573-bd3a-b09ee7da1755,,released,,1,2021-04-20T10:33:00.663172-05:00,"Radiation, 2D Conventional",Residual Disease,
HCM-BROD-0595-C43,87cd2ae0-d743-4c63-bbb7-694c8d12a21a,ca612bad-38fb-49fc-a6b0-912657f58a6c,3006.0,Adjuvant,2524.0,2021-07-12T12:25:55.528644-05:00,HCM-BROD-0595-C43_treatment8,dcbee059-04af-4cc2-9506-e1f86e5327e8,Treatment Ongoing,released,Trametinib,1,2021-04-20T10:33:00.663172-05:00,Targeted Molecular Therapy,Residual Disease,
HCM-BROD-0595-C43,87cd2ae0-d743-4c63-bbb7-694c8d12a21a,ca612bad-38fb-49fc-a6b0-912657f58a6c,3006.0,Adjuvant,2524.0,2021-07-12T12:25:55.528644-05:00,HCM-BROD-0595-C43_treatment9,e12bf93e-0886-488d-bfc1-ef47775757c5,Treatment Ongoing,released,Dabrafenib,1,2021-04-20T10:33:00.663172-05:00,Targeted Molecular Therapy,Residual Disease,
HCM-BROD-0455-C71,881496db-88ed-4d7c-a5e7-614da6977c10,874f8d45-ec60-4199-9fa8-68538900ecd3,,Neoadjuvant,,2023-02-22T07:39:25.979291-06:00,HCM-BROD-0455-C71_treatment,192b4bfe-6930-46ff-8c1b-4d5c5fc5348d,,released,,0,2020-06-15T13:21:16.318168-05:00,,,
HCM-BROD-0455-C71,881496db-88ed-4d7c-a5e7-614da6977c10,874f8d45-ec60-4199-9fa8-68538900ecd3,,,-3.0,2023-02-27T11:32:22.339496-06:00,HCM-BROD-0455-C71_treatment4,45ba35fc-6987-4094-9be0-5f053624eee2,,released,,1,2020-06-15T13:21:16.318168-05:00,"Surgery, NOS",Initial Diagnosis,
HCM-BROD-0455-C71,881496db-88ed-4d7c-a5e7-614da6977c10,874f8d45-ec60-4199-9fa8-68538900ecd3,0.0,Adjuvant,0.0,2023-02-22T07:39:25.979291-06:00,HCM-BROD-0455-C71_treatment5,5e38427d-cd1e-43ae-94d2-70b3d0335af5,,released,Bevacizumab,1,2020-06-15T13:21:16.318168-05:00,Targeted Molecular Therapy,Residual Disease,
HCM-BROD-0455-C71,881496db-88ed-4d7c-a5e7-614da6977c10,874f8d45-ec60-4199-9fa8-68538900ecd3,0.0,Adjuvant,0.0,2023-02-22T07:39:25.979291-06:00,HCM-BROD-0455-C71_treatment6,8a57f6c6-8d81-46cf-a62d-fdf00cf35403,,released,,1,2020-06-15T13:21:16.318168-05:00,"Radiation Therapy, NOS",Residual Disease,
HCM-BROD-0455-C71,881496db-88ed-4d7c-a5e7-614da6977c10,874f8d45-ec60-4199-9fa8-68538900ecd3,0.0,Adjuvant,0.0,2023-02-22T07:39:25.979291-06:00,HCM-BROD-0455-C71_treatment2,d4de57f9-927e-4319-a299-3283809ea471,,released,Temozolomide,1,2020-06-15T13:21:16.318168-05:00,Chemotherapy,Residual Disease,
HCM-BROD-0455-C71,881496db-88ed-4d7c-a5e7-614da6977c10,874f8d45-ec60-4199-9fa8-68538900ecd3,,Adjuvant,,2023-02-22T07:39:25.979291-06:00,HCM-BROD-0455-C71_treatment3,d863ceaa-923f-442e-827b-b741c82dc699,,released,,0,2020-06-15T13:21:16.318168-05:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-BROD-0102-C71,88335768-5a27-4b29-b3bc-72e53b87015b,0f5fbda8-274e-4b09-9784-f0a5f066b7f7,,Adjuvant,,2023-02-22T07:39:25.979291-06:00,HCM-BROD-0102-C71_treatment4,02085b74-d30d-45a1-b958-ace29a5732bb,,released,,0,2020-09-27T10:26:06.680328-05:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-BROD-0102-C71,88335768-5a27-4b29-b3bc-72e53b87015b,0f5fbda8-274e-4b09-9784-f0a5f066b7f7,720.0,Adjuvant,526.0,2023-02-22T07:39:25.979291-06:00,HCM-BROD-0102-C71_treatment2,286245be-c930-443f-89b9-a2b04ae370b3,,released,Irinotecan,1,2020-09-27T10:26:06.680328-05:00,Chemotherapy,Residual Disease,
HCM-BROD-0102-C71,88335768-5a27-4b29-b3bc-72e53b87015b,0f5fbda8-274e-4b09-9784-f0a5f066b7f7,963.0,Adjuvant,916.0,2023-02-22T07:39:25.979291-06:00,HCM-BROD-0102-C71_treatment8,2d20b7d1-42ae-4763-b2b5-e68cd1755ead,,released,Bevacizumab,1,2020-09-27T10:26:06.680328-05:00,Targeted Molecular Therapy,Residual Disease,
HCM-BROD-0102-C71,88335768-5a27-4b29-b3bc-72e53b87015b,0f5fbda8-274e-4b09-9784-f0a5f066b7f7,,Neoadjuvant,,2023-02-22T07:39:25.979291-06:00,HCM-BROD-0102-C71_treatment,33a73ae6-cd45-4b53-8f28-a5951bde73f9,,released,,0,2019-04-04T14:44:46.021396-05:00,,,
HCM-BROD-0102-C71,88335768-5a27-4b29-b3bc-72e53b87015b,0f5fbda8-274e-4b09-9784-f0a5f066b7f7,720.0,Adjuvant,512.0,2023-02-22T07:39:25.979291-06:00,HCM-BROD-0102-C71_treatment6,48dcba64-2333-4c90-8bb5-be4c4fb323e8,,released,Bevacizumab,1,2020-09-27T10:26:06.680328-05:00,Targeted Molecular Therapy,Residual Disease,
HCM-BROD-0102-C71,88335768-5a27-4b29-b3bc-72e53b87015b,0f5fbda8-274e-4b09-9784-f0a5f066b7f7,,,-12.0,2023-02-27T12:11:05.017087-06:00,HCM-BROD-0102-C71_treatment5,6b94952f-cb30-4a9e-8b55-ba9f5f773685,,released,,1,2020-09-27T10:26:06.680328-05:00,"Surgery, NOS",Initial Diagnosis,
HCM-BROD-0102-C71,88335768-5a27-4b29-b3bc-72e53b87015b,0f5fbda8-274e-4b09-9784-f0a5f066b7f7,837.0,Adjuvant,804.0,2023-02-22T07:39:25.979291-06:00,HCM-BROD-0102-C71_treatment3,6f59f4e0-cacd-45dc-9955-0f614218df45,,released,Carboplatin,1,2020-09-27T10:26:06.680328-05:00,Chemotherapy,Residual Disease,
HCM-BROD-0102-C71,88335768-5a27-4b29-b3bc-72e53b87015b,0f5fbda8-274e-4b09-9784-f0a5f066b7f7,895.0,Adjuvant,776.0,2023-02-22T07:39:25.979291-06:00,HCM-BROD-0102-C71_treatment7,a6834594-8c35-4f7e-ba3b-9afa6644c822,,released,Bevacizumab,1,2020-09-27T10:26:06.680328-05:00,Targeted Molecular Therapy,Residual Disease,
HCM-BROD-0102-C71,88335768-5a27-4b29-b3bc-72e53b87015b,0f5fbda8-274e-4b09-9784-f0a5f066b7f7,,Adjuvant,,2023-02-22T07:39:25.979291-06:00,HCM-BROD-0102-C71_treatment9,d58acf6f-a29a-4f24-a0b5-267f13e2c2a9,,released,,0,2020-09-27T10:26:06.680328-05:00,"Radiation Therapy, NOS",Residual Disease,
HCM-CSHL-0814-C54,8853968f-f813-40ee-9084-cfd2e4ac854d,6be8124e-e2cb-46e0-934f-69c84f5441a0,154.0,Adjuvant,42.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0814-C54_treatment3,19649697-fc3d-4b15-b13c-7c43ddfb0509,,released,Paclitaxel,1,2022-07-14T11:04:20.216364-05:00,Chemotherapy,Residual Disease,
HCM-CSHL-0814-C54,8853968f-f813-40ee-9084-cfd2e4ac854d,6be8124e-e2cb-46e0-934f-69c84f5441a0,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0814-C54_treatment5,1e2f638b-c6ef-4978-aace-984f82e0cf72,,released,,0,2022-07-14T11:04:20.216364-05:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-CSHL-0814-C54,8853968f-f813-40ee-9084-cfd2e4ac854d,6be8124e-e2cb-46e0-934f-69c84f5441a0,230.0,Adjuvant,191.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0814-C54_treatment8,2001a089-6247-4b3e-a694-d3e68259cc8f,,released,,1,2022-07-14T11:04:20.216364-05:00,"Radiation, Intensity-Modulated Radiotherapy",Residual Disease,
HCM-CSHL-0814-C54,8853968f-f813-40ee-9084-cfd2e4ac854d,6be8124e-e2cb-46e0-934f-69c84f5441a0,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0814-C54_treatment7,481b46ff-871f-4072-b838-5ec6caf0933b,,released,,0,2022-07-14T11:04:20.216364-05:00,Targeted Molecular Therapy,Residual Disease,
HCM-CSHL-0814-C54,8853968f-f813-40ee-9084-cfd2e4ac854d,6be8124e-e2cb-46e0-934f-69c84f5441a0,,,0.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0814-C54_treatment6,6123527f-b07a-4b6b-9f4c-c1f31d18b80f,,released,,1,2022-07-14T11:04:20.216364-05:00,"Surgery, NOS",Initial Diagnosis,
HCM-CSHL-0814-C54,8853968f-f813-40ee-9084-cfd2e4ac854d,6be8124e-e2cb-46e0-934f-69c84f5441a0,154.0,Adjuvant,42.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0814-C54_treatment2,91c8fa62-e4f6-4897-b236-7891341a9bae,,released,Carboplatin,1,2022-07-14T11:04:20.216364-05:00,Chemotherapy,Residual Disease,
HCM-CSHL-0814-C54,8853968f-f813-40ee-9084-cfd2e4ac854d,6be8124e-e2cb-46e0-934f-69c84f5441a0,,Neoadjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0814-C54_treatment,d36ed921-b7ce-405d-ae5a-3470d191f8fc,,released,,0,2022-07-14T11:04:20.216364-05:00,,,
HCM-CSHL-0814-C54,8853968f-f813-40ee-9084-cfd2e4ac854d,6be8124e-e2cb-46e0-934f-69c84f5441a0,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0814-C54_treatment4,f92f15e1-5bac-41b2-8c11-fac0836a3455,,released,,0,2022-07-14T11:04:20.216364-05:00,Hormone Therapy,Residual Disease,
HCM-SANG-0778-C25,886d8079-9a5d-40bd-89ea-6ed14ea504b0,4ff2aefd-b99b-4fe3-b45f-33ab3955e9b1,,Neoadjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-SANG-0778-C25_treatment,c80e00ad-5fa2-4968-b863-1e33254988af,,released,,0,2023-02-27T11:54:18.512073-06:00,,,
HCM-BROD-0926-C16,88808858-b4db-4ec6-a505-10339b498dcf,02673a5d-e643-46da-8db6-686e552cc87c,330.0,Maintenance Therapy,16.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0926-C16_treatment17,352c1141-6bb9-4dd0-b916-d17ff94ed47a,Progressive Disease,released,Cisplatin,1,2021-12-21T13:58:08.825531-06:00,,,
HCM-BROD-0926-C16,88808858-b4db-4ec6-a505-10339b498dcf,02673a5d-e643-46da-8db6-686e552cc87c,330.0,Maintenance Therapy,16.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0926-C16_treatment16,44d75c3e-ce65-4c05-b238-b1394ecd1f95,Progressive Disease,released,Oxaliplatin,1,2021-12-21T13:58:08.825531-06:00,,,
HCM-BROD-0926-C16,88808858-b4db-4ec6-a505-10339b498dcf,02673a5d-e643-46da-8db6-686e552cc87c,330.0,Maintenance Therapy,16.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0926-C16_treatment15,4b1c59bd-16e3-4cf6-8adb-19028e525223,Progressive Disease,released,Docetaxel,1,2021-12-21T13:58:08.825531-06:00,,,
HCM-BROD-0926-C16,88808858-b4db-4ec6-a505-10339b498dcf,02673a5d-e643-46da-8db6-686e552cc87c,330.0,Maintenance Therapy,16.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0926-C16_treatment18,621aa3ea-d9a7-4493-96b1-d9847c4a16f0,Progressive Disease,released,Pembrolizumab,1,2021-12-21T13:58:08.825531-06:00,,,
HCM-BROD-0926-C16,88808858-b4db-4ec6-a505-10339b498dcf,02673a5d-e643-46da-8db6-686e552cc87c,330.0,Maintenance Therapy,16.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0926-C16_treatment13,8902c30e-fdf1-45f3-b87b-7a9899b8eaa0,Progressive Disease,released,Irinotecan,1,2021-12-21T13:58:08.825531-06:00,,,
HCM-BROD-0926-C16,88808858-b4db-4ec6-a505-10339b498dcf,02673a5d-e643-46da-8db6-686e552cc87c,330.0,Maintenance Therapy,16.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0926-C16_treatment19,cb425be4-6861-48d1-a380-8484099a0156,Progressive Disease,released,Fluorouracil,1,2021-12-21T13:58:08.825531-06:00,,,
HCM-BROD-0926-C16,88808858-b4db-4ec6-a505-10339b498dcf,02673a5d-e643-46da-8db6-686e552cc87c,330.0,Maintenance Therapy,16.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0926-C16_treatment14,f6c1562e-9d8a-4105-becf-7dcf344b0e8c,Progressive Disease,released,Leucovorin,1,2021-12-21T13:58:08.825531-06:00,,,
HCM-BROD-0926-C16,88808858-b4db-4ec6-a505-10339b498dcf,a3c25e99-f5cc-4ee0-8caf-b352686eb071,231.0,Adjuvant,203.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0926-C16_treatment5,132e5503-c95f-4ed0-8359-d6d4240a7e69,,released,Paclitaxel,1,2021-12-21T13:58:08.825531-06:00,Chemotherapy,Residual Disease,
HCM-BROD-0926-C16,88808858-b4db-4ec6-a505-10339b498dcf,a3c25e99-f5cc-4ee0-8caf-b352686eb071,301.0,Adjuvant,244.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0926-C16_treatment8,170b8af1-6851-4b71-9735-0886b456694a,,released,Irinotecan,1,2021-12-21T13:58:08.825531-06:00,Chemotherapy,Residual Disease,
HCM-BROD-0926-C16,88808858-b4db-4ec6-a505-10339b498dcf,a3c25e99-f5cc-4ee0-8caf-b352686eb071,,Neoadjuvant,2.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0926-C16_treatment,223c9ac0-8b25-479b-bf02-2b8a6d2caf3f,,released,Irinotecan,1,2021-12-21T13:58:08.825531-06:00,Chemotherapy,,
HCM-BROD-0926-C16,88808858-b4db-4ec6-a505-10339b498dcf,a3c25e99-f5cc-4ee0-8caf-b352686eb071,330.0,Adjuvant,302.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0926-C16_treatment9,29e7963d-754d-4ad1-a047-77d55a92bf22,Treatment Ongoing,released,Pembrolizumab,1,2021-12-21T13:58:08.825531-06:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-BROD-0926-C16,88808858-b4db-4ec6-a505-10339b498dcf,a3c25e99-f5cc-4ee0-8caf-b352686eb071,,Neoadjuvant,2.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0926-C16_treatment2,4cda280e-6587-4d60-8bb1-7bb547710182,,released,Oxaliplatin,1,2021-12-21T13:58:08.825531-06:00,Chemotherapy,,
HCM-BROD-0926-C16,88808858-b4db-4ec6-a505-10339b498dcf,a3c25e99-f5cc-4ee0-8caf-b352686eb071,,Neoadjuvant,2.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0926-C16_treatment3,69e04a47-f8be-432a-ba6f-882006b3d69a,,released,Leucovorin,1,2021-12-21T13:58:08.825531-06:00,Chemotherapy,,
HCM-BROD-0926-C16,88808858-b4db-4ec6-a505-10339b498dcf,a3c25e99-f5cc-4ee0-8caf-b352686eb071,,Neoadjuvant,2.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0926-C16_treatment4,73249450-7ed2-4704-9f7e-499b08276d9c,,released,Fluorouracil,1,2021-12-21T13:58:08.825531-06:00,Chemotherapy,,
HCM-BROD-0926-C16,88808858-b4db-4ec6-a505-10339b498dcf,a3c25e99-f5cc-4ee0-8caf-b352686eb071,301.0,Adjuvant,244.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0926-C16_treatment7,7ea81be3-324d-4226-8c28-975f26688aca,,released,Docetaxel,1,2021-12-21T13:58:08.825531-06:00,Chemotherapy,Residual Disease,
HCM-BROD-0926-C16,88808858-b4db-4ec6-a505-10339b498dcf,a3c25e99-f5cc-4ee0-8caf-b352686eb071,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0926-C16_treatment12,872a56d9-78ce-4cff-b728-da96163c906c,,released,,0,2021-12-21T13:58:08.825531-06:00,"Radiation Therapy, NOS",Residual Disease,
HCM-BROD-0926-C16,88808858-b4db-4ec6-a505-10339b498dcf,a3c25e99-f5cc-4ee0-8caf-b352686eb071,231.0,Adjuvant,203.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0926-C16_treatment11,8ea0770b-01ea-4521-8e30-3b995207b6f2,,released,Ramucirumab,1,2021-12-21T13:58:08.825531-06:00,Targeted Molecular Therapy,Residual Disease,
HCM-BROD-0926-C16,88808858-b4db-4ec6-a505-10339b498dcf,a3c25e99-f5cc-4ee0-8caf-b352686eb071,,,,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0926-C16_treatment10,ad9609e3-4be3-4e7c-ad5e-4580be69fd0a,,released,,0,2021-12-21T13:58:08.825531-06:00,"Surgery, NOS",Initial Diagnosis,
HCM-BROD-0926-C16,88808858-b4db-4ec6-a505-10339b498dcf,a3c25e99-f5cc-4ee0-8caf-b352686eb071,301.0,Adjuvant,244.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0926-C16_treatment6,c2b99720-a49d-47ee-bba5-9e38df416a51,,released,Cisplatin,1,2021-12-21T13:58:08.825531-06:00,Chemotherapy,Residual Disease,
HCM-CSHL-0802-C67,88aa1634-d51b-4b0e-89bb-086709b24e2b,58774a23-dbfd-494e-9619-76dabe6945c9,,Neoadjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0802-C67_treatment,461fe876-549d-40af-bdc9-744786a472a4,,released,,0,2021-12-21T14:24:00.546663-06:00,,,
HCM-CSHL-0802-C67,88aa1634-d51b-4b0e-89bb-086709b24e2b,58774a23-dbfd-494e-9619-76dabe6945c9,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0802-C67_treatment3,5471a8da-8942-4db5-9af1-d1a163520bd4,,released,,0,2021-12-21T14:24:00.546663-06:00,"Pharmaceutical Therapy, NOS",Residual Disease,
HCM-CSHL-0802-C67,88aa1634-d51b-4b0e-89bb-086709b24e2b,58774a23-dbfd-494e-9619-76dabe6945c9,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0802-C67_treatment4,815fe59b-026a-495d-9999-aa6cef3db671,,released,,0,2021-12-21T14:24:00.546663-06:00,"Radiation Therapy, NOS",Residual Disease,
HCM-CSHL-0802-C67,88aa1634-d51b-4b0e-89bb-086709b24e2b,58774a23-dbfd-494e-9619-76dabe6945c9,,,0.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0802-C67_treatment2,855f1bc8-8ab2-4c40-a467-3d4dda1637ab,,released,,1,2021-12-21T14:24:00.546663-06:00,"Surgery, NOS",Initial Diagnosis,
HCM-BROD-0120-C15,8a2452ec-72a0-4efb-84ac-d5af5e613e74,84af79fd-f642-4e56-b413-3d1a59cf47a6,,Adjuvant,,2025-01-02T09:33:48.717229-06:00,HCM-BROD-0120-C15_treatment4,0634655a-e60f-48b6-90d6-74d81e62de65,,released,,0,2019-04-16T11:45:59.271275-05:00,"Pharmaceutical Therapy, NOS",Residual Disease,
HCM-BROD-0120-C15,8a2452ec-72a0-4efb-84ac-d5af5e613e74,84af79fd-f642-4e56-b413-3d1a59cf47a6,,Neoadjuvant,,2023-02-22T07:39:25.979291-06:00,HCM-BROD-0120-C15_treatment,0a799d6b-6c55-402f-854e-7371e2865f1d,,released,Unknown,1,2019-04-16T11:45:59.271275-05:00,Chemotherapy,,
HCM-BROD-0120-C15,8a2452ec-72a0-4efb-84ac-d5af5e613e74,84af79fd-f642-4e56-b413-3d1a59cf47a6,,Adjuvant,,2025-01-03T13:32:08.619997-06:00,HCM-BROD-0120-C15_treatment5,bbd24d57-a97d-4450-ba82-6875aa2de873,,released,,0,2025-01-02T09:33:48.717229-06:00,"Radiation Therapy, NOS",Residual Disease,
HCM-BROD-0120-C15,8a2452ec-72a0-4efb-84ac-d5af5e613e74,84af79fd-f642-4e56-b413-3d1a59cf47a6,,,,2025-01-02T09:33:48.717229-06:00,HCM-BROD-0120-C15_treatment3,f396ff3c-94e4-433f-94b8-9a4d8932db4f,,released,,0,2019-04-16T11:45:59.271275-05:00,"Surgery, NOS",Initial Diagnosis,
HCM-BROD-0120-C15,8a2452ec-72a0-4efb-84ac-d5af5e613e74,84af79fd-f642-4e56-b413-3d1a59cf47a6,,Neoadjuvant,,2025-01-02T09:33:48.717229-06:00,HCM-BROD-0120-C15_treatment2,f3a50753-1e8c-416f-ad95-a589ace00caf,,released,,0,2019-04-16T11:45:59.271275-05:00,"Radiation Therapy, NOS",,
HCM-CSHL-0062-C18,8b3b1f24-419e-4043-82be-2bd41268bb0e,e0fffc04-b694-41a0-8d9d-425504b92784,,Neoadjuvant,,2019-05-24T12:11:41.511797-05:00,HCM-CSHL-0062-C18_treatment,a5f95462-2f9c-4e96-82dd-761b43a937d9,,released,,0,2019-05-15T13:02:25.351730-05:00,,,
HCM-CSHL-0062-C18,8b3b1f24-419e-4043-82be-2bd41268bb0e,e0fffc04-b694-41a0-8d9d-425504b92784,,,13.0,2023-03-13T13:33:55.022476-05:00,HCM-CSHL-0062-C18_treatment2,d285edb6-217c-4adc-831a-0eacba431098,,released,,1,2019-05-15T13:02:25.351730-05:00,"Surgery, NOS",Initial Diagnosis,
HCM-CSHL-0062-C18,8b3b1f24-419e-4043-82be-2bd41268bb0e,e0fffc04-b694-41a0-8d9d-425504b92784,,Adjuvant,,2023-03-13T13:33:55.022476-05:00,HCM-CSHL-0062-C18_treatment4,e85a1205-3ae9-4d6a-a94f-10c304ae6762,,released,,unknown,2019-05-15T13:02:25.351730-05:00,"Radiation Therapy, NOS",Residual Disease,
HCM-CSHL-0062-C18,8b3b1f24-419e-4043-82be-2bd41268bb0e,e0fffc04-b694-41a0-8d9d-425504b92784,,Adjuvant,,2023-03-13T13:33:55.022476-05:00,HCM-CSHL-0062-C18_treatment3,edd6b471-04b2-4606-9bf1-ace36786e526,,released,,unknown,2019-05-15T13:02:25.351730-05:00,"Pharmaceutical Therapy, NOS",Residual Disease,
HCM-CSHL-0618-C18,8badcb2e-30f1-47ad-91f1-d832d6289f6a,63347168-9c61-43fc-a495-f42c7e49a542,,Neoadjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0618-C18_treatment,392bf13b-5c14-478f-811f-4984e373560f,,released,,0,2021-12-21T14:12:12.806259-06:00,,,
HCM-CSHL-0618-C18,8badcb2e-30f1-47ad-91f1-d832d6289f6a,63347168-9c61-43fc-a495-f42c7e49a542,,,295.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0618-C18_treatment2,45333cb9-d7f8-4a07-b562-de1b8cf36e88,,released,,1,2021-12-21T14:12:12.806259-06:00,"Surgery, NOS",Initial Diagnosis,
HCM-CSHL-0618-C18,8badcb2e-30f1-47ad-91f1-d832d6289f6a,63347168-9c61-43fc-a495-f42c7e49a542,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0618-C18_treatment3,d5e11430-a6e7-4ab5-98ef-ef765fb92680,,released,,unknown,2021-12-21T14:12:12.806259-06:00,"Pharmaceutical Therapy, NOS",Residual Disease,
HCM-CSHL-0618-C18,8badcb2e-30f1-47ad-91f1-d832d6289f6a,63347168-9c61-43fc-a495-f42c7e49a542,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0618-C18_treatment4,fbd0dd1d-9aa9-4368-b294-9ea1598b3d14,,released,,unknown,2021-12-21T14:12:12.806259-06:00,"Radiation Therapy, NOS",Residual Disease,
HCM-CSHL-0246-C19,8d169383-a8af-4450-a837-01da35fb72c5,f09ca60d-fbde-430e-a661-752883746d5b,,Neoadjuvant,74.0,2021-01-06T22:55:10.531130-06:00,HCM-CSHL-0246-C19_treatment5,1ac7c84d-dc4d-4181-9c29-140188ddbbca,,released,,1,2020-02-27T12:50:41.247072-06:00,Chemotherapy,,FOLFOX
HCM-CSHL-0246-C19,8d169383-a8af-4450-a837-01da35fb72c5,f09ca60d-fbde-430e-a661-752883746d5b,340.0,Adjuvant,314.0,2021-01-06T22:55:10.531130-06:00,HCM-CSHL-0246-C19_treatment8,1fbeebb7-5aac-430d-98d7-96b2d17167b8,,released,Leucovorin,1,2020-02-27T12:50:41.247072-06:00,Chemotherapy,Residual Disease,
HCM-CSHL-0246-C19,8d169383-a8af-4450-a837-01da35fb72c5,f09ca60d-fbde-430e-a661-752883746d5b,,Neoadjuvant,74.0,2021-01-06T22:55:10.531130-06:00,HCM-CSHL-0246-C19_treatment2,48f49df1-8e81-4d7a-a8fc-1ba20a74f72f,,released,Leucovorin Calcium,1,2020-02-27T12:50:41.247072-06:00,Chemotherapy,,
HCM-CSHL-0246-C19,8d169383-a8af-4450-a837-01da35fb72c5,f09ca60d-fbde-430e-a661-752883746d5b,,Adjuvant,567.0,2021-09-07T08:39:47.277409-05:00,HCM-CSHL-0246-C19_treatment13,532dad7d-ebdd-429f-92a1-e44c7aa3d59b,,released,Binimetinib,1,2020-09-28T09:31:14.073398-05:00,Targeted Molecular Therapy,Residual Disease,
HCM-CSHL-0246-C19,8d169383-a8af-4450-a837-01da35fb72c5,f09ca60d-fbde-430e-a661-752883746d5b,,Neoadjuvant,74.0,2021-01-06T22:55:10.531130-06:00,HCM-CSHL-0246-C19_treatment3,5a32ccc2-722f-4042-8c3d-a0a71c892099,,released,Fluorouracil,1,2020-02-27T12:50:41.247072-06:00,Chemotherapy,,
HCM-CSHL-0246-C19,8d169383-a8af-4450-a837-01da35fb72c5,f09ca60d-fbde-430e-a661-752883746d5b,,Neoadjuvant,157.0,2021-01-06T22:55:10.531130-06:00,HCM-CSHL-0246-C19_treatment6,5c1a2288-4c49-49bb-9d53-ee366256501d,,released,,1,2020-02-27T12:50:41.247072-06:00,"Radiation, Intensity-Modulated Radiotherapy",,
HCM-CSHL-0246-C19,8d169383-a8af-4450-a837-01da35fb72c5,f09ca60d-fbde-430e-a661-752883746d5b,,Adjuvant,,2021-09-07T08:39:47.277409-05:00,HCM-CSHL-0246-C19_treatment14,65ba6e28-bd7c-487d-9dc9-25f4174ef555,,released,,0,2020-09-28T09:31:14.073398-05:00,"Radiation Therapy, NOS",Residual Disease,
HCM-CSHL-0246-C19,8d169383-a8af-4450-a837-01da35fb72c5,f09ca60d-fbde-430e-a661-752883746d5b,340.0,Adjuvant,314.0,2021-01-06T22:55:10.531130-06:00,HCM-CSHL-0246-C19_treatment7,769bc527-5a51-4723-9475-61d84172ef27,,released,Fluorouracil,1,2020-02-27T12:50:41.247072-06:00,Chemotherapy,Residual Disease,
HCM-CSHL-0246-C19,8d169383-a8af-4450-a837-01da35fb72c5,f09ca60d-fbde-430e-a661-752883746d5b,,Adjuvant,,2021-09-07T08:39:47.277409-05:00,HCM-CSHL-0246-C19_treatment9,77ba58d2-56af-4b9b-8b92-1a304527c015,,released,,unknown,2020-02-27T12:50:41.247072-06:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-CSHL-0246-C19,8d169383-a8af-4450-a837-01da35fb72c5,f09ca60d-fbde-430e-a661-752883746d5b,,,242.0,2023-03-13T13:30:42.830749-05:00,HCM-CSHL-0246-C19_treatment10,7c605e14-8d3e-4190-b56e-81f0cf331521,,released,,1,2020-02-27T12:50:41.247072-06:00,"Surgery, NOS",Initial Diagnosis,
HCM-CSHL-0246-C19,8d169383-a8af-4450-a837-01da35fb72c5,f09ca60d-fbde-430e-a661-752883746d5b,,Neoadjuvant,74.0,2021-01-06T22:55:10.531130-06:00,HCM-CSHL-0246-C19_treatment4,8318a150-6398-4a07-8752-d3c51956a447,,released,Oxaliplatin,1,2020-02-27T12:50:41.247072-06:00,Chemotherapy,,
HCM-CSHL-0246-C19,8d169383-a8af-4450-a837-01da35fb72c5,f09ca60d-fbde-430e-a661-752883746d5b,,Adjuvant,567.0,2021-09-07T08:39:47.277409-05:00,HCM-CSHL-0246-C19_treatment12,8f871a53-dde9-46d8-9c4d-4c7cf70bd1e1,,released,Encorafenib,1,2020-09-28T09:31:14.073398-05:00,Targeted Molecular Therapy,Residual Disease,
HCM-CSHL-0246-C19,8d169383-a8af-4450-a837-01da35fb72c5,f09ca60d-fbde-430e-a661-752883746d5b,,Neoadjuvant,74.0,2021-01-06T22:55:10.531130-06:00,HCM-CSHL-0246-C19_treatment,b8224d67-c338-45f8-9946-7ddac9f324f1,,released,Capecitabine,1,2020-02-27T12:50:41.247072-06:00,Chemotherapy,,
HCM-CSHL-0246-C19,8d169383-a8af-4450-a837-01da35fb72c5,f09ca60d-fbde-430e-a661-752883746d5b,,Adjuvant,567.0,2021-09-07T08:39:47.277409-05:00,HCM-CSHL-0246-C19_treatment11,e0c86b03-185a-4dc1-b325-ef7eaf012489,,released,Cetuximab,1,2020-02-27T12:50:41.247072-06:00,Targeted Molecular Therapy,Residual Disease,
HCM-SANG-0527-C18,8dcd4d5c-688f-475b-aabb-4a10407a5513,dcb9430d-505f-431e-a11a-8d983b73f24a,,Neoadjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-SANG-0527-C18_treatment,4484725b-bdfb-4f3f-a476-2382ddddfaee,,released,,0,2021-12-21T15:13:32.843781-06:00,,,
HCM-SANG-0533-C20,8de026f0-1817-4e4a-941b-20b5ee7680ff,f436cc32-4eba-4916-9bf6-145a82e56547,,Neoadjuvant,,2023-07-13T10:35:44.371881-05:00,HCM-SANG-0533-C20_treatment,07f5911b-a258-492e-9091-9574b8ca4883,,released,,0,2021-12-21T15:13:49.985067-06:00,,,
HCM-BROD-0711-C64,8ed2333b-d19c-4fa1-9433-f349a91159bf,ae4cd8dd-2422-4a39-bb66-3fdfa3d0eaff,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0711-C64_treatment3,3bc1911e-96f3-4862-a72d-90ef4acbb2f3,,released,,0,2021-12-21T13:47:42.558183-06:00,Hormone Therapy,Residual Disease,
HCM-BROD-0711-C64,8ed2333b-d19c-4fa1-9433-f349a91159bf,ae4cd8dd-2422-4a39-bb66-3fdfa3d0eaff,,,37.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0711-C64_treatment5,711c5887-f51e-41f1-a2a4-9eba5b2419a4,,released,,1,2021-12-21T13:47:42.558183-06:00,"Surgery, NOS",Initial Diagnosis,
HCM-BROD-0711-C64,8ed2333b-d19c-4fa1-9433-f349a91159bf,ae4cd8dd-2422-4a39-bb66-3fdfa3d0eaff,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0711-C64_treatment6,71de1e90-966b-438e-acbb-12afbf9a090c,,released,,0,2021-12-21T13:47:42.558183-06:00,Targeted Molecular Therapy,Residual Disease,
HCM-BROD-0711-C64,8ed2333b-d19c-4fa1-9433-f349a91159bf,ae4cd8dd-2422-4a39-bb66-3fdfa3d0eaff,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0711-C64_treatment7,95b7380e-9e67-4324-bbbf-daa2b7d8c95f,,released,,0,2021-12-21T13:47:42.558183-06:00,"Radiation Therapy, NOS",Residual Disease,
HCM-BROD-0711-C64,8ed2333b-d19c-4fa1-9433-f349a91159bf,ae4cd8dd-2422-4a39-bb66-3fdfa3d0eaff,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0711-C64_treatment4,c4bfaf14-3b91-480c-ab53-83e79bd0c8a5,,released,,0,2021-12-21T13:47:42.558183-06:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-BROD-0711-C64,8ed2333b-d19c-4fa1-9433-f349a91159bf,ae4cd8dd-2422-4a39-bb66-3fdfa3d0eaff,,Neoadjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0711-C64_treatment,d810ed89-fe21-4e60-8257-d380e1518886,,released,,0,2021-12-21T13:47:42.558183-06:00,,,
HCM-BROD-0711-C64,8ed2333b-d19c-4fa1-9433-f349a91159bf,ae4cd8dd-2422-4a39-bb66-3fdfa3d0eaff,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0711-C64_treatment2,f2d6ef00-5c4a-4359-ba0a-289d84ac7808,,released,,0,2021-12-21T13:47:42.558183-06:00,Chemotherapy,Residual Disease,
HCM-STAN-0777-C25,8ee05a9d-2373-4598-afec-a42ed3be4082,eda7626d-4f0d-4169-8a8c-ab51f8ded231,,Neoadjuvant,30.0,2025-04-07T17:13:09.336794-05:00,HCM-STAN-0777-C25_treatment4,07c2b651-c057-4674-aadd-d9562c7d1869,,released,Oxaliplatin,1,2022-09-22T07:02:34.287678-05:00,Chemotherapy,,
HCM-STAN-0777-C25,8ee05a9d-2373-4598-afec-a42ed3be4082,eda7626d-4f0d-4169-8a8c-ab51f8ded231,,Neoadjuvant,30.0,2025-04-07T17:13:09.336794-05:00,HCM-STAN-0777-C25_treatment5,130ecac3-9ce5-49af-a24e-3511407fe149,,released,,1,2022-09-22T07:02:34.287678-05:00,Chemotherapy,,FOLFIRINOX
HCM-STAN-0777-C25,8ee05a9d-2373-4598-afec-a42ed3be4082,eda7626d-4f0d-4169-8a8c-ab51f8ded231,,Neoadjuvant,150.0,2025-04-07T17:13:09.336794-05:00,HCM-STAN-0777-C25_treatment6,14966f38-c076-475f-82fe-19b8250e0352,,released,,1,2022-09-22T07:02:34.287678-05:00,Stereotactic Radiosurgery,,
HCM-STAN-0777-C25,8ee05a9d-2373-4598-afec-a42ed3be4082,eda7626d-4f0d-4169-8a8c-ab51f8ded231,,,230.0,2025-04-07T17:13:09.336794-05:00,HCM-STAN-0777-C25_treatment10,1d6c0564-3c82-4ac2-915d-206ab83da8a4,,released,,1,2022-09-22T07:02:34.287678-05:00,"Surgery, NOS",Initial Diagnosis,
HCM-STAN-0777-C25,8ee05a9d-2373-4598-afec-a42ed3be4082,eda7626d-4f0d-4169-8a8c-ab51f8ded231,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-STAN-0777-C25_treatment12,31dda3ec-1921-40e5-91cb-081c98c0d5b8,,released,,0,2022-09-22T07:02:34.287678-05:00,"Radiation Therapy, NOS",Residual Disease,
HCM-STAN-0777-C25,8ee05a9d-2373-4598-afec-a42ed3be4082,eda7626d-4f0d-4169-8a8c-ab51f8ded231,,Neoadjuvant,30.0,2025-04-07T17:13:09.336794-05:00,HCM-STAN-0777-C25_treatment3,3740d0ca-e4be-46d1-8c06-0008ea473a56,,released,Fluorouracil,1,2022-09-22T07:02:34.287678-05:00,Chemotherapy,,
HCM-STAN-0777-C25,8ee05a9d-2373-4598-afec-a42ed3be4082,eda7626d-4f0d-4169-8a8c-ab51f8ded231,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-STAN-0777-C25_treatment9,3b33b5f1-c289-42bf-b93f-270a978f7ace,,released,,0,2022-09-22T07:02:34.287678-05:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-STAN-0777-C25,8ee05a9d-2373-4598-afec-a42ed3be4082,eda7626d-4f0d-4169-8a8c-ab51f8ded231,400.0,Adjuvant,350.0,2025-04-07T17:13:09.336794-05:00,HCM-STAN-0777-C25_treatment8,77ac4a3d-aacc-42b9-a4dc-7aa6abeb60f3,,released,Gemcitabine,1,2022-09-22T07:02:34.287678-05:00,Chemotherapy,Residual Disease,
HCM-STAN-0777-C25,8ee05a9d-2373-4598-afec-a42ed3be4082,eda7626d-4f0d-4169-8a8c-ab51f8ded231,,Neoadjuvant,30.0,2025-04-07T17:13:09.336794-05:00,HCM-STAN-0777-C25_treatment2,bf9a50eb-766a-467f-840e-54ce113ee059,,released,Leucovorin Calcium,1,2022-09-22T07:02:34.287678-05:00,Chemotherapy,,
HCM-STAN-0777-C25,8ee05a9d-2373-4598-afec-a42ed3be4082,eda7626d-4f0d-4169-8a8c-ab51f8ded231,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-STAN-0777-C25_treatment11,d14fe8f4-be64-40cd-872d-64bb76c2257f,,released,,0,2022-09-22T07:02:34.287678-05:00,Targeted Molecular Therapy,Residual Disease,
HCM-STAN-0777-C25,8ee05a9d-2373-4598-afec-a42ed3be4082,eda7626d-4f0d-4169-8a8c-ab51f8ded231,400.0,Adjuvant,350.0,2025-04-07T17:13:09.336794-05:00,HCM-STAN-0777-C25_treatment7,ed65a5d3-2c04-4897-b4da-9916fd8ede76,,released,Capecitabine,1,2022-09-22T07:02:34.287678-05:00,Chemotherapy,Residual Disease,
HCM-STAN-0777-C25,8ee05a9d-2373-4598-afec-a42ed3be4082,eda7626d-4f0d-4169-8a8c-ab51f8ded231,,Neoadjuvant,30.0,2025-04-07T17:13:09.336794-05:00,HCM-STAN-0777-C25_treatment,f36625a5-7b0b-4371-ba6b-20873610c7a2,,released,Irinotecan Hydrochloride,1,2022-09-22T07:02:34.287678-05:00,Chemotherapy,,
HCM-SANG-1312-C20,8fbd0f97-3cf8-40eb-b55d-416fbaffe82a,de76c00d-c676-4a46-968f-b01cbceaf848,,Neoadjuvant,202.0,2025-04-07T17:13:09.336794-05:00,HCM-SANG-1312-C20_treatment3,2f84876e-c6fe-40dd-9548-4a4cb8d04614,,released,,1,2023-02-27T13:23:39.607757-06:00,"Radiation, 2D Conventional",,
HCM-SANG-1312-C20,8fbd0f97-3cf8-40eb-b55d-416fbaffe82a,de76c00d-c676-4a46-968f-b01cbceaf848,,Neoadjuvant,202.0,2025-04-07T17:13:09.336794-05:00,HCM-SANG-1312-C20_treatment,99ea4854-d084-4dcc-941f-2b1ff09e20b8,,released,Capecitabine,1,2023-02-27T13:23:39.607757-06:00,Chemotherapy,,
HCM-SANG-1312-C20,8fbd0f97-3cf8-40eb-b55d-416fbaffe82a,de76c00d-c676-4a46-968f-b01cbceaf848,,Neoadjuvant,202.0,2025-04-07T17:13:09.336794-05:00,HCM-SANG-1312-C20_treatment2,f4c8ddc5-3f4d-42be-beb7-8ea275d2bfb6,,released,Oxaliplatin,1,2023-02-27T13:23:39.607757-06:00,Chemotherapy,,
HCM-CSHL-0432-C20,8ff694fc-0d95-423b-89fa-5e78d759cbe3,84fc422c-e6fa-4714-bd5e-28c9da4c7ab4,,Adjuvant,,2023-03-13T12:54:48.325925-05:00,HCM-CSHL-0432-C20_treatment3,115772e4-d8df-4993-b115-ea374ae6782a,,released,,0,2020-09-28T10:09:05.134510-05:00,"Pharmaceutical Therapy, NOS",Residual Disease,
HCM-CSHL-0432-C20,8ff694fc-0d95-423b-89fa-5e78d759cbe3,84fc422c-e6fa-4714-bd5e-28c9da4c7ab4,,Adjuvant,,2023-03-13T12:54:48.325925-05:00,HCM-CSHL-0432-C20_treatment4,5e14da49-cb52-4d27-a43a-183fafb9210f,,released,,0,2020-09-28T10:09:05.134510-05:00,"Radiation Therapy, NOS",Residual Disease,
HCM-CSHL-0432-C20,8ff694fc-0d95-423b-89fa-5e78d759cbe3,84fc422c-e6fa-4714-bd5e-28c9da4c7ab4,,Neoadjuvant,,2023-02-22T07:39:25.979291-06:00,HCM-CSHL-0432-C20_treatment,62e83dc2-b95d-4b71-a681-fabac1d2483b,,released,,0,2020-09-28T10:09:05.134510-05:00,,,
HCM-CSHL-0432-C20,8ff694fc-0d95-423b-89fa-5e78d759cbe3,84fc422c-e6fa-4714-bd5e-28c9da4c7ab4,,,25.0,2023-03-13T12:54:48.325925-05:00,HCM-CSHL-0432-C20_treatment2,936ab65f-a6d0-4434-ab46-f68e09748f87,,released,,1,2020-09-28T10:09:05.134510-05:00,"Surgery, NOS",Initial Diagnosis,
HCM-SANG-1325-C15,908161cf-4761-41b1-8f37-8100e781d90e,5d02091b-ca60-46a3-94c4-4348578a622e,,Neoadjuvant,109.0,2025-04-07T17:13:09.336794-05:00,HCM-SANG-1325-C15_treatment3,48049dcc-73cf-48d8-8d90-9b68f21fdcff,,released,Docetaxel,1,2023-02-27T13:12:40.861483-06:00,Chemotherapy,,
HCM-SANG-1325-C15,908161cf-4761-41b1-8f37-8100e781d90e,5d02091b-ca60-46a3-94c4-4348578a622e,,Neoadjuvant,109.0,2025-04-07T17:13:09.336794-05:00,HCM-SANG-1325-C15_treatment4,6992ac50-42e9-4b5c-b687-3406a9bdee4d,,released,Oxaliplatin,1,2023-02-27T13:12:40.861483-06:00,Chemotherapy,,
HCM-SANG-1325-C15,908161cf-4761-41b1-8f37-8100e781d90e,5d02091b-ca60-46a3-94c4-4348578a622e,,Neoadjuvant,109.0,2025-04-07T17:13:09.336794-05:00,HCM-SANG-1325-C15_treatment2,a7c748a4-323e-45fa-88b6-60c53d89c0c9,,released,Fluorouracil,1,2023-02-27T13:12:40.861483-06:00,Chemotherapy,,
HCM-SANG-1325-C15,908161cf-4761-41b1-8f37-8100e781d90e,5d02091b-ca60-46a3-94c4-4348578a622e,,Neoadjuvant,109.0,2025-04-07T17:13:09.336794-05:00,HCM-SANG-1325-C15_treatment,f921ac8e-d774-4beb-a00f-c7a667267662,,released,Leucovorin,1,2023-02-27T13:12:40.861483-06:00,Chemotherapy,,
HCM-BROD-0098-C15,9097285b-eeb1-4f36-a0ab-0d0592043792,07e4c6d5-8727-4cc5-9d21-cec1873d39c7,,Adjuvant,,2021-01-06T22:55:10.531130-06:00,HCM-BROD-0098-C15_treatment6,096ae1e3-a026-4387-8f69-e45c039e24e2,,released,,unknown,2020-02-27T12:28:44.104835-06:00,"Radiation Therapy, NOS",Residual Disease,
HCM-BROD-0098-C15,9097285b-eeb1-4f36-a0ab-0d0592043792,07e4c6d5-8727-4cc5-9d21-cec1873d39c7,,,,2023-02-27T12:26:25.142151-06:00,HCM-BROD-0098-C15_treatment4,2ebf812c-1c5b-4b90-9e29-069c75ca7d4c,,released,,0,2020-02-27T12:28:44.104835-06:00,"Surgery, NOS",Initial Diagnosis,
HCM-BROD-0098-C15,9097285b-eeb1-4f36-a0ab-0d0592043792,07e4c6d5-8727-4cc5-9d21-cec1873d39c7,,Adjuvant,,2021-01-06T22:55:10.531130-06:00,HCM-BROD-0098-C15_treatment2,47b3e364-67c9-4917-a118-8bcb1fb1c905,,released,,unknown,2020-02-27T12:28:44.104835-06:00,Chemotherapy,Residual Disease,
HCM-BROD-0098-C15,9097285b-eeb1-4f36-a0ab-0d0592043792,07e4c6d5-8727-4cc5-9d21-cec1873d39c7,,Adjuvant,,2021-01-06T22:55:10.531130-06:00,HCM-BROD-0098-C15_treatment3,b74e76fa-6a4c-4bd3-9df7-1588bfdecf91,,released,,unknown,2020-02-27T12:28:44.104835-06:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-BROD-0098-C15,9097285b-eeb1-4f36-a0ab-0d0592043792,07e4c6d5-8727-4cc5-9d21-cec1873d39c7,,Adjuvant,,2021-01-06T22:55:10.531130-06:00,HCM-BROD-0098-C15_treatment5,cc4de299-ccf1-428c-92a5-cb2b9a36fdc7,,released,,unknown,2020-02-27T12:28:44.104835-06:00,Targeted Molecular Therapy,Residual Disease,
HCM-BROD-0098-C15,9097285b-eeb1-4f36-a0ab-0d0592043792,07e4c6d5-8727-4cc5-9d21-cec1873d39c7,,Neoadjuvant,,2021-01-06T22:55:10.531130-06:00,HCM-BROD-0098-C15_treatment,f8bb3072-bf9c-496a-b5ea-b61369cb9fb1,,released,,0,2019-04-04T15:50:02.707866-05:00,,,
HCM-CSHL-0374-C25,9166c115-0c9d-4c72-9c2e-da3a3b94072d,cea3047d-5cb5-4200-b083-6106e4969591,,Adjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0374-C25_treatment3,32c235f3-7eea-455a-ba68-43ee131e35ea,,released,,0,2020-09-28T13:00:02.112853-05:00,"Pharmaceutical Therapy, NOS",Residual Disease,
HCM-CSHL-0374-C25,9166c115-0c9d-4c72-9c2e-da3a3b94072d,cea3047d-5cb5-4200-b083-6106e4969591,,Adjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0374-C25_treatment4,52c2e8c0-6dff-440d-9e8f-46b3fd17b7f3,,released,,0,2020-09-28T13:00:02.112853-05:00,"Radiation Therapy, NOS",Residual Disease,
HCM-CSHL-0374-C25,9166c115-0c9d-4c72-9c2e-da3a3b94072d,cea3047d-5cb5-4200-b083-6106e4969591,,,-13.0,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0374-C25_treatment2,9b0245ad-22ef-4435-87c2-f3d925135e70,,released,,1,2020-09-28T13:00:02.112853-05:00,"Surgery, NOS",Initial Diagnosis,
HCM-CSHL-0374-C25,9166c115-0c9d-4c72-9c2e-da3a3b94072d,cea3047d-5cb5-4200-b083-6106e4969591,,Neoadjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0374-C25_treatment,d21cb31b-8366-4bc0-936b-4b0dc806a117,,released,,0,2020-09-28T13:00:02.112853-05:00,,,
HCM-CSHL-0666-C24,91ebd37e-c8ea-4e03-ae01-35d111678dbd,29f83149-20d3-463f-bf7c-aff8075d2488,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0666-C24_treatment3,2154c458-77ab-44b8-82c4-7adb5cedb91a,,released,,0,2021-12-21T14:16:50.471945-06:00,"Pharmaceutical Therapy, NOS",Residual Disease,
HCM-CSHL-0666-C24,91ebd37e-c8ea-4e03-ae01-35d111678dbd,29f83149-20d3-463f-bf7c-aff8075d2488,,,-31.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0666-C24_treatment2,3b7e1055-859b-466a-8967-378de59e5dba,,released,,1,2021-12-21T14:16:50.471945-06:00,"Surgery, NOS",Initial Diagnosis,
HCM-CSHL-0666-C24,91ebd37e-c8ea-4e03-ae01-35d111678dbd,29f83149-20d3-463f-bf7c-aff8075d2488,,Neoadjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0666-C24_treatment,c2ed6257-da0b-4d48-9dc3-48922bb7951d,,released,,0,2021-12-21T14:16:50.471945-06:00,,,
HCM-CSHL-0666-C24,91ebd37e-c8ea-4e03-ae01-35d111678dbd,29f83149-20d3-463f-bf7c-aff8075d2488,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0666-C24_treatment4,e9a97d82-dda5-4310-b791-b28ea484db43,,released,,0,2021-12-21T14:16:50.471945-06:00,"Radiation Therapy, NOS",Residual Disease,
HCM-BROD-1123-C71,9239cb75-6ed2-4335-9124-4b760e0d7e50,229aa478-f17a-4109-a9ba-f0f114911ae6,525.0,Maintenance Therapy,197.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-1123-C71_treatment7,d3197911-7acc-4cd1-ba8f-cbe8d5b2f6c9,Progressive Disease,released,Temozolomide,1,2021-12-21T14:01:36.099050-06:00,,,
HCM-BROD-1123-C71,9239cb75-6ed2-4335-9124-4b760e0d7e50,35f03cb2-d0a0-4fc4-bb99-eb7e53f2f689,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-BROD-1123-C71_treatment5,03de4b50-775e-4001-a486-f820e46f8c6f,,released,,0,2021-12-21T14:01:36.099050-06:00,Targeted Molecular Therapy,Residual Disease,
HCM-BROD-1123-C71,9239cb75-6ed2-4335-9124-4b760e0d7e50,35f03cb2-d0a0-4fc4-bb99-eb7e53f2f689,,,0.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-1123-C71_treatment4,183bbebc-b0c3-4b1f-8bef-03546cf4f2fb,,released,,1,2021-12-21T14:01:36.099050-06:00,"Surgery, NOS",Initial Diagnosis,
HCM-BROD-1123-C71,9239cb75-6ed2-4335-9124-4b760e0d7e50,35f03cb2-d0a0-4fc4-bb99-eb7e53f2f689,,Neoadjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-BROD-1123-C71_treatment,a7ddcb77-8b40-41ca-945c-65585cda0d1e,,released,,0,2021-12-21T14:01:36.099050-06:00,,,
HCM-BROD-1123-C71,9239cb75-6ed2-4335-9124-4b760e0d7e50,35f03cb2-d0a0-4fc4-bb99-eb7e53f2f689,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-BROD-1123-C71_treatment3,d868500a-59a0-47db-a6bc-ffb34aa0c425,,released,,0,2021-12-21T14:01:36.099050-06:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-BROD-1123-C71,9239cb75-6ed2-4335-9124-4b760e0d7e50,35f03cb2-d0a0-4fc4-bb99-eb7e53f2f689,623.0,Adjuvant,581.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-1123-C71_treatment2,e39f4406-e8ea-4c8d-ae0c-b24429928f0c,Treatment Ongoing,released,Temozolomide,1,2021-12-21T14:01:36.099050-06:00,Chemotherapy,Residual Disease,
HCM-BROD-1123-C71,9239cb75-6ed2-4335-9124-4b760e0d7e50,35f03cb2-d0a0-4fc4-bb99-eb7e53f2f689,594.0,Adjuvant,584.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-1123-C71_treatment6,ea385a75-8a4f-44f8-a065-1e4689fcdf5b,,released,,1,2021-12-21T14:01:36.099050-06:00,"Radiation Therapy, NOS",Residual Disease,
HCM-CSHL-0323-C20,92555ec0-7c74-4974-a243-bcfa2b0d55be,12f2c92e-799a-434b-bbe4-0a7d54391af0,,,14.0,2023-03-13T13:29:37.923012-05:00,HCM-CSHL-0323-C20_treatment4,0b68320b-518d-4c6f-a7b7-5c6e066afce8,,released,,1,2020-09-28T09:40:17.931033-05:00,"Surgery, NOS",Initial Diagnosis,
HCM-CSHL-0323-C20,92555ec0-7c74-4974-a243-bcfa2b0d55be,12f2c92e-799a-434b-bbe4-0a7d54391af0,,Adjuvant,,2023-02-22T07:39:25.979291-06:00,HCM-CSHL-0323-C20_treatment5,17fa85da-2641-4ecb-89c3-42ed5dcde5c8,,released,,0,2020-09-28T09:40:17.931033-05:00,Targeted Molecular Therapy,Residual Disease,
HCM-CSHL-0323-C20,92555ec0-7c74-4974-a243-bcfa2b0d55be,12f2c92e-799a-434b-bbe4-0a7d54391af0,,Adjuvant,,2023-02-22T07:39:25.979291-06:00,HCM-CSHL-0323-C20_treatment3,1a199e91-28de-49ce-b01c-f3b2499771cd,,released,,0,2020-09-28T09:40:17.931033-05:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-CSHL-0323-C20,92555ec0-7c74-4974-a243-bcfa2b0d55be,12f2c92e-799a-434b-bbe4-0a7d54391af0,,Neoadjuvant,,2023-02-22T07:39:25.979291-06:00,HCM-CSHL-0323-C20_treatment,39a0e59b-5dca-49a0-a8fe-5404d948fe5f,,released,,0,2020-09-28T09:40:17.931033-05:00,,,
HCM-CSHL-0323-C20,92555ec0-7c74-4974-a243-bcfa2b0d55be,12f2c92e-799a-434b-bbe4-0a7d54391af0,,Adjuvant,,2023-02-22T07:39:25.979291-06:00,HCM-CSHL-0323-C20_treatment2,61cbdbe0-b1c0-4c89-930b-3839336825e6,Treatment Ongoing,released,Capecitabine,1,2020-09-28T09:40:17.931033-05:00,Chemotherapy,Residual Disease,
HCM-CSHL-0323-C20,92555ec0-7c74-4974-a243-bcfa2b0d55be,12f2c92e-799a-434b-bbe4-0a7d54391af0,152.0,Adjuvant,106.0,2023-02-22T07:39:25.979291-06:00,HCM-CSHL-0323-C20_treatment6,ddcb60be-c8cf-4729-a6a9-4afe4bd8a19f,,released,,1,2020-09-28T09:40:17.931033-05:00,"Radiation, Intensity-Modulated Radiotherapy",Residual Disease,
HCM-CSHL-0193-C25,926ed139-205a-4dba-bfa2-9d435adfbb14,67806c5e-be12-4556-a477-dcbce1c5f15b,,Adjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0193-C25_treatment7,0168dfbf-307b-4869-b305-4fe22e8068dd,,released,,0,2020-09-28T09:16:54.676104-05:00,Targeted Molecular Therapy,Residual Disease,
HCM-CSHL-0193-C25,926ed139-205a-4dba-bfa2-9d435adfbb14,67806c5e-be12-4556-a477-dcbce1c5f15b,,Adjuvant,398.0,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0193-C25_treatment3,03823adf-2e31-4e7f-8a60-58019ab0543d,Treatment Ongoing,released,Gemcitabine,1,2020-09-28T09:16:54.676104-05:00,Chemotherapy,Residual Disease,
HCM-CSHL-0193-C25,926ed139-205a-4dba-bfa2-9d435adfbb14,67806c5e-be12-4556-a477-dcbce1c5f15b,,,-5.0,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0193-C25_treatment6,06c0ee37-daa6-4161-b298-832f61fdcd63,,released,,1,2020-09-28T09:16:54.676104-05:00,"Surgery, NOS",Initial Diagnosis,
HCM-CSHL-0193-C25,926ed139-205a-4dba-bfa2-9d435adfbb14,67806c5e-be12-4556-a477-dcbce1c5f15b,,Adjuvant,398.0,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0193-C25_treatment4,1ab88884-de4b-4110-a15b-767e5022b65f,Treatment Ongoing,released,Nab-paclitaxel,1,2020-09-28T09:16:54.676104-05:00,Chemotherapy,Residual Disease,
HCM-CSHL-0193-C25,926ed139-205a-4dba-bfa2-9d435adfbb14,67806c5e-be12-4556-a477-dcbce1c5f15b,139.0,Adjuvant,105.0,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0193-C25_treatment8,5fe69566-49c9-4626-8495-59329f389f2a,,released,,1,2020-09-28T09:16:54.676104-05:00,"Radiation, 2D Conventional",Residual Disease,
HCM-CSHL-0193-C25,926ed139-205a-4dba-bfa2-9d435adfbb14,67806c5e-be12-4556-a477-dcbce1c5f15b,223.0,Adjuvant,44.0,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0193-C25_treatment2,7a0940bc-e64f-4949-8849-a7e04ff56490,,released,Gemcitabine,1,2020-09-28T09:16:54.676104-05:00,Chemotherapy,Residual Disease,
HCM-CSHL-0193-C25,926ed139-205a-4dba-bfa2-9d435adfbb14,67806c5e-be12-4556-a477-dcbce1c5f15b,,Adjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0193-C25_treatment5,8d6340b4-2ad4-4d28-b2fa-2dd7ae2519b0,,released,,0,2020-09-28T09:16:54.676104-05:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-CSHL-0193-C25,926ed139-205a-4dba-bfa2-9d435adfbb14,67806c5e-be12-4556-a477-dcbce1c5f15b,,Neoadjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0193-C25_treatment,e8705b00-3259-47fd-9c21-e95ac41efc3c,,released,,0,2020-09-28T09:16:54.676104-05:00,,,
HCM-BROD-0206-C25,92c3a008-dd39-4243-8f29-3d45e73c1d04,60654d01-ce01-44f9-9a83-b7a600aa02d9,628.0,Adjuvant,551.0,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0206-C25_treatment5,066221be-198d-43f7-a307-56abb4b89005,,released,Oxaliplatin,1,2020-09-17T16:01:59.926485-05:00,Chemotherapy,Residual Disease,
HCM-BROD-0206-C25,92c3a008-dd39-4243-8f29-3d45e73c1d04,60654d01-ce01-44f9-9a83-b7a600aa02d9,,Adjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0206-C25_treatment6,18113bfb-bca8-4f18-af1a-23727991504e,,released,,0,2020-09-17T16:01:59.926485-05:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-BROD-0206-C25,92c3a008-dd39-4243-8f29-3d45e73c1d04,60654d01-ce01-44f9-9a83-b7a600aa02d9,628.0,Adjuvant,551.0,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0206-C25_treatment4,21f5d051-a956-49ec-b0e7-5228c68457ae,,released,Leucovorin,1,2020-09-17T16:01:59.926485-05:00,Chemotherapy,Residual Disease,
HCM-BROD-0206-C25,92c3a008-dd39-4243-8f29-3d45e73c1d04,60654d01-ce01-44f9-9a83-b7a600aa02d9,,Neoadjuvant,615.0,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0206-C25_treatment,255c6596-bda0-4ec1-b712-82f09a57a03e,,released,Gemcitabine,1,2020-09-17T16:01:59.926485-05:00,Chemotherapy,,
HCM-BROD-0206-C25,92c3a008-dd39-4243-8f29-3d45e73c1d04,60654d01-ce01-44f9-9a83-b7a600aa02d9,,Neoadjuvant,615.0,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0206-C25_treatment2,61b49102-d594-4603-b543-6800e93e6c6e,,released,Nab-paclitaxel,1,2020-09-17T16:01:59.926485-05:00,Chemotherapy,,
HCM-BROD-0206-C25,92c3a008-dd39-4243-8f29-3d45e73c1d04,60654d01-ce01-44f9-9a83-b7a600aa02d9,628.0,Adjuvant,551.0,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0206-C25_treatment3,977b3616-64d7-46e5-a12f-66b3e8076636,,released,Fluorouracil,1,2020-09-17T16:01:59.926485-05:00,Chemotherapy,Residual Disease,
HCM-BROD-0206-C25,92c3a008-dd39-4243-8f29-3d45e73c1d04,60654d01-ce01-44f9-9a83-b7a600aa02d9,,Adjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0206-C25_treatment8,a6c3815f-f7e6-48f5-aa71-6098b1a064b5,,released,,0,2020-09-17T16:01:59.926485-05:00,Targeted Molecular Therapy,Residual Disease,
HCM-BROD-0206-C25,92c3a008-dd39-4243-8f29-3d45e73c1d04,60654d01-ce01-44f9-9a83-b7a600aa02d9,,,364.0,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0206-C25_treatment7,b4258ee2-522d-4860-a9aa-142c3c0b2469,,released,,1,2020-09-17T16:01:59.926485-05:00,"Surgery, NOS",Initial Diagnosis,
HCM-BROD-0206-C25,92c3a008-dd39-4243-8f29-3d45e73c1d04,60654d01-ce01-44f9-9a83-b7a600aa02d9,,Adjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0206-C25_treatment9,bf81ceb8-49b5-47c6-9757-97b2caa11234,,released,,0,2020-09-17T16:01:59.926485-05:00,"Radiation Therapy, NOS",Residual Disease,
HCM-CSHL-0261-C50,9323fd2e-57cb-4149-ba36-274921d70215,49c4ace2-9695-4972-9a5a-2f32bbb4e2e0,,Adjuvant,,2023-02-22T07:39:25.979291-06:00,HCM-CSHL-0261-C50_treatment6,1e27fe00-9e33-450a-9b3a-728613de98ac,,released,,0,2020-09-28T09:34:59.697286-05:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-CSHL-0261-C50,9323fd2e-57cb-4149-ba36-274921d70215,49c4ace2-9695-4972-9a5a-2f32bbb4e2e0,,Adjuvant,,2023-02-22T07:39:25.979291-06:00,HCM-CSHL-0261-C50_treatment8,752df194-cf26-4c5d-b05f-07eca0be5151,,released,,0,2020-09-28T09:34:59.697286-05:00,Targeted Molecular Therapy,Residual Disease,
HCM-CSHL-0261-C50,9323fd2e-57cb-4149-ba36-274921d70215,49c4ace2-9695-4972-9a5a-2f32bbb4e2e0,,Neoadjuvant,,2023-02-22T07:39:25.979291-06:00,HCM-CSHL-0261-C50_treatment,7c0d34ca-fe48-4997-84ea-99cbcceb128f,,released,,0,2020-09-28T09:34:59.697286-05:00,,,
HCM-CSHL-0261-C50,9323fd2e-57cb-4149-ba36-274921d70215,49c4ace2-9695-4972-9a5a-2f32bbb4e2e0,246.0,Adjuvant,116.0,2023-02-22T07:39:25.979291-06:00,HCM-CSHL-0261-C50_treatment2,7f6a5692-b2a7-4bcb-ba0e-dddd6dd54f51,Treatment Ongoing,released,Doxorubicin,1,2020-09-28T09:34:59.697286-05:00,Chemotherapy,Residual Disease,
HCM-CSHL-0261-C50,9323fd2e-57cb-4149-ba36-274921d70215,49c4ace2-9695-4972-9a5a-2f32bbb4e2e0,,Adjuvant,,2023-02-22T07:39:25.979291-06:00,HCM-CSHL-0261-C50_treatment5,80bd5857-3687-4257-8e6b-950b70f74b1a,,released,,0,2020-09-28T09:34:59.697286-05:00,Hormone Therapy,Residual Disease,
HCM-CSHL-0261-C50,9323fd2e-57cb-4149-ba36-274921d70215,49c4ace2-9695-4972-9a5a-2f32bbb4e2e0,246.0,Adjuvant,116.0,2023-02-22T07:39:25.979291-06:00,HCM-CSHL-0261-C50_treatment4,8c5de103-b94a-41c7-9c52-884f5a0987a5,Treatment Ongoing,released,Paclitaxel,1,2020-09-28T09:34:59.697286-05:00,Chemotherapy,Residual Disease,
HCM-CSHL-0261-C50,9323fd2e-57cb-4149-ba36-274921d70215,49c4ace2-9695-4972-9a5a-2f32bbb4e2e0,,Adjuvant,,2023-02-22T07:39:25.979291-06:00,HCM-CSHL-0261-C50_treatment9,d9726b62-c79f-4ee2-aefa-696704e08191,,released,,1,2020-09-28T09:34:59.697286-05:00,"Radiation Therapy, NOS",Residual Disease,
HCM-CSHL-0261-C50,9323fd2e-57cb-4149-ba36-274921d70215,49c4ace2-9695-4972-9a5a-2f32bbb4e2e0,246.0,Adjuvant,116.0,2023-02-22T07:39:25.979291-06:00,HCM-CSHL-0261-C50_treatment3,e99e38f9-7f4d-401b-b024-0e6708ff969a,Treatment Ongoing,released,Cyclophosphamide,1,2020-09-28T09:34:59.697286-05:00,Chemotherapy,Residual Disease,
HCM-CSHL-0261-C50,9323fd2e-57cb-4149-ba36-274921d70215,49c4ace2-9695-4972-9a5a-2f32bbb4e2e0,,,23.0,2023-03-13T13:27:00.314098-05:00,HCM-CSHL-0261-C50_treatment7,ebaa0111-5bde-4f7c-b89b-57a7d1441085,,released,,1,2020-09-28T09:34:59.697286-05:00,"Surgery, NOS",Initial Diagnosis,
HCM-BROD-0561-C43,937294e7-5aab-4d1e-a8ca-1fbb73b0aae8,c6662957-5685-4707-a4ec-88f5377bf35e,,Adjuvant,,2021-03-03T15:15:08.075155-06:00,HCM-BROD-0561-C43_treatment8,37304c55-7005-4f00-9bf6-eaae7d2c4076,,released,,0,2020-09-27T12:01:46.136723-05:00,"Radiation Therapy, NOS",Residual Disease,
HCM-BROD-0561-C43,937294e7-5aab-4d1e-a8ca-1fbb73b0aae8,c6662957-5685-4707-a4ec-88f5377bf35e,,Neoadjuvant,,2021-03-03T15:15:08.075155-06:00,HCM-BROD-0561-C43_treatment,47129706-e8fd-4735-b76a-bf69905963b9,,released,,unknown,2020-07-31T09:30:09.163762-05:00,"Pharmaceutical Therapy, NOS",,
HCM-BROD-0561-C43,937294e7-5aab-4d1e-a8ca-1fbb73b0aae8,c6662957-5685-4707-a4ec-88f5377bf35e,,Adjuvant,,2021-03-03T15:15:08.075155-06:00,HCM-BROD-0561-C43_treatment4,8b35f85e-ff96-4e05-8632-4dde9771b9df,,released,,0,2020-07-31T09:30:09.163762-05:00,Hormone Therapy,Residual Disease,
HCM-BROD-0561-C43,937294e7-5aab-4d1e-a8ca-1fbb73b0aae8,c6662957-5685-4707-a4ec-88f5377bf35e,,,,2023-02-27T11:51:39.373266-06:00,HCM-BROD-0561-C43_treatment6,adbcdddd-67cd-4e5c-a171-0c456987334e,,released,,unknown,2020-07-31T09:30:09.163762-05:00,"Surgery, NOS",Initial Diagnosis,
HCM-BROD-0561-C43,937294e7-5aab-4d1e-a8ca-1fbb73b0aae8,c6662957-5685-4707-a4ec-88f5377bf35e,,Neoadjuvant,,2021-03-03T15:15:08.075155-06:00,HCM-BROD-0561-C43_treatment2,c43c0915-2ac9-42ea-bc69-f367eeb95c94,,released,,unknown,2020-07-31T09:30:09.163762-05:00,"Radiation Therapy, NOS",,
HCM-BROD-0561-C43,937294e7-5aab-4d1e-a8ca-1fbb73b0aae8,c6662957-5685-4707-a4ec-88f5377bf35e,788.0,Adjuvant,418.0,2021-03-03T15:15:08.075155-06:00,HCM-BROD-0561-C43_treatment5,c4b9ca72-11f6-452b-a72e-65634ada42e7,,released,Not Reported,1,2020-07-31T09:30:09.163762-05:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-BROD-0561-C43,937294e7-5aab-4d1e-a8ca-1fbb73b0aae8,c6662957-5685-4707-a4ec-88f5377bf35e,335.0,Adjuvant,26.0,2021-03-03T15:15:08.075155-06:00,HCM-BROD-0561-C43_treatment7,c858b7c1-72d2-43a7-91ee-655298cb71bd,,released,Not Reported,1,2020-07-31T09:30:09.163762-05:00,Targeted Molecular Therapy,Residual Disease,
HCM-BROD-0561-C43,937294e7-5aab-4d1e-a8ca-1fbb73b0aae8,c6662957-5685-4707-a4ec-88f5377bf35e,,Adjuvant,,2021-03-03T15:15:08.075155-06:00,HCM-BROD-0561-C43_treatment3,f361464e-cd78-456c-bb8a-530f227558ef,,released,,0,2020-07-31T09:30:09.163762-05:00,Chemotherapy,Residual Disease,
HCM-BROD-0132-C25,93d1a30b-21c8-4cf7-9d51-49f6e03ef679,2d4ac6fc-6c45-4e02-a57e-5cb7accec807,,Adjuvant,,2023-07-13T10:35:44.371881-05:00,HCM-BROD-0132-C25_treatment17,22a3b9fd-ab74-439a-92c4-8b96a422c04d,,released,,0,2020-09-27T10:48:53.723866-05:00,Targeted Molecular Therapy,Residual Disease,
HCM-BROD-0132-C25,93d1a30b-21c8-4cf7-9d51-49f6e03ef679,2d4ac6fc-6c45-4e02-a57e-5cb7accec807,,Neoadjuvant,14.0,2023-07-13T10:35:44.371881-05:00,HCM-BROD-0132-C25_treatment2,2d51c8e0-0ea8-4670-991c-2a61f9d27998,,released,Leucovorin Calcium,1,2020-07-23T14:37:44.201923-05:00,Chemotherapy,,
HCM-BROD-0132-C25,93d1a30b-21c8-4cf7-9d51-49f6e03ef679,2d4ac6fc-6c45-4e02-a57e-5cb7accec807,,Neoadjuvant,,2023-07-13T10:35:44.371881-05:00,HCM-BROD-0132-C25_treatment8,42fffdcf-2b78-47fc-a461-379d552e6dc8,,released,,1,2020-07-23T14:37:44.201923-05:00,Targeted Molecular Therapy,,
HCM-BROD-0132-C25,93d1a30b-21c8-4cf7-9d51-49f6e03ef679,2d4ac6fc-6c45-4e02-a57e-5cb7accec807,,Neoadjuvant,14.0,2023-07-13T10:35:44.371881-05:00,HCM-BROD-0132-C25_treatment4,4971f02b-e1d4-4979-9a80-c3358dd78374,,released,Oxaliplatin,1,2020-07-23T14:37:44.201923-05:00,Chemotherapy,,
HCM-BROD-0132-C25,93d1a30b-21c8-4cf7-9d51-49f6e03ef679,2d4ac6fc-6c45-4e02-a57e-5cb7accec807,,Neoadjuvant,14.0,2023-07-13T10:35:44.371881-05:00,HCM-BROD-0132-C25_treatment5,6476f8ee-9b18-4ad7-b897-81641b05f4f3,,released,,1,2020-07-23T14:37:44.201923-05:00,Chemotherapy,,FOLFIRINOX
HCM-BROD-0132-C25,93d1a30b-21c8-4cf7-9d51-49f6e03ef679,2d4ac6fc-6c45-4e02-a57e-5cb7accec807,185.0,Adjuvant,25.0,2023-07-13T10:35:44.371881-05:00,HCM-BROD-0132-C25_treatment9,70d82882-12eb-4c54-aabe-e7d67fd0c105,,released,Irinotecan Hydrochloride,1,2020-07-23T14:37:44.201923-05:00,Chemotherapy,Residual Disease,
HCM-BROD-0132-C25,93d1a30b-21c8-4cf7-9d51-49f6e03ef679,2d4ac6fc-6c45-4e02-a57e-5cb7accec807,185.0,Adjuvant,25.0,2023-07-13T10:35:44.371881-05:00,HCM-BROD-0132-C25_treatment12,7465a716-a2ee-4acc-a586-0253ec3385c2,,released,Oxaliplatin,1,2020-09-27T10:48:53.723866-05:00,Chemotherapy,Residual Disease,
HCM-BROD-0132-C25,93d1a30b-21c8-4cf7-9d51-49f6e03ef679,2d4ac6fc-6c45-4e02-a57e-5cb7accec807,235.0,Adjuvant,227.0,2023-07-13T10:35:44.371881-05:00,HCM-BROD-0132-C25_treatment14,7aef82a6-66a4-40bf-96e1-479a1bdfaf95,,released,Gemcitabine,1,2020-09-27T10:48:53.723866-05:00,Chemotherapy,Residual Disease,
HCM-BROD-0132-C25,93d1a30b-21c8-4cf7-9d51-49f6e03ef679,2d4ac6fc-6c45-4e02-a57e-5cb7accec807,,Adjuvant,,2023-07-13T10:35:44.371881-05:00,HCM-BROD-0132-C25_treatment15,8fc0da15-6d4f-4fd5-a15c-8b3514e0055f,,released,,0,2020-09-27T10:48:53.723866-05:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-BROD-0132-C25,93d1a30b-21c8-4cf7-9d51-49f6e03ef679,2d4ac6fc-6c45-4e02-a57e-5cb7accec807,185.0,Adjuvant,25.0,2023-07-13T10:35:44.371881-05:00,HCM-BROD-0132-C25_treatment10,a52a2020-f414-4088-8ede-55e2124b47f8,,released,Leucovorin Calcium,1,2020-07-23T14:37:44.201923-05:00,Chemotherapy,Residual Disease,
HCM-BROD-0132-C25,93d1a30b-21c8-4cf7-9d51-49f6e03ef679,2d4ac6fc-6c45-4e02-a57e-5cb7accec807,,Adjuvant,,2023-07-13T10:35:44.371881-05:00,HCM-BROD-0132-C25_treatment18,a9e59252-293c-429f-8328-703643b9ed44,,released,,0,2020-09-27T10:48:53.723866-05:00,"Radiation Therapy, NOS",Residual Disease,
HCM-BROD-0132-C25,93d1a30b-21c8-4cf7-9d51-49f6e03ef679,2d4ac6fc-6c45-4e02-a57e-5cb7accec807,,Neoadjuvant,14.0,2023-07-13T10:35:44.371881-05:00,HCM-BROD-0132-C25_treatment7,ba9e17a9-6f00-4ba8-9e33-ab86ca3948a1,,released,Nab-paclitaxel,1,2020-07-23T14:37:44.201923-05:00,Chemotherapy,,
HCM-BROD-0132-C25,93d1a30b-21c8-4cf7-9d51-49f6e03ef679,2d4ac6fc-6c45-4e02-a57e-5cb7accec807,,Neoadjuvant,14.0,2023-07-13T10:35:44.371881-05:00,HCM-BROD-0132-C25_treatment3,bc12468c-7c2a-423b-9e68-34a44d0d9d43,,released,Fluorouracil,1,2020-07-23T14:37:44.201923-05:00,Chemotherapy,,
HCM-BROD-0132-C25,93d1a30b-21c8-4cf7-9d51-49f6e03ef679,2d4ac6fc-6c45-4e02-a57e-5cb7accec807,,Neoadjuvant,14.0,2023-07-13T10:35:44.371881-05:00,HCM-BROD-0132-C25_treatment6,c3ee34fa-01f4-4a4a-8f55-f4b80590e091,,released,Gemcitabine,1,2020-07-23T14:37:44.201923-05:00,Chemotherapy,,
HCM-BROD-0132-C25,93d1a30b-21c8-4cf7-9d51-49f6e03ef679,2d4ac6fc-6c45-4e02-a57e-5cb7accec807,,,,2023-07-13T10:35:44.371881-05:00,HCM-BROD-0132-C25_treatment16,d0ab3f37-9b09-4e3f-9d35-f52e6d7d5f16,,released,,0,2020-09-27T10:48:53.723866-05:00,"Surgery, NOS",Initial Diagnosis,
HCM-BROD-0132-C25,93d1a30b-21c8-4cf7-9d51-49f6e03ef679,2d4ac6fc-6c45-4e02-a57e-5cb7accec807,,Neoadjuvant,14.0,2023-07-13T10:35:44.371881-05:00,HCM-BROD-0132-C25_treatment,d1537b98-5da2-4047-b7c4-091fcd2c56a5,,released,Irinotecan Hydrochloride,1,2020-07-23T14:37:44.201923-05:00,Chemotherapy,,
HCM-BROD-0132-C25,93d1a30b-21c8-4cf7-9d51-49f6e03ef679,2d4ac6fc-6c45-4e02-a57e-5cb7accec807,185.0,Adjuvant,25.0,2023-07-13T10:35:44.371881-05:00,HCM-BROD-0132-C25_treatment11,dce96ecf-6d4b-4c48-a077-26f11689467d,,released,Fluorouracil,1,2020-09-27T10:48:53.723866-05:00,Chemotherapy,Residual Disease,
HCM-BROD-0132-C25,93d1a30b-21c8-4cf7-9d51-49f6e03ef679,2d4ac6fc-6c45-4e02-a57e-5cb7accec807,185.0,Adjuvant,25.0,2023-07-13T10:35:44.371881-05:00,HCM-BROD-0132-C25_treatment13,f299193c-98ff-4e6d-a567-d3ca6eb37c04,,released,,1,2020-09-27T10:48:53.723866-05:00,Chemotherapy,Residual Disease,FOLFIRINOX
HCM-CSHL-0653-C18,93e57b22-1606-47a8-88de-482159a8623d,684d9285-ebcb-4c3f-bff4-c5b821f7c56b,82.0,Maintenance Therapy,12.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0653-C18_treatment17,1a1d8238-e3c1-4bcd-8709-ebbfc9e18ade,Stable Disease,released,,1,2021-12-21T14:13:49.405059-06:00,,,FOLFOX
HCM-CSHL-0653-C18,93e57b22-1606-47a8-88de-482159a8623d,684d9285-ebcb-4c3f-bff4-c5b821f7c56b,82.0,Maintenance Therapy,12.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0653-C18_treatment16,56661ba1-9207-4a07-8599-ef7a3c06027f,Stable Disease,released,Oxaliplatin,1,2021-12-21T14:13:49.405059-06:00,,,
HCM-CSHL-0653-C18,93e57b22-1606-47a8-88de-482159a8623d,684d9285-ebcb-4c3f-bff4-c5b821f7c56b,82.0,Maintenance Therapy,12.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0653-C18_treatment15,95e2fd7e-23b9-4cd6-b22a-e39b712fa973,Stable Disease,released,Fluorouracil,1,2021-12-21T14:13:49.405059-06:00,,,
HCM-CSHL-0653-C18,93e57b22-1606-47a8-88de-482159a8623d,684d9285-ebcb-4c3f-bff4-c5b821f7c56b,82.0,Maintenance Therapy,12.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0653-C18_treatment14,f995116a-1e92-4721-9063-b01f3cc1cd33,Stable Disease,released,Leucovorin Calcium,1,2021-12-21T14:13:49.405059-06:00,,,
HCM-CSHL-0653-C18,93e57b22-1606-47a8-88de-482159a8623d,d6d3ad28-b326-4de8-a826-ce85cf57ce52,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0653-C18_treatment13,108dd368-0df2-4826-8c25-8f247d718f18,,released,,0,2021-12-21T14:13:49.405059-06:00,"Radiation Therapy, NOS",Residual Disease,
HCM-CSHL-0653-C18,93e57b22-1606-47a8-88de-482159a8623d,d6d3ad28-b326-4de8-a826-ce85cf57ce52,256.0,Adjuvant,182.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0653-C18_treatment8,1f950a84-3ff7-46b7-8304-f6a79a73ac53,,released,,1,2021-12-21T14:13:49.405059-06:00,Chemotherapy,Residual Disease,FOLFOX
HCM-CSHL-0653-C18,93e57b22-1606-47a8-88de-482159a8623d,d6d3ad28-b326-4de8-a826-ce85cf57ce52,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0653-C18_treatment10,326276a1-9b85-430f-aae1-ce18a8ce2836,,released,,0,2021-12-21T14:13:49.405059-06:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-CSHL-0653-C18,93e57b22-1606-47a8-88de-482159a8623d,d6d3ad28-b326-4de8-a826-ce85cf57ce52,256.0,Adjuvant,182.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0653-C18_treatment7,35de9ca1-5ba6-4ad9-a697-94d9209e70f3,,released,Oxaliplatin,1,2021-12-21T14:13:49.405059-06:00,Chemotherapy,Residual Disease,
HCM-CSHL-0653-C18,93e57b22-1606-47a8-88de-482159a8623d,d6d3ad28-b326-4de8-a826-ce85cf57ce52,531.0,Adjuvant,285.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0653-C18_treatment9,4c6dcc01-388d-4bb0-adc5-52d8611ebd00,,released,Capecitabine,1,2021-12-21T14:13:49.405059-06:00,Chemotherapy,Residual Disease,
HCM-CSHL-0653-C18,93e57b22-1606-47a8-88de-482159a8623d,d6d3ad28-b326-4de8-a826-ce85cf57ce52,,,114.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0653-C18_treatment11,555c75df-c5d8-414f-bd53-bd0d673f95f3,,released,,1,2021-12-21T14:13:49.405059-06:00,"Surgery, NOS",Initial Diagnosis,
HCM-CSHL-0653-C18,93e57b22-1606-47a8-88de-482159a8623d,d6d3ad28-b326-4de8-a826-ce85cf57ce52,,Neoadjuvant,12.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0653-C18_treatment3,621295fc-0cf4-40b0-ba8a-0bad28b3deca,,released,Oxaliplatin,1,2021-12-21T14:13:49.405059-06:00,Chemotherapy,,
HCM-CSHL-0653-C18,93e57b22-1606-47a8-88de-482159a8623d,d6d3ad28-b326-4de8-a826-ce85cf57ce52,,Neoadjuvant,12.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0653-C18_treatment2,98244215-deb5-43bb-9325-5b212e961aa7,,released,Fluorouracil,1,2021-12-21T14:13:49.405059-06:00,Chemotherapy,,
HCM-CSHL-0653-C18,93e57b22-1606-47a8-88de-482159a8623d,d6d3ad28-b326-4de8-a826-ce85cf57ce52,256.0,Adjuvant,182.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0653-C18_treatment5,ab5f569b-351f-4d77-9832-3dbe80e5616d,,released,Leucovorin Calcium,1,2021-12-21T14:13:49.405059-06:00,Chemotherapy,Residual Disease,
HCM-CSHL-0653-C18,93e57b22-1606-47a8-88de-482159a8623d,d6d3ad28-b326-4de8-a826-ce85cf57ce52,256.0,Adjuvant,182.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0653-C18_treatment6,b92d85c9-5c72-4d19-9aaa-ae57d792825a,,released,Fluorouracil,1,2021-12-21T14:13:49.405059-06:00,Chemotherapy,Residual Disease,
HCM-CSHL-0653-C18,93e57b22-1606-47a8-88de-482159a8623d,d6d3ad28-b326-4de8-a826-ce85cf57ce52,,Neoadjuvant,12.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0653-C18_treatment,e1393acc-962e-4363-9ffb-574d1cb0884d,,released,Leucovorin Calcium,1,2021-12-21T14:13:49.405059-06:00,Chemotherapy,,
HCM-CSHL-0653-C18,93e57b22-1606-47a8-88de-482159a8623d,d6d3ad28-b326-4de8-a826-ce85cf57ce52,531.0,Adjuvant,285.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0653-C18_treatment12,e38dd100-937c-4d39-b09e-76df8b6bc277,,released,Bevacizumab,1,2021-12-21T14:13:49.405059-06:00,Targeted Molecular Therapy,Residual Disease,
HCM-CSHL-0653-C18,93e57b22-1606-47a8-88de-482159a8623d,d6d3ad28-b326-4de8-a826-ce85cf57ce52,,Neoadjuvant,12.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0653-C18_treatment4,ec6015fc-c869-4f84-bb70-4d6f7147d4d5,,released,,1,2021-12-21T14:13:49.405059-06:00,Chemotherapy,,FOLFOX
HCM-CSHL-0426-C18,93eb458f-2b57-498b-a356-9b5540cc545c,b4f7fa12-c984-4546-aea6-cbf0e92706d8,,Adjuvant,,2021-07-12T12:25:55.528644-05:00,HCM-CSHL-0426-C18_treatment4,09de93bb-116b-47d7-8655-64d3102d4cf6,,released,,0,2020-09-28T10:09:25.305641-05:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-CSHL-0426-C18,93eb458f-2b57-498b-a356-9b5540cc545c,b4f7fa12-c984-4546-aea6-cbf0e92706d8,,Adjuvant,90.0,2021-07-12T12:25:55.528644-05:00,HCM-CSHL-0426-C18_treatment2,0bd1f82a-4e35-4b0d-96b2-5455d686e88e,,released,Capecitabine,1,2020-09-28T10:09:25.305641-05:00,Chemotherapy,Residual Disease,
HCM-CSHL-0426-C18,93eb458f-2b57-498b-a356-9b5540cc545c,b4f7fa12-c984-4546-aea6-cbf0e92706d8,,Adjuvant,,2021-07-12T12:25:55.528644-05:00,HCM-CSHL-0426-C18_treatment6,2da19a96-9b5f-4be1-9eae-99d9de26aefd,,released,,0,2020-09-28T10:09:25.305641-05:00,Targeted Molecular Therapy,Residual Disease,
HCM-CSHL-0426-C18,93eb458f-2b57-498b-a356-9b5540cc545c,b4f7fa12-c984-4546-aea6-cbf0e92706d8,,Adjuvant,90.0,2021-07-12T12:25:55.528644-05:00,HCM-CSHL-0426-C18_treatment3,647f5ce7-fff7-469c-83bb-45a7bcbfa005,,released,Oxaliplatin,1,2020-09-28T10:09:25.305641-05:00,Chemotherapy,Residual Disease,
HCM-CSHL-0426-C18,93eb458f-2b57-498b-a356-9b5540cc545c,b4f7fa12-c984-4546-aea6-cbf0e92706d8,,Neoadjuvant,,2021-07-12T12:25:55.528644-05:00,HCM-CSHL-0426-C18_treatment,75a55d65-9e3f-4074-a63c-313df509c3d4,,released,,0,2020-09-28T10:09:25.305641-05:00,,,
HCM-CSHL-0426-C18,93eb458f-2b57-498b-a356-9b5540cc545c,b4f7fa12-c984-4546-aea6-cbf0e92706d8,,,34.0,2023-03-13T12:47:57.590074-05:00,HCM-CSHL-0426-C18_treatment5,86826a4e-3b50-4e03-be07-9a15b63e3183,,released,,1,2020-09-28T10:09:25.305641-05:00,"Surgery, NOS",Initial Diagnosis,
HCM-CSHL-0426-C18,93eb458f-2b57-498b-a356-9b5540cc545c,b4f7fa12-c984-4546-aea6-cbf0e92706d8,,Adjuvant,,2021-07-12T12:25:55.528644-05:00,HCM-CSHL-0426-C18_treatment7,a2499ac0-a7f0-4003-9063-146d6e7dc7fb,,released,,0,2020-09-28T10:09:25.305641-05:00,"Radiation Therapy, NOS",Residual Disease,
HCM-CSHL-0403-C25,943e817d-37f3-4df0-84c5-d572ca3de923,5f861766-3eaf-41f4-ace3-9e97d6b473cf,470.0,Adjuvant,466.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0403-C25_treatment10,09a488ec-8ea8-43d9-82bb-36d59efd0cca,,released,,1,2021-12-21T14:05:44.575048-06:00,"Radiation, Mixed Photon Beam",Residual Disease,
HCM-CSHL-0403-C25,943e817d-37f3-4df0-84c5-d572ca3de923,5f861766-3eaf-41f4-ace3-9e97d6b473cf,517.0,Adjuvant,454.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0403-C25_treatment2,425e31c2-d501-41f6-b681-10fb12013628,,released,Irinotecan Hydrochloride,1,2021-12-21T14:05:44.575048-06:00,Chemotherapy,Residual Disease,
HCM-CSHL-0403-C25,943e817d-37f3-4df0-84c5-d572ca3de923,5f861766-3eaf-41f4-ace3-9e97d6b473cf,,,36.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0403-C25_treatment8,4540b2dd-9dad-469e-8a68-31e6c397e0e5,,released,,1,2021-12-21T14:05:44.575048-06:00,"Surgery, NOS",Initial Diagnosis,
HCM-CSHL-0403-C25,943e817d-37f3-4df0-84c5-d572ca3de923,5f861766-3eaf-41f4-ace3-9e97d6b473cf,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0403-C25_treatment7,77bdec68-a0b6-4f77-956a-de6590c69d19,,released,,0,2021-12-21T14:05:44.575048-06:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-CSHL-0403-C25,943e817d-37f3-4df0-84c5-d572ca3de923,5f861766-3eaf-41f4-ace3-9e97d6b473cf,,Neoadjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0403-C25_treatment,8fa0adab-37c0-4463-83e0-fe3318549e59,,released,,0,2021-12-21T14:05:44.575048-06:00,,,
HCM-CSHL-0403-C25,943e817d-37f3-4df0-84c5-d572ca3de923,5f861766-3eaf-41f4-ace3-9e97d6b473cf,517.0,Adjuvant,454.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0403-C25_treatment5,92802753-f3e4-4b24-bb21-14dce82abb73,,released,Oxaliplatin,1,2021-12-21T14:05:44.575048-06:00,Chemotherapy,Residual Disease,
HCM-CSHL-0403-C25,943e817d-37f3-4df0-84c5-d572ca3de923,5f861766-3eaf-41f4-ace3-9e97d6b473cf,517.0,Adjuvant,454.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0403-C25_treatment6,92f5362f-c3b6-44df-8a83-4e1a866e65e3,,released,,1,2021-12-21T14:05:44.575048-06:00,Chemotherapy,Residual Disease,FOLFIRINOX
HCM-CSHL-0403-C25,943e817d-37f3-4df0-84c5-d572ca3de923,5f861766-3eaf-41f4-ace3-9e97d6b473cf,517.0,Adjuvant,454.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0403-C25_treatment4,ed0c88b9-1991-4413-b5e4-a96b22aa6231,,released,Fluorouracil,1,2021-12-21T14:05:44.575048-06:00,Chemotherapy,Residual Disease,
HCM-CSHL-0403-C25,943e817d-37f3-4df0-84c5-d572ca3de923,5f861766-3eaf-41f4-ace3-9e97d6b473cf,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0403-C25_treatment9,fa77070f-5ecd-452f-8310-6300f835177f,,released,,0,2021-12-21T14:05:44.575048-06:00,Targeted Molecular Therapy,Residual Disease,
HCM-CSHL-0403-C25,943e817d-37f3-4df0-84c5-d572ca3de923,5f861766-3eaf-41f4-ace3-9e97d6b473cf,517.0,Adjuvant,454.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0403-C25_treatment3,fde7fb23-edde-4dd5-ab0a-8561f7de2cbf,,released,Leucovorin Calcium,1,2021-12-21T14:05:44.575048-06:00,Chemotherapy,Residual Disease,
HCM-BROD-0959-C18,94780bed-98b3-4556-ac0d-7b998921c4c0,04751488-0f66-4a6c-8b1d-fb603e2ed016,,Neoadjuvant,30.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0959-C18_treatment2,076c7502-05db-46b8-8db9-c1c6818a0d33,,released,Fluorouracil,1,2021-12-21T13:58:49.208526-06:00,Chemotherapy,,
HCM-BROD-0959-C18,94780bed-98b3-4556-ac0d-7b998921c4c0,04751488-0f66-4a6c-8b1d-fb603e2ed016,,Neoadjuvant,30.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0959-C18_treatment4,38d1979d-e18a-44c5-b151-0e9797f28c69,,released,,1,2021-12-21T13:58:49.208526-06:00,Chemotherapy,,FOLFOX
HCM-BROD-0959-C18,94780bed-98b3-4556-ac0d-7b998921c4c0,04751488-0f66-4a6c-8b1d-fb603e2ed016,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0959-C18_treatment5,5475247d-6493-4636-964f-c43b333d0f70,,released,,0,2021-12-21T13:58:49.208526-06:00,Chemotherapy,Residual Disease,
HCM-BROD-0959-C18,94780bed-98b3-4556-ac0d-7b998921c4c0,04751488-0f66-4a6c-8b1d-fb603e2ed016,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0959-C18_treatment9,ad32bde6-e468-4ee4-ab0d-bb4524403694,,released,,0,2021-12-21T13:58:49.208526-06:00,"Radiation Therapy, NOS",Residual Disease,
HCM-BROD-0959-C18,94780bed-98b3-4556-ac0d-7b998921c4c0,04751488-0f66-4a6c-8b1d-fb603e2ed016,,Neoadjuvant,30.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0959-C18_treatment,b250a944-1928-44b1-a669-35c208c2dda1,,released,Leucovorin Calcium,1,2021-12-21T13:58:49.208526-06:00,Chemotherapy,,
HCM-BROD-0959-C18,94780bed-98b3-4556-ac0d-7b998921c4c0,04751488-0f66-4a6c-8b1d-fb603e2ed016,1443.0,Adjuvant,938.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0959-C18_treatment8,b7687b4b-22e4-430a-bf16-f4450e875561,Treatment Ongoing,released,Unknown,1,2021-12-21T13:58:49.208526-06:00,Targeted Molecular Therapy,Residual Disease,
HCM-BROD-0959-C18,94780bed-98b3-4556-ac0d-7b998921c4c0,04751488-0f66-4a6c-8b1d-fb603e2ed016,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0959-C18_treatment6,b800009d-b6a5-4287-8009-1cfc57963e88,,released,,0,2021-12-21T13:58:49.208526-06:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-BROD-0959-C18,94780bed-98b3-4556-ac0d-7b998921c4c0,04751488-0f66-4a6c-8b1d-fb603e2ed016,,Neoadjuvant,30.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0959-C18_treatment3,d006ccb0-98f1-47ba-ad8c-f72b7103bb20,,released,Oxaliplatin,1,2021-12-21T13:58:49.208526-06:00,Chemotherapy,,
HCM-BROD-0959-C18,94780bed-98b3-4556-ac0d-7b998921c4c0,04751488-0f66-4a6c-8b1d-fb603e2ed016,,,0.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0959-C18_treatment7,d050947a-66ae-483d-8762-672b1d5c4fab,,released,,1,2021-12-21T13:58:49.208526-06:00,"Surgery, NOS",Initial Diagnosis,
HCM-BROD-0679-C43,94b66b8a-d5e9-4e4c-ab44-290c6d12480e,e78a1331-3289-4d7d-89e0-859f65eaa90e,587.0,Adjuvant,370.0,2021-09-10T10:36:37.981324-05:00,HCM-BROD-0679-C43_treatment4,04e4b12c-a37d-4001-92a5-f40759661c14,,released,Pembrolizumab,1,2021-07-19T20:14:30.018265-05:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-BROD-0679-C43,94b66b8a-d5e9-4e4c-ab44-290c6d12480e,e78a1331-3289-4d7d-89e0-859f65eaa90e,,Adjuvant,,2021-09-10T10:36:37.981324-05:00,HCM-BROD-0679-C43_treatment6,14c7abd9-c172-4c42-a7f3-196d447535aa,,released,,0,2021-07-19T20:14:30.018265-05:00,Targeted Molecular Therapy,Residual Disease,
HCM-BROD-0679-C43,94b66b8a-d5e9-4e4c-ab44-290c6d12480e,e78a1331-3289-4d7d-89e0-859f65eaa90e,,Neoadjuvant,,2021-09-10T10:36:37.981324-05:00,HCM-BROD-0679-C43_treatment,29aeaee3-32e4-4ea3-9648-437ca2a779d4,,released,,0,2021-07-19T20:14:30.018265-05:00,,,
HCM-BROD-0679-C43,94b66b8a-d5e9-4e4c-ab44-290c6d12480e,e78a1331-3289-4d7d-89e0-859f65eaa90e,,Adjuvant,,2021-09-10T10:36:37.981324-05:00,HCM-BROD-0679-C43_treatment7,629ac084-5274-4609-8e69-974f198ae244,,released,,0,2021-07-19T20:14:30.018265-05:00,"Radiation Therapy, NOS",Residual Disease,
HCM-BROD-0679-C43,94b66b8a-d5e9-4e4c-ab44-290c6d12480e,e78a1331-3289-4d7d-89e0-859f65eaa90e,,,0.0,2023-02-27T13:29:09.387718-06:00,HCM-BROD-0679-C43_treatment5,68f0c4ee-e5a9-43c0-a0a3-679098dd8b1b,,released,,1,2021-07-19T20:14:30.018265-05:00,"Surgery, NOS",Initial Diagnosis,
HCM-BROD-0679-C43,94b66b8a-d5e9-4e4c-ab44-290c6d12480e,e78a1331-3289-4d7d-89e0-859f65eaa90e,,Adjuvant,,2021-09-10T10:36:37.981324-05:00,HCM-BROD-0679-C43_treatment2,7e3e3783-685e-4413-b6ea-6beeaa145724,,released,,0,2021-07-19T20:14:30.018265-05:00,Chemotherapy,Residual Disease,
HCM-BROD-0679-C43,94b66b8a-d5e9-4e4c-ab44-290c6d12480e,e78a1331-3289-4d7d-89e0-859f65eaa90e,,Adjuvant,,2021-09-10T10:36:37.981324-05:00,HCM-BROD-0679-C43_treatment3,b244dfdf-5848-4ab1-a30b-bfb87c500387,,released,,0,2021-07-19T20:14:30.018265-05:00,Hormone Therapy,Residual Disease,
HCM-CSHL-1268-C24,94eb0a19-ba87-4ca8-a021-01a2609845b3,a7706857-9bf4-4723-81c2-ec6db76395fe,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-1268-C24_treatment10,047119f5-cd6c-45f1-8d74-3ea090a4ab04,,released,,0,2021-12-23T08:09:27.059690-06:00,Targeted Molecular Therapy,Residual Disease,
HCM-CSHL-1268-C24,94eb0a19-ba87-4ca8-a021-01a2609845b3,a7706857-9bf4-4723-81c2-ec6db76395fe,,,-8.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-1268-C24_treatment9,26f4f3d9-5051-4129-b815-dda7c33ca028,,released,,1,2021-12-23T08:09:27.059690-06:00,"Surgery, NOS",Initial Diagnosis,
HCM-CSHL-1268-C24,94eb0a19-ba87-4ca8-a021-01a2609845b3,a7706857-9bf4-4723-81c2-ec6db76395fe,202.0,Adjuvant,51.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-1268-C24_treatment2,6e3f3c16-0361-467f-ba22-3e14abe3d6b0,,released,Leucovorin Calcium,1,2021-12-23T08:09:27.059690-06:00,Chemotherapy,Residual Disease,
HCM-CSHL-1268-C24,94eb0a19-ba87-4ca8-a021-01a2609845b3,a7706857-9bf4-4723-81c2-ec6db76395fe,202.0,Adjuvant,51.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-1268-C24_treatment3,82a188c4-d70d-4e12-9ae4-76485b3836ed,,released,Irinotecan Hydrochloride,1,2021-12-23T08:09:27.059690-06:00,Chemotherapy,Residual Disease,
HCM-CSHL-1268-C24,94eb0a19-ba87-4ca8-a021-01a2609845b3,a7706857-9bf4-4723-81c2-ec6db76395fe,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-1268-C24_treatment7,8b6dbee7-9e76-4c4b-8ba3-3a4ef8bb296d,,released,,0,2021-12-23T08:09:27.059690-06:00,Hormone Therapy,Residual Disease,
HCM-CSHL-1268-C24,94eb0a19-ba87-4ca8-a021-01a2609845b3,a7706857-9bf4-4723-81c2-ec6db76395fe,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-1268-C24_treatment11,8f2965ff-8a06-4b92-bf35-fa4df57f2362,,released,,0,2021-12-23T08:09:27.059690-06:00,"Radiation Therapy, NOS",Residual Disease,
HCM-CSHL-1268-C24,94eb0a19-ba87-4ca8-a021-01a2609845b3,a7706857-9bf4-4723-81c2-ec6db76395fe,,Neoadjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-1268-C24_treatment,93058434-ccb5-41dc-8ac5-55e29dccd85e,,released,,0,2021-12-23T08:09:27.059690-06:00,,,
HCM-CSHL-1268-C24,94eb0a19-ba87-4ca8-a021-01a2609845b3,a7706857-9bf4-4723-81c2-ec6db76395fe,202.0,Adjuvant,51.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-1268-C24_treatment5,ce99beab-5773-4aea-ad49-407dad580493,,released,Fluorouracil,1,2021-12-23T08:09:27.059690-06:00,Chemotherapy,Residual Disease,
HCM-CSHL-1268-C24,94eb0a19-ba87-4ca8-a021-01a2609845b3,a7706857-9bf4-4723-81c2-ec6db76395fe,202.0,Adjuvant,51.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-1268-C24_treatment4,d7e00cbc-9881-4e93-b749-a5d3bd58ca1b,,released,Oxaliplatin,1,2021-12-23T08:09:27.059690-06:00,Chemotherapy,Residual Disease,
HCM-CSHL-1268-C24,94eb0a19-ba87-4ca8-a021-01a2609845b3,a7706857-9bf4-4723-81c2-ec6db76395fe,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-1268-C24_treatment8,de9d7092-8615-41d3-80b1-235ad9cefa6b,,released,,0,2021-12-23T08:09:27.059690-06:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-CSHL-1268-C24,94eb0a19-ba87-4ca8-a021-01a2609845b3,a7706857-9bf4-4723-81c2-ec6db76395fe,202.0,Adjuvant,51.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-1268-C24_treatment6,f8e27734-dc5f-4b1a-9dd7-eef2981e98eb,,released,,1,2021-12-23T08:09:27.059690-06:00,Chemotherapy,Residual Disease,FOLFIRINOX
HCM-BROD-0221-C43,95228cfd-9465-486e-8202-b27f834433c2,5336ad19-1a6b-4ef3-98c1-a59d45c82f5a,328.0,Adjuvant,223.0,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0221-C43_treatment4,24daf54a-6a46-484b-a9ad-9dda080f263e,,released,Pembrolizumab,1,2020-10-09T15:12:41.054401-05:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-BROD-0221-C43,95228cfd-9465-486e-8202-b27f834433c2,5336ad19-1a6b-4ef3-98c1-a59d45c82f5a,,Adjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0221-C43_treatment3,34a84040-781e-46f8-9e16-3607866c37bb,,released,,0,2020-10-09T15:12:41.054401-05:00,Hormone Therapy,Residual Disease,
HCM-BROD-0221-C43,95228cfd-9465-486e-8202-b27f834433c2,5336ad19-1a6b-4ef3-98c1-a59d45c82f5a,,,0.0,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0221-C43_treatment5,61fde8d5-7bea-4c91-b1ad-c905b3332056,,released,,1,2020-10-09T15:12:41.054401-05:00,"Surgery, NOS",Initial Diagnosis,
HCM-BROD-0221-C43,95228cfd-9465-486e-8202-b27f834433c2,5336ad19-1a6b-4ef3-98c1-a59d45c82f5a,,Adjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0221-C43_treatment6,67c1be88-03bb-438a-bba1-4ba918e596df,,released,,0,2020-10-09T15:12:41.054401-05:00,Targeted Molecular Therapy,Residual Disease,
HCM-BROD-0221-C43,95228cfd-9465-486e-8202-b27f834433c2,5336ad19-1a6b-4ef3-98c1-a59d45c82f5a,,Adjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0221-C43_treatment2,75ea5a6b-6861-4533-b32e-c84ce65ebf3b,,released,,0,2020-10-09T15:12:41.054401-05:00,Chemotherapy,Residual Disease,
HCM-BROD-0221-C43,95228cfd-9465-486e-8202-b27f834433c2,5336ad19-1a6b-4ef3-98c1-a59d45c82f5a,,Neoadjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0221-C43_treatment,a10a8443-d054-44c2-b104-51113b7b3e70,,released,,0,2020-10-09T15:12:41.054401-05:00,,,
HCM-BROD-0221-C43,95228cfd-9465-486e-8202-b27f834433c2,5336ad19-1a6b-4ef3-98c1-a59d45c82f5a,,Adjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0221-C43_treatment7,ef827bae-d7e8-4d52-88af-e6caba5ef449,,released,,0,2020-10-09T15:12:41.054401-05:00,"Radiation Therapy, NOS",Residual Disease,
HCM-SANG-1313-C18,964de890-fe31-4b2d-98ce-a8d8e95a7da2,c48de4fb-9043-479e-b5ae-b5d1d3a90cf0,,Neoadjuvant,166.0,2025-04-07T17:13:09.336794-05:00,HCM-SANG-1313-C18_treatment2,200e7a94-440b-4734-b002-1e61d6c3b830,,released,Fluorouracil,1,2023-02-27T13:34:10.221561-06:00,Chemotherapy,,
HCM-SANG-1313-C18,964de890-fe31-4b2d-98ce-a8d8e95a7da2,c48de4fb-9043-479e-b5ae-b5d1d3a90cf0,,Neoadjuvant,166.0,2025-04-07T17:13:09.336794-05:00,HCM-SANG-1313-C18_treatment3,2733e1fc-9d9e-4600-9cdf-0bbf746bd4b7,,released,Oxaliplatin,1,2023-02-27T13:34:10.221561-06:00,Chemotherapy,,
HCM-SANG-1313-C18,964de890-fe31-4b2d-98ce-a8d8e95a7da2,c48de4fb-9043-479e-b5ae-b5d1d3a90cf0,,Neoadjuvant,166.0,2025-04-07T17:13:09.336794-05:00,HCM-SANG-1313-C18_treatment,7dc2a41f-b826-4744-b408-d73055d98a40,,released,Leucovorin Calcium,1,2023-02-27T13:34:10.221561-06:00,Chemotherapy,,
HCM-SANG-1313-C18,964de890-fe31-4b2d-98ce-a8d8e95a7da2,c48de4fb-9043-479e-b5ae-b5d1d3a90cf0,,Neoadjuvant,166.0,2025-04-07T17:13:09.336794-05:00,HCM-SANG-1313-C18_treatment4,ef51c51e-53a8-44fb-a57a-5fbb85ff90f2,,released,,1,2023-02-27T13:34:10.221561-06:00,Chemotherapy,,FOLFOX
HCM-SANG-0284-C18,96dea2e6-e29b-4e09-b708-ae3b010a9906,b1389f91-1a9c-4c9e-b37f-3e3fc9626a97,,Neoadjuvant,,2023-02-22T07:39:25.979291-06:00,HCM-SANG-0284-C18_treatment,6aa6facc-f9b3-414c-8ede-11a83c830c6a,,released,,0,2020-06-15T12:07:29.247252-05:00,,,
HCM-SANG-1087-C18,97951f84-798d-451e-8f8e-d208c19d3955,4b1f5a8c-7625-4d37-857f-b17a875ee3f0,,Neoadjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-SANG-1087-C18_treatment,f7fdea41-7a77-4735-9608-4257dcf657f8,,released,,0,2023-02-27T12:57:30.418415-06:00,,,
HCM-BROD-0020-C15,97bd888f-4686-4c1d-b663-2920d3bdc7d8,c1331272-a205-43ef-8ce4-2d6ca05a2ef7,670.0,Adjuvant,607.0,2021-03-03T15:15:08.075155-06:00,HCM-BROD-0020-C15_treatment2,01f35929-d74a-4746-9d3b-485f2c484620,,released,Leucovorin,1,2020-02-11T15:30:15.502165-06:00,Chemotherapy,Residual Disease,
HCM-BROD-0020-C15,97bd888f-4686-4c1d-b663-2920d3bdc7d8,c1331272-a205-43ef-8ce4-2d6ca05a2ef7,,Adjuvant,,2021-03-03T15:15:08.075155-06:00,HCM-BROD-0020-C15_treatment7,04990ed0-e2f8-45e3-85dd-5ac0310b4e83,,released,,0,2020-02-11T15:30:15.502165-06:00,Targeted Molecular Therapy,Residual Disease,
HCM-BROD-0020-C15,97bd888f-4686-4c1d-b663-2920d3bdc7d8,c1331272-a205-43ef-8ce4-2d6ca05a2ef7,,Adjuvant,,2021-03-03T15:15:08.075155-06:00,HCM-BROD-0020-C15_treatment5,431f0015-202b-4f20-a46a-f1f3bdbac032,,released,,0,2020-02-11T15:30:15.502165-06:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-BROD-0020-C15,97bd888f-4686-4c1d-b663-2920d3bdc7d8,c1331272-a205-43ef-8ce4-2d6ca05a2ef7,670.0,Adjuvant,607.0,2021-03-03T15:15:08.075155-06:00,HCM-BROD-0020-C15_treatment4,46727137-c8da-4e6c-b692-61b474563f74,,released,Irinotecan,1,2020-02-11T15:30:15.502165-06:00,Chemotherapy,Residual Disease,
HCM-BROD-0020-C15,97bd888f-4686-4c1d-b663-2920d3bdc7d8,c1331272-a205-43ef-8ce4-2d6ca05a2ef7,670.0,Adjuvant,607.0,2021-03-03T15:15:08.075155-06:00,HCM-BROD-0020-C15_treatment3,a35a9734-a61e-4a11-a41e-7764765767f5,,released,Fluorouracil,1,2020-02-11T15:30:15.502165-06:00,Chemotherapy,Residual Disease,
HCM-BROD-0020-C15,97bd888f-4686-4c1d-b663-2920d3bdc7d8,c1331272-a205-43ef-8ce4-2d6ca05a2ef7,587.0,Adjuvant,569.0,2023-07-07T13:03:34.077367-05:00,HCM-BROD-0020-C15_treatment8,aa625bba-f39f-4abd-b22a-95aff1f046a7,,released,,1,2020-02-11T15:30:15.502165-06:00,"Radiation Therapy, NOS",Residual Disease,
HCM-BROD-0020-C15,97bd888f-4686-4c1d-b663-2920d3bdc7d8,c1331272-a205-43ef-8ce4-2d6ca05a2ef7,,Neoadjuvant,,2021-03-03T15:15:08.075155-06:00,HCM-BROD-0020-C15_treatment,bc8f44a7-f017-408b-9863-1dad3cedd936,,released,,0,2020-02-11T15:30:15.502165-06:00,,,
HCM-BROD-0020-C15,97bd888f-4686-4c1d-b663-2920d3bdc7d8,c1331272-a205-43ef-8ce4-2d6ca05a2ef7,,,,2023-02-27T12:34:00.485824-06:00,HCM-BROD-0020-C15_treatment6,eac39bcb-f8b1-45eb-8fb1-f860ef4c1fdd,,released,,0,2020-02-11T15:30:15.502165-06:00,"Surgery, NOS",Initial Diagnosis,
HCM-BROD-0695-C71,9997df42-0549-4ce0-bdf8-991ee54e0701,54d6f4ec-355d-4977-9b69-301b4e5ce319,209.0,Maintenance Therapy,4.0,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0695-C71_treatment7,c26f480d-07fe-4a8f-be53-43db98c8bfbb,Progressive Disease,released,Temozolomide,1,2021-12-21T13:46:00.694576-06:00,,,
HCM-BROD-0695-C71,9997df42-0549-4ce0-bdf8-991ee54e0701,a0efdf54-fd90-4efb-bc87-db07e87ea74a,,Neoadjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0695-C71_treatment,58a144d8-3fe2-4390-b0c3-8a1eea479b48,,released,,0,2021-12-21T13:46:00.694576-06:00,,,
HCM-BROD-0695-C71,9997df42-0549-4ce0-bdf8-991ee54e0701,a0efdf54-fd90-4efb-bc87-db07e87ea74a,446.0,Adjuvant,446.0,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0695-C71_treatment5,5fcd13f2-932c-4f38-8a1c-f3552c6d7a21,,released,Bevacizumab,1,2021-12-21T13:46:00.694576-06:00,Targeted Molecular Therapy,Residual Disease,
HCM-BROD-0695-C71,9997df42-0549-4ce0-bdf8-991ee54e0701,a0efdf54-fd90-4efb-bc87-db07e87ea74a,,Adjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0695-C71_treatment2,651c6be7-be9d-463a-b4a6-d95535dde1fe,,released,,0,2021-12-21T13:46:00.694576-06:00,Chemotherapy,Residual Disease,
HCM-BROD-0695-C71,9997df42-0549-4ce0-bdf8-991ee54e0701,a0efdf54-fd90-4efb-bc87-db07e87ea74a,277.0,Adjuvant,248.0,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0695-C71_treatment6,c9ae8830-8ea7-463b-999a-d4f61d4919e5,,released,,1,2021-12-21T13:46:00.694576-06:00,"Radiation, 2D Conventional",Residual Disease,
HCM-BROD-0695-C71,9997df42-0549-4ce0-bdf8-991ee54e0701,a0efdf54-fd90-4efb-bc87-db07e87ea74a,,,-30.0,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0695-C71_treatment4,d4e77552-3460-4bcf-bf6f-62a0d3ee10e7,,released,,1,2021-12-21T13:46:00.694576-06:00,"Surgery, NOS",Initial Diagnosis,
HCM-BROD-0695-C71,9997df42-0549-4ce0-bdf8-991ee54e0701,a0efdf54-fd90-4efb-bc87-db07e87ea74a,440.0,Adjuvant,248.0,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0695-C71_treatment3,f514e972-c342-46fd-a517-197bb1f9f030,,released,Not Reported,1,2021-12-21T13:46:00.694576-06:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-CSHL-0725-C02,9bf63d26-2156-4556-a56e-7c49148441ce,a811b2b2-a663-457e-87d6-3ef05467cfc1,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0725-C02_treatment4,4978e7d4-db08-45a2-8368-466ec84c6127,,released,,0,2021-12-21T14:18:32.309495-06:00,"Radiation Therapy, NOS",Residual Disease,
HCM-CSHL-0725-C02,9bf63d26-2156-4556-a56e-7c49148441ce,a811b2b2-a663-457e-87d6-3ef05467cfc1,,Neoadjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0725-C02_treatment,60582934-cc6d-4698-adf9-1bee9146e3d9,,released,,0,2021-12-21T14:18:32.309495-06:00,,,
HCM-CSHL-0725-C02,9bf63d26-2156-4556-a56e-7c49148441ce,a811b2b2-a663-457e-87d6-3ef05467cfc1,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0725-C02_treatment3,ec7c9d23-880b-4e73-aeb9-a9da49aaccb0,,released,,0,2021-12-21T14:18:32.309495-06:00,"Pharmaceutical Therapy, NOS",Residual Disease,
HCM-CSHL-0725-C02,9bf63d26-2156-4556-a56e-7c49148441ce,a811b2b2-a663-457e-87d6-3ef05467cfc1,,,0.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0725-C02_treatment2,f132b53e-0211-40c0-83fb-d732eab09af7,,released,,1,2021-12-21T14:18:32.309495-06:00,"Surgery, NOS",Initial Diagnosis,
HCM-BROD-0451-C15,9bfc8171-9b0a-4636-a230-a0a34ebaaac2,d8bd9c30-91f3-4543-986d-813b27343663,,Adjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0451-C15_treatment7,0b016d4a-8f7b-4544-866b-d949dd743227,,released,,0,2020-09-27T11:38:29.665034-05:00,Chemotherapy,Residual Disease,
HCM-BROD-0451-C15,9bfc8171-9b0a-4636-a230-a0a34ebaaac2,d8bd9c30-91f3-4543-986d-813b27343663,,Neoadjuvant,26.0,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0451-C15_treatment3,21aaec91-f0b2-4248-b8ac-cf5773077b19,,released,Paclitaxel,1,2020-09-27T11:38:29.665034-05:00,Chemotherapy,,
HCM-BROD-0451-C15,9bfc8171-9b0a-4636-a230-a0a34ebaaac2,d8bd9c30-91f3-4543-986d-813b27343663,,Adjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0451-C15_treatment11,39a6ea72-08ba-464d-aea9-f61d1355af16,,released,,0,2020-09-27T11:38:29.665034-05:00,"Radiation Therapy, NOS",Residual Disease,
HCM-BROD-0451-C15,9bfc8171-9b0a-4636-a230-a0a34ebaaac2,d8bd9c30-91f3-4543-986d-813b27343663,,Neoadjuvant,26.0,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0451-C15_treatment5,42c7c21d-7705-4db5-9fe4-118f1caae975,,released,Carboplatin,1,2020-09-27T11:38:29.665034-05:00,Chemotherapy,,
HCM-BROD-0451-C15,9bfc8171-9b0a-4636-a230-a0a34ebaaac2,d8bd9c30-91f3-4543-986d-813b27343663,,Adjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0451-C15_treatment10,62883e81-cc7f-4451-9daa-1f9f1ada7a25,,released,,0,2020-09-27T11:38:29.665034-05:00,Targeted Molecular Therapy,Residual Disease,
HCM-BROD-0451-C15,9bfc8171-9b0a-4636-a230-a0a34ebaaac2,d8bd9c30-91f3-4543-986d-813b27343663,,Neoadjuvant,26.0,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0451-C15_treatment2,6875e56f-a8a8-4e49-9f3c-df52f5ae4421,,released,Oxaliplatin,1,2020-09-27T11:38:29.665034-05:00,Chemotherapy,,
HCM-BROD-0451-C15,9bfc8171-9b0a-4636-a230-a0a34ebaaac2,d8bd9c30-91f3-4543-986d-813b27343663,,Neoadjuvant,26.0,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0451-C15_treatment4,8d47e7c6-ba04-4b7e-8560-f9606f0afbcb,,released,Leucovorin,1,2020-09-27T11:38:29.665034-05:00,Chemotherapy,,
HCM-BROD-0451-C15,9bfc8171-9b0a-4636-a230-a0a34ebaaac2,d8bd9c30-91f3-4543-986d-813b27343663,,Neoadjuvant,26.0,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0451-C15_treatment,bd1f736c-7de3-4750-af93-ab057562a835,,released,Fluorouracil,1,2020-09-27T11:38:29.665034-05:00,Chemotherapy,,
HCM-BROD-0451-C15,9bfc8171-9b0a-4636-a230-a0a34ebaaac2,d8bd9c30-91f3-4543-986d-813b27343663,,Neoadjuvant,26.0,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0451-C15_treatment6,eebadfae-4be9-475c-bd79-b3e5c202178e,,released,,1,2020-09-27T11:38:29.665034-05:00,"Radiation Therapy, NOS",,
HCM-BROD-0451-C15,9bfc8171-9b0a-4636-a230-a0a34ebaaac2,d8bd9c30-91f3-4543-986d-813b27343663,,,,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0451-C15_treatment9,f05aaa81-8ae2-48f4-8bc0-fe1f3d1b5f43,,released,,0,2020-09-27T11:38:29.665034-05:00,"Surgery, NOS",Initial Diagnosis,
HCM-BROD-0451-C15,9bfc8171-9b0a-4636-a230-a0a34ebaaac2,d8bd9c30-91f3-4543-986d-813b27343663,,Adjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0451-C15_treatment8,f7555c17-7429-4354-8147-9f6ab15cded6,,released,,0,2020-09-27T11:38:29.665034-05:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-BROD-0957-C34,9c24da6e-5546-4037-8ef6-61fc5c2c0901,6a2634ed-e4c9-4308-8fe4-54dae84a7369,572.0,Maintenance Therapy,0.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0957-C34_treatment6,47681a0f-5c06-457c-8dde-b30aa7b44fc6,Progressive Disease,released,Carboplatin,1,2023-02-28T13:01:22.482469-06:00,,,
HCM-BROD-0957-C34,9c24da6e-5546-4037-8ef6-61fc5c2c0901,6a2634ed-e4c9-4308-8fe4-54dae84a7369,572.0,Maintenance Therapy,0.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0957-C34_treatment8,a1b0f558-4e72-4055-accc-f69e81166f5e,Progressive Disease,released,Abemaciclib,1,2021-12-21T13:58:37.792595-06:00,,,
HCM-BROD-0957-C34,9c24da6e-5546-4037-8ef6-61fc5c2c0901,6a2634ed-e4c9-4308-8fe4-54dae84a7369,572.0,Maintenance Therapy,0.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0957-C34_treatment7,b1f6903b-88d7-46dd-b1ba-331ecc4e6049,Progressive Disease,released,Pemetrexed,1,2023-02-28T13:01:22.482469-06:00,,,
HCM-BROD-0957-C34,9c24da6e-5546-4037-8ef6-61fc5c2c0901,6a2634ed-e4c9-4308-8fe4-54dae84a7369,572.0,Maintenance Therapy,0.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0957-C34_treatment5,ed7ccf54-2eed-40c0-ace8-c3282e80ddd2,Progressive Disease,released,Pembrolizumab,1,2023-02-28T13:01:22.482469-06:00,,,
HCM-BROD-0957-C34,9c24da6e-5546-4037-8ef6-61fc5c2c0901,a1304c23-6a82-4bc8-8799-69d43a790054,,Neoadjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0957-C34_treatment,5ab27dd4-13fe-4d0c-833d-41127711f051,,released,,0,2021-12-21T13:58:37.792595-06:00,,,
HCM-BROD-0957-C34,9c24da6e-5546-4037-8ef6-61fc5c2c0901,a1304c23-6a82-4bc8-8799-69d43a790054,,,,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0957-C34_treatment2,937aaf60-26d4-4d34-9a49-f366a65d94fb,,released,,0,2021-12-21T13:58:37.792595-06:00,"Surgery, NOS",Initial Diagnosis,
HCM-BROD-0957-C34,9c24da6e-5546-4037-8ef6-61fc5c2c0901,a1304c23-6a82-4bc8-8799-69d43a790054,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0957-C34_treatment3,e11a15a3-fb3e-410a-b7df-ca6f1d79f65b,,released,,0,2021-12-21T13:58:37.792595-06:00,"Pharmaceutical Therapy, NOS",Residual Disease,
HCM-BROD-0957-C34,9c24da6e-5546-4037-8ef6-61fc5c2c0901,a1304c23-6a82-4bc8-8799-69d43a790054,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0957-C34_treatment4,e6cda0dd-a37e-4772-bc73-9c0cb3687215,,released,,0,2021-12-21T13:58:37.792595-06:00,"Radiation Therapy, NOS",Residual Disease,
HCM-CSHL-0868-C56,9c439d71-50e3-48d2-82a6-4ff0b4ce284a,4f6379f6-1a71-4e73-9896-43fddf5b816c,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0868-C56_treatment9,1c991392-25d3-498a-af1a-475531068cad,,released,,0,2021-12-21T14:36:45.609855-06:00,"Radiation Therapy, NOS",Residual Disease,
HCM-CSHL-0868-C56,9c439d71-50e3-48d2-82a6-4ff0b4ce284a,4f6379f6-1a71-4e73-9896-43fddf5b816c,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0868-C56_treatment5,246527dd-9a79-460c-ac74-3e7425e8c8fc,,released,,0,2021-12-21T14:36:45.609855-06:00,Hormone Therapy,Residual Disease,
HCM-CSHL-0868-C56,9c439d71-50e3-48d2-82a6-4ff0b4ce284a,4f6379f6-1a71-4e73-9896-43fddf5b816c,,Neoadjuvant,94.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0868-C56_treatment,3bbee6a7-e427-4820-9bab-ceaf9af9a8fd,,released,Carboplatin,1,2021-12-21T14:36:45.609855-06:00,Chemotherapy,,
HCM-CSHL-0868-C56,9c439d71-50e3-48d2-82a6-4ff0b4ce284a,4f6379f6-1a71-4e73-9896-43fddf5b816c,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0868-C56_treatment6,50d2bed4-29cb-4fce-bbe3-5ba38477e0f3,,released,,0,2021-12-21T14:36:45.609855-06:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-CSHL-0868-C56,9c439d71-50e3-48d2-82a6-4ff0b4ce284a,4f6379f6-1a71-4e73-9896-43fddf5b816c,60.0,Adjuvant,20.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0868-C56_treatment4,62da69dc-a9a4-407d-9b3d-cd26f18e3199,,released,Paclitaxel,1,2021-12-21T14:36:45.609855-06:00,Chemotherapy,Residual Disease,
HCM-CSHL-0868-C56,9c439d71-50e3-48d2-82a6-4ff0b4ce284a,4f6379f6-1a71-4e73-9896-43fddf5b816c,60.0,Adjuvant,20.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0868-C56_treatment3,74faa39b-dea7-4648-b2e8-4955d308d6f7,,released,Carboplatin,1,2021-12-21T14:36:45.609855-06:00,Chemotherapy,Residual Disease,
HCM-CSHL-0868-C56,9c439d71-50e3-48d2-82a6-4ff0b4ce284a,4f6379f6-1a71-4e73-9896-43fddf5b816c,,Neoadjuvant,94.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0868-C56_treatment2,88f00cda-78ad-49d7-9a4a-f7f7531431c7,,released,Paclitaxel,1,2021-12-21T14:36:45.609855-06:00,Chemotherapy,,
HCM-CSHL-0868-C56,9c439d71-50e3-48d2-82a6-4ff0b4ce284a,4f6379f6-1a71-4e73-9896-43fddf5b816c,,,16.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0868-C56_treatment7,93b7250a-10bf-474d-94d1-37a78b2a78f7,,released,,1,2021-12-21T14:36:45.609855-06:00,"Surgery, NOS",Initial Diagnosis,
HCM-CSHL-0868-C56,9c439d71-50e3-48d2-82a6-4ff0b4ce284a,4f6379f6-1a71-4e73-9896-43fddf5b816c,,Neoadjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0868-C56_treatment10,c2c19057-7ac3-45d9-8f29-1b8c35d1d1b3,Partial Response,released,,1,2021-12-21T14:36:45.609855-06:00,Chemotherapy,,
HCM-CSHL-0868-C56,9c439d71-50e3-48d2-82a6-4ff0b4ce284a,4f6379f6-1a71-4e73-9896-43fddf5b816c,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0868-C56_treatment8,ca4e20b2-bdd0-419d-af70-49b00bf55a70,,released,,0,2021-12-21T14:36:45.609855-06:00,Targeted Molecular Therapy,Residual Disease,
HCM-CSHL-0075-C25,9d03a2ac-ff8d-4017-b482-ece0c9eec5ed,bfd2eb2d-3612-483d-a234-ff2a6d1687a5,261.0,Adjuvant,179.0,2023-02-22T07:39:25.979291-06:00,HCM-CSHL-0075-C25_treatment2,04fe4050-b74c-4849-9040-d1ad34639751,,released,Gemcitabine,1,2020-09-28T12:58:45.391535-05:00,Chemotherapy,Residual Disease,
HCM-CSHL-0075-C25,9d03a2ac-ff8d-4017-b482-ece0c9eec5ed,bfd2eb2d-3612-483d-a234-ff2a6d1687a5,337.0,Adjuvant,264.0,2023-02-22T07:39:25.979291-06:00,HCM-CSHL-0075-C25_treatment7,17bf02e4-a7ff-4648-b652-5afcb33a5443,,released,,1,2020-09-28T12:58:45.391535-05:00,Chemotherapy,Residual Disease,FOLFIRI
HCM-CSHL-0075-C25,9d03a2ac-ff8d-4017-b482-ece0c9eec5ed,bfd2eb2d-3612-483d-a234-ff2a6d1687a5,,Neoadjuvant,,2023-02-22T07:39:25.979291-06:00,HCM-CSHL-0075-C25_treatment,236d8f77-d567-45e1-8cdd-c63a76a84698,,released,,0,2020-09-28T12:58:45.391535-05:00,,,
HCM-CSHL-0075-C25,9d03a2ac-ff8d-4017-b482-ece0c9eec5ed,bfd2eb2d-3612-483d-a234-ff2a6d1687a5,337.0,Adjuvant,264.0,2023-02-22T07:39:25.979291-06:00,HCM-CSHL-0075-C25_treatment4,391ca4e8-dc4e-4547-a539-e44e4e7666e3,,released,Leucovorin Calcium,1,2020-09-28T12:58:45.391535-05:00,Chemotherapy,Residual Disease,
HCM-CSHL-0075-C25,9d03a2ac-ff8d-4017-b482-ece0c9eec5ed,bfd2eb2d-3612-483d-a234-ff2a6d1687a5,,Adjuvant,351.0,2023-02-22T07:39:25.979291-06:00,HCM-CSHL-0075-C25_treatment8,3a7eaf16-d89c-41a7-ae71-91f941c7dfc1,Treatment Ongoing,released,Liposomal Irinotecan,1,2020-09-28T12:58:45.391535-05:00,Chemotherapy,Residual Disease,
HCM-CSHL-0075-C25,9d03a2ac-ff8d-4017-b482-ece0c9eec5ed,bfd2eb2d-3612-483d-a234-ff2a6d1687a5,261.0,Adjuvant,179.0,2023-02-22T07:39:25.979291-06:00,HCM-CSHL-0075-C25_treatment3,619a85a6-1ae2-45db-84bd-cee103c653b5,,released,Nab-paclitaxel,1,2020-09-28T12:58:45.391535-05:00,Chemotherapy,Residual Disease,
HCM-CSHL-0075-C25,9d03a2ac-ff8d-4017-b482-ece0c9eec5ed,bfd2eb2d-3612-483d-a234-ff2a6d1687a5,,,-14.0,2023-02-27T13:16:16.158881-06:00,HCM-CSHL-0075-C25_treatment10,779187eb-1f4f-4059-9c93-0a09b6c5f9ed,,released,,1,2020-09-28T12:58:45.391535-05:00,"Surgery, NOS",Initial Diagnosis,
HCM-CSHL-0075-C25,9d03a2ac-ff8d-4017-b482-ece0c9eec5ed,bfd2eb2d-3612-483d-a234-ff2a6d1687a5,337.0,Adjuvant,264.0,2023-02-22T07:39:25.979291-06:00,HCM-CSHL-0075-C25_treatment5,8dce2440-1481-4ae8-bfe3-b3dbf4fa9b6e,,released,Fluorouracil,1,2020-09-28T12:58:45.391535-05:00,Chemotherapy,Residual Disease,
HCM-CSHL-0075-C25,9d03a2ac-ff8d-4017-b482-ece0c9eec5ed,bfd2eb2d-3612-483d-a234-ff2a6d1687a5,,Adjuvant,,2023-02-22T07:39:25.979291-06:00,HCM-CSHL-0075-C25_treatment11,93498de9-803e-46b0-b41b-8da43da2940d,,released,,0,2020-09-28T12:58:45.391535-05:00,Targeted Molecular Therapy,Residual Disease,
HCM-CSHL-0075-C25,9d03a2ac-ff8d-4017-b482-ece0c9eec5ed,bfd2eb2d-3612-483d-a234-ff2a6d1687a5,,Adjuvant,,2023-02-22T07:39:25.979291-06:00,HCM-CSHL-0075-C25_treatment12,9e0d45f3-f76f-4b13-8bd7-d58d554a2af4,,released,,0,2020-09-28T12:58:45.391535-05:00,"Radiation Therapy, NOS",Residual Disease,
HCM-CSHL-0075-C25,9d03a2ac-ff8d-4017-b482-ece0c9eec5ed,bfd2eb2d-3612-483d-a234-ff2a6d1687a5,,Adjuvant,,2023-02-22T07:39:25.979291-06:00,HCM-CSHL-0075-C25_treatment9,b6928278-e955-450d-8723-bd850439532d,,released,,0,2020-09-28T12:58:45.391535-05:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-CSHL-0075-C25,9d03a2ac-ff8d-4017-b482-ece0c9eec5ed,bfd2eb2d-3612-483d-a234-ff2a6d1687a5,337.0,Adjuvant,264.0,2023-02-22T07:39:25.979291-06:00,HCM-CSHL-0075-C25_treatment6,f242ce67-1415-4e56-afb2-5e4da998f60d,,released,Irinotecan,1,2020-09-28T12:58:45.391535-05:00,Chemotherapy,Residual Disease,
HCM-SANG-0536-C18,9d868cf7-4c23-45f6-9897-015db647fc6e,8137ae83-d206-4ff9-b2d8-dc04f22571d6,,Neoadjuvant,138.0,2025-03-31T16:34:59.906497-05:00,HCM-SANG-0536-C18_treatment,349783b0-0868-47ab-87a4-48ce7de5f220,,released,Capecitabine,1,2021-12-21T15:15:15.506039-06:00,Chemotherapy,,
HCM-SANG-0536-C18,9d868cf7-4c23-45f6-9897-015db647fc6e,8137ae83-d206-4ff9-b2d8-dc04f22571d6,,Neoadjuvant,138.0,2025-03-31T16:34:59.906497-05:00,HCM-SANG-0536-C18_treatment2,79d5e8c2-7f82-4b1a-a378-c2fe9a06efba,,released,Oxaliplatin,1,2021-12-21T15:15:15.506039-06:00,Chemotherapy,,
HCM-CSHL-0598-C25,9daf1b17-1086-497e-875b-f1a86e486e34,fe9eb589-c1ed-41b0-b2ba-1180e7c1e9b4,,Neoadjuvant,325.0,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0598-C25_treatment3,0aa6cb79-eabe-4f8c-be55-63a6b199648d,,released,Fluorouracil,1,2021-12-21T14:08:53.186720-06:00,Chemotherapy,,
HCM-CSHL-0598-C25,9daf1b17-1086-497e-875b-f1a86e486e34,fe9eb589-c1ed-41b0-b2ba-1180e7c1e9b4,,Adjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0598-C25_treatment8,2c9fe158-00ee-4813-aeb8-ef73262d51bd,,released,,0,2021-12-21T14:08:53.186720-06:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-CSHL-0598-C25,9daf1b17-1086-497e-875b-f1a86e486e34,fe9eb589-c1ed-41b0-b2ba-1180e7c1e9b4,,Neoadjuvant,325.0,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0598-C25_treatment5,2eee6cad-b974-4766-959f-559162fd03f1,,released,,1,2021-12-21T14:08:53.186720-06:00,Chemotherapy,,FOLFIRINOX
HCM-CSHL-0598-C25,9daf1b17-1086-497e-875b-f1a86e486e34,fe9eb589-c1ed-41b0-b2ba-1180e7c1e9b4,,Adjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0598-C25_treatment11,5bf675ad-f379-4d05-8535-b11f0173d4c1,,released,,0,2021-12-21T14:08:53.186720-06:00,"Radiation Therapy, NOS",Residual Disease,
HCM-CSHL-0598-C25,9daf1b17-1086-497e-875b-f1a86e486e34,fe9eb589-c1ed-41b0-b2ba-1180e7c1e9b4,,,-2.0,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0598-C25_treatment9,5fdad3d2-580c-470f-a767-7245abda4e37,,released,,1,2021-12-21T14:08:53.186720-06:00,"Surgery, NOS",Initial Diagnosis,
HCM-CSHL-0598-C25,9daf1b17-1086-497e-875b-f1a86e486e34,fe9eb589-c1ed-41b0-b2ba-1180e7c1e9b4,,Neoadjuvant,325.0,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0598-C25_treatment,6a6d339b-8f0a-41e5-a6f7-81293cd4801f,,released,Irinotecan Hydrochloride,1,2021-12-21T14:08:53.186720-06:00,Chemotherapy,,
HCM-CSHL-0598-C25,9daf1b17-1086-497e-875b-f1a86e486e34,fe9eb589-c1ed-41b0-b2ba-1180e7c1e9b4,,Adjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0598-C25_treatment10,91615b24-356e-4dd7-87b7-bf95e97401d3,,released,,0,2021-12-21T14:08:53.186720-06:00,Targeted Molecular Therapy,Residual Disease,
HCM-CSHL-0598-C25,9daf1b17-1086-497e-875b-f1a86e486e34,fe9eb589-c1ed-41b0-b2ba-1180e7c1e9b4,,Neoadjuvant,325.0,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0598-C25_treatment4,aed80abf-6bcd-46fd-ae14-be6f49723399,,released,Oxaliplatin,1,2021-12-21T14:08:53.186720-06:00,Chemotherapy,,
HCM-CSHL-0598-C25,9daf1b17-1086-497e-875b-f1a86e486e34,fe9eb589-c1ed-41b0-b2ba-1180e7c1e9b4,,Adjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0598-C25_treatment6,b385576c-afda-42e4-8857-e0e3a482671f,,released,Gemcitabine,1,2021-12-21T14:08:53.186720-06:00,Chemotherapy,Residual Disease,
HCM-CSHL-0598-C25,9daf1b17-1086-497e-875b-f1a86e486e34,fe9eb589-c1ed-41b0-b2ba-1180e7c1e9b4,,Neoadjuvant,325.0,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0598-C25_treatment2,b41d2654-8660-4a20-b165-3bda641e7bf3,,released,Leucovorin Calcium,1,2021-12-21T14:08:53.186720-06:00,Chemotherapy,,
HCM-CSHL-0598-C25,9daf1b17-1086-497e-875b-f1a86e486e34,fe9eb589-c1ed-41b0-b2ba-1180e7c1e9b4,,Adjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0598-C25_treatment7,f9a64ba7-28e0-4397-ae08-dfdc4bc3fb6d,,released,Nab-paclitaxel,1,2021-12-21T14:08:53.186720-06:00,Chemotherapy,Residual Disease,
HCM-SANG-0780-C25,9ddacfb1-46c5-4b93-8f96-937ef10e08f2,e1e84cfa-a937-4268-a735-11e7bbbcd038,,Neoadjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-SANG-0780-C25_treatment,7bbfbb16-3815-4bde-bf7a-63be1534a470,,released,,0,2023-02-27T12:53:59.442112-06:00,,,
HCM-WCMC-0948-C67,9e0540ab-1888-43f8-9271-1dd040c3e8ea,4508afa7-8d2a-444f-b55f-4ad4b8b08e83,,Neoadjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-WCMC-0948-C67_treatment,32d8bf66-6077-4b60-af92-4dfae7115388,,released,,0,2023-02-27T12:44:52.767416-06:00,,,
HCM-WCMC-0948-C67,9e0540ab-1888-43f8-9271-1dd040c3e8ea,4508afa7-8d2a-444f-b55f-4ad4b8b08e83,,,0.0,2025-04-07T17:13:09.336794-05:00,HCM-WCMC-0948-C67_treatment2,5c32fdba-acdc-49f5-a194-807dccbb47b8,,released,,1,2023-02-27T12:44:52.767416-06:00,"Surgery, NOS",Initial Diagnosis,
HCM-WCMC-0948-C67,9e0540ab-1888-43f8-9271-1dd040c3e8ea,4508afa7-8d2a-444f-b55f-4ad4b8b08e83,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-WCMC-0948-C67_treatment4,d9d698a8-7d4b-4265-a119-321d250ee3df,,released,,0,2023-02-27T12:44:52.767416-06:00,"Radiation Therapy, NOS",Residual Disease,
HCM-WCMC-0948-C67,9e0540ab-1888-43f8-9271-1dd040c3e8ea,4508afa7-8d2a-444f-b55f-4ad4b8b08e83,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-WCMC-0948-C67_treatment3,e3360559-e256-47d2-9a39-dacbe2d1d461,,released,,0,2023-02-27T12:44:52.767416-06:00,"Pharmaceutical Therapy, NOS",Residual Disease,
HCM-CSHL-0090-C25,9e615018-8669-4dd6-8265-25e766a34dd0,807dc915-5b1b-48a1-b21f-0e986f33a347,,Adjuvant,,2020-03-26T16:04:47.706904-05:00,HCM-CSHL-0090-C25_treatment5,234dd285-223a-424e-affe-47a171e5bf50,,released,,0,2020-02-11T14:38:31.889814-06:00,Targeted Molecular Therapy,Residual Disease,
HCM-CSHL-0090-C25,9e615018-8669-4dd6-8265-25e766a34dd0,807dc915-5b1b-48a1-b21f-0e986f33a347,,Adjuvant,,2020-03-26T16:04:47.706904-05:00,HCM-CSHL-0090-C25_treatment2,30e0efc8-2571-49f0-beee-8ac4213ad6a1,,released,,unknown,2020-02-11T14:38:31.889814-06:00,Chemotherapy,Residual Disease,
HCM-CSHL-0090-C25,9e615018-8669-4dd6-8265-25e766a34dd0,807dc915-5b1b-48a1-b21f-0e986f33a347,,,-9.0,2023-02-27T11:50:33.721668-06:00,HCM-CSHL-0090-C25_treatment4,4f60ac64-c544-4eea-bc44-33b17011dcb4,,released,,1,2020-02-11T14:38:31.889814-06:00,"Surgery, NOS",Initial Diagnosis,
HCM-CSHL-0090-C25,9e615018-8669-4dd6-8265-25e766a34dd0,807dc915-5b1b-48a1-b21f-0e986f33a347,,Adjuvant,,2020-03-26T16:04:47.706904-05:00,HCM-CSHL-0090-C25_treatment6,6bebb34a-e392-4f95-80c9-b8da9d30e8b6,,released,,0,2020-02-11T14:38:31.889814-06:00,"Radiation Therapy, NOS",Residual Disease,
HCM-CSHL-0090-C25,9e615018-8669-4dd6-8265-25e766a34dd0,807dc915-5b1b-48a1-b21f-0e986f33a347,,Neoadjuvant,,2020-03-26T16:04:47.706904-05:00,HCM-CSHL-0090-C25_treatment,bee9f204-9c26-452f-ba2d-a12c593c46c5,,released,,0,2020-02-11T14:38:31.889814-06:00,,,
HCM-CSHL-0090-C25,9e615018-8669-4dd6-8265-25e766a34dd0,807dc915-5b1b-48a1-b21f-0e986f33a347,,Adjuvant,,2020-03-26T16:04:47.706904-05:00,HCM-CSHL-0090-C25_treatment3,eec73f66-be53-4878-8253-86a668f7619c,,released,,0,2020-02-11T14:38:31.889814-06:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-CSHL-0239-C18,9ee323b8-6447-4447-b70f-a7260b3b8f8e,814eb7dc-bd7b-4f96-a5ad-c6e244d45c6a,127.0,Adjuvant,51.0,2023-02-22T07:39:25.979291-06:00,HCM-CSHL-0239-C18_treatment3,29155d98-d49b-49a3-8212-d1d52ebfd658,,released,Fluorouracil,1,2020-09-28T09:20:10.214374-05:00,Chemotherapy,Residual Disease,
HCM-CSHL-0239-C18,9ee323b8-6447-4447-b70f-a7260b3b8f8e,814eb7dc-bd7b-4f96-a5ad-c6e244d45c6a,,Neoadjuvant,,2023-02-22T07:39:25.979291-06:00,HCM-CSHL-0239-C18_treatment,291de62c-c8a6-428c-b2cf-69c65cf6f55b,,released,,0,2020-09-28T09:20:10.214374-05:00,,,
HCM-CSHL-0239-C18,9ee323b8-6447-4447-b70f-a7260b3b8f8e,814eb7dc-bd7b-4f96-a5ad-c6e244d45c6a,,Adjuvant,,2023-02-22T07:39:25.979291-06:00,HCM-CSHL-0239-C18_treatment10,2dc5cf78-2c57-4d46-9875-28c295db2c35,,released,,0,2020-09-28T09:20:10.214374-05:00,"Radiation Therapy, NOS",Residual Disease,
HCM-CSHL-0239-C18,9ee323b8-6447-4447-b70f-a7260b3b8f8e,814eb7dc-bd7b-4f96-a5ad-c6e244d45c6a,,Adjuvant,,2023-02-22T07:39:25.979291-06:00,HCM-CSHL-0239-C18_treatment7,509b3195-9303-4406-adab-f04a5495efd9,,released,,0,2020-09-28T09:20:10.214374-05:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-CSHL-0239-C18,9ee323b8-6447-4447-b70f-a7260b3b8f8e,814eb7dc-bd7b-4f96-a5ad-c6e244d45c6a,,,12.0,2023-02-27T12:37:36.509885-06:00,HCM-CSHL-0239-C18_treatment8,5384f9ff-e714-4be6-8fd8-ff691ea440cd,,released,,1,2020-09-28T09:20:10.214374-05:00,"Surgery, NOS",Initial Diagnosis,
HCM-CSHL-0239-C18,9ee323b8-6447-4447-b70f-a7260b3b8f8e,814eb7dc-bd7b-4f96-a5ad-c6e244d45c6a,127.0,Adjuvant,51.0,2023-02-22T07:39:25.979291-06:00,HCM-CSHL-0239-C18_treatment2,554d043e-a10a-4a74-9579-1728f740abc1,,released,Leucovorin Calcium,1,2020-09-28T09:20:10.214374-05:00,Chemotherapy,Residual Disease,
HCM-CSHL-0239-C18,9ee323b8-6447-4447-b70f-a7260b3b8f8e,814eb7dc-bd7b-4f96-a5ad-c6e244d45c6a,127.0,Adjuvant,51.0,2023-02-22T07:39:25.979291-06:00,HCM-CSHL-0239-C18_treatment5,74001467-d809-456a-a425-216a1079a696,,released,,1,2020-09-28T09:20:10.214374-05:00,Chemotherapy,Residual Disease,FOLFOX
HCM-CSHL-0239-C18,9ee323b8-6447-4447-b70f-a7260b3b8f8e,814eb7dc-bd7b-4f96-a5ad-c6e244d45c6a,211.0,Adjuvant,132.0,2023-02-22T07:39:25.979291-06:00,HCM-CSHL-0239-C18_treatment6,82ce0945-327c-4afe-bf9c-b47a4e9b9771,,released,Fluorouracil,1,2020-09-28T09:20:10.214374-05:00,Chemotherapy,Residual Disease,
HCM-CSHL-0239-C18,9ee323b8-6447-4447-b70f-a7260b3b8f8e,814eb7dc-bd7b-4f96-a5ad-c6e244d45c6a,127.0,Adjuvant,51.0,2023-02-22T07:39:25.979291-06:00,HCM-CSHL-0239-C18_treatment4,bad9c784-5f44-4d07-8d66-bdfc62fb3ffd,,released,Oxaliplatin,1,2020-09-28T09:20:10.214374-05:00,Chemotherapy,Residual Disease,
HCM-CSHL-0239-C18,9ee323b8-6447-4447-b70f-a7260b3b8f8e,814eb7dc-bd7b-4f96-a5ad-c6e244d45c6a,,Adjuvant,,2023-02-22T07:39:25.979291-06:00,HCM-CSHL-0239-C18_treatment9,fd87885a-df33-482d-9167-679bca39b021,,released,,0,2020-09-28T09:20:10.214374-05:00,Targeted Molecular Therapy,Residual Disease,
HCM-BROD-0234-C49,9f4d0076-c4a2-46d4-879f-896946338c09,8768c96d-1487-4dbd-ac75-0ad2a3f95969,,,-13.0,2023-02-27T12:02:41.486454-06:00,HCM-BROD-0234-C49_treatment5,07d1a8a0-3707-40a5-9c01-75b023759326,,released,,1,2020-10-08T12:08:22.339827-05:00,"Surgery, NOS",Initial Diagnosis,
HCM-BROD-0234-C49,9f4d0076-c4a2-46d4-879f-896946338c09,8768c96d-1487-4dbd-ac75-0ad2a3f95969,,Adjuvant,,2021-03-03T15:15:08.075155-06:00,HCM-BROD-0234-C49_treatment3,75831f1b-b2ab-4afa-966e-929d4456baf0,,released,,0,2020-06-15T13:19:36.113829-05:00,Hormone Therapy,Residual Disease,
HCM-BROD-0234-C49,9f4d0076-c4a2-46d4-879f-896946338c09,8768c96d-1487-4dbd-ac75-0ad2a3f95969,,Neoadjuvant,,2021-03-03T15:15:08.075155-06:00,HCM-BROD-0234-C49_treatment,9e527598-365b-4680-a3d8-eadb977826fc,,released,,0,2020-06-15T13:19:36.113829-05:00,,,
HCM-BROD-0234-C49,9f4d0076-c4a2-46d4-879f-896946338c09,8768c96d-1487-4dbd-ac75-0ad2a3f95969,,Adjuvant,,2021-03-03T15:15:08.075155-06:00,HCM-BROD-0234-C49_treatment4,a040c038-d46a-4bde-9846-595117259d99,,released,,0,2020-06-15T13:19:36.113829-05:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-BROD-0234-C49,9f4d0076-c4a2-46d4-879f-896946338c09,8768c96d-1487-4dbd-ac75-0ad2a3f95969,793.0,Adjuvant,782.0,2021-03-03T15:15:08.075155-06:00,HCM-BROD-0234-C49_treatment2,cb536e3f-4da4-4da7-b21c-9aa239f50198,,released,Doxorubicin Hydrochloride,1,2020-06-15T13:19:36.113829-05:00,Chemotherapy,Residual Disease,
HCM-BROD-0234-C49,9f4d0076-c4a2-46d4-879f-896946338c09,8768c96d-1487-4dbd-ac75-0ad2a3f95969,,Adjuvant,,2021-03-03T15:15:08.075155-06:00,HCM-BROD-0234-C49_treatment6,d9cc06f3-9eb8-41c2-9069-dbaf7575d6b1,,released,,0,2020-10-08T12:08:22.339827-05:00,Targeted Molecular Therapy,Residual Disease,
HCM-BROD-0234-C49,9f4d0076-c4a2-46d4-879f-896946338c09,8768c96d-1487-4dbd-ac75-0ad2a3f95969,625.0,Adjuvant,619.0,2021-03-03T15:15:08.075155-06:00,HCM-BROD-0234-C49_treatment7,ec7068a0-539d-4f42-befc-500042e7faa7,,released,,1,2020-10-08T12:08:22.339827-05:00,"Radiation, Stereotactic/Gamma Knife/SRS",Residual Disease,
HCM-CSHL-0730-C25,9f4d122a-e88e-433f-85a7-dbc4060ec7b8,2a92c0d9-8816-4348-ae30-be79727455f5,,Adjuvant,,2023-02-22T07:39:25.979291-06:00,HCM-CSHL-0730-C25_treatment3,06b23257-981d-43b7-a3d6-711652998326,,released,,0,2021-11-23T08:38:29.033717-06:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-CSHL-0730-C25,9f4d122a-e88e-433f-85a7-dbc4060ec7b8,2a92c0d9-8816-4348-ae30-be79727455f5,,Adjuvant,,2023-02-22T07:39:25.979291-06:00,HCM-CSHL-0730-C25_treatment2,21aeead5-284a-4c8d-bbbe-1fcd2648bc20,,released,,1,2021-11-23T08:38:29.033717-06:00,Chemotherapy,Residual Disease,
HCM-CSHL-0730-C25,9f4d122a-e88e-433f-85a7-dbc4060ec7b8,2a92c0d9-8816-4348-ae30-be79727455f5,,Neoadjuvant,,2023-02-22T07:39:25.979291-06:00,HCM-CSHL-0730-C25_treatment,2832cee2-b917-409c-bb48-7a44227d5fc5,,released,,0,2021-11-23T08:38:29.033717-06:00,,,
HCM-CSHL-0730-C25,9f4d122a-e88e-433f-85a7-dbc4060ec7b8,2a92c0d9-8816-4348-ae30-be79727455f5,,Adjuvant,,2023-02-22T07:39:25.979291-06:00,HCM-CSHL-0730-C25_treatment5,34674f1a-c9b8-478c-8bea-26ad08289660,,released,,0,2021-11-23T08:38:29.033717-06:00,Targeted Molecular Therapy,Residual Disease,
HCM-CSHL-0730-C25,9f4d122a-e88e-433f-85a7-dbc4060ec7b8,2a92c0d9-8816-4348-ae30-be79727455f5,,,,2023-02-27T11:22:33.219313-06:00,HCM-CSHL-0730-C25_treatment4,7d368064-0086-4921-a3a7-f106b93ffe82,,released,,0,2021-11-23T08:38:29.033717-06:00,"Surgery, NOS",Initial Diagnosis,
HCM-CSHL-0730-C25,9f4d122a-e88e-433f-85a7-dbc4060ec7b8,2a92c0d9-8816-4348-ae30-be79727455f5,,Adjuvant,,2023-02-22T07:39:25.979291-06:00,HCM-CSHL-0730-C25_treatment6,a7c9c88c-283c-4b91-94b5-c606c693736e,,released,,0,2021-11-23T08:38:29.033717-06:00,"Radiation Therapy, NOS",Residual Disease,
HCM-CSHL-0634-C30,9ffb2777-3c88-4ee4-bb86-956c7c4fb6c4,8919e1d4-e61f-434c-9844-704245611404,,Neoadjuvant,,2023-11-07T14:28:29.403873-06:00,HCM-CSHL-0634-C30_treatment,03e07844-5af2-470f-ae99-21279223d9da,,released,,0,2020-10-08T13:35:37.193951-05:00,,,
HCM-CSHL-0634-C30,9ffb2777-3c88-4ee4-bb86-956c7c4fb6c4,8919e1d4-e61f-434c-9844-704245611404,,,39.0,2023-11-07T14:28:29.403873-06:00,HCM-CSHL-0634-C30_treatment2,091ebf8a-d650-4f57-abb8-6c6aee27e695,,released,,1,2020-10-08T13:35:37.193951-05:00,"Surgery, NOS",Initial Diagnosis,
HCM-CSHL-0634-C30,9ffb2777-3c88-4ee4-bb86-956c7c4fb6c4,8919e1d4-e61f-434c-9844-704245611404,103.0,Adjuvant,67.0,2023-11-07T14:28:29.403873-06:00,HCM-CSHL-0634-C30_treatment4,0dab74dc-12a6-4858-a8a8-c43ea3d0ac2b,,released,,1,2020-10-08T13:35:37.193951-05:00,"Radiation, Intensity-Modulated Radiotherapy",Residual Disease,
HCM-CSHL-0634-C30,9ffb2777-3c88-4ee4-bb86-956c7c4fb6c4,8919e1d4-e61f-434c-9844-704245611404,,Adjuvant,,2023-11-07T14:28:29.403873-06:00,HCM-CSHL-0634-C30_treatment3,ab607e3b-2e51-49a6-8179-9ebb703b2766,,released,,0,2020-10-08T13:35:37.193951-05:00,"Pharmaceutical Therapy, NOS",Residual Disease,
HCM-WCMC-1344-C18,a02b068f-adff-47ca-82fb-2f03a34cd75f,b305b46c-50f1-4599-a34a-b9f660481009,,Neoadjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-WCMC-1344-C18_treatment,17a22201-faeb-47be-b110-37cf46504a92,,released,,0,2023-02-27T13:01:54.644926-06:00,,,
HCM-WCMC-1344-C18,a02b068f-adff-47ca-82fb-2f03a34cd75f,b305b46c-50f1-4599-a34a-b9f660481009,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-WCMC-1344-C18_treatment4,19e1fc6e-13e1-4760-8db3-3e193c78e493,,released,,0,2023-02-27T13:01:54.644926-06:00,"Radiation Therapy, NOS",Residual Disease,
HCM-WCMC-1344-C18,a02b068f-adff-47ca-82fb-2f03a34cd75f,b305b46c-50f1-4599-a34a-b9f660481009,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-WCMC-1344-C18_treatment3,6fdc5ad9-64f0-4696-8744-ca691c04248f,,released,,0,2023-02-27T13:01:54.644926-06:00,"Pharmaceutical Therapy, NOS",Residual Disease,
HCM-WCMC-1344-C18,a02b068f-adff-47ca-82fb-2f03a34cd75f,b305b46c-50f1-4599-a34a-b9f660481009,,,9.0,2025-04-07T17:13:09.336794-05:00,HCM-WCMC-1344-C18_treatment2,9e1117f5-3ec8-40c8-a151-a214692a59b5,,released,,1,2023-02-27T13:01:54.644926-06:00,"Surgery, NOS",Initial Diagnosis,
HCM-SANG-1092-C18,a06ae06a-7c75-475d-833b-29c43c5a4d67,cf487e86-f6a0-42ea-9f36-0dd6bb78a9f7,,Neoadjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-SANG-1092-C18_treatment,387ff94f-796e-4c7a-933b-91f0498f6e70,,released,,0,2023-02-27T11:27:05.254143-06:00,,,
HCM-SANG-0297-C15,a0cac428-0e4d-471f-a3a1-9d3ea026b58e,865560ca-001a-4f87-a0a3-4ed2438d3323,,Neoadjuvant,,2023-02-22T07:39:25.979291-06:00,HCM-SANG-0297-C15_treatment,5c4bdc2c-ccc2-420f-8243-b0af0591c55e,,released,,0,2020-02-11T16:00:14.801928-06:00,,,
HCM-SANG-0281-C18,a13f7c10-76c8-473a-b87b-8b680706d189,5f18c19a-572d-49c4-85c2-44954bb37c5a,,Neoadjuvant,,2023-02-22T07:39:25.979291-06:00,HCM-SANG-0281-C18_treatment,b0130383-79a8-4656-8405-21b3f9adf00d,,released,,0,2021-04-20T10:33:14.082471-05:00,,,
HCM-CSHL-0586-C32,a1d1b84f-51e1-49cc-b13d-905292264b92,b1bf689a-2f2f-41b7-bc81-f5227c048270,,Adjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0586-C32_treatment3,10985d8b-95a5-4633-99b6-96216a8d6ed1,,released,,0,2020-10-08T13:35:22.455060-05:00,"Pharmaceutical Therapy, NOS",Residual Disease,
HCM-CSHL-0586-C32,a1d1b84f-51e1-49cc-b13d-905292264b92,b1bf689a-2f2f-41b7-bc81-f5227c048270,,Neoadjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0586-C32_treatment,3843352b-f901-41c7-8b9f-0ff2a02b39a9,,released,,0,2020-10-08T13:35:22.455060-05:00,,,
HCM-CSHL-0586-C32,a1d1b84f-51e1-49cc-b13d-905292264b92,b1bf689a-2f2f-41b7-bc81-f5227c048270,,,14.0,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0586-C32_treatment2,41f5eb56-6630-42c5-8c6a-b87ad7dad4ca,,released,,1,2020-10-08T13:35:22.455060-05:00,"Surgery, NOS",Initial Diagnosis,
HCM-CSHL-0586-C32,a1d1b84f-51e1-49cc-b13d-905292264b92,b1bf689a-2f2f-41b7-bc81-f5227c048270,64.0,Adjuvant,28.0,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0586-C32_treatment4,7ab916bc-6e38-4c7d-9065-777f5023d28b,,released,,1,2020-10-08T13:35:22.455060-05:00,"Radiation, Intensity-Modulated Radiotherapy",Residual Disease,
HCM-BROD-0445-C15,a21e6302-cc54-4b1d-87a9-c7fa4475beca,f213eb8d-7769-4a71-9d99-dff95b3b8b14,777.0,Adjuvant,412.0,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0445-C15_treatment2,0e9dcce8-1fb3-40ae-a654-734f86faed94,Treatment Ongoing,released,Oxaliplatin,1,2020-09-27T11:36:45.323899-05:00,Chemotherapy,Residual Disease,
HCM-BROD-0445-C15,a21e6302-cc54-4b1d-87a9-c7fa4475beca,f213eb8d-7769-4a71-9d99-dff95b3b8b14,777.0,Adjuvant,412.0,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0445-C15_treatment5,12d67fa3-3a66-471e-a31e-f2276c384354,Treatment Ongoing,released,,1,2020-09-27T11:36:45.323899-05:00,Chemotherapy,Residual Disease,FU-LV regimen
HCM-BROD-0445-C15,a21e6302-cc54-4b1d-87a9-c7fa4475beca,f213eb8d-7769-4a71-9d99-dff95b3b8b14,777.0,Adjuvant,412.0,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0445-C15_treatment3,1fa782f2-ddbe-4d80-afbe-3ee8597beccd,Treatment Ongoing,released,Fluorouracil,1,2020-09-27T11:36:45.323899-05:00,Chemotherapy,Residual Disease,
HCM-BROD-0445-C15,a21e6302-cc54-4b1d-87a9-c7fa4475beca,f213eb8d-7769-4a71-9d99-dff95b3b8b14,,Adjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0445-C15_treatment6,223ef0d9-40c7-4c16-ad5e-6682c8ce9d7f,,released,,0,2020-09-27T11:36:45.323899-05:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-BROD-0445-C15,a21e6302-cc54-4b1d-87a9-c7fa4475beca,f213eb8d-7769-4a71-9d99-dff95b3b8b14,,,,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0445-C15_treatment7,412d0933-3df4-4075-982b-a2765b580b39,,released,,unknown,2020-09-27T11:36:45.323899-05:00,"Surgery, NOS",Initial Diagnosis,
HCM-BROD-0445-C15,a21e6302-cc54-4b1d-87a9-c7fa4475beca,f213eb8d-7769-4a71-9d99-dff95b3b8b14,,Neoadjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0445-C15_treatment,41ec54fb-30e5-4ab9-9c72-d0a35ced2dfc,,released,,0,2020-09-27T11:36:45.323899-05:00,,,
HCM-BROD-0445-C15,a21e6302-cc54-4b1d-87a9-c7fa4475beca,f213eb8d-7769-4a71-9d99-dff95b3b8b14,777.0,Adjuvant,412.0,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0445-C15_treatment8,801cef7d-42b3-472d-bd38-42f98222b82e,Treatment Ongoing,released,Trastuzumab,1,2020-09-27T11:36:45.323899-05:00,Targeted Molecular Therapy,Residual Disease,
HCM-BROD-0445-C15,a21e6302-cc54-4b1d-87a9-c7fa4475beca,f213eb8d-7769-4a71-9d99-dff95b3b8b14,777.0,Adjuvant,412.0,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0445-C15_treatment4,829c3e4e-ccf9-4d1f-b66b-f4c9efaa9219,Treatment Ongoing,released,Leucovorin,1,2020-09-27T11:36:45.323899-05:00,Chemotherapy,Residual Disease,
HCM-BROD-0445-C15,a21e6302-cc54-4b1d-87a9-c7fa4475beca,f213eb8d-7769-4a71-9d99-dff95b3b8b14,,Adjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0445-C15_treatment9,b8cc9403-d9c0-4b41-9b12-350998225365,,released,,0,2020-09-27T11:36:45.323899-05:00,"Radiation Therapy, NOS",Residual Disease,
HCM-BROD-1102-C85,a2e9805f-e36a-46c1-b36c-fc064848501c,a7b0c28e-e4b1-4074-8653-a997720ea187,,Neoadjuvant,1575.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-1102-C85_treatment2,177a257e-696b-468b-ac40-3d8c5a607f8e,,released,Rituximab,1,2021-12-21T15:23:35.717319-06:00,Immunotherapy (Including Vaccines),,
HCM-BROD-1102-C85,a2e9805f-e36a-46c1-b36c-fc064848501c,a7b0c28e-e4b1-4074-8653-a997720ea187,,,,2025-04-07T17:13:09.336794-05:00,HCM-BROD-1102-C85_treatment8,46a16bf9-aea2-48f4-9af4-8ada60530344,,released,,0,2021-12-21T15:23:35.717319-06:00,"Surgery, NOS",Initial Diagnosis,
HCM-BROD-1102-C85,a2e9805f-e36a-46c1-b36c-fc064848501c,a7b0c28e-e4b1-4074-8653-a997720ea187,,Neoadjuvant,1571.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-1102-C85_treatment,7319b375-7e46-4628-87b4-b7345f8f3bad,,released,Bendamustine,1,2021-12-21T15:23:35.717319-06:00,Chemotherapy,,
HCM-BROD-1102-C85,a2e9805f-e36a-46c1-b36c-fc064848501c,a7b0c28e-e4b1-4074-8653-a997720ea187,1571.0,Adjuvant,1555.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-1102-C85_treatment4,84a1c09d-9a15-4247-a8f7-1a5ef4946ad1,,released,Doxorubicin Hydrochloride,1,2021-12-21T15:23:35.717319-06:00,Chemotherapy,Residual Disease,
HCM-BROD-1102-C85,a2e9805f-e36a-46c1-b36c-fc064848501c,a7b0c28e-e4b1-4074-8653-a997720ea187,1571.0,Adjuvant,1555.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-1102-C85_treatment3,882a99b8-06e7-468d-9fd9-e6ad7f3ea97d,,released,Cyclophosphamide,1,2021-12-21T15:23:35.717319-06:00,Chemotherapy,Residual Disease,
HCM-BROD-1102-C85,a2e9805f-e36a-46c1-b36c-fc064848501c,a7b0c28e-e4b1-4074-8653-a997720ea187,1571.0,Adjuvant,1555.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-1102-C85_treatment5,98c16bb2-18ef-4d64-a058-9fecfef5c26f,,released,Vincristine,1,2021-12-21T15:23:35.717319-06:00,Chemotherapy,Residual Disease,
HCM-BROD-1102-C85,a2e9805f-e36a-46c1-b36c-fc064848501c,a7b0c28e-e4b1-4074-8653-a997720ea187,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-BROD-1102-C85_treatment9,a6a2f456-b2e7-425a-9083-b40a5e8f9887,,released,,0,2021-12-21T15:23:35.717319-06:00,Targeted Molecular Therapy,Residual Disease,
HCM-BROD-1102-C85,a2e9805f-e36a-46c1-b36c-fc064848501c,a7b0c28e-e4b1-4074-8653-a997720ea187,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-BROD-1102-C85_treatment7,b814edae-e149-43d3-a532-11002ade7928,,released,,0,2021-12-21T15:23:35.717319-06:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-BROD-1102-C85,a2e9805f-e36a-46c1-b36c-fc064848501c,a7b0c28e-e4b1-4074-8653-a997720ea187,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-BROD-1102-C85_treatment6,b9bdd1dc-9200-4924-adca-89c42a06e118,,released,,0,2021-12-21T15:23:35.717319-06:00,Hormone Therapy,Residual Disease,
HCM-BROD-1102-C85,a2e9805f-e36a-46c1-b36c-fc064848501c,a7b0c28e-e4b1-4074-8653-a997720ea187,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-BROD-1102-C85_treatment10,bfa11dba-f989-4e48-868b-6cbbb6ac873f,,released,,0,2021-12-21T15:23:35.717319-06:00,"Radiation Therapy, NOS",Residual Disease,
HCM-BROD-0050-C49,a35ed933-bca3-4fb3-8262-ab1405cdbdbf,31981f27-b9e3-4836-b59f-1877fc690a26,,,0.0,2023-03-13T13:27:38.479646-05:00,HCM-BROD-0050-C49_treatment2,1582ed02-4982-4819-993c-49ec8aa1f413,,released,,1,2021-12-21T13:36:23.000545-06:00,"Surgery, NOS",Initial Diagnosis,
HCM-BROD-0050-C49,a35ed933-bca3-4fb3-8262-ab1405cdbdbf,31981f27-b9e3-4836-b59f-1877fc690a26,,Adjuvant,,2023-03-13T13:27:38.479646-05:00,HCM-BROD-0050-C49_treatment3,7307771a-f86a-49f6-8436-05f26cee1d19,,released,,0,2021-12-21T13:36:23.000545-06:00,"Pharmaceutical Therapy, NOS",Residual Disease,
HCM-BROD-0050-C49,a35ed933-bca3-4fb3-8262-ab1405cdbdbf,31981f27-b9e3-4836-b59f-1877fc690a26,,Adjuvant,,2023-03-13T13:27:38.479646-05:00,HCM-BROD-0050-C49_treatment4,a7eff41b-a737-4e48-a7d0-61ebc4970043,,released,,0,2021-12-21T13:36:23.000545-06:00,"Radiation Therapy, NOS",Residual Disease,
HCM-BROD-0050-C49,a35ed933-bca3-4fb3-8262-ab1405cdbdbf,31981f27-b9e3-4836-b59f-1877fc690a26,,Neoadjuvant,,2023-02-22T07:39:25.979291-06:00,HCM-BROD-0050-C49_treatment,cbe1a379-44d9-47a9-bfd8-6a524381f40e,,released,,0,2021-12-21T13:36:23.000545-06:00,,,
HCM-BROD-0050-C49,a35ed933-bca3-4fb3-8262-ab1405cdbdbf,77ad5e2c-e04b-40f9-bd91-e4dada43a5d8,822.0,Maintenance Therapy,30.0,2023-03-14T11:40:17.645275-05:00,HCM-BROD-0050-C49_treatment7,13944cf0-1873-4c93-b762-c84f37a48e7f,Progressive Disease,released,Gemcitabine Hydrochloride,1,2023-03-13T13:27:38.479646-05:00,,,
HCM-BROD-0050-C49,a35ed933-bca3-4fb3-8262-ab1405cdbdbf,77ad5e2c-e04b-40f9-bd91-e4dada43a5d8,822.0,Maintenance Therapy,30.0,2023-03-13T13:27:38.479646-05:00,HCM-BROD-0050-C49_treatment9,3867b772-063d-4f52-9a72-b0fb51456cea,Progressive Disease,released,Doxorubicin Hydrochloride,1,2021-12-21T13:36:23.000545-06:00,,,
HCM-BROD-0050-C49,a35ed933-bca3-4fb3-8262-ab1405cdbdbf,77ad5e2c-e04b-40f9-bd91-e4dada43a5d8,822.0,Maintenance Therapy,30.0,2023-03-14T11:40:17.645275-05:00,HCM-BROD-0050-C49_treatment6,550949ea-d2a0-436d-916b-3757b7e4e2d9,Progressive Disease,released,Cisplatin,1,2023-03-13T13:27:38.479646-05:00,,,
HCM-BROD-0050-C49,a35ed933-bca3-4fb3-8262-ab1405cdbdbf,77ad5e2c-e04b-40f9-bd91-e4dada43a5d8,822.0,Maintenance Therapy,30.0,2023-03-14T11:40:17.645275-05:00,HCM-BROD-0050-C49_treatment5,9c9413ca-eedd-4b54-a676-bed16ad9e99b,Progressive Disease,released,Carboplatin,1,2023-03-13T13:27:38.479646-05:00,,,
HCM-BROD-0050-C49,a35ed933-bca3-4fb3-8262-ab1405cdbdbf,77ad5e2c-e04b-40f9-bd91-e4dada43a5d8,822.0,Maintenance Therapy,30.0,2023-03-14T11:40:17.645275-05:00,HCM-BROD-0050-C49_treatment8,d0b8137b-d2e0-442b-8013-4b1023f7a712,Progressive Disease,released,Ifosfamide,1,2023-03-13T13:27:38.479646-05:00,,,
HCM-BROD-0055-C64,a3b71c6f-77cc-4e80-8c1c-96cdf836b42e,3382e6e7-88db-4179-a0a0-9a305a8758d5,396.0,Adjuvant,151.0,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0055-C64_treatment7,042e569e-0aaa-4aad-ac6a-4dbe3e2c75ae,,released,Vincristine,1,2020-09-27T10:18:57.448599-05:00,Chemotherapy,Residual Disease,
HCM-BROD-0055-C64,a3b71c6f-77cc-4e80-8c1c-96cdf836b42e,3382e6e7-88db-4179-a0a0-9a305a8758d5,151.0,Adjuvant,92.0,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0055-C64_treatment2,12bfbfba-1a5e-432e-855f-528360598092,,released,Doxorubicin Hydrochloride,1,2020-09-27T10:18:57.448599-05:00,Chemotherapy,Residual Disease,
HCM-BROD-0055-C64,a3b71c6f-77cc-4e80-8c1c-96cdf836b42e,3382e6e7-88db-4179-a0a0-9a305a8758d5,396.0,Adjuvant,151.0,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0055-C64_treatment12,23528d55-4129-49bb-8faf-7437a840b963,,released,,1,2020-09-27T10:18:57.448599-05:00,Chemotherapy,Residual Disease,VDC/IE
HCM-BROD-0055-C64,a3b71c6f-77cc-4e80-8c1c-96cdf836b42e,3382e6e7-88db-4179-a0a0-9a305a8758d5,396.0,Adjuvant,151.0,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0055-C64_treatment11,2467ac09-3894-4056-aad6-f6210360da1c,,released,Etoposide,1,2020-09-27T10:18:57.448599-05:00,Chemotherapy,Residual Disease,
HCM-BROD-0055-C64,a3b71c6f-77cc-4e80-8c1c-96cdf836b42e,3382e6e7-88db-4179-a0a0-9a305a8758d5,151.0,Adjuvant,92.0,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0055-C64_treatment6,32576bb0-2ddf-43f0-9c01-e520e6ce3f8d,,released,,1,2020-09-27T10:18:57.448599-05:00,Chemotherapy,Residual Disease,VAC
HCM-BROD-0055-C64,a3b71c6f-77cc-4e80-8c1c-96cdf836b42e,3382e6e7-88db-4179-a0a0-9a305a8758d5,,Adjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0055-C64_treatment17,577248f4-0ab6-4838-8441-b86e8b883d13,,released,,0,2020-09-27T10:18:57.448599-05:00,Targeted Molecular Therapy,Residual Disease,
HCM-BROD-0055-C64,a3b71c6f-77cc-4e80-8c1c-96cdf836b42e,3382e6e7-88db-4179-a0a0-9a305a8758d5,396.0,Adjuvant,151.0,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0055-C64_treatment8,7e51bf6b-e9c9-440d-a716-18867925a725,,released,Ifosfamide,1,2020-09-27T10:18:57.448599-05:00,Chemotherapy,Residual Disease,
HCM-BROD-0055-C64,a3b71c6f-77cc-4e80-8c1c-96cdf836b42e,3382e6e7-88db-4179-a0a0-9a305a8758d5,,Adjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0055-C64_treatment15,8e1b9de7-352c-4f80-aaa3-4a2f498b1c46,,released,,0,2020-09-27T10:18:57.448599-05:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-BROD-0055-C64,a3b71c6f-77cc-4e80-8c1c-96cdf836b42e,3382e6e7-88db-4179-a0a0-9a305a8758d5,151.0,Adjuvant,92.0,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0055-C64_treatment5,8e22c491-f944-45c6-ac6d-63f992f9bb14,,released,Cyclophosphamide,1,2020-09-27T10:18:57.448599-05:00,Chemotherapy,Residual Disease,
HCM-BROD-0055-C64,a3b71c6f-77cc-4e80-8c1c-96cdf836b42e,3382e6e7-88db-4179-a0a0-9a305a8758d5,151.0,Adjuvant,92.0,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0055-C64_treatment4,96c9d487-66ef-40a6-8214-54fa626a4011,,released,Dactinomycin,1,2020-09-27T10:18:57.448599-05:00,Chemotherapy,Residual Disease,
HCM-BROD-0055-C64,a3b71c6f-77cc-4e80-8c1c-96cdf836b42e,3382e6e7-88db-4179-a0a0-9a305a8758d5,151.0,Adjuvant,92.0,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0055-C64_treatment3,98d9384d-8c9d-43d2-a930-35e5adffb041,,released,Vincristine,1,2020-09-27T10:18:57.448599-05:00,Chemotherapy,Residual Disease,
HCM-BROD-0055-C64,a3b71c6f-77cc-4e80-8c1c-96cdf836b42e,3382e6e7-88db-4179-a0a0-9a305a8758d5,,Adjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0055-C64_treatment18,9c322494-1a32-4a6d-aab7-79d790783c93,,released,,0,2020-09-27T10:18:57.448599-05:00,"Radiation Therapy, NOS",Residual Disease,
HCM-BROD-0055-C64,a3b71c6f-77cc-4e80-8c1c-96cdf836b42e,3382e6e7-88db-4179-a0a0-9a305a8758d5,396.0,Adjuvant,151.0,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0055-C64_treatment14,9cc317f1-5e16-400f-8f1e-547323e26b52,,released,,1,2020-09-27T10:18:57.448599-05:00,Chemotherapy,Residual Disease,ICE
HCM-BROD-0055-C64,a3b71c6f-77cc-4e80-8c1c-96cdf836b42e,3382e6e7-88db-4179-a0a0-9a305a8758d5,,,,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0055-C64_treatment16,cd3a6890-bb2b-4298-8584-fe3effb0e8c2,,released,,1,2020-09-27T10:18:57.448599-05:00,"Surgery, NOS",Initial Diagnosis,
HCM-BROD-0055-C64,a3b71c6f-77cc-4e80-8c1c-96cdf836b42e,3382e6e7-88db-4179-a0a0-9a305a8758d5,396.0,Adjuvant,151.0,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0055-C64_treatment13,d2d2ac7a-d7b1-4f18-a437-51708fb14545,,released,Carboplatin,1,2020-09-27T10:18:57.448599-05:00,Chemotherapy,Residual Disease,
HCM-BROD-0055-C64,a3b71c6f-77cc-4e80-8c1c-96cdf836b42e,3382e6e7-88db-4179-a0a0-9a305a8758d5,,Neoadjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0055-C64_treatment,debbd9b6-5798-494e-82c7-44b0599f9d72,,released,,0,2019-04-04T13:39:17.305307-05:00,,,
HCM-BROD-0055-C64,a3b71c6f-77cc-4e80-8c1c-96cdf836b42e,3382e6e7-88db-4179-a0a0-9a305a8758d5,396.0,Adjuvant,151.0,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0055-C64_treatment10,e6ad058c-8b34-40ba-8ac4-b4438da48642,,released,Doxorubicin,1,2020-09-27T10:18:57.448599-05:00,Chemotherapy,Residual Disease,
HCM-BROD-0055-C64,a3b71c6f-77cc-4e80-8c1c-96cdf836b42e,3382e6e7-88db-4179-a0a0-9a305a8758d5,396.0,Adjuvant,151.0,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0055-C64_treatment9,f1518b83-2639-4c84-9ed0-47719f777a8b,,released,Cyclophosphamide,1,2020-09-27T10:18:57.448599-05:00,Chemotherapy,Residual Disease,
HCM-BROD-0415-C71,a42da11c-f1c5-4641-98f4-535c675d43d5,20ebb213-ae8d-4b68-ac38-9bf33c452af9,,,-7.0,2023-03-13T12:53:04.709475-05:00,HCM-BROD-0415-C71_treatment4,1855993a-951d-43f1-a794-ed89db21debd,,released,,1,2020-09-27T11:31:52.443671-05:00,"Surgery, NOS",Initial Diagnosis,
HCM-BROD-0415-C71,a42da11c-f1c5-4641-98f4-535c675d43d5,20ebb213-ae8d-4b68-ac38-9bf33c452af9,,Adjuvant,,2021-03-03T15:15:08.075155-06:00,HCM-BROD-0415-C71_treatment6,4386423b-fd61-4f7e-9516-0795b89a457d,,released,,0,2020-09-27T11:31:52.443671-05:00,"Radiation Therapy, NOS",Residual Disease,
HCM-BROD-0415-C71,a42da11c-f1c5-4641-98f4-535c675d43d5,20ebb213-ae8d-4b68-ac38-9bf33c452af9,,Adjuvant,,2021-03-03T15:15:08.075155-06:00,HCM-BROD-0415-C71_treatment2,5e5cee47-7d5b-45e9-a0ae-8d0a5d7952ec,,released,,1,2020-09-27T11:31:52.443671-05:00,Chemotherapy,Residual Disease,
HCM-BROD-0415-C71,a42da11c-f1c5-4641-98f4-535c675d43d5,20ebb213-ae8d-4b68-ac38-9bf33c452af9,,Adjuvant,,2021-03-03T15:15:08.075155-06:00,HCM-BROD-0415-C71_treatment5,67fdae04-3eb8-4da0-adcb-07ab1a2df826,,released,,0,2020-09-27T11:31:52.443671-05:00,Targeted Molecular Therapy,Residual Disease,
HCM-BROD-0415-C71,a42da11c-f1c5-4641-98f4-535c675d43d5,20ebb213-ae8d-4b68-ac38-9bf33c452af9,,Adjuvant,,2021-03-03T15:15:08.075155-06:00,HCM-BROD-0415-C71_treatment3,ace8afb7-3d43-4fa6-a1ef-d878ccbfa71b,,released,,0,2020-09-27T11:31:52.443671-05:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-BROD-0415-C71,a42da11c-f1c5-4641-98f4-535c675d43d5,20ebb213-ae8d-4b68-ac38-9bf33c452af9,,Neoadjuvant,,2021-03-03T15:15:08.075155-06:00,HCM-BROD-0415-C71_treatment,e1f22239-4227-4151-8527-c80666374284,,released,,0,2020-09-27T11:31:52.443671-05:00,,,
HCM-BROD-0485-C15,a43460d9-c2cd-4656-bc5a-d2ba54bad91d,10a1ce51-1113-4b8f-9e6e-aa923eedd342,,Neoadjuvant,33.0,2023-02-22T07:39:25.979291-06:00,HCM-BROD-0485-C15_treatment5,0c537502-32c0-4b7c-a854-8d34df7b859c,,released,,1,2021-12-21T13:38:25.074573-06:00,Chemotherapy,,FOLFOX
HCM-BROD-0485-C15,a43460d9-c2cd-4656-bc5a-d2ba54bad91d,10a1ce51-1113-4b8f-9e6e-aa923eedd342,259.0,Adjuvant,33.0,2023-02-22T07:39:25.979291-06:00,HCM-BROD-0485-C15_treatment9,236ec883-0164-4857-930b-c42545a8c9dd,,released,Oxaliplatin,1,2021-12-21T13:38:25.074573-06:00,Chemotherapy,Residual Disease,
HCM-BROD-0485-C15,a43460d9-c2cd-4656-bc5a-d2ba54bad91d,10a1ce51-1113-4b8f-9e6e-aa923eedd342,,Neoadjuvant,33.0,2023-02-22T07:39:25.979291-06:00,HCM-BROD-0485-C15_treatment4,240c6ec5-f9c4-4ba5-af13-55a533566990,,released,Oxaliplatin,1,2021-12-21T13:38:25.074573-06:00,Chemotherapy,,
HCM-BROD-0485-C15,a43460d9-c2cd-4656-bc5a-d2ba54bad91d,10a1ce51-1113-4b8f-9e6e-aa923eedd342,,Neoadjuvant,33.0,2023-02-22T07:39:25.979291-06:00,HCM-BROD-0485-C15_treatment6,534d66eb-a9a2-4478-a845-932bf50abc7b,,released,,1,2021-12-21T13:38:25.074573-06:00,Chemotherapy,,FOLFIRI
HCM-BROD-0485-C15,a43460d9-c2cd-4656-bc5a-d2ba54bad91d,10a1ce51-1113-4b8f-9e6e-aa923eedd342,665.0,Adjuvant,260.0,2023-02-22T07:39:25.979291-06:00,HCM-BROD-0485-C15_treatment14,5acda9b4-0ada-483c-ba2a-459c4738e4f3,,released,,1,2021-12-21T13:38:25.074573-06:00,Chemotherapy,Residual Disease,FOLFIRI
HCM-BROD-0485-C15,a43460d9-c2cd-4656-bc5a-d2ba54bad91d,10a1ce51-1113-4b8f-9e6e-aa923eedd342,259.0,Adjuvant,33.0,2023-02-22T07:39:25.979291-06:00,HCM-BROD-0485-C15_treatment8,73692a4f-7bb2-48bb-b1ef-7d0a3e881fd4,,released,Fluorouracil,1,2021-12-21T13:38:25.074573-06:00,Chemotherapy,Residual Disease,
HCM-BROD-0485-C15,a43460d9-c2cd-4656-bc5a-d2ba54bad91d,10a1ce51-1113-4b8f-9e6e-aa923eedd342,665.0,Adjuvant,260.0,2023-02-22T07:39:25.979291-06:00,HCM-BROD-0485-C15_treatment11,7d70a3d3-77dd-4256-bd0f-c82e2c7c46fb,,released,Leucovorin Calcium,1,2021-12-21T13:38:25.074573-06:00,Chemotherapy,Residual Disease,
HCM-BROD-0485-C15,a43460d9-c2cd-4656-bc5a-d2ba54bad91d,10a1ce51-1113-4b8f-9e6e-aa923eedd342,,Neoadjuvant,33.0,2023-02-22T07:39:25.979291-06:00,HCM-BROD-0485-C15_treatment3,9f24676f-bf49-4d1e-b473-f6a077470e7a,,released,Irinotecan,1,2021-12-21T13:38:25.074573-06:00,Chemotherapy,,
HCM-BROD-0485-C15,a43460d9-c2cd-4656-bc5a-d2ba54bad91d,10a1ce51-1113-4b8f-9e6e-aa923eedd342,259.0,Adjuvant,33.0,2023-02-22T07:39:25.979291-06:00,HCM-BROD-0485-C15_treatment7,ad28f5ac-0bc9-4898-bf4f-cb5fabb240b4,,released,Leucovorin Calcium,1,2021-12-21T13:38:25.074573-06:00,Chemotherapy,Residual Disease,
HCM-BROD-0485-C15,a43460d9-c2cd-4656-bc5a-d2ba54bad91d,10a1ce51-1113-4b8f-9e6e-aa923eedd342,665.0,Adjuvant,260.0,2023-02-22T07:39:25.979291-06:00,HCM-BROD-0485-C15_treatment13,afa13f20-493c-428e-aea1-5ca32286c845,,released,Irinotecan,1,2021-12-21T13:38:25.074573-06:00,Chemotherapy,Residual Disease,
HCM-BROD-0485-C15,a43460d9-c2cd-4656-bc5a-d2ba54bad91d,10a1ce51-1113-4b8f-9e6e-aa923eedd342,,Neoadjuvant,33.0,2023-02-22T07:39:25.979291-06:00,HCM-BROD-0485-C15_treatment,b615605a-a5e9-4be1-a4ab-8efe7b0e3abd,,released,Leucovorin Calcium,1,2021-12-21T13:38:25.074573-06:00,Chemotherapy,,
HCM-BROD-0485-C15,a43460d9-c2cd-4656-bc5a-d2ba54bad91d,10a1ce51-1113-4b8f-9e6e-aa923eedd342,259.0,Adjuvant,33.0,2023-02-22T07:39:25.979291-06:00,HCM-BROD-0485-C15_treatment10,bbf2a8c7-6361-41e5-8153-2d3c2f57045e,,released,,1,2021-12-21T13:38:25.074573-06:00,Chemotherapy,Residual Disease,FOLFOX
HCM-BROD-0485-C15,a43460d9-c2cd-4656-bc5a-d2ba54bad91d,10a1ce51-1113-4b8f-9e6e-aa923eedd342,,Adjuvant,,2023-02-22T07:39:25.979291-06:00,HCM-BROD-0485-C15_treatment17,bdf1a40d-3c86-458a-a0b0-d91c7d79d8d8,,released,,0,2021-12-21T13:38:25.074573-06:00,Targeted Molecular Therapy,Residual Disease,
HCM-BROD-0485-C15,a43460d9-c2cd-4656-bc5a-d2ba54bad91d,10a1ce51-1113-4b8f-9e6e-aa923eedd342,665.0,Adjuvant,260.0,2023-02-22T07:39:25.979291-06:00,HCM-BROD-0485-C15_treatment12,c27e471c-a858-45e8-b7e2-bdc3178a99e2,,released,Fluorouracil,1,2021-12-21T13:38:25.074573-06:00,Chemotherapy,Residual Disease,
HCM-BROD-0485-C15,a43460d9-c2cd-4656-bc5a-d2ba54bad91d,10a1ce51-1113-4b8f-9e6e-aa923eedd342,,Neoadjuvant,33.0,2023-02-22T07:39:25.979291-06:00,HCM-BROD-0485-C15_treatment2,caaef774-e106-47a0-aecd-4fc3e93f1e41,,released,Fluorouracil,1,2021-12-21T13:38:25.074573-06:00,Chemotherapy,,
HCM-BROD-0485-C15,a43460d9-c2cd-4656-bc5a-d2ba54bad91d,10a1ce51-1113-4b8f-9e6e-aa923eedd342,,,3.0,2023-03-13T13:15:59.653103-05:00,HCM-BROD-0485-C15_treatment16,d0e2797e-c8d1-4c79-b44c-d9ef70828354,,released,,1,2021-12-21T13:38:25.074573-06:00,"Surgery, NOS",Initial Diagnosis,
HCM-BROD-0485-C15,a43460d9-c2cd-4656-bc5a-d2ba54bad91d,10a1ce51-1113-4b8f-9e6e-aa923eedd342,,Adjuvant,,2023-02-22T07:39:25.979291-06:00,HCM-BROD-0485-C15_treatment18,e4552e35-187d-4b56-bb53-a1c492a5e9fd,,released,,0,2021-12-21T13:38:25.074573-06:00,"Radiation Therapy, NOS",Residual Disease,
HCM-BROD-0485-C15,a43460d9-c2cd-4656-bc5a-d2ba54bad91d,10a1ce51-1113-4b8f-9e6e-aa923eedd342,,Adjuvant,,2023-02-22T07:39:25.979291-06:00,HCM-BROD-0485-C15_treatment15,faab57da-4747-43da-9070-85a045a2ba87,,released,,0,2021-12-21T13:38:25.074573-06:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-WCMC-1292-C67,a4f7fe06-4bef-4e32-afce-f3fa80588aa4,45810202-33cd-42fb-a640-2d3ed6ceb4a3,1528.0,Adjuvant,1508.0,2025-04-07T17:13:09.336794-05:00,HCM-WCMC-1292-C67_treatment10,0547f9b0-b6c8-4dbd-ac57-71739d2ff433,,released,,1,2023-02-27T12:39:00.427328-06:00,"Radiation, Intensity-Modulated Radiotherapy",Residual Disease,
HCM-WCMC-1292-C67,a4f7fe06-4bef-4e32-afce-f3fa80588aa4,45810202-33cd-42fb-a640-2d3ed6ceb4a3,,,0.0,2025-04-07T17:13:09.336794-05:00,HCM-WCMC-1292-C67_treatment8,1135f166-dc4d-4318-83af-238f6ba83804,,released,,1,2023-02-27T12:39:00.427328-06:00,"Surgery, NOS",Initial Diagnosis,
HCM-WCMC-1292-C67,a4f7fe06-4bef-4e32-afce-f3fa80588aa4,45810202-33cd-42fb-a640-2d3ed6ceb4a3,953.0,Adjuvant,841.0,2025-04-07T17:13:09.336794-05:00,HCM-WCMC-1292-C67_treatment2,71e23152-93eb-4f85-9337-398a606d9d2d,,released,Gemcitabine,1,2023-02-27T12:39:00.427328-06:00,Chemotherapy,Residual Disease,
HCM-WCMC-1292-C67,a4f7fe06-4bef-4e32-afce-f3fa80588aa4,45810202-33cd-42fb-a640-2d3ed6ceb4a3,,Neoadjuvant,414.0,2025-04-07T17:13:09.336794-05:00,HCM-WCMC-1292-C67_treatment,7aa8cccf-8350-4bd4-bf87-86deef43fb66,,released,Pembrolizumab,1,2023-02-27T12:39:00.427328-06:00,Immunotherapy (Including Vaccines),,
HCM-WCMC-1292-C67,a4f7fe06-4bef-4e32-afce-f3fa80588aa4,45810202-33cd-42fb-a640-2d3ed6ceb4a3,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-WCMC-1292-C67_treatment9,7f34965b-809e-4ebf-a225-4b00bfe6caaf,,released,,0,2023-02-27T12:39:00.427328-06:00,Targeted Molecular Therapy,Residual Disease,
HCM-WCMC-1292-C67,a4f7fe06-4bef-4e32-afce-f3fa80588aa4,45810202-33cd-42fb-a640-2d3ed6ceb4a3,1695.0,Adjuvant,1240.0,2025-04-07T17:13:09.336794-05:00,HCM-WCMC-1292-C67_treatment5,891351f0-fe65-4f0b-8a4b-1b1d2a553d0b,Treatment Ongoing,released,Pembrolizumab,1,2023-02-27T12:39:00.427328-06:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-WCMC-1292-C67,a4f7fe06-4bef-4e32-afce-f3fa80588aa4,45810202-33cd-42fb-a640-2d3ed6ceb4a3,1457.0,Adjuvant,1240.0,2025-04-07T17:13:09.336794-05:00,HCM-WCMC-1292-C67_treatment6,df23d980-95c2-4a4e-83f0-e656acc39e7f,,released,Enfortumab Vedotin,1,2023-02-27T12:39:00.427328-06:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-WCMC-1292-C67,a4f7fe06-4bef-4e32-afce-f3fa80588aa4,45810202-33cd-42fb-a640-2d3ed6ceb4a3,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-WCMC-1292-C67_treatment4,eb9433f8-d4df-4c92-9cc5-f2bd9accef7d,,released,,0,2023-02-27T12:39:00.427328-06:00,Hormone Therapy,Residual Disease,
HCM-WCMC-1292-C67,a4f7fe06-4bef-4e32-afce-f3fa80588aa4,45810202-33cd-42fb-a640-2d3ed6ceb4a3,1765.0,Adjuvant,1534.0,2025-04-07T17:13:09.336794-05:00,HCM-WCMC-1292-C67_treatment7,ed1e6362-4c89-45e5-a68c-4423de8f114f,Treatment Ongoing,released,Sacituzumab Govitecan,1,2023-02-27T12:39:00.427328-06:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-WCMC-1292-C67,a4f7fe06-4bef-4e32-afce-f3fa80588aa4,45810202-33cd-42fb-a640-2d3ed6ceb4a3,953.0,Adjuvant,841.0,2025-04-07T17:13:09.336794-05:00,HCM-WCMC-1292-C67_treatment3,fd798d4b-c436-4eda-af64-2b180fe21783,,released,Carboplatin,1,2023-02-27T12:39:00.427328-06:00,Chemotherapy,Residual Disease,
HCM-SANG-1311-C18,a54e76e9-7d37-4f9d-9b63-f2fa25f1b1b1,c9bb3885-f91a-4c88-ae92-327a19b7fa29,,Neoadjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-SANG-1311-C18_treatment,f269429a-085f-4277-b9ec-b5d9c1ea10c6,,released,,0,2023-02-27T12:16:27.111036-06:00,,,
HCM-CSHL-0907-C50,a578c191-9220-4d93-a772-9415a5733913,df4b3412-f981-4c87-b2a7-a892b6abb23d,,,64.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0907-C50_treatment2,052b37ab-4dbc-4a42-805c-1000ce05502c,,released,,1,2021-12-21T14:38:27.851732-06:00,"Surgery, NOS",Initial Diagnosis,
HCM-CSHL-0907-C50,a578c191-9220-4d93-a772-9415a5733913,df4b3412-f981-4c87-b2a7-a892b6abb23d,,,515.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0907-C50_treatment3,2ded8c5a-d58c-4769-a34b-6cda1b2b0660,,released,,1,2021-12-21T14:38:27.851732-06:00,"Surgery, NOS",Initial Diagnosis,
HCM-CSHL-0907-C50,a578c191-9220-4d93-a772-9415a5733913,df4b3412-f981-4c87-b2a7-a892b6abb23d,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0907-C50_treatment5,42c277a9-4e18-4801-9543-54dd54e6fddc,,released,,0,2021-12-21T14:38:27.851732-06:00,"Radiation Therapy, NOS",Residual Disease,
HCM-CSHL-0907-C50,a578c191-9220-4d93-a772-9415a5733913,df4b3412-f981-4c87-b2a7-a892b6abb23d,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0907-C50_treatment4,9df204bb-bf73-4978-8abe-4c7368ee56b7,,released,,0,2021-12-21T14:38:27.851732-06:00,"Pharmaceutical Therapy, NOS",Residual Disease,
HCM-CSHL-0907-C50,a578c191-9220-4d93-a772-9415a5733913,df4b3412-f981-4c87-b2a7-a892b6abb23d,,Prevention,,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0907-C50_treatment6,f488289f-f4f3-4d37-8d5e-46bf291c842e,,released,,0,2021-12-21T14:38:27.851732-06:00,Hormone Therapy,,
HCM-CSHL-0907-C50,a578c191-9220-4d93-a772-9415a5733913,df4b3412-f981-4c87-b2a7-a892b6abb23d,,Neoadjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0907-C50_treatment,fb9533d4-28cc-4f10-b96f-5444fee51238,,released,,0,2021-12-21T14:38:27.851732-06:00,,,
HCM-CSHL-0907-C50,a578c191-9220-4d93-a772-9415a5733913,e5527439-932f-4942-bcc8-4b6cf428ae40,,Prevention,,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0907-C50_treatment7,d15bc90b-97d7-4646-b85b-5ae2ee8e828f,,released,,0,2023-02-28T11:40:01.459982-06:00,Hormone Therapy,,
HCM-CSHL-0162-C19,a5d2e190-acdc-4bd9-be42-bd8c17bfa205,795d1110-a5ba-4afe-9a12-82cb260c2da6,,Neoadjuvant,,2021-07-12T12:25:55.528644-05:00,HCM-CSHL-0162-C19_treatment,31242780-0ad4-43a6-ba88-ac1b05d79a15,,released,,0,2020-09-27T13:02:32.687727-05:00,,,
HCM-CSHL-0162-C19,a5d2e190-acdc-4bd9-be42-bd8c17bfa205,795d1110-a5ba-4afe-9a12-82cb260c2da6,,Adjuvant,,2023-03-13T13:19:09.535084-05:00,HCM-CSHL-0162-C19_treatment3,5cb662c4-7dab-4048-add3-1dbae6f4ffd7,,released,,0,2020-09-27T13:02:32.687727-05:00,"Pharmaceutical Therapy, NOS",Residual Disease,
HCM-CSHL-0162-C19,a5d2e190-acdc-4bd9-be42-bd8c17bfa205,795d1110-a5ba-4afe-9a12-82cb260c2da6,,Adjuvant,,2023-03-13T13:19:09.535084-05:00,HCM-CSHL-0162-C19_treatment4,75eb5a7a-83d1-43e6-a110-9b7d9d207042,,released,,0,2020-09-27T13:02:32.687727-05:00,"Radiation Therapy, NOS",Residual Disease,
HCM-CSHL-0162-C19,a5d2e190-acdc-4bd9-be42-bd8c17bfa205,795d1110-a5ba-4afe-9a12-82cb260c2da6,,,119.0,2023-03-13T13:19:09.535084-05:00,HCM-CSHL-0162-C19_treatment2,92703657-dfef-46a6-b0e3-75d14e9b58d8,,released,,1,2020-09-27T13:02:32.687727-05:00,"Surgery, NOS",Initial Diagnosis,
HCM-CSHL-0393-C18,a691cd0c-1878-47a6-8a0f-37e4fe12d20a,46abf0b5-e1e2-4424-b28e-af0cdaad0302,121.0,Adjuvant,49.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0393-C18_treatment4,0156c429-85dc-4e5d-bb69-5a639acd5236,,released,,1,2021-12-21T14:05:37.466399-06:00,"Radiation, Intensity-Modulated Radiotherapy",Residual Disease,
HCM-CSHL-0393-C18,a691cd0c-1878-47a6-8a0f-37e4fe12d20a,46abf0b5-e1e2-4424-b28e-af0cdaad0302,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0393-C18_treatment3,5c15c0b6-7c68-4c8e-8df0-028db5dba3a8,,released,,0,2021-12-21T14:05:37.466399-06:00,"Pharmaceutical Therapy, NOS",Residual Disease,
HCM-CSHL-0393-C18,a691cd0c-1878-47a6-8a0f-37e4fe12d20a,46abf0b5-e1e2-4424-b28e-af0cdaad0302,,Neoadjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0393-C18_treatment,dea1c984-5857-4ed8-a342-8475c7e96c35,,released,,0,2021-12-21T14:05:37.466399-06:00,,,
HCM-CSHL-0393-C18,a691cd0c-1878-47a6-8a0f-37e4fe12d20a,46abf0b5-e1e2-4424-b28e-af0cdaad0302,,,49.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0393-C18_treatment2,f432c59f-6fbc-488e-ba9e-b5fa36d482c1,,released,,1,2021-12-21T14:05:37.466399-06:00,"Surgery, NOS",Initial Diagnosis,
HCM-CSHL-0853-C56,a7364c7c-cc66-468d-8a6e-11cc58adf3d6,8c566440-c9b8-445a-b171-6f8eaf76e055,,,0.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0853-C56_treatment2,4666ff5f-dd2e-4234-9eef-ff33ebbe246f,,released,,1,2021-12-21T14:34:26.314279-06:00,"Surgery, NOS",Initial Diagnosis,
HCM-CSHL-0853-C56,a7364c7c-cc66-468d-8a6e-11cc58adf3d6,8c566440-c9b8-445a-b171-6f8eaf76e055,,Neoadjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0853-C56_treatment,bcc4e6b6-2e8b-40db-86b5-010ca4912d72,,released,,0,2021-12-21T14:34:26.314279-06:00,,,
HCM-CSHL-0853-C56,a7364c7c-cc66-468d-8a6e-11cc58adf3d6,8c566440-c9b8-445a-b171-6f8eaf76e055,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0853-C56_treatment3,fd36fec7-104d-457c-92a1-1128b9c37b16,,released,,unknown,2021-12-21T14:34:26.314279-06:00,"Pharmaceutical Therapy, NOS",Residual Disease,
HCM-CSHL-0853-C56,a7364c7c-cc66-468d-8a6e-11cc58adf3d6,8c566440-c9b8-445a-b171-6f8eaf76e055,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0853-C56_treatment4,ff76bcfe-2bb1-45e3-b8a6-f1f537141b60,,released,,unknown,2021-12-21T14:34:26.314279-06:00,"Radiation Therapy, NOS",Residual Disease,
HCM-WCMC-0945-C54,a826f214-8322-443e-b8a9-8495c5d81b2f,1ab21429-f684-4560-8bea-33d233704799,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-WCMC-0945-C54_treatment4,07282310-076b-42ca-b0ca-86b86967f44c,,released,,0,2022-09-16T08:11:08.252347-05:00,"Radiation Therapy, NOS",Residual Disease,
HCM-WCMC-0945-C54,a826f214-8322-443e-b8a9-8495c5d81b2f,1ab21429-f684-4560-8bea-33d233704799,,,26.0,2025-04-07T17:13:09.336794-05:00,HCM-WCMC-0945-C54_treatment2,15d4a769-3a28-4141-944b-f98a761c8fe0,,released,,1,2022-09-16T08:11:08.252347-05:00,"Surgery, NOS",Initial Diagnosis,
HCM-WCMC-0945-C54,a826f214-8322-443e-b8a9-8495c5d81b2f,1ab21429-f684-4560-8bea-33d233704799,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-WCMC-0945-C54_treatment3,a2f322ef-cc0b-4ec9-b95e-eeab1553ba4a,,released,,0,2022-09-16T08:11:08.252347-05:00,"Pharmaceutical Therapy, NOS",Residual Disease,
HCM-WCMC-0945-C54,a826f214-8322-443e-b8a9-8495c5d81b2f,1ab21429-f684-4560-8bea-33d233704799,,Neoadjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-WCMC-0945-C54_treatment,a95911e4-7ff6-45ee-aa9b-5b88b4926a62,,released,,0,2022-09-16T08:11:08.252347-05:00,,,
HCM-SANG-0517-C20,a8408536-bd05-4a7d-8792-8390cceca6ae,2893234e-01b4-41e5-8eb0-21cb662eb853,,Neoadjuvant,,2023-07-13T10:35:44.371881-05:00,HCM-SANG-0517-C20_treatment,f85edbb8-0483-4de8-a59d-07de2c90e0b5,,released,,0,2021-12-21T15:11:39.956181-06:00,,,
HCM-CSHL-0698-C06,a870c27c-b854-4c7e-81c3-9a3d66d4d778,a5419929-de7b-4c87-b417-695e93343d74,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0698-C06_treatment4,a78be499-9052-474b-8832-58a20157fe9f,,released,,0,2021-12-21T14:18:22.070341-06:00,"Radiation Therapy, NOS",Residual Disease,
HCM-CSHL-0698-C06,a870c27c-b854-4c7e-81c3-9a3d66d4d778,a5419929-de7b-4c87-b417-695e93343d74,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0698-C06_treatment3,c907fc67-4635-4fff-97f6-a95448fcab4c,,released,,0,2021-12-21T14:18:22.070341-06:00,"Pharmaceutical Therapy, NOS",Residual Disease,
HCM-CSHL-0698-C06,a870c27c-b854-4c7e-81c3-9a3d66d4d778,a5419929-de7b-4c87-b417-695e93343d74,,Neoadjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0698-C06_treatment,f36a358a-39ed-4587-a264-434f2d36e7fa,,released,,0,2021-12-21T14:18:22.070341-06:00,,,
HCM-CSHL-0698-C06,a870c27c-b854-4c7e-81c3-9a3d66d4d778,a5419929-de7b-4c87-b417-695e93343d74,,,0.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0698-C06_treatment2,fc44be00-83a9-49c4-b1f3-9c982b3f240b,,released,,1,2021-12-21T14:18:22.070341-06:00,"Surgery, NOS",Initial Diagnosis,
HCM-SANG-0311-C15,a881a43e-42ef-48ba-9b10-456792261a3a,ac8b4842-7b4e-4275-9469-ca5927dddc8d,,Neoadjuvant,,2023-07-13T10:35:44.371881-05:00,HCM-SANG-0311-C15_treatment,dba1b702-a969-435e-b613-670554fb05f6,,released,,0,2021-12-21T15:11:14.586990-06:00,,,
HCM-BROD-1117-C56,a8856f5a-594e-4ce6-86f2-4ddc5ec46df5,0ea4d1d4-d11a-44ae-af64-1fbe2ae38a10,156.0,Adjuvant,20.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-1117-C56_treatment2,4ea2ef35-fdf9-4ba4-8244-fb3241a94618,,released,Carboplatin,1,2021-12-21T14:01:02.858391-06:00,Chemotherapy,Residual Disease,
HCM-BROD-1117-C56,a8856f5a-594e-4ce6-86f2-4ddc5ec46df5,0ea4d1d4-d11a-44ae-af64-1fbe2ae38a10,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-BROD-1117-C56_treatment4,560a249d-8de6-481c-826e-7607ece4a67c,,released,,0,2021-12-21T14:01:02.858391-06:00,Hormone Therapy,Residual Disease,
HCM-BROD-1117-C56,a8856f5a-594e-4ce6-86f2-4ddc5ec46df5,0ea4d1d4-d11a-44ae-af64-1fbe2ae38a10,156.0,Adjuvant,20.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-1117-C56_treatment3,5c62fe31-2a8e-42ca-a9fc-723761471c78,,released,Paclitaxel,1,2021-12-21T14:01:02.858391-06:00,Chemotherapy,Residual Disease,
HCM-BROD-1117-C56,a8856f5a-594e-4ce6-86f2-4ddc5ec46df5,0ea4d1d4-d11a-44ae-af64-1fbe2ae38a10,,Neoadjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-BROD-1117-C56_treatment,63f574ae-f314-4e1e-a634-07fe7ceeb1d6,,released,,0,2021-12-21T14:01:02.858391-06:00,,,
HCM-BROD-1117-C56,a8856f5a-594e-4ce6-86f2-4ddc5ec46df5,0ea4d1d4-d11a-44ae-af64-1fbe2ae38a10,,,0.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-1117-C56_treatment6,764a7f66-ba63-4628-970f-69c7192f2477,,released,,1,2021-12-21T14:01:02.858391-06:00,"Surgery, NOS",Initial Diagnosis,
HCM-BROD-1117-C56,a8856f5a-594e-4ce6-86f2-4ddc5ec46df5,0ea4d1d4-d11a-44ae-af64-1fbe2ae38a10,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-BROD-1117-C56_treatment7,813d955d-c9d0-46c9-ab29-015010020757,,released,,0,2021-12-21T14:01:02.858391-06:00,Targeted Molecular Therapy,Residual Disease,
HCM-BROD-1117-C56,a8856f5a-594e-4ce6-86f2-4ddc5ec46df5,0ea4d1d4-d11a-44ae-af64-1fbe2ae38a10,287.0,Adjuvant,268.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-1117-C56_treatment5,99d6fdf5-6b53-40cb-bb91-59750a71465c,,released,Unknown,1,2021-12-21T14:01:02.858391-06:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-BROD-1117-C56,a8856f5a-594e-4ce6-86f2-4ddc5ec46df5,0ea4d1d4-d11a-44ae-af64-1fbe2ae38a10,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-BROD-1117-C56_treatment8,e84fab36-aa66-46ea-a474-0ef42b2c33f1,,released,,0,2021-12-21T14:01:02.858391-06:00,"Radiation Therapy, NOS",Residual Disease,
HCM-CSHL-0852-C76,a947e983-07c7-4bdf-9b3b-e6e72b6c41e5,5e8f7135-a329-43de-b536-978f1d81c537,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0852-C76_treatment4,1cc7aa47-b638-4d51-868a-74728044bc9b,,released,,unknown,2021-12-21T14:34:17.055382-06:00,"Radiation Therapy, NOS",Residual Disease,
HCM-CSHL-0852-C76,a947e983-07c7-4bdf-9b3b-e6e72b6c41e5,5e8f7135-a329-43de-b536-978f1d81c537,,,0.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0852-C76_treatment2,613fee0f-c545-4b83-9867-ce6afac50926,,released,,1,2021-12-21T14:34:17.055382-06:00,"Surgery, NOS",Initial Diagnosis,
HCM-CSHL-0852-C76,a947e983-07c7-4bdf-9b3b-e6e72b6c41e5,5e8f7135-a329-43de-b536-978f1d81c537,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0852-C76_treatment3,8fe065c5-0352-48dd-8574-2f31b4e1b2be,,released,,0,2021-12-21T14:34:17.055382-06:00,"Pharmaceutical Therapy, NOS",Residual Disease,
HCM-CSHL-0852-C76,a947e983-07c7-4bdf-9b3b-e6e72b6c41e5,5e8f7135-a329-43de-b536-978f1d81c537,,Neoadjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0852-C76_treatment,d406be06-8a60-43c3-b9e1-15f978f346ed,,released,,0,2021-12-21T14:34:17.055382-06:00,,,
HCM-CSHL-0740-C18,aa0d437f-845b-43af-98e9-c7e5c3b55d33,15e0c3da-4c20-4570-aa4a-42184c78ac35,,Maintenance Therapy,,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0740-C18_treatment17,07b4491b-0f68-4bf9-bf53-cc50ba8a897b,Progressive Disease,released,Leucovorin Calcium,1,2021-12-21T14:21:18.708703-06:00,,,
HCM-CSHL-0740-C18,aa0d437f-845b-43af-98e9-c7e5c3b55d33,15e0c3da-4c20-4570-aa4a-42184c78ac35,,Maintenance Therapy,,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0740-C18_treatment13,1096530c-e559-4926-a09a-ada54ca71527,Progressive Disease,released,Bevacizumab,1,2021-12-21T14:21:18.708703-06:00,,,
HCM-CSHL-0740-C18,aa0d437f-845b-43af-98e9-c7e5c3b55d33,15e0c3da-4c20-4570-aa4a-42184c78ac35,,Maintenance Therapy,,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0740-C18_treatment15,26ab7212-0988-4b1f-8dfa-18dd3ba3d643,Progressive Disease,released,Oxaliplatin,1,2021-12-21T14:21:18.708703-06:00,,,
HCM-CSHL-0740-C18,aa0d437f-845b-43af-98e9-c7e5c3b55d33,15e0c3da-4c20-4570-aa4a-42184c78ac35,,Maintenance Therapy,,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0740-C18_treatment19,68284556-eb23-4583-8119-53cd1baca12c,Progressive Disease,released,,1,2021-12-21T14:21:18.708703-06:00,,,FOLFOX
HCM-CSHL-0740-C18,aa0d437f-845b-43af-98e9-c7e5c3b55d33,15e0c3da-4c20-4570-aa4a-42184c78ac35,,Maintenance Therapy,,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0740-C18_treatment18,70e7bcd6-500e-4fab-98e1-ad570a3406e3,Progressive Disease,released,Fluorouracil,1,2021-12-21T14:21:18.708703-06:00,,,
HCM-CSHL-0740-C18,aa0d437f-845b-43af-98e9-c7e5c3b55d33,15e0c3da-4c20-4570-aa4a-42184c78ac35,,Maintenance Therapy,,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0740-C18_treatment14,c6cb7f37-96e7-41b9-980a-fce10b41ae00,Progressive Disease,released,Irinotecan,1,2021-12-21T14:21:18.708703-06:00,,,
HCM-CSHL-0740-C18,aa0d437f-845b-43af-98e9-c7e5c3b55d33,15e0c3da-4c20-4570-aa4a-42184c78ac35,,Maintenance Therapy,,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0740-C18_treatment16,e1d9313d-5888-4a00-8df3-eef64525b769,Progressive Disease,released,Xeloda,1,2021-12-21T14:21:18.708703-06:00,,,
HCM-CSHL-0740-C18,aa0d437f-845b-43af-98e9-c7e5c3b55d33,bf45b491-ff56-44a4-ae3c-0a7d72b700fb,245.0,Adjuvant,70.0,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0740-C18_treatment4,12b6b7e2-beb5-4f11-9115-ad22c1211f4d,,released,Oxaliplatin,1,2021-12-21T14:21:18.708703-06:00,Chemotherapy,Residual Disease,
HCM-CSHL-0740-C18,aa0d437f-845b-43af-98e9-c7e5c3b55d33,bf45b491-ff56-44a4-ae3c-0a7d72b700fb,,,17.0,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0740-C18_treatment9,296f0e0e-2b04-452f-84dc-f9e3677bdead,,released,,1,2021-12-21T14:21:18.708703-06:00,"Surgery, NOS",Initial Diagnosis,
HCM-CSHL-0740-C18,aa0d437f-845b-43af-98e9-c7e5c3b55d33,bf45b491-ff56-44a4-ae3c-0a7d72b700fb,,Neoadjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0740-C18_treatment,2b7725b0-5973-455c-b659-b1414d0fa1d8,,released,,0,2021-12-21T14:21:18.708703-06:00,,,
HCM-CSHL-0740-C18,aa0d437f-845b-43af-98e9-c7e5c3b55d33,bf45b491-ff56-44a4-ae3c-0a7d72b700fb,245.0,Adjuvant,70.0,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0740-C18_treatment5,37f3d3b9-29b2-4e36-b4b4-cab3a0122f9d,,released,,1,2021-12-21T14:21:18.708703-06:00,Chemotherapy,Residual Disease,FOLFOX
HCM-CSHL-0740-C18,aa0d437f-845b-43af-98e9-c7e5c3b55d33,bf45b491-ff56-44a4-ae3c-0a7d72b700fb,,Adjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0740-C18_treatment8,4abf7498-c6a9-44a2-93fe-917beb4671ce,,released,,0,2021-12-21T14:21:18.708703-06:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-CSHL-0740-C18,aa0d437f-845b-43af-98e9-c7e5c3b55d33,bf45b491-ff56-44a4-ae3c-0a7d72b700fb,791.0,Adjuvant,714.0,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0740-C18_treatment7,684c4e73-f8ab-4552-ae28-906d13e4bb5a,,released,Irinotecan,1,2021-12-21T14:21:18.708703-06:00,Chemotherapy,Residual Disease,
HCM-CSHL-0740-C18,aa0d437f-845b-43af-98e9-c7e5c3b55d33,bf45b491-ff56-44a4-ae3c-0a7d72b700fb,245.0,Adjuvant,70.0,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0740-C18_treatment3,687520d5-34f4-46d6-b5f7-7d6b2bd57928,,released,Fluorouracil,1,2021-12-21T14:21:18.708703-06:00,Chemotherapy,Residual Disease,
HCM-CSHL-0740-C18,aa0d437f-845b-43af-98e9-c7e5c3b55d33,bf45b491-ff56-44a4-ae3c-0a7d72b700fb,791.0,Adjuvant,593.0,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0740-C18_treatment11,76d80df0-dcb4-4919-969d-7c85df9709d8,,released,Bevacizumab,1,2021-12-21T14:21:18.708703-06:00,Targeted Molecular Therapy,Residual Disease,
HCM-CSHL-0740-C18,aa0d437f-845b-43af-98e9-c7e5c3b55d33,bf45b491-ff56-44a4-ae3c-0a7d72b700fb,245.0,Adjuvant,70.0,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0740-C18_treatment2,aa86736e-ff44-4d3e-80de-7ea730c5327f,,released,Leucovorin Calcium,1,2021-12-21T14:21:18.708703-06:00,Chemotherapy,Residual Disease,
HCM-CSHL-0740-C18,aa0d437f-845b-43af-98e9-c7e5c3b55d33,bf45b491-ff56-44a4-ae3c-0a7d72b700fb,706.0,Adjuvant,343.0,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0740-C18_treatment6,c44e987c-1651-4c68-bc4e-5296778c3a4f,,released,Capecitabine,1,2021-12-21T14:21:18.708703-06:00,Chemotherapy,Residual Disease,
HCM-CSHL-0740-C18,aa0d437f-845b-43af-98e9-c7e5c3b55d33,bf45b491-ff56-44a4-ae3c-0a7d72b700fb,984.0,Adjuvant,969.0,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0740-C18_treatment12,ca55386e-aea0-49c9-a02f-e03993e0f6fa,,released,,1,2021-12-21T14:21:18.708703-06:00,"Radiation, 3D Conformal",Residual Disease,
HCM-CSHL-0740-C18,aa0d437f-845b-43af-98e9-c7e5c3b55d33,bf45b491-ff56-44a4-ae3c-0a7d72b700fb,,,1218.0,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0740-C18_treatment10,f9fe9fb0-4137-4a89-afb1-264d7fb2cd48,,released,,1,2021-12-21T14:21:18.708703-06:00,"Surgery, NOS",Initial Diagnosis,
HCM-BROD-0416-C71,aa17554b-2291-4947-9858-eadb82704f9b,de976004-e763-4759-9a7a-5b24a7f4aafe,,Adjuvant,,2021-07-12T12:25:55.528644-05:00,HCM-BROD-0416-C71_treatment3,0d167298-0b5b-4039-be6b-12b1af520a76,,released,,0,2020-07-31T09:29:09.924872-05:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-BROD-0416-C71,aa17554b-2291-4947-9858-eadb82704f9b,de976004-e763-4759-9a7a-5b24a7f4aafe,185.0,Adjuvant,127.0,2021-07-12T12:25:55.528644-05:00,HCM-BROD-0416-C71_treatment5,38fa97b6-7f4e-4135-9cfa-580c912d4d03,,released,Bevacizumab,1,2020-07-31T09:29:09.924872-05:00,Targeted Molecular Therapy,Residual Disease,
HCM-BROD-0416-C71,aa17554b-2291-4947-9858-eadb82704f9b,de976004-e763-4759-9a7a-5b24a7f4aafe,85.0,Adjuvant,37.0,2021-07-12T12:25:55.528644-05:00,HCM-BROD-0416-C71_treatment2,58bb6e95-fcc8-4d37-b58e-19c493f3d2a7,,released,Temozolomide,1,2020-07-31T09:29:09.924872-05:00,Chemotherapy,Residual Disease,
HCM-BROD-0416-C71,aa17554b-2291-4947-9858-eadb82704f9b,de976004-e763-4759-9a7a-5b24a7f4aafe,85.0,Adjuvant,37.0,2023-07-07T13:17:11.385689-05:00,HCM-BROD-0416-C71_treatment6,63eb748d-e859-4dc7-adcd-3596698bb538,,released,,1,2020-07-31T09:29:09.924872-05:00,"Radiation Therapy, NOS",Residual Disease,
HCM-BROD-0416-C71,aa17554b-2291-4947-9858-eadb82704f9b,de976004-e763-4759-9a7a-5b24a7f4aafe,,Neoadjuvant,,2021-07-12T12:25:55.528644-05:00,HCM-BROD-0416-C71_treatment,8f826653-fba9-4bec-9781-3d7cb518ae26,,released,,0,2020-07-31T09:29:09.924872-05:00,,,
HCM-BROD-0416-C71,aa17554b-2291-4947-9858-eadb82704f9b,de976004-e763-4759-9a7a-5b24a7f4aafe,,,-6.0,2023-02-27T12:22:45.056235-06:00,HCM-BROD-0416-C71_treatment4,a2ce9a4c-47d2-4598-b7aa-016a6e4fbb4b,,released,,1,2020-07-31T09:29:09.924872-05:00,"Surgery, NOS",Initial Diagnosis,
HCM-CSHL-0809-C54,aa72adc9-e4ae-4d38-a1ff-5cdac2c3fc06,08819f7e-9910-4910-9013-b3cad97b6131,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0809-C54_treatment4,0c9d9eec-54ad-4aa7-a892-1642b31277d9,,released,,0,2021-12-21T14:26:49.793201-06:00,Hormone Therapy,Residual Disease,
HCM-CSHL-0809-C54,aa72adc9-e4ae-4d38-a1ff-5cdac2c3fc06,08819f7e-9910-4910-9013-b3cad97b6131,,,0.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0809-C54_treatment6,479f0b19-741b-4694-a38a-36f9c0e6c9e7,,released,,1,2021-12-21T14:26:49.793201-06:00,"Surgery, NOS",Initial Diagnosis,
HCM-CSHL-0809-C54,aa72adc9-e4ae-4d38-a1ff-5cdac2c3fc06,08819f7e-9910-4910-9013-b3cad97b6131,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0809-C54_treatment7,792c7d23-d4de-4580-86b4-5637995c6702,,released,,0,2021-12-21T14:26:49.793201-06:00,Targeted Molecular Therapy,Residual Disease,
HCM-CSHL-0809-C54,aa72adc9-e4ae-4d38-a1ff-5cdac2c3fc06,08819f7e-9910-4910-9013-b3cad97b6131,,Neoadjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0809-C54_treatment,8414af98-aba3-4591-8626-9ca26ff378af,,released,,0,2021-12-21T14:26:49.793201-06:00,,,
HCM-CSHL-0809-C54,aa72adc9-e4ae-4d38-a1ff-5cdac2c3fc06,08819f7e-9910-4910-9013-b3cad97b6131,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0809-C54_treatment8,96866583-25a7-40d7-839c-16138a1ed0c3,,released,,0,2021-12-21T14:26:49.793201-06:00,"Radiation Therapy, NOS",Residual Disease,
HCM-CSHL-0809-C54,aa72adc9-e4ae-4d38-a1ff-5cdac2c3fc06,08819f7e-9910-4910-9013-b3cad97b6131,146.0,Adjuvant,42.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0809-C54_treatment3,ad85e3cc-cba6-4138-bb67-8de0bbd8f3b1,,released,Paclitaxel,1,2021-12-21T14:26:49.793201-06:00,Chemotherapy,Residual Disease,
HCM-CSHL-0809-C54,aa72adc9-e4ae-4d38-a1ff-5cdac2c3fc06,08819f7e-9910-4910-9013-b3cad97b6131,146.0,Adjuvant,42.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0809-C54_treatment2,c67c63fe-13f5-44a2-b606-570b2ef51748,,released,Carboplatin,1,2021-12-21T14:26:49.793201-06:00,Chemotherapy,Residual Disease,
HCM-CSHL-0809-C54,aa72adc9-e4ae-4d38-a1ff-5cdac2c3fc06,08819f7e-9910-4910-9013-b3cad97b6131,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0809-C54_treatment5,e0c715f9-d3f2-4655-8bde-9fb9f22d89b6,,released,,0,2021-12-21T14:26:49.793201-06:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-CSHL-0467-C56,aa78feca-4396-4e6b-8621-84fafedf29c9,f221d11e-9aab-434c-a164-c44d3ac60f38,,Adjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0467-C56_treatment7,34d6c205-a038-40eb-8706-bf60f8c5cdc8,,released,,0,2020-10-08T14:39:34.026726-05:00,"Radiation Therapy, NOS",Residual Disease,
HCM-CSHL-0467-C56,aa78feca-4396-4e6b-8621-84fafedf29c9,f221d11e-9aab-434c-a164-c44d3ac60f38,,Neoadjuvant,-45.0,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0467-C56_treatment,35b4225a-d28f-4334-8595-ee9b68f547ea,,released,Acetylcysteine,1,2020-10-08T14:39:34.026726-05:00,Chemotherapy,,
HCM-CSHL-0467-C56,aa78feca-4396-4e6b-8621-84fafedf29c9,f221d11e-9aab-434c-a164-c44d3ac60f38,,Adjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0467-C56_treatment3,3d315175-a56c-4c05-9a57-f1e56f1226f0,,released,,0,2020-10-08T14:39:34.026726-05:00,Hormone Therapy,Residual Disease,
HCM-CSHL-0467-C56,aa78feca-4396-4e6b-8621-84fafedf29c9,f221d11e-9aab-434c-a164-c44d3ac60f38,,Adjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0467-C56_treatment4,8fa3daf9-492b-4227-a5ed-cf8b97173c08,,released,,unknown,2020-10-08T14:39:34.026726-05:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-CSHL-0467-C56,aa78feca-4396-4e6b-8621-84fafedf29c9,f221d11e-9aab-434c-a164-c44d3ac60f38,,Adjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0467-C56_treatment6,bfbcf6a2-1a79-401f-86a9-46274c748055,,released,,0,2020-10-08T14:39:34.026726-05:00,Targeted Molecular Therapy,Residual Disease,
HCM-CSHL-0467-C56,aa78feca-4396-4e6b-8621-84fafedf29c9,f221d11e-9aab-434c-a164-c44d3ac60f38,,,51.0,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0467-C56_treatment5,c0b7fbe3-f0dc-45fa-8193-dbb3d8dbcd2c,,released,,1,2020-10-08T14:39:34.026726-05:00,"Surgery, NOS",Initial Diagnosis,
HCM-CSHL-0467-C56,aa78feca-4396-4e6b-8621-84fafedf29c9,f221d11e-9aab-434c-a164-c44d3ac60f38,,Adjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0467-C56_treatment2,c4eadd49-36e8-4603-b21d-078131477709,,released,,1,2020-10-08T14:39:34.026726-05:00,Chemotherapy,Residual Disease,
HCM-SANG-0292-C15,aaf31083-8293-4e48-92b0-37d294c0cc64,333e1d27-ca99-40b8-9866-14d4fc2fcaa7,,Neoadjuvant,98.0,2023-03-13T12:53:16.971018-05:00,HCM-SANG-0292-C15_treatment4,7840d1f3-06e7-41ac-8cde-ae4167500ecf,,released,,1,2021-07-06T11:32:00.685812-05:00,Chemotherapy,,EOX
HCM-SANG-0292-C15,aaf31083-8293-4e48-92b0-37d294c0cc64,333e1d27-ca99-40b8-9866-14d4fc2fcaa7,,Neoadjuvant,98.0,2023-03-13T12:53:16.971018-05:00,HCM-SANG-0292-C15_treatment3,7ed0fda4-ab21-446e-8dfb-dfa0dd3c7580,,released,Capecitabine,1,2021-07-06T11:32:00.685812-05:00,Chemotherapy,,
HCM-SANG-0292-C15,aaf31083-8293-4e48-92b0-37d294c0cc64,333e1d27-ca99-40b8-9866-14d4fc2fcaa7,,Neoadjuvant,98.0,2023-03-13T12:53:16.971018-05:00,HCM-SANG-0292-C15_treatment,debea6c0-7a12-4924-81df-45f28fd900a7,,released,Epirubicin,1,2021-07-06T11:32:00.685812-05:00,Chemotherapy,,
HCM-SANG-0292-C15,aaf31083-8293-4e48-92b0-37d294c0cc64,333e1d27-ca99-40b8-9866-14d4fc2fcaa7,,Neoadjuvant,98.0,2023-03-13T12:53:16.971018-05:00,HCM-SANG-0292-C15_treatment2,f8204a8e-2fc0-46a4-9495-908c11fb2c3d,,released,Oxaliplatin,1,2021-07-06T11:32:00.685812-05:00,Chemotherapy,,
HCM-WCMC-1281-C67,ab18b5a1-e3b6-41f5-b0f7-22cd7d5a4e62,73bf72ba-a1f6-4c0d-b16c-61fee698a2c8,,Neoadjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-WCMC-1281-C67_treatment,1805137e-9670-43d7-9453-80fd43c76013,,released,,0,2023-02-27T11:17:41.777806-06:00,,,
HCM-WCMC-1281-C67,ab18b5a1-e3b6-41f5-b0f7-22cd7d5a4e62,73bf72ba-a1f6-4c0d-b16c-61fee698a2c8,91.0,Adjuvant,19.0,2025-04-07T17:13:09.336794-05:00,HCM-WCMC-1281-C67_treatment6,2a1ebcb3-699b-4249-a5e1-cbbc2d8e8dba,,released,,1,2023-02-27T11:17:41.777806-06:00,Chemotherapy,Residual Disease,MVAC-Growth Factor Regimen
HCM-WCMC-1281-C67,ab18b5a1-e3b6-41f5-b0f7-22cd7d5a4e62,73bf72ba-a1f6-4c0d-b16c-61fee698a2c8,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-WCMC-1281-C67_treatment11,59156264-c7b4-46dd-b13d-03e7cb4a8c65,,released,,0,2023-02-27T11:17:41.777806-06:00,Targeted Molecular Therapy,Residual Disease,
HCM-WCMC-1281-C67,ab18b5a1-e3b6-41f5-b0f7-22cd7d5a4e62,73bf72ba-a1f6-4c0d-b16c-61fee698a2c8,91.0,Adjuvant,19.0,2025-04-07T17:13:09.336794-05:00,HCM-WCMC-1281-C67_treatment3,5f997282-a8e8-43a5-ae69-cb62da128ed4,,released,Cisplatin,1,2023-02-27T11:17:41.777806-06:00,Chemotherapy,Residual Disease,
HCM-WCMC-1281-C67,ab18b5a1-e3b6-41f5-b0f7-22cd7d5a4e62,73bf72ba-a1f6-4c0d-b16c-61fee698a2c8,533.0,Adjuvant,519.0,2025-04-07T17:13:09.336794-05:00,HCM-WCMC-1281-C67_treatment13,7f3b1441-b298-48e0-bc33-0dc4e24afcbf,,released,,1,2023-02-27T11:17:41.777806-06:00,"Radiation Therapy, NOS",Residual Disease,
HCM-WCMC-1281-C67,ab18b5a1-e3b6-41f5-b0f7-22cd7d5a4e62,73bf72ba-a1f6-4c0d-b16c-61fee698a2c8,,,476.0,2025-04-07T17:13:09.336794-05:00,HCM-WCMC-1281-C67_treatment10,81cb65e8-21a2-4a45-9d61-79c6ac578947,,released,,1,2023-02-27T11:17:41.777806-06:00,"Surgery, NOS",Initial Diagnosis,
HCM-WCMC-1281-C67,ab18b5a1-e3b6-41f5-b0f7-22cd7d5a4e62,73bf72ba-a1f6-4c0d-b16c-61fee698a2c8,531.0,Adjuvant,405.0,2025-04-07T17:13:09.336794-05:00,HCM-WCMC-1281-C67_treatment8,8a46f200-a465-46e5-ab25-f0c19667372f,,released,Pembrolizumab,1,2023-02-27T11:17:41.777806-06:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-WCMC-1281-C67,ab18b5a1-e3b6-41f5-b0f7-22cd7d5a4e62,73bf72ba-a1f6-4c0d-b16c-61fee698a2c8,91.0,Adjuvant,19.0,2025-04-07T17:13:09.336794-05:00,HCM-WCMC-1281-C67_treatment4,94bcd89b-3f07-45b4-9834-98f57101b286,,released,Doxorubicin,1,2023-02-27T11:17:41.777806-06:00,Chemotherapy,Residual Disease,
HCM-WCMC-1281-C67,ab18b5a1-e3b6-41f5-b0f7-22cd7d5a4e62,73bf72ba-a1f6-4c0d-b16c-61fee698a2c8,91.0,Adjuvant,19.0,2025-04-07T17:13:09.336794-05:00,HCM-WCMC-1281-C67_treatment5,98c5998f-1e95-4672-9153-aa4222ee738b,,released,Methotrexate,1,2023-02-27T11:17:41.777806-06:00,Chemotherapy,Residual Disease,
HCM-WCMC-1281-C67,ab18b5a1-e3b6-41f5-b0f7-22cd7d5a4e62,73bf72ba-a1f6-4c0d-b16c-61fee698a2c8,579.0,Adjuvant,548.0,2025-04-07T17:13:09.336794-05:00,HCM-WCMC-1281-C67_treatment14,9c51431f-27c8-4e62-a6b7-1219ef0b1460,,released,,1,2023-02-27T11:17:41.777806-06:00,"Radiation Therapy, NOS",Residual Disease,
HCM-WCMC-1281-C67,ab18b5a1-e3b6-41f5-b0f7-22cd7d5a4e62,73bf72ba-a1f6-4c0d-b16c-61fee698a2c8,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-WCMC-1281-C67_treatment7,a1e33696-badf-40b8-9084-38bd0c0f1bff,,released,,0,2023-02-27T11:17:41.777806-06:00,Hormone Therapy,Residual Disease,
HCM-WCMC-1281-C67,ab18b5a1-e3b6-41f5-b0f7-22cd7d5a4e62,73bf72ba-a1f6-4c0d-b16c-61fee698a2c8,91.0,Adjuvant,19.0,2025-04-07T17:13:09.336794-05:00,HCM-WCMC-1281-C67_treatment2,d6c75f5b-4f65-4184-bd11-0acf4fece9db,,released,Vinblastine,1,2023-02-27T11:17:41.777806-06:00,Chemotherapy,Residual Disease,
HCM-WCMC-1281-C67,ab18b5a1-e3b6-41f5-b0f7-22cd7d5a4e62,73bf72ba-a1f6-4c0d-b16c-61fee698a2c8,378.0,Adjuvant,368.0,2025-04-07T17:13:09.336794-05:00,HCM-WCMC-1281-C67_treatment12,da3d2076-98c6-4aea-b529-ff4ba7a5456a,,released,,1,2023-02-27T11:17:41.777806-06:00,"Radiation Therapy, NOS",Residual Disease,
HCM-WCMC-1281-C67,ab18b5a1-e3b6-41f5-b0f7-22cd7d5a4e62,73bf72ba-a1f6-4c0d-b16c-61fee698a2c8,644.0,Adjuvant,586.0,2025-04-07T17:13:09.336794-05:00,HCM-WCMC-1281-C67_treatment9,fff2069f-69af-4cb2-8cd6-e08372565e91,Treatment Ongoing,released,Sacituzumab Govitecan,1,2023-02-27T11:17:41.777806-06:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-SANG-0277-C18,ab4f0038-1f79-47cf-a88d-0c8587df3bbe,2395212a-0e8d-456e-ba0e-27ab0eafd1fa,,Neoadjuvant,,2023-11-07T14:28:29.403873-06:00,HCM-SANG-0277-C18_treatment,ad421d51-1555-4c29-8760-7ee03f7e69e5,,released,,0,2021-12-21T15:07:03.167351-06:00,,,
HCM-CSHL-0817-C22,ab92cc58-7772-4b5a-b3fe-c7630b9ec71f,dda80950-15a5-4bfd-ab0e-e56cc065795b,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0817-C22_treatment4,484113cb-e52b-487c-a3a6-be6b880be6bd,,released,,unknown,2021-12-21T14:29:20.810491-06:00,"Radiation Therapy, NOS",Residual Disease,
HCM-CSHL-0817-C22,ab92cc58-7772-4b5a-b3fe-c7630b9ec71f,dda80950-15a5-4bfd-ab0e-e56cc065795b,,Neoadjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0817-C22_treatment,6b1045c6-e8c5-431f-8a3c-1c7588f37c04,,released,,0,2021-12-21T14:29:20.810491-06:00,,,
HCM-CSHL-0817-C22,ab92cc58-7772-4b5a-b3fe-c7630b9ec71f,dda80950-15a5-4bfd-ab0e-e56cc065795b,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0817-C22_treatment3,72071a73-f6fc-454d-b873-9a76dc806c18,,released,,unknown,2021-12-21T14:29:20.810491-06:00,"Pharmaceutical Therapy, NOS",Residual Disease,
HCM-CSHL-0817-C22,ab92cc58-7772-4b5a-b3fe-c7630b9ec71f,dda80950-15a5-4bfd-ab0e-e56cc065795b,,,-54.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0817-C22_treatment2,a536e777-724a-4f08-b7e0-18514ed28cd8,,released,,1,2021-12-21T14:29:20.810491-06:00,"Surgery, NOS",Initial Diagnosis,
HCM-CSHL-0433-C24,aba4536f-6457-4ec2-90ac-1e0464352d7b,b46bdcc5-5001-4e21-ae32-0cb3caa57238,252.0,Adjuvant,,2021-01-06T22:55:10.531130-06:00,HCM-CSHL-0433-C24_treatment5,067a34e1-a3f7-4d89-80fe-27b09ba6871c,,released,,1,2020-09-28T10:08:51.891641-05:00,Chemotherapy,Residual Disease,GEMOX
HCM-CSHL-0433-C24,aba4536f-6457-4ec2-90ac-1e0464352d7b,b46bdcc5-5001-4e21-ae32-0cb3caa57238,,Adjuvant,,2021-01-06T22:55:10.531130-06:00,HCM-CSHL-0433-C24_treatment10,2705821b-74ca-43d0-af75-dda68a034bd8,,released,,0,2020-09-28T10:08:51.891641-05:00,"Radiation Therapy, NOS",Residual Disease,
HCM-CSHL-0433-C24,aba4536f-6457-4ec2-90ac-1e0464352d7b,b46bdcc5-5001-4e21-ae32-0cb3caa57238,,Adjuvant,,2021-01-06T22:55:10.531130-06:00,HCM-CSHL-0433-C24_treatment9,6befaeea-67aa-4b96-9f80-b97491b738e5,,released,,0,2020-09-28T10:08:51.891641-05:00,Targeted Molecular Therapy,Residual Disease,
HCM-CSHL-0433-C24,aba4536f-6457-4ec2-90ac-1e0464352d7b,b46bdcc5-5001-4e21-ae32-0cb3caa57238,,Adjuvant,,2021-01-06T22:55:10.531130-06:00,HCM-CSHL-0433-C24_treatment6,6f93e212-0373-4c18-b724-0cffc9500b44,,released,,0,2020-09-28T10:08:51.891641-05:00,Hormone Therapy,Residual Disease,
HCM-CSHL-0433-C24,aba4536f-6457-4ec2-90ac-1e0464352d7b,b46bdcc5-5001-4e21-ae32-0cb3caa57238,,Adjuvant,,2021-01-06T22:55:10.531130-06:00,HCM-CSHL-0433-C24_treatment7,7ccb908d-84a0-42e3-8763-f31bb28f5360,,released,,0,2020-09-28T10:08:51.891641-05:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-CSHL-0433-C24,aba4536f-6457-4ec2-90ac-1e0464352d7b,b46bdcc5-5001-4e21-ae32-0cb3caa57238,252.0,Adjuvant,,2021-01-06T22:55:10.531130-06:00,HCM-CSHL-0433-C24_treatment4,832ea635-6904-44a7-85d5-76e32f22b025,,released,Gemcitabine,1,2020-09-28T10:08:51.891641-05:00,Chemotherapy,Residual Disease,
HCM-CSHL-0433-C24,aba4536f-6457-4ec2-90ac-1e0464352d7b,b46bdcc5-5001-4e21-ae32-0cb3caa57238,,,-16.0,2023-02-27T12:21:49.126109-06:00,HCM-CSHL-0433-C24_treatment8,8bacabeb-eedc-4402-873e-6dbc9e6275b1,,released,,1,2020-09-28T10:08:51.891641-05:00,"Surgery, NOS",Initial Diagnosis,
HCM-CSHL-0433-C24,aba4536f-6457-4ec2-90ac-1e0464352d7b,b46bdcc5-5001-4e21-ae32-0cb3caa57238,,Neoadjuvant,,2021-01-06T22:55:10.531130-06:00,HCM-CSHL-0433-C24_treatment,c822ed42-6900-4c90-8752-00830147131d,,released,,0,2020-09-28T10:08:51.891641-05:00,,,
HCM-CSHL-0433-C24,aba4536f-6457-4ec2-90ac-1e0464352d7b,b46bdcc5-5001-4e21-ae32-0cb3caa57238,,Adjuvant,,2021-01-06T22:55:10.531130-06:00,HCM-CSHL-0433-C24_treatment2,dba82b89-83ea-4276-9395-cf2493111efc,,released,Capecitabine,1,2020-09-28T10:08:51.891641-05:00,Chemotherapy,Residual Disease,
HCM-CSHL-0433-C24,aba4536f-6457-4ec2-90ac-1e0464352d7b,b46bdcc5-5001-4e21-ae32-0cb3caa57238,252.0,Adjuvant,,2021-01-06T22:55:10.531130-06:00,HCM-CSHL-0433-C24_treatment3,e94a5647-eb35-41a0-8e39-759aa54b5077,,released,Oxaliplatin,1,2020-09-28T10:08:51.891641-05:00,Chemotherapy,Residual Disease,
HCM-BROD-0418-C71,ac2e7c63-300d-4bbe-b479-3de513dc8872,469fce91-b3fa-4d58-8dff-51085b70aa8b,47.0,Adjuvant,5.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0418-C71_treatment6,2f31af8d-768d-4afc-a9c1-4373b68325e5,,released,,1,2021-06-03T07:46:05.572465-05:00,"Radiation Therapy, NOS",Residual Disease,
HCM-BROD-0418-C71,ac2e7c63-300d-4bbe-b479-3de513dc8872,469fce91-b3fa-4d58-8dff-51085b70aa8b,87.0,Adjuvant,5.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0418-C71_treatment5,321382ed-dd65-4bf3-98d3-f8dc041ba03c,,released,Bevacizumab,1,2021-06-03T07:46:05.572465-05:00,Targeted Molecular Therapy,Residual Disease,
HCM-BROD-0418-C71,ac2e7c63-300d-4bbe-b479-3de513dc8872,469fce91-b3fa-4d58-8dff-51085b70aa8b,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0418-C71_treatment3,75e4b2ba-4777-4e56-b68e-8da29f66dedf,,released,,0,2021-06-03T07:46:05.572465-05:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-BROD-0418-C71,ac2e7c63-300d-4bbe-b479-3de513dc8872,469fce91-b3fa-4d58-8dff-51085b70aa8b,,Neoadjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0418-C71_treatment,7e96cd36-a553-4529-986b-4475766d0e3b,,released,,0,2021-06-03T07:46:05.572465-05:00,,,
HCM-BROD-0418-C71,ac2e7c63-300d-4bbe-b479-3de513dc8872,469fce91-b3fa-4d58-8dff-51085b70aa8b,173.0,Adjuvant,5.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0418-C71_treatment2,845303f4-57f5-4dda-8258-b75d622b7a33,,released,Temozolomide,1,2021-06-03T07:46:05.572465-05:00,Chemotherapy,Residual Disease,
HCM-BROD-0418-C71,ac2e7c63-300d-4bbe-b479-3de513dc8872,469fce91-b3fa-4d58-8dff-51085b70aa8b,,,-17.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0418-C71_treatment4,84f4ef35-4dfd-47fd-b477-3785d6b5066c,,released,,1,2021-06-03T07:46:05.572465-05:00,"Surgery, NOS",Initial Diagnosis,
HCM-BROD-0448-C15,ac371bd7-dd43-4784-8b13-8efb9b7a3474,306daa56-ee8e-4ed3-9fe7-597bb35d89fd,,,,2023-03-13T13:20:10.019120-05:00,HCM-BROD-0448-C15_treatment4,5dceb802-39bd-4bd5-ac7f-87522d235eb6,,released,,0,2020-09-27T11:37:03.385796-05:00,"Surgery, NOS",Initial Diagnosis,
HCM-BROD-0448-C15,ac371bd7-dd43-4784-8b13-8efb9b7a3474,306daa56-ee8e-4ed3-9fe7-597bb35d89fd,,Neoadjuvant,,2023-02-22T07:39:25.979291-06:00,HCM-BROD-0448-C15_treatment,7d42bb86-1277-409c-971e-dad5166eb37a,,released,,0,2020-09-27T11:37:03.385796-05:00,,,
HCM-BROD-0448-C15,ac371bd7-dd43-4784-8b13-8efb9b7a3474,306daa56-ee8e-4ed3-9fe7-597bb35d89fd,,Adjuvant,,2023-02-22T07:39:25.979291-06:00,HCM-BROD-0448-C15_treatment5,9d0ed2a0-58f9-4f85-b9ed-3c4cb12b5bd1,,released,,0,2020-09-27T11:37:03.385796-05:00,Targeted Molecular Therapy,Residual Disease,
HCM-BROD-0448-C15,ac371bd7-dd43-4784-8b13-8efb9b7a3474,306daa56-ee8e-4ed3-9fe7-597bb35d89fd,,Adjuvant,,2023-02-22T07:39:25.979291-06:00,HCM-BROD-0448-C15_treatment6,d6b7e22c-3370-4720-a107-42dc3d5a0ba7,,released,,0,2020-09-27T11:37:03.385796-05:00,"Radiation Therapy, NOS",Residual Disease,
HCM-BROD-0448-C15,ac371bd7-dd43-4784-8b13-8efb9b7a3474,306daa56-ee8e-4ed3-9fe7-597bb35d89fd,,Adjuvant,,2023-02-22T07:39:25.979291-06:00,HCM-BROD-0448-C15_treatment3,e62fb7c4-ad30-40ae-8f17-bcb645948b40,,released,,0,2020-09-27T11:37:03.385796-05:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-BROD-0448-C15,ac371bd7-dd43-4784-8b13-8efb9b7a3474,306daa56-ee8e-4ed3-9fe7-597bb35d89fd,,Adjuvant,,2023-02-22T07:39:25.979291-06:00,HCM-BROD-0448-C15_treatment2,efc271f6-03c1-4180-9ae4-78f85c685e9f,,released,,0,2020-09-27T11:37:03.385796-05:00,Chemotherapy,Residual Disease,
HCM-CSHL-0153-C50,ad400773-3306-4e97-bda6-f03fcc471692,30ff556b-3ff5-4c9f-a00a-fc3520f1f2a4,,Adjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0153-C50_treatment3,679c9930-ab69-4651-ac3f-0419c002b4ea,,released,,0,2020-09-27T12:59:22.493017-05:00,"Pharmaceutical Therapy, NOS",Residual Disease,
HCM-CSHL-0153-C50,ad400773-3306-4e97-bda6-f03fcc471692,30ff556b-3ff5-4c9f-a00a-fc3520f1f2a4,,Neoadjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0153-C50_treatment,8b7e4ed1-efc1-4be7-ba55-0e889a224f07,,released,,0,2020-09-27T12:59:22.493017-05:00,,,
HCM-CSHL-0153-C50,ad400773-3306-4e97-bda6-f03fcc471692,30ff556b-3ff5-4c9f-a00a-fc3520f1f2a4,165.0,Adjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0153-C50_treatment4,cba2fc5d-81a6-49b4-95df-3d5f11b3b0b7,,released,,1,2020-09-27T12:59:22.493017-05:00,"Radiation Therapy, NOS",Residual Disease,
HCM-CSHL-0153-C50,ad400773-3306-4e97-bda6-f03fcc471692,30ff556b-3ff5-4c9f-a00a-fc3520f1f2a4,,,53.0,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0153-C50_treatment2,d1588b3f-6225-4110-bae9-891fab21a0f6,,released,,1,2020-09-27T12:59:22.493017-05:00,"Surgery, NOS",Initial Diagnosis,
HCM-STAN-0846-C20,aec335a5-60e4-4754-b631-f496e5e15d01,6e78366d-26b9-4b9b-bc12-992f67c943b5,,Neoadjuvant,58.0,2025-04-07T17:13:09.336794-05:00,HCM-STAN-0846-C20_treatment7,1ab8f788-bd20-4892-8b1b-59236a1a14da,,released,,1,2022-09-22T07:06:09.394837-05:00,Stereotactic Radiosurgery,,
HCM-STAN-0846-C20,aec335a5-60e4-4754-b631-f496e5e15d01,6e78366d-26b9-4b9b-bc12-992f67c943b5,1331.0,Adjuvant,447.0,2025-04-07T17:13:09.336794-05:00,HCM-STAN-0846-C20_treatment8,1d9a55d5-7a2d-4500-ac01-e2685d35f161,,released,Leucovorin Calcium,1,2022-09-22T07:06:09.394837-05:00,Chemotherapy,Residual Disease,
HCM-STAN-0846-C20,aec335a5-60e4-4754-b631-f496e5e15d01,6e78366d-26b9-4b9b-bc12-992f67c943b5,,Neoadjuvant,360.0,2025-04-07T17:13:09.336794-05:00,HCM-STAN-0846-C20_treatment,484f57bb-0fbb-4aea-a11c-56cdc1a3be9c,,released,Leucovorin Calcium,1,2022-09-22T07:06:09.394837-05:00,Chemotherapy,,
HCM-STAN-0846-C20,aec335a5-60e4-4754-b631-f496e5e15d01,6e78366d-26b9-4b9b-bc12-992f67c943b5,,Neoadjuvant,360.0,2025-04-07T17:13:09.336794-05:00,HCM-STAN-0846-C20_treatment6,57366622-ab9f-46f2-9896-c59f0b35b9c1,,released,,1,2022-09-22T07:06:09.394837-05:00,Chemotherapy,,FOLFOX
HCM-STAN-0846-C20,aec335a5-60e4-4754-b631-f496e5e15d01,6e78366d-26b9-4b9b-bc12-992f67c943b5,,Neoadjuvant,360.0,2025-04-07T17:13:09.336794-05:00,HCM-STAN-0846-C20_treatment4,5deb9457-56de-4126-91cd-8552459cee80,,released,,1,2022-09-22T07:06:09.394837-05:00,Chemotherapy,,FOLFIRI
HCM-STAN-0846-C20,aec335a5-60e4-4754-b631-f496e5e15d01,6e78366d-26b9-4b9b-bc12-992f67c943b5,,Neoadjuvant,360.0,2025-04-07T17:13:09.336794-05:00,HCM-STAN-0846-C20_treatment2,6b551828-46e8-4d3a-9ab9-7408f2cb09b4,,released,Fluorouracil,1,2022-09-22T07:06:09.394837-05:00,Chemotherapy,,
HCM-STAN-0846-C20,aec335a5-60e4-4754-b631-f496e5e15d01,6e78366d-26b9-4b9b-bc12-992f67c943b5,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-STAN-0846-C20_treatment12,6e2957a7-196b-4294-a7ba-cf265129542c,,released,,0,2022-09-22T07:06:09.394837-05:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-STAN-0846-C20,aec335a5-60e4-4754-b631-f496e5e15d01,6e78366d-26b9-4b9b-bc12-992f67c943b5,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-STAN-0846-C20_treatment15,70e0a24a-76d7-48c7-ba50-9cce702b6726,,released,,0,2022-09-22T07:06:09.394837-05:00,"Radiation Therapy, NOS",Residual Disease,
HCM-STAN-0846-C20,aec335a5-60e4-4754-b631-f496e5e15d01,6e78366d-26b9-4b9b-bc12-992f67c943b5,1331.0,Adjuvant,447.0,2025-04-07T17:13:09.336794-05:00,HCM-STAN-0846-C20_treatment11,7fe7f9ea-ab60-4930-a3ae-02849c3cb655,,released,,1,2022-09-22T07:06:09.394837-05:00,Chemotherapy,Residual Disease,FOLFIRI
HCM-STAN-0846-C20,aec335a5-60e4-4754-b631-f496e5e15d01,6e78366d-26b9-4b9b-bc12-992f67c943b5,1331.0,Adjuvant,447.0,2025-04-07T17:13:09.336794-05:00,HCM-STAN-0846-C20_treatment10,89a7efbd-02b1-4960-b1f4-2177989c9868,,released,Irinotecan,1,2022-09-22T07:06:09.394837-05:00,Chemotherapy,Residual Disease,
HCM-STAN-0846-C20,aec335a5-60e4-4754-b631-f496e5e15d01,6e78366d-26b9-4b9b-bc12-992f67c943b5,,Neoadjuvant,360.0,2025-04-07T17:13:09.336794-05:00,HCM-STAN-0846-C20_treatment3,99a45cc1-62b2-41d0-a464-a838ae61b20e,,released,Irinotecan,1,2022-09-22T07:06:09.394837-05:00,Chemotherapy,,
HCM-STAN-0846-C20,aec335a5-60e4-4754-b631-f496e5e15d01,6e78366d-26b9-4b9b-bc12-992f67c943b5,,,575.0,2025-04-07T17:13:09.336794-05:00,HCM-STAN-0846-C20_treatment13,d9fe22c8-2004-4b91-bd65-750017112978,,released,,1,2022-09-22T07:06:09.394837-05:00,"Surgery, NOS",Initial Diagnosis,
HCM-STAN-0846-C20,aec335a5-60e4-4754-b631-f496e5e15d01,6e78366d-26b9-4b9b-bc12-992f67c943b5,,Neoadjuvant,360.0,2025-04-07T17:13:09.336794-05:00,HCM-STAN-0846-C20_treatment5,e2626c9d-fd82-42c8-8261-defd1464888e,,released,Oxaliplatin,1,2022-09-22T07:06:09.394837-05:00,Chemotherapy,,
HCM-STAN-0846-C20,aec335a5-60e4-4754-b631-f496e5e15d01,6e78366d-26b9-4b9b-bc12-992f67c943b5,1331.0,Adjuvant,447.0,2025-04-07T17:13:09.336794-05:00,HCM-STAN-0846-C20_treatment9,f32d4df1-16a9-469c-96ea-ffefdc810618,,released,Fluorouracil,1,2022-09-22T07:06:09.394837-05:00,Chemotherapy,Residual Disease,
HCM-STAN-0846-C20,aec335a5-60e4-4754-b631-f496e5e15d01,6e78366d-26b9-4b9b-bc12-992f67c943b5,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-STAN-0846-C20_treatment14,f98d044a-5313-4780-84f6-6708eb87f684,,released,,0,2022-09-22T07:06:09.394837-05:00,Targeted Molecular Therapy,Residual Disease,
HCM-STAN-1109-D13,af78a845-bdb6-4245-b3a2-c94dbbf18653,200a434e-555a-4dbb-998f-fdef0c1a358c,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-STAN-1109-D13_treatment3,375dcb72-36ef-4042-9b76-225233850264,,released,,0,2022-09-22T07:11:01.210786-05:00,"Pharmaceutical Therapy, NOS",Residual Disease,
HCM-STAN-1109-D13,af78a845-bdb6-4245-b3a2-c94dbbf18653,200a434e-555a-4dbb-998f-fdef0c1a358c,,,0.0,2025-04-07T17:13:09.336794-05:00,HCM-STAN-1109-D13_treatment2,53019006-8a3b-4cd3-aa9f-adc9e74f4e2d,,released,,1,2022-09-22T07:11:01.210786-05:00,"Surgery, NOS",Initial Diagnosis,
HCM-STAN-1109-D13,af78a845-bdb6-4245-b3a2-c94dbbf18653,200a434e-555a-4dbb-998f-fdef0c1a358c,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-STAN-1109-D13_treatment4,70f2c2cd-bd4a-4a25-90e1-14016d7a6a6c,,released,,0,2022-09-22T07:11:01.210786-05:00,"Radiation Therapy, NOS",Residual Disease,
HCM-STAN-1109-D13,af78a845-bdb6-4245-b3a2-c94dbbf18653,200a434e-555a-4dbb-998f-fdef0c1a358c,,Neoadjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-STAN-1109-D13_treatment,7afec659-fcbb-445d-884b-ed2dd33a1c41,,released,,0,2022-09-22T07:11:01.210786-05:00,,,
HCM-BROD-0106-C71,afa149e0-edb7-4f8e-9f56-6e1c0ac78287,2610ed82-d82d-4d6b-8de9-5cf01e30606a,,Adjuvant,,2023-03-13T12:46:52.529652-05:00,HCM-BROD-0106-C71_treatment3,8f32a1e8-3c06-46c3-8c4f-173d2d76d7a9,,released,,0,2020-02-27T12:29:44.523556-06:00,"Pharmaceutical Therapy, NOS",Residual Disease,
HCM-BROD-0106-C71,afa149e0-edb7-4f8e-9f56-6e1c0ac78287,2610ed82-d82d-4d6b-8de9-5cf01e30606a,,,-3.0,2023-03-13T12:46:52.529652-05:00,HCM-BROD-0106-C71_treatment2,90801ef1-e0a9-4d41-887e-310c03b7a9d5,,released,,1,2020-02-27T12:29:44.523556-06:00,"Surgery, NOS",Initial Diagnosis,
HCM-BROD-0106-C71,afa149e0-edb7-4f8e-9f56-6e1c0ac78287,2610ed82-d82d-4d6b-8de9-5cf01e30606a,,Neoadjuvant,,2021-03-03T15:15:08.075155-06:00,HCM-BROD-0106-C71_treatment,acbeeded-7831-4f2e-9a2e-eaa01dc149a9,,released,,0,2019-04-04T14:53:07.103421-05:00,,,
HCM-BROD-0106-C71,afa149e0-edb7-4f8e-9f56-6e1c0ac78287,2610ed82-d82d-4d6b-8de9-5cf01e30606a,,Adjuvant,,2023-03-13T12:46:52.529652-05:00,HCM-BROD-0106-C71_treatment4,afa60250-a2b7-4290-bb5d-377a2c730406,,released,,0,2020-02-27T12:29:44.523556-06:00,"Radiation Therapy, NOS",Residual Disease,
HCM-BROD-0922-C71,b0362a57-b459-4ece-ab3b-e44f8d1820f3,c1a9d234-1d6e-4b35-95dc-6a38692e2cb3,395.0,Adjuvant,353.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0922-C71_treatment6,410c2d7d-67aa-4ea2-bd46-b4e5e6016863,,released,Not Reported,1,2021-12-21T13:56:55.611200-06:00,Targeted Molecular Therapy,Residual Disease,
HCM-BROD-0922-C71,b0362a57-b459-4ece-ab3b-e44f8d1820f3,c1a9d234-1d6e-4b35-95dc-6a38692e2cb3,491.0,Adjuvant,400.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0922-C71_treatment7,598775c3-d481-4dea-bc6e-6821713d8ec0,,released,Bevacizumab,1,2021-12-21T13:56:55.611200-06:00,Targeted Molecular Therapy,Residual Disease,
HCM-BROD-0922-C71,b0362a57-b459-4ece-ab3b-e44f8d1820f3,c1a9d234-1d6e-4b35-95dc-6a38692e2cb3,,Neoadjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0922-C71_treatment,677d97b4-a47c-43db-aaac-a2f8837447f8,,released,,0,2021-12-21T13:56:55.611200-06:00,,,
HCM-BROD-0922-C71,b0362a57-b459-4ece-ab3b-e44f8d1820f3,c1a9d234-1d6e-4b35-95dc-6a38692e2cb3,316.0,Adjuvant,46.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0922-C71_treatment5,68e25027-d0d7-49ad-8cd9-c65ce6dd5be9,,released,Not Reported,1,2021-12-21T13:56:55.611200-06:00,Targeted Molecular Therapy,Residual Disease,
HCM-BROD-0922-C71,b0362a57-b459-4ece-ab3b-e44f8d1820f3,c1a9d234-1d6e-4b35-95dc-6a38692e2cb3,501.0,Adjuvant,499.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0922-C71_treatment9,9d0ae1e0-b4fa-4335-ac15-f368a4198ab8,,released,,1,2021-12-21T13:56:55.611200-06:00,"Radiation Therapy, NOS",Residual Disease,
HCM-BROD-0922-C71,b0362a57-b459-4ece-ab3b-e44f8d1820f3,c1a9d234-1d6e-4b35-95dc-6a38692e2cb3,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0922-C71_treatment3,ae91ad51-a495-4a05-8733-1c05c70a0edb,,released,,0,2021-12-21T13:56:55.611200-06:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-BROD-0922-C71,b0362a57-b459-4ece-ab3b-e44f8d1820f3,c1a9d234-1d6e-4b35-95dc-6a38692e2cb3,,,0.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0922-C71_treatment4,b4d88f93-fbf7-41b7-b7ab-cb40db6179b5,,released,,1,2021-12-21T13:56:55.611200-06:00,"Surgery, NOS",Initial Diagnosis,
HCM-BROD-0922-C71,b0362a57-b459-4ece-ab3b-e44f8d1820f3,c1a9d234-1d6e-4b35-95dc-6a38692e2cb3,88.0,Adjuvant,46.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0922-C71_treatment2,cdb6cc64-2c96-4a8e-a027-f27c323860fc,,released,Temozolomide,1,2021-12-21T13:56:55.611200-06:00,Chemotherapy,Residual Disease,
HCM-BROD-0922-C71,b0362a57-b459-4ece-ab3b-e44f8d1820f3,c1a9d234-1d6e-4b35-95dc-6a38692e2cb3,88.0,Adjuvant,46.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0922-C71_treatment8,f9bea552-25da-40da-9e12-2f243aacd964,,released,,1,2021-12-21T13:56:55.611200-06:00,"Radiation Therapy, NOS",Residual Disease,
HCM-BROD-0457-C71,b03d2210-9c3c-44aa-8d73-4ef9588df1a5,bf1d9613-fd32-497b-b83b-497fa90f5453,,Adjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0457-C71_treatment5,08cc5bbe-d98f-4ca2-9ae7-0c76957256e5,,released,,0,2020-04-21T14:54:05.963037-05:00,Targeted Molecular Therapy,Residual Disease,
HCM-BROD-0457-C71,b03d2210-9c3c-44aa-8d73-4ef9588df1a5,bf1d9613-fd32-497b-b83b-497fa90f5453,51.0,Adjuvant,30.0,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0457-C71_treatment6,44f9314f-195a-4ef5-a95d-ca6207b7961d,,released,,1,2020-04-21T14:54:05.963037-05:00,"Radiation Therapy, NOS",Residual Disease,
HCM-BROD-0457-C71,b03d2210-9c3c-44aa-8d73-4ef9588df1a5,bf1d9613-fd32-497b-b83b-497fa90f5453,,Adjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0457-C71_treatment3,8ef1bca7-cc8e-430f-998f-1d8c2f531ece,,released,,0,2020-04-21T14:54:05.963037-05:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-BROD-0457-C71,b03d2210-9c3c-44aa-8d73-4ef9588df1a5,bf1d9613-fd32-497b-b83b-497fa90f5453,,,-10.0,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0457-C71_treatment4,a4d13566-1adf-4735-8eff-ee0fabefaff5,,released,,1,2020-04-21T14:54:05.963037-05:00,"Surgery, NOS",Initial Diagnosis,
HCM-BROD-0457-C71,b03d2210-9c3c-44aa-8d73-4ef9588df1a5,bf1d9613-fd32-497b-b83b-497fa90f5453,51.0,Adjuvant,30.0,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0457-C71_treatment2,ba2774ce-f8b3-4e81-844e-4d69e72c10d0,,released,Temozolomide,1,2020-04-21T14:54:05.963037-05:00,Chemotherapy,Residual Disease,
HCM-BROD-0457-C71,b03d2210-9c3c-44aa-8d73-4ef9588df1a5,bf1d9613-fd32-497b-b83b-497fa90f5453,,Neoadjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0457-C71_treatment,c4374030-b168-40a5-9ed7-0a04a48c1f5d,,released,,0,2020-04-21T14:54:05.963037-05:00,,,
HCM-BROD-0755-C43,b0f583f9-177a-4578-ad47-908b8023ff99,def1f37e-7fb8-49d7-a28e-3f2eb6d94fe0,992.0,Adjuvant,633.0,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0755-C43_treatment4,00b7b153-078b-4d1c-b62d-a948b432bdd9,,released,Pembrolizumab,1,2021-12-21T13:49:39.002223-06:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-BROD-0755-C43,b0f583f9-177a-4578-ad47-908b8023ff99,def1f37e-7fb8-49d7-a28e-3f2eb6d94fe0,,Adjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0755-C43_treatment6,18285901-3fd2-4340-a4d1-65eccfc8daec,,released,,0,2021-12-21T13:49:39.002223-06:00,Targeted Molecular Therapy,Residual Disease,
HCM-BROD-0755-C43,b0f583f9-177a-4578-ad47-908b8023ff99,def1f37e-7fb8-49d7-a28e-3f2eb6d94fe0,,,0.0,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0755-C43_treatment5,4276d22c-d978-43bb-aaa5-33d3c999ce5c,,released,,1,2021-12-21T13:49:39.002223-06:00,"Surgery, NOS",Initial Diagnosis,
HCM-BROD-0755-C43,b0f583f9-177a-4578-ad47-908b8023ff99,def1f37e-7fb8-49d7-a28e-3f2eb6d94fe0,,Adjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0755-C43_treatment7,5ba629ef-d9b3-4558-83a4-27262d345166,,released,,0,2021-12-21T13:49:39.002223-06:00,"Radiation Therapy, NOS",Residual Disease,
HCM-BROD-0755-C43,b0f583f9-177a-4578-ad47-908b8023ff99,def1f37e-7fb8-49d7-a28e-3f2eb6d94fe0,,Adjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0755-C43_treatment3,70b19ce8-e023-4759-883c-53665fdfa1bb,,released,,0,2021-12-21T13:49:39.002223-06:00,Hormone Therapy,Residual Disease,
HCM-BROD-0755-C43,b0f583f9-177a-4578-ad47-908b8023ff99,def1f37e-7fb8-49d7-a28e-3f2eb6d94fe0,,Adjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0755-C43_treatment2,af928c19-408b-4b2c-aa85-2090bb2876c6,,released,,0,2021-12-21T13:49:39.002223-06:00,Chemotherapy,Residual Disease,
HCM-BROD-0755-C43,b0f583f9-177a-4578-ad47-908b8023ff99,def1f37e-7fb8-49d7-a28e-3f2eb6d94fe0,,Neoadjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0755-C43_treatment,f5ccdbdf-6d80-4db0-a4c0-812695484520,,released,,0,2021-12-21T13:49:39.002223-06:00,,,
HCM-CSHL-0461-D12,b1021eee-f5c8-43a7-aab9-79553bca2265,e8b18a49-fa7b-4ada-a37d-8b71085cce26,,Adjuvant,,2023-03-13T13:20:41.394270-05:00,HCM-CSHL-0461-D12_treatment4,1c855a77-4f0d-4bd3-808c-0ab2c6a96e4f,,released,,0,2020-06-15T13:26:01.915974-05:00,"Radiation Therapy, NOS",Residual Disease,
HCM-CSHL-0461-D12,b1021eee-f5c8-43a7-aab9-79553bca2265,e8b18a49-fa7b-4ada-a37d-8b71085cce26,,,105.0,2023-03-13T13:20:41.394270-05:00,HCM-CSHL-0461-D12_treatment2,59e20a9b-f813-4e0b-be05-104f7bd03a11,,released,,1,2020-06-15T13:26:01.915974-05:00,"Surgery, NOS",Initial Diagnosis,
HCM-CSHL-0461-D12,b1021eee-f5c8-43a7-aab9-79553bca2265,e8b18a49-fa7b-4ada-a37d-8b71085cce26,,Neoadjuvant,,2020-10-20T19:20:06.800740-05:00,HCM-CSHL-0461-D12_treatment,ba8e3148-ceb3-4f2f-8db6-3d916d9a72c1,,released,,0,2020-06-15T13:26:01.915974-05:00,,,
HCM-CSHL-0461-D12,b1021eee-f5c8-43a7-aab9-79553bca2265,e8b18a49-fa7b-4ada-a37d-8b71085cce26,,Adjuvant,,2023-03-13T13:20:41.394270-05:00,HCM-CSHL-0461-D12_treatment3,bed49cc4-2464-4e1c-ba04-054d3bf2baf9,,released,,0,2020-06-15T13:26:01.915974-05:00,"Pharmaceutical Therapy, NOS",Residual Disease,
HCM-BROD-0353-C64,b1ed6908-e164-4e0f-accd-11605edf4c81,28511f89-01fd-48b1-8a51-704c607d2e94,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0353-C64_treatment6,33bd6501-27f3-4942-95d7-4496d3fb818b,,released,,0,2021-12-21T13:37:53.180502-06:00,"Radiation Therapy, NOS",Residual Disease,
HCM-BROD-0353-C64,b1ed6908-e164-4e0f-accd-11605edf4c81,28511f89-01fd-48b1-8a51-704c607d2e94,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0353-C64_treatment3,3da4c6f7-9934-4ed2-a3eb-e00774c260c7,,released,,0,2021-12-21T13:37:53.180502-06:00,Hormone Therapy,Residual Disease,
HCM-BROD-0353-C64,b1ed6908-e164-4e0f-accd-11605edf4c81,28511f89-01fd-48b1-8a51-704c607d2e94,,,0.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0353-C64_treatment5,611af60a-342d-443d-a0f1-e889efb390fd,,released,,1,2021-12-21T13:37:53.180502-06:00,"Surgery, NOS",Initial Diagnosis,
HCM-BROD-0353-C64,b1ed6908-e164-4e0f-accd-11605edf4c81,28511f89-01fd-48b1-8a51-704c607d2e94,95.0,Adjuvant,73.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0353-C64_treatment4,6beb34e4-58c7-4b2f-a7fe-17e323bb5fab,,released,Pembrolizumab,1,2021-12-21T13:37:53.180502-06:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-BROD-0353-C64,b1ed6908-e164-4e0f-accd-11605edf4c81,28511f89-01fd-48b1-8a51-704c607d2e94,,Neoadjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0353-C64_treatment,8af13d8d-4b26-46a6-acc3-9822a1532ac2,,released,,0,2021-12-21T13:37:53.180502-06:00,,,
HCM-BROD-0353-C64,b1ed6908-e164-4e0f-accd-11605edf4c81,28511f89-01fd-48b1-8a51-704c607d2e94,73.0,Adjuvant,28.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0353-C64_treatment2,8f15f219-2d1f-4a88-bd05-00e02caa4880,,released,Carboplatin,1,2021-12-21T13:37:53.180502-06:00,Chemotherapy,Residual Disease,
HCM-SANG-1310-C15,b2b4474b-63d8-42f8-820f-d572814583c7,5c1cae51-631c-4909-a99a-4884ca32a751,,Neoadjuvant,99.0,2025-04-07T17:13:09.336794-05:00,HCM-SANG-1310-C15_treatment,2257eeaf-2786-4f1f-9838-6e9e5683d66c,,released,Leucovorin,1,2023-02-27T13:23:11.219313-06:00,Chemotherapy,,
HCM-SANG-1310-C15,b2b4474b-63d8-42f8-820f-d572814583c7,5c1cae51-631c-4909-a99a-4884ca32a751,,Neoadjuvant,99.0,2025-04-07T17:13:09.336794-05:00,HCM-SANG-1310-C15_treatment3,4a68e94c-f5fd-4f5f-8ad2-405f933a3ce1,,released,Docetaxel,1,2023-02-27T13:23:11.219313-06:00,Chemotherapy,,
HCM-SANG-1310-C15,b2b4474b-63d8-42f8-820f-d572814583c7,5c1cae51-631c-4909-a99a-4884ca32a751,,Neoadjuvant,99.0,2025-04-07T17:13:09.336794-05:00,HCM-SANG-1310-C15_treatment4,b09eed2d-3b8d-4c89-952a-c0f8398064e3,,released,Oxaliplatin,1,2023-02-27T13:23:11.219313-06:00,Chemotherapy,,
HCM-SANG-1310-C15,b2b4474b-63d8-42f8-820f-d572814583c7,5c1cae51-631c-4909-a99a-4884ca32a751,,Neoadjuvant,99.0,2025-04-07T17:13:09.336794-05:00,HCM-SANG-1310-C15_treatment2,f17ef87f-d7fa-4b87-8258-5fd66c7d5acc,,released,Fluorouracil,1,2023-02-27T13:23:11.219313-06:00,Chemotherapy,,
HCM-BROD-0450-C15,b35898b6-7e8a-43a9-b6f2-4dfc91255e26,e9ba55ca-531b-4afa-8070-44b2b312a6dd,,Neoadjuvant,38.0,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0450-C15_treatment,01a851bb-6127-4e6e-a570-b294ee94ad9a,,released,Docetaxel,1,2020-07-23T14:38:28.482021-05:00,Chemotherapy,,
HCM-BROD-0450-C15,b35898b6-7e8a-43a9-b6f2-4dfc91255e26,e9ba55ca-531b-4afa-8070-44b2b312a6dd,,Neoadjuvant,38.0,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0450-C15_treatment3,1c2a1b8d-a476-4193-b9dc-680a7b9bea52,,released,Oxaliplatin,1,2020-07-23T14:38:28.482021-05:00,Chemotherapy,,
HCM-BROD-0450-C15,b35898b6-7e8a-43a9-b6f2-4dfc91255e26,e9ba55ca-531b-4afa-8070-44b2b312a6dd,,Adjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0450-C15_treatment7,3d76de5c-b253-4e45-977f-71a8d350d80c,,released,,0,2020-07-23T14:38:28.482021-05:00,Chemotherapy,Residual Disease,
HCM-BROD-0450-C15,b35898b6-7e8a-43a9-b6f2-4dfc91255e26,e9ba55ca-531b-4afa-8070-44b2b312a6dd,,,112.0,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0450-C15_treatment9,4f0fc80c-36a2-4133-bbe2-0c0efcf98125,,released,,1,2020-07-23T14:38:28.482021-05:00,"Surgery, NOS",Initial Diagnosis,
HCM-BROD-0450-C15,b35898b6-7e8a-43a9-b6f2-4dfc91255e26,e9ba55ca-531b-4afa-8070-44b2b312a6dd,,Neoadjuvant,38.0,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0450-C15_treatment4,8328cce2-65ba-4e24-be1b-6deee3cb7f92,,released,Leucovorin,1,2020-07-23T14:38:28.482021-05:00,Chemotherapy,,
HCM-BROD-0450-C15,b35898b6-7e8a-43a9-b6f2-4dfc91255e26,e9ba55ca-531b-4afa-8070-44b2b312a6dd,,Neoadjuvant,38.0,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0450-C15_treatment5,8e44e1b6-9989-4321-981b-838c2c429acf,,released,,1,2020-07-23T14:38:28.482021-05:00,Chemotherapy,,FU-LV regimen
HCM-BROD-0450-C15,b35898b6-7e8a-43a9-b6f2-4dfc91255e26,e9ba55ca-531b-4afa-8070-44b2b312a6dd,,Neoadjuvant,192.0,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0450-C15_treatment6,97d15e6d-d94d-44ac-9143-f43465a723b0,,released,Pembrolizumab,1,2020-07-23T14:38:28.482021-05:00,Immunotherapy (Including Vaccines),,
HCM-BROD-0450-C15,b35898b6-7e8a-43a9-b6f2-4dfc91255e26,e9ba55ca-531b-4afa-8070-44b2b312a6dd,,Adjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0450-C15_treatment11,9d7924a2-48e5-40aa-a382-277ea2de1c29,,released,,0,2020-09-27T11:38:27.094339-05:00,"Radiation Therapy, NOS",Residual Disease,
HCM-BROD-0450-C15,b35898b6-7e8a-43a9-b6f2-4dfc91255e26,e9ba55ca-531b-4afa-8070-44b2b312a6dd,,Neoadjuvant,38.0,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0450-C15_treatment2,ca7d0a5e-7170-44c5-9ea3-e043688a6f28,,released,Fluorouracil,1,2020-07-23T14:38:28.482021-05:00,Chemotherapy,,
HCM-BROD-0450-C15,b35898b6-7e8a-43a9-b6f2-4dfc91255e26,e9ba55ca-531b-4afa-8070-44b2b312a6dd,,Adjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0450-C15_treatment8,d506d67b-fa44-438e-ac89-21df84e4575a,,released,,0,2020-07-23T14:38:28.482021-05:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-BROD-0450-C15,b35898b6-7e8a-43a9-b6f2-4dfc91255e26,e9ba55ca-531b-4afa-8070-44b2b312a6dd,413.0,Adjuvant,287.0,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0450-C15_treatment10,e1b31a82-ef83-4b3e-9d69-f99287758d39,,released,Not Reported,1,2020-09-27T11:38:27.094339-05:00,Targeted Molecular Therapy,Residual Disease,
HCM-SANG-0273-C18,b3b23c0b-a9bd-434a-9875-5cfba04cfe7f,79e0985b-1dd5-4901-b174-4d7b4f9b1997,,Neoadjuvant,,2023-02-22T07:39:25.979291-06:00,HCM-SANG-0273-C18_treatment,6d4ab6f6-9811-42e2-8e38-b8d7ecfc8595,,released,,0,2020-02-11T15:31:58.093766-06:00,,,
HCM-BROD-0613-C71,b3cc0754-6a21-4683-a491-b2fb8b6175a4,98d80c92-7a76-4e51-9770-a2fa1c1a863f,,Adjuvant,,2021-09-10T10:36:37.981324-05:00,HCM-BROD-0613-C71_treatment3,13a844aa-6319-41bd-81ad-55a1363cd383,,released,,0,2021-08-25T20:31:52.368991-05:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-BROD-0613-C71,b3cc0754-6a21-4683-a491-b2fb8b6175a4,98d80c92-7a76-4e51-9770-a2fa1c1a863f,,Adjuvant,,2021-09-10T10:36:37.981324-05:00,HCM-BROD-0613-C71_treatment5,86cf95f6-75a1-4119-a8e5-fbcc1b30e07c,,released,,0,2021-08-25T20:31:52.368991-05:00,Targeted Molecular Therapy,Residual Disease,
HCM-BROD-0613-C71,b3cc0754-6a21-4683-a491-b2fb8b6175a4,98d80c92-7a76-4e51-9770-a2fa1c1a863f,,Adjuvant,,2021-09-10T10:36:37.981324-05:00,HCM-BROD-0613-C71_treatment2,aec9bcec-c6c6-45e5-8664-f14339e39ccc,,released,,0,2021-08-25T20:31:52.368991-05:00,Chemotherapy,Residual Disease,
HCM-BROD-0613-C71,b3cc0754-6a21-4683-a491-b2fb8b6175a4,98d80c92-7a76-4e51-9770-a2fa1c1a863f,,,12.0,2023-02-27T11:30:39.801279-06:00,HCM-BROD-0613-C71_treatment4,b22f2892-3732-495e-94be-823152ee8dac,,released,,1,2021-08-25T20:31:52.368991-05:00,"Surgery, NOS",Initial Diagnosis,
HCM-BROD-0613-C71,b3cc0754-6a21-4683-a491-b2fb8b6175a4,98d80c92-7a76-4e51-9770-a2fa1c1a863f,,Neoadjuvant,,2021-03-11T14:53:13.958052-06:00,HCM-BROD-0613-C71_treatment,d125235a-7b80-421b-bde8-1f865fb3f8e4,,released,,0,2021-03-11T14:32:16.169484-06:00,,,
HCM-BROD-0613-C71,b3cc0754-6a21-4683-a491-b2fb8b6175a4,98d80c92-7a76-4e51-9770-a2fa1c1a863f,34.0,Adjuvant,28.0,2023-07-07T13:21:35.030120-05:00,HCM-BROD-0613-C71_treatment6,d773d9ec-457b-440e-bbf5-b27826152674,,released,,1,2021-08-25T20:31:52.368991-05:00,"Radiation Therapy, NOS",Residual Disease,
HCM-SANG-1305-C15,b3d87033-c8cd-431d-9ada-e3c6407a96bc,56e42793-7467-4318-a94c-362e7e543867,,Neoadjuvant,123.0,2025-04-07T17:13:09.336794-05:00,HCM-SANG-1305-C15_treatment3,3e6eaf0d-998d-45ae-bf45-f0fa66b05994,,released,Docetaxel,1,2023-02-27T12:13:25.689397-06:00,Chemotherapy,,
HCM-SANG-1305-C15,b3d87033-c8cd-431d-9ada-e3c6407a96bc,56e42793-7467-4318-a94c-362e7e543867,,Neoadjuvant,123.0,2025-04-07T17:13:09.336794-05:00,HCM-SANG-1305-C15_treatment,66434fd4-9a42-4a68-b48d-d346a8f79b59,,released,Leucovorin,1,2023-02-27T12:13:25.689397-06:00,Chemotherapy,,
HCM-SANG-1305-C15,b3d87033-c8cd-431d-9ada-e3c6407a96bc,56e42793-7467-4318-a94c-362e7e543867,,Neoadjuvant,123.0,2025-04-07T17:13:09.336794-05:00,HCM-SANG-1305-C15_treatment2,ccb6ad0d-c9e4-4d6a-9d2a-97bc59e47429,,released,Fluorouracil,1,2023-02-27T12:13:25.689397-06:00,Chemotherapy,,
HCM-SANG-1305-C15,b3d87033-c8cd-431d-9ada-e3c6407a96bc,56e42793-7467-4318-a94c-362e7e543867,,Neoadjuvant,123.0,2025-04-07T17:13:09.336794-05:00,HCM-SANG-1305-C15_treatment4,f6f2c2c0-3176-4478-939f-892948117357,,released,Oxaliplatin,1,2023-02-27T12:13:25.689397-06:00,Chemotherapy,,
HCM-SANG-0519-C20,b41f4663-31fe-405a-8abc-3d09f3d4163a,effe731f-0e65-48d8-ae79-99e34a401413,,Neoadjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-SANG-0519-C20_treatment,ced996aa-090f-4206-a300-75ed992b62dc,,released,,0,2021-12-21T15:13:02.883651-06:00,,,
HCM-BROD-0195-C71,b44ee47e-c360-41bf-8e0d-a95dc6f9f9cc,c5993e86-fe12-428b-9f7f-db1cc0021ce8,28.0,Adjuvant,25.0,2021-01-06T22:55:10.531130-06:00,HCM-BROD-0195-C71_treatment5,30cb36b1-3676-4adc-b85d-08470617e8dd,,released,Bevacizumab,1,2019-04-04T15:06:45.805167-05:00,Targeted Molecular Therapy,Residual Disease,
HCM-BROD-0195-C71,b44ee47e-c360-41bf-8e0d-a95dc6f9f9cc,c5993e86-fe12-428b-9f7f-db1cc0021ce8,49.0,Adjuvant,25.0,2021-01-06T22:55:10.531130-06:00,HCM-BROD-0195-C71_treatment2,3719a89a-9538-4a0e-9732-3f413ccd9dbe,,released,Temozolomide,1,2019-04-04T15:06:45.805167-05:00,Chemotherapy,Residual Disease,
HCM-BROD-0195-C71,b44ee47e-c360-41bf-8e0d-a95dc6f9f9cc,c5993e86-fe12-428b-9f7f-db1cc0021ce8,,Neoadjuvant,,2021-01-06T22:55:10.531130-06:00,HCM-BROD-0195-C71_treatment,3ffd8303-d622-456c-a663-d84e601e3a91,,released,,0,2019-04-04T15:06:45.805167-05:00,,,
HCM-BROD-0195-C71,b44ee47e-c360-41bf-8e0d-a95dc6f9f9cc,c5993e86-fe12-428b-9f7f-db1cc0021ce8,,,-3.0,2023-02-27T12:51:18.388710-06:00,HCM-BROD-0195-C71_treatment4,44fb0695-376c-44da-af58-2e38944bb75c,,released,,1,2019-04-04T15:06:45.805167-05:00,"Surgery, NOS",Initial Diagnosis,
HCM-BROD-0195-C71,b44ee47e-c360-41bf-8e0d-a95dc6f9f9cc,c5993e86-fe12-428b-9f7f-db1cc0021ce8,28.0,Adjuvant,25.0,2021-01-06T22:55:10.531130-06:00,HCM-BROD-0195-C71_treatment6,ae4ce8b1-4d5b-4f97-a17e-0e46ab17c5e9,,released,,1,2019-04-04T15:06:45.805167-05:00,"Radiation Therapy, NOS",Residual Disease,
HCM-BROD-0195-C71,b44ee47e-c360-41bf-8e0d-a95dc6f9f9cc,c5993e86-fe12-428b-9f7f-db1cc0021ce8,,Adjuvant,,2021-01-06T22:55:10.531130-06:00,HCM-BROD-0195-C71_treatment3,d048bbcd-8808-49c1-aad0-fce2c9b61a51,,released,,0,2019-04-04T15:06:45.805167-05:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-BROD-0029-C71,b5160217-33c3-47cd-8540-44ca283c8464,f443f1a9-c536-4924-a69e-d1f5dc244f45,,Adjuvant,,2021-07-12T12:25:55.528644-05:00,HCM-BROD-0029-C71_treatment2,09885e5c-37d4-4d80-8005-51b4483d60be,,released,,0,2019-04-04T14:19:01.320721-05:00,Chemotherapy,Residual Disease,
HCM-BROD-0029-C71,b5160217-33c3-47cd-8540-44ca283c8464,f443f1a9-c536-4924-a69e-d1f5dc244f45,,,-6.0,2023-03-13T13:27:19.706801-05:00,HCM-BROD-0029-C71_treatment4,26ad6597-fc67-44c2-9c3c-c206002a1070,,released,,1,2019-04-04T14:19:01.320721-05:00,"Surgery, NOS",Initial Diagnosis,
HCM-BROD-0029-C71,b5160217-33c3-47cd-8540-44ca283c8464,f443f1a9-c536-4924-a69e-d1f5dc244f45,,Adjuvant,,2021-07-12T12:25:55.528644-05:00,HCM-BROD-0029-C71_treatment6,36e4cdd3-a094-4f75-a800-ccacdee5fbf3,,released,,0,2019-04-04T14:19:01.320721-05:00,"Radiation Therapy, NOS",Residual Disease,
HCM-BROD-0029-C71,b5160217-33c3-47cd-8540-44ca283c8464,f443f1a9-c536-4924-a69e-d1f5dc244f45,,Neoadjuvant,,2021-07-12T12:25:55.528644-05:00,HCM-BROD-0029-C71_treatment,4f6a0086-8e86-4a22-a0e8-5247c33c2d8c,,released,,0,2019-03-12T10:16:14.056923-05:00,,,
HCM-BROD-0029-C71,b5160217-33c3-47cd-8540-44ca283c8464,f443f1a9-c536-4924-a69e-d1f5dc244f45,239.0,Adjuvant,222.0,2021-07-12T12:25:55.528644-05:00,HCM-BROD-0029-C71_treatment5,5d74bcb1-abfe-4657-b6a3-843fcc83cbc3,,released,Bevacizumab,1,2019-04-04T14:19:01.320721-05:00,Targeted Molecular Therapy,Residual Disease,
HCM-BROD-0029-C71,b5160217-33c3-47cd-8540-44ca283c8464,f443f1a9-c536-4924-a69e-d1f5dc244f45,,Adjuvant,,2021-07-12T12:25:55.528644-05:00,HCM-BROD-0029-C71_treatment3,d86e7079-2230-4994-ab3b-970c7186ecb0,,released,,0,2019-04-04T14:19:01.320721-05:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-SANG-0526-C15,b519e4e3-46d7-4ac8-811d-899fd4ee1e9b,69aefe87-3a5b-410e-8c44-6380ea3848aa,,Neoadjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-SANG-0526-C15_treatment,c2dde05a-e96d-4f94-ba48-401f2448c599,,released,,0,2023-02-27T12:40:48.380787-06:00,,,
HCM-CSHL-0065-C20,b5fe3fa5-0f46-4e63-8e1f-dc3d28734936,027c64ba-cd09-40e9-9495-12142f99aeb6,,Neoadjuvant,,2019-05-24T12:11:41.511797-05:00,HCM-CSHL-0065-C20_treatment,264d526a-d2f1-4467-a79f-4ec36603ef77,,released,,0,2019-05-15T15:01:01.539372-05:00,,,
HCM-CSHL-0065-C20,b5fe3fa5-0f46-4e63-8e1f-dc3d28734936,027c64ba-cd09-40e9-9495-12142f99aeb6,,Adjuvant,,2023-03-13T13:12:30.451357-05:00,HCM-CSHL-0065-C20_treatment4,38911bae-56f7-409d-99d1-21b33a950812,,released,,0,2019-05-15T15:01:01.539372-05:00,"Radiation Therapy, NOS",Residual Disease,
HCM-CSHL-0065-C20,b5fe3fa5-0f46-4e63-8e1f-dc3d28734936,027c64ba-cd09-40e9-9495-12142f99aeb6,,,48.0,2023-03-13T13:12:30.451357-05:00,HCM-CSHL-0065-C20_treatment2,81c3c43d-8e0f-4095-a299-4c4bc185a63e,,released,,1,2019-05-15T15:01:01.539372-05:00,"Surgery, NOS",Initial Diagnosis,
HCM-CSHL-0065-C20,b5fe3fa5-0f46-4e63-8e1f-dc3d28734936,027c64ba-cd09-40e9-9495-12142f99aeb6,,Adjuvant,,2023-03-13T13:12:30.451357-05:00,HCM-CSHL-0065-C20_treatment3,8db0f431-51a2-4c17-a0c8-2c60ce097f4c,,released,,0,2019-05-15T15:01:01.539372-05:00,"Pharmaceutical Therapy, NOS",Residual Disease,
HCM-WCMC-0785-C67,b655b06f-fd1e-4e55-b9e0-d8181ab8f7a5,e56c36f6-6e5e-47e9-ae85-630c1164e5de,656.0,Adjuvant,61.0,2025-04-07T17:13:09.336794-05:00,HCM-WCMC-0785-C67_treatment5,00f27a54-4681-4f92-830e-f07af5b97ae9,,released,,1,2023-02-27T13:09:11.827042-06:00,Chemotherapy,Residual Disease,FOLFOX
HCM-WCMC-0785-C67,b655b06f-fd1e-4e55-b9e0-d8181ab8f7a5,e56c36f6-6e5e-47e9-ae85-630c1164e5de,633.0,Adjuvant,627.0,2025-04-07T17:13:09.336794-05:00,HCM-WCMC-0785-C67_treatment14,0ec677d3-e22a-4e28-afe7-231dfed20e44,,released,,1,2023-02-27T13:09:11.827042-06:00,"Radiation, Stereotactic/Gamma Knife/SRS",Residual Disease,
HCM-WCMC-0785-C67,b655b06f-fd1e-4e55-b9e0-d8181ab8f7a5,e56c36f6-6e5e-47e9-ae85-630c1164e5de,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-WCMC-0785-C67_treatment11,41c1e1e8-9911-4690-8329-3587c0f8cf04,,released,,0,2023-02-27T13:09:11.827042-06:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-WCMC-0785-C67,b655b06f-fd1e-4e55-b9e0-d8181ab8f7a5,e56c36f6-6e5e-47e9-ae85-630c1164e5de,656.0,Adjuvant,509.0,2025-04-07T17:13:09.336794-05:00,HCM-WCMC-0785-C67_treatment8,49298fc3-74f6-4631-8065-38647f436764,,released,,1,2023-02-27T13:09:11.827042-06:00,Chemotherapy,Residual Disease,FU-LV regimen
HCM-WCMC-0785-C67,b655b06f-fd1e-4e55-b9e0-d8181ab8f7a5,e56c36f6-6e5e-47e9-ae85-630c1164e5de,656.0,Adjuvant,509.0,2025-04-07T17:13:09.336794-05:00,HCM-WCMC-0785-C67_treatment9,5001e2c7-340e-4091-af91-2085f7e3134f,,released,Oxaliplatin,1,2023-02-27T13:09:11.827042-06:00,Chemotherapy,Residual Disease,
HCM-WCMC-0785-C67,b655b06f-fd1e-4e55-b9e0-d8181ab8f7a5,e56c36f6-6e5e-47e9-ae85-630c1164e5de,,,0.0,2025-04-07T17:13:09.336794-05:00,HCM-WCMC-0785-C67_treatment12,6f958ccf-fff3-40eb-a138-bb6a04b6f841,,released,,1,2023-02-27T13:09:11.827042-06:00,"Surgery, NOS",Initial Diagnosis,
HCM-WCMC-0785-C67,b655b06f-fd1e-4e55-b9e0-d8181ab8f7a5,e56c36f6-6e5e-47e9-ae85-630c1164e5de,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-WCMC-0785-C67_treatment13,8061da82-fcfd-4bea-ae33-941f68b821b3,,released,,0,2023-02-27T13:09:11.827042-06:00,Targeted Molecular Therapy,Residual Disease,
HCM-WCMC-0785-C67,b655b06f-fd1e-4e55-b9e0-d8181ab8f7a5,e56c36f6-6e5e-47e9-ae85-630c1164e5de,656.0,Adjuvant,61.0,2025-04-07T17:13:09.336794-05:00,HCM-WCMC-0785-C67_treatment3,8390ab93-0386-4554-931c-65c9d182562c,,released,Fluorouracil,1,2023-02-27T13:09:11.827042-06:00,Chemotherapy,Residual Disease,
HCM-WCMC-0785-C67,b655b06f-fd1e-4e55-b9e0-d8181ab8f7a5,e56c36f6-6e5e-47e9-ae85-630c1164e5de,656.0,Adjuvant,509.0,2025-04-07T17:13:09.336794-05:00,HCM-WCMC-0785-C67_treatment6,852fd510-39f8-4ae1-bba0-ac44d84f5a18,,released,Leucovorin,1,2023-02-27T13:09:11.827042-06:00,Chemotherapy,Residual Disease,
HCM-WCMC-0785-C67,b655b06f-fd1e-4e55-b9e0-d8181ab8f7a5,e56c36f6-6e5e-47e9-ae85-630c1164e5de,656.0,Adjuvant,61.0,2025-04-07T17:13:09.336794-05:00,HCM-WCMC-0785-C67_treatment4,9b15c602-7726-4830-b6cb-1695b46f78bb,,released,Oxaliplatin,1,2023-02-27T13:09:11.827042-06:00,Chemotherapy,Residual Disease,
HCM-WCMC-0785-C67,b655b06f-fd1e-4e55-b9e0-d8181ab8f7a5,e56c36f6-6e5e-47e9-ae85-630c1164e5de,656.0,Adjuvant,61.0,2025-04-07T17:13:09.336794-05:00,HCM-WCMC-0785-C67_treatment2,9e37a7e8-bd38-4767-9d31-790bfbbc60ed,,released,Leucovorin Calcium,1,2023-02-27T13:09:11.827042-06:00,Chemotherapy,Residual Disease,
HCM-WCMC-0785-C67,b655b06f-fd1e-4e55-b9e0-d8181ab8f7a5,e56c36f6-6e5e-47e9-ae85-630c1164e5de,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-WCMC-0785-C67_treatment10,b6237b3c-63c9-421b-83cf-7be5e013e2cc,,released,,0,2023-02-27T13:09:11.827042-06:00,Hormone Therapy,Residual Disease,
HCM-WCMC-0785-C67,b655b06f-fd1e-4e55-b9e0-d8181ab8f7a5,e56c36f6-6e5e-47e9-ae85-630c1164e5de,656.0,Adjuvant,509.0,2025-04-07T17:13:09.336794-05:00,HCM-WCMC-0785-C67_treatment7,c62a7a6a-445c-4792-ab24-d0feaa042fdf,,released,Fluorouracil,1,2023-02-27T13:09:11.827042-06:00,Chemotherapy,Residual Disease,
HCM-WCMC-0785-C67,b655b06f-fd1e-4e55-b9e0-d8181ab8f7a5,e56c36f6-6e5e-47e9-ae85-630c1164e5de,,Neoadjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-WCMC-0785-C67_treatment,d266e7f8-1cb3-4540-8661-3fb199441692,,released,,0,2023-02-27T13:09:11.827042-06:00,,,
HCM-BROD-0642-C43,b68751b4-ffee-4ab8-93e3-8b38866bffb8,63292b30-720b-4716-a655-a6a9e9305859,,Adjuvant,,2023-02-22T07:39:25.979291-06:00,HCM-BROD-0642-C43_treatment3,5cc206f3-1a12-44eb-b618-c11952c4841e,,released,,0,2021-12-21T13:42:14.109552-06:00,Hormone Therapy,Residual Disease,
HCM-BROD-0642-C43,b68751b4-ffee-4ab8-93e3-8b38866bffb8,63292b30-720b-4716-a655-a6a9e9305859,,,0.0,2023-02-27T12:39:44.744541-06:00,HCM-BROD-0642-C43_treatment5,61d07b57-d860-447a-984f-89703921f610,,released,,1,2021-12-21T13:42:14.109552-06:00,"Surgery, NOS",Initial Diagnosis,
HCM-BROD-0642-C43,b68751b4-ffee-4ab8-93e3-8b38866bffb8,63292b30-720b-4716-a655-a6a9e9305859,2469.0,Adjuvant,1762.0,2023-02-22T07:39:25.979291-06:00,HCM-BROD-0642-C43_treatment4,740ce2ec-ccce-4d8f-9b28-dcbaa140827f,Treatment Ongoing,released,Nivolumab,1,2021-12-21T13:42:14.109552-06:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-BROD-0642-C43,b68751b4-ffee-4ab8-93e3-8b38866bffb8,63292b30-720b-4716-a655-a6a9e9305859,,Adjuvant,,2023-02-22T07:39:25.979291-06:00,HCM-BROD-0642-C43_treatment6,81a4ef30-dd6a-4f6b-a22b-821e6b503fd6,,released,,0,2021-12-21T13:42:14.109552-06:00,Targeted Molecular Therapy,Residual Disease,
HCM-BROD-0642-C43,b68751b4-ffee-4ab8-93e3-8b38866bffb8,63292b30-720b-4716-a655-a6a9e9305859,,Adjuvant,,2023-02-22T07:39:25.979291-06:00,HCM-BROD-0642-C43_treatment2,afa42cfc-ffa6-4c6c-ada6-8c09cfa5c034,,released,,0,2021-12-21T13:42:14.109552-06:00,Chemotherapy,Residual Disease,
HCM-BROD-0642-C43,b68751b4-ffee-4ab8-93e3-8b38866bffb8,63292b30-720b-4716-a655-a6a9e9305859,,Neoadjuvant,,2023-02-22T07:39:25.979291-06:00,HCM-BROD-0642-C43_treatment,bb9cd46a-5f11-43da-a317-9a37fc628e0d,,released,,0,2021-12-21T13:42:14.109552-06:00,,,
HCM-BROD-0642-C43,b68751b4-ffee-4ab8-93e3-8b38866bffb8,63292b30-720b-4716-a655-a6a9e9305859,,Adjuvant,,2023-02-22T07:39:25.979291-06:00,HCM-BROD-0642-C43_treatment7,e4ce5a05-721a-4fe7-8b18-f20ed6f9090e,,released,,0,2021-12-21T13:42:14.109552-06:00,"Radiation Therapy, NOS",Residual Disease,
HCM-BROD-0642-C43,b68751b4-ffee-4ab8-93e3-8b38866bffb8,accd1509-52ae-4ad3-8fce-e25a1b259b09,,Maintenance Therapy,,2023-02-22T07:39:25.979291-06:00,HCM-BROD-0642-C43_treatment8,c5c9af9d-cc30-428e-be6e-783c98eb6733,Complete Response,released,Pembrolizumab,1,2021-12-21T13:42:14.109552-06:00,,,
HCM-SANG-1299-C15,b68a5c9e-76f3-47a2-b60f-35c99bb9ffbb,456b203d-2a42-49b1-83ec-88a42674e954,,Neoadjuvant,144.0,2025-04-07T17:13:09.336794-05:00,HCM-SANG-1299-C15_treatment3,7628da6d-7e8e-4640-bc4b-b0fd6caa9e95,,released,Cisplatin,1,2023-02-27T13:22:44.669887-06:00,Chemotherapy,,
HCM-SANG-1299-C15,b68a5c9e-76f3-47a2-b60f-35c99bb9ffbb,456b203d-2a42-49b1-83ec-88a42674e954,,Neoadjuvant,144.0,2025-04-07T17:13:09.336794-05:00,HCM-SANG-1299-C15_treatment,7e304794-c1ff-4aca-9a42-ed687179af57,,released,Epirubicin,1,2023-02-27T13:22:44.669887-06:00,Chemotherapy,,
HCM-SANG-1299-C15,b68a5c9e-76f3-47a2-b60f-35c99bb9ffbb,456b203d-2a42-49b1-83ec-88a42674e954,,Neoadjuvant,144.0,2025-04-07T17:13:09.336794-05:00,HCM-SANG-1299-C15_treatment4,86d0f4ee-fa4a-4764-adfb-810d1acd363d,,released,,1,2023-02-27T13:22:44.669887-06:00,Chemotherapy,,ECX
HCM-SANG-1299-C15,b68a5c9e-76f3-47a2-b60f-35c99bb9ffbb,456b203d-2a42-49b1-83ec-88a42674e954,,Neoadjuvant,144.0,2025-04-07T17:13:09.336794-05:00,HCM-SANG-1299-C15_treatment2,c7b653de-4eff-4f63-927b-00a92d2254f7,,released,Capecitabine,1,2023-02-27T13:22:44.669887-06:00,Chemotherapy,,
HCM-BROD-0097-C15,b6c440ae-67b1-46e0-a9fc-f08e51f15448,f33e4bf3-3d58-4abe-8d03-58f587d40a88,,,,2023-02-27T12:41:22.495041-06:00,HCM-BROD-0097-C15_treatment7,06a1c658-1455-4d0d-abcf-9f524fa5d3fa,,released,,0,2019-04-04T15:59:44.268527-05:00,"Surgery, NOS",Initial Diagnosis,
HCM-BROD-0097-C15,b6c440ae-67b1-46e0-a9fc-f08e51f15448,f33e4bf3-3d58-4abe-8d03-58f587d40a88,392.0,Adjuvant,315.0,2021-07-12T12:25:55.528644-05:00,HCM-BROD-0097-C15_treatment5,19995478-736f-4840-817e-fde58eef0fe1,,released,,1,2019-04-04T15:59:44.268527-05:00,Chemotherapy,Residual Disease,FU-LV regimen
HCM-BROD-0097-C15,b6c440ae-67b1-46e0-a9fc-f08e51f15448,f33e4bf3-3d58-4abe-8d03-58f587d40a88,,Adjuvant,,2021-07-12T12:25:55.528644-05:00,HCM-BROD-0097-C15_treatment6,32715a73-4dc2-41e3-b283-7c2c7ac2ba72,,released,,0,2019-04-04T15:59:44.268527-05:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-BROD-0097-C15,b6c440ae-67b1-46e0-a9fc-f08e51f15448,f33e4bf3-3d58-4abe-8d03-58f587d40a88,,Neoadjuvant,,2021-07-12T12:25:55.528644-05:00,HCM-BROD-0097-C15_treatment2,4ecc439e-908e-409e-b36a-b63415466fec,,released,,1,2019-04-04T15:59:44.268527-05:00,"Radiation Therapy, NOS",,
HCM-BROD-0097-C15,b6c440ae-67b1-46e0-a9fc-f08e51f15448,f33e4bf3-3d58-4abe-8d03-58f587d40a88,392.0,Adjuvant,315.0,2021-07-12T12:25:55.528644-05:00,HCM-BROD-0097-C15_treatment3,5ad478ce-486d-4819-9601-73b0f6cb8165,,released,Fluorouracil,1,2019-04-04T15:59:44.268527-05:00,Chemotherapy,Residual Disease,
HCM-BROD-0097-C15,b6c440ae-67b1-46e0-a9fc-f08e51f15448,f33e4bf3-3d58-4abe-8d03-58f587d40a88,,Neoadjuvant,,2021-07-12T12:25:55.528644-05:00,HCM-BROD-0097-C15_treatment,7ef8caf2-92ad-40af-9f58-3704b806ba9d,,released,Unknown,1,2019-04-04T15:59:44.268527-05:00,Chemotherapy,,
HCM-BROD-0097-C15,b6c440ae-67b1-46e0-a9fc-f08e51f15448,f33e4bf3-3d58-4abe-8d03-58f587d40a88,,Adjuvant,,2021-07-12T12:25:55.528644-05:00,HCM-BROD-0097-C15_treatment9,a3cc2b9b-46f9-411d-aad9-926ebd0ec5b6,,released,,0,2020-09-27T10:23:21.637490-05:00,"Radiation Therapy, NOS",Residual Disease,
HCM-BROD-0097-C15,b6c440ae-67b1-46e0-a9fc-f08e51f15448,f33e4bf3-3d58-4abe-8d03-58f587d40a88,392.0,Adjuvant,315.0,2021-07-12T12:25:55.528644-05:00,HCM-BROD-0097-C15_treatment4,f76e1623-f07e-462a-b171-674924ef5ded,,released,Leucovorin,1,2019-04-04T15:59:44.268527-05:00,Chemotherapy,Residual Disease,
HCM-BROD-0097-C15,b6c440ae-67b1-46e0-a9fc-f08e51f15448,f33e4bf3-3d58-4abe-8d03-58f587d40a88,,Adjuvant,,2021-07-12T12:25:55.528644-05:00,HCM-BROD-0097-C15_treatment8,fcd5608b-7c24-48f9-94ef-7cbc06c7aee8,,released,,0,2020-09-27T10:23:21.637490-05:00,Targeted Molecular Therapy,Residual Disease,
HCM-BROD-1078-C49,b72a905b-4179-4da4-8bfb-e0287d28bab2,a7fbe4bf-3035-4171-aff6-eda696553e4e,1342.0,Adjuvant,1271.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-1078-C49_treatment2,15d83e58-5529-4cc0-bff1-38cc5381a130,,released,Unknown,1,2021-12-21T14:00:47.487748-06:00,Chemotherapy,Residual Disease,
HCM-BROD-1078-C49,b72a905b-4179-4da4-8bfb-e0287d28bab2,a7fbe4bf-3035-4171-aff6-eda696553e4e,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-BROD-1078-C49_treatment7,3e193d54-4f77-4e05-a80c-03bb3ebee8c6,,released,,0,2021-12-21T14:00:47.487748-06:00,"Radiation Therapy, NOS",Residual Disease,
HCM-BROD-1078-C49,b72a905b-4179-4da4-8bfb-e0287d28bab2,a7fbe4bf-3035-4171-aff6-eda696553e4e,,,0.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-1078-C49_treatment5,41c72ba6-0d4c-45d4-9dcb-0ae2f24e1e07,,released,,1,2021-12-21T14:00:47.487748-06:00,"Surgery, NOS",Initial Diagnosis,
HCM-BROD-1078-C49,b72a905b-4179-4da4-8bfb-e0287d28bab2,a7fbe4bf-3035-4171-aff6-eda696553e4e,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-BROD-1078-C49_treatment3,963241f0-f78c-4e80-bd9e-2709c21dea00,,released,,0,2021-12-21T14:00:47.487748-06:00,Hormone Therapy,Residual Disease,
HCM-BROD-1078-C49,b72a905b-4179-4da4-8bfb-e0287d28bab2,a7fbe4bf-3035-4171-aff6-eda696553e4e,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-BROD-1078-C49_treatment4,c1415405-a231-4c97-86ff-b57ac37ad54f,,released,,0,2021-12-21T14:00:47.487748-06:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-BROD-1078-C49,b72a905b-4179-4da4-8bfb-e0287d28bab2,a7fbe4bf-3035-4171-aff6-eda696553e4e,,Neoadjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-BROD-1078-C49_treatment,db33142a-8639-4c5e-900a-e60c63ac713a,,released,,0,2021-12-21T14:00:47.487748-06:00,,,
HCM-BROD-1078-C49,b72a905b-4179-4da4-8bfb-e0287d28bab2,a7fbe4bf-3035-4171-aff6-eda696553e4e,1398.0,Adjuvant,1271.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-1078-C49_treatment6,f6b57081-0064-44a7-b6af-6e3400fb2f1b,Treatment Ongoing,released,Unknown,1,2021-12-21T14:00:47.487748-06:00,Targeted Molecular Therapy,Residual Disease,
HCM-CSHL-0617-C22,b7db0140-9259-4949-bcff-36ad81db6306,e7dd3a67-317e-4098-9219-9e002de883d2,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0617-C22_treatment4,1590db6c-6aa4-438f-97cc-32dc06564a18,,released,,0,2021-12-21T14:12:08.012504-06:00,"Radiation Therapy, NOS",Residual Disease,
HCM-CSHL-0617-C22,b7db0140-9259-4949-bcff-36ad81db6306,e7dd3a67-317e-4098-9219-9e002de883d2,,Neoadjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0617-C22_treatment,4d93fbbd-baa2-48b2-8ddf-772517893a11,,released,,0,2021-12-21T14:12:08.012504-06:00,,,
HCM-CSHL-0617-C22,b7db0140-9259-4949-bcff-36ad81db6306,e7dd3a67-317e-4098-9219-9e002de883d2,,Neoadjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0617-C22_treatment5,56230ab1-5452-4056-88d3-b8180214fc16,,released,,1,2021-12-21T14:12:08.012504-06:00,,,
HCM-CSHL-0617-C22,b7db0140-9259-4949-bcff-36ad81db6306,e7dd3a67-317e-4098-9219-9e002de883d2,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0617-C22_treatment3,65b6293a-80ab-4526-90c2-7eaba21fc72f,,released,,0,2021-12-21T14:12:08.012504-06:00,"Pharmaceutical Therapy, NOS",Residual Disease,
HCM-CSHL-0617-C22,b7db0140-9259-4949-bcff-36ad81db6306,e7dd3a67-317e-4098-9219-9e002de883d2,,,-80.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0617-C22_treatment2,e9fccc74-a9a3-4478-bbc7-12fc0a07605b,,released,,1,2021-12-21T14:12:08.012504-06:00,"Surgery, NOS",Initial Diagnosis,
HCM-STAN-0627-C34,b89e2bf1-21be-4916-9cfc-3e75c52ecfa7,1161707b-5d1a-498d-83de-5ce49c99a0d1,,Adjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-STAN-0627-C34_treatment7,05047e21-8e89-46e0-b98b-f46deac2ddd2,,released,,0,2022-09-22T07:02:04.463899-05:00,Targeted Molecular Therapy,Residual Disease,
HCM-STAN-0627-C34,b89e2bf1-21be-4916-9cfc-3e75c52ecfa7,1161707b-5d1a-498d-83de-5ce49c99a0d1,209.0,Adjuvant,77.0,2025-03-31T16:34:59.906497-05:00,HCM-STAN-0627-C34_treatment3,30050b02-9b63-46d6-824a-b71f55f9b299,,released,Cisplatin,1,2022-09-22T07:02:04.463899-05:00,Chemotherapy,Residual Disease,
HCM-STAN-0627-C34,b89e2bf1-21be-4916-9cfc-3e75c52ecfa7,1161707b-5d1a-498d-83de-5ce49c99a0d1,,,56.0,2025-03-31T16:34:59.906497-05:00,HCM-STAN-0627-C34_treatment6,3c8f249b-0ea6-42b7-9149-ba3b3ccdc953,,released,,1,2022-09-22T07:02:04.463899-05:00,"Surgery, NOS",Initial Diagnosis,
HCM-STAN-0627-C34,b89e2bf1-21be-4916-9cfc-3e75c52ecfa7,1161707b-5d1a-498d-83de-5ce49c99a0d1,209.0,Adjuvant,77.0,2025-03-31T16:34:59.906497-05:00,HCM-STAN-0627-C34_treatment4,689dc0e0-efcd-4637-9360-b58b1a1bee12,,released,Gemcitabine,1,2022-09-22T07:02:04.463899-05:00,Chemotherapy,Residual Disease,
HCM-STAN-0627-C34,b89e2bf1-21be-4916-9cfc-3e75c52ecfa7,1161707b-5d1a-498d-83de-5ce49c99a0d1,,Neoadjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-STAN-0627-C34_treatment2,72c7b12b-27f8-44de-b70c-50432611c255,,released,,unknown,2022-09-22T07:02:04.463899-05:00,"Radiation Therapy, NOS",,
HCM-STAN-0627-C34,b89e2bf1-21be-4916-9cfc-3e75c52ecfa7,1161707b-5d1a-498d-83de-5ce49c99a0d1,,Adjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-STAN-0627-C34_treatment5,8310081a-b315-4eed-8bb7-1e972ffe02ef,,released,,0,2022-09-22T07:02:04.463899-05:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-STAN-0627-C34,b89e2bf1-21be-4916-9cfc-3e75c52ecfa7,1161707b-5d1a-498d-83de-5ce49c99a0d1,,Neoadjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-STAN-0627-C34_treatment,cc1fbb5d-54b2-4577-974a-9bfcea60c649,,released,,unknown,2022-09-22T07:02:04.463899-05:00,"Pharmaceutical Therapy, NOS",,
HCM-STAN-0627-C34,b89e2bf1-21be-4916-9cfc-3e75c52ecfa7,1161707b-5d1a-498d-83de-5ce49c99a0d1,,Adjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-STAN-0627-C34_treatment8,f097646f-b3bf-43ca-8880-d523c340e864,,released,,0,2022-09-22T07:02:04.463899-05:00,"Radiation Therapy, NOS",Residual Disease,
HCM-STAN-0914-C34,b9ff4f43-7add-4cf0-a72d-cdfc92cc6b7d,56bc193e-9948-4ac7-94a7-789930f139bf,,Maintenance Therapy,704.0,2025-04-07T17:13:09.336794-05:00,HCM-STAN-0914-C34_treatment5,b5eab272-4be6-4731-ab49-115d916d21c2,Progressive Disease,released,Osimertinib,1,2023-02-28T13:38:57.891162-06:00,,,
HCM-STAN-0914-C34,b9ff4f43-7add-4cf0-a72d-cdfc92cc6b7d,9a07853f-8ad0-4960-a4ca-2ee6058736c2,,,,2025-04-07T17:13:09.336794-05:00,HCM-STAN-0914-C34_treatment2,4484a8ce-02e0-4e87-b26b-19c68ed3ace8,,released,,0,2022-09-22T07:09:17.978969-05:00,"Surgery, NOS",Initial Diagnosis,
HCM-STAN-0914-C34,b9ff4f43-7add-4cf0-a72d-cdfc92cc6b7d,9a07853f-8ad0-4960-a4ca-2ee6058736c2,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-STAN-0914-C34_treatment3,52070b18-71fb-4a3c-9f20-c94b6d05cbcc,,released,,unknown,2022-09-22T07:09:17.978969-05:00,"Pharmaceutical Therapy, NOS",Residual Disease,
HCM-STAN-0914-C34,b9ff4f43-7add-4cf0-a72d-cdfc92cc6b7d,9a07853f-8ad0-4960-a4ca-2ee6058736c2,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-STAN-0914-C34_treatment4,6fe29cd1-b3f5-4317-9927-d1f2f7e60ca1,,released,,unknown,2022-09-22T07:09:17.978969-05:00,"Radiation Therapy, NOS",Residual Disease,
HCM-STAN-0914-C34,b9ff4f43-7add-4cf0-a72d-cdfc92cc6b7d,9a07853f-8ad0-4960-a4ca-2ee6058736c2,,Neoadjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-STAN-0914-C34_treatment,a6bfc6e6-f999-4610-88cf-58f5b8df9d24,,released,,0,2022-09-22T07:09:17.978969-05:00,,,
HCM-BROD-0923-C64,ba085153-6dbd-4134-a78d-1be7579f8369,8aba8985-c48b-41fd-841c-861a9a9ea10e,,,0.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0923-C64_treatment5,30537b67-c064-42e8-8af9-96f4f99e371d,,released,,1,2021-12-21T13:57:02.327815-06:00,"Surgery, NOS",Initial Diagnosis,
HCM-BROD-0923-C64,ba085153-6dbd-4134-a78d-1be7579f8369,8aba8985-c48b-41fd-841c-861a9a9ea10e,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0923-C64_treatment6,399b7747-393a-4536-a3cf-47d5fa55f075,,released,,0,2021-12-21T13:57:02.327815-06:00,Targeted Molecular Therapy,Residual Disease,
HCM-BROD-0923-C64,ba085153-6dbd-4134-a78d-1be7579f8369,8aba8985-c48b-41fd-841c-861a9a9ea10e,153.0,Adjuvant,30.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0923-C64_treatment3,52c31b18-46be-4680-8690-462538e6b93f,,released,Doxorubicin Hydrochloride,1,2021-12-21T13:57:02.327815-06:00,Chemotherapy,Residual Disease,
HCM-BROD-0923-C64,ba085153-6dbd-4134-a78d-1be7579f8369,8aba8985-c48b-41fd-841c-861a9a9ea10e,183.0,Adjuvant,0.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0923-C64_treatment2,5c4c88e2-0bef-4850-9bbd-4f921f663004,,released,Vincristine,1,2021-12-21T13:57:02.327815-06:00,Chemotherapy,Residual Disease,
HCM-BROD-0923-C64,ba085153-6dbd-4134-a78d-1be7579f8369,8aba8985-c48b-41fd-841c-861a9a9ea10e,,Neoadjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0923-C64_treatment,6bc0143b-2ea4-4399-b92e-d1a016d63b48,,released,,0,2021-12-21T13:57:02.327815-06:00,,,
HCM-BROD-0923-C64,ba085153-6dbd-4134-a78d-1be7579f8369,8aba8985-c48b-41fd-841c-861a9a9ea10e,61.0,Adjuvant,30.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0923-C64_treatment7,71a4677d-0a01-4816-ac5d-b81f64714e5f,,released,,1,2021-12-21T13:57:02.327815-06:00,"Radiation, Intensity-Modulated Radiotherapy",Residual Disease,
HCM-BROD-0923-C64,ba085153-6dbd-4134-a78d-1be7579f8369,8aba8985-c48b-41fd-841c-861a9a9ea10e,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0923-C64_treatment4,f594daeb-b3a8-4383-b0a1-a8dfba240f1e,,released,,0,2021-12-21T13:57:02.327815-06:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-CSHL-0636-C02,ba455f85-09e8-4da3-8bf1-750848adc52d,adecc939-c479-46fe-913c-e865fd706a82,,,43.0,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0636-C02_treatment5,1117774d-1d8e-419f-a94f-548803406d22,,released,,1,2020-10-08T13:32:20.959263-05:00,"Surgery, NOS",Initial Diagnosis,
HCM-CSHL-0636-C02,ba455f85-09e8-4da3-8bf1-750848adc52d,adecc939-c479-46fe-913c-e865fd706a82,,Adjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0636-C02_treatment7,54df6357-b1b1-4473-9945-b9680e5ba010,,released,,0,2020-10-08T13:32:20.959263-05:00,"Radiation Therapy, NOS",Residual Disease,
HCM-CSHL-0636-C02,ba455f85-09e8-4da3-8bf1-750848adc52d,adecc939-c479-46fe-913c-e865fd706a82,,Neoadjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0636-C02_treatment,8dd4b796-ed9a-45cb-a6dc-b682d1179683,,released,,0,2020-10-08T13:32:20.959263-05:00,,,
HCM-CSHL-0636-C02,ba455f85-09e8-4da3-8bf1-750848adc52d,adecc939-c479-46fe-913c-e865fd706a82,,Adjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0636-C02_treatment3,aaff419a-328e-4523-becb-a70c5eb725e2,,released,,0,2020-10-08T13:32:20.959263-05:00,Hormone Therapy,Residual Disease,
HCM-CSHL-0636-C02,ba455f85-09e8-4da3-8bf1-750848adc52d,adecc939-c479-46fe-913c-e865fd706a82,,Adjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0636-C02_treatment4,ad7abb1e-c234-4b73-a148-d3053003559e,,released,,0,2020-10-08T13:32:20.959263-05:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-CSHL-0636-C02,ba455f85-09e8-4da3-8bf1-750848adc52d,adecc939-c479-46fe-913c-e865fd706a82,,Adjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0636-C02_treatment6,ea6034ed-6620-4f27-a6ba-4050488c2d73,,released,,0,2020-10-08T13:32:20.959263-05:00,Targeted Molecular Therapy,Residual Disease,
HCM-CSHL-0636-C02,ba455f85-09e8-4da3-8bf1-750848adc52d,adecc939-c479-46fe-913c-e865fd706a82,75.0,Adjuvant,33.0,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0636-C02_treatment2,f221fb27-2eec-4166-bff5-d58d6390b411,,released,Cisplatin,1,2020-10-08T13:32:20.959263-05:00,Chemotherapy,Residual Disease,
HCM-BROD-0047-C71,babbc3cb-14b7-4894-b91d-c160f4cb48e0,58796e30-de8c-46fe-883f-53c49f918c77,,Adjuvant,,2020-01-13T20:10:25.832065-06:00,HCM-BROD-0047-C71_treatment2,3cdbd2aa-cb9a-4c42-b975-33026b678952,,released,,unknown,2019-03-12T10:14:29.676556-05:00,Chemotherapy,Residual Disease,
HCM-BROD-0047-C71,babbc3cb-14b7-4894-b91d-c160f4cb48e0,58796e30-de8c-46fe-883f-53c49f918c77,,Adjuvant,,2020-01-13T20:10:25.832065-06:00,HCM-BROD-0047-C71_treatment6,6621a9ca-483c-4c06-a9c4-ef544088e31b,,released,,unknown,2019-03-12T10:14:29.676556-05:00,"Radiation Therapy, NOS",Residual Disease,
HCM-BROD-0047-C71,babbc3cb-14b7-4894-b91d-c160f4cb48e0,58796e30-de8c-46fe-883f-53c49f918c77,,Adjuvant,,2020-01-13T20:10:25.832065-06:00,HCM-BROD-0047-C71_treatment3,9babbff4-76e5-4544-a587-329c06533268,,released,,unknown,2019-03-12T10:14:29.676556-05:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-BROD-0047-C71,babbc3cb-14b7-4894-b91d-c160f4cb48e0,58796e30-de8c-46fe-883f-53c49f918c77,,Neoadjuvant,,2020-01-13T20:10:25.832065-06:00,HCM-BROD-0047-C71_treatment,aa7d98f0-43e1-4829-9e61-253420bf87f0,,released,,0,2019-03-12T10:14:29.676556-05:00,,,
HCM-BROD-0047-C71,babbc3cb-14b7-4894-b91d-c160f4cb48e0,58796e30-de8c-46fe-883f-53c49f918c77,,Adjuvant,,2020-01-13T20:10:25.832065-06:00,HCM-BROD-0047-C71_treatment5,debc1a69-0733-4143-a5d9-eebfb6845d15,,released,,unknown,2019-04-08T09:49:22.693558-05:00,Targeted Molecular Therapy,Residual Disease,
HCM-BROD-0047-C71,babbc3cb-14b7-4894-b91d-c160f4cb48e0,58796e30-de8c-46fe-883f-53c49f918c77,,,-5.0,2023-02-27T12:50:47.373684-06:00,HCM-BROD-0047-C71_treatment4,f016fe2c-fc74-4c8f-827c-bd566faeb5c3,,released,,1,2019-04-08T09:49:22.693558-05:00,"Surgery, NOS",Initial Diagnosis,
HCM-BROD-0721-C43,bae134d5-d971-4fff-9c92-64e399e0d3ce,3b82b5d6-0b3a-47b9-b130-5021974fbcf8,1258.0,Maintenance Therapy,468.0,2023-02-22T07:39:25.979291-06:00,HCM-BROD-0721-C43_treatment8,a4ae0de0-4891-49fd-915d-5f1da6fc38d7,Complete Response,released,Pembrolizumab,1,2021-12-21T13:48:17.092398-06:00,,,
HCM-BROD-0721-C43,bae134d5-d971-4fff-9c92-64e399e0d3ce,901c2557-f576-404c-ada5-091740185336,,Adjuvant,,2023-02-22T07:39:25.979291-06:00,HCM-BROD-0721-C43_treatment6,3e907a4e-570e-4e7a-85fe-74aab82522b4,,released,,0,2021-12-21T13:48:17.092398-06:00,Targeted Molecular Therapy,Residual Disease,
HCM-BROD-0721-C43,bae134d5-d971-4fff-9c92-64e399e0d3ce,901c2557-f576-404c-ada5-091740185336,,Neoadjuvant,468.0,2023-02-22T07:39:25.979291-06:00,HCM-BROD-0721-C43_treatment,50e3c8a7-0fb6-4ebf-9341-05b33a3d6dc5,,released,Pembrolizumab,1,2021-12-21T13:48:17.092398-06:00,Immunotherapy (Including Vaccines),,
HCM-BROD-0721-C43,bae134d5-d971-4fff-9c92-64e399e0d3ce,901c2557-f576-404c-ada5-091740185336,,,0.0,2023-02-27T12:32:41.487837-06:00,HCM-BROD-0721-C43_treatment5,73fd57dd-ae50-4019-ba9b-31bdf12e2bcf,,released,,1,2021-12-21T13:48:17.092398-06:00,"Surgery, NOS",Initial Diagnosis,
HCM-BROD-0721-C43,bae134d5-d971-4fff-9c92-64e399e0d3ce,901c2557-f576-404c-ada5-091740185336,,Adjuvant,,2023-02-22T07:39:25.979291-06:00,HCM-BROD-0721-C43_treatment2,79016dad-9e4f-43eb-a3bf-3995bfff57ab,,released,,0,2021-12-21T13:48:17.092398-06:00,Chemotherapy,Residual Disease,
HCM-BROD-0721-C43,bae134d5-d971-4fff-9c92-64e399e0d3ce,901c2557-f576-404c-ada5-091740185336,1258.0,Adjuvant,866.0,2023-02-22T07:39:25.979291-06:00,HCM-BROD-0721-C43_treatment4,7e231114-b885-46cc-9fd8-7d0d89150ab8,,released,Pembrolizumab,1,2021-12-21T13:48:17.092398-06:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-BROD-0721-C43,bae134d5-d971-4fff-9c92-64e399e0d3ce,901c2557-f576-404c-ada5-091740185336,,Adjuvant,,2023-02-22T07:39:25.979291-06:00,HCM-BROD-0721-C43_treatment3,a07ac284-2f33-40bd-906d-e5437bb62f69,,released,,0,2021-12-21T13:48:17.092398-06:00,Hormone Therapy,Residual Disease,
HCM-BROD-0721-C43,bae134d5-d971-4fff-9c92-64e399e0d3ce,901c2557-f576-404c-ada5-091740185336,,Adjuvant,,2023-02-22T07:39:25.979291-06:00,HCM-BROD-0721-C43_treatment7,cc990abe-bffc-4f21-a447-172ce10ec5fa,,released,,0,2021-12-21T13:48:17.092398-06:00,"Radiation Therapy, NOS",Residual Disease,
HCM-BROD-0225-C43,bb71a9ce-2934-40a4-a99a-b8e5b5491a55,3cc998f4-43b8-4bcf-85cc-0e875882931a,2786.0,Maintenance Therapy,1420.0,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0225-C43_treatment8,2e983d13-72cf-4f62-b051-ef63d9757567,Stable Disease,released,Not Otherwise Specified,1,2020-09-17T16:06:27.860274-05:00,,,
HCM-BROD-0225-C43,bb71a9ce-2934-40a4-a99a-b8e5b5491a55,3fdb31b7-5655-4f62-a217-c97f1e51845d,,,,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0225-C43_treatment5,025d0792-b44d-4b16-9053-7b157acf5641,,released,,unknown,2020-09-17T16:06:27.860274-05:00,"Surgery, NOS",Initial Diagnosis,
HCM-BROD-0225-C43,bb71a9ce-2934-40a4-a99a-b8e5b5491a55,3fdb31b7-5655-4f62-a217-c97f1e51845d,,Neoadjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0225-C43_treatment,35fdc9b7-133d-4fe2-beed-8ea01afbe096,,released,,0,2020-09-17T16:06:27.860274-05:00,,,
HCM-BROD-0225-C43,bb71a9ce-2934-40a4-a99a-b8e5b5491a55,3fdb31b7-5655-4f62-a217-c97f1e51845d,,Adjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0225-C43_treatment2,427def5c-0b51-4de0-8b9a-ca480d55d148,,released,,0,2020-09-17T16:06:27.860274-05:00,Chemotherapy,Residual Disease,
HCM-BROD-0225-C43,bb71a9ce-2934-40a4-a99a-b8e5b5491a55,3fdb31b7-5655-4f62-a217-c97f1e51845d,,Adjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0225-C43_treatment7,98d6a826-2d1d-4a1d-bf75-b03c561d0e73,,released,,0,2020-09-17T16:06:27.860274-05:00,"Radiation Therapy, NOS",Residual Disease,
HCM-BROD-0225-C43,bb71a9ce-2934-40a4-a99a-b8e5b5491a55,3fdb31b7-5655-4f62-a217-c97f1e51845d,,Adjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0225-C43_treatment3,9cd36100-7b1b-454c-bc9e-f4122229d576,,released,,0,2020-09-17T16:06:27.860274-05:00,Hormone Therapy,Residual Disease,
HCM-BROD-0225-C43,bb71a9ce-2934-40a4-a99a-b8e5b5491a55,3fdb31b7-5655-4f62-a217-c97f1e51845d,2917.0,Adjuvant,2876.0,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0225-C43_treatment4,9ce99f64-9acb-4842-98e5-500ad35d43c1,,released,Not Reported,1,2020-09-17T16:06:27.860274-05:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-BROD-0225-C43,bb71a9ce-2934-40a4-a99a-b8e5b5491a55,3fdb31b7-5655-4f62-a217-c97f1e51845d,,Adjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0225-C43_treatment6,a25b2649-ecc4-42ec-8e50-92e85f7ef414,,released,,0,2020-09-17T16:06:27.860274-05:00,Targeted Molecular Therapy,Residual Disease,
HCM-CSHL-0608-C17,bc1f75d5-8910-45ee-ae52-0d34ee41ee02,efdb7f21-24bc-4be0-a723-5dca68cb8844,,Neoadjuvant,-459.0,2024-05-07T14:59:44.030028-05:00,HCM-CSHL-0608-C17_treatment2,28cc82c8-a08e-4ea0-904f-c0e71bf7ebb8,,released,Streptozocin,1,2021-12-21T14:12:05.127154-06:00,Chemotherapy,,
HCM-CSHL-0608-C17,bc1f75d5-8910-45ee-ae52-0d34ee41ee02,efdb7f21-24bc-4be0-a723-5dca68cb8844,,Neoadjuvant,-490.0,2024-05-07T14:59:44.030028-05:00,HCM-CSHL-0608-C17_treatment4,4564fbcc-3ace-44bf-b990-91e7521faebf,,released,Lanreotide Acetate,1,2021-12-21T14:12:05.127154-06:00,Hormone Therapy,,
HCM-CSHL-0608-C17,bc1f75d5-8910-45ee-ae52-0d34ee41ee02,efdb7f21-24bc-4be0-a723-5dca68cb8844,,Adjuvant,,2023-03-13T13:32:39.550055-05:00,HCM-CSHL-0608-C17_treatment6,7c08bc40-8740-48fc-aa3b-92ef2f31f8a6,,released,,0,2021-12-21T14:12:05.127154-06:00,"Pharmaceutical Therapy, NOS",Residual Disease,
HCM-CSHL-0608-C17,bc1f75d5-8910-45ee-ae52-0d34ee41ee02,efdb7f21-24bc-4be0-a723-5dca68cb8844,,Neoadjuvant,-459.0,2024-05-07T14:59:44.030028-05:00,HCM-CSHL-0608-C17_treatment3,9e1357f9-9a55-4492-a90b-34739466614e,,released,Everolimus,1,2021-12-21T14:12:05.127154-06:00,Chemotherapy,,
HCM-CSHL-0608-C17,bc1f75d5-8910-45ee-ae52-0d34ee41ee02,efdb7f21-24bc-4be0-a723-5dca68cb8844,,Adjuvant,137.0,2023-03-13T13:32:39.550055-05:00,HCM-CSHL-0608-C17_treatment7,ad0f08fc-9a3d-412b-aeef-11eee8b02982,,released,,1,2021-12-21T14:12:05.127154-06:00,Peptide Receptor Radionuclide Therapy (PRRT),Residual Disease,
HCM-CSHL-0608-C17,bc1f75d5-8910-45ee-ae52-0d34ee41ee02,efdb7f21-24bc-4be0-a723-5dca68cb8844,,,-9.0,2023-03-13T13:32:39.550055-05:00,HCM-CSHL-0608-C17_treatment5,d690aaee-4c16-4813-965c-790d9eec86ab,,released,,1,2021-12-21T14:12:05.127154-06:00,"Surgery, NOS",Initial Diagnosis,
HCM-CSHL-0608-C17,bc1f75d5-8910-45ee-ae52-0d34ee41ee02,efdb7f21-24bc-4be0-a723-5dca68cb8844,,Neoadjuvant,-459.0,2024-05-07T14:59:44.030028-05:00,HCM-CSHL-0608-C17_treatment,f6dfa768-918b-4e99-ac07-3707e417f328,,released,Fluorouracil,1,2021-12-21T14:12:05.127154-06:00,Chemotherapy,,
HCM-CSHL-0378-C18,bc9d0b90-993d-4ecd-95cc-4514410e25ea,37a924b4-6021-480c-9f06-2cde00f2d431,,,13.0,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0378-C18_treatment2,4815b25b-91eb-444c-bebc-2d09864fda1e,,released,,1,2020-09-28T09:56:09.685950-05:00,"Surgery, NOS",Initial Diagnosis,
HCM-CSHL-0378-C18,bc9d0b90-993d-4ecd-95cc-4514410e25ea,37a924b4-6021-480c-9f06-2cde00f2d431,,Adjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0378-C18_treatment4,51415803-d434-4908-ad9a-d23ea6615c62,,released,,0,2020-09-28T09:56:09.685950-05:00,"Radiation Therapy, NOS",Residual Disease,
HCM-CSHL-0378-C18,bc9d0b90-993d-4ecd-95cc-4514410e25ea,37a924b4-6021-480c-9f06-2cde00f2d431,,Neoadjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0378-C18_treatment,5ceb4aef-317b-4b8d-817d-61e52daa9872,,released,,0,2020-09-28T09:56:09.685950-05:00,,,
HCM-CSHL-0378-C18,bc9d0b90-993d-4ecd-95cc-4514410e25ea,37a924b4-6021-480c-9f06-2cde00f2d431,,Adjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0378-C18_treatment3,df93bde1-9381-47b2-97d1-612e2415da84,,released,,0,2020-09-28T09:56:09.685950-05:00,"Pharmaceutical Therapy, NOS",Residual Disease,
HCM-CSHL-0880-C18,bd21e38c-bc6a-42f4-b10a-64f009c0d25a,9b502b5b-a7b8-4f07-9d95-95b4b3be5efb,170.0,Maintenance Therapy,42.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0880-C18_treatment11,0ec09ca1-2137-48ab-a60d-201d8c869c98,Not Reported,released,Oxaliplatin,1,2021-12-21T14:38:13.271162-06:00,,,
HCM-CSHL-0880-C18,bd21e38c-bc6a-42f4-b10a-64f009c0d25a,9b502b5b-a7b8-4f07-9d95-95b4b3be5efb,170.0,Maintenance Therapy,42.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0880-C18_treatment13,6ca2776a-9655-404b-aaef-c55a23d8b33c,Not Reported,released,Fluorouracil,1,2021-12-21T14:38:13.271162-06:00,,,
HCM-CSHL-0880-C18,bd21e38c-bc6a-42f4-b10a-64f009c0d25a,9b502b5b-a7b8-4f07-9d95-95b4b3be5efb,170.0,Maintenance Therapy,42.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0880-C18_treatment14,d7706395-5ac8-4a54-a112-d0395b5c543d,Not Reported,released,,1,2021-12-21T14:38:13.271162-06:00,,,FOLFOX
HCM-CSHL-0880-C18,bd21e38c-bc6a-42f4-b10a-64f009c0d25a,9b502b5b-a7b8-4f07-9d95-95b4b3be5efb,170.0,Maintenance Therapy,42.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0880-C18_treatment12,f224d5ba-b2cf-44ea-a1cf-7139a68c40dc,Not Reported,released,Leucovorin Calcium,1,2021-12-21T14:38:13.271162-06:00,,,
HCM-CSHL-0880-C18,bd21e38c-bc6a-42f4-b10a-64f009c0d25a,9b502b5b-a7b8-4f07-9d95-95b4b3be5efb,170.0,Maintenance Therapy,42.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0880-C18_treatment10,f3e5f4d0-93a4-435b-97db-13a6d7ada492,Not Reported,released,Bevacizumab,1,2021-12-21T14:38:13.271162-06:00,,,
HCM-CSHL-0880-C18,bd21e38c-bc6a-42f4-b10a-64f009c0d25a,f9c61623-a73f-43b5-a9bd-9074782a9b22,171.0,Adjuvant,64.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0880-C18_treatment8,226d85e4-abf9-46fc-a299-da238f3fd708,,released,Bevacizumab,1,2021-12-21T14:38:13.271162-06:00,Targeted Molecular Therapy,Residual Disease,
HCM-CSHL-0880-C18,bd21e38c-bc6a-42f4-b10a-64f009c0d25a,f9c61623-a73f-43b5-a9bd-9074782a9b22,171.0,Adjuvant,64.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0880-C18_treatment2,25504313-3aa1-4ad2-a4cd-66a7ccc6e8f3,,released,Leucovorin Calcium,1,2021-12-21T14:38:13.271162-06:00,Chemotherapy,Residual Disease,
HCM-CSHL-0880-C18,bd21e38c-bc6a-42f4-b10a-64f009c0d25a,f9c61623-a73f-43b5-a9bd-9074782a9b22,,,1.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0880-C18_treatment7,3ec919b6-344e-418d-a870-7f2538348b65,,released,,1,2021-12-21T14:38:13.271162-06:00,"Surgery, NOS",Initial Diagnosis,
HCM-CSHL-0880-C18,bd21e38c-bc6a-42f4-b10a-64f009c0d25a,f9c61623-a73f-43b5-a9bd-9074782a9b22,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0880-C18_treatment9,55fb1696-7313-43be-832d-cd0930c73fd0,,released,,0,2021-12-21T14:38:13.271162-06:00,"Radiation Therapy, NOS",Residual Disease,
HCM-CSHL-0880-C18,bd21e38c-bc6a-42f4-b10a-64f009c0d25a,f9c61623-a73f-43b5-a9bd-9074782a9b22,171.0,Adjuvant,64.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0880-C18_treatment4,6ea6efe0-8cae-4aee-a339-6d163e41593b,,released,Oxaliplatin,1,2021-12-21T14:38:13.271162-06:00,Chemotherapy,Residual Disease,
HCM-CSHL-0880-C18,bd21e38c-bc6a-42f4-b10a-64f009c0d25a,f9c61623-a73f-43b5-a9bd-9074782a9b22,171.0,Adjuvant,64.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0880-C18_treatment3,84711e82-5779-4b45-86a1-7d470bbac4ce,,released,Fluorouracil,1,2021-12-21T14:38:13.271162-06:00,Chemotherapy,Residual Disease,
HCM-CSHL-0880-C18,bd21e38c-bc6a-42f4-b10a-64f009c0d25a,f9c61623-a73f-43b5-a9bd-9074782a9b22,171.0,Adjuvant,64.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0880-C18_treatment5,ac0b70b8-f921-4a13-975b-1b0581a2c772,,released,,1,2021-12-21T14:38:13.271162-06:00,Chemotherapy,Residual Disease,FOLFOX
HCM-CSHL-0880-C18,bd21e38c-bc6a-42f4-b10a-64f009c0d25a,f9c61623-a73f-43b5-a9bd-9074782a9b22,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0880-C18_treatment6,bdda7631-6ad9-4add-be13-43def337f9d7,,released,,0,2021-12-21T14:38:13.271162-06:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-CSHL-0880-C18,bd21e38c-bc6a-42f4-b10a-64f009c0d25a,f9c61623-a73f-43b5-a9bd-9074782a9b22,,Neoadjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0880-C18_treatment,c5f7f91e-b1ae-403f-844b-55dae7466837,,released,,0,2021-12-21T14:38:13.271162-06:00,,,
HCM-BROD-1131-C06,be13c558-9f05-46c5-9dd3-b45050a5bb12,032f6922-fe0a-4d2e-b236-fa842c202132,,,0.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-1131-C06_treatment2,929afb4d-5df5-47f8-9c9a-fd19d70046de,,released,,1,2021-12-21T14:02:43.894700-06:00,"Surgery, NOS",Initial Diagnosis,
HCM-BROD-1131-C06,be13c558-9f05-46c5-9dd3-b45050a5bb12,032f6922-fe0a-4d2e-b236-fa842c202132,,Neoadjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-BROD-1131-C06_treatment,9938dc2d-4513-4b54-884a-47777f733cd4,,released,,0,2021-12-21T14:02:43.894700-06:00,,,
HCM-BROD-1131-C06,be13c558-9f05-46c5-9dd3-b45050a5bb12,032f6922-fe0a-4d2e-b236-fa842c202132,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-BROD-1131-C06_treatment3,cb29866b-ce7f-400a-9392-25c5465a4f5a,,released,,0,2021-12-21T14:02:43.894700-06:00,"Pharmaceutical Therapy, NOS",Residual Disease,
HCM-BROD-1131-C06,be13c558-9f05-46c5-9dd3-b45050a5bb12,032f6922-fe0a-4d2e-b236-fa842c202132,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-BROD-1131-C06_treatment4,e7f37064-83fd-4144-b335-397ea540e83f,,released,,0,2021-12-21T14:02:43.894700-06:00,"Radiation Therapy, NOS",Residual Disease,
HCM-BROD-0200-C71,be408fe2-5f92-4593-9b1d-190a4d46f9f8,9a05a4e1-7711-4a63-bd28-77cc6c8c2ddd,,,-9.0,2023-02-27T13:21:10.844513-06:00,HCM-BROD-0200-C71_treatment4,1036fe2a-6f4f-4ab5-8cda-b3569e59aa90,,released,,1,2020-02-27T12:34:54.905008-06:00,"Surgery, NOS",Initial Diagnosis,
HCM-BROD-0200-C71,be408fe2-5f92-4593-9b1d-190a4d46f9f8,9a05a4e1-7711-4a63-bd28-77cc6c8c2ddd,,Adjuvant,,2023-02-22T07:39:25.979291-06:00,HCM-BROD-0200-C71_treatment3,5dce854e-6a7b-4f5b-be1d-6e42045a7001,,released,,0,2020-02-27T12:34:54.905008-06:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-BROD-0200-C71,be408fe2-5f92-4593-9b1d-190a4d46f9f8,9a05a4e1-7711-4a63-bd28-77cc6c8c2ddd,,Neoadjuvant,,2023-02-22T07:39:25.979291-06:00,HCM-BROD-0200-C71_treatment,600c7c88-bc4e-48aa-a57d-9ab9acb98d9f,,released,,0,2019-04-04T15:01:44.993944-05:00,,,
HCM-BROD-0200-C71,be408fe2-5f92-4593-9b1d-190a4d46f9f8,9a05a4e1-7711-4a63-bd28-77cc6c8c2ddd,360.0,Adjuvant,57.0,2023-02-22T07:39:25.979291-06:00,HCM-BROD-0200-C71_treatment2,6c69d098-bd5b-4ade-be07-71ad16a76705,,released,Temozolomide,1,2020-02-27T12:34:54.905008-06:00,Chemotherapy,Residual Disease,
HCM-BROD-0200-C71,be408fe2-5f92-4593-9b1d-190a4d46f9f8,9a05a4e1-7711-4a63-bd28-77cc6c8c2ddd,,Adjuvant,,2023-02-22T07:39:25.979291-06:00,HCM-BROD-0200-C71_treatment5,d23a8e33-d116-4e79-a840-7a3aa34cefc9,,released,,0,2020-02-27T12:34:54.905008-06:00,Targeted Molecular Therapy,Residual Disease,
HCM-BROD-0200-C71,be408fe2-5f92-4593-9b1d-190a4d46f9f8,9a05a4e1-7711-4a63-bd28-77cc6c8c2ddd,,Adjuvant,,2023-02-22T07:39:25.979291-06:00,HCM-BROD-0200-C71_treatment6,ee27c606-8bed-49b7-a9f6-8dc45737729d,,released,,0,2020-02-27T12:34:54.905008-06:00,"Radiation Therapy, NOS",Residual Disease,
HCM-BROD-0413-C25,bea1726c-ae87-4697-8d35-06c37eee0999,da6af363-88cf-403a-9ffb-ff942c71e24b,436.0,Adjuvant,370.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0413-C25_treatment6,07344cc6-6519-4a9d-9d1c-35a9533aef10,,released,Gemcitabine,1,2020-09-27T11:30:43.095544-05:00,Chemotherapy,Residual Disease,
HCM-BROD-0413-C25,bea1726c-ae87-4697-8d35-06c37eee0999,da6af363-88cf-403a-9ffb-ff942c71e24b,,Neoadjuvant,23.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0413-C25_treatment3,2dd176d2-1568-40f4-abc6-924961531893,,released,Fluorouracil,1,2020-09-27T11:30:43.095544-05:00,Chemotherapy,,
HCM-BROD-0413-C25,bea1726c-ae87-4697-8d35-06c37eee0999,da6af363-88cf-403a-9ffb-ff942c71e24b,436.0,Adjuvant,370.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0413-C25_treatment7,3927d443-ba77-4b14-8283-1443f1d1523f,,released,Nab-paclitaxel,1,2020-09-27T11:30:43.095544-05:00,Chemotherapy,Residual Disease,
HCM-BROD-0413-C25,bea1726c-ae87-4697-8d35-06c37eee0999,da6af363-88cf-403a-9ffb-ff942c71e24b,,Neoadjuvant,23.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0413-C25_treatment2,3d40263e-c3d7-4d6f-97f6-746af03b4270,,released,Leucovorin Calcium,1,2020-09-27T11:30:43.095544-05:00,Chemotherapy,,
HCM-BROD-0413-C25,bea1726c-ae87-4697-8d35-06c37eee0999,da6af363-88cf-403a-9ffb-ff942c71e24b,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0413-C25_treatment10,57eb5ea2-7f20-42b2-b2a7-740d9d84dab1,,released,,0,2020-09-27T11:30:43.095544-05:00,Targeted Molecular Therapy,Residual Disease,
HCM-BROD-0413-C25,bea1726c-ae87-4697-8d35-06c37eee0999,da6af363-88cf-403a-9ffb-ff942c71e24b,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0413-C25_treatment11,68525ba6-f2cd-4251-bacb-5f26e7c5cce4,,released,,0,2020-09-27T11:30:43.095544-05:00,"Radiation Therapy, NOS",Residual Disease,
HCM-BROD-0413-C25,bea1726c-ae87-4697-8d35-06c37eee0999,da6af363-88cf-403a-9ffb-ff942c71e24b,,Neoadjuvant,23.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0413-C25_treatment5,7ab979dc-f0bd-4d1d-9f05-ffae0ef85308,,released,,1,2020-09-27T11:30:43.095544-05:00,Chemotherapy,,FOLFIRINOX
HCM-BROD-0413-C25,bea1726c-ae87-4697-8d35-06c37eee0999,da6af363-88cf-403a-9ffb-ff942c71e24b,,Neoadjuvant,23.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0413-C25_treatment4,98e4b748-7e6c-4755-a03f-382150d3b681,,released,Oxaliplatin,1,2020-09-27T11:30:43.095544-05:00,Chemotherapy,,
HCM-BROD-0413-C25,bea1726c-ae87-4697-8d35-06c37eee0999,da6af363-88cf-403a-9ffb-ff942c71e24b,,Neoadjuvant,23.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0413-C25_treatment,b580fbec-e7bc-4688-921e-4e9cb4c174c3,,released,Irinotecan Hydrochloride,1,2020-09-27T11:30:43.095544-05:00,Chemotherapy,,
HCM-BROD-0413-C25,bea1726c-ae87-4697-8d35-06c37eee0999,da6af363-88cf-403a-9ffb-ff942c71e24b,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0413-C25_treatment8,de590567-7891-4bdc-9ba6-7d274aa10b71,,released,,0,2020-09-27T11:30:43.095544-05:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-BROD-0413-C25,bea1726c-ae87-4697-8d35-06c37eee0999,da6af363-88cf-403a-9ffb-ff942c71e24b,,,,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0413-C25_treatment9,e121b513-e07d-426a-a248-cb23a20cefc9,,released,,unknown,2020-09-27T11:30:43.095544-05:00,"Surgery, NOS",Initial Diagnosis,
HCM-BROD-0043-C16,bea4ff97-4e53-434e-b260-81d6aa33106d,776e5d52-b0fb-46c2-b0ac-12c23882c298,,,,2023-03-13T13:33:32.380710-05:00,HCM-BROD-0043-C16_treatment2,21c7e153-1b15-4337-aeb1-db3fa4e5c49c,,released,,0,2019-04-04T15:20:11.998625-05:00,"Surgery, NOS",Initial Diagnosis,
HCM-BROD-0043-C16,bea4ff97-4e53-434e-b260-81d6aa33106d,776e5d52-b0fb-46c2-b0ac-12c23882c298,,Adjuvant,,2023-03-13T13:33:32.380710-05:00,HCM-BROD-0043-C16_treatment4,4e4cf6e4-8ee2-4b42-9cb5-99fdbc60a337,,released,,0,2019-04-04T15:20:11.998625-05:00,"Radiation Therapy, NOS",Residual Disease,
HCM-BROD-0043-C16,bea4ff97-4e53-434e-b260-81d6aa33106d,776e5d52-b0fb-46c2-b0ac-12c23882c298,,Adjuvant,,2023-03-13T13:33:32.380710-05:00,HCM-BROD-0043-C16_treatment3,56b76ca1-6642-4a93-8747-8dbe79fdcd3e,,released,,0,2019-04-04T15:20:11.998625-05:00,"Pharmaceutical Therapy, NOS",Residual Disease,
HCM-BROD-0043-C16,bea4ff97-4e53-434e-b260-81d6aa33106d,776e5d52-b0fb-46c2-b0ac-12c23882c298,,Neoadjuvant,,2021-03-03T15:15:08.075155-06:00,HCM-BROD-0043-C16_treatment,8d1f851f-9325-45b8-b629-041eecf564e1,,released,,0,2019-04-04T15:20:11.998625-05:00,,,
HCM-BROD-0472-C34,bf1dca4b-9176-4390-9ba9-6b0bcf3ccf04,49c748de-9d9b-4224-a069-6f189369ae9c,76.0,Adjuvant,29.0,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0472-C34_treatment2,19181081-7d0d-424a-b108-f07f20026e6d,,released,Carboplatin,1,2020-09-27T11:44:52.849074-05:00,Chemotherapy,Residual Disease,
HCM-BROD-0472-C34,bf1dca4b-9176-4390-9ba9-6b0bcf3ccf04,49c748de-9d9b-4224-a069-6f189369ae9c,,Adjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0472-C34_treatment6,3a88ce38-2cad-4adf-8149-5c4a2302e30e,,released,,0,2020-09-27T11:44:52.849074-05:00,Targeted Molecular Therapy,Residual Disease,
HCM-BROD-0472-C34,bf1dca4b-9176-4390-9ba9-6b0bcf3ccf04,49c748de-9d9b-4224-a069-6f189369ae9c,,Adjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0472-C34_treatment4,5fcc779f-bd74-4555-8b2f-af5abf8f9fbf,,released,,0,2020-09-27T11:44:52.849074-05:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-BROD-0472-C34,bf1dca4b-9176-4390-9ba9-6b0bcf3ccf04,49c748de-9d9b-4224-a069-6f189369ae9c,,Neoadjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0472-C34_treatment,86bee889-a02a-4cde-9e0c-0c2ee9e5b74e,,released,,0,2020-09-27T11:44:52.849074-05:00,,,
HCM-BROD-0472-C34,bf1dca4b-9176-4390-9ba9-6b0bcf3ccf04,49c748de-9d9b-4224-a069-6f189369ae9c,,,,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0472-C34_treatment5,da592f71-00bd-4c8f-9a13-2d2410d76623,,released,,0,2020-09-27T11:44:52.849074-05:00,"Surgery, NOS",Initial Diagnosis,
HCM-BROD-0472-C34,bf1dca4b-9176-4390-9ba9-6b0bcf3ccf04,49c748de-9d9b-4224-a069-6f189369ae9c,48.0,Adjuvant,43.0,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0472-C34_treatment7,f8d8f7ac-8641-4bb9-b0a6-869a3d3fd644,,released,,1,2020-09-27T11:44:52.849074-05:00,"Radiation, 2D Conventional",Residual Disease,
HCM-BROD-0472-C34,bf1dca4b-9176-4390-9ba9-6b0bcf3ccf04,49c748de-9d9b-4224-a069-6f189369ae9c,76.0,Adjuvant,29.0,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0472-C34_treatment3,fdc4f648-91b6-4bed-8814-6eb9484cc2b8,,released,Pemetrexed,1,2020-09-27T11:44:52.849074-05:00,Chemotherapy,Residual Disease,
HCM-BROD-0955-C15,bf369dae-eb71-46f7-8e5b-196b1ebcc168,4cd9f7ae-a578-449c-9c60-235e031e811c,80.0,Maintenance Therapy,24.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0955-C15_treatment10,50c6bcf3-d158-43e1-99ce-41f7fd0d0219,Progressive Disease,released,Capmatinib,1,2021-12-21T13:58:33.827628-06:00,,,
HCM-BROD-0955-C15,bf369dae-eb71-46f7-8e5b-196b1ebcc168,4cd9f7ae-a578-449c-9c60-235e031e811c,80.0,Maintenance Therapy,24.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0955-C15_treatment8,5a8dcf3e-ed1c-46ec-b4da-52a64db87673,Progressive Disease,released,Fluorouracil,1,2021-12-21T13:58:33.827628-06:00,,,
HCM-BROD-0955-C15,bf369dae-eb71-46f7-8e5b-196b1ebcc168,4cd9f7ae-a578-449c-9c60-235e031e811c,80.0,Maintenance Therapy,24.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0955-C15_treatment9,6a20dd6c-df64-4c91-bc97-877d8f21dbb0,Progressive Disease,released,Ramucirumab,1,2021-12-21T13:58:33.827628-06:00,,,
HCM-BROD-0955-C15,bf369dae-eb71-46f7-8e5b-196b1ebcc168,4cd9f7ae-a578-449c-9c60-235e031e811c,80.0,Maintenance Therapy,24.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0955-C15_treatment7,700975b1-7ca7-4598-bcb0-30471cf7740b,Progressive Disease,released,Leucovorin Calcium,1,2023-02-28T13:09:27.089187-06:00,,,
HCM-BROD-0955-C15,bf369dae-eb71-46f7-8e5b-196b1ebcc168,4cd9f7ae-a578-449c-9c60-235e031e811c,80.0,Maintenance Therapy,24.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0955-C15_treatment11,72ef8fcf-4821-4cf6-9a94-8eca099ef765,Progressive Disease,released,,1,2021-12-21T13:58:33.827628-06:00,,,FOLFOX
HCM-BROD-0955-C15,bf369dae-eb71-46f7-8e5b-196b1ebcc168,4cd9f7ae-a578-449c-9c60-235e031e811c,80.0,Maintenance Therapy,24.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0955-C15_treatment6,99e4828b-ba75-403f-8298-9a191b199665,Progressive Disease,released,Paclitaxel,1,2023-02-28T13:09:27.089187-06:00,,,
HCM-BROD-0955-C15,bf369dae-eb71-46f7-8e5b-196b1ebcc168,4cd9f7ae-a578-449c-9c60-235e031e811c,80.0,Maintenance Therapy,24.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0955-C15_treatment5,ae030512-6627-46b2-ae7c-17655ba04fe8,Progressive Disease,released,Oxaliplatin,1,2023-02-28T13:09:27.089187-06:00,,,
HCM-BROD-0955-C15,bf369dae-eb71-46f7-8e5b-196b1ebcc168,bf62c7f4-82c9-4b56-8623-c80374215ff0,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0955-C15_treatment3,279769e2-6fa9-45ce-a4f8-3c7a4d195643,,released,,0,2021-12-21T13:58:33.827628-06:00,"Pharmaceutical Therapy, NOS",Residual Disease,
HCM-BROD-0955-C15,bf369dae-eb71-46f7-8e5b-196b1ebcc168,bf62c7f4-82c9-4b56-8623-c80374215ff0,,Neoadjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0955-C15_treatment,52dcbeb2-b15e-4bc0-af41-e0c2b6dbc923,,released,,0,2021-12-21T13:58:33.827628-06:00,,,
HCM-BROD-0955-C15,bf369dae-eb71-46f7-8e5b-196b1ebcc168,bf62c7f4-82c9-4b56-8623-c80374215ff0,,,,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0955-C15_treatment2,c93a2a32-22d9-4033-9dbd-af68cc5f91d4,,released,,0,2021-12-21T13:58:33.827628-06:00,"Surgery, NOS",Initial Diagnosis,
HCM-BROD-0955-C15,bf369dae-eb71-46f7-8e5b-196b1ebcc168,bf62c7f4-82c9-4b56-8623-c80374215ff0,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0955-C15_treatment4,f1f4d82d-45c9-445f-aabc-6fb942c6bbb5,,released,,0,2021-12-21T13:58:33.827628-06:00,"Radiation Therapy, NOS",Residual Disease,
HCM-CSHL-0606-C17,bf582b38-0592-4076-bd3e-900d06d7d8a8,c3743908-e078-4b20-9d2e-04bd476d1e9f,,Adjuvant,,2023-07-13T10:35:44.371881-05:00,HCM-CSHL-0606-C17_treatment8,17e7217b-761a-462b-b21e-0edf5d7970dd,,released,,0,2021-12-21T14:09:46.673449-06:00,"Radiation Therapy, NOS",Residual Disease,
HCM-CSHL-0606-C17,bf582b38-0592-4076-bd3e-900d06d7d8a8,c3743908-e078-4b20-9d2e-04bd476d1e9f,,Adjuvant,,2023-07-13T10:35:44.371881-05:00,HCM-CSHL-0606-C17_treatment4,18b9c338-46e0-4383-9d49-f4acb4d12f4d,,released,,0,2021-12-21T14:09:46.673449-06:00,Hormone Therapy,Residual Disease,
HCM-CSHL-0606-C17,bf582b38-0592-4076-bd3e-900d06d7d8a8,c3743908-e078-4b20-9d2e-04bd476d1e9f,204.0,Adjuvant,56.0,2023-07-13T10:35:44.371881-05:00,HCM-CSHL-0606-C17_treatment3,21f209f2-d561-4630-bab3-9e0f6016f418,,released,Capecitabine,1,2021-12-21T14:09:46.673449-06:00,Chemotherapy,Residual Disease,
HCM-CSHL-0606-C17,bf582b38-0592-4076-bd3e-900d06d7d8a8,c3743908-e078-4b20-9d2e-04bd476d1e9f,,,-6.0,2023-07-13T10:35:44.371881-05:00,HCM-CSHL-0606-C17_treatment6,57125674-cccc-400a-a446-3409a59f76a1,,released,,1,2021-12-21T14:09:46.673449-06:00,"Surgery, NOS",Initial Diagnosis,
HCM-CSHL-0606-C17,bf582b38-0592-4076-bd3e-900d06d7d8a8,c3743908-e078-4b20-9d2e-04bd476d1e9f,,Neoadjuvant,,2023-07-13T10:35:44.371881-05:00,HCM-CSHL-0606-C17_treatment,5a85ca2d-5e71-4bd7-b634-0d46fa72c001,,released,,0,2021-12-21T14:09:46.673449-06:00,,,
HCM-CSHL-0606-C17,bf582b38-0592-4076-bd3e-900d06d7d8a8,c3743908-e078-4b20-9d2e-04bd476d1e9f,,Adjuvant,,2023-07-13T10:35:44.371881-05:00,HCM-CSHL-0606-C17_treatment5,bca40079-fb47-4d1b-b706-d80a5f5f05ba,,released,,0,2021-12-21T14:09:46.673449-06:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-CSHL-0606-C17,bf582b38-0592-4076-bd3e-900d06d7d8a8,c3743908-e078-4b20-9d2e-04bd476d1e9f,,Adjuvant,,2023-07-13T10:35:44.371881-05:00,HCM-CSHL-0606-C17_treatment7,c8b5e081-ed4a-4910-b408-4a2a307613e2,,released,,0,2021-12-21T14:09:46.673449-06:00,Targeted Molecular Therapy,Residual Disease,
HCM-CSHL-0606-C17,bf582b38-0592-4076-bd3e-900d06d7d8a8,c3743908-e078-4b20-9d2e-04bd476d1e9f,204.0,Adjuvant,56.0,2023-07-13T10:35:44.371881-05:00,HCM-CSHL-0606-C17_treatment2,e01c8e1c-e56e-4f81-974a-7b2218ce8082,,released,Oxaliplatin,1,2021-12-21T14:09:46.673449-06:00,Chemotherapy,Residual Disease,
HCM-SANG-1083-C16,bf87fe29-de9d-437b-925f-2da57830070c,dfb44a9a-e701-45a9-8890-9746e221ccf2,,Neoadjuvant,92.0,2025-03-31T16:34:59.906497-05:00,HCM-SANG-1083-C16_treatment3,6c6e31a3-99de-40e5-b68c-1d160fcd3096,,released,Docetaxel,1,2023-02-27T12:29:28.834927-06:00,Chemotherapy,,
HCM-SANG-1083-C16,bf87fe29-de9d-437b-925f-2da57830070c,dfb44a9a-e701-45a9-8890-9746e221ccf2,,Neoadjuvant,92.0,2025-03-31T16:34:59.906497-05:00,HCM-SANG-1083-C16_treatment,7b59e269-413f-4c81-b848-d42dea9c32c3,,released,Leucovorin,1,2023-02-27T12:29:28.834927-06:00,Chemotherapy,,
HCM-SANG-1083-C16,bf87fe29-de9d-437b-925f-2da57830070c,dfb44a9a-e701-45a9-8890-9746e221ccf2,,Neoadjuvant,92.0,2025-03-31T16:34:59.906497-05:00,HCM-SANG-1083-C16_treatment2,a8d3c4f9-0a8c-4ea6-8344-f58b62b33947,,released,Fluorouracil,1,2023-02-27T12:29:28.834927-06:00,Chemotherapy,,
HCM-SANG-1083-C16,bf87fe29-de9d-437b-925f-2da57830070c,dfb44a9a-e701-45a9-8890-9746e221ccf2,,Neoadjuvant,92.0,2025-03-31T16:34:59.906497-05:00,HCM-SANG-1083-C16_treatment4,e7a379cc-a021-4537-bc51-f210b100fd60,,released,Oxaliplatin,1,2023-02-27T12:29:28.834927-06:00,Chemotherapy,,
HCM-CSHL-0056-C18,bfe15f44-e1dd-46ed-b429-908822d0a781,000db971-fd42-4030-ac42-e606531ec9d0,,Neoadjuvant,,2020-10-20T19:20:06.800740-05:00,HCM-CSHL-0056-C18_treatment,452b4591-3fe0-4a11-ace2-1054a233d2d4,,released,,0,2020-02-27T12:37:46.290948-06:00,,,
HCM-CSHL-0056-C18,bfe15f44-e1dd-46ed-b429-908822d0a781,000db971-fd42-4030-ac42-e606531ec9d0,,Adjuvant,,2023-03-13T13:26:25.157213-05:00,HCM-CSHL-0056-C18_treatment4,acc3f317-ce21-44cc-ba40-f71a5a2fa992,,released,,unknown,2020-02-27T12:37:46.290948-06:00,"Radiation Therapy, NOS",Residual Disease,
HCM-CSHL-0056-C18,bfe15f44-e1dd-46ed-b429-908822d0a781,000db971-fd42-4030-ac42-e606531ec9d0,,Adjuvant,,2023-03-13T13:26:25.157213-05:00,HCM-CSHL-0056-C18_treatment3,b3051254-f109-4018-9dd8-100f7950e838,,released,,unknown,2020-02-27T12:37:46.290948-06:00,"Pharmaceutical Therapy, NOS",Residual Disease,
HCM-CSHL-0056-C18,bfe15f44-e1dd-46ed-b429-908822d0a781,000db971-fd42-4030-ac42-e606531ec9d0,,,50.0,2023-03-13T13:26:25.157213-05:00,HCM-CSHL-0056-C18_treatment2,c934b5ea-03e3-47fd-8ea9-cb7b8dfdbea7,,released,,1,2020-02-27T12:37:46.290948-06:00,"Surgery, NOS",Initial Diagnosis,
HCM-CSHL-0820-C34,c045ba6f-3078-4dbd-9163-5ccd75cc1259,03280498-0125-48d7-b2a0-d972a14717c6,,Maintenance Therapy,,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0820-C34_treatment7,a29078c0-247c-45b6-b8c2-1af7fc1ef44a,Treatment Ongoing,released,Carboplatin,1,2021-12-21T14:29:36.487318-06:00,,,
HCM-CSHL-0820-C34,c045ba6f-3078-4dbd-9163-5ccd75cc1259,03280498-0125-48d7-b2a0-d972a14717c6,,Maintenance Therapy,,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0820-C34_treatment9,b4d53081-09e3-4a4f-8ef2-ed5669ab0365,Treatment Ongoing,released,Erlotinib,1,2021-12-21T14:29:36.487318-06:00,,,
HCM-CSHL-0820-C34,c045ba6f-3078-4dbd-9163-5ccd75cc1259,03280498-0125-48d7-b2a0-d972a14717c6,,Maintenance Therapy,,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0820-C34_treatment8,cb44bc97-b741-4e63-a26b-eca239e7721b,Treatment Ongoing,released,Paclitaxel,1,2021-12-21T14:29:36.487318-06:00,,,
HCM-CSHL-0820-C34,c045ba6f-3078-4dbd-9163-5ccd75cc1259,c2c0b9be-2726-4dbe-98a1-1a58bc5fd839,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0820-C34_treatment2,2a46d8f5-c058-4a0d-be83-df53e4353ac8,,released,,0,2021-12-21T14:29:36.487318-06:00,Chemotherapy,Residual Disease,
HCM-CSHL-0820-C34,c045ba6f-3078-4dbd-9163-5ccd75cc1259,c2c0b9be-2726-4dbe-98a1-1a58bc5fd839,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0820-C34_treatment3,410e9781-ddc6-42c4-bb8f-dc5a67553fd9,,released,,0,2021-12-21T14:29:36.487318-06:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-CSHL-0820-C34,c045ba6f-3078-4dbd-9163-5ccd75cc1259,c2c0b9be-2726-4dbe-98a1-1a58bc5fd839,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0820-C34_treatment6,759b86cb-66a8-492c-b404-c9316f178197,,released,,0,2021-12-21T14:29:36.487318-06:00,"Radiation Therapy, NOS",Residual Disease,
HCM-CSHL-0820-C34,c045ba6f-3078-4dbd-9163-5ccd75cc1259,c2c0b9be-2726-4dbe-98a1-1a58bc5fd839,,,620.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0820-C34_treatment4,9006043c-7cd9-490e-9f88-c3c539a3e83b,,released,,1,2021-12-21T14:29:36.487318-06:00,"Surgery, NOS",Initial Diagnosis,
HCM-CSHL-0820-C34,c045ba6f-3078-4dbd-9163-5ccd75cc1259,c2c0b9be-2726-4dbe-98a1-1a58bc5fd839,,Neoadjuvant,63.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0820-C34_treatment,9e40cb68-6930-45e8-b081-cea97f9ccc8f,,released,,1,2021-12-21T14:29:36.487318-06:00,"Radiation, 2D Conventional",,
HCM-CSHL-0820-C34,c045ba6f-3078-4dbd-9163-5ccd75cc1259,c2c0b9be-2726-4dbe-98a1-1a58bc5fd839,,Adjuvant,643.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0820-C34_treatment5,a6298990-b413-4170-a7b8-821e62fd8fdb,Treatment Ongoing,released,Erlotinib,1,2021-12-21T14:29:36.487318-06:00,Targeted Molecular Therapy,Residual Disease,
HCM-CSHL-0178-C25,c04e722d-67a3-40ad-af5d-858b6eab0f6a,85afd906-a960-497a-a7cd-93ec89371c91,,Adjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0178-C25_treatment5,5b2b3e05-5aac-44a4-a97f-21a7330293e6,,released,,0,2020-09-28T09:13:17.218745-05:00,Targeted Molecular Therapy,Residual Disease,
HCM-CSHL-0178-C25,c04e722d-67a3-40ad-af5d-858b6eab0f6a,85afd906-a960-497a-a7cd-93ec89371c91,,,-8.0,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0178-C25_treatment4,5da7a4ed-ca2d-437d-b801-4d1ceb35ec4c,,released,,1,2020-09-28T09:13:17.218745-05:00,"Surgery, NOS",Initial Diagnosis,
HCM-CSHL-0178-C25,c04e722d-67a3-40ad-af5d-858b6eab0f6a,85afd906-a960-497a-a7cd-93ec89371c91,,Adjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0178-C25_treatment3,8a92b9fb-05df-45fb-9362-b0d8b359d71d,,released,,0,2020-09-28T09:13:17.218745-05:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-CSHL-0178-C25,c04e722d-67a3-40ad-af5d-858b6eab0f6a,85afd906-a960-497a-a7cd-93ec89371c91,,Neoadjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0178-C25_treatment,a29d1ade-b12c-49cc-81b9-1473b1f80022,,released,,0,2020-09-28T09:13:17.218745-05:00,,,
HCM-CSHL-0178-C25,c04e722d-67a3-40ad-af5d-858b6eab0f6a,85afd906-a960-497a-a7cd-93ec89371c91,,Adjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0178-C25_treatment6,e8623b22-e991-40e0-bdd2-de5c2efaca92,,released,,0,2020-09-28T09:13:17.218745-05:00,"Radiation Therapy, NOS",Residual Disease,
HCM-CSHL-0178-C25,c04e722d-67a3-40ad-af5d-858b6eab0f6a,85afd906-a960-497a-a7cd-93ec89371c91,,Adjuvant,47.0,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0178-C25_treatment2,f6c47165-e468-43e9-a70d-0b4b301b881d,,released,Gemcitabine,1,2020-09-28T09:13:17.218745-05:00,Chemotherapy,Residual Disease,
HCM-WCMC-0749-C34,c14d7245-1a9c-45cf-b284-8f49c3fe2ec9,65917837-b46b-46ca-97a2-e8007e514f0f,,Adjuvant,,2023-11-07T14:20:00.017270-06:00,HCM-WCMC-0749-C34_treatment3,3e575f83-2ece-4761-a93c-4351e7330df4,,released,,0,2023-02-27T12:53:43.965698-06:00,"Pharmaceutical Therapy, NOS",Residual Disease,
HCM-WCMC-0749-C34,c14d7245-1a9c-45cf-b284-8f49c3fe2ec9,65917837-b46b-46ca-97a2-e8007e514f0f,,Neoadjuvant,,2023-11-07T14:20:00.017270-06:00,HCM-WCMC-0749-C34_treatment,4a98d4f7-9e64-4068-a71d-d5039dc71cfd,,released,,0,2023-02-27T12:53:43.965698-06:00,,,
HCM-WCMC-0749-C34,c14d7245-1a9c-45cf-b284-8f49c3fe2ec9,65917837-b46b-46ca-97a2-e8007e514f0f,,,262.0,2023-11-07T14:20:00.017270-06:00,HCM-WCMC-0749-C34_treatment2,7040a381-2dd5-4148-9ede-ea40ed3577e4,,released,,1,2023-02-27T12:53:43.965698-06:00,"Surgery, NOS",Initial Diagnosis,
HCM-WCMC-0749-C34,c14d7245-1a9c-45cf-b284-8f49c3fe2ec9,65917837-b46b-46ca-97a2-e8007e514f0f,,Adjuvant,,2023-11-07T14:20:00.017270-06:00,HCM-WCMC-0749-C34_treatment4,c25e158f-c76d-4d27-a362-8054b6c97db0,,released,,0,2023-02-27T12:53:43.965698-06:00,"Radiation Therapy, NOS",Residual Disease,
HCM-CSHL-1096-C44,c156af60-87f6-496a-b847-33ed9c51ac18,5aba16f9-fdd0-4631-94eb-c966ac6766b2,,,363.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-1096-C44_treatment5,14e95d95-87e6-400e-bf59-87ecb53da024,,released,,1,2021-12-21T14:38:56.979805-06:00,"Surgery, NOS",Initial Diagnosis,
HCM-CSHL-1096-C44,c156af60-87f6-496a-b847-33ed9c51ac18,5aba16f9-fdd0-4631-94eb-c966ac6766b2,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-1096-C44_treatment2,5694987c-57f3-46bb-9f32-04ea35f848bb,,released,,0,2021-12-21T14:38:56.979805-06:00,Chemotherapy,Residual Disease,
HCM-CSHL-1096-C44,c156af60-87f6-496a-b847-33ed9c51ac18,5aba16f9-fdd0-4631-94eb-c966ac6766b2,,Neoadjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-1096-C44_treatment,745a7a12-b151-472a-aadf-48360b2eb56d,,released,,0,2021-12-21T14:38:56.979805-06:00,,,
HCM-CSHL-1096-C44,c156af60-87f6-496a-b847-33ed9c51ac18,5aba16f9-fdd0-4631-94eb-c966ac6766b2,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-1096-C44_treatment3,984101d8-7820-4f21-ac06-b1c0bf31764d,,released,,0,2021-12-21T14:38:56.979805-06:00,Hormone Therapy,Residual Disease,
HCM-CSHL-1096-C44,c156af60-87f6-496a-b847-33ed9c51ac18,5aba16f9-fdd0-4631-94eb-c966ac6766b2,106.0,Adjuvant,56.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-1096-C44_treatment8,a1f5a23d-be76-46ab-b63b-9aa63191f3be,,released,,1,2021-12-21T14:38:56.979805-06:00,"Radiation, Intensity-Modulated Radiotherapy",Residual Disease,
HCM-CSHL-1096-C44,c156af60-87f6-496a-b847-33ed9c51ac18,5aba16f9-fdd0-4631-94eb-c966ac6766b2,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-1096-C44_treatment4,c8532081-70d6-4933-9e1d-1e137d195e6f,,released,,0,2021-12-21T14:38:56.979805-06:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-CSHL-1096-C44,c156af60-87f6-496a-b847-33ed9c51ac18,5aba16f9-fdd0-4631-94eb-c966ac6766b2,,,0.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-1096-C44_treatment6,ddddaaa2-99a4-4b7e-bdee-e98b667edb10,,released,,1,2021-12-21T14:38:56.979805-06:00,"Surgery, NOS",Initial Diagnosis,
HCM-CSHL-1096-C44,c156af60-87f6-496a-b847-33ed9c51ac18,5aba16f9-fdd0-4631-94eb-c966ac6766b2,252.0,Adjuvant,231.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-1096-C44_treatment7,fec59f44-ce81-47f5-be07-24643a65d941,Treatment Ongoing,released,Pembrolizumab,1,2021-12-21T14:38:56.979805-06:00,Targeted Molecular Therapy,Residual Disease,
HCM-BROD-1128-C15,c17e8249-b8d4-4d88-b0f3-d27aeb6a15a4,16016586-44fb-4602-ad7e-80e8e57111d8,253.0,Maintenance Therapy,29.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-1128-C15_treatment11,08098f71-8232-4c9b-b922-6e2a1cec50ca,Progressive Disease,released,Fluorouracil,1,2021-12-21T14:02:12.322064-06:00,,,
HCM-BROD-1128-C15,c17e8249-b8d4-4d88-b0f3-d27aeb6a15a4,16016586-44fb-4602-ad7e-80e8e57111d8,253.0,Maintenance Therapy,29.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-1128-C15_treatment10,26aa25a0-0166-4476-9af7-3bd1aebfd883,Progressive Disease,released,Leucovorin Calcium,1,2021-12-21T14:02:12.322064-06:00,,,
HCM-BROD-1128-C15,c17e8249-b8d4-4d88-b0f3-d27aeb6a15a4,16016586-44fb-4602-ad7e-80e8e57111d8,253.0,Maintenance Therapy,29.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-1128-C15_treatment8,4df6ec92-4728-42ed-8793-fd4ca9f6146e,Progressive Disease,released,Paclitaxel,1,2021-12-21T14:02:12.322064-06:00,,,
HCM-BROD-1128-C15,c17e8249-b8d4-4d88-b0f3-d27aeb6a15a4,16016586-44fb-4602-ad7e-80e8e57111d8,253.0,Maintenance Therapy,29.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-1128-C15_treatment12,6825f2e0-3a6d-4445-99b5-6d8c428a6615,Progressive Disease,released,,1,2021-12-21T14:02:12.322064-06:00,,,FOLFOX
HCM-BROD-1128-C15,c17e8249-b8d4-4d88-b0f3-d27aeb6a15a4,16016586-44fb-4602-ad7e-80e8e57111d8,253.0,Maintenance Therapy,29.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-1128-C15_treatment9,b5a251cb-eecd-4a7c-b29c-b5ad6d120ec7,Progressive Disease,released,Carboplatin,1,2021-12-21T14:02:12.322064-06:00,,,
HCM-BROD-1128-C15,c17e8249-b8d4-4d88-b0f3-d27aeb6a15a4,16016586-44fb-4602-ad7e-80e8e57111d8,253.0,Maintenance Therapy,29.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-1128-C15_treatment7,cc4cd813-93a4-4da8-a0c5-bd2280516a00,Progressive Disease,released,Oxaliplatin,1,2021-12-21T14:02:12.322064-06:00,,,
HCM-BROD-1128-C15,c17e8249-b8d4-4d88-b0f3-d27aeb6a15a4,95dbc5ad-3a9c-44ab-b9ab-c181b88876f0,303.0,Adjuvant,262.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-1128-C15_treatment5,08b6d52a-2e70-4517-8e0b-ae18124ed62b,Treatment Ongoing,released,Ramucirumab,1,2021-12-21T14:02:12.322064-06:00,Targeted Molecular Therapy,Residual Disease,
HCM-BROD-1128-C15,c17e8249-b8d4-4d88-b0f3-d27aeb6a15a4,95dbc5ad-3a9c-44ab-b9ab-c181b88876f0,,Neoadjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-BROD-1128-C15_treatment,0a10d3e7-0cfe-47cd-809f-8b516078a395,,released,,0,2021-12-21T14:02:12.322064-06:00,,,
HCM-BROD-1128-C15,c17e8249-b8d4-4d88-b0f3-d27aeb6a15a4,95dbc5ad-3a9c-44ab-b9ab-c181b88876f0,303.0,Adjuvant,262.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-1128-C15_treatment2,4b8fe689-9339-4aea-9caa-cc023b725000,Treatment Ongoing,released,Paclitaxel,1,2021-12-21T14:02:12.322064-06:00,Chemotherapy,Residual Disease,
HCM-BROD-1128-C15,c17e8249-b8d4-4d88-b0f3-d27aeb6a15a4,95dbc5ad-3a9c-44ab-b9ab-c181b88876f0,,,0.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-1128-C15_treatment4,7e00d075-221d-488f-8b33-fb62328660de,,released,,1,2021-12-21T14:02:12.322064-06:00,"Surgery, NOS",Initial Diagnosis,
HCM-BROD-1128-C15,c17e8249-b8d4-4d88-b0f3-d27aeb6a15a4,95dbc5ad-3a9c-44ab-b9ab-c181b88876f0,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-BROD-1128-C15_treatment3,a932cc25-57aa-4a7d-bc06-ca30189ccf5e,,released,,0,2021-12-21T14:02:12.322064-06:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-BROD-1128-C15,c17e8249-b8d4-4d88-b0f3-d27aeb6a15a4,95dbc5ad-3a9c-44ab-b9ab-c181b88876f0,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-BROD-1128-C15_treatment6,ad061db2-98ae-45c8-accf-717db963a761,,released,,0,2021-12-21T14:02:12.322064-06:00,"Radiation Therapy, NOS",Residual Disease,
HCM-CSHL-0187-C25,c229960d-31f7-43d2-9bb5-599c1dd88350,8506d541-bf9c-4eef-ae04-b0bae0dd6266,408.0,Adjuvant,204.0,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0187-C25_treatment3,0ca6b63d-ac8e-4b58-b56f-8aad58a31fc9,,released,Nab-paclitaxel,1,2020-09-28T09:15:42.250618-05:00,Chemotherapy,Residual Disease,
HCM-CSHL-0187-C25,c229960d-31f7-43d2-9bb5-599c1dd88350,8506d541-bf9c-4eef-ae04-b0bae0dd6266,,Neoadjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0187-C25_treatment,3c7dd566-eeba-4d02-aeb2-9504777706af,,released,,0,2020-09-28T09:15:42.250618-05:00,,,
HCM-CSHL-0187-C25,c229960d-31f7-43d2-9bb5-599c1dd88350,8506d541-bf9c-4eef-ae04-b0bae0dd6266,,Adjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0187-C25_treatment4,75603701-cb1b-4e8f-b1e7-a1ca2a6a864b,,released,,0,2020-09-28T09:15:42.250618-05:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-CSHL-0187-C25,c229960d-31f7-43d2-9bb5-599c1dd88350,8506d541-bf9c-4eef-ae04-b0bae0dd6266,,Adjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0187-C25_treatment7,8ac7291a-a02b-44bf-887a-76ca161b882d,,released,,0,2020-09-28T09:15:42.250618-05:00,"Radiation Therapy, NOS",Residual Disease,
HCM-CSHL-0187-C25,c229960d-31f7-43d2-9bb5-599c1dd88350,8506d541-bf9c-4eef-ae04-b0bae0dd6266,,Adjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0187-C25_treatment6,8e806520-af67-498c-b1ca-7ccbaac4e307,,released,,0,2020-09-28T09:15:42.250618-05:00,Targeted Molecular Therapy,Residual Disease,
HCM-CSHL-0187-C25,c229960d-31f7-43d2-9bb5-599c1dd88350,8506d541-bf9c-4eef-ae04-b0bae0dd6266,,,-12.0,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0187-C25_treatment5,b1c2cafa-03d9-4b3b-b7fc-1d997450287e,,released,,1,2020-09-28T09:15:42.250618-05:00,"Surgery, NOS",Initial Diagnosis,
HCM-CSHL-0187-C25,c229960d-31f7-43d2-9bb5-599c1dd88350,8506d541-bf9c-4eef-ae04-b0bae0dd6266,408.0,Adjuvant,204.0,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0187-C25_treatment2,b8077894-d86f-48d8-a479-bec0dd3fbc47,,released,Gemcitabine,1,2020-09-28T09:15:42.250618-05:00,Chemotherapy,Residual Disease,
HCM-BROD-0118-C16,c297718c-1d40-439a-a5de-09c5eb5ccea9,1c3d2a59-938a-49f4-a900-844b8e69b777,301.0,Adjuvant,257.0,2021-03-03T15:15:08.075155-06:00,HCM-BROD-0118-C16_treatment2,0ee1101c-8171-44b4-b459-f2a5594ec1f1,,released,Irinotecan,1,2020-02-27T12:32:17.917166-06:00,Chemotherapy,Residual Disease,
HCM-BROD-0118-C16,c297718c-1d40-439a-a5de-09c5eb5ccea9,1c3d2a59-938a-49f4-a900-844b8e69b777,,,,2023-02-27T11:53:07.344239-06:00,HCM-BROD-0118-C16_treatment4,7bd8581a-4008-4ca8-b5b1-1df6982cd03d,,released,,0,2020-02-27T12:32:17.917166-06:00,"Surgery, NOS",Initial Diagnosis,
HCM-BROD-0118-C16,c297718c-1d40-439a-a5de-09c5eb5ccea9,1c3d2a59-938a-49f4-a900-844b8e69b777,,Adjuvant,,2021-03-03T15:15:08.075155-06:00,HCM-BROD-0118-C16_treatment6,9e0a46d6-4f83-4353-8249-82e3c7611900,,released,,0,2020-02-27T12:32:17.917166-06:00,"Radiation Therapy, NOS",Residual Disease,
HCM-BROD-0118-C16,c297718c-1d40-439a-a5de-09c5eb5ccea9,1c3d2a59-938a-49f4-a900-844b8e69b777,,Adjuvant,,2021-03-03T15:15:08.075155-06:00,HCM-BROD-0118-C16_treatment3,b07ba21d-19b1-44cb-a461-c9f185fbdc87,,released,,0,2020-02-27T12:32:17.917166-06:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-BROD-0118-C16,c297718c-1d40-439a-a5de-09c5eb5ccea9,1c3d2a59-938a-49f4-a900-844b8e69b777,301.0,Adjuvant,257.0,2021-03-03T15:15:08.075155-06:00,HCM-BROD-0118-C16_treatment5,d8bb2a53-4453-4855-b10a-4b3d9ffb1dde,,released,Trastuzumab,1,2020-02-27T12:32:17.917166-06:00,Targeted Molecular Therapy,Residual Disease,
HCM-BROD-0118-C16,c297718c-1d40-439a-a5de-09c5eb5ccea9,1c3d2a59-938a-49f4-a900-844b8e69b777,,Neoadjuvant,,2021-03-03T15:15:08.075155-06:00,HCM-BROD-0118-C16_treatment,daf08382-bb26-4100-b56f-c736b980e4be,,released,,1,2019-04-04T15:25:23.174159-05:00,Chemotherapy,,
HCM-SANG-0314-C15,c2db7ccf-6c5e-424f-bc0e-a27a319622ab,d0791cfd-4784-42c2-a2ef-5567b55e86fa,,Neoadjuvant,100.0,2025-03-31T16:34:59.906497-05:00,HCM-SANG-0314-C15_treatment3,02534a08-6c22-493c-86c8-9a3c6e92aec2,,released,Cisplatin,1,2021-12-21T15:11:39.089560-06:00,Chemotherapy,,
HCM-SANG-0314-C15,c2db7ccf-6c5e-424f-bc0e-a27a319622ab,d0791cfd-4784-42c2-a2ef-5567b55e86fa,,Neoadjuvant,100.0,2025-03-31T16:34:59.906497-05:00,HCM-SANG-0314-C15_treatment4,1296d385-b9af-4483-94dd-dfebbd22a1f7,,released,,1,2021-12-21T15:11:39.089560-06:00,Chemotherapy,,ECX
HCM-SANG-0314-C15,c2db7ccf-6c5e-424f-bc0e-a27a319622ab,d0791cfd-4784-42c2-a2ef-5567b55e86fa,,Neoadjuvant,100.0,2025-03-31T16:34:59.906497-05:00,HCM-SANG-0314-C15_treatment,852de895-8a68-4828-b294-6d921d8e8199,,released,Epirubicin,1,2021-12-21T15:11:39.089560-06:00,Chemotherapy,,
HCM-SANG-0314-C15,c2db7ccf-6c5e-424f-bc0e-a27a319622ab,d0791cfd-4784-42c2-a2ef-5567b55e86fa,,Neoadjuvant,100.0,2025-03-31T16:34:59.906497-05:00,HCM-SANG-0314-C15_treatment2,cebe32ff-cb85-41d1-9a8f-c4cf01d9ac01,,released,Capecitabine,1,2021-12-21T15:11:39.089560-06:00,Chemotherapy,,
HCM-CSHL-0240-C18,c2e4432f-08a8-46bf-870b-f49cda508c51,04aa9d7c-df4d-42eb-8ee3-c89ba03db8c1,,Neoadjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0240-C18_treatment,5fbbda66-f5b9-450a-9a67-6fcc85460bac,,released,,0,2020-09-28T09:20:21.028815-05:00,,,
HCM-CSHL-0240-C18,c2e4432f-08a8-46bf-870b-f49cda508c51,04aa9d7c-df4d-42eb-8ee3-c89ba03db8c1,,Adjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0240-C18_treatment3,bc860ce8-7208-4cf1-9a9f-dbe7188a888b,,released,,0,2020-09-28T09:20:21.028815-05:00,"Pharmaceutical Therapy, NOS",Residual Disease,
HCM-CSHL-0240-C18,c2e4432f-08a8-46bf-870b-f49cda508c51,04aa9d7c-df4d-42eb-8ee3-c89ba03db8c1,,Adjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0240-C18_treatment4,de327a3b-3778-4e36-a15a-b51e60ba2838,,released,,0,2020-09-28T09:20:21.028815-05:00,"Radiation Therapy, NOS",Residual Disease,
HCM-CSHL-0240-C18,c2e4432f-08a8-46bf-870b-f49cda508c51,04aa9d7c-df4d-42eb-8ee3-c89ba03db8c1,,,22.0,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0240-C18_treatment2,e57df4f0-9d8b-412a-8900-f01edfd7fa56,,released,,1,2020-09-28T09:20:21.028815-05:00,"Surgery, NOS",Initial Diagnosis,
HCM-SANG-0276-C18,c39349d1-2cde-48d8-8a20-4ec319edd0d7,fd367f78-7ec5-496e-a3a5-2c13edff2d6c,,Neoadjuvant,,2023-03-13T12:57:02.333692-05:00,HCM-SANG-0276-C18_treatment,d9d69cb3-6b34-49b1-9b73-4fe05fcbdb52,,released,,0,2020-02-11T15:52:57.509024-06:00,,,
HCM-BROD-0423-C71,c3f76e7e-661c-44fb-b0b6-3635da058fce,5c3c7784-e620-44ba-9b32-8877ece5988b,,Neoadjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0423-C71_treatment,076c699f-f8d6-4e41-bee7-4b7f6c1774b4,,released,,0,2020-09-27T11:35:01.642685-05:00,,,
HCM-BROD-0423-C71,c3f76e7e-661c-44fb-b0b6-3635da058fce,5c3c7784-e620-44ba-9b32-8877ece5988b,58.0,Adjuvant,16.0,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0423-C71_treatment2,3bf08838-2da6-4df9-969c-4d00c50448e8,,released,Temozolomide,1,2020-09-27T11:35:01.642685-05:00,Chemotherapy,Residual Disease,
HCM-BROD-0423-C71,c3f76e7e-661c-44fb-b0b6-3635da058fce,5c3c7784-e620-44ba-9b32-8877ece5988b,450.0,Adjuvant,261.0,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0423-C71_treatment6,6b24e567-1c6a-478c-84ce-d82f42f16c6c,,released,Bevacizumab,1,2020-09-27T11:35:01.642685-05:00,Targeted Molecular Therapy,Residual Disease,
HCM-BROD-0423-C71,c3f76e7e-661c-44fb-b0b6-3635da058fce,5c3c7784-e620-44ba-9b32-8877ece5988b,,,-11.0,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0423-C71_treatment5,74b581f6-79d0-4e09-909f-e81a66315441,,released,,1,2020-09-27T11:35:01.642685-05:00,"Surgery, NOS",Initial Diagnosis,
HCM-BROD-0423-C71,c3f76e7e-661c-44fb-b0b6-3635da058fce,5c3c7784-e620-44ba-9b32-8877ece5988b,183.0,Adjuvant,95.0,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0423-C71_treatment3,ab17f78b-f623-43f1-9656-d79fdaed88ed,,released,Temozolomide,1,2020-09-27T11:35:01.642685-05:00,Chemotherapy,Residual Disease,
HCM-BROD-0423-C71,c3f76e7e-661c-44fb-b0b6-3635da058fce,5c3c7784-e620-44ba-9b32-8877ece5988b,59.0,Adjuvant,16.0,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0423-C71_treatment7,cb91e636-4092-4c1e-a526-2d34a3398c79,,released,,1,2020-09-27T11:35:01.642685-05:00,"Radiation Therapy, NOS",Residual Disease,
HCM-BROD-0423-C71,c3f76e7e-661c-44fb-b0b6-3635da058fce,5c3c7784-e620-44ba-9b32-8877ece5988b,,Adjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0423-C71_treatment4,d41eabf1-547b-4186-bc63-04a0f892c46e,,released,,0,2020-09-27T11:35:01.642685-05:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-CSHL-0434-C24,c4025241-d423-4daa-b0fc-b27873d4e314,96f02d0e-0bcd-4ef7-b13a-e65b3c8824d1,,Adjuvant,,2023-03-13T12:50:23.854202-05:00,HCM-CSHL-0434-C24_treatment4,1a8b69e3-7dcf-4dd7-90d6-2fb2ebe083cb,,released,,unknown,2020-09-28T10:08:23.548874-05:00,"Radiation Therapy, NOS",Residual Disease,
HCM-CSHL-0434-C24,c4025241-d423-4daa-b0fc-b27873d4e314,96f02d0e-0bcd-4ef7-b13a-e65b3c8824d1,,Adjuvant,,2023-03-13T12:50:23.854202-05:00,HCM-CSHL-0434-C24_treatment3,36400b3e-ed80-4c5b-9852-14a150487ab9,,released,,unknown,2020-09-28T10:08:23.548874-05:00,"Pharmaceutical Therapy, NOS",Residual Disease,
HCM-CSHL-0434-C24,c4025241-d423-4daa-b0fc-b27873d4e314,96f02d0e-0bcd-4ef7-b13a-e65b3c8824d1,,,-12.0,2023-03-13T12:50:23.854202-05:00,HCM-CSHL-0434-C24_treatment2,4237d7ec-ebd8-480e-b792-d607bdbbf183,,released,,1,2020-09-28T10:08:23.548874-05:00,"Surgery, NOS",Initial Diagnosis,
HCM-CSHL-0434-C24,c4025241-d423-4daa-b0fc-b27873d4e314,96f02d0e-0bcd-4ef7-b13a-e65b3c8824d1,,Neoadjuvant,,2021-01-06T22:55:10.531130-06:00,HCM-CSHL-0434-C24_treatment,53412044-7b4a-4acf-961b-b1305d260d58,,released,,0,2020-09-28T10:08:23.548874-05:00,,,
HCM-CSHL-0237-C18,c446e9cd-f5cc-4daa-b573-b261d7ea8f42,4e9c062a-e131-49e6-a0ab-08188c4d5cb0,,Neoadjuvant,,2023-02-22T07:39:25.979291-06:00,HCM-CSHL-0237-C18_treatment,050b7c8f-83ab-44ff-a8bd-30b8e84b39e3,,released,,0,2020-09-28T09:19:52.351022-05:00,,,
HCM-CSHL-0237-C18,c446e9cd-f5cc-4daa-b573-b261d7ea8f42,4e9c062a-e131-49e6-a0ab-08188c4d5cb0,,Adjuvant,,2023-02-22T07:39:25.979291-06:00,HCM-CSHL-0237-C18_treatment5,339e1369-f4b0-4c0e-891c-5fc18741dd19,,released,,0,2020-09-28T09:19:52.351022-05:00,Targeted Molecular Therapy,Residual Disease,
HCM-CSHL-0237-C18,c446e9cd-f5cc-4daa-b573-b261d7ea8f42,4e9c062a-e131-49e6-a0ab-08188c4d5cb0,271.0,Adjuvant,94.0,2023-02-22T07:39:25.979291-06:00,HCM-CSHL-0237-C18_treatment2,3bf121aa-e252-4d93-ae18-ad4c26a8af25,,released,Capecitabine,1,2020-09-28T09:19:52.351022-05:00,Chemotherapy,Residual Disease,
HCM-CSHL-0237-C18,c446e9cd-f5cc-4daa-b573-b261d7ea8f42,4e9c062a-e131-49e6-a0ab-08188c4d5cb0,,Adjuvant,,2023-02-22T07:39:25.979291-06:00,HCM-CSHL-0237-C18_treatment6,941afdb9-6296-4147-b38c-c36cb73153fc,,released,,0,2020-09-28T09:19:52.351022-05:00,"Radiation Therapy, NOS",Residual Disease,
HCM-CSHL-0237-C18,c446e9cd-f5cc-4daa-b573-b261d7ea8f42,4e9c062a-e131-49e6-a0ab-08188c4d5cb0,,Adjuvant,,2023-02-22T07:39:25.979291-06:00,HCM-CSHL-0237-C18_treatment3,a3e767d8-1c85-4ba0-8df6-e82acf220cef,,released,,0,2020-09-28T09:19:52.351022-05:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-CSHL-0237-C18,c446e9cd-f5cc-4daa-b573-b261d7ea8f42,4e9c062a-e131-49e6-a0ab-08188c4d5cb0,,,39.0,2023-03-13T13:08:02.211009-05:00,HCM-CSHL-0237-C18_treatment4,f10e3c49-9a2e-4b36-9099-928804ab9b43,,released,,1,2020-09-28T09:19:52.351022-05:00,"Surgery, NOS",Initial Diagnosis,
HCM-CSHL-0654-C26,c5d2e21e-6987-4085-8c67-9d41630957b5,1b0ba87c-0a22-4687-9516-7fd12b5ee992,,,,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0654-C26_treatment3,166173e7-0da2-4854-8ae6-523e0a5832d3,,released,,0,2021-12-21T14:13:56.994423-06:00,"Surgery, NOS",Initial Diagnosis,
HCM-CSHL-0654-C26,c5d2e21e-6987-4085-8c67-9d41630957b5,1b0ba87c-0a22-4687-9516-7fd12b5ee992,,Neoadjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0654-C26_treatment2,1730edad-f93c-4431-af5c-631a2bd57037,,released,,unknown,2021-12-21T14:13:56.994423-06:00,"Radiation Therapy, NOS",,
HCM-CSHL-0654-C26,c5d2e21e-6987-4085-8c67-9d41630957b5,1b0ba87c-0a22-4687-9516-7fd12b5ee992,,Adjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0654-C26_treatment5,388c2994-1050-47e0-9e81-cb1bf630a1c8,,released,,unknown,2021-12-21T14:13:56.994423-06:00,"Radiation Therapy, NOS",Residual Disease,
HCM-CSHL-0654-C26,c5d2e21e-6987-4085-8c67-9d41630957b5,1b0ba87c-0a22-4687-9516-7fd12b5ee992,,Adjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0654-C26_treatment4,3a9724d3-1ca5-4fad-9a4b-9b461e9ce69a,,released,,unknown,2021-12-21T14:13:56.994423-06:00,"Pharmaceutical Therapy, NOS",Residual Disease,
HCM-CSHL-0654-C26,c5d2e21e-6987-4085-8c67-9d41630957b5,1b0ba87c-0a22-4687-9516-7fd12b5ee992,,Neoadjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0654-C26_treatment,884a0668-c493-4b00-8df1-7797f3dfe13a,,released,,unknown,2021-12-21T14:13:56.994423-06:00,"Pharmaceutical Therapy, NOS",,
HCM-CSHL-0082-C25,c5e8675b-6d0b-485c-9dd7-8bfb59b5c44a,e6b64c75-59c9-4ad1-bde4-7ac95da7f160,,Adjuvant,,2023-02-22T07:39:25.979291-06:00,HCM-CSHL-0082-C25_treatment7,070eb922-9dc9-4fd1-8c00-5660ca360584,,released,,0,2020-09-27T12:48:20.920531-05:00,Targeted Molecular Therapy,Residual Disease,
HCM-CSHL-0082-C25,c5e8675b-6d0b-485c-9dd7-8bfb59b5c44a,e6b64c75-59c9-4ad1-bde4-7ac95da7f160,,Neoadjuvant,,2023-02-22T07:39:25.979291-06:00,HCM-CSHL-0082-C25_treatment,1bcebf46-7120-4797-b953-4ca185532f56,,released,,0,2020-09-27T12:48:20.920531-05:00,,,
HCM-CSHL-0082-C25,c5e8675b-6d0b-485c-9dd7-8bfb59b5c44a,e6b64c75-59c9-4ad1-bde4-7ac95da7f160,,Adjuvant,778.0,2023-02-22T07:39:25.979291-06:00,HCM-CSHL-0082-C25_treatment3,5acc1ebd-8251-4fd3-92a9-7cb9a91e7e03,Treatment Ongoing,released,Gemcitabine,1,2020-09-27T12:48:20.920531-05:00,Chemotherapy,Residual Disease,
HCM-CSHL-0082-C25,c5e8675b-6d0b-485c-9dd7-8bfb59b5c44a,e6b64c75-59c9-4ad1-bde4-7ac95da7f160,,Adjuvant,17.0,2023-02-22T07:39:25.979291-06:00,HCM-CSHL-0082-C25_treatment2,7c84eef6-b5cd-4d49-9c5f-b5dcf488d599,,released,Gemcitabine,1,2020-09-27T12:48:20.920531-05:00,Chemotherapy,Residual Disease,
HCM-CSHL-0082-C25,c5e8675b-6d0b-485c-9dd7-8bfb59b5c44a,e6b64c75-59c9-4ad1-bde4-7ac95da7f160,,Adjuvant,,2023-02-22T07:39:25.979291-06:00,HCM-CSHL-0082-C25_treatment5,7cd8a019-a7de-4bae-bae0-42952c9dd3e4,,released,,0,2020-09-27T12:48:20.920531-05:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-CSHL-0082-C25,c5e8675b-6d0b-485c-9dd7-8bfb59b5c44a,e6b64c75-59c9-4ad1-bde4-7ac95da7f160,,,-15.0,2023-02-27T11:39:33.052635-06:00,HCM-CSHL-0082-C25_treatment6,7ff5b71d-fa55-4b8c-bac2-a006596616e3,,released,,1,2020-09-27T12:48:20.920531-05:00,"Surgery, NOS",Initial Diagnosis,
HCM-CSHL-0082-C25,c5e8675b-6d0b-485c-9dd7-8bfb59b5c44a,e6b64c75-59c9-4ad1-bde4-7ac95da7f160,,Adjuvant,778.0,2023-02-22T07:39:25.979291-06:00,HCM-CSHL-0082-C25_treatment4,d28125dc-c2aa-4d4b-ab10-5e42b3bd6f3b,Treatment Ongoing,released,Nab-paclitaxel,1,2020-09-27T12:48:20.920531-05:00,Chemotherapy,Residual Disease,
HCM-CSHL-0082-C25,c5e8675b-6d0b-485c-9dd7-8bfb59b5c44a,e6b64c75-59c9-4ad1-bde4-7ac95da7f160,,Adjuvant,,2023-02-22T07:39:25.979291-06:00,HCM-CSHL-0082-C25_treatment8,e3123a9d-85e0-46ba-91e9-6552646dfefe,,released,,0,2020-09-27T12:48:20.920531-05:00,"Radiation Therapy, NOS",Residual Disease,
HCM-CSHL-0089-C25,c5e9a845-e0ff-4612-aa8e-c310098503a7,f948667b-7daa-4316-a77d-5cfb3f2c8156,,Adjuvant,,2021-01-06T22:55:10.531130-06:00,HCM-CSHL-0089-C25_treatment9,90db9c69-67a3-4462-98c7-66622adeaeff,,released,,0,2020-11-04T16:32:28.833799-06:00,"Radiation Therapy, NOS",Residual Disease,
HCM-CSHL-0089-C25,c5e9a845-e0ff-4612-aa8e-c310098503a7,f948667b-7daa-4316-a77d-5cfb3f2c8156,,Neoadjuvant,,2020-03-26T16:04:47.706904-05:00,HCM-CSHL-0089-C25_treatment,990cf73c-6491-4530-9c96-4ebb33bcc200,,released,,0,2020-02-27T13:55:43.042019-06:00,,,
HCM-CSHL-0089-C25,c5e9a845-e0ff-4612-aa8e-c310098503a7,f948667b-7daa-4316-a77d-5cfb3f2c8156,,Adjuvant,153.0,2020-06-15T12:06:06.840898-05:00,HCM-CSHL-0089-C25_treatment4,9cef0bd3-56c6-4f24-ab0f-37348ecbfb74,,released,Fluorouracil,1,2020-02-27T13:55:43.042019-06:00,Chemotherapy,Residual Disease,
HCM-CSHL-0089-C25,c5e9a845-e0ff-4612-aa8e-c310098503a7,f948667b-7daa-4316-a77d-5cfb3f2c8156,129.0,Adjuvant,31.0,2020-03-26T16:04:47.706904-05:00,HCM-CSHL-0089-C25_treatment2,a4a7da84-bcc7-4d9d-ae1e-6c1977fbc1ce,,released,Gemcitabine,1,2020-02-27T13:55:43.042019-06:00,Chemotherapy,Residual Disease,
HCM-CSHL-0089-C25,c5e9a845-e0ff-4612-aa8e-c310098503a7,f948667b-7daa-4316-a77d-5cfb3f2c8156,,Adjuvant,,2020-11-04T16:32:28.833799-06:00,HCM-CSHL-0089-C25_treatment6,a6e88a57-8220-4838-b3e7-f5fe7155ff25,,released,,0,2020-02-27T13:55:43.042019-06:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-CSHL-0089-C25,c5e9a845-e0ff-4612-aa8e-c310098503a7,f948667b-7daa-4316-a77d-5cfb3f2c8156,,Adjuvant,153.0,2020-06-15T12:06:06.840898-05:00,HCM-CSHL-0089-C25_treatment5,acb99bfc-7b09-4bd1-81ca-d3f023a26730,,released,Irinotecan,1,2020-02-27T13:55:43.042019-06:00,Chemotherapy,Residual Disease,
HCM-CSHL-0089-C25,c5e9a845-e0ff-4612-aa8e-c310098503a7,f948667b-7daa-4316-a77d-5cfb3f2c8156,,Adjuvant,,2021-01-06T22:55:10.531130-06:00,HCM-CSHL-0089-C25_treatment8,ae8b015e-0b3b-4e8a-aa81-cab90df6faf2,,released,,0,2020-11-04T16:32:28.833799-06:00,Targeted Molecular Therapy,Residual Disease,
HCM-CSHL-0089-C25,c5e9a845-e0ff-4612-aa8e-c310098503a7,f948667b-7daa-4316-a77d-5cfb3f2c8156,129.0,Adjuvant,59.0,2020-03-26T16:04:47.706904-05:00,HCM-CSHL-0089-C25_treatment3,dd3a4e5b-8540-4836-bd4b-c1003dcbbc0c,,released,Paclitaxel,1,2020-02-27T13:55:43.042019-06:00,Chemotherapy,Residual Disease,
HCM-CSHL-0089-C25,c5e9a845-e0ff-4612-aa8e-c310098503a7,f948667b-7daa-4316-a77d-5cfb3f2c8156,,,-28.0,2023-02-27T11:53:44.591061-06:00,HCM-CSHL-0089-C25_treatment7,e249ea49-f7db-47bf-a4b5-898bed9cf4b3,,released,,1,2020-03-26T12:46:11.344349-05:00,"Surgery, NOS",Initial Diagnosis,
HCM-CSHL-0242-C18,c67a338b-394f-4108-8e78-6dbd5a5eeaec,154b2dc1-3f99-4ff5-ae0f-7f0bfcf0f17e,,Adjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0242-C18_treatment4,2ceb2336-fcd5-4e6f-bc63-570d5d4943d2,,released,,0,2020-09-28T09:25:31.191977-05:00,"Radiation Therapy, NOS",Residual Disease,
HCM-CSHL-0242-C18,c67a338b-394f-4108-8e78-6dbd5a5eeaec,154b2dc1-3f99-4ff5-ae0f-7f0bfcf0f17e,,,1.0,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0242-C18_treatment2,51a8bace-297b-42d2-9b0f-6a358de9a76d,,released,,1,2020-09-28T09:25:31.191977-05:00,"Surgery, NOS",Initial Diagnosis,
HCM-CSHL-0242-C18,c67a338b-394f-4108-8e78-6dbd5a5eeaec,154b2dc1-3f99-4ff5-ae0f-7f0bfcf0f17e,,Neoadjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0242-C18_treatment,bce9f69c-482d-423a-aea9-2ac906832c30,,released,,0,2020-09-28T09:25:31.191977-05:00,,,
HCM-CSHL-0242-C18,c67a338b-394f-4108-8e78-6dbd5a5eeaec,154b2dc1-3f99-4ff5-ae0f-7f0bfcf0f17e,,Adjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0242-C18_treatment3,d1001fd1-6f28-4c45-a58a-d7e17dad023a,,released,,0,2020-09-28T09:25:31.191977-05:00,"Pharmaceutical Therapy, NOS",Residual Disease,
HCM-SANG-0307-C15,c7343e5c-95ef-492b-a53d-44ccc9b7d6ee,637cf4a4-5028-4fe4-b0b1-78f787166f19,,Neoadjuvant,,2023-03-13T13:08:49.343936-05:00,HCM-SANG-0307-C15_treatment,266ec7ff-2188-4b1d-8c91-91824e416f65,,released,,0,2021-12-21T15:10:51.328824-06:00,,,
HCM-SANG-0274-C18,c7a011a7-e72c-4535-8367-43d07d80fb67,e722e1eb-090d-47b3-9965-c15b4318d837,,Neoadjuvant,,2023-03-13T12:43:22.171755-05:00,HCM-SANG-0274-C18_treatment,71055b73-bde7-48d4-a34a-c0548d70d847,,released,,0,2021-04-20T10:33:03.211403-05:00,,,
HCM-SANG-0291-C15,c7b268b6-2c22-4225-943f-0690b37db259,75cd9d3b-e58e-4b8c-90f2-f282e18b21b5,,Neoadjuvant,,2023-02-22T07:39:25.979291-06:00,HCM-SANG-0291-C15_treatment,590f0960-6b29-4cc1-a41d-6e78f51c7246,,released,,0,2020-02-27T12:52:16.527318-06:00,,,
HCM-BROD-0003-C71,c811d6dd-992f-435a-80ec-b282a2e38aad,7c0759eb-9a3d-4b98-8412-f156a7f04234,341.0,Adjuvant,320.0,2020-06-15T09:47:04.797727-05:00,HCM-BROD-0003-C71_treatment5,51c3bffa-ae51-4ff0-92b6-3d0277369c86,,released,Bevacizumab,1,2019-04-04T14:40:31.851849-05:00,Targeted Molecular Therapy,Residual Disease,
HCM-BROD-0003-C71,c811d6dd-992f-435a-80ec-b282a2e38aad,7c0759eb-9a3d-4b98-8412-f156a7f04234,341.0,Adjuvant,320.0,2020-06-15T09:47:04.797727-05:00,HCM-BROD-0003-C71_treatment3,64499630-5748-41cf-8f80-084be1b0a8e0,,released,Pembrolizumab,1,2019-04-04T14:40:31.851849-05:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-BROD-0003-C71,c811d6dd-992f-435a-80ec-b282a2e38aad,7c0759eb-9a3d-4b98-8412-f156a7f04234,47.0,Adjuvant,24.0,2020-01-13T20:10:25.832065-06:00,HCM-BROD-0003-C71_treatment2,6b49f4a1-8329-466f-9e99-2c8596565726,,released,Temozolomide,1,2019-04-04T14:40:31.851849-05:00,Chemotherapy,Residual Disease,
HCM-BROD-0003-C71,c811d6dd-992f-435a-80ec-b282a2e38aad,7c0759eb-9a3d-4b98-8412-f156a7f04234,,,-3.0,2023-03-13T12:43:16.596245-05:00,HCM-BROD-0003-C71_treatment4,7aadd75f-d90e-485a-8afb-4d1c8be96454,,released,,1,2019-04-04T14:40:31.851849-05:00,"Surgery, NOS",Initial Diagnosis,
HCM-BROD-0003-C71,c811d6dd-992f-435a-80ec-b282a2e38aad,7c0759eb-9a3d-4b98-8412-f156a7f04234,47.0,Adjuvant,24.0,2020-01-13T20:10:25.832065-06:00,HCM-BROD-0003-C71_treatment6,effac174-c724-4d9e-876c-bf74628e97d5,,released,,1,2019-04-04T14:40:31.851849-05:00,"Radiation Therapy, NOS",Residual Disease,
HCM-BROD-0003-C71,c811d6dd-992f-435a-80ec-b282a2e38aad,7c0759eb-9a3d-4b98-8412-f156a7f04234,,Neoadjuvant,,2020-01-13T20:10:25.832065-06:00,HCM-BROD-0003-C71_treatment,f0ba8210-997f-4272-90ce-c930e46cb943,,released,,0,2019-04-04T14:40:31.851849-05:00,,,
HCM-CSHL-0379-C18,c8f87337-a6d6-492d-943f-33207c8b40d3,cd9b2155-b63c-4635-a596-8978a233c4e3,,Adjuvant,929.0,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0379-C18_treatment2,228edd51-9bf3-4464-a09d-8943da3fb5d9,Treatment Ongoing,released,Leucovorin Calcium,1,2020-09-28T09:55:50.716360-05:00,Chemotherapy,Residual Disease,
HCM-CSHL-0379-C18,c8f87337-a6d6-492d-943f-33207c8b40d3,cd9b2155-b63c-4635-a596-8978a233c4e3,,Neoadjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0379-C18_treatment,862da968-14f6-4c35-9ff9-61d4bdd4c87b,,released,,0,2020-09-28T09:55:50.716360-05:00,,,
HCM-CSHL-0379-C18,c8f87337-a6d6-492d-943f-33207c8b40d3,cd9b2155-b63c-4635-a596-8978a233c4e3,,Adjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0379-C18_treatment10,878a268a-5c13-4688-a30e-ea0b86b36d01,,released,,0,2021-08-26T14:45:23.703807-05:00,"Radiation Therapy, NOS",Residual Disease,
HCM-CSHL-0379-C18,c8f87337-a6d6-492d-943f-33207c8b40d3,cd9b2155-b63c-4635-a596-8978a233c4e3,,,12.0,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0379-C18_treatment7,88014299-1967-4fe5-afda-5e7ebe56930a,,released,,1,2021-08-26T14:45:23.703807-05:00,"Surgery, NOS",Initial Diagnosis,
HCM-CSHL-0379-C18,c8f87337-a6d6-492d-943f-33207c8b40d3,cd9b2155-b63c-4635-a596-8978a233c4e3,,Adjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0379-C18_treatment9,92f246d7-281a-4444-b1a0-2df2db317545,,released,,0,2021-08-26T14:45:23.703807-05:00,Targeted Molecular Therapy,Residual Disease,
HCM-CSHL-0379-C18,c8f87337-a6d6-492d-943f-33207c8b40d3,cd9b2155-b63c-4635-a596-8978a233c4e3,,,860.0,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0379-C18_treatment8,9d3bc68d-6659-4a45-be6a-59d8b45e00ad,,released,,1,2021-08-26T14:45:23.703807-05:00,"Surgery, NOS",Initial Diagnosis,
HCM-CSHL-0379-C18,c8f87337-a6d6-492d-943f-33207c8b40d3,cd9b2155-b63c-4635-a596-8978a233c4e3,,Adjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0379-C18_treatment6,ac3cde2d-c503-4a16-b87b-63e61efaf815,,released,,0,2021-08-26T14:45:23.703807-05:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-CSHL-0379-C18,c8f87337-a6d6-492d-943f-33207c8b40d3,cd9b2155-b63c-4635-a596-8978a233c4e3,,Adjuvant,929.0,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0379-C18_treatment5,b2e27ca8-fd97-49bf-b365-7422b31e3589,Treatment Ongoing,released,,1,2021-08-26T14:45:23.703807-05:00,Chemotherapy,Residual Disease,FOLFOX
HCM-CSHL-0379-C18,c8f87337-a6d6-492d-943f-33207c8b40d3,cd9b2155-b63c-4635-a596-8978a233c4e3,,Adjuvant,929.0,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0379-C18_treatment4,d7a438ac-78a8-4f0e-92f6-97efcdaedab8,Treatment Ongoing,released,Oxaliplatin,1,2020-09-28T09:55:50.716360-05:00,Chemotherapy,Residual Disease,
HCM-CSHL-0379-C18,c8f87337-a6d6-492d-943f-33207c8b40d3,cd9b2155-b63c-4635-a596-8978a233c4e3,,Adjuvant,929.0,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0379-C18_treatment3,f7dc7116-433e-4c3f-a3fc-5aeca0d8d85c,Treatment Ongoing,released,Fluorouracil,1,2020-09-28T09:55:50.716360-05:00,Chemotherapy,Residual Disease,
HCM-BROD-0782-C71,c902d2a4-d473-498e-a235-c66960ffdefe,e2aa8c52-9b9f-4945-9945-37b409aea59d,1153.0,Maintenance Therapy,14.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0782-C71_treatment8,9c68efed-05a3-457f-aa08-7d6fa41f9ada,Progressive Disease,released,Temozolomide,1,2021-12-21T13:51:15.957667-06:00,,,
HCM-BROD-0782-C71,c902d2a4-d473-498e-a235-c66960ffdefe,ff028af5-c8a2-4e7a-b5c0-e456c67c679a,1279.0,Adjuvant,1251.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0782-C71_treatment2,0da16c7f-65b6-40b9-99d7-edf41ce64960,,released,Irinotecan,1,2021-12-21T13:51:15.957667-06:00,Chemotherapy,Residual Disease,
HCM-BROD-0782-C71,c902d2a4-d473-498e-a235-c66960ffdefe,ff028af5-c8a2-4e7a-b5c0-e456c67c679a,,,-6.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0782-C71_treatment4,22ee7349-c61c-4b9e-ab1d-1020c1905464,,released,,1,2021-12-21T13:51:15.957667-06:00,"Surgery, NOS",Initial Diagnosis,
HCM-BROD-0782-C71,c902d2a4-d473-498e-a235-c66960ffdefe,ff028af5-c8a2-4e7a-b5c0-e456c67c679a,1279.0,Adjuvant,1251.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0782-C71_treatment6,4a6d386b-8908-470b-86a1-a018f342a914,,released,Bevacizumab,1,2021-12-21T13:51:15.957667-06:00,Targeted Molecular Therapy,Residual Disease,
HCM-BROD-0782-C71,c902d2a4-d473-498e-a235-c66960ffdefe,ff028af5-c8a2-4e7a-b5c0-e456c67c679a,,Neoadjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0782-C71_treatment,51b397ac-3a1d-46e2-babe-2aab877e988a,,released,,0,2021-12-21T13:51:15.957667-06:00,,,
HCM-BROD-0782-C71,c902d2a4-d473-498e-a235-c66960ffdefe,ff028af5-c8a2-4e7a-b5c0-e456c67c679a,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0782-C71_treatment3,bfc36527-4326-4392-8438-d2d7d1eac31d,,released,,0,2021-12-21T13:51:15.957667-06:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-BROD-0782-C71,c902d2a4-d473-498e-a235-c66960ffdefe,ff028af5-c8a2-4e7a-b5c0-e456c67c679a,1245.0,Adjuvant,1161.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0782-C71_treatment5,dcf896c3-5332-4dc1-973c-8661342f6e2d,,released,Not Reported,1,2021-12-21T13:51:15.957667-06:00,Targeted Molecular Therapy,Residual Disease,
HCM-BROD-0782-C71,c902d2a4-d473-498e-a235-c66960ffdefe,ff028af5-c8a2-4e7a-b5c0-e456c67c679a,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0782-C71_treatment7,fcea76a8-933b-4dd4-9496-43c3d5fdb171,,released,,0,2021-12-21T13:51:15.957667-06:00,"Radiation Therapy, NOS",Residual Disease,
HCM-CSHL-1270-C18,c95492e0-26ba-4a9c-a99b-f6aee9d33f20,31e1a98c-da17-430b-9240-0a530d14d22e,311.0,Adjuvant,269.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-1270-C18_treatment12,135f8186-219c-42a2-ae79-55c9ff723325,,released,Bevacizumab,1,2022-03-11T20:05:02.480016-06:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-CSHL-1270-C18,c95492e0-26ba-4a9c-a99b-f6aee9d33f20,31e1a98c-da17-430b-9240-0a530d14d22e,402.0,Adjuvant,332.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-1270-C18_treatment7,2441faeb-b9d5-4d65-8b1c-f93cbbeadf2f,,released,Irinotecan,1,2022-03-11T20:05:02.480016-06:00,Chemotherapy,Residual Disease,
HCM-CSHL-1270-C18,c95492e0-26ba-4a9c-a99b-f6aee9d33f20,31e1a98c-da17-430b-9240-0a530d14d22e,402.0,Adjuvant,332.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-1270-C18_treatment8,2aec7709-cd30-4b2d-9f12-437998af74d0,,released,Leucovorin Calcium,1,2022-03-11T20:05:02.480016-06:00,Chemotherapy,Residual Disease,
HCM-CSHL-1270-C18,c95492e0-26ba-4a9c-a99b-f6aee9d33f20,31e1a98c-da17-430b-9240-0a530d14d22e,170.0,Adjuvant,28.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-1270-C18_treatment5,496d2151-6e43-43e4-a4c7-43229e1220e8,,released,Bevacizumab,1,2022-03-11T20:05:02.480016-06:00,Chemotherapy,Residual Disease,
HCM-CSHL-1270-C18,c95492e0-26ba-4a9c-a99b-f6aee9d33f20,31e1a98c-da17-430b-9240-0a530d14d22e,402.0,Adjuvant,332.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-1270-C18_treatment9,6a819965-be15-4eeb-88e8-675193911514,,released,Fluorouracil,1,2022-03-11T20:05:02.480016-06:00,Chemotherapy,Residual Disease,
HCM-CSHL-1270-C18,c95492e0-26ba-4a9c-a99b-f6aee9d33f20,31e1a98c-da17-430b-9240-0a530d14d22e,534.0,Adjuvant,423.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-1270-C18_treatment14,7ea7214b-a4ea-40d2-a1a4-ee5503b20d57,,released,Encorafenib,1,2022-03-11T20:05:02.480016-06:00,Targeted Molecular Therapy,Residual Disease,
HCM-CSHL-1270-C18,c95492e0-26ba-4a9c-a99b-f6aee9d33f20,31e1a98c-da17-430b-9240-0a530d14d22e,170.0,Adjuvant,28.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-1270-C18_treatment3,89d323b6-fce6-47b6-bb29-9465fe9bbfe1,,released,Fluorouracil,1,2022-03-11T20:05:02.480016-06:00,Chemotherapy,Residual Disease,
HCM-CSHL-1270-C18,c95492e0-26ba-4a9c-a99b-f6aee9d33f20,31e1a98c-da17-430b-9240-0a530d14d22e,170.0,Adjuvant,28.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-1270-C18_treatment2,97cb1511-efc3-4abe-8185-048552d65a1e,,released,Leucovorin Calcium,1,2022-03-11T20:05:02.480016-06:00,Chemotherapy,Residual Disease,
HCM-CSHL-1270-C18,c95492e0-26ba-4a9c-a99b-f6aee9d33f20,31e1a98c-da17-430b-9240-0a530d14d22e,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-1270-C18_treatment15,a633bc12-b347-4a52-9da2-7d8b60f8d1bc,,released,,0,2022-03-11T20:05:02.480016-06:00,"Radiation Therapy, NOS",Residual Disease,
HCM-CSHL-1270-C18,c95492e0-26ba-4a9c-a99b-f6aee9d33f20,31e1a98c-da17-430b-9240-0a530d14d22e,402.0,Adjuvant,332.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-1270-C18_treatment10,c546faa0-451c-4936-a42c-384933a305a4,,released,Cetuximab,1,2022-03-11T20:05:02.480016-06:00,Chemotherapy,Residual Disease,
HCM-CSHL-1270-C18,c95492e0-26ba-4a9c-a99b-f6aee9d33f20,31e1a98c-da17-430b-9240-0a530d14d22e,170.0,Adjuvant,28.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-1270-C18_treatment4,d35718a5-d4bb-4c59-9623-7cc756c84f12,,released,Irinotecan,1,2022-03-11T20:05:02.480016-06:00,Chemotherapy,Residual Disease,
HCM-CSHL-1270-C18,c95492e0-26ba-4a9c-a99b-f6aee9d33f20,31e1a98c-da17-430b-9240-0a530d14d22e,170.0,Adjuvant,28.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-1270-C18_treatment6,d7ddc618-4fd9-4c9e-962e-e03473550415,,released,,1,2022-03-11T20:05:02.480016-06:00,Chemotherapy,Residual Disease,FOLFIRI
HCM-CSHL-1270-C18,c95492e0-26ba-4a9c-a99b-f6aee9d33f20,31e1a98c-da17-430b-9240-0a530d14d22e,,,548.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-1270-C18_treatment13,e0730d63-e8f0-4f42-9bfc-49b78c87ef22,,released,,1,2022-03-11T20:05:02.480016-06:00,"Surgery, NOS",Initial Diagnosis,
HCM-CSHL-1270-C18,c95492e0-26ba-4a9c-a99b-f6aee9d33f20,31e1a98c-da17-430b-9240-0a530d14d22e,,Neoadjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-1270-C18_treatment,e36dca43-6ee6-45c3-a5ce-ad32207d3555,,released,,0,2022-03-11T20:05:02.480016-06:00,,,
HCM-CSHL-1270-C18,c95492e0-26ba-4a9c-a99b-f6aee9d33f20,31e1a98c-da17-430b-9240-0a530d14d22e,402.0,Adjuvant,332.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-1270-C18_treatment11,f000a6a6-f431-4697-a281-b0701b522b05,,released,,1,2022-03-11T20:05:02.480016-06:00,Chemotherapy,Residual Disease,FOLFIRI-cetuximab
HCM-CSHL-1270-C18,c95492e0-26ba-4a9c-a99b-f6aee9d33f20,cfcb4d2d-7c78-4bb6-9d61-49b06cee0da3,170.0,Maintenance Therapy,28.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-1270-C18_treatment17,186611f6-75da-4ffb-9c70-29c336ab19ca,Progressive Disease,released,Bevacizumab,1,2022-03-11T20:05:02.480016-06:00,,,
HCM-CSHL-1270-C18,c95492e0-26ba-4a9c-a99b-f6aee9d33f20,cfcb4d2d-7c78-4bb6-9d61-49b06cee0da3,170.0,Maintenance Therapy,28.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-1270-C18_treatment20,187f8cc8-2aee-41ea-b906-4685f8b0a783,Progressive Disease,released,,1,2022-03-11T20:05:02.480016-06:00,,,FOLFIRI
HCM-CSHL-1270-C18,c95492e0-26ba-4a9c-a99b-f6aee9d33f20,cfcb4d2d-7c78-4bb6-9d61-49b06cee0da3,170.0,Maintenance Therapy,28.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-1270-C18_treatment18,27651bfd-3edb-4c65-8b29-c853c43a707c,Progressive Disease,released,Leucovorin Calcium,1,2022-03-11T20:05:02.480016-06:00,,,
HCM-CSHL-1270-C18,c95492e0-26ba-4a9c-a99b-f6aee9d33f20,cfcb4d2d-7c78-4bb6-9d61-49b06cee0da3,170.0,Maintenance Therapy,28.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-1270-C18_treatment19,3c2b81a0-3d90-4d71-a798-f6ff0d67f551,Progressive Disease,released,Fluorouracil,1,2022-03-11T20:05:02.480016-06:00,,,
HCM-CSHL-1270-C18,c95492e0-26ba-4a9c-a99b-f6aee9d33f20,cfcb4d2d-7c78-4bb6-9d61-49b06cee0da3,170.0,Maintenance Therapy,28.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-1270-C18_treatment16,b773c893-4a53-47c4-a5f8-eec6271772b9,Progressive Disease,released,Irinotecan,1,2022-03-11T20:05:02.480016-06:00,,,
HCM-CSHL-0147-C24,c992b973-299c-49d0-b5b5-3bdabb7ef575,3bc3a18d-b3b5-46cc-875e-09545978654a,,,54.0,2023-03-13T13:14:10.278336-05:00,HCM-CSHL-0147-C24_treatment2,6a5c6fc4-b729-453a-b73f-7dd3fccf0fc0,,released,,1,2020-02-11T15:25:23.744984-06:00,"Surgery, NOS",Initial Diagnosis,
HCM-CSHL-0147-C24,c992b973-299c-49d0-b5b5-3bdabb7ef575,3bc3a18d-b3b5-46cc-875e-09545978654a,,Adjuvant,,2023-03-13T13:14:10.278336-05:00,HCM-CSHL-0147-C24_treatment3,7fddcd58-c17b-4187-bc84-d0e0dc673367,,released,,0,2020-02-11T15:25:23.744984-06:00,"Pharmaceutical Therapy, NOS",Residual Disease,
HCM-CSHL-0147-C24,c992b973-299c-49d0-b5b5-3bdabb7ef575,3bc3a18d-b3b5-46cc-875e-09545978654a,,Adjuvant,,2023-03-13T13:14:10.278336-05:00,HCM-CSHL-0147-C24_treatment4,88da1c6e-ab02-4c35-ac46-cf6a2e80b164,,released,,0,2020-02-11T15:25:23.744984-06:00,"Radiation Therapy, NOS",Residual Disease,
HCM-CSHL-0147-C24,c992b973-299c-49d0-b5b5-3bdabb7ef575,3bc3a18d-b3b5-46cc-875e-09545978654a,,Neoadjuvant,,2020-01-13T20:10:25.832065-06:00,HCM-CSHL-0147-C24_treatment,c4574c56-946b-49c5-94fc-86759df035d2,,released,,0,2019-04-03T17:50:51.184182-05:00,,,
HCM-BROD-0482-C34,c996d442-45aa-47e8-9a9c-82727085d22d,0ae82a47-7478-4dfa-b354-84d31eac76a9,,Adjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0482-C34_treatment6,1b422500-d09e-4f49-9f75-9896c1ad9840,,released,,0,2020-09-27T11:53:42.973662-05:00,Targeted Molecular Therapy,Residual Disease,
HCM-BROD-0482-C34,c996d442-45aa-47e8-9a9c-82727085d22d,0ae82a47-7478-4dfa-b354-84d31eac76a9,964.0,Adjuvant,720.0,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0482-C34_treatment3,21c2b8f5-4dbd-4a10-aa29-0772084414c6,,released,Etoposide,1,2020-09-27T11:53:42.973662-05:00,Chemotherapy,Residual Disease,
HCM-BROD-0482-C34,c996d442-45aa-47e8-9a9c-82727085d22d,0ae82a47-7478-4dfa-b354-84d31eac76a9,,Adjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0482-C34_treatment4,4306c16d-0bd8-4cd3-a172-5b70c86c9671,,released,,0,2020-09-27T11:53:42.973662-05:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-BROD-0482-C34,c996d442-45aa-47e8-9a9c-82727085d22d,0ae82a47-7478-4dfa-b354-84d31eac76a9,,,,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0482-C34_treatment5,728b445e-80b5-423d-badb-c6a16be18ef9,,released,,unknown,2020-09-27T11:53:42.973662-05:00,"Surgery, NOS",Initial Diagnosis,
HCM-BROD-0482-C34,c996d442-45aa-47e8-9a9c-82727085d22d,0ae82a47-7478-4dfa-b354-84d31eac76a9,,Neoadjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0482-C34_treatment,7cdb093e-3b23-4be3-b114-016c788647b1,,released,,0,2020-09-27T11:53:42.973662-05:00,,,
HCM-BROD-0482-C34,c996d442-45aa-47e8-9a9c-82727085d22d,0ae82a47-7478-4dfa-b354-84d31eac76a9,,Adjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0482-C34_treatment7,b0a091d4-fe95-407b-9e74-dc14f411332e,,released,,0,2020-09-27T11:53:42.973662-05:00,"Radiation Therapy, NOS",Residual Disease,
HCM-BROD-0482-C34,c996d442-45aa-47e8-9a9c-82727085d22d,0ae82a47-7478-4dfa-b354-84d31eac76a9,110.0,Adjuvant,2.0,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0482-C34_treatment2,e389aedd-8d4c-4951-b5ab-2617bfa29730,,released,Carboplatin,1,2020-09-27T11:53:42.973662-05:00,Chemotherapy,Residual Disease,
HCM-BROD-0482-C34,c996d442-45aa-47e8-9a9c-82727085d22d,914b3169-c5ef-4013-a946-6341a998a16b,714.0,Maintenance Therapy,1.0,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0482-C34_treatment8,40702cd9-64d4-49b3-a2f2-47ff1af64a9b,Not Reported,released,Nivolumab,1,2020-09-27T11:53:42.973662-05:00,,,
HCM-BROD-0482-C34,c996d442-45aa-47e8-9a9c-82727085d22d,914b3169-c5ef-4013-a946-6341a998a16b,714.0,Maintenance Therapy,1.0,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0482-C34_treatment9,ff4315fa-8686-402f-9cfc-9943509e9b55,Not Reported,released,Carboplatin,1,2020-09-27T11:53:42.973662-05:00,,,
HCM-BROD-0482-C34,c996d442-45aa-47e8-9a9c-82727085d22d,df44e9ad-7ce3-40d1-8080-34731a2c7732,799.0,Maintenance Therapy,1.0,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0482-C34_treatment10,05025f8a-dd1b-4557-a3ea-ab5e1a2efcd7,Stable Disease,released,Carboplatin,1,2021-10-21T11:26:10.709913-05:00,,,
HCM-BROD-0482-C34,c996d442-45aa-47e8-9a9c-82727085d22d,df44e9ad-7ce3-40d1-8080-34731a2c7732,799.0,Maintenance Therapy,1.0,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0482-C34_treatment11,7c9cdac2-6050-482e-a376-8b02de5702cd,Stable Disease,released,Etoposide,1,2021-10-21T11:26:10.709913-05:00,,,
HCM-SANG-1095-C25,c9bf8ca1-80dd-4b27-9b02-7347de171e12,da916421-ffeb-4415-9bd8-01e54604cdb7,,Neoadjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-SANG-1095-C25_treatment,784303eb-5a55-4dff-8183-9a5ba7a4aed4,,released,,0,2023-02-27T11:17:25.586966-06:00,,,
HCM-CSHL-0858-C25,ca0b8e86-7e21-4192-8113-c8d051768365,729b83cb-2166-4431-8929-393cfb7caf15,198.0,Adjuvant,73.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0858-C25_treatment3,4645288f-af01-4e18-a578-60cb2c8bbdd5,,released,Leucovorin Calcium,1,2021-12-21T14:34:49.028238-06:00,Chemotherapy,Residual Disease,
HCM-CSHL-0858-C25,ca0b8e86-7e21-4192-8113-c8d051768365,729b83cb-2166-4431-8929-393cfb7caf15,198.0,Adjuvant,73.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0858-C25_treatment2,5f75345d-4bb8-496a-b774-a3d412b31b97,,released,Irinotecan Hydrochloride,1,2021-12-21T14:34:49.028238-06:00,Chemotherapy,Residual Disease,
HCM-CSHL-0858-C25,ca0b8e86-7e21-4192-8113-c8d051768365,729b83cb-2166-4431-8929-393cfb7caf15,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0858-C25_treatment8,757e257d-c842-461e-b41e-249c87e47b6c,,released,,1,2021-12-21T14:34:49.028238-06:00,Chemotherapy,Residual Disease,
HCM-CSHL-0858-C25,ca0b8e86-7e21-4192-8113-c8d051768365,729b83cb-2166-4431-8929-393cfb7caf15,364.0,Adjuvant,364.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0858-C25_treatment7,7f1bfbe0-c8e4-4bcc-843f-eff2fa3ebcd9,,released,Gemcitabine,1,2021-12-21T14:34:49.028238-06:00,Chemotherapy,Residual Disease,
HCM-CSHL-0858-C25,ca0b8e86-7e21-4192-8113-c8d051768365,729b83cb-2166-4431-8929-393cfb7caf15,198.0,Adjuvant,73.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0858-C25_treatment4,a93c3462-464b-4a64-a196-3d0644cdb7b2,,released,Fluorouracil,1,2021-12-21T14:34:49.028238-06:00,Chemotherapy,Residual Disease,
HCM-CSHL-0858-C25,ca0b8e86-7e21-4192-8113-c8d051768365,729b83cb-2166-4431-8929-393cfb7caf15,198.0,Adjuvant,73.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0858-C25_treatment5,b76fe413-854b-4681-bacd-043b5a75f512,,released,Oxaliplatin,1,2021-12-21T14:34:49.028238-06:00,Chemotherapy,Residual Disease,
HCM-CSHL-0858-C25,ca0b8e86-7e21-4192-8113-c8d051768365,729b83cb-2166-4431-8929-393cfb7caf15,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0858-C25_treatment11,b8b5fc90-eb2d-4a4f-8a5d-bbd27fc7df44,,released,,0,2021-12-21T14:34:49.028238-06:00,Targeted Molecular Therapy,Residual Disease,
HCM-CSHL-0858-C25,ca0b8e86-7e21-4192-8113-c8d051768365,729b83cb-2166-4431-8929-393cfb7caf15,198.0,Adjuvant,73.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0858-C25_treatment6,c99ce5fc-55d5-465a-99ff-7241ccb95f3a,,released,,1,2021-12-21T14:34:49.028238-06:00,Chemotherapy,Residual Disease,
HCM-CSHL-0858-C25,ca0b8e86-7e21-4192-8113-c8d051768365,729b83cb-2166-4431-8929-393cfb7caf15,,,,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0858-C25_treatment10,cc34dc9b-c44c-4274-b7ed-601c126441f2,,released,,1,2021-12-21T14:34:49.028238-06:00,"Surgery, NOS",Initial Diagnosis,
HCM-CSHL-0858-C25,ca0b8e86-7e21-4192-8113-c8d051768365,729b83cb-2166-4431-8929-393cfb7caf15,,Neoadjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0858-C25_treatment,d0fd6462-1c66-48a4-afd5-16a6524849fb,,released,,0,2021-12-21T14:34:49.028238-06:00,,,
HCM-CSHL-0858-C25,ca0b8e86-7e21-4192-8113-c8d051768365,729b83cb-2166-4431-8929-393cfb7caf15,,,,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0858-C25_treatment9,e33adb2e-c7fd-4cc9-bcd5-13292f3517e3,,released,,0,2021-12-21T14:34:49.028238-06:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-CSHL-0858-C25,ca0b8e86-7e21-4192-8113-c8d051768365,fcc8413c-676c-4e16-afaf-0cfcf788eee5,249.0,Maintenance Therapy,73.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0858-C25_treatment14,3415d7db-4338-4afa-8c62-afddea0f2864,Not Reported,released,Irinotecan Hydrochloride,1,2022-02-03T08:25:33.513186-06:00,,,
HCM-CSHL-0858-C25,ca0b8e86-7e21-4192-8113-c8d051768365,fcc8413c-676c-4e16-afaf-0cfcf788eee5,249.0,Maintenance Therapy,73.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0858-C25_treatment13,b9e71da3-bb98-4b98-aec2-8e4657f00eda,Not Reported,released,Leucovorin Calcium,1,2021-12-21T14:34:49.028238-06:00,,,
HCM-CSHL-0858-C25,ca0b8e86-7e21-4192-8113-c8d051768365,fcc8413c-676c-4e16-afaf-0cfcf788eee5,249.0,Maintenance Therapy,73.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0858-C25_treatment15,e0f604c0-5305-49e5-be38-64f005b00eb6,Not Reported,released,Oxaliplatin,1,2022-02-03T08:25:33.513186-06:00,,,
HCM-BROD-0253-C15,ca7aecd3-f8a4-4282-8167-f85368bec527,e6cb5829-48af-4687-9247-79a1f66e86bf,279.0,Adjuvant,223.0,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0253-C15_treatment8,0f8e8f30-d1f3-4fdc-a1f1-6355f9389d19,,released,Ramucirumab,1,2020-09-27T11:16:43.688605-05:00,Targeted Molecular Therapy,Residual Disease,
HCM-BROD-0253-C15,ca7aecd3-f8a4-4282-8167-f85368bec527,e6cb5829-48af-4687-9247-79a1f66e86bf,279.0,Adjuvant,223.0,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0253-C15_treatment5,498e7376-54c2-4e36-b7c3-5a507f6e9370,,released,Paclitaxel,1,2020-09-27T11:16:43.688605-05:00,Chemotherapy,Residual Disease,
HCM-BROD-0253-C15,ca7aecd3-f8a4-4282-8167-f85368bec527,e6cb5829-48af-4687-9247-79a1f66e86bf,,,,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0253-C15_treatment7,6a1052a1-2c1e-490a-b944-54ab2445449b,,released,,0,2020-09-27T11:16:43.688605-05:00,"Surgery, NOS",Initial Diagnosis,
HCM-BROD-0253-C15,ca7aecd3-f8a4-4282-8167-f85368bec527,e6cb5829-48af-4687-9247-79a1f66e86bf,,Adjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0253-C15_treatment6,897d32fb-f1ff-4a3b-b348-02ce67b2aa4e,,released,,0,2020-09-27T11:16:43.688605-05:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-BROD-0253-C15,ca7aecd3-f8a4-4282-8167-f85368bec527,e6cb5829-48af-4687-9247-79a1f66e86bf,195.0,Adjuvant,167.0,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0253-C15_treatment2,92bec0f4-a0a6-4245-9b71-15904fbd243a,,released,Fluorouracil,1,2020-09-27T11:16:43.688605-05:00,Chemotherapy,Residual Disease,
HCM-BROD-0253-C15,ca7aecd3-f8a4-4282-8167-f85368bec527,e6cb5829-48af-4687-9247-79a1f66e86bf,195.0,Adjuvant,167.0,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0253-C15_treatment3,a5fe50dc-21de-482b-9f7b-5341ce25c19c,,released,Leucovorin,1,2020-09-27T11:16:43.688605-05:00,Chemotherapy,Residual Disease,
HCM-BROD-0253-C15,ca7aecd3-f8a4-4282-8167-f85368bec527,e6cb5829-48af-4687-9247-79a1f66e86bf,195.0,Adjuvant,167.0,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0253-C15_treatment4,ac1e01f9-88e4-4647-aed1-cad560155c5e,,released,Oxaliplatin,1,2020-09-27T11:16:43.688605-05:00,Chemotherapy,Residual Disease,
HCM-BROD-0253-C15,ca7aecd3-f8a4-4282-8167-f85368bec527,e6cb5829-48af-4687-9247-79a1f66e86bf,,Adjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0253-C15_treatment9,cd369cec-72fc-4a01-83e8-3429f22c7a84,,released,,0,2020-09-27T11:16:43.688605-05:00,"Radiation Therapy, NOS",Residual Disease,
HCM-BROD-0253-C15,ca7aecd3-f8a4-4282-8167-f85368bec527,e6cb5829-48af-4687-9247-79a1f66e86bf,,Neoadjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0253-C15_treatment,d7eedd48-2f6d-465d-b806-13baa0acbfed,,released,,1,2019-04-04T15:55:02.493893-05:00,Chemotherapy,,
HCM-BROD-1129-C56,ca7bc7fd-6ce1-4d63-b935-804ff4d3abc2,12bb4e82-23c5-45ca-8c3c-17a38cdc71f0,1168.0,Maintenance Therapy,1057.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-1129-C56_treatment11,270688a6-8639-46af-b824-8daf603bd0eb,Progressive Disease,released,Niraparib,1,2021-12-21T14:02:14.278160-06:00,,,
HCM-BROD-1129-C56,ca7bc7fd-6ce1-4d63-b935-804ff4d3abc2,12bb4e82-23c5-45ca-8c3c-17a38cdc71f0,1168.0,Maintenance Therapy,1057.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-1129-C56_treatment10,9999772a-f1ad-4202-bd31-d4e8590bd7a4,Progressive Disease,released,Paclitaxel,1,2021-12-21T14:02:14.278160-06:00,,,
HCM-BROD-1129-C56,ca7bc7fd-6ce1-4d63-b935-804ff4d3abc2,12bb4e82-23c5-45ca-8c3c-17a38cdc71f0,1168.0,Maintenance Therapy,1057.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-1129-C56_treatment9,d0fd9aa2-f44d-41c8-abad-88a860b6fe93,Progressive Disease,released,Bevacizumab,1,2021-12-21T14:02:14.278160-06:00,,,
HCM-BROD-1129-C56,ca7bc7fd-6ce1-4d63-b935-804ff4d3abc2,12bb4e82-23c5-45ca-8c3c-17a38cdc71f0,1168.0,Maintenance Therapy,1057.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-1129-C56_treatment12,d7c3da0b-53d0-4b08-9861-5890b098533e,Progressive Disease,released,Carboplatin,1,2021-12-21T14:02:14.278160-06:00,,,
HCM-BROD-1129-C56,ca7bc7fd-6ce1-4d63-b935-804ff4d3abc2,a9f49053-682c-4d41-bced-0dea73ac9851,,Neoadjuvant,20.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-1129-C56_treatment2,001d70d5-8b61-42f2-892b-f089830f20fd,,released,Paclitaxel,1,2021-12-21T14:02:14.278160-06:00,Chemotherapy,,
HCM-BROD-1129-C56,ca7bc7fd-6ce1-4d63-b935-804ff4d3abc2,a9f49053-682c-4d41-bced-0dea73ac9851,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-BROD-1129-C56_treatment5,1057dcac-5a8e-4dff-8d5f-5fa39b12216a,,released,,0,2021-12-21T14:02:14.278160-06:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-BROD-1129-C56,ca7bc7fd-6ce1-4d63-b935-804ff4d3abc2,a9f49053-682c-4d41-bced-0dea73ac9851,1379.0,Adjuvant,1321.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-1129-C56_treatment7,10d7da81-724a-435f-9aa9-1c41ccb72e91,,released,Bevacizumab,1,2021-12-21T14:02:14.278160-06:00,Targeted Molecular Therapy,Residual Disease,
HCM-BROD-1129-C56,ca7bc7fd-6ce1-4d63-b935-804ff4d3abc2,a9f49053-682c-4d41-bced-0dea73ac9851,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-BROD-1129-C56_treatment8,279c24bb-25e2-4279-bc03-f29c999a41cd,,released,,0,2021-12-21T14:02:14.278160-06:00,"Radiation Therapy, NOS",Residual Disease,
HCM-BROD-1129-C56,ca7bc7fd-6ce1-4d63-b935-804ff4d3abc2,a9f49053-682c-4d41-bced-0dea73ac9851,,Neoadjuvant,20.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-1129-C56_treatment,2c00d9e2-8d08-4049-8683-1b2f62b3b04d,,released,Carboplatin,1,2021-12-21T14:02:14.278160-06:00,Chemotherapy,,
HCM-BROD-1129-C56,ca7bc7fd-6ce1-4d63-b935-804ff4d3abc2,a9f49053-682c-4d41-bced-0dea73ac9851,,,0.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-1129-C56_treatment6,ad5a088e-4cf7-4f7b-a22e-e902529fe3b6,,released,,1,2021-12-21T14:02:14.278160-06:00,"Surgery, NOS",Initial Diagnosis,
HCM-BROD-1129-C56,ca7bc7fd-6ce1-4d63-b935-804ff4d3abc2,a9f49053-682c-4d41-bced-0dea73ac9851,1379.0,Adjuvant,1321.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-1129-C56_treatment3,ea59f672-adb5-4fb1-aabb-134785a4028c,,released,Paclitaxel,1,2021-12-21T14:02:14.278160-06:00,Chemotherapy,Residual Disease,
HCM-BROD-1129-C56,ca7bc7fd-6ce1-4d63-b935-804ff4d3abc2,a9f49053-682c-4d41-bced-0dea73ac9851,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-BROD-1129-C56_treatment4,ef9e2cf0-ed71-451d-b1cc-499e694741b4,,released,,0,2021-12-21T14:02:14.278160-06:00,Hormone Therapy,Residual Disease,
HCM-CSHL-0192-C25,caa4afe4-b5e1-4427-ae52-9d41c7c8b93f,7e38f63b-a983-4dd9-85c7-0a8eb045af47,,Adjuvant,225.0,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0192-C25_treatment6,244105ef-5ae0-4206-9bdd-5a6dd7c9077d,,released,,1,2020-09-28T09:16:43.682099-05:00,"Radiation, 2D Conventional",Residual Disease,
HCM-CSHL-0192-C25,caa4afe4-b5e1-4427-ae52-9d41c7c8b93f,7e38f63b-a983-4dd9-85c7-0a8eb045af47,194.0,Adjuvant,11.0,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0192-C25_treatment2,2e7f6821-4835-4745-83ad-73a2e75e07c3,,released,Gemcitabine,1,2020-09-28T09:16:43.682099-05:00,Chemotherapy,Residual Disease,
HCM-CSHL-0192-C25,caa4afe4-b5e1-4427-ae52-9d41c7c8b93f,7e38f63b-a983-4dd9-85c7-0a8eb045af47,,,-12.0,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0192-C25_treatment4,58f31333-f745-4135-8c0e-97c90ed29db9,,released,,1,2020-09-28T09:16:43.682099-05:00,"Surgery, NOS",Initial Diagnosis,
HCM-CSHL-0192-C25,caa4afe4-b5e1-4427-ae52-9d41c7c8b93f,7e38f63b-a983-4dd9-85c7-0a8eb045af47,,Neoadjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0192-C25_treatment,914e5a18-557b-41c6-b795-dfd5caa4c5df,,released,,0,2020-09-28T09:16:43.682099-05:00,,,
HCM-CSHL-0192-C25,caa4afe4-b5e1-4427-ae52-9d41c7c8b93f,7e38f63b-a983-4dd9-85c7-0a8eb045af47,,Adjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0192-C25_treatment5,9fbd8b19-5503-4db1-b47f-a92dc7a84beb,,released,,0,2020-09-28T09:16:43.682099-05:00,Targeted Molecular Therapy,Residual Disease,
HCM-CSHL-0192-C25,caa4afe4-b5e1-4427-ae52-9d41c7c8b93f,7e38f63b-a983-4dd9-85c7-0a8eb045af47,,Adjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0192-C25_treatment3,aff99000-5234-48d5-86b4-e967b88f34b2,,released,,0,2020-09-28T09:16:43.682099-05:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-BROD-0104-C71,cad9953c-7293-4699-9c47-3e24bc592f9a,e709b419-ae09-438d-8c90-241926771c33,69.0,Adjuvant,26.0,2021-01-06T22:55:10.531130-06:00,HCM-BROD-0104-C71_treatment7,5575e0be-81cf-4c1e-baab-ef016aecc159,,released,,1,2020-04-21T14:49:59.575847-05:00,"Radiation Therapy, NOS",Residual Disease,
HCM-BROD-0104-C71,cad9953c-7293-4699-9c47-3e24bc592f9a,e709b419-ae09-438d-8c90-241926771c33,106.0,Adjuvant,102.0,2021-01-06T22:55:10.531130-06:00,HCM-BROD-0104-C71_treatment2,6429f7fb-5550-439b-8ba9-62652c21f3bc,,released,Temozolomide,1,2020-04-21T14:49:59.575847-05:00,Chemotherapy,Residual Disease,
HCM-BROD-0104-C71,cad9953c-7293-4699-9c47-3e24bc592f9a,e709b419-ae09-438d-8c90-241926771c33,,,-9.0,2023-02-27T12:49:58.796338-06:00,HCM-BROD-0104-C71_treatment5,a12b6b04-5d5d-4a87-ae60-ab0b2f010ea9,,released,,1,2020-04-21T14:49:59.575847-05:00,"Surgery, NOS",Initial Diagnosis,
HCM-BROD-0104-C71,cad9953c-7293-4699-9c47-3e24bc592f9a,e709b419-ae09-438d-8c90-241926771c33,,Adjuvant,,2021-01-06T22:55:10.531130-06:00,HCM-BROD-0104-C71_treatment4,a32625cf-b421-4da9-a813-182e3b560b62,,released,,0,2020-04-21T14:49:59.575847-05:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-BROD-0104-C71,cad9953c-7293-4699-9c47-3e24bc592f9a,e709b419-ae09-438d-8c90-241926771c33,236.0,Adjuvant,153.0,2021-01-06T22:55:10.531130-06:00,HCM-BROD-0104-C71_treatment6,b277dd7d-e671-41a6-82c8-a5ad78ecf4c7,,released,Bevacizumab,1,2020-04-21T14:49:59.575847-05:00,Targeted Molecular Therapy,Residual Disease,
HCM-BROD-0104-C71,cad9953c-7293-4699-9c47-3e24bc592f9a,e709b419-ae09-438d-8c90-241926771c33,,Neoadjuvant,,2021-01-06T22:55:10.531130-06:00,HCM-BROD-0104-C71_treatment,cb90aa7d-5f66-4550-b460-8b5c1bb41d37,,released,,0,2019-04-04T14:47:07.963906-05:00,,,
HCM-BROD-0104-C71,cad9953c-7293-4699-9c47-3e24bc592f9a,e709b419-ae09-438d-8c90-241926771c33,148.0,Adjuvant,109.0,2021-01-06T22:55:10.531130-06:00,HCM-BROD-0104-C71_treatment3,d7f2ddec-91ad-4fd1-895d-96d0bc2da848,,released,Temozolomide,1,2020-04-21T14:49:59.575847-05:00,Chemotherapy,Residual Disease,
HCM-BROD-1130-C06,cb56773d-4a53-4313-8c10-51254698b3bd,dbfa0892-42af-4417-b634-5235aeccc068,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-BROD-1130-C06_treatment3,2704515c-5140-49aa-8c94-2e5cd98f3f4b,,released,,unknown,2021-12-21T14:02:20.455776-06:00,"Pharmaceutical Therapy, NOS",Residual Disease,
HCM-BROD-1130-C06,cb56773d-4a53-4313-8c10-51254698b3bd,dbfa0892-42af-4417-b634-5235aeccc068,,Neoadjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-BROD-1130-C06_treatment,2c71f8e4-2aee-44ea-bd1e-e878956bd99a,,released,,0,2021-12-21T14:02:20.455776-06:00,,,
HCM-BROD-1130-C06,cb56773d-4a53-4313-8c10-51254698b3bd,dbfa0892-42af-4417-b634-5235aeccc068,102.0,Adjuvant,60.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-1130-C06_treatment4,6db9b9fe-6517-4c66-b2c3-ce0d816fba3b,,released,,1,2021-12-21T14:02:20.455776-06:00,"Radiation Therapy, NOS",Residual Disease,
HCM-BROD-1130-C06,cb56773d-4a53-4313-8c10-51254698b3bd,dbfa0892-42af-4417-b634-5235aeccc068,,,0.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-1130-C06_treatment2,7332eace-56d2-42fe-855c-fe44040e8f76,,released,,1,2021-12-21T14:02:20.455776-06:00,"Surgery, NOS",Initial Diagnosis,
HCM-CSHL-1262-C19,cc3f9ed5-edcc-4a5a-883b-25bfca20b730,08408f5b-9f10-4457-b7e3-af92fa605d13,111.0,Adjuvant,9.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-1262-C19_treatment9,0f8cb71f-31ba-48c8-bfbe-dbb24a2199c9,,released,Cetuximab,1,2021-12-23T08:32:56.149950-06:00,Chemotherapy,Residual Disease,
HCM-CSHL-1262-C19,cc3f9ed5-edcc-4a5a-883b-25bfca20b730,08408f5b-9f10-4457-b7e3-af92fa605d13,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-1262-C19_treatment38,1021bd11-4442-45c8-891c-7908b92f0ffd,,released,,0,2021-12-23T08:32:56.149950-06:00,"Radiation Therapy, NOS",Residual Disease,
HCM-CSHL-1262-C19,cc3f9ed5-edcc-4a5a-883b-25bfca20b730,08408f5b-9f10-4457-b7e3-af92fa605d13,,Neoadjuvant,52.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-1262-C19_treatment4,1177a149-836d-4acb-a9dc-5db8958e8fad,,released,,1,2021-12-23T08:32:56.149950-06:00,Chemotherapy,,FOLFIRI
HCM-CSHL-1262-C19,cc3f9ed5-edcc-4a5a-883b-25bfca20b730,08408f5b-9f10-4457-b7e3-af92fa605d13,441.0,Adjuvant,349.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-1262-C19_treatment14,14fe4ef3-afca-4f98-8a9f-9e91218f7917,,released,Fluorouracil,1,2021-12-23T08:32:56.149950-06:00,Chemotherapy,Residual Disease,
HCM-CSHL-1262-C19,cc3f9ed5-edcc-4a5a-883b-25bfca20b730,08408f5b-9f10-4457-b7e3-af92fa605d13,710.0,Adjuvant,542.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-1262-C19_treatment17,1796e410-c167-465c-950c-4762cec3de36,,released,Irinotecan,1,2021-12-23T08:32:56.149950-06:00,Chemotherapy,Residual Disease,
HCM-CSHL-1262-C19,cc3f9ed5-edcc-4a5a-883b-25bfca20b730,08408f5b-9f10-4457-b7e3-af92fa605d13,948.0,Adjuvant,920.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-1262-C19_treatment26,188e23fd-24af-45e7-a616-12154a148449,,released,Cetuximab,1,2021-12-23T08:32:56.149950-06:00,Chemotherapy,Residual Disease,
HCM-CSHL-1262-C19,cc3f9ed5-edcc-4a5a-883b-25bfca20b730,08408f5b-9f10-4457-b7e3-af92fa605d13,1109.0,Adjuvant,1049.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-1262-C19_treatment28,1b651b3f-0b7f-40c0-854a-ca4c8a4eaeae,,released,Irinotecan,1,2021-12-23T08:32:56.149950-06:00,Chemotherapy,Residual Disease,
HCM-CSHL-1262-C19,cc3f9ed5-edcc-4a5a-883b-25bfca20b730,08408f5b-9f10-4457-b7e3-af92fa605d13,111.0,Adjuvant,9.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-1262-C19_treatment6,1e1aa9fc-f599-45cb-86f3-3ec064e9f2c9,,released,Irinotecan,1,2021-12-23T08:32:56.149950-06:00,Chemotherapy,Residual Disease,
HCM-CSHL-1262-C19,cc3f9ed5-edcc-4a5a-883b-25bfca20b730,08408f5b-9f10-4457-b7e3-af92fa605d13,710.0,Adjuvant,542.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-1262-C19_treatment18,20cd4068-f76f-4e10-9786-0572d4e6d19d,,released,Leucovorin Calcium,1,2021-12-23T08:32:56.149950-06:00,Chemotherapy,Residual Disease,
HCM-CSHL-1262-C19,cc3f9ed5-edcc-4a5a-883b-25bfca20b730,08408f5b-9f10-4457-b7e3-af92fa605d13,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-1262-C19_treatment35,235b3f32-47af-430e-b170-287299bda1ad,,released,Not Reported,1,2021-12-23T08:32:56.149950-06:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-CSHL-1262-C19,cc3f9ed5-edcc-4a5a-883b-25bfca20b730,08408f5b-9f10-4457-b7e3-af92fa605d13,111.0,Adjuvant,9.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-1262-C19_treatment8,2c4a1908-5c98-4f16-bc1f-128b4044e50c,,released,Fluorouracil,1,2021-12-23T08:32:56.149950-06:00,Chemotherapy,Residual Disease,
HCM-CSHL-1262-C19,cc3f9ed5-edcc-4a5a-883b-25bfca20b730,08408f5b-9f10-4457-b7e3-af92fa605d13,441.0,Adjuvant,349.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-1262-C19_treatment12,2e21143b-783e-4cba-b144-755364600fcc,,released,Bevacizumab,1,2021-12-23T08:32:56.149950-06:00,Chemotherapy,Residual Disease,
HCM-CSHL-1262-C19,cc3f9ed5-edcc-4a5a-883b-25bfca20b730,08408f5b-9f10-4457-b7e3-af92fa605d13,1109.0,Adjuvant,1049.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-1262-C19_treatment30,34dc7b0b-aa92-4de8-acab-b9333ef8e7bc,,released,Fluorouracil,1,2021-12-23T08:32:56.149950-06:00,Chemotherapy,Residual Disease,
HCM-CSHL-1262-C19,cc3f9ed5-edcc-4a5a-883b-25bfca20b730,08408f5b-9f10-4457-b7e3-af92fa605d13,,Neoadjuvant,52.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-1262-C19_treatment3,3c227293-f669-4cf7-a94e-f673993e3f01,,released,Irinotecan,1,2021-12-23T08:32:56.149950-06:00,Chemotherapy,,
HCM-CSHL-1262-C19,cc3f9ed5-edcc-4a5a-883b-25bfca20b730,08408f5b-9f10-4457-b7e3-af92fa605d13,948.0,Adjuvant,920.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-1262-C19_treatment27,3c31a8c7-3d82-41d6-a6f0-d940c373c969,,released,,1,2021-12-23T08:32:56.149950-06:00,Chemotherapy,Residual Disease,FOLFIRI-cetuximab
HCM-CSHL-1262-C19,cc3f9ed5-edcc-4a5a-883b-25bfca20b730,08408f5b-9f10-4457-b7e3-af92fa605d13,948.0,Adjuvant,920.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-1262-C19_treatment23,3d72deaf-2ec4-47ac-9d19-c1b57a5ddf3e,,released,Irinotecan,1,2021-12-23T08:32:56.149950-06:00,Chemotherapy,Residual Disease,
HCM-CSHL-1262-C19,cc3f9ed5-edcc-4a5a-883b-25bfca20b730,08408f5b-9f10-4457-b7e3-af92fa605d13,1202.0,Adjuvant,1166.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-1262-C19_treatment33,441bae58-d206-44c0-9cde-0ee56aa28681,,released,Trifluridine and Tipiracil Hydrochloride,1,2021-12-23T08:32:56.149950-06:00,Chemotherapy,Residual Disease,
HCM-CSHL-1262-C19,cc3f9ed5-edcc-4a5a-883b-25bfca20b730,08408f5b-9f10-4457-b7e3-af92fa605d13,111.0,Adjuvant,9.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-1262-C19_treatment7,47bec76f-0258-42fc-aa24-2f688e50c5a8,,released,Leucovorin Calcium,1,2021-12-23T08:32:56.149950-06:00,Chemotherapy,Residual Disease,
HCM-CSHL-1262-C19,cc3f9ed5-edcc-4a5a-883b-25bfca20b730,08408f5b-9f10-4457-b7e3-af92fa605d13,948.0,Adjuvant,920.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-1262-C19_treatment24,536597ea-36f3-48f9-a156-a52f234088c9,,released,Leucovorin Calcium,1,2021-12-23T08:32:56.149950-06:00,Chemotherapy,Residual Disease,
HCM-CSHL-1262-C19,cc3f9ed5-edcc-4a5a-883b-25bfca20b730,08408f5b-9f10-4457-b7e3-af92fa605d13,1109.0,Adjuvant,1049.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-1262-C19_treatment31,58254aee-7609-439b-b7f1-86e33a3dac48,,released,Cetuximab,1,2021-12-23T08:32:56.149950-06:00,Chemotherapy,Residual Disease,
HCM-CSHL-1262-C19,cc3f9ed5-edcc-4a5a-883b-25bfca20b730,08408f5b-9f10-4457-b7e3-af92fa605d13,710.0,Adjuvant,542.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-1262-C19_treatment21,5f50ac0c-b108-47c1-a03d-0f7aaff3b6d7,,released,,1,2021-12-23T08:32:56.149950-06:00,Chemotherapy,Residual Disease,FOLFIRI-cetuximab
HCM-CSHL-1262-C19,cc3f9ed5-edcc-4a5a-883b-25bfca20b730,08408f5b-9f10-4457-b7e3-af92fa605d13,441.0,Adjuvant,349.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-1262-C19_treatment11,6963c1c7-6286-4c5c-b938-e2003623b39f,,released,Oxaliplatin,1,2021-12-23T08:32:56.149950-06:00,Chemotherapy,Residual Disease,
HCM-CSHL-1262-C19,cc3f9ed5-edcc-4a5a-883b-25bfca20b730,08408f5b-9f10-4457-b7e3-af92fa605d13,900.0,Adjuvant,721.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-1262-C19_treatment22,6b379d82-48d1-4053-8acc-0bc79e3bff26,,released,,1,2021-12-23T08:32:56.149950-06:00,Chemotherapy,Residual Disease,
HCM-CSHL-1262-C19,cc3f9ed5-edcc-4a5a-883b-25bfca20b730,08408f5b-9f10-4457-b7e3-af92fa605d13,1166.0,Adjuvant,1118.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-1262-C19_treatment37,788356cf-35e3-4fda-b273-6aaf674ec8ef,,released,Regorafenib,1,2021-12-23T08:32:56.149950-06:00,Targeted Molecular Therapy,Residual Disease,
HCM-CSHL-1262-C19,cc3f9ed5-edcc-4a5a-883b-25bfca20b730,08408f5b-9f10-4457-b7e3-af92fa605d13,,,998.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-1262-C19_treatment36,7ab319f0-6d67-43a1-8da9-f1c53ffd5207,,released,,1,2021-12-23T08:32:56.149950-06:00,"Surgery, NOS",Initial Diagnosis,
HCM-CSHL-1262-C19,cc3f9ed5-edcc-4a5a-883b-25bfca20b730,08408f5b-9f10-4457-b7e3-af92fa605d13,160.0,Adjuvant,150.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-1262-C19_treatment34,81f5437a-db20-46ef-9c04-cbf100d59a33,,released,Cetuximab,1,2021-12-23T08:32:56.149950-06:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-CSHL-1262-C19,cc3f9ed5-edcc-4a5a-883b-25bfca20b730,08408f5b-9f10-4457-b7e3-af92fa605d13,,Neoadjuvant,52.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-1262-C19_treatment5,8bf46be2-1db0-4744-b65c-6224ca1fb9c6,,released,Cetuximab,1,2021-12-23T08:32:56.149950-06:00,Chemotherapy,,
HCM-CSHL-1262-C19,cc3f9ed5-edcc-4a5a-883b-25bfca20b730,08408f5b-9f10-4457-b7e3-af92fa605d13,1109.0,Adjuvant,1049.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-1262-C19_treatment32,8c0418ca-9de7-4db8-97b4-42560a466fbe,,released,,1,2021-12-23T08:32:56.149950-06:00,Chemotherapy,Residual Disease,FOLFIRI-cetuximab
HCM-CSHL-1262-C19,cc3f9ed5-edcc-4a5a-883b-25bfca20b730,08408f5b-9f10-4457-b7e3-af92fa605d13,,Neoadjuvant,52.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-1262-C19_treatment2,9aa70d21-c6eb-4d84-b9b1-0d8e5c281140,,released,Fluorouracil,1,2021-12-23T08:32:56.149950-06:00,Chemotherapy,,
HCM-CSHL-1262-C19,cc3f9ed5-edcc-4a5a-883b-25bfca20b730,08408f5b-9f10-4457-b7e3-af92fa605d13,111.0,Adjuvant,9.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-1262-C19_treatment10,c0661d9c-09dc-4db4-8aea-a69584182d50,,released,,1,2021-12-23T08:32:56.149950-06:00,Chemotherapy,Residual Disease,FOLFIRI-cetuximab
HCM-CSHL-1262-C19,cc3f9ed5-edcc-4a5a-883b-25bfca20b730,08408f5b-9f10-4457-b7e3-af92fa605d13,441.0,Adjuvant,349.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-1262-C19_treatment15,ca7a6b5a-ed8b-4518-8c46-fd11c2de444d,,released,,1,2021-12-23T08:32:56.149950-06:00,Chemotherapy,Residual Disease,FOLFOX
HCM-CSHL-1262-C19,cc3f9ed5-edcc-4a5a-883b-25bfca20b730,08408f5b-9f10-4457-b7e3-af92fa605d13,537.0,Adjuvant,441.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-1262-C19_treatment16,ce1a8fc2-05cc-4015-aef3-8300bb57060a,,released,,1,2021-12-23T08:32:56.149950-06:00,Chemotherapy,Residual Disease,
HCM-CSHL-1262-C19,cc3f9ed5-edcc-4a5a-883b-25bfca20b730,08408f5b-9f10-4457-b7e3-af92fa605d13,,Neoadjuvant,52.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-1262-C19_treatment,d1119838-34f5-411f-829a-3a8cdcb0872f,,released,Leucovorin Calcium,1,2021-12-23T08:32:56.149950-06:00,Chemotherapy,,
HCM-CSHL-1262-C19,cc3f9ed5-edcc-4a5a-883b-25bfca20b730,08408f5b-9f10-4457-b7e3-af92fa605d13,948.0,Adjuvant,920.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-1262-C19_treatment25,e447d10a-47e6-47de-9b0d-057ba63d4923,,released,Fluorouracil,1,2021-12-23T08:32:56.149950-06:00,Chemotherapy,Residual Disease,
HCM-CSHL-1262-C19,cc3f9ed5-edcc-4a5a-883b-25bfca20b730,08408f5b-9f10-4457-b7e3-af92fa605d13,710.0,Adjuvant,542.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-1262-C19_treatment20,e66d6d3c-91f9-4ded-84da-11572b42ac4f,,released,Cetuximab,1,2021-12-23T08:32:56.149950-06:00,Chemotherapy,Residual Disease,
HCM-CSHL-1262-C19,cc3f9ed5-edcc-4a5a-883b-25bfca20b730,08408f5b-9f10-4457-b7e3-af92fa605d13,710.0,Adjuvant,542.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-1262-C19_treatment19,ea1f8c5f-21fd-4ad0-ae55-96265814500a,,released,Fluorouracil,1,2021-12-23T08:32:56.149950-06:00,Chemotherapy,Residual Disease,
HCM-CSHL-1262-C19,cc3f9ed5-edcc-4a5a-883b-25bfca20b730,08408f5b-9f10-4457-b7e3-af92fa605d13,1109.0,Adjuvant,1049.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-1262-C19_treatment29,f193c2f3-7976-4376-a606-a09c25073421,,released,Leucovorin Calcium,1,2021-12-23T08:32:56.149950-06:00,Chemotherapy,Residual Disease,
HCM-CSHL-1262-C19,cc3f9ed5-edcc-4a5a-883b-25bfca20b730,08408f5b-9f10-4457-b7e3-af92fa605d13,441.0,Adjuvant,349.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-1262-C19_treatment13,f9a1a59c-9208-48ea-b7d1-2f02fc20f0e1,,released,Leucovorin Calcium,1,2021-12-23T08:32:56.149950-06:00,Chemotherapy,Residual Disease,
HCM-CSHL-1262-C19,cc3f9ed5-edcc-4a5a-883b-25bfca20b730,31013d7b-f1e9-44a8-aebe-076c9d1ca9ff,142.0,Maintenance Therapy,52.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-1262-C19_treatment43,a5a5e84b-ce48-4ec4-b793-f21c5face1bf,Progressive Disease,released,,1,2021-12-23T08:32:56.149950-06:00,,,FOLFIRI-cetuximab
HCM-CSHL-1262-C19,cc3f9ed5-edcc-4a5a-883b-25bfca20b730,31013d7b-f1e9-44a8-aebe-076c9d1ca9ff,142.0,Maintenance Therapy,52.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-1262-C19_treatment39,dd98436f-bef5-4ed1-9530-ec18834aa5d9,Progressive Disease,released,Irinotecan,1,2021-12-23T08:32:56.149950-06:00,,,
HCM-CSHL-1262-C19,cc3f9ed5-edcc-4a5a-883b-25bfca20b730,31013d7b-f1e9-44a8-aebe-076c9d1ca9ff,142.0,Maintenance Therapy,52.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-1262-C19_treatment40,df4e6c3f-50ce-4ee8-9e01-b3635f29b80d,Progressive Disease,released,Leucovorin Calcium,1,2021-12-23T08:32:56.149950-06:00,,,
HCM-CSHL-1262-C19,cc3f9ed5-edcc-4a5a-883b-25bfca20b730,31013d7b-f1e9-44a8-aebe-076c9d1ca9ff,142.0,Maintenance Therapy,52.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-1262-C19_treatment41,e056cfe3-6bc5-44e0-a5e3-7db81edc5360,Progressive Disease,released,Fluorouracil,1,2021-12-23T08:32:56.149950-06:00,,,
HCM-CSHL-1262-C19,cc3f9ed5-edcc-4a5a-883b-25bfca20b730,31013d7b-f1e9-44a8-aebe-076c9d1ca9ff,142.0,Maintenance Therapy,52.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-1262-C19_treatment42,f0933a9e-cdfa-4c10-8dc9-4206d7cd43aa,Progressive Disease,released,Cetuximab,1,2021-12-23T08:32:56.149950-06:00,,,
HCM-WCMC-1280-C54,cc86271e-34bc-4f3a-bd1b-9200a606a3fa,d64679c9-c5b7-4f7d-8d48-74fec98fb9d7,188.0,Adjuvant,76.0,2025-04-07T17:13:09.336794-05:00,HCM-WCMC-1280-C54_treatment3,06552f9f-c15d-485f-9814-dbc3b6dc1d8a,,released,Paclitaxel,1,2023-02-27T11:41:20.597188-06:00,Chemotherapy,Residual Disease,
HCM-WCMC-1280-C54,cc86271e-34bc-4f3a-bd1b-9200a606a3fa,d64679c9-c5b7-4f7d-8d48-74fec98fb9d7,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-WCMC-1280-C54_treatment7,3b717a56-c190-4c03-843a-0ee31f2fc482,,released,,0,2023-02-27T11:41:20.597188-06:00,Targeted Molecular Therapy,Residual Disease,
HCM-WCMC-1280-C54,cc86271e-34bc-4f3a-bd1b-9200a606a3fa,d64679c9-c5b7-4f7d-8d48-74fec98fb9d7,111.0,Adjuvant,83.0,2025-04-07T17:13:09.336794-05:00,HCM-WCMC-1280-C54_treatment8,8e242dc6-d2c6-4ca2-8b23-ec29e0ec6fc8,,released,,1,2023-02-27T11:41:20.597188-06:00,"Radiation Therapy, NOS",Residual Disease,
HCM-WCMC-1280-C54,cc86271e-34bc-4f3a-bd1b-9200a606a3fa,d64679c9-c5b7-4f7d-8d48-74fec98fb9d7,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-WCMC-1280-C54_treatment5,8ed2be13-36d6-4c9a-bd24-28738919d33c,,released,,0,2023-02-27T11:41:20.597188-06:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-WCMC-1280-C54,cc86271e-34bc-4f3a-bd1b-9200a606a3fa,d64679c9-c5b7-4f7d-8d48-74fec98fb9d7,,,23.0,2025-04-07T17:13:09.336794-05:00,HCM-WCMC-1280-C54_treatment6,9a7f2aab-95a1-4c56-995a-ff186dca08fb,,released,,1,2023-02-27T11:41:20.597188-06:00,"Surgery, NOS",Initial Diagnosis,
HCM-WCMC-1280-C54,cc86271e-34bc-4f3a-bd1b-9200a606a3fa,d64679c9-c5b7-4f7d-8d48-74fec98fb9d7,188.0,Adjuvant,76.0,2025-04-07T17:13:09.336794-05:00,HCM-WCMC-1280-C54_treatment2,a3e98dba-55ef-4d81-bd25-d79eb741cf3e,,released,Carboplatin,1,2023-02-27T11:41:20.597188-06:00,Chemotherapy,Residual Disease,
HCM-WCMC-1280-C54,cc86271e-34bc-4f3a-bd1b-9200a606a3fa,d64679c9-c5b7-4f7d-8d48-74fec98fb9d7,188.0,Adjuvant,76.0,2025-04-07T17:13:09.336794-05:00,HCM-WCMC-1280-C54_treatment4,bb02fcb7-3661-4fd5-9c55-642517bca998,,released,Anastrozole,1,2023-02-27T11:41:20.597188-06:00,Hormone Therapy,Residual Disease,
HCM-WCMC-1280-C54,cc86271e-34bc-4f3a-bd1b-9200a606a3fa,d64679c9-c5b7-4f7d-8d48-74fec98fb9d7,,Neoadjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-WCMC-1280-C54_treatment,f197edc7-368b-4e84-a47d-7b684ef5ad8b,,released,,0,2023-02-27T11:41:20.597188-06:00,,,
HCM-STAN-0909-C16,cd38c16c-c935-47a1-889b-0a48a6cd681c,77d94980-096f-4f28-9ace-7c69aa241d8c,,Neoadjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-STAN-0909-C16_treatment,36b30f95-6423-41cc-941f-9a2e5b2f2a3d,,released,,0,2022-09-22T07:09:10.640670-05:00,,,
HCM-STAN-0909-C16,cd38c16c-c935-47a1-889b-0a48a6cd681c,77d94980-096f-4f28-9ace-7c69aa241d8c,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-STAN-0909-C16_treatment4,549a4df6-941b-40a6-a959-0be48e84c156,,released,,0,2022-09-22T07:09:10.640670-05:00,"Radiation Therapy, NOS",Residual Disease,
HCM-STAN-0909-C16,cd38c16c-c935-47a1-889b-0a48a6cd681c,77d94980-096f-4f28-9ace-7c69aa241d8c,,,0.0,2025-04-07T17:13:09.336794-05:00,HCM-STAN-0909-C16_treatment2,c01bd9e8-b198-49f4-8bec-3bdbbe5eb8a4,,released,,1,2022-09-22T07:09:10.640670-05:00,"Surgery, NOS",Initial Diagnosis,
HCM-STAN-0909-C16,cd38c16c-c935-47a1-889b-0a48a6cd681c,77d94980-096f-4f28-9ace-7c69aa241d8c,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-STAN-0909-C16_treatment3,e5bb0398-807a-4971-a398-3f58560f3aa5,,released,,0,2022-09-22T07:09:10.640670-05:00,"Pharmaceutical Therapy, NOS",Residual Disease,
HCM-CSHL-0064-C18,cd6f37d5-d192-48b9-a63f-54d8d1e810c6,5dea9a2b-f5da-4f3d-aefa-f53f21a81fde,,Adjuvant,,2023-03-13T13:14:10.133380-05:00,HCM-CSHL-0064-C18_treatment3,1c1a4e2e-4426-4109-91f9-dd5f349cdea0,,released,,0,2019-05-15T13:04:39.907559-05:00,"Pharmaceutical Therapy, NOS",Residual Disease,
HCM-CSHL-0064-C18,cd6f37d5-d192-48b9-a63f-54d8d1e810c6,5dea9a2b-f5da-4f3d-aefa-f53f21a81fde,,Adjuvant,,2023-03-13T13:14:10.133380-05:00,HCM-CSHL-0064-C18_treatment4,69b806c9-fa81-442a-a64f-26afb9b03a51,,released,,0,2019-05-15T13:04:39.907559-05:00,"Radiation Therapy, NOS",Residual Disease,
HCM-CSHL-0064-C18,cd6f37d5-d192-48b9-a63f-54d8d1e810c6,5dea9a2b-f5da-4f3d-aefa-f53f21a81fde,,,28.0,2023-03-13T13:14:10.133380-05:00,HCM-CSHL-0064-C18_treatment2,6a465ce3-b993-42e1-95cd-0bed9e969503,,released,,1,2019-05-15T13:04:39.907559-05:00,"Surgery, NOS",Initial Diagnosis,
HCM-CSHL-0064-C18,cd6f37d5-d192-48b9-a63f-54d8d1e810c6,5dea9a2b-f5da-4f3d-aefa-f53f21a81fde,,Neoadjuvant,,2019-05-24T12:11:41.511797-05:00,HCM-CSHL-0064-C18_treatment,c2e8158e-4b18-42fc-a1f9-8cec78917599,,released,,0,2019-05-15T13:04:39.907559-05:00,,,
HCM-BROD-0574-C71,ce4c2cc5-ddbb-4870-a879-5b98305a9d2d,fa825e06-b2c4-492f-aa45-794d4452c608,231.0,Adjuvant,20.0,2023-02-22T07:39:25.979291-06:00,HCM-BROD-0574-C71_treatment2,01a18281-a8e9-408e-b532-891095df18af,,released,Temozolomide,1,2021-12-03T10:08:33.037445-06:00,Chemotherapy,Residual Disease,
HCM-BROD-0574-C71,ce4c2cc5-ddbb-4870-a879-5b98305a9d2d,fa825e06-b2c4-492f-aa45-794d4452c608,,Adjuvant,,2023-02-22T07:39:25.979291-06:00,HCM-BROD-0574-C71_treatment3,286b630a-51ac-45ac-b4e0-1aaaba148085,,released,,0,2021-12-03T10:08:33.037445-06:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-BROD-0574-C71,ce4c2cc5-ddbb-4870-a879-5b98305a9d2d,fa825e06-b2c4-492f-aa45-794d4452c608,41.0,Adjuvant,20.0,2023-02-22T07:39:25.979291-06:00,HCM-BROD-0574-C71_treatment6,689c69aa-b848-44d0-90ae-49f7f7a9923b,,released,,1,2021-12-03T10:08:33.037445-06:00,"Radiation, 3D Conformal",Residual Disease,
HCM-BROD-0574-C71,ce4c2cc5-ddbb-4870-a879-5b98305a9d2d,fa825e06-b2c4-492f-aa45-794d4452c608,,Neoadjuvant,,2023-02-22T07:39:25.979291-06:00,HCM-BROD-0574-C71_treatment,6e0a4e63-6fa3-4dd0-adcc-a4abc4590c9d,,released,,0,2021-12-03T10:08:33.037445-06:00,,,
HCM-BROD-0574-C71,ce4c2cc5-ddbb-4870-a879-5b98305a9d2d,fa825e06-b2c4-492f-aa45-794d4452c608,,,-6.0,2023-02-27T13:16:57.530709-06:00,HCM-BROD-0574-C71_treatment4,9c2bb99e-d646-4896-9f1f-79d81c0058ab,,released,,1,2021-12-03T10:08:33.037445-06:00,"Surgery, NOS",Initial Diagnosis,
HCM-BROD-0574-C71,ce4c2cc5-ddbb-4870-a879-5b98305a9d2d,fa825e06-b2c4-492f-aa45-794d4452c608,436.0,Adjuvant,413.0,2023-02-22T07:39:25.979291-06:00,HCM-BROD-0574-C71_treatment5,b1dd3239-a6bc-48ff-8f05-bbc3fcb2df44,,released,Bevacizumab,1,2021-12-03T10:08:33.037445-06:00,Targeted Molecular Therapy,Residual Disease,
HCM-SANG-0549-C15,ce97cd4b-f81f-4f99-a96d-29ca5f814af5,d8347942-7ac8-449f-a94a-7a46c30a3402,,Neoadjuvant,118.0,2025-03-31T16:34:59.906497-05:00,HCM-SANG-0549-C15_treatment,1da5e93f-87a3-41f4-b879-7c27a45aa46e,,released,Epirubicin,1,2021-12-21T15:17:17.992885-06:00,Chemotherapy,,
HCM-SANG-0549-C15,ce97cd4b-f81f-4f99-a96d-29ca5f814af5,d8347942-7ac8-449f-a94a-7a46c30a3402,,Neoadjuvant,118.0,2025-03-31T16:34:59.906497-05:00,HCM-SANG-0549-C15_treatment2,796a147b-8a0b-473c-95cf-60d802d2128b,,released,Capecitabine,1,2021-12-21T15:17:17.992885-06:00,Chemotherapy,,
HCM-SANG-0549-C15,ce97cd4b-f81f-4f99-a96d-29ca5f814af5,d8347942-7ac8-449f-a94a-7a46c30a3402,,Neoadjuvant,118.0,2025-03-31T16:34:59.906497-05:00,HCM-SANG-0549-C15_treatment3,9e115a45-5818-4155-9c04-0a793bd8ee85,,released,Cisplatin,1,2021-12-21T15:17:17.992885-06:00,Chemotherapy,,
HCM-SANG-0549-C15,ce97cd4b-f81f-4f99-a96d-29ca5f814af5,d8347942-7ac8-449f-a94a-7a46c30a3402,,Neoadjuvant,118.0,2025-03-31T16:34:59.906497-05:00,HCM-SANG-0549-C15_treatment4,a7095369-7536-488e-99c1-40816e99d407,,released,,1,2021-12-21T15:17:17.992885-06:00,Chemotherapy,,ECX
HCM-SANG-0549-C15,ce97cd4b-f81f-4f99-a96d-29ca5f814af5,d8347942-7ac8-449f-a94a-7a46c30a3402,,Neoadjuvant,118.0,2025-03-31T16:34:59.906497-05:00,HCM-SANG-0549-C15_treatment5,f1ba2da9-34cc-44b6-88d3-39382a3d1136,,released,Dexamethasone,1,2021-12-21T15:17:17.992885-06:00,Chemotherapy,,
HCM-SANG-0282-C18,cf3e235e-676c-45de-a746-2ea45fd2142f,012a9f99-40b7-4da1-94ba-958285d5e5ef,,Neoadjuvant,,2023-02-22T07:39:25.979291-06:00,HCM-SANG-0282-C18_treatment,34be8d18-6bff-476d-b0c4-d1a8d6877f29,,released,,0,2020-02-11T15:57:56.567720-06:00,,,
HCM-BROD-0015-C25,cf4e22e6-18dc-4a1b-a1d3-1c9ceddd232d,a753468d-9c43-4fd5-a1a0-152e772d9cdf,,Adjuvant,,2023-07-13T10:35:44.371881-05:00,HCM-BROD-0015-C25_treatment9,1a9e579f-9e89-4750-9947-57d7bec3c2e5,,released,,0,2020-09-27T10:03:21.592898-05:00,"Radiation Therapy, NOS",Residual Disease,
HCM-BROD-0015-C25,cf4e22e6-18dc-4a1b-a1d3-1c9ceddd232d,a753468d-9c43-4fd5-a1a0-152e772d9cdf,,Adjuvant,316.0,2023-07-13T10:35:44.371881-05:00,HCM-BROD-0015-C25_treatment5,44ef1706-c92b-4716-983c-067e8fb55f7f,,released,Nab-paclitaxel,1,2019-04-16T11:20:11.037816-05:00,Chemotherapy,Residual Disease,
HCM-BROD-0015-C25,cf4e22e6-18dc-4a1b-a1d3-1c9ceddd232d,a753468d-9c43-4fd5-a1a0-152e772d9cdf,,Adjuvant,36.0,2023-07-13T10:35:44.371881-05:00,HCM-BROD-0015-C25_treatment3,5203949b-945c-479e-b58a-bd9ef8cd7f3a,,released,Nab-paclitaxel,1,2019-04-16T11:20:11.037816-05:00,Chemotherapy,Residual Disease,
HCM-BROD-0015-C25,cf4e22e6-18dc-4a1b-a1d3-1c9ceddd232d,a753468d-9c43-4fd5-a1a0-152e772d9cdf,,Adjuvant,36.0,2023-07-13T10:35:44.371881-05:00,HCM-BROD-0015-C25_treatment2,680f38cb-662e-44d3-854c-6b28c43207fd,,released,Gemcitabine,1,2019-04-16T11:20:11.037816-05:00,Chemotherapy,Residual Disease,
HCM-BROD-0015-C25,cf4e22e6-18dc-4a1b-a1d3-1c9ceddd232d,a753468d-9c43-4fd5-a1a0-152e772d9cdf,,Neoadjuvant,,2023-07-13T10:35:44.371881-05:00,HCM-BROD-0015-C25_treatment,7acdfc32-05ec-4404-8193-4b19883bff0b,,released,,0,2019-04-16T11:20:11.037816-05:00,,,
HCM-BROD-0015-C25,cf4e22e6-18dc-4a1b-a1d3-1c9ceddd232d,a753468d-9c43-4fd5-a1a0-152e772d9cdf,,Adjuvant,,2023-07-13T10:35:44.371881-05:00,HCM-BROD-0015-C25_treatment8,9e163469-e776-46f2-b2a3-1be1525cf2e2,,released,,0,2020-09-27T10:03:21.592898-05:00,Targeted Molecular Therapy,Residual Disease,
HCM-BROD-0015-C25,cf4e22e6-18dc-4a1b-a1d3-1c9ceddd232d,a753468d-9c43-4fd5-a1a0-152e772d9cdf,,Adjuvant,316.0,2023-07-13T10:35:44.371881-05:00,HCM-BROD-0015-C25_treatment4,a7480fe2-44a9-431d-90ea-b360e1fb5950,,released,Gemcitabine,1,2019-04-16T11:20:11.037816-05:00,Chemotherapy,Residual Disease,
HCM-BROD-0015-C25,cf4e22e6-18dc-4a1b-a1d3-1c9ceddd232d,a753468d-9c43-4fd5-a1a0-152e772d9cdf,,Adjuvant,,2023-07-13T10:35:44.371881-05:00,HCM-BROD-0015-C25_treatment6,a875e192-6cf2-4623-8436-516fb0036c4a,,released,,0,2019-04-16T11:20:11.037816-05:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-BROD-0015-C25,cf4e22e6-18dc-4a1b-a1d3-1c9ceddd232d,a753468d-9c43-4fd5-a1a0-152e772d9cdf,,,-8.0,2023-07-13T10:35:44.371881-05:00,HCM-BROD-0015-C25_treatment7,c4448171-1e7c-4a01-9164-53e0adb16043,,released,,1,2019-04-16T11:20:11.037816-05:00,"Surgery, NOS",Initial Diagnosis,
HCM-CSHL-0320-C02,cf726c27-b74c-4feb-96ef-bd463ae9c179,76aba0fa-1161-4a88-99e3-934eb8be5d90,,Neoadjuvant,,2023-07-13T10:35:44.371881-05:00,HCM-CSHL-0320-C02_treatment,4ee7b3ab-edec-4dee-8310-220ba4c6d620,,released,,0,2020-09-28T09:47:50.528705-05:00,,,
HCM-CSHL-0320-C02,cf726c27-b74c-4feb-96ef-bd463ae9c179,76aba0fa-1161-4a88-99e3-934eb8be5d90,,Adjuvant,,2023-07-13T10:35:44.371881-05:00,HCM-CSHL-0320-C02_treatment4,5172afdd-cbbe-48f6-a774-d4a31f7894ef,,released,,1,2020-09-28T09:47:50.528705-05:00,"Radiation, Intensity-Modulated Radiotherapy",Residual Disease,
HCM-CSHL-0320-C02,cf726c27-b74c-4feb-96ef-bd463ae9c179,76aba0fa-1161-4a88-99e3-934eb8be5d90,,Adjuvant,,2023-07-13T10:35:44.371881-05:00,HCM-CSHL-0320-C02_treatment3,9dd66c77-743e-4d47-bc98-e67156eaf7f8,,released,,0,2020-09-28T09:47:50.528705-05:00,"Pharmaceutical Therapy, NOS",Residual Disease,
HCM-CSHL-0320-C02,cf726c27-b74c-4feb-96ef-bd463ae9c179,76aba0fa-1161-4a88-99e3-934eb8be5d90,,,56.0,2023-07-13T10:35:44.371881-05:00,HCM-CSHL-0320-C02_treatment2,b98c8874-8c29-4338-afd1-60efe230700a,,released,,1,2020-09-28T09:47:50.528705-05:00,"Surgery, NOS",Initial Diagnosis,
HCM-BROD-0648-C71,cf7c73f3-b680-496d-94e5-22951ef84b79,6b9e8493-2a08-4518-93ad-5c5643487a87,55.0,Adjuvant,3.0,2023-03-13T12:55:14.373273-05:00,HCM-BROD-0648-C71_treatment7,136693ea-d26d-4497-a6f6-a2fcf9dfe427,,released,,1,2021-12-21T13:42:24.003548-06:00,"Radiation, 3D Conformal",Residual Disease,
HCM-BROD-0648-C71,cf7c73f3-b680-496d-94e5-22951ef84b79,6b9e8493-2a08-4518-93ad-5c5643487a87,,Neoadjuvant,,2023-02-22T07:39:25.979291-06:00,HCM-BROD-0648-C71_treatment3,5ed3ac90-7d4d-408f-bf6c-40869e4cddf3,,released,,1,2021-12-21T13:42:24.003548-06:00,Targeted Molecular Therapy,,
HCM-BROD-0648-C71,cf7c73f3-b680-496d-94e5-22951ef84b79,6b9e8493-2a08-4518-93ad-5c5643487a87,,Neoadjuvant,3.0,2023-02-22T07:39:25.979291-06:00,HCM-BROD-0648-C71_treatment2,7e5c5a03-7176-4ebc-b1b1-745a311cd319,,released,,1,2021-12-21T13:42:24.003548-06:00,"Radiation, 3D Conformal",,
HCM-BROD-0648-C71,cf7c73f3-b680-496d-94e5-22951ef84b79,6b9e8493-2a08-4518-93ad-5c5643487a87,414.0,Adjuvant,3.0,2023-02-22T07:39:25.979291-06:00,HCM-BROD-0648-C71_treatment4,8e472462-939d-4635-9788-c84d45a78b00,,released,Temozolomide,1,2021-12-21T13:42:24.003548-06:00,Chemotherapy,Residual Disease,
HCM-BROD-0648-C71,cf7c73f3-b680-496d-94e5-22951ef84b79,6b9e8493-2a08-4518-93ad-5c5643487a87,1686.0,Adjuvant,1639.0,2023-03-13T12:55:14.373273-05:00,HCM-BROD-0648-C71_treatment6,a4a6eee8-73cd-4864-a951-8c470f20b1a6,,released,Bevacizumab,1,2021-12-21T13:42:24.003548-06:00,Targeted Molecular Therapy,Residual Disease,
HCM-BROD-0648-C71,cf7c73f3-b680-496d-94e5-22951ef84b79,6b9e8493-2a08-4518-93ad-5c5643487a87,,,-22.0,2023-03-13T12:55:14.373273-05:00,HCM-BROD-0648-C71_treatment5,d35c3350-da13-4d5d-a045-bfcaff28a308,,released,,1,2021-12-21T13:42:24.003548-06:00,"Surgery, NOS",Initial Diagnosis,
HCM-BROD-0648-C71,cf7c73f3-b680-496d-94e5-22951ef84b79,6b9e8493-2a08-4518-93ad-5c5643487a87,,Neoadjuvant,3.0,2023-02-22T07:39:25.979291-06:00,HCM-BROD-0648-C71_treatment,da621066-e927-4fb4-9ec3-1430983887a6,,released,Temozolomide,1,2021-12-21T13:42:24.003548-06:00,Chemotherapy,,
HCM-BROD-0648-C71,cf7c73f3-b680-496d-94e5-22951ef84b79,b26eda69-cd41-4748-baa1-8472b2440b5c,1534.0,Maintenance Therapy,3.0,2023-03-14T11:40:17.645275-05:00,HCM-BROD-0648-C71_treatment8,f8f97b07-5f37-48dc-a16b-ab1bf7299529,Progressive Disease,released,Temozolomide,1,2023-03-13T12:55:14.373273-05:00,,,
HCM-CSHL-0057-C18,d000dcfe-181c-46fe-93ba-5fce8336b52d,3dc3296f-d00f-4e44-abc2-e85f05ec5d94,,Adjuvant,38.0,2020-10-08T18:58:28.680234-05:00,HCM-CSHL-0057-C18_treatment7,08b5becb-0e84-4e12-bace-8a38bdc6489d,,released,Oxaliplatin,1,2020-02-11T14:43:34.823831-06:00,Chemotherapy,Residual Disease,
HCM-CSHL-0057-C18,d000dcfe-181c-46fe-93ba-5fce8336b52d,3dc3296f-d00f-4e44-abc2-e85f05ec5d94,,Neoadjuvant,38.0,2020-10-08T18:58:28.680234-05:00,HCM-CSHL-0057-C18_treatment4,0be1fac3-5294-42ad-b539-b4b0f5842090,,released,,1,2020-02-11T14:43:34.823831-06:00,Chemotherapy,,FOLFOX
HCM-CSHL-0057-C18,d000dcfe-181c-46fe-93ba-5fce8336b52d,3dc3296f-d00f-4e44-abc2-e85f05ec5d94,,Adjuvant,203.0,2020-10-20T19:20:06.800740-05:00,HCM-CSHL-0057-C18_treatment12,302ece20-6e9a-4817-bea7-baba6adc40df,,released,,1,2020-10-08T18:58:28.680234-05:00,Chemotherapy,Residual Disease,FOLFIRI
HCM-CSHL-0057-C18,d000dcfe-181c-46fe-93ba-5fce8336b52d,3dc3296f-d00f-4e44-abc2-e85f05ec5d94,,Adjuvant,203.0,2020-10-20T19:20:06.800740-05:00,HCM-CSHL-0057-C18_treatment17,34748745-38b7-4827-8a84-a573f1755c2e,Treatment Ongoing,released,Bevacizumab,1,2020-10-08T18:58:28.680234-05:00,Targeted Molecular Therapy,Residual Disease,
HCM-CSHL-0057-C18,d000dcfe-181c-46fe-93ba-5fce8336b52d,3dc3296f-d00f-4e44-abc2-e85f05ec5d94,,Adjuvant,331.0,2020-10-20T19:20:06.800740-05:00,HCM-CSHL-0057-C18_treatment14,3e75cff4-ce62-4be7-ac3c-4a4f7759318b,Treatment Ongoing,released,Irinotecan,1,2020-10-08T18:58:28.680234-05:00,Chemotherapy,Residual Disease,
HCM-CSHL-0057-C18,d000dcfe-181c-46fe-93ba-5fce8336b52d,3dc3296f-d00f-4e44-abc2-e85f05ec5d94,,Adjuvant,123.0,2020-10-20T19:20:06.800740-05:00,HCM-CSHL-0057-C18_treatment18,448806ee-38ae-4bd2-94bc-0745af2cf6b4,,released,,1,2020-10-08T18:58:28.680234-05:00,"Ablation, Radiofrequency",Residual Disease,
HCM-CSHL-0057-C18,d000dcfe-181c-46fe-93ba-5fce8336b52d,3dc3296f-d00f-4e44-abc2-e85f05ec5d94,,Neoadjuvant,38.0,2020-10-08T18:58:28.680234-05:00,HCM-CSHL-0057-C18_treatment,4652a854-86e4-4043-9dcc-4b932ff62e47,,released,Leucovorin Calcium,1,2020-02-11T14:43:34.823831-06:00,Chemotherapy,,
HCM-CSHL-0057-C18,d000dcfe-181c-46fe-93ba-5fce8336b52d,3dc3296f-d00f-4e44-abc2-e85f05ec5d94,,Neoadjuvant,38.0,2020-10-08T18:58:28.680234-05:00,HCM-CSHL-0057-C18_treatment2,648001c6-3c0c-4daf-a00e-7d1688de3f30,,released,Fluorouracil,1,2020-02-11T14:43:34.823831-06:00,Chemotherapy,,
HCM-CSHL-0057-C18,d000dcfe-181c-46fe-93ba-5fce8336b52d,3dc3296f-d00f-4e44-abc2-e85f05ec5d94,,Adjuvant,203.0,2020-10-20T19:20:06.800740-05:00,HCM-CSHL-0057-C18_treatment10,8e8738d0-57e0-41f7-bd25-f59eec360925,,released,Fluorouracil,1,2020-10-08T18:58:28.680234-05:00,Chemotherapy,Residual Disease,
HCM-CSHL-0057-C18,d000dcfe-181c-46fe-93ba-5fce8336b52d,3dc3296f-d00f-4e44-abc2-e85f05ec5d94,,Adjuvant,38.0,2020-10-08T18:58:28.680234-05:00,HCM-CSHL-0057-C18_treatment5,91e58cd4-79b6-432f-82f2-3f109e2be2cf,,released,Leucovorin Calcium,1,2020-02-11T14:43:34.823831-06:00,Chemotherapy,Residual Disease,
HCM-CSHL-0057-C18,d000dcfe-181c-46fe-93ba-5fce8336b52d,3dc3296f-d00f-4e44-abc2-e85f05ec5d94,,Adjuvant,38.0,2020-10-08T18:58:28.680234-05:00,HCM-CSHL-0057-C18_treatment6,a4fd8d31-1be0-441a-83b1-2fdb13e73741,,released,Fluorouracil,1,2020-02-11T14:43:34.823831-06:00,Chemotherapy,Residual Disease,
HCM-CSHL-0057-C18,d000dcfe-181c-46fe-93ba-5fce8336b52d,3dc3296f-d00f-4e44-abc2-e85f05ec5d94,,Adjuvant,203.0,2020-10-08T18:58:28.680234-05:00,HCM-CSHL-0057-C18_treatment9,b2c093d2-c9fb-43a7-aa33-595eb8474184,,released,Leucovorin Calcium,1,2020-02-11T14:43:34.823831-06:00,Chemotherapy,Residual Disease,
HCM-CSHL-0057-C18,d000dcfe-181c-46fe-93ba-5fce8336b52d,3dc3296f-d00f-4e44-abc2-e85f05ec5d94,,Adjuvant,38.0,2020-10-08T18:58:28.680234-05:00,HCM-CSHL-0057-C18_treatment8,bbb425dc-3899-4d9d-957b-c46f6f63e748,,released,,1,2020-02-11T14:43:34.823831-06:00,Chemotherapy,Residual Disease,FOLFOX
HCM-CSHL-0057-C18,d000dcfe-181c-46fe-93ba-5fce8336b52d,3dc3296f-d00f-4e44-abc2-e85f05ec5d94,,,123.0,2023-03-13T13:24:57.687758-05:00,HCM-CSHL-0057-C18_treatment16,d54666cf-3635-4db6-a451-57edcb9b18aa,,released,,1,2020-10-08T18:58:28.680234-05:00,"Surgery, NOS",Initial Diagnosis,
HCM-CSHL-0057-C18,d000dcfe-181c-46fe-93ba-5fce8336b52d,3dc3296f-d00f-4e44-abc2-e85f05ec5d94,,Adjuvant,,2020-10-20T19:20:06.800740-05:00,HCM-CSHL-0057-C18_treatment15,d690ba9b-6364-428c-997c-0f9d15a24ae6,,released,,0,2020-10-08T18:58:28.680234-05:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-CSHL-0057-C18,d000dcfe-181c-46fe-93ba-5fce8336b52d,3dc3296f-d00f-4e44-abc2-e85f05ec5d94,,Adjuvant,203.0,2020-10-20T19:20:06.800740-05:00,HCM-CSHL-0057-C18_treatment11,e6902cc3-153c-433a-ba92-d64161e51964,,released,Irinotecan,1,2020-10-08T18:58:28.680234-05:00,Chemotherapy,Residual Disease,
HCM-CSHL-0057-C18,d000dcfe-181c-46fe-93ba-5fce8336b52d,3dc3296f-d00f-4e44-abc2-e85f05ec5d94,,Adjuvant,331.0,2020-10-20T19:20:06.800740-05:00,HCM-CSHL-0057-C18_treatment13,ee90bb66-9a20-4674-a767-abfaa5c04027,Treatment Ongoing,released,Capecitabine,1,2020-10-08T18:58:28.680234-05:00,Chemotherapy,Residual Disease,
HCM-CSHL-0057-C18,d000dcfe-181c-46fe-93ba-5fce8336b52d,3dc3296f-d00f-4e44-abc2-e85f05ec5d94,,Neoadjuvant,38.0,2020-10-08T18:58:28.680234-05:00,HCM-CSHL-0057-C18_treatment3,f1f57b87-e52e-43b1-8607-1684bc676090,,released,Oxaliplatin,1,2020-02-11T14:43:34.823831-06:00,Chemotherapy,,
HCM-CSHL-0369-D37,d15fc66d-22d5-45f5-9d6b-ba268aac35f3,12210be0-aaa1-4b28-bbd3-170bb066223a,,Neoadjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0369-D37_treatment,235fa68d-07e4-4aa1-a74f-1af043788870,,released,,0,2020-09-28T09:53:16.211313-05:00,,,
HCM-CSHL-0369-D37,d15fc66d-22d5-45f5-9d6b-ba268aac35f3,12210be0-aaa1-4b28-bbd3-170bb066223a,,Adjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0369-D37_treatment3,426e9b0e-a6ba-4642-879a-7a2cb2ce9e6b,,released,,0,2020-09-28T09:53:16.211313-05:00,"Pharmaceutical Therapy, NOS",Residual Disease,
HCM-CSHL-0369-D37,d15fc66d-22d5-45f5-9d6b-ba268aac35f3,12210be0-aaa1-4b28-bbd3-170bb066223a,,Adjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0369-D37_treatment4,8a982599-fcff-489f-a403-e16b2837a44c,,released,,0,2020-09-28T09:53:16.211313-05:00,"Radiation Therapy, NOS",Residual Disease,
HCM-CSHL-0369-D37,d15fc66d-22d5-45f5-9d6b-ba268aac35f3,12210be0-aaa1-4b28-bbd3-170bb066223a,,,6.0,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0369-D37_treatment2,ea7cd995-5010-42e1-83a0-6b6aa2985d13,,released,,1,2020-09-28T09:53:16.211313-05:00,"Surgery, NOS",Initial Diagnosis,
HCM-SANG-1334-C18,d1cf2815-e9df-410a-a62e-e74883edc960,b9ee57dc-2501-4cc7-b4ce-450b0b478124,,Neoadjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-SANG-1334-C18_treatment,d86152a9-71e5-4944-9915-9270a180be94,,released,,0,2023-02-27T12:41:01.367731-06:00,,,
HCM-SANG-1301-C20,d22d578c-1bdd-4a01-a6dc-731a717b7e2c,2cf46fce-ea34-4fa2-bcb7-ca87da569a9c,,Neoadjuvant,1051.0,2025-04-07T17:13:09.336794-05:00,HCM-SANG-1301-C20_treatment,1e72fa66-f294-4698-b89f-62c1e5ed1d91,,released,Capecitabine,1,2023-02-27T13:22:45.548221-06:00,Chemotherapy,,
HCM-SANG-1301-C20,d22d578c-1bdd-4a01-a6dc-731a717b7e2c,2cf46fce-ea34-4fa2-bcb7-ca87da569a9c,,Neoadjuvant,1051.0,2025-04-07T17:13:09.336794-05:00,HCM-SANG-1301-C20_treatment2,96b85f8a-c31b-4392-b728-fedded4cee1a,,released,,1,2023-02-27T13:22:45.548221-06:00,"Radiation Therapy, NOS",,
HCM-BROD-0925-C71,d230be66-fdb1-463f-90d6-484a6e968277,23969820-ec4e-4cb0-9a10-5c0ea085e192,1801.0,Adjuvant,1780.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0925-C71_treatment5,2b7678e2-78e2-47ed-9fe9-5fcb4040ac83,,released,Bevacizumab,1,2021-12-21T13:57:16.889602-06:00,Targeted Molecular Therapy,Residual Disease,
HCM-BROD-0925-C71,d230be66-fdb1-463f-90d6-484a6e968277,23969820-ec4e-4cb0-9a10-5c0ea085e192,,Neoadjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0925-C71_treatment,50c6cf15-6476-4ffc-9979-0f25f4b687f8,,released,,0,2021-12-21T13:57:16.889602-06:00,,,
HCM-BROD-0925-C71,d230be66-fdb1-463f-90d6-484a6e968277,23969820-ec4e-4cb0-9a10-5c0ea085e192,,,0.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0925-C71_treatment4,928fbe0d-8a97-49a5-86ac-220a54ea082f,,released,,1,2021-12-21T13:57:16.889602-06:00,"Surgery, NOS",Initial Diagnosis,
HCM-BROD-0925-C71,d230be66-fdb1-463f-90d6-484a6e968277,23969820-ec4e-4cb0-9a10-5c0ea085e192,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0925-C71_treatment2,a2cdc168-2378-4c0f-b861-f4e378421241,,released,,0,2021-12-21T13:57:16.889602-06:00,Chemotherapy,Residual Disease,
HCM-BROD-0925-C71,d230be66-fdb1-463f-90d6-484a6e968277,23969820-ec4e-4cb0-9a10-5c0ea085e192,1675.0,Adjuvant,1515.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0925-C71_treatment3,c18b3d70-a868-430d-b049-fb143ef5b4cf,,released,Not Reported,1,2021-12-21T13:57:16.889602-06:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-BROD-0925-C71,d230be66-fdb1-463f-90d6-484a6e968277,23969820-ec4e-4cb0-9a10-5c0ea085e192,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0925-C71_treatment6,ed6ca049-10ae-4889-99e7-a0fe1b92a475,,released,,0,2021-12-21T13:57:16.889602-06:00,"Radiation Therapy, NOS",Residual Disease,
HCM-BROD-0925-C71,d230be66-fdb1-463f-90d6-484a6e968277,72a6e958-ea4c-4246-8627-378febde427d,1515.0,Maintenance Therapy,31.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0925-C71_treatment7,9d013032-3b23-43ba-8779-2fd4819f58a1,Treatment Ongoing,released,Temozolomide,1,2021-12-21T13:57:16.889602-06:00,,,
HCM-SANG-1093-C18,d2a6bc00-8278-40f4-a30a-664a907b7754,7d2ce11d-e5da-43fc-9da4-da92a7b0b59a,,Neoadjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-SANG-1093-C18_treatment,2bf800ca-ce23-4639-b973-40671abe1b52,,released,,0,2023-02-27T11:28:18.202722-06:00,,,
HCM-CSHL-0765-C56,d2d0522a-bad8-4282-b67d-bed52e7efab4,0ed0dad0-8d5e-4d99-9fb3-9fca090aa172,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0765-C56_treatment3,36f14c9e-2e37-49a2-99fb-59be4ac39827,,released,,unknown,2021-12-21T14:21:53.350414-06:00,"Pharmaceutical Therapy, NOS",Residual Disease,
HCM-CSHL-0765-C56,d2d0522a-bad8-4282-b67d-bed52e7efab4,0ed0dad0-8d5e-4d99-9fb3-9fca090aa172,,,,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0765-C56_treatment2,8217d19e-0610-4b34-a538-e4a0d8635c44,,released,,unknown,2021-12-21T14:21:53.350414-06:00,"Surgery, NOS",Initial Diagnosis,
HCM-CSHL-0765-C56,d2d0522a-bad8-4282-b67d-bed52e7efab4,0ed0dad0-8d5e-4d99-9fb3-9fca090aa172,,Neoadjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0765-C56_treatment,aabdccb2-57d6-4a73-a705-2269fab0fb8e,,released,,0,2021-12-21T14:21:53.350414-06:00,,,
HCM-CSHL-0864-C44,d2de259e-d8bb-40ae-a155-c288e016fee6,08f912cd-92f4-4b6a-be1f-fcc23a868f9f,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0864-C44_treatment3,66c9a2ed-ee84-45a1-8a7e-c7babf12e7d5,,released,,0,2021-12-21T14:36:08.386361-06:00,"Pharmaceutical Therapy, NOS",Residual Disease,
HCM-CSHL-0864-C44,d2de259e-d8bb-40ae-a155-c288e016fee6,08f912cd-92f4-4b6a-be1f-fcc23a868f9f,,,240.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0864-C44_treatment2,6790d74c-6198-43f0-9ede-90a4d515ed27,,released,,1,2021-12-21T14:36:08.386361-06:00,"Surgery, NOS",Initial Diagnosis,
HCM-CSHL-0864-C44,d2de259e-d8bb-40ae-a155-c288e016fee6,08f912cd-92f4-4b6a-be1f-fcc23a868f9f,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0864-C44_treatment4,7f588ac9-af08-445b-801a-f001598842d6,,released,,1,2021-12-21T14:36:08.386361-06:00,"Radiation Therapy, NOS",Residual Disease,
HCM-CSHL-0864-C44,d2de259e-d8bb-40ae-a155-c288e016fee6,08f912cd-92f4-4b6a-be1f-fcc23a868f9f,,Neoadjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0864-C44_treatment,f1a754aa-bf79-4939-bb82-5cdd77600f35,,released,,0,2021-12-21T14:36:08.386361-06:00,,,
HCM-CSHL-0864-C44,d2de259e-d8bb-40ae-a155-c288e016fee6,68ec592d-024a-4808-b2e6-d411279166fc,,Maintenance Therapy,30.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0864-C44_treatment5,7d9d26cc-c3d2-4036-8821-cd17e8ebe4f0,Stable Disease,released,,1,2023-02-28T11:48:02.210717-06:00,,,
HCM-CSHL-0768-C56,d341953c-f4a1-4c6b-ac1a-50f1b956c696,4441f9ee-bf7b-48a8-955a-be59bb7868ce,,,0.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0768-C56_treatment2,5209fffa-36c5-4dd9-8186-062c32154832,,released,,1,2021-12-21T14:22:05.298239-06:00,"Surgery, NOS",Initial Diagnosis,
HCM-CSHL-0768-C56,d341953c-f4a1-4c6b-ac1a-50f1b956c696,4441f9ee-bf7b-48a8-955a-be59bb7868ce,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0768-C56_treatment3,61281cb8-817b-4128-a334-8f66a56fe897,,released,,unknown,2021-12-21T14:22:05.298239-06:00,"Pharmaceutical Therapy, NOS",Residual Disease,
HCM-CSHL-0768-C56,d341953c-f4a1-4c6b-ac1a-50f1b956c696,4441f9ee-bf7b-48a8-955a-be59bb7868ce,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0768-C56_treatment4,81b6a182-2fc4-400f-8662-71ecad12e671,,released,,unknown,2021-12-21T14:22:05.298239-06:00,"Radiation Therapy, NOS",Residual Disease,
HCM-CSHL-0768-C56,d341953c-f4a1-4c6b-ac1a-50f1b956c696,4441f9ee-bf7b-48a8-955a-be59bb7868ce,,Neoadjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0768-C56_treatment,f27fed65-c65e-4733-b482-1e24ae389c5e,,released,,0,2021-12-21T14:22:05.298239-06:00,,,
HCM-BROD-0615-C16,d3a9dd49-6f2b-40aa-8027-e4c24421bf9f,6399baeb-5f6a-4647-ac8f-8c3c4cec7b9a,334.0,Maintenance Therapy,287.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0615-C16_treatment18,27578afc-dd31-417e-8d88-fe41a81d281d,Not Reported,released,,1,2021-12-21T13:42:09.704693-06:00,,,FOLFIRI
HCM-BROD-0615-C16,d3a9dd49-6f2b-40aa-8027-e4c24421bf9f,6399baeb-5f6a-4647-ac8f-8c3c4cec7b9a,334.0,Maintenance Therapy,287.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0615-C16_treatment16,59a41da6-ebb4-4e02-a2c7-4b0bb364870d,Not Reported,released,Fluorouracil,1,2021-12-21T13:42:09.704693-06:00,,,
HCM-BROD-0615-C16,d3a9dd49-6f2b-40aa-8027-e4c24421bf9f,6399baeb-5f6a-4647-ac8f-8c3c4cec7b9a,334.0,Maintenance Therapy,287.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0615-C16_treatment17,a1e6c242-0869-41ae-9871-9b967dbe04f7,Not Reported,released,Irinotecan,1,2021-12-21T13:42:09.704693-06:00,,,
HCM-BROD-0615-C16,d3a9dd49-6f2b-40aa-8027-e4c24421bf9f,6399baeb-5f6a-4647-ac8f-8c3c4cec7b9a,334.0,Maintenance Therapy,287.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0615-C16_treatment15,aad26504-f6a2-40f5-9578-2830dae4e959,Not Reported,released,Leucovorin Calcium,1,2021-12-21T13:42:09.704693-06:00,,,
HCM-BROD-0615-C16,d3a9dd49-6f2b-40aa-8027-e4c24421bf9f,c7970450-8598-459e-bc41-406da574b525,,,0.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0615-C16_treatment12,271795c6-2e58-4b22-ba01-4bb92840ca34,,released,,1,2021-12-21T13:42:09.704693-06:00,"Surgery, NOS",Initial Diagnosis,
HCM-BROD-0615-C16,d3a9dd49-6f2b-40aa-8027-e4c24421bf9f,c7970450-8598-459e-bc41-406da574b525,334.0,Adjuvant,287.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0615-C16_treatment8,2bd8874f-4cf5-4b97-be80-e6dbbf01093a,,released,Fluorouracil,1,2021-12-21T13:42:09.704693-06:00,Chemotherapy,Residual Disease,
HCM-BROD-0615-C16,d3a9dd49-6f2b-40aa-8027-e4c24421bf9f,c7970450-8598-459e-bc41-406da574b525,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0615-C16_treatment14,3644896d-4c97-4af9-9b31-2afd1151667b,,released,,0,2021-12-21T13:42:09.704693-06:00,"Radiation Therapy, NOS",Residual Disease,
HCM-BROD-0615-C16,d3a9dd49-6f2b-40aa-8027-e4c24421bf9f,c7970450-8598-459e-bc41-406da574b525,96.0,Adjuvant,35.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0615-C16_treatment5,55ef3e4e-d9df-4607-903c-25bd451cbf73,,released,,1,2021-12-21T13:42:09.704693-06:00,Chemotherapy,Residual Disease,FOLFOX
HCM-BROD-0615-C16,d3a9dd49-6f2b-40aa-8027-e4c24421bf9f,c7970450-8598-459e-bc41-406da574b525,334.0,Adjuvant,287.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0615-C16_treatment10,6b73f98c-0bd9-4f2c-abca-5b8206774c5c,,released,,1,2021-12-21T13:42:09.704693-06:00,Chemotherapy,Residual Disease,FOLFIRI
HCM-BROD-0615-C16,d3a9dd49-6f2b-40aa-8027-e4c24421bf9f,c7970450-8598-459e-bc41-406da574b525,,Neoadjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0615-C16_treatment,6ddbd07e-ae17-42c4-a9a9-031617779603,,released,,0,2021-12-21T13:42:09.704693-06:00,,,
HCM-BROD-0615-C16,d3a9dd49-6f2b-40aa-8027-e4c24421bf9f,c7970450-8598-459e-bc41-406da574b525,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0615-C16_treatment11,6ed5ddd9-23b4-4e26-bf77-055b573226d7,,released,,0,2021-12-21T13:42:09.704693-06:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-BROD-0615-C16,d3a9dd49-6f2b-40aa-8027-e4c24421bf9f,c7970450-8598-459e-bc41-406da574b525,334.0,Adjuvant,287.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0615-C16_treatment9,91ba9553-8d3e-47c5-9f7e-f11e8ea3cb81,,released,Irinotecan,1,2021-12-21T13:42:09.704693-06:00,Chemotherapy,Residual Disease,
HCM-BROD-0615-C16,d3a9dd49-6f2b-40aa-8027-e4c24421bf9f,c7970450-8598-459e-bc41-406da574b525,247.0,Adjuvant,137.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0615-C16_treatment6,bf794637-0103-40b2-bef5-c2f5487f72b1,,released,Capecitabine,1,2021-12-21T13:42:09.704693-06:00,Chemotherapy,Residual Disease,
HCM-BROD-0615-C16,d3a9dd49-6f2b-40aa-8027-e4c24421bf9f,c7970450-8598-459e-bc41-406da574b525,96.0,Adjuvant,35.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0615-C16_treatment2,c6c14d4f-0ada-4dd6-b59d-aef48920163c,,released,Leucovorin Calcium,1,2021-12-21T13:42:09.704693-06:00,Chemotherapy,Residual Disease,
HCM-BROD-0615-C16,d3a9dd49-6f2b-40aa-8027-e4c24421bf9f,c7970450-8598-459e-bc41-406da574b525,96.0,Adjuvant,35.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0615-C16_treatment4,c6fda8ef-5c38-4c45-bb32-1be67bfac0b9,,released,Oxaliplatin,1,2021-12-21T13:42:09.704693-06:00,Chemotherapy,Residual Disease,
HCM-BROD-0615-C16,d3a9dd49-6f2b-40aa-8027-e4c24421bf9f,c7970450-8598-459e-bc41-406da574b525,96.0,Adjuvant,35.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0615-C16_treatment3,cdb72a5d-cc20-48f8-8eb8-dd9a7c8c3ea5,,released,Fluorouracil,1,2021-12-21T13:42:09.704693-06:00,Chemotherapy,Residual Disease,
HCM-BROD-0615-C16,d3a9dd49-6f2b-40aa-8027-e4c24421bf9f,c7970450-8598-459e-bc41-406da574b525,334.0,Adjuvant,287.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0615-C16_treatment7,f19f3e12-a4a2-4c31-9b8e-1132f9fb9b54,,released,Leucovorin Calcium,1,2021-12-21T13:42:09.704693-06:00,Chemotherapy,Residual Disease,
HCM-BROD-0615-C16,d3a9dd49-6f2b-40aa-8027-e4c24421bf9f,c7970450-8598-459e-bc41-406da574b525,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0615-C16_treatment13,f817707e-5c10-44ad-92c6-d00674c7f3a4,,released,,0,2021-12-21T13:42:09.704693-06:00,Targeted Molecular Therapy,Residual Disease,
HCM-BROD-0210-C71,d420e653-3fb2-432b-9e81-81232a80264d,75ba645e-7756-4208-825b-67cff507ac69,,Adjuvant,,2021-03-03T15:15:08.075155-06:00,HCM-BROD-0210-C71_treatment3,12538b62-ff88-49fb-a700-ef75c632e060,,released,,0,2020-02-27T13:00:21.361098-06:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-BROD-0210-C71,d420e653-3fb2-432b-9e81-81232a80264d,75ba645e-7756-4208-825b-67cff507ac69,,Adjuvant,,2021-03-03T15:15:08.075155-06:00,HCM-BROD-0210-C71_treatment5,206d23c7-798e-4cae-88fa-6405b0eb0078,,released,,0,2020-02-27T13:00:21.361098-06:00,Targeted Molecular Therapy,Residual Disease,
HCM-BROD-0210-C71,d420e653-3fb2-432b-9e81-81232a80264d,75ba645e-7756-4208-825b-67cff507ac69,,Adjuvant,,2021-03-03T15:15:08.075155-06:00,HCM-BROD-0210-C71_treatment6,6257f60b-6c86-4e73-94ba-1d63d0819613,,released,,0,2020-02-27T13:00:21.361098-06:00,"Radiation Therapy, NOS",Residual Disease,
HCM-BROD-0210-C71,d420e653-3fb2-432b-9e81-81232a80264d,75ba645e-7756-4208-825b-67cff507ac69,375.0,Adjuvant,370.0,2021-03-03T15:15:08.075155-06:00,HCM-BROD-0210-C71_treatment2,7b1e6c59-e82d-4418-8605-c17c5d428724,,released,Temozolomide,1,2020-02-27T13:00:21.361098-06:00,Chemotherapy,Residual Disease,
HCM-BROD-0210-C71,d420e653-3fb2-432b-9e81-81232a80264d,75ba645e-7756-4208-825b-67cff507ac69,,Neoadjuvant,,2021-03-03T15:15:08.075155-06:00,HCM-BROD-0210-C71_treatment,833e8c31-2b6f-4fe1-a2df-3d36c6cf6e6b,,released,,0,2020-02-27T13:00:21.361098-06:00,,,
HCM-BROD-0210-C71,d420e653-3fb2-432b-9e81-81232a80264d,75ba645e-7756-4208-825b-67cff507ac69,,,-3.0,2023-02-27T13:27:25.664154-06:00,HCM-BROD-0210-C71_treatment4,bb3603cb-68dc-46b8-a97b-20b578cbaece,,released,,1,2020-02-27T13:00:21.361098-06:00,"Surgery, NOS",Initial Diagnosis,
HCM-SANG-1302-C15,d43f47fd-56fb-45f5-b12c-62ef044ca3f5,4947c119-abe5-47cd-857e-edd4ea728885,,Neoadjuvant,112.0,2025-04-07T17:13:09.336794-05:00,HCM-SANG-1302-C15_treatment,7cc3795a-cfad-4039-b9de-49a610eb844c,,released,Leucovorin,1,2023-02-27T12:21:31.521886-06:00,Chemotherapy,,
HCM-SANG-1302-C15,d43f47fd-56fb-45f5-b12c-62ef044ca3f5,4947c119-abe5-47cd-857e-edd4ea728885,,Neoadjuvant,112.0,2025-04-07T17:13:09.336794-05:00,HCM-SANG-1302-C15_treatment2,9f5135e0-c265-47d6-9ec3-9b6b1d494e0b,,released,Fluorouracil,1,2023-02-27T12:21:31.521886-06:00,Chemotherapy,,
HCM-SANG-1302-C15,d43f47fd-56fb-45f5-b12c-62ef044ca3f5,4947c119-abe5-47cd-857e-edd4ea728885,,Neoadjuvant,112.0,2025-04-07T17:13:09.336794-05:00,HCM-SANG-1302-C15_treatment4,d3a8286f-84fd-416c-9946-805b1c09ffbf,,released,Oxaliplatin,1,2023-02-27T12:21:31.521886-06:00,Chemotherapy,,
HCM-SANG-1302-C15,d43f47fd-56fb-45f5-b12c-62ef044ca3f5,4947c119-abe5-47cd-857e-edd4ea728885,,Neoadjuvant,112.0,2025-04-07T17:13:09.336794-05:00,HCM-SANG-1302-C15_treatment3,dd9a42a1-41a4-4b36-b4ec-420a70afd1d9,,released,Docetaxel,1,2023-02-27T12:21:31.521886-06:00,Chemotherapy,,
HCM-CSHL-0183-C25,d4850437-8b6e-4b6f-a636-2c0068a14121,db0b64de-7882-4a8d-a834-a567b202364f,,Adjuvant,,2023-07-13T10:35:44.371881-05:00,HCM-CSHL-0183-C25_treatment4,098375a3-b009-452f-9c2c-eb764429cac6,,released,,0,2020-09-28T09:14:42.141645-05:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-CSHL-0183-C25,d4850437-8b6e-4b6f-a636-2c0068a14121,db0b64de-7882-4a8d-a834-a567b202364f,120.0,Adjuvant,13.0,2023-07-13T10:35:44.371881-05:00,HCM-CSHL-0183-C25_treatment3,7bdd5963-e9a0-4ba5-905c-b87258bac77b,,released,Capecitabine,1,2020-09-28T09:14:42.141645-05:00,Chemotherapy,Residual Disease,
HCM-CSHL-0183-C25,d4850437-8b6e-4b6f-a636-2c0068a14121,db0b64de-7882-4a8d-a834-a567b202364f,,Neoadjuvant,,2023-07-13T10:35:44.371881-05:00,HCM-CSHL-0183-C25_treatment,96e62c69-62ea-4fd8-a277-f5cab8698bfb,,released,,0,2020-09-28T09:14:42.141645-05:00,,,
HCM-CSHL-0183-C25,d4850437-8b6e-4b6f-a636-2c0068a14121,db0b64de-7882-4a8d-a834-a567b202364f,,Adjuvant,,2023-07-13T10:35:44.371881-05:00,HCM-CSHL-0183-C25_treatment6,b00bb685-ea79-4c06-a0c2-7a1b27d200f8,,released,,0,2020-09-28T09:14:42.141645-05:00,Targeted Molecular Therapy,Residual Disease,
HCM-CSHL-0183-C25,d4850437-8b6e-4b6f-a636-2c0068a14121,db0b64de-7882-4a8d-a834-a567b202364f,,Adjuvant,,2023-07-13T10:35:44.371881-05:00,HCM-CSHL-0183-C25_treatment7,cd4d02b9-c8bb-43f2-9c2e-7788e4b24c93,,released,,0,2020-09-28T09:14:42.141645-05:00,"Radiation Therapy, NOS",Residual Disease,
HCM-CSHL-0183-C25,d4850437-8b6e-4b6f-a636-2c0068a14121,db0b64de-7882-4a8d-a834-a567b202364f,,,-29.0,2023-07-13T10:35:44.371881-05:00,HCM-CSHL-0183-C25_treatment5,e738bf6e-f6bb-47db-bca0-cfe5c2bb630a,,released,,1,2020-09-28T09:14:42.141645-05:00,"Surgery, NOS",Initial Diagnosis,
HCM-CSHL-0183-C25,d4850437-8b6e-4b6f-a636-2c0068a14121,db0b64de-7882-4a8d-a834-a567b202364f,120.0,Adjuvant,13.0,2023-07-13T10:35:44.371881-05:00,HCM-CSHL-0183-C25_treatment2,ed753a44-cb13-456d-aac5-2b3af89dcdca,,released,Gemcitabine,1,2020-09-28T09:14:42.141645-05:00,Chemotherapy,Residual Disease,
HCM-STAN-1113-C18,d4e59654-f1b9-40a7-bfef-b57eaf571aef,9adc0cda-7245-4e74-8ff6-013b34f47d17,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-STAN-1113-C18_treatment6,34b53c3e-10eb-48d2-8415-aaa4fe01bcf7,,released,,0,2022-09-22T07:11:49.222712-05:00,"Radiation Therapy, NOS",Residual Disease,
HCM-STAN-1113-C18,d4e59654-f1b9-40a7-bfef-b57eaf571aef,9adc0cda-7245-4e74-8ff6-013b34f47d17,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-STAN-1113-C18_treatment5,3d3e0602-61f5-45c2-9dbf-ba1c657c9fd0,,released,,0,2022-09-22T07:11:49.222712-05:00,Targeted Molecular Therapy,Residual Disease,
HCM-STAN-1113-C18,d4e59654-f1b9-40a7-bfef-b57eaf571aef,9adc0cda-7245-4e74-8ff6-013b34f47d17,,Neoadjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-STAN-1113-C18_treatment,560868f4-6e7f-4406-83fe-405d2100d62d,,released,,0,2022-09-22T07:11:49.222712-05:00,,,
HCM-STAN-1113-C18,d4e59654-f1b9-40a7-bfef-b57eaf571aef,9adc0cda-7245-4e74-8ff6-013b34f47d17,241.0,Adjuvant,84.0,2025-04-07T17:13:09.336794-05:00,HCM-STAN-1113-C18_treatment2,cb6c4b5b-d243-42c7-814e-efebf6bed8be,,released,Capecitabine,1,2022-09-22T07:11:49.222712-05:00,Chemotherapy,Residual Disease,
HCM-STAN-1113-C18,d4e59654-f1b9-40a7-bfef-b57eaf571aef,9adc0cda-7245-4e74-8ff6-013b34f47d17,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-STAN-1113-C18_treatment3,e657fecc-84ce-4801-b60d-3230d15a439d,,released,,0,2022-09-22T07:11:49.222712-05:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-STAN-1113-C18,d4e59654-f1b9-40a7-bfef-b57eaf571aef,9adc0cda-7245-4e74-8ff6-013b34f47d17,,,51.0,2025-04-07T17:13:09.336794-05:00,HCM-STAN-1113-C18_treatment4,fd246be5-266d-4ddb-a4a3-0d8875862198,,released,,1,2022-09-22T07:11:49.222712-05:00,"Surgery, NOS",Initial Diagnosis,
HCM-CSHL-0380-C18,d4f36b88-d98b-4bfb-892e-0c45e740e91f,68312fe8-44ed-41ac-ae06-1d0409a7692c,,Neoadjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0380-C18_treatment,036452d1-7069-416a-b00b-45dd8d93b335,,released,,0,2020-09-28T09:55:33.628045-05:00,,,
HCM-CSHL-0380-C18,d4f36b88-d98b-4bfb-892e-0c45e740e91f,68312fe8-44ed-41ac-ae06-1d0409a7692c,,Adjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0380-C18_treatment9,08b1cd2e-e193-4956-b05c-9a629331cfc2,,released,,0,2020-09-28T09:55:33.628045-05:00,"Radiation Therapy, NOS",Residual Disease,
HCM-CSHL-0380-C18,d4f36b88-d98b-4bfb-892e-0c45e740e91f,68312fe8-44ed-41ac-ae06-1d0409a7692c,135.0,Adjuvant,79.0,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0380-C18_treatment2,2ae18f2c-488e-4380-a144-76b964eda8a0,,released,Leucovorin Calcium,1,2020-09-28T09:55:33.628045-05:00,Chemotherapy,Residual Disease,
HCM-CSHL-0380-C18,d4f36b88-d98b-4bfb-892e-0c45e740e91f,68312fe8-44ed-41ac-ae06-1d0409a7692c,135.0,Adjuvant,79.0,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0380-C18_treatment5,40fed41f-82e9-4d44-9ea1-3a6556a7dd7e,,released,,1,2020-09-28T09:55:33.628045-05:00,Chemotherapy,Residual Disease,FOLFOX
HCM-CSHL-0380-C18,d4f36b88-d98b-4bfb-892e-0c45e740e91f,68312fe8-44ed-41ac-ae06-1d0409a7692c,135.0,Adjuvant,79.0,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0380-C18_treatment4,5d0dd6f4-c09d-454a-98c4-9d7ddcf40516,,released,Oxaliplatin,1,2020-09-28T09:55:33.628045-05:00,Chemotherapy,Residual Disease,
HCM-CSHL-0380-C18,d4f36b88-d98b-4bfb-892e-0c45e740e91f,68312fe8-44ed-41ac-ae06-1d0409a7692c,,,34.0,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0380-C18_treatment7,6335435a-953a-4917-8c02-b061b7177677,,released,,1,2020-09-28T09:55:33.628045-05:00,"Surgery, NOS",Initial Diagnosis,
HCM-CSHL-0380-C18,d4f36b88-d98b-4bfb-892e-0c45e740e91f,68312fe8-44ed-41ac-ae06-1d0409a7692c,,Adjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0380-C18_treatment8,a5eff330-ef7a-410c-8f11-3ac09217b052,,released,,0,2020-09-28T09:55:33.628045-05:00,Targeted Molecular Therapy,Residual Disease,
HCM-CSHL-0380-C18,d4f36b88-d98b-4bfb-892e-0c45e740e91f,68312fe8-44ed-41ac-ae06-1d0409a7692c,,Adjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0380-C18_treatment6,a8a48eab-4b74-4c80-9a4e-0de0a8a902eb,,released,,0,2020-09-28T09:55:33.628045-05:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-CSHL-0380-C18,d4f36b88-d98b-4bfb-892e-0c45e740e91f,68312fe8-44ed-41ac-ae06-1d0409a7692c,135.0,Adjuvant,79.0,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0380-C18_treatment3,d26deb67-fac3-4aa8-9288-9e7bcbb52b49,,released,Fluorouracil,1,2020-09-28T09:55:33.628045-05:00,Chemotherapy,Residual Disease,
HCM-CSHL-0377-C18,d58136f6-2e90-40b4-b7fb-3478011efa00,4a1c85d7-5721-4610-8534-3498c36d6178,,Neoadjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0377-C18_treatment,49fc83e0-bd53-43f0-bc0d-1b7b12d9beff,,released,,0,2020-09-28T09:56:32.894105-05:00,,,
HCM-CSHL-0377-C18,d58136f6-2e90-40b4-b7fb-3478011efa00,4a1c85d7-5721-4610-8534-3498c36d6178,,,53.0,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0377-C18_treatment2,555026d6-cb32-4d5a-b29e-6855c1f35dbf,,released,,1,2020-09-28T09:56:32.894105-05:00,"Surgery, NOS",Initial Diagnosis,
HCM-CSHL-0377-C18,d58136f6-2e90-40b4-b7fb-3478011efa00,4a1c85d7-5721-4610-8534-3498c36d6178,,Adjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0377-C18_treatment3,5d8c20d9-c8f5-4053-b8aa-2c4c903c8754,,released,,0,2020-09-28T09:56:32.894105-05:00,"Pharmaceutical Therapy, NOS",Residual Disease,
HCM-CSHL-0377-C18,d58136f6-2e90-40b4-b7fb-3478011efa00,4a1c85d7-5721-4610-8534-3498c36d6178,,Adjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0377-C18_treatment4,6f82b888-a8ee-4e36-b2ab-498b38fc6db0,,released,,0,2020-09-28T09:56:32.894105-05:00,"Radiation Therapy, NOS",Residual Disease,
HCM-BROD-0194-C15,d585a79e-19e2-4829-9e3f-80b74d65b243,d0705df4-2226-4840-a518-36208abff2c2,17.0,Adjuvant,17.0,2021-01-06T22:55:10.531130-06:00,HCM-BROD-0194-C15_treatment6,00ae6090-b759-4953-8e9c-498b81a5ca5e,,released,,1,2020-04-21T15:05:08.724140-05:00,"Radiation Therapy, NOS",Residual Disease,
HCM-BROD-0194-C15,d585a79e-19e2-4829-9e3f-80b74d65b243,d0705df4-2226-4840-a518-36208abff2c2,,Neoadjuvant,,2021-01-06T22:55:10.531130-06:00,HCM-BROD-0194-C15_treatment,4da8404a-98cb-4e9a-b100-17ed46466705,,released,,0,2019-04-04T15:54:16.407898-05:00,,,
HCM-BROD-0194-C15,d585a79e-19e2-4829-9e3f-80b74d65b243,d0705df4-2226-4840-a518-36208abff2c2,,Adjuvant,,2021-01-06T22:55:10.531130-06:00,HCM-BROD-0194-C15_treatment5,98b2591a-1303-4635-afa8-cb60577b3351,,released,,0,2020-04-21T15:05:08.724140-05:00,Targeted Molecular Therapy,Residual Disease,
HCM-BROD-0194-C15,d585a79e-19e2-4829-9e3f-80b74d65b243,d0705df4-2226-4840-a518-36208abff2c2,,,,2023-03-13T13:30:26.957058-05:00,HCM-BROD-0194-C15_treatment4,990e74bb-e92a-4933-a0c0-3838573a9368,,released,,0,2020-04-21T15:05:08.724140-05:00,"Surgery, NOS",Initial Diagnosis,
HCM-BROD-0194-C15,d585a79e-19e2-4829-9e3f-80b74d65b243,d0705df4-2226-4840-a518-36208abff2c2,,Adjuvant,,2021-01-06T22:55:10.531130-06:00,HCM-BROD-0194-C15_treatment2,c1084a10-bba3-47c2-bc37-339b494feb1b,,released,,0,2020-04-21T15:05:08.724140-05:00,Chemotherapy,Residual Disease,
HCM-BROD-0194-C15,d585a79e-19e2-4829-9e3f-80b74d65b243,d0705df4-2226-4840-a518-36208abff2c2,,Adjuvant,,2021-01-06T22:55:10.531130-06:00,HCM-BROD-0194-C15_treatment3,f63b686e-d513-43c9-9fd2-2dde8bdcb3d1,,released,,0,2020-04-21T15:05:08.724140-05:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-CSHL-0839-C34,d6164ae2-9071-418f-9682-b2ce941b02c5,ddad1751-4ef4-4740-8820-2ddf9cd63bfd,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0839-C34_treatment3,1aea5665-3cd0-434f-ac7b-1bf540d9b2c1,,released,,0,2021-12-21T14:34:07.455953-06:00,Chemotherapy,Residual Disease,
HCM-CSHL-0839-C34,d6164ae2-9071-418f-9682-b2ce941b02c5,ddad1751-4ef4-4740-8820-2ddf9cd63bfd,,,1106.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0839-C34_treatment6,66709ca2-acdd-46c0-8d2c-3a18645cfc5a,,released,,1,2021-12-21T14:34:07.455953-06:00,"Surgery, NOS",Initial Diagnosis,
HCM-CSHL-0839-C34,d6164ae2-9071-418f-9682-b2ce941b02c5,ddad1751-4ef4-4740-8820-2ddf9cd63bfd,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0839-C34_treatment4,8c1ca293-483c-4586-b583-0ff89aba2c1f,,released,,0,2021-12-21T14:34:07.455953-06:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-CSHL-0839-C34,d6164ae2-9071-418f-9682-b2ce941b02c5,ddad1751-4ef4-4740-8820-2ddf9cd63bfd,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0839-C34_treatment7,9dae94c7-cee7-43d3-af98-607e211556d1,,released,Gefitinib,1,2021-12-21T14:34:07.455953-06:00,Targeted Molecular Therapy,Residual Disease,
HCM-CSHL-0839-C34,d6164ae2-9071-418f-9682-b2ce941b02c5,ddad1751-4ef4-4740-8820-2ddf9cd63bfd,,,217.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0839-C34_treatment5,a5098c83-f835-4e8b-ab1e-270a0f78aadf,,released,,1,2021-12-21T14:34:07.455953-06:00,"Surgery, NOS",Initial Diagnosis,
HCM-CSHL-0839-C34,d6164ae2-9071-418f-9682-b2ce941b02c5,ddad1751-4ef4-4740-8820-2ddf9cd63bfd,,Neoadjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0839-C34_treatment2,ad633664-0774-4b56-82de-6f2b94540b75,,released,Erlotinib,1,2021-12-21T14:34:07.455953-06:00,Targeted Molecular Therapy,,
HCM-CSHL-0839-C34,d6164ae2-9071-418f-9682-b2ce941b02c5,ddad1751-4ef4-4740-8820-2ddf9cd63bfd,,Neoadjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0839-C34_treatment,d597f539-93fd-4c66-8be0-efc4a502a5cc,,released,Pembrolizumab,1,2021-12-21T14:34:07.455953-06:00,Immunotherapy (Including Vaccines),,
HCM-CSHL-0839-C34,d6164ae2-9071-418f-9682-b2ce941b02c5,ddad1751-4ef4-4740-8820-2ddf9cd63bfd,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0839-C34_treatment8,da6a056f-c30d-4ca7-b50b-85b6bc0bba12,,released,,unknown,2021-12-21T14:34:07.455953-06:00,"Radiation Therapy, NOS",Residual Disease,
HCM-CSHL-0839-C34,d6164ae2-9071-418f-9682-b2ce941b02c5,ffaaa4e9-d5a3-477c-a424-ba7e5bb0888e,,Maintenance Therapy,,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0839-C34_treatment9,0471bef8-f712-48d4-8923-d4659c5cc424,Not Reported,released,Pembrolizumab,1,2021-12-21T14:34:07.455953-06:00,,,
HCM-CSHL-0839-C34,d6164ae2-9071-418f-9682-b2ce941b02c5,ffaaa4e9-d5a3-477c-a424-ba7e5bb0888e,,Maintenance Therapy,,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0839-C34_treatment10,0f24aa25-08a6-40a3-ab90-b15af153a740,Not Reported,released,Gefitinib,1,2021-12-21T14:34:07.455953-06:00,,,
HCM-BROD-0226-C43,d73ad293-edf5-4f88-8a06-65695f5f5ff0,51039f26-182b-49cf-8a90-e26e357e19e4,,Adjuvant,,2023-02-22T07:39:25.979291-06:00,HCM-BROD-0226-C43_treatment3,6a144450-b456-433a-9b57-916212d829f4,,released,,0,2020-06-15T13:26:54.697689-05:00,Hormone Therapy,Residual Disease,
HCM-BROD-0226-C43,d73ad293-edf5-4f88-8a06-65695f5f5ff0,51039f26-182b-49cf-8a90-e26e357e19e4,3109.0,Adjuvant,2260.0,2023-02-22T07:39:25.979291-06:00,HCM-BROD-0226-C43_treatment4,8c3d2e39-5528-4ae4-b35d-dd9af93aaf77,Treatment Ongoing,released,Nivolumab,1,2020-06-15T13:26:54.697689-05:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-BROD-0226-C43,d73ad293-edf5-4f88-8a06-65695f5f5ff0,51039f26-182b-49cf-8a90-e26e357e19e4,2348.0,Adjuvant,2348.0,2023-02-22T07:39:25.979291-06:00,HCM-BROD-0226-C43_treatment7,9474e3a9-ef94-4eff-aeb8-b5a40fdd1a24,,released,,1,2020-10-08T12:08:02.591624-05:00,"Radiation Therapy, NOS",Residual Disease,
HCM-BROD-0226-C43,d73ad293-edf5-4f88-8a06-65695f5f5ff0,51039f26-182b-49cf-8a90-e26e357e19e4,,Adjuvant,,2023-02-22T07:39:25.979291-06:00,HCM-BROD-0226-C43_treatment2,a070efd1-090f-47c6-ba16-f05ac14fe277,,released,,0,2020-06-15T13:26:54.697689-05:00,Chemotherapy,Residual Disease,
HCM-BROD-0226-C43,d73ad293-edf5-4f88-8a06-65695f5f5ff0,51039f26-182b-49cf-8a90-e26e357e19e4,,Neoadjuvant,,2023-02-22T07:39:25.979291-06:00,HCM-BROD-0226-C43_treatment,c9d714e0-2152-4b4d-a249-abd14537a4df,,released,,0,2020-06-15T13:26:54.697689-05:00,,,
HCM-BROD-0226-C43,d73ad293-edf5-4f88-8a06-65695f5f5ff0,51039f26-182b-49cf-8a90-e26e357e19e4,,Adjuvant,,2023-02-22T07:39:25.979291-06:00,HCM-BROD-0226-C43_treatment6,d270ec44-5c4d-4586-9f84-c66ad23f9881,,released,,0,2020-06-15T13:26:54.697689-05:00,Targeted Molecular Therapy,Residual Disease,
HCM-BROD-0226-C43,d73ad293-edf5-4f88-8a06-65695f5f5ff0,51039f26-182b-49cf-8a90-e26e357e19e4,,,,2023-02-27T11:24:21.434557-06:00,HCM-BROD-0226-C43_treatment5,f72252aa-6fb2-4931-8e60-cf4030e49852,,released,,unknown,2020-06-15T13:26:54.697689-05:00,"Surgery, NOS",Initial Diagnosis,
HCM-BROD-0483-C16,d7426469-359e-45e4-a58a-f70e4147cd10,322357fb-c35a-4e01-9512-94634b1b7447,170.0,Maintenance Therapy,164.0,2021-07-12T12:25:55.528644-05:00,HCM-BROD-0483-C16_treatment7,156f64ca-66e4-4253-99be-d7585bc3b92f,Not Reported,released,Cabozantinib,1,2020-09-27T11:55:39.509964-05:00,,,
HCM-BROD-0483-C16,d7426469-359e-45e4-a58a-f70e4147cd10,322357fb-c35a-4e01-9512-94634b1b7447,170.0,Maintenance Therapy,164.0,2021-07-12T12:25:55.528644-05:00,HCM-BROD-0483-C16_treatment8,4f9702ae-a2c3-423b-8741-a997bb3e8932,Not Reported,released,Pembrolizumab,1,2020-09-27T11:55:39.509964-05:00,,,
HCM-BROD-0483-C16,d7426469-359e-45e4-a58a-f70e4147cd10,a3959155-217b-4204-83ce-fb9afa31b470,,,,2023-02-27T11:58:38.940528-06:00,HCM-BROD-0483-C16_treatment4,020cb834-cf88-4bd7-ae6a-8bcc0a2f5725,,released,,unknown,2020-09-27T11:55:39.509964-05:00,"Surgery, NOS",Initial Diagnosis,
HCM-BROD-0483-C16,d7426469-359e-45e4-a58a-f70e4147cd10,a3959155-217b-4204-83ce-fb9afa31b470,,Adjuvant,,2021-07-12T12:25:55.528644-05:00,HCM-BROD-0483-C16_treatment6,0c6880da-1249-49c3-8127-0f71cb30616e,,released,,unknown,2020-09-27T11:55:39.509964-05:00,"Radiation Therapy, NOS",Residual Disease,
HCM-BROD-0483-C16,d7426469-359e-45e4-a58a-f70e4147cd10,a3959155-217b-4204-83ce-fb9afa31b470,,Neoadjuvant,,2021-07-12T12:25:55.528644-05:00,HCM-BROD-0483-C16_treatment,13adbc02-45cf-437c-88d3-511ac802a4cf,,released,,0,2020-09-27T11:55:39.509964-05:00,,,
HCM-BROD-0483-C16,d7426469-359e-45e4-a58a-f70e4147cd10,a3959155-217b-4204-83ce-fb9afa31b470,164.0,Adjuvant,164.0,2021-07-12T12:25:55.528644-05:00,HCM-BROD-0483-C16_treatment3,34b13484-0eef-4d38-90f6-68ea70107721,,released,Pembrolizumab,1,2020-09-27T11:55:39.509964-05:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-BROD-0483-C16,d7426469-359e-45e4-a58a-f70e4147cd10,a3959155-217b-4204-83ce-fb9afa31b470,,Adjuvant,,2021-07-12T12:25:55.528644-05:00,HCM-BROD-0483-C16_treatment2,7b2e699e-2a12-44cc-b617-b968173fbcd8,,released,,0,2020-09-27T11:55:39.509964-05:00,Chemotherapy,Residual Disease,
HCM-BROD-0483-C16,d7426469-359e-45e4-a58a-f70e4147cd10,a3959155-217b-4204-83ce-fb9afa31b470,,Adjuvant,,2021-07-12T12:25:55.528644-05:00,HCM-BROD-0483-C16_treatment5,b506115b-66e0-4802-abe6-08ac318a9e05,,released,,0,2020-09-27T11:55:39.509964-05:00,Targeted Molecular Therapy,Residual Disease,
HCM-CSHL-0258-C18,d77ca75a-491a-4616-9a1c-7b69fdd03585,7d7651c7-7153-4b87-96d1-491631c58b1e,,Adjuvant,,2023-03-13T12:39:57.679450-05:00,HCM-CSHL-0258-C18_treatment3,1c6cac63-60ef-471e-806c-e699375b0157,,released,,0,2020-09-28T09:37:26.712488-05:00,"Pharmaceutical Therapy, NOS",Residual Disease,
HCM-CSHL-0258-C18,d77ca75a-491a-4616-9a1c-7b69fdd03585,7d7651c7-7153-4b87-96d1-491631c58b1e,,,42.0,2023-03-13T12:39:57.679450-05:00,HCM-CSHL-0258-C18_treatment2,3fdbb54f-a68c-4f50-9b5d-0a93a0f53121,,released,,1,2020-09-28T09:37:26.712488-05:00,"Surgery, NOS",Initial Diagnosis,
HCM-CSHL-0258-C18,d77ca75a-491a-4616-9a1c-7b69fdd03585,7d7651c7-7153-4b87-96d1-491631c58b1e,,Neoadjuvant,,2023-02-22T07:39:25.979291-06:00,HCM-CSHL-0258-C18_treatment,56a8a9d6-7e45-4880-b27f-af8ef202ab24,,released,,0,2020-09-28T09:37:26.712488-05:00,,,
HCM-CSHL-0258-C18,d77ca75a-491a-4616-9a1c-7b69fdd03585,7d7651c7-7153-4b87-96d1-491631c58b1e,,Adjuvant,,2023-03-13T12:39:57.679450-05:00,HCM-CSHL-0258-C18_treatment4,c280ec63-4830-472b-be3f-6c8385f45f37,,released,,0,2021-08-26T14:37:52.029035-05:00,"Radiation Therapy, NOS",Residual Disease,
HCM-CSHL-0514-C50,d7b49708-3dd6-4837-856a-bce8ceb8e76f,e13f6187-5532-48fe-a240-cd291658c1d2,,Prevention,,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0514-C50_treatment5,0dfafe9b-705a-4c33-ac0d-bf4ae4bbd4e8,,released,,0,2021-12-21T14:08:41.282941-06:00,Hormone Therapy,,
HCM-CSHL-0514-C50,d7b49708-3dd6-4837-856a-bce8ceb8e76f,e13f6187-5532-48fe-a240-cd291658c1d2,,,22.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0514-C50_treatment2,5881495a-e32b-4a0f-a1df-4ca0ccb42806,,released,,1,2021-12-21T14:08:41.282941-06:00,"Surgery, NOS",Initial Diagnosis,
HCM-CSHL-0514-C50,d7b49708-3dd6-4837-856a-bce8ceb8e76f,e13f6187-5532-48fe-a240-cd291658c1d2,80.0,Adjuvant,62.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0514-C50_treatment4,807f70c6-1a06-4213-98ee-df1d437a4c50,,released,,1,2021-12-21T14:08:41.282941-06:00,"Radiation Therapy, NOS",Residual Disease,
HCM-CSHL-0514-C50,d7b49708-3dd6-4837-856a-bce8ceb8e76f,e13f6187-5532-48fe-a240-cd291658c1d2,,Neoadjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0514-C50_treatment,b49a4065-8571-4f0d-bb4b-310b47eba4cf,,released,,0,2021-12-21T14:08:41.282941-06:00,,,
HCM-CSHL-0514-C50,d7b49708-3dd6-4837-856a-bce8ceb8e76f,e13f6187-5532-48fe-a240-cd291658c1d2,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0514-C50_treatment3,fb10a66c-879c-4263-9058-e7d572b1e1a1,,released,,0,2021-12-21T14:08:41.282941-06:00,"Pharmaceutical Therapy, NOS",Residual Disease,
HCM-CSHL-0092-C25,d7fc5874-8ae0-4357-9d8d-01af39ee521f,1744a5aa-897d-4bf9-a9f6-c82131b9a086,,Adjuvant,,2020-04-02T10:09:29.076604-05:00,HCM-CSHL-0092-C25_treatment6,092fd164-53fc-49a4-a841-5402302825ca,,released,,0,2020-02-11T14:40:28.597230-06:00,Targeted Molecular Therapy,Residual Disease,
HCM-CSHL-0092-C25,d7fc5874-8ae0-4357-9d8d-01af39ee521f,1744a5aa-897d-4bf9-a9f6-c82131b9a086,219.0,Adjuvant,51.0,2020-06-15T12:09:36.909420-05:00,HCM-CSHL-0092-C25_treatment2,0c4a49ae-44a8-41a1-8687-192e27485c4b,,released,Gemcitabine,1,2020-02-11T14:40:28.597230-06:00,Chemotherapy,Residual Disease,
HCM-CSHL-0092-C25,d7fc5874-8ae0-4357-9d8d-01af39ee521f,1744a5aa-897d-4bf9-a9f6-c82131b9a086,219.0,Adjuvant,51.0,2020-06-15T12:09:36.909420-05:00,HCM-CSHL-0092-C25_treatment3,2ee4c37f-4969-4f86-9f3f-7fc02219cc30,,released,Nab-paclitaxel,1,2020-02-11T14:40:28.597230-06:00,Chemotherapy,Residual Disease,
HCM-CSHL-0092-C25,d7fc5874-8ae0-4357-9d8d-01af39ee521f,1744a5aa-897d-4bf9-a9f6-c82131b9a086,,Adjuvant,,2020-04-02T14:23:02.380597-05:00,HCM-CSHL-0092-C25_treatment7,7cea2ade-c0b7-48e8-8fbc-0359df2a5427,,released,,0,2020-04-02T10:09:29.076604-05:00,"Radiation Therapy, NOS",Residual Disease,
HCM-CSHL-0092-C25,d7fc5874-8ae0-4357-9d8d-01af39ee521f,1744a5aa-897d-4bf9-a9f6-c82131b9a086,,,-20.0,2023-02-27T13:26:48.050823-06:00,HCM-CSHL-0092-C25_treatment5,875eb13a-7355-4c46-b1cd-65471884198e,,released,,1,2020-02-11T14:40:28.597230-06:00,"Surgery, NOS",Initial Diagnosis,
HCM-CSHL-0092-C25,d7fc5874-8ae0-4357-9d8d-01af39ee521f,1744a5aa-897d-4bf9-a9f6-c82131b9a086,,Adjuvant,,2020-04-02T10:09:29.076604-05:00,HCM-CSHL-0092-C25_treatment4,d92a3739-22cb-41f5-8a0b-4c356cd01e65,,released,,0,2020-02-11T14:40:28.597230-06:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-CSHL-0092-C25,d7fc5874-8ae0-4357-9d8d-01af39ee521f,1744a5aa-897d-4bf9-a9f6-c82131b9a086,,Neoadjuvant,,2020-03-26T16:04:47.706904-05:00,HCM-CSHL-0092-C25_treatment,f4f04cd3-6d63-4af6-9e1c-ea4df00a88ec,,released,,0,2020-02-11T14:40:28.597230-06:00,,,
HCM-SANG-0535-C20,d847f721-5801-4052-b5ed-88845889e7da,89d84d42-1755-4018-b6f1-97a4ff642a1a,,Neoadjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-SANG-0535-C20_treatment2,4e732b86-4cac-40a3-9872-40451fa2df6a,,released,,1,2021-12-21T15:15:08.027397-06:00,"Radiation, 2D Conventional",,
HCM-SANG-0535-C20,d847f721-5801-4052-b5ed-88845889e7da,89d84d42-1755-4018-b6f1-97a4ff642a1a,,Neoadjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-SANG-0535-C20_treatment,d4519e32-d57a-448c-82a8-c1d491187acc,,released,Capecitabine,1,2021-12-21T15:15:08.027397-06:00,Chemotherapy,,
HCM-WCMC-0949-C67,d8522fe4-e14f-46de-ab9d-f7445099d5a5,0a686fbe-c6a0-43f9-9b72-828fc82305ff,,Neoadjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-WCMC-0949-C67_treatment,26e2637d-85be-44e4-b3b2-98457a0f8ee0,,released,,0,2023-02-27T13:28:37.123553-06:00,,,
HCM-WCMC-0949-C67,d8522fe4-e14f-46de-ab9d-f7445099d5a5,0a686fbe-c6a0-43f9-9b72-828fc82305ff,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-WCMC-0949-C67_treatment4,3f9cf0a9-62f8-42ae-8d52-acdccaa77f22,,released,,0,2023-02-27T13:28:37.123553-06:00,"Radiation Therapy, NOS",Residual Disease,
HCM-WCMC-0949-C67,d8522fe4-e14f-46de-ab9d-f7445099d5a5,0a686fbe-c6a0-43f9-9b72-828fc82305ff,,,0.0,2025-04-07T17:13:09.336794-05:00,HCM-WCMC-0949-C67_treatment2,9a2ce788-3ae5-4f84-8870-e0faf775c0cb,,released,,1,2023-02-27T13:28:37.123553-06:00,"Surgery, NOS",Initial Diagnosis,
HCM-WCMC-0949-C67,d8522fe4-e14f-46de-ab9d-f7445099d5a5,0a686fbe-c6a0-43f9-9b72-828fc82305ff,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-WCMC-0949-C67_treatment3,d727a1de-3008-4b52-8429-b853489f2e49,,released,,0,2023-02-27T13:28:37.123553-06:00,"Pharmaceutical Therapy, NOS",Residual Disease,
HCM-CSHL-0607-C19,d8b5fbeb-3c4c-424c-a1e7-5a7a085b005a,53ef5019-bf54-47f8-8302-d3824d4bf1a9,192.0,Maintenance Therapy,42.0,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0607-C19_treatment17,17ff6d74-c5a0-4ff5-b4a5-eec19392b792,Treatment Ongoing,released,Fluorouracil,1,2022-11-18T13:16:16.849949-06:00,,,
HCM-CSHL-0607-C19,d8b5fbeb-3c4c-424c-a1e7-5a7a085b005a,53ef5019-bf54-47f8-8302-d3824d4bf1a9,192.0,Maintenance Therapy,42.0,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0607-C19_treatment19,53684e9b-47a2-4bb0-b6f1-8eddea2b60ba,Treatment Ongoing,released,,1,2022-11-18T13:16:16.849949-06:00,,,FOLFIRI-cetuximab
HCM-CSHL-0607-C19,d8b5fbeb-3c4c-424c-a1e7-5a7a085b005a,53ef5019-bf54-47f8-8302-d3824d4bf1a9,192.0,Maintenance Therapy,42.0,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0607-C19_treatment18,71f7818c-3f90-4302-9ad7-5e1f64705a54,Treatment Ongoing,released,Irinotecan,1,2022-11-18T13:16:16.849949-06:00,,,
HCM-CSHL-0607-C19,d8b5fbeb-3c4c-424c-a1e7-5a7a085b005a,53ef5019-bf54-47f8-8302-d3824d4bf1a9,192.0,Maintenance Therapy,42.0,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0607-C19_treatment16,c3ec3e1a-25aa-4e76-83d5-5e85473e801a,Treatment Ongoing,released,Leucovorin Calcium,1,2022-11-18T13:16:16.849949-06:00,,,
HCM-CSHL-0607-C19,d8b5fbeb-3c4c-424c-a1e7-5a7a085b005a,53ef5019-bf54-47f8-8302-d3824d4bf1a9,192.0,Maintenance Therapy,42.0,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0607-C19_treatment15,e55782d5-1620-46f5-b99d-4302b7fa3ea2,Treatment Ongoing,released,Cetuximab,1,2022-11-18T13:16:16.849949-06:00,,,
HCM-CSHL-0607-C19,d8b5fbeb-3c4c-424c-a1e7-5a7a085b005a,a817f114-2391-4419-9144-91fb3bbf713b,,Adjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0607-C19_treatment11,109b82de-d617-4a72-bcc2-d40a83fa58b6,,released,,0,2022-11-18T13:16:16.849949-06:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-CSHL-0607-C19,d8b5fbeb-3c4c-424c-a1e7-5a7a085b005a,a817f114-2391-4419-9144-91fb3bbf713b,780.0,Adjuvant,42.0,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0607-C19_treatment8,1d54e9bd-9775-4993-922b-60869cd8e1e9,,released,Fluorouracil,1,2022-11-18T13:16:16.849949-06:00,Chemotherapy,Residual Disease,
HCM-CSHL-0607-C19,d8b5fbeb-3c4c-424c-a1e7-5a7a085b005a,a817f114-2391-4419-9144-91fb3bbf713b,780.0,Adjuvant,42.0,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0607-C19_treatment10,3e8597b3-7563-4da7-abe7-64b613bed75e,,released,,1,2022-11-18T13:16:16.849949-06:00,Chemotherapy,Residual Disease,FOLFIRI-cetuximab
HCM-CSHL-0607-C19,d8b5fbeb-3c4c-424c-a1e7-5a7a085b005a,a817f114-2391-4419-9144-91fb3bbf713b,,,236.0,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0607-C19_treatment12,49e74695-64a7-48ae-a67b-079339069c95,,released,,1,2022-11-18T13:16:16.849949-06:00,"Surgery, NOS",Initial Diagnosis,
HCM-CSHL-0607-C19,d8b5fbeb-3c4c-424c-a1e7-5a7a085b005a,a817f114-2391-4419-9144-91fb3bbf713b,780.0,Adjuvant,42.0,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0607-C19_treatment6,5c149e1c-f0b3-43d1-b120-3bd5984f9523,,released,Irinotecan,1,2022-11-18T13:16:16.849949-06:00,Chemotherapy,Residual Disease,
HCM-CSHL-0607-C19,d8b5fbeb-3c4c-424c-a1e7-5a7a085b005a,a817f114-2391-4419-9144-91fb3bbf713b,,Neoadjuvant,42.0,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0607-C19_treatment3,604a4540-82f7-4e32-a253-2a725d189d9d,,released,Irinotecan,1,2022-11-18T13:16:16.849949-06:00,Chemotherapy,,
HCM-CSHL-0607-C19,d8b5fbeb-3c4c-424c-a1e7-5a7a085b005a,a817f114-2391-4419-9144-91fb3bbf713b,,Neoadjuvant,42.0,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0607-C19_treatment,6bd143b5-1221-438e-a90a-730020903ee7,,released,Leucovorin Calcium,1,2022-11-18T13:16:16.849949-06:00,Chemotherapy,,
HCM-CSHL-0607-C19,d8b5fbeb-3c4c-424c-a1e7-5a7a085b005a,a817f114-2391-4419-9144-91fb3bbf713b,,Adjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0607-C19_treatment14,9325f4da-04f5-4e50-b915-2e681e452e6a,,released,,0,2022-11-18T13:16:16.849949-06:00,"Radiation Therapy, NOS",Residual Disease,
HCM-CSHL-0607-C19,d8b5fbeb-3c4c-424c-a1e7-5a7a085b005a,a817f114-2391-4419-9144-91fb3bbf713b,780.0,Adjuvant,42.0,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0607-C19_treatment9,9fc86fec-c6d0-415d-bd9c-41a00d676a57,,released,Cetuximab,1,2022-11-18T13:16:16.849949-06:00,Chemotherapy,Residual Disease,
HCM-CSHL-0607-C19,d8b5fbeb-3c4c-424c-a1e7-5a7a085b005a,a817f114-2391-4419-9144-91fb3bbf713b,,Adjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0607-C19_treatment13,a227e1e4-939a-4361-8e5f-433dc1f4cbd0,,released,,0,2022-11-18T13:16:16.849949-06:00,Targeted Molecular Therapy,Residual Disease,
HCM-CSHL-0607-C19,d8b5fbeb-3c4c-424c-a1e7-5a7a085b005a,a817f114-2391-4419-9144-91fb3bbf713b,,Neoadjuvant,42.0,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0607-C19_treatment2,b31d7648-0a60-4e96-a7f7-24d7f2653a9c,,released,Fluorouracil,1,2022-11-18T13:16:16.849949-06:00,Chemotherapy,,
HCM-CSHL-0607-C19,d8b5fbeb-3c4c-424c-a1e7-5a7a085b005a,a817f114-2391-4419-9144-91fb3bbf713b,,Neoadjuvant,42.0,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0607-C19_treatment5,d2290ef4-4658-4e02-9ab8-4dcef455eca8,,released,Cetuximab,1,2022-11-18T13:16:16.849949-06:00,Chemotherapy,,
HCM-CSHL-0607-C19,d8b5fbeb-3c4c-424c-a1e7-5a7a085b005a,a817f114-2391-4419-9144-91fb3bbf713b,,Neoadjuvant,42.0,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0607-C19_treatment4,f291285f-094d-4a7f-baff-32e31c480617,,released,,1,2022-11-18T13:16:16.849949-06:00,Chemotherapy,,FOLFIRI
HCM-CSHL-0607-C19,d8b5fbeb-3c4c-424c-a1e7-5a7a085b005a,a817f114-2391-4419-9144-91fb3bbf713b,780.0,Adjuvant,42.0,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0607-C19_treatment7,f856e02d-3591-46b7-8b71-bdef2d101e94,,released,Leucovorin Calcium,1,2022-11-18T13:16:16.849949-06:00,Chemotherapy,Residual Disease,
HCM-BROD-0578-C15,d8f43a06-92ab-4a24-9410-d9121eccd119,8aad90a1-f912-4e6e-af01-0a57c8279fed,57.0,Maintenance Therapy,7.0,2023-02-22T07:39:25.979291-06:00,HCM-BROD-0578-C15_treatment9,38ae57ad-7171-4b3d-9568-812f171c8008,Progressive Disease,released,Leucovorin Calcium,1,2020-10-08T19:50:02.424698-05:00,,,
HCM-BROD-0578-C15,d8f43a06-92ab-4a24-9410-d9121eccd119,8aad90a1-f912-4e6e-af01-0a57c8279fed,57.0,Maintenance Therapy,7.0,2023-02-22T07:39:25.979291-06:00,HCM-BROD-0578-C15_treatment10,41151cc2-21f7-416c-86e3-0c79f2ddaf96,Progressive Disease,released,Fluorouracil,1,2020-10-08T19:50:02.424698-05:00,,,
HCM-BROD-0578-C15,d8f43a06-92ab-4a24-9410-d9121eccd119,8aad90a1-f912-4e6e-af01-0a57c8279fed,57.0,Maintenance Therapy,7.0,2023-02-22T07:39:25.979291-06:00,HCM-BROD-0578-C15_treatment11,59a4928e-0268-4cde-9f56-a3849c3a65fa,Progressive Disease,released,Oxaliplatin,1,2020-10-08T19:50:02.424698-05:00,,,
HCM-BROD-0578-C15,d8f43a06-92ab-4a24-9410-d9121eccd119,8aad90a1-f912-4e6e-af01-0a57c8279fed,57.0,Maintenance Therapy,7.0,2023-02-22T07:39:25.979291-06:00,HCM-BROD-0578-C15_treatment12,8d197fd0-d7b1-4d92-9930-4271eeef4caf,Progressive Disease,released,,1,2020-10-08T19:50:02.424698-05:00,,,FOLFOX
HCM-BROD-0578-C15,d8f43a06-92ab-4a24-9410-d9121eccd119,9c417e0e-12a8-4d6f-9a1e-490024dab185,70.0,Adjuvant,7.0,2023-02-22T07:39:25.979291-06:00,HCM-BROD-0578-C15_treatment3,21bc7b79-96cc-4932-bc55-f04212d09767,,released,Leucovorin,1,2020-10-08T19:50:02.424698-05:00,Chemotherapy,Residual Disease,
HCM-BROD-0578-C15,d8f43a06-92ab-4a24-9410-d9121eccd119,9c417e0e-12a8-4d6f-9a1e-490024dab185,70.0,Adjuvant,7.0,2023-02-22T07:39:25.979291-06:00,HCM-BROD-0578-C15_treatment4,586212d6-d487-4b61-a9bb-3b1d782b61e5,,released,,1,2020-10-08T19:50:02.424698-05:00,Chemotherapy,Residual Disease,FU-LV regimen
HCM-BROD-0578-C15,d8f43a06-92ab-4a24-9410-d9121eccd119,9c417e0e-12a8-4d6f-9a1e-490024dab185,70.0,Adjuvant,7.0,2023-02-22T07:39:25.979291-06:00,HCM-BROD-0578-C15_treatment2,5d52439d-c597-4a10-a8ce-2cf6a50c7be2,,released,Fluorouracil,1,2020-10-08T19:50:02.424698-05:00,Chemotherapy,Residual Disease,
HCM-BROD-0578-C15,d8f43a06-92ab-4a24-9410-d9121eccd119,9c417e0e-12a8-4d6f-9a1e-490024dab185,,Adjuvant,,2023-02-22T07:39:25.979291-06:00,HCM-BROD-0578-C15_treatment7,8da4ede9-d0bf-4e0b-a03c-c343af38914b,,released,,0,2020-10-08T19:50:02.424698-05:00,Targeted Molecular Therapy,Residual Disease,
HCM-BROD-0578-C15,d8f43a06-92ab-4a24-9410-d9121eccd119,9c417e0e-12a8-4d6f-9a1e-490024dab185,92.0,Adjuvant,86.0,2023-02-22T07:39:25.979291-06:00,HCM-BROD-0578-C15_treatment8,a281ffe9-edf2-47ed-b5d5-12c3349924c8,,released,,1,2020-10-08T19:50:02.424698-05:00,"Radiation Therapy, NOS",Residual Disease,
HCM-BROD-0578-C15,d8f43a06-92ab-4a24-9410-d9121eccd119,9c417e0e-12a8-4d6f-9a1e-490024dab185,,Adjuvant,,2023-02-22T07:39:25.979291-06:00,HCM-BROD-0578-C15_treatment5,b888327a-7cd7-44ff-97c0-bdaa966240d3,,released,,0,2020-10-08T19:50:02.424698-05:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-BROD-0578-C15,d8f43a06-92ab-4a24-9410-d9121eccd119,9c417e0e-12a8-4d6f-9a1e-490024dab185,,,,2023-02-27T11:40:41.217720-06:00,HCM-BROD-0578-C15_treatment6,c168825d-e6ef-4ad0-b14f-6a6fa163eeb6,,released,,0,2020-10-08T19:50:02.424698-05:00,"Surgery, NOS",Initial Diagnosis,
HCM-BROD-0578-C15,d8f43a06-92ab-4a24-9410-d9121eccd119,9c417e0e-12a8-4d6f-9a1e-490024dab185,,Neoadjuvant,,2023-02-22T07:39:25.979291-06:00,HCM-BROD-0578-C15_treatment,e5bb77be-d889-4f79-aba2-49ff53e2d29a,,released,,0,2020-10-08T19:50:02.424698-05:00,,,
HCM-BROD-0796-C71,da09b63f-a076-48b9-9c88-2218db08e313,2d40a529-8f76-4fde-86d6-6c1e431bdb2a,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0796-C71_treatment4,508887ef-cf54-4ded-8747-7d7411338432,,released,,0,2021-12-21T13:53:55.106868-06:00,"Radiation Therapy, NOS",Residual Disease,
HCM-BROD-0796-C71,da09b63f-a076-48b9-9c88-2218db08e313,2d40a529-8f76-4fde-86d6-6c1e431bdb2a,,Neoadjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0796-C71_treatment,59518a79-8421-43cb-8857-f4d808bf01d3,,released,,0,2021-12-21T13:53:55.106868-06:00,,,
HCM-BROD-0796-C71,da09b63f-a076-48b9-9c88-2218db08e313,2d40a529-8f76-4fde-86d6-6c1e431bdb2a,,,0.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0796-C71_treatment2,5a83f790-4d15-425a-abda-f5297aa691f2,,released,,1,2021-12-21T13:53:55.106868-06:00,"Surgery, NOS",Initial Diagnosis,
HCM-BROD-0796-C71,da09b63f-a076-48b9-9c88-2218db08e313,2d40a529-8f76-4fde-86d6-6c1e431bdb2a,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0796-C71_treatment3,cb8699bc-ec3c-4037-97be-7baeba47370e,,released,,0,2021-12-21T13:53:55.106868-06:00,"Pharmaceutical Therapy, NOS",Residual Disease,
HCM-WCMC-0952-C34,da2509d3-513e-4d0d-b05e-99c4a8817c59,56e44f1e-c0fb-45ad-9ac4-c85f021e4c70,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-WCMC-0952-C34_treatment3,34e426cc-612e-4903-b387-ee1bf45a5b28,,released,,0,2023-02-27T11:22:03.477672-06:00,"Pharmaceutical Therapy, NOS",Residual Disease,
HCM-WCMC-0952-C34,da2509d3-513e-4d0d-b05e-99c4a8817c59,56e44f1e-c0fb-45ad-9ac4-c85f021e4c70,,Neoadjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-WCMC-0952-C34_treatment,4f7a5083-85c4-4e07-8c83-f5cec1d90455,,released,,0,2023-02-27T11:22:03.477672-06:00,,,
HCM-WCMC-0952-C34,da2509d3-513e-4d0d-b05e-99c4a8817c59,56e44f1e-c0fb-45ad-9ac4-c85f021e4c70,,,29.0,2025-04-07T17:13:09.336794-05:00,HCM-WCMC-0952-C34_treatment2,5ff93d6a-70ee-4560-b300-7456bde6d337,,released,,1,2023-02-27T11:22:03.477672-06:00,"Surgery, NOS",Initial Diagnosis,
HCM-WCMC-0952-C34,da2509d3-513e-4d0d-b05e-99c4a8817c59,56e44f1e-c0fb-45ad-9ac4-c85f021e4c70,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-WCMC-0952-C34_treatment4,fe24477e-2f92-47b2-957c-23a13a8e0380,,released,,0,2023-02-27T11:22:03.477672-06:00,"Radiation Therapy, NOS",Residual Disease,
HCM-WCMC-0788-C34,da8c7e2c-9dd3-4df6-a4b5-b6fff01e6da8,2041a4f6-782d-4d57-a28c-fb2f9db330ab,216.0,Adjuvant,125.0,2025-04-07T17:13:09.336794-05:00,HCM-WCMC-0788-C34_treatment2,094e6e01-8674-44d6-bcca-9ef0fbcc747a,,released,Cisplatin,1,2023-02-27T12:55:12.177706-06:00,Chemotherapy,Residual Disease,
HCM-WCMC-0788-C34,da8c7e2c-9dd3-4df6-a4b5-b6fff01e6da8,2041a4f6-782d-4d57-a28c-fb2f9db330ab,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-WCMC-0788-C34_treatment7,12366cd7-9ec6-4d46-a3df-3f9f561689e9,,released,,0,2023-02-27T12:55:12.177706-06:00,"Radiation Therapy, NOS",Residual Disease,
HCM-WCMC-0788-C34,da8c7e2c-9dd3-4df6-a4b5-b6fff01e6da8,2041a4f6-782d-4d57-a28c-fb2f9db330ab,216.0,Adjuvant,125.0,2025-04-07T17:13:09.336794-05:00,HCM-WCMC-0788-C34_treatment3,212c222d-c48c-447a-bca6-77563a404a83,,released,Vinorelbine Tartrate,1,2023-02-27T12:55:12.177706-06:00,Chemotherapy,Residual Disease,
HCM-WCMC-0788-C34,da8c7e2c-9dd3-4df6-a4b5-b6fff01e6da8,2041a4f6-782d-4d57-a28c-fb2f9db330ab,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-WCMC-0788-C34_treatment6,4bc965e3-3fce-46fe-aec6-e9757b957510,,released,,0,2023-02-27T12:55:12.177706-06:00,Targeted Molecular Therapy,Residual Disease,
HCM-WCMC-0788-C34,da8c7e2c-9dd3-4df6-a4b5-b6fff01e6da8,2041a4f6-782d-4d57-a28c-fb2f9db330ab,,,109.0,2025-04-07T17:13:09.336794-05:00,HCM-WCMC-0788-C34_treatment5,cf4fb1e2-4bad-43d5-9653-481b939292a4,,released,,1,2023-02-27T12:55:12.177706-06:00,"Surgery, NOS",Initial Diagnosis,
HCM-WCMC-0788-C34,da8c7e2c-9dd3-4df6-a4b5-b6fff01e6da8,2041a4f6-782d-4d57-a28c-fb2f9db330ab,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-WCMC-0788-C34_treatment4,df0349b0-5031-488b-aa40-c1f08e30dea4,,released,,0,2023-02-27T12:55:12.177706-06:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-WCMC-0788-C34,da8c7e2c-9dd3-4df6-a4b5-b6fff01e6da8,2041a4f6-782d-4d57-a28c-fb2f9db330ab,,Neoadjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-WCMC-0788-C34_treatment,fe2b6399-7bfb-4f9e-b9e1-180ca63d244c,,released,,0,2023-02-27T12:55:12.177706-06:00,,,
HCM-SANG-0269-C18,daf1dd34-2188-4cb0-95a5-286e0a0ba5ad,367f0e75-0929-49d6-986a-6a72290e7b9b,,Neoadjuvant,,2023-02-22T07:39:25.979291-06:00,HCM-SANG-0269-C18_treatment,1496a5c2-1fff-441d-bb20-2ac3c144c653,,released,,0,2020-02-11T15:50:56.392198-06:00,,,
HCM-CSHL-0669-C18,dc5a908f-fd2f-4eea-85cb-49b4de137286,9c3763b0-6d59-496a-abf1-fe301338f6a3,1159.0,Maintenance Therapy,42.0,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0669-C18_treatment10,1bf8da58-f7ab-49e9-bdaf-e5b3882a4d80,Progressive Disease,released,Fluorouracil,1,2021-12-21T14:16:57.212899-06:00,,,
HCM-CSHL-0669-C18,dc5a908f-fd2f-4eea-85cb-49b4de137286,9c3763b0-6d59-496a-abf1-fe301338f6a3,1159.0,Maintenance Therapy,42.0,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0669-C18_treatment15,3008e4ef-b138-483b-92b9-e4909f289950,Progressive Disease,released,Irinotecan,1,2021-12-21T14:16:57.212899-06:00,,,
HCM-CSHL-0669-C18,dc5a908f-fd2f-4eea-85cb-49b4de137286,9c3763b0-6d59-496a-abf1-fe301338f6a3,1159.0,Maintenance Therapy,42.0,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0669-C18_treatment14,50e52f97-94d0-4501-b4d1-ceaa0d14a99f,Progressive Disease,released,Trifluridine and Tipiracil Hydrochloride,1,2021-12-21T14:16:57.212899-06:00,,,
HCM-CSHL-0669-C18,dc5a908f-fd2f-4eea-85cb-49b4de137286,9c3763b0-6d59-496a-abf1-fe301338f6a3,1159.0,Maintenance Therapy,42.0,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0669-C18_treatment17,7a62931a-497a-4f3d-b0c3-7ef5d6c18e4c,Progressive Disease,released,,1,2021-12-21T14:16:57.212899-06:00,,,FOLFOX
HCM-CSHL-0669-C18,dc5a908f-fd2f-4eea-85cb-49b4de137286,9c3763b0-6d59-496a-abf1-fe301338f6a3,1159.0,Maintenance Therapy,42.0,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0669-C18_treatment12,80d38736-2ea5-44a3-a1c5-88f147647c14,Progressive Disease,released,Leucovorin Calcium,1,2021-12-21T14:16:57.212899-06:00,,,
HCM-CSHL-0669-C18,dc5a908f-fd2f-4eea-85cb-49b4de137286,9c3763b0-6d59-496a-abf1-fe301338f6a3,1159.0,Maintenance Therapy,42.0,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0669-C18_treatment13,83e639a2-899c-42d7-88c9-52c3ac03b2ab,Progressive Disease,released,Oxaliplatin,1,2021-12-21T14:16:57.212899-06:00,,,
HCM-CSHL-0669-C18,dc5a908f-fd2f-4eea-85cb-49b4de137286,9c3763b0-6d59-496a-abf1-fe301338f6a3,1159.0,Maintenance Therapy,42.0,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0669-C18_treatment16,a545abe6-8a20-49b8-9e0a-09483eab0d18,Progressive Disease,released,Unknown,1,2021-12-21T14:16:57.212899-06:00,,,
HCM-CSHL-0669-C18,dc5a908f-fd2f-4eea-85cb-49b4de137286,9c3763b0-6d59-496a-abf1-fe301338f6a3,1159.0,Maintenance Therapy,42.0,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0669-C18_treatment18,e269467d-2685-4e92-87f0-dcbba1e1dead,Progressive Disease,released,,1,2021-12-21T14:16:57.212899-06:00,,,FOLFIRI
HCM-CSHL-0669-C18,dc5a908f-fd2f-4eea-85cb-49b4de137286,9c3763b0-6d59-496a-abf1-fe301338f6a3,1159.0,Maintenance Therapy,42.0,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0669-C18_treatment11,e6829566-d328-497c-9782-590d60738cf5,Progressive Disease,released,Panitumumab,1,2021-12-21T14:16:57.212899-06:00,,,
HCM-CSHL-0669-C18,dc5a908f-fd2f-4eea-85cb-49b4de137286,b3f2c2ae-407a-46d8-b8e5-78a80214823c,89.0,Adjuvant,39.0,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0669-C18_treatment5,0c91dc78-0f9e-4563-a798-c23b1ef32f8e,,released,,1,2021-12-21T14:16:57.212899-06:00,Chemotherapy,Residual Disease,FOLFOX
HCM-CSHL-0669-C18,dc5a908f-fd2f-4eea-85cb-49b4de137286,b3f2c2ae-407a-46d8-b8e5-78a80214823c,,Adjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0669-C18_treatment9,2c2cb73d-59d5-4562-bf68-bdc71c057013,,released,,0,2021-12-21T14:16:57.212899-06:00,"Radiation Therapy, NOS",Residual Disease,
HCM-CSHL-0669-C18,dc5a908f-fd2f-4eea-85cb-49b4de137286,b3f2c2ae-407a-46d8-b8e5-78a80214823c,89.0,Adjuvant,39.0,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0669-C18_treatment2,39a55b12-e53c-4d1c-b3ee-f87c2e9e0bb0,,released,Leucovorin Calcium,1,2021-12-21T14:16:57.212899-06:00,Chemotherapy,Residual Disease,
HCM-CSHL-0669-C18,dc5a908f-fd2f-4eea-85cb-49b4de137286,b3f2c2ae-407a-46d8-b8e5-78a80214823c,89.0,Adjuvant,39.0,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0669-C18_treatment4,4c4c65bd-573e-4fb9-b949-ee7f2bd435c6,,released,Oxaliplatin,1,2021-12-21T14:16:57.212899-06:00,Chemotherapy,Residual Disease,
HCM-CSHL-0669-C18,dc5a908f-fd2f-4eea-85cb-49b4de137286,b3f2c2ae-407a-46d8-b8e5-78a80214823c,89.0,Adjuvant,39.0,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0669-C18_treatment3,83c7d940-783a-4bc9-a370-a2f854d30ee2,,released,Fluorouracil,1,2021-12-21T14:16:57.212899-06:00,Chemotherapy,Residual Disease,
HCM-CSHL-0669-C18,dc5a908f-fd2f-4eea-85cb-49b4de137286,b3f2c2ae-407a-46d8-b8e5-78a80214823c,89.0,Adjuvant,39.0,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0669-C18_treatment8,9cd68e8f-ca47-4d2e-8e8e-0449e761d4b0,,released,Bevacizumab,1,2021-12-21T14:16:57.212899-06:00,Targeted Molecular Therapy,Residual Disease,
HCM-CSHL-0669-C18,dc5a908f-fd2f-4eea-85cb-49b4de137286,b3f2c2ae-407a-46d8-b8e5-78a80214823c,,Adjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0669-C18_treatment6,a2fed6d7-4972-409d-ae48-44935e62d9c6,,released,,0,2021-12-21T14:16:57.212899-06:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-CSHL-0669-C18,dc5a908f-fd2f-4eea-85cb-49b4de137286,b3f2c2ae-407a-46d8-b8e5-78a80214823c,,,4.0,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0669-C18_treatment7,a9cf90c2-5dcf-4dcf-9e61-55940cde73ff,,released,,1,2021-12-21T14:16:57.212899-06:00,"Surgery, NOS",Initial Diagnosis,
HCM-CSHL-0669-C18,dc5a908f-fd2f-4eea-85cb-49b4de137286,b3f2c2ae-407a-46d8-b8e5-78a80214823c,,Neoadjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0669-C18_treatment,ec66b149-19e5-47f4-afa8-68b5fda6d9a4,,released,,0,2021-12-21T14:16:57.212899-06:00,,,
HCM-CSHL-0669-C18,dc5a908f-fd2f-4eea-85cb-49b4de137286,e9ccb9bc-2e96-47b2-a994-441be77cc91a,1159.0,Maintenance Therapy,42.0,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0669-C18_treatment19,090d7a08-602b-4780-81d7-5f7cd4944748,Progressive Disease,released,Fluorouracil,1,2021-12-21T14:16:57.212899-06:00,,,
HCM-CSHL-0669-C18,dc5a908f-fd2f-4eea-85cb-49b4de137286,e9ccb9bc-2e96-47b2-a994-441be77cc91a,1159.0,Maintenance Therapy,42.0,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0669-C18_treatment25,1719782c-6403-48c1-b2a9-d0f079196356,Progressive Disease,released,Unknown,1,2021-12-21T14:16:57.212899-06:00,,,
HCM-CSHL-0669-C18,dc5a908f-fd2f-4eea-85cb-49b4de137286,e9ccb9bc-2e96-47b2-a994-441be77cc91a,1159.0,Maintenance Therapy,42.0,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0669-C18_treatment23,50d149a9-face-49e4-9320-52b94056b532,Progressive Disease,released,Trifluridine and Tipiracil Hydrochloride,1,2021-12-21T14:16:57.212899-06:00,,,
HCM-CSHL-0669-C18,dc5a908f-fd2f-4eea-85cb-49b4de137286,e9ccb9bc-2e96-47b2-a994-441be77cc91a,1159.0,Maintenance Therapy,42.0,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0669-C18_treatment21,58d0043e-2a41-456e-b35f-6b5711474c3b,Progressive Disease,released,Leucovorin Calcium,1,2021-12-21T14:16:57.212899-06:00,,,
HCM-CSHL-0669-C18,dc5a908f-fd2f-4eea-85cb-49b4de137286,e9ccb9bc-2e96-47b2-a994-441be77cc91a,1159.0,Maintenance Therapy,42.0,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0669-C18_treatment24,8ead1078-4e50-4794-82fa-0e61968df4dd,Progressive Disease,released,Irinotecan,1,2021-12-21T14:16:57.212899-06:00,,,
HCM-CSHL-0669-C18,dc5a908f-fd2f-4eea-85cb-49b4de137286,e9ccb9bc-2e96-47b2-a994-441be77cc91a,1159.0,Maintenance Therapy,42.0,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0669-C18_treatment26,94cc009d-4826-4e16-a4a3-637a61d37cfc,Progressive Disease,released,,1,2021-12-21T14:16:57.212899-06:00,,,FOLFOX
HCM-CSHL-0669-C18,dc5a908f-fd2f-4eea-85cb-49b4de137286,e9ccb9bc-2e96-47b2-a994-441be77cc91a,1159.0,Maintenance Therapy,42.0,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0669-C18_treatment27,c073cf25-22b2-44e0-bb85-5cb5c7fdfcdd,Progressive Disease,released,,1,2021-12-21T14:16:57.212899-06:00,,,FOLFIRI
HCM-CSHL-0669-C18,dc5a908f-fd2f-4eea-85cb-49b4de137286,e9ccb9bc-2e96-47b2-a994-441be77cc91a,1159.0,Maintenance Therapy,42.0,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0669-C18_treatment20,d81f0578-bce9-44fb-95fe-225b47a7227d,Progressive Disease,released,Panitumumab,1,2021-12-21T14:16:57.212899-06:00,,,
HCM-CSHL-0669-C18,dc5a908f-fd2f-4eea-85cb-49b4de137286,e9ccb9bc-2e96-47b2-a994-441be77cc91a,1159.0,Maintenance Therapy,42.0,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0669-C18_treatment22,e84fdc12-d107-47e3-8c65-efc67c86b1fe,Progressive Disease,released,Oxaliplatin,1,2021-12-21T14:16:57.212899-06:00,,,
HCM-CSHL-0669-C18,dc5a908f-fd2f-4eea-85cb-49b4de137286,fdb6ba1a-5416-40b4-8236-13163b2a664e,1159.0,Maintenance Therapy,42.0,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0669-C18_treatment35,08bf372f-2fcf-47ad-981b-7cec0d7912d3,Progressive Disease,released,,1,2021-12-21T14:16:57.212899-06:00,,,FOLFOX
HCM-CSHL-0669-C18,dc5a908f-fd2f-4eea-85cb-49b4de137286,fdb6ba1a-5416-40b4-8236-13163b2a664e,1159.0,Maintenance Therapy,42.0,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0669-C18_treatment30,2aa5c97a-9e4c-4cc2-a113-67989229820e,Progressive Disease,released,Leucovorin Calcium,1,2021-12-21T14:16:57.212899-06:00,,,
HCM-CSHL-0669-C18,dc5a908f-fd2f-4eea-85cb-49b4de137286,fdb6ba1a-5416-40b4-8236-13163b2a664e,1159.0,Maintenance Therapy,42.0,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0669-C18_treatment29,304c9cb3-10f9-489f-9de6-768a887f49b9,Progressive Disease,released,Panitumumab,1,2021-12-21T14:16:57.212899-06:00,,,
HCM-CSHL-0669-C18,dc5a908f-fd2f-4eea-85cb-49b4de137286,fdb6ba1a-5416-40b4-8236-13163b2a664e,1159.0,Maintenance Therapy,42.0,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0669-C18_treatment33,4b9edeb4-8795-4a92-bd8d-0e34c2bbd97f,Progressive Disease,released,Irinotecan,1,2021-12-21T14:16:57.212899-06:00,,,
HCM-CSHL-0669-C18,dc5a908f-fd2f-4eea-85cb-49b4de137286,fdb6ba1a-5416-40b4-8236-13163b2a664e,1159.0,Maintenance Therapy,42.0,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0669-C18_treatment34,7295a9b1-b224-4d02-95dd-8631e251175c,Progressive Disease,released,Unknown,1,2021-12-21T14:16:57.212899-06:00,,,
HCM-CSHL-0669-C18,dc5a908f-fd2f-4eea-85cb-49b4de137286,fdb6ba1a-5416-40b4-8236-13163b2a664e,1159.0,Maintenance Therapy,42.0,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0669-C18_treatment31,9f149fcb-8099-4e1b-a19b-857999dd0c40,Progressive Disease,released,Oxaliplatin,1,2021-12-21T14:16:57.212899-06:00,,,
HCM-CSHL-0669-C18,dc5a908f-fd2f-4eea-85cb-49b4de137286,fdb6ba1a-5416-40b4-8236-13163b2a664e,1159.0,Maintenance Therapy,42.0,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0669-C18_treatment28,a19bd679-13bb-4ae5-bf55-0399890c4293,Progressive Disease,released,Fluorouracil,1,2021-12-21T14:16:57.212899-06:00,,,
HCM-CSHL-0669-C18,dc5a908f-fd2f-4eea-85cb-49b4de137286,fdb6ba1a-5416-40b4-8236-13163b2a664e,1159.0,Maintenance Therapy,42.0,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0669-C18_treatment32,b01303f3-21cb-4d47-9ddf-009a2929f5bc,Progressive Disease,released,Trifluridine and Tipiracil Hydrochloride,1,2021-12-21T14:16:57.212899-06:00,,,
HCM-CSHL-0669-C18,dc5a908f-fd2f-4eea-85cb-49b4de137286,fdb6ba1a-5416-40b4-8236-13163b2a664e,1159.0,Maintenance Therapy,42.0,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0669-C18_treatment36,c3afcce6-b496-46e2-904d-73cb48b0743b,Progressive Disease,released,,1,2021-12-21T14:16:57.212899-06:00,,,FOLFIRI
HCM-SANG-0294-C15,dd73ec51-8600-4f56-8591-92fd11c3cc92,277c6b71-4731-4bdd-8c52-9fe527558597,,Neoadjuvant,125.0,2023-03-13T12:56:41.912799-05:00,HCM-SANG-0294-C15_treatment,7d253559-06e4-4362-a733-80da58c9ae55,,released,Cisplatin,1,2021-12-21T15:09:09.929940-06:00,Chemotherapy,,
HCM-SANG-0294-C15,dd73ec51-8600-4f56-8591-92fd11c3cc92,277c6b71-4731-4bdd-8c52-9fe527558597,,Neoadjuvant,125.0,2023-03-13T12:56:41.912799-05:00,HCM-SANG-0294-C15_treatment2,bbb64815-40d0-40f9-9dd9-d59f15c4e90d,,released,Capecitabine,1,2021-12-21T15:09:09.929940-06:00,Chemotherapy,,
HCM-SANG-0294-C15,dd73ec51-8600-4f56-8591-92fd11c3cc92,277c6b71-4731-4bdd-8c52-9fe527558597,,Neoadjuvant,125.0,2023-03-13T12:56:41.912799-05:00,HCM-SANG-0294-C15_treatment3,bc08ec29-d69a-4605-a0be-09a187a4c2f6,,released,Trastuzumab,1,2021-12-21T15:09:09.929940-06:00,Chemotherapy,,
HCM-BROD-0328-C15,dd7c58fc-0765-4d02-9a60-515a721cd369,adb35634-5e40-4885-a3ac-9b33f83e2e90,,Adjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0328-C15_treatment5,2ba4454e-0ea2-4c8c-b976-43cc1ca99bed,,released,,0,2020-09-27T11:17:36.279473-05:00,Targeted Molecular Therapy,Residual Disease,
HCM-BROD-0328-C15,dd7c58fc-0765-4d02-9a60-515a721cd369,adb35634-5e40-4885-a3ac-9b33f83e2e90,,Adjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0328-C15_treatment3,83b1426f-53ae-49f6-ad2e-10bf52f35a3f,,released,,0,2020-09-27T11:17:36.279473-05:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-BROD-0328-C15,dd7c58fc-0765-4d02-9a60-515a721cd369,adb35634-5e40-4885-a3ac-9b33f83e2e90,,Neoadjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0328-C15_treatment,a14cf86a-9649-41eb-bc43-d29f17cb946e,,released,,0,2019-04-04T15:56:24.085531-05:00,,,
HCM-BROD-0328-C15,dd7c58fc-0765-4d02-9a60-515a721cd369,adb35634-5e40-4885-a3ac-9b33f83e2e90,,Adjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0328-C15_treatment6,a88f92f4-f3ef-499b-a78f-cf4271ff47ae,,released,,0,2020-09-27T11:17:36.279473-05:00,"Radiation Therapy, NOS",Residual Disease,
HCM-BROD-0328-C15,dd7c58fc-0765-4d02-9a60-515a721cd369,adb35634-5e40-4885-a3ac-9b33f83e2e90,,,,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0328-C15_treatment4,c656c2ca-35ee-4292-b42a-4fc33dd31858,,released,,0,2020-09-27T11:17:36.279473-05:00,"Surgery, NOS",Initial Diagnosis,
HCM-BROD-0328-C15,dd7c58fc-0765-4d02-9a60-515a721cd369,adb35634-5e40-4885-a3ac-9b33f83e2e90,,Adjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0328-C15_treatment2,f8e057bf-43b0-4564-88fd-f7ebcb7d917a,,released,,0,2020-09-27T11:17:36.279473-05:00,Chemotherapy,Residual Disease,
HCM-BROD-0449-C34,dd88a8a4-517b-40ad-a4f3-201e20875cfe,1c29ab94-e14f-4c82-b13b-8173a85c97df,232.0,Maintenance Therapy,232.0,2021-07-12T12:25:55.528644-05:00,HCM-BROD-0449-C34_treatment,4da2ba3d-3209-4107-ab3b-99cac5919481,Progressive Disease,released,,1,2020-06-15T13:40:46.229195-05:00,,Progressive Disease,
HCM-BROD-0449-C34,dd88a8a4-517b-40ad-a4f3-201e20875cfe,1c29ab94-e14f-4c82-b13b-8173a85c97df,406.0,Adjuvant,400.0,2023-03-13T13:11:23.509596-05:00,HCM-BROD-0449-C34_treatment5,75e8c09a-9bf3-461a-a645-6582f9a1e5e8,,released,,1,2020-06-15T13:40:46.229195-05:00,"Radiation, Stereotactic/Gamma Knife/SRS",Residual Disease,
HCM-BROD-0449-C34,dd88a8a4-517b-40ad-a4f3-201e20875cfe,1c29ab94-e14f-4c82-b13b-8173a85c97df,,,-14.0,2023-03-13T13:11:23.509596-05:00,HCM-BROD-0449-C34_treatment3,803cbe2a-4c90-42a8-8c68-76bb6c191aa7,,released,,1,2020-06-15T13:40:46.229195-05:00,"Surgery, NOS",Initial Diagnosis,
HCM-BROD-0449-C34,dd88a8a4-517b-40ad-a4f3-201e20875cfe,1c29ab94-e14f-4c82-b13b-8173a85c97df,,Neoadjuvant,232.0,2021-07-12T12:25:55.528644-05:00,HCM-BROD-0449-C34_treatment2,b8cbb412-7f21-4350-9582-1a02cf7d200e,,released,,1,2020-06-15T13:40:46.229195-05:00,Stereotactic Radiosurgery,,
HCM-BROD-0449-C34,dd88a8a4-517b-40ad-a4f3-201e20875cfe,1c29ab94-e14f-4c82-b13b-8173a85c97df,,Adjuvant,,2023-03-13T13:11:23.509596-05:00,HCM-BROD-0449-C34_treatment4,d3107141-a9a9-4c8e-9e0d-62a5a49a7c5a,,released,,0,2020-06-15T13:40:46.229195-05:00,"Pharmaceutical Therapy, NOS",Residual Disease,
HCM-CSHL-0728-C25,ddba0c54-930d-4dc4-b74f-48e29961c945,27415163-a825-491e-8d19-917ec6a7d259,,Adjuvant,,2023-02-22T07:39:25.979291-06:00,HCM-CSHL-0728-C25_treatment3,684371bb-dbc8-4ed9-b2a0-a860fa25deff,,released,,0,2021-12-21T14:19:07.289376-06:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-CSHL-0728-C25,ddba0c54-930d-4dc4-b74f-48e29961c945,27415163-a825-491e-8d19-917ec6a7d259,,Adjuvant,,2023-02-22T07:39:25.979291-06:00,HCM-CSHL-0728-C25_treatment5,7b215ae3-0f4c-44d6-98bd-5f1820763b25,,released,,0,2021-12-21T14:19:07.289376-06:00,Targeted Molecular Therapy,Residual Disease,
HCM-CSHL-0728-C25,ddba0c54-930d-4dc4-b74f-48e29961c945,27415163-a825-491e-8d19-917ec6a7d259,,Neoadjuvant,,2023-02-22T07:39:25.979291-06:00,HCM-CSHL-0728-C25_treatment,bfe06b07-1b7b-4a17-8aa8-84be528348cb,,released,,0,2021-12-21T14:19:07.289376-06:00,,,
HCM-CSHL-0728-C25,ddba0c54-930d-4dc4-b74f-48e29961c945,27415163-a825-491e-8d19-917ec6a7d259,,Adjuvant,,2023-02-22T07:39:25.979291-06:00,HCM-CSHL-0728-C25_treatment2,cbfa1ba6-6004-4344-be1e-fb295cb58f0f,,released,,1,2021-12-21T14:19:07.289376-06:00,Chemotherapy,Residual Disease,
HCM-CSHL-0728-C25,ddba0c54-930d-4dc4-b74f-48e29961c945,27415163-a825-491e-8d19-917ec6a7d259,,,,2023-02-27T13:17:56.041961-06:00,HCM-CSHL-0728-C25_treatment4,d8250998-32c1-463e-a25a-28764629ba0b,,released,,0,2021-12-21T14:19:07.289376-06:00,"Surgery, NOS",Initial Diagnosis,
HCM-CSHL-0728-C25,ddba0c54-930d-4dc4-b74f-48e29961c945,27415163-a825-491e-8d19-917ec6a7d259,,Adjuvant,,2023-02-22T07:39:25.979291-06:00,HCM-CSHL-0728-C25_treatment6,fc5a6f17-0a43-4888-a99b-615b7a7316a1,,released,,0,2021-12-21T14:19:07.289376-06:00,"Radiation Therapy, NOS",Residual Disease,
HCM-CSHL-0317-C18,de19bdf6-63b3-4e75-bf11-a7b6ebcea466,b8265fae-09e2-4089-a109-1963035574b5,,Neoadjuvant,,2021-07-12T12:25:55.528644-05:00,HCM-CSHL-0317-C18_treatment,39c1f3d9-b457-47d7-be8c-ed73ddcf9fea,,released,,0,2020-09-28T09:38:09.520270-05:00,,,
HCM-CSHL-0317-C18,de19bdf6-63b3-4e75-bf11-a7b6ebcea466,b8265fae-09e2-4089-a109-1963035574b5,,Adjuvant,,2023-03-13T12:45:18.744376-05:00,HCM-CSHL-0317-C18_treatment3,569d5653-7ed9-4e06-b37e-197462717e62,,released,,0,2020-09-28T09:38:09.520270-05:00,"Pharmaceutical Therapy, NOS",Residual Disease,
HCM-CSHL-0317-C18,de19bdf6-63b3-4e75-bf11-a7b6ebcea466,b8265fae-09e2-4089-a109-1963035574b5,,Adjuvant,,2023-03-13T12:45:18.744376-05:00,HCM-CSHL-0317-C18_treatment4,8028f110-91ff-4091-815f-03f47b6e020d,,released,,unknown,2020-09-28T09:38:09.520270-05:00,"Radiation Therapy, NOS",Residual Disease,
HCM-CSHL-0317-C18,de19bdf6-63b3-4e75-bf11-a7b6ebcea466,b8265fae-09e2-4089-a109-1963035574b5,,,35.0,2023-03-13T12:45:18.744376-05:00,HCM-CSHL-0317-C18_treatment2,ec712fb0-8265-468a-9670-bd336dfc0b3d,,released,,1,2020-09-28T09:38:09.520270-05:00,"Surgery, NOS",Initial Diagnosis,
HCM-BROD-0559-C16,de431792-364a-4c0a-9ab6-1166816c979a,2f4f475b-3d30-4268-bc06-e36784c7a0a5,171.0,Maintenance Therapy,25.0,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0559-C16_treatment12,15a95e4e-79f4-4f39-9f1d-d4f3b6e273dc,Progressive Disease,released,Fluorouracil,1,2020-10-08T14:46:22.743263-05:00,,,
HCM-BROD-0559-C16,de431792-364a-4c0a-9ab6-1166816c979a,2f4f475b-3d30-4268-bc06-e36784c7a0a5,171.0,Maintenance Therapy,25.0,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0559-C16_treatment14,2c3e3049-b2a6-44e8-89d3-628b171c5f35,Progressive Disease,released,,1,2020-10-08T14:46:22.743263-05:00,,,FOLFOX
HCM-BROD-0559-C16,de431792-364a-4c0a-9ab6-1166816c979a,2f4f475b-3d30-4268-bc06-e36784c7a0a5,171.0,Maintenance Therapy,25.0,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0559-C16_treatment13,61caff41-9703-4ef4-bf78-8a74b065e4c1,Progressive Disease,released,Oxaliplatin,1,2020-10-08T14:46:22.743263-05:00,,,
HCM-BROD-0559-C16,de431792-364a-4c0a-9ab6-1166816c979a,2f4f475b-3d30-4268-bc06-e36784c7a0a5,171.0,Maintenance Therapy,25.0,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0559-C16_treatment11,8dd561cc-6cec-4c68-a7d0-856ae0e7f44f,Progressive Disease,released,Leucovorin Calcium,1,2020-10-08T14:46:22.743263-05:00,,,
HCM-BROD-0559-C16,de431792-364a-4c0a-9ab6-1166816c979a,f0de5767-e099-4b6c-a563-35dec74058dd,171.0,Adjuvant,25.0,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0559-C16_treatment4,01d7640b-0cd9-4bc3-b7cc-8e0baa414a6b,,released,Oxaliplatin,1,2020-10-08T14:46:22.743263-05:00,Chemotherapy,Residual Disease,
HCM-BROD-0559-C16,de431792-364a-4c0a-9ab6-1166816c979a,f0de5767-e099-4b6c-a563-35dec74058dd,,Adjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0559-C16_treatment7,19fafeb3-d52d-4663-8b33-94ffbd2be156,,released,,0,2020-10-08T14:46:22.743263-05:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-BROD-0559-C16,de431792-364a-4c0a-9ab6-1166816c979a,f0de5767-e099-4b6c-a563-35dec74058dd,171.0,Adjuvant,25.0,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0559-C16_treatment5,3939266f-0054-4448-b4a3-13ca375af2a5,,released,,1,2020-10-08T14:46:22.743263-05:00,Chemotherapy,Residual Disease,FOLFOX
HCM-BROD-0559-C16,de431792-364a-4c0a-9ab6-1166816c979a,f0de5767-e099-4b6c-a563-35dec74058dd,,Neoadjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0559-C16_treatment,404c273e-77b2-4da0-b150-94510b6aa6f3,,released,,0,2020-10-08T14:46:22.743263-05:00,,,
HCM-BROD-0559-C16,de431792-364a-4c0a-9ab6-1166816c979a,f0de5767-e099-4b6c-a563-35dec74058dd,171.0,Adjuvant,25.0,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0559-C16_treatment2,56eaf6f6-3cbc-4538-bf9d-30d0f9675cd4,,released,Leucovorin Calcium,1,2020-10-08T14:46:22.743263-05:00,Chemotherapy,Residual Disease,
HCM-BROD-0559-C16,de431792-364a-4c0a-9ab6-1166816c979a,f0de5767-e099-4b6c-a563-35dec74058dd,171.0,Adjuvant,25.0,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0559-C16_treatment3,6aec4563-0c5d-45d5-bcd5-2068d921ff15,,released,Fluorouracil,1,2020-10-08T14:46:22.743263-05:00,Chemotherapy,Residual Disease,
HCM-BROD-0559-C16,de431792-364a-4c0a-9ab6-1166816c979a,f0de5767-e099-4b6c-a563-35dec74058dd,,,,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0559-C16_treatment8,a9a7ccae-61f8-4a23-a5fa-355f9b4a55be,,released,,0,2020-10-08T14:46:22.743263-05:00,"Surgery, NOS",Initial Diagnosis,
HCM-BROD-0559-C16,de431792-364a-4c0a-9ab6-1166816c979a,f0de5767-e099-4b6c-a563-35dec74058dd,,Adjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0559-C16_treatment10,ca3831af-f448-49af-a381-878daf874dc0,,released,,0,2020-10-08T14:46:22.743263-05:00,"Radiation Therapy, NOS",Residual Disease,
HCM-BROD-0559-C16,de431792-364a-4c0a-9ab6-1166816c979a,f0de5767-e099-4b6c-a563-35dec74058dd,207.0,Adjuvant,207.0,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0559-C16_treatment6,efd65059-57d4-413f-aba2-5789f09e97c6,,released,Paclitaxel,1,2020-10-08T14:46:22.743263-05:00,Chemotherapy,Residual Disease,
HCM-BROD-0559-C16,de431792-364a-4c0a-9ab6-1166816c979a,f0de5767-e099-4b6c-a563-35dec74058dd,,Adjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0559-C16_treatment9,fc0060f0-322b-428f-becd-ac518390c608,,released,,0,2020-10-08T14:46:22.743263-05:00,Targeted Molecular Therapy,Residual Disease,
HCM-CSHL-0245-C18,df69a9b0-63a6-47f4-b3a7-beb37edf100d,9fe82384-f165-4c0e-a49f-bbb9cd3a16fc,188.0,Maintenance Therapy,27.0,2021-09-07T12:04:46.644318-05:00,HCM-CSHL-0245-C18_treatment18,5943527e-3ffc-438c-99e5-90133d7e9f09,Treatment Ongoing,released,Oxaliplatin,1,2020-10-08T12:09:37.935146-05:00,,,
HCM-CSHL-0245-C18,df69a9b0-63a6-47f4-b3a7-beb37edf100d,9fe82384-f165-4c0e-a49f-bbb9cd3a16fc,188.0,Maintenance Therapy,27.0,2021-09-07T12:04:46.644318-05:00,HCM-CSHL-0245-C18_treatment19,7f6273d2-916f-4f3b-840d-bdb35d71260a,Treatment Ongoing,released,,1,2020-10-08T12:09:37.935146-05:00,,,FOLFOX
HCM-CSHL-0245-C18,df69a9b0-63a6-47f4-b3a7-beb37edf100d,9fe82384-f165-4c0e-a49f-bbb9cd3a16fc,188.0,Maintenance Therapy,27.0,2021-09-07T12:04:46.644318-05:00,HCM-CSHL-0245-C18_treatment17,c5d668a6-4787-4ae7-8144-18a372afa711,Treatment Ongoing,released,Fluorouracil,1,2020-10-08T12:09:37.935146-05:00,,,
HCM-CSHL-0245-C18,df69a9b0-63a6-47f4-b3a7-beb37edf100d,9fe82384-f165-4c0e-a49f-bbb9cd3a16fc,188.0,Maintenance Therapy,27.0,2021-09-10T10:36:37.981324-05:00,HCM-CSHL-0245-C18_treatment16,fcc2083b-91a9-4877-acc3-d9433f23ba56,Treatment Ongoing,released,Leucovorin Calcium,1,2021-09-07T12:04:46.644318-05:00,,,
HCM-CSHL-0245-C18,df69a9b0-63a6-47f4-b3a7-beb37edf100d,d2dcedb9-1fd0-4efc-8256-0e44cdbf0d8e,624.0,Adjuvant,479.0,2021-07-12T12:25:55.528644-05:00,HCM-CSHL-0245-C18_treatment8,22a0a153-d6f0-44d4-9f8d-9f66418d7502,,released,Irinotecan,1,2020-06-15T13:42:51.396910-05:00,Chemotherapy,Residual Disease,
HCM-CSHL-0245-C18,df69a9b0-63a6-47f4-b3a7-beb37edf100d,d2dcedb9-1fd0-4efc-8256-0e44cdbf0d8e,351.0,Adjuvant,260.0,2021-07-12T12:25:55.528644-05:00,HCM-CSHL-0245-C18_treatment5,49afef21-eac6-4e2a-9035-56a6510911ae,,released,Capecitabine,1,2020-06-15T13:42:51.396910-05:00,Chemotherapy,Residual Disease,
HCM-CSHL-0245-C18,df69a9b0-63a6-47f4-b3a7-beb37edf100d,d2dcedb9-1fd0-4efc-8256-0e44cdbf0d8e,,Adjuvant,,2021-09-07T12:04:46.644318-05:00,HCM-CSHL-0245-C18_treatment10,4da54849-43b9-4c81-9b76-f68e708c1d9f,,released,,0,2020-06-15T13:42:51.396910-05:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-CSHL-0245-C18,df69a9b0-63a6-47f4-b3a7-beb37edf100d,d2dcedb9-1fd0-4efc-8256-0e44cdbf0d8e,,Neoadjuvant,27.0,2021-07-12T12:25:55.528644-05:00,HCM-CSHL-0245-C18_treatment,4f9923db-167a-4cc5-b8a1-2b6bf6a5f31d,,released,Leucovorin Calcium,1,2020-06-15T13:42:51.396910-05:00,Chemotherapy,,
HCM-CSHL-0245-C18,df69a9b0-63a6-47f4-b3a7-beb37edf100d,d2dcedb9-1fd0-4efc-8256-0e44cdbf0d8e,624.0,Adjuvant,479.0,2021-07-12T12:25:55.528644-05:00,HCM-CSHL-0245-C18_treatment9,6a1a3d91-a4a1-4d02-ba3b-1d6a01a1eb1a,,released,,1,2020-06-15T13:42:51.396910-05:00,Chemotherapy,Residual Disease,FOLFIRI
HCM-CSHL-0245-C18,df69a9b0-63a6-47f4-b3a7-beb37edf100d,d2dcedb9-1fd0-4efc-8256-0e44cdbf0d8e,,,231.0,2023-03-13T12:50:22.160826-05:00,HCM-CSHL-0245-C18_treatment11,6d54f1a2-4582-4ed6-90e0-2e1ccb2f4081,,released,,1,2020-10-08T12:09:37.935146-05:00,"Surgery, NOS",Initial Diagnosis,
HCM-CSHL-0245-C18,df69a9b0-63a6-47f4-b3a7-beb37edf100d,d2dcedb9-1fd0-4efc-8256-0e44cdbf0d8e,624.0,Adjuvant,502.0,2021-09-07T12:04:46.644318-05:00,HCM-CSHL-0245-C18_treatment12,82888015-a0ca-4daa-8d28-458cd29239c4,,released,Bevacizumab,1,2020-10-08T12:09:37.935146-05:00,Targeted Molecular Therapy,Residual Disease,
HCM-CSHL-0245-C18,df69a9b0-63a6-47f4-b3a7-beb37edf100d,d2dcedb9-1fd0-4efc-8256-0e44cdbf0d8e,,Adjuvant,,2021-09-07T12:04:46.644318-05:00,HCM-CSHL-0245-C18_treatment15,906d3732-d28e-4ea6-9897-a670c04b5a73,,released,,0,2020-10-08T12:09:37.935146-05:00,"Radiation Therapy, NOS",Residual Disease,
HCM-CSHL-0245-C18,df69a9b0-63a6-47f4-b3a7-beb37edf100d,d2dcedb9-1fd0-4efc-8256-0e44cdbf0d8e,,Neoadjuvant,27.0,2021-07-12T12:25:55.528644-05:00,HCM-CSHL-0245-C18_treatment4,9656f0ff-881f-4229-a8a0-e7bdce73eac3,,released,,1,2020-06-15T13:42:51.396910-05:00,Chemotherapy,,FOLFOX
HCM-CSHL-0245-C18,df69a9b0-63a6-47f4-b3a7-beb37edf100d,d2dcedb9-1fd0-4efc-8256-0e44cdbf0d8e,,Adjuvant,607.0,2021-09-07T12:04:46.644318-05:00,HCM-CSHL-0245-C18_treatment14,ade5820b-0384-4ea3-bbec-75afceaacc59,Treatment Ongoing,released,Monalizumab,1,2020-10-08T12:09:37.935146-05:00,Targeted Molecular Therapy,Residual Disease,
HCM-CSHL-0245-C18,df69a9b0-63a6-47f4-b3a7-beb37edf100d,d2dcedb9-1fd0-4efc-8256-0e44cdbf0d8e,624.0,Adjuvant,479.0,2021-07-12T12:25:55.528644-05:00,HCM-CSHL-0245-C18_treatment6,b808b192-630c-47ea-8141-3a08b60ebcac,,released,Leucovorin Calcium,1,2020-06-15T13:42:51.396910-05:00,Chemotherapy,Residual Disease,
HCM-CSHL-0245-C18,df69a9b0-63a6-47f4-b3a7-beb37edf100d,d2dcedb9-1fd0-4efc-8256-0e44cdbf0d8e,,Neoadjuvant,27.0,2021-07-12T12:25:55.528644-05:00,HCM-CSHL-0245-C18_treatment2,be874168-6132-4833-b731-826ff22e7782,,released,Fluorouracil,1,2020-06-15T13:42:51.396910-05:00,Chemotherapy,,
HCM-CSHL-0245-C18,df69a9b0-63a6-47f4-b3a7-beb37edf100d,d2dcedb9-1fd0-4efc-8256-0e44cdbf0d8e,,Neoadjuvant,27.0,2021-07-12T12:25:55.528644-05:00,HCM-CSHL-0245-C18_treatment3,cb52b4d3-74aa-470a-8f5b-92e27145e002,,released,Oxaliplatin,1,2020-06-15T13:42:51.396910-05:00,Chemotherapy,,
HCM-CSHL-0245-C18,df69a9b0-63a6-47f4-b3a7-beb37edf100d,d2dcedb9-1fd0-4efc-8256-0e44cdbf0d8e,624.0,Adjuvant,479.0,2021-07-12T12:25:55.528644-05:00,HCM-CSHL-0245-C18_treatment7,d4fe201f-c3b0-4cac-ac45-4127adcb65ad,,released,Fluorouracil,1,2020-06-15T13:42:51.396910-05:00,Chemotherapy,Residual Disease,
HCM-CSHL-0245-C18,df69a9b0-63a6-47f4-b3a7-beb37edf100d,d2dcedb9-1fd0-4efc-8256-0e44cdbf0d8e,,Adjuvant,607.0,2021-09-07T12:04:46.644318-05:00,HCM-CSHL-0245-C18_treatment13,f6445099-bcb3-468f-810f-bccba536db71,Treatment Ongoing,released,Cetuximab,1,2020-10-08T12:09:37.935146-05:00,Targeted Molecular Therapy,Residual Disease,
HCM-BROD-1103-C86,df8d98d5-5c5d-425f-9e12-ecaf49a50b9c,39a1d7ea-a5bf-4a26-876c-09988c47439e,,Neoadjuvant,139.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-1103-C86_treatment,0186d4d5-1a01-41dc-a3fd-4f8efa63eaa6,,released,Cyclophosphamide,1,2021-12-21T15:23:46.579882-06:00,Chemotherapy,,
HCM-BROD-1103-C86,df8d98d5-5c5d-425f-9e12-ecaf49a50b9c,39a1d7ea-a5bf-4a26-876c-09988c47439e,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-BROD-1103-C86_treatment8,3aba7a6f-a817-450f-9595-f990873331ca,,released,,unknown,2021-12-21T15:23:46.579882-06:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-BROD-1103-C86,df8d98d5-5c5d-425f-9e12-ecaf49a50b9c,39a1d7ea-a5bf-4a26-876c-09988c47439e,,,,2025-04-07T17:13:09.336794-05:00,HCM-BROD-1103-C86_treatment9,401b222b-098e-450d-919e-9c7583c76553,,released,,0,2021-12-21T15:23:46.579882-06:00,"Surgery, NOS",Initial Diagnosis,
HCM-BROD-1103-C86,df8d98d5-5c5d-425f-9e12-ecaf49a50b9c,39a1d7ea-a5bf-4a26-876c-09988c47439e,,Neoadjuvant,139.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-1103-C86_treatment4,423de288-55f6-40c4-b410-e6fa9c411124,,released,Prednisone,1,2021-12-21T15:23:46.579882-06:00,Chemotherapy,,
HCM-BROD-1103-C86,df8d98d5-5c5d-425f-9e12-ecaf49a50b9c,39a1d7ea-a5bf-4a26-876c-09988c47439e,,Neoadjuvant,139.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-1103-C86_treatment2,4525ba5e-c52b-4179-9ab5-f4efead5ebf6,,released,Vincristine Sulfate,1,2021-12-21T15:23:46.579882-06:00,Chemotherapy,,
HCM-BROD-1103-C86,df8d98d5-5c5d-425f-9e12-ecaf49a50b9c,39a1d7ea-a5bf-4a26-876c-09988c47439e,,Neoadjuvant,139.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-1103-C86_treatment3,55722165-e61a-4b1d-a10c-bfa432d7d4db,,released,Doxorubicin Hydrochloride,1,2021-12-21T15:23:46.579882-06:00,Chemotherapy,,
HCM-BROD-1103-C86,df8d98d5-5c5d-425f-9e12-ecaf49a50b9c,39a1d7ea-a5bf-4a26-876c-09988c47439e,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-BROD-1103-C86_treatment7,680a7453-37a9-4cde-8ea0-a264b20e6add,,released,,unknown,2021-12-21T15:23:46.579882-06:00,Hormone Therapy,Residual Disease,
HCM-BROD-1103-C86,df8d98d5-5c5d-425f-9e12-ecaf49a50b9c,39a1d7ea-a5bf-4a26-876c-09988c47439e,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-BROD-1103-C86_treatment11,7a61997c-4ca2-4f0e-9088-8eeae8e07329,,released,,unknown,2021-12-21T15:23:46.579882-06:00,"Radiation Therapy, NOS",Residual Disease,
HCM-BROD-1103-C86,df8d98d5-5c5d-425f-9e12-ecaf49a50b9c,39a1d7ea-a5bf-4a26-876c-09988c47439e,,Neoadjuvant,139.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-1103-C86_treatment5,9270207e-0556-4217-ba24-1ebbfa4ec0ac,,released,Etoposide Phosphate,1,2021-12-21T15:23:46.579882-06:00,Chemotherapy,,
HCM-BROD-1103-C86,df8d98d5-5c5d-425f-9e12-ecaf49a50b9c,39a1d7ea-a5bf-4a26-876c-09988c47439e,215.0,Adjuvant,215.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-1103-C86_treatment6,c232c846-9f60-4ab9-867e-f1d5a36a3dba,,released,Bendamustine,1,2021-12-21T15:23:46.579882-06:00,Chemotherapy,Residual Disease,
HCM-BROD-1103-C86,df8d98d5-5c5d-425f-9e12-ecaf49a50b9c,39a1d7ea-a5bf-4a26-876c-09988c47439e,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-BROD-1103-C86_treatment10,dcf2fd5f-351c-404f-b6e4-86f3319911a8,,released,,unknown,2021-12-21T15:23:46.579882-06:00,Targeted Molecular Therapy,Residual Disease,
HCM-SANG-0530-C15,dfa2e46f-43f2-4cbb-ab19-ea1f5e4b00a1,73dcd83b-cf69-46d8-b336-091b7091daaf,,Neoadjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-SANG-0530-C15_treatment,bff5e1b8-399f-459c-8fdd-960f1b398da1,,released,,0,2023-02-27T13:12:07.133471-06:00,,,
HCM-CSHL-0191-C25,dfa988f5-226e-47ca-b4c5-ef950c9efac5,a0bd5b0d-5d09-46e1-8a46-c925d95fa5b1,,,-13.0,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0191-C25_treatment5,029946aa-8b74-44d9-99d4-b23176dd5e00,,released,,1,2020-09-28T09:16:01.450517-05:00,"Surgery, NOS",Initial Diagnosis,
HCM-CSHL-0191-C25,dfa988f5-226e-47ca-b4c5-ef950c9efac5,a0bd5b0d-5d09-46e1-8a46-c925d95fa5b1,,Adjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0191-C25_treatment7,07bbe4c9-d9f9-4244-aa15-0707f220e03c,,released,,0,2021-08-26T14:32:09.295136-05:00,"Radiation Therapy, NOS",Residual Disease,
HCM-CSHL-0191-C25,dfa988f5-226e-47ca-b4c5-ef950c9efac5,a0bd5b0d-5d09-46e1-8a46-c925d95fa5b1,251.0,Adjuvant,62.0,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0191-C25_treatment3,382ff8e6-e157-48e2-89c0-7dd1d3f213fe,,released,Nab-paclitaxel,1,2020-09-28T09:16:01.450517-05:00,Chemotherapy,Residual Disease,
HCM-CSHL-0191-C25,dfa988f5-226e-47ca-b4c5-ef950c9efac5,a0bd5b0d-5d09-46e1-8a46-c925d95fa5b1,,Adjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0191-C25_treatment6,aae6c3de-6379-4a61-a052-473e7743aa4d,,released,,0,2020-09-28T09:16:01.450517-05:00,Targeted Molecular Therapy,Residual Disease,
HCM-CSHL-0191-C25,dfa988f5-226e-47ca-b4c5-ef950c9efac5,a0bd5b0d-5d09-46e1-8a46-c925d95fa5b1,,Adjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0191-C25_treatment4,d4b97868-dc68-4816-81a7-2ad07b7436a4,,released,,0,2020-09-28T09:16:01.450517-05:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-CSHL-0191-C25,dfa988f5-226e-47ca-b4c5-ef950c9efac5,a0bd5b0d-5d09-46e1-8a46-c925d95fa5b1,,Neoadjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0191-C25_treatment,f02d100c-e8cf-45a2-beef-3f586bea32f8,,released,,0,2020-09-28T09:16:01.450517-05:00,,,
HCM-CSHL-0191-C25,dfa988f5-226e-47ca-b4c5-ef950c9efac5,a0bd5b0d-5d09-46e1-8a46-c925d95fa5b1,251.0,Adjuvant,62.0,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0191-C25_treatment2,f7f74b61-ee27-4f11-ae24-5183dbf81f2f,,released,Gemcitabine,1,2020-09-28T09:16:01.450517-05:00,Chemotherapy,Residual Disease,
HCM-BROD-0100-C15,e00914a1-997e-44ba-9c88-a5e8741b4ee1,0a37ccf7-cabd-4589-b04e-2ed8f84399e7,,Neoadjuvant,,2020-10-08T12:47:18.316908-05:00,HCM-BROD-0100-C15_treatment,0347ee0a-6f71-4378-8a03-f221073547bd,,released,Unknown,1,2019-04-16T11:45:26.694088-05:00,Chemotherapy,,
HCM-BROD-0100-C15,e00914a1-997e-44ba-9c88-a5e8741b4ee1,0a37ccf7-cabd-4589-b04e-2ed8f84399e7,483.0,Adjuvant,444.0,2023-03-13T13:10:54.923311-05:00,HCM-BROD-0100-C15_treatment5,06f864dc-8a15-4c5f-990b-27f9222582a3,,released,,1,2019-04-16T11:45:26.694088-05:00,"Radiation, External Beam",Residual Disease,
HCM-BROD-0100-C15,e00914a1-997e-44ba-9c88-a5e8741b4ee1,0a37ccf7-cabd-4589-b04e-2ed8f84399e7,,Adjuvant,,2023-03-13T13:10:54.923311-05:00,HCM-BROD-0100-C15_treatment4,165488f7-12b0-42d2-8768-2ab07ed0353e,,released,,0,2019-04-16T11:45:26.694088-05:00,"Pharmaceutical Therapy, NOS",Residual Disease,
HCM-BROD-0100-C15,e00914a1-997e-44ba-9c88-a5e8741b4ee1,0a37ccf7-cabd-4589-b04e-2ed8f84399e7,,Neoadjuvant,,2020-01-13T20:10:25.832065-06:00,HCM-BROD-0100-C15_treatment2,1d3f9072-2e32-4a48-b8d4-28d747f4c7b8,,released,,1,2019-04-16T11:45:26.694088-05:00,"Radiation, 3D Conformal",,
HCM-BROD-0100-C15,e00914a1-997e-44ba-9c88-a5e8741b4ee1,0a37ccf7-cabd-4589-b04e-2ed8f84399e7,,,,2023-03-13T13:10:54.923311-05:00,HCM-BROD-0100-C15_treatment3,70435cde-cb29-4a03-8ed6-7a56e280ead0,,released,,0,2019-04-16T11:45:26.694088-05:00,"Surgery, NOS",Initial Diagnosis,
HCM-SANG-1323-C15,e20192b7-5dd5-45c9-a813-71071fb143be,3ccbbf05-540a-41d6-9654-2d9914e56a5c,,Neoadjuvant,109.0,2025-04-07T17:13:09.336794-05:00,HCM-SANG-1323-C15_treatment,02a7653c-cf2e-4385-becb-c85ffe85a990,,released,Leucovorin,1,2023-02-27T12:53:08.208937-06:00,Chemotherapy,,
HCM-SANG-1323-C15,e20192b7-5dd5-45c9-a813-71071fb143be,3ccbbf05-540a-41d6-9654-2d9914e56a5c,,Neoadjuvant,109.0,2025-04-07T17:13:09.336794-05:00,HCM-SANG-1323-C15_treatment2,413f5875-78a1-4247-b39c-2e560b61b4a4,,released,Fluorouracil,1,2023-02-27T12:53:08.208937-06:00,Chemotherapy,,
HCM-SANG-1323-C15,e20192b7-5dd5-45c9-a813-71071fb143be,3ccbbf05-540a-41d6-9654-2d9914e56a5c,,Neoadjuvant,109.0,2025-04-07T17:13:09.336794-05:00,HCM-SANG-1323-C15_treatment4,43a7b8fe-b929-49ca-acf4-12a117e45c81,,released,Oxaliplatin,1,2023-02-27T12:53:08.208937-06:00,Chemotherapy,,
HCM-SANG-1323-C15,e20192b7-5dd5-45c9-a813-71071fb143be,3ccbbf05-540a-41d6-9654-2d9914e56a5c,,Neoadjuvant,109.0,2025-04-07T17:13:09.336794-05:00,HCM-SANG-1323-C15_treatment3,6094e07b-d479-4b70-9fa5-758446cd4e84,,released,Docetaxel,1,2023-02-27T12:53:08.208937-06:00,Chemotherapy,,
HCM-BROD-0962-C16,e36812a9-2637-43aa-87b1-6722019136b4,80a770b0-efff-4598-9c5c-d0d07a887eb4,,Neoadjuvant,16.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0962-C16_treatment2,02b017ab-7cbb-4899-8a3b-26cd716bbbc7,,released,Fluorouracil,1,2021-12-21T13:59:49.229209-06:00,Chemotherapy,,
HCM-BROD-0962-C16,e36812a9-2637-43aa-87b1-6722019136b4,80a770b0-efff-4598-9c5c-d0d07a887eb4,,Neoadjuvant,16.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0962-C16_treatment6,193f434b-ce13-41a6-ac31-160269fd13b1,,released,,1,2021-12-21T13:59:49.229209-06:00,Chemotherapy,,FOLFOX
HCM-BROD-0962-C16,e36812a9-2637-43aa-87b1-6722019136b4,80a770b0-efff-4598-9c5c-d0d07a887eb4,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0962-C16_treatment9,348ac6f6-ddee-42ca-bf05-3b008f9e670f,,released,,0,2021-12-21T13:59:49.229209-06:00,Chemotherapy,Residual Disease,
HCM-BROD-0962-C16,e36812a9-2637-43aa-87b1-6722019136b4,80a770b0-efff-4598-9c5c-d0d07a887eb4,,,,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0962-C16_treatment11,3585342d-5d1f-407c-9e07-543c6d1b3c29,,released,,0,2021-12-21T13:59:49.229209-06:00,"Surgery, NOS",Initial Diagnosis,
HCM-BROD-0962-C16,e36812a9-2637-43aa-87b1-6722019136b4,80a770b0-efff-4598-9c5c-d0d07a887eb4,,Neoadjuvant,16.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0962-C16_treatment,53ccbf8e-7285-49a2-84c0-ef6d7fa12419,,released,Paclitaxel,1,2021-12-21T13:59:49.229209-06:00,Chemotherapy,,
HCM-BROD-0962-C16,e36812a9-2637-43aa-87b1-6722019136b4,80a770b0-efff-4598-9c5c-d0d07a887eb4,,Neoadjuvant,16.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0962-C16_treatment3,6b5ea0fb-c08e-4e1c-9bf8-9e6c3ff75b79,,released,Irinotecan,1,2021-12-21T13:59:49.229209-06:00,Chemotherapy,,
HCM-BROD-0962-C16,e36812a9-2637-43aa-87b1-6722019136b4,80a770b0-efff-4598-9c5c-d0d07a887eb4,331.0,Adjuvant,331.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0962-C16_treatment10,ad138b2b-7608-448d-8db9-47f398046e0c,,released,Pembrolizumab,1,2021-12-21T13:59:49.229209-06:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-BROD-0962-C16,e36812a9-2637-43aa-87b1-6722019136b4,80a770b0-efff-4598-9c5c-d0d07a887eb4,,Neoadjuvant,16.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0962-C16_treatment4,b713aaa1-b670-4971-bff5-821fd4754f6a,,released,Oxaliplatin,1,2021-12-21T13:59:49.229209-06:00,Chemotherapy,,
HCM-BROD-0962-C16,e36812a9-2637-43aa-87b1-6722019136b4,80a770b0-efff-4598-9c5c-d0d07a887eb4,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0962-C16_treatment12,bed3909f-cd16-4fb5-b803-d35d6763f222,,released,,0,2021-12-21T13:59:49.229209-06:00,Targeted Molecular Therapy,Residual Disease,
HCM-BROD-0962-C16,e36812a9-2637-43aa-87b1-6722019136b4,80a770b0-efff-4598-9c5c-d0d07a887eb4,,Neoadjuvant,16.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0962-C16_treatment5,c22d5ada-33dd-4f62-886a-89eab2cb6292,,released,Leucovorin Calcium,1,2021-12-21T13:59:49.229209-06:00,Chemotherapy,,
HCM-BROD-0962-C16,e36812a9-2637-43aa-87b1-6722019136b4,80a770b0-efff-4598-9c5c-d0d07a887eb4,,Neoadjuvant,156.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0962-C16_treatment8,dbad4c9c-3cee-4a49-b0ae-9d2b73f9d220,,released,Ramucirumab,1,2021-12-21T13:59:49.229209-06:00,Targeted Molecular Therapy,,
HCM-BROD-0962-C16,e36812a9-2637-43aa-87b1-6722019136b4,80a770b0-efff-4598-9c5c-d0d07a887eb4,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0962-C16_treatment13,e7238653-5f69-422b-9dd1-b7c24cb621bc,,released,,0,2021-12-21T13:59:49.229209-06:00,"Radiation Therapy, NOS",Residual Disease,
HCM-BROD-0962-C16,e36812a9-2637-43aa-87b1-6722019136b4,80a770b0-efff-4598-9c5c-d0d07a887eb4,,Neoadjuvant,16.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0962-C16_treatment7,ef3f15b3-7db1-452f-b89e-e13c29e50b49,,released,,1,2021-12-21T13:59:49.229209-06:00,Chemotherapy,,FOLFIRI
HCM-CSHL-0074-C25,e3b32485-b204-43a7-93a5-601408fcdf96,fa6d5c8a-3d61-49e3-805e-e14b58514a7e,255.0,Adjuvant,229.0,2023-02-22T07:39:25.979291-06:00,HCM-CSHL-0074-C25_treatment6,08b4599f-59ed-449f-890a-7c8ac760579c,,released,,1,2020-09-27T12:45:44.335430-05:00,"Radiation Therapy, NOS",Residual Disease,
HCM-CSHL-0074-C25,e3b32485-b204-43a7-93a5-601408fcdf96,fa6d5c8a-3d61-49e3-805e-e14b58514a7e,,Adjuvant,,2023-02-22T07:39:25.979291-06:00,HCM-CSHL-0074-C25_treatment3,1595ea8e-da3a-4663-872d-db806ad31e00,,released,,0,2020-09-27T12:45:44.335430-05:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-CSHL-0074-C25,e3b32485-b204-43a7-93a5-601408fcdf96,fa6d5c8a-3d61-49e3-805e-e14b58514a7e,,,-7.0,2023-02-27T13:29:37.505444-06:00,HCM-CSHL-0074-C25_treatment4,ad522c7c-a32d-4cdb-9acc-1cb43bb22e61,,released,,1,2020-09-27T12:45:44.335430-05:00,"Surgery, NOS",Initial Diagnosis,
HCM-CSHL-0074-C25,e3b32485-b204-43a7-93a5-601408fcdf96,fa6d5c8a-3d61-49e3-805e-e14b58514a7e,,Adjuvant,,2023-02-22T07:39:25.979291-06:00,HCM-CSHL-0074-C25_treatment5,ceee4b22-f748-43a1-992f-ba854196968c,,released,,0,2020-09-27T12:45:44.335430-05:00,Targeted Molecular Therapy,Residual Disease,
HCM-CSHL-0074-C25,e3b32485-b204-43a7-93a5-601408fcdf96,fa6d5c8a-3d61-49e3-805e-e14b58514a7e,,Neoadjuvant,,2023-02-22T07:39:25.979291-06:00,HCM-CSHL-0074-C25_treatment,da2c312b-5cf1-4021-9dbf-95a92c10cbc0,,released,,0,2020-09-27T12:45:44.335430-05:00,,,
HCM-CSHL-0074-C25,e3b32485-b204-43a7-93a5-601408fcdf96,fa6d5c8a-3d61-49e3-805e-e14b58514a7e,218.0,Adjuvant,48.0,2023-02-22T07:39:25.979291-06:00,HCM-CSHL-0074-C25_treatment2,f92aab0b-899a-40d6-a1b2-0abfe20966b1,,released,Gemcitabine,1,2020-09-27T12:45:44.335430-05:00,Chemotherapy,Residual Disease,
HCM-BROD-0793-C15,e3b7a023-92a8-4c61-b1c9-be10f5d03bc9,52633907-0c25-4f6b-91e2-a7ed6a75b168,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0793-C15_treatment11,0d7f4764-b306-4a58-a268-c5faacebcbd0,,released,,0,2021-12-21T13:53:39.167413-06:00,Targeted Molecular Therapy,Residual Disease,
HCM-BROD-0793-C15,e3b7a023-92a8-4c61-b1c9-be10f5d03bc9,52633907-0c25-4f6b-91e2-a7ed6a75b168,320.0,Adjuvant,236.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0793-C15_treatment4,14bab20a-ec8c-40d4-a897-4f9afa2f2b28,,released,Leucovorin Calcium,1,2021-12-21T13:53:39.167413-06:00,Chemotherapy,Residual Disease,
HCM-BROD-0793-C15,e3b7a023-92a8-4c61-b1c9-be10f5d03bc9,52633907-0c25-4f6b-91e2-a7ed6a75b168,320.0,Adjuvant,236.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0793-C15_treatment6,21ec9da9-e261-4316-93ee-568ad757eb04,,released,Oxaliplatin,1,2021-12-21T13:53:39.167413-06:00,Chemotherapy,Residual Disease,
HCM-BROD-0793-C15,e3b7a023-92a8-4c61-b1c9-be10f5d03bc9,52633907-0c25-4f6b-91e2-a7ed6a75b168,320.0,Adjuvant,236.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0793-C15_treatment7,4323be5f-56a3-44c9-9161-1a90abee63c0,,released,,1,2021-12-21T13:53:39.167413-06:00,Chemotherapy,Residual Disease,FOLFOX
HCM-BROD-0793-C15,e3b7a023-92a8-4c61-b1c9-be10f5d03bc9,52633907-0c25-4f6b-91e2-a7ed6a75b168,,Neoadjuvant,59.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0793-C15_treatment3,43e07e38-469a-4add-956b-c4728fe758cd,,released,,1,2021-12-21T13:53:39.167413-06:00,"Radiation Therapy, NOS",,
HCM-BROD-0793-C15,e3b7a023-92a8-4c61-b1c9-be10f5d03bc9,52633907-0c25-4f6b-91e2-a7ed6a75b168,405.0,Adjuvant,349.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0793-C15_treatment8,4a14106a-b6f7-4720-b5a0-e1cf4fb7938b,,released,Paclitaxel,1,2021-12-21T13:53:39.167413-06:00,Chemotherapy,Residual Disease,
HCM-BROD-0793-C15,e3b7a023-92a8-4c61-b1c9-be10f5d03bc9,52633907-0c25-4f6b-91e2-a7ed6a75b168,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0793-C15_treatment12,52d49071-c825-4935-87dd-1984f4a16730,,released,,0,2021-12-21T13:53:39.167413-06:00,"Radiation Therapy, NOS",Residual Disease,
HCM-BROD-0793-C15,e3b7a023-92a8-4c61-b1c9-be10f5d03bc9,52633907-0c25-4f6b-91e2-a7ed6a75b168,,,115.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0793-C15_treatment10,5cefe308-cbe9-4fc7-9875-ddd6aec3df5d,,released,,1,2021-12-21T13:53:39.167413-06:00,"Surgery, NOS",Initial Diagnosis,
HCM-BROD-0793-C15,e3b7a023-92a8-4c61-b1c9-be10f5d03bc9,52633907-0c25-4f6b-91e2-a7ed6a75b168,,Neoadjuvant,32.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0793-C15_treatment,6c5edcdf-97a7-4e65-85e4-b56a86bfeeee,,released,Carboplatin,1,2021-12-21T13:53:39.167413-06:00,Chemotherapy,,
HCM-BROD-0793-C15,e3b7a023-92a8-4c61-b1c9-be10f5d03bc9,52633907-0c25-4f6b-91e2-a7ed6a75b168,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0793-C15_treatment9,ad1ab0d6-d92a-4b1d-8531-790e00ebcac5,,released,,0,2021-12-21T13:53:39.167413-06:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-BROD-0793-C15,e3b7a023-92a8-4c61-b1c9-be10f5d03bc9,52633907-0c25-4f6b-91e2-a7ed6a75b168,320.0,Adjuvant,236.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0793-C15_treatment5,c77da8a8-4a29-42cd-9133-3829fd3ed5b2,,released,Fluorouracil,1,2021-12-21T13:53:39.167413-06:00,Chemotherapy,Residual Disease,
HCM-BROD-0793-C15,e3b7a023-92a8-4c61-b1c9-be10f5d03bc9,52633907-0c25-4f6b-91e2-a7ed6a75b168,,Neoadjuvant,32.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0793-C15_treatment2,f484af27-a302-4989-9efe-3b542f31899d,,released,Paclitaxel,1,2021-12-21T13:53:39.167413-06:00,Chemotherapy,,
HCM-BROD-0793-C15,e3b7a023-92a8-4c61-b1c9-be10f5d03bc9,92b3dc89-c16c-43a3-a0ee-a3a2707cd3bd,405.0,Maintenance Therapy,32.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0793-C15_treatment13,020c48ae-d3e4-4b68-96a3-ec04dc3591a3,Progressive Disease,released,Carboplatin,1,2021-12-21T13:53:39.167413-06:00,,,
HCM-BROD-0793-C15,e3b7a023-92a8-4c61-b1c9-be10f5d03bc9,92b3dc89-c16c-43a3-a0ee-a3a2707cd3bd,405.0,Maintenance Therapy,32.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0793-C15_treatment16,a7143433-6f31-4ec2-b702-98c2ab381012,Progressive Disease,released,Leucovorin Calcium,1,2021-12-21T13:53:39.167413-06:00,,,
HCM-BROD-0793-C15,e3b7a023-92a8-4c61-b1c9-be10f5d03bc9,92b3dc89-c16c-43a3-a0ee-a3a2707cd3bd,405.0,Maintenance Therapy,32.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0793-C15_treatment17,c822a894-aa6f-461c-9531-8296e43d24e1,Progressive Disease,released,Fluorouracil,1,2021-12-21T13:53:39.167413-06:00,,,
HCM-BROD-0793-C15,e3b7a023-92a8-4c61-b1c9-be10f5d03bc9,92b3dc89-c16c-43a3-a0ee-a3a2707cd3bd,405.0,Maintenance Therapy,32.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0793-C15_treatment15,ccd95202-f58c-4f4b-89c2-818b54e7eb5b,Progressive Disease,released,Oxaliplatin,1,2021-12-21T13:53:39.167413-06:00,,,
HCM-BROD-0793-C15,e3b7a023-92a8-4c61-b1c9-be10f5d03bc9,92b3dc89-c16c-43a3-a0ee-a3a2707cd3bd,405.0,Maintenance Therapy,32.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0793-C15_treatment18,d68525ed-207f-4612-ac95-c9e769e5aebc,Progressive Disease,released,,1,2021-12-21T13:53:39.167413-06:00,,,FOLFOX
HCM-BROD-0793-C15,e3b7a023-92a8-4c61-b1c9-be10f5d03bc9,92b3dc89-c16c-43a3-a0ee-a3a2707cd3bd,405.0,Maintenance Therapy,32.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0793-C15_treatment14,e1ff8649-7e07-40d3-97e3-452e9180b968,Progressive Disease,released,Paclitaxel,1,2021-12-21T13:53:39.167413-06:00,,,
HCM-BROD-0724-C43,e46ea440-c987-4c4f-8b7e-bacca42d32d8,fa0a0975-098d-4ae7-bb6b-517880f7d7fb,,Neoadjuvant,,2023-07-13T10:35:44.371881-05:00,HCM-BROD-0724-C43_treatment,1834dc26-1edc-47d0-8161-d94a221420ba,,released,,0,2021-12-21T13:48:47.342295-06:00,,,
HCM-BROD-0724-C43,e46ea440-c987-4c4f-8b7e-bacca42d32d8,fa0a0975-098d-4ae7-bb6b-517880f7d7fb,,Adjuvant,,2023-07-13T10:35:44.371881-05:00,HCM-BROD-0724-C43_treatment6,55f1d912-afc7-4230-be90-e8a1b2be2744,,released,,0,2021-12-21T13:48:47.342295-06:00,Targeted Molecular Therapy,Residual Disease,
HCM-BROD-0724-C43,e46ea440-c987-4c4f-8b7e-bacca42d32d8,fa0a0975-098d-4ae7-bb6b-517880f7d7fb,567.0,Adjuvant,472.0,2023-07-13T10:35:44.371881-05:00,HCM-BROD-0724-C43_treatment2,5787239f-58a5-41aa-9251-04cd9be9bcb6,Treatment Ongoing,released,Capecitabine,1,2021-12-21T13:48:47.342295-06:00,Chemotherapy,Residual Disease,
HCM-BROD-0724-C43,e46ea440-c987-4c4f-8b7e-bacca42d32d8,fa0a0975-098d-4ae7-bb6b-517880f7d7fb,,,,2023-07-13T10:35:44.371881-05:00,HCM-BROD-0724-C43_treatment5,6fb4235e-bfec-4cc4-9293-eff0158175d6,,released,,0,2021-12-21T13:48:47.342295-06:00,"Surgery, NOS",Initial Diagnosis,
HCM-BROD-0724-C43,e46ea440-c987-4c4f-8b7e-bacca42d32d8,fa0a0975-098d-4ae7-bb6b-517880f7d7fb,,Adjuvant,,2023-07-13T10:35:44.371881-05:00,HCM-BROD-0724-C43_treatment3,9132ddbb-7dc8-4ed2-8d4d-2e423509c2db,,released,,0,2021-12-21T13:48:47.342295-06:00,Hormone Therapy,Residual Disease,
HCM-BROD-0724-C43,e46ea440-c987-4c4f-8b7e-bacca42d32d8,fa0a0975-098d-4ae7-bb6b-517880f7d7fb,353.0,Adjuvant,18.0,2023-07-13T10:35:44.371881-05:00,HCM-BROD-0724-C43_treatment4,aae4ef59-a425-481a-914e-0b1ca545bed3,,released,Nivolumab,1,2021-12-21T13:48:47.342295-06:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-BROD-0724-C43,e46ea440-c987-4c4f-8b7e-bacca42d32d8,fa0a0975-098d-4ae7-bb6b-517880f7d7fb,,Adjuvant,,2023-07-13T10:35:44.371881-05:00,HCM-BROD-0724-C43_treatment7,c2587929-16c6-4229-a00d-62efa0d70850,,released,,0,2021-12-21T13:48:47.342295-06:00,"Radiation Therapy, NOS",Residual Disease,
HCM-CSHL-0801-C56,e4b062d4-30a1-4661-b5ec-28c532cbad0d,a0bef82a-5d53-4221-96aa-fac3a47481b5,,Neoadjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0801-C56_treatment5,6c7e73c6-cd17-4770-880d-99de9b457b62,Unknown,released,,1,2021-12-21T14:23:55.645184-06:00,Chemotherapy,,
HCM-CSHL-0801-C56,e4b062d4-30a1-4661-b5ec-28c532cbad0d,a0bef82a-5d53-4221-96aa-fac3a47481b5,,,0.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0801-C56_treatment2,a810e996-c534-42c5-b361-7d98c64b3aad,,released,,1,2021-12-21T14:23:55.645184-06:00,"Surgery, NOS",Initial Diagnosis,
HCM-CSHL-0801-C56,e4b062d4-30a1-4661-b5ec-28c532cbad0d,a0bef82a-5d53-4221-96aa-fac3a47481b5,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0801-C56_treatment4,e64fbd42-bef4-4c34-90b2-fa8df1d0fb72,,released,,0,2021-12-21T14:23:55.645184-06:00,"Radiation Therapy, NOS",Residual Disease,
HCM-CSHL-0801-C56,e4b062d4-30a1-4661-b5ec-28c532cbad0d,a0bef82a-5d53-4221-96aa-fac3a47481b5,,Neoadjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0801-C56_treatment,ec34c4b3-066d-403b-9eed-39885da4deca,,released,,0,2021-12-21T14:23:55.645184-06:00,,,
HCM-CSHL-0801-C56,e4b062d4-30a1-4661-b5ec-28c532cbad0d,a0bef82a-5d53-4221-96aa-fac3a47481b5,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0801-C56_treatment3,fabd7f11-e814-4d03-a6c3-dbbf98349b60,,released,,0,2021-12-21T14:23:55.645184-06:00,"Pharmaceutical Therapy, NOS",Residual Disease,
HCM-BROD-0134-C25,e4f98856-8ba9-498d-bbd5-443bb1bf4591,921b4c7a-5691-4d1d-8751-072a79402a9b,233.0,Adjuvant,233.0,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0134-C25_treatment7,358f677c-a1cf-4356-89d8-bf4f180c33c9,,released,Gemcitabine,1,2020-09-17T16:01:02.431006-05:00,Chemotherapy,Residual Disease,
HCM-BROD-0134-C25,e4f98856-8ba9-498d-bbd5-443bb1bf4591,921b4c7a-5691-4d1d-8751-072a79402a9b,,,,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0134-C25_treatment10,5952ae83-4a12-4114-b816-19308935e5ed,,released,,0,2020-09-17T16:01:02.431006-05:00,"Surgery, NOS",Initial Diagnosis,
HCM-BROD-0134-C25,e4f98856-8ba9-498d-bbd5-443bb1bf4591,921b4c7a-5691-4d1d-8751-072a79402a9b,217.0,Adjuvant,7.0,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0134-C25_treatment6,5e976f53-43d9-4cd9-87f9-b4b6af3c96e1,,released,,1,2020-09-17T16:01:02.431006-05:00,Chemotherapy,Residual Disease,FOLFIRINOX
HCM-BROD-0134-C25,e4f98856-8ba9-498d-bbd5-443bb1bf4591,921b4c7a-5691-4d1d-8751-072a79402a9b,217.0,Adjuvant,7.0,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0134-C25_treatment4,61a4d85e-1eb4-46df-8829-bb4d2d35181b,,released,Fluorouracil,1,2020-09-17T16:01:02.431006-05:00,Chemotherapy,Residual Disease,
HCM-BROD-0134-C25,e4f98856-8ba9-498d-bbd5-443bb1bf4591,921b4c7a-5691-4d1d-8751-072a79402a9b,,Adjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0134-C25_treatment11,61d278fe-9fa9-4ce7-8e82-914aa0c0928d,,released,,0,2020-09-17T16:01:02.431006-05:00,Targeted Molecular Therapy,Residual Disease,
HCM-BROD-0134-C25,e4f98856-8ba9-498d-bbd5-443bb1bf4591,921b4c7a-5691-4d1d-8751-072a79402a9b,233.0,Adjuvant,233.0,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0134-C25_treatment8,6b10c105-17b5-49ea-bb83-319a9176be74,,released,Nab-paclitaxel,1,2020-09-17T16:01:02.431006-05:00,Chemotherapy,Residual Disease,
HCM-BROD-0134-C25,e4f98856-8ba9-498d-bbd5-443bb1bf4591,921b4c7a-5691-4d1d-8751-072a79402a9b,,Adjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0134-C25_treatment9,7f3ccec0-d67c-45a1-ac5f-71bf532f830d,,released,,0,2020-09-17T16:01:02.431006-05:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-BROD-0134-C25,e4f98856-8ba9-498d-bbd5-443bb1bf4591,921b4c7a-5691-4d1d-8751-072a79402a9b,,Neoadjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0134-C25_treatment,89601104-0ce0-4767-971d-64f069879e91,,released,,0,2020-09-17T16:01:02.431006-05:00,,,
HCM-BROD-0134-C25,e4f98856-8ba9-498d-bbd5-443bb1bf4591,921b4c7a-5691-4d1d-8751-072a79402a9b,217.0,Adjuvant,7.0,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0134-C25_treatment3,ad2b4c2b-fddf-4e10-ab80-5675b5053c98,,released,Leucovorin Calcium,1,2020-09-17T16:01:02.431006-05:00,Chemotherapy,Residual Disease,
HCM-BROD-0134-C25,e4f98856-8ba9-498d-bbd5-443bb1bf4591,921b4c7a-5691-4d1d-8751-072a79402a9b,217.0,Adjuvant,7.0,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0134-C25_treatment5,bf0fab8c-06b0-411e-b706-d0f07289d9df,,released,Oxaliplatin,1,2020-09-17T16:01:02.431006-05:00,Chemotherapy,Residual Disease,
HCM-BROD-0134-C25,e4f98856-8ba9-498d-bbd5-443bb1bf4591,921b4c7a-5691-4d1d-8751-072a79402a9b,,Adjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0134-C25_treatment12,d7ea86fd-ca06-4147-af65-d7c649974c45,,released,,0,2020-09-17T16:01:02.431006-05:00,"Radiation Therapy, NOS",Residual Disease,
HCM-BROD-0134-C25,e4f98856-8ba9-498d-bbd5-443bb1bf4591,921b4c7a-5691-4d1d-8751-072a79402a9b,217.0,Adjuvant,7.0,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0134-C25_treatment2,eee590e1-32a0-4f54-9835-e0b46e4d43a4,,released,Irinotecan Hydrochloride,1,2020-09-17T16:01:02.431006-05:00,Chemotherapy,Residual Disease,
HCM-BROD-0007-C49,e506251d-4072-4479-b2ce-5c75387dc7fc,34cda512-45a5-44b8-bc07-0807a5a94149,,Adjuvant,,2021-01-06T22:55:10.531130-06:00,HCM-BROD-0007-C49_treatment15,04f3c2d7-dcef-461a-9278-264b786fface,,released,,0,2020-09-27T09:57:36.711627-05:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-BROD-0007-C49,e506251d-4072-4479-b2ce-5c75387dc7fc,34cda512-45a5-44b8-bc07-0807a5a94149,,Neoadjuvant,,2021-01-06T22:55:10.531130-06:00,HCM-BROD-0007-C49_treatment3,0aaf52e8-2914-4d2a-a675-d9462803b949,,released,Cyclophosphamide,1,2020-02-27T12:02:13.282956-06:00,Chemotherapy,,
HCM-BROD-0007-C49,e506251d-4072-4479-b2ce-5c75387dc7fc,34cda512-45a5-44b8-bc07-0807a5a94149,,Adjuvant,,2021-01-06T22:55:10.531130-06:00,HCM-BROD-0007-C49_treatment18,423e410b-7151-4851-a40e-b48bbe4197ba,,released,,0,2020-09-27T09:57:36.711627-05:00,"Radiation Therapy, NOS",Residual Disease,
HCM-BROD-0007-C49,e506251d-4072-4479-b2ce-5c75387dc7fc,34cda512-45a5-44b8-bc07-0807a5a94149,,Maintenance Therapy,,2021-01-06T22:55:10.531130-06:00,HCM-BROD-0007-C49_treatment9,4ab8f63d-fa87-4934-a2bf-de30d7f09c82,Progressive Disease,released,Cyclophosphamide,1,2020-09-27T09:57:36.711627-05:00,,Progressive Disease,
HCM-BROD-0007-C49,e506251d-4072-4479-b2ce-5c75387dc7fc,34cda512-45a5-44b8-bc07-0807a5a94149,,Maintenance Therapy,,2021-01-06T22:55:10.531130-06:00,HCM-BROD-0007-C49_treatment7,54fceb11-6464-4089-bb04-3a3ecdb1c2f7,Progressive Disease,released,Vincristine,1,2020-02-27T12:02:13.282956-06:00,,Progressive Disease,
HCM-BROD-0007-C49,e506251d-4072-4479-b2ce-5c75387dc7fc,34cda512-45a5-44b8-bc07-0807a5a94149,,Adjuvant,,2021-01-06T22:55:10.531130-06:00,HCM-BROD-0007-C49_treatment14,56127fc4-b80d-4ab6-bcc0-f559e3223ff6,,released,,0,2020-09-27T09:57:36.711627-05:00,Chemotherapy,Residual Disease,
HCM-BROD-0007-C49,e506251d-4072-4479-b2ce-5c75387dc7fc,34cda512-45a5-44b8-bc07-0807a5a94149,,Maintenance Therapy,,2021-01-06T22:55:10.531130-06:00,HCM-BROD-0007-C49_treatment11,56a0bfaf-8fc6-4a9a-889a-d80d0ac2c0e0,Progressive Disease,released,Etoposide,1,2020-09-27T09:57:36.711627-05:00,,Progressive Disease,
HCM-BROD-0007-C49,e506251d-4072-4479-b2ce-5c75387dc7fc,34cda512-45a5-44b8-bc07-0807a5a94149,,Maintenance Therapy,,2021-01-06T22:55:10.531130-06:00,HCM-BROD-0007-C49_treatment12,66a4b550-e517-4671-8351-c4c5b755528e,Progressive Disease,released,,1,2020-09-27T09:57:36.711627-05:00,,Progressive Disease,VDC/IE
HCM-BROD-0007-C49,e506251d-4072-4479-b2ce-5c75387dc7fc,34cda512-45a5-44b8-bc07-0807a5a94149,519.0,Adjuvant,488.0,2021-01-06T22:55:10.531130-06:00,HCM-BROD-0007-C49_treatment17,796ab6d5-6635-40e6-a458-c30c50a393ce,,released,Not Otherwise Specified,1,2020-09-27T09:57:36.711627-05:00,Targeted Molecular Therapy,Residual Disease,
HCM-BROD-0007-C49,e506251d-4072-4479-b2ce-5c75387dc7fc,34cda512-45a5-44b8-bc07-0807a5a94149,,Neoadjuvant,,2021-01-06T22:55:10.531130-06:00,HCM-BROD-0007-C49_treatment13,9461d33f-1673-486e-9c3f-f7e9d3666436,,released,Unknown,1,2020-09-27T09:57:36.711627-05:00,Targeted Molecular Therapy,,
HCM-BROD-0007-C49,e506251d-4072-4479-b2ce-5c75387dc7fc,34cda512-45a5-44b8-bc07-0807a5a94149,,,,2023-02-24T14:48:28.769480-06:00,HCM-BROD-0007-C49_treatment16,a79feec9-50c1-47df-8d5e-980b9b273664,,released,,0,2020-09-27T09:57:36.711627-05:00,"Surgery, NOS",Initial Diagnosis,
HCM-BROD-0007-C49,e506251d-4072-4479-b2ce-5c75387dc7fc,34cda512-45a5-44b8-bc07-0807a5a94149,,Neoadjuvant,,2021-01-06T22:55:10.531130-06:00,HCM-BROD-0007-C49_treatment,aedf5720-9d97-4beb-99a2-d42afbb4db96,,released,Vincristine,1,2020-02-27T12:02:13.282956-06:00,Chemotherapy,,
HCM-BROD-0007-C49,e506251d-4072-4479-b2ce-5c75387dc7fc,34cda512-45a5-44b8-bc07-0807a5a94149,,Maintenance Therapy,,2021-01-06T22:55:10.531130-06:00,HCM-BROD-0007-C49_treatment10,c3f0b075-078d-444d-be05-b8ae3e0c850f,Progressive Disease,released,Doxorubicin,1,2020-09-27T09:57:36.711627-05:00,,Progressive Disease,
HCM-BROD-0007-C49,e506251d-4072-4479-b2ce-5c75387dc7fc,34cda512-45a5-44b8-bc07-0807a5a94149,,Maintenance Therapy,,2021-01-06T22:55:10.531130-06:00,HCM-BROD-0007-C49_treatment8,d8811ce7-b7a4-41e0-8c0f-04e319e904bf,Progressive Disease,released,Ifosfamide,1,2020-02-27T12:02:13.282956-06:00,,Progressive Disease,
HCM-BROD-0007-C49,e506251d-4072-4479-b2ce-5c75387dc7fc,34cda512-45a5-44b8-bc07-0807a5a94149,,Neoadjuvant,,2021-01-06T22:55:10.531130-06:00,HCM-BROD-0007-C49_treatment5,e6504ef2-d403-4388-9a88-c92861600595,,released,Etoposide,1,2020-02-27T12:02:13.282956-06:00,Chemotherapy,,
HCM-BROD-0007-C49,e506251d-4072-4479-b2ce-5c75387dc7fc,34cda512-45a5-44b8-bc07-0807a5a94149,,Neoadjuvant,,2021-01-06T22:55:10.531130-06:00,HCM-BROD-0007-C49_treatment2,f126d2e4-9314-4c0f-81c5-0f92fe22e73d,,released,Ifosfamide,1,2020-02-27T12:02:13.282956-06:00,Chemotherapy,,
HCM-BROD-0007-C49,e506251d-4072-4479-b2ce-5c75387dc7fc,34cda512-45a5-44b8-bc07-0807a5a94149,,Neoadjuvant,,2021-01-06T22:55:10.531130-06:00,HCM-BROD-0007-C49_treatment6,f35369c9-cd84-4c1c-9c16-420a586785d1,,released,,1,2020-02-27T12:02:13.282956-06:00,Chemotherapy,,VDC/IE
HCM-BROD-0007-C49,e506251d-4072-4479-b2ce-5c75387dc7fc,34cda512-45a5-44b8-bc07-0807a5a94149,,Neoadjuvant,,2021-01-06T22:55:10.531130-06:00,HCM-BROD-0007-C49_treatment4,f70a405b-0cb1-48fe-b4cc-90d45199c86e,,released,Doxorubicin,1,2020-02-27T12:02:13.282956-06:00,Chemotherapy,,
HCM-CSHL-0664-C18,e681e4d0-b358-49ad-9ef8-88a32a6acb12,2633b3ed-1180-40d1-8b20-24bfcae3a9a4,2738.0,Adjuvant,2677.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0664-C18_treatment13,358a25cc-740b-467f-b12f-9217d3e3cde5,,released,Cetuximab,1,2021-12-21T14:15:27.479937-06:00,Chemotherapy,Residual Disease,
HCM-CSHL-0664-C18,e681e4d0-b358-49ad-9ef8-88a32a6acb12,2633b3ed-1180-40d1-8b20-24bfcae3a9a4,2404.0,Adjuvant,2223.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0664-C18_treatment11,4abf8c16-c3cd-4e90-aa97-57a847252dd6,,released,,1,2021-12-21T14:15:27.479937-06:00,Chemotherapy,Residual Disease,FOLFOX
HCM-CSHL-0664-C18,e681e4d0-b358-49ad-9ef8-88a32a6acb12,2633b3ed-1180-40d1-8b20-24bfcae3a9a4,,,3210.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0664-C18_treatment15,4f1eef64-eecb-4d30-859f-993076322ccc,,released,,1,2021-12-21T14:15:27.479937-06:00,"Surgery, NOS",Initial Diagnosis,
HCM-CSHL-0664-C18,e681e4d0-b358-49ad-9ef8-88a32a6acb12,2633b3ed-1180-40d1-8b20-24bfcae3a9a4,2404.0,Adjuvant,2223.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0664-C18_treatment10,5070bf18-9516-40b8-9546-5be58e0e5ce0,,released,Fluorouracil,1,2021-12-21T14:15:27.479937-06:00,Chemotherapy,Residual Disease,
HCM-CSHL-0664-C18,e681e4d0-b358-49ad-9ef8-88a32a6acb12,2633b3ed-1180-40d1-8b20-24bfcae3a9a4,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0664-C18_treatment16,5692a9c7-37ec-4e8d-b5e0-dfc57c81fa6c,,released,,0,2021-12-21T14:15:27.479937-06:00,Targeted Molecular Therapy,Residual Disease,
HCM-CSHL-0664-C18,e681e4d0-b358-49ad-9ef8-88a32a6acb12,2633b3ed-1180-40d1-8b20-24bfcae3a9a4,2738.0,Adjuvant,2677.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0664-C18_treatment12,5c03d1a8-acff-45c0-b888-ea33b54e98fb,,released,Irinotecan,1,2021-12-21T14:15:27.479937-06:00,Chemotherapy,Residual Disease,
HCM-CSHL-0664-C18,e681e4d0-b358-49ad-9ef8-88a32a6acb12,2633b3ed-1180-40d1-8b20-24bfcae3a9a4,,Neoadjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0664-C18_treatment,6e45e4cc-909b-446f-ba0b-c77e4746151d,,released,,0,2021-12-21T14:15:27.479937-06:00,,,
HCM-CSHL-0664-C18,e681e4d0-b358-49ad-9ef8-88a32a6acb12,2633b3ed-1180-40d1-8b20-24bfcae3a9a4,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0664-C18_treatment14,795c828c-dd74-419b-8bed-951107ab0098,,released,,0,2021-12-21T14:15:27.479937-06:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-CSHL-0664-C18,e681e4d0-b358-49ad-9ef8-88a32a6acb12,2633b3ed-1180-40d1-8b20-24bfcae3a9a4,2131.0,Adjuvant,1846.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0664-C18_treatment6,7dc57a3c-2556-424e-9288-04d4d1f2a79f,,released,,1,2021-12-21T14:15:27.479937-06:00,Chemotherapy,Residual Disease,FOLFIRI-cetuximab
HCM-CSHL-0664-C18,e681e4d0-b358-49ad-9ef8-88a32a6acb12,2633b3ed-1180-40d1-8b20-24bfcae3a9a4,2131.0,Adjuvant,1846.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0664-C18_treatment3,7f37b340-46a5-405d-a3e7-dd1a4899b1e5,,released,Leucovorin Calcium,1,2021-12-21T14:15:27.479937-06:00,Chemotherapy,Residual Disease,
HCM-CSHL-0664-C18,e681e4d0-b358-49ad-9ef8-88a32a6acb12,2633b3ed-1180-40d1-8b20-24bfcae3a9a4,2131.0,Adjuvant,1846.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0664-C18_treatment4,88727bb7-09d7-4cb3-92b3-2af92f8ecfef,,released,Fluorouracil,1,2021-12-21T14:15:27.479937-06:00,Chemotherapy,Residual Disease,
HCM-CSHL-0664-C18,e681e4d0-b358-49ad-9ef8-88a32a6acb12,2633b3ed-1180-40d1-8b20-24bfcae3a9a4,2131.0,Adjuvant,1846.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0664-C18_treatment2,907d1018-ecee-4b2d-a174-21a3e34d8377,,released,Irinotecan,1,2021-12-21T14:15:27.479937-06:00,Chemotherapy,Residual Disease,
HCM-CSHL-0664-C18,e681e4d0-b358-49ad-9ef8-88a32a6acb12,2633b3ed-1180-40d1-8b20-24bfcae3a9a4,2131.0,Adjuvant,1846.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0664-C18_treatment5,b1318043-5e1c-43d9-a2ce-373b76b61b6f,,released,Cetuximab,1,2021-12-21T14:15:27.479937-06:00,Chemotherapy,Residual Disease,
HCM-CSHL-0664-C18,e681e4d0-b358-49ad-9ef8-88a32a6acb12,2633b3ed-1180-40d1-8b20-24bfcae3a9a4,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0664-C18_treatment17,b9dca538-7d85-4ed3-91d0-ff5941610a77,,released,,0,2021-12-21T14:15:27.479937-06:00,"Radiation Therapy, NOS",Residual Disease,
HCM-CSHL-0664-C18,e681e4d0-b358-49ad-9ef8-88a32a6acb12,2633b3ed-1180-40d1-8b20-24bfcae3a9a4,2404.0,Adjuvant,2223.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0664-C18_treatment9,cb0ac646-7483-4078-a236-a440e7d6ccdf,,released,Leucovorin Calcium,1,2021-12-21T14:15:27.479937-06:00,Chemotherapy,Residual Disease,
HCM-CSHL-0664-C18,e681e4d0-b358-49ad-9ef8-88a32a6acb12,2633b3ed-1180-40d1-8b20-24bfcae3a9a4,2404.0,Adjuvant,2223.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0664-C18_treatment7,dac4565e-f022-4e76-912f-500156993cce,,released,Oxaliplatin,1,2021-12-21T14:15:27.479937-06:00,Chemotherapy,Residual Disease,
HCM-CSHL-0664-C18,e681e4d0-b358-49ad-9ef8-88a32a6acb12,2633b3ed-1180-40d1-8b20-24bfcae3a9a4,2404.0,Adjuvant,2223.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0664-C18_treatment8,e1172b70-b00f-4139-8a74-4ff277ffb858,,released,Bevacizumab,1,2021-12-21T14:15:27.479937-06:00,Chemotherapy,Residual Disease,
HCM-CSHL-0664-C18,e681e4d0-b358-49ad-9ef8-88a32a6acb12,4b4c8f75-32b7-4753-b8e2-0e9b55b13dea,2888.0,Maintenance Therapy,2677.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0664-C18_treatment18,4288c6fd-7991-4861-a3fd-26470296fdd8,Progressive Disease,released,Irinotecan,1,2021-12-21T14:15:27.479937-06:00,,,
HCM-CSHL-0664-C18,e681e4d0-b358-49ad-9ef8-88a32a6acb12,4b4c8f75-32b7-4753-b8e2-0e9b55b13dea,2888.0,Maintenance Therapy,2677.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0664-C18_treatment19,e3fb4333-9385-4204-8239-b71a2de56f24,Progressive Disease,released,Cetuximab,1,2021-12-21T14:15:27.479937-06:00,,,
HCM-SANG-1086-C18,e7448c61-2f2b-49b0-8f10-e7eda3f59444,7fa2f73d-7214-4b96-98cf-641162c3bf57,,Neoadjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-SANG-1086-C18_treatment,4229eb2c-45de-42f3-aba2-498d964d28c0,,released,,0,2023-02-27T11:48:05.553392-06:00,,,
HCM-SANG-1094-C16,e7ec711b-2d50-44e9-8622-99cb3e4aa4fe,63aad08b-71f9-41a9-a438-7812f7197502,,Neoadjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-SANG-1094-C16_treatment,14202154-82f3-4bc3-b48a-a30535e071cb,,released,,0,2023-02-27T11:24:11.653157-06:00,,,
HCM-CSHL-0063-C18,e802e579-5293-465c-a867-74e290268299,78f75aac-8d68-4525-a68e-0336f44737f6,713.0,Adjuvant,531.0,2020-10-08T19:00:37.191737-05:00,HCM-CSHL-0063-C18_treatment5,0441282f-5049-433d-8c6c-58299c8b5e54,,released,Oxaliplatin,1,2020-02-27T12:40:16.625347-06:00,Chemotherapy,Residual Disease,
HCM-CSHL-0063-C18,e802e579-5293-465c-a867-74e290268299,78f75aac-8d68-4525-a68e-0336f44737f6,,Adjuvant,,2020-10-20T19:20:06.800740-05:00,HCM-CSHL-0063-C18_treatment9,0d110aef-6cab-4ada-8a99-587c1cb1b8b7,,released,,unknown,2020-10-08T19:00:37.191737-05:00,Targeted Molecular Therapy,Residual Disease,
HCM-CSHL-0063-C18,e802e579-5293-465c-a867-74e290268299,78f75aac-8d68-4525-a68e-0336f44737f6,713.0,Adjuvant,531.0,2020-10-08T19:00:37.191737-05:00,HCM-CSHL-0063-C18_treatment4,2af5f6a4-9873-412b-9327-aaeeab5d8647,,released,Fluorouracil,1,2020-02-27T12:40:16.625347-06:00,Chemotherapy,Residual Disease,
HCM-CSHL-0063-C18,e802e579-5293-465c-a867-74e290268299,78f75aac-8d68-4525-a68e-0336f44737f6,428.0,Adjuvant,273.0,2020-03-26T16:04:47.706904-05:00,HCM-CSHL-0063-C18_treatment2,56b6b604-b134-484e-8d60-d94d370f60ed,,released,Capecitabine,1,2020-02-27T12:40:16.625347-06:00,Chemotherapy,Residual Disease,
HCM-CSHL-0063-C18,e802e579-5293-465c-a867-74e290268299,78f75aac-8d68-4525-a68e-0336f44737f6,,,196.0,2023-02-27T13:00:51.463665-06:00,HCM-CSHL-0063-C18_treatment8,852f6eef-2ca8-4b5d-84f6-4a09817a275a,,released,,1,2020-10-08T19:00:37.191737-05:00,"Surgery, NOS",Initial Diagnosis,
HCM-CSHL-0063-C18,e802e579-5293-465c-a867-74e290268299,78f75aac-8d68-4525-a68e-0336f44737f6,,Adjuvant,,2020-10-20T19:20:06.800740-05:00,HCM-CSHL-0063-C18_treatment10,a3a2a9fb-d1e9-4501-85bc-cf94699ad1b9,,released,,0,2020-10-08T19:00:37.191737-05:00,"Radiation Therapy, NOS",Residual Disease,
HCM-CSHL-0063-C18,e802e579-5293-465c-a867-74e290268299,78f75aac-8d68-4525-a68e-0336f44737f6,,Neoadjuvant,,2019-05-24T12:11:41.511797-05:00,HCM-CSHL-0063-C18_treatment,ca2e0503-f096-456e-b6ea-7f6743d8707d,,released,,0,2019-05-15T14:59:45.171654-05:00,,,
HCM-CSHL-0063-C18,e802e579-5293-465c-a867-74e290268299,78f75aac-8d68-4525-a68e-0336f44737f6,713.0,Adjuvant,531.0,2020-10-08T19:00:37.191737-05:00,HCM-CSHL-0063-C18_treatment6,d26bdccd-8730-4638-8cae-41afa00f8492,,released,,1,2020-02-27T12:40:16.625347-06:00,Chemotherapy,Residual Disease,FOLFOX
HCM-CSHL-0063-C18,e802e579-5293-465c-a867-74e290268299,78f75aac-8d68-4525-a68e-0336f44737f6,713.0,Adjuvant,531.0,2020-10-08T19:00:37.191737-05:00,HCM-CSHL-0063-C18_treatment3,f0adace6-c319-4f64-a67b-e9513717661b,,released,Leucovorin Calcium,1,2020-02-27T12:40:16.625347-06:00,Chemotherapy,Residual Disease,
HCM-CSHL-0063-C18,e802e579-5293-465c-a867-74e290268299,78f75aac-8d68-4525-a68e-0336f44737f6,,Adjuvant,,2020-10-08T19:00:37.191737-05:00,HCM-CSHL-0063-C18_treatment7,ff49ecc4-f5ca-443c-a336-0d31b4c7eadb,,released,,unknown,2020-02-27T12:40:16.625347-06:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-BROD-0099-C15,e89fb71d-dd21-4e48-bb32-0d9435addd84,f4f5f003-75b1-4498-9d6b-bb68aa622040,,Adjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0099-C15_treatment5,0778b42b-f879-4cf3-8b0a-45211b25c13e,,released,,0,2020-09-27T10:23:58.185112-05:00,Targeted Molecular Therapy,Residual Disease,
HCM-BROD-0099-C15,e89fb71d-dd21-4e48-bb32-0d9435addd84,f4f5f003-75b1-4498-9d6b-bb68aa622040,,Adjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0099-C15_treatment6,4f026f79-0a59-4e48-a260-421a9782f9ab,,released,,0,2020-09-27T10:23:58.185112-05:00,"Radiation Therapy, NOS",Residual Disease,
HCM-BROD-0099-C15,e89fb71d-dd21-4e48-bb32-0d9435addd84,f4f5f003-75b1-4498-9d6b-bb68aa622040,,Adjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0099-C15_treatment3,77afaf6d-db26-464b-8b30-ca82918ab572,,released,,0,2020-09-27T10:23:58.185112-05:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-BROD-0099-C15,e89fb71d-dd21-4e48-bb32-0d9435addd84,f4f5f003-75b1-4498-9d6b-bb68aa622040,,,,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0099-C15_treatment4,a3ec967d-6df0-4ea4-b311-fe2b9fe4bdff,,released,,0,2020-09-27T10:23:58.185112-05:00,"Surgery, NOS",Initial Diagnosis,
HCM-BROD-0099-C15,e89fb71d-dd21-4e48-bb32-0d9435addd84,f4f5f003-75b1-4498-9d6b-bb68aa622040,,Adjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0099-C15_treatment2,c2369fb0-5e3a-4d8b-ad88-d9714fa77795,,released,,0,2020-09-27T10:23:58.185112-05:00,Chemotherapy,Residual Disease,
HCM-BROD-0099-C15,e89fb71d-dd21-4e48-bb32-0d9435addd84,f4f5f003-75b1-4498-9d6b-bb68aa622040,,Neoadjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0099-C15_treatment,ee481fed-5bdc-4b44-b4b1-2d9578469f23,,released,,1,2019-04-04T15:51:07.087068-05:00,Chemotherapy,,
HCM-BROD-0709-C64,e8c47711-aab4-4f33-a3d4-d80cd4a8d821,d33040f0-cc95-41a5-85a1-c2dfad84b3b5,,Neoadjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0709-C64_treatment,0ea9d469-9eda-486f-89f5-64177388ec17,,released,,0,2021-12-21T13:46:27.027251-06:00,,,
HCM-BROD-0709-C64,e8c47711-aab4-4f33-a3d4-d80cd4a8d821,d33040f0-cc95-41a5-85a1-c2dfad84b3b5,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0709-C64_treatment2,2398f92e-2dff-4cd2-a2ea-efe90f00f6f7,,released,,0,2021-12-21T13:46:27.027251-06:00,Chemotherapy,Residual Disease,
HCM-BROD-0709-C64,e8c47711-aab4-4f33-a3d4-d80cd4a8d821,d33040f0-cc95-41a5-85a1-c2dfad84b3b5,,,0.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0709-C64_treatment5,258af527-1da8-4e15-ae8b-74ae1d094635,,released,,1,2021-12-21T13:46:27.027251-06:00,"Surgery, NOS",Initial Diagnosis,
HCM-BROD-0709-C64,e8c47711-aab4-4f33-a3d4-d80cd4a8d821,d33040f0-cc95-41a5-85a1-c2dfad84b3b5,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0709-C64_treatment7,656ee1d2-7296-486f-85ab-379b31fceb14,,released,,0,2021-12-21T13:46:27.027251-06:00,"Radiation Therapy, NOS",Residual Disease,
HCM-BROD-0709-C64,e8c47711-aab4-4f33-a3d4-d80cd4a8d821,d33040f0-cc95-41a5-85a1-c2dfad84b3b5,770.0,Adjuvant,511.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0709-C64_treatment6,c0aa57cf-b1ae-4585-881b-2a68689eacf8,Treatment Ongoing,released,Cabozantinib,1,2021-12-21T13:46:27.027251-06:00,Targeted Molecular Therapy,Residual Disease,
HCM-BROD-0709-C64,e8c47711-aab4-4f33-a3d4-d80cd4a8d821,d33040f0-cc95-41a5-85a1-c2dfad84b3b5,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0709-C64_treatment3,c8d9d990-d5d5-4d54-bd50-4c8cecddccf2,,released,,0,2021-12-21T13:46:27.027251-06:00,Hormone Therapy,Residual Disease,
HCM-BROD-0709-C64,e8c47711-aab4-4f33-a3d4-d80cd4a8d821,d33040f0-cc95-41a5-85a1-c2dfad84b3b5,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0709-C64_treatment4,e3cfc14c-6edc-43a7-bc4d-ca95f40f939f,,released,,0,2021-12-21T13:46:27.027251-06:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-BROD-0356-C16,e8feb714-c8fc-4cc7-a139-36267ac147a2,646b3bfc-faf6-4816-a92b-267060dc99b4,,Neoadjuvant,65.0,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0356-C16_treatment2,1a5a525f-6d45-4ec6-8d99-a758bf10e64d,,released,,1,2020-09-17T16:11:20.651412-05:00,"Radiation Therapy, NOS",,
HCM-BROD-0356-C16,e8feb714-c8fc-4cc7-a139-36267ac147a2,646b3bfc-faf6-4816-a92b-267060dc99b4,,Neoadjuvant,37.0,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0356-C16_treatment,77e0b3fb-ab8f-4f4a-8b6b-c6c157597849,,released,Carboplatin,1,2020-09-17T16:11:20.651412-05:00,Chemotherapy,,
HCM-BROD-0356-C16,e8feb714-c8fc-4cc7-a139-36267ac147a2,646b3bfc-faf6-4816-a92b-267060dc99b4,,Adjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0356-C16_treatment7,8e350734-374b-4fa7-a454-913ea79bad44,,released,,0,2020-09-17T16:11:20.651412-05:00,"Radiation Therapy, NOS",Residual Disease,
HCM-BROD-0356-C16,e8feb714-c8fc-4cc7-a139-36267ac147a2,646b3bfc-faf6-4816-a92b-267060dc99b4,,Adjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0356-C16_treatment4,96db89b3-e484-440a-9d8f-a9fc4dbde753,,released,,0,2020-09-17T16:11:20.651412-05:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-BROD-0356-C16,e8feb714-c8fc-4cc7-a139-36267ac147a2,646b3bfc-faf6-4816-a92b-267060dc99b4,,Adjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0356-C16_treatment3,d88d3c11-9f38-4a0d-b3a2-9063be54af78,,released,,0,2020-09-17T16:11:20.651412-05:00,Chemotherapy,Residual Disease,
HCM-BROD-0356-C16,e8feb714-c8fc-4cc7-a139-36267ac147a2,646b3bfc-faf6-4816-a92b-267060dc99b4,,,140.0,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0356-C16_treatment5,fae466aa-13aa-4f0f-9c1d-6bff5aadf294,,released,,1,2020-09-17T16:11:20.651412-05:00,"Surgery, NOS",Initial Diagnosis,
HCM-BROD-0356-C16,e8feb714-c8fc-4cc7-a139-36267ac147a2,646b3bfc-faf6-4816-a92b-267060dc99b4,,Adjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0356-C16_treatment6,fc937955-e34b-469a-a0de-8c34b4ca073e,,released,,0,2020-09-17T16:11:20.651412-05:00,Targeted Molecular Therapy,Residual Disease,
HCM-BROD-0130-C25,e9615c7c-0e14-45bc-a58e-ce3afbb6d40d,aacad1a2-5ef1-43f5-9187-4ad1adae42d4,,,,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0130-C25_treatment17,17ba9b6e-9611-48b0-b400-227a76e43961,,released,,0,2020-09-17T15:58:56.367246-05:00,"Surgery, NOS",Initial Diagnosis,
HCM-BROD-0130-C25,e9615c7c-0e14-45bc-a58e-ce3afbb6d40d,aacad1a2-5ef1-43f5-9187-4ad1adae42d4,61.0,Adjuvant,6.0,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0130-C25_treatment11,1aa75541-2b4f-429e-a3ea-d8773ebe73e9,,released,Fluorouracil,1,2020-09-17T15:58:56.367246-05:00,Chemotherapy,Residual Disease,
HCM-BROD-0130-C25,e9615c7c-0e14-45bc-a58e-ce3afbb6d40d,aacad1a2-5ef1-43f5-9187-4ad1adae42d4,,Neoadjuvant,6.0,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0130-C25_treatment3,1bf1e861-c82b-4cd6-9bd1-ae1e52eeae71,,released,Fluorouracil,1,2020-09-17T15:58:56.367246-05:00,Chemotherapy,,
HCM-BROD-0130-C25,e9615c7c-0e14-45bc-a58e-ce3afbb6d40d,aacad1a2-5ef1-43f5-9187-4ad1adae42d4,262.0,Adjuvant,262.0,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0130-C25_treatment19,3bcd3c20-d32e-43e5-87be-d9323fd1b6d2,,released,,1,2020-09-17T15:58:56.367246-05:00,"Radiation Therapy, NOS",Residual Disease,
HCM-BROD-0130-C25,e9615c7c-0e14-45bc-a58e-ce3afbb6d40d,aacad1a2-5ef1-43f5-9187-4ad1adae42d4,,Neoadjuvant,6.0,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0130-C25_treatment2,6275d342-a243-4a90-b977-e8f67d1ee338,,released,Leucovorin Calcium,1,2020-09-17T15:58:56.367246-05:00,Chemotherapy,,
HCM-BROD-0130-C25,e9615c7c-0e14-45bc-a58e-ce3afbb6d40d,aacad1a2-5ef1-43f5-9187-4ad1adae42d4,61.0,Adjuvant,6.0,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0130-C25_treatment9,62d4375f-efda-4c2e-993e-bbd30741a262,,released,Irinotecan Hydrochloride,1,2020-09-17T15:58:56.367246-05:00,Chemotherapy,Residual Disease,
HCM-BROD-0130-C25,e9615c7c-0e14-45bc-a58e-ce3afbb6d40d,aacad1a2-5ef1-43f5-9187-4ad1adae42d4,236.0,Adjuvant,124.0,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0130-C25_treatment14,63ed7933-b79c-429c-a5b9-326b76ad2830,,released,Gemcitabine,1,2020-09-17T15:58:56.367246-05:00,Chemotherapy,Residual Disease,
HCM-BROD-0130-C25,e9615c7c-0e14-45bc-a58e-ce3afbb6d40d,aacad1a2-5ef1-43f5-9187-4ad1adae42d4,61.0,Adjuvant,6.0,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0130-C25_treatment13,63f3555f-007c-4217-828f-4feaa951b5c5,,released,,1,2020-09-17T15:58:56.367246-05:00,Chemotherapy,Residual Disease,FOLFIRINOX
HCM-BROD-0130-C25,e9615c7c-0e14-45bc-a58e-ce3afbb6d40d,aacad1a2-5ef1-43f5-9187-4ad1adae42d4,,Adjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0130-C25_treatment18,6410be36-110e-4e89-a12f-c8062e3d34c4,,released,,0,2020-09-17T15:58:56.367246-05:00,Targeted Molecular Therapy,Residual Disease,
HCM-BROD-0130-C25,e9615c7c-0e14-45bc-a58e-ce3afbb6d40d,aacad1a2-5ef1-43f5-9187-4ad1adae42d4,,Neoadjuvant,6.0,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0130-C25_treatment4,7990ca86-f806-472f-aa34-417c5d87d0ae,,released,Oxaliplatin,1,2020-09-17T15:58:56.367246-05:00,Chemotherapy,,
HCM-BROD-0130-C25,e9615c7c-0e14-45bc-a58e-ce3afbb6d40d,aacad1a2-5ef1-43f5-9187-4ad1adae42d4,61.0,Adjuvant,6.0,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0130-C25_treatment10,800c88d4-0f86-4feb-a1d6-dd70282f16ef,,released,Leucovorin Calcium,1,2020-09-17T15:58:56.367246-05:00,Chemotherapy,Residual Disease,
HCM-BROD-0130-C25,e9615c7c-0e14-45bc-a58e-ce3afbb6d40d,aacad1a2-5ef1-43f5-9187-4ad1adae42d4,,Neoadjuvant,6.0,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0130-C25_treatment,8ed6217a-20c9-4094-b58c-487f303c76e8,,released,Irinotecan Hydrochloride,1,2020-09-17T15:58:56.367246-05:00,Chemotherapy,,
HCM-BROD-0130-C25,e9615c7c-0e14-45bc-a58e-ce3afbb6d40d,aacad1a2-5ef1-43f5-9187-4ad1adae42d4,,Adjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0130-C25_treatment16,90dbd512-4c4a-41c8-82e7-151db7ab44e0,,released,,0,2020-09-17T15:58:56.367246-05:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-BROD-0130-C25,e9615c7c-0e14-45bc-a58e-ce3afbb6d40d,aacad1a2-5ef1-43f5-9187-4ad1adae42d4,236.0,Adjuvant,124.0,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0130-C25_treatment15,92e32e54-24ab-4c1d-b4f5-f98cdbe4b735,,released,Nab-paclitaxel,1,2020-09-17T15:58:56.367246-05:00,Chemotherapy,Residual Disease,
HCM-BROD-0130-C25,e9615c7c-0e14-45bc-a58e-ce3afbb6d40d,aacad1a2-5ef1-43f5-9187-4ad1adae42d4,,Neoadjuvant,6.0,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0130-C25_treatment6,9a08ba2f-4130-4bf6-8b4f-6eda6f510154,,released,Gemcitabine,1,2020-09-17T15:58:56.367246-05:00,Chemotherapy,,
HCM-BROD-0130-C25,e9615c7c-0e14-45bc-a58e-ce3afbb6d40d,aacad1a2-5ef1-43f5-9187-4ad1adae42d4,,Neoadjuvant,6.0,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0130-C25_treatment5,a2d0292d-cf9a-4a8d-88be-c5e3f9d481ab,,released,,1,2020-09-17T15:58:56.367246-05:00,Chemotherapy,,FOLFIRINOX
HCM-BROD-0130-C25,e9615c7c-0e14-45bc-a58e-ce3afbb6d40d,aacad1a2-5ef1-43f5-9187-4ad1adae42d4,,Neoadjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0130-C25_treatment8,b2bb02d7-31e1-4727-9bd3-524564c562d2,,released,,1,2020-09-17T15:58:56.367246-05:00,"Radiation Therapy, NOS",,
HCM-BROD-0130-C25,e9615c7c-0e14-45bc-a58e-ce3afbb6d40d,aacad1a2-5ef1-43f5-9187-4ad1adae42d4,,Neoadjuvant,6.0,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0130-C25_treatment7,b9572557-b719-43eb-90a2-1ffe9d543618,,released,Nab-paclitaxel,1,2020-09-17T15:58:56.367246-05:00,Chemotherapy,,
HCM-BROD-0130-C25,e9615c7c-0e14-45bc-a58e-ce3afbb6d40d,aacad1a2-5ef1-43f5-9187-4ad1adae42d4,61.0,Adjuvant,6.0,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0130-C25_treatment12,c63c616c-1294-4fd8-b9f8-0b235a347deb,,released,Oxaliplatin,1,2020-09-17T15:58:56.367246-05:00,Chemotherapy,Residual Disease,
HCM-SANG-0285-C18,e980e3c5-a9fb-42ad-ad02-b8bedc54ce23,25cd8725-77e8-4a55-b5d5-24787f44615d,,Neoadjuvant,,2023-03-13T12:48:22.226715-05:00,HCM-SANG-0285-C18_treatment,bccdc33c-eadf-45fa-a7db-52950f6974c1,,released,,0,2021-12-21T15:08:33.270418-06:00,,,
HCM-CSHL-0726-C18,ea53b476-afdd-4df7-bfbb-c3fac39319f7,1907a1b0-9675-42d3-8a6c-fe1fd68f873a,544.0,Maintenance Therapy,453.0,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0726-C18_treatment17,0adbd60f-6309-41c0-9e9c-34a71b35b76f,Treatment Ongoing,released,Leucovorin Calcium,1,2021-12-21T14:18:47.639394-06:00,,,
HCM-CSHL-0726-C18,ea53b476-afdd-4df7-bfbb-c3fac39319f7,1907a1b0-9675-42d3-8a6c-fe1fd68f873a,544.0,Maintenance Therapy,453.0,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0726-C18_treatment19,3db6c1bb-172f-4fc0-a94f-5b28a7b80dea,Treatment Ongoing,released,Oxaliplatin,1,2021-12-21T14:18:47.639394-06:00,,,
HCM-CSHL-0726-C18,ea53b476-afdd-4df7-bfbb-c3fac39319f7,1907a1b0-9675-42d3-8a6c-fe1fd68f873a,544.0,Maintenance Therapy,453.0,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0726-C18_treatment18,5784f420-577d-44cc-9d3f-aa93e1ba5aec,Treatment Ongoing,released,Fluorouracil,1,2021-12-21T14:18:47.639394-06:00,,,
HCM-CSHL-0726-C18,ea53b476-afdd-4df7-bfbb-c3fac39319f7,1907a1b0-9675-42d3-8a6c-fe1fd68f873a,544.0,Maintenance Therapy,453.0,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0726-C18_treatment20,9b6ba664-0be0-485c-bc39-38824246b37e,Treatment Ongoing,released,,1,2021-12-21T14:18:47.639394-06:00,,,FOLFOX
HCM-CSHL-0726-C18,ea53b476-afdd-4df7-bfbb-c3fac39319f7,1907a1b0-9675-42d3-8a6c-fe1fd68f873a,544.0,Maintenance Therapy,453.0,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0726-C18_treatment16,dce4f577-2114-4153-80f7-08357ff5f977,Treatment Ongoing,released,Bevacizumab,1,2021-12-21T14:18:47.639394-06:00,,,
HCM-CSHL-0726-C18,ea53b476-afdd-4df7-bfbb-c3fac39319f7,63bdd3c8-da01-4602-a660-aa43b24e2216,1147.0,Adjuvant,1078.0,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0726-C18_treatment14,04828ea4-3b50-4a86-8be4-92abbc46e843,,released,Regorafenib,1,2021-12-21T14:18:47.639394-06:00,Targeted Molecular Therapy,Residual Disease,
HCM-CSHL-0726-C18,ea53b476-afdd-4df7-bfbb-c3fac39319f7,63bdd3c8-da01-4602-a660-aa43b24e2216,1098.0,Adjuvant,972.0,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0726-C18_treatment6,0c9b994c-bd83-442a-b50f-3aeb1a90fb9d,,released,Leucovorin Calcium,1,2021-12-21T14:18:47.639394-06:00,Chemotherapy,Residual Disease,
HCM-CSHL-0726-C18,ea53b476-afdd-4df7-bfbb-c3fac39319f7,63bdd3c8-da01-4602-a660-aa43b24e2216,,Neoadjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0726-C18_treatment,3fd9aaac-f811-4d1a-9b92-a8768e6cb29f,,released,,0,2021-12-21T14:18:47.639394-06:00,,,
HCM-CSHL-0726-C18,ea53b476-afdd-4df7-bfbb-c3fac39319f7,63bdd3c8-da01-4602-a660-aa43b24e2216,1098.0,Adjuvant,972.0,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0726-C18_treatment7,455cfa0c-26b7-4625-9cf5-4cc2231745d6,,released,Fluorouracil,1,2021-12-21T14:18:47.639394-06:00,Chemotherapy,Residual Disease,
HCM-CSHL-0726-C18,ea53b476-afdd-4df7-bfbb-c3fac39319f7,63bdd3c8-da01-4602-a660-aa43b24e2216,,Adjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0726-C18_treatment10,4a68f2a9-8743-4863-b241-6755df8a0df5,,released,,0,2021-12-21T14:18:47.639394-06:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-CSHL-0726-C18,ea53b476-afdd-4df7-bfbb-c3fac39319f7,63bdd3c8-da01-4602-a660-aa43b24e2216,544.0,Adjuvant,454.0,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0726-C18_treatment3,56541426-d9df-43e5-a7c8-dfd3d743da11,,released,Fluorouracil,1,2021-12-21T14:18:47.639394-06:00,Chemotherapy,Residual Disease,
HCM-CSHL-0726-C18,ea53b476-afdd-4df7-bfbb-c3fac39319f7,63bdd3c8-da01-4602-a660-aa43b24e2216,1050.0,Adjuvant,1050.0,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0726-C18_treatment15,8214386a-68de-4084-be4c-8e4fcfdd6717,,released,,1,2021-12-21T14:18:47.639394-06:00,"Radiation, Stereotactic/Gamma Knife/SRS",Residual Disease,
HCM-CSHL-0726-C18,ea53b476-afdd-4df7-bfbb-c3fac39319f7,63bdd3c8-da01-4602-a660-aa43b24e2216,544.0,Adjuvant,454.0,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0726-C18_treatment4,8cfe7ef7-4dd6-499a-b7cf-2fa0796d81c6,,released,Oxaliplatin,1,2021-12-21T14:18:47.639394-06:00,Chemotherapy,Residual Disease,
HCM-CSHL-0726-C18,ea53b476-afdd-4df7-bfbb-c3fac39319f7,63bdd3c8-da01-4602-a660-aa43b24e2216,,,36.0,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0726-C18_treatment11,c12c6f66-d1fa-4622-a5bb-137beb399656,,released,,1,2021-12-21T14:18:47.639394-06:00,"Surgery, NOS",Initial Diagnosis,
HCM-CSHL-0726-C18,ea53b476-afdd-4df7-bfbb-c3fac39319f7,63bdd3c8-da01-4602-a660-aa43b24e2216,544.0,Adjuvant,454.0,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0726-C18_treatment2,ce3b85fc-a240-429f-ba02-c40d625567f4,,released,Leucovorin Calcium,1,2021-12-21T14:18:47.639394-06:00,Chemotherapy,Residual Disease,
HCM-CSHL-0726-C18,ea53b476-afdd-4df7-bfbb-c3fac39319f7,63bdd3c8-da01-4602-a660-aa43b24e2216,1098.0,Adjuvant,972.0,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0726-C18_treatment9,d980645b-2815-4c69-b14e-0e0539d4731e,,released,,1,2021-12-21T14:18:47.639394-06:00,Chemotherapy,Residual Disease,FOLFIRI
HCM-CSHL-0726-C18,ea53b476-afdd-4df7-bfbb-c3fac39319f7,63bdd3c8-da01-4602-a660-aa43b24e2216,1098.0,Adjuvant,972.0,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0726-C18_treatment13,e7890655-5d47-4ec5-870e-032831aacf6a,,released,Ramucirumab,1,2021-12-21T14:18:47.639394-06:00,Targeted Molecular Therapy,Residual Disease,
HCM-CSHL-0726-C18,ea53b476-afdd-4df7-bfbb-c3fac39319f7,63bdd3c8-da01-4602-a660-aa43b24e2216,544.0,Adjuvant,454.0,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0726-C18_treatment12,ee183e33-588f-41bd-a712-19f68dc8c2f4,,released,Bevacizumab,1,2021-12-21T14:18:47.639394-06:00,Targeted Molecular Therapy,Residual Disease,
HCM-CSHL-0726-C18,ea53b476-afdd-4df7-bfbb-c3fac39319f7,63bdd3c8-da01-4602-a660-aa43b24e2216,1098.0,Adjuvant,972.0,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0726-C18_treatment8,f2bc1fb7-10f5-4448-a6b4-5f58f533cc03,,released,Irinotecan,1,2021-12-21T14:18:47.639394-06:00,Chemotherapy,Residual Disease,
HCM-CSHL-0726-C18,ea53b476-afdd-4df7-bfbb-c3fac39319f7,63bdd3c8-da01-4602-a660-aa43b24e2216,544.0,Adjuvant,454.0,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0726-C18_treatment5,fe57d3cb-461a-4f22-823d-3828aae02f7a,,released,,1,2021-12-21T14:18:47.639394-06:00,Chemotherapy,Residual Disease,FOLFOX
HCM-BROD-0038-C41,ea983695-b464-44d5-afe7-c5ab4366aad7,90443dfd-faed-41fd-abb5-3d8ddccd1b60,,,,2023-03-13T13:01:07.521001-05:00,HCM-BROD-0038-C41_treatment8,2d12ad8c-3a93-45f4-bf8c-4a1b9508e140,,released,,unknown,2020-09-27T10:12:49.245808-05:00,"Surgery, NOS",Initial Diagnosis,
HCM-BROD-0038-C41,ea983695-b464-44d5-afe7-c5ab4366aad7,90443dfd-faed-41fd-abb5-3d8ddccd1b60,,Adjuvant,610.0,2023-02-22T07:39:25.979291-06:00,HCM-BROD-0038-C41_treatment6,2d23f78b-4570-488b-ab82-dfe7adfd2b48,,released,Etoposide,1,2019-04-03T18:06:48.774309-05:00,Chemotherapy,Residual Disease,
HCM-BROD-0038-C41,ea983695-b464-44d5-afe7-c5ab4366aad7,90443dfd-faed-41fd-abb5-3d8ddccd1b60,,Neoadjuvant,0.0,2023-02-22T07:39:25.979291-06:00,HCM-BROD-0038-C41_treatment4,48b6c432-33bd-44d6-8410-b7bcec8e2df6,,released,,1,2019-04-03T18:06:48.774309-05:00,Chemotherapy,,MAP
HCM-BROD-0038-C41,ea983695-b464-44d5-afe7-c5ab4366aad7,90443dfd-faed-41fd-abb5-3d8ddccd1b60,,Adjuvant,,2023-02-22T07:39:25.979291-06:00,HCM-BROD-0038-C41_treatment10,4cc32729-7d06-4f2c-b254-9b0a92f9ec1d,,released,,0,2020-09-27T10:12:49.245808-05:00,"Radiation Therapy, NOS",Residual Disease,
HCM-BROD-0038-C41,ea983695-b464-44d5-afe7-c5ab4366aad7,90443dfd-faed-41fd-abb5-3d8ddccd1b60,,Adjuvant,,2023-02-22T07:39:25.979291-06:00,HCM-BROD-0038-C41_treatment7,889de307-2abd-4ff0-9ef3-bc1ca54c37f0,,released,,0,2020-09-27T10:12:49.245808-05:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-BROD-0038-C41,ea983695-b464-44d5-afe7-c5ab4366aad7,90443dfd-faed-41fd-abb5-3d8ddccd1b60,,Neoadjuvant,0.0,2023-02-22T07:39:25.979291-06:00,HCM-BROD-0038-C41_treatment2,9653417c-6809-43a5-872e-b36e0df26601,,released,Methotrexate,1,2019-04-03T18:06:48.774309-05:00,Chemotherapy,,
HCM-BROD-0038-C41,ea983695-b464-44d5-afe7-c5ab4366aad7,90443dfd-faed-41fd-abb5-3d8ddccd1b60,,Adjuvant,610.0,2023-02-22T07:39:25.979291-06:00,HCM-BROD-0038-C41_treatment5,a5a7165f-74f6-46ca-be81-5dae3efe827a,,released,Ifosfamide,1,2019-04-03T18:06:48.774309-05:00,Chemotherapy,Residual Disease,
HCM-BROD-0038-C41,ea983695-b464-44d5-afe7-c5ab4366aad7,90443dfd-faed-41fd-abb5-3d8ddccd1b60,,Neoadjuvant,0.0,2023-02-22T07:39:25.979291-06:00,HCM-BROD-0038-C41_treatment3,d2271219-b629-4de3-820f-7dbb79d57077,,released,Cisplatin,1,2019-04-03T18:06:48.774309-05:00,Chemotherapy,,
HCM-BROD-0038-C41,ea983695-b464-44d5-afe7-c5ab4366aad7,90443dfd-faed-41fd-abb5-3d8ddccd1b60,,Adjuvant,549.0,2023-02-22T07:39:25.979291-06:00,HCM-BROD-0038-C41_treatment9,df59610a-32d2-4db8-849f-3ca35cf19a4a,,released,Sorafenib,1,2020-09-27T10:12:49.245808-05:00,Targeted Molecular Therapy,Residual Disease,
HCM-BROD-0038-C41,ea983695-b464-44d5-afe7-c5ab4366aad7,90443dfd-faed-41fd-abb5-3d8ddccd1b60,,Neoadjuvant,0.0,2023-02-22T07:39:25.979291-06:00,HCM-BROD-0038-C41_treatment,e0948e8e-1c1b-46e7-a764-86b026926212,,released,Doxorubicin,1,2019-04-03T18:06:48.774309-05:00,Chemotherapy,,
HCM-SANG-1309-C25,eab27cd5-9c85-442a-8b4a-7bf161c23d7a,6b538bda-1f56-4e79-816a-fe2f172f5299,,Neoadjuvant,96.0,2025-04-07T17:13:09.336794-05:00,HCM-SANG-1309-C25_treatment,58c00fe9-c88a-4713-9d0f-1d1cb1988872,,released,Capecitabine,1,2023-02-27T11:57:30.755234-06:00,Chemotherapy,,
HCM-SANG-1309-C25,eab27cd5-9c85-442a-8b4a-7bf161c23d7a,6b538bda-1f56-4e79-816a-fe2f172f5299,,Neoadjuvant,96.0,2025-04-07T17:13:09.336794-05:00,HCM-SANG-1309-C25_treatment2,5c6ab1ed-a364-439d-a1f1-274ea46cde94,,released,Gemcitabine,1,2023-02-27T11:57:30.755234-06:00,Chemotherapy,,
HCM-SANG-0283-C18,eb537fd2-ac06-4f63-8c0a-0ca73dd06a3a,f899b712-5afc-4dd3-a81d-0c0b733d17e3,,Neoadjuvant,,2023-03-13T13:28:42.971924-05:00,HCM-SANG-0283-C18_treatment,e3c2acc3-e2f2-4ef1-a0ec-17650950c074,,released,,0,2021-07-06T11:32:07.490834-05:00,,,
HCM-CSHL-0322-C20,ebbca85e-a234-4794-9825-4780144cfe7a,721148e8-94ba-4013-aa4f-160c521aa487,,Neoadjuvant,,2023-02-22T07:39:25.979291-06:00,HCM-CSHL-0322-C20_treatment,0fe309bc-00c3-4ead-8e8d-03300ea3dfb7,,released,,0,2020-06-15T13:22:54.567032-05:00,,,
HCM-CSHL-0322-C20,ebbca85e-a234-4794-9825-4780144cfe7a,721148e8-94ba-4013-aa4f-160c521aa487,,Adjuvant,,2023-03-13T13:19:18.727260-05:00,HCM-CSHL-0322-C20_treatment4,6da75c5c-f037-4daf-ba0c-cbe4a3fabdec,,released,,0,2020-06-15T13:22:54.567032-05:00,"Radiation Therapy, NOS",Residual Disease,
HCM-CSHL-0322-C20,ebbca85e-a234-4794-9825-4780144cfe7a,721148e8-94ba-4013-aa4f-160c521aa487,,Adjuvant,,2023-03-13T13:19:18.727260-05:00,HCM-CSHL-0322-C20_treatment3,cbadaf9d-b6b3-419c-bbd9-4425ad3e302d,,released,,0,2020-06-15T13:22:54.567032-05:00,"Pharmaceutical Therapy, NOS",Residual Disease,
HCM-CSHL-0322-C20,ebbca85e-a234-4794-9825-4780144cfe7a,721148e8-94ba-4013-aa4f-160c521aa487,,,22.0,2023-03-13T13:19:18.727260-05:00,HCM-CSHL-0322-C20_treatment2,e4f48d9e-4acb-4d9d-953d-84faf8b0ba55,,released,,1,2020-06-15T13:22:54.567032-05:00,"Surgery, NOS",Initial Diagnosis,
HCM-SANG-1306-C25,ec45b9c0-f668-43f6-90cb-3d5bc9931b80,dbebc5ba-7319-48f5-b315-a81e2dd1dc1d,,Neoadjuvant,188.0,2025-04-07T17:13:09.336794-05:00,HCM-SANG-1306-C25_treatment3,81badd50-007f-4e9b-9262-d3f2a25ea82c,,released,Nab-paclitaxel,1,2023-02-27T12:03:43.180400-06:00,Chemotherapy,,
HCM-SANG-1306-C25,ec45b9c0-f668-43f6-90cb-3d5bc9931b80,dbebc5ba-7319-48f5-b315-a81e2dd1dc1d,,Neoadjuvant,188.0,2025-04-07T17:13:09.336794-05:00,HCM-SANG-1306-C25_treatment,85492fce-b6a3-495d-8efc-ed5defaf9044,,released,Cisplatin,1,2023-02-27T12:03:43.180400-06:00,Chemotherapy,,
HCM-SANG-1306-C25,ec45b9c0-f668-43f6-90cb-3d5bc9931b80,dbebc5ba-7319-48f5-b315-a81e2dd1dc1d,,Neoadjuvant,188.0,2025-04-07T17:13:09.336794-05:00,HCM-SANG-1306-C25_treatment2,8e64f1d9-8332-4840-9f99-6e2dd2fdc211,,released,Gemcitabine,1,2023-02-27T12:03:43.180400-06:00,Chemotherapy,,
HCM-CSHL-0077-C25,ecf740ab-ecd5-4a85-94be-e0610463c72f,a33b3df7-05d2-42d7-9fbc-17e48d5cf3bf,,Adjuvant,,2023-02-22T07:39:25.979291-06:00,HCM-CSHL-0077-C25_treatment7,38c7fa2c-afd9-4f9b-a0fa-20fee0de785a,,released,,0,2020-09-27T12:46:38.869276-05:00,Targeted Molecular Therapy,Residual Disease,
HCM-CSHL-0077-C25,ecf740ab-ecd5-4a85-94be-e0610463c72f,a33b3df7-05d2-42d7-9fbc-17e48d5cf3bf,,Adjuvant,329.0,2023-02-22T07:39:25.979291-06:00,HCM-CSHL-0077-C25_treatment2,678a80be-9718-4a4c-a3b8-b4ff9cc854f4,,released,Gemcitabine,1,2020-09-27T12:46:38.869276-05:00,Chemotherapy,Residual Disease,
HCM-CSHL-0077-C25,ecf740ab-ecd5-4a85-94be-e0610463c72f,a33b3df7-05d2-42d7-9fbc-17e48d5cf3bf,,Adjuvant,329.0,2023-02-22T07:39:25.979291-06:00,HCM-CSHL-0077-C25_treatment3,86e9ba2d-9f5c-4808-8aa4-407965d3f8f6,,released,Nab-paclitaxel,1,2020-09-27T12:46:38.869276-05:00,Chemotherapy,Residual Disease,
HCM-CSHL-0077-C25,ecf740ab-ecd5-4a85-94be-e0610463c72f,a33b3df7-05d2-42d7-9fbc-17e48d5cf3bf,,Adjuvant,,2023-02-22T07:39:25.979291-06:00,HCM-CSHL-0077-C25_treatment8,c71e38be-9ef4-4dbf-99c6-eda22bffd42f,,released,,0,2020-09-27T12:46:38.869276-05:00,"Radiation Therapy, NOS",Residual Disease,
HCM-CSHL-0077-C25,ecf740ab-ecd5-4a85-94be-e0610463c72f,a33b3df7-05d2-42d7-9fbc-17e48d5cf3bf,,Neoadjuvant,,2023-02-22T07:39:25.979291-06:00,HCM-CSHL-0077-C25_treatment,ccd0533b-cec2-4727-a1c2-f039759ceed8,,released,,0,2020-09-27T12:46:38.869276-05:00,,,
HCM-CSHL-0077-C25,ecf740ab-ecd5-4a85-94be-e0610463c72f,a33b3df7-05d2-42d7-9fbc-17e48d5cf3bf,,Adjuvant,,2023-02-22T07:39:25.979291-06:00,HCM-CSHL-0077-C25_treatment5,e032abbc-fe30-4db2-9f04-25e39a0ff754,,released,,0,2020-09-27T12:46:38.869276-05:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-CSHL-0077-C25,ecf740ab-ecd5-4a85-94be-e0610463c72f,a33b3df7-05d2-42d7-9fbc-17e48d5cf3bf,,,-8.0,2023-02-27T11:30:31.052531-06:00,HCM-CSHL-0077-C25_treatment6,eac835d2-99d3-4fd5-8280-b3728e70c582,,released,,1,2020-09-27T12:46:38.869276-05:00,"Surgery, NOS",Initial Diagnosis,
HCM-CSHL-0077-C25,ecf740ab-ecd5-4a85-94be-e0610463c72f,a33b3df7-05d2-42d7-9fbc-17e48d5cf3bf,794.0,Adjuvant,610.0,2023-02-22T07:39:25.979291-06:00,HCM-CSHL-0077-C25_treatment4,f7ab8c26-b540-499d-a62a-c90fb4211d49,,released,Oxaliplatin,1,2020-09-27T12:46:38.869276-05:00,Chemotherapy,Residual Disease,
HCM-SANG-1082-C15,ede7bfd3-af7e-4905-b32d-844cbb25e0b5,76aa2990-04c9-43fc-8149-bfa21e69297a,,Neoadjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-SANG-1082-C15_treatment,c090176c-2892-4966-b5f7-edc07e627a5d,,released,,0,2023-02-27T12:04:17.459333-06:00,,,
HCM-BROD-0414-C25,ee0d306f-e708-478b-8bad-6f9f3bedefbf,7f64a08a-3b81-4177-b204-e7a3ba119f55,124.0,Adjuvant,19.0,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0414-C25_treatment5,0587cdcd-afc8-4e6d-ba94-993c8ccb8892,,released,Oxaliplatin,1,2020-09-27T11:31:41.312580-05:00,Chemotherapy,Residual Disease,
HCM-BROD-0414-C25,ee0d306f-e708-478b-8bad-6f9f3bedefbf,7f64a08a-3b81-4177-b204-e7a3ba119f55,,Adjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0414-C25_treatment11,0d2c4316-1ec5-47ec-97ca-73f461d6929d,,released,,0,2020-09-27T11:31:41.312580-05:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-BROD-0414-C25,ee0d306f-e708-478b-8bad-6f9f3bedefbf,7f64a08a-3b81-4177-b204-e7a3ba119f55,124.0,Adjuvant,19.0,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0414-C25_treatment2,2f57a2a4-26b1-4390-94a7-69d264f9a02d,,released,Irinotecan Hydrochloride,1,2020-09-27T11:31:41.312580-05:00,Chemotherapy,Residual Disease,
HCM-BROD-0414-C25,ee0d306f-e708-478b-8bad-6f9f3bedefbf,7f64a08a-3b81-4177-b204-e7a3ba119f55,,,,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0414-C25_treatment12,69ffecb5-e9ef-4bc7-b14c-fe60471f2856,,released,,unknown,2020-09-27T11:31:41.312580-05:00,"Surgery, NOS",Initial Diagnosis,
HCM-BROD-0414-C25,ee0d306f-e708-478b-8bad-6f9f3bedefbf,7f64a08a-3b81-4177-b204-e7a3ba119f55,191.0,Adjuvant,124.0,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0414-C25_treatment7,6b34ed7e-0b0b-4a02-ab91-02ccddbf445a,,released,Leucovorin Calcium,1,2020-09-27T11:31:41.312580-05:00,Chemotherapy,Residual Disease,
HCM-BROD-0414-C25,ee0d306f-e708-478b-8bad-6f9f3bedefbf,7f64a08a-3b81-4177-b204-e7a3ba119f55,202.0,Adjuvant,201.0,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0414-C25_treatment14,7855e8a3-0bbc-41e4-a74f-b5febaea7b03,,released,,1,2020-09-27T11:31:41.312580-05:00,"Radiation Therapy, NOS",Residual Disease,
HCM-BROD-0414-C25,ee0d306f-e708-478b-8bad-6f9f3bedefbf,7f64a08a-3b81-4177-b204-e7a3ba119f55,191.0,Adjuvant,124.0,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0414-C25_treatment10,853ca8e5-dbb0-4c9e-b54f-e4fa4d4a0ddd,,released,,1,2020-09-27T11:31:41.312580-05:00,Chemotherapy,Residual Disease,FOLFOX
HCM-BROD-0414-C25,ee0d306f-e708-478b-8bad-6f9f3bedefbf,7f64a08a-3b81-4177-b204-e7a3ba119f55,124.0,Adjuvant,19.0,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0414-C25_treatment4,953393a4-bf25-4347-90b5-41762005eac3,,released,Fluorouracil,1,2020-09-27T11:31:41.312580-05:00,Chemotherapy,Residual Disease,
HCM-BROD-0414-C25,ee0d306f-e708-478b-8bad-6f9f3bedefbf,7f64a08a-3b81-4177-b204-e7a3ba119f55,124.0,Adjuvant,19.0,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0414-C25_treatment3,9831b6fa-e242-42d4-9fa0-57e31d86f57d,,released,Leucovorin Calcium,1,2020-09-27T11:31:41.312580-05:00,Chemotherapy,Residual Disease,
HCM-BROD-0414-C25,ee0d306f-e708-478b-8bad-6f9f3bedefbf,7f64a08a-3b81-4177-b204-e7a3ba119f55,124.0,Adjuvant,19.0,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0414-C25_treatment6,9f4b4a69-2f7a-4042-8d97-06d904e2b2c2,,released,,1,2020-09-27T11:31:41.312580-05:00,Chemotherapy,Residual Disease,FOLFIRINOX
HCM-BROD-0414-C25,ee0d306f-e708-478b-8bad-6f9f3bedefbf,7f64a08a-3b81-4177-b204-e7a3ba119f55,191.0,Adjuvant,124.0,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0414-C25_treatment8,cb76fbcf-2a6e-4cf8-9fb1-d9b90821d767,,released,Fluorouracil,1,2020-09-27T11:31:41.312580-05:00,Chemotherapy,Residual Disease,
HCM-BROD-0414-C25,ee0d306f-e708-478b-8bad-6f9f3bedefbf,7f64a08a-3b81-4177-b204-e7a3ba119f55,,Neoadjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0414-C25_treatment,cd81d347-91d8-4974-9dc1-03cd6cb70ae0,,released,,0,2020-09-27T11:31:41.312580-05:00,,,
HCM-BROD-0414-C25,ee0d306f-e708-478b-8bad-6f9f3bedefbf,7f64a08a-3b81-4177-b204-e7a3ba119f55,191.0,Adjuvant,124.0,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0414-C25_treatment9,cf768dcb-4127-4b24-ad9d-a29e3ef0d537,,released,Oxaliplatin,1,2020-09-27T11:31:41.312580-05:00,Chemotherapy,Residual Disease,
HCM-BROD-0414-C25,ee0d306f-e708-478b-8bad-6f9f3bedefbf,7f64a08a-3b81-4177-b204-e7a3ba119f55,,Adjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0414-C25_treatment13,d8acca3a-304d-421a-8ffa-51d0afda9149,,released,,0,2020-09-27T11:31:41.312580-05:00,Targeted Molecular Therapy,Residual Disease,
HCM-CSHL-0184-C25,ee35fde8-183f-48d2-b4ea-460c40445daa,0aa1ae32-a57d-4108-8134-b0feb8199048,,Adjuvant,,2023-02-22T07:39:25.979291-06:00,HCM-CSHL-0184-C25_treatment5,2ceafe60-f89e-4350-9a27-dcbc8fe2de1e,,released,,0,2020-09-28T09:14:48.001375-05:00,Targeted Molecular Therapy,Residual Disease,
HCM-CSHL-0184-C25,ee35fde8-183f-48d2-b4ea-460c40445daa,0aa1ae32-a57d-4108-8134-b0feb8199048,,Adjuvant,,2023-02-22T07:39:25.979291-06:00,HCM-CSHL-0184-C25_treatment6,816e106e-3150-4a7a-a6a6-a7a77e78664d,,released,,0,2020-09-28T09:14:48.001375-05:00,"Radiation Therapy, NOS",Residual Disease,
HCM-CSHL-0184-C25,ee35fde8-183f-48d2-b4ea-460c40445daa,0aa1ae32-a57d-4108-8134-b0feb8199048,,,-12.0,2023-02-27T12:00:34.139966-06:00,HCM-CSHL-0184-C25_treatment4,b85573ee-4688-43d8-bd09-f9b9870c6298,,released,,1,2020-09-28T09:14:48.001375-05:00,"Surgery, NOS",Initial Diagnosis,
HCM-CSHL-0184-C25,ee35fde8-183f-48d2-b4ea-460c40445daa,0aa1ae32-a57d-4108-8134-b0feb8199048,,Neoadjuvant,,2023-02-22T07:39:25.979291-06:00,HCM-CSHL-0184-C25_treatment,c61af65e-51b1-4c16-896b-d98cc56cf560,,released,,0,2020-09-28T09:14:48.001375-05:00,,,
HCM-CSHL-0184-C25,ee35fde8-183f-48d2-b4ea-460c40445daa,0aa1ae32-a57d-4108-8134-b0feb8199048,,Adjuvant,,2023-02-22T07:39:25.979291-06:00,HCM-CSHL-0184-C25_treatment3,ddf1fa23-773f-48de-b4b2-bb2e8c62f575,,released,,0,2020-09-28T09:14:48.001375-05:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-CSHL-0184-C25,ee35fde8-183f-48d2-b4ea-460c40445daa,0aa1ae32-a57d-4108-8134-b0feb8199048,,Adjuvant,,2023-02-22T07:39:25.979291-06:00,HCM-CSHL-0184-C25_treatment2,e1d46f60-9ce6-4475-84b6-1aa9039cd003,,released,Gemcitabine,1,2020-09-28T09:14:48.001375-05:00,Chemotherapy,Residual Disease,
HCM-SANG-1308-C25,efc49baf-1c53-427c-afe1-267d9438ded0,41753b7c-48cc-410b-8733-fc796bae9f23,,Neoadjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-SANG-1308-C25_treatment,aad78666-70aa-4f9e-8315-06c35d651e39,,released,,0,2023-02-27T12:11:05.950496-06:00,,,
HCM-BROD-0332-C43,f0c1dd21-a156-4284-afda-985cd2656a9f,aa079003-2029-472c-a443-ad0405969d75,,,55.0,2023-03-13T12:51:23.432216-05:00,HCM-BROD-0332-C43_treatment2,0d02d1bb-170c-44c3-a84b-42bfe6aa124c,,released,,1,2020-06-15T13:33:11.402718-05:00,"Surgery, NOS",Initial Diagnosis,
HCM-BROD-0332-C43,f0c1dd21-a156-4284-afda-985cd2656a9f,aa079003-2029-472c-a443-ad0405969d75,,Adjuvant,,2023-03-13T12:51:23.432216-05:00,HCM-BROD-0332-C43_treatment3,4e169bb8-a519-4f2f-b9fd-5f5aacdf9012,,released,,0,2020-06-15T13:33:11.402718-05:00,"Pharmaceutical Therapy, NOS",Residual Disease,
HCM-BROD-0332-C43,f0c1dd21-a156-4284-afda-985cd2656a9f,aa079003-2029-472c-a443-ad0405969d75,,Neoadjuvant,,2021-01-06T22:55:10.531130-06:00,HCM-BROD-0332-C43_treatment,71767087-e72e-42b8-bc32-b15752c796ac,,released,,0,2020-06-15T13:33:11.402718-05:00,,,
HCM-BROD-0332-C43,f0c1dd21-a156-4284-afda-985cd2656a9f,aa079003-2029-472c-a443-ad0405969d75,,Adjuvant,,2023-03-13T12:51:23.432216-05:00,HCM-BROD-0332-C43_treatment4,dfa367f9-8dfc-4684-82bb-135ca4f041e7,,released,,0,2020-06-15T13:33:11.402718-05:00,"Radiation Therapy, NOS",Residual Disease,
HCM-CSHL-0257-C18,f0c6e5b9-3d64-456e-85ab-9978a91ffd43,bde4d9ec-a9c6-4b41-8b2f-a38064e1944f,,Adjuvant,104.0,2021-07-12T12:25:55.528644-05:00,HCM-CSHL-0257-C18_treatment3,109f174b-42ce-4a43-ba1b-38541b9e1723,,released,Oxaliplatin,1,2020-09-28T09:37:09.746532-05:00,Chemotherapy,Residual Disease,
HCM-CSHL-0257-C18,f0c6e5b9-3d64-456e-85ab-9978a91ffd43,bde4d9ec-a9c6-4b41-8b2f-a38064e1944f,,Neoadjuvant,,2021-07-12T12:25:55.528644-05:00,HCM-CSHL-0257-C18_treatment,3192d37c-3dc0-4e45-8bb4-54da4159da49,,released,,0,2020-09-28T09:37:09.746532-05:00,,,
HCM-CSHL-0257-C18,f0c6e5b9-3d64-456e-85ab-9978a91ffd43,bde4d9ec-a9c6-4b41-8b2f-a38064e1944f,,,20.0,2023-03-13T13:28:59.783352-05:00,HCM-CSHL-0257-C18_treatment5,324efd95-f30b-4c0c-84b4-1f5939ff6e81,,released,,1,2020-09-28T09:37:09.746532-05:00,"Surgery, NOS",Initial Diagnosis,
HCM-CSHL-0257-C18,f0c6e5b9-3d64-456e-85ab-9978a91ffd43,bde4d9ec-a9c6-4b41-8b2f-a38064e1944f,,Adjuvant,,2021-07-12T12:25:55.528644-05:00,HCM-CSHL-0257-C18_treatment4,4494eb67-42f1-4c79-9ccc-94c98b1c8a19,,released,,0,2020-09-28T09:37:09.746532-05:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-CSHL-0257-C18,f0c6e5b9-3d64-456e-85ab-9978a91ffd43,bde4d9ec-a9c6-4b41-8b2f-a38064e1944f,,Adjuvant,,2021-07-12T12:25:55.528644-05:00,HCM-CSHL-0257-C18_treatment6,791dd893-1bbe-4e32-8f06-aae018b9525e,,released,,0,2020-09-28T09:37:09.746532-05:00,Targeted Molecular Therapy,Residual Disease,
HCM-CSHL-0257-C18,f0c6e5b9-3d64-456e-85ab-9978a91ffd43,bde4d9ec-a9c6-4b41-8b2f-a38064e1944f,,Adjuvant,,2021-07-12T12:25:55.528644-05:00,HCM-CSHL-0257-C18_treatment7,7dde952e-d30b-48ac-88ba-de15a489bc53,,released,,0,2020-09-28T09:37:09.746532-05:00,"Radiation Therapy, NOS",Residual Disease,
HCM-CSHL-0257-C18,f0c6e5b9-3d64-456e-85ab-9978a91ffd43,bde4d9ec-a9c6-4b41-8b2f-a38064e1944f,,Adjuvant,104.0,2021-07-12T12:25:55.528644-05:00,HCM-CSHL-0257-C18_treatment2,b88dac42-10ce-4dec-ac1b-9660e7b5bf8e,,released,Capecitabine,1,2020-09-28T09:37:09.746532-05:00,Chemotherapy,Residual Disease,
HCM-BROD-0419-C71,f0ee7109-8e30-4789-b071-cd80bec493a3,e0eebcb5-db01-4ec4-b90b-d50ec9b2d15d,262.0,Adjuvant,30.0,2021-07-12T12:25:55.528644-05:00,HCM-BROD-0419-C71_treatment2,2e90da02-b0fe-472b-82ec-22e917f5e37d,,released,Temozolomide,1,2020-04-21T14:52:24.369316-05:00,Chemotherapy,Residual Disease,
HCM-BROD-0419-C71,f0ee7109-8e30-4789-b071-cd80bec493a3,e0eebcb5-db01-4ec4-b90b-d50ec9b2d15d,,Adjuvant,,2021-07-12T12:25:55.528644-05:00,HCM-BROD-0419-C71_treatment5,46bad561-7f4c-4929-944e-a10e1c6cbaec,,released,,0,2020-04-21T14:52:24.369316-05:00,Targeted Molecular Therapy,Residual Disease,
HCM-BROD-0419-C71,f0ee7109-8e30-4789-b071-cd80bec493a3,e0eebcb5-db01-4ec4-b90b-d50ec9b2d15d,,Neoadjuvant,,2021-07-12T12:25:55.528644-05:00,HCM-BROD-0419-C71_treatment,51dfbcaa-e816-4026-933e-66c49b9afe0d,,released,,0,2020-04-21T14:52:24.369316-05:00,,,
HCM-BROD-0419-C71,f0ee7109-8e30-4789-b071-cd80bec493a3,e0eebcb5-db01-4ec4-b90b-d50ec9b2d15d,,,-9.0,2023-03-13T13:11:55.725683-05:00,HCM-BROD-0419-C71_treatment4,5d53dab6-9427-468c-a59c-273ad6380d05,,released,,1,2020-04-21T14:52:24.369316-05:00,"Surgery, NOS",Initial Diagnosis,
HCM-BROD-0419-C71,f0ee7109-8e30-4789-b071-cd80bec493a3,e0eebcb5-db01-4ec4-b90b-d50ec9b2d15d,,Adjuvant,,2021-07-12T12:25:55.528644-05:00,HCM-BROD-0419-C71_treatment3,5ffce97c-679d-405e-9ab4-9eaf4d3c2919,,released,,0,2020-04-21T14:52:24.369316-05:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-BROD-0419-C71,f0ee7109-8e30-4789-b071-cd80bec493a3,e0eebcb5-db01-4ec4-b90b-d50ec9b2d15d,64.0,Adjuvant,20.0,2021-07-12T12:25:55.528644-05:00,HCM-BROD-0419-C71_treatment6,bf4ac417-d798-463f-b6a8-3de1dedf73cd,,released,,1,2020-04-21T14:52:24.369316-05:00,"Radiation Therapy, NOS",Residual Disease,
HCM-BROD-0831-C71,f12fbecd-c941-47c2-b69c-4d07b81e0394,12a4316b-e78a-44c1-8969-59086ffa83cb,,Adjuvant,,2023-02-22T07:39:25.979291-06:00,HCM-BROD-0831-C71_treatment3,25194a12-e278-47f7-a767-aa494883077a,,released,,0,2021-12-21T13:54:19.010596-06:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-BROD-0831-C71,f12fbecd-c941-47c2-b69c-4d07b81e0394,12a4316b-e78a-44c1-8969-59086ffa83cb,40.0,Adjuvant,15.0,2023-02-22T07:39:25.979291-06:00,HCM-BROD-0831-C71_treatment6,64bc7b4b-66c4-4184-b73c-e0334888e2d6,,released,,1,2021-12-21T13:54:19.010596-06:00,"Radiation, 2D Conventional",Residual Disease,
HCM-BROD-0831-C71,f12fbecd-c941-47c2-b69c-4d07b81e0394,12a4316b-e78a-44c1-8969-59086ffa83cb,175.0,Adjuvant,155.0,2023-02-22T07:39:25.979291-06:00,HCM-BROD-0831-C71_treatment5,9357a203-66f6-4c38-8b6b-e3c4ea672e2b,,released,Bevacizumab,1,2021-12-21T13:54:19.010596-06:00,Targeted Molecular Therapy,Residual Disease,
HCM-BROD-0831-C71,f12fbecd-c941-47c2-b69c-4d07b81e0394,12a4316b-e78a-44c1-8969-59086ffa83cb,,,2.0,2023-02-27T13:06:02.174105-06:00,HCM-BROD-0831-C71_treatment4,a7cc75df-b2e3-478c-a2ad-4ff8cb123616,,released,,1,2021-12-21T13:54:19.010596-06:00,"Surgery, NOS",Initial Diagnosis,
HCM-BROD-0831-C71,f12fbecd-c941-47c2-b69c-4d07b81e0394,12a4316b-e78a-44c1-8969-59086ffa83cb,174.0,Adjuvant,8.0,2023-02-22T07:39:25.979291-06:00,HCM-BROD-0831-C71_treatment2,ae010cab-f6bd-466b-99e3-549abbaf8f00,,released,Temozolomide,1,2021-12-21T13:54:19.010596-06:00,Chemotherapy,Residual Disease,
HCM-BROD-0831-C71,f12fbecd-c941-47c2-b69c-4d07b81e0394,12a4316b-e78a-44c1-8969-59086ffa83cb,,Neoadjuvant,,2023-02-22T07:39:25.979291-06:00,HCM-BROD-0831-C71_treatment,eb459fe9-4f29-42cf-981e-09e52c4f0493,,released,,0,2021-12-21T13:54:19.010596-06:00,,,
HCM-BROD-0693-C71,f1332ba6-887b-45ec-846b-1180cbfd66b7,5fcca466-96ef-4f4b-af4e-bc72d7a0e4d2,,,-4.0,2023-02-27T11:49:16.496783-06:00,HCM-BROD-0693-C71_treatment4,1c16c29d-1472-4ea3-a4a3-32da03f238b6,,released,,1,2021-12-21T13:45:34.286716-06:00,"Surgery, NOS",Initial Diagnosis,
HCM-BROD-0693-C71,f1332ba6-887b-45ec-846b-1180cbfd66b7,5fcca466-96ef-4f4b-af4e-bc72d7a0e4d2,73.0,Adjuvant,31.0,2023-02-22T07:39:25.979291-06:00,HCM-BROD-0693-C71_treatment6,1c9e268c-afc6-40f2-93e9-54b609575099,,released,,1,2021-12-21T13:45:34.286716-06:00,"Radiation, 3D Conformal",Residual Disease,
HCM-BROD-0693-C71,f1332ba6-887b-45ec-846b-1180cbfd66b7,5fcca466-96ef-4f4b-af4e-bc72d7a0e4d2,268.0,Adjuvant,30.0,2023-02-22T07:39:25.979291-06:00,HCM-BROD-0693-C71_treatment2,23a77352-8b8e-433d-a9ce-83815b3711f1,,released,Temozolomide,1,2021-12-21T13:45:34.286716-06:00,Chemotherapy,Residual Disease,
HCM-BROD-0693-C71,f1332ba6-887b-45ec-846b-1180cbfd66b7,5fcca466-96ef-4f4b-af4e-bc72d7a0e4d2,296.0,Adjuvant,296.0,2023-02-22T07:39:25.979291-06:00,HCM-BROD-0693-C71_treatment5,58c5156b-293d-44d2-90b1-d34e1ec525ca,,released,Bevacizumab,1,2021-12-21T13:45:34.286716-06:00,Targeted Molecular Therapy,Residual Disease,
HCM-BROD-0693-C71,f1332ba6-887b-45ec-846b-1180cbfd66b7,5fcca466-96ef-4f4b-af4e-bc72d7a0e4d2,,Neoadjuvant,,2023-02-22T07:39:25.979291-06:00,HCM-BROD-0693-C71_treatment,8a2cc028-9269-41f4-9301-c0e93c6bef7d,,released,,0,2021-12-21T13:45:34.286716-06:00,,,
HCM-BROD-0693-C71,f1332ba6-887b-45ec-846b-1180cbfd66b7,5fcca466-96ef-4f4b-af4e-bc72d7a0e4d2,,Adjuvant,,2023-02-22T07:39:25.979291-06:00,HCM-BROD-0693-C71_treatment3,8ca07f77-cb98-4f65-b590-adcc9b63718a,,released,,0,2021-12-21T13:45:34.286716-06:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-BROD-0198-C71,f21ba837-795e-4032-9c2d-5ff557e4a439,481a3f2f-a779-4b7e-8195-f6ea9cc4164c,,Adjuvant,,2021-01-06T22:55:10.531130-06:00,HCM-BROD-0198-C71_treatment6,12d75474-f061-43a5-9afd-72e90680039e,,released,,0,2020-04-21T14:50:59.719711-05:00,Targeted Molecular Therapy,Residual Disease,
HCM-BROD-0198-C71,f21ba837-795e-4032-9c2d-5ff557e4a439,481a3f2f-a779-4b7e-8195-f6ea9cc4164c,82.0,Adjuvant,40.0,2021-01-06T22:55:10.531130-06:00,HCM-BROD-0198-C71_treatment7,6f7c9b43-b96c-45d0-9e2b-5d1156b6d13a,,released,,1,2020-04-21T14:50:59.719711-05:00,"Radiation Therapy, NOS",Residual Disease,
HCM-BROD-0198-C71,f21ba837-795e-4032-9c2d-5ff557e4a439,481a3f2f-a779-4b7e-8195-f6ea9cc4164c,172.0,Adjuvant,40.0,2021-01-06T22:55:10.531130-06:00,HCM-BROD-0198-C71_treatment2,96f10ce7-24d8-4548-8942-0717a713dda6,,released,Temozolomide,1,2020-04-21T14:50:59.719711-05:00,Chemotherapy,Residual Disease,
HCM-BROD-0198-C71,f21ba837-795e-4032-9c2d-5ff557e4a439,481a3f2f-a779-4b7e-8195-f6ea9cc4164c,,Adjuvant,,2021-01-06T22:55:10.531130-06:00,HCM-BROD-0198-C71_treatment4,c3143b3b-67d6-4935-bf81-79c33bc15fa5,,released,,0,2020-04-21T14:50:59.719711-05:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-BROD-0198-C71,f21ba837-795e-4032-9c2d-5ff557e4a439,481a3f2f-a779-4b7e-8195-f6ea9cc4164c,240.0,Adjuvant,193.0,2021-01-06T22:55:10.531130-06:00,HCM-BROD-0198-C71_treatment3,c9a585d5-8fd5-4c4d-a8c2-16847ffce773,,released,Temozolomide,1,2020-04-21T14:50:59.719711-05:00,Chemotherapy,Residual Disease,
HCM-BROD-0198-C71,f21ba837-795e-4032-9c2d-5ff557e4a439,481a3f2f-a779-4b7e-8195-f6ea9cc4164c,,Neoadjuvant,,2021-01-06T22:55:10.531130-06:00,HCM-BROD-0198-C71_treatment,d4a09445-bb5d-4cf8-a2e7-40bcd73f7df4,,released,,0,2019-04-04T14:57:52.051017-05:00,,,
HCM-BROD-0198-C71,f21ba837-795e-4032-9c2d-5ff557e4a439,481a3f2f-a779-4b7e-8195-f6ea9cc4164c,,,-15.0,2023-02-27T12:26:48.617695-06:00,HCM-BROD-0198-C71_treatment5,fd1caf25-df77-404c-8ce1-c47ae26bbbe0,,released,,1,2020-04-21T14:50:59.719711-05:00,"Surgery, NOS",Initial Diagnosis,
HCM-CSHL-0463-C50,f2461357-8aa6-461b-9a13-1f18d44e50e9,3426eb89-601e-45de-b90a-19acccc39678,,Adjuvant,35.0,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0463-C50_treatment2,002d70a6-4384-44b3-99fc-07861f499cd4,Treatment Ongoing,released,Paclitaxel,1,2020-09-28T10:19:04.791166-05:00,Chemotherapy,Residual Disease,
HCM-CSHL-0463-C50,f2461357-8aa6-461b-9a13-1f18d44e50e9,3426eb89-601e-45de-b90a-19acccc39678,,Adjuvant,35.0,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0463-C50_treatment4,3e91b65c-5e24-4c76-aae9-27ac2ce33fb9,Treatment Ongoing,released,Doxorubicin,1,2020-09-28T10:19:04.791166-05:00,Chemotherapy,Residual Disease,
HCM-CSHL-0463-C50,f2461357-8aa6-461b-9a13-1f18d44e50e9,3426eb89-601e-45de-b90a-19acccc39678,,Adjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0463-C50_treatment6,7124e24e-ab88-4e28-bb5c-f416303f93c0,,released,,0,2020-09-28T10:19:04.791166-05:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-CSHL-0463-C50,f2461357-8aa6-461b-9a13-1f18d44e50e9,3426eb89-601e-45de-b90a-19acccc39678,,Neoadjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0463-C50_treatment,7b2abcf3-fee2-4954-b606-9de340b94eb3,,released,,0,2020-09-28T10:19:04.791166-05:00,,,
HCM-CSHL-0463-C50,f2461357-8aa6-461b-9a13-1f18d44e50e9,3426eb89-601e-45de-b90a-19acccc39678,,Adjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0463-C50_treatment9,880178fa-3918-4479-a45f-9c4b697597f5,,released,,0,2020-09-28T10:19:04.791166-05:00,"Radiation Therapy, NOS",Residual Disease,
HCM-CSHL-0463-C50,f2461357-8aa6-461b-9a13-1f18d44e50e9,3426eb89-601e-45de-b90a-19acccc39678,,Adjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0463-C50_treatment8,a3d0173a-50b9-42c9-b99b-136c0dca5d96,,released,,0,2020-09-28T10:19:04.791166-05:00,Targeted Molecular Therapy,Residual Disease,
HCM-CSHL-0463-C50,f2461357-8aa6-461b-9a13-1f18d44e50e9,3426eb89-601e-45de-b90a-19acccc39678,,Adjuvant,35.0,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0463-C50_treatment3,aac238b9-2524-46a6-a8ff-89c158c98948,Treatment Ongoing,released,Cyclophosphamide,1,2020-09-28T10:19:04.791166-05:00,Chemotherapy,Residual Disease,
HCM-CSHL-0463-C50,f2461357-8aa6-461b-9a13-1f18d44e50e9,3426eb89-601e-45de-b90a-19acccc39678,,Adjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0463-C50_treatment5,e401a092-ecc6-4b26-8989-d8403ae0c354,,released,,0,2020-09-28T10:19:04.791166-05:00,Hormone Therapy,Residual Disease,
HCM-CSHL-0463-C50,f2461357-8aa6-461b-9a13-1f18d44e50e9,3426eb89-601e-45de-b90a-19acccc39678,,,28.0,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0463-C50_treatment7,e4d3d604-252f-49d4-aa42-1e9606841726,,released,,1,2020-09-28T10:19:04.791166-05:00,"Surgery, NOS",Initial Diagnosis,
HCM-SANG-0310-C15,f255a5f0-49ad-48e5-aceb-520b066e35e8,40dc1391-7f40-4331-9997-b820cdec025d,,Neoadjuvant,103.0,2023-07-13T10:35:44.371881-05:00,HCM-SANG-0310-C15_treatment2,06f1d3a5-ae4c-4647-91f6-e3a45a567dc3,,released,Capecitabine,1,2021-12-21T15:11:13.731443-06:00,Chemotherapy,,
HCM-SANG-0310-C15,f255a5f0-49ad-48e5-aceb-520b066e35e8,40dc1391-7f40-4331-9997-b820cdec025d,,Neoadjuvant,103.0,2023-07-13T10:35:44.371881-05:00,HCM-SANG-0310-C15_treatment3,0b245afd-aa96-4c5f-a058-0cdbeef5e248,,released,Cisplatin,1,2021-12-21T15:11:13.731443-06:00,Chemotherapy,,
HCM-SANG-0310-C15,f255a5f0-49ad-48e5-aceb-520b066e35e8,40dc1391-7f40-4331-9997-b820cdec025d,,Neoadjuvant,103.0,2023-07-13T10:35:44.371881-05:00,HCM-SANG-0310-C15_treatment4,221a4f47-f0d3-4f68-87a7-7b5d8836fb73,,released,,1,2021-12-21T15:11:13.731443-06:00,Chemotherapy,,ECX
HCM-SANG-0310-C15,f255a5f0-49ad-48e5-aceb-520b066e35e8,40dc1391-7f40-4331-9997-b820cdec025d,,Neoadjuvant,103.0,2023-07-13T10:35:44.371881-05:00,HCM-SANG-0310-C15_treatment,ddfe6fac-b91f-49d1-898b-3869f6a6e5c9,,released,Epirubicin,1,2021-12-21T15:11:13.731443-06:00,Chemotherapy,,
HCM-BROD-0694-C43,f25dac3c-3ee1-4a5e-898a-8b4e6b12ebc2,65bf8ad0-6462-4152-83ee-6433f58a5683,1035.0,Adjuvant,1035.0,2023-02-22T07:39:25.979291-06:00,HCM-BROD-0694-C43_treatment9,02d5268f-50b5-4a55-9908-88117f62708b,,released,,1,2021-12-21T13:45:49.799389-06:00,"Radiation, Stereotactic/Gamma Knife/SRS",Residual Disease,
HCM-BROD-0694-C43,f25dac3c-3ee1-4a5e-898a-8b4e6b12ebc2,65bf8ad0-6462-4152-83ee-6433f58a5683,,Neoadjuvant,,2023-02-22T07:39:25.979291-06:00,HCM-BROD-0694-C43_treatment,2672f2ea-caf1-4065-a4ac-885613b6a4a1,,released,,0,2021-12-21T13:45:49.799389-06:00,,,
HCM-BROD-0694-C43,f25dac3c-3ee1-4a5e-898a-8b4e6b12ebc2,65bf8ad0-6462-4152-83ee-6433f58a5683,890.0,Adjuvant,863.0,2023-02-22T07:39:25.979291-06:00,HCM-BROD-0694-C43_treatment8,457ba513-b0b9-4dbc-b648-8341171822e9,,released,Trametinib,1,2021-12-21T13:45:49.799389-06:00,Targeted Molecular Therapy,Residual Disease,
HCM-BROD-0694-C43,f25dac3c-3ee1-4a5e-898a-8b4e6b12ebc2,65bf8ad0-6462-4152-83ee-6433f58a5683,1064.0,Adjuvant,1044.0,2023-02-22T07:39:25.979291-06:00,HCM-BROD-0694-C43_treatment4,50b50d3b-aabc-4c8b-853d-978000b15131,,released,Nivolumab,1,2021-12-21T13:45:49.799389-06:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-BROD-0694-C43,f25dac3c-3ee1-4a5e-898a-8b4e6b12ebc2,65bf8ad0-6462-4152-83ee-6433f58a5683,,,0.0,2023-02-27T12:57:47.001529-06:00,HCM-BROD-0694-C43_treatment5,66e1ec70-8595-443d-ae83-770cc91f872c,,released,,1,2021-12-21T13:45:49.799389-06:00,"Surgery, NOS",Initial Diagnosis,
HCM-BROD-0694-C43,f25dac3c-3ee1-4a5e-898a-8b4e6b12ebc2,65bf8ad0-6462-4152-83ee-6433f58a5683,,Adjuvant,,2023-02-22T07:39:25.979291-06:00,HCM-BROD-0694-C43_treatment3,694a8173-9640-483b-8052-2929d62d42b7,,released,,0,2021-12-21T13:45:49.799389-06:00,Hormone Therapy,Residual Disease,
HCM-BROD-0694-C43,f25dac3c-3ee1-4a5e-898a-8b4e6b12ebc2,65bf8ad0-6462-4152-83ee-6433f58a5683,1064.0,Adjuvant,1044.0,2023-02-22T07:39:25.979291-06:00,HCM-BROD-0694-C43_treatment7,7299940a-833e-4df4-9be6-b5feed0dda10,,released,Bevacizumab,1,2021-12-21T13:45:49.799389-06:00,Targeted Molecular Therapy,Residual Disease,
HCM-BROD-0694-C43,f25dac3c-3ee1-4a5e-898a-8b4e6b12ebc2,65bf8ad0-6462-4152-83ee-6433f58a5683,,Adjuvant,,2023-02-22T07:39:25.979291-06:00,HCM-BROD-0694-C43_treatment2,cc94aa7a-dded-4d51-98da-c69a9620cc86,,released,,0,2021-12-21T13:45:49.799389-06:00,Chemotherapy,Residual Disease,
HCM-BROD-0694-C43,f25dac3c-3ee1-4a5e-898a-8b4e6b12ebc2,65bf8ad0-6462-4152-83ee-6433f58a5683,890.0,Adjuvant,863.0,2023-02-22T07:39:25.979291-06:00,HCM-BROD-0694-C43_treatment6,d5829a3a-0217-49ad-bc8e-52eefb97af16,,released,Dabrafenib,1,2021-12-21T13:45:49.799389-06:00,Targeted Molecular Therapy,Residual Disease,
HCM-CSHL-1263-C24,f394d2fb-970d-4d9f-82b1-3f16abfe2d55,358a0627-67b9-48c8-868e-9268eb6defc3,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-1263-C24_treatment4,13691454-7b26-40c7-ad2e-1e3fbfc39abb,,released,,0,2021-12-23T08:33:20.825776-06:00,"Radiation Therapy, NOS",Residual Disease,
HCM-CSHL-1263-C24,f394d2fb-970d-4d9f-82b1-3f16abfe2d55,358a0627-67b9-48c8-868e-9268eb6defc3,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-1263-C24_treatment3,138a3197-846a-48a8-a149-0b745a2329cf,,released,,0,2021-12-23T08:33:20.825776-06:00,"Pharmaceutical Therapy, NOS",Residual Disease,
HCM-CSHL-1263-C24,f394d2fb-970d-4d9f-82b1-3f16abfe2d55,358a0627-67b9-48c8-868e-9268eb6defc3,,,-12.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-1263-C24_treatment2,8fbd5f60-ea35-4ae2-859e-af36661eed8e,,released,,1,2021-12-23T08:33:20.825776-06:00,"Surgery, NOS",Initial Diagnosis,
HCM-CSHL-1263-C24,f394d2fb-970d-4d9f-82b1-3f16abfe2d55,358a0627-67b9-48c8-868e-9268eb6defc3,,Neoadjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-1263-C24_treatment,b6439e79-343d-4761-b664-d4683b7c1460,,released,,0,2021-12-23T08:33:20.825776-06:00,,,
HCM-CSHL-0668-C18,f3cb5924-1ad1-4119-853a-26f77240763b,4bd0021e-c24b-4861-9d2d-afa4ec350662,219.0,Adjuvant,142.0,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0668-C18_treatment5,024cdc0a-7e1b-4fb4-a6b3-1ddc35abfcab,,released,Oxaliplatin,1,2021-12-21T14:16:52.945779-06:00,Chemotherapy,Residual Disease,
HCM-CSHL-0668-C18,f3cb5924-1ad1-4119-853a-26f77240763b,4bd0021e-c24b-4861-9d2d-afa4ec350662,106.0,Adjuvant,72.0,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0668-C18_treatment2,4103a81c-74f6-4b86-b30b-7b5f4729e097,,released,Capecitabine,1,2021-12-21T14:16:52.945779-06:00,Chemotherapy,Residual Disease,
HCM-CSHL-0668-C18,f3cb5924-1ad1-4119-853a-26f77240763b,4bd0021e-c24b-4861-9d2d-afa4ec350662,,Neoadjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0668-C18_treatment,556dc25e-49dd-499f-928a-6d64da0cb8a6,,released,,0,2021-12-21T14:16:52.945779-06:00,,,
HCM-CSHL-0668-C18,f3cb5924-1ad1-4119-853a-26f77240763b,4bd0021e-c24b-4861-9d2d-afa4ec350662,,,29.0,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0668-C18_treatment8,699fb586-4f94-45ca-821e-fdc8850e8431,,released,,1,2021-12-21T14:16:52.945779-06:00,"Surgery, NOS",Initial Diagnosis,
HCM-CSHL-0668-C18,f3cb5924-1ad1-4119-853a-26f77240763b,4bd0021e-c24b-4861-9d2d-afa4ec350662,219.0,Adjuvant,142.0,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0668-C18_treatment3,865da542-1ab3-4b50-bf61-64f974195f04,,released,Leucovorin Calcium,1,2021-12-21T14:16:52.945779-06:00,Chemotherapy,Residual Disease,
HCM-CSHL-0668-C18,f3cb5924-1ad1-4119-853a-26f77240763b,4bd0021e-c24b-4861-9d2d-afa4ec350662,,Adjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0668-C18_treatment7,b00353bc-2b56-49e9-911b-63202f427865,,released,,0,2021-12-21T14:16:52.945779-06:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-CSHL-0668-C18,f3cb5924-1ad1-4119-853a-26f77240763b,4bd0021e-c24b-4861-9d2d-afa4ec350662,,Adjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0668-C18_treatment9,dddfb158-3d8f-40d3-b79d-cd1761053cf5,,released,,0,2021-12-21T14:16:52.945779-06:00,Targeted Molecular Therapy,Residual Disease,
HCM-CSHL-0668-C18,f3cb5924-1ad1-4119-853a-26f77240763b,4bd0021e-c24b-4861-9d2d-afa4ec350662,219.0,Adjuvant,142.0,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0668-C18_treatment6,e754996a-6d70-4790-be10-04fce5f48748,,released,,1,2021-12-21T14:16:52.945779-06:00,Chemotherapy,Residual Disease,FOLFOX
HCM-CSHL-0668-C18,f3cb5924-1ad1-4119-853a-26f77240763b,4bd0021e-c24b-4861-9d2d-afa4ec350662,219.0,Adjuvant,142.0,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0668-C18_treatment4,f2f74583-4274-4413-bc08-9e6605ea7c50,,released,Fluorouracil,1,2021-12-21T14:16:52.945779-06:00,Chemotherapy,Residual Disease,
HCM-CSHL-0668-C18,f3cb5924-1ad1-4119-853a-26f77240763b,4bd0021e-c24b-4861-9d2d-afa4ec350662,,Adjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0668-C18_treatment10,f559144a-441e-405a-96a7-7a3d607ea280,,released,,0,2021-12-21T14:16:52.945779-06:00,"Radiation Therapy, NOS",Residual Disease,
HCM-SANG-0542-C18,f3dfe620-ca76-4de3-a91f-f81eeb2e7dfc,47cf2a7a-fb5d-4819-ae7a-3b347693e668,,Neoadjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-SANG-0542-C18_treatment,3aa3c1ad-3d45-41c3-99f8-6b51399cdfd8,,released,,0,2023-02-27T11:46:30.142880-06:00,,,
HCM-CSHL-0159-C18,f404fc66-9398-4c2a-a336-993cd326c3ae,9ce5ac65-29f5-4c90-a0fb-edcaa8429502,,,11.0,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0159-C18_treatment2,25ed1130-f672-4482-813b-508ed69222f8,,released,,1,2020-09-27T13:01:09.449718-05:00,"Surgery, NOS",Initial Diagnosis,
HCM-CSHL-0159-C18,f404fc66-9398-4c2a-a336-993cd326c3ae,9ce5ac65-29f5-4c90-a0fb-edcaa8429502,,Adjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0159-C18_treatment4,62f27fcb-0665-42a3-9c1b-fcf5cb23dde7,,released,,unknown,2020-09-27T13:01:09.449718-05:00,"Radiation Therapy, NOS",Residual Disease,
HCM-CSHL-0159-C18,f404fc66-9398-4c2a-a336-993cd326c3ae,9ce5ac65-29f5-4c90-a0fb-edcaa8429502,,Neoadjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0159-C18_treatment,73d252dc-aa2e-4512-a413-8214cc0614bd,,released,,0,2020-09-27T13:01:09.449718-05:00,,,
HCM-CSHL-0159-C18,f404fc66-9398-4c2a-a336-993cd326c3ae,9ce5ac65-29f5-4c90-a0fb-edcaa8429502,,Adjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0159-C18_treatment3,b26b2f1c-17bc-4dc1-b83c-8331a549c618,,released,,unknown,2020-09-27T13:01:09.449718-05:00,"Pharmaceutical Therapy, NOS",Residual Disease,
HCM-BROD-0044-C15,f46b774a-59ce-437a-a8bc-7e6a6a05b45f,abb661c5-a89b-4473-9b0f-5b0ede319d53,,Neoadjuvant,21.0,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0044-C15_treatment,18d8e684-f997-401d-a2ed-ef8fee64732a,,released,Oxaliplatin,1,2019-04-04T15:58:15.647741-05:00,Chemotherapy,,
HCM-BROD-0044-C15,f46b774a-59ce-437a-a8bc-7e6a6a05b45f,abb661c5-a89b-4473-9b0f-5b0ede319d53,,Neoadjuvant,21.0,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0044-C15_treatment2,1ec06c27-0431-4646-bdc0-5accd100e30b,,released,Fluorouracil,1,2019-04-04T15:58:15.647741-05:00,Chemotherapy,,
HCM-BROD-0044-C15,f46b774a-59ce-437a-a8bc-7e6a6a05b45f,abb661c5-a89b-4473-9b0f-5b0ede319d53,77.0,Adjuvant,21.0,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0044-C15_treatment11,206a4384-4ddb-4005-b90a-8ba280f4450e,,released,Trastuzumab,1,2020-09-27T10:14:46.615222-05:00,Targeted Molecular Therapy,Residual Disease,
HCM-BROD-0044-C15,f46b774a-59ce-437a-a8bc-7e6a6a05b45f,abb661c5-a89b-4473-9b0f-5b0ede319d53,77.0,Adjuvant,21.0,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0044-C15_treatment5,305670cc-f9a9-4f67-bd11-2cde287d42b9,,released,Cisplatin,1,2019-04-04T15:58:15.647741-05:00,Chemotherapy,Residual Disease,
HCM-BROD-0044-C15,f46b774a-59ce-437a-a8bc-7e6a6a05b45f,abb661c5-a89b-4473-9b0f-5b0ede319d53,,,,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0044-C15_treatment10,39dfc940-24ad-4021-b1dd-98f9743f9f22,,released,,0,2020-09-27T10:14:46.615222-05:00,"Surgery, NOS",Initial Diagnosis,
HCM-BROD-0044-C15,f46b774a-59ce-437a-a8bc-7e6a6a05b45f,abb661c5-a89b-4473-9b0f-5b0ede319d53,77.0,Adjuvant,21.0,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0044-C15_treatment6,5ef7bc92-887e-4ed3-b1c2-7e1eadc5703e,,released,,1,2019-04-04T15:58:15.647741-05:00,Chemotherapy,Residual Disease,CF
HCM-BROD-0044-C15,f46b774a-59ce-437a-a8bc-7e6a6a05b45f,abb661c5-a89b-4473-9b0f-5b0ede319d53,244.0,Adjuvant,244.0,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0044-C15_treatment8,6ff5ebd2-8abd-4577-86c4-512d94b0b067,,released,Paclitaxel,1,2019-04-04T15:58:15.647741-05:00,Chemotherapy,Residual Disease,
HCM-BROD-0044-C15,f46b774a-59ce-437a-a8bc-7e6a6a05b45f,abb661c5-a89b-4473-9b0f-5b0ede319d53,,Neoadjuvant,21.0,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0044-C15_treatment3,7a2b99d5-dd58-4874-a070-1afd394c778d,,released,Leucovorin,1,2019-04-04T15:58:15.647741-05:00,Chemotherapy,,
HCM-BROD-0044-C15,f46b774a-59ce-437a-a8bc-7e6a6a05b45f,abb661c5-a89b-4473-9b0f-5b0ede319d53,302.0,Adjuvant,244.0,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0044-C15_treatment12,9bc1388d-a45b-4333-b662-60c7834c5b89,,released,Ramucirumab,1,2020-09-27T10:14:46.615222-05:00,Targeted Molecular Therapy,Residual Disease,
HCM-BROD-0044-C15,f46b774a-59ce-437a-a8bc-7e6a6a05b45f,abb661c5-a89b-4473-9b0f-5b0ede319d53,77.0,Adjuvant,21.0,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0044-C15_treatment7,a9a68824-37dd-4c98-82b9-692ac67b9eda,,released,Leucovorin,1,2019-04-04T15:58:15.647741-05:00,Chemotherapy,Residual Disease,
HCM-BROD-0044-C15,f46b774a-59ce-437a-a8bc-7e6a6a05b45f,abb661c5-a89b-4473-9b0f-5b0ede319d53,,Adjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0044-C15_treatment13,b12f998c-5d9e-4939-bcf5-0abb454513b4,,released,,0,2020-09-27T10:14:46.615222-05:00,"Radiation Therapy, NOS",Residual Disease,
HCM-BROD-0044-C15,f46b774a-59ce-437a-a8bc-7e6a6a05b45f,abb661c5-a89b-4473-9b0f-5b0ede319d53,,Adjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0044-C15_treatment9,bf2362f4-e171-4dd0-aef0-a1cf77fa71b8,,released,,0,2019-04-04T15:58:15.647741-05:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-BROD-0044-C15,f46b774a-59ce-437a-a8bc-7e6a6a05b45f,abb661c5-a89b-4473-9b0f-5b0ede319d53,77.0,Adjuvant,21.0,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0044-C15_treatment4,e026b9f0-1eec-4814-a10e-de1e292d3c07,,released,Fluorouracil,1,2019-04-04T15:58:15.647741-05:00,Chemotherapy,Residual Disease,
HCM-CSHL-0384-D37,f49e41f1-ab0a-4e6e-9780-2acdb94fa820,6061595a-508a-4c1c-b9fb-58e3c78404f8,,Neoadjuvant,,2021-03-03T15:15:08.075155-06:00,HCM-CSHL-0384-D37_treatment,01d4d65e-3262-484b-b103-c9a6e493f615,,released,,0,2020-06-15T13:37:25.219265-05:00,,,
HCM-CSHL-0384-D37,f49e41f1-ab0a-4e6e-9780-2acdb94fa820,6061595a-508a-4c1c-b9fb-58e3c78404f8,,,58.0,2023-03-13T13:30:15.724271-05:00,HCM-CSHL-0384-D37_treatment2,7ba33c42-90a8-4baa-96fd-d5802f2eb988,,released,,1,2020-06-15T13:37:25.219265-05:00,"Surgery, NOS",Initial Diagnosis,
HCM-CSHL-0384-D37,f49e41f1-ab0a-4e6e-9780-2acdb94fa820,6061595a-508a-4c1c-b9fb-58e3c78404f8,,Adjuvant,,2023-03-13T13:30:15.724271-05:00,HCM-CSHL-0384-D37_treatment4,a7b21a35-3b33-448d-b0ea-62e3ed9c8ee5,,released,,0,2020-06-15T13:37:25.219265-05:00,"Radiation Therapy, NOS",Residual Disease,
HCM-CSHL-0384-D37,f49e41f1-ab0a-4e6e-9780-2acdb94fa820,6061595a-508a-4c1c-b9fb-58e3c78404f8,,Adjuvant,,2023-03-13T13:30:15.724271-05:00,HCM-CSHL-0384-D37_treatment3,abdb8749-28f8-4ae9-b480-ec125c259fce,,released,,0,2020-06-15T13:37:25.219265-05:00,"Pharmaceutical Therapy, NOS",Residual Disease,
HCM-BROD-0596-C43,f4a7b060-1b0f-4408-b481-7009df25f1ad,7077ffcc-0b3f-4b6f-9f35-2211180e28ec,,Adjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0596-C43_treatment3,71899c4c-8915-4c9a-b8e3-5001415a071f,,released,,0,2021-12-21T13:40:29.663121-06:00,Hormone Therapy,Residual Disease,
HCM-BROD-0596-C43,f4a7b060-1b0f-4408-b481-7009df25f1ad,7077ffcc-0b3f-4b6f-9f35-2211180e28ec,,,,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0596-C43_treatment5,72aa79ba-a13f-401f-ac63-b77df6264195,,released,,unknown,2021-12-21T13:40:29.663121-06:00,"Surgery, NOS",Initial Diagnosis,
HCM-BROD-0596-C43,f4a7b060-1b0f-4408-b481-7009df25f1ad,7077ffcc-0b3f-4b6f-9f35-2211180e28ec,,Adjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0596-C43_treatment7,a635348b-7167-4591-abd7-c9a6bac2a965,,released,,0,2021-12-21T13:40:29.663121-06:00,"Radiation Therapy, NOS",Residual Disease,
HCM-BROD-0596-C43,f4a7b060-1b0f-4408-b481-7009df25f1ad,7077ffcc-0b3f-4b6f-9f35-2211180e28ec,,Adjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0596-C43_treatment6,ba7c72cd-1f96-4b03-97c8-21e39ea140ae,,released,,0,2021-12-21T13:40:29.663121-06:00,Targeted Molecular Therapy,Residual Disease,
HCM-BROD-0596-C43,f4a7b060-1b0f-4408-b481-7009df25f1ad,7077ffcc-0b3f-4b6f-9f35-2211180e28ec,,Adjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0596-C43_treatment2,c5cf4160-85d1-4018-b464-890ffcd72faa,,released,,0,2021-12-21T13:40:29.663121-06:00,Chemotherapy,Residual Disease,
HCM-BROD-0596-C43,f4a7b060-1b0f-4408-b481-7009df25f1ad,7077ffcc-0b3f-4b6f-9f35-2211180e28ec,,Neoadjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0596-C43_treatment,e493c4ef-037c-4e14-8738-1b87f63580b9,,released,,0,2021-12-21T13:40:29.663121-06:00,,,
HCM-BROD-0596-C43,f4a7b060-1b0f-4408-b481-7009df25f1ad,7077ffcc-0b3f-4b6f-9f35-2211180e28ec,727.0,Adjuvant,14.0,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0596-C43_treatment4,e5994dfd-ae22-4f38-bb51-da3d51c23fce,Treatment Ongoing,released,Pembrolizumab,1,2021-12-21T13:40:29.663121-06:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-WCMC-1340-C54,f59aaafe-c04e-44f3-9937-89bef164494a,98d71b77-caa5-4b7b-ae4c-fbb3d91b60ff,345.0,Adjuvant,282.0,2025-04-07T17:13:09.336794-05:00,HCM-WCMC-1340-C54_treatment6,1f0ca36b-e78e-4ff9-8e52-284f73029379,Treatment Ongoing,released,Pembrolizumab,1,2023-02-27T12:10:31.607589-06:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-WCMC-1340-C54,f59aaafe-c04e-44f3-9937-89bef164494a,98d71b77-caa5-4b7b-ae4c-fbb3d91b60ff,115.0,Adjuvant,105.0,2025-04-07T17:13:09.336794-05:00,HCM-WCMC-1340-C54_treatment10,250ed23c-5a49-4270-97b5-ac943574f3af,,released,,1,2023-02-27T12:10:31.607589-06:00,"Brachytherapy, High Dose",Residual Disease,
HCM-WCMC-1340-C54,f59aaafe-c04e-44f3-9937-89bef164494a,98d71b77-caa5-4b7b-ae4c-fbb3d91b60ff,140.0,Adjuvant,35.0,2025-04-07T17:13:09.336794-05:00,HCM-WCMC-1340-C54_treatment2,330df09b-f051-4737-886a-8524b206d53a,,released,Carboplatin,1,2023-02-27T12:10:31.607589-06:00,Chemotherapy,Residual Disease,
HCM-WCMC-1340-C54,f59aaafe-c04e-44f3-9937-89bef164494a,98d71b77-caa5-4b7b-ae4c-fbb3d91b60ff,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-WCMC-1340-C54_treatment9,332bdf08-3f59-4c8d-b1d4-364d94f7720e,,released,,0,2023-02-27T12:10:31.607589-06:00,Targeted Molecular Therapy,Residual Disease,
HCM-WCMC-1340-C54,f59aaafe-c04e-44f3-9937-89bef164494a,98d71b77-caa5-4b7b-ae4c-fbb3d91b60ff,,,15.0,2025-04-07T17:13:09.336794-05:00,HCM-WCMC-1340-C54_treatment8,6989a6a2-3595-4179-97a0-2f8ae6e313a1,,released,,1,2023-02-27T12:10:31.607589-06:00,"Surgery, NOS",Initial Diagnosis,
HCM-WCMC-1340-C54,f59aaafe-c04e-44f3-9937-89bef164494a,98d71b77-caa5-4b7b-ae4c-fbb3d91b60ff,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-WCMC-1340-C54_treatment4,73572a3b-4e8a-401d-a6eb-1dc9a2f6b8ce,,released,,0,2023-02-27T12:10:31.607589-06:00,Hormone Therapy,Residual Disease,
HCM-WCMC-1340-C54,f59aaafe-c04e-44f3-9937-89bef164494a,98d71b77-caa5-4b7b-ae4c-fbb3d91b60ff,140.0,Adjuvant,35.0,2025-04-07T17:13:09.336794-05:00,HCM-WCMC-1340-C54_treatment3,7a44b03a-1480-4bc1-8777-de563faa3add,,released,Paclitaxel,1,2023-02-27T12:10:31.607589-06:00,Chemotherapy,Residual Disease,
HCM-WCMC-1340-C54,f59aaafe-c04e-44f3-9937-89bef164494a,98d71b77-caa5-4b7b-ae4c-fbb3d91b60ff,,Neoadjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-WCMC-1340-C54_treatment,abddb515-21fa-4c0a-a3e0-34b92f5ae81e,,released,,0,2023-02-27T12:10:31.607589-06:00,,,
HCM-WCMC-1340-C54,f59aaafe-c04e-44f3-9937-89bef164494a,98d71b77-caa5-4b7b-ae4c-fbb3d91b60ff,345.0,Adjuvant,282.0,2025-04-07T17:13:09.336794-05:00,HCM-WCMC-1340-C54_treatment5,ae828c06-97fd-4b82-8030-c5e1ebdb1bc7,Treatment Ongoing,released,Lenvatinib,1,2023-02-27T12:10:31.607589-06:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-WCMC-1340-C54,f59aaafe-c04e-44f3-9937-89bef164494a,98d71b77-caa5-4b7b-ae4c-fbb3d91b60ff,345.0,Adjuvant,282.0,2025-04-07T17:13:09.336794-05:00,HCM-WCMC-1340-C54_treatment7,cf7f2d7e-8c93-49a1-9ff1-0bec5e0108ac,Treatment Ongoing,released,,1,2023-02-27T12:10:31.607589-06:00,Immunotherapy (Including Vaccines),Residual Disease,Lenvatinib-Pembrolizumab regimen
HCM-CSHL-0838-C18,f5a13bb2-47f3-499d-b33f-b1caeb5e928b,787d19e7-940b-491c-9100-5192149e5586,1134.0,Adjuvant,1092.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0838-C18_treatment6,0ea4afa6-de58-4b25-8db7-b76d61c0b082,,released,Fluorouracil,1,2021-12-21T14:33:58.982147-06:00,Chemotherapy,Residual Disease,
HCM-CSHL-0838-C18,f5a13bb2-47f3-499d-b33f-b1caeb5e928b,787d19e7-940b-491c-9100-5192149e5586,967.0,Adjuvant,905.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0838-C18_treatment4,1125a5ff-8f34-4f23-bf23-56f088ef191f,,released,Leucovorin,1,2021-12-21T14:33:58.982147-06:00,Chemotherapy,Residual Disease,
HCM-CSHL-0838-C18,f5a13bb2-47f3-499d-b33f-b1caeb5e928b,787d19e7-940b-491c-9100-5192149e5586,1134.0,Adjuvant,1092.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0838-C18_treatment11,25d554fa-e517-4f11-94dd-d568b5c3ef85,,released,Bevacizumab,1,2021-12-21T14:33:58.982147-06:00,Targeted Molecular Therapy,Residual Disease,
HCM-CSHL-0838-C18,f5a13bb2-47f3-499d-b33f-b1caeb5e928b,787d19e7-940b-491c-9100-5192149e5586,,,1.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0838-C18_treatment9,45a218d6-eb8d-4868-83a0-df8e811c84c6,,released,,1,2021-12-21T14:33:58.982147-06:00,"Surgery, NOS",Initial Diagnosis,
HCM-CSHL-0838-C18,f5a13bb2-47f3-499d-b33f-b1caeb5e928b,787d19e7-940b-491c-9100-5192149e5586,,Neoadjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0838-C18_treatment,624700cd-128a-4da8-ae80-25e808ce857a,,released,,0,2021-12-21T14:33:58.982147-06:00,,,
HCM-CSHL-0838-C18,f5a13bb2-47f3-499d-b33f-b1caeb5e928b,787d19e7-940b-491c-9100-5192149e5586,230.0,Adjuvant,54.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0838-C18_treatment2,641eaa33-58e7-46e4-b28b-f6f567fa2adf,,released,Capecitabine,1,2021-12-21T14:33:58.982147-06:00,Chemotherapy,Residual Disease,
HCM-CSHL-0838-C18,f5a13bb2-47f3-499d-b33f-b1caeb5e928b,787d19e7-940b-491c-9100-5192149e5586,1134.0,Adjuvant,1092.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0838-C18_treatment7,7bd2b895-3136-4670-b9e1-96aa55f632ab,,released,Leucovorin,1,2021-12-21T14:33:58.982147-06:00,Chemotherapy,Residual Disease,
HCM-CSHL-0838-C18,f5a13bb2-47f3-499d-b33f-b1caeb5e928b,787d19e7-940b-491c-9100-5192149e5586,967.0,Adjuvant,905.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0838-C18_treatment5,8e1d06d0-886a-4f1a-b5c7-89545c67b59e,,released,Oxaliplatin,1,2021-12-21T14:33:58.982147-06:00,Chemotherapy,Residual Disease,
HCM-CSHL-0838-C18,f5a13bb2-47f3-499d-b33f-b1caeb5e928b,787d19e7-940b-491c-9100-5192149e5586,967.0,Adjuvant,905.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0838-C18_treatment3,abe3bfec-c1dc-45bb-8507-fcf71bf02ef7,,released,Fluorouracil,1,2021-12-21T14:33:58.982147-06:00,Chemotherapy,Residual Disease,
HCM-CSHL-0838-C18,f5a13bb2-47f3-499d-b33f-b1caeb5e928b,787d19e7-940b-491c-9100-5192149e5586,,,1008.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0838-C18_treatment10,d78fb8dd-632d-479b-8489-17900e8560a7,,released,,1,2021-12-21T14:33:58.982147-06:00,"Surgery, NOS",Initial Diagnosis,
HCM-CSHL-0838-C18,f5a13bb2-47f3-499d-b33f-b1caeb5e928b,787d19e7-940b-491c-9100-5192149e5586,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0838-C18_treatment8,d8fe29cf-063f-4832-9ecb-7811ca3ba93b,,released,,0,2021-12-21T14:33:58.982147-06:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-CSHL-0838-C18,f5a13bb2-47f3-499d-b33f-b1caeb5e928b,787d19e7-940b-491c-9100-5192149e5586,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0838-C18_treatment12,ffb6daf5-a5b9-44e6-851f-99f3690315e9,,released,,0,2021-12-21T14:33:58.982147-06:00,"Radiation Therapy, NOS",Residual Disease,
HCM-CSHL-0838-C18,f5a13bb2-47f3-499d-b33f-b1caeb5e928b,f71bb250-5625-4405-91ac-dceed536e45c,,Maintenance Therapy,,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0838-C18_treatment13,87a02917-9dde-43d4-8ff1-5b0f6b3f0207,Progressive Disease,released,,1,2021-12-21T14:33:58.982147-06:00,,,
HCM-SANG-1300-C18,f5dccb7f-c0c5-4990-9092-6f0875a1fe04,a21977f4-b67d-4b46-82c5-9688710a77f6,,Neoadjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-SANG-1300-C18_treatment,e0114748-5625-4377-97b8-1cc977f35677,,released,,0,2023-02-27T12:05:08.292666-06:00,,,
HCM-CSHL-0182-C25,f6824107-f92f-47fc-930a-cbe3bfe58895,bcf45381-7fbd-4130-85b0-ccf528d1786b,,Adjuvant,,2023-03-13T12:52:25.738572-05:00,HCM-CSHL-0182-C25_treatment3,897dc6d9-4d79-43f3-b31c-ee72ecffa3c2,,released,,unknown,2020-09-28T09:14:37.452637-05:00,"Pharmaceutical Therapy, NOS",Residual Disease,
HCM-CSHL-0182-C25,f6824107-f92f-47fc-930a-cbe3bfe58895,bcf45381-7fbd-4130-85b0-ccf528d1786b,,Neoadjuvant,,2023-02-22T07:39:25.979291-06:00,HCM-CSHL-0182-C25_treatment,94252caf-3988-4d33-9307-9db562a84a5e,,released,,0,2020-09-28T09:14:37.452637-05:00,,,
HCM-CSHL-0182-C25,f6824107-f92f-47fc-930a-cbe3bfe58895,bcf45381-7fbd-4130-85b0-ccf528d1786b,,,-13.0,2023-03-13T12:52:25.738572-05:00,HCM-CSHL-0182-C25_treatment2,d9d458aa-aeb4-4dc1-882c-1bcfd5862f73,,released,,1,2020-09-28T09:14:37.452637-05:00,"Surgery, NOS",Initial Diagnosis,
HCM-CSHL-0182-C25,f6824107-f92f-47fc-930a-cbe3bfe58895,bcf45381-7fbd-4130-85b0-ccf528d1786b,,Adjuvant,,2023-03-13T12:52:25.738572-05:00,HCM-CSHL-0182-C25_treatment4,df0e2971-2f83-4b6b-85fd-65c6c9e5af04,,released,,unknown,2020-09-28T09:14:37.452637-05:00,"Radiation Therapy, NOS",Residual Disease,
HCM-CSHL-0729-C18,f6a13511-0819-4219-bc4b-6cb146629f0e,1ac970ad-d196-486b-936f-5576d16ddd6f,,Adjuvant,,2023-02-22T07:39:25.979291-06:00,HCM-CSHL-0729-C18_treatment6,10f5cf33-ef8f-4c46-8c38-67fc5b64e435,,released,,0,2021-12-21T14:19:11.836836-06:00,"Radiation Therapy, NOS",Residual Disease,
HCM-CSHL-0729-C18,f6a13511-0819-4219-bc4b-6cb146629f0e,1ac970ad-d196-486b-936f-5576d16ddd6f,,Adjuvant,,2023-02-22T07:39:25.979291-06:00,HCM-CSHL-0729-C18_treatment5,24841930-5810-4323-9015-470398940a2e,,released,,0,2021-12-21T14:19:11.836836-06:00,Targeted Molecular Therapy,Residual Disease,
HCM-CSHL-0729-C18,f6a13511-0819-4219-bc4b-6cb146629f0e,1ac970ad-d196-486b-936f-5576d16ddd6f,,,39.0,2023-03-13T13:26:46.629546-05:00,HCM-CSHL-0729-C18_treatment4,bb206032-966f-4a3e-a3fb-8d464270785b,,released,,1,2021-12-21T14:19:11.836836-06:00,"Surgery, NOS",Initial Diagnosis,
HCM-CSHL-0729-C18,f6a13511-0819-4219-bc4b-6cb146629f0e,1ac970ad-d196-486b-936f-5576d16ddd6f,,Adjuvant,,2023-02-22T07:39:25.979291-06:00,HCM-CSHL-0729-C18_treatment3,dfc83ae8-ba91-4ae2-b221-7e2c14b26b61,,released,,0,2021-12-21T14:19:11.836836-06:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-CSHL-0729-C18,f6a13511-0819-4219-bc4b-6cb146629f0e,1ac970ad-d196-486b-936f-5576d16ddd6f,157.0,Adjuvant,63.0,2023-02-22T07:39:25.979291-06:00,HCM-CSHL-0729-C18_treatment2,efe90fa5-d09b-4399-b0f6-fb7d0e05ac3c,,released,Capecitabine,1,2021-12-21T14:19:11.836836-06:00,Chemotherapy,Residual Disease,
HCM-CSHL-0729-C18,f6a13511-0819-4219-bc4b-6cb146629f0e,1ac970ad-d196-486b-936f-5576d16ddd6f,,Neoadjuvant,,2023-02-22T07:39:25.979291-06:00,HCM-CSHL-0729-C18_treatment,f1efd112-cc7d-4c33-a2f5-b1d2e5e56f64,,released,,0,2021-12-21T14:19:11.836836-06:00,,,
HCM-BROD-0481-C43,f78051ab-be5e-4d77-953f-df15762e9834,1f79871e-69ed-418c-98d0-a8eb20e1f5a2,,Adjuvant,,2021-07-12T12:25:55.528644-05:00,HCM-BROD-0481-C43_treatment8,1993c4aa-ac39-424b-aba8-ac35dcc794c8,,released,,0,2020-06-15T13:35:43.470739-05:00,Targeted Molecular Therapy,Residual Disease,
HCM-BROD-0481-C43,f78051ab-be5e-4d77-953f-df15762e9834,1f79871e-69ed-418c-98d0-a8eb20e1f5a2,904.0,Adjuvant,716.0,2021-07-12T12:25:55.528644-05:00,HCM-BROD-0481-C43_treatment4,1ba20f7b-c0f8-4e0b-b1fe-801ae9912576,,released,Nab-paclitaxel,1,2020-06-15T13:35:43.470739-05:00,Chemotherapy,Residual Disease,
HCM-BROD-0481-C43,f78051ab-be5e-4d77-953f-df15762e9834,1f79871e-69ed-418c-98d0-a8eb20e1f5a2,,Neoadjuvant,,2021-07-12T12:25:55.528644-05:00,HCM-BROD-0481-C43_treatment2,2080adcc-bf63-475d-a3ee-3dd0544468ba,,released,,unknown,2020-06-15T13:35:43.470739-05:00,"Radiation Therapy, NOS",,
HCM-BROD-0481-C43,f78051ab-be5e-4d77-953f-df15762e9834,1f79871e-69ed-418c-98d0-a8eb20e1f5a2,,Adjuvant,,2021-07-12T12:25:55.528644-05:00,HCM-BROD-0481-C43_treatment6,257d3d3a-999b-4ee0-8425-2a9ea405c204,,released,,0,2020-06-15T13:35:43.470739-05:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-BROD-0481-C43,f78051ab-be5e-4d77-953f-df15762e9834,1f79871e-69ed-418c-98d0-a8eb20e1f5a2,,,,2023-02-27T13:34:36.211212-06:00,HCM-BROD-0481-C43_treatment7,2af86117-2a0b-4204-9f3c-44526374df36,,released,,unknown,2020-06-15T13:35:43.470739-05:00,"Surgery, NOS",Initial Diagnosis,
HCM-BROD-0481-C43,f78051ab-be5e-4d77-953f-df15762e9834,1f79871e-69ed-418c-98d0-a8eb20e1f5a2,,Adjuvant,,2021-07-12T12:25:55.528644-05:00,HCM-BROD-0481-C43_treatment9,387457c1-f09f-4cef-8e4f-f4d06ed6becd,,released,,0,2020-10-08T12:09:27.468387-05:00,"Radiation Therapy, NOS",Residual Disease,
HCM-BROD-0481-C43,f78051ab-be5e-4d77-953f-df15762e9834,1f79871e-69ed-418c-98d0-a8eb20e1f5a2,,Neoadjuvant,,2021-07-12T12:25:55.528644-05:00,HCM-BROD-0481-C43_treatment,4085388a-91e1-4ce0-841c-d1069e4e9579,,released,,unknown,2020-06-15T13:35:43.470739-05:00,"Pharmaceutical Therapy, NOS",,
HCM-BROD-0481-C43,f78051ab-be5e-4d77-953f-df15762e9834,1f79871e-69ed-418c-98d0-a8eb20e1f5a2,,Adjuvant,,2021-07-12T12:25:55.528644-05:00,HCM-BROD-0481-C43_treatment5,759c976a-6748-49ea-badd-97049ea3ed91,,released,,0,2020-06-15T13:35:43.470739-05:00,Hormone Therapy,Residual Disease,
HCM-BROD-0481-C43,f78051ab-be5e-4d77-953f-df15762e9834,1f79871e-69ed-418c-98d0-a8eb20e1f5a2,904.0,Adjuvant,716.0,2021-07-12T12:25:55.528644-05:00,HCM-BROD-0481-C43_treatment3,a67172bb-c302-4579-a4c5-4523465425ef,,released,Carboplatin,1,2020-06-15T13:35:43.470739-05:00,Chemotherapy,Residual Disease,
HCM-BROD-0481-C43,f78051ab-be5e-4d77-953f-df15762e9834,91e19c15-b38d-4769-882b-e9f588dfadb8,904.0,Maintenance Therapy,716.0,2021-07-12T12:25:55.528644-05:00,HCM-BROD-0481-C43_treatment10,68d38616-5ea5-474e-abf1-01733b9590e5,Not Reported,released,Carboplatin,1,2020-06-15T13:35:43.470739-05:00,,,
HCM-BROD-0481-C43,f78051ab-be5e-4d77-953f-df15762e9834,91e19c15-b38d-4769-882b-e9f588dfadb8,904.0,Maintenance Therapy,716.0,2021-07-12T12:25:55.528644-05:00,HCM-BROD-0481-C43_treatment11,f960ee5e-2083-4fd7-b1ac-8264c1876a91,Not Reported,released,Nab-paclitaxel,1,2020-10-08T12:09:27.468387-05:00,,,
HCM-SANG-1088-C18,f78c8d62-a481-4539-8f27-ab681c86b90d,2592c914-f518-4447-a559-cc2a77c6c3d8,,Neoadjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-SANG-1088-C18_treatment,57dee9fb-e513-4d67-804a-d9ca83de59b3,,released,,1,2023-02-27T11:35:00.679212-06:00,Hormone Therapy,,
HCM-SANG-0308-C15,f8825237-31c7-4b78-8743-efb0bd917688,43888acd-6ba0-4048-b74a-8b4fc19125cc,,Neoadjuvant,259.0,2023-03-13T13:04:59.363716-05:00,HCM-SANG-0308-C15_treatment3,16eaf0b5-d5c9-420f-8987-ed420098af1c,,released,Cisplatin,1,2020-11-11T09:37:09.393821-06:00,Chemotherapy,,
HCM-SANG-0308-C15,f8825237-31c7-4b78-8743-efb0bd917688,43888acd-6ba0-4048-b74a-8b4fc19125cc,,Neoadjuvant,259.0,2023-03-13T13:04:59.363716-05:00,HCM-SANG-0308-C15_treatment4,517e08eb-96cf-450f-a338-9f0509e37001,,released,,1,2020-11-11T09:37:09.393821-06:00,Chemotherapy,,ECX
HCM-SANG-0308-C15,f8825237-31c7-4b78-8743-efb0bd917688,43888acd-6ba0-4048-b74a-8b4fc19125cc,,Neoadjuvant,259.0,2023-03-13T13:04:59.363716-05:00,HCM-SANG-0308-C15_treatment2,a7b38a9d-fc5d-498b-8a0d-a1364fad96a8,,released,Capecitabine,1,2020-11-11T09:37:09.393821-06:00,Chemotherapy,,
HCM-SANG-0308-C15,f8825237-31c7-4b78-8743-efb0bd917688,43888acd-6ba0-4048-b74a-8b4fc19125cc,,Neoadjuvant,259.0,2023-03-13T13:04:59.363716-05:00,HCM-SANG-0308-C15_treatment,b4db5784-5b14-4d0a-a7c7-598e7e6db2e7,,released,Epirubicin,1,2020-06-15T13:44:35.761439-05:00,Chemotherapy,,
HCM-SANG-0308-C15,f8825237-31c7-4b78-8743-efb0bd917688,43888acd-6ba0-4048-b74a-8b4fc19125cc,,Neoadjuvant,259.0,2023-03-13T13:04:59.363716-05:00,HCM-SANG-0308-C15_treatment5,f01e8e31-4d2d-4f6f-b384-d8d3623cd619,,released,Leucovorin,1,2021-08-26T15:04:10.604151-05:00,Chemotherapy,,
HCM-SANG-0265-C18,f8a9aab0-6017-483d-b053-9393c6a5af2d,6727e9d1-b102-4e47-b7ae-6e85817f07d9,,Neoadjuvant,,2023-02-22T07:39:25.979291-06:00,HCM-SANG-0265-C18_treatment,fb586d2d-a661-4c01-b06b-1ae983ba3e0c,,released,,0,2021-12-21T15:06:36.188518-06:00,,,
HCM-CSHL-0875-C67,f8c9dead-9a29-44a3-9680-794bf660b383,23a87f65-2a71-447d-85cd-67042a2f7489,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0875-C67_treatment5,7ba88f62-fc08-49df-bdb9-b866d68817eb,,released,,0,2021-12-21T14:36:52.971512-06:00,"Radiation Therapy, NOS",Residual Disease,
HCM-CSHL-0875-C67,f8c9dead-9a29-44a3-9680-794bf660b383,23a87f65-2a71-447d-85cd-67042a2f7489,,Neoadjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0875-C67_treatment,a8ee6e71-f7a4-41d0-8462-50f483bac4f1,,released,Cisplatin,1,2021-12-21T14:36:52.971512-06:00,Chemotherapy,,
HCM-CSHL-0875-C67,f8c9dead-9a29-44a3-9680-794bf660b383,23a87f65-2a71-447d-85cd-67042a2f7489,,,0.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0875-C67_treatment3,afd6f3fa-44b9-4600-aa9a-17ba3eea29eb,,released,,1,2021-12-21T14:36:52.971512-06:00,"Surgery, NOS",Initial Diagnosis,
HCM-CSHL-0875-C67,f8c9dead-9a29-44a3-9680-794bf660b383,23a87f65-2a71-447d-85cd-67042a2f7489,,Neoadjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0875-C67_treatment2,d2e2ba41-6ac1-4613-aaee-d163deefadff,,released,Gemcitabine,1,2021-12-21T14:36:52.971512-06:00,Chemotherapy,,
HCM-CSHL-0875-C67,f8c9dead-9a29-44a3-9680-794bf660b383,23a87f65-2a71-447d-85cd-67042a2f7489,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0875-C67_treatment4,de820766-a512-44da-9f32-97de0f6c2691,,released,,0,2021-12-21T14:36:52.971512-06:00,"Pharmaceutical Therapy, NOS",Residual Disease,
HCM-CSHL-0812-C54,f8e8fead-4979-4c49-9285-02dcbcda974a,68a1cadc-25be-4f60-8803-6faf52f016db,135.0,Adjuvant,121.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0812-C54_treatment4,85171ec5-0587-4137-abcd-0aa985cdc3f3,,released,,1,2021-12-21T14:28:53.477306-06:00,"Brachytherapy, High Dose",Residual Disease,
HCM-CSHL-0812-C54,f8e8fead-4979-4c49-9285-02dcbcda974a,68a1cadc-25be-4f60-8803-6faf52f016db,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0812-C54_treatment3,d100ec58-31e5-4d32-b6c7-f97d9fc03146,,released,,0,2021-12-21T14:28:53.477306-06:00,"Pharmaceutical Therapy, NOS",Residual Disease,
HCM-CSHL-0812-C54,f8e8fead-4979-4c49-9285-02dcbcda974a,68a1cadc-25be-4f60-8803-6faf52f016db,,Neoadjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0812-C54_treatment,f5169339-ff2a-43ca-831d-5cc5047e866a,,released,,0,2021-12-21T14:28:53.477306-06:00,,,
HCM-CSHL-0812-C54,f8e8fead-4979-4c49-9285-02dcbcda974a,68a1cadc-25be-4f60-8803-6faf52f016db,,,0.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0812-C54_treatment2,f891e3f3-af24-499d-87f2-7ffef0e751be,,released,,1,2021-12-21T14:28:53.477306-06:00,"Surgery, NOS",Initial Diagnosis,
HCM-CSHL-0438-C18,f9301129-b7a7-4a42-ba05-27b9a30421fe,f745ab09-615e-43c8-8687-cdc737d5306f,,Neoadjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0438-C18_treatment,2ac6b6d4-d234-4350-a469-5c9497b5b659,,released,,0,2020-09-28T10:11:47.790068-05:00,,,
HCM-CSHL-0438-C18,f9301129-b7a7-4a42-ba05-27b9a30421fe,f745ab09-615e-43c8-8687-cdc737d5306f,,Adjuvant,48.0,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0438-C18_treatment3,65f851a6-dc5a-4792-8963-5a51723533d5,,released,Oxaliplatin,1,2020-09-28T10:11:47.790068-05:00,Chemotherapy,Residual Disease,
HCM-CSHL-0438-C18,f9301129-b7a7-4a42-ba05-27b9a30421fe,f745ab09-615e-43c8-8687-cdc737d5306f,,Adjuvant,48.0,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0438-C18_treatment2,b6ea65c7-9f86-4e4b-a98f-adbcb88c4f87,,released,Capecitabine,1,2020-09-28T10:11:47.790068-05:00,Chemotherapy,Residual Disease,
HCM-CSHL-0438-C18,f9301129-b7a7-4a42-ba05-27b9a30421fe,f745ab09-615e-43c8-8687-cdc737d5306f,,Adjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0438-C18_treatment6,c6604c6a-10c9-4697-940e-c19c082e4f56,,released,,unknown,2020-09-28T10:11:47.790068-05:00,Targeted Molecular Therapy,Residual Disease,
HCM-CSHL-0438-C18,f9301129-b7a7-4a42-ba05-27b9a30421fe,f745ab09-615e-43c8-8687-cdc737d5306f,,Adjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0438-C18_treatment4,dd4aa461-d552-4d7d-96ec-94742a7482c4,,released,,unknown,2020-09-28T10:11:47.790068-05:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-CSHL-0438-C18,f9301129-b7a7-4a42-ba05-27b9a30421fe,f745ab09-615e-43c8-8687-cdc737d5306f,,,11.0,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0438-C18_treatment5,ee2563ea-bb50-4984-9ee0-04185da00745,,released,,1,2020-09-28T10:11:47.790068-05:00,"Surgery, NOS",Initial Diagnosis,
HCM-CSHL-0438-C18,f9301129-b7a7-4a42-ba05-27b9a30421fe,f745ab09-615e-43c8-8687-cdc737d5306f,,Adjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0438-C18_treatment7,f9b452fa-7cee-4c33-a668-f085ca5179af,,released,,0,2020-09-28T10:11:47.790068-05:00,"Radiation Therapy, NOS",Residual Disease,
HCM-BROD-0235-C16,f97b6ab3-1169-4856-bd0a-139104b6c5ab,04806eb9-727b-48a5-af52-17a6228ea802,,,,2023-02-27T12:29:44.782136-06:00,HCM-BROD-0235-C16_treatment6,24c86ebb-5dce-4433-993c-385826814b57,,released,,0,2020-04-21T15:06:51.547280-05:00,"Surgery, NOS",Initial Diagnosis,
HCM-BROD-0235-C16,f97b6ab3-1169-4856-bd0a-139104b6c5ab,04806eb9-727b-48a5-af52-17a6228ea802,204.0,Adjuvant,63.0,2020-10-20T20:46:30.021349-05:00,HCM-BROD-0235-C16_treatment4,46d4a0db-4622-467b-9a0f-1ffb2fe5fcc4,,released,Oxaliplatin,1,2020-04-21T15:06:51.547280-05:00,Chemotherapy,Residual Disease,
HCM-BROD-0235-C16,f97b6ab3-1169-4856-bd0a-139104b6c5ab,04806eb9-727b-48a5-af52-17a6228ea802,204.0,Adjuvant,75.0,2020-10-20T20:46:30.021349-05:00,HCM-BROD-0235-C16_treatment7,7876e1aa-9803-474a-9738-d2d73a6cbdca,,released,Nivolumab,1,2020-04-21T15:06:51.547280-05:00,Targeted Molecular Therapy,Residual Disease,
HCM-BROD-0235-C16,f97b6ab3-1169-4856-bd0a-139104b6c5ab,04806eb9-727b-48a5-af52-17a6228ea802,,Adjuvant,,2020-10-20T20:46:30.021349-05:00,HCM-BROD-0235-C16_treatment5,8fcab9ff-be03-4731-84ac-098308166d1d,,released,,0,2020-04-21T15:06:51.547280-05:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-BROD-0235-C16,f97b6ab3-1169-4856-bd0a-139104b6c5ab,04806eb9-727b-48a5-af52-17a6228ea802,204.0,Adjuvant,63.0,2020-10-20T20:46:30.021349-05:00,HCM-BROD-0235-C16_treatment3,99717c15-45e8-4811-8b85-84cee0a6b683,,released,Leucovorin,1,2020-04-21T15:06:51.547280-05:00,Chemotherapy,Residual Disease,
HCM-BROD-0235-C16,f97b6ab3-1169-4856-bd0a-139104b6c5ab,04806eb9-727b-48a5-af52-17a6228ea802,,Adjuvant,,2020-10-20T20:46:30.021349-05:00,HCM-BROD-0235-C16_treatment8,a738d19c-cd0a-4040-b1aa-588046972c49,,released,,0,2020-04-21T15:06:51.547280-05:00,"Radiation Therapy, NOS",Residual Disease,
HCM-BROD-0235-C16,f97b6ab3-1169-4856-bd0a-139104b6c5ab,04806eb9-727b-48a5-af52-17a6228ea802,,Neoadjuvant,,2020-10-20T20:46:30.021349-05:00,HCM-BROD-0235-C16_treatment,c4e410dc-b373-443c-9786-33ac3428b7d1,,released,,1,2019-04-04T15:44:41.255868-05:00,Chemotherapy,,
HCM-BROD-0235-C16,f97b6ab3-1169-4856-bd0a-139104b6c5ab,04806eb9-727b-48a5-af52-17a6228ea802,204.0,Adjuvant,63.0,2020-10-20T20:46:30.021349-05:00,HCM-BROD-0235-C16_treatment2,c7c4d4dc-d67e-46c4-a2e1-5d355b80c11c,,released,Fluorouracil,1,2020-04-21T15:06:51.547280-05:00,Chemotherapy,Residual Disease,
HCM-CSHL-0241-C18,f9d5bd26-816b-4aaa-809f-19d4b8d74692,d248f41f-ea20-4327-9797-313ebad28042,,,28.0,2023-03-13T13:13:37.997721-05:00,HCM-CSHL-0241-C18_treatment2,10c155b5-4876-4009-90f4-827827af9b80,,released,,1,2021-11-01T07:57:33.689000-05:00,"Surgery, NOS",Initial Diagnosis,
HCM-CSHL-0241-C18,f9d5bd26-816b-4aaa-809f-19d4b8d74692,d248f41f-ea20-4327-9797-313ebad28042,,Adjuvant,,2023-03-13T13:13:37.997721-05:00,HCM-CSHL-0241-C18_treatment4,1a8adf90-f08d-4d4e-9e6e-b2102275ee9f,,released,,0,2021-11-01T07:57:33.689000-05:00,"Radiation Therapy, NOS",Residual Disease,
HCM-CSHL-0241-C18,f9d5bd26-816b-4aaa-809f-19d4b8d74692,d248f41f-ea20-4327-9797-313ebad28042,,Adjuvant,,2023-03-13T13:13:37.997721-05:00,HCM-CSHL-0241-C18_treatment3,5484ab56-ceea-4649-853c-0d1f9738c7b0,,released,,0,2021-11-01T07:57:33.689000-05:00,"Pharmaceutical Therapy, NOS",Residual Disease,
HCM-CSHL-0241-C18,f9d5bd26-816b-4aaa-809f-19d4b8d74692,d248f41f-ea20-4327-9797-313ebad28042,,Neoadjuvant,,2023-02-22T07:39:25.979291-06:00,HCM-CSHL-0241-C18_treatment,57c305a4-e8c6-4f64-98c8-e4bcc93437bd,,released,,0,2021-11-01T07:57:33.689000-05:00,,,
HCM-BROD-0035-C49,fa30fc7f-90b6-4ca0-93b6-1351eae9dfc8,c1bd4b1f-e245-45bd-8569-9ebb5a5afeab,,Neoadjuvant,63.0,2021-07-12T12:25:55.528644-05:00,HCM-BROD-0035-C49_treatment,0c37e225-3890-41ae-a427-bb29f0362cd6,,released,Cyclophosphamide,1,2020-06-15T12:57:49.021995-05:00,Chemotherapy,,
HCM-BROD-0035-C49,fa30fc7f-90b6-4ca0-93b6-1351eae9dfc8,c1bd4b1f-e245-45bd-8569-9ebb5a5afeab,,Adjuvant,,2021-07-12T12:25:55.528644-05:00,HCM-BROD-0035-C49_treatment10,2744938e-bfcf-47e2-ba78-9fd696a6c3d9,,released,,0,2020-06-15T12:57:49.021995-05:00,Hormone Therapy,Residual Disease,
HCM-BROD-0035-C49,fa30fc7f-90b6-4ca0-93b6-1351eae9dfc8,c1bd4b1f-e245-45bd-8569-9ebb5a5afeab,543.0,Adjuvant,510.0,2021-07-12T12:25:55.528644-05:00,HCM-BROD-0035-C49_treatment7,2f53fa4b-f370-47cc-9bfc-a55a79186634,,released,Gemcitabine Hydrochloride,1,2020-06-15T12:57:49.021995-05:00,Chemotherapy,Residual Disease,
HCM-BROD-0035-C49,fa30fc7f-90b6-4ca0-93b6-1351eae9dfc8,c1bd4b1f-e245-45bd-8569-9ebb5a5afeab,,Neoadjuvant,63.0,2021-07-12T12:25:55.528644-05:00,HCM-BROD-0035-C49_treatment4,502eb18a-adbb-4f8f-83d0-c2fcc2c5fd5a,,released,Doxorubicin,1,2020-06-15T12:57:49.021995-05:00,Chemotherapy,,
HCM-BROD-0035-C49,fa30fc7f-90b6-4ca0-93b6-1351eae9dfc8,c1bd4b1f-e245-45bd-8569-9ebb5a5afeab,,Neoadjuvant,63.0,2021-07-12T12:25:55.528644-05:00,HCM-BROD-0035-C49_treatment3,6c2157ff-782e-4d2e-99fc-ed6c758188d9,,released,Vincristine,1,2020-06-15T12:57:49.021995-05:00,Chemotherapy,,
HCM-BROD-0035-C49,fa30fc7f-90b6-4ca0-93b6-1351eae9dfc8,c1bd4b1f-e245-45bd-8569-9ebb5a5afeab,,Adjuvant,,2021-07-12T12:25:55.528644-05:00,HCM-BROD-0035-C49_treatment14,6e50da32-159d-4cd5-ae70-b219b7520c9b,,released,,0,2020-09-30T12:47:19.711789-05:00,"Radiation Therapy, NOS",Residual Disease,
HCM-BROD-0035-C49,fa30fc7f-90b6-4ca0-93b6-1351eae9dfc8,c1bd4b1f-e245-45bd-8569-9ebb5a5afeab,,Neoadjuvant,63.0,2021-07-12T12:25:55.528644-05:00,HCM-BROD-0035-C49_treatment5,85aebd88-5a05-4be8-9507-7ac025a839ac,,released,Etoposide,1,2020-06-15T12:57:49.021995-05:00,Targeted Molecular Therapy,,
HCM-BROD-0035-C49,fa30fc7f-90b6-4ca0-93b6-1351eae9dfc8,c1bd4b1f-e245-45bd-8569-9ebb5a5afeab,543.0,Adjuvant,510.0,2021-07-12T12:25:55.528644-05:00,HCM-BROD-0035-C49_treatment8,9eb1c860-3421-48b8-ac1e-44ba8b19394a,,released,Docetaxel,1,2020-06-15T12:57:49.021995-05:00,Chemotherapy,Residual Disease,
HCM-BROD-0035-C49,fa30fc7f-90b6-4ca0-93b6-1351eae9dfc8,c1bd4b1f-e245-45bd-8569-9ebb5a5afeab,588.0,Adjuvant,557.0,2021-07-12T12:25:55.528644-05:00,HCM-BROD-0035-C49_treatment9,a18d73a6-89ba-4481-b266-0667f4637c40,,released,Vinorelbine Tartrate,1,2020-06-15T12:57:49.021995-05:00,Chemotherapy,Residual Disease,
HCM-BROD-0035-C49,fa30fc7f-90b6-4ca0-93b6-1351eae9dfc8,c1bd4b1f-e245-45bd-8569-9ebb5a5afeab,516.0,Adjuvant,449.0,2021-07-12T12:25:55.528644-05:00,HCM-BROD-0035-C49_treatment6,b1beb77c-558a-478b-a13b-83de237346a5,,released,Cyclophosphamide,1,2020-06-15T12:57:49.021995-05:00,Chemotherapy,Residual Disease,
HCM-BROD-0035-C49,fa30fc7f-90b6-4ca0-93b6-1351eae9dfc8,c1bd4b1f-e245-45bd-8569-9ebb5a5afeab,,Neoadjuvant,63.0,2021-07-12T12:25:55.528644-05:00,HCM-BROD-0035-C49_treatment2,bc645740-bf82-4cc5-8576-f8f500c04dfb,,released,Ifosfamide,1,2020-06-15T12:57:49.021995-05:00,Chemotherapy,,
HCM-BROD-0035-C49,fa30fc7f-90b6-4ca0-93b6-1351eae9dfc8,c1bd4b1f-e245-45bd-8569-9ebb5a5afeab,,,,2023-02-27T13:30:48.835679-06:00,HCM-BROD-0035-C49_treatment12,c1ef79f6-888a-4f37-896f-3f4b1dc32b53,,released,,0,2020-09-30T12:47:19.711789-05:00,"Surgery, NOS",Initial Diagnosis,
HCM-BROD-0035-C49,fa30fc7f-90b6-4ca0-93b6-1351eae9dfc8,c1bd4b1f-e245-45bd-8569-9ebb5a5afeab,,Adjuvant,,2021-07-12T12:25:55.528644-05:00,HCM-BROD-0035-C49_treatment11,cb85b318-0053-41d9-b9c4-f43ced1c47ad,,released,,0,2020-06-15T12:57:49.021995-05:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-BROD-0035-C49,fa30fc7f-90b6-4ca0-93b6-1351eae9dfc8,c1bd4b1f-e245-45bd-8569-9ebb5a5afeab,,Adjuvant,,2021-07-12T12:25:55.528644-05:00,HCM-BROD-0035-C49_treatment13,e8f186fa-e997-4346-a24b-44b01b9313ab,,released,,0,2020-09-30T12:47:19.711789-05:00,Targeted Molecular Therapy,Residual Disease,
HCM-SANG-0309-C15,fa48edba-622f-46e0-ad24-d3da0166abf3,1dbfd825-3343-4337-a69d-39af4aca9a57,,Neoadjuvant,,2023-07-13T10:35:44.371881-05:00,HCM-SANG-0309-C15_treatment,6113bb65-1542-4977-920d-b887a1cf1974,,released,,0,2021-12-21T15:11:00.372640-06:00,,,
HCM-CSHL-0737-C18,fa7bc307-cfc5-4aea-85ce-27a4d73c9766,18f454e3-45d2-4110-93a4-a57c056941bc,548.0,Maintenance Therapy,478.0,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0737-C18_treatment14,02638f5d-8ad4-4e90-97cd-74777880dc5e,Stable Disease,released,,1,2021-12-21T14:21:10.517705-06:00,,,FOLFOX
HCM-CSHL-0737-C18,fa7bc307-cfc5-4aea-85ce-27a4d73c9766,18f454e3-45d2-4110-93a4-a57c056941bc,548.0,Maintenance Therapy,478.0,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0737-C18_treatment11,76333b60-ca4d-493e-b1ca-babc9aa7b745,Stable Disease,released,Leucovorin Calcium,1,2021-12-21T14:21:10.517705-06:00,,,
HCM-CSHL-0737-C18,fa7bc307-cfc5-4aea-85ce-27a4d73c9766,18f454e3-45d2-4110-93a4-a57c056941bc,548.0,Maintenance Therapy,478.0,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0737-C18_treatment13,9f368702-101a-466e-9075-977dee092d0a,Stable Disease,released,Oxaliplatin,1,2021-12-21T14:21:10.517705-06:00,,,
HCM-CSHL-0737-C18,fa7bc307-cfc5-4aea-85ce-27a4d73c9766,18f454e3-45d2-4110-93a4-a57c056941bc,548.0,Maintenance Therapy,478.0,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0737-C18_treatment12,a21d0ea1-e03b-4afa-9f6b-8f0d76dd8a0f,Stable Disease,released,Fluorouracil,1,2021-12-21T14:21:10.517705-06:00,,,
HCM-CSHL-0737-C18,fa7bc307-cfc5-4aea-85ce-27a4d73c9766,9b297dc6-678d-4560-8990-7a6dc2bab480,,Adjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0737-C18_treatment6,399352bb-c7f9-4217-b263-b0777569e932,,released,,0,2021-12-21T14:21:10.517705-06:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-CSHL-0737-C18,fa7bc307-cfc5-4aea-85ce-27a4d73c9766,9b297dc6-678d-4560-8990-7a6dc2bab480,,,9.0,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0737-C18_treatment7,3dde5ee0-f3ae-4f79-a327-f0e2365e7fe8,,released,,1,2021-12-21T14:21:10.517705-06:00,"Surgery, NOS",Initial Diagnosis,
HCM-CSHL-0737-C18,fa7bc307-cfc5-4aea-85ce-27a4d73c9766,9b297dc6-678d-4560-8990-7a6dc2bab480,518.0,Adjuvant,457.0,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0737-C18_treatment4,3df00c57-d796-4dd8-b218-d5becd7959db,,released,Oxaliplatin,1,2021-12-21T14:21:10.517705-06:00,Chemotherapy,Residual Disease,
HCM-CSHL-0737-C18,fa7bc307-cfc5-4aea-85ce-27a4d73c9766,9b297dc6-678d-4560-8990-7a6dc2bab480,,Adjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0737-C18_treatment10,732459bf-da27-48dd-b31c-036b62f43a81,,released,,0,2021-12-21T14:21:10.517705-06:00,"Radiation Therapy, NOS",Residual Disease,
HCM-CSHL-0737-C18,fa7bc307-cfc5-4aea-85ce-27a4d73c9766,9b297dc6-678d-4560-8990-7a6dc2bab480,,,769.0,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0737-C18_treatment8,925aad4f-f2c9-4f73-ae13-5a565aae0eff,,released,,1,2021-12-21T14:21:10.517705-06:00,"Surgery, NOS",Initial Diagnosis,
HCM-CSHL-0737-C18,fa7bc307-cfc5-4aea-85ce-27a4d73c9766,9b297dc6-678d-4560-8990-7a6dc2bab480,518.0,Adjuvant,457.0,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0737-C18_treatment5,a939a2c9-4ef0-41a1-afbc-4a7d0eeed544,,released,,1,2021-12-21T14:21:10.517705-06:00,Chemotherapy,Residual Disease,FOLFOX
HCM-CSHL-0737-C18,fa7bc307-cfc5-4aea-85ce-27a4d73c9766,9b297dc6-678d-4560-8990-7a6dc2bab480,,Adjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0737-C18_treatment9,aced2022-a948-48c5-80df-5d3109a1851a,,released,,0,2021-12-21T14:21:10.517705-06:00,Targeted Molecular Therapy,Residual Disease,
HCM-CSHL-0737-C18,fa7bc307-cfc5-4aea-85ce-27a4d73c9766,9b297dc6-678d-4560-8990-7a6dc2bab480,,Neoadjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0737-C18_treatment,c1ddace3-25b2-47fe-832e-ae3cbcc0cb7f,,released,,0,2021-12-21T14:21:10.517705-06:00,,,
HCM-CSHL-0737-C18,fa7bc307-cfc5-4aea-85ce-27a4d73c9766,9b297dc6-678d-4560-8990-7a6dc2bab480,518.0,Adjuvant,457.0,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0737-C18_treatment3,cf398759-57f4-4df3-9591-27bbec8bc47a,,released,Fluorouracil,1,2021-12-21T14:21:10.517705-06:00,Chemotherapy,Residual Disease,
HCM-CSHL-0737-C18,fa7bc307-cfc5-4aea-85ce-27a4d73c9766,9b297dc6-678d-4560-8990-7a6dc2bab480,518.0,Adjuvant,457.0,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0737-C18_treatment2,cf71ea85-78de-491c-a916-597401c5ccd6,,released,Leucovorin Calcium,1,2021-12-21T14:21:10.517705-06:00,Chemotherapy,Residual Disease,
HCM-BROD-0040-C74,faf9731f-8d64-45d6-8bfc-7d5183243904,4ff1d038-c925-431c-9372-bab866082f37,,Adjuvant,0.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0040-C74_treatment3,149ed310-306a-4133-88bb-b80810c677d9,,released,Vincristine,1,2021-12-21T13:35:53.703486-06:00,Chemotherapy,Residual Disease,
HCM-BROD-0040-C74,faf9731f-8d64-45d6-8bfc-7d5183243904,4ff1d038-c925-431c-9372-bab866082f37,,Adjuvant,31.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0040-C74_treatment4,1b312d1e-11ef-4187-8286-9619fff7fa5e,,released,Etoposide,1,2021-12-21T13:35:53.703486-06:00,Chemotherapy,Residual Disease,
HCM-BROD-0040-C74,faf9731f-8d64-45d6-8bfc-7d5183243904,4ff1d038-c925-431c-9372-bab866082f37,,Adjuvant,31.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0040-C74_treatment5,35937362-09bd-44b8-9c79-0fbb9a1f72f9,,released,Cisplatin,1,2021-12-21T13:35:53.703486-06:00,Chemotherapy,Residual Disease,
HCM-BROD-0040-C74,faf9731f-8d64-45d6-8bfc-7d5183243904,4ff1d038-c925-431c-9372-bab866082f37,,Adjuvant,92.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0040-C74_treatment7,4f20b847-8552-45e2-ab18-e095af9b23da,,released,Dinutuximab,1,2021-12-21T13:35:53.703486-06:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-BROD-0040-C74,faf9731f-8d64-45d6-8bfc-7d5183243904,4ff1d038-c925-431c-9372-bab866082f37,,,,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0040-C74_treatment8,81d656d8-e0e5-45f8-abd2-327507dfe1d7,,released,,unknown,2021-12-21T13:35:53.703486-06:00,"Surgery, NOS",Initial Diagnosis,
HCM-BROD-0040-C74,faf9731f-8d64-45d6-8bfc-7d5183243904,4ff1d038-c925-431c-9372-bab866082f37,,Adjuvant,273.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0040-C74_treatment10,9b08e6c3-bb44-42c4-8a8c-b4cf4a46ab61,,released,,1,2021-12-21T13:35:53.703486-06:00,"Radiation, Proton Beam",Residual Disease,
HCM-BROD-0040-C74,faf9731f-8d64-45d6-8bfc-7d5183243904,4ff1d038-c925-431c-9372-bab866082f37,,Neoadjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0040-C74_treatment,9b7392a9-613d-4d08-b491-c294c9be314a,,released,,0,2021-12-21T13:35:53.703486-06:00,,,
HCM-BROD-0040-C74,faf9731f-8d64-45d6-8bfc-7d5183243904,4ff1d038-c925-431c-9372-bab866082f37,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0040-C74_treatment9,de57c4d0-f80b-4d39-afe1-fb3052442e99,,released,,0,2021-12-21T13:35:53.703486-06:00,Targeted Molecular Therapy,Residual Disease,
HCM-BROD-0040-C74,faf9731f-8d64-45d6-8bfc-7d5183243904,4ff1d038-c925-431c-9372-bab866082f37,,Adjuvant,45.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0040-C74_treatment6,ee442199-fc55-460c-95aa-29f2b60d3110,,released,Doxorubicin Hydrochloride,1,2021-12-21T13:35:53.703486-06:00,Chemotherapy,Residual Disease,
HCM-BROD-0040-C74,faf9731f-8d64-45d6-8bfc-7d5183243904,4ff1d038-c925-431c-9372-bab866082f37,,Adjuvant,0.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0040-C74_treatment2,ef8c86ec-1f68-4a0d-bee6-8ec194b33a88,,released,Cyclophosphamide,1,2021-12-21T13:35:53.703486-06:00,Chemotherapy,Residual Disease,
HCM-BROD-0677-C43,fb3cac25-28e3-4677-868a-0e4ba6703dee,631d2ccb-3581-4fbd-a044-f59d964cfe25,,Adjuvant,,2023-02-22T07:39:25.979291-06:00,HCM-BROD-0677-C43_treatment4,2d59d78d-5a20-4220-ad27-ab18e6e3f6aa,,released,,0,2021-12-03T10:09:41.415545-06:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-BROD-0677-C43,fb3cac25-28e3-4677-868a-0e4ba6703dee,631d2ccb-3581-4fbd-a044-f59d964cfe25,,Neoadjuvant,,2023-02-22T07:39:25.979291-06:00,HCM-BROD-0677-C43_treatment,4b455b40-2e90-49a4-a8db-7a848e10be59,,released,,0,2021-12-03T10:09:41.415545-06:00,,,
HCM-BROD-0677-C43,fb3cac25-28e3-4677-868a-0e4ba6703dee,631d2ccb-3581-4fbd-a044-f59d964cfe25,1464.0,Adjuvant,1464.0,2023-02-22T07:39:25.979291-06:00,HCM-BROD-0677-C43_treatment7,5e647bf7-ddd0-4ba6-a162-1028240ad84a,,released,,1,2021-12-03T10:09:41.415545-06:00,"Radiation Therapy, NOS",Residual Disease,
HCM-BROD-0677-C43,fb3cac25-28e3-4677-868a-0e4ba6703dee,631d2ccb-3581-4fbd-a044-f59d964cfe25,,Adjuvant,,2023-02-22T07:39:25.979291-06:00,HCM-BROD-0677-C43_treatment6,62696c12-03a4-4103-96cd-001b4462c3bd,,released,,0,2021-12-03T10:09:41.415545-06:00,Targeted Molecular Therapy,Residual Disease,
HCM-BROD-0677-C43,fb3cac25-28e3-4677-868a-0e4ba6703dee,631d2ccb-3581-4fbd-a044-f59d964cfe25,,,0.0,2023-02-27T13:04:24.346596-06:00,HCM-BROD-0677-C43_treatment5,62ce96d0-0fe5-41c8-a9ac-85d18566141f,,released,,1,2021-12-03T10:09:41.415545-06:00,"Surgery, NOS",Initial Diagnosis,
HCM-BROD-0677-C43,fb3cac25-28e3-4677-868a-0e4ba6703dee,631d2ccb-3581-4fbd-a044-f59d964cfe25,,Adjuvant,,2023-02-22T07:39:25.979291-06:00,HCM-BROD-0677-C43_treatment3,6e66e386-a5e6-4231-adb8-bb594e2f016b,,released,,0,2021-12-03T10:09:41.415545-06:00,Hormone Therapy,Residual Disease,
HCM-BROD-0677-C43,fb3cac25-28e3-4677-868a-0e4ba6703dee,631d2ccb-3581-4fbd-a044-f59d964cfe25,,Adjuvant,,2023-02-22T07:39:25.979291-06:00,HCM-BROD-0677-C43_treatment2,7a49844a-61ee-4dc1-a24b-a43853dc3d7e,,released,,0,2021-12-03T10:09:41.415545-06:00,Chemotherapy,Residual Disease,
HCM-CSHL-0094-C25,fb50c60e-d191-474b-a5eb-19b922db6688,e7d33624-4934-4338-b98c-7a99c86cc861,,Adjuvant,,2020-10-20T19:20:06.800740-05:00,HCM-CSHL-0094-C25_treatment5,44a451ca-d614-4bb8-b686-0ae244ff2e35,,released,,0,2020-02-27T12:46:31.996700-06:00,Targeted Molecular Therapy,Residual Disease,
HCM-CSHL-0094-C25,fb50c60e-d191-474b-a5eb-19b922db6688,e7d33624-4934-4338-b98c-7a99c86cc861,,,-9.0,2023-02-27T11:58:06.820840-06:00,HCM-CSHL-0094-C25_treatment4,561b2ef1-26ce-4263-baaa-8ab04464022a,,released,,1,2020-02-27T12:46:31.996700-06:00,"Surgery, NOS",Initial Diagnosis,
HCM-CSHL-0094-C25,fb50c60e-d191-474b-a5eb-19b922db6688,e7d33624-4934-4338-b98c-7a99c86cc861,228.0,Adjuvant,18.0,2020-10-20T19:20:06.800740-05:00,HCM-CSHL-0094-C25_treatment2,8bd1ff21-dfb9-4282-bedc-e325e4a5ea87,,released,Gemcitabine,1,2020-02-27T12:46:31.996700-06:00,Chemotherapy,Residual Disease,
HCM-CSHL-0094-C25,fb50c60e-d191-474b-a5eb-19b922db6688,e7d33624-4934-4338-b98c-7a99c86cc861,,Neoadjuvant,,2020-10-20T19:20:06.800740-05:00,HCM-CSHL-0094-C25_treatment,975d366b-df00-4764-92c6-4ec494b5e45e,,released,,0,2020-02-27T12:46:31.996700-06:00,,,
HCM-CSHL-0094-C25,fb50c60e-d191-474b-a5eb-19b922db6688,e7d33624-4934-4338-b98c-7a99c86cc861,,Adjuvant,,2020-10-20T19:20:06.800740-05:00,HCM-CSHL-0094-C25_treatment3,b55f4565-15de-417b-baf6-ff3ee107942a,,released,,0,2020-02-27T12:46:31.996700-06:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-CSHL-0094-C25,fb50c60e-d191-474b-a5eb-19b922db6688,e7d33624-4934-4338-b98c-7a99c86cc861,,Adjuvant,,2020-10-20T19:20:06.800740-05:00,HCM-CSHL-0094-C25_treatment6,f738acaf-26ea-44f8-9761-d9de21944996,,released,,0,2020-02-27T12:46:31.996700-06:00,"Radiation Therapy, NOS",Residual Disease,
HCM-SANG-1336-C15,fb6f7249-7994-4288-8ba8-6b4aeb939f25,eef9acad-b66b-411d-a29a-50ac8ad8c3b6,,Neoadjuvant,105.0,2025-04-07T17:13:09.336794-05:00,HCM-SANG-1336-C15_treatment,19cb0370-0955-42a2-ae85-55a3b3b25bae,,released,Leucovorin,1,2023-02-27T13:15:52.111978-06:00,Chemotherapy,,
HCM-SANG-1336-C15,fb6f7249-7994-4288-8ba8-6b4aeb939f25,eef9acad-b66b-411d-a29a-50ac8ad8c3b6,,Neoadjuvant,105.0,2025-04-07T17:13:09.336794-05:00,HCM-SANG-1336-C15_treatment2,598be0f2-3d57-411e-8f70-221ecfba568e,,released,Fluorouracil,1,2023-02-27T13:15:52.111978-06:00,Chemotherapy,,
HCM-SANG-1336-C15,fb6f7249-7994-4288-8ba8-6b4aeb939f25,eef9acad-b66b-411d-a29a-50ac8ad8c3b6,,Neoadjuvant,105.0,2025-04-07T17:13:09.336794-05:00,HCM-SANG-1336-C15_treatment4,641f10cb-0179-4723-8c90-70a56607fda8,,released,Oxaliplatin,1,2023-02-27T13:15:52.111978-06:00,Chemotherapy,,
HCM-SANG-1336-C15,fb6f7249-7994-4288-8ba8-6b4aeb939f25,eef9acad-b66b-411d-a29a-50ac8ad8c3b6,,Neoadjuvant,105.0,2025-04-07T17:13:09.336794-05:00,HCM-SANG-1336-C15_treatment3,67692449-b5a9-475e-a309-3b9d9dbab06a,,released,Docetaxel,1,2023-02-27T13:15:52.111978-06:00,Chemotherapy,,
HCM-BROD-0579-C16,fc04bbd5-80ec-45a8-9136-6b62f8cca9bf,0c841cd7-ef2a-4770-85cf-9c4a28d23c39,,Neoadjuvant,,2023-07-13T10:35:44.371881-05:00,HCM-BROD-0579-C16_treatment,0e4b3d9b-60df-4f97-8ee8-34e3f1c4373c,,released,,0,2020-10-08T16:18:13.565167-05:00,,,
HCM-BROD-0579-C16,fc04bbd5-80ec-45a8-9136-6b62f8cca9bf,0c841cd7-ef2a-4770-85cf-9c4a28d23c39,,Adjuvant,,2023-07-13T10:35:44.371881-05:00,HCM-BROD-0579-C16_treatment13,19b0533b-ef14-4dcd-833a-394d8b83f842,,released,,0,2020-10-08T16:18:13.565167-05:00,Targeted Molecular Therapy,Residual Disease,
HCM-BROD-0579-C16,fc04bbd5-80ec-45a8-9136-6b62f8cca9bf,0c841cd7-ef2a-4770-85cf-9c4a28d23c39,421.0,Adjuvant,421.0,2023-07-13T10:35:44.371881-05:00,HCM-BROD-0579-C16_treatment9,2950280a-3812-4f7e-a4e8-f084d9500908,,released,,1,2020-10-08T16:18:13.565167-05:00,Chemotherapy,Residual Disease,FOLFIRI
HCM-BROD-0579-C16,fc04bbd5-80ec-45a8-9136-6b62f8cca9bf,0c841cd7-ef2a-4770-85cf-9c4a28d23c39,421.0,Adjuvant,421.0,2023-07-13T10:35:44.371881-05:00,HCM-BROD-0579-C16_treatment8,2a0983ca-92a4-416f-a527-c84ab33f1015,,released,Irinotecan,1,2020-10-08T16:18:13.565167-05:00,Chemotherapy,Residual Disease,
HCM-BROD-0579-C16,fc04bbd5-80ec-45a8-9136-6b62f8cca9bf,0c841cd7-ef2a-4770-85cf-9c4a28d23c39,455.0,Adjuvant,455.0,2023-07-13T10:35:44.371881-05:00,HCM-BROD-0579-C16_treatment10,3f5bfd57-4bac-47c3-b91d-a34bad3bf937,,released,Docetaxel,1,2020-10-08T16:18:13.565167-05:00,Chemotherapy,Residual Disease,
HCM-BROD-0579-C16,fc04bbd5-80ec-45a8-9136-6b62f8cca9bf,0c841cd7-ef2a-4770-85cf-9c4a28d23c39,421.0,Adjuvant,421.0,2023-07-13T10:35:44.371881-05:00,HCM-BROD-0579-C16_treatment6,44404b4e-06e2-45df-b72d-b46cab10a4ee,,released,Leucovorin Calcium,1,2020-10-08T16:18:13.565167-05:00,Chemotherapy,Residual Disease,
HCM-BROD-0579-C16,fc04bbd5-80ec-45a8-9136-6b62f8cca9bf,0c841cd7-ef2a-4770-85cf-9c4a28d23c39,,,0.0,2023-07-13T10:35:44.371881-05:00,HCM-BROD-0579-C16_treatment12,5246fcfa-6ef4-458e-b7c3-e84da93fe3da,,released,,1,2020-10-08T16:18:13.565167-05:00,"Surgery, NOS",Initial Diagnosis,
HCM-BROD-0579-C16,fc04bbd5-80ec-45a8-9136-6b62f8cca9bf,0c841cd7-ef2a-4770-85cf-9c4a28d23c39,406.0,Adjuvant,324.0,2023-07-13T10:35:44.371881-05:00,HCM-BROD-0579-C16_treatment4,6b2085e2-7fc8-473e-b2c2-36420e6701f3,,released,Oxaliplatin,1,2020-10-08T16:18:13.565167-05:00,Chemotherapy,Residual Disease,
HCM-BROD-0579-C16,fc04bbd5-80ec-45a8-9136-6b62f8cca9bf,0c841cd7-ef2a-4770-85cf-9c4a28d23c39,406.0,Adjuvant,324.0,2023-07-13T10:35:44.371881-05:00,HCM-BROD-0579-C16_treatment3,7919fa47-4106-4e39-9ebe-f9d628768c62,,released,Fluorouracil,1,2020-10-08T16:18:13.565167-05:00,Chemotherapy,Residual Disease,
HCM-BROD-0579-C16,fc04bbd5-80ec-45a8-9136-6b62f8cca9bf,0c841cd7-ef2a-4770-85cf-9c4a28d23c39,406.0,Adjuvant,324.0,2023-07-13T10:35:44.371881-05:00,HCM-BROD-0579-C16_treatment5,889fd179-1947-4d00-a59a-226c28138caf,,released,,1,2020-10-08T16:18:13.565167-05:00,Chemotherapy,Residual Disease,FOLFOX
HCM-BROD-0579-C16,fc04bbd5-80ec-45a8-9136-6b62f8cca9bf,0c841cd7-ef2a-4770-85cf-9c4a28d23c39,,Adjuvant,,2023-07-13T10:35:44.371881-05:00,HCM-BROD-0579-C16_treatment14,dc75fd8e-5f82-432e-8cda-f751c4466afc,,released,,unknown,2020-10-08T16:18:13.565167-05:00,"Radiation Therapy, NOS",Residual Disease,
HCM-BROD-0579-C16,fc04bbd5-80ec-45a8-9136-6b62f8cca9bf,0c841cd7-ef2a-4770-85cf-9c4a28d23c39,421.0,Adjuvant,421.0,2023-07-13T10:35:44.371881-05:00,HCM-BROD-0579-C16_treatment7,f08fe438-34bb-41c5-be99-1a10f0171d52,,released,Fluorouracil,1,2020-10-08T16:18:13.565167-05:00,Chemotherapy,Residual Disease,
HCM-BROD-0579-C16,fc04bbd5-80ec-45a8-9136-6b62f8cca9bf,0c841cd7-ef2a-4770-85cf-9c4a28d23c39,,Adjuvant,,2023-07-13T10:35:44.371881-05:00,HCM-BROD-0579-C16_treatment11,f4523b06-d59e-4a79-b092-6448838126c2,,released,,0,2020-10-08T16:18:13.565167-05:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-BROD-0579-C16,fc04bbd5-80ec-45a8-9136-6b62f8cca9bf,0c841cd7-ef2a-4770-85cf-9c4a28d23c39,406.0,Adjuvant,324.0,2023-07-13T10:35:44.371881-05:00,HCM-BROD-0579-C16_treatment2,f604ddd6-1082-4b1f-bb9e-90163cf187f5,,released,Leucovorin Calcium,1,2020-10-08T16:18:13.565167-05:00,Chemotherapy,Residual Disease,
HCM-BROD-0579-C16,fc04bbd5-80ec-45a8-9136-6b62f8cca9bf,4af9bf9e-37d6-435c-9ded-da73584b7c68,421.0,Maintenance Therapy,23.0,2023-07-13T10:35:44.371881-05:00,HCM-BROD-0579-C16_treatment18,34a2e9e7-eb8b-4403-bc9f-2f41b9e51346,Not Reported,released,Leucovorin,1,2020-10-08T16:18:13.565167-05:00,,,
HCM-BROD-0579-C16,fc04bbd5-80ec-45a8-9136-6b62f8cca9bf,4af9bf9e-37d6-435c-9ded-da73584b7c68,421.0,Maintenance Therapy,23.0,2023-07-13T10:35:44.371881-05:00,HCM-BROD-0579-C16_treatment16,445b8544-6d7f-49ce-a7d5-d3002f12d5c3,Not Reported,released,Fluorouracil,1,2020-10-08T16:18:13.565167-05:00,,,
HCM-BROD-0579-C16,fc04bbd5-80ec-45a8-9136-6b62f8cca9bf,4af9bf9e-37d6-435c-9ded-da73584b7c68,421.0,Maintenance Therapy,23.0,2023-07-13T10:35:44.371881-05:00,HCM-BROD-0579-C16_treatment17,4b5083fc-2b7f-4285-a083-8b595537c2e4,Not Reported,released,Oxaliplatin,1,2020-10-08T16:18:13.565167-05:00,,,
HCM-BROD-0579-C16,fc04bbd5-80ec-45a8-9136-6b62f8cca9bf,4af9bf9e-37d6-435c-9ded-da73584b7c68,421.0,Maintenance Therapy,23.0,2023-07-13T10:35:44.371881-05:00,HCM-BROD-0579-C16_treatment19,627396e5-5900-4ca1-a586-64557b828a00,Not Reported,released,,1,2020-10-08T16:18:13.565167-05:00,,,FLOT
HCM-BROD-0579-C16,fc04bbd5-80ec-45a8-9136-6b62f8cca9bf,4af9bf9e-37d6-435c-9ded-da73584b7c68,421.0,Maintenance Therapy,23.0,2023-07-13T10:35:44.371881-05:00,HCM-BROD-0579-C16_treatment15,b75ffefd-6409-4401-9665-6f267056fceb,Not Reported,released,Docetaxel,1,2020-10-08T16:18:13.565167-05:00,,,
HCM-BROD-0579-C16,fc04bbd5-80ec-45a8-9136-6b62f8cca9bf,4af9bf9e-37d6-435c-9ded-da73584b7c68,421.0,Maintenance Therapy,23.0,2023-07-13T10:35:44.371881-05:00,HCM-BROD-0579-C16_treatment20,cb5be656-9377-4510-9381-426d62ce8bee,Not Reported,released,,1,2020-10-08T16:18:13.565167-05:00,,,FOLFOX
HCM-CSHL-0600-C25,fc122a76-4ca2-4f09-94bb-7d0f024a4dad,766972d1-2b67-4184-88a9-4ec0a69d5007,,Adjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0600-C25_treatment6,1f2e3fa0-c429-4a87-8f32-f8327d150275,,released,,0,2021-12-21T14:09:15.630770-06:00,Targeted Molecular Therapy,Residual Disease,
HCM-CSHL-0600-C25,fc122a76-4ca2-4f09-94bb-7d0f024a4dad,766972d1-2b67-4184-88a9-4ec0a69d5007,468.0,Adjuvant,279.0,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0600-C25_treatment3,38d84832-8884-4208-a519-8b023e6d5ecf,,released,Nab-paclitaxel,1,2021-12-21T14:09:15.630770-06:00,Chemotherapy,Residual Disease,
HCM-CSHL-0600-C25,fc122a76-4ca2-4f09-94bb-7d0f024a4dad,766972d1-2b67-4184-88a9-4ec0a69d5007,,Adjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0600-C25_treatment7,751abc3a-ebbf-4797-8627-88b027a82202,,released,,1,2021-12-21T14:09:15.630770-06:00,"Radiation, 2D Conventional",Residual Disease,
HCM-CSHL-0600-C25,fc122a76-4ca2-4f09-94bb-7d0f024a4dad,766972d1-2b67-4184-88a9-4ec0a69d5007,468.0,Adjuvant,279.0,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0600-C25_treatment2,b7cb8296-cc58-4a09-be61-e623182ce308,,released,Gemcitabine,1,2021-12-21T14:09:15.630770-06:00,Chemotherapy,Residual Disease,
HCM-CSHL-0600-C25,fc122a76-4ca2-4f09-94bb-7d0f024a4dad,766972d1-2b67-4184-88a9-4ec0a69d5007,,Adjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0600-C25_treatment4,c617734b-002e-4ac7-a826-88b01303cd2a,,released,,0,2021-12-21T14:09:15.630770-06:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-CSHL-0600-C25,fc122a76-4ca2-4f09-94bb-7d0f024a4dad,766972d1-2b67-4184-88a9-4ec0a69d5007,,,-10.0,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0600-C25_treatment5,e5471702-4277-4c34-b7d8-d4acb738df28,,released,,1,2021-12-21T14:09:15.630770-06:00,"Surgery, NOS",Initial Diagnosis,
HCM-CSHL-0600-C25,fc122a76-4ca2-4f09-94bb-7d0f024a4dad,766972d1-2b67-4184-88a9-4ec0a69d5007,,Neoadjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0600-C25_treatment,f08a9291-6908-49b3-b26e-6c22c297df26,,released,,0,2021-12-21T14:09:15.630770-06:00,,,
HCM-CSHL-0464-C50,fc25bee8-d37a-4bda-9ff3-51fe590e91e8,54b21333-29e2-46bc-9fcc-97a178cf25b0,,,39.0,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0464-C50_treatment2,4fac5a1b-2e12-406e-9ce6-0711fabbb423,,released,,1,2020-09-28T10:18:45.513767-05:00,"Surgery, NOS",Initial Diagnosis,
HCM-CSHL-0464-C50,fc25bee8-d37a-4bda-9ff3-51fe590e91e8,54b21333-29e2-46bc-9fcc-97a178cf25b0,,Adjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0464-C50_treatment4,9904979a-96e1-4a88-b4ae-149cc19f6a46,,released,,0,2020-09-28T10:18:45.513767-05:00,"Radiation Therapy, NOS",Residual Disease,
HCM-CSHL-0464-C50,fc25bee8-d37a-4bda-9ff3-51fe590e91e8,54b21333-29e2-46bc-9fcc-97a178cf25b0,,Adjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0464-C50_treatment3,b06b517d-69e8-4dd9-a5cd-3cf690a5803d,,released,,0,2020-09-28T10:18:45.513767-05:00,"Pharmaceutical Therapy, NOS",Residual Disease,
HCM-CSHL-0464-C50,fc25bee8-d37a-4bda-9ff3-51fe590e91e8,54b21333-29e2-46bc-9fcc-97a178cf25b0,,Neoadjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0464-C50_treatment,db7f56c0-3e11-42d1-8332-02a9f57cb4c7,,released,,0,2020-09-28T10:18:45.513767-05:00,,,
HCM-BROD-0125-C25,fd64b6a9-39e8-4e27-bb73-84110ab0d328,9289315f-f9b8-453f-88a2-63426542aff6,,Neoadjuvant,,2023-02-22T07:39:25.979291-06:00,HCM-BROD-0125-C25_treatment,0e747ee2-cd59-46c1-91e6-cbb47aa8f8b8,,released,,0,2020-09-17T15:57:51.457053-05:00,,,
HCM-BROD-0125-C25,fd64b6a9-39e8-4e27-bb73-84110ab0d328,9289315f-f9b8-453f-88a2-63426542aff6,,Adjuvant,,2023-02-22T07:39:25.979291-06:00,HCM-BROD-0125-C25_treatment8,28b39912-69ab-4fe7-af0b-24ef26a45be7,,released,,0,2020-09-17T15:57:51.457053-05:00,"Radiation Therapy, NOS",Residual Disease,
HCM-BROD-0125-C25,fd64b6a9-39e8-4e27-bb73-84110ab0d328,9289315f-f9b8-453f-88a2-63426542aff6,,Adjuvant,,2023-02-22T07:39:25.979291-06:00,HCM-BROD-0125-C25_treatment7,35e72079-0627-4e8a-98f9-08640e305856,,released,,0,2020-09-17T15:57:51.457053-05:00,Targeted Molecular Therapy,Residual Disease,
HCM-BROD-0125-C25,fd64b6a9-39e8-4e27-bb73-84110ab0d328,9289315f-f9b8-453f-88a2-63426542aff6,,,33.0,2023-02-27T13:32:29.064099-06:00,HCM-BROD-0125-C25_treatment6,3ca54b29-7334-47af-b955-4903020282f6,,released,,1,2020-09-17T15:57:51.457053-05:00,"Surgery, NOS",Initial Diagnosis,
HCM-BROD-0125-C25,fd64b6a9-39e8-4e27-bb73-84110ab0d328,9289315f-f9b8-453f-88a2-63426542aff6,91.0,Adjuvant,70.0,2023-02-22T07:39:25.979291-06:00,HCM-BROD-0125-C25_treatment2,54f89587-e856-44e5-8a6e-2dd681b9f977,,released,Gemcitabine,1,2020-09-17T15:57:51.457053-05:00,Chemotherapy,Residual Disease,
HCM-BROD-0125-C25,fd64b6a9-39e8-4e27-bb73-84110ab0d328,9289315f-f9b8-453f-88a2-63426542aff6,,Adjuvant,,2023-02-22T07:39:25.979291-06:00,HCM-BROD-0125-C25_treatment5,5d167672-cab6-4a58-873c-695e2723e007,,released,,0,2020-09-17T15:57:51.457053-05:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-BROD-0125-C25,fd64b6a9-39e8-4e27-bb73-84110ab0d328,9289315f-f9b8-453f-88a2-63426542aff6,260.0,Adjuvant,140.0,2023-02-22T07:39:25.979291-06:00,HCM-BROD-0125-C25_treatment4,d94ee6cb-8bf3-4ef0-adaa-db7b77e99f0c,,released,Leucovorin,1,2020-09-17T15:57:51.457053-05:00,Chemotherapy,Residual Disease,
HCM-BROD-0125-C25,fd64b6a9-39e8-4e27-bb73-84110ab0d328,9289315f-f9b8-453f-88a2-63426542aff6,260.0,Adjuvant,140.0,2023-02-22T07:39:25.979291-06:00,HCM-BROD-0125-C25_treatment3,f96241a3-a1c6-4448-bd7b-839ecdd919b8,,released,Fluorouracil,1,2020-09-17T15:57:51.457053-05:00,Chemotherapy,Residual Disease,
HCM-BROD-0477-C16,fda02a1d-38f1-4e71-91f9-c58f174605d6,3245d5af-d693-489f-a18f-6f56837c4803,397.0,Adjuvant,214.0,2023-07-13T10:35:44.371881-05:00,HCM-BROD-0477-C16_treatment6,17807a63-e9c8-4b22-a8e5-1082c902fd29,,released,Leucovorin Calcium,1,2021-12-21T13:38:03.263117-06:00,Chemotherapy,Residual Disease,
HCM-BROD-0477-C16,fda02a1d-38f1-4e71-91f9-c58f174605d6,3245d5af-d693-489f-a18f-6f56837c4803,,Neoadjuvant,24.0,2023-07-13T10:35:44.371881-05:00,HCM-BROD-0477-C16_treatment4,1ac1974f-87fa-4c41-b321-b7eade1f08bb,,released,,1,2021-12-21T13:38:03.263117-06:00,Chemotherapy,,FOLFOX
HCM-BROD-0477-C16,fda02a1d-38f1-4e71-91f9-c58f174605d6,3245d5af-d693-489f-a18f-6f56837c4803,,Neoadjuvant,24.0,2023-07-13T10:35:44.371881-05:00,HCM-BROD-0477-C16_treatment3,31cbf734-6e42-48b0-a46f-683b54bf816e,,released,Oxaliplatin,1,2021-12-21T13:38:03.263117-06:00,Chemotherapy,,
HCM-BROD-0477-C16,fda02a1d-38f1-4e71-91f9-c58f174605d6,3245d5af-d693-489f-a18f-6f56837c4803,,,3.0,2023-07-13T10:35:44.371881-05:00,HCM-BROD-0477-C16_treatment11,4414acea-8b3b-4257-a2f3-048de5e88c0a,,released,,1,2021-12-21T13:38:03.263117-06:00,"Surgery, NOS",Initial Diagnosis,
HCM-BROD-0477-C16,fda02a1d-38f1-4e71-91f9-c58f174605d6,3245d5af-d693-489f-a18f-6f56837c4803,,Adjuvant,,2023-07-13T10:35:44.371881-05:00,HCM-BROD-0477-C16_treatment10,5cbbbaee-bf67-4406-828b-241b334dec3b,,released,,0,2021-12-21T13:38:03.263117-06:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-BROD-0477-C16,fda02a1d-38f1-4e71-91f9-c58f174605d6,3245d5af-d693-489f-a18f-6f56837c4803,,Neoadjuvant,24.0,2023-07-13T10:35:44.371881-05:00,HCM-BROD-0477-C16_treatment,65206fff-adc2-458d-8093-f60295227f4d,,released,Leucovorin Calcium,1,2021-12-21T13:38:03.263117-06:00,Chemotherapy,,
HCM-BROD-0477-C16,fda02a1d-38f1-4e71-91f9-c58f174605d6,3245d5af-d693-489f-a18f-6f56837c4803,397.0,Adjuvant,214.0,2023-07-13T10:35:44.371881-05:00,HCM-BROD-0477-C16_treatment12,8d3e3e1a-1ddc-4c15-a90a-aa7f4f4ee7e3,,released,Ramucirumab,1,2021-12-21T13:38:03.263117-06:00,Targeted Molecular Therapy,Residual Disease,
HCM-BROD-0477-C16,fda02a1d-38f1-4e71-91f9-c58f174605d6,3245d5af-d693-489f-a18f-6f56837c4803,,Neoadjuvant,24.0,2023-07-13T10:35:44.371881-05:00,HCM-BROD-0477-C16_treatment5,90b9c789-3c5d-45b8-aee2-154db8f0da25,,released,Ramucirumab,1,2021-12-21T13:38:03.263117-06:00,Targeted Molecular Therapy,,
HCM-BROD-0477-C16,fda02a1d-38f1-4e71-91f9-c58f174605d6,3245d5af-d693-489f-a18f-6f56837c4803,397.0,Adjuvant,214.0,2023-07-13T10:35:44.371881-05:00,HCM-BROD-0477-C16_treatment9,a52736b4-e335-449a-a9bf-3821fa14c2c7,,released,,1,2021-12-21T13:38:03.263117-06:00,Chemotherapy,Residual Disease,FOLFOX
HCM-BROD-0477-C16,fda02a1d-38f1-4e71-91f9-c58f174605d6,3245d5af-d693-489f-a18f-6f56837c4803,397.0,Adjuvant,214.0,2023-07-13T10:35:44.371881-05:00,HCM-BROD-0477-C16_treatment7,ac0f5f8d-4d7d-4428-833a-460c164b161c,,released,Fluorouracil,1,2021-12-21T13:38:03.263117-06:00,Chemotherapy,Residual Disease,
HCM-BROD-0477-C16,fda02a1d-38f1-4e71-91f9-c58f174605d6,3245d5af-d693-489f-a18f-6f56837c4803,,Neoadjuvant,24.0,2023-07-13T10:35:44.371881-05:00,HCM-BROD-0477-C16_treatment2,afdd2595-a67b-4bb0-a30a-aba51aa73685,,released,Fluorouracil,1,2021-12-21T13:38:03.263117-06:00,Chemotherapy,,
HCM-BROD-0477-C16,fda02a1d-38f1-4e71-91f9-c58f174605d6,3245d5af-d693-489f-a18f-6f56837c4803,,Adjuvant,,2023-07-13T10:35:44.371881-05:00,HCM-BROD-0477-C16_treatment13,d819458f-b41f-41fd-8411-23f606436834,,released,,0,2021-12-21T13:38:03.263117-06:00,"Radiation Therapy, NOS",Residual Disease,
HCM-BROD-0477-C16,fda02a1d-38f1-4e71-91f9-c58f174605d6,3245d5af-d693-489f-a18f-6f56837c4803,397.0,Adjuvant,214.0,2023-07-13T10:35:44.371881-05:00,HCM-BROD-0477-C16_treatment8,f3aa5715-9306-467c-b403-4ee42aaac110,,released,Oxaliplatin,1,2021-12-21T13:38:03.263117-06:00,Chemotherapy,Residual Disease,
HCM-SANG-0278-C20,fdc29b73-d788-40f4-8f8d-cef36d100e58,1e224300-d429-4aec-a081-d0080afd075a,,Neoadjuvant,,2023-02-22T07:39:25.979291-06:00,HCM-SANG-0278-C20_treatment,93f1bf2b-4b08-4abb-9c26-8b927b341773,,released,,0,2021-12-21T15:07:09.576986-06:00,,,
HCM-CSHL-0142-C18,fdfd5770-4b64-4d35-b472-9c7908210b22,bd07ba42-e6d2-483b-bc06-d80c53dc7558,,Neoadjuvant,,2020-10-20T19:20:06.800740-05:00,HCM-CSHL-0142-C18_treatment,16140273-7104-47b2-ad94-02d3ae67776c,,released,,0,2020-02-27T12:57:31.266812-06:00,,,
HCM-CSHL-0142-C18,fdfd5770-4b64-4d35-b472-9c7908210b22,bd07ba42-e6d2-483b-bc06-d80c53dc7558,,Adjuvant,,2020-10-20T19:20:06.800740-05:00,HCM-CSHL-0142-C18_treatment6,1cc3b7cf-4661-482f-bb8a-024620126c35,,released,,0,2020-02-27T12:57:31.266812-06:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-CSHL-0142-C18,fdfd5770-4b64-4d35-b472-9c7908210b22,bd07ba42-e6d2-483b-bc06-d80c53dc7558,,,26.0,2023-03-13T13:24:58.015382-05:00,HCM-CSHL-0142-C18_treatment7,52f0cb96-b17d-448e-8667-458e1e588a95,,released,,1,2020-09-27T12:53:56.492882-05:00,"Surgery, NOS",Initial Diagnosis,
HCM-CSHL-0142-C18,fdfd5770-4b64-4d35-b472-9c7908210b22,bd07ba42-e6d2-483b-bc06-d80c53dc7558,250.0,Adjuvant,69.0,2020-10-20T19:20:06.800740-05:00,HCM-CSHL-0142-C18_treatment5,6a48832f-d7f8-4434-bedc-64323513414d,,released,,1,2020-02-27T12:57:31.266812-06:00,Chemotherapy,Residual Disease,FOLFOX
HCM-CSHL-0142-C18,fdfd5770-4b64-4d35-b472-9c7908210b22,bd07ba42-e6d2-483b-bc06-d80c53dc7558,250.0,Adjuvant,69.0,2020-10-20T19:20:06.800740-05:00,HCM-CSHL-0142-C18_treatment2,793e5b5e-cb2d-498b-9d66-8aba6710c7f8,,released,Leucovorin Calcium,1,2020-02-27T12:57:31.266812-06:00,Chemotherapy,Residual Disease,
HCM-CSHL-0142-C18,fdfd5770-4b64-4d35-b472-9c7908210b22,bd07ba42-e6d2-483b-bc06-d80c53dc7558,,Adjuvant,,2020-10-20T19:20:06.800740-05:00,HCM-CSHL-0142-C18_treatment9,aaed4e7a-8cc4-42ed-8cec-7b0157b3baa4,,released,,0,2020-09-27T12:53:56.492882-05:00,"Radiation Therapy, NOS",Residual Disease,
HCM-CSHL-0142-C18,fdfd5770-4b64-4d35-b472-9c7908210b22,bd07ba42-e6d2-483b-bc06-d80c53dc7558,250.0,Adjuvant,69.0,2020-10-20T19:20:06.800740-05:00,HCM-CSHL-0142-C18_treatment3,c06a2669-195a-48f1-8532-a5532cb5922b,,released,Fluorouracil,1,2020-02-27T12:57:31.266812-06:00,Chemotherapy,Residual Disease,
HCM-CSHL-0142-C18,fdfd5770-4b64-4d35-b472-9c7908210b22,bd07ba42-e6d2-483b-bc06-d80c53dc7558,250.0,Adjuvant,69.0,2020-10-20T19:20:06.800740-05:00,HCM-CSHL-0142-C18_treatment4,c9e1b17b-8e52-4fce-8c7b-60d6f85d250e,,released,Oxaliplatin,1,2020-02-27T12:57:31.266812-06:00,Chemotherapy,Residual Disease,
HCM-CSHL-0142-C18,fdfd5770-4b64-4d35-b472-9c7908210b22,bd07ba42-e6d2-483b-bc06-d80c53dc7558,,Adjuvant,,2020-10-20T19:20:06.800740-05:00,HCM-CSHL-0142-C18_treatment8,dbd9c2fe-5d32-47ed-a48c-4357c8420a03,,released,,0,2020-09-27T12:53:56.492882-05:00,Targeted Molecular Therapy,Residual Disease,
HCM-BROD-0115-C16,feaef50b-0e38-4a04-b632-81ae538e1c22,3fd96149-405a-4fb0-8fd7-c9d93cea8ce3,1591.0,Adjuvant,106.0,2023-02-22T07:39:25.979291-06:00,HCM-BROD-0115-C16_treatment8,0c741c56-06a5-4881-8d94-ae0db603e8d2,,released,,1,2020-11-11T10:12:11.090639-06:00,"Radiation, 2D Conventional",Residual Disease,
HCM-BROD-0115-C16,feaef50b-0e38-4a04-b632-81ae538e1c22,3fd96149-405a-4fb0-8fd7-c9d93cea8ce3,1634.0,Adjuvant,1333.0,2023-02-22T07:39:25.979291-06:00,HCM-BROD-0115-C16_treatment5,1b49f943-f970-4163-8809-7eac20282f00,Treatment Ongoing,released,Pembrolizumab,1,2020-11-11T10:12:11.090639-06:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-BROD-0115-C16,feaef50b-0e38-4a04-b632-81ae538e1c22,3fd96149-405a-4fb0-8fd7-c9d93cea8ce3,,Neoadjuvant,,2023-02-22T07:39:25.979291-06:00,HCM-BROD-0115-C16_treatment2,24567d5b-002e-4e40-a2d5-5b30eac4a2e7,,released,,unknown,2019-04-04T15:40:47.201847-05:00,"Radiation Therapy, NOS",,
HCM-BROD-0115-C16,feaef50b-0e38-4a04-b632-81ae538e1c22,3fd96149-405a-4fb0-8fd7-c9d93cea8ce3,,,106.0,2023-03-13T13:18:01.500932-05:00,HCM-BROD-0115-C16_treatment6,2c4c33cb-2243-4ffe-9867-6b78bdf74c12,,released,,1,2020-11-11T10:12:11.090639-06:00,"Surgery, NOS",Initial Diagnosis,
HCM-BROD-0115-C16,feaef50b-0e38-4a04-b632-81ae538e1c22,3fd96149-405a-4fb0-8fd7-c9d93cea8ce3,1059.0,Adjuvant,528.0,2023-02-22T07:39:25.979291-06:00,HCM-BROD-0115-C16_treatment4,3cd0bf2b-1000-402d-b34f-43e866627024,,released,Leucovorin,1,2020-11-11T10:12:11.090639-06:00,Chemotherapy,Residual Disease,
HCM-BROD-0115-C16,feaef50b-0e38-4a04-b632-81ae538e1c22,3fd96149-405a-4fb0-8fd7-c9d93cea8ce3,1059.0,Adjuvant,528.0,2023-02-22T07:39:25.979291-06:00,HCM-BROD-0115-C16_treatment3,6e96521b-8dc9-47e7-a85a-2c3f38a19b2a,,released,Fluorouracil,1,2020-11-11T10:12:11.090639-06:00,Chemotherapy,Residual Disease,
HCM-BROD-0115-C16,feaef50b-0e38-4a04-b632-81ae538e1c22,3fd96149-405a-4fb0-8fd7-c9d93cea8ce3,1059.0,Adjuvant,528.0,2023-02-22T07:39:25.979291-06:00,HCM-BROD-0115-C16_treatment7,de56f784-88ce-4227-ad73-d5534ab44a5f,,released,Trastuzumab,1,2020-11-11T10:12:11.090639-06:00,Targeted Molecular Therapy,Residual Disease,
HCM-BROD-0115-C16,feaef50b-0e38-4a04-b632-81ae538e1c22,3fd96149-405a-4fb0-8fd7-c9d93cea8ce3,,Neoadjuvant,,2023-02-22T07:39:25.979291-06:00,HCM-BROD-0115-C16_treatment,f521c756-ceba-417f-b684-f54c27be8662,,released,,unknown,2019-04-04T15:40:47.201847-05:00,"Pharmaceutical Therapy, NOS",,
HCM-BROD-0115-C16,feaef50b-0e38-4a04-b632-81ae538e1c22,dba301be-3141-4f4c-a39d-08946bca5dae,1046.0,Maintenance Therapy,486.0,2023-02-22T07:39:25.979291-06:00,HCM-BROD-0115-C16_treatment11,14bb9e3d-70ea-46d4-bc19-1cf30e77c6d6,Progressive Disease,released,Trastuzumab,1,2020-11-11T10:12:11.090639-06:00,,,
HCM-BROD-0115-C16,feaef50b-0e38-4a04-b632-81ae538e1c22,dba301be-3141-4f4c-a39d-08946bca5dae,1046.0,Maintenance Therapy,486.0,2023-02-22T07:39:25.979291-06:00,HCM-BROD-0115-C16_treatment10,167d33af-cdc7-4c0b-9af4-56aa149732da,Progressive Disease,released,Fluorouracil,1,2020-11-11T10:12:11.090639-06:00,,,
HCM-BROD-0115-C16,feaef50b-0e38-4a04-b632-81ae538e1c22,dba301be-3141-4f4c-a39d-08946bca5dae,1046.0,Maintenance Therapy,486.0,2023-02-22T07:39:25.979291-06:00,HCM-BROD-0115-C16_treatment9,188aed77-ee20-4aeb-acae-9f1d824c2c96,Progressive Disease,released,Leucovorin,1,2020-11-11T10:12:11.090639-06:00,,,
HCM-CSHL-0059-C25,fed59220-5e35-439c-ae0b-3dcb1fad165e,a5952feb-b389-44a9-89d3-03c044aed1b9,,Adjuvant,,2023-02-22T07:39:25.979291-06:00,HCM-CSHL-0059-C25_treatment5,2321687b-4130-45ff-b11a-79b705ce1902,,released,,0,2020-09-27T12:32:51.374783-05:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-CSHL-0059-C25,fed59220-5e35-439c-ae0b-3dcb1fad165e,a5952feb-b389-44a9-89d3-03c044aed1b9,,Neoadjuvant,,2023-02-22T07:39:25.979291-06:00,HCM-CSHL-0059-C25_treatment,44fd015a-ce36-4339-9ab4-dfb7b5bf1ba7,,released,,0,2020-09-27T12:32:51.374783-05:00,,,
HCM-CSHL-0059-C25,fed59220-5e35-439c-ae0b-3dcb1fad165e,a5952feb-b389-44a9-89d3-03c044aed1b9,830.0,Adjuvant,753.0,2023-02-22T07:39:25.979291-06:00,HCM-CSHL-0059-C25_treatment4,8b70d680-4f3a-48aa-a481-4ffacd00add1,,released,Nab-paclitaxel,1,2020-09-27T12:32:51.374783-05:00,Chemotherapy,Residual Disease,
HCM-CSHL-0059-C25,fed59220-5e35-439c-ae0b-3dcb1fad165e,a5952feb-b389-44a9-89d3-03c044aed1b9,318.0,Adjuvant,136.0,2023-02-22T07:39:25.979291-06:00,HCM-CSHL-0059-C25_treatment2,a356ad77-fe90-4979-bc10-5686c55182c3,,released,Gemcitabine,1,2020-09-27T12:32:51.374783-05:00,Chemotherapy,Residual Disease,
HCM-CSHL-0059-C25,fed59220-5e35-439c-ae0b-3dcb1fad165e,a5952feb-b389-44a9-89d3-03c044aed1b9,,Adjuvant,,2023-02-22T07:39:25.979291-06:00,HCM-CSHL-0059-C25_treatment7,d514deb3-d70a-4d10-93de-d2b5fc391937,,released,,0,2020-09-27T12:32:51.374783-05:00,Targeted Molecular Therapy,Residual Disease,
HCM-CSHL-0059-C25,fed59220-5e35-439c-ae0b-3dcb1fad165e,a5952feb-b389-44a9-89d3-03c044aed1b9,,Adjuvant,,2023-02-22T07:39:25.979291-06:00,HCM-CSHL-0059-C25_treatment8,e10a6f6b-e444-4484-8f2f-a72934ea2022,,released,,0,2020-09-27T12:32:51.374783-05:00,"Radiation Therapy, NOS",Residual Disease,
HCM-CSHL-0059-C25,fed59220-5e35-439c-ae0b-3dcb1fad165e,a5952feb-b389-44a9-89d3-03c044aed1b9,,,36.0,2023-02-27T13:10:45.839462-06:00,HCM-CSHL-0059-C25_treatment6,e546a703-eb58-42e5-8914-e57ca52679cc,,released,,1,2020-09-27T12:32:51.374783-05:00,"Surgery, NOS",Initial Diagnosis,
HCM-CSHL-0059-C25,fed59220-5e35-439c-ae0b-3dcb1fad165e,a5952feb-b389-44a9-89d3-03c044aed1b9,830.0,Adjuvant,753.0,2023-02-22T07:39:25.979291-06:00,HCM-CSHL-0059-C25_treatment3,f70496b8-2b2e-4298-9bfd-7ae4d24a1360,,released,Gemcitabine,1,2020-09-27T12:32:51.374783-05:00,Chemotherapy,Residual Disease,
HCM-BROD-0924-C34,00432ef4-23b6-49ff-8393-b030cfa9a65d,b3209234-7b59-47c2-a899-539e38c41dba,97.0,Maintenance Therapy,55.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0924-C34_treatment7,4a6a0973-10a7-49b6-9382-c882df01b286,Stable Disease,released,Etoposide,1,2021-12-21T13:56:55.642419-06:00,,,
HCM-BROD-0924-C34,00432ef4-23b6-49ff-8393-b030cfa9a65d,b3209234-7b59-47c2-a899-539e38c41dba,97.0,Maintenance Therapy,55.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0924-C34_treatment8,7297b9e9-2253-4de7-a5f2-cd21ee7f4e65,Stable Disease,released,Cisplatin,1,2021-12-21T13:56:55.642419-06:00,,,
HCM-BROD-0924-C34,00432ef4-23b6-49ff-8393-b030cfa9a65d,cf208fb3-ffa0-429b-8a93-2ef9d916bd9b,,,8.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0924-C34_treatment4,62382ff9-f35f-4a3b-af52-25446b9457b9,,released,,1,2021-12-21T13:56:55.642419-06:00,"Surgery, NOS",Initial Diagnosis,
HCM-BROD-0924-C34,00432ef4-23b6-49ff-8393-b030cfa9a65d,cf208fb3-ffa0-429b-8a93-2ef9d916bd9b,713.0,Adjuvant,708.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0924-C34_treatment6,739fd036-1680-40fa-85e3-f72cb18cc0d5,,released,,1,2021-12-21T13:56:55.642419-06:00,"Radiation Therapy, NOS",Residual Disease,
HCM-BROD-0924-C34,00432ef4-23b6-49ff-8393-b030cfa9a65d,cf208fb3-ffa0-429b-8a93-2ef9d916bd9b,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0924-C34_treatment5,76035c39-3a84-4a88-a15b-524381c07463,,released,,0,2021-12-21T13:56:55.642419-06:00,Targeted Molecular Therapy,Residual Disease,
HCM-BROD-0924-C34,00432ef4-23b6-49ff-8393-b030cfa9a65d,cf208fb3-ffa0-429b-8a93-2ef9d916bd9b,896.0,Adjuvant,882.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0924-C34_treatment3,91b0a02d-8ecc-477f-bc3b-e7d4fe7754c7,Treatment Ongoing,released,Nivolumab,1,2021-12-21T13:56:55.642419-06:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-BROD-0924-C34,00432ef4-23b6-49ff-8393-b030cfa9a65d,cf208fb3-ffa0-429b-8a93-2ef9d916bd9b,795.0,Adjuvant,788.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0924-C34_treatment2,d4dde050-7082-4d7d-8d36-27905f87585d,,released,Irinotecan,1,2021-12-21T13:56:55.642419-06:00,Chemotherapy,Residual Disease,
HCM-BROD-0924-C34,00432ef4-23b6-49ff-8393-b030cfa9a65d,cf208fb3-ffa0-429b-8a93-2ef9d916bd9b,,Neoadjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0924-C34_treatment,f097088b-9b45-46d3-bade-862cf6166f8b,,released,,0,2021-12-21T13:56:55.642419-06:00,,,
HCM-EXPT-1207-C19,00adbff7-f496-48fe-b859-819bdf673a30,4d8bd492-6eb7-42c0-9155-b9acba63838e,,Neoadjuvant,,2025-10-08T12:38:51.189053-05:00,HCM-EXPT-1207-C19_treatment3,b554ce87-3a59-4ba3-9f00-e70846a968bf,,released,,1,2023-02-24T14:12:14.156563-06:00,"Radiation Therapy, NOS",,
HCM-EXPT-1207-C19,00adbff7-f496-48fe-b859-819bdf673a30,4d8bd492-6eb7-42c0-9155-b9acba63838e,,Neoadjuvant,,2025-10-08T12:38:51.189053-05:00,HCM-EXPT-1207-C19_treatment,ea0828d7-96b5-47a9-b0d8-af0e311da605,,released,Capecitabine,1,2023-02-24T14:12:14.156563-06:00,Chemotherapy,,
HCM-EXPT-1207-C19,00adbff7-f496-48fe-b859-819bdf673a30,4d8bd492-6eb7-42c0-9155-b9acba63838e,,Neoadjuvant,,2025-10-08T12:38:51.189053-05:00,HCM-EXPT-1207-C19_treatment2,f3c0e096-c71a-42dc-af6b-7dd63b441a64,,released,Oxaliplatin,1,2023-02-24T14:12:14.156563-06:00,Chemotherapy,,
HCM-SANG-0522-C18,00d751af-4f77-488b-aa56-b67d38091c86,d668655f-d979-402f-9baf-375831055e74,,Neoadjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-SANG-0522-C18_treatment,dc09ffc6-0618-456e-a827-45d008a840bf,,released,,0,2021-12-21T15:13:14.297353-06:00,,,
HCM-CSHL-0161-C18,00dc3ba8-5a10-4120-bdad-c1c17b4b1ae7,c9c9c9ae-8c87-44c0-b23b-b36fc07f7953,,Adjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0161-C18_treatment5,0d2665a5-2243-4bde-a9be-415e3a75908c,,released,,0,2020-09-27T13:02:25.775217-05:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-CSHL-0161-C18,00dc3ba8-5a10-4120-bdad-c1c17b4b1ae7,c9c9c9ae-8c87-44c0-b23b-b36fc07f7953,143.0,Adjuvant,51.0,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0161-C18_treatment4,15f0ebda-ced4-48fc-9eda-f0650ea38386,,released,,1,2020-09-27T13:02:25.775217-05:00,Chemotherapy,Residual Disease,XELOX
HCM-CSHL-0161-C18,00dc3ba8-5a10-4120-bdad-c1c17b4b1ae7,c9c9c9ae-8c87-44c0-b23b-b36fc07f7953,,,41.0,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0161-C18_treatment6,1718e6ab-f514-4a50-996c-d743e7159baa,,released,,1,2020-09-27T13:02:25.775217-05:00,"Surgery, NOS",Initial Diagnosis,
HCM-CSHL-0161-C18,00dc3ba8-5a10-4120-bdad-c1c17b4b1ae7,c9c9c9ae-8c87-44c0-b23b-b36fc07f7953,143.0,Adjuvant,51.0,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0161-C18_treatment2,6c67545a-41e7-41d5-be24-e58b1060fdd0,,released,Oxaliplatin,1,2020-09-27T13:02:25.775217-05:00,Chemotherapy,Residual Disease,
HCM-CSHL-0161-C18,00dc3ba8-5a10-4120-bdad-c1c17b4b1ae7,c9c9c9ae-8c87-44c0-b23b-b36fc07f7953,,Neoadjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0161-C18_treatment,7883b0cc-85a7-4309-b43b-5214c76704b5,,released,,0,2020-09-27T13:02:25.775217-05:00,,,
HCM-CSHL-0161-C18,00dc3ba8-5a10-4120-bdad-c1c17b4b1ae7,c9c9c9ae-8c87-44c0-b23b-b36fc07f7953,,Adjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0161-C18_treatment8,873ad34b-4628-41be-ae27-f39c76498eff,,released,,0,2020-09-27T13:02:25.775217-05:00,"Radiation Therapy, NOS",Residual Disease,
HCM-CSHL-0161-C18,00dc3ba8-5a10-4120-bdad-c1c17b4b1ae7,c9c9c9ae-8c87-44c0-b23b-b36fc07f7953,,Adjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0161-C18_treatment7,c003a417-5637-4f01-8ef2-0da9ef9a0663,,released,,0,2020-09-27T13:02:25.775217-05:00,Targeted Molecular Therapy,Residual Disease,
HCM-CSHL-0161-C18,00dc3ba8-5a10-4120-bdad-c1c17b4b1ae7,c9c9c9ae-8c87-44c0-b23b-b36fc07f7953,143.0,Adjuvant,51.0,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0161-C18_treatment3,ec6f46e7-4346-40f8-98f4-0f161d52899b,,released,Capecitabine,1,2020-09-27T13:02:25.775217-05:00,Chemotherapy,Residual Disease,
HCM-CSHL-0867-C18,00ee2954-76fb-4157-bcb8-9ff3b7d94707,66e9ec80-d89d-41ec-b4d4-6a18f116ef9b,,Maintenance Therapy,,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0867-C18_treatment17,4cae4a20-acfc-4264-8e50-30999f03fc7e,Complete Response,released,Xeloda,1,2021-12-21T14:36:31.294022-06:00,,,
HCM-CSHL-0867-C18,00ee2954-76fb-4157-bcb8-9ff3b7d94707,66e9ec80-d89d-41ec-b4d4-6a18f116ef9b,,Maintenance Therapy,,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0867-C18_treatment20,9c413165-de8c-4615-85a4-981d79bdb355,Complete Response,released,,1,2021-12-21T14:36:31.294022-06:00,,,FOLFOX
HCM-CSHL-0867-C18,00ee2954-76fb-4157-bcb8-9ff3b7d94707,66e9ec80-d89d-41ec-b4d4-6a18f116ef9b,,Maintenance Therapy,,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0867-C18_treatment18,a0710a75-eff3-44cb-8889-7a457eaab6b5,Complete Response,released,Leucovorin Calcium,1,2021-12-21T14:36:31.294022-06:00,,,
HCM-CSHL-0867-C18,00ee2954-76fb-4157-bcb8-9ff3b7d94707,66e9ec80-d89d-41ec-b4d4-6a18f116ef9b,,Maintenance Therapy,,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0867-C18_treatment19,ae2dbab3-5b49-49e8-961a-c64733d17db7,Complete Response,released,Fluorouracil,1,2021-12-21T14:36:31.294022-06:00,,,
HCM-CSHL-0867-C18,00ee2954-76fb-4157-bcb8-9ff3b7d94707,66e9ec80-d89d-41ec-b4d4-6a18f116ef9b,,Maintenance Therapy,,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0867-C18_treatment15,d61308c8-3e92-4647-bf4a-a303c38c339a,Complete Response,released,Oxaliplatin,1,2021-12-21T14:36:31.294022-06:00,,,
HCM-CSHL-0867-C18,00ee2954-76fb-4157-bcb8-9ff3b7d94707,66e9ec80-d89d-41ec-b4d4-6a18f116ef9b,,Maintenance Therapy,,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0867-C18_treatment16,ed99b26c-9be8-4818-a3f6-930ebc29797c,Complete Response,released,Leucovorin,1,2021-12-21T14:36:31.294022-06:00,,,
HCM-CSHL-0867-C18,00ee2954-76fb-4157-bcb8-9ff3b7d94707,fa34dd60-be05-4298-984e-6a54d969fecc,174.0,Adjuvant,146.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0867-C18_treatment7,1ac52c5f-8354-4c45-8fe6-a41303f4d243,,released,Fluorouracil,1,2021-12-21T14:36:31.294022-06:00,Chemotherapy,Residual Disease,
HCM-CSHL-0867-C18,00ee2954-76fb-4157-bcb8-9ff3b7d94707,fa34dd60-be05-4298-984e-6a54d969fecc,300.0,Adjuvant,272.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0867-C18_treatment10,22369af6-f3b5-4825-beb2-ee61df249abe,,released,Leucovorin,1,2021-12-21T14:36:31.294022-06:00,Chemotherapy,Residual Disease,
HCM-CSHL-0867-C18,00ee2954-76fb-4157-bcb8-9ff3b7d94707,fa34dd60-be05-4298-984e-6a54d969fecc,132.0,Adjuvant,62.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0867-C18_treatment5,2e57d688-e6cf-42b6-b217-08e1a5315036,,released,Oxaliplatin,1,2021-12-21T14:36:31.294022-06:00,Chemotherapy,Residual Disease,
HCM-CSHL-0867-C18,00ee2954-76fb-4157-bcb8-9ff3b7d94707,fa34dd60-be05-4298-984e-6a54d969fecc,,,196.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0867-C18_treatment12,407ac759-9e03-4e0f-b653-bc2a08490533,,released,,1,2021-12-21T14:36:31.294022-06:00,"Surgery, NOS",Initial Diagnosis,
HCM-CSHL-0867-C18,00ee2954-76fb-4157-bcb8-9ff3b7d94707,fa34dd60-be05-4298-984e-6a54d969fecc,,Neoadjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0867-C18_treatment,4a2d8003-a027-47b9-92b5-d11ed8828579,,released,,0,2021-12-21T14:36:31.294022-06:00,,,
HCM-CSHL-0867-C18,00ee2954-76fb-4157-bcb8-9ff3b7d94707,fa34dd60-be05-4298-984e-6a54d969fecc,174.0,Adjuvant,146.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0867-C18_treatment8,4e23f2a9-6a73-4d11-9baa-1289f339329b,,released,Leucovorin,1,2021-12-21T14:36:31.294022-06:00,Chemotherapy,Residual Disease,
HCM-CSHL-0867-C18,00ee2954-76fb-4157-bcb8-9ff3b7d94707,fa34dd60-be05-4298-984e-6a54d969fecc,300.0,Adjuvant,272.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0867-C18_treatment9,58bd596f-8b41-4308-816e-3c04f046504c,,released,Fluorouracil,1,2021-12-21T14:36:31.294022-06:00,Chemotherapy,Residual Disease,
HCM-CSHL-0867-C18,00ee2954-76fb-4157-bcb8-9ff3b7d94707,fa34dd60-be05-4298-984e-6a54d969fecc,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0867-C18_treatment14,61ac0558-83a1-4eef-ba1d-13dd7eccf704,,released,,0,2021-12-21T14:36:31.294022-06:00,"Radiation Therapy, NOS",Residual Disease,
HCM-CSHL-0867-C18,00ee2954-76fb-4157-bcb8-9ff3b7d94707,fa34dd60-be05-4298-984e-6a54d969fecc,33.0,Adjuvant,12.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0867-C18_treatment2,8223ea59-f79e-4367-9c34-ef9300acb95e,,released,Capecitabine,1,2021-12-21T14:36:31.294022-06:00,Chemotherapy,Residual Disease,
HCM-CSHL-0867-C18,00ee2954-76fb-4157-bcb8-9ff3b7d94707,fa34dd60-be05-4298-984e-6a54d969fecc,132.0,Adjuvant,62.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0867-C18_treatment4,8808f85e-8559-46ba-bb7e-6022cfcbd1a7,,released,Fluorouracil,1,2021-12-21T14:36:31.294022-06:00,Chemotherapy,Residual Disease,
HCM-CSHL-0867-C18,00ee2954-76fb-4157-bcb8-9ff3b7d94707,fa34dd60-be05-4298-984e-6a54d969fecc,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0867-C18_treatment11,8e806829-d29c-4b26-86d0-33de05d58a0d,,released,,0,2021-12-21T14:36:31.294022-06:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-CSHL-0867-C18,00ee2954-76fb-4157-bcb8-9ff3b7d94707,fa34dd60-be05-4298-984e-6a54d969fecc,132.0,Adjuvant,62.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0867-C18_treatment6,dc47d01b-1ded-47b6-a7e2-839576362fea,,released,,1,2021-12-21T14:36:31.294022-06:00,Chemotherapy,Residual Disease,FOLFOX
HCM-CSHL-0867-C18,00ee2954-76fb-4157-bcb8-9ff3b7d94707,fa34dd60-be05-4298-984e-6a54d969fecc,132.0,Adjuvant,62.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0867-C18_treatment3,f3f0eb27-1776-40bc-a736-39211f2907ba,,released,Leucovorin Calcium,1,2021-12-21T14:36:31.294022-06:00,Chemotherapy,Residual Disease,
HCM-CSHL-0867-C18,00ee2954-76fb-4157-bcb8-9ff3b7d94707,fa34dd60-be05-4298-984e-6a54d969fecc,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0867-C18_treatment13,fe98ef74-63b1-4319-a958-51317a85c05e,,released,,0,2021-12-21T14:36:31.294022-06:00,Targeted Molecular Therapy,Residual Disease,
HCM-SANG-0537-C18,01c25a0f-5335-4fbd-870c-e533c4f7c7e1,93fdfe50-2461-4815-b00d-897ff8aa8684,,Neoadjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-SANG-0537-C18_treatment,d3ebc026-6f0b-4a89-913f-b7f822f2c15d,,released,,0,2021-12-21T15:15:21.378045-06:00,,,
HCM-SANG-0293-C15,01c29556-6af2-4ff8-b03b-911dfb5195fd,13c5624d-49ea-4230-b8b4-acce972ce035,,Neoadjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-SANG-0293-C15_treatment,89bae452-506c-4da7-af20-5ff6ec5ea0c7,,released,,0,2021-12-21T15:09:07.683949-06:00,,,
HCM-EXPT-0998-C25,01f8a139-a027-4578-8cc0-3d931743f8d5,7bfc7bec-32fe-4d8f-bb28-565a444b757a,,Neoadjuvant,,2025-10-08T12:37:21.548354-05:00,HCM-EXPT-0998-C25_treatment,a11b75a5-b67c-4467-a17f-f6b27325a19f,,released,,1,2021-12-21T14:52:45.367110-06:00,Chemotherapy,,
HCM-BROD-0759-C15,02187bfb-54f4-4bed-a056-06c9f10e3335,0efa4a6c-b389-4500-8e37-ad77a0883bbb,,Neoadjuvant,250.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0759-C15_treatment5,014ad81f-65a9-4741-be87-5dcad3fe9f28,,released,Nivolumab,1,2021-12-21T13:50:42.579115-06:00,Immunotherapy (Including Vaccines),,
HCM-BROD-0759-C15,02187bfb-54f4-4bed-a056-06c9f10e3335,0efa4a6c-b389-4500-8e37-ad77a0883bbb,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0759-C15_treatment15,0c9eabe8-13d7-4253-be17-711b9738d26c,,released,,0,2021-12-21T13:50:42.579115-06:00,"Radiation Therapy, NOS",Residual Disease,
HCM-BROD-0759-C15,02187bfb-54f4-4bed-a056-06c9f10e3335,0efa4a6c-b389-4500-8e37-ad77a0883bbb,775.0,Adjuvant,733.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0759-C15_treatment10,26e2a6f5-3061-4f94-867d-eade33e313c0,,released,Oxaliplatin,1,2021-12-21T13:50:42.579115-06:00,Chemotherapy,Residual Disease,
HCM-BROD-0759-C15,02187bfb-54f4-4bed-a056-06c9f10e3335,0efa4a6c-b389-4500-8e37-ad77a0883bbb,775.0,Adjuvant,733.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0759-C15_treatment9,3bc249a4-f02c-402a-bcac-03a3a0d3a8a5,,released,Fluorouracil,1,2021-12-21T13:50:42.579115-06:00,Chemotherapy,Residual Disease,
HCM-BROD-0759-C15,02187bfb-54f4-4bed-a056-06c9f10e3335,0efa4a6c-b389-4500-8e37-ad77a0883bbb,,Neoadjuvant,222.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0759-C15_treatment,4f67fa6b-dd40-4694-9462-6f095187f751,,released,Leucovorin Calcium,1,2021-12-21T13:50:42.579115-06:00,Chemotherapy,,
HCM-BROD-0759-C15,02187bfb-54f4-4bed-a056-06c9f10e3335,0efa4a6c-b389-4500-8e37-ad77a0883bbb,706.0,Adjuvant,544.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0759-C15_treatment7,6f881e64-f6f5-431f-aa50-f73423a92a58,,released,Paclitaxel,1,2021-12-21T13:50:42.579115-06:00,Chemotherapy,Residual Disease,
HCM-BROD-0759-C15,02187bfb-54f4-4bed-a056-06c9f10e3335,0efa4a6c-b389-4500-8e37-ad77a0883bbb,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0759-C15_treatment12,77275c64-90f4-42ec-aab5-699750281327,,released,,0,2021-12-21T13:50:42.579115-06:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-BROD-0759-C15,02187bfb-54f4-4bed-a056-06c9f10e3335,0efa4a6c-b389-4500-8e37-ad77a0883bbb,,Neoadjuvant,222.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0759-C15_treatment2,790d6095-fbfb-4e01-aa64-c7d6c1748747,,released,Fluorouracil,1,2021-12-21T13:50:42.579115-06:00,Chemotherapy,,
HCM-BROD-0759-C15,02187bfb-54f4-4bed-a056-06c9f10e3335,0efa4a6c-b389-4500-8e37-ad77a0883bbb,,Neoadjuvant,222.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0759-C15_treatment4,7db41817-2060-432e-b60f-96cb938c00fb,,released,,1,2021-12-21T13:50:42.579115-06:00,Chemotherapy,,FOLFOX
HCM-BROD-0759-C15,02187bfb-54f4-4bed-a056-06c9f10e3335,0efa4a6c-b389-4500-8e37-ad77a0883bbb,775.0,Adjuvant,733.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0759-C15_treatment11,94c63fe0-5b54-4c16-be36-cc01531fd0fd,,released,,1,2021-12-21T13:50:42.579115-06:00,Chemotherapy,Residual Disease,FOLFOX
HCM-BROD-0759-C15,02187bfb-54f4-4bed-a056-06c9f10e3335,0efa4a6c-b389-4500-8e37-ad77a0883bbb,706.0,Adjuvant,544.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0759-C15_treatment14,a3ecf646-f62e-4a06-a72e-ebc1bec9c0de,,released,Ramucirumab,1,2021-12-21T13:50:42.579115-06:00,Targeted Molecular Therapy,Residual Disease,
HCM-BROD-0759-C15,02187bfb-54f4-4bed-a056-06c9f10e3335,0efa4a6c-b389-4500-8e37-ad77a0883bbb,,Neoadjuvant,222.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0759-C15_treatment3,d0d2f922-5f22-4d4a-9dbb-0e2f122ceec7,,released,Oxaliplatin,1,2021-12-21T13:50:42.579115-06:00,Chemotherapy,,
HCM-BROD-0759-C15,02187bfb-54f4-4bed-a056-06c9f10e3335,0efa4a6c-b389-4500-8e37-ad77a0883bbb,,,,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0759-C15_treatment13,dad3b4d0-6e0c-4126-b6ba-28f9eb72351e,,released,,0,2021-12-21T13:50:42.579115-06:00,"Surgery, NOS",Initial Diagnosis,
HCM-BROD-0759-C15,02187bfb-54f4-4bed-a056-06c9f10e3335,0efa4a6c-b389-4500-8e37-ad77a0883bbb,,Neoadjuvant,165.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0759-C15_treatment6,e7340744-0b00-4c83-b47d-5b32b126e4a1,,released,Ramucirumab,1,2021-12-21T13:50:42.579115-06:00,Targeted Molecular Therapy,,
HCM-BROD-0759-C15,02187bfb-54f4-4bed-a056-06c9f10e3335,0efa4a6c-b389-4500-8e37-ad77a0883bbb,775.0,Adjuvant,733.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0759-C15_treatment8,edfa4512-f5ea-4811-99d3-adb1a6f56455,,released,Leucovorin Calcium,1,2021-12-21T13:50:42.579115-06:00,Chemotherapy,Residual Disease,
HCM-WCMC-0946-C34,0249b26e-7928-4d28-a0e7-68a31d49ca33,e9f9d800-b47c-442b-968d-c041adb5d13f,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-WCMC-0946-C34_treatment4,047c2a15-d508-4aeb-b3ca-155b22052d8b,,released,,0,2023-02-27T11:49:45.455791-06:00,"Radiation Therapy, NOS",Residual Disease,
HCM-WCMC-0946-C34,0249b26e-7928-4d28-a0e7-68a31d49ca33,e9f9d800-b47c-442b-968d-c041adb5d13f,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-WCMC-0946-C34_treatment3,274f664e-631e-44b6-99a6-d319b85f5998,,released,,0,2023-02-27T11:49:45.455791-06:00,"Pharmaceutical Therapy, NOS",Residual Disease,
HCM-WCMC-0946-C34,0249b26e-7928-4d28-a0e7-68a31d49ca33,e9f9d800-b47c-442b-968d-c041adb5d13f,,Neoadjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-WCMC-0946-C34_treatment,67f0e8ca-6884-4df2-a084-76bd3029b231,,released,,0,2023-02-27T11:49:45.455791-06:00,,,
HCM-WCMC-0946-C34,0249b26e-7928-4d28-a0e7-68a31d49ca33,e9f9d800-b47c-442b-968d-c041adb5d13f,,,42.0,2025-04-07T17:13:09.336794-05:00,HCM-WCMC-0946-C34_treatment2,c236c884-8bd1-435c-9a12-5bf652cb646c,,released,,1,2023-02-27T11:49:45.455791-06:00,"Surgery, NOS",Initial Diagnosis,
HCM-BROD-0204-C25,0251b915-6bf6-43a3-b3a3-aadbac0be13f,9c113ef5-eccd-4480-a651-4af9f44b398d,,Adjuvant,,2023-11-07T14:28:29.403873-06:00,HCM-BROD-0204-C25_treatment5,524e4a7f-3692-4e8b-9c9c-d991a562008d,,released,,0,2020-09-17T16:01:21.506049-05:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-BROD-0204-C25,0251b915-6bf6-43a3-b3a3-aadbac0be13f,9c113ef5-eccd-4480-a651-4af9f44b398d,,Adjuvant,,2023-11-07T14:28:29.403873-06:00,HCM-BROD-0204-C25_treatment8,54a9e842-c989-43b5-b69d-9bd75d6944b3,,released,,0,2020-09-17T16:01:21.506049-05:00,"Radiation Therapy, NOS",Residual Disease,
HCM-BROD-0204-C25,0251b915-6bf6-43a3-b3a3-aadbac0be13f,9c113ef5-eccd-4480-a651-4af9f44b398d,,Adjuvant,,2023-11-07T14:28:29.403873-06:00,HCM-BROD-0204-C25_treatment7,581662ee-7818-4bbb-a81a-2ef515de00ec,,released,,0,2020-09-17T16:01:21.506049-05:00,Targeted Molecular Therapy,Residual Disease,
HCM-BROD-0204-C25,0251b915-6bf6-43a3-b3a3-aadbac0be13f,9c113ef5-eccd-4480-a651-4af9f44b398d,,Neoadjuvant,,2023-11-07T14:28:29.403873-06:00,HCM-BROD-0204-C25_treatment2,88b9efab-316b-4b8c-9881-d37899ba3738,,released,Nab-paclitaxel,1,2020-09-17T16:01:21.506049-05:00,Chemotherapy,,
HCM-BROD-0204-C25,0251b915-6bf6-43a3-b3a3-aadbac0be13f,9c113ef5-eccd-4480-a651-4af9f44b398d,,Adjuvant,,2023-11-07T14:28:29.403873-06:00,HCM-BROD-0204-C25_treatment4,e9a80b16-583c-42a7-ac0c-171beb51c883,,released,,0,2020-09-17T16:01:21.506049-05:00,Chemotherapy,Residual Disease,
HCM-BROD-0204-C25,0251b915-6bf6-43a3-b3a3-aadbac0be13f,9c113ef5-eccd-4480-a651-4af9f44b398d,,Neoadjuvant,,2023-11-07T14:28:29.403873-06:00,HCM-BROD-0204-C25_treatment3,ea4b9b3c-15ff-4b30-b24d-bc2e8eeaccbb,,released,,1,2020-09-17T16:01:21.506049-05:00,"Radiation Therapy, NOS",,
HCM-BROD-0204-C25,0251b915-6bf6-43a3-b3a3-aadbac0be13f,9c113ef5-eccd-4480-a651-4af9f44b398d,,,301.0,2023-11-07T14:28:29.403873-06:00,HCM-BROD-0204-C25_treatment6,f65075e9-d232-49e4-a440-f06937a8b78d,,released,,1,2020-09-17T16:01:21.506049-05:00,"Surgery, NOS",Initial Diagnosis,
HCM-BROD-0204-C25,0251b915-6bf6-43a3-b3a3-aadbac0be13f,9c113ef5-eccd-4480-a651-4af9f44b398d,,Neoadjuvant,,2023-11-07T14:28:29.403873-06:00,HCM-BROD-0204-C25_treatment,fd641332-1d58-4c26-9aa8-7045fe4c897d,,released,Gemcitabine,1,2020-09-17T16:01:21.506049-05:00,Chemotherapy,,
HCM-CSHL-0084-C25,0286c31b-a704-4d7d-99e3-0bc4e8975b8b,70da7d37-590b-41a5-97c7-17238c0c8652,,Neoadjuvant,,2023-02-22T07:39:25.979291-06:00,HCM-CSHL-0084-C25_treatment,41534693-7349-4d49-b0a3-67c30d6331d1,,released,,0,2020-10-09T15:00:09.016502-05:00,,,
HCM-CSHL-0084-C25,0286c31b-a704-4d7d-99e3-0bc4e8975b8b,70da7d37-590b-41a5-97c7-17238c0c8652,,,-6.0,2023-03-13T12:42:42.837350-05:00,HCM-CSHL-0084-C25_treatment2,7c5955c6-7546-4e88-8df7-5c91a2e42685,,released,,1,2020-10-09T15:00:09.016502-05:00,"Surgery, NOS",Initial Diagnosis,
HCM-CSHL-0670-C18,028fb179-0872-4477-ab89-cf39f1ed9420,4bfe1ee5-ce9c-4f2d-b0bb-883580084f7d,,Adjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0670-C18_treatment12,218b8f1a-b26c-4bb9-90a8-cec2392252f1,,released,,0,2021-12-21T14:18:20.524321-06:00,"Radiation Therapy, NOS",Residual Disease,
HCM-CSHL-0670-C18,028fb179-0872-4477-ab89-cf39f1ed9420,4bfe1ee5-ce9c-4f2d-b0bb-883580084f7d,,Neoadjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0670-C18_treatment,36f8d1b2-1fb6-482b-b9de-f2f2875ab77d,,released,,0,2021-12-21T14:18:20.524321-06:00,,,
HCM-CSHL-0670-C18,028fb179-0872-4477-ab89-cf39f1ed9420,4bfe1ee5-ce9c-4f2d-b0bb-883580084f7d,456.0,Adjuvant,412.0,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0670-C18_treatment7,432670c8-794c-4887-99ad-43f4e50754b7,,released,Leucovorin,1,2021-12-21T14:18:20.524321-06:00,Chemotherapy,Residual Disease,
HCM-CSHL-0670-C18,028fb179-0872-4477-ab89-cf39f1ed9420,4bfe1ee5-ce9c-4f2d-b0bb-883580084f7d,412.0,Adjuvant,55.0,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0670-C18_treatment2,4ab2725e-fd7a-4847-a6e7-27d63d80dbd5,,released,Leucovorin Calcium,1,2021-12-21T14:18:20.524321-06:00,Chemotherapy,Residual Disease,
HCM-CSHL-0670-C18,028fb179-0872-4477-ab89-cf39f1ed9420,4bfe1ee5-ce9c-4f2d-b0bb-883580084f7d,456.0,Adjuvant,412.0,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0670-C18_treatment6,528d4707-eeb3-4754-b97e-7b24e943b403,,released,Fluorouracil,1,2021-12-21T14:18:20.524321-06:00,Chemotherapy,Residual Disease,
HCM-CSHL-0670-C18,028fb179-0872-4477-ab89-cf39f1ed9420,4bfe1ee5-ce9c-4f2d-b0bb-883580084f7d,,,122.0,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0670-C18_treatment10,577b4f98-3d6d-4ea6-a39e-47a921a133e9,,released,,1,2021-12-21T14:18:20.524321-06:00,"Surgery, NOS",Initial Diagnosis,
HCM-CSHL-0670-C18,028fb179-0872-4477-ab89-cf39f1ed9420,4bfe1ee5-ce9c-4f2d-b0bb-883580084f7d,,Adjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0670-C18_treatment11,62953503-78b4-43e5-8e66-201bf746b9cc,,released,,0,2021-12-21T14:18:20.524321-06:00,Targeted Molecular Therapy,Residual Disease,
HCM-CSHL-0670-C18,028fb179-0872-4477-ab89-cf39f1ed9420,4bfe1ee5-ce9c-4f2d-b0bb-883580084f7d,1199.0,Adjuvant,476.0,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0670-C18_treatment8,650af823-bbbf-445c-9979-ef4e2592eb87,,released,Capecitabine,1,2021-12-21T14:18:20.524321-06:00,Chemotherapy,Residual Disease,
HCM-CSHL-0670-C18,028fb179-0872-4477-ab89-cf39f1ed9420,4bfe1ee5-ce9c-4f2d-b0bb-883580084f7d,412.0,Adjuvant,55.0,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0670-C18_treatment3,835c46f8-c198-4143-bfb9-4060114eb1b2,,released,Fluorouracil,1,2021-12-21T14:18:20.524321-06:00,Chemotherapy,Residual Disease,
HCM-CSHL-0670-C18,028fb179-0872-4477-ab89-cf39f1ed9420,4bfe1ee5-ce9c-4f2d-b0bb-883580084f7d,,Adjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0670-C18_treatment9,b6f9196a-d0b5-4d66-809a-e46e3c6a090d,,released,,0,2021-12-21T14:18:20.524321-06:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-CSHL-0670-C18,028fb179-0872-4477-ab89-cf39f1ed9420,4bfe1ee5-ce9c-4f2d-b0bb-883580084f7d,412.0,Adjuvant,55.0,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0670-C18_treatment4,e34f745c-6677-4d62-98ec-c62f5e5b4760,,released,Oxaliplatin,1,2021-12-21T14:18:20.524321-06:00,Chemotherapy,Residual Disease,
HCM-CSHL-0670-C18,028fb179-0872-4477-ab89-cf39f1ed9420,4bfe1ee5-ce9c-4f2d-b0bb-883580084f7d,412.0,Adjuvant,55.0,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0670-C18_treatment5,ef0a0ad5-a737-464c-8134-077b93c20e73,,released,,1,2021-12-21T14:18:20.524321-06:00,Chemotherapy,Residual Disease,FOLFOX
HCM-CSHL-0670-C18,028fb179-0872-4477-ab89-cf39f1ed9420,59a8a0c3-680d-4875-9756-e38306ceceb7,554.0,Maintenance Therapy,43.0,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0670-C18_treatment13,71c64a46-fbe6-4b16-b3c5-56f24fb88d43,Not Reported,released,Xeloda,1,2021-12-21T14:18:20.524321-06:00,,,
HCM-SANG-1337-C18,029399ba-21fa-4e49-8ddf-f73e4704858a,ef67a718-56f8-42c7-8705-4b8b63b7e01f,,Neoadjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-SANG-1337-C18_treatment,9f2c888a-ed1e-42d9-9861-ba0208ab77c2,,released,,0,2023-02-27T12:46:56.622960-06:00,,,
HCM-EXPT-1224-C15,02b9db75-894d-4f2c-908d-8b37b65668b9,5efe5b99-0057-45e2-8690-6e7e87de2963,,Neoadjuvant,98.0,2025-10-08T12:39:14.406630-05:00,HCM-EXPT-1224-C15_treatment,021f263c-3813-4db3-aef9-5d4084267e79,,released,Leucovorin,1,2023-02-24T13:59:38.903423-06:00,Chemotherapy,,
HCM-EXPT-1224-C15,02b9db75-894d-4f2c-908d-8b37b65668b9,5efe5b99-0057-45e2-8690-6e7e87de2963,,Neoadjuvant,98.0,2025-10-08T12:39:14.406630-05:00,HCM-EXPT-1224-C15_treatment2,4a546d3f-fc69-49ce-b6c3-a42e77a8e236,,released,Fluorouracil,1,2023-02-24T13:59:38.903423-06:00,Chemotherapy,,
HCM-EXPT-1224-C15,02b9db75-894d-4f2c-908d-8b37b65668b9,5efe5b99-0057-45e2-8690-6e7e87de2963,,Neoadjuvant,98.0,2025-10-08T12:39:14.406630-05:00,HCM-EXPT-1224-C15_treatment3,98720ebc-f226-4100-b18f-5077a89cfc8c,,released,Docetaxel,1,2023-02-24T13:59:38.903423-06:00,Chemotherapy,,
HCM-EXPT-1224-C15,02b9db75-894d-4f2c-908d-8b37b65668b9,5efe5b99-0057-45e2-8690-6e7e87de2963,,Neoadjuvant,98.0,2025-10-08T12:39:14.406630-05:00,HCM-EXPT-1224-C15_treatment4,bdb3c636-1c8e-41d0-9a83-422f60d7239c,,released,Oxaliplatin,1,2023-02-24T13:59:38.903423-06:00,Chemotherapy,,
HCM-BROD-0408-C71,02f6d684-b6b5-419a-b0e1-b74d0a384a30,9fc0fac7-b813-4c0f-995d-4045f0db272c,,Neoadjuvant,,2023-02-22T07:39:25.979291-06:00,HCM-BROD-0408-C71_treatment,0ad0ffdc-2f6f-40f4-b70f-bac3fbbfab86,,released,,0,2020-06-15T13:40:11.094740-05:00,,,
HCM-BROD-0408-C71,02f6d684-b6b5-419a-b0e1-b74d0a384a30,9fc0fac7-b813-4c0f-995d-4045f0db272c,,Adjuvant,,2023-02-22T07:39:25.979291-06:00,HCM-BROD-0408-C71_treatment6,4f7d83e8-839a-4270-bb96-faf9c2980f36,,released,,0,2020-06-15T13:40:11.094740-05:00,"Radiation Therapy, NOS",Residual Disease,
HCM-BROD-0408-C71,02f6d684-b6b5-419a-b0e1-b74d0a384a30,9fc0fac7-b813-4c0f-995d-4045f0db272c,,Adjuvant,,2023-02-22T07:39:25.979291-06:00,HCM-BROD-0408-C71_treatment2,5e5ff864-7631-46df-9aad-2a408bb29c0f,,released,,1,2020-06-15T13:40:11.094740-05:00,Chemotherapy,Residual Disease,
HCM-BROD-0408-C71,02f6d684-b6b5-419a-b0e1-b74d0a384a30,9fc0fac7-b813-4c0f-995d-4045f0db272c,,Adjuvant,,2023-02-22T07:39:25.979291-06:00,HCM-BROD-0408-C71_treatment5,6b7adf0c-dc46-4947-9091-b9589fd437c7,,released,,0,2020-06-15T13:40:11.094740-05:00,Targeted Molecular Therapy,Residual Disease,
HCM-BROD-0408-C71,02f6d684-b6b5-419a-b0e1-b74d0a384a30,9fc0fac7-b813-4c0f-995d-4045f0db272c,,Adjuvant,,2023-02-22T07:39:25.979291-06:00,HCM-BROD-0408-C71_treatment3,8c8f8717-64df-4556-8cc3-810ab7d9f142,,released,,0,2020-06-15T13:40:11.094740-05:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-BROD-0408-C71,02f6d684-b6b5-419a-b0e1-b74d0a384a30,9fc0fac7-b813-4c0f-995d-4045f0db272c,,,-529.0,2023-03-13T12:52:25.361274-05:00,HCM-BROD-0408-C71_treatment4,b1c41c69-15bc-46c9-ab53-ab0518b5e553,,released,,1,2020-06-15T13:40:11.094740-05:00,"Surgery, NOS",Initial Diagnosis,
HCM-WCMC-0504-C18,031b40e7-2e1d-43e9-83a1-a4fae1e1e6a4,c0c2a085-de17-4b07-b396-0d500271433b,89.0,Maintenance Therapy,42.0,2023-07-13T10:35:44.371881-05:00,HCM-WCMC-0504-C18_treatment13,0f44332c-1e03-4c89-8cca-2ab659828ad0,Complete Response,released,Oxaliplatin,1,2023-02-27T12:20:43.084621-06:00,,,
HCM-WCMC-0504-C18,031b40e7-2e1d-43e9-83a1-a4fae1e1e6a4,c0c2a085-de17-4b07-b396-0d500271433b,89.0,Maintenance Therapy,42.0,2023-07-13T10:35:44.371881-05:00,HCM-WCMC-0504-C18_treatment11,3352d00b-3c47-46e1-b55d-e60691e18dc3,Complete Response,released,Leucovorin Calcium,1,2023-02-27T12:20:43.084621-06:00,,,
HCM-WCMC-0504-C18,031b40e7-2e1d-43e9-83a1-a4fae1e1e6a4,c0c2a085-de17-4b07-b396-0d500271433b,89.0,Maintenance Therapy,42.0,2023-07-13T10:35:44.371881-05:00,HCM-WCMC-0504-C18_treatment12,906a3f93-4f5b-417d-92fd-261802c956fb,Complete Response,released,Fluorouracil,1,2023-02-27T12:20:43.084621-06:00,,,
HCM-WCMC-0504-C18,031b40e7-2e1d-43e9-83a1-a4fae1e1e6a4,c0c2a085-de17-4b07-b396-0d500271433b,89.0,Maintenance Therapy,42.0,2023-07-13T10:35:44.371881-05:00,HCM-WCMC-0504-C18_treatment14,937691d1-b8e2-4c27-adcd-91d068abafbe,Complete Response,released,,1,2023-02-27T12:20:43.084621-06:00,,,FOLFOX
HCM-WCMC-0504-C18,031b40e7-2e1d-43e9-83a1-a4fae1e1e6a4,da906777-f594-4a26-8d09-192c8a3c10b9,89.0,Adjuvant,42.0,2023-07-13T10:35:44.371881-05:00,HCM-WCMC-0504-C18_treatment4,223bf9f1-fc69-42e2-b8d1-9504d14d98de,,released,Fluorouracil,1,2023-02-27T12:20:43.084621-06:00,Chemotherapy,Residual Disease,
HCM-WCMC-0504-C18,031b40e7-2e1d-43e9-83a1-a4fae1e1e6a4,da906777-f594-4a26-8d09-192c8a3c10b9,89.0,Adjuvant,42.0,2023-07-13T10:35:44.371881-05:00,HCM-WCMC-0504-C18_treatment5,3de5204a-cd3d-4e22-bfb0-56b8e3228582,,released,,1,2023-02-27T12:20:43.084621-06:00,Chemotherapy,Residual Disease,FOLFOX-6 (modified)
HCM-WCMC-0504-C18,031b40e7-2e1d-43e9-83a1-a4fae1e1e6a4,da906777-f594-4a26-8d09-192c8a3c10b9,,,1.0,2023-07-13T10:35:44.371881-05:00,HCM-WCMC-0504-C18_treatment8,4d5575d1-61e5-49a0-b381-3499627ce16a,,released,,1,2023-02-27T12:20:43.084621-06:00,"Surgery, NOS",Initial Diagnosis,
HCM-WCMC-0504-C18,031b40e7-2e1d-43e9-83a1-a4fae1e1e6a4,da906777-f594-4a26-8d09-192c8a3c10b9,271.0,Adjuvant,152.0,2023-07-13T10:35:44.371881-05:00,HCM-WCMC-0504-C18_treatment7,762fc9ff-5d28-481f-b5e3-f9271f71cc93,,released,Nivolumab,1,2023-02-27T12:20:43.084621-06:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-WCMC-0504-C18,031b40e7-2e1d-43e9-83a1-a4fae1e1e6a4,da906777-f594-4a26-8d09-192c8a3c10b9,89.0,Adjuvant,42.0,2023-07-13T10:35:44.371881-05:00,HCM-WCMC-0504-C18_treatment3,7a209bb4-c6bb-4334-9d89-5ce74307945d,,released,Oxaliplatin,1,2023-02-27T12:20:43.084621-06:00,Chemotherapy,Residual Disease,
HCM-WCMC-0504-C18,031b40e7-2e1d-43e9-83a1-a4fae1e1e6a4,da906777-f594-4a26-8d09-192c8a3c10b9,,Adjuvant,,2023-07-13T10:35:44.371881-05:00,HCM-WCMC-0504-C18_treatment9,8fc0c866-84cf-47e7-a5b7-9849bdf982b0,,released,,0,2023-02-27T12:20:43.084621-06:00,Targeted Molecular Therapy,Residual Disease,
HCM-WCMC-0504-C18,031b40e7-2e1d-43e9-83a1-a4fae1e1e6a4,da906777-f594-4a26-8d09-192c8a3c10b9,615.0,Adjuvant,293.0,2023-07-13T10:35:44.371881-05:00,HCM-WCMC-0504-C18_treatment6,9a83578f-9472-4815-8c90-7e4bb9e348d0,,released,Pembrolizumab,1,2023-02-27T12:20:43.084621-06:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-WCMC-0504-C18,031b40e7-2e1d-43e9-83a1-a4fae1e1e6a4,da906777-f594-4a26-8d09-192c8a3c10b9,89.0,Adjuvant,42.0,2023-07-13T10:35:44.371881-05:00,HCM-WCMC-0504-C18_treatment2,cb699459-0046-493f-9cc3-7564ec934a99,,released,Leucovorin Calcium,1,2023-02-27T12:20:43.084621-06:00,Chemotherapy,Residual Disease,
HCM-WCMC-0504-C18,031b40e7-2e1d-43e9-83a1-a4fae1e1e6a4,da906777-f594-4a26-8d09-192c8a3c10b9,,Adjuvant,,2023-07-13T10:35:44.371881-05:00,HCM-WCMC-0504-C18_treatment10,cc6a2475-3161-4f3d-aaae-279a05f6ce5d,,released,,0,2023-02-27T12:20:43.084621-06:00,"Radiation Therapy, NOS",Residual Disease,
HCM-WCMC-0504-C18,031b40e7-2e1d-43e9-83a1-a4fae1e1e6a4,da906777-f594-4a26-8d09-192c8a3c10b9,,Neoadjuvant,,2023-07-13T10:35:44.371881-05:00,HCM-WCMC-0504-C18_treatment,dd30d7b8-cc0e-46c6-a095-070ab7c55027,,released,,0,2023-02-27T12:20:43.084621-06:00,,,
HCM-BROD-0108-C25,035fa980-159e-4c0d-87da-d13d3dd7c17c,dad608bb-2695-4823-83c6-6f7b1af6ce22,171.0,Adjuvant,129.0,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0108-C25_treatment5,06e4edb1-4da2-49ba-9f3f-c77c5c6ea312,,released,Irinotecan,1,2020-09-17T15:59:54.285311-05:00,Chemotherapy,Residual Disease,
HCM-BROD-0108-C25,035fa980-159e-4c0d-87da-d13d3dd7c17c,dad608bb-2695-4823-83c6-6f7b1af6ce22,192.0,Adjuvant,192.0,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0108-C25_treatment9,0d7bd7df-4dfb-41eb-a5e1-4a26745f382d,,released,Oxaliplatin,1,2020-09-17T15:59:54.285311-05:00,Chemotherapy,Residual Disease,
HCM-BROD-0108-C25,035fa980-159e-4c0d-87da-d13d3dd7c17c,dad608bb-2695-4823-83c6-6f7b1af6ce22,,Adjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0108-C25_treatment11,31c0de1f-74bb-48ac-99e6-98131d199ee5,,released,,0,2020-09-17T15:59:54.285311-05:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-BROD-0108-C25,035fa980-159e-4c0d-87da-d13d3dd7c17c,dad608bb-2695-4823-83c6-6f7b1af6ce22,,Adjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0108-C25_treatment13,405e693d-f0b9-4bbe-a678-9e4d09d9ce6c,,released,,0,2020-09-17T15:59:54.285311-05:00,Targeted Molecular Therapy,Residual Disease,
HCM-BROD-0108-C25,035fa980-159e-4c0d-87da-d13d3dd7c17c,dad608bb-2695-4823-83c6-6f7b1af6ce22,192.0,Adjuvant,192.0,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0108-C25_treatment10,65f0eac2-efe7-4747-8563-d76192924226,,released,,1,2020-09-17T15:59:54.285311-05:00,Chemotherapy,Residual Disease,FOLFIRINOX
HCM-BROD-0108-C25,035fa980-159e-4c0d-87da-d13d3dd7c17c,dad608bb-2695-4823-83c6-6f7b1af6ce22,,,20.0,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0108-C25_treatment12,665348b2-09f2-43cf-a828-7f11876f4a83,,released,,1,2020-09-17T15:59:54.285311-05:00,"Surgery, NOS",Initial Diagnosis,
HCM-BROD-0108-C25,035fa980-159e-4c0d-87da-d13d3dd7c17c,dad608bb-2695-4823-83c6-6f7b1af6ce22,115.0,Adjuvant,94.0,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0108-C25_treatment4,673e1ab0-2afa-4e8b-8a7c-96fb12511fc4,,released,Nab-paclitaxel,1,2020-09-17T15:59:54.285311-05:00,Chemotherapy,Residual Disease,
HCM-BROD-0108-C25,035fa980-159e-4c0d-87da-d13d3dd7c17c,dad608bb-2695-4823-83c6-6f7b1af6ce22,80.0,Adjuvant,59.0,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0108-C25_treatment2,80f3554d-fa5b-4735-8228-ad95a4e87352,,released,Gemcitabine,1,2020-09-17T15:59:54.285311-05:00,Chemotherapy,Residual Disease,
HCM-BROD-0108-C25,035fa980-159e-4c0d-87da-d13d3dd7c17c,dad608bb-2695-4823-83c6-6f7b1af6ce22,192.0,Adjuvant,192.0,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0108-C25_treatment8,87c13323-3672-45c5-86cf-3c3622136d2d,,released,Fluorouracil,1,2020-09-17T15:59:54.285311-05:00,Chemotherapy,Residual Disease,
HCM-BROD-0108-C25,035fa980-159e-4c0d-87da-d13d3dd7c17c,dad608bb-2695-4823-83c6-6f7b1af6ce22,,Adjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0108-C25_treatment14,ad1a5bd9-6cf8-4f6a-aeb8-141f14ec60a6,,released,,0,2020-09-17T15:59:54.285311-05:00,"Radiation Therapy, NOS",Residual Disease,
HCM-BROD-0108-C25,035fa980-159e-4c0d-87da-d13d3dd7c17c,dad608bb-2695-4823-83c6-6f7b1af6ce22,115.0,Adjuvant,94.0,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0108-C25_treatment3,b27e35fe-d06a-4832-9fb4-74a43b86a3ff,,released,Gemcitabine,1,2020-09-17T15:59:54.285311-05:00,Chemotherapy,Residual Disease,
HCM-BROD-0108-C25,035fa980-159e-4c0d-87da-d13d3dd7c17c,dad608bb-2695-4823-83c6-6f7b1af6ce22,192.0,Adjuvant,192.0,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0108-C25_treatment6,eff6d94c-89ae-4c4f-bbce-6968dccd36f9,,released,Irinotecan Hydrochloride,1,2020-09-17T15:59:54.285311-05:00,Chemotherapy,Residual Disease,
HCM-BROD-0108-C25,035fa980-159e-4c0d-87da-d13d3dd7c17c,dad608bb-2695-4823-83c6-6f7b1af6ce22,192.0,Adjuvant,192.0,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0108-C25_treatment7,f09d144f-f39a-4ce6-ac4e-8aecebbe6450,,released,Leucovorin Calcium,1,2020-09-17T15:59:54.285311-05:00,Chemotherapy,Residual Disease,
HCM-BROD-0334-C43,03974dc9-0162-4de8-9897-09f88693681a,3d666f1b-58c2-451f-8ebf-87b5caa02aaf,,Neoadjuvant,,2021-03-03T15:15:08.075155-06:00,HCM-BROD-0334-C43_treatment,0c6a4143-1879-4c11-81d0-ceddf33f8f14,,released,,0,2020-07-31T09:27:46.473911-05:00,,,
HCM-BROD-0334-C43,03974dc9-0162-4de8-9897-09f88693681a,3d666f1b-58c2-451f-8ebf-87b5caa02aaf,,Adjuvant,,2021-03-03T15:15:08.075155-06:00,HCM-BROD-0334-C43_treatment6,39ef398d-b0c4-4a41-a8fd-134435e7ba96,,released,,0,2020-07-31T09:27:46.473911-05:00,Targeted Molecular Therapy,Residual Disease,
HCM-BROD-0334-C43,03974dc9-0162-4de8-9897-09f88693681a,3d666f1b-58c2-451f-8ebf-87b5caa02aaf,,,,2023-02-27T12:17:49.052980-06:00,HCM-BROD-0334-C43_treatment5,4c1c747f-94a4-4ffb-8b19-178d83e9a175,,released,,0,2020-07-31T09:27:46.473911-05:00,"Surgery, NOS",Initial Diagnosis,
HCM-BROD-0334-C43,03974dc9-0162-4de8-9897-09f88693681a,3d666f1b-58c2-451f-8ebf-87b5caa02aaf,,Adjuvant,,2021-03-03T15:15:08.075155-06:00,HCM-BROD-0334-C43_treatment7,7ef4348b-c662-43d1-9d75-f3b6e1356164,,released,,0,2020-10-08T12:09:21.914666-05:00,"Radiation Therapy, NOS",Residual Disease,
HCM-BROD-0334-C43,03974dc9-0162-4de8-9897-09f88693681a,3d666f1b-58c2-451f-8ebf-87b5caa02aaf,750.0,Adjuvant,645.0,2021-03-03T15:15:08.075155-06:00,HCM-BROD-0334-C43_treatment4,949e0998-a12d-4d96-b975-3de67b747de5,,released,Pembrolizumab,1,2020-07-31T09:27:46.473911-05:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-BROD-0334-C43,03974dc9-0162-4de8-9897-09f88693681a,3d666f1b-58c2-451f-8ebf-87b5caa02aaf,,Adjuvant,,2021-03-03T15:15:08.075155-06:00,HCM-BROD-0334-C43_treatment3,dc298414-f6a0-4545-9425-b07486390aa3,,released,,0,2020-07-31T09:27:46.473911-05:00,Hormone Therapy,Residual Disease,
HCM-BROD-0334-C43,03974dc9-0162-4de8-9897-09f88693681a,3d666f1b-58c2-451f-8ebf-87b5caa02aaf,,Adjuvant,,2021-03-03T15:15:08.075155-06:00,HCM-BROD-0334-C43_treatment2,f5dd53cd-5dc6-4fb5-bf05-e3bda8024308,,released,,0,2020-07-31T09:27:46.473911-05:00,Chemotherapy,Residual Disease,
HCM-BROD-0334-C43,03974dc9-0162-4de8-9897-09f88693681a,fedc3533-85f7-4fc6-b996-a1f596e021df,750.0,Maintenance Therapy,414.0,2021-03-03T15:15:08.075155-06:00,HCM-BROD-0334-C43_treatment8,253633e8-0988-44aa-b2bd-b9e90c1c896f,Stable Disease,released,Pembrolizumab,1,2020-10-08T12:09:21.914666-05:00,,,
HCM-BROD-0124-C25,03bfeb7c-cecf-4691-8263-33cdfe391ea9,00184ed8-780a-4acf-b5f1-b1fcd6b08dcf,,Adjuvant,,2021-07-12T12:25:55.528644-05:00,HCM-BROD-0124-C25_treatment8,22c54d45-1f98-435a-b598-4a4361551014,,released,,0,2020-09-27T10:37:49.634434-05:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-BROD-0124-C25,03bfeb7c-cecf-4691-8263-33cdfe391ea9,00184ed8-780a-4acf-b5f1-b1fcd6b08dcf,420.0,Adjuvant,359.0,2021-07-12T12:25:55.528644-05:00,HCM-BROD-0124-C25_treatment5,411153f6-4ae6-4f1b-a911-b8d65c5972d2,,released,Fluorouracil,1,2019-04-16T11:21:56.471158-05:00,Chemotherapy,Residual Disease,
HCM-BROD-0124-C25,03bfeb7c-cecf-4691-8263-33cdfe391ea9,00184ed8-780a-4acf-b5f1-b1fcd6b08dcf,420.0,Adjuvant,359.0,2021-07-12T12:25:55.528644-05:00,HCM-BROD-0124-C25_treatment4,69a6a8a2-5dc9-4d93-afa4-d39499e0f8ea,,released,Leucovorin Calcium,1,2019-04-16T11:21:56.471158-05:00,Chemotherapy,Residual Disease,
HCM-BROD-0124-C25,03bfeb7c-cecf-4691-8263-33cdfe391ea9,00184ed8-780a-4acf-b5f1-b1fcd6b08dcf,,Neoadjuvant,,2021-07-12T12:25:55.528644-05:00,HCM-BROD-0124-C25_treatment,8b90777b-2b37-4c7f-a4f1-cd6fb6f3508e,,released,,0,2019-04-16T11:21:56.471158-05:00,,,
HCM-BROD-0124-C25,03bfeb7c-cecf-4691-8263-33cdfe391ea9,00184ed8-780a-4acf-b5f1-b1fcd6b08dcf,290.0,Adjuvant,252.0,2021-07-12T12:25:55.528644-05:00,HCM-BROD-0124-C25_treatment11,8c6e6cdc-0e86-48a9-9a21-31612eaa6b07,,released,,1,2020-09-27T10:37:49.634434-05:00,"Radiation, Intensity-Modulated Radiotherapy",Residual Disease,
HCM-BROD-0124-C25,03bfeb7c-cecf-4691-8263-33cdfe391ea9,00184ed8-780a-4acf-b5f1-b1fcd6b08dcf,420.0,Adjuvant,359.0,2021-07-12T12:25:55.528644-05:00,HCM-BROD-0124-C25_treatment7,97178adc-4981-49cc-9f6a-46fd4c3f6446,,released,,1,2019-04-16T11:21:56.471158-05:00,Chemotherapy,Residual Disease,FOLFIRINOX
HCM-BROD-0124-C25,03bfeb7c-cecf-4691-8263-33cdfe391ea9,00184ed8-780a-4acf-b5f1-b1fcd6b08dcf,420.0,Adjuvant,359.0,2021-07-12T12:25:55.528644-05:00,HCM-BROD-0124-C25_treatment6,bc07a93c-580d-462b-843f-71f8afd612b7,,released,Oxaliplatin,1,2019-04-16T11:21:56.471158-05:00,Chemotherapy,Residual Disease,
HCM-BROD-0124-C25,03bfeb7c-cecf-4691-8263-33cdfe391ea9,00184ed8-780a-4acf-b5f1-b1fcd6b08dcf,420.0,Adjuvant,359.0,2021-07-12T12:25:55.528644-05:00,HCM-BROD-0124-C25_treatment3,c23c32ff-e21e-4284-8e06-7b389aafbfe5,,released,Irinotecan Hydrochloride,1,2019-04-16T11:21:56.471158-05:00,Chemotherapy,Residual Disease,
HCM-BROD-0124-C25,03bfeb7c-cecf-4691-8263-33cdfe391ea9,00184ed8-780a-4acf-b5f1-b1fcd6b08dcf,,Adjuvant,,2021-07-12T12:25:55.528644-05:00,HCM-BROD-0124-C25_treatment10,c4c4b6c7-7d73-475a-9488-79baab61c7cf,,released,,0,2020-09-27T10:37:49.634434-05:00,Targeted Molecular Therapy,Residual Disease,
HCM-BROD-0124-C25,03bfeb7c-cecf-4691-8263-33cdfe391ea9,00184ed8-780a-4acf-b5f1-b1fcd6b08dcf,286.0,Adjuvant,252.0,2021-07-12T12:25:55.528644-05:00,HCM-BROD-0124-C25_treatment2,e19f49d5-f266-4c69-85af-7965f6a7fce5,,released,Fluorouracil,1,2019-04-16T11:21:56.471158-05:00,Chemotherapy,Residual Disease,
HCM-BROD-0124-C25,03bfeb7c-cecf-4691-8263-33cdfe391ea9,00184ed8-780a-4acf-b5f1-b1fcd6b08dcf,,,0.0,2023-02-27T13:20:39.786851-06:00,HCM-BROD-0124-C25_treatment9,f31e96e1-80fc-45a2-807a-b6e9b48fbbc2,,released,,1,2020-09-27T10:37:49.634434-05:00,"Surgery, NOS",Initial Diagnosis,
HCM-EXPT-0976-C50,0418bb63-85f4-4799-9c35-109426c837db,6cb29792-3532-4819-b763-0ef283fc2660,,Neoadjuvant,,2025-10-08T12:37:21.548354-05:00,HCM-EXPT-0976-C50_treatment,fcfe9d04-1cf8-45c8-976e-6d39bd564a62,,released,,0,2021-12-21T14:48:51.555378-06:00,,,
HCM-SANG-0272-C20,043a7275-04cd-414d-bd57-05e3e5926129,64cdd445-b4ee-432b-918d-6f54cc200551,,Neoadjuvant,,2023-07-13T10:35:44.371881-05:00,HCM-SANG-0272-C20_treatment,0e7f4416-9d9d-407d-bb84-6d29df073b81,,released,,0,2021-12-21T15:06:44.982024-06:00,,,
HCM-BROD-0219-C15,04ab7e95-8c7f-466b-9209-11e36c95dbfe,d8323b2d-3963-4622-b7e5-db7446715642,,Neoadjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0219-C15_treatment,27dd29a1-3d45-48da-aede-66ba15e45673,,released,Unknown,1,2020-09-17T16:02:22.848569-05:00,Chemotherapy,,
HCM-BROD-0219-C15,04ab7e95-8c7f-466b-9209-11e36c95dbfe,d8323b2d-3963-4622-b7e5-db7446715642,,,,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0219-C15_treatment4,ad16d389-29f1-4c31-9e5e-0141cccdfd4f,,released,,0,2020-09-17T16:02:22.848569-05:00,"Surgery, NOS",Initial Diagnosis,
HCM-BROD-0219-C15,04ab7e95-8c7f-466b-9209-11e36c95dbfe,d8323b2d-3963-4622-b7e5-db7446715642,1156.0,Adjuvant,1150.0,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0219-C15_treatment6,de17d931-4e16-4386-a433-44c82dbc9452,,released,,1,2020-09-17T16:02:22.848569-05:00,"Radiation, Stereotactic/Gamma Knife/SRS",Residual Disease,
HCM-STAN-0841-C18,04b88744-7738-4bc2-ab67-14545f5b761f,70dc7d1b-95be-48e5-99e0-2dbbb522fe64,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-STAN-0841-C18_treatment6,06ff494e-91e1-4c86-986b-d3ff748a6cca,,released,,0,2022-09-22T07:05:13.869683-05:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-STAN-0841-C18,04b88744-7738-4bc2-ab67-14545f5b761f,70dc7d1b-95be-48e5-99e0-2dbbb522fe64,,Neoadjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-STAN-0841-C18_treatment,171bf083-6150-4490-96b2-f8464ad2436a,,released,,0,2022-09-22T07:05:13.869683-05:00,,,
HCM-STAN-0841-C18,04b88744-7738-4bc2-ab67-14545f5b761f,70dc7d1b-95be-48e5-99e0-2dbbb522fe64,,,193.0,2025-04-07T17:13:09.336794-05:00,HCM-STAN-0841-C18_treatment7,6ed7eecf-3b42-4fa2-af43-48ca875710bb,,released,,1,2022-09-22T07:05:13.869683-05:00,"Surgery, NOS",Initial Diagnosis,
HCM-STAN-0841-C18,04b88744-7738-4bc2-ab67-14545f5b761f,70dc7d1b-95be-48e5-99e0-2dbbb522fe64,972.0,Adjuvant,228.0,2025-04-07T17:13:09.336794-05:00,HCM-STAN-0841-C18_treatment2,79bae04b-36c1-441a-ab98-896d5a20f49e,Treatment Ongoing,released,Leucovorin Calcium,1,2022-09-22T07:05:13.869683-05:00,Chemotherapy,Residual Disease,
HCM-STAN-0841-C18,04b88744-7738-4bc2-ab67-14545f5b761f,70dc7d1b-95be-48e5-99e0-2dbbb522fe64,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-STAN-0841-C18_treatment9,7d17c83f-a9be-40fa-9473-27df49af92c5,,released,,0,2022-09-22T07:05:13.869683-05:00,"Radiation Therapy, NOS",Residual Disease,
HCM-STAN-0841-C18,04b88744-7738-4bc2-ab67-14545f5b761f,70dc7d1b-95be-48e5-99e0-2dbbb522fe64,972.0,Adjuvant,228.0,2025-04-07T17:13:09.336794-05:00,HCM-STAN-0841-C18_treatment3,9340d28e-aa42-4764-a8d2-b0a0aaa5ffa7,Treatment Ongoing,released,Fluorouracil,1,2022-09-22T07:05:13.869683-05:00,Chemotherapy,Residual Disease,
HCM-STAN-0841-C18,04b88744-7738-4bc2-ab67-14545f5b761f,70dc7d1b-95be-48e5-99e0-2dbbb522fe64,972.0,Adjuvant,228.0,2025-04-07T17:13:09.336794-05:00,HCM-STAN-0841-C18_treatment5,a571be1e-0331-4421-8e92-a1c4bfcd233b,Treatment Ongoing,released,,1,2022-09-22T07:05:13.869683-05:00,Chemotherapy,Residual Disease,FOLFIRI
HCM-STAN-0841-C18,04b88744-7738-4bc2-ab67-14545f5b761f,70dc7d1b-95be-48e5-99e0-2dbbb522fe64,972.0,Adjuvant,228.0,2025-04-07T17:13:09.336794-05:00,HCM-STAN-0841-C18_treatment4,b5d69abc-cfdd-4e29-9bc0-43754633f81e,Treatment Ongoing,released,Irinotecan,1,2022-09-22T07:05:13.869683-05:00,Chemotherapy,Residual Disease,
HCM-STAN-0841-C18,04b88744-7738-4bc2-ab67-14545f5b761f,70dc7d1b-95be-48e5-99e0-2dbbb522fe64,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-STAN-0841-C18_treatment8,cf4cd56d-08ed-4369-a4bd-3faf5648bb0a,,released,,0,2022-09-22T07:05:13.869683-05:00,Targeted Molecular Therapy,Residual Disease,
HCM-BROD-0761-C71,04ba3395-30c3-4e6e-964a-fe9f82dd8a97,447911c1-3c4a-4608-9c7b-e022cdd69c71,624.0,Adjuvant,509.0,2023-11-07T14:20:00.017270-06:00,HCM-BROD-0761-C71_treatment7,10be068c-5335-4ef4-bc0a-23f385a1d3fc,,released,Bevacizumab,1,2021-12-21T13:50:46.631914-06:00,Targeted Molecular Therapy,Residual Disease,
HCM-BROD-0761-C71,04ba3395-30c3-4e6e-964a-fe9f82dd8a97,447911c1-3c4a-4608-9c7b-e022cdd69c71,68.0,Adjuvant,19.0,2023-11-07T14:20:00.017270-06:00,HCM-BROD-0761-C71_treatment8,14c44f30-f5c6-4631-bcd2-c8df7122e07c,,released,,1,2021-12-21T13:50:46.631914-06:00,"Radiation, 2D Conventional",Residual Disease,
HCM-BROD-0761-C71,04ba3395-30c3-4e6e-964a-fe9f82dd8a97,447911c1-3c4a-4608-9c7b-e022cdd69c71,266.0,Adjuvant,19.0,2023-11-07T14:20:00.017270-06:00,HCM-BROD-0761-C71_treatment2,683152ba-7eaf-47ed-9a78-c149bb6f3b7f,,released,Temozolomide,1,2021-12-21T13:50:46.631914-06:00,Chemotherapy,Residual Disease,
HCM-BROD-0761-C71,04ba3395-30c3-4e6e-964a-fe9f82dd8a97,447911c1-3c4a-4608-9c7b-e022cdd69c71,,,2.0,2023-11-07T14:20:00.017270-06:00,HCM-BROD-0761-C71_treatment5,6a5e7f09-416b-4397-8ee2-0fa834ed69fa,,released,,1,2021-12-21T13:50:46.631914-06:00,"Surgery, NOS",Initial Diagnosis,
HCM-BROD-0761-C71,04ba3395-30c3-4e6e-964a-fe9f82dd8a97,447911c1-3c4a-4608-9c7b-e022cdd69c71,445.0,Adjuvant,404.0,2023-11-07T14:20:00.017270-06:00,HCM-BROD-0761-C71_treatment3,73e9d2f3-a9d4-4c33-935d-ad873124320b,,released,Lomustine,1,2021-12-21T13:50:46.631914-06:00,Chemotherapy,Residual Disease,
HCM-BROD-0761-C71,04ba3395-30c3-4e6e-964a-fe9f82dd8a97,447911c1-3c4a-4608-9c7b-e022cdd69c71,,Neoadjuvant,,2023-11-07T14:20:00.017270-06:00,HCM-BROD-0761-C71_treatment,9981dd39-f9b6-442d-8eb1-28b2f16b3567,,released,,0,2021-12-21T13:50:46.631914-06:00,,,
HCM-BROD-0761-C71,04ba3395-30c3-4e6e-964a-fe9f82dd8a97,447911c1-3c4a-4608-9c7b-e022cdd69c71,,Adjuvant,,2023-11-07T14:20:00.017270-06:00,HCM-BROD-0761-C71_treatment4,aa354819-2f85-4296-abe0-bcfc6f27c414,,released,,0,2021-12-21T13:50:46.631914-06:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-BROD-0761-C71,04ba3395-30c3-4e6e-964a-fe9f82dd8a97,447911c1-3c4a-4608-9c7b-e022cdd69c71,500.0,Adjuvant,455.0,2023-11-07T14:20:00.017270-06:00,HCM-BROD-0761-C71_treatment6,b33b9b8e-ce39-48ec-b3de-88f41bbd6878,,released,Regorafenib,1,2021-12-21T13:50:46.631914-06:00,Targeted Molecular Therapy,Residual Disease,
HCM-BROD-0719-C43,04c73a4a-8dec-4727-979a-6bc041e5a2f6,005284ee-d67e-47bb-a33d-ac53d11c72f7,504.0,Maintenance Therapy,262.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0719-C43_treatment10,0e074979-bda9-442f-96bf-bd56ba119901,Treatment Ongoing,released,Trametinib,1,2021-12-21T13:48:10.469697-06:00,,,
HCM-BROD-0719-C43,04c73a4a-8dec-4727-979a-6bc041e5a2f6,005284ee-d67e-47bb-a33d-ac53d11c72f7,504.0,Maintenance Therapy,262.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0719-C43_treatment9,f6bae2d7-32fd-4cae-84ec-4a1d93d1c52b,Treatment Ongoing,released,Dabrafenib,1,2021-12-21T13:48:10.469697-06:00,,,
HCM-BROD-0719-C43,04c73a4a-8dec-4727-979a-6bc041e5a2f6,e812b591-3758-4c5f-a3d8-633c631e0302,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0719-C43_treatment2,02646e9f-1a88-4cb7-a703-a587dfd7a37e,,released,,0,2021-12-21T13:48:10.469697-06:00,Chemotherapy,Residual Disease,
HCM-BROD-0719-C43,04c73a4a-8dec-4727-979a-6bc041e5a2f6,e812b591-3758-4c5f-a3d8-633c631e0302,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0719-C43_treatment3,47818ed5-947f-4d72-8d2d-e15ca09f8cad,,released,,0,2021-12-21T13:48:10.469697-06:00,Hormone Therapy,Residual Disease,
HCM-BROD-0719-C43,04c73a4a-8dec-4727-979a-6bc041e5a2f6,e812b591-3758-4c5f-a3d8-633c631e0302,,,0.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0719-C43_treatment5,519bae46-944e-4d20-a430-c229f60a2305,,released,,1,2021-12-21T13:48:10.469697-06:00,"Surgery, NOS",Initial Diagnosis,
HCM-BROD-0719-C43,04c73a4a-8dec-4727-979a-6bc041e5a2f6,e812b591-3758-4c5f-a3d8-633c631e0302,771.0,Adjuvant,250.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0719-C43_treatment6,99d31e97-5ad3-4169-ba73-4a097eea09bd,Treatment Ongoing,released,Dabrafenib,1,2021-12-21T13:48:10.469697-06:00,Targeted Molecular Therapy,Residual Disease,
HCM-BROD-0719-C43,04c73a4a-8dec-4727-979a-6bc041e5a2f6,e812b591-3758-4c5f-a3d8-633c631e0302,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0719-C43_treatment8,a540ffe0-ba24-4a21-9c5b-0801a8dd7e6e,,released,,0,2021-12-21T13:48:10.469697-06:00,"Radiation Therapy, NOS",Residual Disease,
HCM-BROD-0719-C43,04c73a4a-8dec-4727-979a-6bc041e5a2f6,e812b591-3758-4c5f-a3d8-633c631e0302,,Neoadjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0719-C43_treatment,d623f4fd-62eb-41a9-9920-c296ecf63218,,released,,0,2021-12-21T13:48:10.469697-06:00,,,
HCM-BROD-0719-C43,04c73a4a-8dec-4727-979a-6bc041e5a2f6,e812b591-3758-4c5f-a3d8-633c631e0302,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0719-C43_treatment4,dc9a0f04-f747-4bfd-b7bc-f52d26e62558,,released,,0,2021-12-21T13:48:10.469697-06:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-BROD-0719-C43,04c73a4a-8dec-4727-979a-6bc041e5a2f6,e812b591-3758-4c5f-a3d8-633c631e0302,771.0,Adjuvant,250.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0719-C43_treatment7,df1a31c1-f9c3-43e8-bc86-668b37fe0f83,Treatment Ongoing,released,Trametinib,1,2021-12-21T13:48:10.469697-06:00,Targeted Molecular Therapy,Residual Disease,
HCM-BROD-0421-C71,04cbceab-f945-482b-956b-840756a17a4a,252e0d9f-6cdb-4849-b981-e5a5ef0bb151,1619.0,Adjuvant,1470.0,2023-02-22T07:39:25.979291-06:00,HCM-BROD-0421-C71_treatment5,035608cf-fbbd-4e4c-9c7c-f1c821c4d93a,,released,Pembrolizumab,1,2020-09-27T11:34:31.711167-05:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-BROD-0421-C71,04cbceab-f945-482b-956b-840756a17a4a,252e0d9f-6cdb-4849-b981-e5a5ef0bb151,195.0,Adjuvant,92.0,2023-02-22T07:39:25.979291-06:00,HCM-BROD-0421-C71_treatment3,4548d38e-b8d7-470c-9b81-ef54f172b83b,,released,Temozolomide,1,2020-09-27T11:34:31.711167-05:00,Chemotherapy,Residual Disease,
HCM-BROD-0421-C71,04cbceab-f945-482b-956b-840756a17a4a,252e0d9f-6cdb-4849-b981-e5a5ef0bb151,,Neoadjuvant,,2023-02-22T07:39:25.979291-06:00,HCM-BROD-0421-C71_treatment,9a9eb40a-f7bc-4d4e-bf80-7ee7e74e6106,,released,,0,2020-09-27T11:34:31.711167-05:00,,,
HCM-BROD-0421-C71,04cbceab-f945-482b-956b-840756a17a4a,252e0d9f-6cdb-4849-b981-e5a5ef0bb151,1619.0,Adjuvant,1415.0,2023-02-22T07:39:25.979291-06:00,HCM-BROD-0421-C71_treatment7,9c4fb67e-5673-4832-99ac-af32d6ddbe44,,released,Bevacizumab,1,2020-09-27T11:34:31.711167-05:00,Targeted Molecular Therapy,Residual Disease,
HCM-BROD-0421-C71,04cbceab-f945-482b-956b-840756a17a4a,252e0d9f-6cdb-4849-b981-e5a5ef0bb151,59.0,Adjuvant,16.0,2023-02-22T07:39:25.979291-06:00,HCM-BROD-0421-C71_treatment2,a6b3741c-d57a-4074-b050-af7902456d1d,,released,Temozolomide,1,2020-09-27T11:34:31.711167-05:00,Chemotherapy,Residual Disease,
HCM-BROD-0421-C71,04cbceab-f945-482b-956b-840756a17a4a,252e0d9f-6cdb-4849-b981-e5a5ef0bb151,1363.0,Adjuvant,1114.0,2023-02-22T07:39:25.979291-06:00,HCM-BROD-0421-C71_treatment4,ab7dbf9c-d24b-4504-bb37-5a48c7360bcc,,released,Temozolomide,1,2020-09-27T11:34:31.711167-05:00,Chemotherapy,Residual Disease,
HCM-BROD-0421-C71,04cbceab-f945-482b-956b-840756a17a4a,252e0d9f-6cdb-4849-b981-e5a5ef0bb151,59.0,Adjuvant,16.0,2023-02-22T07:39:25.979291-06:00,HCM-BROD-0421-C71_treatment8,ac79ca2f-8daa-4e76-8e85-d3db6485e147,,released,,1,2020-09-27T11:34:31.711167-05:00,"Radiation Therapy, NOS",Residual Disease,
HCM-BROD-0421-C71,04cbceab-f945-482b-956b-840756a17a4a,252e0d9f-6cdb-4849-b981-e5a5ef0bb151,,,-6.0,2023-02-27T13:02:41.519762-06:00,HCM-BROD-0421-C71_treatment6,b5746ecb-94c1-4970-990b-a0b169000e1f,,released,,1,2020-09-27T11:34:31.711167-05:00,"Surgery, NOS",Initial Diagnosis,
HCM-EXPT-1031-C50,05c89194-bca7-43e4-8bb4-feffd9efdb99,ab4ff1e6-f016-4bf0-8eff-cd3e6faf7170,,Neoadjuvant,,2025-10-08T12:38:06.952582-05:00,HCM-EXPT-1031-C50_treatment,1ab65fe8-f18d-4093-a6da-c734fe39dcd7,,released,,0,2021-12-21T14:58:23.101790-06:00,,,
HCM-BROD-0650-C56,05cbd57f-0c12-486e-8ced-edb9ed3cbbb0,1dbca213-579a-4de6-8e8e-54fbad934601,85.0,Maintenance Therapy,7.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0650-C56_treatment11,6135afc7-a4ee-42cf-b84c-aa0db094da8d,Progressive Disease,released,Carboplatin,1,2021-12-21T13:42:44.014507-06:00,,,
HCM-BROD-0650-C56,05cbd57f-0c12-486e-8ced-edb9ed3cbbb0,1dbca213-579a-4de6-8e8e-54fbad934601,85.0,Maintenance Therapy,7.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0650-C56_treatment12,73ec3513-a654-42dd-89a0-428d5a59f664,Progressive Disease,released,Paclitaxel,1,2021-12-21T13:42:44.014507-06:00,,,
HCM-BROD-0650-C56,05cbd57f-0c12-486e-8ced-edb9ed3cbbb0,84104925-47b8-4e5e-95c9-183074ec8172,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0650-C56_treatment7,0c1e99fb-41ed-439e-a0c0-37e8444542b0,,released,,0,2021-12-21T13:42:44.014507-06:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-BROD-0650-C56,05cbd57f-0c12-486e-8ced-edb9ed3cbbb0,84104925-47b8-4e5e-95c9-183074ec8172,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0650-C56_treatment10,3a6b6aa9-a798-4c1f-8264-1ac1efc090bb,,released,,0,2021-12-21T13:42:44.014507-06:00,"Radiation Therapy, NOS",Residual Disease,
HCM-BROD-0650-C56,05cbd57f-0c12-486e-8ced-edb9ed3cbbb0,84104925-47b8-4e5e-95c9-183074ec8172,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0650-C56_treatment9,4abbf9e2-086b-47db-a212-6e98d82a072a,,released,,0,2021-12-21T13:42:44.014507-06:00,Targeted Molecular Therapy,Residual Disease,
HCM-BROD-0650-C56,05cbd57f-0c12-486e-8ced-edb9ed3cbbb0,84104925-47b8-4e5e-95c9-183074ec8172,85.0,Adjuvant,7.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0650-C56_treatment3,61497cca-2497-4550-8cb1-9eb7d235fbec,,released,Carboplatin,1,2021-12-21T13:42:44.014507-06:00,Chemotherapy,Residual Disease,
HCM-BROD-0650-C56,05cbd57f-0c12-486e-8ced-edb9ed3cbbb0,84104925-47b8-4e5e-95c9-183074ec8172,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0650-C56_treatment6,b4464f71-c2f6-4161-bba8-dd097989d3a5,,released,,0,2021-12-21T13:42:44.014507-06:00,Hormone Therapy,Residual Disease,
HCM-BROD-0650-C56,05cbd57f-0c12-486e-8ced-edb9ed3cbbb0,84104925-47b8-4e5e-95c9-183074ec8172,964.0,Adjuvant,670.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0650-C56_treatment5,daf12ba7-4056-4e80-8168-aa6353e38d80,,released,Pegylated Liposomal Doxorubicin Hydrochloride,1,2021-12-21T13:42:44.014507-06:00,Chemotherapy,Residual Disease,
HCM-BROD-0650-C56,05cbd57f-0c12-486e-8ced-edb9ed3cbbb0,84104925-47b8-4e5e-95c9-183074ec8172,964.0,Adjuvant,542.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0650-C56_treatment4,f5ce32de-9ac6-4f7f-ae36-d8fa9efd811c,,released,Paclitaxel,1,2021-12-21T13:42:44.014507-06:00,Chemotherapy,Residual Disease,
HCM-BROD-0095-C15,05f41641-ee22-4d41-bb87-2bfa47cd983f,cd0da3ad-189b-4be0-a8c6-55e0294e7c73,188.0,Adjuvant,146.0,2021-01-06T22:55:10.531130-06:00,HCM-BROD-0095-C15_treatment9,06d60b33-b792-47d4-8979-a246b928eb3d,,released,,1,2020-09-27T10:21:12.325852-05:00,Chemotherapy,Residual Disease,FOLFIRI
HCM-BROD-0095-C15,05f41641-ee22-4d41-bb87-2bfa47cd983f,cd0da3ad-189b-4be0-a8c6-55e0294e7c73,,Adjuvant,,2021-01-06T22:55:10.531130-06:00,HCM-BROD-0095-C15_treatment10,0b4b92e1-8bff-4867-9f37-8677002d28dd,,released,,0,2020-09-27T10:21:12.325852-05:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-BROD-0095-C15,05f41641-ee22-4d41-bb87-2bfa47cd983f,cd0da3ad-189b-4be0-a8c6-55e0294e7c73,,Neoadjuvant,,2021-01-06T22:55:10.531130-06:00,HCM-BROD-0095-C15_treatment,13786225-ac07-401c-aaea-187e26ac4811,,released,,0,2019-04-04T14:07:27.780827-05:00,,,
HCM-BROD-0095-C15,05f41641-ee22-4d41-bb87-2bfa47cd983f,cd0da3ad-189b-4be0-a8c6-55e0294e7c73,67.0,Adjuvant,13.0,2021-01-06T22:55:10.531130-06:00,HCM-BROD-0095-C15_treatment2,25a818a9-bb32-4047-a9ba-d811122cc6a1,,released,Oxaliplatin,1,2019-04-04T14:07:27.780827-05:00,Chemotherapy,Residual Disease,
HCM-BROD-0095-C15,05f41641-ee22-4d41-bb87-2bfa47cd983f,cd0da3ad-189b-4be0-a8c6-55e0294e7c73,215.0,Adjuvant,202.0,2021-01-06T22:55:10.531130-06:00,HCM-BROD-0095-C15_treatment13,62e39ce4-89f3-4c11-8661-82fee15c9e63,,released,,1,2020-09-27T10:21:12.325852-05:00,"Radiation, 3D Conformal",Residual Disease,
HCM-BROD-0095-C15,05f41641-ee22-4d41-bb87-2bfa47cd983f,cd0da3ad-189b-4be0-a8c6-55e0294e7c73,67.0,Adjuvant,13.0,2021-01-06T22:55:10.531130-06:00,HCM-BROD-0095-C15_treatment3,87ca94eb-c580-47cb-9f74-5fe4ae0f0af6,,released,Fluorouracil,1,2019-04-04T14:07:27.780827-05:00,Chemotherapy,Residual Disease,
HCM-BROD-0095-C15,05f41641-ee22-4d41-bb87-2bfa47cd983f,cd0da3ad-189b-4be0-a8c6-55e0294e7c73,188.0,Adjuvant,146.0,2021-01-06T22:55:10.531130-06:00,HCM-BROD-0095-C15_treatment7,87da9764-9695-4823-8aa7-2a810343eb08,,released,Fluorouracil,1,2019-04-04T14:07:27.780827-05:00,Chemotherapy,Residual Disease,
HCM-BROD-0095-C15,05f41641-ee22-4d41-bb87-2bfa47cd983f,cd0da3ad-189b-4be0-a8c6-55e0294e7c73,188.0,Adjuvant,146.0,2021-01-06T22:55:10.531130-06:00,HCM-BROD-0095-C15_treatment6,a7e26bed-3986-4384-bb34-a9134b06a26f,,released,Leucovorin Calcium,1,2019-04-04T14:07:27.780827-05:00,Chemotherapy,Residual Disease,
HCM-BROD-0095-C15,05f41641-ee22-4d41-bb87-2bfa47cd983f,cd0da3ad-189b-4be0-a8c6-55e0294e7c73,104.0,Adjuvant,76.0,2021-01-06T22:55:10.531130-06:00,HCM-BROD-0095-C15_treatment5,bb6c3d4f-c692-4cfd-b59c-1827f011aa6e,,released,Paclitaxel,1,2019-04-04T14:07:27.780827-05:00,Chemotherapy,Residual Disease,
HCM-BROD-0095-C15,05f41641-ee22-4d41-bb87-2bfa47cd983f,cd0da3ad-189b-4be0-a8c6-55e0294e7c73,67.0,Adjuvant,13.0,2021-01-06T22:55:10.531130-06:00,HCM-BROD-0095-C15_treatment4,cf7632b1-4c8c-4ff8-b200-d1c47fbe537f,,released,Leucovorin,1,2019-04-04T14:07:27.780827-05:00,Chemotherapy,Residual Disease,
HCM-BROD-0095-C15,05f41641-ee22-4d41-bb87-2bfa47cd983f,cd0da3ad-189b-4be0-a8c6-55e0294e7c73,,,,2023-02-27T11:24:51.849894-06:00,HCM-BROD-0095-C15_treatment11,d8d1fd47-6099-450c-ae9c-bac16725a0ef,,released,,0,2020-09-27T10:21:12.325852-05:00,"Surgery, NOS",Initial Diagnosis,
HCM-BROD-0095-C15,05f41641-ee22-4d41-bb87-2bfa47cd983f,cd0da3ad-189b-4be0-a8c6-55e0294e7c73,104.0,Adjuvant,76.0,2021-01-06T22:55:10.531130-06:00,HCM-BROD-0095-C15_treatment12,e83c75d4-9a25-4af4-a8fa-106365e15e36,,released,Ramucirumab,1,2020-09-27T10:21:12.325852-05:00,Targeted Molecular Therapy,Residual Disease,
HCM-BROD-0095-C15,05f41641-ee22-4d41-bb87-2bfa47cd983f,cd0da3ad-189b-4be0-a8c6-55e0294e7c73,188.0,Adjuvant,146.0,2021-01-06T22:55:10.531130-06:00,HCM-BROD-0095-C15_treatment8,f48b3c47-f60c-4118-9fe3-b6438dcd60bc,,released,Irinotecan,1,2020-09-27T10:21:12.325852-05:00,Chemotherapy,Residual Disease,
HCM-EXPT-1253-C18,0600672e-3077-4545-bc1d-974ebc60b25c,4de7e41d-1a89-4cd0-b8c4-fda6864a1a2d,,Neoadjuvant,,2025-10-08T12:39:59.137357-05:00,HCM-EXPT-1253-C18_treatment,189513a8-7455-40f9-8715-5ea6d98fed93,,released,,0,2022-03-09T11:53:10.990009-06:00,,,
HCM-SANG-1332-C18,0608526c-70d5-4740-a9eb-1cce282ddd15,036320cc-29c9-4a04-8944-e0b525c73305,,Neoadjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-SANG-1332-C18_treatment,45894e36-cb42-4105-974e-d503b5b011ef,,released,,0,2023-02-27T13:17:38.903011-06:00,,,
HCM-CSHL-0511-C24,0693e8b4-9a8d-4356-9f3f-7da3bf1d202d,febc5b31-1966-455a-9110-5784e5ac89f7,,Adjuvant,,2023-02-22T07:39:25.979291-06:00,HCM-CSHL-0511-C24_treatment3,5346cb40-3501-438c-ad6c-54ca4d022172,,released,,0,2021-11-23T08:37:44.393081-06:00,Hormone Therapy,Residual Disease,
HCM-CSHL-0511-C24,0693e8b4-9a8d-4356-9f3f-7da3bf1d202d,febc5b31-1966-455a-9110-5784e5ac89f7,700.0,Adjuvant,514.0,2023-02-22T07:39:25.979291-06:00,HCM-CSHL-0511-C24_treatment2,6e70ffbc-a9bc-473b-9d45-00f28019b84b,,released,Gemcitabine,1,2021-11-23T08:37:44.393081-06:00,Chemotherapy,Residual Disease,
HCM-CSHL-0511-C24,0693e8b4-9a8d-4356-9f3f-7da3bf1d202d,febc5b31-1966-455a-9110-5784e5ac89f7,,Adjuvant,,2023-02-22T07:39:25.979291-06:00,HCM-CSHL-0511-C24_treatment4,d44836fc-36ba-4f69-9f0a-7b3ec730d888,,released,,0,2021-11-23T08:37:44.393081-06:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-CSHL-0511-C24,0693e8b4-9a8d-4356-9f3f-7da3bf1d202d,febc5b31-1966-455a-9110-5784e5ac89f7,,Neoadjuvant,,2023-02-22T07:39:25.979291-06:00,HCM-CSHL-0511-C24_treatment,dfdf6b34-692c-4015-9d5d-82812db0c822,,released,,0,2021-11-23T08:37:44.393081-06:00,,,
HCM-CSHL-0511-C24,0693e8b4-9a8d-4356-9f3f-7da3bf1d202d,febc5b31-1966-455a-9110-5784e5ac89f7,,,-10.0,2023-02-24T14:21:15.453689-06:00,HCM-CSHL-0511-C24_treatment5,e6ebfc35-3bfb-4ef3-bf68-bf7352c7e675,,released,,1,2021-11-23T08:37:44.393081-06:00,"Surgery, NOS",Initial Diagnosis,
HCM-CSHL-0511-C24,0693e8b4-9a8d-4356-9f3f-7da3bf1d202d,febc5b31-1966-455a-9110-5784e5ac89f7,,Adjuvant,,2023-02-22T07:39:25.979291-06:00,HCM-CSHL-0511-C24_treatment6,f9cfb989-d964-4809-aee7-95594f8056e8,,released,,0,2021-11-23T08:37:44.393081-06:00,Targeted Molecular Therapy,Residual Disease,
HCM-CSHL-0511-C24,0693e8b4-9a8d-4356-9f3f-7da3bf1d202d,febc5b31-1966-455a-9110-5784e5ac89f7,,Adjuvant,,2023-02-22T07:39:25.979291-06:00,HCM-CSHL-0511-C24_treatment7,fe25c9dd-c02d-44de-9641-d6301483b0ca,,released,,0,2021-11-23T08:37:44.393081-06:00,"Radiation Therapy, NOS",Residual Disease,
HCM-CSHL-0811-C55,06a0e127-713b-484d-8617-83f4be109792,4d8f3953-eaeb-48b8-b9f2-b34a64968375,,Neoadjuvant,,2023-07-13T10:27:19.665852-05:00,HCM-CSHL-0811-C55_treatment,465ab6ea-eb39-4dd3-8aa0-c261221b7652,,released,,0,2021-12-21T14:27:22.571706-06:00,,,
HCM-CSHL-0811-C55,06a0e127-713b-484d-8617-83f4be109792,4d8f3953-eaeb-48b8-b9f2-b34a64968375,155.0,Adjuvant,43.0,2023-07-13T10:27:19.665852-05:00,HCM-CSHL-0811-C55_treatment3,5a6071ae-f0bf-4803-add9-06505f211639,,released,Paclitaxel,1,2021-12-21T14:27:22.571706-06:00,Chemotherapy,Residual Disease,
HCM-CSHL-0811-C55,06a0e127-713b-484d-8617-83f4be109792,4d8f3953-eaeb-48b8-b9f2-b34a64968375,,Adjuvant,,2023-07-13T10:27:19.665852-05:00,HCM-CSHL-0811-C55_treatment4,6170a906-5e78-486f-a68f-b7d3bf564f7f,,released,,0,2021-12-21T14:27:22.571706-06:00,Hormone Therapy,Residual Disease,
HCM-CSHL-0811-C55,06a0e127-713b-484d-8617-83f4be109792,4d8f3953-eaeb-48b8-b9f2-b34a64968375,155.0,Adjuvant,43.0,2023-07-13T10:27:19.665852-05:00,HCM-CSHL-0811-C55_treatment2,6b5147d8-b6e1-4c35-8b40-982efdd9ee8b,,released,Carboplatin,1,2021-12-21T14:27:22.571706-06:00,Chemotherapy,Residual Disease,
HCM-CSHL-0811-C55,06a0e127-713b-484d-8617-83f4be109792,4d8f3953-eaeb-48b8-b9f2-b34a64968375,,Adjuvant,,2023-07-13T10:27:19.665852-05:00,HCM-CSHL-0811-C55_treatment7,9b4e570a-ae6e-4c8c-bb0f-38886d15ad40,,released,,0,2021-12-21T14:27:22.571706-06:00,Targeted Molecular Therapy,Residual Disease,
HCM-CSHL-0811-C55,06a0e127-713b-484d-8617-83f4be109792,4d8f3953-eaeb-48b8-b9f2-b34a64968375,,,0.0,2023-07-13T10:27:19.665852-05:00,HCM-CSHL-0811-C55_treatment6,e9cf7190-da98-4475-90e3-e405e8641da2,,released,,1,2021-12-21T14:27:22.571706-06:00,"Surgery, NOS",Initial Diagnosis,
HCM-CSHL-0811-C55,06a0e127-713b-484d-8617-83f4be109792,4d8f3953-eaeb-48b8-b9f2-b34a64968375,218.0,Adjuvant,203.0,2023-07-13T10:27:19.665852-05:00,HCM-CSHL-0811-C55_treatment8,f080e7dd-a31b-4575-825c-feadb8ce3db8,,released,,1,2021-12-21T14:27:22.571706-06:00,"Brachytherapy, High Dose",Residual Disease,
HCM-CSHL-0811-C55,06a0e127-713b-484d-8617-83f4be109792,4d8f3953-eaeb-48b8-b9f2-b34a64968375,,Adjuvant,,2023-07-13T10:27:19.665852-05:00,HCM-CSHL-0811-C55_treatment5,f7fb4320-2959-4801-a2c2-15c63b973e49,,released,,0,2021-12-21T14:27:22.571706-06:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-CSHL-0160-C18,06d42c21-4c97-4171-ac00-3979a51a59d9,c48f812c-f619-4846-830d-0ed2c343372d,,Adjuvant,,2023-03-13T13:21:16.151296-05:00,HCM-CSHL-0160-C18_treatment4,6c150e5c-1650-4df7-9228-0e641839fa16,,released,,0,2020-09-27T13:01:16.032710-05:00,"Radiation Therapy, NOS",Residual Disease,
HCM-CSHL-0160-C18,06d42c21-4c97-4171-ac00-3979a51a59d9,c48f812c-f619-4846-830d-0ed2c343372d,,Adjuvant,,2023-03-13T13:21:16.151296-05:00,HCM-CSHL-0160-C18_treatment3,817438a6-61a4-4323-bad0-0a7d520f2c9e,,released,,0,2020-09-27T13:01:16.032710-05:00,"Pharmaceutical Therapy, NOS",Residual Disease,
HCM-CSHL-0160-C18,06d42c21-4c97-4171-ac00-3979a51a59d9,c48f812c-f619-4846-830d-0ed2c343372d,,Neoadjuvant,,2023-02-22T07:39:25.979291-06:00,HCM-CSHL-0160-C18_treatment,bc9c62c1-d78a-4639-bbf2-af767e512eb2,,released,,0,2020-09-27T13:01:16.032710-05:00,,,
HCM-CSHL-0160-C18,06d42c21-4c97-4171-ac00-3979a51a59d9,c48f812c-f619-4846-830d-0ed2c343372d,,,21.0,2023-03-13T13:21:16.151296-05:00,HCM-CSHL-0160-C18_treatment2,f1b96223-f43e-44e3-90c2-d40909db619d,,released,,1,2020-09-27T13:01:16.032710-05:00,"Surgery, NOS",Initial Diagnosis,
HCM-EXPT-1254-C25,076613eb-16ec-4a9f-9697-8c04661615ad,2db91db1-78a9-4d62-8229-63a0f529a305,,Neoadjuvant,,2025-10-08T12:39:59.137357-05:00,HCM-EXPT-1254-C25_treatment,09d02ea4-1cb4-4c85-921c-f3616d10e1fb,,released,,unknown,2023-02-24T14:03:22.114735-06:00,"Pharmaceutical Therapy, NOS",,
HCM-EXPT-1254-C25,076613eb-16ec-4a9f-9697-8c04661615ad,2db91db1-78a9-4d62-8229-63a0f529a305,,Neoadjuvant,,2025-10-08T12:39:59.137357-05:00,HCM-EXPT-1254-C25_treatment2,154c1acc-1397-489f-b774-90f76d97c48e,,released,,unknown,2023-02-24T14:03:22.114735-06:00,"Radiation Therapy, NOS",,
HCM-SANG-0523-C15,0766560b-53a8-4cc9-8f84-4cbe651a86b9,fec6c448-3817-44ff-8cea-773313801d01,,Neoadjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-SANG-0523-C15_treatment,1c1641b0-3b0b-497e-b816-9e4b90da7a0c,,released,,0,2021-12-21T15:13:23.978010-06:00,,,
HCM-BROD-0417-C71,0798bf7a-53f3-4d88-a863-b4fc186bb5b6,2ed95ded-e81e-403f-ad19-d8c5e132b6f5,287.0,Adjuvant,207.0,2023-02-22T07:39:25.979291-06:00,HCM-BROD-0417-C71_treatment6,075b232d-7e73-49b2-b5c8-2b3afd4ba565,,released,Not Reported,1,2021-04-20T10:32:50.415650-05:00,Targeted Molecular Therapy,Residual Disease,
HCM-BROD-0417-C71,0798bf7a-53f3-4d88-a863-b4fc186bb5b6,2ed95ded-e81e-403f-ad19-d8c5e132b6f5,,,2.0,2023-03-13T12:42:05.390156-05:00,HCM-BROD-0417-C71_treatment4,0e6b4fe5-2c98-4533-af18-ce551b0f33d3,,released,,1,2021-04-20T10:32:50.415650-05:00,"Surgery, NOS",Initial Diagnosis,
HCM-BROD-0417-C71,0798bf7a-53f3-4d88-a863-b4fc186bb5b6,2ed95ded-e81e-403f-ad19-d8c5e132b6f5,501.0,Adjuvant,417.0,2023-02-22T07:39:25.979291-06:00,HCM-BROD-0417-C71_treatment7,2036c0f3-a8b2-4da0-97f8-76838c26a9f1,,released,Bevacizumab,1,2021-04-20T10:32:50.415650-05:00,Targeted Molecular Therapy,Residual Disease,
HCM-BROD-0417-C71,0798bf7a-53f3-4d88-a863-b4fc186bb5b6,2ed95ded-e81e-403f-ad19-d8c5e132b6f5,473.0,Adjuvant,417.0,2023-02-22T07:39:25.979291-06:00,HCM-BROD-0417-C71_treatment3,808803c7-1875-4d43-8d3a-54dc38e3193b,,released,Not Reported,1,2021-04-20T10:32:50.415650-05:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-BROD-0417-C71,0798bf7a-53f3-4d88-a863-b4fc186bb5b6,2ed95ded-e81e-403f-ad19-d8c5e132b6f5,,Neoadjuvant,,2023-02-22T07:39:25.979291-06:00,HCM-BROD-0417-C71_treatment,a785fc8f-fbb8-42be-986e-7a0e26ca7c6d,,released,,0,2021-04-20T10:32:50.415650-05:00,,,
HCM-BROD-0417-C71,0798bf7a-53f3-4d88-a863-b4fc186bb5b6,2ed95ded-e81e-403f-ad19-d8c5e132b6f5,170.0,Adjuvant,31.0,2023-02-22T07:39:25.979291-06:00,HCM-BROD-0417-C71_treatment8,d8bebdca-d458-411a-ae29-a93e90627c0e,,released,,1,2021-04-20T10:32:50.415650-05:00,"Radiation Therapy, NOS",Residual Disease,
HCM-BROD-0417-C71,0798bf7a-53f3-4d88-a863-b4fc186bb5b6,2ed95ded-e81e-403f-ad19-d8c5e132b6f5,403.0,Adjuvant,292.0,2023-02-22T07:39:25.979291-06:00,HCM-BROD-0417-C71_treatment2,fa50446c-61d3-47f7-9f22-b12eb182df44,,released,Lomustine,1,2021-04-20T10:32:50.415650-05:00,Chemotherapy,Residual Disease,
HCM-BROD-0417-C71,0798bf7a-53f3-4d88-a863-b4fc186bb5b6,2ed95ded-e81e-403f-ad19-d8c5e132b6f5,170.0,Adjuvant,31.0,2023-02-22T07:39:25.979291-06:00,HCM-BROD-0417-C71_treatment5,fcbe617c-1a97-47af-ab55-d76a363389bc,,released,Not Reported,1,2021-04-20T10:32:50.415650-05:00,Targeted Molecular Therapy,Residual Disease,
HCM-SANG-0268-C18,07a067d0-7dfc-4817-b4c5-9200da20a59f,78f3dc9e-9b51-42b2-b809-405e438f7f68,,Neoadjuvant,,2023-03-13T13:04:20.351769-05:00,HCM-SANG-0268-C18_treatment,b5337798-181a-4b32-ad3a-2edf84643490,,released,,0,2020-06-15T13:43:49.196827-05:00,,,
HCM-EXPT-1028-C50,07c0dad3-becc-4b8b-a8a3-f9180171911a,727cb19d-91dc-4656-b99c-09e8e2ddb46a,,Neoadjuvant,,2025-10-08T12:37:43.816130-05:00,HCM-EXPT-1028-C50_treatment,115c95a4-15fe-4823-a281-809eb5a4d706,,released,,0,2021-12-21T14:57:59.265751-06:00,,,
HCM-BROD-0351-C49,082faf22-1925-4478-94da-f124da62cd7e,2887b881-43cb-4aa2-b199-82512f517d6d,,Neoadjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0351-C49_treatment,46d578ea-d385-4c61-9a76-c764b9f20d73,,released,,0,2021-12-21T13:36:57.884394-06:00,,,
HCM-BROD-0213-C71,08b22310-e8dd-4638-8c5b-dea48328450e,d45af56c-a54d-4c45-a783-3f1422fad837,226.0,Adjuvant,196.0,2021-01-06T22:55:10.531130-06:00,HCM-BROD-0213-C71_treatment3,3b34f429-0eae-4fda-927a-1a9464ff3a15,,released,Temozolomide,1,2020-02-27T12:36:30.343704-06:00,Chemotherapy,Residual Disease,
HCM-BROD-0213-C71,08b22310-e8dd-4638-8c5b-dea48328450e,d45af56c-a54d-4c45-a783-3f1422fad837,,,-9.0,2023-02-27T11:20:52.729333-06:00,HCM-BROD-0213-C71_treatment6,79198132-fa79-4e67-a4a2-27a9a64a9c4a,,released,,1,2020-02-27T12:36:30.343704-06:00,"Surgery, NOS",Initial Diagnosis,
HCM-BROD-0213-C71,08b22310-e8dd-4638-8c5b-dea48328450e,d45af56c-a54d-4c45-a783-3f1422fad837,,Neoadjuvant,,2021-01-06T22:55:10.531130-06:00,HCM-BROD-0213-C71_treatment,8afa85c0-fd37-4ba7-bae8-55bf7732b89d,,released,,0,2019-04-04T15:04:35.955336-05:00,,,
HCM-BROD-0213-C71,08b22310-e8dd-4638-8c5b-dea48328450e,d45af56c-a54d-4c45-a783-3f1422fad837,,Adjuvant,,2021-01-06T22:55:10.531130-06:00,HCM-BROD-0213-C71_treatment7,8c0bc31c-329f-4bd4-9a93-15e3e83e9ea8,,released,,0,2020-02-27T12:36:30.343704-06:00,Targeted Molecular Therapy,Residual Disease,
HCM-BROD-0213-C71,08b22310-e8dd-4638-8c5b-dea48328450e,d45af56c-a54d-4c45-a783-3f1422fad837,291.0,Adjuvant,287.0,2021-01-06T22:55:10.531130-06:00,HCM-BROD-0213-C71_treatment4,b4902fde-a6cd-4676-9e17-421b6e097d33,,released,Temozolomide,1,2020-02-27T12:36:30.343704-06:00,Chemotherapy,Residual Disease,
HCM-BROD-0213-C71,08b22310-e8dd-4638-8c5b-dea48328450e,d45af56c-a54d-4c45-a783-3f1422fad837,,Adjuvant,,2021-01-06T22:55:10.531130-06:00,HCM-BROD-0213-C71_treatment5,c0638bfa-09d7-4a76-908d-5ce1f3b2fb8e,,released,,0,2020-02-27T12:36:30.343704-06:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-BROD-0213-C71,08b22310-e8dd-4638-8c5b-dea48328450e,d45af56c-a54d-4c45-a783-3f1422fad837,159.0,Adjuvant,133.0,2021-01-06T22:55:10.531130-06:00,HCM-BROD-0213-C71_treatment2,ddc23375-0ed3-47cf-bbd5-aa09bd3bbae4,,released,Temozolomide,1,2020-02-27T12:36:30.343704-06:00,Chemotherapy,Residual Disease,
HCM-BROD-0213-C71,08b22310-e8dd-4638-8c5b-dea48328450e,d45af56c-a54d-4c45-a783-3f1422fad837,92.0,Adjuvant,55.0,2021-01-06T22:55:10.531130-06:00,HCM-BROD-0213-C71_treatment8,fc89a4ca-8655-4273-9adb-b628e8aee9aa,,released,,1,2020-02-27T12:36:30.343704-06:00,"Radiation Therapy, NOS",Residual Disease,
HCM-BROD-1124-C16,08fcc52a-8c11-45bd-bff4-9a3fa5ed7d82,d63c784a-9195-4615-bb26-8eb14dbf9892,21.0,Maintenance Therapy,2.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-1124-C16_treatment7,30c4a3dc-70f3-4f49-87ed-d3d15374ebe1,Progressive Disease,released,Oxaliplatin,1,2023-02-28T13:09:27.190728-06:00,,,
HCM-BROD-1124-C16,08fcc52a-8c11-45bd-bff4-9a3fa5ed7d82,d63c784a-9195-4615-bb26-8eb14dbf9892,21.0,Maintenance Therapy,2.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-1124-C16_treatment6,3d2f7f1e-afa0-4cb1-a06f-1c571fa610bb,Progressive Disease,released,Fluorouracil,1,2023-02-28T13:09:27.190728-06:00,,,
HCM-BROD-1124-C16,08fcc52a-8c11-45bd-bff4-9a3fa5ed7d82,d63c784a-9195-4615-bb26-8eb14dbf9892,21.0,Maintenance Therapy,2.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-1124-C16_treatment5,a542f22a-c621-4783-a7a8-6ca988382d8f,Progressive Disease,released,Leucovorin Calcium,1,2023-02-28T13:09:27.190728-06:00,,,
HCM-BROD-1124-C16,08fcc52a-8c11-45bd-bff4-9a3fa5ed7d82,d63c784a-9195-4615-bb26-8eb14dbf9892,21.0,Maintenance Therapy,2.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-1124-C16_treatment8,a9313852-1564-44f0-9b9c-0907350a50be,Progressive Disease,released,,1,2021-12-21T15:25:03.077169-06:00,,,FOLFOX
HCM-BROD-1124-C16,08fcc52a-8c11-45bd-bff4-9a3fa5ed7d82,d84d887b-8233-44cf-8f8a-d13002d2db4f,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-BROD-1124-C16_treatment4,582d829e-f47f-4bb2-a866-9f8b8aedcccf,,released,,0,2021-12-21T15:25:03.077169-06:00,"Radiation Therapy, NOS",Residual Disease,
HCM-BROD-1124-C16,08fcc52a-8c11-45bd-bff4-9a3fa5ed7d82,d84d887b-8233-44cf-8f8a-d13002d2db4f,,Neoadjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-BROD-1124-C16_treatment,a07a8348-2238-47ae-94ef-cb06f770fdf9,,released,,0,2021-12-21T15:25:03.077169-06:00,,,
HCM-BROD-1124-C16,08fcc52a-8c11-45bd-bff4-9a3fa5ed7d82,d84d887b-8233-44cf-8f8a-d13002d2db4f,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-BROD-1124-C16_treatment3,bdff01c2-1c66-43ba-8272-f7cdf6d66cec,,released,,0,2021-12-21T15:25:03.077169-06:00,"Pharmaceutical Therapy, NOS",Residual Disease,
HCM-BROD-1124-C16,08fcc52a-8c11-45bd-bff4-9a3fa5ed7d82,d84d887b-8233-44cf-8f8a-d13002d2db4f,,,,2025-04-07T17:13:09.336794-05:00,HCM-BROD-1124-C16_treatment2,c4be2787-6ec7-4ec4-b927-a3742715fda8,,released,,0,2021-12-21T15:25:03.077169-06:00,"Surgery, NOS",Initial Diagnosis,
HCM-WCMC-0789-C34,098d387f-beb5-48e2-ad69-537db301dff4,bc0375cc-5ebd-4a56-becb-25387517f575,,Neoadjuvant,,2023-11-07T14:20:00.017270-06:00,HCM-WCMC-0789-C34_treatment,08c1e1aa-3f85-44f1-934a-68c2075ebb93,,released,,0,2023-02-27T11:23:49.787909-06:00,,,
HCM-WCMC-0789-C34,098d387f-beb5-48e2-ad69-537db301dff4,bc0375cc-5ebd-4a56-becb-25387517f575,,Adjuvant,,2023-11-07T14:20:00.017270-06:00,HCM-WCMC-0789-C34_treatment3,256d192d-dfa1-4c1e-bf6f-7291691512ea,,released,,0,2023-02-27T11:23:49.787909-06:00,"Pharmaceutical Therapy, NOS",Residual Disease,
HCM-WCMC-0789-C34,098d387f-beb5-48e2-ad69-537db301dff4,bc0375cc-5ebd-4a56-becb-25387517f575,,Adjuvant,,2023-11-07T14:20:00.017270-06:00,HCM-WCMC-0789-C34_treatment4,7a2c5fab-d297-4140-ae79-c7a3297b1e8c,,released,,0,2023-02-27T11:23:49.787909-06:00,"Radiation Therapy, NOS",Residual Disease,
HCM-WCMC-0789-C34,098d387f-beb5-48e2-ad69-537db301dff4,bc0375cc-5ebd-4a56-becb-25387517f575,,,25.0,2023-11-07T14:20:00.017270-06:00,HCM-WCMC-0789-C34_treatment2,cf57c034-ed6e-4582-a6eb-d08e54b23906,,released,,1,2023-02-27T11:23:49.787909-06:00,"Surgery, NOS",Initial Diagnosis,
HCM-WCMC-0786-C34,0992e3ff-b15d-4985-988d-8f0a05e717a7,6e68afd7-ab31-4c6e-aa87-9c81d00c4fe7,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-WCMC-0786-C34_treatment7,06314ab6-b94c-41fd-884f-7acb631c37b1,,released,,0,2023-02-27T12:28:39.745293-06:00,"Radiation Therapy, NOS",Residual Disease,
HCM-WCMC-0786-C34,0992e3ff-b15d-4985-988d-8f0a05e717a7,6e68afd7-ab31-4c6e-aa87-9c81d00c4fe7,305.0,Adjuvant,291.0,2025-04-07T17:13:09.336794-05:00,HCM-WCMC-0786-C34_treatment2,15303a97-ce1f-4f89-9755-9db725ba1a95,,released,Paclitaxel,1,2023-02-27T12:28:39.745293-06:00,Chemotherapy,Residual Disease,
HCM-WCMC-0786-C34,0992e3ff-b15d-4985-988d-8f0a05e717a7,6e68afd7-ab31-4c6e-aa87-9c81d00c4fe7,,Neoadjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-WCMC-0786-C34_treatment,24a0555e-0039-4947-9860-557956304e15,,released,,0,2023-02-27T12:28:39.745293-06:00,,,
HCM-WCMC-0786-C34,0992e3ff-b15d-4985-988d-8f0a05e717a7,6e68afd7-ab31-4c6e-aa87-9c81d00c4fe7,291.0,Adjuvant,291.0,2025-04-07T17:13:09.336794-05:00,HCM-WCMC-0786-C34_treatment3,61df2902-329d-437a-b6e5-c01522f3466d,,released,Carboplatin,1,2023-02-27T12:28:39.745293-06:00,Chemotherapy,Residual Disease,
HCM-WCMC-0786-C34,0992e3ff-b15d-4985-988d-8f0a05e717a7,6e68afd7-ab31-4c6e-aa87-9c81d00c4fe7,291.0,Adjuvant,291.0,2025-04-07T17:13:09.336794-05:00,HCM-WCMC-0786-C34_treatment4,7ba197e5-df62-4665-9b6d-f3d55278f988,,released,Pembrolizumab,1,2023-02-27T12:28:39.745293-06:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-WCMC-0786-C34,0992e3ff-b15d-4985-988d-8f0a05e717a7,6e68afd7-ab31-4c6e-aa87-9c81d00c4fe7,,,0.0,2025-04-07T17:13:09.336794-05:00,HCM-WCMC-0786-C34_treatment5,c15dc135-c8da-41d2-8b92-cf3fa8d4f33c,,released,,1,2023-02-27T12:28:39.745293-06:00,"Surgery, NOS",Initial Diagnosis,
HCM-WCMC-0786-C34,0992e3ff-b15d-4985-988d-8f0a05e717a7,6e68afd7-ab31-4c6e-aa87-9c81d00c4fe7,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-WCMC-0786-C34_treatment6,cb0944be-1735-4c00-84fb-093df78b4982,,released,,0,2023-02-27T12:28:39.745293-06:00,Targeted Molecular Therapy,Residual Disease,
HCM-EXPT-0941-C50,0a5b4efe-4ebe-492f-bee0-4a09e8da44c0,40c9c07d-04ee-411b-a1b0-3ddca18cfe94,,Neoadjuvant,,2025-10-08T12:36:57.024699-05:00,HCM-EXPT-0941-C50_treatment,8814664f-ef0e-4381-8e59-49d5785df5eb,,released,,0,2021-12-21T14:47:01.332306-06:00,,,
HCM-WCMC-0505-C16,0a66800c-c5e6-4fc9-ba09-a147107b721c,90f8d3f9-cc69-4560-92e2-59c7446ba14b,,Adjuvant,,2023-07-13T10:35:44.371881-05:00,HCM-WCMC-0505-C16_treatment4,6378084b-75f3-4e61-81a0-6bc1f7c7cb2a,,released,,0,2023-02-27T13:00:43.499335-06:00,"Radiation Therapy, NOS",Residual Disease,
HCM-WCMC-0505-C16,0a66800c-c5e6-4fc9-ba09-a147107b721c,90f8d3f9-cc69-4560-92e2-59c7446ba14b,,Neoadjuvant,,2023-07-13T10:35:44.371881-05:00,HCM-WCMC-0505-C16_treatment,6c1a7f3d-47ed-4c37-9f9b-9402fde67b13,,released,,0,2023-02-27T13:00:43.499335-06:00,,,
HCM-WCMC-0505-C16,0a66800c-c5e6-4fc9-ba09-a147107b721c,90f8d3f9-cc69-4560-92e2-59c7446ba14b,,Adjuvant,,2023-07-13T10:35:44.371881-05:00,HCM-WCMC-0505-C16_treatment3,d5c837b6-442e-47c6-925e-95c713e1fbdd,,released,,0,2023-02-27T13:00:43.499335-06:00,"Pharmaceutical Therapy, NOS",Residual Disease,
HCM-WCMC-0505-C16,0a66800c-c5e6-4fc9-ba09-a147107b721c,90f8d3f9-cc69-4560-92e2-59c7446ba14b,,,76.0,2023-07-13T10:35:44.371881-05:00,HCM-WCMC-0505-C16_treatment2,de785988-f6db-442a-ad23-f3c0bf955cf1,,released,,1,2023-02-27T13:00:43.499335-06:00,"Surgery, NOS",Initial Diagnosis,
HCM-SANG-0271-D12,0a6a14db-ca5c-4bf9-9125-611d672bc67b,17a41ef7-aafc-4b70-8d8f-484dc5cd27bd,,Neoadjuvant,,2023-02-22T07:39:25.979291-06:00,HCM-SANG-0271-D12_treatment,dea7bc4e-95ec-4d75-9c97-c041a3438f90,,released,,0,2021-12-21T15:06:43.990965-06:00,,,
HCM-CSHL-1266-C20,0ae6526b-17fa-4a08-b79c-916942feb7a1,12b7cade-4170-400c-8e08-0805ad91cc02,,Neoadjuvant,62.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-1266-C20_treatment3,007b33dc-7e90-4874-a417-40ea1982b8f7,,released,Oxaliplatin,1,2021-12-23T08:40:01.625113-06:00,Chemotherapy,,
HCM-CSHL-1266-C20,0ae6526b-17fa-4a08-b79c-916942feb7a1,12b7cade-4170-400c-8e08-0805ad91cc02,353.0,Adjuvant,276.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-1266-C20_treatment11,013e6560-da72-4750-abba-57e221029790,,released,Irinotecan,1,2021-12-23T08:40:01.625113-06:00,Chemotherapy,Residual Disease,
HCM-CSHL-1266-C20,0ae6526b-17fa-4a08-b79c-916942feb7a1,12b7cade-4170-400c-8e08-0805ad91cc02,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-1266-C20_treatment16,0ec74170-2ddb-46e0-9741-fda2b198fd89,,released,,0,2021-12-23T08:40:01.625113-06:00,Targeted Molecular Therapy,Residual Disease,
HCM-CSHL-1266-C20,0ae6526b-17fa-4a08-b79c-916942feb7a1,12b7cade-4170-400c-8e08-0805ad91cc02,234.0,Adjuvant,72.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-1266-C20_treatment7,1740b04a-5781-46c3-be4f-a6ed27d68ccd,,released,Irinotecan,1,2021-12-23T08:40:01.625113-06:00,Chemotherapy,Residual Disease,
HCM-CSHL-1266-C20,0ae6526b-17fa-4a08-b79c-916942feb7a1,12b7cade-4170-400c-8e08-0805ad91cc02,353.0,Adjuvant,276.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-1266-C20_treatment9,3ee4a5b6-39f1-44e1-9ac5-350b9dfe4efd,,released,Ziv-Aflibercept,1,2021-12-23T08:40:01.625113-06:00,Chemotherapy,Residual Disease,
HCM-CSHL-1266-C20,0ae6526b-17fa-4a08-b79c-916942feb7a1,12b7cade-4170-400c-8e08-0805ad91cc02,353.0,Adjuvant,276.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-1266-C20_treatment12,5cd8f706-b54e-42fa-87b9-3a293905482c,,released,Fluorouracil,1,2021-12-23T08:40:01.625113-06:00,Chemotherapy,Residual Disease,
HCM-CSHL-1266-C20,0ae6526b-17fa-4a08-b79c-916942feb7a1,12b7cade-4170-400c-8e08-0805ad91cc02,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-1266-C20_treatment17,85c0bc08-1cef-434e-a161-97d0168e6269,,released,,0,2021-12-23T08:40:01.625113-06:00,"Radiation Therapy, NOS",Residual Disease,
HCM-CSHL-1266-C20,0ae6526b-17fa-4a08-b79c-916942feb7a1,12b7cade-4170-400c-8e08-0805ad91cc02,234.0,Adjuvant,72.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-1266-C20_treatment5,86a8d90a-ba3d-4898-9ce3-94b678c769a2,,released,Leucovorin Calcium,1,2021-12-23T08:40:01.625113-06:00,Chemotherapy,Residual Disease,
HCM-CSHL-1266-C20,0ae6526b-17fa-4a08-b79c-916942feb7a1,12b7cade-4170-400c-8e08-0805ad91cc02,234.0,Adjuvant,72.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-1266-C20_treatment6,88823610-f2f2-4990-87e5-64bbcbeebaa6,,released,Fluorouracil,1,2021-12-23T08:40:01.625113-06:00,Chemotherapy,Residual Disease,
HCM-CSHL-1266-C20,0ae6526b-17fa-4a08-b79c-916942feb7a1,12b7cade-4170-400c-8e08-0805ad91cc02,,Neoadjuvant,62.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-1266-C20_treatment4,b03f49f6-e1c6-4200-8b79-70ad0e7a057e,,released,,1,2021-12-23T08:40:01.625113-06:00,Chemotherapy,,FOLFOX
HCM-CSHL-1266-C20,0ae6526b-17fa-4a08-b79c-916942feb7a1,12b7cade-4170-400c-8e08-0805ad91cc02,234.0,Adjuvant,72.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-1266-C20_treatment8,b7b13645-bfb3-41c7-872e-5663cae00c5f,,released,,1,2021-12-23T08:40:01.625113-06:00,Chemotherapy,Residual Disease,FOLFIRI
HCM-CSHL-1266-C20,0ae6526b-17fa-4a08-b79c-916942feb7a1,12b7cade-4170-400c-8e08-0805ad91cc02,,Neoadjuvant,62.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-1266-C20_treatment2,bec9c582-75f2-49d8-8c53-79801b79ee47,,released,Fluorouracil,1,2021-12-23T08:40:01.625113-06:00,Chemotherapy,,
HCM-CSHL-1266-C20,0ae6526b-17fa-4a08-b79c-916942feb7a1,12b7cade-4170-400c-8e08-0805ad91cc02,353.0,Adjuvant,276.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-1266-C20_treatment13,cb7bfcbf-6108-4709-b676-88082c3d5124,,released,,1,2021-12-23T08:40:01.625113-06:00,Chemotherapy,Residual Disease,FOLFIRI
HCM-CSHL-1266-C20,0ae6526b-17fa-4a08-b79c-916942feb7a1,12b7cade-4170-400c-8e08-0805ad91cc02,,,395.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-1266-C20_treatment15,ce106a72-be9f-4198-a859-13368b80c414,,released,,1,2021-12-23T08:40:01.625113-06:00,"Surgery, NOS",Initial Diagnosis,
HCM-CSHL-1266-C20,0ae6526b-17fa-4a08-b79c-916942feb7a1,12b7cade-4170-400c-8e08-0805ad91cc02,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-1266-C20_treatment14,e8f57f9a-d340-40b8-8c08-1a30910e42d9,,released,,0,2021-12-23T08:40:01.625113-06:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-CSHL-1266-C20,0ae6526b-17fa-4a08-b79c-916942feb7a1,12b7cade-4170-400c-8e08-0805ad91cc02,,Neoadjuvant,62.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-1266-C20_treatment,ebffdbea-f148-49af-963d-276ab0972bb6,,released,Leucovorin Calcium,1,2021-12-23T08:40:01.625113-06:00,Chemotherapy,,
HCM-CSHL-1266-C20,0ae6526b-17fa-4a08-b79c-916942feb7a1,12b7cade-4170-400c-8e08-0805ad91cc02,353.0,Adjuvant,276.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-1266-C20_treatment10,efa7daa1-787c-4b11-83e3-881cd51fef8e,,released,Leucovorin Calcium,1,2021-12-23T08:40:01.625113-06:00,Chemotherapy,Residual Disease,
HCM-CSHL-1266-C20,0ae6526b-17fa-4a08-b79c-916942feb7a1,56369e46-5db3-4c47-8f10-f032090e2e39,234.0,Maintenance Therapy,62.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-1266-C20_treatment23,46a2aeda-d541-4d42-ac1b-95da9c0bd162,Stable Disease,released,Fluorouracil,1,2021-12-23T08:40:01.625113-06:00,,,
HCM-CSHL-1266-C20,0ae6526b-17fa-4a08-b79c-916942feb7a1,56369e46-5db3-4c47-8f10-f032090e2e39,234.0,Maintenance Therapy,62.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-1266-C20_treatment24,6886add6-7359-4e82-9750-56755b1ab817,Stable Disease,released,Oxaliplatin,1,2021-12-23T08:40:01.625113-06:00,,,
HCM-CSHL-1266-C20,0ae6526b-17fa-4a08-b79c-916942feb7a1,56369e46-5db3-4c47-8f10-f032090e2e39,234.0,Maintenance Therapy,62.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-1266-C20_treatment22,afaf75c4-ff0c-4d24-8b3a-d09da719a58e,Stable Disease,released,Leucovorin Calcium,1,2021-12-23T08:40:01.625113-06:00,,,
HCM-CSHL-1266-C20,0ae6526b-17fa-4a08-b79c-916942feb7a1,56369e46-5db3-4c47-8f10-f032090e2e39,234.0,Maintenance Therapy,62.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-1266-C20_treatment25,f4a9dc35-1043-444b-a915-43900f39ae67,Stable Disease,released,,1,2021-12-23T08:40:01.625113-06:00,,,FOLFOX
HCM-CSHL-1266-C20,0ae6526b-17fa-4a08-b79c-916942feb7a1,9f9a8e10-e68a-4f57-8fce-6593c12d30a1,234.0,Maintenance Therapy,62.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-1266-C20_treatment21,23c22f5c-8e6f-414b-942b-eade2e04a3f7,Stable Disease,released,,1,2021-12-23T08:40:01.625113-06:00,,,FOLFOX
HCM-CSHL-1266-C20,0ae6526b-17fa-4a08-b79c-916942feb7a1,9f9a8e10-e68a-4f57-8fce-6593c12d30a1,234.0,Maintenance Therapy,62.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-1266-C20_treatment20,40b023fa-79d2-435d-bdc6-fa368e0ac036,Stable Disease,released,Oxaliplatin,1,2021-12-23T08:40:01.625113-06:00,,,
HCM-CSHL-1266-C20,0ae6526b-17fa-4a08-b79c-916942feb7a1,9f9a8e10-e68a-4f57-8fce-6593c12d30a1,234.0,Maintenance Therapy,62.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-1266-C20_treatment19,56785918-1afa-4afc-804c-06b19a104328,Stable Disease,released,Fluorouracil,1,2021-12-23T08:40:01.625113-06:00,,,
HCM-CSHL-1266-C20,0ae6526b-17fa-4a08-b79c-916942feb7a1,9f9a8e10-e68a-4f57-8fce-6593c12d30a1,234.0,Maintenance Therapy,62.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-1266-C20_treatment18,60c28853-47d9-4867-9316-0f21897ea661,Stable Disease,released,Leucovorin Calcium,1,2021-12-23T08:40:01.625113-06:00,,,
HCM-CSHL-0366-C50,0bbe1b04-f582-453c-9070-7aafc07912fe,56367e18-176b-432a-8389-889547888a87,,Adjuvant,316.0,2020-10-20T19:20:06.800740-05:00,HCM-CSHL-0366-C50_treatment6,03bfd8c1-3387-47b9-8b85-c37d3bc76a21,,released,Exemestane,1,2020-02-27T12:51:45.340980-06:00,Hormone Therapy,Residual Disease,
HCM-CSHL-0366-C50,0bbe1b04-f582-453c-9070-7aafc07912fe,56367e18-176b-432a-8389-889547888a87,,,125.0,2023-02-24T14:44:14.295292-06:00,HCM-CSHL-0366-C50_treatment9,1525b875-71bd-4043-b4c2-8954ab613afd,,released,,1,2020-02-27T12:51:45.340980-06:00,"Surgery, NOS",Initial Diagnosis,
HCM-CSHL-0366-C50,0bbe1b04-f582-453c-9070-7aafc07912fe,56367e18-176b-432a-8389-889547888a87,,Neoadjuvant,40.0,2020-10-20T19:20:06.800740-05:00,HCM-CSHL-0366-C50_treatment4,26d47359-aaa2-42b8-863d-ae40fc41a300,,released,,1,2020-02-27T12:51:45.340980-06:00,Chemotherapy,,dose-dense AC
HCM-CSHL-0366-C50,0bbe1b04-f582-453c-9070-7aafc07912fe,56367e18-176b-432a-8389-889547888a87,,Adjuvant,,2020-10-20T19:20:06.800740-05:00,HCM-CSHL-0366-C50_treatment5,3b2ab66c-ea4d-4bd9-9c85-ee8a9db4eec6,,released,,0,2020-02-27T12:51:45.340980-06:00,Chemotherapy,Residual Disease,
HCM-CSHL-0366-C50,0bbe1b04-f582-453c-9070-7aafc07912fe,56367e18-176b-432a-8389-889547888a87,,Neoadjuvant,40.0,2020-10-20T19:20:06.800740-05:00,HCM-CSHL-0366-C50_treatment,60899f92-ae3b-46e6-a9fb-6cf711448feb,,released,Paclitaxel,1,2020-02-27T12:51:45.340980-06:00,Chemotherapy,,
HCM-CSHL-0366-C50,0bbe1b04-f582-453c-9070-7aafc07912fe,56367e18-176b-432a-8389-889547888a87,,Neoadjuvant,40.0,2020-10-20T19:20:06.800740-05:00,HCM-CSHL-0366-C50_treatment3,72209bf4-d388-438d-ba03-6495c83c7582,,released,Cyclophosphamide,1,2020-02-27T12:51:45.340980-06:00,Chemotherapy,,
HCM-CSHL-0366-C50,0bbe1b04-f582-453c-9070-7aafc07912fe,56367e18-176b-432a-8389-889547888a87,,Adjuvant,,2020-10-20T19:20:06.800740-05:00,HCM-CSHL-0366-C50_treatment8,7f87ead4-5a6e-4cb2-9115-1cae7ca93a0a,,released,,0,2020-02-27T12:51:45.340980-06:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-CSHL-0366-C50,0bbe1b04-f582-453c-9070-7aafc07912fe,56367e18-176b-432a-8389-889547888a87,,Adjuvant,,2020-10-20T19:20:06.800740-05:00,HCM-CSHL-0366-C50_treatment7,9127e258-c5a2-4678-948c-ba056bea7b42,,released,Not Reported,1,2020-02-27T12:51:45.340980-06:00,Hormone Therapy,Residual Disease,
HCM-CSHL-0366-C50,0bbe1b04-f582-453c-9070-7aafc07912fe,56367e18-176b-432a-8389-889547888a87,,Adjuvant,316.0,2020-10-20T19:20:06.800740-05:00,HCM-CSHL-0366-C50_treatment10,931e6d88-84c9-446d-a617-c2e737f08052,,released,Everolimus,1,2020-09-28T09:49:02.526747-05:00,Targeted Molecular Therapy,Residual Disease,
HCM-CSHL-0366-C50,0bbe1b04-f582-453c-9070-7aafc07912fe,56367e18-176b-432a-8389-889547888a87,236.0,Adjuvant,212.0,2020-10-20T19:20:06.800740-05:00,HCM-CSHL-0366-C50_treatment11,c3e20a17-7eb4-4aa0-a9ab-f66cc6f7a8ff,,released,,1,2020-09-28T09:49:02.526747-05:00,"Radiation, Intensity-Modulated Radiotherapy",Residual Disease,
HCM-CSHL-0366-C50,0bbe1b04-f582-453c-9070-7aafc07912fe,56367e18-176b-432a-8389-889547888a87,,Neoadjuvant,40.0,2020-10-20T19:20:06.800740-05:00,HCM-CSHL-0366-C50_treatment2,eb3819db-1236-4659-bf31-dcd5d84fe964,,released,Doxorubicin Hydrochloride,1,2020-02-27T12:51:45.340980-06:00,Chemotherapy,,
HCM-CSHL-0835-C20,0bc32bb1-1770-41cc-8b98-71498a3d7c21,bd14ed25-55ef-4309-b57e-8a47b40e7dfc,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0835-C20_treatment3,7274a069-23ff-4515-a3d4-ba4b09901830,,released,Capecitabine,1,2021-12-21T14:31:56.060828-06:00,Chemotherapy,Residual Disease,
HCM-CSHL-0835-C20,0bc32bb1-1770-41cc-8b98-71498a3d7c21,bd14ed25-55ef-4309-b57e-8a47b40e7dfc,,,1260.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0835-C20_treatment6,741be78a-842c-4a29-9253-60310d863d14,,released,,1,2021-12-21T14:31:56.060828-06:00,"Surgery, NOS",Initial Diagnosis,
HCM-CSHL-0835-C20,0bc32bb1-1770-41cc-8b98-71498a3d7c21,bd14ed25-55ef-4309-b57e-8a47b40e7dfc,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0835-C20_treatment4,77c91739-6a04-4b40-9d6b-99f9ddc8965f,,released,,0,2021-12-21T14:31:56.060828-06:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-CSHL-0835-C20,0bc32bb1-1770-41cc-8b98-71498a3d7c21,bd14ed25-55ef-4309-b57e-8a47b40e7dfc,,,865.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0835-C20_treatment5,8e53f865-eae1-44ce-9fc1-2af1437079ef,,released,,1,2021-12-21T14:31:56.060828-06:00,"Surgery, NOS",Initial Diagnosis,
HCM-CSHL-0835-C20,0bc32bb1-1770-41cc-8b98-71498a3d7c21,bd14ed25-55ef-4309-b57e-8a47b40e7dfc,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0835-C20_treatment7,ba7d9c62-018d-46d0-8767-4915790df1e9,,released,,0,2021-12-21T14:31:56.060828-06:00,Targeted Molecular Therapy,Residual Disease,
HCM-CSHL-0835-C20,0bc32bb1-1770-41cc-8b98-71498a3d7c21,eed15fc5-faf6-482a-8e93-d1e1ecc2ecf2,1212.0,Maintenance Therapy,932.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0835-C20_treatment9,242ab1d8-d67c-4375-95c1-4108f2589ae1,Stable Disease,released,Xeloda,1,2021-12-21T14:31:56.060828-06:00,,,
HCM-SANG-0552-C25,0bcbe03e-51c9-45d8-bc88-34ebada85d3e,a71b3306-27d3-4311-951b-dd43ce73f84b,,Neoadjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-SANG-0552-C25_treatment,07a3a087-d621-49b1-9029-23338bbdc85c,,released,,0,2023-02-27T12:13:08.606836-06:00,,,
HCM-WCMC-0673-C56,0bcca666-3c62-4eb9-a47c-93bb7c020ad6,896de6c7-0272-40b4-a48f-736627753c90,,Neoadjuvant,,2023-02-22T07:39:25.979291-06:00,HCM-WCMC-0673-C56_treatment10,efa821b2-fd8e-4da6-abbf-30dcede71e59,No Response,released,,1,2022-07-13T17:51:20.407651-05:00,Chemotherapy,,
HCM-WCMC-0673-C56,0bcca666-3c62-4eb9-a47c-93bb7c020ad6,b7b4bdb9-dece-403c-a46d-bfe8344b0c27,,,,2023-02-27T11:32:53.810890-06:00,HCM-WCMC-0673-C56_treatment6,0b09216f-c993-4460-9a6b-1e9f05830b80,,released,,0,2022-07-13T17:51:20.407651-05:00,"Surgery, NOS",Initial Diagnosis,
HCM-WCMC-0673-C56,0bcca666-3c62-4eb9-a47c-93bb7c020ad6,b7b4bdb9-dece-403c-a46d-bfe8344b0c27,,Neoadjuvant,37.0,2023-02-22T07:39:25.979291-06:00,HCM-WCMC-0673-C56_treatment,3e9a49d4-4513-4d9d-a7e3-dc11a4d677cd,,released,,1,2022-07-13T17:51:20.407651-05:00,Chemotherapy,,
HCM-WCMC-0673-C56,0bcca666-3c62-4eb9-a47c-93bb7c020ad6,b7b4bdb9-dece-403c-a46d-bfe8344b0c27,,Neoadjuvant,,2023-02-22T07:39:25.979291-06:00,HCM-WCMC-0673-C56_treatment9,65aef658-ca92-4dc8-8857-5c9dc6df72c8,No Response,released,,1,2022-07-13T17:51:20.407651-05:00,Chemotherapy,,
HCM-WCMC-0673-C56,0bcca666-3c62-4eb9-a47c-93bb7c020ad6,b7b4bdb9-dece-403c-a46d-bfe8344b0c27,142.0,Adjuvant,142.0,2023-02-22T07:39:25.979291-06:00,HCM-WCMC-0673-C56_treatment3,dc417814-fac5-48d6-91a2-dbea6e90ee4c,,released,Carboplatin,1,2022-07-13T17:51:20.407651-05:00,Chemotherapy,Residual Disease,
HCM-WCMC-0673-C56,0bcca666-3c62-4eb9-a47c-93bb7c020ad6,b7b4bdb9-dece-403c-a46d-bfe8344b0c27,142.0,Adjuvant,142.0,2023-02-22T07:39:25.979291-06:00,HCM-WCMC-0673-C56_treatment2,e6afde08-19d3-4892-8838-92dfd157952f,,released,Paclitaxel,1,2022-07-13T17:51:20.407651-05:00,Chemotherapy,Residual Disease,
HCM-CSHL-0512-C24,0cafd069-029f-449d-97ce-b69009a80d80,c4f9e2d2-d399-4baa-b172-e024f9ed01fc,,Neoadjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0512-C24_treatment,15f1fc6b-f074-41b1-81d0-06d8253514c3,,released,,0,2021-12-21T14:06:23.747147-06:00,,,
HCM-CSHL-0512-C24,0cafd069-029f-449d-97ce-b69009a80d80,c4f9e2d2-d399-4baa-b172-e024f9ed01fc,,,-11.0,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0512-C24_treatment2,a4211d3b-abaa-4ba7-a08e-2d05926c5d62,,released,,1,2021-12-21T14:06:23.747147-06:00,"Surgery, NOS",Initial Diagnosis,
HCM-BROD-0555-C15,0cd60ea0-92de-44fa-86be-c75842b4123e,3b045dfa-c32b-4998-99db-1a2dced80314,,Neoadjuvant,39.0,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0555-C15_treatment3,0078ab58-2cba-4291-b981-a48fb728d67c,,released,Oxaliplatin,1,2020-09-27T11:57:35.545995-05:00,Chemotherapy,,
HCM-BROD-0555-C15,0cd60ea0-92de-44fa-86be-c75842b4123e,3b045dfa-c32b-4998-99db-1a2dced80314,14.0,Adjuvant,4.0,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0555-C15_treatment8,169d1f10-9c9d-44b6-b1d7-8a879e406b0d,,released,,1,2020-09-27T11:57:35.545995-05:00,Chemotherapy,Residual Disease,FOLFOX
HCM-BROD-0555-C15,0cd60ea0-92de-44fa-86be-c75842b4123e,3b045dfa-c32b-4998-99db-1a2dced80314,14.0,Adjuvant,4.0,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0555-C15_treatment7,27d6f45f-8030-41ff-b3fc-1cc714ee8b24,,released,Oxaliplatin,1,2020-09-27T11:57:35.545995-05:00,Chemotherapy,Residual Disease,
HCM-BROD-0555-C15,0cd60ea0-92de-44fa-86be-c75842b4123e,3b045dfa-c32b-4998-99db-1a2dced80314,,Neoadjuvant,39.0,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0555-C15_treatment4,2cc4389d-b8bb-44e1-b23f-a358518fbadd,,released,,1,2020-09-27T11:57:35.545995-05:00,Chemotherapy,,FOLFOX
HCM-BROD-0555-C15,0cd60ea0-92de-44fa-86be-c75842b4123e,3b045dfa-c32b-4998-99db-1a2dced80314,14.0,Adjuvant,4.0,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0555-C15_treatment5,964f08ef-221b-4c3e-8954-84610702e1e5,,released,Leucovorin Calcium,1,2020-09-27T11:57:35.545995-05:00,Chemotherapy,Residual Disease,
HCM-BROD-0555-C15,0cd60ea0-92de-44fa-86be-c75842b4123e,3b045dfa-c32b-4998-99db-1a2dced80314,,Adjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0555-C15_treatment12,9921979f-f96c-4071-ae9e-5ee12a90849a,,released,,0,2020-09-27T11:57:35.545995-05:00,"Radiation Therapy, NOS",Residual Disease,
HCM-BROD-0555-C15,0cd60ea0-92de-44fa-86be-c75842b4123e,3b045dfa-c32b-4998-99db-1a2dced80314,14.0,Adjuvant,4.0,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0555-C15_treatment6,ba811f38-d575-4b62-aab0-02777586512e,,released,Fluorouracil,1,2020-09-27T11:57:35.545995-05:00,Chemotherapy,Residual Disease,
HCM-BROD-0555-C15,0cd60ea0-92de-44fa-86be-c75842b4123e,3b045dfa-c32b-4998-99db-1a2dced80314,,,,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0555-C15_treatment10,bfef1336-7088-4a65-a8fd-6ccd41d62d0f,,released,,0,2020-09-27T11:57:35.545995-05:00,"Surgery, NOS",Initial Diagnosis,
HCM-BROD-0555-C15,0cd60ea0-92de-44fa-86be-c75842b4123e,3b045dfa-c32b-4998-99db-1a2dced80314,,Neoadjuvant,39.0,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0555-C15_treatment2,d189ef64-46a8-4b87-845f-7f5b0d2dd880,,released,Fluorouracil,1,2020-09-27T11:57:35.545995-05:00,Chemotherapy,,
HCM-BROD-0555-C15,0cd60ea0-92de-44fa-86be-c75842b4123e,3b045dfa-c32b-4998-99db-1a2dced80314,,Neoadjuvant,39.0,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0555-C15_treatment,dd2d266d-cbf2-4a74-b45e-a1ff514d2c5b,,released,Leucovorin Calcium,1,2020-09-27T11:57:35.545995-05:00,Chemotherapy,,
HCM-BROD-0555-C15,0cd60ea0-92de-44fa-86be-c75842b4123e,3b045dfa-c32b-4998-99db-1a2dced80314,,Adjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0555-C15_treatment9,dfe6eb3e-7163-4ad0-8165-3e2b461ca49c,,released,,0,2020-09-27T11:57:35.545995-05:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-BROD-0555-C15,0cd60ea0-92de-44fa-86be-c75842b4123e,3b045dfa-c32b-4998-99db-1a2dced80314,,Adjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0555-C15_treatment11,f7d8a149-600d-4fc4-a47b-05e0da0aa16f,,released,,0,2020-09-27T11:57:35.545995-05:00,Targeted Molecular Therapy,Residual Disease,
HCM-SANG-0287-C20,0cf7d1fe-e9c7-4e84-9497-df13ca2ed2c9,c91c84dc-0e49-412f-9c97-8c69b195cf02,,Neoadjuvant,105.0,2023-03-13T12:47:34.029089-05:00,HCM-SANG-0287-C20_treatment2,06e08cd0-c4e5-460c-8ce4-c55aae27cba2,,released,,1,2021-12-21T15:08:41.557351-06:00,"Radiation Therapy, NOS",,
HCM-SANG-0287-C20,0cf7d1fe-e9c7-4e84-9497-df13ca2ed2c9,c91c84dc-0e49-412f-9c97-8c69b195cf02,,Neoadjuvant,105.0,2023-03-13T12:47:34.029089-05:00,HCM-SANG-0287-C20_treatment,5f3ee649-6672-437d-b085-8188c797d658,,released,Fluorouracil,1,2021-12-21T15:08:41.557351-06:00,Chemotherapy,,
HCM-EXPT-0990-C50,0d98ced3-0c8e-4431-93e5-74f458b80797,a63ab6c9-93d2-45a8-a434-090e8e6a9719,,Neoadjuvant,,2025-10-08T12:37:21.548354-05:00,HCM-EXPT-0990-C50_treatment2,503a802e-3797-4b7c-9525-5557ea9ae765,,released,,1,2021-12-21T14:50:55.093039-06:00,Hormone Therapy,,
HCM-EXPT-0990-C50,0d98ced3-0c8e-4431-93e5-74f458b80797,a63ab6c9-93d2-45a8-a434-090e8e6a9719,,Neoadjuvant,,2025-10-08T12:37:21.548354-05:00,HCM-EXPT-0990-C50_treatment,e55433c8-d43b-4df1-a550-143a0c91f31c,,released,,1,2021-12-21T14:50:55.093039-06:00,Chemotherapy,,
HCM-WCMC-1285-C54,0dc9723e-f5ff-4fe3-98a4-325a23e61b5f,662bfc86-845b-4e30-bb25-3df027046e4e,111.0,Adjuvant,66.0,2025-04-07T17:13:09.336794-05:00,HCM-WCMC-1285-C54_treatment10,0a49eea2-b7ba-431c-870e-fbd1d39db372,,released,,1,2023-02-27T11:52:24.969293-06:00,"Brachytherapy, NOS",Residual Disease,
HCM-WCMC-1285-C54,0dc9723e-f5ff-4fe3-98a4-325a23e61b5f,662bfc86-845b-4e30-bb25-3df027046e4e,229.0,Adjuvant,166.0,2025-04-07T17:13:09.336794-05:00,HCM-WCMC-1285-C54_treatment4,4069c217-9991-49b8-a453-215632eb1fef,,released,Bortezomib,1,2023-02-27T11:52:24.969293-06:00,Chemotherapy,Residual Disease,
HCM-WCMC-1285-C54,0dc9723e-f5ff-4fe3-98a4-325a23e61b5f,662bfc86-845b-4e30-bb25-3df027046e4e,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-WCMC-1285-C54_treatment9,4c4b939b-c6b6-4d27-a8f2-170476f5799c,,released,,0,2023-02-27T11:52:24.969293-06:00,Targeted Molecular Therapy,Residual Disease,
HCM-WCMC-1285-C54,0dc9723e-f5ff-4fe3-98a4-325a23e61b5f,662bfc86-845b-4e30-bb25-3df027046e4e,229.0,Adjuvant,166.0,2025-04-07T17:13:09.336794-05:00,HCM-WCMC-1285-C54_treatment3,964bc6d9-fd48-43a5-bc1d-63a9eef7ffee,,released,Paclitaxel,1,2023-02-27T11:52:24.969293-06:00,Chemotherapy,Residual Disease,
HCM-WCMC-1285-C54,0dc9723e-f5ff-4fe3-98a4-325a23e61b5f,662bfc86-845b-4e30-bb25-3df027046e4e,229.0,Adjuvant,166.0,2025-04-07T17:13:09.336794-05:00,HCM-WCMC-1285-C54_treatment5,9e377009-2b41-4197-9174-a27712fc359f,,released,Carboplatin,1,2023-02-27T11:52:24.969293-06:00,Chemotherapy,Residual Disease,
HCM-WCMC-1285-C54,0dc9723e-f5ff-4fe3-98a4-325a23e61b5f,662bfc86-845b-4e30-bb25-3df027046e4e,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-WCMC-1285-C54_treatment6,9fd90e1c-313b-4d5e-a761-8b0c7722a4f4,,released,,0,2023-02-27T11:52:24.969293-06:00,Hormone Therapy,Residual Disease,
HCM-WCMC-1285-C54,0dc9723e-f5ff-4fe3-98a4-325a23e61b5f,662bfc86-845b-4e30-bb25-3df027046e4e,94.0,Adjuvant,66.0,2025-04-07T17:13:09.336794-05:00,HCM-WCMC-1285-C54_treatment2,a3198f5c-72a3-419d-bee7-12f3e1fb7135,,released,Cisplatin,1,2023-02-27T11:52:24.969293-06:00,Chemotherapy,Residual Disease,
HCM-WCMC-1285-C54,0dc9723e-f5ff-4fe3-98a4-325a23e61b5f,662bfc86-845b-4e30-bb25-3df027046e4e,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-WCMC-1285-C54_treatment7,b56b9146-c561-499e-a01b-d8792b89bd2d,,released,,0,2023-02-27T11:52:24.969293-06:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-WCMC-1285-C54,0dc9723e-f5ff-4fe3-98a4-325a23e61b5f,662bfc86-845b-4e30-bb25-3df027046e4e,,,35.0,2025-04-07T17:13:09.336794-05:00,HCM-WCMC-1285-C54_treatment8,fcb03765-bc39-4239-a4a4-443a21ec38b3,,released,,1,2023-02-27T11:52:24.969293-06:00,"Surgery, NOS",Initial Diagnosis,
HCM-WCMC-1285-C54,0dc9723e-f5ff-4fe3-98a4-325a23e61b5f,662bfc86-845b-4e30-bb25-3df027046e4e,,Neoadjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-WCMC-1285-C54_treatment,fd62f224-c19c-46b1-89a8-5e42eb033f24,,released,,0,2023-02-27T11:52:24.969293-06:00,,,
HCM-CSHL-0248-C19,0df0db7a-b473-4643-9caf-a7c272c54c29,c9aee97d-8ba9-4f4f-9879-9326ad0c91b8,296.0,Adjuvant,88.0,2020-10-20T19:20:06.800740-05:00,HCM-CSHL-0248-C19_treatment2,023f4c99-d9a8-457b-859a-8acf7df207cf,,released,Oxaliplatin,1,2020-02-27T12:51:08.303017-06:00,Chemotherapy,Residual Disease,
HCM-CSHL-0248-C19,0df0db7a-b473-4643-9caf-a7c272c54c29,c9aee97d-8ba9-4f4f-9879-9326ad0c91b8,,Neoadjuvant,,2020-10-20T19:20:06.800740-05:00,HCM-CSHL-0248-C19_treatment,31f0ffe2-774c-4ed9-a8a5-da1f97eb7b54,,released,,0,2020-02-27T12:51:08.303017-06:00,,,
HCM-CSHL-0248-C19,0df0db7a-b473-4643-9caf-a7c272c54c29,c9aee97d-8ba9-4f4f-9879-9326ad0c91b8,,Adjuvant,,2020-10-20T19:20:06.800740-05:00,HCM-CSHL-0248-C19_treatment5,38fdc3f0-5984-4dae-9259-bd06d07817c8,,released,,0,2020-02-27T12:51:08.303017-06:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-CSHL-0248-C19,0df0db7a-b473-4643-9caf-a7c272c54c29,c9aee97d-8ba9-4f4f-9879-9326ad0c91b8,296.0,Adjuvant,88.0,2020-10-20T19:20:06.800740-05:00,HCM-CSHL-0248-C19_treatment3,5839a653-a7be-4bc3-9edf-5840007607a5,,released,Capecitabine,1,2020-02-27T12:51:08.303017-06:00,Chemotherapy,Residual Disease,
HCM-CSHL-0248-C19,0df0db7a-b473-4643-9caf-a7c272c54c29,c9aee97d-8ba9-4f4f-9879-9326ad0c91b8,,,43.0,2023-03-13T13:00:10.926207-05:00,HCM-CSHL-0248-C19_treatment6,84f90c32-a8b4-431c-b6c0-686053c4b517,,released,,1,2020-02-27T12:51:08.303017-06:00,"Surgery, NOS",Initial Diagnosis,
HCM-CSHL-0248-C19,0df0db7a-b473-4643-9caf-a7c272c54c29,c9aee97d-8ba9-4f4f-9879-9326ad0c91b8,,Adjuvant,,2020-10-20T19:20:06.800740-05:00,HCM-CSHL-0248-C19_treatment7,a711fef6-6cf4-4b82-b581-b97c2a8b1ab7,,released,,0,2020-09-28T09:32:55.440268-05:00,Targeted Molecular Therapy,Residual Disease,
HCM-CSHL-0248-C19,0df0db7a-b473-4643-9caf-a7c272c54c29,c9aee97d-8ba9-4f4f-9879-9326ad0c91b8,296.0,Adjuvant,88.0,2020-10-20T19:20:06.800740-05:00,HCM-CSHL-0248-C19_treatment4,d2291678-f5ec-4095-be20-b45c3fdebad1,,released,,1,2020-02-27T12:51:08.303017-06:00,Chemotherapy,Residual Disease,XELOX
HCM-CSHL-0248-C19,0df0db7a-b473-4643-9caf-a7c272c54c29,c9aee97d-8ba9-4f4f-9879-9326ad0c91b8,,Adjuvant,,2020-10-20T19:20:06.800740-05:00,HCM-CSHL-0248-C19_treatment8,e0ecbbe6-c927-4799-bd26-2e84fb47a19f,,released,,0,2020-09-28T09:32:55.440268-05:00,"Radiation Therapy, NOS",Residual Disease,
HCM-CSHL-0507-C20,0e791e67-655b-4d32-93fe-caccae0fd673,b9bc04fb-331b-4825-976a-4c16c7af7f2b,,Adjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0507-C20_treatment4,10a128fa-e0b4-4e89-b294-8360a0ec6e6d,,released,,0,2021-12-21T14:06:12.192771-06:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-CSHL-0507-C20,0e791e67-655b-4d32-93fe-caccae0fd673,b9bc04fb-331b-4825-976a-4c16c7af7f2b,,Neoadjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0507-C20_treatment,5d8006dc-c6ee-45db-84e3-1e96342514be,,released,,0,2021-12-21T14:06:12.192771-06:00,,,
HCM-CSHL-0507-C20,0e791e67-655b-4d32-93fe-caccae0fd673,b9bc04fb-331b-4825-976a-4c16c7af7f2b,,,386.0,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0507-C20_treatment5,5fcd9c50-040d-446a-881b-5682ce8d59df,,released,,1,2021-12-21T14:06:12.192771-06:00,"Surgery, NOS",Initial Diagnosis,
HCM-CSHL-0507-C20,0e791e67-655b-4d32-93fe-caccae0fd673,b9bc04fb-331b-4825-976a-4c16c7af7f2b,592.0,Adjuvant,450.0,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0507-C20_treatment2,68ca966a-320f-4f6a-b6ac-732cc993056c,,released,Oxaliplatin,1,2021-12-21T14:06:12.192771-06:00,Chemotherapy,Residual Disease,
HCM-CSHL-0507-C20,0e791e67-655b-4d32-93fe-caccae0fd673,b9bc04fb-331b-4825-976a-4c16c7af7f2b,,Adjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0507-C20_treatment6,7918da44-b8a7-4882-93bc-c78c4b6457ea,,released,,0,2021-12-21T14:06:12.192771-06:00,Targeted Molecular Therapy,Residual Disease,
HCM-CSHL-0507-C20,0e791e67-655b-4d32-93fe-caccae0fd673,b9bc04fb-331b-4825-976a-4c16c7af7f2b,1021.0,Adjuvant,1016.0,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0507-C20_treatment7,e8ae7e17-0575-4779-b413-2bad402dd3a9,,released,,1,2021-12-21T14:06:12.192771-06:00,"Radiation, Stereotactic/Gamma Knife/SRS",Residual Disease,
HCM-CSHL-0507-C20,0e791e67-655b-4d32-93fe-caccae0fd673,b9bc04fb-331b-4825-976a-4c16c7af7f2b,592.0,Adjuvant,450.0,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0507-C20_treatment3,f9f6d8fa-b6ae-4021-8a1b-3b5dd05440e4,,released,Capecitabine,1,2021-12-21T14:06:12.192771-06:00,Chemotherapy,Residual Disease,
HCM-WCMC-0950-C67,0e9262d1-5aa8-4528-9aee-2815afcd23cd,82806bbe-6770-4697-93aa-c8b87aa73044,,Neoadjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-WCMC-0950-C67_treatment,562ddb00-fd43-4ffb-968d-fb225eb11668,,released,,0,2023-02-27T13:22:20.918362-06:00,,,
HCM-WCMC-0950-C67,0e9262d1-5aa8-4528-9aee-2815afcd23cd,82806bbe-6770-4697-93aa-c8b87aa73044,379.0,Adjuvant,344.0,2025-04-07T17:13:09.336794-05:00,HCM-WCMC-0950-C67_treatment5,56ff1595-a410-4d11-94ec-d76f446b3c62,,released,BCG Vaccine,1,2023-02-27T13:22:20.918362-06:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-WCMC-0950-C67,0e9262d1-5aa8-4528-9aee-2815afcd23cd,82806bbe-6770-4697-93aa-c8b87aa73044,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-WCMC-0950-C67_treatment8,6a058241-7f9c-41ad-9c60-1c5d5fea16de,,released,,0,2023-02-27T13:22:20.918362-06:00,"Radiation Therapy, NOS",Residual Disease,
HCM-WCMC-0950-C67,0e9262d1-5aa8-4528-9aee-2815afcd23cd,82806bbe-6770-4697-93aa-c8b87aa73044,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-WCMC-0950-C67_treatment3,6a0b145e-3b22-482f-9371-fb78bc62a2ad,,released,,0,2023-02-27T13:22:20.918362-06:00,Hormone Therapy,Residual Disease,
HCM-WCMC-0950-C67,0e9262d1-5aa8-4528-9aee-2815afcd23cd,82806bbe-6770-4697-93aa-c8b87aa73044,127.0,Adjuvant,91.0,2025-04-07T17:13:09.336794-05:00,HCM-WCMC-0950-C67_treatment4,aef2b972-cc60-40ab-9d81-9b185b9b1187,,released,BCG Vaccine,1,2023-02-27T13:22:20.918362-06:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-WCMC-0950-C67,0e9262d1-5aa8-4528-9aee-2815afcd23cd,82806bbe-6770-4697-93aa-c8b87aa73044,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-WCMC-0950-C67_treatment2,b994f1bf-6c78-43d4-8a1c-1ff232e9bf88,,released,,0,2023-02-27T13:22:20.918362-06:00,Chemotherapy,Residual Disease,
HCM-WCMC-0950-C67,0e9262d1-5aa8-4528-9aee-2815afcd23cd,82806bbe-6770-4697-93aa-c8b87aa73044,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-WCMC-0950-C67_treatment7,b9b6250c-b29e-42ad-a7eb-65e34afdd420,,released,,0,2023-02-27T13:22:20.918362-06:00,Targeted Molecular Therapy,Residual Disease,
HCM-WCMC-0950-C67,0e9262d1-5aa8-4528-9aee-2815afcd23cd,82806bbe-6770-4697-93aa-c8b87aa73044,,,0.0,2025-04-07T17:13:09.336794-05:00,HCM-WCMC-0950-C67_treatment6,cc247aad-99d4-443b-918f-c20f41b334ed,,released,,1,2023-02-27T13:22:20.918362-06:00,"Surgery, NOS",Initial Diagnosis,
HCM-CSHL-0376-D37,0e9a9e97-f0bf-4f4a-84cc-73eccfc627b1,9ce37f22-bbde-4447-bbf0-28e85f4f2837,,Adjuvant,,2023-03-13T12:49:00.711770-05:00,HCM-CSHL-0376-D37_treatment3,1d53cda2-38a1-48ac-9457-5b16f471f6cc,,released,,0,2020-09-28T09:57:03.740068-05:00,"Pharmaceutical Therapy, NOS",Residual Disease,
HCM-CSHL-0376-D37,0e9a9e97-f0bf-4f4a-84cc-73eccfc627b1,9ce37f22-bbde-4447-bbf0-28e85f4f2837,,,78.0,2023-03-13T12:49:00.711770-05:00,HCM-CSHL-0376-D37_treatment2,4fdd878b-e879-4e4c-914f-69d5ba2b0c4c,,released,,1,2020-09-28T09:57:03.740068-05:00,"Surgery, NOS",Initial Diagnosis,
HCM-CSHL-0376-D37,0e9a9e97-f0bf-4f4a-84cc-73eccfc627b1,9ce37f22-bbde-4447-bbf0-28e85f4f2837,,Adjuvant,,2023-03-13T12:49:00.711770-05:00,HCM-CSHL-0376-D37_treatment4,b554b536-8816-4378-a3c9-efad1a51b0af,,released,,0,2020-09-28T09:57:03.740068-05:00,"Radiation Therapy, NOS",Residual Disease,
HCM-CSHL-0376-D37,0e9a9e97-f0bf-4f4a-84cc-73eccfc627b1,9ce37f22-bbde-4447-bbf0-28e85f4f2837,,Neoadjuvant,,2023-02-22T07:39:25.979291-06:00,HCM-CSHL-0376-D37_treatment,fd770e14-5f77-4e4a-b01b-e26ed5acc8cd,,released,,0,2020-09-28T09:57:03.740068-05:00,,,
HCM-EXPT-0983-C18,0e9b2366-3f29-4263-957c-05dc443a0911,556931d7-130b-4b4b-a6ec-f20a257f6559,,Neoadjuvant,,2025-10-08T12:37:21.548354-05:00,HCM-EXPT-0983-C18_treatment,1b1403e4-5c4e-4a32-b55d-66fbd9349dff,,released,,1,2021-12-21T14:50:33.834263-06:00,Chemotherapy,,
HCM-BROD-0682-C64,0ee53efd-b992-4aeb-a091-8dd1bd32da6e,3c95e3a3-c388-452c-88e8-13704668f55a,632.0,Adjuvant,612.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0682-C64_treatment5,07302338-3d57-4994-8b18-664df8c333de,,released,Ipilimumab,1,2021-12-21T13:42:59.028809-06:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-BROD-0682-C64,0ee53efd-b992-4aeb-a091-8dd1bd32da6e,3c95e3a3-c388-452c-88e8-13704668f55a,1435.0,Adjuvant,672.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0682-C64_treatment7,08435b27-dc90-4bbb-a3a7-0d7d8762c593,Treatment Ongoing,released,Cabozantinib,1,2021-12-21T13:42:59.028809-06:00,Targeted Molecular Therapy,Residual Disease,
HCM-BROD-0682-C64,0ee53efd-b992-4aeb-a091-8dd1bd32da6e,3c95e3a3-c388-452c-88e8-13704668f55a,,Neoadjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0682-C64_treatment,571a1c4d-feef-493a-8657-047594523649,,released,,0,2021-12-21T13:42:59.028809-06:00,,,
HCM-BROD-0682-C64,0ee53efd-b992-4aeb-a091-8dd1bd32da6e,3c95e3a3-c388-452c-88e8-13704668f55a,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0682-C64_treatment3,6d286cb0-5e5b-401b-b32d-e11850f4e874,,released,,0,2021-12-21T13:42:59.028809-06:00,Hormone Therapy,Residual Disease,
HCM-BROD-0682-C64,0ee53efd-b992-4aeb-a091-8dd1bd32da6e,3c95e3a3-c388-452c-88e8-13704668f55a,,,0.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0682-C64_treatment6,701b6ae2-68b5-47f0-888e-30cb2eacbd02,,released,,1,2021-12-21T13:42:59.028809-06:00,"Surgery, NOS",Initial Diagnosis,
HCM-BROD-0682-C64,0ee53efd-b992-4aeb-a091-8dd1bd32da6e,3c95e3a3-c388-452c-88e8-13704668f55a,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0682-C64_treatment2,71302855-5e8b-499b-af73-64c0a7a38eef,,released,,0,2021-12-21T13:42:59.028809-06:00,Chemotherapy,Residual Disease,
HCM-BROD-0682-C64,0ee53efd-b992-4aeb-a091-8dd1bd32da6e,3c95e3a3-c388-452c-88e8-13704668f55a,632.0,Adjuvant,612.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0682-C64_treatment4,be0e2c19-e8be-4a10-9c01-621165989978,,released,Nivolumab,1,2021-12-21T13:42:59.028809-06:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-BROD-0960-C16,0f1a10df-5962-40d1-b15c-bb998d0934c9,8f5aea83-441c-4115-99ea-271c483e71b8,149.0,Adjuvant,113.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0960-C16_treatment8,09eb66f0-b8e2-4d40-baf3-8cd08751aac8,,released,,1,2021-12-21T13:59:06.485421-06:00,Chemotherapy,Residual Disease,FOLFIRI
HCM-BROD-0960-C16,0f1a10df-5962-40d1-b15c-bb998d0934c9,8f5aea83-441c-4115-99ea-271c483e71b8,212.0,Adjuvant,149.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0960-C16_treatment12,20bc020f-0efe-47d1-b0b2-de4f128acaf1,,released,Ramucirumab,1,2021-12-21T13:59:06.485421-06:00,Targeted Molecular Therapy,Residual Disease,
HCM-BROD-0960-C16,0f1a10df-5962-40d1-b15c-bb998d0934c9,8f5aea83-441c-4115-99ea-271c483e71b8,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0960-C16_treatment10,2427a98b-fc62-464a-b66d-77818dd35218,,released,,0,2021-12-21T13:59:06.485421-06:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-BROD-0960-C16,0f1a10df-5962-40d1-b15c-bb998d0934c9,8f5aea83-441c-4115-99ea-271c483e71b8,92.0,Adjuvant,15.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0960-C16_treatment3,31bcad67-5495-4b43-b299-c0e64f169f31,,released,Fluorouracil,1,2021-12-21T13:59:06.485421-06:00,Chemotherapy,Residual Disease,
HCM-BROD-0960-C16,0f1a10df-5962-40d1-b15c-bb998d0934c9,8f5aea83-441c-4115-99ea-271c483e71b8,149.0,Adjuvant,113.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0960-C16_treatment5,5bf1afda-b480-4242-9da4-c880e0d3e201,,released,Fluorouracil,1,2021-12-21T13:59:06.485421-06:00,Chemotherapy,Residual Disease,
HCM-BROD-0960-C16,0f1a10df-5962-40d1-b15c-bb998d0934c9,8f5aea83-441c-4115-99ea-271c483e71b8,,,,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0960-C16_treatment11,758e57bf-c0e5-44fc-803f-14e05c841685,,released,,0,2021-12-21T13:59:06.485421-06:00,"Surgery, NOS",Initial Diagnosis,
HCM-BROD-0960-C16,0f1a10df-5962-40d1-b15c-bb998d0934c9,8f5aea83-441c-4115-99ea-271c483e71b8,149.0,Adjuvant,113.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0960-C16_treatment6,86eeb8a6-7ba2-4f3d-9ad7-02fe74baf7dc,,released,Leucovorin Calcium,1,2021-12-21T13:59:06.485421-06:00,Chemotherapy,Residual Disease,
HCM-BROD-0960-C16,0f1a10df-5962-40d1-b15c-bb998d0934c9,8f5aea83-441c-4115-99ea-271c483e71b8,149.0,Adjuvant,113.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0960-C16_treatment7,872a98c8-3e55-4e2b-b01f-271a7ece4e0a,,released,Irinotecan,1,2021-12-21T13:59:06.485421-06:00,Chemotherapy,Residual Disease,
HCM-BROD-0960-C16,0f1a10df-5962-40d1-b15c-bb998d0934c9,8f5aea83-441c-4115-99ea-271c483e71b8,92.0,Adjuvant,15.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0960-C16_treatment2,89520dcb-e1bc-4233-88df-c4f2e4bcc31b,,released,Docetaxel,1,2021-12-21T13:59:06.485421-06:00,Chemotherapy,Residual Disease,
HCM-BROD-0960-C16,0f1a10df-5962-40d1-b15c-bb998d0934c9,8f5aea83-441c-4115-99ea-271c483e71b8,212.0,Adjuvant,176.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0960-C16_treatment9,aa98dc53-90b2-4e3c-bb4e-24415a53982c,,released,Paclitaxel,1,2021-12-21T13:59:06.485421-06:00,Chemotherapy,Residual Disease,
HCM-BROD-0960-C16,0f1a10df-5962-40d1-b15c-bb998d0934c9,8f5aea83-441c-4115-99ea-271c483e71b8,,Neoadjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0960-C16_treatment,c4bf215b-f13c-4e57-8787-e2df8b3c44ad,,released,,0,2021-12-21T13:59:06.485421-06:00,,,
HCM-BROD-0960-C16,0f1a10df-5962-40d1-b15c-bb998d0934c9,8f5aea83-441c-4115-99ea-271c483e71b8,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0960-C16_treatment13,d82bc353-f9d3-4822-b18e-40c9dca5482f,,released,,0,2021-12-21T13:59:06.485421-06:00,"Radiation Therapy, NOS",Residual Disease,
HCM-BROD-0960-C16,0f1a10df-5962-40d1-b15c-bb998d0934c9,8f5aea83-441c-4115-99ea-271c483e71b8,92.0,Adjuvant,15.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0960-C16_treatment4,de844f56-b16b-4846-87ec-d16b100cc22f,,released,Oxaliplatin,1,2021-12-21T13:59:06.485421-06:00,Chemotherapy,Residual Disease,
HCM-BROD-0960-C16,0f1a10df-5962-40d1-b15c-bb998d0934c9,f715238a-5ed1-4072-9385-495c9306dedd,176.0,Maintenance Therapy,113.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0960-C16_treatment16,522b803e-f584-4aac-99b9-29e820f56df9,Progressive Disease,released,Irinotecan,1,2021-12-21T13:59:06.485421-06:00,,,
HCM-BROD-0960-C16,0f1a10df-5962-40d1-b15c-bb998d0934c9,f715238a-5ed1-4072-9385-495c9306dedd,176.0,Maintenance Therapy,113.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0960-C16_treatment15,7e5909ea-7ab6-4606-8b9e-2bc21a9b0920,Progressive Disease,released,Fluorouracil,1,2021-12-21T13:59:06.485421-06:00,,,
HCM-BROD-0960-C16,0f1a10df-5962-40d1-b15c-bb998d0934c9,f715238a-5ed1-4072-9385-495c9306dedd,176.0,Maintenance Therapy,113.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0960-C16_treatment14,ebc77254-216b-40d8-a33c-f33b568e3d14,Progressive Disease,released,Leucovorin Calcium,1,2021-12-21T13:59:06.485421-06:00,,,
HCM-BROD-0960-C16,0f1a10df-5962-40d1-b15c-bb998d0934c9,f715238a-5ed1-4072-9385-495c9306dedd,176.0,Maintenance Therapy,113.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0960-C16_treatment17,fdb981ac-3639-4ee1-a206-e6cc6da493f8,Progressive Disease,released,,1,2021-12-21T13:59:06.485421-06:00,,,FOLFIRI
HCM-EXPT-1073-C18,0f28235c-b4bb-451b-8b89-6092a231f0f9,d912dbad-16b1-4d6b-9248-4026a262c4ba,,Neoadjuvant,,2025-10-08T12:38:28.988690-05:00,HCM-EXPT-1073-C18_treatment,75c7e1ce-0f61-4a23-8d83-9c5ae07d2da1,,released,,1,2021-12-21T15:05:02.653400-06:00,Chemotherapy,,
HCM-BROD-0012-C71,0f89e089-4a1d-4e66-8537-502a788cfe75,26192cfd-1129-40b7-a99c-7ae133fcb595,,Adjuvant,,2019-04-29T14:45:04.583966-05:00,HCM-BROD-0012-C71_treatment3,2976e2d5-ec09-4cf9-bf71-a0f7816b1300,,released,,0,2019-04-04T14:16:25.317982-05:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-BROD-0012-C71,0f89e089-4a1d-4e66-8537-502a788cfe75,26192cfd-1129-40b7-a99c-7ae133fcb595,,,25.0,2023-03-13T13:31:26.371099-05:00,HCM-BROD-0012-C71_treatment4,55f82d82-95ab-497b-bd6d-ddaa550248db,,released,,1,2019-04-04T14:16:25.317982-05:00,"Surgery, NOS",Initial Diagnosis,
HCM-BROD-0012-C71,0f89e089-4a1d-4e66-8537-502a788cfe75,26192cfd-1129-40b7-a99c-7ae133fcb595,,Neoadjuvant,,2019-04-29T14:45:04.583966-05:00,HCM-BROD-0012-C71_treatment,8c275d6e-bd3a-481b-b381-5b6fb496d263,,released,,0,2019-03-12T10:15:03.937781-05:00,,,
HCM-BROD-0012-C71,0f89e089-4a1d-4e66-8537-502a788cfe75,26192cfd-1129-40b7-a99c-7ae133fcb595,148.0,Adjuvant,110.0,2019-04-29T14:45:04.583966-05:00,HCM-BROD-0012-C71_treatment2,d674d04c-4df4-41b2-adbb-88b8da1a9285,,released,Temozolomide,1,2019-04-04T14:16:25.317982-05:00,Chemotherapy,Residual Disease,
HCM-BROD-0012-C71,0f89e089-4a1d-4e66-8537-502a788cfe75,26192cfd-1129-40b7-a99c-7ae133fcb595,,Adjuvant,,2019-04-29T14:45:04.583966-05:00,HCM-BROD-0012-C71_treatment5,e9d9bb09-e916-4e88-be9d-3605e1435a7d,,released,,0,2019-04-04T14:16:25.317982-05:00,Targeted Molecular Therapy,Residual Disease,
HCM-BROD-0012-C71,0f89e089-4a1d-4e66-8537-502a788cfe75,26192cfd-1129-40b7-a99c-7ae133fcb595,148.0,Adjuvant,110.0,2019-04-29T14:45:04.583966-05:00,HCM-BROD-0012-C71_treatment6,f5d5457f-66df-42b1-afee-f03a04080044,,released,,1,2019-04-04T14:16:25.317982-05:00,"Radiation Therapy, NOS",Residual Disease,
HCM-BROD-0568-C15,10bd5d19-7a67-41c2-bb24-898e9078fd04,a5186653-9f3a-4648-bab6-4c50d1d1edcf,,Neoadjuvant,26.0,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0568-C15_treatment3,2b920a3f-1af0-4605-8697-2211e6de6bea,,released,Oxaliplatin,1,2020-09-27T12:00:38.167753-05:00,Chemotherapy,,
HCM-BROD-0568-C15,10bd5d19-7a67-41c2-bb24-898e9078fd04,a5186653-9f3a-4648-bab6-4c50d1d1edcf,,Neoadjuvant,26.0,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0568-C15_treatment2,4a2fa9ff-9356-4999-9669-6750e79d1dfa,,released,Fluorouracil,1,2020-09-27T12:00:38.167753-05:00,Chemotherapy,,
HCM-BROD-0568-C15,10bd5d19-7a67-41c2-bb24-898e9078fd04,a5186653-9f3a-4648-bab6-4c50d1d1edcf,83.0,Adjuvant,26.0,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0568-C15_treatment6,52bf01c0-aa06-4634-b2e4-8af4a47d000a,,released,Leucovorin Calcium,1,2020-09-27T12:00:38.167753-05:00,Chemotherapy,Residual Disease,
HCM-BROD-0568-C15,10bd5d19-7a67-41c2-bb24-898e9078fd04,a5186653-9f3a-4648-bab6-4c50d1d1edcf,,Neoadjuvant,26.0,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0568-C15_treatment4,6404cd70-55af-44d0-9472-1211a91430b9,,released,Leucovorin,1,2020-09-27T12:00:38.167753-05:00,Chemotherapy,,
HCM-BROD-0568-C15,10bd5d19-7a67-41c2-bb24-898e9078fd04,a5186653-9f3a-4648-bab6-4c50d1d1edcf,83.0,Adjuvant,26.0,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0568-C15_treatment8,6584b537-10f2-4a31-9bad-dcd1e802577d,,released,Oxaliplatin,1,2020-09-27T12:00:38.167753-05:00,Chemotherapy,Residual Disease,
HCM-BROD-0568-C15,10bd5d19-7a67-41c2-bb24-898e9078fd04,a5186653-9f3a-4648-bab6-4c50d1d1edcf,,Adjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0568-C15_treatment14,6b9de8ce-146c-47eb-b619-aae5d1feeae9,,released,,0,2020-09-27T12:00:38.167753-05:00,"Radiation Therapy, NOS",Residual Disease,
HCM-BROD-0568-C15,10bd5d19-7a67-41c2-bb24-898e9078fd04,a5186653-9f3a-4648-bab6-4c50d1d1edcf,83.0,Adjuvant,26.0,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0568-C15_treatment9,8dbd74c8-130a-41fd-b868-00086d6eaf65,,released,,1,2020-09-27T12:00:38.167753-05:00,Chemotherapy,Residual Disease,FOLFOX
HCM-BROD-0568-C15,10bd5d19-7a67-41c2-bb24-898e9078fd04,a5186653-9f3a-4648-bab6-4c50d1d1edcf,,Adjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0568-C15_treatment13,93787d9e-cd7b-492a-acc4-93289fb1ffd4,,released,,0,2020-09-27T12:00:38.167753-05:00,Targeted Molecular Therapy,Residual Disease,
HCM-BROD-0568-C15,10bd5d19-7a67-41c2-bb24-898e9078fd04,a5186653-9f3a-4648-bab6-4c50d1d1edcf,83.0,Adjuvant,26.0,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0568-C15_treatment7,bd37254c-c6da-4320-93cb-0edca7a1358b,,released,Fluorouracil,1,2020-09-27T12:00:38.167753-05:00,Chemotherapy,Residual Disease,
HCM-BROD-0568-C15,10bd5d19-7a67-41c2-bb24-898e9078fd04,a5186653-9f3a-4648-bab6-4c50d1d1edcf,,Neoadjuvant,26.0,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0568-C15_treatment,bfdb0b9e-aee0-410a-98ee-4da87ab8d1c2,,released,Paclitaxel,1,2020-09-27T12:00:38.167753-05:00,Chemotherapy,,
HCM-BROD-0568-C15,10bd5d19-7a67-41c2-bb24-898e9078fd04,a5186653-9f3a-4648-bab6-4c50d1d1edcf,265.0,Adjuvant,139.0,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0568-C15_treatment10,dbe9e08b-59c6-4696-a71b-456193b11d65,,released,Paclitaxel,1,2020-09-27T12:00:38.167753-05:00,Chemotherapy,Residual Disease,
HCM-BROD-0568-C15,10bd5d19-7a67-41c2-bb24-898e9078fd04,a5186653-9f3a-4648-bab6-4c50d1d1edcf,,Adjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0568-C15_treatment11,ddec443b-a80d-40c1-9517-3b4bb5212cf9,,released,,0,2020-09-27T12:00:38.167753-05:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-BROD-0568-C15,10bd5d19-7a67-41c2-bb24-898e9078fd04,a5186653-9f3a-4648-bab6-4c50d1d1edcf,,,300.0,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0568-C15_treatment12,e407b4a2-2cd5-4301-ba30-072c5a553b2f,,released,,1,2020-09-27T12:00:38.167753-05:00,"Surgery, NOS",Initial Diagnosis,
HCM-BROD-0568-C15,10bd5d19-7a67-41c2-bb24-898e9078fd04,a5186653-9f3a-4648-bab6-4c50d1d1edcf,,Neoadjuvant,26.0,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0568-C15_treatment5,fa78d5ed-8e95-4203-982b-951ebb87c95e,,released,,1,2020-09-27T12:00:38.167753-05:00,Chemotherapy,,FU-LV regimen
HCM-SANG-0312-C15,10e69494-3ce2-4c13-ab1b-6fc0e6b14853,0afc2770-d043-487a-bd81-035e40310397,,Neoadjuvant,110.0,2023-07-13T10:35:44.371881-05:00,HCM-SANG-0312-C15_treatment,1027f917-2a26-4058-a376-49e990ecc50f,,released,Paclitaxel,1,2021-12-21T15:11:24.973771-06:00,Chemotherapy,,
HCM-SANG-0312-C15,10e69494-3ce2-4c13-ab1b-6fc0e6b14853,0afc2770-d043-487a-bd81-035e40310397,,Neoadjuvant,110.0,2023-07-13T10:35:44.371881-05:00,HCM-SANG-0312-C15_treatment3,74d73996-d98f-45cb-96fd-32a133bd6156,,released,,1,2021-12-21T15:11:24.973771-06:00,"Radiation, 2D Conventional",,
HCM-SANG-0312-C15,10e69494-3ce2-4c13-ab1b-6fc0e6b14853,0afc2770-d043-487a-bd81-035e40310397,,Neoadjuvant,110.0,2023-07-13T10:35:44.371881-05:00,HCM-SANG-0312-C15_treatment2,f68797dd-145a-4a2a-b5b8-ed3451559e2f,,released,Carboplatin,1,2021-12-21T15:11:24.973771-06:00,Chemotherapy,,
HCM-EXPT-1204-C20,110de1cc-65ce-4fc5-9d03-63cc0fe904cc,2af774a5-2014-40d7-a497-6922749ed057,,Neoadjuvant,,2025-10-08T12:38:51.189053-05:00,HCM-EXPT-1204-C20_treatment,e00fec8a-9456-457a-bb8a-b81868cffff0,,released,,0,2023-02-24T13:57:39.640653-06:00,,,
HCM-CSHL-0061-C18,118bf677-caed-4f7f-a837-dd966dce5ca7,e4625cb5-071d-4de7-af73-29b2e44af6cb,,Neoadjuvant,,2019-05-24T12:11:41.511797-05:00,HCM-CSHL-0061-C18_treatment,0559ee63-b76e-4a34-b426-da10cbb36ea5,,released,,0,2019-05-15T15:00:21.508948-05:00,,,
HCM-CSHL-0061-C18,118bf677-caed-4f7f-a837-dd966dce5ca7,e4625cb5-071d-4de7-af73-29b2e44af6cb,,,8.0,2023-02-27T12:48:38.152597-06:00,HCM-CSHL-0061-C18_treatment7,11865103-44e9-4d9c-a19c-ac8945a8e3b6,,released,,1,2020-10-08T19:00:15.562772-05:00,"Surgery, NOS",Initial Diagnosis,
HCM-CSHL-0061-C18,118bf677-caed-4f7f-a837-dd966dce5ca7,e4625cb5-071d-4de7-af73-29b2e44af6cb,,Adjuvant,,2020-10-08T19:00:15.562772-05:00,HCM-CSHL-0061-C18_treatment6,124aa9f8-fbcc-47f6-8863-aa53cb6e911a,,released,,0,2019-05-15T15:00:21.508948-05:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-CSHL-0061-C18,118bf677-caed-4f7f-a837-dd966dce5ca7,e4625cb5-071d-4de7-af73-29b2e44af6cb,144.0,Adjuvant,40.0,2020-10-08T19:00:15.562772-05:00,HCM-CSHL-0061-C18_treatment2,12543e2f-55c6-4f64-b5a1-e9f9b28f0cb4,,released,Leucovorin Calcium,1,2019-05-15T15:00:21.508948-05:00,Chemotherapy,Residual Disease,
HCM-CSHL-0061-C18,118bf677-caed-4f7f-a837-dd966dce5ca7,e4625cb5-071d-4de7-af73-29b2e44af6cb,144.0,Adjuvant,40.0,2020-10-08T19:00:15.562772-05:00,HCM-CSHL-0061-C18_treatment3,1c94fab9-66bd-4eaf-ada6-fa83584fcea5,,released,Fluorouracil,1,2019-05-15T15:00:21.508948-05:00,Chemotherapy,Residual Disease,
HCM-CSHL-0061-C18,118bf677-caed-4f7f-a837-dd966dce5ca7,e4625cb5-071d-4de7-af73-29b2e44af6cb,144.0,Adjuvant,40.0,2020-10-08T19:00:15.562772-05:00,HCM-CSHL-0061-C18_treatment4,9d80590b-05b0-4023-9acc-121b093de6dd,,released,Oxaliplatin,1,2019-05-15T15:00:21.508948-05:00,Chemotherapy,Residual Disease,
HCM-CSHL-0061-C18,118bf677-caed-4f7f-a837-dd966dce5ca7,e4625cb5-071d-4de7-af73-29b2e44af6cb,,Adjuvant,,2020-10-20T19:20:06.800740-05:00,HCM-CSHL-0061-C18_treatment9,9dad17d6-348f-4666-8cd1-49b1cc568081,,released,,0,2020-10-08T19:00:15.562772-05:00,"Radiation Therapy, NOS",Residual Disease,
HCM-CSHL-0061-C18,118bf677-caed-4f7f-a837-dd966dce5ca7,e4625cb5-071d-4de7-af73-29b2e44af6cb,,Adjuvant,,2020-10-20T19:20:06.800740-05:00,HCM-CSHL-0061-C18_treatment8,a927e28a-9d63-4600-8dc5-d483bcc0d624,,released,,0,2020-10-08T19:00:15.562772-05:00,Targeted Molecular Therapy,Residual Disease,
HCM-CSHL-0061-C18,118bf677-caed-4f7f-a837-dd966dce5ca7,e4625cb5-071d-4de7-af73-29b2e44af6cb,144.0,Adjuvant,40.0,2020-10-08T19:00:15.562772-05:00,HCM-CSHL-0061-C18_treatment5,e8f7a402-4433-4545-8d47-4c0f2cd146c1,,released,,1,2019-05-15T15:00:21.508948-05:00,Chemotherapy,Residual Disease,FOLFOX
HCM-EXPT-1029-C34,11c42dc9-6c86-4471-8659-f9f9fced374f,22dd4ae0-a7d1-4961-8050-a7aadf212249,,Neoadjuvant,,2025-10-08T12:38:06.952582-05:00,HCM-EXPT-1029-C34_treatment,d0444d2a-b809-4539-b6f4-142e756be520,,released,,0,2021-12-21T14:58:02.368474-06:00,,,
HCM-SANG-1335-C18,12603388-e5f0-45ac-ab7b-3a839de7a9e8,05c6c397-b06f-4fc3-806d-584e01bb976b,,Neoadjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-SANG-1335-C18_treatment,fb507039-1610-4163-bbe0-ef0a04fca83c,,released,,0,2023-02-27T12:14:36.021883-06:00,,,
HCM-SANG-1322-C15,1312ba61-8d33-4b61-89cf-0c6e5c6d06a7,1b0aa02b-19d9-4e30-98d7-86d641180351,,Neoadjuvant,119.0,2025-04-07T17:13:09.336794-05:00,HCM-SANG-1322-C15_treatment2,a29ee214-cb81-4f1a-9a61-8b94fcc752fb,,released,Capecitabine,1,2023-02-27T11:42:39.683110-06:00,Chemotherapy,,
HCM-SANG-1322-C15,1312ba61-8d33-4b61-89cf-0c6e5c6d06a7,1b0aa02b-19d9-4e30-98d7-86d641180351,,Neoadjuvant,119.0,2025-04-07T17:13:09.336794-05:00,HCM-SANG-1322-C15_treatment3,a2a62e7e-2314-43d6-bc76-02912eb56dde,,released,Cisplatin,1,2023-02-27T11:42:39.683110-06:00,Chemotherapy,,
HCM-SANG-1322-C15,1312ba61-8d33-4b61-89cf-0c6e5c6d06a7,1b0aa02b-19d9-4e30-98d7-86d641180351,,Neoadjuvant,119.0,2025-04-07T17:13:09.336794-05:00,HCM-SANG-1322-C15_treatment,cd34a4b4-02e3-47f0-9e76-e272f425d6cd,,released,Epirubicin,1,2023-02-27T11:42:39.683110-06:00,Chemotherapy,,
HCM-SANG-1322-C15,1312ba61-8d33-4b61-89cf-0c6e5c6d06a7,1b0aa02b-19d9-4e30-98d7-86d641180351,,Neoadjuvant,119.0,2025-04-07T17:13:09.336794-05:00,HCM-SANG-1322-C15_treatment4,df02076c-ebad-42c3-9a88-a89fe69bd6e5,,released,,1,2023-02-27T11:42:39.683110-06:00,Chemotherapy,,ECX
HCM-SANG-1317-C20,13cacc39-4a3d-440e-87da-75772dc0a3fe,167f8ec0-65f1-4925-9a6a-4b100149ce13,,Neoadjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-SANG-1317-C20_treatment,aa8de378-e941-4a94-85db-b88e247a085b,,released,,0,2023-02-27T12:45:14.910829-06:00,,,
HCM-CSHL-0621-C18,13f33795-7d8b-411d-8b33-998e66e484ea,82c4c99b-3b7f-4774-8aac-cec3bc3a5f67,,,1996.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0621-C18_treatment2,1b6b253b-da0b-4a34-9e62-a1c43ebb88bb,,released,,1,2021-12-21T14:12:18.020478-06:00,"Surgery, NOS",Initial Diagnosis,
HCM-CSHL-0621-C18,13f33795-7d8b-411d-8b33-998e66e484ea,82c4c99b-3b7f-4774-8aac-cec3bc3a5f67,,Neoadjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0621-C18_treatment,3073ac3b-c756-474e-8958-006f4a532cee,,released,,0,2021-12-21T14:12:18.020478-06:00,,,
HCM-CSHL-0621-C18,13f33795-7d8b-411d-8b33-998e66e484ea,82c4c99b-3b7f-4774-8aac-cec3bc3a5f67,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0621-C18_treatment4,3e687e75-1d6e-4b9e-993a-77554874d748,,released,,0,2021-12-21T14:12:18.020478-06:00,"Radiation Therapy, NOS",Residual Disease,
HCM-CSHL-0621-C18,13f33795-7d8b-411d-8b33-998e66e484ea,82c4c99b-3b7f-4774-8aac-cec3bc3a5f67,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0621-C18_treatment3,792bc6c0-23ce-4d72-ac54-2a579ea1699d,,released,,0,2021-12-21T14:12:18.020478-06:00,"Pharmaceutical Therapy, NOS",Residual Disease,
HCM-CSHL-0621-C18,13f33795-7d8b-411d-8b33-998e66e484ea,cc522711-b772-4e78-9c6a-079a2b6650aa,,Maintenance Therapy,,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0621-C18_treatment5,7245468e-ecff-4b5e-86de-4cbb4b6a2cc6,Not Reported,released,Capecitabine,1,2023-02-28T12:14:10.005746-06:00,,,
HCM-BROD-0232-C25,13f667da-a66b-4622-9e6a-b3e861e96961,9db2a11b-291d-4ea8-b226-9b52ef1b045d,,,,2023-02-27T12:00:51.566501-06:00,HCM-BROD-0232-C25_treatment5,15d29f24-b42f-4b8d-a33b-808da5b1266d,,released,,0,2020-06-15T13:29:02.624490-05:00,"Surgery, NOS",Initial Diagnosis,
HCM-BROD-0232-C25,13f667da-a66b-4622-9e6a-b3e861e96961,9db2a11b-291d-4ea8-b226-9b52ef1b045d,,Adjuvant,,2023-02-22T07:39:25.979291-06:00,HCM-BROD-0232-C25_treatment4,5f0b24f2-447c-455c-b94f-0b7977ca4970,,released,,0,2020-06-15T13:29:02.624490-05:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-BROD-0232-C25,13f667da-a66b-4622-9e6a-b3e861e96961,9db2a11b-291d-4ea8-b226-9b52ef1b045d,,Neoadjuvant,,2023-02-22T07:39:25.979291-06:00,HCM-BROD-0232-C25_treatment,84eed376-47c5-4043-aaeb-aecb7c202c11,,released,,0,2020-06-15T13:29:02.624490-05:00,,,
HCM-BROD-0232-C25,13f667da-a66b-4622-9e6a-b3e861e96961,9db2a11b-291d-4ea8-b226-9b52ef1b045d,314.0,Adjuvant,6.0,2023-02-22T07:39:25.979291-06:00,HCM-BROD-0232-C25_treatment3,8f8a84b9-53f1-47d3-8d21-4d5bbb1bb1d0,,released,Nab-paclitaxel,1,2020-06-15T13:29:02.624490-05:00,Chemotherapy,Residual Disease,
HCM-BROD-0232-C25,13f667da-a66b-4622-9e6a-b3e861e96961,9db2a11b-291d-4ea8-b226-9b52ef1b045d,,Adjuvant,,2023-02-22T07:39:25.979291-06:00,HCM-BROD-0232-C25_treatment7,917d5777-fd89-430f-b29e-11981b271338,,released,,0,2020-06-15T13:29:02.624490-05:00,"Radiation Therapy, NOS",Residual Disease,
HCM-BROD-0232-C25,13f667da-a66b-4622-9e6a-b3e861e96961,9db2a11b-291d-4ea8-b226-9b52ef1b045d,314.0,Adjuvant,6.0,2023-02-22T07:39:25.979291-06:00,HCM-BROD-0232-C25_treatment2,b1282ce5-d5e9-4b48-a124-bcd49d68a8d2,,released,Gemcitabine,1,2020-06-15T13:29:02.624490-05:00,Chemotherapy,Residual Disease,
HCM-BROD-0232-C25,13f667da-a66b-4622-9e6a-b3e861e96961,9db2a11b-291d-4ea8-b226-9b52ef1b045d,,Adjuvant,,2023-02-22T07:39:25.979291-06:00,HCM-BROD-0232-C25_treatment6,e957a200-b186-4f8a-930f-2886a012ae76,,released,,0,2020-06-15T13:29:02.624490-05:00,Targeted Molecular Therapy,Residual Disease,
HCM-SANG-1304-C20,147d66fc-1d48-47a9-b9c8-4b96be0bf152,2ff5ead4-0e8d-4f8e-8893-68d8e770a88e,,Neoadjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-SANG-1304-C20_treatment,79bf9fb4-7c29-4bea-9da1-29a63538d330,,released,,1,2023-02-27T11:42:10.971743-06:00,Chemotherapy,,
HCM-SANG-1304-C20,147d66fc-1d48-47a9-b9c8-4b96be0bf152,2ff5ead4-0e8d-4f8e-8893-68d8e770a88e,,Neoadjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-SANG-1304-C20_treatment2,b1722aa5-ad00-4e24-8231-ccfce658079b,,released,,1,2023-02-27T11:42:10.971743-06:00,"Radiation Therapy, NOS",,
HCM-BROD-0199-C71,149a8565-e0c5-4474-a693-d44f1b445c0c,2d72ecab-4038-4ef7-b921-79b88ad62722,,Adjuvant,,2021-01-06T22:55:10.531130-06:00,HCM-BROD-0199-C71_treatment5,3628d901-a2d8-4648-af85-557da09fb0be,,released,,0,2020-06-15T13:02:56.008585-05:00,Targeted Molecular Therapy,Residual Disease,
HCM-BROD-0199-C71,149a8565-e0c5-4474-a693-d44f1b445c0c,2d72ecab-4038-4ef7-b921-79b88ad62722,,,-6.0,2023-02-27T13:23:57.287898-06:00,HCM-BROD-0199-C71_treatment4,39acc0fc-8776-497e-bd99-48634f0f7a08,,released,,1,2020-06-15T13:02:56.008585-05:00,"Surgery, NOS",Initial Diagnosis,
HCM-BROD-0199-C71,149a8565-e0c5-4474-a693-d44f1b445c0c,2d72ecab-4038-4ef7-b921-79b88ad62722,,Adjuvant,,2021-01-06T22:55:10.531130-06:00,HCM-BROD-0199-C71_treatment3,5d137e7f-f788-4801-b014-f02014038b1c,,released,,0,2020-06-15T13:02:56.008585-05:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-BROD-0199-C71,149a8565-e0c5-4474-a693-d44f1b445c0c,2d72ecab-4038-4ef7-b921-79b88ad62722,77.0,Adjuvant,28.0,2021-01-06T22:55:10.531130-06:00,HCM-BROD-0199-C71_treatment2,6406e648-e6b5-4dcf-99ee-f81940ae5d28,,released,Temozolomide,1,2020-06-15T13:02:56.008585-05:00,Chemotherapy,Residual Disease,
HCM-BROD-0199-C71,149a8565-e0c5-4474-a693-d44f1b445c0c,2d72ecab-4038-4ef7-b921-79b88ad62722,,Neoadjuvant,,2021-01-06T22:55:10.531130-06:00,HCM-BROD-0199-C71_treatment,a0f0d4e4-7007-4c34-892b-e585846b6552,,released,,0,2019-04-04T15:00:32.807421-05:00,,,
HCM-BROD-0199-C71,149a8565-e0c5-4474-a693-d44f1b445c0c,2d72ecab-4038-4ef7-b921-79b88ad62722,77.0,Adjuvant,28.0,2021-01-06T22:55:10.531130-06:00,HCM-BROD-0199-C71_treatment6,d419c6e1-de7f-4b4d-8b6c-0a4fc9a2b318,,released,,1,2020-06-15T13:02:56.008585-05:00,"Radiation Therapy, NOS",Residual Disease,
HCM-BROD-0199-C71,149a8565-e0c5-4474-a693-d44f1b445c0c,df0230e6-d07c-4814-9aee-5be560d1ce58,87.0,Maintenance Therapy,28.0,2021-01-06T22:55:10.531130-06:00,HCM-BROD-0199-C71_treatment7,f80c17b7-e725-45e6-bf8b-b6ac85bc6fd0,Stable Disease,released,Temozolomide,1,2020-06-15T13:02:56.008585-05:00,,,
HCM-BROD-1105-C73,149eef24-418a-4f5e-b32e-060a8baa8322,7480722d-21ee-4b63-9d8c-69cfedc9a107,7288.0,Maintenance Therapy,7151.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-1105-C73_treatment9,4afa9bef-4a12-43e9-a7b4-32cd258c8a21,Progressive Disease,released,Lenvatinib,1,2021-12-21T14:00:57.747810-06:00,,,
HCM-BROD-1105-C73,149eef24-418a-4f5e-b32e-060a8baa8322,7480722d-21ee-4b63-9d8c-69cfedc9a107,7288.0,Maintenance Therapy,7151.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-1105-C73_treatment8,c2bb7f79-ddc8-4825-b6b0-2d936ccd616d,Progressive Disease,released,Sorafenib,1,2021-12-21T14:00:57.747810-06:00,,,
HCM-BROD-1105-C73,149eef24-418a-4f5e-b32e-060a8baa8322,9c9efbbe-9e37-4c2c-ae4a-84a05781e95b,7627.0,Adjuvant,7546.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-1105-C73_treatment6,0883e2d4-3d1c-445b-a88e-f07acc1ed4b7,,released,Not Reported,1,2021-12-21T14:00:57.747810-06:00,Targeted Molecular Therapy,Residual Disease,
HCM-BROD-1105-C73,149eef24-418a-4f5e-b32e-060a8baa8322,9c9efbbe-9e37-4c2c-ae4a-84a05781e95b,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-BROD-1105-C73_treatment7,511b43f1-8476-4f84-ae25-4af8ff91fccd,,released,,0,2021-12-21T14:00:57.747810-06:00,"Radiation Therapy, NOS",Residual Disease,
HCM-BROD-1105-C73,149eef24-418a-4f5e-b32e-060a8baa8322,9c9efbbe-9e37-4c2c-ae4a-84a05781e95b,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-BROD-1105-C73_treatment3,96e447a7-551e-4d2d-a8c7-4812bfaa4eee,,released,,0,2021-12-21T14:00:57.747810-06:00,Hormone Therapy,Residual Disease,
HCM-BROD-1105-C73,149eef24-418a-4f5e-b32e-060a8baa8322,9c9efbbe-9e37-4c2c-ae4a-84a05781e95b,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-BROD-1105-C73_treatment2,b593d062-8130-47af-b721-67bfb125e6a2,,released,,0,2021-12-21T14:00:57.747810-06:00,Chemotherapy,Residual Disease,
HCM-BROD-1105-C73,149eef24-418a-4f5e-b32e-060a8baa8322,9c9efbbe-9e37-4c2c-ae4a-84a05781e95b,,,0.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-1105-C73_treatment5,e5e96843-891b-49e9-8940-23709395694e,,released,,1,2021-12-21T14:00:57.747810-06:00,"Surgery, NOS",Initial Diagnosis,
HCM-BROD-1105-C73,149eef24-418a-4f5e-b32e-060a8baa8322,9c9efbbe-9e37-4c2c-ae4a-84a05781e95b,,Neoadjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-BROD-1105-C73_treatment,e9d9a6a3-8634-497c-adbc-72b0129878d9,,released,,0,2021-12-21T14:00:57.747810-06:00,,,
HCM-BROD-1105-C73,149eef24-418a-4f5e-b32e-060a8baa8322,9c9efbbe-9e37-4c2c-ae4a-84a05781e95b,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-BROD-1105-C73_treatment4,ea0e8676-bc2a-4409-92e1-018968540318,,released,,0,2021-12-21T14:00:57.747810-06:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-EXPT-1195-C18,149f1630-7134-4ac2-a350-6bee91ef8386,8ecf17b9-8e6f-4d50-8c6c-498a9311dc32,,Neoadjuvant,,2025-10-08T12:38:51.189053-05:00,HCM-EXPT-1195-C18_treatment,16a2a649-1f57-4faf-8ad6-5a54112e03c5,,released,,0,2022-03-09T19:41:53.699566-06:00,,,
HCM-CSHL-0625-C18,14d24b35-141b-4743-b4a9-321e2393bb54,dceb4b03-d5e1-4097-a188-e1fa3199f844,,,373.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0625-C18_treatment16,091da4fe-8696-4ba8-b6f6-c430fa0caaa9,,released,,1,2021-12-21T14:13:40.809190-06:00,"Surgery, NOS",Initial Diagnosis,
HCM-CSHL-0625-C18,14d24b35-141b-4743-b4a9-321e2393bb54,dceb4b03-d5e1-4097-a188-e1fa3199f844,,Neoadjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0625-C18_treatment,12414e25-77c8-4a56-8acc-f6981cee9c84,,released,,0,2021-12-21T14:13:40.809190-06:00,,,
HCM-CSHL-0625-C18,14d24b35-141b-4743-b4a9-321e2393bb54,dceb4b03-d5e1-4097-a188-e1fa3199f844,70.0,Adjuvant,47.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0625-C18_treatment4,371af0b4-58c8-4aeb-9717-7bb1075235ad,,released,,1,2021-12-21T14:13:40.809190-06:00,Chemotherapy,Residual Disease,XELOX
HCM-CSHL-0625-C18,14d24b35-141b-4743-b4a9-321e2393bb54,dceb4b03-d5e1-4097-a188-e1fa3199f844,877.0,Adjuvant,684.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0625-C18_treatment11,3d09cde7-f62e-47f2-96a4-1f755e0f05e5,,released,Bevacizumab,1,2021-12-21T14:13:40.809190-06:00,Chemotherapy,Residual Disease,
HCM-CSHL-0625-C18,14d24b35-141b-4743-b4a9-321e2393bb54,dceb4b03-d5e1-4097-a188-e1fa3199f844,246.0,Adjuvant,135.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0625-C18_treatment8,416481f5-17a3-4d40-b217-fbfc5bdd4776,,released,Cetuximab,1,2021-12-21T14:13:40.809190-06:00,Chemotherapy,Residual Disease,
HCM-CSHL-0625-C18,14d24b35-141b-4743-b4a9-321e2393bb54,dceb4b03-d5e1-4097-a188-e1fa3199f844,877.0,Adjuvant,684.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0625-C18_treatment12,47573e09-f174-41b0-8440-59957e6912b9,,released,Leucovorin Calcium,1,2021-12-21T14:13:40.809190-06:00,Chemotherapy,Residual Disease,
HCM-CSHL-0625-C18,14d24b35-141b-4743-b4a9-321e2393bb54,dceb4b03-d5e1-4097-a188-e1fa3199f844,70.0,Adjuvant,47.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0625-C18_treatment3,648e5dc4-ba04-46c7-8670-08bc38181e70,,released,Capecitabine,1,2021-12-21T14:13:40.809190-06:00,Chemotherapy,Residual Disease,
HCM-CSHL-0625-C18,14d24b35-141b-4743-b4a9-321e2393bb54,dceb4b03-d5e1-4097-a188-e1fa3199f844,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0625-C18_treatment17,6acf4d00-e315-40df-9485-fa7990e29138,,released,,0,2021-12-21T14:13:40.809190-06:00,Targeted Molecular Therapy,Residual Disease,
HCM-CSHL-0625-C18,14d24b35-141b-4743-b4a9-321e2393bb54,dceb4b03-d5e1-4097-a188-e1fa3199f844,246.0,Adjuvant,135.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0625-C18_treatment9,7e86f2de-df6a-4be2-b399-f6d4975e7879,,released,,1,2021-12-21T14:13:40.809190-06:00,Chemotherapy,Residual Disease,FOLFIRI-cetuximab
HCM-CSHL-0625-C18,14d24b35-141b-4743-b4a9-321e2393bb54,dceb4b03-d5e1-4097-a188-e1fa3199f844,877.0,Adjuvant,684.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0625-C18_treatment13,8c21240a-2799-439a-98b1-0c5df4483502,,released,Fluorouracil,1,2021-12-21T14:13:40.809190-06:00,Chemotherapy,Residual Disease,
HCM-CSHL-0625-C18,14d24b35-141b-4743-b4a9-321e2393bb54,dceb4b03-d5e1-4097-a188-e1fa3199f844,246.0,Adjuvant,135.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0625-C18_treatment5,8d25ccd1-14bc-4b4c-8dc3-ca33fd406ab7,,released,Irinotecan,1,2021-12-21T14:13:40.809190-06:00,Chemotherapy,Residual Disease,
HCM-CSHL-0625-C18,14d24b35-141b-4743-b4a9-321e2393bb54,dceb4b03-d5e1-4097-a188-e1fa3199f844,590.0,Adjuvant,524.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0625-C18_treatment18,8e77b886-dcd2-4bdc-a396-91a5d1b3cc43,,released,,1,2021-12-21T14:13:40.809190-06:00,"Radiation, Stereotactic/Gamma Knife/SRS",Residual Disease,
HCM-CSHL-0625-C18,14d24b35-141b-4743-b4a9-321e2393bb54,dceb4b03-d5e1-4097-a188-e1fa3199f844,246.0,Adjuvant,135.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0625-C18_treatment7,b113ea8f-151f-41c9-967f-1c4f12e50d74,,released,Fluorouracil,1,2021-12-21T14:13:40.809190-06:00,Chemotherapy,Residual Disease,
HCM-CSHL-0625-C18,14d24b35-141b-4743-b4a9-321e2393bb54,dceb4b03-d5e1-4097-a188-e1fa3199f844,877.0,Adjuvant,684.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0625-C18_treatment14,b5c66d29-8c80-4d15-b19b-f6a0cc2285f0,,released,,1,2021-12-21T14:13:40.809190-06:00,Chemotherapy,Residual Disease,FOLFOX
HCM-CSHL-0625-C18,14d24b35-141b-4743-b4a9-321e2393bb54,dceb4b03-d5e1-4097-a188-e1fa3199f844,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0625-C18_treatment15,bfcdf9f2-c248-44fa-87e4-5b41913f1d27,,released,,0,2021-12-21T14:13:40.809190-06:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-CSHL-0625-C18,14d24b35-141b-4743-b4a9-321e2393bb54,dceb4b03-d5e1-4097-a188-e1fa3199f844,70.0,Adjuvant,47.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0625-C18_treatment2,e5072cc4-c887-41ee-af7a-7733b7856a58,,released,Oxaliplatin,1,2021-12-21T14:13:40.809190-06:00,Chemotherapy,Residual Disease,
HCM-CSHL-0625-C18,14d24b35-141b-4743-b4a9-321e2393bb54,dceb4b03-d5e1-4097-a188-e1fa3199f844,246.0,Adjuvant,135.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0625-C18_treatment6,f11a1598-6310-4083-8ab4-4022e7914c68,,released,Leucovorin Calcium,1,2021-12-21T14:13:40.809190-06:00,Chemotherapy,Residual Disease,
HCM-CSHL-0625-C18,14d24b35-141b-4743-b4a9-321e2393bb54,dceb4b03-d5e1-4097-a188-e1fa3199f844,877.0,Adjuvant,684.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0625-C18_treatment10,ff62f0ec-9857-4759-a6e3-fb871eb5db73,,released,Oxaliplatin,1,2021-12-21T14:13:40.809190-06:00,Chemotherapy,Residual Disease,
HCM-CSHL-0625-C18,14d24b35-141b-4743-b4a9-321e2393bb54,ddc2cd05-9276-45b7-a629-974b02869272,246.0,Maintenance Therapy,47.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0625-C18_treatment22,0b5e1b6e-6c6e-4699-8b96-63b02106eb19,Stable Disease,released,Oxaliplatin,1,2021-12-21T14:13:40.809190-06:00,,,
HCM-CSHL-0625-C18,14d24b35-141b-4743-b4a9-321e2393bb54,ddc2cd05-9276-45b7-a629-974b02869272,246.0,Maintenance Therapy,47.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0625-C18_treatment23,41fd2d64-56f2-4290-8df8-d6200dda4445,Stable Disease,released,Irinotecan,1,2021-12-21T14:13:40.809190-06:00,,,
HCM-CSHL-0625-C18,14d24b35-141b-4743-b4a9-321e2393bb54,ddc2cd05-9276-45b7-a629-974b02869272,246.0,Maintenance Therapy,47.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0625-C18_treatment24,90850d40-77cc-45ee-98a9-c6849b4d0d4e,Stable Disease,released,Capecitabine,1,2021-12-21T14:13:40.809190-06:00,,,
HCM-CSHL-0625-C18,14d24b35-141b-4743-b4a9-321e2393bb54,ddc2cd05-9276-45b7-a629-974b02869272,246.0,Maintenance Therapy,47.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0625-C18_treatment19,a94926c5-fdd2-4434-8361-2f3c33e83da1,Stable Disease,released,Fluorouracil,1,2021-12-21T14:13:40.809190-06:00,,,
HCM-CSHL-0625-C18,14d24b35-141b-4743-b4a9-321e2393bb54,ddc2cd05-9276-45b7-a629-974b02869272,246.0,Maintenance Therapy,47.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0625-C18_treatment20,bc63490c-a58b-4a5a-aba7-685ba0fc3c21,Stable Disease,released,Leucovorin Calcium,1,2021-12-21T14:13:40.809190-06:00,,,
HCM-CSHL-0625-C18,14d24b35-141b-4743-b4a9-321e2393bb54,ddc2cd05-9276-45b7-a629-974b02869272,246.0,Maintenance Therapy,47.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0625-C18_treatment26,e1f41894-187f-4f8a-b182-c9dcb0133ef8,Stable Disease,released,,1,2021-12-21T14:13:40.809190-06:00,,,XELOX
HCM-CSHL-0625-C18,14d24b35-141b-4743-b4a9-321e2393bb54,ddc2cd05-9276-45b7-a629-974b02869272,246.0,Maintenance Therapy,47.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0625-C18_treatment25,eacbe05b-8204-464c-b03e-b242ff17563e,Stable Disease,released,,1,2021-12-21T14:13:40.809190-06:00,,,FOLFIRI
HCM-CSHL-0625-C18,14d24b35-141b-4743-b4a9-321e2393bb54,ddc2cd05-9276-45b7-a629-974b02869272,246.0,Maintenance Therapy,47.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0625-C18_treatment21,eb6009a9-6e0e-4fa7-82d9-709057b00759,Stable Disease,released,Cetuximab,1,2021-12-21T14:13:40.809190-06:00,,,
HCM-EXPT-0944-C50,14f78f65-92c2-4811-b714-513dccee6022,d4600a23-611c-4d05-9332-9969c783c820,,Neoadjuvant,,2025-10-08T12:36:57.024699-05:00,HCM-EXPT-0944-C50_treatment,eb563a62-77fe-48f9-af29-540fef81e8d1,,released,,0,2021-12-21T14:47:55.347011-06:00,,,
HCM-WCMC-1287-C67,150dfaa3-1eb3-427a-a82f-560d706cabc2,3fddd527-5d17-413b-b165-0f0343565004,442.0,Adjuvant,435.0,2025-04-07T17:13:09.336794-05:00,HCM-WCMC-1287-C67_treatment7,254f5555-4049-492f-b065-ffe69fbfbc0a,,released,Enfortumab Vedotin,1,2023-02-27T13:14:48.334547-06:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-WCMC-1287-C67,150dfaa3-1eb3-427a-a82f-560d706cabc2,3fddd527-5d17-413b-b165-0f0343565004,260.0,Adjuvant,190.0,2025-04-07T17:13:09.336794-05:00,HCM-WCMC-1287-C67_treatment6,3bd62b83-c242-4454-993a-e0efbbdb8171,,released,Avelumab,1,2023-02-27T13:14:48.334547-06:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-WCMC-1287-C67,150dfaa3-1eb3-427a-a82f-560d706cabc2,3fddd527-5d17-413b-b165-0f0343565004,155.0,Adjuvant,43.0,2025-04-07T17:13:09.336794-05:00,HCM-WCMC-1287-C67_treatment2,803e7a86-5ac9-4c8e-b4ce-6a22f2dd36fb,,released,Etoposide,1,2023-02-27T13:14:48.334547-06:00,Chemotherapy,Residual Disease,
HCM-WCMC-1287-C67,150dfaa3-1eb3-427a-a82f-560d706cabc2,3fddd527-5d17-413b-b165-0f0343565004,,,0.0,2025-04-07T17:13:09.336794-05:00,HCM-WCMC-1287-C67_treatment8,94ca05d8-c73b-4f5f-b355-4d4275006e17,,released,,1,2023-02-27T13:14:48.334547-06:00,"Surgery, NOS",Initial Diagnosis,
HCM-WCMC-1287-C67,150dfaa3-1eb3-427a-a82f-560d706cabc2,3fddd527-5d17-413b-b165-0f0343565004,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-WCMC-1287-C67_treatment5,9fd62d5a-11c5-4629-9533-c988a934b2b3,,released,,0,2023-02-27T13:14:48.334547-06:00,Hormone Therapy,Residual Disease,
HCM-WCMC-1287-C67,150dfaa3-1eb3-427a-a82f-560d706cabc2,3fddd527-5d17-413b-b165-0f0343565004,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-WCMC-1287-C67_treatment9,a1f3e25c-ab1d-483b-9897-f0e6ddbcf490,,released,,0,2023-02-27T13:14:48.334547-06:00,Targeted Molecular Therapy,Residual Disease,
HCM-WCMC-1287-C67,150dfaa3-1eb3-427a-a82f-560d706cabc2,3fddd527-5d17-413b-b165-0f0343565004,155.0,Adjuvant,43.0,2025-04-07T17:13:09.336794-05:00,HCM-WCMC-1287-C67_treatment3,e3f00d2d-b96f-4786-b311-6f6879f75426,,released,Cisplatin,1,2023-02-27T13:14:48.334547-06:00,Chemotherapy,Residual Disease,
HCM-WCMC-1287-C67,150dfaa3-1eb3-427a-a82f-560d706cabc2,3fddd527-5d17-413b-b165-0f0343565004,407.0,Adjuvant,365.0,2025-04-07T17:13:09.336794-05:00,HCM-WCMC-1287-C67_treatment4,eb030069-112c-436b-a134-6c97364659e8,,released,Lurbinectedin,1,2023-02-27T13:14:48.334547-06:00,Chemotherapy,Residual Disease,
HCM-WCMC-1287-C67,150dfaa3-1eb3-427a-a82f-560d706cabc2,3fddd527-5d17-413b-b165-0f0343565004,,Neoadjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-WCMC-1287-C67_treatment,f98f49cc-1c6a-493c-b772-5764c46d59e0,,released,,0,2023-02-27T13:14:48.334547-06:00,,,
HCM-WCMC-1287-C67,150dfaa3-1eb3-427a-a82f-560d706cabc2,3fddd527-5d17-413b-b165-0f0343565004,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-WCMC-1287-C67_treatment10,fdd52ac1-88b1-4e0c-85d4-ee6660ac8283,,released,,0,2023-02-27T13:14:48.334547-06:00,"Radiation Therapy, NOS",Residual Disease,
HCM-CSHL-0860-C18,157d4813-8461-4593-8232-863c7ace4b35,43034527-795f-4d93-8ce0-777dd3947050,,Neoadjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0860-C18_treatment,04773181-1ac6-4659-9be6-a23e6e17f844,,released,,0,2021-12-21T14:36:00.645302-06:00,,,
HCM-CSHL-0860-C18,157d4813-8461-4593-8232-863c7ace4b35,43034527-795f-4d93-8ce0-777dd3947050,122.0,Adjuvant,62.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0860-C18_treatment2,0d32b1a0-d7c1-4a19-9fbb-64edc685d508,,released,Oxaliplatin,1,2021-12-21T14:36:00.645302-06:00,Chemotherapy,Residual Disease,
HCM-CSHL-0860-C18,157d4813-8461-4593-8232-863c7ace4b35,43034527-795f-4d93-8ce0-777dd3947050,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0860-C18_treatment12,2ba801ff-06e6-4437-9d22-4ad49e0f0d0c,,released,,0,2021-12-21T14:36:00.645302-06:00,"Radiation Therapy, NOS",Residual Disease,
HCM-CSHL-0860-C18,157d4813-8461-4593-8232-863c7ace4b35,43034527-795f-4d93-8ce0-777dd3947050,428.0,Adjuvant,397.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0860-C18_treatment7,4365571a-a77f-4b0d-9e04-a8869259a38f,,released,Fluorouracil,1,2021-12-21T14:36:00.645302-06:00,Chemotherapy,Residual Disease,
HCM-CSHL-0860-C18,157d4813-8461-4593-8232-863c7ace4b35,43034527-795f-4d93-8ce0-777dd3947050,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0860-C18_treatment11,55f84249-afa9-4279-9236-e3b72b33e7ba,,released,,0,2021-12-21T14:36:00.645302-06:00,Targeted Molecular Therapy,Residual Disease,
HCM-CSHL-0860-C18,157d4813-8461-4593-8232-863c7ace4b35,43034527-795f-4d93-8ce0-777dd3947050,428.0,Adjuvant,397.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0860-C18_treatment5,6d8fb0cd-e78a-42fe-8a5e-b48a74e194e8,,released,Bevacizumab,1,2021-12-21T14:36:00.645302-06:00,Chemotherapy,Residual Disease,
HCM-CSHL-0860-C18,157d4813-8461-4593-8232-863c7ace4b35,43034527-795f-4d93-8ce0-777dd3947050,122.0,Adjuvant,62.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0860-C18_treatment3,77f5501c-b709-4827-848d-4fe82a1e2945,,released,Capecitabine,1,2021-12-21T14:36:00.645302-06:00,Chemotherapy,Residual Disease,
HCM-CSHL-0860-C18,157d4813-8461-4593-8232-863c7ace4b35,43034527-795f-4d93-8ce0-777dd3947050,428.0,Adjuvant,397.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0860-C18_treatment6,8d3040b3-ad37-4b5c-82aa-33077af50f60,,released,Leucovorin Calcium,1,2021-12-21T14:36:00.645302-06:00,Chemotherapy,Residual Disease,
HCM-CSHL-0860-C18,157d4813-8461-4593-8232-863c7ace4b35,43034527-795f-4d93-8ce0-777dd3947050,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0860-C18_treatment9,aed041ed-dd12-47eb-a311-75282c1a3311,,released,,0,2021-12-21T14:36:00.645302-06:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-CSHL-0860-C18,157d4813-8461-4593-8232-863c7ace4b35,43034527-795f-4d93-8ce0-777dd3947050,428.0,Adjuvant,397.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0860-C18_treatment8,c0ba084e-df46-4b44-a7b0-84a2b271a64d,,released,,1,2021-12-21T14:36:00.645302-06:00,Chemotherapy,Residual Disease,FOLFOX
HCM-CSHL-0860-C18,157d4813-8461-4593-8232-863c7ace4b35,43034527-795f-4d93-8ce0-777dd3947050,428.0,Adjuvant,397.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0860-C18_treatment4,dd73d23a-d260-4e12-96e2-554544f3dcdd,,released,Oxaliplatin,1,2021-12-21T14:36:00.645302-06:00,Chemotherapy,Residual Disease,
HCM-CSHL-0860-C18,157d4813-8461-4593-8232-863c7ace4b35,43034527-795f-4d93-8ce0-777dd3947050,,,200.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0860-C18_treatment10,fdb66eb5-09b9-4e43-bf6d-7a6093fa5fbe,,released,,1,2021-12-21T14:36:00.645302-06:00,"Surgery, NOS",Initial Diagnosis,
HCM-CSHL-0860-C18,157d4813-8461-4593-8232-863c7ace4b35,de5b2d58-3b24-4e7a-bc6f-8558fc7ec068,149.0,Maintenance Therapy,72.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0860-C18_treatment13,241cea9c-f039-480c-9468-ce681a20786f,Progressive Disease,released,Oxaliplatin,1,2021-12-21T14:36:00.645302-06:00,,,
HCM-CSHL-0860-C18,157d4813-8461-4593-8232-863c7ace4b35,de5b2d58-3b24-4e7a-bc6f-8558fc7ec068,149.0,Maintenance Therapy,72.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0860-C18_treatment14,75020a20-a1aa-4226-b40c-9797e4457afc,Progressive Disease,released,Capecitabine,1,2021-12-21T14:36:00.645302-06:00,,,
HCM-CSHL-0860-C18,157d4813-8461-4593-8232-863c7ace4b35,de5b2d58-3b24-4e7a-bc6f-8558fc7ec068,149.0,Maintenance Therapy,72.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0860-C18_treatment15,acc29839-6207-4714-ac3b-7d63a05d78f8,Progressive Disease,released,,1,2021-12-21T14:36:00.645302-06:00,,,XELOX
HCM-EXPT-0885-C25,159b2484-d704-4b1f-85a7-4e88155c8223,37c1af4b-7d26-4ae7-a18c-feeedbf4177a,,Neoadjuvant,,2025-10-08T12:36:32.654639-05:00,HCM-EXPT-0885-C25_treatment,30eedc48-1a2b-45fc-b391-6c146bc91411,,released,,0,2021-12-21T15:26:59.053832-06:00,,,
HCM-BROD-0489-C15,15fda26e-ea06-4ead-be90-9af1d94473aa,ba6fc32c-3904-4580-8522-cf1c155cee90,,Neoadjuvant,15.0,2023-07-13T10:35:44.371881-05:00,HCM-BROD-0489-C15_treatment3,07b607ae-ccd0-4c56-88b9-b5970c011e25,,released,Irinotecan,1,2021-12-21T13:38:35.778498-06:00,Chemotherapy,,
HCM-BROD-0489-C15,15fda26e-ea06-4ead-be90-9af1d94473aa,ba6fc32c-3904-4580-8522-cf1c155cee90,435.0,Adjuvant,15.0,2023-07-13T10:35:44.371881-05:00,HCM-BROD-0489-C15_treatment9,197785f8-0a2f-4aff-a8a9-69e722bd4512,,released,,1,2021-12-21T13:38:35.778498-06:00,Chemotherapy,Residual Disease,FOLFOX
HCM-BROD-0489-C15,15fda26e-ea06-4ead-be90-9af1d94473aa,ba6fc32c-3904-4580-8522-cf1c155cee90,435.0,Adjuvant,15.0,2023-07-13T10:35:44.371881-05:00,HCM-BROD-0489-C15_treatment8,2d4a0139-b0b0-4bea-8406-11fdd2b34c27,,released,Oxaliplatin,1,2021-12-21T13:38:35.778498-06:00,Chemotherapy,Residual Disease,
HCM-BROD-0489-C15,15fda26e-ea06-4ead-be90-9af1d94473aa,ba6fc32c-3904-4580-8522-cf1c155cee90,,Neoadjuvant,15.0,2023-07-13T10:35:44.371881-05:00,HCM-BROD-0489-C15_treatment4,364ecc9f-d2df-4c3a-9912-2772d8a0bb66,,released,,1,2021-12-21T13:38:35.778498-06:00,Chemotherapy,,FOLFIRI
HCM-BROD-0489-C15,15fda26e-ea06-4ead-be90-9af1d94473aa,ba6fc32c-3904-4580-8522-cf1c155cee90,,Neoadjuvant,15.0,2023-07-13T10:35:44.371881-05:00,HCM-BROD-0489-C15_treatment2,48bc8e06-76d8-4e71-b2d3-5a18ab42151f,,released,Fluorouracil,1,2021-12-21T13:38:35.778498-06:00,Chemotherapy,,
HCM-BROD-0489-C15,15fda26e-ea06-4ead-be90-9af1d94473aa,ba6fc32c-3904-4580-8522-cf1c155cee90,,Neoadjuvant,15.0,2023-07-13T10:35:44.371881-05:00,HCM-BROD-0489-C15_treatment5,5d728fbb-d988-4237-9e0e-189ebf236949,,released,Ramucirumab,1,2021-12-21T13:38:35.778498-06:00,Targeted Molecular Therapy,,
HCM-BROD-0489-C15,15fda26e-ea06-4ead-be90-9af1d94473aa,ba6fc32c-3904-4580-8522-cf1c155cee90,,Adjuvant,,2023-07-13T10:35:44.371881-05:00,HCM-BROD-0489-C15_treatment12,676274c7-7c0e-48ab-89e5-88d06bdc5460,,released,,0,2021-12-21T13:38:35.778498-06:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-BROD-0489-C15,15fda26e-ea06-4ead-be90-9af1d94473aa,ba6fc32c-3904-4580-8522-cf1c155cee90,,Adjuvant,,2023-07-13T10:35:44.371881-05:00,HCM-BROD-0489-C15_treatment14,87d0e9b2-43fb-426e-97fe-a6d68aae1bb5,,released,,0,2021-12-21T13:38:35.778498-06:00,Targeted Molecular Therapy,Residual Disease,
HCM-BROD-0489-C15,15fda26e-ea06-4ead-be90-9af1d94473aa,ba6fc32c-3904-4580-8522-cf1c155cee90,,Neoadjuvant,15.0,2023-07-13T10:35:44.371881-05:00,HCM-BROD-0489-C15_treatment,8eef039a-4f1a-40a0-b8d8-9b157daa48c5,,released,Leucovorin Calcium,1,2021-12-21T13:38:35.778498-06:00,Chemotherapy,,
HCM-BROD-0489-C15,15fda26e-ea06-4ead-be90-9af1d94473aa,ba6fc32c-3904-4580-8522-cf1c155cee90,435.0,Adjuvant,15.0,2023-07-13T10:35:44.371881-05:00,HCM-BROD-0489-C15_treatment6,9c1d598f-36e0-4d8b-9f94-076e3a653beb,,released,Leucovorin Calcium,1,2021-12-21T13:38:35.778498-06:00,Chemotherapy,Residual Disease,
HCM-BROD-0489-C15,15fda26e-ea06-4ead-be90-9af1d94473aa,ba6fc32c-3904-4580-8522-cf1c155cee90,435.0,Adjuvant,15.0,2023-07-13T10:35:44.371881-05:00,HCM-BROD-0489-C15_treatment7,ceb066ec-791e-4980-a3af-9ae14b364d81,,released,Fluorouracil,1,2021-12-21T13:38:35.778498-06:00,Chemotherapy,Residual Disease,
HCM-BROD-0489-C15,15fda26e-ea06-4ead-be90-9af1d94473aa,ba6fc32c-3904-4580-8522-cf1c155cee90,,,0.0,2023-07-13T10:35:44.371881-05:00,HCM-BROD-0489-C15_treatment13,d9c256c3-0af3-4b71-b2c8-511edc0fe988,,released,,1,2021-12-21T13:38:35.778498-06:00,"Surgery, NOS",Initial Diagnosis,
HCM-BROD-0489-C15,15fda26e-ea06-4ead-be90-9af1d94473aa,ba6fc32c-3904-4580-8522-cf1c155cee90,435.0,Adjuvant,15.0,2023-07-13T10:35:44.371881-05:00,HCM-BROD-0489-C15_treatment10,e8703381-b984-4572-840c-3f541979d624,,released,Irinotecan,1,2021-12-21T13:38:35.778498-06:00,Chemotherapy,Residual Disease,
HCM-BROD-0489-C15,15fda26e-ea06-4ead-be90-9af1d94473aa,ba6fc32c-3904-4580-8522-cf1c155cee90,435.0,Adjuvant,15.0,2023-07-13T10:35:44.371881-05:00,HCM-BROD-0489-C15_treatment11,ee79cba8-6d93-4b07-9a4f-5d67a25ec895,,released,,1,2021-12-21T13:38:35.778498-06:00,Chemotherapy,Residual Disease,FOLFIRI
HCM-BROD-0489-C15,15fda26e-ea06-4ead-be90-9af1d94473aa,ba6fc32c-3904-4580-8522-cf1c155cee90,,Adjuvant,,2023-07-13T10:35:44.371881-05:00,HCM-BROD-0489-C15_treatment15,f9e35320-f6f9-4c80-b9e9-9d86fdaf13f2,,released,,0,2021-12-21T13:38:35.778498-06:00,"Radiation Therapy, NOS",Residual Disease,
HCM-BROD-0111-C25,164eeaa7-4229-493f-ae77-0843f36af6b8,2c65803b-ecf3-4990-afd6-f9fab6c17ea9,,Neoadjuvant,3.0,2023-11-07T14:28:29.403873-06:00,HCM-BROD-0111-C25_treatment8,03ac042a-5f5c-4f0e-b832-5703d615087d,,released,Nab-paclitaxel,1,2020-09-17T15:45:42.548915-05:00,Chemotherapy,,
HCM-BROD-0111-C25,164eeaa7-4229-493f-ae77-0843f36af6b8,2c65803b-ecf3-4990-afd6-f9fab6c17ea9,,Adjuvant,,2023-11-07T14:28:29.403873-06:00,HCM-BROD-0111-C25_treatment11,043d646a-8446-42bc-be3a-b2a0327ad855,,released,,0,2020-09-17T15:45:42.548915-05:00,Chemotherapy,Residual Disease,
HCM-BROD-0111-C25,164eeaa7-4229-493f-ae77-0843f36af6b8,2c65803b-ecf3-4990-afd6-f9fab6c17ea9,,Adjuvant,,2023-11-07T14:28:29.403873-06:00,HCM-BROD-0111-C25_treatment14,26083536-0686-459a-a23e-7a0f1947e152,,released,,0,2020-09-17T15:45:42.548915-05:00,Targeted Molecular Therapy,Residual Disease,
HCM-BROD-0111-C25,164eeaa7-4229-493f-ae77-0843f36af6b8,2c65803b-ecf3-4990-afd6-f9fab6c17ea9,,Adjuvant,,2023-11-07T14:28:29.403873-06:00,HCM-BROD-0111-C25_treatment12,311ab237-d60b-4060-a494-f80906a8515e,,released,,0,2020-09-17T15:45:42.548915-05:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-BROD-0111-C25,164eeaa7-4229-493f-ae77-0843f36af6b8,2c65803b-ecf3-4990-afd6-f9fab6c17ea9,,Neoadjuvant,3.0,2023-11-07T14:28:29.403873-06:00,HCM-BROD-0111-C25_treatment4,319a31ea-79d6-4015-8060-3e1d018d3831,,released,Oxaliplatin,1,2020-09-17T15:45:42.548915-05:00,Chemotherapy,,
HCM-BROD-0111-C25,164eeaa7-4229-493f-ae77-0843f36af6b8,2c65803b-ecf3-4990-afd6-f9fab6c17ea9,,Neoadjuvant,3.0,2023-11-07T14:28:29.403873-06:00,HCM-BROD-0111-C25_treatment,82258f1e-1fe5-471a-92b6-01efdde6725c,,released,Irinotecan Hydrochloride,1,2020-09-17T15:45:42.548915-05:00,Chemotherapy,,
HCM-BROD-0111-C25,164eeaa7-4229-493f-ae77-0843f36af6b8,2c65803b-ecf3-4990-afd6-f9fab6c17ea9,,Neoadjuvant,3.0,2023-11-07T14:28:29.403873-06:00,HCM-BROD-0111-C25_treatment2,869423df-4f9f-432a-a43c-85422eb7a13e,,released,Leucovorin Calcium,1,2020-09-17T15:45:42.548915-05:00,Chemotherapy,,
HCM-BROD-0111-C25,164eeaa7-4229-493f-ae77-0843f36af6b8,2c65803b-ecf3-4990-afd6-f9fab6c17ea9,,Neoadjuvant,3.0,2023-11-07T14:28:29.403873-06:00,HCM-BROD-0111-C25_treatment3,ba2a6d13-03af-40f3-b27e-62105aa5bea1,,released,Fluorouracil,1,2020-09-17T15:45:42.548915-05:00,Chemotherapy,,
HCM-BROD-0111-C25,164eeaa7-4229-493f-ae77-0843f36af6b8,2c65803b-ecf3-4990-afd6-f9fab6c17ea9,,,,2023-11-07T14:28:29.403873-06:00,HCM-BROD-0111-C25_treatment13,c4893d31-5e02-42ac-b1e6-74cd9da35779,,released,,0,2020-09-17T15:45:42.548915-05:00,"Surgery, NOS",Initial Diagnosis,
HCM-BROD-0111-C25,164eeaa7-4229-493f-ae77-0843f36af6b8,2c65803b-ecf3-4990-afd6-f9fab6c17ea9,,Neoadjuvant,3.0,2023-11-07T14:28:29.403873-06:00,HCM-BROD-0111-C25_treatment10,c851b0fc-11ab-4d18-a97d-b856826f4eae,,released,,1,2020-09-17T15:45:42.548915-05:00,Chemotherapy,,FU-LV regimen
HCM-BROD-0111-C25,164eeaa7-4229-493f-ae77-0843f36af6b8,2c65803b-ecf3-4990-afd6-f9fab6c17ea9,,Neoadjuvant,3.0,2023-11-07T14:28:29.403873-06:00,HCM-BROD-0111-C25_treatment5,c8e613bb-5722-4162-94fe-58d1a75db02b,,released,,1,2020-09-17T15:45:42.548915-05:00,Chemotherapy,,FOLFIRINOX
HCM-BROD-0111-C25,164eeaa7-4229-493f-ae77-0843f36af6b8,2c65803b-ecf3-4990-afd6-f9fab6c17ea9,,Neoadjuvant,3.0,2023-11-07T14:28:29.403873-06:00,HCM-BROD-0111-C25_treatment9,d645b039-e227-4418-96f4-88d990cff467,,released,Leucovorin,1,2020-09-17T15:45:42.548915-05:00,Chemotherapy,,
HCM-BROD-0111-C25,164eeaa7-4229-493f-ae77-0843f36af6b8,2c65803b-ecf3-4990-afd6-f9fab6c17ea9,,Neoadjuvant,3.0,2023-11-07T14:28:29.403873-06:00,HCM-BROD-0111-C25_treatment7,d6a6f4ef-591a-403f-a789-7fb5dfc14fb3,,released,Gemcitabine,1,2020-09-17T15:45:42.548915-05:00,Chemotherapy,,
HCM-BROD-0111-C25,164eeaa7-4229-493f-ae77-0843f36af6b8,2c65803b-ecf3-4990-afd6-f9fab6c17ea9,,Adjuvant,,2023-11-07T14:28:29.403873-06:00,HCM-BROD-0111-C25_treatment15,e07cf33a-30ae-49bf-93a8-d21f574138d8,,released,,0,2020-09-17T15:45:42.548915-05:00,"Radiation Therapy, NOS",Residual Disease,
HCM-BROD-0111-C25,164eeaa7-4229-493f-ae77-0843f36af6b8,2c65803b-ecf3-4990-afd6-f9fab6c17ea9,,Neoadjuvant,3.0,2023-11-07T14:28:29.403873-06:00,HCM-BROD-0111-C25_treatment6,e5a97aed-2c6a-4d2c-96eb-4e7d5b9a3c82,,released,Irinotecan,1,2020-09-17T15:45:42.548915-05:00,Chemotherapy,,
HCM-WCMC-0951-C67,165c2263-819e-46f2-9ccf-4f7ea4d83300,97e0e5f2-bbd1-4381-adbc-7a916aa24f5d,,,0.0,2025-04-07T17:13:09.336794-05:00,HCM-WCMC-0951-C67_treatment5,2b6c4943-e18a-4e18-948b-df13e43558b2,,released,,1,2023-02-27T12:12:04.050227-06:00,"Surgery, NOS",Initial Diagnosis,
HCM-WCMC-0951-C67,165c2263-819e-46f2-9ccf-4f7ea4d83300,97e0e5f2-bbd1-4381-adbc-7a916aa24f5d,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-WCMC-0951-C67_treatment2,43e731d6-fa3d-4124-887f-f8ed0f4f6807,,released,,0,2023-02-27T12:12:04.050227-06:00,Chemotherapy,Residual Disease,
HCM-WCMC-0951-C67,165c2263-819e-46f2-9ccf-4f7ea4d83300,97e0e5f2-bbd1-4381-adbc-7a916aa24f5d,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-WCMC-0951-C67_treatment7,5e060a10-435b-4e06-8be8-05b9660c9216,,released,,0,2023-02-27T12:12:04.050227-06:00,"Radiation Therapy, NOS",Residual Disease,
HCM-WCMC-0951-C67,165c2263-819e-46f2-9ccf-4f7ea4d83300,97e0e5f2-bbd1-4381-adbc-7a916aa24f5d,,Neoadjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-WCMC-0951-C67_treatment,7cbadabd-8e7a-464e-bfbd-58f6afd4fb6f,,released,,0,2023-02-27T12:12:04.050227-06:00,,,
HCM-WCMC-0951-C67,165c2263-819e-46f2-9ccf-4f7ea4d83300,97e0e5f2-bbd1-4381-adbc-7a916aa24f5d,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-WCMC-0951-C67_treatment3,80f498e9-ae2c-4843-bfe8-ceec07ce256b,,released,,0,2023-02-27T12:12:04.050227-06:00,Hormone Therapy,Residual Disease,
HCM-WCMC-0951-C67,165c2263-819e-46f2-9ccf-4f7ea4d83300,97e0e5f2-bbd1-4381-adbc-7a916aa24f5d,0.0,Adjuvant,0.0,2025-04-07T17:13:09.336794-05:00,HCM-WCMC-0951-C67_treatment4,afd5cd16-c16f-43aa-b97c-db19646879d6,,released,BCG Solution,1,2023-02-27T12:12:04.050227-06:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-WCMC-0951-C67,165c2263-819e-46f2-9ccf-4f7ea4d83300,97e0e5f2-bbd1-4381-adbc-7a916aa24f5d,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-WCMC-0951-C67_treatment6,ce06452a-8918-44f1-8fa2-ca6847783dae,,released,,0,2023-02-27T12:12:04.050227-06:00,Targeted Molecular Therapy,Residual Disease,
HCM-EXPT-0401-C50,17264882-995a-4d9f-91dc-00de991f3ea0,8d3c5e65-3ac2-46c2-b151-b709eea44367,,Neoadjuvant,,2025-10-08T12:36:32.654639-05:00,HCM-EXPT-0401-C50_treatment,89a2aa98-e45c-4c71-8885-84bb677961bd,,released,,0,2021-12-21T14:40:43.070931-06:00,,,
HCM-CSHL-0176-C25,17f4b889-d7b9-42d1-adb8-cbad65a56547,d27c890b-2652-4ac8-9302-d1595c8ce831,,,-6.0,2023-03-13T13:22:30.424061-05:00,HCM-CSHL-0176-C25_treatment2,a413dfb1-54d4-4a52-bd9c-16cfc2d5cbbe,,released,,1,2020-09-28T09:13:08.711050-05:00,"Surgery, NOS",Initial Diagnosis,
HCM-CSHL-0176-C25,17f4b889-d7b9-42d1-adb8-cbad65a56547,d27c890b-2652-4ac8-9302-d1595c8ce831,,Neoadjuvant,,2023-02-22T07:39:25.979291-06:00,HCM-CSHL-0176-C25_treatment,dd3ec9f7-ee98-4dff-8b3f-54533a24368e,,released,,0,2020-09-28T09:13:08.711050-05:00,,,
HCM-BROD-0009-C25,18909e2d-a178-49b3-9a70-998f944af8a3,e50d0efe-b604-41d8-ae6e-9a8adaf43e3e,,Adjuvant,,2021-07-12T12:25:55.528644-05:00,HCM-BROD-0009-C25_treatment10,2ac1902c-445f-4b1c-9109-7854dff19d0a,,released,,0,2020-09-27T09:59:38.839530-05:00,"Radiation Therapy, NOS",Residual Disease,
HCM-BROD-0009-C25,18909e2d-a178-49b3-9a70-998f944af8a3,e50d0efe-b604-41d8-ae6e-9a8adaf43e3e,,Adjuvant,,2021-07-12T12:25:55.528644-05:00,HCM-BROD-0009-C25_treatment7,2d6f422d-7597-43f0-9960-cb7ef6429749,,released,,0,2020-09-27T09:59:38.839530-05:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-BROD-0009-C25,18909e2d-a178-49b3-9a70-998f944af8a3,e50d0efe-b604-41d8-ae6e-9a8adaf43e3e,,Adjuvant,,2021-07-12T12:25:55.528644-05:00,HCM-BROD-0009-C25_treatment9,3562d800-8470-4042-a3a1-f5b9cba48757,,released,,0,2020-09-27T09:59:38.839530-05:00,Targeted Molecular Therapy,Residual Disease,
HCM-BROD-0009-C25,18909e2d-a178-49b3-9a70-998f944af8a3,e50d0efe-b604-41d8-ae6e-9a8adaf43e3e,221.0,Adjuvant,67.0,2021-07-12T12:25:55.528644-05:00,HCM-BROD-0009-C25_treatment3,39c41b1b-3d27-4dbb-9446-8e319970385e,,released,Leucovorin Calcium,1,2019-04-16T11:17:51.825330-05:00,Chemotherapy,Residual Disease,
HCM-BROD-0009-C25,18909e2d-a178-49b3-9a70-998f944af8a3,e50d0efe-b604-41d8-ae6e-9a8adaf43e3e,221.0,Adjuvant,67.0,2021-07-12T12:25:55.528644-05:00,HCM-BROD-0009-C25_treatment4,4a038cdb-8716-48c6-9eb1-a7bcb6100cdb,,released,Fluorouracil,1,2019-04-16T11:17:51.825330-05:00,Chemotherapy,Residual Disease,
HCM-BROD-0009-C25,18909e2d-a178-49b3-9a70-998f944af8a3,e50d0efe-b604-41d8-ae6e-9a8adaf43e3e,221.0,Adjuvant,67.0,2021-07-12T12:25:55.528644-05:00,HCM-BROD-0009-C25_treatment6,540f1ace-df95-443e-b1c0-aeb5acbaa176,,released,,1,2019-04-16T11:17:51.825330-05:00,Chemotherapy,Residual Disease,FOLFIRINOX
HCM-BROD-0009-C25,18909e2d-a178-49b3-9a70-998f944af8a3,e50d0efe-b604-41d8-ae6e-9a8adaf43e3e,221.0,Adjuvant,67.0,2021-07-12T12:25:55.528644-05:00,HCM-BROD-0009-C25_treatment5,941187fe-6ac4-4716-b55b-6f57e35cf7c9,,released,Oxaliplatin,1,2019-04-16T11:17:51.825330-05:00,Chemotherapy,Residual Disease,
HCM-BROD-0009-C25,18909e2d-a178-49b3-9a70-998f944af8a3,e50d0efe-b604-41d8-ae6e-9a8adaf43e3e,,,17.0,2023-02-27T11:52:53.196293-06:00,HCM-BROD-0009-C25_treatment8,a710514d-305f-4d9c-afcf-ec0ff359613e,,released,,1,2020-09-27T09:59:38.839530-05:00,"Surgery, NOS",Initial Diagnosis,
HCM-BROD-0009-C25,18909e2d-a178-49b3-9a70-998f944af8a3,e50d0efe-b604-41d8-ae6e-9a8adaf43e3e,221.0,Adjuvant,67.0,2021-07-12T12:25:55.528644-05:00,HCM-BROD-0009-C25_treatment2,bad47bbb-1f23-407d-8679-a07ec12c9cdd,,released,Irinotecan Hydrochloride,1,2019-04-16T11:17:51.825330-05:00,Chemotherapy,Residual Disease,
HCM-BROD-0009-C25,18909e2d-a178-49b3-9a70-998f944af8a3,e50d0efe-b604-41d8-ae6e-9a8adaf43e3e,,Neoadjuvant,,2021-07-12T12:25:55.528644-05:00,HCM-BROD-0009-C25_treatment,cc4bbe6b-2231-47f6-8e50-fbd9b624a096,,released,,0,2019-04-16T11:17:51.825330-05:00,,,
HCM-WCMC-0502-C15,18d012fb-77b9-4a9f-b3c7-986f9a0592d1,71ab8cea-7131-49cb-a85b-d6de056592ab,,Neoadjuvant,34.0,2023-07-13T10:35:44.371881-05:00,HCM-WCMC-0502-C15_treatment2,05b2aae6-5a99-4470-b98e-0a3998a7343c,,released,Fluorouracil,1,2023-02-27T12:15:10.249107-06:00,Chemotherapy,,
HCM-WCMC-0502-C15,18d012fb-77b9-4a9f-b3c7-986f9a0592d1,71ab8cea-7131-49cb-a85b-d6de056592ab,253.0,Adjuvant,34.0,2023-07-13T10:35:44.371881-05:00,HCM-WCMC-0502-C15_treatment13,1bc4726e-356a-4aa7-9da4-a8216e00693b,,released,Andecaliximab,1,2023-02-27T12:15:10.249107-06:00,Targeted Molecular Therapy,Residual Disease,
HCM-WCMC-0502-C15,18d012fb-77b9-4a9f-b3c7-986f9a0592d1,71ab8cea-7131-49cb-a85b-d6de056592ab,,Adjuvant,,2023-07-13T10:35:44.371881-05:00,HCM-WCMC-0502-C15_treatment15,42b286c5-7f36-45d5-abc2-3e94555a345f,,released,,0,2023-02-27T12:15:10.249107-06:00,"Radiation Therapy, NOS",Residual Disease,
HCM-WCMC-0502-C15,18d012fb-77b9-4a9f-b3c7-986f9a0592d1,71ab8cea-7131-49cb-a85b-d6de056592ab,253.0,Adjuvant,34.0,2023-07-13T10:35:44.371881-05:00,HCM-WCMC-0502-C15_treatment6,5684a20a-a1dc-4575-b7c6-e37295d9241b,,released,Leucovorin Calcium,1,2023-02-27T12:15:10.249107-06:00,Chemotherapy,Residual Disease,
HCM-WCMC-0502-C15,18d012fb-77b9-4a9f-b3c7-986f9a0592d1,71ab8cea-7131-49cb-a85b-d6de056592ab,,,349.0,2023-07-13T10:35:44.371881-05:00,HCM-WCMC-0502-C15_treatment12,60b22fca-b419-4800-b799-1002360d8320,,released,,1,2023-02-27T12:15:10.249107-06:00,"Surgery, NOS",Initial Diagnosis,
HCM-WCMC-0502-C15,18d012fb-77b9-4a9f-b3c7-986f9a0592d1,71ab8cea-7131-49cb-a85b-d6de056592ab,,Neoadjuvant,34.0,2023-07-13T10:35:44.371881-05:00,HCM-WCMC-0502-C15_treatment4,71b9f582-14e6-4d82-b1eb-cd1a5c92fdee,,released,,1,2023-02-27T12:15:10.249107-06:00,Chemotherapy,,FOLFOX
HCM-WCMC-0502-C15,18d012fb-77b9-4a9f-b3c7-986f9a0592d1,71ab8cea-7131-49cb-a85b-d6de056592ab,,Neoadjuvant,34.0,2023-07-13T10:35:44.371881-05:00,HCM-WCMC-0502-C15_treatment3,9315627e-06d4-4631-bec9-b1ad03d9f521,,released,Oxaliplatin,1,2023-02-27T12:15:10.249107-06:00,Chemotherapy,,
HCM-WCMC-0502-C15,18d012fb-77b9-4a9f-b3c7-986f9a0592d1,71ab8cea-7131-49cb-a85b-d6de056592ab,315.0,Adjuvant,273.0,2023-07-13T10:35:44.371881-05:00,HCM-WCMC-0502-C15_treatment10,9366b705-71f6-4ab0-b3ef-54c8fd33bd03,,released,Paclitaxel,1,2023-02-27T12:15:10.249107-06:00,Chemotherapy,Residual Disease,
HCM-WCMC-0502-C15,18d012fb-77b9-4a9f-b3c7-986f9a0592d1,71ab8cea-7131-49cb-a85b-d6de056592ab,253.0,Adjuvant,34.0,2023-07-13T10:35:44.371881-05:00,HCM-WCMC-0502-C15_treatment7,9cb797d8-97aa-480b-a932-1fb226ea5cf7,,released,Fluorouracil,1,2023-02-27T12:15:10.249107-06:00,Chemotherapy,Residual Disease,
HCM-WCMC-0502-C15,18d012fb-77b9-4a9f-b3c7-986f9a0592d1,71ab8cea-7131-49cb-a85b-d6de056592ab,,Neoadjuvant,34.0,2023-07-13T10:35:44.371881-05:00,HCM-WCMC-0502-C15_treatment5,9d28bfe7-1b8f-4eab-9e93-0ba06a0044ee,,released,,1,2023-02-27T12:15:10.249107-06:00,Targeted Molecular Therapy,,
HCM-WCMC-0502-C15,18d012fb-77b9-4a9f-b3c7-986f9a0592d1,71ab8cea-7131-49cb-a85b-d6de056592ab,,Adjuvant,,2023-07-13T10:35:44.371881-05:00,HCM-WCMC-0502-C15_treatment11,acb51489-97a8-4197-9121-3788dea0faad,,released,,0,2023-02-27T12:15:10.249107-06:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-WCMC-0502-C15,18d012fb-77b9-4a9f-b3c7-986f9a0592d1,71ab8cea-7131-49cb-a85b-d6de056592ab,,Neoadjuvant,34.0,2023-07-13T10:35:44.371881-05:00,HCM-WCMC-0502-C15_treatment,c488d0d6-be9d-4dad-9a8d-484fe691dedb,,released,Leucovorin Calcium,1,2023-02-27T12:15:10.249107-06:00,Chemotherapy,,
HCM-WCMC-0502-C15,18d012fb-77b9-4a9f-b3c7-986f9a0592d1,71ab8cea-7131-49cb-a85b-d6de056592ab,253.0,Adjuvant,34.0,2023-07-13T10:35:44.371881-05:00,HCM-WCMC-0502-C15_treatment9,e0cbfed6-7cbb-4340-858f-9dae489b604a,,released,,1,2023-02-27T12:15:10.249107-06:00,Chemotherapy,Residual Disease,FOLFOX
HCM-WCMC-0502-C15,18d012fb-77b9-4a9f-b3c7-986f9a0592d1,71ab8cea-7131-49cb-a85b-d6de056592ab,253.0,Adjuvant,34.0,2023-07-13T10:35:44.371881-05:00,HCM-WCMC-0502-C15_treatment8,f5e6c796-b340-4dfd-b32a-cfcde0bd9666,,released,Oxaliplatin,1,2023-02-27T12:15:10.249107-06:00,Chemotherapy,Residual Disease,
HCM-WCMC-0502-C15,18d012fb-77b9-4a9f-b3c7-986f9a0592d1,71ab8cea-7131-49cb-a85b-d6de056592ab,315.0,Adjuvant,273.0,2023-07-13T10:35:44.371881-05:00,HCM-WCMC-0502-C15_treatment14,fea92f89-4342-44ce-9c6e-d8fe5393bce7,,released,Ramucirumab,1,2023-02-27T12:15:10.249107-06:00,Targeted Molecular Therapy,Residual Disease,
HCM-BROD-0829-C71,18eab58c-ac14-4f6a-a30a-2c05134a2a46,ae09717d-8154-4e6e-85d0-2548d1d624be,409.0,Adjuvant,307.0,2023-11-07T14:20:00.017270-06:00,HCM-BROD-0829-C71_treatment6,192cdcd7-cde2-4798-84b8-2ea72cc5fff5,,released,Bevacizumab,1,2021-12-21T13:54:13.466196-06:00,Targeted Molecular Therapy,Residual Disease,
HCM-BROD-0829-C71,18eab58c-ac14-4f6a-a30a-2c05134a2a46,ae09717d-8154-4e6e-85d0-2548d1d624be,,Adjuvant,,2023-11-07T14:20:00.017270-06:00,HCM-BROD-0829-C71_treatment4,2170c9ca-a235-45a4-8e22-4fb09743e72d,,released,,0,2021-12-21T13:54:13.466196-06:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-BROD-0829-C71,18eab58c-ac14-4f6a-a30a-2c05134a2a46,ae09717d-8154-4e6e-85d0-2548d1d624be,297.0,Adjuvant,10.0,2023-11-07T14:20:00.017270-06:00,HCM-BROD-0829-C71_treatment3,23bef5c0-e9c8-4afc-aeba-5de5a8b5ab76,,released,Temozolomide,1,2021-12-21T13:54:13.466196-06:00,Chemotherapy,Residual Disease,
HCM-BROD-0829-C71,18eab58c-ac14-4f6a-a30a-2c05134a2a46,ae09717d-8154-4e6e-85d0-2548d1d624be,,,0.0,2023-11-07T14:20:00.017270-06:00,HCM-BROD-0829-C71_treatment5,2dbbf65c-06b1-4120-acd2-b107da433c4c,,released,,1,2021-12-21T13:54:13.466196-06:00,"Surgery, NOS",Initial Diagnosis,
HCM-BROD-0829-C71,18eab58c-ac14-4f6a-a30a-2c05134a2a46,ae09717d-8154-4e6e-85d0-2548d1d624be,307.0,Adjuvant,307.0,2023-11-07T14:20:00.017270-06:00,HCM-BROD-0829-C71_treatment2,622072e3-7d62-45fb-b87b-c710987f8894,,released,Lomustine,1,2021-12-21T13:54:13.466196-06:00,Chemotherapy,Residual Disease,
HCM-BROD-0829-C71,18eab58c-ac14-4f6a-a30a-2c05134a2a46,ae09717d-8154-4e6e-85d0-2548d1d624be,,Neoadjuvant,,2023-11-07T14:20:00.017270-06:00,HCM-BROD-0829-C71_treatment,f79da244-0202-4d63-b10d-d99aa0805dc8,,released,,0,2021-12-21T13:54:13.466196-06:00,,,
HCM-BROD-0829-C71,18eab58c-ac14-4f6a-a30a-2c05134a2a46,ae09717d-8154-4e6e-85d0-2548d1d624be,61.0,Adjuvant,10.0,2023-11-07T14:20:00.017270-06:00,HCM-BROD-0829-C71_treatment7,f7e4e301-8bdb-4af2-b2b3-66f97e10b0f9,,released,,1,2021-12-21T13:54:13.466196-06:00,"Radiation, 2D Conventional",Residual Disease,
HCM-BROD-0564-C71,19252fcc-76e8-4072-aebe-ce8845771090,7a3821f8-ed7c-4bba-b47b-a5b3b5380b39,,Adjuvant,,2023-02-22T07:39:25.979291-06:00,HCM-BROD-0564-C71_treatment7,2c0a220d-e3c7-4738-955c-82c3c9d8aa48,,released,,1,2020-07-31T09:31:26.101160-05:00,"Radiation Therapy, NOS",Residual Disease,
HCM-BROD-0564-C71,19252fcc-76e8-4072-aebe-ce8845771090,7a3821f8-ed7c-4bba-b47b-a5b3b5380b39,,Neoadjuvant,90.0,2023-02-22T07:39:25.979291-06:00,HCM-BROD-0564-C71_treatment2,48b0f6a9-30a7-46e5-9d37-886b80cb5d37,,released,,1,2020-07-31T09:31:26.101160-05:00,"Radiation Therapy, NOS",,
HCM-BROD-0564-C71,19252fcc-76e8-4072-aebe-ce8845771090,7a3821f8-ed7c-4bba-b47b-a5b3b5380b39,,,0.0,2023-02-27T12:58:27.903823-06:00,HCM-BROD-0564-C71_treatment5,c9ab2e5b-857f-4a90-ac59-4c018202cf21,,released,,1,2020-07-31T09:31:26.101160-05:00,"Surgery, NOS",Initial Diagnosis,
HCM-BROD-0564-C71,19252fcc-76e8-4072-aebe-ce8845771090,7a3821f8-ed7c-4bba-b47b-a5b3b5380b39,,Neoadjuvant,82.0,2023-02-22T07:39:25.979291-06:00,HCM-BROD-0564-C71_treatment,f9386dba-5fc4-42df-87b7-a5e279f3cc89,,released,Temozolomide,1,2020-07-31T09:31:26.101160-05:00,Chemotherapy,,
HCM-EXPT-1246-C25,1970ecdd-154f-4591-9dc5-6b668fecde7d,2d8340ac-b8b4-4685-a861-6434a09739bf,,Neoadjuvant,,2025-10-08T12:39:37.798161-05:00,HCM-EXPT-1246-C25_treatment2,249bff3f-8c22-4c40-b9da-caecae9b1465,,released,,unknown,2023-02-24T13:47:17.248876-06:00,"Radiation Therapy, NOS",,
HCM-EXPT-1246-C25,1970ecdd-154f-4591-9dc5-6b668fecde7d,2d8340ac-b8b4-4685-a861-6434a09739bf,,Neoadjuvant,,2025-10-08T12:39:37.798161-05:00,HCM-EXPT-1246-C25_treatment,7bfdad90-4c81-4c8f-98a6-29e6c4e63503,,released,,unknown,2023-02-24T13:47:17.248876-06:00,"Pharmaceutical Therapy, NOS",,
HCM-SANG-0299-C15,19b1e69a-355a-4dd7-9c56-d701f6c2c5a0,c1a6f70f-b871-4b4e-a292-aef67c2d4776,,Neoadjuvant,,2023-03-13T13:20:58.494686-05:00,HCM-SANG-0299-C15_treatment,de0c16ce-c9bb-4304-b1fe-dfa68060c598,,released,,0,2021-12-21T15:09:13.654991-06:00,,,
HCM-CSHL-0081-C25,19f1d344-4c14-4733-abbd-c2db6737e210,c1cca3a7-e0ac-40a1-9db7-6902b48d3c62,,Adjuvant,43.0,2023-02-22T07:39:25.979291-06:00,HCM-CSHL-0081-C25_treatment3,2812a954-8977-4cb1-b38d-1320c9321643,,released,Nab-paclitaxel,1,2020-09-27T12:48:03.448906-05:00,Chemotherapy,Residual Disease,
HCM-CSHL-0081-C25,19f1d344-4c14-4733-abbd-c2db6737e210,c1cca3a7-e0ac-40a1-9db7-6902b48d3c62,,Adjuvant,,2023-02-22T07:39:25.979291-06:00,HCM-CSHL-0081-C25_treatment9,2de06f30-7300-417b-9e54-b3dbe81f8b02,,released,,0,2020-09-27T12:48:03.448906-05:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-CSHL-0081-C25,19f1d344-4c14-4733-abbd-c2db6737e210,c1cca3a7-e0ac-40a1-9db7-6902b48d3c62,188.0,Adjuvant,,2023-02-22T07:39:25.979291-06:00,HCM-CSHL-0081-C25_treatment6,4c5349b0-3d48-48d8-8e3a-84dda4456bdd,,released,Fluorouracil,1,2020-09-27T12:48:03.448906-05:00,Chemotherapy,Residual Disease,
HCM-CSHL-0081-C25,19f1d344-4c14-4733-abbd-c2db6737e210,c1cca3a7-e0ac-40a1-9db7-6902b48d3c62,,,-5.0,2023-02-27T11:47:19.767665-06:00,HCM-CSHL-0081-C25_treatment10,6a959097-6e20-4b0c-a353-2b7f60403779,,released,,1,2020-09-27T12:48:03.448906-05:00,"Surgery, NOS",Initial Diagnosis,
HCM-CSHL-0081-C25,19f1d344-4c14-4733-abbd-c2db6737e210,c1cca3a7-e0ac-40a1-9db7-6902b48d3c62,,Adjuvant,43.0,2023-02-22T07:39:25.979291-06:00,HCM-CSHL-0081-C25_treatment2,72f0330b-d588-490f-b0d7-a17eff69dfe3,,released,Gemcitabine,1,2020-09-27T12:48:03.448906-05:00,Chemotherapy,Residual Disease,
HCM-CSHL-0081-C25,19f1d344-4c14-4733-abbd-c2db6737e210,c1cca3a7-e0ac-40a1-9db7-6902b48d3c62,,Adjuvant,,2023-02-22T07:39:25.979291-06:00,HCM-CSHL-0081-C25_treatment12,7fe73c39-4d46-4ad6-b9f0-dee5cb0fbdac,,released,,0,2020-09-27T12:48:03.448906-05:00,"Radiation Therapy, NOS",Residual Disease,
HCM-CSHL-0081-C25,19f1d344-4c14-4733-abbd-c2db6737e210,c1cca3a7-e0ac-40a1-9db7-6902b48d3c62,,Neoadjuvant,,2023-02-22T07:39:25.979291-06:00,HCM-CSHL-0081-C25_treatment,b972799b-7423-4953-a4a3-e9216cc91c74,,released,,0,2020-09-27T12:48:03.448906-05:00,,,
HCM-CSHL-0081-C25,19f1d344-4c14-4733-abbd-c2db6737e210,c1cca3a7-e0ac-40a1-9db7-6902b48d3c62,188.0,Adjuvant,,2023-02-22T07:39:25.979291-06:00,HCM-CSHL-0081-C25_treatment5,bd7970bb-f093-4ffd-a3d3-5e4e5e803e13,,released,Leucovorin Calcium,1,2020-09-27T12:48:03.448906-05:00,Chemotherapy,Residual Disease,
HCM-CSHL-0081-C25,19f1d344-4c14-4733-abbd-c2db6737e210,c1cca3a7-e0ac-40a1-9db7-6902b48d3c62,188.0,Adjuvant,,2023-02-22T07:39:25.979291-06:00,HCM-CSHL-0081-C25_treatment4,cea2bd57-fa6e-4994-8bed-846dc8337040,,released,Irinotecan Hydrochloride,1,2020-09-27T12:48:03.448906-05:00,Chemotherapy,Residual Disease,
HCM-CSHL-0081-C25,19f1d344-4c14-4733-abbd-c2db6737e210,c1cca3a7-e0ac-40a1-9db7-6902b48d3c62,188.0,Adjuvant,,2023-02-22T07:39:25.979291-06:00,HCM-CSHL-0081-C25_treatment8,d0ee8dc8-8278-4136-914f-d9c6770f6965,,released,,1,2020-09-27T12:48:03.448906-05:00,Chemotherapy,Residual Disease,FOLFIRINOX
HCM-CSHL-0081-C25,19f1d344-4c14-4733-abbd-c2db6737e210,c1cca3a7-e0ac-40a1-9db7-6902b48d3c62,188.0,Adjuvant,,2023-02-22T07:39:25.979291-06:00,HCM-CSHL-0081-C25_treatment7,d7693755-5f57-4ccf-a8c1-be332e885f43,,released,Oxaliplatin,1,2020-09-27T12:48:03.448906-05:00,Chemotherapy,Residual Disease,
HCM-CSHL-0081-C25,19f1d344-4c14-4733-abbd-c2db6737e210,c1cca3a7-e0ac-40a1-9db7-6902b48d3c62,,Adjuvant,,2023-02-22T07:39:25.979291-06:00,HCM-CSHL-0081-C25_treatment11,fe99547d-8570-4d84-8baa-dfc6867acd8f,,released,,0,2020-09-27T12:48:03.448906-05:00,Targeted Molecular Therapy,Residual Disease,
HCM-BROD-0103-C71,1aad065b-567d-4f08-9cf0-bcc57e8ef496,f9689239-d224-4a99-a094-c81db1714640,,,0.0,2023-02-27T13:07:49.929552-06:00,HCM-BROD-0103-C71_treatment4,486decc8-8839-46f8-a7ff-812b7a26d32d,,released,,1,2020-04-21T14:48:23.815762-05:00,"Surgery, NOS",Initial Diagnosis,
HCM-BROD-0103-C71,1aad065b-567d-4f08-9cf0-bcc57e8ef496,f9689239-d224-4a99-a094-c81db1714640,,Neoadjuvant,,2021-01-06T22:55:10.531130-06:00,HCM-BROD-0103-C71_treatment,5fe08f9b-124d-494f-82aa-89e94ff8efe7,,released,,0,2019-04-04T14:46:12.859480-05:00,,,
HCM-BROD-0103-C71,1aad065b-567d-4f08-9cf0-bcc57e8ef496,f9689239-d224-4a99-a094-c81db1714640,226.0,Adjuvant,134.0,2021-01-06T22:55:10.531130-06:00,HCM-BROD-0103-C71_treatment5,61a2ac5f-263d-44b2-842e-2db462e75d28,,released,Bevacizumab,1,2020-04-21T14:48:23.815762-05:00,Targeted Molecular Therapy,Residual Disease,
HCM-BROD-0103-C71,1aad065b-567d-4f08-9cf0-bcc57e8ef496,f9689239-d224-4a99-a094-c81db1714640,92.0,Adjuvant,50.0,2021-01-06T22:55:10.531130-06:00,HCM-BROD-0103-C71_treatment6,ca4f5702-39eb-4b7c-8ef4-f90f54e2f394,,released,,1,2020-04-21T14:48:23.815762-05:00,"Radiation, Proton Beam",Residual Disease,
HCM-BROD-0103-C71,1aad065b-567d-4f08-9cf0-bcc57e8ef496,f9689239-d224-4a99-a094-c81db1714640,,Adjuvant,,2021-01-06T22:55:10.531130-06:00,HCM-BROD-0103-C71_treatment2,e570fed4-624e-411e-84fd-901cb002ab92,,released,,0,2020-04-21T14:48:23.815762-05:00,Chemotherapy,Residual Disease,
HCM-BROD-0103-C71,1aad065b-567d-4f08-9cf0-bcc57e8ef496,f9689239-d224-4a99-a094-c81db1714640,226.0,Adjuvant,134.0,2021-01-06T22:55:10.531130-06:00,HCM-BROD-0103-C71_treatment3,e7429dd5-5250-488d-8bda-6e23992c3c9c,,released,Pembrolizumab,1,2020-04-21T14:48:23.815762-05:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-BROD-0231-C25,1ae8657f-477f-4e1a-aef2-dd1c1ab5f26a,6c563424-6cf6-4a5f-9615-46f87b430169,,Adjuvant,,2023-02-22T07:39:25.979291-06:00,HCM-BROD-0231-C25_treatment10,1bccc7bd-9805-4de0-9aed-c1030a5f6297,,released,,0,2020-09-17T16:08:31.238891-05:00,"Radiation Therapy, NOS",Residual Disease,
HCM-BROD-0231-C25,1ae8657f-477f-4e1a-aef2-dd1c1ab5f26a,6c563424-6cf6-4a5f-9615-46f87b430169,54.0,Adjuvant,12.0,2023-02-22T07:39:25.979291-06:00,HCM-BROD-0231-C25_treatment2,281e85da-1443-4505-bf83-40d9c707acfb,,released,Irinotecan Hydrochloride,1,2020-09-17T16:08:31.238891-05:00,Chemotherapy,Residual Disease,
HCM-BROD-0231-C25,1ae8657f-477f-4e1a-aef2-dd1c1ab5f26a,6c563424-6cf6-4a5f-9615-46f87b430169,,Neoadjuvant,,2023-02-22T07:39:25.979291-06:00,HCM-BROD-0231-C25_treatment,28c0471f-1e19-43e9-a377-addeaf079304,,released,,0,2020-09-17T16:08:31.238891-05:00,,,
HCM-BROD-0231-C25,1ae8657f-477f-4e1a-aef2-dd1c1ab5f26a,6c563424-6cf6-4a5f-9615-46f87b430169,,Adjuvant,,2023-02-22T07:39:25.979291-06:00,HCM-BROD-0231-C25_treatment9,46b18ed9-81e4-48c7-a668-aa8f4d2f18ba,,released,,0,2020-09-17T16:08:31.238891-05:00,Targeted Molecular Therapy,Residual Disease,
HCM-BROD-0231-C25,1ae8657f-477f-4e1a-aef2-dd1c1ab5f26a,6c563424-6cf6-4a5f-9615-46f87b430169,54.0,Adjuvant,12.0,2023-02-22T07:39:25.979291-06:00,HCM-BROD-0231-C25_treatment5,4a8710fa-143f-4656-a589-370a4842f60f,,released,Oxaliplatin,1,2020-09-17T16:08:31.238891-05:00,Chemotherapy,Residual Disease,
HCM-BROD-0231-C25,1ae8657f-477f-4e1a-aef2-dd1c1ab5f26a,6c563424-6cf6-4a5f-9615-46f87b430169,,,,2023-02-27T11:44:29.151934-06:00,HCM-BROD-0231-C25_treatment8,61ceddf6-7e0d-481a-bc75-d1b365b17c2f,,released,,0,2020-09-17T16:08:31.238891-05:00,"Surgery, NOS",Initial Diagnosis,
HCM-BROD-0231-C25,1ae8657f-477f-4e1a-aef2-dd1c1ab5f26a,6c563424-6cf6-4a5f-9615-46f87b430169,180.0,Adjuvant,137.0,2023-02-22T07:39:25.979291-06:00,HCM-BROD-0231-C25_treatment7,8a9662a9-bc72-4006-b2af-6580f49b00dc,,released,Trametinib,1,2020-09-17T16:08:31.238891-05:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-BROD-0231-C25,1ae8657f-477f-4e1a-aef2-dd1c1ab5f26a,6c563424-6cf6-4a5f-9615-46f87b430169,54.0,Adjuvant,12.0,2023-02-22T07:39:25.979291-06:00,HCM-BROD-0231-C25_treatment6,dbdb1a46-0e86-4d43-b3bd-242811b29a48,,released,,1,2020-09-17T16:08:31.238891-05:00,Chemotherapy,Residual Disease,FOLFIRINOX
HCM-BROD-0231-C25,1ae8657f-477f-4e1a-aef2-dd1c1ab5f26a,6c563424-6cf6-4a5f-9615-46f87b430169,54.0,Adjuvant,12.0,2023-02-22T07:39:25.979291-06:00,HCM-BROD-0231-C25_treatment4,e31a80d3-0152-4ed0-be86-c45790a9b284,,released,Fluorouracil,1,2020-09-17T16:08:31.238891-05:00,Chemotherapy,Residual Disease,
HCM-BROD-0231-C25,1ae8657f-477f-4e1a-aef2-dd1c1ab5f26a,6c563424-6cf6-4a5f-9615-46f87b430169,54.0,Adjuvant,12.0,2023-02-22T07:39:25.979291-06:00,HCM-BROD-0231-C25_treatment3,fb3c6e6b-a426-4fe3-b8fe-5aefc7832bb5,,released,Leucovorin Calcium,1,2020-09-17T16:08:31.238891-05:00,Chemotherapy,Residual Disease,
HCM-BROD-0745-C43,1afc9344-bb0c-4074-a7d8-dc941a47266d,60a1174e-2822-47cf-afec-6be5a3fcdb4a,,Adjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0745-C43_treatment3,20907ca2-47fa-4d8c-830d-923d40e5bcf7,,released,,0,2021-12-21T13:48:54.827002-06:00,Hormone Therapy,Residual Disease,
HCM-BROD-0745-C43,1afc9344-bb0c-4074-a7d8-dc941a47266d,60a1174e-2822-47cf-afec-6be5a3fcdb4a,141.0,Adjuvant,78.0,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0745-C43_treatment4,6622fb34-c93a-422e-aba5-21d15ac9db1e,,released,Pembrolizumab,1,2021-12-21T13:48:54.827002-06:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-BROD-0745-C43,1afc9344-bb0c-4074-a7d8-dc941a47266d,60a1174e-2822-47cf-afec-6be5a3fcdb4a,148.0,Adjuvant,148.0,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0745-C43_treatment5,6ada17ed-85ad-4045-b6c8-9d8a9331247c,,released,Nivolumab,1,2021-12-21T13:48:54.827002-06:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-BROD-0745-C43,1afc9344-bb0c-4074-a7d8-dc941a47266d,60a1174e-2822-47cf-afec-6be5a3fcdb4a,526.0,Adjuvant,186.0,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0745-C43_treatment9,7093bfbf-3957-4437-b29e-0659be6efc5b,,released,Binimetinib,1,2021-12-21T13:48:54.827002-06:00,Targeted Molecular Therapy,Residual Disease,
HCM-BROD-0745-C43,1afc9344-bb0c-4074-a7d8-dc941a47266d,60a1174e-2822-47cf-afec-6be5a3fcdb4a,526.0,Adjuvant,186.0,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0745-C43_treatment8,7bff4ed3-4818-4b59-abb4-546b0b8098d0,,released,Encorafenib,1,2021-12-21T13:48:54.827002-06:00,Targeted Molecular Therapy,Residual Disease,
HCM-BROD-0745-C43,1afc9344-bb0c-4074-a7d8-dc941a47266d,60a1174e-2822-47cf-afec-6be5a3fcdb4a,,,4.0,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0745-C43_treatment7,a1c83b7b-df1e-472b-a5bd-eecc3e0c1b52,,released,,1,2021-12-21T13:48:54.827002-06:00,"Surgery, NOS",Initial Diagnosis,
HCM-BROD-0745-C43,1afc9344-bb0c-4074-a7d8-dc941a47266d,60a1174e-2822-47cf-afec-6be5a3fcdb4a,,Adjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0745-C43_treatment2,b01c8647-95c0-47eb-ad24-8799c38dea21,,released,,0,2021-12-21T13:48:54.827002-06:00,Chemotherapy,Residual Disease,
HCM-BROD-0745-C43,1afc9344-bb0c-4074-a7d8-dc941a47266d,60a1174e-2822-47cf-afec-6be5a3fcdb4a,148.0,Adjuvant,148.0,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0745-C43_treatment6,c929ff44-f5a9-4416-9f9c-429f47bb88f3,,released,Ipilimumab,1,2021-12-21T13:48:54.827002-06:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-BROD-0745-C43,1afc9344-bb0c-4074-a7d8-dc941a47266d,60a1174e-2822-47cf-afec-6be5a3fcdb4a,,Adjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0745-C43_treatment10,d16cd1d9-30e5-49d3-9462-196114ba5f30,,released,,0,2021-12-21T13:48:54.827002-06:00,"Radiation Therapy, NOS",Residual Disease,
HCM-BROD-0745-C43,1afc9344-bb0c-4074-a7d8-dc941a47266d,60a1174e-2822-47cf-afec-6be5a3fcdb4a,,Neoadjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0745-C43_treatment,ed88cb11-9abc-41a1-9eb4-59e091669586,,released,,0,2021-12-21T13:48:54.827002-06:00,,,
HCM-CSHL-0584-C19,1b6aad54-f571-4cb0-bce2-a79447b9bb64,8b9619da-f859-4d40-bf50-98f24c681106,,Adjuvant,290.0,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0584-C19_treatment14,020b9336-dfe0-4cca-ab52-7c3101ee4273,,released,Bevacizumab,1,2024-06-12T17:45:48.543879-05:00,Targeted Molecular Therapy,Residual Disease,
HCM-CSHL-0584-C19,1b6aad54-f571-4cb0-bce2-a79447b9bb64,8b9619da-f859-4d40-bf50-98f24c681106,136.0,Adjuvant,71.0,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0584-C19_treatment4,06259d2d-20f7-4f18-b279-d5d4b63f9ab3,,released,Fluorouracil,1,2021-12-21T14:08:49.042087-06:00,Chemotherapy,Residual Disease,
HCM-CSHL-0584-C19,1b6aad54-f571-4cb0-bce2-a79447b9bb64,8b9619da-f859-4d40-bf50-98f24c681106,,Adjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0584-C19_treatment11,07c0fcac-618c-456a-a90b-bf11f5f5126d,,released,,0,2024-06-12T17:45:48.543879-05:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-CSHL-0584-C19,1b6aad54-f571-4cb0-bce2-a79447b9bb64,8b9619da-f859-4d40-bf50-98f24c681106,,,178.0,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0584-C19_treatment13,0ed63cec-8cfd-4d0c-9edf-151039d7f921,,released,,1,2024-06-12T17:45:48.543879-05:00,"Surgery, NOS",Initial Diagnosis,
HCM-CSHL-0584-C19,1b6aad54-f571-4cb0-bce2-a79447b9bb64,8b9619da-f859-4d40-bf50-98f24c681106,,Adjuvant,290.0,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0584-C19_treatment10,1d98cd07-72c6-4f77-b56b-6540b892679d,,released,,1,2021-12-21T14:08:49.042087-06:00,Chemotherapy,Residual Disease,FOLFOX
HCM-CSHL-0584-C19,1b6aad54-f571-4cb0-bce2-a79447b9bb64,8b9619da-f859-4d40-bf50-98f24c681106,,Adjuvant,290.0,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0584-C19_treatment8,358e4a8a-1358-4c52-a632-b4b6b99e1bcd,,released,Fluorouracil,1,2021-12-21T14:08:49.042087-06:00,Chemotherapy,Residual Disease,
HCM-CSHL-0584-C19,1b6aad54-f571-4cb0-bce2-a79447b9bb64,8b9619da-f859-4d40-bf50-98f24c681106,136.0,Adjuvant,71.0,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0584-C19_treatment5,409840e7-5dfd-4980-9e24-57d281e6efab,,released,Oxaliplatin,1,2021-12-21T14:08:49.042087-06:00,Chemotherapy,Residual Disease,
HCM-CSHL-0584-C19,1b6aad54-f571-4cb0-bce2-a79447b9bb64,8b9619da-f859-4d40-bf50-98f24c681106,,,6.0,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0584-C19_treatment12,6a969c01-0389-4320-bc29-6c0e440c4944,,released,,1,2024-06-12T17:45:48.543879-05:00,"Surgery, NOS",Initial Diagnosis,
HCM-CSHL-0584-C19,1b6aad54-f571-4cb0-bce2-a79447b9bb64,8b9619da-f859-4d40-bf50-98f24c681106,,Adjuvant,290.0,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0584-C19_treatment7,790ade68-52e1-454b-8e55-b482fb0e55fe,,released,Leucovorin Calcium,1,2021-12-21T14:08:49.042087-06:00,Chemotherapy,Residual Disease,
HCM-CSHL-0584-C19,1b6aad54-f571-4cb0-bce2-a79447b9bb64,8b9619da-f859-4d40-bf50-98f24c681106,136.0,Adjuvant,71.0,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0584-C19_treatment6,86c3938f-e644-48f3-9909-2842ebf0464d,,released,,1,2021-12-21T14:08:49.042087-06:00,Chemotherapy,Residual Disease,FOLFOX
HCM-CSHL-0584-C19,1b6aad54-f571-4cb0-bce2-a79447b9bb64,8b9619da-f859-4d40-bf50-98f24c681106,,Adjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0584-C19_treatment15,8a38a04b-0c36-4f6a-8195-e02356ca7172,,released,,0,2024-06-12T17:45:48.543879-05:00,"Radiation Therapy, NOS",Residual Disease,
HCM-CSHL-0584-C19,1b6aad54-f571-4cb0-bce2-a79447b9bb64,8b9619da-f859-4d40-bf50-98f24c681106,136.0,Adjuvant,71.0,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0584-C19_treatment3,ea23e7dc-bbce-446e-8132-7a9635281f69,,released,Leucovorin Calcium,1,2021-12-21T14:08:49.042087-06:00,Chemotherapy,Residual Disease,
HCM-CSHL-0584-C19,1b6aad54-f571-4cb0-bce2-a79447b9bb64,8b9619da-f859-4d40-bf50-98f24c681106,,Adjuvant,290.0,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0584-C19_treatment9,fefd5119-901e-44f9-9c3a-f298e6b56480,,released,Oxaliplatin,1,2021-12-21T14:08:49.042087-06:00,Chemotherapy,Residual Disease,
HCM-CSHL-0584-C19,1b6aad54-f571-4cb0-bce2-a79447b9bb64,91caed88-500c-44dc-bed3-352fdf8771db,,Maintenance Therapy,,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0584-C19_treatment18,2021d392-f299-4aaa-b607-0e1b3e25568b,Progressive Disease,released,Oxaliplatin,1,2024-06-12T17:45:48.543879-05:00,,,
HCM-CSHL-0584-C19,1b6aad54-f571-4cb0-bce2-a79447b9bb64,91caed88-500c-44dc-bed3-352fdf8771db,,Maintenance Therapy,,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0584-C19_treatment19,6a0a994f-ece8-4767-be2a-80daa7dd60a4,Progressive Disease,released,,1,2024-06-12T17:45:48.543879-05:00,,,FOLFOX
HCM-CSHL-0584-C19,1b6aad54-f571-4cb0-bce2-a79447b9bb64,91caed88-500c-44dc-bed3-352fdf8771db,,Maintenance Therapy,,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0584-C19_treatment17,9a8a6efb-4b05-4aed-8347-b0d00a7fcf7f,Progressive Disease,released,Fluorouracil,1,2024-06-12T17:45:48.543879-05:00,,,
HCM-CSHL-0584-C19,1b6aad54-f571-4cb0-bce2-a79447b9bb64,91caed88-500c-44dc-bed3-352fdf8771db,,Maintenance Therapy,,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0584-C19_treatment16,f83d37bc-cdab-44de-859f-c05a0b43ac14,Progressive Disease,released,Leucovorin Calcium,1,2024-06-12T17:45:48.543879-05:00,,,
HCM-EXPT-1242-C18,1bd5b5e6-3a81-4624-8241-ee006a272e5c,982d27b7-a1de-457b-9926-cd989f00221e,,Neoadjuvant,,2025-10-08T12:39:37.798161-05:00,HCM-EXPT-1242-C18_treatment,e0716215-678f-4037-a5f0-93db7702090f,,released,,0,2023-02-24T13:54:42.456409-06:00,,,
HCM-CSHL-0818-C56,1bfa0189-6e43-4d76-928c-026673ec775e,f411b58c-7dc2-40af-ac55-5e21a2391029,,,12.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0818-C56_treatment6,135ce18d-4312-466a-89da-93eb4500cb38,,released,,1,2021-12-21T14:29:33.343810-06:00,"Surgery, NOS",Initial Diagnosis,
HCM-CSHL-0818-C56,1bfa0189-6e43-4d76-928c-026673ec775e,f411b58c-7dc2-40af-ac55-5e21a2391029,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0818-C56_treatment5,18d3d786-ce47-4ddb-ab49-b1ec7bee583f,,released,,0,2021-12-21T14:29:33.343810-06:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-CSHL-0818-C56,1bfa0189-6e43-4d76-928c-026673ec775e,f411b58c-7dc2-40af-ac55-5e21a2391029,,Neoadjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0818-C56_treatment,360343d8-a35d-4803-8754-085d80585acf,,released,,0,2021-12-21T14:29:33.343810-06:00,,,
HCM-CSHL-0818-C56,1bfa0189-6e43-4d76-928c-026673ec775e,f411b58c-7dc2-40af-ac55-5e21a2391029,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0818-C56_treatment8,65a39ccc-ede8-4996-bbc6-739129e18dd1,,released,,0,2021-12-21T14:29:33.343810-06:00,"Radiation Therapy, NOS",Residual Disease,
HCM-CSHL-0818-C56,1bfa0189-6e43-4d76-928c-026673ec775e,f411b58c-7dc2-40af-ac55-5e21a2391029,145.0,Adjuvant,33.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0818-C56_treatment2,7be2aecd-e640-4c91-b6c6-86bb54b4d8d6,,released,Cisplatin,1,2021-12-21T14:29:33.343810-06:00,Chemotherapy,Residual Disease,
HCM-CSHL-0818-C56,1bfa0189-6e43-4d76-928c-026673ec775e,f411b58c-7dc2-40af-ac55-5e21a2391029,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0818-C56_treatment4,97696191-d2e9-4d79-9fb9-c08c8682f3f6,,released,,0,2021-12-21T14:29:33.343810-06:00,Hormone Therapy,Residual Disease,
HCM-CSHL-0818-C56,1bfa0189-6e43-4d76-928c-026673ec775e,f411b58c-7dc2-40af-ac55-5e21a2391029,145.0,Adjuvant,33.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0818-C56_treatment3,c66519c8-b03f-477d-922c-730ca9698ce6,,released,Paclitaxel,1,2021-12-21T14:29:33.343810-06:00,Chemotherapy,Residual Disease,
HCM-CSHL-0818-C56,1bfa0189-6e43-4d76-928c-026673ec775e,f411b58c-7dc2-40af-ac55-5e21a2391029,,Adjuvant,181.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0818-C56_treatment7,d10d3c22-43af-41f8-b8e6-d5f81946118c,Treatment Ongoing,released,Niraparib,1,2021-12-21T14:29:33.343810-06:00,Targeted Molecular Therapy,Residual Disease,
HCM-BROD-0643-C43,1c54d889-a752-4025-90ce-af896cdb95d4,379deec7-50a8-4219-9bd2-1737e7908d50,,,0.0,2023-02-27T11:45:06.247824-06:00,HCM-BROD-0643-C43_treatment5,4eb8991d-f7ea-4b0f-9595-ba648630889b,,released,,1,2021-09-07T12:03:47.327892-05:00,"Surgery, NOS",Initial Diagnosis,
HCM-BROD-0643-C43,1c54d889-a752-4025-90ce-af896cdb95d4,379deec7-50a8-4219-9bd2-1737e7908d50,,Adjuvant,,2021-09-10T10:36:37.981324-05:00,HCM-BROD-0643-C43_treatment7,5e2133f5-e611-4218-b7fd-aaa15694905f,,released,,0,2021-09-07T12:03:47.327892-05:00,"Radiation Therapy, NOS",Residual Disease,
HCM-BROD-0643-C43,1c54d889-a752-4025-90ce-af896cdb95d4,379deec7-50a8-4219-9bd2-1737e7908d50,,Adjuvant,,2021-09-10T10:36:37.981324-05:00,HCM-BROD-0643-C43_treatment2,603f7ab7-d1aa-47fa-a7a0-47bc71177a9b,,released,,0,2021-09-07T12:03:47.327892-05:00,Chemotherapy,Residual Disease,
HCM-BROD-0643-C43,1c54d889-a752-4025-90ce-af896cdb95d4,379deec7-50a8-4219-9bd2-1737e7908d50,,Neoadjuvant,,2021-03-11T14:53:13.958052-06:00,HCM-BROD-0643-C43_treatment,83598b19-b0eb-4f35-9be8-91bdb9674e85,,released,,0,2021-03-11T14:33:32.013919-06:00,,,
HCM-BROD-0643-C43,1c54d889-a752-4025-90ce-af896cdb95d4,379deec7-50a8-4219-9bd2-1737e7908d50,,Adjuvant,,2021-09-10T10:36:37.981324-05:00,HCM-BROD-0643-C43_treatment3,be663c30-1b65-42fd-8744-977b665739a7,,released,,0,2021-09-07T12:03:47.327892-05:00,Hormone Therapy,Residual Disease,
HCM-BROD-0643-C43,1c54d889-a752-4025-90ce-af896cdb95d4,379deec7-50a8-4219-9bd2-1737e7908d50,,Adjuvant,,2021-09-10T10:36:37.981324-05:00,HCM-BROD-0643-C43_treatment6,e41f0ee1-e030-4fa1-93d2-b2d14983b513,,released,,0,2021-09-07T12:03:47.327892-05:00,Targeted Molecular Therapy,Residual Disease,
HCM-BROD-0643-C43,1c54d889-a752-4025-90ce-af896cdb95d4,379deec7-50a8-4219-9bd2-1737e7908d50,,Adjuvant,1104.0,2021-09-10T10:36:37.981324-05:00,HCM-BROD-0643-C43_treatment4,ecb520bb-f21d-4f12-8e12-308a3fec97e0,Treatment Ongoing,released,Nivolumab,1,2021-09-07T12:03:47.327892-05:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-BROD-0643-C43,1c54d889-a752-4025-90ce-af896cdb95d4,3ea0fe35-fd02-4e73-b294-965afe66a719,,Maintenance Therapy,,2021-09-10T10:36:37.981324-05:00,HCM-BROD-0643-C43_treatment8,d57337b6-13d2-4c2f-8425-fb229f0caa65,Treatment Ongoing,released,Nivolumab,1,2021-09-07T12:03:47.327892-05:00,,,
HCM-BROD-0758-C43,1c906cee-df63-4348-9354-0a523ab88dfa,640cca22-1494-46df-82e5-8f9bffd253ce,,Neoadjuvant,,2023-02-22T07:39:25.979291-06:00,HCM-BROD-0758-C43_treatment,2fb9ae99-2b2f-4280-bc4f-01cc1e2f2f81,,released,,0,2021-12-21T13:49:35.680126-06:00,,,
HCM-BROD-0758-C43,1c906cee-df63-4348-9354-0a523ab88dfa,640cca22-1494-46df-82e5-8f9bffd253ce,1446.0,Adjuvant,1350.0,2023-02-22T07:39:25.979291-06:00,HCM-BROD-0758-C43_treatment7,344ac719-ca2d-42d1-a332-5146e9db2e49,,released,Trametinib,1,2021-12-21T13:49:35.680126-06:00,Targeted Molecular Therapy,Residual Disease,
HCM-BROD-0758-C43,1c906cee-df63-4348-9354-0a523ab88dfa,640cca22-1494-46df-82e5-8f9bffd253ce,,,-21.0,2023-03-13T12:57:25.671139-05:00,HCM-BROD-0758-C43_treatment6,444eb6a3-7c26-4803-8867-88c2de01bcc2,,released,,1,2021-12-21T13:49:35.680126-06:00,"Surgery, NOS",Initial Diagnosis,
HCM-BROD-0758-C43,1c906cee-df63-4348-9354-0a523ab88dfa,640cca22-1494-46df-82e5-8f9bffd253ce,1330.0,Adjuvant,1309.0,2023-02-22T07:39:25.979291-06:00,HCM-BROD-0758-C43_treatment5,5603df9e-948d-4091-b352-e7428a50df84,,released,Ipilimumab,1,2021-12-21T13:49:35.680126-06:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-BROD-0758-C43,1c906cee-df63-4348-9354-0a523ab88dfa,640cca22-1494-46df-82e5-8f9bffd253ce,1446.0,Adjuvant,1350.0,2023-02-22T07:39:25.979291-06:00,HCM-BROD-0758-C43_treatment8,6ce7a0c3-f759-425a-9c80-5c708ab85998,,released,Dabrafenib,1,2021-12-21T13:49:35.680126-06:00,Targeted Molecular Therapy,Residual Disease,
HCM-BROD-0758-C43,1c906cee-df63-4348-9354-0a523ab88dfa,640cca22-1494-46df-82e5-8f9bffd253ce,1329.0,Adjuvant,1313.0,2023-02-22T07:39:25.979291-06:00,HCM-BROD-0758-C43_treatment9,76ea7217-ca28-482c-b914-2ebece15e2d5,,released,,1,2021-12-21T13:49:35.680126-06:00,"Radiation Therapy, NOS",Residual Disease,
HCM-BROD-0758-C43,1c906cee-df63-4348-9354-0a523ab88dfa,640cca22-1494-46df-82e5-8f9bffd253ce,,Adjuvant,,2023-02-22T07:39:25.979291-06:00,HCM-BROD-0758-C43_treatment3,9b173226-53cf-482e-b21c-9651370d83d7,,released,,0,2021-12-21T13:49:35.680126-06:00,Hormone Therapy,Residual Disease,
HCM-BROD-0758-C43,1c906cee-df63-4348-9354-0a523ab88dfa,640cca22-1494-46df-82e5-8f9bffd253ce,1329.0,Adjuvant,1309.0,2023-02-22T07:39:25.979291-06:00,HCM-BROD-0758-C43_treatment4,9fedce83-d033-42a9-87aa-9466d3bb14b0,,released,Nivolumab,1,2021-12-21T13:49:35.680126-06:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-BROD-0758-C43,1c906cee-df63-4348-9354-0a523ab88dfa,640cca22-1494-46df-82e5-8f9bffd253ce,,Adjuvant,,2023-02-22T07:39:25.979291-06:00,HCM-BROD-0758-C43_treatment2,b9b42ed2-0e29-400b-ba07-05dbd61ad1fd,,released,,0,2021-12-21T13:49:35.680126-06:00,Chemotherapy,Residual Disease,
HCM-EXPT-0928-C50,1cbdddb6-af99-4137-9629-2e45e1afb8ca,ac7ee612-e0b9-4c52-9c3b-a3b933f70970,,Neoadjuvant,,2025-10-08T12:36:57.024699-05:00,HCM-EXPT-0928-C50_treatment,c6f5b2ad-4f1b-463f-b8b6-dfe3286fbac9,,released,,0,2021-12-21T14:44:22.651658-06:00,,,
HCM-SANG-0300-C15,1cddb064-84ff-4ca1-b980-fb3ec30053eb,f571e3ff-e4b8-492e-955d-f72c2af83ffa,,Neoadjuvant,,2023-02-22T07:39:25.979291-06:00,HCM-SANG-0300-C15_treatment,a35cf4c2-79c5-4ffa-87d9-486c1cee392e,,released,,0,2021-12-21T15:09:30.575820-06:00,,,
HCM-EXPT-0894-C25,1d5008c9-5a12-45ce-836b-64cfd1b232c8,5f4d28fe-e2b7-4c06-8755-9f2d347f8630,,Neoadjuvant,,2025-10-08T12:36:32.654639-05:00,HCM-EXPT-0894-C25_treatment,ca7bc9ac-ea2b-40b6-8b34-b9ef4bf1feae,,released,,0,2021-12-21T14:44:02.057459-06:00,,,
HCM-CSHL-0368-D37,1d8a21f2-0671-45ce-ba44-94d3d0d29dd4,f10edebf-938a-420e-b4eb-6a35b1064a7c,,Adjuvant,,2023-03-13T13:15:06.728296-05:00,HCM-CSHL-0368-D37_treatment3,307b188c-7033-4e99-a278-750802818ee5,,released,,0,2020-09-28T10:43:11.850886-05:00,"Pharmaceutical Therapy, NOS",Residual Disease,
HCM-CSHL-0368-D37,1d8a21f2-0671-45ce-ba44-94d3d0d29dd4,f10edebf-938a-420e-b4eb-6a35b1064a7c,,Adjuvant,,2023-03-13T13:15:06.728296-05:00,HCM-CSHL-0368-D37_treatment4,38e71cc8-07c6-4347-b97e-b1da5cb4a141,,released,,0,2020-09-28T10:43:11.850886-05:00,"Radiation Therapy, NOS",Residual Disease,
HCM-CSHL-0368-D37,1d8a21f2-0671-45ce-ba44-94d3d0d29dd4,f10edebf-938a-420e-b4eb-6a35b1064a7c,,,11.0,2023-03-13T13:15:06.728296-05:00,HCM-CSHL-0368-D37_treatment2,b31cae76-2462-4b51-9a72-2a1798260348,,released,,1,2020-09-28T10:43:11.850886-05:00,"Surgery, NOS",Initial Diagnosis,
HCM-CSHL-0368-D37,1d8a21f2-0671-45ce-ba44-94d3d0d29dd4,f10edebf-938a-420e-b4eb-6a35b1064a7c,,Neoadjuvant,,2023-02-22T07:39:25.979291-06:00,HCM-CSHL-0368-D37_treatment,fb7ac6da-09be-40d8-bbb2-7182f019a2e9,,released,,0,2020-09-28T10:43:11.850886-05:00,,,
HCM-BROD-0121-C41,1da2dae2-d5ed-49c9-9f9e-c12e6e262dc4,f07d5d79-a50a-4893-a7ec-dec09cc52da4,,Neoadjuvant,334.0,2021-07-12T12:25:55.528644-05:00,HCM-BROD-0121-C41_treatment5,14ff269f-e6b1-4f08-8cbe-8d55382cfac3,,released,,1,2019-04-03T18:03:55.442588-05:00,Chemotherapy,,VIT
HCM-BROD-0121-C41,1da2dae2-d5ed-49c9-9f9e-c12e6e262dc4,f07d5d79-a50a-4893-a7ec-dec09cc52da4,,Neoadjuvant,,2021-07-12T12:25:55.528644-05:00,HCM-BROD-0121-C41_treatment13,226334ee-5320-4bf3-ad04-ca7e28a37a35,,released,,1,2020-09-27T10:36:45.842746-05:00,"Radiation Therapy, NOS",,
HCM-BROD-0121-C41,1da2dae2-d5ed-49c9-9f9e-c12e6e262dc4,f07d5d79-a50a-4893-a7ec-dec09cc52da4,,Neoadjuvant,334.0,2021-07-12T12:25:55.528644-05:00,HCM-BROD-0121-C41_treatment2,273aaada-de3c-4c50-bda6-73378ca08d32,,released,Vincristine,1,2019-04-03T18:03:55.442588-05:00,Chemotherapy,,
HCM-BROD-0121-C41,1da2dae2-d5ed-49c9-9f9e-c12e6e262dc4,f07d5d79-a50a-4893-a7ec-dec09cc52da4,,Maintenance Therapy,0.0,2021-07-12T12:25:55.528644-05:00,HCM-BROD-0121-C41_treatment7,28dba380-efe7-436d-bf44-96d09bcacb97,Progressive Disease,released,Vincristine,1,2019-04-03T18:03:55.442588-05:00,,Progressive Disease,
HCM-BROD-0121-C41,1da2dae2-d5ed-49c9-9f9e-c12e6e262dc4,f07d5d79-a50a-4893-a7ec-dec09cc52da4,,Neoadjuvant,334.0,2021-07-12T12:25:55.528644-05:00,HCM-BROD-0121-C41_treatment6,3a3be4d9-4bae-47c7-8dae-94acab37d4c2,,released,Pembrolizumab,1,2019-04-03T18:03:55.442588-05:00,Immunotherapy (Including Vaccines),,
HCM-BROD-0121-C41,1da2dae2-d5ed-49c9-9f9e-c12e6e262dc4,f07d5d79-a50a-4893-a7ec-dec09cc52da4,365.0,Adjuvant,334.0,2021-07-12T12:25:55.528644-05:00,HCM-BROD-0121-C41_treatment15,5e8dfefa-7c3e-449b-9a51-8a22c1a5768f,,released,Pembrolizumab,1,2020-09-27T10:36:45.842746-05:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-BROD-0121-C41,1da2dae2-d5ed-49c9-9f9e-c12e6e262dc4,f07d5d79-a50a-4893-a7ec-dec09cc52da4,,Neoadjuvant,334.0,2021-07-12T12:25:55.528644-05:00,HCM-BROD-0121-C41_treatment3,7b377513-3542-458b-b14f-ec64cc80a0b7,,released,Temozolomide,1,2019-04-03T18:03:55.442588-05:00,Chemotherapy,,
HCM-BROD-0121-C41,1da2dae2-d5ed-49c9-9f9e-c12e6e262dc4,f07d5d79-a50a-4893-a7ec-dec09cc52da4,,Adjuvant,,2021-07-12T12:25:55.528644-05:00,HCM-BROD-0121-C41_treatment18,7fabbc82-a456-40d1-843e-36a5cf61c55a,,released,,0,2020-09-27T10:36:45.842746-05:00,"Radiation Therapy, NOS",Residual Disease,
HCM-BROD-0121-C41,1da2dae2-d5ed-49c9-9f9e-c12e6e262dc4,f07d5d79-a50a-4893-a7ec-dec09cc52da4,,Adjuvant,,2021-07-12T12:25:55.528644-05:00,HCM-BROD-0121-C41_treatment14,a053b193-e95e-40a3-a218-4476fb4d9bc5,,released,,0,2020-09-27T10:36:45.842746-05:00,Chemotherapy,Residual Disease,
HCM-BROD-0121-C41,1da2dae2-d5ed-49c9-9f9e-c12e6e262dc4,f07d5d79-a50a-4893-a7ec-dec09cc52da4,,Adjuvant,,2021-07-12T12:25:55.528644-05:00,HCM-BROD-0121-C41_treatment17,a23185be-9cc2-4cfe-a297-51c5e1431960,,released,,0,2020-09-27T10:36:45.842746-05:00,Targeted Molecular Therapy,Residual Disease,
HCM-BROD-0121-C41,1da2dae2-d5ed-49c9-9f9e-c12e6e262dc4,f07d5d79-a50a-4893-a7ec-dec09cc52da4,,Maintenance Therapy,0.0,2021-07-12T12:25:55.528644-05:00,HCM-BROD-0121-C41_treatment11,aaf8a389-edb0-49bd-a268-939c4e616b31,Progressive Disease,released,Etoposide,1,2020-09-27T10:36:45.842746-05:00,,Progressive Disease,
HCM-BROD-0121-C41,1da2dae2-d5ed-49c9-9f9e-c12e6e262dc4,f07d5d79-a50a-4893-a7ec-dec09cc52da4,,Neoadjuvant,334.0,2021-07-12T12:25:55.528644-05:00,HCM-BROD-0121-C41_treatment,b0d84256-085c-4c20-819d-53da757482b1,,released,Cyclophosphamide,1,2019-04-03T18:03:55.442588-05:00,Chemotherapy,,
HCM-BROD-0121-C41,1da2dae2-d5ed-49c9-9f9e-c12e6e262dc4,f07d5d79-a50a-4893-a7ec-dec09cc52da4,,Maintenance Therapy,0.0,2021-07-12T12:25:55.528644-05:00,HCM-BROD-0121-C41_treatment8,b27824dd-5691-4ccc-9231-d0524418736b,Progressive Disease,released,Ifosfamide,1,2019-04-03T18:03:55.442588-05:00,,Progressive Disease,
HCM-BROD-0121-C41,1da2dae2-d5ed-49c9-9f9e-c12e6e262dc4,f07d5d79-a50a-4893-a7ec-dec09cc52da4,,Maintenance Therapy,0.0,2021-07-12T12:25:55.528644-05:00,HCM-BROD-0121-C41_treatment10,baa34262-f5f1-45a3-8ed0-4d972d561ed9,Progressive Disease,released,Doxorubicin,1,2020-09-27T10:36:45.842746-05:00,,Progressive Disease,
HCM-BROD-0121-C41,1da2dae2-d5ed-49c9-9f9e-c12e6e262dc4,f07d5d79-a50a-4893-a7ec-dec09cc52da4,,Maintenance Therapy,0.0,2021-07-12T12:25:55.528644-05:00,HCM-BROD-0121-C41_treatment9,d2788b87-1ec5-45da-810f-36c146b0602f,Progressive Disease,released,Cyclophosphamide,1,2019-04-03T18:03:55.442588-05:00,,Progressive Disease,
HCM-BROD-0121-C41,1da2dae2-d5ed-49c9-9f9e-c12e6e262dc4,f07d5d79-a50a-4893-a7ec-dec09cc52da4,,Maintenance Therapy,0.0,2021-07-12T12:25:55.528644-05:00,HCM-BROD-0121-C41_treatment12,f03302c3-afd3-4f0b-aa9f-f97e70875569,Progressive Disease,released,,1,2020-09-27T10:36:45.842746-05:00,,Progressive Disease,VDC/IE
HCM-BROD-0121-C41,1da2dae2-d5ed-49c9-9f9e-c12e6e262dc4,f07d5d79-a50a-4893-a7ec-dec09cc52da4,,Neoadjuvant,334.0,2021-07-12T12:25:55.528644-05:00,HCM-BROD-0121-C41_treatment4,f3104541-8af0-4313-9dc2-4e5e8525caee,,released,Irinotecan,1,2019-04-03T18:03:55.442588-05:00,Chemotherapy,,
HCM-SANG-0544-C15,1deecd23-2a3a-4de3-9b79-26ad4492787f,11f19aca-4e57-4d6f-8b7f-02976e5695bc,,Neoadjuvant,105.0,2025-03-31T16:34:59.906497-05:00,HCM-SANG-0544-C15_treatment4,2bac9fa8-2984-458f-b238-f5d22dc569f7,,released,,1,2021-12-21T15:15:32.809805-06:00,Chemotherapy,,ECX
HCM-SANG-0544-C15,1deecd23-2a3a-4de3-9b79-26ad4492787f,11f19aca-4e57-4d6f-8b7f-02976e5695bc,,Neoadjuvant,105.0,2025-03-31T16:34:59.906497-05:00,HCM-SANG-0544-C15_treatment,34b47072-aac4-4a11-8ff0-e4ff63797a0e,,released,Epirubicin,1,2021-12-21T15:15:32.809805-06:00,Chemotherapy,,
HCM-SANG-0544-C15,1deecd23-2a3a-4de3-9b79-26ad4492787f,11f19aca-4e57-4d6f-8b7f-02976e5695bc,,Neoadjuvant,105.0,2025-03-31T16:34:59.906497-05:00,HCM-SANG-0544-C15_treatment2,bf2dc235-fd22-4c6f-8995-e30deffdde2e,,released,Capecitabine,1,2021-12-21T15:15:32.809805-06:00,Chemotherapy,,
HCM-SANG-0544-C15,1deecd23-2a3a-4de3-9b79-26ad4492787f,11f19aca-4e57-4d6f-8b7f-02976e5695bc,,Neoadjuvant,105.0,2025-03-31T16:34:59.906497-05:00,HCM-SANG-0544-C15_treatment3,d2259c81-0677-4c90-b26d-12f9e0ccb79c,,released,Cisplatin,1,2021-12-21T15:15:32.809805-06:00,Chemotherapy,,
HCM-EXPT-1019-C50,1e4fd897-4fcb-49d4-a431-37467b1b08d3,b4dfecba-f9f6-469e-a3f7-a82b97552317,,Neoadjuvant,,2025-10-08T12:37:43.816130-05:00,HCM-EXPT-1019-C50_treatment,32a67b93-7c2d-4948-9d97-aa1392bf5cb6,,released,,0,2021-12-21T14:56:25.208576-06:00,,,
HCM-BROD-0794-C16,1e76d41a-9cf7-4114-b48a-84571c929f22,302030b4-7c58-4eef-be7e-419d85657d3c,1286.0,Maintenance Therapy,7.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0794-C16_treatment21,09f8d999-62c4-465f-80b5-80a58b3e165d,Progressive Disease,released,,1,2021-12-21T13:53:40.883770-06:00,,,FOLFOX
HCM-BROD-0794-C16,1e76d41a-9cf7-4114-b48a-84571c929f22,302030b4-7c58-4eef-be7e-419d85657d3c,1286.0,Maintenance Therapy,7.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0794-C16_treatment20,49e2b4b4-3a5c-4569-b0dd-a3226d396363,Progressive Disease,released,,1,2021-12-21T13:53:40.883770-06:00,,,FOLFIRINOX
HCM-BROD-0794-C16,1e76d41a-9cf7-4114-b48a-84571c929f22,302030b4-7c58-4eef-be7e-419d85657d3c,1286.0,Maintenance Therapy,7.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0794-C16_treatment13,5efcd8c9-85e8-43c2-a9f3-6c6745fa4538,Progressive Disease,released,Irinotecan Hydrochloride,1,2021-12-21T13:53:40.883770-06:00,,,
HCM-BROD-0794-C16,1e76d41a-9cf7-4114-b48a-84571c929f22,302030b4-7c58-4eef-be7e-419d85657d3c,1286.0,Maintenance Therapy,7.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0794-C16_treatment16,5fbb8e40-5660-4fe4-b626-46d61f4793a8,Progressive Disease,released,Epirubicin,1,2021-12-21T13:53:40.883770-06:00,,,
HCM-BROD-0794-C16,1e76d41a-9cf7-4114-b48a-84571c929f22,302030b4-7c58-4eef-be7e-419d85657d3c,1286.0,Maintenance Therapy,7.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0794-C16_treatment12,7746c702-0768-42ab-9838-cd1176d8cb7c,Progressive Disease,released,Capecitabine,1,2021-12-21T13:53:40.883770-06:00,,,
HCM-BROD-0794-C16,1e76d41a-9cf7-4114-b48a-84571c929f22,302030b4-7c58-4eef-be7e-419d85657d3c,1286.0,Maintenance Therapy,7.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0794-C16_treatment15,86964b74-381b-4613-be84-28bfae9670b5,Progressive Disease,released,Oxaliplatin,1,2021-12-21T13:53:40.883770-06:00,,,
HCM-BROD-0794-C16,1e76d41a-9cf7-4114-b48a-84571c929f22,302030b4-7c58-4eef-be7e-419d85657d3c,1286.0,Maintenance Therapy,7.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0794-C16_treatment18,b0d293b9-d61b-4f93-834d-a4032330c0fc,Progressive Disease,released,,1,2021-12-21T13:53:40.883770-06:00,,,FOLFIRI
HCM-BROD-0794-C16,1e76d41a-9cf7-4114-b48a-84571c929f22,302030b4-7c58-4eef-be7e-419d85657d3c,1286.0,Maintenance Therapy,7.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0794-C16_treatment10,c19db555-f700-4e1d-8440-c2faa83aca69,Progressive Disease,released,Paclitaxel,1,2021-12-21T13:53:40.883770-06:00,,,
HCM-BROD-0794-C16,1e76d41a-9cf7-4114-b48a-84571c929f22,302030b4-7c58-4eef-be7e-419d85657d3c,1286.0,Maintenance Therapy,7.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0794-C16_treatment14,d879e330-c7f7-4ff1-ac13-d7274fbad8c5,Progressive Disease,released,Leucovorin Calcium,1,2021-12-21T13:53:40.883770-06:00,,,
HCM-BROD-0794-C16,1e76d41a-9cf7-4114-b48a-84571c929f22,302030b4-7c58-4eef-be7e-419d85657d3c,1286.0,Maintenance Therapy,7.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0794-C16_treatment19,d88f720d-2a49-4c6c-8583-4576fbaea4d3,Progressive Disease,released,,1,2021-12-21T13:53:40.883770-06:00,,,EOX
HCM-BROD-0794-C16,1e76d41a-9cf7-4114-b48a-84571c929f22,302030b4-7c58-4eef-be7e-419d85657d3c,1286.0,Maintenance Therapy,7.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0794-C16_treatment17,dc7cf3a1-00e3-407d-a1de-cac4720e0ed4,Progressive Disease,released,Fluorouracil,1,2021-12-21T13:53:40.883770-06:00,,,
HCM-BROD-0794-C16,1e76d41a-9cf7-4114-b48a-84571c929f22,302030b4-7c58-4eef-be7e-419d85657d3c,1286.0,Maintenance Therapy,7.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0794-C16_treatment11,f35308ce-343e-460d-9b10-2817b2537cb1,Progressive Disease,released,Ramucirumab,1,2021-12-21T13:53:40.883770-06:00,,,
HCM-BROD-0794-C16,1e76d41a-9cf7-4114-b48a-84571c929f22,cc1abd43-a9cf-4834-a954-0e9b59045b17,,Neoadjuvant,7.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0794-C16_treatment3,0f2e6b21-9cb7-473a-89ed-237847f80e71,,released,Capecitabine,1,2021-12-21T13:53:40.883770-06:00,Chemotherapy,,
HCM-BROD-0794-C16,1e76d41a-9cf7-4114-b48a-84571c929f22,cc1abd43-a9cf-4834-a954-0e9b59045b17,,Neoadjuvant,7.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0794-C16_treatment4,2832fc63-95ef-40bc-8112-559c4ee3bddf,,released,,1,2021-12-21T13:53:40.883770-06:00,Chemotherapy,,EOX
HCM-BROD-0794-C16,1e76d41a-9cf7-4114-b48a-84571c929f22,cc1abd43-a9cf-4834-a954-0e9b59045b17,,Neoadjuvant,7.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0794-C16_treatment,4f990a91-1f34-4e72-9187-e6b828478273,,released,Epirubicin,1,2021-12-21T13:53:40.883770-06:00,Chemotherapy,,
HCM-BROD-0794-C16,1e76d41a-9cf7-4114-b48a-84571c929f22,cc1abd43-a9cf-4834-a954-0e9b59045b17,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0794-C16_treatment6,5ac2f9b9-9f57-4630-8376-ea282965d022,,released,,0,2021-12-21T13:53:40.883770-06:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-BROD-0794-C16,1e76d41a-9cf7-4114-b48a-84571c929f22,cc1abd43-a9cf-4834-a954-0e9b59045b17,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0794-C16_treatment8,6ce570d0-f546-498b-aebb-92710292ed9a,,released,,0,2021-12-21T13:53:40.883770-06:00,Targeted Molecular Therapy,Residual Disease,
HCM-BROD-0794-C16,1e76d41a-9cf7-4114-b48a-84571c929f22,cc1abd43-a9cf-4834-a954-0e9b59045b17,,Neoadjuvant,7.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0794-C16_treatment2,707a254f-2891-43ca-817e-f38c54f3c61d,,released,Oxaliplatin,1,2021-12-21T13:53:40.883770-06:00,Chemotherapy,,
HCM-BROD-0794-C16,1e76d41a-9cf7-4114-b48a-84571c929f22,cc1abd43-a9cf-4834-a954-0e9b59045b17,,,,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0794-C16_treatment7,96172379-2c3e-4575-9b10-fac78ace5343,,released,,0,2021-12-21T13:53:40.883770-06:00,"Surgery, NOS",Initial Diagnosis,
HCM-BROD-0794-C16,1e76d41a-9cf7-4114-b48a-84571c929f22,cc1abd43-a9cf-4834-a954-0e9b59045b17,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0794-C16_treatment5,cb42267c-e17e-4d0e-bc12-ac2343323078,,released,,0,2021-12-21T13:53:40.883770-06:00,Chemotherapy,Residual Disease,
HCM-BROD-0794-C16,1e76d41a-9cf7-4114-b48a-84571c929f22,cc1abd43-a9cf-4834-a954-0e9b59045b17,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0794-C16_treatment9,e5a03da3-5966-4ea9-bc9f-295446d746c6,,released,,0,2021-12-21T13:53:40.883770-06:00,"Radiation Therapy, NOS",Residual Disease,
HCM-BROD-0597-C64,1e93db0d-0b15-4682-80d9-0a29ae04ce68,8a04affb-eb75-404d-9570-53f598547cc9,214.0,Adjuvant,30.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0597-C64_treatment4,0ad22d66-d52d-4881-b43e-3fb737627a1a,,released,Doxorubicin Hydrochloride,1,2021-12-21T13:40:44.901195-06:00,Chemotherapy,Residual Disease,
HCM-BROD-0597-C64,1e93db0d-0b15-4682-80d9-0a29ae04ce68,8a04affb-eb75-404d-9570-53f598547cc9,214.0,Adjuvant,0.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0597-C64_treatment2,261298a9-d1a0-429c-aae0-fba4a76a85cb,,released,Vincristine,1,2021-12-21T13:40:44.901195-06:00,Chemotherapy,Residual Disease,
HCM-BROD-0597-C64,1e93db0d-0b15-4682-80d9-0a29ae04ce68,8a04affb-eb75-404d-9570-53f598547cc9,214.0,Adjuvant,0.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0597-C64_treatment3,50adcc28-c08c-40d3-a125-f70d80174bfd,,released,Dactinomycin,1,2021-12-21T13:40:44.901195-06:00,Chemotherapy,Residual Disease,
HCM-BROD-0597-C64,1e93db0d-0b15-4682-80d9-0a29ae04ce68,8a04affb-eb75-404d-9570-53f598547cc9,122.0,Adjuvant,92.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0597-C64_treatment10,639de7f2-5a3b-4013-a064-f6f0f3b1b5af,,released,,1,2021-12-21T13:40:44.901195-06:00,"Radiation, Intensity-Modulated Radiotherapy",Residual Disease,
HCM-BROD-0597-C64,1e93db0d-0b15-4682-80d9-0a29ae04ce68,8a04affb-eb75-404d-9570-53f598547cc9,,Neoadjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0597-C64_treatment,6606741f-9dcf-4964-8892-081ff8011c77,,released,,0,2021-12-21T13:40:44.901195-06:00,,,
HCM-BROD-0597-C64,1e93db0d-0b15-4682-80d9-0a29ae04ce68,8a04affb-eb75-404d-9570-53f598547cc9,183.0,Adjuvant,30.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0597-C64_treatment6,8d56616a-ecb9-48cb-883d-6a1c2d1724b0,,released,Etoposide,1,2021-12-21T13:40:44.901195-06:00,Chemotherapy,Residual Disease,
HCM-BROD-0597-C64,1e93db0d-0b15-4682-80d9-0a29ae04ce68,8a04affb-eb75-404d-9570-53f598547cc9,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0597-C64_treatment7,a1cca6d1-cd36-420e-b2ae-daeae4bbb87e,,released,,0,2021-12-21T13:40:44.901195-06:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-BROD-0597-C64,1e93db0d-0b15-4682-80d9-0a29ae04ce68,8a04affb-eb75-404d-9570-53f598547cc9,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0597-C64_treatment9,af66fdec-b016-4155-9b91-8ba6ef936a10,,released,,0,2021-12-21T13:40:44.901195-06:00,Targeted Molecular Therapy,Residual Disease,
HCM-BROD-0597-C64,1e93db0d-0b15-4682-80d9-0a29ae04ce68,8a04affb-eb75-404d-9570-53f598547cc9,183.0,Adjuvant,30.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0597-C64_treatment5,cac33e70-6362-42aa-af9c-e9be6c3e0a29,,released,Cyclophosphamide,1,2021-12-21T13:40:44.901195-06:00,Chemotherapy,Residual Disease,
HCM-BROD-0597-C64,1e93db0d-0b15-4682-80d9-0a29ae04ce68,8a04affb-eb75-404d-9570-53f598547cc9,,,92.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0597-C64_treatment8,dda20cd0-b420-4e5e-9acf-9b0a2368ac4f,,released,,1,2021-12-21T13:40:44.901195-06:00,"Surgery, NOS",Initial Diagnosis,
HCM-BROD-0954-C34,1ee582bc-c8f2-4c31-836a-e9e3fd8ecd72,58cc191c-8e69-47c9-b77f-63263b4d217c,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0954-C34_treatment3,ac086c6d-80ec-472d-9518-93376f8630da,,released,,0,2021-12-21T13:58:17.376016-06:00,"Pharmaceutical Therapy, NOS",Residual Disease,
HCM-BROD-0954-C34,1ee582bc-c8f2-4c31-836a-e9e3fd8ecd72,58cc191c-8e69-47c9-b77f-63263b4d217c,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0954-C34_treatment4,c0f11261-1672-4328-91cc-d926fa34fa4d,,released,,0,2021-12-21T13:58:17.376016-06:00,"Radiation Therapy, NOS",Residual Disease,
HCM-BROD-0954-C34,1ee582bc-c8f2-4c31-836a-e9e3fd8ecd72,58cc191c-8e69-47c9-b77f-63263b4d217c,,Neoadjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0954-C34_treatment,c65de1a0-4e3a-40da-825a-6f7f7725e55c,,released,,0,2021-12-21T13:58:17.376016-06:00,,,
HCM-BROD-0954-C34,1ee582bc-c8f2-4c31-836a-e9e3fd8ecd72,58cc191c-8e69-47c9-b77f-63263b4d217c,,,8.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0954-C34_treatment2,da46b897-2a62-4034-83e7-763c080babab,,released,,1,2021-12-21T13:58:17.376016-06:00,"Surgery, NOS",Initial Diagnosis,
HCM-BROD-0783-C71,1ef1165f-72e5-43eb-ba3a-9886aa1f2fc4,118616a5-f55b-4914-91e6-b1785957647f,,Adjuvant,,2023-11-07T14:20:00.017270-06:00,HCM-BROD-0783-C71_treatment6,0e6beacb-d147-40d2-8d49-1fdc00bd1ed0,,released,,0,2021-12-21T13:53:25.043083-06:00,"Radiation Therapy, NOS",Residual Disease,
HCM-BROD-0783-C71,1ef1165f-72e5-43eb-ba3a-9886aa1f2fc4,118616a5-f55b-4914-91e6-b1785957647f,,Adjuvant,,2023-11-07T14:20:00.017270-06:00,HCM-BROD-0783-C71_treatment5,54d7788b-de20-4f5a-97a7-8132fca88505,,released,,0,2021-12-21T13:53:25.043083-06:00,Targeted Molecular Therapy,Residual Disease,
HCM-BROD-0783-C71,1ef1165f-72e5-43eb-ba3a-9886aa1f2fc4,118616a5-f55b-4914-91e6-b1785957647f,197.0,Adjuvant,166.0,2023-11-07T14:20:00.017270-06:00,HCM-BROD-0783-C71_treatment2,54fa310b-f098-40e4-8ff0-a50990dc2b5c,,released,Irinotecan,1,2021-12-21T13:53:25.043083-06:00,Chemotherapy,Residual Disease,
HCM-BROD-0783-C71,1ef1165f-72e5-43eb-ba3a-9886aa1f2fc4,118616a5-f55b-4914-91e6-b1785957647f,,,-4.0,2023-11-07T14:20:00.017270-06:00,HCM-BROD-0783-C71_treatment4,6f5834f1-dd50-4df1-94fa-19be37569cd5,,released,,1,2021-12-21T13:53:25.043083-06:00,"Surgery, NOS",Initial Diagnosis,
HCM-BROD-0783-C71,1ef1165f-72e5-43eb-ba3a-9886aa1f2fc4,118616a5-f55b-4914-91e6-b1785957647f,,Neoadjuvant,,2023-11-07T14:20:00.017270-06:00,HCM-BROD-0783-C71_treatment,bc0e8bb9-b978-4148-8bd8-0e71d6adab8b,,released,,0,2021-12-21T13:53:25.043083-06:00,,,
HCM-BROD-0783-C71,1ef1165f-72e5-43eb-ba3a-9886aa1f2fc4,118616a5-f55b-4914-91e6-b1785957647f,,Adjuvant,,2023-11-07T14:20:00.017270-06:00,HCM-BROD-0783-C71_treatment3,ea091c8a-4e56-42cb-aa67-2bb0f4531bc2,,released,,0,2021-12-21T13:53:25.043083-06:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-BROD-0783-C71,1ef1165f-72e5-43eb-ba3a-9886aa1f2fc4,4af50a79-9d81-4ecf-b669-58b062e3d04e,82.0,Maintenance Therapy,8.0,2023-11-07T14:20:00.017270-06:00,HCM-BROD-0783-C71_treatment7,7eb5705a-7ff6-4345-889d-755faa95deb8,Progressive Disease,released,Temozolomide,1,2021-12-21T13:53:25.043083-06:00,,,
HCM-CSHL-0837-D01,1ef761af-e22d-44ac-8718-c09cbe588a0b,bfba5a5a-5487-47f2-9aa8-9dcd9cd49dcd,,Adjuvant,,2025-08-20T09:56:36.143985-05:00,HCM-CSHL-0837-D01_treatment4,3a94d108-88c0-4b7b-b48a-4f039cd63ab3,,released,,0,2021-12-21T14:33:53.222814-06:00,"Radiation Therapy, NOS",Residual Disease,
HCM-CSHL-0837-D01,1ef761af-e22d-44ac-8718-c09cbe588a0b,bfba5a5a-5487-47f2-9aa8-9dcd9cd49dcd,,Adjuvant,,2025-08-20T09:56:36.143985-05:00,HCM-CSHL-0837-D01_treatment3,7492d1be-5288-4b32-90dd-7be13eba993b,,released,,0,2021-12-21T14:33:53.222814-06:00,"Pharmaceutical Therapy, NOS",Residual Disease,
HCM-CSHL-0837-D01,1ef761af-e22d-44ac-8718-c09cbe588a0b,bfba5a5a-5487-47f2-9aa8-9dcd9cd49dcd,,,8.0,2025-08-20T09:56:36.143985-05:00,HCM-CSHL-0837-D01_treatment2,aa5a9672-a20f-42e0-8d56-083fd7efcc26,,released,,1,2021-12-21T14:33:53.222814-06:00,"Surgery, NOS",Initial Diagnosis,
HCM-CSHL-0837-D01,1ef761af-e22d-44ac-8718-c09cbe588a0b,bfba5a5a-5487-47f2-9aa8-9dcd9cd49dcd,,Neoadjuvant,,2025-08-20T09:56:36.143985-05:00,HCM-CSHL-0837-D01_treatment,d8a3c7a6-95a1-4a88-a133-e8ee936b53ee,,released,,0,2021-12-21T14:33:53.222814-06:00,,,
HCM-BROD-0116-C16,1f080fcb-15c8-452a-a083-05ed83098a52,6ea02426-0463-4156-be3c-87878458bea9,,,101.0,2023-03-13T13:18:01.324308-05:00,HCM-BROD-0116-C16_treatment2,15c422d5-203f-453f-9aa1-17c975968a3c,,released,,1,2019-04-04T15:42:26.851849-05:00,"Surgery, NOS",Initial Diagnosis,
HCM-BROD-0116-C16,1f080fcb-15c8-452a-a083-05ed83098a52,6ea02426-0463-4156-be3c-87878458bea9,,Neoadjuvant,,2021-07-12T12:25:55.528644-05:00,HCM-BROD-0116-C16_treatment,4cc64f5a-33f0-4dcb-bdc0-a2a2d16e5c32,,released,,1,2019-04-04T15:42:26.851849-05:00,Chemotherapy,,
HCM-EXPT-1245-C15,1f2a2c24-fc96-4e6a-9e32-668aba3146da,b646325c-850e-4a59-8eb0-6e7bf454964b,,Neoadjuvant,89.0,2025-10-08T12:39:37.798161-05:00,HCM-EXPT-1245-C15_treatment2,3ec9d7ed-6eda-4af5-a527-f78691c218a0,,released,Capecitabine,1,2023-02-24T14:09:15.146311-06:00,Chemotherapy,,
HCM-EXPT-1245-C15,1f2a2c24-fc96-4e6a-9e32-668aba3146da,b646325c-850e-4a59-8eb0-6e7bf454964b,,Neoadjuvant,89.0,2025-10-08T12:39:37.798161-05:00,HCM-EXPT-1245-C15_treatment3,60def490-6b45-43bf-b3ac-421a0591f9ad,,released,Cisplatin,1,2023-02-24T14:09:15.146311-06:00,Chemotherapy,,
HCM-EXPT-1245-C15,1f2a2c24-fc96-4e6a-9e32-668aba3146da,b646325c-850e-4a59-8eb0-6e7bf454964b,,Neoadjuvant,89.0,2025-10-08T12:39:37.798161-05:00,HCM-EXPT-1245-C15_treatment,6700ca28-83ef-404c-b62e-d233c81388e4,,released,Epirubicin,1,2023-02-24T14:09:15.146311-06:00,Chemotherapy,,
HCM-EXPT-1245-C15,1f2a2c24-fc96-4e6a-9e32-668aba3146da,b646325c-850e-4a59-8eb0-6e7bf454964b,,Neoadjuvant,89.0,2025-10-08T12:39:37.798161-05:00,HCM-EXPT-1245-C15_treatment4,af9aae24-072a-4e7f-b882-10c5bb695e93,,released,,1,2023-02-24T14:09:15.146311-06:00,Chemotherapy,,ECX
HCM-EXPT-1024-C50,1f49f9c4-362b-46b6-93a5-f64a526b083e,bf7ff711-e2fc-46c4-904c-4a3fb3e6f381,,Neoadjuvant,,2025-10-08T12:37:43.816130-05:00,HCM-EXPT-1024-C50_treatment,128c4105-0f87-4589-9565-f1b920c067b8,,released,,1,2021-12-21T14:57:55.462610-06:00,Hormone Therapy,,
HCM-EXPT-1219-C18,2085d720-f57e-47a0-9355-c0f64fc363a9,5d281f85-342c-4832-9b09-fe59dfa12560,,Neoadjuvant,,2025-10-08T12:39:14.406630-05:00,HCM-EXPT-1219-C18_treatment,31f30806-6d97-430a-9654-6d7ccc8cf7c7,,released,,0,2022-03-09T19:43:28.403665-06:00,,,
HCM-BROD-0577-C15,20b6fd08-f99a-47f0-9f41-ff2163490057,ac6b2224-eb4e-4b5d-a6a4-afdd75c77e9b,,,,2023-07-13T10:35:44.371881-05:00,HCM-BROD-0577-C15_treatment7,030a8855-2548-4049-a82a-2dd57d941a1b,,released,,0,2020-10-08T14:46:59.857659-05:00,"Surgery, NOS",Initial Diagnosis,
HCM-BROD-0577-C15,20b6fd08-f99a-47f0-9f41-ff2163490057,ac6b2224-eb4e-4b5d-a6a4-afdd75c77e9b,,Neoadjuvant,50.0,2023-07-13T10:35:44.371881-05:00,HCM-BROD-0577-C15_treatment4,241639e5-87f0-4f17-a08c-5ef9aff79ae7,,released,,1,2020-10-08T14:46:59.857659-05:00,Chemotherapy,,FOLFOX
HCM-BROD-0577-C15,20b6fd08-f99a-47f0-9f41-ff2163490057,ac6b2224-eb4e-4b5d-a6a4-afdd75c77e9b,,Adjuvant,,2023-07-13T10:35:44.371881-05:00,HCM-BROD-0577-C15_treatment6,60cefbc7-807a-40db-ac47-520e0947a47d,,released,,0,2020-10-08T14:46:59.857659-05:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-BROD-0577-C15,20b6fd08-f99a-47f0-9f41-ff2163490057,ac6b2224-eb4e-4b5d-a6a4-afdd75c77e9b,,Neoadjuvant,50.0,2023-07-13T10:35:44.371881-05:00,HCM-BROD-0577-C15_treatment2,67a3451a-c69e-4b1b-bfb8-e2e9a6285a93,,released,Fluorouracil,1,2020-10-08T14:46:59.857659-05:00,Chemotherapy,,
HCM-BROD-0577-C15,20b6fd08-f99a-47f0-9f41-ff2163490057,ac6b2224-eb4e-4b5d-a6a4-afdd75c77e9b,,Neoadjuvant,50.0,2023-07-13T10:35:44.371881-05:00,HCM-BROD-0577-C15_treatment3,740325bb-08d1-4f4d-b83b-eb2431b0f175,,released,Oxaliplatin,1,2020-10-08T14:46:59.857659-05:00,Chemotherapy,,
HCM-BROD-0577-C15,20b6fd08-f99a-47f0-9f41-ff2163490057,ac6b2224-eb4e-4b5d-a6a4-afdd75c77e9b,,Adjuvant,,2023-07-13T10:35:44.371881-05:00,HCM-BROD-0577-C15_treatment9,93e6845e-641e-42d9-9c93-7e88c0e9c712,,released,,0,2020-10-08T14:46:59.857659-05:00,"Radiation Therapy, NOS",Residual Disease,
HCM-BROD-0577-C15,20b6fd08-f99a-47f0-9f41-ff2163490057,ac6b2224-eb4e-4b5d-a6a4-afdd75c77e9b,,Neoadjuvant,50.0,2023-07-13T10:35:44.371881-05:00,HCM-BROD-0577-C15_treatment,b39b2ce8-c7ab-4b9b-b914-42e9812b2277,,released,Leucovorin Calcium,1,2020-10-08T14:46:59.857659-05:00,Chemotherapy,,
HCM-BROD-0577-C15,20b6fd08-f99a-47f0-9f41-ff2163490057,ac6b2224-eb4e-4b5d-a6a4-afdd75c77e9b,465.0,Adjuvant,295.0,2023-07-13T10:35:44.371881-05:00,HCM-BROD-0577-C15_treatment5,cb91beab-179a-4df6-ab83-5d1a12b0f196,,released,Paclitaxel,1,2020-10-08T14:46:59.857659-05:00,Chemotherapy,Residual Disease,
HCM-BROD-0577-C15,20b6fd08-f99a-47f0-9f41-ff2163490057,ac6b2224-eb4e-4b5d-a6a4-afdd75c77e9b,,Adjuvant,,2023-07-13T10:35:44.371881-05:00,HCM-BROD-0577-C15_treatment8,ec9b3fde-999d-49e0-98c7-956f810a1943,,released,,0,2020-10-08T14:46:59.857659-05:00,Targeted Molecular Therapy,Residual Disease,
HCM-SANG-0315-C25,2127626f-247f-4c47-b096-a876f08db1a0,cb47433e-612c-4d5a-9e2a-03d8c712234a,,Neoadjuvant,208.0,2023-03-13T12:51:12.978797-05:00,HCM-SANG-0315-C25_treatment3,0e08adac-88eb-42c2-a70d-fd9d28f2df0a,,released,,1,2021-08-26T15:04:30.424290-05:00,"Radiation Therapy, NOS",,
HCM-SANG-0315-C25,2127626f-247f-4c47-b096-a876f08db1a0,cb47433e-612c-4d5a-9e2a-03d8c712234a,,Neoadjuvant,208.0,2023-03-13T12:51:12.978797-05:00,HCM-SANG-0315-C25_treatment,4cac4490-6353-4067-a942-2116416e5eb1,,released,Capecitabine,1,2020-02-27T12:54:33.401352-06:00,Chemotherapy,,
HCM-SANG-0315-C25,2127626f-247f-4c47-b096-a876f08db1a0,cb47433e-612c-4d5a-9e2a-03d8c712234a,,Neoadjuvant,208.0,2023-03-13T12:51:12.978797-05:00,HCM-SANG-0315-C25_treatment2,f1ea8b82-f8c8-4d62-9df1-d50ef089864d,,released,Gemcitabine,1,2020-02-27T12:54:33.401352-06:00,Chemotherapy,,
HCM-BROD-0348-C25,219cfe52-363e-424b-b833-717637eab99a,af0b06a9-eaa1-4da9-b780-5e819eac899c,423.0,Adjuvant,17.0,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0348-C25_treatment2,13b1ee66-5d7a-4931-83c0-757ed76120db,,released,Gemcitabine,1,2020-09-17T16:10:55.318135-05:00,Chemotherapy,Residual Disease,
HCM-BROD-0348-C25,219cfe52-363e-424b-b833-717637eab99a,af0b06a9-eaa1-4da9-b780-5e819eac899c,,,,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0348-C25_treatment5,26b56316-afaf-4a26-8dd4-6ed7daa8d162,,released,,0,2020-09-17T16:10:55.318135-05:00,"Surgery, NOS",Initial Diagnosis,
HCM-BROD-0348-C25,219cfe52-363e-424b-b833-717637eab99a,af0b06a9-eaa1-4da9-b780-5e819eac899c,,Adjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0348-C25_treatment4,47447822-0ed8-4ff3-957e-7c332db4097a,,released,,0,2020-09-17T16:10:55.318135-05:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-BROD-0348-C25,219cfe52-363e-424b-b833-717637eab99a,af0b06a9-eaa1-4da9-b780-5e819eac899c,,Adjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0348-C25_treatment6,492cf357-867d-4a9e-9e71-4eae4fd05894,,released,,0,2020-09-17T16:10:55.318135-05:00,Targeted Molecular Therapy,Residual Disease,
HCM-BROD-0348-C25,219cfe52-363e-424b-b833-717637eab99a,af0b06a9-eaa1-4da9-b780-5e819eac899c,423.0,Adjuvant,17.0,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0348-C25_treatment3,79e5a2a0-09e1-421a-a80c-03fd65c2d7f0,,released,Nab-paclitaxel,1,2020-09-17T16:10:55.318135-05:00,Chemotherapy,Residual Disease,
HCM-BROD-0348-C25,219cfe52-363e-424b-b833-717637eab99a,af0b06a9-eaa1-4da9-b780-5e819eac899c,,Adjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0348-C25_treatment7,b9b0c1aa-2cd8-4440-8cc7-4bb305c30e8d,,released,,0,2020-09-17T16:10:55.318135-05:00,"Radiation Therapy, NOS",Residual Disease,
HCM-BROD-0348-C25,219cfe52-363e-424b-b833-717637eab99a,af0b06a9-eaa1-4da9-b780-5e819eac899c,,Neoadjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0348-C25_treatment,bb7aeb24-b91d-4021-a82a-bc4ee9abec74,,released,,0,2020-09-17T16:10:55.318135-05:00,,,
HCM-EXPT-1209-C20,21bba866-e2d8-4256-978e-fbbd2f3dbfaa,75294bc2-8a75-495d-a41d-4c3c551a9b21,,Neoadjuvant,,2025-10-08T12:38:51.189053-05:00,HCM-EXPT-1209-C20_treatment,8f115127-e8e3-4331-805f-d93d37419389,,released,,0,2023-02-24T14:16:47.369786-06:00,,,
HCM-SANG-1326-C15,220be274-e7e5-4148-9bd2-60c36ae5d688,ab1e2849-9fbb-4906-9369-588c902f3ebf,,Neoadjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-SANG-1326-C15_treatment,325fae4e-6875-4fe7-bc53-1d55c39c9939,,released,,0,2023-02-27T13:14:41.300709-06:00,,,
HCM-EXPT-1001-C50,22d416fe-9fc4-40af-a679-b731676bf024,a23cdb23-1230-49bd-a952-930cef2b4ea7,,Neoadjuvant,,2025-10-08T12:37:43.816130-05:00,HCM-EXPT-1001-C50_treatment,4dfce4d0-a3cb-433b-b3c1-64339c99b051,,released,Trastuzumab,1,2021-12-21T14:52:59.754174-06:00,Immunotherapy (Including Vaccines),,
HCM-EXPT-1001-C50,22d416fe-9fc4-40af-a679-b731676bf024,a23cdb23-1230-49bd-a952-930cef2b4ea7,,Neoadjuvant,,2025-10-08T12:37:43.816130-05:00,HCM-EXPT-1001-C50_treatment2,c782b2b5-0fa2-497f-9603-caba903f383a,,released,Tamoxifen,1,2021-12-21T14:52:59.754174-06:00,Hormone Therapy,,
HCM-BROD-0229-C25,22f26b5c-41b7-4142-9d87-6cf8b7fee3af,1541cf35-c584-422f-91b2-cb98bd9b46e4,,Neoadjuvant,30.0,2021-01-06T22:55:10.531130-06:00,HCM-BROD-0229-C25_treatment7,02ee9c06-5e6d-4000-98a7-c4fa1a6cd01c,,released,Nab-paclitaxel,1,2020-06-15T13:28:13.853772-05:00,Chemotherapy,,
HCM-BROD-0229-C25,22f26b5c-41b7-4142-9d87-6cf8b7fee3af,1541cf35-c584-422f-91b2-cb98bd9b46e4,,Adjuvant,,2021-01-06T22:55:10.531130-06:00,HCM-BROD-0229-C25_treatment17,0cf64084-8ead-4833-bd6e-f011089be555,,released,,0,2020-09-27T11:11:28.468142-05:00,Targeted Molecular Therapy,Residual Disease,
HCM-BROD-0229-C25,22f26b5c-41b7-4142-9d87-6cf8b7fee3af,1541cf35-c584-422f-91b2-cb98bd9b46e4,,Neoadjuvant,30.0,2021-01-06T22:55:10.531130-06:00,HCM-BROD-0229-C25_treatment3,12488dc6-479b-433f-bdb2-b13302697c42,,released,Fluorouracil,1,2020-06-15T13:28:13.853772-05:00,Chemotherapy,,
HCM-BROD-0229-C25,22f26b5c-41b7-4142-9d87-6cf8b7fee3af,1541cf35-c584-422f-91b2-cb98bd9b46e4,57.0,Adjuvant,17.0,2021-01-06T22:55:10.531130-06:00,HCM-BROD-0229-C25_treatment10,1500f8f1-433a-4932-9c40-4f89b8e17a21,,released,Fluorouracil,1,2020-06-15T13:28:13.853772-05:00,Chemotherapy,Residual Disease,
HCM-BROD-0229-C25,22f26b5c-41b7-4142-9d87-6cf8b7fee3af,1541cf35-c584-422f-91b2-cb98bd9b46e4,,Adjuvant,,2021-01-06T22:55:10.531130-06:00,HCM-BROD-0229-C25_treatment15,16042fa2-59f5-443c-a5a9-7929554d61d0,,released,,0,2020-09-27T11:11:28.468142-05:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-BROD-0229-C25,22f26b5c-41b7-4142-9d87-6cf8b7fee3af,1541cf35-c584-422f-91b2-cb98bd9b46e4,57.0,Adjuvant,17.0,2021-01-06T22:55:10.531130-06:00,HCM-BROD-0229-C25_treatment11,49daccfc-e58c-456a-a77f-86dca0e14dbc,,released,Oxaliplatin,1,2020-09-27T11:11:28.468142-05:00,Chemotherapy,Residual Disease,
HCM-BROD-0229-C25,22f26b5c-41b7-4142-9d87-6cf8b7fee3af,1541cf35-c584-422f-91b2-cb98bd9b46e4,57.0,Adjuvant,17.0,2021-01-06T22:55:10.531130-06:00,HCM-BROD-0229-C25_treatment8,605ad9f6-8a98-4fa7-acec-55da435afbe1,,released,Irinotecan Hydrochloride,1,2020-06-15T13:28:13.853772-05:00,Chemotherapy,Residual Disease,
HCM-BROD-0229-C25,22f26b5c-41b7-4142-9d87-6cf8b7fee3af,1541cf35-c584-422f-91b2-cb98bd9b46e4,57.0,Adjuvant,17.0,2021-01-06T22:55:10.531130-06:00,HCM-BROD-0229-C25_treatment9,6e4344fd-a8f9-4342-9a02-3ee982a10250,,released,Leucovorin Calcium,1,2020-06-15T13:28:13.853772-05:00,Chemotherapy,Residual Disease,
HCM-BROD-0229-C25,22f26b5c-41b7-4142-9d87-6cf8b7fee3af,1541cf35-c584-422f-91b2-cb98bd9b46e4,,Neoadjuvant,30.0,2021-01-06T22:55:10.531130-06:00,HCM-BROD-0229-C25_treatment,703af59c-dd7d-40e1-b6d6-65e5d83f33a3,,released,Irinotecan Hydrochloride,1,2020-06-15T13:28:13.853772-05:00,Chemotherapy,,
HCM-BROD-0229-C25,22f26b5c-41b7-4142-9d87-6cf8b7fee3af,1541cf35-c584-422f-91b2-cb98bd9b46e4,190.0,Adjuvant,78.0,2021-01-06T22:55:10.531130-06:00,HCM-BROD-0229-C25_treatment14,7dd12456-4fc0-4299-8887-5cd2f76cba84,,released,Nab-paclitaxel,1,2020-09-27T11:11:28.468142-05:00,Chemotherapy,Residual Disease,
HCM-BROD-0229-C25,22f26b5c-41b7-4142-9d87-6cf8b7fee3af,1541cf35-c584-422f-91b2-cb98bd9b46e4,,,,2023-02-27T12:16:48.434053-06:00,HCM-BROD-0229-C25_treatment16,80beeb46-6014-404b-b68d-9d3e45d94548,,released,,0,2020-09-27T11:11:28.468142-05:00,"Surgery, NOS",Initial Diagnosis,
HCM-BROD-0229-C25,22f26b5c-41b7-4142-9d87-6cf8b7fee3af,1541cf35-c584-422f-91b2-cb98bd9b46e4,,Neoadjuvant,30.0,2021-01-06T22:55:10.531130-06:00,HCM-BROD-0229-C25_treatment5,863c4aa4-9aa3-42e1-b25b-10a1b0786c3d,,released,,1,2020-06-15T13:28:13.853772-05:00,Chemotherapy,,FOLFIRINOX
HCM-BROD-0229-C25,22f26b5c-41b7-4142-9d87-6cf8b7fee3af,1541cf35-c584-422f-91b2-cb98bd9b46e4,190.0,Adjuvant,78.0,2021-01-06T22:55:10.531130-06:00,HCM-BROD-0229-C25_treatment13,987e3c0c-dc81-4f9c-8c73-7e109f699f8c,,released,Gemcitabine,1,2020-09-27T11:11:28.468142-05:00,Chemotherapy,Residual Disease,
HCM-BROD-0229-C25,22f26b5c-41b7-4142-9d87-6cf8b7fee3af,1541cf35-c584-422f-91b2-cb98bd9b46e4,,Neoadjuvant,30.0,2021-01-06T22:55:10.531130-06:00,HCM-BROD-0229-C25_treatment6,b52a6ce7-ea39-4cba-a828-6dc235206278,,released,Gemcitabine,1,2020-06-15T13:28:13.853772-05:00,Chemotherapy,,
HCM-BROD-0229-C25,22f26b5c-41b7-4142-9d87-6cf8b7fee3af,1541cf35-c584-422f-91b2-cb98bd9b46e4,57.0,Adjuvant,17.0,2021-01-06T22:55:10.531130-06:00,HCM-BROD-0229-C25_treatment12,b776bfbc-92dc-4eac-8d40-241a17303065,,released,,1,2020-09-27T11:11:28.468142-05:00,Chemotherapy,Residual Disease,FOLFIRINOX
HCM-BROD-0229-C25,22f26b5c-41b7-4142-9d87-6cf8b7fee3af,1541cf35-c584-422f-91b2-cb98bd9b46e4,,Neoadjuvant,30.0,2021-01-06T22:55:10.531130-06:00,HCM-BROD-0229-C25_treatment4,bca48180-94ce-40e3-8af3-8668508868fd,,released,Oxaliplatin,1,2020-06-15T13:28:13.853772-05:00,Chemotherapy,,
HCM-BROD-0229-C25,22f26b5c-41b7-4142-9d87-6cf8b7fee3af,1541cf35-c584-422f-91b2-cb98bd9b46e4,,Adjuvant,,2021-01-06T22:55:10.531130-06:00,HCM-BROD-0229-C25_treatment18,c53eec3f-708e-45e2-9c99-fece015665b0,,released,,0,2020-09-27T11:11:28.468142-05:00,"Radiation Therapy, NOS",Residual Disease,
HCM-BROD-0229-C25,22f26b5c-41b7-4142-9d87-6cf8b7fee3af,1541cf35-c584-422f-91b2-cb98bd9b46e4,,Neoadjuvant,30.0,2021-01-06T22:55:10.531130-06:00,HCM-BROD-0229-C25_treatment2,cf351140-42d2-405d-8951-c261666a9157,,released,Leucovorin Calcium,1,2020-06-15T13:28:13.853772-05:00,Chemotherapy,,
HCM-CSHL-0141-C18,23443700-fe39-4fd5-862f-ffb02cda3947,4985cf41-de70-458f-b1c6-efdf4e3eb663,,Adjuvant,,2021-07-12T12:25:55.528644-05:00,HCM-CSHL-0141-C18_treatment9,572b2fd6-c961-4347-82e1-2b8f1fb02b89,,released,,0,2020-09-27T12:53:37.241394-05:00,"Radiation Therapy, NOS",Residual Disease,
HCM-CSHL-0141-C18,23443700-fe39-4fd5-862f-ffb02cda3947,4985cf41-de70-458f-b1c6-efdf4e3eb663,189.0,Adjuvant,30.0,2021-07-12T12:25:55.528644-05:00,HCM-CSHL-0141-C18_treatment3,66865703-185d-4795-b4d2-89e17a11eaac,,released,Fluorouracil,1,2020-09-27T12:53:37.241394-05:00,Chemotherapy,Residual Disease,
HCM-CSHL-0141-C18,23443700-fe39-4fd5-862f-ffb02cda3947,4985cf41-de70-458f-b1c6-efdf4e3eb663,,,10.0,2023-03-13T12:54:06.590212-05:00,HCM-CSHL-0141-C18_treatment7,a478561a-4c22-4292-8e77-588de69851a8,,released,,1,2020-09-27T12:53:37.241394-05:00,"Surgery, NOS",Initial Diagnosis,
HCM-CSHL-0141-C18,23443700-fe39-4fd5-862f-ffb02cda3947,4985cf41-de70-458f-b1c6-efdf4e3eb663,189.0,Adjuvant,30.0,2021-07-12T12:25:55.528644-05:00,HCM-CSHL-0141-C18_treatment4,adc444f8-7bf2-471b-8bda-99251ae27a80,,released,Oxaliplatin,1,2020-09-27T12:53:37.241394-05:00,Chemotherapy,Residual Disease,
HCM-CSHL-0141-C18,23443700-fe39-4fd5-862f-ffb02cda3947,4985cf41-de70-458f-b1c6-efdf4e3eb663,,Neoadjuvant,,2021-07-12T12:25:55.528644-05:00,HCM-CSHL-0141-C18_treatment,ae0ac17e-ce60-4358-980c-af0cea6e1e60,,released,,0,2020-09-27T12:53:37.241394-05:00,,,
HCM-CSHL-0141-C18,23443700-fe39-4fd5-862f-ffb02cda3947,4985cf41-de70-458f-b1c6-efdf4e3eb663,,Adjuvant,,2021-07-12T12:25:55.528644-05:00,HCM-CSHL-0141-C18_treatment6,d0077754-efed-412b-9c30-d16159a81388,,released,,0,2020-09-27T12:53:37.241394-05:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-CSHL-0141-C18,23443700-fe39-4fd5-862f-ffb02cda3947,4985cf41-de70-458f-b1c6-efdf4e3eb663,,Adjuvant,,2021-07-12T12:25:55.528644-05:00,HCM-CSHL-0141-C18_treatment8,d7d8c9e0-cf69-4145-927f-f022eb84a26e,,released,,0,2020-09-27T12:53:37.241394-05:00,Targeted Molecular Therapy,Residual Disease,
HCM-CSHL-0141-C18,23443700-fe39-4fd5-862f-ffb02cda3947,4985cf41-de70-458f-b1c6-efdf4e3eb663,189.0,Adjuvant,30.0,2021-07-12T12:25:55.528644-05:00,HCM-CSHL-0141-C18_treatment2,e1fb390c-ddc5-4e94-9344-8ffffc36e55f,,released,Leucovorin Calcium,1,2020-09-27T12:53:37.241394-05:00,Chemotherapy,Residual Disease,
HCM-CSHL-0141-C18,23443700-fe39-4fd5-862f-ffb02cda3947,4985cf41-de70-458f-b1c6-efdf4e3eb663,189.0,Adjuvant,30.0,2021-07-12T12:25:55.528644-05:00,HCM-CSHL-0141-C18_treatment5,e6c2a4c3-e6bf-4dc0-9f01-97184c694ab5,,released,,1,2020-09-27T12:53:37.241394-05:00,Chemotherapy,Residual Disease,FOLFOX
HCM-EXPT-0933-C50,23cedc54-ef61-48f8-9ea9-fdf20c9d56ca,654871a0-1327-4b71-9ce5-a2b0e3272b39,,Neoadjuvant,,2025-10-08T12:36:57.024699-05:00,HCM-EXPT-0933-C50_treatment,bdf218cd-0007-49f1-b84e-18ebfdec48d7,,released,,0,2021-12-21T14:45:38.024610-06:00,,,
HCM-CSHL-0158-C20,24d58043-7070-4791-ac86-fdd4af8f2431,05ea5e59-b1e1-4852-afd0-fa83a479b5f3,300.0,Adjuvant,40.0,2020-10-20T19:20:06.800740-05:00,HCM-CSHL-0158-C20_treatment3,048dd01e-19e4-42ac-9992-48c2b2f6c852,,released,Fluorouracil,1,2020-02-27T12:48:29.327947-06:00,Chemotherapy,Residual Disease,
HCM-CSHL-0158-C20,24d58043-7070-4791-ac86-fdd4af8f2431,05ea5e59-b1e1-4852-afd0-fa83a479b5f3,,Adjuvant,657.0,2020-10-20T19:20:06.800740-05:00,HCM-CSHL-0158-C20_treatment11,13cc6804-a792-4b47-9d00-cd5d19ad7c39,Treatment Ongoing,released,Panitumumab,1,2020-09-27T13:01:16.920342-05:00,Targeted Molecular Therapy,Residual Disease,
HCM-CSHL-0158-C20,24d58043-7070-4791-ac86-fdd4af8f2431,05ea5e59-b1e1-4852-afd0-fa83a479b5f3,,,12.0,2023-03-13T12:41:23.183781-05:00,HCM-CSHL-0158-C20_treatment9,188a229c-e875-488a-ae7e-261d5c6d72ad,,released,,1,2020-09-27T13:01:16.920342-05:00,"Surgery, NOS",Initial Diagnosis,
HCM-CSHL-0158-C20,24d58043-7070-4791-ac86-fdd4af8f2431,05ea5e59-b1e1-4852-afd0-fa83a479b5f3,,Neoadjuvant,,2020-10-20T19:20:06.800740-05:00,HCM-CSHL-0158-C20_treatment,30ae3e82-0a06-420a-aeb1-472d5c303ab4,,released,,0,2020-02-27T12:48:29.327947-06:00,,,
HCM-CSHL-0158-C20,24d58043-7070-4791-ac86-fdd4af8f2431,05ea5e59-b1e1-4852-afd0-fa83a479b5f3,538.0,Adjuvant,462.0,2020-10-20T19:20:06.800740-05:00,HCM-CSHL-0158-C20_treatment10,337e25f1-3f07-4c62-9edf-31852b4fbb0e,,released,Panitumumab,1,2020-09-27T13:01:16.920342-05:00,Targeted Molecular Therapy,Residual Disease,
HCM-CSHL-0158-C20,24d58043-7070-4791-ac86-fdd4af8f2431,05ea5e59-b1e1-4852-afd0-fa83a479b5f3,,Adjuvant,657.0,2020-10-20T19:20:06.800740-05:00,HCM-CSHL-0158-C20_treatment7,5515fb26-c722-4ec7-a8c4-9b8ba7a02363,Treatment Ongoing,released,Irinotecan,1,2020-02-27T12:48:29.327947-06:00,Chemotherapy,Residual Disease,
HCM-CSHL-0158-C20,24d58043-7070-4791-ac86-fdd4af8f2431,05ea5e59-b1e1-4852-afd0-fa83a479b5f3,300.0,Adjuvant,40.0,2020-10-20T19:20:06.800740-05:00,HCM-CSHL-0158-C20_treatment4,987dbaf7-e147-4887-af61-678345156eb4,,released,Oxaliplatin,1,2020-02-27T12:48:29.327947-06:00,Chemotherapy,Residual Disease,
HCM-CSHL-0158-C20,24d58043-7070-4791-ac86-fdd4af8f2431,05ea5e59-b1e1-4852-afd0-fa83a479b5f3,538.0,Adjuvant,462.0,2020-10-20T19:20:06.800740-05:00,HCM-CSHL-0158-C20_treatment6,9ac79ea0-15e4-4fd1-a8ac-3fa7f876b13f,,released,Irinotecan,1,2020-02-27T12:48:29.327947-06:00,Chemotherapy,Residual Disease,
HCM-CSHL-0158-C20,24d58043-7070-4791-ac86-fdd4af8f2431,05ea5e59-b1e1-4852-afd0-fa83a479b5f3,300.0,Adjuvant,40.0,2020-10-20T19:20:06.800740-05:00,HCM-CSHL-0158-C20_treatment2,a86f861d-3797-4678-9fde-77cf0520ea20,,released,Leucovorin Calcium,1,2020-02-27T12:48:29.327947-06:00,Chemotherapy,Residual Disease,
HCM-CSHL-0158-C20,24d58043-7070-4791-ac86-fdd4af8f2431,05ea5e59-b1e1-4852-afd0-fa83a479b5f3,,Adjuvant,,2020-10-20T19:20:06.800740-05:00,HCM-CSHL-0158-C20_treatment12,c2cbd0dd-908c-40c7-94d6-7b3e4c65e45c,,released,,0,2020-09-27T13:01:16.920342-05:00,"Radiation Therapy, NOS",Residual Disease,
HCM-CSHL-0158-C20,24d58043-7070-4791-ac86-fdd4af8f2431,05ea5e59-b1e1-4852-afd0-fa83a479b5f3,300.0,Adjuvant,40.0,2020-10-20T19:20:06.800740-05:00,HCM-CSHL-0158-C20_treatment5,c307bc3f-18e5-4898-85a0-a2944dbe4be9,,released,,1,2020-02-27T12:48:29.327947-06:00,Chemotherapy,Residual Disease,FOLFOX
HCM-CSHL-0158-C20,24d58043-7070-4791-ac86-fdd4af8f2431,05ea5e59-b1e1-4852-afd0-fa83a479b5f3,,Adjuvant,,2020-10-20T19:20:06.800740-05:00,HCM-CSHL-0158-C20_treatment8,c6329b5d-2cc8-4d17-b6f3-8679604063b7,,released,,0,2020-02-27T12:48:29.327947-06:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-EXPT-1221-C18,24da43ae-b254-4238-9b55-813ccb1e8f35,b115c24a-f0a2-46f2-962f-9c61185d6d91,,Neoadjuvant,,2025-10-08T12:39:14.406630-05:00,HCM-EXPT-1221-C18_treatment,5c34e9d4-f5ab-471d-93e0-e5e1d458c4b5,,released,,0,2022-03-09T19:43:42.462018-06:00,,,
HCM-BROD-1186-C64,2539dadb-533b-4aa3-b9b1-475052a93551,c3657f42-faaf-4dac-994f-0fa66a716917,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-BROD-1186-C64_treatment3,50456ce6-697e-4231-8dc4-37d18783b453,,released,,0,2021-12-21T14:03:03.340777-06:00,Hormone Therapy,Residual Disease,
HCM-BROD-1186-C64,2539dadb-533b-4aa3-b9b1-475052a93551,c3657f42-faaf-4dac-994f-0fa66a716917,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-BROD-1186-C64_treatment7,87abe780-9452-46e3-9182-eaedc99070c9,,released,,0,2021-12-21T14:03:03.340777-06:00,"Radiation Therapy, NOS",Residual Disease,
HCM-BROD-1186-C64,2539dadb-533b-4aa3-b9b1-475052a93551,c3657f42-faaf-4dac-994f-0fa66a716917,,,13.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-1186-C64_treatment5,9d3da606-a2cd-4247-8ca0-92be7915f146,,released,,1,2021-12-21T14:03:03.340777-06:00,"Surgery, NOS",Initial Diagnosis,
HCM-BROD-1186-C64,2539dadb-533b-4aa3-b9b1-475052a93551,c3657f42-faaf-4dac-994f-0fa66a716917,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-BROD-1186-C64_treatment6,aef9caa1-01f4-4991-9a8c-335624b179df,,released,,0,2021-12-21T14:03:03.340777-06:00,Targeted Molecular Therapy,Residual Disease,
HCM-BROD-1186-C64,2539dadb-533b-4aa3-b9b1-475052a93551,c3657f42-faaf-4dac-994f-0fa66a716917,143.0,Adjuvant,55.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-1186-C64_treatment2,d98828df-fb2d-4373-91f1-af6af35ba7df,Treatment Ongoing,released,Carboplatin,1,2021-12-21T14:03:03.340777-06:00,Chemotherapy,Residual Disease,
HCM-BROD-1186-C64,2539dadb-533b-4aa3-b9b1-475052a93551,c3657f42-faaf-4dac-994f-0fa66a716917,,Neoadjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-BROD-1186-C64_treatment,ee2a5b56-d828-4027-987b-058eaa10dce7,,released,,0,2021-12-21T14:03:03.340777-06:00,,,
HCM-BROD-1186-C64,2539dadb-533b-4aa3-b9b1-475052a93551,c3657f42-faaf-4dac-994f-0fa66a716917,143.0,Adjuvant,55.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-1186-C64_treatment4,ff2e6a5a-b39a-440d-bde2-91004bb30868,Treatment Ongoing,released,Nivolumab,1,2021-12-21T14:03:03.340777-06:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-EXPT-1198-C18,25455ba4-759e-467d-b880-c938c9f39408,c915a9b0-1c6a-42d8-9c9f-a63c96f62220,,Neoadjuvant,,2025-10-08T12:38:51.189053-05:00,HCM-EXPT-1198-C18_treatment,c4f9ae24-be29-4131-810b-6ae0279cb319,,released,,0,2022-03-09T19:42:08.178180-06:00,,,
HCM-SANG-1089-C18,267f7bca-ae79-4066-9657-a42407f570a4,11faa574-0363-446c-9ac4-b1204d5d1184,,Neoadjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-SANG-1089-C18_treatment,93a4eb3a-6f97-45ae-b288-a9243937181e,,released,,0,2023-02-27T11:55:52.445394-06:00,,,
HCM-EXPT-0994-C25,272d4173-001c-4a7f-b221-34ea907aba5a,8e6c0aa0-af97-446f-8f86-53a2c7874634,,Neoadjuvant,,2025-10-08T12:37:21.548354-05:00,HCM-EXPT-0994-C25_treatment,0951d4f2-5d41-47eb-909d-5729a56d11a3,,released,,1,2021-12-21T14:52:22.244250-06:00,Chemotherapy,,
HCM-CSHL-0806-C54,27d256aa-9f73-47e0-8eec-7814c019bb45,b850de55-0c34-46b1-a1f1-2a3f4f61e29b,,Adjuvant,,2023-11-07T14:20:00.017270-06:00,HCM-CSHL-0806-C54_treatment7,5a3173f2-4ade-4e80-9b96-0fe29d7cab03,,released,,0,2021-12-21T14:26:36.514249-06:00,Targeted Molecular Therapy,Residual Disease,
HCM-CSHL-0806-C54,27d256aa-9f73-47e0-8eec-7814c019bb45,b850de55-0c34-46b1-a1f1-2a3f4f61e29b,164.0,Adjuvant,60.0,2023-11-07T14:20:00.017270-06:00,HCM-CSHL-0806-C54_treatment3,89b1ccd1-2d03-4b7d-add7-b71208ab2161,,released,Paclitaxel,1,2021-12-21T14:26:36.514249-06:00,Chemotherapy,Residual Disease,
HCM-CSHL-0806-C54,27d256aa-9f73-47e0-8eec-7814c019bb45,b850de55-0c34-46b1-a1f1-2a3f4f61e29b,164.0,Adjuvant,60.0,2023-11-07T14:20:00.017270-06:00,HCM-CSHL-0806-C54_treatment2,8dca11d6-e1ec-42ba-acf7-cf3fab0da6e9,,released,Carboplatin,1,2021-12-21T14:26:36.514249-06:00,Chemotherapy,Residual Disease,
HCM-CSHL-0806-C54,27d256aa-9f73-47e0-8eec-7814c019bb45,b850de55-0c34-46b1-a1f1-2a3f4f61e29b,,,0.0,2023-11-07T14:20:00.017270-06:00,HCM-CSHL-0806-C54_treatment6,ab02fe21-6751-47e2-833c-39d02cf9615f,,released,,1,2021-12-21T14:26:36.514249-06:00,"Surgery, NOS",Initial Diagnosis,
HCM-CSHL-0806-C54,27d256aa-9f73-47e0-8eec-7814c019bb45,b850de55-0c34-46b1-a1f1-2a3f4f61e29b,254.0,Adjuvant,192.0,2023-11-07T14:20:00.017270-06:00,HCM-CSHL-0806-C54_treatment8,b5db5213-0959-4b5b-8c6c-6404b352c0c2,,released,,1,2021-12-21T14:26:36.514249-06:00,"Radiation, Intensity-Modulated Radiotherapy",Residual Disease,
HCM-CSHL-0806-C54,27d256aa-9f73-47e0-8eec-7814c019bb45,b850de55-0c34-46b1-a1f1-2a3f4f61e29b,,Neoadjuvant,,2023-11-07T14:20:00.017270-06:00,HCM-CSHL-0806-C54_treatment,c36648e8-f122-4065-b77c-3a083c1baaac,,released,,0,2021-12-21T14:26:36.514249-06:00,,,
HCM-CSHL-0806-C54,27d256aa-9f73-47e0-8eec-7814c019bb45,b850de55-0c34-46b1-a1f1-2a3f4f61e29b,,Adjuvant,,2023-11-07T14:20:00.017270-06:00,HCM-CSHL-0806-C54_treatment5,ef50868e-4fdd-4510-9956-a06edecadb70,,released,,0,2021-12-21T14:26:36.514249-06:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-CSHL-0806-C54,27d256aa-9f73-47e0-8eec-7814c019bb45,b850de55-0c34-46b1-a1f1-2a3f4f61e29b,,Adjuvant,,2023-11-07T14:20:00.017270-06:00,HCM-CSHL-0806-C54_treatment4,fbb58f94-0398-49c9-a1e7-c1e9496f60b4,,released,,0,2021-12-21T14:26:36.514249-06:00,Hormone Therapy,Residual Disease,
HCM-CSHL-0079-C25,27e13777-6ed1-4411-a935-245ba6953cf5,6e120ed7-9f57-4ecf-ba20-d56eefeaa97e,,Neoadjuvant,,2020-10-20T19:20:06.800740-05:00,HCM-CSHL-0079-C25_treatment,0a871992-1572-49f4-bdb2-9add21ddbc2b,,released,,0,2020-02-27T13:23:43.301369-06:00,,,
HCM-CSHL-0079-C25,27e13777-6ed1-4411-a935-245ba6953cf5,6e120ed7-9f57-4ecf-ba20-d56eefeaa97e,,Adjuvant,,2020-10-20T19:20:06.800740-05:00,HCM-CSHL-0079-C25_treatment2,0f20fc49-7ed2-46e0-8c83-5e8ed814963f,,released,Gemcitabine,1,2020-02-27T13:23:43.301369-06:00,Chemotherapy,Residual Disease,
HCM-CSHL-0079-C25,27e13777-6ed1-4411-a935-245ba6953cf5,6e120ed7-9f57-4ecf-ba20-d56eefeaa97e,,Adjuvant,,2020-10-20T19:20:06.800740-05:00,HCM-CSHL-0079-C25_treatment6,52e03ea4-d5cc-45be-bafc-324438259984,,released,,0,2020-02-27T13:23:43.301369-06:00,Targeted Molecular Therapy,Residual Disease,
HCM-CSHL-0079-C25,27e13777-6ed1-4411-a935-245ba6953cf5,6e120ed7-9f57-4ecf-ba20-d56eefeaa97e,,Adjuvant,,2020-10-20T19:20:06.800740-05:00,HCM-CSHL-0079-C25_treatment7,b4161c12-e42b-417d-a11c-a903159779e3,,released,,0,2020-06-15T12:50:05.758097-05:00,"Radiation Therapy, NOS",Residual Disease,
HCM-CSHL-0079-C25,27e13777-6ed1-4411-a935-245ba6953cf5,6e120ed7-9f57-4ecf-ba20-d56eefeaa97e,,,-19.0,2023-02-27T11:48:29.690584-06:00,HCM-CSHL-0079-C25_treatment5,d74e078f-0b70-4078-8c9e-cc666e2f37f2,,released,,1,2020-02-27T13:23:43.301369-06:00,"Surgery, NOS",Initial Diagnosis,
HCM-CSHL-0079-C25,27e13777-6ed1-4411-a935-245ba6953cf5,6e120ed7-9f57-4ecf-ba20-d56eefeaa97e,,Adjuvant,,2020-10-20T19:20:06.800740-05:00,HCM-CSHL-0079-C25_treatment3,da65efd5-12aa-4db4-964c-16a8459a60b1,,released,Nab-paclitaxel,1,2020-02-27T13:23:43.301369-06:00,Chemotherapy,Residual Disease,
HCM-CSHL-0079-C25,27e13777-6ed1-4411-a935-245ba6953cf5,6e120ed7-9f57-4ecf-ba20-d56eefeaa97e,,Adjuvant,,2020-10-20T19:20:06.800740-05:00,HCM-CSHL-0079-C25_treatment4,dcd92441-a7e1-4bce-961e-ba72b9a5d4fc,,released,,0,2020-02-27T13:23:43.301369-06:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-BROD-0873-C43,284c98af-cf5d-4f6a-9994-4d99a2ad8aeb,84a23d91-a55f-46da-9f79-50b2fcd41e0f,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0873-C43_treatment2,00bbca24-27b5-446e-a97a-42f174e2bb5d,,released,,0,2021-12-21T13:56:23.281428-06:00,Chemotherapy,Residual Disease,
HCM-BROD-0873-C43,284c98af-cf5d-4f6a-9994-4d99a2ad8aeb,84a23d91-a55f-46da-9f79-50b2fcd41e0f,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0873-C43_treatment3,10ff938a-e8b4-445f-a6eb-d0eb7637f66d,,released,,0,2021-12-21T13:56:23.281428-06:00,Hormone Therapy,Residual Disease,
HCM-BROD-0873-C43,284c98af-cf5d-4f6a-9994-4d99a2ad8aeb,84a23d91-a55f-46da-9f79-50b2fcd41e0f,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0873-C43_treatment7,49882cd9-8a08-4926-ae67-dcc7933061af,,released,,0,2021-12-21T13:56:23.281428-06:00,"Radiation Therapy, NOS",Residual Disease,
HCM-BROD-0873-C43,284c98af-cf5d-4f6a-9994-4d99a2ad8aeb,84a23d91-a55f-46da-9f79-50b2fcd41e0f,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0873-C43_treatment6,7f0b3564-522c-4afb-9c0b-ae1506d9d2ad,,released,,0,2021-12-21T13:56:23.281428-06:00,Targeted Molecular Therapy,Residual Disease,
HCM-BROD-0873-C43,284c98af-cf5d-4f6a-9994-4d99a2ad8aeb,84a23d91-a55f-46da-9f79-50b2fcd41e0f,,,2.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0873-C43_treatment5,9ee8b828-d86c-4c7e-a8cf-6ca283f2b904,,released,,1,2021-12-21T13:56:23.281428-06:00,"Surgery, NOS",Initial Diagnosis,
HCM-BROD-0873-C43,284c98af-cf5d-4f6a-9994-4d99a2ad8aeb,84a23d91-a55f-46da-9f79-50b2fcd41e0f,192.0,Adjuvant,94.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0873-C43_treatment4,da7e8e46-c1f2-49fc-b148-6514dc265c5a,,released,Nivolumab,1,2021-12-21T13:56:23.281428-06:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-BROD-0873-C43,284c98af-cf5d-4f6a-9994-4d99a2ad8aeb,84a23d91-a55f-46da-9f79-50b2fcd41e0f,,Neoadjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0873-C43_treatment,e8195205-8647-4e93-beb1-473ea001e7b6,,released,,0,2021-12-21T13:56:23.281428-06:00,,,
HCM-BROD-0208-C16,288f90bf-43fc-40ef-b3fa-40f35ce0007e,20d7f1bf-2fa9-4984-9a25-dfedc8a76bc5,,Adjuvant,,2021-07-12T12:25:55.528644-05:00,HCM-BROD-0208-C16_treatment9,0757e60f-5bdd-478e-8224-6f7c4453505b,,released,,0,2020-09-27T10:59:04.648230-05:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-BROD-0208-C16,288f90bf-43fc-40ef-b3fa-40f35ce0007e,20d7f1bf-2fa9-4984-9a25-dfedc8a76bc5,192.0,Adjuvant,165.0,2021-07-12T12:25:55.528644-05:00,HCM-BROD-0208-C16_treatment3,5e31ae72-1f75-4b5e-a74f-b17e601b07cf,,released,Oxaliplatin,1,2020-02-11T15:46:21.987672-06:00,Chemotherapy,Residual Disease,
HCM-BROD-0208-C16,288f90bf-43fc-40ef-b3fa-40f35ce0007e,20d7f1bf-2fa9-4984-9a25-dfedc8a76bc5,,Adjuvant,,2021-07-12T12:25:55.528644-05:00,HCM-BROD-0208-C16_treatment12,69f95a9c-e24b-4104-bdf0-7886fccb85f7,,released,,0,2020-09-27T10:59:04.648230-05:00,"Radiation Therapy, NOS",Residual Disease,
HCM-BROD-0208-C16,288f90bf-43fc-40ef-b3fa-40f35ce0007e,20d7f1bf-2fa9-4984-9a25-dfedc8a76bc5,658.0,Adjuvant,461.0,2021-07-12T12:25:55.528644-05:00,HCM-BROD-0208-C16_treatment8,78f5b2f1-9f10-4d89-95fd-310b74ce466f,Treatment Ongoing,released,,1,2020-09-27T10:59:04.648230-05:00,Chemotherapy,Residual Disease,FOLFIRI
HCM-BROD-0208-C16,288f90bf-43fc-40ef-b3fa-40f35ce0007e,20d7f1bf-2fa9-4984-9a25-dfedc8a76bc5,,Neoadjuvant,,2021-07-12T12:25:55.528644-05:00,HCM-BROD-0208-C16_treatment,8989be34-c8d4-414d-b926-98f1565a3fcd,,released,Unknown,1,2020-02-11T15:46:21.987672-06:00,Chemotherapy,,
HCM-BROD-0208-C16,288f90bf-43fc-40ef-b3fa-40f35ce0007e,20d7f1bf-2fa9-4984-9a25-dfedc8a76bc5,,Adjuvant,,2021-07-12T12:25:55.528644-05:00,HCM-BROD-0208-C16_treatment11,8caa9180-ee74-4a0e-91e4-130a9ec4277c,,released,,0,2020-09-27T10:59:04.648230-05:00,Targeted Molecular Therapy,Residual Disease,
HCM-BROD-0208-C16,288f90bf-43fc-40ef-b3fa-40f35ce0007e,20d7f1bf-2fa9-4984-9a25-dfedc8a76bc5,192.0,Adjuvant,165.0,2021-07-12T12:25:55.528644-05:00,HCM-BROD-0208-C16_treatment4,9baec952-ca96-4d1a-ac24-f65960f1a5f2,,released,Docetaxel,1,2020-02-11T15:46:21.987672-06:00,Chemotherapy,Residual Disease,
HCM-BROD-0208-C16,288f90bf-43fc-40ef-b3fa-40f35ce0007e,20d7f1bf-2fa9-4984-9a25-dfedc8a76bc5,658.0,Adjuvant,461.0,2021-07-12T12:25:55.528644-05:00,HCM-BROD-0208-C16_treatment6,a36a87cb-93d3-4a6b-9884-3f4630fab3c5,Treatment Ongoing,released,Fluorouracil,1,2020-02-11T15:46:21.987672-06:00,Chemotherapy,Residual Disease,
HCM-BROD-0208-C16,288f90bf-43fc-40ef-b3fa-40f35ce0007e,20d7f1bf-2fa9-4984-9a25-dfedc8a76bc5,192.0,Adjuvant,165.0,2021-07-12T12:25:55.528644-05:00,HCM-BROD-0208-C16_treatment2,a65f5b08-6d18-4253-904c-326a66983569,,released,Fluorouracil,1,2020-02-11T15:46:21.987672-06:00,Chemotherapy,Residual Disease,
HCM-BROD-0208-C16,288f90bf-43fc-40ef-b3fa-40f35ce0007e,20d7f1bf-2fa9-4984-9a25-dfedc8a76bc5,,,122.0,2023-02-27T11:38:12.773337-06:00,HCM-BROD-0208-C16_treatment10,c27713be-a8fa-43cb-a8b1-e28694ac6f81,,released,,1,2020-09-27T10:59:04.648230-05:00,"Surgery, NOS",Initial Diagnosis,
HCM-BROD-0208-C16,288f90bf-43fc-40ef-b3fa-40f35ce0007e,20d7f1bf-2fa9-4984-9a25-dfedc8a76bc5,658.0,Adjuvant,461.0,2021-07-12T12:25:55.528644-05:00,HCM-BROD-0208-C16_treatment7,f28f99e7-b33c-4054-b876-7b016ef726ab,Treatment Ongoing,released,Irinotecan,1,2020-02-11T15:46:21.987672-06:00,Chemotherapy,Residual Disease,
HCM-BROD-0208-C16,288f90bf-43fc-40ef-b3fa-40f35ce0007e,20d7f1bf-2fa9-4984-9a25-dfedc8a76bc5,658.0,Adjuvant,461.0,2021-07-12T12:25:55.528644-05:00,HCM-BROD-0208-C16_treatment5,f5263429-cc67-4e27-9bf5-332eba50a092,Treatment Ongoing,released,Leucovorin Calcium,1,2020-02-11T15:46:21.987672-06:00,Chemotherapy,Residual Disease,
HCM-CSHL-0255-C18,28dbcedb-a919-4fee-86a3-a3de2f0ce254,2044d8c2-dd27-44ee-800f-5c8fcca45466,,Neoadjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0255-C18_treatment,6a2ed170-ebba-4949-bc0a-05838603d0e5,,released,,0,2020-09-28T09:36:26.618730-05:00,,,
HCM-CSHL-0255-C18,28dbcedb-a919-4fee-86a3-a3de2f0ce254,2044d8c2-dd27-44ee-800f-5c8fcca45466,,Adjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0255-C18_treatment4,79be2a8c-d085-48db-8903-abf98c945885,,released,,0,2020-09-28T09:36:26.618730-05:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-CSHL-0255-C18,28dbcedb-a919-4fee-86a3-a3de2f0ce254,2044d8c2-dd27-44ee-800f-5c8fcca45466,,Adjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0255-C18_treatment6,91bc13c2-3fcb-4ec9-9fe2-d186e1d88bb4,,released,,0,2020-09-28T09:36:26.618730-05:00,Targeted Molecular Therapy,Residual Disease,
HCM-CSHL-0255-C18,28dbcedb-a919-4fee-86a3-a3de2f0ce254,2044d8c2-dd27-44ee-800f-5c8fcca45466,,,16.0,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0255-C18_treatment5,b551f4b7-1871-478f-8fbe-bc0168523698,,released,,1,2020-09-28T09:36:26.618730-05:00,"Surgery, NOS",Initial Diagnosis,
HCM-CSHL-0255-C18,28dbcedb-a919-4fee-86a3-a3de2f0ce254,2044d8c2-dd27-44ee-800f-5c8fcca45466,,Adjuvant,64.0,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0255-C18_treatment2,ec462ecc-996b-40e0-9c8d-9f41e37f8f4e,,released,Capecitabine,1,2020-09-28T09:36:26.618730-05:00,Chemotherapy,Residual Disease,
HCM-CSHL-0255-C18,28dbcedb-a919-4fee-86a3-a3de2f0ce254,2044d8c2-dd27-44ee-800f-5c8fcca45466,,Adjuvant,64.0,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0255-C18_treatment3,fd634d6c-27df-46d2-9922-694903decb4d,,released,Oxaliplatin,1,2020-09-28T09:36:26.618730-05:00,Chemotherapy,Residual Disease,
HCM-CSHL-0255-C18,28dbcedb-a919-4fee-86a3-a3de2f0ce254,2044d8c2-dd27-44ee-800f-5c8fcca45466,,Adjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0255-C18_treatment7,fd9a23c3-27d7-407a-8df4-6fdc28f9c03f,,released,,0,2020-09-28T09:36:26.618730-05:00,"Radiation Therapy, NOS",Residual Disease,
HCM-CSHL-0727-C18,28f77d34-e59d-4b80-8885-88d11c2ced74,2833b1ba-f46b-4fbc-8ed1-ae4c1f342654,,Adjuvant,,2023-02-22T07:39:25.979291-06:00,HCM-CSHL-0727-C18_treatment5,350eec24-26f6-4d58-9576-d0ce96f1910c,,released,,0,2021-12-21T14:18:56.750090-06:00,Targeted Molecular Therapy,Residual Disease,
HCM-CSHL-0727-C18,28f77d34-e59d-4b80-8885-88d11c2ced74,2833b1ba-f46b-4fbc-8ed1-ae4c1f342654,,Adjuvant,,2023-02-22T07:39:25.979291-06:00,HCM-CSHL-0727-C18_treatment3,47968968-7dd7-4f52-aebd-bf8af1a8f7ad,,released,,0,2021-12-21T14:18:56.750090-06:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-CSHL-0727-C18,28f77d34-e59d-4b80-8885-88d11c2ced74,2833b1ba-f46b-4fbc-8ed1-ae4c1f342654,,Neoadjuvant,,2023-02-22T07:39:25.979291-06:00,HCM-CSHL-0727-C18_treatment,509304b9-5270-45ce-9737-f119c2b1d886,,released,,0,2021-12-21T14:18:56.750090-06:00,,,
HCM-CSHL-0727-C18,28f77d34-e59d-4b80-8885-88d11c2ced74,2833b1ba-f46b-4fbc-8ed1-ae4c1f342654,,,91.0,2023-03-13T13:01:05.369786-05:00,HCM-CSHL-0727-C18_treatment4,65c83a2d-a56c-4c1a-9400-04456d2090dc,,released,,1,2021-12-21T14:18:56.750090-06:00,"Surgery, NOS",Initial Diagnosis,
HCM-CSHL-0727-C18,28f77d34-e59d-4b80-8885-88d11c2ced74,2833b1ba-f46b-4fbc-8ed1-ae4c1f342654,,Adjuvant,,2023-02-22T07:39:25.979291-06:00,HCM-CSHL-0727-C18_treatment6,6b788707-ebd3-4c7b-b4ba-33e3e52990fb,,released,,0,2021-12-21T14:18:56.750090-06:00,"Radiation Therapy, NOS",Residual Disease,
HCM-CSHL-0727-C18,28f77d34-e59d-4b80-8885-88d11c2ced74,2833b1ba-f46b-4fbc-8ed1-ae4c1f342654,307.0,Adjuvant,139.0,2023-02-22T07:39:25.979291-06:00,HCM-CSHL-0727-C18_treatment2,c000c2ed-2c27-4d1c-9913-eeecfaaa4bf5,,released,Capecitabine,1,2021-12-21T14:18:56.750090-06:00,Chemotherapy,Residual Disease,
HCM-SANG-0286-C20,291bc57c-0163-4dae-8eab-afb756a565e6,5d161d86-206d-4157-9a99-366aa6027caa,,Neoadjuvant,713.0,2023-03-13T13:09:06.826915-05:00,HCM-SANG-0286-C20_treatment,1ec2339d-ca78-4d46-9122-735ff0d3ce22,,released,Oxaliplatin,1,2021-12-21T15:08:36.662144-06:00,Chemotherapy,,
HCM-SANG-0286-C20,291bc57c-0163-4dae-8eab-afb756a565e6,5d161d86-206d-4157-9a99-366aa6027caa,,Neoadjuvant,713.0,2023-03-13T13:09:06.826915-05:00,HCM-SANG-0286-C20_treatment2,2c4d1ee0-fda5-4399-8725-61d437f2712d,,released,Dexamethasone,1,2021-12-21T15:08:36.662144-06:00,Chemotherapy,,
HCM-SANG-0286-C20,291bc57c-0163-4dae-8eab-afb756a565e6,5d161d86-206d-4157-9a99-366aa6027caa,,Neoadjuvant,713.0,2023-03-13T13:09:06.826915-05:00,HCM-SANG-0286-C20_treatment3,8757ee5f-2279-413b-872f-e9674ef497d0,,released,Bevacizumab,1,2021-12-21T15:08:36.662144-06:00,Targeted Molecular Therapy,,
HCM-CSHL-0250-C50,291dcbe0-c3cb-48ae-a988-b217fc840a5c,be5d793b-c1a1-46c2-aef3-d41a949ff8ae,,Adjuvant,,2023-02-22T07:39:25.979291-06:00,HCM-CSHL-0250-C50_treatment7,2d7a9867-8214-48ce-a7b7-854a2b7f6319,,released,,0,2020-09-28T09:34:37.567256-05:00,Targeted Molecular Therapy,Residual Disease,
HCM-CSHL-0250-C50,291dcbe0-c3cb-48ae-a988-b217fc840a5c,be5d793b-c1a1-46c2-aef3-d41a949ff8ae,,Adjuvant,,2023-02-22T07:39:25.979291-06:00,HCM-CSHL-0250-C50_treatment8,4e0a0c1d-4f8d-472f-947d-66199af4f77d,,released,,0,2020-09-28T09:34:37.567256-05:00,"Radiation Therapy, NOS",Residual Disease,
HCM-CSHL-0250-C50,291dcbe0-c3cb-48ae-a988-b217fc840a5c,be5d793b-c1a1-46c2-aef3-d41a949ff8ae,,Neoadjuvant,,2023-02-22T07:39:25.979291-06:00,HCM-CSHL-0250-C50_treatment,4ec82461-578d-4eea-ba74-0713d46aed60,,released,,0,2020-09-28T09:34:37.567256-05:00,,,
HCM-CSHL-0250-C50,291dcbe0-c3cb-48ae-a988-b217fc840a5c,be5d793b-c1a1-46c2-aef3-d41a949ff8ae,,,39.0,2023-02-24T14:43:30.006889-06:00,HCM-CSHL-0250-C50_treatment6,4ecd23e8-c6a0-461c-9890-f23df0bed657,,released,,1,2020-09-28T09:34:37.567256-05:00,"Surgery, NOS",Initial Diagnosis,
HCM-CSHL-0250-C50,291dcbe0-c3cb-48ae-a988-b217fc840a5c,be5d793b-c1a1-46c2-aef3-d41a949ff8ae,,Adjuvant,,2023-02-22T07:39:25.979291-06:00,HCM-CSHL-0250-C50_treatment3,5bd29428-4a0d-40c3-8cfb-0e405f728351,,released,Cyclophosphamide,1,2020-09-28T09:34:37.567256-05:00,Chemotherapy,Residual Disease,
HCM-CSHL-0250-C50,291dcbe0-c3cb-48ae-a988-b217fc840a5c,be5d793b-c1a1-46c2-aef3-d41a949ff8ae,,Adjuvant,,2023-02-22T07:39:25.979291-06:00,HCM-CSHL-0250-C50_treatment2,6420ce44-5b0f-44e0-9c59-50dddb5ebdef,,released,Docetaxel,1,2020-09-28T09:34:37.567256-05:00,Chemotherapy,Residual Disease,
HCM-CSHL-0250-C50,291dcbe0-c3cb-48ae-a988-b217fc840a5c,be5d793b-c1a1-46c2-aef3-d41a949ff8ae,,Adjuvant,,2023-02-22T07:39:25.979291-06:00,HCM-CSHL-0250-C50_treatment5,83b78695-e287-4942-8668-5eb69b824b44,,released,,0,2020-09-28T09:34:37.567256-05:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-CSHL-0250-C50,291dcbe0-c3cb-48ae-a988-b217fc840a5c,be5d793b-c1a1-46c2-aef3-d41a949ff8ae,203.0,Adjuvant,152.0,2023-02-22T07:39:25.979291-06:00,HCM-CSHL-0250-C50_treatment4,a3f5fabb-c67b-46db-b79c-e004826dc78b,,released,Not Reported,1,2020-09-28T09:34:37.567256-05:00,Hormone Therapy,Residual Disease,
HCM-SANG-0551-C18,29730787-a20b-4957-8b5c-afc8a3e4a7db,0bf5c29a-33bf-46ce-81f6-2c9f3c89da70,,Neoadjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-SANG-0551-C18_treatment,d26a2a78-4f39-4e41-9089-782cee55fa50,,released,,0,2021-12-21T15:17:21.484672-06:00,,,
HCM-SANG-0275-C18,29df97f4-6e7e-48a0-a320-09df82fc0b81,c5277378-c3f8-4bfb-920e-111824621c28,,Neoadjuvant,,2023-11-07T14:28:29.403873-06:00,HCM-SANG-0275-C18_treatment,c817ad0f-503e-4ba4-99ac-9b1a11e99c7c,,released,,0,2021-12-21T15:06:49.907685-06:00,,,
HCM-SANG-0543-C15,2a12f40c-d79a-4e24-a0f1-bf80a65c62d4,05d118ee-a09f-40b7-aa68-81700a5a0958,,Neoadjuvant,103.0,2025-03-31T16:34:59.906497-05:00,HCM-SANG-0543-C15_treatment,472e7ef4-2086-4555-9173-f73ded1d7fbf,,released,Oxaliplatin,1,2023-02-27T12:13:45.942880-06:00,Chemotherapy,,
HCM-SANG-0543-C15,2a12f40c-d79a-4e24-a0f1-bf80a65c62d4,05d118ee-a09f-40b7-aa68-81700a5a0958,,Neoadjuvant,103.0,2025-03-31T16:34:59.906497-05:00,HCM-SANG-0543-C15_treatment2,cf794855-3c92-4660-9cb9-9c75674138cd,,released,Capecitabine,1,2023-02-27T12:13:45.942880-06:00,Chemotherapy,,
HCM-BROD-0008-C25,2a40e945-95d5-4f4d-9865-b3dc2a27782c,1d096cb3-570b-4cc6-983f-fe142192cf4c,,Neoadjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0008-C25_treatment,3a138ef8-98ab-443c-9458-129f44e95082,,released,,0,2019-04-16T11:16:53.684381-05:00,,,
HCM-BROD-0008-C25,2a40e945-95d5-4f4d-9865-b3dc2a27782c,1d096cb3-570b-4cc6-983f-fe142192cf4c,,Adjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0008-C25_treatment4,ad7137d0-c0f0-434d-8c6e-c3338756e90e,,released,,0,2019-04-16T11:16:53.684381-05:00,"Radiation Therapy, NOS",Residual Disease,
HCM-BROD-0008-C25,2a40e945-95d5-4f4d-9865-b3dc2a27782c,1d096cb3-570b-4cc6-983f-fe142192cf4c,,Adjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0008-C25_treatment3,e7f14641-cc0b-4b32-a5ca-ee99ea2cbe78,,released,,0,2019-04-16T11:16:53.684381-05:00,"Pharmaceutical Therapy, NOS",Residual Disease,
HCM-BROD-0475-C16,2ae5f389-df9b-46d8-8234-193bc40fe742,feab693d-b0cb-4bda-8956-eb4d28ee4e54,,Neoadjuvant,17.0,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0475-C16_treatment,0e429a19-e2b5-4219-b0ab-0f6787b999a7,,released,Oxaliplatin,1,2020-10-08T14:45:50.496219-05:00,Chemotherapy,,
HCM-BROD-0475-C16,2ae5f389-df9b-46d8-8234-193bc40fe742,feab693d-b0cb-4bda-8956-eb4d28ee4e54,441.0,Adjuvant,402.0,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0475-C16_treatment4,13c87f48-d97b-46c6-a2b2-7bc95a032234,,released,Paclitaxel,1,2020-10-08T14:45:50.496219-05:00,Chemotherapy,Residual Disease,
HCM-BROD-0475-C16,2ae5f389-df9b-46d8-8234-193bc40fe742,feab693d-b0cb-4bda-8956-eb4d28ee4e54,,Adjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0475-C16_treatment7,76658278-5520-4c93-96de-8bbcfd8eb9fe,,released,,0,2020-10-08T14:45:50.496219-05:00,Targeted Molecular Therapy,Residual Disease,
HCM-BROD-0475-C16,2ae5f389-df9b-46d8-8234-193bc40fe742,feab693d-b0cb-4bda-8956-eb4d28ee4e54,,Neoadjuvant,17.0,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0475-C16_treatment3,7e2b3636-eee6-4d75-a5d0-846508e86013,,released,Fluorouracil,1,2020-10-08T14:45:50.496219-05:00,Chemotherapy,,
HCM-BROD-0475-C16,2ae5f389-df9b-46d8-8234-193bc40fe742,feab693d-b0cb-4bda-8956-eb4d28ee4e54,,Adjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0475-C16_treatment8,9ab03115-f3cd-4b42-ac84-5a480c1fe3c3,,released,,0,2020-10-08T14:45:50.496219-05:00,"Radiation Therapy, NOS",Residual Disease,
HCM-BROD-0475-C16,2ae5f389-df9b-46d8-8234-193bc40fe742,feab693d-b0cb-4bda-8956-eb4d28ee4e54,,Neoadjuvant,17.0,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0475-C16_treatment2,b9699a54-a5c3-477e-b41a-219e200b9b85,,released,Docetaxel,1,2020-10-08T14:45:50.496219-05:00,Chemotherapy,,
HCM-BROD-0475-C16,2ae5f389-df9b-46d8-8234-193bc40fe742,feab693d-b0cb-4bda-8956-eb4d28ee4e54,,Adjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0475-C16_treatment5,f5a5c4e8-3341-4f91-b66e-14bf8cc85242,,released,,0,2020-10-08T14:45:50.496219-05:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-BROD-0411-C25,2b1c768d-fbc5-4956-b834-dff3b3559e75,d02eb1ee-62f2-49af-bade-15e75745bf3b,,Adjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0411-C25_treatment2,1d0b2679-7616-4ec5-b00d-35770ffa2e22,,released,,0,2020-09-27T11:30:21.442104-05:00,Chemotherapy,Residual Disease,
HCM-BROD-0411-C25,2b1c768d-fbc5-4956-b834-dff3b3559e75,d02eb1ee-62f2-49af-bade-15e75745bf3b,,Adjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0411-C25_treatment3,20f5a531-09f6-4c56-a540-3706f74ed835,,released,,0,2020-09-27T11:30:21.442104-05:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-BROD-0411-C25,2b1c768d-fbc5-4956-b834-dff3b3559e75,d02eb1ee-62f2-49af-bade-15e75745bf3b,,Adjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0411-C25_treatment6,3859eec1-6efa-4022-b7d6-d715ae08c2c2,,released,,0,2020-09-27T11:30:21.442104-05:00,"Radiation Therapy, NOS",Residual Disease,
HCM-BROD-0411-C25,2b1c768d-fbc5-4956-b834-dff3b3559e75,d02eb1ee-62f2-49af-bade-15e75745bf3b,,Neoadjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0411-C25_treatment,8b7c35fa-bcf7-4404-a7f4-dbafacaa92b5,,released,,0,2020-09-27T11:30:21.442104-05:00,,,
HCM-BROD-0411-C25,2b1c768d-fbc5-4956-b834-dff3b3559e75,d02eb1ee-62f2-49af-bade-15e75745bf3b,,,,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0411-C25_treatment4,b0cc1a82-d08a-4fa4-b5bb-7bb672708079,,released,,0,2020-09-27T11:30:21.442104-05:00,"Surgery, NOS",Initial Diagnosis,
HCM-BROD-0411-C25,2b1c768d-fbc5-4956-b834-dff3b3559e75,d02eb1ee-62f2-49af-bade-15e75745bf3b,,Adjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0411-C25_treatment5,bda36d22-9ffe-43c9-8974-b035763d074e,,released,,0,2020-09-27T11:30:21.442104-05:00,Targeted Molecular Therapy,Residual Disease,
HCM-BROD-0458-C15,2b746913-bcba-4374-a6a0-0350ff814041,684fc7e4-8839-4b68-a812-6d2524947940,,Adjuvant,,2021-07-12T12:25:55.528644-05:00,HCM-BROD-0458-C15_treatment6,6a064d60-7213-44e5-85aa-4ed9762de823,,released,,0,2020-09-27T11:40:20.063316-05:00,"Radiation Therapy, NOS",Residual Disease,
HCM-BROD-0458-C15,2b746913-bcba-4374-a6a0-0350ff814041,684fc7e4-8839-4b68-a812-6d2524947940,,,249.0,2023-02-27T12:28:48.906509-06:00,HCM-BROD-0458-C15_treatment4,6e043851-1f67-44c0-b9c1-d2b9a49ef055,,released,,1,2020-09-27T11:40:20.063316-05:00,"Surgery, NOS",Initial Diagnosis,
HCM-BROD-0458-C15,2b746913-bcba-4374-a6a0-0350ff814041,684fc7e4-8839-4b68-a812-6d2524947940,,Adjuvant,,2021-07-12T12:25:55.528644-05:00,HCM-BROD-0458-C15_treatment3,8a5ddc62-a77e-4857-918e-b074e1996a0d,,released,,0,2020-09-27T11:40:20.063316-05:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-BROD-0458-C15,2b746913-bcba-4374-a6a0-0350ff814041,684fc7e4-8839-4b68-a812-6d2524947940,,Neoadjuvant,,2021-07-12T12:25:55.528644-05:00,HCM-BROD-0458-C15_treatment,cf4e8b35-b8e6-4611-aefe-ccea7cd817b4,,released,,0,2020-09-27T11:40:20.063316-05:00,,,
HCM-BROD-0458-C15,2b746913-bcba-4374-a6a0-0350ff814041,684fc7e4-8839-4b68-a812-6d2524947940,,Adjuvant,,2021-07-12T12:25:55.528644-05:00,HCM-BROD-0458-C15_treatment5,d5695b84-7ff9-4a79-b435-727af5d6f462,,released,,0,2020-09-27T11:40:20.063316-05:00,Targeted Molecular Therapy,Residual Disease,
HCM-BROD-0458-C15,2b746913-bcba-4374-a6a0-0350ff814041,684fc7e4-8839-4b68-a812-6d2524947940,,Adjuvant,,2021-07-12T12:25:55.528644-05:00,HCM-BROD-0458-C15_treatment2,d710ef67-a5b6-4b81-b1ab-97cc03ca37ba,,released,,0,2020-09-27T11:40:20.063316-05:00,Chemotherapy,Residual Disease,
HCM-CSHL-1269-C18,2b7832fe-682f-4bca-97ec-5f7bf6070e5f,7fadc2dd-2f87-4f96-ab6c-ea3062fabe0d,,Adjuvant,1711.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-1269-C18_treatment20,02295665-51cc-433f-aad2-0c7db0237d01,Treatment Ongoing,released,Leucovorin Calcium,1,2021-12-23T08:44:59.608138-06:00,Chemotherapy,Residual Disease,
HCM-CSHL-1269-C18,2b7832fe-682f-4bca-97ec-5f7bf6070e5f,7fadc2dd-2f87-4f96-ab6c-ea3062fabe0d,,Adjuvant,1711.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-1269-C18_treatment22,04be71c2-9021-40e3-8314-8f4da693b73e,Treatment Ongoing,released,Oxaliplatin,1,2021-12-23T08:44:59.608138-06:00,Chemotherapy,Residual Disease,
HCM-CSHL-1269-C18,2b7832fe-682f-4bca-97ec-5f7bf6070e5f,7fadc2dd-2f87-4f96-ab6c-ea3062fabe0d,939.0,Adjuvant,817.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-1269-C18_treatment10,0a6a7fb9-4199-41fa-949e-3cb585d0d8aa,,released,Bevacizumab,1,2021-12-23T08:44:59.608138-06:00,Chemotherapy,Residual Disease,
HCM-CSHL-1269-C18,2b7832fe-682f-4bca-97ec-5f7bf6070e5f,7fadc2dd-2f87-4f96-ab6c-ea3062fabe0d,,Adjuvant,1711.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-1269-C18_treatment21,10722166-de7e-4a16-94c2-e5a093197586,Treatment Ongoing,released,Fluorouracil,1,2021-12-23T08:44:59.608138-06:00,Chemotherapy,Residual Disease,
HCM-CSHL-1269-C18,2b7832fe-682f-4bca-97ec-5f7bf6070e5f,7fadc2dd-2f87-4f96-ab6c-ea3062fabe0d,209.0,Adjuvant,26.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-1269-C18_treatment3,25021b27-39a5-4fd8-8c44-3f8962f2adeb,,released,Bevacizumab,1,2021-12-23T08:44:59.608138-06:00,Chemotherapy,Residual Disease,
HCM-CSHL-1269-C18,2b7832fe-682f-4bca-97ec-5f7bf6070e5f,7fadc2dd-2f87-4f96-ab6c-ea3062fabe0d,209.0,Adjuvant,26.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-1269-C18_treatment6,25841336-e7c4-4a31-bded-64b6b54895b2,,released,,1,2021-12-23T08:44:59.608138-06:00,Chemotherapy,Residual Disease,FOLFIRI
HCM-CSHL-1269-C18,2b7832fe-682f-4bca-97ec-5f7bf6070e5f,7fadc2dd-2f87-4f96-ab6c-ea3062fabe0d,209.0,Adjuvant,26.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-1269-C18_treatment2,2a120c80-77be-432d-8d9d-e1f3252e41ef,,released,Irinotecan,1,2021-12-23T08:44:59.608138-06:00,Chemotherapy,Residual Disease,
HCM-CSHL-1269-C18,2b7832fe-682f-4bca-97ec-5f7bf6070e5f,7fadc2dd-2f87-4f96-ab6c-ea3062fabe0d,,Adjuvant,939.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-1269-C18_treatment14,2df86da6-255d-4dcf-9339-cd934958a77e,,released,Capecitabine,1,2021-12-23T08:44:59.608138-06:00,Chemotherapy,Residual Disease,
HCM-CSHL-1269-C18,2b7832fe-682f-4bca-97ec-5f7bf6070e5f,7fadc2dd-2f87-4f96-ab6c-ea3062fabe0d,209.0,Adjuvant,26.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-1269-C18_treatment5,360adeaf-cc7e-4cda-8c90-58512903b760,,released,Fluorouracil,1,2021-12-23T08:44:59.608138-06:00,Chemotherapy,Residual Disease,
HCM-CSHL-1269-C18,2b7832fe-682f-4bca-97ec-5f7bf6070e5f,7fadc2dd-2f87-4f96-ab6c-ea3062fabe0d,786.0,Adjuvant,209.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-1269-C18_treatment7,383e51fd-85e2-43a2-a835-99b17b4d0646,,released,Capecitabine,1,2021-12-23T08:44:59.608138-06:00,Chemotherapy,Residual Disease,
HCM-CSHL-1269-C18,2b7832fe-682f-4bca-97ec-5f7bf6070e5f,7fadc2dd-2f87-4f96-ab6c-ea3062fabe0d,,Adjuvant,1442.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-1269-C18_treatment19,3b756879-1d75-450e-bcf2-ad2f01ccfe61,,released,,1,2021-12-23T08:44:59.608138-06:00,Chemotherapy,Residual Disease,FOLFIRI
HCM-CSHL-1269-C18,2b7832fe-682f-4bca-97ec-5f7bf6070e5f,7fadc2dd-2f87-4f96-ab6c-ea3062fabe0d,,Adjuvant,421.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-1269-C18_treatment27,3ee8ed70-4a5a-4d68-9210-b7e9186d452c,,released,,1,2021-12-23T08:44:59.608138-06:00,"Radiation, Stereotactic/Gamma Knife/SRS",Residual Disease,
HCM-CSHL-1269-C18,2b7832fe-682f-4bca-97ec-5f7bf6070e5f,7fadc2dd-2f87-4f96-ab6c-ea3062fabe0d,,Adjuvant,1442.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-1269-C18_treatment18,50d64641-d8bf-47e2-8374-e1ae5717b8ee,,released,Bevacizumab,1,2021-12-23T08:44:59.608138-06:00,Chemotherapy,Residual Disease,
HCM-CSHL-1269-C18,2b7832fe-682f-4bca-97ec-5f7bf6070e5f,7fadc2dd-2f87-4f96-ab6c-ea3062fabe0d,939.0,Adjuvant,817.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-1269-C18_treatment12,7156489c-c770-428b-a3ab-5fa4507bfc78,,released,Fluorouracil,1,2021-12-23T08:44:59.608138-06:00,Chemotherapy,Residual Disease,
HCM-CSHL-1269-C18,2b7832fe-682f-4bca-97ec-5f7bf6070e5f,7fadc2dd-2f87-4f96-ab6c-ea3062fabe0d,,,1250.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-1269-C18_treatment25,763d69b1-1b8f-48ca-9e08-a1a55b661d56,,released,,1,2021-12-23T08:44:59.608138-06:00,"Surgery, NOS",Initial Diagnosis,
HCM-CSHL-1269-C18,2b7832fe-682f-4bca-97ec-5f7bf6070e5f,7fadc2dd-2f87-4f96-ab6c-ea3062fabe0d,,Neoadjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-1269-C18_treatment,7b2822b0-cc36-4c1a-a481-c8b2036259c2,,released,,0,2021-12-23T08:44:59.608138-06:00,,,
HCM-CSHL-1269-C18,2b7832fe-682f-4bca-97ec-5f7bf6070e5f,7fadc2dd-2f87-4f96-ab6c-ea3062fabe0d,939.0,Adjuvant,817.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-1269-C18_treatment13,80f611eb-ebcf-4468-8c2b-cfc932c704cb,,released,,1,2021-12-23T08:44:59.608138-06:00,Chemotherapy,Residual Disease,FOLFIRI
HCM-CSHL-1269-C18,2b7832fe-682f-4bca-97ec-5f7bf6070e5f,7fadc2dd-2f87-4f96-ab6c-ea3062fabe0d,939.0,Adjuvant,817.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-1269-C18_treatment11,91bd7777-91ff-4f9d-92b2-b4c4a3b23963,,released,Leucovorin Calcium,1,2021-12-23T08:44:59.608138-06:00,Chemotherapy,Residual Disease,
HCM-CSHL-1269-C18,2b7832fe-682f-4bca-97ec-5f7bf6070e5f,7fadc2dd-2f87-4f96-ab6c-ea3062fabe0d,,Adjuvant,1711.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-1269-C18_treatment23,9402d615-3030-428d-9e1e-996109f086e9,Treatment Ongoing,released,,1,2021-12-23T08:44:59.608138-06:00,Chemotherapy,Residual Disease,FOLFOX
HCM-CSHL-1269-C18,2b7832fe-682f-4bca-97ec-5f7bf6070e5f,7fadc2dd-2f87-4f96-ab6c-ea3062fabe0d,939.0,Adjuvant,817.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-1269-C18_treatment9,9f3847f9-5ca0-428d-9c3b-95d122095b7a,,released,Irinotecan,1,2021-12-23T08:44:59.608138-06:00,Chemotherapy,Residual Disease,
HCM-CSHL-1269-C18,2b7832fe-682f-4bca-97ec-5f7bf6070e5f,7fadc2dd-2f87-4f96-ab6c-ea3062fabe0d,1442.0,Adjuvant,1275.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-1269-C18_treatment24,a6bd5217-d98c-47cc-b1e2-f3ede8419081,,released,Bevacizumab,1,2021-12-23T08:44:59.608138-06:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-CSHL-1269-C18,2b7832fe-682f-4bca-97ec-5f7bf6070e5f,7fadc2dd-2f87-4f96-ab6c-ea3062fabe0d,,Adjuvant,1442.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-1269-C18_treatment16,b16c116a-a2e1-43ac-9044-d9740a161f49,,released,Fluorouracil,1,2021-12-23T08:44:59.608138-06:00,Chemotherapy,Residual Disease,
HCM-CSHL-1269-C18,2b7832fe-682f-4bca-97ec-5f7bf6070e5f,7fadc2dd-2f87-4f96-ab6c-ea3062fabe0d,,Adjuvant,1442.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-1269-C18_treatment17,b8119dda-43ba-41c8-b899-04e70b73fb73,,released,Irinotecan,1,2021-12-23T08:44:59.608138-06:00,Chemotherapy,Residual Disease,
HCM-CSHL-1269-C18,2b7832fe-682f-4bca-97ec-5f7bf6070e5f,7fadc2dd-2f87-4f96-ab6c-ea3062fabe0d,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-1269-C18_treatment26,d02e463e-579e-4337-aca9-d439a01a38d8,,released,,0,2021-12-23T08:44:59.608138-06:00,Targeted Molecular Therapy,Residual Disease,
HCM-CSHL-1269-C18,2b7832fe-682f-4bca-97ec-5f7bf6070e5f,7fadc2dd-2f87-4f96-ab6c-ea3062fabe0d,,Adjuvant,1442.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-1269-C18_treatment15,eb1e6bb0-9787-4186-8570-c246d8550180,,released,Leucovorin Calcium,1,2021-12-23T08:44:59.608138-06:00,Chemotherapy,Residual Disease,
HCM-CSHL-1269-C18,2b7832fe-682f-4bca-97ec-5f7bf6070e5f,7fadc2dd-2f87-4f96-ab6c-ea3062fabe0d,209.0,Adjuvant,26.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-1269-C18_treatment4,f6f818c7-9d18-42e6-ae79-df1a234ced18,,released,Leucovorin Calcium,1,2021-12-23T08:44:59.608138-06:00,Chemotherapy,Residual Disease,
HCM-CSHL-1269-C18,2b7832fe-682f-4bca-97ec-5f7bf6070e5f,7fadc2dd-2f87-4f96-ab6c-ea3062fabe0d,786.0,Adjuvant,209.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-1269-C18_treatment8,f759af9c-1a77-43c4-902b-19c80c89725c,,released,Bevacizumab,1,2021-12-23T08:44:59.608138-06:00,Chemotherapy,Residual Disease,
HCM-CSHL-1269-C18,2b7832fe-682f-4bca-97ec-5f7bf6070e5f,d673ee45-40ff-4fec-b1b6-df1e0ead878d,1548.0,Maintenance Therapy,121.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-1269-C18_treatment28,0e9c9600-e41b-4669-9845-1b7bbec14395,Stable Disease,released,Irinotecan,1,2021-12-23T08:44:59.608138-06:00,,,
HCM-CSHL-1269-C18,2b7832fe-682f-4bca-97ec-5f7bf6070e5f,d673ee45-40ff-4fec-b1b6-df1e0ead878d,1548.0,Maintenance Therapy,121.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-1269-C18_treatment29,5a6e69e2-6066-4920-b397-ef5410bc049b,Stable Disease,released,Bevacizumab,1,2021-12-23T08:44:59.608138-06:00,,,
HCM-CSHL-1269-C18,2b7832fe-682f-4bca-97ec-5f7bf6070e5f,d673ee45-40ff-4fec-b1b6-df1e0ead878d,1548.0,Maintenance Therapy,121.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-1269-C18_treatment30,8afdcc5d-0079-456a-8303-52d0fc020d39,Stable Disease,released,Leucovorin Calcium,1,2021-12-23T08:44:59.608138-06:00,,,
HCM-CSHL-1269-C18,2b7832fe-682f-4bca-97ec-5f7bf6070e5f,d673ee45-40ff-4fec-b1b6-df1e0ead878d,1548.0,Maintenance Therapy,121.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-1269-C18_treatment31,d3cc08c7-e35f-44ba-bfbd-b8ee240b9ac9,Stable Disease,released,Fluorouracil,1,2021-12-23T08:44:59.608138-06:00,,,
HCM-CSHL-1269-C18,2b7832fe-682f-4bca-97ec-5f7bf6070e5f,d673ee45-40ff-4fec-b1b6-df1e0ead878d,1548.0,Maintenance Therapy,121.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-1269-C18_treatment32,e92ba4c3-b526-4283-b658-03822825090d,Stable Disease,released,,1,2021-12-23T08:44:59.608138-06:00,,,FOLFIRI
HCM-EXPT-1248-C15,2bc89b05-ae9e-4c27-bfd6-e5c4c4845ff9,c8b210e5-3e24-40d7-8c64-cff5c9f20342,,Neoadjuvant,110.0,2025-10-08T12:39:37.798161-05:00,HCM-EXPT-1248-C15_treatment3,14dccc98-3367-4f89-8a0e-412f6d37e7db,,released,Docetaxel,1,2023-02-24T13:47:25.186053-06:00,Chemotherapy,,
HCM-EXPT-1248-C15,2bc89b05-ae9e-4c27-bfd6-e5c4c4845ff9,c8b210e5-3e24-40d7-8c64-cff5c9f20342,,Neoadjuvant,110.0,2025-10-08T12:39:37.798161-05:00,HCM-EXPT-1248-C15_treatment,8910c4f0-88d4-4e38-b704-feacca10d9bf,,released,Leucovorin,1,2023-02-24T13:47:25.186053-06:00,Chemotherapy,,
HCM-EXPT-1248-C15,2bc89b05-ae9e-4c27-bfd6-e5c4c4845ff9,c8b210e5-3e24-40d7-8c64-cff5c9f20342,,Neoadjuvant,110.0,2025-10-08T12:39:37.798161-05:00,HCM-EXPT-1248-C15_treatment4,f2396c0a-166c-4560-82fe-184b67e232fc,,released,Oxaliplatin,1,2023-02-24T13:47:25.186053-06:00,Chemotherapy,,
HCM-EXPT-1248-C15,2bc89b05-ae9e-4c27-bfd6-e5c4c4845ff9,c8b210e5-3e24-40d7-8c64-cff5c9f20342,,Neoadjuvant,110.0,2025-10-08T12:39:37.798161-05:00,HCM-EXPT-1248-C15_treatment2,fef562d2-31a6-4820-aee8-c778ab32cc8f,,released,Fluorouracil,1,2023-02-24T13:47:25.186053-06:00,Chemotherapy,,
HCM-EXPT-0890-C25,2bfe9b75-69d3-4794-a622-3e7244a97489,a5ef2125-cdce-4a09-bba7-a6c3f2916a3e,,Neoadjuvant,,2025-10-08T12:36:32.654639-05:00,HCM-EXPT-0890-C25_treatment,57dd18d4-685b-4888-9fb7-00ad26552c4f,,released,,0,2021-12-21T14:42:21.868595-06:00,,,
HCM-BROD-0649-C49,2c0409da-a354-4e40-bb7c-442f454aca8b,4a43f458-e49e-4290-adfa-2f91f029b8b8,1170.0,Maintenance Therapy,214.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0649-C49_treatment8,94653a66-9e75-4d8c-a341-f56caa63be0c,Progressive Disease,released,Rivaroxaban,1,2021-12-21T13:42:24.455337-06:00,,,
HCM-BROD-0649-C49,2c0409da-a354-4e40-bb7c-442f454aca8b,e1d7e626-f499-4022-afbd-33dcf7bf6e12,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0649-C49_treatment6,3232bba4-6d69-419b-b508-11ad53886362,,released,,0,2021-12-21T13:42:24.455337-06:00,Targeted Molecular Therapy,Residual Disease,
HCM-BROD-0649-C49,2c0409da-a354-4e40-bb7c-442f454aca8b,e1d7e626-f499-4022-afbd-33dcf7bf6e12,1294.0,Adjuvant,1247.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0649-C49_treatment2,439f75f6-7973-4883-b635-02599f6ff80b,,released,Doxorubicin Hydrochloride,1,2021-12-21T13:42:24.455337-06:00,Chemotherapy,Residual Disease,
HCM-BROD-0649-C49,2c0409da-a354-4e40-bb7c-442f454aca8b,e1d7e626-f499-4022-afbd-33dcf7bf6e12,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0649-C49_treatment7,5b10fe59-066d-471b-84fe-af81a2181345,,released,,0,2021-12-21T13:42:24.455337-06:00,"Radiation Therapy, NOS",Residual Disease,
HCM-BROD-0649-C49,2c0409da-a354-4e40-bb7c-442f454aca8b,e1d7e626-f499-4022-afbd-33dcf7bf6e12,,Neoadjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0649-C49_treatment,ab1a9049-beaa-4422-aaa7-2bfc05e40ef3,,released,,0,2021-12-21T13:42:24.455337-06:00,,,
HCM-BROD-0649-C49,2c0409da-a354-4e40-bb7c-442f454aca8b,e1d7e626-f499-4022-afbd-33dcf7bf6e12,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0649-C49_treatment3,b8a502ef-bf79-4f3d-bd85-ed91d207b772,,released,,0,2021-12-21T13:42:24.455337-06:00,Hormone Therapy,Residual Disease,
HCM-BROD-0649-C49,2c0409da-a354-4e40-bb7c-442f454aca8b,e1d7e626-f499-4022-afbd-33dcf7bf6e12,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0649-C49_treatment4,fc120df0-139a-4b4c-a839-5178ae6a63ff,,released,,0,2021-12-21T13:42:24.455337-06:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-BROD-0209-C71,2c636721-d11e-463e-8f77-a23501dd3d60,9e6f18f6-e306-4366-8fb8-a6d2b346b0dd,,Adjuvant,,2021-03-03T15:15:08.075155-06:00,HCM-BROD-0209-C71_treatment6,042c502e-f162-48f2-9d71-99b8e1644bd1,,released,,0,2020-02-27T12:35:20.972329-06:00,"Radiation Therapy, NOS",Residual Disease,
HCM-BROD-0209-C71,2c636721-d11e-463e-8f77-a23501dd3d60,9e6f18f6-e306-4366-8fb8-a6d2b346b0dd,693.0,Adjuvant,648.0,2021-03-03T15:15:08.075155-06:00,HCM-BROD-0209-C71_treatment5,5cccb008-6054-4c38-8218-ff99f8a7c232,,released,Bevacizumab,1,2020-02-27T12:35:20.972329-06:00,Targeted Molecular Therapy,Residual Disease,
HCM-BROD-0209-C71,2c636721-d11e-463e-8f77-a23501dd3d60,9e6f18f6-e306-4366-8fb8-a6d2b346b0dd,,Adjuvant,,2021-03-03T15:15:08.075155-06:00,HCM-BROD-0209-C71_treatment3,785c5d69-0d88-4cd3-954d-fb3b1692009e,,released,,0,2020-02-27T12:35:20.972329-06:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-BROD-0209-C71,2c636721-d11e-463e-8f77-a23501dd3d60,9e6f18f6-e306-4366-8fb8-a6d2b346b0dd,,,-28.0,2023-03-13T13:32:34.313354-05:00,HCM-BROD-0209-C71_treatment4,9158a3ed-ee74-4ae1-9960-524a6e7ef513,,released,,1,2020-02-27T12:35:20.972329-06:00,"Surgery, NOS",Initial Diagnosis,
HCM-BROD-0209-C71,2c636721-d11e-463e-8f77-a23501dd3d60,9e6f18f6-e306-4366-8fb8-a6d2b346b0dd,,Adjuvant,,2021-03-03T15:15:08.075155-06:00,HCM-BROD-0209-C71_treatment2,993b55bf-5067-4ff3-8ea8-3f1bf2914993,,released,,0,2020-02-27T12:35:20.972329-06:00,Chemotherapy,Residual Disease,
HCM-BROD-0209-C71,2c636721-d11e-463e-8f77-a23501dd3d60,9e6f18f6-e306-4366-8fb8-a6d2b346b0dd,,Neoadjuvant,,2021-03-03T15:15:08.075155-06:00,HCM-BROD-0209-C71_treatment,cc8a5a8d-7f1d-47cc-a89d-65c8527bc496,,released,,0,2019-04-04T15:02:40.743808-05:00,,,
HCM-CSHL-0900-C54,2cd10d26-8dc7-4e0c-a7f8-9cc0dee9543f,9174a136-2577-46d6-a623-d62ae82f4b32,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0900-C54_treatment7,07c420f9-929f-4158-a64c-2efe0f32a785,,released,,0,2021-12-21T14:38:22.483956-06:00,Targeted Molecular Therapy,Residual Disease,
HCM-CSHL-0900-C54,2cd10d26-8dc7-4e0c-a7f8-9cc0dee9543f,9174a136-2577-46d6-a623-d62ae82f4b32,,,0.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0900-C54_treatment6,0ebb2811-3322-4461-8f90-efc1948bca27,,released,,1,2021-12-21T14:38:22.483956-06:00,"Surgery, NOS",Initial Diagnosis,
HCM-CSHL-0900-C54,2cd10d26-8dc7-4e0c-a7f8-9cc0dee9543f,9174a136-2577-46d6-a623-d62ae82f4b32,,Neoadjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0900-C54_treatment,1eee8081-c483-470f-a1ee-3aad63a1061a,,released,,0,2021-12-21T14:38:22.483956-06:00,,,
HCM-CSHL-0900-C54,2cd10d26-8dc7-4e0c-a7f8-9cc0dee9543f,9174a136-2577-46d6-a623-d62ae82f4b32,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0900-C54_treatment4,3ff3ef17-42b5-4787-abaa-ddf21ef27eb8,,released,,0,2021-12-21T14:38:22.483956-06:00,Hormone Therapy,Residual Disease,
HCM-CSHL-0900-C54,2cd10d26-8dc7-4e0c-a7f8-9cc0dee9543f,9174a136-2577-46d6-a623-d62ae82f4b32,152.0,Adjuvant,47.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0900-C54_treatment2,8c5a570b-d413-467a-beaf-e905ba12e1f3,,released,Carboplatin,1,2021-12-21T14:38:22.483956-06:00,Chemotherapy,Residual Disease,
HCM-CSHL-0900-C54,2cd10d26-8dc7-4e0c-a7f8-9cc0dee9543f,9174a136-2577-46d6-a623-d62ae82f4b32,152.0,Adjuvant,47.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0900-C54_treatment3,931a14bf-53ef-4cc1-a376-9ecd160e2c68,,released,Paclitaxel,1,2021-12-21T14:38:22.483956-06:00,Chemotherapy,Residual Disease,
HCM-CSHL-0900-C54,2cd10d26-8dc7-4e0c-a7f8-9cc0dee9543f,9174a136-2577-46d6-a623-d62ae82f4b32,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0900-C54_treatment5,e492891a-494e-44f3-abb4-36247842c892,,released,,0,2021-12-21T14:38:22.483956-06:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-CSHL-0900-C54,2cd10d26-8dc7-4e0c-a7f8-9cc0dee9543f,9174a136-2577-46d6-a623-d62ae82f4b32,227.0,Adjuvant,186.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0900-C54_treatment8,f0d98d24-c357-426d-a047-761eedb4ce44,,released,,1,2021-12-21T14:38:22.483956-06:00,"Radiation, Intensity-Modulated Radiotherapy",Residual Disease,
HCM-SANG-1307-C25,2d0b1976-6a09-4623-a32c-eed22e944dbf,cb33e4d8-6aad-4545-92e1-8769c4a81bb5,,Neoadjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-SANG-1307-C25_treatment,8344103a-7f50-4a62-acdc-7e0b248e55ea,,released,,0,2023-02-27T11:19:20.846732-06:00,,,
HCM-CSHL-0516-C56,2df05263-7905-463f-9a78-3ece600174e5,11571bf0-82f3-4b02-b096-4572b9609eb0,,Adjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0516-C56_treatment4,0832b944-87be-4088-b70e-5ee9eec77aa2,,released,,0,2020-10-08T13:36:23.961006-05:00,"Radiation Therapy, NOS",Residual Disease,
HCM-CSHL-0516-C56,2df05263-7905-463f-9a78-3ece600174e5,11571bf0-82f3-4b02-b096-4572b9609eb0,,Neoadjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0516-C56_treatment,a6ac5cfd-8572-4e43-82df-14544d2f5cba,,released,,0,2020-10-08T13:36:23.961006-05:00,,,
HCM-CSHL-0516-C56,2df05263-7905-463f-9a78-3ece600174e5,11571bf0-82f3-4b02-b096-4572b9609eb0,,,70.0,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0516-C56_treatment2,bff41cd3-309e-4e50-aae1-2942a79d40c4,,released,,1,2020-10-08T13:36:23.961006-05:00,"Surgery, NOS",Initial Diagnosis,
HCM-SANG-1081-C20,2e54fb22-3161-4495-acf7-2a60ceda8fa5,1fc7dfba-b825-45a2-8cae-2aaf79d5e31a,,Neoadjuvant,446.0,2025-03-31T16:34:59.906497-05:00,HCM-SANG-1081-C20_treatment3,3d07bf29-ba5e-49ee-bd43-e62ec3dbb160,,released,,1,2023-02-27T12:08:42.282291-06:00,"Radiation, 2D Conventional",,
HCM-SANG-1081-C20,2e54fb22-3161-4495-acf7-2a60ceda8fa5,1fc7dfba-b825-45a2-8cae-2aaf79d5e31a,,Neoadjuvant,446.0,2025-03-31T16:34:59.906497-05:00,HCM-SANG-1081-C20_treatment2,66142017-0d2f-469f-a429-68239b924d2f,,released,Oxaliplatin,1,2023-02-27T12:08:42.282291-06:00,Chemotherapy,,
HCM-SANG-1081-C20,2e54fb22-3161-4495-acf7-2a60ceda8fa5,1fc7dfba-b825-45a2-8cae-2aaf79d5e31a,,Neoadjuvant,446.0,2025-03-31T16:34:59.906497-05:00,HCM-SANG-1081-C20_treatment,d5047d17-7643-4da0-ad64-72892283a7a2,,released,Capecitabine,1,2023-02-27T12:08:42.282291-06:00,Chemotherapy,,
HCM-SANG-0529-C18,2ecaa554-37da-43ee-96be-66f274789929,3ee43486-d593-4df5-b31d-aecae51b207d,,Neoadjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-SANG-0529-C18_treatment,324c6b96-51dc-4ba0-b6fe-e3ce7b4bfad9,,released,,0,2021-12-21T15:13:45.953350-06:00,,,
HCM-EXPT-1196-C18,2f2f82b6-f842-46d6-b381-cd315e34f122,6683b189-4061-43cd-8d14-1bab445a7686,,Neoadjuvant,,2025-10-08T12:38:51.189053-05:00,HCM-EXPT-1196-C18_treatment,ff077fc0-9538-41ce-8ef9-ca5aab07700a,,released,,0,2022-03-09T19:42:07.422472-06:00,,,
HCM-EXPT-0935-C50,2f4e5472-9156-49ee-b663-baa481b30130,3603d3c5-4cd6-4c79-929e-bb9bf6f514e2,,Neoadjuvant,,2025-10-08T12:36:57.024699-05:00,HCM-EXPT-0935-C50_treatment,51d5a309-64c6-43e9-b3d9-6df0aa79a6c7,,released,,0,2021-12-21T14:46:21.143319-06:00,,,
HCM-BROD-0444-C43,2f644ec3-923d-41b0-8ab2-de0f74fe2bd8,89182e66-f1ad-43dc-811c-8a9aef97ff55,,,-20.0,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0444-C43_treatment5,1cf18dd9-6262-4788-b990-7c8891f1dcc2,,released,,1,2020-09-27T11:35:50.827695-05:00,"Surgery, NOS",Initial Diagnosis,
HCM-BROD-0444-C43,2f644ec3-923d-41b0-8ab2-de0f74fe2bd8,89182e66-f1ad-43dc-811c-8a9aef97ff55,,Adjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0444-C43_treatment6,52aad011-a5db-4872-be0c-07118e47dc8d,,released,,0,2020-09-27T11:35:50.827695-05:00,Targeted Molecular Therapy,Residual Disease,
HCM-BROD-0444-C43,2f644ec3-923d-41b0-8ab2-de0f74fe2bd8,89182e66-f1ad-43dc-811c-8a9aef97ff55,,Neoadjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0444-C43_treatment,6a296e7c-3224-451c-95af-d6304e9f6750,,released,,0,2020-09-27T11:35:50.827695-05:00,,,
HCM-BROD-0444-C43,2f644ec3-923d-41b0-8ab2-de0f74fe2bd8,89182e66-f1ad-43dc-811c-8a9aef97ff55,2446.0,Adjuvant,2442.0,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0444-C43_treatment7,b7ce3958-0f13-4243-bef3-f9270443c0e1,,released,,1,2020-09-27T11:35:50.827695-05:00,"Radiation, Stereotactic/Gamma Knife/SRS",Residual Disease,
HCM-BROD-0444-C43,2f644ec3-923d-41b0-8ab2-de0f74fe2bd8,89182e66-f1ad-43dc-811c-8a9aef97ff55,,Adjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0444-C43_treatment2,c13ae508-5cfd-4d7d-ab1f-3ab2abc75d06,,released,,0,2020-09-27T11:35:50.827695-05:00,Chemotherapy,Residual Disease,
HCM-BROD-0444-C43,2f644ec3-923d-41b0-8ab2-de0f74fe2bd8,89182e66-f1ad-43dc-811c-8a9aef97ff55,,Adjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0444-C43_treatment3,e0871738-729b-4713-a7b3-bab6da3590cc,,released,,0,2020-09-27T11:35:50.827695-05:00,Hormone Therapy,Residual Disease,
HCM-BROD-0444-C43,2f644ec3-923d-41b0-8ab2-de0f74fe2bd8,89182e66-f1ad-43dc-811c-8a9aef97ff55,2555.0,Adjuvant,2444.0,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0444-C43_treatment4,e15d7484-7b75-47ac-a370-1f7d3c696861,,released,Nivolumab,1,2020-09-27T11:35:50.827695-05:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-BROD-0444-C43,2f644ec3-923d-41b0-8ab2-de0f74fe2bd8,b2141d2c-847a-4dbb-abe2-cbfa5de6d08c,1245.0,Maintenance Therapy,1198.0,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0444-C43_treatment8,3aab6a47-2a1d-428a-bdaf-174652366397,Progressive Disease,released,Nivolumab,1,2020-09-27T11:35:50.827695-05:00,,,
HCM-BROD-0444-C43,2f644ec3-923d-41b0-8ab2-de0f74fe2bd8,b2141d2c-847a-4dbb-abe2-cbfa5de6d08c,1245.0,Maintenance Therapy,1198.0,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0444-C43_treatment9,e3dceea1-4da7-4b4f-a754-4588b3fd3c47,Progressive Disease,released,Ipilimumab,1,2020-09-27T11:35:50.827695-05:00,,,
HCM-BROD-0834-C43,2fe77db2-e5c5-49e8-87c0-ba82521c17c5,9992b928-ab2d-438f-80ad-9bdf33aee4eb,,Adjuvant,,2023-07-13T10:27:19.665852-05:00,HCM-BROD-0834-C43_treatment6,0ece948d-515e-4881-ba8c-4189819624e0,,released,,0,2021-12-21T13:54:43.690373-06:00,Targeted Molecular Therapy,Residual Disease,
HCM-BROD-0834-C43,2fe77db2-e5c5-49e8-87c0-ba82521c17c5,9992b928-ab2d-438f-80ad-9bdf33aee4eb,497.0,Adjuvant,119.0,2023-07-13T10:27:19.665852-05:00,HCM-BROD-0834-C43_treatment4,5f9590c8-6c0c-4ac3-92fe-9bd2f37401a5,Treatment Ongoing,released,Nivolumab,1,2021-12-21T13:54:43.690373-06:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-BROD-0834-C43,2fe77db2-e5c5-49e8-87c0-ba82521c17c5,9992b928-ab2d-438f-80ad-9bdf33aee4eb,,Adjuvant,,2023-07-13T10:27:19.665852-05:00,HCM-BROD-0834-C43_treatment2,6e658866-36e8-4469-998b-c7c22a8bbd2d,,released,,0,2021-12-21T13:54:43.690373-06:00,Chemotherapy,Residual Disease,
HCM-BROD-0834-C43,2fe77db2-e5c5-49e8-87c0-ba82521c17c5,9992b928-ab2d-438f-80ad-9bdf33aee4eb,,,0.0,2023-07-13T10:27:19.665852-05:00,HCM-BROD-0834-C43_treatment5,77d427e9-7761-43e9-a042-71264ee705d7,,released,,1,2021-12-21T13:54:43.690373-06:00,"Surgery, NOS",Initial Diagnosis,
HCM-BROD-0834-C43,2fe77db2-e5c5-49e8-87c0-ba82521c17c5,9992b928-ab2d-438f-80ad-9bdf33aee4eb,,Neoadjuvant,,2023-07-13T10:27:19.665852-05:00,HCM-BROD-0834-C43_treatment,88e5ebff-ccfe-4034-9a1b-97f39f75bb9f,,released,,0,2021-12-21T13:54:43.690373-06:00,,,
HCM-BROD-0834-C43,2fe77db2-e5c5-49e8-87c0-ba82521c17c5,9992b928-ab2d-438f-80ad-9bdf33aee4eb,,Adjuvant,,2023-07-13T10:27:19.665852-05:00,HCM-BROD-0834-C43_treatment7,d5380384-42c5-447d-b595-8b2acc8725b4,,released,,0,2021-12-21T13:54:43.690373-06:00,"Radiation Therapy, NOS",Residual Disease,
HCM-BROD-0834-C43,2fe77db2-e5c5-49e8-87c0-ba82521c17c5,9992b928-ab2d-438f-80ad-9bdf33aee4eb,,Adjuvant,,2023-07-13T10:27:19.665852-05:00,HCM-BROD-0834-C43_treatment3,fb1e81b7-274a-40c4-8e8e-4d606f5e7482,,released,,0,2021-12-21T13:54:43.690373-06:00,Hormone Therapy,Residual Disease,
HCM-BROD-0254-C49,300223b2-7479-4849-8de5-14b30c586c3a,2cc13d6e-5c91-4a3b-8753-0fe1ce141fdb,,Neoadjuvant,275.0,2021-07-12T12:25:55.528644-05:00,HCM-BROD-0254-C49_treatment,02291c51-5918-44e9-a7e9-4b46ab064d29,,released,Vinorelbine Tartrate,1,2020-06-15T13:32:11.417090-05:00,Chemotherapy,,
HCM-BROD-0254-C49,300223b2-7479-4849-8de5-14b30c586c3a,2cc13d6e-5c91-4a3b-8753-0fe1ce141fdb,487.0,Adjuvant,440.0,2021-07-12T12:25:55.528644-05:00,HCM-BROD-0254-C49_treatment12,05953126-8531-4df4-909a-a86afb9aef67,,released,Docetaxel,1,2020-06-15T13:32:11.417090-05:00,Chemotherapy,Residual Disease,
HCM-BROD-0254-C49,300223b2-7479-4849-8de5-14b30c586c3a,2cc13d6e-5c91-4a3b-8753-0fe1ce141fdb,,Neoadjuvant,275.0,2021-07-12T12:25:55.528644-05:00,HCM-BROD-0254-C49_treatment8,19726d31-00ae-463a-aad9-6f571eeed918,,released,Docetaxel,1,2020-06-15T13:32:11.417090-05:00,Chemotherapy,,
HCM-BROD-0254-C49,300223b2-7479-4849-8de5-14b30c586c3a,2cc13d6e-5c91-4a3b-8753-0fe1ce141fdb,,Neoadjuvant,275.0,2021-07-12T12:25:55.528644-05:00,HCM-BROD-0254-C49_treatment4,22535d9e-a865-49f9-80e7-ab0358349cff,,released,Irinotecan,1,2020-06-15T13:32:11.417090-05:00,Chemotherapy,,
HCM-BROD-0254-C49,300223b2-7479-4849-8de5-14b30c586c3a,2cc13d6e-5c91-4a3b-8753-0fe1ce141fdb,,Neoadjuvant,275.0,2021-07-12T12:25:55.528644-05:00,HCM-BROD-0254-C49_treatment6,369aedc4-54eb-4933-9046-6026a8d4f9d4,,released,,1,2020-06-15T13:32:11.417090-05:00,Chemotherapy,,VAC/VI
HCM-BROD-0254-C49,300223b2-7479-4849-8de5-14b30c586c3a,2cc13d6e-5c91-4a3b-8753-0fe1ce141fdb,441.0,Adjuvant,440.0,2021-07-12T12:25:55.528644-05:00,HCM-BROD-0254-C49_treatment16,5d57463b-8a7b-4cc9-9045-46c24a5fe2e5,,released,,1,2020-10-09T15:11:23.023062-05:00,"Radiation Therapy, NOS",Residual Disease,
HCM-BROD-0254-C49,300223b2-7479-4849-8de5-14b30c586c3a,2cc13d6e-5c91-4a3b-8753-0fe1ce141fdb,487.0,Adjuvant,440.0,2021-07-12T12:25:55.528644-05:00,HCM-BROD-0254-C49_treatment11,6df29d9b-1179-4995-9490-88c83e606cb2,,released,Gemcitabine,1,2020-06-15T13:32:11.417090-05:00,Chemotherapy,Residual Disease,
HCM-BROD-0254-C49,300223b2-7479-4849-8de5-14b30c586c3a,2cc13d6e-5c91-4a3b-8753-0fe1ce141fdb,,Adjuvant,,2021-07-12T12:25:55.528644-05:00,HCM-BROD-0254-C49_treatment15,94a98847-d4c2-42d8-96df-378bb4e8acde,,released,,0,2020-10-09T15:11:23.023062-05:00,Targeted Molecular Therapy,Residual Disease,
HCM-BROD-0254-C49,300223b2-7479-4849-8de5-14b30c586c3a,2cc13d6e-5c91-4a3b-8753-0fe1ce141fdb,,Neoadjuvant,334.0,2021-07-12T12:25:55.528644-05:00,HCM-BROD-0254-C49_treatment10,991e6e19-661f-46b3-897e-950762d094bb,,released,Temsirolimus,1,2020-06-15T13:32:11.417090-05:00,Targeted Molecular Therapy,,
HCM-BROD-0254-C49,300223b2-7479-4849-8de5-14b30c586c3a,2cc13d6e-5c91-4a3b-8753-0fe1ce141fdb,,Adjuvant,,2021-07-12T12:25:55.528644-05:00,HCM-BROD-0254-C49_treatment13,bc02baaf-ccfc-4df1-a446-c398c3bbbb9e,,released,,0,2020-10-09T15:11:23.023062-05:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-BROD-0254-C49,300223b2-7479-4849-8de5-14b30c586c3a,2cc13d6e-5c91-4a3b-8753-0fe1ce141fdb,,Neoadjuvant,275.0,2021-07-12T12:25:55.528644-05:00,HCM-BROD-0254-C49_treatment5,ca52ad48-d2f1-4361-b188-0978ed2603fb,,released,Cyclophosphamide,1,2020-06-15T13:32:11.417090-05:00,Chemotherapy,,
HCM-BROD-0254-C49,300223b2-7479-4849-8de5-14b30c586c3a,2cc13d6e-5c91-4a3b-8753-0fe1ce141fdb,,Neoadjuvant,275.0,2021-07-12T12:25:55.528644-05:00,HCM-BROD-0254-C49_treatment2,cb6e94df-8183-476a-8955-1ef0748de8a1,,released,Vincristine,1,2020-06-15T13:32:11.417090-05:00,Chemotherapy,,
HCM-BROD-0254-C49,300223b2-7479-4849-8de5-14b30c586c3a,2cc13d6e-5c91-4a3b-8753-0fe1ce141fdb,,Neoadjuvant,275.0,2021-07-12T12:25:55.528644-05:00,HCM-BROD-0254-C49_treatment3,d0a11c25-a115-4bdd-bc90-eae7652397cb,,released,Dactinomycin,1,2020-06-15T13:32:11.417090-05:00,Chemotherapy,,
HCM-BROD-0254-C49,300223b2-7479-4849-8de5-14b30c586c3a,2cc13d6e-5c91-4a3b-8753-0fe1ce141fdb,,Neoadjuvant,275.0,2021-07-12T12:25:55.528644-05:00,HCM-BROD-0254-C49_treatment7,eb172a44-1b7a-4e77-a0cb-1095b3b3ea0c,,released,Gemcitabine Hydrochloride,1,2020-06-15T13:32:11.417090-05:00,Chemotherapy,,
HCM-BROD-0254-C49,300223b2-7479-4849-8de5-14b30c586c3a,2cc13d6e-5c91-4a3b-8753-0fe1ce141fdb,,Neoadjuvant,,2021-07-12T12:25:55.528644-05:00,HCM-BROD-0254-C49_treatment9,edc4b18e-209d-4554-846b-628338e8fa0a,,released,,1,2020-06-15T13:32:11.417090-05:00,"Radiation Therapy, NOS",,
HCM-EXPT-1233-C15,3028393c-05be-4b06-a52e-46656a420fd2,2e9da023-c254-479f-be39-f1141fc745c5,,Neoadjuvant,131.0,2025-10-08T12:39:14.406630-05:00,HCM-EXPT-1233-C15_treatment,1f289893-215d-4d42-bb9f-e330c5505d63,,released,Epirubicin,1,2023-02-24T14:19:30.760963-06:00,Chemotherapy,,
HCM-EXPT-1233-C15,3028393c-05be-4b06-a52e-46656a420fd2,2e9da023-c254-479f-be39-f1141fc745c5,,Neoadjuvant,131.0,2025-10-08T12:39:14.406630-05:00,HCM-EXPT-1233-C15_treatment4,b4b3e671-5822-4a32-a6ee-0f88a05c88aa,,released,,1,2023-02-24T14:19:30.760963-06:00,Chemotherapy,,ECX
HCM-EXPT-1233-C15,3028393c-05be-4b06-a52e-46656a420fd2,2e9da023-c254-479f-be39-f1141fc745c5,,Neoadjuvant,131.0,2025-10-08T12:39:14.406630-05:00,HCM-EXPT-1233-C15_treatment3,e4c7ad4c-3b76-404a-80b6-c69119d8be4a,,released,Cisplatin,1,2023-02-24T14:19:30.760963-06:00,Chemotherapy,,
HCM-EXPT-1233-C15,3028393c-05be-4b06-a52e-46656a420fd2,2e9da023-c254-479f-be39-f1141fc745c5,,Neoadjuvant,131.0,2025-10-08T12:39:14.406630-05:00,HCM-EXPT-1233-C15_treatment2,e8e620ed-0cc2-45e8-9618-3f065d522430,,released,Capecitabine,1,2023-02-24T14:19:30.760963-06:00,Chemotherapy,,
HCM-BROD-0036-C41,307c905f-c276-4501-988a-b083f9462a98,c45b5acf-9aad-4308-9fd4-acaa0a536bc1,,Adjuvant,,2020-10-20T19:20:06.800740-05:00,HCM-BROD-0036-C41_treatment16,0373bea4-3a88-4fbe-b12f-b82c5f6cd669,,released,,0,2020-10-08T15:37:15.255262-05:00,Targeted Molecular Therapy,Residual Disease,
HCM-BROD-0036-C41,307c905f-c276-4501-988a-b083f9462a98,c45b5acf-9aad-4308-9fd4-acaa0a536bc1,,Maintenance Therapy,1157.0,2020-10-08T15:37:15.255262-05:00,HCM-BROD-0036-C41_treatment10,0aa0e95a-44ba-4858-8b5b-2c725aa0caab,Progressive Disease,released,,1,2020-03-26T12:37:41.457145-05:00,,Progressive Disease,VAC
HCM-BROD-0036-C41,307c905f-c276-4501-988a-b083f9462a98,c45b5acf-9aad-4308-9fd4-acaa0a536bc1,,Maintenance Therapy,1157.0,2020-10-08T15:37:15.255262-05:00,HCM-BROD-0036-C41_treatment8,0c39aec9-513b-4138-83a6-5cfd220d31fd,Progressive Disease,released,Etoposide,1,2019-04-03T17:59:55.017435-05:00,,Progressive Disease,
HCM-BROD-0036-C41,307c905f-c276-4501-988a-b083f9462a98,c45b5acf-9aad-4308-9fd4-acaa0a536bc1,,Maintenance Therapy,1157.0,2020-10-08T15:37:15.255262-05:00,HCM-BROD-0036-C41_treatment2,187dbc66-47bf-4002-82ee-8cbdb58d06c9,Progressive Disease,released,Temozolomide,1,2019-04-03T17:59:55.017435-05:00,,Progressive Disease,
HCM-BROD-0036-C41,307c905f-c276-4501-988a-b083f9462a98,c45b5acf-9aad-4308-9fd4-acaa0a536bc1,,Neoadjuvant,,2020-10-08T15:37:15.255262-05:00,HCM-BROD-0036-C41_treatment11,1d7d1b91-15b0-4850-a1e8-d6a5af7dfb5a,,released,,1,2020-03-26T12:37:41.457145-05:00,"Radiation Therapy, NOS",,
HCM-BROD-0036-C41,307c905f-c276-4501-988a-b083f9462a98,c45b5acf-9aad-4308-9fd4-acaa0a536bc1,,Adjuvant,,2020-10-20T19:20:06.800740-05:00,HCM-BROD-0036-C41_treatment17,32719bd1-5be1-4829-b77f-dd76315e6a3d,,released,,0,2020-10-08T15:37:15.255262-05:00,"Radiation Therapy, NOS",Residual Disease,
HCM-BROD-0036-C41,307c905f-c276-4501-988a-b083f9462a98,c45b5acf-9aad-4308-9fd4-acaa0a536bc1,,Adjuvant,,2020-10-20T19:20:06.800740-05:00,HCM-BROD-0036-C41_treatment13,54c98415-38fa-4859-bb7c-d70b0874b8a0,,released,,0,2020-10-08T15:37:15.255262-05:00,Chemotherapy,Residual Disease,
HCM-BROD-0036-C41,307c905f-c276-4501-988a-b083f9462a98,c45b5acf-9aad-4308-9fd4-acaa0a536bc1,,Maintenance Therapy,1157.0,2020-10-08T15:37:15.255262-05:00,HCM-BROD-0036-C41_treatment7,74082899-07b2-44e3-a929-981c307040dc,Progressive Disease,released,Irinotecan,1,2019-04-03T17:59:55.017435-05:00,,Progressive Disease,
HCM-BROD-0036-C41,307c905f-c276-4501-988a-b083f9462a98,c45b5acf-9aad-4308-9fd4-acaa0a536bc1,,Neoadjuvant,,2020-10-08T15:37:15.255262-05:00,HCM-BROD-0036-C41_treatment,8351edcf-f56c-4cc2-a052-45f1650a0c1a,,released,Unknown,1,2019-04-03T17:59:55.017435-05:00,Chemotherapy,,
HCM-BROD-0036-C41,307c905f-c276-4501-988a-b083f9462a98,c45b5acf-9aad-4308-9fd4-acaa0a536bc1,,Maintenance Therapy,1157.0,2020-10-08T15:37:15.255262-05:00,HCM-BROD-0036-C41_treatment4,ae2ae478-3ebf-481b-a64c-b6109b33ceaa,Progressive Disease,released,Vincristine,1,2019-04-03T17:59:55.017435-05:00,,Progressive Disease,
HCM-BROD-0036-C41,307c905f-c276-4501-988a-b083f9462a98,c45b5acf-9aad-4308-9fd4-acaa0a536bc1,,Maintenance Therapy,1157.0,2020-10-08T15:37:15.255262-05:00,HCM-BROD-0036-C41_treatment6,c67539e2-8790-40c4-99ca-ad62f4c0dc0e,Progressive Disease,released,Cyclophosphamide,1,2019-04-03T17:59:55.017435-05:00,,Progressive Disease,
HCM-BROD-0036-C41,307c905f-c276-4501-988a-b083f9462a98,c45b5acf-9aad-4308-9fd4-acaa0a536bc1,,Maintenance Therapy,1157.0,2020-10-08T15:37:15.255262-05:00,HCM-BROD-0036-C41_treatment3,d22e0dd8-81d2-47ee-95e4-67d778142f42,Progressive Disease,released,Dactinomycin,1,2019-04-03T17:59:55.017435-05:00,,Progressive Disease,
HCM-BROD-0036-C41,307c905f-c276-4501-988a-b083f9462a98,c45b5acf-9aad-4308-9fd4-acaa0a536bc1,,Adjuvant,4656.0,2020-10-20T19:20:06.800740-05:00,HCM-BROD-0036-C41_treatment14,dcb805dd-8417-45cd-986e-7478c2cdf5a9,,released,Pembrolizumab,1,2020-10-08T15:37:15.255262-05:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-BROD-0036-C41,307c905f-c276-4501-988a-b083f9462a98,c45b5acf-9aad-4308-9fd4-acaa0a536bc1,,Maintenance Therapy,1157.0,2020-10-08T15:37:15.255262-05:00,HCM-BROD-0036-C41_treatment5,f2c4c403-cacb-4759-8c41-5dda2ad1f84d,Progressive Disease,released,Ifosfamide,1,2019-04-03T17:59:55.017435-05:00,,Progressive Disease,
HCM-BROD-0036-C41,307c905f-c276-4501-988a-b083f9462a98,c45b5acf-9aad-4308-9fd4-acaa0a536bc1,,Maintenance Therapy,1157.0,2020-10-08T15:37:15.255262-05:00,HCM-BROD-0036-C41_treatment9,f859a9ce-5041-4f69-82e4-ad0ca70d7c77,Progressive Disease,released,,1,2019-04-03T17:59:55.017435-05:00,,Progressive Disease,VIT
HCM-BROD-0036-C41,307c905f-c276-4501-988a-b083f9462a98,c45b5acf-9aad-4308-9fd4-acaa0a536bc1,,Neoadjuvant,4506.0,2020-10-20T19:20:06.800740-05:00,HCM-BROD-0036-C41_treatment12,fffd90bc-bd36-4f4b-8059-57ed94254371,,released,Regorafenib,1,2020-10-08T15:37:15.255262-05:00,Targeted Molecular Therapy,,
HCM-BROD-0002-C71,3092d72b-75b1-4ae2-ac38-d4c1cd377e4c,f68b1f17-da54-4595-b017-37fd6d6d1e3e,,Neoadjuvant,,2020-01-13T20:10:25.832065-06:00,HCM-BROD-0002-C71_treatment,07c5c0b5-735e-44f0-9124-897ff844ea9e,,released,,0,2019-03-12T10:12:01.634698-05:00,,,
HCM-BROD-0002-C71,3092d72b-75b1-4ae2-ac38-d4c1cd377e4c,f68b1f17-da54-4595-b017-37fd6d6d1e3e,,Adjuvant,,2020-01-13T20:10:25.832065-06:00,HCM-BROD-0002-C71_treatment3,2642c297-b1b5-43ca-8a2c-ca43fcfc5925,,released,,0,2019-04-04T14:12:17.703236-05:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-BROD-0002-C71,3092d72b-75b1-4ae2-ac38-d4c1cd377e4c,f68b1f17-da54-4595-b017-37fd6d6d1e3e,,,-12.0,2023-02-27T12:26:09.116772-06:00,HCM-BROD-0002-C71_treatment4,2f6fac8c-16ad-44ea-9537-bbe0d47f49a0,,released,,1,2019-04-04T14:12:17.703236-05:00,"Surgery, NOS",Initial Diagnosis,
HCM-BROD-0002-C71,3092d72b-75b1-4ae2-ac38-d4c1cd377e4c,f68b1f17-da54-4595-b017-37fd6d6d1e3e,69.0,Adjuvant,49.0,2020-01-13T20:10:25.832065-06:00,HCM-BROD-0002-C71_treatment6,5b30641f-53dd-429b-af46-cb4d220a5eea,,released,,1,2019-04-04T14:12:17.703236-05:00,"Radiation Therapy, NOS",Residual Disease,
HCM-BROD-0002-C71,3092d72b-75b1-4ae2-ac38-d4c1cd377e4c,f68b1f17-da54-4595-b017-37fd6d6d1e3e,210.0,Adjuvant,18.0,2020-01-13T20:10:25.832065-06:00,HCM-BROD-0002-C71_treatment2,6e712acb-bd35-4f67-9b9a-6a2e4bf147ca,,released,Temozolomide,1,2019-04-04T14:12:17.703236-05:00,Chemotherapy,Residual Disease,
HCM-BROD-0002-C71,3092d72b-75b1-4ae2-ac38-d4c1cd377e4c,f68b1f17-da54-4595-b017-37fd6d6d1e3e,525.0,Adjuvant,322.0,2020-06-25T08:43:53.820342-05:00,HCM-BROD-0002-C71_treatment5,9da2bb50-6b21-47db-a544-552c2c76b88c,,released,Bevacizumab,1,2019-04-04T14:12:17.703236-05:00,Targeted Molecular Therapy,Residual Disease,
HCM-CSHL-0459-C17,30ad857e-34d5-4ae1-8ca1-e962d10d6440,2b6add79-1643-48f6-9d7e-0b10afd504ce,,Adjuvant,,2023-03-13T13:21:58.189766-05:00,HCM-CSHL-0459-C17_treatment3,17cf08da-9304-47fc-8e2a-d5230d23abed,,released,,0,2020-06-15T13:08:11.882136-05:00,"Pharmaceutical Therapy, NOS",Residual Disease,
HCM-CSHL-0459-C17,30ad857e-34d5-4ae1-8ca1-e962d10d6440,2b6add79-1643-48f6-9d7e-0b10afd504ce,,,30.0,2023-03-13T13:21:58.189766-05:00,HCM-CSHL-0459-C17_treatment2,43aa98eb-81a6-4ede-bd99-936297207db8,,released,,1,2020-06-15T13:08:11.882136-05:00,"Surgery, NOS",Initial Diagnosis,
HCM-CSHL-0459-C17,30ad857e-34d5-4ae1-8ca1-e962d10d6440,2b6add79-1643-48f6-9d7e-0b10afd504ce,,Adjuvant,,2023-03-13T13:21:58.189766-05:00,HCM-CSHL-0459-C17_treatment4,91849286-8952-40d0-86dd-c77007b14438,,released,,0,2020-06-15T13:08:11.882136-05:00,"Radiation Therapy, NOS",Residual Disease,
HCM-CSHL-0459-C17,30ad857e-34d5-4ae1-8ca1-e962d10d6440,2b6add79-1643-48f6-9d7e-0b10afd504ce,,Neoadjuvant,,2020-10-20T20:46:30.021349-05:00,HCM-CSHL-0459-C17_treatment,f8e49bd5-2547-453e-a7a6-f50511d42a36,,released,,0,2020-06-15T13:08:11.882136-05:00,,,
HCM-SANG-1338-C20,30c7489c-dd72-4d6a-9371-6df76a072282,cff80cce-389e-436f-9d0e-6d4d18711bb0,,Neoadjuvant,98.0,2025-04-07T17:13:09.336794-05:00,HCM-SANG-1338-C20_treatment2,4b1ef1c3-161f-4997-83e9-072d2d70d6ec,,released,,1,2023-02-27T11:30:04.999985-06:00,"Radiation Therapy, NOS",,
HCM-SANG-1338-C20,30c7489c-dd72-4d6a-9371-6df76a072282,cff80cce-389e-436f-9d0e-6d4d18711bb0,,Neoadjuvant,98.0,2025-04-07T17:13:09.336794-05:00,HCM-SANG-1338-C20_treatment,d6b35b05-0056-4d80-a347-88c7ac6cb0c7,,released,Capecitabine,1,2023-02-27T11:30:04.999985-06:00,Chemotherapy,,
HCM-BROD-0476-C56,30eb4b39-20c9-4d1c-8d87-ec84971943fc,981bc3f4-25ac-4fe1-9d8b-6d344dcf3455,,Adjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0476-C56_treatment10,36793f96-56fd-436f-8275-4f4d5ad0cf73,,released,,0,2021-12-21T13:38:00.857158-06:00,"Radiation Therapy, NOS",Residual Disease,
HCM-BROD-0476-C56,30eb4b39-20c9-4d1c-8d87-ec84971943fc,981bc3f4-25ac-4fe1-9d8b-6d344dcf3455,,Adjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0476-C56_treatment7,4cac7c94-5dcc-4f1d-a698-56cfcabb0be0,,released,,0,2021-12-21T13:38:00.857158-06:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-BROD-0476-C56,30eb4b39-20c9-4d1c-8d87-ec84971943fc,981bc3f4-25ac-4fe1-9d8b-6d344dcf3455,,Adjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0476-C56_treatment6,524c8aa1-4bcb-47b3-895d-0d4b753a096f,,released,,0,2021-12-21T13:38:00.857158-06:00,Hormone Therapy,Residual Disease,
HCM-BROD-0476-C56,30eb4b39-20c9-4d1c-8d87-ec84971943fc,981bc3f4-25ac-4fe1-9d8b-6d344dcf3455,,Adjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0476-C56_treatment9,5563ba70-b64a-4356-9d02-0d8c118437be,,released,,0,2021-12-21T13:38:00.857158-06:00,Targeted Molecular Therapy,Residual Disease,
HCM-BROD-0476-C56,30eb4b39-20c9-4d1c-8d87-ec84971943fc,981bc3f4-25ac-4fe1-9d8b-6d344dcf3455,2265.0,Adjuvant,2265.0,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0476-C56_treatment5,703fb4e3-95a8-42d1-9b74-2728a11900d7,,released,Pegylated Liposomal Doxorubicin Hydrochloride,1,2021-12-21T13:38:00.857158-06:00,Chemotherapy,Residual Disease,
HCM-BROD-0476-C56,30eb4b39-20c9-4d1c-8d87-ec84971943fc,981bc3f4-25ac-4fe1-9d8b-6d344dcf3455,2149.0,Adjuvant,1990.0,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0476-C56_treatment3,9d59b807-a060-4d90-86e6-f22aeafc3178,,released,Paclitaxel,1,2021-12-21T13:38:00.857158-06:00,Chemotherapy,Residual Disease,
HCM-BROD-0476-C56,30eb4b39-20c9-4d1c-8d87-ec84971943fc,981bc3f4-25ac-4fe1-9d8b-6d344dcf3455,2265.0,Adjuvant,2265.0,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0476-C56_treatment4,bbe4e9c9-5ce9-460d-8cc3-2a29d181dd15,,released,Carboplatin,1,2021-12-21T13:38:00.857158-06:00,Chemotherapy,Residual Disease,
HCM-BROD-0476-C56,30eb4b39-20c9-4d1c-8d87-ec84971943fc,bbd98e7e-5b22-4274-bcc5-630e24149607,3102.0,Maintenance Therapy,1990.0,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0476-C56_treatment11,10936666-7bb5-4770-b038-78051634a2d9,Not Reported,released,Anastrozole,1,2021-12-21T13:38:00.857158-06:00,,,
HCM-BROD-0476-C56,30eb4b39-20c9-4d1c-8d87-ec84971943fc,bbd98e7e-5b22-4274-bcc5-630e24149607,3102.0,Maintenance Therapy,1990.0,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0476-C56_treatment14,92f55b58-8e6f-44bc-b248-ba4d91a98d7a,Not Reported,released,Pegylated Liposomal Doxorubicin Hydrochloride,1,2021-12-21T13:38:00.857158-06:00,,,
HCM-BROD-0476-C56,30eb4b39-20c9-4d1c-8d87-ec84971943fc,bbd98e7e-5b22-4274-bcc5-630e24149607,3102.0,Maintenance Therapy,1990.0,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0476-C56_treatment12,b3999be2-b165-4481-af2b-71171d29aea3,Not Reported,released,Carboplatin,1,2021-12-21T13:38:00.857158-06:00,,,
HCM-BROD-0476-C56,30eb4b39-20c9-4d1c-8d87-ec84971943fc,bbd98e7e-5b22-4274-bcc5-630e24149607,3102.0,Maintenance Therapy,1990.0,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0476-C56_treatment15,bc0704a3-a710-46b0-9c44-e72cd64c58db,Not Reported,released,Encorafenib,1,2021-12-21T13:38:00.857158-06:00,,,
HCM-BROD-0476-C56,30eb4b39-20c9-4d1c-8d87-ec84971943fc,bbd98e7e-5b22-4274-bcc5-630e24149607,3102.0,Maintenance Therapy,1990.0,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0476-C56_treatment13,d832961f-54fa-4fc2-a7f7-aa57d90d907a,Not Reported,released,Paclitaxel,1,2021-12-21T13:38:00.857158-06:00,,,
HCM-EXPT-0972-C50,31d3630d-72f3-4cfa-9cd9-c48497075440,18db68a5-9913-4581-8948-26418882f57b,,Neoadjuvant,,2025-10-08T12:37:21.548354-05:00,HCM-EXPT-0972-C50_treatment,6698a9ab-ed6f-44e6-b8c5-1ebca6fd23c3,,released,,0,2021-12-21T14:48:41.646340-06:00,,,
HCM-BROD-1121-C71,31e8c099-f4f0-4736-b8a1-2baf7f8777c8,46049f22-1278-4334-9234-c760fbc2db09,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-BROD-1121-C71_treatment5,26abd488-a8c1-4e04-a935-c0481322cd5b,,released,,0,2021-12-21T14:01:22.321497-06:00,Targeted Molecular Therapy,Residual Disease,
HCM-BROD-1121-C71,31e8c099-f4f0-4736-b8a1-2baf7f8777c8,46049f22-1278-4334-9234-c760fbc2db09,,,0.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-1121-C71_treatment4,33397f21-9bd5-4c8e-b10f-49e6eee175b0,,released,,1,2021-12-21T14:01:22.321497-06:00,"Surgery, NOS",Initial Diagnosis,
HCM-BROD-1121-C71,31e8c099-f4f0-4736-b8a1-2baf7f8777c8,46049f22-1278-4334-9234-c760fbc2db09,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-BROD-1121-C71_treatment3,768a1790-c469-42df-825f-ec3d13ea001b,,released,,0,2021-12-21T14:01:22.321497-06:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-BROD-1121-C71,31e8c099-f4f0-4736-b8a1-2baf7f8777c8,46049f22-1278-4334-9234-c760fbc2db09,,Neoadjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-BROD-1121-C71_treatment,7741be8f-b22e-430c-a4d5-45c5b0f28aa9,,released,,0,2021-12-21T14:01:22.321497-06:00,,,
HCM-BROD-1121-C71,31e8c099-f4f0-4736-b8a1-2baf7f8777c8,46049f22-1278-4334-9234-c760fbc2db09,81.0,Adjuvant,38.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-1121-C71_treatment2,e73bcb86-6229-47da-be8e-0f7b451ed522,,released,Temozolomide,1,2021-12-21T14:01:22.321497-06:00,Chemotherapy,Residual Disease,
HCM-BROD-1121-C71,31e8c099-f4f0-4736-b8a1-2baf7f8777c8,46049f22-1278-4334-9234-c760fbc2db09,81.0,Adjuvant,38.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-1121-C71_treatment6,ffc3a8f5-7832-43da-a51e-557f489f78ca,,released,,1,2021-12-21T14:01:22.321497-06:00,"Radiation Therapy, NOS",Residual Disease,
HCM-BROD-0870-C43,325efd72-eaf4-4e85-80d0-911d360434d1,2b8e661e-a1c9-4b0a-8d89-bd3ba3d80bb0,,Adjuvant,,2023-11-07T14:20:00.017270-06:00,HCM-BROD-0870-C43_treatment2,2c5b8caf-1bee-4807-884e-638fcea57a55,,released,,0,2021-12-21T13:56:11.124122-06:00,Chemotherapy,Residual Disease,
HCM-BROD-0870-C43,325efd72-eaf4-4e85-80d0-911d360434d1,2b8e661e-a1c9-4b0a-8d89-bd3ba3d80bb0,3752.0,Adjuvant,3669.0,2023-11-07T14:20:00.017270-06:00,HCM-BROD-0870-C43_treatment6,51038656-10f9-468c-9616-95a0d1186a7c,Treatment Ongoing,released,Not Reported,1,2021-12-21T13:56:11.124122-06:00,Targeted Molecular Therapy,Residual Disease,
HCM-BROD-0870-C43,325efd72-eaf4-4e85-80d0-911d360434d1,2b8e661e-a1c9-4b0a-8d89-bd3ba3d80bb0,,Adjuvant,,2023-11-07T14:20:00.017270-06:00,HCM-BROD-0870-C43_treatment7,65f652ef-2daa-46d1-b3b1-7e8b3188170b,,released,,0,2021-12-21T13:56:11.124122-06:00,"Radiation Therapy, NOS",Residual Disease,
HCM-BROD-0870-C43,325efd72-eaf4-4e85-80d0-911d360434d1,2b8e661e-a1c9-4b0a-8d89-bd3ba3d80bb0,,Adjuvant,,2023-11-07T14:20:00.017270-06:00,HCM-BROD-0870-C43_treatment3,85f539ee-5212-420a-affb-755b007e052f,,released,,0,2021-12-21T13:56:11.124122-06:00,Hormone Therapy,Residual Disease,
HCM-BROD-0870-C43,325efd72-eaf4-4e85-80d0-911d360434d1,2b8e661e-a1c9-4b0a-8d89-bd3ba3d80bb0,,,0.0,2023-11-07T14:20:00.017270-06:00,HCM-BROD-0870-C43_treatment5,a838b38e-a52b-49ae-9471-4d95e5f253c6,,released,,1,2021-12-21T13:56:11.124122-06:00,"Surgery, NOS",Initial Diagnosis,
HCM-BROD-0870-C43,325efd72-eaf4-4e85-80d0-911d360434d1,2b8e661e-a1c9-4b0a-8d89-bd3ba3d80bb0,,Neoadjuvant,818.0,2023-11-07T14:20:00.017270-06:00,HCM-BROD-0870-C43_treatment,c005aab4-18ea-4010-b4c1-97daf4a384ff,,released,Unknown,1,2021-12-21T13:56:11.124122-06:00,Immunotherapy (Including Vaccines),,
HCM-BROD-0870-C43,325efd72-eaf4-4e85-80d0-911d360434d1,2b8e661e-a1c9-4b0a-8d89-bd3ba3d80bb0,3752.0,Adjuvant,3669.0,2023-11-07T14:20:00.017270-06:00,HCM-BROD-0870-C43_treatment4,fc07eb4f-c28b-4e5d-b43c-3c37fcfe63f6,Treatment Ongoing,released,Not Reported,1,2021-12-21T13:56:11.124122-06:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-BROD-0870-C43,325efd72-eaf4-4e85-80d0-911d360434d1,40385f8e-ba4b-40eb-a2c3-851f7f67964b,3374.0,Maintenance Therapy,3254.0,2023-11-07T14:20:00.017270-06:00,HCM-BROD-0870-C43_treatment8,3fc88889-f6c8-4c75-a4ee-a1a0999d986c,Stable Disease,released,,1,2021-12-21T13:56:11.124122-06:00,,,
HCM-BROD-0871-C49,33165ed4-5f38-4566-8d0d-82e2a6d2743f,d245f226-ed78-44d4-a452-9f219612c88c,2948.0,Maintenance Therapy,58.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0871-C49_treatment8,76109255-7f20-48d8-8482-b72f23d1508a,Progressive Disease,released,Docetaxel,1,2023-02-28T13:08:35.301254-06:00,,,
HCM-BROD-0871-C49,33165ed4-5f38-4566-8d0d-82e2a6d2743f,d245f226-ed78-44d4-a452-9f219612c88c,2948.0,Maintenance Therapy,58.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0871-C49_treatment6,cfcd2fb2-2f4d-4d59-a6b9-16ca315e054b,Progressive Disease,released,Anastrozole,1,2023-02-28T13:08:35.301254-06:00,,,
HCM-BROD-0871-C49,33165ed4-5f38-4566-8d0d-82e2a6d2743f,d245f226-ed78-44d4-a452-9f219612c88c,2948.0,Maintenance Therapy,58.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0871-C49_treatment5,f02cf39c-ced5-48c0-b96b-4fa14208e29a,Progressive Disease,released,Trabectedin,1,2023-02-28T13:08:35.301254-06:00,,,
HCM-BROD-0871-C49,33165ed4-5f38-4566-8d0d-82e2a6d2743f,d245f226-ed78-44d4-a452-9f219612c88c,2948.0,Maintenance Therapy,58.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0871-C49_treatment7,faf96ff4-3186-45b9-b4dc-a43c31f4eec9,Progressive Disease,released,Dacarbazine,1,2023-02-28T13:08:35.301254-06:00,,,
HCM-BROD-0871-C49,33165ed4-5f38-4566-8d0d-82e2a6d2743f,f297b2b5-29a7-4f2d-a094-e2666fb04bf5,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0871-C49_treatment4,c9127c5d-aeaf-4190-a9e1-1bda3f94d73b,,released,,0,2021-12-21T13:56:21.205280-06:00,"Radiation Therapy, NOS",Residual Disease,
HCM-BROD-0871-C49,33165ed4-5f38-4566-8d0d-82e2a6d2743f,f297b2b5-29a7-4f2d-a094-e2666fb04bf5,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0871-C49_treatment3,ed001e27-67ce-49ab-a745-28c645b6fe2b,,released,,0,2021-12-21T13:56:21.205280-06:00,"Pharmaceutical Therapy, NOS",Residual Disease,
HCM-BROD-0871-C49,33165ed4-5f38-4566-8d0d-82e2a6d2743f,f297b2b5-29a7-4f2d-a094-e2666fb04bf5,,Neoadjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0871-C49_treatment,f4e07579-b9c3-41dc-9abc-e7667d7603cb,,released,,0,2021-12-21T13:56:21.205280-06:00,,,
HCM-BROD-0871-C49,33165ed4-5f38-4566-8d0d-82e2a6d2743f,f297b2b5-29a7-4f2d-a094-e2666fb04bf5,,,0.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0871-C49_treatment2,fb5d36b8-781f-407c-ba81-3d307320b82a,,released,,1,2021-12-21T13:56:21.205280-06:00,"Surgery, NOS",Initial Diagnosis,
HCM-CSHL-1264-C25,331b37c2-0a17-4078-8364-0df9ae026900,8e175cb2-5c53-4478-b19f-5b8a5708f8ee,218.0,Adjuvant,65.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-1264-C25_treatment3,1b6bde4c-c5e7-4b6a-952c-3cbb4e09b901,,released,Nab-paclitaxel,1,2021-12-23T08:33:45.148749-06:00,Chemotherapy,Residual Disease,
HCM-CSHL-1264-C25,331b37c2-0a17-4078-8364-0df9ae026900,8e175cb2-5c53-4478-b19f-5b8a5708f8ee,218.0,Adjuvant,65.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-1264-C25_treatment2,5d75d993-a01e-4a37-89b4-de01fa314f13,,released,Gemcitabine,1,2021-12-23T08:33:45.148749-06:00,Chemotherapy,Residual Disease,
HCM-CSHL-1264-C25,331b37c2-0a17-4078-8364-0df9ae026900,8e175cb2-5c53-4478-b19f-5b8a5708f8ee,,,-10.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-1264-C25_treatment5,69ec511b-ae9d-4dd0-949c-ab60fc63cf09,,released,,1,2021-12-23T08:33:45.148749-06:00,"Surgery, NOS",Initial Diagnosis,
HCM-CSHL-1264-C25,331b37c2-0a17-4078-8364-0df9ae026900,8e175cb2-5c53-4478-b19f-5b8a5708f8ee,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-1264-C25_treatment7,7544a64c-8d0b-440d-84cb-fde1b9c17cdb,,released,,0,2021-12-23T08:33:45.148749-06:00,"Radiation Therapy, NOS",Residual Disease,
HCM-CSHL-1264-C25,331b37c2-0a17-4078-8364-0df9ae026900,8e175cb2-5c53-4478-b19f-5b8a5708f8ee,,Neoadjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-1264-C25_treatment,77d9e558-a51e-4b79-977e-c9958572cbbb,,released,,0,2021-12-23T08:33:45.148749-06:00,,,
HCM-CSHL-1264-C25,331b37c2-0a17-4078-8364-0df9ae026900,8e175cb2-5c53-4478-b19f-5b8a5708f8ee,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-1264-C25_treatment4,8b24ce5e-9dbf-4625-b4f8-8cd17725bb4b,,released,,0,2021-12-23T08:33:45.148749-06:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-CSHL-1264-C25,331b37c2-0a17-4078-8364-0df9ae026900,8e175cb2-5c53-4478-b19f-5b8a5708f8ee,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-1264-C25_treatment6,d00ab4c8-cc7a-466b-98f6-086e9b07134a,,released,,0,2021-12-23T08:33:45.148749-06:00,Targeted Molecular Therapy,Residual Disease,
HCM-STAN-1111-C19,337c0400-baff-494d-a790-03169ed1e547,0ed72b53-465b-417f-8f70-e8206e523b29,,Neoadjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-STAN-1111-C19_treatment,2336a478-06d3-426f-9bfc-f6c86e34959f,,released,,0,2022-09-22T07:11:20.934917-05:00,,,
HCM-STAN-1111-C19,337c0400-baff-494d-a790-03169ed1e547,0ed72b53-465b-417f-8f70-e8206e523b29,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-STAN-1111-C19_treatment4,65c11847-b7f4-499b-b366-2568329e3baf,,released,,0,2022-09-22T07:11:20.934917-05:00,"Radiation Therapy, NOS",Residual Disease,
HCM-STAN-1111-C19,337c0400-baff-494d-a790-03169ed1e547,0ed72b53-465b-417f-8f70-e8206e523b29,,,0.0,2025-04-07T17:13:09.336794-05:00,HCM-STAN-1111-C19_treatment2,f3a25481-1337-4323-8917-8508876ff5df,,released,,1,2022-09-22T07:11:20.934917-05:00,"Surgery, NOS",Initial Diagnosis,
HCM-STAN-1111-C19,337c0400-baff-494d-a790-03169ed1e547,0ed72b53-465b-417f-8f70-e8206e523b29,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-STAN-1111-C19_treatment3,f4e083c7-51e7-4834-9765-abc38a5c31fc,,released,,0,2022-09-22T07:11:20.934917-05:00,"Pharmaceutical Therapy, NOS",Residual Disease,
HCM-CSHL-0429-C06,345d11d3-7376-4a47-bcc2-cd6cf5c2ed0f,6d5c80c6-0d27-4934-92cb-f6a82ffea58f,,Neoadjuvant,,2023-11-07T14:28:29.403873-06:00,HCM-CSHL-0429-C06_treatment,447ec792-1f90-4b07-b7ea-60b9b0145869,,released,,0,2020-09-28T10:05:25.577038-05:00,,,
HCM-CSHL-0429-C06,345d11d3-7376-4a47-bcc2-cd6cf5c2ed0f,6d5c80c6-0d27-4934-92cb-f6a82ffea58f,,,41.0,2023-11-07T14:28:29.403873-06:00,HCM-CSHL-0429-C06_treatment2,5d9a4a0b-2738-41c6-8198-27fe9f8124c7,,released,,1,2020-09-28T10:05:25.577038-05:00,"Surgery, NOS",Initial Diagnosis,
HCM-CSHL-0429-C06,345d11d3-7376-4a47-bcc2-cd6cf5c2ed0f,6d5c80c6-0d27-4934-92cb-f6a82ffea58f,,Adjuvant,,2023-11-07T14:28:29.403873-06:00,HCM-CSHL-0429-C06_treatment3,6e6fa051-e302-4a4f-831e-aeeda9153b04,,released,,0,2020-09-28T10:05:25.577038-05:00,"Pharmaceutical Therapy, NOS",Residual Disease,
HCM-CSHL-0429-C06,345d11d3-7376-4a47-bcc2-cd6cf5c2ed0f,6d5c80c6-0d27-4934-92cb-f6a82ffea58f,,Adjuvant,,2023-11-07T14:28:29.403873-06:00,HCM-CSHL-0429-C06_treatment4,7bad2e20-2499-4762-9c91-16ba5ea3c6b4,,released,,0,2020-09-28T10:05:25.577038-05:00,"Radiation Therapy, NOS",Residual Disease,
HCM-BROD-0016-C25,359ca5c2-0d00-4b88-be2d-476e6b4c02ef,c6875de1-a360-40c3-8c74-c28de273a1bc,80.0,Adjuvant,40.0,2023-02-22T07:39:25.979291-06:00,HCM-BROD-0016-C25_treatment3,1090dd67-497f-49b9-85a8-a48db458fb0d,,released,Fluorouracil,1,2020-09-17T15:42:55.614463-05:00,Chemotherapy,Residual Disease,
HCM-BROD-0016-C25,359ca5c2-0d00-4b88-be2d-476e6b4c02ef,c6875de1-a360-40c3-8c74-c28de273a1bc,208.0,Adjuvant,122.0,2023-02-22T07:39:25.979291-06:00,HCM-BROD-0016-C25_treatment6,2207cd92-039e-4f28-8c4e-81c8b9416d41,,released,Gemcitabine,1,2020-09-17T15:42:55.614463-05:00,Chemotherapy,Residual Disease,
HCM-BROD-0016-C25,359ca5c2-0d00-4b88-be2d-476e6b4c02ef,c6875de1-a360-40c3-8c74-c28de273a1bc,,Adjuvant,,2023-02-22T07:39:25.979291-06:00,HCM-BROD-0016-C25_treatment8,296a9661-d8ff-4b42-b158-5d118ff87aa7,,released,,0,2020-09-17T15:42:55.614463-05:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-BROD-0016-C25,359ca5c2-0d00-4b88-be2d-476e6b4c02ef,c6875de1-a360-40c3-8c74-c28de273a1bc,80.0,Adjuvant,40.0,2023-02-22T07:39:25.979291-06:00,HCM-BROD-0016-C25_treatment4,3d832512-2fe6-439d-937b-0b323023607e,,released,Leucovorin,1,2020-09-17T15:42:55.614463-05:00,Chemotherapy,Residual Disease,
HCM-BROD-0016-C25,359ca5c2-0d00-4b88-be2d-476e6b4c02ef,c6875de1-a360-40c3-8c74-c28de273a1bc,,Adjuvant,,2023-02-22T07:39:25.979291-06:00,HCM-BROD-0016-C25_treatment10,53c656ca-dc60-4d5a-af12-a6088df902e2,,released,,0,2020-09-17T15:42:55.614463-05:00,Targeted Molecular Therapy,Residual Disease,
HCM-BROD-0016-C25,359ca5c2-0d00-4b88-be2d-476e6b4c02ef,c6875de1-a360-40c3-8c74-c28de273a1bc,,Neoadjuvant,40.0,2023-02-22T07:39:25.979291-06:00,HCM-BROD-0016-C25_treatment2,8dbcec3c-5ed7-43ee-b522-729680341a15,,released,Oxaliplatin,1,2020-09-17T15:42:55.614463-05:00,Chemotherapy,,
HCM-BROD-0016-C25,359ca5c2-0d00-4b88-be2d-476e6b4c02ef,c6875de1-a360-40c3-8c74-c28de273a1bc,,,,2023-02-27T11:33:53.107589-06:00,HCM-BROD-0016-C25_treatment9,a5ec6e55-fa1d-46a1-a7e8-abf6dbf08fe9,,released,,0,2020-09-17T15:42:55.614463-05:00,"Surgery, NOS",Initial Diagnosis,
HCM-BROD-0016-C25,359ca5c2-0d00-4b88-be2d-476e6b4c02ef,c6875de1-a360-40c3-8c74-c28de273a1bc,,Adjuvant,,2023-02-22T07:39:25.979291-06:00,HCM-BROD-0016-C25_treatment11,ab2c5872-4ee0-4780-8b93-9b6d985d2c6d,,released,,0,2020-09-17T15:42:55.614463-05:00,"Radiation Therapy, NOS",Residual Disease,
HCM-BROD-0016-C25,359ca5c2-0d00-4b88-be2d-476e6b4c02ef,c6875de1-a360-40c3-8c74-c28de273a1bc,208.0,Adjuvant,122.0,2023-02-22T07:39:25.979291-06:00,HCM-BROD-0016-C25_treatment7,ade23f87-d17f-4360-a063-aba36f86751d,,released,Nab-paclitaxel,1,2020-09-17T15:42:55.614463-05:00,Chemotherapy,Residual Disease,
HCM-BROD-0016-C25,359ca5c2-0d00-4b88-be2d-476e6b4c02ef,c6875de1-a360-40c3-8c74-c28de273a1bc,80.0,Adjuvant,40.0,2023-02-22T07:39:25.979291-06:00,HCM-BROD-0016-C25_treatment5,c37da40d-10ac-4753-a140-5ee25dd9ce3c,,released,Oxaliplatin,1,2020-09-17T15:42:55.614463-05:00,Chemotherapy,Residual Disease,
HCM-BROD-0016-C25,359ca5c2-0d00-4b88-be2d-476e6b4c02ef,c6875de1-a360-40c3-8c74-c28de273a1bc,,Neoadjuvant,40.0,2023-02-22T07:39:25.979291-06:00,HCM-BROD-0016-C25_treatment,db8cbac7-a59b-48f4-9b7c-1deca73cb992,,released,Fluorouracil,1,2020-09-17T15:42:55.614463-05:00,Chemotherapy,,
HCM-BROD-0046-C71,35a8dada-9a8b-4dd7-8565-e5e2c1e69958,bbe94910-fbe5-49bf-b984-2d2021bc1b30,,Neoadjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0046-C71_treatment,80960eef-a273-477f-a526-f0d65e6dd8e3,,released,,0,2019-04-04T14:43:01.620260-05:00,,,
HCM-BROD-0046-C71,35a8dada-9a8b-4dd7-8565-e5e2c1e69958,bbe94910-fbe5-49bf-b984-2d2021bc1b30,,Adjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0046-C71_treatment3,995c1320-c2d9-4e92-8af8-9d7108ab1f61,,released,,0,2020-02-27T12:15:20.030640-06:00,"Pharmaceutical Therapy, NOS",Residual Disease,
HCM-BROD-0046-C71,35a8dada-9a8b-4dd7-8565-e5e2c1e69958,bbe94910-fbe5-49bf-b984-2d2021bc1b30,,,-2.0,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0046-C71_treatment2,bc77ace7-046f-4130-8ebf-7101a045f95a,,released,,1,2020-02-27T12:15:20.030640-06:00,"Surgery, NOS",Initial Diagnosis,
HCM-BROD-0046-C71,35a8dada-9a8b-4dd7-8565-e5e2c1e69958,bbe94910-fbe5-49bf-b984-2d2021bc1b30,,Adjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0046-C71_treatment4,d36bdd6b-d332-46f0-9ebc-248a536c4b5b,,released,,0,2020-02-27T12:15:20.030640-06:00,"Radiation Therapy, NOS",Residual Disease,
HCM-SANG-1339-C18,35e5f3ec-89ea-4859-914c-5995b7162a0d,9a5f738b-e7fd-4f43-b198-6abee3075f35,,Neoadjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-SANG-1339-C18_treatment,9bcf12eb-b0a0-4dc2-90fd-9921e7a7732e,,released,,0,2023-02-27T11:54:51.687953-06:00,,,
HCM-EXPT-1171-C71,36a5d5b3-1a24-46ad-aa32-45d9ec0eaf3e,c17d0cf4-39e0-441b-8a7e-12ef3ad30498,,Neoadjuvant,208.0,2025-10-08T12:38:28.988690-05:00,HCM-EXPT-1171-C71_treatment2,08da63b4-de9c-4197-848f-8b8b807d3b5c,,released,Bevacizumab,1,2021-12-21T15:05:27.408607-06:00,Targeted Molecular Therapy,,
HCM-EXPT-1171-C71,36a5d5b3-1a24-46ad-aa32-45d9ec0eaf3e,c17d0cf4-39e0-441b-8a7e-12ef3ad30498,,Neoadjuvant,560.0,2025-10-08T12:38:28.988690-05:00,HCM-EXPT-1171-C71_treatment,e7ded033-2067-477e-bd22-c41d1b51aae4,,released,Temozolomide,1,2021-12-21T15:05:27.408607-06:00,Chemotherapy,,
HCM-CSHL-0622-C18,36a9ed92-cc75-4e39-ba21-afe93f3af7c2,0a0d94d1-57b5-47f4-9f21-6e0867da18d5,,Adjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0622-C18_treatment7,0e19d0fe-582c-411a-a789-bc86afd3020b,,released,,0,2021-12-21T14:12:44.771571-06:00,"Radiation Therapy, NOS",Residual Disease,
HCM-CSHL-0622-C18,36a9ed92-cc75-4e39-ba21-afe93f3af7c2,0a0d94d1-57b5-47f4-9f21-6e0867da18d5,,Adjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0622-C18_treatment6,6f9661af-bbcd-4876-8f88-371ae8573d5c,,released,,0,2021-12-21T14:12:44.771571-06:00,"Pharmaceutical Therapy, NOS",Residual Disease,
HCM-CSHL-0622-C18,36a9ed92-cc75-4e39-ba21-afe93f3af7c2,0a0d94d1-57b5-47f4-9f21-6e0867da18d5,,Neoadjuvant,28.0,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0622-C18_treatment3,8bbe646d-09fc-4baa-8255-45471ea13100,,released,Irinotecan,1,2021-12-21T14:12:44.771571-06:00,Chemotherapy,,
HCM-CSHL-0622-C18,36a9ed92-cc75-4e39-ba21-afe93f3af7c2,0a0d94d1-57b5-47f4-9f21-6e0867da18d5,,Neoadjuvant,28.0,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0622-C18_treatment,99074269-0f46-4d6c-bb77-ee5eb17072f4,,released,Leucovorin Calcium,1,2021-12-21T14:12:44.771571-06:00,Chemotherapy,,
HCM-CSHL-0622-C18,36a9ed92-cc75-4e39-ba21-afe93f3af7c2,0a0d94d1-57b5-47f4-9f21-6e0867da18d5,,Neoadjuvant,28.0,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0622-C18_treatment4,9a2cbee0-4302-4f16-9bef-db0f2580beef,,released,,1,2021-12-21T14:12:44.771571-06:00,Chemotherapy,,FOLFIRI
HCM-CSHL-0622-C18,36a9ed92-cc75-4e39-ba21-afe93f3af7c2,0a0d94d1-57b5-47f4-9f21-6e0867da18d5,,Neoadjuvant,28.0,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0622-C18_treatment2,be37bdc0-8bbf-46a3-a387-fa9fa645a884,,released,Fluorouracil,1,2021-12-21T14:12:44.771571-06:00,Chemotherapy,,
HCM-CSHL-0622-C18,36a9ed92-cc75-4e39-ba21-afe93f3af7c2,0a0d94d1-57b5-47f4-9f21-6e0867da18d5,,,203.0,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0622-C18_treatment5,c393090b-2966-4e7f-865a-0fa568da38fb,,released,,1,2021-12-21T14:12:44.771571-06:00,"Surgery, NOS",Initial Diagnosis,
HCM-CSHL-0622-C18,36a9ed92-cc75-4e39-ba21-afe93f3af7c2,5f417ec2-b0e6-465a-aaa7-175848f3f94c,152.0,Maintenance Therapy,28.0,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0622-C18_treatment9,41682223-24f6-47e3-8246-eab4ff3c60e9,Stable Disease,released,Fluorouracil,1,2023-02-28T12:14:53.271670-06:00,,,
HCM-CSHL-0622-C18,36a9ed92-cc75-4e39-ba21-afe93f3af7c2,5f417ec2-b0e6-465a-aaa7-175848f3f94c,152.0,Maintenance Therapy,28.0,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0622-C18_treatment8,b1e2fa89-fa7e-41af-ad5f-dda938e58606,Stable Disease,released,Leucovorin Calcium,1,2023-02-28T12:14:53.271670-06:00,,,
HCM-CSHL-0622-C18,36a9ed92-cc75-4e39-ba21-afe93f3af7c2,5f417ec2-b0e6-465a-aaa7-175848f3f94c,152.0,Maintenance Therapy,28.0,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0622-C18_treatment10,c694212a-ca6e-4bed-8f3a-eca061c36ac8,Stable Disease,released,Irinotecan,1,2023-02-28T12:14:53.271670-06:00,,,
HCM-CSHL-0622-C18,36a9ed92-cc75-4e39-ba21-afe93f3af7c2,5f417ec2-b0e6-465a-aaa7-175848f3f94c,152.0,Maintenance Therapy,28.0,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0622-C18_treatment11,cf0ee83a-20fd-4378-a790-dbcc0f19a151,Stable Disease,released,,1,2021-12-21T14:12:44.771571-06:00,,,FOLFIRI
HCM-CSHL-0085-C24,373c15fd-f995-419d-beef-951db2706411,eafbdc4a-d4f4-4be7-80b4-cc2e220d6bf1,,Neoadjuvant,,2020-10-20T19:20:06.800740-05:00,HCM-CSHL-0085-C24_treatment,bfd3adad-fd17-429e-9edf-472e71f1031c,,released,,0,2019-04-03T17:46:39.008727-05:00,,,
HCM-EXPT-0580-C34,3762208b-fe46-400d-bec8-dd0301d5675d,009a6dd9-2d0d-4bfd-ba0a-8ce774f4d852,,Neoadjuvant,,2025-10-08T12:36:32.654639-05:00,HCM-EXPT-0580-C34_treatment,0c5e7e27-7585-4e58-8d1b-353689bb05af,,released,Carboplatin,1,2021-12-21T14:40:48.303070-06:00,Chemotherapy,,
HCM-EXPT-0580-C34,3762208b-fe46-400d-bec8-dd0301d5675d,009a6dd9-2d0d-4bfd-ba0a-8ce774f4d852,,Neoadjuvant,,2025-10-08T12:36:32.654639-05:00,HCM-EXPT-0580-C34_treatment2,34c5ce44-f5de-47fa-833c-6021bed938b6,,released,Paclitaxel,1,2021-12-21T14:40:48.303070-06:00,Chemotherapy,,
HCM-SANG-1327-C18,37e1311a-a125-4ea8-9db1-1f1b14f87856,926a4720-6364-46bc-8004-bc1b5372d599,,Neoadjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-SANG-1327-C18_treatment,f563d462-b915-4f69-8db7-19af2658c53b,,released,,0,2023-02-27T11:54:58.655785-06:00,,,
HCM-CSHL-0151-C50,38349235-a34c-4ced-a4a0-051090e47332,69839ce1-c66e-4f00-8509-a9f26bf06fe3,,Adjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0151-C50_treatment6,03dbe73e-548c-4070-9a67-4fb3ccd42b32,,released,,0,2020-09-27T12:58:24.162952-05:00,Targeted Molecular Therapy,Residual Disease,
HCM-CSHL-0151-C50,38349235-a34c-4ced-a4a0-051090e47332,69839ce1-c66e-4f00-8509-a9f26bf06fe3,,Adjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0151-C50_treatment4,05a22f85-d9b4-428c-93be-607db558909d,,released,,0,2020-09-27T12:58:24.162952-05:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-CSHL-0151-C50,38349235-a34c-4ced-a4a0-051090e47332,69839ce1-c66e-4f00-8509-a9f26bf06fe3,,,96.0,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0151-C50_treatment5,2503cec1-4474-4cab-bdda-3ee3d35d929e,,released,,1,2020-09-27T12:58:24.162952-05:00,"Surgery, NOS",Initial Diagnosis,
HCM-CSHL-0151-C50,38349235-a34c-4ced-a4a0-051090e47332,69839ce1-c66e-4f00-8509-a9f26bf06fe3,,Adjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0151-C50_treatment2,3034f150-0f22-42b3-8dd9-73e33e4807dd,,released,,0,2020-09-27T12:58:24.162952-05:00,Chemotherapy,Residual Disease,
HCM-CSHL-0151-C50,38349235-a34c-4ced-a4a0-051090e47332,69839ce1-c66e-4f00-8509-a9f26bf06fe3,,Adjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0151-C50_treatment7,635391cc-3d3f-4ee5-91cd-1e25f07836e3,,released,,0,2020-09-27T12:58:24.162952-05:00,"Radiation Therapy, NOS",Residual Disease,
HCM-CSHL-0151-C50,38349235-a34c-4ced-a4a0-051090e47332,69839ce1-c66e-4f00-8509-a9f26bf06fe3,,Neoadjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0151-C50_treatment,b7f8e9bc-d4cf-49d6-b1e8-821f58f2cfda,,released,,0,2020-09-27T12:58:24.162952-05:00,,,
HCM-CSHL-0151-C50,38349235-a34c-4ced-a4a0-051090e47332,69839ce1-c66e-4f00-8509-a9f26bf06fe3,,Adjuvant,166.0,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0151-C50_treatment3,e05cf28b-89b1-458e-be23-89109dcc5995,Treatment Ongoing,released,Tamoxifen,1,2020-09-27T12:58:24.162952-05:00,Hormone Therapy,Residual Disease,
HCM-EXPT-1047-C18,3839c70c-c250-40af-a96a-4d5df8e3f700,b187071d-208f-4e17-b7ba-bc203a5881da,,Neoadjuvant,,2025-10-08T12:38:06.952582-05:00,HCM-EXPT-1047-C18_treatment2,0f62f5cf-e6a3-493e-b200-90b50bdd2343,,released,Fluorouracil,1,2021-12-21T15:01:25.855830-06:00,Chemotherapy,,
HCM-EXPT-1047-C18,3839c70c-c250-40af-a96a-4d5df8e3f700,b187071d-208f-4e17-b7ba-bc203a5881da,,Neoadjuvant,,2025-10-08T12:38:06.952582-05:00,HCM-EXPT-1047-C18_treatment3,3ed1226c-6a6f-490a-8883-4b421ff721cc,,released,Irinotecan,1,2021-12-21T15:01:25.855830-06:00,Chemotherapy,,
HCM-EXPT-1047-C18,3839c70c-c250-40af-a96a-4d5df8e3f700,b187071d-208f-4e17-b7ba-bc203a5881da,,Neoadjuvant,,2025-10-08T12:38:06.952582-05:00,HCM-EXPT-1047-C18_treatment6,7050f37f-1dd5-44c4-bb7c-6139645f85e9,,released,,1,2021-12-21T15:01:25.855830-06:00,Chemotherapy,,FOLFOX
HCM-EXPT-1047-C18,3839c70c-c250-40af-a96a-4d5df8e3f700,b187071d-208f-4e17-b7ba-bc203a5881da,,Neoadjuvant,,2025-10-08T12:38:06.952582-05:00,HCM-EXPT-1047-C18_treatment5,a6382894-9f8e-4397-9dd1-3f27970f1e8d,,released,Oxaliplatin,1,2021-12-21T15:01:25.855830-06:00,Chemotherapy,,
HCM-EXPT-1047-C18,3839c70c-c250-40af-a96a-4d5df8e3f700,b187071d-208f-4e17-b7ba-bc203a5881da,,Neoadjuvant,,2025-10-08T12:38:06.952582-05:00,HCM-EXPT-1047-C18_treatment,b472a798-4f6a-4727-a1a1-92f6174e5907,,released,Leucovorin Calcium,1,2021-12-21T15:01:25.855830-06:00,Chemotherapy,,
HCM-EXPT-1047-C18,3839c70c-c250-40af-a96a-4d5df8e3f700,b187071d-208f-4e17-b7ba-bc203a5881da,,Neoadjuvant,,2025-10-08T12:38:06.952582-05:00,HCM-EXPT-1047-C18_treatment4,e1de54b4-260f-41eb-b07d-f5b8d7ce0f7d,,released,,1,2021-12-21T15:01:25.855830-06:00,Chemotherapy,,FOLFIRI
HCM-CSHL-0186-C25,387a6f37-fe35-4ffc-a4b3-dda1af08f6c3,ec57a3df-7c69-4379-a9da-bcf784b3a52b,,Neoadjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0186-C25_treatment,d9b88631-97e5-4f95-838d-debb7239b4b7,,released,,0,2020-09-28T09:15:30.201930-05:00,,,
HCM-SANG-0288-C18,388c484f-639a-448c-882e-2897f29e55b2,3ea77bd2-af57-4bb1-89f9-6901b98910d6,,Neoadjuvant,,2023-02-22T07:39:25.979291-06:00,HCM-SANG-0288-C18_treatment,caf1d54a-373a-4570-b016-15173e70ed1a,,released,,0,2021-12-21T15:08:43.427372-06:00,,,
HCM-EXPT-1193-C15,38c90d30-b777-4ee3-935c-b169a8185c29,afcf6f0e-2cd8-425b-b653-ff614b383cc5,,Neoadjuvant,61.0,2025-10-08T12:38:28.988690-05:00,HCM-EXPT-1193-C15_treatment3,0b8a9210-c96e-4a43-873e-aca65a46f7dc,,released,Docetaxel,1,2023-02-24T14:08:20.709906-06:00,Chemotherapy,,
HCM-EXPT-1193-C15,38c90d30-b777-4ee3-935c-b169a8185c29,afcf6f0e-2cd8-425b-b653-ff614b383cc5,,Neoadjuvant,61.0,2025-10-08T12:38:28.988690-05:00,HCM-EXPT-1193-C15_treatment2,c9be27ba-4415-4ebd-aba2-d8e6cff18592,,released,Fluorouracil,1,2023-02-24T14:08:20.709906-06:00,Chemotherapy,,
HCM-EXPT-1193-C15,38c90d30-b777-4ee3-935c-b169a8185c29,afcf6f0e-2cd8-425b-b653-ff614b383cc5,,Neoadjuvant,61.0,2025-10-08T12:38:28.988690-05:00,HCM-EXPT-1193-C15_treatment4,fb21ae7c-c691-4d5d-a050-a40c726c5e3e,,released,Oxaliplatin,1,2023-02-24T14:08:20.709906-06:00,Chemotherapy,,
HCM-EXPT-1193-C15,38c90d30-b777-4ee3-935c-b169a8185c29,afcf6f0e-2cd8-425b-b653-ff614b383cc5,,Neoadjuvant,61.0,2025-10-08T12:38:28.988690-05:00,HCM-EXPT-1193-C15_treatment,fdfebe76-414f-4c1f-a896-1c31ca6cef95,,released,Leucovorin,1,2023-02-24T14:08:20.709906-06:00,Chemotherapy,,
HCM-BROD-0614-C71,39aa41b3-af16-4ac0-aaab-49baf567e77c,6aaf0e48-a34e-46a3-8e4c-58a03e4c5ec0,99.0,Adjuvant,57.0,2023-02-22T07:39:25.979291-06:00,HCM-BROD-0614-C71_treatment6,65ee600b-4b48-4f3f-96d0-e157b2487b68,,released,,1,2021-11-23T08:36:18.243684-06:00,"Radiation, 2D Conventional",Residual Disease,
HCM-BROD-0614-C71,39aa41b3-af16-4ac0-aaab-49baf567e77c,6aaf0e48-a34e-46a3-8e4c-58a03e4c5ec0,,Neoadjuvant,,2023-02-22T07:39:25.979291-06:00,HCM-BROD-0614-C71_treatment,697fecd7-4356-43e5-806e-2f830c30705d,,released,,0,2021-11-23T08:36:18.243684-06:00,,,
HCM-BROD-0614-C71,39aa41b3-af16-4ac0-aaab-49baf567e77c,6aaf0e48-a34e-46a3-8e4c-58a03e4c5ec0,,Adjuvant,,2023-02-22T07:39:25.979291-06:00,HCM-BROD-0614-C71_treatment3,90dfd3cf-0356-46b2-9b2e-4e5f7defd3a9,,released,,0,2021-11-23T08:36:18.243684-06:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-BROD-0614-C71,39aa41b3-af16-4ac0-aaab-49baf567e77c,6aaf0e48-a34e-46a3-8e4c-58a03e4c5ec0,,,0.0,2023-02-27T11:50:37.841811-06:00,HCM-BROD-0614-C71_treatment4,9691dbd8-7238-4a84-8883-36996dd3a27b,,released,,1,2021-11-23T08:36:18.243684-06:00,"Surgery, NOS",Initial Diagnosis,
HCM-BROD-0614-C71,39aa41b3-af16-4ac0-aaab-49baf567e77c,6aaf0e48-a34e-46a3-8e4c-58a03e4c5ec0,272.0,Adjuvant,128.0,2023-02-22T07:39:25.979291-06:00,HCM-BROD-0614-C71_treatment5,c19b07a1-834f-41e5-a828-91a342d39f21,,released,Bevacizumab,1,2021-11-23T08:36:18.243684-06:00,Targeted Molecular Therapy,Residual Disease,
HCM-BROD-0614-C71,39aa41b3-af16-4ac0-aaab-49baf567e77c,6aaf0e48-a34e-46a3-8e4c-58a03e4c5ec0,272.0,Adjuvant,128.0,2023-02-22T07:39:25.979291-06:00,HCM-BROD-0614-C71_treatment2,d9e2a070-117d-4551-9eac-23cc4b1de327,,released,Temozolomide,1,2021-11-23T08:36:18.243684-06:00,Chemotherapy,Residual Disease,
HCM-SANG-0545-C15,39ad1462-013d-460c-af44-c0b36ebb07a7,a21e8f93-5bdf-4a91-baca-5146119157a5,,Neoadjuvant,160.0,2025-03-31T16:34:59.906497-05:00,HCM-SANG-0545-C15_treatment3,46f2c558-222c-4119-96e2-d2b2c540c2ff,,released,Cisplatin,1,2021-12-21T15:15:36.750890-06:00,Chemotherapy,,
HCM-SANG-0545-C15,39ad1462-013d-460c-af44-c0b36ebb07a7,a21e8f93-5bdf-4a91-baca-5146119157a5,,Neoadjuvant,160.0,2025-03-31T16:34:59.906497-05:00,HCM-SANG-0545-C15_treatment4,a1c178db-2612-42c6-87f0-05fcc9d97137,,released,,1,2021-12-21T15:15:36.750890-06:00,Chemotherapy,,ECX
HCM-SANG-0545-C15,39ad1462-013d-460c-af44-c0b36ebb07a7,a21e8f93-5bdf-4a91-baca-5146119157a5,,Neoadjuvant,160.0,2025-03-31T16:34:59.906497-05:00,HCM-SANG-0545-C15_treatment,b5962f17-b976-4596-aff7-16a572b9e9cc,,released,Epirubicin,1,2021-12-21T15:15:36.750890-06:00,Chemotherapy,,
HCM-SANG-0545-C15,39ad1462-013d-460c-af44-c0b36ebb07a7,a21e8f93-5bdf-4a91-baca-5146119157a5,,Neoadjuvant,160.0,2025-03-31T16:34:59.906497-05:00,HCM-SANG-0545-C15_treatment2,e6e279bf-f3bc-4850-8410-2d361314ca2b,,released,Capecitabine,1,2021-12-21T15:15:36.750890-06:00,Chemotherapy,,
HCM-BROD-0131-C25,3a37b417-9f45-4bd4-a545-f4084e7e68c2,a60cb174-cbb2-44e1-903c-b4ae99a81c91,,Neoadjuvant,7.0,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0131-C25_treatment5,02ee2ad6-0560-476b-a5a5-9791b8b3f530,,released,,1,2020-09-17T15:59:41.557221-05:00,Chemotherapy,,FOLFIRINOX
HCM-BROD-0131-C25,3a37b417-9f45-4bd4-a545-f4084e7e68c2,a60cb174-cbb2-44e1-903c-b4ae99a81c91,,Neoadjuvant,7.0,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0131-C25_treatment4,1940b1e5-6835-4e50-80fc-909773277708,,released,Oxaliplatin,1,2020-09-17T15:59:41.557221-05:00,Chemotherapy,,
HCM-BROD-0131-C25,3a37b417-9f45-4bd4-a545-f4084e7e68c2,a60cb174-cbb2-44e1-903c-b4ae99a81c91,,Adjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0131-C25_treatment11,204ddb68-acfe-4759-beed-944216f069db,,released,,0,2020-09-17T15:59:41.557221-05:00,"Radiation Therapy, NOS",Residual Disease,
HCM-BROD-0131-C25,3a37b417-9f45-4bd4-a545-f4084e7e68c2,a60cb174-cbb2-44e1-903c-b4ae99a81c91,146.0,Adjuvant,139.0,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0131-C25_treatment6,45fdd3e1-a4b5-4d82-b5f6-dab1f2002e8b,,released,Gemcitabine,1,2020-09-17T15:59:41.557221-05:00,Chemotherapy,Residual Disease,
HCM-BROD-0131-C25,3a37b417-9f45-4bd4-a545-f4084e7e68c2,a60cb174-cbb2-44e1-903c-b4ae99a81c91,,Neoadjuvant,7.0,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0131-C25_treatment2,52f6b81f-abb1-4178-a2ef-fe14ad6afcac,,released,Leucovorin Calcium,1,2020-09-17T15:59:41.557221-05:00,Chemotherapy,,
HCM-BROD-0131-C25,3a37b417-9f45-4bd4-a545-f4084e7e68c2,a60cb174-cbb2-44e1-903c-b4ae99a81c91,,Neoadjuvant,7.0,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0131-C25_treatment,6e1411de-7570-4e10-b10e-f72091dfe792,,released,Irinotecan Hydrochloride,1,2020-09-17T15:59:41.557221-05:00,Chemotherapy,,
HCM-BROD-0131-C25,3a37b417-9f45-4bd4-a545-f4084e7e68c2,a60cb174-cbb2-44e1-903c-b4ae99a81c91,,Adjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0131-C25_treatment10,78078809-b163-4999-a06e-d00f5365c3bf,,released,,0,2020-09-17T15:59:41.557221-05:00,Targeted Molecular Therapy,Residual Disease,
HCM-BROD-0131-C25,3a37b417-9f45-4bd4-a545-f4084e7e68c2,a60cb174-cbb2-44e1-903c-b4ae99a81c91,,Neoadjuvant,7.0,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0131-C25_treatment3,93ab00b9-31c4-475a-8e07-714b2d76a556,,released,Fluorouracil,1,2020-09-17T15:59:41.557221-05:00,Chemotherapy,,
HCM-BROD-0131-C25,3a37b417-9f45-4bd4-a545-f4084e7e68c2,a60cb174-cbb2-44e1-903c-b4ae99a81c91,146.0,Adjuvant,139.0,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0131-C25_treatment7,bc0c3dbd-4bd8-4175-884a-b03826b2d952,,released,Nab-paclitaxel,1,2020-09-17T15:59:41.557221-05:00,Chemotherapy,Residual Disease,
HCM-BROD-0131-C25,3a37b417-9f45-4bd4-a545-f4084e7e68c2,a60cb174-cbb2-44e1-903c-b4ae99a81c91,,,,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0131-C25_treatment9,de595f09-a881-4d4c-be63-cab159b2739d,,released,,0,2020-09-17T15:59:41.557221-05:00,"Surgery, NOS",Initial Diagnosis,
HCM-BROD-0131-C25,3a37b417-9f45-4bd4-a545-f4084e7e68c2,a60cb174-cbb2-44e1-903c-b4ae99a81c91,,Adjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0131-C25_treatment8,ed03c412-76ba-449a-8f95-d6f844a27a45,,released,,0,2020-09-17T15:59:41.557221-05:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-CSHL-0058-C34,3b013c00-dfc1-451e-aacc-be734f4b1c00,77a6c840-5cfc-40c3-8264-8d3b4b62692b,,,8.0,2023-03-13T12:53:36.302130-05:00,HCM-CSHL-0058-C34_treatment2,1e9f5100-fb0a-4cb5-919a-11fa88863ff3,,released,,1,2019-04-04T15:12:48.367373-05:00,"Surgery, NOS",Initial Diagnosis,
HCM-CSHL-0058-C34,3b013c00-dfc1-451e-aacc-be734f4b1c00,77a6c840-5cfc-40c3-8264-8d3b4b62692b,,Neoadjuvant,,2020-10-20T19:20:06.800740-05:00,HCM-CSHL-0058-C34_treatment,2d2e3f41-ae69-4cf3-a3b9-a69aa4e80bc9,,released,,0,2019-04-04T15:12:48.367373-05:00,,,
HCM-CSHL-0058-C34,3b013c00-dfc1-451e-aacc-be734f4b1c00,77a6c840-5cfc-40c3-8264-8d3b4b62692b,,Adjuvant,,2023-03-13T12:53:36.302130-05:00,HCM-CSHL-0058-C34_treatment4,65018b06-046a-4724-8390-a92f678a49ae,,released,,0,2019-04-04T15:12:48.367373-05:00,"Radiation Therapy, NOS",Residual Disease,
HCM-CSHL-0058-C34,3b013c00-dfc1-451e-aacc-be734f4b1c00,77a6c840-5cfc-40c3-8264-8d3b4b62692b,,Adjuvant,,2023-03-13T12:53:36.302130-05:00,HCM-CSHL-0058-C34_treatment3,9d51023d-32f0-45a8-9e62-735d3c43df5d,,released,,0,2019-04-04T15:12:48.367373-05:00,"Pharmaceutical Therapy, NOS",Residual Disease,
HCM-CSHL-0080-C25,3b348a82-127f-42ac-bc41-c55fdf8cac7a,dee72a2c-cc97-4cbb-a1e3-a0bcae4214f4,272.0,Adjuvant,233.0,2023-02-22T07:39:25.979291-06:00,HCM-CSHL-0080-C25_treatment7,07806536-7cc2-42bc-9f86-6f0b63583e1d,,released,,1,2020-10-09T14:58:16.760417-05:00,"Radiation, 2D Conventional",Residual Disease,
HCM-CSHL-0080-C25,3b348a82-127f-42ac-bc41-c55fdf8cac7a,dee72a2c-cc97-4cbb-a1e3-a0bcae4214f4,200.0,Adjuvant,43.0,2023-02-22T07:39:25.979291-06:00,HCM-CSHL-0080-C25_treatment3,24a0b1ef-2485-4f4e-932d-1e08b537afeb,,released,Nab-paclitaxel,1,2020-10-09T14:58:16.760417-05:00,Chemotherapy,Residual Disease,
HCM-CSHL-0080-C25,3b348a82-127f-42ac-bc41-c55fdf8cac7a,dee72a2c-cc97-4cbb-a1e3-a0bcae4214f4,200.0,Adjuvant,43.0,2023-02-22T07:39:25.979291-06:00,HCM-CSHL-0080-C25_treatment2,56ded739-75c1-41ea-afd5-961f1c9047a7,,released,Gemcitabine,1,2020-10-09T14:58:16.760417-05:00,Chemotherapy,Residual Disease,
HCM-CSHL-0080-C25,3b348a82-127f-42ac-bc41-c55fdf8cac7a,dee72a2c-cc97-4cbb-a1e3-a0bcae4214f4,,,-22.0,2023-02-27T11:35:24.204429-06:00,HCM-CSHL-0080-C25_treatment5,63db03c8-acfe-4030-966f-72a9a82bd794,,released,,1,2020-10-09T14:58:16.760417-05:00,"Surgery, NOS",Initial Diagnosis,
HCM-CSHL-0080-C25,3b348a82-127f-42ac-bc41-c55fdf8cac7a,dee72a2c-cc97-4cbb-a1e3-a0bcae4214f4,,Neoadjuvant,,2023-02-22T07:39:25.979291-06:00,HCM-CSHL-0080-C25_treatment,c27ed7e3-6e7e-46ea-a7ca-9409426ae3f0,,released,,0,2020-10-09T14:58:16.760417-05:00,,,
HCM-CSHL-0080-C25,3b348a82-127f-42ac-bc41-c55fdf8cac7a,dee72a2c-cc97-4cbb-a1e3-a0bcae4214f4,,Adjuvant,,2023-02-22T07:39:25.979291-06:00,HCM-CSHL-0080-C25_treatment6,ce6708c4-5e8b-4d77-9cbf-3a28746bd88b,,released,,0,2020-10-09T14:58:16.760417-05:00,Targeted Molecular Therapy,Residual Disease,
HCM-CSHL-0080-C25,3b348a82-127f-42ac-bc41-c55fdf8cac7a,dee72a2c-cc97-4cbb-a1e3-a0bcae4214f4,,Adjuvant,,2023-02-22T07:39:25.979291-06:00,HCM-CSHL-0080-C25_treatment4,cfa6af83-93bb-4f58-add4-d71242999839,,released,,0,2020-10-09T14:58:16.760417-05:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-CSHL-0060-C18,3b797720-33ef-45e0-9830-5f6007f1d5a7,bb2a4816-93d8-49d1-acc9-e6aefc5095f7,150.0,Adjuvant,80.0,2020-10-08T18:59:08.767031-05:00,HCM-CSHL-0060-C18_treatment3,133ab461-7799-4e44-810a-ad69c64b59c5,,released,Fluorouracil,1,2020-02-11T14:36:35.999470-06:00,Chemotherapy,Residual Disease,
HCM-CSHL-0060-C18,3b797720-33ef-45e0-9830-5f6007f1d5a7,bb2a4816-93d8-49d1-acc9-e6aefc5095f7,150.0,Adjuvant,80.0,2020-10-08T18:59:08.767031-05:00,HCM-CSHL-0060-C18_treatment5,46f62c14-2cdb-4221-b628-206c2ad109fc,,released,,1,2020-02-11T14:36:35.999470-06:00,Chemotherapy,Residual Disease,FOLFOX
HCM-CSHL-0060-C18,3b797720-33ef-45e0-9830-5f6007f1d5a7,bb2a4816-93d8-49d1-acc9-e6aefc5095f7,,Adjuvant,,2020-10-08T18:59:08.767031-05:00,HCM-CSHL-0060-C18_treatment6,5e7cdcea-b09d-484a-b41b-bf28c9ae98a4,,released,,0,2020-02-11T14:36:35.999470-06:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-CSHL-0060-C18,3b797720-33ef-45e0-9830-5f6007f1d5a7,bb2a4816-93d8-49d1-acc9-e6aefc5095f7,,,25.0,2023-03-13T12:58:03.899566-05:00,HCM-CSHL-0060-C18_treatment7,6b76a315-4dd5-421c-a650-37499d85e834,,released,,1,2020-10-08T18:59:08.767031-05:00,"Surgery, NOS",Initial Diagnosis,
HCM-CSHL-0060-C18,3b797720-33ef-45e0-9830-5f6007f1d5a7,bb2a4816-93d8-49d1-acc9-e6aefc5095f7,,Adjuvant,,2020-10-20T19:20:06.800740-05:00,HCM-CSHL-0060-C18_treatment9,906586eb-b94f-457c-a008-6c711e47ddd4,,released,,0,2020-10-08T18:59:08.767031-05:00,"Radiation Therapy, NOS",Residual Disease,
HCM-CSHL-0060-C18,3b797720-33ef-45e0-9830-5f6007f1d5a7,bb2a4816-93d8-49d1-acc9-e6aefc5095f7,,Neoadjuvant,,2020-03-26T16:04:47.706904-05:00,HCM-CSHL-0060-C18_treatment,98f5860a-83ff-4670-b0a0-c8027b5e348c,,released,,0,2020-02-11T14:36:35.999470-06:00,,,
HCM-CSHL-0060-C18,3b797720-33ef-45e0-9830-5f6007f1d5a7,bb2a4816-93d8-49d1-acc9-e6aefc5095f7,150.0,Adjuvant,80.0,2020-10-08T18:59:08.767031-05:00,HCM-CSHL-0060-C18_treatment2,b13eb825-5cb4-4b16-bea4-5337d9320d72,,released,Leucovorin Calcium,1,2020-02-11T14:36:35.999470-06:00,Chemotherapy,Residual Disease,
HCM-CSHL-0060-C18,3b797720-33ef-45e0-9830-5f6007f1d5a7,bb2a4816-93d8-49d1-acc9-e6aefc5095f7,,Adjuvant,,2020-10-20T19:20:06.800740-05:00,HCM-CSHL-0060-C18_treatment8,d6a0d466-5081-4cb8-84a3-69475b9462b0,,released,,0,2020-10-08T18:59:08.767031-05:00,Targeted Molecular Therapy,Residual Disease,
HCM-CSHL-0060-C18,3b797720-33ef-45e0-9830-5f6007f1d5a7,bb2a4816-93d8-49d1-acc9-e6aefc5095f7,150.0,Adjuvant,80.0,2020-10-08T18:59:08.767031-05:00,HCM-CSHL-0060-C18_treatment4,f84f00ac-f051-4404-8170-e41c2f1a9dc6,,released,Oxaliplatin,1,2020-02-11T14:36:35.999470-06:00,Chemotherapy,Residual Disease,
HCM-BROD-0339-C43,3b84c894-91d7-4c3e-8f17-4d6adc8bb468,1c9f6d6d-12e9-4e4d-b301-8e9ec59c12d8,,Adjuvant,,2021-01-06T22:55:10.531130-06:00,HCM-BROD-0339-C43_treatment3,175ac743-669b-468d-af64-276628f10c09,,released,,0,2020-06-15T13:34:01.593117-05:00,Hormone Therapy,Residual Disease,
HCM-BROD-0339-C43,3b84c894-91d7-4c3e-8f17-4d6adc8bb468,1c9f6d6d-12e9-4e4d-b301-8e9ec59c12d8,,Adjuvant,,2021-01-06T22:55:10.531130-06:00,HCM-BROD-0339-C43_treatment4,5c3c08ce-1179-46b9-8f27-7f6ebe141185,,released,,0,2020-06-15T13:34:01.593117-05:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-BROD-0339-C43,3b84c894-91d7-4c3e-8f17-4d6adc8bb468,1c9f6d6d-12e9-4e4d-b301-8e9ec59c12d8,,Neoadjuvant,,2021-01-06T22:55:10.531130-06:00,HCM-BROD-0339-C43_treatment,9f0dc4e3-f4e1-4650-899f-86c729d32094,,released,,0,2020-06-15T13:34:01.593117-05:00,,,
HCM-BROD-0339-C43,3b84c894-91d7-4c3e-8f17-4d6adc8bb468,1c9f6d6d-12e9-4e4d-b301-8e9ec59c12d8,11977.0,Adjuvant,11627.0,2021-01-06T22:55:10.531130-06:00,HCM-BROD-0339-C43_treatment6,c6657cd3-4186-4855-b32a-823307736141,,released,Nivolumab,1,2020-06-15T13:34:01.593117-05:00,Targeted Molecular Therapy,Residual Disease,
HCM-BROD-0339-C43,3b84c894-91d7-4c3e-8f17-4d6adc8bb468,1c9f6d6d-12e9-4e4d-b301-8e9ec59c12d8,11601.0,Adjuvant,11576.0,2021-01-06T22:55:10.531130-06:00,HCM-BROD-0339-C43_treatment7,d82f418f-804e-4cf6-999a-cf59cbf16073,,released,,1,2020-09-27T11:25:50.357917-05:00,"Radiation Therapy, NOS",Residual Disease,
HCM-BROD-0339-C43,3b84c894-91d7-4c3e-8f17-4d6adc8bb468,1c9f6d6d-12e9-4e4d-b301-8e9ec59c12d8,,Adjuvant,,2021-01-06T22:55:10.531130-06:00,HCM-BROD-0339-C43_treatment2,ecba704e-76cb-4d4c-a885-070202292386,,released,,0,2020-06-15T13:34:01.593117-05:00,Chemotherapy,Residual Disease,
HCM-BROD-1100-C84,3bf3c1c9-413a-4013-8577-b7338a15c4f4,84c06531-78fb-4109-947c-746fbaed1892,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-BROD-1100-C84_treatment7,0322ffb6-9bec-4d37-9811-416e8121519b,,released,,0,2021-12-21T15:23:24.032739-06:00,"Radiation Therapy, NOS",Residual Disease,
HCM-BROD-1100-C84,3bf3c1c9-413a-4013-8577-b7338a15c4f4,84c06531-78fb-4109-947c-746fbaed1892,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-BROD-1100-C84_treatment3,07a1f5cc-1b1b-4289-9df2-f3a1284fce10,,released,,0,2021-12-21T15:23:24.032739-06:00,Hormone Therapy,Residual Disease,
HCM-BROD-1100-C84,3bf3c1c9-413a-4013-8577-b7338a15c4f4,84c06531-78fb-4109-947c-746fbaed1892,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-BROD-1100-C84_treatment6,2141c443-a2a9-4365-b3e3-f060dcb497e1,,released,,0,2021-12-21T15:23:24.032739-06:00,Targeted Molecular Therapy,Residual Disease,
HCM-BROD-1100-C84,3bf3c1c9-413a-4013-8577-b7338a15c4f4,84c06531-78fb-4109-947c-746fbaed1892,477.0,Adjuvant,388.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-1100-C84_treatment4,7ea11644-bcf6-4949-8635-39e20341a07c,,released,Brentuximab,1,2021-12-21T15:23:24.032739-06:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-BROD-1100-C84,3bf3c1c9-413a-4013-8577-b7338a15c4f4,84c06531-78fb-4109-947c-746fbaed1892,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-BROD-1100-C84_treatment2,9e520ff4-c94c-4f34-8c8a-3948841ea663,,released,,0,2021-12-21T15:23:24.032739-06:00,Chemotherapy,Residual Disease,
HCM-BROD-1100-C84,3bf3c1c9-413a-4013-8577-b7338a15c4f4,84c06531-78fb-4109-947c-746fbaed1892,,,,2025-04-07T17:13:09.336794-05:00,HCM-BROD-1100-C84_treatment5,e880f7c2-d6c7-40f3-a34b-79dee6e1dfc4,,released,,0,2021-12-21T15:23:24.032739-06:00,"Surgery, NOS",Initial Diagnosis,
HCM-BROD-1100-C84,3bf3c1c9-413a-4013-8577-b7338a15c4f4,84c06531-78fb-4109-947c-746fbaed1892,,Neoadjuvant,117.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-1100-C84_treatment,f4698ef1-92b7-49e0-a665-4bf0bd101bc2,,released,Alemtuzumab,1,2021-12-21T15:23:24.032739-06:00,Immunotherapy (Including Vaccines),,
HCM-BROD-0052-C49,3d06ca77-a9a1-4e52-9b3d-a6f4f98167d6,cc58e97e-7ddb-4ff9-a617-8669c49e1021,,Neoadjuvant,,2023-02-22T07:39:25.979291-06:00,HCM-BROD-0052-C49_treatment,1156256f-d033-4073-aaa2-cdc7c8b6d639,,released,,0,2020-06-15T13:10:23.732353-05:00,,,
HCM-BROD-0052-C49,3d06ca77-a9a1-4e52-9b3d-a6f4f98167d6,cc58e97e-7ddb-4ff9-a617-8669c49e1021,150.0,Adjuvant,150.0,2023-02-22T07:39:25.979291-06:00,HCM-BROD-0052-C49_treatment4,66e5bb9c-ba38-4603-b351-769b73e4401a,,released,Gemcitabine Hydrochloride,1,2020-06-15T13:10:23.732353-05:00,Chemotherapy,Residual Disease,
HCM-BROD-0052-C49,3d06ca77-a9a1-4e52-9b3d-a6f4f98167d6,cc58e97e-7ddb-4ff9-a617-8669c49e1021,,Adjuvant,,2023-02-22T07:39:25.979291-06:00,HCM-BROD-0052-C49_treatment10,925d855b-4c10-4352-afc7-60f99f1c2667,,released,,0,2020-09-27T10:18:11.209035-05:00,"Radiation Therapy, NOS",Residual Disease,
HCM-BROD-0052-C49,3d06ca77-a9a1-4e52-9b3d-a6f4f98167d6,cc58e97e-7ddb-4ff9-a617-8669c49e1021,150.0,Adjuvant,150.0,2023-02-22T07:39:25.979291-06:00,HCM-BROD-0052-C49_treatment5,977c8324-f236-49c0-aecb-2c3ab22e6e63,,released,Docetaxel,1,2020-06-15T13:10:23.732353-05:00,Chemotherapy,Residual Disease,
HCM-BROD-0052-C49,3d06ca77-a9a1-4e52-9b3d-a6f4f98167d6,cc58e97e-7ddb-4ff9-a617-8669c49e1021,150.0,Adjuvant,89.0,2023-02-22T07:39:25.979291-06:00,HCM-BROD-0052-C49_treatment2,b282d154-5208-4f87-9ebb-5ed5ec527ce0,,released,Irinotecan,1,2020-06-15T13:10:23.732353-05:00,Chemotherapy,Residual Disease,
HCM-BROD-0052-C49,3d06ca77-a9a1-4e52-9b3d-a6f4f98167d6,cc58e97e-7ddb-4ff9-a617-8669c49e1021,,Adjuvant,,2023-02-22T07:39:25.979291-06:00,HCM-BROD-0052-C49_treatment9,b883e9f7-81d0-4336-a0b9-7f646eb0c3a8,,released,,0,2020-09-27T10:18:11.209035-05:00,Targeted Molecular Therapy,Residual Disease,
HCM-BROD-0052-C49,3d06ca77-a9a1-4e52-9b3d-a6f4f98167d6,cc58e97e-7ddb-4ff9-a617-8669c49e1021,,Adjuvant,,2023-02-22T07:39:25.979291-06:00,HCM-BROD-0052-C49_treatment6,cb5f4bd1-6c38-4e64-8382-ecf18b86ba6b,,released,,0,2020-06-15T13:10:23.732353-05:00,Hormone Therapy,Residual Disease,
HCM-BROD-0052-C49,3d06ca77-a9a1-4e52-9b3d-a6f4f98167d6,cc58e97e-7ddb-4ff9-a617-8669c49e1021,,Adjuvant,,2023-02-22T07:39:25.979291-06:00,HCM-BROD-0052-C49_treatment7,cf8eb82a-f25f-4722-b401-cb097635e885,,released,,0,2020-06-15T13:10:23.732353-05:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-BROD-0052-C49,3d06ca77-a9a1-4e52-9b3d-a6f4f98167d6,cc58e97e-7ddb-4ff9-a617-8669c49e1021,150.0,Adjuvant,89.0,2023-02-22T07:39:25.979291-06:00,HCM-BROD-0052-C49_treatment3,dc83a5af-9eb4-4f91-a082-23bb92e7e475,,released,Temozolomide,1,2020-06-15T13:10:23.732353-05:00,Chemotherapy,Residual Disease,
HCM-EXPT-1201-C20,3d5a921b-fb6c-41fe-84f4-7d9127629e98,71ae9604-5b24-464b-acc3-1215f2930785,,Neoadjuvant,,2025-10-08T12:38:51.189053-05:00,HCM-EXPT-1201-C20_treatment2,4db34d06-6fb7-4231-9d30-1d3bf4f2d8e8,,released,,1,2023-02-24T14:10:00.789200-06:00,"Radiation Therapy, NOS",,
HCM-EXPT-1201-C20,3d5a921b-fb6c-41fe-84f4-7d9127629e98,71ae9604-5b24-464b-acc3-1215f2930785,,Neoadjuvant,,2025-10-08T12:38:51.189053-05:00,HCM-EXPT-1201-C20_treatment,59277d4d-9f19-43f4-a40a-4fd08c44a1ac,,released,Capecitabine,1,2023-02-24T14:10:00.789200-06:00,Chemotherapy,,
HCM-SANG-0280-C18,3dab73f4-1fd2-440d-a194-4368818ee701,d82fe2d4-ba50-4289-ab5e-ed2757f042c8,,Neoadjuvant,,2023-11-07T14:28:29.403873-06:00,HCM-SANG-0280-C18_treatment,ff874aa1-e4af-4b36-9aee-cc3bd20ecb97,,released,,0,2021-12-21T15:07:11.731422-06:00,,,
HCM-CSHL-0803-C54,3e296517-6c60-4f65-ab54-98b1753ed39c,9d93b4d8-995a-477c-9d46-95409711b43f,,Adjuvant,,2023-11-07T14:20:00.017270-06:00,HCM-CSHL-0803-C54_treatment5,02efa19a-fd72-42f5-b583-27a1fabd20e6,,released,,0,2021-12-21T14:24:17.054829-06:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-CSHL-0803-C54,3e296517-6c60-4f65-ab54-98b1753ed39c,9d93b4d8-995a-477c-9d46-95409711b43f,,Adjuvant,,2023-11-07T14:20:00.017270-06:00,HCM-CSHL-0803-C54_treatment7,6461eeda-aabe-45b0-bd14-e986ecffe5f1,,released,,0,2021-12-21T14:24:17.054829-06:00,Targeted Molecular Therapy,Residual Disease,
HCM-CSHL-0803-C54,3e296517-6c60-4f65-ab54-98b1753ed39c,9d93b4d8-995a-477c-9d46-95409711b43f,,Adjuvant,,2023-11-07T14:20:00.017270-06:00,HCM-CSHL-0803-C54_treatment4,7376ef51-1951-4bcf-b504-2153fae10305,,released,,0,2021-12-21T14:24:17.054829-06:00,Hormone Therapy,Residual Disease,
HCM-CSHL-0803-C54,3e296517-6c60-4f65-ab54-98b1753ed39c,9d93b4d8-995a-477c-9d46-95409711b43f,,,0.0,2023-11-07T14:20:00.017270-06:00,HCM-CSHL-0803-C54_treatment6,9562f79a-d90b-47b1-a708-5ce4703fb172,,released,,1,2021-12-21T14:24:17.054829-06:00,"Surgery, NOS",Initial Diagnosis,
HCM-CSHL-0803-C54,3e296517-6c60-4f65-ab54-98b1753ed39c,9d93b4d8-995a-477c-9d46-95409711b43f,156.0,Adjuvant,53.0,2023-11-07T14:20:00.017270-06:00,HCM-CSHL-0803-C54_treatment2,afb1fa3b-b3c5-46c9-aaf5-46b6b7c5ec17,,released,Carboplatin,1,2021-12-21T14:24:17.054829-06:00,Chemotherapy,Residual Disease,
HCM-CSHL-0803-C54,3e296517-6c60-4f65-ab54-98b1753ed39c,9d93b4d8-995a-477c-9d46-95409711b43f,156.0,Adjuvant,53.0,2023-11-07T14:20:00.017270-06:00,HCM-CSHL-0803-C54_treatment3,ccd65059-8f79-40e8-9421-0ed873c9b775,,released,Paclitaxel,1,2021-12-21T14:24:17.054829-06:00,Chemotherapy,Residual Disease,
HCM-CSHL-0803-C54,3e296517-6c60-4f65-ab54-98b1753ed39c,9d93b4d8-995a-477c-9d46-95409711b43f,,Neoadjuvant,,2023-11-07T14:20:00.017270-06:00,HCM-CSHL-0803-C54_treatment,cf9de150-16f2-427f-9f63-39312eadbf1d,,released,,0,2021-12-21T14:24:17.054829-06:00,,,
HCM-CSHL-0803-C54,3e296517-6c60-4f65-ab54-98b1753ed39c,9d93b4d8-995a-477c-9d46-95409711b43f,206.0,Adjuvant,197.0,2023-11-07T14:20:00.017270-06:00,HCM-CSHL-0803-C54_treatment8,f71f80a1-04b2-41dc-874a-176ba025bb80,,released,,1,2021-12-21T14:24:17.054829-06:00,"Brachytherapy, High Dose",Residual Disease,
HCM-EXPT-1049-C50,3f30f072-f7c8-4737-afab-e0e29d6fb093,d0244659-b465-4b21-a370-0c6bf2d7d9c9,,Neoadjuvant,,2025-10-08T12:38:06.952582-05:00,HCM-EXPT-1049-C50_treatment,2126a5cb-62c6-4c62-bc8c-50d83e709e74,,released,,0,2021-12-21T15:01:30.094988-06:00,,,
HCM-SANG-0313-C15,3faa062f-758e-4c76-91ec-a8566dded5c2,04b8ec69-2d9f-44f7-ae8e-13ac9c2e36cd,,Neoadjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-SANG-0313-C15_treatment,ac7a0b16-0709-4b40-9cf6-161f4eef9b5c,,released,,0,2021-12-21T15:11:29.925173-06:00,,,
HCM-EXPT-1212-C25,40357899-a869-431e-8f60-20a7c69522ae,b7e04757-6702-4637-99a1-ad115872190b,,Neoadjuvant,,2025-10-08T12:38:51.189053-05:00,HCM-EXPT-1212-C25_treatment,869aa506-ed2a-4ca0-9c2a-6ddc85148073,,released,,unknown,2023-02-24T13:50:53.713436-06:00,"Pharmaceutical Therapy, NOS",,
HCM-EXPT-1212-C25,40357899-a869-431e-8f60-20a7c69522ae,b7e04757-6702-4637-99a1-ad115872190b,,Neoadjuvant,,2025-10-08T12:38:51.189053-05:00,HCM-EXPT-1212-C25_treatment2,fe2f2b28-95d1-4e2a-bffd-5784f7b08515,,released,,unknown,2023-02-24T13:50:53.713436-06:00,"Radiation Therapy, NOS",,
HCM-SANG-0306-C15,40520215-88c6-4cab-8f58-af3936a8faba,cf7f6f4d-cba6-4ca4-bd3b-ecd6e483a946,,Neoadjuvant,140.0,2023-03-13T13:32:18.365304-05:00,HCM-SANG-0306-C15_treatment4,6d3a610b-f07d-49b4-bfde-8985776113b7,,released,,1,2021-12-21T15:10:53.904524-06:00,Chemotherapy,,ECX
HCM-SANG-0306-C15,40520215-88c6-4cab-8f58-af3936a8faba,cf7f6f4d-cba6-4ca4-bd3b-ecd6e483a946,,Neoadjuvant,140.0,2023-03-13T13:32:18.365304-05:00,HCM-SANG-0306-C15_treatment2,719bc294-05d6-4be7-89c1-888d14ad3804,,released,Capecitabine,1,2021-12-21T15:10:53.904524-06:00,Chemotherapy,,
HCM-SANG-0306-C15,40520215-88c6-4cab-8f58-af3936a8faba,cf7f6f4d-cba6-4ca4-bd3b-ecd6e483a946,,Neoadjuvant,140.0,2023-03-13T13:32:18.365304-05:00,HCM-SANG-0306-C15_treatment3,8552fe99-f54b-4eaf-8970-1a86408e3f49,,released,Cisplatin,1,2021-12-21T15:10:53.904524-06:00,Chemotherapy,,
HCM-SANG-0306-C15,40520215-88c6-4cab-8f58-af3936a8faba,cf7f6f4d-cba6-4ca4-bd3b-ecd6e483a946,,Neoadjuvant,140.0,2023-03-13T13:32:18.365304-05:00,HCM-SANG-0306-C15_treatment,c52b5fed-94a8-47f3-86a4-a3344df93c47,,released,Epirubicin,1,2021-12-21T15:10:53.904524-06:00,Chemotherapy,,
HCM-BROD-0112-C25,41537847-e29c-446a-b83b-ef0bb5085c75,778b73fd-b284-4c2f-8c1d-bdb75d23f15d,,Adjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0112-C25_treatment10,128d88ed-fa0d-44a7-b940-bd4af7da99df,,released,,0,2020-09-17T15:48:24.843145-05:00,"Radiation Therapy, NOS",Residual Disease,
HCM-BROD-0112-C25,41537847-e29c-446a-b83b-ef0bb5085c75,778b73fd-b284-4c2f-8c1d-bdb75d23f15d,,Adjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0112-C25_treatment6,2511db6c-59b0-4fd0-aa91-3c18933dc85f,,released,,0,2020-09-17T15:48:24.843145-05:00,Chemotherapy,Residual Disease,
HCM-BROD-0112-C25,41537847-e29c-446a-b83b-ef0bb5085c75,778b73fd-b284-4c2f-8c1d-bdb75d23f15d,,Neoadjuvant,10.0,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0112-C25_treatment4,52f2b11f-1109-4476-8880-1f0251d7d6c5,,released,Oxaliplatin,1,2020-09-17T15:48:24.843145-05:00,Chemotherapy,,
HCM-BROD-0112-C25,41537847-e29c-446a-b83b-ef0bb5085c75,778b73fd-b284-4c2f-8c1d-bdb75d23f15d,,Adjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0112-C25_treatment7,61232390-5d9b-452f-95cf-5cc91833bae7,,released,,0,2020-09-17T15:48:24.843145-05:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-BROD-0112-C25,41537847-e29c-446a-b83b-ef0bb5085c75,778b73fd-b284-4c2f-8c1d-bdb75d23f15d,,Neoadjuvant,10.0,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0112-C25_treatment,9152c739-223d-4add-99ca-6f91c1c860d7,,released,Irinotecan Hydrochloride,1,2020-09-17T15:48:24.843145-05:00,Chemotherapy,,
HCM-BROD-0112-C25,41537847-e29c-446a-b83b-ef0bb5085c75,778b73fd-b284-4c2f-8c1d-bdb75d23f15d,,Neoadjuvant,10.0,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0112-C25_treatment3,ad5f8972-07cf-4ec8-a661-d149d380d6c2,,released,Fluorouracil,1,2020-09-17T15:48:24.843145-05:00,Chemotherapy,,
HCM-BROD-0112-C25,41537847-e29c-446a-b83b-ef0bb5085c75,778b73fd-b284-4c2f-8c1d-bdb75d23f15d,,,,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0112-C25_treatment8,bac62e6c-f523-4fb2-ad65-e54aa47249a3,,released,,0,2020-09-17T15:48:24.843145-05:00,"Surgery, NOS",Initial Diagnosis,
HCM-BROD-0112-C25,41537847-e29c-446a-b83b-ef0bb5085c75,778b73fd-b284-4c2f-8c1d-bdb75d23f15d,,Neoadjuvant,10.0,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0112-C25_treatment5,db2187c3-b8ca-4d8d-97bd-49db0f71a871,,released,,1,2020-09-17T15:48:24.843145-05:00,Chemotherapy,,FOLFIRINOX
HCM-BROD-0112-C25,41537847-e29c-446a-b83b-ef0bb5085c75,778b73fd-b284-4c2f-8c1d-bdb75d23f15d,,Neoadjuvant,10.0,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0112-C25_treatment2,dc339feb-ef89-4177-a210-f1e4103db8c4,,released,Leucovorin Calcium,1,2020-09-17T15:48:24.843145-05:00,Chemotherapy,,
HCM-BROD-0112-C25,41537847-e29c-446a-b83b-ef0bb5085c75,778b73fd-b284-4c2f-8c1d-bdb75d23f15d,,Adjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0112-C25_treatment9,f79e2c34-9bf3-47b5-977a-c10ef4d88011,,released,,0,2020-09-17T15:48:24.843145-05:00,Targeted Molecular Therapy,Residual Disease,
HCM-BROD-0690-C43,427b401b-b73a-450d-ad99-028033c6aa54,04f68b24-0175-4ded-867e-d6a11c534996,,Neoadjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0690-C43_treatment,6254a9dd-1b7d-4376-8402-52bd1f200369,,released,,0,2021-12-21T13:45:27.089477-06:00,,,
HCM-BROD-0690-C43,427b401b-b73a-450d-ad99-028033c6aa54,04f68b24-0175-4ded-867e-d6a11c534996,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0690-C43_treatment6,7893e1f9-493c-4dae-83bf-cdb7497798ac,,released,,0,2021-12-21T13:45:27.089477-06:00,Targeted Molecular Therapy,Residual Disease,
HCM-BROD-0690-C43,427b401b-b73a-450d-ad99-028033c6aa54,04f68b24-0175-4ded-867e-d6a11c534996,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0690-C43_treatment3,a0c7af63-e1fd-4d06-8670-de3a0e0bc563,,released,,0,2021-12-21T13:45:27.089477-06:00,Hormone Therapy,Residual Disease,
HCM-BROD-0690-C43,427b401b-b73a-450d-ad99-028033c6aa54,04f68b24-0175-4ded-867e-d6a11c534996,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0690-C43_treatment2,b5693e5e-75c6-41da-8e7c-2d0b27cd2dc3,,released,,0,2021-12-21T13:45:27.089477-06:00,Chemotherapy,Residual Disease,
HCM-BROD-0690-C43,427b401b-b73a-450d-ad99-028033c6aa54,04f68b24-0175-4ded-867e-d6a11c534996,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0690-C43_treatment7,e9652c2e-f98e-4a05-bafa-fc5a715503e1,,released,,0,2021-12-21T13:45:27.089477-06:00,"Radiation Therapy, NOS",Residual Disease,
HCM-BROD-0690-C43,427b401b-b73a-450d-ad99-028033c6aa54,04f68b24-0175-4ded-867e-d6a11c534996,2397.0,Adjuvant,2331.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0690-C43_treatment4,f1453efd-d21e-47d0-90b8-d35103c6259a,,released,Ipilimumab,1,2021-12-21T13:45:27.089477-06:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-BROD-0690-C43,427b401b-b73a-450d-ad99-028033c6aa54,04f68b24-0175-4ded-867e-d6a11c534996,,,0.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0690-C43_treatment5,f28e7a14-6e30-46f0-b337-dbceeb4b70ca,,released,,1,2021-12-21T13:45:27.089477-06:00,"Surgery, NOS",Initial Diagnosis,
HCM-BROD-0690-C43,427b401b-b73a-450d-ad99-028033c6aa54,5e3015c5-bedb-48f8-900d-aaeef0204c38,2219.0,Maintenance Therapy,1973.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0690-C43_treatment8,c7a32724-90de-4f44-9a32-946956d42b7a,Not Reported,released,Temozolomide,1,2021-12-21T13:45:27.089477-06:00,,,
HCM-BROD-0025-C16,42d1a293-4c3b-496b-92b5-7482c8020751,d27c6e9b-79d8-43ac-80bc-fca9e7ca8242,,Neoadjuvant,,2021-03-03T15:15:08.075155-06:00,HCM-BROD-0025-C16_treatment,236d8b19-0c6c-43bd-93e6-dd5d39913e67,,released,Unknown,1,2019-04-04T14:02:39.021089-05:00,Chemotherapy,,
HCM-BROD-0025-C16,42d1a293-4c3b-496b-92b5-7482c8020751,d27c6e9b-79d8-43ac-80bc-fca9e7ca8242,206.0,Adjuvant,165.0,2021-03-03T15:15:08.075155-06:00,HCM-BROD-0025-C16_treatment2,5a1c30a2-5587-4bed-946e-9c5d767be5ae,,released,Docetaxel,1,2019-04-04T14:02:39.021089-05:00,Chemotherapy,Residual Disease,
HCM-BROD-0025-C16,42d1a293-4c3b-496b-92b5-7482c8020751,d27c6e9b-79d8-43ac-80bc-fca9e7ca8242,206.0,Adjuvant,165.0,2021-03-03T15:15:08.075155-06:00,HCM-BROD-0025-C16_treatment4,6ff85af0-faa6-4ec9-8658-ba6a54ff06e5,,released,Fluorouracil,1,2019-04-04T14:02:39.021089-05:00,Chemotherapy,Residual Disease,
HCM-BROD-0025-C16,42d1a293-4c3b-496b-92b5-7482c8020751,d27c6e9b-79d8-43ac-80bc-fca9e7ca8242,206.0,Adjuvant,165.0,2021-03-03T15:15:08.075155-06:00,HCM-BROD-0025-C16_treatment3,76125707-39fc-4e5f-87cd-154308eca7af,,released,Cisplatin,1,2019-04-04T14:02:39.021089-05:00,Chemotherapy,Residual Disease,
HCM-BROD-0025-C16,42d1a293-4c3b-496b-92b5-7482c8020751,d27c6e9b-79d8-43ac-80bc-fca9e7ca8242,,Adjuvant,,2021-03-03T15:15:08.075155-06:00,HCM-BROD-0025-C16_treatment8,80ca8767-36ed-4c26-9f23-4d2c79945ad8,,released,,0,2020-09-27T10:06:56.872923-05:00,"Radiation Therapy, NOS",Residual Disease,
HCM-BROD-0025-C16,42d1a293-4c3b-496b-92b5-7482c8020751,d27c6e9b-79d8-43ac-80bc-fca9e7ca8242,,,104.0,2023-03-13T13:31:42.178829-05:00,HCM-BROD-0025-C16_treatment6,821a0f60-f405-451e-a36e-b46769a6a016,,released,,1,2019-04-04T14:02:39.021089-05:00,"Surgery, NOS",Initial Diagnosis,
HCM-BROD-0025-C16,42d1a293-4c3b-496b-92b5-7482c8020751,d27c6e9b-79d8-43ac-80bc-fca9e7ca8242,,Adjuvant,,2021-03-03T15:15:08.075155-06:00,HCM-BROD-0025-C16_treatment5,a2452e3c-3cb4-4a9f-a262-ed056eb1ceb7,,released,,0,2019-04-04T14:02:39.021089-05:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-BROD-0025-C16,42d1a293-4c3b-496b-92b5-7482c8020751,d27c6e9b-79d8-43ac-80bc-fca9e7ca8242,,Adjuvant,,2021-03-03T15:15:08.075155-06:00,HCM-BROD-0025-C16_treatment7,a89e29a0-feab-46dc-88e3-17873842f321,,released,,0,2020-09-27T10:06:56.872923-05:00,Targeted Molecular Therapy,Residual Disease,
HCM-BROD-1104-C85,42f8ece8-70dc-48b8-a9ec-28dc218a735a,84583c76-531a-402b-aa22-28ec99bda9e6,,,,2025-04-07T17:13:09.336794-05:00,HCM-BROD-1104-C85_treatment2,1bc57c0a-d348-46f2-a410-dc0dea8e72cc,,released,,0,2021-12-21T15:24:48.933387-06:00,"Surgery, NOS",Initial Diagnosis,
HCM-BROD-1104-C85,42f8ece8-70dc-48b8-a9ec-28dc218a735a,84583c76-531a-402b-aa22-28ec99bda9e6,,Neoadjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-BROD-1104-C85_treatment,1c303fca-0d83-4922-8cf5-69ea559de8c8,,released,,0,2021-12-21T15:24:48.933387-06:00,,,
HCM-SANG-0528-C25,4362ae25-19a3-4d5c-b608-af73414f1aa3,ed70022f-2cd2-4394-8140-6b038c27f6cf,,Neoadjuvant,684.0,2025-03-31T16:34:59.906497-05:00,HCM-SANG-0528-C25_treatment3,41aa943d-0787-4eca-9805-a42acc41abea,,released,Dexamethasone,1,2021-12-21T15:13:36.893598-06:00,Chemotherapy,,
HCM-SANG-0528-C25,4362ae25-19a3-4d5c-b608-af73414f1aa3,ed70022f-2cd2-4394-8140-6b038c27f6cf,,Neoadjuvant,684.0,2025-03-31T16:34:59.906497-05:00,HCM-SANG-0528-C25_treatment2,63b245dc-0d13-4f81-8963-e6e4b1ffd7ab,,released,Oxaliplatin,1,2021-12-21T15:13:36.893598-06:00,Chemotherapy,,
HCM-SANG-0528-C25,4362ae25-19a3-4d5c-b608-af73414f1aa3,ed70022f-2cd2-4394-8140-6b038c27f6cf,,Neoadjuvant,684.0,2025-03-31T16:34:59.906497-05:00,HCM-SANG-0528-C25_treatment,e88747b6-3443-43b2-a130-a9b9da8d6a5e,,released,Fluorouracil,1,2021-12-21T15:13:36.893598-06:00,Chemotherapy,,
HCM-EXPT-1005-C25,43c1f1bf-953f-4fe9-9756-f747c55232e5,46c2a09f-b267-4e23-92d4-bc93c4181284,,Neoadjuvant,,2025-10-08T12:37:43.816130-05:00,HCM-EXPT-1005-C25_treatment,61166e46-5a24-485c-b8d4-c6f19458860c,,released,,0,2021-12-21T14:54:12.367622-06:00,,,
HCM-SANG-0298-C15,43cf7159-9c43-4a01-91ef-ca5df26acfca,65068696-aca2-40eb-af2e-8a07e86397e8,,Neoadjuvant,92.0,2023-03-13T13:04:40.693103-05:00,HCM-SANG-0298-C15_treatment3,55a41344-9ed1-42d5-87b1-78a6e605fd88,,released,Cisplatin,1,2021-12-21T15:09:06.137162-06:00,Chemotherapy,,
HCM-SANG-0298-C15,43cf7159-9c43-4a01-91ef-ca5df26acfca,65068696-aca2-40eb-af2e-8a07e86397e8,,Neoadjuvant,92.0,2023-03-13T13:04:40.693103-05:00,HCM-SANG-0298-C15_treatment,a946aaa8-c5af-467f-a66d-2fc99ef34152,,released,Epirubicin,1,2021-12-21T15:09:06.137162-06:00,Chemotherapy,,
HCM-SANG-0298-C15,43cf7159-9c43-4a01-91ef-ca5df26acfca,65068696-aca2-40eb-af2e-8a07e86397e8,,Neoadjuvant,92.0,2023-03-13T13:04:40.693103-05:00,HCM-SANG-0298-C15_treatment2,d1a796ca-9c03-4b40-a9ca-d0e44c51e88c,,released,Capecitabine,1,2021-12-21T15:09:06.137162-06:00,Chemotherapy,,
HCM-SANG-0298-C15,43cf7159-9c43-4a01-91ef-ca5df26acfca,65068696-aca2-40eb-af2e-8a07e86397e8,,Neoadjuvant,92.0,2023-03-13T13:04:40.693103-05:00,HCM-SANG-0298-C15_treatment4,e2ef89c1-73a0-4bbc-ab3e-7d202e119ae7,,released,,1,2021-12-21T15:09:06.137162-06:00,Chemotherapy,,ECX
HCM-CSHL-1267-C22,43e0c10d-9f88-4715-b476-9ce8f9f8f421,211556b7-56f4-4d25-a0fc-545ea9d62422,,Adjuvant,,2025-08-20T09:56:36.143985-05:00,HCM-CSHL-1267-C22_treatment4,75f17e3a-4cd3-4e51-af00-be22fac6caa0,,released,,0,2021-12-23T08:34:54.455384-06:00,"Radiation Therapy, NOS",Residual Disease,
HCM-CSHL-1267-C22,43e0c10d-9f88-4715-b476-9ce8f9f8f421,211556b7-56f4-4d25-a0fc-545ea9d62422,,Adjuvant,,2025-08-20T09:56:36.143985-05:00,HCM-CSHL-1267-C22_treatment3,9044f3f4-772b-4edf-8c35-dc7499cb414f,,released,,0,2021-12-23T08:34:54.455384-06:00,"Pharmaceutical Therapy, NOS",Residual Disease,
HCM-CSHL-1267-C22,43e0c10d-9f88-4715-b476-9ce8f9f8f421,211556b7-56f4-4d25-a0fc-545ea9d62422,,Neoadjuvant,,2025-08-20T09:56:36.143985-05:00,HCM-CSHL-1267-C22_treatment,bb973852-36be-401b-b374-e395b327f95e,,released,,0,2021-12-23T08:34:54.455384-06:00,,,
HCM-CSHL-1267-C22,43e0c10d-9f88-4715-b476-9ce8f9f8f421,211556b7-56f4-4d25-a0fc-545ea9d62422,,,-53.0,2025-08-20T09:56:36.143985-05:00,HCM-CSHL-1267-C22_treatment2,ca636eb0-4713-434b-8a84-510f87ef3aaf,,released,,1,2021-12-23T08:34:54.455384-06:00,"Surgery, NOS",Initial Diagnosis,
HCM-EXPT-1056-C50,44025d79-fb5a-4fc5-b5ed-8db867df9893,0e02e2d1-c8fe-46cc-81a9-df81604d8097,,Neoadjuvant,,2025-10-08T12:38:06.952582-05:00,HCM-EXPT-1056-C50_treatment,5096d293-e26b-41ea-8e3c-a63d8a3a4619,,released,,0,2021-12-21T15:01:53.442540-06:00,,,
HCM-BROD-0703-C16,45ae5a7e-95c8-453c-bd9d-446cd0f3734e,8720807f-d6d0-404d-b312-5e812ef4f0e9,363.0,Maintenance Therapy,307.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0703-C16_treatment17,3d670f4c-2415-4421-a5de-566a1b855684,Progressive Disease,released,Ramucirumab,1,2021-12-21T13:46:04.444314-06:00,,,
HCM-BROD-0703-C16,45ae5a7e-95c8-453c-bd9d-446cd0f3734e,8720807f-d6d0-404d-b312-5e812ef4f0e9,363.0,Maintenance Therapy,307.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0703-C16_treatment18,8c1927f1-e9e1-42c7-84a0-d3d425b63207,Progressive Disease,released,Paclitaxel,1,2021-12-21T13:46:04.444314-06:00,,,
HCM-BROD-0703-C16,45ae5a7e-95c8-453c-bd9d-446cd0f3734e,ad1eb6a6-dc4a-40b9-8d85-3d99e529124b,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0703-C16_treatment12,05e46ac1-4940-42e3-bde5-1132bfa11c52,,released,,0,2021-12-21T13:46:04.444314-06:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-BROD-0703-C16,45ae5a7e-95c8-453c-bd9d-446cd0f3734e,ad1eb6a6-dc4a-40b9-8d85-3d99e529124b,,Neoadjuvant,307.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0703-C16_treatment6,0abd9b56-6c29-4d2c-a976-be2dce6f5c80,,released,Ramucirumab,1,2021-12-21T13:46:04.444314-06:00,Targeted Molecular Therapy,,
HCM-BROD-0703-C16,45ae5a7e-95c8-453c-bd9d-446cd0f3734e,ad1eb6a6-dc4a-40b9-8d85-3d99e529124b,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0703-C16_treatment16,0b39bd18-405e-4d0e-ab06-a438df65a7c4,,released,,0,2021-12-21T13:46:04.444314-06:00,"Radiation Therapy, NOS",Residual Disease,
HCM-BROD-0703-C16,45ae5a7e-95c8-453c-bd9d-446cd0f3734e,ad1eb6a6-dc4a-40b9-8d85-3d99e529124b,,Neoadjuvant,11.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0703-C16_treatment3,2194c2a1-dd57-40e8-9398-844cffa264d9,,released,Oxaliplatin,1,2021-12-21T13:46:04.444314-06:00,Chemotherapy,,
HCM-BROD-0703-C16,45ae5a7e-95c8-453c-bd9d-446cd0f3734e,ad1eb6a6-dc4a-40b9-8d85-3d99e529124b,,Neoadjuvant,11.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0703-C16_treatment2,21b971c1-619f-4743-87dd-a4090d1d20ae,,released,Leucovorin Calcium,1,2021-12-21T13:46:04.444314-06:00,Chemotherapy,,
HCM-BROD-0703-C16,45ae5a7e-95c8-453c-bd9d-446cd0f3734e,ad1eb6a6-dc4a-40b9-8d85-3d99e529124b,,Neoadjuvant,11.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0703-C16_treatment4,5a7b6f15-a0f5-476d-9dc5-d01010b75c61,,released,Paclitaxel,1,2021-12-21T13:46:04.444314-06:00,Chemotherapy,,
HCM-BROD-0703-C16,45ae5a7e-95c8-453c-bd9d-446cd0f3734e,ad1eb6a6-dc4a-40b9-8d85-3d99e529124b,477.0,Adjuvant,381.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0703-C16_treatment15,5ab72e28-8f5d-4134-9076-1723a953eefc,,released,Erdafitinib,1,2021-12-21T13:46:04.444314-06:00,Targeted Molecular Therapy,Residual Disease,
HCM-BROD-0703-C16,45ae5a7e-95c8-453c-bd9d-446cd0f3734e,ad1eb6a6-dc4a-40b9-8d85-3d99e529124b,306.0,Adjuvant,11.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0703-C16_treatment10,6eaee507-448a-495e-ab23-0c080d4daae1,,released,,1,2021-12-21T13:46:04.444314-06:00,Chemotherapy,Residual Disease,FOLFOX
HCM-BROD-0703-C16,45ae5a7e-95c8-453c-bd9d-446cd0f3734e,ad1eb6a6-dc4a-40b9-8d85-3d99e529124b,,Neoadjuvant,11.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0703-C16_treatment,7369b421-f7bb-4d18-965d-6349dde25155,,released,Fluorouracil,1,2021-12-21T13:46:04.444314-06:00,Chemotherapy,,
HCM-BROD-0703-C16,45ae5a7e-95c8-453c-bd9d-446cd0f3734e,ad1eb6a6-dc4a-40b9-8d85-3d99e529124b,306.0,Adjuvant,11.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0703-C16_treatment9,7b356d44-ef99-4f92-b801-794ff0a1af2f,,released,Oxaliplatin,1,2021-12-21T13:46:04.444314-06:00,Chemotherapy,Residual Disease,
HCM-BROD-0703-C16,45ae5a7e-95c8-453c-bd9d-446cd0f3734e,ad1eb6a6-dc4a-40b9-8d85-3d99e529124b,,,,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0703-C16_treatment13,ae424bce-3722-4c13-a592-b867a5ed5ea3,,released,,0,2021-12-21T13:46:04.444314-06:00,"Surgery, NOS",Initial Diagnosis,
HCM-BROD-0703-C16,45ae5a7e-95c8-453c-bd9d-446cd0f3734e,ad1eb6a6-dc4a-40b9-8d85-3d99e529124b,477.0,Adjuvant,381.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0703-C16_treatment11,ae7ee945-c48a-4c04-b60d-1407e2dc72ac,,released,Paclitaxel,1,2021-12-21T13:46:04.444314-06:00,Chemotherapy,Residual Disease,
HCM-BROD-0703-C16,45ae5a7e-95c8-453c-bd9d-446cd0f3734e,ad1eb6a6-dc4a-40b9-8d85-3d99e529124b,306.0,Adjuvant,11.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0703-C16_treatment8,c0ef904e-cacf-45d9-81de-67e1140d278c,,released,Fluorouracil,1,2021-12-21T13:46:04.444314-06:00,Chemotherapy,Residual Disease,
HCM-BROD-0703-C16,45ae5a7e-95c8-453c-bd9d-446cd0f3734e,ad1eb6a6-dc4a-40b9-8d85-3d99e529124b,363.0,Adjuvant,307.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0703-C16_treatment14,c772185d-a486-4255-9c28-8790d4652d81,,released,Ramucirumab,1,2021-12-21T13:46:04.444314-06:00,Targeted Molecular Therapy,Residual Disease,
HCM-BROD-0703-C16,45ae5a7e-95c8-453c-bd9d-446cd0f3734e,ad1eb6a6-dc4a-40b9-8d85-3d99e529124b,,Neoadjuvant,11.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0703-C16_treatment5,d5b382fa-acb4-43c0-bf16-0d131360c073,,released,,1,2021-12-21T13:46:04.444314-06:00,Chemotherapy,,FOLFOX
HCM-BROD-0703-C16,45ae5a7e-95c8-453c-bd9d-446cd0f3734e,ad1eb6a6-dc4a-40b9-8d85-3d99e529124b,306.0,Adjuvant,11.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0703-C16_treatment7,ff29495a-585d-4c85-893a-9d8c96e8e5df,,released,Leucovorin Calcium,1,2021-12-21T13:46:04.444314-06:00,Chemotherapy,Residual Disease,
HCM-BROD-0138-C25,45f60f6f-3ee8-4da5-b3de-bd5e29b25198,dca73664-3063-4032-b33b-140bb6bda50a,,Adjuvant,,2023-03-13T12:58:53.847307-05:00,HCM-BROD-0138-C25_treatment3,74dbf001-8d27-47ce-9420-b6222f6ec47f,,released,,0,2020-03-26T12:54:12.737375-05:00,"Pharmaceutical Therapy, NOS",Residual Disease,
HCM-BROD-0138-C25,45f60f6f-3ee8-4da5-b3de-bd5e29b25198,dca73664-3063-4032-b33b-140bb6bda50a,,,,2023-03-13T12:58:53.847307-05:00,HCM-BROD-0138-C25_treatment2,801afd8d-6712-4f88-ab42-2fca29b0bbcc,,released,,0,2019-04-16T11:22:52.061182-05:00,"Surgery, NOS",Initial Diagnosis,
HCM-BROD-0138-C25,45f60f6f-3ee8-4da5-b3de-bd5e29b25198,dca73664-3063-4032-b33b-140bb6bda50a,,Neoadjuvant,,2023-02-22T07:39:25.979291-06:00,HCM-BROD-0138-C25_treatment,d39e249c-0d10-4c0f-9ecd-641706212596,,released,,0,2019-04-16T11:22:52.061182-05:00,,,
HCM-BROD-0138-C25,45f60f6f-3ee8-4da5-b3de-bd5e29b25198,dca73664-3063-4032-b33b-140bb6bda50a,,Adjuvant,,2023-03-13T12:58:53.847307-05:00,HCM-BROD-0138-C25_treatment4,d7495088-c248-4233-8806-eb0a0aba1d7d,,released,,0,2020-03-26T12:54:12.737375-05:00,"Radiation Therapy, NOS",Residual Disease,
HCM-EXPT-1011-C50,4677f7c1-8953-4f64-8722-4574f1a8ebef,d10b923a-c177-4972-998c-934b9ab406f2,,Neoadjuvant,,2025-10-08T12:37:43.816130-05:00,HCM-EXPT-1011-C50_treatment4,5187fdf0-e035-4169-ac5d-8cd2f93c7e11,,released,,1,2021-12-21T14:54:30.095464-06:00,Chemotherapy,,
HCM-EXPT-1011-C50,4677f7c1-8953-4f64-8722-4574f1a8ebef,d10b923a-c177-4972-998c-934b9ab406f2,,Neoadjuvant,,2025-10-08T12:37:43.816130-05:00,HCM-EXPT-1011-C50_treatment,7cc1b0ad-9cbb-491a-a95b-e8b058269372,,released,Cyclophosphamide,1,2021-12-21T14:54:30.095464-06:00,Chemotherapy,,
HCM-EXPT-1011-C50,4677f7c1-8953-4f64-8722-4574f1a8ebef,d10b923a-c177-4972-998c-934b9ab406f2,,Neoadjuvant,,2025-10-08T12:37:43.816130-05:00,HCM-EXPT-1011-C50_treatment3,a7f29f8f-7564-4d29-86b5-d70cc22b7421,,released,Paclitaxel,1,2021-12-21T14:54:30.095464-06:00,Chemotherapy,,
HCM-EXPT-1011-C50,4677f7c1-8953-4f64-8722-4574f1a8ebef,d10b923a-c177-4972-998c-934b9ab406f2,,Neoadjuvant,,2025-10-08T12:37:43.816130-05:00,HCM-EXPT-1011-C50_treatment2,b11624ac-3d7f-45ad-bb61-9af27d101f29,,released,Pegylated Liposomal Doxorubicin Hydrochloride,1,2021-12-21T14:54:30.095464-06:00,Chemotherapy,,
HCM-BROD-0051-C64,46b1210c-4042-4c67-9e68-06e960f201f2,31003449-79c0-4c54-a2bd-4604737894e1,,Maintenance Therapy,,2021-08-05T13:55:08.207361-05:00,HCM-BROD-0051-C64_treatment11,09b8e78f-b8e8-4047-8d25-31b1d21160a2,Not Reported,released,Etoposide,1,2020-09-27T10:18:35.076340-05:00,,Progressive Disease,
HCM-BROD-0051-C64,46b1210c-4042-4c67-9e68-06e960f201f2,31003449-79c0-4c54-a2bd-4604737894e1,,Neoadjuvant,61.0,2021-07-12T12:25:55.528644-05:00,HCM-BROD-0051-C64_treatment3,3b596e47-6f1a-4ffe-b5ff-84a92b20a855,,released,Vincristine,1,2019-04-04T13:42:46.632048-05:00,Chemotherapy,,
HCM-BROD-0051-C64,46b1210c-4042-4c67-9e68-06e960f201f2,31003449-79c0-4c54-a2bd-4604737894e1,,Maintenance Therapy,,2021-08-05T13:55:08.207361-05:00,HCM-BROD-0051-C64_treatment7,622bd277-a796-430f-a866-70944295fdd4,Not Reported,released,Dactinomycin,1,2020-02-27T12:17:46.865711-06:00,,Progressive Disease,
HCM-BROD-0051-C64,46b1210c-4042-4c67-9e68-06e960f201f2,31003449-79c0-4c54-a2bd-4604737894e1,,Maintenance Therapy,,2021-08-05T13:55:08.207361-05:00,HCM-BROD-0051-C64_treatment10,6a531eb9-d50d-4e34-842a-38e62de4d159,Not Reported,released,Doxorubicin,1,2020-09-27T10:18:35.076340-05:00,,Progressive Disease,
HCM-BROD-0051-C64,46b1210c-4042-4c67-9e68-06e960f201f2,31003449-79c0-4c54-a2bd-4604737894e1,,Maintenance Therapy,,2021-08-05T13:55:08.207361-05:00,HCM-BROD-0051-C64_treatment12,6e1a74b9-749d-49c9-a6b8-b7ca25b38a36,Not Reported,released,,1,2020-09-27T10:18:35.076340-05:00,,Progressive Disease,DD4A
HCM-BROD-0051-C64,46b1210c-4042-4c67-9e68-06e960f201f2,31003449-79c0-4c54-a2bd-4604737894e1,,Neoadjuvant,61.0,2021-07-12T12:25:55.528644-05:00,HCM-BROD-0051-C64_treatment2,9432d678-4537-4bc9-a341-89b2477580fa,,released,Etoposide,1,2019-04-04T13:42:46.632048-05:00,Chemotherapy,,
HCM-BROD-0051-C64,46b1210c-4042-4c67-9e68-06e960f201f2,31003449-79c0-4c54-a2bd-4604737894e1,,Neoadjuvant,61.0,2021-07-12T12:25:55.528644-05:00,HCM-BROD-0051-C64_treatment,a3f6e8e1-b05a-461c-aabf-c4cd73fd9982,,released,Doxorubicin Hydrochloride,1,2019-04-04T13:42:46.632048-05:00,Chemotherapy,,
HCM-BROD-0051-C64,46b1210c-4042-4c67-9e68-06e960f201f2,31003449-79c0-4c54-a2bd-4604737894e1,,Neoadjuvant,61.0,2021-08-05T13:55:08.207361-05:00,HCM-BROD-0051-C64_treatment5,a6fbc0ec-0453-46d0-a839-532d660a1f25,,released,Cyclophosphamide,1,2019-04-04T13:42:46.632048-05:00,Chemotherapy,,
HCM-BROD-0051-C64,46b1210c-4042-4c67-9e68-06e960f201f2,31003449-79c0-4c54-a2bd-4604737894e1,,Maintenance Therapy,,2021-08-05T13:55:08.207361-05:00,HCM-BROD-0051-C64_treatment8,b2f466bb-355d-41c1-88f8-43ef98388590,Not Reported,released,Vincristine,1,2020-02-27T12:17:46.865711-06:00,,Progressive Disease,
HCM-BROD-0051-C64,46b1210c-4042-4c67-9e68-06e960f201f2,31003449-79c0-4c54-a2bd-4604737894e1,,Neoadjuvant,122.0,2021-08-05T13:55:08.207361-05:00,HCM-BROD-0051-C64_treatment13,cda66db0-5e1c-4771-96e8-54494030e0a6,,released,,1,2020-09-27T10:18:35.076340-05:00,"Radiation Therapy, NOS",,
HCM-BROD-0051-C64,46b1210c-4042-4c67-9e68-06e960f201f2,31003449-79c0-4c54-a2bd-4604737894e1,,Neoadjuvant,61.0,2021-08-05T13:55:08.207361-05:00,HCM-BROD-0051-C64_treatment4,dc2f616d-900f-4546-87fc-dbe484d679dc,,released,Dactinomycin,1,2019-04-04T13:42:46.632048-05:00,Chemotherapy,,
HCM-BROD-0051-C64,46b1210c-4042-4c67-9e68-06e960f201f2,31003449-79c0-4c54-a2bd-4604737894e1,,Neoadjuvant,61.0,2021-08-05T13:55:08.207361-05:00,HCM-BROD-0051-C64_treatment6,dec955e4-9ab5-4c86-8722-9138565a61be,,released,,1,2019-04-04T13:42:46.632048-05:00,Chemotherapy,,VAC
HCM-BROD-0051-C64,46b1210c-4042-4c67-9e68-06e960f201f2,31003449-79c0-4c54-a2bd-4604737894e1,,Maintenance Therapy,,2021-08-05T13:55:08.207361-05:00,HCM-BROD-0051-C64_treatment9,ea55d05b-9a98-428b-9c51-a4fbcd962a6c,Not Reported,released,Cyclophosphamide,1,2020-02-27T12:17:46.865711-06:00,,Progressive Disease,
HCM-BROD-0335-C43,47322ea3-6bbe-442b-a656-c48469cc99c1,207053c5-a053-449c-94c4-a3e36f19b161,,Adjuvant,,2021-07-12T12:25:55.528644-05:00,HCM-BROD-0335-C43_treatment7,50431878-a88e-451c-89ae-9e0c9362157a,,released,,0,2020-09-17T16:10:31.527022-05:00,"Radiation Therapy, NOS",Residual Disease,
HCM-BROD-0335-C43,47322ea3-6bbe-442b-a656-c48469cc99c1,207053c5-a053-449c-94c4-a3e36f19b161,278.0,Adjuvant,171.0,2021-07-12T12:25:55.528644-05:00,HCM-BROD-0335-C43_treatment4,754099ca-0b2d-4f17-a2c8-7114322eaddd,,released,Not Reported,1,2020-09-17T16:10:31.527022-05:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-BROD-0335-C43,47322ea3-6bbe-442b-a656-c48469cc99c1,207053c5-a053-449c-94c4-a3e36f19b161,,Adjuvant,,2021-07-12T12:25:55.528644-05:00,HCM-BROD-0335-C43_treatment3,765105fd-a45f-4486-be8a-7b1174ca5063,,released,,0,2020-09-17T16:10:31.527022-05:00,Hormone Therapy,Residual Disease,
HCM-BROD-0335-C43,47322ea3-6bbe-442b-a656-c48469cc99c1,207053c5-a053-449c-94c4-a3e36f19b161,,Neoadjuvant,,2021-07-12T12:25:55.528644-05:00,HCM-BROD-0335-C43_treatment,9308453c-950a-45eb-a57c-cdafc5ec5daa,,released,,0,2020-09-17T16:10:31.527022-05:00,,,
HCM-BROD-0335-C43,47322ea3-6bbe-442b-a656-c48469cc99c1,207053c5-a053-449c-94c4-a3e36f19b161,,Adjuvant,,2021-07-12T12:25:55.528644-05:00,HCM-BROD-0335-C43_treatment6,af689515-a8d3-4e2d-97e9-4fee3e17fddc,,released,,0,2020-09-17T16:10:31.527022-05:00,Targeted Molecular Therapy,Residual Disease,
HCM-BROD-0335-C43,47322ea3-6bbe-442b-a656-c48469cc99c1,207053c5-a053-449c-94c4-a3e36f19b161,,Adjuvant,,2021-07-12T12:25:55.528644-05:00,HCM-BROD-0335-C43_treatment2,bfcc4117-4aff-4d46-852d-05665938a2ad,,released,,0,2020-09-17T16:10:31.527022-05:00,Chemotherapy,Residual Disease,
HCM-BROD-0335-C43,47322ea3-6bbe-442b-a656-c48469cc99c1,207053c5-a053-449c-94c4-a3e36f19b161,,,0.0,2023-02-27T12:14:45.179018-06:00,HCM-BROD-0335-C43_treatment5,dcb06f47-c5a4-458f-ae7a-9479ffa35c90,,released,,1,2020-09-17T16:10:31.527022-05:00,"Surgery, NOS",Initial Diagnosis,
HCM-CSHL-0318-C18,4770c370-5846-49af-bafb-e49229ca2319,ecf8cf14-fb2a-4218-ae3d-63f5d474579d,,Adjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0318-C18_treatment4,1ad9c065-9aeb-47fa-bebd-bf8dcf8f1944,,released,,0,2020-09-28T09:39:00.295202-05:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-CSHL-0318-C18,4770c370-5846-49af-bafb-e49229ca2319,ecf8cf14-fb2a-4218-ae3d-63f5d474579d,,,27.0,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0318-C18_treatment5,1ed785ea-942b-4cd7-908a-96e5cabe9c4a,,released,,1,2020-09-28T09:39:00.295202-05:00,"Surgery, NOS",Initial Diagnosis,
HCM-CSHL-0318-C18,4770c370-5846-49af-bafb-e49229ca2319,ecf8cf14-fb2a-4218-ae3d-63f5d474579d,,Adjuvant,64.0,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0318-C18_treatment3,2b6a8389-dc40-4a89-b867-d14b8a79b9ad,,released,Oxaliplatin,1,2020-09-28T09:39:00.295202-05:00,Chemotherapy,Residual Disease,
HCM-CSHL-0318-C18,4770c370-5846-49af-bafb-e49229ca2319,ecf8cf14-fb2a-4218-ae3d-63f5d474579d,,Adjuvant,64.0,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0318-C18_treatment2,37332d6b-66fc-48b3-8129-3cbffb43bd4c,,released,Capecitabine,1,2020-09-28T09:39:00.295202-05:00,Chemotherapy,Residual Disease,
HCM-CSHL-0318-C18,4770c370-5846-49af-bafb-e49229ca2319,ecf8cf14-fb2a-4218-ae3d-63f5d474579d,,Neoadjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0318-C18_treatment,aefd3586-9cc6-4d70-a44d-8ccb15cd83ce,,released,,0,2020-09-28T09:39:00.295202-05:00,,,
HCM-CSHL-0318-C18,4770c370-5846-49af-bafb-e49229ca2319,ecf8cf14-fb2a-4218-ae3d-63f5d474579d,,Adjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0318-C18_treatment6,caf444eb-61b2-430a-a530-a1b99869df5c,,released,,0,2020-09-28T09:39:00.295202-05:00,Targeted Molecular Therapy,Residual Disease,
HCM-BROD-0683-C43,4776d0d4-489f-4fb4-9ab3-03d6790baa66,af74743a-f72a-47e3-9be6-69a4c31a5536,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0683-C43_treatment7,23df4bb2-550b-485e-bf9f-840f91101bf8,,released,,0,2021-12-21T13:45:18.119299-06:00,"Radiation Therapy, NOS",Residual Disease,
HCM-BROD-0683-C43,4776d0d4-489f-4fb4-9ab3-03d6790baa66,af74743a-f72a-47e3-9be6-69a4c31a5536,,,0.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0683-C43_treatment5,3f1f4034-b7f8-420a-aff6-c106b3235d32,,released,,1,2021-12-21T13:45:18.119299-06:00,"Surgery, NOS",Initial Diagnosis,
HCM-BROD-0683-C43,4776d0d4-489f-4fb4-9ab3-03d6790baa66,af74743a-f72a-47e3-9be6-69a4c31a5536,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0683-C43_treatment2,84518389-05a8-4939-a7c6-aae4a1b8ce35,,released,,0,2021-12-21T13:45:18.119299-06:00,Chemotherapy,Residual Disease,
HCM-BROD-0683-C43,4776d0d4-489f-4fb4-9ab3-03d6790baa66,af74743a-f72a-47e3-9be6-69a4c31a5536,436.0,Adjuvant,410.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0683-C43_treatment4,c59c7ef1-df3d-40bd-a8ac-37386cba4f00,,released,Ipilimumab,1,2021-12-21T13:45:18.119299-06:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-BROD-0683-C43,4776d0d4-489f-4fb4-9ab3-03d6790baa66,af74743a-f72a-47e3-9be6-69a4c31a5536,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0683-C43_treatment6,cc0467cc-b634-4373-8a86-92d943155a22,,released,,0,2021-12-21T13:45:18.119299-06:00,Targeted Molecular Therapy,Residual Disease,
HCM-BROD-0683-C43,4776d0d4-489f-4fb4-9ab3-03d6790baa66,af74743a-f72a-47e3-9be6-69a4c31a5536,,Neoadjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0683-C43_treatment,d126e889-c8fc-4ce4-91bd-525eca41ba84,,released,,0,2021-12-21T13:45:18.119299-06:00,,,
HCM-BROD-0683-C43,4776d0d4-489f-4fb4-9ab3-03d6790baa66,af74743a-f72a-47e3-9be6-69a4c31a5536,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0683-C43_treatment3,f7088571-d446-48f6-ac67-e5efa6e7b5a6,,released,,0,2021-12-21T13:45:18.119299-06:00,Hormone Therapy,Residual Disease,
HCM-BROD-0001-C18,4829dd8c-5445-41b3-ae37-bbcc333e8c9e,a7f019db-c623-4d56-94e9-102cc4574f88,,Maintenance Therapy,53.0,2021-07-12T12:25:55.528644-05:00,HCM-BROD-0001-C18_treatment4,0619e104-8110-441b-97ef-a6a13d6823bb,Progressive Disease,released,Oxaliplatin,1,2020-07-31T09:25:24.402855-05:00,,Progressive Disease,
HCM-BROD-0001-C18,4829dd8c-5445-41b3-ae37-bbcc333e8c9e,a7f019db-c623-4d56-94e9-102cc4574f88,,Neoadjuvant,,2021-07-12T12:25:55.528644-05:00,HCM-BROD-0001-C18_treatment6,1c552e4c-343e-4f8b-8f97-20b8991f5bd4,,released,,0,2020-07-31T09:25:24.402855-05:00,,,
HCM-BROD-0001-C18,4829dd8c-5445-41b3-ae37-bbcc333e8c9e,a7f019db-c623-4d56-94e9-102cc4574f88,,Maintenance Therapy,53.0,2021-07-12T12:25:55.528644-05:00,HCM-BROD-0001-C18_treatment5,2a07cf82-209e-44d1-8547-3e9c38e50b9d,Progressive Disease,released,,1,2020-07-31T09:25:24.402855-05:00,,Progressive Disease,FOLFIRINOX
HCM-BROD-0001-C18,4829dd8c-5445-41b3-ae37-bbcc333e8c9e,a7f019db-c623-4d56-94e9-102cc4574f88,916.0,Adjuvant,902.0,2023-07-07T13:02:23.902070-05:00,HCM-BROD-0001-C18_treatment9,3059b954-3336-4da3-9c6c-0c0e6e3e4373,,released,,1,2020-09-25T16:42:46.477800-05:00,"Radiation Therapy, NOS",Residual Disease,
HCM-BROD-0001-C18,4829dd8c-5445-41b3-ae37-bbcc333e8c9e,a7f019db-c623-4d56-94e9-102cc4574f88,,Maintenance Therapy,53.0,2021-07-12T12:25:55.528644-05:00,HCM-BROD-0001-C18_treatment2,43fa9dd4-6205-44f7-9aa4-0edb84d456fe,Progressive Disease,released,Leucovorin Calcium,1,2020-07-31T09:25:24.402855-05:00,,Progressive Disease,
HCM-BROD-0001-C18,4829dd8c-5445-41b3-ae37-bbcc333e8c9e,a7f019db-c623-4d56-94e9-102cc4574f88,,Maintenance Therapy,53.0,2021-07-12T12:25:55.528644-05:00,HCM-BROD-0001-C18_treatment,5943365f-0bd4-4736-b0ac-c283bd58c821,Progressive Disease,released,Irinotecan Hydrochloride,1,2020-07-31T09:25:24.402855-05:00,,Progressive Disease,
HCM-BROD-0001-C18,4829dd8c-5445-41b3-ae37-bbcc333e8c9e,a7f019db-c623-4d56-94e9-102cc4574f88,,Maintenance Therapy,53.0,2021-07-12T12:25:55.528644-05:00,HCM-BROD-0001-C18_treatment3,b46f832c-4b86-4395-94bf-500af2bdcd35,Progressive Disease,released,Fluorouracil,1,2020-07-31T09:25:24.402855-05:00,,Progressive Disease,
HCM-BROD-0001-C18,4829dd8c-5445-41b3-ae37-bbcc333e8c9e,a7f019db-c623-4d56-94e9-102cc4574f88,,Adjuvant,,2023-03-13T13:02:40.283252-05:00,HCM-BROD-0001-C18_treatment8,cf1cce8f-b3ab-4ff3-a848-b2e9ded1a95b,,released,,0,2020-09-25T16:42:46.477800-05:00,"Pharmaceutical Therapy, NOS",Residual Disease,
HCM-WCMC-0751-C54,482c0ee1-5046-4fc7-b284-57923228ca23,0e0ca5a2-a776-4916-b80d-050f9c79d57b,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-WCMC-0751-C54_treatment3,4867eb6a-1ecd-4ccd-a06b-1cadb9ed66b5,,released,,0,2023-02-27T13:29:26.421692-06:00,"Pharmaceutical Therapy, NOS",Residual Disease,
HCM-WCMC-0751-C54,482c0ee1-5046-4fc7-b284-57923228ca23,0e0ca5a2-a776-4916-b80d-050f9c79d57b,96.0,Adjuvant,47.0,2025-04-07T17:13:09.336794-05:00,HCM-WCMC-0751-C54_treatment4,7af18639-9788-4a86-bb5c-5da211466abd,,released,,1,2023-02-27T13:29:26.421692-06:00,"Radiation, External Beam",Residual Disease,
HCM-WCMC-0751-C54,482c0ee1-5046-4fc7-b284-57923228ca23,0e0ca5a2-a776-4916-b80d-050f9c79d57b,,Neoadjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-WCMC-0751-C54_treatment,7c30da6c-cb7c-4db4-b01e-6c139f47348f,,released,,0,2023-02-27T13:29:26.421692-06:00,,,
HCM-WCMC-0751-C54,482c0ee1-5046-4fc7-b284-57923228ca23,0e0ca5a2-a776-4916-b80d-050f9c79d57b,,,0.0,2025-04-07T17:13:09.336794-05:00,HCM-WCMC-0751-C54_treatment2,a360ebd5-6ac3-41ef-b4cf-6c0ba5ee8bef,,released,,1,2023-02-27T13:29:26.421692-06:00,"Surgery, NOS",Initial Diagnosis,
HCM-CSHL-0180-C25,489ae53c-0c19-433b-b22d-8dc09f2161be,eeefcad2-9a62-45d1-8d27-4c9554922a23,,Adjuvant,,2023-02-22T07:39:25.979291-06:00,HCM-CSHL-0180-C25_treatment10,33968ee3-8b3e-4887-ab05-2026caf19e3e,,released,,0,2020-09-28T09:13:36.939899-05:00,Targeted Molecular Therapy,Residual Disease,
HCM-CSHL-0180-C25,489ae53c-0c19-433b-b22d-8dc09f2161be,eeefcad2-9a62-45d1-8d27-4c9554922a23,,Adjuvant,360.0,2023-02-22T07:39:25.979291-06:00,HCM-CSHL-0180-C25_treatment4,3de81377-f1b6-4457-a537-993b19af2c37,,released,Leucovorin Calcium,1,2020-09-28T09:13:36.939899-05:00,Chemotherapy,Residual Disease,
HCM-CSHL-0180-C25,489ae53c-0c19-433b-b22d-8dc09f2161be,eeefcad2-9a62-45d1-8d27-4c9554922a23,,Neoadjuvant,,2023-02-22T07:39:25.979291-06:00,HCM-CSHL-0180-C25_treatment,3f1439b9-6efe-40cb-be52-4b2d01235a84,,released,,0,2020-09-28T09:13:36.939899-05:00,,,
HCM-CSHL-0180-C25,489ae53c-0c19-433b-b22d-8dc09f2161be,eeefcad2-9a62-45d1-8d27-4c9554922a23,,Adjuvant,360.0,2023-02-22T07:39:25.979291-06:00,HCM-CSHL-0180-C25_treatment5,411a94c7-b8c4-4cdb-9aa4-c85b2952cf44,,released,Fluorouracil,1,2020-09-28T09:13:36.939899-05:00,Chemotherapy,Residual Disease,
HCM-CSHL-0180-C25,489ae53c-0c19-433b-b22d-8dc09f2161be,eeefcad2-9a62-45d1-8d27-4c9554922a23,,,-20.0,2023-02-27T12:30:24.075160-06:00,HCM-CSHL-0180-C25_treatment9,4758d852-6e89-49b1-a8c2-71793d4f37b0,,released,,1,2020-09-28T09:13:36.939899-05:00,"Surgery, NOS",Initial Diagnosis,
HCM-CSHL-0180-C25,489ae53c-0c19-433b-b22d-8dc09f2161be,eeefcad2-9a62-45d1-8d27-4c9554922a23,317.0,Adjuvant,164.0,2023-02-22T07:39:25.979291-06:00,HCM-CSHL-0180-C25_treatment2,5fc24220-9f93-40f5-a14e-1c1d5e4e840b,,released,Gemcitabine,1,2020-09-28T09:13:36.939899-05:00,Chemotherapy,Residual Disease,
HCM-CSHL-0180-C25,489ae53c-0c19-433b-b22d-8dc09f2161be,eeefcad2-9a62-45d1-8d27-4c9554922a23,,Adjuvant,,2023-02-22T07:39:25.979291-06:00,HCM-CSHL-0180-C25_treatment11,6a3dc737-fa04-4097-9484-ce08bb9854c7,,released,,0,2020-09-28T09:13:36.939899-05:00,"Radiation Therapy, NOS",Residual Disease,
HCM-CSHL-0180-C25,489ae53c-0c19-433b-b22d-8dc09f2161be,eeefcad2-9a62-45d1-8d27-4c9554922a23,,Adjuvant,360.0,2023-02-22T07:39:25.979291-06:00,HCM-CSHL-0180-C25_treatment6,858b5832-030f-4b25-8c7d-a0fbbe02550c,,released,Irinotecan,1,2020-09-28T09:13:36.939899-05:00,Chemotherapy,Residual Disease,
HCM-CSHL-0180-C25,489ae53c-0c19-433b-b22d-8dc09f2161be,eeefcad2-9a62-45d1-8d27-4c9554922a23,,Adjuvant,360.0,2023-02-22T07:39:25.979291-06:00,HCM-CSHL-0180-C25_treatment7,affaba00-2b6f-497d-ab6f-2762341f21ce,,released,,1,2020-09-28T09:13:36.939899-05:00,Chemotherapy,Residual Disease,FOLFIRI
HCM-CSHL-0180-C25,489ae53c-0c19-433b-b22d-8dc09f2161be,eeefcad2-9a62-45d1-8d27-4c9554922a23,317.0,Adjuvant,164.0,2023-02-22T07:39:25.979291-06:00,HCM-CSHL-0180-C25_treatment3,b92f1953-0283-4d4f-8d6e-f706949d17ef,,released,Nab-paclitaxel,1,2020-09-28T09:13:36.939899-05:00,Chemotherapy,Residual Disease,
HCM-CSHL-0180-C25,489ae53c-0c19-433b-b22d-8dc09f2161be,eeefcad2-9a62-45d1-8d27-4c9554922a23,,Adjuvant,,2023-02-22T07:39:25.979291-06:00,HCM-CSHL-0180-C25_treatment8,f571ba36-8ad1-4844-954b-c1a9c45df94d,,released,,0,2020-09-28T09:13:36.939899-05:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-CSHL-0601-C25,491159e8-4599-4dec-a05c-1d35dc6f3d05,e22d19c9-a416-491f-a8dc-e0ffaa846312,,Adjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0601-C25_treatment6,2dbbdb96-23ac-4d74-a7cc-57d206dbaab3,,released,,0,2021-12-21T14:09:26.597980-06:00,"Pharmaceutical Therapy, NOS",Residual Disease,
HCM-CSHL-0601-C25,491159e8-4599-4dec-a05c-1d35dc6f3d05,e22d19c9-a416-491f-a8dc-e0ffaa846312,,,-21.0,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0601-C25_treatment5,2e75259c-71cf-4983-9713-8da0646e1399,,released,,1,2021-12-21T14:09:26.597980-06:00,"Surgery, NOS",Initial Diagnosis,
HCM-CSHL-0601-C25,491159e8-4599-4dec-a05c-1d35dc6f3d05,e22d19c9-a416-491f-a8dc-e0ffaa846312,,Neoadjuvant,92.0,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0601-C25_treatment2,68b58f75-b03b-4360-b818-7e5c50cbbf77,,released,Fluorouracil,1,2021-12-21T14:09:26.597980-06:00,Chemotherapy,,
HCM-CSHL-0601-C25,491159e8-4599-4dec-a05c-1d35dc6f3d05,e22d19c9-a416-491f-a8dc-e0ffaa846312,,Neoadjuvant,92.0,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0601-C25_treatment3,96151e93-d652-495d-a60f-19eb0d66315f,,released,Oxaliplatin,1,2021-12-21T14:09:26.597980-06:00,Chemotherapy,,
HCM-CSHL-0601-C25,491159e8-4599-4dec-a05c-1d35dc6f3d05,e22d19c9-a416-491f-a8dc-e0ffaa846312,,Neoadjuvant,92.0,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0601-C25_treatment4,c1861590-6f3b-4ad4-a233-961e29ef1eb8,,released,,1,2021-12-21T14:09:26.597980-06:00,Chemotherapy,,FOLFOX
HCM-CSHL-0601-C25,491159e8-4599-4dec-a05c-1d35dc6f3d05,e22d19c9-a416-491f-a8dc-e0ffaa846312,,Neoadjuvant,92.0,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0601-C25_treatment,dec73750-71b6-42ff-bb66-4ad7370771e7,,released,Leucovorin Calcium,1,2021-12-21T14:09:26.597980-06:00,Chemotherapy,,
HCM-CSHL-0601-C25,491159e8-4599-4dec-a05c-1d35dc6f3d05,e22d19c9-a416-491f-a8dc-e0ffaa846312,,Adjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0601-C25_treatment7,fc98776e-3567-4d82-9bfc-9ad256eaa05d,,released,,0,2021-12-21T14:09:26.597980-06:00,"Radiation Therapy, NOS",Residual Disease,
HCM-CSHL-0155-C50,496a0dcf-431a-467a-a150-5c7486d72bee,f16bec06-481e-410b-8874-0a5b7ce52289,,,34.0,2023-03-13T13:02:10.450107-05:00,HCM-CSHL-0155-C50_treatment2,78c1d1fa-aa3c-4634-b4b3-47bb62f691d6,,released,,1,2020-09-27T12:59:52.462518-05:00,"Surgery, NOS",Initial Diagnosis,
HCM-CSHL-0155-C50,496a0dcf-431a-467a-a150-5c7486d72bee,f16bec06-481e-410b-8874-0a5b7ce52289,,Neoadjuvant,,2023-02-22T07:39:25.979291-06:00,HCM-CSHL-0155-C50_treatment,e28e339d-46d6-4278-94e9-01cc7358255a,,released,,0,2020-09-27T12:59:52.462518-05:00,,,
HCM-CSHL-0810-C54,49ad0220-8d59-4277-a174-011677a80f69,7a5daba7-5c1c-4834-9f67-eabcd11d54ad,,,0.0,2023-07-13T10:27:19.665852-05:00,HCM-CSHL-0810-C54_treatment6,72344c10-d3e6-4ba8-a643-ad5d775d5af6,,released,,1,2021-12-21T14:27:10.723212-06:00,"Surgery, NOS",Initial Diagnosis,
HCM-CSHL-0810-C54,49ad0220-8d59-4277-a174-011677a80f69,7a5daba7-5c1c-4834-9f67-eabcd11d54ad,,Adjuvant,,2023-07-13T10:27:19.665852-05:00,HCM-CSHL-0810-C54_treatment4,7db14c65-5a14-44d0-b0d6-3c0eb0e907c6,,released,,0,2021-12-21T14:27:10.723212-06:00,Hormone Therapy,Residual Disease,
HCM-CSHL-0810-C54,49ad0220-8d59-4277-a174-011677a80f69,7a5daba7-5c1c-4834-9f67-eabcd11d54ad,,Adjuvant,,2023-07-13T10:27:19.665852-05:00,HCM-CSHL-0810-C54_treatment5,b1f57664-cf00-4145-859b-602468842bb3,,released,,0,2021-12-21T14:27:10.723212-06:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-CSHL-0810-C54,49ad0220-8d59-4277-a174-011677a80f69,7a5daba7-5c1c-4834-9f67-eabcd11d54ad,,Neoadjuvant,,2023-07-13T10:27:19.665852-05:00,HCM-CSHL-0810-C54_treatment,c28c5eed-55c2-415a-bbe8-eebe9192ff82,,released,,0,2021-12-21T14:27:10.723212-06:00,,,
HCM-CSHL-0810-C54,49ad0220-8d59-4277-a174-011677a80f69,7a5daba7-5c1c-4834-9f67-eabcd11d54ad,,Adjuvant,,2023-07-13T10:27:19.665852-05:00,HCM-CSHL-0810-C54_treatment7,c296d5bf-879a-4a96-b9a5-11dab45dbfda,,released,,0,2021-12-21T14:27:10.723212-06:00,Targeted Molecular Therapy,Residual Disease,
HCM-CSHL-0810-C54,49ad0220-8d59-4277-a174-011677a80f69,7a5daba7-5c1c-4834-9f67-eabcd11d54ad,158.0,Adjuvant,48.0,2023-07-13T10:27:19.665852-05:00,HCM-CSHL-0810-C54_treatment3,e44f19dd-d2e9-4ea7-b987-cf2ffccdf5e3,,released,Paclitaxel,1,2021-12-21T14:27:10.723212-06:00,Chemotherapy,Residual Disease,
HCM-CSHL-0810-C54,49ad0220-8d59-4277-a174-011677a80f69,7a5daba7-5c1c-4834-9f67-eabcd11d54ad,158.0,Adjuvant,48.0,2023-07-13T10:27:19.665852-05:00,HCM-CSHL-0810-C54_treatment2,ed16dc9b-d248-4101-b8e4-d14bbf76c260,,released,Carboplatin,1,2021-12-21T14:27:10.723212-06:00,Chemotherapy,Residual Disease,
HCM-CSHL-0810-C54,49ad0220-8d59-4277-a174-011677a80f69,7a5daba7-5c1c-4834-9f67-eabcd11d54ad,235.0,Adjuvant,208.0,2023-07-13T10:27:19.665852-05:00,HCM-CSHL-0810-C54_treatment8,f76850f7-3993-49e7-bec4-31b91fdd6c99,,released,,1,2021-12-21T14:27:10.723212-06:00,External Beam Radiation,Residual Disease,
HCM-SANG-1084-C15,49c761f2-8804-41ac-ad2f-93ba8a2a6ef5,0db47c45-4a58-4d6c-bae1-8daee3f8c92b,,Neoadjuvant,109.0,2025-03-31T16:34:59.906497-05:00,HCM-SANG-1084-C15_treatment3,3d288258-0fb8-4237-acb8-4d606ca6ab57,,released,,1,2023-02-27T12:24:26.861822-06:00,"Radiation, 2D Conventional",,
HCM-SANG-1084-C15,49c761f2-8804-41ac-ad2f-93ba8a2a6ef5,0db47c45-4a58-4d6c-bae1-8daee3f8c92b,,Neoadjuvant,109.0,2025-03-31T16:34:59.906497-05:00,HCM-SANG-1084-C15_treatment,956ac140-0177-46ee-96ca-581ce5b81220,,released,Paclitaxel,1,2023-02-27T12:24:26.861822-06:00,Chemotherapy,,
HCM-SANG-1084-C15,49c761f2-8804-41ac-ad2f-93ba8a2a6ef5,0db47c45-4a58-4d6c-bae1-8daee3f8c92b,,Neoadjuvant,109.0,2025-03-31T16:34:59.906497-05:00,HCM-SANG-1084-C15_treatment2,ee212578-3a6a-4c1f-bf0a-f0b7926eba94,,released,Carboplatin,1,2023-02-27T12:24:26.861822-06:00,Chemotherapy,,
HCM-BROD-0953-C34,49c7df8f-26db-4e9c-9f9b-8f1a515df3b5,2946de7c-a5db-4fcc-bbcb-aca0ca5c8334,96.0,Adjuvant,56.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0953-C34_treatment4,1e598eb8-c550-4425-8bc5-69aead465277,,released,Leucovorin,1,2022-03-09T20:55:52.463525-06:00,Chemotherapy,Residual Disease,
HCM-BROD-0953-C34,49c7df8f-26db-4e9c-9f9b-8f1a515df3b5,2946de7c-a5db-4fcc-bbcb-aca0ca5c8334,,Neoadjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0953-C34_treatment,27dec9b0-67d1-4904-bc1d-62d56d2d20fd,,released,,0,2022-03-09T20:55:52.463525-06:00,,,
HCM-BROD-0953-C34,49c7df8f-26db-4e9c-9f9b-8f1a515df3b5,2946de7c-a5db-4fcc-bbcb-aca0ca5c8334,,,,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0953-C34_treatment6,2e1793cc-0268-42c6-bc63-5a40c3122b6c,,released,,0,2022-03-09T20:55:52.463525-06:00,"Surgery, NOS",Initial Diagnosis,
HCM-BROD-0953-C34,49c7df8f-26db-4e9c-9f9b-8f1a515df3b5,2946de7c-a5db-4fcc-bbcb-aca0ca5c8334,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0953-C34_treatment5,7bbdcf28-00f6-457b-a986-d4194475f404,,released,,0,2022-03-09T20:55:52.463525-06:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-BROD-0953-C34,49c7df8f-26db-4e9c-9f9b-8f1a515df3b5,2946de7c-a5db-4fcc-bbcb-aca0ca5c8334,96.0,Adjuvant,56.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0953-C34_treatment3,a7366228-7b2b-4cb7-b0cf-80db53e7e096,,released,Fluorouracil,1,2022-03-09T20:55:52.463525-06:00,Chemotherapy,Residual Disease,
HCM-BROD-0953-C34,49c7df8f-26db-4e9c-9f9b-8f1a515df3b5,2946de7c-a5db-4fcc-bbcb-aca0ca5c8334,26.0,Adjuvant,20.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0953-C34_treatment8,bc0fef7f-3b0c-445d-8f3a-b80a994a3106,,released,,1,2022-03-09T20:55:52.463525-06:00,Stereotactic Radiosurgery,Residual Disease,
HCM-BROD-0953-C34,49c7df8f-26db-4e9c-9f9b-8f1a515df3b5,2946de7c-a5db-4fcc-bbcb-aca0ca5c8334,96.0,Adjuvant,56.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0953-C34_treatment2,e999804d-42b3-49df-a2fb-d974c508e948,,released,Oxaliplatin,1,2022-03-09T20:55:52.463525-06:00,Chemotherapy,Residual Disease,
HCM-BROD-0953-C34,49c7df8f-26db-4e9c-9f9b-8f1a515df3b5,2946de7c-a5db-4fcc-bbcb-aca0ca5c8334,96.0,Adjuvant,56.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0953-C34_treatment7,e9eaf96e-b8da-4854-8f26-21e131750c97,,released,Bevacizumab,1,2022-03-09T20:55:52.463525-06:00,Targeted Molecular Therapy,Residual Disease,
HCM-SANG-1090-C18,4a10a586-64ab-4136-8dba-0545589772cd,68770c77-4915-4aec-95b4-345d2c1ac1fe,,Neoadjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-SANG-1090-C18_treatment,55fe0bfb-fda7-402d-aadb-c4be5b5f1462,,released,,0,2023-02-27T12:29:44.231473-06:00,,,
HCM-CSHL-0639-C56,4a10c499-7f11-49dc-b865-b6cbaf5b1df7,8022dec2-f6e8-4fe9-9c7d-6a892bf65166,,Neoadjuvant,-107.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0639-C56_treatment3,2f808f87-9f86-4102-a67c-5ea9198002c5,,released,Acetylcysteine,1,2021-12-21T14:13:43.925636-06:00,Chemotherapy,,
HCM-CSHL-0639-C56,4a10c499-7f11-49dc-b865-b6cbaf5b1df7,8022dec2-f6e8-4fe9-9c7d-6a892bf65166,,,0.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0639-C56_treatment4,7b6445ed-2d60-4328-9ac3-0bf9ed1eecc9,,released,,1,2021-12-21T14:13:43.925636-06:00,"Surgery, NOS",Initial Diagnosis,
HCM-CSHL-0639-C56,4a10c499-7f11-49dc-b865-b6cbaf5b1df7,8022dec2-f6e8-4fe9-9c7d-6a892bf65166,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0639-C56_treatment6,8d83fca8-453a-48b1-9379-b06a26770559,,released,,0,2021-12-21T14:13:43.925636-06:00,"Radiation Therapy, NOS",Residual Disease,
HCM-CSHL-0639-C56,4a10c499-7f11-49dc-b865-b6cbaf5b1df7,8022dec2-f6e8-4fe9-9c7d-6a892bf65166,,Neoadjuvant,-107.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0639-C56_treatment2,a9e0b77f-fe63-4f58-84fb-546002af64e8,,released,Paclitaxel,1,2021-12-21T14:13:43.925636-06:00,Chemotherapy,,
HCM-CSHL-0639-C56,4a10c499-7f11-49dc-b865-b6cbaf5b1df7,8022dec2-f6e8-4fe9-9c7d-6a892bf65166,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0639-C56_treatment5,b68c0acb-7c3f-42cd-8d98-0d2080a1740c,,released,,0,2021-12-21T14:13:43.925636-06:00,"Pharmaceutical Therapy, NOS",Residual Disease,
HCM-CSHL-0639-C56,4a10c499-7f11-49dc-b865-b6cbaf5b1df7,8022dec2-f6e8-4fe9-9c7d-6a892bf65166,,Neoadjuvant,-107.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0639-C56_treatment,dc3e9fa6-3206-4d88-9205-2b46f3d205aa,,released,Carboplatin,1,2021-12-21T14:13:43.925636-06:00,Chemotherapy,,
HCM-EXPT-1170-C43,4adcfafe-8330-4064-b0c7-f197d6a2cf99,0bde4321-fde5-46ff-b287-7b32947a1c32,,Neoadjuvant,,2025-10-08T12:38:28.988690-05:00,HCM-EXPT-1170-C43_treatment,618f48f2-f9e8-447f-b3f2-55be15583bf1,,released,,1,2021-12-21T15:05:22.819753-06:00,"Pharmaceutical Therapy, NOS",,
HCM-BROD-0048-C71,4b9b3130-2483-4e5d-8c4d-e225590a5cd2,7f7968f0-e608-441d-b7a6-61c30361d16d,,Adjuvant,,2021-03-03T15:15:08.075155-06:00,HCM-BROD-0048-C71_treatment6,08474a1e-f8b2-4c18-b605-c3e00149d0ed,,released,,0,2020-02-27T12:16:53.481408-06:00,Targeted Molecular Therapy,Residual Disease,
HCM-BROD-0048-C71,4b9b3130-2483-4e5d-8c4d-e225590a5cd2,7f7968f0-e608-441d-b7a6-61c30361d16d,60.0,Adjuvant,29.0,2021-03-03T15:15:08.075155-06:00,HCM-BROD-0048-C71_treatment2,3e2b3782-eec3-49b1-88fa-04f34571fda5,,released,Temozolomide,1,2020-02-27T12:16:53.481408-06:00,Chemotherapy,Residual Disease,
HCM-BROD-0048-C71,4b9b3130-2483-4e5d-8c4d-e225590a5cd2,7f7968f0-e608-441d-b7a6-61c30361d16d,508.0,Adjuvant,109.0,2021-03-03T15:15:08.075155-06:00,HCM-BROD-0048-C71_treatment3,5caf0316-e104-4ae6-ae37-8420c1407a10,,released,Temozolomide,1,2020-02-27T12:16:53.481408-06:00,Chemotherapy,Residual Disease,
HCM-BROD-0048-C71,4b9b3130-2483-4e5d-8c4d-e225590a5cd2,7f7968f0-e608-441d-b7a6-61c30361d16d,,Adjuvant,,2021-03-03T15:15:08.075155-06:00,HCM-BROD-0048-C71_treatment4,5e5e3b5d-c231-430f-8956-33fbb4a2970b,,released,,0,2020-02-27T12:16:53.481408-06:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-BROD-0048-C71,4b9b3130-2483-4e5d-8c4d-e225590a5cd2,7f7968f0-e608-441d-b7a6-61c30361d16d,,,-5.0,2023-02-27T13:23:09.240312-06:00,HCM-BROD-0048-C71_treatment5,b71bff6e-95e8-43d3-8e61-d08c15f7f2dc,,released,,1,2020-02-27T12:16:53.481408-06:00,"Surgery, NOS",Initial Diagnosis,
HCM-BROD-0048-C71,4b9b3130-2483-4e5d-8c4d-e225590a5cd2,7f7968f0-e608-441d-b7a6-61c30361d16d,60.0,Adjuvant,29.0,2021-03-03T15:15:08.075155-06:00,HCM-BROD-0048-C71_treatment7,cf707c68-0352-46cc-b5b4-7f7e48380d7b,,released,,1,2020-02-27T12:16:53.481408-06:00,"Radiation Therapy, NOS",Residual Disease,
HCM-BROD-0048-C71,4b9b3130-2483-4e5d-8c4d-e225590a5cd2,7f7968f0-e608-441d-b7a6-61c30361d16d,,Neoadjuvant,,2021-03-03T15:15:08.075155-06:00,HCM-BROD-0048-C71_treatment,ededa8f1-37df-429d-8f7b-7e2ec83aa7c9,,released,,0,2019-04-04T14:43:48.822667-05:00,,,
HCM-BROD-0488-C16,4ba45a91-c521-42cc-b2c5-8c4d04444d22,314fb703-c8aa-4cc7-918a-21578e21a779,,Neoadjuvant,17.0,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0488-C16_treatment3,10654e22-f014-453a-a581-3796f9bf093e,,released,Leucovorin,1,2020-10-08T14:46:17.696741-05:00,Chemotherapy,,
HCM-BROD-0488-C16,4ba45a91-c521-42cc-b2c5-8c4d04444d22,314fb703-c8aa-4cc7-918a-21578e21a779,,Neoadjuvant,17.0,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0488-C16_treatment5,237673b0-19f0-441d-b1ac-4d340ad86765,,released,Capecitabine,1,2020-10-08T14:46:17.696741-05:00,Chemotherapy,,
HCM-BROD-0488-C16,4ba45a91-c521-42cc-b2c5-8c4d04444d22,314fb703-c8aa-4cc7-918a-21578e21a779,,Neoadjuvant,17.0,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0488-C16_treatment4,54cf82ae-c0f5-4b16-a8ce-677e1ea4cf0c,,released,Fluorouracil,1,2020-10-08T14:46:17.696741-05:00,Chemotherapy,,
HCM-BROD-0488-C16,4ba45a91-c521-42cc-b2c5-8c4d04444d22,314fb703-c8aa-4cc7-918a-21578e21a779,,Adjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0488-C16_treatment14,565090de-2cec-4748-8c84-cdc565d7f32f,,released,,0,2020-10-08T14:46:17.696741-05:00,"Radiation Therapy, NOS",Residual Disease,
HCM-BROD-0488-C16,4ba45a91-c521-42cc-b2c5-8c4d04444d22,314fb703-c8aa-4cc7-918a-21578e21a779,,Neoadjuvant,17.0,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0488-C16_treatment,689fa079-d875-460a-88e5-9166ab4b5836,,released,Oxaliplatin,1,2020-10-08T14:46:17.696741-05:00,Chemotherapy,,
HCM-BROD-0488-C16,4ba45a91-c521-42cc-b2c5-8c4d04444d22,314fb703-c8aa-4cc7-918a-21578e21a779,,Neoadjuvant,2507.0,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0488-C16_treatment9,7f19405e-44c9-45ce-b2c7-e3a99ccb24d9,,released,Trastuzumab,1,2020-10-08T14:46:17.696741-05:00,Targeted Molecular Therapy,,
HCM-BROD-0488-C16,4ba45a91-c521-42cc-b2c5-8c4d04444d22,314fb703-c8aa-4cc7-918a-21578e21a779,,Neoadjuvant,17.0,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0488-C16_treatment6,8a75f6e1-3e86-4d1e-8d58-dc3a3d895258,,released,,1,2020-10-08T14:46:17.696741-05:00,Chemotherapy,,FU-LV regimen
HCM-BROD-0488-C16,4ba45a91-c521-42cc-b2c5-8c4d04444d22,314fb703-c8aa-4cc7-918a-21578e21a779,,,0.0,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0488-C16_treatment12,914edf2d-cb85-4b2a-83dd-be06f592b187,,released,,1,2020-10-08T14:46:17.696741-05:00,"Surgery, NOS",Initial Diagnosis,
HCM-BROD-0488-C16,4ba45a91-c521-42cc-b2c5-8c4d04444d22,314fb703-c8aa-4cc7-918a-21578e21a779,,Neoadjuvant,17.0,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0488-C16_treatment7,af607608-19f6-4f52-ad33-ea998c100536,,released,,1,2020-10-08T14:46:17.696741-05:00,"Radiation Therapy, NOS",,
HCM-BROD-0488-C16,4ba45a91-c521-42cc-b2c5-8c4d04444d22,314fb703-c8aa-4cc7-918a-21578e21a779,,Neoadjuvant,17.0,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0488-C16_treatment2,c852d390-b009-4108-9357-c1e65ef43dc4,,released,Irinotecan,1,2020-10-08T14:46:17.696741-05:00,Chemotherapy,,
HCM-BROD-0488-C16,4ba45a91-c521-42cc-b2c5-8c4d04444d22,314fb703-c8aa-4cc7-918a-21578e21a779,,Neoadjuvant,2507.0,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0488-C16_treatment8,e98f1140-f477-4807-a867-1adfaffc78c8,,released,Cetuximab,1,2020-10-08T14:46:17.696741-05:00,Targeted Molecular Therapy,,
HCM-CSHL-0881-C20,4c36a726-10fd-4311-b523-27714fd22bf5,e7bd3c54-f4b5-4316-9386-d9a5be180004,160.0,Adjuvant,134.0,2025-08-20T09:56:36.143985-05:00,HCM-CSHL-0881-C20_treatment2,1288d5d8-2b8c-4b84-aa74-a558401ca405,,released,Capecitabine,1,2021-12-21T14:38:19.920534-06:00,Chemotherapy,Residual Disease,
HCM-CSHL-0881-C20,4c36a726-10fd-4311-b523-27714fd22bf5,e7bd3c54-f4b5-4316-9386-d9a5be180004,,Neoadjuvant,,2025-08-20T09:56:36.143985-05:00,HCM-CSHL-0881-C20_treatment,344dacec-5963-4156-90da-6cb097c8cf27,,released,,0,2021-12-21T14:38:19.920534-06:00,,,
HCM-CSHL-0881-C20,4c36a726-10fd-4311-b523-27714fd22bf5,e7bd3c54-f4b5-4316-9386-d9a5be180004,316.0,Adjuvant,205.0,2025-08-20T09:56:36.143985-05:00,HCM-CSHL-0881-C20_treatment3,3e4ba2fb-9065-4824-b534-ad361d2815fe,,released,Fluorouracil,1,2021-12-21T14:38:19.920534-06:00,Chemotherapy,Residual Disease,
HCM-CSHL-0881-C20,4c36a726-10fd-4311-b523-27714fd22bf5,e7bd3c54-f4b5-4316-9386-d9a5be180004,,,60.0,2025-08-20T09:56:36.143985-05:00,HCM-CSHL-0881-C20_treatment5,48e7523e-77f7-4068-bd96-4a74b19c38c0,,released,,1,2021-12-21T14:38:19.920534-06:00,"Surgery, NOS",Initial Diagnosis,
HCM-CSHL-0881-C20,4c36a726-10fd-4311-b523-27714fd22bf5,e7bd3c54-f4b5-4316-9386-d9a5be180004,,Adjuvant,,2025-08-20T09:56:36.143985-05:00,HCM-CSHL-0881-C20_treatment4,70e05850-be2b-44e5-a874-47e4651f96be,,released,,0,2021-12-21T14:38:19.920534-06:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-CSHL-0881-C20,4c36a726-10fd-4311-b523-27714fd22bf5,e7bd3c54-f4b5-4316-9386-d9a5be180004,316.0,Adjuvant,205.0,2025-08-20T09:56:36.143985-05:00,HCM-CSHL-0881-C20_treatment7,958df6bc-07ad-42b6-b699-d454d3ddba07,,released,,1,2021-12-21T14:38:19.920534-06:00,"Radiation, 3D Conformal",Residual Disease,
HCM-CSHL-0881-C20,4c36a726-10fd-4311-b523-27714fd22bf5,e7bd3c54-f4b5-4316-9386-d9a5be180004,,Adjuvant,,2025-08-20T09:56:36.143985-05:00,HCM-CSHL-0881-C20_treatment6,a3cbf7d7-11aa-473c-a8f7-fedb9262989a,,released,,0,2021-12-21T14:38:19.920534-06:00,Targeted Molecular Therapy,Residual Disease,
HCM-CSHL-0179-C25,4c48e9c9-5f8f-43e2-a972-367b260b40eb,9e52827a-5b12-45f1-b701-259bf2c45f63,,,-12.0,2023-02-27T12:43:35.769603-06:00,HCM-CSHL-0179-C25_treatment4,6478502f-cd05-4867-9775-b5b5b0ad3209,,released,,1,2020-09-28T09:13:27.999637-05:00,"Surgery, NOS",Initial Diagnosis,
HCM-CSHL-0179-C25,4c48e9c9-5f8f-43e2-a972-367b260b40eb,9e52827a-5b12-45f1-b701-259bf2c45f63,258.0,Adjuvant,13.0,2023-02-22T07:39:25.979291-06:00,HCM-CSHL-0179-C25_treatment2,7b97103c-0f8d-4afc-8e55-c1a69c2e1592,,released,Gemcitabine,1,2020-09-28T09:13:27.999637-05:00,Chemotherapy,Residual Disease,
HCM-CSHL-0179-C25,4c48e9c9-5f8f-43e2-a972-367b260b40eb,9e52827a-5b12-45f1-b701-259bf2c45f63,,Adjuvant,,2023-02-22T07:39:25.979291-06:00,HCM-CSHL-0179-C25_treatment5,b5a59d32-8e62-420b-bfbf-062d9d64d80b,,released,,0,2020-09-28T09:13:27.999637-05:00,Targeted Molecular Therapy,Residual Disease,
HCM-CSHL-0179-C25,4c48e9c9-5f8f-43e2-a972-367b260b40eb,9e52827a-5b12-45f1-b701-259bf2c45f63,313.0,Adjuvant,289.0,2023-02-22T07:39:25.979291-06:00,HCM-CSHL-0179-C25_treatment6,deadab53-2029-47ba-a249-b97b91091c62,,released,,1,2020-09-28T09:13:27.999637-05:00,"Radiation, 2D Conventional",Residual Disease,
HCM-CSHL-0179-C25,4c48e9c9-5f8f-43e2-a972-367b260b40eb,9e52827a-5b12-45f1-b701-259bf2c45f63,,Neoadjuvant,,2023-02-22T07:39:25.979291-06:00,HCM-CSHL-0179-C25_treatment,e3d0963d-6e97-424d-a5f0-e608df51b614,,released,,0,2020-09-28T09:13:27.999637-05:00,,,
HCM-CSHL-0179-C25,4c48e9c9-5f8f-43e2-a972-367b260b40eb,9e52827a-5b12-45f1-b701-259bf2c45f63,,Adjuvant,,2023-02-22T07:39:25.979291-06:00,HCM-CSHL-0179-C25_treatment3,fb3fc2b3-c02d-4393-9f0b-4e69eaa320ad,,released,,0,2020-09-28T09:13:27.999637-05:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-EXPT-1017-C34,4cc88877-69b3-4f86-9074-3bc6b23d5c94,d6ca9a3c-6cc0-43e2-9f4a-698af75827eb,,Neoadjuvant,,2025-10-08T12:37:43.816130-05:00,HCM-EXPT-1017-C34_treatment,bdda5933-94d8-4018-b6e2-de6e1aa08470,,released,,0,2021-12-21T14:56:10.525473-06:00,,,
HCM-SANG-0541-C20,4d4cc629-2f04-4688-a396-a3c30ca27886,5723233c-8350-4cf9-950e-510b6046394f,,Neoadjuvant,20.0,2025-03-31T16:34:59.906497-05:00,HCM-SANG-0541-C20_treatment,be4dad67-b5c6-468b-bc7c-0fe58bff3ca0,,released,,1,2023-02-27T12:39:27.253834-06:00,"Radiation, 2D Conventional",,
HCM-BROD-0715-C43,4e3d5c85-6a93-4421-8ae6-de4826abdcb5,8c0fc9bf-de6c-4077-80cb-f6937658e453,6414.0,Adjuvant,5148.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0715-C43_treatment4,2b29ab12-b6c7-4695-bd67-0c8f5716ce8b,,released,Nivolumab,1,2021-12-21T13:47:47.449535-06:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-BROD-0715-C43,4e3d5c85-6a93-4421-8ae6-de4826abdcb5,8c0fc9bf-de6c-4077-80cb-f6937658e453,,Neoadjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0715-C43_treatment,3ea4b1bc-9a63-4e68-8982-bd596554d59f,,released,,0,2021-12-21T13:47:47.449535-06:00,,,
HCM-BROD-0715-C43,4e3d5c85-6a93-4421-8ae6-de4826abdcb5,8c0fc9bf-de6c-4077-80cb-f6937658e453,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0715-C43_treatment3,4d085213-1547-4f24-9998-3b50234d2b96,,released,,0,2021-12-21T13:47:47.449535-06:00,Hormone Therapy,Residual Disease,
HCM-BROD-0715-C43,4e3d5c85-6a93-4421-8ae6-de4826abdcb5,8c0fc9bf-de6c-4077-80cb-f6937658e453,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0715-C43_treatment7,79ed5ca5-9e52-4c17-b99b-226cf4b30d2e,,released,,0,2021-12-21T13:47:47.449535-06:00,"Radiation Therapy, NOS",Residual Disease,
HCM-BROD-0715-C43,4e3d5c85-6a93-4421-8ae6-de4826abdcb5,8c0fc9bf-de6c-4077-80cb-f6937658e453,,,0.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0715-C43_treatment5,85ffebf6-57f9-4b42-9916-ae789ab86ab9,,released,,1,2021-12-21T13:47:47.449535-06:00,"Surgery, NOS",Initial Diagnosis,
HCM-BROD-0715-C43,4e3d5c85-6a93-4421-8ae6-de4826abdcb5,8c0fc9bf-de6c-4077-80cb-f6937658e453,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0715-C43_treatment6,92c49395-58fd-4bf2-a2d6-6c0f8665609a,,released,,0,2021-12-21T13:47:47.449535-06:00,Targeted Molecular Therapy,Residual Disease,
HCM-BROD-0715-C43,4e3d5c85-6a93-4421-8ae6-de4826abdcb5,8c0fc9bf-de6c-4077-80cb-f6937658e453,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0715-C43_treatment2,a07a7c46-d2e2-4f42-8688-828a295b84b4,,released,,0,2021-12-21T13:47:47.449535-06:00,Chemotherapy,Residual Disease,
HCM-BROD-0715-C43,4e3d5c85-6a93-4421-8ae6-de4826abdcb5,9d5facf3-b617-47dd-a609-d34c46d0629e,5105.0,Maintenance Therapy,4192.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0715-C43_treatment8,d3ea573d-689d-48af-9768-a0222d26af00,Stable Disease,released,Nivolumab,1,2021-12-21T13:47:47.449535-06:00,,,
HCM-CSHL-0383-C18,4e727a6a-72b0-447c-9fa4-0f81f0736562,ddbd32c0-b282-4408-8db0-61941c5181cf,,,27.0,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0383-C18_treatment4,02541a26-1564-4a4d-9826-38ee8c5a4148,,released,,1,2020-09-28T09:58:42.545234-05:00,"Surgery, NOS",Initial Diagnosis,
HCM-CSHL-0383-C18,4e727a6a-72b0-447c-9fa4-0f81f0736562,ddbd32c0-b282-4408-8db0-61941c5181cf,63.0,Adjuvant,63.0,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0383-C18_treatment2,0563f7e4-d463-45c2-8eb3-ec54de93121f,,released,Capecitabine,1,2020-09-28T09:58:42.545234-05:00,Chemotherapy,Residual Disease,
HCM-CSHL-0383-C18,4e727a6a-72b0-447c-9fa4-0f81f0736562,ddbd32c0-b282-4408-8db0-61941c5181cf,,Adjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0383-C18_treatment5,35e693f5-b061-4ac2-b54c-155cae694fa8,,released,,0,2020-09-28T09:58:42.545234-05:00,Targeted Molecular Therapy,Residual Disease,
HCM-CSHL-0383-C18,4e727a6a-72b0-447c-9fa4-0f81f0736562,ddbd32c0-b282-4408-8db0-61941c5181cf,,Adjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0383-C18_treatment6,6640d8f1-01dd-4a77-960b-4de6556eba24,,released,,0,2020-09-28T09:58:42.545234-05:00,"Radiation Therapy, NOS",Residual Disease,
HCM-CSHL-0383-C18,4e727a6a-72b0-447c-9fa4-0f81f0736562,ddbd32c0-b282-4408-8db0-61941c5181cf,,Neoadjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0383-C18_treatment,6e484735-2c17-4f92-b222-f53409538731,,released,,0,2020-09-28T09:58:42.545234-05:00,,,
HCM-CSHL-0383-C18,4e727a6a-72b0-447c-9fa4-0f81f0736562,ddbd32c0-b282-4408-8db0-61941c5181cf,,Adjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0383-C18_treatment3,84c1a2e4-7a50-4697-98a6-c5453465a300,,released,,0,2020-09-28T09:58:42.545234-05:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-BROD-0569-C43,4e828c35-5fc3-40af-a2ee-10b4281c77b8,5191a8e6-4ec6-4a84-af18-70d24c53d97d,733.0,Maintenance Therapy,518.0,2021-09-10T10:36:37.981324-05:00,HCM-BROD-0569-C43_treatment8,c8a24f2b-2fa7-4b8a-ada2-1ed29530e625,Treatment Ongoing,released,Nivolumab,1,2021-09-07T12:02:33.564120-05:00,,,
HCM-BROD-0569-C43,4e828c35-5fc3-40af-a2ee-10b4281c77b8,e795772c-a156-49cc-8578-4ba5901f374e,,Neoadjuvant,,2021-03-11T14:53:13.958052-06:00,HCM-BROD-0569-C43_treatment,0f83528e-48e3-4547-9337-2436adce2efd,,released,,0,2021-03-11T14:31:21.933263-06:00,,,
HCM-BROD-0569-C43,4e828c35-5fc3-40af-a2ee-10b4281c77b8,e795772c-a156-49cc-8578-4ba5901f374e,,Adjuvant,,2021-09-10T10:36:37.981324-05:00,HCM-BROD-0569-C43_treatment3,298bbd94-371e-44ba-b06b-e37dc161406b,,released,,0,2021-09-07T12:02:33.564120-05:00,Hormone Therapy,Residual Disease,
HCM-BROD-0569-C43,4e828c35-5fc3-40af-a2ee-10b4281c77b8,e795772c-a156-49cc-8578-4ba5901f374e,892.0,Adjuvant,518.0,2021-09-10T10:36:37.981324-05:00,HCM-BROD-0569-C43_treatment4,5f34e6ed-ca77-46c9-bd65-c94a9e14cb5b,,released,Nivolumab,1,2021-09-07T12:02:33.564120-05:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-BROD-0569-C43,4e828c35-5fc3-40af-a2ee-10b4281c77b8,e795772c-a156-49cc-8578-4ba5901f374e,,,0.0,2023-02-27T12:40:11.295181-06:00,HCM-BROD-0569-C43_treatment5,77640169-c586-476a-82b3-67f055d7d86b,,released,,1,2021-09-07T12:02:33.564120-05:00,"Surgery, NOS",Initial Diagnosis,
HCM-BROD-0569-C43,4e828c35-5fc3-40af-a2ee-10b4281c77b8,e795772c-a156-49cc-8578-4ba5901f374e,,Adjuvant,,2021-09-10T10:36:37.981324-05:00,HCM-BROD-0569-C43_treatment2,da0deb5d-fc8e-4022-9887-f5fea7902309,,released,,0,2021-09-07T12:02:33.564120-05:00,Chemotherapy,Residual Disease,
HCM-BROD-0569-C43,4e828c35-5fc3-40af-a2ee-10b4281c77b8,e795772c-a156-49cc-8578-4ba5901f374e,,Adjuvant,,2021-09-10T10:36:37.981324-05:00,HCM-BROD-0569-C43_treatment7,e12b8693-5e83-48a6-8bb3-4142bb56c7d9,,released,,0,2021-09-07T12:02:33.564120-05:00,"Radiation Therapy, NOS",Residual Disease,
HCM-BROD-0569-C43,4e828c35-5fc3-40af-a2ee-10b4281c77b8,e795772c-a156-49cc-8578-4ba5901f374e,,Adjuvant,,2021-09-10T10:36:37.981324-05:00,HCM-BROD-0569-C43_treatment6,e14dfea8-6f8f-49a5-ae75-36b213545ed5,,released,,0,2021-09-07T12:02:33.564120-05:00,Targeted Molecular Therapy,Residual Disease,
HCM-EXPT-1247-C18,4e99c213-bf46-4b46-a85c-653bae172b0e,dd494fde-1702-4b77-a55d-080ec128db75,,Neoadjuvant,,2025-10-08T12:39:37.798161-05:00,HCM-EXPT-1247-C18_treatment,a7416559-8c8a-4ece-b1d7-d578f6eaaf93,,released,,0,2023-02-24T13:53:25.441556-06:00,,,
HCM-EXPT-1258-C20,4ebd9b62-4c82-412e-b022-c1cea0ff8bd8,03dbf569-a478-48ba-801f-0628c02c629e,,Neoadjuvant,93.0,2025-10-08T12:39:59.137357-05:00,HCM-EXPT-1258-C20_treatment3,19c1ef14-6c4b-4e15-9572-0b6ae6340fdf,,released,Mitomycin,1,2023-02-24T13:54:48.342628-06:00,Chemotherapy,,
HCM-EXPT-1258-C20,4ebd9b62-4c82-412e-b022-c1cea0ff8bd8,03dbf569-a478-48ba-801f-0628c02c629e,,Neoadjuvant,93.0,2025-10-08T12:39:59.137357-05:00,HCM-EXPT-1258-C20_treatment4,3be807f4-5563-40c4-bdb9-31598f4945b5,,released,,1,2023-02-24T13:54:48.342628-06:00,"Radiation, 2D Conventional",,
HCM-EXPT-1258-C20,4ebd9b62-4c82-412e-b022-c1cea0ff8bd8,03dbf569-a478-48ba-801f-0628c02c629e,,Neoadjuvant,93.0,2025-10-08T12:39:59.137357-05:00,HCM-EXPT-1258-C20_treatment2,be545cb9-7167-423a-a487-153f983e86d6,,released,Oxaliplatin,1,2023-02-24T13:54:48.342628-06:00,Chemotherapy,,
HCM-EXPT-1258-C20,4ebd9b62-4c82-412e-b022-c1cea0ff8bd8,03dbf569-a478-48ba-801f-0628c02c629e,,Neoadjuvant,93.0,2025-10-08T12:39:59.137357-05:00,HCM-EXPT-1258-C20_treatment,ff212589-0851-4b63-b486-13153b4d89fa,,released,Capecitabine,1,2023-02-24T13:54:48.342628-06:00,Chemotherapy,,
HCM-CSHL-0462-D05,4eea6e7d-a49d-49c5-b849-48665b79548b,c59eada7-59f3-49d5-9b0f-263cd36c621e,,Adjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0462-D05_treatment3,5edd7795-c7dd-4be8-bad8-76812df6cbed,,released,,0,2020-08-31T19:17:26.755105-05:00,"Pharmaceutical Therapy, NOS",Residual Disease,
HCM-CSHL-0462-D05,4eea6e7d-a49d-49c5-b849-48665b79548b,c59eada7-59f3-49d5-9b0f-263cd36c621e,,Adjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0462-D05_treatment4,6600fb28-f9b4-4a3f-8f7e-94d4480ff0f1,,released,,0,2020-08-31T19:17:26.755105-05:00,"Radiation Therapy, NOS",Residual Disease,
HCM-CSHL-0462-D05,4eea6e7d-a49d-49c5-b849-48665b79548b,c59eada7-59f3-49d5-9b0f-263cd36c621e,,,76.0,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0462-D05_treatment2,9b031a7a-a43e-4590-94a8-46e35f01e6a5,,released,,1,2020-08-31T19:17:26.755105-05:00,"Surgery, NOS",Initial Diagnosis,
HCM-CSHL-0462-D05,4eea6e7d-a49d-49c5-b849-48665b79548b,c59eada7-59f3-49d5-9b0f-263cd36c621e,,Neoadjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0462-D05_treatment,ceb15621-a552-48bc-98bd-f8548a6b0447,,released,,0,2020-08-31T19:17:26.755105-05:00,,,
HCM-BROD-0140-C16,4f86f0ad-83af-45fb-8579-16cf09f4de2f,cff61451-d48e-4ef8-ac7a-f376937c8fbf,,Adjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0140-C16_treatment2,0db1273b-572f-4d2f-a7c8-367dad0fe432,,released,,0,2020-04-21T15:04:13.043029-05:00,Chemotherapy,Residual Disease,
HCM-BROD-0140-C16,4f86f0ad-83af-45fb-8579-16cf09f4de2f,cff61451-d48e-4ef8-ac7a-f376937c8fbf,,,,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0140-C16_treatment4,19387388-9c93-42b2-8e68-bfbd7b45824f,,released,,0,2020-04-21T15:04:13.043029-05:00,"Surgery, NOS",Initial Diagnosis,
HCM-BROD-0140-C16,4f86f0ad-83af-45fb-8579-16cf09f4de2f,cff61451-d48e-4ef8-ac7a-f376937c8fbf,,Neoadjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0140-C16_treatment,92479cc9-dad2-42b7-8206-14a2fd3db8e2,,released,,0,2019-04-04T15:43:03.494155-05:00,,,
HCM-BROD-0140-C16,4f86f0ad-83af-45fb-8579-16cf09f4de2f,cff61451-d48e-4ef8-ac7a-f376937c8fbf,,Adjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0140-C16_treatment6,9c976371-7290-48bf-9075-52efd55e56ad,,released,,0,2020-04-21T15:04:13.043029-05:00,"Radiation Therapy, NOS",Residual Disease,
HCM-BROD-0140-C16,4f86f0ad-83af-45fb-8579-16cf09f4de2f,cff61451-d48e-4ef8-ac7a-f376937c8fbf,,Adjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0140-C16_treatment5,a4ea2447-7233-4755-9ed1-4beddefbe1f4,,released,,0,2020-04-21T15:04:13.043029-05:00,Targeted Molecular Therapy,Residual Disease,
HCM-BROD-0140-C16,4f86f0ad-83af-45fb-8579-16cf09f4de2f,cff61451-d48e-4ef8-ac7a-f376937c8fbf,,Adjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0140-C16_treatment3,c4846b89-4298-4f4e-97bb-6d02a2b5076e,,released,,0,2020-04-21T15:04:13.043029-05:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-CSHL-0189-C25,4fc3862d-16a0-459b-a0b4-7f9edd6dd087,a4c314cb-2f3e-4fd2-b551-27c8c5d97d1a,,Adjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0189-C25_treatment4,79c75275-cedf-4b8b-94d5-5cd5631adf75,,released,,0,2020-09-28T12:59:20.372901-05:00,"Radiation Therapy, NOS",Residual Disease,
HCM-CSHL-0189-C25,4fc3862d-16a0-459b-a0b4-7f9edd6dd087,a4c314cb-2f3e-4fd2-b551-27c8c5d97d1a,,Neoadjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0189-C25_treatment,7e554bf4-12d8-4062-bf2e-ee4bb4b99b66,,released,,0,2020-09-28T12:59:20.372901-05:00,,,
HCM-CSHL-0189-C25,4fc3862d-16a0-459b-a0b4-7f9edd6dd087,a4c314cb-2f3e-4fd2-b551-27c8c5d97d1a,,,-4.0,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0189-C25_treatment2,cf95a17d-faa0-4e22-9c1f-4ede112c98bc,,released,,1,2020-09-28T12:59:20.372901-05:00,"Surgery, NOS",Initial Diagnosis,
HCM-CSHL-0189-C25,4fc3862d-16a0-459b-a0b4-7f9edd6dd087,a4c314cb-2f3e-4fd2-b551-27c8c5d97d1a,,Adjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0189-C25_treatment3,feae9685-85a4-419f-8372-78255292d046,,released,,0,2020-09-28T12:59:20.372901-05:00,"Pharmaceutical Therapy, NOS",Residual Disease,
HCM-EXPT-1220-C18,5029f6b9-2698-47af-b309-929888fe8263,8b217bd6-4529-4277-b633-f00da7fd7c92,,Neoadjuvant,,2025-10-08T12:39:14.406630-05:00,HCM-EXPT-1220-C18_treatment,a6e9b48e-d87a-4722-83ef-b076034987dd,,released,,0,2022-03-09T19:43:33.319840-06:00,,,
HCM-EXPT-0982-C50,5070731d-6f96-4824-bb25-2f21750c8864,74ff16c5-953e-41ca-b012-6fa3a3e17163,,Neoadjuvant,,2025-10-08T12:37:21.548354-05:00,HCM-EXPT-0982-C50_treatment,02568757-99e4-4f9d-95b9-01b18fe7b2d0,,released,,1,2021-12-21T14:50:27.397288-06:00,Hormone Therapy,,
HCM-SANG-1085-C20,50854c28-2457-4b22-98a9-50d4b7c66701,a0657433-5e14-442d-b0f6-ed42542a13de,,Neoadjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-SANG-1085-C20_treatment2,0e7fde1f-d0ca-450b-8de5-b3df4609522f,,released,Oxaliplatin,1,2023-02-27T12:09:53.209916-06:00,Chemotherapy,,
HCM-SANG-1085-C20,50854c28-2457-4b22-98a9-50d4b7c66701,a0657433-5e14-442d-b0f6-ed42542a13de,,Neoadjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-SANG-1085-C20_treatment3,85521275-b4fa-45f7-9850-44551027212d,,released,,1,2023-02-27T12:09:53.209916-06:00,"Radiation, 2D Conventional",,
HCM-SANG-1085-C20,50854c28-2457-4b22-98a9-50d4b7c66701,a0657433-5e14-442d-b0f6-ed42542a13de,,Neoadjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-SANG-1085-C20_treatment,f62f7029-1b92-4b13-a5c1-849791213561,,released,Capecitabine,1,2023-02-27T12:09:53.209916-06:00,Chemotherapy,,
HCM-BROD-0762-C49,509a9942-11da-479b-b38a-2ca2a30b5134,0421d309-7e63-446d-b8a8-5f4f4d9cff58,313.0,Adjuvant,1.0,2023-07-13T10:27:19.665852-05:00,HCM-BROD-0762-C49_treatment4,08acad03-1917-4ce3-af05-d530bd312e41,,released,Vinblastine,1,2021-12-21T13:50:53.446920-06:00,Chemotherapy,Residual Disease,
HCM-BROD-0762-C49,509a9942-11da-479b-b38a-2ca2a30b5134,0421d309-7e63-446d-b8a8-5f4f4d9cff58,313.0,Adjuvant,1.0,2023-07-13T10:27:19.665852-05:00,HCM-BROD-0762-C49_treatment3,1c5dfe0f-f80e-412f-a75d-027bdd8e0c1d,,released,Methotrexate,1,2021-12-21T13:50:53.446920-06:00,Chemotherapy,Residual Disease,
HCM-BROD-0762-C49,509a9942-11da-479b-b38a-2ca2a30b5134,0421d309-7e63-446d-b8a8-5f4f4d9cff58,,Neoadjuvant,183.0,2023-07-13T10:27:19.665852-05:00,HCM-BROD-0762-C49_treatment2,324888f3-4129-4ae8-9f2c-0adda184e648,,released,Vinblastine,1,2021-12-21T13:50:53.446920-06:00,Chemotherapy,,
HCM-BROD-0762-C49,509a9942-11da-479b-b38a-2ca2a30b5134,0421d309-7e63-446d-b8a8-5f4f4d9cff58,,Adjuvant,,2023-07-13T10:27:19.665852-05:00,HCM-BROD-0762-C49_treatment9,4bca5a08-a55c-4ef5-97d1-4b3d30c31033,,released,,0,2021-12-21T13:50:53.446920-06:00,"Radiation Therapy, NOS",Residual Disease,
HCM-BROD-0762-C49,509a9942-11da-479b-b38a-2ca2a30b5134,0421d309-7e63-446d-b8a8-5f4f4d9cff58,,,5.0,2023-07-13T10:27:19.665852-05:00,HCM-BROD-0762-C49_treatment7,a23b5c70-b924-4fbc-af8f-5c401ad02f4a,,released,,1,2021-12-21T13:50:53.446920-06:00,"Surgery, NOS",Initial Diagnosis,
HCM-BROD-0762-C49,509a9942-11da-479b-b38a-2ca2a30b5134,0421d309-7e63-446d-b8a8-5f4f4d9cff58,,Adjuvant,,2023-07-13T10:27:19.665852-05:00,HCM-BROD-0762-C49_treatment8,b6a92e7f-f7a8-469c-8781-1a786cbad73b,,released,,0,2021-12-21T13:50:53.446920-06:00,Targeted Molecular Therapy,Residual Disease,
HCM-BROD-0762-C49,509a9942-11da-479b-b38a-2ca2a30b5134,0421d309-7e63-446d-b8a8-5f4f4d9cff58,,Neoadjuvant,183.0,2023-07-13T10:27:19.665852-05:00,HCM-BROD-0762-C49_treatment,c09826f3-a5ea-45c6-989d-090e8dcde3be,,released,Methotrexate,1,2021-12-21T13:50:53.446920-06:00,Chemotherapy,,
HCM-BROD-0762-C49,509a9942-11da-479b-b38a-2ca2a30b5134,0421d309-7e63-446d-b8a8-5f4f4d9cff58,,Adjuvant,,2023-07-13T10:27:19.665852-05:00,HCM-BROD-0762-C49_treatment5,cd9d5350-b622-41e7-aa3f-c3b7fcd95313,,released,,0,2021-12-21T13:50:53.446920-06:00,Hormone Therapy,Residual Disease,
HCM-BROD-0762-C49,509a9942-11da-479b-b38a-2ca2a30b5134,0421d309-7e63-446d-b8a8-5f4f4d9cff58,,Adjuvant,,2023-07-13T10:27:19.665852-05:00,HCM-BROD-0762-C49_treatment6,fad621b7-2b63-467f-bfa1-6bb3c0ea74aa,,released,,0,2021-12-21T13:50:53.446920-06:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-CSHL-0800-C67,50d40aee-8e5d-4094-81e3-46c1bcb85abf,dcfdb561-ac74-4793-95fc-e73dee5b0061,76.0,Adjuvant,27.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0800-C67_treatment2,068d43b7-bf20-4794-8652-ac4936ea04c7,,released,Carboplatin,1,2021-12-21T14:23:50.850864-06:00,Chemotherapy,Residual Disease,
HCM-CSHL-0800-C67,50d40aee-8e5d-4094-81e3-46c1bcb85abf,dcfdb561-ac74-4793-95fc-e73dee5b0061,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0800-C67_treatment4,0bfb2660-adbc-4064-81e5-0f1ddf2ea89b,,released,,0,2021-12-21T14:23:50.850864-06:00,Hormone Therapy,Residual Disease,
HCM-CSHL-0800-C67,50d40aee-8e5d-4094-81e3-46c1bcb85abf,dcfdb561-ac74-4793-95fc-e73dee5b0061,,,0.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0800-C67_treatment6,0d1af18c-f3ad-4340-8292-bad014eba81a,,released,,1,2021-12-21T14:23:50.850864-06:00,"Surgery, NOS",Initial Diagnosis,
HCM-CSHL-0800-C67,50d40aee-8e5d-4094-81e3-46c1bcb85abf,dcfdb561-ac74-4793-95fc-e73dee5b0061,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0800-C67_treatment5,84a8c019-d8b8-463b-9447-0eb19252e9db,,released,,0,2021-12-21T14:23:50.850864-06:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-CSHL-0800-C67,50d40aee-8e5d-4094-81e3-46c1bcb85abf,dcfdb561-ac74-4793-95fc-e73dee5b0061,,Neoadjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0800-C67_treatment,d3f0c13e-e143-4a86-b7d4-a221227240b7,,released,,0,2021-12-21T14:23:50.850864-06:00,,,
HCM-CSHL-0800-C67,50d40aee-8e5d-4094-81e3-46c1bcb85abf,dcfdb561-ac74-4793-95fc-e73dee5b0061,76.0,Adjuvant,27.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0800-C67_treatment3,e29737d4-6321-4fde-877b-1693173f53be,,released,Gemcitabine,1,2021-12-21T14:23:50.850864-06:00,Chemotherapy,Residual Disease,
HCM-CSHL-0800-C67,50d40aee-8e5d-4094-81e3-46c1bcb85abf,dcfdb561-ac74-4793-95fc-e73dee5b0061,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0800-C67_treatment7,f04bf1e2-724c-4dc5-a43f-da8a1f9f4721,,released,,0,2021-12-21T14:23:50.850864-06:00,Targeted Molecular Therapy,Residual Disease,
HCM-CSHL-0800-C67,50d40aee-8e5d-4094-81e3-46c1bcb85abf,dcfdb561-ac74-4793-95fc-e73dee5b0061,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0800-C67_treatment8,f0636ca8-eb72-4438-87c3-e4c02523eca2,,released,,0,2021-12-21T14:23:50.850864-06:00,"Radiation Therapy, NOS",Residual Disease,
HCM-BROD-0685-C71,50d99ee7-b965-4211-9a4e-b857f4775208,9008c037-11a2-45db-bf92-099853808c23,480.0,Adjuvant,453.0,2023-02-22T07:39:25.979291-06:00,HCM-BROD-0685-C71_treatment3,59e8b741-af79-460a-a4ba-2438276f8528,,released,Temozolomide,1,2021-12-21T13:45:22.009055-06:00,Chemotherapy,Residual Disease,
HCM-BROD-0685-C71,50d99ee7-b965-4211-9a4e-b857f4775208,9008c037-11a2-45db-bf92-099853808c23,,Neoadjuvant,,2023-02-22T07:39:25.979291-06:00,HCM-BROD-0685-C71_treatment,60f9ee7a-35fa-4463-9891-031388c379bf,,released,,0,2021-12-21T13:45:22.009055-06:00,,,
HCM-BROD-0685-C71,50d99ee7-b965-4211-9a4e-b857f4775208,9008c037-11a2-45db-bf92-099853808c23,,Adjuvant,,2023-02-22T07:39:25.979291-06:00,HCM-BROD-0685-C71_treatment4,6ef815c4-3b30-4875-9c94-d6f03a011d54,,released,,0,2021-12-21T13:45:22.009055-06:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-BROD-0685-C71,50d99ee7-b965-4211-9a4e-b857f4775208,9008c037-11a2-45db-bf92-099853808c23,62.0,Adjuvant,20.0,2023-02-22T07:39:25.979291-06:00,HCM-BROD-0685-C71_treatment7,804142c1-a5a1-46a7-89da-5bbf348890ba,,released,,1,2021-12-21T13:45:22.009055-06:00,"Radiation Therapy, NOS",Residual Disease,
HCM-BROD-0685-C71,50d99ee7-b965-4211-9a4e-b857f4775208,9008c037-11a2-45db-bf92-099853808c23,,,0.0,2023-02-27T13:11:15.714825-06:00,HCM-BROD-0685-C71_treatment5,923cf6d2-4a07-431c-a5ba-3651a00d9d25,,released,,1,2021-12-21T13:45:22.009055-06:00,"Surgery, NOS",Initial Diagnosis,
HCM-BROD-0685-C71,50d99ee7-b965-4211-9a4e-b857f4775208,9008c037-11a2-45db-bf92-099853808c23,600.0,Adjuvant,579.0,2023-02-22T07:39:25.979291-06:00,HCM-BROD-0685-C71_treatment6,9f117353-5aff-41d6-81cb-05344b00f4cf,,released,Bevacizumab,1,2021-12-21T13:45:22.009055-06:00,Targeted Molecular Therapy,Residual Disease,
HCM-BROD-0685-C71,50d99ee7-b965-4211-9a4e-b857f4775208,9008c037-11a2-45db-bf92-099853808c23,260.0,Adjuvant,20.0,2023-02-22T07:39:25.979291-06:00,HCM-BROD-0685-C71_treatment2,a1648d86-d045-46ac-a425-2a95f242129a,,released,Temozolomide,1,2021-12-21T13:45:22.009055-06:00,Chemotherapy,Residual Disease,
HCM-BROD-1119-C43,511b885f-5e6d-4d7c-a08a-8dda5d042b4e,c9d7280a-54b6-4bba-890c-dcf954f3d572,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-BROD-1119-C43_treatment4,1691c872-e1c4-4742-8904-6f9c86b90a8d,,released,,0,2021-12-21T14:01:05.755510-06:00,"Radiation Therapy, NOS",Residual Disease,
HCM-BROD-1119-C43,511b885f-5e6d-4d7c-a08a-8dda5d042b4e,c9d7280a-54b6-4bba-890c-dcf954f3d572,,,0.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-1119-C43_treatment2,333b8c0a-eea9-49fc-9a7c-bb5e8a9d55b8,,released,,1,2021-12-21T14:01:05.755510-06:00,"Surgery, NOS",Initial Diagnosis,
HCM-BROD-1119-C43,511b885f-5e6d-4d7c-a08a-8dda5d042b4e,c9d7280a-54b6-4bba-890c-dcf954f3d572,,Neoadjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-BROD-1119-C43_treatment,8b8898ec-ba99-4552-9149-474a54b95213,,released,,0,2021-12-21T14:01:05.755510-06:00,,,
HCM-BROD-1119-C43,511b885f-5e6d-4d7c-a08a-8dda5d042b4e,c9d7280a-54b6-4bba-890c-dcf954f3d572,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-BROD-1119-C43_treatment3,ad4f5b3e-25cb-443d-886b-d999b654d5ae,,released,,0,2021-12-21T14:01:05.755510-06:00,"Pharmaceutical Therapy, NOS",Residual Disease,
HCM-BROD-1119-C43,511b885f-5e6d-4d7c-a08a-8dda5d042b4e,e2ef59e0-3a6e-4dfb-8b05-334038b17625,1633.0,Maintenance Therapy,1403.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-1119-C43_treatment5,ac7d71b5-ecdb-4178-8868-0e54b4ff7442,Complete Response,released,Unknown,1,2023-02-28T13:43:31.801497-06:00,,,
HCM-BROD-0196-C71,51b83c83-b639-424b-a023-fd5fe7c2f4b5,dbd3dfca-2deb-4ae0-abd7-1a49c5d92d2d,78.0,Adjuvant,36.0,2021-01-06T22:55:10.531130-06:00,HCM-BROD-0196-C71_treatment2,1d521697-fef3-491e-be88-a0a7c9a25cf9,,released,Temozolomide,1,2020-02-27T12:33:21.669786-06:00,Chemotherapy,Residual Disease,
HCM-BROD-0196-C71,51b83c83-b639-424b-a023-fd5fe7c2f4b5,dbd3dfca-2deb-4ae0-abd7-1a49c5d92d2d,,Adjuvant,,2021-01-06T22:55:10.531130-06:00,HCM-BROD-0196-C71_treatment6,24d77377-3f7f-440f-8de4-1581a00cca57,,released,,0,2020-02-27T12:33:21.669786-06:00,Targeted Molecular Therapy,Residual Disease,
HCM-BROD-0196-C71,51b83c83-b639-424b-a023-fd5fe7c2f4b5,dbd3dfca-2deb-4ae0-abd7-1a49c5d92d2d,,Adjuvant,,2021-01-06T22:55:10.531130-06:00,HCM-BROD-0196-C71_treatment4,2e19f73d-2fa2-4980-9b83-54a5fac6eae0,,released,,0,2020-02-27T12:33:21.669786-06:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-BROD-0196-C71,51b83c83-b639-424b-a023-fd5fe7c2f4b5,dbd3dfca-2deb-4ae0-abd7-1a49c5d92d2d,,Neoadjuvant,,2021-01-06T22:55:10.531130-06:00,HCM-BROD-0196-C71_treatment,4f2aef9b-b10e-4aaf-b587-3e3eb2ade75a,,released,,0,2019-04-04T14:54:33.197276-05:00,,,
HCM-BROD-0196-C71,51b83c83-b639-424b-a023-fd5fe7c2f4b5,dbd3dfca-2deb-4ae0-abd7-1a49c5d92d2d,246.0,Adjuvant,93.0,2021-01-06T22:55:10.531130-06:00,HCM-BROD-0196-C71_treatment3,618800b5-25ea-4eac-9e57-5aab47f64c6d,,released,Temozolomide,1,2020-02-27T12:33:21.669786-06:00,Chemotherapy,Residual Disease,
HCM-BROD-0196-C71,51b83c83-b639-424b-a023-fd5fe7c2f4b5,dbd3dfca-2deb-4ae0-abd7-1a49c5d92d2d,,,-6.0,2023-02-27T12:55:17.047225-06:00,HCM-BROD-0196-C71_treatment5,7ac9291d-27f6-43a6-8921-934d1132781e,,released,,1,2020-02-27T12:33:21.669786-06:00,"Surgery, NOS",Initial Diagnosis,
HCM-BROD-0196-C71,51b83c83-b639-424b-a023-fd5fe7c2f4b5,dbd3dfca-2deb-4ae0-abd7-1a49c5d92d2d,78.0,Adjuvant,36.0,2021-01-06T22:55:10.531130-06:00,HCM-BROD-0196-C71_treatment7,e644ee0b-5202-46ae-b22f-6481ffef6508,,released,,1,2020-02-27T12:33:21.669786-06:00,"Radiation Therapy, NOS",Residual Disease,
HCM-EXPT-1033-C50,520e3648-4760-404e-ab5a-21edcbe07650,127bc010-1550-4eab-b8f6-880ebfb93f7a,,Neoadjuvant,,2025-10-08T12:38:06.952582-05:00,HCM-EXPT-1033-C50_treatment,f496e768-1d6a-4bcb-9673-511916b9e61f,,released,,0,2021-12-21T14:58:24.005007-06:00,,,
HCM-EXPT-0886-C25,5251a533-866b-4056-8082-b88d0915f9c8,90995297-fe95-4f96-8b4e-290eccce788c,,Neoadjuvant,,2025-10-08T12:36:32.654639-05:00,HCM-EXPT-0886-C25_treatment,35303050-82d6-4268-9c9e-5ad72ae8e210,,released,,0,2021-12-21T14:40:55.430607-06:00,,,
HCM-EXPT-1039-C34,5314a3fc-6129-4d68-89f5-1084bfd0442d,8042d172-e9a9-445b-99ab-0b3afa39d6b8,,Neoadjuvant,,2025-10-08T12:38:06.952582-05:00,HCM-EXPT-1039-C34_treatment,6bee19e0-4a57-43ba-9817-912772eaa43f,,released,,0,2021-12-21T14:59:49.955431-06:00,,,
HCM-BROD-0230-C25,53159c56-0604-455c-8efc-db9cdaa7642c,f4801c96-ff19-45d2-9e9d-b43a05702c6a,708.0,Adjuvant,673.0,2023-07-13T10:35:44.371881-05:00,HCM-BROD-0230-C25_treatment7,185882c5-740b-4c9b-9d5c-223fc6cf759e,,released,Unknown,1,2020-09-17T16:07:29.990615-05:00,Targeted Molecular Therapy,Residual Disease,
HCM-BROD-0230-C25,53159c56-0604-455c-8efc-db9cdaa7642c,f4801c96-ff19-45d2-9e9d-b43a05702c6a,,,,2023-07-13T10:35:44.371881-05:00,HCM-BROD-0230-C25_treatment6,1b0c1c64-26d3-47d1-960d-6665f40c12eb,,released,,0,2020-09-17T16:07:29.990615-05:00,"Surgery, NOS",Initial Diagnosis,
HCM-BROD-0230-C25,53159c56-0604-455c-8efc-db9cdaa7642c,f4801c96-ff19-45d2-9e9d-b43a05702c6a,,Neoadjuvant,586.0,2023-07-13T10:35:44.371881-05:00,HCM-BROD-0230-C25_treatment2,34dc5b27-c66e-403e-9263-3be5fc30d612,,released,Nab-paclitaxel,1,2020-09-17T16:07:29.990615-05:00,Chemotherapy,,
HCM-BROD-0230-C25,53159c56-0604-455c-8efc-db9cdaa7642c,f4801c96-ff19-45d2-9e9d-b43a05702c6a,,Neoadjuvant,,2023-07-13T10:35:44.371881-05:00,HCM-BROD-0230-C25_treatment3,478ae97e-f322-4455-b028-192ac280ad27,,released,,1,2020-09-17T16:07:29.990615-05:00,Targeted Molecular Therapy,,
HCM-BROD-0230-C25,53159c56-0604-455c-8efc-db9cdaa7642c,f4801c96-ff19-45d2-9e9d-b43a05702c6a,,Adjuvant,,2023-07-13T10:35:44.371881-05:00,HCM-BROD-0230-C25_treatment5,50005c75-2f5c-4876-8ff8-23a741ec4c98,,released,,0,2020-09-17T16:07:29.990615-05:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-BROD-0230-C25,53159c56-0604-455c-8efc-db9cdaa7642c,f4801c96-ff19-45d2-9e9d-b43a05702c6a,,Neoadjuvant,586.0,2023-07-13T10:35:44.371881-05:00,HCM-BROD-0230-C25_treatment,823c8e55-eef4-4a6b-93b1-15f052af17d8,,released,Gemcitabine,1,2020-09-17T16:07:29.990615-05:00,Chemotherapy,,
HCM-BROD-0230-C25,53159c56-0604-455c-8efc-db9cdaa7642c,f4801c96-ff19-45d2-9e9d-b43a05702c6a,,Adjuvant,,2023-07-13T10:35:44.371881-05:00,HCM-BROD-0230-C25_treatment4,b00766be-b9c2-42a5-a3da-42b6fdfbb473,,released,,0,2020-09-17T16:07:29.990615-05:00,Chemotherapy,Residual Disease,
HCM-BROD-0230-C25,53159c56-0604-455c-8efc-db9cdaa7642c,f4801c96-ff19-45d2-9e9d-b43a05702c6a,,Adjuvant,,2023-07-13T10:35:44.371881-05:00,HCM-BROD-0230-C25_treatment8,d849e4d7-32be-40af-9107-c4aee0a4c8ce,,released,,0,2020-09-17T16:07:29.990615-05:00,"Radiation Therapy, NOS",Residual Disease,
HCM-EXPT-0931-C50,53ad2260-7dae-45c8-8455-20a48535cd28,0e402eae-475a-41a8-97f0-eeadd5ab5939,,Neoadjuvant,,2025-10-08T12:36:57.024699-05:00,HCM-EXPT-0931-C50_treatment,97a07722-a26a-437a-a279-ddf56f0c0e0b,,released,,0,2021-12-21T14:45:24.638668-06:00,,,
HCM-CSHL-0181-C25,5426912c-da56-46dd-b00c-dedb7d5c89cc,131ddc91-4d80-47a0-9bc4-993c8632c635,,Adjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0181-C25_treatment4,03ef0680-850e-40fc-a3e5-2157efae53a5,,released,,0,2020-09-28T09:14:25.343113-05:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-CSHL-0181-C25,5426912c-da56-46dd-b00c-dedb7d5c89cc,131ddc91-4d80-47a0-9bc4-993c8632c635,112.0,Adjuvant,69.0,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0181-C25_treatment2,341c3d34-fe62-4b6b-b5cf-b7f354b36a5e,,released,Gemcitabine,1,2020-09-28T09:14:25.343113-05:00,Chemotherapy,Residual Disease,
HCM-CSHL-0181-C25,5426912c-da56-46dd-b00c-dedb7d5c89cc,131ddc91-4d80-47a0-9bc4-993c8632c635,174.0,Adjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0181-C25_treatment7,4915e13f-045d-44bb-a180-43622f8f4147,,released,,1,2020-09-28T09:14:25.343113-05:00,"Radiation, 2D Conventional",Residual Disease,
HCM-CSHL-0181-C25,5426912c-da56-46dd-b00c-dedb7d5c89cc,131ddc91-4d80-47a0-9bc4-993c8632c635,,Adjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0181-C25_treatment6,4a3fa713-b8a5-4632-bf3a-ad4e3e74c670,,released,,0,2020-09-28T09:14:25.343113-05:00,Targeted Molecular Therapy,Residual Disease,
HCM-CSHL-0181-C25,5426912c-da56-46dd-b00c-dedb7d5c89cc,131ddc91-4d80-47a0-9bc4-993c8632c635,,Neoadjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0181-C25_treatment,73e60edd-5a0b-4108-9d28-06e0fa8da8a5,,released,,0,2020-09-28T09:14:25.343113-05:00,,,
HCM-CSHL-0181-C25,5426912c-da56-46dd-b00c-dedb7d5c89cc,131ddc91-4d80-47a0-9bc4-993c8632c635,112.0,Adjuvant,69.0,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0181-C25_treatment3,7a9ab0a5-6f6e-4d26-b213-a7f2698e1b67,,released,Nab-paclitaxel,1,2020-09-28T09:14:25.343113-05:00,Chemotherapy,Residual Disease,
HCM-CSHL-0181-C25,5426912c-da56-46dd-b00c-dedb7d5c89cc,131ddc91-4d80-47a0-9bc4-993c8632c635,,,-11.0,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0181-C25_treatment5,8a8d4b38-30d5-4d98-8440-63ce08e215fb,,released,,1,2020-09-28T09:14:25.343113-05:00,"Surgery, NOS",Initial Diagnosis,
HCM-SANG-0267-D12,54722e41-2feb-4c8a-b29f-3780da916e49,10303cf9-f830-48d5-8f92-d77467d461fe,,Neoadjuvant,,2023-02-22T07:39:25.979291-06:00,HCM-SANG-0267-D12_treatment,5943b9ec-46b6-4919-b834-3258b30dcd92,,released,,0,2020-02-27T12:19:29.618761-06:00,,,
HCM-EXPT-1064-C18,547967e5-7452-439b-a60a-a2526f0ac2cb,697de62e-2148-4f8b-a981-0ad7cb82bb68,,Neoadjuvant,,2025-10-08T12:38:28.988690-05:00,HCM-EXPT-1064-C18_treatment,edce4539-a3b6-43b2-bed2-f48677b84568,,released,,0,2021-12-21T15:03:28.116971-06:00,,,
HCM-EXPT-1239-C18,551f7d70-23b0-4deb-8a8e-b063457fb435,117bb727-c858-4990-9a1d-952fa09d610e,,Neoadjuvant,,2025-10-08T12:39:37.798161-05:00,HCM-EXPT-1239-C18_treatment,0fbc2a96-aedd-4c5f-9f8c-f3e905d8754f,,released,,0,2023-02-24T13:55:10.855359-06:00,,,
HCM-WCMC-1074-C56,5538445e-03c2-4466-a09a-83d5a527b26e,b2ee880b-b20c-443b-9e73-1300c21840cf,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-WCMC-1074-C56_treatment4,24312c9f-cd1b-49fc-ba65-11eb9b3c3854,,released,,0,2022-07-14T11:05:36.215897-05:00,"Radiation Therapy, NOS",Residual Disease,
HCM-WCMC-1074-C56,5538445e-03c2-4466-a09a-83d5a527b26e,b2ee880b-b20c-443b-9e73-1300c21840cf,,Neoadjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-WCMC-1074-C56_treatment,29c7170c-64fe-43bc-8119-b5ee6b53d806,,released,,0,2022-07-14T11:05:36.215897-05:00,,,
HCM-WCMC-1074-C56,5538445e-03c2-4466-a09a-83d5a527b26e,b2ee880b-b20c-443b-9e73-1300c21840cf,,,0.0,2025-04-07T17:13:09.336794-05:00,HCM-WCMC-1074-C56_treatment2,2dfa0f29-36fa-443c-9394-6f5a7db2ec23,,released,,1,2022-07-14T11:05:36.215897-05:00,"Surgery, NOS",Initial Diagnosis,
HCM-WCMC-1074-C56,5538445e-03c2-4466-a09a-83d5a527b26e,b2ee880b-b20c-443b-9e73-1300c21840cf,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-WCMC-1074-C56_treatment3,8e0f40a5-3c80-4806-8381-267d8dfaaa48,,released,,0,2022-07-14T11:05:36.215897-05:00,"Pharmaceutical Therapy, NOS",Residual Disease,
HCM-EXPT-1054-C50,55c66900-a14d-4bb7-9071-7c0feaecabfe,b1b29b03-012a-49e1-9a44-b4cd601f6dd2,,Neoadjuvant,,2025-10-08T12:38:06.952582-05:00,HCM-EXPT-1054-C50_treatment,367a472c-be7d-49d9-934b-b0bffd73948d,,released,,0,2021-12-21T15:01:50.652165-06:00,,,
HCM-CSHL-0861-C25,561a4c46-ca78-444f-8346-c30daa041d27,3a277df3-fcf7-4b58-a1b6-a814dbb19f32,,Adjuvant,45.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0861-C25_treatment2,0c206897-bcf5-45f4-934a-c8ce5ba36ff0,,released,Gemcitabine,1,2021-12-21T14:36:01.031311-06:00,Chemotherapy,Residual Disease,
HCM-CSHL-0861-C25,561a4c46-ca78-444f-8346-c30daa041d27,3a277df3-fcf7-4b58-a1b6-a814dbb19f32,,Neoadjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0861-C25_treatment,15e9ec58-caee-4cde-95c5-bef565074f06,,released,,0,2021-12-21T14:36:01.031311-06:00,,,
HCM-CSHL-0861-C25,561a4c46-ca78-444f-8346-c30daa041d27,3a277df3-fcf7-4b58-a1b6-a814dbb19f32,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0861-C25_treatment3,18f97627-7375-4f74-816e-2d28682e37e5,,released,,0,2021-12-21T14:36:01.031311-06:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-CSHL-0861-C25,561a4c46-ca78-444f-8346-c30daa041d27,3a277df3-fcf7-4b58-a1b6-a814dbb19f32,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0861-C25_treatment6,481bb7b7-bb2b-436f-a8a4-f85dd4630a4d,,released,,0,2021-12-21T14:36:01.031311-06:00,"Radiation Therapy, NOS",Residual Disease,
HCM-CSHL-0861-C25,561a4c46-ca78-444f-8346-c30daa041d27,3a277df3-fcf7-4b58-a1b6-a814dbb19f32,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0861-C25_treatment5,d2a7fff3-feb9-4695-b18c-153a85e0168a,,released,,0,2021-12-21T14:36:01.031311-06:00,Targeted Molecular Therapy,Residual Disease,
HCM-CSHL-0861-C25,561a4c46-ca78-444f-8346-c30daa041d27,3a277df3-fcf7-4b58-a1b6-a814dbb19f32,,,-6.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0861-C25_treatment4,d60372a6-19af-4e51-a45e-b799dd8fdb52,,released,,1,2021-12-21T14:36:01.031311-06:00,"Surgery, NOS",Initial Diagnosis,
HCM-EXPT-1252-C18,56a4bd00-b687-4869-9966-25a6caef8ced,befbbb5c-eb4b-4a88-bdcc-251193e59196,,Neoadjuvant,,2025-10-08T12:39:37.798161-05:00,HCM-EXPT-1252-C18_treatment,9ac92c34-943c-483e-8d14-d93f2146dfe6,,released,,0,2023-02-24T14:08:38.426968-06:00,,,
HCM-BROD-0027-C34,56c07b06-c6d3-4c03-9e57-7be636e7cc5c,b8698977-9702-4a4c-96b7-55db868e6c71,252.0,Adjuvant,246.0,2020-01-13T20:10:25.832065-06:00,HCM-BROD-0027-C34_treatment6,26b53016-2c58-4e39-8885-6a24c240feda,,released,,1,2019-04-04T15:11:28.695214-05:00,Stereotactic Radiosurgery,Residual Disease,
HCM-BROD-0027-C34,56c07b06-c6d3-4c03-9e57-7be636e7cc5c,b8698977-9702-4a4c-96b7-55db868e6c71,,Neoadjuvant,,2020-01-13T20:10:25.832065-06:00,HCM-BROD-0027-C34_treatment,4b918f22-a15a-4f24-b962-418839960e93,,released,,0,2019-04-04T15:11:28.695214-05:00,,,
HCM-BROD-0027-C34,56c07b06-c6d3-4c03-9e57-7be636e7cc5c,b8698977-9702-4a4c-96b7-55db868e6c71,,,,2023-02-27T12:43:03.593510-06:00,HCM-BROD-0027-C34_treatment4,97bd8233-822b-448f-89c5-30a6d9c9e1da,,released,,0,2019-04-04T15:11:28.695214-05:00,"Surgery, NOS",Initial Diagnosis,
HCM-BROD-0027-C34,56c07b06-c6d3-4c03-9e57-7be636e7cc5c,b8698977-9702-4a4c-96b7-55db868e6c71,,Adjuvant,,2020-01-13T20:10:25.832065-06:00,HCM-BROD-0027-C34_treatment2,9b8dca2c-0e17-4476-9ef3-fd1a13db4025,,released,,0,2019-04-04T15:11:28.695214-05:00,Chemotherapy,Residual Disease,
HCM-BROD-0027-C34,56c07b06-c6d3-4c03-9e57-7be636e7cc5c,b8698977-9702-4a4c-96b7-55db868e6c71,1065.0,Adjuvant,1022.0,2020-01-13T20:10:25.832065-06:00,HCM-BROD-0027-C34_treatment3,a5cd0216-04ef-4131-b328-0393170b70b2,Treatment Ongoing,released,Pembrolizumab,1,2019-04-04T15:11:28.695214-05:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-BROD-0027-C34,56c07b06-c6d3-4c03-9e57-7be636e7cc5c,b8698977-9702-4a4c-96b7-55db868e6c71,,Adjuvant,,2020-01-13T20:10:25.832065-06:00,HCM-BROD-0027-C34_treatment5,fd1432df-aa0a-49d6-87c5-a334fe668eab,,released,,0,2019-04-04T15:11:28.695214-05:00,Targeted Molecular Therapy,Residual Disease,
HCM-CSHL-0174-C22,5739bcf8-92f0-406a-b4ee-45b6b989bdb5,26f98bcf-809b-43cd-bd77-3cfa80cdb4de,,Adjuvant,,2020-10-20T19:20:06.800740-05:00,HCM-CSHL-0174-C22_treatment5,0cbdb89a-7f47-4803-b7e8-337da02832bb,,released,,0,2020-09-28T09:12:25.398710-05:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-CSHL-0174-C22,5739bcf8-92f0-406a-b4ee-45b6b989bdb5,26f98bcf-809b-43cd-bd77-3cfa80cdb4de,,Neoadjuvant,,2020-10-20T19:20:06.800740-05:00,HCM-CSHL-0174-C22_treatment,31210c89-11db-4f98-b707-ef96abae4228,,released,,0,2020-09-28T09:12:25.398710-05:00,,,
HCM-CSHL-0174-C22,5739bcf8-92f0-406a-b4ee-45b6b989bdb5,26f98bcf-809b-43cd-bd77-3cfa80cdb4de,169.0,Adjuvant,41.0,2020-10-20T19:20:06.800740-05:00,HCM-CSHL-0174-C22_treatment2,5281a679-4d72-41ad-ab8f-46884dc6b50e,,released,Gemcitabine,1,2020-09-28T09:12:25.398710-05:00,Chemotherapy,Residual Disease,
HCM-CSHL-0174-C22,5739bcf8-92f0-406a-b4ee-45b6b989bdb5,26f98bcf-809b-43cd-bd77-3cfa80cdb4de,,Adjuvant,,2020-10-20T19:20:06.800740-05:00,HCM-CSHL-0174-C22_treatment4,8ba63422-208e-4692-93b2-ca54cdf64e9a,,released,,0,2020-09-28T09:12:25.398710-05:00,Hormone Therapy,Residual Disease,
HCM-CSHL-0174-C22,5739bcf8-92f0-406a-b4ee-45b6b989bdb5,26f98bcf-809b-43cd-bd77-3cfa80cdb4de,,,-34.0,2023-02-24T15:07:45.741368-06:00,HCM-CSHL-0174-C22_treatment6,90724f64-01c4-4b3b-b439-7a8992693a2e,,released,,1,2020-09-28T09:12:25.398710-05:00,"Surgery, NOS",Initial Diagnosis,
HCM-CSHL-0174-C22,5739bcf8-92f0-406a-b4ee-45b6b989bdb5,26f98bcf-809b-43cd-bd77-3cfa80cdb4de,,Adjuvant,,2020-10-20T19:20:06.800740-05:00,HCM-CSHL-0174-C22_treatment7,aa4dd8fd-f27c-4292-8d19-b48d9463314d,,released,,0,2020-09-28T09:12:25.398710-05:00,Targeted Molecular Therapy,Residual Disease,
HCM-CSHL-0174-C22,5739bcf8-92f0-406a-b4ee-45b6b989bdb5,26f98bcf-809b-43cd-bd77-3cfa80cdb4de,,Adjuvant,,2020-10-20T19:20:06.800740-05:00,HCM-CSHL-0174-C22_treatment8,da2d7b0b-2992-472e-8cdf-43d1aa6efa46,,released,,0,2020-09-28T09:12:25.398710-05:00,"Radiation Therapy, NOS",Residual Disease,
HCM-CSHL-0174-C22,5739bcf8-92f0-406a-b4ee-45b6b989bdb5,26f98bcf-809b-43cd-bd77-3cfa80cdb4de,274.0,Adjuvant,190.0,2020-10-20T19:20:06.800740-05:00,HCM-CSHL-0174-C22_treatment3,e00ccf54-93eb-4c0f-9a8e-541e923211ef,,released,Oxaliplatin,1,2020-09-28T09:12:25.398710-05:00,Chemotherapy,Residual Disease,
HCM-BROD-0791-C43,575844b7-cfa1-406a-b0dd-d55cf9fff978,1b8eabc7-922b-469e-a712-99965d780ea1,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0791-C43_treatment3,0565f23f-8ca5-4fe5-851a-286ff87d1746,,released,,0,2021-12-21T13:53:28.705789-06:00,Hormone Therapy,Residual Disease,
HCM-BROD-0791-C43,575844b7-cfa1-406a-b0dd-d55cf9fff978,1b8eabc7-922b-469e-a712-99965d780ea1,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0791-C43_treatment2,25a33a38-07c5-4a68-923f-4a25b6575d7c,,released,,0,2021-12-21T13:53:28.705789-06:00,Chemotherapy,Residual Disease,
HCM-BROD-0791-C43,575844b7-cfa1-406a-b0dd-d55cf9fff978,1b8eabc7-922b-469e-a712-99965d780ea1,,Neoadjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0791-C43_treatment,39ece580-fe35-44a2-881e-722d39dd355c,,released,,0,2021-12-21T13:53:28.705789-06:00,,,
HCM-BROD-0791-C43,575844b7-cfa1-406a-b0dd-d55cf9fff978,1b8eabc7-922b-469e-a712-99965d780ea1,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0791-C43_treatment7,783a821c-5d37-47fa-97f4-f8229c4582fc,,released,,0,2021-12-21T13:53:28.705789-06:00,"Radiation Therapy, NOS",Residual Disease,
HCM-BROD-0791-C43,575844b7-cfa1-406a-b0dd-d55cf9fff978,1b8eabc7-922b-469e-a712-99965d780ea1,,,196.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0791-C43_treatment5,c719261e-c01e-4941-87fb-6018d14503aa,,released,,1,2021-12-21T13:53:28.705789-06:00,"Surgery, NOS",Initial Diagnosis,
HCM-BROD-0791-C43,575844b7-cfa1-406a-b0dd-d55cf9fff978,1b8eabc7-922b-469e-a712-99965d780ea1,2062.0,Adjuvant,1999.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0791-C43_treatment4,debcbd8c-6cf8-4cf9-919b-c33a2515d2e4,,released,Ipilimumab,1,2021-12-21T13:53:28.705789-06:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-BROD-0791-C43,575844b7-cfa1-406a-b0dd-d55cf9fff978,1b8eabc7-922b-469e-a712-99965d780ea1,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0791-C43_treatment6,f39925eb-f768-4a3a-a782-08621d1e913a,,released,,0,2021-12-21T13:53:28.705789-06:00,Targeted Molecular Therapy,Residual Disease,
HCM-BROD-0791-C43,575844b7-cfa1-406a-b0dd-d55cf9fff978,ce0a590f-3bc7-4e28-84ad-0b8a94d250c9,2038.0,Maintenance Therapy,33.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0791-C43_treatment10,5f260d9c-220c-42ed-98c7-aeb23afe18df,Progressive Disease,released,Binimetinib,1,2021-12-21T13:53:28.705789-06:00,,,
HCM-BROD-0791-C43,575844b7-cfa1-406a-b0dd-d55cf9fff978,ce0a590f-3bc7-4e28-84ad-0b8a94d250c9,2038.0,Maintenance Therapy,33.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0791-C43_treatment9,5fa3a044-6dbc-40c5-9ba7-87a5fa38dab9,Progressive Disease,released,Ipilimumab,1,2021-12-21T13:53:28.705789-06:00,,,
HCM-BROD-0791-C43,575844b7-cfa1-406a-b0dd-d55cf9fff978,ce0a590f-3bc7-4e28-84ad-0b8a94d250c9,2038.0,Maintenance Therapy,33.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0791-C43_treatment12,af823ae0-493f-4834-bb03-e89631ffe34e,Progressive Disease,released,Entinostat,1,2021-12-21T13:53:28.705789-06:00,,,
HCM-BROD-0791-C43,575844b7-cfa1-406a-b0dd-d55cf9fff978,ce0a590f-3bc7-4e28-84ad-0b8a94d250c9,2038.0,Maintenance Therapy,33.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0791-C43_treatment8,b2bd01bb-3c4a-461b-a0f5-71ad646b2770,Progressive Disease,released,BRAFV600/PI3K Inhibitor ASN003,1,2021-12-21T13:53:28.705789-06:00,,,
HCM-BROD-0791-C43,575844b7-cfa1-406a-b0dd-d55cf9fff978,ce0a590f-3bc7-4e28-84ad-0b8a94d250c9,2038.0,Maintenance Therapy,33.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0791-C43_treatment11,b3830cc3-ba9b-4c71-96d3-33d2bc13fc06,Progressive Disease,released,Pembrolizumab,1,2021-12-21T13:53:28.705789-06:00,,,
HCM-BROD-0791-C43,575844b7-cfa1-406a-b0dd-d55cf9fff978,ce0a590f-3bc7-4e28-84ad-0b8a94d250c9,2038.0,Maintenance Therapy,33.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0791-C43_treatment13,b5159583-5a00-49b3-a954-d344eec44c3e,Progressive Disease,released,PI3K-gamma Inhibitor IPI-549,1,2021-12-21T13:53:28.705789-06:00,,,
HCM-BROD-0791-C43,575844b7-cfa1-406a-b0dd-d55cf9fff978,ce0a590f-3bc7-4e28-84ad-0b8a94d250c9,2038.0,Maintenance Therapy,33.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0791-C43_treatment14,de9b7d71-11a4-4296-9051-63cef59a2011,Progressive Disease,released,Nivolumab,1,2021-12-21T13:53:28.705789-06:00,,,
HCM-BROD-0791-C43,575844b7-cfa1-406a-b0dd-d55cf9fff978,ef3bb758-7e47-4d02-8a15-3b81293e2c51,2089.0,Maintenance Therapy,33.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0791-C43_treatment15,167dd094-0e7c-48de-a7a8-29a8e8f6fff9,Progressive Disease,released,BRAFV600/PI3K Inhibitor ASN003,1,2021-12-21T13:53:28.705789-06:00,,,
HCM-BROD-0791-C43,575844b7-cfa1-406a-b0dd-d55cf9fff978,ef3bb758-7e47-4d02-8a15-3b81293e2c51,2089.0,Maintenance Therapy,33.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0791-C43_treatment17,4e04f56d-c2d5-4466-8427-246f9a1254b1,Progressive Disease,released,Binimetinib,1,2021-12-21T13:53:28.705789-06:00,,,
HCM-BROD-0791-C43,575844b7-cfa1-406a-b0dd-d55cf9fff978,ef3bb758-7e47-4d02-8a15-3b81293e2c51,2089.0,Maintenance Therapy,33.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0791-C43_treatment18,69574b2c-8355-4bdc-9d81-5df2965e3a7c,Progressive Disease,released,Pembrolizumab,1,2021-12-21T13:53:28.705789-06:00,,,
HCM-BROD-0791-C43,575844b7-cfa1-406a-b0dd-d55cf9fff978,ef3bb758-7e47-4d02-8a15-3b81293e2c51,2089.0,Maintenance Therapy,33.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0791-C43_treatment21,834759bc-6749-4628-a39f-4fac18e6211e,Progressive Disease,released,Nivolumab,1,2021-12-21T13:53:28.705789-06:00,,,
HCM-BROD-0791-C43,575844b7-cfa1-406a-b0dd-d55cf9fff978,ef3bb758-7e47-4d02-8a15-3b81293e2c51,2089.0,Maintenance Therapy,33.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0791-C43_treatment20,ad757f6f-927a-4bd0-b34d-ffe578c8ecae,Progressive Disease,released,PI3K-gamma Inhibitor IPI-549,1,2021-12-21T13:53:28.705789-06:00,,,
HCM-BROD-0791-C43,575844b7-cfa1-406a-b0dd-d55cf9fff978,ef3bb758-7e47-4d02-8a15-3b81293e2c51,2089.0,Maintenance Therapy,33.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0791-C43_treatment16,af39dab9-4b88-4a01-92de-d3c4b3c42687,Progressive Disease,released,Ipilimumab,1,2021-12-21T13:53:28.705789-06:00,,,
HCM-BROD-0791-C43,575844b7-cfa1-406a-b0dd-d55cf9fff978,ef3bb758-7e47-4d02-8a15-3b81293e2c51,2089.0,Maintenance Therapy,33.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0791-C43_treatment19,fe426c8b-7207-4e7a-a8e2-12817136cc44,Progressive Disease,released,Entinostat,1,2021-12-21T13:53:28.705789-06:00,,,
HCM-WCMC-0753-C54,57c28338-4fbb-47ab-94a0-c9988a650cda,3b29eb33-6982-4662-a466-8cf003d41b32,71.0,Adjuvant,36.0,2025-04-07T17:13:09.336794-05:00,HCM-WCMC-0753-C54_treatment4,28961364-b4b4-4997-95b1-75b4101aaadb,,released,,1,2023-02-27T12:57:22.683342-06:00,"Radiation Therapy, NOS",Residual Disease,
HCM-WCMC-0753-C54,57c28338-4fbb-47ab-94a0-c9988a650cda,3b29eb33-6982-4662-a466-8cf003d41b32,,,0.0,2025-04-07T17:13:09.336794-05:00,HCM-WCMC-0753-C54_treatment2,359c184e-d1d6-419e-97c0-48985db5947d,,released,,1,2023-02-27T12:57:22.683342-06:00,"Surgery, NOS",Initial Diagnosis,
HCM-WCMC-0753-C54,57c28338-4fbb-47ab-94a0-c9988a650cda,3b29eb33-6982-4662-a466-8cf003d41b32,,Neoadjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-WCMC-0753-C54_treatment,79ed67af-f2f7-4340-98e6-7fac244a86f2,,released,,0,2023-02-27T12:57:22.683342-06:00,,,
HCM-WCMC-0753-C54,57c28338-4fbb-47ab-94a0-c9988a650cda,3b29eb33-6982-4662-a466-8cf003d41b32,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-WCMC-0753-C54_treatment3,f8a600fb-7a25-44ce-a936-31a88bbd20dd,,released,,0,2023-02-27T12:57:22.683342-06:00,"Pharmaceutical Therapy, NOS",Residual Disease,
HCM-EXPT-1205-C18,57eaeb64-3172-4f2b-bc38-33d703ded1f6,41e7d1d4-7e13-4095-8439-c7f289cd1203,,Neoadjuvant,,2025-10-08T12:38:51.189053-05:00,HCM-EXPT-1205-C18_treatment,2efcb238-5543-4d3a-905b-54d4c4d1d751,,released,Capecitabine,1,2023-02-24T14:08:01.127239-06:00,Chemotherapy,,
HCM-EXPT-1205-C18,57eaeb64-3172-4f2b-bc38-33d703ded1f6,41e7d1d4-7e13-4095-8439-c7f289cd1203,,Neoadjuvant,,2025-10-08T12:38:51.189053-05:00,HCM-EXPT-1205-C18_treatment2,f6ddb0bd-294a-45f3-9424-802bc06619a1,,released,Oxaliplatin,1,2023-02-24T14:08:01.127239-06:00,Chemotherapy,,
HCM-SANG-0548-C25,585787a1-db13-4dbf-bfaa-8268381afa62,39e0dece-56e5-4cc2-88f9-21869d8fa82b,,Neoadjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-SANG-0548-C25_treatment,5bb4848b-e91c-4c3f-a4be-d3c4b6cf312c,,released,,0,2021-12-21T15:15:58.502986-06:00,,,
HCM-CSHL-0582-C18,5868f125-ca3b-4b98-85ea-64f0ea5b45da,21126e95-4518-417c-bd7c-e7c00c88a0e7,484.0,Maintenance Therapy,344.0,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0582-C18_treatment19,0bc73bbd-b2fa-4cc8-b2fe-a142d2a227f0,Progressive Disease,released,Fluorouracil,1,2021-12-21T14:08:47.221959-06:00,,,
HCM-CSHL-0582-C18,5868f125-ca3b-4b98-85ea-64f0ea5b45da,21126e95-4518-417c-bd7c-e7c00c88a0e7,484.0,Maintenance Therapy,344.0,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0582-C18_treatment20,9120bef4-3328-4612-9ebb-db5727ce5899,Progressive Disease,released,Irinotecan,1,2021-12-21T14:08:47.221959-06:00,,,
HCM-CSHL-0582-C18,5868f125-ca3b-4b98-85ea-64f0ea5b45da,21126e95-4518-417c-bd7c-e7c00c88a0e7,484.0,Maintenance Therapy,344.0,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0582-C18_treatment18,a6d3ebca-094e-4108-9811-4345c314d035,Progressive Disease,released,Leucovorin Calcium,1,2021-12-21T14:08:47.221959-06:00,,,
HCM-CSHL-0582-C18,5868f125-ca3b-4b98-85ea-64f0ea5b45da,21126e95-4518-417c-bd7c-e7c00c88a0e7,484.0,Maintenance Therapy,344.0,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0582-C18_treatment21,d8ad4106-df60-47ba-bcbd-1f83658d145a,Progressive Disease,released,,1,2021-12-21T14:08:47.221959-06:00,,,FOLFIRI
HCM-CSHL-0582-C18,5868f125-ca3b-4b98-85ea-64f0ea5b45da,a3a2c172-34bc-4879-98ce-b520afe288d9,,,520.0,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0582-C18_treatment15,1238ee4f-0a49-4899-b26f-fd68ed8b4734,,released,,1,2021-12-21T14:08:47.221959-06:00,"Surgery, NOS",Initial Diagnosis,
HCM-CSHL-0582-C18,5868f125-ca3b-4b98-85ea-64f0ea5b45da,a3a2c172-34bc-4879-98ce-b520afe288d9,624.0,Adjuvant,568.0,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0582-C18_treatment11,179df153-4450-49fd-9015-667ebb46986c,,released,Irinotecan,1,2021-12-21T14:08:47.221959-06:00,Chemotherapy,Residual Disease,
HCM-CSHL-0582-C18,5868f125-ca3b-4b98-85ea-64f0ea5b45da,a3a2c172-34bc-4879-98ce-b520afe288d9,484.0,Adjuvant,344.0,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0582-C18_treatment8,1d188634-11dd-4b0a-a5af-a74fd08af130,,released,,1,2021-12-21T14:08:47.221959-06:00,Chemotherapy,Residual Disease,FOLFIRI
HCM-CSHL-0582-C18,5868f125-ca3b-4b98-85ea-64f0ea5b45da,a3a2c172-34bc-4879-98ce-b520afe288d9,,Adjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0582-C18_treatment16,28a90ccb-ad7b-4a57-98ca-b763afbbc7b8,,released,,0,2021-12-21T14:08:47.221959-06:00,Targeted Molecular Therapy,Residual Disease,
HCM-CSHL-0582-C18,5868f125-ca3b-4b98-85ea-64f0ea5b45da,a3a2c172-34bc-4879-98ce-b520afe288d9,484.0,Adjuvant,344.0,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0582-C18_treatment5,3525302c-c9b9-4024-b645-d721453a7a1e,,released,Leucovorin Calcium,1,2021-12-21T14:08:47.221959-06:00,Chemotherapy,Residual Disease,
HCM-CSHL-0582-C18,5868f125-ca3b-4b98-85ea-64f0ea5b45da,a3a2c172-34bc-4879-98ce-b520afe288d9,624.0,Adjuvant,568.0,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0582-C18_treatment9,36b9b4ce-0022-4a37-8fa8-101498a0c1fa,,released,Leucovorin Calcium,1,2021-12-21T14:08:47.221959-06:00,Chemotherapy,Residual Disease,
HCM-CSHL-0582-C18,5868f125-ca3b-4b98-85ea-64f0ea5b45da,a3a2c172-34bc-4879-98ce-b520afe288d9,,Adjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0582-C18_treatment17,72ee6bb3-56c3-4443-a888-f993abcbd487,,released,,0,2021-12-21T14:08:47.221959-06:00,"Radiation Therapy, NOS",Residual Disease,
HCM-CSHL-0582-C18,5868f125-ca3b-4b98-85ea-64f0ea5b45da,a3a2c172-34bc-4879-98ce-b520afe288d9,,,34.0,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0582-C18_treatment14,78d4af15-f036-4c1d-a675-24efd68b9441,,released,,1,2021-12-21T14:08:47.221959-06:00,"Surgery, NOS",Initial Diagnosis,
HCM-CSHL-0582-C18,5868f125-ca3b-4b98-85ea-64f0ea5b45da,a3a2c172-34bc-4879-98ce-b520afe288d9,191.0,Adjuvant,64.0,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0582-C18_treatment2,886bb414-6766-4aaa-89ed-be5b0b0d5547,,released,Oxaliplatin,1,2021-12-21T14:08:47.221959-06:00,Chemotherapy,Residual Disease,
HCM-CSHL-0582-C18,5868f125-ca3b-4b98-85ea-64f0ea5b45da,a3a2c172-34bc-4879-98ce-b520afe288d9,624.0,Adjuvant,568.0,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0582-C18_treatment10,8e5e6048-a8b0-401f-b761-395c5125093f,,released,Fluorouracil,1,2021-12-21T14:08:47.221959-06:00,Chemotherapy,Residual Disease,
HCM-CSHL-0582-C18,5868f125-ca3b-4b98-85ea-64f0ea5b45da,a3a2c172-34bc-4879-98ce-b520afe288d9,,Adjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0582-C18_treatment13,b034ddc1-986b-478c-97f0-a49b101b18fe,,released,,0,2021-12-21T14:08:47.221959-06:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-CSHL-0582-C18,5868f125-ca3b-4b98-85ea-64f0ea5b45da,a3a2c172-34bc-4879-98ce-b520afe288d9,191.0,Adjuvant,64.0,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0582-C18_treatment3,bb7b965c-390b-4c0f-a612-795aa619ee52,,released,Capecitabine,1,2021-12-21T14:08:47.221959-06:00,Chemotherapy,Residual Disease,
HCM-CSHL-0582-C18,5868f125-ca3b-4b98-85ea-64f0ea5b45da,a3a2c172-34bc-4879-98ce-b520afe288d9,624.0,Adjuvant,568.0,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0582-C18_treatment12,bcca64e7-5e05-4cd9-8340-8c64d8973a0c,,released,,1,2021-12-21T14:08:47.221959-06:00,Chemotherapy,Residual Disease,FOLFIRI
HCM-CSHL-0582-C18,5868f125-ca3b-4b98-85ea-64f0ea5b45da,a3a2c172-34bc-4879-98ce-b520afe288d9,484.0,Adjuvant,344.0,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0582-C18_treatment6,c9be243d-6012-46d9-bbf7-f262a66ee29c,,released,Fluorouracil,1,2021-12-21T14:08:47.221959-06:00,Chemotherapy,Residual Disease,
HCM-CSHL-0582-C18,5868f125-ca3b-4b98-85ea-64f0ea5b45da,a3a2c172-34bc-4879-98ce-b520afe288d9,,Neoadjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0582-C18_treatment,d6e9e53f-51ee-488a-8941-2f956eb4eebf,,released,,0,2021-12-21T14:08:47.221959-06:00,,,
HCM-CSHL-0582-C18,5868f125-ca3b-4b98-85ea-64f0ea5b45da,a3a2c172-34bc-4879-98ce-b520afe288d9,484.0,Adjuvant,344.0,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0582-C18_treatment7,eb7d5877-a6af-4dfe-aafd-67a98b2e6620,,released,Irinotecan,1,2021-12-21T14:08:47.221959-06:00,Chemotherapy,Residual Disease,
HCM-CSHL-0582-C18,5868f125-ca3b-4b98-85ea-64f0ea5b45da,a3a2c172-34bc-4879-98ce-b520afe288d9,191.0,Adjuvant,64.0,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0582-C18_treatment4,ebf688bd-ed53-4723-bf74-20e1125ba67c,,released,,1,2021-12-21T14:08:47.221959-06:00,Chemotherapy,Residual Disease,XELOX
HCM-CSHL-0808-C55,58c8d6cf-e866-4991-b2c0-04f7bf5f71bd,0f74e2f7-ce3a-4940-b97a-b1b190b43ba8,,Neoadjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0808-C55_treatment,01acc186-5d0f-4d1d-a4c7-9efbfae1d2ee,,released,,0,2021-12-21T14:26:47.235159-06:00,,,
HCM-CSHL-0808-C55,58c8d6cf-e866-4991-b2c0-04f7bf5f71bd,0f74e2f7-ce3a-4940-b97a-b1b190b43ba8,230.0,Adjuvant,189.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0808-C55_treatment8,4740b7ba-1202-4207-a07d-ec5b793f424b,,released,,1,2021-12-21T14:26:47.235159-06:00,"Radiation, Intensity-Modulated Radiotherapy",Residual Disease,
HCM-CSHL-0808-C55,58c8d6cf-e866-4991-b2c0-04f7bf5f71bd,0f74e2f7-ce3a-4940-b97a-b1b190b43ba8,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0808-C55_treatment7,480e71cd-f39f-4dab-aa7c-dbb12a2d8523,,released,,0,2021-12-21T14:26:47.235159-06:00,Targeted Molecular Therapy,Residual Disease,
HCM-CSHL-0808-C55,58c8d6cf-e866-4991-b2c0-04f7bf5f71bd,0f74e2f7-ce3a-4940-b97a-b1b190b43ba8,146.0,Adjuvant,41.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0808-C55_treatment2,5a523cce-b89d-45f4-8f13-a09d9b8cab0e,,released,Carboplatin,1,2021-12-21T14:26:47.235159-06:00,Chemotherapy,Residual Disease,
HCM-CSHL-0808-C55,58c8d6cf-e866-4991-b2c0-04f7bf5f71bd,0f74e2f7-ce3a-4940-b97a-b1b190b43ba8,,,0.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0808-C55_treatment6,a9293b16-73be-4a95-8282-efeed39a5644,,released,,1,2021-12-21T14:26:47.235159-06:00,"Surgery, NOS",Initial Diagnosis,
HCM-CSHL-0808-C55,58c8d6cf-e866-4991-b2c0-04f7bf5f71bd,0f74e2f7-ce3a-4940-b97a-b1b190b43ba8,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0808-C55_treatment4,b55041c4-8ae3-4b98-a070-70a185260f33,,released,,0,2021-12-21T14:26:47.235159-06:00,Hormone Therapy,Residual Disease,
HCM-CSHL-0808-C55,58c8d6cf-e866-4991-b2c0-04f7bf5f71bd,0f74e2f7-ce3a-4940-b97a-b1b190b43ba8,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0808-C55_treatment5,d4645f90-af4a-47c7-a6a3-57596eaabf39,,released,,0,2021-12-21T14:26:47.235159-06:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-CSHL-0808-C55,58c8d6cf-e866-4991-b2c0-04f7bf5f71bd,0f74e2f7-ce3a-4940-b97a-b1b190b43ba8,146.0,Adjuvant,41.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0808-C55_treatment3,e31fdaa4-ae65-4834-b629-e4d835c97eb2,,released,Paclitaxel,1,2021-12-21T14:26:47.235159-06:00,Chemotherapy,Residual Disease,
HCM-SANG-1333-C20,58f3fa31-4c91-4fce-9807-afdd200cc194,032d2fb6-a74d-4b6f-b4f9-7b396dcda7ec,,Neoadjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-SANG-1333-C20_treatment,64679e56-e0ed-4805-be99-6fd71ed3c534,,released,,0,2023-02-27T13:05:35.901748-06:00,,,
HCM-EXPT-0937-C50,5a4beafc-8663-4456-a999-77721f072f44,d9d55ae2-4d9d-4dcd-a3ff-d4a60b4105e3,,Neoadjuvant,,2025-10-08T12:36:57.024699-05:00,HCM-EXPT-0937-C50_treatment,67efcf14-b7ed-4e1e-90fb-186f6fe78934,,released,,0,2021-12-21T14:46:31.709613-06:00,,,
HCM-CSHL-0823-C34,5c09c5da-e995-49df-be9e-16ca3388771e,38ab0e18-e405-4ea2-858b-3849af81c51d,,Neoadjuvant,13.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0823-C34_treatment6,06ee8f05-4197-474c-9da9-0fb039216862,,released,,1,2021-12-21T14:31:22.244867-06:00,"Radiation Therapy, NOS",,
HCM-CSHL-0823-C34,5c09c5da-e995-49df-be9e-16ca3388771e,38ab0e18-e405-4ea2-858b-3849af81c51d,,,482.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0823-C34_treatment10,0b75e00a-e04f-4127-98d2-2c170b47bd07,,released,,1,2021-12-21T14:31:22.244867-06:00,"Surgery, NOS",Initial Diagnosis,
HCM-CSHL-0823-C34,5c09c5da-e995-49df-be9e-16ca3388771e,38ab0e18-e405-4ea2-858b-3849af81c51d,,Neoadjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0823-C34_treatment3,15bb6b5e-e418-40bc-b5f9-53d3b212c87d,,released,Gemcitabine,1,2021-12-21T14:31:22.244867-06:00,Chemotherapy,,
HCM-CSHL-0823-C34,5c09c5da-e995-49df-be9e-16ca3388771e,38ab0e18-e405-4ea2-858b-3849af81c51d,,,777.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0823-C34_treatment11,1c01bb44-a92e-442c-9d88-b73eba0bcecc,,released,,1,2021-12-21T14:31:22.244867-06:00,"Surgery, NOS",Initial Diagnosis,
HCM-CSHL-0823-C34,5c09c5da-e995-49df-be9e-16ca3388771e,38ab0e18-e405-4ea2-858b-3849af81c51d,939.0,Adjuvant,827.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0823-C34_treatment9,2f8eb7a7-8a4e-4cef-8568-ded081ae1957,,released,Pembrolizumab,1,2021-12-21T14:31:22.244867-06:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-CSHL-0823-C34,5c09c5da-e995-49df-be9e-16ca3388771e,38ab0e18-e405-4ea2-858b-3849af81c51d,939.0,Adjuvant,827.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0823-C34_treatment8,4b129911-0862-4577-8e24-987d9e196ada,,released,Paclitaxel,1,2021-12-21T14:31:22.244867-06:00,Chemotherapy,Residual Disease,
HCM-CSHL-0823-C34,5c09c5da-e995-49df-be9e-16ca3388771e,38ab0e18-e405-4ea2-858b-3849af81c51d,,Neoadjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0823-C34_treatment,a91c6204-3e25-4699-8726-2f358dbb6513,,released,Cisplatin,1,2021-12-21T14:31:22.244867-06:00,Chemotherapy,,
HCM-CSHL-0823-C34,5c09c5da-e995-49df-be9e-16ca3388771e,38ab0e18-e405-4ea2-858b-3849af81c51d,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0823-C34_treatment13,b8e9043b-0c41-499e-9ef5-a19aa56851f9,,released,,0,2021-12-21T14:31:22.244867-06:00,"Radiation Therapy, NOS",Residual Disease,
HCM-CSHL-0823-C34,5c09c5da-e995-49df-be9e-16ca3388771e,38ab0e18-e405-4ea2-858b-3849af81c51d,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0823-C34_treatment12,bf236769-4202-4cc2-ab66-b1ac73da7373,,released,,0,2021-12-21T14:31:22.244867-06:00,Targeted Molecular Therapy,Residual Disease,
HCM-CSHL-0823-C34,5c09c5da-e995-49df-be9e-16ca3388771e,38ab0e18-e405-4ea2-858b-3849af81c51d,,Neoadjuvant,223.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0823-C34_treatment5,bfca953e-37cc-45dc-9a8d-1ca7699ef59c,,released,Durvalumab,1,2021-12-21T14:31:22.244867-06:00,Immunotherapy (Including Vaccines),,
HCM-CSHL-0823-C34,5c09c5da-e995-49df-be9e-16ca3388771e,38ab0e18-e405-4ea2-858b-3849af81c51d,,Neoadjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0823-C34_treatment2,ca4ebb20-e0f5-4940-9c6e-4e0aa3397c04,,released,Carboplatin,1,2021-12-21T14:31:22.244867-06:00,Chemotherapy,,
HCM-CSHL-0823-C34,5c09c5da-e995-49df-be9e-16ca3388771e,38ab0e18-e405-4ea2-858b-3849af81c51d,939.0,Adjuvant,827.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0823-C34_treatment7,d0a8663d-8dd7-4d2d-a795-5bc5c4acc540,,released,Carboplatin,1,2021-12-21T14:31:22.244867-06:00,Chemotherapy,Residual Disease,
HCM-CSHL-0823-C34,5c09c5da-e995-49df-be9e-16ca3388771e,38ab0e18-e405-4ea2-858b-3849af81c51d,,Neoadjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0823-C34_treatment4,f2919538-0e88-42fa-93a3-64fd5ec2a725,,released,Paclitaxel,1,2021-12-21T14:31:22.244867-06:00,Chemotherapy,,
HCM-BROD-0019-C25,5c2bff0f-0e8e-4d98-83c5-0d9ab866241a,5366d9e1-4958-4337-839c-5ba4179f38db,212.0,Adjuvant,58.0,2023-07-13T10:35:44.371881-05:00,HCM-BROD-0019-C25_treatment2,3c4f4e6b-b013-4289-88ed-c159c0d70486,,released,Gemcitabine,1,2020-09-17T15:44:14.005206-05:00,Chemotherapy,Residual Disease,
HCM-BROD-0019-C25,5c2bff0f-0e8e-4d98-83c5-0d9ab866241a,5366d9e1-4958-4337-839c-5ba4179f38db,,Adjuvant,,2023-07-13T10:35:44.371881-05:00,HCM-BROD-0019-C25_treatment4,3e78ff32-60a3-4258-ac9a-6a1e85870a74,,released,,0,2020-09-17T15:44:14.005206-05:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-BROD-0019-C25,5c2bff0f-0e8e-4d98-83c5-0d9ab866241a,5366d9e1-4958-4337-839c-5ba4179f38db,,Adjuvant,,2023-07-13T10:35:44.371881-05:00,HCM-BROD-0019-C25_treatment6,757f0ffa-14d1-4fb8-84ea-c14980faca5b,,released,,0,2020-09-17T15:44:14.005206-05:00,Targeted Molecular Therapy,Residual Disease,
HCM-BROD-0019-C25,5c2bff0f-0e8e-4d98-83c5-0d9ab866241a,5366d9e1-4958-4337-839c-5ba4179f38db,212.0,Adjuvant,58.0,2023-07-13T10:35:44.371881-05:00,HCM-BROD-0019-C25_treatment3,9bc09eac-d8ed-49a5-8637-3926e0625c2b,,released,Capecitabine,1,2020-09-17T15:44:14.005206-05:00,Chemotherapy,Residual Disease,
HCM-BROD-0019-C25,5c2bff0f-0e8e-4d98-83c5-0d9ab866241a,5366d9e1-4958-4337-839c-5ba4179f38db,,Adjuvant,,2023-07-13T10:35:44.371881-05:00,HCM-BROD-0019-C25_treatment7,a1f96d37-2316-488e-a6f3-b96dbd484f29,,released,,0,2020-09-17T15:44:14.005206-05:00,"Radiation Therapy, NOS",Residual Disease,
HCM-BROD-0019-C25,5c2bff0f-0e8e-4d98-83c5-0d9ab866241a,5366d9e1-4958-4337-839c-5ba4179f38db,,Neoadjuvant,,2023-07-13T10:35:44.371881-05:00,HCM-BROD-0019-C25_treatment,c3abb904-a7dc-4124-ae3e-0d0002eddc13,,released,,0,2020-09-17T15:44:14.005206-05:00,,,
HCM-EXPT-1213-C20,5c4d59f0-c31f-407d-b407-4c075061625a,b07fd18a-3ce4-419d-b7a5-dd60ac87e282,,Neoadjuvant,,2025-10-08T12:38:51.189053-05:00,HCM-EXPT-1213-C20_treatment,ee5b1037-d8f1-4654-a01f-bb9c9847fb95,,released,,0,2023-02-24T13:50:29.493914-06:00,,,
HCM-BROD-0214-C71,5c5ef9c4-5896-4553-bbbd-afe4e4b52a6a,fd765487-c517-44d5-92dc-2dcd6424d975,,Neoadjuvant,,2023-02-22T07:39:25.979291-06:00,HCM-BROD-0214-C71_treatment,282c72ac-0fd6-409b-980a-8b9f9a196d75,,released,,0,2019-04-04T15:07:48.286883-05:00,,,
HCM-BROD-0214-C71,5c5ef9c4-5896-4553-bbbd-afe4e4b52a6a,fd765487-c517-44d5-92dc-2dcd6424d975,604.0,Adjuvant,596.0,2023-02-22T07:39:25.979291-06:00,HCM-BROD-0214-C71_treatment8,664c6092-a45a-483a-a4a8-6591d195aead,,released,,1,2020-09-27T11:01:01.785781-05:00,"Radiation Therapy, NOS",Residual Disease,
HCM-BROD-0214-C71,5c5ef9c4-5896-4553-bbbd-afe4e4b52a6a,fd765487-c517-44d5-92dc-2dcd6424d975,783.0,Adjuvant,699.0,2023-02-22T07:39:25.979291-06:00,HCM-BROD-0214-C71_treatment7,756f6f6b-0f38-4ec8-b957-f9143220b1e6,,released,Bevacizumab,1,2019-04-04T15:07:48.286883-05:00,Targeted Molecular Therapy,Residual Disease,
HCM-BROD-0214-C71,5c5ef9c4-5896-4553-bbbd-afe4e4b52a6a,fd765487-c517-44d5-92dc-2dcd6424d975,699.0,Adjuvant,617.0,2023-02-22T07:39:25.979291-06:00,HCM-BROD-0214-C71_treatment3,8b6ad854-0439-4b59-be10-20347565e34e,,released,Irinotecan,1,2019-04-04T15:07:48.286883-05:00,Chemotherapy,Residual Disease,
HCM-BROD-0214-C71,5c5ef9c4-5896-4553-bbbd-afe4e4b52a6a,fd765487-c517-44d5-92dc-2dcd6424d975,699.0,Adjuvant,596.0,2023-02-22T07:39:25.979291-06:00,HCM-BROD-0214-C71_treatment2,c42ca838-fec7-4655-b9f1-71dffbed1e4a,,released,Temozolomide,1,2019-04-04T15:07:48.286883-05:00,Chemotherapy,Residual Disease,
HCM-BROD-0214-C71,5c5ef9c4-5896-4553-bbbd-afe4e4b52a6a,fd765487-c517-44d5-92dc-2dcd6424d975,783.0,Adjuvant,699.0,2023-02-22T07:39:25.979291-06:00,HCM-BROD-0214-C71_treatment4,c54cf29c-7ad3-446b-b91e-a44192acd44e,,released,Carboplatin,1,2019-04-04T15:07:48.286883-05:00,Chemotherapy,Residual Disease,
HCM-BROD-0214-C71,5c5ef9c4-5896-4553-bbbd-afe4e4b52a6a,fd765487-c517-44d5-92dc-2dcd6424d975,,Adjuvant,,2023-02-22T07:39:25.979291-06:00,HCM-BROD-0214-C71_treatment5,d40dc4d1-64c7-4f8c-843a-2b68155304d9,,released,,0,2019-04-04T15:07:48.286883-05:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-BROD-0214-C71,5c5ef9c4-5896-4553-bbbd-afe4e4b52a6a,fd765487-c517-44d5-92dc-2dcd6424d975,,,0.0,2023-02-27T11:58:16.269229-06:00,HCM-BROD-0214-C71_treatment6,f8d8f003-ef65-4a28-975a-1d24737bf577,,released,,1,2019-04-04T15:07:48.286883-05:00,"Surgery, NOS",Initial Diagnosis,
HCM-CSHL-0603-C18,5d27f395-e77f-46af-baf1-4ac783449f52,704b721b-850f-4489-8355-82ba7606cd36,983.0,Adjuvant,799.0,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0603-C18_treatment6,087cc5fa-9c74-42d5-8874-5192c775cee1,,released,,1,2021-12-21T14:09:27.521398-06:00,Chemotherapy,Residual Disease,FOLFIRI-cetuximab
HCM-CSHL-0603-C18,5d27f395-e77f-46af-baf1-4ac783449f52,704b721b-850f-4489-8355-82ba7606cd36,,Neoadjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0603-C18_treatment,0e7b3f23-6417-4d57-9496-a1e14a7da134,,released,,0,2021-12-21T14:09:27.521398-06:00,,,
HCM-CSHL-0603-C18,5d27f395-e77f-46af-baf1-4ac783449f52,704b721b-850f-4489-8355-82ba7606cd36,983.0,Adjuvant,799.0,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0603-C18_treatment2,3419702c-58ad-48e9-ade5-b892543ffb99,,released,Irinotecan,1,2021-12-21T14:09:27.521398-06:00,Chemotherapy,Residual Disease,
HCM-CSHL-0603-C18,5d27f395-e77f-46af-baf1-4ac783449f52,704b721b-850f-4489-8355-82ba7606cd36,,Adjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0603-C18_treatment9,b402761f-1ede-484d-ac8c-a2c6254f1596,,released,,0,2021-12-21T14:09:27.521398-06:00,Targeted Molecular Therapy,Residual Disease,
HCM-CSHL-0603-C18,5d27f395-e77f-46af-baf1-4ac783449f52,704b721b-850f-4489-8355-82ba7606cd36,,,1143.0,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0603-C18_treatment8,c7d7dd61-b336-4726-a19c-ebc35cba8035,,released,,1,2021-12-21T14:09:27.521398-06:00,"Surgery, NOS",Initial Diagnosis,
HCM-CSHL-0603-C18,5d27f395-e77f-46af-baf1-4ac783449f52,704b721b-850f-4489-8355-82ba7606cd36,983.0,Adjuvant,799.0,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0603-C18_treatment5,cdcf75d3-1919-4b83-aeb0-47c839adf280,,released,Cetuximab,1,2021-12-21T14:09:27.521398-06:00,Chemotherapy,Residual Disease,
HCM-CSHL-0603-C18,5d27f395-e77f-46af-baf1-4ac783449f52,704b721b-850f-4489-8355-82ba7606cd36,983.0,Adjuvant,799.0,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0603-C18_treatment4,d9d3f5a4-21dd-4d32-8402-812d41f9cb8d,,released,Fluorouracil,1,2021-12-21T14:09:27.521398-06:00,Chemotherapy,Residual Disease,
HCM-CSHL-0603-C18,5d27f395-e77f-46af-baf1-4ac783449f52,704b721b-850f-4489-8355-82ba7606cd36,,Adjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0603-C18_treatment10,e480635b-fc28-4dfc-ae70-fb4f7e1a957e,,released,,0,2021-12-21T14:09:27.521398-06:00,"Radiation Therapy, NOS",Residual Disease,
HCM-CSHL-0603-C18,5d27f395-e77f-46af-baf1-4ac783449f52,704b721b-850f-4489-8355-82ba7606cd36,983.0,Adjuvant,799.0,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0603-C18_treatment3,f8ed8832-2aa3-4b16-a4b3-f35308b54b68,,released,Leucovorin Calcium,1,2021-12-21T14:09:27.521398-06:00,Chemotherapy,Residual Disease,
HCM-CSHL-0603-C18,5d27f395-e77f-46af-baf1-4ac783449f52,704b721b-850f-4489-8355-82ba7606cd36,,Adjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0603-C18_treatment7,fcb52132-7587-4938-9d42-4c1b768c072e,,released,,0,2021-12-21T14:09:27.521398-06:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-CSHL-0603-C18,5d27f395-e77f-46af-baf1-4ac783449f52,c928728d-159c-4f0f-8f17-23a1dfbfb163,1113.0,Maintenance Therapy,800.0,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0603-C18_treatment14,2bead3d5-d517-4e22-a97a-79285dea336f,Treatment Ongoing,released,Irinotecan,1,2021-12-21T14:09:27.521398-06:00,,,
HCM-CSHL-0603-C18,5d27f395-e77f-46af-baf1-4ac783449f52,c928728d-159c-4f0f-8f17-23a1dfbfb163,1113.0,Maintenance Therapy,800.0,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0603-C18_treatment12,3b852a2c-a276-4031-9c9c-45d40fb63a46,Treatment Ongoing,released,Leucovorin Calcium,1,2021-12-21T14:09:27.521398-06:00,,,
HCM-CSHL-0603-C18,5d27f395-e77f-46af-baf1-4ac783449f52,c928728d-159c-4f0f-8f17-23a1dfbfb163,1113.0,Maintenance Therapy,800.0,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0603-C18_treatment11,b62a766f-c516-44b0-a8e9-323f83618d4b,Treatment Ongoing,released,Cetuximab,1,2021-12-21T14:09:27.521398-06:00,,,
HCM-CSHL-0603-C18,5d27f395-e77f-46af-baf1-4ac783449f52,c928728d-159c-4f0f-8f17-23a1dfbfb163,1113.0,Maintenance Therapy,800.0,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0603-C18_treatment15,d3d7763f-bb60-4590-b896-56482b7b4f87,Treatment Ongoing,released,,1,2021-12-21T14:09:27.521398-06:00,,,FOLFIRI-cetuximab
HCM-CSHL-0603-C18,5d27f395-e77f-46af-baf1-4ac783449f52,c928728d-159c-4f0f-8f17-23a1dfbfb163,1113.0,Maintenance Therapy,800.0,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0603-C18_treatment13,da08766d-57a7-4e81-b418-d80094cdebff,Treatment Ongoing,released,Fluorouracil,1,2021-12-21T14:09:27.521398-06:00,,,
HCM-BROD-0010-C25,5d47d75b-1c71-4864-a2d9-b7f55967c6f4,c1bb31b0-74d5-49b1-8a94-0b9e961f6b65,286.0,Adjuvant,216.0,2023-02-22T07:39:25.979291-06:00,HCM-BROD-0010-C25_treatment8,007af535-ec4e-4443-ab7f-123cd0803b68,,released,Nab-paclitaxel,1,2020-06-15T13:38:29.761225-05:00,Chemotherapy,Residual Disease,
HCM-BROD-0010-C25,5d47d75b-1c71-4864-a2d9-b7f55967c6f4,c1bb31b0-74d5-49b1-8a94-0b9e961f6b65,182.0,Adjuvant,18.0,2023-02-22T07:39:25.979291-06:00,HCM-BROD-0010-C25_treatment4,07746601-a9ee-4f05-a7f9-1b84ee5c2242,,released,Fluorouracil,1,2019-04-16T11:19:01.055673-05:00,Chemotherapy,Residual Disease,
HCM-BROD-0010-C25,5d47d75b-1c71-4864-a2d9-b7f55967c6f4,c1bb31b0-74d5-49b1-8a94-0b9e961f6b65,182.0,Adjuvant,18.0,2023-02-22T07:39:25.979291-06:00,HCM-BROD-0010-C25_treatment3,126fa08a-b493-4d96-9bb5-f84eb336640d,,released,Leucovorin Calcium,1,2019-04-16T11:19:01.055673-05:00,Chemotherapy,Residual Disease,
HCM-BROD-0010-C25,5d47d75b-1c71-4864-a2d9-b7f55967c6f4,c1bb31b0-74d5-49b1-8a94-0b9e961f6b65,182.0,Adjuvant,18.0,2023-02-22T07:39:25.979291-06:00,HCM-BROD-0010-C25_treatment6,1a220bac-ee46-45eb-8172-f7d39173b32a,,released,,1,2019-04-16T11:19:01.055673-05:00,Chemotherapy,Residual Disease,FOLFIRINOX
HCM-BROD-0010-C25,5d47d75b-1c71-4864-a2d9-b7f55967c6f4,c1bb31b0-74d5-49b1-8a94-0b9e961f6b65,,,,2023-02-27T12:07:30.067556-06:00,HCM-BROD-0010-C25_treatment10,27d1b8dc-9c6f-40dd-9de1-83885c2ee0ab,,released,,0,2020-09-27T10:01:16.656962-05:00,"Surgery, NOS",Initial Diagnosis,
HCM-BROD-0010-C25,5d47d75b-1c71-4864-a2d9-b7f55967c6f4,c1bb31b0-74d5-49b1-8a94-0b9e961f6b65,,Adjuvant,,2023-02-22T07:39:25.979291-06:00,HCM-BROD-0010-C25_treatment11,42d3fc90-0ea5-4018-b77f-5d7ba5c8f02c,,released,,0,2020-09-27T10:01:16.656962-05:00,Targeted Molecular Therapy,Residual Disease,
HCM-BROD-0010-C25,5d47d75b-1c71-4864-a2d9-b7f55967c6f4,c1bb31b0-74d5-49b1-8a94-0b9e961f6b65,,Adjuvant,,2023-02-22T07:39:25.979291-06:00,HCM-BROD-0010-C25_treatment12,522a8540-d7db-41c9-9301-1ef9927fb224,,released,,0,2020-09-27T10:01:16.656962-05:00,"Radiation Therapy, NOS",Residual Disease,
HCM-BROD-0010-C25,5d47d75b-1c71-4864-a2d9-b7f55967c6f4,c1bb31b0-74d5-49b1-8a94-0b9e961f6b65,286.0,Adjuvant,216.0,2023-02-22T07:39:25.979291-06:00,HCM-BROD-0010-C25_treatment7,589f0a75-89f6-449a-a8b2-ac7e22596564,,released,Gemcitabine,1,2019-04-16T11:19:01.055673-05:00,Chemotherapy,Residual Disease,
HCM-BROD-0010-C25,5d47d75b-1c71-4864-a2d9-b7f55967c6f4,c1bb31b0-74d5-49b1-8a94-0b9e961f6b65,,Neoadjuvant,,2023-02-22T07:39:25.979291-06:00,HCM-BROD-0010-C25_treatment,81db8a7d-afe8-4edc-b4dd-cd9efebf0007,,released,,0,2019-04-16T11:19:01.055673-05:00,,,
HCM-BROD-0010-C25,5d47d75b-1c71-4864-a2d9-b7f55967c6f4,c1bb31b0-74d5-49b1-8a94-0b9e961f6b65,182.0,Adjuvant,18.0,2023-02-22T07:39:25.979291-06:00,HCM-BROD-0010-C25_treatment2,9db92a5c-aa95-4e71-b9e1-bc41e79c5a85,,released,Irinotecan Hydrochloride,1,2019-04-16T11:19:01.055673-05:00,Chemotherapy,Residual Disease,
HCM-BROD-0010-C25,5d47d75b-1c71-4864-a2d9-b7f55967c6f4,c1bb31b0-74d5-49b1-8a94-0b9e961f6b65,,Adjuvant,,2023-02-22T07:39:25.979291-06:00,HCM-BROD-0010-C25_treatment9,f0420514-3157-438c-a6e6-efd0a88cb6a6,,released,,0,2020-09-27T10:01:16.656962-05:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-BROD-0010-C25,5d47d75b-1c71-4864-a2d9-b7f55967c6f4,c1bb31b0-74d5-49b1-8a94-0b9e961f6b65,182.0,Adjuvant,18.0,2023-02-22T07:39:25.979291-06:00,HCM-BROD-0010-C25_treatment5,f7aa7985-4c9d-468e-8d1e-95cc4c20b8f8,,released,Oxaliplatin,1,2019-04-16T11:19:01.055673-05:00,Chemotherapy,Residual Disease,
HCM-BROD-0053-C49,5d62edfc-03c7-4545-91b1-9ad3abfcfeb8,994211f5-ade5-4659-977e-e650136d56a9,,Adjuvant,,2023-02-22T07:39:25.979291-06:00,HCM-BROD-0053-C49_treatment11,12f3d718-b74d-46ca-b0a2-b2820941e91f,,released,,0,2020-10-08T12:07:19.366528-05:00,"Radiation Therapy, NOS",Residual Disease,
HCM-BROD-0053-C49,5d62edfc-03c7-4545-91b1-9ad3abfcfeb8,994211f5-ade5-4659-977e-e650136d56a9,,Neoadjuvant,0.0,2023-02-22T07:39:25.979291-06:00,HCM-BROD-0053-C49_treatment,257528e1-a2a8-4de7-b92a-31fe44641448,,released,Docetaxel,1,2020-06-15T13:00:20.616704-05:00,Chemotherapy,,
HCM-BROD-0053-C49,5d62edfc-03c7-4545-91b1-9ad3abfcfeb8,994211f5-ade5-4659-977e-e650136d56a9,,Adjuvant,,2023-02-22T07:39:25.979291-06:00,HCM-BROD-0053-C49_treatment6,63738d8c-d391-4409-a162-3e07fe63f87a,,released,,0,2020-06-15T13:00:20.616704-05:00,Chemotherapy,Residual Disease,
HCM-BROD-0053-C49,5d62edfc-03c7-4545-91b1-9ad3abfcfeb8,994211f5-ade5-4659-977e-e650136d56a9,,Neoadjuvant,0.0,2023-02-22T07:39:25.979291-06:00,HCM-BROD-0053-C49_treatment4,69c4c4c3-6288-4f4c-bf9a-a4d8590d85ff,,released,Doxorubicin,1,2020-06-15T13:00:20.616704-05:00,Chemotherapy,,
HCM-BROD-0053-C49,5d62edfc-03c7-4545-91b1-9ad3abfcfeb8,994211f5-ade5-4659-977e-e650136d56a9,,,,2023-03-13T13:20:23.289665-05:00,HCM-BROD-0053-C49_treatment9,6c60d1d4-91e6-4aed-8fa8-f123729ae261,,released,,0,2020-10-08T12:07:19.366528-05:00,"Surgery, NOS",Initial Diagnosis,
HCM-BROD-0053-C49,5d62edfc-03c7-4545-91b1-9ad3abfcfeb8,994211f5-ade5-4659-977e-e650136d56a9,,Adjuvant,,2023-02-22T07:39:25.979291-06:00,HCM-BROD-0053-C49_treatment7,713d1ed3-f8ea-4c6a-8f74-be08dfe3a98c,,released,,0,2020-06-15T13:00:20.616704-05:00,Hormone Therapy,Residual Disease,
HCM-BROD-0053-C49,5d62edfc-03c7-4545-91b1-9ad3abfcfeb8,994211f5-ade5-4659-977e-e650136d56a9,,Neoadjuvant,0.0,2023-02-22T07:39:25.979291-06:00,HCM-BROD-0053-C49_treatment2,726752b4-0180-4d00-b64e-175b2f50d6dc,,released,Gemcitabine,1,2020-06-15T13:00:20.616704-05:00,Chemotherapy,,
HCM-BROD-0053-C49,5d62edfc-03c7-4545-91b1-9ad3abfcfeb8,994211f5-ade5-4659-977e-e650136d56a9,,Neoadjuvant,62.0,2023-02-22T07:39:25.979291-06:00,HCM-BROD-0053-C49_treatment5,c3cee61b-f466-49e4-87e7-575330b4c132,,released,,1,2020-06-15T13:00:20.616704-05:00,"Radiation Therapy, NOS",,
HCM-BROD-0053-C49,5d62edfc-03c7-4545-91b1-9ad3abfcfeb8,994211f5-ade5-4659-977e-e650136d56a9,212.0,Adjuvant,182.0,2023-02-22T07:39:25.979291-06:00,HCM-BROD-0053-C49_treatment8,cf10fec2-c3ea-48ea-a217-761484d75c7a,,released,Pembrolizumab,1,2020-06-15T15:23:52.477289-05:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-BROD-0053-C49,5d62edfc-03c7-4545-91b1-9ad3abfcfeb8,994211f5-ade5-4659-977e-e650136d56a9,,Neoadjuvant,0.0,2023-02-22T07:39:25.979291-06:00,HCM-BROD-0053-C49_treatment3,f846a145-1afa-47ac-89ea-2ff4b3fac63c,,released,Ifosfamide,1,2020-06-15T13:00:20.616704-05:00,Chemotherapy,,
HCM-BROD-0053-C49,5d62edfc-03c7-4545-91b1-9ad3abfcfeb8,994211f5-ade5-4659-977e-e650136d56a9,182.0,Adjuvant,151.0,2023-02-22T07:39:25.979291-06:00,HCM-BROD-0053-C49_treatment10,f87ae6d5-75fd-4596-b700-3e67b2e35b74,,released,Not Reported,1,2020-10-08T12:07:19.366528-05:00,Targeted Molecular Therapy,Residual Disease,
HCM-SANG-1328-C15,5dc3e355-af0d-414e-a612-caa7e75d7614,8c50b4dc-d6bd-479c-a485-5da38dac8c42,,Neoadjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-SANG-1328-C15_treatment,a5aae5dd-e2f5-4f0c-b332-a5002317afe7,,released,,0,2023-02-27T12:04:03.165739-06:00,,,
HCM-BROD-1099-C84,5e2f613c-4a63-44da-b367-329c9245a762,416a3d59-4951-46a1-9b4b-c21b627149a2,,Neoadjuvant,19.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-1099-C84_treatment3,16e436fb-a6b5-4533-a6fb-04fde448dae5,,released,Vincristine,1,2021-12-21T15:23:12.145029-06:00,Chemotherapy,,
HCM-BROD-1099-C84,5e2f613c-4a63-44da-b367-329c9245a762,416a3d59-4951-46a1-9b4b-c21b627149a2,,Neoadjuvant,19.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-1099-C84_treatment7,46e7c61c-a751-46a2-b3d6-d612c0e6d67a,,released,Ifosfamide,1,2021-12-21T15:23:12.145029-06:00,Chemotherapy,,
HCM-BROD-1099-C84,5e2f613c-4a63-44da-b367-329c9245a762,416a3d59-4951-46a1-9b4b-c21b627149a2,,Neoadjuvant,19.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-1099-C84_treatment5,6043d8df-7cf5-40b1-b0af-96b306ec2012,,released,Doxorubicin,1,2021-12-21T15:23:12.145029-06:00,Chemotherapy,,
HCM-BROD-1099-C84,5e2f613c-4a63-44da-b367-329c9245a762,416a3d59-4951-46a1-9b4b-c21b627149a2,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-BROD-1099-C84_treatment12,6b091207-f75d-4062-b186-22471d47151e,,released,,0,2021-12-21T15:23:12.145029-06:00,"Radiation Therapy, NOS",Residual Disease,
HCM-BROD-1099-C84,5e2f613c-4a63-44da-b367-329c9245a762,416a3d59-4951-46a1-9b4b-c21b627149a2,,Neoadjuvant,19.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-1099-C84_treatment,6b20bfba-6229-4015-96fa-da351c8f0934,,released,Carboplatin,1,2021-12-21T15:23:12.145029-06:00,Chemotherapy,,
HCM-BROD-1099-C84,5e2f613c-4a63-44da-b367-329c9245a762,416a3d59-4951-46a1-9b4b-c21b627149a2,,Neoadjuvant,19.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-1099-C84_treatment4,6ce01d4f-9300-461a-b59f-840470ec26f0,,released,Romidepsin,1,2021-12-21T15:23:12.145029-06:00,Chemotherapy,,
HCM-BROD-1099-C84,5e2f613c-4a63-44da-b367-329c9245a762,416a3d59-4951-46a1-9b4b-c21b627149a2,,,,2025-04-07T17:13:09.336794-05:00,HCM-BROD-1099-C84_treatment10,804b33fc-35a4-445a-95fa-e7fab1b390b8,,released,,0,2021-12-21T15:23:12.145029-06:00,"Surgery, NOS",Initial Diagnosis,
HCM-BROD-1099-C84,5e2f613c-4a63-44da-b367-329c9245a762,416a3d59-4951-46a1-9b4b-c21b627149a2,,Neoadjuvant,19.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-1099-C84_treatment6,8c280a3c-7e76-4ce3-abdb-9fbdef7c8958,,released,Etoposide,1,2021-12-21T15:23:12.145029-06:00,Chemotherapy,,
HCM-BROD-1099-C84,5e2f613c-4a63-44da-b367-329c9245a762,416a3d59-4951-46a1-9b4b-c21b627149a2,,Neoadjuvant,274.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-1099-C84_treatment9,8f55f129-39ca-4335-b900-5d09fde465c2,,released,,1,2021-12-21T15:23:12.145029-06:00,Immunotherapy (Including Vaccines),,
HCM-BROD-1099-C84,5e2f613c-4a63-44da-b367-329c9245a762,416a3d59-4951-46a1-9b4b-c21b627149a2,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-BROD-1099-C84_treatment11,adeda203-c7d2-4ddb-932c-20267041f9d1,,released,,0,2021-12-21T15:23:12.145029-06:00,"Pharmaceutical Therapy, NOS",Residual Disease,
HCM-BROD-1099-C84,5e2f613c-4a63-44da-b367-329c9245a762,416a3d59-4951-46a1-9b4b-c21b627149a2,,Neoadjuvant,19.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-1099-C84_treatment2,cde37d1d-0fd4-4c6b-b5eb-dd184baf1634,,released,Cyclophosphamide,1,2021-12-21T15:23:12.145029-06:00,Chemotherapy,,
HCM-BROD-1099-C84,5e2f613c-4a63-44da-b367-329c9245a762,416a3d59-4951-46a1-9b4b-c21b627149a2,,Neoadjuvant,19.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-1099-C84_treatment8,df2ae7ce-d89e-4307-9fe9-0ed6f2a6797a,,released,Prednisone,1,2021-12-21T15:23:12.145029-06:00,Chemotherapy,,
HCM-WCMC-0675-C67,5e44aad4-b3e9-4007-9983-e41188b749c9,a8b4d8fd-6f7a-4cfb-8bc1-dde88d2ef5d7,5021.0,Adjuvant,4400.0,2025-03-31T16:34:59.906497-05:00,HCM-WCMC-0675-C67_treatment4,18262690-e942-4d14-bcb6-5dd0ba8a326e,,released,Pembrolizumab,1,2023-02-27T13:24:36.630783-06:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-WCMC-0675-C67,5e44aad4-b3e9-4007-9983-e41188b749c9,a8b4d8fd-6f7a-4cfb-8bc1-dde88d2ef5d7,,Adjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-WCMC-0675-C67_treatment6,4136dc83-640b-49b9-8a1e-2d1b16690ded,,released,,0,2023-02-27T13:24:36.630783-06:00,Targeted Molecular Therapy,Residual Disease,
HCM-WCMC-0675-C67,5e44aad4-b3e9-4007-9983-e41188b749c9,a8b4d8fd-6f7a-4cfb-8bc1-dde88d2ef5d7,5021.0,Adjuvant,5021.0,2025-03-31T16:34:59.906497-05:00,HCM-WCMC-0675-C67_treatment7,77603ae9-9f7d-4241-9664-41c385fd36cb,,released,,1,2023-02-27T13:24:36.630783-06:00,"Radiation, Stereotactic/Gamma Knife/SRS",Residual Disease,
HCM-WCMC-0675-C67,5e44aad4-b3e9-4007-9983-e41188b749c9,a8b4d8fd-6f7a-4cfb-8bc1-dde88d2ef5d7,,,693.0,2025-03-31T16:34:59.906497-05:00,HCM-WCMC-0675-C67_treatment5,b82050fd-ea4b-41c2-a35e-bcf0365cd4a7,,released,,1,2023-02-27T13:24:36.630783-06:00,"Surgery, NOS",Initial Diagnosis,
HCM-WCMC-0675-C67,5e44aad4-b3e9-4007-9983-e41188b749c9,a8b4d8fd-6f7a-4cfb-8bc1-dde88d2ef5d7,,Adjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-WCMC-0675-C67_treatment2,b86c84b0-f144-4732-8b61-2a90d45be1ad,,released,,0,2023-02-27T13:24:36.630783-06:00,Chemotherapy,Residual Disease,
HCM-WCMC-0675-C67,5e44aad4-b3e9-4007-9983-e41188b749c9,a8b4d8fd-6f7a-4cfb-8bc1-dde88d2ef5d7,,Adjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-WCMC-0675-C67_treatment3,c0cb4a2a-ca62-4886-b71f-34e4f0bf648d,,released,,0,2023-02-27T13:24:36.630783-06:00,Hormone Therapy,Residual Disease,
HCM-WCMC-0675-C67,5e44aad4-b3e9-4007-9983-e41188b749c9,a8b4d8fd-6f7a-4cfb-8bc1-dde88d2ef5d7,,Neoadjuvant,693.0,2025-03-31T16:34:59.906497-05:00,HCM-WCMC-0675-C67_treatment,ca91235a-a9e6-4398-90c5-e55ac10ac63d,,released,,1,2023-02-27T13:24:36.630783-06:00,Immunotherapy (Including Vaccines),,
HCM-BROD-0014-C71,5e5684d2-14b0-4823-9956-d69aea6d6beb,ba1d7f88-da33-4a82-84d1-5c8192c6842d,,,-6.0,2023-03-13T13:00:33.467907-05:00,HCM-BROD-0014-C71_treatment4,4247142f-0652-4531-b772-7bc8b50b273e,,released,,1,2019-04-04T14:17:46.995307-05:00,"Surgery, NOS",Initial Diagnosis,
HCM-BROD-0014-C71,5e5684d2-14b0-4823-9956-d69aea6d6beb,ba1d7f88-da33-4a82-84d1-5c8192c6842d,,Neoadjuvant,,2020-01-13T20:10:25.832065-06:00,HCM-BROD-0014-C71_treatment,6ff2363a-d7cd-48f0-965a-1fd83da2664b,,released,,0,2019-03-12T10:15:41.981178-05:00,,,
HCM-BROD-0129-C25,5ea6bd70-feef-407b-8b88-55fcb2695e7d,908a5955-92eb-4c27-807c-ca861bd080fe,241.0,Adjuvant,85.0,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0129-C25_treatment2,43c7c303-67dc-4146-927a-6e5e0f0061bb,,released,Gemcitabine,1,2020-09-17T15:58:23.646791-05:00,Chemotherapy,Residual Disease,
HCM-BROD-0129-C25,5ea6bd70-feef-407b-8b88-55fcb2695e7d,908a5955-92eb-4c27-807c-ca861bd080fe,,Adjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0129-C25_treatment3,78b6f764-a9ec-4ab0-9556-7e037e3ee24a,,released,,0,2020-09-17T15:58:23.646791-05:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-BROD-0129-C25,5ea6bd70-feef-407b-8b88-55fcb2695e7d,908a5955-92eb-4c27-807c-ca861bd080fe,,,42.0,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0129-C25_treatment4,7dd4e0b4-3e0e-440f-aa8d-c472ab3b407b,,released,,1,2020-09-17T15:58:23.646791-05:00,"Surgery, NOS",Initial Diagnosis,
HCM-BROD-0129-C25,5ea6bd70-feef-407b-8b88-55fcb2695e7d,908a5955-92eb-4c27-807c-ca861bd080fe,,Adjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0129-C25_treatment5,873fb173-b4bf-4ca1-ab12-7aa2cd0851b8,,released,,0,2020-09-17T15:58:23.646791-05:00,Targeted Molecular Therapy,Residual Disease,
HCM-BROD-0129-C25,5ea6bd70-feef-407b-8b88-55fcb2695e7d,908a5955-92eb-4c27-807c-ca861bd080fe,,Adjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0129-C25_treatment6,b9f5abec-ab64-4b28-9c34-13e24830de72,,released,,0,2020-09-17T15:58:23.646791-05:00,"Radiation Therapy, NOS",Residual Disease,
HCM-BROD-0611-C71,5ec86383-f228-4987-a10a-214a603932f8,c0e4677a-9a45-4510-a565-e7567702bd2f,552.0,Adjuvant,377.0,2023-07-13T10:35:44.371881-05:00,HCM-BROD-0611-C71_treatment3,13696381-6184-4fa0-89bc-2d3f9122e29b,,released,Pembrolizumab,1,2021-12-21T13:40:51.118675-06:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-BROD-0611-C71,5ec86383-f228-4987-a10a-214a603932f8,c0e4677a-9a45-4510-a565-e7567702bd2f,781.0,Adjuvant,46.0,2023-07-13T10:35:44.371881-05:00,HCM-BROD-0611-C71_treatment5,46fb6360-3b8c-4999-8e48-b820b0a34d22,,released,Bevacizumab,1,2021-12-21T13:40:51.118675-06:00,Targeted Molecular Therapy,Residual Disease,
HCM-BROD-0611-C71,5ec86383-f228-4987-a10a-214a603932f8,c0e4677a-9a45-4510-a565-e7567702bd2f,,,-3.0,2023-07-13T10:35:44.371881-05:00,HCM-BROD-0611-C71_treatment4,6d88984a-0296-48a7-8d7c-b118f979bd7b,,released,,1,2021-12-21T13:40:51.118675-06:00,"Surgery, NOS",Initial Diagnosis,
HCM-BROD-0611-C71,5ec86383-f228-4987-a10a-214a603932f8,c0e4677a-9a45-4510-a565-e7567702bd2f,,Neoadjuvant,,2023-07-13T10:35:44.371881-05:00,HCM-BROD-0611-C71_treatment,b80ffd22-44bf-4616-a28a-c227ac1c2c8a,,released,,0,2021-12-21T13:40:51.118675-06:00,,,
HCM-BROD-0611-C71,5ec86383-f228-4987-a10a-214a603932f8,c0e4677a-9a45-4510-a565-e7567702bd2f,107.0,Adjuvant,46.0,2023-07-13T10:35:44.371881-05:00,HCM-BROD-0611-C71_treatment2,d4c1ab21-b37f-409c-b5d4-a32d156ee4ba,,released,Temozolomide,1,2021-12-21T13:40:51.118675-06:00,Chemotherapy,Residual Disease,
HCM-BROD-0611-C71,5ec86383-f228-4987-a10a-214a603932f8,c0e4677a-9a45-4510-a565-e7567702bd2f,77.0,Adjuvant,46.0,2023-07-13T10:35:44.371881-05:00,HCM-BROD-0611-C71_treatment6,dbc2d070-c6f7-4167-8547-c1c9176c8a0b,,released,,1,2021-12-21T13:40:51.118675-06:00,"Radiation, 3D Conformal",Residual Disease,
HCM-BROD-0611-C71,5ec86383-f228-4987-a10a-214a603932f8,d64d123d-9098-4515-af9b-ec51c59d6829,552.0,Maintenance Therapy,40.0,2023-07-13T10:35:44.371881-05:00,HCM-BROD-0611-C71_treatment9,133215c9-315a-49a3-88b9-fadb25aa2936,Treatment Ongoing,released,Pembrolizumab,1,2021-12-21T13:40:51.118675-06:00,,,
HCM-BROD-0611-C71,5ec86383-f228-4987-a10a-214a603932f8,d64d123d-9098-4515-af9b-ec51c59d6829,552.0,Maintenance Therapy,40.0,2023-07-13T10:35:44.371881-05:00,HCM-BROD-0611-C71_treatment8,36064817-a6c9-472a-b0bc-aca34fbfe473,Treatment Ongoing,released,Temozolomide,1,2021-12-21T13:40:51.118675-06:00,,,
HCM-BROD-0611-C71,5ec86383-f228-4987-a10a-214a603932f8,d64d123d-9098-4515-af9b-ec51c59d6829,552.0,Maintenance Therapy,40.0,2023-07-13T10:35:44.371881-05:00,HCM-BROD-0611-C71_treatment7,72053212-de3e-4efe-bf32-49e260de7d66,Treatment Ongoing,released,Bavituximab,1,2021-12-21T13:40:51.118675-06:00,,,
HCM-EXPT-0942-C50,5f82427a-1859-4a47-b6ca-e377784d99d4,015ba5a6-d346-493a-ad7a-0a03cd210d95,,Neoadjuvant,,2025-10-08T12:36:57.024699-05:00,HCM-EXPT-0942-C50_treatment,6978c204-77f2-4c4a-b06f-18f8f93e29e0,,released,,0,2021-12-21T14:47:43.767037-06:00,,,
HCM-SANG-1315-C18,5f93dc35-0917-4206-bc5f-8903db299abc,cf874eaf-b593-45f2-b99c-b3bcbefe5ad2,,Neoadjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-SANG-1315-C18_treatment,5f09d207-3eaf-423b-b63d-9a25d35da56f,,released,,0,2023-02-27T11:50:03.066599-06:00,,,
HCM-BROD-0958-C56,5fd76dd8-87e1-422d-bac2-63e447ca3ba4,6ab071c3-07c7-4e65-a3d5-cab43509e113,,Neoadjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0958-C56_treatment,336da3a9-e685-4457-b6e4-895a1bc29712,,released,,0,2021-12-21T13:58:45.389627-06:00,,,
HCM-BROD-0958-C56,5fd76dd8-87e1-422d-bac2-63e447ca3ba4,6ab071c3-07c7-4e65-a3d5-cab43509e113,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0958-C56_treatment7,4a8be664-a55f-4692-b960-b405428c9646,,released,,0,2021-12-21T13:58:45.389627-06:00,"Radiation Therapy, NOS",Residual Disease,
HCM-BROD-0958-C56,5fd76dd8-87e1-422d-bac2-63e447ca3ba4,6ab071c3-07c7-4e65-a3d5-cab43509e113,,,0.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0958-C56_treatment5,6104921c-be7c-4ef5-8a4a-6b6a86986627,,released,,1,2021-12-21T13:58:45.389627-06:00,"Surgery, NOS",Initial Diagnosis,
HCM-BROD-0958-C56,5fd76dd8-87e1-422d-bac2-63e447ca3ba4,6ab071c3-07c7-4e65-a3d5-cab43509e113,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0958-C56_treatment6,74f5d5ab-b99a-44b7-930b-2c44aeb35415,,released,,0,2021-12-21T13:58:45.389627-06:00,Targeted Molecular Therapy,Residual Disease,
HCM-BROD-0958-C56,5fd76dd8-87e1-422d-bac2-63e447ca3ba4,6ab071c3-07c7-4e65-a3d5-cab43509e113,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0958-C56_treatment4,7eee1a7c-3070-4782-8e3e-85b650403d2e,,released,,0,2021-12-21T13:58:45.389627-06:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-BROD-0958-C56,5fd76dd8-87e1-422d-bac2-63e447ca3ba4,6ab071c3-07c7-4e65-a3d5-cab43509e113,1429.0,Adjuvant,1346.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0958-C56_treatment2,d249c685-c6e5-4c73-8b9f-de1c2329cdba,,released,Carboplatin,1,2021-12-21T13:58:45.389627-06:00,Chemotherapy,Residual Disease,
HCM-BROD-0958-C56,5fd76dd8-87e1-422d-bac2-63e447ca3ba4,6ab071c3-07c7-4e65-a3d5-cab43509e113,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0958-C56_treatment3,fd8c563d-1f2f-4e25-a172-101d75717fc4,,released,,0,2021-12-21T13:58:45.389627-06:00,Hormone Therapy,Residual Disease,
HCM-BROD-0958-C56,5fd76dd8-87e1-422d-bac2-63e447ca3ba4,89dcf4e4-5c6d-417d-9e77-1e65564dc365,1291.0,Maintenance Therapy,31.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0958-C56_treatment11,0ea05712-0136-4e60-a8a4-aefbcea0facc,Progressive Disease,released,Doxorubicin,1,2021-12-21T13:58:45.389627-06:00,,,
HCM-BROD-0958-C56,5fd76dd8-87e1-422d-bac2-63e447ca3ba4,89dcf4e4-5c6d-417d-9e77-1e65564dc365,1291.0,Maintenance Therapy,31.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0958-C56_treatment14,48d56289-2882-4c85-876b-14cbb4f73521,Progressive Disease,released,Vinorelbine,1,2021-12-21T13:58:45.389627-06:00,,,
HCM-BROD-0958-C56,5fd76dd8-87e1-422d-bac2-63e447ca3ba4,89dcf4e4-5c6d-417d-9e77-1e65564dc365,1291.0,Maintenance Therapy,31.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0958-C56_treatment13,5aa1019d-7c93-446e-bccf-ba7e4f80617b,Progressive Disease,released,Olaparib,1,2021-12-21T13:58:45.389627-06:00,,,
HCM-BROD-0958-C56,5fd76dd8-87e1-422d-bac2-63e447ca3ba4,89dcf4e4-5c6d-417d-9e77-1e65564dc365,1291.0,Maintenance Therapy,31.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0958-C56_treatment8,6abb2ebe-0db6-4d69-b324-25878531c942,Progressive Disease,released,Gemcitabine,1,2021-12-21T13:58:45.389627-06:00,,,
HCM-BROD-0958-C56,5fd76dd8-87e1-422d-bac2-63e447ca3ba4,89dcf4e4-5c6d-417d-9e77-1e65564dc365,1291.0,Maintenance Therapy,31.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0958-C56_treatment9,6cb63472-946e-4cb9-bac1-6abf2492774a,Progressive Disease,released,Carboplatin,1,2021-12-21T13:58:45.389627-06:00,,,
HCM-BROD-0958-C56,5fd76dd8-87e1-422d-bac2-63e447ca3ba4,89dcf4e4-5c6d-417d-9e77-1e65564dc365,1291.0,Maintenance Therapy,31.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0958-C56_treatment10,7f3e7139-c3d6-452b-a5a5-7564090e6b87,Progressive Disease,released,Paclitaxel,1,2021-12-21T13:58:45.389627-06:00,,,
HCM-BROD-0958-C56,5fd76dd8-87e1-422d-bac2-63e447ca3ba4,89dcf4e4-5c6d-417d-9e77-1e65564dc365,1291.0,Maintenance Therapy,31.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0958-C56_treatment12,9c7572df-ea99-435d-87dd-c8dad56a5882,Progressive Disease,released,Bevacizumab,1,2021-12-21T13:58:45.389627-06:00,,,
HCM-WCMC-0671-C18,603035e9-eef7-490a-a102-af4eb005fb73,eb926bf9-6d68-4bda-948b-e1266312e800,88.0,Adjuvant,46.0,2023-02-22T07:39:25.979291-06:00,HCM-WCMC-0671-C18_treatment2,1813455c-617c-4c36-8c05-489e67669efa,,released,Oxaliplatin,1,2022-07-06T10:24:47.413062-05:00,Chemotherapy,Residual Disease,
HCM-WCMC-0671-C18,603035e9-eef7-490a-a102-af4eb005fb73,eb926bf9-6d68-4bda-948b-e1266312e800,,Neoadjuvant,,2023-02-22T07:39:25.979291-06:00,HCM-WCMC-0671-C18_treatment,49b57a26-5fa9-4c9c-afe0-ba7b5afc5958,,released,,0,2022-07-06T10:24:47.413062-05:00,,,
HCM-WCMC-0671-C18,603035e9-eef7-490a-a102-af4eb005fb73,eb926bf9-6d68-4bda-948b-e1266312e800,88.0,Adjuvant,46.0,2023-02-22T07:39:25.979291-06:00,HCM-WCMC-0671-C18_treatment3,7491645b-aae0-4ca2-bca6-64934ccfe8ce,,released,Capecitabine,1,2022-07-06T10:24:47.413062-05:00,Chemotherapy,Residual Disease,
HCM-WCMC-0671-C18,603035e9-eef7-490a-a102-af4eb005fb73,eb926bf9-6d68-4bda-948b-e1266312e800,88.0,Adjuvant,46.0,2023-02-22T07:39:25.979291-06:00,HCM-WCMC-0671-C18_treatment4,d902368b-f5d3-4578-8e24-496be3be1da8,,released,,1,2022-07-06T10:24:47.413062-05:00,Chemotherapy,Residual Disease,XELOX
HCM-WCMC-0671-C18,603035e9-eef7-490a-a102-af4eb005fb73,eb926bf9-6d68-4bda-948b-e1266312e800,,,0.0,2023-03-13T13:03:37.092948-05:00,HCM-WCMC-0671-C18_treatment6,ee0e3194-8b0a-4227-acd3-b1456445ab1a,,released,,1,2022-07-06T10:24:47.413062-05:00,"Surgery, NOS",Initial Diagnosis,
HCM-CSHL-0164-C20,6058fb8d-eb5d-4dbc-b939-7e92c7cd2776,1f1bf129-fcfa-43f9-8726-4e50323d183e,163.0,Maintenance Therapy,37.0,2021-08-26T08:54:54.023984-05:00,HCM-CSHL-0164-C20_treatment8,41cdcb80-427f-4225-9ccb-5b6dfcb22993,Treatment Ongoing,released,Fluorouracil,1,2020-09-27T13:03:40.864508-05:00,,Progressive Disease,
HCM-CSHL-0164-C20,6058fb8d-eb5d-4dbc-b939-7e92c7cd2776,1f1bf129-fcfa-43f9-8726-4e50323d183e,,Neoadjuvant,37.0,2021-01-06T22:55:10.531130-06:00,HCM-CSHL-0164-C20_treatment3,5fc998c2-4741-4d6c-bc18-d3a410b2b142,,released,Oxaliplatin,1,2020-02-27T12:49:04.421900-06:00,Chemotherapy,,
HCM-CSHL-0164-C20,6058fb8d-eb5d-4dbc-b939-7e92c7cd2776,1f1bf129-fcfa-43f9-8726-4e50323d183e,,Neoadjuvant,37.0,2021-01-06T22:55:10.531130-06:00,HCM-CSHL-0164-C20_treatment4,617105e9-3995-4548-a44f-3dc827bc2dc6,,released,,1,2020-02-27T12:49:04.421900-06:00,Chemotherapy,,FOLFOX
HCM-CSHL-0164-C20,6058fb8d-eb5d-4dbc-b939-7e92c7cd2776,1f1bf129-fcfa-43f9-8726-4e50323d183e,,Neoadjuvant,37.0,2021-08-26T08:54:54.023984-05:00,HCM-CSHL-0164-C20_treatment6,705d2394-f5c2-41a7-a017-f438f132cf25,,released,,1,2020-02-27T12:49:04.421900-06:00,Chemotherapy,,FOLFOXIRI
HCM-CSHL-0164-C20,6058fb8d-eb5d-4dbc-b939-7e92c7cd2776,1f1bf129-fcfa-43f9-8726-4e50323d183e,,,272.0,2023-03-13T12:43:48.711224-05:00,HCM-CSHL-0164-C20_treatment13,7d9f1c66-7bd5-4fa3-8ac5-ba8b343ab8eb,,released,,1,2020-09-27T13:03:40.864508-05:00,"Surgery, NOS",Initial Diagnosis,
HCM-CSHL-0164-C20,6058fb8d-eb5d-4dbc-b939-7e92c7cd2776,1f1bf129-fcfa-43f9-8726-4e50323d183e,,Neoadjuvant,37.0,2021-01-06T22:55:10.531130-06:00,HCM-CSHL-0164-C20_treatment2,a06e6755-372c-4727-9533-b2a3eb750fa6,,released,Fluorouracil,1,2020-02-27T12:49:04.421900-06:00,Chemotherapy,,
HCM-CSHL-0164-C20,6058fb8d-eb5d-4dbc-b939-7e92c7cd2776,1f1bf129-fcfa-43f9-8726-4e50323d183e,163.0,Maintenance Therapy,37.0,2021-08-26T08:54:54.023984-05:00,HCM-CSHL-0164-C20_treatment7,b072a765-6839-4db4-b09c-d8cca341736e,Treatment Ongoing,released,Leucovorin Calcium,1,2020-09-27T13:03:40.864508-05:00,,Progressive Disease,
HCM-CSHL-0164-C20,6058fb8d-eb5d-4dbc-b939-7e92c7cd2776,1f1bf129-fcfa-43f9-8726-4e50323d183e,163.0,Maintenance Therapy,37.0,2021-08-26T08:54:54.023984-05:00,HCM-CSHL-0164-C20_treatment12,cd29e5a3-1ce4-4d78-9836-9758a466b034,Treatment Ongoing,released,,1,2020-09-27T13:03:40.864508-05:00,,Progressive Disease,FOLFOXIRI
HCM-CSHL-0164-C20,6058fb8d-eb5d-4dbc-b939-7e92c7cd2776,1f1bf129-fcfa-43f9-8726-4e50323d183e,163.0,Maintenance Therapy,37.0,2021-08-26T08:54:54.023984-05:00,HCM-CSHL-0164-C20_treatment9,d00addc6-183d-43d8-8ad5-fbf1d13f529d,Treatment Ongoing,released,Oxaliplatin,1,2020-09-27T13:03:40.864508-05:00,,Progressive Disease,
HCM-CSHL-0164-C20,6058fb8d-eb5d-4dbc-b939-7e92c7cd2776,1f1bf129-fcfa-43f9-8726-4e50323d183e,163.0,Maintenance Therapy,37.0,2021-08-26T08:54:54.023984-05:00,HCM-CSHL-0164-C20_treatment10,d7a92524-4ba1-499e-801d-0b70c3df822a,Treatment Ongoing,released,Irinotecan,1,2020-09-27T13:03:40.864508-05:00,,Progressive Disease,
HCM-CSHL-0164-C20,6058fb8d-eb5d-4dbc-b939-7e92c7cd2776,1f1bf129-fcfa-43f9-8726-4e50323d183e,,Neoadjuvant,37.0,2021-01-06T22:55:10.531130-06:00,HCM-CSHL-0164-C20_treatment,d934ff0e-fa10-4955-83f6-912aa088753d,,released,Leucovorin Calcium,1,2020-02-27T12:49:04.421900-06:00,Chemotherapy,,
HCM-CSHL-0164-C20,6058fb8d-eb5d-4dbc-b939-7e92c7cd2776,1f1bf129-fcfa-43f9-8726-4e50323d183e,163.0,Maintenance Therapy,37.0,2021-08-26T08:54:54.023984-05:00,HCM-CSHL-0164-C20_treatment11,edc647aa-28aa-4c30-90e2-66f1c9596be7,Treatment Ongoing,released,,1,2020-09-27T13:03:40.864508-05:00,,Progressive Disease,FOLFOX
HCM-CSHL-0164-C20,6058fb8d-eb5d-4dbc-b939-7e92c7cd2776,1f1bf129-fcfa-43f9-8726-4e50323d183e,,Neoadjuvant,37.0,2021-08-26T08:54:54.023984-05:00,HCM-CSHL-0164-C20_treatment5,ee2f1674-4acd-4391-ab10-c08bc1f0d328,,released,Irinotecan,1,2020-02-27T12:49:04.421900-06:00,Chemotherapy,,
HCM-EXPT-1208-C20,605c869d-61cf-4801-826e-a6149f14be49,b73c3c19-32d5-4172-a469-f6abca65aa7f,,Neoadjuvant,,2025-10-08T12:38:51.189053-05:00,HCM-EXPT-1208-C20_treatment,1e2d87ee-da5f-4bf6-9903-926fba0fcf52,,released,,0,2023-02-24T14:17:40.648924-06:00,,,
HCM-EXPT-1197-C18,6113f817-ab45-4d67-9050-92e24cb69669,6a0a8795-1dcc-46e8-8dd6-04840438bf9d,,Neoadjuvant,,2025-10-08T12:38:51.189053-05:00,HCM-EXPT-1197-C18_treatment,001a6442-a3d8-4bf6-b29e-47e0860caf0d,,released,,0,2023-02-24T13:46:42.255205-06:00,,,
HCM-SANG-1329-C15,612e9381-a24f-49cb-8d48-1f4e1b90f64c,ee33764d-232f-4a30-9e56-7eec310eea1b,,Neoadjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-SANG-1329-C15_treatment,94647a0c-f9da-48ef-a10a-46479f0ab3c8,,released,,0,2023-02-27T12:04:31.149300-06:00,,,
HCM-CSHL-0773-C50,6135448b-e32a-4836-8355-b00036503577,6ac827aa-3756-4a9e-b3df-2e922f821073,,Maintenance Therapy,,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0773-C50_treatment15,281a96e0-49fc-4d00-8288-2e1d90349df2,Treatment Ongoing,released,Nab-paclitaxel,1,2021-12-21T14:23:45.161475-06:00,,,
HCM-CSHL-0773-C50,6135448b-e32a-4836-8355-b00036503577,6ac827aa-3756-4a9e-b3df-2e922f821073,,Maintenance Therapy,,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0773-C50_treatment16,28a75c90-0fc3-4e8f-98bd-5c86f1e8da5c,Treatment Ongoing,released,Xeloda,1,2021-12-21T14:23:45.161475-06:00,,,
HCM-CSHL-0773-C50,6135448b-e32a-4836-8355-b00036503577,6ac827aa-3756-4a9e-b3df-2e922f821073,,Maintenance Therapy,,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0773-C50_treatment18,3b960c1b-a8b0-46ae-8d87-aee889ff7f72,Treatment Ongoing,released,Anastrozole,1,2021-12-21T14:23:45.161475-06:00,,,
HCM-CSHL-0773-C50,6135448b-e32a-4836-8355-b00036503577,6ac827aa-3756-4a9e-b3df-2e922f821073,,Maintenance Therapy,,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0773-C50_treatment17,93d09e16-05b9-4c94-b5d7-7b549b850e25,Treatment Ongoing,released,Letrozole,1,2021-12-21T14:23:45.161475-06:00,,,
HCM-CSHL-0773-C50,6135448b-e32a-4836-8355-b00036503577,6ac827aa-3756-4a9e-b3df-2e922f821073,,Prevention,,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0773-C50_treatment20,c39c29ff-0b03-4530-ace2-a142f4bc523d,,released,,0,2021-12-21T14:23:45.161475-06:00,Hormone Therapy,,
HCM-CSHL-0773-C50,6135448b-e32a-4836-8355-b00036503577,ceeaa9ad-43f6-4466-80c8-ad2eaa0e42de,3808.0,Adjuvant,3794.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0773-C50_treatment14,1b59c13d-a1fe-4ecd-8299-5093d4221b31,,released,,1,2021-12-21T14:23:45.161475-06:00,"Radiation Therapy, NOS",Residual Disease,
HCM-CSHL-0773-C50,6135448b-e32a-4836-8355-b00036503577,ceeaa9ad-43f6-4466-80c8-ad2eaa0e42de,,Prevention,,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0773-C50_treatment19,3e57c94e-ddf1-426d-9754-d2b43d4ef03c,,released,,0,2021-12-21T14:23:45.161475-06:00,Hormone Therapy,,
HCM-CSHL-0773-C50,6135448b-e32a-4836-8355-b00036503577,ceeaa9ad-43f6-4466-80c8-ad2eaa0e42de,3979.0,Adjuvant,3817.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0773-C50_treatment3,43de2a69-aeeb-4588-8ed0-dd29c2aa689c,,released,Capecitabine,1,2021-12-21T14:23:45.161475-06:00,Chemotherapy,Residual Disease,
HCM-CSHL-0773-C50,6135448b-e32a-4836-8355-b00036503577,ceeaa9ad-43f6-4466-80c8-ad2eaa0e42de,,,3.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0773-C50_treatment12,5a396c7b-e17f-473a-a23e-33d2f9764a0f,,released,,1,2021-12-21T14:23:45.161475-06:00,"Surgery, NOS",Initial Diagnosis,
HCM-CSHL-0773-C50,6135448b-e32a-4836-8355-b00036503577,ceeaa9ad-43f6-4466-80c8-ad2eaa0e42de,1526.0,Adjuvant,54.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0773-C50_treatment8,738a242b-4da7-4f73-9fd3-e1f58b6ebfcf,,released,Not Reported,1,2021-12-21T14:23:45.161475-06:00,Hormone Therapy,Residual Disease,
HCM-CSHL-0773-C50,6135448b-e32a-4836-8355-b00036503577,ceeaa9ad-43f6-4466-80c8-ad2eaa0e42de,,Adjuvant,4507.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0773-C50_treatment7,74d40bad-2e9c-48b0-8523-bf11fea99d57,,released,Carboplatin,1,2021-12-21T14:23:45.161475-06:00,Chemotherapy,Residual Disease,
HCM-CSHL-0773-C50,6135448b-e32a-4836-8355-b00036503577,ceeaa9ad-43f6-4466-80c8-ad2eaa0e42de,,Adjuvant,4638.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0773-C50_treatment6,85ba0fc8-ed19-4d29-9e6a-d2085b87d91f,Treatment Ongoing,released,Docetaxel,1,2021-12-21T14:23:45.161475-06:00,Chemotherapy,Residual Disease,
HCM-CSHL-0773-C50,6135448b-e32a-4836-8355-b00036503577,ceeaa9ad-43f6-4466-80c8-ad2eaa0e42de,4467.0,Adjuvant,4420.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0773-C50_treatment13,860cbff5-f53e-4eec-a597-d862774ff98a,,released,Everolimus,1,2021-12-21T14:23:45.161475-06:00,Targeted Molecular Therapy,Residual Disease,
HCM-CSHL-0773-C50,6135448b-e32a-4836-8355-b00036503577,ceeaa9ad-43f6-4466-80c8-ad2eaa0e42de,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0773-C50_treatment11,aa5641da-7e70-43ed-b66b-186bd141f459,,released,Not Reported,1,2021-12-21T14:23:45.161475-06:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-CSHL-0773-C50,6135448b-e32a-4836-8355-b00036503577,ceeaa9ad-43f6-4466-80c8-ad2eaa0e42de,4194.0,Adjuvant,4141.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0773-C50_treatment4,b22e7d3f-201b-45d0-9ccc-5dbb70c0e305,,released,Pegylated Liposomal Doxorubicin Hydrochloride,1,2021-12-21T14:23:45.161475-06:00,Chemotherapy,Residual Disease,
HCM-CSHL-0773-C50,6135448b-e32a-4836-8355-b00036503577,ceeaa9ad-43f6-4466-80c8-ad2eaa0e42de,,Adjuvant,4305.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0773-C50_treatment10,c6a06d40-405e-404e-9302-11e496b46e68,,released,Sacituzumab Govitecan,1,2021-12-21T14:23:45.161475-06:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-CSHL-0773-C50,6135448b-e32a-4836-8355-b00036503577,ceeaa9ad-43f6-4466-80c8-ad2eaa0e42de,,Neoadjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0773-C50_treatment,d6838390-57bd-40c7-8ad1-d1ad490268d1,,released,,0,2021-12-21T14:23:45.161475-06:00,,,
HCM-CSHL-0773-C50,6135448b-e32a-4836-8355-b00036503577,ceeaa9ad-43f6-4466-80c8-ad2eaa0e42de,4132.0,Adjuvant,3979.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0773-C50_treatment2,e67c6ef6-643a-47ad-aa93-1fbed5f67d87,,released,Paclitaxel,1,2021-12-21T14:23:45.161475-06:00,Chemotherapy,Residual Disease,
HCM-CSHL-0773-C50,6135448b-e32a-4836-8355-b00036503577,ceeaa9ad-43f6-4466-80c8-ad2eaa0e42de,4254.0,Adjuvant,4227.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0773-C50_treatment5,f15eaa71-3143-4129-b18d-c57561952979,,released,Eribulin Mesylate,1,2021-12-21T14:23:45.161475-06:00,Chemotherapy,Residual Disease,
HCM-CSHL-0773-C50,6135448b-e32a-4836-8355-b00036503577,ceeaa9ad-43f6-4466-80c8-ad2eaa0e42de,1880.0,Adjuvant,1545.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0773-C50_treatment9,f2fa0011-4ccb-4b52-b6eb-d8874eb22f59,,released,Letrozole,1,2021-12-21T14:23:45.161475-06:00,Hormone Therapy,Residual Disease,
HCM-WCMC-1359-C34,6199d20e-91c3-4ebb-9f87-16777ab803d6,76710a04-3b6c-4499-b0dc-8c5318292bfd,119.0,Adjuvant,56.0,2025-04-07T17:13:09.336794-05:00,HCM-WCMC-1359-C34_treatment4,2b1eee57-86a7-496e-b42c-d31e62b8381e,,released,,1,2023-02-27T11:31:25.359113-06:00,Chemotherapy,Residual Disease,Cisplatin-Pemetrexed regimen
HCM-WCMC-1359-C34,6199d20e-91c3-4ebb-9f87-16777ab803d6,76710a04-3b6c-4499-b0dc-8c5318292bfd,119.0,Adjuvant,56.0,2025-04-07T17:13:09.336794-05:00,HCM-WCMC-1359-C34_treatment2,520de0e3-1afc-4704-8931-936744016035,,released,Pemetrexed,1,2023-02-27T11:31:25.359113-06:00,Chemotherapy,Residual Disease,
HCM-WCMC-1359-C34,6199d20e-91c3-4ebb-9f87-16777ab803d6,76710a04-3b6c-4499-b0dc-8c5318292bfd,119.0,Adjuvant,56.0,2025-04-07T17:13:09.336794-05:00,HCM-WCMC-1359-C34_treatment3,7e538d60-1f37-4e7c-9f6a-14af83e769f7,,released,Cisplatin,1,2023-02-27T11:31:25.359113-06:00,Chemotherapy,Residual Disease,
HCM-WCMC-1359-C34,6199d20e-91c3-4ebb-9f87-16777ab803d6,76710a04-3b6c-4499-b0dc-8c5318292bfd,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-WCMC-1359-C34_treatment7,81a14a51-8d42-40a8-bc21-054681a85e7d,,released,,0,2023-02-27T11:31:25.359113-06:00,Targeted Molecular Therapy,Residual Disease,
HCM-WCMC-1359-C34,6199d20e-91c3-4ebb-9f87-16777ab803d6,76710a04-3b6c-4499-b0dc-8c5318292bfd,,Neoadjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-WCMC-1359-C34_treatment,a4876b5a-255c-4818-b722-2ca023f2b84b,,released,,0,2023-02-27T11:31:25.359113-06:00,,,
HCM-WCMC-1359-C34,6199d20e-91c3-4ebb-9f87-16777ab803d6,76710a04-3b6c-4499-b0dc-8c5318292bfd,180.0,Adjuvant,173.0,2025-04-07T17:13:09.336794-05:00,HCM-WCMC-1359-C34_treatment8,c87a73a7-7de0-4ee0-8e22-a71f2147c310,,released,,1,2023-02-27T11:31:25.359113-06:00,"Radiation Therapy, NOS",Residual Disease,
HCM-WCMC-1359-C34,6199d20e-91c3-4ebb-9f87-16777ab803d6,76710a04-3b6c-4499-b0dc-8c5318292bfd,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-WCMC-1359-C34_treatment5,d2693e5c-d330-40cc-8b67-48e9c03d1468,,released,,0,2023-02-27T11:31:25.359113-06:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-WCMC-1359-C34,6199d20e-91c3-4ebb-9f87-16777ab803d6,76710a04-3b6c-4499-b0dc-8c5318292bfd,,,14.0,2025-04-07T17:13:09.336794-05:00,HCM-WCMC-1359-C34_treatment6,f696a50d-788d-4226-925b-cfaaa2dd9da2,,released,,1,2023-02-27T11:31:25.359113-06:00,"Surgery, NOS",Initial Diagnosis,
HCM-EXPT-1249-C18,6223b52d-1861-4c93-82ab-db79e117fbbc,691f735c-6845-4fc8-939d-26a2602cfd21,,Neoadjuvant,,2025-10-08T12:39:37.798161-05:00,HCM-EXPT-1249-C18_treatment,95ea9cc8-4ead-4d44-819d-10292e95b9fd,,released,,0,2022-03-09T11:53:02.069893-06:00,,,
HCM-BROD-0478-C16,623abf17-efbf-4433-86e9-0089601de5c0,e2e5f402-db94-4d99-a51d-8a2b85b0dd3b,118.0,Adjuvant,20.0,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0478-C16_treatment6,53cbdfc0-1ce5-4e73-827f-9c4d140c995b,,released,Pembrolizumab,1,2020-09-27T11:43:19.684874-05:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-BROD-0478-C16,623abf17-efbf-4433-86e9-0089601de5c0,e2e5f402-db94-4d99-a51d-8a2b85b0dd3b,,Neoadjuvant,13.0,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0478-C16_treatment2,54737f8c-067c-436d-9a0e-04ccea2181e2,,released,Fluorouracil,1,2020-09-27T11:43:19.684874-05:00,Chemotherapy,,
HCM-BROD-0478-C16,623abf17-efbf-4433-86e9-0089601de5c0,e2e5f402-db94-4d99-a51d-8a2b85b0dd3b,,Adjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0478-C16_treatment8,655f5ee2-09a1-46c6-9414-0993a84fb38e,,released,,0,2020-09-27T11:43:19.684874-05:00,Targeted Molecular Therapy,Residual Disease,
HCM-BROD-0478-C16,623abf17-efbf-4433-86e9-0089601de5c0,e2e5f402-db94-4d99-a51d-8a2b85b0dd3b,,Neoadjuvant,13.0,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0478-C16_treatment3,8927e72b-9ed5-46d0-b67f-40720e87738f,,released,Leucovorin,1,2020-09-27T11:43:19.684874-05:00,Chemotherapy,,
HCM-BROD-0478-C16,623abf17-efbf-4433-86e9-0089601de5c0,e2e5f402-db94-4d99-a51d-8a2b85b0dd3b,,Neoadjuvant,13.0,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0478-C16_treatment,8a18fd31-0aa8-4962-ab7e-6c8ec40cba94,,released,Irinotecan,1,2020-09-27T11:43:19.684874-05:00,Chemotherapy,,
HCM-BROD-0478-C16,623abf17-efbf-4433-86e9-0089601de5c0,e2e5f402-db94-4d99-a51d-8a2b85b0dd3b,161.0,Adjuvant,125.0,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0478-C16_treatment5,9fd4f73f-e10e-4c28-9c28-227ee1c27455,,released,Paclitaxel,1,2020-09-27T11:43:19.684874-05:00,Chemotherapy,Residual Disease,
HCM-BROD-0478-C16,623abf17-efbf-4433-86e9-0089601de5c0,e2e5f402-db94-4d99-a51d-8a2b85b0dd3b,,Neoadjuvant,13.0,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0478-C16_treatment4,cab58eb8-62e0-42b6-9496-7d3aedc17a5e,,released,,1,2020-09-27T11:43:19.684874-05:00,Chemotherapy,,FU-LV regimen
HCM-BROD-0478-C16,623abf17-efbf-4433-86e9-0089601de5c0,e2e5f402-db94-4d99-a51d-8a2b85b0dd3b,,Adjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0478-C16_treatment9,ef9098fd-4424-4e23-875e-e62b8e684819,,released,,0,2020-09-27T11:43:19.684874-05:00,"Radiation Therapy, NOS",Residual Disease,
HCM-BROD-0004-C64,63653137-c694-4ad6-83a3-eaaff1df2ca7,1f0360f7-90da-4d15-b0f4-894719a6c971,,Neoadjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0004-C64_treatment,14f3b343-c629-460e-bb59-608f54e89538,,released,,0,2019-04-04T13:36:52.336425-05:00,,,
HCM-BROD-0004-C64,63653137-c694-4ad6-83a3-eaaff1df2ca7,1f0360f7-90da-4d15-b0f4-894719a6c971,,Adjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0004-C64_treatment10,31978212-a435-4e32-9380-e2915dc5add4,,released,,0,2020-09-16T19:51:33.759052-05:00,Targeted Molecular Therapy,Residual Disease,
HCM-BROD-0004-C64,63653137-c694-4ad6-83a3-eaaff1df2ca7,1f0360f7-90da-4d15-b0f4-894719a6c971,625.0,Adjuvant,610.0,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0004-C64_treatment6,7d5c331d-ffb4-4752-b693-85b18d2492f2,,released,Etoposide,1,2020-09-16T19:51:33.759052-05:00,Chemotherapy,Residual Disease,
HCM-BROD-0004-C64,63653137-c694-4ad6-83a3-eaaff1df2ca7,1f0360f7-90da-4d15-b0f4-894719a6c971,625.0,Adjuvant,610.0,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0004-C64_treatment2,8a3128ea-5bc5-48ff-8e95-01368d3f1294,,released,Vincristine,1,2020-09-16T19:51:33.759052-05:00,Chemotherapy,Residual Disease,
HCM-BROD-0004-C64,63653137-c694-4ad6-83a3-eaaff1df2ca7,1f0360f7-90da-4d15-b0f4-894719a6c971,625.0,Adjuvant,610.0,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0004-C64_treatment3,8d379317-f310-4cc3-803c-514987db162f,,released,Ifosfamide,1,2020-09-16T19:51:33.759052-05:00,Chemotherapy,Residual Disease,
HCM-BROD-0004-C64,63653137-c694-4ad6-83a3-eaaff1df2ca7,1f0360f7-90da-4d15-b0f4-894719a6c971,625.0,Adjuvant,610.0,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0004-C64_treatment11,8e0c11cc-e0ec-49ce-960f-2d8cdbdcc42a,,released,,1,2020-09-16T19:51:33.759052-05:00,"Radiation Therapy, NOS",Residual Disease,
HCM-BROD-0004-C64,63653137-c694-4ad6-83a3-eaaff1df2ca7,1f0360f7-90da-4d15-b0f4-894719a6c971,625.0,Adjuvant,610.0,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0004-C64_treatment5,98163382-4651-4ff2-a4eb-de556b1919b3,,released,Doxorubicin,1,2020-09-16T19:51:33.759052-05:00,Chemotherapy,Residual Disease,
HCM-BROD-0004-C64,63653137-c694-4ad6-83a3-eaaff1df2ca7,1f0360f7-90da-4d15-b0f4-894719a6c971,,Adjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0004-C64_treatment8,aaef3944-2aef-41eb-a958-38caab76d509,,released,,0,2020-09-16T19:51:33.759052-05:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-BROD-0004-C64,63653137-c694-4ad6-83a3-eaaff1df2ca7,1f0360f7-90da-4d15-b0f4-894719a6c971,625.0,Adjuvant,610.0,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0004-C64_treatment7,af17a5a9-7ea2-4016-995e-5b363efaed10,,released,,1,2020-09-16T19:51:33.759052-05:00,Chemotherapy,Residual Disease,VDC/IE
HCM-BROD-0004-C64,63653137-c694-4ad6-83a3-eaaff1df2ca7,1f0360f7-90da-4d15-b0f4-894719a6c971,625.0,Adjuvant,610.0,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0004-C64_treatment4,b54b5e91-7fe6-48ce-a2bc-01cb7d838031,,released,Cyclophosphamide,1,2020-09-16T19:51:33.759052-05:00,Chemotherapy,Residual Disease,
HCM-BROD-0028-C71,6375cc59-6cd1-4b1e-8de1-510841c3bebd,2c497764-9031-4c03-b7f7-45615b605416,876.0,Adjuvant,771.0,2020-01-13T20:10:25.832065-06:00,HCM-BROD-0028-C71_treatment2,0e5301ca-a25f-4a53-9655-f6f7904ff795,,released,Temozolomide,1,2019-04-04T14:18:18.835652-05:00,Chemotherapy,Residual Disease,
HCM-BROD-0028-C71,6375cc59-6cd1-4b1e-8de1-510841c3bebd,2c497764-9031-4c03-b7f7-45615b605416,,Adjuvant,,2020-01-13T20:10:25.832065-06:00,HCM-BROD-0028-C71_treatment6,210c09d6-56eb-494c-a32b-8e43929b93bf,,released,,0,2019-04-04T14:18:18.835652-05:00,"Radiation Therapy, NOS",Residual Disease,
HCM-BROD-0028-C71,6375cc59-6cd1-4b1e-8de1-510841c3bebd,2c497764-9031-4c03-b7f7-45615b605416,,Neoadjuvant,,2020-01-13T20:10:25.832065-06:00,HCM-BROD-0028-C71_treatment,529b058e-3906-448d-8a4c-c31c3fce063a,,released,,0,2019-03-12T10:13:49.767516-05:00,,,
HCM-BROD-0028-C71,6375cc59-6cd1-4b1e-8de1-510841c3bebd,2c497764-9031-4c03-b7f7-45615b605416,,,-1.0,2023-03-13T13:05:58.768371-05:00,HCM-BROD-0028-C71_treatment4,70e0bb57-5dce-4685-afcd-aee597892ede,,released,,1,2019-04-04T14:18:18.835652-05:00,"Surgery, NOS",Initial Diagnosis,
HCM-BROD-0028-C71,6375cc59-6cd1-4b1e-8de1-510841c3bebd,2c497764-9031-4c03-b7f7-45615b605416,876.0,Adjuvant,771.0,2020-06-15T09:41:27.974207-05:00,HCM-BROD-0028-C71_treatment5,9acc224a-9744-4f4f-ba3f-597e3196b4cb,,released,Bevacizumab,1,2019-04-04T14:18:18.835652-05:00,Targeted Molecular Therapy,Residual Disease,
HCM-BROD-0028-C71,6375cc59-6cd1-4b1e-8de1-510841c3bebd,2c497764-9031-4c03-b7f7-45615b605416,,Adjuvant,,2020-01-13T20:10:25.832065-06:00,HCM-BROD-0028-C71_treatment3,b6104ef6-30e3-4f22-bea6-ff9e0c285870,,released,,0,2019-04-04T14:18:18.835652-05:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-CSHL-0510-D13,6380f4ca-f7ca-41ee-90ed-54403bed84f6,7ca3765b-c0dd-495d-be3e-9333fe62a2a7,,,-10.0,2023-03-13T12:56:18.548626-05:00,HCM-CSHL-0510-D13_treatment2,212d727b-e848-44b2-bf48-335127c78c74,,released,,1,2021-08-26T09:37:18.881696-05:00,"Surgery, NOS",Initial Diagnosis,
HCM-CSHL-0510-D13,6380f4ca-f7ca-41ee-90ed-54403bed84f6,7ca3765b-c0dd-495d-be3e-9333fe62a2a7,,Neoadjuvant,,2021-09-10T10:36:37.981324-05:00,HCM-CSHL-0510-D13_treatment,610f5acb-bda6-4b10-89a2-6347d2413371,,released,,0,2021-07-19T20:13:23.885391-05:00,,,
HCM-CSHL-0510-D13,6380f4ca-f7ca-41ee-90ed-54403bed84f6,7ca3765b-c0dd-495d-be3e-9333fe62a2a7,,Adjuvant,,2023-03-13T12:56:18.548626-05:00,HCM-CSHL-0510-D13_treatment4,c1adba06-be30-49e3-b250-d12f87f949dc,,released,,0,2021-08-26T09:37:18.881696-05:00,"Radiation Therapy, NOS",Residual Disease,
HCM-CSHL-0510-D13,6380f4ca-f7ca-41ee-90ed-54403bed84f6,7ca3765b-c0dd-495d-be3e-9333fe62a2a7,,Adjuvant,,2023-03-13T12:56:18.548626-05:00,HCM-CSHL-0510-D13_treatment3,c3fb197d-e27e-47f6-a2c7-b1239cc66369,,released,,0,2021-08-26T09:37:18.881696-05:00,"Pharmaceutical Therapy, NOS",Residual Disease,
HCM-CSHL-0623-C18,6382c82d-dffb-4f43-8fb2-1d0ec187363e,31da82c5-2a39-4901-a980-a007294b6118,283.0,Maintenance Therapy,214.0,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0623-C18_treatment20,10b86ee1-1a95-460b-b2c1-77b55e107f6c,Progressive Disease,released,,1,2021-12-21T14:12:50.204791-06:00,,,XELOX
HCM-CSHL-0623-C18,6382c82d-dffb-4f43-8fb2-1d0ec187363e,31da82c5-2a39-4901-a980-a007294b6118,283.0,Maintenance Therapy,214.0,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0623-C18_treatment13,1237ef20-d6bb-48c2-a07b-c398cc9b352b,Progressive Disease,released,Oxaliplatin,1,2021-12-21T14:12:50.204791-06:00,,,
HCM-CSHL-0623-C18,6382c82d-dffb-4f43-8fb2-1d0ec187363e,31da82c5-2a39-4901-a980-a007294b6118,283.0,Maintenance Therapy,214.0,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0623-C18_treatment18,13e43020-7efe-4da1-98cf-dc377b6023a7,Progressive Disease,released,Irinotecan,1,2021-12-21T14:12:50.204791-06:00,,,
HCM-CSHL-0623-C18,6382c82d-dffb-4f43-8fb2-1d0ec187363e,31da82c5-2a39-4901-a980-a007294b6118,283.0,Maintenance Therapy,214.0,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0623-C18_treatment16,2db95c85-3505-4826-8644-f096408e005e,Progressive Disease,released,Capecitabine,1,2021-12-21T14:12:50.204791-06:00,,,
HCM-CSHL-0623-C18,6382c82d-dffb-4f43-8fb2-1d0ec187363e,31da82c5-2a39-4901-a980-a007294b6118,283.0,Maintenance Therapy,214.0,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0623-C18_treatment17,378079cd-643d-48e4-bce6-0fa225fcc72f,Progressive Disease,released,Leucovorin Calcium,1,2021-12-21T14:12:50.204791-06:00,,,
HCM-CSHL-0623-C18,6382c82d-dffb-4f43-8fb2-1d0ec187363e,31da82c5-2a39-4901-a980-a007294b6118,283.0,Maintenance Therapy,214.0,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0623-C18_treatment15,5ed91c19-f67c-4f87-9251-90a2738d25b3,Progressive Disease,released,Cetuximab,1,2021-12-21T14:12:50.204791-06:00,,,
HCM-CSHL-0623-C18,6382c82d-dffb-4f43-8fb2-1d0ec187363e,31da82c5-2a39-4901-a980-a007294b6118,283.0,Maintenance Therapy,214.0,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0623-C18_treatment19,93de4434-b003-455b-85a7-137c523662bf,Progressive Disease,released,,1,2021-12-21T14:12:50.204791-06:00,,,FOLFIRI
HCM-CSHL-0623-C18,6382c82d-dffb-4f43-8fb2-1d0ec187363e,31da82c5-2a39-4901-a980-a007294b6118,283.0,Maintenance Therapy,214.0,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0623-C18_treatment14,fcf49555-0299-463f-abcf-8a9105828c66,Progressive Disease,released,Fluorouracil,1,2021-12-21T14:12:50.204791-06:00,,,
HCM-CSHL-0623-C18,6382c82d-dffb-4f43-8fb2-1d0ec187363e,efb55859-77f5-47ba-bced-ebb193b5847c,285.0,Adjuvant,237.0,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0623-C18_treatment6,219b1fa7-6608-4315-9b54-3e620df1364a,,released,Fluorouracil,1,2021-12-21T14:12:50.204791-06:00,Chemotherapy,Residual Disease,
HCM-CSHL-0623-C18,6382c82d-dffb-4f43-8fb2-1d0ec187363e,efb55859-77f5-47ba-bced-ebb193b5847c,,,404.0,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0623-C18_treatment10,364b9887-ad7d-4c7b-a6e0-30aba88e1a9b,,released,,1,2021-12-21T14:12:50.204791-06:00,"Surgery, NOS",Initial Diagnosis,
HCM-CSHL-0623-C18,6382c82d-dffb-4f43-8fb2-1d0ec187363e,efb55859-77f5-47ba-bced-ebb193b5847c,,Adjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0623-C18_treatment9,3fe07eec-d246-40be-9dee-d204135b5196,,released,,0,2021-12-21T14:12:50.204791-06:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-CSHL-0623-C18,6382c82d-dffb-4f43-8fb2-1d0ec187363e,efb55859-77f5-47ba-bced-ebb193b5847c,285.0,Adjuvant,237.0,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0623-C18_treatment7,43aaadda-00cc-4164-ba73-f5c258d58466,,released,Cetuximab,1,2021-12-21T14:12:50.204791-06:00,Chemotherapy,Residual Disease,
HCM-CSHL-0623-C18,6382c82d-dffb-4f43-8fb2-1d0ec187363e,efb55859-77f5-47ba-bced-ebb193b5847c,,Neoadjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0623-C18_treatment,4784ea7c-c57e-40cb-89e7-368eac6ad851,,released,,0,2021-12-21T14:12:50.204791-06:00,,,
HCM-CSHL-0623-C18,6382c82d-dffb-4f43-8fb2-1d0ec187363e,efb55859-77f5-47ba-bced-ebb193b5847c,285.0,Adjuvant,237.0,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0623-C18_treatment5,6b3b0ca3-b780-4884-8546-67d6408d5a63,,released,Leucovorin Calcium,1,2021-12-21T14:12:50.204791-06:00,Chemotherapy,Residual Disease,
HCM-CSHL-0623-C18,6382c82d-dffb-4f43-8fb2-1d0ec187363e,efb55859-77f5-47ba-bced-ebb193b5847c,285.0,Adjuvant,237.0,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0623-C18_treatment4,760135f0-c616-4615-9788-a843be4ac204,,released,Irinotecan,1,2021-12-21T14:12:50.204791-06:00,Chemotherapy,Residual Disease,
HCM-CSHL-0623-C18,6382c82d-dffb-4f43-8fb2-1d0ec187363e,efb55859-77f5-47ba-bced-ebb193b5847c,196.0,Adjuvant,32.0,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0623-C18_treatment2,84121acc-b3c1-4317-bd1c-9737d49cbb33,,released,Oxaliplatin,1,2021-12-21T14:12:50.204791-06:00,Chemotherapy,Residual Disease,
HCM-CSHL-0623-C18,6382c82d-dffb-4f43-8fb2-1d0ec187363e,efb55859-77f5-47ba-bced-ebb193b5847c,,Adjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0623-C18_treatment11,98815661-6b61-4e0d-9d68-193119f99200,,released,,0,2021-12-21T14:12:50.204791-06:00,Targeted Molecular Therapy,Residual Disease,
HCM-CSHL-0623-C18,6382c82d-dffb-4f43-8fb2-1d0ec187363e,efb55859-77f5-47ba-bced-ebb193b5847c,561.0,Adjuvant,438.0,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0623-C18_treatment12,b8ac6fbd-763c-413f-bbeb-e02c10762505,,released,,1,2021-12-21T14:12:50.204791-06:00,"Radiation, Stereotactic/Gamma Knife/SRS",Residual Disease,
HCM-CSHL-0623-C18,6382c82d-dffb-4f43-8fb2-1d0ec187363e,efb55859-77f5-47ba-bced-ebb193b5847c,285.0,Adjuvant,237.0,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0623-C18_treatment8,dd12d6a2-5897-4365-8ad1-628bf21ae290,,released,,1,2021-12-21T14:12:50.204791-06:00,Chemotherapy,Residual Disease,FOLFIRI-cetuximab
HCM-CSHL-0623-C18,6382c82d-dffb-4f43-8fb2-1d0ec187363e,efb55859-77f5-47ba-bced-ebb193b5847c,196.0,Adjuvant,32.0,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0623-C18_treatment3,ebb24790-6b92-4a09-8c69-215df488ef89,,released,Capecitabine,1,2021-12-21T14:12:50.204791-06:00,Chemotherapy,Residual Disease,
HCM-SANG-0270-C20,6397deca-2bff-4c0a-a8c1-1b8c14bddabe,92f088d8-d7d2-4948-9658-3ef12baaebd2,,Neoadjuvant,,2023-03-13T13:25:53.708410-05:00,HCM-SANG-0270-C20_treatment2,34ebeedc-a923-44b4-8ff8-7e06b83e324f,,released,,1,2020-02-11T15:51:58.477251-06:00,"Radiation, 2D Conventional",,
HCM-SANG-0270-C20,6397deca-2bff-4c0a-a8c1-1b8c14bddabe,92f088d8-d7d2-4948-9658-3ef12baaebd2,,Neoadjuvant,,2023-03-13T13:25:53.708410-05:00,HCM-SANG-0270-C20_treatment,d5a4183d-5f9a-4161-9579-6d75ad7384bf,,released,Capecitabine,1,2020-02-11T15:51:58.477251-06:00,Chemotherapy,,
HCM-EXPT-1228-C18,63bb50c3-9857-4c9b-a765-7227943e070c,4174b41c-bde5-44f8-b94a-82a155605171,,Neoadjuvant,,2025-10-08T12:39:14.406630-05:00,HCM-EXPT-1228-C18_treatment,e43384a4-d0f1-4b6c-8b54-6ffdac28a282,,released,,0,2022-03-09T19:43:52.151883-06:00,,,
HCM-EXPT-1040-C50,63e7cf10-56ac-40c9-90b0-e78a99af789a,7d533f25-83cf-461f-9d34-562000db7f70,,Neoadjuvant,,2025-10-08T12:38:06.952582-05:00,HCM-EXPT-1040-C50_treatment,d62c68b3-4421-4f32-a5d6-563f535c0f57,,released,,0,2021-12-21T14:59:55.462789-06:00,,,
HCM-CSHL-0088-C25,64a54aa5-ce7c-4002-87f8-3b61f912104a,3dd66d45-e706-44ab-8400-7aa22e5fb81a,,Neoadjuvant,,2023-02-22T07:39:25.979291-06:00,HCM-CSHL-0088-C25_treatment,1d6c2b64-c78f-4f25-a5d4-e72f688a324c,,released,,0,2020-09-27T12:49:21.089408-05:00,,,
HCM-CSHL-0088-C25,64a54aa5-ce7c-4002-87f8-3b61f912104a,3dd66d45-e706-44ab-8400-7aa22e5fb81a,,Adjuvant,,2023-02-22T07:39:25.979291-06:00,HCM-CSHL-0088-C25_treatment7,36014c09-011f-47f6-ba08-96216ab579a1,,released,,0,2020-09-27T12:49:21.089408-05:00,Targeted Molecular Therapy,Residual Disease,
HCM-CSHL-0088-C25,64a54aa5-ce7c-4002-87f8-3b61f912104a,3dd66d45-e706-44ab-8400-7aa22e5fb81a,695.0,Adjuvant,603.0,2023-02-22T07:39:25.979291-06:00,HCM-CSHL-0088-C25_treatment4,3c8b5824-83ea-44c5-a60d-08b58510e8d4,,released,Oxaliplatin,1,2020-09-27T12:49:21.089408-05:00,Chemotherapy,Residual Disease,
HCM-CSHL-0088-C25,64a54aa5-ce7c-4002-87f8-3b61f912104a,3dd66d45-e706-44ab-8400-7aa22e5fb81a,,Adjuvant,289.0,2023-02-22T07:39:25.979291-06:00,HCM-CSHL-0088-C25_treatment2,442deeb7-c693-49c7-800b-2763a498b4ee,,released,Gemcitabine,1,2020-09-27T12:49:21.089408-05:00,Chemotherapy,Residual Disease,
HCM-CSHL-0088-C25,64a54aa5-ce7c-4002-87f8-3b61f912104a,3dd66d45-e706-44ab-8400-7aa22e5fb81a,,Adjuvant,,2023-02-22T07:39:25.979291-06:00,HCM-CSHL-0088-C25_treatment5,5446423d-9126-4c0c-8924-53e13e69cca7,,released,,0,2020-09-27T12:49:21.089408-05:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-CSHL-0088-C25,64a54aa5-ce7c-4002-87f8-3b61f912104a,3dd66d45-e706-44ab-8400-7aa22e5fb81a,,Adjuvant,289.0,2023-02-22T07:39:25.979291-06:00,HCM-CSHL-0088-C25_treatment3,5924669e-476d-4c62-8681-2a361ad88bdb,,released,Nab-paclitaxel,1,2020-09-27T12:49:21.089408-05:00,Chemotherapy,Residual Disease,
HCM-CSHL-0088-C25,64a54aa5-ce7c-4002-87f8-3b61f912104a,3dd66d45-e706-44ab-8400-7aa22e5fb81a,,,-5.0,2023-02-27T11:51:56.052926-06:00,HCM-CSHL-0088-C25_treatment6,dce6c3ea-94a9-4671-84a4-95a489073a0d,,released,,1,2020-09-27T12:49:21.089408-05:00,"Surgery, NOS",Initial Diagnosis,
HCM-CSHL-0088-C25,64a54aa5-ce7c-4002-87f8-3b61f912104a,3dd66d45-e706-44ab-8400-7aa22e5fb81a,,Adjuvant,,2023-02-22T07:39:25.979291-06:00,HCM-CSHL-0088-C25_treatment8,dcf21381-f59c-4319-91a3-b53c442cb1b2,,released,,0,2020-09-27T12:49:21.089408-05:00,"Radiation Therapy, NOS",Residual Disease,
HCM-BROD-0710-C43,64fbbfbe-8749-4b31-8ee6-ef711518fa66,02e8ff45-41ef-4450-82f3-dd889d18408e,,Adjuvant,,2023-11-07T14:20:00.017270-06:00,HCM-BROD-0710-C43_treatment7,131a7d41-a500-4c7c-8325-81d1759b9708,,released,,0,2021-12-21T13:47:39.506854-06:00,Targeted Molecular Therapy,Residual Disease,
HCM-BROD-0710-C43,64fbbfbe-8749-4b31-8ee6-ef711518fa66,02e8ff45-41ef-4450-82f3-dd889d18408e,,Adjuvant,,2023-11-07T14:20:00.017270-06:00,HCM-BROD-0710-C43_treatment2,13435b97-1938-4ea1-a9b1-bcb6e9052df8,,released,,0,2021-12-21T13:47:39.506854-06:00,Chemotherapy,Residual Disease,
HCM-BROD-0710-C43,64fbbfbe-8749-4b31-8ee6-ef711518fa66,02e8ff45-41ef-4450-82f3-dd889d18408e,,Adjuvant,,2023-11-07T14:20:00.017270-06:00,HCM-BROD-0710-C43_treatment3,21a6fa68-3e92-4948-bb0b-4929e710dc60,,released,,0,2021-12-21T13:47:39.506854-06:00,Hormone Therapy,Residual Disease,
HCM-BROD-0710-C43,64fbbfbe-8749-4b31-8ee6-ef711518fa66,02e8ff45-41ef-4450-82f3-dd889d18408e,,Adjuvant,,2023-11-07T14:20:00.017270-06:00,HCM-BROD-0710-C43_treatment8,45fc71fd-2aee-4f73-8ca3-a6bbc678ca81,,released,,0,2021-12-21T13:47:39.506854-06:00,"Radiation Therapy, NOS",Residual Disease,
HCM-BROD-0710-C43,64fbbfbe-8749-4b31-8ee6-ef711518fa66,02e8ff45-41ef-4450-82f3-dd889d18408e,,Neoadjuvant,965.0,2023-11-07T14:20:00.017270-06:00,HCM-BROD-0710-C43_treatment,5aedadd3-acb3-4654-b57c-b5c6181bb96f,,released,Nivolumab,1,2021-12-21T13:47:39.506854-06:00,Immunotherapy (Including Vaccines),,
HCM-BROD-0710-C43,64fbbfbe-8749-4b31-8ee6-ef711518fa66,02e8ff45-41ef-4450-82f3-dd889d18408e,2024.0,Adjuvant,1879.0,2023-11-07T14:20:00.017270-06:00,HCM-BROD-0710-C43_treatment4,6173d598-0bbc-4fcc-bc92-5042384c1ed9,,released,Nivolumab,1,2021-12-21T13:47:39.506854-06:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-BROD-0710-C43,64fbbfbe-8749-4b31-8ee6-ef711518fa66,02e8ff45-41ef-4450-82f3-dd889d18408e,,,0.0,2023-11-07T14:20:00.017270-06:00,HCM-BROD-0710-C43_treatment6,a3b373ca-b413-439a-90c6-2bfa8b3cb698,,released,,1,2021-12-21T13:47:39.506854-06:00,"Surgery, NOS",Initial Diagnosis,
HCM-BROD-0710-C43,64fbbfbe-8749-4b31-8ee6-ef711518fa66,02e8ff45-41ef-4450-82f3-dd889d18408e,2024.0,Adjuvant,1879.0,2023-11-07T14:20:00.017270-06:00,HCM-BROD-0710-C43_treatment5,d5114cca-2f5b-4fd1-aba5-5fb706f3c407,,released,Ipilimumab,1,2021-12-21T13:47:39.506854-06:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-BROD-0710-C43,64fbbfbe-8749-4b31-8ee6-ef711518fa66,ed425758-d374-4f95-9747-3f51dea7337e,1441.0,Maintenance Therapy,965.0,2023-11-07T14:20:00.017270-06:00,HCM-BROD-0710-C43_treatment9,638009a5-7f9a-4358-85c3-cbb399fe382e,Progressive Disease,released,Nivolumab,1,2021-12-21T13:47:39.506854-06:00,,,
HCM-CSHL-0078-C25,653a556f-c127-421d-8118-4bf98929fe53,87e438c1-5af0-435b-8cc3-d68f11e49d9c,,,-12.0,2023-03-13T13:05:18.703281-05:00,HCM-CSHL-0078-C25_treatment4,13b5f1cd-8013-44e4-a244-4869ef224d74,,released,,1,2020-09-27T12:46:52.359288-05:00,"Surgery, NOS",Initial Diagnosis,
HCM-CSHL-0078-C25,653a556f-c127-421d-8118-4bf98929fe53,87e438c1-5af0-435b-8cc3-d68f11e49d9c,,Adjuvant,,2023-02-22T07:39:25.979291-06:00,HCM-CSHL-0078-C25_treatment3,1892e8b9-d4e8-4a17-b15f-35096d24c6fa,,released,,0,2020-09-27T12:46:52.359288-05:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-CSHL-0078-C25,653a556f-c127-421d-8118-4bf98929fe53,87e438c1-5af0-435b-8cc3-d68f11e49d9c,,Adjuvant,,2023-02-22T07:39:25.979291-06:00,HCM-CSHL-0078-C25_treatment5,6643ff5d-67be-4360-88b0-a05e54b9849e,,released,,0,2020-09-27T12:46:52.359288-05:00,Targeted Molecular Therapy,Residual Disease,
HCM-CSHL-0078-C25,653a556f-c127-421d-8118-4bf98929fe53,87e438c1-5af0-435b-8cc3-d68f11e49d9c,89.0,Adjuvant,89.0,2023-02-22T07:39:25.979291-06:00,HCM-CSHL-0078-C25_treatment2,a5ca5e42-fafa-4746-a2be-397de974c0bb,,released,Gemcitabine,1,2020-09-27T12:46:52.359288-05:00,Chemotherapy,Residual Disease,
HCM-CSHL-0078-C25,653a556f-c127-421d-8118-4bf98929fe53,87e438c1-5af0-435b-8cc3-d68f11e49d9c,,Neoadjuvant,,2023-02-22T07:39:25.979291-06:00,HCM-CSHL-0078-C25_treatment,bd2c0269-3b95-4266-aff7-e3b34f00e9f5,,released,,0,2020-09-27T12:46:52.359288-05:00,,,
HCM-CSHL-0078-C25,653a556f-c127-421d-8118-4bf98929fe53,87e438c1-5af0-435b-8cc3-d68f11e49d9c,,Adjuvant,,2023-02-22T07:39:25.979291-06:00,HCM-CSHL-0078-C25_treatment6,e03beb89-0c43-4de0-bfd9-1955b701e882,,released,,0,2020-09-27T12:46:52.359288-05:00,"Radiation Therapy, NOS",Residual Disease,
HCM-CSHL-0076-C25,6548cb23-ee55-47c2-811a-156a090fbaee,9a4a502b-1c0e-4f9f-aeff-13732c7e6b04,197.0,Adjuvant,34.0,2023-02-22T07:39:25.979291-06:00,HCM-CSHL-0076-C25_treatment2,4bb933a9-014e-4543-b9b7-0f48b9bb6f33,,released,Gemcitabine,1,2020-09-27T12:46:28.410824-05:00,Chemotherapy,Residual Disease,
HCM-CSHL-0076-C25,6548cb23-ee55-47c2-811a-156a090fbaee,9a4a502b-1c0e-4f9f-aeff-13732c7e6b04,,Adjuvant,,2023-02-22T07:39:25.979291-06:00,HCM-CSHL-0076-C25_treatment6,558c0851-9ad1-4154-ba82-051142be4684,,released,,0,2020-09-27T12:46:28.410824-05:00,"Radiation Therapy, NOS",Residual Disease,
HCM-CSHL-0076-C25,6548cb23-ee55-47c2-811a-156a090fbaee,9a4a502b-1c0e-4f9f-aeff-13732c7e6b04,,,-6.0,2023-02-27T12:31:40.264091-06:00,HCM-CSHL-0076-C25_treatment4,5fdfa321-683f-4cb4-b0b7-2a79c65148ee,,released,,1,2020-09-27T12:46:28.410824-05:00,"Surgery, NOS",Initial Diagnosis,
HCM-CSHL-0076-C25,6548cb23-ee55-47c2-811a-156a090fbaee,9a4a502b-1c0e-4f9f-aeff-13732c7e6b04,,Neoadjuvant,,2023-02-22T07:39:25.979291-06:00,HCM-CSHL-0076-C25_treatment,600d3948-a77d-4677-a537-e5a6b241b2f7,,released,,0,2020-09-27T12:46:28.410824-05:00,,,
HCM-CSHL-0076-C25,6548cb23-ee55-47c2-811a-156a090fbaee,9a4a502b-1c0e-4f9f-aeff-13732c7e6b04,,Adjuvant,,2023-02-22T07:39:25.979291-06:00,HCM-CSHL-0076-C25_treatment3,d595b8ff-3bc3-4f5c-a09c-0e8c0e581759,,released,,0,2020-09-27T12:46:28.410824-05:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-CSHL-0076-C25,6548cb23-ee55-47c2-811a-156a090fbaee,9a4a502b-1c0e-4f9f-aeff-13732c7e6b04,,Adjuvant,,2023-02-22T07:39:25.979291-06:00,HCM-CSHL-0076-C25_treatment5,e8c0d52b-5f26-4651-bf0f-40e9562ecc3f,,released,,0,2020-09-27T12:46:28.410824-05:00,Targeted Molecular Therapy,Residual Disease,
HCM-BROD-0101-C15,662665d0-31b6-4a71-ab27-1190365cf856,ea9a5891-f381-4035-bdad-983f00261507,,Adjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0101-C15_treatment7,15300641-335d-422a-9500-62cf3a3b12c4,,released,,0,2020-09-27T10:25:54.901290-05:00,Targeted Molecular Therapy,Residual Disease,
HCM-BROD-0101-C15,662665d0-31b6-4a71-ab27-1190365cf856,ea9a5891-f381-4035-bdad-983f00261507,,Neoadjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0101-C15_treatment2,1714024d-9a64-4fc4-8533-79d5bc8989f2,,released,,1,2019-04-04T15:53:25.081649-05:00,Immunotherapy (Including Vaccines),,
HCM-BROD-0101-C15,662665d0-31b6-4a71-ab27-1190365cf856,ea9a5891-f381-4035-bdad-983f00261507,,,,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0101-C15_treatment6,22952015-a9aa-43e1-8a2d-8ec67588cead,,released,,0,2020-09-27T10:25:54.901290-05:00,"Surgery, NOS",Initial Diagnosis,
HCM-BROD-0101-C15,662665d0-31b6-4a71-ab27-1190365cf856,ea9a5891-f381-4035-bdad-983f00261507,,Neoadjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0101-C15_treatment,9282aeea-5666-46fa-b037-1e1a39ef9adb,,released,,1,2019-04-04T15:53:25.081649-05:00,Chemotherapy,,
HCM-BROD-0101-C15,662665d0-31b6-4a71-ab27-1190365cf856,ea9a5891-f381-4035-bdad-983f00261507,436.0,Adjuvant,333.0,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0101-C15_treatment3,94c84547-2d35-4eed-8946-7e622ec952e8,,released,Fluorouracil,1,2020-09-27T10:25:54.901290-05:00,Chemotherapy,Residual Disease,
HCM-BROD-0101-C15,662665d0-31b6-4a71-ab27-1190365cf856,ea9a5891-f381-4035-bdad-983f00261507,436.0,Adjuvant,333.0,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0101-C15_treatment4,a8c7dfb1-30fb-41ee-8ddf-f85e07b55553,,released,Leucovorin,1,2020-09-27T10:25:54.901290-05:00,Chemotherapy,Residual Disease,
HCM-BROD-0101-C15,662665d0-31b6-4a71-ab27-1190365cf856,ea9a5891-f381-4035-bdad-983f00261507,,Adjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0101-C15_treatment8,d79f562c-9bd1-4265-8920-8836da292046,,released,,0,2020-09-27T10:25:54.901290-05:00,"Radiation Therapy, NOS",Residual Disease,
HCM-BROD-0101-C15,662665d0-31b6-4a71-ab27-1190365cf856,ea9a5891-f381-4035-bdad-983f00261507,,Adjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0101-C15_treatment5,e1a7da75-50fb-4497-ae6e-308a5af2798a,,released,,0,2020-09-27T10:25:54.901290-05:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-EXPT-1059-C50,66a63a36-0422-4834-ac11-63e8eafed6d9,d0c087c2-f081-483a-9855-9e3b132ec200,,Neoadjuvant,,2025-10-08T12:38:28.988690-05:00,HCM-EXPT-1059-C50_treatment,b273f2a3-5b0a-4902-93b1-75d26e5e3c04,,released,,0,2021-12-21T15:03:11.127946-06:00,,,
HCM-CSHL-0655-C50,66f2f8d4-f8e2-4bb6-93e1-3edd7c5a3b48,2935a4d9-979a-4507-841b-afc4ba3458ee,,Neoadjuvant,,2023-11-07T14:28:29.403873-06:00,HCM-CSHL-0655-C50_treatment,25f04c4d-edee-4ba8-a350-129e1fa0b2f3,,released,,0,2021-12-21T14:14:23.961730-06:00,,,
HCM-CSHL-0655-C50,66f2f8d4-f8e2-4bb6-93e1-3edd7c5a3b48,2935a4d9-979a-4507-841b-afc4ba3458ee,,Prevention,,2023-11-07T14:28:29.403873-06:00,HCM-CSHL-0655-C50_treatment10,2f0be315-6bcf-4ce2-8a58-3dc49f0c60f9,,released,,0,2021-12-21T14:14:23.961730-06:00,Hormone Therapy,,
HCM-CSHL-0655-C50,66f2f8d4-f8e2-4bb6-93e1-3edd7c5a3b48,2935a4d9-979a-4507-841b-afc4ba3458ee,99.0,Adjuvant,62.0,2023-11-07T14:28:29.403873-06:00,HCM-CSHL-0655-C50_treatment2,52fe517e-3f9c-4871-93c5-83c0230c61c0,,released,Cyclophosphamide,1,2021-12-21T14:14:23.961730-06:00,Chemotherapy,Residual Disease,
HCM-CSHL-0655-C50,66f2f8d4-f8e2-4bb6-93e1-3edd7c5a3b48,2935a4d9-979a-4507-841b-afc4ba3458ee,319.0,Adjuvant,285.0,2023-11-07T14:28:29.403873-06:00,HCM-CSHL-0655-C50_treatment9,6dd32b96-a85c-465c-9c9b-bc29bc9bd8bc,,released,,1,2021-12-21T14:14:23.961730-06:00,"Radiation, Intensity-Modulated Radiotherapy",Residual Disease,
HCM-CSHL-0655-C50,66f2f8d4-f8e2-4bb6-93e1-3edd7c5a3b48,2935a4d9-979a-4507-841b-afc4ba3458ee,,Adjuvant,,2023-11-07T14:28:29.403873-06:00,HCM-CSHL-0655-C50_treatment5,7a11bbb4-3a00-4dac-b699-a9575041fc34,,released,,0,2021-12-21T14:14:23.961730-06:00,Hormone Therapy,Residual Disease,
HCM-CSHL-0655-C50,66f2f8d4-f8e2-4bb6-93e1-3edd7c5a3b48,2935a4d9-979a-4507-841b-afc4ba3458ee,,,12.0,2023-11-07T14:28:29.403873-06:00,HCM-CSHL-0655-C50_treatment7,7cb78892-8feb-42b8-9b93-30961fe302d0,,released,,1,2021-12-21T14:14:23.961730-06:00,"Surgery, NOS",Initial Diagnosis,
HCM-CSHL-0655-C50,66f2f8d4-f8e2-4bb6-93e1-3edd7c5a3b48,2935a4d9-979a-4507-841b-afc4ba3458ee,99.0,Adjuvant,62.0,2023-11-07T14:28:29.403873-06:00,HCM-CSHL-0655-C50_treatment3,9d67b042-d1ba-4319-ba58-bc1ce0394462,,released,Doxorubicin,1,2021-12-21T14:14:23.961730-06:00,Chemotherapy,Residual Disease,
HCM-CSHL-0655-C50,66f2f8d4-f8e2-4bb6-93e1-3edd7c5a3b48,2935a4d9-979a-4507-841b-afc4ba3458ee,,Adjuvant,,2023-11-07T14:28:29.403873-06:00,HCM-CSHL-0655-C50_treatment6,deee9815-fc54-4cc2-a0ff-396890069c64,,released,,0,2021-12-21T14:14:23.961730-06:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-CSHL-0655-C50,66f2f8d4-f8e2-4bb6-93e1-3edd7c5a3b48,2935a4d9-979a-4507-841b-afc4ba3458ee,,Adjuvant,,2023-11-07T14:28:29.403873-06:00,HCM-CSHL-0655-C50_treatment8,e808a7cf-01db-410d-89f6-b7ca3a4dd9ea,,released,,0,2021-12-21T14:14:23.961730-06:00,Targeted Molecular Therapy,Residual Disease,
HCM-CSHL-0655-C50,66f2f8d4-f8e2-4bb6-93e1-3edd7c5a3b48,2935a4d9-979a-4507-841b-afc4ba3458ee,169.0,Adjuvant,113.0,2023-11-07T14:28:29.403873-06:00,HCM-CSHL-0655-C50_treatment4,f860252a-d032-495a-a221-34920fe88f3c,,released,Paclitaxel,1,2021-12-21T14:14:23.961730-06:00,Chemotherapy,Residual Disease,
HCM-CSHL-0655-C50,66f2f8d4-f8e2-4bb6-93e1-3edd7c5a3b48,f67a4a87-2095-4972-bb29-797c331de34d,,Prevention,,2023-11-07T14:28:29.403873-06:00,HCM-CSHL-0655-C50_treatment11,34bd3b16-425f-42d0-8148-7b7b1a19f86d,,released,,0,2021-12-21T14:14:23.961730-06:00,Hormone Therapy,,
HCM-CSHL-0243-C18,6767fba3-9c1f-4df7-9f2b-2461d8f99d51,db11e998-792e-49ad-9105-97996ca3a7a6,,Adjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0243-C18_treatment3,022c0fd2-f688-4dc7-9db4-68739d12b41e,,released,,0,2020-09-28T09:25:38.761011-05:00,"Pharmaceutical Therapy, NOS",Residual Disease,
HCM-CSHL-0243-C18,6767fba3-9c1f-4df7-9f2b-2461d8f99d51,db11e998-792e-49ad-9105-97996ca3a7a6,,Neoadjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0243-C18_treatment,4159a650-c8c1-4169-a648-c8c8ce955bcf,,released,,0,2020-09-28T09:25:38.761011-05:00,,,
HCM-CSHL-0243-C18,6767fba3-9c1f-4df7-9f2b-2461d8f99d51,db11e998-792e-49ad-9105-97996ca3a7a6,,Adjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0243-C18_treatment4,4a99591b-3106-477b-843c-5a58a61c4089,,released,,0,2020-09-28T09:25:38.761011-05:00,"Radiation Therapy, NOS",Residual Disease,
HCM-CSHL-0243-C18,6767fba3-9c1f-4df7-9f2b-2461d8f99d51,db11e998-792e-49ad-9105-97996ca3a7a6,,,42.0,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0243-C18_treatment2,b5fdd9f8-812b-40d3-96a4-c793c58b87c3,,released,,1,2020-09-28T09:25:38.761011-05:00,"Surgery, NOS",Initial Diagnosis,
HCM-STAN-1277-C55,6784de63-5d64-4203-9e17-336202359820,7624ba62-bbfc-433f-9ee5-3c13b60a6f9d,252.0,Adjuvant,39.0,2025-04-07T17:13:09.336794-05:00,HCM-STAN-1277-C55_treatment2,06e19576-f43a-4352-803b-d66cde5084f0,,released,Paclitaxel,1,2023-01-03T13:01:07.483192-06:00,Chemotherapy,Residual Disease,
HCM-STAN-1277-C55,6784de63-5d64-4203-9e17-336202359820,7624ba62-bbfc-433f-9ee5-3c13b60a6f9d,,,0.0,2025-04-07T17:13:09.336794-05:00,HCM-STAN-1277-C55_treatment6,2b6766e5-8afc-4546-9694-971b90322c99,,released,,1,2023-01-03T13:01:07.483192-06:00,"Surgery, NOS",Initial Diagnosis,
HCM-STAN-1277-C55,6784de63-5d64-4203-9e17-336202359820,7624ba62-bbfc-433f-9ee5-3c13b60a6f9d,252.0,Adjuvant,39.0,2025-04-07T17:13:09.336794-05:00,HCM-STAN-1277-C55_treatment3,57362a2b-220d-4637-8d11-06f66625cf70,,released,Carboplatin,1,2023-01-03T13:01:07.483192-06:00,Chemotherapy,Residual Disease,
HCM-STAN-1277-C55,6784de63-5d64-4203-9e17-336202359820,7624ba62-bbfc-433f-9ee5-3c13b60a6f9d,,Neoadjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-STAN-1277-C55_treatment,5fd00747-3498-470f-b0e8-5f8e4a649927,,released,,0,2023-01-03T13:01:07.483192-06:00,,,
HCM-STAN-1277-C55,6784de63-5d64-4203-9e17-336202359820,7624ba62-bbfc-433f-9ee5-3c13b60a6f9d,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-STAN-1277-C55_treatment5,7d0e5e9f-6122-4d35-b257-bd44ac569086,,released,,0,2023-01-03T13:01:07.483192-06:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-STAN-1277-C55,6784de63-5d64-4203-9e17-336202359820,7624ba62-bbfc-433f-9ee5-3c13b60a6f9d,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-STAN-1277-C55_treatment7,7ed871c6-1e47-4ef9-9b0b-47568681c2c2,,released,,0,2023-01-03T13:01:07.483192-06:00,Targeted Molecular Therapy,Residual Disease,
HCM-STAN-1277-C55,6784de63-5d64-4203-9e17-336202359820,7624ba62-bbfc-433f-9ee5-3c13b60a6f9d,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-STAN-1277-C55_treatment4,a10361b6-2f59-4da3-9946-216c2ac5cff6,,released,,0,2023-01-03T13:01:07.483192-06:00,Hormone Therapy,Residual Disease,
HCM-STAN-1277-C55,6784de63-5d64-4203-9e17-336202359820,7624ba62-bbfc-433f-9ee5-3c13b60a6f9d,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-STAN-1277-C55_treatment8,f056b8d4-f2c6-4474-8198-c891be29f470,,released,,0,2023-01-03T13:01:07.483192-06:00,"Radiation Therapy, NOS",Residual Disease,
HCM-CSHL-0091-C25,6796ddd8-0295-4965-911c-d4ad67232d13,9f1ffa4a-0aa8-4bc7-8226-79b2896a04b9,,Adjuvant,600.0,2020-10-08T19:08:57.989157-05:00,HCM-CSHL-0091-C25_treatment7,24318916-859c-4a73-8c66-ea172b8b2eda,Treatment Ongoing,released,Leucovorin Calcium,1,2020-03-26T12:47:31.001478-05:00,Chemotherapy,Residual Disease,
HCM-CSHL-0091-C25,6796ddd8-0295-4965-911c-d4ad67232d13,9f1ffa4a-0aa8-4bc7-8226-79b2896a04b9,,Adjuvant,600.0,2020-10-08T19:08:57.989157-05:00,HCM-CSHL-0091-C25_treatment8,32385bd7-3859-4127-9173-ece06cb75368,Treatment Ongoing,released,Fluorouracil,1,2020-03-26T12:47:31.001478-05:00,Chemotherapy,Residual Disease,
HCM-CSHL-0091-C25,6796ddd8-0295-4965-911c-d4ad67232d13,9f1ffa4a-0aa8-4bc7-8226-79b2896a04b9,,Adjuvant,,2020-10-20T19:20:06.800740-05:00,HCM-CSHL-0091-C25_treatment11,4a3232e6-c4cb-4a5e-8e71-7510b099880b,,released,,0,2020-10-08T19:08:57.989157-05:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-CSHL-0091-C25,6796ddd8-0295-4965-911c-d4ad67232d13,9f1ffa4a-0aa8-4bc7-8226-79b2896a04b9,392.0,Adjuvant,300.0,2020-06-15T12:08:36.760818-05:00,HCM-CSHL-0091-C25_treatment4,4b302d47-db01-44d7-857d-126f35cfeaef,,released,Gemcitabine,1,2020-02-11T14:42:16.450679-06:00,Chemotherapy,Residual Disease,
HCM-CSHL-0091-C25,6796ddd8-0295-4965-911c-d4ad67232d13,9f1ffa4a-0aa8-4bc7-8226-79b2896a04b9,,Adjuvant,,2020-10-20T19:20:06.800740-05:00,HCM-CSHL-0091-C25_treatment14,86085982-d4de-4cc2-bdd5-47b687f9fa0b,,released,,1,2020-10-08T19:08:57.989157-05:00,"Radiation Therapy, NOS",Residual Disease,
HCM-CSHL-0091-C25,6796ddd8-0295-4965-911c-d4ad67232d13,9f1ffa4a-0aa8-4bc7-8226-79b2896a04b9,,Neoadjuvant,,2020-03-26T16:04:47.706904-05:00,HCM-CSHL-0091-C25_treatment,877b5843-564b-4525-8643-b7fb1380a18b,,released,,0,2020-02-11T14:42:16.450679-06:00,,,
HCM-CSHL-0091-C25,6796ddd8-0295-4965-911c-d4ad67232d13,9f1ffa4a-0aa8-4bc7-8226-79b2896a04b9,139.0,Adjuvant,27.0,2020-03-26T16:04:47.706904-05:00,HCM-CSHL-0091-C25_treatment3,89d614b1-252a-43bf-88a2-a7a5158ac317,,released,Capecitabine,1,2020-02-11T14:42:16.450679-06:00,Chemotherapy,Residual Disease,
HCM-CSHL-0091-C25,6796ddd8-0295-4965-911c-d4ad67232d13,9f1ffa4a-0aa8-4bc7-8226-79b2896a04b9,,,-7.0,2023-02-27T12:37:26.482115-06:00,HCM-CSHL-0091-C25_treatment12,8a6ec1ed-0f2a-4545-aad4-f10263ce3946,,released,,1,2020-10-08T19:08:57.989157-05:00,"Surgery, NOS",Initial Diagnosis,
HCM-CSHL-0091-C25,6796ddd8-0295-4965-911c-d4ad67232d13,9f1ffa4a-0aa8-4bc7-8226-79b2896a04b9,,Adjuvant,600.0,2020-10-20T19:20:06.800740-05:00,HCM-CSHL-0091-C25_treatment10,94cd4188-dc4b-46e3-80df-f513f1b946b1,Treatment Ongoing,released,,1,2020-10-08T19:08:57.989157-05:00,Chemotherapy,Residual Disease,FOLFIRINOX
HCM-CSHL-0091-C25,6796ddd8-0295-4965-911c-d4ad67232d13,9f1ffa4a-0aa8-4bc7-8226-79b2896a04b9,392.0,Adjuvant,300.0,2020-06-15T12:08:36.760818-05:00,HCM-CSHL-0091-C25_treatment5,9ed48989-68bf-4a0d-a63e-e5997c57860f,,released,Nab-paclitaxel,1,2020-02-11T14:42:16.450679-06:00,Chemotherapy,Residual Disease,
HCM-CSHL-0091-C25,6796ddd8-0295-4965-911c-d4ad67232d13,9f1ffa4a-0aa8-4bc7-8226-79b2896a04b9,,Adjuvant,600.0,2020-10-08T19:08:57.989157-05:00,HCM-CSHL-0091-C25_treatment6,a166afc8-a92a-4095-a1c0-26adb0da49e7,Treatment Ongoing,released,Irinotecan Hydrochloride,1,2020-02-11T14:42:16.450679-06:00,Chemotherapy,Residual Disease,
HCM-CSHL-0091-C25,6796ddd8-0295-4965-911c-d4ad67232d13,9f1ffa4a-0aa8-4bc7-8226-79b2896a04b9,,Adjuvant,,2020-10-20T19:20:06.800740-05:00,HCM-CSHL-0091-C25_treatment13,a349fbef-69c6-4c70-9b16-bb106ce7f2c3,,released,,0,2020-10-08T19:08:57.989157-05:00,Targeted Molecular Therapy,Residual Disease,
HCM-CSHL-0091-C25,6796ddd8-0295-4965-911c-d4ad67232d13,9f1ffa4a-0aa8-4bc7-8226-79b2896a04b9,,Adjuvant,600.0,2020-10-20T19:20:06.800740-05:00,HCM-CSHL-0091-C25_treatment9,a3746a99-c151-4565-b29e-b3d0fe3e4140,Treatment Ongoing,released,Oxaliplatin,1,2020-10-08T19:08:57.989157-05:00,Chemotherapy,Residual Disease,
HCM-CSHL-0091-C25,6796ddd8-0295-4965-911c-d4ad67232d13,9f1ffa4a-0aa8-4bc7-8226-79b2896a04b9,139.0,Adjuvant,27.0,2020-03-26T16:04:47.706904-05:00,HCM-CSHL-0091-C25_treatment2,baec325b-3d17-49ee-830a-40f6afeac77d,,released,Gemcitabine,1,2020-02-11T14:42:16.450679-06:00,Chemotherapy,Residual Disease,
HCM-CSHL-0238-C18,67e3c17e-e524-4681-8162-99742c802256,0d48a2dd-33e1-47f1-a05d-6d2611a9b0a1,,,4.0,2023-03-13T12:56:55.371895-05:00,HCM-CSHL-0238-C18_treatment2,ae259239-30d4-4da4-8994-94784569829c,,released,,1,2020-02-27T12:49:49.846763-06:00,"Surgery, NOS",Initial Diagnosis,
HCM-CSHL-0238-C18,67e3c17e-e524-4681-8162-99742c802256,0d48a2dd-33e1-47f1-a05d-6d2611a9b0a1,,Neoadjuvant,,2020-10-20T19:20:06.800740-05:00,HCM-CSHL-0238-C18_treatment,c25d5bea-8e07-4fb3-84af-25261c2be3d0,,released,,0,2020-02-27T12:49:49.846763-06:00,,,
HCM-EXPT-1041-C18,6816430e-41fe-4c8b-b56d-125efc074b3a,c9e2b358-1efb-4a7e-8b99-a93b7f84274d,,Neoadjuvant,,2025-10-08T12:38:06.952582-05:00,HCM-EXPT-1041-C18_treatment,331dea94-7b74-45ce-aa49-7a6ce3100ee4,,released,,0,2021-12-21T14:59:59.818304-06:00,,,
HCM-EXPT-0888-C25,6837697e-c58e-45f2-8f07-7b3ba9d7a8de,52f3f0e9-a833-4c93-a10a-0ce0959ed839,,Neoadjuvant,,2025-10-08T12:36:32.654639-05:00,HCM-EXPT-0888-C25_treatment,1eb5d078-5311-4314-8742-965d74195e3c,,released,,0,2021-12-21T14:42:12.774420-06:00,,,
HCM-EXPT-1256-C15,685b40df-128b-406b-b253-baa413fd43eb,434a3f04-0fec-4a09-8a62-ef69d1442c14,,Neoadjuvant,,2025-10-08T12:39:59.137357-05:00,HCM-EXPT-1256-C15_treatment,53bbb42b-6d73-4c79-9665-25b2ed43361e,,released,,0,2023-02-24T14:05:21.842991-06:00,,,
HCM-CSHL-0372-C25,68fda2a7-baf4-4bba-90ff-9ebd35b71a4b,39867bea-5718-45ef-a23f-0c2517e8b4be,,,-12.0,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0372-C25_treatment2,2c270401-ea77-4916-87fe-ad0cd20724c9,,released,,1,2020-09-28T09:54:13.372132-05:00,"Surgery, NOS",Initial Diagnosis,
HCM-CSHL-0372-C25,68fda2a7-baf4-4bba-90ff-9ebd35b71a4b,39867bea-5718-45ef-a23f-0c2517e8b4be,,Neoadjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0372-C25_treatment,4f2475d7-8c51-4c30-a200-940848919786,,released,,0,2020-09-28T09:54:13.372132-05:00,,,
HCM-CSHL-0372-C25,68fda2a7-baf4-4bba-90ff-9ebd35b71a4b,39867bea-5718-45ef-a23f-0c2517e8b4be,,Adjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0372-C25_treatment4,6c15ed23-bffd-4fcd-8413-ddcd7aee1355,,released,,0,2020-09-28T09:54:13.372132-05:00,"Radiation Therapy, NOS",Residual Disease,
HCM-CSHL-0372-C25,68fda2a7-baf4-4bba-90ff-9ebd35b71a4b,39867bea-5718-45ef-a23f-0c2517e8b4be,,Adjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0372-C25_treatment3,6cbd74b5-aa9f-4a5b-8d2b-20b6d5292b10,,released,,0,2020-09-28T09:54:13.372132-05:00,"Pharmaceutical Therapy, NOS",Residual Disease,
HCM-EXPT-1044-C50,692d8c0b-9657-403a-8d93-b0fd6ce8d0f0,8a1a27df-9fbb-4cbe-83e5-be975ef4b83a,,Neoadjuvant,,2025-10-08T12:38:06.952582-05:00,HCM-EXPT-1044-C50_treatment,1288802b-5118-4e8f-8b07-865dc77af016,,released,,1,2021-12-21T15:01:18.187828-06:00,Hormone Therapy,,
HCM-CSHL-0371-C25,69b4a2cd-dc6f-4413-bdb4-b6f44ff8677f,439a8ccc-7812-4292-98b5-38b78f1e448f,,,-6.0,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0371-C25_treatment2,76d8dbf3-d831-441e-b20d-143b149a7382,,released,,1,2020-09-28T09:54:23.248510-05:00,"Surgery, NOS",Initial Diagnosis,
HCM-CSHL-0371-C25,69b4a2cd-dc6f-4413-bdb4-b6f44ff8677f,439a8ccc-7812-4292-98b5-38b78f1e448f,,Neoadjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0371-C25_treatment,861ce86e-6d7a-4717-aefa-cf31b93654fb,,released,,0,2020-09-28T09:54:23.248510-05:00,,,
HCM-BROD-0011-C71,69eced5b-1e76-45c9-bc9c-2aa71a921c57,7b142a98-5022-43e9-bcbb-647d3b28b308,69.0,Adjuvant,27.0,2022-09-09T16:33:51.233314-05:00,HCM-BROD-0011-C71_treatment10,012d6d85-7bf7-4ff6-9947-11b95e13c21a,,released,,1,2019-04-04T14:14:00.900831-05:00,"Radiation Therapy, NOS",Residual Disease,
HCM-BROD-0011-C71,69eced5b-1e76-45c9-bc9c-2aa71a921c57,7b142a98-5022-43e9-bcbb-647d3b28b308,,Neoadjuvant,,2022-09-09T16:33:51.233314-05:00,HCM-BROD-0011-C71_treatment,3714a756-2832-4a31-83ca-bc9da41361a9,,released,,0,2019-03-12T10:13:02.718709-05:00,,,
HCM-BROD-0011-C71,69eced5b-1e76-45c9-bc9c-2aa71a921c57,7b142a98-5022-43e9-bcbb-647d3b28b308,109.0,Adjuvant,109.0,2022-09-09T16:33:51.233314-05:00,HCM-BROD-0011-C71_treatment3,5c0296c6-e15a-4b7c-9a8a-451acef6a59b,,released,Temozolomide,1,2019-04-04T14:14:00.900831-05:00,Chemotherapy,Residual Disease,
HCM-BROD-0011-C71,69eced5b-1e76-45c9-bc9c-2aa71a921c57,7b142a98-5022-43e9-bcbb-647d3b28b308,144.0,Adjuvant,144.0,2022-09-09T16:33:51.233314-05:00,HCM-BROD-0011-C71_treatment5,74e7a791-4e10-4ba6-87e9-9f77b3dc5626,,released,Temozolomide,1,2019-04-04T14:14:00.900831-05:00,Chemotherapy,Residual Disease,
HCM-BROD-0011-C71,69eced5b-1e76-45c9-bc9c-2aa71a921c57,7b142a98-5022-43e9-bcbb-647d3b28b308,295.0,Adjuvant,239.0,2022-09-09T16:33:51.233314-05:00,HCM-BROD-0011-C71_treatment6,7c146a16-0ca3-4e22-8e9d-bdbe56ee4b73,,released,Irinotecan,1,2019-04-04T14:14:00.900831-05:00,Chemotherapy,Residual Disease,
HCM-BROD-0011-C71,69eced5b-1e76-45c9-bc9c-2aa71a921c57,7b142a98-5022-43e9-bcbb-647d3b28b308,,Adjuvant,,2022-09-09T16:33:51.233314-05:00,HCM-BROD-0011-C71_treatment7,7f0626d7-30f0-4f27-b1f9-a67e4df3a1e2,,released,,0,2019-04-04T14:14:00.900831-05:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-BROD-0011-C71,69eced5b-1e76-45c9-bc9c-2aa71a921c57,7b142a98-5022-43e9-bcbb-647d3b28b308,295.0,Adjuvant,216.0,2022-09-09T16:33:51.233314-05:00,HCM-BROD-0011-C71_treatment9,8eebccaf-7619-427a-97aa-6edb7c9ad1f2,,released,Bevacizumab,1,2019-04-04T14:14:00.900831-05:00,Targeted Molecular Therapy,Residual Disease,
HCM-BROD-0011-C71,69eced5b-1e76-45c9-bc9c-2aa71a921c57,7b142a98-5022-43e9-bcbb-647d3b28b308,69.0,Adjuvant,50.0,2022-09-09T16:33:51.233314-05:00,HCM-BROD-0011-C71_treatment2,ba69b647-695d-474a-b721-b7b30d759bd0,,released,Temozolomide,1,2019-04-04T14:14:00.900831-05:00,Chemotherapy,Residual Disease,
HCM-BROD-0011-C71,69eced5b-1e76-45c9-bc9c-2aa71a921c57,7b142a98-5022-43e9-bcbb-647d3b28b308,137.0,Adjuvant,137.0,2022-09-09T16:33:51.233314-05:00,HCM-BROD-0011-C71_treatment4,f6c77d78-52af-4de1-ae5c-b977faecd05c,,released,Temozolomide,1,2019-04-04T14:14:00.900831-05:00,Chemotherapy,Residual Disease,
HCM-BROD-0011-C71,69eced5b-1e76-45c9-bc9c-2aa71a921c57,7b142a98-5022-43e9-bcbb-647d3b28b308,,,-7.0,2023-03-15T10:53:43.774863-05:00,HCM-BROD-0011-C71_treatment8,ff608e4f-1813-4adc-b589-b8a4105f46d4,,released,,1,2019-04-04T14:14:00.900831-05:00,"Surgery, NOS",Initial Diagnosis,
HCM-SANG-0539-C18,6a5157d6-cdb8-42e1-ab48-6d354be62b44,6d476ae2-253b-4bbd-92f6-3cdea9071f8c,,Neoadjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-SANG-0539-C18_treatment,ff38c272-560f-4049-81e4-7667906fe742,,released,,0,2023-02-27T13:31:22.819448-06:00,,,
HCM-CSHL-0093-C25,6a8427ec-14cc-4168-a536-12c8ad27ba89,07bfbd03-b5de-4615-90be-d1c8c90e7a7f,193.0,Adjuvant,37.0,2020-10-20T19:20:06.800740-05:00,HCM-CSHL-0093-C25_treatment2,0b8ea714-d930-4b03-9990-8d13fbb5fcda,,released,Gemcitabine,1,2020-02-27T12:45:56.146309-06:00,Chemotherapy,Residual Disease,
HCM-CSHL-0093-C25,6a8427ec-14cc-4168-a536-12c8ad27ba89,07bfbd03-b5de-4615-90be-d1c8c90e7a7f,193.0,Adjuvant,37.0,2020-10-20T19:20:06.800740-05:00,HCM-CSHL-0093-C25_treatment3,3588a38f-8d9e-451d-a3ac-9f3ed758494a,,released,Nab-paclitaxel,1,2020-02-27T12:45:56.146309-06:00,Chemotherapy,Residual Disease,
HCM-CSHL-0093-C25,6a8427ec-14cc-4168-a536-12c8ad27ba89,07bfbd03-b5de-4615-90be-d1c8c90e7a7f,,Adjuvant,,2020-10-20T19:20:06.800740-05:00,HCM-CSHL-0093-C25_treatment7,3b67243e-dc30-4b79-b835-a42964ce9a8e,,released,,0,2020-06-15T09:54:41.762402-05:00,"Radiation Therapy, NOS",Residual Disease,
HCM-CSHL-0093-C25,6a8427ec-14cc-4168-a536-12c8ad27ba89,07bfbd03-b5de-4615-90be-d1c8c90e7a7f,,Adjuvant,,2020-10-20T19:20:06.800740-05:00,HCM-CSHL-0093-C25_treatment4,3b78473b-f1ba-4c47-9760-e9d6f589c89c,,released,,0,2020-02-27T12:45:56.146309-06:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-CSHL-0093-C25,6a8427ec-14cc-4168-a536-12c8ad27ba89,07bfbd03-b5de-4615-90be-d1c8c90e7a7f,,Neoadjuvant,,2020-10-20T19:20:06.800740-05:00,HCM-CSHL-0093-C25_treatment,5da20016-933e-40b0-905a-158750049f65,,released,,0,2020-02-27T12:45:56.146309-06:00,,,
HCM-CSHL-0093-C25,6a8427ec-14cc-4168-a536-12c8ad27ba89,07bfbd03-b5de-4615-90be-d1c8c90e7a7f,,,-15.0,2023-02-27T12:14:17.015540-06:00,HCM-CSHL-0093-C25_treatment5,a718ca0b-9286-4911-8586-4d8b7c903a98,,released,,1,2020-02-27T12:45:56.146309-06:00,"Surgery, NOS",Initial Diagnosis,
HCM-CSHL-0093-C25,6a8427ec-14cc-4168-a536-12c8ad27ba89,07bfbd03-b5de-4615-90be-d1c8c90e7a7f,,Adjuvant,,2020-10-20T19:20:06.800740-05:00,HCM-CSHL-0093-C25_treatment6,cd0e06ae-4434-4b71-8a92-d60c869375af,,released,,0,2020-02-27T12:45:56.146309-06:00,Targeted Molecular Therapy,Residual Disease,
HCM-BROD-0013-C71,6a9d7152-bc4b-4137-ada9-5b8a50121482,bdc93ab2-6a09-4315-805a-aded5a7c4e03,,,-15.0,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0013-C71_treatment2,230565da-fe83-42cc-9f52-6d99bc1a557e,,released,,1,2020-02-27T12:08:23.501334-06:00,"Surgery, NOS",Initial Diagnosis,
HCM-BROD-0013-C71,6a9d7152-bc4b-4137-ada9-5b8a50121482,bdc93ab2-6a09-4315-805a-aded5a7c4e03,,Neoadjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0013-C71_treatment,477cfa5a-a312-4aa1-b56a-56c7edad4751,,released,,0,2019-04-04T14:41:36.734325-05:00,,,
HCM-BROD-0013-C71,6a9d7152-bc4b-4137-ada9-5b8a50121482,bdc93ab2-6a09-4315-805a-aded5a7c4e03,,Adjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0013-C71_treatment4,73bd116f-fd1c-4ba4-8008-e61135f031fd,,released,,0,2020-02-27T12:08:23.501334-06:00,"Radiation Therapy, NOS",Residual Disease,
HCM-BROD-0013-C71,6a9d7152-bc4b-4137-ada9-5b8a50121482,bdc93ab2-6a09-4315-805a-aded5a7c4e03,,Adjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0013-C71_treatment3,c715cf05-0c7b-4a09-b9bc-479540935f61,,released,,0,2020-02-27T12:08:23.501334-06:00,"Pharmaceutical Therapy, NOS",Residual Disease,
HCM-BROD-0236-C34,6ae8e01b-bcff-44c1-ad03-b354aae0d7d5,797b5b6d-f990-4608-baf2-fee902249f7f,363.0,Adjuvant,340.0,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0236-C34_treatment4,059f0393-65c2-48e2-83ea-e951be215dd9,,released,,1,2019-04-04T15:17:12.952975-05:00,Stereotactic Radiosurgery,Residual Disease,
HCM-BROD-0236-C34,6ae8e01b-bcff-44c1-ad03-b354aae0d7d5,797b5b6d-f990-4608-baf2-fee902249f7f,,,25.0,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0236-C34_treatment2,61e5d1d8-be5f-46f7-b467-a573cb37d12d,,released,,1,2019-04-04T15:17:12.952975-05:00,"Surgery, NOS",Initial Diagnosis,
HCM-BROD-0236-C34,6ae8e01b-bcff-44c1-ad03-b354aae0d7d5,797b5b6d-f990-4608-baf2-fee902249f7f,,Adjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0236-C34_treatment3,a3d506aa-ec0c-419d-acde-c01e5a224b37,,released,,0,2019-04-04T15:17:12.952975-05:00,"Pharmaceutical Therapy, NOS",Residual Disease,
HCM-BROD-0236-C34,6ae8e01b-bcff-44c1-ad03-b354aae0d7d5,797b5b6d-f990-4608-baf2-fee902249f7f,,Neoadjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0236-C34_treatment,aae923d2-4b41-4e99-8935-c6be2a2c91fa,,released,,0,2019-04-04T15:17:12.952975-05:00,,,
HCM-CSHL-0857-C19,6b69e46e-41af-4709-a04a-74474f32ba34,38216e73-0e92-4afe-8f0d-e4c071336298,,Neoadjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0857-C19_treatment4,1927c919-efc4-42e6-91f0-e34468c1d514,,released,,1,2021-12-21T14:34:47.554758-06:00,Chemotherapy,,FOLFOX
HCM-CSHL-0857-C19,6b69e46e-41af-4709-a04a-74474f32ba34,38216e73-0e92-4afe-8f0d-e4c071336298,,Neoadjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0857-C19_treatment3,41fbd431-60cb-48d5-94fa-244e012ee563,,released,Oxaliplatin,1,2021-12-21T14:34:47.554758-06:00,Chemotherapy,,
HCM-CSHL-0857-C19,6b69e46e-41af-4709-a04a-74474f32ba34,38216e73-0e92-4afe-8f0d-e4c071336298,,Neoadjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0857-C19_treatment,7ae1409e-da89-4d9b-b44c-a9a54df3c04b,,released,Leucovorin Calcium,1,2021-12-21T14:34:47.554758-06:00,Chemotherapy,,
HCM-CSHL-0857-C19,6b69e46e-41af-4709-a04a-74474f32ba34,38216e73-0e92-4afe-8f0d-e4c071336298,,Neoadjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0857-C19_treatment5,9242ff3f-469f-4d73-b5e8-bfb03a7438b0,,released,Cetuximab,1,2021-12-21T14:34:47.554758-06:00,Chemotherapy,,
HCM-CSHL-0857-C19,6b69e46e-41af-4709-a04a-74474f32ba34,38216e73-0e92-4afe-8f0d-e4c071336298,,,97.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0857-C19_treatment6,bbf0bc54-fb74-4a9f-847b-eff5ffc91ac6,,released,,1,2021-12-21T14:34:47.554758-06:00,"Surgery, NOS",Initial Diagnosis,
HCM-CSHL-0857-C19,6b69e46e-41af-4709-a04a-74474f32ba34,38216e73-0e92-4afe-8f0d-e4c071336298,,Neoadjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0857-C19_treatment2,c8743404-4e54-4b31-9c36-e2bb51e51897,,released,Fluorouracil,1,2021-12-21T14:34:47.554758-06:00,Chemotherapy,,
HCM-CSHL-1097-C18,6bbc3ea9-7cd3-4526-9d1e-bacab5b50d42,b45467bc-065f-424e-8b6d-795bf7016885,,Neoadjuvant,26.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-1097-C18_treatment6,07485a38-31f3-441d-b699-2b26d0057663,,released,,1,2021-12-21T14:38:58.240418-06:00,Chemotherapy,,FOLFOX
HCM-CSHL-1097-C18,6bbc3ea9-7cd3-4526-9d1e-bacab5b50d42,b45467bc-065f-424e-8b6d-795bf7016885,,,,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-1097-C18_treatment7,1c46413b-33de-4e27-9c99-a5183e87cde8,,released,,0,2021-12-21T14:38:58.240418-06:00,"Surgery, NOS",Initial Diagnosis,
HCM-CSHL-1097-C18,6bbc3ea9-7cd3-4526-9d1e-bacab5b50d42,b45467bc-065f-424e-8b6d-795bf7016885,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-1097-C18_treatment9,35c971b7-3858-4d7a-9763-c776340a07c7,,released,,0,2021-12-21T14:38:58.240418-06:00,"Radiation Therapy, NOS",Residual Disease,
HCM-CSHL-1097-C18,6bbc3ea9-7cd3-4526-9d1e-bacab5b50d42,b45467bc-065f-424e-8b6d-795bf7016885,,Neoadjuvant,26.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-1097-C18_treatment4,41edf2ca-ed4f-416a-940c-b1288099c970,,released,,1,2021-12-21T14:38:58.240418-06:00,Chemotherapy,,FOLFIRI
HCM-CSHL-1097-C18,6bbc3ea9-7cd3-4526-9d1e-bacab5b50d42,b45467bc-065f-424e-8b6d-795bf7016885,,Neoadjuvant,26.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-1097-C18_treatment3,76ba8cf4-4fb4-4a6d-9d08-7a5a0c5a10c7,,released,Irinotecan,1,2021-12-21T14:38:58.240418-06:00,Chemotherapy,,
HCM-CSHL-1097-C18,6bbc3ea9-7cd3-4526-9d1e-bacab5b50d42,b45467bc-065f-424e-8b6d-795bf7016885,,Neoadjuvant,26.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-1097-C18_treatment5,8905917b-516d-435c-b567-d29964f74379,,released,Oxaliplatin,1,2021-12-21T14:38:58.240418-06:00,Chemotherapy,,
HCM-CSHL-1097-C18,6bbc3ea9-7cd3-4526-9d1e-bacab5b50d42,b45467bc-065f-424e-8b6d-795bf7016885,,Neoadjuvant,26.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-1097-C18_treatment,8d9066aa-171b-42ec-a8fd-624af552ce53,,released,Leucovorin Calcium,1,2021-12-21T14:38:58.240418-06:00,Chemotherapy,,
HCM-CSHL-1097-C18,6bbc3ea9-7cd3-4526-9d1e-bacab5b50d42,b45467bc-065f-424e-8b6d-795bf7016885,,Neoadjuvant,26.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-1097-C18_treatment2,f7b5e905-6547-4d46-a1d8-44e7a649f4f4,,released,Fluorouracil,1,2021-12-21T14:38:58.240418-06:00,Chemotherapy,,
HCM-CSHL-1097-C18,6bbc3ea9-7cd3-4526-9d1e-bacab5b50d42,b45467bc-065f-424e-8b6d-795bf7016885,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-1097-C18_treatment8,fd4aeeb6-aac8-438a-8af5-018ff3e8a087,,released,,0,2021-12-21T14:38:58.240418-06:00,"Pharmaceutical Therapy, NOS",Residual Disease,
HCM-CSHL-0736-C18,6bcd339d-a1fb-469e-aab7-9621ede29188,821657aa-415b-44eb-b0d4-c9f9849cc53f,728.0,Adjuvant,605.0,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0736-C18_treatment4,012821f6-4dff-489b-8055-dcc13e9dd9f8,,released,Oxaliplatin,1,2021-12-21T14:21:07.435329-06:00,Chemotherapy,Residual Disease,
HCM-CSHL-0736-C18,6bcd339d-a1fb-469e-aab7-9621ede29188,821657aa-415b-44eb-b0d4-c9f9849cc53f,,,7.0,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0736-C18_treatment7,189d7860-1c01-4a72-a9a9-6e3324288a19,,released,,1,2021-12-21T14:21:07.435329-06:00,"Surgery, NOS",Initial Diagnosis,
HCM-CSHL-0736-C18,6bcd339d-a1fb-469e-aab7-9621ede29188,821657aa-415b-44eb-b0d4-c9f9849cc53f,728.0,Adjuvant,605.0,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0736-C18_treatment5,1adb6de7-5795-44cb-b398-8dabe4405ef5,,released,,1,2021-12-21T14:21:07.435329-06:00,Chemotherapy,Residual Disease,FOLFOX
HCM-CSHL-0736-C18,6bcd339d-a1fb-469e-aab7-9621ede29188,821657aa-415b-44eb-b0d4-c9f9849cc53f,848.0,Adjuvant,788.0,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0736-C18_treatment10,1dc4d260-1816-41d8-9e2b-c971b75895b7,,released,,1,2021-12-21T14:21:07.435329-06:00,"Radiation Therapy, NOS",Residual Disease,
HCM-CSHL-0736-C18,6bcd339d-a1fb-469e-aab7-9621ede29188,821657aa-415b-44eb-b0d4-c9f9849cc53f,728.0,Adjuvant,605.0,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0736-C18_treatment2,8ce466c6-74cb-4b9c-a6ce-03493ee6051a,,released,Leucovorin Calcium,1,2021-12-21T14:21:07.435329-06:00,Chemotherapy,Residual Disease,
HCM-CSHL-0736-C18,6bcd339d-a1fb-469e-aab7-9621ede29188,821657aa-415b-44eb-b0d4-c9f9849cc53f,,,1559.0,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0736-C18_treatment8,abe69758-e85e-4143-bc0b-6b60178588a8,,released,,1,2021-12-21T14:21:07.435329-06:00,"Surgery, NOS",Initial Diagnosis,
HCM-CSHL-0736-C18,6bcd339d-a1fb-469e-aab7-9621ede29188,821657aa-415b-44eb-b0d4-c9f9849cc53f,,Adjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0736-C18_treatment6,bda8848e-b2fb-470a-ad91-dc428e90e315,,released,,0,2021-12-21T14:21:07.435329-06:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-CSHL-0736-C18,6bcd339d-a1fb-469e-aab7-9621ede29188,821657aa-415b-44eb-b0d4-c9f9849cc53f,,Neoadjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0736-C18_treatment,d18f7a35-c9b2-41a4-ba26-c819dac88bfd,,released,,0,2021-12-21T14:21:07.435329-06:00,,,
HCM-CSHL-0736-C18,6bcd339d-a1fb-469e-aab7-9621ede29188,821657aa-415b-44eb-b0d4-c9f9849cc53f,728.0,Adjuvant,605.0,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0736-C18_treatment9,f53cd436-8864-4c65-8b09-f5b859ddfb08,,released,Bevacizumab,1,2021-12-21T14:21:07.435329-06:00,Targeted Molecular Therapy,Residual Disease,
HCM-CSHL-0736-C18,6bcd339d-a1fb-469e-aab7-9621ede29188,821657aa-415b-44eb-b0d4-c9f9849cc53f,728.0,Adjuvant,605.0,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0736-C18_treatment3,f875be68-6158-4620-b47b-f8742ca0d36c,,released,Fluorouracil,1,2021-12-21T14:21:07.435329-06:00,Chemotherapy,Residual Disease,
HCM-CSHL-0736-C18,6bcd339d-a1fb-469e-aab7-9621ede29188,adace733-853a-4b41-9423-01fdd760f5a9,,Maintenance Therapy,,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0736-C18_treatment13,1fbcdaba-96a2-42f7-acd4-beabae835e1f,Stable Disease,released,Leucovorin Calcium,1,2021-12-21T14:21:07.435329-06:00,,,
HCM-CSHL-0736-C18,6bcd339d-a1fb-469e-aab7-9621ede29188,adace733-853a-4b41-9423-01fdd760f5a9,,Maintenance Therapy,,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0736-C18_treatment11,5dcab3c3-ae2b-4c84-9d80-d1817e680376,Stable Disease,released,Bevacizumab,1,2021-12-21T14:21:07.435329-06:00,,,
HCM-CSHL-0736-C18,6bcd339d-a1fb-469e-aab7-9621ede29188,adace733-853a-4b41-9423-01fdd760f5a9,,Maintenance Therapy,,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0736-C18_treatment15,5fd1610b-9029-4c2f-b1eb-afb491e2fd07,Stable Disease,released,,1,2021-12-21T14:21:07.435329-06:00,,,FOLFOX
HCM-CSHL-0736-C18,6bcd339d-a1fb-469e-aab7-9621ede29188,adace733-853a-4b41-9423-01fdd760f5a9,,Maintenance Therapy,,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0736-C18_treatment14,744a8f0e-dedf-4c15-8e94-b235fd4d7458,Stable Disease,released,Fluorouracil,1,2021-12-21T14:21:07.435329-06:00,,,
HCM-CSHL-0736-C18,6bcd339d-a1fb-469e-aab7-9621ede29188,adace733-853a-4b41-9423-01fdd760f5a9,,Maintenance Therapy,,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0736-C18_treatment12,da0898c2-28bc-4345-b172-23e3cbb1d7bb,Stable Disease,released,Oxaliplatin,1,2021-12-21T14:21:07.435329-06:00,,,
HCM-EXPT-0991-C18,6c31694d-800f-4d63-89f5-25e47393836c,a32c4efb-18b4-4d9c-af6a-aaa132f34349,,Neoadjuvant,,2025-10-08T12:37:21.548354-05:00,HCM-EXPT-0991-C18_treatment,21f5c41d-d6b3-4a34-8c2f-3ec4d4ee1618,,released,,0,2021-12-21T14:52:18.771003-06:00,,,
HCM-CSHL-0657-C25,6cb73e78-c352-4fed-b206-5eabc02a5045,f4b747b4-fa26-4c13-a56b-b5a96b961f93,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0657-C25_treatment2,0e7ae9dd-99c3-470d-a9fd-db2709c4fef0,,released,,0,2021-12-21T14:15:11.353788-06:00,Chemotherapy,Residual Disease,
HCM-CSHL-0657-C25,6cb73e78-c352-4fed-b206-5eabc02a5045,f4b747b4-fa26-4c13-a56b-b5a96b961f93,,,,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0657-C25_treatment4,140682fe-d3d9-499e-ab6f-4db30864afbb,,released,,0,2021-12-21T14:15:11.353788-06:00,"Surgery, NOS",Initial Diagnosis,
HCM-CSHL-0657-C25,6cb73e78-c352-4fed-b206-5eabc02a5045,f4b747b4-fa26-4c13-a56b-b5a96b961f93,,Neoadjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0657-C25_treatment,61365c0f-4145-4543-8e95-3b717145cdc9,,released,,0,2021-12-21T14:15:11.353788-06:00,,,
HCM-CSHL-0657-C25,6cb73e78-c352-4fed-b206-5eabc02a5045,f4b747b4-fa26-4c13-a56b-b5a96b961f93,132.0,Adjuvant,37.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0657-C25_treatment3,a34409e8-b3c6-4df7-99d5-ceb5e7920227,,released,Lanreotide Acetate,1,2021-12-21T14:15:11.353788-06:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-CSHL-0657-C25,6cb73e78-c352-4fed-b206-5eabc02a5045,f4b747b4-fa26-4c13-a56b-b5a96b961f93,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0657-C25_treatment5,a619c0a7-6463-437b-8118-6981896c2c42,,released,,0,2021-12-21T14:15:11.353788-06:00,Targeted Molecular Therapy,Residual Disease,
HCM-CSHL-0657-C25,6cb73e78-c352-4fed-b206-5eabc02a5045,f4b747b4-fa26-4c13-a56b-b5a96b961f93,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0657-C25_treatment6,b3ec5309-596c-4eef-ac66-dbed0dd2b356,,released,,0,2021-12-21T14:15:11.353788-06:00,"Radiation Therapy, NOS",Residual Disease,
HCM-EXPT-0989-C34,6cf32442-8c7e-4681-a098-2aef3592e33a,112f2dc9-1e61-4458-9324-07da7371f8ec,,Neoadjuvant,,2025-10-08T12:37:21.548354-05:00,HCM-EXPT-0989-C34_treatment,56ecebc6-5e27-4027-857e-227429b7601d,,released,,0,2021-12-21T14:50:46.484679-06:00,,,
HCM-EXPT-1014-C50,6cfb3fbb-7dae-4626-8977-a53b2097c576,6ced5620-376a-4c5e-b619-9b436e3863e9,,Neoadjuvant,,2025-10-08T12:37:43.816130-05:00,HCM-EXPT-1014-C50_treatment,64faff73-2fe0-4e88-a789-235be78d27f1,,released,,0,2021-12-21T14:56:03.058020-06:00,,,
HCM-SANG-0295-C15,6d0825eb-bac2-45be-9f2a-58f6bacba2ef,64a26b2d-d713-4353-847a-dde195cb5c6b,,Neoadjuvant,,2023-02-22T07:39:25.979291-06:00,HCM-SANG-0295-C15_treatment,5aacfa37-ded6-4b00-bfdb-e31d2a232b60,,released,,0,2020-02-27T12:53:09.114302-06:00,,,
HCM-BROD-0557-C43,6ded7d89-1235-4b52-90aa-52c57c669301,4e02019a-674d-49a1-9d7c-af3daeaec684,,Adjuvant,,2021-09-10T10:36:37.981324-05:00,HCM-BROD-0557-C43_treatment4,09866f72-9c1f-4f96-90f6-5974a0039125,,released,,0,2021-09-07T08:30:04.904922-05:00,Hormone Therapy,Residual Disease,
HCM-BROD-0557-C43,6ded7d89-1235-4b52-90aa-52c57c669301,4e02019a-674d-49a1-9d7c-af3daeaec684,,Adjuvant,,2021-09-10T10:36:37.981324-05:00,HCM-BROD-0557-C43_treatment8,52187edc-e125-43e9-9857-fb3baa7f2578,,released,,0,2021-09-07T08:30:04.904922-05:00,Targeted Molecular Therapy,Residual Disease,
HCM-BROD-0557-C43,6ded7d89-1235-4b52-90aa-52c57c669301,4e02019a-674d-49a1-9d7c-af3daeaec684,738.0,Adjuvant,299.0,2021-09-10T10:36:37.981324-05:00,HCM-BROD-0557-C43_treatment6,82496790-d5c0-4c4e-a763-38e6d83ebb25,Treatment Ongoing,released,Ipilimumab,1,2021-09-07T08:30:04.904922-05:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-BROD-0557-C43,6ded7d89-1235-4b52-90aa-52c57c669301,4e02019a-674d-49a1-9d7c-af3daeaec684,,Neoadjuvant,354.0,2021-09-07T08:30:04.904922-05:00,HCM-BROD-0557-C43_treatment2,9bf1b7df-bfd9-4821-83bc-2d0602b38c34,,released,Nivolumab,1,2021-03-11T14:30:11.765496-06:00,Immunotherapy (Including Vaccines),,
HCM-BROD-0557-C43,6ded7d89-1235-4b52-90aa-52c57c669301,4e02019a-674d-49a1-9d7c-af3daeaec684,13.0,Adjuvant,6.0,2021-09-10T10:36:37.981324-05:00,HCM-BROD-0557-C43_treatment9,ac9605d8-a15b-4458-9172-7c0e8e14511b,,released,,1,2021-09-07T08:30:04.904922-05:00,"Radiation, Stereotactic/Gamma Knife/SRS",Residual Disease,
HCM-BROD-0557-C43,6ded7d89-1235-4b52-90aa-52c57c669301,4e02019a-674d-49a1-9d7c-af3daeaec684,,Neoadjuvant,354.0,2021-09-07T08:30:04.904922-05:00,HCM-BROD-0557-C43_treatment,b37af2a6-fd8e-4bb3-bf7d-bd768b3c98a9,,released,Ipilimumab,1,2021-03-11T14:30:11.765496-06:00,Immunotherapy (Including Vaccines),,
HCM-BROD-0557-C43,6ded7d89-1235-4b52-90aa-52c57c669301,4e02019a-674d-49a1-9d7c-af3daeaec684,,Adjuvant,,2021-09-10T10:36:37.981324-05:00,HCM-BROD-0557-C43_treatment3,de43e6b4-0568-4f05-8676-dbf25b346f4a,,released,,0,2021-09-07T08:30:04.904922-05:00,Chemotherapy,Residual Disease,
HCM-BROD-0557-C43,6ded7d89-1235-4b52-90aa-52c57c669301,4e02019a-674d-49a1-9d7c-af3daeaec684,149.0,Adjuvant,54.0,2021-09-10T10:36:37.981324-05:00,HCM-BROD-0557-C43_treatment5,f975a98c-a9b6-461d-9b4b-6bedef640c81,Treatment Ongoing,released,Nivolumab,1,2021-09-07T08:30:04.904922-05:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-EXPT-1234-C20,6df83b7c-a2f4-462c-bf4e-91423fda6553,326395ce-7b21-43f1-a3e4-7f4cfee002ef,,Neoadjuvant,,2025-10-08T12:39:14.406630-05:00,HCM-EXPT-1234-C20_treatment,ebe3f84e-cffd-420e-9bde-b92fa0383c82,,released,,unknown,2023-02-24T14:07:04.201253-06:00,"Pharmaceutical Therapy, NOS",,
HCM-EXPT-1234-C20,6df83b7c-a2f4-462c-bf4e-91423fda6553,326395ce-7b21-43f1-a3e4-7f4cfee002ef,,Neoadjuvant,,2025-10-08T12:39:37.798161-05:00,HCM-EXPT-1234-C20_treatment2,fc53f1ea-f6d3-4db9-a0bf-480074c41dc8,,released,,unknown,2023-02-24T14:07:04.201253-06:00,"Radiation Therapy, NOS",,
HCM-CSHL-0405-C25,6e3a1f73-d16b-4dc8-acc2-ae452eec1bbd,f665edcb-a441-4485-babe-ddd368efed1a,,Neoadjuvant,23.0,2023-07-13T10:35:44.371881-05:00,HCM-CSHL-0405-C25_treatment5,06ff7940-960b-49d9-bb23-9ce794c126b7,,released,,1,2020-09-28T10:02:28.555012-05:00,Chemotherapy,,FOLFIRINOX
HCM-CSHL-0405-C25,6e3a1f73-d16b-4dc8-acc2-ae452eec1bbd,f665edcb-a441-4485-babe-ddd368efed1a,,Neoadjuvant,23.0,2023-07-13T10:35:44.371881-05:00,HCM-CSHL-0405-C25_treatment3,727f2cec-631e-4244-919e-55df5bf0477d,,released,Fluorouracil,1,2020-09-28T10:02:28.555012-05:00,Chemotherapy,,
HCM-CSHL-0405-C25,6e3a1f73-d16b-4dc8-acc2-ae452eec1bbd,f665edcb-a441-4485-babe-ddd368efed1a,,Neoadjuvant,23.0,2023-07-13T10:35:44.371881-05:00,HCM-CSHL-0405-C25_treatment2,816532d7-02d0-47d6-ad1c-adeb0952619f,,released,Leucovorin Calcium,1,2020-09-28T10:02:28.555012-05:00,Chemotherapy,,
HCM-CSHL-0405-C25,6e3a1f73-d16b-4dc8-acc2-ae452eec1bbd,f665edcb-a441-4485-babe-ddd368efed1a,,Neoadjuvant,23.0,2023-07-13T10:35:44.371881-05:00,HCM-CSHL-0405-C25_treatment4,cb78324d-5752-478f-9734-00bc7280b68d,,released,Oxaliplatin,1,2020-09-28T10:02:28.555012-05:00,Chemotherapy,,
HCM-CSHL-0405-C25,6e3a1f73-d16b-4dc8-acc2-ae452eec1bbd,f665edcb-a441-4485-babe-ddd368efed1a,,Adjuvant,,2023-07-13T10:35:44.371881-05:00,HCM-CSHL-0405-C25_treatment8,cd6907e7-e91f-455d-8a9f-e166d5e9952f,,released,,0,2020-09-28T10:02:28.555012-05:00,"Radiation Therapy, NOS",Residual Disease,
HCM-CSHL-0405-C25,6e3a1f73-d16b-4dc8-acc2-ae452eec1bbd,f665edcb-a441-4485-babe-ddd368efed1a,,Adjuvant,,2023-07-13T10:35:44.371881-05:00,HCM-CSHL-0405-C25_treatment7,dea6492b-16a6-4d98-89b6-5a40ed39d3d1,,released,,0,2020-09-28T10:02:28.555012-05:00,"Pharmaceutical Therapy, NOS",Residual Disease,
HCM-CSHL-0405-C25,6e3a1f73-d16b-4dc8-acc2-ae452eec1bbd,f665edcb-a441-4485-babe-ddd368efed1a,,,162.0,2023-07-13T10:35:44.371881-05:00,HCM-CSHL-0405-C25_treatment6,e4148282-ebda-4d3e-8f90-943bb2da3be1,,released,,1,2020-09-28T10:02:28.555012-05:00,"Surgery, NOS",Initial Diagnosis,
HCM-CSHL-0405-C25,6e3a1f73-d16b-4dc8-acc2-ae452eec1bbd,f665edcb-a441-4485-babe-ddd368efed1a,,Neoadjuvant,23.0,2023-07-13T10:35:44.371881-05:00,HCM-CSHL-0405-C25_treatment,f52bedd2-70ec-4126-a4aa-9c5eb875ecb2,,released,Irinotecan Hydrochloride,1,2020-09-28T10:02:28.555012-05:00,Chemotherapy,,
HCM-WCMC-0491-C16,6e757d59-1eb2-4f38-b662-f3f543ba5844,a1e3f4b9-1a5e-4d3c-b470-d276d1c27b4b,1128.0,Adjuvant,962.0,2023-07-13T10:35:44.371881-05:00,HCM-WCMC-0491-C16_treatment19,0015cff5-3037-4c9e-b470-000ae3833457,,released,Trastuzumab,1,2023-02-27T11:45:33.310572-06:00,Targeted Molecular Therapy,Residual Disease,
HCM-WCMC-0491-C16,6e757d59-1eb2-4f38-b662-f3f543ba5844,a1e3f4b9-1a5e-4d3c-b470-d276d1c27b4b,619.0,Adjuvant,374.0,2023-07-13T10:35:44.371881-05:00,HCM-WCMC-0491-C16_treatment13,15cdd3d5-4a4e-424f-8fa5-094cff8de316,,released,Capecitabine,1,2023-02-27T11:45:33.310572-06:00,Chemotherapy,Residual Disease,
HCM-WCMC-0491-C16,6e757d59-1eb2-4f38-b662-f3f543ba5844,a1e3f4b9-1a5e-4d3c-b470-d276d1c27b4b,360.0,Adjuvant,234.0,2023-07-13T10:35:44.371881-05:00,HCM-WCMC-0491-C16_treatment12,1fd50b18-b5fa-4554-a9be-a59e6e6d2c10,,released,,1,2023-02-27T11:45:33.310572-06:00,Chemotherapy,Residual Disease,FU-LV regimen
HCM-WCMC-0491-C16,6e757d59-1eb2-4f38-b662-f3f543ba5844,a1e3f4b9-1a5e-4d3c-b470-d276d1c27b4b,1182.0,Adjuvant,1177.0,2023-07-13T10:35:44.371881-05:00,HCM-WCMC-0491-C16_treatment8,31fe0d35-4cb6-4104-9ffd-3977a73ee914,,released,Oxaliplatin,1,2023-02-27T11:45:33.310572-06:00,Chemotherapy,Residual Disease,
HCM-WCMC-0491-C16,6e757d59-1eb2-4f38-b662-f3f543ba5844,a1e3f4b9-1a5e-4d3c-b470-d276d1c27b4b,1182.0,Adjuvant,1177.0,2023-07-13T10:35:44.371881-05:00,HCM-WCMC-0491-C16_treatment6,36e8166f-276d-4fe3-b13e-a1d0705fdc16,,released,Leucovorin Calcium,1,2023-02-27T11:45:33.310572-06:00,Chemotherapy,Residual Disease,
HCM-WCMC-0491-C16,6e757d59-1eb2-4f38-b662-f3f543ba5844,a1e3f4b9-1a5e-4d3c-b470-d276d1c27b4b,1046.0,Adjuvant,962.0,2023-07-13T10:35:44.371881-05:00,HCM-WCMC-0491-C16_treatment14,40daa11e-f6ac-4193-971b-24e0ea6245a9,,released,Fluorouracil,1,2023-02-27T11:45:33.310572-06:00,Chemotherapy,Residual Disease,
HCM-WCMC-0491-C16,6e757d59-1eb2-4f38-b662-f3f543ba5844,a1e3f4b9-1a5e-4d3c-b470-d276d1c27b4b,,Neoadjuvant,15.0,2023-07-13T10:35:44.371881-05:00,HCM-WCMC-0491-C16_treatment3,694cac2a-412c-45d7-a26e-b01c3ffc731d,,released,Oxaliplatin,1,2023-02-27T11:45:33.310572-06:00,Chemotherapy,,
HCM-WCMC-0491-C16,6e757d59-1eb2-4f38-b662-f3f543ba5844,a1e3f4b9-1a5e-4d3c-b470-d276d1c27b4b,1182.0,Adjuvant,1177.0,2023-07-13T10:35:44.371881-05:00,HCM-WCMC-0491-C16_treatment17,8556264f-dd96-428a-9fe0-83cfa619bd52,,released,Trastuzumab,1,2023-02-27T11:45:33.310572-06:00,Targeted Molecular Therapy,Residual Disease,
HCM-WCMC-0491-C16,6e757d59-1eb2-4f38-b662-f3f543ba5844,a1e3f4b9-1a5e-4d3c-b470-d276d1c27b4b,,Adjuvant,,2023-07-13T10:35:44.371881-05:00,HCM-WCMC-0491-C16_treatment15,9547fa50-4da2-43db-9638-c8c8ec0e0de1,,released,,0,2023-02-27T11:45:33.310572-06:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-WCMC-0491-C16,6e757d59-1eb2-4f38-b662-f3f543ba5844,a1e3f4b9-1a5e-4d3c-b470-d276d1c27b4b,360.0,Adjuvant,234.0,2023-07-13T10:35:44.371881-05:00,HCM-WCMC-0491-C16_treatment10,9955ac39-ebe3-4379-a7a7-2749a3338ed9,,released,Leucovorin,1,2023-02-27T11:45:33.310572-06:00,Chemotherapy,Residual Disease,
HCM-WCMC-0491-C16,6e757d59-1eb2-4f38-b662-f3f543ba5844,a1e3f4b9-1a5e-4d3c-b470-d276d1c27b4b,619.0,Adjuvant,374.0,2023-07-13T10:35:44.371881-05:00,HCM-WCMC-0491-C16_treatment18,aa6e413a-a152-484e-a8e7-b192c4dbcd10,,released,Trastuzumab,1,2023-02-27T11:45:33.310572-06:00,Targeted Molecular Therapy,Residual Disease,
HCM-WCMC-0491-C16,6e757d59-1eb2-4f38-b662-f3f543ba5844,a1e3f4b9-1a5e-4d3c-b470-d276d1c27b4b,,,730.0,2023-07-13T10:35:44.371881-05:00,HCM-WCMC-0491-C16_treatment16,af60960b-b3c7-466c-aec0-7719100ebeab,,released,,1,2023-02-27T11:45:33.310572-06:00,"Surgery, NOS",Initial Diagnosis,
HCM-WCMC-0491-C16,6e757d59-1eb2-4f38-b662-f3f543ba5844,a1e3f4b9-1a5e-4d3c-b470-d276d1c27b4b,1182.0,Adjuvant,1177.0,2023-07-13T10:35:44.371881-05:00,HCM-WCMC-0491-C16_treatment7,bbf0c34e-9c41-487f-a6ce-b00c37545c0f,,released,Fluorouracil,1,2023-02-27T11:45:33.310572-06:00,Chemotherapy,Residual Disease,
HCM-WCMC-0491-C16,6e757d59-1eb2-4f38-b662-f3f543ba5844,a1e3f4b9-1a5e-4d3c-b470-d276d1c27b4b,,Neoadjuvant,15.0,2023-07-13T10:35:44.371881-05:00,HCM-WCMC-0491-C16_treatment5,d4859560-7973-46a7-83f7-ab0cfab9b1da,,released,,1,2023-02-27T11:45:33.310572-06:00,Chemotherapy,,FOLFOX
HCM-WCMC-0491-C16,6e757d59-1eb2-4f38-b662-f3f543ba5844,a1e3f4b9-1a5e-4d3c-b470-d276d1c27b4b,1182.0,Adjuvant,1177.0,2023-07-13T10:35:44.371881-05:00,HCM-WCMC-0491-C16_treatment9,d5b3f6a9-1c86-4866-b6f6-f352bab4931f,,released,,1,2023-02-27T11:45:33.310572-06:00,Chemotherapy,Residual Disease,FOLFOX
HCM-WCMC-0491-C16,6e757d59-1eb2-4f38-b662-f3f543ba5844,a1e3f4b9-1a5e-4d3c-b470-d276d1c27b4b,,Neoadjuvant,15.0,2023-07-13T10:35:44.371881-05:00,HCM-WCMC-0491-C16_treatment2,d8cf418a-98cb-4e5d-bdcc-d36a0aceed4e,,released,Fluorouracil,1,2023-02-27T11:45:33.310572-06:00,Chemotherapy,,
HCM-WCMC-0491-C16,6e757d59-1eb2-4f38-b662-f3f543ba5844,a1e3f4b9-1a5e-4d3c-b470-d276d1c27b4b,,Neoadjuvant,15.0,2023-07-13T10:35:44.371881-05:00,HCM-WCMC-0491-C16_treatment4,e63a508c-59e0-4c31-8a30-b25adc6b1653,,released,Trastuzumab,1,2023-02-27T11:45:33.310572-06:00,Chemotherapy,,
HCM-WCMC-0491-C16,6e757d59-1eb2-4f38-b662-f3f543ba5844,a1e3f4b9-1a5e-4d3c-b470-d276d1c27b4b,1182.0,Adjuvant,1177.0,2023-07-13T10:35:44.371881-05:00,HCM-WCMC-0491-C16_treatment20,ed2df4c8-ef2c-4575-b472-10a64432ae60,,released,,1,2023-02-27T11:45:33.310572-06:00,"Radiation Therapy, NOS",Residual Disease,
HCM-WCMC-0491-C16,6e757d59-1eb2-4f38-b662-f3f543ba5844,a1e3f4b9-1a5e-4d3c-b470-d276d1c27b4b,,Neoadjuvant,15.0,2023-07-13T10:35:44.371881-05:00,HCM-WCMC-0491-C16_treatment,f5553dbf-9e2a-4621-b8d3-8ca9f3996d2d,,released,Leucovorin Calcium,1,2023-02-27T11:45:33.310572-06:00,Chemotherapy,,
HCM-WCMC-0491-C16,6e757d59-1eb2-4f38-b662-f3f543ba5844,a1e3f4b9-1a5e-4d3c-b470-d276d1c27b4b,360.0,Adjuvant,234.0,2023-07-13T10:35:44.371881-05:00,HCM-WCMC-0491-C16_treatment11,fab5f0b0-35ae-4fc6-89e7-b061ea4a8076,,released,Fluorouracil,1,2023-02-27T11:45:33.310572-06:00,Chemotherapy,Residual Disease,
HCM-CSHL-0585-C06,6ea6550b-389d-416f-ab43-f532c5afcc94,7b6353a5-d434-45b0-b842-5dd542028862,,,29.0,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0585-C06_treatment5,1a37e1e9-747d-43a5-818a-515de0411a37,,released,,1,2020-10-08T13:35:18.675146-05:00,"Surgery, NOS",Initial Diagnosis,
HCM-CSHL-0585-C06,6ea6550b-389d-416f-ab43-f532c5afcc94,7b6353a5-d434-45b0-b842-5dd542028862,,Neoadjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0585-C06_treatment,1a462939-a9bb-4e5f-9480-3248b091f34d,,released,,0,2020-10-08T13:35:18.675146-05:00,,,
HCM-CSHL-0585-C06,6ea6550b-389d-416f-ab43-f532c5afcc94,7b6353a5-d434-45b0-b842-5dd542028862,,Adjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0585-C06_treatment4,2e4a3f74-a294-40f5-9628-1b6aa8ee493f,,released,,0,2020-10-08T13:35:18.675146-05:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-CSHL-0585-C06,6ea6550b-389d-416f-ab43-f532c5afcc94,7b6353a5-d434-45b0-b842-5dd542028862,,Adjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0585-C06_treatment6,51f21d0d-d50f-410c-aeb6-d54816e7bf8e,,released,,0,2020-10-08T13:35:18.675146-05:00,Targeted Molecular Therapy,Residual Disease,
HCM-CSHL-0585-C06,6ea6550b-389d-416f-ab43-f532c5afcc94,7b6353a5-d434-45b0-b842-5dd542028862,,Adjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0585-C06_treatment7,97b35105-d817-4ee7-97cc-623397ffb378,,released,,0,2020-10-08T13:35:18.675146-05:00,"Radiation Therapy, NOS",Residual Disease,
HCM-CSHL-0585-C06,6ea6550b-389d-416f-ab43-f532c5afcc94,7b6353a5-d434-45b0-b842-5dd542028862,96.0,Adjuvant,72.0,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0585-C06_treatment2,c3e1fea2-7a15-44f9-995a-80ea9526b275,,released,Cisplatin,1,2020-10-08T13:35:18.675146-05:00,Chemotherapy,Residual Disease,
HCM-CSHL-0585-C06,6ea6550b-389d-416f-ab43-f532c5afcc94,7b6353a5-d434-45b0-b842-5dd542028862,,Adjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0585-C06_treatment3,e6dcbda6-59be-44e6-ba16-b22aa94f29e8,,released,,0,2020-10-08T13:35:18.675146-05:00,Hormone Therapy,Residual Disease,
HCM-EXPT-0938-C50,6eb81662-642e-473e-b035-60b69ef223ad,73e0dd22-a244-4303-a649-614ca5770ad7,,Neoadjuvant,,2025-10-08T12:36:57.024699-05:00,HCM-EXPT-0938-C50_treatment,ebe98c3e-48dd-4d95-b09b-02218fa9ff4d,,released,,0,2021-12-21T14:46:52.727540-06:00,,,
HCM-CSHL-0509-C24,6ecd59ce-a391-4187-87a3-a69a71919585,78385db4-82a6-4b0a-95dc-9e2365b19a69,,Adjuvant,,2023-03-13T12:40:26.862946-05:00,HCM-CSHL-0509-C24_treatment4,570976af-6989-4e6d-9617-d35d36c6185d,,released,,0,2021-12-21T14:06:19.428202-06:00,"Radiation Therapy, NOS",Residual Disease,
HCM-CSHL-0509-C24,6ecd59ce-a391-4187-87a3-a69a71919585,78385db4-82a6-4b0a-95dc-9e2365b19a69,,Neoadjuvant,,2023-02-22T07:39:25.979291-06:00,HCM-CSHL-0509-C24_treatment,a76be820-9071-43ad-8e35-eccbaa132c75,,released,,0,2021-12-21T14:06:19.428202-06:00,,,
HCM-CSHL-0509-C24,6ecd59ce-a391-4187-87a3-a69a71919585,78385db4-82a6-4b0a-95dc-9e2365b19a69,,Adjuvant,,2023-03-13T12:40:26.862946-05:00,HCM-CSHL-0509-C24_treatment3,c391dea6-1ce2-44e4-9f1a-5e42b42ebc62,,released,,0,2021-12-21T14:06:19.428202-06:00,"Pharmaceutical Therapy, NOS",Residual Disease,
HCM-CSHL-0509-C24,6ecd59ce-a391-4187-87a3-a69a71919585,78385db4-82a6-4b0a-95dc-9e2365b19a69,,,-13.0,2023-03-13T12:40:26.862946-05:00,HCM-CSHL-0509-C24_treatment2,fa945718-2cff-4767-9a1a-96b736fac40f,,released,,1,2021-12-21T14:06:19.428202-06:00,"Surgery, NOS",Initial Diagnosis,
HCM-BROD-1122-C49,6f991912-1110-4ba2-9c63-078ee2bd6b59,458fd285-796b-4c0b-b38c-9ba26cb110fa,,Neoadjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-BROD-1122-C49_treatment,9c6f01cb-580b-4beb-bcaa-2de43b909c6f,,released,,0,2021-12-21T14:01:27.654348-06:00,,,
HCM-BROD-1122-C49,6f991912-1110-4ba2-9c63-078ee2bd6b59,458fd285-796b-4c0b-b38c-9ba26cb110fa,,,40.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-1122-C49_treatment2,adc25186-056d-4a0f-9c03-3d8fcee3a832,,released,,1,2021-12-21T14:01:27.654348-06:00,"Surgery, NOS",Initial Diagnosis,
HCM-BROD-1122-C49,6f991912-1110-4ba2-9c63-078ee2bd6b59,458fd285-796b-4c0b-b38c-9ba26cb110fa,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-BROD-1122-C49_treatment4,dfeb9c70-d4b8-4191-81f9-2dd4564416fb,,released,,0,2021-12-21T14:01:27.654348-06:00,"Radiation Therapy, NOS",Residual Disease,
HCM-BROD-1122-C49,6f991912-1110-4ba2-9c63-078ee2bd6b59,458fd285-796b-4c0b-b38c-9ba26cb110fa,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-BROD-1122-C49_treatment3,f9ea92de-73cd-48cb-8363-60ea01b5dbd5,,released,,0,2021-12-21T14:01:27.654348-06:00,"Pharmaceutical Therapy, NOS",Residual Disease,
HCM-EXPT-1071-C50,6f9bbecc-fea5-4a66-b311-41dfb8956b8f,349b030a-d753-4cdc-8ca7-a8ce708b610a,,Neoadjuvant,,2025-10-08T12:38:28.988690-05:00,HCM-EXPT-1071-C50_treatment,0f1344d1-c41e-4f56-8199-6f2eaccd7e83,,released,,0,2021-12-21T15:03:40.876430-06:00,,,
HCM-BROD-0220-C15,6fd2c09d-e1d8-4cb8-bd86-39fa5d1c0cd5,bfbf99d5-d984-4c5b-aa22-8a8f007c4f56,,Neoadjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0220-C15_treatment,37a92ed1-fbc2-4cd9-9231-59e5b55c5957,,released,,0,2019-04-04T16:03:09.368016-05:00,,,
HCM-BROD-0220-C15,6fd2c09d-e1d8-4cb8-bd86-39fa5d1c0cd5,bfbf99d5-d984-4c5b-aa22-8a8f007c4f56,226.0,Adjuvant,14.0,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0220-C15_treatment6,74a75c47-86c6-45fb-99f1-f3235851176e,,released,Trastuzumab,1,2019-04-04T16:03:09.368016-05:00,Targeted Molecular Therapy,Residual Disease,
HCM-BROD-0220-C15,6fd2c09d-e1d8-4cb8-bd86-39fa5d1c0cd5,bfbf99d5-d984-4c5b-aa22-8a8f007c4f56,226.0,Adjuvant,14.0,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0220-C15_treatment3,8f79909b-48cf-48aa-9fbf-2f72c69b1c9c,,released,Oxaliplatin,1,2019-04-04T16:03:09.368016-05:00,Chemotherapy,Residual Disease,
HCM-BROD-0220-C15,6fd2c09d-e1d8-4cb8-bd86-39fa5d1c0cd5,bfbf99d5-d984-4c5b-aa22-8a8f007c4f56,226.0,Adjuvant,14.0,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0220-C15_treatment2,b593d98c-1c0e-428f-9c1b-6428c9a7e111,,released,Fluorouracil,1,2019-04-04T16:03:09.368016-05:00,Chemotherapy,Residual Disease,
HCM-BROD-0220-C15,6fd2c09d-e1d8-4cb8-bd86-39fa5d1c0cd5,bfbf99d5-d984-4c5b-aa22-8a8f007c4f56,,,-3.0,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0220-C15_treatment5,c192b6f5-5a4d-4422-84f5-876dbd22c2a3,,released,,1,2019-04-04T16:03:09.368016-05:00,"Surgery, NOS",Initial Diagnosis,
HCM-BROD-0220-C15,6fd2c09d-e1d8-4cb8-bd86-39fa5d1c0cd5,bfbf99d5-d984-4c5b-aa22-8a8f007c4f56,,Adjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0220-C15_treatment7,da70fec4-38dd-477a-bbc7-10f7b931be8f,,released,,0,2020-09-27T11:02:16.043743-05:00,"Radiation Therapy, NOS",Residual Disease,
HCM-BROD-0220-C15,6fd2c09d-e1d8-4cb8-bd86-39fa5d1c0cd5,bfbf99d5-d984-4c5b-aa22-8a8f007c4f56,,Adjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0220-C15_treatment4,eb42a841-3365-455b-a0b6-540cb601fda0,,released,,0,2019-04-04T16:03:09.368016-05:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-CSHL-0177-C25,6fd57448-daf9-4d8c-9cbc-88e53b246932,419f63d2-a093-43eb-a1c0-a3ec42f1577a,,,-12.0,2023-02-27T13:35:25.883698-06:00,HCM-CSHL-0177-C25_treatment4,118a7f2e-1530-4a1a-9dee-35b7c42a6eb9,,released,,1,2020-09-28T09:13:10.234692-05:00,"Surgery, NOS",Initial Diagnosis,
HCM-CSHL-0177-C25,6fd57448-daf9-4d8c-9cbc-88e53b246932,419f63d2-a093-43eb-a1c0-a3ec42f1577a,,Adjuvant,,2023-02-22T07:39:25.979291-06:00,HCM-CSHL-0177-C25_treatment3,3c60877d-ac74-47d0-8e51-cccc472431c8,,released,,0,2020-09-28T09:13:10.234692-05:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-CSHL-0177-C25,6fd57448-daf9-4d8c-9cbc-88e53b246932,419f63d2-a093-43eb-a1c0-a3ec42f1577a,285.0,Adjuvant,223.0,2023-02-22T07:39:25.979291-06:00,HCM-CSHL-0177-C25_treatment6,9d5a0644-bc74-4298-ad72-1a858af0cc9d,,released,,1,2020-09-28T09:13:10.234692-05:00,"Radiation Therapy, NOS",Residual Disease,
HCM-CSHL-0177-C25,6fd57448-daf9-4d8c-9cbc-88e53b246932,419f63d2-a093-43eb-a1c0-a3ec42f1577a,,Adjuvant,40.0,2023-02-22T07:39:25.979291-06:00,HCM-CSHL-0177-C25_treatment2,c2c4b472-0499-4b5a-afa7-4844f5f639ba,,released,Gemcitabine,1,2020-09-28T09:13:10.234692-05:00,Chemotherapy,Residual Disease,
HCM-CSHL-0177-C25,6fd57448-daf9-4d8c-9cbc-88e53b246932,419f63d2-a093-43eb-a1c0-a3ec42f1577a,,Adjuvant,,2023-02-22T07:39:25.979291-06:00,HCM-CSHL-0177-C25_treatment5,cafd8ac8-a376-4738-9059-d42d71f6ef3d,,released,,0,2020-09-28T09:13:10.234692-05:00,Targeted Molecular Therapy,Residual Disease,
HCM-CSHL-0177-C25,6fd57448-daf9-4d8c-9cbc-88e53b246932,419f63d2-a093-43eb-a1c0-a3ec42f1577a,,Neoadjuvant,,2023-02-22T07:39:25.979291-06:00,HCM-CSHL-0177-C25_treatment,e2861960-f18a-4270-af8f-8ffa67032cc7,,released,,0,2020-09-28T09:13:10.234692-05:00,,,
HCM-SANG-0525-C18,6fe93402-3532-42bf-9df9-981213da81f8,6f510377-afa0-4475-ba8a-2e35d35c25fe,,Neoadjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-SANG-0525-C18_treatment,c60b3e12-e3de-4022-b1f0-7297e526b26c,,released,,0,2023-02-27T12:00:18.574983-06:00,,,
HCM-SANG-0534-C18,708cf1d9-3214-469b-9530-715fa4d41352,420058fd-c4a1-4d8c-81fd-effbd912cc55,,Neoadjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-SANG-0534-C18_treatment,085af3b2-36a1-435e-9081-e936cb1d86a6,,released,,0,2021-12-21T15:15:03.850895-06:00,,,
HCM-BROD-0096-C15,70e98240-6f6d-4d45-bb10-566ea820e5de,b5087abb-360a-4c0c-8a19-76c4d4178ca2,,Adjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0096-C15_treatment7,1b1a93bc-ee56-42f6-8e07-992e8dfa28ee,,released,,0,2020-09-27T10:21:35.786095-05:00,"Radiation Therapy, NOS",Residual Disease,
HCM-BROD-0096-C15,70e98240-6f6d-4d45-bb10-566ea820e5de,b5087abb-360a-4c0c-8a19-76c4d4178ca2,,Adjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0096-C15_treatment6,498539a4-859f-4e49-836f-7eaf78718e62,,released,,0,2020-09-27T10:21:35.786095-05:00,Targeted Molecular Therapy,Residual Disease,
HCM-BROD-0096-C15,70e98240-6f6d-4d45-bb10-566ea820e5de,b5087abb-360a-4c0c-8a19-76c4d4178ca2,,,126.0,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0096-C15_treatment5,b8a301c3-b38a-4a7c-9404-0b216d311b8d,,released,,1,2020-09-27T10:21:35.786095-05:00,"Surgery, NOS",Initial Diagnosis,
HCM-BROD-0096-C15,70e98240-6f6d-4d45-bb10-566ea820e5de,b5087abb-360a-4c0c-8a19-76c4d4178ca2,,Adjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0096-C15_treatment3,c24611aa-d301-4204-be31-683215346ccd,,released,,0,2020-09-27T10:21:35.786095-05:00,Chemotherapy,Residual Disease,
HCM-BROD-0096-C15,70e98240-6f6d-4d45-bb10-566ea820e5de,b5087abb-360a-4c0c-8a19-76c4d4178ca2,,Adjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0096-C15_treatment4,c8bfb08b-6f77-4bf4-a6bb-c8b37465af3a,,released,,0,2020-09-27T10:21:35.786095-05:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-BROD-0781-C71,711f0482-0800-4f18-962f-1d35f9d30727,719c55ae-9cce-4c25-ae68-58b355c4fbea,,Adjuvant,,2023-11-07T14:20:00.017270-06:00,HCM-BROD-0781-C71_treatment3,011aab10-8f00-4985-9dbb-efd91c1f8db0,,released,,0,2021-12-21T13:50:58.029147-06:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-BROD-0781-C71,711f0482-0800-4f18-962f-1d35f9d30727,719c55ae-9cce-4c25-ae68-58b355c4fbea,,,-14.0,2023-11-07T14:20:00.017270-06:00,HCM-BROD-0781-C71_treatment4,1570b448-977f-4906-b702-bfd1861b723d,,released,,1,2021-12-21T13:50:58.029147-06:00,"Surgery, NOS",Initial Diagnosis,
HCM-BROD-0781-C71,711f0482-0800-4f18-962f-1d35f9d30727,719c55ae-9cce-4c25-ae68-58b355c4fbea,194.0,Adjuvant,105.0,2024-04-08T09:01:30.151723-05:00,HCM-BROD-0781-C71_treatment5,547b9afc-2a14-4a57-b77a-d4ce946e4173,,released,Bevacizumab,1,2021-12-21T13:50:58.029147-06:00,Targeted Molecular Therapy,Residual Disease,
HCM-BROD-0781-C71,711f0482-0800-4f18-962f-1d35f9d30727,719c55ae-9cce-4c25-ae68-58b355c4fbea,68.0,Adjuvant,32.0,2023-11-07T14:20:00.017270-06:00,HCM-BROD-0781-C71_treatment2,836900c9-bf37-4d95-bdf6-0522fb2a6169,,released,Temozolomide,1,2021-12-21T13:50:58.029147-06:00,Chemotherapy,Residual Disease,
HCM-BROD-0781-C71,711f0482-0800-4f18-962f-1d35f9d30727,719c55ae-9cce-4c25-ae68-58b355c4fbea,68.0,Adjuvant,32.0,2023-11-07T14:20:00.017270-06:00,HCM-BROD-0781-C71_treatment6,bab9a380-1151-4fad-bf87-f33eaf922607,,released,,1,2021-12-21T13:50:58.029147-06:00,"Radiation, 2D Conventional",Residual Disease,
HCM-BROD-0781-C71,711f0482-0800-4f18-962f-1d35f9d30727,719c55ae-9cce-4c25-ae68-58b355c4fbea,,Neoadjuvant,,2023-11-07T14:20:00.017270-06:00,HCM-BROD-0781-C71_treatment,e1329f40-a9e6-4ccf-85c6-dcb71d8a4b80,,released,,0,2021-12-21T13:50:58.029147-06:00,,,
HCM-BROD-0702-C43,71dd56c3-0048-4ec9-89cb-53b5e966255a,9ce4d590-fc03-4b3f-9cb3-012ae0639d37,612.0,Maintenance Therapy,304.0,2023-02-22T07:39:25.979291-06:00,HCM-BROD-0702-C43_treatment10,0a509779-e240-4dfa-9bf8-164f72595c9e,Progressive Disease,released,Ipilimumab,1,2021-11-23T08:37:02.024883-06:00,,,
HCM-BROD-0702-C43,71dd56c3-0048-4ec9-89cb-53b5e966255a,9ce4d590-fc03-4b3f-9cb3-012ae0639d37,612.0,Maintenance Therapy,304.0,2023-02-22T07:39:25.979291-06:00,HCM-BROD-0702-C43_treatment9,808b751b-6e3b-4ce1-b7e3-5c1c742a603b,Progressive Disease,released,Pembrolizumab,1,2021-11-23T08:37:02.024883-06:00,,,
HCM-CSHL-0381-C20,723fd0ed-5223-41ef-8f09-677a1b3ca9d4,0b8dc911-8727-455a-8050-1658e81b463d,,,234.0,2023-03-13T12:45:41.823572-05:00,HCM-CSHL-0381-C20_treatment5,0a8cb547-50c6-48db-afad-52567ea99158,,released,,1,2020-06-15T13:36:29.216615-05:00,"Surgery, NOS",Initial Diagnosis,
HCM-CSHL-0381-C20,723fd0ed-5223-41ef-8f09-677a1b3ca9d4,0b8dc911-8727-455a-8050-1658e81b463d,,Adjuvant,,2021-01-06T22:55:10.531130-06:00,HCM-CSHL-0381-C20_treatment6,55ebadd6-50bb-4b80-b6cd-d91d96e1c4c7,,released,,0,2020-06-15T13:36:29.216615-05:00,Targeted Molecular Therapy,Residual Disease,
HCM-CSHL-0381-C20,723fd0ed-5223-41ef-8f09-677a1b3ca9d4,0b8dc911-8727-455a-8050-1658e81b463d,,Neoadjuvant,315.0,2021-01-06T22:55:10.531130-06:00,HCM-CSHL-0381-C20_treatment,820c5cd6-2db9-435a-ad85-1e2727f6ff3b,,released,Capecitabine,1,2020-06-15T13:36:29.216615-05:00,Chemotherapy,,
HCM-CSHL-0381-C20,723fd0ed-5223-41ef-8f09-677a1b3ca9d4,0b8dc911-8727-455a-8050-1658e81b463d,,Adjuvant,,2021-01-06T22:55:10.531130-06:00,HCM-CSHL-0381-C20_treatment7,8ae3ee18-882f-4ed7-9b30-a6475d6fa00e,,released,,0,2020-06-15T13:36:29.216615-05:00,"Radiation Therapy, NOS",Residual Disease,
HCM-CSHL-0381-C20,723fd0ed-5223-41ef-8f09-677a1b3ca9d4,0b8dc911-8727-455a-8050-1658e81b463d,,Neoadjuvant,88.0,2021-01-06T22:55:10.531130-06:00,HCM-CSHL-0381-C20_treatment2,c4eba771-728e-45ed-bdf9-042760baf2d2,,released,,1,2020-06-15T13:36:29.216615-05:00,"Radiation, Intensity-Modulated Radiotherapy",,
HCM-CSHL-0381-C20,723fd0ed-5223-41ef-8f09-677a1b3ca9d4,0b8dc911-8727-455a-8050-1658e81b463d,,Adjuvant,,2021-01-06T22:55:10.531130-06:00,HCM-CSHL-0381-C20_treatment4,f0117a64-dcea-4081-8144-2361a8374b8a,,released,,0,2020-06-15T13:36:29.216615-05:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-CSHL-0381-C20,723fd0ed-5223-41ef-8f09-677a1b3ca9d4,0b8dc911-8727-455a-8050-1658e81b463d,464.0,Adjuvant,299.0,2021-01-06T22:55:10.531130-06:00,HCM-CSHL-0381-C20_treatment3,fe89cfb5-a459-4b01-be61-390a8e004a32,,released,Capecitabine,1,2020-06-15T13:36:29.216615-05:00,Chemotherapy,Residual Disease,
HCM-SANG-1321-C18,72b32ae9-d75d-43d4-a094-04b457ed99a6,7cc9d591-6653-43c3-8919-cdc4bcbdf636,,Neoadjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-SANG-1321-C18_treatment,a1afee1d-7d10-4714-9e22-96945d704505,,released,,0,2023-02-27T12:29:05.643617-06:00,,,
HCM-EXPT-1260-C15,72ec3906-fc3f-4310-96ad-6032c65220c0,4fef1c6c-739d-4f93-a858-89de7651cebb,,Neoadjuvant,111.0,2025-10-08T12:39:59.137357-05:00,HCM-EXPT-1260-C15_treatment,3129140d-0701-4f26-ba57-f2f1f3c4778e,,released,Paclitaxel,1,2023-02-24T13:53:34.138170-06:00,Chemotherapy,,
HCM-EXPT-1260-C15,72ec3906-fc3f-4310-96ad-6032c65220c0,4fef1c6c-739d-4f93-a858-89de7651cebb,,Neoadjuvant,111.0,2025-10-08T12:39:59.137357-05:00,HCM-EXPT-1260-C15_treatment2,3fe96f31-8821-4120-81fc-ddb6fca2a830,,released,Carboplatin,1,2023-02-24T13:53:34.138170-06:00,Chemotherapy,,
HCM-EXPT-1260-C15,72ec3906-fc3f-4310-96ad-6032c65220c0,4fef1c6c-739d-4f93-a858-89de7651cebb,,Neoadjuvant,111.0,2025-10-08T12:39:59.137357-05:00,HCM-EXPT-1260-C15_treatment3,a31d64b6-195c-4add-ad9b-f5c3f7c6053a,,released,,1,2023-02-24T13:53:34.138170-06:00,"Radiation Therapy, NOS",,
HCM-WCMC-0747-C50,74016d27-4ade-46de-85d9-504e6e840042,13725bda-eaad-4888-be9c-14ddaaa0cf20,928.0,Maintenance Therapy,106.0,2025-04-07T17:13:09.336794-05:00,HCM-WCMC-0747-C50_treatment13,1a5bc4b6-279d-4999-a315-863bd37b5462,Treatment Ongoing,released,Leuprolide Acetate,1,2023-02-24T14:47:25.740338-06:00,,,
HCM-WCMC-0747-C50,74016d27-4ade-46de-85d9-504e6e840042,13725bda-eaad-4888-be9c-14ddaaa0cf20,928.0,Maintenance Therapy,106.0,2025-04-07T17:13:09.336794-05:00,HCM-WCMC-0747-C50_treatment14,92f4919b-6d70-43f5-acd5-8ed787fc1c8a,Treatment Ongoing,released,Tamoxifen,1,2023-02-24T14:47:25.740338-06:00,,,
HCM-WCMC-0747-C50,74016d27-4ade-46de-85d9-504e6e840042,13725bda-eaad-4888-be9c-14ddaaa0cf20,,Prevention,,2025-04-07T17:13:09.336794-05:00,HCM-WCMC-0747-C50_treatment16,a6f0dd1e-c9cb-46f8-a6f2-5fa30bd63931,,released,,1,2023-02-24T14:47:25.740338-06:00,Hormone Therapy,,
HCM-WCMC-0747-C50,74016d27-4ade-46de-85d9-504e6e840042,3e2aed94-79e2-42d5-a63e-aeffaf920b81,411.0,Adjuvant,106.0,2025-04-07T17:13:09.336794-05:00,HCM-WCMC-0747-C50_treatment8,07c65af6-bdcf-45f6-bcee-e173bd6ca5bd,,released,Tamoxifen,1,2023-02-24T14:47:25.740338-06:00,Hormone Therapy,Residual Disease,
HCM-WCMC-0747-C50,74016d27-4ade-46de-85d9-504e6e840042,3e2aed94-79e2-42d5-a63e-aeffaf920b81,1175.0,Adjuvant,745.0,2025-04-07T17:13:09.336794-05:00,HCM-WCMC-0747-C50_treatment5,1ff08f18-f686-4663-8685-d5312d96ea42,Treatment Ongoing,released,Anastrozole,1,2023-02-24T14:47:25.740338-06:00,Hormone Therapy,Residual Disease,
HCM-WCMC-0747-C50,74016d27-4ade-46de-85d9-504e6e840042,3e2aed94-79e2-42d5-a63e-aeffaf920b81,,Prevention,,2025-04-07T17:13:09.336794-05:00,HCM-WCMC-0747-C50_treatment15,4d286d88-c75e-4ae8-a773-04d71e1a1d4a,,released,,0,2023-02-24T14:47:25.740338-06:00,Hormone Therapy,,
HCM-WCMC-0747-C50,74016d27-4ade-46de-85d9-504e6e840042,3e2aed94-79e2-42d5-a63e-aeffaf920b81,,,43.0,2025-04-07T17:13:09.336794-05:00,HCM-WCMC-0747-C50_treatment10,8efa1358-99d1-4112-85b4-09d6492e0c90,,released,,1,2023-02-24T14:47:25.740338-06:00,"Surgery, NOS",Initial Diagnosis,
HCM-WCMC-0747-C50,74016d27-4ade-46de-85d9-504e6e840042,3e2aed94-79e2-42d5-a63e-aeffaf920b81,,Neoadjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-WCMC-0747-C50_treatment,959df3dd-ed50-451f-835d-b0b9a8a3b88a,,released,,0,2023-02-24T14:47:25.740338-06:00,,,
HCM-WCMC-0747-C50,74016d27-4ade-46de-85d9-504e6e840042,3e2aed94-79e2-42d5-a63e-aeffaf920b81,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-WCMC-0747-C50_treatment11,9e8507a6-7c02-44c2-8fa1-80019ae14a6a,,released,,0,2023-02-24T14:47:25.740338-06:00,Targeted Molecular Therapy,Residual Disease,
HCM-WCMC-0747-C50,74016d27-4ade-46de-85d9-504e6e840042,3e2aed94-79e2-42d5-a63e-aeffaf920b81,435.0,Adjuvant,435.0,2025-04-07T17:13:09.336794-05:00,HCM-WCMC-0747-C50_treatment7,bd7dbbf0-658a-4e51-a140-1b93cbf885ad,,released,Leuprolide,1,2023-02-24T14:47:25.740338-06:00,Hormone Therapy,Residual Disease,
HCM-WCMC-0747-C50,74016d27-4ade-46de-85d9-504e6e840042,3e2aed94-79e2-42d5-a63e-aeffaf920b81,613.0,Adjuvant,580.0,2025-04-07T17:13:09.336794-05:00,HCM-WCMC-0747-C50_treatment12,c0ea8953-65a0-4023-9e52-9d89b6c6be3f,,released,,1,2023-02-24T14:47:25.740338-06:00,"Radiation Therapy, NOS",Residual Disease,
HCM-WCMC-0747-C50,74016d27-4ade-46de-85d9-504e6e840042,3e2aed94-79e2-42d5-a63e-aeffaf920b81,1175.0,Adjuvant,745.0,2025-04-07T17:13:09.336794-05:00,HCM-WCMC-0747-C50_treatment6,ccf9b793-ec1f-45af-8f5f-80c53219cb9a,Treatment Ongoing,released,Leuprolide,1,2023-02-24T14:47:25.740338-06:00,Hormone Therapy,Residual Disease,
HCM-WCMC-0747-C50,74016d27-4ade-46de-85d9-504e6e840042,3e2aed94-79e2-42d5-a63e-aeffaf920b81,764.0,Adjuvant,594.0,2025-04-07T17:13:09.336794-05:00,HCM-WCMC-0747-C50_treatment3,d504a013-d555-4d3e-b71a-a9fd58604e16,,released,Leuprolide,1,2023-02-24T14:47:25.740338-06:00,Hormone Therapy,Residual Disease,
HCM-WCMC-0747-C50,74016d27-4ade-46de-85d9-504e6e840042,3e2aed94-79e2-42d5-a63e-aeffaf920b81,552.0,Adjuvant,510.0,2025-04-07T17:13:09.336794-05:00,HCM-WCMC-0747-C50_treatment2,d982d5a5-a716-4468-a829-0dfcea0a6e7f,,released,Paclitaxel,1,2023-02-24T14:47:25.740338-06:00,Chemotherapy,Residual Disease,
HCM-WCMC-0747-C50,74016d27-4ade-46de-85d9-504e6e840042,3e2aed94-79e2-42d5-a63e-aeffaf920b81,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-WCMC-0747-C50_treatment9,da57e4ea-a300-40be-b198-dce252546667,,released,,0,2023-02-24T14:47:25.740338-06:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-WCMC-0747-C50,74016d27-4ade-46de-85d9-504e6e840042,3e2aed94-79e2-42d5-a63e-aeffaf920b81,764.0,Adjuvant,594.0,2025-04-07T17:13:09.336794-05:00,HCM-WCMC-0747-C50_treatment4,fe3de1bc-66a7-443b-b8c3-c562b6229d10,,released,Letrozole,1,2023-02-24T14:47:25.740338-06:00,Hormone Therapy,Residual Disease,
HCM-EXPT-1261-C18,741236d1-b662-47a6-b1f4-94dfc004efca,d54387c8-39ea-4221-8ead-f41ad9a3b1d0,,Neoadjuvant,,2025-10-08T12:39:59.137357-05:00,HCM-EXPT-1261-C18_treatment,4af58b4b-7e9b-4c48-bab7-bb91898edd45,,released,,0,2022-03-13T20:25:28.051290-05:00,,,
HCM-BROD-0344-C25,74250d5d-e275-4315-8775-589aa79c7fac,1d076ae2-cee6-4f0f-82a1-43aa92e84fc0,,Adjuvant,,2021-07-12T12:25:55.528644-05:00,HCM-BROD-0344-C25_treatment3,1741db55-938f-4819-887b-8d48a2118641,,released,,0,2020-07-31T09:28:27.709218-05:00,Chemotherapy,Residual Disease,
HCM-BROD-0344-C25,74250d5d-e275-4315-8775-589aa79c7fac,1d076ae2-cee6-4f0f-82a1-43aa92e84fc0,,Neoadjuvant,,2021-07-12T12:25:55.528644-05:00,HCM-BROD-0344-C25_treatment,70965b52-296e-4388-8324-5ac7aa4126ec,,released,,1,2020-07-31T09:28:27.709218-05:00,Chemotherapy,,
HCM-BROD-0344-C25,74250d5d-e275-4315-8775-589aa79c7fac,1d076ae2-cee6-4f0f-82a1-43aa92e84fc0,,Adjuvant,,2021-07-12T12:25:55.528644-05:00,HCM-BROD-0344-C25_treatment7,adc15e98-f13b-4d0b-97fc-4dda0293ef9b,,released,,0,2020-07-31T09:28:27.709218-05:00,"Radiation Therapy, NOS",Residual Disease,
HCM-BROD-0344-C25,74250d5d-e275-4315-8775-589aa79c7fac,1d076ae2-cee6-4f0f-82a1-43aa92e84fc0,,Adjuvant,,2021-07-12T12:25:55.528644-05:00,HCM-BROD-0344-C25_treatment4,c44ecf29-df9b-4e8b-971c-692264bed2de,,released,,0,2020-07-31T09:28:27.709218-05:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-BROD-0344-C25,74250d5d-e275-4315-8775-589aa79c7fac,1d076ae2-cee6-4f0f-82a1-43aa92e84fc0,,Adjuvant,,2021-07-12T12:25:55.528644-05:00,HCM-BROD-0344-C25_treatment6,d131c5ed-6d8d-4446-aec2-e48d9cca4390,,released,,0,2020-07-31T09:28:27.709218-05:00,Targeted Molecular Therapy,Residual Disease,
HCM-BROD-0344-C25,74250d5d-e275-4315-8775-589aa79c7fac,1d076ae2-cee6-4f0f-82a1-43aa92e84fc0,,,,2023-03-13T13:10:52.878565-05:00,HCM-BROD-0344-C25_treatment5,d1356326-d66c-4457-b32d-486093d39142,,released,,0,2020-07-31T09:28:27.709218-05:00,"Surgery, NOS",Initial Diagnosis,
HCM-BROD-0344-C25,74250d5d-e275-4315-8775-589aa79c7fac,1d076ae2-cee6-4f0f-82a1-43aa92e84fc0,,Neoadjuvant,,2021-07-12T12:25:55.528644-05:00,HCM-BROD-0344-C25_treatment2,f02675f2-aa3d-4099-82c9-4041ee25e024,,released,,1,2020-07-31T09:28:27.709218-05:00,"Radiation Therapy, NOS",,
HCM-SANG-0779-C25,74512b64-70e7-4d12-b9b8-8810d7a3bf34,df599677-dde3-4ff0-8cae-11a6463cf274,,Neoadjuvant,133.0,2025-03-31T16:34:59.906497-05:00,HCM-SANG-0779-C25_treatment2,1b69880f-3f86-41f9-aaa6-f3ff16ee3fba,,released,Irinotecan,1,2023-02-27T11:24:02.783341-06:00,Chemotherapy,,
HCM-SANG-0779-C25,74512b64-70e7-4d12-b9b8-8810d7a3bf34,df599677-dde3-4ff0-8cae-11a6463cf274,,Neoadjuvant,133.0,2025-03-31T16:34:59.906497-05:00,HCM-SANG-0779-C25_treatment,31c93f89-2f51-4365-b141-4b131e5bb3d9,,released,Fluorouracil,1,2023-02-27T11:24:02.783341-06:00,Chemotherapy,,
HCM-SANG-0779-C25,74512b64-70e7-4d12-b9b8-8810d7a3bf34,df599677-dde3-4ff0-8cae-11a6463cf274,,Neoadjuvant,133.0,2025-03-31T16:34:59.906497-05:00,HCM-SANG-0779-C25_treatment4,42bffe27-e681-4384-b347-d39e6acfd0fb,,released,Leucovorin,1,2023-02-27T11:24:02.783341-06:00,Chemotherapy,,
HCM-SANG-0779-C25,74512b64-70e7-4d12-b9b8-8810d7a3bf34,df599677-dde3-4ff0-8cae-11a6463cf274,,Neoadjuvant,133.0,2025-03-31T16:34:59.906497-05:00,HCM-SANG-0779-C25_treatment3,90ada73f-93aa-4008-b129-23206cd8c039,,released,Oxaliplatin,1,2023-02-27T11:24:02.783341-06:00,Chemotherapy,,
HCM-BROD-0644-C25,745d26a1-1072-4ac0-b168-03f4287c32b0,87084624-73bb-47ea-9ae3-380158c67ac0,,Adjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0644-C25_treatment5,05e5a80b-26bb-42f4-89e2-55a1d57d7c62,,released,,0,2020-10-08T14:49:03.103433-05:00,"Pharmaceutical Therapy, NOS",Residual Disease,
HCM-BROD-0644-C25,745d26a1-1072-4ac0-b168-03f4287c32b0,87084624-73bb-47ea-9ae3-380158c67ac0,,,,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0644-C25_treatment4,3b8d598b-3595-473d-9db8-cb5b3ab54ea4,,released,,0,2020-10-08T14:49:03.103433-05:00,"Surgery, NOS",Initial Diagnosis,
HCM-BROD-0644-C25,745d26a1-1072-4ac0-b168-03f4287c32b0,87084624-73bb-47ea-9ae3-380158c67ac0,,Neoadjuvant,742.0,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0644-C25_treatment2,47b625d4-b113-43f0-8d3c-c9ad70b5cf3b,,released,Gemcitabine,1,2020-10-08T14:49:03.103433-05:00,Chemotherapy,,
HCM-BROD-0644-C25,745d26a1-1072-4ac0-b168-03f4287c32b0,87084624-73bb-47ea-9ae3-380158c67ac0,,Neoadjuvant,907.0,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0644-C25_treatment3,aaf26bf2-0d02-478b-840a-64fb4c7bf992,,released,,1,2020-10-08T14:49:03.103433-05:00,Stereotactic Radiosurgery,,
HCM-BROD-0644-C25,745d26a1-1072-4ac0-b168-03f4287c32b0,87084624-73bb-47ea-9ae3-380158c67ac0,,Adjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0644-C25_treatment6,acfa3580-e2b4-4531-a852-b428374a88e9,,released,,0,2020-10-08T14:49:03.103433-05:00,"Radiation Therapy, NOS",Residual Disease,
HCM-BROD-0644-C25,745d26a1-1072-4ac0-b168-03f4287c32b0,87084624-73bb-47ea-9ae3-380158c67ac0,,Neoadjuvant,742.0,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0644-C25_treatment,e1f8c11d-0409-4784-8007-394a8ffd15b9,,released,Cisplatin,1,2020-10-08T14:49:03.103433-05:00,Chemotherapy,,
HCM-BROD-0644-C25,745d26a1-1072-4ac0-b168-03f4287c32b0,c4383dd9-ba1a-480d-8fd1-6cda99501eb1,944.0,Maintenance Therapy,742.0,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0644-C25_treatment9,14fcbc77-3706-4ad1-bde6-1dc2db826fcf,Progressive Disease,released,Gemcitabine,1,2023-02-28T13:21:18.868545-06:00,,,
HCM-BROD-0644-C25,745d26a1-1072-4ac0-b168-03f4287c32b0,c4383dd9-ba1a-480d-8fd1-6cda99501eb1,944.0,Maintenance Therapy,742.0,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0644-C25_treatment8,681739d8-2beb-4d22-8418-15c2e3330162,Progressive Disease,released,Nab-paclitaxel,1,2023-02-28T13:21:18.868545-06:00,,,
HCM-BROD-0644-C25,745d26a1-1072-4ac0-b168-03f4287c32b0,c4383dd9-ba1a-480d-8fd1-6cda99501eb1,944.0,Maintenance Therapy,742.0,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0644-C25_treatment7,7add3454-3645-4f8f-9f8d-3bb48812f32c,Progressive Disease,released,Capecitabine,1,2023-02-28T13:21:18.868545-06:00,,,
HCM-BROD-0594-C43,74862d9d-4f3d-4ba9-a345-2f2fd38e2490,6d96f62a-af25-4ff0-ab1a-83c0ce25b6bb,945.0,Maintenance Therapy,924.0,2023-11-07T14:20:00.017270-06:00,HCM-BROD-0594-C43_treatment5,31736403-c7b2-439d-96ae-1a84fded72ac,Progressive Disease,released,Pembrolizumab,1,2023-02-28T12:25:07.226372-06:00,,,
HCM-BROD-0594-C43,74862d9d-4f3d-4ba9-a345-2f2fd38e2490,c5a5bc34-308b-479d-9185-355cf1281ae9,,,0.0,2023-11-07T14:20:00.017270-06:00,HCM-BROD-0594-C43_treatment2,3e02cbce-d354-4c45-957d-e1e88e1fc24b,,released,,1,2021-12-21T13:40:23.585768-06:00,"Surgery, NOS",Initial Diagnosis,
HCM-BROD-0594-C43,74862d9d-4f3d-4ba9-a345-2f2fd38e2490,c5a5bc34-308b-479d-9185-355cf1281ae9,,Neoadjuvant,,2023-11-07T14:20:00.017270-06:00,HCM-BROD-0594-C43_treatment,591ca0cf-2252-42ec-a917-c6e3834c4e42,,released,,0,2021-12-21T13:40:23.585768-06:00,,,
HCM-BROD-0594-C43,74862d9d-4f3d-4ba9-a345-2f2fd38e2490,c5a5bc34-308b-479d-9185-355cf1281ae9,,Adjuvant,,2023-11-07T14:20:00.017270-06:00,HCM-BROD-0594-C43_treatment3,c64a186b-c2ed-4cfd-bd16-9a2b47f58fcd,,released,,0,2021-12-21T13:40:23.585768-06:00,"Pharmaceutical Therapy, NOS",Residual Disease,
HCM-BROD-0594-C43,74862d9d-4f3d-4ba9-a345-2f2fd38e2490,c5a5bc34-308b-479d-9185-355cf1281ae9,,Adjuvant,,2023-11-07T14:20:00.017270-06:00,HCM-BROD-0594-C43_treatment4,ecd702d1-848d-454f-a1bd-44e344c87362,,released,,0,2021-12-21T13:40:23.585768-06:00,"Radiation Therapy, NOS",Residual Disease,
HCM-EXPT-0996-C18,74c4156d-f5ee-498c-a3c8-c0e9ac873cab,91b05868-fda3-4168-8227-00ba5849fcdd,,Neoadjuvant,,2025-10-08T12:37:21.548354-05:00,HCM-EXPT-0996-C18_treatment,ed55e3ed-45c6-4ba0-854d-96c2ecd256e0,,released,,1,2021-12-21T14:52:28.843377-06:00,Chemotherapy,,
HCM-SANG-1330-C19,74dcf5eb-e06f-46bc-88b2-9702ac41b2f2,7cb692f8-5b94-40e6-b693-765aa8410319,,Neoadjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-SANG-1330-C19_treatment,4fb83f7e-ae7c-4e07-9c69-0d790d6a3a4c,,released,,0,2023-02-27T11:56:30.932101-06:00,,,
HCM-STAN-0848-C20,7588a6b5-7c21-4a45-90ba-42a8220e11ac,64d78e96-8683-4479-aad6-c6b25dec813f,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-STAN-0848-C20_treatment9,52f75b72-60a9-41a9-a557-f186fe991605,,released,,0,2022-09-22T07:07:22.929533-05:00,Targeted Molecular Therapy,Residual Disease,
HCM-STAN-0848-C20,7588a6b5-7c21-4a45-90ba-42a8220e11ac,64d78e96-8683-4479-aad6-c6b25dec813f,567.0,Adjuvant,497.0,2025-04-07T17:13:09.336794-05:00,HCM-STAN-0848-C20_treatment5,8de0abc0-38fe-4f2c-86ed-3b4d11eec66d,,released,Oxaliplatin,1,2022-09-22T07:07:22.929533-05:00,Chemotherapy,Residual Disease,
HCM-STAN-0848-C20,7588a6b5-7c21-4a45-90ba-42a8220e11ac,64d78e96-8683-4479-aad6-c6b25dec813f,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-STAN-0848-C20_treatment7,ba56c94a-d82a-4fce-82e4-bd0f764f022d,,released,,0,2022-09-22T07:07:22.929533-05:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-STAN-0848-C20,7588a6b5-7c21-4a45-90ba-42a8220e11ac,64d78e96-8683-4479-aad6-c6b25dec813f,,Neoadjuvant,42.0,2025-04-07T17:13:09.336794-05:00,HCM-STAN-0848-C20_treatment2,bc27735b-fffd-4ba1-8731-11067f8655e2,,released,,1,2022-09-22T07:07:22.929533-05:00,"Radiation, 2D Conventional",,
HCM-STAN-0848-C20,7588a6b5-7c21-4a45-90ba-42a8220e11ac,64d78e96-8683-4479-aad6-c6b25dec813f,567.0,Adjuvant,497.0,2025-04-07T17:13:09.336794-05:00,HCM-STAN-0848-C20_treatment6,cc993889-d263-4329-b34b-bad462befc47,,released,,1,2022-09-22T07:07:22.929533-05:00,Chemotherapy,Residual Disease,FOLFOX
HCM-STAN-0848-C20,7588a6b5-7c21-4a45-90ba-42a8220e11ac,64d78e96-8683-4479-aad6-c6b25dec813f,,,0.0,2025-04-07T17:13:09.336794-05:00,HCM-STAN-0848-C20_treatment8,ccf85517-bb54-4359-a094-8e9cb71fee77,,released,,1,2022-09-22T07:07:22.929533-05:00,"Surgery, NOS",Initial Diagnosis,
HCM-STAN-0848-C20,7588a6b5-7c21-4a45-90ba-42a8220e11ac,64d78e96-8683-4479-aad6-c6b25dec813f,567.0,Adjuvant,497.0,2025-04-07T17:13:09.336794-05:00,HCM-STAN-0848-C20_treatment4,d8af83b5-12fc-4d0d-8248-10476f666ed2,,released,Fluorouracil,1,2022-09-22T07:07:22.929533-05:00,Chemotherapy,Residual Disease,
HCM-STAN-0848-C20,7588a6b5-7c21-4a45-90ba-42a8220e11ac,64d78e96-8683-4479-aad6-c6b25dec813f,,Neoadjuvant,291.0,2025-04-07T17:13:09.336794-05:00,HCM-STAN-0848-C20_treatment,d8c7aa9a-f4a4-44b0-89e4-a835308d5b45,,released,Capecitabine,1,2022-09-22T07:07:22.929533-05:00,Chemotherapy,,
HCM-STAN-0848-C20,7588a6b5-7c21-4a45-90ba-42a8220e11ac,64d78e96-8683-4479-aad6-c6b25dec813f,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-STAN-0848-C20_treatment10,f6abbbe4-9819-4fea-afec-596ccef2dfc0,,released,,0,2022-09-22T07:07:22.929533-05:00,"Radiation Therapy, NOS",Residual Disease,
HCM-STAN-0848-C20,7588a6b5-7c21-4a45-90ba-42a8220e11ac,64d78e96-8683-4479-aad6-c6b25dec813f,567.0,Adjuvant,497.0,2025-04-07T17:13:09.336794-05:00,HCM-STAN-0848-C20_treatment3,ff867d05-009b-4f24-99b5-8e4215ba2697,,released,Leucovorin Calcium,1,2022-09-22T07:07:22.929533-05:00,Chemotherapy,Residual Disease,
HCM-CSHL-0244-C20,75a0e6f3-8ae3-4fd3-ac81-17eaffacd796,57b05d2e-4c61-4439-a608-49dbd4fd7fde,,,462.0,2023-02-27T12:00:06.680645-06:00,HCM-CSHL-0244-C20_treatment5,03fe61d4-0b64-4137-a84a-72999fc58d1f,,released,,1,2020-09-28T09:25:47.675598-05:00,"Surgery, NOS",Initial Diagnosis,
HCM-CSHL-0244-C20,75a0e6f3-8ae3-4fd3-ac81-17eaffacd796,57b05d2e-4c61-4439-a608-49dbd4fd7fde,,Adjuvant,,2021-01-06T22:55:10.531130-06:00,HCM-CSHL-0244-C20_treatment6,24113873-4fba-4d13-9d7b-ddfdecbf704a,,released,,0,2020-09-28T09:25:47.675598-05:00,Targeted Molecular Therapy,Residual Disease,
HCM-CSHL-0244-C20,75a0e6f3-8ae3-4fd3-ac81-17eaffacd796,57b05d2e-4c61-4439-a608-49dbd4fd7fde,,Adjuvant,,2021-01-06T22:55:10.531130-06:00,HCM-CSHL-0244-C20_treatment4,60b53d43-59c9-4578-b17a-5dfae79ec46f,,released,,0,2020-09-28T09:25:47.675598-05:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-CSHL-0244-C20,75a0e6f3-8ae3-4fd3-ac81-17eaffacd796,57b05d2e-4c61-4439-a608-49dbd4fd7fde,,Neoadjuvant,0.0,2021-01-06T22:55:10.531130-06:00,HCM-CSHL-0244-C20_treatment,7fd155b8-c83c-45c2-b9fb-bf9ef557d303,,released,,1,2020-09-28T09:25:47.675598-05:00,Chemotherapy,,
HCM-CSHL-0244-C20,75a0e6f3-8ae3-4fd3-ac81-17eaffacd796,57b05d2e-4c61-4439-a608-49dbd4fd7fde,615.0,Adjuvant,498.0,2021-01-06T22:55:10.531130-06:00,HCM-CSHL-0244-C20_treatment3,d799a489-97a0-42f3-b933-e06b62ceef2b,,released,Unknown,1,2020-09-28T09:25:47.675598-05:00,Chemotherapy,Residual Disease,
HCM-CSHL-0244-C20,75a0e6f3-8ae3-4fd3-ac81-17eaffacd796,57b05d2e-4c61-4439-a608-49dbd4fd7fde,,Neoadjuvant,0.0,2021-01-06T22:55:10.531130-06:00,HCM-CSHL-0244-C20_treatment2,ddbb0d51-527c-4326-9c79-850a5c4cea74,,released,,1,2020-09-28T09:25:47.675598-05:00,"Radiation Therapy, NOS",,
HCM-BROD-0701-C43,76190b91-c744-4fc5-8e4d-eba10785d98b,e6349d25-3851-4ff5-9b67-b0b55abda9ca,,Adjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0701-C43_treatment2,0adcb103-00b0-4dcd-aeb9-2e4c936a58b5,,released,,0,2021-12-21T13:46:02.975813-06:00,Chemotherapy,Residual Disease,
HCM-BROD-0701-C43,76190b91-c744-4fc5-8e4d-eba10785d98b,e6349d25-3851-4ff5-9b67-b0b55abda9ca,,Adjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0701-C43_treatment6,51be59ba-713e-420f-b72e-d18729ad875a,,released,,0,2021-12-21T13:46:02.975813-06:00,Targeted Molecular Therapy,Residual Disease,
HCM-BROD-0701-C43,76190b91-c744-4fc5-8e4d-eba10785d98b,e6349d25-3851-4ff5-9b67-b0b55abda9ca,,Adjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0701-C43_treatment7,570766b4-3e08-49ca-8578-e5210ca37713,,released,,0,2021-12-21T13:46:02.975813-06:00,"Radiation Therapy, NOS",Residual Disease,
HCM-BROD-0701-C43,76190b91-c744-4fc5-8e4d-eba10785d98b,e6349d25-3851-4ff5-9b67-b0b55abda9ca,,Neoadjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0701-C43_treatment,a2b170a2-b629-40d9-9f4f-ae84c993393d,,released,,0,2021-12-21T13:46:02.975813-06:00,,,
HCM-BROD-0701-C43,76190b91-c744-4fc5-8e4d-eba10785d98b,e6349d25-3851-4ff5-9b67-b0b55abda9ca,449.0,Adjuvant,323.0,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0701-C43_treatment4,af80214f-cfcb-4143-8cc3-03a97c580568,,released,Pembrolizumab,1,2021-12-21T13:46:02.975813-06:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-BROD-0701-C43,76190b91-c744-4fc5-8e4d-eba10785d98b,e6349d25-3851-4ff5-9b67-b0b55abda9ca,,Adjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0701-C43_treatment3,b6514a9b-b9bf-4096-90de-b108ae138ce0,,released,,0,2021-12-21T13:46:02.975813-06:00,Hormone Therapy,Residual Disease,
HCM-BROD-0701-C43,76190b91-c744-4fc5-8e4d-eba10785d98b,e6349d25-3851-4ff5-9b67-b0b55abda9ca,,,0.0,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0701-C43_treatment5,f700c757-3e4e-4ccc-8730-75051963561c,,released,,1,2021-12-21T13:46:02.975813-06:00,"Surgery, NOS",Initial Diagnosis,
HCM-EXPT-1012-C50,76b3a463-5f6a-4f54-ad7c-861b7420ef96,fa0ba9a0-8284-4023-adf1-e76cc857a3fa,,Neoadjuvant,,2025-10-08T12:37:43.816130-05:00,HCM-EXPT-1012-C50_treatment,62af44ad-405b-4ce9-97cc-4548b3633547,,released,,0,2021-12-21T14:54:35.368472-06:00,,,
HCM-EXPT-1061-C50,770a4929-73e0-4420-bdc4-94355f5a46bc,885a2f7d-50c4-4231-ac0a-afa80ac7621b,,Neoadjuvant,,2025-10-08T12:38:28.988690-05:00,HCM-EXPT-1061-C50_treatment,af9c44d1-13b9-4cc6-b819-8a8a19e12913,,released,,0,2021-12-21T15:03:22.940160-06:00,,,
HCM-CSHL-0073-C25,77163cf2-4651-475f-9d60-4306c1712ed7,72d109a1-4d2a-4b98-8ece-e0dd7baf598f,,,-6.0,2023-03-13T13:03:52.297539-05:00,HCM-CSHL-0073-C25_treatment2,370fd0e0-1675-4bcf-8bbe-dbdff303201b,,released,,1,2020-02-27T13:22:59.636834-06:00,"Surgery, NOS",Initial Diagnosis,
HCM-CSHL-0073-C25,77163cf2-4651-475f-9d60-4306c1712ed7,72d109a1-4d2a-4b98-8ece-e0dd7baf598f,,Neoadjuvant,,2020-10-20T19:20:06.800740-05:00,HCM-CSHL-0073-C25_treatment,4ba4e78d-7a47-4482-a755-20c20d2f2b3e,,released,,0,2020-02-27T13:22:59.636834-06:00,,,
HCM-SANG-0266-C20,7717ccee-02fc-42aa-9951-e28ecb689ed5,64b215db-2341-44bf-8aaf-aad136a81150,,Neoadjuvant,461.0,2023-03-13T13:04:39.154718-05:00,HCM-SANG-0266-C20_treatment,13ce11c2-91a2-4311-bc00-790e975bae68,,released,Leucovorin Calcium,1,2020-02-11T15:49:08.229652-06:00,Chemotherapy,,
HCM-SANG-0266-C20,7717ccee-02fc-42aa-9951-e28ecb689ed5,64b215db-2341-44bf-8aaf-aad136a81150,,Neoadjuvant,461.0,2023-03-13T13:04:39.154718-05:00,HCM-SANG-0266-C20_treatment2,1e107747-ff6d-4d4b-91e4-3acfb83d7c72,,released,Fluorouracil,1,2020-02-11T15:49:08.229652-06:00,Chemotherapy,,
HCM-SANG-0266-C20,7717ccee-02fc-42aa-9951-e28ecb689ed5,64b215db-2341-44bf-8aaf-aad136a81150,,Neoadjuvant,461.0,2023-03-13T13:04:39.154718-05:00,HCM-SANG-0266-C20_treatment4,3cdee5e5-b670-4534-a1a4-5eaf045a0980,,released,,1,2021-08-26T15:00:47.360883-05:00,Chemotherapy,,FOLFOX
HCM-SANG-0266-C20,7717ccee-02fc-42aa-9951-e28ecb689ed5,64b215db-2341-44bf-8aaf-aad136a81150,,Neoadjuvant,461.0,2023-03-13T13:04:39.154718-05:00,HCM-SANG-0266-C20_treatment3,686107e1-9ad5-4922-9396-e6025a28360a,,released,Oxaliplatin,1,2021-08-26T15:00:47.360883-05:00,Chemotherapy,,
HCM-SANG-0266-C20,7717ccee-02fc-42aa-9951-e28ecb689ed5,64b215db-2341-44bf-8aaf-aad136a81150,,Neoadjuvant,461.0,2023-03-13T13:04:39.154718-05:00,HCM-SANG-0266-C20_treatment5,c11dd977-4ed1-4d23-a9d4-1ae5e946e626,,released,,1,2021-08-26T15:00:47.360883-05:00,"Radiation, 2D Conventional",,
HCM-SANG-0266-C20,7717ccee-02fc-42aa-9951-e28ecb689ed5,64b215db-2341-44bf-8aaf-aad136a81150,,Neoadjuvant,461.0,2023-03-13T13:04:39.154718-05:00,HCM-SANG-0266-C20_treatment6,ce11d367-7d42-4eb6-a735-8ee3336388ea,,released,Bevacizumab,1,2021-08-26T15:00:47.360883-05:00,Targeted Molecular Therapy,,
HCM-CSHL-0143-C20,77c0c6b9-2d22-404f-91da-3f588a9174ab,d3cb666f-62a3-4a8d-8a33-e69e1cadebaf,,Adjuvant,,2023-03-13T13:08:11.599529-05:00,HCM-CSHL-0143-C20_treatment4,01a6a1b3-542d-4983-a023-97ac4cea06a5,,released,,0,2020-02-27T12:47:09.609777-06:00,"Radiation Therapy, NOS",Residual Disease,
HCM-CSHL-0143-C20,77c0c6b9-2d22-404f-91da-3f588a9174ab,d3cb666f-62a3-4a8d-8a33-e69e1cadebaf,,Neoadjuvant,,2020-10-20T19:20:06.800740-05:00,HCM-CSHL-0143-C20_treatment,9ba7fc13-d3d1-4853-966b-72d494e3af68,,released,,0,2020-02-27T12:47:09.609777-06:00,,,
HCM-CSHL-0143-C20,77c0c6b9-2d22-404f-91da-3f588a9174ab,d3cb666f-62a3-4a8d-8a33-e69e1cadebaf,,Adjuvant,,2023-03-13T13:08:11.599529-05:00,HCM-CSHL-0143-C20_treatment3,a1309ca5-b8c5-45d8-a1b7-fc117580f434,,released,,0,2020-02-27T12:47:09.609777-06:00,"Pharmaceutical Therapy, NOS",Residual Disease,
HCM-CSHL-0143-C20,77c0c6b9-2d22-404f-91da-3f588a9174ab,d3cb666f-62a3-4a8d-8a33-e69e1cadebaf,,,60.0,2023-03-13T13:08:11.599529-05:00,HCM-CSHL-0143-C20_treatment2,d786a97b-d31d-4bf0-b553-4ef6d30ad542,,released,,1,2020-02-27T12:47:09.609777-06:00,"Surgery, NOS",Initial Diagnosis,
HCM-CSHL-0807-C54,77e36a58-fc44-4b8a-a81c-173362967082,ca464a66-eb1f-4030-a065-cf9dc130955c,199.0,Adjuvant,185.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0807-C54_treatment8,45b93fd2-9929-4bba-899b-a3df29e67871,,released,,1,2021-12-21T14:26:39.957485-06:00,"Brachytherapy, High Dose",Residual Disease,
HCM-CSHL-0807-C54,77e36a58-fc44-4b8a-a81c-173362967082,ca464a66-eb1f-4030-a065-cf9dc130955c,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0807-C54_treatment5,70a76e22-0ddd-4918-a8ff-7d34a93c21ad,,released,,0,2021-12-21T14:26:39.957485-06:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-CSHL-0807-C54,77e36a58-fc44-4b8a-a81c-173362967082,ca464a66-eb1f-4030-a065-cf9dc130955c,,,0.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0807-C54_treatment6,74cfe856-81f7-4635-8959-050cd75aab29,,released,,1,2021-12-21T14:26:39.957485-06:00,"Surgery, NOS",Initial Diagnosis,
HCM-CSHL-0807-C54,77e36a58-fc44-4b8a-a81c-173362967082,ca464a66-eb1f-4030-a065-cf9dc130955c,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0807-C54_treatment7,8127fda0-ef4a-431d-bb23-cf2e0c0cac30,,released,,0,2021-12-21T14:26:39.957485-06:00,Targeted Molecular Therapy,Residual Disease,
HCM-CSHL-0807-C54,77e36a58-fc44-4b8a-a81c-173362967082,ca464a66-eb1f-4030-a065-cf9dc130955c,145.0,Adjuvant,39.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0807-C54_treatment2,aaa27398-96db-4281-8df9-b4019b8ab6a3,,released,Carboplatin,1,2021-12-21T14:26:39.957485-06:00,Chemotherapy,Residual Disease,
HCM-CSHL-0807-C54,77e36a58-fc44-4b8a-a81c-173362967082,ca464a66-eb1f-4030-a065-cf9dc130955c,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0807-C54_treatment4,b4b38a5b-7df9-451b-8900-be289ea7aaab,,released,,0,2021-12-21T14:26:39.957485-06:00,Hormone Therapy,Residual Disease,
HCM-CSHL-0807-C54,77e36a58-fc44-4b8a-a81c-173362967082,ca464a66-eb1f-4030-a065-cf9dc130955c,145.0,Adjuvant,39.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0807-C54_treatment3,d7a25673-b6e6-42a6-98a8-6804c308baf3,,released,Paclitaxel,1,2021-12-21T14:26:39.957485-06:00,Chemotherapy,Residual Disease,
HCM-CSHL-0807-C54,77e36a58-fc44-4b8a-a81c-173362967082,ca464a66-eb1f-4030-a065-cf9dc130955c,,Neoadjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0807-C54_treatment,dd4fa0a2-1ab8-403a-acb4-25105b7c4a2e,,released,,0,2021-12-21T14:26:39.957485-06:00,,,
HCM-BROD-0716-C43,78b05ced-6b5e-44e0-b8e2-07ab9b69e440,3c60679c-040d-4809-aa03-24d976c7d4c2,,Adjuvant,,2023-02-22T07:39:25.979291-06:00,HCM-BROD-0716-C43_treatment7,5a70a381-ea95-4660-bae7-5955dab158b2,,released,,0,2021-12-21T13:47:52.557823-06:00,"Radiation Therapy, NOS",Residual Disease,
HCM-BROD-0716-C43,78b05ced-6b5e-44e0-b8e2-07ab9b69e440,3c60679c-040d-4809-aa03-24d976c7d4c2,,Adjuvant,,2023-02-22T07:39:25.979291-06:00,HCM-BROD-0716-C43_treatment2,a0610632-8556-4c58-9ef5-0b4c7c360230,,released,,0,2021-12-21T13:47:52.557823-06:00,Chemotherapy,Residual Disease,
HCM-BROD-0716-C43,78b05ced-6b5e-44e0-b8e2-07ab9b69e440,3c60679c-040d-4809-aa03-24d976c7d4c2,,Adjuvant,3160.0,2023-02-22T07:39:25.979291-06:00,HCM-BROD-0716-C43_treatment4,b47661ac-8ce7-46c8-8e12-8e28560632fd,Treatment Ongoing,released,Nivolumab,1,2021-12-21T13:47:52.557823-06:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-BROD-0716-C43,78b05ced-6b5e-44e0-b8e2-07ab9b69e440,3c60679c-040d-4809-aa03-24d976c7d4c2,,,0.0,2023-02-27T12:06:19.992797-06:00,HCM-BROD-0716-C43_treatment5,d9af5cfa-7769-48c1-ab54-bb6232232125,,released,,1,2021-12-21T13:47:52.557823-06:00,"Surgery, NOS",Initial Diagnosis,
HCM-BROD-0716-C43,78b05ced-6b5e-44e0-b8e2-07ab9b69e440,3c60679c-040d-4809-aa03-24d976c7d4c2,,Adjuvant,,2023-02-22T07:39:25.979291-06:00,HCM-BROD-0716-C43_treatment6,e93e29e0-fc8b-4835-8144-e2b8304e916c,,released,,0,2021-12-21T13:47:52.557823-06:00,Targeted Molecular Therapy,Residual Disease,
HCM-BROD-0716-C43,78b05ced-6b5e-44e0-b8e2-07ab9b69e440,3c60679c-040d-4809-aa03-24d976c7d4c2,,Neoadjuvant,,2023-02-22T07:39:25.979291-06:00,HCM-BROD-0716-C43_treatment,ed534ad1-e4d6-4630-a480-7c7cc7274e6b,,released,,0,2021-12-21T13:47:52.557823-06:00,,,
HCM-BROD-0716-C43,78b05ced-6b5e-44e0-b8e2-07ab9b69e440,3c60679c-040d-4809-aa03-24d976c7d4c2,,Adjuvant,,2023-02-22T07:39:25.979291-06:00,HCM-BROD-0716-C43_treatment3,fed82810-2c0d-4b9f-8ee0-24876fc3ad99,,released,,0,2021-12-21T13:47:52.557823-06:00,Hormone Therapy,Residual Disease,
HCM-CSHL-0859-C22,78b640aa-5327-496a-87bc-8e264cd772f2,99e9d21c-9a5b-44f2-8022-562a376a3875,483.0,Adjuvant,352.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0859-C22_treatment6,14f6451d-849c-4bc9-9cfa-d3724cbdda58,,released,Oxaliplatin,1,2021-12-21T14:34:52.141751-06:00,Chemotherapy,Residual Disease,
HCM-CSHL-0859-C22,78b640aa-5327-496a-87bc-8e264cd772f2,99e9d21c-9a5b-44f2-8022-562a376a3875,483.0,Adjuvant,352.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0859-C22_treatment7,4c572f90-1571-4ed1-9466-3e8c887fb685,,released,,1,2021-12-21T14:34:52.141751-06:00,Chemotherapy,Residual Disease,FOLFOX
HCM-CSHL-0859-C22,78b640aa-5327-496a-87bc-8e264cd772f2,99e9d21c-9a5b-44f2-8022-562a376a3875,483.0,Adjuvant,352.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0859-C22_treatment4,50078654-ef64-4fa4-946c-53e2504445cb,,released,Leucovorin Calcium,1,2021-12-21T14:34:52.141751-06:00,Chemotherapy,Residual Disease,
HCM-CSHL-0859-C22,78b640aa-5327-496a-87bc-8e264cd772f2,99e9d21c-9a5b-44f2-8022-562a376a3875,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0859-C22_treatment12,71cb8cd3-0c0b-4fd0-bb42-3b6307c82215,,released,,0,2021-12-21T14:34:52.141751-06:00,"Radiation Therapy, NOS",Residual Disease,
HCM-CSHL-0859-C22,78b640aa-5327-496a-87bc-8e264cd772f2,99e9d21c-9a5b-44f2-8022-562a376a3875,483.0,Adjuvant,352.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0859-C22_treatment5,8abc4f92-af15-4ca7-83d2-a48de6176251,,released,Fluorouracil,1,2021-12-21T14:34:52.141751-06:00,Chemotherapy,Residual Disease,
HCM-CSHL-0859-C22,78b640aa-5327-496a-87bc-8e264cd772f2,99e9d21c-9a5b-44f2-8022-562a376a3875,295.0,Adjuvant,223.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0859-C22_treatment3,8b66ec97-77cf-4d23-b154-9d02c9cf8542,,released,Gemcitabine,1,2021-12-21T14:34:52.141751-06:00,Chemotherapy,Residual Disease,
HCM-CSHL-0859-C22,78b640aa-5327-496a-87bc-8e264cd772f2,99e9d21c-9a5b-44f2-8022-562a376a3875,,Neoadjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0859-C22_treatment,af8a8bb0-64a2-4b41-a566-c2f3419c093a,,released,,0,2021-12-21T14:34:52.141751-06:00,,,
HCM-CSHL-0859-C22,78b640aa-5327-496a-87bc-8e264cd772f2,99e9d21c-9a5b-44f2-8022-562a376a3875,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0859-C22_treatment8,b57cea08-dfc8-4552-9285-023dc52fe72f,,released,,0,2021-12-21T14:34:52.141751-06:00,Hormone Therapy,Residual Disease,
HCM-CSHL-0859-C22,78b640aa-5327-496a-87bc-8e264cd772f2,99e9d21c-9a5b-44f2-8022-562a376a3875,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0859-C22_treatment9,c76bb420-4753-4b79-b5e7-56a748c6f074,,released,,0,2021-12-21T14:34:52.141751-06:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-CSHL-0859-C22,78b640aa-5327-496a-87bc-8e264cd772f2,99e9d21c-9a5b-44f2-8022-562a376a3875,295.0,Adjuvant,223.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0859-C22_treatment2,d07f5779-a711-4da0-bc84-9d5d615f6ba8,,released,Cisplatin,1,2021-12-21T14:34:52.141751-06:00,Chemotherapy,Residual Disease,
HCM-CSHL-0859-C22,78b640aa-5327-496a-87bc-8e264cd772f2,99e9d21c-9a5b-44f2-8022-562a376a3875,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0859-C22_treatment11,f1aaa607-f586-42d5-b037-73f97e4c5d49,,released,,0,2021-12-21T14:34:52.141751-06:00,Targeted Molecular Therapy,Residual Disease,
HCM-CSHL-0859-C22,78b640aa-5327-496a-87bc-8e264cd772f2,99e9d21c-9a5b-44f2-8022-562a376a3875,,,-36.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0859-C22_treatment10,fb8368b5-eaf4-4bdd-a31e-8f52159cd960,,released,,1,2021-12-21T14:34:52.141751-06:00,"Surgery, NOS",Initial Diagnosis,
HCM-SANG-0303-C15,78c3e337-c084-4033-9d30-2505060192a3,f744cfe9-aa79-432c-bf46-ac1566ac1e8f,,Neoadjuvant,,2023-03-13T12:50:00.399644-05:00,HCM-SANG-0303-C15_treatment,8304093f-01a6-470c-a9c3-f91388bef633,,released,,0,2021-12-21T15:10:44.302303-06:00,,,
HCM-CSHL-1265-C25,78f0db28-1e72-4fad-9515-5ff0e0d9ddf7,92438f0f-0732-4ea0-9a75-9b8c23d47885,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-1265-C25_treatment4,24dac94c-eb8f-44ba-80c3-af8f9b6681e8,,released,,0,2022-03-13T19:48:02.989676-05:00,"Radiation Therapy, NOS",Residual Disease,
HCM-CSHL-1265-C25,78f0db28-1e72-4fad-9515-5ff0e0d9ddf7,92438f0f-0732-4ea0-9a75-9b8c23d47885,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-1265-C25_treatment3,52d7ffdf-6561-4dc0-8567-d32e71573270,,released,,0,2022-03-13T19:48:02.989676-05:00,"Pharmaceutical Therapy, NOS",Residual Disease,
HCM-CSHL-1265-C25,78f0db28-1e72-4fad-9515-5ff0e0d9ddf7,92438f0f-0732-4ea0-9a75-9b8c23d47885,,,-25.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-1265-C25_treatment2,7a32a250-6d3d-41e7-9425-ce8535b5a054,,released,,1,2022-03-13T19:48:02.989676-05:00,"Surgery, NOS",Initial Diagnosis,
HCM-CSHL-1265-C25,78f0db28-1e72-4fad-9515-5ff0e0d9ddf7,92438f0f-0732-4ea0-9a75-9b8c23d47885,,Neoadjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-1265-C25_treatment,ce5d5898-1d41-46b4-b28c-613afc117e50,,released,,0,2022-03-13T19:48:02.989676-05:00,,,
HCM-BROD-0110-C25,792ea820-f289-49b9-80f7-e746eddc2922,5280569e-17d8-4554-9303-69b2dadc47f6,,,69.0,2023-02-27T12:52:14.793536-06:00,HCM-BROD-0110-C25_treatment5,28fa7eb7-1095-4349-9bf5-704c5b508fa2,,released,,1,2020-09-17T15:46:02.505191-05:00,"Surgery, NOS",Initial Diagnosis,
HCM-BROD-0110-C25,792ea820-f289-49b9-80f7-e746eddc2922,5280569e-17d8-4554-9303-69b2dadc47f6,216.0,Adjuvant,125.0,2023-02-22T07:39:25.979291-06:00,HCM-BROD-0110-C25_treatment3,3b2cf470-7a42-4d4e-93bb-aec8cee93fec,,released,Nab-paclitaxel,1,2020-09-17T15:46:02.505191-05:00,Chemotherapy,Residual Disease,
HCM-BROD-0110-C25,792ea820-f289-49b9-80f7-e746eddc2922,5280569e-17d8-4554-9303-69b2dadc47f6,216.0,Adjuvant,125.0,2023-02-22T07:39:25.979291-06:00,HCM-BROD-0110-C25_treatment2,3cee24e2-4028-45be-914b-e5fb017f752d,,released,Gemcitabine,1,2020-09-17T15:46:02.505191-05:00,Chemotherapy,Residual Disease,
HCM-BROD-0110-C25,792ea820-f289-49b9-80f7-e746eddc2922,5280569e-17d8-4554-9303-69b2dadc47f6,,Adjuvant,,2023-02-22T07:39:25.979291-06:00,HCM-BROD-0110-C25_treatment4,9a5411cb-e618-4d49-841a-3a5096271c32,,released,,0,2020-09-17T15:46:02.505191-05:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-BROD-0110-C25,792ea820-f289-49b9-80f7-e746eddc2922,5280569e-17d8-4554-9303-69b2dadc47f6,,Adjuvant,,2023-02-22T07:39:25.979291-06:00,HCM-BROD-0110-C25_treatment6,ae2f7f10-09a5-4fda-a2a9-e9aaf54a892a,,released,,0,2020-09-17T15:46:02.505191-05:00,Targeted Molecular Therapy,Residual Disease,
HCM-BROD-0678-C71,79858538-bc27-4abd-9b42-16659ad5da56,d96f0dad-49dc-4977-ab8a-6d65d1c6783e,,Adjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0678-C71_treatment3,3e3c34ca-5a95-441f-9f7a-8cb90cff99a2,,released,,0,2020-10-08T14:47:08.707719-05:00,"Pharmaceutical Therapy, NOS",Residual Disease,
HCM-BROD-0678-C71,79858538-bc27-4abd-9b42-16659ad5da56,d96f0dad-49dc-4977-ab8a-6d65d1c6783e,,Neoadjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0678-C71_treatment,47b759b9-b12e-4f45-8843-8fdab86be245,,released,,0,2020-10-08T14:47:08.707719-05:00,,,
HCM-BROD-0678-C71,79858538-bc27-4abd-9b42-16659ad5da56,d96f0dad-49dc-4977-ab8a-6d65d1c6783e,,,13.0,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0678-C71_treatment2,9616b102-0a59-44af-812a-c6eaa26ee93c,,released,,1,2020-10-08T14:47:08.707719-05:00,"Surgery, NOS",Initial Diagnosis,
HCM-BROD-0678-C71,79858538-bc27-4abd-9b42-16659ad5da56,d96f0dad-49dc-4977-ab8a-6d65d1c6783e,,Adjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0678-C71_treatment4,e1584f99-20ab-4cd1-9f1f-0e9d5ee9a01c,,released,,0,2020-10-08T14:47:08.707719-05:00,"Radiation Therapy, NOS",Residual Disease,
HCM-SANG-0302-C15,799c9373-815b-4031-a495-47858e06908e,5d6a9815-8342-4a70-a154-bcc0fce20f37,,Neoadjuvant,12.0,2023-03-13T13:00:48.763169-05:00,HCM-SANG-0302-C15_treatment4,3995288a-e7c2-471e-9309-aed6863c2cd6,,released,,1,2021-12-21T15:09:34.237412-06:00,Chemotherapy,,ECX
HCM-SANG-0302-C15,799c9373-815b-4031-a495-47858e06908e,5d6a9815-8342-4a70-a154-bcc0fce20f37,,Neoadjuvant,12.0,2023-03-13T13:00:48.763169-05:00,HCM-SANG-0302-C15_treatment,5691cf24-8f91-4485-b89b-9f5854fed02e,,released,Epirubicin,1,2021-12-21T15:09:34.237412-06:00,Chemotherapy,,
HCM-SANG-0302-C15,799c9373-815b-4031-a495-47858e06908e,5d6a9815-8342-4a70-a154-bcc0fce20f37,,Neoadjuvant,12.0,2023-03-13T13:00:48.763169-05:00,HCM-SANG-0302-C15_treatment2,930fa744-3428-407d-bed0-99981e4b57e7,,released,Capecitabine,1,2021-12-21T15:09:34.237412-06:00,Chemotherapy,,
HCM-SANG-0302-C15,799c9373-815b-4031-a495-47858e06908e,5d6a9815-8342-4a70-a154-bcc0fce20f37,,Neoadjuvant,12.0,2023-03-13T13:00:48.763169-05:00,HCM-SANG-0302-C15_treatment3,a2b36a40-1e46-40bb-90bd-39035d2b236f,,released,Cisplatin,1,2021-12-21T15:09:34.237412-06:00,Chemotherapy,,
HCM-SANG-0518-C18,79bb4e5b-5dc9-4103-9f61-5a43b15c56fa,a4235ce1-4426-4bb2-b0e6-bac541b359ce,,Neoadjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-SANG-0518-C18_treatment,c4cb0fbe-76ea-4c37-97b8-1d398f1ecfdc,,released,,0,2021-12-21T15:12:59.124373-06:00,,,
HCM-EXPT-1202-C15,79d5db4e-9b07-4105-a5f7-0831fd99e04e,38535a55-1101-4d91-b6c8-1f4f25501af5,,Neoadjuvant,,2025-10-08T12:38:51.189053-05:00,HCM-EXPT-1202-C15_treatment,6856b51b-5be3-4ce8-b8d3-7e70c3fbb1d9,,released,,0,2023-02-24T14:19:29.016736-06:00,,,
HCM-BROD-0453-C16,7a4676bb-3b9f-4e1c-b58f-30f80660df44,d77b94e3-d684-4197-a5d2-c67ac610964d,,Neoadjuvant,26.0,2023-02-22T07:39:25.979291-06:00,HCM-BROD-0453-C16_treatment,187c828c-8ce9-4776-aa31-bc40effeeb42,,released,Oxaliplatin,1,2020-09-27T11:38:45.277683-05:00,Chemotherapy,,
HCM-BROD-0453-C16,7a4676bb-3b9f-4e1c-b58f-30f80660df44,d77b94e3-d684-4197-a5d2-c67ac610964d,,Neoadjuvant,26.0,2023-02-22T07:39:25.979291-06:00,HCM-BROD-0453-C16_treatment2,2da20b25-fd65-4855-9bb3-569d7d5209fb,,released,Docetaxel,1,2020-09-27T11:38:45.277683-05:00,Chemotherapy,,
HCM-BROD-0453-C16,7a4676bb-3b9f-4e1c-b58f-30f80660df44,d77b94e3-d684-4197-a5d2-c67ac610964d,278.0,Adjuvant,179.0,2023-02-22T07:39:25.979291-06:00,HCM-BROD-0453-C16_treatment6,31e49f92-1f47-4028-bcdc-e8558e7709cb,,released,Fluorouracil,1,2020-09-27T11:38:45.277683-05:00,Chemotherapy,Residual Disease,
HCM-BROD-0453-C16,7a4676bb-3b9f-4e1c-b58f-30f80660df44,d77b94e3-d684-4197-a5d2-c67ac610964d,,Neoadjuvant,26.0,2023-02-22T07:39:25.979291-06:00,HCM-BROD-0453-C16_treatment5,3a80de79-e876-493e-8722-52cfe17ebd8c,,released,,1,2020-09-27T11:38:45.277683-05:00,Chemotherapy,,FU-LV regimen
HCM-BROD-0453-C16,7a4676bb-3b9f-4e1c-b58f-30f80660df44,d77b94e3-d684-4197-a5d2-c67ac610964d,395.0,Adjuvant,336.0,2023-02-22T07:39:25.979291-06:00,HCM-BROD-0453-C16_treatment7,3afbdd40-c786-4053-a460-fd726d5616d2,Treatment Ongoing,released,Docetaxel,1,2020-09-27T11:38:45.277683-05:00,Chemotherapy,Residual Disease,
HCM-BROD-0453-C16,7a4676bb-3b9f-4e1c-b58f-30f80660df44,d77b94e3-d684-4197-a5d2-c67ac610964d,,Adjuvant,,2023-02-22T07:39:25.979291-06:00,HCM-BROD-0453-C16_treatment12,81ad83b2-f3d7-458f-ba76-8b00030a4a1a,,released,,0,2020-09-27T11:38:45.277683-05:00,Targeted Molecular Therapy,Residual Disease,
HCM-BROD-0453-C16,7a4676bb-3b9f-4e1c-b58f-30f80660df44,d77b94e3-d684-4197-a5d2-c67ac610964d,395.0,Adjuvant,334.0,2023-02-22T07:39:25.979291-06:00,HCM-BROD-0453-C16_treatment8,839ae1c6-dcdc-4fea-bb9c-259a3f26d7cf,Treatment Ongoing,released,Oxaliplatin,1,2020-09-27T11:38:45.277683-05:00,Chemotherapy,Residual Disease,
HCM-BROD-0453-C16,7a4676bb-3b9f-4e1c-b58f-30f80660df44,d77b94e3-d684-4197-a5d2-c67ac610964d,,Neoadjuvant,26.0,2023-02-22T07:39:25.979291-06:00,HCM-BROD-0453-C16_treatment4,9a57dbfd-fac6-42a2-9253-22cbd9eed35f,,released,Leucovorin,1,2020-09-27T11:38:45.277683-05:00,Chemotherapy,,
HCM-BROD-0453-C16,7a4676bb-3b9f-4e1c-b58f-30f80660df44,d77b94e3-d684-4197-a5d2-c67ac610964d,,Adjuvant,,2023-02-22T07:39:25.979291-06:00,HCM-BROD-0453-C16_treatment10,9e382c0c-1a3a-4831-bdee-3d0cac38dd6a,,released,,0,2020-09-27T11:38:45.277683-05:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-BROD-0453-C16,7a4676bb-3b9f-4e1c-b58f-30f80660df44,d77b94e3-d684-4197-a5d2-c67ac610964d,395.0,Adjuvant,336.0,2023-02-22T07:39:25.979291-06:00,HCM-BROD-0453-C16_treatment9,c9fc2916-066e-4f1b-9bec-1a4f23dff42c,Treatment Ongoing,released,Fluorouracil,1,2020-09-27T11:38:45.277683-05:00,Chemotherapy,Residual Disease,
HCM-BROD-0453-C16,7a4676bb-3b9f-4e1c-b58f-30f80660df44,d77b94e3-d684-4197-a5d2-c67ac610964d,216.0,Adjuvant,179.0,2023-02-22T07:39:25.979291-06:00,HCM-BROD-0453-C16_treatment13,f3c0c992-29a1-4de3-a882-8aebb7d6a11f,,released,,1,2020-09-27T11:38:45.277683-05:00,"Radiation Therapy, NOS",Residual Disease,
HCM-BROD-0453-C16,7a4676bb-3b9f-4e1c-b58f-30f80660df44,d77b94e3-d684-4197-a5d2-c67ac610964d,,Neoadjuvant,26.0,2023-02-22T07:39:25.979291-06:00,HCM-BROD-0453-C16_treatment3,ff238100-5704-4948-8234-095c4deb50a5,,released,Fluorouracil,1,2020-09-27T11:38:45.277683-05:00,Chemotherapy,,
HCM-SANG-0296-C15,7ad830fb-890c-4a3e-b1ac-aa59f23a9333,b872062b-6b79-417e-a717-5226c2a0aa2d,,Neoadjuvant,95.0,2023-03-13T13:03:30.293145-05:00,HCM-SANG-0296-C15_treatment,11bfa38e-91cd-4968-817d-8bba342ee3f3,,released,Epirubicin,1,2020-02-27T12:53:26.911590-06:00,Chemotherapy,,
HCM-SANG-0296-C15,7ad830fb-890c-4a3e-b1ac-aa59f23a9333,b872062b-6b79-417e-a717-5226c2a0aa2d,,Neoadjuvant,95.0,2023-03-13T13:03:30.293145-05:00,HCM-SANG-0296-C15_treatment3,531fd1d0-82cf-425d-88eb-688e8c391416,,released,Cisplatin,1,2020-11-11T09:36:43.716814-06:00,Chemotherapy,,
HCM-SANG-0296-C15,7ad830fb-890c-4a3e-b1ac-aa59f23a9333,b872062b-6b79-417e-a717-5226c2a0aa2d,,Neoadjuvant,95.0,2023-03-13T13:03:30.293145-05:00,HCM-SANG-0296-C15_treatment2,9fe4a627-d255-4ae2-964a-909a62a75555,,released,Capecitabine,1,2020-11-11T09:36:43.716814-06:00,Chemotherapy,,
HCM-SANG-0296-C15,7ad830fb-890c-4a3e-b1ac-aa59f23a9333,b872062b-6b79-417e-a717-5226c2a0aa2d,,Neoadjuvant,95.0,2023-03-13T13:03:30.293145-05:00,HCM-SANG-0296-C15_treatment4,aa5e806c-4061-4e2b-b372-88e01a662574,,released,,1,2020-11-11T09:36:43.716814-06:00,Chemotherapy,,ECX
HCM-SANG-1091-C18,7ae084ae-e644-46e1-97f5-52be2ed93538,9ed6b482-2fca-45ab-9e42-f3df0d4a0f4b,,Neoadjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-SANG-1091-C18_treatment,bdb759eb-ba77-4d0a-af89-c9421add0dda,,released,,0,2023-02-27T11:44:06.995961-06:00,,,
HCM-EXPT-1232-C15,7afe7012-a43f-48b7-a77c-a38ec942f77b,822a5971-500f-4baa-8dc6-4ed78b745c20,,Neoadjuvant,,2025-10-08T12:39:14.406630-05:00,HCM-EXPT-1232-C15_treatment,a424e0db-adb3-4216-973c-27135406d6a7,,released,,0,2023-02-24T14:13:08.090814-06:00,,,
HCM-CSHL-0658-C20,7b9b67c9-28f3-47f3-beb0-1b2e8c0b05d7,b3bdf29a-4ab4-4a48-9eca-7dc5f314b0fe,,Neoadjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0658-C20_treatment,294868dd-4bee-46f0-af91-77a2c28084fc,,released,,0,2021-12-21T14:15:16.458472-06:00,,,
HCM-CSHL-0658-C20,7b9b67c9-28f3-47f3-beb0-1b2e8c0b05d7,b3bdf29a-4ab4-4a48-9eca-7dc5f314b0fe,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0658-C20_treatment7,94d103d4-5245-422f-852c-ed162ff4c3e9,,released,,0,2021-12-21T14:15:16.458472-06:00,"Radiation Therapy, NOS",Residual Disease,
HCM-CSHL-0658-C20,7b9b67c9-28f3-47f3-beb0-1b2e8c0b05d7,b3bdf29a-4ab4-4a48-9eca-7dc5f314b0fe,,,932.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0658-C20_treatment4,aeadbb69-c8c6-4f33-9969-5909144d5a6c,,released,,1,2021-12-21T14:15:16.458472-06:00,"Surgery, NOS",Initial Diagnosis,
HCM-CSHL-0658-C20,7b9b67c9-28f3-47f3-beb0-1b2e8c0b05d7,b3bdf29a-4ab4-4a48-9eca-7dc5f314b0fe,,,1093.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0658-C20_treatment5,b95fc487-1cc3-4b25-9a89-fb52d5201b37,,released,,1,2021-12-21T14:15:16.458472-06:00,"Surgery, NOS",Initial Diagnosis,
HCM-CSHL-0373-C25,7b9b6956-d4b6-46cd-8ad9-41e9c21a0316,f2f7992c-7f09-4f62-9548-732ed9859f0d,,,-14.0,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0373-C25_treatment5,0e34316a-c30c-4efb-b5e2-84515b668ac4,,released,,1,2020-09-28T09:54:05.598221-05:00,"Surgery, NOS",Initial Diagnosis,
HCM-CSHL-0373-C25,7b9b6956-d4b6-46cd-8ad9-41e9c21a0316,f2f7992c-7f09-4f62-9548-732ed9859f0d,,Adjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0373-C25_treatment2,12f38442-c1f2-459b-a5f6-c4e75f88285e,,released,Gemcitabine,1,2020-09-28T09:54:05.598221-05:00,Chemotherapy,Residual Disease,
HCM-CSHL-0373-C25,7b9b6956-d4b6-46cd-8ad9-41e9c21a0316,f2f7992c-7f09-4f62-9548-732ed9859f0d,,Adjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0373-C25_treatment4,2493062a-24df-4dd3-9416-365b1a86abcc,,released,,0,2020-09-28T09:54:05.598221-05:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-CSHL-0373-C25,7b9b6956-d4b6-46cd-8ad9-41e9c21a0316,f2f7992c-7f09-4f62-9548-732ed9859f0d,,Adjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0373-C25_treatment3,93b82051-1415-48c9-80d2-65204c12706d,,released,Carboplatin,1,2020-09-28T09:54:05.598221-05:00,Chemotherapy,Residual Disease,
HCM-CSHL-0373-C25,7b9b6956-d4b6-46cd-8ad9-41e9c21a0316,f2f7992c-7f09-4f62-9548-732ed9859f0d,,Neoadjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0373-C25_treatment,93d287eb-a0de-436e-8352-86dfd670951d,,released,,0,2020-09-28T09:54:05.598221-05:00,,,
HCM-CSHL-0373-C25,7b9b6956-d4b6-46cd-8ad9-41e9c21a0316,f2f7992c-7f09-4f62-9548-732ed9859f0d,,Adjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0373-C25_treatment6,9c1d07ba-697a-48d9-a6a9-e49a09100779,,released,,0,2020-09-28T09:54:05.598221-05:00,Targeted Molecular Therapy,Residual Disease,
HCM-CSHL-0373-C25,7b9b6956-d4b6-46cd-8ad9-41e9c21a0316,f2f7992c-7f09-4f62-9548-732ed9859f0d,,Adjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0373-C25_treatment7,bf3aa0e4-1a5b-4181-becf-d7fcb3d82945,,released,,0,2020-09-28T09:54:05.598221-05:00,"Radiation Therapy, NOS",Residual Disease,
HCM-BROD-0122-C25,7cdc52da-546a-4318-adb8-00ade0a941db,6ff09240-b994-4c1c-ba3b-3392cd45b632,,Neoadjuvant,,2023-07-13T10:35:44.371881-05:00,HCM-BROD-0122-C25_treatment,3fbf0c1b-e316-4d8c-9738-d4993068a79a,,released,,0,2020-07-23T14:36:17.120169-05:00,,,
HCM-BROD-0122-C25,7cdc52da-546a-4318-adb8-00ade0a941db,6ff09240-b994-4c1c-ba3b-3392cd45b632,,,,2023-07-13T10:35:44.371881-05:00,HCM-BROD-0122-C25_treatment4,62068cca-4040-4259-9573-bbd2e53aa327,,released,,0,2020-07-23T14:36:17.120169-05:00,"Surgery, NOS",Initial Diagnosis,
HCM-BROD-0122-C25,7cdc52da-546a-4318-adb8-00ade0a941db,6ff09240-b994-4c1c-ba3b-3392cd45b632,,Adjuvant,,2023-07-13T10:35:44.371881-05:00,HCM-BROD-0122-C25_treatment6,a344a62c-051d-466e-8767-1c06e9bc82d1,,released,,0,2020-07-23T14:36:17.120169-05:00,"Radiation Therapy, NOS",Residual Disease,
HCM-BROD-1098-C91,7d03e209-ad89-461e-b5f9-f7dc88a2684c,0fc79262-4c6e-434e-98ed-c2c2202bc47a,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-BROD-1098-C91_treatment4,34408269-a359-4d69-8f9b-d3d9b4f76809,,released,,0,2021-12-21T15:22:16.674428-06:00,Hormone Therapy,Residual Disease,
HCM-BROD-1098-C91,7d03e209-ad89-461e-b5f9-f7dc88a2684c,0fc79262-4c6e-434e-98ed-c2c2202bc47a,,,,2025-04-07T17:13:09.336794-05:00,HCM-BROD-1098-C91_treatment6,39b2cc02-ecf1-4aab-964f-ec3a168276e6,,released,,0,2021-12-21T15:22:16.674428-06:00,"Surgery, NOS",Initial Diagnosis,
HCM-BROD-1098-C91,7d03e209-ad89-461e-b5f9-f7dc88a2684c,0fc79262-4c6e-434e-98ed-c2c2202bc47a,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-BROD-1098-C91_treatment8,4262e2c4-b433-419f-b07f-3b4fd6180ce6,,released,,0,2021-12-21T15:22:16.674428-06:00,"Radiation Therapy, NOS",Residual Disease,
HCM-BROD-1098-C91,7d03e209-ad89-461e-b5f9-f7dc88a2684c,0fc79262-4c6e-434e-98ed-c2c2202bc47a,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-BROD-1098-C91_treatment5,614eed52-24cc-4fdc-9f77-51369387f755,,released,,0,2021-12-21T15:22:16.674428-06:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-BROD-1098-C91,7d03e209-ad89-461e-b5f9-f7dc88a2684c,0fc79262-4c6e-434e-98ed-c2c2202bc47a,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-BROD-1098-C91_treatment7,6c936689-08ce-49da-8411-4027d7fcbc86,,released,,0,2021-12-21T15:22:16.674428-06:00,Targeted Molecular Therapy,Residual Disease,
HCM-BROD-1098-C91,7d03e209-ad89-461e-b5f9-f7dc88a2684c,0fc79262-4c6e-434e-98ed-c2c2202bc47a,1310.0,Adjuvant,1307.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-1098-C91_treatment2,79058ae4-b9e2-421b-9cfb-7bcf95b54cfc,,released,Fludarabine,1,2021-12-21T15:22:16.674428-06:00,Chemotherapy,Residual Disease,
HCM-BROD-1098-C91,7d03e209-ad89-461e-b5f9-f7dc88a2684c,0fc79262-4c6e-434e-98ed-c2c2202bc47a,1310.0,Adjuvant,1307.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-1098-C91_treatment3,8568ed81-bbc3-4a69-b634-079192801de1,,released,Busulfan,1,2021-12-21T15:22:16.674428-06:00,Chemotherapy,Residual Disease,
HCM-BROD-1098-C91,7d03e209-ad89-461e-b5f9-f7dc88a2684c,0fc79262-4c6e-434e-98ed-c2c2202bc47a,,Neoadjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-BROD-1098-C91_treatment,d117ecdc-5e39-4041-8305-2abd0cb28941,,released,,0,2021-12-21T15:22:16.674428-06:00,,,
HCM-BROD-1098-C91,7d03e209-ad89-461e-b5f9-f7dc88a2684c,0fc79262-4c6e-434e-98ed-c2c2202bc47a,,,1306.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-1098-C91_treatment9,e46a5eb3-bf7a-446b-9f7a-0b47c94f5ad7,,released,,1,2021-12-21T15:22:16.674428-06:00,"Stem Cell Transplantation, Allogeneic",,
HCM-WCMC-0790-C67,7d2af728-4620-4ed4-946c-70956f6e6f57,402e910d-bfbc-4433-b8e9-a3260e56608a,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-WCMC-0790-C67_treatment10,06bddd32-e22d-4856-b8ca-e048f77ff921,,released,,0,2023-02-27T11:29:02.317289-06:00,Targeted Molecular Therapy,Residual Disease,
HCM-WCMC-0790-C67,7d2af728-4620-4ed4-946c-70956f6e6f57,402e910d-bfbc-4433-b8e9-a3260e56608a,,Neoadjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-WCMC-0790-C67_treatment,1048b2d0-9c7a-457e-b1cb-ac3c7dd781c3,,released,,0,2023-02-27T11:29:02.317289-06:00,,,
HCM-WCMC-0790-C67,7d2af728-4620-4ed4-946c-70956f6e6f57,402e910d-bfbc-4433-b8e9-a3260e56608a,211.0,Adjuvant,167.0,2025-04-07T17:13:09.336794-05:00,HCM-WCMC-0790-C67_treatment3,206d2902-550d-4fdb-ac58-ac46eeb17104,,released,Cisplatin,1,2023-02-27T11:29:02.317289-06:00,Chemotherapy,Residual Disease,
HCM-WCMC-0790-C67,7d2af728-4620-4ed4-946c-70956f6e6f57,402e910d-bfbc-4433-b8e9-a3260e56608a,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-WCMC-0790-C67_treatment8,64d95ee8-5da8-4fb0-a830-490970b73c0d,,released,,0,2023-02-27T11:29:02.317289-06:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-WCMC-0790-C67,7d2af728-4620-4ed4-946c-70956f6e6f57,402e910d-bfbc-4433-b8e9-a3260e56608a,211.0,Adjuvant,167.0,2025-04-07T17:13:09.336794-05:00,HCM-WCMC-0790-C67_treatment2,8f4eda46-5994-4db8-9a43-aac0a89e6d37,,released,Vinblastine,1,2023-02-27T11:29:02.317289-06:00,Chemotherapy,Residual Disease,
HCM-WCMC-0790-C67,7d2af728-4620-4ed4-946c-70956f6e6f57,402e910d-bfbc-4433-b8e9-a3260e56608a,,,94.0,2025-04-07T17:13:09.336794-05:00,HCM-WCMC-0790-C67_treatment9,972ba69f-1157-4431-906f-50419773b19c,,released,,1,2023-02-27T11:29:02.317289-06:00,"Surgery, NOS",Initial Diagnosis,
HCM-WCMC-0790-C67,7d2af728-4620-4ed4-946c-70956f6e6f57,402e910d-bfbc-4433-b8e9-a3260e56608a,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-WCMC-0790-C67_treatment11,bb6b18e5-d172-4ac0-8096-dc3ce94fc5e8,,released,,0,2023-02-27T11:29:02.317289-06:00,"Radiation Therapy, NOS",Residual Disease,
HCM-WCMC-0790-C67,7d2af728-4620-4ed4-946c-70956f6e6f57,402e910d-bfbc-4433-b8e9-a3260e56608a,211.0,Adjuvant,167.0,2025-04-07T17:13:09.336794-05:00,HCM-WCMC-0790-C67_treatment4,d14b3a76-f5a7-46d2-bbed-f8de7f36a22c,,released,Doxorubicin,1,2023-02-27T11:29:02.317289-06:00,Chemotherapy,Residual Disease,
HCM-WCMC-0790-C67,7d2af728-4620-4ed4-946c-70956f6e6f57,402e910d-bfbc-4433-b8e9-a3260e56608a,211.0,Adjuvant,167.0,2025-04-07T17:13:09.336794-05:00,HCM-WCMC-0790-C67_treatment5,d3cb29b6-aa68-4857-8f6a-8eea13f53dba,,released,Methotrexate,1,2023-02-27T11:29:02.317289-06:00,Chemotherapy,Residual Disease,
HCM-WCMC-0790-C67,7d2af728-4620-4ed4-946c-70956f6e6f57,402e910d-bfbc-4433-b8e9-a3260e56608a,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-WCMC-0790-C67_treatment7,d4fd661d-295b-4346-940d-c143a8c80207,,released,,0,2023-02-27T11:29:02.317289-06:00,Hormone Therapy,Residual Disease,
HCM-WCMC-0790-C67,7d2af728-4620-4ed4-946c-70956f6e6f57,402e910d-bfbc-4433-b8e9-a3260e56608a,211.0,Adjuvant,167.0,2025-04-07T17:13:09.336794-05:00,HCM-WCMC-0790-C67_treatment6,e5b37129-3287-4eb5-b51e-5356ba1b439d,,released,,1,2023-02-27T11:29:02.317289-06:00,Chemotherapy,Residual Disease,MVAC-Growth Factor Regimen
HCM-BROD-0676-C71,7da47919-73f4-4e05-a5f5-16aa5cd243bf,1641b1b9-f479-4234-86cf-52f6df837d8d,86.0,Maintenance Therapy,45.0,2023-02-22T07:39:25.979291-06:00,HCM-BROD-0676-C71_treatment7,1a15c094-7b0e-4219-980c-4a18fd24ab0c,Progressive Disease,released,Temozolomide,1,2021-12-21T13:42:52.738810-06:00,,,
HCM-BROD-0676-C71,7da47919-73f4-4e05-a5f5-16aa5cd243bf,29252521-279f-4244-b996-7de71a21b46c,,,0.0,2023-02-27T13:33:37.524548-06:00,HCM-BROD-0676-C71_treatment4,3843a35e-171f-4bce-900e-56e619096017,,released,,1,2021-12-21T13:42:52.738810-06:00,"Surgery, NOS",Initial Diagnosis,
HCM-BROD-0676-C71,7da47919-73f4-4e05-a5f5-16aa5cd243bf,29252521-279f-4244-b996-7de71a21b46c,,Adjuvant,,2023-02-22T07:39:25.979291-06:00,HCM-BROD-0676-C71_treatment3,3f4ac288-e2bb-4a1c-84fa-ead0544500db,,released,,0,2021-12-21T13:42:52.738810-06:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-BROD-0676-C71,7da47919-73f4-4e05-a5f5-16aa5cd243bf,29252521-279f-4244-b996-7de71a21b46c,355.0,Adjuvant,283.0,2023-02-22T07:39:25.979291-06:00,HCM-BROD-0676-C71_treatment5,7dd73152-a211-4867-b3c6-e954d04084ac,,released,Not Reported,1,2021-12-21T13:42:52.738810-06:00,Targeted Molecular Therapy,Residual Disease,
HCM-BROD-0676-C71,7da47919-73f4-4e05-a5f5-16aa5cd243bf,29252521-279f-4244-b996-7de71a21b46c,,Adjuvant,,2023-02-22T07:39:25.979291-06:00,HCM-BROD-0676-C71_treatment2,8c31df20-55dc-4ae3-b8ea-681b4c390c3d,,released,,0,2021-12-21T13:42:52.738810-06:00,Chemotherapy,Residual Disease,
HCM-BROD-0676-C71,7da47919-73f4-4e05-a5f5-16aa5cd243bf,29252521-279f-4244-b996-7de71a21b46c,,Neoadjuvant,,2023-02-22T07:39:25.979291-06:00,HCM-BROD-0676-C71_treatment,9222fb62-1d70-461b-88cf-67a37bdb2228,,released,,0,2021-12-21T13:42:52.738810-06:00,,,
HCM-BROD-0676-C71,7da47919-73f4-4e05-a5f5-16aa5cd243bf,29252521-279f-4244-b996-7de71a21b46c,,Adjuvant,,2023-02-22T07:39:25.979291-06:00,HCM-BROD-0676-C71_treatment6,f7402b61-6ed7-44fc-84ec-02f008c62c82,,released,,0,2021-12-21T13:42:52.738810-06:00,"Radiation Therapy, NOS",Residual Disease,
HCM-BROD-0869-C43,7e4f2097-9694-48de-aa29-2130dd39416b,1ba37c32-da52-457c-9968-26e4a1704b34,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0869-C43_treatment8,0ceabfe7-2981-41dc-a837-317055bd6135,,released,,0,2021-12-21T13:56:14.406589-06:00,Targeted Molecular Therapy,Residual Disease,
HCM-BROD-0869-C43,7e4f2097-9694-48de-aa29-2130dd39416b,1ba37c32-da52-457c-9968-26e4a1704b34,579.0,Adjuvant,497.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0869-C43_treatment6,1ac7302b-ff0d-4479-bc4e-f12d732c065b,,released,Nivolumab,1,2021-12-21T13:56:14.406589-06:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-BROD-0869-C43,7e4f2097-9694-48de-aa29-2130dd39416b,1ba37c32-da52-457c-9968-26e4a1704b34,,,0.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0869-C43_treatment7,2fe0de05-52d4-4d0c-9ca2-25a57fe1150d,,released,,1,2021-12-21T13:56:14.406589-06:00,"Surgery, NOS",Initial Diagnosis,
HCM-BROD-0869-C43,7e4f2097-9694-48de-aa29-2130dd39416b,1ba37c32-da52-457c-9968-26e4a1704b34,579.0,Adjuvant,497.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0869-C43_treatment5,3afcfc45-3ace-41ae-b7e7-ef1b6115b2c5,,released,Ipilimumab,1,2021-12-21T13:56:14.406589-06:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-BROD-0869-C43,7e4f2097-9694-48de-aa29-2130dd39416b,1ba37c32-da52-457c-9968-26e4a1704b34,,Neoadjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0869-C43_treatment,49f9818f-6760-4a78-9fb9-7cc60e78df64,,released,,0,2021-12-21T13:56:14.406589-06:00,,,
HCM-BROD-0869-C43,7e4f2097-9694-48de-aa29-2130dd39416b,1ba37c32-da52-457c-9968-26e4a1704b34,490.0,Adjuvant,122.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0869-C43_treatment4,82980f80-ab75-40be-ba19-c55b9356da8a,,released,Pembrolizumab,1,2021-12-21T13:56:14.406589-06:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-BROD-0869-C43,7e4f2097-9694-48de-aa29-2130dd39416b,1ba37c32-da52-457c-9968-26e4a1704b34,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0869-C43_treatment9,b3c58f20-d0c1-4cf7-89ba-5614539f8599,,released,,0,2021-12-21T13:56:14.406589-06:00,"Radiation Therapy, NOS",Residual Disease,
HCM-BROD-0869-C43,7e4f2097-9694-48de-aa29-2130dd39416b,1ba37c32-da52-457c-9968-26e4a1704b34,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0869-C43_treatment3,d1c82d94-6b2a-41e4-b442-e43f351165fb,,released,,0,2021-12-21T13:56:14.406589-06:00,Hormone Therapy,Residual Disease,
HCM-BROD-0869-C43,7e4f2097-9694-48de-aa29-2130dd39416b,1ba37c32-da52-457c-9968-26e4a1704b34,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0869-C43_treatment2,f9fcd8d5-9330-4494-9058-749e46a33131,,released,,0,2021-12-21T13:56:14.406589-06:00,Chemotherapy,Residual Disease,
HCM-CSHL-0460-C50,7eb28d9c-d25e-4112-9666-145bf7cee7c5,0212cd72-ea8c-44d2-98e5-47eaa67722c6,,Adjuvant,68.0,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0460-C50_treatment3,094ec7cf-07fb-4fb8-b6b7-c177623e72e3,Treatment Ongoing,released,Not Reported,1,2020-09-28T10:19:40.728772-05:00,Hormone Therapy,Residual Disease,
HCM-CSHL-0460-C50,7eb28d9c-d25e-4112-9666-145bf7cee7c5,0212cd72-ea8c-44d2-98e5-47eaa67722c6,,Adjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0460-C50_treatment2,0b6a824b-042d-4fea-9ffe-af76a8d11d96,,released,,0,2020-09-28T10:19:40.728772-05:00,Chemotherapy,Residual Disease,
HCM-CSHL-0460-C50,7eb28d9c-d25e-4112-9666-145bf7cee7c5,0212cd72-ea8c-44d2-98e5-47eaa67722c6,,Neoadjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0460-C50_treatment,72c6d113-2b98-47a4-85e2-a9fafe1a4dcc,,released,,0,2020-09-28T10:19:40.728772-05:00,,,
HCM-CSHL-0460-C50,7eb28d9c-d25e-4112-9666-145bf7cee7c5,0212cd72-ea8c-44d2-98e5-47eaa67722c6,,Adjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0460-C50_treatment7,bdc27cfa-12af-4848-8af5-79b3c2fde4ce,,released,,0,2020-09-28T10:19:40.728772-05:00,"Radiation Therapy, NOS",Residual Disease,
HCM-CSHL-0460-C50,7eb28d9c-d25e-4112-9666-145bf7cee7c5,0212cd72-ea8c-44d2-98e5-47eaa67722c6,,,30.0,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0460-C50_treatment5,cc690333-f732-4248-ba28-768dc4a34762,,released,,1,2020-09-28T10:19:40.728772-05:00,"Surgery, NOS",Initial Diagnosis,
HCM-CSHL-0460-C50,7eb28d9c-d25e-4112-9666-145bf7cee7c5,0212cd72-ea8c-44d2-98e5-47eaa67722c6,,Adjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0460-C50_treatment6,cfdd8585-58a4-47c1-8377-f2d3ba90df64,,released,,0,2020-09-28T10:19:40.728772-05:00,Targeted Molecular Therapy,Residual Disease,
HCM-CSHL-0460-C50,7eb28d9c-d25e-4112-9666-145bf7cee7c5,0212cd72-ea8c-44d2-98e5-47eaa67722c6,,Adjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0460-C50_treatment4,ed86a962-1470-4722-b9e2-58e703498ad7,,released,,0,2020-09-28T10:19:40.728772-05:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-BROD-0227-C43,7ec96446-8a5e-400a-966b-986452c972e4,538d631d-9d1b-4fac-b5df-36547334d590,,,0.0,2023-02-27T11:20:10.957339-06:00,HCM-BROD-0227-C43_treatment5,12cffa0a-328c-4ed8-a06b-7347b788e7a4,,released,,1,2020-07-31T09:26:18.684105-05:00,"Surgery, NOS",Initial Diagnosis,
HCM-BROD-0227-C43,7ec96446-8a5e-400a-966b-986452c972e4,538d631d-9d1b-4fac-b5df-36547334d590,,Adjuvant,,2021-01-06T22:55:10.531130-06:00,HCM-BROD-0227-C43_treatment2,1de9a2ab-158e-4b95-b166-3154a85108af,,released,,0,2020-07-31T09:26:18.684105-05:00,Chemotherapy,Residual Disease,
HCM-BROD-0227-C43,7ec96446-8a5e-400a-966b-986452c972e4,538d631d-9d1b-4fac-b5df-36547334d590,90.0,Adjuvant,62.0,2021-01-06T22:55:10.531130-06:00,HCM-BROD-0227-C43_treatment7,2047a6d4-5c8c-4dd5-95f4-2d9f9b00c3c4,,released,,1,2020-09-27T11:09:01.249053-05:00,"Radiation Therapy, NOS",Residual Disease,
HCM-BROD-0227-C43,7ec96446-8a5e-400a-966b-986452c972e4,538d631d-9d1b-4fac-b5df-36547334d590,,Adjuvant,,2021-01-06T22:55:10.531130-06:00,HCM-BROD-0227-C43_treatment3,af822ff8-1078-46d8-8c5a-73a5bb9172a1,,released,,0,2020-07-31T09:26:18.684105-05:00,Hormone Therapy,Residual Disease,
HCM-BROD-0227-C43,7ec96446-8a5e-400a-966b-986452c972e4,538d631d-9d1b-4fac-b5df-36547334d590,420.0,Adjuvant,98.0,2021-01-06T22:55:10.531130-06:00,HCM-BROD-0227-C43_treatment6,b139591c-bb34-4f08-acde-af2661d60763,Treatment Ongoing,released,Nivolumab,1,2020-07-31T09:26:18.684105-05:00,Targeted Molecular Therapy,Residual Disease,
HCM-BROD-0227-C43,7ec96446-8a5e-400a-966b-986452c972e4,538d631d-9d1b-4fac-b5df-36547334d590,,Neoadjuvant,,2021-01-06T22:55:10.531130-06:00,HCM-BROD-0227-C43_treatment,e6010cb2-7f38-459c-ae4d-089199b5b37a,,released,,0,2020-07-31T09:26:18.684105-05:00,,,
HCM-BROD-0227-C43,7ec96446-8a5e-400a-966b-986452c972e4,538d631d-9d1b-4fac-b5df-36547334d590,,Adjuvant,,2021-01-06T22:55:10.531130-06:00,HCM-BROD-0227-C43_treatment4,ecec33fc-195a-47c2-83f8-045ce4ea8830,,released,Not Reported,1,2020-07-31T09:26:18.684105-05:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-SANG-1318-C20,7edcd40e-5a42-42ab-85d7-61a950cf0d2d,6ec2c98d-c607-4f56-87f5-e70619ba78fd,,Neoadjuvant,132.0,2025-04-07T17:13:09.336794-05:00,HCM-SANG-1318-C20_treatment,00613eb9-4d68-45c7-b5e6-039fbb5dd804,,released,Capecitabine,1,2023-02-27T13:27:49.470335-06:00,Chemotherapy,,
HCM-SANG-1318-C20,7edcd40e-5a42-42ab-85d7-61a950cf0d2d,6ec2c98d-c607-4f56-87f5-e70619ba78fd,,Neoadjuvant,132.0,2025-04-07T17:13:09.336794-05:00,HCM-SANG-1318-C20_treatment2,80d7ca3f-cec6-4cf4-bbf5-0ba321507710,,released,Oxaliplatin,1,2023-02-27T13:27:49.470335-06:00,Chemotherapy,,
HCM-CSHL-0382-C19,7ee0c283-701b-47ac-bc3a-30f45e5c4eb2,2cb76b91-c491-471a-bb1d-1f6e8153b329,,Adjuvant,,2022-03-15T20:08:16.194346-05:00,HCM-CSHL-0382-C19_treatment4,18bae5ea-f93d-47fd-89ae-b94c9633461c,,released,,0,2020-06-15T13:24:58.329176-05:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-CSHL-0382-C19,7ee0c283-701b-47ac-bc3a-30f45e5c4eb2,2cb76b91-c491-471a-bb1d-1f6e8153b329,,Adjuvant,,2022-03-15T20:08:16.194346-05:00,HCM-CSHL-0382-C19_treatment7,5f7b8831-970b-4d61-a646-4ddf159974d0,,released,,0,2020-06-15T13:24:58.329176-05:00,Targeted Molecular Therapy,Residual Disease,
HCM-CSHL-0382-C19,7ee0c283-701b-47ac-bc3a-30f45e5c4eb2,2cb76b91-c491-471a-bb1d-1f6e8153b329,219.0,Adjuvant,38.0,2022-03-15T20:08:16.194346-05:00,HCM-CSHL-0382-C19_treatment3,6a5cc475-f86f-45fd-890f-f0250f25d8fc,,released,Leucovorin,1,2020-06-15T13:24:58.329176-05:00,Chemotherapy,Residual Disease,
HCM-CSHL-0382-C19,7ee0c283-701b-47ac-bc3a-30f45e5c4eb2,2cb76b91-c491-471a-bb1d-1f6e8153b329,,,765.0,2023-03-13T12:54:05.176421-05:00,HCM-CSHL-0382-C19_treatment6,6dc44141-27dc-481f-9bd6-b4f27597e95c,,released,,1,2020-06-15T13:24:58.329176-05:00,"Surgery, NOS",Initial Diagnosis,
HCM-CSHL-0382-C19,7ee0c283-701b-47ac-bc3a-30f45e5c4eb2,2cb76b91-c491-471a-bb1d-1f6e8153b329,219.0,Adjuvant,38.0,2022-03-15T20:08:16.194346-05:00,HCM-CSHL-0382-C19_treatment2,92d4af99-7d10-4ce6-bc49-2dd75bea700b,,released,Fluorouracil,1,2020-06-15T13:24:58.329176-05:00,Chemotherapy,Residual Disease,
HCM-CSHL-0382-C19,7ee0c283-701b-47ac-bc3a-30f45e5c4eb2,2cb76b91-c491-471a-bb1d-1f6e8153b329,,,6.0,2023-03-13T12:54:05.176421-05:00,HCM-CSHL-0382-C19_treatment5,a6574bda-a61c-4153-a455-ceb35305237e,,released,,1,2020-06-15T13:24:58.329176-05:00,"Surgery, NOS",Initial Diagnosis,
HCM-CSHL-0382-C19,7ee0c283-701b-47ac-bc3a-30f45e5c4eb2,2cb76b91-c491-471a-bb1d-1f6e8153b329,,Neoadjuvant,,2021-03-03T15:15:08.075155-06:00,HCM-CSHL-0382-C19_treatment,f2209d2f-9939-4649-aad2-a1b36e6f809f,,released,,0,2020-06-15T13:24:58.329176-05:00,,,
HCM-CSHL-0382-C19,7ee0c283-701b-47ac-bc3a-30f45e5c4eb2,2cb76b91-c491-471a-bb1d-1f6e8153b329,914.0,Adjuvant,905.0,2022-03-15T20:08:16.194346-05:00,HCM-CSHL-0382-C19_treatment8,f23d76ec-22b3-491c-8cd5-a96daebf3edf,,released,,1,2020-09-28T09:59:11.818404-05:00,"Radiation, Stereotactic/Gamma Knife/SRS",Residual Disease,
HCM-CSHL-0382-C19,7ee0c283-701b-47ac-bc3a-30f45e5c4eb2,5b2a6f0f-db0a-4266-9c24-b25a3ab9c466,,Maintenance Therapy,,2023-03-14T11:40:17.645275-05:00,HCM-CSHL-0382-C19_treatment9,bdd2e837-36c1-4ce3-bf08-28a1a11a28f9,Treatment Ongoing,released,Fluorouracil,1,2022-03-15T20:08:16.194346-05:00,,,
HCM-CSHL-0382-C19,7ee0c283-701b-47ac-bc3a-30f45e5c4eb2,5b2a6f0f-db0a-4266-9c24-b25a3ab9c466,,Maintenance Therapy,,2023-03-14T11:40:17.645275-05:00,HCM-CSHL-0382-C19_treatment10,e8531664-d6de-4b01-a5ef-e71ce8b856b0,Treatment Ongoing,released,Leucovorin,1,2022-03-15T20:08:16.194346-05:00,,,
HCM-EXPT-0999-C49,7efd0ed7-54dd-43a3-adb7-d786d83cb1df,3490554f-bd07-434a-b2da-97cdceb2567b,,Neoadjuvant,,2025-10-08T12:37:21.548354-05:00,HCM-EXPT-0999-C49_treatment,82e560c8-2b98-4d29-9039-0b966cf7f87c,,released,,0,2021-12-21T14:52:44.191303-06:00,,,
HCM-SANG-0546-C15,7f1867a9-37cc-4604-8c15-56467c12e193,fad3e16f-fcf0-4177-9c67-a421f4c172d8,,Neoadjuvant,100.0,2025-03-31T16:34:59.906497-05:00,HCM-SANG-0546-C15_treatment,6c708dc2-9271-4643-ab45-62bb3a500625,,released,Leucovorin,1,2021-12-21T15:15:48.932931-06:00,Chemotherapy,,
HCM-SANG-0546-C15,7f1867a9-37cc-4604-8c15-56467c12e193,fad3e16f-fcf0-4177-9c67-a421f4c172d8,,Neoadjuvant,100.0,2025-03-31T16:34:59.906497-05:00,HCM-SANG-0546-C15_treatment2,71d83e46-dbae-4cf8-94d9-36ab161f7d2c,,released,Fluorouracil,1,2021-12-21T15:15:48.932931-06:00,Chemotherapy,,
HCM-SANG-0546-C15,7f1867a9-37cc-4604-8c15-56467c12e193,fad3e16f-fcf0-4177-9c67-a421f4c172d8,,Neoadjuvant,100.0,2025-03-31T16:34:59.906497-05:00,HCM-SANG-0546-C15_treatment3,768245ab-e99f-4e56-a852-af21d66a4388,,released,Docetaxel,1,2021-12-21T15:15:48.932931-06:00,Chemotherapy,,
HCM-SANG-0546-C15,7f1867a9-37cc-4604-8c15-56467c12e193,fad3e16f-fcf0-4177-9c67-a421f4c172d8,,Neoadjuvant,100.0,2025-03-31T16:34:59.906497-05:00,HCM-SANG-0546-C15_treatment4,e28a2eac-b665-4517-bb33-86aa338887dd,,released,Oxaliplatin,1,2021-12-21T15:15:48.932931-06:00,Chemotherapy,,
HCM-BROD-0874-C43,7fa35302-efb7-4ca9-a23a-a5dcb54197c7,fc20dc18-b842-4dd4-bf9c-3404a5017219,,Neoadjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0874-C43_treatment,1965e0c3-0d60-4c70-9ccc-dcec07ff07ab,,released,,0,2021-12-21T13:56:41.209883-06:00,,,
HCM-BROD-0874-C43,7fa35302-efb7-4ca9-a23a-a5dcb54197c7,fc20dc18-b842-4dd4-bf9c-3404a5017219,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0874-C43_treatment4,2a267b10-592f-4d25-8836-c2d2e773ba12,,released,,0,2021-12-21T13:56:41.209883-06:00,"Radiation Therapy, NOS",Residual Disease,
HCM-BROD-0874-C43,7fa35302-efb7-4ca9-a23a-a5dcb54197c7,fc20dc18-b842-4dd4-bf9c-3404a5017219,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0874-C43_treatment3,3c542f53-bae6-4ec2-9f28-4b6c5745f437,,released,,0,2021-12-21T13:56:41.209883-06:00,"Pharmaceutical Therapy, NOS",Residual Disease,
HCM-BROD-0874-C43,7fa35302-efb7-4ca9-a23a-a5dcb54197c7,fc20dc18-b842-4dd4-bf9c-3404a5017219,,,,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0874-C43_treatment2,cfd19ba1-6576-4736-b3bb-9b05842ef495,,released,,0,2021-12-21T13:56:41.209883-06:00,"Surgery, NOS",Initial Diagnosis,
HCM-CSHL-0247-C18,7fa8bc57-4bc7-48a5-99fe-98ed02fa17e8,cde4e8e5-19c5-4576-9647-80d190ca2bf5,,Adjuvant,155.0,2021-07-12T12:25:55.528644-05:00,HCM-CSHL-0247-C18_treatment5,12b4c665-9161-43e7-8c8a-f9f02cad532e,,released,,1,2020-04-21T14:57:30.109195-05:00,Chemotherapy,Residual Disease,FOLFOX
HCM-CSHL-0247-C18,7fa8bc57-4bc7-48a5-99fe-98ed02fa17e8,cde4e8e5-19c5-4576-9647-80d190ca2bf5,,Adjuvant,,2021-07-12T12:25:55.528644-05:00,HCM-CSHL-0247-C18_treatment12,3ceb476d-da26-4049-9e85-01383486cfae,,released,,0,2020-10-08T12:09:47.671632-05:00,"Radiation Therapy, NOS",Residual Disease,
HCM-CSHL-0247-C18,7fa8bc57-4bc7-48a5-99fe-98ed02fa17e8,cde4e8e5-19c5-4576-9647-80d190ca2bf5,,,56.0,2023-03-13T13:15:01.199579-05:00,HCM-CSHL-0247-C18_treatment10,507740ed-af9c-42cb-a53e-50514dc1c882,,released,,1,2020-10-08T12:09:47.671632-05:00,"Surgery, NOS",Initial Diagnosis,
HCM-CSHL-0247-C18,7fa8bc57-4bc7-48a5-99fe-98ed02fa17e8,cde4e8e5-19c5-4576-9647-80d190ca2bf5,,Adjuvant,392.0,2021-07-12T12:25:55.528644-05:00,HCM-CSHL-0247-C18_treatment8,621b555f-451f-4d6c-81cf-5afda9709a28,Treatment Ongoing,released,Oxaliplatin,1,2020-10-08T12:09:47.671632-05:00,Chemotherapy,Residual Disease,
HCM-CSHL-0247-C18,7fa8bc57-4bc7-48a5-99fe-98ed02fa17e8,cde4e8e5-19c5-4576-9647-80d190ca2bf5,,Adjuvant,155.0,2021-07-12T12:25:55.528644-05:00,HCM-CSHL-0247-C18_treatment11,79f83b59-bf84-43e8-be08-6efaa5ab6e5c,Treatment Ongoing,released,Bevacizumab,1,2020-10-08T12:09:47.671632-05:00,Targeted Molecular Therapy,Residual Disease,
HCM-CSHL-0247-C18,7fa8bc57-4bc7-48a5-99fe-98ed02fa17e8,cde4e8e5-19c5-4576-9647-80d190ca2bf5,,Adjuvant,,2021-07-12T12:25:55.528644-05:00,HCM-CSHL-0247-C18_treatment9,8faa0b0f-541e-4673-94fb-ad1e45b036cd,,released,,0,2020-10-08T12:09:47.671632-05:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-CSHL-0247-C18,7fa8bc57-4bc7-48a5-99fe-98ed02fa17e8,cde4e8e5-19c5-4576-9647-80d190ca2bf5,,Neoadjuvant,,2021-07-12T12:25:55.528644-05:00,HCM-CSHL-0247-C18_treatment,9ae03485-c2d9-4e15-a171-38d05aaa5e74,,released,,0,2020-04-21T14:57:30.109195-05:00,,,
HCM-CSHL-0247-C18,7fa8bc57-4bc7-48a5-99fe-98ed02fa17e8,cde4e8e5-19c5-4576-9647-80d190ca2bf5,,Adjuvant,155.0,2021-07-12T12:25:55.528644-05:00,HCM-CSHL-0247-C18_treatment4,b4e00b9e-2ded-4bce-8ab6-56190e790f04,,released,Oxaliplatin,1,2020-04-21T14:57:30.109195-05:00,Chemotherapy,Residual Disease,
HCM-CSHL-0247-C18,7fa8bc57-4bc7-48a5-99fe-98ed02fa17e8,cde4e8e5-19c5-4576-9647-80d190ca2bf5,,Adjuvant,392.0,2021-07-12T12:25:55.528644-05:00,HCM-CSHL-0247-C18_treatment7,cafdb21c-4fc4-40b5-80dc-a1acd5caddb2,Treatment Ongoing,released,Leucovorin,1,2020-04-21T14:57:30.109195-05:00,Chemotherapy,Residual Disease,
HCM-CSHL-0247-C18,7fa8bc57-4bc7-48a5-99fe-98ed02fa17e8,cde4e8e5-19c5-4576-9647-80d190ca2bf5,,Adjuvant,155.0,2021-07-12T12:25:55.528644-05:00,HCM-CSHL-0247-C18_treatment2,df082093-a2b9-48a4-8814-486a8d36aec8,,released,Leucovorin Calcium,1,2020-04-21T14:57:30.109195-05:00,Chemotherapy,Residual Disease,
HCM-CSHL-0247-C18,7fa8bc57-4bc7-48a5-99fe-98ed02fa17e8,cde4e8e5-19c5-4576-9647-80d190ca2bf5,,Adjuvant,155.0,2021-07-12T12:25:55.528644-05:00,HCM-CSHL-0247-C18_treatment3,f2f83b32-19a8-4529-b36c-3c32662f1391,,released,Fluorouracil,1,2020-04-21T14:57:30.109195-05:00,Chemotherapy,Residual Disease,
HCM-CSHL-0247-C18,7fa8bc57-4bc7-48a5-99fe-98ed02fa17e8,cde4e8e5-19c5-4576-9647-80d190ca2bf5,,Adjuvant,392.0,2021-07-12T12:25:55.528644-05:00,HCM-CSHL-0247-C18_treatment6,fa3c33a2-da1e-4b17-b2d0-3191f946936a,Treatment Ongoing,released,Fluorouracil,1,2020-04-21T14:57:30.109195-05:00,Chemotherapy,Residual Disease,
HCM-CSHL-0863-C18,80662c9b-a131-4e8e-8622-07eca4e1127b,4458e439-d28d-4a08-9da5-a1758b6b9de5,45.0,Maintenance Therapy,,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0863-C18_treatment8,602ad20f-1007-4fcb-bd02-a3dd08a07991,Not Reported,released,Bevacizumab,1,2021-12-21T14:36:07.036845-06:00,,,
HCM-CSHL-0863-C18,80662c9b-a131-4e8e-8622-07eca4e1127b,91c3aa2b-c76c-44ee-b9fd-821c914ca487,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0863-C18_treatment7,1a02d652-2ace-4271-84db-e6174d7f18ac,,released,,0,2021-12-21T14:36:07.036845-06:00,"Radiation Therapy, NOS",Residual Disease,
HCM-CSHL-0863-C18,80662c9b-a131-4e8e-8622-07eca4e1127b,91c3aa2b-c76c-44ee-b9fd-821c914ca487,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0863-C18_treatment3,29f005aa-6daf-47d3-9b11-c42e1add7810,,released,,0,2021-12-21T14:36:07.036845-06:00,Chemotherapy,Residual Disease,
HCM-CSHL-0863-C18,80662c9b-a131-4e8e-8622-07eca4e1127b,91c3aa2b-c76c-44ee-b9fd-821c914ca487,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0863-C18_treatment4,5338a67d-c7f3-484e-903c-d3f9b4d4fdd0,,released,,0,2021-12-21T14:36:07.036845-06:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-CSHL-0863-C18,80662c9b-a131-4e8e-8622-07eca4e1127b,91c3aa2b-c76c-44ee-b9fd-821c914ca487,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0863-C18_treatment6,ccc9cfa7-eecd-4f4b-b348-1a35437e2e1d,,released,Bevacizumab,1,2021-12-21T14:36:07.036845-06:00,Targeted Molecular Therapy,Residual Disease,
HCM-CSHL-0863-C18,80662c9b-a131-4e8e-8622-07eca4e1127b,91c3aa2b-c76c-44ee-b9fd-821c914ca487,,,29.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0863-C18_treatment5,e1c46ce6-8eca-4b7b-ade4-596595f4c1ce,,released,,1,2021-12-21T14:36:07.036845-06:00,"Surgery, NOS",Initial Diagnosis,
HCM-CSHL-0385-C18,80a596d1-04f0-447b-8151-fc74ca6f7c5e,3b71bc66-8111-4b16-8fef-504a5db6bf98,,Neoadjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0385-C18_treatment,7481e096-2107-42d8-93c9-cc253b88e3a0,,released,,0,2020-09-28T09:58:12.339518-05:00,,,
HCM-CSHL-0385-C18,80a596d1-04f0-447b-8151-fc74ca6f7c5e,3b71bc66-8111-4b16-8fef-504a5db6bf98,,Adjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0385-C18_treatment3,7f8548d6-4b2b-4bc0-9148-6dafb6aa7747,,released,,0,2020-09-28T09:58:12.339518-05:00,"Pharmaceutical Therapy, NOS",Residual Disease,
HCM-CSHL-0385-C18,80a596d1-04f0-447b-8151-fc74ca6f7c5e,3b71bc66-8111-4b16-8fef-504a5db6bf98,,,6.0,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0385-C18_treatment2,9842befe-701b-4cfe-ba22-af56cad9bf7e,,released,,1,2020-09-28T09:58:12.339518-05:00,"Surgery, NOS",Initial Diagnosis,
HCM-CSHL-0385-C18,80a596d1-04f0-447b-8151-fc74ca6f7c5e,3b71bc66-8111-4b16-8fef-504a5db6bf98,,Adjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0385-C18_treatment4,cda5b12d-31cb-46a0-b1c1-6e114610a2b5,,released,,0,2020-09-28T09:58:12.339518-05:00,"Radiation Therapy, NOS",Residual Disease,
HCM-SANG-0289-C15,80bbff05-a62d-49c3-adee-08d992f0ba67,e75ceab9-5ad2-4638-8031-6db63ec00fb7,,Neoadjuvant,91.0,2023-03-13T13:25:37.212375-05:00,HCM-SANG-0289-C15_treatment4,0451ea6e-1fe4-4f1e-836e-d8e48c3eba03,,released,,1,2020-11-11T09:35:23.035588-06:00,Chemotherapy,,ECX
HCM-SANG-0289-C15,80bbff05-a62d-49c3-adee-08d992f0ba67,e75ceab9-5ad2-4638-8031-6db63ec00fb7,,Neoadjuvant,91.0,2023-03-13T13:25:37.212375-05:00,HCM-SANG-0289-C15_treatment,5e51cc84-bc17-4733-bb3b-cc9ae9ccdeb0,,released,Epirubicin,1,2020-02-11T15:32:50.052516-06:00,Chemotherapy,,
HCM-SANG-0289-C15,80bbff05-a62d-49c3-adee-08d992f0ba67,e75ceab9-5ad2-4638-8031-6db63ec00fb7,,Neoadjuvant,91.0,2023-03-13T13:25:37.212375-05:00,HCM-SANG-0289-C15_treatment2,c17524c2-6ec1-4610-9c4d-0455c25ef51e,,released,Capecitabine,1,2020-11-11T09:35:23.035588-06:00,Chemotherapy,,
HCM-SANG-0289-C15,80bbff05-a62d-49c3-adee-08d992f0ba67,e75ceab9-5ad2-4638-8031-6db63ec00fb7,,Neoadjuvant,91.0,2023-03-13T13:25:37.212375-05:00,HCM-SANG-0289-C15_treatment3,fb5a10b8-07fa-458b-bdc0-144b8522492e,,released,Cisplatin,1,2020-11-11T09:35:23.035588-06:00,Chemotherapy,,
HCM-EXPT-0929-C50,80d0b6ea-ae26-4b60-a2b7-68d0095e3fa3,742b3f6a-5387-4af4-85c9-bfeed1b527e2,,Neoadjuvant,,2025-10-08T12:36:57.024699-05:00,HCM-EXPT-0929-C50_treatment,727e1a3a-0006-4201-a384-46a5c290a93f,,released,,0,2021-12-21T14:44:30.630204-06:00,,,
HCM-SANG-1314-C18,80e571e3-8edf-40ff-883d-bce4e31acac2,7c31d333-3de3-4f6e-b60f-c68f84ac76a3,,Neoadjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-SANG-1314-C18_treatment,47cff4fd-c62c-443d-871f-16645dbc0f05,,released,,0,2023-02-27T12:11:41.179818-06:00,,,
HCM-EXPT-1200-C15,8169ce16-4ddb-457a-8e87-029f9bc6e02a,46dde69c-583a-430a-b558-b2eb1ca85b23,,Neoadjuvant,94.0,2025-10-08T12:38:51.189053-05:00,HCM-EXPT-1200-C15_treatment3,cf8d730e-831d-456f-a469-a38af5cca95b,,released,Cisplatin,1,2023-02-24T13:48:49.942385-06:00,Chemotherapy,,
HCM-EXPT-1200-C15,8169ce16-4ddb-457a-8e87-029f9bc6e02a,46dde69c-583a-430a-b558-b2eb1ca85b23,,Neoadjuvant,94.0,2025-10-08T12:38:51.189053-05:00,HCM-EXPT-1200-C15_treatment,d9eaa5cb-6745-4e65-8c30-8fdd2e58d405,,released,Epirubicin,1,2023-02-24T13:48:49.942385-06:00,Chemotherapy,,
HCM-EXPT-1200-C15,8169ce16-4ddb-457a-8e87-029f9bc6e02a,46dde69c-583a-430a-b558-b2eb1ca85b23,,Neoadjuvant,94.0,2025-10-08T12:38:51.189053-05:00,HCM-EXPT-1200-C15_treatment2,e1b59cb7-312b-4eff-94fd-85762e76cfbf,,released,Capecitabine,1,2023-02-24T13:48:49.942385-06:00,Chemotherapy,,
HCM-EXPT-1200-C15,8169ce16-4ddb-457a-8e87-029f9bc6e02a,46dde69c-583a-430a-b558-b2eb1ca85b23,,Neoadjuvant,94.0,2025-10-08T12:38:51.189053-05:00,HCM-EXPT-1200-C15_treatment4,e6ca6f2b-684e-4532-9803-94445c7e8bb0,,released,,1,2023-02-24T13:48:49.942385-06:00,Chemotherapy,,ECX
HCM-BROD-0681-C71,816e3eb6-1d9c-4f79-b672-c76b3af02d1c,176c7d32-9b90-4693-b9cc-553171a6aedc,862.0,Adjuvant,629.0,2023-02-22T07:39:25.979291-06:00,HCM-BROD-0681-C71_treatment3,09bf7f72-51d8-46c0-a71d-c64c15b84ad4,,released,Nivolumab,1,2021-12-21T13:42:59.125837-06:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-BROD-0681-C71,816e3eb6-1d9c-4f79-b672-c76b3af02d1c,176c7d32-9b90-4693-b9cc-553171a6aedc,,,-1.0,2023-02-27T12:46:16.349750-06:00,HCM-BROD-0681-C71_treatment4,0d8b1957-2bcd-491c-8bbf-aa1acba48fba,,released,,1,2021-12-21T13:42:59.125837-06:00,"Surgery, NOS",Initial Diagnosis,
HCM-BROD-0681-C71,816e3eb6-1d9c-4f79-b672-c76b3af02d1c,176c7d32-9b90-4693-b9cc-553171a6aedc,289.0,Adjuvant,41.0,2023-02-22T07:39:25.979291-06:00,HCM-BROD-0681-C71_treatment2,0fcc908c-9392-42f1-8553-3135135f8ffd,,released,Temozolomide,1,2021-12-21T13:42:59.125837-06:00,Chemotherapy,Residual Disease,
HCM-BROD-0681-C71,816e3eb6-1d9c-4f79-b672-c76b3af02d1c,176c7d32-9b90-4693-b9cc-553171a6aedc,,Neoadjuvant,,2023-02-22T07:39:25.979291-06:00,HCM-BROD-0681-C71_treatment,7946e2c8-4e63-4605-96bd-32e755a0c759,,released,,0,2021-12-21T13:42:59.125837-06:00,,,
HCM-BROD-0681-C71,816e3eb6-1d9c-4f79-b672-c76b3af02d1c,176c7d32-9b90-4693-b9cc-553171a6aedc,,Adjuvant,,2023-02-22T07:39:25.979291-06:00,HCM-BROD-0681-C71_treatment5,98be0462-9119-4885-8f55-d277739e315f,,released,,0,2021-12-21T13:42:59.125837-06:00,Targeted Molecular Therapy,Residual Disease,
HCM-BROD-0681-C71,816e3eb6-1d9c-4f79-b672-c76b3af02d1c,176c7d32-9b90-4693-b9cc-553171a6aedc,956.0,Adjuvant,41.0,2023-02-22T07:39:25.979291-06:00,HCM-BROD-0681-C71_treatment6,ba807133-02cc-4a26-a394-bd591fb58e5c,,released,,1,2021-12-21T13:42:59.125837-06:00,"Radiation, 3D Conformal",Residual Disease,
HCM-BROD-0681-C71,816e3eb6-1d9c-4f79-b672-c76b3af02d1c,d732d362-9c5b-47a3-8a10-29e1d91508a2,862.0,Maintenance Therapy,41.0,2023-02-22T07:39:25.979291-06:00,HCM-BROD-0681-C71_treatment8,1004b761-6220-43b5-b532-b091d46986d7,Treatment Ongoing,released,Temozolomide,1,2021-12-21T13:42:59.125837-06:00,,,
HCM-BROD-0681-C71,816e3eb6-1d9c-4f79-b672-c76b3af02d1c,d732d362-9c5b-47a3-8a10-29e1d91508a2,862.0,Maintenance Therapy,41.0,2023-02-22T07:39:25.979291-06:00,HCM-BROD-0681-C71_treatment7,d40f682e-9cfd-4e24-bef3-c1a626763a43,Treatment Ongoing,released,Nivolumab,1,2021-12-21T13:42:59.125837-06:00,,,
HCM-SANG-0304-C15,818627f6-9dda-446c-8ea7-d8f6fa707c27,8e4ed005-24a6-4ded-89bc-86a5b4829d5d,,Neoadjuvant,,2023-02-22T07:39:25.979291-06:00,HCM-SANG-0304-C15_treatment,c0798f78-7de9-4575-b9ca-12c3d159c477,,released,,0,2020-02-27T12:54:00.713566-06:00,,,
HCM-BROD-0041-C64,819b41c2-1aa4-4a98-959f-096fd3df1446,f3df3538-722b-4d28-b8cd-f7265b250f2a,273.0,Adjuvant,0.0,2023-02-22T07:39:25.979291-06:00,HCM-BROD-0041-C64_treatment2,096a3721-50d5-4d23-adf4-c7ac2c400937,,released,Ifosfamide,1,2020-09-27T10:13:30.616701-05:00,Chemotherapy,Residual Disease,
HCM-BROD-0041-C64,819b41c2-1aa4-4a98-959f-096fd3df1446,f3df3538-722b-4d28-b8cd-f7265b250f2a,273.0,Adjuvant,0.0,2023-02-22T07:39:25.979291-06:00,HCM-BROD-0041-C64_treatment5,46ed5f36-27e2-4de4-b854-9a75475d5f89,,released,,1,2020-09-27T10:13:30.616701-05:00,Chemotherapy,Residual Disease,ICE
HCM-BROD-0041-C64,819b41c2-1aa4-4a98-959f-096fd3df1446,f3df3538-722b-4d28-b8cd-f7265b250f2a,273.0,Adjuvant,0.0,2023-02-22T07:39:25.979291-06:00,HCM-BROD-0041-C64_treatment6,71c0e88a-906d-45a6-bca7-ab499108adb7,,released,Doxorubicin Hydrochloride,1,2020-09-27T10:13:30.616701-05:00,Chemotherapy,Residual Disease,
HCM-BROD-0041-C64,819b41c2-1aa4-4a98-959f-096fd3df1446,f3df3538-722b-4d28-b8cd-f7265b250f2a,,,0.0,2023-02-24T14:52:49.856107-06:00,HCM-BROD-0041-C64_treatment10,9490d1c1-96a3-4205-9c6a-d4962137ef68,,released,,1,2020-09-27T10:13:30.616701-05:00,"Surgery, NOS",Initial Diagnosis,
HCM-BROD-0041-C64,819b41c2-1aa4-4a98-959f-096fd3df1446,f3df3538-722b-4d28-b8cd-f7265b250f2a,,Adjuvant,,2023-02-22T07:39:25.979291-06:00,HCM-BROD-0041-C64_treatment11,aefd9448-e05d-4705-ae45-4eb15e75cf8d,,released,,0,2020-09-27T10:13:30.616701-05:00,Targeted Molecular Therapy,Residual Disease,
HCM-BROD-0041-C64,819b41c2-1aa4-4a98-959f-096fd3df1446,f3df3538-722b-4d28-b8cd-f7265b250f2a,,Neoadjuvant,,2023-02-22T07:39:25.979291-06:00,HCM-BROD-0041-C64_treatment,b8d56ee2-56c6-4e2b-8936-d8afbde956c6,,released,,0,2019-04-04T13:38:32.954522-05:00,,,
HCM-BROD-0041-C64,819b41c2-1aa4-4a98-959f-096fd3df1446,f3df3538-722b-4d28-b8cd-f7265b250f2a,,Adjuvant,,2023-02-22T07:39:25.979291-06:00,HCM-BROD-0041-C64_treatment9,c908a5d4-0766-43ee-834e-3d1fb34a19d5,,released,,0,2020-09-27T10:13:30.616701-05:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-BROD-0041-C64,819b41c2-1aa4-4a98-959f-096fd3df1446,f3df3538-722b-4d28-b8cd-f7265b250f2a,273.0,Adjuvant,0.0,2023-02-22T07:39:25.979291-06:00,HCM-BROD-0041-C64_treatment8,cd147d5b-7bb3-48a6-b299-7230374b603e,,released,Vincristine,1,2020-09-27T10:13:30.616701-05:00,Chemotherapy,Residual Disease,
HCM-BROD-0041-C64,819b41c2-1aa4-4a98-959f-096fd3df1446,f3df3538-722b-4d28-b8cd-f7265b250f2a,273.0,Adjuvant,0.0,2023-02-22T07:39:25.979291-06:00,HCM-BROD-0041-C64_treatment4,ce1aad05-322d-41b9-86fb-f7a0a070efc2,,released,Etoposide,1,2020-09-27T10:13:30.616701-05:00,Chemotherapy,Residual Disease,
HCM-BROD-0041-C64,819b41c2-1aa4-4a98-959f-096fd3df1446,f3df3538-722b-4d28-b8cd-f7265b250f2a,273.0,Adjuvant,0.0,2023-02-22T07:39:25.979291-06:00,HCM-BROD-0041-C64_treatment3,cfca2c4d-b6bd-4e50-a189-86df11803c08,,released,Carboplatin,1,2020-09-27T10:13:30.616701-05:00,Chemotherapy,Residual Disease,
HCM-BROD-0041-C64,819b41c2-1aa4-4a98-959f-096fd3df1446,f3df3538-722b-4d28-b8cd-f7265b250f2a,273.0,Adjuvant,0.0,2023-02-22T07:39:25.979291-06:00,HCM-BROD-0041-C64_treatment7,d66cddab-2246-4339-9efe-54b09706bf3f,,released,Cyclophosphamide,1,2020-09-27T10:13:30.616701-05:00,Chemotherapy,Residual Disease,
HCM-BROD-0041-C64,819b41c2-1aa4-4a98-959f-096fd3df1446,f3df3538-722b-4d28-b8cd-f7265b250f2a,1.0,Adjuvant,0.0,2023-02-22T07:39:25.979291-06:00,HCM-BROD-0041-C64_treatment12,e7846f99-99fb-46b6-a5d5-5aee27402e1c,,released,,1,2020-09-27T10:13:30.616701-05:00,"Radiation Therapy, NOS",Residual Disease,
HCM-CSHL-0878-C18,81d695dd-8c6d-42fc-b169-52996a7d93ad,6287add5-e096-42f6-ae9c-930f75add617,,Adjuvant,212.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0878-C18_treatment9,1faf96b5-95fa-441d-b029-1cef50206574,Treatment Ongoing,released,,1,2021-12-21T14:37:00.592878-06:00,Chemotherapy,Residual Disease,FOLFOX
HCM-CSHL-0878-C18,81d695dd-8c6d-42fc-b169-52996a7d93ad,6287add5-e096-42f6-ae9c-930f75add617,,Neoadjuvant,34.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0878-C18_treatment4,2ce26241-a677-4504-ad5d-9bd935c762f2,,released,,1,2021-12-21T14:37:00.592878-06:00,Chemotherapy,,FOLFIRI
HCM-CSHL-0878-C18,81d695dd-8c6d-42fc-b169-52996a7d93ad,6287add5-e096-42f6-ae9c-930f75add617,,Neoadjuvant,34.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0878-C18_treatment2,348df54a-02fb-4dac-bdc6-3426855d74e8,,released,Fluorouracil,1,2021-12-21T14:37:00.592878-06:00,Chemotherapy,,
HCM-CSHL-0878-C18,81d695dd-8c6d-42fc-b169-52996a7d93ad,6287add5-e096-42f6-ae9c-930f75add617,,Adjuvant,212.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0878-C18_treatment8,5e2dc983-b04d-48f9-a4a0-c393f6556908,Treatment Ongoing,released,Oxaliplatin,1,2021-12-21T14:37:00.592878-06:00,Chemotherapy,Residual Disease,
HCM-CSHL-0878-C18,81d695dd-8c6d-42fc-b169-52996a7d93ad,6287add5-e096-42f6-ae9c-930f75add617,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0878-C18_treatment12,63ef015e-69ad-40f2-83f1-6a80359ce4a2,,released,,0,2021-12-21T14:37:00.592878-06:00,Targeted Molecular Therapy,Residual Disease,
HCM-CSHL-0878-C18,81d695dd-8c6d-42fc-b169-52996a7d93ad,6287add5-e096-42f6-ae9c-930f75add617,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0878-C18_treatment10,69249e46-bc58-498f-be27-41b8b36a5fb5,,released,,0,2021-12-21T14:37:00.592878-06:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-CSHL-0878-C18,81d695dd-8c6d-42fc-b169-52996a7d93ad,6287add5-e096-42f6-ae9c-930f75add617,188.0,Adjuvant,188.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0878-C18_treatment5,796ee72e-19bd-4bb6-b8e7-9c16c9f0e8dd,,released,Fluorouracil,1,2021-12-21T14:37:00.592878-06:00,Chemotherapy,Residual Disease,
HCM-CSHL-0878-C18,81d695dd-8c6d-42fc-b169-52996a7d93ad,6287add5-e096-42f6-ae9c-930f75add617,,Adjuvant,212.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0878-C18_treatment7,7c7af29e-b2cd-4793-9322-4acc886cad18,Treatment Ongoing,released,Fluorouracil,1,2021-12-21T14:37:00.592878-06:00,Chemotherapy,Residual Disease,
HCM-CSHL-0878-C18,81d695dd-8c6d-42fc-b169-52996a7d93ad,6287add5-e096-42f6-ae9c-930f75add617,,Neoadjuvant,34.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0878-C18_treatment,87dba89b-423f-499f-bd7b-94b290dd61e8,,released,Leucovorin Calcium,1,2021-12-21T14:37:00.592878-06:00,Chemotherapy,,
HCM-CSHL-0878-C18,81d695dd-8c6d-42fc-b169-52996a7d93ad,6287add5-e096-42f6-ae9c-930f75add617,,Neoadjuvant,34.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0878-C18_treatment3,8f0cc086-0e4b-4852-9e93-49cd9228540a,,released,Irinotecan,1,2021-12-21T14:37:00.592878-06:00,Chemotherapy,,
HCM-CSHL-0878-C18,81d695dd-8c6d-42fc-b169-52996a7d93ad,6287add5-e096-42f6-ae9c-930f75add617,,,129.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0878-C18_treatment11,92e710c4-3d83-4163-8187-57f4ae1870b6,,released,,1,2021-12-21T14:37:00.592878-06:00,"Surgery, NOS",Initial Diagnosis,
HCM-CSHL-0878-C18,81d695dd-8c6d-42fc-b169-52996a7d93ad,6287add5-e096-42f6-ae9c-930f75add617,,Adjuvant,212.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0878-C18_treatment6,9c0ea79b-f1d8-4fb3-9dec-5f03f2afc593,Treatment Ongoing,released,Leucovorin Calcium,1,2021-12-21T14:37:00.592878-06:00,Chemotherapy,Residual Disease,
HCM-CSHL-0878-C18,81d695dd-8c6d-42fc-b169-52996a7d93ad,6287add5-e096-42f6-ae9c-930f75add617,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0878-C18_treatment13,d7093751-4c44-427c-9502-d7a89d3ebb09,,released,,0,2021-12-21T14:37:00.592878-06:00,"Radiation Therapy, NOS",Residual Disease,
HCM-BROD-0689-C71,81f2ed11-f83b-489a-b9a9-d0c7f99a2022,14a08303-ac60-4816-bccb-6d9423ade109,266.0,Maintenance Therapy,106.0,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0689-C71_treatment5,527f03f0-f3bb-4280-9e1a-eacdb9ed0507,Progressive Disease,released,Temozolomide,1,2023-02-28T11:50:33.536090-06:00,,,
HCM-BROD-0689-C71,81f2ed11-f83b-489a-b9a9-d0c7f99a2022,991c40a4-3ca7-4263-b423-745404230d4c,,Neoadjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0689-C71_treatment,2abb7de5-091d-4c92-840b-48f18f05d8d7,,released,,0,2020-10-08T14:47:13.024720-05:00,,,
HCM-BROD-0689-C71,81f2ed11-f83b-489a-b9a9-d0c7f99a2022,991c40a4-3ca7-4263-b423-745404230d4c,,Adjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0689-C71_treatment3,6753af2a-98f9-43f8-b44a-3368f648c777,,released,,0,2020-10-08T14:47:13.024720-05:00,"Pharmaceutical Therapy, NOS",Residual Disease,
HCM-BROD-0689-C71,81f2ed11-f83b-489a-b9a9-d0c7f99a2022,991c40a4-3ca7-4263-b423-745404230d4c,,,0.0,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0689-C71_treatment2,e1229cba-e510-4e9b-b44e-275b4da41541,,released,,1,2020-10-08T14:47:13.024720-05:00,"Surgery, NOS",Initial Diagnosis,
HCM-BROD-0689-C71,81f2ed11-f83b-489a-b9a9-d0c7f99a2022,991c40a4-3ca7-4263-b423-745404230d4c,,Adjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0689-C71_treatment4,e6dc63e7-901e-4440-9bb1-1944b9e374e3,,released,,0,2020-10-08T14:47:13.024720-05:00,"Radiation Therapy, NOS",Residual Disease,
HCM-EXPT-0943-C50,8227df15-0672-42be-8d86-463a2bae8183,4c388851-a29f-4940-9bcc-cad07a8ab02b,,Neoadjuvant,,2025-10-08T12:36:57.024699-05:00,HCM-EXPT-0943-C50_treatment,36f1c008-0bc5-40b2-8b31-af32e2eac967,,released,,0,2021-12-21T14:47:46.967654-06:00,,,
HCM-CSHL-0731-C19,82caa0cd-b0ec-4d24-95bb-144b9fcc293e,803d9e30-c9b8-4715-a766-96764e53147a,,Neoadjuvant,31.0,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0731-C19_treatment2,02770ba6-1585-494d-a7c0-e53d9cf42ed8,,released,,1,2021-12-21T14:21:04.684129-06:00,"Radiation, Intensity-Modulated Radiotherapy",,
HCM-CSHL-0731-C19,82caa0cd-b0ec-4d24-95bb-144b9fcc293e,803d9e30-c9b8-4715-a766-96764e53147a,,Adjuvant,518.0,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0731-C19_treatment10,05068255-f7fa-4535-97e5-9259eaa57985,Treatment Ongoing,released,,1,2021-12-21T14:21:04.684129-06:00,Chemotherapy,Residual Disease,FOLFIRI
HCM-CSHL-0731-C19,82caa0cd-b0ec-4d24-95bb-144b9fcc293e,803d9e30-c9b8-4715-a766-96764e53147a,,Adjuvant,518.0,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0731-C19_treatment9,05a8eed8-f442-48e1-a7af-de5e7c0a02a0,Treatment Ongoing,released,Irinotecan,1,2021-12-21T14:21:04.684129-06:00,Chemotherapy,Residual Disease,
HCM-CSHL-0731-C19,82caa0cd-b0ec-4d24-95bb-144b9fcc293e,803d9e30-c9b8-4715-a766-96764e53147a,680.0,Adjuvant,644.0,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0731-C19_treatment15,3ada79fa-8adc-4b13-87b3-8e9e992dc8e2,,released,,1,2021-12-21T14:21:04.684129-06:00,"Radiation, Stereotactic/Gamma Knife/SRS",Residual Disease,
HCM-CSHL-0731-C19,82caa0cd-b0ec-4d24-95bb-144b9fcc293e,803d9e30-c9b8-4715-a766-96764e53147a,,,307.0,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0731-C19_treatment13,49f9b1e0-8040-45e4-8364-261ec8526788,,released,,1,2021-12-21T14:21:04.684129-06:00,"Surgery, NOS",Initial Diagnosis,
HCM-CSHL-0731-C19,82caa0cd-b0ec-4d24-95bb-144b9fcc293e,803d9e30-c9b8-4715-a766-96764e53147a,258.0,Adjuvant,149.0,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0731-C19_treatment3,4a77e2eb-b298-4c7c-8039-2cabd55c46d8,,released,Leucovorin Calcium,1,2021-12-21T14:21:04.684129-06:00,Chemotherapy,Residual Disease,
HCM-CSHL-0731-C19,82caa0cd-b0ec-4d24-95bb-144b9fcc293e,803d9e30-c9b8-4715-a766-96764e53147a,,Adjuvant,518.0,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0731-C19_treatment8,5a205899-2165-488b-9c33-5a43e347c20c,Treatment Ongoing,released,Fluorouracil,1,2021-12-21T14:21:04.684129-06:00,Chemotherapy,Residual Disease,
HCM-CSHL-0731-C19,82caa0cd-b0ec-4d24-95bb-144b9fcc293e,803d9e30-c9b8-4715-a766-96764e53147a,,Neoadjuvant,31.0,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0731-C19_treatment,605bb853-bd58-4277-bae0-fa323725a456,,released,Capecitabine,1,2021-12-21T14:21:04.684129-06:00,Chemotherapy,,
HCM-CSHL-0731-C19,82caa0cd-b0ec-4d24-95bb-144b9fcc293e,803d9e30-c9b8-4715-a766-96764e53147a,,Adjuvant,518.0,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0731-C19_treatment14,74d7b340-5378-4c94-87ac-49c4f9e34ce2,Treatment Ongoing,released,Panitumumab,1,2021-12-21T14:21:04.684129-06:00,Targeted Molecular Therapy,Residual Disease,
HCM-CSHL-0731-C19,82caa0cd-b0ec-4d24-95bb-144b9fcc293e,803d9e30-c9b8-4715-a766-96764e53147a,,Adjuvant,518.0,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0731-C19_treatment7,9d435ca3-c083-400c-8f17-c3c73f418ffa,Treatment Ongoing,released,Leucovorin Calcium,1,2021-12-21T14:21:04.684129-06:00,Chemotherapy,Residual Disease,
HCM-CSHL-0731-C19,82caa0cd-b0ec-4d24-95bb-144b9fcc293e,803d9e30-c9b8-4715-a766-96764e53147a,,,107.0,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0731-C19_treatment12,b1e51d3a-4145-4d28-bc6d-b869f997bb16,,released,,1,2021-12-21T14:21:04.684129-06:00,"Surgery, NOS",Initial Diagnosis,
HCM-CSHL-0731-C19,82caa0cd-b0ec-4d24-95bb-144b9fcc293e,803d9e30-c9b8-4715-a766-96764e53147a,,Adjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0731-C19_treatment11,c1d06716-ee78-48c4-b086-c1bff1488be8,,released,,0,2021-12-21T14:21:04.684129-06:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-CSHL-0731-C19,82caa0cd-b0ec-4d24-95bb-144b9fcc293e,803d9e30-c9b8-4715-a766-96764e53147a,258.0,Adjuvant,149.0,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0731-C19_treatment6,d380f405-2dfb-497b-a492-9873dbbf7b4c,,released,,1,2021-12-21T14:21:04.684129-06:00,Chemotherapy,Residual Disease,FOLFOX
HCM-CSHL-0731-C19,82caa0cd-b0ec-4d24-95bb-144b9fcc293e,803d9e30-c9b8-4715-a766-96764e53147a,258.0,Adjuvant,149.0,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0731-C19_treatment5,d51accc8-3200-41b9-b18c-a28d999334a8,,released,Oxaliplatin,1,2021-12-21T14:21:04.684129-06:00,Chemotherapy,Residual Disease,
HCM-CSHL-0731-C19,82caa0cd-b0ec-4d24-95bb-144b9fcc293e,803d9e30-c9b8-4715-a766-96764e53147a,258.0,Adjuvant,149.0,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0731-C19_treatment4,eef062a8-8f5e-43f4-bf4b-48cb875f2984,,released,Fluorouracil,1,2021-12-21T14:21:04.684129-06:00,Chemotherapy,Residual Disease,
HCM-CSHL-0731-C19,82caa0cd-b0ec-4d24-95bb-144b9fcc293e,9783a7d6-2be4-44d5-a49d-68695f41a1c3,276.0,Maintenance Therapy,149.0,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0731-C19_treatment17,38bd4a39-fd2b-4732-8662-9c5aa34a87c8,Stable Disease,released,Fluorouracil,1,2021-12-21T14:21:04.684129-06:00,,,
HCM-CSHL-0731-C19,82caa0cd-b0ec-4d24-95bb-144b9fcc293e,9783a7d6-2be4-44d5-a49d-68695f41a1c3,276.0,Maintenance Therapy,149.0,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0731-C19_treatment18,5100a120-27f0-4c3f-90c3-87c7e1de5f44,Stable Disease,released,Oxaliplatin,1,2021-12-21T14:21:04.684129-06:00,,,
HCM-CSHL-0731-C19,82caa0cd-b0ec-4d24-95bb-144b9fcc293e,9783a7d6-2be4-44d5-a49d-68695f41a1c3,276.0,Maintenance Therapy,149.0,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0731-C19_treatment16,6da3467c-d1fb-435c-8c56-c94cd6abc3bf,Stable Disease,released,Leucovorin Calcium,1,2021-12-21T14:21:04.684129-06:00,,,
HCM-CSHL-0731-C19,82caa0cd-b0ec-4d24-95bb-144b9fcc293e,9783a7d6-2be4-44d5-a49d-68695f41a1c3,276.0,Maintenance Therapy,149.0,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0731-C19_treatment19,f61cfd08-5797-487d-8cf4-69b64da373ec,Stable Disease,released,,1,2021-12-21T14:21:04.684129-06:00,,,FOLFOX
HCM-SANG-1316-C18,82ce9f95-f322-4867-8abb-266b5b8289d0,76319dd7-8d88-4cb5-a6e3-0cc3fa0a62b1,,Neoadjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-SANG-1316-C18_treatment,7f0364c0-0557-4a08-a28b-63a886529fcc,,released,,0,2023-02-27T12:18:18.690363-06:00,,,
HCM-EXPT-1257-C15,83012811-6529-4e25-9a7b-7b1edd544c01,e18fdb5c-3844-4808-9eb7-f0511ed58aab,,Neoadjuvant,,2025-10-08T12:39:59.137357-05:00,HCM-EXPT-1257-C15_treatment,0fa288b3-0d16-410b-bc5a-987aa6d6b7a3,,released,,0,2023-02-24T13:56:46.531335-06:00,,,
HCM-CSHL-0659-C18,8376d8ee-20ce-41bc-b36d-3fbadd194084,0bc6de7c-9af2-473e-acd8-22dc25502808,,Maintenance Therapy,,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0659-C18_treatment19,09d84ec0-060b-4a5a-bc0c-68b1d475302a,Treatment Ongoing,released,Fluorouracil,1,2021-12-21T14:15:22.541820-06:00,,,
HCM-CSHL-0659-C18,8376d8ee-20ce-41bc-b36d-3fbadd194084,0bc6de7c-9af2-473e-acd8-22dc25502808,,Maintenance Therapy,,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0659-C18_treatment23,1966a941-f7e6-49bf-ba6b-8ba14a66e80a,Treatment Ongoing,released,,1,2021-12-21T14:15:22.541820-06:00,,,FOLFIRI
HCM-CSHL-0659-C18,8376d8ee-20ce-41bc-b36d-3fbadd194084,0bc6de7c-9af2-473e-acd8-22dc25502808,,Maintenance Therapy,,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0659-C18_treatment22,6e3a448d-b566-4cb0-8901-1a3a83bd06f1,Treatment Ongoing,released,Leucovorin Calcium,1,2021-12-21T14:15:22.541820-06:00,,,
HCM-CSHL-0659-C18,8376d8ee-20ce-41bc-b36d-3fbadd194084,0bc6de7c-9af2-473e-acd8-22dc25502808,,Maintenance Therapy,,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0659-C18_treatment21,83389510-6e37-4075-beb0-1de1fd4f78ae,Treatment Ongoing,released,Irinotecan,1,2021-12-21T14:15:22.541820-06:00,,,
HCM-CSHL-0659-C18,8376d8ee-20ce-41bc-b36d-3fbadd194084,0bc6de7c-9af2-473e-acd8-22dc25502808,,Maintenance Therapy,,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0659-C18_treatment20,fae59eb0-6b6c-40a2-850f-65c76430e54a,Treatment Ongoing,released,Bevacizumab,1,2021-12-21T14:15:22.541820-06:00,,,
HCM-CSHL-0659-C18,8376d8ee-20ce-41bc-b36d-3fbadd194084,d0594736-0baa-41d8-811b-ce376f6d0d4a,,Neoadjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0659-C18_treatment,00135817-1f47-4ca1-bf94-c740b40f18bf,,released,,0,2021-12-21T14:15:22.541820-06:00,,,
HCM-CSHL-0659-C18,8376d8ee-20ce-41bc-b36d-3fbadd194084,d0594736-0baa-41d8-811b-ce376f6d0d4a,674.0,Adjuvant,656.0,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0659-C18_treatment15,22e0db74-4233-4892-b8e6-ce0dac862b0e,,released,Regorafenib,1,2021-12-21T14:15:22.541820-06:00,Targeted Molecular Therapy,Residual Disease,
HCM-CSHL-0659-C18,8376d8ee-20ce-41bc-b36d-3fbadd194084,d0594736-0baa-41d8-811b-ce376f6d0d4a,271.0,Adjuvant,40.0,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0659-C18_treatment4,23a2a8e1-e0ab-4eef-ae6d-0e6071441352,,released,Oxaliplatin,1,2021-12-21T14:15:22.541820-06:00,Chemotherapy,Residual Disease,
HCM-CSHL-0659-C18,8376d8ee-20ce-41bc-b36d-3fbadd194084,d0594736-0baa-41d8-811b-ce376f6d0d4a,,,509.0,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0659-C18_treatment13,2685e23e-e59f-422c-b655-492a682c7bd2,,released,,1,2021-12-21T14:15:22.541820-06:00,"Surgery, NOS",Initial Diagnosis,
HCM-CSHL-0659-C18,8376d8ee-20ce-41bc-b36d-3fbadd194084,d0594736-0baa-41d8-811b-ce376f6d0d4a,271.0,Adjuvant,40.0,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0659-C18_treatment5,2918ebea-2bbf-43b1-a58a-f0934c315f73,,released,,1,2021-12-21T14:15:22.541820-06:00,Chemotherapy,Residual Disease,FOLFOX
HCM-CSHL-0659-C18,8376d8ee-20ce-41bc-b36d-3fbadd194084,d0594736-0baa-41d8-811b-ce376f6d0d4a,,,9.0,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0659-C18_treatment12,3ef0daa0-d9cc-4a74-a41e-a1e44e69f473,,released,,1,2021-12-21T14:15:22.541820-06:00,"Surgery, NOS",Initial Diagnosis,
HCM-CSHL-0659-C18,8376d8ee-20ce-41bc-b36d-3fbadd194084,d0594736-0baa-41d8-811b-ce376f6d0d4a,674.0,Adjuvant,592.0,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0659-C18_treatment10,46680579-a7a2-49f6-bd37-a45f787250c4,,released,Capecitabine,1,2021-12-21T14:15:22.541820-06:00,Chemotherapy,Residual Disease,
HCM-CSHL-0659-C18,8376d8ee-20ce-41bc-b36d-3fbadd194084,d0594736-0baa-41d8-811b-ce376f6d0d4a,488.0,Adjuvant,390.0,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0659-C18_treatment9,716e57e0-7974-4c1b-96c8-f4586d682bfc,,released,,1,2021-12-21T14:15:22.541820-06:00,Chemotherapy,Residual Disease,FOLFIRI
HCM-CSHL-0659-C18,8376d8ee-20ce-41bc-b36d-3fbadd194084,d0594736-0baa-41d8-811b-ce376f6d0d4a,460.0,Adjuvant,390.0,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0659-C18_treatment14,7c785a38-64e5-483b-8cf4-1dd4ed81b20b,,released,Bevacizumab,1,2021-12-21T14:15:22.541820-06:00,Targeted Molecular Therapy,Residual Disease,
HCM-CSHL-0659-C18,8376d8ee-20ce-41bc-b36d-3fbadd194084,d0594736-0baa-41d8-811b-ce376f6d0d4a,271.0,Adjuvant,40.0,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0659-C18_treatment2,84aab4fe-7588-4337-9884-97d5f0b96cbf,,released,Leucovorin Calcium,1,2021-12-21T14:15:22.541820-06:00,Chemotherapy,Residual Disease,
HCM-CSHL-0659-C18,8376d8ee-20ce-41bc-b36d-3fbadd194084,d0594736-0baa-41d8-811b-ce376f6d0d4a,,Adjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0659-C18_treatment18,85fd00b0-3e77-4761-8dd1-b3430fd7c2f5,,released,,0,2021-12-21T14:15:22.541820-06:00,"Radiation Therapy, NOS",Residual Disease,
HCM-CSHL-0659-C18,8376d8ee-20ce-41bc-b36d-3fbadd194084,d0594736-0baa-41d8-811b-ce376f6d0d4a,,Adjuvant,807.0,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0659-C18_treatment16,97d7a1ef-422d-4358-8815-f78d5d675341,Treatment Ongoing,released,Ipilimumab,1,2021-12-21T14:15:22.541820-06:00,Targeted Molecular Therapy,Residual Disease,
HCM-CSHL-0659-C18,8376d8ee-20ce-41bc-b36d-3fbadd194084,d0594736-0baa-41d8-811b-ce376f6d0d4a,,Adjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0659-C18_treatment11,9a8358ac-3638-4d0e-8da5-4125fd4edc02,,released,,0,2021-12-21T14:15:22.541820-06:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-CSHL-0659-C18,8376d8ee-20ce-41bc-b36d-3fbadd194084,d0594736-0baa-41d8-811b-ce376f6d0d4a,488.0,Adjuvant,390.0,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0659-C18_treatment8,ae50247b-0e31-46d9-a7b5-4fcfa2e867e9,,released,Irinotecan,1,2021-12-21T14:15:22.541820-06:00,Chemotherapy,Residual Disease,
HCM-CSHL-0659-C18,8376d8ee-20ce-41bc-b36d-3fbadd194084,d0594736-0baa-41d8-811b-ce376f6d0d4a,271.0,Adjuvant,40.0,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0659-C18_treatment3,ccc80ef8-f9cf-444b-ba52-bb9ce9e526ad,,released,Fluorouracil,1,2021-12-21T14:15:22.541820-06:00,Chemotherapy,Residual Disease,
HCM-CSHL-0659-C18,8376d8ee-20ce-41bc-b36d-3fbadd194084,d0594736-0baa-41d8-811b-ce376f6d0d4a,488.0,Adjuvant,390.0,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0659-C18_treatment7,db231961-19f5-4ccd-b13b-a5735cac3991,,released,Fluorouracil,1,2021-12-21T14:15:22.541820-06:00,Chemotherapy,Residual Disease,
HCM-CSHL-0659-C18,8376d8ee-20ce-41bc-b36d-3fbadd194084,d0594736-0baa-41d8-811b-ce376f6d0d4a,488.0,Adjuvant,390.0,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0659-C18_treatment6,eeb73428-19ee-4afe-bb84-523b485cca9e,,released,Leucovorin Calcium,1,2021-12-21T14:15:22.541820-06:00,Chemotherapy,Residual Disease,
HCM-CSHL-0659-C18,8376d8ee-20ce-41bc-b36d-3fbadd194084,d0594736-0baa-41d8-811b-ce376f6d0d4a,,Adjuvant,807.0,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0659-C18_treatment17,fc1040a8-43b5-4ba3-9387-f93ba55e9be7,Treatment Ongoing,released,Nivolumab,1,2021-12-21T14:15:22.541820-06:00,Targeted Molecular Therapy,Residual Disease,
HCM-EXPT-1194-C18,83d72552-6453-4a48-a2a5-68b9c02af103,f6855a58-988b-4d0b-9cc7-352a3a0dfc3d,,Neoadjuvant,,2025-10-08T12:38:28.988690-05:00,HCM-EXPT-1194-C18_treatment,bd410544-b997-40fc-b7de-2b70a555afb7,,released,,0,2023-02-24T14:12:47.583116-06:00,,,
HCM-EXPT-1243-C20,83eec9f5-8c83-42f1-b77b-1fbaec52afc0,289a4a97-64a3-473f-9692-dca4cea99337,,Neoadjuvant,,2025-10-08T12:39:37.798161-05:00,HCM-EXPT-1243-C20_treatment,00b611fc-9dca-4097-ace5-dbd11fb2771e,,released,,0,2023-02-24T14:19:03.737280-06:00,,,
HCM-BROD-0045-C16,844a5119-2fc7-43c5-be14-6285e6c79474,b8fded20-edf7-46d2-8ac1-120e1c0c16c1,,Adjuvant,,2023-03-13T12:49:04.196418-05:00,HCM-BROD-0045-C16_treatment4,2a742f86-3cfb-4487-a465-9ba186d6cfbe,,released,,0,2019-04-04T15:22:17.422971-05:00,"Radiation Therapy, NOS",Residual Disease,
HCM-BROD-0045-C16,844a5119-2fc7-43c5-be14-6285e6c79474,b8fded20-edf7-46d2-8ac1-120e1c0c16c1,,Adjuvant,,2023-03-13T12:49:04.196418-05:00,HCM-BROD-0045-C16_treatment3,419fb921-3a10-4df0-933e-75bdb62c80fa,,released,,0,2019-04-04T15:22:17.422971-05:00,"Pharmaceutical Therapy, NOS",Residual Disease,
HCM-BROD-0045-C16,844a5119-2fc7-43c5-be14-6285e6c79474,b8fded20-edf7-46d2-8ac1-120e1c0c16c1,,,,2023-03-13T12:49:04.196418-05:00,HCM-BROD-0045-C16_treatment2,563d0d52-847c-44ba-bfc7-8da28264b452,,released,,0,2019-04-04T15:22:17.422971-05:00,"Surgery, NOS",Initial Diagnosis,
HCM-BROD-0045-C16,844a5119-2fc7-43c5-be14-6285e6c79474,b8fded20-edf7-46d2-8ac1-120e1c0c16c1,,Neoadjuvant,,2021-07-12T12:25:55.528644-05:00,HCM-BROD-0045-C16_treatment,e862dae4-be1c-475b-be04-1ddcbbcbeea7,,released,,0,2019-04-04T15:22:17.422971-05:00,,,
HCM-SANG-1320-C25,848d6440-7980-449d-9698-52de610ea561,b6a71928-c42a-478c-ac4f-25b45b3cc997,,Neoadjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-SANG-1320-C25_treatment,cfaffbea-65c6-480e-99f1-4d4d6f2fc159,,released,,0,2023-02-27T11:50:22.760459-06:00,,,
HCM-SANG-0547-C25,854e555d-16d1-4817-a63b-e45cfad8161b,231c5b38-f68e-48e0-95a7-05f0162a0dce,,Neoadjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-SANG-0547-C25_treatment,1df5312a-3708-48a2-947f-fb0d2bf4954b,,released,,0,2021-12-21T15:15:52.686861-06:00,,,
HCM-EXPT-1216-C15,855b539a-0bb5-4fc9-a8f6-6ebddc87cbc4,4f4f45a0-3878-4d13-811b-ccaa348a35c1,,Neoadjuvant,111.0,2025-10-08T12:38:51.189053-05:00,HCM-EXPT-1216-C15_treatment,04b02b9b-17a8-4b25-aa78-39a2aa5210c2,,released,Epirubicin,1,2023-02-24T14:15:49.880987-06:00,Chemotherapy,,
HCM-EXPT-1216-C15,855b539a-0bb5-4fc9-a8f6-6ebddc87cbc4,4f4f45a0-3878-4d13-811b-ccaa348a35c1,,Neoadjuvant,111.0,2025-10-08T12:38:51.189053-05:00,HCM-EXPT-1216-C15_treatment4,435582ae-014e-44c3-8753-d60d4c1ca764,,released,,1,2023-02-24T14:15:49.880987-06:00,Chemotherapy,,ECX
HCM-EXPT-1216-C15,855b539a-0bb5-4fc9-a8f6-6ebddc87cbc4,4f4f45a0-3878-4d13-811b-ccaa348a35c1,,Neoadjuvant,111.0,2025-10-08T12:38:51.189053-05:00,HCM-EXPT-1216-C15_treatment2,76e8a60c-dea0-4b13-a631-6fd56ffd06e4,,released,Capecitabine,1,2023-02-24T14:15:49.880987-06:00,Chemotherapy,,
HCM-EXPT-1216-C15,855b539a-0bb5-4fc9-a8f6-6ebddc87cbc4,4f4f45a0-3878-4d13-811b-ccaa348a35c1,,Neoadjuvant,111.0,2025-10-08T12:38:51.189053-05:00,HCM-EXPT-1216-C15_treatment3,a04d1c32-8a48-4f35-9800-a44c83667af0,,released,Cisplatin,1,2023-02-24T14:15:49.880987-06:00,Chemotherapy,,
HCM-BROD-1127-C15,856282a3-fcad-4002-9190-64825ae6d77f,30428dd0-e6e4-406e-810f-17f1f71ce9f5,266.0,Maintenance Therapy,28.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-1127-C15_treatment12,4d93aa81-d3f4-4ee1-9687-f1768a29fb12,Progressive Disease,released,Trastuzumab,1,2021-12-21T14:02:07.696604-06:00,,,
HCM-BROD-1127-C15,856282a3-fcad-4002-9190-64825ae6d77f,30428dd0-e6e4-406e-810f-17f1f71ce9f5,266.0,Maintenance Therapy,28.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-1127-C15_treatment11,862e473a-c452-4bd0-a588-e68326801706,Progressive Disease,released,Paclitaxel,1,2021-12-21T14:02:07.696604-06:00,,,
HCM-BROD-1127-C15,856282a3-fcad-4002-9190-64825ae6d77f,30428dd0-e6e4-406e-810f-17f1f71ce9f5,266.0,Maintenance Therapy,28.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-1127-C15_treatment16,9cae3138-c538-4c57-acb4-71812a786bd3,Progressive Disease,released,,1,2021-12-21T14:02:07.696604-06:00,,,FOLFOX
HCM-BROD-1127-C15,856282a3-fcad-4002-9190-64825ae6d77f,30428dd0-e6e4-406e-810f-17f1f71ce9f5,266.0,Maintenance Therapy,28.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-1127-C15_treatment10,a85a59fa-e6d6-4c00-b4a0-ecc258ed3d08,Progressive Disease,released,Oxaliplatin,1,2021-12-21T14:02:07.696604-06:00,,,
HCM-BROD-1127-C15,856282a3-fcad-4002-9190-64825ae6d77f,30428dd0-e6e4-406e-810f-17f1f71ce9f5,266.0,Maintenance Therapy,28.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-1127-C15_treatment13,a8f7f391-3de8-4107-976a-69a28138d9bc,Progressive Disease,released,Leucovorin Calcium,1,2021-12-21T14:02:07.696604-06:00,,,
HCM-BROD-1127-C15,856282a3-fcad-4002-9190-64825ae6d77f,30428dd0-e6e4-406e-810f-17f1f71ce9f5,266.0,Maintenance Therapy,28.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-1127-C15_treatment15,bd7a3cba-fa18-4ec8-bb3c-9097d4d33ba4,Progressive Disease,released,Ramucirumab,1,2021-12-21T14:02:07.696604-06:00,,,
HCM-BROD-1127-C15,856282a3-fcad-4002-9190-64825ae6d77f,30428dd0-e6e4-406e-810f-17f1f71ce9f5,266.0,Maintenance Therapy,28.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-1127-C15_treatment14,f231148e-066e-46e1-995e-610cdf66cb6b,Progressive Disease,released,Fluorouracil,1,2021-12-21T14:02:07.696604-06:00,,,
HCM-BROD-1127-C15,856282a3-fcad-4002-9190-64825ae6d77f,c30b4e81-962c-49b5-926b-2008f5a36642,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-BROD-1127-C15_treatment8,051e35c6-b7fe-420f-9937-56f643911591,,released,,0,2021-12-21T14:02:07.696604-06:00,Targeted Molecular Therapy,Residual Disease,
HCM-BROD-1127-C15,856282a3-fcad-4002-9190-64825ae6d77f,c30b4e81-962c-49b5-926b-2008f5a36642,287.0,Adjuvant,287.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-1127-C15_treatment5,0a3a9908-059f-41f0-8a5b-5fb6ed908677,Treatment Ongoing,released,,1,2021-12-21T14:02:07.696604-06:00,Chemotherapy,Residual Disease,FU-LV regimen
HCM-BROD-1127-C15,856282a3-fcad-4002-9190-64825ae6d77f,c30b4e81-962c-49b5-926b-2008f5a36642,,Neoadjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-BROD-1127-C15_treatment,0fb7820a-cbb0-4657-91aa-6fded41a8856,,released,,0,2021-12-21T14:02:07.696604-06:00,,,
HCM-BROD-1127-C15,856282a3-fcad-4002-9190-64825ae6d77f,c30b4e81-962c-49b5-926b-2008f5a36642,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-BROD-1127-C15_treatment9,57ae85c0-442d-4e6c-af1e-381007dce269,,released,,0,2021-12-21T14:02:07.696604-06:00,"Radiation Therapy, NOS",Residual Disease,
HCM-BROD-1127-C15,856282a3-fcad-4002-9190-64825ae6d77f,c30b4e81-962c-49b5-926b-2008f5a36642,287.0,Adjuvant,287.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-1127-C15_treatment4,8e9c4260-864d-45c7-8e19-87c40f59a541,Treatment Ongoing,released,Leucovorin,1,2021-12-21T14:02:07.696604-06:00,Chemotherapy,Residual Disease,
HCM-BROD-1127-C15,856282a3-fcad-4002-9190-64825ae6d77f,c30b4e81-962c-49b5-926b-2008f5a36642,,,0.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-1127-C15_treatment7,b9c01f96-0ad3-401a-95ac-419770dc6dd5,,released,,1,2021-12-21T14:02:07.696604-06:00,"Surgery, NOS",Initial Diagnosis,
HCM-BROD-1127-C15,856282a3-fcad-4002-9190-64825ae6d77f,c30b4e81-962c-49b5-926b-2008f5a36642,287.0,Adjuvant,287.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-1127-C15_treatment3,c3a86878-6685-43e7-85c0-b2c2fc1cfb8e,Treatment Ongoing,released,Fluorouracil,1,2021-12-21T14:02:07.696604-06:00,Chemotherapy,Residual Disease,
HCM-BROD-1127-C15,856282a3-fcad-4002-9190-64825ae6d77f,c30b4e81-962c-49b5-926b-2008f5a36642,287.0,Adjuvant,287.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-1127-C15_treatment2,e99c0a0f-bf4e-497b-95ca-f7a8c60f2caf,Treatment Ongoing,released,Irinotecan,1,2021-12-21T14:02:07.696604-06:00,Chemotherapy,Residual Disease,
HCM-BROD-1127-C15,856282a3-fcad-4002-9190-64825ae6d77f,c30b4e81-962c-49b5-926b-2008f5a36642,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-BROD-1127-C15_treatment6,f1b5875c-61f9-479e-a990-2f3bacbb450e,,released,,0,2021-12-21T14:02:07.696604-06:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-WCMC-0494-C16,858a84e1-002b-451c-a2dc-cf5673f08992,af559a9c-9422-4239-a671-eeb7c357bc10,,Neoadjuvant,,2023-07-13T10:35:44.371881-05:00,HCM-WCMC-0494-C16_treatment,0963e3b7-821f-403d-a72d-574d8346c0d0,,released,,0,2023-02-27T12:05:25.583371-06:00,,,
HCM-WCMC-0494-C16,858a84e1-002b-451c-a2dc-cf5673f08992,af559a9c-9422-4239-a671-eeb7c357bc10,,Adjuvant,,2023-07-13T10:35:44.371881-05:00,HCM-WCMC-0494-C16_treatment8,3a853791-bd9f-4ec6-aa55-4f908b2dd9cf,,released,,0,2023-02-27T12:05:25.583371-06:00,Targeted Molecular Therapy,Residual Disease,
HCM-WCMC-0494-C16,858a84e1-002b-451c-a2dc-cf5673f08992,af559a9c-9422-4239-a671-eeb7c357bc10,190.0,Adjuvant,95.0,2023-07-13T10:35:44.371881-05:00,HCM-WCMC-0494-C16_treatment2,4ca9adc6-8b14-41eb-a46a-f0396ea9956e,,released,Leucovorin,1,2023-02-27T12:05:25.583371-06:00,Chemotherapy,Residual Disease,
HCM-WCMC-0494-C16,858a84e1-002b-451c-a2dc-cf5673f08992,af559a9c-9422-4239-a671-eeb7c357bc10,149.0,Adjuvant,121.0,2023-07-13T10:35:44.371881-05:00,HCM-WCMC-0494-C16_treatment5,5b3b1632-2ab5-48e0-a86f-45178b45c3d3,,released,Capecitabine,1,2023-02-27T12:05:25.583371-06:00,Chemotherapy,Residual Disease,
HCM-WCMC-0494-C16,858a84e1-002b-451c-a2dc-cf5673f08992,af559a9c-9422-4239-a671-eeb7c357bc10,,Adjuvant,,2023-07-13T10:35:44.371881-05:00,HCM-WCMC-0494-C16_treatment6,732c56b7-233d-44c2-8f46-f6a28f6241b7,,released,,0,2023-02-27T12:05:25.583371-06:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-WCMC-0494-C16,858a84e1-002b-451c-a2dc-cf5673f08992,af559a9c-9422-4239-a671-eeb7c357bc10,190.0,Adjuvant,95.0,2023-07-13T10:35:44.371881-05:00,HCM-WCMC-0494-C16_treatment3,8302ce9e-7b3f-45b4-989e-ea709e158ec1,,released,Fluorouracil,1,2023-02-27T12:05:25.583371-06:00,Chemotherapy,Residual Disease,
HCM-WCMC-0494-C16,858a84e1-002b-451c-a2dc-cf5673f08992,af559a9c-9422-4239-a671-eeb7c357bc10,155.0,Adjuvant,121.0,2023-07-13T10:35:44.371881-05:00,HCM-WCMC-0494-C16_treatment9,8d3b317d-d5d7-4130-aaed-dd4209f880e3,,released,,1,2023-02-27T12:05:25.583371-06:00,"Radiation Therapy, NOS",Residual Disease,
HCM-WCMC-0494-C16,858a84e1-002b-451c-a2dc-cf5673f08992,af559a9c-9422-4239-a671-eeb7c357bc10,190.0,Adjuvant,95.0,2023-07-13T10:35:44.371881-05:00,HCM-WCMC-0494-C16_treatment4,d9c953e9-29ab-4398-85da-c422ad5fefbc,,released,,1,2023-02-27T12:05:25.583371-06:00,Chemotherapy,Residual Disease,FU-LV regimen
HCM-WCMC-0494-C16,858a84e1-002b-451c-a2dc-cf5673f08992,af559a9c-9422-4239-a671-eeb7c357bc10,,,44.0,2023-07-13T10:35:44.371881-05:00,HCM-WCMC-0494-C16_treatment7,feeaeb44-a452-42ea-952a-59289c048358,,released,,1,2023-02-27T12:05:25.583371-06:00,"Surgery, NOS",Initial Diagnosis,
HCM-CSHL-0665-C24,85defb91-94b6-4f5e-b4b4-3d857a429ab3,d8615033-b394-4242-bfaa-e8f422fe9e47,214.0,Adjuvant,103.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0665-C24_treatment2,099d0756-82ff-44d6-9e11-76ff2e1e7d5b,,released,Capecitabine,1,2021-12-21T14:16:43.785688-06:00,Chemotherapy,Residual Disease,
HCM-CSHL-0665-C24,85defb91-94b6-4f5e-b4b4-3d857a429ab3,d8615033-b394-4242-bfaa-e8f422fe9e47,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0665-C24_treatment6,4a52f505-0db4-463f-8b9a-5ec6e9991ec5,,released,,0,2021-12-21T14:16:43.785688-06:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-CSHL-0665-C24,85defb91-94b6-4f5e-b4b4-3d857a429ab3,d8615033-b394-4242-bfaa-e8f422fe9e47,,Neoadjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0665-C24_treatment,62bf0f84-9c01-4696-91e4-7c4159287ecd,,released,,0,2021-12-21T14:16:43.785688-06:00,,,
HCM-CSHL-0665-C24,85defb91-94b6-4f5e-b4b4-3d857a429ab3,d8615033-b394-4242-bfaa-e8f422fe9e47,,,-8.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0665-C24_treatment7,652a8b11-ac5e-4653-8f58-48be13550edc,,released,,1,2021-12-21T14:16:43.785688-06:00,"Surgery, NOS",Initial Diagnosis,
HCM-CSHL-0665-C24,85defb91-94b6-4f5e-b4b4-3d857a429ab3,d8615033-b394-4242-bfaa-e8f422fe9e47,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0665-C24_treatment5,6551c8fa-0780-40ea-8783-7bf75f3018c9,,released,,0,2021-12-21T14:16:43.785688-06:00,Hormone Therapy,Residual Disease,
HCM-CSHL-0665-C24,85defb91-94b6-4f5e-b4b4-3d857a429ab3,d8615033-b394-4242-bfaa-e8f422fe9e47,,Adjuvant,367.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0665-C24_treatment3,81740285-d8ba-4ed1-b124-d03b8b8e2534,Treatment Ongoing,released,Oxaliplatin,1,2021-12-21T14:16:43.785688-06:00,Chemotherapy,Residual Disease,
HCM-CSHL-0665-C24,85defb91-94b6-4f5e-b4b4-3d857a429ab3,d8615033-b394-4242-bfaa-e8f422fe9e47,,Adjuvant,367.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0665-C24_treatment4,81e750ba-73c1-4d73-aa73-b5cecbf0423c,Treatment Ongoing,released,Capecitabine,1,2021-12-21T14:16:43.785688-06:00,Chemotherapy,Residual Disease,
HCM-CSHL-0665-C24,85defb91-94b6-4f5e-b4b4-3d857a429ab3,d8615033-b394-4242-bfaa-e8f422fe9e47,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0665-C24_treatment8,e38f62d8-c01f-421d-9676-04de4f3d4cff,,released,,0,2021-12-21T14:16:43.785688-06:00,Targeted Molecular Therapy,Residual Disease,
HCM-CSHL-0665-C24,85defb91-94b6-4f5e-b4b4-3d857a429ab3,d8615033-b394-4242-bfaa-e8f422fe9e47,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0665-C24_treatment9,f4c765bd-b852-4d0f-8458-fcf035626c80,,released,,0,2021-12-21T14:16:43.785688-06:00,"Radiation Therapy, NOS",Residual Disease,
HCM-BROD-0830-C71,85f48da8-16cc-4e6f-9f1b-2eaed60f93d8,3beedeef-9cc3-44f9-8618-52f7c423d223,,Adjuvant,,2023-03-13T12:51:50.849462-05:00,HCM-BROD-0830-C71_treatment3,91c125c4-d26c-4cb7-9bc2-0965bbde7bbf,,released,,0,2021-12-21T13:54:14.357230-06:00,"Pharmaceutical Therapy, NOS",Residual Disease,
HCM-BROD-0830-C71,85f48da8-16cc-4e6f-9f1b-2eaed60f93d8,3beedeef-9cc3-44f9-8618-52f7c423d223,,Neoadjuvant,,2023-02-22T07:39:25.979291-06:00,HCM-BROD-0830-C71_treatment,96042a14-4ae8-4717-84b1-bb9f6220e4ea,,released,,0,2021-12-21T13:54:14.357230-06:00,,,
HCM-BROD-0830-C71,85f48da8-16cc-4e6f-9f1b-2eaed60f93d8,3beedeef-9cc3-44f9-8618-52f7c423d223,,Adjuvant,,2023-03-13T12:51:50.849462-05:00,HCM-BROD-0830-C71_treatment4,bdda715c-bf8d-483e-9644-584ae15fbdca,,released,,0,2021-12-21T13:54:14.357230-06:00,"Radiation Therapy, NOS",Residual Disease,
HCM-BROD-0830-C71,85f48da8-16cc-4e6f-9f1b-2eaed60f93d8,3beedeef-9cc3-44f9-8618-52f7c423d223,,,0.0,2023-03-13T12:51:50.849462-05:00,HCM-BROD-0830-C71_treatment2,de874f16-d631-42a2-997b-53e988a289f8,,released,,1,2021-12-21T13:54:14.357230-06:00,"Surgery, NOS",Initial Diagnosis,
HCM-BROD-0830-C71,85f48da8-16cc-4e6f-9f1b-2eaed60f93d8,e150df26-fa11-463e-86da-c45f24a66a89,328.0,Maintenance Therapy,202.0,2023-03-14T11:40:17.645275-05:00,HCM-BROD-0830-C71_treatment5,7921d43c-51fb-4089-95ec-efa450ffc330,Progressive Disease,released,Temozolomide,1,2023-03-13T12:51:50.849462-05:00,,,
HCM-EXPT-1016-C18,861a1852-cd32-42e4-902f-0e3db208e5ba,a81dd86d-58a9-499c-a675-29557f92c8aa,,Neoadjuvant,,2025-10-08T12:37:43.816130-05:00,HCM-EXPT-1016-C18_treatment,19820be0-0f05-4863-8493-4240bb9a4fa6,,released,,0,2021-12-21T14:56:08.130437-06:00,,,
HCM-BROD-0420-C71,864de84d-7936-4bfd-89ff-b552a9d470aa,ea678a7c-2a3a-4e03-8eed-f8ca208ed0b6,,,0.0,2023-02-27T11:36:21.099672-06:00,HCM-BROD-0420-C71_treatment5,1e194a40-965b-429b-ab1e-98110cd051e5,,released,,1,2020-08-31T19:03:03.372481-05:00,"Surgery, NOS",Initial Diagnosis,
HCM-BROD-0420-C71,864de84d-7936-4bfd-89ff-b552a9d470aa,ea678a7c-2a3a-4e03-8eed-f8ca208ed0b6,,Adjuvant,,2021-07-12T12:25:55.528644-05:00,HCM-BROD-0420-C71_treatment4,323bd2dc-740c-4a0e-b56c-1497ea81ab2e,,released,,0,2020-08-31T19:03:03.372481-05:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-BROD-0420-C71,864de84d-7936-4bfd-89ff-b552a9d470aa,ea678a7c-2a3a-4e03-8eed-f8ca208ed0b6,,Neoadjuvant,36.0,2021-07-12T12:25:55.528644-05:00,HCM-BROD-0420-C71_treatment2,5017fc3b-3b92-4971-8501-09b9165b6f37,,released,,1,2020-08-31T19:03:03.372481-05:00,"Radiation Therapy, NOS",,
HCM-BROD-0420-C71,864de84d-7936-4bfd-89ff-b552a9d470aa,ea678a7c-2a3a-4e03-8eed-f8ca208ed0b6,283.0,Adjuvant,222.0,2021-07-12T12:25:55.528644-05:00,HCM-BROD-0420-C71_treatment3,508a9153-9660-4c33-a6d6-b0ac00a63295,,released,Temozolomide,1,2020-08-31T19:03:03.372481-05:00,Chemotherapy,Residual Disease,
HCM-BROD-0420-C71,864de84d-7936-4bfd-89ff-b552a9d470aa,ea678a7c-2a3a-4e03-8eed-f8ca208ed0b6,,Neoadjuvant,36.0,2021-07-12T12:25:55.528644-05:00,HCM-BROD-0420-C71_treatment,664d7d0c-bca9-48dc-9cba-e0985b7a4acf,,released,Temozolomide,1,2020-08-31T19:03:03.372481-05:00,Chemotherapy,,
HCM-BROD-0420-C71,864de84d-7936-4bfd-89ff-b552a9d470aa,ea678a7c-2a3a-4e03-8eed-f8ca208ed0b6,,Adjuvant,,2021-07-12T12:25:55.528644-05:00,HCM-BROD-0420-C71_treatment6,98ce7ca9-9e86-415f-8142-a37c44520878,,released,,0,2020-08-31T19:03:03.372481-05:00,Targeted Molecular Therapy,Residual Disease,
HCM-BROD-0420-C71,864de84d-7936-4bfd-89ff-b552a9d470aa,ea678a7c-2a3a-4e03-8eed-f8ca208ed0b6,88.0,Adjuvant,36.0,2021-07-12T12:25:55.528644-05:00,HCM-BROD-0420-C71_treatment7,dd56bc11-3225-4fe1-82c4-b97a49ebcc58,,released,,1,2020-08-31T19:03:03.372481-05:00,"Radiation Therapy, NOS",Residual Disease,
HCM-EXPT-1060-C18,865ea4cc-9245-4d3b-8f22-16ec05632426,fff29295-2249-4a43-aa6a-9a2599cf70e5,,Neoadjuvant,,2025-10-08T12:38:28.988690-05:00,HCM-EXPT-1060-C18_treatment,bee36b51-6569-4034-8e2f-c2c4fee0b923,,released,,0,2021-12-21T15:03:16.613601-06:00,,,
HCM-SANG-0532-C20,8747f56e-c1bf-4c1e-bb1c-02d46ae597db,bc0a5c9b-2d16-4942-9743-0564d4fb12f1,,Neoadjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-SANG-0532-C20_treatment3,0f148d63-fff6-4694-b584-bbcb4d73b712,,released,,1,2023-02-27T11:27:03.619777-06:00,"Radiation, 2D Conventional",,
HCM-SANG-0532-C20,8747f56e-c1bf-4c1e-bb1c-02d46ae597db,bc0a5c9b-2d16-4942-9743-0564d4fb12f1,,Neoadjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-SANG-0532-C20_treatment2,374b5aee-0a01-4df6-9851-b22f08783415,,released,Oxaliplatin,1,2023-02-27T11:27:03.619777-06:00,Chemotherapy,,
HCM-SANG-0532-C20,8747f56e-c1bf-4c1e-bb1c-02d46ae597db,bc0a5c9b-2d16-4942-9743-0564d4fb12f1,,Neoadjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-SANG-0532-C20_treatment,752b8040-6189-448a-a34c-7b232b893d34,,released,Capecitabine,1,2023-02-27T11:27:03.619777-06:00,Chemotherapy,,
HCM-CSHL-0821-C19,87653787-214f-4c79-af6d-087cb0240521,5ed84145-ca40-4e4f-8361-9d0ba4d37b81,250.0,Maintenance Therapy,55.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0821-C19_treatment13,0eb89dd6-7261-4233-ba71-c08f9dae3de8,Stable Disease,released,Oxaliplatin,1,2021-12-21T14:31:19.659505-06:00,,,
HCM-CSHL-0821-C19,87653787-214f-4c79-af6d-087cb0240521,5ed84145-ca40-4e4f-8361-9d0ba4d37b81,250.0,Maintenance Therapy,55.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0821-C19_treatment14,21d478df-1cd8-4782-b52b-f1015936d455,Stable Disease,released,,1,2021-12-21T14:31:19.659505-06:00,,,FOLFOX
HCM-CSHL-0821-C19,87653787-214f-4c79-af6d-087cb0240521,5ed84145-ca40-4e4f-8361-9d0ba4d37b81,250.0,Maintenance Therapy,55.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0821-C19_treatment12,71e844e1-8cd9-40de-b2dc-a4b2cd6b04e5,Stable Disease,released,Fluorouracil,1,2021-12-21T14:31:19.659505-06:00,,,
HCM-CSHL-0821-C19,87653787-214f-4c79-af6d-087cb0240521,5ed84145-ca40-4e4f-8361-9d0ba4d37b81,250.0,Maintenance Therapy,55.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0821-C19_treatment11,7b8e8ac4-ecb3-4b4f-b473-5e5aae4c6792,Stable Disease,released,Leucovorin Calcium,1,2021-12-21T14:31:19.659505-06:00,,,
HCM-CSHL-0821-C19,87653787-214f-4c79-af6d-087cb0240521,c319566f-35d5-4ee3-8bad-54003b198d44,250.0,Adjuvant,55.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0821-C19_treatment5,10a38db7-60e7-4ead-85a4-b6963b1d476e,,released,,1,2021-12-21T14:31:19.659505-06:00,Chemotherapy,Residual Disease,FOLFOX
HCM-CSHL-0821-C19,87653787-214f-4c79-af6d-087cb0240521,c319566f-35d5-4ee3-8bad-54003b198d44,250.0,Adjuvant,55.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0821-C19_treatment3,1a06a35a-2eec-426e-b111-0c8647371d28,,released,Fluorouracil,1,2021-12-21T14:31:19.659505-06:00,Chemotherapy,Residual Disease,
HCM-CSHL-0821-C19,87653787-214f-4c79-af6d-087cb0240521,c319566f-35d5-4ee3-8bad-54003b198d44,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0821-C19_treatment10,1d93f571-83d5-4675-a54c-e99dfa3574fb,,released,,0,2021-12-21T14:31:19.659505-06:00,"Radiation Therapy, NOS",Residual Disease,
HCM-CSHL-0821-C19,87653787-214f-4c79-af6d-087cb0240521,c319566f-35d5-4ee3-8bad-54003b198d44,,,1533.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0821-C19_treatment8,3883739e-0c74-4132-961c-2d1a95cce6cd,,released,,1,2021-12-21T14:31:19.659505-06:00,"Surgery, NOS",Initial Diagnosis,
HCM-CSHL-0821-C19,87653787-214f-4c79-af6d-087cb0240521,c319566f-35d5-4ee3-8bad-54003b198d44,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0821-C19_treatment6,58046ae6-3fe5-4aae-ba93-4dd4d3abc5ed,,released,,0,2021-12-21T14:31:19.659505-06:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-CSHL-0821-C19,87653787-214f-4c79-af6d-087cb0240521,c319566f-35d5-4ee3-8bad-54003b198d44,,Neoadjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0821-C19_treatment,5a9c91e3-57b2-402b-83e7-19b19ab87a11,,released,,0,2021-12-21T14:31:19.659505-06:00,,,
HCM-CSHL-0821-C19,87653787-214f-4c79-af6d-087cb0240521,c319566f-35d5-4ee3-8bad-54003b198d44,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0821-C19_treatment9,79c9c247-1ae0-42c2-b7fd-30de5314b1bb,,released,,0,2021-12-21T14:31:19.659505-06:00,Targeted Molecular Therapy,Residual Disease,
HCM-CSHL-0821-C19,87653787-214f-4c79-af6d-087cb0240521,c319566f-35d5-4ee3-8bad-54003b198d44,,,15.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0821-C19_treatment7,b90f204e-9e3b-40ad-9247-0bcbf4d29cd9,,released,,1,2021-12-21T14:31:19.659505-06:00,"Surgery, NOS",Initial Diagnosis,
HCM-CSHL-0821-C19,87653787-214f-4c79-af6d-087cb0240521,c319566f-35d5-4ee3-8bad-54003b198d44,250.0,Adjuvant,55.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0821-C19_treatment4,c7a3c698-ea3a-47ec-9382-c44bd7ac7eab,,released,Oxaliplatin,1,2021-12-21T14:31:19.659505-06:00,Chemotherapy,Residual Disease,
HCM-CSHL-0821-C19,87653787-214f-4c79-af6d-087cb0240521,c319566f-35d5-4ee3-8bad-54003b198d44,250.0,Adjuvant,55.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0821-C19_treatment2,e8d3d475-1a82-4bd0-a69f-b99622253dfa,,released,Leucovorin Calcium,1,2021-12-21T14:31:19.659505-06:00,Chemotherapy,Residual Disease,
HCM-BROD-0223-C43,87804fe2-1c07-4bcc-80c6-d225e4089ba6,6b3960fc-a3d1-47a2-bc7a-8a565ea8623b,545.0,Maintenance Therapy,545.0,2021-01-06T22:55:10.531130-06:00,HCM-BROD-0223-C43_treatment8,0d75ec22-3ab2-4121-bd90-21eb3701cd58,Stable Disease,released,,1,2020-10-08T12:07:53.915718-05:00,,,
HCM-BROD-0223-C43,87804fe2-1c07-4bcc-80c6-d225e4089ba6,b31cc85f-f637-4b9b-889f-78d472b98255,,Adjuvant,,2021-01-06T22:55:10.531130-06:00,HCM-BROD-0223-C43_treatment7,127e196e-72a1-42ab-ac3a-7740fdc5b70c,,released,,0,2020-10-08T12:07:53.915718-05:00,"Radiation Therapy, NOS",Residual Disease,
HCM-BROD-0223-C43,87804fe2-1c07-4bcc-80c6-d225e4089ba6,b31cc85f-f637-4b9b-889f-78d472b98255,,Adjuvant,,2021-01-06T22:55:10.531130-06:00,HCM-BROD-0223-C43_treatment3,1342ab49-f196-406f-98ba-d3c9a7fb90de,,released,,0,2020-06-15T13:39:37.499745-05:00,Hormone Therapy,Residual Disease,
HCM-BROD-0223-C43,87804fe2-1c07-4bcc-80c6-d225e4089ba6,b31cc85f-f637-4b9b-889f-78d472b98255,,Adjuvant,,2021-01-06T22:55:10.531130-06:00,HCM-BROD-0223-C43_treatment2,1832bc62-8aed-44ef-a55c-12bee451ad72,,released,,0,2020-06-15T13:39:37.499745-05:00,Chemotherapy,Residual Disease,
HCM-BROD-0223-C43,87804fe2-1c07-4bcc-80c6-d225e4089ba6,b31cc85f-f637-4b9b-889f-78d472b98255,,Adjuvant,,2021-01-06T22:55:10.531130-06:00,HCM-BROD-0223-C43_treatment6,1a34aa5f-7536-47ef-84d3-ed7830cab78c,,released,,0,2020-06-15T13:39:37.499745-05:00,Targeted Molecular Therapy,Residual Disease,
HCM-BROD-0223-C43,87804fe2-1c07-4bcc-80c6-d225e4089ba6,b31cc85f-f637-4b9b-889f-78d472b98255,,Neoadjuvant,545.0,2021-01-06T22:55:10.531130-06:00,HCM-BROD-0223-C43_treatment,8674057b-75f6-40a8-8765-e6f4ca837038,,released,,1,2020-06-15T13:39:37.499745-05:00,Stereotactic Radiosurgery,,
HCM-BROD-0223-C43,87804fe2-1c07-4bcc-80c6-d225e4089ba6,b31cc85f-f637-4b9b-889f-78d472b98255,,,-18.0,2023-02-27T12:21:31.406431-06:00,HCM-BROD-0223-C43_treatment5,d681d715-58b6-488e-9c4e-b3cf88754d3c,,released,,1,2020-06-15T13:39:37.499745-05:00,"Surgery, NOS",Initial Diagnosis,
HCM-BROD-0223-C43,87804fe2-1c07-4bcc-80c6-d225e4089ba6,b31cc85f-f637-4b9b-889f-78d472b98255,954.0,Adjuvant,647.0,2021-01-06T22:55:10.531130-06:00,HCM-BROD-0223-C43_treatment4,e0d4ba8b-944e-410a-ac14-57ff1d85db59,,released,Pembrolizumab,1,2020-06-15T13:39:37.499745-05:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-BROD-0595-C43,87cd2ae0-d743-4c63-bbb7-694c8d12a21a,42061609-7b24-460a-b6da-6e1355e18e0e,2111.0,Maintenance Therapy,15.0,2021-07-12T12:25:55.528644-05:00,HCM-BROD-0595-C43_treatment12,1a27a89f-2c35-4ed0-aa61-85d2c94bd521,Treatment Ongoing,released,Vemurafenib,1,2021-04-20T10:33:00.663172-05:00,,,
HCM-BROD-0595-C43,87cd2ae0-d743-4c63-bbb7-694c8d12a21a,42061609-7b24-460a-b6da-6e1355e18e0e,2111.0,Maintenance Therapy,15.0,2021-07-12T12:25:55.528644-05:00,HCM-BROD-0595-C43_treatment11,fe54c5fd-d9ea-4bc3-b9f4-a0b26d8362c0,Treatment Ongoing,released,Pembrolizumab,1,2021-04-20T10:33:00.663172-05:00,,,
HCM-BROD-0595-C43,87cd2ae0-d743-4c63-bbb7-694c8d12a21a,ca612bad-38fb-49fc-a6b0-912657f58a6c,,Adjuvant,,2021-07-12T12:25:55.528644-05:00,HCM-BROD-0595-C43_treatment3,3f166e0b-a787-4208-84a6-57164943ee43,,released,,0,2021-04-20T10:33:00.663172-05:00,Chemotherapy,Residual Disease,
HCM-BROD-0595-C43,87cd2ae0-d743-4c63-bbb7-694c8d12a21a,ca612bad-38fb-49fc-a6b0-912657f58a6c,2133.0,Adjuvant,237.0,2021-07-12T12:25:55.528644-05:00,HCM-BROD-0595-C43_treatment5,491e7d3a-5a7e-47e0-b6c8-6464e6f39152,,released,Pembrolizumab,1,2021-04-20T10:33:00.663172-05:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-BROD-0595-C43,87cd2ae0-d743-4c63-bbb7-694c8d12a21a,ca612bad-38fb-49fc-a6b0-912657f58a6c,2482.0,Adjuvant,2425.0,2021-07-12T12:25:55.528644-05:00,HCM-BROD-0595-C43_treatment6,842cb0df-358a-4c34-929c-fe5226d3dec2,,released,Nivolumab,1,2021-04-20T10:33:00.663172-05:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-BROD-0595-C43,87cd2ae0-d743-4c63-bbb7-694c8d12a21a,ca612bad-38fb-49fc-a6b0-912657f58a6c,,,,2023-02-27T11:18:13.660494-06:00,HCM-BROD-0595-C43_treatment7,96d9ead7-09ff-49ae-b13d-f74c23caa35c,,released,,0,2021-04-20T10:33:00.663172-05:00,"Surgery, NOS",Initial Diagnosis,
HCM-BROD-0595-C43,87cd2ae0-d743-4c63-bbb7-694c8d12a21a,ca612bad-38fb-49fc-a6b0-912657f58a6c,,Adjuvant,,2021-07-12T12:25:55.528644-05:00,HCM-BROD-0595-C43_treatment4,d3a1b9fb-dbc8-4c9b-80b2-4973023b4fab,,released,,0,2021-04-20T10:33:00.663172-05:00,Hormone Therapy,Residual Disease,
HCM-BROD-0595-C43,87cd2ae0-d743-4c63-bbb7-694c8d12a21a,ca612bad-38fb-49fc-a6b0-912657f58a6c,2291.0,Adjuvant,2278.0,2021-07-12T12:25:55.528644-05:00,HCM-BROD-0595-C43_treatment10,d7231eef-d5b7-4573-bd3a-b09ee7da1755,,released,,1,2021-04-20T10:33:00.663172-05:00,"Radiation, 2D Conventional",Residual Disease,
HCM-BROD-0595-C43,87cd2ae0-d743-4c63-bbb7-694c8d12a21a,ca612bad-38fb-49fc-a6b0-912657f58a6c,3006.0,Adjuvant,2524.0,2021-07-12T12:25:55.528644-05:00,HCM-BROD-0595-C43_treatment8,dcbee059-04af-4cc2-9506-e1f86e5327e8,Treatment Ongoing,released,Trametinib,1,2021-04-20T10:33:00.663172-05:00,Targeted Molecular Therapy,Residual Disease,
HCM-BROD-0595-C43,87cd2ae0-d743-4c63-bbb7-694c8d12a21a,ca612bad-38fb-49fc-a6b0-912657f58a6c,3006.0,Adjuvant,2524.0,2021-07-12T12:25:55.528644-05:00,HCM-BROD-0595-C43_treatment9,e12bf93e-0886-488d-bfc1-ef47775757c5,Treatment Ongoing,released,Dabrafenib,1,2021-04-20T10:33:00.663172-05:00,Targeted Molecular Therapy,Residual Disease,
HCM-EXPT-1034-C50,87d5b9f8-a744-4419-87bf-b68a5e55cf2f,03e82d8f-fbc3-44de-ada1-d560825b0762,,Neoadjuvant,,2025-10-08T12:38:06.952582-05:00,HCM-EXPT-1034-C50_treatment,6386b910-338f-4a17-95fd-138859b3c7d7,,released,,0,2021-12-21T14:59:31.346049-06:00,,,
HCM-BROD-0455-C71,881496db-88ed-4d7c-a5e7-614da6977c10,874f8d45-ec60-4199-9fa8-68538900ecd3,,Neoadjuvant,,2023-02-22T07:39:25.979291-06:00,HCM-BROD-0455-C71_treatment,192b4bfe-6930-46ff-8c1b-4d5c5fc5348d,,released,,0,2020-06-15T13:21:16.318168-05:00,,,
HCM-BROD-0455-C71,881496db-88ed-4d7c-a5e7-614da6977c10,874f8d45-ec60-4199-9fa8-68538900ecd3,,,-3.0,2023-02-27T11:32:22.339496-06:00,HCM-BROD-0455-C71_treatment4,45ba35fc-6987-4094-9be0-5f053624eee2,,released,,1,2020-06-15T13:21:16.318168-05:00,"Surgery, NOS",Initial Diagnosis,
HCM-BROD-0455-C71,881496db-88ed-4d7c-a5e7-614da6977c10,874f8d45-ec60-4199-9fa8-68538900ecd3,0.0,Adjuvant,0.0,2023-02-22T07:39:25.979291-06:00,HCM-BROD-0455-C71_treatment5,5e38427d-cd1e-43ae-94d2-70b3d0335af5,,released,Bevacizumab,1,2020-06-15T13:21:16.318168-05:00,Targeted Molecular Therapy,Residual Disease,
HCM-BROD-0455-C71,881496db-88ed-4d7c-a5e7-614da6977c10,874f8d45-ec60-4199-9fa8-68538900ecd3,0.0,Adjuvant,0.0,2023-02-22T07:39:25.979291-06:00,HCM-BROD-0455-C71_treatment6,8a57f6c6-8d81-46cf-a62d-fdf00cf35403,,released,,1,2020-06-15T13:21:16.318168-05:00,"Radiation Therapy, NOS",Residual Disease,
HCM-BROD-0455-C71,881496db-88ed-4d7c-a5e7-614da6977c10,874f8d45-ec60-4199-9fa8-68538900ecd3,0.0,Adjuvant,0.0,2023-02-22T07:39:25.979291-06:00,HCM-BROD-0455-C71_treatment2,d4de57f9-927e-4319-a299-3283809ea471,,released,Temozolomide,1,2020-06-15T13:21:16.318168-05:00,Chemotherapy,Residual Disease,
HCM-BROD-0455-C71,881496db-88ed-4d7c-a5e7-614da6977c10,874f8d45-ec60-4199-9fa8-68538900ecd3,,Adjuvant,,2023-02-22T07:39:25.979291-06:00,HCM-BROD-0455-C71_treatment3,d863ceaa-923f-442e-827b-b741c82dc699,,released,,0,2020-06-15T13:21:16.318168-05:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-BROD-0102-C71,88335768-5a27-4b29-b3bc-72e53b87015b,0f5fbda8-274e-4b09-9784-f0a5f066b7f7,,Adjuvant,,2023-02-22T07:39:25.979291-06:00,HCM-BROD-0102-C71_treatment4,02085b74-d30d-45a1-b958-ace29a5732bb,,released,,0,2020-09-27T10:26:06.680328-05:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-BROD-0102-C71,88335768-5a27-4b29-b3bc-72e53b87015b,0f5fbda8-274e-4b09-9784-f0a5f066b7f7,720.0,Adjuvant,526.0,2023-02-22T07:39:25.979291-06:00,HCM-BROD-0102-C71_treatment2,286245be-c930-443f-89b9-a2b04ae370b3,,released,Irinotecan,1,2020-09-27T10:26:06.680328-05:00,Chemotherapy,Residual Disease,
HCM-BROD-0102-C71,88335768-5a27-4b29-b3bc-72e53b87015b,0f5fbda8-274e-4b09-9784-f0a5f066b7f7,963.0,Adjuvant,916.0,2023-02-22T07:39:25.979291-06:00,HCM-BROD-0102-C71_treatment8,2d20b7d1-42ae-4763-b2b5-e68cd1755ead,,released,Bevacizumab,1,2020-09-27T10:26:06.680328-05:00,Targeted Molecular Therapy,Residual Disease,
HCM-BROD-0102-C71,88335768-5a27-4b29-b3bc-72e53b87015b,0f5fbda8-274e-4b09-9784-f0a5f066b7f7,,Neoadjuvant,,2023-02-22T07:39:25.979291-06:00,HCM-BROD-0102-C71_treatment,33a73ae6-cd45-4b53-8f28-a5951bde73f9,,released,,0,2019-04-04T14:44:46.021396-05:00,,,
HCM-BROD-0102-C71,88335768-5a27-4b29-b3bc-72e53b87015b,0f5fbda8-274e-4b09-9784-f0a5f066b7f7,720.0,Adjuvant,512.0,2023-02-22T07:39:25.979291-06:00,HCM-BROD-0102-C71_treatment6,48dcba64-2333-4c90-8bb5-be4c4fb323e8,,released,Bevacizumab,1,2020-09-27T10:26:06.680328-05:00,Targeted Molecular Therapy,Residual Disease,
HCM-BROD-0102-C71,88335768-5a27-4b29-b3bc-72e53b87015b,0f5fbda8-274e-4b09-9784-f0a5f066b7f7,,,-12.0,2023-02-27T12:11:05.017087-06:00,HCM-BROD-0102-C71_treatment5,6b94952f-cb30-4a9e-8b55-ba9f5f773685,,released,,1,2020-09-27T10:26:06.680328-05:00,"Surgery, NOS",Initial Diagnosis,
HCM-BROD-0102-C71,88335768-5a27-4b29-b3bc-72e53b87015b,0f5fbda8-274e-4b09-9784-f0a5f066b7f7,837.0,Adjuvant,804.0,2023-02-22T07:39:25.979291-06:00,HCM-BROD-0102-C71_treatment3,6f59f4e0-cacd-45dc-9955-0f614218df45,,released,Carboplatin,1,2020-09-27T10:26:06.680328-05:00,Chemotherapy,Residual Disease,
HCM-BROD-0102-C71,88335768-5a27-4b29-b3bc-72e53b87015b,0f5fbda8-274e-4b09-9784-f0a5f066b7f7,895.0,Adjuvant,776.0,2023-02-22T07:39:25.979291-06:00,HCM-BROD-0102-C71_treatment7,a6834594-8c35-4f7e-ba3b-9afa6644c822,,released,Bevacizumab,1,2020-09-27T10:26:06.680328-05:00,Targeted Molecular Therapy,Residual Disease,
HCM-BROD-0102-C71,88335768-5a27-4b29-b3bc-72e53b87015b,0f5fbda8-274e-4b09-9784-f0a5f066b7f7,,Adjuvant,,2023-02-22T07:39:25.979291-06:00,HCM-BROD-0102-C71_treatment9,d58acf6f-a29a-4f24-a0b5-267f13e2c2a9,,released,,0,2020-09-27T10:26:06.680328-05:00,"Radiation Therapy, NOS",Residual Disease,
HCM-CSHL-0814-C54,8853968f-f813-40ee-9084-cfd2e4ac854d,6be8124e-e2cb-46e0-934f-69c84f5441a0,154.0,Adjuvant,42.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0814-C54_treatment3,19649697-fc3d-4b15-b13c-7c43ddfb0509,,released,Paclitaxel,1,2022-07-14T11:04:20.216364-05:00,Chemotherapy,Residual Disease,
HCM-CSHL-0814-C54,8853968f-f813-40ee-9084-cfd2e4ac854d,6be8124e-e2cb-46e0-934f-69c84f5441a0,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0814-C54_treatment5,1e2f638b-c6ef-4978-aace-984f82e0cf72,,released,,0,2022-07-14T11:04:20.216364-05:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-CSHL-0814-C54,8853968f-f813-40ee-9084-cfd2e4ac854d,6be8124e-e2cb-46e0-934f-69c84f5441a0,230.0,Adjuvant,191.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0814-C54_treatment8,2001a089-6247-4b3e-a694-d3e68259cc8f,,released,,1,2022-07-14T11:04:20.216364-05:00,"Radiation, Intensity-Modulated Radiotherapy",Residual Disease,
HCM-CSHL-0814-C54,8853968f-f813-40ee-9084-cfd2e4ac854d,6be8124e-e2cb-46e0-934f-69c84f5441a0,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0814-C54_treatment7,481b46ff-871f-4072-b838-5ec6caf0933b,,released,,0,2022-07-14T11:04:20.216364-05:00,Targeted Molecular Therapy,Residual Disease,
HCM-CSHL-0814-C54,8853968f-f813-40ee-9084-cfd2e4ac854d,6be8124e-e2cb-46e0-934f-69c84f5441a0,,,0.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0814-C54_treatment6,6123527f-b07a-4b6b-9f4c-c1f31d18b80f,,released,,1,2022-07-14T11:04:20.216364-05:00,"Surgery, NOS",Initial Diagnosis,
HCM-CSHL-0814-C54,8853968f-f813-40ee-9084-cfd2e4ac854d,6be8124e-e2cb-46e0-934f-69c84f5441a0,154.0,Adjuvant,42.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0814-C54_treatment2,91c8fa62-e4f6-4897-b236-7891341a9bae,,released,Carboplatin,1,2022-07-14T11:04:20.216364-05:00,Chemotherapy,Residual Disease,
HCM-CSHL-0814-C54,8853968f-f813-40ee-9084-cfd2e4ac854d,6be8124e-e2cb-46e0-934f-69c84f5441a0,,Neoadjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0814-C54_treatment,d36ed921-b7ce-405d-ae5a-3470d191f8fc,,released,,0,2022-07-14T11:04:20.216364-05:00,,,
HCM-CSHL-0814-C54,8853968f-f813-40ee-9084-cfd2e4ac854d,6be8124e-e2cb-46e0-934f-69c84f5441a0,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0814-C54_treatment4,f92f15e1-5bac-41b2-8c11-fac0836a3455,,released,,0,2022-07-14T11:04:20.216364-05:00,Hormone Therapy,Residual Disease,
HCM-SANG-0778-C25,886d8079-9a5d-40bd-89ea-6ed14ea504b0,4ff2aefd-b99b-4fe3-b45f-33ab3955e9b1,,Neoadjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-SANG-0778-C25_treatment,c80e00ad-5fa2-4968-b863-1e33254988af,,released,,0,2023-02-27T11:54:18.512073-06:00,,,
HCM-BROD-0926-C16,88808858-b4db-4ec6-a505-10339b498dcf,02673a5d-e643-46da-8db6-686e552cc87c,330.0,Maintenance Therapy,16.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0926-C16_treatment17,352c1141-6bb9-4dd0-b916-d17ff94ed47a,Progressive Disease,released,Cisplatin,1,2021-12-21T13:58:08.825531-06:00,,,
HCM-BROD-0926-C16,88808858-b4db-4ec6-a505-10339b498dcf,02673a5d-e643-46da-8db6-686e552cc87c,330.0,Maintenance Therapy,16.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0926-C16_treatment16,44d75c3e-ce65-4c05-b238-b1394ecd1f95,Progressive Disease,released,Oxaliplatin,1,2021-12-21T13:58:08.825531-06:00,,,
HCM-BROD-0926-C16,88808858-b4db-4ec6-a505-10339b498dcf,02673a5d-e643-46da-8db6-686e552cc87c,330.0,Maintenance Therapy,16.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0926-C16_treatment15,4b1c59bd-16e3-4cf6-8adb-19028e525223,Progressive Disease,released,Docetaxel,1,2021-12-21T13:58:08.825531-06:00,,,
HCM-BROD-0926-C16,88808858-b4db-4ec6-a505-10339b498dcf,02673a5d-e643-46da-8db6-686e552cc87c,330.0,Maintenance Therapy,16.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0926-C16_treatment18,621aa3ea-d9a7-4493-96b1-d9847c4a16f0,Progressive Disease,released,Pembrolizumab,1,2021-12-21T13:58:08.825531-06:00,,,
HCM-BROD-0926-C16,88808858-b4db-4ec6-a505-10339b498dcf,02673a5d-e643-46da-8db6-686e552cc87c,330.0,Maintenance Therapy,16.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0926-C16_treatment13,8902c30e-fdf1-45f3-b87b-7a9899b8eaa0,Progressive Disease,released,Irinotecan,1,2021-12-21T13:58:08.825531-06:00,,,
HCM-BROD-0926-C16,88808858-b4db-4ec6-a505-10339b498dcf,02673a5d-e643-46da-8db6-686e552cc87c,330.0,Maintenance Therapy,16.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0926-C16_treatment19,cb425be4-6861-48d1-a380-8484099a0156,Progressive Disease,released,Fluorouracil,1,2021-12-21T13:58:08.825531-06:00,,,
HCM-BROD-0926-C16,88808858-b4db-4ec6-a505-10339b498dcf,02673a5d-e643-46da-8db6-686e552cc87c,330.0,Maintenance Therapy,16.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0926-C16_treatment14,f6c1562e-9d8a-4105-becf-7dcf344b0e8c,Progressive Disease,released,Leucovorin,1,2021-12-21T13:58:08.825531-06:00,,,
HCM-BROD-0926-C16,88808858-b4db-4ec6-a505-10339b498dcf,a3c25e99-f5cc-4ee0-8caf-b352686eb071,231.0,Adjuvant,203.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0926-C16_treatment5,132e5503-c95f-4ed0-8359-d6d4240a7e69,,released,Paclitaxel,1,2021-12-21T13:58:08.825531-06:00,Chemotherapy,Residual Disease,
HCM-BROD-0926-C16,88808858-b4db-4ec6-a505-10339b498dcf,a3c25e99-f5cc-4ee0-8caf-b352686eb071,301.0,Adjuvant,244.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0926-C16_treatment8,170b8af1-6851-4b71-9735-0886b456694a,,released,Irinotecan,1,2021-12-21T13:58:08.825531-06:00,Chemotherapy,Residual Disease,
HCM-BROD-0926-C16,88808858-b4db-4ec6-a505-10339b498dcf,a3c25e99-f5cc-4ee0-8caf-b352686eb071,,Neoadjuvant,2.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0926-C16_treatment,223c9ac0-8b25-479b-bf02-2b8a6d2caf3f,,released,Irinotecan,1,2021-12-21T13:58:08.825531-06:00,Chemotherapy,,
HCM-BROD-0926-C16,88808858-b4db-4ec6-a505-10339b498dcf,a3c25e99-f5cc-4ee0-8caf-b352686eb071,330.0,Adjuvant,302.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0926-C16_treatment9,29e7963d-754d-4ad1-a047-77d55a92bf22,Treatment Ongoing,released,Pembrolizumab,1,2021-12-21T13:58:08.825531-06:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-BROD-0926-C16,88808858-b4db-4ec6-a505-10339b498dcf,a3c25e99-f5cc-4ee0-8caf-b352686eb071,,Neoadjuvant,2.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0926-C16_treatment2,4cda280e-6587-4d60-8bb1-7bb547710182,,released,Oxaliplatin,1,2021-12-21T13:58:08.825531-06:00,Chemotherapy,,
HCM-BROD-0926-C16,88808858-b4db-4ec6-a505-10339b498dcf,a3c25e99-f5cc-4ee0-8caf-b352686eb071,,Neoadjuvant,2.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0926-C16_treatment3,69e04a47-f8be-432a-ba6f-882006b3d69a,,released,Leucovorin,1,2021-12-21T13:58:08.825531-06:00,Chemotherapy,,
HCM-BROD-0926-C16,88808858-b4db-4ec6-a505-10339b498dcf,a3c25e99-f5cc-4ee0-8caf-b352686eb071,,Neoadjuvant,2.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0926-C16_treatment4,73249450-7ed2-4704-9f7e-499b08276d9c,,released,Fluorouracil,1,2021-12-21T13:58:08.825531-06:00,Chemotherapy,,
HCM-BROD-0926-C16,88808858-b4db-4ec6-a505-10339b498dcf,a3c25e99-f5cc-4ee0-8caf-b352686eb071,301.0,Adjuvant,244.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0926-C16_treatment7,7ea81be3-324d-4226-8c28-975f26688aca,,released,Docetaxel,1,2021-12-21T13:58:08.825531-06:00,Chemotherapy,Residual Disease,
HCM-BROD-0926-C16,88808858-b4db-4ec6-a505-10339b498dcf,a3c25e99-f5cc-4ee0-8caf-b352686eb071,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0926-C16_treatment12,872a56d9-78ce-4cff-b728-da96163c906c,,released,,0,2021-12-21T13:58:08.825531-06:00,"Radiation Therapy, NOS",Residual Disease,
HCM-BROD-0926-C16,88808858-b4db-4ec6-a505-10339b498dcf,a3c25e99-f5cc-4ee0-8caf-b352686eb071,231.0,Adjuvant,203.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0926-C16_treatment11,8ea0770b-01ea-4521-8e30-3b995207b6f2,,released,Ramucirumab,1,2021-12-21T13:58:08.825531-06:00,Targeted Molecular Therapy,Residual Disease,
HCM-BROD-0926-C16,88808858-b4db-4ec6-a505-10339b498dcf,a3c25e99-f5cc-4ee0-8caf-b352686eb071,,,,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0926-C16_treatment10,ad9609e3-4be3-4e7c-ad5e-4580be69fd0a,,released,,0,2021-12-21T13:58:08.825531-06:00,"Surgery, NOS",Initial Diagnosis,
HCM-BROD-0926-C16,88808858-b4db-4ec6-a505-10339b498dcf,a3c25e99-f5cc-4ee0-8caf-b352686eb071,301.0,Adjuvant,244.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0926-C16_treatment6,c2b99720-a49d-47ee-bba5-9e38df416a51,,released,Cisplatin,1,2021-12-21T13:58:08.825531-06:00,Chemotherapy,Residual Disease,
HCM-CSHL-0802-C67,88aa1634-d51b-4b0e-89bb-086709b24e2b,58774a23-dbfd-494e-9619-76dabe6945c9,,Neoadjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0802-C67_treatment,461fe876-549d-40af-bdc9-744786a472a4,,released,,0,2021-12-21T14:24:00.546663-06:00,,,
HCM-CSHL-0802-C67,88aa1634-d51b-4b0e-89bb-086709b24e2b,58774a23-dbfd-494e-9619-76dabe6945c9,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0802-C67_treatment3,5471a8da-8942-4db5-9af1-d1a163520bd4,,released,,0,2021-12-21T14:24:00.546663-06:00,"Pharmaceutical Therapy, NOS",Residual Disease,
HCM-CSHL-0802-C67,88aa1634-d51b-4b0e-89bb-086709b24e2b,58774a23-dbfd-494e-9619-76dabe6945c9,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0802-C67_treatment4,815fe59b-026a-495d-9999-aa6cef3db671,,released,,0,2021-12-21T14:24:00.546663-06:00,"Radiation Therapy, NOS",Residual Disease,
HCM-CSHL-0802-C67,88aa1634-d51b-4b0e-89bb-086709b24e2b,58774a23-dbfd-494e-9619-76dabe6945c9,,,0.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0802-C67_treatment2,855f1bc8-8ab2-4c40-a467-3d4dda1637ab,,released,,1,2021-12-21T14:24:00.546663-06:00,"Surgery, NOS",Initial Diagnosis,
HCM-STAN-0840-C49,890b4995-c64f-4d1f-bfd3-131e318e8ac3,075e55d4-7b57-4dc7-9003-260040f52baa,,,78.0,2025-08-20T09:56:36.143985-05:00,HCM-STAN-0840-C49_treatment7,07be50ff-ebc8-4bfa-9a42-22b095b8a420,,released,,1,2022-09-22T07:05:09.947005-05:00,"Surgery, NOS",Initial Diagnosis,
HCM-STAN-0840-C49,890b4995-c64f-4d1f-bfd3-131e318e8ac3,075e55d4-7b57-4dc7-9003-260040f52baa,,Adjuvant,,2025-08-20T09:56:36.143985-05:00,HCM-STAN-0840-C49_treatment5,1c421f88-302a-460e-89a5-1e239d8d8b41,,released,,0,2022-09-22T07:05:09.947005-05:00,Hormone Therapy,Residual Disease,
HCM-STAN-0840-C49,890b4995-c64f-4d1f-bfd3-131e318e8ac3,075e55d4-7b57-4dc7-9003-260040f52baa,,Adjuvant,,2025-08-20T09:56:36.143985-05:00,HCM-STAN-0840-C49_treatment8,1cc333b1-7200-4984-bf42-b9e0ffe927c2,,released,,0,2022-09-22T07:05:09.947005-05:00,Targeted Molecular Therapy,Residual Disease,
HCM-STAN-0840-C49,890b4995-c64f-4d1f-bfd3-131e318e8ac3,075e55d4-7b57-4dc7-9003-260040f52baa,304.0,Adjuvant,78.0,2025-08-20T09:56:36.143985-05:00,HCM-STAN-0840-C49_treatment3,57c52052-5c9c-4f2d-b3ca-798fae581e8b,,released,Docetaxel,1,2022-09-22T07:05:09.947005-05:00,Chemotherapy,Residual Disease,
HCM-STAN-0840-C49,890b4995-c64f-4d1f-bfd3-131e318e8ac3,075e55d4-7b57-4dc7-9003-260040f52baa,,Adjuvant,,2025-08-20T09:56:36.143985-05:00,HCM-STAN-0840-C49_treatment9,ccbb2934-e7a3-4b07-b8a2-fc69a5abffb5,,released,,0,2022-09-22T07:05:09.947005-05:00,"Radiation Therapy, NOS",Residual Disease,
HCM-STAN-0840-C49,890b4995-c64f-4d1f-bfd3-131e318e8ac3,075e55d4-7b57-4dc7-9003-260040f52baa,,Adjuvant,,2025-08-20T09:56:36.143985-05:00,HCM-STAN-0840-C49_treatment6,d17afba6-4c9b-4204-9a3e-318c74def92d,,released,,0,2022-09-22T07:05:09.947005-05:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-STAN-0840-C49,890b4995-c64f-4d1f-bfd3-131e318e8ac3,075e55d4-7b57-4dc7-9003-260040f52baa,304.0,Adjuvant,78.0,2025-08-20T09:56:36.143985-05:00,HCM-STAN-0840-C49_treatment4,d515e794-1395-4501-af66-c92f83ffecb4,,released,Gemcitabine,1,2022-09-22T07:05:09.947005-05:00,Chemotherapy,Residual Disease,
HCM-STAN-0840-C49,890b4995-c64f-4d1f-bfd3-131e318e8ac3,075e55d4-7b57-4dc7-9003-260040f52baa,,Neoadjuvant,18.0,2025-08-20T09:56:36.143985-05:00,HCM-STAN-0840-C49_treatment,da8bfff9-fcef-4261-8b65-ed412fce0382,,released,Ifosfamide,1,2022-09-22T07:05:09.947005-05:00,Chemotherapy,,
HCM-STAN-0840-C49,890b4995-c64f-4d1f-bfd3-131e318e8ac3,075e55d4-7b57-4dc7-9003-260040f52baa,,Neoadjuvant,18.0,2025-08-20T09:56:36.143985-05:00,HCM-STAN-0840-C49_treatment2,f29f7ac9-c7e2-4a59-a793-375c7a4a325b,,released,,1,2022-09-22T07:05:09.947005-05:00,"Brachytherapy, High Dose",,
HCM-BROD-0120-C15,8a2452ec-72a0-4efb-84ac-d5af5e613e74,84af79fd-f642-4e56-b413-3d1a59cf47a6,,Adjuvant,,2025-01-02T09:33:48.717229-06:00,HCM-BROD-0120-C15_treatment4,0634655a-e60f-48b6-90d6-74d81e62de65,,released,,0,2019-04-16T11:45:59.271275-05:00,"Pharmaceutical Therapy, NOS",Residual Disease,
HCM-BROD-0120-C15,8a2452ec-72a0-4efb-84ac-d5af5e613e74,84af79fd-f642-4e56-b413-3d1a59cf47a6,,Neoadjuvant,,2023-02-22T07:39:25.979291-06:00,HCM-BROD-0120-C15_treatment,0a799d6b-6c55-402f-854e-7371e2865f1d,,released,Unknown,1,2019-04-16T11:45:59.271275-05:00,Chemotherapy,,
HCM-BROD-0120-C15,8a2452ec-72a0-4efb-84ac-d5af5e613e74,84af79fd-f642-4e56-b413-3d1a59cf47a6,,Adjuvant,,2025-01-03T13:32:08.619997-06:00,HCM-BROD-0120-C15_treatment5,bbd24d57-a97d-4450-ba82-6875aa2de873,,released,,0,2025-01-02T09:33:48.717229-06:00,"Radiation Therapy, NOS",Residual Disease,
HCM-BROD-0120-C15,8a2452ec-72a0-4efb-84ac-d5af5e613e74,84af79fd-f642-4e56-b413-3d1a59cf47a6,,,,2025-01-02T09:33:48.717229-06:00,HCM-BROD-0120-C15_treatment3,f396ff3c-94e4-433f-94b8-9a4d8932db4f,,released,,0,2019-04-16T11:45:59.271275-05:00,"Surgery, NOS",Initial Diagnosis,
HCM-BROD-0120-C15,8a2452ec-72a0-4efb-84ac-d5af5e613e74,84af79fd-f642-4e56-b413-3d1a59cf47a6,,Neoadjuvant,,2025-01-02T09:33:48.717229-06:00,HCM-BROD-0120-C15_treatment2,f3a50753-1e8c-416f-ad95-a589ace00caf,,released,,0,2019-04-16T11:45:59.271275-05:00,"Radiation Therapy, NOS",,
HCM-EXPT-0895-C25,8aae6830-a433-49a8-a0e9-2602aa44f353,26600c40-b019-46e4-b96e-2efecc70526f,,Neoadjuvant,,2025-10-08T12:36:32.654639-05:00,HCM-EXPT-0895-C25_treatment,765b0760-d310-4cfe-b216-3f62775640e5,,released,,0,2021-12-21T14:44:03.596790-06:00,,,
HCM-CSHL-0062-C18,8b3b1f24-419e-4043-82be-2bd41268bb0e,e0fffc04-b694-41a0-8d9d-425504b92784,,Neoadjuvant,,2019-05-24T12:11:41.511797-05:00,HCM-CSHL-0062-C18_treatment,a5f95462-2f9c-4e96-82dd-761b43a937d9,,released,,0,2019-05-15T13:02:25.351730-05:00,,,
HCM-CSHL-0062-C18,8b3b1f24-419e-4043-82be-2bd41268bb0e,e0fffc04-b694-41a0-8d9d-425504b92784,,,13.0,2023-03-13T13:33:55.022476-05:00,HCM-CSHL-0062-C18_treatment2,d285edb6-217c-4adc-831a-0eacba431098,,released,,1,2019-05-15T13:02:25.351730-05:00,"Surgery, NOS",Initial Diagnosis,
HCM-CSHL-0618-C18,8badcb2e-30f1-47ad-91f1-d832d6289f6a,63347168-9c61-43fc-a495-f42c7e49a542,,Neoadjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0618-C18_treatment,392bf13b-5c14-478f-811f-4984e373560f,,released,,0,2021-12-21T14:12:12.806259-06:00,,,
HCM-CSHL-0618-C18,8badcb2e-30f1-47ad-91f1-d832d6289f6a,63347168-9c61-43fc-a495-f42c7e49a542,,,295.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0618-C18_treatment2,45333cb9-d7f8-4a07-b562-de1b8cf36e88,,released,,1,2021-12-21T14:12:12.806259-06:00,"Surgery, NOS",Initial Diagnosis,
HCM-EXPT-1007-C50,8bc7eb06-6875-48b2-9a3f-84514c4022ad,02996481-c98e-4aa2-bef0-2be819ea5ab2,,Neoadjuvant,,2025-10-08T12:37:43.816130-05:00,HCM-EXPT-1007-C50_treatment,d78c7d14-5948-4f8e-8bb4-11aa1e3da06d,,released,,0,2021-12-21T14:54:17.656008-06:00,,,
HCM-CSHL-0246-C19,8d169383-a8af-4450-a837-01da35fb72c5,f09ca60d-fbde-430e-a661-752883746d5b,,Neoadjuvant,74.0,2021-01-06T22:55:10.531130-06:00,HCM-CSHL-0246-C19_treatment5,1ac7c84d-dc4d-4181-9c29-140188ddbbca,,released,,1,2020-02-27T12:50:41.247072-06:00,Chemotherapy,,FOLFOX
HCM-CSHL-0246-C19,8d169383-a8af-4450-a837-01da35fb72c5,f09ca60d-fbde-430e-a661-752883746d5b,340.0,Adjuvant,314.0,2021-01-06T22:55:10.531130-06:00,HCM-CSHL-0246-C19_treatment8,1fbeebb7-5aac-430d-98d7-96b2d17167b8,,released,Leucovorin,1,2020-02-27T12:50:41.247072-06:00,Chemotherapy,Residual Disease,
HCM-CSHL-0246-C19,8d169383-a8af-4450-a837-01da35fb72c5,f09ca60d-fbde-430e-a661-752883746d5b,,Neoadjuvant,74.0,2021-01-06T22:55:10.531130-06:00,HCM-CSHL-0246-C19_treatment2,48f49df1-8e81-4d7a-a8fc-1ba20a74f72f,,released,Leucovorin Calcium,1,2020-02-27T12:50:41.247072-06:00,Chemotherapy,,
HCM-CSHL-0246-C19,8d169383-a8af-4450-a837-01da35fb72c5,f09ca60d-fbde-430e-a661-752883746d5b,,Adjuvant,567.0,2021-09-07T08:39:47.277409-05:00,HCM-CSHL-0246-C19_treatment13,532dad7d-ebdd-429f-92a1-e44c7aa3d59b,,released,Binimetinib,1,2020-09-28T09:31:14.073398-05:00,Targeted Molecular Therapy,Residual Disease,
HCM-CSHL-0246-C19,8d169383-a8af-4450-a837-01da35fb72c5,f09ca60d-fbde-430e-a661-752883746d5b,,Neoadjuvant,74.0,2021-01-06T22:55:10.531130-06:00,HCM-CSHL-0246-C19_treatment3,5a32ccc2-722f-4042-8c3d-a0a71c892099,,released,Fluorouracil,1,2020-02-27T12:50:41.247072-06:00,Chemotherapy,,
HCM-CSHL-0246-C19,8d169383-a8af-4450-a837-01da35fb72c5,f09ca60d-fbde-430e-a661-752883746d5b,,Neoadjuvant,157.0,2021-01-06T22:55:10.531130-06:00,HCM-CSHL-0246-C19_treatment6,5c1a2288-4c49-49bb-9d53-ee366256501d,,released,,1,2020-02-27T12:50:41.247072-06:00,"Radiation, Intensity-Modulated Radiotherapy",,
HCM-CSHL-0246-C19,8d169383-a8af-4450-a837-01da35fb72c5,f09ca60d-fbde-430e-a661-752883746d5b,,Adjuvant,,2021-09-07T08:39:47.277409-05:00,HCM-CSHL-0246-C19_treatment14,65ba6e28-bd7c-487d-9dc9-25f4174ef555,,released,,0,2020-09-28T09:31:14.073398-05:00,"Radiation Therapy, NOS",Residual Disease,
HCM-CSHL-0246-C19,8d169383-a8af-4450-a837-01da35fb72c5,f09ca60d-fbde-430e-a661-752883746d5b,340.0,Adjuvant,314.0,2021-01-06T22:55:10.531130-06:00,HCM-CSHL-0246-C19_treatment7,769bc527-5a51-4723-9475-61d84172ef27,,released,Fluorouracil,1,2020-02-27T12:50:41.247072-06:00,Chemotherapy,Residual Disease,
HCM-CSHL-0246-C19,8d169383-a8af-4450-a837-01da35fb72c5,f09ca60d-fbde-430e-a661-752883746d5b,,,242.0,2023-03-13T13:30:42.830749-05:00,HCM-CSHL-0246-C19_treatment10,7c605e14-8d3e-4190-b56e-81f0cf331521,,released,,1,2020-02-27T12:50:41.247072-06:00,"Surgery, NOS",Initial Diagnosis,
HCM-CSHL-0246-C19,8d169383-a8af-4450-a837-01da35fb72c5,f09ca60d-fbde-430e-a661-752883746d5b,,Neoadjuvant,74.0,2021-01-06T22:55:10.531130-06:00,HCM-CSHL-0246-C19_treatment4,8318a150-6398-4a07-8752-d3c51956a447,,released,Oxaliplatin,1,2020-02-27T12:50:41.247072-06:00,Chemotherapy,,
HCM-CSHL-0246-C19,8d169383-a8af-4450-a837-01da35fb72c5,f09ca60d-fbde-430e-a661-752883746d5b,,Adjuvant,567.0,2021-09-07T08:39:47.277409-05:00,HCM-CSHL-0246-C19_treatment12,8f871a53-dde9-46d8-9c4d-4c7cf70bd1e1,,released,Encorafenib,1,2020-09-28T09:31:14.073398-05:00,Targeted Molecular Therapy,Residual Disease,
HCM-CSHL-0246-C19,8d169383-a8af-4450-a837-01da35fb72c5,f09ca60d-fbde-430e-a661-752883746d5b,,Neoadjuvant,74.0,2021-01-06T22:55:10.531130-06:00,HCM-CSHL-0246-C19_treatment,b8224d67-c338-45f8-9946-7ddac9f324f1,,released,Capecitabine,1,2020-02-27T12:50:41.247072-06:00,Chemotherapy,,
HCM-CSHL-0246-C19,8d169383-a8af-4450-a837-01da35fb72c5,f09ca60d-fbde-430e-a661-752883746d5b,,Adjuvant,567.0,2021-09-07T08:39:47.277409-05:00,HCM-CSHL-0246-C19_treatment11,e0c86b03-185a-4dc1-b325-ef7eaf012489,,released,Cetuximab,1,2020-02-27T12:50:41.247072-06:00,Targeted Molecular Therapy,Residual Disease,
HCM-SANG-0527-C18,8dcd4d5c-688f-475b-aabb-4a10407a5513,dcb9430d-505f-431e-a11a-8d983b73f24a,,Neoadjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-SANG-0527-C18_treatment,4484725b-bdfb-4f3f-a476-2382ddddfaee,,released,,0,2021-12-21T15:13:32.843781-06:00,,,
HCM-SANG-0533-C20,8de026f0-1817-4e4a-941b-20b5ee7680ff,f436cc32-4eba-4916-9bf6-145a82e56547,,Neoadjuvant,,2023-07-13T10:35:44.371881-05:00,HCM-SANG-0533-C20_treatment,07f5911b-a258-492e-9091-9574b8ca4883,,released,,0,2021-12-21T15:13:49.985067-06:00,,,
HCM-BROD-0711-C64,8ed2333b-d19c-4fa1-9433-f349a91159bf,ae4cd8dd-2422-4a39-bb66-3fdfa3d0eaff,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0711-C64_treatment3,3bc1911e-96f3-4862-a72d-90ef4acbb2f3,,released,,0,2021-12-21T13:47:42.558183-06:00,Hormone Therapy,Residual Disease,
HCM-BROD-0711-C64,8ed2333b-d19c-4fa1-9433-f349a91159bf,ae4cd8dd-2422-4a39-bb66-3fdfa3d0eaff,,,37.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0711-C64_treatment5,711c5887-f51e-41f1-a2a4-9eba5b2419a4,,released,,1,2021-12-21T13:47:42.558183-06:00,"Surgery, NOS",Initial Diagnosis,
HCM-BROD-0711-C64,8ed2333b-d19c-4fa1-9433-f349a91159bf,ae4cd8dd-2422-4a39-bb66-3fdfa3d0eaff,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0711-C64_treatment6,71de1e90-966b-438e-acbb-12afbf9a090c,,released,,0,2021-12-21T13:47:42.558183-06:00,Targeted Molecular Therapy,Residual Disease,
HCM-BROD-0711-C64,8ed2333b-d19c-4fa1-9433-f349a91159bf,ae4cd8dd-2422-4a39-bb66-3fdfa3d0eaff,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0711-C64_treatment7,95b7380e-9e67-4324-bbbf-daa2b7d8c95f,,released,,0,2021-12-21T13:47:42.558183-06:00,"Radiation Therapy, NOS",Residual Disease,
HCM-BROD-0711-C64,8ed2333b-d19c-4fa1-9433-f349a91159bf,ae4cd8dd-2422-4a39-bb66-3fdfa3d0eaff,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0711-C64_treatment4,c4bfaf14-3b91-480c-ab53-83e79bd0c8a5,,released,,0,2021-12-21T13:47:42.558183-06:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-BROD-0711-C64,8ed2333b-d19c-4fa1-9433-f349a91159bf,ae4cd8dd-2422-4a39-bb66-3fdfa3d0eaff,,Neoadjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0711-C64_treatment,d810ed89-fe21-4e60-8257-d380e1518886,,released,,0,2021-12-21T13:47:42.558183-06:00,,,
HCM-BROD-0711-C64,8ed2333b-d19c-4fa1-9433-f349a91159bf,ae4cd8dd-2422-4a39-bb66-3fdfa3d0eaff,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0711-C64_treatment2,f2d6ef00-5c4a-4359-ba0a-289d84ac7808,,released,,0,2021-12-21T13:47:42.558183-06:00,Chemotherapy,Residual Disease,
HCM-STAN-0777-C25,8ee05a9d-2373-4598-afec-a42ed3be4082,eda7626d-4f0d-4169-8a8c-ab51f8ded231,,Neoadjuvant,30.0,2025-04-07T17:13:09.336794-05:00,HCM-STAN-0777-C25_treatment4,07c2b651-c057-4674-aadd-d9562c7d1869,,released,Oxaliplatin,1,2022-09-22T07:02:34.287678-05:00,Chemotherapy,,
HCM-STAN-0777-C25,8ee05a9d-2373-4598-afec-a42ed3be4082,eda7626d-4f0d-4169-8a8c-ab51f8ded231,,Neoadjuvant,30.0,2025-04-07T17:13:09.336794-05:00,HCM-STAN-0777-C25_treatment5,130ecac3-9ce5-49af-a24e-3511407fe149,,released,,1,2022-09-22T07:02:34.287678-05:00,Chemotherapy,,FOLFIRINOX
HCM-STAN-0777-C25,8ee05a9d-2373-4598-afec-a42ed3be4082,eda7626d-4f0d-4169-8a8c-ab51f8ded231,,Neoadjuvant,150.0,2025-04-07T17:13:09.336794-05:00,HCM-STAN-0777-C25_treatment6,14966f38-c076-475f-82fe-19b8250e0352,,released,,1,2022-09-22T07:02:34.287678-05:00,Stereotactic Radiosurgery,,
HCM-STAN-0777-C25,8ee05a9d-2373-4598-afec-a42ed3be4082,eda7626d-4f0d-4169-8a8c-ab51f8ded231,,,230.0,2025-04-07T17:13:09.336794-05:00,HCM-STAN-0777-C25_treatment10,1d6c0564-3c82-4ac2-915d-206ab83da8a4,,released,,1,2022-09-22T07:02:34.287678-05:00,"Surgery, NOS",Initial Diagnosis,
HCM-STAN-0777-C25,8ee05a9d-2373-4598-afec-a42ed3be4082,eda7626d-4f0d-4169-8a8c-ab51f8ded231,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-STAN-0777-C25_treatment12,31dda3ec-1921-40e5-91cb-081c98c0d5b8,,released,,0,2022-09-22T07:02:34.287678-05:00,"Radiation Therapy, NOS",Residual Disease,
HCM-STAN-0777-C25,8ee05a9d-2373-4598-afec-a42ed3be4082,eda7626d-4f0d-4169-8a8c-ab51f8ded231,,Neoadjuvant,30.0,2025-04-07T17:13:09.336794-05:00,HCM-STAN-0777-C25_treatment3,3740d0ca-e4be-46d1-8c06-0008ea473a56,,released,Fluorouracil,1,2022-09-22T07:02:34.287678-05:00,Chemotherapy,,
HCM-STAN-0777-C25,8ee05a9d-2373-4598-afec-a42ed3be4082,eda7626d-4f0d-4169-8a8c-ab51f8ded231,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-STAN-0777-C25_treatment9,3b33b5f1-c289-42bf-b93f-270a978f7ace,,released,,0,2022-09-22T07:02:34.287678-05:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-STAN-0777-C25,8ee05a9d-2373-4598-afec-a42ed3be4082,eda7626d-4f0d-4169-8a8c-ab51f8ded231,400.0,Adjuvant,350.0,2025-04-07T17:13:09.336794-05:00,HCM-STAN-0777-C25_treatment8,77ac4a3d-aacc-42b9-a4dc-7aa6abeb60f3,,released,Gemcitabine,1,2022-09-22T07:02:34.287678-05:00,Chemotherapy,Residual Disease,
HCM-STAN-0777-C25,8ee05a9d-2373-4598-afec-a42ed3be4082,eda7626d-4f0d-4169-8a8c-ab51f8ded231,,Neoadjuvant,30.0,2025-04-07T17:13:09.336794-05:00,HCM-STAN-0777-C25_treatment2,bf9a50eb-766a-467f-840e-54ce113ee059,,released,Leucovorin Calcium,1,2022-09-22T07:02:34.287678-05:00,Chemotherapy,,
HCM-STAN-0777-C25,8ee05a9d-2373-4598-afec-a42ed3be4082,eda7626d-4f0d-4169-8a8c-ab51f8ded231,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-STAN-0777-C25_treatment11,d14fe8f4-be64-40cd-872d-64bb76c2257f,,released,,0,2022-09-22T07:02:34.287678-05:00,Targeted Molecular Therapy,Residual Disease,
HCM-STAN-0777-C25,8ee05a9d-2373-4598-afec-a42ed3be4082,eda7626d-4f0d-4169-8a8c-ab51f8ded231,400.0,Adjuvant,350.0,2025-04-07T17:13:09.336794-05:00,HCM-STAN-0777-C25_treatment7,ed65a5d3-2c04-4897-b4da-9916fd8ede76,,released,Capecitabine,1,2022-09-22T07:02:34.287678-05:00,Chemotherapy,Residual Disease,
HCM-STAN-0777-C25,8ee05a9d-2373-4598-afec-a42ed3be4082,eda7626d-4f0d-4169-8a8c-ab51f8ded231,,Neoadjuvant,30.0,2025-04-07T17:13:09.336794-05:00,HCM-STAN-0777-C25_treatment,f36625a5-7b0b-4371-ba6b-20873610c7a2,,released,Irinotecan Hydrochloride,1,2022-09-22T07:02:34.287678-05:00,Chemotherapy,,
HCM-EXPT-1020-C18,8f534be9-3e29-4d81-83f4-44d8fe6d662a,653ca593-3cf1-4bb6-b3a9-286dbf832ae1,,Neoadjuvant,,2025-10-08T12:37:43.816130-05:00,HCM-EXPT-1020-C18_treatment,3d4aad13-2580-43f9-a9ba-febac33812af,,released,,1,2021-12-21T14:57:46.376449-06:00,Chemotherapy,,
HCM-SANG-1312-C20,8fbd0f97-3cf8-40eb-b55d-416fbaffe82a,de76c00d-c676-4a46-968f-b01cbceaf848,,Neoadjuvant,202.0,2025-04-07T17:13:09.336794-05:00,HCM-SANG-1312-C20_treatment3,2f84876e-c6fe-40dd-9548-4a4cb8d04614,,released,,1,2023-02-27T13:23:39.607757-06:00,"Radiation, 2D Conventional",,
HCM-SANG-1312-C20,8fbd0f97-3cf8-40eb-b55d-416fbaffe82a,de76c00d-c676-4a46-968f-b01cbceaf848,,Neoadjuvant,202.0,2025-04-07T17:13:09.336794-05:00,HCM-SANG-1312-C20_treatment,99ea4854-d084-4dcc-941f-2b1ff09e20b8,,released,Capecitabine,1,2023-02-27T13:23:39.607757-06:00,Chemotherapy,,
HCM-SANG-1312-C20,8fbd0f97-3cf8-40eb-b55d-416fbaffe82a,de76c00d-c676-4a46-968f-b01cbceaf848,,Neoadjuvant,202.0,2025-04-07T17:13:09.336794-05:00,HCM-SANG-1312-C20_treatment2,f4c8ddc5-3f4d-42be-beb7-8ea275d2bfb6,,released,Oxaliplatin,1,2023-02-27T13:23:39.607757-06:00,Chemotherapy,,
HCM-CSHL-0432-C20,8ff694fc-0d95-423b-89fa-5e78d759cbe3,84fc422c-e6fa-4714-bd5e-28c9da4c7ab4,,Adjuvant,,2023-03-13T12:54:48.325925-05:00,HCM-CSHL-0432-C20_treatment3,115772e4-d8df-4993-b115-ea374ae6782a,,released,,0,2020-09-28T10:09:05.134510-05:00,"Pharmaceutical Therapy, NOS",Residual Disease,
HCM-CSHL-0432-C20,8ff694fc-0d95-423b-89fa-5e78d759cbe3,84fc422c-e6fa-4714-bd5e-28c9da4c7ab4,,Adjuvant,,2023-03-13T12:54:48.325925-05:00,HCM-CSHL-0432-C20_treatment4,5e14da49-cb52-4d27-a43a-183fafb9210f,,released,,0,2020-09-28T10:09:05.134510-05:00,"Radiation Therapy, NOS",Residual Disease,
HCM-CSHL-0432-C20,8ff694fc-0d95-423b-89fa-5e78d759cbe3,84fc422c-e6fa-4714-bd5e-28c9da4c7ab4,,Neoadjuvant,,2023-02-22T07:39:25.979291-06:00,HCM-CSHL-0432-C20_treatment,62e83dc2-b95d-4b71-a681-fabac1d2483b,,released,,0,2020-09-28T10:09:05.134510-05:00,,,
HCM-CSHL-0432-C20,8ff694fc-0d95-423b-89fa-5e78d759cbe3,84fc422c-e6fa-4714-bd5e-28c9da4c7ab4,,,25.0,2023-03-13T12:54:48.325925-05:00,HCM-CSHL-0432-C20_treatment2,936ab65f-a6d0-4434-ab46-f68e09748f87,,released,,1,2020-09-28T10:09:05.134510-05:00,"Surgery, NOS",Initial Diagnosis,
HCM-EXPT-0887-C25,90369f31-800e-4a61-b2bd-c70e882cc747,4907f5ca-fb5b-4510-8ad2-9492ff4f499b,,Neoadjuvant,,2025-10-08T12:36:32.654639-05:00,HCM-EXPT-0887-C25_treatment,3ae4e303-8c9c-4e8d-8f52-5e515e133735,,released,,0,2021-12-21T14:42:11.227487-06:00,,,
HCM-SANG-1325-C15,908161cf-4761-41b1-8f37-8100e781d90e,5d02091b-ca60-46a3-94c4-4348578a622e,,Neoadjuvant,109.0,2025-04-07T17:13:09.336794-05:00,HCM-SANG-1325-C15_treatment3,48049dcc-73cf-48d8-8d90-9b68f21fdcff,,released,Docetaxel,1,2023-02-27T13:12:40.861483-06:00,Chemotherapy,,
HCM-SANG-1325-C15,908161cf-4761-41b1-8f37-8100e781d90e,5d02091b-ca60-46a3-94c4-4348578a622e,,Neoadjuvant,109.0,2025-04-07T17:13:09.336794-05:00,HCM-SANG-1325-C15_treatment4,6992ac50-42e9-4b5c-b687-3406a9bdee4d,,released,Oxaliplatin,1,2023-02-27T13:12:40.861483-06:00,Chemotherapy,,
HCM-SANG-1325-C15,908161cf-4761-41b1-8f37-8100e781d90e,5d02091b-ca60-46a3-94c4-4348578a622e,,Neoadjuvant,109.0,2025-04-07T17:13:09.336794-05:00,HCM-SANG-1325-C15_treatment2,a7c748a4-323e-45fa-88b6-60c53d89c0c9,,released,Fluorouracil,1,2023-02-27T13:12:40.861483-06:00,Chemotherapy,,
HCM-SANG-1325-C15,908161cf-4761-41b1-8f37-8100e781d90e,5d02091b-ca60-46a3-94c4-4348578a622e,,Neoadjuvant,109.0,2025-04-07T17:13:09.336794-05:00,HCM-SANG-1325-C15_treatment,f921ac8e-d774-4beb-a00f-c7a667267662,,released,Leucovorin,1,2023-02-27T13:12:40.861483-06:00,Chemotherapy,,
HCM-BROD-0098-C15,9097285b-eeb1-4f36-a0ab-0d0592043792,07e4c6d5-8727-4cc5-9d21-cec1873d39c7,,,,2023-02-27T12:26:25.142151-06:00,HCM-BROD-0098-C15_treatment4,2ebf812c-1c5b-4b90-9e29-069c75ca7d4c,,released,,0,2020-02-27T12:28:44.104835-06:00,"Surgery, NOS",Initial Diagnosis,
HCM-BROD-0098-C15,9097285b-eeb1-4f36-a0ab-0d0592043792,07e4c6d5-8727-4cc5-9d21-cec1873d39c7,,Neoadjuvant,,2021-01-06T22:55:10.531130-06:00,HCM-BROD-0098-C15_treatment,f8bb3072-bf9c-496a-b5ea-b61369cb9fb1,,released,,0,2019-04-04T15:50:02.707866-05:00,,,
HCM-CSHL-0374-C25,9166c115-0c9d-4c72-9c2e-da3a3b94072d,cea3047d-5cb5-4200-b083-6106e4969591,,Adjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0374-C25_treatment3,32c235f3-7eea-455a-ba68-43ee131e35ea,,released,,0,2020-09-28T13:00:02.112853-05:00,"Pharmaceutical Therapy, NOS",Residual Disease,
HCM-CSHL-0374-C25,9166c115-0c9d-4c72-9c2e-da3a3b94072d,cea3047d-5cb5-4200-b083-6106e4969591,,Adjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0374-C25_treatment4,52c2e8c0-6dff-440d-9e8f-46b3fd17b7f3,,released,,0,2020-09-28T13:00:02.112853-05:00,"Radiation Therapy, NOS",Residual Disease,
HCM-CSHL-0374-C25,9166c115-0c9d-4c72-9c2e-da3a3b94072d,cea3047d-5cb5-4200-b083-6106e4969591,,,-13.0,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0374-C25_treatment2,9b0245ad-22ef-4435-87c2-f3d925135e70,,released,,1,2020-09-28T13:00:02.112853-05:00,"Surgery, NOS",Initial Diagnosis,
HCM-CSHL-0374-C25,9166c115-0c9d-4c72-9c2e-da3a3b94072d,cea3047d-5cb5-4200-b083-6106e4969591,,Neoadjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0374-C25_treatment,d21cb31b-8366-4bc0-936b-4b0dc806a117,,released,,0,2020-09-28T13:00:02.112853-05:00,,,
HCM-CSHL-0666-C24,91ebd37e-c8ea-4e03-ae01-35d111678dbd,29f83149-20d3-463f-bf7c-aff8075d2488,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0666-C24_treatment3,2154c458-77ab-44b8-82c4-7adb5cedb91a,,released,,0,2021-12-21T14:16:50.471945-06:00,"Pharmaceutical Therapy, NOS",Residual Disease,
HCM-CSHL-0666-C24,91ebd37e-c8ea-4e03-ae01-35d111678dbd,29f83149-20d3-463f-bf7c-aff8075d2488,,,-31.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0666-C24_treatment2,3b7e1055-859b-466a-8967-378de59e5dba,,released,,1,2021-12-21T14:16:50.471945-06:00,"Surgery, NOS",Initial Diagnosis,
HCM-CSHL-0666-C24,91ebd37e-c8ea-4e03-ae01-35d111678dbd,29f83149-20d3-463f-bf7c-aff8075d2488,,Neoadjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0666-C24_treatment,c2ed6257-da0b-4d48-9dc3-48922bb7951d,,released,,0,2021-12-21T14:16:50.471945-06:00,,,
HCM-CSHL-0666-C24,91ebd37e-c8ea-4e03-ae01-35d111678dbd,29f83149-20d3-463f-bf7c-aff8075d2488,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0666-C24_treatment4,e9a97d82-dda5-4310-b791-b28ea484db43,,released,,0,2021-12-21T14:16:50.471945-06:00,"Radiation Therapy, NOS",Residual Disease,
HCM-BROD-1123-C71,9239cb75-6ed2-4335-9124-4b760e0d7e50,229aa478-f17a-4109-a9ba-f0f114911ae6,525.0,Maintenance Therapy,197.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-1123-C71_treatment7,d3197911-7acc-4cd1-ba8f-cbe8d5b2f6c9,Progressive Disease,released,Temozolomide,1,2021-12-21T14:01:36.099050-06:00,,,
HCM-BROD-1123-C71,9239cb75-6ed2-4335-9124-4b760e0d7e50,35f03cb2-d0a0-4fc4-bb99-eb7e53f2f689,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-BROD-1123-C71_treatment5,03de4b50-775e-4001-a486-f820e46f8c6f,,released,,0,2021-12-21T14:01:36.099050-06:00,Targeted Molecular Therapy,Residual Disease,
HCM-BROD-1123-C71,9239cb75-6ed2-4335-9124-4b760e0d7e50,35f03cb2-d0a0-4fc4-bb99-eb7e53f2f689,,,0.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-1123-C71_treatment4,183bbebc-b0c3-4b1f-8bef-03546cf4f2fb,,released,,1,2021-12-21T14:01:36.099050-06:00,"Surgery, NOS",Initial Diagnosis,
HCM-BROD-1123-C71,9239cb75-6ed2-4335-9124-4b760e0d7e50,35f03cb2-d0a0-4fc4-bb99-eb7e53f2f689,,Neoadjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-BROD-1123-C71_treatment,a7ddcb77-8b40-41ca-945c-65585cda0d1e,,released,,0,2021-12-21T14:01:36.099050-06:00,,,
HCM-BROD-1123-C71,9239cb75-6ed2-4335-9124-4b760e0d7e50,35f03cb2-d0a0-4fc4-bb99-eb7e53f2f689,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-BROD-1123-C71_treatment3,d868500a-59a0-47db-a6bc-ffb34aa0c425,,released,,0,2021-12-21T14:01:36.099050-06:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-BROD-1123-C71,9239cb75-6ed2-4335-9124-4b760e0d7e50,35f03cb2-d0a0-4fc4-bb99-eb7e53f2f689,623.0,Adjuvant,581.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-1123-C71_treatment2,e39f4406-e8ea-4c8d-ae0c-b24429928f0c,Treatment Ongoing,released,Temozolomide,1,2021-12-21T14:01:36.099050-06:00,Chemotherapy,Residual Disease,
HCM-BROD-1123-C71,9239cb75-6ed2-4335-9124-4b760e0d7e50,35f03cb2-d0a0-4fc4-bb99-eb7e53f2f689,594.0,Adjuvant,584.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-1123-C71_treatment6,ea385a75-8a4f-44f8-a065-1e4689fcdf5b,,released,,1,2021-12-21T14:01:36.099050-06:00,"Radiation Therapy, NOS",Residual Disease,
HCM-CSHL-0323-C20,92555ec0-7c74-4974-a243-bcfa2b0d55be,12f2c92e-799a-434b-bbe4-0a7d54391af0,,,14.0,2023-03-13T13:29:37.923012-05:00,HCM-CSHL-0323-C20_treatment4,0b68320b-518d-4c6f-a7b7-5c6e066afce8,,released,,1,2020-09-28T09:40:17.931033-05:00,"Surgery, NOS",Initial Diagnosis,
HCM-CSHL-0323-C20,92555ec0-7c74-4974-a243-bcfa2b0d55be,12f2c92e-799a-434b-bbe4-0a7d54391af0,,Adjuvant,,2023-02-22T07:39:25.979291-06:00,HCM-CSHL-0323-C20_treatment5,17fa85da-2641-4ecb-89c3-42ed5dcde5c8,,released,,0,2020-09-28T09:40:17.931033-05:00,Targeted Molecular Therapy,Residual Disease,
HCM-CSHL-0323-C20,92555ec0-7c74-4974-a243-bcfa2b0d55be,12f2c92e-799a-434b-bbe4-0a7d54391af0,,Adjuvant,,2023-02-22T07:39:25.979291-06:00,HCM-CSHL-0323-C20_treatment3,1a199e91-28de-49ce-b01c-f3b2499771cd,,released,,0,2020-09-28T09:40:17.931033-05:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-CSHL-0323-C20,92555ec0-7c74-4974-a243-bcfa2b0d55be,12f2c92e-799a-434b-bbe4-0a7d54391af0,,Neoadjuvant,,2023-02-22T07:39:25.979291-06:00,HCM-CSHL-0323-C20_treatment,39a0e59b-5dca-49a0-a8fe-5404d948fe5f,,released,,0,2020-09-28T09:40:17.931033-05:00,,,
HCM-CSHL-0323-C20,92555ec0-7c74-4974-a243-bcfa2b0d55be,12f2c92e-799a-434b-bbe4-0a7d54391af0,,Adjuvant,,2023-02-22T07:39:25.979291-06:00,HCM-CSHL-0323-C20_treatment2,61cbdbe0-b1c0-4c89-930b-3839336825e6,Treatment Ongoing,released,Capecitabine,1,2020-09-28T09:40:17.931033-05:00,Chemotherapy,Residual Disease,
HCM-CSHL-0323-C20,92555ec0-7c74-4974-a243-bcfa2b0d55be,12f2c92e-799a-434b-bbe4-0a7d54391af0,152.0,Adjuvant,106.0,2023-02-22T07:39:25.979291-06:00,HCM-CSHL-0323-C20_treatment6,ddcb60be-c8cf-4729-a6a9-4afe4bd8a19f,,released,,1,2020-09-28T09:40:17.931033-05:00,"Radiation, Intensity-Modulated Radiotherapy",Residual Disease,
HCM-CSHL-0193-C25,926ed139-205a-4dba-bfa2-9d435adfbb14,67806c5e-be12-4556-a477-dcbce1c5f15b,,Adjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0193-C25_treatment7,0168dfbf-307b-4869-b305-4fe22e8068dd,,released,,0,2020-09-28T09:16:54.676104-05:00,Targeted Molecular Therapy,Residual Disease,
HCM-CSHL-0193-C25,926ed139-205a-4dba-bfa2-9d435adfbb14,67806c5e-be12-4556-a477-dcbce1c5f15b,,Adjuvant,398.0,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0193-C25_treatment3,03823adf-2e31-4e7f-8a60-58019ab0543d,Treatment Ongoing,released,Gemcitabine,1,2020-09-28T09:16:54.676104-05:00,Chemotherapy,Residual Disease,
HCM-CSHL-0193-C25,926ed139-205a-4dba-bfa2-9d435adfbb14,67806c5e-be12-4556-a477-dcbce1c5f15b,,,-5.0,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0193-C25_treatment6,06c0ee37-daa6-4161-b298-832f61fdcd63,,released,,1,2020-09-28T09:16:54.676104-05:00,"Surgery, NOS",Initial Diagnosis,
HCM-CSHL-0193-C25,926ed139-205a-4dba-bfa2-9d435adfbb14,67806c5e-be12-4556-a477-dcbce1c5f15b,,Adjuvant,398.0,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0193-C25_treatment4,1ab88884-de4b-4110-a15b-767e5022b65f,Treatment Ongoing,released,Nab-paclitaxel,1,2020-09-28T09:16:54.676104-05:00,Chemotherapy,Residual Disease,
HCM-CSHL-0193-C25,926ed139-205a-4dba-bfa2-9d435adfbb14,67806c5e-be12-4556-a477-dcbce1c5f15b,139.0,Adjuvant,105.0,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0193-C25_treatment8,5fe69566-49c9-4626-8495-59329f389f2a,,released,,1,2020-09-28T09:16:54.676104-05:00,"Radiation, 2D Conventional",Residual Disease,
HCM-CSHL-0193-C25,926ed139-205a-4dba-bfa2-9d435adfbb14,67806c5e-be12-4556-a477-dcbce1c5f15b,223.0,Adjuvant,44.0,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0193-C25_treatment2,7a0940bc-e64f-4949-8849-a7e04ff56490,,released,Gemcitabine,1,2020-09-28T09:16:54.676104-05:00,Chemotherapy,Residual Disease,
HCM-CSHL-0193-C25,926ed139-205a-4dba-bfa2-9d435adfbb14,67806c5e-be12-4556-a477-dcbce1c5f15b,,Adjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0193-C25_treatment5,8d6340b4-2ad4-4d28-b2fa-2dd7ae2519b0,,released,,0,2020-09-28T09:16:54.676104-05:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-CSHL-0193-C25,926ed139-205a-4dba-bfa2-9d435adfbb14,67806c5e-be12-4556-a477-dcbce1c5f15b,,Neoadjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0193-C25_treatment,e8705b00-3259-47fd-9c21-e95ac41efc3c,,released,,0,2020-09-28T09:16:54.676104-05:00,,,
HCM-BROD-0206-C25,92c3a008-dd39-4243-8f29-3d45e73c1d04,60654d01-ce01-44f9-9a83-b7a600aa02d9,628.0,Adjuvant,551.0,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0206-C25_treatment5,066221be-198d-43f7-a307-56abb4b89005,,released,Oxaliplatin,1,2020-09-17T16:01:59.926485-05:00,Chemotherapy,Residual Disease,
HCM-BROD-0206-C25,92c3a008-dd39-4243-8f29-3d45e73c1d04,60654d01-ce01-44f9-9a83-b7a600aa02d9,,Adjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0206-C25_treatment6,18113bfb-bca8-4f18-af1a-23727991504e,,released,,0,2020-09-17T16:01:59.926485-05:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-BROD-0206-C25,92c3a008-dd39-4243-8f29-3d45e73c1d04,60654d01-ce01-44f9-9a83-b7a600aa02d9,628.0,Adjuvant,551.0,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0206-C25_treatment4,21f5d051-a956-49ec-b0e7-5228c68457ae,,released,Leucovorin,1,2020-09-17T16:01:59.926485-05:00,Chemotherapy,Residual Disease,
HCM-BROD-0206-C25,92c3a008-dd39-4243-8f29-3d45e73c1d04,60654d01-ce01-44f9-9a83-b7a600aa02d9,,Neoadjuvant,615.0,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0206-C25_treatment,255c6596-bda0-4ec1-b712-82f09a57a03e,,released,Gemcitabine,1,2020-09-17T16:01:59.926485-05:00,Chemotherapy,,
HCM-BROD-0206-C25,92c3a008-dd39-4243-8f29-3d45e73c1d04,60654d01-ce01-44f9-9a83-b7a600aa02d9,,Neoadjuvant,615.0,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0206-C25_treatment2,61b49102-d594-4603-b543-6800e93e6c6e,,released,Nab-paclitaxel,1,2020-09-17T16:01:59.926485-05:00,Chemotherapy,,
HCM-BROD-0206-C25,92c3a008-dd39-4243-8f29-3d45e73c1d04,60654d01-ce01-44f9-9a83-b7a600aa02d9,628.0,Adjuvant,551.0,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0206-C25_treatment3,977b3616-64d7-46e5-a12f-66b3e8076636,,released,Fluorouracil,1,2020-09-17T16:01:59.926485-05:00,Chemotherapy,Residual Disease,
HCM-BROD-0206-C25,92c3a008-dd39-4243-8f29-3d45e73c1d04,60654d01-ce01-44f9-9a83-b7a600aa02d9,,Adjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0206-C25_treatment8,a6c3815f-f7e6-48f5-aa71-6098b1a064b5,,released,,0,2020-09-17T16:01:59.926485-05:00,Targeted Molecular Therapy,Residual Disease,
HCM-BROD-0206-C25,92c3a008-dd39-4243-8f29-3d45e73c1d04,60654d01-ce01-44f9-9a83-b7a600aa02d9,,,364.0,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0206-C25_treatment7,b4258ee2-522d-4860-a9aa-142c3c0b2469,,released,,1,2020-09-17T16:01:59.926485-05:00,"Surgery, NOS",Initial Diagnosis,
HCM-BROD-0206-C25,92c3a008-dd39-4243-8f29-3d45e73c1d04,60654d01-ce01-44f9-9a83-b7a600aa02d9,,Adjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0206-C25_treatment9,bf81ceb8-49b5-47c6-9757-97b2caa11234,,released,,0,2020-09-17T16:01:59.926485-05:00,"Radiation Therapy, NOS",Residual Disease,
HCM-EXPT-1013-C50,92c91aac-b8c9-4f2a-8d45-778691ea6743,505279d2-c11a-4515-8fbc-fea2bdaab209,,Neoadjuvant,,2025-10-08T12:37:43.816130-05:00,HCM-EXPT-1013-C50_treatment4,82415a2c-29bd-4a71-9d54-d2fc1c9ada75,,released,,1,2021-12-21T14:55:57.824649-06:00,"Radiation Therapy, NOS",,
HCM-EXPT-1013-C50,92c91aac-b8c9-4f2a-8d45-778691ea6743,505279d2-c11a-4515-8fbc-fea2bdaab209,,Neoadjuvant,,2025-10-08T12:37:43.816130-05:00,HCM-EXPT-1013-C50_treatment3,9a9d5fed-f5ba-4b56-ba1d-47388f7f5934,,released,Atezolizumab,1,2021-12-21T14:55:57.824649-06:00,Immunotherapy (Including Vaccines),,
HCM-EXPT-1013-C50,92c91aac-b8c9-4f2a-8d45-778691ea6743,505279d2-c11a-4515-8fbc-fea2bdaab209,,Neoadjuvant,,2025-10-08T12:37:43.816130-05:00,HCM-EXPT-1013-C50_treatment2,c99de1da-0773-41bc-b59c-7db080da2b13,,released,Paclitaxel,1,2021-12-21T14:55:57.824649-06:00,Chemotherapy,,
HCM-EXPT-1013-C50,92c91aac-b8c9-4f2a-8d45-778691ea6743,505279d2-c11a-4515-8fbc-fea2bdaab209,,Neoadjuvant,,2025-10-08T12:37:43.816130-05:00,HCM-EXPT-1013-C50_treatment,eb256787-f167-46a0-806e-9a339940ff11,,released,Pegylated Liposomal Doxorubicin Hydrochloride,1,2021-12-21T14:55:57.824649-06:00,Chemotherapy,,
HCM-CSHL-0261-C50,9323fd2e-57cb-4149-ba36-274921d70215,49c4ace2-9695-4972-9a5a-2f32bbb4e2e0,,Adjuvant,,2023-02-22T07:39:25.979291-06:00,HCM-CSHL-0261-C50_treatment6,1e27fe00-9e33-450a-9b3a-728613de98ac,,released,,0,2020-09-28T09:34:59.697286-05:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-CSHL-0261-C50,9323fd2e-57cb-4149-ba36-274921d70215,49c4ace2-9695-4972-9a5a-2f32bbb4e2e0,,Adjuvant,,2023-02-22T07:39:25.979291-06:00,HCM-CSHL-0261-C50_treatment8,752df194-cf26-4c5d-b05f-07eca0be5151,,released,,0,2020-09-28T09:34:59.697286-05:00,Targeted Molecular Therapy,Residual Disease,
HCM-CSHL-0261-C50,9323fd2e-57cb-4149-ba36-274921d70215,49c4ace2-9695-4972-9a5a-2f32bbb4e2e0,,Neoadjuvant,,2023-02-22T07:39:25.979291-06:00,HCM-CSHL-0261-C50_treatment,7c0d34ca-fe48-4997-84ea-99cbcceb128f,,released,,0,2020-09-28T09:34:59.697286-05:00,,,
HCM-CSHL-0261-C50,9323fd2e-57cb-4149-ba36-274921d70215,49c4ace2-9695-4972-9a5a-2f32bbb4e2e0,246.0,Adjuvant,116.0,2023-02-22T07:39:25.979291-06:00,HCM-CSHL-0261-C50_treatment2,7f6a5692-b2a7-4bcb-ba0e-dddd6dd54f51,Treatment Ongoing,released,Doxorubicin,1,2020-09-28T09:34:59.697286-05:00,Chemotherapy,Residual Disease,
HCM-CSHL-0261-C50,9323fd2e-57cb-4149-ba36-274921d70215,49c4ace2-9695-4972-9a5a-2f32bbb4e2e0,,Adjuvant,,2023-02-22T07:39:25.979291-06:00,HCM-CSHL-0261-C50_treatment5,80bd5857-3687-4257-8e6b-950b70f74b1a,,released,,0,2020-09-28T09:34:59.697286-05:00,Hormone Therapy,Residual Disease,
HCM-CSHL-0261-C50,9323fd2e-57cb-4149-ba36-274921d70215,49c4ace2-9695-4972-9a5a-2f32bbb4e2e0,246.0,Adjuvant,116.0,2023-02-22T07:39:25.979291-06:00,HCM-CSHL-0261-C50_treatment4,8c5de103-b94a-41c7-9c52-884f5a0987a5,Treatment Ongoing,released,Paclitaxel,1,2020-09-28T09:34:59.697286-05:00,Chemotherapy,Residual Disease,
HCM-CSHL-0261-C50,9323fd2e-57cb-4149-ba36-274921d70215,49c4ace2-9695-4972-9a5a-2f32bbb4e2e0,,Adjuvant,,2023-02-22T07:39:25.979291-06:00,HCM-CSHL-0261-C50_treatment9,d9726b62-c79f-4ee2-aefa-696704e08191,,released,,1,2020-09-28T09:34:59.697286-05:00,"Radiation Therapy, NOS",Residual Disease,
HCM-CSHL-0261-C50,9323fd2e-57cb-4149-ba36-274921d70215,49c4ace2-9695-4972-9a5a-2f32bbb4e2e0,246.0,Adjuvant,116.0,2023-02-22T07:39:25.979291-06:00,HCM-CSHL-0261-C50_treatment3,e99e38f9-7f4d-401b-b024-0e6708ff969a,Treatment Ongoing,released,Cyclophosphamide,1,2020-09-28T09:34:59.697286-05:00,Chemotherapy,Residual Disease,
HCM-CSHL-0261-C50,9323fd2e-57cb-4149-ba36-274921d70215,49c4ace2-9695-4972-9a5a-2f32bbb4e2e0,,,23.0,2023-03-13T13:27:00.314098-05:00,HCM-CSHL-0261-C50_treatment7,ebaa0111-5bde-4f7c-b89b-57a7d1441085,,released,,1,2020-09-28T09:34:59.697286-05:00,"Surgery, NOS",Initial Diagnosis,
HCM-BROD-0561-C43,937294e7-5aab-4d1e-a8ca-1fbb73b0aae8,c6662957-5685-4707-a4ec-88f5377bf35e,,Adjuvant,,2021-03-03T15:15:08.075155-06:00,HCM-BROD-0561-C43_treatment8,37304c55-7005-4f00-9bf6-eaae7d2c4076,,released,,0,2020-09-27T12:01:46.136723-05:00,"Radiation Therapy, NOS",Residual Disease,
HCM-BROD-0561-C43,937294e7-5aab-4d1e-a8ca-1fbb73b0aae8,c6662957-5685-4707-a4ec-88f5377bf35e,,Adjuvant,,2021-03-03T15:15:08.075155-06:00,HCM-BROD-0561-C43_treatment4,8b35f85e-ff96-4e05-8632-4dde9771b9df,,released,,0,2020-07-31T09:30:09.163762-05:00,Hormone Therapy,Residual Disease,
HCM-BROD-0561-C43,937294e7-5aab-4d1e-a8ca-1fbb73b0aae8,c6662957-5685-4707-a4ec-88f5377bf35e,788.0,Adjuvant,418.0,2021-03-03T15:15:08.075155-06:00,HCM-BROD-0561-C43_treatment5,c4b9ca72-11f6-452b-a72e-65634ada42e7,,released,Not Reported,1,2020-07-31T09:30:09.163762-05:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-BROD-0561-C43,937294e7-5aab-4d1e-a8ca-1fbb73b0aae8,c6662957-5685-4707-a4ec-88f5377bf35e,335.0,Adjuvant,26.0,2021-03-03T15:15:08.075155-06:00,HCM-BROD-0561-C43_treatment7,c858b7c1-72d2-43a7-91ee-655298cb71bd,,released,Not Reported,1,2020-07-31T09:30:09.163762-05:00,Targeted Molecular Therapy,Residual Disease,
HCM-BROD-0561-C43,937294e7-5aab-4d1e-a8ca-1fbb73b0aae8,c6662957-5685-4707-a4ec-88f5377bf35e,,Adjuvant,,2021-03-03T15:15:08.075155-06:00,HCM-BROD-0561-C43_treatment3,f361464e-cd78-456c-bb8a-530f227558ef,,released,,0,2020-07-31T09:30:09.163762-05:00,Chemotherapy,Residual Disease,
HCM-BROD-0132-C25,93d1a30b-21c8-4cf7-9d51-49f6e03ef679,2d4ac6fc-6c45-4e02-a57e-5cb7accec807,,Adjuvant,,2023-07-13T10:35:44.371881-05:00,HCM-BROD-0132-C25_treatment17,22a3b9fd-ab74-439a-92c4-8b96a422c04d,,released,,0,2020-09-27T10:48:53.723866-05:00,Targeted Molecular Therapy,Residual Disease,
HCM-BROD-0132-C25,93d1a30b-21c8-4cf7-9d51-49f6e03ef679,2d4ac6fc-6c45-4e02-a57e-5cb7accec807,,Neoadjuvant,14.0,2023-07-13T10:35:44.371881-05:00,HCM-BROD-0132-C25_treatment2,2d51c8e0-0ea8-4670-991c-2a61f9d27998,,released,Leucovorin Calcium,1,2020-07-23T14:37:44.201923-05:00,Chemotherapy,,
HCM-BROD-0132-C25,93d1a30b-21c8-4cf7-9d51-49f6e03ef679,2d4ac6fc-6c45-4e02-a57e-5cb7accec807,,Neoadjuvant,,2023-07-13T10:35:44.371881-05:00,HCM-BROD-0132-C25_treatment8,42fffdcf-2b78-47fc-a461-379d552e6dc8,,released,,1,2020-07-23T14:37:44.201923-05:00,Targeted Molecular Therapy,,
HCM-BROD-0132-C25,93d1a30b-21c8-4cf7-9d51-49f6e03ef679,2d4ac6fc-6c45-4e02-a57e-5cb7accec807,,Neoadjuvant,14.0,2023-07-13T10:35:44.371881-05:00,HCM-BROD-0132-C25_treatment4,4971f02b-e1d4-4979-9a80-c3358dd78374,,released,Oxaliplatin,1,2020-07-23T14:37:44.201923-05:00,Chemotherapy,,
HCM-BROD-0132-C25,93d1a30b-21c8-4cf7-9d51-49f6e03ef679,2d4ac6fc-6c45-4e02-a57e-5cb7accec807,,Neoadjuvant,14.0,2023-07-13T10:35:44.371881-05:00,HCM-BROD-0132-C25_treatment5,6476f8ee-9b18-4ad7-b897-81641b05f4f3,,released,,1,2020-07-23T14:37:44.201923-05:00,Chemotherapy,,FOLFIRINOX
HCM-BROD-0132-C25,93d1a30b-21c8-4cf7-9d51-49f6e03ef679,2d4ac6fc-6c45-4e02-a57e-5cb7accec807,185.0,Adjuvant,25.0,2023-07-13T10:35:44.371881-05:00,HCM-BROD-0132-C25_treatment9,70d82882-12eb-4c54-aabe-e7d67fd0c105,,released,Irinotecan Hydrochloride,1,2020-07-23T14:37:44.201923-05:00,Chemotherapy,Residual Disease,
HCM-BROD-0132-C25,93d1a30b-21c8-4cf7-9d51-49f6e03ef679,2d4ac6fc-6c45-4e02-a57e-5cb7accec807,185.0,Adjuvant,25.0,2023-07-13T10:35:44.371881-05:00,HCM-BROD-0132-C25_treatment12,7465a716-a2ee-4acc-a586-0253ec3385c2,,released,Oxaliplatin,1,2020-09-27T10:48:53.723866-05:00,Chemotherapy,Residual Disease,
HCM-BROD-0132-C25,93d1a30b-21c8-4cf7-9d51-49f6e03ef679,2d4ac6fc-6c45-4e02-a57e-5cb7accec807,235.0,Adjuvant,227.0,2023-07-13T10:35:44.371881-05:00,HCM-BROD-0132-C25_treatment14,7aef82a6-66a4-40bf-96e1-479a1bdfaf95,,released,Gemcitabine,1,2020-09-27T10:48:53.723866-05:00,Chemotherapy,Residual Disease,
HCM-BROD-0132-C25,93d1a30b-21c8-4cf7-9d51-49f6e03ef679,2d4ac6fc-6c45-4e02-a57e-5cb7accec807,,Adjuvant,,2023-07-13T10:35:44.371881-05:00,HCM-BROD-0132-C25_treatment15,8fc0da15-6d4f-4fd5-a15c-8b3514e0055f,,released,,0,2020-09-27T10:48:53.723866-05:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-BROD-0132-C25,93d1a30b-21c8-4cf7-9d51-49f6e03ef679,2d4ac6fc-6c45-4e02-a57e-5cb7accec807,185.0,Adjuvant,25.0,2023-07-13T10:35:44.371881-05:00,HCM-BROD-0132-C25_treatment10,a52a2020-f414-4088-8ede-55e2124b47f8,,released,Leucovorin Calcium,1,2020-07-23T14:37:44.201923-05:00,Chemotherapy,Residual Disease,
HCM-BROD-0132-C25,93d1a30b-21c8-4cf7-9d51-49f6e03ef679,2d4ac6fc-6c45-4e02-a57e-5cb7accec807,,Adjuvant,,2023-07-13T10:35:44.371881-05:00,HCM-BROD-0132-C25_treatment18,a9e59252-293c-429f-8328-703643b9ed44,,released,,0,2020-09-27T10:48:53.723866-05:00,"Radiation Therapy, NOS",Residual Disease,
HCM-BROD-0132-C25,93d1a30b-21c8-4cf7-9d51-49f6e03ef679,2d4ac6fc-6c45-4e02-a57e-5cb7accec807,,Neoadjuvant,14.0,2023-07-13T10:35:44.371881-05:00,HCM-BROD-0132-C25_treatment7,ba9e17a9-6f00-4ba8-9e33-ab86ca3948a1,,released,Nab-paclitaxel,1,2020-07-23T14:37:44.201923-05:00,Chemotherapy,,
HCM-BROD-0132-C25,93d1a30b-21c8-4cf7-9d51-49f6e03ef679,2d4ac6fc-6c45-4e02-a57e-5cb7accec807,,Neoadjuvant,14.0,2023-07-13T10:35:44.371881-05:00,HCM-BROD-0132-C25_treatment3,bc12468c-7c2a-423b-9e68-34a44d0d9d43,,released,Fluorouracil,1,2020-07-23T14:37:44.201923-05:00,Chemotherapy,,
HCM-BROD-0132-C25,93d1a30b-21c8-4cf7-9d51-49f6e03ef679,2d4ac6fc-6c45-4e02-a57e-5cb7accec807,,Neoadjuvant,14.0,2023-07-13T10:35:44.371881-05:00,HCM-BROD-0132-C25_treatment6,c3ee34fa-01f4-4a4a-8f55-f4b80590e091,,released,Gemcitabine,1,2020-07-23T14:37:44.201923-05:00,Chemotherapy,,
HCM-BROD-0132-C25,93d1a30b-21c8-4cf7-9d51-49f6e03ef679,2d4ac6fc-6c45-4e02-a57e-5cb7accec807,,,,2023-07-13T10:35:44.371881-05:00,HCM-BROD-0132-C25_treatment16,d0ab3f37-9b09-4e3f-9d35-f52e6d7d5f16,,released,,0,2020-09-27T10:48:53.723866-05:00,"Surgery, NOS",Initial Diagnosis,
HCM-BROD-0132-C25,93d1a30b-21c8-4cf7-9d51-49f6e03ef679,2d4ac6fc-6c45-4e02-a57e-5cb7accec807,,Neoadjuvant,14.0,2023-07-13T10:35:44.371881-05:00,HCM-BROD-0132-C25_treatment,d1537b98-5da2-4047-b7c4-091fcd2c56a5,,released,Irinotecan Hydrochloride,1,2020-07-23T14:37:44.201923-05:00,Chemotherapy,,
HCM-BROD-0132-C25,93d1a30b-21c8-4cf7-9d51-49f6e03ef679,2d4ac6fc-6c45-4e02-a57e-5cb7accec807,185.0,Adjuvant,25.0,2023-07-13T10:35:44.371881-05:00,HCM-BROD-0132-C25_treatment11,dce96ecf-6d4b-4c48-a077-26f11689467d,,released,Fluorouracil,1,2020-09-27T10:48:53.723866-05:00,Chemotherapy,Residual Disease,
HCM-BROD-0132-C25,93d1a30b-21c8-4cf7-9d51-49f6e03ef679,2d4ac6fc-6c45-4e02-a57e-5cb7accec807,185.0,Adjuvant,25.0,2023-07-13T10:35:44.371881-05:00,HCM-BROD-0132-C25_treatment13,f299193c-98ff-4e6d-a567-d3ca6eb37c04,,released,,1,2020-09-27T10:48:53.723866-05:00,Chemotherapy,Residual Disease,FOLFIRINOX
HCM-CSHL-0653-C18,93e57b22-1606-47a8-88de-482159a8623d,684d9285-ebcb-4c3f-bff4-c5b821f7c56b,82.0,Maintenance Therapy,12.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0653-C18_treatment17,1a1d8238-e3c1-4bcd-8709-ebbfc9e18ade,Stable Disease,released,,1,2021-12-21T14:13:49.405059-06:00,,,FOLFOX
HCM-CSHL-0653-C18,93e57b22-1606-47a8-88de-482159a8623d,684d9285-ebcb-4c3f-bff4-c5b821f7c56b,82.0,Maintenance Therapy,12.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0653-C18_treatment16,56661ba1-9207-4a07-8599-ef7a3c06027f,Stable Disease,released,Oxaliplatin,1,2021-12-21T14:13:49.405059-06:00,,,
HCM-CSHL-0653-C18,93e57b22-1606-47a8-88de-482159a8623d,684d9285-ebcb-4c3f-bff4-c5b821f7c56b,82.0,Maintenance Therapy,12.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0653-C18_treatment15,95e2fd7e-23b9-4cd6-b22a-e39b712fa973,Stable Disease,released,Fluorouracil,1,2021-12-21T14:13:49.405059-06:00,,,
HCM-CSHL-0653-C18,93e57b22-1606-47a8-88de-482159a8623d,684d9285-ebcb-4c3f-bff4-c5b821f7c56b,82.0,Maintenance Therapy,12.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0653-C18_treatment14,f995116a-1e92-4721-9063-b01f3cc1cd33,Stable Disease,released,Leucovorin Calcium,1,2021-12-21T14:13:49.405059-06:00,,,
HCM-CSHL-0653-C18,93e57b22-1606-47a8-88de-482159a8623d,d6d3ad28-b326-4de8-a826-ce85cf57ce52,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0653-C18_treatment13,108dd368-0df2-4826-8c25-8f247d718f18,,released,,0,2021-12-21T14:13:49.405059-06:00,"Radiation Therapy, NOS",Residual Disease,
HCM-CSHL-0653-C18,93e57b22-1606-47a8-88de-482159a8623d,d6d3ad28-b326-4de8-a826-ce85cf57ce52,256.0,Adjuvant,182.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0653-C18_treatment8,1f950a84-3ff7-46b7-8304-f6a79a73ac53,,released,,1,2021-12-21T14:13:49.405059-06:00,Chemotherapy,Residual Disease,FOLFOX
HCM-CSHL-0653-C18,93e57b22-1606-47a8-88de-482159a8623d,d6d3ad28-b326-4de8-a826-ce85cf57ce52,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0653-C18_treatment10,326276a1-9b85-430f-aae1-ce18a8ce2836,,released,,0,2021-12-21T14:13:49.405059-06:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-CSHL-0653-C18,93e57b22-1606-47a8-88de-482159a8623d,d6d3ad28-b326-4de8-a826-ce85cf57ce52,256.0,Adjuvant,182.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0653-C18_treatment7,35de9ca1-5ba6-4ad9-a697-94d9209e70f3,,released,Oxaliplatin,1,2021-12-21T14:13:49.405059-06:00,Chemotherapy,Residual Disease,
HCM-CSHL-0653-C18,93e57b22-1606-47a8-88de-482159a8623d,d6d3ad28-b326-4de8-a826-ce85cf57ce52,531.0,Adjuvant,285.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0653-C18_treatment9,4c6dcc01-388d-4bb0-adc5-52d8611ebd00,,released,Capecitabine,1,2021-12-21T14:13:49.405059-06:00,Chemotherapy,Residual Disease,
HCM-CSHL-0653-C18,93e57b22-1606-47a8-88de-482159a8623d,d6d3ad28-b326-4de8-a826-ce85cf57ce52,,,114.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0653-C18_treatment11,555c75df-c5d8-414f-bd53-bd0d673f95f3,,released,,1,2021-12-21T14:13:49.405059-06:00,"Surgery, NOS",Initial Diagnosis,
HCM-CSHL-0653-C18,93e57b22-1606-47a8-88de-482159a8623d,d6d3ad28-b326-4de8-a826-ce85cf57ce52,,Neoadjuvant,12.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0653-C18_treatment3,621295fc-0cf4-40b0-ba8a-0bad28b3deca,,released,Oxaliplatin,1,2021-12-21T14:13:49.405059-06:00,Chemotherapy,,
HCM-CSHL-0653-C18,93e57b22-1606-47a8-88de-482159a8623d,d6d3ad28-b326-4de8-a826-ce85cf57ce52,,Neoadjuvant,12.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0653-C18_treatment2,98244215-deb5-43bb-9325-5b212e961aa7,,released,Fluorouracil,1,2021-12-21T14:13:49.405059-06:00,Chemotherapy,,
HCM-CSHL-0653-C18,93e57b22-1606-47a8-88de-482159a8623d,d6d3ad28-b326-4de8-a826-ce85cf57ce52,256.0,Adjuvant,182.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0653-C18_treatment5,ab5f569b-351f-4d77-9832-3dbe80e5616d,,released,Leucovorin Calcium,1,2021-12-21T14:13:49.405059-06:00,Chemotherapy,Residual Disease,
HCM-CSHL-0653-C18,93e57b22-1606-47a8-88de-482159a8623d,d6d3ad28-b326-4de8-a826-ce85cf57ce52,256.0,Adjuvant,182.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0653-C18_treatment6,b92d85c9-5c72-4d19-9aaa-ae57d792825a,,released,Fluorouracil,1,2021-12-21T14:13:49.405059-06:00,Chemotherapy,Residual Disease,
HCM-CSHL-0653-C18,93e57b22-1606-47a8-88de-482159a8623d,d6d3ad28-b326-4de8-a826-ce85cf57ce52,,Neoadjuvant,12.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0653-C18_treatment,e1393acc-962e-4363-9ffb-574d1cb0884d,,released,Leucovorin Calcium,1,2021-12-21T14:13:49.405059-06:00,Chemotherapy,,
HCM-CSHL-0653-C18,93e57b22-1606-47a8-88de-482159a8623d,d6d3ad28-b326-4de8-a826-ce85cf57ce52,531.0,Adjuvant,285.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0653-C18_treatment12,e38dd100-937c-4d39-b09e-76df8b6bc277,,released,Bevacizumab,1,2021-12-21T14:13:49.405059-06:00,Targeted Molecular Therapy,Residual Disease,
HCM-CSHL-0653-C18,93e57b22-1606-47a8-88de-482159a8623d,d6d3ad28-b326-4de8-a826-ce85cf57ce52,,Neoadjuvant,12.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0653-C18_treatment4,ec6015fc-c869-4f84-bb70-4d6f7147d4d5,,released,,1,2021-12-21T14:13:49.405059-06:00,Chemotherapy,,FOLFOX
HCM-CSHL-0426-C18,93eb458f-2b57-498b-a356-9b5540cc545c,b4f7fa12-c984-4546-aea6-cbf0e92706d8,,Adjuvant,,2021-07-12T12:25:55.528644-05:00,HCM-CSHL-0426-C18_treatment4,09de93bb-116b-47d7-8655-64d3102d4cf6,,released,,0,2020-09-28T10:09:25.305641-05:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-CSHL-0426-C18,93eb458f-2b57-498b-a356-9b5540cc545c,b4f7fa12-c984-4546-aea6-cbf0e92706d8,,Adjuvant,90.0,2021-07-12T12:25:55.528644-05:00,HCM-CSHL-0426-C18_treatment2,0bd1f82a-4e35-4b0d-96b2-5455d686e88e,,released,Capecitabine,1,2020-09-28T10:09:25.305641-05:00,Chemotherapy,Residual Disease,
HCM-CSHL-0426-C18,93eb458f-2b57-498b-a356-9b5540cc545c,b4f7fa12-c984-4546-aea6-cbf0e92706d8,,Adjuvant,,2021-07-12T12:25:55.528644-05:00,HCM-CSHL-0426-C18_treatment6,2da19a96-9b5f-4be1-9eae-99d9de26aefd,,released,,0,2020-09-28T10:09:25.305641-05:00,Targeted Molecular Therapy,Residual Disease,
HCM-CSHL-0426-C18,93eb458f-2b57-498b-a356-9b5540cc545c,b4f7fa12-c984-4546-aea6-cbf0e92706d8,,Adjuvant,90.0,2021-07-12T12:25:55.528644-05:00,HCM-CSHL-0426-C18_treatment3,647f5ce7-fff7-469c-83bb-45a7bcbfa005,,released,Oxaliplatin,1,2020-09-28T10:09:25.305641-05:00,Chemotherapy,Residual Disease,
HCM-CSHL-0426-C18,93eb458f-2b57-498b-a356-9b5540cc545c,b4f7fa12-c984-4546-aea6-cbf0e92706d8,,Neoadjuvant,,2021-07-12T12:25:55.528644-05:00,HCM-CSHL-0426-C18_treatment,75a55d65-9e3f-4074-a63c-313df509c3d4,,released,,0,2020-09-28T10:09:25.305641-05:00,,,
HCM-CSHL-0426-C18,93eb458f-2b57-498b-a356-9b5540cc545c,b4f7fa12-c984-4546-aea6-cbf0e92706d8,,,34.0,2023-03-13T12:47:57.590074-05:00,HCM-CSHL-0426-C18_treatment5,86826a4e-3b50-4e03-be07-9a15b63e3183,,released,,1,2020-09-28T10:09:25.305641-05:00,"Surgery, NOS",Initial Diagnosis,
HCM-CSHL-0426-C18,93eb458f-2b57-498b-a356-9b5540cc545c,b4f7fa12-c984-4546-aea6-cbf0e92706d8,,Adjuvant,,2021-07-12T12:25:55.528644-05:00,HCM-CSHL-0426-C18_treatment7,a2499ac0-a7f0-4003-9063-146d6e7dc7fb,,released,,0,2020-09-28T10:09:25.305641-05:00,"Radiation Therapy, NOS",Residual Disease,
HCM-CSHL-0403-C25,943e817d-37f3-4df0-84c5-d572ca3de923,5f861766-3eaf-41f4-ace3-9e97d6b473cf,470.0,Adjuvant,466.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0403-C25_treatment10,09a488ec-8ea8-43d9-82bb-36d59efd0cca,,released,,1,2021-12-21T14:05:44.575048-06:00,"Radiation, Mixed Photon Beam",Residual Disease,
HCM-CSHL-0403-C25,943e817d-37f3-4df0-84c5-d572ca3de923,5f861766-3eaf-41f4-ace3-9e97d6b473cf,517.0,Adjuvant,454.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0403-C25_treatment2,425e31c2-d501-41f6-b681-10fb12013628,,released,Irinotecan Hydrochloride,1,2021-12-21T14:05:44.575048-06:00,Chemotherapy,Residual Disease,
HCM-CSHL-0403-C25,943e817d-37f3-4df0-84c5-d572ca3de923,5f861766-3eaf-41f4-ace3-9e97d6b473cf,,,36.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0403-C25_treatment8,4540b2dd-9dad-469e-8a68-31e6c397e0e5,,released,,1,2021-12-21T14:05:44.575048-06:00,"Surgery, NOS",Initial Diagnosis,
HCM-CSHL-0403-C25,943e817d-37f3-4df0-84c5-d572ca3de923,5f861766-3eaf-41f4-ace3-9e97d6b473cf,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0403-C25_treatment7,77bdec68-a0b6-4f77-956a-de6590c69d19,,released,,0,2021-12-21T14:05:44.575048-06:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-CSHL-0403-C25,943e817d-37f3-4df0-84c5-d572ca3de923,5f861766-3eaf-41f4-ace3-9e97d6b473cf,,Neoadjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0403-C25_treatment,8fa0adab-37c0-4463-83e0-fe3318549e59,,released,,0,2021-12-21T14:05:44.575048-06:00,,,
HCM-CSHL-0403-C25,943e817d-37f3-4df0-84c5-d572ca3de923,5f861766-3eaf-41f4-ace3-9e97d6b473cf,517.0,Adjuvant,454.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0403-C25_treatment5,92802753-f3e4-4b24-bb21-14dce82abb73,,released,Oxaliplatin,1,2021-12-21T14:05:44.575048-06:00,Chemotherapy,Residual Disease,
HCM-CSHL-0403-C25,943e817d-37f3-4df0-84c5-d572ca3de923,5f861766-3eaf-41f4-ace3-9e97d6b473cf,517.0,Adjuvant,454.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0403-C25_treatment6,92f5362f-c3b6-44df-8a83-4e1a866e65e3,,released,,1,2021-12-21T14:05:44.575048-06:00,Chemotherapy,Residual Disease,FOLFIRINOX
HCM-CSHL-0403-C25,943e817d-37f3-4df0-84c5-d572ca3de923,5f861766-3eaf-41f4-ace3-9e97d6b473cf,517.0,Adjuvant,454.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0403-C25_treatment4,ed0c88b9-1991-4413-b5e4-a96b22aa6231,,released,Fluorouracil,1,2021-12-21T14:05:44.575048-06:00,Chemotherapy,Residual Disease,
HCM-CSHL-0403-C25,943e817d-37f3-4df0-84c5-d572ca3de923,5f861766-3eaf-41f4-ace3-9e97d6b473cf,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0403-C25_treatment9,fa77070f-5ecd-452f-8310-6300f835177f,,released,,0,2021-12-21T14:05:44.575048-06:00,Targeted Molecular Therapy,Residual Disease,
HCM-CSHL-0403-C25,943e817d-37f3-4df0-84c5-d572ca3de923,5f861766-3eaf-41f4-ace3-9e97d6b473cf,517.0,Adjuvant,454.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0403-C25_treatment3,fde7fb23-edde-4dd5-ab0a-8561f7de2cbf,,released,Leucovorin Calcium,1,2021-12-21T14:05:44.575048-06:00,Chemotherapy,Residual Disease,
HCM-BROD-0959-C18,94780bed-98b3-4556-ac0d-7b998921c4c0,04751488-0f66-4a6c-8b1d-fb603e2ed016,,Neoadjuvant,30.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0959-C18_treatment2,076c7502-05db-46b8-8db9-c1c6818a0d33,,released,Fluorouracil,1,2021-12-21T13:58:49.208526-06:00,Chemotherapy,,
HCM-BROD-0959-C18,94780bed-98b3-4556-ac0d-7b998921c4c0,04751488-0f66-4a6c-8b1d-fb603e2ed016,,Neoadjuvant,30.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0959-C18_treatment4,38d1979d-e18a-44c5-b151-0e9797f28c69,,released,,1,2021-12-21T13:58:49.208526-06:00,Chemotherapy,,FOLFOX
HCM-BROD-0959-C18,94780bed-98b3-4556-ac0d-7b998921c4c0,04751488-0f66-4a6c-8b1d-fb603e2ed016,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0959-C18_treatment5,5475247d-6493-4636-964f-c43b333d0f70,,released,,0,2021-12-21T13:58:49.208526-06:00,Chemotherapy,Residual Disease,
HCM-BROD-0959-C18,94780bed-98b3-4556-ac0d-7b998921c4c0,04751488-0f66-4a6c-8b1d-fb603e2ed016,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0959-C18_treatment9,ad32bde6-e468-4ee4-ab0d-bb4524403694,,released,,0,2021-12-21T13:58:49.208526-06:00,"Radiation Therapy, NOS",Residual Disease,
HCM-BROD-0959-C18,94780bed-98b3-4556-ac0d-7b998921c4c0,04751488-0f66-4a6c-8b1d-fb603e2ed016,,Neoadjuvant,30.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0959-C18_treatment,b250a944-1928-44b1-a669-35c208c2dda1,,released,Leucovorin Calcium,1,2021-12-21T13:58:49.208526-06:00,Chemotherapy,,
HCM-BROD-0959-C18,94780bed-98b3-4556-ac0d-7b998921c4c0,04751488-0f66-4a6c-8b1d-fb603e2ed016,1443.0,Adjuvant,938.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0959-C18_treatment8,b7687b4b-22e4-430a-bf16-f4450e875561,Treatment Ongoing,released,Unknown,1,2021-12-21T13:58:49.208526-06:00,Targeted Molecular Therapy,Residual Disease,
HCM-BROD-0959-C18,94780bed-98b3-4556-ac0d-7b998921c4c0,04751488-0f66-4a6c-8b1d-fb603e2ed016,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0959-C18_treatment6,b800009d-b6a5-4287-8009-1cfc57963e88,,released,,0,2021-12-21T13:58:49.208526-06:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-BROD-0959-C18,94780bed-98b3-4556-ac0d-7b998921c4c0,04751488-0f66-4a6c-8b1d-fb603e2ed016,,Neoadjuvant,30.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0959-C18_treatment3,d006ccb0-98f1-47ba-ad8c-f72b7103bb20,,released,Oxaliplatin,1,2021-12-21T13:58:49.208526-06:00,Chemotherapy,,
HCM-BROD-0959-C18,94780bed-98b3-4556-ac0d-7b998921c4c0,04751488-0f66-4a6c-8b1d-fb603e2ed016,,,0.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0959-C18_treatment7,d050947a-66ae-483d-8762-672b1d5c4fab,,released,,1,2021-12-21T13:58:49.208526-06:00,"Surgery, NOS",Initial Diagnosis,
HCM-BROD-0679-C43,94b66b8a-d5e9-4e4c-ab44-290c6d12480e,e78a1331-3289-4d7d-89e0-859f65eaa90e,587.0,Adjuvant,370.0,2021-09-10T10:36:37.981324-05:00,HCM-BROD-0679-C43_treatment4,04e4b12c-a37d-4001-92a5-f40759661c14,,released,Pembrolizumab,1,2021-07-19T20:14:30.018265-05:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-BROD-0679-C43,94b66b8a-d5e9-4e4c-ab44-290c6d12480e,e78a1331-3289-4d7d-89e0-859f65eaa90e,,Adjuvant,,2021-09-10T10:36:37.981324-05:00,HCM-BROD-0679-C43_treatment6,14c7abd9-c172-4c42-a7f3-196d447535aa,,released,,0,2021-07-19T20:14:30.018265-05:00,Targeted Molecular Therapy,Residual Disease,
HCM-BROD-0679-C43,94b66b8a-d5e9-4e4c-ab44-290c6d12480e,e78a1331-3289-4d7d-89e0-859f65eaa90e,,Neoadjuvant,,2021-09-10T10:36:37.981324-05:00,HCM-BROD-0679-C43_treatment,29aeaee3-32e4-4ea3-9648-437ca2a779d4,,released,,0,2021-07-19T20:14:30.018265-05:00,,,
HCM-BROD-0679-C43,94b66b8a-d5e9-4e4c-ab44-290c6d12480e,e78a1331-3289-4d7d-89e0-859f65eaa90e,,Adjuvant,,2021-09-10T10:36:37.981324-05:00,HCM-BROD-0679-C43_treatment7,629ac084-5274-4609-8e69-974f198ae244,,released,,0,2021-07-19T20:14:30.018265-05:00,"Radiation Therapy, NOS",Residual Disease,
HCM-BROD-0679-C43,94b66b8a-d5e9-4e4c-ab44-290c6d12480e,e78a1331-3289-4d7d-89e0-859f65eaa90e,,,0.0,2023-02-27T13:29:09.387718-06:00,HCM-BROD-0679-C43_treatment5,68f0c4ee-e5a9-43c0-a0a3-679098dd8b1b,,released,,1,2021-07-19T20:14:30.018265-05:00,"Surgery, NOS",Initial Diagnosis,
HCM-BROD-0679-C43,94b66b8a-d5e9-4e4c-ab44-290c6d12480e,e78a1331-3289-4d7d-89e0-859f65eaa90e,,Adjuvant,,2021-09-10T10:36:37.981324-05:00,HCM-BROD-0679-C43_treatment2,7e3e3783-685e-4413-b6ea-6beeaa145724,,released,,0,2021-07-19T20:14:30.018265-05:00,Chemotherapy,Residual Disease,
HCM-BROD-0679-C43,94b66b8a-d5e9-4e4c-ab44-290c6d12480e,e78a1331-3289-4d7d-89e0-859f65eaa90e,,Adjuvant,,2021-09-10T10:36:37.981324-05:00,HCM-BROD-0679-C43_treatment3,b244dfdf-5848-4ab1-a30b-bfb87c500387,,released,,0,2021-07-19T20:14:30.018265-05:00,Hormone Therapy,Residual Disease,
HCM-CSHL-1268-C24,94eb0a19-ba87-4ca8-a021-01a2609845b3,a7706857-9bf4-4723-81c2-ec6db76395fe,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-1268-C24_treatment10,047119f5-cd6c-45f1-8d74-3ea090a4ab04,,released,,0,2021-12-23T08:09:27.059690-06:00,Targeted Molecular Therapy,Residual Disease,
HCM-CSHL-1268-C24,94eb0a19-ba87-4ca8-a021-01a2609845b3,a7706857-9bf4-4723-81c2-ec6db76395fe,,,-8.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-1268-C24_treatment9,26f4f3d9-5051-4129-b815-dda7c33ca028,,released,,1,2021-12-23T08:09:27.059690-06:00,"Surgery, NOS",Initial Diagnosis,
HCM-CSHL-1268-C24,94eb0a19-ba87-4ca8-a021-01a2609845b3,a7706857-9bf4-4723-81c2-ec6db76395fe,202.0,Adjuvant,51.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-1268-C24_treatment2,6e3f3c16-0361-467f-ba22-3e14abe3d6b0,,released,Leucovorin Calcium,1,2021-12-23T08:09:27.059690-06:00,Chemotherapy,Residual Disease,
HCM-CSHL-1268-C24,94eb0a19-ba87-4ca8-a021-01a2609845b3,a7706857-9bf4-4723-81c2-ec6db76395fe,202.0,Adjuvant,51.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-1268-C24_treatment3,82a188c4-d70d-4e12-9ae4-76485b3836ed,,released,Irinotecan Hydrochloride,1,2021-12-23T08:09:27.059690-06:00,Chemotherapy,Residual Disease,
HCM-CSHL-1268-C24,94eb0a19-ba87-4ca8-a021-01a2609845b3,a7706857-9bf4-4723-81c2-ec6db76395fe,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-1268-C24_treatment7,8b6dbee7-9e76-4c4b-8ba3-3a4ef8bb296d,,released,,0,2021-12-23T08:09:27.059690-06:00,Hormone Therapy,Residual Disease,
HCM-CSHL-1268-C24,94eb0a19-ba87-4ca8-a021-01a2609845b3,a7706857-9bf4-4723-81c2-ec6db76395fe,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-1268-C24_treatment11,8f2965ff-8a06-4b92-bf35-fa4df57f2362,,released,,0,2021-12-23T08:09:27.059690-06:00,"Radiation Therapy, NOS",Residual Disease,
HCM-CSHL-1268-C24,94eb0a19-ba87-4ca8-a021-01a2609845b3,a7706857-9bf4-4723-81c2-ec6db76395fe,,Neoadjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-1268-C24_treatment,93058434-ccb5-41dc-8ac5-55e29dccd85e,,released,,0,2021-12-23T08:09:27.059690-06:00,,,
HCM-CSHL-1268-C24,94eb0a19-ba87-4ca8-a021-01a2609845b3,a7706857-9bf4-4723-81c2-ec6db76395fe,202.0,Adjuvant,51.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-1268-C24_treatment5,ce99beab-5773-4aea-ad49-407dad580493,,released,Fluorouracil,1,2021-12-23T08:09:27.059690-06:00,Chemotherapy,Residual Disease,
HCM-CSHL-1268-C24,94eb0a19-ba87-4ca8-a021-01a2609845b3,a7706857-9bf4-4723-81c2-ec6db76395fe,202.0,Adjuvant,51.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-1268-C24_treatment4,d7e00cbc-9881-4e93-b749-a5d3bd58ca1b,,released,Oxaliplatin,1,2021-12-23T08:09:27.059690-06:00,Chemotherapy,Residual Disease,
HCM-CSHL-1268-C24,94eb0a19-ba87-4ca8-a021-01a2609845b3,a7706857-9bf4-4723-81c2-ec6db76395fe,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-1268-C24_treatment8,de9d7092-8615-41d3-80b1-235ad9cefa6b,,released,,0,2021-12-23T08:09:27.059690-06:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-CSHL-1268-C24,94eb0a19-ba87-4ca8-a021-01a2609845b3,a7706857-9bf4-4723-81c2-ec6db76395fe,202.0,Adjuvant,51.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-1268-C24_treatment6,f8e27734-dc5f-4b1a-9dd7-eef2981e98eb,,released,,1,2021-12-23T08:09:27.059690-06:00,Chemotherapy,Residual Disease,FOLFIRINOX
HCM-BROD-0221-C43,95228cfd-9465-486e-8202-b27f834433c2,5336ad19-1a6b-4ef3-98c1-a59d45c82f5a,328.0,Adjuvant,223.0,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0221-C43_treatment4,24daf54a-6a46-484b-a9ad-9dda080f263e,,released,Pembrolizumab,1,2020-10-09T15:12:41.054401-05:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-BROD-0221-C43,95228cfd-9465-486e-8202-b27f834433c2,5336ad19-1a6b-4ef3-98c1-a59d45c82f5a,,Adjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0221-C43_treatment3,34a84040-781e-46f8-9e16-3607866c37bb,,released,,0,2020-10-09T15:12:41.054401-05:00,Hormone Therapy,Residual Disease,
HCM-BROD-0221-C43,95228cfd-9465-486e-8202-b27f834433c2,5336ad19-1a6b-4ef3-98c1-a59d45c82f5a,,,0.0,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0221-C43_treatment5,61fde8d5-7bea-4c91-b1ad-c905b3332056,,released,,1,2020-10-09T15:12:41.054401-05:00,"Surgery, NOS",Initial Diagnosis,
HCM-BROD-0221-C43,95228cfd-9465-486e-8202-b27f834433c2,5336ad19-1a6b-4ef3-98c1-a59d45c82f5a,,Adjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0221-C43_treatment6,67c1be88-03bb-438a-bba1-4ba918e596df,,released,,0,2020-10-09T15:12:41.054401-05:00,Targeted Molecular Therapy,Residual Disease,
HCM-BROD-0221-C43,95228cfd-9465-486e-8202-b27f834433c2,5336ad19-1a6b-4ef3-98c1-a59d45c82f5a,,Adjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0221-C43_treatment2,75ea5a6b-6861-4533-b32e-c84ce65ebf3b,,released,,0,2020-10-09T15:12:41.054401-05:00,Chemotherapy,Residual Disease,
HCM-BROD-0221-C43,95228cfd-9465-486e-8202-b27f834433c2,5336ad19-1a6b-4ef3-98c1-a59d45c82f5a,,Neoadjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0221-C43_treatment,a10a8443-d054-44c2-b104-51113b7b3e70,,released,,0,2020-10-09T15:12:41.054401-05:00,,,
HCM-BROD-0221-C43,95228cfd-9465-486e-8202-b27f834433c2,5336ad19-1a6b-4ef3-98c1-a59d45c82f5a,,Adjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0221-C43_treatment7,ef827bae-d7e8-4d52-88af-e6caba5ef449,,released,,0,2020-10-09T15:12:41.054401-05:00,"Radiation Therapy, NOS",Residual Disease,
HCM-SANG-1313-C18,964de890-fe31-4b2d-98ce-a8d8e95a7da2,c48de4fb-9043-479e-b5ae-b5d1d3a90cf0,,Neoadjuvant,166.0,2025-04-07T17:13:09.336794-05:00,HCM-SANG-1313-C18_treatment2,200e7a94-440b-4734-b002-1e61d6c3b830,,released,Fluorouracil,1,2023-02-27T13:34:10.221561-06:00,Chemotherapy,,
HCM-SANG-1313-C18,964de890-fe31-4b2d-98ce-a8d8e95a7da2,c48de4fb-9043-479e-b5ae-b5d1d3a90cf0,,Neoadjuvant,166.0,2025-04-07T17:13:09.336794-05:00,HCM-SANG-1313-C18_treatment3,2733e1fc-9d9e-4600-9cdf-0bbf746bd4b7,,released,Oxaliplatin,1,2023-02-27T13:34:10.221561-06:00,Chemotherapy,,
HCM-SANG-1313-C18,964de890-fe31-4b2d-98ce-a8d8e95a7da2,c48de4fb-9043-479e-b5ae-b5d1d3a90cf0,,Neoadjuvant,166.0,2025-04-07T17:13:09.336794-05:00,HCM-SANG-1313-C18_treatment,7dc2a41f-b826-4744-b408-d73055d98a40,,released,Leucovorin Calcium,1,2023-02-27T13:34:10.221561-06:00,Chemotherapy,,
HCM-SANG-1313-C18,964de890-fe31-4b2d-98ce-a8d8e95a7da2,c48de4fb-9043-479e-b5ae-b5d1d3a90cf0,,Neoadjuvant,166.0,2025-04-07T17:13:09.336794-05:00,HCM-SANG-1313-C18_treatment4,ef51c51e-53a8-44fb-a57a-5fbb85ff90f2,,released,,1,2023-02-27T13:34:10.221561-06:00,Chemotherapy,,FOLFOX
HCM-SANG-0284-C18,96dea2e6-e29b-4e09-b708-ae3b010a9906,b1389f91-1a9c-4c9e-b37f-3e3fc9626a97,,Neoadjuvant,,2023-02-22T07:39:25.979291-06:00,HCM-SANG-0284-C18_treatment,6aa6facc-f9b3-414c-8ede-11a83c830c6a,,released,,0,2020-06-15T12:07:29.247252-05:00,,,
HCM-EXPT-1072-C18,96f589bb-36b6-49a9-b461-afd0175ee661,c112b96e-d87d-470a-9939-6755c7066c52,,Neoadjuvant,,2025-10-08T12:38:28.988690-05:00,HCM-EXPT-1072-C18_treatment,fecc8269-b73d-43e2-aa4d-730463fe6c46,,released,,0,2021-12-21T15:05:00.297017-06:00,,,
HCM-SANG-1087-C18,97951f84-798d-451e-8f8e-d208c19d3955,4b1f5a8c-7625-4d37-857f-b17a875ee3f0,,Neoadjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-SANG-1087-C18_treatment,f7fdea41-7a77-4735-9608-4257dcf657f8,,released,,0,2023-02-27T12:57:30.418415-06:00,,,
HCM-BROD-0020-C15,97bd888f-4686-4c1d-b663-2920d3bdc7d8,c1331272-a205-43ef-8ce4-2d6ca05a2ef7,670.0,Adjuvant,607.0,2021-03-03T15:15:08.075155-06:00,HCM-BROD-0020-C15_treatment2,01f35929-d74a-4746-9d3b-485f2c484620,,released,Leucovorin,1,2020-02-11T15:30:15.502165-06:00,Chemotherapy,Residual Disease,
HCM-BROD-0020-C15,97bd888f-4686-4c1d-b663-2920d3bdc7d8,c1331272-a205-43ef-8ce4-2d6ca05a2ef7,,Adjuvant,,2021-03-03T15:15:08.075155-06:00,HCM-BROD-0020-C15_treatment7,04990ed0-e2f8-45e3-85dd-5ac0310b4e83,,released,,0,2020-02-11T15:30:15.502165-06:00,Targeted Molecular Therapy,Residual Disease,
HCM-BROD-0020-C15,97bd888f-4686-4c1d-b663-2920d3bdc7d8,c1331272-a205-43ef-8ce4-2d6ca05a2ef7,,Adjuvant,,2021-03-03T15:15:08.075155-06:00,HCM-BROD-0020-C15_treatment5,431f0015-202b-4f20-a46a-f1f3bdbac032,,released,,0,2020-02-11T15:30:15.502165-06:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-BROD-0020-C15,97bd888f-4686-4c1d-b663-2920d3bdc7d8,c1331272-a205-43ef-8ce4-2d6ca05a2ef7,670.0,Adjuvant,607.0,2021-03-03T15:15:08.075155-06:00,HCM-BROD-0020-C15_treatment4,46727137-c8da-4e6c-b692-61b474563f74,,released,Irinotecan,1,2020-02-11T15:30:15.502165-06:00,Chemotherapy,Residual Disease,
HCM-BROD-0020-C15,97bd888f-4686-4c1d-b663-2920d3bdc7d8,c1331272-a205-43ef-8ce4-2d6ca05a2ef7,670.0,Adjuvant,607.0,2021-03-03T15:15:08.075155-06:00,HCM-BROD-0020-C15_treatment3,a35a9734-a61e-4a11-a41e-7764765767f5,,released,Fluorouracil,1,2020-02-11T15:30:15.502165-06:00,Chemotherapy,Residual Disease,
HCM-BROD-0020-C15,97bd888f-4686-4c1d-b663-2920d3bdc7d8,c1331272-a205-43ef-8ce4-2d6ca05a2ef7,587.0,Adjuvant,569.0,2023-07-07T13:03:34.077367-05:00,HCM-BROD-0020-C15_treatment8,aa625bba-f39f-4abd-b22a-95aff1f046a7,,released,,1,2020-02-11T15:30:15.502165-06:00,"Radiation Therapy, NOS",Residual Disease,
HCM-BROD-0020-C15,97bd888f-4686-4c1d-b663-2920d3bdc7d8,c1331272-a205-43ef-8ce4-2d6ca05a2ef7,,Neoadjuvant,,2021-03-03T15:15:08.075155-06:00,HCM-BROD-0020-C15_treatment,bc8f44a7-f017-408b-9863-1dad3cedd936,,released,,0,2020-02-11T15:30:15.502165-06:00,,,
HCM-BROD-0020-C15,97bd888f-4686-4c1d-b663-2920d3bdc7d8,c1331272-a205-43ef-8ce4-2d6ca05a2ef7,,,,2023-02-27T12:34:00.485824-06:00,HCM-BROD-0020-C15_treatment6,eac39bcb-f8b1-45eb-8fb1-f860ef4c1fdd,,released,,0,2020-02-11T15:30:15.502165-06:00,"Surgery, NOS",Initial Diagnosis,
HCM-BROD-0695-C71,9997df42-0549-4ce0-bdf8-991ee54e0701,54d6f4ec-355d-4977-9b69-301b4e5ce319,209.0,Maintenance Therapy,4.0,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0695-C71_treatment7,c26f480d-07fe-4a8f-be53-43db98c8bfbb,Progressive Disease,released,Temozolomide,1,2021-12-21T13:46:00.694576-06:00,,,
HCM-BROD-0695-C71,9997df42-0549-4ce0-bdf8-991ee54e0701,a0efdf54-fd90-4efb-bc87-db07e87ea74a,,Neoadjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0695-C71_treatment,58a144d8-3fe2-4390-b0c3-8a1eea479b48,,released,,0,2021-12-21T13:46:00.694576-06:00,,,
HCM-BROD-0695-C71,9997df42-0549-4ce0-bdf8-991ee54e0701,a0efdf54-fd90-4efb-bc87-db07e87ea74a,446.0,Adjuvant,446.0,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0695-C71_treatment5,5fcd13f2-932c-4f38-8a1c-f3552c6d7a21,,released,Bevacizumab,1,2021-12-21T13:46:00.694576-06:00,Targeted Molecular Therapy,Residual Disease,
HCM-BROD-0695-C71,9997df42-0549-4ce0-bdf8-991ee54e0701,a0efdf54-fd90-4efb-bc87-db07e87ea74a,,Adjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0695-C71_treatment2,651c6be7-be9d-463a-b4a6-d95535dde1fe,,released,,0,2021-12-21T13:46:00.694576-06:00,Chemotherapy,Residual Disease,
HCM-BROD-0695-C71,9997df42-0549-4ce0-bdf8-991ee54e0701,a0efdf54-fd90-4efb-bc87-db07e87ea74a,277.0,Adjuvant,248.0,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0695-C71_treatment6,c9ae8830-8ea7-463b-999a-d4f61d4919e5,,released,,1,2021-12-21T13:46:00.694576-06:00,"Radiation, 2D Conventional",Residual Disease,
HCM-BROD-0695-C71,9997df42-0549-4ce0-bdf8-991ee54e0701,a0efdf54-fd90-4efb-bc87-db07e87ea74a,,,-30.0,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0695-C71_treatment4,d4e77552-3460-4bcf-bf6f-62a0d3ee10e7,,released,,1,2021-12-21T13:46:00.694576-06:00,"Surgery, NOS",Initial Diagnosis,
HCM-BROD-0695-C71,9997df42-0549-4ce0-bdf8-991ee54e0701,a0efdf54-fd90-4efb-bc87-db07e87ea74a,440.0,Adjuvant,248.0,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0695-C71_treatment3,f514e972-c342-46fd-a517-197bb1f9f030,,released,Not Reported,1,2021-12-21T13:46:00.694576-06:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-EXPT-0930-C50,99d9dcaf-3d7b-446f-84ff-c4ac443a140a,d61f8a4c-50e4-45bb-b144-348643b15f2b,,Neoadjuvant,,2025-10-08T12:36:57.024699-05:00,HCM-EXPT-0930-C50_treatment,55ca28a8-42b2-4507-b411-6563b333b629,,released,,0,2021-12-21T14:44:32.513111-06:00,,,
HCM-EXPT-1230-C18,9aeb319b-7c05-473f-95bd-f892737b8830,5d49f453-4af7-45ad-9734-6dfbd79cfe1e,,Neoadjuvant,,2025-10-08T12:39:14.406630-05:00,HCM-EXPT-1230-C18_treatment,3f3608b0-dcce-4cec-978a-38a92c77bd27,,released,,unknown,2023-02-24T13:53:05.967426-06:00,"Pharmaceutical Therapy, NOS",,
HCM-EXPT-1230-C18,9aeb319b-7c05-473f-95bd-f892737b8830,5d49f453-4af7-45ad-9734-6dfbd79cfe1e,,Neoadjuvant,,2025-10-08T12:39:14.406630-05:00,HCM-EXPT-1230-C18_treatment2,b017e346-9a0f-438d-8803-71978cb8d7ae,,released,,unknown,2023-02-24T13:53:05.967426-06:00,"Radiation Therapy, NOS",,
HCM-CSHL-0725-C02,9bf63d26-2156-4556-a56e-7c49148441ce,a811b2b2-a663-457e-87d6-3ef05467cfc1,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0725-C02_treatment4,4978e7d4-db08-45a2-8368-466ec84c6127,,released,,0,2021-12-21T14:18:32.309495-06:00,"Radiation Therapy, NOS",Residual Disease,
HCM-CSHL-0725-C02,9bf63d26-2156-4556-a56e-7c49148441ce,a811b2b2-a663-457e-87d6-3ef05467cfc1,,Neoadjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0725-C02_treatment,60582934-cc6d-4698-adf9-1bee9146e3d9,,released,,0,2021-12-21T14:18:32.309495-06:00,,,
HCM-CSHL-0725-C02,9bf63d26-2156-4556-a56e-7c49148441ce,a811b2b2-a663-457e-87d6-3ef05467cfc1,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0725-C02_treatment3,ec7c9d23-880b-4e73-aeb9-a9da49aaccb0,,released,,0,2021-12-21T14:18:32.309495-06:00,"Pharmaceutical Therapy, NOS",Residual Disease,
HCM-CSHL-0725-C02,9bf63d26-2156-4556-a56e-7c49148441ce,a811b2b2-a663-457e-87d6-3ef05467cfc1,,,0.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0725-C02_treatment2,f132b53e-0211-40c0-83fb-d732eab09af7,,released,,1,2021-12-21T14:18:32.309495-06:00,"Surgery, NOS",Initial Diagnosis,
HCM-BROD-0451-C15,9bfc8171-9b0a-4636-a230-a0a34ebaaac2,d8bd9c30-91f3-4543-986d-813b27343663,,Adjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0451-C15_treatment7,0b016d4a-8f7b-4544-866b-d949dd743227,,released,,0,2020-09-27T11:38:29.665034-05:00,Chemotherapy,Residual Disease,
HCM-BROD-0451-C15,9bfc8171-9b0a-4636-a230-a0a34ebaaac2,d8bd9c30-91f3-4543-986d-813b27343663,,Neoadjuvant,26.0,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0451-C15_treatment3,21aaec91-f0b2-4248-b8ac-cf5773077b19,,released,Paclitaxel,1,2020-09-27T11:38:29.665034-05:00,Chemotherapy,,
HCM-BROD-0451-C15,9bfc8171-9b0a-4636-a230-a0a34ebaaac2,d8bd9c30-91f3-4543-986d-813b27343663,,Adjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0451-C15_treatment11,39a6ea72-08ba-464d-aea9-f61d1355af16,,released,,0,2020-09-27T11:38:29.665034-05:00,"Radiation Therapy, NOS",Residual Disease,
HCM-BROD-0451-C15,9bfc8171-9b0a-4636-a230-a0a34ebaaac2,d8bd9c30-91f3-4543-986d-813b27343663,,Neoadjuvant,26.0,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0451-C15_treatment5,42c7c21d-7705-4db5-9fe4-118f1caae975,,released,Carboplatin,1,2020-09-27T11:38:29.665034-05:00,Chemotherapy,,
HCM-BROD-0451-C15,9bfc8171-9b0a-4636-a230-a0a34ebaaac2,d8bd9c30-91f3-4543-986d-813b27343663,,Adjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0451-C15_treatment10,62883e81-cc7f-4451-9daa-1f9f1ada7a25,,released,,0,2020-09-27T11:38:29.665034-05:00,Targeted Molecular Therapy,Residual Disease,
HCM-BROD-0451-C15,9bfc8171-9b0a-4636-a230-a0a34ebaaac2,d8bd9c30-91f3-4543-986d-813b27343663,,Neoadjuvant,26.0,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0451-C15_treatment2,6875e56f-a8a8-4e49-9f3c-df52f5ae4421,,released,Oxaliplatin,1,2020-09-27T11:38:29.665034-05:00,Chemotherapy,,
HCM-BROD-0451-C15,9bfc8171-9b0a-4636-a230-a0a34ebaaac2,d8bd9c30-91f3-4543-986d-813b27343663,,Neoadjuvant,26.0,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0451-C15_treatment4,8d47e7c6-ba04-4b7e-8560-f9606f0afbcb,,released,Leucovorin,1,2020-09-27T11:38:29.665034-05:00,Chemotherapy,,
HCM-BROD-0451-C15,9bfc8171-9b0a-4636-a230-a0a34ebaaac2,d8bd9c30-91f3-4543-986d-813b27343663,,Neoadjuvant,26.0,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0451-C15_treatment,bd1f736c-7de3-4750-af93-ab057562a835,,released,Fluorouracil,1,2020-09-27T11:38:29.665034-05:00,Chemotherapy,,
HCM-BROD-0451-C15,9bfc8171-9b0a-4636-a230-a0a34ebaaac2,d8bd9c30-91f3-4543-986d-813b27343663,,Neoadjuvant,26.0,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0451-C15_treatment6,eebadfae-4be9-475c-bd79-b3e5c202178e,,released,,1,2020-09-27T11:38:29.665034-05:00,"Radiation Therapy, NOS",,
HCM-BROD-0451-C15,9bfc8171-9b0a-4636-a230-a0a34ebaaac2,d8bd9c30-91f3-4543-986d-813b27343663,,,,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0451-C15_treatment9,f05aaa81-8ae2-48f4-8bc0-fe1f3d1b5f43,,released,,0,2020-09-27T11:38:29.665034-05:00,"Surgery, NOS",Initial Diagnosis,
HCM-BROD-0451-C15,9bfc8171-9b0a-4636-a230-a0a34ebaaac2,d8bd9c30-91f3-4543-986d-813b27343663,,Adjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0451-C15_treatment8,f7555c17-7429-4354-8147-9f6ab15cded6,,released,,0,2020-09-27T11:38:29.665034-05:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-BROD-0957-C34,9c24da6e-5546-4037-8ef6-61fc5c2c0901,6a2634ed-e4c9-4308-8fe4-54dae84a7369,572.0,Maintenance Therapy,0.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0957-C34_treatment6,47681a0f-5c06-457c-8dde-b30aa7b44fc6,Progressive Disease,released,Carboplatin,1,2023-02-28T13:01:22.482469-06:00,,,
HCM-BROD-0957-C34,9c24da6e-5546-4037-8ef6-61fc5c2c0901,6a2634ed-e4c9-4308-8fe4-54dae84a7369,572.0,Maintenance Therapy,0.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0957-C34_treatment8,a1b0f558-4e72-4055-accc-f69e81166f5e,Progressive Disease,released,Abemaciclib,1,2021-12-21T13:58:37.792595-06:00,,,
HCM-BROD-0957-C34,9c24da6e-5546-4037-8ef6-61fc5c2c0901,6a2634ed-e4c9-4308-8fe4-54dae84a7369,572.0,Maintenance Therapy,0.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0957-C34_treatment7,b1f6903b-88d7-46dd-b1ba-331ecc4e6049,Progressive Disease,released,Pemetrexed,1,2023-02-28T13:01:22.482469-06:00,,,
HCM-BROD-0957-C34,9c24da6e-5546-4037-8ef6-61fc5c2c0901,6a2634ed-e4c9-4308-8fe4-54dae84a7369,572.0,Maintenance Therapy,0.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0957-C34_treatment5,ed7ccf54-2eed-40c0-ace8-c3282e80ddd2,Progressive Disease,released,Pembrolizumab,1,2023-02-28T13:01:22.482469-06:00,,,
HCM-BROD-0957-C34,9c24da6e-5546-4037-8ef6-61fc5c2c0901,a1304c23-6a82-4bc8-8799-69d43a790054,,Neoadjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0957-C34_treatment,5ab27dd4-13fe-4d0c-833d-41127711f051,,released,,0,2021-12-21T13:58:37.792595-06:00,,,
HCM-BROD-0957-C34,9c24da6e-5546-4037-8ef6-61fc5c2c0901,a1304c23-6a82-4bc8-8799-69d43a790054,,,,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0957-C34_treatment2,937aaf60-26d4-4d34-9a49-f366a65d94fb,,released,,0,2021-12-21T13:58:37.792595-06:00,"Surgery, NOS",Initial Diagnosis,
HCM-BROD-0957-C34,9c24da6e-5546-4037-8ef6-61fc5c2c0901,a1304c23-6a82-4bc8-8799-69d43a790054,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0957-C34_treatment3,e11a15a3-fb3e-410a-b7df-ca6f1d79f65b,,released,,0,2021-12-21T13:58:37.792595-06:00,"Pharmaceutical Therapy, NOS",Residual Disease,
HCM-BROD-0957-C34,9c24da6e-5546-4037-8ef6-61fc5c2c0901,a1304c23-6a82-4bc8-8799-69d43a790054,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0957-C34_treatment4,e6cda0dd-a37e-4772-bc73-9c0cb3687215,,released,,0,2021-12-21T13:58:37.792595-06:00,"Radiation Therapy, NOS",Residual Disease,
HCM-CSHL-0868-C56,9c439d71-50e3-48d2-82a6-4ff0b4ce284a,4f6379f6-1a71-4e73-9896-43fddf5b816c,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0868-C56_treatment9,1c991392-25d3-498a-af1a-475531068cad,,released,,0,2021-12-21T14:36:45.609855-06:00,"Radiation Therapy, NOS",Residual Disease,
HCM-CSHL-0868-C56,9c439d71-50e3-48d2-82a6-4ff0b4ce284a,4f6379f6-1a71-4e73-9896-43fddf5b816c,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0868-C56_treatment5,246527dd-9a79-460c-ac74-3e7425e8c8fc,,released,,0,2021-12-21T14:36:45.609855-06:00,Hormone Therapy,Residual Disease,
HCM-CSHL-0868-C56,9c439d71-50e3-48d2-82a6-4ff0b4ce284a,4f6379f6-1a71-4e73-9896-43fddf5b816c,,Neoadjuvant,94.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0868-C56_treatment,3bbee6a7-e427-4820-9bab-ceaf9af9a8fd,,released,Carboplatin,1,2021-12-21T14:36:45.609855-06:00,Chemotherapy,,
HCM-CSHL-0868-C56,9c439d71-50e3-48d2-82a6-4ff0b4ce284a,4f6379f6-1a71-4e73-9896-43fddf5b816c,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0868-C56_treatment6,50d2bed4-29cb-4fce-bbe3-5ba38477e0f3,,released,,0,2021-12-21T14:36:45.609855-06:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-CSHL-0868-C56,9c439d71-50e3-48d2-82a6-4ff0b4ce284a,4f6379f6-1a71-4e73-9896-43fddf5b816c,60.0,Adjuvant,20.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0868-C56_treatment4,62da69dc-a9a4-407d-9b3d-cd26f18e3199,,released,Paclitaxel,1,2021-12-21T14:36:45.609855-06:00,Chemotherapy,Residual Disease,
HCM-CSHL-0868-C56,9c439d71-50e3-48d2-82a6-4ff0b4ce284a,4f6379f6-1a71-4e73-9896-43fddf5b816c,60.0,Adjuvant,20.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0868-C56_treatment3,74faa39b-dea7-4648-b2e8-4955d308d6f7,,released,Carboplatin,1,2021-12-21T14:36:45.609855-06:00,Chemotherapy,Residual Disease,
HCM-CSHL-0868-C56,9c439d71-50e3-48d2-82a6-4ff0b4ce284a,4f6379f6-1a71-4e73-9896-43fddf5b816c,,Neoadjuvant,94.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0868-C56_treatment2,88f00cda-78ad-49d7-9a4a-f7f7531431c7,,released,Paclitaxel,1,2021-12-21T14:36:45.609855-06:00,Chemotherapy,,
HCM-CSHL-0868-C56,9c439d71-50e3-48d2-82a6-4ff0b4ce284a,4f6379f6-1a71-4e73-9896-43fddf5b816c,,,16.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0868-C56_treatment7,93b7250a-10bf-474d-94d1-37a78b2a78f7,,released,,1,2021-12-21T14:36:45.609855-06:00,"Surgery, NOS",Initial Diagnosis,
HCM-CSHL-0868-C56,9c439d71-50e3-48d2-82a6-4ff0b4ce284a,4f6379f6-1a71-4e73-9896-43fddf5b816c,,Neoadjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0868-C56_treatment10,c2c19057-7ac3-45d9-8f29-1b8c35d1d1b3,Partial Response,released,,1,2021-12-21T14:36:45.609855-06:00,Chemotherapy,,
HCM-CSHL-0868-C56,9c439d71-50e3-48d2-82a6-4ff0b4ce284a,4f6379f6-1a71-4e73-9896-43fddf5b816c,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0868-C56_treatment8,ca4e20b2-bdd0-419d-af70-49b00bf55a70,,released,,0,2021-12-21T14:36:45.609855-06:00,Targeted Molecular Therapy,Residual Disease,
HCM-CSHL-0075-C25,9d03a2ac-ff8d-4017-b482-ece0c9eec5ed,bfd2eb2d-3612-483d-a234-ff2a6d1687a5,261.0,Adjuvant,179.0,2023-02-22T07:39:25.979291-06:00,HCM-CSHL-0075-C25_treatment2,04fe4050-b74c-4849-9040-d1ad34639751,,released,Gemcitabine,1,2020-09-28T12:58:45.391535-05:00,Chemotherapy,Residual Disease,
HCM-CSHL-0075-C25,9d03a2ac-ff8d-4017-b482-ece0c9eec5ed,bfd2eb2d-3612-483d-a234-ff2a6d1687a5,337.0,Adjuvant,264.0,2023-02-22T07:39:25.979291-06:00,HCM-CSHL-0075-C25_treatment7,17bf02e4-a7ff-4648-b652-5afcb33a5443,,released,,1,2020-09-28T12:58:45.391535-05:00,Chemotherapy,Residual Disease,FOLFIRI
HCM-CSHL-0075-C25,9d03a2ac-ff8d-4017-b482-ece0c9eec5ed,bfd2eb2d-3612-483d-a234-ff2a6d1687a5,,Neoadjuvant,,2023-02-22T07:39:25.979291-06:00,HCM-CSHL-0075-C25_treatment,236d8f77-d567-45e1-8cdd-c63a76a84698,,released,,0,2020-09-28T12:58:45.391535-05:00,,,
HCM-CSHL-0075-C25,9d03a2ac-ff8d-4017-b482-ece0c9eec5ed,bfd2eb2d-3612-483d-a234-ff2a6d1687a5,337.0,Adjuvant,264.0,2023-02-22T07:39:25.979291-06:00,HCM-CSHL-0075-C25_treatment4,391ca4e8-dc4e-4547-a539-e44e4e7666e3,,released,Leucovorin Calcium,1,2020-09-28T12:58:45.391535-05:00,Chemotherapy,Residual Disease,
HCM-CSHL-0075-C25,9d03a2ac-ff8d-4017-b482-ece0c9eec5ed,bfd2eb2d-3612-483d-a234-ff2a6d1687a5,,Adjuvant,351.0,2023-02-22T07:39:25.979291-06:00,HCM-CSHL-0075-C25_treatment8,3a7eaf16-d89c-41a7-ae71-91f941c7dfc1,Treatment Ongoing,released,Liposomal Irinotecan,1,2020-09-28T12:58:45.391535-05:00,Chemotherapy,Residual Disease,
HCM-CSHL-0075-C25,9d03a2ac-ff8d-4017-b482-ece0c9eec5ed,bfd2eb2d-3612-483d-a234-ff2a6d1687a5,261.0,Adjuvant,179.0,2023-02-22T07:39:25.979291-06:00,HCM-CSHL-0075-C25_treatment3,619a85a6-1ae2-45db-84bd-cee103c653b5,,released,Nab-paclitaxel,1,2020-09-28T12:58:45.391535-05:00,Chemotherapy,Residual Disease,
HCM-CSHL-0075-C25,9d03a2ac-ff8d-4017-b482-ece0c9eec5ed,bfd2eb2d-3612-483d-a234-ff2a6d1687a5,,,-14.0,2023-02-27T13:16:16.158881-06:00,HCM-CSHL-0075-C25_treatment10,779187eb-1f4f-4059-9c93-0a09b6c5f9ed,,released,,1,2020-09-28T12:58:45.391535-05:00,"Surgery, NOS",Initial Diagnosis,
HCM-CSHL-0075-C25,9d03a2ac-ff8d-4017-b482-ece0c9eec5ed,bfd2eb2d-3612-483d-a234-ff2a6d1687a5,337.0,Adjuvant,264.0,2023-02-22T07:39:25.979291-06:00,HCM-CSHL-0075-C25_treatment5,8dce2440-1481-4ae8-bfe3-b3dbf4fa9b6e,,released,Fluorouracil,1,2020-09-28T12:58:45.391535-05:00,Chemotherapy,Residual Disease,
HCM-CSHL-0075-C25,9d03a2ac-ff8d-4017-b482-ece0c9eec5ed,bfd2eb2d-3612-483d-a234-ff2a6d1687a5,,Adjuvant,,2023-02-22T07:39:25.979291-06:00,HCM-CSHL-0075-C25_treatment11,93498de9-803e-46b0-b41b-8da43da2940d,,released,,0,2020-09-28T12:58:45.391535-05:00,Targeted Molecular Therapy,Residual Disease,
HCM-CSHL-0075-C25,9d03a2ac-ff8d-4017-b482-ece0c9eec5ed,bfd2eb2d-3612-483d-a234-ff2a6d1687a5,,Adjuvant,,2023-02-22T07:39:25.979291-06:00,HCM-CSHL-0075-C25_treatment12,9e0d45f3-f76f-4b13-8bd7-d58d554a2af4,,released,,0,2020-09-28T12:58:45.391535-05:00,"Radiation Therapy, NOS",Residual Disease,
HCM-CSHL-0075-C25,9d03a2ac-ff8d-4017-b482-ece0c9eec5ed,bfd2eb2d-3612-483d-a234-ff2a6d1687a5,,Adjuvant,,2023-02-22T07:39:25.979291-06:00,HCM-CSHL-0075-C25_treatment9,b6928278-e955-450d-8723-bd850439532d,,released,,0,2020-09-28T12:58:45.391535-05:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-CSHL-0075-C25,9d03a2ac-ff8d-4017-b482-ece0c9eec5ed,bfd2eb2d-3612-483d-a234-ff2a6d1687a5,337.0,Adjuvant,264.0,2023-02-22T07:39:25.979291-06:00,HCM-CSHL-0075-C25_treatment6,f242ce67-1415-4e56-afb2-5e4da998f60d,,released,Irinotecan,1,2020-09-28T12:58:45.391535-05:00,Chemotherapy,Residual Disease,
HCM-EXPT-1250-C18,9d76f109-f7b0-44c6-9c88-cc21e908dc79,5c32812b-ffec-4fd1-b911-e81ec1692f9d,,Neoadjuvant,,2025-10-08T12:39:37.798161-05:00,HCM-EXPT-1250-C18_treatment,3c461148-ef78-488f-b8cf-e1d56d701559,,released,,0,2022-03-09T11:53:06.499907-06:00,,,
HCM-SANG-0536-C18,9d868cf7-4c23-45f6-9897-015db647fc6e,8137ae83-d206-4ff9-b2d8-dc04f22571d6,,Neoadjuvant,138.0,2025-03-31T16:34:59.906497-05:00,HCM-SANG-0536-C18_treatment,349783b0-0868-47ab-87a4-48ce7de5f220,,released,Capecitabine,1,2021-12-21T15:15:15.506039-06:00,Chemotherapy,,
HCM-SANG-0536-C18,9d868cf7-4c23-45f6-9897-015db647fc6e,8137ae83-d206-4ff9-b2d8-dc04f22571d6,,Neoadjuvant,138.0,2025-03-31T16:34:59.906497-05:00,HCM-SANG-0536-C18_treatment2,79d5e8c2-7f82-4b1a-a378-c2fe9a06efba,,released,Oxaliplatin,1,2021-12-21T15:15:15.506039-06:00,Chemotherapy,,
HCM-CSHL-0598-C25,9daf1b17-1086-497e-875b-f1a86e486e34,fe9eb589-c1ed-41b0-b2ba-1180e7c1e9b4,,Neoadjuvant,325.0,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0598-C25_treatment3,0aa6cb79-eabe-4f8c-be55-63a6b199648d,,released,Fluorouracil,1,2021-12-21T14:08:53.186720-06:00,Chemotherapy,,
HCM-CSHL-0598-C25,9daf1b17-1086-497e-875b-f1a86e486e34,fe9eb589-c1ed-41b0-b2ba-1180e7c1e9b4,,Adjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0598-C25_treatment8,2c9fe158-00ee-4813-aeb8-ef73262d51bd,,released,,0,2021-12-21T14:08:53.186720-06:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-CSHL-0598-C25,9daf1b17-1086-497e-875b-f1a86e486e34,fe9eb589-c1ed-41b0-b2ba-1180e7c1e9b4,,Neoadjuvant,325.0,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0598-C25_treatment5,2eee6cad-b974-4766-959f-559162fd03f1,,released,,1,2021-12-21T14:08:53.186720-06:00,Chemotherapy,,FOLFIRINOX
HCM-CSHL-0598-C25,9daf1b17-1086-497e-875b-f1a86e486e34,fe9eb589-c1ed-41b0-b2ba-1180e7c1e9b4,,Adjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0598-C25_treatment11,5bf675ad-f379-4d05-8535-b11f0173d4c1,,released,,0,2021-12-21T14:08:53.186720-06:00,"Radiation Therapy, NOS",Residual Disease,
HCM-CSHL-0598-C25,9daf1b17-1086-497e-875b-f1a86e486e34,fe9eb589-c1ed-41b0-b2ba-1180e7c1e9b4,,,-2.0,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0598-C25_treatment9,5fdad3d2-580c-470f-a767-7245abda4e37,,released,,1,2021-12-21T14:08:53.186720-06:00,"Surgery, NOS",Initial Diagnosis,
HCM-CSHL-0598-C25,9daf1b17-1086-497e-875b-f1a86e486e34,fe9eb589-c1ed-41b0-b2ba-1180e7c1e9b4,,Neoadjuvant,325.0,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0598-C25_treatment,6a6d339b-8f0a-41e5-a6f7-81293cd4801f,,released,Irinotecan Hydrochloride,1,2021-12-21T14:08:53.186720-06:00,Chemotherapy,,
HCM-CSHL-0598-C25,9daf1b17-1086-497e-875b-f1a86e486e34,fe9eb589-c1ed-41b0-b2ba-1180e7c1e9b4,,Adjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0598-C25_treatment10,91615b24-356e-4dd7-87b7-bf95e97401d3,,released,,0,2021-12-21T14:08:53.186720-06:00,Targeted Molecular Therapy,Residual Disease,
HCM-CSHL-0598-C25,9daf1b17-1086-497e-875b-f1a86e486e34,fe9eb589-c1ed-41b0-b2ba-1180e7c1e9b4,,Neoadjuvant,325.0,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0598-C25_treatment4,aed80abf-6bcd-46fd-ae14-be6f49723399,,released,Oxaliplatin,1,2021-12-21T14:08:53.186720-06:00,Chemotherapy,,
HCM-CSHL-0598-C25,9daf1b17-1086-497e-875b-f1a86e486e34,fe9eb589-c1ed-41b0-b2ba-1180e7c1e9b4,,Adjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0598-C25_treatment6,b385576c-afda-42e4-8857-e0e3a482671f,,released,Gemcitabine,1,2021-12-21T14:08:53.186720-06:00,Chemotherapy,Residual Disease,
HCM-CSHL-0598-C25,9daf1b17-1086-497e-875b-f1a86e486e34,fe9eb589-c1ed-41b0-b2ba-1180e7c1e9b4,,Neoadjuvant,325.0,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0598-C25_treatment2,b41d2654-8660-4a20-b165-3bda641e7bf3,,released,Leucovorin Calcium,1,2021-12-21T14:08:53.186720-06:00,Chemotherapy,,
HCM-CSHL-0598-C25,9daf1b17-1086-497e-875b-f1a86e486e34,fe9eb589-c1ed-41b0-b2ba-1180e7c1e9b4,,Adjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0598-C25_treatment7,f9a64ba7-28e0-4397-ae08-dfdc4bc3fb6d,,released,Nab-paclitaxel,1,2021-12-21T14:08:53.186720-06:00,Chemotherapy,Residual Disease,
HCM-SANG-0780-C25,9ddacfb1-46c5-4b93-8f96-937ef10e08f2,e1e84cfa-a937-4268-a735-11e7bbbcd038,,Neoadjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-SANG-0780-C25_treatment,7bbfbb16-3815-4bde-bf7a-63be1534a470,,released,,0,2023-02-27T12:53:59.442112-06:00,,,
HCM-WCMC-0948-C67,9e0540ab-1888-43f8-9271-1dd040c3e8ea,4508afa7-8d2a-444f-b55f-4ad4b8b08e83,,Neoadjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-WCMC-0948-C67_treatment,32d8bf66-6077-4b60-af92-4dfae7115388,,released,,0,2023-02-27T12:44:52.767416-06:00,,,
HCM-WCMC-0948-C67,9e0540ab-1888-43f8-9271-1dd040c3e8ea,4508afa7-8d2a-444f-b55f-4ad4b8b08e83,,,0.0,2025-04-07T17:13:09.336794-05:00,HCM-WCMC-0948-C67_treatment2,5c32fdba-acdc-49f5-a194-807dccbb47b8,,released,,1,2023-02-27T12:44:52.767416-06:00,"Surgery, NOS",Initial Diagnosis,
HCM-WCMC-0948-C67,9e0540ab-1888-43f8-9271-1dd040c3e8ea,4508afa7-8d2a-444f-b55f-4ad4b8b08e83,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-WCMC-0948-C67_treatment4,d9d698a8-7d4b-4265-a119-321d250ee3df,,released,,0,2023-02-27T12:44:52.767416-06:00,"Radiation Therapy, NOS",Residual Disease,
HCM-WCMC-0948-C67,9e0540ab-1888-43f8-9271-1dd040c3e8ea,4508afa7-8d2a-444f-b55f-4ad4b8b08e83,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-WCMC-0948-C67_treatment3,e3360559-e256-47d2-9a39-dacbe2d1d461,,released,,0,2023-02-27T12:44:52.767416-06:00,"Pharmaceutical Therapy, NOS",Residual Disease,
HCM-CSHL-0090-C25,9e615018-8669-4dd6-8265-25e766a34dd0,807dc915-5b1b-48a1-b21f-0e986f33a347,,Adjuvant,,2020-03-26T16:04:47.706904-05:00,HCM-CSHL-0090-C25_treatment5,234dd285-223a-424e-affe-47a171e5bf50,,released,,0,2020-02-11T14:38:31.889814-06:00,Targeted Molecular Therapy,Residual Disease,
HCM-CSHL-0090-C25,9e615018-8669-4dd6-8265-25e766a34dd0,807dc915-5b1b-48a1-b21f-0e986f33a347,,,-9.0,2023-02-27T11:50:33.721668-06:00,HCM-CSHL-0090-C25_treatment4,4f60ac64-c544-4eea-bc44-33b17011dcb4,,released,,1,2020-02-11T14:38:31.889814-06:00,"Surgery, NOS",Initial Diagnosis,
HCM-CSHL-0090-C25,9e615018-8669-4dd6-8265-25e766a34dd0,807dc915-5b1b-48a1-b21f-0e986f33a347,,Adjuvant,,2020-03-26T16:04:47.706904-05:00,HCM-CSHL-0090-C25_treatment6,6bebb34a-e392-4f95-80c9-b8da9d30e8b6,,released,,0,2020-02-11T14:38:31.889814-06:00,"Radiation Therapy, NOS",Residual Disease,
HCM-CSHL-0090-C25,9e615018-8669-4dd6-8265-25e766a34dd0,807dc915-5b1b-48a1-b21f-0e986f33a347,,Neoadjuvant,,2020-03-26T16:04:47.706904-05:00,HCM-CSHL-0090-C25_treatment,bee9f204-9c26-452f-ba2d-a12c593c46c5,,released,,0,2020-02-11T14:38:31.889814-06:00,,,
HCM-CSHL-0090-C25,9e615018-8669-4dd6-8265-25e766a34dd0,807dc915-5b1b-48a1-b21f-0e986f33a347,,Adjuvant,,2020-03-26T16:04:47.706904-05:00,HCM-CSHL-0090-C25_treatment3,eec73f66-be53-4878-8253-86a668f7619c,,released,,0,2020-02-11T14:38:31.889814-06:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-CSHL-0239-C18,9ee323b8-6447-4447-b70f-a7260b3b8f8e,814eb7dc-bd7b-4f96-a5ad-c6e244d45c6a,127.0,Adjuvant,51.0,2023-02-22T07:39:25.979291-06:00,HCM-CSHL-0239-C18_treatment3,29155d98-d49b-49a3-8212-d1d52ebfd658,,released,Fluorouracil,1,2020-09-28T09:20:10.214374-05:00,Chemotherapy,Residual Disease,
HCM-CSHL-0239-C18,9ee323b8-6447-4447-b70f-a7260b3b8f8e,814eb7dc-bd7b-4f96-a5ad-c6e244d45c6a,,Neoadjuvant,,2023-02-22T07:39:25.979291-06:00,HCM-CSHL-0239-C18_treatment,291de62c-c8a6-428c-b2cf-69c65cf6f55b,,released,,0,2020-09-28T09:20:10.214374-05:00,,,
HCM-CSHL-0239-C18,9ee323b8-6447-4447-b70f-a7260b3b8f8e,814eb7dc-bd7b-4f96-a5ad-c6e244d45c6a,,Adjuvant,,2023-02-22T07:39:25.979291-06:00,HCM-CSHL-0239-C18_treatment10,2dc5cf78-2c57-4d46-9875-28c295db2c35,,released,,0,2020-09-28T09:20:10.214374-05:00,"Radiation Therapy, NOS",Residual Disease,
HCM-CSHL-0239-C18,9ee323b8-6447-4447-b70f-a7260b3b8f8e,814eb7dc-bd7b-4f96-a5ad-c6e244d45c6a,,Adjuvant,,2023-02-22T07:39:25.979291-06:00,HCM-CSHL-0239-C18_treatment7,509b3195-9303-4406-adab-f04a5495efd9,,released,,0,2020-09-28T09:20:10.214374-05:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-CSHL-0239-C18,9ee323b8-6447-4447-b70f-a7260b3b8f8e,814eb7dc-bd7b-4f96-a5ad-c6e244d45c6a,,,12.0,2023-02-27T12:37:36.509885-06:00,HCM-CSHL-0239-C18_treatment8,5384f9ff-e714-4be6-8fd8-ff691ea440cd,,released,,1,2020-09-28T09:20:10.214374-05:00,"Surgery, NOS",Initial Diagnosis,
HCM-CSHL-0239-C18,9ee323b8-6447-4447-b70f-a7260b3b8f8e,814eb7dc-bd7b-4f96-a5ad-c6e244d45c6a,127.0,Adjuvant,51.0,2023-02-22T07:39:25.979291-06:00,HCM-CSHL-0239-C18_treatment2,554d043e-a10a-4a74-9579-1728f740abc1,,released,Leucovorin Calcium,1,2020-09-28T09:20:10.214374-05:00,Chemotherapy,Residual Disease,
HCM-CSHL-0239-C18,9ee323b8-6447-4447-b70f-a7260b3b8f8e,814eb7dc-bd7b-4f96-a5ad-c6e244d45c6a,127.0,Adjuvant,51.0,2023-02-22T07:39:25.979291-06:00,HCM-CSHL-0239-C18_treatment5,74001467-d809-456a-a425-216a1079a696,,released,,1,2020-09-28T09:20:10.214374-05:00,Chemotherapy,Residual Disease,FOLFOX
HCM-CSHL-0239-C18,9ee323b8-6447-4447-b70f-a7260b3b8f8e,814eb7dc-bd7b-4f96-a5ad-c6e244d45c6a,211.0,Adjuvant,132.0,2023-02-22T07:39:25.979291-06:00,HCM-CSHL-0239-C18_treatment6,82ce0945-327c-4afe-bf9c-b47a4e9b9771,,released,Fluorouracil,1,2020-09-28T09:20:10.214374-05:00,Chemotherapy,Residual Disease,
HCM-CSHL-0239-C18,9ee323b8-6447-4447-b70f-a7260b3b8f8e,814eb7dc-bd7b-4f96-a5ad-c6e244d45c6a,127.0,Adjuvant,51.0,2023-02-22T07:39:25.979291-06:00,HCM-CSHL-0239-C18_treatment4,bad9c784-5f44-4d07-8d66-bdfc62fb3ffd,,released,Oxaliplatin,1,2020-09-28T09:20:10.214374-05:00,Chemotherapy,Residual Disease,
HCM-CSHL-0239-C18,9ee323b8-6447-4447-b70f-a7260b3b8f8e,814eb7dc-bd7b-4f96-a5ad-c6e244d45c6a,,Adjuvant,,2023-02-22T07:39:25.979291-06:00,HCM-CSHL-0239-C18_treatment9,fd87885a-df33-482d-9167-679bca39b021,,released,,0,2020-09-28T09:20:10.214374-05:00,Targeted Molecular Therapy,Residual Disease,
HCM-BROD-0234-C49,9f4d0076-c4a2-46d4-879f-896946338c09,8768c96d-1487-4dbd-ac75-0ad2a3f95969,,,-13.0,2023-02-27T12:02:41.486454-06:00,HCM-BROD-0234-C49_treatment5,07d1a8a0-3707-40a5-9c01-75b023759326,,released,,1,2020-10-08T12:08:22.339827-05:00,"Surgery, NOS",Initial Diagnosis,
HCM-BROD-0234-C49,9f4d0076-c4a2-46d4-879f-896946338c09,8768c96d-1487-4dbd-ac75-0ad2a3f95969,,Adjuvant,,2021-03-03T15:15:08.075155-06:00,HCM-BROD-0234-C49_treatment3,75831f1b-b2ab-4afa-966e-929d4456baf0,,released,,0,2020-06-15T13:19:36.113829-05:00,Hormone Therapy,Residual Disease,
HCM-BROD-0234-C49,9f4d0076-c4a2-46d4-879f-896946338c09,8768c96d-1487-4dbd-ac75-0ad2a3f95969,,Neoadjuvant,,2021-03-03T15:15:08.075155-06:00,HCM-BROD-0234-C49_treatment,9e527598-365b-4680-a3d8-eadb977826fc,,released,,0,2020-06-15T13:19:36.113829-05:00,,,
HCM-BROD-0234-C49,9f4d0076-c4a2-46d4-879f-896946338c09,8768c96d-1487-4dbd-ac75-0ad2a3f95969,,Adjuvant,,2021-03-03T15:15:08.075155-06:00,HCM-BROD-0234-C49_treatment4,a040c038-d46a-4bde-9846-595117259d99,,released,,0,2020-06-15T13:19:36.113829-05:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-BROD-0234-C49,9f4d0076-c4a2-46d4-879f-896946338c09,8768c96d-1487-4dbd-ac75-0ad2a3f95969,793.0,Adjuvant,782.0,2021-03-03T15:15:08.075155-06:00,HCM-BROD-0234-C49_treatment2,cb536e3f-4da4-4da7-b21c-9aa239f50198,,released,Doxorubicin Hydrochloride,1,2020-06-15T13:19:36.113829-05:00,Chemotherapy,Residual Disease,
HCM-BROD-0234-C49,9f4d0076-c4a2-46d4-879f-896946338c09,8768c96d-1487-4dbd-ac75-0ad2a3f95969,,Adjuvant,,2021-03-03T15:15:08.075155-06:00,HCM-BROD-0234-C49_treatment6,d9cc06f3-9eb8-41c2-9069-dbaf7575d6b1,,released,,0,2020-10-08T12:08:22.339827-05:00,Targeted Molecular Therapy,Residual Disease,
HCM-BROD-0234-C49,9f4d0076-c4a2-46d4-879f-896946338c09,8768c96d-1487-4dbd-ac75-0ad2a3f95969,625.0,Adjuvant,619.0,2021-03-03T15:15:08.075155-06:00,HCM-BROD-0234-C49_treatment7,ec7068a0-539d-4f42-befc-500042e7faa7,,released,,1,2020-10-08T12:08:22.339827-05:00,"Radiation, Stereotactic/Gamma Knife/SRS",Residual Disease,
HCM-CSHL-0730-C25,9f4d122a-e88e-433f-85a7-dbc4060ec7b8,2a92c0d9-8816-4348-ae30-be79727455f5,,Adjuvant,,2023-02-22T07:39:25.979291-06:00,HCM-CSHL-0730-C25_treatment3,06b23257-981d-43b7-a3d6-711652998326,,released,,0,2021-11-23T08:38:29.033717-06:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-CSHL-0730-C25,9f4d122a-e88e-433f-85a7-dbc4060ec7b8,2a92c0d9-8816-4348-ae30-be79727455f5,,Adjuvant,,2023-02-22T07:39:25.979291-06:00,HCM-CSHL-0730-C25_treatment2,21aeead5-284a-4c8d-bbbe-1fcd2648bc20,,released,,1,2021-11-23T08:38:29.033717-06:00,Chemotherapy,Residual Disease,
HCM-CSHL-0730-C25,9f4d122a-e88e-433f-85a7-dbc4060ec7b8,2a92c0d9-8816-4348-ae30-be79727455f5,,Neoadjuvant,,2023-02-22T07:39:25.979291-06:00,HCM-CSHL-0730-C25_treatment,2832cee2-b917-409c-bb48-7a44227d5fc5,,released,,0,2021-11-23T08:38:29.033717-06:00,,,
HCM-CSHL-0730-C25,9f4d122a-e88e-433f-85a7-dbc4060ec7b8,2a92c0d9-8816-4348-ae30-be79727455f5,,Adjuvant,,2023-02-22T07:39:25.979291-06:00,HCM-CSHL-0730-C25_treatment5,34674f1a-c9b8-478c-8bea-26ad08289660,,released,,0,2021-11-23T08:38:29.033717-06:00,Targeted Molecular Therapy,Residual Disease,
HCM-CSHL-0730-C25,9f4d122a-e88e-433f-85a7-dbc4060ec7b8,2a92c0d9-8816-4348-ae30-be79727455f5,,,,2023-02-27T11:22:33.219313-06:00,HCM-CSHL-0730-C25_treatment4,7d368064-0086-4921-a3a7-f106b93ffe82,,released,,0,2021-11-23T08:38:29.033717-06:00,"Surgery, NOS",Initial Diagnosis,
HCM-CSHL-0730-C25,9f4d122a-e88e-433f-85a7-dbc4060ec7b8,2a92c0d9-8816-4348-ae30-be79727455f5,,Adjuvant,,2023-02-22T07:39:25.979291-06:00,HCM-CSHL-0730-C25_treatment6,a7c9c88c-283c-4b91-94b5-c606c693736e,,released,,0,2021-11-23T08:38:29.033717-06:00,"Radiation Therapy, NOS",Residual Disease,
HCM-CSHL-0634-C30,9ffb2777-3c88-4ee4-bb86-956c7c4fb6c4,8919e1d4-e61f-434c-9844-704245611404,,Neoadjuvant,,2023-11-07T14:28:29.403873-06:00,HCM-CSHL-0634-C30_treatment,03e07844-5af2-470f-ae99-21279223d9da,,released,,0,2020-10-08T13:35:37.193951-05:00,,,
HCM-CSHL-0634-C30,9ffb2777-3c88-4ee4-bb86-956c7c4fb6c4,8919e1d4-e61f-434c-9844-704245611404,,,39.0,2023-11-07T14:28:29.403873-06:00,HCM-CSHL-0634-C30_treatment2,091ebf8a-d650-4f57-abb8-6c6aee27e695,,released,,1,2020-10-08T13:35:37.193951-05:00,"Surgery, NOS",Initial Diagnosis,
HCM-CSHL-0634-C30,9ffb2777-3c88-4ee4-bb86-956c7c4fb6c4,8919e1d4-e61f-434c-9844-704245611404,103.0,Adjuvant,67.0,2023-11-07T14:28:29.403873-06:00,HCM-CSHL-0634-C30_treatment4,0dab74dc-12a6-4858-a8a8-c43ea3d0ac2b,,released,,1,2020-10-08T13:35:37.193951-05:00,"Radiation, Intensity-Modulated Radiotherapy",Residual Disease,
HCM-CSHL-0634-C30,9ffb2777-3c88-4ee4-bb86-956c7c4fb6c4,8919e1d4-e61f-434c-9844-704245611404,,Adjuvant,,2023-11-07T14:28:29.403873-06:00,HCM-CSHL-0634-C30_treatment3,ab607e3b-2e51-49a6-8179-9ebb703b2766,,released,,0,2020-10-08T13:35:37.193951-05:00,"Pharmaceutical Therapy, NOS",Residual Disease,
HCM-EXPT-1237-C20,a01bee43-90de-498f-89e8-6f083b623fd9,bafc7b85-6aef-417d-a7a8-7196edd6755b,,Neoadjuvant,,2025-10-08T12:39:37.798161-05:00,HCM-EXPT-1237-C20_treatment,2961d121-02fb-4ac4-87ab-ad161cc06639,,released,Capecitabine,1,2023-02-24T14:02:51.893706-06:00,Chemotherapy,,
HCM-EXPT-1237-C20,a01bee43-90de-498f-89e8-6f083b623fd9,bafc7b85-6aef-417d-a7a8-7196edd6755b,,Neoadjuvant,,2025-10-08T12:39:37.798161-05:00,HCM-EXPT-1237-C20_treatment2,bde9de24-dd17-4a56-b112-76400acfe3e3,,released,Oxaliplatin,1,2023-02-24T14:02:51.893706-06:00,Chemotherapy,,
HCM-EXPT-1237-C20,a01bee43-90de-498f-89e8-6f083b623fd9,bafc7b85-6aef-417d-a7a8-7196edd6755b,,Neoadjuvant,,2025-10-08T12:39:37.798161-05:00,HCM-EXPT-1237-C20_treatment3,be2caa76-669a-477c-93d3-c14c8788c37f,,released,,1,2023-02-24T14:02:51.893706-06:00,"Radiation Therapy, NOS",,
HCM-WCMC-1344-C18,a02b068f-adff-47ca-82fb-2f03a34cd75f,b305b46c-50f1-4599-a34a-b9f660481009,,Neoadjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-WCMC-1344-C18_treatment,17a22201-faeb-47be-b110-37cf46504a92,,released,,0,2023-02-27T13:01:54.644926-06:00,,,
HCM-WCMC-1344-C18,a02b068f-adff-47ca-82fb-2f03a34cd75f,b305b46c-50f1-4599-a34a-b9f660481009,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-WCMC-1344-C18_treatment4,19e1fc6e-13e1-4760-8db3-3e193c78e493,,released,,0,2023-02-27T13:01:54.644926-06:00,"Radiation Therapy, NOS",Residual Disease,
HCM-WCMC-1344-C18,a02b068f-adff-47ca-82fb-2f03a34cd75f,b305b46c-50f1-4599-a34a-b9f660481009,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-WCMC-1344-C18_treatment3,6fdc5ad9-64f0-4696-8744-ca691c04248f,,released,,0,2023-02-27T13:01:54.644926-06:00,"Pharmaceutical Therapy, NOS",Residual Disease,
HCM-WCMC-1344-C18,a02b068f-adff-47ca-82fb-2f03a34cd75f,b305b46c-50f1-4599-a34a-b9f660481009,,,9.0,2025-04-07T17:13:09.336794-05:00,HCM-WCMC-1344-C18_treatment2,9e1117f5-3ec8-40c8-a151-a214692a59b5,,released,,1,2023-02-27T13:01:54.644926-06:00,"Surgery, NOS",Initial Diagnosis,
HCM-EXPT-1051-C50,a04ad320-8e35-46b8-b213-9646694c05e4,393f7a7f-5352-4d96-ba43-cf8adc8252b3,,Neoadjuvant,,2025-10-08T12:38:06.952582-05:00,HCM-EXPT-1051-C50_treatment2,3cb082c8-3d5b-4eb6-97fe-a717461e3491,,released,,1,2021-12-21T15:01:38.223453-06:00,"Radiation Therapy, NOS",,
HCM-EXPT-1051-C50,a04ad320-8e35-46b8-b213-9646694c05e4,393f7a7f-5352-4d96-ba43-cf8adc8252b3,,Neoadjuvant,,2025-10-08T12:38:06.952582-05:00,HCM-EXPT-1051-C50_treatment,5880cd54-a21b-493b-9695-9e052f084821,,released,,1,2021-12-21T15:01:38.223453-06:00,Hormone Therapy,,
HCM-SANG-1092-C18,a06ae06a-7c75-475d-833b-29c43c5a4d67,cf487e86-f6a0-42ea-9f36-0dd6bb78a9f7,,Neoadjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-SANG-1092-C18_treatment,387ff94f-796e-4c7a-933b-91f0498f6e70,,released,,0,2023-02-27T11:27:05.254143-06:00,,,
HCM-EXPT-1036-C34,a0a8a68a-c712-4c67-8b83-c4eb5a5c90aa,5ebcc9ca-e2b1-4e88-b943-1c79cfb46a31,,Neoadjuvant,,2025-10-08T12:38:06.952582-05:00,HCM-EXPT-1036-C34_treatment,e2aad237-3149-4931-aeaf-a80841e4f6cd,,released,,0,2021-12-21T14:59:36.441780-06:00,,,
HCM-SANG-0297-C15,a0cac428-0e4d-471f-a3a1-9d3ea026b58e,865560ca-001a-4f87-a0a3-4ed2438d3323,,Neoadjuvant,,2023-02-22T07:39:25.979291-06:00,HCM-SANG-0297-C15_treatment,5c4bdc2c-ccc2-420f-8243-b0af0591c55e,,released,,0,2020-02-11T16:00:14.801928-06:00,,,
HCM-SANG-0281-C18,a13f7c10-76c8-473a-b87b-8b680706d189,5f18c19a-572d-49c4-85c2-44954bb37c5a,,Neoadjuvant,,2023-02-22T07:39:25.979291-06:00,HCM-SANG-0281-C18_treatment,b0130383-79a8-4656-8405-21b3f9adf00d,,released,,0,2021-04-20T10:33:14.082471-05:00,,,
HCM-CSHL-0586-C32,a1d1b84f-51e1-49cc-b13d-905292264b92,b1bf689a-2f2f-41b7-bc81-f5227c048270,,Adjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0586-C32_treatment3,10985d8b-95a5-4633-99b6-96216a8d6ed1,,released,,0,2020-10-08T13:35:22.455060-05:00,"Pharmaceutical Therapy, NOS",Residual Disease,
HCM-CSHL-0586-C32,a1d1b84f-51e1-49cc-b13d-905292264b92,b1bf689a-2f2f-41b7-bc81-f5227c048270,,Neoadjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0586-C32_treatment,3843352b-f901-41c7-8b9f-0ff2a02b39a9,,released,,0,2020-10-08T13:35:22.455060-05:00,,,
HCM-CSHL-0586-C32,a1d1b84f-51e1-49cc-b13d-905292264b92,b1bf689a-2f2f-41b7-bc81-f5227c048270,,,14.0,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0586-C32_treatment2,41f5eb56-6630-42c5-8c6a-b87ad7dad4ca,,released,,1,2020-10-08T13:35:22.455060-05:00,"Surgery, NOS",Initial Diagnosis,
HCM-CSHL-0586-C32,a1d1b84f-51e1-49cc-b13d-905292264b92,b1bf689a-2f2f-41b7-bc81-f5227c048270,64.0,Adjuvant,28.0,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0586-C32_treatment4,7ab916bc-6e38-4c7d-9065-777f5023d28b,,released,,1,2020-10-08T13:35:22.455060-05:00,"Radiation, Intensity-Modulated Radiotherapy",Residual Disease,
HCM-BROD-0445-C15,a21e6302-cc54-4b1d-87a9-c7fa4475beca,f213eb8d-7769-4a71-9d99-dff95b3b8b14,777.0,Adjuvant,412.0,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0445-C15_treatment2,0e9dcce8-1fb3-40ae-a654-734f86faed94,Treatment Ongoing,released,Oxaliplatin,1,2020-09-27T11:36:45.323899-05:00,Chemotherapy,Residual Disease,
HCM-BROD-0445-C15,a21e6302-cc54-4b1d-87a9-c7fa4475beca,f213eb8d-7769-4a71-9d99-dff95b3b8b14,777.0,Adjuvant,412.0,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0445-C15_treatment5,12d67fa3-3a66-471e-a31e-f2276c384354,Treatment Ongoing,released,,1,2020-09-27T11:36:45.323899-05:00,Chemotherapy,Residual Disease,FU-LV regimen
HCM-BROD-0445-C15,a21e6302-cc54-4b1d-87a9-c7fa4475beca,f213eb8d-7769-4a71-9d99-dff95b3b8b14,777.0,Adjuvant,412.0,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0445-C15_treatment3,1fa782f2-ddbe-4d80-afbe-3ee8597beccd,Treatment Ongoing,released,Fluorouracil,1,2020-09-27T11:36:45.323899-05:00,Chemotherapy,Residual Disease,
HCM-BROD-0445-C15,a21e6302-cc54-4b1d-87a9-c7fa4475beca,f213eb8d-7769-4a71-9d99-dff95b3b8b14,,Adjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0445-C15_treatment6,223ef0d9-40c7-4c16-ad5e-6682c8ce9d7f,,released,,0,2020-09-27T11:36:45.323899-05:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-BROD-0445-C15,a21e6302-cc54-4b1d-87a9-c7fa4475beca,f213eb8d-7769-4a71-9d99-dff95b3b8b14,,Neoadjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0445-C15_treatment,41ec54fb-30e5-4ab9-9c72-d0a35ced2dfc,,released,,0,2020-09-27T11:36:45.323899-05:00,,,
HCM-BROD-0445-C15,a21e6302-cc54-4b1d-87a9-c7fa4475beca,f213eb8d-7769-4a71-9d99-dff95b3b8b14,777.0,Adjuvant,412.0,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0445-C15_treatment8,801cef7d-42b3-472d-bd38-42f98222b82e,Treatment Ongoing,released,Trastuzumab,1,2020-09-27T11:36:45.323899-05:00,Targeted Molecular Therapy,Residual Disease,
HCM-BROD-0445-C15,a21e6302-cc54-4b1d-87a9-c7fa4475beca,f213eb8d-7769-4a71-9d99-dff95b3b8b14,777.0,Adjuvant,412.0,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0445-C15_treatment4,829c3e4e-ccf9-4d1f-b66b-f4c9efaa9219,Treatment Ongoing,released,Leucovorin,1,2020-09-27T11:36:45.323899-05:00,Chemotherapy,Residual Disease,
HCM-BROD-0445-C15,a21e6302-cc54-4b1d-87a9-c7fa4475beca,f213eb8d-7769-4a71-9d99-dff95b3b8b14,,Adjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0445-C15_treatment9,b8cc9403-d9c0-4b41-9b12-350998225365,,released,,0,2020-09-27T11:36:45.323899-05:00,"Radiation Therapy, NOS",Residual Disease,
HCM-EXPT-0883-C25,a276f47b-75eb-4e47-aabf-bf1fcb2e07eb,bdd63901-6f97-409f-be09-96b717251d67,,Neoadjuvant,,2025-10-08T12:36:32.654639-05:00,HCM-EXPT-0883-C25_treatment,28a38937-edf4-4fc9-b5a9-e2b3a3faf4cf,,released,,0,2021-12-21T15:26:27.648755-06:00,,,
HCM-EXPT-0974-C18,a2c1fc43-d285-493f-8090-89a3d14d0380,9560193e-c98c-49f7-9d1a-887d59ff57e2,,Neoadjuvant,,2025-10-08T12:37:21.548354-05:00,HCM-EXPT-0974-C18_treatment,e89337e0-0780-4907-a6b5-d2fdef7ed3e8,,released,,0,2021-12-21T14:48:46.309562-06:00,,,
HCM-BROD-1102-C85,a2e9805f-e36a-46c1-b36c-fc064848501c,a7b0c28e-e4b1-4074-8653-a997720ea187,,Neoadjuvant,1575.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-1102-C85_treatment2,177a257e-696b-468b-ac40-3d8c5a607f8e,,released,Rituximab,1,2021-12-21T15:23:35.717319-06:00,Immunotherapy (Including Vaccines),,
HCM-BROD-1102-C85,a2e9805f-e36a-46c1-b36c-fc064848501c,a7b0c28e-e4b1-4074-8653-a997720ea187,,,,2025-04-07T17:13:09.336794-05:00,HCM-BROD-1102-C85_treatment8,46a16bf9-aea2-48f4-9af4-8ada60530344,,released,,0,2021-12-21T15:23:35.717319-06:00,"Surgery, NOS",Initial Diagnosis,
HCM-BROD-1102-C85,a2e9805f-e36a-46c1-b36c-fc064848501c,a7b0c28e-e4b1-4074-8653-a997720ea187,,Neoadjuvant,1571.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-1102-C85_treatment,7319b375-7e46-4628-87b4-b7345f8f3bad,,released,Bendamustine,1,2021-12-21T15:23:35.717319-06:00,Chemotherapy,,
HCM-BROD-1102-C85,a2e9805f-e36a-46c1-b36c-fc064848501c,a7b0c28e-e4b1-4074-8653-a997720ea187,1571.0,Adjuvant,1555.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-1102-C85_treatment4,84a1c09d-9a15-4247-a8f7-1a5ef4946ad1,,released,Doxorubicin Hydrochloride,1,2021-12-21T15:23:35.717319-06:00,Chemotherapy,Residual Disease,
HCM-BROD-1102-C85,a2e9805f-e36a-46c1-b36c-fc064848501c,a7b0c28e-e4b1-4074-8653-a997720ea187,1571.0,Adjuvant,1555.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-1102-C85_treatment3,882a99b8-06e7-468d-9fd9-e6ad7f3ea97d,,released,Cyclophosphamide,1,2021-12-21T15:23:35.717319-06:00,Chemotherapy,Residual Disease,
HCM-BROD-1102-C85,a2e9805f-e36a-46c1-b36c-fc064848501c,a7b0c28e-e4b1-4074-8653-a997720ea187,1571.0,Adjuvant,1555.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-1102-C85_treatment5,98c16bb2-18ef-4d64-a058-9fecfef5c26f,,released,Vincristine,1,2021-12-21T15:23:35.717319-06:00,Chemotherapy,Residual Disease,
HCM-BROD-1102-C85,a2e9805f-e36a-46c1-b36c-fc064848501c,a7b0c28e-e4b1-4074-8653-a997720ea187,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-BROD-1102-C85_treatment9,a6a2f456-b2e7-425a-9083-b40a5e8f9887,,released,,0,2021-12-21T15:23:35.717319-06:00,Targeted Molecular Therapy,Residual Disease,
HCM-BROD-1102-C85,a2e9805f-e36a-46c1-b36c-fc064848501c,a7b0c28e-e4b1-4074-8653-a997720ea187,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-BROD-1102-C85_treatment7,b814edae-e149-43d3-a532-11002ade7928,,released,,0,2021-12-21T15:23:35.717319-06:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-BROD-1102-C85,a2e9805f-e36a-46c1-b36c-fc064848501c,a7b0c28e-e4b1-4074-8653-a997720ea187,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-BROD-1102-C85_treatment6,b9bdd1dc-9200-4924-adca-89c42a06e118,,released,,0,2021-12-21T15:23:35.717319-06:00,Hormone Therapy,Residual Disease,
HCM-BROD-1102-C85,a2e9805f-e36a-46c1-b36c-fc064848501c,a7b0c28e-e4b1-4074-8653-a997720ea187,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-BROD-1102-C85_treatment10,bfa11dba-f989-4e48-868b-6cbbb6ac873f,,released,,0,2021-12-21T15:23:35.717319-06:00,"Radiation Therapy, NOS",Residual Disease,
HCM-WCMC-1294-C18,a30d5ca4-146c-43d6-b3f3-ca3ec860f777,07b8d521-306b-4a17-9ed6-28ecb2a925ef,,Neoadjuvant,22.0,2025-08-20T09:56:36.143985-05:00,HCM-WCMC-1294-C18_treatment,045df27d-d2f3-405d-a9ed-45f3d5d00a89,,released,Capecitabine,1,2023-02-27T11:26:14.805451-06:00,Chemotherapy,,
HCM-WCMC-1294-C18,a30d5ca4-146c-43d6-b3f3-ca3ec860f777,07b8d521-306b-4a17-9ed6-28ecb2a925ef,253.0,Adjuvant,155.0,2025-08-20T09:56:36.143985-05:00,HCM-WCMC-1294-C18_treatment4,148928aa-44c2-4754-9838-d768a5fbe190,,released,Oxaliplatin,1,2023-02-27T11:26:14.805451-06:00,Chemotherapy,Residual Disease,
HCM-WCMC-1294-C18,a30d5ca4-146c-43d6-b3f3-ca3ec860f777,07b8d521-306b-4a17-9ed6-28ecb2a925ef,,Neoadjuvant,22.0,2025-08-20T09:56:36.143985-05:00,HCM-WCMC-1294-C18_treatment3,15a5da20-34c1-4037-8e1f-a5ca0d3affe3,,released,,1,2023-02-27T11:26:14.805451-06:00,Chemotherapy,,XELOX
HCM-WCMC-1294-C18,a30d5ca4-146c-43d6-b3f3-ca3ec860f777,07b8d521-306b-4a17-9ed6-28ecb2a925ef,,Adjuvant,,2025-08-20T09:56:36.143985-05:00,HCM-WCMC-1294-C18_treatment9,16960486-71c9-4ff6-a40c-adaa3744907d,,released,,0,2023-02-27T11:26:14.805451-06:00,Targeted Molecular Therapy,Residual Disease,
HCM-WCMC-1294-C18,a30d5ca4-146c-43d6-b3f3-ca3ec860f777,07b8d521-306b-4a17-9ed6-28ecb2a925ef,,Adjuvant,,2025-08-20T09:56:36.143985-05:00,HCM-WCMC-1294-C18_treatment7,667332d8-435a-4d4e-9c1d-338310eb5765,,released,,0,2023-02-27T11:26:14.805451-06:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-WCMC-1294-C18,a30d5ca4-146c-43d6-b3f3-ca3ec860f777,07b8d521-306b-4a17-9ed6-28ecb2a925ef,,,0.0,2025-08-20T09:56:36.143985-05:00,HCM-WCMC-1294-C18_treatment8,80362a8b-7567-428e-bb61-2d0d89f78bab,,released,,1,2023-02-27T11:26:14.805451-06:00,"Surgery, NOS",Initial Diagnosis,
HCM-WCMC-1294-C18,a30d5ca4-146c-43d6-b3f3-ca3ec860f777,07b8d521-306b-4a17-9ed6-28ecb2a925ef,253.0,Adjuvant,155.0,2025-08-20T09:56:36.143985-05:00,HCM-WCMC-1294-C18_treatment5,9df78e59-91ca-49ad-807b-d9afb32f0275,,released,Capecitabine,1,2023-02-27T11:26:14.805451-06:00,Chemotherapy,Residual Disease,
HCM-WCMC-1294-C18,a30d5ca4-146c-43d6-b3f3-ca3ec860f777,07b8d521-306b-4a17-9ed6-28ecb2a925ef,253.0,Adjuvant,155.0,2025-08-20T09:56:36.143985-05:00,HCM-WCMC-1294-C18_treatment6,b9db2208-3d67-48f2-b397-00559e719855,,released,,1,2023-02-27T11:26:14.805451-06:00,Chemotherapy,Residual Disease,XELOX
HCM-WCMC-1294-C18,a30d5ca4-146c-43d6-b3f3-ca3ec860f777,07b8d521-306b-4a17-9ed6-28ecb2a925ef,,Adjuvant,,2025-08-20T09:56:36.143985-05:00,HCM-WCMC-1294-C18_treatment10,eb96588b-7199-4f59-95f0-94267e5f5f8b,,released,,0,2023-02-27T11:26:14.805451-06:00,"Radiation Therapy, NOS",Residual Disease,
HCM-WCMC-1294-C18,a30d5ca4-146c-43d6-b3f3-ca3ec860f777,07b8d521-306b-4a17-9ed6-28ecb2a925ef,,Neoadjuvant,22.0,2025-08-20T09:56:36.143985-05:00,HCM-WCMC-1294-C18_treatment2,ed1cace4-dc0f-4a9e-93f8-71b14eacc40d,,released,Oxaliplatin,1,2023-02-27T11:26:14.805451-06:00,Chemotherapy,,
HCM-BROD-0050-C49,a35ed933-bca3-4fb3-8262-ab1405cdbdbf,31981f27-b9e3-4836-b59f-1877fc690a26,,,0.0,2023-03-13T13:27:38.479646-05:00,HCM-BROD-0050-C49_treatment2,1582ed02-4982-4819-993c-49ec8aa1f413,,released,,1,2021-12-21T13:36:23.000545-06:00,"Surgery, NOS",Initial Diagnosis,
HCM-BROD-0050-C49,a35ed933-bca3-4fb3-8262-ab1405cdbdbf,31981f27-b9e3-4836-b59f-1877fc690a26,,Adjuvant,,2023-03-13T13:27:38.479646-05:00,HCM-BROD-0050-C49_treatment3,7307771a-f86a-49f6-8436-05f26cee1d19,,released,,0,2021-12-21T13:36:23.000545-06:00,"Pharmaceutical Therapy, NOS",Residual Disease,
HCM-BROD-0050-C49,a35ed933-bca3-4fb3-8262-ab1405cdbdbf,31981f27-b9e3-4836-b59f-1877fc690a26,,Adjuvant,,2023-03-13T13:27:38.479646-05:00,HCM-BROD-0050-C49_treatment4,a7eff41b-a737-4e48-a7d0-61ebc4970043,,released,,0,2021-12-21T13:36:23.000545-06:00,"Radiation Therapy, NOS",Residual Disease,
HCM-BROD-0050-C49,a35ed933-bca3-4fb3-8262-ab1405cdbdbf,31981f27-b9e3-4836-b59f-1877fc690a26,,Neoadjuvant,,2023-02-22T07:39:25.979291-06:00,HCM-BROD-0050-C49_treatment,cbe1a379-44d9-47a9-bfd8-6a524381f40e,,released,,0,2021-12-21T13:36:23.000545-06:00,,,
HCM-BROD-0050-C49,a35ed933-bca3-4fb3-8262-ab1405cdbdbf,77ad5e2c-e04b-40f9-bd91-e4dada43a5d8,822.0,Maintenance Therapy,30.0,2023-03-14T11:40:17.645275-05:00,HCM-BROD-0050-C49_treatment7,13944cf0-1873-4c93-b762-c84f37a48e7f,Progressive Disease,released,Gemcitabine Hydrochloride,1,2023-03-13T13:27:38.479646-05:00,,,
HCM-BROD-0050-C49,a35ed933-bca3-4fb3-8262-ab1405cdbdbf,77ad5e2c-e04b-40f9-bd91-e4dada43a5d8,822.0,Maintenance Therapy,30.0,2023-03-13T13:27:38.479646-05:00,HCM-BROD-0050-C49_treatment9,3867b772-063d-4f52-9a72-b0fb51456cea,Progressive Disease,released,Doxorubicin Hydrochloride,1,2021-12-21T13:36:23.000545-06:00,,,
HCM-BROD-0050-C49,a35ed933-bca3-4fb3-8262-ab1405cdbdbf,77ad5e2c-e04b-40f9-bd91-e4dada43a5d8,822.0,Maintenance Therapy,30.0,2023-03-14T11:40:17.645275-05:00,HCM-BROD-0050-C49_treatment6,550949ea-d2a0-436d-916b-3757b7e4e2d9,Progressive Disease,released,Cisplatin,1,2023-03-13T13:27:38.479646-05:00,,,
HCM-BROD-0050-C49,a35ed933-bca3-4fb3-8262-ab1405cdbdbf,77ad5e2c-e04b-40f9-bd91-e4dada43a5d8,822.0,Maintenance Therapy,30.0,2023-03-14T11:40:17.645275-05:00,HCM-BROD-0050-C49_treatment5,9c9413ca-eedd-4b54-a676-bed16ad9e99b,Progressive Disease,released,Carboplatin,1,2023-03-13T13:27:38.479646-05:00,,,
HCM-BROD-0050-C49,a35ed933-bca3-4fb3-8262-ab1405cdbdbf,77ad5e2c-e04b-40f9-bd91-e4dada43a5d8,822.0,Maintenance Therapy,30.0,2023-03-14T11:40:17.645275-05:00,HCM-BROD-0050-C49_treatment8,d0b8137b-d2e0-442b-8013-4b1023f7a712,Progressive Disease,released,Ifosfamide,1,2023-03-13T13:27:38.479646-05:00,,,
HCM-EXPT-0882-C25,a394e01a-d47f-4eb5-aa2d-89e684936271,009b8db7-ac65-4acb-90d9-40052847ae9c,,Neoadjuvant,,2025-10-08T12:36:32.654639-05:00,HCM-EXPT-0882-C25_treatment,43bd4ffc-7e47-46af-862c-659ddf27f732,,released,,0,2021-12-21T15:26:12.904924-06:00,,,
HCM-BROD-0055-C64,a3b71c6f-77cc-4e80-8c1c-96cdf836b42e,3382e6e7-88db-4179-a0a0-9a305a8758d5,396.0,Adjuvant,151.0,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0055-C64_treatment7,042e569e-0aaa-4aad-ac6a-4dbe3e2c75ae,,released,Vincristine,1,2020-09-27T10:18:57.448599-05:00,Chemotherapy,Residual Disease,
HCM-BROD-0055-C64,a3b71c6f-77cc-4e80-8c1c-96cdf836b42e,3382e6e7-88db-4179-a0a0-9a305a8758d5,151.0,Adjuvant,92.0,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0055-C64_treatment2,12bfbfba-1a5e-432e-855f-528360598092,,released,Doxorubicin Hydrochloride,1,2020-09-27T10:18:57.448599-05:00,Chemotherapy,Residual Disease,
HCM-BROD-0055-C64,a3b71c6f-77cc-4e80-8c1c-96cdf836b42e,3382e6e7-88db-4179-a0a0-9a305a8758d5,396.0,Adjuvant,151.0,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0055-C64_treatment12,23528d55-4129-49bb-8faf-7437a840b963,,released,,1,2020-09-27T10:18:57.448599-05:00,Chemotherapy,Residual Disease,VDC/IE
HCM-BROD-0055-C64,a3b71c6f-77cc-4e80-8c1c-96cdf836b42e,3382e6e7-88db-4179-a0a0-9a305a8758d5,396.0,Adjuvant,151.0,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0055-C64_treatment11,2467ac09-3894-4056-aad6-f6210360da1c,,released,Etoposide,1,2020-09-27T10:18:57.448599-05:00,Chemotherapy,Residual Disease,
HCM-BROD-0055-C64,a3b71c6f-77cc-4e80-8c1c-96cdf836b42e,3382e6e7-88db-4179-a0a0-9a305a8758d5,151.0,Adjuvant,92.0,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0055-C64_treatment6,32576bb0-2ddf-43f0-9c01-e520e6ce3f8d,,released,,1,2020-09-27T10:18:57.448599-05:00,Chemotherapy,Residual Disease,VAC
HCM-BROD-0055-C64,a3b71c6f-77cc-4e80-8c1c-96cdf836b42e,3382e6e7-88db-4179-a0a0-9a305a8758d5,,Adjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0055-C64_treatment17,577248f4-0ab6-4838-8441-b86e8b883d13,,released,,0,2020-09-27T10:18:57.448599-05:00,Targeted Molecular Therapy,Residual Disease,
HCM-BROD-0055-C64,a3b71c6f-77cc-4e80-8c1c-96cdf836b42e,3382e6e7-88db-4179-a0a0-9a305a8758d5,396.0,Adjuvant,151.0,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0055-C64_treatment8,7e51bf6b-e9c9-440d-a716-18867925a725,,released,Ifosfamide,1,2020-09-27T10:18:57.448599-05:00,Chemotherapy,Residual Disease,
HCM-BROD-0055-C64,a3b71c6f-77cc-4e80-8c1c-96cdf836b42e,3382e6e7-88db-4179-a0a0-9a305a8758d5,,Adjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0055-C64_treatment15,8e1b9de7-352c-4f80-aaa3-4a2f498b1c46,,released,,0,2020-09-27T10:18:57.448599-05:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-BROD-0055-C64,a3b71c6f-77cc-4e80-8c1c-96cdf836b42e,3382e6e7-88db-4179-a0a0-9a305a8758d5,151.0,Adjuvant,92.0,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0055-C64_treatment5,8e22c491-f944-45c6-ac6d-63f992f9bb14,,released,Cyclophosphamide,1,2020-09-27T10:18:57.448599-05:00,Chemotherapy,Residual Disease,
HCM-BROD-0055-C64,a3b71c6f-77cc-4e80-8c1c-96cdf836b42e,3382e6e7-88db-4179-a0a0-9a305a8758d5,151.0,Adjuvant,92.0,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0055-C64_treatment4,96c9d487-66ef-40a6-8214-54fa626a4011,,released,Dactinomycin,1,2020-09-27T10:18:57.448599-05:00,Chemotherapy,Residual Disease,
HCM-BROD-0055-C64,a3b71c6f-77cc-4e80-8c1c-96cdf836b42e,3382e6e7-88db-4179-a0a0-9a305a8758d5,151.0,Adjuvant,92.0,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0055-C64_treatment3,98d9384d-8c9d-43d2-a930-35e5adffb041,,released,Vincristine,1,2020-09-27T10:18:57.448599-05:00,Chemotherapy,Residual Disease,
HCM-BROD-0055-C64,a3b71c6f-77cc-4e80-8c1c-96cdf836b42e,3382e6e7-88db-4179-a0a0-9a305a8758d5,,Adjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0055-C64_treatment18,9c322494-1a32-4a6d-aab7-79d790783c93,,released,,0,2020-09-27T10:18:57.448599-05:00,"Radiation Therapy, NOS",Residual Disease,
HCM-BROD-0055-C64,a3b71c6f-77cc-4e80-8c1c-96cdf836b42e,3382e6e7-88db-4179-a0a0-9a305a8758d5,396.0,Adjuvant,151.0,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0055-C64_treatment14,9cc317f1-5e16-400f-8f1e-547323e26b52,,released,,1,2020-09-27T10:18:57.448599-05:00,Chemotherapy,Residual Disease,ICE
HCM-BROD-0055-C64,a3b71c6f-77cc-4e80-8c1c-96cdf836b42e,3382e6e7-88db-4179-a0a0-9a305a8758d5,,,,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0055-C64_treatment16,cd3a6890-bb2b-4298-8584-fe3effb0e8c2,,released,,1,2020-09-27T10:18:57.448599-05:00,"Surgery, NOS",Initial Diagnosis,
HCM-BROD-0055-C64,a3b71c6f-77cc-4e80-8c1c-96cdf836b42e,3382e6e7-88db-4179-a0a0-9a305a8758d5,396.0,Adjuvant,151.0,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0055-C64_treatment13,d2d2ac7a-d7b1-4f18-a437-51708fb14545,,released,Carboplatin,1,2020-09-27T10:18:57.448599-05:00,Chemotherapy,Residual Disease,
HCM-BROD-0055-C64,a3b71c6f-77cc-4e80-8c1c-96cdf836b42e,3382e6e7-88db-4179-a0a0-9a305a8758d5,,Neoadjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0055-C64_treatment,debbd9b6-5798-494e-82c7-44b0599f9d72,,released,,0,2019-04-04T13:39:17.305307-05:00,,,
HCM-BROD-0055-C64,a3b71c6f-77cc-4e80-8c1c-96cdf836b42e,3382e6e7-88db-4179-a0a0-9a305a8758d5,396.0,Adjuvant,151.0,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0055-C64_treatment10,e6ad058c-8b34-40ba-8ac4-b4438da48642,,released,Doxorubicin,1,2020-09-27T10:18:57.448599-05:00,Chemotherapy,Residual Disease,
HCM-BROD-0055-C64,a3b71c6f-77cc-4e80-8c1c-96cdf836b42e,3382e6e7-88db-4179-a0a0-9a305a8758d5,396.0,Adjuvant,151.0,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0055-C64_treatment9,f1518b83-2639-4c84-9ed0-47719f777a8b,,released,Cyclophosphamide,1,2020-09-27T10:18:57.448599-05:00,Chemotherapy,Residual Disease,
HCM-BROD-0415-C71,a42da11c-f1c5-4641-98f4-535c675d43d5,20ebb213-ae8d-4b68-ac38-9bf33c452af9,,,-7.0,2023-03-13T12:53:04.709475-05:00,HCM-BROD-0415-C71_treatment4,1855993a-951d-43f1-a794-ed89db21debd,,released,,1,2020-09-27T11:31:52.443671-05:00,"Surgery, NOS",Initial Diagnosis,
HCM-BROD-0415-C71,a42da11c-f1c5-4641-98f4-535c675d43d5,20ebb213-ae8d-4b68-ac38-9bf33c452af9,,Adjuvant,,2021-03-03T15:15:08.075155-06:00,HCM-BROD-0415-C71_treatment6,4386423b-fd61-4f7e-9516-0795b89a457d,,released,,0,2020-09-27T11:31:52.443671-05:00,"Radiation Therapy, NOS",Residual Disease,
HCM-BROD-0415-C71,a42da11c-f1c5-4641-98f4-535c675d43d5,20ebb213-ae8d-4b68-ac38-9bf33c452af9,,Adjuvant,,2021-03-03T15:15:08.075155-06:00,HCM-BROD-0415-C71_treatment2,5e5cee47-7d5b-45e9-a0ae-8d0a5d7952ec,,released,,1,2020-09-27T11:31:52.443671-05:00,Chemotherapy,Residual Disease,
HCM-BROD-0415-C71,a42da11c-f1c5-4641-98f4-535c675d43d5,20ebb213-ae8d-4b68-ac38-9bf33c452af9,,Adjuvant,,2021-03-03T15:15:08.075155-06:00,HCM-BROD-0415-C71_treatment5,67fdae04-3eb8-4da0-adcb-07ab1a2df826,,released,,0,2020-09-27T11:31:52.443671-05:00,Targeted Molecular Therapy,Residual Disease,
HCM-BROD-0415-C71,a42da11c-f1c5-4641-98f4-535c675d43d5,20ebb213-ae8d-4b68-ac38-9bf33c452af9,,Adjuvant,,2021-03-03T15:15:08.075155-06:00,HCM-BROD-0415-C71_treatment3,ace8afb7-3d43-4fa6-a1ef-d878ccbfa71b,,released,,0,2020-09-27T11:31:52.443671-05:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-BROD-0415-C71,a42da11c-f1c5-4641-98f4-535c675d43d5,20ebb213-ae8d-4b68-ac38-9bf33c452af9,,Neoadjuvant,,2021-03-03T15:15:08.075155-06:00,HCM-BROD-0415-C71_treatment,e1f22239-4227-4151-8527-c80666374284,,released,,0,2020-09-27T11:31:52.443671-05:00,,,
HCM-BROD-0485-C15,a43460d9-c2cd-4656-bc5a-d2ba54bad91d,10a1ce51-1113-4b8f-9e6e-aa923eedd342,,Neoadjuvant,33.0,2023-02-22T07:39:25.979291-06:00,HCM-BROD-0485-C15_treatment5,0c537502-32c0-4b7c-a854-8d34df7b859c,,released,,1,2021-12-21T13:38:25.074573-06:00,Chemotherapy,,FOLFOX
HCM-BROD-0485-C15,a43460d9-c2cd-4656-bc5a-d2ba54bad91d,10a1ce51-1113-4b8f-9e6e-aa923eedd342,259.0,Adjuvant,33.0,2023-02-22T07:39:25.979291-06:00,HCM-BROD-0485-C15_treatment9,236ec883-0164-4857-930b-c42545a8c9dd,,released,Oxaliplatin,1,2021-12-21T13:38:25.074573-06:00,Chemotherapy,Residual Disease,
HCM-BROD-0485-C15,a43460d9-c2cd-4656-bc5a-d2ba54bad91d,10a1ce51-1113-4b8f-9e6e-aa923eedd342,,Neoadjuvant,33.0,2023-02-22T07:39:25.979291-06:00,HCM-BROD-0485-C15_treatment4,240c6ec5-f9c4-4ba5-af13-55a533566990,,released,Oxaliplatin,1,2021-12-21T13:38:25.074573-06:00,Chemotherapy,,
HCM-BROD-0485-C15,a43460d9-c2cd-4656-bc5a-d2ba54bad91d,10a1ce51-1113-4b8f-9e6e-aa923eedd342,,Neoadjuvant,33.0,2023-02-22T07:39:25.979291-06:00,HCM-BROD-0485-C15_treatment6,534d66eb-a9a2-4478-a845-932bf50abc7b,,released,,1,2021-12-21T13:38:25.074573-06:00,Chemotherapy,,FOLFIRI
HCM-BROD-0485-C15,a43460d9-c2cd-4656-bc5a-d2ba54bad91d,10a1ce51-1113-4b8f-9e6e-aa923eedd342,665.0,Adjuvant,260.0,2023-02-22T07:39:25.979291-06:00,HCM-BROD-0485-C15_treatment14,5acda9b4-0ada-483c-ba2a-459c4738e4f3,,released,,1,2021-12-21T13:38:25.074573-06:00,Chemotherapy,Residual Disease,FOLFIRI
HCM-BROD-0485-C15,a43460d9-c2cd-4656-bc5a-d2ba54bad91d,10a1ce51-1113-4b8f-9e6e-aa923eedd342,259.0,Adjuvant,33.0,2023-02-22T07:39:25.979291-06:00,HCM-BROD-0485-C15_treatment8,73692a4f-7bb2-48bb-b1ef-7d0a3e881fd4,,released,Fluorouracil,1,2021-12-21T13:38:25.074573-06:00,Chemotherapy,Residual Disease,
HCM-BROD-0485-C15,a43460d9-c2cd-4656-bc5a-d2ba54bad91d,10a1ce51-1113-4b8f-9e6e-aa923eedd342,665.0,Adjuvant,260.0,2023-02-22T07:39:25.979291-06:00,HCM-BROD-0485-C15_treatment11,7d70a3d3-77dd-4256-bd0f-c82e2c7c46fb,,released,Leucovorin Calcium,1,2021-12-21T13:38:25.074573-06:00,Chemotherapy,Residual Disease,
HCM-BROD-0485-C15,a43460d9-c2cd-4656-bc5a-d2ba54bad91d,10a1ce51-1113-4b8f-9e6e-aa923eedd342,,Neoadjuvant,33.0,2023-02-22T07:39:25.979291-06:00,HCM-BROD-0485-C15_treatment3,9f24676f-bf49-4d1e-b473-f6a077470e7a,,released,Irinotecan,1,2021-12-21T13:38:25.074573-06:00,Chemotherapy,,
HCM-BROD-0485-C15,a43460d9-c2cd-4656-bc5a-d2ba54bad91d,10a1ce51-1113-4b8f-9e6e-aa923eedd342,259.0,Adjuvant,33.0,2023-02-22T07:39:25.979291-06:00,HCM-BROD-0485-C15_treatment7,ad28f5ac-0bc9-4898-bf4f-cb5fabb240b4,,released,Leucovorin Calcium,1,2021-12-21T13:38:25.074573-06:00,Chemotherapy,Residual Disease,
HCM-BROD-0485-C15,a43460d9-c2cd-4656-bc5a-d2ba54bad91d,10a1ce51-1113-4b8f-9e6e-aa923eedd342,665.0,Adjuvant,260.0,2023-02-22T07:39:25.979291-06:00,HCM-BROD-0485-C15_treatment13,afa13f20-493c-428e-aea1-5ca32286c845,,released,Irinotecan,1,2021-12-21T13:38:25.074573-06:00,Chemotherapy,Residual Disease,
HCM-BROD-0485-C15,a43460d9-c2cd-4656-bc5a-d2ba54bad91d,10a1ce51-1113-4b8f-9e6e-aa923eedd342,,Neoadjuvant,33.0,2023-02-22T07:39:25.979291-06:00,HCM-BROD-0485-C15_treatment,b615605a-a5e9-4be1-a4ab-8efe7b0e3abd,,released,Leucovorin Calcium,1,2021-12-21T13:38:25.074573-06:00,Chemotherapy,,
HCM-BROD-0485-C15,a43460d9-c2cd-4656-bc5a-d2ba54bad91d,10a1ce51-1113-4b8f-9e6e-aa923eedd342,259.0,Adjuvant,33.0,2023-02-22T07:39:25.979291-06:00,HCM-BROD-0485-C15_treatment10,bbf2a8c7-6361-41e5-8153-2d3c2f57045e,,released,,1,2021-12-21T13:38:25.074573-06:00,Chemotherapy,Residual Disease,FOLFOX
HCM-BROD-0485-C15,a43460d9-c2cd-4656-bc5a-d2ba54bad91d,10a1ce51-1113-4b8f-9e6e-aa923eedd342,,Adjuvant,,2023-02-22T07:39:25.979291-06:00,HCM-BROD-0485-C15_treatment17,bdf1a40d-3c86-458a-a0b0-d91c7d79d8d8,,released,,0,2021-12-21T13:38:25.074573-06:00,Targeted Molecular Therapy,Residual Disease,
HCM-BROD-0485-C15,a43460d9-c2cd-4656-bc5a-d2ba54bad91d,10a1ce51-1113-4b8f-9e6e-aa923eedd342,665.0,Adjuvant,260.0,2023-02-22T07:39:25.979291-06:00,HCM-BROD-0485-C15_treatment12,c27e471c-a858-45e8-b7e2-bdc3178a99e2,,released,Fluorouracil,1,2021-12-21T13:38:25.074573-06:00,Chemotherapy,Residual Disease,
HCM-BROD-0485-C15,a43460d9-c2cd-4656-bc5a-d2ba54bad91d,10a1ce51-1113-4b8f-9e6e-aa923eedd342,,Neoadjuvant,33.0,2023-02-22T07:39:25.979291-06:00,HCM-BROD-0485-C15_treatment2,caaef774-e106-47a0-aecd-4fc3e93f1e41,,released,Fluorouracil,1,2021-12-21T13:38:25.074573-06:00,Chemotherapy,,
HCM-BROD-0485-C15,a43460d9-c2cd-4656-bc5a-d2ba54bad91d,10a1ce51-1113-4b8f-9e6e-aa923eedd342,,,3.0,2023-03-13T13:15:59.653103-05:00,HCM-BROD-0485-C15_treatment16,d0e2797e-c8d1-4c79-b44c-d9ef70828354,,released,,1,2021-12-21T13:38:25.074573-06:00,"Surgery, NOS",Initial Diagnosis,
HCM-BROD-0485-C15,a43460d9-c2cd-4656-bc5a-d2ba54bad91d,10a1ce51-1113-4b8f-9e6e-aa923eedd342,,Adjuvant,,2023-02-22T07:39:25.979291-06:00,HCM-BROD-0485-C15_treatment18,e4552e35-187d-4b56-bb53-a1c492a5e9fd,,released,,0,2021-12-21T13:38:25.074573-06:00,"Radiation Therapy, NOS",Residual Disease,
HCM-BROD-0485-C15,a43460d9-c2cd-4656-bc5a-d2ba54bad91d,10a1ce51-1113-4b8f-9e6e-aa923eedd342,,Adjuvant,,2023-02-22T07:39:25.979291-06:00,HCM-BROD-0485-C15_treatment15,faab57da-4747-43da-9070-85a045a2ba87,,released,,0,2021-12-21T13:38:25.074573-06:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-WCMC-1292-C67,a4f7fe06-4bef-4e32-afce-f3fa80588aa4,45810202-33cd-42fb-a640-2d3ed6ceb4a3,1528.0,Adjuvant,1508.0,2025-04-07T17:13:09.336794-05:00,HCM-WCMC-1292-C67_treatment10,0547f9b0-b6c8-4dbd-ac57-71739d2ff433,,released,,1,2023-02-27T12:39:00.427328-06:00,"Radiation, Intensity-Modulated Radiotherapy",Residual Disease,
HCM-WCMC-1292-C67,a4f7fe06-4bef-4e32-afce-f3fa80588aa4,45810202-33cd-42fb-a640-2d3ed6ceb4a3,,,0.0,2025-04-07T17:13:09.336794-05:00,HCM-WCMC-1292-C67_treatment8,1135f166-dc4d-4318-83af-238f6ba83804,,released,,1,2023-02-27T12:39:00.427328-06:00,"Surgery, NOS",Initial Diagnosis,
HCM-WCMC-1292-C67,a4f7fe06-4bef-4e32-afce-f3fa80588aa4,45810202-33cd-42fb-a640-2d3ed6ceb4a3,953.0,Adjuvant,841.0,2025-04-07T17:13:09.336794-05:00,HCM-WCMC-1292-C67_treatment2,71e23152-93eb-4f85-9337-398a606d9d2d,,released,Gemcitabine,1,2023-02-27T12:39:00.427328-06:00,Chemotherapy,Residual Disease,
HCM-WCMC-1292-C67,a4f7fe06-4bef-4e32-afce-f3fa80588aa4,45810202-33cd-42fb-a640-2d3ed6ceb4a3,,Neoadjuvant,414.0,2025-04-07T17:13:09.336794-05:00,HCM-WCMC-1292-C67_treatment,7aa8cccf-8350-4bd4-bf87-86deef43fb66,,released,Pembrolizumab,1,2023-02-27T12:39:00.427328-06:00,Immunotherapy (Including Vaccines),,
HCM-WCMC-1292-C67,a4f7fe06-4bef-4e32-afce-f3fa80588aa4,45810202-33cd-42fb-a640-2d3ed6ceb4a3,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-WCMC-1292-C67_treatment9,7f34965b-809e-4ebf-a225-4b00bfe6caaf,,released,,0,2023-02-27T12:39:00.427328-06:00,Targeted Molecular Therapy,Residual Disease,
HCM-WCMC-1292-C67,a4f7fe06-4bef-4e32-afce-f3fa80588aa4,45810202-33cd-42fb-a640-2d3ed6ceb4a3,1695.0,Adjuvant,1240.0,2025-04-07T17:13:09.336794-05:00,HCM-WCMC-1292-C67_treatment5,891351f0-fe65-4f0b-8a4b-1b1d2a553d0b,Treatment Ongoing,released,Pembrolizumab,1,2023-02-27T12:39:00.427328-06:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-WCMC-1292-C67,a4f7fe06-4bef-4e32-afce-f3fa80588aa4,45810202-33cd-42fb-a640-2d3ed6ceb4a3,1457.0,Adjuvant,1240.0,2025-04-07T17:13:09.336794-05:00,HCM-WCMC-1292-C67_treatment6,df23d980-95c2-4a4e-83f0-e656acc39e7f,,released,Enfortumab Vedotin,1,2023-02-27T12:39:00.427328-06:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-WCMC-1292-C67,a4f7fe06-4bef-4e32-afce-f3fa80588aa4,45810202-33cd-42fb-a640-2d3ed6ceb4a3,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-WCMC-1292-C67_treatment4,eb9433f8-d4df-4c92-9cc5-f2bd9accef7d,,released,,0,2023-02-27T12:39:00.427328-06:00,Hormone Therapy,Residual Disease,
HCM-WCMC-1292-C67,a4f7fe06-4bef-4e32-afce-f3fa80588aa4,45810202-33cd-42fb-a640-2d3ed6ceb4a3,1765.0,Adjuvant,1534.0,2025-04-07T17:13:09.336794-05:00,HCM-WCMC-1292-C67_treatment7,ed1e6362-4c89-45e5-a68c-4423de8f114f,Treatment Ongoing,released,Sacituzumab Govitecan,1,2023-02-27T12:39:00.427328-06:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-WCMC-1292-C67,a4f7fe06-4bef-4e32-afce-f3fa80588aa4,45810202-33cd-42fb-a640-2d3ed6ceb4a3,953.0,Adjuvant,841.0,2025-04-07T17:13:09.336794-05:00,HCM-WCMC-1292-C67_treatment3,fd798d4b-c436-4eda-af64-2b180fe21783,,released,Carboplatin,1,2023-02-27T12:39:00.427328-06:00,Chemotherapy,Residual Disease,
HCM-SANG-1311-C18,a54e76e9-7d37-4f9d-9b63-f2fa25f1b1b1,c9bb3885-f91a-4c88-ae92-327a19b7fa29,,Neoadjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-SANG-1311-C18_treatment,f269429a-085f-4277-b9ec-b5d9c1ea10c6,,released,,0,2023-02-27T12:16:27.111036-06:00,,,
HCM-CSHL-0907-C50,a578c191-9220-4d93-a772-9415a5733913,df4b3412-f981-4c87-b2a7-a892b6abb23d,,,64.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0907-C50_treatment2,052b37ab-4dbc-4a42-805c-1000ce05502c,,released,,1,2021-12-21T14:38:27.851732-06:00,"Surgery, NOS",Initial Diagnosis,
HCM-CSHL-0907-C50,a578c191-9220-4d93-a772-9415a5733913,df4b3412-f981-4c87-b2a7-a892b6abb23d,,,515.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0907-C50_treatment3,2ded8c5a-d58c-4769-a34b-6cda1b2b0660,,released,,1,2021-12-21T14:38:27.851732-06:00,"Surgery, NOS",Initial Diagnosis,
HCM-CSHL-0907-C50,a578c191-9220-4d93-a772-9415a5733913,df4b3412-f981-4c87-b2a7-a892b6abb23d,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0907-C50_treatment5,42c277a9-4e18-4801-9543-54dd54e6fddc,,released,,0,2021-12-21T14:38:27.851732-06:00,"Radiation Therapy, NOS",Residual Disease,
HCM-CSHL-0907-C50,a578c191-9220-4d93-a772-9415a5733913,df4b3412-f981-4c87-b2a7-a892b6abb23d,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0907-C50_treatment4,9df204bb-bf73-4978-8abe-4c7368ee56b7,,released,,0,2021-12-21T14:38:27.851732-06:00,"Pharmaceutical Therapy, NOS",Residual Disease,
HCM-CSHL-0907-C50,a578c191-9220-4d93-a772-9415a5733913,df4b3412-f981-4c87-b2a7-a892b6abb23d,,Prevention,,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0907-C50_treatment6,f488289f-f4f3-4d37-8d5e-46bf291c842e,,released,,0,2021-12-21T14:38:27.851732-06:00,Hormone Therapy,,
HCM-CSHL-0907-C50,a578c191-9220-4d93-a772-9415a5733913,df4b3412-f981-4c87-b2a7-a892b6abb23d,,Neoadjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0907-C50_treatment,fb9533d4-28cc-4f10-b96f-5444fee51238,,released,,0,2021-12-21T14:38:27.851732-06:00,,,
HCM-CSHL-0907-C50,a578c191-9220-4d93-a772-9415a5733913,e5527439-932f-4942-bcc8-4b6cf428ae40,,Prevention,,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0907-C50_treatment7,d15bc90b-97d7-4646-b85b-5ae2ee8e828f,,released,,0,2023-02-28T11:40:01.459982-06:00,Hormone Therapy,,
HCM-CSHL-0162-C19,a5d2e190-acdc-4bd9-be42-bd8c17bfa205,795d1110-a5ba-4afe-9a12-82cb260c2da6,,Neoadjuvant,,2021-07-12T12:25:55.528644-05:00,HCM-CSHL-0162-C19_treatment,31242780-0ad4-43a6-ba88-ac1b05d79a15,,released,,0,2020-09-27T13:02:32.687727-05:00,,,
HCM-CSHL-0162-C19,a5d2e190-acdc-4bd9-be42-bd8c17bfa205,795d1110-a5ba-4afe-9a12-82cb260c2da6,,Adjuvant,,2023-03-13T13:19:09.535084-05:00,HCM-CSHL-0162-C19_treatment3,5cb662c4-7dab-4048-add3-1dbae6f4ffd7,,released,,0,2020-09-27T13:02:32.687727-05:00,"Pharmaceutical Therapy, NOS",Residual Disease,
HCM-CSHL-0162-C19,a5d2e190-acdc-4bd9-be42-bd8c17bfa205,795d1110-a5ba-4afe-9a12-82cb260c2da6,,Adjuvant,,2023-03-13T13:19:09.535084-05:00,HCM-CSHL-0162-C19_treatment4,75eb5a7a-83d1-43e6-a110-9b7d9d207042,,released,,0,2020-09-27T13:02:32.687727-05:00,"Radiation Therapy, NOS",Residual Disease,
HCM-CSHL-0162-C19,a5d2e190-acdc-4bd9-be42-bd8c17bfa205,795d1110-a5ba-4afe-9a12-82cb260c2da6,,,119.0,2023-03-13T13:19:09.535084-05:00,HCM-CSHL-0162-C19_treatment2,92703657-dfef-46a6-b0e3-75d14e9b58d8,,released,,1,2020-09-27T13:02:32.687727-05:00,"Surgery, NOS",Initial Diagnosis,
HCM-CSHL-0393-C18,a691cd0c-1878-47a6-8a0f-37e4fe12d20a,46abf0b5-e1e2-4424-b28e-af0cdaad0302,121.0,Adjuvant,49.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0393-C18_treatment4,0156c429-85dc-4e5d-bb69-5a639acd5236,,released,,1,2021-12-21T14:05:37.466399-06:00,"Radiation, Intensity-Modulated Radiotherapy",Residual Disease,
HCM-CSHL-0393-C18,a691cd0c-1878-47a6-8a0f-37e4fe12d20a,46abf0b5-e1e2-4424-b28e-af0cdaad0302,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0393-C18_treatment3,5c15c0b6-7c68-4c8e-8df0-028db5dba3a8,,released,,0,2021-12-21T14:05:37.466399-06:00,"Pharmaceutical Therapy, NOS",Residual Disease,
HCM-CSHL-0393-C18,a691cd0c-1878-47a6-8a0f-37e4fe12d20a,46abf0b5-e1e2-4424-b28e-af0cdaad0302,,Neoadjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0393-C18_treatment,dea1c984-5857-4ed8-a342-8475c7e96c35,,released,,0,2021-12-21T14:05:37.466399-06:00,,,
HCM-CSHL-0393-C18,a691cd0c-1878-47a6-8a0f-37e4fe12d20a,46abf0b5-e1e2-4424-b28e-af0cdaad0302,,,49.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0393-C18_treatment2,f432c59f-6fbc-488e-ba9e-b5fa36d482c1,,released,,1,2021-12-21T14:05:37.466399-06:00,"Surgery, NOS",Initial Diagnosis,
HCM-EXPT-1042-C50,a699ebed-f444-43cc-861f-3595ac15dda5,2d9ee042-9c1a-43ea-a38d-d0ca460ea574,,Neoadjuvant,,2025-10-08T12:38:06.952582-05:00,HCM-EXPT-1042-C50_treatment,3e7e2766-5388-4a2f-af94-df20c6f6d2cd,,released,,0,2021-12-21T15:00:03.353272-06:00,,,
HCM-EXPT-1223-C15,a6f4e42f-e2ae-4391-8ea1-5fb7bd267d4e,6185d56a-4b86-4439-a8cb-0c27deed13d6,,Neoadjuvant,,2025-10-08T12:39:14.406630-05:00,HCM-EXPT-1223-C15_treatment,5d916493-0139-44ef-bf38-276bbfe62087,,released,,0,2023-02-24T13:47:04.368085-06:00,,,
HCM-CSHL-0853-C56,a7364c7c-cc66-468d-8a6e-11cc58adf3d6,8c566440-c9b8-445a-b171-6f8eaf76e055,,,0.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0853-C56_treatment2,4666ff5f-dd2e-4234-9eef-ff33ebbe246f,,released,,1,2021-12-21T14:34:26.314279-06:00,"Surgery, NOS",Initial Diagnosis,
HCM-CSHL-0853-C56,a7364c7c-cc66-468d-8a6e-11cc58adf3d6,8c566440-c9b8-445a-b171-6f8eaf76e055,,Neoadjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0853-C56_treatment,bcc4e6b6-2e8b-40db-86b5-010ca4912d72,,released,,0,2021-12-21T14:34:26.314279-06:00,,,
HCM-WCMC-0945-C54,a826f214-8322-443e-b8a9-8495c5d81b2f,1ab21429-f684-4560-8bea-33d233704799,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-WCMC-0945-C54_treatment4,07282310-076b-42ca-b0ca-86b86967f44c,,released,,0,2022-09-16T08:11:08.252347-05:00,"Radiation Therapy, NOS",Residual Disease,
HCM-WCMC-0945-C54,a826f214-8322-443e-b8a9-8495c5d81b2f,1ab21429-f684-4560-8bea-33d233704799,,,26.0,2025-04-07T17:13:09.336794-05:00,HCM-WCMC-0945-C54_treatment2,15d4a769-3a28-4141-944b-f98a761c8fe0,,released,,1,2022-09-16T08:11:08.252347-05:00,"Surgery, NOS",Initial Diagnosis,
HCM-WCMC-0945-C54,a826f214-8322-443e-b8a9-8495c5d81b2f,1ab21429-f684-4560-8bea-33d233704799,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-WCMC-0945-C54_treatment3,a2f322ef-cc0b-4ec9-b95e-eeab1553ba4a,,released,,0,2022-09-16T08:11:08.252347-05:00,"Pharmaceutical Therapy, NOS",Residual Disease,
HCM-WCMC-0945-C54,a826f214-8322-443e-b8a9-8495c5d81b2f,1ab21429-f684-4560-8bea-33d233704799,,Neoadjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-WCMC-0945-C54_treatment,a95911e4-7ff6-45ee-aa9b-5b88b4926a62,,released,,0,2022-09-16T08:11:08.252347-05:00,,,
HCM-SANG-0517-C20,a8408536-bd05-4a7d-8792-8390cceca6ae,2893234e-01b4-41e5-8eb0-21cb662eb853,,Neoadjuvant,,2023-07-13T10:35:44.371881-05:00,HCM-SANG-0517-C20_treatment,f85edbb8-0483-4de8-a59d-07de2c90e0b5,,released,,0,2021-12-21T15:11:39.956181-06:00,,,
HCM-CSHL-0698-C06,a870c27c-b854-4c7e-81c3-9a3d66d4d778,a5419929-de7b-4c87-b417-695e93343d74,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0698-C06_treatment4,a78be499-9052-474b-8832-58a20157fe9f,,released,,0,2021-12-21T14:18:22.070341-06:00,"Radiation Therapy, NOS",Residual Disease,
HCM-CSHL-0698-C06,a870c27c-b854-4c7e-81c3-9a3d66d4d778,a5419929-de7b-4c87-b417-695e93343d74,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0698-C06_treatment3,c907fc67-4635-4fff-97f6-a95448fcab4c,,released,,0,2021-12-21T14:18:22.070341-06:00,"Pharmaceutical Therapy, NOS",Residual Disease,
HCM-CSHL-0698-C06,a870c27c-b854-4c7e-81c3-9a3d66d4d778,a5419929-de7b-4c87-b417-695e93343d74,,Neoadjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0698-C06_treatment,f36a358a-39ed-4587-a264-434f2d36e7fa,,released,,0,2021-12-21T14:18:22.070341-06:00,,,
HCM-CSHL-0698-C06,a870c27c-b854-4c7e-81c3-9a3d66d4d778,a5419929-de7b-4c87-b417-695e93343d74,,,0.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0698-C06_treatment2,fc44be00-83a9-49c4-b1f3-9c982b3f240b,,released,,1,2021-12-21T14:18:22.070341-06:00,"Surgery, NOS",Initial Diagnosis,
HCM-SANG-0311-C15,a881a43e-42ef-48ba-9b10-456792261a3a,ac8b4842-7b4e-4275-9469-ca5927dddc8d,,Neoadjuvant,,2023-07-13T10:35:44.371881-05:00,HCM-SANG-0311-C15_treatment,dba1b702-a969-435e-b613-670554fb05f6,,released,,0,2021-12-21T15:11:14.586990-06:00,,,
HCM-BROD-1117-C56,a8856f5a-594e-4ce6-86f2-4ddc5ec46df5,0ea4d1d4-d11a-44ae-af64-1fbe2ae38a10,156.0,Adjuvant,20.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-1117-C56_treatment2,4ea2ef35-fdf9-4ba4-8244-fb3241a94618,,released,Carboplatin,1,2021-12-21T14:01:02.858391-06:00,Chemotherapy,Residual Disease,
HCM-BROD-1117-C56,a8856f5a-594e-4ce6-86f2-4ddc5ec46df5,0ea4d1d4-d11a-44ae-af64-1fbe2ae38a10,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-BROD-1117-C56_treatment4,560a249d-8de6-481c-826e-7607ece4a67c,,released,,0,2021-12-21T14:01:02.858391-06:00,Hormone Therapy,Residual Disease,
HCM-BROD-1117-C56,a8856f5a-594e-4ce6-86f2-4ddc5ec46df5,0ea4d1d4-d11a-44ae-af64-1fbe2ae38a10,156.0,Adjuvant,20.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-1117-C56_treatment3,5c62fe31-2a8e-42ca-a9fc-723761471c78,,released,Paclitaxel,1,2021-12-21T14:01:02.858391-06:00,Chemotherapy,Residual Disease,
HCM-BROD-1117-C56,a8856f5a-594e-4ce6-86f2-4ddc5ec46df5,0ea4d1d4-d11a-44ae-af64-1fbe2ae38a10,,Neoadjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-BROD-1117-C56_treatment,63f574ae-f314-4e1e-a634-07fe7ceeb1d6,,released,,0,2021-12-21T14:01:02.858391-06:00,,,
HCM-BROD-1117-C56,a8856f5a-594e-4ce6-86f2-4ddc5ec46df5,0ea4d1d4-d11a-44ae-af64-1fbe2ae38a10,,,0.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-1117-C56_treatment6,764a7f66-ba63-4628-970f-69c7192f2477,,released,,1,2021-12-21T14:01:02.858391-06:00,"Surgery, NOS",Initial Diagnosis,
HCM-BROD-1117-C56,a8856f5a-594e-4ce6-86f2-4ddc5ec46df5,0ea4d1d4-d11a-44ae-af64-1fbe2ae38a10,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-BROD-1117-C56_treatment7,813d955d-c9d0-46c9-ab29-015010020757,,released,,0,2021-12-21T14:01:02.858391-06:00,Targeted Molecular Therapy,Residual Disease,
HCM-BROD-1117-C56,a8856f5a-594e-4ce6-86f2-4ddc5ec46df5,0ea4d1d4-d11a-44ae-af64-1fbe2ae38a10,287.0,Adjuvant,268.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-1117-C56_treatment5,99d6fdf5-6b53-40cb-bb91-59750a71465c,,released,Unknown,1,2021-12-21T14:01:02.858391-06:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-BROD-1117-C56,a8856f5a-594e-4ce6-86f2-4ddc5ec46df5,0ea4d1d4-d11a-44ae-af64-1fbe2ae38a10,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-BROD-1117-C56_treatment8,e84fab36-aa66-46ea-a474-0ef42b2c33f1,,released,,0,2021-12-21T14:01:02.858391-06:00,"Radiation Therapy, NOS",Residual Disease,
HCM-EXPT-1115-C43,a8b4b97d-a95a-4190-a35d-55a01de18bfe,c075a728-6721-41c1-940d-4507a01b43db,,Neoadjuvant,,2025-10-08T12:38:28.988690-05:00,HCM-EXPT-1115-C43_treatment,e9b12066-ef6d-4732-a287-04d558d4ab63,,released,,0,2021-12-21T15:05:06.351037-06:00,,,
HCM-EXPT-1057-C50,a936b054-5baa-4582-83d5-4b9e94892981,b31fe712-2fc4-47aa-a112-cdabd5e54fe4,,Neoadjuvant,,2025-10-08T12:38:28.988690-05:00,HCM-EXPT-1057-C50_treatment2,130bcc4c-4130-419d-87c5-81f32d67b5e2,,released,,1,2021-12-21T15:01:54.554765-06:00,Hormone Therapy,,
HCM-EXPT-1057-C50,a936b054-5baa-4582-83d5-4b9e94892981,b31fe712-2fc4-47aa-a112-cdabd5e54fe4,,Neoadjuvant,,2025-10-08T12:38:28.988690-05:00,HCM-EXPT-1057-C50_treatment,298cec34-bb9e-4d9c-9d75-62d6ba22cfc6,,released,,1,2021-12-21T15:01:54.554765-06:00,Chemotherapy,,
HCM-EXPT-1057-C50,a936b054-5baa-4582-83d5-4b9e94892981,b31fe712-2fc4-47aa-a112-cdabd5e54fe4,,Neoadjuvant,,2025-10-08T12:38:28.988690-05:00,HCM-EXPT-1057-C50_treatment3,a47b5086-8935-4ac9-b0df-0073b45e66d2,,released,,1,2021-12-21T15:01:54.554765-06:00,"Radiation Therapy, NOS",,
HCM-CSHL-0852-C76,a947e983-07c7-4bdf-9b3b-e6e72b6c41e5,5e8f7135-a329-43de-b536-978f1d81c537,,,0.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0852-C76_treatment2,613fee0f-c545-4b83-9867-ce6afac50926,,released,,1,2021-12-21T14:34:17.055382-06:00,"Surgery, NOS",Initial Diagnosis,
HCM-CSHL-0852-C76,a947e983-07c7-4bdf-9b3b-e6e72b6c41e5,5e8f7135-a329-43de-b536-978f1d81c537,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0852-C76_treatment3,8fe065c5-0352-48dd-8574-2f31b4e1b2be,,released,,0,2021-12-21T14:34:17.055382-06:00,"Pharmaceutical Therapy, NOS",Residual Disease,
HCM-CSHL-0852-C76,a947e983-07c7-4bdf-9b3b-e6e72b6c41e5,5e8f7135-a329-43de-b536-978f1d81c537,,Neoadjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0852-C76_treatment,d406be06-8a60-43c3-b9e1-15f978f346ed,,released,,0,2021-12-21T14:34:17.055382-06:00,,,
HCM-CSHL-0740-C18,aa0d437f-845b-43af-98e9-c7e5c3b55d33,15e0c3da-4c20-4570-aa4a-42184c78ac35,,Maintenance Therapy,,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0740-C18_treatment17,07b4491b-0f68-4bf9-bf53-cc50ba8a897b,Progressive Disease,released,Leucovorin Calcium,1,2021-12-21T14:21:18.708703-06:00,,,
HCM-CSHL-0740-C18,aa0d437f-845b-43af-98e9-c7e5c3b55d33,15e0c3da-4c20-4570-aa4a-42184c78ac35,,Maintenance Therapy,,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0740-C18_treatment13,1096530c-e559-4926-a09a-ada54ca71527,Progressive Disease,released,Bevacizumab,1,2021-12-21T14:21:18.708703-06:00,,,
HCM-CSHL-0740-C18,aa0d437f-845b-43af-98e9-c7e5c3b55d33,15e0c3da-4c20-4570-aa4a-42184c78ac35,,Maintenance Therapy,,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0740-C18_treatment15,26ab7212-0988-4b1f-8dfa-18dd3ba3d643,Progressive Disease,released,Oxaliplatin,1,2021-12-21T14:21:18.708703-06:00,,,
HCM-CSHL-0740-C18,aa0d437f-845b-43af-98e9-c7e5c3b55d33,15e0c3da-4c20-4570-aa4a-42184c78ac35,,Maintenance Therapy,,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0740-C18_treatment19,68284556-eb23-4583-8119-53cd1baca12c,Progressive Disease,released,,1,2021-12-21T14:21:18.708703-06:00,,,FOLFOX
HCM-CSHL-0740-C18,aa0d437f-845b-43af-98e9-c7e5c3b55d33,15e0c3da-4c20-4570-aa4a-42184c78ac35,,Maintenance Therapy,,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0740-C18_treatment18,70e7bcd6-500e-4fab-98e1-ad570a3406e3,Progressive Disease,released,Fluorouracil,1,2021-12-21T14:21:18.708703-06:00,,,
HCM-CSHL-0740-C18,aa0d437f-845b-43af-98e9-c7e5c3b55d33,15e0c3da-4c20-4570-aa4a-42184c78ac35,,Maintenance Therapy,,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0740-C18_treatment14,c6cb7f37-96e7-41b9-980a-fce10b41ae00,Progressive Disease,released,Irinotecan,1,2021-12-21T14:21:18.708703-06:00,,,
HCM-CSHL-0740-C18,aa0d437f-845b-43af-98e9-c7e5c3b55d33,15e0c3da-4c20-4570-aa4a-42184c78ac35,,Maintenance Therapy,,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0740-C18_treatment16,e1d9313d-5888-4a00-8df3-eef64525b769,Progressive Disease,released,Xeloda,1,2021-12-21T14:21:18.708703-06:00,,,
HCM-CSHL-0740-C18,aa0d437f-845b-43af-98e9-c7e5c3b55d33,bf45b491-ff56-44a4-ae3c-0a7d72b700fb,245.0,Adjuvant,70.0,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0740-C18_treatment4,12b6b7e2-beb5-4f11-9115-ad22c1211f4d,,released,Oxaliplatin,1,2021-12-21T14:21:18.708703-06:00,Chemotherapy,Residual Disease,
HCM-CSHL-0740-C18,aa0d437f-845b-43af-98e9-c7e5c3b55d33,bf45b491-ff56-44a4-ae3c-0a7d72b700fb,,,17.0,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0740-C18_treatment9,296f0e0e-2b04-452f-84dc-f9e3677bdead,,released,,1,2021-12-21T14:21:18.708703-06:00,"Surgery, NOS",Initial Diagnosis,
HCM-CSHL-0740-C18,aa0d437f-845b-43af-98e9-c7e5c3b55d33,bf45b491-ff56-44a4-ae3c-0a7d72b700fb,,Neoadjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0740-C18_treatment,2b7725b0-5973-455c-b659-b1414d0fa1d8,,released,,0,2021-12-21T14:21:18.708703-06:00,,,
HCM-CSHL-0740-C18,aa0d437f-845b-43af-98e9-c7e5c3b55d33,bf45b491-ff56-44a4-ae3c-0a7d72b700fb,245.0,Adjuvant,70.0,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0740-C18_treatment5,37f3d3b9-29b2-4e36-b4b4-cab3a0122f9d,,released,,1,2021-12-21T14:21:18.708703-06:00,Chemotherapy,Residual Disease,FOLFOX
HCM-CSHL-0740-C18,aa0d437f-845b-43af-98e9-c7e5c3b55d33,bf45b491-ff56-44a4-ae3c-0a7d72b700fb,,Adjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0740-C18_treatment8,4abf7498-c6a9-44a2-93fe-917beb4671ce,,released,,0,2021-12-21T14:21:18.708703-06:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-CSHL-0740-C18,aa0d437f-845b-43af-98e9-c7e5c3b55d33,bf45b491-ff56-44a4-ae3c-0a7d72b700fb,791.0,Adjuvant,714.0,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0740-C18_treatment7,684c4e73-f8ab-4552-ae28-906d13e4bb5a,,released,Irinotecan,1,2021-12-21T14:21:18.708703-06:00,Chemotherapy,Residual Disease,
HCM-CSHL-0740-C18,aa0d437f-845b-43af-98e9-c7e5c3b55d33,bf45b491-ff56-44a4-ae3c-0a7d72b700fb,245.0,Adjuvant,70.0,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0740-C18_treatment3,687520d5-34f4-46d6-b5f7-7d6b2bd57928,,released,Fluorouracil,1,2021-12-21T14:21:18.708703-06:00,Chemotherapy,Residual Disease,
HCM-CSHL-0740-C18,aa0d437f-845b-43af-98e9-c7e5c3b55d33,bf45b491-ff56-44a4-ae3c-0a7d72b700fb,791.0,Adjuvant,593.0,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0740-C18_treatment11,76d80df0-dcb4-4919-969d-7c85df9709d8,,released,Bevacizumab,1,2021-12-21T14:21:18.708703-06:00,Targeted Molecular Therapy,Residual Disease,
HCM-CSHL-0740-C18,aa0d437f-845b-43af-98e9-c7e5c3b55d33,bf45b491-ff56-44a4-ae3c-0a7d72b700fb,245.0,Adjuvant,70.0,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0740-C18_treatment2,aa86736e-ff44-4d3e-80de-7ea730c5327f,,released,Leucovorin Calcium,1,2021-12-21T14:21:18.708703-06:00,Chemotherapy,Residual Disease,
HCM-CSHL-0740-C18,aa0d437f-845b-43af-98e9-c7e5c3b55d33,bf45b491-ff56-44a4-ae3c-0a7d72b700fb,706.0,Adjuvant,343.0,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0740-C18_treatment6,c44e987c-1651-4c68-bc4e-5296778c3a4f,,released,Capecitabine,1,2021-12-21T14:21:18.708703-06:00,Chemotherapy,Residual Disease,
HCM-CSHL-0740-C18,aa0d437f-845b-43af-98e9-c7e5c3b55d33,bf45b491-ff56-44a4-ae3c-0a7d72b700fb,984.0,Adjuvant,969.0,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0740-C18_treatment12,ca55386e-aea0-49c9-a02f-e03993e0f6fa,,released,,1,2021-12-21T14:21:18.708703-06:00,"Radiation, 3D Conformal",Residual Disease,
HCM-CSHL-0740-C18,aa0d437f-845b-43af-98e9-c7e5c3b55d33,bf45b491-ff56-44a4-ae3c-0a7d72b700fb,,,1218.0,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0740-C18_treatment10,f9fe9fb0-4137-4a89-afb1-264d7fb2cd48,,released,,1,2021-12-21T14:21:18.708703-06:00,"Surgery, NOS",Initial Diagnosis,
HCM-BROD-0416-C71,aa17554b-2291-4947-9858-eadb82704f9b,de976004-e763-4759-9a7a-5b24a7f4aafe,,Adjuvant,,2021-07-12T12:25:55.528644-05:00,HCM-BROD-0416-C71_treatment3,0d167298-0b5b-4039-be6b-12b1af520a76,,released,,0,2020-07-31T09:29:09.924872-05:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-BROD-0416-C71,aa17554b-2291-4947-9858-eadb82704f9b,de976004-e763-4759-9a7a-5b24a7f4aafe,185.0,Adjuvant,127.0,2021-07-12T12:25:55.528644-05:00,HCM-BROD-0416-C71_treatment5,38fa97b6-7f4e-4135-9cfa-580c912d4d03,,released,Bevacizumab,1,2020-07-31T09:29:09.924872-05:00,Targeted Molecular Therapy,Residual Disease,
HCM-BROD-0416-C71,aa17554b-2291-4947-9858-eadb82704f9b,de976004-e763-4759-9a7a-5b24a7f4aafe,85.0,Adjuvant,37.0,2021-07-12T12:25:55.528644-05:00,HCM-BROD-0416-C71_treatment2,58bb6e95-fcc8-4d37-b58e-19c493f3d2a7,,released,Temozolomide,1,2020-07-31T09:29:09.924872-05:00,Chemotherapy,Residual Disease,
HCM-BROD-0416-C71,aa17554b-2291-4947-9858-eadb82704f9b,de976004-e763-4759-9a7a-5b24a7f4aafe,85.0,Adjuvant,37.0,2023-07-07T13:17:11.385689-05:00,HCM-BROD-0416-C71_treatment6,63eb748d-e859-4dc7-adcd-3596698bb538,,released,,1,2020-07-31T09:29:09.924872-05:00,"Radiation Therapy, NOS",Residual Disease,
HCM-BROD-0416-C71,aa17554b-2291-4947-9858-eadb82704f9b,de976004-e763-4759-9a7a-5b24a7f4aafe,,Neoadjuvant,,2021-07-12T12:25:55.528644-05:00,HCM-BROD-0416-C71_treatment,8f826653-fba9-4bec-9781-3d7cb518ae26,,released,,0,2020-07-31T09:29:09.924872-05:00,,,
HCM-BROD-0416-C71,aa17554b-2291-4947-9858-eadb82704f9b,de976004-e763-4759-9a7a-5b24a7f4aafe,,,-6.0,2023-02-27T12:22:45.056235-06:00,HCM-BROD-0416-C71_treatment4,a2ce9a4c-47d2-4598-b7aa-016a6e4fbb4b,,released,,1,2020-07-31T09:29:09.924872-05:00,"Surgery, NOS",Initial Diagnosis,
HCM-CSHL-0809-C54,aa72adc9-e4ae-4d38-a1ff-5cdac2c3fc06,08819f7e-9910-4910-9013-b3cad97b6131,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0809-C54_treatment4,0c9d9eec-54ad-4aa7-a892-1642b31277d9,,released,,0,2021-12-21T14:26:49.793201-06:00,Hormone Therapy,Residual Disease,
HCM-CSHL-0809-C54,aa72adc9-e4ae-4d38-a1ff-5cdac2c3fc06,08819f7e-9910-4910-9013-b3cad97b6131,,,0.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0809-C54_treatment6,479f0b19-741b-4694-a38a-36f9c0e6c9e7,,released,,1,2021-12-21T14:26:49.793201-06:00,"Surgery, NOS",Initial Diagnosis,
HCM-CSHL-0809-C54,aa72adc9-e4ae-4d38-a1ff-5cdac2c3fc06,08819f7e-9910-4910-9013-b3cad97b6131,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0809-C54_treatment7,792c7d23-d4de-4580-86b4-5637995c6702,,released,,0,2021-12-21T14:26:49.793201-06:00,Targeted Molecular Therapy,Residual Disease,
HCM-CSHL-0809-C54,aa72adc9-e4ae-4d38-a1ff-5cdac2c3fc06,08819f7e-9910-4910-9013-b3cad97b6131,,Neoadjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0809-C54_treatment,8414af98-aba3-4591-8626-9ca26ff378af,,released,,0,2021-12-21T14:26:49.793201-06:00,,,
HCM-CSHL-0809-C54,aa72adc9-e4ae-4d38-a1ff-5cdac2c3fc06,08819f7e-9910-4910-9013-b3cad97b6131,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0809-C54_treatment8,96866583-25a7-40d7-839c-16138a1ed0c3,,released,,0,2021-12-21T14:26:49.793201-06:00,"Radiation Therapy, NOS",Residual Disease,
HCM-CSHL-0809-C54,aa72adc9-e4ae-4d38-a1ff-5cdac2c3fc06,08819f7e-9910-4910-9013-b3cad97b6131,146.0,Adjuvant,42.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0809-C54_treatment3,ad85e3cc-cba6-4138-bb67-8de0bbd8f3b1,,released,Paclitaxel,1,2021-12-21T14:26:49.793201-06:00,Chemotherapy,Residual Disease,
HCM-CSHL-0809-C54,aa72adc9-e4ae-4d38-a1ff-5cdac2c3fc06,08819f7e-9910-4910-9013-b3cad97b6131,146.0,Adjuvant,42.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0809-C54_treatment2,c67c63fe-13f5-44a2-b606-570b2ef51748,,released,Carboplatin,1,2021-12-21T14:26:49.793201-06:00,Chemotherapy,Residual Disease,
HCM-CSHL-0809-C54,aa72adc9-e4ae-4d38-a1ff-5cdac2c3fc06,08819f7e-9910-4910-9013-b3cad97b6131,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0809-C54_treatment5,e0c715f9-d3f2-4655-8bde-9fb9f22d89b6,,released,,0,2021-12-21T14:26:49.793201-06:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-CSHL-0467-C56,aa78feca-4396-4e6b-8621-84fafedf29c9,f221d11e-9aab-434c-a164-c44d3ac60f38,,Adjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0467-C56_treatment7,34d6c205-a038-40eb-8706-bf60f8c5cdc8,,released,,0,2020-10-08T14:39:34.026726-05:00,"Radiation Therapy, NOS",Residual Disease,
HCM-CSHL-0467-C56,aa78feca-4396-4e6b-8621-84fafedf29c9,f221d11e-9aab-434c-a164-c44d3ac60f38,,Neoadjuvant,-45.0,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0467-C56_treatment,35b4225a-d28f-4334-8595-ee9b68f547ea,,released,Acetylcysteine,1,2020-10-08T14:39:34.026726-05:00,Chemotherapy,,
HCM-CSHL-0467-C56,aa78feca-4396-4e6b-8621-84fafedf29c9,f221d11e-9aab-434c-a164-c44d3ac60f38,,Adjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0467-C56_treatment3,3d315175-a56c-4c05-9a57-f1e56f1226f0,,released,,0,2020-10-08T14:39:34.026726-05:00,Hormone Therapy,Residual Disease,
HCM-CSHL-0467-C56,aa78feca-4396-4e6b-8621-84fafedf29c9,f221d11e-9aab-434c-a164-c44d3ac60f38,,Adjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0467-C56_treatment6,bfbcf6a2-1a79-401f-86a9-46274c748055,,released,,0,2020-10-08T14:39:34.026726-05:00,Targeted Molecular Therapy,Residual Disease,
HCM-CSHL-0467-C56,aa78feca-4396-4e6b-8621-84fafedf29c9,f221d11e-9aab-434c-a164-c44d3ac60f38,,,51.0,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0467-C56_treatment5,c0b7fbe3-f0dc-45fa-8193-dbb3d8dbcd2c,,released,,1,2020-10-08T14:39:34.026726-05:00,"Surgery, NOS",Initial Diagnosis,
HCM-CSHL-0467-C56,aa78feca-4396-4e6b-8621-84fafedf29c9,f221d11e-9aab-434c-a164-c44d3ac60f38,,Adjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0467-C56_treatment2,c4eadd49-36e8-4603-b21d-078131477709,,released,,1,2020-10-08T14:39:34.026726-05:00,Chemotherapy,Residual Disease,
HCM-EXPT-0987-C50,aaa77a52-da6a-4c72-b190-6a5bd6863b62,0e8fbf38-0f7b-4680-a36b-58abcd37369f,,Neoadjuvant,,2025-10-08T12:37:21.548354-05:00,HCM-EXPT-0987-C50_treatment,9647d076-1459-4215-818d-76e35715048b,,released,,0,2021-12-21T14:50:41.273379-06:00,,,
HCM-SANG-0292-C15,aaf31083-8293-4e48-92b0-37d294c0cc64,333e1d27-ca99-40b8-9866-14d4fc2fcaa7,,Neoadjuvant,98.0,2023-03-13T12:53:16.971018-05:00,HCM-SANG-0292-C15_treatment4,7840d1f3-06e7-41ac-8cde-ae4167500ecf,,released,,1,2021-07-06T11:32:00.685812-05:00,Chemotherapy,,EOX
HCM-SANG-0292-C15,aaf31083-8293-4e48-92b0-37d294c0cc64,333e1d27-ca99-40b8-9866-14d4fc2fcaa7,,Neoadjuvant,98.0,2023-03-13T12:53:16.971018-05:00,HCM-SANG-0292-C15_treatment3,7ed0fda4-ab21-446e-8dfb-dfa0dd3c7580,,released,Capecitabine,1,2021-07-06T11:32:00.685812-05:00,Chemotherapy,,
HCM-SANG-0292-C15,aaf31083-8293-4e48-92b0-37d294c0cc64,333e1d27-ca99-40b8-9866-14d4fc2fcaa7,,Neoadjuvant,98.0,2023-03-13T12:53:16.971018-05:00,HCM-SANG-0292-C15_treatment,debea6c0-7a12-4924-81df-45f28fd900a7,,released,Epirubicin,1,2021-07-06T11:32:00.685812-05:00,Chemotherapy,,
HCM-SANG-0292-C15,aaf31083-8293-4e48-92b0-37d294c0cc64,333e1d27-ca99-40b8-9866-14d4fc2fcaa7,,Neoadjuvant,98.0,2023-03-13T12:53:16.971018-05:00,HCM-SANG-0292-C15_treatment2,f8204a8e-2fc0-46a4-9495-908c11fb2c3d,,released,Oxaliplatin,1,2021-07-06T11:32:00.685812-05:00,Chemotherapy,,
HCM-WCMC-1281-C67,ab18b5a1-e3b6-41f5-b0f7-22cd7d5a4e62,73bf72ba-a1f6-4c0d-b16c-61fee698a2c8,,Neoadjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-WCMC-1281-C67_treatment,1805137e-9670-43d7-9453-80fd43c76013,,released,,0,2023-02-27T11:17:41.777806-06:00,,,
HCM-WCMC-1281-C67,ab18b5a1-e3b6-41f5-b0f7-22cd7d5a4e62,73bf72ba-a1f6-4c0d-b16c-61fee698a2c8,91.0,Adjuvant,19.0,2025-04-07T17:13:09.336794-05:00,HCM-WCMC-1281-C67_treatment6,2a1ebcb3-699b-4249-a5e1-cbbc2d8e8dba,,released,,1,2023-02-27T11:17:41.777806-06:00,Chemotherapy,Residual Disease,MVAC-Growth Factor Regimen
HCM-WCMC-1281-C67,ab18b5a1-e3b6-41f5-b0f7-22cd7d5a4e62,73bf72ba-a1f6-4c0d-b16c-61fee698a2c8,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-WCMC-1281-C67_treatment11,59156264-c7b4-46dd-b13d-03e7cb4a8c65,,released,,0,2023-02-27T11:17:41.777806-06:00,Targeted Molecular Therapy,Residual Disease,
HCM-WCMC-1281-C67,ab18b5a1-e3b6-41f5-b0f7-22cd7d5a4e62,73bf72ba-a1f6-4c0d-b16c-61fee698a2c8,91.0,Adjuvant,19.0,2025-04-07T17:13:09.336794-05:00,HCM-WCMC-1281-C67_treatment3,5f997282-a8e8-43a5-ae69-cb62da128ed4,,released,Cisplatin,1,2023-02-27T11:17:41.777806-06:00,Chemotherapy,Residual Disease,
HCM-WCMC-1281-C67,ab18b5a1-e3b6-41f5-b0f7-22cd7d5a4e62,73bf72ba-a1f6-4c0d-b16c-61fee698a2c8,533.0,Adjuvant,519.0,2025-04-07T17:13:09.336794-05:00,HCM-WCMC-1281-C67_treatment13,7f3b1441-b298-48e0-bc33-0dc4e24afcbf,,released,,1,2023-02-27T11:17:41.777806-06:00,"Radiation Therapy, NOS",Residual Disease,
HCM-WCMC-1281-C67,ab18b5a1-e3b6-41f5-b0f7-22cd7d5a4e62,73bf72ba-a1f6-4c0d-b16c-61fee698a2c8,,,476.0,2025-04-07T17:13:09.336794-05:00,HCM-WCMC-1281-C67_treatment10,81cb65e8-21a2-4a45-9d61-79c6ac578947,,released,,1,2023-02-27T11:17:41.777806-06:00,"Surgery, NOS",Initial Diagnosis,
HCM-WCMC-1281-C67,ab18b5a1-e3b6-41f5-b0f7-22cd7d5a4e62,73bf72ba-a1f6-4c0d-b16c-61fee698a2c8,531.0,Adjuvant,405.0,2025-04-07T17:13:09.336794-05:00,HCM-WCMC-1281-C67_treatment8,8a46f200-a465-46e5-ab25-f0c19667372f,,released,Pembrolizumab,1,2023-02-27T11:17:41.777806-06:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-WCMC-1281-C67,ab18b5a1-e3b6-41f5-b0f7-22cd7d5a4e62,73bf72ba-a1f6-4c0d-b16c-61fee698a2c8,91.0,Adjuvant,19.0,2025-04-07T17:13:09.336794-05:00,HCM-WCMC-1281-C67_treatment4,94bcd89b-3f07-45b4-9834-98f57101b286,,released,Doxorubicin,1,2023-02-27T11:17:41.777806-06:00,Chemotherapy,Residual Disease,
HCM-WCMC-1281-C67,ab18b5a1-e3b6-41f5-b0f7-22cd7d5a4e62,73bf72ba-a1f6-4c0d-b16c-61fee698a2c8,91.0,Adjuvant,19.0,2025-04-07T17:13:09.336794-05:00,HCM-WCMC-1281-C67_treatment5,98c5998f-1e95-4672-9153-aa4222ee738b,,released,Methotrexate,1,2023-02-27T11:17:41.777806-06:00,Chemotherapy,Residual Disease,
HCM-WCMC-1281-C67,ab18b5a1-e3b6-41f5-b0f7-22cd7d5a4e62,73bf72ba-a1f6-4c0d-b16c-61fee698a2c8,579.0,Adjuvant,548.0,2025-04-07T17:13:09.336794-05:00,HCM-WCMC-1281-C67_treatment14,9c51431f-27c8-4e62-a6b7-1219ef0b1460,,released,,1,2023-02-27T11:17:41.777806-06:00,"Radiation Therapy, NOS",Residual Disease,
HCM-WCMC-1281-C67,ab18b5a1-e3b6-41f5-b0f7-22cd7d5a4e62,73bf72ba-a1f6-4c0d-b16c-61fee698a2c8,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-WCMC-1281-C67_treatment7,a1e33696-badf-40b8-9084-38bd0c0f1bff,,released,,0,2023-02-27T11:17:41.777806-06:00,Hormone Therapy,Residual Disease,
HCM-WCMC-1281-C67,ab18b5a1-e3b6-41f5-b0f7-22cd7d5a4e62,73bf72ba-a1f6-4c0d-b16c-61fee698a2c8,91.0,Adjuvant,19.0,2025-04-07T17:13:09.336794-05:00,HCM-WCMC-1281-C67_treatment2,d6c75f5b-4f65-4184-bd11-0acf4fece9db,,released,Vinblastine,1,2023-02-27T11:17:41.777806-06:00,Chemotherapy,Residual Disease,
HCM-WCMC-1281-C67,ab18b5a1-e3b6-41f5-b0f7-22cd7d5a4e62,73bf72ba-a1f6-4c0d-b16c-61fee698a2c8,378.0,Adjuvant,368.0,2025-04-07T17:13:09.336794-05:00,HCM-WCMC-1281-C67_treatment12,da3d2076-98c6-4aea-b529-ff4ba7a5456a,,released,,1,2023-02-27T11:17:41.777806-06:00,"Radiation Therapy, NOS",Residual Disease,
HCM-WCMC-1281-C67,ab18b5a1-e3b6-41f5-b0f7-22cd7d5a4e62,73bf72ba-a1f6-4c0d-b16c-61fee698a2c8,644.0,Adjuvant,586.0,2025-04-07T17:13:09.336794-05:00,HCM-WCMC-1281-C67_treatment9,fff2069f-69af-4cb2-8cd6-e08372565e91,Treatment Ongoing,released,Sacituzumab Govitecan,1,2023-02-27T11:17:41.777806-06:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-SANG-0277-C18,ab4f0038-1f79-47cf-a88d-0c8587df3bbe,2395212a-0e8d-456e-ba0e-27ab0eafd1fa,,Neoadjuvant,,2023-11-07T14:28:29.403873-06:00,HCM-SANG-0277-C18_treatment,ad421d51-1555-4c29-8760-7ee03f7e69e5,,released,,0,2021-12-21T15:07:03.167351-06:00,,,
HCM-EXPT-1229-C15,ab76b315-cea9-4e62-8036-a62bcb64d43a,0d443958-a8f6-4431-9434-1dddedbb4ffb,,Neoadjuvant,,2025-10-08T12:39:14.406630-05:00,HCM-EXPT-1229-C15_treatment,18b7898f-a908-46b9-8a56-7770f44bc5c1,,released,,0,2023-02-24T14:10:28.565659-06:00,,,
HCM-CSHL-0817-C22,ab92cc58-7772-4b5a-b3fe-c7630b9ec71f,dda80950-15a5-4bfd-ab0e-e56cc065795b,,Neoadjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0817-C22_treatment,6b1045c6-e8c5-431f-8a3c-1c7588f37c04,,released,,0,2021-12-21T14:29:20.810491-06:00,,,
HCM-CSHL-0817-C22,ab92cc58-7772-4b5a-b3fe-c7630b9ec71f,dda80950-15a5-4bfd-ab0e-e56cc065795b,,,-54.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0817-C22_treatment2,a536e777-724a-4f08-b7e0-18514ed28cd8,,released,,1,2021-12-21T14:29:20.810491-06:00,"Surgery, NOS",Initial Diagnosis,
HCM-CSHL-0433-C24,aba4536f-6457-4ec2-90ac-1e0464352d7b,b46bdcc5-5001-4e21-ae32-0cb3caa57238,252.0,Adjuvant,,2021-01-06T22:55:10.531130-06:00,HCM-CSHL-0433-C24_treatment5,067a34e1-a3f7-4d89-80fe-27b09ba6871c,,released,,1,2020-09-28T10:08:51.891641-05:00,Chemotherapy,Residual Disease,GEMOX
HCM-CSHL-0433-C24,aba4536f-6457-4ec2-90ac-1e0464352d7b,b46bdcc5-5001-4e21-ae32-0cb3caa57238,,Adjuvant,,2021-01-06T22:55:10.531130-06:00,HCM-CSHL-0433-C24_treatment10,2705821b-74ca-43d0-af75-dda68a034bd8,,released,,0,2020-09-28T10:08:51.891641-05:00,"Radiation Therapy, NOS",Residual Disease,
HCM-CSHL-0433-C24,aba4536f-6457-4ec2-90ac-1e0464352d7b,b46bdcc5-5001-4e21-ae32-0cb3caa57238,,Adjuvant,,2021-01-06T22:55:10.531130-06:00,HCM-CSHL-0433-C24_treatment9,6befaeea-67aa-4b96-9f80-b97491b738e5,,released,,0,2020-09-28T10:08:51.891641-05:00,Targeted Molecular Therapy,Residual Disease,
HCM-CSHL-0433-C24,aba4536f-6457-4ec2-90ac-1e0464352d7b,b46bdcc5-5001-4e21-ae32-0cb3caa57238,,Adjuvant,,2021-01-06T22:55:10.531130-06:00,HCM-CSHL-0433-C24_treatment6,6f93e212-0373-4c18-b724-0cffc9500b44,,released,,0,2020-09-28T10:08:51.891641-05:00,Hormone Therapy,Residual Disease,
HCM-CSHL-0433-C24,aba4536f-6457-4ec2-90ac-1e0464352d7b,b46bdcc5-5001-4e21-ae32-0cb3caa57238,,Adjuvant,,2021-01-06T22:55:10.531130-06:00,HCM-CSHL-0433-C24_treatment7,7ccb908d-84a0-42e3-8763-f31bb28f5360,,released,,0,2020-09-28T10:08:51.891641-05:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-CSHL-0433-C24,aba4536f-6457-4ec2-90ac-1e0464352d7b,b46bdcc5-5001-4e21-ae32-0cb3caa57238,252.0,Adjuvant,,2021-01-06T22:55:10.531130-06:00,HCM-CSHL-0433-C24_treatment4,832ea635-6904-44a7-85d5-76e32f22b025,,released,Gemcitabine,1,2020-09-28T10:08:51.891641-05:00,Chemotherapy,Residual Disease,
HCM-CSHL-0433-C24,aba4536f-6457-4ec2-90ac-1e0464352d7b,b46bdcc5-5001-4e21-ae32-0cb3caa57238,,,-16.0,2023-02-27T12:21:49.126109-06:00,HCM-CSHL-0433-C24_treatment8,8bacabeb-eedc-4402-873e-6dbc9e6275b1,,released,,1,2020-09-28T10:08:51.891641-05:00,"Surgery, NOS",Initial Diagnosis,
HCM-CSHL-0433-C24,aba4536f-6457-4ec2-90ac-1e0464352d7b,b46bdcc5-5001-4e21-ae32-0cb3caa57238,,Neoadjuvant,,2021-01-06T22:55:10.531130-06:00,HCM-CSHL-0433-C24_treatment,c822ed42-6900-4c90-8752-00830147131d,,released,,0,2020-09-28T10:08:51.891641-05:00,,,
HCM-CSHL-0433-C24,aba4536f-6457-4ec2-90ac-1e0464352d7b,b46bdcc5-5001-4e21-ae32-0cb3caa57238,,Adjuvant,,2021-01-06T22:55:10.531130-06:00,HCM-CSHL-0433-C24_treatment2,dba82b89-83ea-4276-9395-cf2493111efc,,released,Capecitabine,1,2020-09-28T10:08:51.891641-05:00,Chemotherapy,Residual Disease,
HCM-CSHL-0433-C24,aba4536f-6457-4ec2-90ac-1e0464352d7b,b46bdcc5-5001-4e21-ae32-0cb3caa57238,252.0,Adjuvant,,2021-01-06T22:55:10.531130-06:00,HCM-CSHL-0433-C24_treatment3,e94a5647-eb35-41a0-8e39-759aa54b5077,,released,Oxaliplatin,1,2020-09-28T10:08:51.891641-05:00,Chemotherapy,Residual Disease,
HCM-BROD-0418-C71,ac2e7c63-300d-4bbe-b479-3de513dc8872,469fce91-b3fa-4d58-8dff-51085b70aa8b,47.0,Adjuvant,5.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0418-C71_treatment6,2f31af8d-768d-4afc-a9c1-4373b68325e5,,released,,1,2021-06-03T07:46:05.572465-05:00,"Radiation Therapy, NOS",Residual Disease,
HCM-BROD-0418-C71,ac2e7c63-300d-4bbe-b479-3de513dc8872,469fce91-b3fa-4d58-8dff-51085b70aa8b,87.0,Adjuvant,5.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0418-C71_treatment5,321382ed-dd65-4bf3-98d3-f8dc041ba03c,,released,Bevacizumab,1,2021-06-03T07:46:05.572465-05:00,Targeted Molecular Therapy,Residual Disease,
HCM-BROD-0418-C71,ac2e7c63-300d-4bbe-b479-3de513dc8872,469fce91-b3fa-4d58-8dff-51085b70aa8b,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0418-C71_treatment3,75e4b2ba-4777-4e56-b68e-8da29f66dedf,,released,,0,2021-06-03T07:46:05.572465-05:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-BROD-0418-C71,ac2e7c63-300d-4bbe-b479-3de513dc8872,469fce91-b3fa-4d58-8dff-51085b70aa8b,,Neoadjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0418-C71_treatment,7e96cd36-a553-4529-986b-4475766d0e3b,,released,,0,2021-06-03T07:46:05.572465-05:00,,,
HCM-BROD-0418-C71,ac2e7c63-300d-4bbe-b479-3de513dc8872,469fce91-b3fa-4d58-8dff-51085b70aa8b,173.0,Adjuvant,5.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0418-C71_treatment2,845303f4-57f5-4dda-8258-b75d622b7a33,,released,Temozolomide,1,2021-06-03T07:46:05.572465-05:00,Chemotherapy,Residual Disease,
HCM-BROD-0418-C71,ac2e7c63-300d-4bbe-b479-3de513dc8872,469fce91-b3fa-4d58-8dff-51085b70aa8b,,,-17.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0418-C71_treatment4,84f4ef35-4dfd-47fd-b477-3785d6b5066c,,released,,1,2021-06-03T07:46:05.572465-05:00,"Surgery, NOS",Initial Diagnosis,
HCM-BROD-0448-C15,ac371bd7-dd43-4784-8b13-8efb9b7a3474,306daa56-ee8e-4ed3-9fe7-597bb35d89fd,,,,2023-03-13T13:20:10.019120-05:00,HCM-BROD-0448-C15_treatment4,5dceb802-39bd-4bd5-ac7f-87522d235eb6,,released,,0,2020-09-27T11:37:03.385796-05:00,"Surgery, NOS",Initial Diagnosis,
HCM-BROD-0448-C15,ac371bd7-dd43-4784-8b13-8efb9b7a3474,306daa56-ee8e-4ed3-9fe7-597bb35d89fd,,Neoadjuvant,,2023-02-22T07:39:25.979291-06:00,HCM-BROD-0448-C15_treatment,7d42bb86-1277-409c-971e-dad5166eb37a,,released,,0,2020-09-27T11:37:03.385796-05:00,,,
HCM-BROD-0448-C15,ac371bd7-dd43-4784-8b13-8efb9b7a3474,306daa56-ee8e-4ed3-9fe7-597bb35d89fd,,Adjuvant,,2023-02-22T07:39:25.979291-06:00,HCM-BROD-0448-C15_treatment5,9d0ed2a0-58f9-4f85-b9ed-3c4cb12b5bd1,,released,,0,2020-09-27T11:37:03.385796-05:00,Targeted Molecular Therapy,Residual Disease,
HCM-BROD-0448-C15,ac371bd7-dd43-4784-8b13-8efb9b7a3474,306daa56-ee8e-4ed3-9fe7-597bb35d89fd,,Adjuvant,,2023-02-22T07:39:25.979291-06:00,HCM-BROD-0448-C15_treatment6,d6b7e22c-3370-4720-a107-42dc3d5a0ba7,,released,,0,2020-09-27T11:37:03.385796-05:00,"Radiation Therapy, NOS",Residual Disease,
HCM-BROD-0448-C15,ac371bd7-dd43-4784-8b13-8efb9b7a3474,306daa56-ee8e-4ed3-9fe7-597bb35d89fd,,Adjuvant,,2023-02-22T07:39:25.979291-06:00,HCM-BROD-0448-C15_treatment3,e62fb7c4-ad30-40ae-8f17-bcb645948b40,,released,,0,2020-09-27T11:37:03.385796-05:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-BROD-0448-C15,ac371bd7-dd43-4784-8b13-8efb9b7a3474,306daa56-ee8e-4ed3-9fe7-597bb35d89fd,,Adjuvant,,2023-02-22T07:39:25.979291-06:00,HCM-BROD-0448-C15_treatment2,efc271f6-03c1-4180-9ae4-78f85c685e9f,,released,,0,2020-09-27T11:37:03.385796-05:00,Chemotherapy,Residual Disease,
HCM-CSHL-0153-C50,ad400773-3306-4e97-bda6-f03fcc471692,30ff556b-3ff5-4c9f-a00a-fc3520f1f2a4,,Adjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0153-C50_treatment3,679c9930-ab69-4651-ac3f-0419c002b4ea,,released,,0,2020-09-27T12:59:22.493017-05:00,"Pharmaceutical Therapy, NOS",Residual Disease,
HCM-CSHL-0153-C50,ad400773-3306-4e97-bda6-f03fcc471692,30ff556b-3ff5-4c9f-a00a-fc3520f1f2a4,,Neoadjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0153-C50_treatment,8b7e4ed1-efc1-4be7-ba55-0e889a224f07,,released,,0,2020-09-27T12:59:22.493017-05:00,,,
HCM-CSHL-0153-C50,ad400773-3306-4e97-bda6-f03fcc471692,30ff556b-3ff5-4c9f-a00a-fc3520f1f2a4,165.0,Adjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0153-C50_treatment4,cba2fc5d-81a6-49b4-95df-3d5f11b3b0b7,,released,,1,2020-09-27T12:59:22.493017-05:00,"Radiation Therapy, NOS",Residual Disease,
HCM-CSHL-0153-C50,ad400773-3306-4e97-bda6-f03fcc471692,30ff556b-3ff5-4c9f-a00a-fc3520f1f2a4,,,53.0,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0153-C50_treatment2,d1588b3f-6225-4110-bae9-891fab21a0f6,,released,,1,2020-09-27T12:59:22.493017-05:00,"Surgery, NOS",Initial Diagnosis,
HCM-EXPT-1226-C18,add1a8ad-6a0a-4945-b1e4-2bbe3f554421,862de072-1c65-4cad-8df5-8db2a78fd3ba,,Neoadjuvant,,2025-10-08T12:39:14.406630-05:00,HCM-EXPT-1226-C18_treatment,d4ab82be-467a-4344-88cb-3c1a4b3f557c,,released,,0,2023-02-24T14:20:29.664225-06:00,,,
HCM-STAN-0846-C20,aec335a5-60e4-4754-b631-f496e5e15d01,6e78366d-26b9-4b9b-bc12-992f67c943b5,,Neoadjuvant,58.0,2025-04-07T17:13:09.336794-05:00,HCM-STAN-0846-C20_treatment7,1ab8f788-bd20-4892-8b1b-59236a1a14da,,released,,1,2022-09-22T07:06:09.394837-05:00,Stereotactic Radiosurgery,,
HCM-STAN-0846-C20,aec335a5-60e4-4754-b631-f496e5e15d01,6e78366d-26b9-4b9b-bc12-992f67c943b5,1331.0,Adjuvant,447.0,2025-04-07T17:13:09.336794-05:00,HCM-STAN-0846-C20_treatment8,1d9a55d5-7a2d-4500-ac01-e2685d35f161,,released,Leucovorin Calcium,1,2022-09-22T07:06:09.394837-05:00,Chemotherapy,Residual Disease,
HCM-STAN-0846-C20,aec335a5-60e4-4754-b631-f496e5e15d01,6e78366d-26b9-4b9b-bc12-992f67c943b5,,Neoadjuvant,360.0,2025-04-07T17:13:09.336794-05:00,HCM-STAN-0846-C20_treatment,484f57bb-0fbb-4aea-a11c-56cdc1a3be9c,,released,Leucovorin Calcium,1,2022-09-22T07:06:09.394837-05:00,Chemotherapy,,
HCM-STAN-0846-C20,aec335a5-60e4-4754-b631-f496e5e15d01,6e78366d-26b9-4b9b-bc12-992f67c943b5,,Neoadjuvant,360.0,2025-04-07T17:13:09.336794-05:00,HCM-STAN-0846-C20_treatment6,57366622-ab9f-46f2-9896-c59f0b35b9c1,,released,,1,2022-09-22T07:06:09.394837-05:00,Chemotherapy,,FOLFOX
HCM-STAN-0846-C20,aec335a5-60e4-4754-b631-f496e5e15d01,6e78366d-26b9-4b9b-bc12-992f67c943b5,,Neoadjuvant,360.0,2025-04-07T17:13:09.336794-05:00,HCM-STAN-0846-C20_treatment4,5deb9457-56de-4126-91cd-8552459cee80,,released,,1,2022-09-22T07:06:09.394837-05:00,Chemotherapy,,FOLFIRI
HCM-STAN-0846-C20,aec335a5-60e4-4754-b631-f496e5e15d01,6e78366d-26b9-4b9b-bc12-992f67c943b5,,Neoadjuvant,360.0,2025-04-07T17:13:09.336794-05:00,HCM-STAN-0846-C20_treatment2,6b551828-46e8-4d3a-9ab9-7408f2cb09b4,,released,Fluorouracil,1,2022-09-22T07:06:09.394837-05:00,Chemotherapy,,
HCM-STAN-0846-C20,aec335a5-60e4-4754-b631-f496e5e15d01,6e78366d-26b9-4b9b-bc12-992f67c943b5,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-STAN-0846-C20_treatment12,6e2957a7-196b-4294-a7ba-cf265129542c,,released,,0,2022-09-22T07:06:09.394837-05:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-STAN-0846-C20,aec335a5-60e4-4754-b631-f496e5e15d01,6e78366d-26b9-4b9b-bc12-992f67c943b5,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-STAN-0846-C20_treatment15,70e0a24a-76d7-48c7-ba50-9cce702b6726,,released,,0,2022-09-22T07:06:09.394837-05:00,"Radiation Therapy, NOS",Residual Disease,
HCM-STAN-0846-C20,aec335a5-60e4-4754-b631-f496e5e15d01,6e78366d-26b9-4b9b-bc12-992f67c943b5,1331.0,Adjuvant,447.0,2025-04-07T17:13:09.336794-05:00,HCM-STAN-0846-C20_treatment11,7fe7f9ea-ab60-4930-a3ae-02849c3cb655,,released,,1,2022-09-22T07:06:09.394837-05:00,Chemotherapy,Residual Disease,FOLFIRI
HCM-STAN-0846-C20,aec335a5-60e4-4754-b631-f496e5e15d01,6e78366d-26b9-4b9b-bc12-992f67c943b5,1331.0,Adjuvant,447.0,2025-04-07T17:13:09.336794-05:00,HCM-STAN-0846-C20_treatment10,89a7efbd-02b1-4960-b1f4-2177989c9868,,released,Irinotecan,1,2022-09-22T07:06:09.394837-05:00,Chemotherapy,Residual Disease,
HCM-STAN-0846-C20,aec335a5-60e4-4754-b631-f496e5e15d01,6e78366d-26b9-4b9b-bc12-992f67c943b5,,Neoadjuvant,360.0,2025-04-07T17:13:09.336794-05:00,HCM-STAN-0846-C20_treatment3,99a45cc1-62b2-41d0-a464-a838ae61b20e,,released,Irinotecan,1,2022-09-22T07:06:09.394837-05:00,Chemotherapy,,
HCM-STAN-0846-C20,aec335a5-60e4-4754-b631-f496e5e15d01,6e78366d-26b9-4b9b-bc12-992f67c943b5,,,575.0,2025-04-07T17:13:09.336794-05:00,HCM-STAN-0846-C20_treatment13,d9fe22c8-2004-4b91-bd65-750017112978,,released,,1,2022-09-22T07:06:09.394837-05:00,"Surgery, NOS",Initial Diagnosis,
HCM-STAN-0846-C20,aec335a5-60e4-4754-b631-f496e5e15d01,6e78366d-26b9-4b9b-bc12-992f67c943b5,,Neoadjuvant,360.0,2025-04-07T17:13:09.336794-05:00,HCM-STAN-0846-C20_treatment5,e2626c9d-fd82-42c8-8261-defd1464888e,,released,Oxaliplatin,1,2022-09-22T07:06:09.394837-05:00,Chemotherapy,,
HCM-STAN-0846-C20,aec335a5-60e4-4754-b631-f496e5e15d01,6e78366d-26b9-4b9b-bc12-992f67c943b5,1331.0,Adjuvant,447.0,2025-04-07T17:13:09.336794-05:00,HCM-STAN-0846-C20_treatment9,f32d4df1-16a9-469c-96ea-ffefdc810618,,released,Fluorouracil,1,2022-09-22T07:06:09.394837-05:00,Chemotherapy,Residual Disease,
HCM-STAN-0846-C20,aec335a5-60e4-4754-b631-f496e5e15d01,6e78366d-26b9-4b9b-bc12-992f67c943b5,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-STAN-0846-C20_treatment14,f98d044a-5313-4780-84f6-6708eb87f684,,released,,0,2022-09-22T07:06:09.394837-05:00,Targeted Molecular Therapy,Residual Disease,
HCM-EXPT-1227-C18,af28043e-c85c-48cf-aa29-853fa0407cf0,60e0b6f9-04d1-4ad8-9371-4cdb767757a3,,Neoadjuvant,,2025-10-08T12:39:14.406630-05:00,HCM-EXPT-1227-C18_treatment2,69007c71-5224-41b0-b9dd-ef7dd0a64467,,released,,unknown,2022-03-09T19:43:47.110836-06:00,"Radiation Therapy, NOS",,
HCM-EXPT-1227-C18,af28043e-c85c-48cf-aa29-853fa0407cf0,60e0b6f9-04d1-4ad8-9371-4cdb767757a3,,Neoadjuvant,,2025-10-08T12:39:14.406630-05:00,HCM-EXPT-1227-C18_treatment,71b83abd-49e5-4147-8166-5398ac195b96,,released,,unknown,2022-03-09T19:43:47.110836-06:00,"Pharmaceutical Therapy, NOS",,
HCM-EXPT-0980-C50,af344e6d-19b5-494f-8b43-3f0f897bb703,b15ba135-0e23-4e20-98c9-fb4d515e80d9,,Neoadjuvant,,2025-10-08T12:37:21.548354-05:00,HCM-EXPT-0980-C50_treatment,f78ca25a-2f3f-483a-b9d7-bafd400ec82c,,released,,0,2021-12-21T14:49:21.040767-06:00,,,
HCM-STAN-1109-D13,af78a845-bdb6-4245-b3a2-c94dbbf18653,200a434e-555a-4dbb-998f-fdef0c1a358c,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-STAN-1109-D13_treatment3,375dcb72-36ef-4042-9b76-225233850264,,released,,0,2022-09-22T07:11:01.210786-05:00,"Pharmaceutical Therapy, NOS",Residual Disease,
HCM-STAN-1109-D13,af78a845-bdb6-4245-b3a2-c94dbbf18653,200a434e-555a-4dbb-998f-fdef0c1a358c,,,0.0,2025-04-07T17:13:09.336794-05:00,HCM-STAN-1109-D13_treatment2,53019006-8a3b-4cd3-aa9f-adc9e74f4e2d,,released,,1,2022-09-22T07:11:01.210786-05:00,"Surgery, NOS",Initial Diagnosis,
HCM-STAN-1109-D13,af78a845-bdb6-4245-b3a2-c94dbbf18653,200a434e-555a-4dbb-998f-fdef0c1a358c,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-STAN-1109-D13_treatment4,70f2c2cd-bd4a-4a25-90e1-14016d7a6a6c,,released,,0,2022-09-22T07:11:01.210786-05:00,"Radiation Therapy, NOS",Residual Disease,
HCM-STAN-1109-D13,af78a845-bdb6-4245-b3a2-c94dbbf18653,200a434e-555a-4dbb-998f-fdef0c1a358c,,Neoadjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-STAN-1109-D13_treatment,7afec659-fcbb-445d-884b-ed2dd33a1c41,,released,,0,2022-09-22T07:11:01.210786-05:00,,,
HCM-BROD-0106-C71,afa149e0-edb7-4f8e-9f56-6e1c0ac78287,2610ed82-d82d-4d6b-8de9-5cf01e30606a,,Adjuvant,,2023-03-13T12:46:52.529652-05:00,HCM-BROD-0106-C71_treatment3,8f32a1e8-3c06-46c3-8c4f-173d2d76d7a9,,released,,0,2020-02-27T12:29:44.523556-06:00,"Pharmaceutical Therapy, NOS",Residual Disease,
HCM-BROD-0106-C71,afa149e0-edb7-4f8e-9f56-6e1c0ac78287,2610ed82-d82d-4d6b-8de9-5cf01e30606a,,,-3.0,2023-03-13T12:46:52.529652-05:00,HCM-BROD-0106-C71_treatment2,90801ef1-e0a9-4d41-887e-310c03b7a9d5,,released,,1,2020-02-27T12:29:44.523556-06:00,"Surgery, NOS",Initial Diagnosis,
HCM-BROD-0106-C71,afa149e0-edb7-4f8e-9f56-6e1c0ac78287,2610ed82-d82d-4d6b-8de9-5cf01e30606a,,Neoadjuvant,,2021-03-03T15:15:08.075155-06:00,HCM-BROD-0106-C71_treatment,acbeeded-7831-4f2e-9a2e-eaa01dc149a9,,released,,0,2019-04-04T14:53:07.103421-05:00,,,
HCM-BROD-0106-C71,afa149e0-edb7-4f8e-9f56-6e1c0ac78287,2610ed82-d82d-4d6b-8de9-5cf01e30606a,,Adjuvant,,2023-03-13T12:46:52.529652-05:00,HCM-BROD-0106-C71_treatment4,afa60250-a2b7-4290-bb5d-377a2c730406,,released,,0,2020-02-27T12:29:44.523556-06:00,"Radiation Therapy, NOS",Residual Disease,
HCM-BROD-0922-C71,b0362a57-b459-4ece-ab3b-e44f8d1820f3,c1a9d234-1d6e-4b35-95dc-6a38692e2cb3,395.0,Adjuvant,353.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0922-C71_treatment6,410c2d7d-67aa-4ea2-bd46-b4e5e6016863,,released,Not Reported,1,2021-12-21T13:56:55.611200-06:00,Targeted Molecular Therapy,Residual Disease,
HCM-BROD-0922-C71,b0362a57-b459-4ece-ab3b-e44f8d1820f3,c1a9d234-1d6e-4b35-95dc-6a38692e2cb3,491.0,Adjuvant,400.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0922-C71_treatment7,598775c3-d481-4dea-bc6e-6821713d8ec0,,released,Bevacizumab,1,2021-12-21T13:56:55.611200-06:00,Targeted Molecular Therapy,Residual Disease,
HCM-BROD-0922-C71,b0362a57-b459-4ece-ab3b-e44f8d1820f3,c1a9d234-1d6e-4b35-95dc-6a38692e2cb3,,Neoadjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0922-C71_treatment,677d97b4-a47c-43db-aaac-a2f8837447f8,,released,,0,2021-12-21T13:56:55.611200-06:00,,,
HCM-BROD-0922-C71,b0362a57-b459-4ece-ab3b-e44f8d1820f3,c1a9d234-1d6e-4b35-95dc-6a38692e2cb3,316.0,Adjuvant,46.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0922-C71_treatment5,68e25027-d0d7-49ad-8cd9-c65ce6dd5be9,,released,Not Reported,1,2021-12-21T13:56:55.611200-06:00,Targeted Molecular Therapy,Residual Disease,
HCM-BROD-0922-C71,b0362a57-b459-4ece-ab3b-e44f8d1820f3,c1a9d234-1d6e-4b35-95dc-6a38692e2cb3,501.0,Adjuvant,499.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0922-C71_treatment9,9d0ae1e0-b4fa-4335-ac15-f368a4198ab8,,released,,1,2021-12-21T13:56:55.611200-06:00,"Radiation Therapy, NOS",Residual Disease,
HCM-BROD-0922-C71,b0362a57-b459-4ece-ab3b-e44f8d1820f3,c1a9d234-1d6e-4b35-95dc-6a38692e2cb3,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0922-C71_treatment3,ae91ad51-a495-4a05-8733-1c05c70a0edb,,released,,0,2021-12-21T13:56:55.611200-06:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-BROD-0922-C71,b0362a57-b459-4ece-ab3b-e44f8d1820f3,c1a9d234-1d6e-4b35-95dc-6a38692e2cb3,,,0.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0922-C71_treatment4,b4d88f93-fbf7-41b7-b7ab-cb40db6179b5,,released,,1,2021-12-21T13:56:55.611200-06:00,"Surgery, NOS",Initial Diagnosis,
HCM-BROD-0922-C71,b0362a57-b459-4ece-ab3b-e44f8d1820f3,c1a9d234-1d6e-4b35-95dc-6a38692e2cb3,88.0,Adjuvant,46.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0922-C71_treatment2,cdb6cc64-2c96-4a8e-a027-f27c323860fc,,released,Temozolomide,1,2021-12-21T13:56:55.611200-06:00,Chemotherapy,Residual Disease,
HCM-BROD-0922-C71,b0362a57-b459-4ece-ab3b-e44f8d1820f3,c1a9d234-1d6e-4b35-95dc-6a38692e2cb3,88.0,Adjuvant,46.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0922-C71_treatment8,f9bea552-25da-40da-9e12-2f243aacd964,,released,,1,2021-12-21T13:56:55.611200-06:00,"Radiation Therapy, NOS",Residual Disease,
HCM-BROD-0457-C71,b03d2210-9c3c-44aa-8d73-4ef9588df1a5,bf1d9613-fd32-497b-b83b-497fa90f5453,,Adjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0457-C71_treatment5,08cc5bbe-d98f-4ca2-9ae7-0c76957256e5,,released,,0,2020-04-21T14:54:05.963037-05:00,Targeted Molecular Therapy,Residual Disease,
HCM-BROD-0457-C71,b03d2210-9c3c-44aa-8d73-4ef9588df1a5,bf1d9613-fd32-497b-b83b-497fa90f5453,51.0,Adjuvant,30.0,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0457-C71_treatment6,44f9314f-195a-4ef5-a95d-ca6207b7961d,,released,,1,2020-04-21T14:54:05.963037-05:00,"Radiation Therapy, NOS",Residual Disease,
HCM-BROD-0457-C71,b03d2210-9c3c-44aa-8d73-4ef9588df1a5,bf1d9613-fd32-497b-b83b-497fa90f5453,,Adjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0457-C71_treatment3,8ef1bca7-cc8e-430f-998f-1d8c2f531ece,,released,,0,2020-04-21T14:54:05.963037-05:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-BROD-0457-C71,b03d2210-9c3c-44aa-8d73-4ef9588df1a5,bf1d9613-fd32-497b-b83b-497fa90f5453,,,-10.0,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0457-C71_treatment4,a4d13566-1adf-4735-8eff-ee0fabefaff5,,released,,1,2020-04-21T14:54:05.963037-05:00,"Surgery, NOS",Initial Diagnosis,
HCM-BROD-0457-C71,b03d2210-9c3c-44aa-8d73-4ef9588df1a5,bf1d9613-fd32-497b-b83b-497fa90f5453,51.0,Adjuvant,30.0,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0457-C71_treatment2,ba2774ce-f8b3-4e81-844e-4d69e72c10d0,,released,Temozolomide,1,2020-04-21T14:54:05.963037-05:00,Chemotherapy,Residual Disease,
HCM-BROD-0457-C71,b03d2210-9c3c-44aa-8d73-4ef9588df1a5,bf1d9613-fd32-497b-b83b-497fa90f5453,,Neoadjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0457-C71_treatment,c4374030-b168-40a5-9ed7-0a04a48c1f5d,,released,,0,2020-04-21T14:54:05.963037-05:00,,,
HCM-BROD-0755-C43,b0f583f9-177a-4578-ad47-908b8023ff99,def1f37e-7fb8-49d7-a28e-3f2eb6d94fe0,992.0,Adjuvant,633.0,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0755-C43_treatment4,00b7b153-078b-4d1c-b62d-a948b432bdd9,,released,Pembrolizumab,1,2021-12-21T13:49:39.002223-06:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-BROD-0755-C43,b0f583f9-177a-4578-ad47-908b8023ff99,def1f37e-7fb8-49d7-a28e-3f2eb6d94fe0,,Adjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0755-C43_treatment6,18285901-3fd2-4340-a4d1-65eccfc8daec,,released,,0,2021-12-21T13:49:39.002223-06:00,Targeted Molecular Therapy,Residual Disease,
HCM-BROD-0755-C43,b0f583f9-177a-4578-ad47-908b8023ff99,def1f37e-7fb8-49d7-a28e-3f2eb6d94fe0,,,0.0,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0755-C43_treatment5,4276d22c-d978-43bb-aaa5-33d3c999ce5c,,released,,1,2021-12-21T13:49:39.002223-06:00,"Surgery, NOS",Initial Diagnosis,
HCM-BROD-0755-C43,b0f583f9-177a-4578-ad47-908b8023ff99,def1f37e-7fb8-49d7-a28e-3f2eb6d94fe0,,Adjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0755-C43_treatment7,5ba629ef-d9b3-4558-83a4-27262d345166,,released,,0,2021-12-21T13:49:39.002223-06:00,"Radiation Therapy, NOS",Residual Disease,
HCM-BROD-0755-C43,b0f583f9-177a-4578-ad47-908b8023ff99,def1f37e-7fb8-49d7-a28e-3f2eb6d94fe0,,Adjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0755-C43_treatment3,70b19ce8-e023-4759-883c-53665fdfa1bb,,released,,0,2021-12-21T13:49:39.002223-06:00,Hormone Therapy,Residual Disease,
HCM-BROD-0755-C43,b0f583f9-177a-4578-ad47-908b8023ff99,def1f37e-7fb8-49d7-a28e-3f2eb6d94fe0,,Adjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0755-C43_treatment2,af928c19-408b-4b2c-aa85-2090bb2876c6,,released,,0,2021-12-21T13:49:39.002223-06:00,Chemotherapy,Residual Disease,
HCM-BROD-0755-C43,b0f583f9-177a-4578-ad47-908b8023ff99,def1f37e-7fb8-49d7-a28e-3f2eb6d94fe0,,Neoadjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0755-C43_treatment,f5ccdbdf-6d80-4db0-a4c0-812695484520,,released,,0,2021-12-21T13:49:39.002223-06:00,,,
HCM-CSHL-0461-D12,b1021eee-f5c8-43a7-aab9-79553bca2265,e8b18a49-fa7b-4ada-a37d-8b71085cce26,,Adjuvant,,2023-03-13T13:20:41.394270-05:00,HCM-CSHL-0461-D12_treatment4,1c855a77-4f0d-4bd3-808c-0ab2c6a96e4f,,released,,0,2020-06-15T13:26:01.915974-05:00,"Radiation Therapy, NOS",Residual Disease,
HCM-CSHL-0461-D12,b1021eee-f5c8-43a7-aab9-79553bca2265,e8b18a49-fa7b-4ada-a37d-8b71085cce26,,,105.0,2023-03-13T13:20:41.394270-05:00,HCM-CSHL-0461-D12_treatment2,59e20a9b-f813-4e0b-be05-104f7bd03a11,,released,,1,2020-06-15T13:26:01.915974-05:00,"Surgery, NOS",Initial Diagnosis,
HCM-CSHL-0461-D12,b1021eee-f5c8-43a7-aab9-79553bca2265,e8b18a49-fa7b-4ada-a37d-8b71085cce26,,Neoadjuvant,,2020-10-20T19:20:06.800740-05:00,HCM-CSHL-0461-D12_treatment,ba8e3148-ceb3-4f2f-8db6-3d916d9a72c1,,released,,0,2020-06-15T13:26:01.915974-05:00,,,
HCM-CSHL-0461-D12,b1021eee-f5c8-43a7-aab9-79553bca2265,e8b18a49-fa7b-4ada-a37d-8b71085cce26,,Adjuvant,,2023-03-13T13:20:41.394270-05:00,HCM-CSHL-0461-D12_treatment3,bed49cc4-2464-4e1c-ba04-054d3bf2baf9,,released,,0,2020-06-15T13:26:01.915974-05:00,"Pharmaceutical Therapy, NOS",Residual Disease,
HCM-EXPT-1004-C50,b1cef01b-8b17-46b1-a58a-745b55a2e94f,776f00c4-9838-4b22-8501-79298a970a42,,Neoadjuvant,,2025-10-08T12:37:43.816130-05:00,HCM-EXPT-1004-C50_treatment,0d1f1a52-d185-4de3-ab1f-4c6185fd4bb9,,released,,0,2021-12-21T14:54:06.254058-06:00,,,
HCM-BROD-0353-C64,b1ed6908-e164-4e0f-accd-11605edf4c81,28511f89-01fd-48b1-8a51-704c607d2e94,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0353-C64_treatment6,33bd6501-27f3-4942-95d7-4496d3fb818b,,released,,0,2021-12-21T13:37:53.180502-06:00,"Radiation Therapy, NOS",Residual Disease,
HCM-BROD-0353-C64,b1ed6908-e164-4e0f-accd-11605edf4c81,28511f89-01fd-48b1-8a51-704c607d2e94,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0353-C64_treatment3,3da4c6f7-9934-4ed2-a3eb-e00774c260c7,,released,,0,2021-12-21T13:37:53.180502-06:00,Hormone Therapy,Residual Disease,
HCM-BROD-0353-C64,b1ed6908-e164-4e0f-accd-11605edf4c81,28511f89-01fd-48b1-8a51-704c607d2e94,,,0.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0353-C64_treatment5,611af60a-342d-443d-a0f1-e889efb390fd,,released,,1,2021-12-21T13:37:53.180502-06:00,"Surgery, NOS",Initial Diagnosis,
HCM-BROD-0353-C64,b1ed6908-e164-4e0f-accd-11605edf4c81,28511f89-01fd-48b1-8a51-704c607d2e94,95.0,Adjuvant,73.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0353-C64_treatment4,6beb34e4-58c7-4b2f-a7fe-17e323bb5fab,,released,Pembrolizumab,1,2021-12-21T13:37:53.180502-06:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-BROD-0353-C64,b1ed6908-e164-4e0f-accd-11605edf4c81,28511f89-01fd-48b1-8a51-704c607d2e94,,Neoadjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0353-C64_treatment,8af13d8d-4b26-46a6-acc3-9822a1532ac2,,released,,0,2021-12-21T13:37:53.180502-06:00,,,
HCM-BROD-0353-C64,b1ed6908-e164-4e0f-accd-11605edf4c81,28511f89-01fd-48b1-8a51-704c607d2e94,73.0,Adjuvant,28.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0353-C64_treatment2,8f15f219-2d1f-4a88-bd05-00e02caa4880,,released,Carboplatin,1,2021-12-21T13:37:53.180502-06:00,Chemotherapy,Residual Disease,
HCM-EXPT-1069-C18,b2765761-9c40-4b33-ab6b-e3154e34c644,a9930011-aa44-4923-8112-ccf82e135b4d,,Neoadjuvant,,2025-10-08T12:38:28.988690-05:00,HCM-EXPT-1069-C18_treatment,1945d988-4edd-4d9f-9a8c-fd104de219b1,,released,,1,2021-12-21T15:03:36.614454-06:00,Chemotherapy,,
HCM-SANG-1310-C15,b2b4474b-63d8-42f8-820f-d572814583c7,5c1cae51-631c-4909-a99a-4884ca32a751,,Neoadjuvant,99.0,2025-04-07T17:13:09.336794-05:00,HCM-SANG-1310-C15_treatment,2257eeaf-2786-4f1f-9838-6e9e5683d66c,,released,Leucovorin,1,2023-02-27T13:23:11.219313-06:00,Chemotherapy,,
HCM-SANG-1310-C15,b2b4474b-63d8-42f8-820f-d572814583c7,5c1cae51-631c-4909-a99a-4884ca32a751,,Neoadjuvant,99.0,2025-04-07T17:13:09.336794-05:00,HCM-SANG-1310-C15_treatment3,4a68e94c-f5fd-4f5f-8ad2-405f933a3ce1,,released,Docetaxel,1,2023-02-27T13:23:11.219313-06:00,Chemotherapy,,
HCM-SANG-1310-C15,b2b4474b-63d8-42f8-820f-d572814583c7,5c1cae51-631c-4909-a99a-4884ca32a751,,Neoadjuvant,99.0,2025-04-07T17:13:09.336794-05:00,HCM-SANG-1310-C15_treatment4,b09eed2d-3b8d-4c89-952a-c0f8398064e3,,released,Oxaliplatin,1,2023-02-27T13:23:11.219313-06:00,Chemotherapy,,
HCM-SANG-1310-C15,b2b4474b-63d8-42f8-820f-d572814583c7,5c1cae51-631c-4909-a99a-4884ca32a751,,Neoadjuvant,99.0,2025-04-07T17:13:09.336794-05:00,HCM-SANG-1310-C15_treatment2,f17ef87f-d7fa-4b87-8258-5fd66c7d5acc,,released,Fluorouracil,1,2023-02-27T13:23:11.219313-06:00,Chemotherapy,,
HCM-EXPT-1255-C25,b2bcc99e-10ea-42e7-a1d9-181f0732d25e,0e270326-c698-49c5-85f8-fed095b9b341,,Neoadjuvant,,2025-10-08T12:39:59.137357-05:00,HCM-EXPT-1255-C25_treatment,df6d1730-9d5d-44ab-a8ea-c34a3ccefe98,,released,,0,2023-02-24T14:06:29.536296-06:00,,,
HCM-EXPT-0897-C25,b353e733-cef9-408c-bbde-1c8f5c1ca81c,9f4e5952-372c-46dd-baba-34c6bbbec006,,Neoadjuvant,,2025-10-08T12:36:32.654639-05:00,HCM-EXPT-0897-C25_treatment,1e6d0980-8c23-476e-b3c5-4df140237ded,,released,,0,2021-12-21T14:44:10.197086-06:00,,,
HCM-BROD-0450-C15,b35898b6-7e8a-43a9-b6f2-4dfc91255e26,e9ba55ca-531b-4afa-8070-44b2b312a6dd,,Neoadjuvant,38.0,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0450-C15_treatment,01a851bb-6127-4e6e-a570-b294ee94ad9a,,released,Docetaxel,1,2020-07-23T14:38:28.482021-05:00,Chemotherapy,,
HCM-BROD-0450-C15,b35898b6-7e8a-43a9-b6f2-4dfc91255e26,e9ba55ca-531b-4afa-8070-44b2b312a6dd,,Neoadjuvant,38.0,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0450-C15_treatment3,1c2a1b8d-a476-4193-b9dc-680a7b9bea52,,released,Oxaliplatin,1,2020-07-23T14:38:28.482021-05:00,Chemotherapy,,
HCM-BROD-0450-C15,b35898b6-7e8a-43a9-b6f2-4dfc91255e26,e9ba55ca-531b-4afa-8070-44b2b312a6dd,,Adjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0450-C15_treatment7,3d76de5c-b253-4e45-977f-71a8d350d80c,,released,,0,2020-07-23T14:38:28.482021-05:00,Chemotherapy,Residual Disease,
HCM-BROD-0450-C15,b35898b6-7e8a-43a9-b6f2-4dfc91255e26,e9ba55ca-531b-4afa-8070-44b2b312a6dd,,,112.0,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0450-C15_treatment9,4f0fc80c-36a2-4133-bbe2-0c0efcf98125,,released,,1,2020-07-23T14:38:28.482021-05:00,"Surgery, NOS",Initial Diagnosis,
HCM-BROD-0450-C15,b35898b6-7e8a-43a9-b6f2-4dfc91255e26,e9ba55ca-531b-4afa-8070-44b2b312a6dd,,Neoadjuvant,38.0,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0450-C15_treatment4,8328cce2-65ba-4e24-be1b-6deee3cb7f92,,released,Leucovorin,1,2020-07-23T14:38:28.482021-05:00,Chemotherapy,,
HCM-BROD-0450-C15,b35898b6-7e8a-43a9-b6f2-4dfc91255e26,e9ba55ca-531b-4afa-8070-44b2b312a6dd,,Neoadjuvant,38.0,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0450-C15_treatment5,8e44e1b6-9989-4321-981b-838c2c429acf,,released,,1,2020-07-23T14:38:28.482021-05:00,Chemotherapy,,FU-LV regimen
HCM-BROD-0450-C15,b35898b6-7e8a-43a9-b6f2-4dfc91255e26,e9ba55ca-531b-4afa-8070-44b2b312a6dd,,Neoadjuvant,192.0,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0450-C15_treatment6,97d15e6d-d94d-44ac-9143-f43465a723b0,,released,Pembrolizumab,1,2020-07-23T14:38:28.482021-05:00,Immunotherapy (Including Vaccines),,
HCM-BROD-0450-C15,b35898b6-7e8a-43a9-b6f2-4dfc91255e26,e9ba55ca-531b-4afa-8070-44b2b312a6dd,,Adjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0450-C15_treatment11,9d7924a2-48e5-40aa-a382-277ea2de1c29,,released,,0,2020-09-27T11:38:27.094339-05:00,"Radiation Therapy, NOS",Residual Disease,
HCM-BROD-0450-C15,b35898b6-7e8a-43a9-b6f2-4dfc91255e26,e9ba55ca-531b-4afa-8070-44b2b312a6dd,,Neoadjuvant,38.0,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0450-C15_treatment2,ca7d0a5e-7170-44c5-9ea3-e043688a6f28,,released,Fluorouracil,1,2020-07-23T14:38:28.482021-05:00,Chemotherapy,,
HCM-BROD-0450-C15,b35898b6-7e8a-43a9-b6f2-4dfc91255e26,e9ba55ca-531b-4afa-8070-44b2b312a6dd,,Adjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0450-C15_treatment8,d506d67b-fa44-438e-ac89-21df84e4575a,,released,,0,2020-07-23T14:38:28.482021-05:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-BROD-0450-C15,b35898b6-7e8a-43a9-b6f2-4dfc91255e26,e9ba55ca-531b-4afa-8070-44b2b312a6dd,413.0,Adjuvant,287.0,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0450-C15_treatment10,e1b31a82-ef83-4b3e-9d69-f99287758d39,,released,Not Reported,1,2020-09-27T11:38:27.094339-05:00,Targeted Molecular Therapy,Residual Disease,
HCM-SANG-0273-C18,b3b23c0b-a9bd-434a-9875-5cfba04cfe7f,79e0985b-1dd5-4901-b174-4d7b4f9b1997,,Neoadjuvant,,2023-02-22T07:39:25.979291-06:00,HCM-SANG-0273-C18_treatment,6d4ab6f6-9811-42e2-8e38-b8d7ecfc8595,,released,,0,2020-02-11T15:31:58.093766-06:00,,,
HCM-EXPT-1235-C18,b3c6f765-beb5-4d1f-938e-9f96b33f4ef1,4edbb757-ddf6-4801-88f8-714768c30af2,,Neoadjuvant,,2025-10-08T12:39:37.798161-05:00,HCM-EXPT-1235-C18_treatment,4c8532fd-9bf6-483c-97e1-4e9829df141f,,released,,0,2022-03-09T19:43:56.689428-06:00,,,
HCM-BROD-0613-C71,b3cc0754-6a21-4683-a491-b2fb8b6175a4,98d80c92-7a76-4e51-9770-a2fa1c1a863f,,Adjuvant,,2021-09-10T10:36:37.981324-05:00,HCM-BROD-0613-C71_treatment3,13a844aa-6319-41bd-81ad-55a1363cd383,,released,,0,2021-08-25T20:31:52.368991-05:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-BROD-0613-C71,b3cc0754-6a21-4683-a491-b2fb8b6175a4,98d80c92-7a76-4e51-9770-a2fa1c1a863f,,Adjuvant,,2021-09-10T10:36:37.981324-05:00,HCM-BROD-0613-C71_treatment5,86cf95f6-75a1-4119-a8e5-fbcc1b30e07c,,released,,0,2021-08-25T20:31:52.368991-05:00,Targeted Molecular Therapy,Residual Disease,
HCM-BROD-0613-C71,b3cc0754-6a21-4683-a491-b2fb8b6175a4,98d80c92-7a76-4e51-9770-a2fa1c1a863f,,Adjuvant,,2021-09-10T10:36:37.981324-05:00,HCM-BROD-0613-C71_treatment2,aec9bcec-c6c6-45e5-8664-f14339e39ccc,,released,,0,2021-08-25T20:31:52.368991-05:00,Chemotherapy,Residual Disease,
HCM-BROD-0613-C71,b3cc0754-6a21-4683-a491-b2fb8b6175a4,98d80c92-7a76-4e51-9770-a2fa1c1a863f,,,12.0,2023-02-27T11:30:39.801279-06:00,HCM-BROD-0613-C71_treatment4,b22f2892-3732-495e-94be-823152ee8dac,,released,,1,2021-08-25T20:31:52.368991-05:00,"Surgery, NOS",Initial Diagnosis,
HCM-BROD-0613-C71,b3cc0754-6a21-4683-a491-b2fb8b6175a4,98d80c92-7a76-4e51-9770-a2fa1c1a863f,,Neoadjuvant,,2021-03-11T14:53:13.958052-06:00,HCM-BROD-0613-C71_treatment,d125235a-7b80-421b-bde8-1f865fb3f8e4,,released,,0,2021-03-11T14:32:16.169484-06:00,,,
HCM-BROD-0613-C71,b3cc0754-6a21-4683-a491-b2fb8b6175a4,98d80c92-7a76-4e51-9770-a2fa1c1a863f,34.0,Adjuvant,28.0,2023-07-07T13:21:35.030120-05:00,HCM-BROD-0613-C71_treatment6,d773d9ec-457b-440e-bbf5-b27826152674,,released,,1,2021-08-25T20:31:52.368991-05:00,"Radiation Therapy, NOS",Residual Disease,
HCM-SANG-1305-C15,b3d87033-c8cd-431d-9ada-e3c6407a96bc,56e42793-7467-4318-a94c-362e7e543867,,Neoadjuvant,123.0,2025-04-07T17:13:09.336794-05:00,HCM-SANG-1305-C15_treatment3,3e6eaf0d-998d-45ae-bf45-f0fa66b05994,,released,Docetaxel,1,2023-02-27T12:13:25.689397-06:00,Chemotherapy,,
HCM-SANG-1305-C15,b3d87033-c8cd-431d-9ada-e3c6407a96bc,56e42793-7467-4318-a94c-362e7e543867,,Neoadjuvant,123.0,2025-04-07T17:13:09.336794-05:00,HCM-SANG-1305-C15_treatment,66434fd4-9a42-4a68-b48d-d346a8f79b59,,released,Leucovorin,1,2023-02-27T12:13:25.689397-06:00,Chemotherapy,,
HCM-SANG-1305-C15,b3d87033-c8cd-431d-9ada-e3c6407a96bc,56e42793-7467-4318-a94c-362e7e543867,,Neoadjuvant,123.0,2025-04-07T17:13:09.336794-05:00,HCM-SANG-1305-C15_treatment2,ccb6ad0d-c9e4-4d6a-9d2a-97bc59e47429,,released,Fluorouracil,1,2023-02-27T12:13:25.689397-06:00,Chemotherapy,,
HCM-SANG-1305-C15,b3d87033-c8cd-431d-9ada-e3c6407a96bc,56e42793-7467-4318-a94c-362e7e543867,,Neoadjuvant,123.0,2025-04-07T17:13:09.336794-05:00,HCM-SANG-1305-C15_treatment4,f6f2c2c0-3176-4478-939f-892948117357,,released,Oxaliplatin,1,2023-02-27T12:13:25.689397-06:00,Chemotherapy,,
HCM-SANG-0519-C20,b41f4663-31fe-405a-8abc-3d09f3d4163a,effe731f-0e65-48d8-ae79-99e34a401413,,Neoadjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-SANG-0519-C20_treatment,ced996aa-090f-4206-a300-75ed992b62dc,,released,,0,2021-12-21T15:13:02.883651-06:00,,,
HCM-BROD-0195-C71,b44ee47e-c360-41bf-8e0d-a95dc6f9f9cc,c5993e86-fe12-428b-9f7f-db1cc0021ce8,28.0,Adjuvant,25.0,2021-01-06T22:55:10.531130-06:00,HCM-BROD-0195-C71_treatment5,30cb36b1-3676-4adc-b85d-08470617e8dd,,released,Bevacizumab,1,2019-04-04T15:06:45.805167-05:00,Targeted Molecular Therapy,Residual Disease,
HCM-BROD-0195-C71,b44ee47e-c360-41bf-8e0d-a95dc6f9f9cc,c5993e86-fe12-428b-9f7f-db1cc0021ce8,49.0,Adjuvant,25.0,2021-01-06T22:55:10.531130-06:00,HCM-BROD-0195-C71_treatment2,3719a89a-9538-4a0e-9732-3f413ccd9dbe,,released,Temozolomide,1,2019-04-04T15:06:45.805167-05:00,Chemotherapy,Residual Disease,
HCM-BROD-0195-C71,b44ee47e-c360-41bf-8e0d-a95dc6f9f9cc,c5993e86-fe12-428b-9f7f-db1cc0021ce8,,Neoadjuvant,,2021-01-06T22:55:10.531130-06:00,HCM-BROD-0195-C71_treatment,3ffd8303-d622-456c-a663-d84e601e3a91,,released,,0,2019-04-04T15:06:45.805167-05:00,,,
HCM-BROD-0195-C71,b44ee47e-c360-41bf-8e0d-a95dc6f9f9cc,c5993e86-fe12-428b-9f7f-db1cc0021ce8,,,-3.0,2023-02-27T12:51:18.388710-06:00,HCM-BROD-0195-C71_treatment4,44fb0695-376c-44da-af58-2e38944bb75c,,released,,1,2019-04-04T15:06:45.805167-05:00,"Surgery, NOS",Initial Diagnosis,
HCM-BROD-0195-C71,b44ee47e-c360-41bf-8e0d-a95dc6f9f9cc,c5993e86-fe12-428b-9f7f-db1cc0021ce8,28.0,Adjuvant,25.0,2021-01-06T22:55:10.531130-06:00,HCM-BROD-0195-C71_treatment6,ae4ce8b1-4d5b-4f97-a17e-0e46ab17c5e9,,released,,1,2019-04-04T15:06:45.805167-05:00,"Radiation Therapy, NOS",Residual Disease,
HCM-BROD-0195-C71,b44ee47e-c360-41bf-8e0d-a95dc6f9f9cc,c5993e86-fe12-428b-9f7f-db1cc0021ce8,,Adjuvant,,2021-01-06T22:55:10.531130-06:00,HCM-BROD-0195-C71_treatment3,d048bbcd-8808-49c1-aad0-fce2c9b61a51,,released,,0,2019-04-04T15:06:45.805167-05:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-EXPT-0984-C34,b4c738d2-663f-4b18-ae65-e8397ce9a34e,2c501bbf-3b4a-4d7f-be34-5af76580a730,,Neoadjuvant,,2025-10-08T12:37:21.548354-05:00,HCM-EXPT-0984-C34_treatment,e7198915-6ed4-4265-9e44-297460086bc8,,released,,0,2021-12-21T14:50:35.217660-06:00,,,
HCM-BROD-0029-C71,b5160217-33c3-47cd-8540-44ca283c8464,f443f1a9-c536-4924-a69e-d1f5dc244f45,,Adjuvant,,2021-07-12T12:25:55.528644-05:00,HCM-BROD-0029-C71_treatment2,09885e5c-37d4-4d80-8005-51b4483d60be,,released,,0,2019-04-04T14:19:01.320721-05:00,Chemotherapy,Residual Disease,
HCM-BROD-0029-C71,b5160217-33c3-47cd-8540-44ca283c8464,f443f1a9-c536-4924-a69e-d1f5dc244f45,,,-6.0,2023-03-13T13:27:19.706801-05:00,HCM-BROD-0029-C71_treatment4,26ad6597-fc67-44c2-9c3c-c206002a1070,,released,,1,2019-04-04T14:19:01.320721-05:00,"Surgery, NOS",Initial Diagnosis,
HCM-BROD-0029-C71,b5160217-33c3-47cd-8540-44ca283c8464,f443f1a9-c536-4924-a69e-d1f5dc244f45,,Adjuvant,,2021-07-12T12:25:55.528644-05:00,HCM-BROD-0029-C71_treatment6,36e4cdd3-a094-4f75-a800-ccacdee5fbf3,,released,,0,2019-04-04T14:19:01.320721-05:00,"Radiation Therapy, NOS",Residual Disease,
HCM-BROD-0029-C71,b5160217-33c3-47cd-8540-44ca283c8464,f443f1a9-c536-4924-a69e-d1f5dc244f45,,Neoadjuvant,,2021-07-12T12:25:55.528644-05:00,HCM-BROD-0029-C71_treatment,4f6a0086-8e86-4a22-a0e8-5247c33c2d8c,,released,,0,2019-03-12T10:16:14.056923-05:00,,,
HCM-BROD-0029-C71,b5160217-33c3-47cd-8540-44ca283c8464,f443f1a9-c536-4924-a69e-d1f5dc244f45,239.0,Adjuvant,222.0,2021-07-12T12:25:55.528644-05:00,HCM-BROD-0029-C71_treatment5,5d74bcb1-abfe-4657-b6a3-843fcc83cbc3,,released,Bevacizumab,1,2019-04-04T14:19:01.320721-05:00,Targeted Molecular Therapy,Residual Disease,
HCM-BROD-0029-C71,b5160217-33c3-47cd-8540-44ca283c8464,f443f1a9-c536-4924-a69e-d1f5dc244f45,,Adjuvant,,2021-07-12T12:25:55.528644-05:00,HCM-BROD-0029-C71_treatment3,d86e7079-2230-4994-ab3b-970c7186ecb0,,released,,0,2019-04-04T14:19:01.320721-05:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-SANG-0526-C15,b519e4e3-46d7-4ac8-811d-899fd4ee1e9b,69aefe87-3a5b-410e-8c44-6380ea3848aa,,Neoadjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-SANG-0526-C15_treatment,c2dde05a-e96d-4f94-ba48-401f2448c599,,released,,0,2023-02-27T12:40:48.380787-06:00,,,
HCM-EXPT-1241-C20,b55e8368-6a56-4d21-8848-751bf59c4216,3810b360-5421-403f-94d2-d2c700b7891c,,Neoadjuvant,,2025-10-08T12:39:37.798161-05:00,HCM-EXPT-1241-C20_treatment,e3a51c09-d506-4538-8943-97c975adb336,,released,,0,2023-02-24T14:04:44.814698-06:00,,,
HCM-CSHL-0065-C20,b5fe3fa5-0f46-4e63-8e1f-dc3d28734936,027c64ba-cd09-40e9-9495-12142f99aeb6,,Neoadjuvant,,2019-05-24T12:11:41.511797-05:00,HCM-CSHL-0065-C20_treatment,264d526a-d2f1-4467-a79f-4ec36603ef77,,released,,0,2019-05-15T15:01:01.539372-05:00,,,
HCM-CSHL-0065-C20,b5fe3fa5-0f46-4e63-8e1f-dc3d28734936,027c64ba-cd09-40e9-9495-12142f99aeb6,,Adjuvant,,2023-03-13T13:12:30.451357-05:00,HCM-CSHL-0065-C20_treatment4,38911bae-56f7-409d-99d1-21b33a950812,,released,,0,2019-05-15T15:01:01.539372-05:00,"Radiation Therapy, NOS",Residual Disease,
HCM-CSHL-0065-C20,b5fe3fa5-0f46-4e63-8e1f-dc3d28734936,027c64ba-cd09-40e9-9495-12142f99aeb6,,,48.0,2023-03-13T13:12:30.451357-05:00,HCM-CSHL-0065-C20_treatment2,81c3c43d-8e0f-4095-a299-4c4bc185a63e,,released,,1,2019-05-15T15:01:01.539372-05:00,"Surgery, NOS",Initial Diagnosis,
HCM-CSHL-0065-C20,b5fe3fa5-0f46-4e63-8e1f-dc3d28734936,027c64ba-cd09-40e9-9495-12142f99aeb6,,Adjuvant,,2023-03-13T13:12:30.451357-05:00,HCM-CSHL-0065-C20_treatment3,8db0f431-51a2-4c17-a0c8-2c60ce097f4c,,released,,0,2019-05-15T15:01:01.539372-05:00,"Pharmaceutical Therapy, NOS",Residual Disease,
HCM-WCMC-0785-C67,b655b06f-fd1e-4e55-b9e0-d8181ab8f7a5,e56c36f6-6e5e-47e9-ae85-630c1164e5de,656.0,Adjuvant,61.0,2025-04-07T17:13:09.336794-05:00,HCM-WCMC-0785-C67_treatment5,00f27a54-4681-4f92-830e-f07af5b97ae9,,released,,1,2023-02-27T13:09:11.827042-06:00,Chemotherapy,Residual Disease,FOLFOX
HCM-WCMC-0785-C67,b655b06f-fd1e-4e55-b9e0-d8181ab8f7a5,e56c36f6-6e5e-47e9-ae85-630c1164e5de,633.0,Adjuvant,627.0,2025-04-07T17:13:09.336794-05:00,HCM-WCMC-0785-C67_treatment14,0ec677d3-e22a-4e28-afe7-231dfed20e44,,released,,1,2023-02-27T13:09:11.827042-06:00,"Radiation, Stereotactic/Gamma Knife/SRS",Residual Disease,
HCM-WCMC-0785-C67,b655b06f-fd1e-4e55-b9e0-d8181ab8f7a5,e56c36f6-6e5e-47e9-ae85-630c1164e5de,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-WCMC-0785-C67_treatment11,41c1e1e8-9911-4690-8329-3587c0f8cf04,,released,,0,2023-02-27T13:09:11.827042-06:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-WCMC-0785-C67,b655b06f-fd1e-4e55-b9e0-d8181ab8f7a5,e56c36f6-6e5e-47e9-ae85-630c1164e5de,656.0,Adjuvant,509.0,2025-04-07T17:13:09.336794-05:00,HCM-WCMC-0785-C67_treatment8,49298fc3-74f6-4631-8065-38647f436764,,released,,1,2023-02-27T13:09:11.827042-06:00,Chemotherapy,Residual Disease,FU-LV regimen
HCM-WCMC-0785-C67,b655b06f-fd1e-4e55-b9e0-d8181ab8f7a5,e56c36f6-6e5e-47e9-ae85-630c1164e5de,656.0,Adjuvant,509.0,2025-04-07T17:13:09.336794-05:00,HCM-WCMC-0785-C67_treatment9,5001e2c7-340e-4091-af91-2085f7e3134f,,released,Oxaliplatin,1,2023-02-27T13:09:11.827042-06:00,Chemotherapy,Residual Disease,
HCM-WCMC-0785-C67,b655b06f-fd1e-4e55-b9e0-d8181ab8f7a5,e56c36f6-6e5e-47e9-ae85-630c1164e5de,,,0.0,2025-04-07T17:13:09.336794-05:00,HCM-WCMC-0785-C67_treatment12,6f958ccf-fff3-40eb-a138-bb6a04b6f841,,released,,1,2023-02-27T13:09:11.827042-06:00,"Surgery, NOS",Initial Diagnosis,
HCM-WCMC-0785-C67,b655b06f-fd1e-4e55-b9e0-d8181ab8f7a5,e56c36f6-6e5e-47e9-ae85-630c1164e5de,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-WCMC-0785-C67_treatment13,8061da82-fcfd-4bea-ae33-941f68b821b3,,released,,0,2023-02-27T13:09:11.827042-06:00,Targeted Molecular Therapy,Residual Disease,
HCM-WCMC-0785-C67,b655b06f-fd1e-4e55-b9e0-d8181ab8f7a5,e56c36f6-6e5e-47e9-ae85-630c1164e5de,656.0,Adjuvant,61.0,2025-04-07T17:13:09.336794-05:00,HCM-WCMC-0785-C67_treatment3,8390ab93-0386-4554-931c-65c9d182562c,,released,Fluorouracil,1,2023-02-27T13:09:11.827042-06:00,Chemotherapy,Residual Disease,
HCM-WCMC-0785-C67,b655b06f-fd1e-4e55-b9e0-d8181ab8f7a5,e56c36f6-6e5e-47e9-ae85-630c1164e5de,656.0,Adjuvant,509.0,2025-04-07T17:13:09.336794-05:00,HCM-WCMC-0785-C67_treatment6,852fd510-39f8-4ae1-bba0-ac44d84f5a18,,released,Leucovorin,1,2023-02-27T13:09:11.827042-06:00,Chemotherapy,Residual Disease,
HCM-WCMC-0785-C67,b655b06f-fd1e-4e55-b9e0-d8181ab8f7a5,e56c36f6-6e5e-47e9-ae85-630c1164e5de,656.0,Adjuvant,61.0,2025-04-07T17:13:09.336794-05:00,HCM-WCMC-0785-C67_treatment4,9b15c602-7726-4830-b6cb-1695b46f78bb,,released,Oxaliplatin,1,2023-02-27T13:09:11.827042-06:00,Chemotherapy,Residual Disease,
HCM-WCMC-0785-C67,b655b06f-fd1e-4e55-b9e0-d8181ab8f7a5,e56c36f6-6e5e-47e9-ae85-630c1164e5de,656.0,Adjuvant,61.0,2025-04-07T17:13:09.336794-05:00,HCM-WCMC-0785-C67_treatment2,9e37a7e8-bd38-4767-9d31-790bfbbc60ed,,released,Leucovorin Calcium,1,2023-02-27T13:09:11.827042-06:00,Chemotherapy,Residual Disease,
HCM-WCMC-0785-C67,b655b06f-fd1e-4e55-b9e0-d8181ab8f7a5,e56c36f6-6e5e-47e9-ae85-630c1164e5de,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-WCMC-0785-C67_treatment10,b6237b3c-63c9-421b-83cf-7be5e013e2cc,,released,,0,2023-02-27T13:09:11.827042-06:00,Hormone Therapy,Residual Disease,
HCM-WCMC-0785-C67,b655b06f-fd1e-4e55-b9e0-d8181ab8f7a5,e56c36f6-6e5e-47e9-ae85-630c1164e5de,656.0,Adjuvant,509.0,2025-04-07T17:13:09.336794-05:00,HCM-WCMC-0785-C67_treatment7,c62a7a6a-445c-4792-ab24-d0feaa042fdf,,released,Fluorouracil,1,2023-02-27T13:09:11.827042-06:00,Chemotherapy,Residual Disease,
HCM-WCMC-0785-C67,b655b06f-fd1e-4e55-b9e0-d8181ab8f7a5,e56c36f6-6e5e-47e9-ae85-630c1164e5de,,Neoadjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-WCMC-0785-C67_treatment,d266e7f8-1cb3-4540-8661-3fb199441692,,released,,0,2023-02-27T13:09:11.827042-06:00,,,
HCM-BROD-0642-C43,b68751b4-ffee-4ab8-93e3-8b38866bffb8,63292b30-720b-4716-a655-a6a9e9305859,,Adjuvant,,2023-02-22T07:39:25.979291-06:00,HCM-BROD-0642-C43_treatment3,5cc206f3-1a12-44eb-b618-c11952c4841e,,released,,0,2021-12-21T13:42:14.109552-06:00,Hormone Therapy,Residual Disease,
HCM-BROD-0642-C43,b68751b4-ffee-4ab8-93e3-8b38866bffb8,63292b30-720b-4716-a655-a6a9e9305859,,,0.0,2023-02-27T12:39:44.744541-06:00,HCM-BROD-0642-C43_treatment5,61d07b57-d860-447a-984f-89703921f610,,released,,1,2021-12-21T13:42:14.109552-06:00,"Surgery, NOS",Initial Diagnosis,
HCM-BROD-0642-C43,b68751b4-ffee-4ab8-93e3-8b38866bffb8,63292b30-720b-4716-a655-a6a9e9305859,2469.0,Adjuvant,1762.0,2023-02-22T07:39:25.979291-06:00,HCM-BROD-0642-C43_treatment4,740ce2ec-ccce-4d8f-9b28-dcbaa140827f,Treatment Ongoing,released,Nivolumab,1,2021-12-21T13:42:14.109552-06:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-BROD-0642-C43,b68751b4-ffee-4ab8-93e3-8b38866bffb8,63292b30-720b-4716-a655-a6a9e9305859,,Adjuvant,,2023-02-22T07:39:25.979291-06:00,HCM-BROD-0642-C43_treatment6,81a4ef30-dd6a-4f6b-a22b-821e6b503fd6,,released,,0,2021-12-21T13:42:14.109552-06:00,Targeted Molecular Therapy,Residual Disease,
HCM-BROD-0642-C43,b68751b4-ffee-4ab8-93e3-8b38866bffb8,63292b30-720b-4716-a655-a6a9e9305859,,Adjuvant,,2023-02-22T07:39:25.979291-06:00,HCM-BROD-0642-C43_treatment2,afa42cfc-ffa6-4c6c-ada6-8c09cfa5c034,,released,,0,2021-12-21T13:42:14.109552-06:00,Chemotherapy,Residual Disease,
HCM-BROD-0642-C43,b68751b4-ffee-4ab8-93e3-8b38866bffb8,63292b30-720b-4716-a655-a6a9e9305859,,Neoadjuvant,,2023-02-22T07:39:25.979291-06:00,HCM-BROD-0642-C43_treatment,bb9cd46a-5f11-43da-a317-9a37fc628e0d,,released,,0,2021-12-21T13:42:14.109552-06:00,,,
HCM-BROD-0642-C43,b68751b4-ffee-4ab8-93e3-8b38866bffb8,63292b30-720b-4716-a655-a6a9e9305859,,Adjuvant,,2023-02-22T07:39:25.979291-06:00,HCM-BROD-0642-C43_treatment7,e4ce5a05-721a-4fe7-8b18-f20ed6f9090e,,released,,0,2021-12-21T13:42:14.109552-06:00,"Radiation Therapy, NOS",Residual Disease,
HCM-BROD-0642-C43,b68751b4-ffee-4ab8-93e3-8b38866bffb8,accd1509-52ae-4ad3-8fce-e25a1b259b09,,Maintenance Therapy,,2023-02-22T07:39:25.979291-06:00,HCM-BROD-0642-C43_treatment8,c5c9af9d-cc30-428e-be6e-783c98eb6733,Complete Response,released,Pembrolizumab,1,2021-12-21T13:42:14.109552-06:00,,,
HCM-SANG-1299-C15,b68a5c9e-76f3-47a2-b60f-35c99bb9ffbb,456b203d-2a42-49b1-83ec-88a42674e954,,Neoadjuvant,144.0,2025-04-07T17:13:09.336794-05:00,HCM-SANG-1299-C15_treatment3,7628da6d-7e8e-4640-bc4b-b0fd6caa9e95,,released,Cisplatin,1,2023-02-27T13:22:44.669887-06:00,Chemotherapy,,
HCM-SANG-1299-C15,b68a5c9e-76f3-47a2-b60f-35c99bb9ffbb,456b203d-2a42-49b1-83ec-88a42674e954,,Neoadjuvant,144.0,2025-04-07T17:13:09.336794-05:00,HCM-SANG-1299-C15_treatment,7e304794-c1ff-4aca-9a42-ed687179af57,,released,Epirubicin,1,2023-02-27T13:22:44.669887-06:00,Chemotherapy,,
HCM-SANG-1299-C15,b68a5c9e-76f3-47a2-b60f-35c99bb9ffbb,456b203d-2a42-49b1-83ec-88a42674e954,,Neoadjuvant,144.0,2025-04-07T17:13:09.336794-05:00,HCM-SANG-1299-C15_treatment4,86d0f4ee-fa4a-4764-adfb-810d1acd363d,,released,,1,2023-02-27T13:22:44.669887-06:00,Chemotherapy,,ECX
HCM-SANG-1299-C15,b68a5c9e-76f3-47a2-b60f-35c99bb9ffbb,456b203d-2a42-49b1-83ec-88a42674e954,,Neoadjuvant,144.0,2025-04-07T17:13:09.336794-05:00,HCM-SANG-1299-C15_treatment2,c7b653de-4eff-4f63-927b-00a92d2254f7,,released,Capecitabine,1,2023-02-27T13:22:44.669887-06:00,Chemotherapy,,
HCM-BROD-0097-C15,b6c440ae-67b1-46e0-a9fc-f08e51f15448,f33e4bf3-3d58-4abe-8d03-58f587d40a88,,,,2023-02-27T12:41:22.495041-06:00,HCM-BROD-0097-C15_treatment7,06a1c658-1455-4d0d-abcf-9f524fa5d3fa,,released,,0,2019-04-04T15:59:44.268527-05:00,"Surgery, NOS",Initial Diagnosis,
HCM-BROD-0097-C15,b6c440ae-67b1-46e0-a9fc-f08e51f15448,f33e4bf3-3d58-4abe-8d03-58f587d40a88,392.0,Adjuvant,315.0,2021-07-12T12:25:55.528644-05:00,HCM-BROD-0097-C15_treatment5,19995478-736f-4840-817e-fde58eef0fe1,,released,,1,2019-04-04T15:59:44.268527-05:00,Chemotherapy,Residual Disease,FU-LV regimen
HCM-BROD-0097-C15,b6c440ae-67b1-46e0-a9fc-f08e51f15448,f33e4bf3-3d58-4abe-8d03-58f587d40a88,,Adjuvant,,2021-07-12T12:25:55.528644-05:00,HCM-BROD-0097-C15_treatment6,32715a73-4dc2-41e3-b283-7c2c7ac2ba72,,released,,0,2019-04-04T15:59:44.268527-05:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-BROD-0097-C15,b6c440ae-67b1-46e0-a9fc-f08e51f15448,f33e4bf3-3d58-4abe-8d03-58f587d40a88,,Neoadjuvant,,2021-07-12T12:25:55.528644-05:00,HCM-BROD-0097-C15_treatment2,4ecc439e-908e-409e-b36a-b63415466fec,,released,,1,2019-04-04T15:59:44.268527-05:00,"Radiation Therapy, NOS",,
HCM-BROD-0097-C15,b6c440ae-67b1-46e0-a9fc-f08e51f15448,f33e4bf3-3d58-4abe-8d03-58f587d40a88,392.0,Adjuvant,315.0,2021-07-12T12:25:55.528644-05:00,HCM-BROD-0097-C15_treatment3,5ad478ce-486d-4819-9601-73b0f6cb8165,,released,Fluorouracil,1,2019-04-04T15:59:44.268527-05:00,Chemotherapy,Residual Disease,
HCM-BROD-0097-C15,b6c440ae-67b1-46e0-a9fc-f08e51f15448,f33e4bf3-3d58-4abe-8d03-58f587d40a88,,Neoadjuvant,,2021-07-12T12:25:55.528644-05:00,HCM-BROD-0097-C15_treatment,7ef8caf2-92ad-40af-9f58-3704b806ba9d,,released,Unknown,1,2019-04-04T15:59:44.268527-05:00,Chemotherapy,,
HCM-BROD-0097-C15,b6c440ae-67b1-46e0-a9fc-f08e51f15448,f33e4bf3-3d58-4abe-8d03-58f587d40a88,,Adjuvant,,2021-07-12T12:25:55.528644-05:00,HCM-BROD-0097-C15_treatment9,a3cc2b9b-46f9-411d-aad9-926ebd0ec5b6,,released,,0,2020-09-27T10:23:21.637490-05:00,"Radiation Therapy, NOS",Residual Disease,
HCM-BROD-0097-C15,b6c440ae-67b1-46e0-a9fc-f08e51f15448,f33e4bf3-3d58-4abe-8d03-58f587d40a88,392.0,Adjuvant,315.0,2021-07-12T12:25:55.528644-05:00,HCM-BROD-0097-C15_treatment4,f76e1623-f07e-462a-b171-674924ef5ded,,released,Leucovorin,1,2019-04-04T15:59:44.268527-05:00,Chemotherapy,Residual Disease,
HCM-BROD-0097-C15,b6c440ae-67b1-46e0-a9fc-f08e51f15448,f33e4bf3-3d58-4abe-8d03-58f587d40a88,,Adjuvant,,2021-07-12T12:25:55.528644-05:00,HCM-BROD-0097-C15_treatment8,fcd5608b-7c24-48f9-94ef-7cbc06c7aee8,,released,,0,2020-09-27T10:23:21.637490-05:00,Targeted Molecular Therapy,Residual Disease,
HCM-EXPT-1030-C18,b7036145-5949-4598-94ef-0e671416892b,a34e63f3-8789-413d-958f-4ad0a0033aaa,,Neoadjuvant,,2025-10-08T12:38:06.952582-05:00,HCM-EXPT-1030-C18_treatment,fd19fe9b-e791-4c03-a6dc-04d4b9b91156,,released,,0,2021-12-21T14:58:19.521030-06:00,,,
HCM-BROD-1078-C49,b72a905b-4179-4da4-8bfb-e0287d28bab2,a7fbe4bf-3035-4171-aff6-eda696553e4e,1342.0,Adjuvant,1271.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-1078-C49_treatment2,15d83e58-5529-4cc0-bff1-38cc5381a130,,released,Unknown,1,2021-12-21T14:00:47.487748-06:00,Chemotherapy,Residual Disease,
HCM-BROD-1078-C49,b72a905b-4179-4da4-8bfb-e0287d28bab2,a7fbe4bf-3035-4171-aff6-eda696553e4e,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-BROD-1078-C49_treatment7,3e193d54-4f77-4e05-a80c-03bb3ebee8c6,,released,,0,2021-12-21T14:00:47.487748-06:00,"Radiation Therapy, NOS",Residual Disease,
HCM-BROD-1078-C49,b72a905b-4179-4da4-8bfb-e0287d28bab2,a7fbe4bf-3035-4171-aff6-eda696553e4e,,,0.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-1078-C49_treatment5,41c72ba6-0d4c-45d4-9dcb-0ae2f24e1e07,,released,,1,2021-12-21T14:00:47.487748-06:00,"Surgery, NOS",Initial Diagnosis,
HCM-BROD-1078-C49,b72a905b-4179-4da4-8bfb-e0287d28bab2,a7fbe4bf-3035-4171-aff6-eda696553e4e,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-BROD-1078-C49_treatment3,963241f0-f78c-4e80-bd9e-2709c21dea00,,released,,0,2021-12-21T14:00:47.487748-06:00,Hormone Therapy,Residual Disease,
HCM-BROD-1078-C49,b72a905b-4179-4da4-8bfb-e0287d28bab2,a7fbe4bf-3035-4171-aff6-eda696553e4e,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-BROD-1078-C49_treatment4,c1415405-a231-4c97-86ff-b57ac37ad54f,,released,,0,2021-12-21T14:00:47.487748-06:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-BROD-1078-C49,b72a905b-4179-4da4-8bfb-e0287d28bab2,a7fbe4bf-3035-4171-aff6-eda696553e4e,,Neoadjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-BROD-1078-C49_treatment,db33142a-8639-4c5e-900a-e60c63ac713a,,released,,0,2021-12-21T14:00:47.487748-06:00,,,
HCM-BROD-1078-C49,b72a905b-4179-4da4-8bfb-e0287d28bab2,a7fbe4bf-3035-4171-aff6-eda696553e4e,1398.0,Adjuvant,1271.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-1078-C49_treatment6,f6b57081-0064-44a7-b6af-6e3400fb2f1b,Treatment Ongoing,released,Unknown,1,2021-12-21T14:00:47.487748-06:00,Targeted Molecular Therapy,Residual Disease,
HCM-EXPT-0364-C50,b7affc3b-dec4-48b4-afe8-c7b5d8c4f495,6c6742bd-27d7-4d81-9fb9-3b47db0dd610,,Neoadjuvant,,2025-10-08T12:36:32.654639-05:00,HCM-EXPT-0364-C50_treatment,93a80de6-0f8f-456d-add4-7570269d9471,,released,,0,2021-12-21T14:40:38.250613-06:00,,,
HCM-CSHL-0617-C22,b7db0140-9259-4949-bcff-36ad81db6306,e7dd3a67-317e-4098-9219-9e002de883d2,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0617-C22_treatment4,1590db6c-6aa4-438f-97cc-32dc06564a18,,released,,0,2021-12-21T14:12:08.012504-06:00,"Radiation Therapy, NOS",Residual Disease,
HCM-CSHL-0617-C22,b7db0140-9259-4949-bcff-36ad81db6306,e7dd3a67-317e-4098-9219-9e002de883d2,,Neoadjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0617-C22_treatment,4d93fbbd-baa2-48b2-8ddf-772517893a11,,released,,0,2021-12-21T14:12:08.012504-06:00,,,
HCM-CSHL-0617-C22,b7db0140-9259-4949-bcff-36ad81db6306,e7dd3a67-317e-4098-9219-9e002de883d2,,Neoadjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0617-C22_treatment5,56230ab1-5452-4056-88d3-b8180214fc16,,released,,1,2021-12-21T14:12:08.012504-06:00,,,
HCM-CSHL-0617-C22,b7db0140-9259-4949-bcff-36ad81db6306,e7dd3a67-317e-4098-9219-9e002de883d2,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0617-C22_treatment3,65b6293a-80ab-4526-90c2-7eaba21fc72f,,released,,0,2021-12-21T14:12:08.012504-06:00,"Pharmaceutical Therapy, NOS",Residual Disease,
HCM-CSHL-0617-C22,b7db0140-9259-4949-bcff-36ad81db6306,e7dd3a67-317e-4098-9219-9e002de883d2,,,-80.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0617-C22_treatment2,e9fccc74-a9a3-4478-bbc7-12fc0a07605b,,released,,1,2021-12-21T14:12:08.012504-06:00,"Surgery, NOS",Initial Diagnosis,
HCM-STAN-0627-C34,b89e2bf1-21be-4916-9cfc-3e75c52ecfa7,1161707b-5d1a-498d-83de-5ce49c99a0d1,,Adjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-STAN-0627-C34_treatment7,05047e21-8e89-46e0-b98b-f46deac2ddd2,,released,,0,2022-09-22T07:02:04.463899-05:00,Targeted Molecular Therapy,Residual Disease,
HCM-STAN-0627-C34,b89e2bf1-21be-4916-9cfc-3e75c52ecfa7,1161707b-5d1a-498d-83de-5ce49c99a0d1,209.0,Adjuvant,77.0,2025-03-31T16:34:59.906497-05:00,HCM-STAN-0627-C34_treatment3,30050b02-9b63-46d6-824a-b71f55f9b299,,released,Cisplatin,1,2022-09-22T07:02:04.463899-05:00,Chemotherapy,Residual Disease,
HCM-STAN-0627-C34,b89e2bf1-21be-4916-9cfc-3e75c52ecfa7,1161707b-5d1a-498d-83de-5ce49c99a0d1,,,56.0,2025-03-31T16:34:59.906497-05:00,HCM-STAN-0627-C34_treatment6,3c8f249b-0ea6-42b7-9149-ba3b3ccdc953,,released,,1,2022-09-22T07:02:04.463899-05:00,"Surgery, NOS",Initial Diagnosis,
HCM-STAN-0627-C34,b89e2bf1-21be-4916-9cfc-3e75c52ecfa7,1161707b-5d1a-498d-83de-5ce49c99a0d1,209.0,Adjuvant,77.0,2025-03-31T16:34:59.906497-05:00,HCM-STAN-0627-C34_treatment4,689dc0e0-efcd-4637-9360-b58b1a1bee12,,released,Gemcitabine,1,2022-09-22T07:02:04.463899-05:00,Chemotherapy,Residual Disease,
HCM-STAN-0627-C34,b89e2bf1-21be-4916-9cfc-3e75c52ecfa7,1161707b-5d1a-498d-83de-5ce49c99a0d1,,Adjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-STAN-0627-C34_treatment5,8310081a-b315-4eed-8bb7-1e972ffe02ef,,released,,0,2022-09-22T07:02:04.463899-05:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-STAN-0627-C34,b89e2bf1-21be-4916-9cfc-3e75c52ecfa7,1161707b-5d1a-498d-83de-5ce49c99a0d1,,Adjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-STAN-0627-C34_treatment8,f097646f-b3bf-43ca-8880-d523c340e864,,released,,0,2022-09-22T07:02:04.463899-05:00,"Radiation Therapy, NOS",Residual Disease,
HCM-STAN-0914-C34,b9ff4f43-7add-4cf0-a72d-cdfc92cc6b7d,56bc193e-9948-4ac7-94a7-789930f139bf,,Maintenance Therapy,704.0,2025-04-07T17:13:09.336794-05:00,HCM-STAN-0914-C34_treatment5,b5eab272-4be6-4731-ab49-115d916d21c2,Progressive Disease,released,Osimertinib,1,2023-02-28T13:38:57.891162-06:00,,,
HCM-STAN-0914-C34,b9ff4f43-7add-4cf0-a72d-cdfc92cc6b7d,9a07853f-8ad0-4960-a4ca-2ee6058736c2,,,,2025-04-07T17:13:09.336794-05:00,HCM-STAN-0914-C34_treatment2,4484a8ce-02e0-4e87-b26b-19c68ed3ace8,,released,,0,2022-09-22T07:09:17.978969-05:00,"Surgery, NOS",Initial Diagnosis,
HCM-STAN-0914-C34,b9ff4f43-7add-4cf0-a72d-cdfc92cc6b7d,9a07853f-8ad0-4960-a4ca-2ee6058736c2,,Neoadjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-STAN-0914-C34_treatment,a6bfc6e6-f999-4610-88cf-58f5b8df9d24,,released,,0,2022-09-22T07:09:17.978969-05:00,,,
HCM-BROD-0923-C64,ba085153-6dbd-4134-a78d-1be7579f8369,8aba8985-c48b-41fd-841c-861a9a9ea10e,,,0.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0923-C64_treatment5,30537b67-c064-42e8-8af9-96f4f99e371d,,released,,1,2021-12-21T13:57:02.327815-06:00,"Surgery, NOS",Initial Diagnosis,
HCM-BROD-0923-C64,ba085153-6dbd-4134-a78d-1be7579f8369,8aba8985-c48b-41fd-841c-861a9a9ea10e,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0923-C64_treatment6,399b7747-393a-4536-a3cf-47d5fa55f075,,released,,0,2021-12-21T13:57:02.327815-06:00,Targeted Molecular Therapy,Residual Disease,
HCM-BROD-0923-C64,ba085153-6dbd-4134-a78d-1be7579f8369,8aba8985-c48b-41fd-841c-861a9a9ea10e,153.0,Adjuvant,30.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0923-C64_treatment3,52c31b18-46be-4680-8690-462538e6b93f,,released,Doxorubicin Hydrochloride,1,2021-12-21T13:57:02.327815-06:00,Chemotherapy,Residual Disease,
HCM-BROD-0923-C64,ba085153-6dbd-4134-a78d-1be7579f8369,8aba8985-c48b-41fd-841c-861a9a9ea10e,183.0,Adjuvant,0.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0923-C64_treatment2,5c4c88e2-0bef-4850-9bbd-4f921f663004,,released,Vincristine,1,2021-12-21T13:57:02.327815-06:00,Chemotherapy,Residual Disease,
HCM-BROD-0923-C64,ba085153-6dbd-4134-a78d-1be7579f8369,8aba8985-c48b-41fd-841c-861a9a9ea10e,,Neoadjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0923-C64_treatment,6bc0143b-2ea4-4399-b92e-d1a016d63b48,,released,,0,2021-12-21T13:57:02.327815-06:00,,,
HCM-BROD-0923-C64,ba085153-6dbd-4134-a78d-1be7579f8369,8aba8985-c48b-41fd-841c-861a9a9ea10e,61.0,Adjuvant,30.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0923-C64_treatment7,71a4677d-0a01-4816-ac5d-b81f64714e5f,,released,,1,2021-12-21T13:57:02.327815-06:00,"Radiation, Intensity-Modulated Radiotherapy",Residual Disease,
HCM-BROD-0923-C64,ba085153-6dbd-4134-a78d-1be7579f8369,8aba8985-c48b-41fd-841c-861a9a9ea10e,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0923-C64_treatment4,f594daeb-b3a8-4383-b0a1-a8dfba240f1e,,released,,0,2021-12-21T13:57:02.327815-06:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-CSHL-0636-C02,ba455f85-09e8-4da3-8bf1-750848adc52d,adecc939-c479-46fe-913c-e865fd706a82,,,43.0,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0636-C02_treatment5,1117774d-1d8e-419f-a94f-548803406d22,,released,,1,2020-10-08T13:32:20.959263-05:00,"Surgery, NOS",Initial Diagnosis,
HCM-CSHL-0636-C02,ba455f85-09e8-4da3-8bf1-750848adc52d,adecc939-c479-46fe-913c-e865fd706a82,,Adjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0636-C02_treatment7,54df6357-b1b1-4473-9945-b9680e5ba010,,released,,0,2020-10-08T13:32:20.959263-05:00,"Radiation Therapy, NOS",Residual Disease,
HCM-CSHL-0636-C02,ba455f85-09e8-4da3-8bf1-750848adc52d,adecc939-c479-46fe-913c-e865fd706a82,,Neoadjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0636-C02_treatment,8dd4b796-ed9a-45cb-a6dc-b682d1179683,,released,,0,2020-10-08T13:32:20.959263-05:00,,,
HCM-CSHL-0636-C02,ba455f85-09e8-4da3-8bf1-750848adc52d,adecc939-c479-46fe-913c-e865fd706a82,,Adjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0636-C02_treatment3,aaff419a-328e-4523-becb-a70c5eb725e2,,released,,0,2020-10-08T13:32:20.959263-05:00,Hormone Therapy,Residual Disease,
HCM-CSHL-0636-C02,ba455f85-09e8-4da3-8bf1-750848adc52d,adecc939-c479-46fe-913c-e865fd706a82,,Adjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0636-C02_treatment4,ad7abb1e-c234-4b73-a148-d3053003559e,,released,,0,2020-10-08T13:32:20.959263-05:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-CSHL-0636-C02,ba455f85-09e8-4da3-8bf1-750848adc52d,adecc939-c479-46fe-913c-e865fd706a82,,Adjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0636-C02_treatment6,ea6034ed-6620-4f27-a6ba-4050488c2d73,,released,,0,2020-10-08T13:32:20.959263-05:00,Targeted Molecular Therapy,Residual Disease,
HCM-CSHL-0636-C02,ba455f85-09e8-4da3-8bf1-750848adc52d,adecc939-c479-46fe-913c-e865fd706a82,75.0,Adjuvant,33.0,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0636-C02_treatment2,f221fb27-2eec-4166-bff5-d58d6390b411,,released,Cisplatin,1,2020-10-08T13:32:20.959263-05:00,Chemotherapy,Residual Disease,
HCM-BROD-0047-C71,babbc3cb-14b7-4894-b91d-c160f4cb48e0,58796e30-de8c-46fe-883f-53c49f918c77,,Neoadjuvant,,2020-01-13T20:10:25.832065-06:00,HCM-BROD-0047-C71_treatment,aa7d98f0-43e1-4829-9e61-253420bf87f0,,released,,0,2019-03-12T10:14:29.676556-05:00,,,
HCM-BROD-0047-C71,babbc3cb-14b7-4894-b91d-c160f4cb48e0,58796e30-de8c-46fe-883f-53c49f918c77,,,-5.0,2023-02-27T12:50:47.373684-06:00,HCM-BROD-0047-C71_treatment4,f016fe2c-fc74-4c8f-827c-bd566faeb5c3,,released,,1,2019-04-08T09:49:22.693558-05:00,"Surgery, NOS",Initial Diagnosis,
HCM-BROD-0721-C43,bae134d5-d971-4fff-9c92-64e399e0d3ce,3b82b5d6-0b3a-47b9-b130-5021974fbcf8,1258.0,Maintenance Therapy,468.0,2023-02-22T07:39:25.979291-06:00,HCM-BROD-0721-C43_treatment8,a4ae0de0-4891-49fd-915d-5f1da6fc38d7,Complete Response,released,Pembrolizumab,1,2021-12-21T13:48:17.092398-06:00,,,
HCM-BROD-0721-C43,bae134d5-d971-4fff-9c92-64e399e0d3ce,901c2557-f576-404c-ada5-091740185336,,Adjuvant,,2023-02-22T07:39:25.979291-06:00,HCM-BROD-0721-C43_treatment6,3e907a4e-570e-4e7a-85fe-74aab82522b4,,released,,0,2021-12-21T13:48:17.092398-06:00,Targeted Molecular Therapy,Residual Disease,
HCM-BROD-0721-C43,bae134d5-d971-4fff-9c92-64e399e0d3ce,901c2557-f576-404c-ada5-091740185336,,Neoadjuvant,468.0,2023-02-22T07:39:25.979291-06:00,HCM-BROD-0721-C43_treatment,50e3c8a7-0fb6-4ebf-9341-05b33a3d6dc5,,released,Pembrolizumab,1,2021-12-21T13:48:17.092398-06:00,Immunotherapy (Including Vaccines),,
HCM-BROD-0721-C43,bae134d5-d971-4fff-9c92-64e399e0d3ce,901c2557-f576-404c-ada5-091740185336,,,0.0,2023-02-27T12:32:41.487837-06:00,HCM-BROD-0721-C43_treatment5,73fd57dd-ae50-4019-ba9b-31bdf12e2bcf,,released,,1,2021-12-21T13:48:17.092398-06:00,"Surgery, NOS",Initial Diagnosis,
HCM-BROD-0721-C43,bae134d5-d971-4fff-9c92-64e399e0d3ce,901c2557-f576-404c-ada5-091740185336,,Adjuvant,,2023-02-22T07:39:25.979291-06:00,HCM-BROD-0721-C43_treatment2,79016dad-9e4f-43eb-a3bf-3995bfff57ab,,released,,0,2021-12-21T13:48:17.092398-06:00,Chemotherapy,Residual Disease,
HCM-BROD-0721-C43,bae134d5-d971-4fff-9c92-64e399e0d3ce,901c2557-f576-404c-ada5-091740185336,1258.0,Adjuvant,866.0,2023-02-22T07:39:25.979291-06:00,HCM-BROD-0721-C43_treatment4,7e231114-b885-46cc-9fd8-7d0d89150ab8,,released,Pembrolizumab,1,2021-12-21T13:48:17.092398-06:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-BROD-0721-C43,bae134d5-d971-4fff-9c92-64e399e0d3ce,901c2557-f576-404c-ada5-091740185336,,Adjuvant,,2023-02-22T07:39:25.979291-06:00,HCM-BROD-0721-C43_treatment3,a07ac284-2f33-40bd-906d-e5437bb62f69,,released,,0,2021-12-21T13:48:17.092398-06:00,Hormone Therapy,Residual Disease,
HCM-BROD-0721-C43,bae134d5-d971-4fff-9c92-64e399e0d3ce,901c2557-f576-404c-ada5-091740185336,,Adjuvant,,2023-02-22T07:39:25.979291-06:00,HCM-BROD-0721-C43_treatment7,cc990abe-bffc-4f21-a447-172ce10ec5fa,,released,,0,2021-12-21T13:48:17.092398-06:00,"Radiation Therapy, NOS",Residual Disease,
HCM-BROD-0225-C43,bb71a9ce-2934-40a4-a99a-b8e5b5491a55,3cc998f4-43b8-4bcf-85cc-0e875882931a,2786.0,Maintenance Therapy,1420.0,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0225-C43_treatment8,2e983d13-72cf-4f62-b051-ef63d9757567,Stable Disease,released,Not Otherwise Specified,1,2020-09-17T16:06:27.860274-05:00,,,
HCM-BROD-0225-C43,bb71a9ce-2934-40a4-a99a-b8e5b5491a55,3fdb31b7-5655-4f62-a217-c97f1e51845d,,Neoadjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0225-C43_treatment,35fdc9b7-133d-4fe2-beed-8ea01afbe096,,released,,0,2020-09-17T16:06:27.860274-05:00,,,
HCM-BROD-0225-C43,bb71a9ce-2934-40a4-a99a-b8e5b5491a55,3fdb31b7-5655-4f62-a217-c97f1e51845d,,Adjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0225-C43_treatment2,427def5c-0b51-4de0-8b9a-ca480d55d148,,released,,0,2020-09-17T16:06:27.860274-05:00,Chemotherapy,Residual Disease,
HCM-BROD-0225-C43,bb71a9ce-2934-40a4-a99a-b8e5b5491a55,3fdb31b7-5655-4f62-a217-c97f1e51845d,,Adjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0225-C43_treatment7,98d6a826-2d1d-4a1d-bf75-b03c561d0e73,,released,,0,2020-09-17T16:06:27.860274-05:00,"Radiation Therapy, NOS",Residual Disease,
HCM-BROD-0225-C43,bb71a9ce-2934-40a4-a99a-b8e5b5491a55,3fdb31b7-5655-4f62-a217-c97f1e51845d,,Adjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0225-C43_treatment3,9cd36100-7b1b-454c-bc9e-f4122229d576,,released,,0,2020-09-17T16:06:27.860274-05:00,Hormone Therapy,Residual Disease,
HCM-BROD-0225-C43,bb71a9ce-2934-40a4-a99a-b8e5b5491a55,3fdb31b7-5655-4f62-a217-c97f1e51845d,2917.0,Adjuvant,2876.0,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0225-C43_treatment4,9ce99f64-9acb-4842-98e5-500ad35d43c1,,released,Not Reported,1,2020-09-17T16:06:27.860274-05:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-BROD-0225-C43,bb71a9ce-2934-40a4-a99a-b8e5b5491a55,3fdb31b7-5655-4f62-a217-c97f1e51845d,,Adjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0225-C43_treatment6,a25b2649-ecc4-42ec-8e50-92e85f7ef414,,released,,0,2020-09-17T16:06:27.860274-05:00,Targeted Molecular Therapy,Residual Disease,
HCM-CSHL-0608-C17,bc1f75d5-8910-45ee-ae52-0d34ee41ee02,efdb7f21-24bc-4be0-a723-5dca68cb8844,,Neoadjuvant,-459.0,2024-05-07T14:59:44.030028-05:00,HCM-CSHL-0608-C17_treatment2,28cc82c8-a08e-4ea0-904f-c0e71bf7ebb8,,released,Streptozocin,1,2021-12-21T14:12:05.127154-06:00,Chemotherapy,,
HCM-CSHL-0608-C17,bc1f75d5-8910-45ee-ae52-0d34ee41ee02,efdb7f21-24bc-4be0-a723-5dca68cb8844,,Neoadjuvant,-490.0,2024-05-07T14:59:44.030028-05:00,HCM-CSHL-0608-C17_treatment4,4564fbcc-3ace-44bf-b990-91e7521faebf,,released,Lanreotide Acetate,1,2021-12-21T14:12:05.127154-06:00,Hormone Therapy,,
HCM-CSHL-0608-C17,bc1f75d5-8910-45ee-ae52-0d34ee41ee02,efdb7f21-24bc-4be0-a723-5dca68cb8844,,Adjuvant,,2023-03-13T13:32:39.550055-05:00,HCM-CSHL-0608-C17_treatment6,7c08bc40-8740-48fc-aa3b-92ef2f31f8a6,,released,,0,2021-12-21T14:12:05.127154-06:00,"Pharmaceutical Therapy, NOS",Residual Disease,
HCM-CSHL-0608-C17,bc1f75d5-8910-45ee-ae52-0d34ee41ee02,efdb7f21-24bc-4be0-a723-5dca68cb8844,,Neoadjuvant,-459.0,2024-05-07T14:59:44.030028-05:00,HCM-CSHL-0608-C17_treatment3,9e1357f9-9a55-4492-a90b-34739466614e,,released,Everolimus,1,2021-12-21T14:12:05.127154-06:00,Chemotherapy,,
HCM-CSHL-0608-C17,bc1f75d5-8910-45ee-ae52-0d34ee41ee02,efdb7f21-24bc-4be0-a723-5dca68cb8844,,Adjuvant,137.0,2023-03-13T13:32:39.550055-05:00,HCM-CSHL-0608-C17_treatment7,ad0f08fc-9a3d-412b-aeef-11eee8b02982,,released,,1,2021-12-21T14:12:05.127154-06:00,Peptide Receptor Radionuclide Therapy (PRRT),Residual Disease,
HCM-CSHL-0608-C17,bc1f75d5-8910-45ee-ae52-0d34ee41ee02,efdb7f21-24bc-4be0-a723-5dca68cb8844,,,-9.0,2023-03-13T13:32:39.550055-05:00,HCM-CSHL-0608-C17_treatment5,d690aaee-4c16-4813-965c-790d9eec86ab,,released,,1,2021-12-21T14:12:05.127154-06:00,"Surgery, NOS",Initial Diagnosis,
HCM-CSHL-0608-C17,bc1f75d5-8910-45ee-ae52-0d34ee41ee02,efdb7f21-24bc-4be0-a723-5dca68cb8844,,Neoadjuvant,-459.0,2024-05-07T14:59:44.030028-05:00,HCM-CSHL-0608-C17_treatment,f6dfa768-918b-4e99-ac07-3707e417f328,,released,Fluorouracil,1,2021-12-21T14:12:05.127154-06:00,Chemotherapy,,
HCM-CSHL-0378-C18,bc9d0b90-993d-4ecd-95cc-4514410e25ea,37a924b4-6021-480c-9f06-2cde00f2d431,,,13.0,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0378-C18_treatment2,4815b25b-91eb-444c-bebc-2d09864fda1e,,released,,1,2020-09-28T09:56:09.685950-05:00,"Surgery, NOS",Initial Diagnosis,
HCM-CSHL-0378-C18,bc9d0b90-993d-4ecd-95cc-4514410e25ea,37a924b4-6021-480c-9f06-2cde00f2d431,,Adjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0378-C18_treatment4,51415803-d434-4908-ad9a-d23ea6615c62,,released,,0,2020-09-28T09:56:09.685950-05:00,"Radiation Therapy, NOS",Residual Disease,
HCM-CSHL-0378-C18,bc9d0b90-993d-4ecd-95cc-4514410e25ea,37a924b4-6021-480c-9f06-2cde00f2d431,,Neoadjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0378-C18_treatment,5ceb4aef-317b-4b8d-817d-61e52daa9872,,released,,0,2020-09-28T09:56:09.685950-05:00,,,
HCM-CSHL-0378-C18,bc9d0b90-993d-4ecd-95cc-4514410e25ea,37a924b4-6021-480c-9f06-2cde00f2d431,,Adjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0378-C18_treatment3,df93bde1-9381-47b2-97d1-612e2415da84,,released,,0,2020-09-28T09:56:09.685950-05:00,"Pharmaceutical Therapy, NOS",Residual Disease,
HCM-CSHL-0880-C18,bd21e38c-bc6a-42f4-b10a-64f009c0d25a,9b502b5b-a7b8-4f07-9d95-95b4b3be5efb,170.0,Maintenance Therapy,42.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0880-C18_treatment11,0ec09ca1-2137-48ab-a60d-201d8c869c98,Not Reported,released,Oxaliplatin,1,2021-12-21T14:38:13.271162-06:00,,,
HCM-CSHL-0880-C18,bd21e38c-bc6a-42f4-b10a-64f009c0d25a,9b502b5b-a7b8-4f07-9d95-95b4b3be5efb,170.0,Maintenance Therapy,42.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0880-C18_treatment13,6ca2776a-9655-404b-aaef-c55a23d8b33c,Not Reported,released,Fluorouracil,1,2021-12-21T14:38:13.271162-06:00,,,
HCM-CSHL-0880-C18,bd21e38c-bc6a-42f4-b10a-64f009c0d25a,9b502b5b-a7b8-4f07-9d95-95b4b3be5efb,170.0,Maintenance Therapy,42.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0880-C18_treatment14,d7706395-5ac8-4a54-a112-d0395b5c543d,Not Reported,released,,1,2021-12-21T14:38:13.271162-06:00,,,FOLFOX
HCM-CSHL-0880-C18,bd21e38c-bc6a-42f4-b10a-64f009c0d25a,9b502b5b-a7b8-4f07-9d95-95b4b3be5efb,170.0,Maintenance Therapy,42.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0880-C18_treatment12,f224d5ba-b2cf-44ea-a1cf-7139a68c40dc,Not Reported,released,Leucovorin Calcium,1,2021-12-21T14:38:13.271162-06:00,,,
HCM-CSHL-0880-C18,bd21e38c-bc6a-42f4-b10a-64f009c0d25a,9b502b5b-a7b8-4f07-9d95-95b4b3be5efb,170.0,Maintenance Therapy,42.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0880-C18_treatment10,f3e5f4d0-93a4-435b-97db-13a6d7ada492,Not Reported,released,Bevacizumab,1,2021-12-21T14:38:13.271162-06:00,,,
HCM-CSHL-0880-C18,bd21e38c-bc6a-42f4-b10a-64f009c0d25a,f9c61623-a73f-43b5-a9bd-9074782a9b22,171.0,Adjuvant,64.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0880-C18_treatment8,226d85e4-abf9-46fc-a299-da238f3fd708,,released,Bevacizumab,1,2021-12-21T14:38:13.271162-06:00,Targeted Molecular Therapy,Residual Disease,
HCM-CSHL-0880-C18,bd21e38c-bc6a-42f4-b10a-64f009c0d25a,f9c61623-a73f-43b5-a9bd-9074782a9b22,171.0,Adjuvant,64.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0880-C18_treatment2,25504313-3aa1-4ad2-a4cd-66a7ccc6e8f3,,released,Leucovorin Calcium,1,2021-12-21T14:38:13.271162-06:00,Chemotherapy,Residual Disease,
HCM-CSHL-0880-C18,bd21e38c-bc6a-42f4-b10a-64f009c0d25a,f9c61623-a73f-43b5-a9bd-9074782a9b22,,,1.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0880-C18_treatment7,3ec919b6-344e-418d-a870-7f2538348b65,,released,,1,2021-12-21T14:38:13.271162-06:00,"Surgery, NOS",Initial Diagnosis,
HCM-CSHL-0880-C18,bd21e38c-bc6a-42f4-b10a-64f009c0d25a,f9c61623-a73f-43b5-a9bd-9074782a9b22,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0880-C18_treatment9,55fb1696-7313-43be-832d-cd0930c73fd0,,released,,0,2021-12-21T14:38:13.271162-06:00,"Radiation Therapy, NOS",Residual Disease,
HCM-CSHL-0880-C18,bd21e38c-bc6a-42f4-b10a-64f009c0d25a,f9c61623-a73f-43b5-a9bd-9074782a9b22,171.0,Adjuvant,64.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0880-C18_treatment4,6ea6efe0-8cae-4aee-a339-6d163e41593b,,released,Oxaliplatin,1,2021-12-21T14:38:13.271162-06:00,Chemotherapy,Residual Disease,
HCM-CSHL-0880-C18,bd21e38c-bc6a-42f4-b10a-64f009c0d25a,f9c61623-a73f-43b5-a9bd-9074782a9b22,171.0,Adjuvant,64.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0880-C18_treatment3,84711e82-5779-4b45-86a1-7d470bbac4ce,,released,Fluorouracil,1,2021-12-21T14:38:13.271162-06:00,Chemotherapy,Residual Disease,
HCM-CSHL-0880-C18,bd21e38c-bc6a-42f4-b10a-64f009c0d25a,f9c61623-a73f-43b5-a9bd-9074782a9b22,171.0,Adjuvant,64.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0880-C18_treatment5,ac0b70b8-f921-4a13-975b-1b0581a2c772,,released,,1,2021-12-21T14:38:13.271162-06:00,Chemotherapy,Residual Disease,FOLFOX
HCM-CSHL-0880-C18,bd21e38c-bc6a-42f4-b10a-64f009c0d25a,f9c61623-a73f-43b5-a9bd-9074782a9b22,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0880-C18_treatment6,bdda7631-6ad9-4add-be13-43def337f9d7,,released,,0,2021-12-21T14:38:13.271162-06:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-CSHL-0880-C18,bd21e38c-bc6a-42f4-b10a-64f009c0d25a,f9c61623-a73f-43b5-a9bd-9074782a9b22,,Neoadjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0880-C18_treatment,c5f7f91e-b1ae-403f-844b-55dae7466837,,released,,0,2021-12-21T14:38:13.271162-06:00,,,
HCM-BROD-1131-C06,be13c558-9f05-46c5-9dd3-b45050a5bb12,032f6922-fe0a-4d2e-b236-fa842c202132,,,0.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-1131-C06_treatment2,929afb4d-5df5-47f8-9c9a-fd19d70046de,,released,,1,2021-12-21T14:02:43.894700-06:00,"Surgery, NOS",Initial Diagnosis,
HCM-BROD-1131-C06,be13c558-9f05-46c5-9dd3-b45050a5bb12,032f6922-fe0a-4d2e-b236-fa842c202132,,Neoadjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-BROD-1131-C06_treatment,9938dc2d-4513-4b54-884a-47777f733cd4,,released,,0,2021-12-21T14:02:43.894700-06:00,,,
HCM-BROD-1131-C06,be13c558-9f05-46c5-9dd3-b45050a5bb12,032f6922-fe0a-4d2e-b236-fa842c202132,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-BROD-1131-C06_treatment3,cb29866b-ce7f-400a-9392-25c5465a4f5a,,released,,0,2021-12-21T14:02:43.894700-06:00,"Pharmaceutical Therapy, NOS",Residual Disease,
HCM-BROD-1131-C06,be13c558-9f05-46c5-9dd3-b45050a5bb12,032f6922-fe0a-4d2e-b236-fa842c202132,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-BROD-1131-C06_treatment4,e7f37064-83fd-4144-b335-397ea540e83f,,released,,0,2021-12-21T14:02:43.894700-06:00,"Radiation Therapy, NOS",Residual Disease,
HCM-BROD-0200-C71,be408fe2-5f92-4593-9b1d-190a4d46f9f8,9a05a4e1-7711-4a63-bd28-77cc6c8c2ddd,,,-9.0,2023-02-27T13:21:10.844513-06:00,HCM-BROD-0200-C71_treatment4,1036fe2a-6f4f-4ab5-8cda-b3569e59aa90,,released,,1,2020-02-27T12:34:54.905008-06:00,"Surgery, NOS",Initial Diagnosis,
HCM-BROD-0200-C71,be408fe2-5f92-4593-9b1d-190a4d46f9f8,9a05a4e1-7711-4a63-bd28-77cc6c8c2ddd,,Adjuvant,,2023-02-22T07:39:25.979291-06:00,HCM-BROD-0200-C71_treatment3,5dce854e-6a7b-4f5b-be1d-6e42045a7001,,released,,0,2020-02-27T12:34:54.905008-06:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-BROD-0200-C71,be408fe2-5f92-4593-9b1d-190a4d46f9f8,9a05a4e1-7711-4a63-bd28-77cc6c8c2ddd,,Neoadjuvant,,2023-02-22T07:39:25.979291-06:00,HCM-BROD-0200-C71_treatment,600c7c88-bc4e-48aa-a57d-9ab9acb98d9f,,released,,0,2019-04-04T15:01:44.993944-05:00,,,
HCM-BROD-0200-C71,be408fe2-5f92-4593-9b1d-190a4d46f9f8,9a05a4e1-7711-4a63-bd28-77cc6c8c2ddd,360.0,Adjuvant,57.0,2023-02-22T07:39:25.979291-06:00,HCM-BROD-0200-C71_treatment2,6c69d098-bd5b-4ade-be07-71ad16a76705,,released,Temozolomide,1,2020-02-27T12:34:54.905008-06:00,Chemotherapy,Residual Disease,
HCM-BROD-0200-C71,be408fe2-5f92-4593-9b1d-190a4d46f9f8,9a05a4e1-7711-4a63-bd28-77cc6c8c2ddd,,Adjuvant,,2023-02-22T07:39:25.979291-06:00,HCM-BROD-0200-C71_treatment5,d23a8e33-d116-4e79-a840-7a3aa34cefc9,,released,,0,2020-02-27T12:34:54.905008-06:00,Targeted Molecular Therapy,Residual Disease,
HCM-BROD-0200-C71,be408fe2-5f92-4593-9b1d-190a4d46f9f8,9a05a4e1-7711-4a63-bd28-77cc6c8c2ddd,,Adjuvant,,2023-02-22T07:39:25.979291-06:00,HCM-BROD-0200-C71_treatment6,ee27c606-8bed-49b7-a9f6-8dc45737729d,,released,,0,2020-02-27T12:34:54.905008-06:00,"Radiation Therapy, NOS",Residual Disease,
HCM-BROD-0413-C25,bea1726c-ae87-4697-8d35-06c37eee0999,da6af363-88cf-403a-9ffb-ff942c71e24b,436.0,Adjuvant,370.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0413-C25_treatment6,07344cc6-6519-4a9d-9d1c-35a9533aef10,,released,Gemcitabine,1,2020-09-27T11:30:43.095544-05:00,Chemotherapy,Residual Disease,
HCM-BROD-0413-C25,bea1726c-ae87-4697-8d35-06c37eee0999,da6af363-88cf-403a-9ffb-ff942c71e24b,,Neoadjuvant,23.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0413-C25_treatment3,2dd176d2-1568-40f4-abc6-924961531893,,released,Fluorouracil,1,2020-09-27T11:30:43.095544-05:00,Chemotherapy,,
HCM-BROD-0413-C25,bea1726c-ae87-4697-8d35-06c37eee0999,da6af363-88cf-403a-9ffb-ff942c71e24b,436.0,Adjuvant,370.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0413-C25_treatment7,3927d443-ba77-4b14-8283-1443f1d1523f,,released,Nab-paclitaxel,1,2020-09-27T11:30:43.095544-05:00,Chemotherapy,Residual Disease,
HCM-BROD-0413-C25,bea1726c-ae87-4697-8d35-06c37eee0999,da6af363-88cf-403a-9ffb-ff942c71e24b,,Neoadjuvant,23.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0413-C25_treatment2,3d40263e-c3d7-4d6f-97f6-746af03b4270,,released,Leucovorin Calcium,1,2020-09-27T11:30:43.095544-05:00,Chemotherapy,,
HCM-BROD-0413-C25,bea1726c-ae87-4697-8d35-06c37eee0999,da6af363-88cf-403a-9ffb-ff942c71e24b,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0413-C25_treatment10,57eb5ea2-7f20-42b2-b2a7-740d9d84dab1,,released,,0,2020-09-27T11:30:43.095544-05:00,Targeted Molecular Therapy,Residual Disease,
HCM-BROD-0413-C25,bea1726c-ae87-4697-8d35-06c37eee0999,da6af363-88cf-403a-9ffb-ff942c71e24b,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0413-C25_treatment11,68525ba6-f2cd-4251-bacb-5f26e7c5cce4,,released,,0,2020-09-27T11:30:43.095544-05:00,"Radiation Therapy, NOS",Residual Disease,
HCM-BROD-0413-C25,bea1726c-ae87-4697-8d35-06c37eee0999,da6af363-88cf-403a-9ffb-ff942c71e24b,,Neoadjuvant,23.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0413-C25_treatment5,7ab979dc-f0bd-4d1d-9f05-ffae0ef85308,,released,,1,2020-09-27T11:30:43.095544-05:00,Chemotherapy,,FOLFIRINOX
HCM-BROD-0413-C25,bea1726c-ae87-4697-8d35-06c37eee0999,da6af363-88cf-403a-9ffb-ff942c71e24b,,Neoadjuvant,23.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0413-C25_treatment4,98e4b748-7e6c-4755-a03f-382150d3b681,,released,Oxaliplatin,1,2020-09-27T11:30:43.095544-05:00,Chemotherapy,,
HCM-BROD-0413-C25,bea1726c-ae87-4697-8d35-06c37eee0999,da6af363-88cf-403a-9ffb-ff942c71e24b,,Neoadjuvant,23.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0413-C25_treatment,b580fbec-e7bc-4688-921e-4e9cb4c174c3,,released,Irinotecan Hydrochloride,1,2020-09-27T11:30:43.095544-05:00,Chemotherapy,,
HCM-BROD-0413-C25,bea1726c-ae87-4697-8d35-06c37eee0999,da6af363-88cf-403a-9ffb-ff942c71e24b,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0413-C25_treatment8,de590567-7891-4bdc-9ba6-7d274aa10b71,,released,,0,2020-09-27T11:30:43.095544-05:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-BROD-0043-C16,bea4ff97-4e53-434e-b260-81d6aa33106d,776e5d52-b0fb-46c2-b0ac-12c23882c298,,,,2023-03-13T13:33:32.380710-05:00,HCM-BROD-0043-C16_treatment2,21c7e153-1b15-4337-aeb1-db3fa4e5c49c,,released,,0,2019-04-04T15:20:11.998625-05:00,"Surgery, NOS",Initial Diagnosis,
HCM-BROD-0043-C16,bea4ff97-4e53-434e-b260-81d6aa33106d,776e5d52-b0fb-46c2-b0ac-12c23882c298,,Adjuvant,,2023-03-13T13:33:32.380710-05:00,HCM-BROD-0043-C16_treatment4,4e4cf6e4-8ee2-4b42-9cb5-99fdbc60a337,,released,,0,2019-04-04T15:20:11.998625-05:00,"Radiation Therapy, NOS",Residual Disease,
HCM-BROD-0043-C16,bea4ff97-4e53-434e-b260-81d6aa33106d,776e5d52-b0fb-46c2-b0ac-12c23882c298,,Adjuvant,,2023-03-13T13:33:32.380710-05:00,HCM-BROD-0043-C16_treatment3,56b76ca1-6642-4a93-8747-8dbe79fdcd3e,,released,,0,2019-04-04T15:20:11.998625-05:00,"Pharmaceutical Therapy, NOS",Residual Disease,
HCM-BROD-0043-C16,bea4ff97-4e53-434e-b260-81d6aa33106d,776e5d52-b0fb-46c2-b0ac-12c23882c298,,Neoadjuvant,,2021-03-03T15:15:08.075155-06:00,HCM-BROD-0043-C16_treatment,8d1f851f-9325-45b8-b629-041eecf564e1,,released,,0,2019-04-04T15:20:11.998625-05:00,,,
HCM-BROD-0472-C34,bf1dca4b-9176-4390-9ba9-6b0bcf3ccf04,49c748de-9d9b-4224-a069-6f189369ae9c,76.0,Adjuvant,29.0,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0472-C34_treatment2,19181081-7d0d-424a-b108-f07f20026e6d,,released,Carboplatin,1,2020-09-27T11:44:52.849074-05:00,Chemotherapy,Residual Disease,
HCM-BROD-0472-C34,bf1dca4b-9176-4390-9ba9-6b0bcf3ccf04,49c748de-9d9b-4224-a069-6f189369ae9c,,Adjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0472-C34_treatment6,3a88ce38-2cad-4adf-8149-5c4a2302e30e,,released,,0,2020-09-27T11:44:52.849074-05:00,Targeted Molecular Therapy,Residual Disease,
HCM-BROD-0472-C34,bf1dca4b-9176-4390-9ba9-6b0bcf3ccf04,49c748de-9d9b-4224-a069-6f189369ae9c,,Adjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0472-C34_treatment4,5fcc779f-bd74-4555-8b2f-af5abf8f9fbf,,released,,0,2020-09-27T11:44:52.849074-05:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-BROD-0472-C34,bf1dca4b-9176-4390-9ba9-6b0bcf3ccf04,49c748de-9d9b-4224-a069-6f189369ae9c,,Neoadjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0472-C34_treatment,86bee889-a02a-4cde-9e0c-0c2ee9e5b74e,,released,,0,2020-09-27T11:44:52.849074-05:00,,,
HCM-BROD-0472-C34,bf1dca4b-9176-4390-9ba9-6b0bcf3ccf04,49c748de-9d9b-4224-a069-6f189369ae9c,,,,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0472-C34_treatment5,da592f71-00bd-4c8f-9a13-2d2410d76623,,released,,0,2020-09-27T11:44:52.849074-05:00,"Surgery, NOS",Initial Diagnosis,
HCM-BROD-0472-C34,bf1dca4b-9176-4390-9ba9-6b0bcf3ccf04,49c748de-9d9b-4224-a069-6f189369ae9c,48.0,Adjuvant,43.0,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0472-C34_treatment7,f8d8f7ac-8641-4bb9-b0a6-869a3d3fd644,,released,,1,2020-09-27T11:44:52.849074-05:00,"Radiation, 2D Conventional",Residual Disease,
HCM-BROD-0472-C34,bf1dca4b-9176-4390-9ba9-6b0bcf3ccf04,49c748de-9d9b-4224-a069-6f189369ae9c,76.0,Adjuvant,29.0,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0472-C34_treatment3,fdc4f648-91b6-4bed-8814-6eb9484cc2b8,,released,Pemetrexed,1,2020-09-27T11:44:52.849074-05:00,Chemotherapy,Residual Disease,
HCM-BROD-0955-C15,bf369dae-eb71-46f7-8e5b-196b1ebcc168,4cd9f7ae-a578-449c-9c60-235e031e811c,80.0,Maintenance Therapy,24.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0955-C15_treatment10,50c6bcf3-d158-43e1-99ce-41f7fd0d0219,Progressive Disease,released,Capmatinib,1,2021-12-21T13:58:33.827628-06:00,,,
HCM-BROD-0955-C15,bf369dae-eb71-46f7-8e5b-196b1ebcc168,4cd9f7ae-a578-449c-9c60-235e031e811c,80.0,Maintenance Therapy,24.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0955-C15_treatment8,5a8dcf3e-ed1c-46ec-b4da-52a64db87673,Progressive Disease,released,Fluorouracil,1,2021-12-21T13:58:33.827628-06:00,,,
HCM-BROD-0955-C15,bf369dae-eb71-46f7-8e5b-196b1ebcc168,4cd9f7ae-a578-449c-9c60-235e031e811c,80.0,Maintenance Therapy,24.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0955-C15_treatment9,6a20dd6c-df64-4c91-bc97-877d8f21dbb0,Progressive Disease,released,Ramucirumab,1,2021-12-21T13:58:33.827628-06:00,,,
HCM-BROD-0955-C15,bf369dae-eb71-46f7-8e5b-196b1ebcc168,4cd9f7ae-a578-449c-9c60-235e031e811c,80.0,Maintenance Therapy,24.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0955-C15_treatment7,700975b1-7ca7-4598-bcb0-30471cf7740b,Progressive Disease,released,Leucovorin Calcium,1,2023-02-28T13:09:27.089187-06:00,,,
HCM-BROD-0955-C15,bf369dae-eb71-46f7-8e5b-196b1ebcc168,4cd9f7ae-a578-449c-9c60-235e031e811c,80.0,Maintenance Therapy,24.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0955-C15_treatment11,72ef8fcf-4821-4cf6-9a94-8eca099ef765,Progressive Disease,released,,1,2021-12-21T13:58:33.827628-06:00,,,FOLFOX
HCM-BROD-0955-C15,bf369dae-eb71-46f7-8e5b-196b1ebcc168,4cd9f7ae-a578-449c-9c60-235e031e811c,80.0,Maintenance Therapy,24.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0955-C15_treatment6,99e4828b-ba75-403f-8298-9a191b199665,Progressive Disease,released,Paclitaxel,1,2023-02-28T13:09:27.089187-06:00,,,
HCM-BROD-0955-C15,bf369dae-eb71-46f7-8e5b-196b1ebcc168,4cd9f7ae-a578-449c-9c60-235e031e811c,80.0,Maintenance Therapy,24.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0955-C15_treatment5,ae030512-6627-46b2-ae7c-17655ba04fe8,Progressive Disease,released,Oxaliplatin,1,2023-02-28T13:09:27.089187-06:00,,,
HCM-BROD-0955-C15,bf369dae-eb71-46f7-8e5b-196b1ebcc168,bf62c7f4-82c9-4b56-8623-c80374215ff0,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0955-C15_treatment3,279769e2-6fa9-45ce-a4f8-3c7a4d195643,,released,,0,2021-12-21T13:58:33.827628-06:00,"Pharmaceutical Therapy, NOS",Residual Disease,
HCM-BROD-0955-C15,bf369dae-eb71-46f7-8e5b-196b1ebcc168,bf62c7f4-82c9-4b56-8623-c80374215ff0,,Neoadjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0955-C15_treatment,52dcbeb2-b15e-4bc0-af41-e0c2b6dbc923,,released,,0,2021-12-21T13:58:33.827628-06:00,,,
HCM-BROD-0955-C15,bf369dae-eb71-46f7-8e5b-196b1ebcc168,bf62c7f4-82c9-4b56-8623-c80374215ff0,,,,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0955-C15_treatment2,c93a2a32-22d9-4033-9dbd-af68cc5f91d4,,released,,0,2021-12-21T13:58:33.827628-06:00,"Surgery, NOS",Initial Diagnosis,
HCM-BROD-0955-C15,bf369dae-eb71-46f7-8e5b-196b1ebcc168,bf62c7f4-82c9-4b56-8623-c80374215ff0,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0955-C15_treatment4,f1f4d82d-45c9-445f-aabc-6fb942c6bbb5,,released,,0,2021-12-21T13:58:33.827628-06:00,"Radiation Therapy, NOS",Residual Disease,
HCM-CSHL-0606-C17,bf582b38-0592-4076-bd3e-900d06d7d8a8,c3743908-e078-4b20-9d2e-04bd476d1e9f,,Adjuvant,,2023-07-13T10:35:44.371881-05:00,HCM-CSHL-0606-C17_treatment8,17e7217b-761a-462b-b21e-0edf5d7970dd,,released,,0,2021-12-21T14:09:46.673449-06:00,"Radiation Therapy, NOS",Residual Disease,
HCM-CSHL-0606-C17,bf582b38-0592-4076-bd3e-900d06d7d8a8,c3743908-e078-4b20-9d2e-04bd476d1e9f,,Adjuvant,,2023-07-13T10:35:44.371881-05:00,HCM-CSHL-0606-C17_treatment4,18b9c338-46e0-4383-9d49-f4acb4d12f4d,,released,,0,2021-12-21T14:09:46.673449-06:00,Hormone Therapy,Residual Disease,
HCM-CSHL-0606-C17,bf582b38-0592-4076-bd3e-900d06d7d8a8,c3743908-e078-4b20-9d2e-04bd476d1e9f,204.0,Adjuvant,56.0,2023-07-13T10:35:44.371881-05:00,HCM-CSHL-0606-C17_treatment3,21f209f2-d561-4630-bab3-9e0f6016f418,,released,Capecitabine,1,2021-12-21T14:09:46.673449-06:00,Chemotherapy,Residual Disease,
HCM-CSHL-0606-C17,bf582b38-0592-4076-bd3e-900d06d7d8a8,c3743908-e078-4b20-9d2e-04bd476d1e9f,,,-6.0,2023-07-13T10:35:44.371881-05:00,HCM-CSHL-0606-C17_treatment6,57125674-cccc-400a-a446-3409a59f76a1,,released,,1,2021-12-21T14:09:46.673449-06:00,"Surgery, NOS",Initial Diagnosis,
HCM-CSHL-0606-C17,bf582b38-0592-4076-bd3e-900d06d7d8a8,c3743908-e078-4b20-9d2e-04bd476d1e9f,,Neoadjuvant,,2023-07-13T10:35:44.371881-05:00,HCM-CSHL-0606-C17_treatment,5a85ca2d-5e71-4bd7-b634-0d46fa72c001,,released,,0,2021-12-21T14:09:46.673449-06:00,,,
HCM-CSHL-0606-C17,bf582b38-0592-4076-bd3e-900d06d7d8a8,c3743908-e078-4b20-9d2e-04bd476d1e9f,,Adjuvant,,2023-07-13T10:35:44.371881-05:00,HCM-CSHL-0606-C17_treatment5,bca40079-fb47-4d1b-b706-d80a5f5f05ba,,released,,0,2021-12-21T14:09:46.673449-06:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-CSHL-0606-C17,bf582b38-0592-4076-bd3e-900d06d7d8a8,c3743908-e078-4b20-9d2e-04bd476d1e9f,,Adjuvant,,2023-07-13T10:35:44.371881-05:00,HCM-CSHL-0606-C17_treatment7,c8b5e081-ed4a-4910-b408-4a2a307613e2,,released,,0,2021-12-21T14:09:46.673449-06:00,Targeted Molecular Therapy,Residual Disease,
HCM-CSHL-0606-C17,bf582b38-0592-4076-bd3e-900d06d7d8a8,c3743908-e078-4b20-9d2e-04bd476d1e9f,204.0,Adjuvant,56.0,2023-07-13T10:35:44.371881-05:00,HCM-CSHL-0606-C17_treatment2,e01c8e1c-e56e-4f81-974a-7b2218ce8082,,released,Oxaliplatin,1,2021-12-21T14:09:46.673449-06:00,Chemotherapy,Residual Disease,
HCM-SANG-1083-C16,bf87fe29-de9d-437b-925f-2da57830070c,dfb44a9a-e701-45a9-8890-9746e221ccf2,,Neoadjuvant,92.0,2025-03-31T16:34:59.906497-05:00,HCM-SANG-1083-C16_treatment3,6c6e31a3-99de-40e5-b68c-1d160fcd3096,,released,Docetaxel,1,2023-02-27T12:29:28.834927-06:00,Chemotherapy,,
HCM-SANG-1083-C16,bf87fe29-de9d-437b-925f-2da57830070c,dfb44a9a-e701-45a9-8890-9746e221ccf2,,Neoadjuvant,92.0,2025-03-31T16:34:59.906497-05:00,HCM-SANG-1083-C16_treatment,7b59e269-413f-4c81-b848-d42dea9c32c3,,released,Leucovorin,1,2023-02-27T12:29:28.834927-06:00,Chemotherapy,,
HCM-SANG-1083-C16,bf87fe29-de9d-437b-925f-2da57830070c,dfb44a9a-e701-45a9-8890-9746e221ccf2,,Neoadjuvant,92.0,2025-03-31T16:34:59.906497-05:00,HCM-SANG-1083-C16_treatment2,a8d3c4f9-0a8c-4ea6-8344-f58b62b33947,,released,Fluorouracil,1,2023-02-27T12:29:28.834927-06:00,Chemotherapy,,
HCM-SANG-1083-C16,bf87fe29-de9d-437b-925f-2da57830070c,dfb44a9a-e701-45a9-8890-9746e221ccf2,,Neoadjuvant,92.0,2025-03-31T16:34:59.906497-05:00,HCM-SANG-1083-C16_treatment4,e7a379cc-a021-4537-bc51-f210b100fd60,,released,Oxaliplatin,1,2023-02-27T12:29:28.834927-06:00,Chemotherapy,,
HCM-CSHL-0056-C18,bfe15f44-e1dd-46ed-b429-908822d0a781,000db971-fd42-4030-ac42-e606531ec9d0,,Neoadjuvant,,2020-10-20T19:20:06.800740-05:00,HCM-CSHL-0056-C18_treatment,452b4591-3fe0-4a11-ace2-1054a233d2d4,,released,,0,2020-02-27T12:37:46.290948-06:00,,,
HCM-CSHL-0056-C18,bfe15f44-e1dd-46ed-b429-908822d0a781,000db971-fd42-4030-ac42-e606531ec9d0,,,50.0,2023-03-13T13:26:25.157213-05:00,HCM-CSHL-0056-C18_treatment2,c934b5ea-03e3-47fd-8ea9-cb7b8dfdbea7,,released,,1,2020-02-27T12:37:46.290948-06:00,"Surgery, NOS",Initial Diagnosis,
HCM-CSHL-0820-C34,c045ba6f-3078-4dbd-9163-5ccd75cc1259,03280498-0125-48d7-b2a0-d972a14717c6,,Maintenance Therapy,,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0820-C34_treatment7,a29078c0-247c-45b6-b8c2-1af7fc1ef44a,Treatment Ongoing,released,Carboplatin,1,2021-12-21T14:29:36.487318-06:00,,,
HCM-CSHL-0820-C34,c045ba6f-3078-4dbd-9163-5ccd75cc1259,03280498-0125-48d7-b2a0-d972a14717c6,,Maintenance Therapy,,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0820-C34_treatment9,b4d53081-09e3-4a4f-8ef2-ed5669ab0365,Treatment Ongoing,released,Erlotinib,1,2021-12-21T14:29:36.487318-06:00,,,
HCM-CSHL-0820-C34,c045ba6f-3078-4dbd-9163-5ccd75cc1259,03280498-0125-48d7-b2a0-d972a14717c6,,Maintenance Therapy,,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0820-C34_treatment8,cb44bc97-b741-4e63-a26b-eca239e7721b,Treatment Ongoing,released,Paclitaxel,1,2021-12-21T14:29:36.487318-06:00,,,
HCM-CSHL-0820-C34,c045ba6f-3078-4dbd-9163-5ccd75cc1259,c2c0b9be-2726-4dbe-98a1-1a58bc5fd839,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0820-C34_treatment2,2a46d8f5-c058-4a0d-be83-df53e4353ac8,,released,,0,2021-12-21T14:29:36.487318-06:00,Chemotherapy,Residual Disease,
HCM-CSHL-0820-C34,c045ba6f-3078-4dbd-9163-5ccd75cc1259,c2c0b9be-2726-4dbe-98a1-1a58bc5fd839,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0820-C34_treatment3,410e9781-ddc6-42c4-bb8f-dc5a67553fd9,,released,,0,2021-12-21T14:29:36.487318-06:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-CSHL-0820-C34,c045ba6f-3078-4dbd-9163-5ccd75cc1259,c2c0b9be-2726-4dbe-98a1-1a58bc5fd839,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0820-C34_treatment6,759b86cb-66a8-492c-b404-c9316f178197,,released,,0,2021-12-21T14:29:36.487318-06:00,"Radiation Therapy, NOS",Residual Disease,
HCM-CSHL-0820-C34,c045ba6f-3078-4dbd-9163-5ccd75cc1259,c2c0b9be-2726-4dbe-98a1-1a58bc5fd839,,,620.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0820-C34_treatment4,9006043c-7cd9-490e-9f88-c3c539a3e83b,,released,,1,2021-12-21T14:29:36.487318-06:00,"Surgery, NOS",Initial Diagnosis,
HCM-CSHL-0820-C34,c045ba6f-3078-4dbd-9163-5ccd75cc1259,c2c0b9be-2726-4dbe-98a1-1a58bc5fd839,,Neoadjuvant,63.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0820-C34_treatment,9e40cb68-6930-45e8-b081-cea97f9ccc8f,,released,,1,2021-12-21T14:29:36.487318-06:00,"Radiation, 2D Conventional",,
HCM-CSHL-0820-C34,c045ba6f-3078-4dbd-9163-5ccd75cc1259,c2c0b9be-2726-4dbe-98a1-1a58bc5fd839,,Adjuvant,643.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0820-C34_treatment5,a6298990-b413-4170-a7b8-821e62fd8fdb,Treatment Ongoing,released,Erlotinib,1,2021-12-21T14:29:36.487318-06:00,Targeted Molecular Therapy,Residual Disease,
HCM-CSHL-0178-C25,c04e722d-67a3-40ad-af5d-858b6eab0f6a,85afd906-a960-497a-a7cd-93ec89371c91,,Adjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0178-C25_treatment5,5b2b3e05-5aac-44a4-a97f-21a7330293e6,,released,,0,2020-09-28T09:13:17.218745-05:00,Targeted Molecular Therapy,Residual Disease,
HCM-CSHL-0178-C25,c04e722d-67a3-40ad-af5d-858b6eab0f6a,85afd906-a960-497a-a7cd-93ec89371c91,,,-8.0,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0178-C25_treatment4,5da7a4ed-ca2d-437d-b801-4d1ceb35ec4c,,released,,1,2020-09-28T09:13:17.218745-05:00,"Surgery, NOS",Initial Diagnosis,
HCM-CSHL-0178-C25,c04e722d-67a3-40ad-af5d-858b6eab0f6a,85afd906-a960-497a-a7cd-93ec89371c91,,Adjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0178-C25_treatment3,8a92b9fb-05df-45fb-9362-b0d8b359d71d,,released,,0,2020-09-28T09:13:17.218745-05:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-CSHL-0178-C25,c04e722d-67a3-40ad-af5d-858b6eab0f6a,85afd906-a960-497a-a7cd-93ec89371c91,,Neoadjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0178-C25_treatment,a29d1ade-b12c-49cc-81b9-1473b1f80022,,released,,0,2020-09-28T09:13:17.218745-05:00,,,
HCM-CSHL-0178-C25,c04e722d-67a3-40ad-af5d-858b6eab0f6a,85afd906-a960-497a-a7cd-93ec89371c91,,Adjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0178-C25_treatment6,e8623b22-e991-40e0-bdd2-de5c2efaca92,,released,,0,2020-09-28T09:13:17.218745-05:00,"Radiation Therapy, NOS",Residual Disease,
HCM-CSHL-0178-C25,c04e722d-67a3-40ad-af5d-858b6eab0f6a,85afd906-a960-497a-a7cd-93ec89371c91,,Adjuvant,47.0,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0178-C25_treatment2,f6c47165-e468-43e9-a70d-0b4b301b881d,,released,Gemcitabine,1,2020-09-28T09:13:17.218745-05:00,Chemotherapy,Residual Disease,
HCM-EXPT-1050-C18,c0d09c37-7571-4ea6-af52-7d17c344172e,48f90b4b-da1e-463a-96ba-bc55cc064d4d,,Neoadjuvant,,2025-10-08T12:38:06.952582-05:00,HCM-EXPT-1050-C18_treatment,6463edab-d0a9-48c9-bb24-61e1e98fe17e,,released,,0,2021-12-21T15:01:34.713805-06:00,,,
HCM-EXPT-1244-C18,c0fcadbc-11f7-4dc9-8cf4-906419ea84e6,f2a30240-fdd9-4e47-a9c3-a62220a2d709,,Neoadjuvant,,2025-10-08T12:39:37.798161-05:00,HCM-EXPT-1244-C18_treatment,5d9920a5-0f35-4446-badc-8bbe53db6cc1,,released,,0,2023-02-24T14:09:50.228616-06:00,,,
HCM-WCMC-0749-C34,c14d7245-1a9c-45cf-b284-8f49c3fe2ec9,65917837-b46b-46ca-97a2-e8007e514f0f,,Adjuvant,,2023-11-07T14:20:00.017270-06:00,HCM-WCMC-0749-C34_treatment3,3e575f83-2ece-4761-a93c-4351e7330df4,,released,,0,2023-02-27T12:53:43.965698-06:00,"Pharmaceutical Therapy, NOS",Residual Disease,
HCM-WCMC-0749-C34,c14d7245-1a9c-45cf-b284-8f49c3fe2ec9,65917837-b46b-46ca-97a2-e8007e514f0f,,Neoadjuvant,,2023-11-07T14:20:00.017270-06:00,HCM-WCMC-0749-C34_treatment,4a98d4f7-9e64-4068-a71d-d5039dc71cfd,,released,,0,2023-02-27T12:53:43.965698-06:00,,,
HCM-WCMC-0749-C34,c14d7245-1a9c-45cf-b284-8f49c3fe2ec9,65917837-b46b-46ca-97a2-e8007e514f0f,,,262.0,2023-11-07T14:20:00.017270-06:00,HCM-WCMC-0749-C34_treatment2,7040a381-2dd5-4148-9ede-ea40ed3577e4,,released,,1,2023-02-27T12:53:43.965698-06:00,"Surgery, NOS",Initial Diagnosis,
HCM-WCMC-0749-C34,c14d7245-1a9c-45cf-b284-8f49c3fe2ec9,65917837-b46b-46ca-97a2-e8007e514f0f,,Adjuvant,,2023-11-07T14:20:00.017270-06:00,HCM-WCMC-0749-C34_treatment4,c25e158f-c76d-4d27-a362-8054b6c97db0,,released,,0,2023-02-27T12:53:43.965698-06:00,"Radiation Therapy, NOS",Residual Disease,
HCM-CSHL-1096-C44,c156af60-87f6-496a-b847-33ed9c51ac18,5aba16f9-fdd0-4631-94eb-c966ac6766b2,,,363.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-1096-C44_treatment5,14e95d95-87e6-400e-bf59-87ecb53da024,,released,,1,2021-12-21T14:38:56.979805-06:00,"Surgery, NOS",Initial Diagnosis,
HCM-CSHL-1096-C44,c156af60-87f6-496a-b847-33ed9c51ac18,5aba16f9-fdd0-4631-94eb-c966ac6766b2,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-1096-C44_treatment2,5694987c-57f3-46bb-9f32-04ea35f848bb,,released,,0,2021-12-21T14:38:56.979805-06:00,Chemotherapy,Residual Disease,
HCM-CSHL-1096-C44,c156af60-87f6-496a-b847-33ed9c51ac18,5aba16f9-fdd0-4631-94eb-c966ac6766b2,,Neoadjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-1096-C44_treatment,745a7a12-b151-472a-aadf-48360b2eb56d,,released,,0,2021-12-21T14:38:56.979805-06:00,,,
HCM-CSHL-1096-C44,c156af60-87f6-496a-b847-33ed9c51ac18,5aba16f9-fdd0-4631-94eb-c966ac6766b2,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-1096-C44_treatment3,984101d8-7820-4f21-ac06-b1c0bf31764d,,released,,0,2021-12-21T14:38:56.979805-06:00,Hormone Therapy,Residual Disease,
HCM-CSHL-1096-C44,c156af60-87f6-496a-b847-33ed9c51ac18,5aba16f9-fdd0-4631-94eb-c966ac6766b2,106.0,Adjuvant,56.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-1096-C44_treatment8,a1f5a23d-be76-46ab-b63b-9aa63191f3be,,released,,1,2021-12-21T14:38:56.979805-06:00,"Radiation, Intensity-Modulated Radiotherapy",Residual Disease,
HCM-CSHL-1096-C44,c156af60-87f6-496a-b847-33ed9c51ac18,5aba16f9-fdd0-4631-94eb-c966ac6766b2,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-1096-C44_treatment4,c8532081-70d6-4933-9e1d-1e137d195e6f,,released,,0,2021-12-21T14:38:56.979805-06:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-CSHL-1096-C44,c156af60-87f6-496a-b847-33ed9c51ac18,5aba16f9-fdd0-4631-94eb-c966ac6766b2,,,0.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-1096-C44_treatment6,ddddaaa2-99a4-4b7e-bdee-e98b667edb10,,released,,1,2021-12-21T14:38:56.979805-06:00,"Surgery, NOS",Initial Diagnosis,
HCM-CSHL-1096-C44,c156af60-87f6-496a-b847-33ed9c51ac18,5aba16f9-fdd0-4631-94eb-c966ac6766b2,252.0,Adjuvant,231.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-1096-C44_treatment7,fec59f44-ce81-47f5-be07-24643a65d941,Treatment Ongoing,released,Pembrolizumab,1,2021-12-21T14:38:56.979805-06:00,Targeted Molecular Therapy,Residual Disease,
HCM-BROD-1128-C15,c17e8249-b8d4-4d88-b0f3-d27aeb6a15a4,16016586-44fb-4602-ad7e-80e8e57111d8,253.0,Maintenance Therapy,29.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-1128-C15_treatment11,08098f71-8232-4c9b-b922-6e2a1cec50ca,Progressive Disease,released,Fluorouracil,1,2021-12-21T14:02:12.322064-06:00,,,
HCM-BROD-1128-C15,c17e8249-b8d4-4d88-b0f3-d27aeb6a15a4,16016586-44fb-4602-ad7e-80e8e57111d8,253.0,Maintenance Therapy,29.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-1128-C15_treatment10,26aa25a0-0166-4476-9af7-3bd1aebfd883,Progressive Disease,released,Leucovorin Calcium,1,2021-12-21T14:02:12.322064-06:00,,,
HCM-BROD-1128-C15,c17e8249-b8d4-4d88-b0f3-d27aeb6a15a4,16016586-44fb-4602-ad7e-80e8e57111d8,253.0,Maintenance Therapy,29.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-1128-C15_treatment8,4df6ec92-4728-42ed-8793-fd4ca9f6146e,Progressive Disease,released,Paclitaxel,1,2021-12-21T14:02:12.322064-06:00,,,
HCM-BROD-1128-C15,c17e8249-b8d4-4d88-b0f3-d27aeb6a15a4,16016586-44fb-4602-ad7e-80e8e57111d8,253.0,Maintenance Therapy,29.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-1128-C15_treatment12,6825f2e0-3a6d-4445-99b5-6d8c428a6615,Progressive Disease,released,,1,2021-12-21T14:02:12.322064-06:00,,,FOLFOX
HCM-BROD-1128-C15,c17e8249-b8d4-4d88-b0f3-d27aeb6a15a4,16016586-44fb-4602-ad7e-80e8e57111d8,253.0,Maintenance Therapy,29.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-1128-C15_treatment9,b5a251cb-eecd-4a7c-b29c-b5ad6d120ec7,Progressive Disease,released,Carboplatin,1,2021-12-21T14:02:12.322064-06:00,,,
HCM-BROD-1128-C15,c17e8249-b8d4-4d88-b0f3-d27aeb6a15a4,16016586-44fb-4602-ad7e-80e8e57111d8,253.0,Maintenance Therapy,29.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-1128-C15_treatment7,cc4cd813-93a4-4da8-a0c5-bd2280516a00,Progressive Disease,released,Oxaliplatin,1,2021-12-21T14:02:12.322064-06:00,,,
HCM-BROD-1128-C15,c17e8249-b8d4-4d88-b0f3-d27aeb6a15a4,95dbc5ad-3a9c-44ab-b9ab-c181b88876f0,303.0,Adjuvant,262.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-1128-C15_treatment5,08b6d52a-2e70-4517-8e0b-ae18124ed62b,Treatment Ongoing,released,Ramucirumab,1,2021-12-21T14:02:12.322064-06:00,Targeted Molecular Therapy,Residual Disease,
HCM-BROD-1128-C15,c17e8249-b8d4-4d88-b0f3-d27aeb6a15a4,95dbc5ad-3a9c-44ab-b9ab-c181b88876f0,,Neoadjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-BROD-1128-C15_treatment,0a10d3e7-0cfe-47cd-809f-8b516078a395,,released,,0,2021-12-21T14:02:12.322064-06:00,,,
HCM-BROD-1128-C15,c17e8249-b8d4-4d88-b0f3-d27aeb6a15a4,95dbc5ad-3a9c-44ab-b9ab-c181b88876f0,303.0,Adjuvant,262.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-1128-C15_treatment2,4b8fe689-9339-4aea-9caa-cc023b725000,Treatment Ongoing,released,Paclitaxel,1,2021-12-21T14:02:12.322064-06:00,Chemotherapy,Residual Disease,
HCM-BROD-1128-C15,c17e8249-b8d4-4d88-b0f3-d27aeb6a15a4,95dbc5ad-3a9c-44ab-b9ab-c181b88876f0,,,0.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-1128-C15_treatment4,7e00d075-221d-488f-8b33-fb62328660de,,released,,1,2021-12-21T14:02:12.322064-06:00,"Surgery, NOS",Initial Diagnosis,
HCM-BROD-1128-C15,c17e8249-b8d4-4d88-b0f3-d27aeb6a15a4,95dbc5ad-3a9c-44ab-b9ab-c181b88876f0,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-BROD-1128-C15_treatment3,a932cc25-57aa-4a7d-bc06-ca30189ccf5e,,released,,0,2021-12-21T14:02:12.322064-06:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-BROD-1128-C15,c17e8249-b8d4-4d88-b0f3-d27aeb6a15a4,95dbc5ad-3a9c-44ab-b9ab-c181b88876f0,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-BROD-1128-C15_treatment6,ad061db2-98ae-45c8-accf-717db963a761,,released,,0,2021-12-21T14:02:12.322064-06:00,"Radiation Therapy, NOS",Residual Disease,
HCM-CSHL-0187-C25,c229960d-31f7-43d2-9bb5-599c1dd88350,8506d541-bf9c-4eef-ae04-b0bae0dd6266,408.0,Adjuvant,204.0,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0187-C25_treatment3,0ca6b63d-ac8e-4b58-b56f-8aad58a31fc9,,released,Nab-paclitaxel,1,2020-09-28T09:15:42.250618-05:00,Chemotherapy,Residual Disease,
HCM-CSHL-0187-C25,c229960d-31f7-43d2-9bb5-599c1dd88350,8506d541-bf9c-4eef-ae04-b0bae0dd6266,,Neoadjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0187-C25_treatment,3c7dd566-eeba-4d02-aeb2-9504777706af,,released,,0,2020-09-28T09:15:42.250618-05:00,,,
HCM-CSHL-0187-C25,c229960d-31f7-43d2-9bb5-599c1dd88350,8506d541-bf9c-4eef-ae04-b0bae0dd6266,,Adjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0187-C25_treatment4,75603701-cb1b-4e8f-b1e7-a1ca2a6a864b,,released,,0,2020-09-28T09:15:42.250618-05:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-CSHL-0187-C25,c229960d-31f7-43d2-9bb5-599c1dd88350,8506d541-bf9c-4eef-ae04-b0bae0dd6266,,Adjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0187-C25_treatment7,8ac7291a-a02b-44bf-887a-76ca161b882d,,released,,0,2020-09-28T09:15:42.250618-05:00,"Radiation Therapy, NOS",Residual Disease,
HCM-CSHL-0187-C25,c229960d-31f7-43d2-9bb5-599c1dd88350,8506d541-bf9c-4eef-ae04-b0bae0dd6266,,Adjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0187-C25_treatment6,8e806520-af67-498c-b1ca-7ccbaac4e307,,released,,0,2020-09-28T09:15:42.250618-05:00,Targeted Molecular Therapy,Residual Disease,
HCM-CSHL-0187-C25,c229960d-31f7-43d2-9bb5-599c1dd88350,8506d541-bf9c-4eef-ae04-b0bae0dd6266,,,-12.0,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0187-C25_treatment5,b1c2cafa-03d9-4b3b-b7fc-1d997450287e,,released,,1,2020-09-28T09:15:42.250618-05:00,"Surgery, NOS",Initial Diagnosis,
HCM-CSHL-0187-C25,c229960d-31f7-43d2-9bb5-599c1dd88350,8506d541-bf9c-4eef-ae04-b0bae0dd6266,408.0,Adjuvant,204.0,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0187-C25_treatment2,b8077894-d86f-48d8-a479-bec0dd3fbc47,,released,Gemcitabine,1,2020-09-28T09:15:42.250618-05:00,Chemotherapy,Residual Disease,
HCM-BROD-0118-C16,c297718c-1d40-439a-a5de-09c5eb5ccea9,1c3d2a59-938a-49f4-a900-844b8e69b777,301.0,Adjuvant,257.0,2021-03-03T15:15:08.075155-06:00,HCM-BROD-0118-C16_treatment2,0ee1101c-8171-44b4-b459-f2a5594ec1f1,,released,Irinotecan,1,2020-02-27T12:32:17.917166-06:00,Chemotherapy,Residual Disease,
HCM-BROD-0118-C16,c297718c-1d40-439a-a5de-09c5eb5ccea9,1c3d2a59-938a-49f4-a900-844b8e69b777,,,,2023-02-27T11:53:07.344239-06:00,HCM-BROD-0118-C16_treatment4,7bd8581a-4008-4ca8-b5b1-1df6982cd03d,,released,,0,2020-02-27T12:32:17.917166-06:00,"Surgery, NOS",Initial Diagnosis,
HCM-BROD-0118-C16,c297718c-1d40-439a-a5de-09c5eb5ccea9,1c3d2a59-938a-49f4-a900-844b8e69b777,,Adjuvant,,2021-03-03T15:15:08.075155-06:00,HCM-BROD-0118-C16_treatment6,9e0a46d6-4f83-4353-8249-82e3c7611900,,released,,0,2020-02-27T12:32:17.917166-06:00,"Radiation Therapy, NOS",Residual Disease,
HCM-BROD-0118-C16,c297718c-1d40-439a-a5de-09c5eb5ccea9,1c3d2a59-938a-49f4-a900-844b8e69b777,,Adjuvant,,2021-03-03T15:15:08.075155-06:00,HCM-BROD-0118-C16_treatment3,b07ba21d-19b1-44cb-a461-c9f185fbdc87,,released,,0,2020-02-27T12:32:17.917166-06:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-BROD-0118-C16,c297718c-1d40-439a-a5de-09c5eb5ccea9,1c3d2a59-938a-49f4-a900-844b8e69b777,301.0,Adjuvant,257.0,2021-03-03T15:15:08.075155-06:00,HCM-BROD-0118-C16_treatment5,d8bb2a53-4453-4855-b10a-4b3d9ffb1dde,,released,Trastuzumab,1,2020-02-27T12:32:17.917166-06:00,Targeted Molecular Therapy,Residual Disease,
HCM-BROD-0118-C16,c297718c-1d40-439a-a5de-09c5eb5ccea9,1c3d2a59-938a-49f4-a900-844b8e69b777,,Neoadjuvant,,2021-03-03T15:15:08.075155-06:00,HCM-BROD-0118-C16_treatment,daf08382-bb26-4100-b56f-c736b980e4be,,released,,1,2019-04-04T15:25:23.174159-05:00,Chemotherapy,,
HCM-SANG-0314-C15,c2db7ccf-6c5e-424f-bc0e-a27a319622ab,d0791cfd-4784-42c2-a2ef-5567b55e86fa,,Neoadjuvant,100.0,2025-03-31T16:34:59.906497-05:00,HCM-SANG-0314-C15_treatment3,02534a08-6c22-493c-86c8-9a3c6e92aec2,,released,Cisplatin,1,2021-12-21T15:11:39.089560-06:00,Chemotherapy,,
HCM-SANG-0314-C15,c2db7ccf-6c5e-424f-bc0e-a27a319622ab,d0791cfd-4784-42c2-a2ef-5567b55e86fa,,Neoadjuvant,100.0,2025-03-31T16:34:59.906497-05:00,HCM-SANG-0314-C15_treatment4,1296d385-b9af-4483-94dd-dfebbd22a1f7,,released,,1,2021-12-21T15:11:39.089560-06:00,Chemotherapy,,ECX
HCM-SANG-0314-C15,c2db7ccf-6c5e-424f-bc0e-a27a319622ab,d0791cfd-4784-42c2-a2ef-5567b55e86fa,,Neoadjuvant,100.0,2025-03-31T16:34:59.906497-05:00,HCM-SANG-0314-C15_treatment,852de895-8a68-4828-b294-6d921d8e8199,,released,Epirubicin,1,2021-12-21T15:11:39.089560-06:00,Chemotherapy,,
HCM-SANG-0314-C15,c2db7ccf-6c5e-424f-bc0e-a27a319622ab,d0791cfd-4784-42c2-a2ef-5567b55e86fa,,Neoadjuvant,100.0,2025-03-31T16:34:59.906497-05:00,HCM-SANG-0314-C15_treatment2,cebe32ff-cb85-41d1-9a8f-c4cf01d9ac01,,released,Capecitabine,1,2021-12-21T15:11:39.089560-06:00,Chemotherapy,,
HCM-CSHL-0240-C18,c2e4432f-08a8-46bf-870b-f49cda508c51,04aa9d7c-df4d-42eb-8ee3-c89ba03db8c1,,Neoadjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0240-C18_treatment,5fbbda66-f5b9-450a-9a67-6fcc85460bac,,released,,0,2020-09-28T09:20:21.028815-05:00,,,
HCM-CSHL-0240-C18,c2e4432f-08a8-46bf-870b-f49cda508c51,04aa9d7c-df4d-42eb-8ee3-c89ba03db8c1,,Adjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0240-C18_treatment3,bc860ce8-7208-4cf1-9a9f-dbe7188a888b,,released,,0,2020-09-28T09:20:21.028815-05:00,"Pharmaceutical Therapy, NOS",Residual Disease,
HCM-CSHL-0240-C18,c2e4432f-08a8-46bf-870b-f49cda508c51,04aa9d7c-df4d-42eb-8ee3-c89ba03db8c1,,Adjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0240-C18_treatment4,de327a3b-3778-4e36-a15a-b51e60ba2838,,released,,0,2020-09-28T09:20:21.028815-05:00,"Radiation Therapy, NOS",Residual Disease,
HCM-CSHL-0240-C18,c2e4432f-08a8-46bf-870b-f49cda508c51,04aa9d7c-df4d-42eb-8ee3-c89ba03db8c1,,,22.0,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0240-C18_treatment2,e57df4f0-9d8b-412a-8900-f01edfd7fa56,,released,,1,2020-09-28T09:20:21.028815-05:00,"Surgery, NOS",Initial Diagnosis,
HCM-SANG-0276-C18,c39349d1-2cde-48d8-8a20-4ec319edd0d7,fd367f78-7ec5-496e-a3a5-2c13edff2d6c,,Neoadjuvant,,2023-03-13T12:57:02.333692-05:00,HCM-SANG-0276-C18_treatment,d9d69cb3-6b34-49b1-9b73-4fe05fcbdb52,,released,,0,2020-02-11T15:52:57.509024-06:00,,,
HCM-BROD-0423-C71,c3f76e7e-661c-44fb-b0b6-3635da058fce,5c3c7784-e620-44ba-9b32-8877ece5988b,,Neoadjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0423-C71_treatment,076c699f-f8d6-4e41-bee7-4b7f6c1774b4,,released,,0,2020-09-27T11:35:01.642685-05:00,,,
HCM-BROD-0423-C71,c3f76e7e-661c-44fb-b0b6-3635da058fce,5c3c7784-e620-44ba-9b32-8877ece5988b,58.0,Adjuvant,16.0,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0423-C71_treatment2,3bf08838-2da6-4df9-969c-4d00c50448e8,,released,Temozolomide,1,2020-09-27T11:35:01.642685-05:00,Chemotherapy,Residual Disease,
HCM-BROD-0423-C71,c3f76e7e-661c-44fb-b0b6-3635da058fce,5c3c7784-e620-44ba-9b32-8877ece5988b,450.0,Adjuvant,261.0,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0423-C71_treatment6,6b24e567-1c6a-478c-84ce-d82f42f16c6c,,released,Bevacizumab,1,2020-09-27T11:35:01.642685-05:00,Targeted Molecular Therapy,Residual Disease,
HCM-BROD-0423-C71,c3f76e7e-661c-44fb-b0b6-3635da058fce,5c3c7784-e620-44ba-9b32-8877ece5988b,,,-11.0,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0423-C71_treatment5,74b581f6-79d0-4e09-909f-e81a66315441,,released,,1,2020-09-27T11:35:01.642685-05:00,"Surgery, NOS",Initial Diagnosis,
HCM-BROD-0423-C71,c3f76e7e-661c-44fb-b0b6-3635da058fce,5c3c7784-e620-44ba-9b32-8877ece5988b,183.0,Adjuvant,95.0,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0423-C71_treatment3,ab17f78b-f623-43f1-9656-d79fdaed88ed,,released,Temozolomide,1,2020-09-27T11:35:01.642685-05:00,Chemotherapy,Residual Disease,
HCM-BROD-0423-C71,c3f76e7e-661c-44fb-b0b6-3635da058fce,5c3c7784-e620-44ba-9b32-8877ece5988b,59.0,Adjuvant,16.0,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0423-C71_treatment7,cb91e636-4092-4c1e-a526-2d34a3398c79,,released,,1,2020-09-27T11:35:01.642685-05:00,"Radiation Therapy, NOS",Residual Disease,
HCM-BROD-0423-C71,c3f76e7e-661c-44fb-b0b6-3635da058fce,5c3c7784-e620-44ba-9b32-8877ece5988b,,Adjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0423-C71_treatment4,d41eabf1-547b-4186-bc63-04a0f892c46e,,released,,0,2020-09-27T11:35:01.642685-05:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-CSHL-0434-C24,c4025241-d423-4daa-b0fc-b27873d4e314,96f02d0e-0bcd-4ef7-b13a-e65b3c8824d1,,,-12.0,2023-03-13T12:50:23.854202-05:00,HCM-CSHL-0434-C24_treatment2,4237d7ec-ebd8-480e-b792-d607bdbbf183,,released,,1,2020-09-28T10:08:23.548874-05:00,"Surgery, NOS",Initial Diagnosis,
HCM-CSHL-0434-C24,c4025241-d423-4daa-b0fc-b27873d4e314,96f02d0e-0bcd-4ef7-b13a-e65b3c8824d1,,Neoadjuvant,,2021-01-06T22:55:10.531130-06:00,HCM-CSHL-0434-C24_treatment,53412044-7b4a-4acf-961b-b1305d260d58,,released,,0,2020-09-28T10:08:23.548874-05:00,,,
HCM-CSHL-0237-C18,c446e9cd-f5cc-4daa-b573-b261d7ea8f42,4e9c062a-e131-49e6-a0ab-08188c4d5cb0,,Neoadjuvant,,2023-02-22T07:39:25.979291-06:00,HCM-CSHL-0237-C18_treatment,050b7c8f-83ab-44ff-a8bd-30b8e84b39e3,,released,,0,2020-09-28T09:19:52.351022-05:00,,,
HCM-CSHL-0237-C18,c446e9cd-f5cc-4daa-b573-b261d7ea8f42,4e9c062a-e131-49e6-a0ab-08188c4d5cb0,,Adjuvant,,2023-02-22T07:39:25.979291-06:00,HCM-CSHL-0237-C18_treatment5,339e1369-f4b0-4c0e-891c-5fc18741dd19,,released,,0,2020-09-28T09:19:52.351022-05:00,Targeted Molecular Therapy,Residual Disease,
HCM-CSHL-0237-C18,c446e9cd-f5cc-4daa-b573-b261d7ea8f42,4e9c062a-e131-49e6-a0ab-08188c4d5cb0,271.0,Adjuvant,94.0,2023-02-22T07:39:25.979291-06:00,HCM-CSHL-0237-C18_treatment2,3bf121aa-e252-4d93-ae18-ad4c26a8af25,,released,Capecitabine,1,2020-09-28T09:19:52.351022-05:00,Chemotherapy,Residual Disease,
HCM-CSHL-0237-C18,c446e9cd-f5cc-4daa-b573-b261d7ea8f42,4e9c062a-e131-49e6-a0ab-08188c4d5cb0,,Adjuvant,,2023-02-22T07:39:25.979291-06:00,HCM-CSHL-0237-C18_treatment6,941afdb9-6296-4147-b38c-c36cb73153fc,,released,,0,2020-09-28T09:19:52.351022-05:00,"Radiation Therapy, NOS",Residual Disease,
HCM-CSHL-0237-C18,c446e9cd-f5cc-4daa-b573-b261d7ea8f42,4e9c062a-e131-49e6-a0ab-08188c4d5cb0,,Adjuvant,,2023-02-22T07:39:25.979291-06:00,HCM-CSHL-0237-C18_treatment3,a3e767d8-1c85-4ba0-8df6-e82acf220cef,,released,,0,2020-09-28T09:19:52.351022-05:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-CSHL-0237-C18,c446e9cd-f5cc-4daa-b573-b261d7ea8f42,4e9c062a-e131-49e6-a0ab-08188c4d5cb0,,,39.0,2023-03-13T13:08:02.211009-05:00,HCM-CSHL-0237-C18_treatment4,f10e3c49-9a2e-4b36-9099-928804ab9b43,,released,,1,2020-09-28T09:19:52.351022-05:00,"Surgery, NOS",Initial Diagnosis,
HCM-EXPT-0940-C50,c4e63551-fa43-46d6-935e-652eaf04312b,97e56e1c-c629-4f7a-bae1-ec91c8961952,,Neoadjuvant,,2025-10-08T12:36:57.024699-05:00,HCM-EXPT-0940-C50_treatment,f2dc2aca-16b3-4e2c-add3-1695de38777e,,released,,0,2021-12-21T14:46:57.433242-06:00,,,
HCM-EXPT-0936-C50,c527e349-7263-445b-9d57-b6ab0dcbc133,34560ede-aada-4d4f-93b4-e822cfdaaf26,,Neoadjuvant,,2025-10-08T12:36:57.024699-05:00,HCM-EXPT-0936-C50_treatment,a7cb39b5-b17f-42df-a456-345ae87a29ce,,released,,1,2021-12-21T14:46:24.887456-06:00,Chemotherapy,,
HCM-EXPT-0936-C50,c527e349-7263-445b-9d57-b6ab0dcbc133,34560ede-aada-4d4f-93b4-e822cfdaaf26,,Neoadjuvant,,2025-10-08T12:36:57.024699-05:00,HCM-EXPT-0936-C50_treatment2,e36edad7-4c28-4ae2-8650-ff48ed1be14f,,released,Exemestane,1,2021-12-21T14:46:24.887456-06:00,Hormone Therapy,,
HCM-CSHL-0654-C26,c5d2e21e-6987-4085-8c67-9d41630957b5,1b0ba87c-0a22-4687-9516-7fd12b5ee992,,,,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0654-C26_treatment3,166173e7-0da2-4854-8ae6-523e0a5832d3,,released,,0,2021-12-21T14:13:56.994423-06:00,"Surgery, NOS",Initial Diagnosis,
HCM-CSHL-0082-C25,c5e8675b-6d0b-485c-9dd7-8bfb59b5c44a,e6b64c75-59c9-4ad1-bde4-7ac95da7f160,,Adjuvant,,2023-02-22T07:39:25.979291-06:00,HCM-CSHL-0082-C25_treatment7,070eb922-9dc9-4fd1-8c00-5660ca360584,,released,,0,2020-09-27T12:48:20.920531-05:00,Targeted Molecular Therapy,Residual Disease,
HCM-CSHL-0082-C25,c5e8675b-6d0b-485c-9dd7-8bfb59b5c44a,e6b64c75-59c9-4ad1-bde4-7ac95da7f160,,Neoadjuvant,,2023-02-22T07:39:25.979291-06:00,HCM-CSHL-0082-C25_treatment,1bcebf46-7120-4797-b953-4ca185532f56,,released,,0,2020-09-27T12:48:20.920531-05:00,,,
HCM-CSHL-0082-C25,c5e8675b-6d0b-485c-9dd7-8bfb59b5c44a,e6b64c75-59c9-4ad1-bde4-7ac95da7f160,,Adjuvant,778.0,2023-02-22T07:39:25.979291-06:00,HCM-CSHL-0082-C25_treatment3,5acc1ebd-8251-4fd3-92a9-7cb9a91e7e03,Treatment Ongoing,released,Gemcitabine,1,2020-09-27T12:48:20.920531-05:00,Chemotherapy,Residual Disease,
HCM-CSHL-0082-C25,c5e8675b-6d0b-485c-9dd7-8bfb59b5c44a,e6b64c75-59c9-4ad1-bde4-7ac95da7f160,,Adjuvant,17.0,2023-02-22T07:39:25.979291-06:00,HCM-CSHL-0082-C25_treatment2,7c84eef6-b5cd-4d49-9c5f-b5dcf488d599,,released,Gemcitabine,1,2020-09-27T12:48:20.920531-05:00,Chemotherapy,Residual Disease,
HCM-CSHL-0082-C25,c5e8675b-6d0b-485c-9dd7-8bfb59b5c44a,e6b64c75-59c9-4ad1-bde4-7ac95da7f160,,Adjuvant,,2023-02-22T07:39:25.979291-06:00,HCM-CSHL-0082-C25_treatment5,7cd8a019-a7de-4bae-bae0-42952c9dd3e4,,released,,0,2020-09-27T12:48:20.920531-05:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-CSHL-0082-C25,c5e8675b-6d0b-485c-9dd7-8bfb59b5c44a,e6b64c75-59c9-4ad1-bde4-7ac95da7f160,,,-15.0,2023-02-27T11:39:33.052635-06:00,HCM-CSHL-0082-C25_treatment6,7ff5b71d-fa55-4b8c-bac2-a006596616e3,,released,,1,2020-09-27T12:48:20.920531-05:00,"Surgery, NOS",Initial Diagnosis,
HCM-CSHL-0082-C25,c5e8675b-6d0b-485c-9dd7-8bfb59b5c44a,e6b64c75-59c9-4ad1-bde4-7ac95da7f160,,Adjuvant,778.0,2023-02-22T07:39:25.979291-06:00,HCM-CSHL-0082-C25_treatment4,d28125dc-c2aa-4d4b-ab10-5e42b3bd6f3b,Treatment Ongoing,released,Nab-paclitaxel,1,2020-09-27T12:48:20.920531-05:00,Chemotherapy,Residual Disease,
HCM-CSHL-0082-C25,c5e8675b-6d0b-485c-9dd7-8bfb59b5c44a,e6b64c75-59c9-4ad1-bde4-7ac95da7f160,,Adjuvant,,2023-02-22T07:39:25.979291-06:00,HCM-CSHL-0082-C25_treatment8,e3123a9d-85e0-46ba-91e9-6552646dfefe,,released,,0,2020-09-27T12:48:20.920531-05:00,"Radiation Therapy, NOS",Residual Disease,
HCM-CSHL-0089-C25,c5e9a845-e0ff-4612-aa8e-c310098503a7,f948667b-7daa-4316-a77d-5cfb3f2c8156,,Adjuvant,,2021-01-06T22:55:10.531130-06:00,HCM-CSHL-0089-C25_treatment9,90db9c69-67a3-4462-98c7-66622adeaeff,,released,,0,2020-11-04T16:32:28.833799-06:00,"Radiation Therapy, NOS",Residual Disease,
HCM-CSHL-0089-C25,c5e9a845-e0ff-4612-aa8e-c310098503a7,f948667b-7daa-4316-a77d-5cfb3f2c8156,,Neoadjuvant,,2020-03-26T16:04:47.706904-05:00,HCM-CSHL-0089-C25_treatment,990cf73c-6491-4530-9c96-4ebb33bcc200,,released,,0,2020-02-27T13:55:43.042019-06:00,,,
HCM-CSHL-0089-C25,c5e9a845-e0ff-4612-aa8e-c310098503a7,f948667b-7daa-4316-a77d-5cfb3f2c8156,,Adjuvant,153.0,2020-06-15T12:06:06.840898-05:00,HCM-CSHL-0089-C25_treatment4,9cef0bd3-56c6-4f24-ab0f-37348ecbfb74,,released,Fluorouracil,1,2020-02-27T13:55:43.042019-06:00,Chemotherapy,Residual Disease,
HCM-CSHL-0089-C25,c5e9a845-e0ff-4612-aa8e-c310098503a7,f948667b-7daa-4316-a77d-5cfb3f2c8156,129.0,Adjuvant,31.0,2020-03-26T16:04:47.706904-05:00,HCM-CSHL-0089-C25_treatment2,a4a7da84-bcc7-4d9d-ae1e-6c1977fbc1ce,,released,Gemcitabine,1,2020-02-27T13:55:43.042019-06:00,Chemotherapy,Residual Disease,
HCM-CSHL-0089-C25,c5e9a845-e0ff-4612-aa8e-c310098503a7,f948667b-7daa-4316-a77d-5cfb3f2c8156,,Adjuvant,,2020-11-04T16:32:28.833799-06:00,HCM-CSHL-0089-C25_treatment6,a6e88a57-8220-4838-b3e7-f5fe7155ff25,,released,,0,2020-02-27T13:55:43.042019-06:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-CSHL-0089-C25,c5e9a845-e0ff-4612-aa8e-c310098503a7,f948667b-7daa-4316-a77d-5cfb3f2c8156,,Adjuvant,153.0,2020-06-15T12:06:06.840898-05:00,HCM-CSHL-0089-C25_treatment5,acb99bfc-7b09-4bd1-81ca-d3f023a26730,,released,Irinotecan,1,2020-02-27T13:55:43.042019-06:00,Chemotherapy,Residual Disease,
HCM-CSHL-0089-C25,c5e9a845-e0ff-4612-aa8e-c310098503a7,f948667b-7daa-4316-a77d-5cfb3f2c8156,,Adjuvant,,2021-01-06T22:55:10.531130-06:00,HCM-CSHL-0089-C25_treatment8,ae8b015e-0b3b-4e8a-aa81-cab90df6faf2,,released,,0,2020-11-04T16:32:28.833799-06:00,Targeted Molecular Therapy,Residual Disease,
HCM-CSHL-0089-C25,c5e9a845-e0ff-4612-aa8e-c310098503a7,f948667b-7daa-4316-a77d-5cfb3f2c8156,129.0,Adjuvant,59.0,2020-03-26T16:04:47.706904-05:00,HCM-CSHL-0089-C25_treatment3,dd3a4e5b-8540-4836-bd4b-c1003dcbbc0c,,released,Paclitaxel,1,2020-02-27T13:55:43.042019-06:00,Chemotherapy,Residual Disease,
HCM-CSHL-0089-C25,c5e9a845-e0ff-4612-aa8e-c310098503a7,f948667b-7daa-4316-a77d-5cfb3f2c8156,,,-28.0,2023-02-27T11:53:44.591061-06:00,HCM-CSHL-0089-C25_treatment7,e249ea49-f7db-47bf-a4b5-898bed9cf4b3,,released,,1,2020-03-26T12:46:11.344349-05:00,"Surgery, NOS",Initial Diagnosis,
HCM-CSHL-0242-C18,c67a338b-394f-4108-8e78-6dbd5a5eeaec,154b2dc1-3f99-4ff5-ae0f-7f0bfcf0f17e,,Adjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0242-C18_treatment4,2ceb2336-fcd5-4e6f-bc63-570d5d4943d2,,released,,0,2020-09-28T09:25:31.191977-05:00,"Radiation Therapy, NOS",Residual Disease,
HCM-CSHL-0242-C18,c67a338b-394f-4108-8e78-6dbd5a5eeaec,154b2dc1-3f99-4ff5-ae0f-7f0bfcf0f17e,,,1.0,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0242-C18_treatment2,51a8bace-297b-42d2-9b0f-6a358de9a76d,,released,,1,2020-09-28T09:25:31.191977-05:00,"Surgery, NOS",Initial Diagnosis,
HCM-CSHL-0242-C18,c67a338b-394f-4108-8e78-6dbd5a5eeaec,154b2dc1-3f99-4ff5-ae0f-7f0bfcf0f17e,,Neoadjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0242-C18_treatment,bce9f69c-482d-423a-aea9-2ac906832c30,,released,,0,2020-09-28T09:25:31.191977-05:00,,,
HCM-CSHL-0242-C18,c67a338b-394f-4108-8e78-6dbd5a5eeaec,154b2dc1-3f99-4ff5-ae0f-7f0bfcf0f17e,,Adjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0242-C18_treatment3,d1001fd1-6f28-4c45-a58a-d7e17dad023a,,released,,0,2020-09-28T09:25:31.191977-05:00,"Pharmaceutical Therapy, NOS",Residual Disease,
HCM-SANG-0307-C15,c7343e5c-95ef-492b-a53d-44ccc9b7d6ee,637cf4a4-5028-4fe4-b0b1-78f787166f19,,Neoadjuvant,,2023-03-13T13:08:49.343936-05:00,HCM-SANG-0307-C15_treatment,266ec7ff-2188-4b1d-8c91-91824e416f65,,released,,0,2021-12-21T15:10:51.328824-06:00,,,
HCM-SANG-0274-C18,c7a011a7-e72c-4535-8367-43d07d80fb67,e722e1eb-090d-47b3-9965-c15b4318d837,,Neoadjuvant,,2023-03-13T12:43:22.171755-05:00,HCM-SANG-0274-C18_treatment,71055b73-bde7-48d4-a34a-c0548d70d847,,released,,0,2021-04-20T10:33:03.211403-05:00,,,
HCM-SANG-0291-C15,c7b268b6-2c22-4225-943f-0690b37db259,75cd9d3b-e58e-4b8c-90f2-f282e18b21b5,,Neoadjuvant,,2023-02-22T07:39:25.979291-06:00,HCM-SANG-0291-C15_treatment,590f0960-6b29-4cc1-a41d-6e78f51c7246,,released,,0,2020-02-27T12:52:16.527318-06:00,,,
HCM-BROD-0003-C71,c811d6dd-992f-435a-80ec-b282a2e38aad,7c0759eb-9a3d-4b98-8412-f156a7f04234,341.0,Adjuvant,320.0,2020-06-15T09:47:04.797727-05:00,HCM-BROD-0003-C71_treatment5,51c3bffa-ae51-4ff0-92b6-3d0277369c86,,released,Bevacizumab,1,2019-04-04T14:40:31.851849-05:00,Targeted Molecular Therapy,Residual Disease,
HCM-BROD-0003-C71,c811d6dd-992f-435a-80ec-b282a2e38aad,7c0759eb-9a3d-4b98-8412-f156a7f04234,341.0,Adjuvant,320.0,2020-06-15T09:47:04.797727-05:00,HCM-BROD-0003-C71_treatment3,64499630-5748-41cf-8f80-084be1b0a8e0,,released,Pembrolizumab,1,2019-04-04T14:40:31.851849-05:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-BROD-0003-C71,c811d6dd-992f-435a-80ec-b282a2e38aad,7c0759eb-9a3d-4b98-8412-f156a7f04234,47.0,Adjuvant,24.0,2020-01-13T20:10:25.832065-06:00,HCM-BROD-0003-C71_treatment2,6b49f4a1-8329-466f-9e99-2c8596565726,,released,Temozolomide,1,2019-04-04T14:40:31.851849-05:00,Chemotherapy,Residual Disease,
HCM-BROD-0003-C71,c811d6dd-992f-435a-80ec-b282a2e38aad,7c0759eb-9a3d-4b98-8412-f156a7f04234,,,-3.0,2023-03-13T12:43:16.596245-05:00,HCM-BROD-0003-C71_treatment4,7aadd75f-d90e-485a-8afb-4d1c8be96454,,released,,1,2019-04-04T14:40:31.851849-05:00,"Surgery, NOS",Initial Diagnosis,
HCM-BROD-0003-C71,c811d6dd-992f-435a-80ec-b282a2e38aad,7c0759eb-9a3d-4b98-8412-f156a7f04234,47.0,Adjuvant,24.0,2020-01-13T20:10:25.832065-06:00,HCM-BROD-0003-C71_treatment6,effac174-c724-4d9e-876c-bf74628e97d5,,released,,1,2019-04-04T14:40:31.851849-05:00,"Radiation Therapy, NOS",Residual Disease,
HCM-BROD-0003-C71,c811d6dd-992f-435a-80ec-b282a2e38aad,7c0759eb-9a3d-4b98-8412-f156a7f04234,,Neoadjuvant,,2020-01-13T20:10:25.832065-06:00,HCM-BROD-0003-C71_treatment,f0ba8210-997f-4272-90ce-c930e46cb943,,released,,0,2019-04-04T14:40:31.851849-05:00,,,
HCM-CSHL-0379-C18,c8f87337-a6d6-492d-943f-33207c8b40d3,cd9b2155-b63c-4635-a596-8978a233c4e3,,Adjuvant,929.0,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0379-C18_treatment2,228edd51-9bf3-4464-a09d-8943da3fb5d9,Treatment Ongoing,released,Leucovorin Calcium,1,2020-09-28T09:55:50.716360-05:00,Chemotherapy,Residual Disease,
HCM-CSHL-0379-C18,c8f87337-a6d6-492d-943f-33207c8b40d3,cd9b2155-b63c-4635-a596-8978a233c4e3,,Neoadjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0379-C18_treatment,862da968-14f6-4c35-9ff9-61d4bdd4c87b,,released,,0,2020-09-28T09:55:50.716360-05:00,,,
HCM-CSHL-0379-C18,c8f87337-a6d6-492d-943f-33207c8b40d3,cd9b2155-b63c-4635-a596-8978a233c4e3,,Adjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0379-C18_treatment10,878a268a-5c13-4688-a30e-ea0b86b36d01,,released,,0,2021-08-26T14:45:23.703807-05:00,"Radiation Therapy, NOS",Residual Disease,
HCM-CSHL-0379-C18,c8f87337-a6d6-492d-943f-33207c8b40d3,cd9b2155-b63c-4635-a596-8978a233c4e3,,,12.0,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0379-C18_treatment7,88014299-1967-4fe5-afda-5e7ebe56930a,,released,,1,2021-08-26T14:45:23.703807-05:00,"Surgery, NOS",Initial Diagnosis,
HCM-CSHL-0379-C18,c8f87337-a6d6-492d-943f-33207c8b40d3,cd9b2155-b63c-4635-a596-8978a233c4e3,,Adjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0379-C18_treatment9,92f246d7-281a-4444-b1a0-2df2db317545,,released,,0,2021-08-26T14:45:23.703807-05:00,Targeted Molecular Therapy,Residual Disease,
HCM-CSHL-0379-C18,c8f87337-a6d6-492d-943f-33207c8b40d3,cd9b2155-b63c-4635-a596-8978a233c4e3,,,860.0,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0379-C18_treatment8,9d3bc68d-6659-4a45-be6a-59d8b45e00ad,,released,,1,2021-08-26T14:45:23.703807-05:00,"Surgery, NOS",Initial Diagnosis,
HCM-CSHL-0379-C18,c8f87337-a6d6-492d-943f-33207c8b40d3,cd9b2155-b63c-4635-a596-8978a233c4e3,,Adjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0379-C18_treatment6,ac3cde2d-c503-4a16-b87b-63e61efaf815,,released,,0,2021-08-26T14:45:23.703807-05:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-CSHL-0379-C18,c8f87337-a6d6-492d-943f-33207c8b40d3,cd9b2155-b63c-4635-a596-8978a233c4e3,,Adjuvant,929.0,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0379-C18_treatment5,b2e27ca8-fd97-49bf-b365-7422b31e3589,Treatment Ongoing,released,,1,2021-08-26T14:45:23.703807-05:00,Chemotherapy,Residual Disease,FOLFOX
HCM-CSHL-0379-C18,c8f87337-a6d6-492d-943f-33207c8b40d3,cd9b2155-b63c-4635-a596-8978a233c4e3,,Adjuvant,929.0,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0379-C18_treatment4,d7a438ac-78a8-4f0e-92f6-97efcdaedab8,Treatment Ongoing,released,Oxaliplatin,1,2020-09-28T09:55:50.716360-05:00,Chemotherapy,Residual Disease,
HCM-CSHL-0379-C18,c8f87337-a6d6-492d-943f-33207c8b40d3,cd9b2155-b63c-4635-a596-8978a233c4e3,,Adjuvant,929.0,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0379-C18_treatment3,f7dc7116-433e-4c3f-a3fc-5aeca0d8d85c,Treatment Ongoing,released,Fluorouracil,1,2020-09-28T09:55:50.716360-05:00,Chemotherapy,Residual Disease,
HCM-BROD-0782-C71,c902d2a4-d473-498e-a235-c66960ffdefe,e2aa8c52-9b9f-4945-9945-37b409aea59d,1153.0,Maintenance Therapy,14.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0782-C71_treatment8,9c68efed-05a3-457f-aa08-7d6fa41f9ada,Progressive Disease,released,Temozolomide,1,2021-12-21T13:51:15.957667-06:00,,,
HCM-BROD-0782-C71,c902d2a4-d473-498e-a235-c66960ffdefe,ff028af5-c8a2-4e7a-b5c0-e456c67c679a,1279.0,Adjuvant,1251.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0782-C71_treatment2,0da16c7f-65b6-40b9-99d7-edf41ce64960,,released,Irinotecan,1,2021-12-21T13:51:15.957667-06:00,Chemotherapy,Residual Disease,
HCM-BROD-0782-C71,c902d2a4-d473-498e-a235-c66960ffdefe,ff028af5-c8a2-4e7a-b5c0-e456c67c679a,,,-6.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0782-C71_treatment4,22ee7349-c61c-4b9e-ab1d-1020c1905464,,released,,1,2021-12-21T13:51:15.957667-06:00,"Surgery, NOS",Initial Diagnosis,
HCM-BROD-0782-C71,c902d2a4-d473-498e-a235-c66960ffdefe,ff028af5-c8a2-4e7a-b5c0-e456c67c679a,1279.0,Adjuvant,1251.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0782-C71_treatment6,4a6d386b-8908-470b-86a1-a018f342a914,,released,Bevacizumab,1,2021-12-21T13:51:15.957667-06:00,Targeted Molecular Therapy,Residual Disease,
HCM-BROD-0782-C71,c902d2a4-d473-498e-a235-c66960ffdefe,ff028af5-c8a2-4e7a-b5c0-e456c67c679a,,Neoadjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0782-C71_treatment,51b397ac-3a1d-46e2-babe-2aab877e988a,,released,,0,2021-12-21T13:51:15.957667-06:00,,,
HCM-BROD-0782-C71,c902d2a4-d473-498e-a235-c66960ffdefe,ff028af5-c8a2-4e7a-b5c0-e456c67c679a,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0782-C71_treatment3,bfc36527-4326-4392-8438-d2d7d1eac31d,,released,,0,2021-12-21T13:51:15.957667-06:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-BROD-0782-C71,c902d2a4-d473-498e-a235-c66960ffdefe,ff028af5-c8a2-4e7a-b5c0-e456c67c679a,1245.0,Adjuvant,1161.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0782-C71_treatment5,dcf896c3-5332-4dc1-973c-8661342f6e2d,,released,Not Reported,1,2021-12-21T13:51:15.957667-06:00,Targeted Molecular Therapy,Residual Disease,
HCM-BROD-0782-C71,c902d2a4-d473-498e-a235-c66960ffdefe,ff028af5-c8a2-4e7a-b5c0-e456c67c679a,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0782-C71_treatment7,fcea76a8-933b-4dd4-9496-43c3d5fdb171,,released,,0,2021-12-21T13:51:15.957667-06:00,"Radiation Therapy, NOS",Residual Disease,
HCM-CSHL-1270-C18,c95492e0-26ba-4a9c-a99b-f6aee9d33f20,31e1a98c-da17-430b-9240-0a530d14d22e,311.0,Adjuvant,269.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-1270-C18_treatment12,135f8186-219c-42a2-ae79-55c9ff723325,,released,Bevacizumab,1,2022-03-11T20:05:02.480016-06:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-CSHL-1270-C18,c95492e0-26ba-4a9c-a99b-f6aee9d33f20,31e1a98c-da17-430b-9240-0a530d14d22e,402.0,Adjuvant,332.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-1270-C18_treatment7,2441faeb-b9d5-4d65-8b1c-f93cbbeadf2f,,released,Irinotecan,1,2022-03-11T20:05:02.480016-06:00,Chemotherapy,Residual Disease,
HCM-CSHL-1270-C18,c95492e0-26ba-4a9c-a99b-f6aee9d33f20,31e1a98c-da17-430b-9240-0a530d14d22e,402.0,Adjuvant,332.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-1270-C18_treatment8,2aec7709-cd30-4b2d-9f12-437998af74d0,,released,Leucovorin Calcium,1,2022-03-11T20:05:02.480016-06:00,Chemotherapy,Residual Disease,
HCM-CSHL-1270-C18,c95492e0-26ba-4a9c-a99b-f6aee9d33f20,31e1a98c-da17-430b-9240-0a530d14d22e,170.0,Adjuvant,28.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-1270-C18_treatment5,496d2151-6e43-43e4-a4c7-43229e1220e8,,released,Bevacizumab,1,2022-03-11T20:05:02.480016-06:00,Chemotherapy,Residual Disease,
HCM-CSHL-1270-C18,c95492e0-26ba-4a9c-a99b-f6aee9d33f20,31e1a98c-da17-430b-9240-0a530d14d22e,402.0,Adjuvant,332.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-1270-C18_treatment9,6a819965-be15-4eeb-88e8-675193911514,,released,Fluorouracil,1,2022-03-11T20:05:02.480016-06:00,Chemotherapy,Residual Disease,
HCM-CSHL-1270-C18,c95492e0-26ba-4a9c-a99b-f6aee9d33f20,31e1a98c-da17-430b-9240-0a530d14d22e,534.0,Adjuvant,423.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-1270-C18_treatment14,7ea7214b-a4ea-40d2-a1a4-ee5503b20d57,,released,Encorafenib,1,2022-03-11T20:05:02.480016-06:00,Targeted Molecular Therapy,Residual Disease,
HCM-CSHL-1270-C18,c95492e0-26ba-4a9c-a99b-f6aee9d33f20,31e1a98c-da17-430b-9240-0a530d14d22e,170.0,Adjuvant,28.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-1270-C18_treatment3,89d323b6-fce6-47b6-bb29-9465fe9bbfe1,,released,Fluorouracil,1,2022-03-11T20:05:02.480016-06:00,Chemotherapy,Residual Disease,
HCM-CSHL-1270-C18,c95492e0-26ba-4a9c-a99b-f6aee9d33f20,31e1a98c-da17-430b-9240-0a530d14d22e,170.0,Adjuvant,28.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-1270-C18_treatment2,97cb1511-efc3-4abe-8185-048552d65a1e,,released,Leucovorin Calcium,1,2022-03-11T20:05:02.480016-06:00,Chemotherapy,Residual Disease,
HCM-CSHL-1270-C18,c95492e0-26ba-4a9c-a99b-f6aee9d33f20,31e1a98c-da17-430b-9240-0a530d14d22e,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-1270-C18_treatment15,a633bc12-b347-4a52-9da2-7d8b60f8d1bc,,released,,0,2022-03-11T20:05:02.480016-06:00,"Radiation Therapy, NOS",Residual Disease,
HCM-CSHL-1270-C18,c95492e0-26ba-4a9c-a99b-f6aee9d33f20,31e1a98c-da17-430b-9240-0a530d14d22e,402.0,Adjuvant,332.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-1270-C18_treatment10,c546faa0-451c-4936-a42c-384933a305a4,,released,Cetuximab,1,2022-03-11T20:05:02.480016-06:00,Chemotherapy,Residual Disease,
HCM-CSHL-1270-C18,c95492e0-26ba-4a9c-a99b-f6aee9d33f20,31e1a98c-da17-430b-9240-0a530d14d22e,170.0,Adjuvant,28.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-1270-C18_treatment4,d35718a5-d4bb-4c59-9623-7cc756c84f12,,released,Irinotecan,1,2022-03-11T20:05:02.480016-06:00,Chemotherapy,Residual Disease,
HCM-CSHL-1270-C18,c95492e0-26ba-4a9c-a99b-f6aee9d33f20,31e1a98c-da17-430b-9240-0a530d14d22e,170.0,Adjuvant,28.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-1270-C18_treatment6,d7ddc618-4fd9-4c9e-962e-e03473550415,,released,,1,2022-03-11T20:05:02.480016-06:00,Chemotherapy,Residual Disease,FOLFIRI
HCM-CSHL-1270-C18,c95492e0-26ba-4a9c-a99b-f6aee9d33f20,31e1a98c-da17-430b-9240-0a530d14d22e,,,548.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-1270-C18_treatment13,e0730d63-e8f0-4f42-9bfc-49b78c87ef22,,released,,1,2022-03-11T20:05:02.480016-06:00,"Surgery, NOS",Initial Diagnosis,
HCM-CSHL-1270-C18,c95492e0-26ba-4a9c-a99b-f6aee9d33f20,31e1a98c-da17-430b-9240-0a530d14d22e,,Neoadjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-1270-C18_treatment,e36dca43-6ee6-45c3-a5ce-ad32207d3555,,released,,0,2022-03-11T20:05:02.480016-06:00,,,
HCM-CSHL-1270-C18,c95492e0-26ba-4a9c-a99b-f6aee9d33f20,31e1a98c-da17-430b-9240-0a530d14d22e,402.0,Adjuvant,332.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-1270-C18_treatment11,f000a6a6-f431-4697-a281-b0701b522b05,,released,,1,2022-03-11T20:05:02.480016-06:00,Chemotherapy,Residual Disease,FOLFIRI-cetuximab
HCM-CSHL-1270-C18,c95492e0-26ba-4a9c-a99b-f6aee9d33f20,cfcb4d2d-7c78-4bb6-9d61-49b06cee0da3,170.0,Maintenance Therapy,28.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-1270-C18_treatment17,186611f6-75da-4ffb-9c70-29c336ab19ca,Progressive Disease,released,Bevacizumab,1,2022-03-11T20:05:02.480016-06:00,,,
HCM-CSHL-1270-C18,c95492e0-26ba-4a9c-a99b-f6aee9d33f20,cfcb4d2d-7c78-4bb6-9d61-49b06cee0da3,170.0,Maintenance Therapy,28.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-1270-C18_treatment20,187f8cc8-2aee-41ea-b906-4685f8b0a783,Progressive Disease,released,,1,2022-03-11T20:05:02.480016-06:00,,,FOLFIRI
HCM-CSHL-1270-C18,c95492e0-26ba-4a9c-a99b-f6aee9d33f20,cfcb4d2d-7c78-4bb6-9d61-49b06cee0da3,170.0,Maintenance Therapy,28.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-1270-C18_treatment18,27651bfd-3edb-4c65-8b29-c853c43a707c,Progressive Disease,released,Leucovorin Calcium,1,2022-03-11T20:05:02.480016-06:00,,,
HCM-CSHL-1270-C18,c95492e0-26ba-4a9c-a99b-f6aee9d33f20,cfcb4d2d-7c78-4bb6-9d61-49b06cee0da3,170.0,Maintenance Therapy,28.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-1270-C18_treatment19,3c2b81a0-3d90-4d71-a798-f6ff0d67f551,Progressive Disease,released,Fluorouracil,1,2022-03-11T20:05:02.480016-06:00,,,
HCM-CSHL-1270-C18,c95492e0-26ba-4a9c-a99b-f6aee9d33f20,cfcb4d2d-7c78-4bb6-9d61-49b06cee0da3,170.0,Maintenance Therapy,28.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-1270-C18_treatment16,b773c893-4a53-47c4-a5f8-eec6271772b9,Progressive Disease,released,Irinotecan,1,2022-03-11T20:05:02.480016-06:00,,,
HCM-CSHL-0147-C24,c992b973-299c-49d0-b5b5-3bdabb7ef575,3bc3a18d-b3b5-46cc-875e-09545978654a,,,54.0,2023-03-13T13:14:10.278336-05:00,HCM-CSHL-0147-C24_treatment2,6a5c6fc4-b729-453a-b73f-7dd3fccf0fc0,,released,,1,2020-02-11T15:25:23.744984-06:00,"Surgery, NOS",Initial Diagnosis,
HCM-CSHL-0147-C24,c992b973-299c-49d0-b5b5-3bdabb7ef575,3bc3a18d-b3b5-46cc-875e-09545978654a,,Adjuvant,,2023-03-13T13:14:10.278336-05:00,HCM-CSHL-0147-C24_treatment3,7fddcd58-c17b-4187-bc84-d0e0dc673367,,released,,0,2020-02-11T15:25:23.744984-06:00,"Pharmaceutical Therapy, NOS",Residual Disease,
HCM-CSHL-0147-C24,c992b973-299c-49d0-b5b5-3bdabb7ef575,3bc3a18d-b3b5-46cc-875e-09545978654a,,Adjuvant,,2023-03-13T13:14:10.278336-05:00,HCM-CSHL-0147-C24_treatment4,88da1c6e-ab02-4c35-ac46-cf6a2e80b164,,released,,0,2020-02-11T15:25:23.744984-06:00,"Radiation Therapy, NOS",Residual Disease,
HCM-CSHL-0147-C24,c992b973-299c-49d0-b5b5-3bdabb7ef575,3bc3a18d-b3b5-46cc-875e-09545978654a,,Neoadjuvant,,2020-01-13T20:10:25.832065-06:00,HCM-CSHL-0147-C24_treatment,c4574c56-946b-49c5-94fc-86759df035d2,,released,,0,2019-04-03T17:50:51.184182-05:00,,,
HCM-BROD-0482-C34,c996d442-45aa-47e8-9a9c-82727085d22d,0ae82a47-7478-4dfa-b354-84d31eac76a9,,Adjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0482-C34_treatment6,1b422500-d09e-4f49-9f75-9896c1ad9840,,released,,0,2020-09-27T11:53:42.973662-05:00,Targeted Molecular Therapy,Residual Disease,
HCM-BROD-0482-C34,c996d442-45aa-47e8-9a9c-82727085d22d,0ae82a47-7478-4dfa-b354-84d31eac76a9,964.0,Adjuvant,720.0,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0482-C34_treatment3,21c2b8f5-4dbd-4a10-aa29-0772084414c6,,released,Etoposide,1,2020-09-27T11:53:42.973662-05:00,Chemotherapy,Residual Disease,
HCM-BROD-0482-C34,c996d442-45aa-47e8-9a9c-82727085d22d,0ae82a47-7478-4dfa-b354-84d31eac76a9,,Adjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0482-C34_treatment4,4306c16d-0bd8-4cd3-a172-5b70c86c9671,,released,,0,2020-09-27T11:53:42.973662-05:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-BROD-0482-C34,c996d442-45aa-47e8-9a9c-82727085d22d,0ae82a47-7478-4dfa-b354-84d31eac76a9,,Neoadjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0482-C34_treatment,7cdb093e-3b23-4be3-b114-016c788647b1,,released,,0,2020-09-27T11:53:42.973662-05:00,,,
HCM-BROD-0482-C34,c996d442-45aa-47e8-9a9c-82727085d22d,0ae82a47-7478-4dfa-b354-84d31eac76a9,,Adjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0482-C34_treatment7,b0a091d4-fe95-407b-9e74-dc14f411332e,,released,,0,2020-09-27T11:53:42.973662-05:00,"Radiation Therapy, NOS",Residual Disease,
HCM-BROD-0482-C34,c996d442-45aa-47e8-9a9c-82727085d22d,0ae82a47-7478-4dfa-b354-84d31eac76a9,110.0,Adjuvant,2.0,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0482-C34_treatment2,e389aedd-8d4c-4951-b5ab-2617bfa29730,,released,Carboplatin,1,2020-09-27T11:53:42.973662-05:00,Chemotherapy,Residual Disease,
HCM-BROD-0482-C34,c996d442-45aa-47e8-9a9c-82727085d22d,914b3169-c5ef-4013-a946-6341a998a16b,714.0,Maintenance Therapy,1.0,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0482-C34_treatment8,40702cd9-64d4-49b3-a2f2-47ff1af64a9b,Not Reported,released,Nivolumab,1,2020-09-27T11:53:42.973662-05:00,,,
HCM-BROD-0482-C34,c996d442-45aa-47e8-9a9c-82727085d22d,914b3169-c5ef-4013-a946-6341a998a16b,714.0,Maintenance Therapy,1.0,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0482-C34_treatment9,ff4315fa-8686-402f-9cfc-9943509e9b55,Not Reported,released,Carboplatin,1,2020-09-27T11:53:42.973662-05:00,,,
HCM-BROD-0482-C34,c996d442-45aa-47e8-9a9c-82727085d22d,df44e9ad-7ce3-40d1-8080-34731a2c7732,799.0,Maintenance Therapy,1.0,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0482-C34_treatment10,05025f8a-dd1b-4557-a3ea-ab5e1a2efcd7,Stable Disease,released,Carboplatin,1,2021-10-21T11:26:10.709913-05:00,,,
HCM-BROD-0482-C34,c996d442-45aa-47e8-9a9c-82727085d22d,df44e9ad-7ce3-40d1-8080-34731a2c7732,799.0,Maintenance Therapy,1.0,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0482-C34_treatment11,7c9cdac2-6050-482e-a376-8b02de5702cd,Stable Disease,released,Etoposide,1,2021-10-21T11:26:10.709913-05:00,,,
HCM-EXPT-1215-C15,c9bb8d6f-cd84-4b15-9fa3-a3257726a338,64523c25-070f-477e-aeeb-9eca489cd09c,,Neoadjuvant,114.0,2025-10-08T12:38:51.189053-05:00,HCM-EXPT-1215-C15_treatment,012a7df7-c39f-4ca9-8cf5-fb28dda4e879,,released,Leucovorin,1,2023-02-24T13:58:42.020794-06:00,Chemotherapy,,
HCM-EXPT-1215-C15,c9bb8d6f-cd84-4b15-9fa3-a3257726a338,64523c25-070f-477e-aeeb-9eca489cd09c,,Neoadjuvant,114.0,2025-10-08T12:38:51.189053-05:00,HCM-EXPT-1215-C15_treatment3,777bb795-9ccb-4bed-b067-a6033641fcc6,,released,Docetaxel,1,2023-02-24T13:58:42.020794-06:00,Chemotherapy,,
HCM-EXPT-1215-C15,c9bb8d6f-cd84-4b15-9fa3-a3257726a338,64523c25-070f-477e-aeeb-9eca489cd09c,,Neoadjuvant,114.0,2025-10-08T12:38:51.189053-05:00,HCM-EXPT-1215-C15_treatment4,82172b42-5726-4c6a-a624-7b52117e36c5,,released,Oxaliplatin,1,2023-02-24T13:58:42.020794-06:00,Chemotherapy,,
HCM-EXPT-1215-C15,c9bb8d6f-cd84-4b15-9fa3-a3257726a338,64523c25-070f-477e-aeeb-9eca489cd09c,,Neoadjuvant,114.0,2025-10-08T12:38:51.189053-05:00,HCM-EXPT-1215-C15_treatment2,c9e55f4d-f695-4a9b-bd0e-0f6e34198ec0,,released,Fluorouracil,1,2023-02-24T13:58:42.020794-06:00,Chemotherapy,,
HCM-SANG-1095-C25,c9bf8ca1-80dd-4b27-9b02-7347de171e12,da916421-ffeb-4415-9bd8-01e54604cdb7,,Neoadjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-SANG-1095-C25_treatment,784303eb-5a55-4dff-8183-9a5ba7a4aed4,,released,,0,2023-02-27T11:17:25.586966-06:00,,,
HCM-CSHL-0858-C25,ca0b8e86-7e21-4192-8113-c8d051768365,729b83cb-2166-4431-8929-393cfb7caf15,198.0,Adjuvant,73.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0858-C25_treatment3,4645288f-af01-4e18-a578-60cb2c8bbdd5,,released,Leucovorin Calcium,1,2021-12-21T14:34:49.028238-06:00,Chemotherapy,Residual Disease,
HCM-CSHL-0858-C25,ca0b8e86-7e21-4192-8113-c8d051768365,729b83cb-2166-4431-8929-393cfb7caf15,198.0,Adjuvant,73.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0858-C25_treatment2,5f75345d-4bb8-496a-b774-a3d412b31b97,,released,Irinotecan Hydrochloride,1,2021-12-21T14:34:49.028238-06:00,Chemotherapy,Residual Disease,
HCM-CSHL-0858-C25,ca0b8e86-7e21-4192-8113-c8d051768365,729b83cb-2166-4431-8929-393cfb7caf15,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0858-C25_treatment8,757e257d-c842-461e-b41e-249c87e47b6c,,released,,1,2021-12-21T14:34:49.028238-06:00,Chemotherapy,Residual Disease,
HCM-CSHL-0858-C25,ca0b8e86-7e21-4192-8113-c8d051768365,729b83cb-2166-4431-8929-393cfb7caf15,364.0,Adjuvant,364.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0858-C25_treatment7,7f1bfbe0-c8e4-4bcc-843f-eff2fa3ebcd9,,released,Gemcitabine,1,2021-12-21T14:34:49.028238-06:00,Chemotherapy,Residual Disease,
HCM-CSHL-0858-C25,ca0b8e86-7e21-4192-8113-c8d051768365,729b83cb-2166-4431-8929-393cfb7caf15,198.0,Adjuvant,73.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0858-C25_treatment4,a93c3462-464b-4a64-a196-3d0644cdb7b2,,released,Fluorouracil,1,2021-12-21T14:34:49.028238-06:00,Chemotherapy,Residual Disease,
HCM-CSHL-0858-C25,ca0b8e86-7e21-4192-8113-c8d051768365,729b83cb-2166-4431-8929-393cfb7caf15,198.0,Adjuvant,73.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0858-C25_treatment5,b76fe413-854b-4681-bacd-043b5a75f512,,released,Oxaliplatin,1,2021-12-21T14:34:49.028238-06:00,Chemotherapy,Residual Disease,
HCM-CSHL-0858-C25,ca0b8e86-7e21-4192-8113-c8d051768365,729b83cb-2166-4431-8929-393cfb7caf15,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0858-C25_treatment11,b8b5fc90-eb2d-4a4f-8a5d-bbd27fc7df44,,released,,0,2021-12-21T14:34:49.028238-06:00,Targeted Molecular Therapy,Residual Disease,
HCM-CSHL-0858-C25,ca0b8e86-7e21-4192-8113-c8d051768365,729b83cb-2166-4431-8929-393cfb7caf15,198.0,Adjuvant,73.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0858-C25_treatment6,c99ce5fc-55d5-465a-99ff-7241ccb95f3a,,released,,1,2021-12-21T14:34:49.028238-06:00,Chemotherapy,Residual Disease,
HCM-CSHL-0858-C25,ca0b8e86-7e21-4192-8113-c8d051768365,729b83cb-2166-4431-8929-393cfb7caf15,,,,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0858-C25_treatment10,cc34dc9b-c44c-4274-b7ed-601c126441f2,,released,,1,2021-12-21T14:34:49.028238-06:00,"Surgery, NOS",Initial Diagnosis,
HCM-CSHL-0858-C25,ca0b8e86-7e21-4192-8113-c8d051768365,729b83cb-2166-4431-8929-393cfb7caf15,,Neoadjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0858-C25_treatment,d0fd6462-1c66-48a4-afd5-16a6524849fb,,released,,0,2021-12-21T14:34:49.028238-06:00,,,
HCM-CSHL-0858-C25,ca0b8e86-7e21-4192-8113-c8d051768365,729b83cb-2166-4431-8929-393cfb7caf15,,,,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0858-C25_treatment9,e33adb2e-c7fd-4cc9-bcd5-13292f3517e3,,released,,0,2021-12-21T14:34:49.028238-06:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-CSHL-0858-C25,ca0b8e86-7e21-4192-8113-c8d051768365,fcc8413c-676c-4e16-afaf-0cfcf788eee5,249.0,Maintenance Therapy,73.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0858-C25_treatment14,3415d7db-4338-4afa-8c62-afddea0f2864,Not Reported,released,Irinotecan Hydrochloride,1,2022-02-03T08:25:33.513186-06:00,,,
HCM-CSHL-0858-C25,ca0b8e86-7e21-4192-8113-c8d051768365,fcc8413c-676c-4e16-afaf-0cfcf788eee5,249.0,Maintenance Therapy,73.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0858-C25_treatment13,b9e71da3-bb98-4b98-aec2-8e4657f00eda,Not Reported,released,Leucovorin Calcium,1,2021-12-21T14:34:49.028238-06:00,,,
HCM-CSHL-0858-C25,ca0b8e86-7e21-4192-8113-c8d051768365,fcc8413c-676c-4e16-afaf-0cfcf788eee5,249.0,Maintenance Therapy,73.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0858-C25_treatment15,e0f604c0-5305-49e5-be38-64f005b00eb6,Not Reported,released,Oxaliplatin,1,2022-02-03T08:25:33.513186-06:00,,,
HCM-BROD-0253-C15,ca7aecd3-f8a4-4282-8167-f85368bec527,e6cb5829-48af-4687-9247-79a1f66e86bf,279.0,Adjuvant,223.0,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0253-C15_treatment8,0f8e8f30-d1f3-4fdc-a1f1-6355f9389d19,,released,Ramucirumab,1,2020-09-27T11:16:43.688605-05:00,Targeted Molecular Therapy,Residual Disease,
HCM-BROD-0253-C15,ca7aecd3-f8a4-4282-8167-f85368bec527,e6cb5829-48af-4687-9247-79a1f66e86bf,279.0,Adjuvant,223.0,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0253-C15_treatment5,498e7376-54c2-4e36-b7c3-5a507f6e9370,,released,Paclitaxel,1,2020-09-27T11:16:43.688605-05:00,Chemotherapy,Residual Disease,
HCM-BROD-0253-C15,ca7aecd3-f8a4-4282-8167-f85368bec527,e6cb5829-48af-4687-9247-79a1f66e86bf,,,,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0253-C15_treatment7,6a1052a1-2c1e-490a-b944-54ab2445449b,,released,,0,2020-09-27T11:16:43.688605-05:00,"Surgery, NOS",Initial Diagnosis,
HCM-BROD-0253-C15,ca7aecd3-f8a4-4282-8167-f85368bec527,e6cb5829-48af-4687-9247-79a1f66e86bf,,Adjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0253-C15_treatment6,897d32fb-f1ff-4a3b-b348-02ce67b2aa4e,,released,,0,2020-09-27T11:16:43.688605-05:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-BROD-0253-C15,ca7aecd3-f8a4-4282-8167-f85368bec527,e6cb5829-48af-4687-9247-79a1f66e86bf,195.0,Adjuvant,167.0,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0253-C15_treatment2,92bec0f4-a0a6-4245-9b71-15904fbd243a,,released,Fluorouracil,1,2020-09-27T11:16:43.688605-05:00,Chemotherapy,Residual Disease,
HCM-BROD-0253-C15,ca7aecd3-f8a4-4282-8167-f85368bec527,e6cb5829-48af-4687-9247-79a1f66e86bf,195.0,Adjuvant,167.0,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0253-C15_treatment3,a5fe50dc-21de-482b-9f7b-5341ce25c19c,,released,Leucovorin,1,2020-09-27T11:16:43.688605-05:00,Chemotherapy,Residual Disease,
HCM-BROD-0253-C15,ca7aecd3-f8a4-4282-8167-f85368bec527,e6cb5829-48af-4687-9247-79a1f66e86bf,195.0,Adjuvant,167.0,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0253-C15_treatment4,ac1e01f9-88e4-4647-aed1-cad560155c5e,,released,Oxaliplatin,1,2020-09-27T11:16:43.688605-05:00,Chemotherapy,Residual Disease,
HCM-BROD-0253-C15,ca7aecd3-f8a4-4282-8167-f85368bec527,e6cb5829-48af-4687-9247-79a1f66e86bf,,Adjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0253-C15_treatment9,cd369cec-72fc-4a01-83e8-3429f22c7a84,,released,,0,2020-09-27T11:16:43.688605-05:00,"Radiation Therapy, NOS",Residual Disease,
HCM-BROD-0253-C15,ca7aecd3-f8a4-4282-8167-f85368bec527,e6cb5829-48af-4687-9247-79a1f66e86bf,,Neoadjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0253-C15_treatment,d7eedd48-2f6d-465d-b806-13baa0acbfed,,released,,1,2019-04-04T15:55:02.493893-05:00,Chemotherapy,,
HCM-BROD-1129-C56,ca7bc7fd-6ce1-4d63-b935-804ff4d3abc2,12bb4e82-23c5-45ca-8c3c-17a38cdc71f0,1168.0,Maintenance Therapy,1057.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-1129-C56_treatment11,270688a6-8639-46af-b824-8daf603bd0eb,Progressive Disease,released,Niraparib,1,2021-12-21T14:02:14.278160-06:00,,,
HCM-BROD-1129-C56,ca7bc7fd-6ce1-4d63-b935-804ff4d3abc2,12bb4e82-23c5-45ca-8c3c-17a38cdc71f0,1168.0,Maintenance Therapy,1057.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-1129-C56_treatment10,9999772a-f1ad-4202-bd31-d4e8590bd7a4,Progressive Disease,released,Paclitaxel,1,2021-12-21T14:02:14.278160-06:00,,,
HCM-BROD-1129-C56,ca7bc7fd-6ce1-4d63-b935-804ff4d3abc2,12bb4e82-23c5-45ca-8c3c-17a38cdc71f0,1168.0,Maintenance Therapy,1057.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-1129-C56_treatment9,d0fd9aa2-f44d-41c8-abad-88a860b6fe93,Progressive Disease,released,Bevacizumab,1,2021-12-21T14:02:14.278160-06:00,,,
HCM-BROD-1129-C56,ca7bc7fd-6ce1-4d63-b935-804ff4d3abc2,12bb4e82-23c5-45ca-8c3c-17a38cdc71f0,1168.0,Maintenance Therapy,1057.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-1129-C56_treatment12,d7c3da0b-53d0-4b08-9861-5890b098533e,Progressive Disease,released,Carboplatin,1,2021-12-21T14:02:14.278160-06:00,,,
HCM-BROD-1129-C56,ca7bc7fd-6ce1-4d63-b935-804ff4d3abc2,a9f49053-682c-4d41-bced-0dea73ac9851,,Neoadjuvant,20.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-1129-C56_treatment2,001d70d5-8b61-42f2-892b-f089830f20fd,,released,Paclitaxel,1,2021-12-21T14:02:14.278160-06:00,Chemotherapy,,
HCM-BROD-1129-C56,ca7bc7fd-6ce1-4d63-b935-804ff4d3abc2,a9f49053-682c-4d41-bced-0dea73ac9851,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-BROD-1129-C56_treatment5,1057dcac-5a8e-4dff-8d5f-5fa39b12216a,,released,,0,2021-12-21T14:02:14.278160-06:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-BROD-1129-C56,ca7bc7fd-6ce1-4d63-b935-804ff4d3abc2,a9f49053-682c-4d41-bced-0dea73ac9851,1379.0,Adjuvant,1321.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-1129-C56_treatment7,10d7da81-724a-435f-9aa9-1c41ccb72e91,,released,Bevacizumab,1,2021-12-21T14:02:14.278160-06:00,Targeted Molecular Therapy,Residual Disease,
HCM-BROD-1129-C56,ca7bc7fd-6ce1-4d63-b935-804ff4d3abc2,a9f49053-682c-4d41-bced-0dea73ac9851,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-BROD-1129-C56_treatment8,279c24bb-25e2-4279-bc03-f29c999a41cd,,released,,0,2021-12-21T14:02:14.278160-06:00,"Radiation Therapy, NOS",Residual Disease,
HCM-BROD-1129-C56,ca7bc7fd-6ce1-4d63-b935-804ff4d3abc2,a9f49053-682c-4d41-bced-0dea73ac9851,,Neoadjuvant,20.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-1129-C56_treatment,2c00d9e2-8d08-4049-8683-1b2f62b3b04d,,released,Carboplatin,1,2021-12-21T14:02:14.278160-06:00,Chemotherapy,,
HCM-BROD-1129-C56,ca7bc7fd-6ce1-4d63-b935-804ff4d3abc2,a9f49053-682c-4d41-bced-0dea73ac9851,,,0.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-1129-C56_treatment6,ad5a088e-4cf7-4f7b-a22e-e902529fe3b6,,released,,1,2021-12-21T14:02:14.278160-06:00,"Surgery, NOS",Initial Diagnosis,
HCM-BROD-1129-C56,ca7bc7fd-6ce1-4d63-b935-804ff4d3abc2,a9f49053-682c-4d41-bced-0dea73ac9851,1379.0,Adjuvant,1321.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-1129-C56_treatment3,ea59f672-adb5-4fb1-aabb-134785a4028c,,released,Paclitaxel,1,2021-12-21T14:02:14.278160-06:00,Chemotherapy,Residual Disease,
HCM-BROD-1129-C56,ca7bc7fd-6ce1-4d63-b935-804ff4d3abc2,a9f49053-682c-4d41-bced-0dea73ac9851,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-BROD-1129-C56_treatment4,ef9e2cf0-ed71-451d-b1cc-499e694741b4,,released,,0,2021-12-21T14:02:14.278160-06:00,Hormone Therapy,Residual Disease,
HCM-CSHL-0192-C25,caa4afe4-b5e1-4427-ae52-9d41c7c8b93f,7e38f63b-a983-4dd9-85c7-0a8eb045af47,,Adjuvant,225.0,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0192-C25_treatment6,244105ef-5ae0-4206-9bdd-5a6dd7c9077d,,released,,1,2020-09-28T09:16:43.682099-05:00,"Radiation, 2D Conventional",Residual Disease,
HCM-CSHL-0192-C25,caa4afe4-b5e1-4427-ae52-9d41c7c8b93f,7e38f63b-a983-4dd9-85c7-0a8eb045af47,194.0,Adjuvant,11.0,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0192-C25_treatment2,2e7f6821-4835-4745-83ad-73a2e75e07c3,,released,Gemcitabine,1,2020-09-28T09:16:43.682099-05:00,Chemotherapy,Residual Disease,
HCM-CSHL-0192-C25,caa4afe4-b5e1-4427-ae52-9d41c7c8b93f,7e38f63b-a983-4dd9-85c7-0a8eb045af47,,,-12.0,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0192-C25_treatment4,58f31333-f745-4135-8c0e-97c90ed29db9,,released,,1,2020-09-28T09:16:43.682099-05:00,"Surgery, NOS",Initial Diagnosis,
HCM-CSHL-0192-C25,caa4afe4-b5e1-4427-ae52-9d41c7c8b93f,7e38f63b-a983-4dd9-85c7-0a8eb045af47,,Neoadjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0192-C25_treatment,914e5a18-557b-41c6-b795-dfd5caa4c5df,,released,,0,2020-09-28T09:16:43.682099-05:00,,,
HCM-CSHL-0192-C25,caa4afe4-b5e1-4427-ae52-9d41c7c8b93f,7e38f63b-a983-4dd9-85c7-0a8eb045af47,,Adjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0192-C25_treatment5,9fbd8b19-5503-4db1-b47f-a92dc7a84beb,,released,,0,2020-09-28T09:16:43.682099-05:00,Targeted Molecular Therapy,Residual Disease,
HCM-CSHL-0192-C25,caa4afe4-b5e1-4427-ae52-9d41c7c8b93f,7e38f63b-a983-4dd9-85c7-0a8eb045af47,,Adjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0192-C25_treatment3,aff99000-5234-48d5-86b4-e967b88f34b2,,released,,0,2020-09-28T09:16:43.682099-05:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-BROD-0104-C71,cad9953c-7293-4699-9c47-3e24bc592f9a,e709b419-ae09-438d-8c90-241926771c33,69.0,Adjuvant,26.0,2021-01-06T22:55:10.531130-06:00,HCM-BROD-0104-C71_treatment7,5575e0be-81cf-4c1e-baab-ef016aecc159,,released,,1,2020-04-21T14:49:59.575847-05:00,"Radiation Therapy, NOS",Residual Disease,
HCM-BROD-0104-C71,cad9953c-7293-4699-9c47-3e24bc592f9a,e709b419-ae09-438d-8c90-241926771c33,106.0,Adjuvant,102.0,2021-01-06T22:55:10.531130-06:00,HCM-BROD-0104-C71_treatment2,6429f7fb-5550-439b-8ba9-62652c21f3bc,,released,Temozolomide,1,2020-04-21T14:49:59.575847-05:00,Chemotherapy,Residual Disease,
HCM-BROD-0104-C71,cad9953c-7293-4699-9c47-3e24bc592f9a,e709b419-ae09-438d-8c90-241926771c33,,,-9.0,2023-02-27T12:49:58.796338-06:00,HCM-BROD-0104-C71_treatment5,a12b6b04-5d5d-4a87-ae60-ab0b2f010ea9,,released,,1,2020-04-21T14:49:59.575847-05:00,"Surgery, NOS",Initial Diagnosis,
HCM-BROD-0104-C71,cad9953c-7293-4699-9c47-3e24bc592f9a,e709b419-ae09-438d-8c90-241926771c33,,Adjuvant,,2021-01-06T22:55:10.531130-06:00,HCM-BROD-0104-C71_treatment4,a32625cf-b421-4da9-a813-182e3b560b62,,released,,0,2020-04-21T14:49:59.575847-05:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-BROD-0104-C71,cad9953c-7293-4699-9c47-3e24bc592f9a,e709b419-ae09-438d-8c90-241926771c33,236.0,Adjuvant,153.0,2021-01-06T22:55:10.531130-06:00,HCM-BROD-0104-C71_treatment6,b277dd7d-e671-41a6-82c8-a5ad78ecf4c7,,released,Bevacizumab,1,2020-04-21T14:49:59.575847-05:00,Targeted Molecular Therapy,Residual Disease,
HCM-BROD-0104-C71,cad9953c-7293-4699-9c47-3e24bc592f9a,e709b419-ae09-438d-8c90-241926771c33,,Neoadjuvant,,2021-01-06T22:55:10.531130-06:00,HCM-BROD-0104-C71_treatment,cb90aa7d-5f66-4550-b460-8b5c1bb41d37,,released,,0,2019-04-04T14:47:07.963906-05:00,,,
HCM-BROD-0104-C71,cad9953c-7293-4699-9c47-3e24bc592f9a,e709b419-ae09-438d-8c90-241926771c33,148.0,Adjuvant,109.0,2021-01-06T22:55:10.531130-06:00,HCM-BROD-0104-C71_treatment3,d7f2ddec-91ad-4fd1-895d-96d0bc2da848,,released,Temozolomide,1,2020-04-21T14:49:59.575847-05:00,Chemotherapy,Residual Disease,
HCM-EXPT-0893-C25,caeb19f1-7bd6-4a05-bd33-4b894610fa9d,a2698b5c-152a-4233-851b-daa2f08b375d,,Neoadjuvant,,2025-10-08T12:36:32.654639-05:00,HCM-EXPT-0893-C25_treatment,a530aa3f-4492-4a4d-8174-ae6dbf20cd7d,,released,,0,2021-12-21T14:42:33.322066-06:00,,,
HCM-BROD-1130-C06,cb56773d-4a53-4313-8c10-51254698b3bd,dbfa0892-42af-4417-b634-5235aeccc068,,Neoadjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-BROD-1130-C06_treatment,2c71f8e4-2aee-44ea-bd1e-e878956bd99a,,released,,0,2021-12-21T14:02:20.455776-06:00,,,
HCM-BROD-1130-C06,cb56773d-4a53-4313-8c10-51254698b3bd,dbfa0892-42af-4417-b634-5235aeccc068,102.0,Adjuvant,60.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-1130-C06_treatment4,6db9b9fe-6517-4c66-b2c3-ce0d816fba3b,,released,,1,2021-12-21T14:02:20.455776-06:00,"Radiation Therapy, NOS",Residual Disease,
HCM-BROD-1130-C06,cb56773d-4a53-4313-8c10-51254698b3bd,dbfa0892-42af-4417-b634-5235aeccc068,,,0.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-1130-C06_treatment2,7332eace-56d2-42fe-855c-fe44040e8f76,,released,,1,2021-12-21T14:02:20.455776-06:00,"Surgery, NOS",Initial Diagnosis,
HCM-EXPT-1191-C15,cba81c26-946c-4581-bb5a-2451fa3912b5,438b7e89-1509-4665-9258-e0ca559c1226,,Neoadjuvant,99.0,2025-10-08T12:38:28.988690-05:00,HCM-EXPT-1191-C15_treatment3,2578dc77-d9f9-4ff6-b72a-6319fbfd5f51,,released,Cisplatin,1,2022-03-17T09:36:10.511130-05:00,Chemotherapy,,
HCM-EXPT-1191-C15,cba81c26-946c-4581-bb5a-2451fa3912b5,438b7e89-1509-4665-9258-e0ca559c1226,,Neoadjuvant,99.0,2025-10-08T12:38:28.988690-05:00,HCM-EXPT-1191-C15_treatment2,49af54e2-69fe-46dc-a789-8c69545a9b4d,,released,Capecitabine,1,2022-03-17T09:36:10.511130-05:00,Chemotherapy,,
HCM-EXPT-1191-C15,cba81c26-946c-4581-bb5a-2451fa3912b5,438b7e89-1509-4665-9258-e0ca559c1226,,Neoadjuvant,99.0,2025-10-08T12:38:28.988690-05:00,HCM-EXPT-1191-C15_treatment,92693c46-3202-4fbd-8e1f-10b3fb6aa05a,,released,Epirubicin,1,2022-03-17T09:36:10.511130-05:00,Chemotherapy,,
HCM-EXPT-1191-C15,cba81c26-946c-4581-bb5a-2451fa3912b5,438b7e89-1509-4665-9258-e0ca559c1226,,Neoadjuvant,99.0,2025-10-08T12:38:28.988690-05:00,HCM-EXPT-1191-C15_treatment4,d492f0df-8046-492f-9f5f-d246ffdec998,,released,,1,2022-03-17T09:36:10.511130-05:00,Chemotherapy,,ECX
HCM-CSHL-1262-C19,cc3f9ed5-edcc-4a5a-883b-25bfca20b730,08408f5b-9f10-4457-b7e3-af92fa605d13,111.0,Adjuvant,9.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-1262-C19_treatment9,0f8cb71f-31ba-48c8-bfbe-dbb24a2199c9,,released,Cetuximab,1,2021-12-23T08:32:56.149950-06:00,Chemotherapy,Residual Disease,
HCM-CSHL-1262-C19,cc3f9ed5-edcc-4a5a-883b-25bfca20b730,08408f5b-9f10-4457-b7e3-af92fa605d13,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-1262-C19_treatment38,1021bd11-4442-45c8-891c-7908b92f0ffd,,released,,0,2021-12-23T08:32:56.149950-06:00,"Radiation Therapy, NOS",Residual Disease,
HCM-CSHL-1262-C19,cc3f9ed5-edcc-4a5a-883b-25bfca20b730,08408f5b-9f10-4457-b7e3-af92fa605d13,,Neoadjuvant,52.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-1262-C19_treatment4,1177a149-836d-4acb-a9dc-5db8958e8fad,,released,,1,2021-12-23T08:32:56.149950-06:00,Chemotherapy,,FOLFIRI
HCM-CSHL-1262-C19,cc3f9ed5-edcc-4a5a-883b-25bfca20b730,08408f5b-9f10-4457-b7e3-af92fa605d13,441.0,Adjuvant,349.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-1262-C19_treatment14,14fe4ef3-afca-4f98-8a9f-9e91218f7917,,released,Fluorouracil,1,2021-12-23T08:32:56.149950-06:00,Chemotherapy,Residual Disease,
HCM-CSHL-1262-C19,cc3f9ed5-edcc-4a5a-883b-25bfca20b730,08408f5b-9f10-4457-b7e3-af92fa605d13,710.0,Adjuvant,542.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-1262-C19_treatment17,1796e410-c167-465c-950c-4762cec3de36,,released,Irinotecan,1,2021-12-23T08:32:56.149950-06:00,Chemotherapy,Residual Disease,
HCM-CSHL-1262-C19,cc3f9ed5-edcc-4a5a-883b-25bfca20b730,08408f5b-9f10-4457-b7e3-af92fa605d13,948.0,Adjuvant,920.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-1262-C19_treatment26,188e23fd-24af-45e7-a616-12154a148449,,released,Cetuximab,1,2021-12-23T08:32:56.149950-06:00,Chemotherapy,Residual Disease,
HCM-CSHL-1262-C19,cc3f9ed5-edcc-4a5a-883b-25bfca20b730,08408f5b-9f10-4457-b7e3-af92fa605d13,1109.0,Adjuvant,1049.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-1262-C19_treatment28,1b651b3f-0b7f-40c0-854a-ca4c8a4eaeae,,released,Irinotecan,1,2021-12-23T08:32:56.149950-06:00,Chemotherapy,Residual Disease,
HCM-CSHL-1262-C19,cc3f9ed5-edcc-4a5a-883b-25bfca20b730,08408f5b-9f10-4457-b7e3-af92fa605d13,111.0,Adjuvant,9.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-1262-C19_treatment6,1e1aa9fc-f599-45cb-86f3-3ec064e9f2c9,,released,Irinotecan,1,2021-12-23T08:32:56.149950-06:00,Chemotherapy,Residual Disease,
HCM-CSHL-1262-C19,cc3f9ed5-edcc-4a5a-883b-25bfca20b730,08408f5b-9f10-4457-b7e3-af92fa605d13,710.0,Adjuvant,542.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-1262-C19_treatment18,20cd4068-f76f-4e10-9786-0572d4e6d19d,,released,Leucovorin Calcium,1,2021-12-23T08:32:56.149950-06:00,Chemotherapy,Residual Disease,
HCM-CSHL-1262-C19,cc3f9ed5-edcc-4a5a-883b-25bfca20b730,08408f5b-9f10-4457-b7e3-af92fa605d13,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-1262-C19_treatment35,235b3f32-47af-430e-b170-287299bda1ad,,released,Not Reported,1,2021-12-23T08:32:56.149950-06:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-CSHL-1262-C19,cc3f9ed5-edcc-4a5a-883b-25bfca20b730,08408f5b-9f10-4457-b7e3-af92fa605d13,111.0,Adjuvant,9.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-1262-C19_treatment8,2c4a1908-5c98-4f16-bc1f-128b4044e50c,,released,Fluorouracil,1,2021-12-23T08:32:56.149950-06:00,Chemotherapy,Residual Disease,
HCM-CSHL-1262-C19,cc3f9ed5-edcc-4a5a-883b-25bfca20b730,08408f5b-9f10-4457-b7e3-af92fa605d13,441.0,Adjuvant,349.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-1262-C19_treatment12,2e21143b-783e-4cba-b144-755364600fcc,,released,Bevacizumab,1,2021-12-23T08:32:56.149950-06:00,Chemotherapy,Residual Disease,
HCM-CSHL-1262-C19,cc3f9ed5-edcc-4a5a-883b-25bfca20b730,08408f5b-9f10-4457-b7e3-af92fa605d13,1109.0,Adjuvant,1049.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-1262-C19_treatment30,34dc7b0b-aa92-4de8-acab-b9333ef8e7bc,,released,Fluorouracil,1,2021-12-23T08:32:56.149950-06:00,Chemotherapy,Residual Disease,
HCM-CSHL-1262-C19,cc3f9ed5-edcc-4a5a-883b-25bfca20b730,08408f5b-9f10-4457-b7e3-af92fa605d13,,Neoadjuvant,52.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-1262-C19_treatment3,3c227293-f669-4cf7-a94e-f673993e3f01,,released,Irinotecan,1,2021-12-23T08:32:56.149950-06:00,Chemotherapy,,
HCM-CSHL-1262-C19,cc3f9ed5-edcc-4a5a-883b-25bfca20b730,08408f5b-9f10-4457-b7e3-af92fa605d13,948.0,Adjuvant,920.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-1262-C19_treatment27,3c31a8c7-3d82-41d6-a6f0-d940c373c969,,released,,1,2021-12-23T08:32:56.149950-06:00,Chemotherapy,Residual Disease,FOLFIRI-cetuximab
HCM-CSHL-1262-C19,cc3f9ed5-edcc-4a5a-883b-25bfca20b730,08408f5b-9f10-4457-b7e3-af92fa605d13,948.0,Adjuvant,920.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-1262-C19_treatment23,3d72deaf-2ec4-47ac-9d19-c1b57a5ddf3e,,released,Irinotecan,1,2021-12-23T08:32:56.149950-06:00,Chemotherapy,Residual Disease,
HCM-CSHL-1262-C19,cc3f9ed5-edcc-4a5a-883b-25bfca20b730,08408f5b-9f10-4457-b7e3-af92fa605d13,1202.0,Adjuvant,1166.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-1262-C19_treatment33,441bae58-d206-44c0-9cde-0ee56aa28681,,released,Trifluridine and Tipiracil Hydrochloride,1,2021-12-23T08:32:56.149950-06:00,Chemotherapy,Residual Disease,
HCM-CSHL-1262-C19,cc3f9ed5-edcc-4a5a-883b-25bfca20b730,08408f5b-9f10-4457-b7e3-af92fa605d13,111.0,Adjuvant,9.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-1262-C19_treatment7,47bec76f-0258-42fc-aa24-2f688e50c5a8,,released,Leucovorin Calcium,1,2021-12-23T08:32:56.149950-06:00,Chemotherapy,Residual Disease,
HCM-CSHL-1262-C19,cc3f9ed5-edcc-4a5a-883b-25bfca20b730,08408f5b-9f10-4457-b7e3-af92fa605d13,948.0,Adjuvant,920.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-1262-C19_treatment24,536597ea-36f3-48f9-a156-a52f234088c9,,released,Leucovorin Calcium,1,2021-12-23T08:32:56.149950-06:00,Chemotherapy,Residual Disease,
HCM-CSHL-1262-C19,cc3f9ed5-edcc-4a5a-883b-25bfca20b730,08408f5b-9f10-4457-b7e3-af92fa605d13,1109.0,Adjuvant,1049.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-1262-C19_treatment31,58254aee-7609-439b-b7f1-86e33a3dac48,,released,Cetuximab,1,2021-12-23T08:32:56.149950-06:00,Chemotherapy,Residual Disease,
HCM-CSHL-1262-C19,cc3f9ed5-edcc-4a5a-883b-25bfca20b730,08408f5b-9f10-4457-b7e3-af92fa605d13,710.0,Adjuvant,542.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-1262-C19_treatment21,5f50ac0c-b108-47c1-a03d-0f7aaff3b6d7,,released,,1,2021-12-23T08:32:56.149950-06:00,Chemotherapy,Residual Disease,FOLFIRI-cetuximab
HCM-CSHL-1262-C19,cc3f9ed5-edcc-4a5a-883b-25bfca20b730,08408f5b-9f10-4457-b7e3-af92fa605d13,441.0,Adjuvant,349.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-1262-C19_treatment11,6963c1c7-6286-4c5c-b938-e2003623b39f,,released,Oxaliplatin,1,2021-12-23T08:32:56.149950-06:00,Chemotherapy,Residual Disease,
HCM-CSHL-1262-C19,cc3f9ed5-edcc-4a5a-883b-25bfca20b730,08408f5b-9f10-4457-b7e3-af92fa605d13,900.0,Adjuvant,721.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-1262-C19_treatment22,6b379d82-48d1-4053-8acc-0bc79e3bff26,,released,,1,2021-12-23T08:32:56.149950-06:00,Chemotherapy,Residual Disease,
HCM-CSHL-1262-C19,cc3f9ed5-edcc-4a5a-883b-25bfca20b730,08408f5b-9f10-4457-b7e3-af92fa605d13,1166.0,Adjuvant,1118.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-1262-C19_treatment37,788356cf-35e3-4fda-b273-6aaf674ec8ef,,released,Regorafenib,1,2021-12-23T08:32:56.149950-06:00,Targeted Molecular Therapy,Residual Disease,
HCM-CSHL-1262-C19,cc3f9ed5-edcc-4a5a-883b-25bfca20b730,08408f5b-9f10-4457-b7e3-af92fa605d13,,,998.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-1262-C19_treatment36,7ab319f0-6d67-43a1-8da9-f1c53ffd5207,,released,,1,2021-12-23T08:32:56.149950-06:00,"Surgery, NOS",Initial Diagnosis,
HCM-CSHL-1262-C19,cc3f9ed5-edcc-4a5a-883b-25bfca20b730,08408f5b-9f10-4457-b7e3-af92fa605d13,160.0,Adjuvant,150.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-1262-C19_treatment34,81f5437a-db20-46ef-9c04-cbf100d59a33,,released,Cetuximab,1,2021-12-23T08:32:56.149950-06:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-CSHL-1262-C19,cc3f9ed5-edcc-4a5a-883b-25bfca20b730,08408f5b-9f10-4457-b7e3-af92fa605d13,,Neoadjuvant,52.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-1262-C19_treatment5,8bf46be2-1db0-4744-b65c-6224ca1fb9c6,,released,Cetuximab,1,2021-12-23T08:32:56.149950-06:00,Chemotherapy,,
HCM-CSHL-1262-C19,cc3f9ed5-edcc-4a5a-883b-25bfca20b730,08408f5b-9f10-4457-b7e3-af92fa605d13,1109.0,Adjuvant,1049.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-1262-C19_treatment32,8c0418ca-9de7-4db8-97b4-42560a466fbe,,released,,1,2021-12-23T08:32:56.149950-06:00,Chemotherapy,Residual Disease,FOLFIRI-cetuximab
HCM-CSHL-1262-C19,cc3f9ed5-edcc-4a5a-883b-25bfca20b730,08408f5b-9f10-4457-b7e3-af92fa605d13,,Neoadjuvant,52.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-1262-C19_treatment2,9aa70d21-c6eb-4d84-b9b1-0d8e5c281140,,released,Fluorouracil,1,2021-12-23T08:32:56.149950-06:00,Chemotherapy,,
HCM-CSHL-1262-C19,cc3f9ed5-edcc-4a5a-883b-25bfca20b730,08408f5b-9f10-4457-b7e3-af92fa605d13,111.0,Adjuvant,9.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-1262-C19_treatment10,c0661d9c-09dc-4db4-8aea-a69584182d50,,released,,1,2021-12-23T08:32:56.149950-06:00,Chemotherapy,Residual Disease,FOLFIRI-cetuximab
HCM-CSHL-1262-C19,cc3f9ed5-edcc-4a5a-883b-25bfca20b730,08408f5b-9f10-4457-b7e3-af92fa605d13,441.0,Adjuvant,349.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-1262-C19_treatment15,ca7a6b5a-ed8b-4518-8c46-fd11c2de444d,,released,,1,2021-12-23T08:32:56.149950-06:00,Chemotherapy,Residual Disease,FOLFOX
HCM-CSHL-1262-C19,cc3f9ed5-edcc-4a5a-883b-25bfca20b730,08408f5b-9f10-4457-b7e3-af92fa605d13,537.0,Adjuvant,441.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-1262-C19_treatment16,ce1a8fc2-05cc-4015-aef3-8300bb57060a,,released,,1,2021-12-23T08:32:56.149950-06:00,Chemotherapy,Residual Disease,
HCM-CSHL-1262-C19,cc3f9ed5-edcc-4a5a-883b-25bfca20b730,08408f5b-9f10-4457-b7e3-af92fa605d13,,Neoadjuvant,52.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-1262-C19_treatment,d1119838-34f5-411f-829a-3a8cdcb0872f,,released,Leucovorin Calcium,1,2021-12-23T08:32:56.149950-06:00,Chemotherapy,,
HCM-CSHL-1262-C19,cc3f9ed5-edcc-4a5a-883b-25bfca20b730,08408f5b-9f10-4457-b7e3-af92fa605d13,948.0,Adjuvant,920.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-1262-C19_treatment25,e447d10a-47e6-47de-9b0d-057ba63d4923,,released,Fluorouracil,1,2021-12-23T08:32:56.149950-06:00,Chemotherapy,Residual Disease,
HCM-CSHL-1262-C19,cc3f9ed5-edcc-4a5a-883b-25bfca20b730,08408f5b-9f10-4457-b7e3-af92fa605d13,710.0,Adjuvant,542.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-1262-C19_treatment20,e66d6d3c-91f9-4ded-84da-11572b42ac4f,,released,Cetuximab,1,2021-12-23T08:32:56.149950-06:00,Chemotherapy,Residual Disease,
HCM-CSHL-1262-C19,cc3f9ed5-edcc-4a5a-883b-25bfca20b730,08408f5b-9f10-4457-b7e3-af92fa605d13,710.0,Adjuvant,542.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-1262-C19_treatment19,ea1f8c5f-21fd-4ad0-ae55-96265814500a,,released,Fluorouracil,1,2021-12-23T08:32:56.149950-06:00,Chemotherapy,Residual Disease,
HCM-CSHL-1262-C19,cc3f9ed5-edcc-4a5a-883b-25bfca20b730,08408f5b-9f10-4457-b7e3-af92fa605d13,1109.0,Adjuvant,1049.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-1262-C19_treatment29,f193c2f3-7976-4376-a606-a09c25073421,,released,Leucovorin Calcium,1,2021-12-23T08:32:56.149950-06:00,Chemotherapy,Residual Disease,
HCM-CSHL-1262-C19,cc3f9ed5-edcc-4a5a-883b-25bfca20b730,08408f5b-9f10-4457-b7e3-af92fa605d13,441.0,Adjuvant,349.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-1262-C19_treatment13,f9a1a59c-9208-48ea-b7d1-2f02fc20f0e1,,released,Leucovorin Calcium,1,2021-12-23T08:32:56.149950-06:00,Chemotherapy,Residual Disease,
HCM-CSHL-1262-C19,cc3f9ed5-edcc-4a5a-883b-25bfca20b730,31013d7b-f1e9-44a8-aebe-076c9d1ca9ff,142.0,Maintenance Therapy,52.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-1262-C19_treatment43,a5a5e84b-ce48-4ec4-b793-f21c5face1bf,Progressive Disease,released,,1,2021-12-23T08:32:56.149950-06:00,,,FOLFIRI-cetuximab
HCM-CSHL-1262-C19,cc3f9ed5-edcc-4a5a-883b-25bfca20b730,31013d7b-f1e9-44a8-aebe-076c9d1ca9ff,142.0,Maintenance Therapy,52.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-1262-C19_treatment39,dd98436f-bef5-4ed1-9530-ec18834aa5d9,Progressive Disease,released,Irinotecan,1,2021-12-23T08:32:56.149950-06:00,,,
HCM-CSHL-1262-C19,cc3f9ed5-edcc-4a5a-883b-25bfca20b730,31013d7b-f1e9-44a8-aebe-076c9d1ca9ff,142.0,Maintenance Therapy,52.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-1262-C19_treatment40,df4e6c3f-50ce-4ee8-9e01-b3635f29b80d,Progressive Disease,released,Leucovorin Calcium,1,2021-12-23T08:32:56.149950-06:00,,,
HCM-CSHL-1262-C19,cc3f9ed5-edcc-4a5a-883b-25bfca20b730,31013d7b-f1e9-44a8-aebe-076c9d1ca9ff,142.0,Maintenance Therapy,52.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-1262-C19_treatment41,e056cfe3-6bc5-44e0-a5e3-7db81edc5360,Progressive Disease,released,Fluorouracil,1,2021-12-23T08:32:56.149950-06:00,,,
HCM-CSHL-1262-C19,cc3f9ed5-edcc-4a5a-883b-25bfca20b730,31013d7b-f1e9-44a8-aebe-076c9d1ca9ff,142.0,Maintenance Therapy,52.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-1262-C19_treatment42,f0933a9e-cdfa-4c10-8dc9-4206d7cd43aa,Progressive Disease,released,Cetuximab,1,2021-12-23T08:32:56.149950-06:00,,,
HCM-WCMC-1280-C54,cc86271e-34bc-4f3a-bd1b-9200a606a3fa,d64679c9-c5b7-4f7d-8d48-74fec98fb9d7,188.0,Adjuvant,76.0,2025-04-07T17:13:09.336794-05:00,HCM-WCMC-1280-C54_treatment3,06552f9f-c15d-485f-9814-dbc3b6dc1d8a,,released,Paclitaxel,1,2023-02-27T11:41:20.597188-06:00,Chemotherapy,Residual Disease,
HCM-WCMC-1280-C54,cc86271e-34bc-4f3a-bd1b-9200a606a3fa,d64679c9-c5b7-4f7d-8d48-74fec98fb9d7,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-WCMC-1280-C54_treatment7,3b717a56-c190-4c03-843a-0ee31f2fc482,,released,,0,2023-02-27T11:41:20.597188-06:00,Targeted Molecular Therapy,Residual Disease,
HCM-WCMC-1280-C54,cc86271e-34bc-4f3a-bd1b-9200a606a3fa,d64679c9-c5b7-4f7d-8d48-74fec98fb9d7,111.0,Adjuvant,83.0,2025-04-07T17:13:09.336794-05:00,HCM-WCMC-1280-C54_treatment8,8e242dc6-d2c6-4ca2-8b23-ec29e0ec6fc8,,released,,1,2023-02-27T11:41:20.597188-06:00,"Radiation Therapy, NOS",Residual Disease,
HCM-WCMC-1280-C54,cc86271e-34bc-4f3a-bd1b-9200a606a3fa,d64679c9-c5b7-4f7d-8d48-74fec98fb9d7,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-WCMC-1280-C54_treatment5,8ed2be13-36d6-4c9a-bd24-28738919d33c,,released,,0,2023-02-27T11:41:20.597188-06:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-WCMC-1280-C54,cc86271e-34bc-4f3a-bd1b-9200a606a3fa,d64679c9-c5b7-4f7d-8d48-74fec98fb9d7,,,23.0,2025-04-07T17:13:09.336794-05:00,HCM-WCMC-1280-C54_treatment6,9a7f2aab-95a1-4c56-995a-ff186dca08fb,,released,,1,2023-02-27T11:41:20.597188-06:00,"Surgery, NOS",Initial Diagnosis,
HCM-WCMC-1280-C54,cc86271e-34bc-4f3a-bd1b-9200a606a3fa,d64679c9-c5b7-4f7d-8d48-74fec98fb9d7,188.0,Adjuvant,76.0,2025-04-07T17:13:09.336794-05:00,HCM-WCMC-1280-C54_treatment2,a3e98dba-55ef-4d81-bd25-d79eb741cf3e,,released,Carboplatin,1,2023-02-27T11:41:20.597188-06:00,Chemotherapy,Residual Disease,
HCM-WCMC-1280-C54,cc86271e-34bc-4f3a-bd1b-9200a606a3fa,d64679c9-c5b7-4f7d-8d48-74fec98fb9d7,188.0,Adjuvant,76.0,2025-04-07T17:13:09.336794-05:00,HCM-WCMC-1280-C54_treatment4,bb02fcb7-3661-4fd5-9c55-642517bca998,,released,Anastrozole,1,2023-02-27T11:41:20.597188-06:00,Hormone Therapy,Residual Disease,
HCM-WCMC-1280-C54,cc86271e-34bc-4f3a-bd1b-9200a606a3fa,d64679c9-c5b7-4f7d-8d48-74fec98fb9d7,,Neoadjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-WCMC-1280-C54_treatment,f197edc7-368b-4e84-a47d-7b684ef5ad8b,,released,,0,2023-02-27T11:41:20.597188-06:00,,,
HCM-STAN-0909-C16,cd38c16c-c935-47a1-889b-0a48a6cd681c,77d94980-096f-4f28-9ace-7c69aa241d8c,,Neoadjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-STAN-0909-C16_treatment,36b30f95-6423-41cc-941f-9a2e5b2f2a3d,,released,,0,2022-09-22T07:09:10.640670-05:00,,,
HCM-STAN-0909-C16,cd38c16c-c935-47a1-889b-0a48a6cd681c,77d94980-096f-4f28-9ace-7c69aa241d8c,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-STAN-0909-C16_treatment4,549a4df6-941b-40a6-a959-0be48e84c156,,released,,0,2022-09-22T07:09:10.640670-05:00,"Radiation Therapy, NOS",Residual Disease,
HCM-STAN-0909-C16,cd38c16c-c935-47a1-889b-0a48a6cd681c,77d94980-096f-4f28-9ace-7c69aa241d8c,,,0.0,2025-04-07T17:13:09.336794-05:00,HCM-STAN-0909-C16_treatment2,c01bd9e8-b198-49f4-8bec-3bdbbe5eb8a4,,released,,1,2022-09-22T07:09:10.640670-05:00,"Surgery, NOS",Initial Diagnosis,
HCM-STAN-0909-C16,cd38c16c-c935-47a1-889b-0a48a6cd681c,77d94980-096f-4f28-9ace-7c69aa241d8c,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-STAN-0909-C16_treatment3,e5bb0398-807a-4971-a398-3f58560f3aa5,,released,,0,2022-09-22T07:09:10.640670-05:00,"Pharmaceutical Therapy, NOS",Residual Disease,
HCM-CSHL-0064-C18,cd6f37d5-d192-48b9-a63f-54d8d1e810c6,5dea9a2b-f5da-4f3d-aefa-f53f21a81fde,,Adjuvant,,2023-03-13T13:14:10.133380-05:00,HCM-CSHL-0064-C18_treatment3,1c1a4e2e-4426-4109-91f9-dd5f349cdea0,,released,,0,2019-05-15T13:04:39.907559-05:00,"Pharmaceutical Therapy, NOS",Residual Disease,
HCM-CSHL-0064-C18,cd6f37d5-d192-48b9-a63f-54d8d1e810c6,5dea9a2b-f5da-4f3d-aefa-f53f21a81fde,,Adjuvant,,2023-03-13T13:14:10.133380-05:00,HCM-CSHL-0064-C18_treatment4,69b806c9-fa81-442a-a64f-26afb9b03a51,,released,,0,2019-05-15T13:04:39.907559-05:00,"Radiation Therapy, NOS",Residual Disease,
HCM-CSHL-0064-C18,cd6f37d5-d192-48b9-a63f-54d8d1e810c6,5dea9a2b-f5da-4f3d-aefa-f53f21a81fde,,,28.0,2023-03-13T13:14:10.133380-05:00,HCM-CSHL-0064-C18_treatment2,6a465ce3-b993-42e1-95cd-0bed9e969503,,released,,1,2019-05-15T13:04:39.907559-05:00,"Surgery, NOS",Initial Diagnosis,
HCM-CSHL-0064-C18,cd6f37d5-d192-48b9-a63f-54d8d1e810c6,5dea9a2b-f5da-4f3d-aefa-f53f21a81fde,,Neoadjuvant,,2019-05-24T12:11:41.511797-05:00,HCM-CSHL-0064-C18_treatment,c2e8158e-4b18-42fc-a1f9-8cec78917599,,released,,0,2019-05-15T13:04:39.907559-05:00,,,
HCM-BROD-0574-C71,ce4c2cc5-ddbb-4870-a879-5b98305a9d2d,fa825e06-b2c4-492f-aa45-794d4452c608,231.0,Adjuvant,20.0,2023-02-22T07:39:25.979291-06:00,HCM-BROD-0574-C71_treatment2,01a18281-a8e9-408e-b532-891095df18af,,released,Temozolomide,1,2021-12-03T10:08:33.037445-06:00,Chemotherapy,Residual Disease,
HCM-BROD-0574-C71,ce4c2cc5-ddbb-4870-a879-5b98305a9d2d,fa825e06-b2c4-492f-aa45-794d4452c608,,Adjuvant,,2023-02-22T07:39:25.979291-06:00,HCM-BROD-0574-C71_treatment3,286b630a-51ac-45ac-b4e0-1aaaba148085,,released,,0,2021-12-03T10:08:33.037445-06:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-BROD-0574-C71,ce4c2cc5-ddbb-4870-a879-5b98305a9d2d,fa825e06-b2c4-492f-aa45-794d4452c608,41.0,Adjuvant,20.0,2023-02-22T07:39:25.979291-06:00,HCM-BROD-0574-C71_treatment6,689c69aa-b848-44d0-90ae-49f7f7a9923b,,released,,1,2021-12-03T10:08:33.037445-06:00,"Radiation, 3D Conformal",Residual Disease,
HCM-BROD-0574-C71,ce4c2cc5-ddbb-4870-a879-5b98305a9d2d,fa825e06-b2c4-492f-aa45-794d4452c608,,Neoadjuvant,,2023-02-22T07:39:25.979291-06:00,HCM-BROD-0574-C71_treatment,6e0a4e63-6fa3-4dd0-adcc-a4abc4590c9d,,released,,0,2021-12-03T10:08:33.037445-06:00,,,
HCM-BROD-0574-C71,ce4c2cc5-ddbb-4870-a879-5b98305a9d2d,fa825e06-b2c4-492f-aa45-794d4452c608,,,-6.0,2023-02-27T13:16:57.530709-06:00,HCM-BROD-0574-C71_treatment4,9c2bb99e-d646-4896-9f1f-79d81c0058ab,,released,,1,2021-12-03T10:08:33.037445-06:00,"Surgery, NOS",Initial Diagnosis,
HCM-BROD-0574-C71,ce4c2cc5-ddbb-4870-a879-5b98305a9d2d,fa825e06-b2c4-492f-aa45-794d4452c608,436.0,Adjuvant,413.0,2023-02-22T07:39:25.979291-06:00,HCM-BROD-0574-C71_treatment5,b1dd3239-a6bc-48ff-8f05-bbc3fcb2df44,,released,Bevacizumab,1,2021-12-03T10:08:33.037445-06:00,Targeted Molecular Therapy,Residual Disease,
HCM-EXPT-0898-C25,ce96bebc-8d72-4921-af1e-f9ecb5056f33,7ef27c02-7cc9-43ef-be7f-9bf3cdb75684,,Neoadjuvant,,2025-10-08T12:36:57.024699-05:00,HCM-EXPT-0898-C25_treatment,003a466f-7605-435d-a3dd-6e32997f6464,,released,,0,2021-12-21T14:44:22.855633-06:00,,,
HCM-SANG-0549-C15,ce97cd4b-f81f-4f99-a96d-29ca5f814af5,d8347942-7ac8-449f-a94a-7a46c30a3402,,Neoadjuvant,118.0,2025-03-31T16:34:59.906497-05:00,HCM-SANG-0549-C15_treatment,1da5e93f-87a3-41f4-b879-7c27a45aa46e,,released,Epirubicin,1,2021-12-21T15:17:17.992885-06:00,Chemotherapy,,
HCM-SANG-0549-C15,ce97cd4b-f81f-4f99-a96d-29ca5f814af5,d8347942-7ac8-449f-a94a-7a46c30a3402,,Neoadjuvant,118.0,2025-03-31T16:34:59.906497-05:00,HCM-SANG-0549-C15_treatment2,796a147b-8a0b-473c-95cf-60d802d2128b,,released,Capecitabine,1,2021-12-21T15:17:17.992885-06:00,Chemotherapy,,
HCM-SANG-0549-C15,ce97cd4b-f81f-4f99-a96d-29ca5f814af5,d8347942-7ac8-449f-a94a-7a46c30a3402,,Neoadjuvant,118.0,2025-03-31T16:34:59.906497-05:00,HCM-SANG-0549-C15_treatment3,9e115a45-5818-4155-9c04-0a793bd8ee85,,released,Cisplatin,1,2021-12-21T15:17:17.992885-06:00,Chemotherapy,,
HCM-SANG-0549-C15,ce97cd4b-f81f-4f99-a96d-29ca5f814af5,d8347942-7ac8-449f-a94a-7a46c30a3402,,Neoadjuvant,118.0,2025-03-31T16:34:59.906497-05:00,HCM-SANG-0549-C15_treatment4,a7095369-7536-488e-99c1-40816e99d407,,released,,1,2021-12-21T15:17:17.992885-06:00,Chemotherapy,,ECX
HCM-SANG-0549-C15,ce97cd4b-f81f-4f99-a96d-29ca5f814af5,d8347942-7ac8-449f-a94a-7a46c30a3402,,Neoadjuvant,118.0,2025-03-31T16:34:59.906497-05:00,HCM-SANG-0549-C15_treatment5,f1ba2da9-34cc-44b6-88d3-39382a3d1136,,released,Dexamethasone,1,2021-12-21T15:17:17.992885-06:00,Chemotherapy,,
HCM-BROD-1181-C73,cea2d371-6cd9-454b-a64b-be6c7b217134,68f2312b-78c1-4b7b-92d1-519c947b62f9,,Adjuvant,,2025-11-26T11:21:17.386971-06:00,HCM-BROD-1181-C73_treatment2,1da9c2ff-0401-44d0-a583-d5bc8c9d8607,,released,,0,2021-12-21T14:02:51.146988-06:00,Chemotherapy,Residual Disease,
HCM-BROD-1181-C73,cea2d371-6cd9-454b-a64b-be6c7b217134,68f2312b-78c1-4b7b-92d1-519c947b62f9,,Adjuvant,,2025-11-26T11:21:17.386971-06:00,HCM-BROD-1181-C73_treatment4,3f5b1fbe-c011-4e88-a027-057afc32796f,,released,,0,2021-12-21T14:02:51.146988-06:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-BROD-1181-C73,cea2d371-6cd9-454b-a64b-be6c7b217134,68f2312b-78c1-4b7b-92d1-519c947b62f9,4064.0,Adjuvant,3974.0,2025-11-26T11:21:17.386971-06:00,HCM-BROD-1181-C73_treatment6,41bee858-5d8d-49f6-9d6b-5b9cb412befa,,released,Lenvatinib,1,2021-12-21T14:02:51.146988-06:00,Targeted Molecular Therapy,Residual Disease,
HCM-BROD-1181-C73,cea2d371-6cd9-454b-a64b-be6c7b217134,68f2312b-78c1-4b7b-92d1-519c947b62f9,,,0.0,2025-11-26T11:21:17.386971-06:00,HCM-BROD-1181-C73_treatment5,48cf20b1-9f4b-4200-95bf-c1d43ad9c771,,released,,1,2021-12-21T14:02:51.146988-06:00,"Surgery, NOS",Initial Diagnosis,
HCM-BROD-1181-C73,cea2d371-6cd9-454b-a64b-be6c7b217134,68f2312b-78c1-4b7b-92d1-519c947b62f9,,Adjuvant,,2025-11-26T11:21:17.386971-06:00,HCM-BROD-1181-C73_treatment3,b2a2b1d1-18fb-4298-9053-df96a149fb10,,released,,0,2021-12-21T14:02:51.146988-06:00,Hormone Therapy,Residual Disease,
HCM-BROD-1181-C73,cea2d371-6cd9-454b-a64b-be6c7b217134,68f2312b-78c1-4b7b-92d1-519c947b62f9,,Adjuvant,,2025-11-26T11:21:17.386971-06:00,HCM-BROD-1181-C73_treatment7,d8582be2-1c34-4271-868b-8b3937b10d45,,released,,0,2021-12-21T14:02:51.146988-06:00,"Radiation Therapy, NOS",Residual Disease,
HCM-BROD-1181-C73,cea2d371-6cd9-454b-a64b-be6c7b217134,68f2312b-78c1-4b7b-92d1-519c947b62f9,,Neoadjuvant,,2025-11-26T11:21:17.386971-06:00,HCM-BROD-1181-C73_treatment,e6239421-63b7-4bb8-9bb3-916c7faff4b7,,released,,0,2021-12-21T14:02:51.146988-06:00,,,
HCM-BROD-1181-C73,cea2d371-6cd9-454b-a64b-be6c7b217134,f9ab86b6-4d89-4e8d-bf5b-7368432fa434,4064.0,Maintenance Therapy,3222.0,2025-11-26T11:21:17.386971-06:00,HCM-BROD-1181-C73_treatment8,a3573442-1d41-43a6-862f-a7101e13a644,Progressive Disease,released,Lenvatinib,1,2021-12-21T14:02:51.146988-06:00,,,
HCM-SANG-0282-C18,cf3e235e-676c-45de-a746-2ea45fd2142f,012a9f99-40b7-4da1-94ba-958285d5e5ef,,Neoadjuvant,,2023-02-22T07:39:25.979291-06:00,HCM-SANG-0282-C18_treatment,34be8d18-6bff-476d-b0c4-d1a8d6877f29,,released,,0,2020-02-11T15:57:56.567720-06:00,,,
HCM-BROD-0015-C25,cf4e22e6-18dc-4a1b-a1d3-1c9ceddd232d,a753468d-9c43-4fd5-a1a0-152e772d9cdf,,Adjuvant,,2023-07-13T10:35:44.371881-05:00,HCM-BROD-0015-C25_treatment9,1a9e579f-9e89-4750-9947-57d7bec3c2e5,,released,,0,2020-09-27T10:03:21.592898-05:00,"Radiation Therapy, NOS",Residual Disease,
HCM-BROD-0015-C25,cf4e22e6-18dc-4a1b-a1d3-1c9ceddd232d,a753468d-9c43-4fd5-a1a0-152e772d9cdf,,Adjuvant,316.0,2023-07-13T10:35:44.371881-05:00,HCM-BROD-0015-C25_treatment5,44ef1706-c92b-4716-983c-067e8fb55f7f,,released,Nab-paclitaxel,1,2019-04-16T11:20:11.037816-05:00,Chemotherapy,Residual Disease,
HCM-BROD-0015-C25,cf4e22e6-18dc-4a1b-a1d3-1c9ceddd232d,a753468d-9c43-4fd5-a1a0-152e772d9cdf,,Adjuvant,36.0,2023-07-13T10:35:44.371881-05:00,HCM-BROD-0015-C25_treatment3,5203949b-945c-479e-b58a-bd9ef8cd7f3a,,released,Nab-paclitaxel,1,2019-04-16T11:20:11.037816-05:00,Chemotherapy,Residual Disease,
HCM-BROD-0015-C25,cf4e22e6-18dc-4a1b-a1d3-1c9ceddd232d,a753468d-9c43-4fd5-a1a0-152e772d9cdf,,Adjuvant,36.0,2023-07-13T10:35:44.371881-05:00,HCM-BROD-0015-C25_treatment2,680f38cb-662e-44d3-854c-6b28c43207fd,,released,Gemcitabine,1,2019-04-16T11:20:11.037816-05:00,Chemotherapy,Residual Disease,
HCM-BROD-0015-C25,cf4e22e6-18dc-4a1b-a1d3-1c9ceddd232d,a753468d-9c43-4fd5-a1a0-152e772d9cdf,,Neoadjuvant,,2023-07-13T10:35:44.371881-05:00,HCM-BROD-0015-C25_treatment,7acdfc32-05ec-4404-8193-4b19883bff0b,,released,,0,2019-04-16T11:20:11.037816-05:00,,,
HCM-BROD-0015-C25,cf4e22e6-18dc-4a1b-a1d3-1c9ceddd232d,a753468d-9c43-4fd5-a1a0-152e772d9cdf,,Adjuvant,,2023-07-13T10:35:44.371881-05:00,HCM-BROD-0015-C25_treatment8,9e163469-e776-46f2-b2a3-1be1525cf2e2,,released,,0,2020-09-27T10:03:21.592898-05:00,Targeted Molecular Therapy,Residual Disease,
HCM-BROD-0015-C25,cf4e22e6-18dc-4a1b-a1d3-1c9ceddd232d,a753468d-9c43-4fd5-a1a0-152e772d9cdf,,Adjuvant,316.0,2023-07-13T10:35:44.371881-05:00,HCM-BROD-0015-C25_treatment4,a7480fe2-44a9-431d-90ea-b360e1fb5950,,released,Gemcitabine,1,2019-04-16T11:20:11.037816-05:00,Chemotherapy,Residual Disease,
HCM-BROD-0015-C25,cf4e22e6-18dc-4a1b-a1d3-1c9ceddd232d,a753468d-9c43-4fd5-a1a0-152e772d9cdf,,Adjuvant,,2023-07-13T10:35:44.371881-05:00,HCM-BROD-0015-C25_treatment6,a875e192-6cf2-4623-8436-516fb0036c4a,,released,,0,2019-04-16T11:20:11.037816-05:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-BROD-0015-C25,cf4e22e6-18dc-4a1b-a1d3-1c9ceddd232d,a753468d-9c43-4fd5-a1a0-152e772d9cdf,,,-8.0,2023-07-13T10:35:44.371881-05:00,HCM-BROD-0015-C25_treatment7,c4448171-1e7c-4a01-9164-53e0adb16043,,released,,1,2019-04-16T11:20:11.037816-05:00,"Surgery, NOS",Initial Diagnosis,
HCM-CSHL-0320-C02,cf726c27-b74c-4feb-96ef-bd463ae9c179,76aba0fa-1161-4a88-99e3-934eb8be5d90,,Neoadjuvant,,2023-07-13T10:35:44.371881-05:00,HCM-CSHL-0320-C02_treatment,4ee7b3ab-edec-4dee-8310-220ba4c6d620,,released,,0,2020-09-28T09:47:50.528705-05:00,,,
HCM-CSHL-0320-C02,cf726c27-b74c-4feb-96ef-bd463ae9c179,76aba0fa-1161-4a88-99e3-934eb8be5d90,,Adjuvant,,2023-07-13T10:35:44.371881-05:00,HCM-CSHL-0320-C02_treatment4,5172afdd-cbbe-48f6-a774-d4a31f7894ef,,released,,1,2020-09-28T09:47:50.528705-05:00,"Radiation, Intensity-Modulated Radiotherapy",Residual Disease,
HCM-CSHL-0320-C02,cf726c27-b74c-4feb-96ef-bd463ae9c179,76aba0fa-1161-4a88-99e3-934eb8be5d90,,Adjuvant,,2023-07-13T10:35:44.371881-05:00,HCM-CSHL-0320-C02_treatment3,9dd66c77-743e-4d47-bc98-e67156eaf7f8,,released,,0,2020-09-28T09:47:50.528705-05:00,"Pharmaceutical Therapy, NOS",Residual Disease,
HCM-CSHL-0320-C02,cf726c27-b74c-4feb-96ef-bd463ae9c179,76aba0fa-1161-4a88-99e3-934eb8be5d90,,,56.0,2023-07-13T10:35:44.371881-05:00,HCM-CSHL-0320-C02_treatment2,b98c8874-8c29-4338-afd1-60efe230700a,,released,,1,2020-09-28T09:47:50.528705-05:00,"Surgery, NOS",Initial Diagnosis,
HCM-BROD-0648-C71,cf7c73f3-b680-496d-94e5-22951ef84b79,6b9e8493-2a08-4518-93ad-5c5643487a87,55.0,Adjuvant,3.0,2023-03-13T12:55:14.373273-05:00,HCM-BROD-0648-C71_treatment7,136693ea-d26d-4497-a6f6-a2fcf9dfe427,,released,,1,2021-12-21T13:42:24.003548-06:00,"Radiation, 3D Conformal",Residual Disease,
HCM-BROD-0648-C71,cf7c73f3-b680-496d-94e5-22951ef84b79,6b9e8493-2a08-4518-93ad-5c5643487a87,,Neoadjuvant,,2023-02-22T07:39:25.979291-06:00,HCM-BROD-0648-C71_treatment3,5ed3ac90-7d4d-408f-bf6c-40869e4cddf3,,released,,1,2021-12-21T13:42:24.003548-06:00,Targeted Molecular Therapy,,
HCM-BROD-0648-C71,cf7c73f3-b680-496d-94e5-22951ef84b79,6b9e8493-2a08-4518-93ad-5c5643487a87,,Neoadjuvant,3.0,2023-02-22T07:39:25.979291-06:00,HCM-BROD-0648-C71_treatment2,7e5c5a03-7176-4ebc-b1b1-745a311cd319,,released,,1,2021-12-21T13:42:24.003548-06:00,"Radiation, 3D Conformal",,
HCM-BROD-0648-C71,cf7c73f3-b680-496d-94e5-22951ef84b79,6b9e8493-2a08-4518-93ad-5c5643487a87,414.0,Adjuvant,3.0,2023-02-22T07:39:25.979291-06:00,HCM-BROD-0648-C71_treatment4,8e472462-939d-4635-9788-c84d45a78b00,,released,Temozolomide,1,2021-12-21T13:42:24.003548-06:00,Chemotherapy,Residual Disease,
HCM-BROD-0648-C71,cf7c73f3-b680-496d-94e5-22951ef84b79,6b9e8493-2a08-4518-93ad-5c5643487a87,1686.0,Adjuvant,1639.0,2023-03-13T12:55:14.373273-05:00,HCM-BROD-0648-C71_treatment6,a4a6eee8-73cd-4864-a951-8c470f20b1a6,,released,Bevacizumab,1,2021-12-21T13:42:24.003548-06:00,Targeted Molecular Therapy,Residual Disease,
HCM-BROD-0648-C71,cf7c73f3-b680-496d-94e5-22951ef84b79,6b9e8493-2a08-4518-93ad-5c5643487a87,,,-22.0,2023-03-13T12:55:14.373273-05:00,HCM-BROD-0648-C71_treatment5,d35c3350-da13-4d5d-a045-bfcaff28a308,,released,,1,2021-12-21T13:42:24.003548-06:00,"Surgery, NOS",Initial Diagnosis,
HCM-BROD-0648-C71,cf7c73f3-b680-496d-94e5-22951ef84b79,6b9e8493-2a08-4518-93ad-5c5643487a87,,Neoadjuvant,3.0,2023-02-22T07:39:25.979291-06:00,HCM-BROD-0648-C71_treatment,da621066-e927-4fb4-9ec3-1430983887a6,,released,Temozolomide,1,2021-12-21T13:42:24.003548-06:00,Chemotherapy,,
HCM-BROD-0648-C71,cf7c73f3-b680-496d-94e5-22951ef84b79,b26eda69-cd41-4748-baa1-8472b2440b5c,1534.0,Maintenance Therapy,3.0,2023-03-14T11:40:17.645275-05:00,HCM-BROD-0648-C71_treatment8,f8f97b07-5f37-48dc-a16b-ab1bf7299529,Progressive Disease,released,Temozolomide,1,2023-03-13T12:55:14.373273-05:00,,,
HCM-CSHL-0057-C18,d000dcfe-181c-46fe-93ba-5fce8336b52d,3dc3296f-d00f-4e44-abc2-e85f05ec5d94,,Adjuvant,38.0,2020-10-08T18:58:28.680234-05:00,HCM-CSHL-0057-C18_treatment7,08b5becb-0e84-4e12-bace-8a38bdc6489d,,released,Oxaliplatin,1,2020-02-11T14:43:34.823831-06:00,Chemotherapy,Residual Disease,
HCM-CSHL-0057-C18,d000dcfe-181c-46fe-93ba-5fce8336b52d,3dc3296f-d00f-4e44-abc2-e85f05ec5d94,,Neoadjuvant,38.0,2020-10-08T18:58:28.680234-05:00,HCM-CSHL-0057-C18_treatment4,0be1fac3-5294-42ad-b539-b4b0f5842090,,released,,1,2020-02-11T14:43:34.823831-06:00,Chemotherapy,,FOLFOX
HCM-CSHL-0057-C18,d000dcfe-181c-46fe-93ba-5fce8336b52d,3dc3296f-d00f-4e44-abc2-e85f05ec5d94,,Adjuvant,203.0,2020-10-20T19:20:06.800740-05:00,HCM-CSHL-0057-C18_treatment12,302ece20-6e9a-4817-bea7-baba6adc40df,,released,,1,2020-10-08T18:58:28.680234-05:00,Chemotherapy,Residual Disease,FOLFIRI
HCM-CSHL-0057-C18,d000dcfe-181c-46fe-93ba-5fce8336b52d,3dc3296f-d00f-4e44-abc2-e85f05ec5d94,,Adjuvant,203.0,2020-10-20T19:20:06.800740-05:00,HCM-CSHL-0057-C18_treatment17,34748745-38b7-4827-8a84-a573f1755c2e,Treatment Ongoing,released,Bevacizumab,1,2020-10-08T18:58:28.680234-05:00,Targeted Molecular Therapy,Residual Disease,
HCM-CSHL-0057-C18,d000dcfe-181c-46fe-93ba-5fce8336b52d,3dc3296f-d00f-4e44-abc2-e85f05ec5d94,,Adjuvant,331.0,2020-10-20T19:20:06.800740-05:00,HCM-CSHL-0057-C18_treatment14,3e75cff4-ce62-4be7-ac3c-4a4f7759318b,Treatment Ongoing,released,Irinotecan,1,2020-10-08T18:58:28.680234-05:00,Chemotherapy,Residual Disease,
HCM-CSHL-0057-C18,d000dcfe-181c-46fe-93ba-5fce8336b52d,3dc3296f-d00f-4e44-abc2-e85f05ec5d94,,Adjuvant,123.0,2020-10-20T19:20:06.800740-05:00,HCM-CSHL-0057-C18_treatment18,448806ee-38ae-4bd2-94bc-0745af2cf6b4,,released,,1,2020-10-08T18:58:28.680234-05:00,"Ablation, Radiofrequency",Residual Disease,
HCM-CSHL-0057-C18,d000dcfe-181c-46fe-93ba-5fce8336b52d,3dc3296f-d00f-4e44-abc2-e85f05ec5d94,,Neoadjuvant,38.0,2020-10-08T18:58:28.680234-05:00,HCM-CSHL-0057-C18_treatment,4652a854-86e4-4043-9dcc-4b932ff62e47,,released,Leucovorin Calcium,1,2020-02-11T14:43:34.823831-06:00,Chemotherapy,,
HCM-CSHL-0057-C18,d000dcfe-181c-46fe-93ba-5fce8336b52d,3dc3296f-d00f-4e44-abc2-e85f05ec5d94,,Neoadjuvant,38.0,2020-10-08T18:58:28.680234-05:00,HCM-CSHL-0057-C18_treatment2,648001c6-3c0c-4daf-a00e-7d1688de3f30,,released,Fluorouracil,1,2020-02-11T14:43:34.823831-06:00,Chemotherapy,,
HCM-CSHL-0057-C18,d000dcfe-181c-46fe-93ba-5fce8336b52d,3dc3296f-d00f-4e44-abc2-e85f05ec5d94,,Adjuvant,203.0,2020-10-20T19:20:06.800740-05:00,HCM-CSHL-0057-C18_treatment10,8e8738d0-57e0-41f7-bd25-f59eec360925,,released,Fluorouracil,1,2020-10-08T18:58:28.680234-05:00,Chemotherapy,Residual Disease,
HCM-CSHL-0057-C18,d000dcfe-181c-46fe-93ba-5fce8336b52d,3dc3296f-d00f-4e44-abc2-e85f05ec5d94,,Adjuvant,38.0,2020-10-08T18:58:28.680234-05:00,HCM-CSHL-0057-C18_treatment5,91e58cd4-79b6-432f-82f2-3f109e2be2cf,,released,Leucovorin Calcium,1,2020-02-11T14:43:34.823831-06:00,Chemotherapy,Residual Disease,
HCM-CSHL-0057-C18,d000dcfe-181c-46fe-93ba-5fce8336b52d,3dc3296f-d00f-4e44-abc2-e85f05ec5d94,,Adjuvant,38.0,2020-10-08T18:58:28.680234-05:00,HCM-CSHL-0057-C18_treatment6,a4fd8d31-1be0-441a-83b1-2fdb13e73741,,released,Fluorouracil,1,2020-02-11T14:43:34.823831-06:00,Chemotherapy,Residual Disease,
HCM-CSHL-0057-C18,d000dcfe-181c-46fe-93ba-5fce8336b52d,3dc3296f-d00f-4e44-abc2-e85f05ec5d94,,Adjuvant,203.0,2020-10-08T18:58:28.680234-05:00,HCM-CSHL-0057-C18_treatment9,b2c093d2-c9fb-43a7-aa33-595eb8474184,,released,Leucovorin Calcium,1,2020-02-11T14:43:34.823831-06:00,Chemotherapy,Residual Disease,
HCM-CSHL-0057-C18,d000dcfe-181c-46fe-93ba-5fce8336b52d,3dc3296f-d00f-4e44-abc2-e85f05ec5d94,,Adjuvant,38.0,2020-10-08T18:58:28.680234-05:00,HCM-CSHL-0057-C18_treatment8,bbb425dc-3899-4d9d-957b-c46f6f63e748,,released,,1,2020-02-11T14:43:34.823831-06:00,Chemotherapy,Residual Disease,FOLFOX
HCM-CSHL-0057-C18,d000dcfe-181c-46fe-93ba-5fce8336b52d,3dc3296f-d00f-4e44-abc2-e85f05ec5d94,,,123.0,2023-03-13T13:24:57.687758-05:00,HCM-CSHL-0057-C18_treatment16,d54666cf-3635-4db6-a451-57edcb9b18aa,,released,,1,2020-10-08T18:58:28.680234-05:00,"Surgery, NOS",Initial Diagnosis,
HCM-CSHL-0057-C18,d000dcfe-181c-46fe-93ba-5fce8336b52d,3dc3296f-d00f-4e44-abc2-e85f05ec5d94,,Adjuvant,,2020-10-20T19:20:06.800740-05:00,HCM-CSHL-0057-C18_treatment15,d690ba9b-6364-428c-997c-0f9d15a24ae6,,released,,0,2020-10-08T18:58:28.680234-05:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-CSHL-0057-C18,d000dcfe-181c-46fe-93ba-5fce8336b52d,3dc3296f-d00f-4e44-abc2-e85f05ec5d94,,Adjuvant,203.0,2020-10-20T19:20:06.800740-05:00,HCM-CSHL-0057-C18_treatment11,e6902cc3-153c-433a-ba92-d64161e51964,,released,Irinotecan,1,2020-10-08T18:58:28.680234-05:00,Chemotherapy,Residual Disease,
HCM-CSHL-0057-C18,d000dcfe-181c-46fe-93ba-5fce8336b52d,3dc3296f-d00f-4e44-abc2-e85f05ec5d94,,Adjuvant,331.0,2020-10-20T19:20:06.800740-05:00,HCM-CSHL-0057-C18_treatment13,ee90bb66-9a20-4674-a767-abfaa5c04027,Treatment Ongoing,released,Capecitabine,1,2020-10-08T18:58:28.680234-05:00,Chemotherapy,Residual Disease,
HCM-CSHL-0057-C18,d000dcfe-181c-46fe-93ba-5fce8336b52d,3dc3296f-d00f-4e44-abc2-e85f05ec5d94,,Neoadjuvant,38.0,2020-10-08T18:58:28.680234-05:00,HCM-CSHL-0057-C18_treatment3,f1f57b87-e52e-43b1-8607-1684bc676090,,released,Oxaliplatin,1,2020-02-11T14:43:34.823831-06:00,Chemotherapy,,
HCM-EXPT-1217-C25,d034a12b-4013-4922-9026-b1d8c927e4f8,338de514-6802-42c3-8c44-96c4d68f1c47,,Neoadjuvant,,2025-10-08T12:39:14.406630-05:00,HCM-EXPT-1217-C25_treatment2,1b3bdaf0-0fc7-4675-83c3-c9317aff3338,,released,,unknown,2023-02-24T14:07:32.400953-06:00,"Radiation Therapy, NOS",,
HCM-EXPT-1217-C25,d034a12b-4013-4922-9026-b1d8c927e4f8,338de514-6802-42c3-8c44-96c4d68f1c47,,Neoadjuvant,,2025-10-08T12:39:14.406630-05:00,HCM-EXPT-1217-C25_treatment,9fa3f178-4692-4fe3-89f3-b62b33f27847,,released,,unknown,2023-02-24T14:07:32.400953-06:00,"Pharmaceutical Therapy, NOS",,
HCM-EXPT-1225-C25,d0f22766-c584-4e09-a92a-5fdca2cf5472,b8f7b662-584a-4052-861d-1bcf0b03d9ea,,Neoadjuvant,,2025-10-08T12:39:14.406630-05:00,HCM-EXPT-1225-C25_treatment2,772d765a-58cb-4d96-8d72-36febcfadf1a,,released,,unknown,2023-02-24T14:03:09.207800-06:00,"Radiation Therapy, NOS",,
HCM-EXPT-1225-C25,d0f22766-c584-4e09-a92a-5fdca2cf5472,b8f7b662-584a-4052-861d-1bcf0b03d9ea,,Neoadjuvant,,2025-10-08T12:39:14.406630-05:00,HCM-EXPT-1225-C25_treatment,9df78e60-2414-4cd1-ba77-0ba822821bb3,,released,,unknown,2023-02-24T14:03:09.207800-06:00,"Pharmaceutical Therapy, NOS",,
HCM-CSHL-0369-D37,d15fc66d-22d5-45f5-9d6b-ba268aac35f3,12210be0-aaa1-4b28-bbd3-170bb066223a,,Neoadjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0369-D37_treatment,235fa68d-07e4-4aa1-a74f-1af043788870,,released,,0,2020-09-28T09:53:16.211313-05:00,,,
HCM-CSHL-0369-D37,d15fc66d-22d5-45f5-9d6b-ba268aac35f3,12210be0-aaa1-4b28-bbd3-170bb066223a,,Adjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0369-D37_treatment3,426e9b0e-a6ba-4642-879a-7a2cb2ce9e6b,,released,,0,2020-09-28T09:53:16.211313-05:00,"Pharmaceutical Therapy, NOS",Residual Disease,
HCM-CSHL-0369-D37,d15fc66d-22d5-45f5-9d6b-ba268aac35f3,12210be0-aaa1-4b28-bbd3-170bb066223a,,Adjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0369-D37_treatment4,8a982599-fcff-489f-a403-e16b2837a44c,,released,,0,2020-09-28T09:53:16.211313-05:00,"Radiation Therapy, NOS",Residual Disease,
HCM-CSHL-0369-D37,d15fc66d-22d5-45f5-9d6b-ba268aac35f3,12210be0-aaa1-4b28-bbd3-170bb066223a,,,6.0,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0369-D37_treatment2,ea7cd995-5010-42e1-83a0-6b6aa2985d13,,released,,1,2020-09-28T09:53:16.211313-05:00,"Surgery, NOS",Initial Diagnosis,
HCM-SANG-1334-C18,d1cf2815-e9df-410a-a62e-e74883edc960,b9ee57dc-2501-4cc7-b4ce-450b0b478124,,Neoadjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-SANG-1334-C18_treatment,d86152a9-71e5-4944-9915-9270a180be94,,released,,0,2023-02-27T12:41:01.367731-06:00,,,
HCM-SANG-1301-C20,d22d578c-1bdd-4a01-a6dc-731a717b7e2c,2cf46fce-ea34-4fa2-bcb7-ca87da569a9c,,Neoadjuvant,1051.0,2025-04-07T17:13:09.336794-05:00,HCM-SANG-1301-C20_treatment,1e72fa66-f294-4698-b89f-62c1e5ed1d91,,released,Capecitabine,1,2023-02-27T13:22:45.548221-06:00,Chemotherapy,,
HCM-SANG-1301-C20,d22d578c-1bdd-4a01-a6dc-731a717b7e2c,2cf46fce-ea34-4fa2-bcb7-ca87da569a9c,,Neoadjuvant,1051.0,2025-04-07T17:13:09.336794-05:00,HCM-SANG-1301-C20_treatment2,96b85f8a-c31b-4392-b728-fedded4cee1a,,released,,1,2023-02-27T13:22:45.548221-06:00,"Radiation Therapy, NOS",,
HCM-BROD-0925-C71,d230be66-fdb1-463f-90d6-484a6e968277,23969820-ec4e-4cb0-9a10-5c0ea085e192,1801.0,Adjuvant,1780.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0925-C71_treatment5,2b7678e2-78e2-47ed-9fe9-5fcb4040ac83,,released,Bevacizumab,1,2021-12-21T13:57:16.889602-06:00,Targeted Molecular Therapy,Residual Disease,
HCM-BROD-0925-C71,d230be66-fdb1-463f-90d6-484a6e968277,23969820-ec4e-4cb0-9a10-5c0ea085e192,,Neoadjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0925-C71_treatment,50c6cf15-6476-4ffc-9979-0f25f4b687f8,,released,,0,2021-12-21T13:57:16.889602-06:00,,,
HCM-BROD-0925-C71,d230be66-fdb1-463f-90d6-484a6e968277,23969820-ec4e-4cb0-9a10-5c0ea085e192,,,0.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0925-C71_treatment4,928fbe0d-8a97-49a5-86ac-220a54ea082f,,released,,1,2021-12-21T13:57:16.889602-06:00,"Surgery, NOS",Initial Diagnosis,
HCM-BROD-0925-C71,d230be66-fdb1-463f-90d6-484a6e968277,23969820-ec4e-4cb0-9a10-5c0ea085e192,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0925-C71_treatment2,a2cdc168-2378-4c0f-b861-f4e378421241,,released,,0,2021-12-21T13:57:16.889602-06:00,Chemotherapy,Residual Disease,
HCM-BROD-0925-C71,d230be66-fdb1-463f-90d6-484a6e968277,23969820-ec4e-4cb0-9a10-5c0ea085e192,1675.0,Adjuvant,1515.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0925-C71_treatment3,c18b3d70-a868-430d-b049-fb143ef5b4cf,,released,Not Reported,1,2021-12-21T13:57:16.889602-06:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-BROD-0925-C71,d230be66-fdb1-463f-90d6-484a6e968277,23969820-ec4e-4cb0-9a10-5c0ea085e192,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0925-C71_treatment6,ed6ca049-10ae-4889-99e7-a0fe1b92a475,,released,,0,2021-12-21T13:57:16.889602-06:00,"Radiation Therapy, NOS",Residual Disease,
HCM-BROD-0925-C71,d230be66-fdb1-463f-90d6-484a6e968277,72a6e958-ea4c-4246-8627-378febde427d,1515.0,Maintenance Therapy,31.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0925-C71_treatment7,9d013032-3b23-43ba-8779-2fd4819f58a1,Treatment Ongoing,released,Temozolomide,1,2021-12-21T13:57:16.889602-06:00,,,
HCM-SANG-1093-C18,d2a6bc00-8278-40f4-a30a-664a907b7754,7d2ce11d-e5da-43fc-9da4-da92a7b0b59a,,Neoadjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-SANG-1093-C18_treatment,2bf800ca-ce23-4639-b973-40671abe1b52,,released,,0,2023-02-27T11:28:18.202722-06:00,,,
HCM-CSHL-0765-C56,d2d0522a-bad8-4282-b67d-bed52e7efab4,0ed0dad0-8d5e-4d99-9fb3-9fca090aa172,,Neoadjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0765-C56_treatment,aabdccb2-57d6-4a73-a705-2269fab0fb8e,,released,,0,2021-12-21T14:21:53.350414-06:00,,,
HCM-CSHL-0864-C44,d2de259e-d8bb-40ae-a155-c288e016fee6,08f912cd-92f4-4b6a-be1f-fcc23a868f9f,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0864-C44_treatment3,66c9a2ed-ee84-45a1-8a7e-c7babf12e7d5,,released,,0,2021-12-21T14:36:08.386361-06:00,"Pharmaceutical Therapy, NOS",Residual Disease,
HCM-CSHL-0864-C44,d2de259e-d8bb-40ae-a155-c288e016fee6,08f912cd-92f4-4b6a-be1f-fcc23a868f9f,,,240.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0864-C44_treatment2,6790d74c-6198-43f0-9ede-90a4d515ed27,,released,,1,2021-12-21T14:36:08.386361-06:00,"Surgery, NOS",Initial Diagnosis,
HCM-CSHL-0864-C44,d2de259e-d8bb-40ae-a155-c288e016fee6,08f912cd-92f4-4b6a-be1f-fcc23a868f9f,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0864-C44_treatment4,7f588ac9-af08-445b-801a-f001598842d6,,released,,1,2021-12-21T14:36:08.386361-06:00,"Radiation Therapy, NOS",Residual Disease,
HCM-CSHL-0864-C44,d2de259e-d8bb-40ae-a155-c288e016fee6,08f912cd-92f4-4b6a-be1f-fcc23a868f9f,,Neoadjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0864-C44_treatment,f1a754aa-bf79-4939-bb82-5cdd77600f35,,released,,0,2021-12-21T14:36:08.386361-06:00,,,
HCM-CSHL-0864-C44,d2de259e-d8bb-40ae-a155-c288e016fee6,68ec592d-024a-4808-b2e6-d411279166fc,,Maintenance Therapy,30.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0864-C44_treatment5,7d9d26cc-c3d2-4036-8821-cd17e8ebe4f0,Stable Disease,released,,1,2023-02-28T11:48:02.210717-06:00,,,
HCM-CSHL-0768-C56,d341953c-f4a1-4c6b-ac1a-50f1b956c696,4441f9ee-bf7b-48a8-955a-be59bb7868ce,,,0.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0768-C56_treatment2,5209fffa-36c5-4dd9-8186-062c32154832,,released,,1,2021-12-21T14:22:05.298239-06:00,"Surgery, NOS",Initial Diagnosis,
HCM-CSHL-0768-C56,d341953c-f4a1-4c6b-ac1a-50f1b956c696,4441f9ee-bf7b-48a8-955a-be59bb7868ce,,Neoadjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0768-C56_treatment,f27fed65-c65e-4733-b482-1e24ae389c5e,,released,,0,2021-12-21T14:22:05.298239-06:00,,,
HCM-EXPT-0896-C25,d36aa50d-b457-4c64-bf02-f5360ceeb0cd,8c797b49-a0d2-4900-b6bf-ef820f85a4fc,,Neoadjuvant,,2025-10-08T12:36:32.654639-05:00,HCM-EXPT-0896-C25_treatment,4d3cbe91-eb1d-48b8-9cb2-6b1a5dc6f38c,,released,,0,2021-12-21T14:44:09.175087-06:00,,,
HCM-BROD-0615-C16,d3a9dd49-6f2b-40aa-8027-e4c24421bf9f,6399baeb-5f6a-4647-ac8f-8c3c4cec7b9a,334.0,Maintenance Therapy,287.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0615-C16_treatment18,27578afc-dd31-417e-8d88-fe41a81d281d,Not Reported,released,,1,2021-12-21T13:42:09.704693-06:00,,,FOLFIRI
HCM-BROD-0615-C16,d3a9dd49-6f2b-40aa-8027-e4c24421bf9f,6399baeb-5f6a-4647-ac8f-8c3c4cec7b9a,334.0,Maintenance Therapy,287.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0615-C16_treatment16,59a41da6-ebb4-4e02-a2c7-4b0bb364870d,Not Reported,released,Fluorouracil,1,2021-12-21T13:42:09.704693-06:00,,,
HCM-BROD-0615-C16,d3a9dd49-6f2b-40aa-8027-e4c24421bf9f,6399baeb-5f6a-4647-ac8f-8c3c4cec7b9a,334.0,Maintenance Therapy,287.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0615-C16_treatment17,a1e6c242-0869-41ae-9871-9b967dbe04f7,Not Reported,released,Irinotecan,1,2021-12-21T13:42:09.704693-06:00,,,
HCM-BROD-0615-C16,d3a9dd49-6f2b-40aa-8027-e4c24421bf9f,6399baeb-5f6a-4647-ac8f-8c3c4cec7b9a,334.0,Maintenance Therapy,287.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0615-C16_treatment15,aad26504-f6a2-40f5-9578-2830dae4e959,Not Reported,released,Leucovorin Calcium,1,2021-12-21T13:42:09.704693-06:00,,,
HCM-BROD-0615-C16,d3a9dd49-6f2b-40aa-8027-e4c24421bf9f,c7970450-8598-459e-bc41-406da574b525,,,0.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0615-C16_treatment12,271795c6-2e58-4b22-ba01-4bb92840ca34,,released,,1,2021-12-21T13:42:09.704693-06:00,"Surgery, NOS",Initial Diagnosis,
HCM-BROD-0615-C16,d3a9dd49-6f2b-40aa-8027-e4c24421bf9f,c7970450-8598-459e-bc41-406da574b525,334.0,Adjuvant,287.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0615-C16_treatment8,2bd8874f-4cf5-4b97-be80-e6dbbf01093a,,released,Fluorouracil,1,2021-12-21T13:42:09.704693-06:00,Chemotherapy,Residual Disease,
HCM-BROD-0615-C16,d3a9dd49-6f2b-40aa-8027-e4c24421bf9f,c7970450-8598-459e-bc41-406da574b525,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0615-C16_treatment14,3644896d-4c97-4af9-9b31-2afd1151667b,,released,,0,2021-12-21T13:42:09.704693-06:00,"Radiation Therapy, NOS",Residual Disease,
HCM-BROD-0615-C16,d3a9dd49-6f2b-40aa-8027-e4c24421bf9f,c7970450-8598-459e-bc41-406da574b525,96.0,Adjuvant,35.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0615-C16_treatment5,55ef3e4e-d9df-4607-903c-25bd451cbf73,,released,,1,2021-12-21T13:42:09.704693-06:00,Chemotherapy,Residual Disease,FOLFOX
HCM-BROD-0615-C16,d3a9dd49-6f2b-40aa-8027-e4c24421bf9f,c7970450-8598-459e-bc41-406da574b525,334.0,Adjuvant,287.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0615-C16_treatment10,6b73f98c-0bd9-4f2c-abca-5b8206774c5c,,released,,1,2021-12-21T13:42:09.704693-06:00,Chemotherapy,Residual Disease,FOLFIRI
HCM-BROD-0615-C16,d3a9dd49-6f2b-40aa-8027-e4c24421bf9f,c7970450-8598-459e-bc41-406da574b525,,Neoadjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0615-C16_treatment,6ddbd07e-ae17-42c4-a9a9-031617779603,,released,,0,2021-12-21T13:42:09.704693-06:00,,,
HCM-BROD-0615-C16,d3a9dd49-6f2b-40aa-8027-e4c24421bf9f,c7970450-8598-459e-bc41-406da574b525,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0615-C16_treatment11,6ed5ddd9-23b4-4e26-bf77-055b573226d7,,released,,0,2021-12-21T13:42:09.704693-06:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-BROD-0615-C16,d3a9dd49-6f2b-40aa-8027-e4c24421bf9f,c7970450-8598-459e-bc41-406da574b525,334.0,Adjuvant,287.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0615-C16_treatment9,91ba9553-8d3e-47c5-9f7e-f11e8ea3cb81,,released,Irinotecan,1,2021-12-21T13:42:09.704693-06:00,Chemotherapy,Residual Disease,
HCM-BROD-0615-C16,d3a9dd49-6f2b-40aa-8027-e4c24421bf9f,c7970450-8598-459e-bc41-406da574b525,247.0,Adjuvant,137.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0615-C16_treatment6,bf794637-0103-40b2-bef5-c2f5487f72b1,,released,Capecitabine,1,2021-12-21T13:42:09.704693-06:00,Chemotherapy,Residual Disease,
HCM-BROD-0615-C16,d3a9dd49-6f2b-40aa-8027-e4c24421bf9f,c7970450-8598-459e-bc41-406da574b525,96.0,Adjuvant,35.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0615-C16_treatment2,c6c14d4f-0ada-4dd6-b59d-aef48920163c,,released,Leucovorin Calcium,1,2021-12-21T13:42:09.704693-06:00,Chemotherapy,Residual Disease,
HCM-BROD-0615-C16,d3a9dd49-6f2b-40aa-8027-e4c24421bf9f,c7970450-8598-459e-bc41-406da574b525,96.0,Adjuvant,35.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0615-C16_treatment4,c6fda8ef-5c38-4c45-bb32-1be67bfac0b9,,released,Oxaliplatin,1,2021-12-21T13:42:09.704693-06:00,Chemotherapy,Residual Disease,
HCM-BROD-0615-C16,d3a9dd49-6f2b-40aa-8027-e4c24421bf9f,c7970450-8598-459e-bc41-406da574b525,96.0,Adjuvant,35.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0615-C16_treatment3,cdb72a5d-cc20-48f8-8eb8-dd9a7c8c3ea5,,released,Fluorouracil,1,2021-12-21T13:42:09.704693-06:00,Chemotherapy,Residual Disease,
HCM-BROD-0615-C16,d3a9dd49-6f2b-40aa-8027-e4c24421bf9f,c7970450-8598-459e-bc41-406da574b525,334.0,Adjuvant,287.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0615-C16_treatment7,f19f3e12-a4a2-4c31-9b8e-1132f9fb9b54,,released,Leucovorin Calcium,1,2021-12-21T13:42:09.704693-06:00,Chemotherapy,Residual Disease,
HCM-BROD-0615-C16,d3a9dd49-6f2b-40aa-8027-e4c24421bf9f,c7970450-8598-459e-bc41-406da574b525,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0615-C16_treatment13,f817707e-5c10-44ad-92c6-d00674c7f3a4,,released,,0,2021-12-21T13:42:09.704693-06:00,Targeted Molecular Therapy,Residual Disease,
HCM-BROD-0210-C71,d420e653-3fb2-432b-9e81-81232a80264d,75ba645e-7756-4208-825b-67cff507ac69,,Adjuvant,,2021-03-03T15:15:08.075155-06:00,HCM-BROD-0210-C71_treatment3,12538b62-ff88-49fb-a700-ef75c632e060,,released,,0,2020-02-27T13:00:21.361098-06:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-BROD-0210-C71,d420e653-3fb2-432b-9e81-81232a80264d,75ba645e-7756-4208-825b-67cff507ac69,,Adjuvant,,2021-03-03T15:15:08.075155-06:00,HCM-BROD-0210-C71_treatment5,206d23c7-798e-4cae-88fa-6405b0eb0078,,released,,0,2020-02-27T13:00:21.361098-06:00,Targeted Molecular Therapy,Residual Disease,
HCM-BROD-0210-C71,d420e653-3fb2-432b-9e81-81232a80264d,75ba645e-7756-4208-825b-67cff507ac69,,Adjuvant,,2021-03-03T15:15:08.075155-06:00,HCM-BROD-0210-C71_treatment6,6257f60b-6c86-4e73-94ba-1d63d0819613,,released,,0,2020-02-27T13:00:21.361098-06:00,"Radiation Therapy, NOS",Residual Disease,
HCM-BROD-0210-C71,d420e653-3fb2-432b-9e81-81232a80264d,75ba645e-7756-4208-825b-67cff507ac69,375.0,Adjuvant,370.0,2021-03-03T15:15:08.075155-06:00,HCM-BROD-0210-C71_treatment2,7b1e6c59-e82d-4418-8605-c17c5d428724,,released,Temozolomide,1,2020-02-27T13:00:21.361098-06:00,Chemotherapy,Residual Disease,
HCM-BROD-0210-C71,d420e653-3fb2-432b-9e81-81232a80264d,75ba645e-7756-4208-825b-67cff507ac69,,Neoadjuvant,,2021-03-03T15:15:08.075155-06:00,HCM-BROD-0210-C71_treatment,833e8c31-2b6f-4fe1-a2df-3d36c6cf6e6b,,released,,0,2020-02-27T13:00:21.361098-06:00,,,
HCM-BROD-0210-C71,d420e653-3fb2-432b-9e81-81232a80264d,75ba645e-7756-4208-825b-67cff507ac69,,,-3.0,2023-02-27T13:27:25.664154-06:00,HCM-BROD-0210-C71_treatment4,bb3603cb-68dc-46b8-a97b-20b578cbaece,,released,,1,2020-02-27T13:00:21.361098-06:00,"Surgery, NOS",Initial Diagnosis,
HCM-SANG-1302-C15,d43f47fd-56fb-45f5-b12c-62ef044ca3f5,4947c119-abe5-47cd-857e-edd4ea728885,,Neoadjuvant,112.0,2025-04-07T17:13:09.336794-05:00,HCM-SANG-1302-C15_treatment,7cc3795a-cfad-4039-b9de-49a610eb844c,,released,Leucovorin,1,2023-02-27T12:21:31.521886-06:00,Chemotherapy,,
HCM-SANG-1302-C15,d43f47fd-56fb-45f5-b12c-62ef044ca3f5,4947c119-abe5-47cd-857e-edd4ea728885,,Neoadjuvant,112.0,2025-04-07T17:13:09.336794-05:00,HCM-SANG-1302-C15_treatment2,9f5135e0-c265-47d6-9ec3-9b6b1d494e0b,,released,Fluorouracil,1,2023-02-27T12:21:31.521886-06:00,Chemotherapy,,
HCM-SANG-1302-C15,d43f47fd-56fb-45f5-b12c-62ef044ca3f5,4947c119-abe5-47cd-857e-edd4ea728885,,Neoadjuvant,112.0,2025-04-07T17:13:09.336794-05:00,HCM-SANG-1302-C15_treatment4,d3a8286f-84fd-416c-9946-805b1c09ffbf,,released,Oxaliplatin,1,2023-02-27T12:21:31.521886-06:00,Chemotherapy,,
HCM-SANG-1302-C15,d43f47fd-56fb-45f5-b12c-62ef044ca3f5,4947c119-abe5-47cd-857e-edd4ea728885,,Neoadjuvant,112.0,2025-04-07T17:13:09.336794-05:00,HCM-SANG-1302-C15_treatment3,dd9a42a1-41a4-4b36-b4ec-420a70afd1d9,,released,Docetaxel,1,2023-02-27T12:21:31.521886-06:00,Chemotherapy,,
HCM-CSHL-0183-C25,d4850437-8b6e-4b6f-a636-2c0068a14121,db0b64de-7882-4a8d-a834-a567b202364f,,Adjuvant,,2023-07-13T10:35:44.371881-05:00,HCM-CSHL-0183-C25_treatment4,098375a3-b009-452f-9c2c-eb764429cac6,,released,,0,2020-09-28T09:14:42.141645-05:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-CSHL-0183-C25,d4850437-8b6e-4b6f-a636-2c0068a14121,db0b64de-7882-4a8d-a834-a567b202364f,120.0,Adjuvant,13.0,2023-07-13T10:35:44.371881-05:00,HCM-CSHL-0183-C25_treatment3,7bdd5963-e9a0-4ba5-905c-b87258bac77b,,released,Capecitabine,1,2020-09-28T09:14:42.141645-05:00,Chemotherapy,Residual Disease,
HCM-CSHL-0183-C25,d4850437-8b6e-4b6f-a636-2c0068a14121,db0b64de-7882-4a8d-a834-a567b202364f,,Neoadjuvant,,2023-07-13T10:35:44.371881-05:00,HCM-CSHL-0183-C25_treatment,96e62c69-62ea-4fd8-a277-f5cab8698bfb,,released,,0,2020-09-28T09:14:42.141645-05:00,,,
HCM-CSHL-0183-C25,d4850437-8b6e-4b6f-a636-2c0068a14121,db0b64de-7882-4a8d-a834-a567b202364f,,Adjuvant,,2023-07-13T10:35:44.371881-05:00,HCM-CSHL-0183-C25_treatment6,b00bb685-ea79-4c06-a0c2-7a1b27d200f8,,released,,0,2020-09-28T09:14:42.141645-05:00,Targeted Molecular Therapy,Residual Disease,
HCM-CSHL-0183-C25,d4850437-8b6e-4b6f-a636-2c0068a14121,db0b64de-7882-4a8d-a834-a567b202364f,,Adjuvant,,2023-07-13T10:35:44.371881-05:00,HCM-CSHL-0183-C25_treatment7,cd4d02b9-c8bb-43f2-9c2e-7788e4b24c93,,released,,0,2020-09-28T09:14:42.141645-05:00,"Radiation Therapy, NOS",Residual Disease,
HCM-CSHL-0183-C25,d4850437-8b6e-4b6f-a636-2c0068a14121,db0b64de-7882-4a8d-a834-a567b202364f,,,-29.0,2023-07-13T10:35:44.371881-05:00,HCM-CSHL-0183-C25_treatment5,e738bf6e-f6bb-47db-bca0-cfe5c2bb630a,,released,,1,2020-09-28T09:14:42.141645-05:00,"Surgery, NOS",Initial Diagnosis,
HCM-CSHL-0183-C25,d4850437-8b6e-4b6f-a636-2c0068a14121,db0b64de-7882-4a8d-a834-a567b202364f,120.0,Adjuvant,13.0,2023-07-13T10:35:44.371881-05:00,HCM-CSHL-0183-C25_treatment2,ed753a44-cb13-456d-aac5-2b3af89dcdca,,released,Gemcitabine,1,2020-09-28T09:14:42.141645-05:00,Chemotherapy,Residual Disease,
HCM-STAN-1113-C18,d4e59654-f1b9-40a7-bfef-b57eaf571aef,9adc0cda-7245-4e74-8ff6-013b34f47d17,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-STAN-1113-C18_treatment6,34b53c3e-10eb-48d2-8415-aaa4fe01bcf7,,released,,0,2022-09-22T07:11:49.222712-05:00,"Radiation Therapy, NOS",Residual Disease,
HCM-STAN-1113-C18,d4e59654-f1b9-40a7-bfef-b57eaf571aef,9adc0cda-7245-4e74-8ff6-013b34f47d17,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-STAN-1113-C18_treatment5,3d3e0602-61f5-45c2-9dbf-ba1c657c9fd0,,released,,0,2022-09-22T07:11:49.222712-05:00,Targeted Molecular Therapy,Residual Disease,
HCM-STAN-1113-C18,d4e59654-f1b9-40a7-bfef-b57eaf571aef,9adc0cda-7245-4e74-8ff6-013b34f47d17,,Neoadjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-STAN-1113-C18_treatment,560868f4-6e7f-4406-83fe-405d2100d62d,,released,,0,2022-09-22T07:11:49.222712-05:00,,,
HCM-STAN-1113-C18,d4e59654-f1b9-40a7-bfef-b57eaf571aef,9adc0cda-7245-4e74-8ff6-013b34f47d17,241.0,Adjuvant,84.0,2025-04-07T17:13:09.336794-05:00,HCM-STAN-1113-C18_treatment2,cb6c4b5b-d243-42c7-814e-efebf6bed8be,,released,Capecitabine,1,2022-09-22T07:11:49.222712-05:00,Chemotherapy,Residual Disease,
HCM-STAN-1113-C18,d4e59654-f1b9-40a7-bfef-b57eaf571aef,9adc0cda-7245-4e74-8ff6-013b34f47d17,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-STAN-1113-C18_treatment3,e657fecc-84ce-4801-b60d-3230d15a439d,,released,,0,2022-09-22T07:11:49.222712-05:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-STAN-1113-C18,d4e59654-f1b9-40a7-bfef-b57eaf571aef,9adc0cda-7245-4e74-8ff6-013b34f47d17,,,51.0,2025-04-07T17:13:09.336794-05:00,HCM-STAN-1113-C18_treatment4,fd246be5-266d-4ddb-a4a3-0d8875862198,,released,,1,2022-09-22T07:11:49.222712-05:00,"Surgery, NOS",Initial Diagnosis,
HCM-CSHL-0380-C18,d4f36b88-d98b-4bfb-892e-0c45e740e91f,68312fe8-44ed-41ac-ae06-1d0409a7692c,,Neoadjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0380-C18_treatment,036452d1-7069-416a-b00b-45dd8d93b335,,released,,0,2020-09-28T09:55:33.628045-05:00,,,
HCM-CSHL-0380-C18,d4f36b88-d98b-4bfb-892e-0c45e740e91f,68312fe8-44ed-41ac-ae06-1d0409a7692c,,Adjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0380-C18_treatment9,08b1cd2e-e193-4956-b05c-9a629331cfc2,,released,,0,2020-09-28T09:55:33.628045-05:00,"Radiation Therapy, NOS",Residual Disease,
HCM-CSHL-0380-C18,d4f36b88-d98b-4bfb-892e-0c45e740e91f,68312fe8-44ed-41ac-ae06-1d0409a7692c,135.0,Adjuvant,79.0,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0380-C18_treatment2,2ae18f2c-488e-4380-a144-76b964eda8a0,,released,Leucovorin Calcium,1,2020-09-28T09:55:33.628045-05:00,Chemotherapy,Residual Disease,
HCM-CSHL-0380-C18,d4f36b88-d98b-4bfb-892e-0c45e740e91f,68312fe8-44ed-41ac-ae06-1d0409a7692c,135.0,Adjuvant,79.0,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0380-C18_treatment5,40fed41f-82e9-4d44-9ea1-3a6556a7dd7e,,released,,1,2020-09-28T09:55:33.628045-05:00,Chemotherapy,Residual Disease,FOLFOX
HCM-CSHL-0380-C18,d4f36b88-d98b-4bfb-892e-0c45e740e91f,68312fe8-44ed-41ac-ae06-1d0409a7692c,135.0,Adjuvant,79.0,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0380-C18_treatment4,5d0dd6f4-c09d-454a-98c4-9d7ddcf40516,,released,Oxaliplatin,1,2020-09-28T09:55:33.628045-05:00,Chemotherapy,Residual Disease,
HCM-CSHL-0380-C18,d4f36b88-d98b-4bfb-892e-0c45e740e91f,68312fe8-44ed-41ac-ae06-1d0409a7692c,,,34.0,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0380-C18_treatment7,6335435a-953a-4917-8c02-b061b7177677,,released,,1,2020-09-28T09:55:33.628045-05:00,"Surgery, NOS",Initial Diagnosis,
HCM-CSHL-0380-C18,d4f36b88-d98b-4bfb-892e-0c45e740e91f,68312fe8-44ed-41ac-ae06-1d0409a7692c,,Adjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0380-C18_treatment8,a5eff330-ef7a-410c-8f11-3ac09217b052,,released,,0,2020-09-28T09:55:33.628045-05:00,Targeted Molecular Therapy,Residual Disease,
HCM-CSHL-0380-C18,d4f36b88-d98b-4bfb-892e-0c45e740e91f,68312fe8-44ed-41ac-ae06-1d0409a7692c,,Adjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0380-C18_treatment6,a8a48eab-4b74-4c80-9a4e-0de0a8a902eb,,released,,0,2020-09-28T09:55:33.628045-05:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-CSHL-0380-C18,d4f36b88-d98b-4bfb-892e-0c45e740e91f,68312fe8-44ed-41ac-ae06-1d0409a7692c,135.0,Adjuvant,79.0,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0380-C18_treatment3,d26deb67-fac3-4aa8-9288-9e7bcbb52b49,,released,Fluorouracil,1,2020-09-28T09:55:33.628045-05:00,Chemotherapy,Residual Disease,
HCM-CSHL-0377-C18,d58136f6-2e90-40b4-b7fb-3478011efa00,4a1c85d7-5721-4610-8534-3498c36d6178,,Neoadjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0377-C18_treatment,49fc83e0-bd53-43f0-bc0d-1b7b12d9beff,,released,,0,2020-09-28T09:56:32.894105-05:00,,,
HCM-CSHL-0377-C18,d58136f6-2e90-40b4-b7fb-3478011efa00,4a1c85d7-5721-4610-8534-3498c36d6178,,,53.0,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0377-C18_treatment2,555026d6-cb32-4d5a-b29e-6855c1f35dbf,,released,,1,2020-09-28T09:56:32.894105-05:00,"Surgery, NOS",Initial Diagnosis,
HCM-CSHL-0377-C18,d58136f6-2e90-40b4-b7fb-3478011efa00,4a1c85d7-5721-4610-8534-3498c36d6178,,Adjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0377-C18_treatment3,5d8c20d9-c8f5-4053-b8aa-2c4c903c8754,,released,,0,2020-09-28T09:56:32.894105-05:00,"Pharmaceutical Therapy, NOS",Residual Disease,
HCM-CSHL-0377-C18,d58136f6-2e90-40b4-b7fb-3478011efa00,4a1c85d7-5721-4610-8534-3498c36d6178,,Adjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0377-C18_treatment4,6f82b888-a8ee-4e36-b2ab-498b38fc6db0,,released,,0,2020-09-28T09:56:32.894105-05:00,"Radiation Therapy, NOS",Residual Disease,
HCM-BROD-0194-C15,d585a79e-19e2-4829-9e3f-80b74d65b243,d0705df4-2226-4840-a518-36208abff2c2,17.0,Adjuvant,17.0,2021-01-06T22:55:10.531130-06:00,HCM-BROD-0194-C15_treatment6,00ae6090-b759-4953-8e9c-498b81a5ca5e,,released,,1,2020-04-21T15:05:08.724140-05:00,"Radiation Therapy, NOS",Residual Disease,
HCM-BROD-0194-C15,d585a79e-19e2-4829-9e3f-80b74d65b243,d0705df4-2226-4840-a518-36208abff2c2,,Neoadjuvant,,2021-01-06T22:55:10.531130-06:00,HCM-BROD-0194-C15_treatment,4da8404a-98cb-4e9a-b100-17ed46466705,,released,,0,2019-04-04T15:54:16.407898-05:00,,,
HCM-BROD-0194-C15,d585a79e-19e2-4829-9e3f-80b74d65b243,d0705df4-2226-4840-a518-36208abff2c2,,Adjuvant,,2021-01-06T22:55:10.531130-06:00,HCM-BROD-0194-C15_treatment5,98b2591a-1303-4635-afa8-cb60577b3351,,released,,0,2020-04-21T15:05:08.724140-05:00,Targeted Molecular Therapy,Residual Disease,
HCM-BROD-0194-C15,d585a79e-19e2-4829-9e3f-80b74d65b243,d0705df4-2226-4840-a518-36208abff2c2,,,,2023-03-13T13:30:26.957058-05:00,HCM-BROD-0194-C15_treatment4,990e74bb-e92a-4933-a0c0-3838573a9368,,released,,0,2020-04-21T15:05:08.724140-05:00,"Surgery, NOS",Initial Diagnosis,
HCM-BROD-0194-C15,d585a79e-19e2-4829-9e3f-80b74d65b243,d0705df4-2226-4840-a518-36208abff2c2,,Adjuvant,,2021-01-06T22:55:10.531130-06:00,HCM-BROD-0194-C15_treatment2,c1084a10-bba3-47c2-bc37-339b494feb1b,,released,,0,2020-04-21T15:05:08.724140-05:00,Chemotherapy,Residual Disease,
HCM-BROD-0194-C15,d585a79e-19e2-4829-9e3f-80b74d65b243,d0705df4-2226-4840-a518-36208abff2c2,,Adjuvant,,2021-01-06T22:55:10.531130-06:00,HCM-BROD-0194-C15_treatment3,f63b686e-d513-43c9-9fd2-2dde8bdcb3d1,,released,,0,2020-04-21T15:05:08.724140-05:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-CSHL-0839-C34,d6164ae2-9071-418f-9682-b2ce941b02c5,ddad1751-4ef4-4740-8820-2ddf9cd63bfd,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0839-C34_treatment3,1aea5665-3cd0-434f-ac7b-1bf540d9b2c1,,released,,0,2021-12-21T14:34:07.455953-06:00,Chemotherapy,Residual Disease,
HCM-CSHL-0839-C34,d6164ae2-9071-418f-9682-b2ce941b02c5,ddad1751-4ef4-4740-8820-2ddf9cd63bfd,,,1106.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0839-C34_treatment6,66709ca2-acdd-46c0-8d2c-3a18645cfc5a,,released,,1,2021-12-21T14:34:07.455953-06:00,"Surgery, NOS",Initial Diagnosis,
HCM-CSHL-0839-C34,d6164ae2-9071-418f-9682-b2ce941b02c5,ddad1751-4ef4-4740-8820-2ddf9cd63bfd,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0839-C34_treatment4,8c1ca293-483c-4586-b583-0ff89aba2c1f,,released,,0,2021-12-21T14:34:07.455953-06:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-CSHL-0839-C34,d6164ae2-9071-418f-9682-b2ce941b02c5,ddad1751-4ef4-4740-8820-2ddf9cd63bfd,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0839-C34_treatment7,9dae94c7-cee7-43d3-af98-607e211556d1,,released,Gefitinib,1,2021-12-21T14:34:07.455953-06:00,Targeted Molecular Therapy,Residual Disease,
HCM-CSHL-0839-C34,d6164ae2-9071-418f-9682-b2ce941b02c5,ddad1751-4ef4-4740-8820-2ddf9cd63bfd,,,217.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0839-C34_treatment5,a5098c83-f835-4e8b-ab1e-270a0f78aadf,,released,,1,2021-12-21T14:34:07.455953-06:00,"Surgery, NOS",Initial Diagnosis,
HCM-CSHL-0839-C34,d6164ae2-9071-418f-9682-b2ce941b02c5,ddad1751-4ef4-4740-8820-2ddf9cd63bfd,,Neoadjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0839-C34_treatment2,ad633664-0774-4b56-82de-6f2b94540b75,,released,Erlotinib,1,2021-12-21T14:34:07.455953-06:00,Targeted Molecular Therapy,,
HCM-CSHL-0839-C34,d6164ae2-9071-418f-9682-b2ce941b02c5,ddad1751-4ef4-4740-8820-2ddf9cd63bfd,,Neoadjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0839-C34_treatment,d597f539-93fd-4c66-8be0-efc4a502a5cc,,released,Pembrolizumab,1,2021-12-21T14:34:07.455953-06:00,Immunotherapy (Including Vaccines),,
HCM-CSHL-0839-C34,d6164ae2-9071-418f-9682-b2ce941b02c5,ffaaa4e9-d5a3-477c-a424-ba7e5bb0888e,,Maintenance Therapy,,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0839-C34_treatment9,0471bef8-f712-48d4-8923-d4659c5cc424,Not Reported,released,Pembrolizumab,1,2021-12-21T14:34:07.455953-06:00,,,
HCM-CSHL-0839-C34,d6164ae2-9071-418f-9682-b2ce941b02c5,ffaaa4e9-d5a3-477c-a424-ba7e5bb0888e,,Maintenance Therapy,,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0839-C34_treatment10,0f24aa25-08a6-40a3-ab90-b15af153a740,Not Reported,released,Gefitinib,1,2021-12-21T14:34:07.455953-06:00,,,
HCM-EXPT-0970-C18,d6c76e91-940f-425a-84c0-f742ac783dd8,46e747b0-481a-4005-ab6c-7b9eab54a119,,Neoadjuvant,,2025-10-08T12:36:57.024699-05:00,HCM-EXPT-0970-C18_treatment,7875a190-3df8-4d5a-b52c-77aef5486175,,released,,1,2021-12-21T14:48:00.237700-06:00,Chemotherapy,,
HCM-BROD-0226-C43,d73ad293-edf5-4f88-8a06-65695f5f5ff0,51039f26-182b-49cf-8a90-e26e357e19e4,,Adjuvant,,2023-02-22T07:39:25.979291-06:00,HCM-BROD-0226-C43_treatment3,6a144450-b456-433a-9b57-916212d829f4,,released,,0,2020-06-15T13:26:54.697689-05:00,Hormone Therapy,Residual Disease,
HCM-BROD-0226-C43,d73ad293-edf5-4f88-8a06-65695f5f5ff0,51039f26-182b-49cf-8a90-e26e357e19e4,3109.0,Adjuvant,2260.0,2023-02-22T07:39:25.979291-06:00,HCM-BROD-0226-C43_treatment4,8c3d2e39-5528-4ae4-b35d-dd9af93aaf77,Treatment Ongoing,released,Nivolumab,1,2020-06-15T13:26:54.697689-05:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-BROD-0226-C43,d73ad293-edf5-4f88-8a06-65695f5f5ff0,51039f26-182b-49cf-8a90-e26e357e19e4,2348.0,Adjuvant,2348.0,2023-02-22T07:39:25.979291-06:00,HCM-BROD-0226-C43_treatment7,9474e3a9-ef94-4eff-aeb8-b5a40fdd1a24,,released,,1,2020-10-08T12:08:02.591624-05:00,"Radiation Therapy, NOS",Residual Disease,
HCM-BROD-0226-C43,d73ad293-edf5-4f88-8a06-65695f5f5ff0,51039f26-182b-49cf-8a90-e26e357e19e4,,Adjuvant,,2023-02-22T07:39:25.979291-06:00,HCM-BROD-0226-C43_treatment2,a070efd1-090f-47c6-ba16-f05ac14fe277,,released,,0,2020-06-15T13:26:54.697689-05:00,Chemotherapy,Residual Disease,
HCM-BROD-0226-C43,d73ad293-edf5-4f88-8a06-65695f5f5ff0,51039f26-182b-49cf-8a90-e26e357e19e4,,Neoadjuvant,,2023-02-22T07:39:25.979291-06:00,HCM-BROD-0226-C43_treatment,c9d714e0-2152-4b4d-a249-abd14537a4df,,released,,0,2020-06-15T13:26:54.697689-05:00,,,
HCM-BROD-0226-C43,d73ad293-edf5-4f88-8a06-65695f5f5ff0,51039f26-182b-49cf-8a90-e26e357e19e4,,Adjuvant,,2023-02-22T07:39:25.979291-06:00,HCM-BROD-0226-C43_treatment6,d270ec44-5c4d-4586-9f84-c66ad23f9881,,released,,0,2020-06-15T13:26:54.697689-05:00,Targeted Molecular Therapy,Residual Disease,
HCM-BROD-0483-C16,d7426469-359e-45e4-a58a-f70e4147cd10,322357fb-c35a-4e01-9512-94634b1b7447,170.0,Maintenance Therapy,164.0,2021-07-12T12:25:55.528644-05:00,HCM-BROD-0483-C16_treatment7,156f64ca-66e4-4253-99be-d7585bc3b92f,Not Reported,released,Cabozantinib,1,2020-09-27T11:55:39.509964-05:00,,,
HCM-BROD-0483-C16,d7426469-359e-45e4-a58a-f70e4147cd10,322357fb-c35a-4e01-9512-94634b1b7447,170.0,Maintenance Therapy,164.0,2021-07-12T12:25:55.528644-05:00,HCM-BROD-0483-C16_treatment8,4f9702ae-a2c3-423b-8741-a997bb3e8932,Not Reported,released,Pembrolizumab,1,2020-09-27T11:55:39.509964-05:00,,,
HCM-BROD-0483-C16,d7426469-359e-45e4-a58a-f70e4147cd10,a3959155-217b-4204-83ce-fb9afa31b470,,Neoadjuvant,,2021-07-12T12:25:55.528644-05:00,HCM-BROD-0483-C16_treatment,13adbc02-45cf-437c-88d3-511ac802a4cf,,released,,0,2020-09-27T11:55:39.509964-05:00,,,
HCM-BROD-0483-C16,d7426469-359e-45e4-a58a-f70e4147cd10,a3959155-217b-4204-83ce-fb9afa31b470,164.0,Adjuvant,164.0,2021-07-12T12:25:55.528644-05:00,HCM-BROD-0483-C16_treatment3,34b13484-0eef-4d38-90f6-68ea70107721,,released,Pembrolizumab,1,2020-09-27T11:55:39.509964-05:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-BROD-0483-C16,d7426469-359e-45e4-a58a-f70e4147cd10,a3959155-217b-4204-83ce-fb9afa31b470,,Adjuvant,,2021-07-12T12:25:55.528644-05:00,HCM-BROD-0483-C16_treatment2,7b2e699e-2a12-44cc-b617-b968173fbcd8,,released,,0,2020-09-27T11:55:39.509964-05:00,Chemotherapy,Residual Disease,
HCM-BROD-0483-C16,d7426469-359e-45e4-a58a-f70e4147cd10,a3959155-217b-4204-83ce-fb9afa31b470,,Adjuvant,,2021-07-12T12:25:55.528644-05:00,HCM-BROD-0483-C16_treatment5,b506115b-66e0-4802-abe6-08ac318a9e05,,released,,0,2020-09-27T11:55:39.509964-05:00,Targeted Molecular Therapy,Residual Disease,
HCM-CSHL-0258-C18,d77ca75a-491a-4616-9a1c-7b69fdd03585,7d7651c7-7153-4b87-96d1-491631c58b1e,,Adjuvant,,2023-03-13T12:39:57.679450-05:00,HCM-CSHL-0258-C18_treatment3,1c6cac63-60ef-471e-806c-e699375b0157,,released,,0,2020-09-28T09:37:26.712488-05:00,"Pharmaceutical Therapy, NOS",Residual Disease,
HCM-CSHL-0258-C18,d77ca75a-491a-4616-9a1c-7b69fdd03585,7d7651c7-7153-4b87-96d1-491631c58b1e,,,42.0,2023-03-13T12:39:57.679450-05:00,HCM-CSHL-0258-C18_treatment2,3fdbb54f-a68c-4f50-9b5d-0a93a0f53121,,released,,1,2020-09-28T09:37:26.712488-05:00,"Surgery, NOS",Initial Diagnosis,
HCM-CSHL-0258-C18,d77ca75a-491a-4616-9a1c-7b69fdd03585,7d7651c7-7153-4b87-96d1-491631c58b1e,,Neoadjuvant,,2023-02-22T07:39:25.979291-06:00,HCM-CSHL-0258-C18_treatment,56a8a9d6-7e45-4880-b27f-af8ef202ab24,,released,,0,2020-09-28T09:37:26.712488-05:00,,,
HCM-CSHL-0258-C18,d77ca75a-491a-4616-9a1c-7b69fdd03585,7d7651c7-7153-4b87-96d1-491631c58b1e,,Adjuvant,,2023-03-13T12:39:57.679450-05:00,HCM-CSHL-0258-C18_treatment4,c280ec63-4830-472b-be3f-6c8385f45f37,,released,,0,2021-08-26T14:37:52.029035-05:00,"Radiation Therapy, NOS",Residual Disease,
HCM-CSHL-0514-C50,d7b49708-3dd6-4837-856a-bce8ceb8e76f,e13f6187-5532-48fe-a240-cd291658c1d2,,Prevention,,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0514-C50_treatment5,0dfafe9b-705a-4c33-ac0d-bf4ae4bbd4e8,,released,,0,2021-12-21T14:08:41.282941-06:00,Hormone Therapy,,
HCM-CSHL-0514-C50,d7b49708-3dd6-4837-856a-bce8ceb8e76f,e13f6187-5532-48fe-a240-cd291658c1d2,,,22.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0514-C50_treatment2,5881495a-e32b-4a0f-a1df-4ca0ccb42806,,released,,1,2021-12-21T14:08:41.282941-06:00,"Surgery, NOS",Initial Diagnosis,
HCM-CSHL-0514-C50,d7b49708-3dd6-4837-856a-bce8ceb8e76f,e13f6187-5532-48fe-a240-cd291658c1d2,80.0,Adjuvant,62.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0514-C50_treatment4,807f70c6-1a06-4213-98ee-df1d437a4c50,,released,,1,2021-12-21T14:08:41.282941-06:00,"Radiation Therapy, NOS",Residual Disease,
HCM-CSHL-0514-C50,d7b49708-3dd6-4837-856a-bce8ceb8e76f,e13f6187-5532-48fe-a240-cd291658c1d2,,Neoadjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0514-C50_treatment,b49a4065-8571-4f0d-bb4b-310b47eba4cf,,released,,0,2021-12-21T14:08:41.282941-06:00,,,
HCM-CSHL-0514-C50,d7b49708-3dd6-4837-856a-bce8ceb8e76f,e13f6187-5532-48fe-a240-cd291658c1d2,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0514-C50_treatment3,fb10a66c-879c-4263-9058-e7d572b1e1a1,,released,,0,2021-12-21T14:08:41.282941-06:00,"Pharmaceutical Therapy, NOS",Residual Disease,
HCM-CSHL-0092-C25,d7fc5874-8ae0-4357-9d8d-01af39ee521f,1744a5aa-897d-4bf9-a9f6-c82131b9a086,,Adjuvant,,2020-04-02T10:09:29.076604-05:00,HCM-CSHL-0092-C25_treatment6,092fd164-53fc-49a4-a841-5402302825ca,,released,,0,2020-02-11T14:40:28.597230-06:00,Targeted Molecular Therapy,Residual Disease,
HCM-CSHL-0092-C25,d7fc5874-8ae0-4357-9d8d-01af39ee521f,1744a5aa-897d-4bf9-a9f6-c82131b9a086,219.0,Adjuvant,51.0,2020-06-15T12:09:36.909420-05:00,HCM-CSHL-0092-C25_treatment2,0c4a49ae-44a8-41a1-8687-192e27485c4b,,released,Gemcitabine,1,2020-02-11T14:40:28.597230-06:00,Chemotherapy,Residual Disease,
HCM-CSHL-0092-C25,d7fc5874-8ae0-4357-9d8d-01af39ee521f,1744a5aa-897d-4bf9-a9f6-c82131b9a086,219.0,Adjuvant,51.0,2020-06-15T12:09:36.909420-05:00,HCM-CSHL-0092-C25_treatment3,2ee4c37f-4969-4f86-9f3f-7fc02219cc30,,released,Nab-paclitaxel,1,2020-02-11T14:40:28.597230-06:00,Chemotherapy,Residual Disease,
HCM-CSHL-0092-C25,d7fc5874-8ae0-4357-9d8d-01af39ee521f,1744a5aa-897d-4bf9-a9f6-c82131b9a086,,Adjuvant,,2020-04-02T14:23:02.380597-05:00,HCM-CSHL-0092-C25_treatment7,7cea2ade-c0b7-48e8-8fbc-0359df2a5427,,released,,0,2020-04-02T10:09:29.076604-05:00,"Radiation Therapy, NOS",Residual Disease,
HCM-CSHL-0092-C25,d7fc5874-8ae0-4357-9d8d-01af39ee521f,1744a5aa-897d-4bf9-a9f6-c82131b9a086,,,-20.0,2023-02-27T13:26:48.050823-06:00,HCM-CSHL-0092-C25_treatment5,875eb13a-7355-4c46-b1cd-65471884198e,,released,,1,2020-02-11T14:40:28.597230-06:00,"Surgery, NOS",Initial Diagnosis,
HCM-CSHL-0092-C25,d7fc5874-8ae0-4357-9d8d-01af39ee521f,1744a5aa-897d-4bf9-a9f6-c82131b9a086,,Adjuvant,,2020-04-02T10:09:29.076604-05:00,HCM-CSHL-0092-C25_treatment4,d92a3739-22cb-41f5-8a0b-4c356cd01e65,,released,,0,2020-02-11T14:40:28.597230-06:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-CSHL-0092-C25,d7fc5874-8ae0-4357-9d8d-01af39ee521f,1744a5aa-897d-4bf9-a9f6-c82131b9a086,,Neoadjuvant,,2020-03-26T16:04:47.706904-05:00,HCM-CSHL-0092-C25_treatment,f4f04cd3-6d63-4af6-9e1c-ea4df00a88ec,,released,,0,2020-02-11T14:40:28.597230-06:00,,,
HCM-SANG-0535-C20,d847f721-5801-4052-b5ed-88845889e7da,89d84d42-1755-4018-b6f1-97a4ff642a1a,,Neoadjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-SANG-0535-C20_treatment2,4e732b86-4cac-40a3-9872-40451fa2df6a,,released,,1,2021-12-21T15:15:08.027397-06:00,"Radiation, 2D Conventional",,
HCM-SANG-0535-C20,d847f721-5801-4052-b5ed-88845889e7da,89d84d42-1755-4018-b6f1-97a4ff642a1a,,Neoadjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-SANG-0535-C20_treatment,d4519e32-d57a-448c-82a8-c1d491187acc,,released,Capecitabine,1,2021-12-21T15:15:08.027397-06:00,Chemotherapy,,
HCM-WCMC-0949-C67,d8522fe4-e14f-46de-ab9d-f7445099d5a5,0a686fbe-c6a0-43f9-9b72-828fc82305ff,,Neoadjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-WCMC-0949-C67_treatment,26e2637d-85be-44e4-b3b2-98457a0f8ee0,,released,,0,2023-02-27T13:28:37.123553-06:00,,,
HCM-WCMC-0949-C67,d8522fe4-e14f-46de-ab9d-f7445099d5a5,0a686fbe-c6a0-43f9-9b72-828fc82305ff,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-WCMC-0949-C67_treatment4,3f9cf0a9-62f8-42ae-8d52-acdccaa77f22,,released,,0,2023-02-27T13:28:37.123553-06:00,"Radiation Therapy, NOS",Residual Disease,
HCM-WCMC-0949-C67,d8522fe4-e14f-46de-ab9d-f7445099d5a5,0a686fbe-c6a0-43f9-9b72-828fc82305ff,,,0.0,2025-04-07T17:13:09.336794-05:00,HCM-WCMC-0949-C67_treatment2,9a2ce788-3ae5-4f84-8870-e0faf775c0cb,,released,,1,2023-02-27T13:28:37.123553-06:00,"Surgery, NOS",Initial Diagnosis,
HCM-WCMC-0949-C67,d8522fe4-e14f-46de-ab9d-f7445099d5a5,0a686fbe-c6a0-43f9-9b72-828fc82305ff,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-WCMC-0949-C67_treatment3,d727a1de-3008-4b52-8429-b853489f2e49,,released,,0,2023-02-27T13:28:37.123553-06:00,"Pharmaceutical Therapy, NOS",Residual Disease,
HCM-CSHL-0607-C19,d8b5fbeb-3c4c-424c-a1e7-5a7a085b005a,53ef5019-bf54-47f8-8302-d3824d4bf1a9,192.0,Maintenance Therapy,42.0,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0607-C19_treatment17,17ff6d74-c5a0-4ff5-b4a5-eec19392b792,Treatment Ongoing,released,Fluorouracil,1,2022-11-18T13:16:16.849949-06:00,,,
HCM-CSHL-0607-C19,d8b5fbeb-3c4c-424c-a1e7-5a7a085b005a,53ef5019-bf54-47f8-8302-d3824d4bf1a9,192.0,Maintenance Therapy,42.0,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0607-C19_treatment19,53684e9b-47a2-4bb0-b6f1-8eddea2b60ba,Treatment Ongoing,released,,1,2022-11-18T13:16:16.849949-06:00,,,FOLFIRI-cetuximab
HCM-CSHL-0607-C19,d8b5fbeb-3c4c-424c-a1e7-5a7a085b005a,53ef5019-bf54-47f8-8302-d3824d4bf1a9,192.0,Maintenance Therapy,42.0,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0607-C19_treatment18,71f7818c-3f90-4302-9ad7-5e1f64705a54,Treatment Ongoing,released,Irinotecan,1,2022-11-18T13:16:16.849949-06:00,,,
HCM-CSHL-0607-C19,d8b5fbeb-3c4c-424c-a1e7-5a7a085b005a,53ef5019-bf54-47f8-8302-d3824d4bf1a9,192.0,Maintenance Therapy,42.0,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0607-C19_treatment16,c3ec3e1a-25aa-4e76-83d5-5e85473e801a,Treatment Ongoing,released,Leucovorin Calcium,1,2022-11-18T13:16:16.849949-06:00,,,
HCM-CSHL-0607-C19,d8b5fbeb-3c4c-424c-a1e7-5a7a085b005a,53ef5019-bf54-47f8-8302-d3824d4bf1a9,192.0,Maintenance Therapy,42.0,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0607-C19_treatment15,e55782d5-1620-46f5-b99d-4302b7fa3ea2,Treatment Ongoing,released,Cetuximab,1,2022-11-18T13:16:16.849949-06:00,,,
HCM-CSHL-0607-C19,d8b5fbeb-3c4c-424c-a1e7-5a7a085b005a,a817f114-2391-4419-9144-91fb3bbf713b,,Adjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0607-C19_treatment11,109b82de-d617-4a72-bcc2-d40a83fa58b6,,released,,0,2022-11-18T13:16:16.849949-06:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-CSHL-0607-C19,d8b5fbeb-3c4c-424c-a1e7-5a7a085b005a,a817f114-2391-4419-9144-91fb3bbf713b,780.0,Adjuvant,42.0,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0607-C19_treatment8,1d54e9bd-9775-4993-922b-60869cd8e1e9,,released,Fluorouracil,1,2022-11-18T13:16:16.849949-06:00,Chemotherapy,Residual Disease,
HCM-CSHL-0607-C19,d8b5fbeb-3c4c-424c-a1e7-5a7a085b005a,a817f114-2391-4419-9144-91fb3bbf713b,780.0,Adjuvant,42.0,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0607-C19_treatment10,3e8597b3-7563-4da7-abe7-64b613bed75e,,released,,1,2022-11-18T13:16:16.849949-06:00,Chemotherapy,Residual Disease,FOLFIRI-cetuximab
HCM-CSHL-0607-C19,d8b5fbeb-3c4c-424c-a1e7-5a7a085b005a,a817f114-2391-4419-9144-91fb3bbf713b,,,236.0,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0607-C19_treatment12,49e74695-64a7-48ae-a67b-079339069c95,,released,,1,2022-11-18T13:16:16.849949-06:00,"Surgery, NOS",Initial Diagnosis,
HCM-CSHL-0607-C19,d8b5fbeb-3c4c-424c-a1e7-5a7a085b005a,a817f114-2391-4419-9144-91fb3bbf713b,780.0,Adjuvant,42.0,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0607-C19_treatment6,5c149e1c-f0b3-43d1-b120-3bd5984f9523,,released,Irinotecan,1,2022-11-18T13:16:16.849949-06:00,Chemotherapy,Residual Disease,
HCM-CSHL-0607-C19,d8b5fbeb-3c4c-424c-a1e7-5a7a085b005a,a817f114-2391-4419-9144-91fb3bbf713b,,Neoadjuvant,42.0,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0607-C19_treatment3,604a4540-82f7-4e32-a253-2a725d189d9d,,released,Irinotecan,1,2022-11-18T13:16:16.849949-06:00,Chemotherapy,,
HCM-CSHL-0607-C19,d8b5fbeb-3c4c-424c-a1e7-5a7a085b005a,a817f114-2391-4419-9144-91fb3bbf713b,,Neoadjuvant,42.0,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0607-C19_treatment,6bd143b5-1221-438e-a90a-730020903ee7,,released,Leucovorin Calcium,1,2022-11-18T13:16:16.849949-06:00,Chemotherapy,,
HCM-CSHL-0607-C19,d8b5fbeb-3c4c-424c-a1e7-5a7a085b005a,a817f114-2391-4419-9144-91fb3bbf713b,,Adjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0607-C19_treatment14,9325f4da-04f5-4e50-b915-2e681e452e6a,,released,,0,2022-11-18T13:16:16.849949-06:00,"Radiation Therapy, NOS",Residual Disease,
HCM-CSHL-0607-C19,d8b5fbeb-3c4c-424c-a1e7-5a7a085b005a,a817f114-2391-4419-9144-91fb3bbf713b,780.0,Adjuvant,42.0,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0607-C19_treatment9,9fc86fec-c6d0-415d-bd9c-41a00d676a57,,released,Cetuximab,1,2022-11-18T13:16:16.849949-06:00,Chemotherapy,Residual Disease,
HCM-CSHL-0607-C19,d8b5fbeb-3c4c-424c-a1e7-5a7a085b005a,a817f114-2391-4419-9144-91fb3bbf713b,,Adjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0607-C19_treatment13,a227e1e4-939a-4361-8e5f-433dc1f4cbd0,,released,,0,2022-11-18T13:16:16.849949-06:00,Targeted Molecular Therapy,Residual Disease,
HCM-CSHL-0607-C19,d8b5fbeb-3c4c-424c-a1e7-5a7a085b005a,a817f114-2391-4419-9144-91fb3bbf713b,,Neoadjuvant,42.0,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0607-C19_treatment2,b31d7648-0a60-4e96-a7f7-24d7f2653a9c,,released,Fluorouracil,1,2022-11-18T13:16:16.849949-06:00,Chemotherapy,,
HCM-CSHL-0607-C19,d8b5fbeb-3c4c-424c-a1e7-5a7a085b005a,a817f114-2391-4419-9144-91fb3bbf713b,,Neoadjuvant,42.0,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0607-C19_treatment5,d2290ef4-4658-4e02-9ab8-4dcef455eca8,,released,Cetuximab,1,2022-11-18T13:16:16.849949-06:00,Chemotherapy,,
HCM-CSHL-0607-C19,d8b5fbeb-3c4c-424c-a1e7-5a7a085b005a,a817f114-2391-4419-9144-91fb3bbf713b,,Neoadjuvant,42.0,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0607-C19_treatment4,f291285f-094d-4a7f-baff-32e31c480617,,released,,1,2022-11-18T13:16:16.849949-06:00,Chemotherapy,,FOLFIRI
HCM-CSHL-0607-C19,d8b5fbeb-3c4c-424c-a1e7-5a7a085b005a,a817f114-2391-4419-9144-91fb3bbf713b,780.0,Adjuvant,42.0,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0607-C19_treatment7,f856e02d-3591-46b7-8b71-bdef2d101e94,,released,Leucovorin Calcium,1,2022-11-18T13:16:16.849949-06:00,Chemotherapy,Residual Disease,
HCM-BROD-0578-C15,d8f43a06-92ab-4a24-9410-d9121eccd119,8aad90a1-f912-4e6e-af01-0a57c8279fed,57.0,Maintenance Therapy,7.0,2023-02-22T07:39:25.979291-06:00,HCM-BROD-0578-C15_treatment9,38ae57ad-7171-4b3d-9568-812f171c8008,Progressive Disease,released,Leucovorin Calcium,1,2020-10-08T19:50:02.424698-05:00,,,
HCM-BROD-0578-C15,d8f43a06-92ab-4a24-9410-d9121eccd119,8aad90a1-f912-4e6e-af01-0a57c8279fed,57.0,Maintenance Therapy,7.0,2023-02-22T07:39:25.979291-06:00,HCM-BROD-0578-C15_treatment10,41151cc2-21f7-416c-86e3-0c79f2ddaf96,Progressive Disease,released,Fluorouracil,1,2020-10-08T19:50:02.424698-05:00,,,
HCM-BROD-0578-C15,d8f43a06-92ab-4a24-9410-d9121eccd119,8aad90a1-f912-4e6e-af01-0a57c8279fed,57.0,Maintenance Therapy,7.0,2023-02-22T07:39:25.979291-06:00,HCM-BROD-0578-C15_treatment11,59a4928e-0268-4cde-9f56-a3849c3a65fa,Progressive Disease,released,Oxaliplatin,1,2020-10-08T19:50:02.424698-05:00,,,
HCM-BROD-0578-C15,d8f43a06-92ab-4a24-9410-d9121eccd119,8aad90a1-f912-4e6e-af01-0a57c8279fed,57.0,Maintenance Therapy,7.0,2023-02-22T07:39:25.979291-06:00,HCM-BROD-0578-C15_treatment12,8d197fd0-d7b1-4d92-9930-4271eeef4caf,Progressive Disease,released,,1,2020-10-08T19:50:02.424698-05:00,,,FOLFOX
HCM-BROD-0578-C15,d8f43a06-92ab-4a24-9410-d9121eccd119,9c417e0e-12a8-4d6f-9a1e-490024dab185,70.0,Adjuvant,7.0,2023-02-22T07:39:25.979291-06:00,HCM-BROD-0578-C15_treatment3,21bc7b79-96cc-4932-bc55-f04212d09767,,released,Leucovorin,1,2020-10-08T19:50:02.424698-05:00,Chemotherapy,Residual Disease,
HCM-BROD-0578-C15,d8f43a06-92ab-4a24-9410-d9121eccd119,9c417e0e-12a8-4d6f-9a1e-490024dab185,70.0,Adjuvant,7.0,2023-02-22T07:39:25.979291-06:00,HCM-BROD-0578-C15_treatment4,586212d6-d487-4b61-a9bb-3b1d782b61e5,,released,,1,2020-10-08T19:50:02.424698-05:00,Chemotherapy,Residual Disease,FU-LV regimen
HCM-BROD-0578-C15,d8f43a06-92ab-4a24-9410-d9121eccd119,9c417e0e-12a8-4d6f-9a1e-490024dab185,70.0,Adjuvant,7.0,2023-02-22T07:39:25.979291-06:00,HCM-BROD-0578-C15_treatment2,5d52439d-c597-4a10-a8ce-2cf6a50c7be2,,released,Fluorouracil,1,2020-10-08T19:50:02.424698-05:00,Chemotherapy,Residual Disease,
HCM-BROD-0578-C15,d8f43a06-92ab-4a24-9410-d9121eccd119,9c417e0e-12a8-4d6f-9a1e-490024dab185,,Adjuvant,,2023-02-22T07:39:25.979291-06:00,HCM-BROD-0578-C15_treatment7,8da4ede9-d0bf-4e0b-a03c-c343af38914b,,released,,0,2020-10-08T19:50:02.424698-05:00,Targeted Molecular Therapy,Residual Disease,
HCM-BROD-0578-C15,d8f43a06-92ab-4a24-9410-d9121eccd119,9c417e0e-12a8-4d6f-9a1e-490024dab185,92.0,Adjuvant,86.0,2023-02-22T07:39:25.979291-06:00,HCM-BROD-0578-C15_treatment8,a281ffe9-edf2-47ed-b5d5-12c3349924c8,,released,,1,2020-10-08T19:50:02.424698-05:00,"Radiation Therapy, NOS",Residual Disease,
HCM-BROD-0578-C15,d8f43a06-92ab-4a24-9410-d9121eccd119,9c417e0e-12a8-4d6f-9a1e-490024dab185,,Adjuvant,,2023-02-22T07:39:25.979291-06:00,HCM-BROD-0578-C15_treatment5,b888327a-7cd7-44ff-97c0-bdaa966240d3,,released,,0,2020-10-08T19:50:02.424698-05:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-BROD-0578-C15,d8f43a06-92ab-4a24-9410-d9121eccd119,9c417e0e-12a8-4d6f-9a1e-490024dab185,,,,2023-02-27T11:40:41.217720-06:00,HCM-BROD-0578-C15_treatment6,c168825d-e6ef-4ad0-b14f-6a6fa163eeb6,,released,,0,2020-10-08T19:50:02.424698-05:00,"Surgery, NOS",Initial Diagnosis,
HCM-BROD-0578-C15,d8f43a06-92ab-4a24-9410-d9121eccd119,9c417e0e-12a8-4d6f-9a1e-490024dab185,,Neoadjuvant,,2023-02-22T07:39:25.979291-06:00,HCM-BROD-0578-C15_treatment,e5bb77be-d889-4f79-aba2-49ff53e2d29a,,released,,0,2020-10-08T19:50:02.424698-05:00,,,
HCM-EXPT-1002-C50,d9e4acaa-d6b8-4740-a880-e6dc3a9c2332,d7351f1c-31c4-46c2-ac05-97e21c17a74d,,Neoadjuvant,,2025-10-08T12:37:43.816130-05:00,HCM-EXPT-1002-C50_treatment,ffd24eb9-d6b3-4202-adca-1aeccce64032,,released,,0,2021-12-21T14:54:01.878205-06:00,,,
HCM-BROD-0796-C71,da09b63f-a076-48b9-9c88-2218db08e313,2d40a529-8f76-4fde-86d6-6c1e431bdb2a,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0796-C71_treatment4,508887ef-cf54-4ded-8747-7d7411338432,,released,,0,2021-12-21T13:53:55.106868-06:00,"Radiation Therapy, NOS",Residual Disease,
HCM-BROD-0796-C71,da09b63f-a076-48b9-9c88-2218db08e313,2d40a529-8f76-4fde-86d6-6c1e431bdb2a,,Neoadjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0796-C71_treatment,59518a79-8421-43cb-8857-f4d808bf01d3,,released,,0,2021-12-21T13:53:55.106868-06:00,,,
HCM-BROD-0796-C71,da09b63f-a076-48b9-9c88-2218db08e313,2d40a529-8f76-4fde-86d6-6c1e431bdb2a,,,0.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0796-C71_treatment2,5a83f790-4d15-425a-abda-f5297aa691f2,,released,,1,2021-12-21T13:53:55.106868-06:00,"Surgery, NOS",Initial Diagnosis,
HCM-BROD-0796-C71,da09b63f-a076-48b9-9c88-2218db08e313,2d40a529-8f76-4fde-86d6-6c1e431bdb2a,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0796-C71_treatment3,cb8699bc-ec3c-4037-97be-7baeba47370e,,released,,0,2021-12-21T13:53:55.106868-06:00,"Pharmaceutical Therapy, NOS",Residual Disease,
HCM-WCMC-0952-C34,da2509d3-513e-4d0d-b05e-99c4a8817c59,56e44f1e-c0fb-45ad-9ac4-c85f021e4c70,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-WCMC-0952-C34_treatment3,34e426cc-612e-4903-b387-ee1bf45a5b28,,released,,0,2023-02-27T11:22:03.477672-06:00,"Pharmaceutical Therapy, NOS",Residual Disease,
HCM-WCMC-0952-C34,da2509d3-513e-4d0d-b05e-99c4a8817c59,56e44f1e-c0fb-45ad-9ac4-c85f021e4c70,,Neoadjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-WCMC-0952-C34_treatment,4f7a5083-85c4-4e07-8c83-f5cec1d90455,,released,,0,2023-02-27T11:22:03.477672-06:00,,,
HCM-WCMC-0952-C34,da2509d3-513e-4d0d-b05e-99c4a8817c59,56e44f1e-c0fb-45ad-9ac4-c85f021e4c70,,,29.0,2025-04-07T17:13:09.336794-05:00,HCM-WCMC-0952-C34_treatment2,5ff93d6a-70ee-4560-b300-7456bde6d337,,released,,1,2023-02-27T11:22:03.477672-06:00,"Surgery, NOS",Initial Diagnosis,
HCM-WCMC-0952-C34,da2509d3-513e-4d0d-b05e-99c4a8817c59,56e44f1e-c0fb-45ad-9ac4-c85f021e4c70,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-WCMC-0952-C34_treatment4,fe24477e-2f92-47b2-957c-23a13a8e0380,,released,,0,2023-02-27T11:22:03.477672-06:00,"Radiation Therapy, NOS",Residual Disease,
HCM-WCMC-0788-C34,da8c7e2c-9dd3-4df6-a4b5-b6fff01e6da8,2041a4f6-782d-4d57-a28c-fb2f9db330ab,216.0,Adjuvant,125.0,2025-04-07T17:13:09.336794-05:00,HCM-WCMC-0788-C34_treatment2,094e6e01-8674-44d6-bcca-9ef0fbcc747a,,released,Cisplatin,1,2023-02-27T12:55:12.177706-06:00,Chemotherapy,Residual Disease,
HCM-WCMC-0788-C34,da8c7e2c-9dd3-4df6-a4b5-b6fff01e6da8,2041a4f6-782d-4d57-a28c-fb2f9db330ab,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-WCMC-0788-C34_treatment7,12366cd7-9ec6-4d46-a3df-3f9f561689e9,,released,,0,2023-02-27T12:55:12.177706-06:00,"Radiation Therapy, NOS",Residual Disease,
HCM-WCMC-0788-C34,da8c7e2c-9dd3-4df6-a4b5-b6fff01e6da8,2041a4f6-782d-4d57-a28c-fb2f9db330ab,216.0,Adjuvant,125.0,2025-04-07T17:13:09.336794-05:00,HCM-WCMC-0788-C34_treatment3,212c222d-c48c-447a-bca6-77563a404a83,,released,Vinorelbine Tartrate,1,2023-02-27T12:55:12.177706-06:00,Chemotherapy,Residual Disease,
HCM-WCMC-0788-C34,da8c7e2c-9dd3-4df6-a4b5-b6fff01e6da8,2041a4f6-782d-4d57-a28c-fb2f9db330ab,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-WCMC-0788-C34_treatment6,4bc965e3-3fce-46fe-aec6-e9757b957510,,released,,0,2023-02-27T12:55:12.177706-06:00,Targeted Molecular Therapy,Residual Disease,
HCM-WCMC-0788-C34,da8c7e2c-9dd3-4df6-a4b5-b6fff01e6da8,2041a4f6-782d-4d57-a28c-fb2f9db330ab,,,109.0,2025-04-07T17:13:09.336794-05:00,HCM-WCMC-0788-C34_treatment5,cf4fb1e2-4bad-43d5-9653-481b939292a4,,released,,1,2023-02-27T12:55:12.177706-06:00,"Surgery, NOS",Initial Diagnosis,
HCM-WCMC-0788-C34,da8c7e2c-9dd3-4df6-a4b5-b6fff01e6da8,2041a4f6-782d-4d57-a28c-fb2f9db330ab,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-WCMC-0788-C34_treatment4,df0349b0-5031-488b-aa40-c1f08e30dea4,,released,,0,2023-02-27T12:55:12.177706-06:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-WCMC-0788-C34,da8c7e2c-9dd3-4df6-a4b5-b6fff01e6da8,2041a4f6-782d-4d57-a28c-fb2f9db330ab,,Neoadjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-WCMC-0788-C34_treatment,fe2b6399-7bfb-4f9e-b9e1-180ca63d244c,,released,,0,2023-02-27T12:55:12.177706-06:00,,,
HCM-EXPT-1065-C50,dacc7c9f-0a5a-4a20-9415-13a4a8477399,53df2d25-b152-4a49-a5ea-477c277afd8a,,Neoadjuvant,,2025-10-08T12:38:28.988690-05:00,HCM-EXPT-1065-C50_treatment,0504d08d-60e0-457c-aecf-4c00ccdefa62,,released,,1,2021-12-21T15:03:29.951494-06:00,Hormone Therapy,,
HCM-EXPT-0932-C50,dae81dc4-d6a4-4ce2-8de7-35e1cbf46666,bc7df6e2-bacd-4133-9ad6-ff22946f5c3b,,Neoadjuvant,,2025-10-08T12:36:57.024699-05:00,HCM-EXPT-0932-C50_treatment,eb93debc-2a28-4216-97a5-19d096dfd73b,,released,,0,2021-12-21T14:45:30.854802-06:00,,,
HCM-SANG-0269-C18,daf1dd34-2188-4cb0-95a5-286e0a0ba5ad,367f0e75-0929-49d6-986a-6a72290e7b9b,,Neoadjuvant,,2023-02-22T07:39:25.979291-06:00,HCM-SANG-0269-C18_treatment,1496a5c2-1fff-441d-bb20-2ac3c144c653,,released,,0,2020-02-11T15:50:56.392198-06:00,,,
HCM-CSHL-0669-C18,dc5a908f-fd2f-4eea-85cb-49b4de137286,9c3763b0-6d59-496a-abf1-fe301338f6a3,1159.0,Maintenance Therapy,42.0,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0669-C18_treatment10,1bf8da58-f7ab-49e9-bdaf-e5b3882a4d80,Progressive Disease,released,Fluorouracil,1,2021-12-21T14:16:57.212899-06:00,,,
HCM-CSHL-0669-C18,dc5a908f-fd2f-4eea-85cb-49b4de137286,9c3763b0-6d59-496a-abf1-fe301338f6a3,1159.0,Maintenance Therapy,42.0,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0669-C18_treatment15,3008e4ef-b138-483b-92b9-e4909f289950,Progressive Disease,released,Irinotecan,1,2021-12-21T14:16:57.212899-06:00,,,
HCM-CSHL-0669-C18,dc5a908f-fd2f-4eea-85cb-49b4de137286,9c3763b0-6d59-496a-abf1-fe301338f6a3,1159.0,Maintenance Therapy,42.0,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0669-C18_treatment14,50e52f97-94d0-4501-b4d1-ceaa0d14a99f,Progressive Disease,released,Trifluridine and Tipiracil Hydrochloride,1,2021-12-21T14:16:57.212899-06:00,,,
HCM-CSHL-0669-C18,dc5a908f-fd2f-4eea-85cb-49b4de137286,9c3763b0-6d59-496a-abf1-fe301338f6a3,1159.0,Maintenance Therapy,42.0,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0669-C18_treatment17,7a62931a-497a-4f3d-b0c3-7ef5d6c18e4c,Progressive Disease,released,,1,2021-12-21T14:16:57.212899-06:00,,,FOLFOX
HCM-CSHL-0669-C18,dc5a908f-fd2f-4eea-85cb-49b4de137286,9c3763b0-6d59-496a-abf1-fe301338f6a3,1159.0,Maintenance Therapy,42.0,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0669-C18_treatment12,80d38736-2ea5-44a3-a1c5-88f147647c14,Progressive Disease,released,Leucovorin Calcium,1,2021-12-21T14:16:57.212899-06:00,,,
HCM-CSHL-0669-C18,dc5a908f-fd2f-4eea-85cb-49b4de137286,9c3763b0-6d59-496a-abf1-fe301338f6a3,1159.0,Maintenance Therapy,42.0,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0669-C18_treatment13,83e639a2-899c-42d7-88c9-52c3ac03b2ab,Progressive Disease,released,Oxaliplatin,1,2021-12-21T14:16:57.212899-06:00,,,
HCM-CSHL-0669-C18,dc5a908f-fd2f-4eea-85cb-49b4de137286,9c3763b0-6d59-496a-abf1-fe301338f6a3,1159.0,Maintenance Therapy,42.0,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0669-C18_treatment16,a545abe6-8a20-49b8-9e0a-09483eab0d18,Progressive Disease,released,Unknown,1,2021-12-21T14:16:57.212899-06:00,,,
HCM-CSHL-0669-C18,dc5a908f-fd2f-4eea-85cb-49b4de137286,9c3763b0-6d59-496a-abf1-fe301338f6a3,1159.0,Maintenance Therapy,42.0,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0669-C18_treatment18,e269467d-2685-4e92-87f0-dcbba1e1dead,Progressive Disease,released,,1,2021-12-21T14:16:57.212899-06:00,,,FOLFIRI
HCM-CSHL-0669-C18,dc5a908f-fd2f-4eea-85cb-49b4de137286,9c3763b0-6d59-496a-abf1-fe301338f6a3,1159.0,Maintenance Therapy,42.0,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0669-C18_treatment11,e6829566-d328-497c-9782-590d60738cf5,Progressive Disease,released,Panitumumab,1,2021-12-21T14:16:57.212899-06:00,,,
HCM-CSHL-0669-C18,dc5a908f-fd2f-4eea-85cb-49b4de137286,b3f2c2ae-407a-46d8-b8e5-78a80214823c,89.0,Adjuvant,39.0,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0669-C18_treatment5,0c91dc78-0f9e-4563-a798-c23b1ef32f8e,,released,,1,2021-12-21T14:16:57.212899-06:00,Chemotherapy,Residual Disease,FOLFOX
HCM-CSHL-0669-C18,dc5a908f-fd2f-4eea-85cb-49b4de137286,b3f2c2ae-407a-46d8-b8e5-78a80214823c,,Adjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0669-C18_treatment9,2c2cb73d-59d5-4562-bf68-bdc71c057013,,released,,0,2021-12-21T14:16:57.212899-06:00,"Radiation Therapy, NOS",Residual Disease,
HCM-CSHL-0669-C18,dc5a908f-fd2f-4eea-85cb-49b4de137286,b3f2c2ae-407a-46d8-b8e5-78a80214823c,89.0,Adjuvant,39.0,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0669-C18_treatment2,39a55b12-e53c-4d1c-b3ee-f87c2e9e0bb0,,released,Leucovorin Calcium,1,2021-12-21T14:16:57.212899-06:00,Chemotherapy,Residual Disease,
HCM-CSHL-0669-C18,dc5a908f-fd2f-4eea-85cb-49b4de137286,b3f2c2ae-407a-46d8-b8e5-78a80214823c,89.0,Adjuvant,39.0,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0669-C18_treatment4,4c4c65bd-573e-4fb9-b949-ee7f2bd435c6,,released,Oxaliplatin,1,2021-12-21T14:16:57.212899-06:00,Chemotherapy,Residual Disease,
HCM-CSHL-0669-C18,dc5a908f-fd2f-4eea-85cb-49b4de137286,b3f2c2ae-407a-46d8-b8e5-78a80214823c,89.0,Adjuvant,39.0,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0669-C18_treatment3,83c7d940-783a-4bc9-a370-a2f854d30ee2,,released,Fluorouracil,1,2021-12-21T14:16:57.212899-06:00,Chemotherapy,Residual Disease,
HCM-CSHL-0669-C18,dc5a908f-fd2f-4eea-85cb-49b4de137286,b3f2c2ae-407a-46d8-b8e5-78a80214823c,89.0,Adjuvant,39.0,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0669-C18_treatment8,9cd68e8f-ca47-4d2e-8e8e-0449e761d4b0,,released,Bevacizumab,1,2021-12-21T14:16:57.212899-06:00,Targeted Molecular Therapy,Residual Disease,
HCM-CSHL-0669-C18,dc5a908f-fd2f-4eea-85cb-49b4de137286,b3f2c2ae-407a-46d8-b8e5-78a80214823c,,Adjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0669-C18_treatment6,a2fed6d7-4972-409d-ae48-44935e62d9c6,,released,,0,2021-12-21T14:16:57.212899-06:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-CSHL-0669-C18,dc5a908f-fd2f-4eea-85cb-49b4de137286,b3f2c2ae-407a-46d8-b8e5-78a80214823c,,,4.0,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0669-C18_treatment7,a9cf90c2-5dcf-4dcf-9e61-55940cde73ff,,released,,1,2021-12-21T14:16:57.212899-06:00,"Surgery, NOS",Initial Diagnosis,
HCM-CSHL-0669-C18,dc5a908f-fd2f-4eea-85cb-49b4de137286,b3f2c2ae-407a-46d8-b8e5-78a80214823c,,Neoadjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0669-C18_treatment,ec66b149-19e5-47f4-afa8-68b5fda6d9a4,,released,,0,2021-12-21T14:16:57.212899-06:00,,,
HCM-CSHL-0669-C18,dc5a908f-fd2f-4eea-85cb-49b4de137286,e9ccb9bc-2e96-47b2-a994-441be77cc91a,1159.0,Maintenance Therapy,42.0,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0669-C18_treatment19,090d7a08-602b-4780-81d7-5f7cd4944748,Progressive Disease,released,Fluorouracil,1,2021-12-21T14:16:57.212899-06:00,,,
HCM-CSHL-0669-C18,dc5a908f-fd2f-4eea-85cb-49b4de137286,e9ccb9bc-2e96-47b2-a994-441be77cc91a,1159.0,Maintenance Therapy,42.0,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0669-C18_treatment25,1719782c-6403-48c1-b2a9-d0f079196356,Progressive Disease,released,Unknown,1,2021-12-21T14:16:57.212899-06:00,,,
HCM-CSHL-0669-C18,dc5a908f-fd2f-4eea-85cb-49b4de137286,e9ccb9bc-2e96-47b2-a994-441be77cc91a,1159.0,Maintenance Therapy,42.0,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0669-C18_treatment23,50d149a9-face-49e4-9320-52b94056b532,Progressive Disease,released,Trifluridine and Tipiracil Hydrochloride,1,2021-12-21T14:16:57.212899-06:00,,,
HCM-CSHL-0669-C18,dc5a908f-fd2f-4eea-85cb-49b4de137286,e9ccb9bc-2e96-47b2-a994-441be77cc91a,1159.0,Maintenance Therapy,42.0,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0669-C18_treatment21,58d0043e-2a41-456e-b35f-6b5711474c3b,Progressive Disease,released,Leucovorin Calcium,1,2021-12-21T14:16:57.212899-06:00,,,
HCM-CSHL-0669-C18,dc5a908f-fd2f-4eea-85cb-49b4de137286,e9ccb9bc-2e96-47b2-a994-441be77cc91a,1159.0,Maintenance Therapy,42.0,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0669-C18_treatment24,8ead1078-4e50-4794-82fa-0e61968df4dd,Progressive Disease,released,Irinotecan,1,2021-12-21T14:16:57.212899-06:00,,,
HCM-CSHL-0669-C18,dc5a908f-fd2f-4eea-85cb-49b4de137286,e9ccb9bc-2e96-47b2-a994-441be77cc91a,1159.0,Maintenance Therapy,42.0,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0669-C18_treatment26,94cc009d-4826-4e16-a4a3-637a61d37cfc,Progressive Disease,released,,1,2021-12-21T14:16:57.212899-06:00,,,FOLFOX
HCM-CSHL-0669-C18,dc5a908f-fd2f-4eea-85cb-49b4de137286,e9ccb9bc-2e96-47b2-a994-441be77cc91a,1159.0,Maintenance Therapy,42.0,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0669-C18_treatment27,c073cf25-22b2-44e0-bb85-5cb5c7fdfcdd,Progressive Disease,released,,1,2021-12-21T14:16:57.212899-06:00,,,FOLFIRI
HCM-CSHL-0669-C18,dc5a908f-fd2f-4eea-85cb-49b4de137286,e9ccb9bc-2e96-47b2-a994-441be77cc91a,1159.0,Maintenance Therapy,42.0,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0669-C18_treatment20,d81f0578-bce9-44fb-95fe-225b47a7227d,Progressive Disease,released,Panitumumab,1,2021-12-21T14:16:57.212899-06:00,,,
HCM-CSHL-0669-C18,dc5a908f-fd2f-4eea-85cb-49b4de137286,e9ccb9bc-2e96-47b2-a994-441be77cc91a,1159.0,Maintenance Therapy,42.0,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0669-C18_treatment22,e84fdc12-d107-47e3-8c65-efc67c86b1fe,Progressive Disease,released,Oxaliplatin,1,2021-12-21T14:16:57.212899-06:00,,,
HCM-CSHL-0669-C18,dc5a908f-fd2f-4eea-85cb-49b4de137286,fdb6ba1a-5416-40b4-8236-13163b2a664e,1159.0,Maintenance Therapy,42.0,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0669-C18_treatment35,08bf372f-2fcf-47ad-981b-7cec0d7912d3,Progressive Disease,released,,1,2021-12-21T14:16:57.212899-06:00,,,FOLFOX
HCM-CSHL-0669-C18,dc5a908f-fd2f-4eea-85cb-49b4de137286,fdb6ba1a-5416-40b4-8236-13163b2a664e,1159.0,Maintenance Therapy,42.0,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0669-C18_treatment30,2aa5c97a-9e4c-4cc2-a113-67989229820e,Progressive Disease,released,Leucovorin Calcium,1,2021-12-21T14:16:57.212899-06:00,,,
HCM-CSHL-0669-C18,dc5a908f-fd2f-4eea-85cb-49b4de137286,fdb6ba1a-5416-40b4-8236-13163b2a664e,1159.0,Maintenance Therapy,42.0,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0669-C18_treatment29,304c9cb3-10f9-489f-9de6-768a887f49b9,Progressive Disease,released,Panitumumab,1,2021-12-21T14:16:57.212899-06:00,,,
HCM-CSHL-0669-C18,dc5a908f-fd2f-4eea-85cb-49b4de137286,fdb6ba1a-5416-40b4-8236-13163b2a664e,1159.0,Maintenance Therapy,42.0,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0669-C18_treatment33,4b9edeb4-8795-4a92-bd8d-0e34c2bbd97f,Progressive Disease,released,Irinotecan,1,2021-12-21T14:16:57.212899-06:00,,,
HCM-CSHL-0669-C18,dc5a908f-fd2f-4eea-85cb-49b4de137286,fdb6ba1a-5416-40b4-8236-13163b2a664e,1159.0,Maintenance Therapy,42.0,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0669-C18_treatment34,7295a9b1-b224-4d02-95dd-8631e251175c,Progressive Disease,released,Unknown,1,2021-12-21T14:16:57.212899-06:00,,,
HCM-CSHL-0669-C18,dc5a908f-fd2f-4eea-85cb-49b4de137286,fdb6ba1a-5416-40b4-8236-13163b2a664e,1159.0,Maintenance Therapy,42.0,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0669-C18_treatment31,9f149fcb-8099-4e1b-a19b-857999dd0c40,Progressive Disease,released,Oxaliplatin,1,2021-12-21T14:16:57.212899-06:00,,,
HCM-CSHL-0669-C18,dc5a908f-fd2f-4eea-85cb-49b4de137286,fdb6ba1a-5416-40b4-8236-13163b2a664e,1159.0,Maintenance Therapy,42.0,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0669-C18_treatment28,a19bd679-13bb-4ae5-bf55-0399890c4293,Progressive Disease,released,Fluorouracil,1,2021-12-21T14:16:57.212899-06:00,,,
HCM-CSHL-0669-C18,dc5a908f-fd2f-4eea-85cb-49b4de137286,fdb6ba1a-5416-40b4-8236-13163b2a664e,1159.0,Maintenance Therapy,42.0,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0669-C18_treatment32,b01303f3-21cb-4d47-9ddf-009a2929f5bc,Progressive Disease,released,Trifluridine and Tipiracil Hydrochloride,1,2021-12-21T14:16:57.212899-06:00,,,
HCM-CSHL-0669-C18,dc5a908f-fd2f-4eea-85cb-49b4de137286,fdb6ba1a-5416-40b4-8236-13163b2a664e,1159.0,Maintenance Therapy,42.0,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0669-C18_treatment36,c3afcce6-b496-46e2-904d-73cb48b0743b,Progressive Disease,released,,1,2021-12-21T14:16:57.212899-06:00,,,FOLFIRI
HCM-EXPT-1000-C18,dccf1a0b-1e0d-4b46-aea2-db98b998033a,c8f5f6b8-c126-416f-8f3b-b40a47289c9b,,Neoadjuvant,,2025-10-08T12:37:43.816130-05:00,HCM-EXPT-1000-C18_treatment,6772fca1-20aa-4414-bb7b-7a707967dc97,,released,,0,2021-12-21T14:52:52.943873-06:00,,,
HCM-SANG-0294-C15,dd73ec51-8600-4f56-8591-92fd11c3cc92,277c6b71-4731-4bdd-8c52-9fe527558597,,Neoadjuvant,125.0,2023-03-13T12:56:41.912799-05:00,HCM-SANG-0294-C15_treatment,7d253559-06e4-4362-a733-80da58c9ae55,,released,Cisplatin,1,2021-12-21T15:09:09.929940-06:00,Chemotherapy,,
HCM-SANG-0294-C15,dd73ec51-8600-4f56-8591-92fd11c3cc92,277c6b71-4731-4bdd-8c52-9fe527558597,,Neoadjuvant,125.0,2023-03-13T12:56:41.912799-05:00,HCM-SANG-0294-C15_treatment2,bbb64815-40d0-40f9-9dd9-d59f15c4e90d,,released,Capecitabine,1,2021-12-21T15:09:09.929940-06:00,Chemotherapy,,
HCM-SANG-0294-C15,dd73ec51-8600-4f56-8591-92fd11c3cc92,277c6b71-4731-4bdd-8c52-9fe527558597,,Neoadjuvant,125.0,2023-03-13T12:56:41.912799-05:00,HCM-SANG-0294-C15_treatment3,bc08ec29-d69a-4605-a0be-09a187a4c2f6,,released,Trastuzumab,1,2021-12-21T15:09:09.929940-06:00,Chemotherapy,,
HCM-BROD-0328-C15,dd7c58fc-0765-4d02-9a60-515a721cd369,adb35634-5e40-4885-a3ac-9b33f83e2e90,,Adjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0328-C15_treatment5,2ba4454e-0ea2-4c8c-b976-43cc1ca99bed,,released,,0,2020-09-27T11:17:36.279473-05:00,Targeted Molecular Therapy,Residual Disease,
HCM-BROD-0328-C15,dd7c58fc-0765-4d02-9a60-515a721cd369,adb35634-5e40-4885-a3ac-9b33f83e2e90,,Adjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0328-C15_treatment3,83b1426f-53ae-49f6-ad2e-10bf52f35a3f,,released,,0,2020-09-27T11:17:36.279473-05:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-BROD-0328-C15,dd7c58fc-0765-4d02-9a60-515a721cd369,adb35634-5e40-4885-a3ac-9b33f83e2e90,,Neoadjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0328-C15_treatment,a14cf86a-9649-41eb-bc43-d29f17cb946e,,released,,0,2019-04-04T15:56:24.085531-05:00,,,
HCM-BROD-0328-C15,dd7c58fc-0765-4d02-9a60-515a721cd369,adb35634-5e40-4885-a3ac-9b33f83e2e90,,Adjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0328-C15_treatment6,a88f92f4-f3ef-499b-a78f-cf4271ff47ae,,released,,0,2020-09-27T11:17:36.279473-05:00,"Radiation Therapy, NOS",Residual Disease,
HCM-BROD-0328-C15,dd7c58fc-0765-4d02-9a60-515a721cd369,adb35634-5e40-4885-a3ac-9b33f83e2e90,,,,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0328-C15_treatment4,c656c2ca-35ee-4292-b42a-4fc33dd31858,,released,,0,2020-09-27T11:17:36.279473-05:00,"Surgery, NOS",Initial Diagnosis,
HCM-BROD-0328-C15,dd7c58fc-0765-4d02-9a60-515a721cd369,adb35634-5e40-4885-a3ac-9b33f83e2e90,,Adjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0328-C15_treatment2,f8e057bf-43b0-4564-88fd-f7ebcb7d917a,,released,,0,2020-09-27T11:17:36.279473-05:00,Chemotherapy,Residual Disease,
HCM-BROD-0449-C34,dd88a8a4-517b-40ad-a4f3-201e20875cfe,1c29ab94-e14f-4c82-b13b-8173a85c97df,232.0,Maintenance Therapy,232.0,2021-07-12T12:25:55.528644-05:00,HCM-BROD-0449-C34_treatment,4da2ba3d-3209-4107-ab3b-99cac5919481,Progressive Disease,released,,1,2020-06-15T13:40:46.229195-05:00,,Progressive Disease,
HCM-BROD-0449-C34,dd88a8a4-517b-40ad-a4f3-201e20875cfe,1c29ab94-e14f-4c82-b13b-8173a85c97df,406.0,Adjuvant,400.0,2023-03-13T13:11:23.509596-05:00,HCM-BROD-0449-C34_treatment5,75e8c09a-9bf3-461a-a645-6582f9a1e5e8,,released,,1,2020-06-15T13:40:46.229195-05:00,"Radiation, Stereotactic/Gamma Knife/SRS",Residual Disease,
HCM-BROD-0449-C34,dd88a8a4-517b-40ad-a4f3-201e20875cfe,1c29ab94-e14f-4c82-b13b-8173a85c97df,,,-14.0,2023-03-13T13:11:23.509596-05:00,HCM-BROD-0449-C34_treatment3,803cbe2a-4c90-42a8-8c68-76bb6c191aa7,,released,,1,2020-06-15T13:40:46.229195-05:00,"Surgery, NOS",Initial Diagnosis,
HCM-BROD-0449-C34,dd88a8a4-517b-40ad-a4f3-201e20875cfe,1c29ab94-e14f-4c82-b13b-8173a85c97df,,Neoadjuvant,232.0,2021-07-12T12:25:55.528644-05:00,HCM-BROD-0449-C34_treatment2,b8cbb412-7f21-4350-9582-1a02cf7d200e,,released,,1,2020-06-15T13:40:46.229195-05:00,Stereotactic Radiosurgery,,
HCM-BROD-0449-C34,dd88a8a4-517b-40ad-a4f3-201e20875cfe,1c29ab94-e14f-4c82-b13b-8173a85c97df,,Adjuvant,,2023-03-13T13:11:23.509596-05:00,HCM-BROD-0449-C34_treatment4,d3107141-a9a9-4c8e-9e0d-62a5a49a7c5a,,released,,0,2020-06-15T13:40:46.229195-05:00,"Pharmaceutical Therapy, NOS",Residual Disease,
HCM-EXPT-0934-C50,dd9f3a2c-2962-4144-b4d1-58ce170d5e6b,f1498ab1-62ba-42f7-a7c0-3afd1d1afe59,,Neoadjuvant,,2025-10-08T12:36:57.024699-05:00,HCM-EXPT-0934-C50_treatment,e807076c-9aeb-408b-b035-1a665e2f2f5e,,released,,0,2021-12-21T14:45:40.004528-06:00,,,
HCM-CSHL-0728-C25,ddba0c54-930d-4dc4-b74f-48e29961c945,27415163-a825-491e-8d19-917ec6a7d259,,Adjuvant,,2023-02-22T07:39:25.979291-06:00,HCM-CSHL-0728-C25_treatment3,684371bb-dbc8-4ed9-b2a0-a860fa25deff,,released,,0,2021-12-21T14:19:07.289376-06:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-CSHL-0728-C25,ddba0c54-930d-4dc4-b74f-48e29961c945,27415163-a825-491e-8d19-917ec6a7d259,,Adjuvant,,2023-02-22T07:39:25.979291-06:00,HCM-CSHL-0728-C25_treatment5,7b215ae3-0f4c-44d6-98bd-5f1820763b25,,released,,0,2021-12-21T14:19:07.289376-06:00,Targeted Molecular Therapy,Residual Disease,
HCM-CSHL-0728-C25,ddba0c54-930d-4dc4-b74f-48e29961c945,27415163-a825-491e-8d19-917ec6a7d259,,Neoadjuvant,,2023-02-22T07:39:25.979291-06:00,HCM-CSHL-0728-C25_treatment,bfe06b07-1b7b-4a17-8aa8-84be528348cb,,released,,0,2021-12-21T14:19:07.289376-06:00,,,
HCM-CSHL-0728-C25,ddba0c54-930d-4dc4-b74f-48e29961c945,27415163-a825-491e-8d19-917ec6a7d259,,Adjuvant,,2023-02-22T07:39:25.979291-06:00,HCM-CSHL-0728-C25_treatment2,cbfa1ba6-6004-4344-be1e-fb295cb58f0f,,released,,1,2021-12-21T14:19:07.289376-06:00,Chemotherapy,Residual Disease,
HCM-CSHL-0728-C25,ddba0c54-930d-4dc4-b74f-48e29961c945,27415163-a825-491e-8d19-917ec6a7d259,,,,2023-02-27T13:17:56.041961-06:00,HCM-CSHL-0728-C25_treatment4,d8250998-32c1-463e-a25a-28764629ba0b,,released,,0,2021-12-21T14:19:07.289376-06:00,"Surgery, NOS",Initial Diagnosis,
HCM-CSHL-0728-C25,ddba0c54-930d-4dc4-b74f-48e29961c945,27415163-a825-491e-8d19-917ec6a7d259,,Adjuvant,,2023-02-22T07:39:25.979291-06:00,HCM-CSHL-0728-C25_treatment6,fc5a6f17-0a43-4888-a99b-615b7a7316a1,,released,,0,2021-12-21T14:19:07.289376-06:00,"Radiation Therapy, NOS",Residual Disease,
HCM-CSHL-0317-C18,de19bdf6-63b3-4e75-bf11-a7b6ebcea466,b8265fae-09e2-4089-a109-1963035574b5,,Neoadjuvant,,2021-07-12T12:25:55.528644-05:00,HCM-CSHL-0317-C18_treatment,39c1f3d9-b457-47d7-be8c-ed73ddcf9fea,,released,,0,2020-09-28T09:38:09.520270-05:00,,,
HCM-CSHL-0317-C18,de19bdf6-63b3-4e75-bf11-a7b6ebcea466,b8265fae-09e2-4089-a109-1963035574b5,,Adjuvant,,2023-03-13T12:45:18.744376-05:00,HCM-CSHL-0317-C18_treatment3,569d5653-7ed9-4e06-b37e-197462717e62,,released,,0,2020-09-28T09:38:09.520270-05:00,"Pharmaceutical Therapy, NOS",Residual Disease,
HCM-CSHL-0317-C18,de19bdf6-63b3-4e75-bf11-a7b6ebcea466,b8265fae-09e2-4089-a109-1963035574b5,,,35.0,2023-03-13T12:45:18.744376-05:00,HCM-CSHL-0317-C18_treatment2,ec712fb0-8265-468a-9670-bd336dfc0b3d,,released,,1,2020-09-28T09:38:09.520270-05:00,"Surgery, NOS",Initial Diagnosis,
HCM-BROD-0559-C16,de431792-364a-4c0a-9ab6-1166816c979a,2f4f475b-3d30-4268-bc06-e36784c7a0a5,171.0,Maintenance Therapy,25.0,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0559-C16_treatment12,15a95e4e-79f4-4f39-9f1d-d4f3b6e273dc,Progressive Disease,released,Fluorouracil,1,2020-10-08T14:46:22.743263-05:00,,,
HCM-BROD-0559-C16,de431792-364a-4c0a-9ab6-1166816c979a,2f4f475b-3d30-4268-bc06-e36784c7a0a5,171.0,Maintenance Therapy,25.0,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0559-C16_treatment14,2c3e3049-b2a6-44e8-89d3-628b171c5f35,Progressive Disease,released,,1,2020-10-08T14:46:22.743263-05:00,,,FOLFOX
HCM-BROD-0559-C16,de431792-364a-4c0a-9ab6-1166816c979a,2f4f475b-3d30-4268-bc06-e36784c7a0a5,171.0,Maintenance Therapy,25.0,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0559-C16_treatment13,61caff41-9703-4ef4-bf78-8a74b065e4c1,Progressive Disease,released,Oxaliplatin,1,2020-10-08T14:46:22.743263-05:00,,,
HCM-BROD-0559-C16,de431792-364a-4c0a-9ab6-1166816c979a,2f4f475b-3d30-4268-bc06-e36784c7a0a5,171.0,Maintenance Therapy,25.0,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0559-C16_treatment11,8dd561cc-6cec-4c68-a7d0-856ae0e7f44f,Progressive Disease,released,Leucovorin Calcium,1,2020-10-08T14:46:22.743263-05:00,,,
HCM-BROD-0559-C16,de431792-364a-4c0a-9ab6-1166816c979a,f0de5767-e099-4b6c-a563-35dec74058dd,171.0,Adjuvant,25.0,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0559-C16_treatment4,01d7640b-0cd9-4bc3-b7cc-8e0baa414a6b,,released,Oxaliplatin,1,2020-10-08T14:46:22.743263-05:00,Chemotherapy,Residual Disease,
HCM-BROD-0559-C16,de431792-364a-4c0a-9ab6-1166816c979a,f0de5767-e099-4b6c-a563-35dec74058dd,,Adjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0559-C16_treatment7,19fafeb3-d52d-4663-8b33-94ffbd2be156,,released,,0,2020-10-08T14:46:22.743263-05:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-BROD-0559-C16,de431792-364a-4c0a-9ab6-1166816c979a,f0de5767-e099-4b6c-a563-35dec74058dd,171.0,Adjuvant,25.0,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0559-C16_treatment5,3939266f-0054-4448-b4a3-13ca375af2a5,,released,,1,2020-10-08T14:46:22.743263-05:00,Chemotherapy,Residual Disease,FOLFOX
HCM-BROD-0559-C16,de431792-364a-4c0a-9ab6-1166816c979a,f0de5767-e099-4b6c-a563-35dec74058dd,,Neoadjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0559-C16_treatment,404c273e-77b2-4da0-b150-94510b6aa6f3,,released,,0,2020-10-08T14:46:22.743263-05:00,,,
HCM-BROD-0559-C16,de431792-364a-4c0a-9ab6-1166816c979a,f0de5767-e099-4b6c-a563-35dec74058dd,171.0,Adjuvant,25.0,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0559-C16_treatment2,56eaf6f6-3cbc-4538-bf9d-30d0f9675cd4,,released,Leucovorin Calcium,1,2020-10-08T14:46:22.743263-05:00,Chemotherapy,Residual Disease,
HCM-BROD-0559-C16,de431792-364a-4c0a-9ab6-1166816c979a,f0de5767-e099-4b6c-a563-35dec74058dd,171.0,Adjuvant,25.0,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0559-C16_treatment3,6aec4563-0c5d-45d5-bcd5-2068d921ff15,,released,Fluorouracil,1,2020-10-08T14:46:22.743263-05:00,Chemotherapy,Residual Disease,
HCM-BROD-0559-C16,de431792-364a-4c0a-9ab6-1166816c979a,f0de5767-e099-4b6c-a563-35dec74058dd,,,,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0559-C16_treatment8,a9a7ccae-61f8-4a23-a5fa-355f9b4a55be,,released,,0,2020-10-08T14:46:22.743263-05:00,"Surgery, NOS",Initial Diagnosis,
HCM-BROD-0559-C16,de431792-364a-4c0a-9ab6-1166816c979a,f0de5767-e099-4b6c-a563-35dec74058dd,,Adjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0559-C16_treatment10,ca3831af-f448-49af-a381-878daf874dc0,,released,,0,2020-10-08T14:46:22.743263-05:00,"Radiation Therapy, NOS",Residual Disease,
HCM-BROD-0559-C16,de431792-364a-4c0a-9ab6-1166816c979a,f0de5767-e099-4b6c-a563-35dec74058dd,207.0,Adjuvant,207.0,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0559-C16_treatment6,efd65059-57d4-413f-aba2-5789f09e97c6,,released,Paclitaxel,1,2020-10-08T14:46:22.743263-05:00,Chemotherapy,Residual Disease,
HCM-BROD-0559-C16,de431792-364a-4c0a-9ab6-1166816c979a,f0de5767-e099-4b6c-a563-35dec74058dd,,Adjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0559-C16_treatment9,fc0060f0-322b-428f-becd-ac518390c608,,released,,0,2020-10-08T14:46:22.743263-05:00,Targeted Molecular Therapy,Residual Disease,
HCM-EXPT-0891-C25,de8fb027-acbe-4edb-8882-ad56778a10b0,a7482940-8364-41e5-a2a5-c97174c7b979,,Neoadjuvant,,2025-10-08T12:36:32.654639-05:00,HCM-EXPT-0891-C25_treatment,2c6117e3-b8c7-43f9-ac7d-98c3831d22d7,,released,,0,2021-12-21T14:42:31.173647-06:00,,,
HCM-CSHL-0245-C18,df69a9b0-63a6-47f4-b3a7-beb37edf100d,9fe82384-f165-4c0e-a49f-bbb9cd3a16fc,188.0,Maintenance Therapy,27.0,2021-09-07T12:04:46.644318-05:00,HCM-CSHL-0245-C18_treatment18,5943527e-3ffc-438c-99e5-90133d7e9f09,Treatment Ongoing,released,Oxaliplatin,1,2020-10-08T12:09:37.935146-05:00,,,
HCM-CSHL-0245-C18,df69a9b0-63a6-47f4-b3a7-beb37edf100d,9fe82384-f165-4c0e-a49f-bbb9cd3a16fc,188.0,Maintenance Therapy,27.0,2021-09-07T12:04:46.644318-05:00,HCM-CSHL-0245-C18_treatment19,7f6273d2-916f-4f3b-840d-bdb35d71260a,Treatment Ongoing,released,,1,2020-10-08T12:09:37.935146-05:00,,,FOLFOX
HCM-CSHL-0245-C18,df69a9b0-63a6-47f4-b3a7-beb37edf100d,9fe82384-f165-4c0e-a49f-bbb9cd3a16fc,188.0,Maintenance Therapy,27.0,2021-09-07T12:04:46.644318-05:00,HCM-CSHL-0245-C18_treatment17,c5d668a6-4787-4ae7-8144-18a372afa711,Treatment Ongoing,released,Fluorouracil,1,2020-10-08T12:09:37.935146-05:00,,,
HCM-CSHL-0245-C18,df69a9b0-63a6-47f4-b3a7-beb37edf100d,9fe82384-f165-4c0e-a49f-bbb9cd3a16fc,188.0,Maintenance Therapy,27.0,2021-09-10T10:36:37.981324-05:00,HCM-CSHL-0245-C18_treatment16,fcc2083b-91a9-4877-acc3-d9433f23ba56,Treatment Ongoing,released,Leucovorin Calcium,1,2021-09-07T12:04:46.644318-05:00,,,
HCM-CSHL-0245-C18,df69a9b0-63a6-47f4-b3a7-beb37edf100d,d2dcedb9-1fd0-4efc-8256-0e44cdbf0d8e,624.0,Adjuvant,479.0,2021-07-12T12:25:55.528644-05:00,HCM-CSHL-0245-C18_treatment8,22a0a153-d6f0-44d4-9f8d-9f66418d7502,,released,Irinotecan,1,2020-06-15T13:42:51.396910-05:00,Chemotherapy,Residual Disease,
HCM-CSHL-0245-C18,df69a9b0-63a6-47f4-b3a7-beb37edf100d,d2dcedb9-1fd0-4efc-8256-0e44cdbf0d8e,351.0,Adjuvant,260.0,2021-07-12T12:25:55.528644-05:00,HCM-CSHL-0245-C18_treatment5,49afef21-eac6-4e2a-9035-56a6510911ae,,released,Capecitabine,1,2020-06-15T13:42:51.396910-05:00,Chemotherapy,Residual Disease,
HCM-CSHL-0245-C18,df69a9b0-63a6-47f4-b3a7-beb37edf100d,d2dcedb9-1fd0-4efc-8256-0e44cdbf0d8e,,Adjuvant,,2021-09-07T12:04:46.644318-05:00,HCM-CSHL-0245-C18_treatment10,4da54849-43b9-4c81-9b76-f68e708c1d9f,,released,,0,2020-06-15T13:42:51.396910-05:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-CSHL-0245-C18,df69a9b0-63a6-47f4-b3a7-beb37edf100d,d2dcedb9-1fd0-4efc-8256-0e44cdbf0d8e,,Neoadjuvant,27.0,2021-07-12T12:25:55.528644-05:00,HCM-CSHL-0245-C18_treatment,4f9923db-167a-4cc5-b8a1-2b6bf6a5f31d,,released,Leucovorin Calcium,1,2020-06-15T13:42:51.396910-05:00,Chemotherapy,,
HCM-CSHL-0245-C18,df69a9b0-63a6-47f4-b3a7-beb37edf100d,d2dcedb9-1fd0-4efc-8256-0e44cdbf0d8e,624.0,Adjuvant,479.0,2021-07-12T12:25:55.528644-05:00,HCM-CSHL-0245-C18_treatment9,6a1a3d91-a4a1-4d02-ba3b-1d6a01a1eb1a,,released,,1,2020-06-15T13:42:51.396910-05:00,Chemotherapy,Residual Disease,FOLFIRI
HCM-CSHL-0245-C18,df69a9b0-63a6-47f4-b3a7-beb37edf100d,d2dcedb9-1fd0-4efc-8256-0e44cdbf0d8e,,,231.0,2023-03-13T12:50:22.160826-05:00,HCM-CSHL-0245-C18_treatment11,6d54f1a2-4582-4ed6-90e0-2e1ccb2f4081,,released,,1,2020-10-08T12:09:37.935146-05:00,"Surgery, NOS",Initial Diagnosis,
HCM-CSHL-0245-C18,df69a9b0-63a6-47f4-b3a7-beb37edf100d,d2dcedb9-1fd0-4efc-8256-0e44cdbf0d8e,624.0,Adjuvant,502.0,2021-09-07T12:04:46.644318-05:00,HCM-CSHL-0245-C18_treatment12,82888015-a0ca-4daa-8d28-458cd29239c4,,released,Bevacizumab,1,2020-10-08T12:09:37.935146-05:00,Targeted Molecular Therapy,Residual Disease,
HCM-CSHL-0245-C18,df69a9b0-63a6-47f4-b3a7-beb37edf100d,d2dcedb9-1fd0-4efc-8256-0e44cdbf0d8e,,Adjuvant,,2021-09-07T12:04:46.644318-05:00,HCM-CSHL-0245-C18_treatment15,906d3732-d28e-4ea6-9897-a670c04b5a73,,released,,0,2020-10-08T12:09:37.935146-05:00,"Radiation Therapy, NOS",Residual Disease,
HCM-CSHL-0245-C18,df69a9b0-63a6-47f4-b3a7-beb37edf100d,d2dcedb9-1fd0-4efc-8256-0e44cdbf0d8e,,Neoadjuvant,27.0,2021-07-12T12:25:55.528644-05:00,HCM-CSHL-0245-C18_treatment4,9656f0ff-881f-4229-a8a0-e7bdce73eac3,,released,,1,2020-06-15T13:42:51.396910-05:00,Chemotherapy,,FOLFOX
HCM-CSHL-0245-C18,df69a9b0-63a6-47f4-b3a7-beb37edf100d,d2dcedb9-1fd0-4efc-8256-0e44cdbf0d8e,,Adjuvant,607.0,2021-09-07T12:04:46.644318-05:00,HCM-CSHL-0245-C18_treatment14,ade5820b-0384-4ea3-bbec-75afceaacc59,Treatment Ongoing,released,Monalizumab,1,2020-10-08T12:09:37.935146-05:00,Targeted Molecular Therapy,Residual Disease,
HCM-CSHL-0245-C18,df69a9b0-63a6-47f4-b3a7-beb37edf100d,d2dcedb9-1fd0-4efc-8256-0e44cdbf0d8e,624.0,Adjuvant,479.0,2021-07-12T12:25:55.528644-05:00,HCM-CSHL-0245-C18_treatment6,b808b192-630c-47ea-8141-3a08b60ebcac,,released,Leucovorin Calcium,1,2020-06-15T13:42:51.396910-05:00,Chemotherapy,Residual Disease,
HCM-CSHL-0245-C18,df69a9b0-63a6-47f4-b3a7-beb37edf100d,d2dcedb9-1fd0-4efc-8256-0e44cdbf0d8e,,Neoadjuvant,27.0,2021-07-12T12:25:55.528644-05:00,HCM-CSHL-0245-C18_treatment2,be874168-6132-4833-b731-826ff22e7782,,released,Fluorouracil,1,2020-06-15T13:42:51.396910-05:00,Chemotherapy,,
HCM-CSHL-0245-C18,df69a9b0-63a6-47f4-b3a7-beb37edf100d,d2dcedb9-1fd0-4efc-8256-0e44cdbf0d8e,,Neoadjuvant,27.0,2021-07-12T12:25:55.528644-05:00,HCM-CSHL-0245-C18_treatment3,cb52b4d3-74aa-470a-8f5b-92e27145e002,,released,Oxaliplatin,1,2020-06-15T13:42:51.396910-05:00,Chemotherapy,,
HCM-CSHL-0245-C18,df69a9b0-63a6-47f4-b3a7-beb37edf100d,d2dcedb9-1fd0-4efc-8256-0e44cdbf0d8e,624.0,Adjuvant,479.0,2021-07-12T12:25:55.528644-05:00,HCM-CSHL-0245-C18_treatment7,d4fe201f-c3b0-4cac-ac45-4127adcb65ad,,released,Fluorouracil,1,2020-06-15T13:42:51.396910-05:00,Chemotherapy,Residual Disease,
HCM-CSHL-0245-C18,df69a9b0-63a6-47f4-b3a7-beb37edf100d,d2dcedb9-1fd0-4efc-8256-0e44cdbf0d8e,,Adjuvant,607.0,2021-09-07T12:04:46.644318-05:00,HCM-CSHL-0245-C18_treatment13,f6445099-bcb3-468f-810f-bccba536db71,Treatment Ongoing,released,Cetuximab,1,2020-10-08T12:09:37.935146-05:00,Targeted Molecular Therapy,Residual Disease,
HCM-BROD-1103-C86,df8d98d5-5c5d-425f-9e12-ecaf49a50b9c,39a1d7ea-a5bf-4a26-876c-09988c47439e,,Neoadjuvant,139.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-1103-C86_treatment,0186d4d5-1a01-41dc-a3fd-4f8efa63eaa6,,released,Cyclophosphamide,1,2021-12-21T15:23:46.579882-06:00,Chemotherapy,,
HCM-BROD-1103-C86,df8d98d5-5c5d-425f-9e12-ecaf49a50b9c,39a1d7ea-a5bf-4a26-876c-09988c47439e,,,,2025-04-07T17:13:09.336794-05:00,HCM-BROD-1103-C86_treatment9,401b222b-098e-450d-919e-9c7583c76553,,released,,0,2021-12-21T15:23:46.579882-06:00,"Surgery, NOS",Initial Diagnosis,
HCM-BROD-1103-C86,df8d98d5-5c5d-425f-9e12-ecaf49a50b9c,39a1d7ea-a5bf-4a26-876c-09988c47439e,,Neoadjuvant,139.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-1103-C86_treatment4,423de288-55f6-40c4-b410-e6fa9c411124,,released,Prednisone,1,2021-12-21T15:23:46.579882-06:00,Chemotherapy,,
HCM-BROD-1103-C86,df8d98d5-5c5d-425f-9e12-ecaf49a50b9c,39a1d7ea-a5bf-4a26-876c-09988c47439e,,Neoadjuvant,139.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-1103-C86_treatment2,4525ba5e-c52b-4179-9ab5-f4efead5ebf6,,released,Vincristine Sulfate,1,2021-12-21T15:23:46.579882-06:00,Chemotherapy,,
HCM-BROD-1103-C86,df8d98d5-5c5d-425f-9e12-ecaf49a50b9c,39a1d7ea-a5bf-4a26-876c-09988c47439e,,Neoadjuvant,139.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-1103-C86_treatment3,55722165-e61a-4b1d-a10c-bfa432d7d4db,,released,Doxorubicin Hydrochloride,1,2021-12-21T15:23:46.579882-06:00,Chemotherapy,,
HCM-BROD-1103-C86,df8d98d5-5c5d-425f-9e12-ecaf49a50b9c,39a1d7ea-a5bf-4a26-876c-09988c47439e,,Neoadjuvant,139.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-1103-C86_treatment5,9270207e-0556-4217-ba24-1ebbfa4ec0ac,,released,Etoposide Phosphate,1,2021-12-21T15:23:46.579882-06:00,Chemotherapy,,
HCM-BROD-1103-C86,df8d98d5-5c5d-425f-9e12-ecaf49a50b9c,39a1d7ea-a5bf-4a26-876c-09988c47439e,215.0,Adjuvant,215.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-1103-C86_treatment6,c232c846-9f60-4ab9-867e-f1d5a36a3dba,,released,Bendamustine,1,2021-12-21T15:23:46.579882-06:00,Chemotherapy,Residual Disease,
HCM-SANG-0530-C15,dfa2e46f-43f2-4cbb-ab19-ea1f5e4b00a1,73dcd83b-cf69-46d8-b336-091b7091daaf,,Neoadjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-SANG-0530-C15_treatment,bff5e1b8-399f-459c-8fdd-960f1b398da1,,released,,0,2023-02-27T13:12:07.133471-06:00,,,
HCM-CSHL-0191-C25,dfa988f5-226e-47ca-b4c5-ef950c9efac5,a0bd5b0d-5d09-46e1-8a46-c925d95fa5b1,,,-13.0,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0191-C25_treatment5,029946aa-8b74-44d9-99d4-b23176dd5e00,,released,,1,2020-09-28T09:16:01.450517-05:00,"Surgery, NOS",Initial Diagnosis,
HCM-CSHL-0191-C25,dfa988f5-226e-47ca-b4c5-ef950c9efac5,a0bd5b0d-5d09-46e1-8a46-c925d95fa5b1,,Adjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0191-C25_treatment7,07bbe4c9-d9f9-4244-aa15-0707f220e03c,,released,,0,2021-08-26T14:32:09.295136-05:00,"Radiation Therapy, NOS",Residual Disease,
HCM-CSHL-0191-C25,dfa988f5-226e-47ca-b4c5-ef950c9efac5,a0bd5b0d-5d09-46e1-8a46-c925d95fa5b1,251.0,Adjuvant,62.0,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0191-C25_treatment3,382ff8e6-e157-48e2-89c0-7dd1d3f213fe,,released,Nab-paclitaxel,1,2020-09-28T09:16:01.450517-05:00,Chemotherapy,Residual Disease,
HCM-CSHL-0191-C25,dfa988f5-226e-47ca-b4c5-ef950c9efac5,a0bd5b0d-5d09-46e1-8a46-c925d95fa5b1,,Adjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0191-C25_treatment6,aae6c3de-6379-4a61-a052-473e7743aa4d,,released,,0,2020-09-28T09:16:01.450517-05:00,Targeted Molecular Therapy,Residual Disease,
HCM-CSHL-0191-C25,dfa988f5-226e-47ca-b4c5-ef950c9efac5,a0bd5b0d-5d09-46e1-8a46-c925d95fa5b1,,Adjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0191-C25_treatment4,d4b97868-dc68-4816-81a7-2ad07b7436a4,,released,,0,2020-09-28T09:16:01.450517-05:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-CSHL-0191-C25,dfa988f5-226e-47ca-b4c5-ef950c9efac5,a0bd5b0d-5d09-46e1-8a46-c925d95fa5b1,,Neoadjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0191-C25_treatment,f02d100c-e8cf-45a2-beef-3f586bea32f8,,released,,0,2020-09-28T09:16:01.450517-05:00,,,
HCM-CSHL-0191-C25,dfa988f5-226e-47ca-b4c5-ef950c9efac5,a0bd5b0d-5d09-46e1-8a46-c925d95fa5b1,251.0,Adjuvant,62.0,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0191-C25_treatment2,f7f74b61-ee27-4f11-ae24-5183dbf81f2f,,released,Gemcitabine,1,2020-09-28T09:16:01.450517-05:00,Chemotherapy,Residual Disease,
HCM-BROD-0100-C15,e00914a1-997e-44ba-9c88-a5e8741b4ee1,0a37ccf7-cabd-4589-b04e-2ed8f84399e7,,Neoadjuvant,,2020-10-08T12:47:18.316908-05:00,HCM-BROD-0100-C15_treatment,0347ee0a-6f71-4378-8a03-f221073547bd,,released,Unknown,1,2019-04-16T11:45:26.694088-05:00,Chemotherapy,,
HCM-BROD-0100-C15,e00914a1-997e-44ba-9c88-a5e8741b4ee1,0a37ccf7-cabd-4589-b04e-2ed8f84399e7,483.0,Adjuvant,444.0,2023-03-13T13:10:54.923311-05:00,HCM-BROD-0100-C15_treatment5,06f864dc-8a15-4c5f-990b-27f9222582a3,,released,,1,2019-04-16T11:45:26.694088-05:00,"Radiation, External Beam",Residual Disease,
HCM-BROD-0100-C15,e00914a1-997e-44ba-9c88-a5e8741b4ee1,0a37ccf7-cabd-4589-b04e-2ed8f84399e7,,Adjuvant,,2023-03-13T13:10:54.923311-05:00,HCM-BROD-0100-C15_treatment4,165488f7-12b0-42d2-8768-2ab07ed0353e,,released,,0,2019-04-16T11:45:26.694088-05:00,"Pharmaceutical Therapy, NOS",Residual Disease,
HCM-BROD-0100-C15,e00914a1-997e-44ba-9c88-a5e8741b4ee1,0a37ccf7-cabd-4589-b04e-2ed8f84399e7,,Neoadjuvant,,2020-01-13T20:10:25.832065-06:00,HCM-BROD-0100-C15_treatment2,1d3f9072-2e32-4a48-b8d4-28d747f4c7b8,,released,,1,2019-04-16T11:45:26.694088-05:00,"Radiation, 3D Conformal",,
HCM-BROD-0100-C15,e00914a1-997e-44ba-9c88-a5e8741b4ee1,0a37ccf7-cabd-4589-b04e-2ed8f84399e7,,,,2023-03-13T13:10:54.923311-05:00,HCM-BROD-0100-C15_treatment3,70435cde-cb29-4a03-8ed6-7a56e280ead0,,released,,0,2019-04-16T11:45:26.694088-05:00,"Surgery, NOS",Initial Diagnosis,
HCM-EXPT-1203-C19,e037ecb6-6680-4758-aa56-8daf451bf396,d33077e1-5c0c-4a18-ba67-0a5fc31f4fd6,,Neoadjuvant,,2025-10-08T12:38:51.189053-05:00,HCM-EXPT-1203-C19_treatment2,0f5adda8-6d1d-4005-98bf-cfd66045218c,,released,,1,2023-02-24T13:47:54.184845-06:00,"Radiation Therapy, NOS",,
HCM-EXPT-1203-C19,e037ecb6-6680-4758-aa56-8daf451bf396,d33077e1-5c0c-4a18-ba67-0a5fc31f4fd6,,Neoadjuvant,,2025-10-08T12:38:51.189053-05:00,HCM-EXPT-1203-C19_treatment,2a01044a-1f62-402e-b420-889986bd5e06,,released,,1,2023-02-24T13:47:54.184845-06:00,Chemotherapy,,
HCM-SANG-1323-C15,e20192b7-5dd5-45c9-a813-71071fb143be,3ccbbf05-540a-41d6-9654-2d9914e56a5c,,Neoadjuvant,109.0,2025-04-07T17:13:09.336794-05:00,HCM-SANG-1323-C15_treatment,02a7653c-cf2e-4385-becb-c85ffe85a990,,released,Leucovorin,1,2023-02-27T12:53:08.208937-06:00,Chemotherapy,,
HCM-SANG-1323-C15,e20192b7-5dd5-45c9-a813-71071fb143be,3ccbbf05-540a-41d6-9654-2d9914e56a5c,,Neoadjuvant,109.0,2025-04-07T17:13:09.336794-05:00,HCM-SANG-1323-C15_treatment2,413f5875-78a1-4247-b39c-2e560b61b4a4,,released,Fluorouracil,1,2023-02-27T12:53:08.208937-06:00,Chemotherapy,,
HCM-SANG-1323-C15,e20192b7-5dd5-45c9-a813-71071fb143be,3ccbbf05-540a-41d6-9654-2d9914e56a5c,,Neoadjuvant,109.0,2025-04-07T17:13:09.336794-05:00,HCM-SANG-1323-C15_treatment4,43a7b8fe-b929-49ca-acf4-12a117e45c81,,released,Oxaliplatin,1,2023-02-27T12:53:08.208937-06:00,Chemotherapy,,
HCM-SANG-1323-C15,e20192b7-5dd5-45c9-a813-71071fb143be,3ccbbf05-540a-41d6-9654-2d9914e56a5c,,Neoadjuvant,109.0,2025-04-07T17:13:09.336794-05:00,HCM-SANG-1323-C15_treatment3,6094e07b-d479-4b70-9fa5-758446cd4e84,,released,Docetaxel,1,2023-02-27T12:53:08.208937-06:00,Chemotherapy,,
HCM-EXPT-0889-C25,e26c3de9-0334-4117-9348-0ac6c434c397,4a2da8a8-60e0-490f-844c-dcc04853aac7,,Neoadjuvant,,2025-10-08T12:36:32.654639-05:00,HCM-EXPT-0889-C25_treatment,39a6c3d4-5db7-436c-8c72-436577e14256,,released,,0,2021-12-21T14:42:19.173698-06:00,,,
HCM-BROD-0962-C16,e36812a9-2637-43aa-87b1-6722019136b4,80a770b0-efff-4598-9c5c-d0d07a887eb4,,Neoadjuvant,16.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0962-C16_treatment2,02b017ab-7cbb-4899-8a3b-26cd716bbbc7,,released,Fluorouracil,1,2021-12-21T13:59:49.229209-06:00,Chemotherapy,,
HCM-BROD-0962-C16,e36812a9-2637-43aa-87b1-6722019136b4,80a770b0-efff-4598-9c5c-d0d07a887eb4,,Neoadjuvant,16.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0962-C16_treatment6,193f434b-ce13-41a6-ac31-160269fd13b1,,released,,1,2021-12-21T13:59:49.229209-06:00,Chemotherapy,,FOLFOX
HCM-BROD-0962-C16,e36812a9-2637-43aa-87b1-6722019136b4,80a770b0-efff-4598-9c5c-d0d07a887eb4,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0962-C16_treatment9,348ac6f6-ddee-42ca-bf05-3b008f9e670f,,released,,0,2021-12-21T13:59:49.229209-06:00,Chemotherapy,Residual Disease,
HCM-BROD-0962-C16,e36812a9-2637-43aa-87b1-6722019136b4,80a770b0-efff-4598-9c5c-d0d07a887eb4,,,,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0962-C16_treatment11,3585342d-5d1f-407c-9e07-543c6d1b3c29,,released,,0,2021-12-21T13:59:49.229209-06:00,"Surgery, NOS",Initial Diagnosis,
HCM-BROD-0962-C16,e36812a9-2637-43aa-87b1-6722019136b4,80a770b0-efff-4598-9c5c-d0d07a887eb4,,Neoadjuvant,16.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0962-C16_treatment,53ccbf8e-7285-49a2-84c0-ef6d7fa12419,,released,Paclitaxel,1,2021-12-21T13:59:49.229209-06:00,Chemotherapy,,
HCM-BROD-0962-C16,e36812a9-2637-43aa-87b1-6722019136b4,80a770b0-efff-4598-9c5c-d0d07a887eb4,,Neoadjuvant,16.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0962-C16_treatment3,6b5ea0fb-c08e-4e1c-9bf8-9e6c3ff75b79,,released,Irinotecan,1,2021-12-21T13:59:49.229209-06:00,Chemotherapy,,
HCM-BROD-0962-C16,e36812a9-2637-43aa-87b1-6722019136b4,80a770b0-efff-4598-9c5c-d0d07a887eb4,331.0,Adjuvant,331.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0962-C16_treatment10,ad138b2b-7608-448d-8db9-47f398046e0c,,released,Pembrolizumab,1,2021-12-21T13:59:49.229209-06:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-BROD-0962-C16,e36812a9-2637-43aa-87b1-6722019136b4,80a770b0-efff-4598-9c5c-d0d07a887eb4,,Neoadjuvant,16.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0962-C16_treatment4,b713aaa1-b670-4971-bff5-821fd4754f6a,,released,Oxaliplatin,1,2021-12-21T13:59:49.229209-06:00,Chemotherapy,,
HCM-BROD-0962-C16,e36812a9-2637-43aa-87b1-6722019136b4,80a770b0-efff-4598-9c5c-d0d07a887eb4,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0962-C16_treatment12,bed3909f-cd16-4fb5-b803-d35d6763f222,,released,,0,2021-12-21T13:59:49.229209-06:00,Targeted Molecular Therapy,Residual Disease,
HCM-BROD-0962-C16,e36812a9-2637-43aa-87b1-6722019136b4,80a770b0-efff-4598-9c5c-d0d07a887eb4,,Neoadjuvant,16.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0962-C16_treatment5,c22d5ada-33dd-4f62-886a-89eab2cb6292,,released,Leucovorin Calcium,1,2021-12-21T13:59:49.229209-06:00,Chemotherapy,,
HCM-BROD-0962-C16,e36812a9-2637-43aa-87b1-6722019136b4,80a770b0-efff-4598-9c5c-d0d07a887eb4,,Neoadjuvant,156.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0962-C16_treatment8,dbad4c9c-3cee-4a49-b0ae-9d2b73f9d220,,released,Ramucirumab,1,2021-12-21T13:59:49.229209-06:00,Targeted Molecular Therapy,,
HCM-BROD-0962-C16,e36812a9-2637-43aa-87b1-6722019136b4,80a770b0-efff-4598-9c5c-d0d07a887eb4,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0962-C16_treatment13,e7238653-5f69-422b-9dd1-b7c24cb621bc,,released,,0,2021-12-21T13:59:49.229209-06:00,"Radiation Therapy, NOS",Residual Disease,
HCM-BROD-0962-C16,e36812a9-2637-43aa-87b1-6722019136b4,80a770b0-efff-4598-9c5c-d0d07a887eb4,,Neoadjuvant,16.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0962-C16_treatment7,ef3f15b3-7db1-452f-b89e-e13c29e50b49,,released,,1,2021-12-21T13:59:49.229209-06:00,Chemotherapy,,FOLFIRI
HCM-CSHL-0074-C25,e3b32485-b204-43a7-93a5-601408fcdf96,fa6d5c8a-3d61-49e3-805e-e14b58514a7e,255.0,Adjuvant,229.0,2023-02-22T07:39:25.979291-06:00,HCM-CSHL-0074-C25_treatment6,08b4599f-59ed-449f-890a-7c8ac760579c,,released,,1,2020-09-27T12:45:44.335430-05:00,"Radiation Therapy, NOS",Residual Disease,
HCM-CSHL-0074-C25,e3b32485-b204-43a7-93a5-601408fcdf96,fa6d5c8a-3d61-49e3-805e-e14b58514a7e,,Adjuvant,,2023-02-22T07:39:25.979291-06:00,HCM-CSHL-0074-C25_treatment3,1595ea8e-da3a-4663-872d-db806ad31e00,,released,,0,2020-09-27T12:45:44.335430-05:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-CSHL-0074-C25,e3b32485-b204-43a7-93a5-601408fcdf96,fa6d5c8a-3d61-49e3-805e-e14b58514a7e,,,-7.0,2023-02-27T13:29:37.505444-06:00,HCM-CSHL-0074-C25_treatment4,ad522c7c-a32d-4cdb-9acc-1cb43bb22e61,,released,,1,2020-09-27T12:45:44.335430-05:00,"Surgery, NOS",Initial Diagnosis,
HCM-CSHL-0074-C25,e3b32485-b204-43a7-93a5-601408fcdf96,fa6d5c8a-3d61-49e3-805e-e14b58514a7e,,Adjuvant,,2023-02-22T07:39:25.979291-06:00,HCM-CSHL-0074-C25_treatment5,ceee4b22-f748-43a1-992f-ba854196968c,,released,,0,2020-09-27T12:45:44.335430-05:00,Targeted Molecular Therapy,Residual Disease,
HCM-CSHL-0074-C25,e3b32485-b204-43a7-93a5-601408fcdf96,fa6d5c8a-3d61-49e3-805e-e14b58514a7e,,Neoadjuvant,,2023-02-22T07:39:25.979291-06:00,HCM-CSHL-0074-C25_treatment,da2c312b-5cf1-4021-9dbf-95a92c10cbc0,,released,,0,2020-09-27T12:45:44.335430-05:00,,,
HCM-CSHL-0074-C25,e3b32485-b204-43a7-93a5-601408fcdf96,fa6d5c8a-3d61-49e3-805e-e14b58514a7e,218.0,Adjuvant,48.0,2023-02-22T07:39:25.979291-06:00,HCM-CSHL-0074-C25_treatment2,f92aab0b-899a-40d6-a1b2-0abfe20966b1,,released,Gemcitabine,1,2020-09-27T12:45:44.335430-05:00,Chemotherapy,Residual Disease,
HCM-BROD-0793-C15,e3b7a023-92a8-4c61-b1c9-be10f5d03bc9,52633907-0c25-4f6b-91e2-a7ed6a75b168,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0793-C15_treatment11,0d7f4764-b306-4a58-a268-c5faacebcbd0,,released,,0,2021-12-21T13:53:39.167413-06:00,Targeted Molecular Therapy,Residual Disease,
HCM-BROD-0793-C15,e3b7a023-92a8-4c61-b1c9-be10f5d03bc9,52633907-0c25-4f6b-91e2-a7ed6a75b168,320.0,Adjuvant,236.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0793-C15_treatment4,14bab20a-ec8c-40d4-a897-4f9afa2f2b28,,released,Leucovorin Calcium,1,2021-12-21T13:53:39.167413-06:00,Chemotherapy,Residual Disease,
HCM-BROD-0793-C15,e3b7a023-92a8-4c61-b1c9-be10f5d03bc9,52633907-0c25-4f6b-91e2-a7ed6a75b168,320.0,Adjuvant,236.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0793-C15_treatment6,21ec9da9-e261-4316-93ee-568ad757eb04,,released,Oxaliplatin,1,2021-12-21T13:53:39.167413-06:00,Chemotherapy,Residual Disease,
HCM-BROD-0793-C15,e3b7a023-92a8-4c61-b1c9-be10f5d03bc9,52633907-0c25-4f6b-91e2-a7ed6a75b168,320.0,Adjuvant,236.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0793-C15_treatment7,4323be5f-56a3-44c9-9161-1a90abee63c0,,released,,1,2021-12-21T13:53:39.167413-06:00,Chemotherapy,Residual Disease,FOLFOX
HCM-BROD-0793-C15,e3b7a023-92a8-4c61-b1c9-be10f5d03bc9,52633907-0c25-4f6b-91e2-a7ed6a75b168,,Neoadjuvant,59.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0793-C15_treatment3,43e07e38-469a-4add-956b-c4728fe758cd,,released,,1,2021-12-21T13:53:39.167413-06:00,"Radiation Therapy, NOS",,
HCM-BROD-0793-C15,e3b7a023-92a8-4c61-b1c9-be10f5d03bc9,52633907-0c25-4f6b-91e2-a7ed6a75b168,405.0,Adjuvant,349.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0793-C15_treatment8,4a14106a-b6f7-4720-b5a0-e1cf4fb7938b,,released,Paclitaxel,1,2021-12-21T13:53:39.167413-06:00,Chemotherapy,Residual Disease,
HCM-BROD-0793-C15,e3b7a023-92a8-4c61-b1c9-be10f5d03bc9,52633907-0c25-4f6b-91e2-a7ed6a75b168,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0793-C15_treatment12,52d49071-c825-4935-87dd-1984f4a16730,,released,,0,2021-12-21T13:53:39.167413-06:00,"Radiation Therapy, NOS",Residual Disease,
HCM-BROD-0793-C15,e3b7a023-92a8-4c61-b1c9-be10f5d03bc9,52633907-0c25-4f6b-91e2-a7ed6a75b168,,,115.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0793-C15_treatment10,5cefe308-cbe9-4fc7-9875-ddd6aec3df5d,,released,,1,2021-12-21T13:53:39.167413-06:00,"Surgery, NOS",Initial Diagnosis,
HCM-BROD-0793-C15,e3b7a023-92a8-4c61-b1c9-be10f5d03bc9,52633907-0c25-4f6b-91e2-a7ed6a75b168,,Neoadjuvant,32.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0793-C15_treatment,6c5edcdf-97a7-4e65-85e4-b56a86bfeeee,,released,Carboplatin,1,2021-12-21T13:53:39.167413-06:00,Chemotherapy,,
HCM-BROD-0793-C15,e3b7a023-92a8-4c61-b1c9-be10f5d03bc9,52633907-0c25-4f6b-91e2-a7ed6a75b168,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0793-C15_treatment9,ad1ab0d6-d92a-4b1d-8531-790e00ebcac5,,released,,0,2021-12-21T13:53:39.167413-06:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-BROD-0793-C15,e3b7a023-92a8-4c61-b1c9-be10f5d03bc9,52633907-0c25-4f6b-91e2-a7ed6a75b168,320.0,Adjuvant,236.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0793-C15_treatment5,c77da8a8-4a29-42cd-9133-3829fd3ed5b2,,released,Fluorouracil,1,2021-12-21T13:53:39.167413-06:00,Chemotherapy,Residual Disease,
HCM-BROD-0793-C15,e3b7a023-92a8-4c61-b1c9-be10f5d03bc9,52633907-0c25-4f6b-91e2-a7ed6a75b168,,Neoadjuvant,32.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0793-C15_treatment2,f484af27-a302-4989-9efe-3b542f31899d,,released,Paclitaxel,1,2021-12-21T13:53:39.167413-06:00,Chemotherapy,,
HCM-BROD-0793-C15,e3b7a023-92a8-4c61-b1c9-be10f5d03bc9,92b3dc89-c16c-43a3-a0ee-a3a2707cd3bd,405.0,Maintenance Therapy,32.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0793-C15_treatment13,020c48ae-d3e4-4b68-96a3-ec04dc3591a3,Progressive Disease,released,Carboplatin,1,2021-12-21T13:53:39.167413-06:00,,,
HCM-BROD-0793-C15,e3b7a023-92a8-4c61-b1c9-be10f5d03bc9,92b3dc89-c16c-43a3-a0ee-a3a2707cd3bd,405.0,Maintenance Therapy,32.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0793-C15_treatment16,a7143433-6f31-4ec2-b702-98c2ab381012,Progressive Disease,released,Leucovorin Calcium,1,2021-12-21T13:53:39.167413-06:00,,,
HCM-BROD-0793-C15,e3b7a023-92a8-4c61-b1c9-be10f5d03bc9,92b3dc89-c16c-43a3-a0ee-a3a2707cd3bd,405.0,Maintenance Therapy,32.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0793-C15_treatment17,c822a894-aa6f-461c-9531-8296e43d24e1,Progressive Disease,released,Fluorouracil,1,2021-12-21T13:53:39.167413-06:00,,,
HCM-BROD-0793-C15,e3b7a023-92a8-4c61-b1c9-be10f5d03bc9,92b3dc89-c16c-43a3-a0ee-a3a2707cd3bd,405.0,Maintenance Therapy,32.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0793-C15_treatment15,ccd95202-f58c-4f4b-89c2-818b54e7eb5b,Progressive Disease,released,Oxaliplatin,1,2021-12-21T13:53:39.167413-06:00,,,
HCM-BROD-0793-C15,e3b7a023-92a8-4c61-b1c9-be10f5d03bc9,92b3dc89-c16c-43a3-a0ee-a3a2707cd3bd,405.0,Maintenance Therapy,32.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0793-C15_treatment18,d68525ed-207f-4612-ac95-c9e769e5aebc,Progressive Disease,released,,1,2021-12-21T13:53:39.167413-06:00,,,FOLFOX
HCM-BROD-0793-C15,e3b7a023-92a8-4c61-b1c9-be10f5d03bc9,92b3dc89-c16c-43a3-a0ee-a3a2707cd3bd,405.0,Maintenance Therapy,32.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0793-C15_treatment14,e1ff8649-7e07-40d3-97e3-452e9180b968,Progressive Disease,released,Paclitaxel,1,2021-12-21T13:53:39.167413-06:00,,,
HCM-BROD-0724-C43,e46ea440-c987-4c4f-8b7e-bacca42d32d8,fa0a0975-098d-4ae7-bb6b-517880f7d7fb,,Neoadjuvant,,2023-07-13T10:35:44.371881-05:00,HCM-BROD-0724-C43_treatment,1834dc26-1edc-47d0-8161-d94a221420ba,,released,,0,2021-12-21T13:48:47.342295-06:00,,,
HCM-BROD-0724-C43,e46ea440-c987-4c4f-8b7e-bacca42d32d8,fa0a0975-098d-4ae7-bb6b-517880f7d7fb,,Adjuvant,,2023-07-13T10:35:44.371881-05:00,HCM-BROD-0724-C43_treatment6,55f1d912-afc7-4230-be90-e8a1b2be2744,,released,,0,2021-12-21T13:48:47.342295-06:00,Targeted Molecular Therapy,Residual Disease,
HCM-BROD-0724-C43,e46ea440-c987-4c4f-8b7e-bacca42d32d8,fa0a0975-098d-4ae7-bb6b-517880f7d7fb,567.0,Adjuvant,472.0,2023-07-13T10:35:44.371881-05:00,HCM-BROD-0724-C43_treatment2,5787239f-58a5-41aa-9251-04cd9be9bcb6,Treatment Ongoing,released,Capecitabine,1,2021-12-21T13:48:47.342295-06:00,Chemotherapy,Residual Disease,
HCM-BROD-0724-C43,e46ea440-c987-4c4f-8b7e-bacca42d32d8,fa0a0975-098d-4ae7-bb6b-517880f7d7fb,,,,2023-07-13T10:35:44.371881-05:00,HCM-BROD-0724-C43_treatment5,6fb4235e-bfec-4cc4-9293-eff0158175d6,,released,,0,2021-12-21T13:48:47.342295-06:00,"Surgery, NOS",Initial Diagnosis,
HCM-BROD-0724-C43,e46ea440-c987-4c4f-8b7e-bacca42d32d8,fa0a0975-098d-4ae7-bb6b-517880f7d7fb,,Adjuvant,,2023-07-13T10:35:44.371881-05:00,HCM-BROD-0724-C43_treatment3,9132ddbb-7dc8-4ed2-8d4d-2e423509c2db,,released,,0,2021-12-21T13:48:47.342295-06:00,Hormone Therapy,Residual Disease,
HCM-BROD-0724-C43,e46ea440-c987-4c4f-8b7e-bacca42d32d8,fa0a0975-098d-4ae7-bb6b-517880f7d7fb,353.0,Adjuvant,18.0,2023-07-13T10:35:44.371881-05:00,HCM-BROD-0724-C43_treatment4,aae4ef59-a425-481a-914e-0b1ca545bed3,,released,Nivolumab,1,2021-12-21T13:48:47.342295-06:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-BROD-0724-C43,e46ea440-c987-4c4f-8b7e-bacca42d32d8,fa0a0975-098d-4ae7-bb6b-517880f7d7fb,,Adjuvant,,2023-07-13T10:35:44.371881-05:00,HCM-BROD-0724-C43_treatment7,c2587929-16c6-4229-a00d-62efa0d70850,,released,,0,2021-12-21T13:48:47.342295-06:00,"Radiation Therapy, NOS",Residual Disease,
HCM-CSHL-0801-C56,e4b062d4-30a1-4661-b5ec-28c532cbad0d,a0bef82a-5d53-4221-96aa-fac3a47481b5,,Neoadjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0801-C56_treatment5,6c7e73c6-cd17-4770-880d-99de9b457b62,Unknown,released,,1,2021-12-21T14:23:55.645184-06:00,Chemotherapy,,
HCM-CSHL-0801-C56,e4b062d4-30a1-4661-b5ec-28c532cbad0d,a0bef82a-5d53-4221-96aa-fac3a47481b5,,,0.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0801-C56_treatment2,a810e996-c534-42c5-b361-7d98c64b3aad,,released,,1,2021-12-21T14:23:55.645184-06:00,"Surgery, NOS",Initial Diagnosis,
HCM-CSHL-0801-C56,e4b062d4-30a1-4661-b5ec-28c532cbad0d,a0bef82a-5d53-4221-96aa-fac3a47481b5,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0801-C56_treatment4,e64fbd42-bef4-4c34-90b2-fa8df1d0fb72,,released,,0,2021-12-21T14:23:55.645184-06:00,"Radiation Therapy, NOS",Residual Disease,
HCM-CSHL-0801-C56,e4b062d4-30a1-4661-b5ec-28c532cbad0d,a0bef82a-5d53-4221-96aa-fac3a47481b5,,Neoadjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0801-C56_treatment,ec34c4b3-066d-403b-9eed-39885da4deca,,released,,0,2021-12-21T14:23:55.645184-06:00,,,
HCM-CSHL-0801-C56,e4b062d4-30a1-4661-b5ec-28c532cbad0d,a0bef82a-5d53-4221-96aa-fac3a47481b5,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0801-C56_treatment3,fabd7f11-e814-4d03-a6c3-dbbf98349b60,,released,,0,2021-12-21T14:23:55.645184-06:00,"Pharmaceutical Therapy, NOS",Residual Disease,
HCM-BROD-0134-C25,e4f98856-8ba9-498d-bbd5-443bb1bf4591,921b4c7a-5691-4d1d-8751-072a79402a9b,233.0,Adjuvant,233.0,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0134-C25_treatment7,358f677c-a1cf-4356-89d8-bf4f180c33c9,,released,Gemcitabine,1,2020-09-17T16:01:02.431006-05:00,Chemotherapy,Residual Disease,
HCM-BROD-0134-C25,e4f98856-8ba9-498d-bbd5-443bb1bf4591,921b4c7a-5691-4d1d-8751-072a79402a9b,,,,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0134-C25_treatment10,5952ae83-4a12-4114-b816-19308935e5ed,,released,,0,2020-09-17T16:01:02.431006-05:00,"Surgery, NOS",Initial Diagnosis,
HCM-BROD-0134-C25,e4f98856-8ba9-498d-bbd5-443bb1bf4591,921b4c7a-5691-4d1d-8751-072a79402a9b,217.0,Adjuvant,7.0,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0134-C25_treatment6,5e976f53-43d9-4cd9-87f9-b4b6af3c96e1,,released,,1,2020-09-17T16:01:02.431006-05:00,Chemotherapy,Residual Disease,FOLFIRINOX
HCM-BROD-0134-C25,e4f98856-8ba9-498d-bbd5-443bb1bf4591,921b4c7a-5691-4d1d-8751-072a79402a9b,217.0,Adjuvant,7.0,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0134-C25_treatment4,61a4d85e-1eb4-46df-8829-bb4d2d35181b,,released,Fluorouracil,1,2020-09-17T16:01:02.431006-05:00,Chemotherapy,Residual Disease,
HCM-BROD-0134-C25,e4f98856-8ba9-498d-bbd5-443bb1bf4591,921b4c7a-5691-4d1d-8751-072a79402a9b,,Adjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0134-C25_treatment11,61d278fe-9fa9-4ce7-8e82-914aa0c0928d,,released,,0,2020-09-17T16:01:02.431006-05:00,Targeted Molecular Therapy,Residual Disease,
HCM-BROD-0134-C25,e4f98856-8ba9-498d-bbd5-443bb1bf4591,921b4c7a-5691-4d1d-8751-072a79402a9b,233.0,Adjuvant,233.0,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0134-C25_treatment8,6b10c105-17b5-49ea-bb83-319a9176be74,,released,Nab-paclitaxel,1,2020-09-17T16:01:02.431006-05:00,Chemotherapy,Residual Disease,
HCM-BROD-0134-C25,e4f98856-8ba9-498d-bbd5-443bb1bf4591,921b4c7a-5691-4d1d-8751-072a79402a9b,,Adjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0134-C25_treatment9,7f3ccec0-d67c-45a1-ac5f-71bf532f830d,,released,,0,2020-09-17T16:01:02.431006-05:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-BROD-0134-C25,e4f98856-8ba9-498d-bbd5-443bb1bf4591,921b4c7a-5691-4d1d-8751-072a79402a9b,,Neoadjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0134-C25_treatment,89601104-0ce0-4767-971d-64f069879e91,,released,,0,2020-09-17T16:01:02.431006-05:00,,,
HCM-BROD-0134-C25,e4f98856-8ba9-498d-bbd5-443bb1bf4591,921b4c7a-5691-4d1d-8751-072a79402a9b,217.0,Adjuvant,7.0,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0134-C25_treatment3,ad2b4c2b-fddf-4e10-ab80-5675b5053c98,,released,Leucovorin Calcium,1,2020-09-17T16:01:02.431006-05:00,Chemotherapy,Residual Disease,
HCM-BROD-0134-C25,e4f98856-8ba9-498d-bbd5-443bb1bf4591,921b4c7a-5691-4d1d-8751-072a79402a9b,217.0,Adjuvant,7.0,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0134-C25_treatment5,bf0fab8c-06b0-411e-b706-d0f07289d9df,,released,Oxaliplatin,1,2020-09-17T16:01:02.431006-05:00,Chemotherapy,Residual Disease,
HCM-BROD-0134-C25,e4f98856-8ba9-498d-bbd5-443bb1bf4591,921b4c7a-5691-4d1d-8751-072a79402a9b,,Adjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0134-C25_treatment12,d7ea86fd-ca06-4147-af65-d7c649974c45,,released,,0,2020-09-17T16:01:02.431006-05:00,"Radiation Therapy, NOS",Residual Disease,
HCM-BROD-0134-C25,e4f98856-8ba9-498d-bbd5-443bb1bf4591,921b4c7a-5691-4d1d-8751-072a79402a9b,217.0,Adjuvant,7.0,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0134-C25_treatment2,eee590e1-32a0-4f54-9835-e0b46e4d43a4,,released,Irinotecan Hydrochloride,1,2020-09-17T16:01:02.431006-05:00,Chemotherapy,Residual Disease,
HCM-WCMC-1284-C67,e4ff1639-9acf-43ee-87e7-207066dcd907,769f3b38-669d-4d95-8a8f-fb301408f726,0.0,Adjuvant,0.0,2025-08-20T09:56:36.143985-05:00,HCM-WCMC-1284-C67_treatment4,6d7bceb0-813c-40e5-9489-6a2ccd722c9d,,released,BCG Vaccine,1,2023-02-27T12:32:18.168412-06:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-WCMC-1284-C67,e4ff1639-9acf-43ee-87e7-207066dcd907,769f3b38-669d-4d95-8a8f-fb301408f726,0.0,Adjuvant,0.0,2025-08-20T09:56:36.143985-05:00,HCM-WCMC-1284-C67_treatment2,81de86b4-2256-4f8f-b470-2258ae2bad2c,,released,Gemcitabine,1,2023-02-27T12:32:18.168412-06:00,Chemotherapy,Residual Disease,
HCM-WCMC-1284-C67,e4ff1639-9acf-43ee-87e7-207066dcd907,769f3b38-669d-4d95-8a8f-fb301408f726,,Adjuvant,,2025-08-20T09:56:36.143985-05:00,HCM-WCMC-1284-C67_treatment3,8cf49c17-9c7e-4887-94cb-4e8e95c6af23,,released,,0,2023-02-27T12:32:18.168412-06:00,Hormone Therapy,Residual Disease,
HCM-WCMC-1284-C67,e4ff1639-9acf-43ee-87e7-207066dcd907,769f3b38-669d-4d95-8a8f-fb301408f726,,Adjuvant,,2025-08-20T09:56:36.143985-05:00,HCM-WCMC-1284-C67_treatment7,942a39db-ee45-44d5-8aae-bdbcc3687f75,,released,,0,2023-02-27T12:32:18.168412-06:00,"Radiation Therapy, NOS",Residual Disease,
HCM-WCMC-1284-C67,e4ff1639-9acf-43ee-87e7-207066dcd907,769f3b38-669d-4d95-8a8f-fb301408f726,,Neoadjuvant,,2025-08-20T09:56:36.143985-05:00,HCM-WCMC-1284-C67_treatment,a7c8545a-a9cf-49da-a2ad-abf7bfc698bd,,released,,0,2023-02-27T12:32:18.168412-06:00,,,
HCM-WCMC-1284-C67,e4ff1639-9acf-43ee-87e7-207066dcd907,769f3b38-669d-4d95-8a8f-fb301408f726,,,0.0,2025-08-20T09:56:36.143985-05:00,HCM-WCMC-1284-C67_treatment5,ddf91559-71ab-4fb9-a09e-38d230e0d57f,,released,,1,2023-02-27T12:32:18.168412-06:00,"Surgery, NOS",Initial Diagnosis,
HCM-WCMC-1284-C67,e4ff1639-9acf-43ee-87e7-207066dcd907,769f3b38-669d-4d95-8a8f-fb301408f726,,Adjuvant,,2025-08-20T09:56:36.143985-05:00,HCM-WCMC-1284-C67_treatment6,fcab203f-6142-48e1-bbd6-0c7b9c1f2d9e,,released,,0,2023-02-27T12:32:18.168412-06:00,Targeted Molecular Therapy,Residual Disease,
HCM-BROD-0007-C49,e506251d-4072-4479-b2ce-5c75387dc7fc,34cda512-45a5-44b8-bc07-0807a5a94149,,Adjuvant,,2021-01-06T22:55:10.531130-06:00,HCM-BROD-0007-C49_treatment15,04f3c2d7-dcef-461a-9278-264b786fface,,released,,0,2020-09-27T09:57:36.711627-05:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-BROD-0007-C49,e506251d-4072-4479-b2ce-5c75387dc7fc,34cda512-45a5-44b8-bc07-0807a5a94149,,Neoadjuvant,,2021-01-06T22:55:10.531130-06:00,HCM-BROD-0007-C49_treatment3,0aaf52e8-2914-4d2a-a675-d9462803b949,,released,Cyclophosphamide,1,2020-02-27T12:02:13.282956-06:00,Chemotherapy,,
HCM-BROD-0007-C49,e506251d-4072-4479-b2ce-5c75387dc7fc,34cda512-45a5-44b8-bc07-0807a5a94149,,Adjuvant,,2021-01-06T22:55:10.531130-06:00,HCM-BROD-0007-C49_treatment18,423e410b-7151-4851-a40e-b48bbe4197ba,,released,,0,2020-09-27T09:57:36.711627-05:00,"Radiation Therapy, NOS",Residual Disease,
HCM-BROD-0007-C49,e506251d-4072-4479-b2ce-5c75387dc7fc,34cda512-45a5-44b8-bc07-0807a5a94149,,Maintenance Therapy,,2021-01-06T22:55:10.531130-06:00,HCM-BROD-0007-C49_treatment9,4ab8f63d-fa87-4934-a2bf-de30d7f09c82,Progressive Disease,released,Cyclophosphamide,1,2020-09-27T09:57:36.711627-05:00,,Progressive Disease,
HCM-BROD-0007-C49,e506251d-4072-4479-b2ce-5c75387dc7fc,34cda512-45a5-44b8-bc07-0807a5a94149,,Maintenance Therapy,,2021-01-06T22:55:10.531130-06:00,HCM-BROD-0007-C49_treatment7,54fceb11-6464-4089-bb04-3a3ecdb1c2f7,Progressive Disease,released,Vincristine,1,2020-02-27T12:02:13.282956-06:00,,Progressive Disease,
HCM-BROD-0007-C49,e506251d-4072-4479-b2ce-5c75387dc7fc,34cda512-45a5-44b8-bc07-0807a5a94149,,Adjuvant,,2021-01-06T22:55:10.531130-06:00,HCM-BROD-0007-C49_treatment14,56127fc4-b80d-4ab6-bcc0-f559e3223ff6,,released,,0,2020-09-27T09:57:36.711627-05:00,Chemotherapy,Residual Disease,
HCM-BROD-0007-C49,e506251d-4072-4479-b2ce-5c75387dc7fc,34cda512-45a5-44b8-bc07-0807a5a94149,,Maintenance Therapy,,2021-01-06T22:55:10.531130-06:00,HCM-BROD-0007-C49_treatment11,56a0bfaf-8fc6-4a9a-889a-d80d0ac2c0e0,Progressive Disease,released,Etoposide,1,2020-09-27T09:57:36.711627-05:00,,Progressive Disease,
HCM-BROD-0007-C49,e506251d-4072-4479-b2ce-5c75387dc7fc,34cda512-45a5-44b8-bc07-0807a5a94149,,Maintenance Therapy,,2021-01-06T22:55:10.531130-06:00,HCM-BROD-0007-C49_treatment12,66a4b550-e517-4671-8351-c4c5b755528e,Progressive Disease,released,,1,2020-09-27T09:57:36.711627-05:00,,Progressive Disease,VDC/IE
HCM-BROD-0007-C49,e506251d-4072-4479-b2ce-5c75387dc7fc,34cda512-45a5-44b8-bc07-0807a5a94149,519.0,Adjuvant,488.0,2021-01-06T22:55:10.531130-06:00,HCM-BROD-0007-C49_treatment17,796ab6d5-6635-40e6-a458-c30c50a393ce,,released,Not Otherwise Specified,1,2020-09-27T09:57:36.711627-05:00,Targeted Molecular Therapy,Residual Disease,
HCM-BROD-0007-C49,e506251d-4072-4479-b2ce-5c75387dc7fc,34cda512-45a5-44b8-bc07-0807a5a94149,,Neoadjuvant,,2021-01-06T22:55:10.531130-06:00,HCM-BROD-0007-C49_treatment13,9461d33f-1673-486e-9c3f-f7e9d3666436,,released,Unknown,1,2020-09-27T09:57:36.711627-05:00,Targeted Molecular Therapy,,
HCM-BROD-0007-C49,e506251d-4072-4479-b2ce-5c75387dc7fc,34cda512-45a5-44b8-bc07-0807a5a94149,,,,2023-02-24T14:48:28.769480-06:00,HCM-BROD-0007-C49_treatment16,a79feec9-50c1-47df-8d5e-980b9b273664,,released,,0,2020-09-27T09:57:36.711627-05:00,"Surgery, NOS",Initial Diagnosis,
HCM-BROD-0007-C49,e506251d-4072-4479-b2ce-5c75387dc7fc,34cda512-45a5-44b8-bc07-0807a5a94149,,Neoadjuvant,,2021-01-06T22:55:10.531130-06:00,HCM-BROD-0007-C49_treatment,aedf5720-9d97-4beb-99a2-d42afbb4db96,,released,Vincristine,1,2020-02-27T12:02:13.282956-06:00,Chemotherapy,,
HCM-BROD-0007-C49,e506251d-4072-4479-b2ce-5c75387dc7fc,34cda512-45a5-44b8-bc07-0807a5a94149,,Maintenance Therapy,,2021-01-06T22:55:10.531130-06:00,HCM-BROD-0007-C49_treatment10,c3f0b075-078d-444d-be05-b8ae3e0c850f,Progressive Disease,released,Doxorubicin,1,2020-09-27T09:57:36.711627-05:00,,Progressive Disease,
HCM-BROD-0007-C49,e506251d-4072-4479-b2ce-5c75387dc7fc,34cda512-45a5-44b8-bc07-0807a5a94149,,Maintenance Therapy,,2021-01-06T22:55:10.531130-06:00,HCM-BROD-0007-C49_treatment8,d8811ce7-b7a4-41e0-8c0f-04e319e904bf,Progressive Disease,released,Ifosfamide,1,2020-02-27T12:02:13.282956-06:00,,Progressive Disease,
HCM-BROD-0007-C49,e506251d-4072-4479-b2ce-5c75387dc7fc,34cda512-45a5-44b8-bc07-0807a5a94149,,Neoadjuvant,,2021-01-06T22:55:10.531130-06:00,HCM-BROD-0007-C49_treatment5,e6504ef2-d403-4388-9a88-c92861600595,,released,Etoposide,1,2020-02-27T12:02:13.282956-06:00,Chemotherapy,,
HCM-BROD-0007-C49,e506251d-4072-4479-b2ce-5c75387dc7fc,34cda512-45a5-44b8-bc07-0807a5a94149,,Neoadjuvant,,2021-01-06T22:55:10.531130-06:00,HCM-BROD-0007-C49_treatment2,f126d2e4-9314-4c0f-81c5-0f92fe22e73d,,released,Ifosfamide,1,2020-02-27T12:02:13.282956-06:00,Chemotherapy,,
HCM-BROD-0007-C49,e506251d-4072-4479-b2ce-5c75387dc7fc,34cda512-45a5-44b8-bc07-0807a5a94149,,Neoadjuvant,,2021-01-06T22:55:10.531130-06:00,HCM-BROD-0007-C49_treatment6,f35369c9-cd84-4c1c-9c16-420a586785d1,,released,,1,2020-02-27T12:02:13.282956-06:00,Chemotherapy,,VDC/IE
HCM-BROD-0007-C49,e506251d-4072-4479-b2ce-5c75387dc7fc,34cda512-45a5-44b8-bc07-0807a5a94149,,Neoadjuvant,,2021-01-06T22:55:10.531130-06:00,HCM-BROD-0007-C49_treatment4,f70a405b-0cb1-48fe-b4cc-90d45199c86e,,released,Doxorubicin,1,2020-02-27T12:02:13.282956-06:00,Chemotherapy,,
HCM-CSHL-0664-C18,e681e4d0-b358-49ad-9ef8-88a32a6acb12,2633b3ed-1180-40d1-8b20-24bfcae3a9a4,2738.0,Adjuvant,2677.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0664-C18_treatment13,358a25cc-740b-467f-b12f-9217d3e3cde5,,released,Cetuximab,1,2021-12-21T14:15:27.479937-06:00,Chemotherapy,Residual Disease,
HCM-CSHL-0664-C18,e681e4d0-b358-49ad-9ef8-88a32a6acb12,2633b3ed-1180-40d1-8b20-24bfcae3a9a4,2404.0,Adjuvant,2223.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0664-C18_treatment11,4abf8c16-c3cd-4e90-aa97-57a847252dd6,,released,,1,2021-12-21T14:15:27.479937-06:00,Chemotherapy,Residual Disease,FOLFOX
HCM-CSHL-0664-C18,e681e4d0-b358-49ad-9ef8-88a32a6acb12,2633b3ed-1180-40d1-8b20-24bfcae3a9a4,,,3210.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0664-C18_treatment15,4f1eef64-eecb-4d30-859f-993076322ccc,,released,,1,2021-12-21T14:15:27.479937-06:00,"Surgery, NOS",Initial Diagnosis,
HCM-CSHL-0664-C18,e681e4d0-b358-49ad-9ef8-88a32a6acb12,2633b3ed-1180-40d1-8b20-24bfcae3a9a4,2404.0,Adjuvant,2223.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0664-C18_treatment10,5070bf18-9516-40b8-9546-5be58e0e5ce0,,released,Fluorouracil,1,2021-12-21T14:15:27.479937-06:00,Chemotherapy,Residual Disease,
HCM-CSHL-0664-C18,e681e4d0-b358-49ad-9ef8-88a32a6acb12,2633b3ed-1180-40d1-8b20-24bfcae3a9a4,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0664-C18_treatment16,5692a9c7-37ec-4e8d-b5e0-dfc57c81fa6c,,released,,0,2021-12-21T14:15:27.479937-06:00,Targeted Molecular Therapy,Residual Disease,
HCM-CSHL-0664-C18,e681e4d0-b358-49ad-9ef8-88a32a6acb12,2633b3ed-1180-40d1-8b20-24bfcae3a9a4,2738.0,Adjuvant,2677.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0664-C18_treatment12,5c03d1a8-acff-45c0-b888-ea33b54e98fb,,released,Irinotecan,1,2021-12-21T14:15:27.479937-06:00,Chemotherapy,Residual Disease,
HCM-CSHL-0664-C18,e681e4d0-b358-49ad-9ef8-88a32a6acb12,2633b3ed-1180-40d1-8b20-24bfcae3a9a4,,Neoadjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0664-C18_treatment,6e45e4cc-909b-446f-ba0b-c77e4746151d,,released,,0,2021-12-21T14:15:27.479937-06:00,,,
HCM-CSHL-0664-C18,e681e4d0-b358-49ad-9ef8-88a32a6acb12,2633b3ed-1180-40d1-8b20-24bfcae3a9a4,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0664-C18_treatment14,795c828c-dd74-419b-8bed-951107ab0098,,released,,0,2021-12-21T14:15:27.479937-06:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-CSHL-0664-C18,e681e4d0-b358-49ad-9ef8-88a32a6acb12,2633b3ed-1180-40d1-8b20-24bfcae3a9a4,2131.0,Adjuvant,1846.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0664-C18_treatment6,7dc57a3c-2556-424e-9288-04d4d1f2a79f,,released,,1,2021-12-21T14:15:27.479937-06:00,Chemotherapy,Residual Disease,FOLFIRI-cetuximab
HCM-CSHL-0664-C18,e681e4d0-b358-49ad-9ef8-88a32a6acb12,2633b3ed-1180-40d1-8b20-24bfcae3a9a4,2131.0,Adjuvant,1846.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0664-C18_treatment3,7f37b340-46a5-405d-a3e7-dd1a4899b1e5,,released,Leucovorin Calcium,1,2021-12-21T14:15:27.479937-06:00,Chemotherapy,Residual Disease,
HCM-CSHL-0664-C18,e681e4d0-b358-49ad-9ef8-88a32a6acb12,2633b3ed-1180-40d1-8b20-24bfcae3a9a4,2131.0,Adjuvant,1846.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0664-C18_treatment4,88727bb7-09d7-4cb3-92b3-2af92f8ecfef,,released,Fluorouracil,1,2021-12-21T14:15:27.479937-06:00,Chemotherapy,Residual Disease,
HCM-CSHL-0664-C18,e681e4d0-b358-49ad-9ef8-88a32a6acb12,2633b3ed-1180-40d1-8b20-24bfcae3a9a4,2131.0,Adjuvant,1846.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0664-C18_treatment2,907d1018-ecee-4b2d-a174-21a3e34d8377,,released,Irinotecan,1,2021-12-21T14:15:27.479937-06:00,Chemotherapy,Residual Disease,
HCM-CSHL-0664-C18,e681e4d0-b358-49ad-9ef8-88a32a6acb12,2633b3ed-1180-40d1-8b20-24bfcae3a9a4,2131.0,Adjuvant,1846.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0664-C18_treatment5,b1318043-5e1c-43d9-a2ce-373b76b61b6f,,released,Cetuximab,1,2021-12-21T14:15:27.479937-06:00,Chemotherapy,Residual Disease,
HCM-CSHL-0664-C18,e681e4d0-b358-49ad-9ef8-88a32a6acb12,2633b3ed-1180-40d1-8b20-24bfcae3a9a4,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0664-C18_treatment17,b9dca538-7d85-4ed3-91d0-ff5941610a77,,released,,0,2021-12-21T14:15:27.479937-06:00,"Radiation Therapy, NOS",Residual Disease,
HCM-CSHL-0664-C18,e681e4d0-b358-49ad-9ef8-88a32a6acb12,2633b3ed-1180-40d1-8b20-24bfcae3a9a4,2404.0,Adjuvant,2223.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0664-C18_treatment9,cb0ac646-7483-4078-a236-a440e7d6ccdf,,released,Leucovorin Calcium,1,2021-12-21T14:15:27.479937-06:00,Chemotherapy,Residual Disease,
HCM-CSHL-0664-C18,e681e4d0-b358-49ad-9ef8-88a32a6acb12,2633b3ed-1180-40d1-8b20-24bfcae3a9a4,2404.0,Adjuvant,2223.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0664-C18_treatment7,dac4565e-f022-4e76-912f-500156993cce,,released,Oxaliplatin,1,2021-12-21T14:15:27.479937-06:00,Chemotherapy,Residual Disease,
HCM-CSHL-0664-C18,e681e4d0-b358-49ad-9ef8-88a32a6acb12,2633b3ed-1180-40d1-8b20-24bfcae3a9a4,2404.0,Adjuvant,2223.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0664-C18_treatment8,e1172b70-b00f-4139-8a74-4ff277ffb858,,released,Bevacizumab,1,2021-12-21T14:15:27.479937-06:00,Chemotherapy,Residual Disease,
HCM-CSHL-0664-C18,e681e4d0-b358-49ad-9ef8-88a32a6acb12,4b4c8f75-32b7-4753-b8e2-0e9b55b13dea,2888.0,Maintenance Therapy,2677.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0664-C18_treatment18,4288c6fd-7991-4861-a3fd-26470296fdd8,Progressive Disease,released,Irinotecan,1,2021-12-21T14:15:27.479937-06:00,,,
HCM-CSHL-0664-C18,e681e4d0-b358-49ad-9ef8-88a32a6acb12,4b4c8f75-32b7-4753-b8e2-0e9b55b13dea,2888.0,Maintenance Therapy,2677.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0664-C18_treatment19,e3fb4333-9385-4204-8239-b71a2de56f24,Progressive Disease,released,Cetuximab,1,2021-12-21T14:15:27.479937-06:00,,,
HCM-SANG-1086-C18,e7448c61-2f2b-49b0-8f10-e7eda3f59444,7fa2f73d-7214-4b96-98cf-641162c3bf57,,Neoadjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-SANG-1086-C18_treatment,4229eb2c-45de-42f3-aba2-498d964d28c0,,released,,0,2023-02-27T11:48:05.553392-06:00,,,
HCM-EXPT-1008-C50,e7d252d1-a6df-4b6d-9e41-1a990db83678,d32cb094-ad2a-4387-a9a9-bc79a78e0108,,Neoadjuvant,,2025-10-08T12:37:43.816130-05:00,HCM-EXPT-1008-C50_treatment,5628f67a-c3d1-4585-b55f-15f0b1ec3a41,,released,,0,2021-12-21T14:54:24.837165-06:00,,,
HCM-SANG-1094-C16,e7ec711b-2d50-44e9-8622-99cb3e4aa4fe,63aad08b-71f9-41a9-a438-7812f7197502,,Neoadjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-SANG-1094-C16_treatment,14202154-82f3-4bc3-b48a-a30535e071cb,,released,,0,2023-02-27T11:24:11.653157-06:00,,,
HCM-CSHL-0063-C18,e802e579-5293-465c-a867-74e290268299,78f75aac-8d68-4525-a68e-0336f44737f6,713.0,Adjuvant,531.0,2020-10-08T19:00:37.191737-05:00,HCM-CSHL-0063-C18_treatment5,0441282f-5049-433d-8c6c-58299c8b5e54,,released,Oxaliplatin,1,2020-02-27T12:40:16.625347-06:00,Chemotherapy,Residual Disease,
HCM-CSHL-0063-C18,e802e579-5293-465c-a867-74e290268299,78f75aac-8d68-4525-a68e-0336f44737f6,713.0,Adjuvant,531.0,2020-10-08T19:00:37.191737-05:00,HCM-CSHL-0063-C18_treatment4,2af5f6a4-9873-412b-9327-aaeeab5d8647,,released,Fluorouracil,1,2020-02-27T12:40:16.625347-06:00,Chemotherapy,Residual Disease,
HCM-CSHL-0063-C18,e802e579-5293-465c-a867-74e290268299,78f75aac-8d68-4525-a68e-0336f44737f6,428.0,Adjuvant,273.0,2020-03-26T16:04:47.706904-05:00,HCM-CSHL-0063-C18_treatment2,56b6b604-b134-484e-8d60-d94d370f60ed,,released,Capecitabine,1,2020-02-27T12:40:16.625347-06:00,Chemotherapy,Residual Disease,
HCM-CSHL-0063-C18,e802e579-5293-465c-a867-74e290268299,78f75aac-8d68-4525-a68e-0336f44737f6,,,196.0,2023-02-27T13:00:51.463665-06:00,HCM-CSHL-0063-C18_treatment8,852f6eef-2ca8-4b5d-84f6-4a09817a275a,,released,,1,2020-10-08T19:00:37.191737-05:00,"Surgery, NOS",Initial Diagnosis,
HCM-CSHL-0063-C18,e802e579-5293-465c-a867-74e290268299,78f75aac-8d68-4525-a68e-0336f44737f6,,Adjuvant,,2020-10-20T19:20:06.800740-05:00,HCM-CSHL-0063-C18_treatment10,a3a2a9fb-d1e9-4501-85bc-cf94699ad1b9,,released,,0,2020-10-08T19:00:37.191737-05:00,"Radiation Therapy, NOS",Residual Disease,
HCM-CSHL-0063-C18,e802e579-5293-465c-a867-74e290268299,78f75aac-8d68-4525-a68e-0336f44737f6,,Neoadjuvant,,2019-05-24T12:11:41.511797-05:00,HCM-CSHL-0063-C18_treatment,ca2e0503-f096-456e-b6ea-7f6743d8707d,,released,,0,2019-05-15T14:59:45.171654-05:00,,,
HCM-CSHL-0063-C18,e802e579-5293-465c-a867-74e290268299,78f75aac-8d68-4525-a68e-0336f44737f6,713.0,Adjuvant,531.0,2020-10-08T19:00:37.191737-05:00,HCM-CSHL-0063-C18_treatment6,d26bdccd-8730-4638-8cae-41afa00f8492,,released,,1,2020-02-27T12:40:16.625347-06:00,Chemotherapy,Residual Disease,FOLFOX
HCM-CSHL-0063-C18,e802e579-5293-465c-a867-74e290268299,78f75aac-8d68-4525-a68e-0336f44737f6,713.0,Adjuvant,531.0,2020-10-08T19:00:37.191737-05:00,HCM-CSHL-0063-C18_treatment3,f0adace6-c319-4f64-a67b-e9513717661b,,released,Leucovorin Calcium,1,2020-02-27T12:40:16.625347-06:00,Chemotherapy,Residual Disease,
HCM-BROD-0099-C15,e89fb71d-dd21-4e48-bb32-0d9435addd84,f4f5f003-75b1-4498-9d6b-bb68aa622040,,Adjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0099-C15_treatment5,0778b42b-f879-4cf3-8b0a-45211b25c13e,,released,,0,2020-09-27T10:23:58.185112-05:00,Targeted Molecular Therapy,Residual Disease,
HCM-BROD-0099-C15,e89fb71d-dd21-4e48-bb32-0d9435addd84,f4f5f003-75b1-4498-9d6b-bb68aa622040,,Adjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0099-C15_treatment6,4f026f79-0a59-4e48-a260-421a9782f9ab,,released,,0,2020-09-27T10:23:58.185112-05:00,"Radiation Therapy, NOS",Residual Disease,
HCM-BROD-0099-C15,e89fb71d-dd21-4e48-bb32-0d9435addd84,f4f5f003-75b1-4498-9d6b-bb68aa622040,,Adjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0099-C15_treatment3,77afaf6d-db26-464b-8b30-ca82918ab572,,released,,0,2020-09-27T10:23:58.185112-05:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-BROD-0099-C15,e89fb71d-dd21-4e48-bb32-0d9435addd84,f4f5f003-75b1-4498-9d6b-bb68aa622040,,,,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0099-C15_treatment4,a3ec967d-6df0-4ea4-b311-fe2b9fe4bdff,,released,,0,2020-09-27T10:23:58.185112-05:00,"Surgery, NOS",Initial Diagnosis,
HCM-BROD-0099-C15,e89fb71d-dd21-4e48-bb32-0d9435addd84,f4f5f003-75b1-4498-9d6b-bb68aa622040,,Adjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0099-C15_treatment2,c2369fb0-5e3a-4d8b-ad88-d9714fa77795,,released,,0,2020-09-27T10:23:58.185112-05:00,Chemotherapy,Residual Disease,
HCM-BROD-0099-C15,e89fb71d-dd21-4e48-bb32-0d9435addd84,f4f5f003-75b1-4498-9d6b-bb68aa622040,,Neoadjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0099-C15_treatment,ee481fed-5bdc-4b44-b4b1-2d9578469f23,,released,,1,2019-04-04T15:51:07.087068-05:00,Chemotherapy,,
HCM-BROD-0709-C64,e8c47711-aab4-4f33-a3d4-d80cd4a8d821,d33040f0-cc95-41a5-85a1-c2dfad84b3b5,,Neoadjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0709-C64_treatment,0ea9d469-9eda-486f-89f5-64177388ec17,,released,,0,2021-12-21T13:46:27.027251-06:00,,,
HCM-BROD-0709-C64,e8c47711-aab4-4f33-a3d4-d80cd4a8d821,d33040f0-cc95-41a5-85a1-c2dfad84b3b5,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0709-C64_treatment2,2398f92e-2dff-4cd2-a2ea-efe90f00f6f7,,released,,0,2021-12-21T13:46:27.027251-06:00,Chemotherapy,Residual Disease,
HCM-BROD-0709-C64,e8c47711-aab4-4f33-a3d4-d80cd4a8d821,d33040f0-cc95-41a5-85a1-c2dfad84b3b5,,,0.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0709-C64_treatment5,258af527-1da8-4e15-ae8b-74ae1d094635,,released,,1,2021-12-21T13:46:27.027251-06:00,"Surgery, NOS",Initial Diagnosis,
HCM-BROD-0709-C64,e8c47711-aab4-4f33-a3d4-d80cd4a8d821,d33040f0-cc95-41a5-85a1-c2dfad84b3b5,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0709-C64_treatment7,656ee1d2-7296-486f-85ab-379b31fceb14,,released,,0,2021-12-21T13:46:27.027251-06:00,"Radiation Therapy, NOS",Residual Disease,
HCM-BROD-0709-C64,e8c47711-aab4-4f33-a3d4-d80cd4a8d821,d33040f0-cc95-41a5-85a1-c2dfad84b3b5,770.0,Adjuvant,511.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0709-C64_treatment6,c0aa57cf-b1ae-4585-881b-2a68689eacf8,Treatment Ongoing,released,Cabozantinib,1,2021-12-21T13:46:27.027251-06:00,Targeted Molecular Therapy,Residual Disease,
HCM-BROD-0709-C64,e8c47711-aab4-4f33-a3d4-d80cd4a8d821,d33040f0-cc95-41a5-85a1-c2dfad84b3b5,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0709-C64_treatment3,c8d9d990-d5d5-4d54-bd50-4c8cecddccf2,,released,,0,2021-12-21T13:46:27.027251-06:00,Hormone Therapy,Residual Disease,
HCM-BROD-0709-C64,e8c47711-aab4-4f33-a3d4-d80cd4a8d821,d33040f0-cc95-41a5-85a1-c2dfad84b3b5,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0709-C64_treatment4,e3cfc14c-6edc-43a7-bc4d-ca95f40f939f,,released,,0,2021-12-21T13:46:27.027251-06:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-BROD-0356-C16,e8feb714-c8fc-4cc7-a139-36267ac147a2,646b3bfc-faf6-4816-a92b-267060dc99b4,,Neoadjuvant,65.0,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0356-C16_treatment2,1a5a525f-6d45-4ec6-8d99-a758bf10e64d,,released,,1,2020-09-17T16:11:20.651412-05:00,"Radiation Therapy, NOS",,
HCM-BROD-0356-C16,e8feb714-c8fc-4cc7-a139-36267ac147a2,646b3bfc-faf6-4816-a92b-267060dc99b4,,Neoadjuvant,37.0,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0356-C16_treatment,77e0b3fb-ab8f-4f4a-8b6b-c6c157597849,,released,Carboplatin,1,2020-09-17T16:11:20.651412-05:00,Chemotherapy,,
HCM-BROD-0356-C16,e8feb714-c8fc-4cc7-a139-36267ac147a2,646b3bfc-faf6-4816-a92b-267060dc99b4,,Adjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0356-C16_treatment7,8e350734-374b-4fa7-a454-913ea79bad44,,released,,0,2020-09-17T16:11:20.651412-05:00,"Radiation Therapy, NOS",Residual Disease,
HCM-BROD-0356-C16,e8feb714-c8fc-4cc7-a139-36267ac147a2,646b3bfc-faf6-4816-a92b-267060dc99b4,,Adjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0356-C16_treatment4,96db89b3-e484-440a-9d8f-a9fc4dbde753,,released,,0,2020-09-17T16:11:20.651412-05:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-BROD-0356-C16,e8feb714-c8fc-4cc7-a139-36267ac147a2,646b3bfc-faf6-4816-a92b-267060dc99b4,,Adjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0356-C16_treatment3,d88d3c11-9f38-4a0d-b3a2-9063be54af78,,released,,0,2020-09-17T16:11:20.651412-05:00,Chemotherapy,Residual Disease,
HCM-BROD-0356-C16,e8feb714-c8fc-4cc7-a139-36267ac147a2,646b3bfc-faf6-4816-a92b-267060dc99b4,,,140.0,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0356-C16_treatment5,fae466aa-13aa-4f0f-9c1d-6bff5aadf294,,released,,1,2020-09-17T16:11:20.651412-05:00,"Surgery, NOS",Initial Diagnosis,
HCM-BROD-0356-C16,e8feb714-c8fc-4cc7-a139-36267ac147a2,646b3bfc-faf6-4816-a92b-267060dc99b4,,Adjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0356-C16_treatment6,fc937955-e34b-469a-a0de-8c34b4ca073e,,released,,0,2020-09-17T16:11:20.651412-05:00,Targeted Molecular Therapy,Residual Disease,
HCM-BROD-0130-C25,e9615c7c-0e14-45bc-a58e-ce3afbb6d40d,aacad1a2-5ef1-43f5-9187-4ad1adae42d4,,,,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0130-C25_treatment17,17ba9b6e-9611-48b0-b400-227a76e43961,,released,,0,2020-09-17T15:58:56.367246-05:00,"Surgery, NOS",Initial Diagnosis,
HCM-BROD-0130-C25,e9615c7c-0e14-45bc-a58e-ce3afbb6d40d,aacad1a2-5ef1-43f5-9187-4ad1adae42d4,61.0,Adjuvant,6.0,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0130-C25_treatment11,1aa75541-2b4f-429e-a3ea-d8773ebe73e9,,released,Fluorouracil,1,2020-09-17T15:58:56.367246-05:00,Chemotherapy,Residual Disease,
HCM-BROD-0130-C25,e9615c7c-0e14-45bc-a58e-ce3afbb6d40d,aacad1a2-5ef1-43f5-9187-4ad1adae42d4,,Neoadjuvant,6.0,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0130-C25_treatment3,1bf1e861-c82b-4cd6-9bd1-ae1e52eeae71,,released,Fluorouracil,1,2020-09-17T15:58:56.367246-05:00,Chemotherapy,,
HCM-BROD-0130-C25,e9615c7c-0e14-45bc-a58e-ce3afbb6d40d,aacad1a2-5ef1-43f5-9187-4ad1adae42d4,262.0,Adjuvant,262.0,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0130-C25_treatment19,3bcd3c20-d32e-43e5-87be-d9323fd1b6d2,,released,,1,2020-09-17T15:58:56.367246-05:00,"Radiation Therapy, NOS",Residual Disease,
HCM-BROD-0130-C25,e9615c7c-0e14-45bc-a58e-ce3afbb6d40d,aacad1a2-5ef1-43f5-9187-4ad1adae42d4,,Neoadjuvant,6.0,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0130-C25_treatment2,6275d342-a243-4a90-b977-e8f67d1ee338,,released,Leucovorin Calcium,1,2020-09-17T15:58:56.367246-05:00,Chemotherapy,,
HCM-BROD-0130-C25,e9615c7c-0e14-45bc-a58e-ce3afbb6d40d,aacad1a2-5ef1-43f5-9187-4ad1adae42d4,61.0,Adjuvant,6.0,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0130-C25_treatment9,62d4375f-efda-4c2e-993e-bbd30741a262,,released,Irinotecan Hydrochloride,1,2020-09-17T15:58:56.367246-05:00,Chemotherapy,Residual Disease,
HCM-BROD-0130-C25,e9615c7c-0e14-45bc-a58e-ce3afbb6d40d,aacad1a2-5ef1-43f5-9187-4ad1adae42d4,236.0,Adjuvant,124.0,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0130-C25_treatment14,63ed7933-b79c-429c-a5b9-326b76ad2830,,released,Gemcitabine,1,2020-09-17T15:58:56.367246-05:00,Chemotherapy,Residual Disease,
HCM-BROD-0130-C25,e9615c7c-0e14-45bc-a58e-ce3afbb6d40d,aacad1a2-5ef1-43f5-9187-4ad1adae42d4,61.0,Adjuvant,6.0,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0130-C25_treatment13,63f3555f-007c-4217-828f-4feaa951b5c5,,released,,1,2020-09-17T15:58:56.367246-05:00,Chemotherapy,Residual Disease,FOLFIRINOX
HCM-BROD-0130-C25,e9615c7c-0e14-45bc-a58e-ce3afbb6d40d,aacad1a2-5ef1-43f5-9187-4ad1adae42d4,,Adjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0130-C25_treatment18,6410be36-110e-4e89-a12f-c8062e3d34c4,,released,,0,2020-09-17T15:58:56.367246-05:00,Targeted Molecular Therapy,Residual Disease,
HCM-BROD-0130-C25,e9615c7c-0e14-45bc-a58e-ce3afbb6d40d,aacad1a2-5ef1-43f5-9187-4ad1adae42d4,,Neoadjuvant,6.0,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0130-C25_treatment4,7990ca86-f806-472f-aa34-417c5d87d0ae,,released,Oxaliplatin,1,2020-09-17T15:58:56.367246-05:00,Chemotherapy,,
HCM-BROD-0130-C25,e9615c7c-0e14-45bc-a58e-ce3afbb6d40d,aacad1a2-5ef1-43f5-9187-4ad1adae42d4,61.0,Adjuvant,6.0,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0130-C25_treatment10,800c88d4-0f86-4feb-a1d6-dd70282f16ef,,released,Leucovorin Calcium,1,2020-09-17T15:58:56.367246-05:00,Chemotherapy,Residual Disease,
HCM-BROD-0130-C25,e9615c7c-0e14-45bc-a58e-ce3afbb6d40d,aacad1a2-5ef1-43f5-9187-4ad1adae42d4,,Neoadjuvant,6.0,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0130-C25_treatment,8ed6217a-20c9-4094-b58c-487f303c76e8,,released,Irinotecan Hydrochloride,1,2020-09-17T15:58:56.367246-05:00,Chemotherapy,,
HCM-BROD-0130-C25,e9615c7c-0e14-45bc-a58e-ce3afbb6d40d,aacad1a2-5ef1-43f5-9187-4ad1adae42d4,,Adjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0130-C25_treatment16,90dbd512-4c4a-41c8-82e7-151db7ab44e0,,released,,0,2020-09-17T15:58:56.367246-05:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-BROD-0130-C25,e9615c7c-0e14-45bc-a58e-ce3afbb6d40d,aacad1a2-5ef1-43f5-9187-4ad1adae42d4,236.0,Adjuvant,124.0,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0130-C25_treatment15,92e32e54-24ab-4c1d-b4f5-f98cdbe4b735,,released,Nab-paclitaxel,1,2020-09-17T15:58:56.367246-05:00,Chemotherapy,Residual Disease,
HCM-BROD-0130-C25,e9615c7c-0e14-45bc-a58e-ce3afbb6d40d,aacad1a2-5ef1-43f5-9187-4ad1adae42d4,,Neoadjuvant,6.0,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0130-C25_treatment6,9a08ba2f-4130-4bf6-8b4f-6eda6f510154,,released,Gemcitabine,1,2020-09-17T15:58:56.367246-05:00,Chemotherapy,,
HCM-BROD-0130-C25,e9615c7c-0e14-45bc-a58e-ce3afbb6d40d,aacad1a2-5ef1-43f5-9187-4ad1adae42d4,,Neoadjuvant,6.0,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0130-C25_treatment5,a2d0292d-cf9a-4a8d-88be-c5e3f9d481ab,,released,,1,2020-09-17T15:58:56.367246-05:00,Chemotherapy,,FOLFIRINOX
HCM-BROD-0130-C25,e9615c7c-0e14-45bc-a58e-ce3afbb6d40d,aacad1a2-5ef1-43f5-9187-4ad1adae42d4,,Neoadjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0130-C25_treatment8,b2bb02d7-31e1-4727-9bd3-524564c562d2,,released,,1,2020-09-17T15:58:56.367246-05:00,"Radiation Therapy, NOS",,
HCM-BROD-0130-C25,e9615c7c-0e14-45bc-a58e-ce3afbb6d40d,aacad1a2-5ef1-43f5-9187-4ad1adae42d4,,Neoadjuvant,6.0,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0130-C25_treatment7,b9572557-b719-43eb-90a2-1ffe9d543618,,released,Nab-paclitaxel,1,2020-09-17T15:58:56.367246-05:00,Chemotherapy,,
HCM-BROD-0130-C25,e9615c7c-0e14-45bc-a58e-ce3afbb6d40d,aacad1a2-5ef1-43f5-9187-4ad1adae42d4,61.0,Adjuvant,6.0,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0130-C25_treatment12,c63c616c-1294-4fd8-b9f8-0b235a347deb,,released,Oxaliplatin,1,2020-09-17T15:58:56.367246-05:00,Chemotherapy,Residual Disease,
HCM-SANG-0285-C18,e980e3c5-a9fb-42ad-ad02-b8bedc54ce23,25cd8725-77e8-4a55-b5d5-24787f44615d,,Neoadjuvant,,2023-03-13T12:48:22.226715-05:00,HCM-SANG-0285-C18_treatment,bccdc33c-eadf-45fa-a7db-52950f6974c1,,released,,0,2021-12-21T15:08:33.270418-06:00,,,
HCM-EXPT-0997-C18,e9e4b631-4c65-40d2-9ce9-f6758269f229,b956ea47-d01a-41d5-9468-d61492802560,,Neoadjuvant,,2025-10-08T12:37:21.548354-05:00,HCM-EXPT-0997-C18_treatment,79630691-5c8a-4431-b716-fb648d28429a,,released,,0,2021-12-21T14:52:40.234208-06:00,,,
HCM-CSHL-0726-C18,ea53b476-afdd-4df7-bfbb-c3fac39319f7,1907a1b0-9675-42d3-8a6c-fe1fd68f873a,544.0,Maintenance Therapy,453.0,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0726-C18_treatment17,0adbd60f-6309-41c0-9e9c-34a71b35b76f,Treatment Ongoing,released,Leucovorin Calcium,1,2021-12-21T14:18:47.639394-06:00,,,
HCM-CSHL-0726-C18,ea53b476-afdd-4df7-bfbb-c3fac39319f7,1907a1b0-9675-42d3-8a6c-fe1fd68f873a,544.0,Maintenance Therapy,453.0,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0726-C18_treatment19,3db6c1bb-172f-4fc0-a94f-5b28a7b80dea,Treatment Ongoing,released,Oxaliplatin,1,2021-12-21T14:18:47.639394-06:00,,,
HCM-CSHL-0726-C18,ea53b476-afdd-4df7-bfbb-c3fac39319f7,1907a1b0-9675-42d3-8a6c-fe1fd68f873a,544.0,Maintenance Therapy,453.0,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0726-C18_treatment18,5784f420-577d-44cc-9d3f-aa93e1ba5aec,Treatment Ongoing,released,Fluorouracil,1,2021-12-21T14:18:47.639394-06:00,,,
HCM-CSHL-0726-C18,ea53b476-afdd-4df7-bfbb-c3fac39319f7,1907a1b0-9675-42d3-8a6c-fe1fd68f873a,544.0,Maintenance Therapy,453.0,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0726-C18_treatment20,9b6ba664-0be0-485c-bc39-38824246b37e,Treatment Ongoing,released,,1,2021-12-21T14:18:47.639394-06:00,,,FOLFOX
HCM-CSHL-0726-C18,ea53b476-afdd-4df7-bfbb-c3fac39319f7,1907a1b0-9675-42d3-8a6c-fe1fd68f873a,544.0,Maintenance Therapy,453.0,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0726-C18_treatment16,dce4f577-2114-4153-80f7-08357ff5f977,Treatment Ongoing,released,Bevacizumab,1,2021-12-21T14:18:47.639394-06:00,,,
HCM-CSHL-0726-C18,ea53b476-afdd-4df7-bfbb-c3fac39319f7,63bdd3c8-da01-4602-a660-aa43b24e2216,1147.0,Adjuvant,1078.0,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0726-C18_treatment14,04828ea4-3b50-4a86-8be4-92abbc46e843,,released,Regorafenib,1,2021-12-21T14:18:47.639394-06:00,Targeted Molecular Therapy,Residual Disease,
HCM-CSHL-0726-C18,ea53b476-afdd-4df7-bfbb-c3fac39319f7,63bdd3c8-da01-4602-a660-aa43b24e2216,1098.0,Adjuvant,972.0,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0726-C18_treatment6,0c9b994c-bd83-442a-b50f-3aeb1a90fb9d,,released,Leucovorin Calcium,1,2021-12-21T14:18:47.639394-06:00,Chemotherapy,Residual Disease,
HCM-CSHL-0726-C18,ea53b476-afdd-4df7-bfbb-c3fac39319f7,63bdd3c8-da01-4602-a660-aa43b24e2216,,Neoadjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0726-C18_treatment,3fd9aaac-f811-4d1a-9b92-a8768e6cb29f,,released,,0,2021-12-21T14:18:47.639394-06:00,,,
HCM-CSHL-0726-C18,ea53b476-afdd-4df7-bfbb-c3fac39319f7,63bdd3c8-da01-4602-a660-aa43b24e2216,1098.0,Adjuvant,972.0,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0726-C18_treatment7,455cfa0c-26b7-4625-9cf5-4cc2231745d6,,released,Fluorouracil,1,2021-12-21T14:18:47.639394-06:00,Chemotherapy,Residual Disease,
HCM-CSHL-0726-C18,ea53b476-afdd-4df7-bfbb-c3fac39319f7,63bdd3c8-da01-4602-a660-aa43b24e2216,,Adjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0726-C18_treatment10,4a68f2a9-8743-4863-b241-6755df8a0df5,,released,,0,2021-12-21T14:18:47.639394-06:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-CSHL-0726-C18,ea53b476-afdd-4df7-bfbb-c3fac39319f7,63bdd3c8-da01-4602-a660-aa43b24e2216,544.0,Adjuvant,454.0,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0726-C18_treatment3,56541426-d9df-43e5-a7c8-dfd3d743da11,,released,Fluorouracil,1,2021-12-21T14:18:47.639394-06:00,Chemotherapy,Residual Disease,
HCM-CSHL-0726-C18,ea53b476-afdd-4df7-bfbb-c3fac39319f7,63bdd3c8-da01-4602-a660-aa43b24e2216,1050.0,Adjuvant,1050.0,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0726-C18_treatment15,8214386a-68de-4084-be4c-8e4fcfdd6717,,released,,1,2021-12-21T14:18:47.639394-06:00,"Radiation, Stereotactic/Gamma Knife/SRS",Residual Disease,
HCM-CSHL-0726-C18,ea53b476-afdd-4df7-bfbb-c3fac39319f7,63bdd3c8-da01-4602-a660-aa43b24e2216,544.0,Adjuvant,454.0,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0726-C18_treatment4,8cfe7ef7-4dd6-499a-b7cf-2fa0796d81c6,,released,Oxaliplatin,1,2021-12-21T14:18:47.639394-06:00,Chemotherapy,Residual Disease,
HCM-CSHL-0726-C18,ea53b476-afdd-4df7-bfbb-c3fac39319f7,63bdd3c8-da01-4602-a660-aa43b24e2216,,,36.0,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0726-C18_treatment11,c12c6f66-d1fa-4622-a5bb-137beb399656,,released,,1,2021-12-21T14:18:47.639394-06:00,"Surgery, NOS",Initial Diagnosis,
HCM-CSHL-0726-C18,ea53b476-afdd-4df7-bfbb-c3fac39319f7,63bdd3c8-da01-4602-a660-aa43b24e2216,544.0,Adjuvant,454.0,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0726-C18_treatment2,ce3b85fc-a240-429f-ba02-c40d625567f4,,released,Leucovorin Calcium,1,2021-12-21T14:18:47.639394-06:00,Chemotherapy,Residual Disease,
HCM-CSHL-0726-C18,ea53b476-afdd-4df7-bfbb-c3fac39319f7,63bdd3c8-da01-4602-a660-aa43b24e2216,1098.0,Adjuvant,972.0,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0726-C18_treatment9,d980645b-2815-4c69-b14e-0e0539d4731e,,released,,1,2021-12-21T14:18:47.639394-06:00,Chemotherapy,Residual Disease,FOLFIRI
HCM-CSHL-0726-C18,ea53b476-afdd-4df7-bfbb-c3fac39319f7,63bdd3c8-da01-4602-a660-aa43b24e2216,1098.0,Adjuvant,972.0,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0726-C18_treatment13,e7890655-5d47-4ec5-870e-032831aacf6a,,released,Ramucirumab,1,2021-12-21T14:18:47.639394-06:00,Targeted Molecular Therapy,Residual Disease,
HCM-CSHL-0726-C18,ea53b476-afdd-4df7-bfbb-c3fac39319f7,63bdd3c8-da01-4602-a660-aa43b24e2216,544.0,Adjuvant,454.0,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0726-C18_treatment12,ee183e33-588f-41bd-a712-19f68dc8c2f4,,released,Bevacizumab,1,2021-12-21T14:18:47.639394-06:00,Targeted Molecular Therapy,Residual Disease,
HCM-CSHL-0726-C18,ea53b476-afdd-4df7-bfbb-c3fac39319f7,63bdd3c8-da01-4602-a660-aa43b24e2216,1098.0,Adjuvant,972.0,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0726-C18_treatment8,f2bc1fb7-10f5-4448-a6b4-5f58f533cc03,,released,Irinotecan,1,2021-12-21T14:18:47.639394-06:00,Chemotherapy,Residual Disease,
HCM-CSHL-0726-C18,ea53b476-afdd-4df7-bfbb-c3fac39319f7,63bdd3c8-da01-4602-a660-aa43b24e2216,544.0,Adjuvant,454.0,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0726-C18_treatment5,fe57d3cb-461a-4f22-823d-3828aae02f7a,,released,,1,2021-12-21T14:18:47.639394-06:00,Chemotherapy,Residual Disease,FOLFOX
HCM-BROD-0038-C41,ea983695-b464-44d5-afe7-c5ab4366aad7,90443dfd-faed-41fd-abb5-3d8ddccd1b60,,Adjuvant,610.0,2023-02-22T07:39:25.979291-06:00,HCM-BROD-0038-C41_treatment6,2d23f78b-4570-488b-ab82-dfe7adfd2b48,,released,Etoposide,1,2019-04-03T18:06:48.774309-05:00,Chemotherapy,Residual Disease,
HCM-BROD-0038-C41,ea983695-b464-44d5-afe7-c5ab4366aad7,90443dfd-faed-41fd-abb5-3d8ddccd1b60,,Neoadjuvant,0.0,2023-02-22T07:39:25.979291-06:00,HCM-BROD-0038-C41_treatment4,48b6c432-33bd-44d6-8410-b7bcec8e2df6,,released,,1,2019-04-03T18:06:48.774309-05:00,Chemotherapy,,MAP
HCM-BROD-0038-C41,ea983695-b464-44d5-afe7-c5ab4366aad7,90443dfd-faed-41fd-abb5-3d8ddccd1b60,,Adjuvant,,2023-02-22T07:39:25.979291-06:00,HCM-BROD-0038-C41_treatment10,4cc32729-7d06-4f2c-b254-9b0a92f9ec1d,,released,,0,2020-09-27T10:12:49.245808-05:00,"Radiation Therapy, NOS",Residual Disease,
HCM-BROD-0038-C41,ea983695-b464-44d5-afe7-c5ab4366aad7,90443dfd-faed-41fd-abb5-3d8ddccd1b60,,Adjuvant,,2023-02-22T07:39:25.979291-06:00,HCM-BROD-0038-C41_treatment7,889de307-2abd-4ff0-9ef3-bc1ca54c37f0,,released,,0,2020-09-27T10:12:49.245808-05:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-BROD-0038-C41,ea983695-b464-44d5-afe7-c5ab4366aad7,90443dfd-faed-41fd-abb5-3d8ddccd1b60,,Neoadjuvant,0.0,2023-02-22T07:39:25.979291-06:00,HCM-BROD-0038-C41_treatment2,9653417c-6809-43a5-872e-b36e0df26601,,released,Methotrexate,1,2019-04-03T18:06:48.774309-05:00,Chemotherapy,,
HCM-BROD-0038-C41,ea983695-b464-44d5-afe7-c5ab4366aad7,90443dfd-faed-41fd-abb5-3d8ddccd1b60,,Adjuvant,610.0,2023-02-22T07:39:25.979291-06:00,HCM-BROD-0038-C41_treatment5,a5a7165f-74f6-46ca-be81-5dae3efe827a,,released,Ifosfamide,1,2019-04-03T18:06:48.774309-05:00,Chemotherapy,Residual Disease,
HCM-BROD-0038-C41,ea983695-b464-44d5-afe7-c5ab4366aad7,90443dfd-faed-41fd-abb5-3d8ddccd1b60,,Neoadjuvant,0.0,2023-02-22T07:39:25.979291-06:00,HCM-BROD-0038-C41_treatment3,d2271219-b629-4de3-820f-7dbb79d57077,,released,Cisplatin,1,2019-04-03T18:06:48.774309-05:00,Chemotherapy,,
HCM-BROD-0038-C41,ea983695-b464-44d5-afe7-c5ab4366aad7,90443dfd-faed-41fd-abb5-3d8ddccd1b60,,Adjuvant,549.0,2023-02-22T07:39:25.979291-06:00,HCM-BROD-0038-C41_treatment9,df59610a-32d2-4db8-849f-3ca35cf19a4a,,released,Sorafenib,1,2020-09-27T10:12:49.245808-05:00,Targeted Molecular Therapy,Residual Disease,
HCM-BROD-0038-C41,ea983695-b464-44d5-afe7-c5ab4366aad7,90443dfd-faed-41fd-abb5-3d8ddccd1b60,,Neoadjuvant,0.0,2023-02-22T07:39:25.979291-06:00,HCM-BROD-0038-C41_treatment,e0948e8e-1c1b-46e7-a764-86b026926212,,released,Doxorubicin,1,2019-04-03T18:06:48.774309-05:00,Chemotherapy,,
HCM-SANG-1309-C25,eab27cd5-9c85-442a-8b4a-7bf161c23d7a,6b538bda-1f56-4e79-816a-fe2f172f5299,,Neoadjuvant,96.0,2025-04-07T17:13:09.336794-05:00,HCM-SANG-1309-C25_treatment,58c00fe9-c88a-4713-9d0f-1d1cb1988872,,released,Capecitabine,1,2023-02-27T11:57:30.755234-06:00,Chemotherapy,,
HCM-SANG-1309-C25,eab27cd5-9c85-442a-8b4a-7bf161c23d7a,6b538bda-1f56-4e79-816a-fe2f172f5299,,Neoadjuvant,96.0,2025-04-07T17:13:09.336794-05:00,HCM-SANG-1309-C25_treatment2,5c6ab1ed-a364-439d-a1f1-274ea46cde94,,released,Gemcitabine,1,2023-02-27T11:57:30.755234-06:00,Chemotherapy,,
HCM-SANG-0283-C18,eb537fd2-ac06-4f63-8c0a-0ca73dd06a3a,f899b712-5afc-4dd3-a81d-0c0b733d17e3,,Neoadjuvant,,2023-03-13T13:28:42.971924-05:00,HCM-SANG-0283-C18_treatment,e3c2acc3-e2f2-4ef1-a0ec-17650950c074,,released,,0,2021-07-06T11:32:07.490834-05:00,,,
HCM-EXPT-1222-C15,eba34bc0-8bf7-4a99-90e8-356dcefdf1e5,b0b27ffd-db21-458e-9251-e8a027c0d10e,,Neoadjuvant,100.0,2025-10-08T12:39:14.406630-05:00,HCM-EXPT-1222-C15_treatment3,310182af-da15-47c3-b0a0-de03024fb5de,,released,Oxaliplatin,1,2023-02-24T14:06:35.178936-06:00,Chemotherapy,,
HCM-EXPT-1222-C15,eba34bc0-8bf7-4a99-90e8-356dcefdf1e5,b0b27ffd-db21-458e-9251-e8a027c0d10e,,Neoadjuvant,100.0,2025-10-08T12:39:14.406630-05:00,HCM-EXPT-1222-C15_treatment,d6a80ef7-a377-43e5-b5b7-c49c6b1fded5,,released,Epirubicin,1,2023-02-24T14:06:35.178936-06:00,Chemotherapy,,
HCM-EXPT-1222-C15,eba34bc0-8bf7-4a99-90e8-356dcefdf1e5,b0b27ffd-db21-458e-9251-e8a027c0d10e,,Neoadjuvant,100.0,2025-10-08T12:39:14.406630-05:00,HCM-EXPT-1222-C15_treatment2,dd20cad7-b4d5-4609-9da7-477cc31d87ea,,released,Fluorouracil,1,2023-02-24T14:06:35.178936-06:00,Chemotherapy,,
HCM-CSHL-0322-C20,ebbca85e-a234-4794-9825-4780144cfe7a,721148e8-94ba-4013-aa4f-160c521aa487,,Neoadjuvant,,2023-02-22T07:39:25.979291-06:00,HCM-CSHL-0322-C20_treatment,0fe309bc-00c3-4ead-8e8d-03300ea3dfb7,,released,,0,2020-06-15T13:22:54.567032-05:00,,,
HCM-CSHL-0322-C20,ebbca85e-a234-4794-9825-4780144cfe7a,721148e8-94ba-4013-aa4f-160c521aa487,,Adjuvant,,2023-03-13T13:19:18.727260-05:00,HCM-CSHL-0322-C20_treatment4,6da75c5c-f037-4daf-ba0c-cbe4a3fabdec,,released,,0,2020-06-15T13:22:54.567032-05:00,"Radiation Therapy, NOS",Residual Disease,
HCM-CSHL-0322-C20,ebbca85e-a234-4794-9825-4780144cfe7a,721148e8-94ba-4013-aa4f-160c521aa487,,Adjuvant,,2023-03-13T13:19:18.727260-05:00,HCM-CSHL-0322-C20_treatment3,cbadaf9d-b6b3-419c-bbd9-4425ad3e302d,,released,,0,2020-06-15T13:22:54.567032-05:00,"Pharmaceutical Therapy, NOS",Residual Disease,
HCM-CSHL-0322-C20,ebbca85e-a234-4794-9825-4780144cfe7a,721148e8-94ba-4013-aa4f-160c521aa487,,,22.0,2023-03-13T13:19:18.727260-05:00,HCM-CSHL-0322-C20_treatment2,e4f48d9e-4acb-4d9d-953d-84faf8b0ba55,,released,,1,2020-06-15T13:22:54.567032-05:00,"Surgery, NOS",Initial Diagnosis,
HCM-SANG-1306-C25,ec45b9c0-f668-43f6-90cb-3d5bc9931b80,dbebc5ba-7319-48f5-b315-a81e2dd1dc1d,,Neoadjuvant,188.0,2025-04-07T17:13:09.336794-05:00,HCM-SANG-1306-C25_treatment3,81badd50-007f-4e9b-9262-d3f2a25ea82c,,released,Nab-paclitaxel,1,2023-02-27T12:03:43.180400-06:00,Chemotherapy,,
HCM-SANG-1306-C25,ec45b9c0-f668-43f6-90cb-3d5bc9931b80,dbebc5ba-7319-48f5-b315-a81e2dd1dc1d,,Neoadjuvant,188.0,2025-04-07T17:13:09.336794-05:00,HCM-SANG-1306-C25_treatment,85492fce-b6a3-495d-8efc-ed5defaf9044,,released,Cisplatin,1,2023-02-27T12:03:43.180400-06:00,Chemotherapy,,
HCM-SANG-1306-C25,ec45b9c0-f668-43f6-90cb-3d5bc9931b80,dbebc5ba-7319-48f5-b315-a81e2dd1dc1d,,Neoadjuvant,188.0,2025-04-07T17:13:09.336794-05:00,HCM-SANG-1306-C25_treatment2,8e64f1d9-8332-4840-9f99-6e2dd2fdc211,,released,Gemcitabine,1,2023-02-27T12:03:43.180400-06:00,Chemotherapy,,
HCM-CSHL-0077-C25,ecf740ab-ecd5-4a85-94be-e0610463c72f,a33b3df7-05d2-42d7-9fbc-17e48d5cf3bf,,Adjuvant,,2023-02-22T07:39:25.979291-06:00,HCM-CSHL-0077-C25_treatment7,38c7fa2c-afd9-4f9b-a0fa-20fee0de785a,,released,,0,2020-09-27T12:46:38.869276-05:00,Targeted Molecular Therapy,Residual Disease,
HCM-CSHL-0077-C25,ecf740ab-ecd5-4a85-94be-e0610463c72f,a33b3df7-05d2-42d7-9fbc-17e48d5cf3bf,,Adjuvant,329.0,2023-02-22T07:39:25.979291-06:00,HCM-CSHL-0077-C25_treatment2,678a80be-9718-4a4c-a3b8-b4ff9cc854f4,,released,Gemcitabine,1,2020-09-27T12:46:38.869276-05:00,Chemotherapy,Residual Disease,
HCM-CSHL-0077-C25,ecf740ab-ecd5-4a85-94be-e0610463c72f,a33b3df7-05d2-42d7-9fbc-17e48d5cf3bf,,Adjuvant,329.0,2023-02-22T07:39:25.979291-06:00,HCM-CSHL-0077-C25_treatment3,86e9ba2d-9f5c-4808-8aa4-407965d3f8f6,,released,Nab-paclitaxel,1,2020-09-27T12:46:38.869276-05:00,Chemotherapy,Residual Disease,
HCM-CSHL-0077-C25,ecf740ab-ecd5-4a85-94be-e0610463c72f,a33b3df7-05d2-42d7-9fbc-17e48d5cf3bf,,Adjuvant,,2023-02-22T07:39:25.979291-06:00,HCM-CSHL-0077-C25_treatment8,c71e38be-9ef4-4dbf-99c6-eda22bffd42f,,released,,0,2020-09-27T12:46:38.869276-05:00,"Radiation Therapy, NOS",Residual Disease,
HCM-CSHL-0077-C25,ecf740ab-ecd5-4a85-94be-e0610463c72f,a33b3df7-05d2-42d7-9fbc-17e48d5cf3bf,,Neoadjuvant,,2023-02-22T07:39:25.979291-06:00,HCM-CSHL-0077-C25_treatment,ccd0533b-cec2-4727-a1c2-f039759ceed8,,released,,0,2020-09-27T12:46:38.869276-05:00,,,
HCM-CSHL-0077-C25,ecf740ab-ecd5-4a85-94be-e0610463c72f,a33b3df7-05d2-42d7-9fbc-17e48d5cf3bf,,Adjuvant,,2023-02-22T07:39:25.979291-06:00,HCM-CSHL-0077-C25_treatment5,e032abbc-fe30-4db2-9f04-25e39a0ff754,,released,,0,2020-09-27T12:46:38.869276-05:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-CSHL-0077-C25,ecf740ab-ecd5-4a85-94be-e0610463c72f,a33b3df7-05d2-42d7-9fbc-17e48d5cf3bf,,,-8.0,2023-02-27T11:30:31.052531-06:00,HCM-CSHL-0077-C25_treatment6,eac835d2-99d3-4fd5-8280-b3728e70c582,,released,,1,2020-09-27T12:46:38.869276-05:00,"Surgery, NOS",Initial Diagnosis,
HCM-CSHL-0077-C25,ecf740ab-ecd5-4a85-94be-e0610463c72f,a33b3df7-05d2-42d7-9fbc-17e48d5cf3bf,794.0,Adjuvant,610.0,2023-02-22T07:39:25.979291-06:00,HCM-CSHL-0077-C25_treatment4,f7ab8c26-b540-499d-a62a-c90fb4211d49,,released,Oxaliplatin,1,2020-09-27T12:46:38.869276-05:00,Chemotherapy,Residual Disease,
HCM-EXPT-1238-C18,ed6a9222-9826-415b-8a1b-517fde951b60,d9c5067a-e379-45f9-9407-a0b5e9b69b47,,Neoadjuvant,,2025-10-08T12:39:37.798161-05:00,HCM-EXPT-1238-C18_treatment,62d5aa4c-3a0c-436b-b100-ce135ba3b673,,released,,0,2022-03-09T19:44:02.020921-06:00,,,
HCM-EXPT-1155-C18,eda3273d-5f57-44d9-ac72-7b3eba91689c,0c1d4b00-5ee0-42aa-9632-3e00576fbc5d,,Neoadjuvant,,2025-10-08T12:38:28.988690-05:00,HCM-EXPT-1155-C18_treatment,9755bd06-0e0b-4fee-9ab4-a60739c6324c,,released,,1,2021-12-21T15:05:14.910299-06:00,"Pharmaceutical Therapy, NOS",,
HCM-SANG-1082-C15,ede7bfd3-af7e-4905-b32d-844cbb25e0b5,76aa2990-04c9-43fc-8149-bfa21e69297a,,Neoadjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-SANG-1082-C15_treatment,c090176c-2892-4966-b5f7-edc07e627a5d,,released,,0,2023-02-27T12:04:17.459333-06:00,,,
HCM-BROD-0414-C25,ee0d306f-e708-478b-8bad-6f9f3bedefbf,7f64a08a-3b81-4177-b204-e7a3ba119f55,124.0,Adjuvant,19.0,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0414-C25_treatment5,0587cdcd-afc8-4e6d-ba94-993c8ccb8892,,released,Oxaliplatin,1,2020-09-27T11:31:41.312580-05:00,Chemotherapy,Residual Disease,
HCM-BROD-0414-C25,ee0d306f-e708-478b-8bad-6f9f3bedefbf,7f64a08a-3b81-4177-b204-e7a3ba119f55,,Adjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0414-C25_treatment11,0d2c4316-1ec5-47ec-97ca-73f461d6929d,,released,,0,2020-09-27T11:31:41.312580-05:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-BROD-0414-C25,ee0d306f-e708-478b-8bad-6f9f3bedefbf,7f64a08a-3b81-4177-b204-e7a3ba119f55,124.0,Adjuvant,19.0,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0414-C25_treatment2,2f57a2a4-26b1-4390-94a7-69d264f9a02d,,released,Irinotecan Hydrochloride,1,2020-09-27T11:31:41.312580-05:00,Chemotherapy,Residual Disease,
HCM-BROD-0414-C25,ee0d306f-e708-478b-8bad-6f9f3bedefbf,7f64a08a-3b81-4177-b204-e7a3ba119f55,191.0,Adjuvant,124.0,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0414-C25_treatment7,6b34ed7e-0b0b-4a02-ab91-02ccddbf445a,,released,Leucovorin Calcium,1,2020-09-27T11:31:41.312580-05:00,Chemotherapy,Residual Disease,
HCM-BROD-0414-C25,ee0d306f-e708-478b-8bad-6f9f3bedefbf,7f64a08a-3b81-4177-b204-e7a3ba119f55,202.0,Adjuvant,201.0,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0414-C25_treatment14,7855e8a3-0bbc-41e4-a74f-b5febaea7b03,,released,,1,2020-09-27T11:31:41.312580-05:00,"Radiation Therapy, NOS",Residual Disease,
HCM-BROD-0414-C25,ee0d306f-e708-478b-8bad-6f9f3bedefbf,7f64a08a-3b81-4177-b204-e7a3ba119f55,191.0,Adjuvant,124.0,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0414-C25_treatment10,853ca8e5-dbb0-4c9e-b54f-e4fa4d4a0ddd,,released,,1,2020-09-27T11:31:41.312580-05:00,Chemotherapy,Residual Disease,FOLFOX
HCM-BROD-0414-C25,ee0d306f-e708-478b-8bad-6f9f3bedefbf,7f64a08a-3b81-4177-b204-e7a3ba119f55,124.0,Adjuvant,19.0,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0414-C25_treatment4,953393a4-bf25-4347-90b5-41762005eac3,,released,Fluorouracil,1,2020-09-27T11:31:41.312580-05:00,Chemotherapy,Residual Disease,
HCM-BROD-0414-C25,ee0d306f-e708-478b-8bad-6f9f3bedefbf,7f64a08a-3b81-4177-b204-e7a3ba119f55,124.0,Adjuvant,19.0,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0414-C25_treatment3,9831b6fa-e242-42d4-9fa0-57e31d86f57d,,released,Leucovorin Calcium,1,2020-09-27T11:31:41.312580-05:00,Chemotherapy,Residual Disease,
HCM-BROD-0414-C25,ee0d306f-e708-478b-8bad-6f9f3bedefbf,7f64a08a-3b81-4177-b204-e7a3ba119f55,124.0,Adjuvant,19.0,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0414-C25_treatment6,9f4b4a69-2f7a-4042-8d97-06d904e2b2c2,,released,,1,2020-09-27T11:31:41.312580-05:00,Chemotherapy,Residual Disease,FOLFIRINOX
HCM-BROD-0414-C25,ee0d306f-e708-478b-8bad-6f9f3bedefbf,7f64a08a-3b81-4177-b204-e7a3ba119f55,191.0,Adjuvant,124.0,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0414-C25_treatment8,cb76fbcf-2a6e-4cf8-9fb1-d9b90821d767,,released,Fluorouracil,1,2020-09-27T11:31:41.312580-05:00,Chemotherapy,Residual Disease,
HCM-BROD-0414-C25,ee0d306f-e708-478b-8bad-6f9f3bedefbf,7f64a08a-3b81-4177-b204-e7a3ba119f55,,Neoadjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0414-C25_treatment,cd81d347-91d8-4974-9dc1-03cd6cb70ae0,,released,,0,2020-09-27T11:31:41.312580-05:00,,,
HCM-BROD-0414-C25,ee0d306f-e708-478b-8bad-6f9f3bedefbf,7f64a08a-3b81-4177-b204-e7a3ba119f55,191.0,Adjuvant,124.0,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0414-C25_treatment9,cf768dcb-4127-4b24-ad9d-a29e3ef0d537,,released,Oxaliplatin,1,2020-09-27T11:31:41.312580-05:00,Chemotherapy,Residual Disease,
HCM-BROD-0414-C25,ee0d306f-e708-478b-8bad-6f9f3bedefbf,7f64a08a-3b81-4177-b204-e7a3ba119f55,,Adjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0414-C25_treatment13,d8acca3a-304d-421a-8ffa-51d0afda9149,,released,,0,2020-09-27T11:31:41.312580-05:00,Targeted Molecular Therapy,Residual Disease,
HCM-CSHL-0184-C25,ee35fde8-183f-48d2-b4ea-460c40445daa,0aa1ae32-a57d-4108-8134-b0feb8199048,,Adjuvant,,2023-02-22T07:39:25.979291-06:00,HCM-CSHL-0184-C25_treatment5,2ceafe60-f89e-4350-9a27-dcbc8fe2de1e,,released,,0,2020-09-28T09:14:48.001375-05:00,Targeted Molecular Therapy,Residual Disease,
HCM-CSHL-0184-C25,ee35fde8-183f-48d2-b4ea-460c40445daa,0aa1ae32-a57d-4108-8134-b0feb8199048,,Adjuvant,,2023-02-22T07:39:25.979291-06:00,HCM-CSHL-0184-C25_treatment6,816e106e-3150-4a7a-a6a6-a7a77e78664d,,released,,0,2020-09-28T09:14:48.001375-05:00,"Radiation Therapy, NOS",Residual Disease,
HCM-CSHL-0184-C25,ee35fde8-183f-48d2-b4ea-460c40445daa,0aa1ae32-a57d-4108-8134-b0feb8199048,,,-12.0,2023-02-27T12:00:34.139966-06:00,HCM-CSHL-0184-C25_treatment4,b85573ee-4688-43d8-bd09-f9b9870c6298,,released,,1,2020-09-28T09:14:48.001375-05:00,"Surgery, NOS",Initial Diagnosis,
HCM-CSHL-0184-C25,ee35fde8-183f-48d2-b4ea-460c40445daa,0aa1ae32-a57d-4108-8134-b0feb8199048,,Neoadjuvant,,2023-02-22T07:39:25.979291-06:00,HCM-CSHL-0184-C25_treatment,c61af65e-51b1-4c16-896b-d98cc56cf560,,released,,0,2020-09-28T09:14:48.001375-05:00,,,
HCM-CSHL-0184-C25,ee35fde8-183f-48d2-b4ea-460c40445daa,0aa1ae32-a57d-4108-8134-b0feb8199048,,Adjuvant,,2023-02-22T07:39:25.979291-06:00,HCM-CSHL-0184-C25_treatment3,ddf1fa23-773f-48de-b4b2-bb2e8c62f575,,released,,0,2020-09-28T09:14:48.001375-05:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-CSHL-0184-C25,ee35fde8-183f-48d2-b4ea-460c40445daa,0aa1ae32-a57d-4108-8134-b0feb8199048,,Adjuvant,,2023-02-22T07:39:25.979291-06:00,HCM-CSHL-0184-C25_treatment2,e1d46f60-9ce6-4475-84b6-1aa9039cd003,,released,Gemcitabine,1,2020-09-28T09:14:48.001375-05:00,Chemotherapy,Residual Disease,
HCM-SANG-1308-C25,efc49baf-1c53-427c-afe1-267d9438ded0,41753b7c-48cc-410b-8733-fc796bae9f23,,Neoadjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-SANG-1308-C25_treatment,aad78666-70aa-4f9e-8315-06c35d651e39,,released,,0,2023-02-27T12:11:05.950496-06:00,,,
HCM-EXPT-1240-C15,efdfc134-112d-4a60-a7ba-df9e1e64b579,f90dae41-179c-49dc-87d4-e72b63959605,,Neoadjuvant,120.0,2025-10-08T12:39:37.798161-05:00,HCM-EXPT-1240-C15_treatment,33043ab9-a74f-4e19-ba1d-92ca80b745f2,,released,Leucovorin,1,2023-02-24T13:58:37.227795-06:00,Chemotherapy,,
HCM-EXPT-1240-C15,efdfc134-112d-4a60-a7ba-df9e1e64b579,f90dae41-179c-49dc-87d4-e72b63959605,,Neoadjuvant,120.0,2025-10-08T12:39:37.798161-05:00,HCM-EXPT-1240-C15_treatment4,34882fb0-7dc6-46ee-bc00-6f9cb1ba2f83,,released,Oxaliplatin,1,2023-02-24T13:58:37.227795-06:00,Chemotherapy,,
HCM-EXPT-1240-C15,efdfc134-112d-4a60-a7ba-df9e1e64b579,f90dae41-179c-49dc-87d4-e72b63959605,,Neoadjuvant,120.0,2025-10-08T12:39:37.798161-05:00,HCM-EXPT-1240-C15_treatment2,81346148-0eca-481d-b62d-19880e63e0a4,,released,Fluorouracil,1,2023-02-24T13:58:37.227795-06:00,Chemotherapy,,
HCM-EXPT-1240-C15,efdfc134-112d-4a60-a7ba-df9e1e64b579,f90dae41-179c-49dc-87d4-e72b63959605,,Neoadjuvant,120.0,2025-10-08T12:39:37.798161-05:00,HCM-EXPT-1240-C15_treatment3,b389f687-ceea-4937-8ace-f8cfc2310ce6,,released,Docetaxel,1,2023-02-24T13:58:37.227795-06:00,Chemotherapy,,
HCM-EXPT-1199-C18,f010de34-4d60-4760-b9ea-63850c34caad,cc7e4e81-19df-4c15-86ea-9e8836eaa5a3,,Neoadjuvant,,2025-10-08T12:38:51.189053-05:00,HCM-EXPT-1199-C18_treatment,24ac09ed-a869-486c-b4d3-3072581bf346,,released,,0,2022-03-09T19:42:13.682712-06:00,,,
HCM-BROD-0332-C43,f0c1dd21-a156-4284-afda-985cd2656a9f,aa079003-2029-472c-a443-ad0405969d75,,,55.0,2023-03-13T12:51:23.432216-05:00,HCM-BROD-0332-C43_treatment2,0d02d1bb-170c-44c3-a84b-42bfe6aa124c,,released,,1,2020-06-15T13:33:11.402718-05:00,"Surgery, NOS",Initial Diagnosis,
HCM-BROD-0332-C43,f0c1dd21-a156-4284-afda-985cd2656a9f,aa079003-2029-472c-a443-ad0405969d75,,Adjuvant,,2023-03-13T12:51:23.432216-05:00,HCM-BROD-0332-C43_treatment3,4e169bb8-a519-4f2f-b9fd-5f5aacdf9012,,released,,0,2020-06-15T13:33:11.402718-05:00,"Pharmaceutical Therapy, NOS",Residual Disease,
HCM-BROD-0332-C43,f0c1dd21-a156-4284-afda-985cd2656a9f,aa079003-2029-472c-a443-ad0405969d75,,Neoadjuvant,,2021-01-06T22:55:10.531130-06:00,HCM-BROD-0332-C43_treatment,71767087-e72e-42b8-bc32-b15752c796ac,,released,,0,2020-06-15T13:33:11.402718-05:00,,,
HCM-BROD-0332-C43,f0c1dd21-a156-4284-afda-985cd2656a9f,aa079003-2029-472c-a443-ad0405969d75,,Adjuvant,,2023-03-13T12:51:23.432216-05:00,HCM-BROD-0332-C43_treatment4,dfa367f9-8dfc-4684-82bb-135ca4f041e7,,released,,0,2020-06-15T13:33:11.402718-05:00,"Radiation Therapy, NOS",Residual Disease,
HCM-CSHL-0257-C18,f0c6e5b9-3d64-456e-85ab-9978a91ffd43,bde4d9ec-a9c6-4b41-8b2f-a38064e1944f,,Adjuvant,104.0,2021-07-12T12:25:55.528644-05:00,HCM-CSHL-0257-C18_treatment3,109f174b-42ce-4a43-ba1b-38541b9e1723,,released,Oxaliplatin,1,2020-09-28T09:37:09.746532-05:00,Chemotherapy,Residual Disease,
HCM-CSHL-0257-C18,f0c6e5b9-3d64-456e-85ab-9978a91ffd43,bde4d9ec-a9c6-4b41-8b2f-a38064e1944f,,Neoadjuvant,,2021-07-12T12:25:55.528644-05:00,HCM-CSHL-0257-C18_treatment,3192d37c-3dc0-4e45-8bb4-54da4159da49,,released,,0,2020-09-28T09:37:09.746532-05:00,,,
HCM-CSHL-0257-C18,f0c6e5b9-3d64-456e-85ab-9978a91ffd43,bde4d9ec-a9c6-4b41-8b2f-a38064e1944f,,,20.0,2023-03-13T13:28:59.783352-05:00,HCM-CSHL-0257-C18_treatment5,324efd95-f30b-4c0c-84b4-1f5939ff6e81,,released,,1,2020-09-28T09:37:09.746532-05:00,"Surgery, NOS",Initial Diagnosis,
HCM-CSHL-0257-C18,f0c6e5b9-3d64-456e-85ab-9978a91ffd43,bde4d9ec-a9c6-4b41-8b2f-a38064e1944f,,Adjuvant,,2021-07-12T12:25:55.528644-05:00,HCM-CSHL-0257-C18_treatment4,4494eb67-42f1-4c79-9ccc-94c98b1c8a19,,released,,0,2020-09-28T09:37:09.746532-05:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-CSHL-0257-C18,f0c6e5b9-3d64-456e-85ab-9978a91ffd43,bde4d9ec-a9c6-4b41-8b2f-a38064e1944f,,Adjuvant,,2021-07-12T12:25:55.528644-05:00,HCM-CSHL-0257-C18_treatment6,791dd893-1bbe-4e32-8f06-aae018b9525e,,released,,0,2020-09-28T09:37:09.746532-05:00,Targeted Molecular Therapy,Residual Disease,
HCM-CSHL-0257-C18,f0c6e5b9-3d64-456e-85ab-9978a91ffd43,bde4d9ec-a9c6-4b41-8b2f-a38064e1944f,,Adjuvant,,2021-07-12T12:25:55.528644-05:00,HCM-CSHL-0257-C18_treatment7,7dde952e-d30b-48ac-88ba-de15a489bc53,,released,,0,2020-09-28T09:37:09.746532-05:00,"Radiation Therapy, NOS",Residual Disease,
HCM-CSHL-0257-C18,f0c6e5b9-3d64-456e-85ab-9978a91ffd43,bde4d9ec-a9c6-4b41-8b2f-a38064e1944f,,Adjuvant,104.0,2021-07-12T12:25:55.528644-05:00,HCM-CSHL-0257-C18_treatment2,b88dac42-10ce-4dec-ac1b-9660e7b5bf8e,,released,Capecitabine,1,2020-09-28T09:37:09.746532-05:00,Chemotherapy,Residual Disease,
HCM-BROD-0419-C71,f0ee7109-8e30-4789-b071-cd80bec493a3,e0eebcb5-db01-4ec4-b90b-d50ec9b2d15d,262.0,Adjuvant,30.0,2021-07-12T12:25:55.528644-05:00,HCM-BROD-0419-C71_treatment2,2e90da02-b0fe-472b-82ec-22e917f5e37d,,released,Temozolomide,1,2020-04-21T14:52:24.369316-05:00,Chemotherapy,Residual Disease,
HCM-BROD-0419-C71,f0ee7109-8e30-4789-b071-cd80bec493a3,e0eebcb5-db01-4ec4-b90b-d50ec9b2d15d,,Adjuvant,,2021-07-12T12:25:55.528644-05:00,HCM-BROD-0419-C71_treatment5,46bad561-7f4c-4929-944e-a10e1c6cbaec,,released,,0,2020-04-21T14:52:24.369316-05:00,Targeted Molecular Therapy,Residual Disease,
HCM-BROD-0419-C71,f0ee7109-8e30-4789-b071-cd80bec493a3,e0eebcb5-db01-4ec4-b90b-d50ec9b2d15d,,Neoadjuvant,,2021-07-12T12:25:55.528644-05:00,HCM-BROD-0419-C71_treatment,51dfbcaa-e816-4026-933e-66c49b9afe0d,,released,,0,2020-04-21T14:52:24.369316-05:00,,,
HCM-BROD-0419-C71,f0ee7109-8e30-4789-b071-cd80bec493a3,e0eebcb5-db01-4ec4-b90b-d50ec9b2d15d,,,-9.0,2023-03-13T13:11:55.725683-05:00,HCM-BROD-0419-C71_treatment4,5d53dab6-9427-468c-a59c-273ad6380d05,,released,,1,2020-04-21T14:52:24.369316-05:00,"Surgery, NOS",Initial Diagnosis,
HCM-BROD-0419-C71,f0ee7109-8e30-4789-b071-cd80bec493a3,e0eebcb5-db01-4ec4-b90b-d50ec9b2d15d,,Adjuvant,,2021-07-12T12:25:55.528644-05:00,HCM-BROD-0419-C71_treatment3,5ffce97c-679d-405e-9ab4-9eaf4d3c2919,,released,,0,2020-04-21T14:52:24.369316-05:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-BROD-0419-C71,f0ee7109-8e30-4789-b071-cd80bec493a3,e0eebcb5-db01-4ec4-b90b-d50ec9b2d15d,64.0,Adjuvant,20.0,2021-07-12T12:25:55.528644-05:00,HCM-BROD-0419-C71_treatment6,bf4ac417-d798-463f-b6a8-3de1dedf73cd,,released,,1,2020-04-21T14:52:24.369316-05:00,"Radiation Therapy, NOS",Residual Disease,
HCM-BROD-0831-C71,f12fbecd-c941-47c2-b69c-4d07b81e0394,12a4316b-e78a-44c1-8969-59086ffa83cb,,Adjuvant,,2023-02-22T07:39:25.979291-06:00,HCM-BROD-0831-C71_treatment3,25194a12-e278-47f7-a767-aa494883077a,,released,,0,2021-12-21T13:54:19.010596-06:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-BROD-0831-C71,f12fbecd-c941-47c2-b69c-4d07b81e0394,12a4316b-e78a-44c1-8969-59086ffa83cb,40.0,Adjuvant,15.0,2023-02-22T07:39:25.979291-06:00,HCM-BROD-0831-C71_treatment6,64bc7b4b-66c4-4184-b73c-e0334888e2d6,,released,,1,2021-12-21T13:54:19.010596-06:00,"Radiation, 2D Conventional",Residual Disease,
HCM-BROD-0831-C71,f12fbecd-c941-47c2-b69c-4d07b81e0394,12a4316b-e78a-44c1-8969-59086ffa83cb,175.0,Adjuvant,155.0,2023-02-22T07:39:25.979291-06:00,HCM-BROD-0831-C71_treatment5,9357a203-66f6-4c38-8b6b-e3c4ea672e2b,,released,Bevacizumab,1,2021-12-21T13:54:19.010596-06:00,Targeted Molecular Therapy,Residual Disease,
HCM-BROD-0831-C71,f12fbecd-c941-47c2-b69c-4d07b81e0394,12a4316b-e78a-44c1-8969-59086ffa83cb,,,2.0,2023-02-27T13:06:02.174105-06:00,HCM-BROD-0831-C71_treatment4,a7cc75df-b2e3-478c-a2ad-4ff8cb123616,,released,,1,2021-12-21T13:54:19.010596-06:00,"Surgery, NOS",Initial Diagnosis,
HCM-BROD-0831-C71,f12fbecd-c941-47c2-b69c-4d07b81e0394,12a4316b-e78a-44c1-8969-59086ffa83cb,174.0,Adjuvant,8.0,2023-02-22T07:39:25.979291-06:00,HCM-BROD-0831-C71_treatment2,ae010cab-f6bd-466b-99e3-549abbaf8f00,,released,Temozolomide,1,2021-12-21T13:54:19.010596-06:00,Chemotherapy,Residual Disease,
HCM-BROD-0831-C71,f12fbecd-c941-47c2-b69c-4d07b81e0394,12a4316b-e78a-44c1-8969-59086ffa83cb,,Neoadjuvant,,2023-02-22T07:39:25.979291-06:00,HCM-BROD-0831-C71_treatment,eb459fe9-4f29-42cf-981e-09e52c4f0493,,released,,0,2021-12-21T13:54:19.010596-06:00,,,
HCM-BROD-0693-C71,f1332ba6-887b-45ec-846b-1180cbfd66b7,5fcca466-96ef-4f4b-af4e-bc72d7a0e4d2,,,-4.0,2023-02-27T11:49:16.496783-06:00,HCM-BROD-0693-C71_treatment4,1c16c29d-1472-4ea3-a4a3-32da03f238b6,,released,,1,2021-12-21T13:45:34.286716-06:00,"Surgery, NOS",Initial Diagnosis,
HCM-BROD-0693-C71,f1332ba6-887b-45ec-846b-1180cbfd66b7,5fcca466-96ef-4f4b-af4e-bc72d7a0e4d2,73.0,Adjuvant,31.0,2023-02-22T07:39:25.979291-06:00,HCM-BROD-0693-C71_treatment6,1c9e268c-afc6-40f2-93e9-54b609575099,,released,,1,2021-12-21T13:45:34.286716-06:00,"Radiation, 3D Conformal",Residual Disease,
HCM-BROD-0693-C71,f1332ba6-887b-45ec-846b-1180cbfd66b7,5fcca466-96ef-4f4b-af4e-bc72d7a0e4d2,268.0,Adjuvant,30.0,2023-02-22T07:39:25.979291-06:00,HCM-BROD-0693-C71_treatment2,23a77352-8b8e-433d-a9ce-83815b3711f1,,released,Temozolomide,1,2021-12-21T13:45:34.286716-06:00,Chemotherapy,Residual Disease,
HCM-BROD-0693-C71,f1332ba6-887b-45ec-846b-1180cbfd66b7,5fcca466-96ef-4f4b-af4e-bc72d7a0e4d2,296.0,Adjuvant,296.0,2023-02-22T07:39:25.979291-06:00,HCM-BROD-0693-C71_treatment5,58c5156b-293d-44d2-90b1-d34e1ec525ca,,released,Bevacizumab,1,2021-12-21T13:45:34.286716-06:00,Targeted Molecular Therapy,Residual Disease,
HCM-BROD-0693-C71,f1332ba6-887b-45ec-846b-1180cbfd66b7,5fcca466-96ef-4f4b-af4e-bc72d7a0e4d2,,Neoadjuvant,,2023-02-22T07:39:25.979291-06:00,HCM-BROD-0693-C71_treatment,8a2cc028-9269-41f4-9301-c0e93c6bef7d,,released,,0,2021-12-21T13:45:34.286716-06:00,,,
HCM-BROD-0693-C71,f1332ba6-887b-45ec-846b-1180cbfd66b7,5fcca466-96ef-4f4b-af4e-bc72d7a0e4d2,,Adjuvant,,2023-02-22T07:39:25.979291-06:00,HCM-BROD-0693-C71_treatment3,8ca07f77-cb98-4f65-b590-adcc9b63718a,,released,,0,2021-12-21T13:45:34.286716-06:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-BROD-0198-C71,f21ba837-795e-4032-9c2d-5ff557e4a439,481a3f2f-a779-4b7e-8195-f6ea9cc4164c,,Adjuvant,,2021-01-06T22:55:10.531130-06:00,HCM-BROD-0198-C71_treatment6,12d75474-f061-43a5-9afd-72e90680039e,,released,,0,2020-04-21T14:50:59.719711-05:00,Targeted Molecular Therapy,Residual Disease,
HCM-BROD-0198-C71,f21ba837-795e-4032-9c2d-5ff557e4a439,481a3f2f-a779-4b7e-8195-f6ea9cc4164c,82.0,Adjuvant,40.0,2021-01-06T22:55:10.531130-06:00,HCM-BROD-0198-C71_treatment7,6f7c9b43-b96c-45d0-9e2b-5d1156b6d13a,,released,,1,2020-04-21T14:50:59.719711-05:00,"Radiation Therapy, NOS",Residual Disease,
HCM-BROD-0198-C71,f21ba837-795e-4032-9c2d-5ff557e4a439,481a3f2f-a779-4b7e-8195-f6ea9cc4164c,172.0,Adjuvant,40.0,2021-01-06T22:55:10.531130-06:00,HCM-BROD-0198-C71_treatment2,96f10ce7-24d8-4548-8942-0717a713dda6,,released,Temozolomide,1,2020-04-21T14:50:59.719711-05:00,Chemotherapy,Residual Disease,
HCM-BROD-0198-C71,f21ba837-795e-4032-9c2d-5ff557e4a439,481a3f2f-a779-4b7e-8195-f6ea9cc4164c,,Adjuvant,,2021-01-06T22:55:10.531130-06:00,HCM-BROD-0198-C71_treatment4,c3143b3b-67d6-4935-bf81-79c33bc15fa5,,released,,0,2020-04-21T14:50:59.719711-05:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-BROD-0198-C71,f21ba837-795e-4032-9c2d-5ff557e4a439,481a3f2f-a779-4b7e-8195-f6ea9cc4164c,240.0,Adjuvant,193.0,2021-01-06T22:55:10.531130-06:00,HCM-BROD-0198-C71_treatment3,c9a585d5-8fd5-4c4d-a8c2-16847ffce773,,released,Temozolomide,1,2020-04-21T14:50:59.719711-05:00,Chemotherapy,Residual Disease,
HCM-BROD-0198-C71,f21ba837-795e-4032-9c2d-5ff557e4a439,481a3f2f-a779-4b7e-8195-f6ea9cc4164c,,Neoadjuvant,,2021-01-06T22:55:10.531130-06:00,HCM-BROD-0198-C71_treatment,d4a09445-bb5d-4cf8-a2e7-40bcd73f7df4,,released,,0,2019-04-04T14:57:52.051017-05:00,,,
HCM-BROD-0198-C71,f21ba837-795e-4032-9c2d-5ff557e4a439,481a3f2f-a779-4b7e-8195-f6ea9cc4164c,,,-15.0,2023-02-27T12:26:48.617695-06:00,HCM-BROD-0198-C71_treatment5,fd1caf25-df77-404c-8ce1-c47ae26bbbe0,,released,,1,2020-04-21T14:50:59.719711-05:00,"Surgery, NOS",Initial Diagnosis,
HCM-CSHL-0463-C50,f2461357-8aa6-461b-9a13-1f18d44e50e9,3426eb89-601e-45de-b90a-19acccc39678,,Adjuvant,35.0,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0463-C50_treatment2,002d70a6-4384-44b3-99fc-07861f499cd4,Treatment Ongoing,released,Paclitaxel,1,2020-09-28T10:19:04.791166-05:00,Chemotherapy,Residual Disease,
HCM-CSHL-0463-C50,f2461357-8aa6-461b-9a13-1f18d44e50e9,3426eb89-601e-45de-b90a-19acccc39678,,Adjuvant,35.0,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0463-C50_treatment4,3e91b65c-5e24-4c76-aae9-27ac2ce33fb9,Treatment Ongoing,released,Doxorubicin,1,2020-09-28T10:19:04.791166-05:00,Chemotherapy,Residual Disease,
HCM-CSHL-0463-C50,f2461357-8aa6-461b-9a13-1f18d44e50e9,3426eb89-601e-45de-b90a-19acccc39678,,Adjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0463-C50_treatment6,7124e24e-ab88-4e28-bb5c-f416303f93c0,,released,,0,2020-09-28T10:19:04.791166-05:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-CSHL-0463-C50,f2461357-8aa6-461b-9a13-1f18d44e50e9,3426eb89-601e-45de-b90a-19acccc39678,,Neoadjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0463-C50_treatment,7b2abcf3-fee2-4954-b606-9de340b94eb3,,released,,0,2020-09-28T10:19:04.791166-05:00,,,
HCM-CSHL-0463-C50,f2461357-8aa6-461b-9a13-1f18d44e50e9,3426eb89-601e-45de-b90a-19acccc39678,,Adjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0463-C50_treatment9,880178fa-3918-4479-a45f-9c4b697597f5,,released,,0,2020-09-28T10:19:04.791166-05:00,"Radiation Therapy, NOS",Residual Disease,
HCM-CSHL-0463-C50,f2461357-8aa6-461b-9a13-1f18d44e50e9,3426eb89-601e-45de-b90a-19acccc39678,,Adjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0463-C50_treatment8,a3d0173a-50b9-42c9-b99b-136c0dca5d96,,released,,0,2020-09-28T10:19:04.791166-05:00,Targeted Molecular Therapy,Residual Disease,
HCM-CSHL-0463-C50,f2461357-8aa6-461b-9a13-1f18d44e50e9,3426eb89-601e-45de-b90a-19acccc39678,,Adjuvant,35.0,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0463-C50_treatment3,aac238b9-2524-46a6-a8ff-89c158c98948,Treatment Ongoing,released,Cyclophosphamide,1,2020-09-28T10:19:04.791166-05:00,Chemotherapy,Residual Disease,
HCM-CSHL-0463-C50,f2461357-8aa6-461b-9a13-1f18d44e50e9,3426eb89-601e-45de-b90a-19acccc39678,,Adjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0463-C50_treatment5,e401a092-ecc6-4b26-8989-d8403ae0c354,,released,,0,2020-09-28T10:19:04.791166-05:00,Hormone Therapy,Residual Disease,
HCM-CSHL-0463-C50,f2461357-8aa6-461b-9a13-1f18d44e50e9,3426eb89-601e-45de-b90a-19acccc39678,,,28.0,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0463-C50_treatment7,e4d3d604-252f-49d4-aa42-1e9606841726,,released,,1,2020-09-28T10:19:04.791166-05:00,"Surgery, NOS",Initial Diagnosis,
HCM-SANG-0310-C15,f255a5f0-49ad-48e5-aceb-520b066e35e8,40dc1391-7f40-4331-9997-b820cdec025d,,Neoadjuvant,103.0,2023-07-13T10:35:44.371881-05:00,HCM-SANG-0310-C15_treatment2,06f1d3a5-ae4c-4647-91f6-e3a45a567dc3,,released,Capecitabine,1,2021-12-21T15:11:13.731443-06:00,Chemotherapy,,
HCM-SANG-0310-C15,f255a5f0-49ad-48e5-aceb-520b066e35e8,40dc1391-7f40-4331-9997-b820cdec025d,,Neoadjuvant,103.0,2023-07-13T10:35:44.371881-05:00,HCM-SANG-0310-C15_treatment3,0b245afd-aa96-4c5f-a058-0cdbeef5e248,,released,Cisplatin,1,2021-12-21T15:11:13.731443-06:00,Chemotherapy,,
HCM-SANG-0310-C15,f255a5f0-49ad-48e5-aceb-520b066e35e8,40dc1391-7f40-4331-9997-b820cdec025d,,Neoadjuvant,103.0,2023-07-13T10:35:44.371881-05:00,HCM-SANG-0310-C15_treatment4,221a4f47-f0d3-4f68-87a7-7b5d8836fb73,,released,,1,2021-12-21T15:11:13.731443-06:00,Chemotherapy,,ECX
HCM-SANG-0310-C15,f255a5f0-49ad-48e5-aceb-520b066e35e8,40dc1391-7f40-4331-9997-b820cdec025d,,Neoadjuvant,103.0,2023-07-13T10:35:44.371881-05:00,HCM-SANG-0310-C15_treatment,ddfe6fac-b91f-49d1-898b-3869f6a6e5c9,,released,Epirubicin,1,2021-12-21T15:11:13.731443-06:00,Chemotherapy,,
HCM-BROD-0694-C43,f25dac3c-3ee1-4a5e-898a-8b4e6b12ebc2,65bf8ad0-6462-4152-83ee-6433f58a5683,1035.0,Adjuvant,1035.0,2023-02-22T07:39:25.979291-06:00,HCM-BROD-0694-C43_treatment9,02d5268f-50b5-4a55-9908-88117f62708b,,released,,1,2021-12-21T13:45:49.799389-06:00,"Radiation, Stereotactic/Gamma Knife/SRS",Residual Disease,
HCM-BROD-0694-C43,f25dac3c-3ee1-4a5e-898a-8b4e6b12ebc2,65bf8ad0-6462-4152-83ee-6433f58a5683,,Neoadjuvant,,2023-02-22T07:39:25.979291-06:00,HCM-BROD-0694-C43_treatment,2672f2ea-caf1-4065-a4ac-885613b6a4a1,,released,,0,2021-12-21T13:45:49.799389-06:00,,,
HCM-BROD-0694-C43,f25dac3c-3ee1-4a5e-898a-8b4e6b12ebc2,65bf8ad0-6462-4152-83ee-6433f58a5683,890.0,Adjuvant,863.0,2023-02-22T07:39:25.979291-06:00,HCM-BROD-0694-C43_treatment8,457ba513-b0b9-4dbc-b648-8341171822e9,,released,Trametinib,1,2021-12-21T13:45:49.799389-06:00,Targeted Molecular Therapy,Residual Disease,
HCM-BROD-0694-C43,f25dac3c-3ee1-4a5e-898a-8b4e6b12ebc2,65bf8ad0-6462-4152-83ee-6433f58a5683,1064.0,Adjuvant,1044.0,2023-02-22T07:39:25.979291-06:00,HCM-BROD-0694-C43_treatment4,50b50d3b-aabc-4c8b-853d-978000b15131,,released,Nivolumab,1,2021-12-21T13:45:49.799389-06:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-BROD-0694-C43,f25dac3c-3ee1-4a5e-898a-8b4e6b12ebc2,65bf8ad0-6462-4152-83ee-6433f58a5683,,,0.0,2023-02-27T12:57:47.001529-06:00,HCM-BROD-0694-C43_treatment5,66e1ec70-8595-443d-ae83-770cc91f872c,,released,,1,2021-12-21T13:45:49.799389-06:00,"Surgery, NOS",Initial Diagnosis,
HCM-BROD-0694-C43,f25dac3c-3ee1-4a5e-898a-8b4e6b12ebc2,65bf8ad0-6462-4152-83ee-6433f58a5683,,Adjuvant,,2023-02-22T07:39:25.979291-06:00,HCM-BROD-0694-C43_treatment3,694a8173-9640-483b-8052-2929d62d42b7,,released,,0,2021-12-21T13:45:49.799389-06:00,Hormone Therapy,Residual Disease,
HCM-BROD-0694-C43,f25dac3c-3ee1-4a5e-898a-8b4e6b12ebc2,65bf8ad0-6462-4152-83ee-6433f58a5683,1064.0,Adjuvant,1044.0,2023-02-22T07:39:25.979291-06:00,HCM-BROD-0694-C43_treatment7,7299940a-833e-4df4-9be6-b5feed0dda10,,released,Bevacizumab,1,2021-12-21T13:45:49.799389-06:00,Targeted Molecular Therapy,Residual Disease,
HCM-BROD-0694-C43,f25dac3c-3ee1-4a5e-898a-8b4e6b12ebc2,65bf8ad0-6462-4152-83ee-6433f58a5683,,Adjuvant,,2023-02-22T07:39:25.979291-06:00,HCM-BROD-0694-C43_treatment2,cc94aa7a-dded-4d51-98da-c69a9620cc86,,released,,0,2021-12-21T13:45:49.799389-06:00,Chemotherapy,Residual Disease,
HCM-BROD-0694-C43,f25dac3c-3ee1-4a5e-898a-8b4e6b12ebc2,65bf8ad0-6462-4152-83ee-6433f58a5683,890.0,Adjuvant,863.0,2023-02-22T07:39:25.979291-06:00,HCM-BROD-0694-C43_treatment6,d5829a3a-0217-49ad-bc8e-52eefb97af16,,released,Dabrafenib,1,2021-12-21T13:45:49.799389-06:00,Targeted Molecular Therapy,Residual Disease,
HCM-EXPT-1218-C18,f36d1708-d159-4429-a667-57107751c9ca,19068e2e-1b30-484c-989b-e1f9fc106bcb,,Neoadjuvant,,2025-10-08T12:39:14.406630-05:00,HCM-EXPT-1218-C18_treatment,1f6a7849-bc95-4690-b23c-80ebff3aef16,,released,,0,2023-02-24T13:54:05.901226-06:00,,,
HCM-CSHL-1263-C24,f394d2fb-970d-4d9f-82b1-3f16abfe2d55,358a0627-67b9-48c8-868e-9268eb6defc3,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-1263-C24_treatment4,13691454-7b26-40c7-ad2e-1e3fbfc39abb,,released,,0,2021-12-23T08:33:20.825776-06:00,"Radiation Therapy, NOS",Residual Disease,
HCM-CSHL-1263-C24,f394d2fb-970d-4d9f-82b1-3f16abfe2d55,358a0627-67b9-48c8-868e-9268eb6defc3,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-1263-C24_treatment3,138a3197-846a-48a8-a149-0b745a2329cf,,released,,0,2021-12-23T08:33:20.825776-06:00,"Pharmaceutical Therapy, NOS",Residual Disease,
HCM-CSHL-1263-C24,f394d2fb-970d-4d9f-82b1-3f16abfe2d55,358a0627-67b9-48c8-868e-9268eb6defc3,,,-12.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-1263-C24_treatment2,8fbd5f60-ea35-4ae2-859e-af36661eed8e,,released,,1,2021-12-23T08:33:20.825776-06:00,"Surgery, NOS",Initial Diagnosis,
HCM-CSHL-1263-C24,f394d2fb-970d-4d9f-82b1-3f16abfe2d55,358a0627-67b9-48c8-868e-9268eb6defc3,,Neoadjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-1263-C24_treatment,b6439e79-343d-4761-b664-d4683b7c1460,,released,,0,2021-12-23T08:33:20.825776-06:00,,,
HCM-CSHL-0668-C18,f3cb5924-1ad1-4119-853a-26f77240763b,4bd0021e-c24b-4861-9d2d-afa4ec350662,219.0,Adjuvant,142.0,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0668-C18_treatment5,024cdc0a-7e1b-4fb4-a6b3-1ddc35abfcab,,released,Oxaliplatin,1,2021-12-21T14:16:52.945779-06:00,Chemotherapy,Residual Disease,
HCM-CSHL-0668-C18,f3cb5924-1ad1-4119-853a-26f77240763b,4bd0021e-c24b-4861-9d2d-afa4ec350662,106.0,Adjuvant,72.0,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0668-C18_treatment2,4103a81c-74f6-4b86-b30b-7b5f4729e097,,released,Capecitabine,1,2021-12-21T14:16:52.945779-06:00,Chemotherapy,Residual Disease,
HCM-CSHL-0668-C18,f3cb5924-1ad1-4119-853a-26f77240763b,4bd0021e-c24b-4861-9d2d-afa4ec350662,,Neoadjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0668-C18_treatment,556dc25e-49dd-499f-928a-6d64da0cb8a6,,released,,0,2021-12-21T14:16:52.945779-06:00,,,
HCM-CSHL-0668-C18,f3cb5924-1ad1-4119-853a-26f77240763b,4bd0021e-c24b-4861-9d2d-afa4ec350662,,,29.0,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0668-C18_treatment8,699fb586-4f94-45ca-821e-fdc8850e8431,,released,,1,2021-12-21T14:16:52.945779-06:00,"Surgery, NOS",Initial Diagnosis,
HCM-CSHL-0668-C18,f3cb5924-1ad1-4119-853a-26f77240763b,4bd0021e-c24b-4861-9d2d-afa4ec350662,219.0,Adjuvant,142.0,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0668-C18_treatment3,865da542-1ab3-4b50-bf61-64f974195f04,,released,Leucovorin Calcium,1,2021-12-21T14:16:52.945779-06:00,Chemotherapy,Residual Disease,
HCM-CSHL-0668-C18,f3cb5924-1ad1-4119-853a-26f77240763b,4bd0021e-c24b-4861-9d2d-afa4ec350662,,Adjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0668-C18_treatment7,b00353bc-2b56-49e9-911b-63202f427865,,released,,0,2021-12-21T14:16:52.945779-06:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-CSHL-0668-C18,f3cb5924-1ad1-4119-853a-26f77240763b,4bd0021e-c24b-4861-9d2d-afa4ec350662,,Adjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0668-C18_treatment9,dddfb158-3d8f-40d3-b79d-cd1761053cf5,,released,,0,2021-12-21T14:16:52.945779-06:00,Targeted Molecular Therapy,Residual Disease,
HCM-CSHL-0668-C18,f3cb5924-1ad1-4119-853a-26f77240763b,4bd0021e-c24b-4861-9d2d-afa4ec350662,219.0,Adjuvant,142.0,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0668-C18_treatment6,e754996a-6d70-4790-be10-04fce5f48748,,released,,1,2021-12-21T14:16:52.945779-06:00,Chemotherapy,Residual Disease,FOLFOX
HCM-CSHL-0668-C18,f3cb5924-1ad1-4119-853a-26f77240763b,4bd0021e-c24b-4861-9d2d-afa4ec350662,219.0,Adjuvant,142.0,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0668-C18_treatment4,f2f74583-4274-4413-bc08-9e6605ea7c50,,released,Fluorouracil,1,2021-12-21T14:16:52.945779-06:00,Chemotherapy,Residual Disease,
HCM-CSHL-0668-C18,f3cb5924-1ad1-4119-853a-26f77240763b,4bd0021e-c24b-4861-9d2d-afa4ec350662,,Adjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0668-C18_treatment10,f559144a-441e-405a-96a7-7a3d607ea280,,released,,0,2021-12-21T14:16:52.945779-06:00,"Radiation Therapy, NOS",Residual Disease,
HCM-SANG-0542-C18,f3dfe620-ca76-4de3-a91f-f81eeb2e7dfc,47cf2a7a-fb5d-4819-ae7a-3b347693e668,,Neoadjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-SANG-0542-C18_treatment,3aa3c1ad-3d45-41c3-99f8-6b51399cdfd8,,released,,0,2023-02-27T11:46:30.142880-06:00,,,
HCM-CSHL-0159-C18,f404fc66-9398-4c2a-a336-993cd326c3ae,9ce5ac65-29f5-4c90-a0fb-edcaa8429502,,,11.0,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0159-C18_treatment2,25ed1130-f672-4482-813b-508ed69222f8,,released,,1,2020-09-27T13:01:09.449718-05:00,"Surgery, NOS",Initial Diagnosis,
HCM-CSHL-0159-C18,f404fc66-9398-4c2a-a336-993cd326c3ae,9ce5ac65-29f5-4c90-a0fb-edcaa8429502,,Neoadjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0159-C18_treatment,73d252dc-aa2e-4512-a413-8214cc0614bd,,released,,0,2020-09-27T13:01:09.449718-05:00,,,
HCM-BROD-0044-C15,f46b774a-59ce-437a-a8bc-7e6a6a05b45f,abb661c5-a89b-4473-9b0f-5b0ede319d53,,Neoadjuvant,21.0,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0044-C15_treatment,18d8e684-f997-401d-a2ed-ef8fee64732a,,released,Oxaliplatin,1,2019-04-04T15:58:15.647741-05:00,Chemotherapy,,
HCM-BROD-0044-C15,f46b774a-59ce-437a-a8bc-7e6a6a05b45f,abb661c5-a89b-4473-9b0f-5b0ede319d53,,Neoadjuvant,21.0,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0044-C15_treatment2,1ec06c27-0431-4646-bdc0-5accd100e30b,,released,Fluorouracil,1,2019-04-04T15:58:15.647741-05:00,Chemotherapy,,
HCM-BROD-0044-C15,f46b774a-59ce-437a-a8bc-7e6a6a05b45f,abb661c5-a89b-4473-9b0f-5b0ede319d53,77.0,Adjuvant,21.0,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0044-C15_treatment11,206a4384-4ddb-4005-b90a-8ba280f4450e,,released,Trastuzumab,1,2020-09-27T10:14:46.615222-05:00,Targeted Molecular Therapy,Residual Disease,
HCM-BROD-0044-C15,f46b774a-59ce-437a-a8bc-7e6a6a05b45f,abb661c5-a89b-4473-9b0f-5b0ede319d53,77.0,Adjuvant,21.0,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0044-C15_treatment5,305670cc-f9a9-4f67-bd11-2cde287d42b9,,released,Cisplatin,1,2019-04-04T15:58:15.647741-05:00,Chemotherapy,Residual Disease,
HCM-BROD-0044-C15,f46b774a-59ce-437a-a8bc-7e6a6a05b45f,abb661c5-a89b-4473-9b0f-5b0ede319d53,,,,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0044-C15_treatment10,39dfc940-24ad-4021-b1dd-98f9743f9f22,,released,,0,2020-09-27T10:14:46.615222-05:00,"Surgery, NOS",Initial Diagnosis,
HCM-BROD-0044-C15,f46b774a-59ce-437a-a8bc-7e6a6a05b45f,abb661c5-a89b-4473-9b0f-5b0ede319d53,77.0,Adjuvant,21.0,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0044-C15_treatment6,5ef7bc92-887e-4ed3-b1c2-7e1eadc5703e,,released,,1,2019-04-04T15:58:15.647741-05:00,Chemotherapy,Residual Disease,CF
HCM-BROD-0044-C15,f46b774a-59ce-437a-a8bc-7e6a6a05b45f,abb661c5-a89b-4473-9b0f-5b0ede319d53,244.0,Adjuvant,244.0,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0044-C15_treatment8,6ff5ebd2-8abd-4577-86c4-512d94b0b067,,released,Paclitaxel,1,2019-04-04T15:58:15.647741-05:00,Chemotherapy,Residual Disease,
HCM-BROD-0044-C15,f46b774a-59ce-437a-a8bc-7e6a6a05b45f,abb661c5-a89b-4473-9b0f-5b0ede319d53,,Neoadjuvant,21.0,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0044-C15_treatment3,7a2b99d5-dd58-4874-a070-1afd394c778d,,released,Leucovorin,1,2019-04-04T15:58:15.647741-05:00,Chemotherapy,,
HCM-BROD-0044-C15,f46b774a-59ce-437a-a8bc-7e6a6a05b45f,abb661c5-a89b-4473-9b0f-5b0ede319d53,302.0,Adjuvant,244.0,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0044-C15_treatment12,9bc1388d-a45b-4333-b662-60c7834c5b89,,released,Ramucirumab,1,2020-09-27T10:14:46.615222-05:00,Targeted Molecular Therapy,Residual Disease,
HCM-BROD-0044-C15,f46b774a-59ce-437a-a8bc-7e6a6a05b45f,abb661c5-a89b-4473-9b0f-5b0ede319d53,77.0,Adjuvant,21.0,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0044-C15_treatment7,a9a68824-37dd-4c98-82b9-692ac67b9eda,,released,Leucovorin,1,2019-04-04T15:58:15.647741-05:00,Chemotherapy,Residual Disease,
HCM-BROD-0044-C15,f46b774a-59ce-437a-a8bc-7e6a6a05b45f,abb661c5-a89b-4473-9b0f-5b0ede319d53,,Adjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0044-C15_treatment13,b12f998c-5d9e-4939-bcf5-0abb454513b4,,released,,0,2020-09-27T10:14:46.615222-05:00,"Radiation Therapy, NOS",Residual Disease,
HCM-BROD-0044-C15,f46b774a-59ce-437a-a8bc-7e6a6a05b45f,abb661c5-a89b-4473-9b0f-5b0ede319d53,,Adjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0044-C15_treatment9,bf2362f4-e171-4dd0-aef0-a1cf77fa71b8,,released,,0,2019-04-04T15:58:15.647741-05:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-BROD-0044-C15,f46b774a-59ce-437a-a8bc-7e6a6a05b45f,abb661c5-a89b-4473-9b0f-5b0ede319d53,77.0,Adjuvant,21.0,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0044-C15_treatment4,e026b9f0-1eec-4814-a10e-de1e292d3c07,,released,Fluorouracil,1,2019-04-04T15:58:15.647741-05:00,Chemotherapy,Residual Disease,
HCM-CSHL-0384-D37,f49e41f1-ab0a-4e6e-9780-2acdb94fa820,6061595a-508a-4c1c-b9fb-58e3c78404f8,,Neoadjuvant,,2021-03-03T15:15:08.075155-06:00,HCM-CSHL-0384-D37_treatment,01d4d65e-3262-484b-b103-c9a6e493f615,,released,,0,2020-06-15T13:37:25.219265-05:00,,,
HCM-CSHL-0384-D37,f49e41f1-ab0a-4e6e-9780-2acdb94fa820,6061595a-508a-4c1c-b9fb-58e3c78404f8,,,58.0,2023-03-13T13:30:15.724271-05:00,HCM-CSHL-0384-D37_treatment2,7ba33c42-90a8-4baa-96fd-d5802f2eb988,,released,,1,2020-06-15T13:37:25.219265-05:00,"Surgery, NOS",Initial Diagnosis,
HCM-CSHL-0384-D37,f49e41f1-ab0a-4e6e-9780-2acdb94fa820,6061595a-508a-4c1c-b9fb-58e3c78404f8,,Adjuvant,,2023-03-13T13:30:15.724271-05:00,HCM-CSHL-0384-D37_treatment4,a7b21a35-3b33-448d-b0ea-62e3ed9c8ee5,,released,,0,2020-06-15T13:37:25.219265-05:00,"Radiation Therapy, NOS",Residual Disease,
HCM-CSHL-0384-D37,f49e41f1-ab0a-4e6e-9780-2acdb94fa820,6061595a-508a-4c1c-b9fb-58e3c78404f8,,Adjuvant,,2023-03-13T13:30:15.724271-05:00,HCM-CSHL-0384-D37_treatment3,abdb8749-28f8-4ae9-b480-ec125c259fce,,released,,0,2020-06-15T13:37:25.219265-05:00,"Pharmaceutical Therapy, NOS",Residual Disease,
HCM-BROD-0596-C43,f4a7b060-1b0f-4408-b481-7009df25f1ad,7077ffcc-0b3f-4b6f-9f35-2211180e28ec,,Adjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0596-C43_treatment3,71899c4c-8915-4c9a-b8e3-5001415a071f,,released,,0,2021-12-21T13:40:29.663121-06:00,Hormone Therapy,Residual Disease,
HCM-BROD-0596-C43,f4a7b060-1b0f-4408-b481-7009df25f1ad,7077ffcc-0b3f-4b6f-9f35-2211180e28ec,,Adjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0596-C43_treatment7,a635348b-7167-4591-abd7-c9a6bac2a965,,released,,0,2021-12-21T13:40:29.663121-06:00,"Radiation Therapy, NOS",Residual Disease,
HCM-BROD-0596-C43,f4a7b060-1b0f-4408-b481-7009df25f1ad,7077ffcc-0b3f-4b6f-9f35-2211180e28ec,,Adjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0596-C43_treatment6,ba7c72cd-1f96-4b03-97c8-21e39ea140ae,,released,,0,2021-12-21T13:40:29.663121-06:00,Targeted Molecular Therapy,Residual Disease,
HCM-BROD-0596-C43,f4a7b060-1b0f-4408-b481-7009df25f1ad,7077ffcc-0b3f-4b6f-9f35-2211180e28ec,,Adjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0596-C43_treatment2,c5cf4160-85d1-4018-b464-890ffcd72faa,,released,,0,2021-12-21T13:40:29.663121-06:00,Chemotherapy,Residual Disease,
HCM-BROD-0596-C43,f4a7b060-1b0f-4408-b481-7009df25f1ad,7077ffcc-0b3f-4b6f-9f35-2211180e28ec,,Neoadjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0596-C43_treatment,e493c4ef-037c-4e14-8738-1b87f63580b9,,released,,0,2021-12-21T13:40:29.663121-06:00,,,
HCM-BROD-0596-C43,f4a7b060-1b0f-4408-b481-7009df25f1ad,7077ffcc-0b3f-4b6f-9f35-2211180e28ec,727.0,Adjuvant,14.0,2025-03-31T16:34:59.906497-05:00,HCM-BROD-0596-C43_treatment4,e5994dfd-ae22-4f38-bb51-da3d51c23fce,Treatment Ongoing,released,Pembrolizumab,1,2021-12-21T13:40:29.663121-06:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-CSHL-0699-C56,f58c43fb-3ed2-4efa-b212-be47475b0717,57d8d44d-4375-42e7-9aac-66490c38512a,,Adjuvant,,2025-08-20T09:56:36.143985-05:00,HCM-CSHL-0699-C56_treatment5,af6310aa-81a3-4168-b898-5b3e7bb31828,,released,,0,2021-12-21T14:18:24.617675-06:00,"Radiation Therapy, NOS",Residual Disease,
HCM-CSHL-0699-C56,f58c43fb-3ed2-4efa-b212-be47475b0717,57d8d44d-4375-42e7-9aac-66490c38512a,,Neoadjuvant,,2025-08-20T09:56:36.143985-05:00,HCM-CSHL-0699-C56_treatment2,b56ca659-9ef6-4a63-bbb8-8588da4a2741,,released,,unknown,2021-12-21T14:18:24.617675-06:00,"Radiation Therapy, NOS",,
HCM-CSHL-0699-C56,f58c43fb-3ed2-4efa-b212-be47475b0717,57d8d44d-4375-42e7-9aac-66490c38512a,,,0.0,2025-08-20T09:56:36.143985-05:00,HCM-CSHL-0699-C56_treatment3,e09d3113-c73a-4044-9888-9e4ebf4d0836,,released,,1,2021-12-21T14:18:24.617675-06:00,"Surgery, NOS",Initial Diagnosis,
HCM-CSHL-0699-C56,f58c43fb-3ed2-4efa-b212-be47475b0717,57d8d44d-4375-42e7-9aac-66490c38512a,,Adjuvant,,2025-08-20T09:56:36.143985-05:00,HCM-CSHL-0699-C56_treatment4,e94e2a48-bc57-4d68-bc77-928e023541dc,,released,,0,2021-12-21T14:18:24.617675-06:00,"Pharmaceutical Therapy, NOS",Residual Disease,
HCM-CSHL-0699-C56,f58c43fb-3ed2-4efa-b212-be47475b0717,57d8d44d-4375-42e7-9aac-66490c38512a,,Neoadjuvant,,2025-08-20T09:56:36.143985-05:00,HCM-CSHL-0699-C56_treatment,f94bf6c1-1a39-4587-ab18-96e915b3cfa2,,released,,unknown,2021-12-21T14:18:24.617675-06:00,"Pharmaceutical Therapy, NOS",,
HCM-WCMC-1340-C54,f59aaafe-c04e-44f3-9937-89bef164494a,98d71b77-caa5-4b7b-ae4c-fbb3d91b60ff,345.0,Adjuvant,282.0,2025-04-07T17:13:09.336794-05:00,HCM-WCMC-1340-C54_treatment6,1f0ca36b-e78e-4ff9-8e52-284f73029379,Treatment Ongoing,released,Pembrolizumab,1,2023-02-27T12:10:31.607589-06:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-WCMC-1340-C54,f59aaafe-c04e-44f3-9937-89bef164494a,98d71b77-caa5-4b7b-ae4c-fbb3d91b60ff,115.0,Adjuvant,105.0,2025-04-07T17:13:09.336794-05:00,HCM-WCMC-1340-C54_treatment10,250ed23c-5a49-4270-97b5-ac943574f3af,,released,,1,2023-02-27T12:10:31.607589-06:00,"Brachytherapy, High Dose",Residual Disease,
HCM-WCMC-1340-C54,f59aaafe-c04e-44f3-9937-89bef164494a,98d71b77-caa5-4b7b-ae4c-fbb3d91b60ff,140.0,Adjuvant,35.0,2025-04-07T17:13:09.336794-05:00,HCM-WCMC-1340-C54_treatment2,330df09b-f051-4737-886a-8524b206d53a,,released,Carboplatin,1,2023-02-27T12:10:31.607589-06:00,Chemotherapy,Residual Disease,
HCM-WCMC-1340-C54,f59aaafe-c04e-44f3-9937-89bef164494a,98d71b77-caa5-4b7b-ae4c-fbb3d91b60ff,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-WCMC-1340-C54_treatment9,332bdf08-3f59-4c8d-b1d4-364d94f7720e,,released,,0,2023-02-27T12:10:31.607589-06:00,Targeted Molecular Therapy,Residual Disease,
HCM-WCMC-1340-C54,f59aaafe-c04e-44f3-9937-89bef164494a,98d71b77-caa5-4b7b-ae4c-fbb3d91b60ff,,,15.0,2025-04-07T17:13:09.336794-05:00,HCM-WCMC-1340-C54_treatment8,6989a6a2-3595-4179-97a0-2f8ae6e313a1,,released,,1,2023-02-27T12:10:31.607589-06:00,"Surgery, NOS",Initial Diagnosis,
HCM-WCMC-1340-C54,f59aaafe-c04e-44f3-9937-89bef164494a,98d71b77-caa5-4b7b-ae4c-fbb3d91b60ff,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-WCMC-1340-C54_treatment4,73572a3b-4e8a-401d-a6eb-1dc9a2f6b8ce,,released,,0,2023-02-27T12:10:31.607589-06:00,Hormone Therapy,Residual Disease,
HCM-WCMC-1340-C54,f59aaafe-c04e-44f3-9937-89bef164494a,98d71b77-caa5-4b7b-ae4c-fbb3d91b60ff,140.0,Adjuvant,35.0,2025-04-07T17:13:09.336794-05:00,HCM-WCMC-1340-C54_treatment3,7a44b03a-1480-4bc1-8777-de563faa3add,,released,Paclitaxel,1,2023-02-27T12:10:31.607589-06:00,Chemotherapy,Residual Disease,
HCM-WCMC-1340-C54,f59aaafe-c04e-44f3-9937-89bef164494a,98d71b77-caa5-4b7b-ae4c-fbb3d91b60ff,,Neoadjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-WCMC-1340-C54_treatment,abddb515-21fa-4c0a-a3e0-34b92f5ae81e,,released,,0,2023-02-27T12:10:31.607589-06:00,,,
HCM-WCMC-1340-C54,f59aaafe-c04e-44f3-9937-89bef164494a,98d71b77-caa5-4b7b-ae4c-fbb3d91b60ff,345.0,Adjuvant,282.0,2025-04-07T17:13:09.336794-05:00,HCM-WCMC-1340-C54_treatment5,ae828c06-97fd-4b82-8030-c5e1ebdb1bc7,Treatment Ongoing,released,Lenvatinib,1,2023-02-27T12:10:31.607589-06:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-WCMC-1340-C54,f59aaafe-c04e-44f3-9937-89bef164494a,98d71b77-caa5-4b7b-ae4c-fbb3d91b60ff,345.0,Adjuvant,282.0,2025-04-07T17:13:09.336794-05:00,HCM-WCMC-1340-C54_treatment7,cf7f2d7e-8c93-49a1-9ff1-0bec5e0108ac,Treatment Ongoing,released,,1,2023-02-27T12:10:31.607589-06:00,Immunotherapy (Including Vaccines),Residual Disease,Lenvatinib-Pembrolizumab regimen
HCM-CSHL-0838-C18,f5a13bb2-47f3-499d-b33f-b1caeb5e928b,787d19e7-940b-491c-9100-5192149e5586,1134.0,Adjuvant,1092.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0838-C18_treatment6,0ea4afa6-de58-4b25-8db7-b76d61c0b082,,released,Fluorouracil,1,2021-12-21T14:33:58.982147-06:00,Chemotherapy,Residual Disease,
HCM-CSHL-0838-C18,f5a13bb2-47f3-499d-b33f-b1caeb5e928b,787d19e7-940b-491c-9100-5192149e5586,967.0,Adjuvant,905.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0838-C18_treatment4,1125a5ff-8f34-4f23-bf23-56f088ef191f,,released,Leucovorin,1,2021-12-21T14:33:58.982147-06:00,Chemotherapy,Residual Disease,
HCM-CSHL-0838-C18,f5a13bb2-47f3-499d-b33f-b1caeb5e928b,787d19e7-940b-491c-9100-5192149e5586,1134.0,Adjuvant,1092.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0838-C18_treatment11,25d554fa-e517-4f11-94dd-d568b5c3ef85,,released,Bevacizumab,1,2021-12-21T14:33:58.982147-06:00,Targeted Molecular Therapy,Residual Disease,
HCM-CSHL-0838-C18,f5a13bb2-47f3-499d-b33f-b1caeb5e928b,787d19e7-940b-491c-9100-5192149e5586,,,1.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0838-C18_treatment9,45a218d6-eb8d-4868-83a0-df8e811c84c6,,released,,1,2021-12-21T14:33:58.982147-06:00,"Surgery, NOS",Initial Diagnosis,
HCM-CSHL-0838-C18,f5a13bb2-47f3-499d-b33f-b1caeb5e928b,787d19e7-940b-491c-9100-5192149e5586,,Neoadjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0838-C18_treatment,624700cd-128a-4da8-ae80-25e808ce857a,,released,,0,2021-12-21T14:33:58.982147-06:00,,,
HCM-CSHL-0838-C18,f5a13bb2-47f3-499d-b33f-b1caeb5e928b,787d19e7-940b-491c-9100-5192149e5586,230.0,Adjuvant,54.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0838-C18_treatment2,641eaa33-58e7-46e4-b28b-f6f567fa2adf,,released,Capecitabine,1,2021-12-21T14:33:58.982147-06:00,Chemotherapy,Residual Disease,
HCM-CSHL-0838-C18,f5a13bb2-47f3-499d-b33f-b1caeb5e928b,787d19e7-940b-491c-9100-5192149e5586,1134.0,Adjuvant,1092.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0838-C18_treatment7,7bd2b895-3136-4670-b9e1-96aa55f632ab,,released,Leucovorin,1,2021-12-21T14:33:58.982147-06:00,Chemotherapy,Residual Disease,
HCM-CSHL-0838-C18,f5a13bb2-47f3-499d-b33f-b1caeb5e928b,787d19e7-940b-491c-9100-5192149e5586,967.0,Adjuvant,905.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0838-C18_treatment5,8e1d06d0-886a-4f1a-b5c7-89545c67b59e,,released,Oxaliplatin,1,2021-12-21T14:33:58.982147-06:00,Chemotherapy,Residual Disease,
HCM-CSHL-0838-C18,f5a13bb2-47f3-499d-b33f-b1caeb5e928b,787d19e7-940b-491c-9100-5192149e5586,967.0,Adjuvant,905.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0838-C18_treatment3,abe3bfec-c1dc-45bb-8507-fcf71bf02ef7,,released,Fluorouracil,1,2021-12-21T14:33:58.982147-06:00,Chemotherapy,Residual Disease,
HCM-CSHL-0838-C18,f5a13bb2-47f3-499d-b33f-b1caeb5e928b,787d19e7-940b-491c-9100-5192149e5586,,,1008.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0838-C18_treatment10,d78fb8dd-632d-479b-8489-17900e8560a7,,released,,1,2021-12-21T14:33:58.982147-06:00,"Surgery, NOS",Initial Diagnosis,
HCM-CSHL-0838-C18,f5a13bb2-47f3-499d-b33f-b1caeb5e928b,787d19e7-940b-491c-9100-5192149e5586,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0838-C18_treatment8,d8fe29cf-063f-4832-9ecb-7811ca3ba93b,,released,,0,2021-12-21T14:33:58.982147-06:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-CSHL-0838-C18,f5a13bb2-47f3-499d-b33f-b1caeb5e928b,787d19e7-940b-491c-9100-5192149e5586,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0838-C18_treatment12,ffb6daf5-a5b9-44e6-851f-99f3690315e9,,released,,0,2021-12-21T14:33:58.982147-06:00,"Radiation Therapy, NOS",Residual Disease,
HCM-CSHL-0838-C18,f5a13bb2-47f3-499d-b33f-b1caeb5e928b,f71bb250-5625-4405-91ac-dceed536e45c,,Maintenance Therapy,,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0838-C18_treatment13,87a02917-9dde-43d4-8ff1-5b0f6b3f0207,Progressive Disease,released,,1,2021-12-21T14:33:58.982147-06:00,,,
HCM-SANG-1300-C18,f5dccb7f-c0c5-4990-9092-6f0875a1fe04,a21977f4-b67d-4b46-82c5-9688710a77f6,,Neoadjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-SANG-1300-C18_treatment,e0114748-5625-4377-97b8-1cc977f35677,,released,,0,2023-02-27T12:05:08.292666-06:00,,,
HCM-CSHL-0182-C25,f6824107-f92f-47fc-930a-cbe3bfe58895,bcf45381-7fbd-4130-85b0-ccf528d1786b,,Neoadjuvant,,2023-02-22T07:39:25.979291-06:00,HCM-CSHL-0182-C25_treatment,94252caf-3988-4d33-9307-9db562a84a5e,,released,,0,2020-09-28T09:14:37.452637-05:00,,,
HCM-CSHL-0182-C25,f6824107-f92f-47fc-930a-cbe3bfe58895,bcf45381-7fbd-4130-85b0-ccf528d1786b,,,-13.0,2023-03-13T12:52:25.738572-05:00,HCM-CSHL-0182-C25_treatment2,d9d458aa-aeb4-4dc1-882c-1bcfd5862f73,,released,,1,2020-09-28T09:14:37.452637-05:00,"Surgery, NOS",Initial Diagnosis,
HCM-CSHL-0729-C18,f6a13511-0819-4219-bc4b-6cb146629f0e,1ac970ad-d196-486b-936f-5576d16ddd6f,,Adjuvant,,2023-02-22T07:39:25.979291-06:00,HCM-CSHL-0729-C18_treatment6,10f5cf33-ef8f-4c46-8c38-67fc5b64e435,,released,,0,2021-12-21T14:19:11.836836-06:00,"Radiation Therapy, NOS",Residual Disease,
HCM-CSHL-0729-C18,f6a13511-0819-4219-bc4b-6cb146629f0e,1ac970ad-d196-486b-936f-5576d16ddd6f,,Adjuvant,,2023-02-22T07:39:25.979291-06:00,HCM-CSHL-0729-C18_treatment5,24841930-5810-4323-9015-470398940a2e,,released,,0,2021-12-21T14:19:11.836836-06:00,Targeted Molecular Therapy,Residual Disease,
HCM-CSHL-0729-C18,f6a13511-0819-4219-bc4b-6cb146629f0e,1ac970ad-d196-486b-936f-5576d16ddd6f,,,39.0,2023-03-13T13:26:46.629546-05:00,HCM-CSHL-0729-C18_treatment4,bb206032-966f-4a3e-a3fb-8d464270785b,,released,,1,2021-12-21T14:19:11.836836-06:00,"Surgery, NOS",Initial Diagnosis,
HCM-CSHL-0729-C18,f6a13511-0819-4219-bc4b-6cb146629f0e,1ac970ad-d196-486b-936f-5576d16ddd6f,,Adjuvant,,2023-02-22T07:39:25.979291-06:00,HCM-CSHL-0729-C18_treatment3,dfc83ae8-ba91-4ae2-b221-7e2c14b26b61,,released,,0,2021-12-21T14:19:11.836836-06:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-CSHL-0729-C18,f6a13511-0819-4219-bc4b-6cb146629f0e,1ac970ad-d196-486b-936f-5576d16ddd6f,157.0,Adjuvant,63.0,2023-02-22T07:39:25.979291-06:00,HCM-CSHL-0729-C18_treatment2,efe90fa5-d09b-4399-b0f6-fb7d0e05ac3c,,released,Capecitabine,1,2021-12-21T14:19:11.836836-06:00,Chemotherapy,Residual Disease,
HCM-CSHL-0729-C18,f6a13511-0819-4219-bc4b-6cb146629f0e,1ac970ad-d196-486b-936f-5576d16ddd6f,,Neoadjuvant,,2023-02-22T07:39:25.979291-06:00,HCM-CSHL-0729-C18_treatment,f1efd112-cc7d-4c33-a2f5-b1d2e5e56f64,,released,,0,2021-12-21T14:19:11.836836-06:00,,,
HCM-BROD-0481-C43,f78051ab-be5e-4d77-953f-df15762e9834,1f79871e-69ed-418c-98d0-a8eb20e1f5a2,,Adjuvant,,2021-07-12T12:25:55.528644-05:00,HCM-BROD-0481-C43_treatment8,1993c4aa-ac39-424b-aba8-ac35dcc794c8,,released,,0,2020-06-15T13:35:43.470739-05:00,Targeted Molecular Therapy,Residual Disease,
HCM-BROD-0481-C43,f78051ab-be5e-4d77-953f-df15762e9834,1f79871e-69ed-418c-98d0-a8eb20e1f5a2,904.0,Adjuvant,716.0,2021-07-12T12:25:55.528644-05:00,HCM-BROD-0481-C43_treatment4,1ba20f7b-c0f8-4e0b-b1fe-801ae9912576,,released,Nab-paclitaxel,1,2020-06-15T13:35:43.470739-05:00,Chemotherapy,Residual Disease,
HCM-BROD-0481-C43,f78051ab-be5e-4d77-953f-df15762e9834,1f79871e-69ed-418c-98d0-a8eb20e1f5a2,,Adjuvant,,2021-07-12T12:25:55.528644-05:00,HCM-BROD-0481-C43_treatment6,257d3d3a-999b-4ee0-8425-2a9ea405c204,,released,,0,2020-06-15T13:35:43.470739-05:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-BROD-0481-C43,f78051ab-be5e-4d77-953f-df15762e9834,1f79871e-69ed-418c-98d0-a8eb20e1f5a2,,Adjuvant,,2021-07-12T12:25:55.528644-05:00,HCM-BROD-0481-C43_treatment9,387457c1-f09f-4cef-8e4f-f4d06ed6becd,,released,,0,2020-10-08T12:09:27.468387-05:00,"Radiation Therapy, NOS",Residual Disease,
HCM-BROD-0481-C43,f78051ab-be5e-4d77-953f-df15762e9834,1f79871e-69ed-418c-98d0-a8eb20e1f5a2,,Adjuvant,,2021-07-12T12:25:55.528644-05:00,HCM-BROD-0481-C43_treatment5,759c976a-6748-49ea-badd-97049ea3ed91,,released,,0,2020-06-15T13:35:43.470739-05:00,Hormone Therapy,Residual Disease,
HCM-BROD-0481-C43,f78051ab-be5e-4d77-953f-df15762e9834,1f79871e-69ed-418c-98d0-a8eb20e1f5a2,904.0,Adjuvant,716.0,2021-07-12T12:25:55.528644-05:00,HCM-BROD-0481-C43_treatment3,a67172bb-c302-4579-a4c5-4523465425ef,,released,Carboplatin,1,2020-06-15T13:35:43.470739-05:00,Chemotherapy,Residual Disease,
HCM-BROD-0481-C43,f78051ab-be5e-4d77-953f-df15762e9834,91e19c15-b38d-4769-882b-e9f588dfadb8,904.0,Maintenance Therapy,716.0,2021-07-12T12:25:55.528644-05:00,HCM-BROD-0481-C43_treatment10,68d38616-5ea5-474e-abf1-01733b9590e5,Not Reported,released,Carboplatin,1,2020-06-15T13:35:43.470739-05:00,,,
HCM-BROD-0481-C43,f78051ab-be5e-4d77-953f-df15762e9834,91e19c15-b38d-4769-882b-e9f588dfadb8,904.0,Maintenance Therapy,716.0,2021-07-12T12:25:55.528644-05:00,HCM-BROD-0481-C43_treatment11,f960ee5e-2083-4fd7-b1ac-8264c1876a91,Not Reported,released,Nab-paclitaxel,1,2020-10-08T12:09:27.468387-05:00,,,
HCM-SANG-1088-C18,f78c8d62-a481-4539-8f27-ab681c86b90d,2592c914-f518-4447-a559-cc2a77c6c3d8,,Neoadjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-SANG-1088-C18_treatment,57dee9fb-e513-4d67-804a-d9ca83de59b3,,released,,1,2023-02-27T11:35:00.679212-06:00,Hormone Therapy,,
HCM-EXPT-0977-C25,f7947194-42ae-4c80-b539-3acf8ca5ca53,c6f6ded3-fc0e-4860-bc0b-2e0ece58778b,,Neoadjuvant,,2025-10-08T12:37:21.548354-05:00,HCM-EXPT-0977-C25_treatment3,1eedf91e-e18b-4da5-bb25-37c5f073ddd3,,released,Fluorouracil,1,2021-12-21T14:48:58.805252-06:00,Chemotherapy,,
HCM-EXPT-0977-C25,f7947194-42ae-4c80-b539-3acf8ca5ca53,c6f6ded3-fc0e-4860-bc0b-2e0ece58778b,,Neoadjuvant,,2025-10-08T12:37:21.548354-05:00,HCM-EXPT-0977-C25_treatment2,b5c43c29-2657-4f40-b743-102c2481f433,,released,Leucovorin Calcium,1,2021-12-21T14:48:58.805252-06:00,Chemotherapy,,
HCM-EXPT-0977-C25,f7947194-42ae-4c80-b539-3acf8ca5ca53,c6f6ded3-fc0e-4860-bc0b-2e0ece58778b,,Neoadjuvant,,2025-10-08T12:37:21.548354-05:00,HCM-EXPT-0977-C25_treatment5,ef74a423-39f2-4aa9-9a17-549f474d3e3c,,released,,1,2021-12-21T14:48:58.805252-06:00,Chemotherapy,,FOLFIRINOX
HCM-EXPT-0977-C25,f7947194-42ae-4c80-b539-3acf8ca5ca53,c6f6ded3-fc0e-4860-bc0b-2e0ece58778b,,Neoadjuvant,,2025-10-08T12:37:21.548354-05:00,HCM-EXPT-0977-C25_treatment4,f84a9404-db98-4ce6-a69b-3ad17eb16e73,,released,Oxaliplatin,1,2021-12-21T14:48:58.805252-06:00,Chemotherapy,,
HCM-EXPT-0977-C25,f7947194-42ae-4c80-b539-3acf8ca5ca53,c6f6ded3-fc0e-4860-bc0b-2e0ece58778b,,Neoadjuvant,,2025-10-08T12:37:21.548354-05:00,HCM-EXPT-0977-C25_treatment,fb0056f9-a821-48be-be35-be6a4f6e786a,,released,Irinotecan Hydrochloride,1,2021-12-21T14:48:58.805252-06:00,Chemotherapy,,
HCM-EXPT-1018-C50,f7cabc6b-5cbd-4d90-aa7d-10619f564df4,22efe57f-d6ad-469f-8022-335b1ba5b495,,Neoadjuvant,,2025-10-08T12:37:43.816130-05:00,HCM-EXPT-1018-C50_treatment2,14496b90-451c-4f2c-a915-5f1327448051,,released,,1,2021-12-21T14:56:19.020701-06:00,"Radiation Therapy, NOS",,
HCM-EXPT-1018-C50,f7cabc6b-5cbd-4d90-aa7d-10619f564df4,22efe57f-d6ad-469f-8022-335b1ba5b495,,Neoadjuvant,,2025-10-08T12:37:43.816130-05:00,HCM-EXPT-1018-C50_treatment,29edc052-c96d-43d4-9a46-92608267315d,,released,,1,2021-12-21T14:56:19.020701-06:00,Hormone Therapy,,
HCM-EXPT-0995-C50,f82259c2-23e4-4868-9b89-7f56ffbeea05,feb451a7-0d8e-4b1e-bb31-72947f661d29,,Neoadjuvant,,2025-10-08T12:37:21.548354-05:00,HCM-EXPT-0995-C50_treatment,9baebf17-e06d-498f-90f7-cc714a58a3de,,released,,0,2021-12-21T14:52:24.082692-06:00,,,
HCM-SANG-0308-C15,f8825237-31c7-4b78-8743-efb0bd917688,43888acd-6ba0-4048-b74a-8b4fc19125cc,,Neoadjuvant,259.0,2023-03-13T13:04:59.363716-05:00,HCM-SANG-0308-C15_treatment3,16eaf0b5-d5c9-420f-8987-ed420098af1c,,released,Cisplatin,1,2020-11-11T09:37:09.393821-06:00,Chemotherapy,,
HCM-SANG-0308-C15,f8825237-31c7-4b78-8743-efb0bd917688,43888acd-6ba0-4048-b74a-8b4fc19125cc,,Neoadjuvant,259.0,2023-03-13T13:04:59.363716-05:00,HCM-SANG-0308-C15_treatment4,517e08eb-96cf-450f-a338-9f0509e37001,,released,,1,2020-11-11T09:37:09.393821-06:00,Chemotherapy,,ECX
HCM-SANG-0308-C15,f8825237-31c7-4b78-8743-efb0bd917688,43888acd-6ba0-4048-b74a-8b4fc19125cc,,Neoadjuvant,259.0,2023-03-13T13:04:59.363716-05:00,HCM-SANG-0308-C15_treatment2,a7b38a9d-fc5d-498b-8a0d-a1364fad96a8,,released,Capecitabine,1,2020-11-11T09:37:09.393821-06:00,Chemotherapy,,
HCM-SANG-0308-C15,f8825237-31c7-4b78-8743-efb0bd917688,43888acd-6ba0-4048-b74a-8b4fc19125cc,,Neoadjuvant,259.0,2023-03-13T13:04:59.363716-05:00,HCM-SANG-0308-C15_treatment,b4db5784-5b14-4d0a-a7c7-598e7e6db2e7,,released,Epirubicin,1,2020-06-15T13:44:35.761439-05:00,Chemotherapy,,
HCM-SANG-0308-C15,f8825237-31c7-4b78-8743-efb0bd917688,43888acd-6ba0-4048-b74a-8b4fc19125cc,,Neoadjuvant,259.0,2023-03-13T13:04:59.363716-05:00,HCM-SANG-0308-C15_treatment5,f01e8e31-4d2d-4f6f-b384-d8d3623cd619,,released,Leucovorin,1,2021-08-26T15:04:10.604151-05:00,Chemotherapy,,
HCM-SANG-0265-C18,f8a9aab0-6017-483d-b053-9393c6a5af2d,6727e9d1-b102-4e47-b7ae-6e85817f07d9,,Neoadjuvant,,2023-02-22T07:39:25.979291-06:00,HCM-SANG-0265-C18_treatment,fb586d2d-a661-4c01-b06b-1ae983ba3e0c,,released,,0,2021-12-21T15:06:36.188518-06:00,,,
HCM-CSHL-0875-C67,f8c9dead-9a29-44a3-9680-794bf660b383,23a87f65-2a71-447d-85cd-67042a2f7489,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0875-C67_treatment5,7ba88f62-fc08-49df-bdb9-b866d68817eb,,released,,0,2021-12-21T14:36:52.971512-06:00,"Radiation Therapy, NOS",Residual Disease,
HCM-CSHL-0875-C67,f8c9dead-9a29-44a3-9680-794bf660b383,23a87f65-2a71-447d-85cd-67042a2f7489,,Neoadjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0875-C67_treatment,a8ee6e71-f7a4-41d0-8462-50f483bac4f1,,released,Cisplatin,1,2021-12-21T14:36:52.971512-06:00,Chemotherapy,,
HCM-CSHL-0875-C67,f8c9dead-9a29-44a3-9680-794bf660b383,23a87f65-2a71-447d-85cd-67042a2f7489,,,0.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0875-C67_treatment3,afd6f3fa-44b9-4600-aa9a-17ba3eea29eb,,released,,1,2021-12-21T14:36:52.971512-06:00,"Surgery, NOS",Initial Diagnosis,
HCM-CSHL-0875-C67,f8c9dead-9a29-44a3-9680-794bf660b383,23a87f65-2a71-447d-85cd-67042a2f7489,,Neoadjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0875-C67_treatment2,d2e2ba41-6ac1-4613-aaee-d163deefadff,,released,Gemcitabine,1,2021-12-21T14:36:52.971512-06:00,Chemotherapy,,
HCM-CSHL-0875-C67,f8c9dead-9a29-44a3-9680-794bf660b383,23a87f65-2a71-447d-85cd-67042a2f7489,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0875-C67_treatment4,de820766-a512-44da-9f32-97de0f6c2691,,released,,0,2021-12-21T14:36:52.971512-06:00,"Pharmaceutical Therapy, NOS",Residual Disease,
HCM-CSHL-0812-C54,f8e8fead-4979-4c49-9285-02dcbcda974a,68a1cadc-25be-4f60-8803-6faf52f016db,135.0,Adjuvant,121.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0812-C54_treatment4,85171ec5-0587-4137-abcd-0aa985cdc3f3,,released,,1,2021-12-21T14:28:53.477306-06:00,"Brachytherapy, High Dose",Residual Disease,
HCM-CSHL-0812-C54,f8e8fead-4979-4c49-9285-02dcbcda974a,68a1cadc-25be-4f60-8803-6faf52f016db,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0812-C54_treatment3,d100ec58-31e5-4d32-b6c7-f97d9fc03146,,released,,0,2021-12-21T14:28:53.477306-06:00,"Pharmaceutical Therapy, NOS",Residual Disease,
HCM-CSHL-0812-C54,f8e8fead-4979-4c49-9285-02dcbcda974a,68a1cadc-25be-4f60-8803-6faf52f016db,,Neoadjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0812-C54_treatment,f5169339-ff2a-43ca-831d-5cc5047e866a,,released,,0,2021-12-21T14:28:53.477306-06:00,,,
HCM-CSHL-0812-C54,f8e8fead-4979-4c49-9285-02dcbcda974a,68a1cadc-25be-4f60-8803-6faf52f016db,,,0.0,2025-04-07T17:13:09.336794-05:00,HCM-CSHL-0812-C54_treatment2,f891e3f3-af24-499d-87f2-7ffef0e751be,,released,,1,2021-12-21T14:28:53.477306-06:00,"Surgery, NOS",Initial Diagnosis,
HCM-CSHL-0438-C18,f9301129-b7a7-4a42-ba05-27b9a30421fe,f745ab09-615e-43c8-8687-cdc737d5306f,,Neoadjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0438-C18_treatment,2ac6b6d4-d234-4350-a469-5c9497b5b659,,released,,0,2020-09-28T10:11:47.790068-05:00,,,
HCM-CSHL-0438-C18,f9301129-b7a7-4a42-ba05-27b9a30421fe,f745ab09-615e-43c8-8687-cdc737d5306f,,Adjuvant,48.0,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0438-C18_treatment3,65f851a6-dc5a-4792-8963-5a51723533d5,,released,Oxaliplatin,1,2020-09-28T10:11:47.790068-05:00,Chemotherapy,Residual Disease,
HCM-CSHL-0438-C18,f9301129-b7a7-4a42-ba05-27b9a30421fe,f745ab09-615e-43c8-8687-cdc737d5306f,,Adjuvant,48.0,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0438-C18_treatment2,b6ea65c7-9f86-4e4b-a98f-adbcb88c4f87,,released,Capecitabine,1,2020-09-28T10:11:47.790068-05:00,Chemotherapy,Residual Disease,
HCM-CSHL-0438-C18,f9301129-b7a7-4a42-ba05-27b9a30421fe,f745ab09-615e-43c8-8687-cdc737d5306f,,,11.0,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0438-C18_treatment5,ee2563ea-bb50-4984-9ee0-04185da00745,,released,,1,2020-09-28T10:11:47.790068-05:00,"Surgery, NOS",Initial Diagnosis,
HCM-CSHL-0438-C18,f9301129-b7a7-4a42-ba05-27b9a30421fe,f745ab09-615e-43c8-8687-cdc737d5306f,,Adjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0438-C18_treatment7,f9b452fa-7cee-4c33-a668-f085ca5179af,,released,,0,2020-09-28T10:11:47.790068-05:00,"Radiation Therapy, NOS",Residual Disease,
HCM-BROD-0235-C16,f97b6ab3-1169-4856-bd0a-139104b6c5ab,04806eb9-727b-48a5-af52-17a6228ea802,,,,2023-02-27T12:29:44.782136-06:00,HCM-BROD-0235-C16_treatment6,24c86ebb-5dce-4433-993c-385826814b57,,released,,0,2020-04-21T15:06:51.547280-05:00,"Surgery, NOS",Initial Diagnosis,
HCM-BROD-0235-C16,f97b6ab3-1169-4856-bd0a-139104b6c5ab,04806eb9-727b-48a5-af52-17a6228ea802,204.0,Adjuvant,63.0,2020-10-20T20:46:30.021349-05:00,HCM-BROD-0235-C16_treatment4,46d4a0db-4622-467b-9a0f-1ffb2fe5fcc4,,released,Oxaliplatin,1,2020-04-21T15:06:51.547280-05:00,Chemotherapy,Residual Disease,
HCM-BROD-0235-C16,f97b6ab3-1169-4856-bd0a-139104b6c5ab,04806eb9-727b-48a5-af52-17a6228ea802,204.0,Adjuvant,75.0,2020-10-20T20:46:30.021349-05:00,HCM-BROD-0235-C16_treatment7,7876e1aa-9803-474a-9738-d2d73a6cbdca,,released,Nivolumab,1,2020-04-21T15:06:51.547280-05:00,Targeted Molecular Therapy,Residual Disease,
HCM-BROD-0235-C16,f97b6ab3-1169-4856-bd0a-139104b6c5ab,04806eb9-727b-48a5-af52-17a6228ea802,,Adjuvant,,2020-10-20T20:46:30.021349-05:00,HCM-BROD-0235-C16_treatment5,8fcab9ff-be03-4731-84ac-098308166d1d,,released,,0,2020-04-21T15:06:51.547280-05:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-BROD-0235-C16,f97b6ab3-1169-4856-bd0a-139104b6c5ab,04806eb9-727b-48a5-af52-17a6228ea802,204.0,Adjuvant,63.0,2020-10-20T20:46:30.021349-05:00,HCM-BROD-0235-C16_treatment3,99717c15-45e8-4811-8b85-84cee0a6b683,,released,Leucovorin,1,2020-04-21T15:06:51.547280-05:00,Chemotherapy,Residual Disease,
HCM-BROD-0235-C16,f97b6ab3-1169-4856-bd0a-139104b6c5ab,04806eb9-727b-48a5-af52-17a6228ea802,,Adjuvant,,2020-10-20T20:46:30.021349-05:00,HCM-BROD-0235-C16_treatment8,a738d19c-cd0a-4040-b1aa-588046972c49,,released,,0,2020-04-21T15:06:51.547280-05:00,"Radiation Therapy, NOS",Residual Disease,
HCM-BROD-0235-C16,f97b6ab3-1169-4856-bd0a-139104b6c5ab,04806eb9-727b-48a5-af52-17a6228ea802,,Neoadjuvant,,2020-10-20T20:46:30.021349-05:00,HCM-BROD-0235-C16_treatment,c4e410dc-b373-443c-9786-33ac3428b7d1,,released,,1,2019-04-04T15:44:41.255868-05:00,Chemotherapy,,
HCM-BROD-0235-C16,f97b6ab3-1169-4856-bd0a-139104b6c5ab,04806eb9-727b-48a5-af52-17a6228ea802,204.0,Adjuvant,63.0,2020-10-20T20:46:30.021349-05:00,HCM-BROD-0235-C16_treatment2,c7c4d4dc-d67e-46c4-a2e1-5d355b80c11c,,released,Fluorouracil,1,2020-04-21T15:06:51.547280-05:00,Chemotherapy,Residual Disease,
HCM-EXPT-1038-C50,f9b191c8-60b1-49ee-bd4b-e45be987f59d,a1c6b446-1120-4211-ba88-30ea388622c9,,Neoadjuvant,,2025-10-08T12:38:06.952582-05:00,HCM-EXPT-1038-C50_treatment,12103c63-d394-4d93-9c42-d56a1b1037b4,,released,Letrozole,1,2021-12-21T14:59:43.218383-06:00,Hormone Therapy,,
HCM-CSHL-0241-C18,f9d5bd26-816b-4aaa-809f-19d4b8d74692,d248f41f-ea20-4327-9797-313ebad28042,,,28.0,2023-03-13T13:13:37.997721-05:00,HCM-CSHL-0241-C18_treatment2,10c155b5-4876-4009-90f4-827827af9b80,,released,,1,2021-11-01T07:57:33.689000-05:00,"Surgery, NOS",Initial Diagnosis,
HCM-CSHL-0241-C18,f9d5bd26-816b-4aaa-809f-19d4b8d74692,d248f41f-ea20-4327-9797-313ebad28042,,Adjuvant,,2023-03-13T13:13:37.997721-05:00,HCM-CSHL-0241-C18_treatment4,1a8adf90-f08d-4d4e-9e6e-b2102275ee9f,,released,,0,2021-11-01T07:57:33.689000-05:00,"Radiation Therapy, NOS",Residual Disease,
HCM-CSHL-0241-C18,f9d5bd26-816b-4aaa-809f-19d4b8d74692,d248f41f-ea20-4327-9797-313ebad28042,,Adjuvant,,2023-03-13T13:13:37.997721-05:00,HCM-CSHL-0241-C18_treatment3,5484ab56-ceea-4649-853c-0d1f9738c7b0,,released,,0,2021-11-01T07:57:33.689000-05:00,"Pharmaceutical Therapy, NOS",Residual Disease,
HCM-CSHL-0241-C18,f9d5bd26-816b-4aaa-809f-19d4b8d74692,d248f41f-ea20-4327-9797-313ebad28042,,Neoadjuvant,,2023-02-22T07:39:25.979291-06:00,HCM-CSHL-0241-C18_treatment,57c305a4-e8c6-4f64-98c8-e4bcc93437bd,,released,,0,2021-11-01T07:57:33.689000-05:00,,,
HCM-BROD-0035-C49,fa30fc7f-90b6-4ca0-93b6-1351eae9dfc8,c1bd4b1f-e245-45bd-8569-9ebb5a5afeab,,Neoadjuvant,63.0,2021-07-12T12:25:55.528644-05:00,HCM-BROD-0035-C49_treatment,0c37e225-3890-41ae-a427-bb29f0362cd6,,released,Cyclophosphamide,1,2020-06-15T12:57:49.021995-05:00,Chemotherapy,,
HCM-BROD-0035-C49,fa30fc7f-90b6-4ca0-93b6-1351eae9dfc8,c1bd4b1f-e245-45bd-8569-9ebb5a5afeab,,Adjuvant,,2021-07-12T12:25:55.528644-05:00,HCM-BROD-0035-C49_treatment10,2744938e-bfcf-47e2-ba78-9fd696a6c3d9,,released,,0,2020-06-15T12:57:49.021995-05:00,Hormone Therapy,Residual Disease,
HCM-BROD-0035-C49,fa30fc7f-90b6-4ca0-93b6-1351eae9dfc8,c1bd4b1f-e245-45bd-8569-9ebb5a5afeab,543.0,Adjuvant,510.0,2021-07-12T12:25:55.528644-05:00,HCM-BROD-0035-C49_treatment7,2f53fa4b-f370-47cc-9bfc-a55a79186634,,released,Gemcitabine Hydrochloride,1,2020-06-15T12:57:49.021995-05:00,Chemotherapy,Residual Disease,
HCM-BROD-0035-C49,fa30fc7f-90b6-4ca0-93b6-1351eae9dfc8,c1bd4b1f-e245-45bd-8569-9ebb5a5afeab,,Neoadjuvant,63.0,2021-07-12T12:25:55.528644-05:00,HCM-BROD-0035-C49_treatment4,502eb18a-adbb-4f8f-83d0-c2fcc2c5fd5a,,released,Doxorubicin,1,2020-06-15T12:57:49.021995-05:00,Chemotherapy,,
HCM-BROD-0035-C49,fa30fc7f-90b6-4ca0-93b6-1351eae9dfc8,c1bd4b1f-e245-45bd-8569-9ebb5a5afeab,,Neoadjuvant,63.0,2021-07-12T12:25:55.528644-05:00,HCM-BROD-0035-C49_treatment3,6c2157ff-782e-4d2e-99fc-ed6c758188d9,,released,Vincristine,1,2020-06-15T12:57:49.021995-05:00,Chemotherapy,,
HCM-BROD-0035-C49,fa30fc7f-90b6-4ca0-93b6-1351eae9dfc8,c1bd4b1f-e245-45bd-8569-9ebb5a5afeab,,Adjuvant,,2021-07-12T12:25:55.528644-05:00,HCM-BROD-0035-C49_treatment14,6e50da32-159d-4cd5-ae70-b219b7520c9b,,released,,0,2020-09-30T12:47:19.711789-05:00,"Radiation Therapy, NOS",Residual Disease,
HCM-BROD-0035-C49,fa30fc7f-90b6-4ca0-93b6-1351eae9dfc8,c1bd4b1f-e245-45bd-8569-9ebb5a5afeab,,Neoadjuvant,63.0,2021-07-12T12:25:55.528644-05:00,HCM-BROD-0035-C49_treatment5,85aebd88-5a05-4be8-9507-7ac025a839ac,,released,Etoposide,1,2020-06-15T12:57:49.021995-05:00,Targeted Molecular Therapy,,
HCM-BROD-0035-C49,fa30fc7f-90b6-4ca0-93b6-1351eae9dfc8,c1bd4b1f-e245-45bd-8569-9ebb5a5afeab,543.0,Adjuvant,510.0,2021-07-12T12:25:55.528644-05:00,HCM-BROD-0035-C49_treatment8,9eb1c860-3421-48b8-ac1e-44ba8b19394a,,released,Docetaxel,1,2020-06-15T12:57:49.021995-05:00,Chemotherapy,Residual Disease,
HCM-BROD-0035-C49,fa30fc7f-90b6-4ca0-93b6-1351eae9dfc8,c1bd4b1f-e245-45bd-8569-9ebb5a5afeab,588.0,Adjuvant,557.0,2021-07-12T12:25:55.528644-05:00,HCM-BROD-0035-C49_treatment9,a18d73a6-89ba-4481-b266-0667f4637c40,,released,Vinorelbine Tartrate,1,2020-06-15T12:57:49.021995-05:00,Chemotherapy,Residual Disease,
HCM-BROD-0035-C49,fa30fc7f-90b6-4ca0-93b6-1351eae9dfc8,c1bd4b1f-e245-45bd-8569-9ebb5a5afeab,516.0,Adjuvant,449.0,2021-07-12T12:25:55.528644-05:00,HCM-BROD-0035-C49_treatment6,b1beb77c-558a-478b-a13b-83de237346a5,,released,Cyclophosphamide,1,2020-06-15T12:57:49.021995-05:00,Chemotherapy,Residual Disease,
HCM-BROD-0035-C49,fa30fc7f-90b6-4ca0-93b6-1351eae9dfc8,c1bd4b1f-e245-45bd-8569-9ebb5a5afeab,,Neoadjuvant,63.0,2021-07-12T12:25:55.528644-05:00,HCM-BROD-0035-C49_treatment2,bc645740-bf82-4cc5-8576-f8f500c04dfb,,released,Ifosfamide,1,2020-06-15T12:57:49.021995-05:00,Chemotherapy,,
HCM-BROD-0035-C49,fa30fc7f-90b6-4ca0-93b6-1351eae9dfc8,c1bd4b1f-e245-45bd-8569-9ebb5a5afeab,,,,2023-02-27T13:30:48.835679-06:00,HCM-BROD-0035-C49_treatment12,c1ef79f6-888a-4f37-896f-3f4b1dc32b53,,released,,0,2020-09-30T12:47:19.711789-05:00,"Surgery, NOS",Initial Diagnosis,
HCM-BROD-0035-C49,fa30fc7f-90b6-4ca0-93b6-1351eae9dfc8,c1bd4b1f-e245-45bd-8569-9ebb5a5afeab,,Adjuvant,,2021-07-12T12:25:55.528644-05:00,HCM-BROD-0035-C49_treatment11,cb85b318-0053-41d9-b9c4-f43ced1c47ad,,released,,0,2020-06-15T12:57:49.021995-05:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-BROD-0035-C49,fa30fc7f-90b6-4ca0-93b6-1351eae9dfc8,c1bd4b1f-e245-45bd-8569-9ebb5a5afeab,,Adjuvant,,2021-07-12T12:25:55.528644-05:00,HCM-BROD-0035-C49_treatment13,e8f186fa-e997-4346-a24b-44b01b9313ab,,released,,0,2020-09-30T12:47:19.711789-05:00,Targeted Molecular Therapy,Residual Disease,
HCM-SANG-0309-C15,fa48edba-622f-46e0-ad24-d3da0166abf3,1dbfd825-3343-4337-a69d-39af4aca9a57,,Neoadjuvant,,2023-07-13T10:35:44.371881-05:00,HCM-SANG-0309-C15_treatment,6113bb65-1542-4977-920d-b887a1cf1974,,released,,0,2021-12-21T15:11:00.372640-06:00,,,
HCM-EXPT-1168-C43,fa5791ff-50c5-4344-a9b5-df2db51f4c15,b4d363b7-4d9d-4a89-8b23-e93feb7beb73,,Neoadjuvant,,2025-10-08T12:38:28.988690-05:00,HCM-EXPT-1168-C43_treatment,c63b27b8-11bc-4689-acd3-c4f0a84688b6,,released,,1,2021-12-21T15:05:19.307364-06:00,Immunotherapy (Including Vaccines),,
HCM-CSHL-0737-C18,fa7bc307-cfc5-4aea-85ce-27a4d73c9766,18f454e3-45d2-4110-93a4-a57c056941bc,548.0,Maintenance Therapy,478.0,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0737-C18_treatment14,02638f5d-8ad4-4e90-97cd-74777880dc5e,Stable Disease,released,,1,2021-12-21T14:21:10.517705-06:00,,,FOLFOX
HCM-CSHL-0737-C18,fa7bc307-cfc5-4aea-85ce-27a4d73c9766,18f454e3-45d2-4110-93a4-a57c056941bc,548.0,Maintenance Therapy,478.0,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0737-C18_treatment11,76333b60-ca4d-493e-b1ca-babc9aa7b745,Stable Disease,released,Leucovorin Calcium,1,2021-12-21T14:21:10.517705-06:00,,,
HCM-CSHL-0737-C18,fa7bc307-cfc5-4aea-85ce-27a4d73c9766,18f454e3-45d2-4110-93a4-a57c056941bc,548.0,Maintenance Therapy,478.0,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0737-C18_treatment13,9f368702-101a-466e-9075-977dee092d0a,Stable Disease,released,Oxaliplatin,1,2021-12-21T14:21:10.517705-06:00,,,
HCM-CSHL-0737-C18,fa7bc307-cfc5-4aea-85ce-27a4d73c9766,18f454e3-45d2-4110-93a4-a57c056941bc,548.0,Maintenance Therapy,478.0,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0737-C18_treatment12,a21d0ea1-e03b-4afa-9f6b-8f0d76dd8a0f,Stable Disease,released,Fluorouracil,1,2021-12-21T14:21:10.517705-06:00,,,
HCM-CSHL-0737-C18,fa7bc307-cfc5-4aea-85ce-27a4d73c9766,9b297dc6-678d-4560-8990-7a6dc2bab480,,Adjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0737-C18_treatment6,399352bb-c7f9-4217-b263-b0777569e932,,released,,0,2021-12-21T14:21:10.517705-06:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-CSHL-0737-C18,fa7bc307-cfc5-4aea-85ce-27a4d73c9766,9b297dc6-678d-4560-8990-7a6dc2bab480,,,9.0,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0737-C18_treatment7,3dde5ee0-f3ae-4f79-a327-f0e2365e7fe8,,released,,1,2021-12-21T14:21:10.517705-06:00,"Surgery, NOS",Initial Diagnosis,
HCM-CSHL-0737-C18,fa7bc307-cfc5-4aea-85ce-27a4d73c9766,9b297dc6-678d-4560-8990-7a6dc2bab480,518.0,Adjuvant,457.0,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0737-C18_treatment4,3df00c57-d796-4dd8-b218-d5becd7959db,,released,Oxaliplatin,1,2021-12-21T14:21:10.517705-06:00,Chemotherapy,Residual Disease,
HCM-CSHL-0737-C18,fa7bc307-cfc5-4aea-85ce-27a4d73c9766,9b297dc6-678d-4560-8990-7a6dc2bab480,,Adjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0737-C18_treatment10,732459bf-da27-48dd-b31c-036b62f43a81,,released,,0,2021-12-21T14:21:10.517705-06:00,"Radiation Therapy, NOS",Residual Disease,
HCM-CSHL-0737-C18,fa7bc307-cfc5-4aea-85ce-27a4d73c9766,9b297dc6-678d-4560-8990-7a6dc2bab480,,,769.0,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0737-C18_treatment8,925aad4f-f2c9-4f73-ae13-5a565aae0eff,,released,,1,2021-12-21T14:21:10.517705-06:00,"Surgery, NOS",Initial Diagnosis,
HCM-CSHL-0737-C18,fa7bc307-cfc5-4aea-85ce-27a4d73c9766,9b297dc6-678d-4560-8990-7a6dc2bab480,518.0,Adjuvant,457.0,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0737-C18_treatment5,a939a2c9-4ef0-41a1-afbc-4a7d0eeed544,,released,,1,2021-12-21T14:21:10.517705-06:00,Chemotherapy,Residual Disease,FOLFOX
HCM-CSHL-0737-C18,fa7bc307-cfc5-4aea-85ce-27a4d73c9766,9b297dc6-678d-4560-8990-7a6dc2bab480,,Adjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0737-C18_treatment9,aced2022-a948-48c5-80df-5d3109a1851a,,released,,0,2021-12-21T14:21:10.517705-06:00,Targeted Molecular Therapy,Residual Disease,
HCM-CSHL-0737-C18,fa7bc307-cfc5-4aea-85ce-27a4d73c9766,9b297dc6-678d-4560-8990-7a6dc2bab480,,Neoadjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0737-C18_treatment,c1ddace3-25b2-47fe-832e-ae3cbcc0cb7f,,released,,0,2021-12-21T14:21:10.517705-06:00,,,
HCM-CSHL-0737-C18,fa7bc307-cfc5-4aea-85ce-27a4d73c9766,9b297dc6-678d-4560-8990-7a6dc2bab480,518.0,Adjuvant,457.0,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0737-C18_treatment3,cf398759-57f4-4df3-9591-27bbec8bc47a,,released,Fluorouracil,1,2021-12-21T14:21:10.517705-06:00,Chemotherapy,Residual Disease,
HCM-CSHL-0737-C18,fa7bc307-cfc5-4aea-85ce-27a4d73c9766,9b297dc6-678d-4560-8990-7a6dc2bab480,518.0,Adjuvant,457.0,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0737-C18_treatment2,cf71ea85-78de-491c-a916-597401c5ccd6,,released,Leucovorin Calcium,1,2021-12-21T14:21:10.517705-06:00,Chemotherapy,Residual Disease,
HCM-BROD-0040-C74,faf9731f-8d64-45d6-8bfc-7d5183243904,4ff1d038-c925-431c-9372-bab866082f37,,Adjuvant,0.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0040-C74_treatment3,149ed310-306a-4133-88bb-b80810c677d9,,released,Vincristine,1,2021-12-21T13:35:53.703486-06:00,Chemotherapy,Residual Disease,
HCM-BROD-0040-C74,faf9731f-8d64-45d6-8bfc-7d5183243904,4ff1d038-c925-431c-9372-bab866082f37,,Adjuvant,31.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0040-C74_treatment4,1b312d1e-11ef-4187-8286-9619fff7fa5e,,released,Etoposide,1,2021-12-21T13:35:53.703486-06:00,Chemotherapy,Residual Disease,
HCM-BROD-0040-C74,faf9731f-8d64-45d6-8bfc-7d5183243904,4ff1d038-c925-431c-9372-bab866082f37,,Adjuvant,31.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0040-C74_treatment5,35937362-09bd-44b8-9c79-0fbb9a1f72f9,,released,Cisplatin,1,2021-12-21T13:35:53.703486-06:00,Chemotherapy,Residual Disease,
HCM-BROD-0040-C74,faf9731f-8d64-45d6-8bfc-7d5183243904,4ff1d038-c925-431c-9372-bab866082f37,,Adjuvant,92.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0040-C74_treatment7,4f20b847-8552-45e2-ab18-e095af9b23da,,released,Dinutuximab,1,2021-12-21T13:35:53.703486-06:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-BROD-0040-C74,faf9731f-8d64-45d6-8bfc-7d5183243904,4ff1d038-c925-431c-9372-bab866082f37,,Adjuvant,273.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0040-C74_treatment10,9b08e6c3-bb44-42c4-8a8c-b4cf4a46ab61,,released,,1,2021-12-21T13:35:53.703486-06:00,"Radiation, Proton Beam",Residual Disease,
HCM-BROD-0040-C74,faf9731f-8d64-45d6-8bfc-7d5183243904,4ff1d038-c925-431c-9372-bab866082f37,,Neoadjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0040-C74_treatment,9b7392a9-613d-4d08-b491-c294c9be314a,,released,,0,2021-12-21T13:35:53.703486-06:00,,,
HCM-BROD-0040-C74,faf9731f-8d64-45d6-8bfc-7d5183243904,4ff1d038-c925-431c-9372-bab866082f37,,Adjuvant,,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0040-C74_treatment9,de57c4d0-f80b-4d39-afe1-fb3052442e99,,released,,0,2021-12-21T13:35:53.703486-06:00,Targeted Molecular Therapy,Residual Disease,
HCM-BROD-0040-C74,faf9731f-8d64-45d6-8bfc-7d5183243904,4ff1d038-c925-431c-9372-bab866082f37,,Adjuvant,45.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0040-C74_treatment6,ee442199-fc55-460c-95aa-29f2b60d3110,,released,Doxorubicin Hydrochloride,1,2021-12-21T13:35:53.703486-06:00,Chemotherapy,Residual Disease,
HCM-BROD-0040-C74,faf9731f-8d64-45d6-8bfc-7d5183243904,4ff1d038-c925-431c-9372-bab866082f37,,Adjuvant,0.0,2025-04-07T17:13:09.336794-05:00,HCM-BROD-0040-C74_treatment2,ef8c86ec-1f68-4a0d-bee6-8ec194b33a88,,released,Cyclophosphamide,1,2021-12-21T13:35:53.703486-06:00,Chemotherapy,Residual Disease,
HCM-BROD-0677-C43,fb3cac25-28e3-4677-868a-0e4ba6703dee,631d2ccb-3581-4fbd-a044-f59d964cfe25,,Adjuvant,,2023-02-22T07:39:25.979291-06:00,HCM-BROD-0677-C43_treatment4,2d59d78d-5a20-4220-ad27-ab18e6e3f6aa,,released,,0,2021-12-03T10:09:41.415545-06:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-BROD-0677-C43,fb3cac25-28e3-4677-868a-0e4ba6703dee,631d2ccb-3581-4fbd-a044-f59d964cfe25,,Neoadjuvant,,2023-02-22T07:39:25.979291-06:00,HCM-BROD-0677-C43_treatment,4b455b40-2e90-49a4-a8db-7a848e10be59,,released,,0,2021-12-03T10:09:41.415545-06:00,,,
HCM-BROD-0677-C43,fb3cac25-28e3-4677-868a-0e4ba6703dee,631d2ccb-3581-4fbd-a044-f59d964cfe25,1464.0,Adjuvant,1464.0,2023-02-22T07:39:25.979291-06:00,HCM-BROD-0677-C43_treatment7,5e647bf7-ddd0-4ba6-a162-1028240ad84a,,released,,1,2021-12-03T10:09:41.415545-06:00,"Radiation Therapy, NOS",Residual Disease,
HCM-BROD-0677-C43,fb3cac25-28e3-4677-868a-0e4ba6703dee,631d2ccb-3581-4fbd-a044-f59d964cfe25,,Adjuvant,,2023-02-22T07:39:25.979291-06:00,HCM-BROD-0677-C43_treatment6,62696c12-03a4-4103-96cd-001b4462c3bd,,released,,0,2021-12-03T10:09:41.415545-06:00,Targeted Molecular Therapy,Residual Disease,
HCM-BROD-0677-C43,fb3cac25-28e3-4677-868a-0e4ba6703dee,631d2ccb-3581-4fbd-a044-f59d964cfe25,,,0.0,2023-02-27T13:04:24.346596-06:00,HCM-BROD-0677-C43_treatment5,62ce96d0-0fe5-41c8-a9ac-85d18566141f,,released,,1,2021-12-03T10:09:41.415545-06:00,"Surgery, NOS",Initial Diagnosis,
HCM-BROD-0677-C43,fb3cac25-28e3-4677-868a-0e4ba6703dee,631d2ccb-3581-4fbd-a044-f59d964cfe25,,Adjuvant,,2023-02-22T07:39:25.979291-06:00,HCM-BROD-0677-C43_treatment3,6e66e386-a5e6-4231-adb8-bb594e2f016b,,released,,0,2021-12-03T10:09:41.415545-06:00,Hormone Therapy,Residual Disease,
HCM-BROD-0677-C43,fb3cac25-28e3-4677-868a-0e4ba6703dee,631d2ccb-3581-4fbd-a044-f59d964cfe25,,Adjuvant,,2023-02-22T07:39:25.979291-06:00,HCM-BROD-0677-C43_treatment2,7a49844a-61ee-4dc1-a24b-a43853dc3d7e,,released,,0,2021-12-03T10:09:41.415545-06:00,Chemotherapy,Residual Disease,
HCM-CSHL-0094-C25,fb50c60e-d191-474b-a5eb-19b922db6688,e7d33624-4934-4338-b98c-7a99c86cc861,,Adjuvant,,2020-10-20T19:20:06.800740-05:00,HCM-CSHL-0094-C25_treatment5,44a451ca-d614-4bb8-b686-0ae244ff2e35,,released,,0,2020-02-27T12:46:31.996700-06:00,Targeted Molecular Therapy,Residual Disease,
HCM-CSHL-0094-C25,fb50c60e-d191-474b-a5eb-19b922db6688,e7d33624-4934-4338-b98c-7a99c86cc861,,,-9.0,2023-02-27T11:58:06.820840-06:00,HCM-CSHL-0094-C25_treatment4,561b2ef1-26ce-4263-baaa-8ab04464022a,,released,,1,2020-02-27T12:46:31.996700-06:00,"Surgery, NOS",Initial Diagnosis,
HCM-CSHL-0094-C25,fb50c60e-d191-474b-a5eb-19b922db6688,e7d33624-4934-4338-b98c-7a99c86cc861,228.0,Adjuvant,18.0,2020-10-20T19:20:06.800740-05:00,HCM-CSHL-0094-C25_treatment2,8bd1ff21-dfb9-4282-bedc-e325e4a5ea87,,released,Gemcitabine,1,2020-02-27T12:46:31.996700-06:00,Chemotherapy,Residual Disease,
HCM-CSHL-0094-C25,fb50c60e-d191-474b-a5eb-19b922db6688,e7d33624-4934-4338-b98c-7a99c86cc861,,Neoadjuvant,,2020-10-20T19:20:06.800740-05:00,HCM-CSHL-0094-C25_treatment,975d366b-df00-4764-92c6-4ec494b5e45e,,released,,0,2020-02-27T12:46:31.996700-06:00,,,
HCM-CSHL-0094-C25,fb50c60e-d191-474b-a5eb-19b922db6688,e7d33624-4934-4338-b98c-7a99c86cc861,,Adjuvant,,2020-10-20T19:20:06.800740-05:00,HCM-CSHL-0094-C25_treatment3,b55f4565-15de-417b-baf6-ff3ee107942a,,released,,0,2020-02-27T12:46:31.996700-06:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-CSHL-0094-C25,fb50c60e-d191-474b-a5eb-19b922db6688,e7d33624-4934-4338-b98c-7a99c86cc861,,Adjuvant,,2020-10-20T19:20:06.800740-05:00,HCM-CSHL-0094-C25_treatment6,f738acaf-26ea-44f8-9761-d9de21944996,,released,,0,2020-02-27T12:46:31.996700-06:00,"Radiation Therapy, NOS",Residual Disease,
HCM-SANG-1336-C15,fb6f7249-7994-4288-8ba8-6b4aeb939f25,eef9acad-b66b-411d-a29a-50ac8ad8c3b6,,Neoadjuvant,105.0,2025-04-07T17:13:09.336794-05:00,HCM-SANG-1336-C15_treatment,19cb0370-0955-42a2-ae85-55a3b3b25bae,,released,Leucovorin,1,2023-02-27T13:15:52.111978-06:00,Chemotherapy,,
HCM-SANG-1336-C15,fb6f7249-7994-4288-8ba8-6b4aeb939f25,eef9acad-b66b-411d-a29a-50ac8ad8c3b6,,Neoadjuvant,105.0,2025-04-07T17:13:09.336794-05:00,HCM-SANG-1336-C15_treatment2,598be0f2-3d57-411e-8f70-221ecfba568e,,released,Fluorouracil,1,2023-02-27T13:15:52.111978-06:00,Chemotherapy,,
HCM-SANG-1336-C15,fb6f7249-7994-4288-8ba8-6b4aeb939f25,eef9acad-b66b-411d-a29a-50ac8ad8c3b6,,Neoadjuvant,105.0,2025-04-07T17:13:09.336794-05:00,HCM-SANG-1336-C15_treatment4,641f10cb-0179-4723-8c90-70a56607fda8,,released,Oxaliplatin,1,2023-02-27T13:15:52.111978-06:00,Chemotherapy,,
HCM-SANG-1336-C15,fb6f7249-7994-4288-8ba8-6b4aeb939f25,eef9acad-b66b-411d-a29a-50ac8ad8c3b6,,Neoadjuvant,105.0,2025-04-07T17:13:09.336794-05:00,HCM-SANG-1336-C15_treatment3,67692449-b5a9-475e-a309-3b9d9dbab06a,,released,Docetaxel,1,2023-02-27T13:15:52.111978-06:00,Chemotherapy,,
HCM-BROD-0579-C16,fc04bbd5-80ec-45a8-9136-6b62f8cca9bf,0c841cd7-ef2a-4770-85cf-9c4a28d23c39,,Neoadjuvant,,2023-07-13T10:35:44.371881-05:00,HCM-BROD-0579-C16_treatment,0e4b3d9b-60df-4f97-8ee8-34e3f1c4373c,,released,,0,2020-10-08T16:18:13.565167-05:00,,,
HCM-BROD-0579-C16,fc04bbd5-80ec-45a8-9136-6b62f8cca9bf,0c841cd7-ef2a-4770-85cf-9c4a28d23c39,,Adjuvant,,2023-07-13T10:35:44.371881-05:00,HCM-BROD-0579-C16_treatment13,19b0533b-ef14-4dcd-833a-394d8b83f842,,released,,0,2020-10-08T16:18:13.565167-05:00,Targeted Molecular Therapy,Residual Disease,
HCM-BROD-0579-C16,fc04bbd5-80ec-45a8-9136-6b62f8cca9bf,0c841cd7-ef2a-4770-85cf-9c4a28d23c39,421.0,Adjuvant,421.0,2023-07-13T10:35:44.371881-05:00,HCM-BROD-0579-C16_treatment9,2950280a-3812-4f7e-a4e8-f084d9500908,,released,,1,2020-10-08T16:18:13.565167-05:00,Chemotherapy,Residual Disease,FOLFIRI
HCM-BROD-0579-C16,fc04bbd5-80ec-45a8-9136-6b62f8cca9bf,0c841cd7-ef2a-4770-85cf-9c4a28d23c39,421.0,Adjuvant,421.0,2023-07-13T10:35:44.371881-05:00,HCM-BROD-0579-C16_treatment8,2a0983ca-92a4-416f-a527-c84ab33f1015,,released,Irinotecan,1,2020-10-08T16:18:13.565167-05:00,Chemotherapy,Residual Disease,
HCM-BROD-0579-C16,fc04bbd5-80ec-45a8-9136-6b62f8cca9bf,0c841cd7-ef2a-4770-85cf-9c4a28d23c39,455.0,Adjuvant,455.0,2023-07-13T10:35:44.371881-05:00,HCM-BROD-0579-C16_treatment10,3f5bfd57-4bac-47c3-b91d-a34bad3bf937,,released,Docetaxel,1,2020-10-08T16:18:13.565167-05:00,Chemotherapy,Residual Disease,
HCM-BROD-0579-C16,fc04bbd5-80ec-45a8-9136-6b62f8cca9bf,0c841cd7-ef2a-4770-85cf-9c4a28d23c39,421.0,Adjuvant,421.0,2023-07-13T10:35:44.371881-05:00,HCM-BROD-0579-C16_treatment6,44404b4e-06e2-45df-b72d-b46cab10a4ee,,released,Leucovorin Calcium,1,2020-10-08T16:18:13.565167-05:00,Chemotherapy,Residual Disease,
HCM-BROD-0579-C16,fc04bbd5-80ec-45a8-9136-6b62f8cca9bf,0c841cd7-ef2a-4770-85cf-9c4a28d23c39,,,0.0,2023-07-13T10:35:44.371881-05:00,HCM-BROD-0579-C16_treatment12,5246fcfa-6ef4-458e-b7c3-e84da93fe3da,,released,,1,2020-10-08T16:18:13.565167-05:00,"Surgery, NOS",Initial Diagnosis,
HCM-BROD-0579-C16,fc04bbd5-80ec-45a8-9136-6b62f8cca9bf,0c841cd7-ef2a-4770-85cf-9c4a28d23c39,406.0,Adjuvant,324.0,2023-07-13T10:35:44.371881-05:00,HCM-BROD-0579-C16_treatment4,6b2085e2-7fc8-473e-b2c2-36420e6701f3,,released,Oxaliplatin,1,2020-10-08T16:18:13.565167-05:00,Chemotherapy,Residual Disease,
HCM-BROD-0579-C16,fc04bbd5-80ec-45a8-9136-6b62f8cca9bf,0c841cd7-ef2a-4770-85cf-9c4a28d23c39,406.0,Adjuvant,324.0,2023-07-13T10:35:44.371881-05:00,HCM-BROD-0579-C16_treatment3,7919fa47-4106-4e39-9ebe-f9d628768c62,,released,Fluorouracil,1,2020-10-08T16:18:13.565167-05:00,Chemotherapy,Residual Disease,
HCM-BROD-0579-C16,fc04bbd5-80ec-45a8-9136-6b62f8cca9bf,0c841cd7-ef2a-4770-85cf-9c4a28d23c39,406.0,Adjuvant,324.0,2023-07-13T10:35:44.371881-05:00,HCM-BROD-0579-C16_treatment5,889fd179-1947-4d00-a59a-226c28138caf,,released,,1,2020-10-08T16:18:13.565167-05:00,Chemotherapy,Residual Disease,FOLFOX
HCM-BROD-0579-C16,fc04bbd5-80ec-45a8-9136-6b62f8cca9bf,0c841cd7-ef2a-4770-85cf-9c4a28d23c39,421.0,Adjuvant,421.0,2023-07-13T10:35:44.371881-05:00,HCM-BROD-0579-C16_treatment7,f08fe438-34bb-41c5-be99-1a10f0171d52,,released,Fluorouracil,1,2020-10-08T16:18:13.565167-05:00,Chemotherapy,Residual Disease,
HCM-BROD-0579-C16,fc04bbd5-80ec-45a8-9136-6b62f8cca9bf,0c841cd7-ef2a-4770-85cf-9c4a28d23c39,,Adjuvant,,2023-07-13T10:35:44.371881-05:00,HCM-BROD-0579-C16_treatment11,f4523b06-d59e-4a79-b092-6448838126c2,,released,,0,2020-10-08T16:18:13.565167-05:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-BROD-0579-C16,fc04bbd5-80ec-45a8-9136-6b62f8cca9bf,0c841cd7-ef2a-4770-85cf-9c4a28d23c39,406.0,Adjuvant,324.0,2023-07-13T10:35:44.371881-05:00,HCM-BROD-0579-C16_treatment2,f604ddd6-1082-4b1f-bb9e-90163cf187f5,,released,Leucovorin Calcium,1,2020-10-08T16:18:13.565167-05:00,Chemotherapy,Residual Disease,
HCM-BROD-0579-C16,fc04bbd5-80ec-45a8-9136-6b62f8cca9bf,4af9bf9e-37d6-435c-9ded-da73584b7c68,421.0,Maintenance Therapy,23.0,2023-07-13T10:35:44.371881-05:00,HCM-BROD-0579-C16_treatment18,34a2e9e7-eb8b-4403-bc9f-2f41b9e51346,Not Reported,released,Leucovorin,1,2020-10-08T16:18:13.565167-05:00,,,
HCM-BROD-0579-C16,fc04bbd5-80ec-45a8-9136-6b62f8cca9bf,4af9bf9e-37d6-435c-9ded-da73584b7c68,421.0,Maintenance Therapy,23.0,2023-07-13T10:35:44.371881-05:00,HCM-BROD-0579-C16_treatment16,445b8544-6d7f-49ce-a7d5-d3002f12d5c3,Not Reported,released,Fluorouracil,1,2020-10-08T16:18:13.565167-05:00,,,
HCM-BROD-0579-C16,fc04bbd5-80ec-45a8-9136-6b62f8cca9bf,4af9bf9e-37d6-435c-9ded-da73584b7c68,421.0,Maintenance Therapy,23.0,2023-07-13T10:35:44.371881-05:00,HCM-BROD-0579-C16_treatment17,4b5083fc-2b7f-4285-a083-8b595537c2e4,Not Reported,released,Oxaliplatin,1,2020-10-08T16:18:13.565167-05:00,,,
HCM-BROD-0579-C16,fc04bbd5-80ec-45a8-9136-6b62f8cca9bf,4af9bf9e-37d6-435c-9ded-da73584b7c68,421.0,Maintenance Therapy,23.0,2023-07-13T10:35:44.371881-05:00,HCM-BROD-0579-C16_treatment19,627396e5-5900-4ca1-a586-64557b828a00,Not Reported,released,,1,2020-10-08T16:18:13.565167-05:00,,,FLOT
HCM-BROD-0579-C16,fc04bbd5-80ec-45a8-9136-6b62f8cca9bf,4af9bf9e-37d6-435c-9ded-da73584b7c68,421.0,Maintenance Therapy,23.0,2023-07-13T10:35:44.371881-05:00,HCM-BROD-0579-C16_treatment15,b75ffefd-6409-4401-9665-6f267056fceb,Not Reported,released,Docetaxel,1,2020-10-08T16:18:13.565167-05:00,,,
HCM-BROD-0579-C16,fc04bbd5-80ec-45a8-9136-6b62f8cca9bf,4af9bf9e-37d6-435c-9ded-da73584b7c68,421.0,Maintenance Therapy,23.0,2023-07-13T10:35:44.371881-05:00,HCM-BROD-0579-C16_treatment20,cb5be656-9377-4510-9381-426d62ce8bee,Not Reported,released,,1,2020-10-08T16:18:13.565167-05:00,,,FOLFOX
HCM-CSHL-0600-C25,fc122a76-4ca2-4f09-94bb-7d0f024a4dad,766972d1-2b67-4184-88a9-4ec0a69d5007,,Adjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0600-C25_treatment6,1f2e3fa0-c429-4a87-8f32-f8327d150275,,released,,0,2021-12-21T14:09:15.630770-06:00,Targeted Molecular Therapy,Residual Disease,
HCM-CSHL-0600-C25,fc122a76-4ca2-4f09-94bb-7d0f024a4dad,766972d1-2b67-4184-88a9-4ec0a69d5007,468.0,Adjuvant,279.0,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0600-C25_treatment3,38d84832-8884-4208-a519-8b023e6d5ecf,,released,Nab-paclitaxel,1,2021-12-21T14:09:15.630770-06:00,Chemotherapy,Residual Disease,
HCM-CSHL-0600-C25,fc122a76-4ca2-4f09-94bb-7d0f024a4dad,766972d1-2b67-4184-88a9-4ec0a69d5007,,Adjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0600-C25_treatment7,751abc3a-ebbf-4797-8627-88b027a82202,,released,,1,2021-12-21T14:09:15.630770-06:00,"Radiation, 2D Conventional",Residual Disease,
HCM-CSHL-0600-C25,fc122a76-4ca2-4f09-94bb-7d0f024a4dad,766972d1-2b67-4184-88a9-4ec0a69d5007,468.0,Adjuvant,279.0,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0600-C25_treatment2,b7cb8296-cc58-4a09-be61-e623182ce308,,released,Gemcitabine,1,2021-12-21T14:09:15.630770-06:00,Chemotherapy,Residual Disease,
HCM-CSHL-0600-C25,fc122a76-4ca2-4f09-94bb-7d0f024a4dad,766972d1-2b67-4184-88a9-4ec0a69d5007,,Adjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0600-C25_treatment4,c617734b-002e-4ac7-a826-88b01303cd2a,,released,,0,2021-12-21T14:09:15.630770-06:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-CSHL-0600-C25,fc122a76-4ca2-4f09-94bb-7d0f024a4dad,766972d1-2b67-4184-88a9-4ec0a69d5007,,,-10.0,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0600-C25_treatment5,e5471702-4277-4c34-b7d8-d4acb738df28,,released,,1,2021-12-21T14:09:15.630770-06:00,"Surgery, NOS",Initial Diagnosis,
HCM-CSHL-0600-C25,fc122a76-4ca2-4f09-94bb-7d0f024a4dad,766972d1-2b67-4184-88a9-4ec0a69d5007,,Neoadjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0600-C25_treatment,f08a9291-6908-49b3-b26e-6c22c297df26,,released,,0,2021-12-21T14:09:15.630770-06:00,,,
HCM-CSHL-0464-C50,fc25bee8-d37a-4bda-9ff3-51fe590e91e8,54b21333-29e2-46bc-9fcc-97a178cf25b0,,,39.0,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0464-C50_treatment2,4fac5a1b-2e12-406e-9ce6-0711fabbb423,,released,,1,2020-09-28T10:18:45.513767-05:00,"Surgery, NOS",Initial Diagnosis,
HCM-CSHL-0464-C50,fc25bee8-d37a-4bda-9ff3-51fe590e91e8,54b21333-29e2-46bc-9fcc-97a178cf25b0,,Adjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0464-C50_treatment4,9904979a-96e1-4a88-b4ae-149cc19f6a46,,released,,0,2020-09-28T10:18:45.513767-05:00,"Radiation Therapy, NOS",Residual Disease,
HCM-CSHL-0464-C50,fc25bee8-d37a-4bda-9ff3-51fe590e91e8,54b21333-29e2-46bc-9fcc-97a178cf25b0,,Adjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0464-C50_treatment3,b06b517d-69e8-4dd9-a5cd-3cf690a5803d,,released,,0,2020-09-28T10:18:45.513767-05:00,"Pharmaceutical Therapy, NOS",Residual Disease,
HCM-CSHL-0464-C50,fc25bee8-d37a-4bda-9ff3-51fe590e91e8,54b21333-29e2-46bc-9fcc-97a178cf25b0,,Neoadjuvant,,2025-03-31T16:34:59.906497-05:00,HCM-CSHL-0464-C50_treatment,db7f56c0-3e11-42d1-8332-02a9f57cb4c7,,released,,0,2020-09-28T10:18:45.513767-05:00,,,
HCM-BROD-0125-C25,fd64b6a9-39e8-4e27-bb73-84110ab0d328,9289315f-f9b8-453f-88a2-63426542aff6,,Neoadjuvant,,2023-02-22T07:39:25.979291-06:00,HCM-BROD-0125-C25_treatment,0e747ee2-cd59-46c1-91e6-cbb47aa8f8b8,,released,,0,2020-09-17T15:57:51.457053-05:00,,,
HCM-BROD-0125-C25,fd64b6a9-39e8-4e27-bb73-84110ab0d328,9289315f-f9b8-453f-88a2-63426542aff6,,Adjuvant,,2023-02-22T07:39:25.979291-06:00,HCM-BROD-0125-C25_treatment8,28b39912-69ab-4fe7-af0b-24ef26a45be7,,released,,0,2020-09-17T15:57:51.457053-05:00,"Radiation Therapy, NOS",Residual Disease,
HCM-BROD-0125-C25,fd64b6a9-39e8-4e27-bb73-84110ab0d328,9289315f-f9b8-453f-88a2-63426542aff6,,Adjuvant,,2023-02-22T07:39:25.979291-06:00,HCM-BROD-0125-C25_treatment7,35e72079-0627-4e8a-98f9-08640e305856,,released,,0,2020-09-17T15:57:51.457053-05:00,Targeted Molecular Therapy,Residual Disease,
HCM-BROD-0125-C25,fd64b6a9-39e8-4e27-bb73-84110ab0d328,9289315f-f9b8-453f-88a2-63426542aff6,,,33.0,2023-02-27T13:32:29.064099-06:00,HCM-BROD-0125-C25_treatment6,3ca54b29-7334-47af-b955-4903020282f6,,released,,1,2020-09-17T15:57:51.457053-05:00,"Surgery, NOS",Initial Diagnosis,
HCM-BROD-0125-C25,fd64b6a9-39e8-4e27-bb73-84110ab0d328,9289315f-f9b8-453f-88a2-63426542aff6,91.0,Adjuvant,70.0,2023-02-22T07:39:25.979291-06:00,HCM-BROD-0125-C25_treatment2,54f89587-e856-44e5-8a6e-2dd681b9f977,,released,Gemcitabine,1,2020-09-17T15:57:51.457053-05:00,Chemotherapy,Residual Disease,
HCM-BROD-0125-C25,fd64b6a9-39e8-4e27-bb73-84110ab0d328,9289315f-f9b8-453f-88a2-63426542aff6,,Adjuvant,,2023-02-22T07:39:25.979291-06:00,HCM-BROD-0125-C25_treatment5,5d167672-cab6-4a58-873c-695e2723e007,,released,,0,2020-09-17T15:57:51.457053-05:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-BROD-0125-C25,fd64b6a9-39e8-4e27-bb73-84110ab0d328,9289315f-f9b8-453f-88a2-63426542aff6,260.0,Adjuvant,140.0,2023-02-22T07:39:25.979291-06:00,HCM-BROD-0125-C25_treatment4,d94ee6cb-8bf3-4ef0-adaa-db7b77e99f0c,,released,Leucovorin,1,2020-09-17T15:57:51.457053-05:00,Chemotherapy,Residual Disease,
HCM-BROD-0125-C25,fd64b6a9-39e8-4e27-bb73-84110ab0d328,9289315f-f9b8-453f-88a2-63426542aff6,260.0,Adjuvant,140.0,2023-02-22T07:39:25.979291-06:00,HCM-BROD-0125-C25_treatment3,f96241a3-a1c6-4448-bd7b-839ecdd919b8,,released,Fluorouracil,1,2020-09-17T15:57:51.457053-05:00,Chemotherapy,Residual Disease,
HCM-BROD-0477-C16,fda02a1d-38f1-4e71-91f9-c58f174605d6,3245d5af-d693-489f-a18f-6f56837c4803,397.0,Adjuvant,214.0,2023-07-13T10:35:44.371881-05:00,HCM-BROD-0477-C16_treatment6,17807a63-e9c8-4b22-a8e5-1082c902fd29,,released,Leucovorin Calcium,1,2021-12-21T13:38:03.263117-06:00,Chemotherapy,Residual Disease,
HCM-BROD-0477-C16,fda02a1d-38f1-4e71-91f9-c58f174605d6,3245d5af-d693-489f-a18f-6f56837c4803,,Neoadjuvant,24.0,2023-07-13T10:35:44.371881-05:00,HCM-BROD-0477-C16_treatment4,1ac1974f-87fa-4c41-b321-b7eade1f08bb,,released,,1,2021-12-21T13:38:03.263117-06:00,Chemotherapy,,FOLFOX
HCM-BROD-0477-C16,fda02a1d-38f1-4e71-91f9-c58f174605d6,3245d5af-d693-489f-a18f-6f56837c4803,,Neoadjuvant,24.0,2023-07-13T10:35:44.371881-05:00,HCM-BROD-0477-C16_treatment3,31cbf734-6e42-48b0-a46f-683b54bf816e,,released,Oxaliplatin,1,2021-12-21T13:38:03.263117-06:00,Chemotherapy,,
HCM-BROD-0477-C16,fda02a1d-38f1-4e71-91f9-c58f174605d6,3245d5af-d693-489f-a18f-6f56837c4803,,,3.0,2023-07-13T10:35:44.371881-05:00,HCM-BROD-0477-C16_treatment11,4414acea-8b3b-4257-a2f3-048de5e88c0a,,released,,1,2021-12-21T13:38:03.263117-06:00,"Surgery, NOS",Initial Diagnosis,
HCM-BROD-0477-C16,fda02a1d-38f1-4e71-91f9-c58f174605d6,3245d5af-d693-489f-a18f-6f56837c4803,,Adjuvant,,2023-07-13T10:35:44.371881-05:00,HCM-BROD-0477-C16_treatment10,5cbbbaee-bf67-4406-828b-241b334dec3b,,released,,0,2021-12-21T13:38:03.263117-06:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-BROD-0477-C16,fda02a1d-38f1-4e71-91f9-c58f174605d6,3245d5af-d693-489f-a18f-6f56837c4803,,Neoadjuvant,24.0,2023-07-13T10:35:44.371881-05:00,HCM-BROD-0477-C16_treatment,65206fff-adc2-458d-8093-f60295227f4d,,released,Leucovorin Calcium,1,2021-12-21T13:38:03.263117-06:00,Chemotherapy,,
HCM-BROD-0477-C16,fda02a1d-38f1-4e71-91f9-c58f174605d6,3245d5af-d693-489f-a18f-6f56837c4803,397.0,Adjuvant,214.0,2023-07-13T10:35:44.371881-05:00,HCM-BROD-0477-C16_treatment12,8d3e3e1a-1ddc-4c15-a90a-aa7f4f4ee7e3,,released,Ramucirumab,1,2021-12-21T13:38:03.263117-06:00,Targeted Molecular Therapy,Residual Disease,
HCM-BROD-0477-C16,fda02a1d-38f1-4e71-91f9-c58f174605d6,3245d5af-d693-489f-a18f-6f56837c4803,,Neoadjuvant,24.0,2023-07-13T10:35:44.371881-05:00,HCM-BROD-0477-C16_treatment5,90b9c789-3c5d-45b8-aee2-154db8f0da25,,released,Ramucirumab,1,2021-12-21T13:38:03.263117-06:00,Targeted Molecular Therapy,,
HCM-BROD-0477-C16,fda02a1d-38f1-4e71-91f9-c58f174605d6,3245d5af-d693-489f-a18f-6f56837c4803,397.0,Adjuvant,214.0,2023-07-13T10:35:44.371881-05:00,HCM-BROD-0477-C16_treatment9,a52736b4-e335-449a-a9bf-3821fa14c2c7,,released,,1,2021-12-21T13:38:03.263117-06:00,Chemotherapy,Residual Disease,FOLFOX
HCM-BROD-0477-C16,fda02a1d-38f1-4e71-91f9-c58f174605d6,3245d5af-d693-489f-a18f-6f56837c4803,397.0,Adjuvant,214.0,2023-07-13T10:35:44.371881-05:00,HCM-BROD-0477-C16_treatment7,ac0f5f8d-4d7d-4428-833a-460c164b161c,,released,Fluorouracil,1,2021-12-21T13:38:03.263117-06:00,Chemotherapy,Residual Disease,
HCM-BROD-0477-C16,fda02a1d-38f1-4e71-91f9-c58f174605d6,3245d5af-d693-489f-a18f-6f56837c4803,,Neoadjuvant,24.0,2023-07-13T10:35:44.371881-05:00,HCM-BROD-0477-C16_treatment2,afdd2595-a67b-4bb0-a30a-aba51aa73685,,released,Fluorouracil,1,2021-12-21T13:38:03.263117-06:00,Chemotherapy,,
HCM-BROD-0477-C16,fda02a1d-38f1-4e71-91f9-c58f174605d6,3245d5af-d693-489f-a18f-6f56837c4803,,Adjuvant,,2023-07-13T10:35:44.371881-05:00,HCM-BROD-0477-C16_treatment13,d819458f-b41f-41fd-8411-23f606436834,,released,,0,2021-12-21T13:38:03.263117-06:00,"Radiation Therapy, NOS",Residual Disease,
HCM-BROD-0477-C16,fda02a1d-38f1-4e71-91f9-c58f174605d6,3245d5af-d693-489f-a18f-6f56837c4803,397.0,Adjuvant,214.0,2023-07-13T10:35:44.371881-05:00,HCM-BROD-0477-C16_treatment8,f3aa5715-9306-467c-b403-4ee42aaac110,,released,Oxaliplatin,1,2021-12-21T13:38:03.263117-06:00,Chemotherapy,Residual Disease,
HCM-SANG-0278-C20,fdc29b73-d788-40f4-8f8d-cef36d100e58,1e224300-d429-4aec-a081-d0080afd075a,,Neoadjuvant,,2023-02-22T07:39:25.979291-06:00,HCM-SANG-0278-C20_treatment,93f1bf2b-4b08-4abb-9c26-8b927b341773,,released,,0,2021-12-21T15:07:09.576986-06:00,,,
HCM-CSHL-0142-C18,fdfd5770-4b64-4d35-b472-9c7908210b22,bd07ba42-e6d2-483b-bc06-d80c53dc7558,,Neoadjuvant,,2020-10-20T19:20:06.800740-05:00,HCM-CSHL-0142-C18_treatment,16140273-7104-47b2-ad94-02d3ae67776c,,released,,0,2020-02-27T12:57:31.266812-06:00,,,
HCM-CSHL-0142-C18,fdfd5770-4b64-4d35-b472-9c7908210b22,bd07ba42-e6d2-483b-bc06-d80c53dc7558,,Adjuvant,,2020-10-20T19:20:06.800740-05:00,HCM-CSHL-0142-C18_treatment6,1cc3b7cf-4661-482f-bb8a-024620126c35,,released,,0,2020-02-27T12:57:31.266812-06:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-CSHL-0142-C18,fdfd5770-4b64-4d35-b472-9c7908210b22,bd07ba42-e6d2-483b-bc06-d80c53dc7558,,,26.0,2023-03-13T13:24:58.015382-05:00,HCM-CSHL-0142-C18_treatment7,52f0cb96-b17d-448e-8667-458e1e588a95,,released,,1,2020-09-27T12:53:56.492882-05:00,"Surgery, NOS",Initial Diagnosis,
HCM-CSHL-0142-C18,fdfd5770-4b64-4d35-b472-9c7908210b22,bd07ba42-e6d2-483b-bc06-d80c53dc7558,250.0,Adjuvant,69.0,2020-10-20T19:20:06.800740-05:00,HCM-CSHL-0142-C18_treatment5,6a48832f-d7f8-4434-bedc-64323513414d,,released,,1,2020-02-27T12:57:31.266812-06:00,Chemotherapy,Residual Disease,FOLFOX
HCM-CSHL-0142-C18,fdfd5770-4b64-4d35-b472-9c7908210b22,bd07ba42-e6d2-483b-bc06-d80c53dc7558,250.0,Adjuvant,69.0,2020-10-20T19:20:06.800740-05:00,HCM-CSHL-0142-C18_treatment2,793e5b5e-cb2d-498b-9d66-8aba6710c7f8,,released,Leucovorin Calcium,1,2020-02-27T12:57:31.266812-06:00,Chemotherapy,Residual Disease,
HCM-CSHL-0142-C18,fdfd5770-4b64-4d35-b472-9c7908210b22,bd07ba42-e6d2-483b-bc06-d80c53dc7558,,Adjuvant,,2020-10-20T19:20:06.800740-05:00,HCM-CSHL-0142-C18_treatment9,aaed4e7a-8cc4-42ed-8cec-7b0157b3baa4,,released,,0,2020-09-27T12:53:56.492882-05:00,"Radiation Therapy, NOS",Residual Disease,
HCM-CSHL-0142-C18,fdfd5770-4b64-4d35-b472-9c7908210b22,bd07ba42-e6d2-483b-bc06-d80c53dc7558,250.0,Adjuvant,69.0,2020-10-20T19:20:06.800740-05:00,HCM-CSHL-0142-C18_treatment3,c06a2669-195a-48f1-8532-a5532cb5922b,,released,Fluorouracil,1,2020-02-27T12:57:31.266812-06:00,Chemotherapy,Residual Disease,
HCM-CSHL-0142-C18,fdfd5770-4b64-4d35-b472-9c7908210b22,bd07ba42-e6d2-483b-bc06-d80c53dc7558,250.0,Adjuvant,69.0,2020-10-20T19:20:06.800740-05:00,HCM-CSHL-0142-C18_treatment4,c9e1b17b-8e52-4fce-8c7b-60d6f85d250e,,released,Oxaliplatin,1,2020-02-27T12:57:31.266812-06:00,Chemotherapy,Residual Disease,
HCM-CSHL-0142-C18,fdfd5770-4b64-4d35-b472-9c7908210b22,bd07ba42-e6d2-483b-bc06-d80c53dc7558,,Adjuvant,,2020-10-20T19:20:06.800740-05:00,HCM-CSHL-0142-C18_treatment8,dbd9c2fe-5d32-47ed-a48c-4357c8420a03,,released,,0,2020-09-27T12:53:56.492882-05:00,Targeted Molecular Therapy,Residual Disease,
HCM-EXPT-1251-C15,fe72b434-4008-4e02-907d-4f32717666bc,37cd869d-2b30-469d-a0af-cf16432446b9,,Neoadjuvant,90.0,2025-10-08T12:39:37.798161-05:00,HCM-EXPT-1251-C15_treatment4,2fa17cca-2b53-4ffd-98f2-bad41f9a31bf,,released,Oxaliplatin,1,2023-02-24T14:02:13.208612-06:00,Chemotherapy,,
HCM-EXPT-1251-C15,fe72b434-4008-4e02-907d-4f32717666bc,37cd869d-2b30-469d-a0af-cf16432446b9,,Neoadjuvant,90.0,2025-10-08T12:39:37.798161-05:00,HCM-EXPT-1251-C15_treatment3,719ba0e6-d578-4834-bde1-b1ee5ba131f8,,released,Docetaxel,1,2023-02-24T14:02:13.208612-06:00,Chemotherapy,,
HCM-EXPT-1251-C15,fe72b434-4008-4e02-907d-4f32717666bc,37cd869d-2b30-469d-a0af-cf16432446b9,,Neoadjuvant,90.0,2025-10-08T12:39:37.798161-05:00,HCM-EXPT-1251-C15_treatment,91c4e516-f8c8-4027-94fe-37134e0596a9,,released,Leucovorin,1,2023-02-24T14:02:13.208612-06:00,Chemotherapy,,
HCM-EXPT-1251-C15,fe72b434-4008-4e02-907d-4f32717666bc,37cd869d-2b30-469d-a0af-cf16432446b9,,Neoadjuvant,90.0,2025-10-08T12:39:37.798161-05:00,HCM-EXPT-1251-C15_treatment2,e7c67f2f-30a2-45b8-bcf4-71b88ee0892d,,released,Fluorouracil,1,2023-02-24T14:02:13.208612-06:00,Chemotherapy,,
HCM-BROD-0115-C16,feaef50b-0e38-4a04-b632-81ae538e1c22,3fd96149-405a-4fb0-8fd7-c9d93cea8ce3,1591.0,Adjuvant,106.0,2023-02-22T07:39:25.979291-06:00,HCM-BROD-0115-C16_treatment8,0c741c56-06a5-4881-8d94-ae0db603e8d2,,released,,1,2020-11-11T10:12:11.090639-06:00,"Radiation, 2D Conventional",Residual Disease,
HCM-BROD-0115-C16,feaef50b-0e38-4a04-b632-81ae538e1c22,3fd96149-405a-4fb0-8fd7-c9d93cea8ce3,1634.0,Adjuvant,1333.0,2023-02-22T07:39:25.979291-06:00,HCM-BROD-0115-C16_treatment5,1b49f943-f970-4163-8809-7eac20282f00,Treatment Ongoing,released,Pembrolizumab,1,2020-11-11T10:12:11.090639-06:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-BROD-0115-C16,feaef50b-0e38-4a04-b632-81ae538e1c22,3fd96149-405a-4fb0-8fd7-c9d93cea8ce3,,,106.0,2023-03-13T13:18:01.500932-05:00,HCM-BROD-0115-C16_treatment6,2c4c33cb-2243-4ffe-9867-6b78bdf74c12,,released,,1,2020-11-11T10:12:11.090639-06:00,"Surgery, NOS",Initial Diagnosis,
HCM-BROD-0115-C16,feaef50b-0e38-4a04-b632-81ae538e1c22,3fd96149-405a-4fb0-8fd7-c9d93cea8ce3,1059.0,Adjuvant,528.0,2023-02-22T07:39:25.979291-06:00,HCM-BROD-0115-C16_treatment4,3cd0bf2b-1000-402d-b34f-43e866627024,,released,Leucovorin,1,2020-11-11T10:12:11.090639-06:00,Chemotherapy,Residual Disease,
HCM-BROD-0115-C16,feaef50b-0e38-4a04-b632-81ae538e1c22,3fd96149-405a-4fb0-8fd7-c9d93cea8ce3,1059.0,Adjuvant,528.0,2023-02-22T07:39:25.979291-06:00,HCM-BROD-0115-C16_treatment3,6e96521b-8dc9-47e7-a85a-2c3f38a19b2a,,released,Fluorouracil,1,2020-11-11T10:12:11.090639-06:00,Chemotherapy,Residual Disease,
HCM-BROD-0115-C16,feaef50b-0e38-4a04-b632-81ae538e1c22,3fd96149-405a-4fb0-8fd7-c9d93cea8ce3,1059.0,Adjuvant,528.0,2023-02-22T07:39:25.979291-06:00,HCM-BROD-0115-C16_treatment7,de56f784-88ce-4227-ad73-d5534ab44a5f,,released,Trastuzumab,1,2020-11-11T10:12:11.090639-06:00,Targeted Molecular Therapy,Residual Disease,
HCM-BROD-0115-C16,feaef50b-0e38-4a04-b632-81ae538e1c22,dba301be-3141-4f4c-a39d-08946bca5dae,1046.0,Maintenance Therapy,486.0,2023-02-22T07:39:25.979291-06:00,HCM-BROD-0115-C16_treatment11,14bb9e3d-70ea-46d4-bc19-1cf30e77c6d6,Progressive Disease,released,Trastuzumab,1,2020-11-11T10:12:11.090639-06:00,,,
HCM-BROD-0115-C16,feaef50b-0e38-4a04-b632-81ae538e1c22,dba301be-3141-4f4c-a39d-08946bca5dae,1046.0,Maintenance Therapy,486.0,2023-02-22T07:39:25.979291-06:00,HCM-BROD-0115-C16_treatment10,167d33af-cdc7-4c0b-9af4-56aa149732da,Progressive Disease,released,Fluorouracil,1,2020-11-11T10:12:11.090639-06:00,,,
HCM-BROD-0115-C16,feaef50b-0e38-4a04-b632-81ae538e1c22,dba301be-3141-4f4c-a39d-08946bca5dae,1046.0,Maintenance Therapy,486.0,2023-02-22T07:39:25.979291-06:00,HCM-BROD-0115-C16_treatment9,188aed77-ee20-4aeb-acae-9f1d824c2c96,Progressive Disease,released,Leucovorin,1,2020-11-11T10:12:11.090639-06:00,,,
HCM-CSHL-0059-C25,fed59220-5e35-439c-ae0b-3dcb1fad165e,a5952feb-b389-44a9-89d3-03c044aed1b9,,Adjuvant,,2023-02-22T07:39:25.979291-06:00,HCM-CSHL-0059-C25_treatment5,2321687b-4130-45ff-b11a-79b705ce1902,,released,,0,2020-09-27T12:32:51.374783-05:00,Immunotherapy (Including Vaccines),Residual Disease,
HCM-CSHL-0059-C25,fed59220-5e35-439c-ae0b-3dcb1fad165e,a5952feb-b389-44a9-89d3-03c044aed1b9,,Neoadjuvant,,2023-02-22T07:39:25.979291-06:00,HCM-CSHL-0059-C25_treatment,44fd015a-ce36-4339-9ab4-dfb7b5bf1ba7,,released,,0,2020-09-27T12:32:51.374783-05:00,,,
HCM-CSHL-0059-C25,fed59220-5e35-439c-ae0b-3dcb1fad165e,a5952feb-b389-44a9-89d3-03c044aed1b9,830.0,Adjuvant,753.0,2023-02-22T07:39:25.979291-06:00,HCM-CSHL-0059-C25_treatment4,8b70d680-4f3a-48aa-a481-4ffacd00add1,,released,Nab-paclitaxel,1,2020-09-27T12:32:51.374783-05:00,Chemotherapy,Residual Disease,
HCM-CSHL-0059-C25,fed59220-5e35-439c-ae0b-3dcb1fad165e,a5952feb-b389-44a9-89d3-03c044aed1b9,318.0,Adjuvant,136.0,2023-02-22T07:39:25.979291-06:00,HCM-CSHL-0059-C25_treatment2,a356ad77-fe90-4979-bc10-5686c55182c3,,released,Gemcitabine,1,2020-09-27T12:32:51.374783-05:00,Chemotherapy,Residual Disease,
HCM-CSHL-0059-C25,fed59220-5e35-439c-ae0b-3dcb1fad165e,a5952feb-b389-44a9-89d3-03c044aed1b9,,Adjuvant,,2023-02-22T07:39:25.979291-06:00,HCM-CSHL-0059-C25_treatment7,d514deb3-d70a-4d10-93de-d2b5fc391937,,released,,0,2020-09-27T12:32:51.374783-05:00,Targeted Molecular Therapy,Residual Disease,
HCM-CSHL-0059-C25,fed59220-5e35-439c-ae0b-3dcb1fad165e,a5952feb-b389-44a9-89d3-03c044aed1b9,,Adjuvant,,2023-02-22T07:39:25.979291-06:00,HCM-CSHL-0059-C25_treatment8,e10a6f6b-e444-4484-8f2f-a72934ea2022,,released,,0,2020-09-27T12:32:51.374783-05:00,"Radiation Therapy, NOS",Residual Disease,
HCM-CSHL-0059-C25,fed59220-5e35-439c-ae0b-3dcb1fad165e,a5952feb-b389-44a9-89d3-03c044aed1b9,,,36.0,2023-02-27T13:10:45.839462-06:00,HCM-CSHL-0059-C25_treatment6,e546a703-eb58-42e5-8914-e57ca52679cc,,released,,1,2020-09-27T12:32:51.374783-05:00,"Surgery, NOS",Initial Diagnosis,
HCM-CSHL-0059-C25,fed59220-5e35-439c-ae0b-3dcb1fad165e,a5952feb-b389-44a9-89d3-03c044aed1b9,830.0,Adjuvant,753.0,2023-02-22T07:39:25.979291-06:00,HCM-CSHL-0059-C25_treatment3,f70496b8-2b2e-4298-9bfd-7ae4d24a1360,,released,Gemcitabine,1,2020-09-27T12:32:51.374783-05:00,Chemotherapy,Residual Disease,
HCM-EXPT-0884-C25,fffe41a6-c74b-4391-a513-2279f03139e9,f044a093-0b9f-4b43-854d-364fff275a1a,,Neoadjuvant,,2025-10-08T12:36:32.654639-05:00,HCM-EXPT-0884-C25_treatment,35d28a90-de1a-4b6c-95cf-fa99249aba39,,released,,0,2021-12-21T15:26:42.615020-06:00,,,
